,category,over_represented_pvalue,under_represented_pvalue,numDEInCat,numInCat,term,ontology,foreground_genes
2590,GO:0005886,7.46873188366138e-14,1,413,2849,plasma membrane,CC,NT5E;SDK2;ADGRL1;SEMA4B;HTRA1;FHL1;SLC16A3;DLG4;MRC2;MARVELD1;EPN3;PRR7;KCNG1;ACVR2B;DOCK4;XPC;PRNP;PARVB;BBS2;FLNC;SLC6A8;TNFRSF6B;WNT7A;APOE;DGKA;TSPAN1;F2R;LRP5;ITGA6;OBSCN;NDRG1;SLCO4A1;ITPR3;PKN1;ARRDC1;NISCH;FCGRT;SH2D5;EGFR;SERPINE2;SCN4B;NOS1;PTPRS;SLC2A9;SPRY2;CAPN2;MST1R;PRSS8;SYTL1;SDC1;ETV5;SHC1;ORAI1;ARL2;SLC7A8;PTPRE;SLC12A7;SLC2A3;RIN1;SNX9;SPRY4;RAPGEF3;GAA;ARAP1;MAP2K2;LPAR3;PLCD3;PTOV1;CSMD2;MAP2K1;SSH1;EXOC2;SLC16A5;KCNJ15;MARCKSL1;TMEM8A;SMURF2;KLC2;SLC9A3R2;SMAD3;SHANK2;LRP1;GJC2;DVL1;HSD17B8;HBEGF;AP2A2;ITGB4;CYBRD1;SHC2;NLGN2;STOM;LY6K;PAG1;ADORA2B;SYT8;SLC6A6;AKT1;TPCN1;GRB7;KCNC4;CORO1B;TTYH3;S100A6;F12;PITPNM1;ENTPD6;RHBDF2;BSG;STK39;ASAP2;DYSF;EPHA1;GGT1;PTPRU;SLC15A4;LRRC8A;CNTN1;IFNGR2;MYZAP;MFSD3;RAB31;FGFR4;PEAR1;FNDC4;LDLR;FGFR1;PRKACB;SIGMAR1;RAC2;KCNAB2;PHF7;SORL1;CEACAM1;LZTS2;RAB11FIP4;TENM2;ANK3;NIPSNAP1;TTC7B;EVC;EFS;SYNGAP1;PLCH2;EDNRA;PLAU;PTK6;FGFBP1;BRI3;RAB3B;CARD11;GSN;IGFBP2;PCSK9;ANO8;BCR;ANTXR2;EHD4;ERRFI1;PRSS22;AIP;SH3D19;SLITRK6;TSPAN18;PAQR6;ALOX15B;SPTB;COL13A1;SLC20A1;NPR2;SNTA1;DGKQ;PLXNB3;MVB12B;CEMIP;PROCR;PKD2;CTSZ;CDC42EP5;CRTC1;IL20RB;GPSM1;AP3D1;ITGB5;ABCA2;C19ORF33;EPOR;EPHB2;GRIN3B;ADAM8;ASIC1;CADM4;GRIP2;GRK6;PLCG1;KIF17;CD81;ENTPD2;SLC29A4;SYNJ2;WNT3;GNAL;TGFB1;SNPH;ABHD17C;SLC43A1;SNTB2;GPC1;NTSR1;B3GNT3;TMEM173;ARHGAP25;ATP7B;SHANK3;PODXL2;SDHA;EFNB3;RASA3;TNFSF15;CLCA2;NSMF;ARAP3;SCART1;FARP1;MC1R;TUB;LCE1E;CROCC;RHOD;ABTB1;ST6GALNAC6;HTR7;PI4K2A;SEMA4F;C1ORF210;RHOF;YIPF3;SLC48A1;LLGL1;PLPP6;RHOBTB2;ADAM19;RIMS3;BBS1;PTPN1;AGRN;CD320;CAMK2N1;LRP4;ESYT2;GPR153;ADAP1;PRKCZ;PRKACA;MINK1;RABGGTA;RCCD1;CD9;ADA;MICALL2;PLEKHG5;ERBB2;ADGRB2;VAMP2;CERCAM;PLEK2;C6ORF89;STK17A;RILPL1;JAK3;RNPEP;NET1;FSCN1;TRPC1;SLC22A17;RASA4;ARHGAP44;PRKCD;CACNB3;IFI6;SV2A;SLC13A5;TRIM4;ITGA1;OLFM2;SH3BP1;GJB4;EREG;TMEM25;PPL;HSD17B7;AHNAK2;RASL10B;FCHO1;TGFBR3;LTB4R2;CPNE7;SLC2A11;DNM1;RGS14;TMEM8B;SCN8A;MSLN;LPCAT1;LRSAM1;ADAM15;REEP2;EHD3;TMEM231;SYMPK;IRAK1;TGFA;INPP5D;PI4K2B;ABCG1;MYO1D;ABCA7;BCAP31;BCAM;SLC9A7;SYNGR1;CD68;SLC22A18;SPPL2B;FYN;RAC3;ICAM5;ARHGAP12;DNM2;ATXN10;CAT;SLC27A1;TPBG;SLC50A1;SLC12A4;ARHGEF4;DDX50;MAPK3;INSR;SLC13A3;RTN2;ARHGEF1;PFKM;ADCY1;HLA-G;ATP8B2;VANGL2;PAK1;MALL;PPP3CB;RNF144A;USP21;GABBR1;SEMA4C;CAPRIN2;ITGA3;SAMD8;BIN1;SRMS;SLC16A13;DLG3;RRAS;LRCH4;MDGA1;ADGRF1;PKD1;TNFRSF25;SIRT2;FAM129B;CDH4;ITGA4;EDA;ANKRD13D;DCBLD2;TRIP10;ADCY7;LTB4R;RAB28;RAP1GAP2;SOCS7;RGS19;NDE1;GPR3;RAB40B;NGFR;TOLLIP;BCORL1;ARVCF;PXN;GRB10;NBEAL2;SLC39A3;HFE;COL6A1;ZP3;CELSR1;IL17RE;SEPT6;FGFR3;MFSD10;PPP1R16A;ST3GAL5;CBLC;PRSS21;LRP11;GSDMA;HOMER2;SLC23A2;APBA1;PI4KAP2;ADCY6;SLC26A11;SDC2
15536,GO:0071944,2.33449806620207e-13,1,419,2921,cell periphery,CC,NT5E;SDK2;ADGRL1;SEMA4B;HTRA1;FHL1;SLC16A3;DLG4;MRC2;MARVELD1;EPN3;PRR7;KCNG1;ACVR2B;DOCK4;XPC;PRNP;PARVB;BBS2;FLNC;SLC6A8;TNFRSF6B;WNT7A;APOE;DGKA;TSPAN1;F2R;LRP5;ITGA6;OBSCN;NDRG1;SLCO4A1;ITPR3;PKN1;ARRDC1;NISCH;FCGRT;SH2D5;EGFR;SERPINE2;SCN4B;NOS1;PTPRS;SLC2A9;SPRY2;CAPN2;MST1R;PRSS8;SYTL1;SDC1;ETV5;SHC1;ORAI1;ARL2;SLC7A8;PTPRE;SLC12A7;SLC2A3;RIN1;SNX9;SPRY4;RAPGEF3;GAA;ARAP1;MAP2K2;LPAR3;PLCD3;PTOV1;CSMD2;MAP2K1;SSH1;EXOC2;SLC16A5;KCNJ15;MARCKSL1;TMEM8A;SMURF2;KLC2;SLC9A3R2;SMAD3;SHANK2;LRP1;GJC2;DVL1;HSD17B8;HBEGF;FAM110C;AP2A2;ITGB4;CYBRD1;SHC2;NLGN2;STOM;LY6K;PAG1;ADORA2B;SYT8;SLC6A6;AKT1;TPCN1;GRB7;KCNC4;CORO1B;TTYH3;S100A6;F12;PITPNM1;ENTPD6;RHBDF2;BSG;STK39;ASAP2;DYSF;EPHA1;GGT1;PTPRU;SLC15A4;LRRC8A;CNTN1;IFNGR2;MYZAP;MFSD3;RAB31;FGFR4;PEAR1;FNDC4;LDLR;FGFR1;PRKACB;SIGMAR1;RAC2;KCNAB2;PHF7;SORL1;CEACAM1;LZTS2;RAB11FIP4;TENM2;ANK3;NIPSNAP1;TTC7B;EVC;EFS;SYNGAP1;PLCH2;EDNRA;PLAU;PTK6;FGFBP1;BRI3;RAB3B;CARD11;GSN;IGFBP2;PCSK9;ANO8;BCR;ANTXR2;EHD4;ERRFI1;SEPT10;WIPF1;PRSS22;AIP;SH3D19;SLITRK6;TSPAN18;PAQR6;ALOX15B;SPTB;COL13A1;SLC20A1;NPR2;SNTA1;DGKQ;PLXNB3;MVB12B;CEMIP;PROCR;PKD2;CTSZ;CDC42EP5;CRTC1;IL20RB;GPSM1;AP3D1;ITGB5;ABCA2;C19ORF33;EPOR;EPHB2;GRIN3B;ADAM8;ASIC1;CADM4;GRIP2;GRK6;PLCG1;KIF17;CD81;ENTPD2;SLC29A4;SYNJ2;WNT3;GNAL;TGFB1;SNPH;ABHD17C;SLC43A1;SNTB2;GPC1;NTSR1;B3GNT3;TMEM173;ARHGAP25;ATP7B;SHANK3;PODXL2;SDHA;EFNB3;RASA3;TNFSF15;CLCA2;NSMF;ARAP3;SCART1;FARP1;MC1R;TUB;LCE1E;CROCC;RHOD;ABTB1;ST6GALNAC6;HTR7;PI4K2A;SEMA4F;C1ORF210;RHOF;YIPF3;SLC48A1;LLGL1;PLPP6;RHOBTB2;ADAM19;RIMS3;BBS1;PTPN1;AGRN;CD320;CAMK2N1;LRP4;ESYT2;GPR153;ADAP1;PRKCZ;PRKACA;MINK1;RABGGTA;RCCD1;CD9;ADA;MICALL2;PLEKHG5;ERBB2;ADGRB2;VAMP2;CERCAM;PLEK2;C6ORF89;STK17A;RILPL1;JAK3;RNPEP;NET1;FSCN1;TRPC1;SLC22A17;RASA4;ARHGAP44;PRKCD;CACNB3;IFI6;BAX;SV2A;SLC13A5;TRIM4;ITGA1;OLFM2;SH3BP1;GJB4;EREG;TMEM25;PPL;HSD17B7;AHNAK2;RASL10B;FCHO1;NID1;TGFBR3;LTB4R2;CPNE7;SLC2A11;DNM1;RGS14;TMEM8B;SCN8A;MSLN;LPCAT1;LRSAM1;ADAM15;REEP2;EHD3;TMEM231;SYMPK;IRAK1;TGFA;INPP5D;PI4K2B;ABCG1;MYO1D;ABCA7;BCAP31;BCAM;SLC9A7;SYNGR1;CD68;SLC22A18;SPPL2B;FYN;RAC3;ICAM5;ARHGAP12;DNM2;ATXN10;CAT;SLC27A1;TPBG;SLC50A1;SLC12A4;ARHGEF4;DDX50;MAPK3;INSR;SLC13A3;RTN2;ARHGEF1;PFKM;ADCY1;HLA-G;ATP8B2;VANGL2;PAK1;MALL;PPP3CB;RNF144A;USP21;GABBR1;SEMA4C;CAPRIN2;ITGA3;SAMD8;BIN1;SRMS;SLC16A13;DLG3;RRAS;LRCH4;MDGA1;ADGRF1;PKD1;TNFRSF25;SIRT2;FAM129B;CDH4;ITGA4;EDA;ANKRD13D;DCBLD2;TRIP10;ADCY7;LTB4R;RAB28;RAP1GAP2;SOCS7;RGS19;NDE1;GPR3;RAB40B;NGFR;TOLLIP;BCORL1;PCLO;ARVCF;PXN;GRB10;NBEAL2;SLC39A3;HFE;COL6A1;ZP3;CELSR1;IL17RE;SEPT6;FGFR3;MFSD10;PPP1R16A;ST3GAL5;CBLC;PRSS21;LRP11;GSDMA;HOMER2;SLC23A2;APBA1;PI4KAP2;ADCY6;SLC26A11;SDC2
10905,GO:0044459,1.15034608734511e-11,1,234,1459,plasma membrane part,CC,ADGRL1;SLC16A3;DLG4;MRC2;EPN3;PRR7;KCNG1;ACVR2B;PRNP;BBS2;SLC6A8;TNFRSF6B;TSPAN1;F2R;LRP5;ITGA6;SLCO4A1;ITPR3;PKN1;SH2D5;EGFR;SERPINE2;SCN4B;NOS1;PTPRS;SLC2A9;SPRY2;MST1R;PRSS8;SYTL1;SDC1;SHC1;ORAI1;ARL2;SLC7A8;SLC12A7;SLC2A3;SNX9;SPRY4;MAP2K2;LPAR3;PLCD3;SSH1;SLC16A5;KCNJ15;TMEM8A;SLC9A3R2;SHANK2;LRP1;GJC2;DVL1;HBEGF;AP2A2;ITGB4;CYBRD1;NLGN2;STOM;PAG1;ADORA2B;SLC6A6;KCNC4;S100A6;PITPNM1;BSG;STK39;DYSF;EPHA1;PTPRU;IFNGR2;MYZAP;MFSD3;FGFR4;PEAR1;LDLR;FGFR1;SIGMAR1;KCNAB2;SORL1;CEACAM1;RAB11FIP4;TENM2;ANK3;NIPSNAP1;EVC;SYNGAP1;EDNRA;PTK6;CARD11;IGFBP2;PCSK9;BCR;ANTXR2;ERRFI1;PRSS22;SLITRK6;TSPAN18;SPTB;COL13A1;SLC20A1;NPR2;SNTA1;PLXNB3;PROCR;PKD2;ITGB5;ABCA2;EPOR;EPHB2;GRIN3B;ADAM8;ASIC1;CADM4;KIF17;CD81;SLC29A4;GNAL;SNPH;ABHD17C;SLC43A1;SNTB2;GPC1;NTSR1;B3GNT3;ARHGAP25;ATP7B;SHANK3;PODXL2;SDHA;EFNB3;RASA3;TNFSF15;CLCA2;NSMF;SCART1;FARP1;MC1R;HTR7;PI4K2A;SEMA4F;RIMS3;BBS1;CD320;CAMK2N1;LRP4;ESYT2;PRKCZ;PRKACA;MINK1;CD9;ADA;ERBB2;VAMP2;PLEK2;JAK3;FSCN1;TRPC1;SLC22A17;RASA4;ARHGAP44;CACNB3;SLC13A5;ITGA1;OLFM2;SH3BP1;GJB4;EREG;AHNAK2;TGFBR3;LTB4R2;DNM1;RGS14;SCN8A;REEP2;EHD3;TMEM231;IRAK1;TGFA;ABCG1;MYO1D;ABCA7;BCAP31;BCAM;SLC22A18;FYN;ICAM5;ARHGAP12;DNM2;TPBG;SLC12A4;ARHGEF4;MAPK3;INSR;SLC13A3;RTN2;PFKM;ADCY1;HLA-G;VANGL2;PAK1;PPP3CB;GABBR1;SEMA4C;ITGA3;SAMD8;BIN1;SRMS;SLC16A13;DLG3;LRCH4;MDGA1;PKD1;TNFRSF25;CDH4;ITGA4;EDA;DCBLD2;TRIP10;LTB4R;RGS19;NDE1;GPR3;NGFR;TOLLIP;HFE;CELSR1;IL17RE;SEPT6;FGFR3;MFSD10;ST3GAL5;HOMER2;SLC23A2;ADCY6;SLC26A11
4283,GO:0009653,8.38826758457008e-10,1,256,1709,anatomical structure morphogenesis,BP,DUSP6;XDH;ERCC1;DUSP5;SDK2;MEF2D;SEMA4B;HTRA1;FHL1;DLG4;CST3;APLN;PGF;PDCD4;CTNNBIP1;ACVR2B;PARVB;BBS2;POSTN;VEGFA;WNT7A;APOE;NAGLU;F2R;LRP5;ITGA6;HMGA2;OBSCN;ELK3;PKN1;EGFR;SERPINE2;WWTR1;OBSL1;NOS1;VAT1;PTPRS;SPRY2;CAPN2;NFATC4;SDC1;ETV5;SHC1;HEXB;ACTA2;PHLDA2;TRNP1;RAPGEF3;ZFP36L1;GAA;ARAP1;LPAR3;PLCD3;MDFI;FOXQ1;MAP2K1;ACP5;SSH1;SMURF2;FBLN1;SMAD3;STAT6;SHANK2;LRP1;DVL1;EPAS1;THBS3;HBEGF;AP2A2;ITGB4;SH3PXD2B;MBOAT7;ADARB1;GRB7;TMOD2;CORO1B;HDAC5;S100A6;SH2D2A;BSG;EPHA1;VEGFB;FMNL2;IMPACT;BRSK1;IFT140;FGFR4;WNT2B;FGFR1;PRKACB;RAC2;SYNE3;GAMT;B4GAT1;KLF7;CEACAM1;TENM2;ZNF385A;ANK3;TSHZ1;TNNT1;TWF2;STRADB;SYNGAP1;EDNRA;SEMA3F;CSNK1E;SOX13;LAMA5;ARHGAP22;BCR;ANGPTL4;ERRFI1;WIPF1;SH3D19;SLITRK6;ARPIN;SPTB;COL13A1;PLXNB3;BNIP3;PKD2;CTSZ;CDC42EP5;FBXW8;ITGB5;SH3PXD2A;EPHB2;ADAM8;PLCG1;NYAP1;CEBPB;WNT3;TGFB1;CLTCL1;RFX2;UNK;ULK2;GPC1;DEAF1;NAB2;FHOD3;SHANK3;EFNB3;KIF26B;NSMF;ARAP3;FARP1;RHOD;LAMB2;RNH1;SEMA4F;RHOF;WASF3;LLGL1;RHOBTB2;LRP4;VHL;RFNG;MLXIPL;PRKCZ;KDM6B;MINK1;CD9;EPN2;ADA;AREG;MICALL2;SDCCAG8;ERBB2;ADGRB2;ULK1;RILPL1;NET1;CYFIP2;FSCN1;PBX2;ARHGAP44;FAM20C;BAX;ITGA1;SH3BP1;FBXW4;EREG;RPS6KA5;DUSP4;PPP1R13L;AHNAK2;LIMK1;TGFBR3;GDI1;LEMD2;CHAD;ADAM15;WDR60;TMEM231;HDAC7;ZFPM1;PPARA;SOX7;ECM1;FYN;STK25;RAC3;EEF2K;ARHGAP12;ARID5B;DNM2;INF2;ZMYM3;MAPK3;INSR;ADCY1;RERE;VANGL2;PAK1;PPP3CB;ROBO4;CUL7;HYAL1;SEMA4C;CAPRIN2;HES7;ITGA3;BCL2L1;DLG3;RRAS;PROX1;PKD1;FAM129B;CDH4;ITGA4;EDA;E2F5;LAMB1;SOCS7;NGFR;PDCD6;GRB10;KIF13B;TCTN1;NBEAL2;CAMK1;SLC39A3;EZH1;COL6A1;BTG1;ZP3;CELSR1;SEMA3B;SSH3;FGFR3;PLAG1;DOK4;TRIM46;SDC2
7252,GO:0031226,1.55535950690931e-09,1,136,776,intrinsic component of plasma membrane,CC,SLC16A3;DLG4;MRC2;KCNG1;ACVR2B;PRNP;SLC6A8;TNFRSF6B;TSPAN1;F2R;ITGA6;SLCO4A1;ITPR3;EGFR;SCN4B;PTPRS;SLC2A9;MST1R;PRSS8;SDC1;ORAI1;SLC7A8;SLC12A7;SLC2A3;LPAR3;SLC16A5;KCNJ15;TMEM8A;SHANK2;LRP1;HBEGF;ITGB4;NLGN2;STOM;PAG1;ADORA2B;SLC6A6;KCNC4;BSG;EPHA1;PTPRU;IFNGR2;MFSD3;FGFR4;LDLR;FGFR1;SIGMAR1;KCNAB2;SORL1;CEACAM1;TENM2;SYNGAP1;EDNRA;PRSS22;SLITRK6;TSPAN18;SPTB;COL13A1;SLC20A1;NPR2;PLXNB3;PROCR;PKD2;ITGB5;EPOR;EPHB2;GRIN3B;ADAM8;ASIC1;CADM4;CD81;SLC43A1;GPC1;NTSR1;B3GNT3;ATP7B;SHANK3;PODXL2;EFNB3;RASA3;TNFSF15;CLCA2;MC1R;HTR7;PI4K2A;SEMA4F;CD320;ESYT2;CD9;ERBB2;VAMP2;TRPC1;SLC22A17;RASA4;SLC13A5;ITGA1;OLFM2;EREG;TGFBR3;LTB4R2;SCN8A;REEP2;IRAK1;TGFA;BCAP31;BCAM;ICAM5;TPBG;SLC12A4;INSR;SLC13A3;ADCY1;GABBR1;ITGA3;SAMD8;SLC16A13;DLG3;MDGA1;PKD1;TNFRSF25;CDH4;ITGA4;EDA;DCBLD2;LTB4R;GPR3;NGFR;TOLLIP;HFE;CELSR1;IL17RE;FGFR3;ST3GAL5;SLC23A2;ADCY6;SLC26A11
1255,GO:0003008,3.60937875587658e-09,1,138,808,system process,BP,DLG4;APLN;CTNNBIP1;DOCK4;PRNP;BBS2;SLC6A8;POSTN;APOE;ESPN;F2R;LRP5;ITPR3;PKN1;NISCH;EGFR;SERPINE2;SCN4B;OBSL1;NOS1;SPRY2;HEXB;ACTA2;GAA;FOS;SMAD3;SHANK2;DVL1;EPAS1;HBEGF;NLGN2;ADORA2B;ADARB1;AKT1;TMOD2;STK39;SERPING1;DYSF;VEGFB;LDLR;FGFR1;PRKACB;KCNAB2;RAG1;GAMT;CEACAM1;ZNF385A;ANK3;NIPSNAP1;TNNT1;SYNGAP1;EDNRA;GAS6;GSN;BCR;ERRFI1;SLITRK6;NPR2;SNTA1;GTF2IRD1;CEMIP;CTSZ;CRTC1;ITGB5;EPHB2;ASIC1;CEBPB;GNAL;TGFB1;DEAF1;NTSR1;SHANK3;EML2;TUB;LAMB2;HTR7;WASF3;BBS1;TPP1;B4GALT2;PRKCZ;PRKACA;GRHPR;RABGGTA;ADA;SMTN;RNPEP;TRPC1;REEP6;CACNB3;ITGA1;OLFM2;GJB4;PPP1R13L;AHNAK2;RASL10B;TPM2;DNM1;RGS14;SCN8A;GSTO1;REEP2;EHD3;MTHFR;PPARA;ABCA7;DOPEY2;PLA2G6;WFS1;SLC22A18;FYN;RAC3;PLCB3;MAPK3;INSR;CAMTA2;TAZ;ADCY1;PAK1;PPP3CB;ITGA3;MAP2K3;ADGRF1;ALDH7A1;LMNA;FAM129B;ADCY7;LTB4R;PXN;TBC1D8;GCH1;NR2F6;ZNF513;BBS10;BLOC1S4;HOMER2;ADCY6;AARS
12674,GO:0050896,1.31725016480389e-08,1,679,5555,response to stimulus,BP,TNIP1;DUSP6;NT5E;XDH;ERCC1;DUSP5;ZMYND8;ADGRL1;CITED4;SEMA4B;HTRA1;EGR1;NR1D1;EDEM1;DLG4;PLAT;CST3;CYP27B1;MRC2;BTBD2;FBXO2;APLN;PRR7;PGF;PDCD4;CTNNBIP1;ACVR2B;DOCK4;XPC;PRNP;PYGB;BBS2;SLC6A8;DDIT4L;POSTN;VEGFA;FAM210B;TNFRSF6B;PGM1;WNT7A;APOE;PYGL;DGKA;TSPAN1;F2R;LRP5;ITGA6;PITPNC1;HMGA2;OBSCN;NDRG1;ELK3;ITPR3;PKN1;MTA1;ARRDC1;NISCH;AKR7A2;FCGRT;EGFR;RPS6KA2;SERPINE2;WWTR1;LOXL1;NOS1;VAT1;PTPRS;TMEM129;HADH;SPRY2;CAPN2;MST1R;NFATC4;LTBP4;SDC1;ETV5;APPL2;SHC1;DDB2;ORAI1;LTBP2;LTBP1;HEXB;GTPBP1;SLC7A8;PTPRE;SLC2A3;RIN1;ACTA2;MMP1;PHLDA2;SPRY4;RAPGEF3;TXNRD3;ZFP36L1;GAA;GLUL;ARAP1;MAP2K2;LPAR3;PLCD3;MDFI;CMTM7;RBCK1;MAP2K1;NAPRT;ACP5;MCTP1;SSH1;POU2F2;ENDOG;SMURF2;FOS;FBLN1;SMAD3;ARHGAP23;STAT6;SHANK2;PIK3R2;ERCC6;LRP1;GJC2;DVL1;EPAS1;DNAJB5;HBEGF;FAM110C;AP2A2;S100A4;ITGB4;CYBRD1;PPP1R14A;PRDX5;SHC2;NLGN2;STOM;PRODH;SALL2;PAG1;ADORA2B;ADARB1;PLCXD2;D2HGDH;AKT1;GRB7;TMOD2;CORO1B;HDAC5;UROS;FAM83A;S100A6;F12;SH2D2A;PPM1F;MMP28;PITPNM1;ENTPD6;PLEKHH3;RHBDF2;PYCR2;BSG;STK39;HK1;SERPING1;ASAP2;DYSF;EPHA1;GGT1;NFKBIZ;PTPRU;VEGFB;ASH2L;IMPACT;SLC15A4;WWC3;LRRC8A;CNTN1;IFNGR2;BRSK1;DAP;IFT140;PTHLH;MYZAP;RAB31;FGFR4;HEBP1;PEAR1;WNT2B;POLD4;FNDC4;LDLR;FGFR1;PRKACB;FUCA1;MAPKBP1;SIGMAR1;RAC2;KCNAB2;SMOC2;PFKL;NPHP4;RAG1;B4GAT1;BPHL;KLF7;RALGDS;SORL1;CEACAM1;ASB13;CIRBP;HMG20B;LZTS2;TENM2;ZNF385A;DOCK6;NSMCE4A;ANK3;IGFBP4;EVC;CCND1;PODNL1;EFS;PCBP4;TNNT1;TWF2;STRADB;SYNGAP1;PLCH2;MAPK13;EDNRA;CARD19;PLAU;GAS6;PTK6;SEMA3F;PFKP;FGFBP1;CSNK1E;BRI3;CTSB;RAB3B;CARD11;SH2B3;LAMA5;DUSP7;GSN;CMTM4;PLEKHG2;MAPKAPK3;IGFBP2;PCSK9;ARHGAP22;RAD23A;BCR;ANTXR2;ANGPTL4;EHD4;ERRFI1;WIPF1;HLCS;AIP;RGL2;SLITRK6;TSPAN18;PAQR6;ARHGAP27;ALOX15B;SPTB;AGAP1;NXPH4;CCS;SLC20A1;NPR2;DGKQ;PLXNB3;BNIP3;PAK6;TFPI2;GTF2IRD1;SHARPIN;MVB12B;PROCR;PKD2;ACY1;FAM3A;GPX3;YPEL3;RASGEF1A;CTSZ;CDC42EP5;CRTC1;IL20RB;AP3D1;ITGB5;ABCA2;MAGEF1;PRSS3;EPOR;EPHB2;GRIN3B;ADAM8;ASIC1;APRT;LTA4H;MNT;GRK6;CDKN1C;PLCG1;CBS;SH3BP2;NYAP1;CD81;CEBPB;RNF135;ENTPD2;ADAMTS13;ZNF217;TIMP2;WNT3;DPP7;GNAL;TMED4;TGFB1;CLTCL1;RFX2;ULK2;GPC1;MKNK2;ADAMTS7;DEAF1;MOAP1;NTSR1;TMEM173;ARHGAP25;ATP7B;SHANK3;MSRB2;EFNB3;RASA3;TNFSF15;MPG;GALNS;NSMF;ARAP3;SCART1;FARP1;MC1R;TUB;RHOD;LAMB2;ABTB1;SNX17;HTR7;VGF;POLL;POLM;PLEKHG4;PI4K2A;SEMA4F;RHOF;ANKZF1;LLGL1;PHF21A;PLEKHG3;KIF7;RHOBTB2;UBXN4;GIGYF1;BBS1;TNFAIP8L1;HMGCL;PTPN1;TPP1;PCK2;B4GALT2;WDR59;AGRN;MBD3;IFNE;CD320;CAMK2N1;LRP4;GPR153;VHL;DNAJC4;TRAP1;ADAP1;PFKFB2;RFNG;MLXIPL;YPEL5;TRIB2;PRKCZ;KDM6B;PRKACA;MINK1;ZNF516;RHPN1;TBKBP1;ACTR1B;TOM1L2;CD9;EPN2;ADA;AREG;PIM2;PLEKHG5;BOK;NEURL1B;ERBB2;ADGRB2;ULK1;AHCY;VAMP2;PRIMPOL;TFDP2;PLEK2;C6ORF89;STK17A;JAK3;NET1;BNIP3L;CYFIP2;FSCN1;TRPC1;SLC22A17;RASA4;PDK1;CYGB;ARHGAP44;PRKCD;FAM20C;MIB2;REEP6;RBL2;CACNB3;USP20;STUB1;IFI6;BAX;CYC1;SLC13A5;TRIM4;ITGA1;SH3BP1;FBXW4;GJB4;EREG;RPS6KA5;DUSP4;TMBIM4;DDIT4;MBTPS2;SPRED3;PPL;PPP1R13L;CARF;HSD17B7;PCSK1N;MT2A;IER2;RASL10B;CES2;TMX4;LIMK1;TGFBR3;PDIA5;GDI1;LTB4R2;CPNE7;LEMD2;RPS6KA6;DNM1;RGS14;MFNG;GSTO1;GIT1;ALDOC;CHAD;MRPS26;LPCAT1;LRSAM1;ADAM15;ASB1;EHD3;TMEM231;LONP2;MAPK12;IRAK1;PPOX;TGFA;HDAC7;INPP5D;MTHFR;CHD2;CHEK2;ZFPM1;PPARA;TMEM161A;SESN2;ABCG1;CDC34;SNN;SOX7;ABCA7;RAB12;BCAP31;MIF;ACO2;SLC25A29;BCAM;PLA2G6;DDT;SYNGR1;ECM1;WFS1;QSOX1;CD68;SLC22A18;DTX3;SPPL2B;FYN;VWA1;UPP1;STK25;RAC3;EEF2K;SUN1;ICAM5;ARHGAP12;ACAP3;ARID5B;DNM2;CYP3A5;BHLHE40;GLB1;PELI1;SNX15;CHKA;CAT;NEIL1;TSPYL2;IGFBP7;SLC27A1;APOBEC3C;SATB1;KIF26A;PLCB3;IQSEC1;APOBEC3F;ARHGEF4;CYP2R1;MAPK3;INSR;SLC13A3;ARHGEF1;GRINA;CAMTA2;ADCY1;C12ORF66;HLA-G;DOCK9;INO80C;TMEM101;RALGAPA1;MORN4;PDXK;ETAA1;PRAF2;VANGL2;PAK1;CAMKK2;RNASET2;PPP3CB;LGALS3BP;MLYCD;CUL7;GABBR1;REV1;MICAL1;HYAL1;SEMA4C;CAPRIN2;WDTC1;HES7;ITGA3;STK32C;DNMT3A;MAN2B1;SRMS;PPP2R5B;MAP2K3;BCL2L1;RRAS;DNASE1L1;PROX1;LRCH4;ADGRF1;LMNA;PKD1;KCTD13;TNFRSF25;SIRT2;FAM129B;CDH4;ITGA4;EDA;UVSSA;DCBLD2;BACH1;TRIP10;ADCY7;LTB4R;RAB28;SERPINB1;RAP1GAP2;SOCS7;MAP3K10;RGS19;GPR3;PELI3;RAB40B;NGFR;TOLLIP;PDCD6;ATP6V1F;PCLO;RNASE7;PXN;GRB10;PLEKHM1;GCH1;LURAP1;KIF13B;MAFF;NR2F6;TCTN1;NBEAL2;PNMA1;CAMK1;CAMKK1;SIRT3;HFE;TERC;ZNF513;WIPI2;GAS2L1;COL6A1;BTG1;BBS10;ZP3;CELSR1;MLF2;IL17RE;SEMA3B;SLC35F3;FGFR3;MFSD10;CCDC88C;NDRG2;BLOC1S4;CBLC;ITPKB;CDC42BPG;LRP11;DOK4;GSDMA;KDM3A;HOMER2;SLC23A2;PKN3;DEDD2;PI4KAP2;AK3;SRSF5;ADCY6;LRRK1;KLHL24;SDC2
2591,GO:0005887,1.55005750539872e-08,1,127,737,integral component of plasma membrane,CC,SLC16A3;DLG4;MRC2;KCNG1;ACVR2B;SLC6A8;TNFRSF6B;TSPAN1;F2R;ITGA6;SLCO4A1;ITPR3;EGFR;SCN4B;PTPRS;SLC2A9;MST1R;SDC1;ORAI1;SLC7A8;SLC12A7;SLC2A3;LPAR3;SLC16A5;KCNJ15;TMEM8A;SHANK2;LRP1;HBEGF;ITGB4;NLGN2;STOM;PAG1;ADORA2B;SLC6A6;KCNC4;BSG;EPHA1;PTPRU;IFNGR2;MFSD3;FGFR4;LDLR;FGFR1;SIGMAR1;KCNAB2;SORL1;CEACAM1;TENM2;EDNRA;SLITRK6;TSPAN18;COL13A1;SLC20A1;NPR2;PLXNB3;PROCR;PKD2;ITGB5;EPOR;EPHB2;GRIN3B;ADAM8;ASIC1;CADM4;CD81;SLC43A1;GPC1;NTSR1;B3GNT3;ATP7B;SHANK3;PODXL2;EFNB3;TNFSF15;CLCA2;MC1R;HTR7;PI4K2A;SEMA4F;CD320;ESYT2;CD9;ERBB2;VAMP2;TRPC1;SLC22A17;SLC13A5;ITGA1;OLFM2;EREG;TGFBR3;LTB4R2;SCN8A;REEP2;IRAK1;TGFA;BCAP31;BCAM;ICAM5;TPBG;SLC12A4;INSR;SLC13A3;ADCY1;GABBR1;ITGA3;SAMD8;SLC16A13;DLG3;PKD1;TNFRSF25;CDH4;ITGA4;EDA;DCBLD2;LTB4R;GPR3;NGFR;TOLLIP;HFE;CELSR1;IL17RE;FGFR3;ST3GAL5;SLC23A2;SLC26A11
7920,GO:0032501,1.78768956355497e-08,1,532,4199,multicellular organismal process,BP,DUSP6;XDH;ERCC1;DUSP5;SDK2;MEF2D;ZMYND8;ADGRL1;SEMA4B;HTRA1;FHL1;EGR1;NR1D1;DLG4;PLAT;CST3;CYP27B1;MRC2;BTBD2;MARVELD1;APLN;PGF;PDCD4;CTNNBIP1;ACVR2B;DOCK4;PRNP;BBS2;SLC6A8;POSTN;VEGFA;FAM210B;TNFRSF6B;WNT7A;APOE;DGKA;ESPN;NAGLU;F2R;LRP5;ITGA6;HMGA2;OBSCN;NDRG1;IDH2;ELK3;ITPR3;PKN1;MTA1;NISCH;EGFR;SERPINE2;WWTR1;LOXL1;SCN4B;OBSL1;NOS1;PTPRS;SPRY2;CAPN2;MST1R;NFATC4;CRTAP;LTBP4;PRSS8;SDC1;ETV5;LMF1;SHC1;LTBP1;HEXB;TCFL5;ACTA2;PHLDA2;TRNP1;SPRY4;RAPGEF3;TXNRD3;ZFP36L1;GAA;LPAR3;PLCD3;MDFI;SMARCA1;CMTM7;PLTP;FOXQ1;MAP2K1;ACP5;SSH1;POU2F2;ENDOG;MARK4;SMURF2;FOS;FBLN1;SMAD3;STAT6;SHANK2;ERCC6;LRP1;GJC2;DVL1;EPAS1;THBS3;HBEGF;AP2A2;S100A4;ITGB4;SH3PXD2B;NLGN2;SALL2;MBOAT7;ADORA2B;ADARB1;AKT1;GRB7;TMOD2;CORO1B;HDAC5;S100A6;F12;SH2D2A;PPM1F;PITPNM1;BSG;STK39;HK1;SERPING1;SCMH1;DYSF;EPHA1;GGT1;PHC2;PTPRU;VEGFB;ASH2L;IMPACT;WWC3;LRRC8A;CNTN1;BRSK1;IFT140;PTHLH;FGFR4;WNT2B;LDLR;FGFR1;PRKACB;MAPKBP1;SIGMAR1;RAC2;KCNAB2;NPHP4;RAG1;GAMT;B4GAT1;KLF7;SORL1;CEACAM1;CCNI;HMG20B;LZTS2;RAB11FIP4;TENM2;ZNF385A;DOCK6;MICALCL;ANK3;NIPSNAP1;IGFBP4;EVC;TSHZ1;TRAPPC9;CCND1;TCF25;TNNT1;TWF2;SYNGAP1;MAPK13;EDNRA;PLAU;GAS6;PTK6;SEMA3F;CSNK1E;CTSB;CARD11;SH2B3;SOX13;LAMA5;GSN;IGFBP2;PCSK9;ARHGAP22;DHTKD1;BCR;ANGPTL4;ERRFI1;DBNDD1;MYEF2;MN1;CDC25B;SLITRK6;ALOX15B;SPTB;COL13A1;NPR2;UNC119B;SNTA1;DGKQ;PLXNB3;BNIP3;TFPI2;GTF2IRD1;SHARPIN;TAGLN3;CEMIP;PROCR;PKD2;CTSZ;CRTC1;IL20RB;FBXW8;GPSM1;AP3D1;ITGB5;PRSS3;SH3PXD2A;EPOR;EPHB2;ADAM8;ASIC1;APRT;MNT;PLCG1;KIF17;NYAP1;CEBPB;RNF135;ENTPD2;ADAMTS13;ZNF217;TIMP2;WNT3;GNAL;TGFB1;SNPH;RFX2;UNK;ULK2;GPC1;MKNK2;ADAMTS7;DEAF1;SLC38A10;NTSR1;NAB2;TMEM173;ATP7B;FHOD3;SHANK3;SDHA;EFNB3;MYCBPAP;EML2;KIF26B;NSMF;FARP1;MC1R;TUB;LCE1E;CROCC;LAMB2;SNX17;RNH1;DNAH1;HTR7;VGF;POLL;POLM;SEMA4F;WASF3;LLGL1;PHGDH;PHF21A;ADAM19;BBS1;HMGCL;TPP1;PCK2;B4GALT2;AGRN;MBD3;IFNE;LRP4;LRP10;CEP131;RFNG;TRIB2;PRKCZ;KDM6B;PRKACA;MINK1;ZNF516;GRHPR;RABGGTA;CD9;EPN2;ADA;AREG;PIM2;MICALL2;PLEKHG5;BOK;WDR18;TDRKH;SDCCAG8;ERBB2;ADGRB2;ULK1;RTL1;TFDP2;SMTN;FAM50A;JAK3;RNPEP;CYFIP2;PBX2;TRPC1;ARHGAP44;PRKCD;FAM20C;REEP6;CACNB3;BAX;SBF1;ITGA1;OLFM2;SH3BP1;FBXW4;GJB4;CHADL;EREG;RPS6KA5;DGUOK;DUSP4;SOX12;DDIT4;SPRED3;PPL;PPP1R13L;AHNAK2;PCSK1N;IER2;RASL10B;ZDHHC8;NID1;LIMK1;TGFBR3;GDI1;TPM2;DIP2A;LTB4R2;RPL39L;LEMD2;RPS6KA6;ZHX3;DNM1;RGS14;SCN8A;MFNG;GSTO1;CHAD;MSLN;LPCAT1;ADAM15;REEP2;ASB1;EHD3;WDR60;TMEM231;MAPK12;IRAK1;HDAC7;INPP5D;MTHFR;CHD2;ZFPM1;PPARA;ABCG1;MYO1D;MYH15;PRR15;SOX7;ABCA7;SPATA20;SPEG;SIX5;BCAP31;MIF;ACO2;DOPEY2;PLA2G6;DDT;ECM1;WFS1;SLC22A18;FYN;VWA1;STK25;RAC3;EEF2K;SUN1;ARID5B;HOXC5;DNM2;BHLHE40;PELI1;ATXN10;CAT;IGFBP7;SLC27A1;ZMYM3;TPBG;SATB1;KIF26A;PLCB3;MAPK3;INSR;CAMTA2;TAZ;ADCY1;RERE;HLA-G;DOCK9;VANGL2;PAK1;TRIM45;MALL;PPP3CB;ROBO4;USP21;PFKFB3;CUL7;MICAL1;HYAL1;SEMA4C;CAPRIN2;WDTC1;HES7;ITGA3;DNMT3A;BIN1;PPP2R5B;HES6;MAP2K3;BCL2L1;DLG3;RRAS;PROX1;LRCH4;MDGA1;ADGRF1;ALDH7A1;LMNA;PKD1;TNFRSF25;SIRT2;FAM129B;CDH4;ITGA4;EDA;ADCY7;E2F5;LTB4R;AZIN2;RAP1GAP2;LAMB1;SOCS7;NDE1;HSD11B1;GTF2IRD2;NGFR;PDCD6;PCLO;ARVCF;PXN;GRB10;TBC1D8;PLEKHM1;GCH1;LURAP1;KIF13B;MAFF;NR2F6;TCTN1;NBEAL2;CAMK1;SLC39A3;EZH1;HFE;ZNF513;COL6A1;BTG1;BBS10;ZP3;CELSR1;TACC1;SEMA3B;SEPT6;PFN2;SSH3;FGFR3;NDRG2;BLOC1S4;ITPKB;PRSS21;PLAG1;LRP11;DOK4;TRIM46;KDM3A;HOMER2;PKN3;APBA1;AK3;SRSF5;ADCY6;LRRK1;AARS;SDC2
10794,GO:0044281,7.44085614721147e-08,1,217,1509,small molecule metabolic process,BP,NT5E;XDH;EGR1;NR1D1;SLC16A3;H6PD;DLG4;CYP27B1;TYSND1;NAGS;SLC6A8;VEGFA;PGM1;APOE;LRP5;OSBPL5;ISYNA1;IDH2;CRAT;ACOT7;ACSF2;NISCH;AKR7A2;DNPH1;NOS1;SLC2A9;HADH;CRTAP;LMF1;HEXB;GTPBP1;SLC7A8;SLC2A3;ALDH4A1;TK2;PHLDA2;RAPGEF3;GAA;GLUL;KDSR;NME4;PLCD3;PLTP;PGLS;PC;NAPRT;CRYL1;ACP5;CPT2;GALE;SRD5A3;HSD17B8;PRODH;NMRK1;ADORA2B;D2HGDH;SLC6A6;AKT1;UROS;ENTPD6;PYCR2;BSG;HK1;GGT1;PTHLH;FGFR4;ACOT1;LDLR;FGFR1;FUCA1;KCNAB2;PFKL;SEC14L2;GAMT;B4GAT1;BPHL;SORL1;CEACAM1;B3GAT3;CBR4;ABCD1;IGFBP4;LHPP;AIG1;PLCH2;PFKP;CARD11;PCSK9;DHTKD1;NADK;PANK4;HLCS;ALOX15B;NPR2;DGKQ;HAGH;CEMIP;PKD2;ACY1;RETSAT;PRSS3;APRT;LTA4H;PLCG1;CBS;MVD;ENTPD2;TIMP2;TGFB1;NTSR1;B3GNT3;PODXL2;SDHA;MDH2;GALNS;ABHD14B;SNX17;ERO1B;PHGDH;PLPP6;HMGCL;PCK2;B4GALT2;CD320;B4GALT6;IDUA;PFKFB2;MLXIPL;GRHPR;ADA;MPI;UCKL1;AHCY;PDK1;ACAD10;CYGB;FAM20C;CYC1;XYLT2;PPCS;DGUOK;DDIT4;MBTPS2;ACADS;HSD17B7;CES2;LTB4R2;GSTO1;ALDOC;ST3GAL3;LONP2;INPP5D;MTHFR;DECR2;PPARA;COQ2;SESN2;FGGY;ABCG1;MIF;ACO2;PHYH;DALRD3;UPP1;ETFB;CKMT1A;GLB1;CHKA;CAT;NEIL1;SLC27A1;APOBEC3C;PLCB3;APOBEC3F;CYP2R1;MAPK3;INSR;TAZ;PFKM;ADCY1;TSTA3;GPT2;PDXK;GLRX;PFKFB3;MLYCD;GABBR1;HYAL1;WDTC1;MAN2B1;NDST2;DLG3;ABHD10;NDUFV3;PROX1;IARS2;ALDH7A1;NMNAT2;NT5C1B;ADCY7;AZIN2;ST3GAL2;CHST14;PHYKPL;GCH1;TST;MAN2B2;ITPKB;PTGR2;SPTLC2;KDM3A;PM20D2;SLC23A2;AK3;CHPF;ADCY6;AARS
8219,GO:0032989,1.2120609552205e-07,1,125,750,cellular component morphogenesis,BP,SEMA4B;DLG4;PARVB;POSTN;VEGFA;WNT7A;APOE;OBSCN;EGFR;OBSL1;PTPRS;NFATC4;SHC1;HEXB;ARAP1;LPAR3;MAP2K1;SSH1;FBLN1;SHANK2;DVL1;ADARB1;GRB7;TMOD2;CORO1B;S100A6;EPHA1;FMNL2;IMPACT;BRSK1;RAC2;SYNE3;B4GAT1;KLF7;TENM2;ZNF385A;ANK3;TNNT1;TWF2;STRADB;SYNGAP1;SEMA3F;CSNK1E;LAMA5;WIPF1;SH3D19;SLITRK6;ARPIN;SPTB;PLXNB3;CDC42EP5;FBXW8;EPHB2;ADAM8;PLCG1;NYAP1;WNT3;RFX2;UNK;ULK2;GPC1;FHOD3;SHANK3;EFNB3;NSMF;ARAP3;FARP1;RHOD;LAMB2;SEMA4F;RHOF;WASF3;LLGL1;RHOBTB2;LRP4;VHL;PRKCZ;MINK1;CD9;MICALL2;ERBB2;ULK1;RILPL1;NET1;CYFIP2;ARHGAP44;BAX;ITGA1;RPS6KA5;AHNAK2;LIMK1;GDI1;ZFPM1;FYN;STK25;RAC3;EEF2K;DNM2;ZMYM3;MAPK3;ADCY1;RERE;VANGL2;PAK1;PPP3CB;CUL7;SEMA4C;CAPRIN2;BCL2L1;PROX1;FAM129B;CDH4;ITGA4;LAMB1;NGFR;GRB10;KIF13B;TCTN1;NBEAL2;SLC39A3;SEMA3B;SSH3;DOK4;TRIM46;SDC2
5438,GO:0016301,1.48095551665235e-07,1,110,637,kinase activity,MF,DLG4;NAGS;ACVR2B;DGKA;HMGA2;OBSCN;NEK9;PKN1;EGFR;RPS6KA2;MST1R;LTBP4;LTBP1;TK2;MAP2K2;NME4;MAP2K1;MARK4;PIK3R2;HBEGF;CDK18;NMRK1;AKT1;STK39;HK1;EPHA1;ZFYVE21;BRSK1;FGFR4;FGFR1;PRKACB;PFKL;CCND1;STRADB;MAPK13;PTK6;PFKP;CSNK1E;CARD11;MAPKAPK3;BCR;NADK;PANK4;NPR2;DGKQ;PAK6;EPHB2;GRK6;SCYL1;ULK2;MKNK2;EFNB3;PIP5KL1;PI4K2A;PFKFB2;PRKCZ;PRKACA;MINK1;PIM2;UCKL1;ERBB2;ULK1;STK17A;JAK3;PDK1;PRKCD;FAM20C;EREG;RPS6KA5;DGUOK;LIMK1;TGFBR3;RPS6KA6;MAPK12;IRAK1;PI4K2B;CHEK2;FGGY;SPEG;FYN;STK25;EEF2K;CKMT1A;PELI1;CHKA;MAPK3;INSR;PFKM;PDXK;PAK1;CAMKK2;ALPK1;PFKFB3;STK32C;SRMS;MAP2K3;DLG3;MAP3K10;PELI3;CAMK1;CAMKK1;CDK11B;FGFR3;ITPKB;CDC42BPG;CLK3;PKN3;PI4KAP2;AK3;LRRK1
17260,GO:0120039,1.49985482403257e-07,1,83,443,plasma membrane bounded cell projection morphogenesis,BP,SEMA4B;DLG4;POSTN;VEGFA;WNT7A;APOE;EGFR;OBSL1;PTPRS;NFATC4;SHC1;LPAR3;MAP2K1;SSH1;SHANK2;DVL1;ADARB1;GRB7;CORO1B;S100A6;IMPACT;BRSK1;RAC2;B4GAT1;KLF7;ANK3;TWF2;SYNGAP1;SEMA3F;SLITRK6;ARPIN;SPTB;PLXNB3;FBXW8;EPHB2;PLCG1;NYAP1;WNT3;ULK2;GPC1;SHANK3;EFNB3;NSMF;FARP1;LAMB2;SEMA4F;LLGL1;LRP4;PRKCZ;MINK1;ERBB2;ULK1;CYFIP2;ARHGAP44;ITGA1;RPS6KA5;LIMK1;GDI1;FYN;STK25;RAC3;EEF2K;DNM2;MAPK3;ADCY1;RERE;VANGL2;PAK1;PPP3CB;CUL7;SEMA4C;CAPRIN2;FAM129B;CDH4;NGFR;GRB10;KIF13B;TCTN1;SEMA3B;SSH3;DOK4;TRIM46;SDC2
323,GO:0000904,1.58040676899699e-07,1,89,486,cell morphogenesis involved in differentiation,BP,SEMA4B;DLG4;PARVB;POSTN;VEGFA;WNT7A;APOE;OBSL1;PTPRS;NFATC4;SHC1;LPAR3;MAP2K1;SSH1;FBLN1;SHANK2;DVL1;ADARB1;GRB7;S100A6;EPHA1;BRSK1;B4GAT1;KLF7;ZNF385A;ANK3;TWF2;SYNGAP1;SEMA3F;LAMA5;SLITRK6;SPTB;PLXNB3;FBXW8;EPHB2;PLCG1;WNT3;UNK;ULK2;GPC1;SHANK3;EFNB3;NSMF;FARP1;LAMB2;SEMA4F;LLGL1;LRP4;MINK1;MICALL2;ERBB2;ULK1;RILPL1;NET1;CYFIP2;ARHGAP44;RPS6KA5;LIMK1;GDI1;ZFPM1;FYN;STK25;RAC3;EEF2K;DNM2;MAPK3;ADCY1;RERE;VANGL2;PAK1;PPP3CB;CUL7;SEMA4C;CAPRIN2;PROX1;FAM129B;CDH4;ITGA4;LAMB1;NGFR;GRB10;KIF13B;TCTN1;NBEAL2;SEMA3B;SSH3;DOK4;TRIM46;SDC2
6556,GO:0022008,1.58388934765852e-07,1,160,1024,neurogenesis,BP,SDK2;ZMYND8;SEMA4B;DLG4;BTBD2;POSTN;VEGFA;WNT7A;APOE;NAGLU;NDRG1;IDH2;EGFR;SERPINE2;OBSL1;NOS1;PTPRS;NFATC4;ETV5;SHC1;HEXB;LPAR3;SMARCA1;MAP2K1;SSH1;SHANK2;LRP1;GJC2;DVL1;MBOAT7;ADARB1;AKT1;GRB7;HDAC5;S100A6;IMPACT;CNTN1;BRSK1;IFT140;WNT2B;LDLR;FGFR1;RAC2;NPHP4;B4GAT1;KLF7;SORL1;HMG20B;TENM2;ANK3;TRAPPC9;TWF2;SYNGAP1;GAS6;PTK6;SEMA3F;CSNK1E;GSN;PCSK9;DBNDD1;MYEF2;SLITRK6;SPTB;UNC119B;PLXNB3;BNIP3;CTSZ;CRTC1;FBXW8;EPHB2;PLCG1;KIF17;NYAP1;CEBPB;TIMP2;WNT3;TGFB1;SNPH;UNK;ULK2;GPC1;NAB2;SHANK3;EFNB3;NSMF;FARP1;LAMB2;SEMA4F;WASF3;LLGL1;AGRN;LRP4;PRKCZ;MINK1;CD9;AREG;MICALL2;BOK;SDCCAG8;ERBB2;ULK1;CYFIP2;ARHGAP44;BAX;ITGA1;RPS6KA5;DGUOK;DDIT4;AHNAK2;IER2;LIMK1;GDI1;LEMD2;RGS14;FYN;STK25;RAC3;EEF2K;SUN1;DNM2;ATXN10;MAPK3;ADCY1;RERE;VANGL2;PAK1;PPP3CB;USP21;CUL7;SEMA4C;CAPRIN2;ITGA3;DNMT3A;BIN1;PPP2R5B;PROX1;MDGA1;ADGRF1;SIRT2;FAM129B;CDH4;RAP1GAP2;LAMB1;SOCS7;NDE1;NGFR;GRB10;KIF13B;NR2F6;TCTN1;CAMK1;CELSR1;SEMA3B;SSH3;BLOC1S4;PLAG1;DOK4;TRIM46;ADCY6;SDC2
12402,GO:0048858,1.65121025234008e-07,1,83,444,cell projection morphogenesis,BP,SEMA4B;DLG4;POSTN;VEGFA;WNT7A;APOE;EGFR;OBSL1;PTPRS;NFATC4;SHC1;LPAR3;MAP2K1;SSH1;SHANK2;DVL1;ADARB1;GRB7;CORO1B;S100A6;IMPACT;BRSK1;RAC2;B4GAT1;KLF7;ANK3;TWF2;SYNGAP1;SEMA3F;SLITRK6;ARPIN;SPTB;PLXNB3;FBXW8;EPHB2;PLCG1;NYAP1;WNT3;ULK2;GPC1;SHANK3;EFNB3;NSMF;FARP1;LAMB2;SEMA4F;LLGL1;LRP4;PRKCZ;MINK1;ERBB2;ULK1;CYFIP2;ARHGAP44;ITGA1;RPS6KA5;LIMK1;GDI1;FYN;STK25;RAC3;EEF2K;DNM2;MAPK3;ADCY1;RERE;VANGL2;PAK1;PPP3CB;CUL7;SEMA4C;CAPRIN2;FAM129B;CDH4;NGFR;GRB10;KIF13B;TCTN1;SEMA3B;SSH3;DOK4;TRIM46;SDC2
6664,GO:0030030,1.69056764416936e-07,1,163,1052,cell projection organization,BP,ZMYND8;SEMA4B;DLG4;PRNP;PARVB;BBS2;POSTN;VEGFA;WNT7A;APOE;ESPN;ITGA6;EVI5L;EGFR;WWTR1;OBSL1;PTPRS;SPRY2;NFATC4;SHC1;NUDCD3;ARAP1;LPAR3;MAP2K1;SSH1;MARK4;SHANK2;LRP1;DVL1;FAM110C;ADARB1;AKT1;GRB7;CORO1B;S100A6;IMPACT;CNTN1;BRSK1;IFT140;DNAAF5;FGFR1;RAC2;NPHP4;B4GAT1;KLF7;TENM2;ANK3;TWF2;SYNGAP1;CEP250;PTK6;SEMA3F;CSNK1E;LAMA5;GSN;SEPT10;DBNDD1;CCDC113;SLITRK6;ARPIN;SPTB;UNC119B;PLXNB3;CTSZ;CDC42EP5;CRTC1;FBXW8;EPHB2;PTPDC1;PLCG1;KIF17;NYAP1;WNT3;RFX2;ULK2;GPC1;SHANK3;EFNB3;NSMF;FARP1;CROCC;RHOD;LAMB2;DNAH1;SEMA4F;WASF3;LLGL1;BBS1;AGRN;LRP4;CEP131;PRKCZ;PRKACA;MINK1;AREG;MICALL2;SDCCAG8;ERBB2;ULK1;NINL;PLEK2;RILPL1;CYFIP2;FSCN1;ARHGAP44;PRKCD;ITGA1;NUBP2;SH3BP1;RPS6KA5;DGUOK;LIMK1;GDI1;EHD3;WDR60;TMEM231;DNAAF3;FYN;STK25;RAC3;EEF2K;DNM2;ATXN10;ARHGEF4;MAPK3;INSR;ADCY1;RERE;CEP72;VANGL2;PAK1;PPP3CB;USP21;CUL7;SEMA4C;CAPRIN2;ITGA3;PPP2R5B;ADGRF1;FAM129B;CDH4;E2F5;RAP1GAP2;LAMB1;NDE1;NGFR;GRB10;PLEKHM1;MSS51;KIF13B;TCTN1;CAMK1;BBS10;SEMA3B;SEPT6;PFN2;SSH3;BLOC1S4;DOK4;TRIM46;TTLL3;ADCY6;SDC2
9786,GO:0040011,1.7869297687938e-07,1,169,1106,locomotion,BP,ZMYND8;SEMA4B;SLC16A3;PLAT;PGF;DOCK4;BBS2;POSTN;VEGFA;WNT7A;APOE;TSPAN1;F2R;LRP5;ITGA6;IDH2;PKN1;NISCH;EGFR;SERPINE2;SPRY2;SDC1;SHC1;HEXB;SLC7A8;MMP1;PHLDA2;CMTM7;PLTP;PC;MAP2K1;MCTP1;SSH1;SMURF2;FBLN1;SMAD3;PIK3R2;LRP1;DVL1;HBEGF;FAM110C;ITGB4;MBOAT7;ADARB1;AKT1;GRB7;CORO1B;HDAC5;PPM1F;MMP28;BSG;EPHA1;PTPRU;VEGFB;FGFR4;FGFR1;ELMO3;RAC2;NPHP4;B4GAT1;KLF7;SORL1;CEACAM1;EFS;PLAU;GAS6;PTK6;SEMA3F;LAMA5;CMTM4;BCR;ARPIN;ALOX15B;SPTB;PLXNB3;PAK6;CEMIP;PROCR;RASGEF1A;PRSS3;EPHB2;ADAM8;PLCG1;CD81;WNT3;TGFB1;UNK;GPC1;SHANK3;PODXL2;EFNB3;NSMF;ARAP3;RHOD;LAMB2;TNS1;DNAH1;SEMA4F;RHOF;RHOBTB2;PRKCZ;MINK1;ADA;PLEKHG5;SDCCAG8;ERBB2;MMP10;JAK3;NET1;CYFIP2;FSCN1;CYGB;PRKCD;BAX;ITGA1;SH3BP1;EREG;RPS6KA5;DDIT4;IER2;TGFBR3;LTB4R2;ADAM15;HDAC7;INPP5D;MIF;PLA2G6;DDT;ECM1;FYN;RAC3;SUN1;ARID5B;MAPK3;INSR;RERE;VANGL2;PAK1;PPP3CB;ROBO4;HYAL1;SEMA4C;ITGA3;MAP2K3;RRAS;PROX1;MDGA1;LMNA;KCTD13;FAM129B;CDH4;ITGA4;LAMB1;SOCS7;NDE1;NGFR;PDCD6;PXN;GRB10;LURAP1;BTG1;ZP3;CELSR1;SEMA3B;PFN2;DOK4;TRIM46;PKN3;SDC2
12378,GO:0048812,1.82606000481364e-07,1,81,431,neuron projection morphogenesis,BP,SEMA4B;DLG4;POSTN;VEGFA;WNT7A;APOE;EGFR;OBSL1;PTPRS;NFATC4;SHC1;LPAR3;MAP2K1;SSH1;SHANK2;DVL1;ADARB1;GRB7;S100A6;IMPACT;BRSK1;RAC2;B4GAT1;KLF7;ANK3;TWF2;SYNGAP1;SEMA3F;SLITRK6;SPTB;PLXNB3;FBXW8;EPHB2;PLCG1;NYAP1;WNT3;ULK2;GPC1;SHANK3;EFNB3;NSMF;FARP1;LAMB2;SEMA4F;LLGL1;LRP4;PRKCZ;MINK1;ERBB2;ULK1;CYFIP2;ARHGAP44;ITGA1;RPS6KA5;LIMK1;GDI1;FYN;STK25;RAC3;EEF2K;DNM2;MAPK3;ADCY1;RERE;VANGL2;PAK1;PPP3CB;CUL7;SEMA4C;CAPRIN2;FAM129B;CDH4;NGFR;GRB10;KIF13B;TCTN1;SEMA3B;SSH3;DOK4;TRIM46;SDC2
8220,GO:0032990,2.09684922651379e-07,1,85,462,cell part morphogenesis,BP,SEMA4B;DLG4;POSTN;VEGFA;WNT7A;APOE;EGFR;OBSL1;PTPRS;NFATC4;SHC1;LPAR3;MAP2K1;SSH1;SHANK2;DVL1;ADARB1;GRB7;CORO1B;S100A6;IMPACT;BRSK1;RAC2;B4GAT1;KLF7;ANK3;TWF2;SYNGAP1;SEMA3F;SLITRK6;ARPIN;SPTB;PLXNB3;FBXW8;EPHB2;PLCG1;NYAP1;WNT3;ULK2;GPC1;SHANK3;EFNB3;NSMF;FARP1;LAMB2;SEMA4F;LLGL1;LRP4;PRKCZ;MINK1;ERBB2;ULK1;CYFIP2;ARHGAP44;BAX;ITGA1;RPS6KA5;LIMK1;GDI1;FYN;STK25;RAC3;EEF2K;DNM2;MAPK3;ADCY1;RERE;VANGL2;PAK1;PPP3CB;CUL7;SEMA4C;CAPRIN2;BCL2L1;FAM129B;CDH4;NGFR;GRB10;KIF13B;TCTN1;SEMA3B;SSH3;DOK4;TRIM46;SDC2
2404,GO:0005576,2.33759935718323e-07,1,359,2809,extracellular region,CC,NT5E;XDH;SEMA4B;HTRA1;THSD4;PLAT;CST3;EPN3;FBXO2;APLN;PGF;XPC;PRNP;PYGB;POSTN;VEGFA;TNFRSF6B;THEM6;MXRA7;PGM1;WNT7A;APOE;PYGL;TSPAN1;NAGLU;F2R;PLD3;ITGA6;NDRG1;IDH2;ACOT7;ARRDC1;AKR7A2;EGFR;SERPINE2;DNPH1;LOXL1;VAT1;PTPRS;CTSO;CAPN2;CRTAP;LTBP4;PRSS8;SYTL1;SDC1;APPL2;LTBP2;LTBP1;ARL2;HEXB;SLC7A8;SLC2A3;ACTA2;MMP1;SNX9;RAPGEF3;GAA;GLUL;MAP2K2;KDSR;CTBS;CMTM7;PLTP;PGLS;MAP2K1;NAPRT;CRYL1;ACP5;MARCKSL1;TMEM8A;GALE;SLC9A3R2;FBLN1;ARHGAP23;THBS3;HBEGF;S100A4;ITGB4;CYBRD1;PRDX5;STOM;LY6K;CORO1B;TTYH3;S100A6;F12;MMP28;ENTPD6;PLEKHH3;BSG;SERPING1;DYSF;GGT1;VEGFB;CNTN1;PTHLH;FGFR4;HEBP1;WNT2B;FNDC4;LDLR;FAM131A;FGFR1;PRKACB;FUCA1;RAC2;SMOC2;PFKL;SEC14L2;GAMT;H2AFJ;B4GAT1;BPHL;SORL1;CEACAM1;B3GAT3;RAB11FIP4;IGFBP4;PODNL1;TWF2;CEP250;PLAU;GAS6;SEMA3F;PFKP;FGFBP1;CTSB;RAB3B;CARD11;LAMA5;GSN;CMTM4;IGFBP2;PCSK9;BCR;ANTXR2;ANGPTL4;EHD4;PRSS22;SLITRK6;ALOX15B;NXPH4;CCS;GGACT;COL13A1;OAF;HAGH;TFPI2;MVB12B;SERINC2;CEMIP;PROCR;PKD2;ACY1;FAM3A;GPX3;PCSK1;CTSZ;ITGB5;MAGEF1;PRSS3;EPOR;EPHB2;CADM4;APRT;LTA4H;CD81;ENTPD2;ADAMTS13;TIMP2;NUDCD2;WNT3;DPP7;GNAL;TMED4;TGFB1;CLTCL1;SNTB2;GPC1;ADAMTS7;DEAF1;TNFSF15;MDH2;GALNS;CLCA2;ABHD8;TUB;CROCC;CGREF1;ABHD14B;LAMB2;RNH1;VGF;TP73-AS1;SEMA4F;RHOF;WASF3;PHGDH;PEX1;TPP1;PCK2;AGRN;OLFML2A;IFNE;CD320;CEP131;TRAP1;IDUA;RFNG;YPEL5;PRKCZ;PRKACA;MINK1;GRHPR;ACTR1B;TOM1L2;CD9;ADA;AREG;MPI;CAPG;CNDP2;NINL;AHCY;VAMP2;MMP10;RNPEP;CYFIP2;FSCN1;PRKCD;FAM20C;RBL2;STUB1;BAX;ITGA1;OLFM2;PPCS;CHADL;EREG;TMEM25;PPL;PPP1R13L;PCSK1N;HPCAL1;CES2;NAGA;NID1;TGFBR3;NTPCR;CPNE7;DNM1;MFNG;GSTO1;ALDOC;CHAD;MSLN;ADAM15;REEP2;WDR60;ST3GAL3;TGFA;CHD2;ABHD15;MYO1D;JADE2;SPATA20;MIF;DOPEY2;BCAM;PLA2G6;DDT;NUDT14;ECM1;QSOX1;HSD11B1L;VWA1;EFEMP2;STK25;RAC3;ETFB;GLB1L2;DNM2;CKMT1A;GLB1;ATXN10;CAT;IGFBP7;ELFN2;ZDHHC1;TUBB6;MAPK3;CBLN3;INSR;SLC13A3;PDZD2;PFKM;ADCY1;HLA-G;TSTA3;PDXK;GLRX;TRIM45;RNASET2;LGALS3BP;CTSF;ROBO4;SLC37A2;GABBR1;HYAL1;SEMA4C;ITGA3;MAN2B1;DLG3;RRAS;DNASE1L1;IGIP;MDGA1;ADGRF1;ALDH7A1;PKD1;TNFRSF25;FAM129B;ITGA4;EDA;GAL3ST4;TRIP10;SERPINB1;ST3GAL2;LAMB1;NGFR;TOLLIP;PDCD6;ATP6V1F;PCLO;CHST14;BIVM;RNASE7;DUSP23;TCTN1;HFE;COL6A1;ZP3;IL17RE;SEMA3B;PFN2;FGFR3;TST;NDRG2;MAN2B2;CBLC;PTGR2;PRSS21;IRF2BPL;PM20D2;MEGF6;SLC26A11;AARS;SDC2
6641,GO:0023052,2.69252189923374e-07,1,497,3950,signaling,BP,TNIP1;DUSP6;XDH;DUSP5;ZMYND8;ADGRL1;SEMA4B;HTRA1;EGR1;NR1D1;EDEM1;DLG4;PLAT;CYP27B1;MRC2;APLN;PGF;PDCD4;CTNNBIP1;ACVR2B;DOCK4;PRNP;BBS2;DDIT4L;POSTN;VEGFA;TNFRSF6B;WNT7A;APOE;DGKA;TSPAN1;F2R;LRP5;ITGA6;PITPNC1;HMGA2;OBSCN;NDRG1;ELK3;ITPR3;PKN1;MTA1;ARRDC1;NISCH;FCGRT;EGFR;RPS6KA2;SERPINE2;WWTR1;SCN4B;NOS1;PTPRS;HADH;SPRY2;MST1R;NFATC4;LTBP4;SYTL1;SDC1;ETV5;APPL2;SHC1;LTBP2;LTBP1;ARL2;GTPBP1;PTPRE;SLC12A7;RIN1;MMP1;PHLDA2;SPRY4;RAPGEF3;ZFP36L1;GLUL;ARAP1;MAP2K2;LPAR3;PLCD3;MDFI;CMTM7;RBCK1;MAP2K1;MCTP1;SSH1;SMURF2;FOS;FBLN1;SMAD3;ARHGAP23;STAT6;SHANK2;PIK3R2;ERCC6;LRP1;GJC2;DVL1;EPAS1;HBEGF;FAM110C;AP2A2;S100A4;ITGB4;SHC2;NLGN2;PRODH;SALL2;PAG1;ADORA2B;ADARB1;PLCXD2;SYT8;AKT1;GRB7;KCNC4;TMOD2;FAM83A;S100A6;SH2D2A;PPM1F;PITPNM1;PLEKHH3;RHBDF2;BSG;STK39;ASAP2;EPHA1;PTPRU;VEGFB;WWC3;LRRC8A;CNTN1;IFNGR2;BRSK1;DAP;IFT140;PTHLH;MYZAP;RAB31;FGFR4;HEBP1;PEAR1;WNT2B;FGFR1;PRKACB;MAPKBP1;SIGMAR1;RAC2;SMOC2;PFKL;NPHP4;RALGDS;SORL1;CEACAM1;ASB13;LZTS2;TENM2;ZNF385A;DOCK6;ANK3;IGFBP4;EVC;CCND1;PODNL1;EFS;PCBP4;STRADB;SYNGAP1;PLCH2;MAPK13;EDNRA;CARD19;PLAU;GAS6;PTK6;SEMA3F;FGFBP1;CSNK1E;CTSB;RAB3B;CARD11;SH2B3;LAMA5;DUSP7;GSN;CMTM4;PLEKHG2;MAPKAPK3;IGFBP2;PCSK9;ARHGAP22;BCR;ANTXR2;ERRFI1;WIPF1;AIP;RGL2;TSPAN18;PAQR6;ARHGAP27;ALOX15B;SPTB;AGAP1;NXPH4;SLC20A1;NPR2;DGKQ;PLXNB3;BNIP3;PAK6;SHARPIN;MVB12B;PKD2;PCSK1;RASGEF1A;CDC42EP5;CRTC1;IL20RB;ITGB5;EPOR;EPHB2;GRIN3B;ADAM8;ASIC1;MNT;GRK6;CDKN1C;PLCG1;SH3BP2;NYAP1;CD81;CEBPB;ENTPD2;ADAMTS13;ZNF217;TIMP2;WNT3;GNAL;TMED4;TGFB1;SNPH;CLTCL1;ULK2;GPC1;MKNK2;MOAP1;NTSR1;ARHGAP25;SHANK3;EFNB3;RASA3;TNFSF15;MYCBPAP;NSMF;ARAP3;FARP1;MC1R;RHOD;SNX17;HTR7;VGF;PLEKHG4;SEMA4F;RHOF;LLGL1;PLEKHG3;KIF7;RHOBTB2;GIGYF1;RIMS3;TNFAIP8L1;PTPN1;TPP1;PCK2;WDR59;AGRN;MBD3;IFNE;CD320;CAMK2N1;LRP4;GPR153;VHL;TRAP1;ADAP1;PFKFB2;RFNG;MLXIPL;TRIB2;PRKCZ;PRKACA;MINK1;ZNF516;RHPN1;TOM1L2;CD9;EPN2;ADA;AREG;PIM2;PLEKHG5;BOK;NEURL1B;ERBB2;ADGRB2;ULK1;VAMP2;TFDP2;PLEK2;STK17A;JAK3;NET1;BNIP3L;CYFIP2;FSCN1;TRPC1;SLC22A17;RASA4;PDK1;ARHGAP44;PRKCD;FAM20C;MIB2;RBL2;CACNB3;USP20;STUB1;IFI6;BAX;SV2A;ITGA1;SH3BP1;FBXW4;EREG;RPS6KA5;DUSP4;TMBIM4;DDIT4;MBTPS2;SPRED3;PPP1R13L;AHNAK2;PCSK1N;MT2A;RASL10B;LIMK1;TGFBR3;PDIA5;GDI1;LTB4R2;LEMD2;RPS6KA6;DNM1;RGS14;SCN8A;MFNG;GSTO1;GIT1;CHAD;LRSAM1;ADAM15;ASB1;EHD3;TMEM231;MAPK12;IRAK1;TGFA;HDAC7;INPP5D;CHEK2;PPARA;TMEM161A;SESN2;CDC34;SOX7;ABCA7;RAB12;BCAP31;MIF;BCAM;PLA2G6;DDT;SYNGR1;ECM1;WFS1;DTX3;SPPL2B;FYN;STK25;RAC3;ARHGAP12;ACAP3;ARID5B;DNM2;PELI1;SNX15;CHKA;CAT;TSPYL2;SLC27A1;KIF26A;SLC12A4;PLCB3;IQSEC1;ARHGEF4;MAPK3;INSR;ARHGEF1;GRINA;PFKM;ADCY1;C12ORF66;HLA-G;DOCK9;TMEM101;RALGAPA1;VANGL2;PAK1;CAMKK2;PPP3CB;LGALS3BP;CUL7;GABBR1;MICAL1;SEMA4C;CAPRIN2;HES7;ITGA3;STK32C;SRMS;PPP2R5B;MAP2K3;BCL2L1;DLG3;RRAS;LRCH4;TBC1D16;ADGRF1;LMNA;PKD1;KCTD13;TNFRSF25;SIRT2;FAM129B;ITGA4;EDA;GAL3ST4;DCBLD2;TRIP10;ADCY7;LTB4R;RAB28;ICA1;RAP1GAP2;SOCS7;MAP3K10;RGS19;GPR3;PELI3;RAB40B;NGFR;TOLLIP;PDCD6;ATP6V1F;PCLO;PXN;GRB10;PLEKHM1;LURAP1;KIF13B;NR2F6;TCTN1;CAMK1;CAMKK1;SIRT3;HFE;ZP3;CELSR1;IL17RE;SEMA3B;PFN2;FGFR3;CCDC88C;NDRG2;CBLC;ITPKB;CDC42BPG;KDM3A;HOMER2;PKN3;APBA1;DEDD2;PI4KAP2;ADCY6;LRRK1;KLHL24;SDC2
12306,GO:0048667,2.86885166071264e-07,1,74,386,cell morphogenesis involved in neuron differentiation,BP,SEMA4B;DLG4;VEGFA;WNT7A;APOE;OBSL1;PTPRS;NFATC4;SHC1;LPAR3;MAP2K1;SSH1;SHANK2;DVL1;ADARB1;GRB7;S100A6;BRSK1;B4GAT1;KLF7;ANK3;TWF2;SYNGAP1;SEMA3F;SLITRK6;SPTB;PLXNB3;FBXW8;EPHB2;PLCG1;WNT3;UNK;ULK2;GPC1;SHANK3;EFNB3;NSMF;FARP1;LAMB2;SEMA4F;LLGL1;LRP4;MINK1;ERBB2;ULK1;CYFIP2;ARHGAP44;RPS6KA5;LIMK1;GDI1;FYN;STK25;EEF2K;DNM2;MAPK3;ADCY1;RERE;VANGL2;PAK1;PPP3CB;CUL7;SEMA4C;CAPRIN2;FAM129B;CDH4;NGFR;GRB10;KIF13B;TCTN1;SEMA3B;SSH3;DOK4;TRIM46;SDC2
322,GO:0000902,2.95887485739633e-07,1,116,693,cell morphogenesis,BP,SEMA4B;DLG4;PARVB;POSTN;VEGFA;WNT7A;APOE;EGFR;OBSL1;PTPRS;NFATC4;SHC1;HEXB;ARAP1;LPAR3;MAP2K1;SSH1;FBLN1;SHANK2;DVL1;ADARB1;GRB7;CORO1B;S100A6;EPHA1;FMNL2;IMPACT;BRSK1;RAC2;SYNE3;B4GAT1;KLF7;TENM2;ZNF385A;ANK3;TWF2;STRADB;SYNGAP1;SEMA3F;CSNK1E;LAMA5;WIPF1;SH3D19;SLITRK6;ARPIN;SPTB;PLXNB3;CDC42EP5;FBXW8;EPHB2;ADAM8;PLCG1;NYAP1;WNT3;UNK;ULK2;GPC1;SHANK3;EFNB3;NSMF;ARAP3;FARP1;RHOD;LAMB2;SEMA4F;RHOF;WASF3;LLGL1;RHOBTB2;LRP4;VHL;PRKCZ;MINK1;MICALL2;ERBB2;ULK1;RILPL1;NET1;CYFIP2;ARHGAP44;ITGA1;RPS6KA5;LIMK1;GDI1;ZFPM1;FYN;STK25;RAC3;EEF2K;DNM2;ZMYM3;MAPK3;ADCY1;RERE;VANGL2;PAK1;PPP3CB;CUL7;SEMA4C;CAPRIN2;PROX1;FAM129B;CDH4;ITGA4;LAMB1;NGFR;GRB10;KIF13B;TCTN1;NBEAL2;SLC39A3;SEMA3B;SSH3;DOK4;TRIM46;SDC2
7146,GO:0031012,3.14777518764742e-07,1,53,248,extracellular matrix,CC,HTRA1;THSD4;CST3;POSTN;VEGFA;MXRA7;WNT7A;APOE;ITGA6;SERPINE2;LOXL1;CRTAP;LTBP4;LTBP2;LTBP1;MMP1;FBLN1;THBS3;MMP28;WNT2B;SMOC2;PODNL1;FGFBP1;LAMA5;ANGPTL4;SLITRK6;TFPI2;ENTPD2;ADAMTS13;TIMP2;WNT3;TGFB1;GPC1;ADAMTS7;LAMB2;AGRN;OLFML2A;MMP10;CHADL;NID1;TGFBR3;CHAD;BCAM;ECM1;VWA1;EFEMP2;IGFBP7;LGALS3BP;SERPINB1;LAMB1;COL6A1;ZP3;SDC2
3373,GO:0007154,3.30608260152066e-07,1,499,3976,cell communication,BP,TNIP1;DUSP6;XDH;DUSP5;ZMYND8;ADGRL1;SEMA4B;HTRA1;EGR1;NR1D1;EDEM1;DLG4;PLAT;CYP27B1;MRC2;APLN;PGF;PDCD4;CTNNBIP1;ACVR2B;DOCK4;PRNP;BBS2;DDIT4L;POSTN;VEGFA;TNFRSF6B;WNT7A;APOE;DGKA;TSPAN1;F2R;LRP5;ITGA6;PITPNC1;HMGA2;OBSCN;NDRG1;ELK3;ITPR3;PKN1;MTA1;ARRDC1;NISCH;FCGRT;EGFR;RPS6KA2;SERPINE2;WWTR1;SCN4B;NOS1;PTPRS;HADH;SPRY2;MST1R;NFATC4;LTBP4;SYTL1;SDC1;ETV5;APPL2;SHC1;LTBP2;LTBP1;ARL2;GTPBP1;PTPRE;SLC12A7;RIN1;MMP1;PHLDA2;SPRY4;RAPGEF3;ZFP36L1;GLUL;ARAP1;MAP2K2;LPAR3;PLCD3;MDFI;CMTM7;RBCK1;MAP2K1;MCTP1;SSH1;SMURF2;FOS;FBLN1;SMAD3;ARHGAP23;STAT6;SHANK2;PIK3R2;ERCC6;LRP1;GJC2;DVL1;EPAS1;HBEGF;FAM110C;AP2A2;S100A4;ITGB4;SHC2;NLGN2;PRODH;SALL2;PAG1;ADORA2B;ADARB1;PLCXD2;SYT8;AKT1;GRB7;KCNC4;TMOD2;FAM83A;S100A6;SH2D2A;PPM1F;PITPNM1;PLEKHH3;RHBDF2;BSG;STK39;ASAP2;EPHA1;PTPRU;VEGFB;IMPACT;WWC3;LRRC8A;CNTN1;IFNGR2;BRSK1;DAP;IFT140;PTHLH;MYZAP;RAB31;FGFR4;HEBP1;PEAR1;WNT2B;FGFR1;PRKACB;MAPKBP1;SIGMAR1;RAC2;SMOC2;PFKL;NPHP4;RALGDS;SORL1;CEACAM1;ASB13;LZTS2;TENM2;ZNF385A;DOCK6;ANK3;IGFBP4;EVC;CCND1;PODNL1;EFS;PCBP4;STRADB;SYNGAP1;PLCH2;MAPK13;EDNRA;CARD19;PLAU;GAS6;PTK6;SEMA3F;FGFBP1;CSNK1E;CTSB;RAB3B;CARD11;SH2B3;LAMA5;DUSP7;GSN;CMTM4;PLEKHG2;MAPKAPK3;IGFBP2;PCSK9;ARHGAP22;BCR;ANTXR2;ERRFI1;WIPF1;AIP;RGL2;TSPAN18;PAQR6;ARHGAP27;ALOX15B;SPTB;AGAP1;NXPH4;SLC20A1;NPR2;DGKQ;PLXNB3;BNIP3;PAK6;SHARPIN;MVB12B;PKD2;PCSK1;RASGEF1A;CDC42EP5;CRTC1;IL20RB;ITGB5;EPOR;EPHB2;GRIN3B;ADAM8;ASIC1;MNT;GRK6;CDKN1C;PLCG1;CBS;SH3BP2;NYAP1;CD81;CEBPB;ENTPD2;ADAMTS13;ZNF217;TIMP2;WNT3;GNAL;TMED4;TGFB1;SNPH;CLTCL1;ULK2;GPC1;MKNK2;MOAP1;NTSR1;ARHGAP25;SHANK3;EFNB3;RASA3;TNFSF15;MYCBPAP;NSMF;ARAP3;FARP1;MC1R;RHOD;SNX17;HTR7;VGF;PLEKHG4;SEMA4F;RHOF;LLGL1;PLEKHG3;KIF7;RHOBTB2;GIGYF1;RIMS3;TNFAIP8L1;PTPN1;TPP1;PCK2;WDR59;AGRN;MBD3;IFNE;CD320;CAMK2N1;LRP4;GPR153;VHL;TRAP1;ADAP1;PFKFB2;RFNG;MLXIPL;TRIB2;PRKCZ;PRKACA;MINK1;ZNF516;RHPN1;TOM1L2;CD9;EPN2;ADA;AREG;PIM2;PLEKHG5;BOK;NEURL1B;ERBB2;ADGRB2;ULK1;VAMP2;TFDP2;PLEK2;STK17A;JAK3;NET1;BNIP3L;CYFIP2;FSCN1;SLC22A17;RASA4;PDK1;ARHGAP44;PRKCD;FAM20C;MIB2;RBL2;CACNB3;USP20;STUB1;IFI6;BAX;SV2A;ITGA1;SH3BP1;FBXW4;GJB4;EREG;RPS6KA5;DUSP4;TMBIM4;DDIT4;MBTPS2;SPRED3;PPP1R13L;AHNAK2;PCSK1N;MT2A;RASL10B;LIMK1;TGFBR3;PDIA5;GDI1;LTB4R2;LEMD2;RPS6KA6;DNM1;RGS14;SCN8A;MFNG;GSTO1;GIT1;CHAD;LRSAM1;ADAM15;ASB1;TMEM231;MAPK12;IRAK1;TGFA;HDAC7;INPP5D;CHEK2;PPARA;TMEM161A;SESN2;CDC34;SOX7;ABCA7;RAB12;BCAP31;MIF;BCAM;PLA2G6;DDT;SYNGR1;ECM1;WFS1;DTX3;SPPL2B;FYN;UPP1;STK25;RAC3;ARHGAP12;ACAP3;ARID5B;DNM2;PELI1;SNX15;CHKA;CAT;TSPYL2;SLC27A1;KIF26A;SLC12A4;PLCB3;IQSEC1;ARHGEF4;MAPK3;INSR;ARHGEF1;GRINA;PFKM;ADCY1;C12ORF66;HLA-G;DOCK9;TMEM101;RALGAPA1;VANGL2;PAK1;CAMKK2;PPP3CB;LGALS3BP;CUL7;GABBR1;MICAL1;SEMA4C;CAPRIN2;HES7;ITGA3;STK32C;SRMS;PPP2R5B;MAP2K3;BCL2L1;DLG3;RRAS;LRCH4;ADGRF1;LMNA;PKD1;KCTD13;TNFRSF25;SIRT2;FAM129B;ITGA4;EDA;GAL3ST4;DCBLD2;TRIP10;ADCY7;LTB4R;RAB28;ICA1;RAP1GAP2;SOCS7;MAP3K10;RGS19;GPR3;PELI3;RAB40B;NGFR;TOLLIP;PDCD6;ATP6V1F;PCLO;PXN;GRB10;PLEKHM1;LURAP1;KIF13B;NR2F6;TCTN1;CAMK1;CAMKK1;SIRT3;HFE;GAS2L1;ZP3;CELSR1;IL17RE;SEMA3B;PFN2;FGFR3;CCDC88C;NDRG2;CBLC;ITPKB;CDC42BPG;KDM3A;HOMER2;PKN3;APBA1;DEDD2;PI4KAP2;ADCY6;LRRK1;KLHL24;SDC2
3256,GO:0006928,3.83320550159115e-07,1,188,1274,movement of cell or subcellular component,BP,ZMYND8;SEMA4B;SLC16A3;PLAT;PGF;DOCK4;BBS2;POSTN;VEGFA;WNT7A;APOE;TSPAN1;F2R;LRP5;ITGA6;IDH2;PKN1;NISCH;EGFR;SERPINE2;SCN4B;SPRY2;SDC1;SHC1;HEXB;SLC7A8;MMP1;PHLDA2;ARAP1;PLTP;MAP2K1;MCTP1;SSH1;SMURF2;KLC2;FBLN1;SMAD3;PIK3R2;LRP1;DVL1;HBEGF;FAM110C;AP2A2;ITGB4;MBOAT7;ADARB1;AKT1;GRB7;CORO1B;HDAC5;PPM1F;MMP28;BSG;EPHA1;PTPRU;VEGFB;IFT140;DNAAF5;FGFR4;FGFR1;ELMO3;RAC2;NPHP4;B4GAT1;KLF7;SORL1;CEACAM1;EFS;TNNT1;PLAU;GAS6;PTK6;SEMA3F;LAMA5;BCR;WIPF1;ARPIN;ALOX15B;SPTB;SNTA1;PLXNB3;PAK6;FYCO1;CEMIP;PROCR;RASGEF1A;AP3D1;PRSS3;EPHB2;ADAM8;PLCG1;KIF17;CD81;WNT3;TGFB1;UNK;GPC1;SHANK3;PODXL2;EFNB3;KIF26B;NSMF;ARAP3;RHOD;LAMB2;TNS1;DNAH1;SEMA4F;RHOF;KIF7;RHOBTB2;CEP131;PRKCZ;MINK1;CD9;ADA;PLEKHG5;SDCCAG8;ERBB2;MMP10;JAK3;NET1;CYFIP2;FSCN1;CYGB;PRKCD;BAX;ITGA1;SH3BP1;EREG;RPS6KA5;DDIT4;IER2;TGFBR3;TPM2;LTB4R2;ADAM15;WDR60;HDAC7;INPP5D;MYO1D;MYH15;MIF;DDT;ECM1;FYN;RAC3;SUN1;ARID5B;KIF26A;MAPK3;INSR;RERE;VANGL2;PAK1;ROBO4;HYAL1;SEMA4C;ITGA3;MAP2K3;RRAS;PROX1;MDGA1;LMNA;KCTD13;FAM129B;CDH4;ITGA4;LAMB1;SOCS7;NDE1;NGFR;PDCD6;PXN;GRB10;LURAP1;KIF13B;BTG1;ZP3;CELSR1;SEMA3B;PFN2;BLOC1S4;DOK4;TRIM46;PKN3;APBA1;SDC2
11424,GO:0045860,3.84630184772616e-07,1,71,372,positive regulation of protein kinase activity,BP,DUSP6;DUSP5;EGR1;DLG4;ACVR2B;PRNP;VEGFA;F2R;PKN1;EGFR;SPRY2;MST1R;SHC1;SNX9;MAP2K2;LPAR3;MAP2K1;ERCC6;SHC2;ADORA2B;AKT1;STK39;FGFR1;PRKACB;CCND1;STRADB;GAS6;DUSP7;MAPKAPK3;CDC25B;DGKQ;PAK6;CEMIP;PKD2;ADAM8;PLCG1;CD81;TGFB1;NAB2;TNFSF15;PTPN1;PRKCZ;PRKACA;MINK1;ERBB2;PRKCD;BAX;ITGA1;EREG;IRAK1;TGFA;MIF;STK25;SLC27A1;MAPK3;INSR;ADCY1;ETAA1;VANGL2;PAK1;CAMKK2;MAP2K3;DLG3;PROX1;PKD1;ADCY7;MAPRE3;MAP3K10;CAMK1;CAMKK1;ADCY6
5664,GO:0016773,4.51072210612664e-07,1,101,583,phosphotransferase activity, alcohol group as acceptor,MF,ACVR2B;DGKA;HMGA2;OBSCN;NEK9;PKN1;EGFR;RPS6KA2;MST1R;LTBP4;LTBP1;MAP2K2;MAP2K1;MARK4;PIK3R2;HBEGF;CDK18;NMRK1;AKT1;STK39;HK1;EPHA1;ZFYVE21;BRSK1;FGFR4;FGFR1;PRKACB;PFKL;CCND1;STRADB;MAPK13;PTK6;PFKP;CSNK1E;MAPKAPK3;BCR;NADK;PANK4;NPR2;DGKQ;PAK6;EPHB2;GRK6;SCYL1;ULK2;MKNK2;EFNB3;PIP5KL1;PI4K2A;PFKFB2;PRKCZ;PRKACA;MINK1;PIM2;ERBB2;ULK1;STK17A;JAK3;PDK1;PRKCD;FAM20C;EREG;RPS6KA5;LIMK1;TGFBR3;RPS6KA6;MAPK12;IRAK1;PI4K2B;CHEK2;FGGY;SPEG;TRPT1;FYN;STK25;EEF2K;PELI1;CHKA;MAPK3;INSR;PFKM;PDXK;PAK1;CAMKK2;ALPK1;PFKFB3;STK32C;SRMS;MAP2K3;MAP3K10;PELI3;CAMK1;CAMKK1;CDK11B;FGFR3;ITPKB;CDC42BPG;CLK3;PKN3;PI4KAP2;LRRK1
4510,GO:0010562,6.29424763835515e-07,1,115,702,positive regulation of phosphorus metabolic process,BP,DUSP6;XDH;DUSP5;EGR1;DLG4;APLN;ACVR2B;PRNP;VEGFA;WNT7A;APOE;F2R;ITGA6;PKN1;EGFR;NOS1;SPRY2;MST1R;SHC1;SNX9;RAPGEF3;MAP2K2;LPAR3;MAP2K1;SMAD3;ERCC6;DVL1;HBEGF;SHC2;ADORA2B;AKT1;STK39;EPHA1;CNTN1;PTHLH;FGFR4;FGFR1;PRKACB;IGFBP4;CCND1;STRADB;GAS6;PTK6;DUSP7;MAPKAPK3;EHD4;CDC25B;DGKQ;PAK6;CEMIP;PKD2;EPHB2;ADAM8;PLCG1;CD81;TIMP2;TGFB1;NTSR1;NAB2;TNFSF15;NSMF;PTPN1;IFNE;LRP4;PFKFB2;MLXIPL;PRKCZ;PRKACA;MINK1;AREG;ERBB2;PRKCD;BAX;ITGA1;EREG;RPS6KA5;SYMPK;IRAK1;TGFA;CHEK2;ABCA7;MIF;PLA2G6;DDT;FYN;STK25;SLC27A1;MAPK3;INSR;TAZ;ADCY1;ETAA1;VANGL2;PAK1;CAMKK2;PFKFB3;SEMA4C;CAPRIN2;MAP2K3;DLG3;PROX1;PKD1;TNFRSF25;ADCY7;MAPRE3;MAP3K10;NGFR;CAMK1;CAMKK1;HFE;ZP3;PFN2;FGFR3;ADCY6;LRRK1
11470,GO:0045937,6.29424763835515e-07,1,115,702,positive regulation of phosphate metabolic process,BP,DUSP6;XDH;DUSP5;EGR1;DLG4;APLN;ACVR2B;PRNP;VEGFA;WNT7A;APOE;F2R;ITGA6;PKN1;EGFR;NOS1;SPRY2;MST1R;SHC1;SNX9;RAPGEF3;MAP2K2;LPAR3;MAP2K1;SMAD3;ERCC6;DVL1;HBEGF;SHC2;ADORA2B;AKT1;STK39;EPHA1;CNTN1;PTHLH;FGFR4;FGFR1;PRKACB;IGFBP4;CCND1;STRADB;GAS6;PTK6;DUSP7;MAPKAPK3;EHD4;CDC25B;DGKQ;PAK6;CEMIP;PKD2;EPHB2;ADAM8;PLCG1;CD81;TIMP2;TGFB1;NTSR1;NAB2;TNFSF15;NSMF;PTPN1;IFNE;LRP4;PFKFB2;MLXIPL;PRKCZ;PRKACA;MINK1;AREG;ERBB2;PRKCD;BAX;ITGA1;EREG;RPS6KA5;SYMPK;IRAK1;TGFA;CHEK2;ABCA7;MIF;PLA2G6;DDT;FYN;STK25;SLC27A1;MAPK3;INSR;TAZ;ADCY1;ETAA1;VANGL2;PAK1;CAMKK2;PFKFB3;SEMA4C;CAPRIN2;MAP2K3;DLG3;PROX1;PKD1;TNFRSF25;ADCY7;MAPRE3;MAP3K10;NGFR;CAMK1;CAMKK1;HFE;ZP3;PFN2;FGFR3;ADCY6;LRRK1
17258,GO:0120036,8.25790377172768e-07,0.999999680458765,158,1031,plasma membrane bounded cell projection organization,BP,ZMYND8;SEMA4B;DLG4;PRNP;PARVB;BBS2;POSTN;VEGFA;WNT7A;APOE;ESPN;ITGA6;EVI5L;EGFR;WWTR1;OBSL1;PTPRS;NFATC4;SHC1;NUDCD3;ARAP1;LPAR3;MAP2K1;SSH1;MARK4;SHANK2;LRP1;DVL1;ADARB1;AKT1;GRB7;CORO1B;S100A6;IMPACT;CNTN1;BRSK1;IFT140;DNAAF5;FGFR1;RAC2;NPHP4;B4GAT1;KLF7;TENM2;ANK3;TWF2;SYNGAP1;CEP250;PTK6;SEMA3F;CSNK1E;LAMA5;GSN;SEPT10;DBNDD1;CCDC113;SLITRK6;ARPIN;SPTB;UNC119B;PLXNB3;CTSZ;CDC42EP5;CRTC1;FBXW8;EPHB2;PTPDC1;PLCG1;KIF17;NYAP1;WNT3;RFX2;ULK2;GPC1;SHANK3;EFNB3;NSMF;FARP1;CROCC;RHOD;LAMB2;DNAH1;SEMA4F;WASF3;LLGL1;BBS1;AGRN;LRP4;CEP131;PRKCZ;PRKACA;MINK1;AREG;MICALL2;SDCCAG8;ERBB2;ULK1;NINL;RILPL1;CYFIP2;FSCN1;ARHGAP44;PRKCD;ITGA1;SH3BP1;RPS6KA5;DGUOK;LIMK1;GDI1;EHD3;WDR60;TMEM231;DNAAF3;FYN;STK25;RAC3;EEF2K;DNM2;ATXN10;ARHGEF4;MAPK3;INSR;ADCY1;RERE;CEP72;VANGL2;PAK1;PPP3CB;USP21;CUL7;SEMA4C;CAPRIN2;ITGA3;PPP2R5B;ADGRF1;FAM129B;CDH4;RAP1GAP2;LAMB1;NDE1;NGFR;GRB10;PLEKHM1;MSS51;KIF13B;TCTN1;CAMK1;BBS10;SEMA3B;SEPT6;PFN2;SSH3;BLOC1S4;DOK4;TRIM46;TTLL3;ADCY6;SDC2
3175,GO:0006796,9.01767965285848e-07,0.999999624463542,307,2297,phosphate-containing compound metabolic process,BP,TNIP1;DUSP6;NT5E;XDH;DUSP5;EGR1;H6PD;DLG4;APLN;PDCD4;ACVR2B;PRNP;VEGFA;PGM1;WNT7A;APOE;PYGL;DGKA;F2R;LRP5;OSBPL5;LPCAT4;ITGA6;ISYNA1;HMGA2;OBSCN;IDH2;NEK9;PKN1;ACOT7;EGFR;RPS6KA2;DNPH1;WWTR1;NOS1;PTPRS;SPRY2;MST1R;SHC1;HEXB;GTPBP1;PTPRE;TK2;SNX9;SPRY4;RAPGEF3;ZFP36L1;MAP2K2;NME4;LPAR3;PLCD3;PPP1R35;PGLS;MAP2K1;NAPRT;CRYL1;ACP5;SSH1;MARK4;FBLN1;SMAD3;PIK3R2;ERCC6;GJC2;SRD5A3;DVL1;PIGQ;HBEGF;PPP1R14A;PPP2R3B;SHC2;MBOAT7;CDK18;NMRK1;ADORA2B;ADARB1;AKT1;NT5DC1;PPM1F;PITPNM1;STK39;HK1;EPHA1;PTPRU;IMPACT;ZFYVE21;CNTN1;BRSK1;PTHLH;FGFR4;LDLR;FGFR1;PRKACB;RAC2;KCNAB2;PFKL;PPM1J;PIGV;SORL1;CEACAM1;B3GAT3;IGFBP4;TTC7B;CCND1;PODNL1;LHPP;STRADB;SYNGAP1;PLCH2;MAPK13;GAS6;PTK6;PFKP;CSNK1E;CARD11;DUSP7;MAPKAPK3;PCSK9;DHTKD1;BCR;EHD4;ERRFI1;NADK;PANK4;CDC25B;SPTB;SLC20A1;NPR2;DGKQ;PAK6;SERINC2;CEMIP;PKD2;RASGEF1A;CDC42EP5;EPHB2;ADAM8;APRT;CTBP1;PTPDC1;GRK6;CDKN1C;PLCG1;CD81;MVD;ENTPD2;TIMP2;SYNJ2;TGFB1;SCYL1;ULK2;MKNK2;NTSR1;NAB2;SHANK3;PODXL2;SDHA;RASA3;PIP5KL1;TNFSF15;MDH2;NSMF;FARP1;ABHD14B;PI4K2A;PLPP6;PTPN1;PCK2;IFNE;CAMK2N1;OSBPL10;LRP4;ACP6;PFKFB2;MLXIPL;TRIB2;PRKCZ;PRKACA;MINK1;ADA;AREG;PIM2;MPI;UCKL1;ERBB2;ULK1;STK17A;JAK3;RASA4;PDK1;PRKCD;FAM20C;RBL2;BAX;CYC1;SBF1;ITGA1;PPCS;EREG;RPS6KA5;DGUOK;DUSP4;DDIT4;LIMK1;TGFBR3;NTPCR;LTB4R2;CPNE7;LEMD2;RPS6KA6;RGS14;ALDOC;CHAD;LPCAT1;SYMPK;MAPK12;IRAK1;TGFA;INPP5D;PI4K2B;CHEK2;PPARA;SESN2;FGGY;MYO1D;ABCA7;SPEG;MIF;PLA2G6;DDT;TRPT1;FYN;PITPNM3;UPP1;STK25;EEF2K;CKMT1A;PELI1;CHKA;NEIL1;TSPYL2;ELFN2;SLC27A1;PLCB3;MAPK3;INSR;TAZ;PFKM;ADCY1;PDXK;ETAA1;VANGL2;PAK1;CAMKK2;PPP3CB;ALPK1;PFKFB3;GABBR1;MICAL1;SEMA4C;CAPRIN2;STK32C;SAMD8;SRMS;PPP2R5B;MAP2K3;DLG3;NDUFV3;RRAS;PROX1;PKD1;TNFRSF25;SIRT2;NMNAT2;NT5C1B;ADCY7;MAPRE3;SOCS7;MAP3K10;PELI3;NGFR;TOLLIP;GRB10;DUSP23;GCH1;CAMK1;CAMKK1;SIRT3;HFE;ZP3;CDK11B;PFN2;SSH3;FGFR3;PPP1R16A;CCDC88C;NDRG2;CBLC;ITPKB;SPTLC2;CDC42BPG;CLK3;PKN3;PI4KAP2;AK3;ADCY6;LRRK1
11143,GO:0045202,1.01929739525065e-06,0.999999641120325,91,519,synapse,CC,SDK2;ZMYND8;ADGRL1;NR1D1;DLG4;FBXO2;PRR7;PRNP;POSTN;WNT7A;F2R;SH2D5;EGFR;SERPINE2;NOS1;PTPRS;SYTL1;GLUL;MCTP1;SHANK2;DVL1;NLGN2;SYT8;AKT1;KCNC4;BRSK1;SIGMAR1;KCNAB2;NPHP4;TENM2;ANK3;NIPSNAP1;SYNGAP1;RAB3B;LAMA5;BCR;DBNDD1;COL13A1;SNTA1;BNIP3;SHARPIN;CRTC1;AP3D1;EPHB2;GRIN3B;ASIC1;SNPH;ABHD17C;SNTB2;NTSR1;SHANK3;NSMF;FARP1;LAMB2;PI4K2A;SEMA4F;RIMS3;AGRN;CAMK2N1;LRP4;MINK1;VAMP2;CYFIP2;ARHGAP44;SV2A;OLFM2;DNM1;RGS14;MTHFR;DTNB;SYNGR1;FYN;EEF2K;DNM2;CBLN3;GABBR1;MICAL1;SEMA4C;ITGA3;BCL2L1;DLG3;NMNAT2;ICA1;NDE1;RAB40B;PCLO;SEPT6;PFN2;HOMER2;APBA1;STRN4
12411,GO:0048870,1.11248330960721e-06,0.999999571792632,148,963,cell motility,BP,ZMYND8;SEMA4B;SLC16A3;PLAT;PGF;DOCK4;BBS2;POSTN;VEGFA;WNT7A;APOE;TSPAN1;F2R;LRP5;ITGA6;IDH2;PKN1;NISCH;EGFR;SERPINE2;SPRY2;SDC1;SHC1;HEXB;SLC7A8;MMP1;PHLDA2;PLTP;MAP2K1;MCTP1;SSH1;SMURF2;FBLN1;SMAD3;PIK3R2;LRP1;HBEGF;FAM110C;ITGB4;MBOAT7;ADARB1;AKT1;GRB7;CORO1B;HDAC5;PPM1F;MMP28;BSG;EPHA1;PTPRU;VEGFB;FGFR4;FGFR1;ELMO3;RAC2;NPHP4;SORL1;CEACAM1;EFS;PLAU;GAS6;PTK6;SEMA3F;LAMA5;BCR;ARPIN;ALOX15B;PLXNB3;PAK6;CEMIP;PROCR;RASGEF1A;PRSS3;ADAM8;PLCG1;CD81;TGFB1;UNK;GPC1;PODXL2;NSMF;ARAP3;RHOD;TNS1;DNAH1;SEMA4F;RHOF;RHOBTB2;PRKCZ;MINK1;ADA;PLEKHG5;SDCCAG8;ERBB2;MMP10;JAK3;NET1;FSCN1;CYGB;PRKCD;BAX;ITGA1;SH3BP1;EREG;DDIT4;IER2;TGFBR3;LTB4R2;ADAM15;HDAC7;INPP5D;MIF;DDT;ECM1;FYN;RAC3;SUN1;ARID5B;MAPK3;INSR;RERE;VANGL2;PAK1;ROBO4;HYAL1;SEMA4C;ITGA3;MAP2K3;RRAS;PROX1;MDGA1;LMNA;KCTD13;ITGA4;LAMB1;SOCS7;NDE1;PDCD6;PXN;LURAP1;BTG1;ZP3;CELSR1;SEMA3B;PFN2;TRIM46;PKN3;SDC2
13118,GO:0051674,1.11248330960721e-06,0.999999571792632,148,963,localization of cell,BP,ZMYND8;SEMA4B;SLC16A3;PLAT;PGF;DOCK4;BBS2;POSTN;VEGFA;WNT7A;APOE;TSPAN1;F2R;LRP5;ITGA6;IDH2;PKN1;NISCH;EGFR;SERPINE2;SPRY2;SDC1;SHC1;HEXB;SLC7A8;MMP1;PHLDA2;PLTP;MAP2K1;MCTP1;SSH1;SMURF2;FBLN1;SMAD3;PIK3R2;LRP1;HBEGF;FAM110C;ITGB4;MBOAT7;ADARB1;AKT1;GRB7;CORO1B;HDAC5;PPM1F;MMP28;BSG;EPHA1;PTPRU;VEGFB;FGFR4;FGFR1;ELMO3;RAC2;NPHP4;SORL1;CEACAM1;EFS;PLAU;GAS6;PTK6;SEMA3F;LAMA5;BCR;ARPIN;ALOX15B;PLXNB3;PAK6;CEMIP;PROCR;RASGEF1A;PRSS3;ADAM8;PLCG1;CD81;TGFB1;UNK;GPC1;PODXL2;NSMF;ARAP3;RHOD;TNS1;DNAH1;SEMA4F;RHOF;RHOBTB2;PRKCZ;MINK1;ADA;PLEKHG5;SDCCAG8;ERBB2;MMP10;JAK3;NET1;FSCN1;CYGB;PRKCD;BAX;ITGA1;SH3BP1;EREG;DDIT4;IER2;TGFBR3;LTB4R2;ADAM15;HDAC7;INPP5D;MIF;DDT;ECM1;FYN;RAC3;SUN1;ARID5B;MAPK3;INSR;RERE;VANGL2;PAK1;ROBO4;HYAL1;SEMA4C;ITGA3;MAP2K3;RRAS;PROX1;MDGA1;LMNA;KCTD13;ITGA4;LAMB1;SOCS7;NDE1;PDCD6;PXN;LURAP1;BTG1;ZP3;CELSR1;SEMA3B;PFN2;TRIM46;PKN3;SDC2
8488,GO:0033674,1.27781250405566e-06,0.99999956652308,76,415,positive regulation of kinase activity,BP,DUSP6;DUSP5;EGR1;DLG4;ACVR2B;PRNP;VEGFA;F2R;PKN1;EGFR;SPRY2;MST1R;SHC1;SNX9;MAP2K2;LPAR3;MAP2K1;ERCC6;SHC2;ADORA2B;AKT1;STK39;EPHA1;FGFR4;FGFR1;PRKACB;CCND1;STRADB;GAS6;DUSP7;MAPKAPK3;CDC25B;DGKQ;PAK6;CEMIP;PKD2;EPHB2;ADAM8;PLCG1;CD81;TGFB1;NAB2;TNFSF15;PTPN1;PFKFB2;PRKCZ;PRKACA;MINK1;ERBB2;PRKCD;BAX;ITGA1;EREG;IRAK1;TGFA;MIF;STK25;SLC27A1;MAPK3;INSR;ADCY1;ETAA1;VANGL2;PAK1;CAMKK2;MAP2K3;DLG3;PROX1;PKD1;ADCY7;MAPRE3;MAP3K10;CAMK1;CAMKK1;FGFR3;ADCY6
10294,GO:0043062,1.3110584536967e-06,0.999999601891111,52,247,extracellular structure organization,BP,HTRA1;THSD4;CST3;POSTN;APOE;ITGA6;LOXL1;CAPN2;SDC1;MMP1;PLTP;FBLN1;SMAD3;LRP1;THBS3;ITGB4;SH3PXD2B;BSG;FGFR4;PRKACB;SMOC2;GAS6;LAMA5;COL13A1;ITGB5;SH3PXD2A;ADAM8;TIMP2;TGFB1;LAMB2;ERO1B;ADAM19;AGRN;OLFML2A;PRKACA;MMP10;FSCN1;ITGA1;CHADL;ZDHHC8;NID1;ADAM15;ABCG1;ABCA7;VWA1;EFEMP2;ICAM5;HYAL1;ITGA3;ITGA4;LAMB1;COL6A1
3587,GO:0008015,1.48995115672944e-06,0.999999545688952,52,250,blood circulation,BP,APLN;CTNNBIP1;DOCK4;BBS2;POSTN;APOE;F2R;LRP5;ITPR3;NISCH;EGFR;SCN4B;NOS1;GAA;SMAD3;EPAS1;HBEGF;ADORA2B;AKT1;STK39;SERPING1;VEGFB;CEACAM1;TNNT1;EDNRA;GAS6;BCR;NPR2;SNTA1;CTSZ;TGFB1;NTSR1;HTR7;PRKACA;ADA;RNPEP;TRPC1;CACNB3;ITGA1;PPP1R13L;RASL10B;GSTO1;EHD3;MTHFR;PPARA;PLA2G6;PLCB3;TAZ;MAP2K3;TBC1D8;GCH1;ADCY6
2406,GO:0005578,1.63674733959761e-06,0.999999363936306,43,190,proteinaceous extracellular matrix,CC,THSD4;CST3;POSTN;VEGFA;WNT7A;ITGA6;LOXL1;CRTAP;LTBP4;LTBP2;LTBP1;MMP1;FBLN1;MMP28;WNT2B;SMOC2;PODNL1;LAMA5;ANGPTL4;SLITRK6;TFPI2;ENTPD2;ADAMTS13;TIMP2;WNT3;TGFB1;GPC1;ADAMTS7;LAMB2;AGRN;OLFML2A;MMP10;CHADL;NID1;TGFBR3;CHAD;ECM1;VWA1;EFEMP2;LGALS3BP;LAMB1;COL6A1;ZP3
12661,GO:0050877,1.66547133480017e-06,0.999999274771799,75,411,nervous system process,BP,DLG4;PRNP;BBS2;APOE;ESPN;F2R;ITPR3;EGFR;SERPINE2;SPRY2;HEXB;GAA;FOS;SHANK2;DVL1;EPAS1;NLGN2;ADARB1;TMOD2;LDLR;FGFR1;KCNAB2;RAG1;ZNF385A;ANK3;NIPSNAP1;SYNGAP1;BCR;SLITRK6;CEMIP;CRTC1;EPHB2;ASIC1;CEBPB;GNAL;DEAF1;NTSR1;SHANK3;EML2;TUB;LAMB2;WASF3;BBS1;TPP1;B4GALT2;PRKCZ;RABGGTA;REEP6;OLFM2;GJB4;AHNAK2;DNM1;RGS14;SCN8A;REEP2;ABCA7;DOPEY2;PLA2G6;WFS1;FYN;RAC3;MAPK3;INSR;ADCY1;PPP3CB;ITGA3;ADGRF1;ALDH7A1;GCH1;NR2F6;ZNF513;BBS10;BLOC1S4;HOMER2;AARS
10420,GO:0043270,1.68290625361672e-06,0.99999946538416,31,121,positive regulation of ion transport,BP,FHL1;APOE;F2R;SCN4B;NOS1;PRSS8;ORAI1;LPAR3;GJC2;AKT1;STK39;CNTN1;ANK3;RAB3B;CEMIP;PKD2;EPHB2;PLCG1;NTSR1;SHANK3;TRPC1;PRKCD;BAX;GSTO1;EHD3;ABCA7;MIF;PLA2G6;WFS1;DNM2;GLRX
1260,GO:0003013,1.91346344964808e-06,0.9999994122971,52,252,circulatory system process,BP,APLN;CTNNBIP1;DOCK4;BBS2;POSTN;APOE;F2R;LRP5;ITPR3;NISCH;EGFR;SCN4B;NOS1;GAA;SMAD3;EPAS1;HBEGF;ADORA2B;AKT1;STK39;SERPING1;VEGFB;CEACAM1;TNNT1;EDNRA;GAS6;BCR;NPR2;SNTA1;CTSZ;TGFB1;NTSR1;HTR7;PRKACA;ADA;RNPEP;TRPC1;CACNB3;ITGA1;PPP1R13L;RASL10B;GSTO1;EHD3;MTHFR;PPARA;PLA2G6;PLCB3;TAZ;MAP2K3;TBC1D8;GCH1;ADCY6
3174,GO:0006793,2.10435685392123e-06,0.99999870294339,314,2369,phosphorus metabolic process,BP,TNIP1;DUSP6;NT5E;XDH;DUSP5;EGR1;H6PD;DLG4;APLN;PDCD4;ACVR2B;PRNP;VEGFA;PGM1;WNT7A;APOE;PYGL;DGKA;F2R;LRP5;OSBPL5;LPCAT4;ITGA6;ISYNA1;HMGA2;OBSCN;IDH2;NEK9;PKN1;ACOT7;ACSF2;EGFR;RPS6KA2;DNPH1;WWTR1;NOS1;PTPRS;SPRY2;MST1R;SHC1;HEXB;GTPBP1;PTPRE;TK2;SNX9;SPRY4;RAPGEF3;ZFP36L1;MAP2K2;NME4;LPAR3;PLCD3;PPP1R35;PGLS;MAP2K1;NAPRT;CRYL1;ACP5;SSH1;MARK4;FBLN1;SMAD3;PIK3R2;ERCC6;GJC2;SRD5A3;DVL1;PIGQ;HSD17B8;HBEGF;PPP1R14A;PPP2R3B;SHC2;MBOAT7;CDK18;NMRK1;ADORA2B;ADARB1;AKT1;NT5DC1;PPM1F;PITPNM1;STK39;HK1;EPHA1;PTPRU;IMPACT;ZFYVE21;CNTN1;BRSK1;PTHLH;FGFR4;ACOT1;LDLR;FGFR1;PRKACB;RAC2;KCNAB2;PFKL;PPM1J;PIGV;SORL1;CEACAM1;B3GAT3;CBR4;IGFBP4;TTC7B;CCND1;PODNL1;LHPP;STRADB;SYNGAP1;PLCH2;MAPK13;GAS6;PTK6;PFKP;CSNK1E;CARD11;DUSP7;MAPKAPK3;PCSK9;DHTKD1;BCR;EHD4;ERRFI1;NADK;PANK4;CDC25B;SPTB;SLC20A1;NPR2;DGKQ;PAK6;SERINC2;CEMIP;PKD2;RASGEF1A;CDC42EP5;EPHB2;ADAM8;APRT;CTBP1;PTPDC1;GRK6;CDKN1C;PLCG1;CD81;MVD;ENTPD2;TIMP2;SYNJ2;TGFB1;SCYL1;ULK2;MKNK2;NTSR1;NAB2;SHANK3;PODXL2;SDHA;RASA3;PIP5KL1;TNFSF15;MDH2;NSMF;FARP1;ABHD14B;PI4K2A;PLPP6;HMGCL;PTPN1;PCK2;IFNE;CAMK2N1;OSBPL10;LRP4;ACP6;PFKFB2;MLXIPL;TRIB2;PRKCZ;PRKACA;MINK1;ADA;AREG;PIM2;MPI;UCKL1;ERBB2;ULK1;STK17A;JAK3;RASA4;PDK1;PRKCD;FAM20C;RBL2;BAX;CYC1;SBF1;ITGA1;PPCS;EREG;RPS6KA5;DGUOK;DUSP4;DDIT4;LIMK1;TGFBR3;NTPCR;LTB4R2;CPNE7;LEMD2;RPS6KA6;RGS14;ALDOC;CHAD;LPCAT1;SYMPK;MAPK12;IRAK1;TGFA;INPP5D;PI4K2B;CHEK2;PPARA;SESN2;FGGY;MYO1D;ABCA7;SPEG;MIF;PLA2G6;DDT;TRPT1;FYN;PITPNM3;UPP1;STK25;EEF2K;CKMT1A;PELI1;CHKA;NEIL1;TSPYL2;ELFN2;SLC27A1;PLCB3;MAPK3;INSR;TAZ;PFKM;ADCY1;TSTA3;PDXK;ETAA1;VANGL2;PAK1;CAMKK2;PPP3CB;ALPK1;PFKFB3;MLYCD;GABBR1;MICAL1;SEMA4C;CAPRIN2;STK32C;SAMD8;SRMS;PPP2R5B;MAP2K3;DLG3;NDUFV3;RRAS;PROX1;PKD1;TNFRSF25;SIRT2;NMNAT2;NT5C1B;ADCY7;MAPRE3;SOCS7;MAP3K10;PELI3;NGFR;TOLLIP;GRB10;DUSP23;GCH1;CAMK1;CAMKK1;SIRT3;HFE;ZP3;CDK11B;PFN2;SSH3;FGFR3;PPP1R16A;CCDC88C;NDRG2;CBLC;ITPKB;SPTLC2;CDC42BPG;CLK3;PKN3;PI4KAP2;AK3;ADCY6;LRRK1
10303,GO:0043085,2.48760197011072e-06,0.999998728194097,154,1023,positive regulation of catalytic activity,BP,DUSP6;XDH;DUSP5;EGR1;DLG4;CYP27B1;ACVR2B;DOCK4;PRNP;VEGFA;APOE;F2R;ITGA6;PKN1;GRAMD4;EVI5L;EGFR;NOS1;SPRY2;MST1R;LMF1;SHC1;TBC1D14;RIN1;SNX9;RAPGEF3;ARAP1;MAP2K2;LPAR3;MAP2K1;FBLN1;SMAD3;ARHGAP23;PIK3R2;ERCC6;SH3PXD2B;SHC2;ADORA2B;AKT1;PPM1F;STK39;ASAP2;EPHA1;DAP;FGFR4;FGFR1;PRKACB;SORL1;B3GAT3;CCND1;STRADB;SYNGAP1;EDNRA;GAS6;DUSP7;GSN;MAPKAPK3;ARHGAP22;BCR;ERRFI1;CDC25B;ARHGAP27;AGAP1;CCS;DGKQ;PAK6;SERINC2;CEMIP;PKD2;CDC42EP5;SH3PXD2A;EPHB2;ADAM8;PLCG1;CD81;TIMP2;TGFB1;TBC1D9B;NAB2;ARHGAP25;RASA3;TNFSF15;ARAP3;PLEKHG4;LLGL1;PTPN1;AGRN;ADAP1;PFKFB2;PRKCZ;PRKACA;MINK1;BOK;ERBB2;C6ORF89;NET1;CYFIP2;RASA4;ARHGAP44;PRKCD;STUB1;BAX;ITGA1;SH3BP1;EREG;GDI1;RGS14;GIT1;MAPK12;IRAK1;TGFA;SOX7;BCAP31;MIF;FYN;STK25;ARHGAP12;ACAP3;DNM2;SLC27A1;IQSEC1;MAPK3;INSR;ARHGEF1;ADCY1;DOCK9;RALGAPA1;ETAA1;VANGL2;PAK1;CAMKK2;MAP2K3;DLG3;SGSM2;PROX1;TBC1D16;PKD1;RABGAP1;TRIP10;ADCY7;MAPRE3;AZIN2;RAP1GAP2;MAP3K10;RGS19;NGFR;PDCD6;TBC1D8;GCH1;CAMK1;CAMKK1;PFN2;FGFR3;ADCY6
10730,GO:0044093,3.04608489855201e-06,0.999998228109663,183,1260,positive regulation of molecular function,BP,DUSP6;XDH;DUSP5;EGR1;DLG4;CYP27B1;ACVR2B;DOCK4;PRNP;VEGFA;APOE;F2R;LRP5;ITGA6;HMGA2;PKN1;GRAMD4;EVI5L;EGFR;NOS1;SPRY2;MST1R;LMF1;SHC1;TBC1D14;RIN1;SNX9;RAPGEF3;ARAP1;MAP2K2;LPAR3;RBCK1;MAP2K1;FBLN1;SMAD3;ARHGAP23;PIK3R2;ERCC6;LRP1;SH3PXD2B;SHC2;ADORA2B;AKT1;HDAC5;PPM1F;STK39;ASAP2;EPHA1;DAP;FGFR4;FGFR1;PRKACB;SORL1;B3GAT3;ANK3;TRAPPC9;CCND1;STRADB;SYNGAP1;EDNRA;GAS6;CARD11;DUSP7;GSN;MAPKAPK3;ARHGAP22;BCR;ERRFI1;CDC25B;ARHGAP27;AGAP1;CCS;DGKQ;PAK6;SERINC2;CEMIP;PKD2;CDC42EP5;CRTC1;GPSM1;SH3PXD2A;EPHB2;ADAM8;PLCG1;CD81;TIMP2;TGFB1;TBC1D9B;NTSR1;NAB2;TMEM173;ARHGAP25;SHANK3;RASA3;TNFSF15;ARAP3;PLEKHG4;LLGL1;PTPN1;AGRN;ADAP1;PFKFB2;RFNG;PRKCZ;PRKACA;MINK1;BOK;ERBB2;C6ORF89;NET1;CYFIP2;RASA4;ARHGAP44;PRKCD;STUB1;BAX;ITGA1;SH3BP1;EREG;RPS6KA5;MBTPS2;GDI1;RGS14;MFNG;GSTO1;GIT1;EHD3;MAPK12;IRAK1;TGFA;SOX7;BCAP31;MIF;FYN;STK25;ARHGAP12;ACAP3;ARID5B;DNM2;CAT;SLC27A1;IQSEC1;MAPK3;INSR;ARHGEF1;ADCY1;DOCK9;RALGAPA1;ETAA1;GLRX;VANGL2;PAK1;CAMKK2;CAPRIN2;PPP2R5B;MAP2K3;DLG3;SGSM2;PROX1;TBC1D16;ADGRF1;PKD1;RABGAP1;SIRT2;FAM129B;EDA;TRIP10;ADCY7;MAPRE3;AZIN2;RAP1GAP2;MAP3K10;RGS19;NGFR;PDCD6;TBC1D8;GCH1;CAMK1;CAMKK1;HFE;PFN2;FGFR3;ADCY6
6640,GO:0023051,3.27023341281209e-06,0.999997862602645,312,2350,regulation of signaling,BP,TNIP1;DUSP6;XDH;DUSP5;ZMYND8;HTRA1;EGR1;NR1D1;DLG4;CYP27B1;APLN;PGF;PDCD4;CTNNBIP1;ACVR2B;PRNP;DDIT4L;POSTN;VEGFA;WNT7A;APOE;F2R;LRP5;ITGA6;OBSCN;ITPR3;PKN1;ARRDC1;NISCH;EGFR;SERPINE2;WWTR1;NOS1;PTPRS;HADH;SPRY2;MST1R;NFATC4;LTBP4;APPL2;SHC1;LTBP1;ARL2;PTPRE;PHLDA2;SPRY4;RAPGEF3;GLUL;ARAP1;MAP2K2;LPAR3;MDFI;CMTM7;RBCK1;MAP2K1;MCTP1;SSH1;SMURF2;FBLN1;SMAD3;ARHGAP23;SHANK2;PIK3R2;ERCC6;LRP1;DVL1;HBEGF;FAM110C;S100A4;SHC2;NLGN2;PAG1;ADORA2B;AKT1;GRB7;KCNC4;TMOD2;SH2D2A;RHBDF2;STK39;ASAP2;EPHA1;VEGFB;WWC3;IFNGR2;IFT140;PTHLH;FGFR4;PEAR1;WNT2B;FGFR1;PRKACB;MAPKBP1;RAC2;PFKL;NPHP4;SORL1;CEACAM1;LZTS2;ZNF385A;IGFBP4;EVC;CCND1;PODNL1;STRADB;SYNGAP1;CARD19;PLAU;GAS6;PTK6;FGFBP1;CSNK1E;RAB3B;CARD11;SH2B3;DUSP7;GSN;CMTM4;PLEKHG2;MAPKAPK3;IGFBP2;PCSK9;ARHGAP22;BCR;ERRFI1;AIP;RGL2;ALOX15B;AGAP1;SLC20A1;NPR2;DGKQ;BNIP3;PAK6;SHARPIN;MVB12B;PKD2;RASGEF1A;CRTC1;EPHB2;ADAM8;ASIC1;MNT;GRK6;CDKN1C;PLCG1;SH3BP2;CD81;TIMP2;WNT3;TMED4;TGFB1;GPC1;MOAP1;NTSR1;ARHGAP25;SHANK3;RASA3;TNFSF15;NSMF;ARAP3;FARP1;MC1R;RHOD;VGF;PLEKHG4;RHOF;LLGL1;PLEKHG3;KIF7;RHOBTB2;RIMS3;TNFAIP8L1;PTPN1;PCK2;WDR59;MBD3;IFNE;CD320;CAMK2N1;LRP4;VHL;TRAP1;ADAP1;PFKFB2;RFNG;TRIB2;PRKCZ;PRKACA;MINK1;EPN2;ADA;AREG;PIM2;PLEKHG5;BOK;ERBB2;VAMP2;TFDP2;NET1;CYFIP2;TRPC1;RASA4;ARHGAP44;PRKCD;FAM20C;MIB2;USP20;STUB1;IFI6;BAX;ITGA1;SH3BP1;EREG;DUSP4;TMBIM4;DDIT4;SPRED3;PPP1R13L;RASL10B;TGFBR3;GDI1;LEMD2;RPS6KA6;DNM1;RGS14;MFNG;GSTO1;GIT1;CHAD;EHD3;IRAK1;TGFA;HDAC7;INPP5D;CHEK2;TMEM161A;SESN2;CDC34;SOX7;ABCA7;BCAP31;MIF;PLA2G6;DDT;SYNGR1;ECM1;WFS1;SPPL2B;FYN;STK25;RAC3;ARHGAP12;ACAP3;DNM2;PELI1;CAT;TSPYL2;KIF26A;IQSEC1;ARHGEF4;MAPK3;INSR;ARHGEF1;GRINA;PFKM;C12ORF66;TMEM101;RALGAPA1;VANGL2;PAK1;PPP3CB;SEMA4C;CAPRIN2;ITGA3;SRMS;PPP2R5B;MAP2K3;BCL2L1;RRAS;TBC1D16;LMNA;KCTD13;TNFRSF25;FAM129B;EDA;TRIP10;ICA1;RAP1GAP2;SOCS7;MAP3K10;RGS19;PELI3;NGFR;PDCD6;PXN;GRB10;LURAP1;TCTN1;SIRT3;HFE;ZP3;PFN2;FGFR3;NDRG2;CBLC;ITPKB;HOMER2;APBA1;DEDD2;LRRK1;KLHL24
11423,GO:0045859,3.27861744839911e-06,0.999998449970469,98,588,regulation of protein kinase activity,BP,DUSP6;DUSP5;EGR1;DLG4;PDCD4;ACVR2B;PRNP;VEGFA;APOE;F2R;LRP5;PKN1;EGFR;WWTR1;SPRY2;MST1R;SHC1;SNX9;SPRY4;MAP2K2;LPAR3;MAP2K1;ERCC6;DVL1;SHC2;ADORA2B;ADARB1;AKT1;PPM1F;STK39;EPHA1;FGFR1;PRKACB;RAC2;SORL1;CEACAM1;CCND1;PODNL1;STRADB;GAS6;PTK6;DUSP7;MAPKAPK3;ERRFI1;CDC25B;DGKQ;PAK6;CEMIP;PKD2;EPHB2;ADAM8;CDKN1C;PLCG1;CD81;TGFB1;NAB2;TNFSF15;PTPN1;CAMK2N1;TRIB2;PRKCZ;PRKACA;MINK1;ERBB2;PRKCD;BAX;ITGA1;EREG;DUSP4;RGS14;CHAD;IRAK1;TGFA;SESN2;MIF;TRPT1;STK25;TSPYL2;SLC27A1;MAPK3;INSR;ADCY1;ETAA1;VANGL2;PAK1;CAMKK2;MAP2K3;DLG3;PROX1;PKD1;ADCY7;MAPRE3;SOCS7;MAP3K10;CAMK1;CAMKK1;CBLC;ADCY6
3563,GO:0007610,3.31304064691664e-06,0.999998627258948,60,312,behavior,BP,DLG4;CST3;APLN;PRNP;BBS2;APOE;ESPN;NAGLU;ITPR3;MTA1;EGFR;SERPINE2;ETV5;HEXB;GAA;FOS;SHANK2;DVL1;NLGN2;ADARB1;TMOD2;LDLR;NPHP4;RAG1;ZNF385A;SYNGAP1;SLITRK6;CRTC1;EPHB2;ASIC1;APRT;CEBPB;DEAF1;NTSR1;SHANK3;EFNB3;B4GALT2;PRKCZ;ADA;AHCY;OLFM2;GJB4;ZDHHC8;DNM1;RGS14;PPARA;ABCA7;PLA2G6;WFS1;FYN;VWA1;INSR;ADCY1;PPP3CB;ITGA3;ADGRF1;MSS51;CELSR1;HOMER2;APBA1
4563,GO:0010646,3.74974660753743e-06,0.999997548264233,308,2319,regulation of cell communication,BP,TNIP1;DUSP6;XDH;DUSP5;ZMYND8;HTRA1;EGR1;NR1D1;DLG4;CYP27B1;APLN;PGF;PDCD4;CTNNBIP1;ACVR2B;PRNP;DDIT4L;POSTN;VEGFA;WNT7A;APOE;F2R;LRP5;ITGA6;OBSCN;ITPR3;PKN1;ARRDC1;NISCH;EGFR;SERPINE2;WWTR1;NOS1;PTPRS;HADH;SPRY2;MST1R;NFATC4;LTBP4;APPL2;SHC1;LTBP1;ARL2;PTPRE;PHLDA2;SPRY4;RAPGEF3;GLUL;ARAP1;MAP2K2;LPAR3;MDFI;CMTM7;RBCK1;MAP2K1;MCTP1;SSH1;SMURF2;FBLN1;SMAD3;ARHGAP23;SHANK2;PIK3R2;ERCC6;LRP1;DVL1;HBEGF;FAM110C;S100A4;SHC2;NLGN2;PAG1;ADORA2B;AKT1;GRB7;KCNC4;TMOD2;SH2D2A;RHBDF2;STK39;ASAP2;EPHA1;VEGFB;WWC3;IFNGR2;IFT140;PTHLH;FGFR4;PEAR1;WNT2B;FGFR1;PRKACB;MAPKBP1;RAC2;PFKL;NPHP4;SORL1;CEACAM1;LZTS2;ZNF385A;ANK3;IGFBP4;EVC;CCND1;PODNL1;STRADB;SYNGAP1;CARD19;PLAU;GAS6;PTK6;FGFBP1;CSNK1E;RAB3B;CARD11;SH2B3;DUSP7;GSN;CMTM4;PLEKHG2;MAPKAPK3;IGFBP2;PCSK9;ARHGAP22;BCR;ERRFI1;AIP;RGL2;ALOX15B;AGAP1;SLC20A1;DGKQ;BNIP3;PAK6;SHARPIN;MVB12B;PKD2;RASGEF1A;CRTC1;EPHB2;ADAM8;ASIC1;MNT;GRK6;CDKN1C;PLCG1;SH3BP2;CD81;TIMP2;WNT3;TMED4;TGFB1;GPC1;MOAP1;NTSR1;ARHGAP25;SHANK3;RASA3;TNFSF15;NSMF;ARAP3;FARP1;MC1R;RHOD;VGF;PLEKHG4;RHOF;LLGL1;PLEKHG3;KIF7;RHOBTB2;RIMS3;TNFAIP8L1;PTPN1;PCK2;WDR59;MBD3;IFNE;CD320;CAMK2N1;LRP4;VHL;TRAP1;ADAP1;PFKFB2;RFNG;TRIB2;PRKCZ;PRKACA;MINK1;EPN2;ADA;AREG;PIM2;PLEKHG5;BOK;ERBB2;VAMP2;TFDP2;NET1;CYFIP2;RASA4;ARHGAP44;PRKCD;FAM20C;MIB2;USP20;STUB1;IFI6;BAX;ITGA1;SH3BP1;EREG;DUSP4;TMBIM4;DDIT4;SPRED3;PPP1R13L;RASL10B;TGFBR3;GDI1;LEMD2;RPS6KA6;DNM1;RGS14;MFNG;GSTO1;GIT1;CHAD;IRAK1;TGFA;HDAC7;INPP5D;CHEK2;TMEM161A;SESN2;CDC34;SOX7;ABCA7;BCAP31;MIF;PLA2G6;DDT;SYNGR1;ECM1;WFS1;SPPL2B;FYN;STK25;RAC3;ARHGAP12;ACAP3;DNM2;PELI1;CAT;TSPYL2;KIF26A;IQSEC1;ARHGEF4;MAPK3;INSR;ARHGEF1;GRINA;PFKM;C12ORF66;TMEM101;RALGAPA1;VANGL2;PAK1;PPP3CB;SEMA4C;CAPRIN2;ITGA3;SRMS;PPP2R5B;MAP2K3;BCL2L1;RRAS;LMNA;KCTD13;TNFRSF25;FAM129B;EDA;TRIP10;ICA1;RAP1GAP2;SOCS7;MAP3K10;RGS19;PELI3;NGFR;PDCD6;PXN;GRB10;LURAP1;TCTN1;SIRT3;HFE;ZP3;PFN2;FGFR3;NDRG2;CBLC;ITPKB;HOMER2;DEDD2;LRRK1;KLHL24
17058,GO:0099537,3.84444078558239e-06,0.999998283680339,59,303,trans-synaptic signaling,BP,ZMYND8;DLG4;PRNP;WNT7A;APOE;F2R;ITPR3;NISCH;EGFR;SERPINE2;NOS1;NFATC4;SYTL1;ETV5;SLC12A7;GLUL;LPAR3;MCTP1;SSH1;SHANK2;DVL1;NLGN2;ADARB1;SYT8;AKT1;KCNC4;TMOD2;BRSK1;SYNGAP1;RAB3B;CRTC1;EPHB2;GRIN3B;ASIC1;SNPH;NTSR1;SHANK3;MYCBPAP;NSMF;HTR7;VGF;RIMS3;PRKCZ;MINK1;VAMP2;CACNB3;SV2A;DNM1;RGS14;PLA2G6;SYNGR1;RAC3;SLC12A4;PPP3CB;DLG3;KCTD13;PCLO;PFN2;APBA1
5515,GO:0016477,3.85692487139654e-06,0.999997851190424,137,891,cell migration,BP,ZMYND8;SEMA4B;SLC16A3;PLAT;PGF;DOCK4;POSTN;VEGFA;WNT7A;APOE;TSPAN1;F2R;LRP5;ITGA6;IDH2;PKN1;NISCH;EGFR;SERPINE2;SPRY2;SDC1;SHC1;HEXB;SLC7A8;MMP1;PHLDA2;MCTP1;SSH1;SMURF2;SMAD3;PIK3R2;LRP1;HBEGF;FAM110C;MBOAT7;ADARB1;AKT1;GRB7;CORO1B;HDAC5;PPM1F;MMP28;BSG;EPHA1;PTPRU;VEGFB;FGFR4;FGFR1;ELMO3;RAC2;SORL1;CEACAM1;EFS;PLAU;GAS6;PTK6;SEMA3F;LAMA5;BCR;ARPIN;ALOX15B;PLXNB3;PAK6;CEMIP;PROCR;RASGEF1A;PRSS3;ADAM8;PLCG1;TGFB1;UNK;GPC1;PODXL2;NSMF;ARAP3;RHOD;TNS1;SEMA4F;RHOF;RHOBTB2;PRKCZ;MINK1;ADA;PLEKHG5;SDCCAG8;MMP10;JAK3;NET1;FSCN1;CYGB;PRKCD;BAX;ITGA1;SH3BP1;DDIT4;TGFBR3;LTB4R2;ADAM15;HDAC7;INPP5D;MIF;DDT;ECM1;FYN;RAC3;SUN1;ARID5B;MAPK3;INSR;RERE;VANGL2;PAK1;ROBO4;HYAL1;SEMA4C;ITGA3;MAP2K3;RRAS;PROX1;MDGA1;LMNA;KCTD13;ITGA4;LAMB1;SOCS7;NDE1;PDCD6;PXN;LURAP1;BTG1;ZP3;CELSR1;SEMA3B;PFN2;TRIM46;PKN3;SDC2
12267,GO:0048585,3.86017525608166e-06,0.999997785098966,163,1105,negative regulation of response to stimulus,BP,TNIP1;DUSP6;NT5E;XDH;ERCC1;DUSP5;SEMA4B;HTRA1;EGR1;NR1D1;PLAT;APLN;PDCD4;CTNNBIP1;PRNP;BBS2;DDIT4L;APOE;ITGA6;HMGA2;ARRDC1;EGFR;SERPINE2;WWTR1;PTPRS;SPRY2;MST1R;NFATC4;LTBP1;PTPRE;SPRY4;MDFI;ACP5;MCTP1;SMURF2;FBLN1;SMAD3;STAT6;PIK3R2;LRP1;DVL1;HBEGF;AKT1;CORO1B;F12;MMP28;STK39;SERPING1;EPHA1;WWC3;FGFR4;PEAR1;FNDC4;FGFR1;PRKACB;MAPKBP1;NPHP4;SORL1;CEACAM1;LZTS2;ZNF385A;IGFBP4;CCND1;PODNL1;STRADB;SYNGAP1;CARD19;PLAU;GAS6;PTK6;SEMA3F;DUSP7;IGFBP2;BCR;ERRFI1;SHARPIN;PKD2;FAM3A;IL20RB;MAGEF1;EPHB2;MNT;TIMP2;WNT3;TGFB1;GPC1;ARHGAP25;RASA3;ARAP3;SEMA4F;KIF7;TNFAIP8L1;PTPN1;CAMK2N1;LRP4;VHL;TRAP1;PRKCZ;CD9;EPN2;ADA;BOK;ERBB2;JAK3;RASA4;ARHGAP44;PRKCD;STUB1;IFI6;BAX;ITGA1;SH3BP1;EREG;DUSP4;DDIT4;TGFBR3;LEMD2;RPS6KA6;DNM1;RGS14;GSTO1;CHAD;HDAC7;INPP5D;CHEK2;PPARA;TMEM161A;SESN2;CDC34;MIF;DDT;ECM1;WFS1;FYN;ARHGAP12;DNM2;KIF26A;INSR;GRINA;C12ORF66;HLA-G;PPP3CB;SEMA4C;ITGA3;SRMS;PPP2R5B;BCL2L1;LMNA;KCTD13;SIRT2;FAM129B;SOCS7;RGS19;PELI3;PDCD6;GRB10;SIRT3;HFE;TERC;SEMA3B;FGFR3;NDRG2;CBLC
17057,GO:0099536,4.28934893767168e-06,0.999998078095774,59,304,synaptic signaling,BP,ZMYND8;DLG4;PRNP;WNT7A;APOE;F2R;ITPR3;NISCH;EGFR;SERPINE2;NOS1;NFATC4;SYTL1;ETV5;SLC12A7;GLUL;LPAR3;MCTP1;SSH1;SHANK2;DVL1;NLGN2;ADARB1;SYT8;AKT1;KCNC4;TMOD2;BRSK1;SYNGAP1;RAB3B;CRTC1;EPHB2;GRIN3B;ASIC1;SNPH;NTSR1;SHANK3;MYCBPAP;NSMF;HTR7;VGF;RIMS3;PRKCZ;MINK1;VAMP2;CACNB3;SV2A;DNM1;RGS14;PLA2G6;SYNGR1;RAC3;SLC12A4;PPP3CB;DLG3;KCTD13;PCLO;PFN2;APBA1
14510,GO:0065009,4.33056709237263e-06,0.99999717155971,299,2254,regulation of molecular function,BP,DUSP6;XDH;DUSP5;FHL1;EGR1;DLG4;CST3;CYP27B1;APLN;PGF;PDCD4;CTNNBIP1;KCNG1;ACVR2B;DOCK4;PRNP;VEGFA;TNFRSF6B;WNT7A;APOE;F2R;LRP5;ITGA6;HMGA2;OBSCN;PKN1;GRAMD4;EVI5L;EGFR;SERPINE2;WWTR1;SCN4B;NOS1;SPRY2;MST1R;NFATC4;PRSS8;LMF1;SHC1;TBC1D14;ARL2;RIN1;PHLDA2;SNX9;SPRY4;RAPGEF3;ARAP1;MAP2K2;LPAR3;MDFI;PPP1R35;CMTM7;RBCK1;MAP2K1;FOS;FBLN1;SMAD3;ARHGAP23;SHANK2;PIK3R2;ERCC6;LRP1;DVL1;HBEGF;PPP1R14A;SH3PXD2B;PPP2R3B;PRDX5;SHC2;NLGN2;STOM;ADORA2B;ADARB1;AKT1;HDAC5;PPM1F;STK39;SERPING1;ASAP2;EPHA1;VEGFB;DAP;PTHLH;FGFR4;FGFR1;PRKACB;RAC2;KCNAB2;MXI1;RAG1;RALGDS;SORL1;CEACAM1;B3GAT3;DOCK6;ANK3;TRAPPC9;CCND1;PODNL1;STRADB;SYNGAP1;EDNRA;PLAU;GAS6;PTK6;CSNK1E;CTSB;CARD11;DUSP7;GSN;CMTM4;PLEKHG2;MAPKAPK3;PCSK9;ARHGAP22;BCR;ANGPTL4;ERRFI1;AIP;CDC25B;RGL2;ARHGAP27;SPTB;AGAP1;CCS;SNTA1;DGKQ;PLXNB3;PAK6;TFPI2;SERINC2;CEMIP;PKD2;RASGEF1A;CTSZ;CDC42EP5;CRTC1;GPSM1;SH3PXD2A;EPHB2;ADAM8;CDKN1C;PLCG1;CD81;TIMP2;WNT3;GNAL;TGFB1;TBC1D9B;NTSR1;NAB2;TMEM173;ARHGAP25;SHANK3;RASA3;TNFSF15;ARAP3;FARP1;RNH1;VGF;PLEKHG4;LLGL1;PLEKHG3;ZER1;PTPN1;AGRN;IFNE;CD320;CAMK2N1;ADAP1;PFKFB2;RFNG;TRIB2;PRKCZ;PRKACA;MINK1;OXA1L;AREG;PIM2;PLEKHG5;BOK;ERBB2;VAMP2;C6ORF89;JAK3;NET1;CYFIP2;RASA4;CYGB;ARHGAP44;PRKCD;RBL2;CACNB3;STUB1;IFI6;BAX;SBF1;ITGA1;SH3BP1;EREG;RPS6KA5;DUSP4;MBTPS2;PCSK1N;LIMK1;TGFBR3;GDI1;TPM2;LTB4R2;RGS14;MFNG;GSTO1;GIT1;CHAD;ADAM15;EHD3;MAPK12;IRAK1;TGFA;ZFPM1;PPARA;SESN2;MYO1D;SOX7;BCAP31;MIF;PLA2G6;ECM1;WFS1;TRPT1;FYN;STK25;ARHGAP12;ACAP3;ARID5B;DNM2;BHLHE40;PELI1;CAT;NEIL1;TSPYL2;ELFN2;SLC27A1;IQSEC1;ARHGEF4;MAPK3;INSR;ARHGEF1;ADCY1;DOCK9;RALGAPA1;ETAA1;GLRX;VANGL2;PAK1;CAMKK2;GABBR1;MICAL1;CAPRIN2;WDTC1;BIN1;PPP2R5B;MAP2K3;DLG3;SGSM2;PROX1;TBC1D16;ADGRF1;ZYG11B;PKD1;RABGAP1;SIRT2;FAM129B;ITGA4;EDA;TRIP10;ADCY7;MAPRE3;AZIN2;SERPINB1;RAP1GAP2;SOCS7;MAP3K10;RGS19;NDE1;NGFR;PDCD6;TBC1D8;GCH1;CAMK1;CAMKK1;HFE;ZP3;PFN2;FGFR3;PPP1R16A;CBLC;ADCY6;KLHL24
7328,GO:0031345,4.55424697312136e-06,0.999998470750605,31,124,negative regulation of cell projection organization,BP,SEMA4B;PRNP;APOE;EVI5L;PTPRS;SPRY2;NFATC4;LRP1;SYNGAP1;SEMA3F;ARPIN;PLXNB3;CTSZ;EPHB2;WNT3;ULK2;EFNB3;SEMA4F;LRP4;PRKCD;DGUOK;GDI1;FYN;DNM2;SEMA4C;ITGA3;RAP1GAP2;NGFR;SEMA3B;PFN2;ADCY6
3495,GO:0007399,4.80392058540135e-06,0.999996983927567,210,1478,nervous system development,BP,SDK2;MEF2D;ZMYND8;ADGRL1;SEMA4B;DLG4;CST3;BTBD2;MARVELD1;BBS2;POSTN;VEGFA;WNT7A;APOE;NAGLU;NDRG1;IDH2;EGFR;SERPINE2;OBSL1;NOS1;PTPRS;NFATC4;ETV5;SHC1;HEXB;TRNP1;ZFP36L1;LPAR3;SMARCA1;MAP2K1;SSH1;MARK4;FOS;SHANK2;LRP1;GJC2;DVL1;NLGN2;SALL2;MBOAT7;ADARB1;AKT1;GRB7;TMOD2;HDAC5;S100A6;PITPNM1;IMPACT;CNTN1;BRSK1;IFT140;FGFR4;WNT2B;LDLR;FGFR1;PRKACB;SIGMAR1;RAC2;NPHP4;B4GAT1;KLF7;SORL1;HMG20B;TENM2;ANK3;TRAPPC9;TWF2;SYNGAP1;EDNRA;GAS6;PTK6;SEMA3F;CSNK1E;GSN;PCSK9;BCR;DBNDD1;MYEF2;SLITRK6;SPTB;UNC119B;PLXNB3;BNIP3;SHARPIN;TAGLN3;PKD2;CTSZ;CRTC1;FBXW8;GPSM1;EPOR;EPHB2;PLCG1;KIF17;NYAP1;CEBPB;TIMP2;WNT3;TGFB1;SNPH;UNK;ULK2;GPC1;DEAF1;NAB2;SHANK3;SDHA;EFNB3;NSMF;FARP1;LAMB2;SEMA4F;WASF3;LLGL1;PHGDH;TPP1;B4GALT2;AGRN;MBD3;LRP4;RFNG;PRKCZ;KDM6B;MINK1;CD9;AREG;MICALL2;BOK;SDCCAG8;ERBB2;ADGRB2;ULK1;CYFIP2;ARHGAP44;BAX;ITGA1;RPS6KA5;DGUOK;SOX12;DDIT4;AHNAK2;IER2;LIMK1;GDI1;LEMD2;RPS6KA6;RGS14;SCN8A;MYO1D;FYN;STK25;RAC3;EEF2K;SUN1;DNM2;ATXN10;TPBG;KIF26A;MAPK3;ADCY1;RERE;VANGL2;PAK1;MALL;PPP3CB;USP21;PFKFB3;CUL7;SEMA4C;CAPRIN2;ITGA3;DNMT3A;BIN1;PPP2R5B;HES6;DLG3;PROX1;LRCH4;MDGA1;ADGRF1;PKD1;SIRT2;FAM129B;CDH4;RAP1GAP2;LAMB1;SOCS7;NDE1;NGFR;PCLO;GRB10;KIF13B;NR2F6;TCTN1;CAMK1;EZH1;CELSR1;TACC1;SEMA3B;SSH3;NDRG2;BLOC1S4;PLAG1;DOK4;TRIM46;APBA1;ADCY6;AARS;SDC2
10795,GO:0044282,5.14746779376028e-06,0.999997691623333,58,304,small molecule catabolic process,BP,NT5E;CYP27B1;TYSND1;PGM1;APOE;LRP5;CRAT;NOS1;HADH;HEXB;ALDH4A1;GLUL;CRYL1;CPT2;GALE;SRD5A3;PRODH;AKT1;ENTPD6;HK1;PFKL;ABCD1;AIG1;PFKP;HAGH;CEMIP;CBS;ENTPD2;TGFB1;NTSR1;SNX17;HMGCL;PCK2;IDUA;PFKFB2;ADA;AHCY;ACAD10;ACADS;ALDOC;LONP2;DECR2;PPARA;SESN2;PHYH;UPP1;ETFB;GLB1;APOBEC3C;APOBEC3F;PFKM;GPT2;MLYCD;HYAL1;ABHD10;ALDH7A1;PHYKPL;PM20D2
3384,GO:0007165,5.47661167262434e-06,0.999996087482121,461,3685,signal transduction,BP,TNIP1;DUSP6;XDH;DUSP5;ZMYND8;ADGRL1;SEMA4B;HTRA1;EGR1;NR1D1;EDEM1;DLG4;PLAT;CYP27B1;MRC2;APLN;PGF;PDCD4;CTNNBIP1;ACVR2B;DOCK4;PRNP;BBS2;DDIT4L;POSTN;VEGFA;TNFRSF6B;WNT7A;APOE;DGKA;TSPAN1;F2R;LRP5;ITGA6;PITPNC1;OBSCN;NDRG1;ELK3;ITPR3;PKN1;MTA1;ARRDC1;NISCH;FCGRT;EGFR;RPS6KA2;SERPINE2;WWTR1;NOS1;PTPRS;SPRY2;MST1R;NFATC4;LTBP4;SDC1;APPL2;SHC1;LTBP2;LTBP1;GTPBP1;PTPRE;RIN1;MMP1;PHLDA2;SPRY4;RAPGEF3;ZFP36L1;ARAP1;MAP2K2;LPAR3;PLCD3;MDFI;CMTM7;RBCK1;MAP2K1;MCTP1;SSH1;SMURF2;FOS;FBLN1;SMAD3;ARHGAP23;STAT6;SHANK2;PIK3R2;ERCC6;LRP1;DVL1;EPAS1;HBEGF;FAM110C;AP2A2;S100A4;ITGB4;SHC2;NLGN2;PRODH;SALL2;PAG1;ADORA2B;PLCXD2;AKT1;GRB7;TMOD2;FAM83A;S100A6;SH2D2A;PPM1F;PITPNM1;PLEKHH3;RHBDF2;BSG;STK39;ASAP2;EPHA1;PTPRU;VEGFB;WWC3;LRRC8A;CNTN1;IFNGR2;BRSK1;DAP;IFT140;PTHLH;MYZAP;RAB31;FGFR4;HEBP1;PEAR1;WNT2B;FGFR1;PRKACB;MAPKBP1;SIGMAR1;RAC2;SMOC2;NPHP4;RALGDS;SORL1;CEACAM1;ASB13;LZTS2;TENM2;ZNF385A;DOCK6;ANK3;IGFBP4;EVC;CCND1;PODNL1;EFS;PCBP4;STRADB;SYNGAP1;PLCH2;MAPK13;EDNRA;CARD19;PLAU;GAS6;PTK6;SEMA3F;FGFBP1;CSNK1E;CTSB;RAB3B;CARD11;SH2B3;LAMA5;DUSP7;GSN;CMTM4;PLEKHG2;MAPKAPK3;IGFBP2;PCSK9;ARHGAP22;BCR;ANTXR2;ERRFI1;WIPF1;AIP;RGL2;TSPAN18;PAQR6;ARHGAP27;ALOX15B;SPTB;AGAP1;NXPH4;SLC20A1;NPR2;DGKQ;PLXNB3;BNIP3;PAK6;SHARPIN;MVB12B;PKD2;RASGEF1A;CDC42EP5;IL20RB;ITGB5;EPOR;EPHB2;GRIN3B;ADAM8;ASIC1;MNT;GRK6;CDKN1C;PLCG1;SH3BP2;NYAP1;CD81;CEBPB;ENTPD2;ADAMTS13;ZNF217;TIMP2;WNT3;GNAL;TMED4;TGFB1;CLTCL1;ULK2;GPC1;MKNK2;MOAP1;NTSR1;ARHGAP25;SHANK3;EFNB3;RASA3;TNFSF15;ARAP3;FARP1;MC1R;RHOD;SNX17;HTR7;VGF;PLEKHG4;SEMA4F;RHOF;LLGL1;PLEKHG3;KIF7;RHOBTB2;GIGYF1;TNFAIP8L1;PTPN1;TPP1;WDR59;AGRN;MBD3;IFNE;CD320;CAMK2N1;LRP4;GPR153;VHL;TRAP1;ADAP1;RFNG;MLXIPL;TRIB2;PRKCZ;PRKACA;MINK1;ZNF516;RHPN1;TOM1L2;CD9;EPN2;ADA;AREG;PIM2;PLEKHG5;BOK;NEURL1B;ERBB2;ADGRB2;ULK1;TFDP2;PLEK2;STK17A;JAK3;NET1;BNIP3L;CYFIP2;FSCN1;SLC22A17;RASA4;PDK1;ARHGAP44;PRKCD;FAM20C;MIB2;RBL2;CACNB3;USP20;STUB1;IFI6;BAX;ITGA1;SH3BP1;FBXW4;EREG;RPS6KA5;DUSP4;TMBIM4;DDIT4;MBTPS2;SPRED3;PPP1R13L;PCSK1N;MT2A;RASL10B;LIMK1;TGFBR3;PDIA5;GDI1;LTB4R2;LEMD2;RPS6KA6;DNM1;RGS14;MFNG;GSTO1;GIT1;CHAD;LRSAM1;ADAM15;ASB1;TMEM231;MAPK12;IRAK1;TGFA;HDAC7;INPP5D;CHEK2;PPARA;TMEM161A;SESN2;CDC34;SOX7;ABCA7;RAB12;BCAP31;MIF;BCAM;PLA2G6;DDT;ECM1;WFS1;DTX3;SPPL2B;FYN;STK25;RAC3;ARHGAP12;ACAP3;ARID5B;DNM2;PELI1;SNX15;CHKA;CAT;TSPYL2;SLC27A1;KIF26A;PLCB3;IQSEC1;ARHGEF4;MAPK3;INSR;ARHGEF1;GRINA;ADCY1;C12ORF66;HLA-G;DOCK9;TMEM101;RALGAPA1;VANGL2;PAK1;CAMKK2;PPP3CB;LGALS3BP;CUL7;GABBR1;MICAL1;SEMA4C;CAPRIN2;HES7;ITGA3;STK32C;SRMS;PPP2R5B;MAP2K3;BCL2L1;RRAS;LRCH4;ADGRF1;LMNA;PKD1;KCTD13;TNFRSF25;SIRT2;FAM129B;ITGA4;EDA;DCBLD2;TRIP10;ADCY7;LTB4R;RAB28;RAP1GAP2;SOCS7;MAP3K10;RGS19;GPR3;PELI3;RAB40B;NGFR;TOLLIP;PDCD6;ATP6V1F;PCLO;PXN;GRB10;PLEKHM1;LURAP1;KIF13B;NR2F6;TCTN1;CAMK1;CAMKK1;SIRT3;HFE;ZP3;CELSR1;IL17RE;SEMA3B;FGFR3;CCDC88C;NDRG2;CBLC;ITPKB;CDC42BPG;KDM3A;HOMER2;PKN3;DEDD2;PI4KAP2;ADCY6;LRRK1;KLHL24;SDC2
3500,GO:0007409,5.59639139513927e-06,0.999997470860503,59,305,axonogenesis,BP,SEMA4B;VEGFA;WNT7A;APOE;PTPRS;SHC1;LPAR3;MAP2K1;SSH1;DVL1;ADARB1;GRB7;S100A6;BRSK1;B4GAT1;KLF7;ANK3;TWF2;SYNGAP1;SEMA3F;SLITRK6;SPTB;PLXNB3;EPHB2;PLCG1;WNT3;ULK2;GPC1;SHANK3;EFNB3;LAMB2;SEMA4F;LLGL1;LRP4;ERBB2;ULK1;CYFIP2;RPS6KA5;LIMK1;GDI1;FYN;STK25;DNM2;MAPK3;ADCY1;VANGL2;PAK1;PPP3CB;SEMA4C;FAM129B;CDH4;NGFR;GRB10;KIF13B;TCTN1;SEMA3B;SSH3;DOK4;TRIM46
3452,GO:0007268,5.78416175919616e-06,0.999997398333688,58,300,chemical synaptic transmission,BP,ZMYND8;DLG4;PRNP;WNT7A;APOE;F2R;ITPR3;NISCH;EGFR;SERPINE2;NFATC4;SYTL1;ETV5;SLC12A7;GLUL;LPAR3;MCTP1;SSH1;SHANK2;DVL1;NLGN2;ADARB1;SYT8;AKT1;KCNC4;TMOD2;BRSK1;SYNGAP1;RAB3B;CRTC1;EPHB2;GRIN3B;ASIC1;SNPH;NTSR1;SHANK3;MYCBPAP;NSMF;HTR7;VGF;RIMS3;PRKCZ;MINK1;VAMP2;CACNB3;SV2A;DNM1;RGS14;PLA2G6;SYNGR1;RAC3;SLC12A4;PPP3CB;DLG3;KCTD13;PCLO;PFN2;APBA1
16937,GO:0098916,5.78416175919616e-06,0.999997398333688,58,300,anterograde trans-synaptic signaling,BP,ZMYND8;DLG4;PRNP;WNT7A;APOE;F2R;ITPR3;NISCH;EGFR;SERPINE2;NFATC4;SYTL1;ETV5;SLC12A7;GLUL;LPAR3;MCTP1;SSH1;SHANK2;DVL1;NLGN2;ADARB1;SYT8;AKT1;KCNC4;TMOD2;BRSK1;SYNGAP1;RAB3B;CRTC1;EPHB2;GRIN3B;ASIC1;SNPH;NTSR1;SHANK3;MYCBPAP;NSMF;HTR7;VGF;RIMS3;PRKCZ;MINK1;VAMP2;CACNB3;SV2A;DNM1;RGS14;PLA2G6;SYNGR1;RAC3;SLC12A4;PPP3CB;DLG3;KCTD13;PCLO;PFN2;APBA1
706,GO:0001932,6.26520237326091e-06,0.999996280998959,143,944,regulation of protein phosphorylation,BP,TNIP1;DUSP6;XDH;DUSP5;EGR1;DLG4;PDCD4;ACVR2B;PRNP;VEGFA;WNT7A;APOE;F2R;LRP5;PKN1;EGFR;WWTR1;SPRY2;MST1R;SHC1;SNX9;SPRY4;RAPGEF3;MAP2K2;LPAR3;MAP2K1;FBLN1;PIK3R2;ERCC6;GJC2;DVL1;HBEGF;SHC2;ADORA2B;ADARB1;AKT1;PPM1F;STK39;EPHA1;IMPACT;CNTN1;FGFR4;FGFR1;PRKACB;RAC2;SORL1;CEACAM1;IGFBP4;CCND1;PODNL1;STRADB;SYNGAP1;GAS6;PTK6;DUSP7;MAPKAPK3;EHD4;ERRFI1;CDC25B;DGKQ;PAK6;CEMIP;PKD2;EPHB2;ADAM8;CDKN1C;PLCG1;CD81;TIMP2;TGFB1;NAB2;TNFSF15;PTPN1;IFNE;CAMK2N1;LRP4;MLXIPL;TRIB2;PRKCZ;PRKACA;MINK1;AREG;ERBB2;PRKCD;BAX;ITGA1;EREG;RPS6KA5;DUSP4;DDIT4;LEMD2;RPS6KA6;RGS14;CHAD;IRAK1;TGFA;CHEK2;SESN2;ABCA7;MIF;PLA2G6;DDT;TRPT1;FYN;STK25;EEF2K;TSPYL2;SLC27A1;MAPK3;INSR;ADCY1;ETAA1;VANGL2;PAK1;CAMKK2;MICAL1;SEMA4C;CAPRIN2;PPP2R5B;MAP2K3;DLG3;RRAS;PROX1;PKD1;TNFRSF25;SIRT2;ADCY7;MAPRE3;SOCS7;MAP3K10;NGFR;CAMK1;CAMKK1;SIRT3;HFE;PFN2;FGFR3;CCDC88C;NDRG2;CBLC;ITPKB;ADCY6;LRRK1
12328,GO:0048699,6.39002273352551e-06,0.999996196633158,145,953,generation of neurons,BP,SDK2;ZMYND8;SEMA4B;DLG4;POSTN;VEGFA;WNT7A;APOE;NAGLU;IDH2;EGFR;SERPINE2;OBSL1;NOS1;PTPRS;NFATC4;ETV5;SHC1;LPAR3;SMARCA1;MAP2K1;SSH1;SHANK2;LRP1;GJC2;DVL1;ADARB1;AKT1;GRB7;HDAC5;S100A6;IMPACT;CNTN1;BRSK1;IFT140;WNT2B;LDLR;FGFR1;RAC2;NPHP4;B4GAT1;KLF7;SORL1;HMG20B;TENM2;ANK3;TRAPPC9;TWF2;SYNGAP1;GAS6;PTK6;SEMA3F;CSNK1E;PCSK9;DBNDD1;MYEF2;SLITRK6;SPTB;UNC119B;PLXNB3;CTSZ;CRTC1;FBXW8;EPHB2;PLCG1;NYAP1;CEBPB;TIMP2;WNT3;TGFB1;SNPH;UNK;ULK2;GPC1;SHANK3;EFNB3;NSMF;FARP1;LAMB2;SEMA4F;LLGL1;AGRN;LRP4;PRKCZ;MINK1;AREG;MICALL2;SDCCAG8;ERBB2;ULK1;CYFIP2;ARHGAP44;BAX;ITGA1;RPS6KA5;DGUOK;DDIT4;IER2;LIMK1;GDI1;RGS14;FYN;STK25;RAC3;EEF2K;DNM2;ATXN10;MAPK3;ADCY1;RERE;VANGL2;PAK1;PPP3CB;USP21;CUL7;SEMA4C;CAPRIN2;ITGA3;DNMT3A;BIN1;PPP2R5B;PROX1;MDGA1;ADGRF1;SIRT2;FAM129B;CDH4;RAP1GAP2;LAMB1;NDE1;NGFR;GRB10;KIF13B;NR2F6;TCTN1;CAMK1;CELSR1;SEMA3B;SSH3;BLOC1S4;PLAG1;DOK4;TRIM46;ADCY6;SDC2
9952,GO:0042327,7.08227956200287e-06,0.999996038034028,106,656,positive regulation of phosphorylation,BP,DUSP6;XDH;DUSP5;EGR1;DLG4;APLN;ACVR2B;PRNP;VEGFA;WNT7A;F2R;ITGA6;PKN1;EGFR;SPRY2;MST1R;SHC1;SNX9;RAPGEF3;MAP2K2;LPAR3;MAP2K1;ERCC6;DVL1;HBEGF;SHC2;ADORA2B;AKT1;STK39;EPHA1;CNTN1;FGFR4;FGFR1;PRKACB;IGFBP4;CCND1;STRADB;GAS6;PTK6;DUSP7;MAPKAPK3;EHD4;CDC25B;DGKQ;PAK6;CEMIP;PKD2;EPHB2;ADAM8;PLCG1;CD81;TIMP2;TGFB1;NAB2;TNFSF15;PTPN1;IFNE;LRP4;PFKFB2;MLXIPL;PRKCZ;PRKACA;MINK1;AREG;ERBB2;PRKCD;BAX;ITGA1;EREG;RPS6KA5;IRAK1;TGFA;CHEK2;ABCA7;MIF;PLA2G6;DDT;FYN;STK25;SLC27A1;MAPK3;INSR;ADCY1;ETAA1;VANGL2;PAK1;CAMKK2;PFKFB3;SEMA4C;CAPRIN2;MAP2K3;DLG3;PROX1;PKD1;TNFRSF25;ADCY7;MAPRE3;MAP3K10;NGFR;CAMK1;CAMKK1;HFE;PFN2;FGFR3;ADCY6;LRRK1
4645,GO:0010769,7.55635232305049e-06,0.999996888953091,43,201,regulation of cell morphogenesis involved in differentiation,BP,SEMA4B;POSTN;VEGFA;WNT7A;APOE;OBSL1;PTPRS;NFATC4;LPAR3;MAP2K1;SSH1;FBLN1;TWF2;SYNGAP1;SEMA3F;PLXNB3;FBXW8;EPHB2;WNT3;ULK2;SHANK3;EFNB3;NSMF;SEMA4F;LRP4;NET1;ARHGAP44;LIMK1;GDI1;STK25;RAC3;EEF2K;DNM2;PAK1;CUL7;SEMA4C;CAPRIN2;CDH4;NGFR;KIF13B;SEMA3B;SSH3;SDC2
10903,GO:0044456,8.00583616215216e-06,0.999995903675465,75,424,synapse part,CC,ZMYND8;ADGRL1;NR1D1;DLG4;FBXO2;PRR7;PRNP;WNT7A;F2R;SH2D5;NOS1;PTPRS;SYTL1;GLUL;MCTP1;SHANK2;DVL1;NLGN2;SYT8;AKT1;KCNC4;BRSK1;SIGMAR1;KCNAB2;TENM2;ANK3;NIPSNAP1;SYNGAP1;RAB3B;LAMA5;BCR;DBNDD1;COL13A1;BNIP3;SHARPIN;AP3D1;EPHB2;GRIN3B;SNPH;ABHD17C;NTSR1;SHANK3;NSMF;FARP1;LAMB2;PI4K2A;SEMA4F;RIMS3;CAMK2N1;LRP4;MINK1;VAMP2;ARHGAP44;SV2A;OLFM2;DNM1;RGS14;SYNGR1;FYN;EEF2K;DNM2;GABBR1;MICAL1;SEMA4C;ITGA3;BCL2L1;DLG3;ICA1;RAB40B;PCLO;SEPT6;PFN2;HOMER2;APBA1;STRN4
708,GO:0001934,9.20960881566074e-06,0.99999487408824,101,622,positive regulation of protein phosphorylation,BP,DUSP6;XDH;DUSP5;EGR1;DLG4;ACVR2B;PRNP;VEGFA;WNT7A;F2R;PKN1;EGFR;SPRY2;MST1R;SHC1;SNX9;RAPGEF3;MAP2K2;LPAR3;MAP2K1;ERCC6;DVL1;HBEGF;SHC2;ADORA2B;AKT1;STK39;EPHA1;CNTN1;FGFR4;FGFR1;PRKACB;IGFBP4;CCND1;STRADB;GAS6;PTK6;DUSP7;MAPKAPK3;EHD4;CDC25B;DGKQ;PAK6;CEMIP;PKD2;EPHB2;ADAM8;PLCG1;CD81;TIMP2;TGFB1;NAB2;TNFSF15;PTPN1;IFNE;LRP4;PRKCZ;PRKACA;MINK1;AREG;ERBB2;PRKCD;BAX;ITGA1;EREG;RPS6KA5;IRAK1;TGFA;CHEK2;ABCA7;MIF;PLA2G6;DDT;FYN;STK25;SLC27A1;MAPK3;INSR;ADCY1;ETAA1;VANGL2;PAK1;CAMKK2;SEMA4C;CAPRIN2;MAP2K3;DLG3;PROX1;PKD1;TNFRSF25;ADCY7;MAPRE3;MAP3K10;NGFR;CAMK1;CAMKK1;HFE;PFN2;FGFR3;ADCY6;LRRK1
10875,GO:0044421,9.80293788069099e-06,0.999993053340114,320,2531,extracellular region part,CC,NT5E;XDH;SEMA4B;HTRA1;THSD4;PLAT;CST3;EPN3;FBXO2;APLN;PGF;XPC;PRNP;PYGB;POSTN;VEGFA;TNFRSF6B;MXRA7;PGM1;WNT7A;APOE;PYGL;TSPAN1;NAGLU;PLD3;ITGA6;NDRG1;IDH2;ACOT7;ARRDC1;AKR7A2;EGFR;SERPINE2;DNPH1;LOXL1;VAT1;PTPRS;CTSO;CAPN2;CRTAP;LTBP4;PRSS8;SYTL1;SDC1;APPL2;LTBP2;LTBP1;ARL2;HEXB;SLC7A8;SLC2A3;ACTA2;MMP1;SNX9;RAPGEF3;GAA;GLUL;KDSR;CTBS;CMTM7;PLTP;PGLS;MAP2K1;NAPRT;CRYL1;ACP5;MARCKSL1;TMEM8A;GALE;SLC9A3R2;FBLN1;ARHGAP23;THBS3;HBEGF;S100A4;ITGB4;CYBRD1;PRDX5;STOM;CORO1B;TTYH3;S100A6;F12;MMP28;ENTPD6;PLEKHH3;BSG;SERPING1;DYSF;GGT1;VEGFB;CNTN1;PTHLH;HEBP1;WNT2B;FNDC4;LDLR;PRKACB;FUCA1;RAC2;SMOC2;PFKL;SEC14L2;GAMT;H2AFJ;B4GAT1;BPHL;SORL1;CEACAM1;B3GAT3;RAB11FIP4;IGFBP4;PODNL1;TWF2;CEP250;PLAU;GAS6;SEMA3F;PFKP;FGFBP1;CTSB;RAB3B;CARD11;LAMA5;GSN;CMTM4;IGFBP2;PCSK9;BCR;ANGPTL4;EHD4;SLITRK6;ALOX15B;CCS;GGACT;OAF;HAGH;TFPI2;MVB12B;SERINC2;PROCR;PKD2;ACY1;FAM3A;GPX3;PCSK1;CTSZ;ITGB5;MAGEF1;PRSS3;CADM4;APRT;LTA4H;CD81;ENTPD2;ADAMTS13;TIMP2;NUDCD2;WNT3;DPP7;GNAL;TMED4;TGFB1;CLTCL1;SNTB2;GPC1;ADAMTS7;TNFSF15;MDH2;GALNS;ABHD8;CROCC;ABHD14B;LAMB2;RNH1;VGF;SEMA4F;RHOF;WASF3;PHGDH;PEX1;TPP1;PCK2;AGRN;OLFML2A;IFNE;CD320;CEP131;TRAP1;IDUA;RFNG;PRKCZ;PRKACA;MINK1;GRHPR;ACTR1B;TOM1L2;CD9;ADA;AREG;MPI;CAPG;CNDP2;NINL;AHCY;VAMP2;MMP10;RNPEP;CYFIP2;FSCN1;PRKCD;FAM20C;RBL2;STUB1;BAX;ITGA1;PPCS;CHADL;EREG;PPL;PPP1R13L;PCSK1N;HPCAL1;CES2;NAGA;NID1;TGFBR3;NTPCR;CPNE7;DNM1;MFNG;GSTO1;ALDOC;CHAD;MSLN;ADAM15;REEP2;WDR60;TGFA;CHD2;MYO1D;JADE2;MIF;DOPEY2;BCAM;PLA2G6;DDT;NUDT14;ECM1;QSOX1;VWA1;EFEMP2;STK25;RAC3;ETFB;DNM2;CKMT1A;GLB1;ATXN10;CAT;IGFBP7;ELFN2;ZDHHC1;TUBB6;MAPK3;CBLN3;INSR;SLC13A3;PFKM;ADCY1;TSTA3;PDXK;GLRX;TRIM45;RNASET2;LGALS3BP;CTSF;ROBO4;SLC37A2;HYAL1;SEMA4C;ITGA3;MAN2B1;DLG3;RRAS;DNASE1L1;MDGA1;ALDH7A1;PKD1;FAM129B;ITGA4;GAL3ST4;TRIP10;SERPINB1;LAMB1;TOLLIP;PDCD6;ATP6V1F;PCLO;CHST14;BIVM;RNASE7;DUSP23;TCTN1;HFE;COL6A1;ZP3;SEMA3B;PFN2;TST;NDRG2;MAN2B2;CBLC;PTGR2;PRSS21;IRF2BPL;PM20D2;SLC26A11;AARS;SDC2
10419,GO:0043269,9.95523763462415e-06,0.999995321706592,57,302,regulation of ion transport,BP,FHL1;DLG4;KCNG1;PRNP;APOE;F2R;SERPINE2;SCN4B;NOS1;PRSS8;ORAI1;LPAR3;KCNJ15;SHANK2;GJC2;NLGN2;STOM;AKT1;TPCN1;KCNC4;STK39;CNTN1;FGFR1;KCNAB2;ANK3;RAB3B;PCSK9;SNTA1;CEMIP;PKD2;EPHB2;GRIN3B;PLCG1;TGFB1;NTSR1;SHANK3;PRKACA;MINK1;VAMP2;TRPC1;PRKCD;CACNB3;BAX;SV2A;SCN8A;GSTO1;EHD3;ABCA7;MIF;PLA2G6;WFS1;FYN;DNM2;GLRX;HFE;HOMER2;KLHL24
18712,GO:1904062,1.01712461652867e-05,0.999996078862982,36,161,regulation of cation transmembrane transport,BP,FHL1;DLG4;KCNG1;PRNP;F2R;SCN4B;NOS1;SHANK2;GJC2;NLGN2;STOM;STK39;KCNAB2;ANK3;PCSK9;SNTA1;CEMIP;PKD2;EPHB2;PLCG1;TGFB1;NTSR1;SHANK3;PRKACA;MINK1;VAMP2;TRPC1;CACNB3;BAX;GSTO1;EHD3;PLA2G6;FYN;DNM2;GLRX;KLHL24
10878,GO:0044425,1.05518808619268e-05,0.999992219797777,463,3721,membrane part,CC,NT5E;SDK2;ADGRL1;SEMA4B;B4GALNT4;SLC16A3;EDEM1;DLG4;MRC2;MARVELD1;EPN3;PRR7;KCNG1;ACVR2B;PRNP;BBS2;SLC6A8;FAM210B;TNFRSF6B;MXRA7;TSPAN1;F2R;LRP5;PLD3;OSBPL5;LPCAT4;ITGA6;SLCO4A1;ITPR3;PKN1;GRAMD4;FCGRT;SH2D5;EGFR;SERPINE2;SCN4B;NOS1;VAT1;PTPRS;TMEM129;SLC2A9;SPRY2;LRP3;CAPN2;MST1R;PRSS8;SYTL1;SDC1;LMF1;ORAI3;SHC1;ORAI1;VPS11;ARL2;SLC7A8;PTPRE;SLC12A7;SLC2A3;KIAA1549L;SNX9;SPRY4;ST6GALNAC2;MAP2K2;KDSR;LPAR3;MARCH9;PLCD3;CSMD2;CMTM7;TP53I11;ACP5;NYNRIN;MCTP1;SSH1;SLC16A5;KCNJ15;TMTC4;TMEM8A;SMURF2;ARMCX2;SLC9A3R2;STAT6;SHANK2;PIK3R2;LRP1;GJC2;SRD5A3;DVL1;PIGQ;HBEGF;AP2A2;ITGB4;CYBRD1;TMEM158;NLGN2;STOM;MBOAT7;REEP4;LY6K;PAG1;ADORA2B;SYT8;SLC6A6;TPCN1;KCNC4;TTYH3;S100A6;PITPNM1;ENTPD6;RHBDF2;BSG;STK39;HK1;DYSF;EPHA1;GGT1;PTPRU;MARCH4;SLC15A4;LRRC8A;CNTN1;IFNGR2;MYZAP;MFSD3;FGFR4;PEAR1;FNDC4;LDLR;FGFR1;SIGMAR1;KCNAB2;SYNE3;B4GAT1;TOMM34;PIGV;SORL1;NAT14;CEACAM1;B3GAT3;RAB11FIP4;TENM2;ABCD1;ANK3;NIPSNAP1;EVC;AIG1;SYNGAP1;EDNRA;CARD19;PTK6;BRI3;CYYR1;RAB3B;CARD11;CMTM4;IGFBP2;PCSK9;ANO8;BCR;ANTXR2;ERRFI1;PRSS22;TMEM200A;SLITRK6;TSPAN18;PAQR6;TMEM132B;ALOX15B;SPTB;COMTD1;PEX10;COL13A1;CORO7;SLC20A1;RRNAD1;NPR2;SNTA1;PLXNB3;BNIP3;MVB12B;SERINC2;CEMIP;PROCR;PKD2;RETSAT;IL20RB;GPSM1;AP3D1;ITGB5;ABCA2;FAM189B;EPOR;EPHB2;GRIN3B;ADAM8;ASIC1;CADM4;TMEM9;KIF17;CD81;ENTPD2;SLC29A4;SYNJ2;GNAL;TMED4;SNPH;CLTCL1;SCYL1;ABHD17C;SLC43A1;SNTB2;GPC1;TBC1D9B;SLC38A10;NTSR1;B3GNT3;TMEM173;ARHGAP25;TMEM134;ATP7B;SHANK3;PODXL2;SDHA;EFNB3;RASA3;TNFSF15;MGAT4B;CLCA2;NSMF;SCART1;FARP1;MC1R;DIRC2;KLRG2;ERO1B;ST6GALNAC6;HTR7;SNX33;PI4K2A;SEMA4F;C1ORF210;YIPF3;ANKZF1;ATG2A;SLC48A1;PLPP6;UBXN4;ADAM19;RIMS3;BBS1;PTPN1;B4GALT2;AGRN;CD320;CAMK2N1;LRP4;LRP10;ESYT2;ZDHHC24;GPR153;B4GALT6;DNAJC4;TMCC3;APCDD1L;RFNG;C14ORF132;PRKCZ;PRKACA;MINK1;OXA1L;CD9;EPN2;ADA;AREG;BOK;ERBB2;ADGRB2;ULK1;VAMP2;TMEM143;RTL1;PLEK2;C6ORF89;NECAB3;JAK3;LRRC37A2;BNIP3L;FSCN1;TRPC1;SLC22A17;RASA4;ARHGAP44;MCFD2;REEP6;CACNB3;IFI6;BAX;CYC1;GRAMD1C;SV2A;SBF1;XYLT2;SLC13A5;ITGA1;OLFM2;SH3BP1;GJB4;EREG;TMEM25;TIMM17B;TMBIM4;MBTPS2;HSD17B7;AHNAK2;GRAMD1A;ZDHHC8;TMX4;FCHO1;TGFBR3;PDIA5;LTB4R2;SLC2A11;LEMD2;TMEM92;DNM1;RGS14;TMEM8B;SCN8A;MFNG;MSLN;LPCAT1;ADAM15;REEP2;EHD3;ST3GAL3;TMEM231;TMEM94;IRAK1;PPOX;TGFA;INPP5D;RNF215;CACFD1;COQ2;TMEM161A;ABCG1;MYO1D;SNN;ABCA7;BCAP31;SLC25A29;BCAM;SLC9A7;SYNGR1;WFS1;QSOX1;CD68;SLC22A18;SPPL2B;FYN;TMCO6;CERS4;SUN1;ICAM5;ARHGAP12;DNM2;CYP3A5;ARMCX1;ELFN2;SLC27A1;TPBG;SLC50A1;ZDHHC1;SLC12A4;ARHGEF4;CYP2R1;MAPK3;INSR;SLC13A3;RTN2;GRINA;TMEM54;TAZ;PFKM;ADCY1;HLA-G;STX10;ATP8B2;TMEM101;PRAF2;VANGL2;PAK1;MALL;PPP3CB;RNF144A;ROBO4;SLC37A2;GABBR1;SEMA4C;ITGA3;SAMD8;BIN1;VPS16;SRMS;SLC16A13;NDST2;BCL2L1;DLG3;NDUFV3;LRCH4;MDGA1;ADGRF1;PKD1;TNFRSF25;CDH4;ITGA4;EDA;GAL3ST4;DCBLD2;TRIP10;ADCY7;ALG12;LTB4R;TMEM154;FAM171A2;ST3GAL2;SLC25A37;RGS19;NDE1;GPR3;HSD11B1;NGFR;TOLLIP;PDCD6;ATP6V1F;CHST14;SLC39A3;HFE;WIPI2;ZP3;VPS51;TMCO3;CELSR1;IL17RE;SEPT6;C2CD2;SLC35F3;FGFR3;MFSD10;KRTCAP3;ST3GAL5;CBLC;SPTLC2;PRSS21;LRP11;TMEM229B;TMEM187;HOMER2;SLC23A2;CHPF;ADCY6;SLC26A11;SDC2
10317,GO:0043113,1.13873463536845e-05,0.999998198917936,13,32,receptor clustering,BP,DLG4;APOE;ETV5;SSH1;DVL1;SYNGAP1;GSN;TGFB1;SHANK3;AGRN;LRP4;DLG3;ITGA4
8145,GO:0032879,1.16928386893938e-05,0.999991998937339,233,1700,regulation of localization,BP,ZMYND8;SEMA4B;FHL1;NR1D1;EDEM1;DLG4;APLN;PGF;KCNG1;DOCK4;PRNP;BBS2;POSTN;VEGFA;WNT7A;APOE;TSPAN1;F2R;LRP5;ITGA6;IDH2;ITPR3;PKN1;EVI5L;NISCH;EGFR;SERPINE2;SCN4B;NOS1;HADH;SPRY2;PRSS8;SYTL1;SDC1;ORAI1;VPS11;TBC1D14;ARL2;PHLDA2;RAPGEF3;ZFP36L1;GLUL;ARAP1;MAP2K2;LPAR3;PLTP;MAP2K1;MCTP1;SSH1;KCNJ15;SMURF2;FBLN1;SMAD3;SHANK2;PIK3R2;LRP1;GJC2;DVL1;HBEGF;FAM110C;NLGN2;STOM;ADORA2B;ADARB1;SYT8;AKT1;TPCN1;GRB7;KCNC4;CORO1B;HDAC5;PPM1F;MMP28;RHBDF2;STK39;HK1;EPHA1;PTPRU;VEGFB;CNTN1;LDLR;FGFR1;MAPKBP1;RAC2;KCNAB2;PFKL;SORL1;CEACAM1;B3GAT3;LZTS2;ANK3;CEP250;PLAU;GAS6;SEMA3F;CSNK1E;RAB3B;LAMA5;GSN;PCSK9;BCR;EHD4;STON1;ARPIN;ALOX15B;SNTA1;PLXNB3;CEMIP;PKD2;AP3D1;ABCA2;EPHB2;GRIN3B;ADAM8;ASIC1;PLCG1;CD81;WNT3;TGFB1;CLTCL1;ABHD17C;TBC1D9B;NTSR1;TMEM173;SHANK3;RASA3;NSMF;ARAP3;TUB;CROCC;RHOD;SNX17;SNX33;SEMA4F;RHOF;LLGL1;RHOBTB2;RIMS3;PTPN1;PCK2;LRP4;CEP131;PFKFB2;PRKCZ;PRKACA;MINK1;CD9;ADA;MICALL2;BOK;ERBB2;VAMP2;MMP10;TFDP2;BNIP3L;TRPC1;CYGB;PRKCD;REEP6;CACNB3;BAX;SV2A;SH3BP1;EREG;RASL10B;ZDHHC8;TGFBR3;GDI1;DNM1;SCN8A;GSTO1;LRSAM1;ADAM15;REEP2;EHD3;TMEM231;HDAC7;PPARA;SESN2;ABCG1;ABCA7;BCAP31;MIF;PLA2G6;DDT;ECM1;WFS1;NBPF3;FYN;EEF2K;DNM2;MAPK3;INSR;RTN2;PFKM;STX10;GLRX;CEP72;PAK1;PPP3CB;ROBO4;MICAL1;HYAL1;SEMA4C;ITGA3;BIN1;VPS16;MAP2K3;BCL2L1;SGSM2;RRAS;PROX1;TBC1D16;LMNA;RABGAP1;ITGA4;AZIN2;ICA1;LAMB1;RAB40B;NGFR;PDCD6;PCLO;GRB10;TBC1D8;CAMK1;SIRT3;HFE;ZP3;SEMA3B;PFN2;HOMER2;KLHL24
6585,GO:0022604,1.26863946119486e-05,0.999993773252375,63,342,regulation of cell morphogenesis,BP,SEMA4B;DLG4;PARVB;POSTN;VEGFA;WNT7A;APOE;OBSL1;PTPRS;NFATC4;HEXB;ARAP1;LPAR3;MAP2K1;SSH1;FBLN1;DVL1;CORO1B;FMNL2;SYNE3;TWF2;SYNGAP1;SEMA3F;CSNK1E;WIPF1;SH3D19;ARPIN;PLXNB3;CDC42EP5;FBXW8;EPHB2;WNT3;ULK2;SHANK3;EFNB3;NSMF;ARAP3;RHOD;SEMA4F;RHOF;WASF3;RHOBTB2;LRP4;NET1;ARHGAP44;LIMK1;GDI1;FYN;STK25;RAC3;EEF2K;DNM2;ZMYM3;PAK1;CUL7;SEMA4C;CAPRIN2;CDH4;NGFR;KIF13B;SEMA3B;SSH3;SDC2
4360,GO:0009966,1.63673911207406e-05,0.999988370091824,284,2148,regulation of signal transduction,BP,TNIP1;DUSP6;XDH;DUSP5;ZMYND8;HTRA1;EGR1;NR1D1;DLG4;CYP27B1;APLN;PGF;PDCD4;CTNNBIP1;ACVR2B;PRNP;DDIT4L;POSTN;VEGFA;WNT7A;APOE;F2R;LRP5;ITGA6;OBSCN;PKN1;ARRDC1;EGFR;SERPINE2;WWTR1;NOS1;PTPRS;SPRY2;MST1R;NFATC4;LTBP4;APPL2;SHC1;LTBP1;PTPRE;PHLDA2;SPRY4;ARAP1;MAP2K2;LPAR3;MDFI;CMTM7;RBCK1;MAP2K1;SSH1;SMURF2;FBLN1;SMAD3;ARHGAP23;SHANK2;PIK3R2;ERCC6;LRP1;DVL1;HBEGF;FAM110C;S100A4;SHC2;NLGN2;PAG1;ADORA2B;AKT1;GRB7;TMOD2;SH2D2A;RHBDF2;STK39;ASAP2;EPHA1;VEGFB;WWC3;IFNGR2;IFT140;PTHLH;FGFR4;PEAR1;WNT2B;FGFR1;PRKACB;MAPKBP1;RAC2;NPHP4;SORL1;CEACAM1;LZTS2;ZNF385A;IGFBP4;EVC;CCND1;PODNL1;STRADB;SYNGAP1;CARD19;PLAU;GAS6;PTK6;FGFBP1;CSNK1E;CARD11;SH2B3;DUSP7;GSN;CMTM4;PLEKHG2;MAPKAPK3;IGFBP2;PCSK9;ARHGAP22;BCR;ERRFI1;AIP;RGL2;ALOX15B;AGAP1;SLC20A1;DGKQ;BNIP3;PAK6;SHARPIN;MVB12B;PKD2;RASGEF1A;EPHB2;ADAM8;MNT;GRK6;CDKN1C;PLCG1;SH3BP2;CD81;TIMP2;WNT3;TMED4;TGFB1;GPC1;MOAP1;NTSR1;ARHGAP25;SHANK3;RASA3;TNFSF15;ARAP3;FARP1;MC1R;RHOD;VGF;PLEKHG4;RHOF;LLGL1;PLEKHG3;KIF7;RHOBTB2;TNFAIP8L1;PTPN1;WDR59;MBD3;IFNE;CD320;CAMK2N1;LRP4;VHL;TRAP1;ADAP1;RFNG;TRIB2;PRKCZ;PRKACA;MINK1;EPN2;ADA;AREG;PIM2;PLEKHG5;BOK;ERBB2;TFDP2;NET1;CYFIP2;RASA4;ARHGAP44;PRKCD;FAM20C;MIB2;USP20;STUB1;IFI6;BAX;ITGA1;SH3BP1;EREG;DUSP4;TMBIM4;DDIT4;SPRED3;PPP1R13L;TGFBR3;GDI1;LEMD2;RPS6KA6;DNM1;RGS14;MFNG;GSTO1;GIT1;CHAD;IRAK1;TGFA;HDAC7;INPP5D;CHEK2;TMEM161A;SESN2;CDC34;SOX7;ABCA7;BCAP31;MIF;PLA2G6;DDT;ECM1;WFS1;SPPL2B;FYN;STK25;RAC3;ARHGAP12;ACAP3;DNM2;PELI1;CAT;TSPYL2;KIF26A;IQSEC1;ARHGEF4;MAPK3;INSR;ARHGEF1;GRINA;C12ORF66;TMEM101;RALGAPA1;VANGL2;PAK1;SEMA4C;CAPRIN2;ITGA3;SRMS;PPP2R5B;MAP2K3;BCL2L1;RRAS;LMNA;KCTD13;TNFRSF25;FAM129B;EDA;TRIP10;RAP1GAP2;SOCS7;MAP3K10;RGS19;PELI3;NGFR;PDCD6;PXN;GRB10;LURAP1;TCTN1;SIRT3;HFE;ZP3;FGFR3;NDRG2;CBLC;ITPKB;HOMER2;DEDD2;LRRK1;KLHL24
10579,GO:0043549,1.65561995396036e-05,0.999990400401069,103,646,regulation of kinase activity,BP,DUSP6;DUSP5;EGR1;DLG4;PDCD4;ACVR2B;PRNP;VEGFA;APOE;F2R;LRP5;PKN1;EGFR;WWTR1;SPRY2;MST1R;SHC1;SNX9;SPRY4;MAP2K2;LPAR3;MAP2K1;PIK3R2;ERCC6;DVL1;SHC2;ADORA2B;ADARB1;AKT1;PPM1F;STK39;EPHA1;FGFR4;FGFR1;PRKACB;RAC2;SORL1;CEACAM1;CCND1;PODNL1;STRADB;GAS6;PTK6;DUSP7;MAPKAPK3;ERRFI1;CDC25B;DGKQ;PAK6;CEMIP;PKD2;EPHB2;ADAM8;CDKN1C;PLCG1;CD81;TGFB1;NAB2;TNFSF15;PTPN1;CAMK2N1;PFKFB2;TRIB2;PRKCZ;PRKACA;MINK1;ERBB2;PRKCD;RBL2;BAX;ITGA1;EREG;DUSP4;RGS14;CHAD;IRAK1;TGFA;SESN2;MIF;TRPT1;STK25;TSPYL2;SLC27A1;MAPK3;INSR;ADCY1;ETAA1;VANGL2;PAK1;CAMKK2;MAP2K3;DLG3;PROX1;PKD1;ADCY7;MAPRE3;SOCS7;MAP3K10;CAMK1;CAMKK1;FGFR3;CBLC;ADCY6
5443,GO:0016310,1.69587122758424e-05,0.99998837824757,225,1653,phosphorylation,BP,TNIP1;DUSP6;XDH;DUSP5;EGR1;DLG4;APLN;PDCD4;ACVR2B;PRNP;VEGFA;PGM1;WNT7A;APOE;DGKA;F2R;LRP5;ITGA6;HMGA2;OBSCN;NEK9;PKN1;EGFR;RPS6KA2;WWTR1;SPRY2;MST1R;SHC1;TK2;SNX9;SPRY4;RAPGEF3;ZFP36L1;MAP2K2;NME4;LPAR3;MAP2K1;MARK4;FBLN1;PIK3R2;ERCC6;GJC2;DVL1;HBEGF;PPP1R14A;SHC2;CDK18;NMRK1;ADORA2B;ADARB1;AKT1;PPM1F;STK39;HK1;EPHA1;IMPACT;ZFYVE21;CNTN1;BRSK1;FGFR4;FGFR1;PRKACB;RAC2;PFKL;SORL1;CEACAM1;IGFBP4;TTC7B;CCND1;PODNL1;STRADB;SYNGAP1;MAPK13;GAS6;PTK6;PFKP;CSNK1E;DUSP7;MAPKAPK3;DHTKD1;BCR;EHD4;ERRFI1;NADK;PANK4;CDC25B;SPTB;NPR2;DGKQ;PAK6;CEMIP;PKD2;RASGEF1A;CDC42EP5;EPHB2;ADAM8;CTBP1;GRK6;CDKN1C;PLCG1;CD81;TIMP2;TGFB1;SCYL1;ULK2;MKNK2;NAB2;SHANK3;SDHA;RASA3;PIP5KL1;TNFSF15;PI4K2A;PTPN1;IFNE;CAMK2N1;LRP4;PFKFB2;MLXIPL;TRIB2;PRKCZ;PRKACA;MINK1;AREG;PIM2;UCKL1;ERBB2;ULK1;STK17A;JAK3;RASA4;PDK1;PRKCD;FAM20C;RBL2;BAX;CYC1;ITGA1;EREG;RPS6KA5;DGUOK;DUSP4;DDIT4;LIMK1;TGFBR3;LEMD2;RPS6KA6;RGS14;ALDOC;CHAD;MAPK12;IRAK1;TGFA;PI4K2B;CHEK2;PPARA;SESN2;FGGY;ABCA7;SPEG;MIF;PLA2G6;DDT;TRPT1;FYN;STK25;EEF2K;CKMT1A;PELI1;CHKA;TSPYL2;SLC27A1;MAPK3;INSR;TAZ;PFKM;ADCY1;PDXK;ETAA1;VANGL2;PAK1;CAMKK2;PPP3CB;ALPK1;PFKFB3;MICAL1;SEMA4C;CAPRIN2;STK32C;SRMS;PPP2R5B;MAP2K3;DLG3;NDUFV3;RRAS;PROX1;PKD1;TNFRSF25;SIRT2;ADCY7;MAPRE3;SOCS7;MAP3K10;PELI3;NGFR;TOLLIP;GRB10;CAMK1;CAMKK1;SIRT3;HFE;CDK11B;PFN2;FGFR3;CCDC88C;NDRG2;CBLC;ITPKB;CDC42BPG;CLK3;PKN3;PI4KAP2;AK3;ADCY6;LRRK1
7327,GO:0031344,1.724794368484e-05,0.999990769393178,76,441,regulation of cell projection organization,BP,ZMYND8;SEMA4B;DLG4;PRNP;VEGFA;WNT7A;APOE;ESPN;EVI5L;OBSL1;PTPRS;SPRY2;NFATC4;ARAP1;LPAR3;MAP2K1;SSH1;SHANK2;LRP1;DVL1;FAM110C;AKT1;CORO1B;CNTN1;IFT140;FGFR1;RAC2;TENM2;TWF2;SYNGAP1;PTK6;SEMA3F;ARPIN;PLXNB3;CTSZ;CDC42EP5;CRTC1;FBXW8;EPHB2;WNT3;ULK2;SHANK3;EFNB3;NSMF;CROCC;SEMA4F;AGRN;LRP4;PLEK2;FSCN1;ARHGAP44;PRKCD;DGUOK;LIMK1;GDI1;FYN;STK25;EEF2K;DNM2;PAK1;CUL7;SEMA4C;CAPRIN2;ITGA3;PPP2R5B;CDH4;RAP1GAP2;NGFR;PLEKHM1;KIF13B;CAMK1;SEMA3B;PFN2;SSH3;ADCY6;SDC2
6252,GO:0019838,1.77052069025816e-05,0.999994742934664,23,85,growth factor binding,MF,HTRA1;ACVR2B;ITGA6;EGFR;LTBP4;SHC1;LTBP2;LTBP1;ITGB4;RHBDF2;FGFR4;FGFR1;IGFBP4;FGFBP1;IGFBP2;GPC1;ERBB2;TGFBR3;IGFBP7;INSR;NGFR;COL6A1;FGFR3
9178,GO:0035556,1.94599442041149e-05,0.999986241363775,266,1993,intracellular signal transduction,BP,TNIP1;DUSP6;XDH;DUSP5;ADGRL1;DLG4;PDCD4;DOCK4;PRNP;VEGFA;WNT7A;APOE;DGKA;F2R;OBSCN;NDRG1;ITPR3;PKN1;NISCH;EGFR;RPS6KA2;SERPINE2;WWTR1;NOS1;SPRY2;MST1R;NFATC4;APPL2;SHC1;SPRY4;RAPGEF3;ZFP36L1;ARAP1;MAP2K2;LPAR3;PLCD3;RBCK1;MAP2K1;MCTP1;FBLN1;ARHGAP23;PIK3R2;ERCC6;DVL1;HBEGF;FAM110C;S100A4;SHC2;PRODH;PAG1;ADORA2B;AKT1;PPM1F;STK39;ASAP2;EPHA1;WWC3;BRSK1;PTHLH;MYZAP;RAB31;FGFR4;FGFR1;MAPKBP1;RAC2;NPHP4;RALGDS;SORL1;CEACAM1;ASB13;ZNF385A;DOCK6;IGFBP4;PODNL1;EFS;PCBP4;STRADB;SYNGAP1;PLCH2;MAPK13;CARD19;GAS6;PTK6;RAB3B;CARD11;SH2B3;DUSP7;GSN;PLEKHG2;MAPKAPK3;ARHGAP22;BCR;ERRFI1;AIP;RGL2;SPTB;AGAP1;SLC20A1;NPR2;DGKQ;BNIP3;PAK6;SHARPIN;PKD2;RASGEF1A;CDC42EP5;EPHB2;ADAM8;PLCG1;NYAP1;CD81;CEBPB;TIMP2;GNAL;TMED4;TGFB1;MKNK2;MOAP1;ARHGAP25;SHANK3;RASA3;TNFSF15;ARAP3;FARP1;MC1R;RHOD;PLEKHG4;RHOF;PLEKHG3;RHOBTB2;TNFAIP8L1;PTPN1;WDR59;MBD3;IFNE;CAMK2N1;VHL;TRAP1;ADAP1;MLXIPL;TRIB2;PRKCZ;PRKACA;MINK1;ADA;PIM2;PLEKHG5;BOK;ERBB2;ADGRB2;TFDP2;PLEK2;STK17A;JAK3;NET1;RASA4;PDK1;ARHGAP44;PRKCD;MIB2;RBL2;BAX;ITGA1;SH3BP1;EREG;RPS6KA5;DUSP4;TMBIM4;DDIT4;PPP1R13L;LIMK1;TGFBR3;GDI1;LEMD2;RPS6KA6;RGS14;GSTO1;GIT1;CHAD;ADAM15;ASB1;MAPK12;IRAK1;TGFA;HDAC7;INPP5D;CHEK2;TMEM161A;SESN2;CDC34;ABCA7;RAB12;BCAP31;MIF;PLA2G6;DDT;ECM1;WFS1;FYN;STK25;RAC3;ARHGAP12;ACAP3;DNM2;PELI1;CAT;PLCB3;IQSEC1;ARHGEF4;MAPK3;INSR;ARHGEF1;GRINA;ADCY1;C12ORF66;DOCK9;TMEM101;RALGAPA1;VANGL2;PAK1;CAMKK2;PPP3CB;SEMA4C;ITGA3;STK32C;PPP2R5B;MAP2K3;BCL2L1;RRAS;ADGRF1;PKD1;KCTD13;TNFRSF25;SIRT2;TRIP10;ADCY7;RAB28;RAP1GAP2;SOCS7;MAP3K10;RGS19;GPR3;RAB40B;NGFR;TOLLIP;PDCD6;PCLO;PLEKHM1;LURAP1;CAMK1;CAMKK1;SIRT3;ZP3;CELSR1;FGFR3;CCDC88C;NDRG2;CBLC;ITPKB;CDC42BPG;HOMER2;PKN3;DEDD2;PI4KAP2;ADCY6;LRRK1
4772,GO:0010959,1.98778424903926e-05,0.99999160967512,40,191,regulation of metal ion transport,BP,FHL1;KCNG1;PRNP;F2R;SERPINE2;SCN4B;NOS1;PRSS8;ORAI1;LPAR3;GJC2;STOM;AKT1;STK39;CNTN1;KCNAB2;ANK3;PCSK9;SNTA1;CEMIP;PKD2;GRIN3B;PLCG1;TGFB1;NTSR1;PRKACA;VAMP2;TRPC1;CACNB3;BAX;GSTO1;EHD3;PLA2G6;WFS1;FYN;DNM2;GLRX;HFE;HOMER2;KLHL24
2937,GO:0006468,2.35731760971912e-05,0.999984077261114,187,1327,protein phosphorylation,BP,TNIP1;DUSP6;XDH;DUSP5;EGR1;DLG4;PDCD4;ACVR2B;PRNP;VEGFA;WNT7A;APOE;F2R;LRP5;HMGA2;OBSCN;NEK9;PKN1;EGFR;RPS6KA2;WWTR1;SPRY2;MST1R;SHC1;SNX9;SPRY4;RAPGEF3;ZFP36L1;MAP2K2;LPAR3;MAP2K1;MARK4;FBLN1;PIK3R2;ERCC6;GJC2;DVL1;HBEGF;SHC2;CDK18;ADORA2B;ADARB1;AKT1;PPM1F;STK39;EPHA1;IMPACT;CNTN1;BRSK1;FGFR4;FGFR1;PRKACB;RAC2;SORL1;CEACAM1;IGFBP4;CCND1;PODNL1;STRADB;SYNGAP1;MAPK13;GAS6;PTK6;CSNK1E;DUSP7;MAPKAPK3;BCR;EHD4;ERRFI1;CDC25B;SPTB;NPR2;DGKQ;PAK6;CEMIP;PKD2;RASGEF1A;CDC42EP5;EPHB2;ADAM8;CTBP1;GRK6;CDKN1C;PLCG1;CD81;TIMP2;TGFB1;SCYL1;ULK2;MKNK2;NAB2;SHANK3;RASA3;TNFSF15;PTPN1;IFNE;CAMK2N1;LRP4;MLXIPL;TRIB2;PRKCZ;PRKACA;MINK1;AREG;PIM2;ERBB2;ULK1;STK17A;JAK3;RASA4;PDK1;PRKCD;FAM20C;BAX;ITGA1;EREG;RPS6KA5;DGUOK;DUSP4;DDIT4;LIMK1;TGFBR3;LEMD2;RPS6KA6;RGS14;CHAD;MAPK12;IRAK1;TGFA;CHEK2;SESN2;ABCA7;SPEG;MIF;PLA2G6;DDT;TRPT1;FYN;STK25;EEF2K;PELI1;TSPYL2;SLC27A1;MAPK3;INSR;ADCY1;ETAA1;VANGL2;PAK1;CAMKK2;PPP3CB;ALPK1;MICAL1;SEMA4C;CAPRIN2;STK32C;SRMS;PPP2R5B;MAP2K3;DLG3;RRAS;PROX1;PKD1;TNFRSF25;SIRT2;ADCY7;MAPRE3;SOCS7;MAP3K10;PELI3;NGFR;CAMK1;CAMKK1;SIRT3;HFE;CDK11B;PFN2;FGFR3;CCDC88C;NDRG2;CBLC;ITPKB;CDC42BPG;CLK3;PKN3;ADCY6;LRRK1
7250,GO:0031224,2.47807681416497e-05,0.999981683896242,356,2786,intrinsic component of membrane,CC,NT5E;SDK2;ADGRL1;SEMA4B;B4GALNT4;SLC16A3;EDEM1;DLG4;MRC2;MARVELD1;PRR7;KCNG1;ACVR2B;PRNP;SLC6A8;FAM210B;TNFRSF6B;MXRA7;TSPAN1;F2R;LRP5;PLD3;OSBPL5;LPCAT4;ITGA6;SLCO4A1;ITPR3;GRAMD4;FCGRT;EGFR;SCN4B;NOS1;VAT1;PTPRS;TMEM129;SLC2A9;LRP3;MST1R;PRSS8;SDC1;LMF1;ORAI3;ORAI1;SLC7A8;PTPRE;SLC12A7;SLC2A3;KIAA1549L;ST6GALNAC2;KDSR;LPAR3;MARCH9;CSMD2;CMTM7;TP53I11;ACP5;NYNRIN;MCTP1;SLC16A5;KCNJ15;TMTC4;TMEM8A;ARMCX2;SHANK2;LRP1;GJC2;SRD5A3;PIGQ;HBEGF;ITGB4;CYBRD1;TMEM158;NLGN2;STOM;MBOAT7;REEP4;LY6K;PAG1;ADORA2B;SYT8;SLC6A6;TPCN1;KCNC4;TTYH3;ENTPD6;RHBDF2;BSG;DYSF;EPHA1;GGT1;PTPRU;MARCH4;SLC15A4;LRRC8A;CNTN1;IFNGR2;MFSD3;FGFR4;PEAR1;FNDC4;LDLR;FGFR1;SIGMAR1;KCNAB2;SYNE3;B4GAT1;TOMM34;PIGV;SORL1;NAT14;CEACAM1;B3GAT3;TENM2;ABCD1;EVC;AIG1;SYNGAP1;EDNRA;CARD19;BRI3;CYYR1;RAB3B;CMTM4;ANO8;ANTXR2;PRSS22;TMEM200A;SLITRK6;TSPAN18;PAQR6;TMEM132B;SPTB;COMTD1;PEX10;COL13A1;CORO7;SLC20A1;RRNAD1;NPR2;PLXNB3;BNIP3;SERINC2;PROCR;PKD2;IL20RB;ITGB5;ABCA2;FAM189B;EPOR;EPHB2;GRIN3B;ADAM8;ASIC1;CADM4;TMEM9;CD81;ENTPD2;SLC29A4;TMED4;SNPH;SLC43A1;GPC1;TBC1D9B;SLC38A10;NTSR1;B3GNT3;TMEM173;TMEM134;ATP7B;SHANK3;PODXL2;EFNB3;RASA3;TNFSF15;MGAT4B;CLCA2;SCART1;MC1R;DIRC2;KLRG2;ST6GALNAC6;HTR7;PI4K2A;SEMA4F;C1ORF210;YIPF3;SLC48A1;PLPP6;ADAM19;B4GALT2;AGRN;CD320;LRP4;LRP10;ESYT2;ZDHHC24;GPR153;B4GALT6;DNAJC4;TMCC3;APCDD1L;RFNG;C14ORF132;PRKACA;OXA1L;CD9;AREG;BOK;ERBB2;ADGRB2;VAMP2;TMEM143;RTL1;C6ORF89;LRRC37A2;BNIP3L;TRPC1;SLC22A17;RASA4;REEP6;CACNB3;IFI6;BAX;CYC1;GRAMD1C;SV2A;SBF1;XYLT2;SLC13A5;ITGA1;OLFM2;GJB4;EREG;TMEM25;TIMM17B;TMBIM4;MBTPS2;HSD17B7;GRAMD1A;ZDHHC8;TMX4;TGFBR3;LTB4R2;SLC2A11;LEMD2;TMEM92;TMEM8B;SCN8A;MFNG;MSLN;LPCAT1;ADAM15;REEP2;ST3GAL3;TMEM231;TMEM94;IRAK1;PPOX;TGFA;RNF215;CACFD1;COQ2;TMEM161A;ABCG1;SNN;ABCA7;BCAP31;SLC25A29;BCAM;SLC9A7;SYNGR1;WFS1;QSOX1;CD68;SLC22A18;SPPL2B;TMCO6;CERS4;SUN1;ICAM5;ARMCX1;ELFN2;SLC27A1;TPBG;SLC50A1;ZDHHC1;SLC12A4;INSR;SLC13A3;RTN2;GRINA;TMEM54;TAZ;ADCY1;HLA-G;STX10;ATP8B2;TMEM101;PRAF2;VANGL2;MALL;RNF144A;ROBO4;SLC37A2;GABBR1;SEMA4C;ITGA3;SAMD8;SLC16A13;NDST2;BCL2L1;DLG3;MDGA1;ADGRF1;PKD1;TNFRSF25;CDH4;ITGA4;EDA;GAL3ST4;DCBLD2;ADCY7;ALG12;LTB4R;TMEM154;FAM171A2;ST3GAL2;SLC25A37;GPR3;HSD11B1;NGFR;TOLLIP;CHST14;SLC39A3;HFE;ZP3;VPS51;TMCO3;CELSR1;IL17RE;C2CD2;SLC35F3;FGFR3;MFSD10;KRTCAP3;ST3GAL5;SPTLC2;PRSS21;LRP11;TMEM229B;TMEM187;SLC23A2;CHPF;ADCY6;SLC26A11;SDC2
7358,GO:0031410,2.54509218207067e-05,0.999982273218681,220,1616,cytoplasmic vesicle,CC,DLG4;PLAT;CST3;EPN3;PYGB;VEGFA;PGM1;WNT7A;APOE;PYGL;F2R;NDRG1;ITPR3;PKN1;ARRDC1;NISCH;EGFR;SERPINE2;LOXL1;VAT1;PTPRS;SYTL1;APPL2;VPS11;TBC1D14;HEXB;SLC2A3;SNX9;GAA;ARAP1;MAP2K2;MAP2K1;NAPRT;MCTP1;LRP1;DVL1;HBEGF;AP2A2;PRDX5;STOM;LY6K;SYT8;TPCN1;BSG;SERPING1;DYSF;VEGFB;SLC15A4;ZFYVE21;IFNGR2;BRSK1;RAB31;FGFR4;LDLR;FGFR1;FUCA1;SIGMAR1;RAC2;KCNAB2;PFKL;SORL1;CEACAM1;RAB11FIP4;PLAU;GAS6;BRI3;CTSB;RAB3B;GSN;IGFBP2;PCSK9;PHLDA1;ANTXR2;EHD4;WIPF1;DBNDD1;CORO7;DGKQ;MVB12B;FYCO1;CEMIP;PKD2;PCSK1;CTSZ;AP3D1;ITGB5;ABCA2;PRSS3;ADAM8;APRT;TMEM9;LTA4H;TIMP2;WNT3;DPP7;TMED4;TGFB1;CLTCL1;SCYL1;ABHD17C;SNTB2;ULK2;GPC1;TMEM173;ATP7B;GALNS;RHOD;SNX17;VGF;SNX33;PI4K2A;C1ORF210;RHOF;YIPF3;SLC48A1;LLGL1;RHOBTB2;PTPN1;TPP1;CD320;CEP131;IDUA;YPEL5;PRKCZ;PRKACA;ACTR1B;CD9;EPN2;ADA;AREG;MICALL2;PLEKHG5;BOK;CAPG;NEURL1B;ERBB2;ULK1;AHCY;VAMP2;JAK3;RNPEP;ARHGAP44;EHBP1L1;MCFD2;PRKCD;MIB2;SV2A;ITGA1;AHNAK2;PCSK1N;ZDHHC8;DNM1;WASH3P;SCN8A;ALDOC;LPCAT1;ADAM15;EHD3;IRAK1;TGFA;PI4K2B;ABCG1;MYO1D;ABCA7;RAB12;BCAP31;MIF;DOPEY2;SLC9A7;SYNGR1;ECM1;QSOX1;CD68;SPPL2B;FYN;SUN1;DNM2;GLB1;SNX15;CAT;MAPK3;INSR;HLA-G;PDXK;PRAF2;VANGL2;MALL;RNASET2;RNF144A;LGALS3BP;HYAL1;SEMA4C;VPS16;MAN2B1;BCL2L1;SGSM2;DNASE1L1;TBC1D16;PKD1;ANKRD13D;NMNAT2;AZIN2;SERPINB1;ICA1;RGS19;RAB40B;NGFR;TOLLIP;PDCD6;PLEKHM1;GCH1;NBEAL2;HFE;VPS51;SEPT6;FGFR3;MFSD10;CLK3;TMEM187;APBA1
2430,GO:0005615,2.58295131856058e-05,0.999981263703164,304,2419,extracellular space,CC,NT5E;XDH;SEMA4B;HTRA1;THSD4;PLAT;CST3;EPN3;FBXO2;APLN;PGF;XPC;PRNP;PYGB;POSTN;VEGFA;TNFRSF6B;PGM1;WNT7A;APOE;PYGL;TSPAN1;NAGLU;PLD3;NDRG1;IDH2;ACOT7;ARRDC1;AKR7A2;EGFR;SERPINE2;DNPH1;LOXL1;VAT1;PTPRS;CTSO;CAPN2;CRTAP;LTBP4;PRSS8;SYTL1;SDC1;APPL2;LTBP2;LTBP1;ARL2;HEXB;SLC7A8;SLC2A3;ACTA2;SNX9;RAPGEF3;GAA;GLUL;KDSR;CTBS;CMTM7;PLTP;PGLS;MAP2K1;NAPRT;CRYL1;ACP5;MARCKSL1;TMEM8A;GALE;SLC9A3R2;FBLN1;ARHGAP23;HBEGF;S100A4;ITGB4;CYBRD1;PRDX5;STOM;CORO1B;TTYH3;S100A6;F12;ENTPD6;PLEKHH3;BSG;SERPING1;DYSF;GGT1;VEGFB;CNTN1;PTHLH;HEBP1;WNT2B;FNDC4;LDLR;PRKACB;FUCA1;RAC2;PFKL;SEC14L2;GAMT;H2AFJ;B4GAT1;BPHL;SORL1;CEACAM1;B3GAT3;RAB11FIP4;IGFBP4;TWF2;CEP250;PLAU;GAS6;SEMA3F;PFKP;FGFBP1;CTSB;RAB3B;CARD11;LAMA5;GSN;CMTM4;IGFBP2;PCSK9;BCR;ANGPTL4;EHD4;SLITRK6;ALOX15B;CCS;GGACT;OAF;HAGH;MVB12B;SERINC2;PROCR;PKD2;ACY1;FAM3A;GPX3;PCSK1;CTSZ;ITGB5;MAGEF1;PRSS3;CADM4;APRT;LTA4H;CD81;ENTPD2;ADAMTS13;TIMP2;NUDCD2;WNT3;DPP7;GNAL;TMED4;TGFB1;CLTCL1;SNTB2;GPC1;ADAMTS7;TNFSF15;MDH2;GALNS;ABHD8;CROCC;ABHD14B;LAMB2;RNH1;VGF;SEMA4F;RHOF;WASF3;PHGDH;PEX1;TPP1;PCK2;AGRN;IFNE;CD320;TRAP1;IDUA;RFNG;PRKCZ;PRKACA;MINK1;GRHPR;ACTR1B;TOM1L2;CD9;ADA;AREG;MPI;CAPG;CNDP2;AHCY;VAMP2;MMP10;RNPEP;CYFIP2;FSCN1;PRKCD;FAM20C;RBL2;STUB1;BAX;ITGA1;PPCS;EREG;PPL;PCSK1N;HPCAL1;CES2;NAGA;NID1;TGFBR3;NTPCR;CPNE7;DNM1;MFNG;GSTO1;ALDOC;MSLN;ADAM15;REEP2;WDR60;TGFA;CHD2;MYO1D;JADE2;MIF;DOPEY2;BCAM;PLA2G6;DDT;NUDT14;ECM1;QSOX1;VWA1;EFEMP2;STK25;RAC3;ETFB;DNM2;CKMT1A;GLB1;ATXN10;CAT;IGFBP7;ELFN2;ZDHHC1;TUBB6;MAPK3;CBLN3;INSR;SLC13A3;PFKM;ADCY1;TSTA3;PDXK;GLRX;RNASET2;LGALS3BP;CTSF;ROBO4;SLC37A2;HYAL1;SEMA4C;ITGA3;MAN2B1;DLG3;RRAS;DNASE1L1;MDGA1;ALDH7A1;PKD1;FAM129B;ITGA4;GAL3ST4;TRIP10;SERPINB1;LAMB1;TOLLIP;PDCD6;ATP6V1F;PCLO;CHST14;BIVM;RNASE7;DUSP23;TCTN1;HFE;COL6A1;ZP3;SEMA3B;PFN2;TST;NDRG2;MAN2B2;CBLC;PTGR2;PRSS21;IRF2BPL;PM20D2;SLC26A11;AARS
5663,GO:0016772,2.64098933983973e-05,0.999983767855113,120,782,transferase activity, transferring phosphorus-containing groups,MF,DLG4;NAGS;ACVR2B;DGKA;HMGA2;OBSCN;NEK9;PKN1;EGFR;RPS6KA2;MST1R;LTBP4;LTBP1;TK2;MAP2K2;NME4;MAP2K1;MARK4;PIK3R2;HBEGF;CDK18;NMRK1;AKT1;STK39;HK1;EPHA1;ZFYVE21;BRSK1;FGFR4;POLD4;FGFR1;PRKACB;PFKL;CCND1;STRADB;MAPK13;PTK6;PFKP;CSNK1E;CARD11;MAPKAPK3;BCR;NADK;PANK4;NPR2;DGKQ;PAK6;EPHB2;GRK6;SCYL1;ULK2;MKNK2;EFNB3;PIP5KL1;POLL;POLM;PI4K2A;PFKFB2;PRKCZ;PRKACA;MINK1;PIM2;UCKL1;ERBB2;ULK1;PRIMPOL;STK17A;JAK3;PDK1;PRKCD;FAM20C;EREG;RPS6KA5;DGUOK;LIMK1;TGFBR3;RPS6KA6;MAPK12;IRAK1;PI4K2B;CHEK2;FGGY;SPEG;TRPT1;FYN;STK25;EEF2K;CKMT1A;PELI1;CHKA;MAPK3;INSR;PFKM;PDXK;PAK1;CAMKK2;ALPK1;PFKFB3;REV1;STK32C;SAMD8;SRMS;MAP2K3;DLG3;NMNAT2;TEP1;MAP3K10;PELI3;CAMK1;CAMKK1;TERC;CDK11B;FGFR3;ITPKB;CDC42BPG;CLK3;PKN3;PI4KAP2;AK3;LRRK1
7237,GO:0031175,2.7376471773619e-05,0.99998372601999,103,650,neuron projection development,BP,ZMYND8;SEMA4B;DLG4;POSTN;VEGFA;WNT7A;APOE;EGFR;OBSL1;PTPRS;NFATC4;SHC1;LPAR3;MAP2K1;SSH1;SHANK2;LRP1;DVL1;ADARB1;AKT1;GRB7;S100A6;IMPACT;CNTN1;BRSK1;FGFR1;RAC2;B4GAT1;KLF7;ANK3;TWF2;SYNGAP1;PTK6;SEMA3F;DBNDD1;SLITRK6;SPTB;PLXNB3;CTSZ;CRTC1;FBXW8;EPHB2;PLCG1;NYAP1;WNT3;ULK2;GPC1;SHANK3;EFNB3;NSMF;FARP1;LAMB2;SEMA4F;LLGL1;LRP4;PRKCZ;MINK1;AREG;MICALL2;ERBB2;ULK1;CYFIP2;ARHGAP44;ITGA1;RPS6KA5;DGUOK;LIMK1;GDI1;FYN;STK25;RAC3;EEF2K;DNM2;ATXN10;MAPK3;ADCY1;RERE;VANGL2;PAK1;PPP3CB;USP21;CUL7;SEMA4C;CAPRIN2;ITGA3;PPP2R5B;ADGRF1;FAM129B;CDH4;RAP1GAP2;LAMB1;NGFR;GRB10;KIF13B;TCTN1;CAMK1;SEMA3B;SSH3;BLOC1S4;DOK4;TRIM46;ADCY6;SDC2
16714,GO:0097708,2.7700019830495e-05,0.999980677349272,220,1618,intracellular vesicle,CC,DLG4;PLAT;CST3;EPN3;PYGB;VEGFA;PGM1;WNT7A;APOE;PYGL;F2R;NDRG1;ITPR3;PKN1;ARRDC1;NISCH;EGFR;SERPINE2;LOXL1;VAT1;PTPRS;SYTL1;APPL2;VPS11;TBC1D14;HEXB;SLC2A3;SNX9;GAA;ARAP1;MAP2K2;MAP2K1;NAPRT;MCTP1;LRP1;DVL1;HBEGF;AP2A2;PRDX5;STOM;LY6K;SYT8;TPCN1;BSG;SERPING1;DYSF;VEGFB;SLC15A4;ZFYVE21;IFNGR2;BRSK1;RAB31;FGFR4;LDLR;FGFR1;FUCA1;SIGMAR1;RAC2;KCNAB2;PFKL;SORL1;CEACAM1;RAB11FIP4;PLAU;GAS6;BRI3;CTSB;RAB3B;GSN;IGFBP2;PCSK9;PHLDA1;ANTXR2;EHD4;WIPF1;DBNDD1;CORO7;DGKQ;MVB12B;FYCO1;CEMIP;PKD2;PCSK1;CTSZ;AP3D1;ITGB5;ABCA2;PRSS3;ADAM8;APRT;TMEM9;LTA4H;TIMP2;WNT3;DPP7;TMED4;TGFB1;CLTCL1;SCYL1;ABHD17C;SNTB2;ULK2;GPC1;TMEM173;ATP7B;GALNS;RHOD;SNX17;VGF;SNX33;PI4K2A;C1ORF210;RHOF;YIPF3;SLC48A1;LLGL1;RHOBTB2;PTPN1;TPP1;CD320;CEP131;IDUA;YPEL5;PRKCZ;PRKACA;ACTR1B;CD9;EPN2;ADA;AREG;MICALL2;PLEKHG5;BOK;CAPG;NEURL1B;ERBB2;ULK1;AHCY;VAMP2;JAK3;RNPEP;ARHGAP44;EHBP1L1;MCFD2;PRKCD;MIB2;SV2A;ITGA1;AHNAK2;PCSK1N;ZDHHC8;DNM1;WASH3P;SCN8A;ALDOC;LPCAT1;ADAM15;EHD3;IRAK1;TGFA;PI4K2B;ABCG1;MYO1D;ABCA7;RAB12;BCAP31;MIF;DOPEY2;SLC9A7;SYNGR1;ECM1;QSOX1;CD68;SPPL2B;FYN;SUN1;DNM2;GLB1;SNX15;CAT;MAPK3;INSR;HLA-G;PDXK;PRAF2;VANGL2;MALL;RNASET2;RNF144A;LGALS3BP;HYAL1;SEMA4C;VPS16;MAN2B1;BCL2L1;SGSM2;DNASE1L1;TBC1D16;PKD1;ANKRD13D;NMNAT2;AZIN2;SERPINB1;ICA1;RGS19;RAB40B;NGFR;TOLLIP;PDCD6;PLEKHM1;GCH1;NBEAL2;HFE;VPS51;SEPT6;FGFR3;MFSD10;CLK3;TMEM187;APBA1
5902,GO:0018108,2.78309281288576e-05,0.999987344917709,46,232,peptidyl-tyrosine phosphorylation,BP,DLG4;PRNP;VEGFA;EGFR;MST1R;SHC1;MAP2K2;MAP2K1;ERCC6;HBEGF;EPHA1;CNTN1;FGFR4;FGFR1;GAS6;PTK6;BCR;EHD4;ERRFI1;DGKQ;EPHB2;CD81;TGFB1;SCYL1;PTPN1;LRP4;PRKCZ;AREG;ERBB2;JAK3;PRKCD;EREG;TGFA;MIF;FYN;MAPK3;INSR;CAMKK2;SRMS;PPP2R5B;MAP2K3;DLG3;FGFR3;CBLC;CLK3;LRRK1
6751,GO:0030182,2.79921469982288e-05,0.999982488585372,130,860,neuron differentiation,BP,SDK2;ZMYND8;SEMA4B;DLG4;POSTN;VEGFA;WNT7A;APOE;NAGLU;EGFR;OBSL1;PTPRS;NFATC4;ETV5;SHC1;LPAR3;SMARCA1;MAP2K1;SSH1;SHANK2;LRP1;DVL1;ADARB1;AKT1;GRB7;HDAC5;S100A6;IMPACT;CNTN1;BRSK1;IFT140;WNT2B;FGFR1;RAC2;NPHP4;B4GAT1;KLF7;HMG20B;TENM2;ANK3;TRAPPC9;TWF2;SYNGAP1;PTK6;SEMA3F;CSNK1E;PCSK9;DBNDD1;MYEF2;SLITRK6;SPTB;UNC119B;PLXNB3;CTSZ;CRTC1;FBXW8;EPHB2;PLCG1;NYAP1;CEBPB;TIMP2;WNT3;SNPH;UNK;ULK2;GPC1;SHANK3;EFNB3;NSMF;FARP1;LAMB2;SEMA4F;LLGL1;AGRN;LRP4;PRKCZ;MINK1;AREG;MICALL2;ERBB2;ULK1;CYFIP2;ARHGAP44;ITGA1;RPS6KA5;DGUOK;DDIT4;IER2;LIMK1;GDI1;FYN;STK25;RAC3;EEF2K;DNM2;ATXN10;MAPK3;ADCY1;RERE;VANGL2;PAK1;PPP3CB;USP21;CUL7;SEMA4C;CAPRIN2;ITGA3;DNMT3A;BIN1;PPP2R5B;PROX1;MDGA1;ADGRF1;FAM129B;CDH4;RAP1GAP2;LAMB1;NGFR;GRB10;KIF13B;NR2F6;TCTN1;CAMK1;SEMA3B;SSH3;BLOC1S4;DOK4;TRIM46;ADCY6;SDC2
2488,GO:0005737,2.93921990666417e-05,0.999978175342418,947,8401,cytoplasm,CC,TNIP1;DUSP6;NT5E;XDH;ERCC1;DUSP5;MEF2D;ZMYND8;H1F0;CITED4;HTRA1;FHL1;EGR1;B4GALNT4;NR1D1;H6PD;CCNG2;EDEM1;DLG4;PLAT;CST3;CYP27B1;TYSND1;HS1BP3;BTBD2;MARVELD1;EPN3;FBXO2;APLN;PRR7;PDCD4;CTNNBIP1;NAGS;ACVR2B;DOCK4;XPC;PRNP;PARVB;PYGB;BBS2;FLNC;DDIT4L;POSTN;VEGFA;FAM210B;PGM1;WNT7A;APOE;PYGL;DGKA;TSPAN1;ESPN;NAGLU;F2R;LRP5;PLD3;OSBPL5;LPCAT4;ISYNA1;PITPNC1;OBSCN;NDRG1;IDH2;NEK9;CRAT;ELK3;ITPR3;PKN1;MTA1;GRAMD4;ACOT7;ARRDC1;ANGEL1;ACSF2;NISCH;AKR7A2;EGFR;RPS6KA2;SERPINE2;DNPH1;WWTR1;LOXL1;OBSL1;NOS1;VAT1;PTPRS;TMEM129;ANKS6;HADH;CTSO;SPRY2;CAPN2;MST1R;NFATC4;TRIM65;CRTAP;SYTL1;SDC1;LMF1;APPL2;SHC1;VPS11;LTBP1;TBC1D14;ARL2;HEXB;GTPBP1;SLC7A8;PTPRE;NPEPL1;SLC2A3;ALDH4A1;TK2;RIN1;ACTA2;CLIP2;PHLDA2;SNX9;NUDCD3;SPRY4;RAPGEF3;TXNRD3;ST6GALNAC2;ZFP36L1;GAA;GLUL;RNPEPL1;ARAP1;MAP2K2;KDSR;NME4;MARCH9;CTBS;PLCD3;FKBP9;MDFI;PTOV1;RBCK1;SUGCT;PGLS;PC;MAP2K1;NAPRT;CRYL1;ACP5;CPT2;MCTP1;SSH1;POU2F2;EXOC2;ENDOG;MARK4;MARCKSL1;MPRIP;TMEM8A;GALE;SMURF2;KLC2;TSC22D1;ARMCX2;OXLD1;FOS;SMAD3;ARHGAP23;STAT6;SHANK2;PIK3R2;LRP1;SRD5A3;DVL1;EPAS1;DNAJB5;PIGQ;HSD17B8;THBS3;HBEGF;FAM110C;RPUSD3;AP2A2;S100A4;CYBRD1;PPP1R14A;SH3PXD2B;PRDX5;SHC2;STOM;PRODH;MBOAT7;CDK18;REEP4;LY6K;FBXW5;RNF187;NMRK1;ADARB1;D2HGDH;SYT8;AKT1;TPCN1;GRB7;TMOD2;CORO1B;HDAC5;UROS;FBXO41;FAM83A;S100A6;F12;SH2D2A;PPM1F;MMP28;PITPNM1;ENTPD6;RHBDF2;PYCR2;BSG;STK39;HK1;SERPING1;ASAP2;DYSF;EPHA1;NFKBIZ;VEGFB;FMNL2;IMPACT;MARCH4;SLC15A4;WWC3;ATG16L2;ZFYVE21;LRRC8A;IFNGR2;BRSK1;IFT140;PTHLH;MYZAP;RAB31;DNAAF5;FGFR4;HEBP1;POLD4;ACOT1;FNDC4;LDLR;FGFR1;PRKACB;FUCA1;MAPKBP1;ELMO3;SIGMAR1;RAC2;KCNAB2;PFKL;SEC14L2;OPLAH;HLTF;MXI1;NPHP4;SYNE3;GAMT;B4GAT1;PACS2;PHF7;TOMM34;BPHL;PIGV;RALGDS;SORL1;CEACAM1;B3GAT3;ASB13;CIRBP;CBR4;LZTS2;RAB11FIP4;TENM2;ZNF385A;DOCK6;MICALCL;ABCD1;ANK3;NIPSNAP1;IGFBP4;TTC7B;EVC;TRAPPC9;CCND1;PODNL1;EFS;PCBP4;LHPP;TNNT1;TWF2;STRADB;SYNGAP1;PLCH2;MAPK13;CEP250;CARD19;PLAU;GAS6;PTK6;PFKP;CSNK1E;BRI3;CTSB;RAB3B;CARD11;SH2B3;DUSP7;MPLKIP;GSN;PLEKHG2;MAPKAPK3;IGFBP2;PCSK9;ARHGAP22;RAD23A;DHTKD1;PHLDA1;ANO8;BCR;ANTXR2;XPOT;MRPS6;EHD4;ERRFI1;SEPT10;WIPF1;NADK;PANK4;HLCS;AIP;DBNDD1;STON1;MYEF2;SH3D19;CCDC113;CDC25B;SH3GLB2;ARHGAP27;ALOX15B;SPTB;AGAP1;COMTD1;RSPH3;PEX10;CCS;RSAD1;COL13A1;CORO7;NPR2;UNC119B;SNTA1;DGKQ;HAGH;BNIP3;PAK6;NOL4L;GTF2IRD1;SHARPIN;MVB12B;FYCO1;CEMIP;PKD2;ACY1;PCSK1;RETSAT;RASGEF1A;CTSZ;CDC42EP5;CRTC1;FBXW8;GPSM1;AP3D1;ITGB5;ABCA2;PRSS3;SH3PXD2A;C19ORF33;EPHB2;ADAM8;ASIC1;APRT;TMEM9;CTBP1;JOSD2;LTA4H;PTPDC1;GRIP2;CDKN1C;PLCG1;FBXL8;ZMIZ2;CBS;KIF17;CEBPB;MVD;RNF135;ENTPD2;LGALS9B;ADAMTS13;ZNF217;TIMP2;NUDCD2;SYNJ2;WNT3;DPP7;C8ORF88;TMED4;TGFB1;LACTB2;SNPH;CLTCL1;RFX2;SCYL1;ABHD17C;UNK;SNTB2;ULK2;GPC1;MKNK2;ADAMTS7;DEAF1;MOAP1;SLC38A10;NTSR1;B3GNT3;TMEM173;ARHGAP25;TMEM134;ATP7B;FHOD3;SHANK3;PODXL2;SDHA;MSRB2;RASA3;PNRC1;MIPEP;PIP5KL1;MYCBPAP;MGAT4B;EML2;KIF26B;MDH2;MPG;GALNS;FBXO17;CLCA2;HEXDC;GOLGA2P5;ENKD1;NSMF;PEG3;ARAP3;SCART1;FARP1;TUB;DIRC2;LCE1E;CROCC;RHOD;ABHD14B;LAMB2;TNS1;ABTB1;SNX17;RNH1;DNAH1;ERO1B;ST6GALNAC6;VGF;FBXO44;SNX33;PI4K2A;SEMA4F;C1ORF210;RHOF;YIPF3;ANKZF1;WASF3;ATG2A;SLC48A1;LLGL1;PHGDH;MIF4GD;KIF7;COA5;RHOBTB2;UBXN4;ADAM19;SAC3D1;TUBG2;RIMS3;BBS1;TNFAIP8L1;HMGCL;PTPN1;PEX1;TPP1;PCK2;B4GALT2;WDR59;AGRN;MBD3;CD320;OSBPL10;ESYT2;ZDHHC24;ACP6;B4GALT6;VHL;CEP131;TRAP1;IDUA;ADAP1;PFKFB2;RFNG;MLXIPL;YPEL5;TRIB2;PRKCZ;PRKACA;MINK1;CENPH;GRHPR;OXA1L;RHPN1;RABGGTA;RCCD1;ACTR1B;CD9;EPN2;ADA;AREG;PIM2;MPI;MICALL2;UCKL1;LGALS9C;PLEKHG5;BOK;WDR18;TDRKH;CAPG;SDCCAG8;ALAS1;NEURL1B;ERBB2;ULK1;CNDP2;NINL;AHCY;VAMP2;CERCAM;PRIMPOL;TMEM143;TFDP2;SMTN;PLEK2;C6ORF89;MZT2A;NECAB3;RILPL1;JAK3;IRF2BP2;RNPEP;NET1;BNIP3L;CYFIP2;FSCN1;SLC22A17;RASA4;GLCCI1;PDK1;ACAD10;CYGB;ARHGAP44;THOP1;EHBP1L1;MCFD2;PRKCD;FAM20C;MIB2;REEP6;RBL2;CACNB3;USP20;STUB1;IFI6;BAX;CYC1;SV2A;SBF1;DTD1;XYLT2;TRIM4;ITGA1;OLFM2;ZNF395;HIST3H2BB;CCDC92;NUBP2;PPCS;SH3BP1;FBXW4;RPS6KA5;DGUOK;DUSP4;TIMM17B;CUL9;TMBIM4;DDIT4;MBTPS2;ACADS;PPL;PPP1R13L;HSD17B7;AHNAK2;PCSK1N;MT2A;IER2;CES2;NAGA;ZDHHC8;TMX4;MZT2B;FCHO1;LIMK1;TGFBR3;PDIA5;GDI1;TPM2;PADI3;CPNE7;RPL39L;LEMD2;RPS6KA6;DNM1;WASH3P;RGS14;TMEM8B;SCN8A;MFNG;GSTO1;GIT1;ALDOC;CHAD;MRPS26;MSLN;LPCAT1;LRSAM1;ADAM15;REEP2;ASB1;EHD3;WDR60;ST3GAL3;LONP2;SYMPK;MAPK12;IRAK1;PPOX;TGFA;HDAC7;FHOD1;INPP5D;MTHFR;PI4K2B;CBX7;PCMTD2;CHEK2;DTNB;DECR2;ZFPM1;COG7;COQ2;SESN2;ABCG1;MYO1D;MYH15;CDC34;RNF123;SNN;SOX7;ABCA7;RAB12;EML3;SIX5;BCAP31;MIF;ACO2;SMOX;EEF2KMT;SLC25A29;DOPEY2;PHYH;MEX3A;SLC9A7;PLA2G6;DDT;SYNGR1;NUDT14;ECM1;WFS1;QSOX1;DNAAF3;CD68;SLC22A18;DTX3;NBPF3;SPPL2B;FYN;PITPNM3;VWA1;UPP1;STK25;RAC3;ETFB;GLB1L2;EEF2K;CERS4;SUN1;ARHGAP12;FLYWCH1;ACAP3;DNM2;CKMT1A;CYP3A5;BHLHE40;GLB1;PELI1;ATXN10;SNX15;INF2;CHKA;CAT;BEX2;NEIL1;TSPYL2;KIAA1147;IGFBP7;ARMCX1;SLC27A1;ZMYM3;TPBG;APOBEC3C;SLC50A1;KIF26A;ASMTL;ZDHHC1;SLC12A4;PLCB3;IQSEC1;APOBEC3F;ARHGEF4;DDX50;CYP2R1;TUBB6;MAPK3;CBLN3;INSR;RTN2;ARHGEF1;PAN2;GRINA;PDZD2;TAZ;PFKM;ADCY1;TNS4;C12ORF66;HLA-G;DOCK9;STX10;TSTA3;ATP8B2;GPT2;RALGAPA1;MORN4;PDXK;PRAF2;GLRX;CEP72;VANGL2;PAK1;TRIM45;MALL;CAMKK2;RNASET2;PPP3CB;RNF144A;LGALS3BP;ALPK1;CTSF;USP21;PFKFB3;MLYCD;CUL7;SLC37A2;GABBR1;MICAL1;HYAL1;SEMA4C;CAPRIN2;WDTC1;ITGA3;DNMT3A;SAMD8;BIN1;VPS16;MAN2B1;SRMS;TSTD1;PPP2R5B;SLC16A13;MAP2K3;NDST2;BCL2L1;DLG3;SGSM2;ABHD10;NDUFV3;DNASE1L1;PROX1;IARS2;LRCH4;TBC1D16;ALDH7A1;LMNA;PKD1;TNFRSF25;RABGAP1;SIRT2;FAM129B;EDA;ANKRD13D;GAL3ST4;NMNAT2;BACH1;NT5C1B;TRIP10;ADCY7;E2F5;ALG12;AFAP1L1;MAPRE3;AZIN2;TEP1;RAB28;SERPINB1;ST3GAL2;ICA1;SLC25A37;RAP1GAP2;LAMB1;SOCS7;MAP3K10;HSDL1;RGS19;NDE1;HSD11B1;PELI3;GTF2IRD2;RAB40B;NGFR;TOLLIP;PDCD6;ATP6V1F;PCLO;ARVCF;CHST14;BIVM;RNASE7;PXN;GRB10;PHYKPL;PLEKHM1;DUSP23;GCH1;MSS51;LURAP1;KIF13B;MAFF;TCTN1;NBEAL2;PNMA1;CAMK1;CAMKK1;SIRT3;HFE;TERC;WIPI2;GAS2L1;COL6A1;BTG1;VPS51;FAM117A;TACC1;MLF2;IL17RE;SEMA3B;SEPT6;CDK11B;PFN2;C2CD2;SSH3;FGFR3;MFSD10;TST;CCDC88C;ST3GAL5;TNRC18;NDRG2;MAN2B2;BLOC1S4;ITPKB;PTGR2;SPTLC2;CDC42BPG;PRSS21;DOK4;GSDMA;CLK3;TRIM46;DHX32;KDM3A;PM20D2;TMEM187;HOMER2;SLC23A2;PKN3;APBA1;TTLL3;PI4KAP2;AK3;SRSF5;CHPF;ADCY6;SLC26A11;LRRK1;AARS;KLHL24;STRN4;SDC2
6680,GO:0030054,2.99819093345769e-05,0.999981017895441,131,882,cell junction,CC,SDK2;ADGRL1;FHL1;DLG4;MRC2;PRR7;PARVB;FLNC;TSPAN1;ITGA6;NDRG1;SH2D5;EGFR;SCN4B;OBSL1;PTPRS;CAPN2;DDB2;ARL2;SPRY4;MAP2K2;MAP2K1;MCTP1;MPRIP;SLC9A3R2;SHANK2;LRP1;GJC2;ITGB4;SH3PXD2B;NLGN2;AKT1;GRB7;CORO1B;BSG;PTPRU;ZFYVE21;BRSK1;MYZAP;FGFR4;SIGMAR1;RAC2;KCNAB2;NPHP4;CEACAM1;TENM2;ANK3;CCND1;PLAU;GSN;ARHGAP22;BCR;COL13A1;SNTA1;PAK6;SHARPIN;PROCR;PKD2;ITGB5;SH3PXD2A;GRIN3B;CADM4;PLCG1;CD81;SNPH;ABHD17C;SNTB2;SHANK3;CLCA2;NSMF;FARP1;TNS1;PI4K2A;RIMS3;AGRN;CAMK2N1;PRKCZ;MINK1;CD9;ADA;MICALL2;PLEKHG5;SDCCAG8;VAMP2;CYFIP2;FSCN1;ARHGAP44;PRKCD;SV2A;ITGA1;OLFM2;SH3BP1;GJB4;PPL;PPP1R13L;LIMK1;SLC2A11;RGS14;GIT1;ADAM15;EHD3;SYMPK;FHOD1;ABCA7;SYNGR1;HOXC5;DNM2;CAT;MAPK3;CBLN3;PDZD2;TNS4;VANGL2;PAK1;GABBR1;SEMA4C;ITGA3;BCL2L1;DLG3;RRAS;SIRT2;FAM129B;CDH4;ITGA4;AFAP1L1;ICA1;PCLO;PXN;FGFR3;HOMER2;KLHL24
6800,GO:0030258,3.14306835509323e-05,0.999986427868429,40,193,lipid modification,BP,TYSND1;APOE;DGKA;CRAT;EGFR;HADH;CPT2;PIK3R2;HBEGF;AKT1;ZFYVE21;FGFR4;FGFR1;ABCD1;TTC7B;DGKQ;SYNJ2;PIP5KL1;PI4K2A;PLPP6;ERBB2;ACAD10;CYGB;EREG;ACADS;LONP2;INPP5D;PI4K2B;DECR2;PPARA;SESN2;ABCG1;PHYH;FYN;ETFB;CYP3A5;MLYCD;ST3GAL2;FGFR3;PI4KAP2
12410,GO:0048869,3.16683445085458e-05,0.999976508121585,344,2696,cellular developmental process,BP,DUSP6;XDH;ERCC1;SDK2;MEF2D;ZMYND8;SEMA4B;HTRA1;FHL1;EGR1;NR1D1;DLG4;CST3;CYP27B1;MRC2;BTBD2;PGF;PDCD4;CTNNBIP1;ACVR2B;PARVB;BBS2;FLNC;POSTN;VEGFA;FAM210B;WNT7A;APOE;NAGLU;LRP5;ITGA6;HMGA2;OBSCN;NDRG1;IDH2;ELK3;EGFR;SERPINE2;DNPH1;WWTR1;OBSL1;NOS1;PTPRS;SPRY2;CAPN2;MST1R;NFATC4;LTBP4;PRSS8;SDC1;ETV5;SHC1;HEXB;TCFL5;ACTA2;ETV4;RAPGEF3;TXNRD3;ZFP36L1;ARAP1;LPAR3;MDFI;SMARCA1;CMTM7;FOXQ1;MAP2K1;SSH1;POU2F2;FOS;FBLN1;SMAD3;STAT6;SHANK2;LRP1;GJC2;DVL1;EPAS1;S100A4;ITGB4;SH3PXD2B;MBOAT7;ADARB1;AKT1;GRB7;TMOD2;CORO1B;HDAC5;S100A6;SH2D2A;EPHA1;PTPRU;FMNL2;ASH2L;IMPACT;LRRC8A;CNTN1;BRSK1;IFT140;PTHLH;FGFR4;WNT2B;LDLR;FGFR1;RAC2;KCNAB2;NPHP4;SYNE3;RAG1;B4GAT1;KLF7;SORL1;CEACAM1;HMG20B;TENM2;ZNF385A;MICALCL;ANK3;TRAPPC9;CCND1;TNNT1;TWF2;STRADB;SYNGAP1;EDNRA;GAS6;PTK6;SEMA3F;CSNK1E;CTSB;CARD11;SH2B3;SOX13;LAMA5;GSN;PCSK9;ARHGAP22;DHTKD1;ANGPTL4;ERRFI1;WIPF1;DBNDD1;CCDC71L;MYEF2;SH3D19;CDC25B;SLITRK6;ARPIN;ALOX15B;SPTB;COL13A1;NPR2;UNC119B;PLXNB3;BNIP3;SHARPIN;YPEL3;CTSZ;CDC42EP5;CRTC1;FBXW8;GPSM1;AP3D1;ITGB5;SH3PXD2A;EPHB2;ADAM8;CTBP1;MNT;PLCG1;KIF17;NYAP1;CEBPB;TIMP2;WNT3;TGFB1;SNPH;RFX2;UNK;ULK2;GPC1;ADAMTS7;DEAF1;NAB2;FHOD3;SHANK3;EFNB3;MYCBPAP;NSMF;ARAP3;FARP1;LCE1E;RHOD;LAMB2;DNAH1;POLM;SEMA4F;RHOF;YIPF3;WASF3;LLGL1;RHOBTB2;TPP1;PCK2;AGRN;IFNE;LRP4;VHL;CEP131;RFNG;TRIB2;PRKCZ;KDM6B;PRKACA;MINK1;ZNF516;CD9;ADA;AREG;MICALL2;BOK;TDRKH;SDCCAG8;ERBB2;ULK1;RILPL1;JAK3;NET1;CYFIP2;ARHGAP44;PRKCD;FAM20C;RBL2;BAX;ITGA1;OLFM2;SH3BP1;CHADL;EREG;RPS6KA5;DGUOK;SOX12;DDIT4;PPL;PPP1R13L;AHNAK2;IER2;LIMK1;TGFBR3;GDI1;LEMD2;ZHX3;RGS14;MFNG;ALDOC;ADAM15;TMEM231;MAPK12;HDAC7;INPP5D;CHD2;CHEK2;ZFPM1;PPARA;ABCG1;SPATA20;SPEG;SIX5;MIF;FYN;STK25;RAC3;EEF2K;SUN1;ARID5B;DNM2;ATXN10;CAT;ZMYM3;SATB1;MAPK3;INSR;ADCY1;RERE;HLA-G;VANGL2;PAK1;PPP3CB;ROBO4;USP21;CUL7;SEMA4C;CAPRIN2;ITGA3;DNMT3A;BIN1;SRMS;PPP2R5B;HES6;BCL2L1;RRAS;PROX1;MDGA1;ADGRF1;LMNA;SIRT2;FAM129B;CDH4;ITGA4;EDA;RAP1GAP2;LAMB1;SOCS7;NDE1;NGFR;TOLLIP;PDCD6;GRB10;KIF13B;MAFF;NR2F6;TCTN1;NBEAL2;CAMK1;SLC39A3;TERC;COL6A1;BTG1;ZP3;CELSR1;SEMA3B;SEPT6;SSH3;FGFR3;TST;NDRG2;BLOC1S4;ITPKB;PLAG1;DOK4;TRIM46;KDM3A;ADCY6;LRRK1;SDC2
12585,GO:0050770,3.17492851095791e-05,0.999988502542069,29,122,regulation of axonogenesis,BP,SEMA4B;VEGFA;WNT7A;APOE;PTPRS;LPAR3;MAP2K1;SSH1;TWF2;SYNGAP1;SEMA3F;PLXNB3;EPHB2;WNT3;ULK2;EFNB3;SEMA4F;LRP4;LIMK1;GDI1;STK25;DNM2;PAK1;SEMA4C;CDH4;NGFR;KIF13B;SEMA3B;SSH3
12400,GO:0048856,3.53929434539865e-05,0.999973065484844,449,3635,anatomical structure development,BP,DUSP6;XDH;ERCC1;DUSP5;SDK2;MEF2D;ZMYND8;ADGRL1;SEMA4B;HTRA1;FHL1;EGR1;NR1D1;DLG4;CST3;CYP27B1;BTBD2;MARVELD1;APLN;PGF;PDCD4;CTNNBIP1;ACVR2B;PARVB;BBS2;FLNC;POSTN;VEGFA;FAM210B;TNFRSF6B;WNT7A;APOE;NAGLU;F2R;LRP5;ITGA6;HMGA2;OBSCN;NDRG1;IDH2;ELK3;PKN1;EGFR;SERPINE2;DNPH1;WWTR1;LOXL1;OBSL1;NOS1;VAT1;PTPRS;SPRY2;CAPN2;MST1R;NFATC4;LTBP4;PRSS8;SDC1;ETV5;SHC1;LTBP1;HEXB;TCFL5;ACTA2;PHLDA2;TRNP1;SPRY4;RAPGEF3;TXNRD3;ZFP36L1;GAA;ARAP1;LPAR3;PLCD3;MDFI;SMARCA1;CMTM7;FOXQ1;MAP2K1;ACP5;SSH1;POU2F2;ENDOG;MARK4;SMURF2;FOS;FBLN1;SMAD3;STAT6;SHANK2;LRP1;GJC2;DVL1;EPAS1;THBS3;HBEGF;AP2A2;S100A4;ITGB4;SH3PXD2B;NLGN2;SALL2;MBOAT7;ADARB1;AKT1;GRB7;TMOD2;CORO1B;HDAC5;S100A6;SH2D2A;PITPNM1;BSG;SCMH1;EPHA1;PHC2;PTPRU;VEGFB;FMNL2;ASH2L;IMPACT;LRRC8A;CNTN1;BRSK1;IFT140;PTHLH;FGFR4;WNT2B;LDLR;FGFR1;PRKACB;SIGMAR1;RAC2;KCNAB2;NPHP4;SYNE3;RAG1;GAMT;B4GAT1;KLF7;SORL1;CEACAM1;HMG20B;LZTS2;RAB11FIP4;TENM2;ZNF385A;MICALCL;ANK3;IGFBP4;EVC;TSHZ1;TRAPPC9;CCND1;TCF25;TNNT1;TWF2;STRADB;SYNGAP1;EDNRA;GAS6;PTK6;SEMA3F;CSNK1E;CTSB;CARD11;SH2B3;SOX13;LAMA5;GSN;PCSK9;ARHGAP22;DHTKD1;BCR;ANGPTL4;ERRFI1;WIPF1;DBNDD1;MYEF2;MN1;SH3D19;CDC25B;SLITRK6;ARPIN;ALOX15B;SPTB;COL13A1;NPR2;UNC119B;PLXNB3;BNIP3;GTF2IRD1;SHARPIN;TAGLN3;PKD2;CTSZ;CDC42EP5;CRTC1;FBXW8;GPSM1;AP3D1;ITGB5;SH3PXD2A;EPOR;EPHB2;ADAM8;APRT;MNT;PLCG1;KIF17;NYAP1;CEBPB;ZNF217;TIMP2;WNT3;TGFB1;SNPH;CLTCL1;RFX2;UNK;ULK2;GPC1;MKNK2;ADAMTS7;DEAF1;SLC38A10;NAB2;ATP7B;FHOD3;SHANK3;SDHA;EFNB3;MYCBPAP;KIF26B;NSMF;ARAP3;FARP1;MC1R;TUB;LCE1E;RHOD;LAMB2;SNX17;RNH1;DNAH1;VGF;POLL;POLM;SEMA4F;RHOF;WASF3;LLGL1;PHGDH;RHOBTB2;ADAM19;HMGCL;TPP1;PCK2;B4GALT2;AGRN;MBD3;IFNE;LRP4;LRP10;VHL;CEP131;RFNG;MLXIPL;PRKCZ;KDM6B;PRKACA;MINK1;ZNF516;CD9;EPN2;ADA;AREG;MICALL2;BOK;WDR18;SDCCAG8;ERBB2;ADGRB2;ULK1;RTL1;TFDP2;SMTN;RILPL1;JAK3;NET1;CYFIP2;FSCN1;PBX2;ARHGAP44;FAM20C;BAX;ITGA1;OLFM2;SH3BP1;FBXW4;CHADL;EREG;RPS6KA5;DGUOK;DUSP4;SOX12;DDIT4;SPRED3;PPL;PPP1R13L;AHNAK2;IER2;NID1;LIMK1;TGFBR3;GDI1;DIP2A;LEMD2;RPS6KA6;RGS14;SCN8A;MFNG;ALDOC;CHAD;MSLN;LPCAT1;ADAM15;ASB1;WDR60;TMEM231;MAPK12;HDAC7;INPP5D;CHD2;ZFPM1;PPARA;MYO1D;MYH15;PRR15;SOX7;SPATA20;SPEG;SIX5;ACO2;DOPEY2;ECM1;WFS1;FYN;STK25;RAC3;EEF2K;SUN1;ARHGAP12;ARID5B;HOXC5;DNM2;ATXN10;INF2;CAT;IGFBP7;ZMYM3;TPBG;SATB1;KIF26A;MAPK3;INSR;TAZ;ADCY1;RERE;HLA-G;VANGL2;PAK1;TRIM45;MALL;PPP3CB;ROBO4;USP21;PFKFB3;CUL7;HYAL1;SEMA4C;CAPRIN2;WDTC1;HES7;ITGA3;DNMT3A;BIN1;PPP2R5B;HES6;BCL2L1;DLG3;RRAS;PROX1;LRCH4;MDGA1;ADGRF1;LMNA;PKD1;TNFRSF25;SIRT2;FAM129B;CDH4;ITGA4;EDA;E2F5;RAP1GAP2;LAMB1;SOCS7;NDE1;HSD11B1;GTF2IRD2;NGFR;TOLLIP;PDCD6;PCLO;ARVCF;GRB10;KIF13B;MAFF;NR2F6;TCTN1;NBEAL2;CAMK1;SLC39A3;EZH1;HFE;ZNF513;COL6A1;BTG1;ZP3;CELSR1;TACC1;SEMA3B;SSH3;FGFR3;TST;NDRG2;BLOC1S4;ITPKB;PLAG1;DOK4;TRIM46;KDM3A;APBA1;SRSF5;ADCY6;LRRK1;AARS;SDC2
12847,GO:0051174,3.79522746539613e-05,0.999974470757693,172,1212,regulation of phosphorus metabolic process,BP,TNIP1;DUSP6;XDH;DUSP5;EGR1;DLG4;APLN;PDCD4;ACVR2B;PRNP;VEGFA;WNT7A;APOE;F2R;LRP5;ITGA6;PKN1;EGFR;WWTR1;NOS1;SPRY2;MST1R;SHC1;SNX9;SPRY4;RAPGEF3;MAP2K2;LPAR3;PPP1R35;MAP2K1;FBLN1;SMAD3;PIK3R2;ERCC6;GJC2;DVL1;HBEGF;PPP1R14A;PPP2R3B;SHC2;ADORA2B;ADARB1;AKT1;PPM1F;STK39;EPHA1;IMPACT;CNTN1;PTHLH;FGFR4;LDLR;FGFR1;PRKACB;RAC2;SORL1;CEACAM1;B3GAT3;IGFBP4;CCND1;PODNL1;STRADB;SYNGAP1;GAS6;PTK6;DUSP7;MAPKAPK3;EHD4;ERRFI1;CDC25B;DGKQ;PAK6;CEMIP;PKD2;EPHB2;ADAM8;CDKN1C;PLCG1;CD81;TIMP2;TGFB1;NTSR1;NAB2;TNFSF15;NSMF;FARP1;PTPN1;IFNE;CAMK2N1;LRP4;PFKFB2;MLXIPL;TRIB2;PRKCZ;PRKACA;MINK1;AREG;ERBB2;PDK1;PRKCD;FAM20C;RBL2;BAX;ITGA1;EREG;RPS6KA5;DUSP4;DDIT4;LTB4R2;LEMD2;RPS6KA6;RGS14;CHAD;LPCAT1;SYMPK;IRAK1;TGFA;CHEK2;PPARA;SESN2;MYO1D;ABCA7;MIF;PLA2G6;DDT;TRPT1;FYN;STK25;EEF2K;TSPYL2;ELFN2;SLC27A1;MAPK3;INSR;TAZ;ADCY1;ETAA1;VANGL2;PAK1;CAMKK2;PFKFB3;GABBR1;MICAL1;SEMA4C;CAPRIN2;PPP2R5B;MAP2K3;DLG3;RRAS;PROX1;PKD1;TNFRSF25;SIRT2;ADCY7;MAPRE3;SOCS7;MAP3K10;NGFR;GRB10;CAMK1;CAMKK1;SIRT3;HFE;ZP3;PFN2;FGFR3;PPP1R16A;CCDC88C;NDRG2;CBLC;ITPKB;ADCY6;LRRK1
3388,GO:0007169,3.83990301318483e-05,0.999978064841594,83,504,transmembrane receptor protein tyrosine kinase signaling pathway,BP,DUSP6;XDH;PLAT;APLN;PGF;VEGFA;EGFR;SPRY2;MST1R;SHC1;PTPRE;SPRY4;ARAP1;PIK3R2;LRP1;HBEGF;AP2A2;SHC2;PAG1;AKT1;GRB7;FAM83A;SH2D2A;RHBDF2;EPHA1;VEGFB;FGFR4;FGFR1;CEACAM1;IGFBP4;EFS;MAPK13;PTK6;FGFBP1;MAPKAPK3;IGFBP2;BCR;ERRFI1;DGKQ;MVB12B;EPHB2;PLCG1;TGFB1;GPC1;EFNB3;GIGYF1;PTPN1;PRKCZ;EPN2;AREG;ERBB2;JAK3;CYFIP2;PRKCD;FAM20C;STUB1;ITGA1;EREG;RPS6KA5;DDIT4;DNM1;RGS14;GIT1;MAPK12;TGFA;FYN;ARID5B;MAPK3;INSR;PAK1;SRMS;PPP2R5B;SIRT2;FAM129B;SOCS7;NGFR;PDCD6;ATP6V1F;PXN;GRB10;FGFR3;CBLC;SDC2
5934,GO:0018212,3.9092733815925e-05,0.999981862379706,46,235,peptidyl-tyrosine modification,BP,DLG4;PRNP;VEGFA;EGFR;MST1R;SHC1;MAP2K2;MAP2K1;ERCC6;HBEGF;EPHA1;CNTN1;FGFR4;FGFR1;GAS6;PTK6;BCR;EHD4;ERRFI1;DGKQ;EPHB2;CD81;TGFB1;SCYL1;PTPN1;LRP4;PRKCZ;AREG;ERBB2;JAK3;PRKCD;EREG;TGFA;MIF;FYN;MAPK3;INSR;CAMKK2;SRMS;PPP2R5B;MAP2K3;DLG3;FGFR3;CBLC;CLK3;LRRK1
14509,GO:0065008,4.04041790712267e-05,0.999970255149407,307,2390,regulation of biological quality,BP,XDH;ERCC1;ZMYND8;ADGRL1;SEMA4B;FHL1;EGR1;NR1D1;DLG4;PLAT;CYP27B1;APLN;CTNNBIP1;ACVR2B;DOCK4;PRNP;PARVB;BBS2;POSTN;VEGFA;FAM210B;WNT7A;APOE;PYGL;DGKA;TSPAN1;F2R;LRP5;SLCO4A1;ITPR3;PKN1;NISCH;EGFR;SERPINE2;SCN4B;NOS1;PTPRS;HADH;NFATC4;CRTAP;LTBP4;SYTL1;ETV5;VPS11;LTBP1;ARL2;HEXB;SLC7A8;SLC12A7;RAPGEF3;TXNRD3;ZFP36L1;GAA;GLUL;ARAP1;LPAR3;MDFI;ACP5;MCTP1;SSH1;ENDOG;FBLN1;SMAD3;SHANK2;PIK3R2;ERCC6;SRD5A3;DVL1;EPAS1;HSD17B8;CYBRD1;SH3PXD2B;PRDX5;NLGN2;ADORA2B;SYT8;AKT1;TPCN1;KCNC4;TMOD2;CORO1B;F12;STK39;HK1;SERPING1;LRRC8A;BRSK1;FGFR4;POLD4;LDLR;FGFR1;PRKACB;RAC2;PFKL;MXI1;NPHP4;SYNE3;RAG1;SORL1;CEACAM1;CIRBP;HMG20B;ZNF385A;DOCK6;ANK3;CCND1;PCBP4;TWF2;SYNGAP1;EDNRA;PLAU;GAS6;SEMA3F;CSNK1E;RAB3B;CARD11;SH2B3;GSN;PLEKHG2;PCSK9;RAD23A;BCR;ANGPTL4;WIPF1;SLITRK6;ARPIN;SPTB;NPR2;SNTA1;DGKQ;PLXNB3;BNIP3;TFPI2;CEMIP;PROCR;PKD2;PCSK1;RETSAT;CTSZ;CDC42EP5;CRTC1;IL20RB;AP3D1;ABCA2;EPHB2;GRIN3B;ADAM8;ASIC1;APRT;PLCG1;CD81;ENTPD2;ADAMTS13;WNT3;TGFB1;SNPH;ULK2;MOAP1;NTSR1;ATP7B;FHOD3;SHANK3;RASA3;NSMF;ARAP3;TUB;CROCC;RHOD;ERO1B;HTR7;VGF;SEMA4F;RHOF;WASF3;PHF21A;RHOBTB2;RIMS3;BBS1;TPP1;PCK2;AGRN;LRP4;VHL;PFKFB2;MLXIPL;PRKCZ;PRKACA;CD9;ADA;PIM2;BOK;CAPG;ADGRB2;VAMP2;TFDP2;JAK3;RNPEP;BNIP3L;TRPC1;SLC22A17;ARHGAP44;PRKCD;CACNB3;STUB1;IFI6;BAX;SV2A;DTD1;ITGA1;SH3BP1;PPP1R13L;HSD17B7;PCSK1N;MT2A;RASL10B;TMX4;LIMK1;TGFBR3;PDIA5;GDI1;DNM1;WASH3P;RGS14;SCN8A;GSTO1;LPCAT1;EHD3;INPP5D;CHEK2;ZFPM1;PPARA;COG7;SESN2;FGGY;ABCG1;ABCA7;BCAP31;MIF;SLC9A7;PLA2G6;SYNGR1;WFS1;QSOX1;FYN;RAC3;EEF2K;SUN1;DNM2;CHKA;SLC27A1;TPBG;SLC12A4;PLCB3;CYP2R1;MAPK3;INSR;GRINA;PFKM;ADCY1;DOCK9;ATP8B2;GLRX;PAK1;MALL;PPP3CB;MICAL1;SEMA4C;CAPRIN2;WDTC1;BCL2L1;IARS2;ALDH7A1;PKD1;FAM129B;CDH4;ADCY7;TEP1;ICA1;SLC25A37;RAP1GAP2;HSD11B1;NGFR;ATP6V1F;PCLO;PLEKHM1;GCH1;MAFF;CAMK1;SLC39A3;SIRT3;HFE;TERC;BBS10;SEMA3B;PFN2;SSH3;CCDC88C;BLOC1S4;ITPKB;HOMER2;APBA1;DEDD2;AK3;ADCY6;SLC26A11;LRRK1;AARS
12305,GO:0048666,4.37592520160534e-05,0.999973066808385,110,711,neuron development,BP,ZMYND8;SEMA4B;DLG4;POSTN;VEGFA;WNT7A;APOE;NAGLU;EGFR;OBSL1;PTPRS;NFATC4;SHC1;LPAR3;MAP2K1;SSH1;SHANK2;LRP1;DVL1;ADARB1;AKT1;GRB7;S100A6;IMPACT;CNTN1;BRSK1;IFT140;FGFR1;RAC2;NPHP4;B4GAT1;KLF7;TENM2;ANK3;TWF2;SYNGAP1;PTK6;SEMA3F;DBNDD1;SLITRK6;SPTB;PLXNB3;CTSZ;CRTC1;FBXW8;EPHB2;PLCG1;NYAP1;WNT3;UNK;ULK2;GPC1;SHANK3;EFNB3;NSMF;FARP1;LAMB2;SEMA4F;LLGL1;AGRN;LRP4;PRKCZ;MINK1;AREG;MICALL2;ERBB2;ULK1;CYFIP2;ARHGAP44;ITGA1;RPS6KA5;DGUOK;LIMK1;GDI1;FYN;STK25;RAC3;EEF2K;DNM2;ATXN10;MAPK3;ADCY1;RERE;VANGL2;PAK1;PPP3CB;USP21;CUL7;SEMA4C;CAPRIN2;ITGA3;PPP2R5B;ADGRF1;FAM129B;CDH4;RAP1GAP2;LAMB1;NGFR;GRB10;KIF13B;NR2F6;TCTN1;CAMK1;SEMA3B;SSH3;BLOC1S4;DOK4;TRIM46;ADCY6;SDC2
6069,GO:0019220,4.44441388527248e-05,0.999969939770788,170,1199,regulation of phosphate metabolic process,BP,TNIP1;DUSP6;XDH;DUSP5;EGR1;DLG4;APLN;PDCD4;ACVR2B;PRNP;VEGFA;WNT7A;APOE;F2R;LRP5;ITGA6;PKN1;EGFR;WWTR1;NOS1;SPRY2;MST1R;SHC1;SNX9;SPRY4;RAPGEF3;MAP2K2;LPAR3;PPP1R35;MAP2K1;FBLN1;SMAD3;PIK3R2;ERCC6;GJC2;DVL1;HBEGF;PPP1R14A;PPP2R3B;SHC2;ADORA2B;ADARB1;AKT1;PPM1F;STK39;EPHA1;IMPACT;CNTN1;PTHLH;FGFR4;LDLR;FGFR1;PRKACB;RAC2;SORL1;CEACAM1;B3GAT3;IGFBP4;CCND1;PODNL1;STRADB;SYNGAP1;GAS6;PTK6;DUSP7;MAPKAPK3;EHD4;ERRFI1;CDC25B;DGKQ;PAK6;CEMIP;PKD2;EPHB2;ADAM8;CDKN1C;PLCG1;CD81;TIMP2;TGFB1;NTSR1;NAB2;TNFSF15;NSMF;FARP1;PTPN1;IFNE;CAMK2N1;LRP4;PFKFB2;MLXIPL;TRIB2;PRKCZ;PRKACA;MINK1;AREG;ERBB2;PRKCD;RBL2;BAX;ITGA1;EREG;RPS6KA5;DUSP4;DDIT4;LTB4R2;LEMD2;RPS6KA6;RGS14;CHAD;LPCAT1;SYMPK;IRAK1;TGFA;CHEK2;PPARA;SESN2;MYO1D;ABCA7;MIF;PLA2G6;DDT;TRPT1;FYN;STK25;EEF2K;TSPYL2;ELFN2;SLC27A1;MAPK3;INSR;TAZ;ADCY1;ETAA1;VANGL2;PAK1;CAMKK2;PFKFB3;GABBR1;MICAL1;SEMA4C;CAPRIN2;PPP2R5B;MAP2K3;DLG3;RRAS;PROX1;PKD1;TNFRSF25;SIRT2;ADCY7;MAPRE3;SOCS7;MAP3K10;NGFR;GRB10;CAMK1;CAMKK1;SIRT3;HFE;ZP3;PFN2;FGFR3;PPP1R16A;CCDC88C;NDRG2;CBLC;ITPKB;ADCY6;LRRK1
9950,GO:0042325,4.79416376736875e-05,0.999968191540824,151,1045,regulation of phosphorylation,BP,TNIP1;DUSP6;XDH;DUSP5;EGR1;DLG4;APLN;PDCD4;ACVR2B;PRNP;VEGFA;WNT7A;APOE;F2R;LRP5;ITGA6;PKN1;EGFR;WWTR1;SPRY2;MST1R;SHC1;SNX9;SPRY4;RAPGEF3;MAP2K2;LPAR3;MAP2K1;FBLN1;PIK3R2;ERCC6;GJC2;DVL1;HBEGF;PPP1R14A;SHC2;ADORA2B;ADARB1;AKT1;PPM1F;STK39;EPHA1;IMPACT;CNTN1;FGFR4;FGFR1;PRKACB;RAC2;SORL1;CEACAM1;IGFBP4;CCND1;PODNL1;STRADB;SYNGAP1;GAS6;PTK6;DUSP7;MAPKAPK3;EHD4;ERRFI1;CDC25B;DGKQ;PAK6;CEMIP;PKD2;EPHB2;ADAM8;CDKN1C;PLCG1;CD81;TIMP2;TGFB1;NAB2;TNFSF15;PTPN1;IFNE;CAMK2N1;LRP4;PFKFB2;MLXIPL;TRIB2;PRKCZ;PRKACA;MINK1;AREG;ERBB2;PRKCD;RBL2;BAX;ITGA1;EREG;RPS6KA5;DUSP4;DDIT4;LEMD2;RPS6KA6;RGS14;CHAD;IRAK1;TGFA;CHEK2;PPARA;SESN2;ABCA7;MIF;PLA2G6;DDT;TRPT1;FYN;STK25;EEF2K;TSPYL2;SLC27A1;MAPK3;INSR;ADCY1;ETAA1;VANGL2;PAK1;CAMKK2;PFKFB3;MICAL1;SEMA4C;CAPRIN2;PPP2R5B;MAP2K3;DLG3;RRAS;PROX1;PKD1;TNFRSF25;SIRT2;ADCY7;MAPRE3;SOCS7;MAP3K10;NGFR;GRB10;CAMK1;CAMKK1;SIRT3;HFE;PFN2;FGFR3;CCDC88C;NDRG2;CBLC;ITPKB;ADCY6;LRRK1
12601,GO:0050790,5.06249592485517e-05,0.999964135829662,218,1617,regulation of catalytic activity,BP,DUSP6;XDH;DUSP5;EGR1;DLG4;CST3;CYP27B1;PDCD4;ACVR2B;DOCK4;PRNP;VEGFA;TNFRSF6B;APOE;F2R;LRP5;ITGA6;PKN1;GRAMD4;EVI5L;EGFR;SERPINE2;WWTR1;NOS1;SPRY2;MST1R;LMF1;SHC1;TBC1D14;ARL2;RIN1;SNX9;SPRY4;RAPGEF3;ARAP1;MAP2K2;LPAR3;PPP1R35;MAP2K1;FBLN1;SMAD3;ARHGAP23;PIK3R2;ERCC6;LRP1;DVL1;PPP1R14A;SH3PXD2B;PPP2R3B;PRDX5;SHC2;ADORA2B;ADARB1;AKT1;PPM1F;STK39;SERPING1;ASAP2;EPHA1;DAP;FGFR4;FGFR1;PRKACB;RAC2;RAG1;RALGDS;SORL1;CEACAM1;B3GAT3;CCND1;PODNL1;STRADB;SYNGAP1;EDNRA;GAS6;PTK6;CTSB;DUSP7;GSN;MAPKAPK3;ARHGAP22;BCR;ANGPTL4;ERRFI1;AIP;CDC25B;ARHGAP27;AGAP1;CCS;DGKQ;PLXNB3;PAK6;TFPI2;SERINC2;CEMIP;PKD2;CDC42EP5;GPSM1;SH3PXD2A;EPHB2;ADAM8;CDKN1C;PLCG1;CD81;TIMP2;GNAL;TGFB1;TBC1D9B;NAB2;ARHGAP25;RASA3;TNFSF15;ARAP3;FARP1;RNH1;PLEKHG4;LLGL1;ZER1;PTPN1;AGRN;CAMK2N1;ADAP1;PFKFB2;TRIB2;PRKCZ;PRKACA;MINK1;OXA1L;BOK;ERBB2;C6ORF89;NET1;CYFIP2;RASA4;CYGB;ARHGAP44;PRKCD;RBL2;STUB1;IFI6;BAX;SBF1;ITGA1;SH3BP1;EREG;DUSP4;PCSK1N;LIMK1;GDI1;TPM2;LTB4R2;RGS14;GIT1;CHAD;MAPK12;IRAK1;TGFA;SESN2;MYO1D;SOX7;BCAP31;MIF;ECM1;TRPT1;FYN;STK25;ARHGAP12;ACAP3;DNM2;NEIL1;TSPYL2;ELFN2;SLC27A1;IQSEC1;MAPK3;INSR;ARHGEF1;ADCY1;DOCK9;RALGAPA1;ETAA1;VANGL2;PAK1;CAMKK2;GABBR1;MICAL1;WDTC1;BIN1;PPP2R5B;MAP2K3;DLG3;SGSM2;PROX1;TBC1D16;ZYG11B;PKD1;RABGAP1;TRIP10;ADCY7;MAPRE3;AZIN2;SERPINB1;RAP1GAP2;SOCS7;MAP3K10;RGS19;NDE1;NGFR;PDCD6;TBC1D8;GCH1;CAMK1;CAMKK1;PFN2;FGFR3;PPP1R16A;CBLC;ADCY6
10396,GO:0043235,5.06421685080896e-05,0.999977871293094,39,188,receptor complex,CC,DLG4;ACVR2B;LRP5;ITGA6;ITPR3;EGFR;MST1R;SMAD3;SHANK2;LRP1;ITGB4;EPHA1;FGFR4;LDLR;FGFR1;CEACAM1;CARD11;AIP;PLXNB3;ITGB5;EPHB2;GRIN3B;SHANK3;LRP4;ERBB2;TRPC1;ITGA1;OLFM2;TGFBR3;IRAK1;INSR;GABBR1;CAPRIN2;ITGA3;DLG3;ITGA4;TOLLIP;HFE;FGFR3
12345,GO:0048731,5.10135406013649e-05,0.999961527386336,372,2957,system development,BP,DUSP6;XDH;ERCC1;SDK2;MEF2D;ZMYND8;ADGRL1;SEMA4B;HTRA1;FHL1;EGR1;DLG4;CST3;CYP27B1;BTBD2;MARVELD1;APLN;PGF;PDCD4;CTNNBIP1;ACVR2B;BBS2;POSTN;VEGFA;FAM210B;WNT7A;APOE;NAGLU;LRP5;ITGA6;HMGA2;NDRG1;IDH2;ELK3;PKN1;EGFR;SERPINE2;WWTR1;LOXL1;OBSL1;NOS1;PTPRS;SPRY2;NFATC4;PRSS8;SDC1;ETV5;SHC1;LTBP1;HEXB;ACTA2;PHLDA2;TRNP1;SPRY4;RAPGEF3;ZFP36L1;GAA;LPAR3;PLCD3;MDFI;SMARCA1;CMTM7;FOXQ1;MAP2K1;ACP5;SSH1;POU2F2;MARK4;SMURF2;FOS;SMAD3;STAT6;SHANK2;LRP1;GJC2;DVL1;EPAS1;THBS3;HBEGF;AP2A2;S100A4;ITGB4;SH3PXD2B;NLGN2;SALL2;MBOAT7;ADARB1;AKT1;GRB7;TMOD2;HDAC5;S100A6;SH2D2A;PITPNM1;BSG;EPHA1;PTPRU;VEGFB;ASH2L;IMPACT;LRRC8A;CNTN1;BRSK1;IFT140;PTHLH;FGFR4;WNT2B;LDLR;FGFR1;PRKACB;SIGMAR1;RAC2;KCNAB2;NPHP4;RAG1;GAMT;B4GAT1;KLF7;SORL1;CEACAM1;HMG20B;LZTS2;RAB11FIP4;TENM2;ZNF385A;ANK3;IGFBP4;EVC;TSHZ1;TRAPPC9;CCND1;TCF25;TWF2;SYNGAP1;EDNRA;GAS6;PTK6;SEMA3F;CSNK1E;CTSB;CARD11;SH2B3;SOX13;LAMA5;GSN;PCSK9;ARHGAP22;DHTKD1;BCR;ANGPTL4;ERRFI1;DBNDD1;MYEF2;SLITRK6;ALOX15B;SPTB;COL13A1;NPR2;UNC119B;PLXNB3;BNIP3;SHARPIN;TAGLN3;PKD2;CTSZ;CRTC1;FBXW8;GPSM1;AP3D1;SH3PXD2A;EPOR;EPHB2;ADAM8;APRT;PLCG1;KIF17;NYAP1;CEBPB;TIMP2;WNT3;TGFB1;SNPH;UNK;ULK2;GPC1;MKNK2;ADAMTS7;DEAF1;SLC38A10;NAB2;ATP7B;FHOD3;SHANK3;SDHA;EFNB3;KIF26B;NSMF;FARP1;TUB;LCE1E;LAMB2;SNX17;RNH1;VGF;POLL;POLM;SEMA4F;WASF3;LLGL1;PHGDH;ADAM19;HMGCL;TPP1;PCK2;B4GALT2;AGRN;MBD3;IFNE;LRP4;LRP10;RFNG;PRKCZ;KDM6B;MINK1;ZNF516;CD9;EPN2;ADA;AREG;MICALL2;BOK;SDCCAG8;ERBB2;ADGRB2;ULK1;TFDP2;SMTN;JAK3;CYFIP2;ARHGAP44;FAM20C;BAX;ITGA1;FBXW4;CHADL;EREG;RPS6KA5;DGUOK;SOX12;DDIT4;PPL;PPP1R13L;AHNAK2;IER2;NID1;LIMK1;TGFBR3;GDI1;LEMD2;RPS6KA6;RGS14;SCN8A;MFNG;CHAD;MSLN;LPCAT1;ADAM15;ASB1;WDR60;TMEM231;MAPK12;HDAC7;INPP5D;CHD2;ZFPM1;PPARA;MYO1D;MYH15;SPEG;SIX5;ACO2;ECM1;WFS1;FYN;STK25;RAC3;EEF2K;SUN1;ARID5B;DNM2;ATXN10;CAT;TPBG;SATB1;KIF26A;MAPK3;INSR;TAZ;ADCY1;RERE;HLA-G;VANGL2;PAK1;TRIM45;MALL;PPP3CB;ROBO4;USP21;PFKFB3;CUL7;HYAL1;SEMA4C;CAPRIN2;HES7;ITGA3;DNMT3A;BIN1;PPP2R5B;HES6;BCL2L1;DLG3;RRAS;PROX1;LRCH4;MDGA1;ADGRF1;LMNA;PKD1;SIRT2;FAM129B;CDH4;ITGA4;EDA;E2F5;RAP1GAP2;LAMB1;SOCS7;NDE1;HSD11B1;NGFR;PDCD6;PCLO;GRB10;KIF13B;MAFF;NR2F6;TCTN1;NBEAL2;CAMK1;SLC39A3;EZH1;HFE;ZNF513;BTG1;ZP3;CELSR1;TACC1;SEMA3B;SSH3;FGFR3;NDRG2;BLOC1S4;ITPKB;PLAG1;DOK4;TRIM46;APBA1;SRSF5;ADCY6;LRRK1;AARS;SDC2
6187,GO:0019637,5.40781309783419e-05,0.999965363858225,124,849,organophosphate metabolic process,BP,NT5E;XDH;H6PD;DLG4;VEGFA;PGM1;APOE;PYGL;DGKA;OSBPL5;LPCAT4;ISYNA1;IDH2;ACOT7;EGFR;DNPH1;NOS1;HEXB;GTPBP1;TK2;RAPGEF3;NME4;PLCD3;PGLS;NAPRT;CRYL1;PIK3R2;SRD5A3;PIGQ;HBEGF;MBOAT7;NMRK1;ADORA2B;PITPNM1;HK1;ZFYVE21;PTHLH;FGFR4;LDLR;FGFR1;KCNAB2;PFKL;PIGV;TTC7B;LHPP;PLCH2;PFKP;CARD11;PCSK9;DHTKD1;NADK;PANK4;NPR2;DGKQ;SERINC2;PKD2;APRT;PLCG1;CD81;MVD;ENTPD2;TIMP2;SYNJ2;TGFB1;NTSR1;PODXL2;SDHA;PIP5KL1;MDH2;ABHD14B;PI4K2A;PCK2;OSBPL10;ACP6;PFKFB2;MLXIPL;ADA;MPI;UCKL1;ERBB2;PRKCD;FAM20C;CYC1;SBF1;PPCS;EREG;DGUOK;DDIT4;LTB4R2;CPNE7;ALDOC;LPCAT1;INPP5D;PI4K2B;PPARA;PLA2G6;FYN;PITPNM3;UPP1;CHKA;NEIL1;SLC27A1;PLCB3;INSR;TAZ;PFKM;ADCY1;PDXK;PFKFB3;GABBR1;SAMD8;DLG3;NDUFV3;NMNAT2;NT5C1B;ADCY7;GCH1;ZP3;FGFR3;ITPKB;SPTLC2;PI4KAP2;AK3;ADCY6
1965,GO:0004674,5.45223017969532e-05,0.999970310381612,69,398,protein serine/threonine kinase activity,MF,ACVR2B;HMGA2;OBSCN;NEK9;PKN1;EGFR;RPS6KA2;MST1R;LTBP4;LTBP1;MAP2K2;MAP2K1;MARK4;CDK18;AKT1;STK39;EPHA1;BRSK1;FGFR4;FGFR1;PRKACB;CCND1;STRADB;MAPK13;CSNK1E;MAPKAPK3;BCR;PAK6;EPHB2;GRK6;ULK2;MKNK2;PRKCZ;PRKACA;MINK1;PIM2;ERBB2;ULK1;STK17A;PRKCD;FAM20C;RPS6KA5;LIMK1;TGFBR3;RPS6KA6;MAPK12;IRAK1;CHEK2;SPEG;STK25;EEF2K;PELI1;MAPK3;INSR;PAK1;CAMKK2;ALPK1;STK32C;MAP2K3;MAP3K10;PELI3;CAMK1;CAMKK1;CDK11B;FGFR3;CDC42BPG;CLK3;PKN3;LRRK1
17257,GO:0120035,5.8030640107423e-05,0.999967618236573,73,434,regulation of plasma membrane bounded cell projection organization,BP,ZMYND8;SEMA4B;DLG4;PRNP;VEGFA;WNT7A;APOE;ESPN;EVI5L;OBSL1;PTPRS;NFATC4;ARAP1;LPAR3;MAP2K1;SSH1;SHANK2;LRP1;DVL1;AKT1;CORO1B;CNTN1;IFT140;FGFR1;RAC2;TENM2;TWF2;SYNGAP1;PTK6;SEMA3F;ARPIN;PLXNB3;CTSZ;CDC42EP5;CRTC1;FBXW8;EPHB2;WNT3;ULK2;SHANK3;EFNB3;NSMF;CROCC;SEMA4F;AGRN;LRP4;FSCN1;ARHGAP44;PRKCD;DGUOK;LIMK1;GDI1;FYN;STK25;EEF2K;DNM2;PAK1;CUL7;SEMA4C;CAPRIN2;ITGA3;PPP2R5B;CDH4;RAP1GAP2;NGFR;PLEKHM1;KIF13B;CAMK1;SEMA3B;PFN2;SSH3;ADCY6;SDC2
2103,GO:0004871,6.07883768035783e-05,0.999962483567713,105,680,signal transducer activity,MF,ADGRL1;NR1D1;MRC2;ACVR2B;PRNP;TNFRSF6B;F2R;LRP5;ITPR3;FCGRT;EGFR;MST1R;LTBP4;SHC1;LTBP1;PTPRE;MAP2K2;LPAR3;PLCD3;MAP2K1;SMAD3;STAT6;PAG1;ADORA2B;PLCXD2;TPCN1;EPHA1;PTPRU;IFNGR2;FGFR4;FGFR1;SIGMAR1;RAC2;SORL1;PLCH2;MAPK13;EDNRA;SH2B3;MAPKAPK3;ANTXR2;AIP;PAQR6;SLC20A1;NPR2;DGKQ;PLXNB3;PKD2;IL20RB;EPOR;EPHB2;GRIN3B;PLCG1;GNAL;TMED4;CLTCL1;NTSR1;EFNB3;RASA3;MC1R;RHOD;HTR7;RHOF;RHOBTB2;LRP4;GPR153;MINK1;PLEKHG5;ERBB2;ADGRB2;SLC22A17;MIB2;LIMK1;TGFBR3;LTB4R2;RGS14;MAPK12;IRAK1;PPARA;ABCA7;BCAM;ECM1;FYN;STK25;RAC3;CHKA;PLCB3;MAPK3;INSR;TMEM101;GABBR1;MAP2K3;ADGRF1;TNFRSF25;ITGA4;LTB4R;MAP3K10;GPR3;NGFR;TOLLIP;NR2F6;CELSR1;IL17RE;FGFR3;CBLC;LRRK1
14343,GO:0061564,6.12074628056764e-05,0.999968166119505,59,330,axon development,BP,SEMA4B;VEGFA;WNT7A;APOE;PTPRS;SHC1;LPAR3;MAP2K1;SSH1;DVL1;ADARB1;GRB7;S100A6;BRSK1;B4GAT1;KLF7;ANK3;TWF2;SYNGAP1;SEMA3F;SLITRK6;SPTB;PLXNB3;EPHB2;PLCG1;WNT3;ULK2;GPC1;SHANK3;EFNB3;LAMB2;SEMA4F;LLGL1;LRP4;ERBB2;ULK1;CYFIP2;RPS6KA5;LIMK1;GDI1;FYN;STK25;DNM2;MAPK3;ADCY1;VANGL2;PAK1;PPP3CB;SEMA4C;FAM129B;CDH4;NGFR;GRB10;KIF13B;TCTN1;SEMA3B;SSH3;DOK4;TRIM46
6287,GO:0019900,6.48998329964073e-05,0.999961177054535,93,586,kinase binding,MF,TNIP1;DLG4;DOCK4;NEK9;PKN1;EGFR;SPRY2;MST1R;SHC1;TBC1D14;SLC12A7;ACTA2;EXOC2;SMAD3;PIK3R2;DVL1;AP2A2;SHC2;FBXW5;PAG1;AKT1;GRB7;HDAC5;FAM83A;PITPNM1;STK39;EPHA1;WWC3;BRSK1;FGFR4;FGFR1;RAC2;PFKL;CEACAM1;MICALCL;CCND1;TWF2;CEP250;GAS6;MAPKAPK3;RAD23A;ERRFI1;CDC25B;DGKQ;EPHB2;PLCG1;CEBPB;TMEM173;RHOD;RHOF;LLGL1;RHOBTB2;PTPN1;CAMK2N1;LRP4;TRAP1;PFKFB2;TRIB2;PRKCZ;PRKACA;TOM1L2;ERBB2;PRKCD;CACNB3;STUB1;SV2A;DNM1;RGS14;HDAC7;CHEK2;PLA2G6;PITPNM3;RAC3;DNM2;SLC12A4;INSR;PFKM;PAK1;MICAL1;MAP2K3;BCL2L1;DLG3;PKD1;MAPRE3;TOLLIP;PXN;GCH1;KIF13B;BTG1;FGFR3;CBLC;SRSF5;ADCY6
7595,GO:0031982,6.62042944375291e-05,0.999949658647096,376,3070,vesicle,CC,NT5E;HTRA1;THSD4;DLG4;PLAT;CST3;EPN3;FBXO2;XPC;PRNP;PYGB;VEGFA;PGM1;WNT7A;APOE;PYGL;TSPAN1;NAGLU;F2R;PLD3;NDRG1;IDH2;ITPR3;PKN1;ACOT7;ARRDC1;NISCH;AKR7A2;EGFR;SERPINE2;DNPH1;LOXL1;NOS1;VAT1;PTPRS;CAPN2;LTBP4;PRSS8;SYTL1;SDC1;APPL2;LTBP2;VPS11;TBC1D14;ARL2;HEXB;SLC7A8;SLC2A3;ACTA2;SNX9;RAPGEF3;GAA;GLUL;ARAP1;MAP2K2;CTBS;PGLS;MAP2K1;NAPRT;CRYL1;ACP5;MCTP1;MARCKSL1;TMEM8A;GALE;SLC9A3R2;FBLN1;ARHGAP23;LRP1;DVL1;HBEGF;AP2A2;S100A4;ITGB4;CYBRD1;PRDX5;STOM;LY6K;SYT8;AKT1;TPCN1;CORO1B;TTYH3;S100A6;F12;ENTPD6;BSG;SERPING1;DYSF;GGT1;VEGFB;SLC15A4;ZFYVE21;CNTN1;IFNGR2;BRSK1;RAB31;FGFR4;HEBP1;LDLR;FGFR1;PRKACB;FUCA1;SIGMAR1;RAC2;KCNAB2;PFKL;SEC14L2;GAMT;H2AFJ;B4GAT1;BPHL;SORL1;CEACAM1;B3GAT3;LZTS2;RAB11FIP4;TWF2;CEP250;PLAU;GAS6;PFKP;BRI3;CTSB;RAB3B;CARD11;LAMA5;GSN;IGFBP2;PCSK9;PHLDA1;BCR;ANTXR2;EHD4;WIPF1;DBNDD1;ALOX15B;GGACT;CORO7;OAF;DGKQ;HAGH;MVB12B;SERINC2;FYCO1;CEMIP;PROCR;PKD2;ACY1;GPX3;PCSK1;CTSZ;AP3D1;ITGB5;ABCA2;MAGEF1;PRSS3;ADAM8;CADM4;APRT;TMEM9;LTA4H;CD81;ENTPD2;TIMP2;NUDCD2;WNT3;DPP7;GNAL;TMED4;TGFB1;CLTCL1;SCYL1;ABHD17C;SNTB2;ULK2;GPC1;TMEM173;ATP7B;MDH2;GALNS;ABHD8;CROCC;RHOD;ABHD14B;LAMB2;SNX17;RNH1;VGF;SNX33;PI4K2A;C1ORF210;RHOF;YIPF3;WASF3;SLC48A1;LLGL1;PHGDH;RHOBTB2;PTPN1;PEX1;TPP1;PCK2;AGRN;CD320;CEP131;TRAP1;IDUA;RFNG;YPEL5;PRKCZ;PRKACA;MINK1;GRHPR;ACTR1B;TOM1L2;CD9;EPN2;ADA;AREG;MPI;MICALL2;PLEKHG5;BOK;CAPG;NEURL1B;ERBB2;ULK1;CNDP2;AHCY;VAMP2;JAK3;RNPEP;CYFIP2;FSCN1;ARHGAP44;EHBP1L1;MCFD2;PRKCD;FAM20C;MIB2;RBL2;STUB1;BAX;SV2A;ITGA1;PPCS;PPL;AHNAK2;PCSK1N;HPCAL1;NAGA;ZDHHC8;NID1;TGFBR3;NTPCR;CPNE7;DNM1;WASH3P;SCN8A;GSTO1;ALDOC;LPCAT1;ADAM15;REEP2;EHD3;WDR60;IRAK1;TGFA;CHD2;PI4K2B;ABCG1;MYO1D;JADE2;ABCA7;RAB12;BCAP31;MIF;DOPEY2;BCAM;SLC9A7;DDT;SYNGR1;NUDT14;ECM1;QSOX1;CD68;SPPL2B;FYN;VWA1;EFEMP2;STK25;RAC3;ETFB;SUN1;DNM2;CKMT1A;GLB1;SNX15;CAT;IGFBP7;ZDHHC1;TUBB6;MAPK3;INSR;SLC13A3;PFKM;ADCY1;HLA-G;STX10;TSTA3;PDXK;PRAF2;GLRX;VANGL2;MALL;RNASET2;RNF144A;LGALS3BP;CTSF;ROBO4;SLC37A2;HYAL1;SEMA4C;ITGA3;VPS16;MAN2B1;BCL2L1;SGSM2;RRAS;DNASE1L1;TBC1D16;ALDH7A1;PKD1;FAM129B;ITGA4;ANKRD13D;GAL3ST4;NMNAT2;TRIP10;AZIN2;SERPINB1;ICA1;LAMB1;RGS19;RAB40B;NGFR;TOLLIP;PDCD6;ATP6V1F;PCLO;CHST14;RNASE7;PLEKHM1;DUSP23;GCH1;NBEAL2;HFE;COL6A1;VPS51;SEMA3B;SEPT6;PFN2;FGFR3;MFSD10;TST;NDRG2;MAN2B2;CBLC;PTGR2;CLK3;PM20D2;TMEM187;APBA1;SLC26A11;AARS
12772,GO:0051056,6.6910934402673e-05,0.999967116076431,50,265,regulation of small GTPase mediated signal transduction,BP,APOE;F2R;OBSCN;SPRY2;APPL2;SPRY4;ARAP1;ARHGAP23;PIK3R2;ASAP2;RAC2;SYNGAP1;PLEKHG2;ARHGAP22;BCR;RGL2;AGAP1;RASGEF1A;EPHB2;TIMP2;ARHGAP25;RASA3;ARAP3;FARP1;RHOD;PLEKHG4;RHOF;PLEKHG3;RHOBTB2;ADAP1;PLEKHG5;NET1;RASA4;ARHGAP44;SH3BP1;GDI1;GIT1;RAC3;ARHGAP12;ACAP3;DNM2;IQSEC1;ARHGEF4;ARHGEF1;RALGAPA1;ITGA3;KCTD13;TRIP10;RAP1GAP2;ITPKB
3062,GO:0006629,6.8657247449789e-05,0.999954539187429,141,976,lipid metabolic process,BP,EGR1;NR1D1;CYP27B1;TYSND1;APOE;DGKA;LRP5;PLD3;OSBPL5;LPCAT4;ISYNA1;CRAT;ACOT7;ACSF2;EGFR;HADH;SDC1;LMF1;HEXB;KDSR;PLCD3;PLTP;PC;CRYL1;CPT2;PIK3R2;LRP1;SRD5A3;PIGQ;HSD17B8;HBEGF;MBOAT7;PLCXD2;AKT1;PITPNM1;GGT1;ZFYVE21;FGFR4;ACOT1;LDLR;FGFR1;FUCA1;SEC14L2;PIGV;SORL1;CEACAM1;CBR4;ABCD1;TTC7B;AIG1;PLCH2;PCSK9;ANGPTL4;CCDC71L;ALOX15B;DGKQ;SERINC2;RETSAT;ABCA2;LTA4H;PLCG1;CD81;MVD;SYNJ2;TGFB1;GPC1;PIP5KL1;SNX17;ST6GALNAC6;PI4K2A;PLPP6;HMGCL;TPP1;PCK2;AGRN;OSBPL10;LRP10;ESYT2;ACP6;B4GALT6;MLXIPL;ALAS1;ERBB2;PDK1;ACAD10;CYGB;PRKCD;RBL2;STUB1;BAX;SBF1;EREG;MBTPS2;ACADS;HSD17B7;CES2;NAGA;CPNE7;LPCAT1;LONP2;INPP5D;PI4K2B;DECR2;PPARA;ABHD15;COQ2;SESN2;ABCG1;MIF;PHYH;PLA2G6;FYN;PITPNM3;ETFB;CERS4;CYP3A5;GLB1;CHKA;CAT;IGFBP7;SLC27A1;PLCB3;CYP2R1;MAPK3;TAZ;MLYCD;WDTC1;SAMD8;PROX1;SIRT2;GAL3ST4;ALG12;ST3GAL2;HSD11B1;ZP3;FGFR3;ST3GAL5;PTGR2;SPTLC2;PI4KAP2;SDC2
6757,GO:0030198,6.88586723755854e-05,0.999968117955496,43,218,extracellular matrix organization,BP,HTRA1;THSD4;CST3;POSTN;ITGA6;LOXL1;CAPN2;MMP1;FBLN1;SMAD3;LRP1;THBS3;ITGB4;SH3PXD2B;BSG;FGFR4;SMOC2;GAS6;LAMA5;COL13A1;ITGB5;SH3PXD2A;ADAM8;TIMP2;TGFB1;LAMB2;ERO1B;ADAM19;AGRN;OLFML2A;MMP10;FSCN1;ITGA1;CHADL;NID1;ADAM15;VWA1;EFEMP2;ICAM5;ITGA3;ITGA4;LAMB1;COL6A1
12956,GO:0051347,6.96929685199685e-05,0.999959959492639,79,483,positive regulation of transferase activity,BP,DUSP6;DUSP5;EGR1;DLG4;ACVR2B;PRNP;VEGFA;F2R;PKN1;EGFR;SPRY2;MST1R;SHC1;SNX9;MAP2K2;LPAR3;MAP2K1;ERCC6;SHC2;ADORA2B;AKT1;STK39;EPHA1;FGFR4;FGFR1;PRKACB;SORL1;CCND1;STRADB;GAS6;DUSP7;MAPKAPK3;CDC25B;DGKQ;PAK6;SERINC2;CEMIP;PKD2;EPHB2;ADAM8;PLCG1;CD81;TGFB1;NAB2;TNFSF15;PTPN1;PFKFB2;PRKCZ;PRKACA;MINK1;ERBB2;PRKCD;STUB1;BAX;ITGA1;EREG;IRAK1;TGFA;MIF;STK25;SLC27A1;MAPK3;INSR;ADCY1;ETAA1;VANGL2;PAK1;CAMKK2;MAP2K3;DLG3;PROX1;PKD1;ADCY7;MAPRE3;MAP3K10;CAMK1;CAMKK1;FGFR3;ADCY6
8914,GO:0034762,7.1606604001572e-05,0.999964667602551,50,270,regulation of transmembrane transport,BP,FHL1;DLG4;KCNG1;PRNP;F2R;SCN4B;NOS1;KCNJ15;SHANK2;PIK3R2;GJC2;NLGN2;STOM;AKT1;TPCN1;KCNC4;STK39;KCNAB2;ANK3;PCSK9;SNTA1;CEMIP;PKD2;EPHB2;PLCG1;TGFB1;CLTCL1;NTSR1;SHANK3;PRKCZ;PRKACA;MINK1;VAMP2;TRPC1;CACNB3;BAX;SCN8A;GSTO1;EHD3;PLA2G6;FYN;DNM2;INSR;RTN2;GLRX;PAK1;AZIN2;NGFR;GRB10;KLHL24
10781,GO:0044255,7.17831469610674e-05,0.999954659950452,114,757,cellular lipid metabolic process,BP,TYSND1;APOE;DGKA;OSBPL5;LPCAT4;ISYNA1;CRAT;ACOT7;ACSF2;EGFR;HADH;SDC1;LMF1;HEXB;KDSR;CRYL1;CPT2;PIK3R2;LRP1;SRD5A3;PIGQ;HSD17B8;HBEGF;MBOAT7;AKT1;PITPNM1;GGT1;ZFYVE21;FGFR4;ACOT1;LDLR;FGFR1;FUCA1;PIGV;CEACAM1;CBR4;ABCD1;TTC7B;AIG1;PLCH2;PCSK9;CCDC71L;ALOX15B;DGKQ;SERINC2;RETSAT;LTA4H;PLCG1;CD81;MVD;SYNJ2;TGFB1;GPC1;PIP5KL1;ST6GALNAC6;PI4K2A;PLPP6;PCK2;AGRN;OSBPL10;ESYT2;ACP6;B4GALT6;MLXIPL;ERBB2;PDK1;ACAD10;CYGB;PRKCD;BAX;SBF1;EREG;ACADS;CES2;NAGA;CPNE7;LPCAT1;LONP2;INPP5D;PI4K2B;DECR2;PPARA;ABHD15;COQ2;SESN2;ABCG1;MIF;PHYH;PLA2G6;FYN;PITPNM3;ETFB;CERS4;CYP3A5;GLB1;CHKA;CAT;SLC27A1;MAPK3;TAZ;MLYCD;WDTC1;SAMD8;SIRT2;GAL3ST4;ALG12;ST3GAL2;ZP3;FGFR3;ST3GAL5;PTGR2;SPTLC2;PI4KAP2;SDC2
3458,GO:0007275,7.65988681288161e-05,0.999941215930611,412,3327,multicellular organism development,BP,DUSP6;XDH;ERCC1;DUSP5;SDK2;MEF2D;ZMYND8;ADGRL1;SEMA4B;HTRA1;FHL1;EGR1;NR1D1;DLG4;CST3;CYP27B1;BTBD2;MARVELD1;APLN;PGF;PDCD4;CTNNBIP1;ACVR2B;BBS2;POSTN;VEGFA;FAM210B;TNFRSF6B;WNT7A;APOE;NAGLU;LRP5;ITGA6;HMGA2;OBSCN;NDRG1;IDH2;ELK3;PKN1;EGFR;SERPINE2;WWTR1;LOXL1;OBSL1;NOS1;PTPRS;SPRY2;CAPN2;MST1R;NFATC4;LTBP4;PRSS8;SDC1;ETV5;SHC1;LTBP1;HEXB;TCFL5;ACTA2;PHLDA2;TRNP1;SPRY4;RAPGEF3;TXNRD3;ZFP36L1;GAA;LPAR3;PLCD3;MDFI;SMARCA1;CMTM7;FOXQ1;MAP2K1;ACP5;SSH1;POU2F2;ENDOG;MARK4;SMURF2;FOS;FBLN1;SMAD3;STAT6;SHANK2;LRP1;GJC2;DVL1;EPAS1;THBS3;HBEGF;AP2A2;S100A4;ITGB4;SH3PXD2B;NLGN2;SALL2;MBOAT7;ADARB1;AKT1;GRB7;TMOD2;HDAC5;S100A6;SH2D2A;PITPNM1;BSG;SCMH1;EPHA1;PHC2;PTPRU;VEGFB;ASH2L;IMPACT;LRRC8A;CNTN1;BRSK1;IFT140;PTHLH;FGFR4;WNT2B;LDLR;FGFR1;PRKACB;SIGMAR1;RAC2;KCNAB2;NPHP4;RAG1;GAMT;B4GAT1;KLF7;SORL1;CEACAM1;HMG20B;LZTS2;RAB11FIP4;TENM2;ZNF385A;MICALCL;ANK3;IGFBP4;EVC;TSHZ1;TRAPPC9;CCND1;TCF25;TWF2;SYNGAP1;EDNRA;GAS6;PTK6;SEMA3F;CSNK1E;CTSB;CARD11;SH2B3;SOX13;LAMA5;GSN;PCSK9;ARHGAP22;DHTKD1;BCR;ANGPTL4;ERRFI1;DBNDD1;MYEF2;MN1;SLITRK6;ALOX15B;SPTB;COL13A1;NPR2;UNC119B;PLXNB3;BNIP3;GTF2IRD1;SHARPIN;TAGLN3;PKD2;CTSZ;CRTC1;FBXW8;GPSM1;AP3D1;ITGB5;SH3PXD2A;EPOR;EPHB2;ADAM8;APRT;MNT;PLCG1;KIF17;NYAP1;CEBPB;ZNF217;TIMP2;WNT3;TGFB1;SNPH;UNK;ULK2;GPC1;MKNK2;ADAMTS7;DEAF1;SLC38A10;NAB2;ATP7B;FHOD3;SHANK3;SDHA;EFNB3;MYCBPAP;KIF26B;NSMF;FARP1;MC1R;TUB;LCE1E;LAMB2;SNX17;RNH1;VGF;POLL;POLM;SEMA4F;WASF3;LLGL1;PHGDH;ADAM19;HMGCL;TPP1;PCK2;B4GALT2;AGRN;MBD3;IFNE;LRP4;LRP10;CEP131;RFNG;PRKCZ;KDM6B;MINK1;ZNF516;CD9;EPN2;ADA;AREG;MICALL2;BOK;WDR18;SDCCAG8;ERBB2;ADGRB2;ULK1;RTL1;TFDP2;SMTN;JAK3;CYFIP2;PBX2;ARHGAP44;FAM20C;BAX;ITGA1;FBXW4;CHADL;EREG;RPS6KA5;DGUOK;DUSP4;SOX12;DDIT4;SPRED3;PPL;PPP1R13L;AHNAK2;IER2;NID1;LIMK1;TGFBR3;GDI1;DIP2A;LEMD2;RPS6KA6;RGS14;SCN8A;MFNG;CHAD;MSLN;LPCAT1;ADAM15;ASB1;WDR60;TMEM231;MAPK12;HDAC7;INPP5D;CHD2;ZFPM1;PPARA;MYO1D;MYH15;PRR15;SOX7;SPATA20;SPEG;SIX5;ACO2;DOPEY2;ECM1;WFS1;FYN;STK25;RAC3;EEF2K;SUN1;ARID5B;HOXC5;DNM2;ATXN10;CAT;IGFBP7;ZMYM3;TPBG;SATB1;KIF26A;MAPK3;INSR;TAZ;ADCY1;RERE;HLA-G;VANGL2;PAK1;TRIM45;MALL;PPP3CB;ROBO4;USP21;PFKFB3;CUL7;HYAL1;SEMA4C;CAPRIN2;WDTC1;HES7;ITGA3;DNMT3A;BIN1;PPP2R5B;HES6;BCL2L1;DLG3;RRAS;PROX1;LRCH4;MDGA1;ADGRF1;LMNA;PKD1;TNFRSF25;SIRT2;FAM129B;CDH4;ITGA4;EDA;E2F5;RAP1GAP2;LAMB1;SOCS7;NDE1;HSD11B1;GTF2IRD2;NGFR;PDCD6;PCLO;ARVCF;GRB10;KIF13B;MAFF;NR2F6;TCTN1;NBEAL2;CAMK1;SLC39A3;EZH1;HFE;ZNF513;COL6A1;BTG1;ZP3;CELSR1;TACC1;SEMA3B;SSH3;FGFR3;NDRG2;BLOC1S4;ITPKB;PLAG1;DOK4;TRIM46;APBA1;SRSF5;ADCY6;LRRK1;AARS;SDC2
1963,GO:0004672,7.73599994601876e-05,0.999955426379202,79,477,protein kinase activity,MF,ACVR2B;HMGA2;OBSCN;NEK9;PKN1;EGFR;RPS6KA2;MST1R;LTBP4;LTBP1;MAP2K2;MAP2K1;MARK4;HBEGF;CDK18;AKT1;STK39;EPHA1;BRSK1;FGFR4;FGFR1;PRKACB;CCND1;STRADB;MAPK13;PTK6;CSNK1E;MAPKAPK3;BCR;NPR2;PAK6;EPHB2;GRK6;SCYL1;ULK2;MKNK2;EFNB3;PRKCZ;PRKACA;MINK1;PIM2;ERBB2;ULK1;STK17A;JAK3;PDK1;PRKCD;FAM20C;EREG;RPS6KA5;LIMK1;TGFBR3;RPS6KA6;MAPK12;IRAK1;CHEK2;SPEG;FYN;STK25;EEF2K;PELI1;MAPK3;INSR;PAK1;CAMKK2;ALPK1;STK32C;SRMS;MAP2K3;MAP3K10;PELI3;CAMK1;CAMKK1;CDK11B;FGFR3;CDC42BPG;CLK3;PKN3;LRRK1
7921,GO:0032502,7.94384571946554e-05,0.9999383444314,477,3920,developmental process,BP,DUSP6;XDH;ERCC1;DUSP5;SDK2;MEF2D;ZMYND8;ADGRL1;CITED4;SEMA4B;HTRA1;FHL1;EGR1;NR1D1;DLG4;CST3;CYP27B1;MRC2;BTBD2;MARVELD1;APLN;PGF;PDCD4;CTNNBIP1;ACVR2B;PRNP;PARVB;BBS2;FLNC;POSTN;VEGFA;FAM210B;TNFRSF6B;WNT7A;APOE;NAGLU;F2R;LRP5;ITGA6;HMGA2;OBSCN;NDRG1;IDH2;ELK3;PKN1;EGFR;SERPINE2;DNPH1;WWTR1;LOXL1;OBSL1;NOS1;VAT1;PTPRS;SPRY2;CAPN2;MST1R;NFATC4;LTBP4;PRSS8;SDC1;ETV5;SHC1;LTBP1;HEXB;TCFL5;ACTA2;ETV4;PHLDA2;NUDCD3;TRNP1;SPRY4;RAPGEF3;TXNRD3;ZFP36L1;GAA;ARAP1;LPAR3;PLCD3;MDFI;SMARCA1;CMTM7;FOXQ1;MAP2K1;ACP5;SSH1;POU2F2;ENDOG;MARK4;SMURF2;FOS;FBLN1;SMAD3;STAT6;SHANK2;ERCC6;LRP1;GJC2;DVL1;EPAS1;THBS3;HBEGF;AP2A2;S100A4;ITGB4;SH3PXD2B;NLGN2;SALL2;MBOAT7;ADARB1;AKT1;GRB7;TMOD2;CORO1B;HDAC5;S100A6;SH2D2A;PITPNM1;BSG;SERPING1;SCMH1;EPHA1;PHC2;PTPRU;VEGFB;FMNL2;ASH2L;IMPACT;WWC3;LRRC8A;CNTN1;BRSK1;IFT140;PTHLH;FGFR4;WNT2B;LDLR;FGFR1;PRKACB;SIGMAR1;RAC2;KCNAB2;NPHP4;SYNE3;RAG1;GAMT;B4GAT1;KLF7;SORL1;CEACAM1;HMG20B;LZTS2;RAB11FIP4;TENM2;ZNF385A;MICALCL;ANK3;IGFBP4;EVC;TSHZ1;TRAPPC9;CCND1;TCF25;TNNT1;TWF2;STRADB;SYNGAP1;EDNRA;GAS6;PTK6;SEMA3F;CSNK1E;CTSB;CARD11;SH2B3;SOX13;LAMA5;GSN;IGFBP2;PCSK9;ARHGAP22;DHTKD1;BCR;ANGPTL4;ERRFI1;WIPF1;DBNDD1;CCDC71L;MYEF2;MN1;SH3D19;CDC25B;SLITRK6;ARPIN;ALOX15B;SPTB;COL13A1;NPR2;UNC119B;PLXNB3;BNIP3;GTF2IRD1;SHARPIN;TAGLN3;PKD2;YPEL3;CTSZ;CDC42EP5;CRTC1;FBXW8;GPSM1;AP3D1;ITGB5;SH3PXD2A;EPOR;EPHB2;ADAM8;APRT;CTBP1;MNT;PLCG1;KIF17;NYAP1;CEBPB;ZNF217;TIMP2;NUDCD2;WNT3;TGFB1;SNPH;CLTCL1;RFX2;UNK;ULK2;GPC1;MKNK2;ADAMTS7;DEAF1;SLC38A10;NAB2;ATP7B;FHOD3;SHANK3;SDHA;EFNB3;MYCBPAP;KIF26B;NSMF;ARAP3;FARP1;MC1R;TUB;LCE1E;RHOD;LAMB2;SNX17;RNH1;DNAH1;VGF;POLL;POLM;SEMA4F;RHOF;YIPF3;WASF3;LLGL1;PHGDH;RHOBTB2;ADAM19;HMGCL;TPP1;PCK2;B4GALT2;AGRN;MBD3;IFNE;LRP4;LRP10;VHL;CEP131;RFNG;MLXIPL;TRIB2;PRKCZ;KDM6B;PRKACA;MINK1;ZNF516;CD9;EPN2;ADA;AREG;MICALL2;BOK;WDR18;TDRKH;SDCCAG8;ERBB2;ADGRB2;ULK1;RTL1;TFDP2;SMTN;RILPL1;JAK3;NET1;CYFIP2;FSCN1;PBX2;ARHGAP44;PRKCD;FAM20C;RBL2;BAX;ITGA1;OLFM2;SH3BP1;FBXW4;CHADL;EREG;RPS6KA5;DGUOK;DUSP4;SOX12;DDIT4;SPRED3;PPL;PPP1R13L;AHNAK2;IER2;NID1;LIMK1;TGFBR3;GDI1;DIP2A;LEMD2;RPS6KA6;ZHX3;RGS14;SCN8A;MFNG;ALDOC;CHAD;MSLN;LPCAT1;ADAM15;ASB1;WDR60;TMEM231;MAPK12;IRAK1;HDAC7;INPP5D;CHD2;CHEK2;ZFPM1;PPARA;ABCG1;MYO1D;MYH15;PRR15;SOX7;SPATA20;SPEG;SIX5;MIF;ACO2;DOPEY2;ECM1;WFS1;FYN;STK25;RAC3;EEF2K;SUN1;ARHGAP12;ARID5B;HOXC5;DNM2;ATXN10;INF2;CAT;IGFBP7;ZMYM3;TPBG;SATB1;KIF26A;MAPK3;INSR;TAZ;ADCY1;RERE;HLA-G;VANGL2;PAK1;TRIM45;MALL;PPP3CB;ROBO4;USP21;PFKFB3;CUL7;HYAL1;SEMA4C;CAPRIN2;WDTC1;HES7;ITGA3;DNMT3A;BIN1;SRMS;PPP2R5B;HES6;BCL2L1;DLG3;RRAS;PROX1;LRCH4;MDGA1;ADGRF1;LMNA;PKD1;TNFRSF25;SIRT2;FAM129B;CDH4;ITGA4;EDA;E2F5;RAP1GAP2;LAMB1;SOCS7;NDE1;HSD11B1;GTF2IRD2;NGFR;TOLLIP;PDCD6;PCLO;ARVCF;GRB10;KIF13B;MAFF;NR2F6;TCTN1;NBEAL2;CAMK1;SLC39A3;EZH1;SIRT3;HFE;TERC;ZNF513;COL6A1;BTG1;ZP3;CELSR1;TACC1;SEMA3B;SEPT6;SSH3;FGFR3;TST;NDRG2;BLOC1S4;ITPKB;PLAG1;DOK4;IRF2BPL;TRIM46;KDM3A;APBA1;SRSF5;ADCY6;LRRK1;AARS;SDC2
3564,GO:0007611,8.10965301972562e-05,0.999968155708363,30,135,learning or memory,BP,DLG4;PRNP;APOE;ITPR3;EGFR;FOS;SHANK2;TMOD2;LDLR;RAG1;ZNF385A;SYNGAP1;CRTC1;EPHB2;ASIC1;CEBPB;DEAF1;NTSR1;SHANK3;B4GALT2;PRKCZ;RGS14;ABCA7;PLA2G6;FYN;INSR;ADCY1;PPP3CB;ITGA3;ADGRF1
12613,GO:0050806,8.18501328958101e-05,0.999973521237698,22,86,positive regulation of synaptic transmission,BP,DLG4;PRNP;WNT7A;APOE;ITPR3;EGFR;SERPINE2;GLUL;SSH1;SHANK2;DVL1;NLGN2;RAB3B;CRTC1;EPHB2;NTSR1;SHANK3;RIMS3;PRKCZ;VAMP2;RGS14;KCTD13
13116,GO:0051668,8.30756018802088e-05,0.999973095571192,22,86,localization within membrane,BP,DLG4;MARVELD1;APOE;ETV5;SSH1;DVL1;SYNGAP1;GSN;AP3D1;KIF17;TGFB1;SHANK3;AGRN;LRP4;RILPL1;ARHGAP44;DNM1;REEP2;DNM2;MALL;DLG3;ITGA4
2670,GO:0006026,8.49572781391478e-05,0.99998129235771,14,42,aminoglycan catabolic process,BP,NAGLU;SDC1;HEXB;CTBS;FUCA1;CEMIP;TGFB1;GPC1;GALNS;AGRN;IDUA;GLB1;HYAL1;SDC2
6730,GO:0030154,8.51129818996281e-05,0.999935939435413,323,2540,cell differentiation,BP,DUSP6;XDH;ERCC1;SDK2;MEF2D;ZMYND8;SEMA4B;HTRA1;FHL1;EGR1;NR1D1;DLG4;CST3;CYP27B1;MRC2;BTBD2;PGF;PDCD4;CTNNBIP1;ACVR2B;PARVB;BBS2;FLNC;POSTN;VEGFA;FAM210B;WNT7A;APOE;NAGLU;LRP5;ITGA6;HMGA2;OBSCN;NDRG1;IDH2;ELK3;EGFR;SERPINE2;DNPH1;WWTR1;OBSL1;NOS1;PTPRS;SPRY2;CAPN2;MST1R;NFATC4;LTBP4;PRSS8;SDC1;ETV5;SHC1;HEXB;TCFL5;ACTA2;ETV4;RAPGEF3;TXNRD3;ZFP36L1;LPAR3;MDFI;SMARCA1;CMTM7;FOXQ1;MAP2K1;SSH1;POU2F2;FOS;FBLN1;SMAD3;STAT6;SHANK2;LRP1;GJC2;DVL1;EPAS1;S100A4;ITGB4;SH3PXD2B;MBOAT7;ADARB1;AKT1;GRB7;TMOD2;HDAC5;S100A6;SH2D2A;EPHA1;PTPRU;ASH2L;IMPACT;LRRC8A;CNTN1;BRSK1;IFT140;PTHLH;FGFR4;WNT2B;LDLR;FGFR1;RAC2;KCNAB2;NPHP4;RAG1;B4GAT1;KLF7;SORL1;CEACAM1;HMG20B;TENM2;ZNF385A;MICALCL;ANK3;TRAPPC9;CCND1;TNNT1;TWF2;SYNGAP1;EDNRA;GAS6;PTK6;SEMA3F;CSNK1E;CTSB;CARD11;SH2B3;SOX13;LAMA5;GSN;PCSK9;ARHGAP22;DHTKD1;ANGPTL4;ERRFI1;DBNDD1;CCDC71L;MYEF2;CDC25B;SLITRK6;ALOX15B;SPTB;COL13A1;NPR2;UNC119B;PLXNB3;BNIP3;SHARPIN;CTSZ;CRTC1;FBXW8;GPSM1;AP3D1;ITGB5;SH3PXD2A;EPHB2;ADAM8;CTBP1;PLCG1;KIF17;NYAP1;CEBPB;TIMP2;WNT3;TGFB1;SNPH;RFX2;UNK;ULK2;GPC1;ADAMTS7;DEAF1;NAB2;FHOD3;SHANK3;EFNB3;MYCBPAP;NSMF;FARP1;LCE1E;LAMB2;DNAH1;POLM;SEMA4F;YIPF3;WASF3;LLGL1;TPP1;PCK2;AGRN;IFNE;LRP4;VHL;CEP131;RFNG;TRIB2;PRKCZ;KDM6B;PRKACA;MINK1;ZNF516;CD9;ADA;AREG;MICALL2;BOK;TDRKH;SDCCAG8;ERBB2;ULK1;RILPL1;JAK3;NET1;CYFIP2;ARHGAP44;FAM20C;RBL2;BAX;ITGA1;OLFM2;SH3BP1;CHADL;EREG;RPS6KA5;DGUOK;SOX12;DDIT4;PPL;PPP1R13L;AHNAK2;IER2;LIMK1;TGFBR3;GDI1;LEMD2;ZHX3;RGS14;MFNG;ALDOC;ADAM15;TMEM231;MAPK12;HDAC7;INPP5D;CHD2;ZFPM1;PPARA;ABCG1;SPATA20;SPEG;SIX5;FYN;STK25;RAC3;EEF2K;SUN1;ARID5B;DNM2;ATXN10;CAT;SATB1;MAPK3;INSR;ADCY1;RERE;HLA-G;VANGL2;PAK1;PPP3CB;ROBO4;USP21;CUL7;SEMA4C;CAPRIN2;ITGA3;DNMT3A;BIN1;SRMS;PPP2R5B;HES6;BCL2L1;RRAS;PROX1;MDGA1;ADGRF1;LMNA;SIRT2;FAM129B;CDH4;ITGA4;EDA;RAP1GAP2;LAMB1;SOCS7;NDE1;NGFR;TOLLIP;PDCD6;GRB10;KIF13B;MAFF;NR2F6;TCTN1;NBEAL2;CAMK1;COL6A1;BTG1;ZP3;CELSR1;SEMA3B;SEPT6;SSH3;FGFR3;TST;NDRG2;BLOC1S4;ITPKB;PLAG1;DOK4;TRIM46;KDM3A;ADCY6;LRRK1;SDC2
3835,GO:0008443,8.70860192718578e-05,0.999998249495053,5,6,phosphofructokinase activity,MF,PFKL;PFKP;PFKFB2;PFKM;PFKFB3
4784,GO:0010975,9.68597564289479e-05,0.999949086666994,57,322,regulation of neuron projection development,BP,ZMYND8;SEMA4B;DLG4;VEGFA;WNT7A;APOE;OBSL1;PTPRS;NFATC4;LPAR3;MAP2K1;SSH1;SHANK2;LRP1;DVL1;AKT1;CNTN1;FGFR1;TWF2;SYNGAP1;PTK6;SEMA3F;PLXNB3;CTSZ;CRTC1;FBXW8;EPHB2;WNT3;ULK2;SHANK3;EFNB3;NSMF;SEMA4F;LRP4;ARHGAP44;DGUOK;LIMK1;GDI1;FYN;STK25;EEF2K;DNM2;PAK1;CUL7;SEMA4C;CAPRIN2;ITGA3;PPP2R5B;CDH4;RAP1GAP2;NGFR;KIF13B;CAMK1;SEMA3B;SSH3;ADCY6;SDC2
9783,GO:0040007,0.000101869445145566,0.999936892673088,100,652,growth,BP,DUSP6;ERCC1;SEMA4B;HTRA1;FHL1;CYP27B1;ACVR2B;BBS2;POSTN;VEGFA;WNT7A;APOE;HMGA2;EGFR;SERPINE2;DNPH1;WWTR1;PTPRS;SPRY2;LTBP4;SHC1;PHLDA2;ZFP36L1;LPAR3;SMAD3;SHANK2;ERCC6;DVL1;THBS3;HBEGF;SH3PXD2B;ADARB1;AKT1;PPM1F;IMPACT;WWC3;FGFR1;GAMT;CEACAM1;IGFBP4;EVC;TWF2;GAS6;PTK6;SEMA3F;GSN;IGFBP2;SLITRK6;ALOX15B;PLXNB3;WNT3;TGFB1;ULK2;SHANK3;KIF26B;LAMB2;SEMA4F;AGRN;LRP4;PRKCZ;AREG;ERBB2;ULK1;NET1;CYFIP2;EREG;PPP1R13L;MT2A;LIMK1;TGFBR3;GDI1;TMEM8B;ADAM15;SESN2;WFS1;ARID5B;DNM2;TSPYL2;IGFBP7;KIF26A;INSR;VANGL2;PAK1;PPP3CB;HYAL1;SEMA4C;CAPRIN2;WDTC1;BCL2L1;PROX1;CDH4;DCBLD2;SOCS7;BTG1;ZP3;SEMA3B;CDK11B;FGFR3;PLAG1;APBA1
16421,GO:0097060,0.000102236066376007,0.999956531403132,34,161,synaptic membrane,CC,ADGRL1;DLG4;PRR7;F2R;SH2D5;PTPRS;SHANK2;NLGN2;SIGMAR1;TENM2;ANK3;NIPSNAP1;BCR;COL13A1;GRIN3B;SNPH;ABHD17C;SHANK3;NSMF;PI4K2A;SEMA4F;RIMS3;CAMK2N1;LRP4;MINK1;OLFM2;DNM1;RGS14;DNM2;GABBR1;SEMA4C;ITGA3;DLG3;HOMER2
2377,GO:0005509,0.000106973097727464,0.999941617313088,63,371,calcium ion binding,MF,EDEM1;DGKA;ITPR3;CAPN2;LTBP4;SYTL1;LTBP2;LTBP1;FKBP9;MCTP1;FBLN1;LRP1;THBS3;S100A4;PPP2R3B;SYT8;S100A6;F12;PITPNM1;DYSF;LDLR;SMOC2;RAB11FIP4;TENM2;TNNT1;PLCH2;GAS6;GSN;EHD4;ALOX15B;PKD2;PRSS3;ADAM8;PLCG1;ADAMTS13;TBC1D9B;CGREF1;AGRN;CD320;LRP4;ESYT2;NINL;NECAB3;MCFD2;FAM20C;HPCAL1;NID1;PADI3;LPCAT1;EHD3;PITPNM3;EFEMP2;EEF2K;PLCB3;CAMKK2;PPP3CB;CDH4;PDCD6;PCLO;GCH1;CELSR1;CBLC;MEGF6
7655,GO:0032091,0.00010731237389876,0.999966714803793,20,78,negative regulation of protein binding,BP,CTNNBIP1;NFATC4;DVL1;AKT1;SORL1;CSNK1E;PCSK9;CTSZ;GPSM1;PIM2;PRKCD;STUB1;BAX;ADAM15;ZFPM1;PPARA;MAPK3;ITGA4;CAMK1;HFE
17024,GO:0099173,0.000107521995186365,0.999968049093482,19,70,postsynapse organization,BP,ZMYND8;DLG4;PRNP;WNT7A;APOE;ETV5;SSH1;SHANK2;DVL1;NLGN2;EPHB2;SHANK3;LRP4;ARHGAP44;FYN;EEF2K;INSR;CAPRIN2;ITGA3
3386,GO:0007167,0.000113235840218267,0.999928524581562,106,698,enzyme linked receptor protein signaling pathway,BP,DUSP6;XDH;HTRA1;EGR1;PLAT;APLN;PGF;PDCD4;ACVR2B;VEGFA;EGFR;WWTR1;SPRY2;MST1R;LTBP4;SHC1;LTBP2;LTBP1;PTPRE;SPRY4;ARAP1;SMURF2;FOS;SMAD3;PIK3R2;LRP1;HBEGF;AP2A2;SHC2;PAG1;AKT1;GRB7;FAM83A;SH2D2A;RHBDF2;EPHA1;PTPRU;VEGFB;FGFR4;FGFR1;CEACAM1;IGFBP4;EFS;MAPK13;GAS6;PTK6;FGFBP1;MAPKAPK3;IGFBP2;BCR;ERRFI1;NPR2;DGKQ;MVB12B;ITGB5;EPHB2;CDKN1C;PLCG1;TGFB1;GPC1;EFNB3;GIGYF1;PTPN1;LRP4;PRKCZ;EPN2;AREG;ERBB2;JAK3;CYFIP2;PRKCD;FAM20C;STUB1;ITGA1;EREG;RPS6KA5;DDIT4;TGFBR3;LEMD2;DNM1;RGS14;GIT1;MAPK12;IRAK1;TGFA;FYN;ARID5B;DNM2;MAPK3;INSR;PAK1;ITGA3;SRMS;PPP2R5B;SIRT2;FAM129B;SOCS7;NGFR;PDCD6;ATP6V1F;PXN;GRB10;HFE;FGFR3;CBLC;SDC2
3566,GO:0007613,0.000113505576469968,0.999967488359745,18,65,memory,BP,PRNP;APOE;ITPR3;LDLR;CRTC1;ASIC1;CEBPB;SHANK3;B4GALT2;PRKCZ;RGS14;ABCA7;PLA2G6;INSR;ADCY1;PPP3CB;ITGA3;ADGRF1
12269,GO:0048589,0.000117476527969744,0.999934310821782,67,396,developmental growth,BP,DUSP6;ERCC1;SEMA4B;ACVR2B;BBS2;POSTN;VEGFA;WNT7A;APOE;WWTR1;PTPRS;SPRY2;PHLDA2;ZFP36L1;LPAR3;SMAD3;SHANK2;ERCC6;DVL1;THBS3;SH3PXD2B;ADARB1;AKT1;IMPACT;WWC3;FGFR1;GAMT;EVC;TWF2;SEMA3F;GSN;SLITRK6;PLXNB3;WNT3;TGFB1;ULK2;SHANK3;KIF26B;LAMB2;SEMA4F;AGRN;LRP4;PRKCZ;AREG;ULK1;CYFIP2;EREG;PPP1R13L;LIMK1;TGFBR3;GDI1;ADAM15;ARID5B;DNM2;INSR;VANGL2;PAK1;PPP3CB;SEMA4C;WDTC1;PROX1;CDH4;ZP3;SEMA3B;FGFR3;PLAG1;APBA1
5312,GO:0016021,0.000121699637036689,0.999907186141921,343,2720,integral component of membrane,CC,SDK2;ADGRL1;SEMA4B;B4GALNT4;SLC16A3;EDEM1;DLG4;MRC2;MARVELD1;PRR7;KCNG1;ACVR2B;SLC6A8;FAM210B;TNFRSF6B;MXRA7;TSPAN1;F2R;LRP5;PLD3;OSBPL5;LPCAT4;ITGA6;SLCO4A1;ITPR3;GRAMD4;FCGRT;EGFR;SCN4B;NOS1;VAT1;PTPRS;TMEM129;SLC2A9;LRP3;MST1R;PRSS8;SDC1;LMF1;ORAI3;ORAI1;SLC7A8;PTPRE;SLC12A7;SLC2A3;KIAA1549L;ST6GALNAC2;KDSR;LPAR3;MARCH9;CSMD2;CMTM7;TP53I11;ACP5;NYNRIN;MCTP1;SLC16A5;KCNJ15;TMTC4;TMEM8A;ARMCX2;SHANK2;LRP1;GJC2;SRD5A3;PIGQ;HBEGF;ITGB4;CYBRD1;TMEM158;NLGN2;STOM;MBOAT7;REEP4;PAG1;ADORA2B;SYT8;SLC6A6;TPCN1;KCNC4;TTYH3;ENTPD6;RHBDF2;BSG;DYSF;EPHA1;GGT1;PTPRU;MARCH4;SLC15A4;LRRC8A;IFNGR2;MFSD3;FGFR4;PEAR1;FNDC4;LDLR;FGFR1;SIGMAR1;KCNAB2;SYNE3;B4GAT1;TOMM34;PIGV;SORL1;NAT14;CEACAM1;B3GAT3;TENM2;ABCD1;EVC;AIG1;EDNRA;CARD19;BRI3;CYYR1;CMTM4;ANO8;ANTXR2;TMEM200A;SLITRK6;TSPAN18;PAQR6;TMEM132B;COMTD1;PEX10;COL13A1;CORO7;SLC20A1;RRNAD1;NPR2;PLXNB3;BNIP3;SERINC2;PROCR;PKD2;IL20RB;ITGB5;ABCA2;FAM189B;EPOR;EPHB2;GRIN3B;ADAM8;ASIC1;CADM4;TMEM9;CD81;ENTPD2;SLC29A4;TMED4;SNPH;SLC43A1;GPC1;TBC1D9B;SLC38A10;NTSR1;B3GNT3;TMEM173;TMEM134;ATP7B;SHANK3;PODXL2;EFNB3;TNFSF15;MGAT4B;CLCA2;SCART1;MC1R;DIRC2;KLRG2;ST6GALNAC6;HTR7;PI4K2A;SEMA4F;C1ORF210;YIPF3;SLC48A1;PLPP6;ADAM19;B4GALT2;AGRN;CD320;LRP4;LRP10;ESYT2;ZDHHC24;GPR153;B4GALT6;DNAJC4;TMCC3;APCDD1L;RFNG;C14ORF132;PRKACA;OXA1L;CD9;AREG;BOK;ERBB2;ADGRB2;VAMP2;TMEM143;RTL1;C6ORF89;LRRC37A2;BNIP3L;TRPC1;SLC22A17;REEP6;CACNB3;IFI6;BAX;CYC1;GRAMD1C;SV2A;SBF1;XYLT2;SLC13A5;ITGA1;OLFM2;GJB4;EREG;TMEM25;TIMM17B;TMBIM4;MBTPS2;HSD17B7;GRAMD1A;ZDHHC8;TMX4;TGFBR3;LTB4R2;SLC2A11;LEMD2;TMEM92;TMEM8B;SCN8A;MFNG;LPCAT1;ADAM15;REEP2;ST3GAL3;TMEM231;TMEM94;IRAK1;PPOX;TGFA;RNF215;CACFD1;COQ2;TMEM161A;ABCG1;SNN;ABCA7;BCAP31;SLC25A29;BCAM;SLC9A7;SYNGR1;WFS1;QSOX1;CD68;SLC22A18;SPPL2B;TMCO6;CERS4;SUN1;ICAM5;ARMCX1;ELFN2;SLC27A1;TPBG;SLC50A1;ZDHHC1;SLC12A4;INSR;SLC13A3;RTN2;GRINA;TMEM54;TAZ;ADCY1;HLA-G;STX10;ATP8B2;TMEM101;PRAF2;VANGL2;MALL;RNF144A;ROBO4;SLC37A2;GABBR1;SEMA4C;ITGA3;SAMD8;SLC16A13;NDST2;BCL2L1;DLG3;ADGRF1;PKD1;TNFRSF25;CDH4;ITGA4;EDA;GAL3ST4;DCBLD2;ADCY7;ALG12;LTB4R;TMEM154;FAM171A2;ST3GAL2;SLC25A37;GPR3;HSD11B1;NGFR;TOLLIP;CHST14;SLC39A3;HFE;ZP3;VPS51;TMCO3;CELSR1;IL17RE;C2CD2;SLC35F3;FGFR3;MFSD10;KRTCAP3;ST3GAL5;SPTLC2;LRP11;TMEM229B;TMEM187;SLC23A2;CHPF;ADCY6;SLC26A11;SDC2
16086,GO:0090066,0.000127175697910079,0.999932244221015,57,327,regulation of anatomical structure size,BP,SEMA4B;APLN;DOCK4;BBS2;VEGFA;WNT7A;APOE;F2R;EGFR;NOS1;PTPRS;SLC12A7;LPAR3;SSH1;ADORA2B;AKT1;TMOD2;CORO1B;LRRC8A;RAC2;TWF2;EDNRA;SEMA3F;RAB3B;GSN;PLEKHG2;WIPF1;ARPIN;SPTB;CDC42EP5;WNT3;ULK2;FHOD3;SHANK3;HTR7;SEMA4F;CAPG;PRKCD;ITGA1;SH3BP1;LIMK1;GDI1;WASH3P;PLA2G6;RAC3;DNM2;SLC12A4;PAK1;SEMA4C;WDTC1;CDH4;RAP1GAP2;GCH1;SEMA3B;PFN2;SSH3;ADCY6
8917,GO:0034765,0.000135700921765041,0.999936065054148,41,214,regulation of ion transmembrane transport,BP,FHL1;DLG4;KCNG1;PRNP;F2R;SCN4B;NOS1;KCNJ15;SHANK2;GJC2;NLGN2;STOM;AKT1;TPCN1;KCNC4;STK39;KCNAB2;ANK3;PCSK9;SNTA1;CEMIP;PKD2;EPHB2;PLCG1;TGFB1;NTSR1;SHANK3;PRKACA;MINK1;VAMP2;TRPC1;CACNB3;BAX;SCN8A;GSTO1;EHD3;PLA2G6;FYN;DNM2;GLRX;KLHL24
10349,GO:0043168,0.000145309235418879,0.999892034406197,263,2006,anion binding,MF,XDH;HS1BP3;PGF;NAGS;ACVR2B;PYGB;POSTN;VEGFA;APOE;PYGL;DGKA;OSBPL5;PITPNC1;OBSCN;NEK9;ITPR3;PKN1;ACOT7;ACSF2;NISCH;EGFR;RPS6KA2;SERPINE2;NOS1;PTPRS;HADH;MST1R;SYTL1;SHC1;LTBP2;ARL2;GTPBP1;TK2;ACTA2;SNX9;RAPGEF3;TXNRD3;GLUL;ARAP1;MAP2K2;NME4;LPAR3;SMARCA1;PLTP;PC;MAP2K1;CRYL1;MCTP1;MARK4;ERCC6;LRP1;HSD17B8;THBS3;HBEGF;SH3PXD2B;PRODH;CDK18;NMRK1;D2HGDH;SYT8;AKT1;GRB7;PITPNM1;STK39;HK1;DYSF;EPHA1;VEGFB;BRSK1;RAB31;FGFR4;FGFR1;PRKACB;RAC2;SMOC2;PFKL;TTLL12;SEC14L2;OPLAH;HLTF;CBR4;ABCD1;TWF2;STRADB;MAPK13;ACBD4;GAS6;PTK6;PFKP;FGFBP1;CSNK1E;RAB3B;MAPKAPK3;DHTKD1;BCR;EHD4;SEPT10;NADK;PANK4;HLCS;AGAP1;COL13A1;NPR2;DGKQ;PAK6;FYCO1;CEMIP;ABCA2;SH3PXD2A;EPHB2;GRIN3B;APRT;GRK6;CBS;KIF17;MVD;ENTPD2;GNAL;SCYL1;ULK2;GPC1;MKNK2;TMEM173;ATP7B;SDHA;PIP5KL1;KIF26B;ARAP3;TUB;RHOD;SNX17;DNAH1;SNX33;PI4K2A;RHOF;ARL10;KIF7;RHOBTB2;TUBG2;HMGCL;PEX1;PCK2;AGRN;OSBPL10;ESYT2;TRAP1;ADAP1;PFKFB2;PRKCZ;PRKACA;MINK1;GRHPR;ACTR1B;PIM2;UCKL1;ALAS1;ERBB2;ULK1;VAMP2;PLEK2;STK17A;JAK3;TRPC1;RASA4;PDK1;ACAD10;ARHGAP44;PRKCD;FAM20C;NUBP2;RPS6KA5;DGUOK;CUL9;ACADS;RASL10B;LIMK1;TGFBR3;NTPCR;RPS6KA6;DNM1;SCN8A;EHD3;LONP2;MAPK12;IRAK1;PPOX;MTHFR;CHD2;PI4K2B;CHEK2;PPARA;SESN2;ABCG1;MYO1D;MYH15;CDC34;ABCA7;RAB12;SPEG;PHYH;DALRD3;FYN;STK25;RAC3;EEF2K;DNM2;CKMT1A;SNX15;CHKA;KIF26A;DDX50;TUBB6;MAPK3;INSR;PFKM;ADCY1;ATP8B2;GPT2;PDXK;PAK1;CAMKK2;ALPK1;PFKFB3;MICAL1;STK32C;SRMS;MAP2K3;RRAS;IARS2;SIRT2;GAL3ST4;NMNAT2;ADCY7;TEP1;RAB28;MAP3K10;RAB40B;PCLO;CHST14;PHYKPL;GCH1;KIF13B;CAMK1;CAMKK1;SIRT3;WIPI2;BBS10;SEPT6;CDK11B;PFN2;FGFR3;ITPKB;SPTLC2;CDC42BPG;GSDMA;CLK3;DHX32;PKN3;TTLL3;AK3;ADCY6;LRRK1;AARS
12586,GO:0050771,0.000150102364803362,0.999964633594374,14,44,negative regulation of axonogenesis,BP,SEMA4B;PTPRS;SYNGAP1;SEMA3F;EPHB2;WNT3;ULK2;EFNB3;SEMA4F;LRP4;GDI1;SEMA4C;NGFR;SEMA3B
715,GO:0001941,0.000152608400066885,0.999978868515454,9,21,postsynaptic membrane organization,BP,ZMYND8;DLG4;APOE;ETV5;SSH1;DVL1;NLGN2;SHANK3;LRP4
2211,GO:0005102,0.000156451047177651,0.999896152959487,127,887,signaling receptor binding,MF,SEMA4B;DLG4;PLAT;APLN;PGF;DOCK4;PRNP;VEGFA;WNT7A;APOE;F2R;ITGA6;CRAT;PKN1;NISCH;EGFR;SERPINE2;NFATC4;LTBP4;SYTL1;SHC1;ARAP1;CMTM7;SMURF2;SLC9A3R2;SMAD3;SHANK2;PIK3R2;LRP1;DVL1;HBEGF;S100A4;ITGB4;PRDX5;SHC2;NLGN2;PAG1;PITPNM1;VEGFB;PTHLH;WNT2B;FGFR1;IGFBP4;GAS6;PTK6;SEMA3F;LAMA5;CMTM4;IGFBP2;PCSK9;AIP;NXPH4;PKD2;EPHB2;CADM4;PLCG1;CD81;CEBPB;ADAMTS13;TIMP2;WNT3;GNAL;TGFB1;SHANK3;EFNB3;TNFSF15;EML2;LAMB2;SNX17;VGF;SEMA4F;BBS1;HMGCL;PTPN1;IFNE;CD320;LRP4;TRAP1;IDUA;CD9;AREG;BOK;ERBB2;JAK3;USP20;STUB1;ITGA1;SH3BP1;EREG;PCSK1N;TGFBR3;DNM1;ADAM15;REEP2;LONP2;TGFA;DECR2;BCAP31;MIF;DDT;ECM1;FYN;PITPNM3;ICAM5;DNM2;CAT;INSR;ARHGEF1;HLA-G;MLYCD;SEMA4C;CAPRIN2;ITGA3;SRMS;DLG3;PROX1;EDA;TOLLIP;PXN;GRB10;HFE;GAS2L1;ZP3;SEMA3B;CBLC;KDM3A;HOMER2
6643,GO:0023057,0.000166861139460127,0.999887774694163,135,946,negative regulation of signaling,BP,TNIP1;DUSP6;XDH;DUSP5;HTRA1;EGR1;NR1D1;APLN;PDCD4;CTNNBIP1;PRNP;DDIT4L;APOE;ITGA6;ARRDC1;EGFR;SERPINE2;WWTR1;PTPRS;HADH;SPRY2;MST1R;NFATC4;LTBP1;PTPRE;SPRY4;MDFI;SMURF2;FBLN1;SMAD3;SHANK2;PIK3R2;LRP1;DVL1;HBEGF;AKT1;EPHA1;WWC3;FGFR4;PEAR1;FGFR1;PRKACB;MAPKBP1;PFKL;NPHP4;SORL1;CEACAM1;LZTS2;ZNF385A;IGFBP4;CCND1;PODNL1;STRADB;SYNGAP1;CARD19;GAS6;PTK6;DUSP7;IGFBP2;PCSK9;ERRFI1;PKD2;EPHB2;ASIC1;MNT;TIMP2;TGFB1;GPC1;ARHGAP25;SHANK3;RASA3;ARAP3;KIF7;TNFAIP8L1;PTPN1;CAMK2N1;LRP4;VHL;TRAP1;PRKCZ;EPN2;ADA;BOK;ERBB2;RASA4;ARHGAP44;PRKCD;STUB1;IFI6;BAX;ITGA1;SH3BP1;EREG;DUSP4;DDIT4;TGFBR3;LEMD2;RPS6KA6;DNM1;RGS14;GSTO1;CHAD;HDAC7;INPP5D;TMEM161A;SESN2;CDC34;MIF;PLA2G6;ECM1;WFS1;FYN;ARHGAP12;DNM2;KIF26A;INSR;GRINA;C12ORF66;ITGA3;SRMS;PPP2R5B;BCL2L1;LMNA;KCTD13;FAM129B;SOCS7;RGS19;PELI3;PDCD6;GRB10;SIRT3;HFE;FGFR3;NDRG2;CBLC
4366,GO:0009986,0.000168498722831684,0.999906084467905,63,374,cell surface,CC,NT5E;PLAT;PRNP;VEGFA;WNT7A;F2R;ITGA6;EGFR;SERPINE2;MST1R;SDC1;HBEGF;ITGB4;NLGN2;ENTPD6;LRRC8A;LDLR;CEACAM1;ANK3;PLAU;FGFBP1;PCSK9;ANTXR2;SLITRK6;PLXNB3;PROCR;CTSZ;ITGB5;ADAM8;ASIC1;ADAMTS13;TIMP2;TGFB1;ADAMTS7;NTSR1;SCART1;TNS1;LRP4;CD9;ADA;AREG;ITGA1;TGFBR3;DIP2A;TMEM8B;MSLN;ADAM15;TGFA;ABCG1;ABCA7;MIF;BCAM;TPBG;INSR;ITGA3;PKD1;CDH4;ITGA4;DCBLD2;NGFR;HFE;FGFR3;SDC2
4350,GO:0009925,0.000177733255532473,0.999974855756356,9,21,basal plasma membrane,CC,ITGA6;EGFR;MST1R;CEACAM1;ANK3;PKD2;CLCA2;ERBB2;SLC23A2
16298,GO:0090407,0.000178275978545166,0.999893689366349,79,499,organophosphate biosynthetic process,BP,PGM1;APOE;PYGL;DGKA;LPCAT4;ISYNA1;IDH2;ACOT7;NOS1;HEXB;TK2;NME4;NAPRT;CRYL1;PIK3R2;SRD5A3;PIGQ;MBOAT7;NMRK1;ADORA2B;PITPNM1;HK1;PTHLH;FGFR4;FGFR1;PFKL;PIGV;LHPP;PFKP;DHTKD1;NADK;PANK4;NPR2;DGKQ;APRT;MVD;TIMP2;SYNJ2;TGFB1;NTSR1;PI4K2A;ACP6;PFKFB2;MLXIPL;ADA;UCKL1;CYC1;SBF1;PPCS;DGUOK;DDIT4;LTB4R2;CPNE7;ALDOC;LPCAT1;INPP5D;PI4K2B;PPARA;PLA2G6;PITPNM3;UPP1;CHKA;SLC27A1;INSR;TAZ;PFKM;ADCY1;PDXK;PFKFB3;GABBR1;SAMD8;NMNAT2;ADCY7;GCH1;ZP3;FGFR3;ITPKB;SPTLC2;ADCY6
12679,GO:0050905,0.000191891133676526,0.999953423693709,14,45,neuromuscular process,BP,DLG4;HEXB;GAA;DVL1;NLGN2;ADARB1;KCNAB2;BCR;SLITRK6;TPP1;RAC3;GCH1;BLOC1S4;AARS
16863,GO:0098794,0.000192036018668725,0.99990198153852,48,263,postsynapse,CC,ZMYND8;NR1D1;DLG4;FBXO2;PRR7;PRNP;F2R;SH2D5;NOS1;PTPRS;SHANK2;DVL1;NLGN2;AKT1;SIGMAR1;KCNAB2;TENM2;ANK3;SYNGAP1;BCR;COL13A1;BNIP3;SHARPIN;AP3D1;EPHB2;GRIN3B;ABHD17C;NTSR1;SHANK3;NSMF;FARP1;SEMA4F;CAMK2N1;LRP4;MINK1;ARHGAP44;DNM1;RGS14;FYN;EEF2K;DNM2;GABBR1;SEMA4C;DLG3;PCLO;HOMER2;APBA1;STRN4
12208,GO:0048468,0.000192059149811139,0.999863816599544,179,1300,cell development,BP,ERCC1;ZMYND8;SEMA4B;DLG4;CST3;PDCD4;PARVB;BBS2;FLNC;POSTN;VEGFA;FAM210B;WNT7A;APOE;NAGLU;LRP5;OBSCN;NDRG1;IDH2;EGFR;SERPINE2;OBSL1;NOS1;PTPRS;NFATC4;SDC1;ETV5;SHC1;HEXB;ACTA2;RAPGEF3;LPAR3;MAP2K1;SSH1;POU2F2;FBLN1;SMAD3;SHANK2;LRP1;GJC2;DVL1;EPAS1;ADARB1;AKT1;GRB7;TMOD2;S100A6;EPHA1;IMPACT;CNTN1;BRSK1;IFT140;PTHLH;LDLR;FGFR1;RAC2;NPHP4;B4GAT1;KLF7;SORL1;HMG20B;TENM2;ZNF385A;ANK3;TNNT1;TWF2;SYNGAP1;EDNRA;PTK6;SEMA3F;CSNK1E;LAMA5;GSN;DBNDD1;CDC25B;SLITRK6;SPTB;NPR2;PLXNB3;CTSZ;CRTC1;FBXW8;EPHB2;PLCG1;NYAP1;TIMP2;WNT3;TGFB1;RFX2;UNK;ULK2;GPC1;DEAF1;FHOD3;SHANK3;EFNB3;NSMF;FARP1;LAMB2;DNAH1;SEMA4F;WASF3;LLGL1;AGRN;LRP4;PRKCZ;PRKACA;MINK1;CD9;AREG;MICALL2;ERBB2;ULK1;RILPL1;NET1;CYFIP2;ARHGAP44;FAM20C;BAX;ITGA1;EREG;RPS6KA5;DGUOK;AHNAK2;LIMK1;TGFBR3;GDI1;RGS14;ZFPM1;SIX5;FYN;STK25;RAC3;EEF2K;ARID5B;DNM2;ATXN10;MAPK3;ADCY1;RERE;VANGL2;PAK1;PPP3CB;USP21;CUL7;SEMA4C;CAPRIN2;ITGA3;BIN1;PPP2R5B;BCL2L1;PROX1;ADGRF1;LMNA;SIRT2;FAM129B;CDH4;ITGA4;RAP1GAP2;LAMB1;NGFR;PDCD6;GRB10;KIF13B;NR2F6;TCTN1;NBEAL2;CAMK1;ZP3;SEMA3B;SSH3;BLOC1S4;PLAG1;DOK4;TRIM46;KDM3A;ADCY6;LRRK1;SDC2
19951,GO:2000463,0.000193058070405807,0.999977094095198,8,17,positive regulation of excitatory postsynaptic potential,BP,DLG4;WNT7A;SSH1;SHANK2;DVL1;NLGN2;SHANK3;PRKCZ
15517,GO:0071902,0.000196098246953333,0.999899746863463,48,266,positive regulation of protein serine/threonine kinase activity,BP,DUSP6;DUSP5;VEGFA;F2R;PKN1;EGFR;SPRY2;MST1R;SHC1;MAP2K2;LPAR3;MAP2K1;ERCC6;SHC2;ADORA2B;AKT1;STK39;FGFR1;CCND1;DUSP7;MAPKAPK3;CEMIP;PKD2;ADAM8;PLCG1;CD81;TGFB1;TNFSF15;PTPN1;MINK1;ERBB2;ITGA1;IRAK1;TGFA;MIF;STK25;SLC27A1;MAPK3;INSR;ETAA1;VANGL2;PAK1;MAP2K3;PROX1;PKD1;MAPRE3;MAP3K10;CAMK1
3532,GO:0007528,0.000196672260221238,0.999963031043618,11,30,neuromuscular junction development,BP,F2R;ETV5;SHANK2;DVL1;ANK3;SHANK3;LAMB2;AGRN;LRP4;ERBB2;CACNB3
3238,GO:0006897,0.000199362259006819,0.999882751762526,74,459,endocytosis,BP,DLG4;MRC2;APLN;VEGFA;APOE;TSPAN1;LRP5;LRP3;RIN1;SNX9;MCTP1;PIK3R2;LRP1;AP2A2;NLGN2;SYT8;RAB31;PEAR1;LDLR;ELMO3;RAC2;SORL1;CEACAM1;GAS6;CSNK1E;GSN;MAPKAPK3;PCSK9;BCR;EHD4;WIPF1;STON1;ARHGAP27;PLCG1;CD81;TGFB1;CLTCL1;ARHGAP25;ARAP3;SCART1;TUB;SNX17;SNX33;PTPN1;LRP4;LRP10;ESYT2;CD9;EPN2;NEURL1B;CYFIP2;PRKCD;USP20;SH3BP1;FCHO1;LIMK1;DNM1;LRSAM1;ABCA7;PLA2G6;FYN;RAC3;EEF2K;ICAM5;ARHGAP12;DNM2;MAPK3;PAK1;LGALS3BP;BIN1;BCL2L1;ITGA4;TRIP10;HFE
4362,GO:0009968,0.000199487755994459,0.999866536541447,128,893,negative regulation of signal transduction,BP,TNIP1;DUSP6;XDH;DUSP5;HTRA1;EGR1;NR1D1;APLN;PDCD4;CTNNBIP1;PRNP;DDIT4L;APOE;ITGA6;ARRDC1;EGFR;SERPINE2;WWTR1;PTPRS;SPRY2;MST1R;NFATC4;LTBP1;PTPRE;SPRY4;MDFI;SMURF2;FBLN1;SMAD3;PIK3R2;LRP1;DVL1;HBEGF;AKT1;EPHA1;WWC3;FGFR4;PEAR1;FGFR1;PRKACB;MAPKBP1;NPHP4;SORL1;CEACAM1;LZTS2;ZNF385A;IGFBP4;CCND1;PODNL1;STRADB;SYNGAP1;CARD19;GAS6;PTK6;DUSP7;IGFBP2;ERRFI1;PKD2;EPHB2;MNT;TIMP2;TGFB1;GPC1;ARHGAP25;RASA3;ARAP3;KIF7;TNFAIP8L1;PTPN1;CAMK2N1;LRP4;VHL;TRAP1;PRKCZ;EPN2;ADA;BOK;ERBB2;RASA4;ARHGAP44;PRKCD;STUB1;IFI6;BAX;ITGA1;SH3BP1;EREG;DUSP4;DDIT4;TGFBR3;LEMD2;RPS6KA6;DNM1;RGS14;GSTO1;CHAD;HDAC7;INPP5D;TMEM161A;SESN2;CDC34;MIF;ECM1;WFS1;FYN;ARHGAP12;DNM2;KIF26A;INSR;GRINA;C12ORF66;ITGA3;SRMS;PPP2R5B;BCL2L1;LMNA;KCTD13;FAM129B;SOCS7;RGS19;PELI3;PDCD6;GRB10;SIRT3;HFE;FGFR3;NDRG2;CBLC
2671,GO:0006027,0.000201314119854358,0.999954305613853,13,40,glycosaminoglycan catabolic process,BP,NAGLU;SDC1;HEXB;FUCA1;CEMIP;TGFB1;GPC1;GALNS;AGRN;IDUA;GLB1;HYAL1;SDC2
2705,GO:0006082,0.000203060689810666,0.999865985321551,119,825,organic acid metabolic process,BP,NR1D1;SLC16A3;TYSND1;NAGS;SLC6A8;PGM1;IDH2;CRAT;ACOT7;ACSF2;NOS1;SLC2A9;HADH;CRTAP;HEXB;SLC7A8;SLC2A3;ALDH4A1;GLUL;PC;CRYL1;CPT2;HSD17B8;PRODH;D2HGDH;SLC6A6;AKT1;UROS;PYCR2;BSG;HK1;GGT1;FGFR4;ACOT1;PFKL;GAMT;B4GAT1;BPHL;CEACAM1;B3GAT3;CBR4;ABCD1;AIG1;PFKP;DHTKD1;HLCS;ALOX15B;HAGH;CEMIP;ACY1;LTA4H;CBS;TGFB1;B3GNT3;PODXL2;SDHA;MDH2;GALNS;ABHD14B;ERO1B;PHGDH;HMGCL;PCK2;B4GALT2;B4GALT6;IDUA;PFKFB2;MLXIPL;GRHPR;AHCY;PDK1;ACAD10;CYGB;XYLT2;DDIT4;ACADS;CES2;GSTO1;ALDOC;ST3GAL3;LONP2;MTHFR;DECR2;PPARA;SESN2;MIF;ACO2;PHYH;DALRD3;ETFB;CKMT1A;GLB1;SLC27A1;CYP2R1;MAPK3;INSR;PFKM;GPT2;PFKFB3;MLYCD;HYAL1;WDTC1;NDST2;ABHD10;PROX1;IARS2;ALDH7A1;NMNAT2;AZIN2;ST3GAL2;CHST14;PHYKPL;GCH1;TST;PTGR2;PM20D2;SLC23A2;CHPF;AARS
17567,GO:1901136,0.000207331924041045,0.999916376929299,28,131,carbohydrate derivative catabolic process,BP,NT5E;EDEM1;CST3;FBXO2;NAGLU;SDC1;HEXB;RAPGEF3;CTBS;FUCA1;CEMIP;TGFB1;GPC1;GALNS;AGRN;IDUA;ADA;AHCY;PRKCD;NAGA;UPP1;GLB1;NEIL1;APOBEC3C;APOBEC3F;HYAL1;ABHD10;SDC2
4565,GO:0010648,0.00021270200484471,0.999856089297907,134,943,negative regulation of cell communication,BP,TNIP1;DUSP6;XDH;DUSP5;HTRA1;EGR1;NR1D1;APLN;PDCD4;CTNNBIP1;PRNP;DDIT4L;APOE;ITGA6;ARRDC1;EGFR;SERPINE2;WWTR1;PTPRS;HADH;SPRY2;MST1R;NFATC4;LTBP1;PTPRE;SPRY4;MDFI;SMURF2;FBLN1;SMAD3;SHANK2;PIK3R2;LRP1;DVL1;HBEGF;AKT1;EPHA1;WWC3;FGFR4;PEAR1;FGFR1;PRKACB;MAPKBP1;PFKL;NPHP4;SORL1;CEACAM1;LZTS2;ZNF385A;IGFBP4;CCND1;PODNL1;STRADB;SYNGAP1;CARD19;GAS6;PTK6;DUSP7;IGFBP2;ERRFI1;PKD2;EPHB2;ASIC1;MNT;TIMP2;TGFB1;GPC1;ARHGAP25;SHANK3;RASA3;ARAP3;KIF7;TNFAIP8L1;PTPN1;CAMK2N1;LRP4;VHL;TRAP1;PRKCZ;EPN2;ADA;BOK;ERBB2;RASA4;ARHGAP44;PRKCD;STUB1;IFI6;BAX;ITGA1;SH3BP1;EREG;DUSP4;DDIT4;TGFBR3;LEMD2;RPS6KA6;DNM1;RGS14;GSTO1;CHAD;HDAC7;INPP5D;TMEM161A;SESN2;CDC34;MIF;PLA2G6;ECM1;WFS1;FYN;ARHGAP12;DNM2;KIF26A;INSR;GRINA;C12ORF66;ITGA3;SRMS;PPP2R5B;BCL2L1;LMNA;KCTD13;FAM129B;SOCS7;RGS19;PELI3;PDCD6;GRB10;SIRT3;HFE;FGFR3;NDRG2;CBLC
12856,GO:0051186,0.000212903720115651,0.999877285572181,68,427,cofactor metabolic process,BP,NT5E;H6PD;PGM1;IDH2;ACOT7;ACSF2;AKR7A2;EGFR;SLC2A3;PGLS;PC;NAPRT;HSD17B8;PRDX5;NMRK1;D2HGDH;AKT1;UROS;HK1;GGT1;ACOT1;RAC2;KCNAB2;PFKL;OPLAH;GAMT;CBR4;PFKP;DHTKD1;NADK;PANK4;HLCS;RSAD1;HAGH;GPX3;PRSS3;MVD;MDH2;HMGCL;PCK2;CD320;PFKFB2;MLXIPL;ALAS1;CNDP2;AHCY;PDK1;NUBP2;PPCS;DDIT4;GSTO1;ALDOC;PPOX;MTHFR;PPARA;COQ2;PHYH;CAT;INSR;PFKM;GPT2;PDXK;PFKFB3;MLYCD;NMNAT2;GCH1;PM20D2;SLC23A2
5311,GO:0016020,0.000213827587818899,0.999829375215726,670,5776,membrane,CC,NT5E;SDK2;ADGRL1;SEMA4B;HTRA1;FHL1;B4GALNT4;SLC16A3;EDEM1;DLG4;CST3;CYP27B1;MRC2;TYSND1;MARVELD1;EPN3;FBXO2;PRR7;PGF;KCNG1;ACVR2B;DOCK4;XPC;PRNP;PARVB;PYGB;BBS2;FLNC;SLC6A8;VEGFA;FAM210B;TNFRSF6B;MXRA7;WNT7A;APOE;DGKA;TSPAN1;F2R;LRP5;PLD3;OSBPL5;LPCAT4;ITGA6;OBSCN;NDRG1;IDH2;CRAT;SLCO4A1;ITPR3;PKN1;GRAMD4;ARRDC1;NISCH;FCGRT;SH2D5;EGFR;SERPINE2;SCN4B;NOS1;VAT1;PTPRS;TMEM129;SLC2A9;HADH;SPRY2;LRP3;CAPN2;MST1R;PRSS8;SYTL1;SDC1;ETV5;LMF1;ORAI3;APPL2;SHC1;ORAI1;VPS11;ARL2;HEXB;GTPBP1;SLC7A8;PTPRE;SLC12A7;SLC2A3;RIN1;PHLDA2;KIAA1549L;SNX9;SPRY4;RAPGEF3;ST6GALNAC2;GAA;ARAP1;MAP2K2;KDSR;NME4;LPAR3;MARCH9;PLCD3;PTOV1;CSMD2;CMTM7;TP53I11;MAP2K1;ACP5;CPT2;NYNRIN;MCTP1;SSH1;EXOC2;SLC16A5;KCNJ15;TMTC4;MARCKSL1;TMEM8A;SMURF2;KLC2;ARMCX2;SLC9A3R2;FOS;SMAD3;STAT6;SHANK2;PIK3R2;LRP1;GJC2;SRD5A3;DVL1;PIGQ;HSD17B8;HBEGF;AP2A2;ITGB4;CYBRD1;TMEM158;SHC2;NLGN2;STOM;PRODH;MBOAT7;REEP4;LY6K;PAG1;ADORA2B;SYT8;SLC6A6;AKT1;TPCN1;GRB7;KCNC4;CORO1B;TTYH3;S100A6;F12;PITPNM1;ENTPD6;RHBDF2;BSG;STK39;HK1;ASAP2;DYSF;EPHA1;GGT1;PTPRU;VEGFB;MARCH4;SLC15A4;ATG16L2;ZFYVE21;LRRC8A;CNTN1;IFNGR2;MYZAP;MFSD3;RAB31;FGFR4;PEAR1;FNDC4;LDLR;FGFR1;PRKACB;SIGMAR1;RAC2;KCNAB2;PFKL;HLTF;SYNE3;B4GAT1;PHF7;TOMM34;BPHL;PIGV;SORL1;NAT14;CEACAM1;B3GAT3;LZTS2;RAB11FIP4;TENM2;ABCD1;ANK3;NIPSNAP1;TTC7B;EVC;TRAPPC9;CCND1;EFS;AIG1;SYNGAP1;PLCH2;EDNRA;CARD19;PLAU;PTK6;PFKP;FGFBP1;BRI3;CYYR1;RAB3B;CARD11;GSN;CMTM4;IGFBP2;PCSK9;ANO8;BCR;ANTXR2;MRPS6;EHD4;ERRFI1;PRSS22;AIP;DBNDD1;STON1;TMEM200A;SH3D19;SLITRK6;TSPAN18;PAQR6;TMEM132B;ARHGAP27;ALOX15B;SPTB;AGAP1;COMTD1;PEX10;COL13A1;CORO7;SLC20A1;RRNAD1;NPR2;SNTA1;DGKQ;PLXNB3;BNIP3;MVB12B;SERINC2;FYCO1;CEMIP;PROCR;PKD2;RETSAT;CTSZ;CDC42EP5;CRTC1;IL20RB;GPSM1;AP3D1;ITGB5;ABCA2;FAM189B;C19ORF33;EPOR;EPHB2;GRIN3B;ADAM8;ASIC1;CADM4;TMEM9;GRIP2;GRK6;PLCG1;KIF17;CD81;ENTPD2;SLC29A4;SYNJ2;WNT3;GNAL;TMED4;TGFB1;SNPH;CLTCL1;SCYL1;ABHD17C;SLC43A1;SNTB2;ULK2;GPC1;MOAP1;TBC1D9B;SLC38A10;NTSR1;B3GNT3;OGFRL1;TMEM173;ARHGAP25;TMEM134;ATP7B;SHANK3;PODXL2;SDHA;EFNB3;RASA3;PIP5KL1;TNFSF15;MYCBPAP;MGAT4B;MDH2;CLCA2;GOLGA2P5;NSMF;ARAP3;SCART1;FARP1;MC1R;TUB;DIRC2;LCE1E;CROCC;KLRG2;RHOD;ABTB1;SNX17;ERO1B;ST6GALNAC6;HTR7;SNX33;PI4K2A;SEMA4F;C1ORF210;RHOF;YIPF3;ANKZF1;ATG2A;SLC48A1;LLGL1;PLPP6;RHOBTB2;UBXN4;ADAM19;RIMS3;BBS1;HMGCL;PTPN1;PEX1;B4GALT2;WDR59;AGRN;CD320;CAMK2N1;LRP4;LRP10;ESYT2;ZDHHC24;GPR153;B4GALT6;VHL;DNAJC4;TMCC3;TRAP1;APCDD1L;ADAP1;RFNG;C14ORF132;PRKCZ;PRKACA;MINK1;OXA1L;RABGGTA;RCCD1;ACTR1B;CD9;EPN2;ADA;AREG;MICALL2;PLEKHG5;BOK;ERBB2;ADGRB2;ULK1;VAMP2;CERCAM;TMEM143;RTL1;PLEK2;C6ORF89;NECAB3;STK17A;RILPL1;JAK3;RNPEP;NET1;LRRC37A2;BNIP3L;CYFIP2;FSCN1;TRPC1;NELFCD;SLC22A17;RASA4;ARHGAP44;EHBP1L1;MCFD2;PRKCD;REEP6;CACNB3;IFI6;BAX;CYC1;GRAMD1C;SV2A;SBF1;XYLT2;SLC13A5;TRIM4;ITGA1;OLFM2;SH3BP1;GJB4;EREG;TMEM25;KLHDC2;TIMM17B;TMBIM4;MBTPS2;SPRED3;PPL;HSD17B7;AHNAK2;GRAMD1A;HPCAL1;RASL10B;ZDHHC8;TMX4;FCHO1;LIMK1;TGFBR3;NTPCR;PDIA5;LTB4R2;CPNE7;SLC2A11;LEMD2;TMEM92;DNM1;WASH3P;RGS14;TMEM8B;SCN8A;MFNG;GIT1;MRPS26;MSLN;LPCAT1;LRSAM1;ADAM15;REEP2;EHD3;ST3GAL3;TMEM231;LONP2;SYMPK;TMEM94;IRAK1;PPOX;TGFA;FHOD1;INPP5D;RNF215;PI4K2B;DECR2;CACFD1;COG7;ABHD15;COQ2;TMEM161A;ABCG1;MYO1D;RNF123;SNN;ABCA7;RAB12;BCAP31;SMOX;SLC25A29;DOPEY2;BCAM;SLC9A7;PLA2G6;SYNGR1;WFS1;QSOX1;CD68;SLC22A18;SPPL2B;FYN;PITPNM3;STK25;RAC3;TMCO6;CERS4;SUN1;ICAM5;ARHGAP12;ACAP3;DNM2;CKMT1A;CYP3A5;ATXN10;SNX15;CAT;ARMCX1;ELFN2;SLC27A1;TPBG;SLC50A1;ZDHHC1;SLC12A4;PLCB3;IQSEC1;ARHGEF4;DDX50;CYP2R1;MAPK3;INSR;SLC13A3;RTN2;ARHGEF1;GRINA;TMEM54;TAZ;PFKM;ADCY1;C12ORF66;HLA-G;DOCK9;STX10;ATP8B2;TMEM101;PRAF2;VANGL2;PAK1;MALL;PPP3CB;RNF144A;LGALS3BP;ROBO4;USP21;SLC37A2;GABBR1;SEMA4C;CAPRIN2;ITGA3;SAMD8;BIN1;VPS16;MAN2B1;SRMS;SLC16A13;MAP2K3;NDST2;BCL2L1;DLG3;NDUFV3;RRAS;LRCH4;MDGA1;ADGRF1;LMNA;PKD1;TNFRSF25;SIRT2;FAM129B;CDH4;ITGA4;EDA;ANKRD13D;GAL3ST4;DCBLD2;NMNAT2;TRIP10;ADCY7;ALG12;LTB4R;AZIN2;TMEM154;FAM171A2;RAB28;SERPINB1;ST3GAL2;ICA1;SLC25A37;RAP1GAP2;SOCS7;RGS19;NDE1;GPR3;HSD11B1;RAB40B;NGFR;TOLLIP;BCORL1;PDCD6;ATP6V1F;PCLO;ARVCF;CHST14;PXN;GRB10;TBC1D8;PLEKHM1;GCH1;TCTN1;NBEAL2;SLC39A3;HFE;WIPI2;COL6A1;ZP3;VPS51;TMCO3;CELSR1;TACC1;MLF2;IL17RE;SEPT6;C2CD2;SLC35F3;FGFR3;MFSD10;PPP1R16A;TST;KRTCAP3;ST3GAL5;TNRC18;MAN2B2;CBLC;ITPKB;SPTLC2;PRSS21;LRP11;GSDMA;CLK3;KDM3A;TMEM229B;TMEM187;HOMER2;SLC23A2;APBA1;PI4KAP2;CHPF;ADCY6;SLC26A11;AARS;STRN4;SDC2
7687,GO:0032147,0.000214458945216449,0.999893455699245,44,238,activation of protein kinase activity,BP,DUSP6;DUSP5;ACVR2B;PRNP;VEGFA;F2R;PKN1;EGFR;SHC1;MAP2K2;LPAR3;MAP2K1;ERCC6;SHC2;ADORA2B;AKT1;STK39;PRKACB;STRADB;GAS6;DUSP7;MAPKAPK3;DGKQ;PAK6;PLCG1;CD81;TNFSF15;PTPN1;PRKCZ;PRKACA;MINK1;PRKCD;ITGA1;IRAK1;TGFA;STK25;MAPK3;INSR;ADCY1;PAK1;MAP2K3;ADCY7;MAP3K10;ADCY6
17616,GO:1901293,0.000216526275388244,0.99989323263734,43,235,nucleoside phosphate biosynthetic process,BP,PGM1;APOE;IDH2;ACOT7;NOS1;TK2;NME4;NAPRT;NMRK1;ADORA2B;HK1;PTHLH;PFKL;LHPP;PFKP;DHTKD1;NADK;PANK4;NPR2;APRT;TIMP2;TGFB1;PFKFB2;MLXIPL;ADA;UCKL1;CYC1;PPCS;DGUOK;DDIT4;LTB4R2;ALDOC;PPARA;UPP1;INSR;TAZ;PFKM;ADCY1;PFKFB3;GABBR1;NMNAT2;ADCY7;ADCY6
12765,GO:0051049,0.000226788858156597,0.99984203244179,156,1125,regulation of transport,BP,FHL1;NR1D1;EDEM1;DLG4;APLN;KCNG1;PRNP;POSTN;VEGFA;APOE;TSPAN1;F2R;LRP5;IDH2;ITPR3;EVI5L;EGFR;SERPINE2;SCN4B;NOS1;HADH;PRSS8;SYTL1;SDC1;ORAI1;VPS11;TBC1D14;ARL2;RAPGEF3;GLUL;MAP2K2;LPAR3;PLTP;MAP2K1;MCTP1;KCNJ15;SHANK2;PIK3R2;LRP1;GJC2;NLGN2;STOM;ADORA2B;SYT8;AKT1;TPCN1;KCNC4;RHBDF2;STK39;HK1;CNTN1;LDLR;FGFR1;MAPKBP1;RAC2;KCNAB2;PFKL;SORL1;CEACAM1;B3GAT3;ANK3;GAS6;RAB3B;PCSK9;BCR;EHD4;STON1;ALOX15B;SNTA1;CEMIP;PKD2;ABCA2;EPHB2;GRIN3B;ADAM8;ASIC1;PLCG1;TGFB1;CLTCL1;TBC1D9B;NTSR1;TMEM173;SHANK3;ARAP3;TUB;SNX17;SNX33;LLGL1;RIMS3;PTPN1;PCK2;CEP131;PFKFB2;PRKCZ;PRKACA;MINK1;ADA;MICALL2;BOK;ERBB2;VAMP2;TFDP2;BNIP3L;TRPC1;PRKCD;REEP6;CACNB3;BAX;SV2A;RASL10B;ZDHHC8;GDI1;DNM1;SCN8A;GSTO1;LRSAM1;REEP2;EHD3;PPARA;ABCG1;ABCA7;BCAP31;MIF;PLA2G6;WFS1;NBPF3;FYN;EEF2K;DNM2;MAPK3;INSR;RTN2;PFKM;GLRX;PAK1;PPP3CB;MICAL1;BIN1;VPS16;SGSM2;TBC1D16;RABGAP1;AZIN2;ICA1;RAB40B;NGFR;PCLO;GRB10;TBC1D8;CAMK1;SIRT3;HFE;ZP3;PFN2;HOMER2;KLHL24
8916,GO:0034764,0.000227827670571499,0.999915295807424,24,105,positive regulation of transmembrane transport,BP,F2R;NOS1;PIK3R2;GJC2;AKT1;STK39;ANK3;CEMIP;PKD2;EPHB2;PLCG1;CLTCL1;NTSR1;SHANK3;PRKCZ;TRPC1;BAX;GSTO1;EHD3;DNM2;INSR;GLRX;PAK1;AZIN2
19770,GO:2000145,0.000230146116426718,0.99985755450283,88,571,regulation of cell motility,BP,ZMYND8;SEMA4B;PGF;DOCK4;BBS2;POSTN;VEGFA;WNT7A;APOE;F2R;ITGA6;IDH2;PKN1;NISCH;EGFR;SERPINE2;SPRY2;PHLDA2;MCTP1;SSH1;SMURF2;FBLN1;SMAD3;LRP1;HBEGF;FAM110C;ADARB1;AKT1;GRB7;CORO1B;HDAC5;PPM1F;MMP28;EPHA1;PTPRU;VEGFB;FGFR1;RAC2;SORL1;CEACAM1;PLAU;GAS6;SEMA3F;LAMA5;BCR;ARPIN;ALOX15B;PLXNB3;CEMIP;ADAM8;PLCG1;CD81;TGFB1;NSMF;ARAP3;RHOD;SEMA4F;RHOF;RHOBTB2;MINK1;ADA;ERBB2;MMP10;CYGB;SH3BP1;EREG;ADAM15;HDAC7;MIF;DDT;ECM1;MAPK3;INSR;PAK1;ROBO4;HYAL1;SEMA4C;ITGA3;MAP2K3;RRAS;PROX1;LMNA;ITGA4;LAMB1;PDCD6;ZP3;SEMA3B;PFN2
5899,GO:0018105,0.00023129277074796,0.99988898495439,40,210,peptidyl-serine phosphorylation,BP,VEGFA;HMGA2;PKN1;EGFR;SPRY2;RAPGEF3;MAP2K2;AKT1;PPM1F;STK39;MAPK13;GAS6;CSNK1E;MAPKAPK3;DGKQ;TGFB1;MKNK2;IFNE;MLXIPL;PRKCZ;PRKACA;ULK1;PRKCD;BAX;RPS6KA5;DDIT4;MAPK12;CHEK2;MIF;MAPK3;PAK1;CAMKK2;CAPRIN2;STK32C;PKD1;MAP3K10;CAMK1;CAMKK1;PFN2;PKN3
16809,GO:0098657,0.000231324029857788,0.99986020730144,80,507,import into cell,BP,DLG4;MRC2;APLN;PRNP;VEGFA;APOE;TSPAN1;LRP5;NOS1;LRP3;RIN1;SNX9;GLUL;MCTP1;PIK3R2;LRP1;AP2A2;NLGN2;SYT8;RAB31;PEAR1;LDLR;ELMO3;RAC2;SORL1;CEACAM1;GAS6;CSNK1E;RAB3B;GSN;MAPKAPK3;PCSK9;BCR;EHD4;WIPF1;STON1;ARHGAP27;PLCG1;CD81;TGFB1;CLTCL1;NTSR1;ARHGAP25;ARAP3;SCART1;TUB;SNX17;SNX33;PTPN1;LRP4;LRP10;ESYT2;CD9;EPN2;NEURL1B;CYFIP2;PRKCD;USP20;SH3BP1;FCHO1;LIMK1;DNM1;LRSAM1;ABCA7;SLC9A7;PLA2G6;FYN;RAC3;EEF2K;ICAM5;ARHGAP12;DNM2;MAPK3;PAK1;LGALS3BP;BIN1;BCL2L1;ITGA4;TRIP10;HFE
14715,GO:0070371,0.00024042967194947,0.999889369860038,36,184,ERK1 and ERK2 cascade,BP,TNIP1;DUSP6;F2R;EGFR;SPRY2;MST1R;SHC1;SPRY4;ZFP36L1;MAP2K2;MAP2K1;FBLN1;EPHA1;FGFR4;FGFR1;CEACAM1;GAS6;ERRFI1;EPHB2;TGFB1;PTPN1;CAMK2N1;PRKCZ;ERBB2;DUSP4;RPS6KA6;RGS14;ABCA7;MIF;DDT;MAPK3;INSR;RRAS;SIRT3;FGFR3;NDRG2
10496,GO:0043405,0.000242168284268135,0.999875874588069,47,261,regulation of MAP kinase activity,BP,DUSP6;DUSP5;PDCD4;VEGFA;APOE;F2R;PKN1;EGFR;SPRY2;MST1R;SHC1;SPRY4;MAP2K2;LPAR3;MAP2K1;ERCC6;SHC2;ADORA2B;STK39;FGFR1;SORL1;DUSP7;MAPKAPK3;EPHB2;ADAM8;PLCG1;CD81;TGFB1;PTPN1;TRIB2;MINK1;ERBB2;PRKCD;ITGA1;DUSP4;RGS14;IRAK1;TGFA;MIF;STK25;MAPK3;INSR;VANGL2;PAK1;MAP2K3;MAP3K10;CBLC
6762,GO:0030203,0.000252422840633501,0.999903284232481,25,110,glycosaminoglycan metabolic process,BP,NAGLU;SDC1;HEXB;AKT1;FUCA1;B4GAT1;B3GAT3;CEMIP;TGFB1;GPC1;B3GNT3;GALNS;B4GALT2;AGRN;B4GALT6;IDUA;XYLT2;ST3GAL3;GLB1;HYAL1;NDST2;ST3GAL2;CHST14;CHPF;SDC2
12265,GO:0048583,0.00025597109551438,0.999802211211826,340,2721,regulation of response to stimulus,BP,TNIP1;DUSP6;NT5E;XDH;ERCC1;DUSP5;ZMYND8;SEMA4B;HTRA1;EGR1;NR1D1;EDEM1;DLG4;PLAT;CYP27B1;APLN;PGF;PDCD4;CTNNBIP1;ACVR2B;PRNP;BBS2;DDIT4L;POSTN;VEGFA;WNT7A;APOE;F2R;LRP5;ITGA6;HMGA2;OBSCN;PKN1;ARRDC1;FCGRT;EGFR;SERPINE2;WWTR1;NOS1;PTPRS;SPRY2;MST1R;NFATC4;LTBP4;APPL2;SHC1;LTBP1;PTPRE;PHLDA2;SPRY4;ARAP1;MAP2K2;LPAR3;MDFI;CMTM7;RBCK1;MAP2K1;ACP5;MCTP1;SSH1;ENDOG;SMURF2;FOS;FBLN1;SMAD3;ARHGAP23;STAT6;SHANK2;PIK3R2;ERCC6;LRP1;DVL1;HBEGF;FAM110C;S100A4;SHC2;NLGN2;PAG1;ADORA2B;AKT1;GRB7;TMOD2;CORO1B;F12;SH2D2A;PPM1F;MMP28;RHBDF2;STK39;HK1;SERPING1;ASAP2;EPHA1;GGT1;VEGFB;IMPACT;WWC3;IFNGR2;IFT140;PTHLH;FGFR4;PEAR1;WNT2B;FNDC4;LDLR;FGFR1;PRKACB;MAPKBP1;RAC2;NPHP4;RAG1;SORL1;CEACAM1;LZTS2;ZNF385A;NSMCE4A;IGFBP4;EVC;CCND1;PODNL1;TNNT1;STRADB;SYNGAP1;MAPK13;CARD19;PLAU;GAS6;PTK6;SEMA3F;FGFBP1;CSNK1E;CTSB;RAB3B;CARD11;SH2B3;DUSP7;GSN;CMTM4;PLEKHG2;MAPKAPK3;IGFBP2;PCSK9;ARHGAP22;BCR;ERRFI1;WIPF1;AIP;RGL2;ALOX15B;AGAP1;SLC20A1;DGKQ;BNIP3;PAK6;GTF2IRD1;SHARPIN;MVB12B;PKD2;FAM3A;YPEL3;RASGEF1A;IL20RB;MAGEF1;EPHB2;ADAM8;MNT;GRK6;CDKN1C;PLCG1;SH3BP2;CD81;RNF135;TIMP2;WNT3;TMED4;TGFB1;GPC1;MOAP1;NTSR1;TMEM173;ARHGAP25;SHANK3;RASA3;TNFSF15;ARAP3;FARP1;MC1R;RHOD;VGF;PLEKHG4;SEMA4F;RHOF;LLGL1;PLEKHG3;KIF7;RHOBTB2;TNFAIP8L1;PTPN1;WDR59;MBD3;IFNE;CD320;CAMK2N1;LRP4;VHL;TRAP1;ADAP1;RFNG;TRIB2;PRKCZ;PRKACA;MINK1;CD9;EPN2;ADA;AREG;PIM2;PLEKHG5;BOK;ERBB2;TFDP2;JAK3;NET1;CYFIP2;RASA4;ARHGAP44;PRKCD;FAM20C;MIB2;CACNB3;USP20;STUB1;IFI6;BAX;ITGA1;SH3BP1;EREG;RPS6KA5;DUSP4;TMBIM4;DDIT4;SPRED3;PPP1R13L;LIMK1;TGFBR3;GDI1;LEMD2;RPS6KA6;DNM1;RGS14;MFNG;GSTO1;GIT1;CHAD;LRSAM1;IRAK1;TGFA;HDAC7;INPP5D;CHEK2;PPARA;TMEM161A;SESN2;CDC34;SOX7;ABCA7;BCAP31;MIF;PLA2G6;DDT;ECM1;WFS1;SPPL2B;FYN;STK25;RAC3;ICAM5;ARHGAP12;ACAP3;DNM2;PELI1;CAT;TSPYL2;KIF26A;IQSEC1;APOBEC3F;ARHGEF4;MAPK3;INSR;ARHGEF1;GRINA;C12ORF66;HLA-G;TMEM101;RALGAPA1;ETAA1;VANGL2;PAK1;PPP3CB;SEMA4C;CAPRIN2;ITGA3;SRMS;PPP2R5B;MAP2K3;BCL2L1;RRAS;LMNA;KCTD13;TNFRSF25;SIRT2;FAM129B;ITGA4;EDA;TRIP10;RAP1GAP2;SOCS7;MAP3K10;RGS19;PELI3;NGFR;PDCD6;PXN;GRB10;GCH1;LURAP1;TCTN1;SIRT3;HFE;TERC;ZP3;SEMA3B;FGFR3;NDRG2;CBLC;ITPKB;HOMER2;DEDD2;LRRK1;KLHL24
14716,GO:0070372,0.000256281622140114,0.999884642457669,34,171,regulation of ERK1 and ERK2 cascade,BP,TNIP1;DUSP6;F2R;EGFR;SPRY2;MST1R;SHC1;SPRY4;MAP2K1;FBLN1;EPHA1;FGFR4;FGFR1;CEACAM1;GAS6;ERRFI1;EPHB2;TGFB1;PTPN1;CAMK2N1;PRKCZ;ERBB2;DUSP4;RPS6KA6;RGS14;ABCA7;MIF;DDT;MAPK3;INSR;RRAS;SIRT3;FGFR3;NDRG2
12513,GO:0050662,0.000257102395492125,0.999874549373942,41,220,coenzyme binding,MF,XDH;H6PD;PYGB;PYGL;IDH2;ACOT7;NOS1;HADH;TXNRD3;PC;CRYL1;HSD17B8;PRODH;D2HGDH;CBR4;ACBD4;DHTKD1;HLCS;CTBP1;CBS;SDHA;PHGDH;HMGCL;GRHPR;ALAS1;AHCY;ACAD10;ACADS;PPOX;MTHFR;PHYH;CAT;TSTA3;GPT2;PDXK;MICAL1;SIRT2;PHYKPL;GCH1;SIRT3;SPTLC2
2667,GO:0006022,0.000279115924392275,0.999889819634285,26,117,aminoglycan metabolic process,BP,NAGLU;SDC1;HEXB;CTBS;AKT1;FUCA1;B4GAT1;B3GAT3;CEMIP;TGFB1;GPC1;B3GNT3;GALNS;B4GALT2;AGRN;B4GALT6;IDUA;XYLT2;ST3GAL3;GLB1;HYAL1;NDST2;ST3GAL2;CHST14;CHPF;SDC2
3190,GO:0006820,0.000279963825180885,0.999845678883496,57,335,anion transport,BP,SLC16A3;PRNP;SLC6A8;APOE;OSBPL5;PITPNC1;SLCO4A1;SLC2A9;SLC7A8;SLC12A7;SLC2A3;PLTP;CPT2;SLC16A5;SLC6A6;AKT1;TTYH3;PITPNM1;BSG;STK39;SLC15A4;LRRC8A;LDLR;FGFR1;CEACAM1;ABCD1;ANO8;SLC20A1;SERINC2;SLC43A1;SLC38A10;NTSR1;CLCA2;OSBPL10;VAMP2;SLC22A17;PRKCD;SV2A;SLC13A5;PPARA;ABCG1;ABCA7;MIF;SLC25A29;PLA2G6;PITPNM3;SLC27A1;SLC12A4;SLC13A3;ATP8B2;PRAF2;SLC37A2;SLC16A13;MFSD10;SLC23A2;APBA1;SLC26A11
16422,GO:0097061,0.000282231963937942,0.999923711257479,15,52,dendritic spine organization,BP,ZMYND8;DLG4;PRNP;WNT7A;APOE;SHANK2;DVL1;EPHB2;SHANK3;ARHGAP44;FYN;EEF2K;INSR;CAPRIN2;ITGA3
7666,GO:0032102,0.000284905049931057,0.999867502713468,36,187,negative regulation of response to external stimulus,BP,NT5E;SEMA4B;HTRA1;PLAT;PDCD4;BBS2;APOE;SERPINE2;PTPRS;ACP5;SMAD3;DVL1;CORO1B;F12;MMP28;SERPING1;FNDC4;MAPKBP1;CEACAM1;PLAU;SEMA3F;BCR;SHARPIN;FAM3A;IL20RB;WNT3;SEMA4F;CD9;ADA;PRKCD;PPARA;MIF;DDT;SEMA4C;SIRT2;SEMA3B
12610,GO:0050803,0.000286866841858791,0.99989155720306,24,105,regulation of synapse structure or activity,BP,ZMYND8;ADGRL1;PRNP;WNT7A;APOE;NFATC4;ETV5;SSH1;NLGN2;SYNGAP1;SLITRK6;EPHB2;SHANK3;AGRN;LRP4;ADGRB2;ARHGAP44;DNM1;FYN;EEF2K;DNM2;TPBG;CAPRIN2;CAMK1
12947,GO:0051338,0.000290048105820564,0.999810403928021,108,736,regulation of transferase activity,BP,DUSP6;DUSP5;EGR1;DLG4;PDCD4;ACVR2B;PRNP;VEGFA;APOE;F2R;LRP5;PKN1;EGFR;WWTR1;SPRY2;MST1R;SHC1;SNX9;SPRY4;MAP2K2;LPAR3;MAP2K1;PIK3R2;ERCC6;DVL1;SHC2;ADORA2B;ADARB1;AKT1;PPM1F;STK39;EPHA1;FGFR4;FGFR1;PRKACB;RAC2;SORL1;CEACAM1;CCND1;PODNL1;STRADB;GAS6;PTK6;DUSP7;MAPKAPK3;ERRFI1;CDC25B;DGKQ;PAK6;SERINC2;CEMIP;PKD2;EPHB2;ADAM8;CDKN1C;PLCG1;CD81;TGFB1;NAB2;TNFSF15;ZER1;PTPN1;CAMK2N1;PFKFB2;TRIB2;PRKCZ;PRKACA;MINK1;ERBB2;PRKCD;RBL2;STUB1;BAX;ITGA1;EREG;DUSP4;LIMK1;RGS14;CHAD;IRAK1;TGFA;SESN2;MIF;TRPT1;STK25;TSPYL2;SLC27A1;MAPK3;INSR;ADCY1;ETAA1;VANGL2;PAK1;CAMKK2;MAP2K3;DLG3;PROX1;ZYG11B;PKD1;ADCY7;MAPRE3;SOCS7;MAP3K10;CAMK1;CAMKK1;FGFR3;CBLC;ADCY6
12611,GO:0050804,0.000291230697900348,0.999864493826621,36,185,modulation of chemical synaptic transmission,BP,ZMYND8;DLG4;PRNP;WNT7A;APOE;F2R;ITPR3;NISCH;EGFR;SERPINE2;NFATC4;GLUL;MCTP1;SSH1;SHANK2;DVL1;NLGN2;KCNC4;SYNGAP1;RAB3B;CRTC1;EPHB2;ASIC1;NTSR1;SHANK3;NSMF;VGF;RIMS3;PRKCZ;VAMP2;RGS14;PLA2G6;SYNGR1;PPP3CB;KCTD13;PFN2
17027,GO:0099177,0.000291230697900348,0.999864493826621,36,185,regulation of trans-synaptic signaling,BP,ZMYND8;DLG4;PRNP;WNT7A;APOE;F2R;ITPR3;NISCH;EGFR;SERPINE2;NFATC4;GLUL;MCTP1;SSH1;SHANK2;DVL1;NLGN2;KCNC4;SYNGAP1;RAB3B;CRTC1;EPHB2;ASIC1;NTSR1;SHANK3;NSMF;VGF;RIMS3;PRKCZ;VAMP2;RGS14;PLA2G6;SYNGR1;PPP3CB;KCTD13;PFN2
2762,GO:0006182,0.000292131742163604,0.999969993730255,7,14,cGMP biosynthetic process,BP,APOE;NOS1;ADORA2B;NPR2;ADCY1;ADCY7;ADCY6
7275,GO:0031267,0.000302362146727175,0.999820601583376,72,446,small GTPase binding,MF,DLG4;DOCK4;OBSCN;NDRG1;PKN1;EVI5L;EGFR;SYTL1;APPL2;SHC1;TBC1D14;RIN1;RAPGEF3;ARAP1;EXOC2;DVL1;HBEGF;SHC2;ASAP2;FMNL2;FGFR4;FGFR1;SORL1;RAB11FIP4;TRAPPC9;PLEKHG2;BCR;XPOT;ERRFI1;RGL2;SPTB;AGAP1;PAK6;RASGEF1A;CDC42EP5;TBC1D9B;ARAP3;FARP1;PLEKHG4;LLGL1;PLEKHG3;RIMS3;ADAP1;RABGGTA;MICALL2;PLEKHG5;ERBB2;ULK1;RILPL1;JAK3;NET1;ARHGAP44;SBF1;SH3BP1;EREG;GDI1;GIT1;FYN;ACAP3;INF2;ARHGEF4;ARHGEF1;PAK1;MICAL1;SGSM2;TBC1D16;KCTD13;RABGAP1;NGFR;TBC1D8;FGFR3;PKN3
6584,GO:0022603,0.00030891236485344,0.999798480605736,106,720,regulation of anatomical structure morphogenesis,BP,DUSP6;XDH;SEMA4B;DLG4;CST3;PGF;PARVB;POSTN;VEGFA;WNT7A;APOE;HMGA2;PKN1;OBSL1;VAT1;PTPRS;SPRY2;NFATC4;ETV5;HEXB;RAPGEF3;ARAP1;LPAR3;MAP2K1;SSH1;SMURF2;FBLN1;DVL1;AP2A2;CORO1B;HDAC5;EPHA1;VEGFB;FMNL2;WNT2B;FGFR1;SYNE3;CEACAM1;TWF2;SYNGAP1;SEMA3F;CSNK1E;BCR;ANGPTL4;WIPF1;SH3D19;ARPIN;PLXNB3;BNIP3;CDC42EP5;FBXW8;EPHB2;PLCG1;WNT3;TGFB1;ULK2;SHANK3;EFNB3;NSMF;ARAP3;RHOD;RNH1;SEMA4F;RHOF;WASF3;RHOBTB2;LRP4;EPN2;ADA;ERBB2;ADGRB2;NET1;ARHGAP44;BAX;LIMK1;GDI1;CHAD;HDAC7;ECM1;FYN;STK25;RAC3;EEF2K;DNM2;INF2;ZMYM3;VANGL2;PAK1;CUL7;HYAL1;SEMA4C;CAPRIN2;HES7;RRAS;PROX1;FAM129B;CDH4;NGFR;PDCD6;KIF13B;CAMK1;BTG1;CELSR1;SEMA3B;SSH3;SDC2
3449,GO:0007265,0.000318534111807162,0.99981952031572,61,365,Ras protein signal transduction,BP,APOE;F2R;OBSCN;NISCH;SPRY2;APPL2;SHC1;SPRY4;RAPGEF3;ARAP1;SHC2;ASAP2;RAB31;RAC2;RALGDS;SYNGAP1;RAB3B;PLEKHG2;MAPKAPK3;BCR;RGL2;AGAP1;PAK6;RASGEF1A;CDC42EP5;EPHB2;TIMP2;RASA3;ARAP3;FARP1;RHOD;PLEKHG4;RHOF;PLEKHG3;RHOBTB2;ADAP1;PLEKHG5;NET1;RASA4;ARHGAP44;SH3BP1;LIMK1;GDI1;GIT1;RAB12;RAC3;ACAP3;DNM2;IQSEC1;ARHGEF4;ARHGEF1;VANGL2;PAK1;ITGA3;RRAS;KCTD13;RAB28;RAB40B;NGFR;CELSR1;ITPKB
17566,GO:1901135,0.000319512824094403,0.999783343275603,127,911,carbohydrate derivative metabolic process,BP,TNIP1;NT5E;H6PD;EDEM1;DLG4;CST3;FBXO2;VEGFA;PGM1;APOE;PYGL;NAGLU;ACOT7;AKR7A2;NOS1;SDC1;LMF1;HEXB;GTPBP1;TK2;RAPGEF3;ST6GALNAC2;NME4;CTBS;PGLS;CRYL1;SRD5A3;PIGQ;HBEGF;ADORA2B;AKT1;HK1;VEGFB;PTHLH;FUCA1;PFKL;GAMT;B4GAT1;PIGV;B3GAT3;CBR4;PFKP;CARD11;DHTKD1;PHLDA1;NADK;PANK4;NPR2;CEMIP;PKD2;APRT;MVD;ADAMTS13;TIMP2;TGFB1;GPC1;ADAMTS7;B3GNT3;PODXL2;SDHA;MGAT4B;GALNS;ABHD14B;ST6GALNAC6;B4GALT2;AGRN;ESYT2;ACP6;B4GALT6;IDUA;PFKFB2;RFNG;MLXIPL;ADA;MPI;UCKL1;AHCY;NECAB3;JAK3;MCFD2;PRKCD;FAM20C;BAX;CYC1;XYLT2;PPCS;DGUOK;DDIT4;NAGA;LTB4R2;MFNG;ALDOC;ST3GAL3;PPARA;COG7;ABCA7;NUDT14;UPP1;GLB1;NEIL1;APOBEC3C;APOBEC3F;INSR;TAZ;PFKM;ADCY1;TSTA3;VANGL2;PFKFB3;GABBR1;HYAL1;MAN2B1;NDST2;DLG3;ABHD10;NDUFV3;GAL3ST4;ADCY7;ALG12;ST3GAL2;CHST14;ST3GAL5;MAN2B2;AK3;CHPF;ADCY6;SDC2
18038,GO:1902531,0.000324065461666241,0.99976730810028,178,1314,regulation of intracellular signal transduction,BP,TNIP1;DUSP6;XDH;DUSP5;PDCD4;PRNP;VEGFA;WNT7A;APOE;F2R;OBSCN;PKN1;EGFR;SERPINE2;NOS1;SPRY2;MST1R;APPL2;SHC1;SPRY4;ARAP1;MAP2K2;LPAR3;RBCK1;MAP2K1;FBLN1;ARHGAP23;PIK3R2;ERCC6;HBEGF;FAM110C;S100A4;SHC2;ADORA2B;AKT1;STK39;ASAP2;EPHA1;WWC3;FGFR4;FGFR1;MAPKBP1;RAC2;SORL1;CEACAM1;ZNF385A;IGFBP4;PODNL1;SYNGAP1;CARD19;GAS6;PTK6;CARD11;DUSP7;PLEKHG2;MAPKAPK3;ARHGAP22;BCR;ERRFI1;AIP;RGL2;AGAP1;SLC20A1;DGKQ;PAK6;SHARPIN;PKD2;RASGEF1A;EPHB2;ADAM8;PLCG1;CD81;TIMP2;TMED4;TGFB1;ARHGAP25;RASA3;TNFSF15;ARAP3;FARP1;MC1R;RHOD;PLEKHG4;RHOF;PLEKHG3;RHOBTB2;TNFAIP8L1;PTPN1;WDR59;MBD3;IFNE;CAMK2N1;VHL;TRAP1;ADAP1;TRIB2;PRKCZ;PRKACA;MINK1;ADA;PIM2;PLEKHG5;BOK;ERBB2;NET1;RASA4;ARHGAP44;PRKCD;MIB2;BAX;ITGA1;SH3BP1;EREG;DUSP4;TMBIM4;DDIT4;PPP1R13L;GDI1;LEMD2;RPS6KA6;RGS14;GSTO1;GIT1;CHAD;IRAK1;TGFA;HDAC7;CHEK2;TMEM161A;SESN2;CDC34;ABCA7;BCAP31;MIF;PLA2G6;DDT;ECM1;WFS1;FYN;STK25;RAC3;ARHGAP12;ACAP3;DNM2;PELI1;CAT;IQSEC1;ARHGEF4;MAPK3;INSR;ARHGEF1;GRINA;C12ORF66;TMEM101;RALGAPA1;VANGL2;PAK1;SEMA4C;ITGA3;PPP2R5B;MAP2K3;BCL2L1;RRAS;KCTD13;TNFRSF25;TRIP10;RAP1GAP2;SOCS7;MAP3K10;NGFR;PDCD6;LURAP1;SIRT3;FGFR3;NDRG2;CBLC;ITPKB;LRRK1
4108,GO:0009165,0.000325148943399801,0.999837672139749,42,232,nucleotide biosynthetic process,BP,PGM1;APOE;IDH2;ACOT7;NOS1;TK2;NME4;NAPRT;NMRK1;ADORA2B;HK1;PTHLH;PFKL;PFKP;DHTKD1;NADK;PANK4;NPR2;APRT;TIMP2;TGFB1;PFKFB2;MLXIPL;ADA;UCKL1;CYC1;PPCS;DGUOK;DDIT4;LTB4R2;ALDOC;PPARA;UPP1;INSR;TAZ;PFKM;ADCY1;PFKFB3;GABBR1;NMNAT2;ADCY7;ADCY6
12313,GO:0048675,0.000325227974021653,0.999885602809814,21,87,axon extension,BP,SEMA4B;VEGFA;APOE;PTPRS;DVL1;TWF2;SEMA3F;PLXNB3;WNT3;ULK2;LAMB2;SEMA4F;ULK1;LIMK1;GDI1;DNM2;PAK1;PPP3CB;SEMA4C;CDH4;SEMA3B
2394,GO:0005539,0.000327290037451754,0.999877780438015,23,102,glycosaminoglycan binding,MF,PGF;PRNP;POSTN;VEGFA;APOE;SERPINE2;PTPRS;LTBP4;LTBP2;THBS3;HBEGF;HK1;VEGFB;FGFR4;FGFR1;SMOC2;FGFBP1;COL13A1;CEMIP;PODXL2;AGRN;TGFBR3;RNASE7
6288,GO:0019901,0.000328290473579789,0.999797861170302,82,526,protein kinase binding,MF,TNIP1;DOCK4;NEK9;PKN1;EGFR;SPRY2;MST1R;SHC1;TBC1D14;SLC12A7;ACTA2;EXOC2;SMAD3;PIK3R2;DVL1;AP2A2;SHC2;FBXW5;PAG1;AKT1;GRB7;HDAC5;FAM83A;PITPNM1;STK39;EPHA1;BRSK1;FGFR4;FGFR1;RAC2;CEACAM1;MICALCL;CCND1;TWF2;CEP250;GAS6;MAPKAPK3;ERRFI1;CDC25B;EPHB2;PLCG1;TMEM173;RHOD;RHOF;LLGL1;RHOBTB2;PTPN1;CAMK2N1;LRP4;TRAP1;PFKFB2;TRIB2;PRKCZ;PRKACA;TOM1L2;ERBB2;PRKCD;CACNB3;SV2A;DNM1;RGS14;HDAC7;CHEK2;PLA2G6;PITPNM3;RAC3;DNM2;SLC12A4;INSR;PAK1;MICAL1;MAP2K3;BCL2L1;PKD1;MAPRE3;PXN;GCH1;KIF13B;FGFR3;CBLC;SRSF5;ADCY6
3184,GO:0006811,0.000334778890374418,0.999774141839497,123,866,ion transport,BP,FHL1;SLC16A3;DLG4;CYP27B1;KCNG1;PRNP;SLC6A8;APOE;F2R;OSBPL5;PITPNC1;SLCO4A1;ITPR3;SERPINE2;SCN4B;NOS1;SLC2A9;PRSS8;ORAI3;ORAI1;SLC7A8;SLC12A7;SLC2A3;LPAR3;PLTP;CPT2;SLC16A5;KCNJ15;SHANK2;GJC2;NLGN2;STOM;SLC6A6;AKT1;TPCN1;KCNC4;TTYH3;S100A6;PITPNM1;BSG;STK39;SLC15A4;LRRC8A;CNTN1;MFSD3;LDLR;FGFR1;KCNAB2;CEACAM1;ABCD1;ANK3;GAS6;RAB3B;PCSK9;ANO8;CCS;SLC20A1;SNTA1;SERINC2;CEMIP;PKD2;EPHB2;GRIN3B;ASIC1;PLCG1;TGFB1;SLC43A1;SLC38A10;NTSR1;ATP7B;SHANK3;RASA3;CLCA2;OSBPL10;PRKACA;MINK1;ADA;VAMP2;TRPC1;SLC22A17;PRKCD;CACNB3;BAX;CYC1;SV2A;SLC13A5;SCN8A;GSTO1;EHD3;PPARA;ABCG1;ABCA7;MIF;SLC25A29;SLC9A7;PLA2G6;WFS1;SLC22A18;FYN;PITPNM3;DNM2;SLC27A1;SLC12A4;SLC13A3;ATP8B2;PRAF2;GLRX;SLC37A2;SLC16A13;DLG3;PKD1;AZIN2;SLC25A37;ATP6V1F;SLC39A3;HFE;TMCO3;MFSD10;HOMER2;SLC23A2;APBA1;SLC26A11;KLHL24
11148,GO:0045211,0.000336365438234051,0.999865387699574,26,118,postsynaptic membrane,CC,DLG4;PRR7;F2R;SH2D5;PTPRS;SHANK2;NLGN2;SIGMAR1;TENM2;ANK3;BCR;COL13A1;GRIN3B;ABHD17C;SHANK3;NSMF;SEMA4F;CAMK2N1;MINK1;DNM1;RGS14;DNM2;GABBR1;SEMA4C;DLG3;HOMER2
19471,GO:1990138,0.000342639903596686,0.999865608553493,25,112,neuron projection extension,BP,SEMA4B;POSTN;VEGFA;APOE;PTPRS;DVL1;IMPACT;TWF2;SEMA3F;PLXNB3;WNT3;ULK2;LAMB2;SEMA4F;PRKCZ;ULK1;CYFIP2;LIMK1;GDI1;DNM2;PAK1;PPP3CB;SEMA4C;CDH4;SEMA3B
4647,GO:0010771,0.000344681458980061,0.999894741466173,17,64,negative regulation of cell morphogenesis involved in differentiation,BP,SEMA4B;POSTN;PTPRS;NFATC4;FBLN1;SYNGAP1;SEMA3F;EPHB2;WNT3;ULK2;EFNB3;SEMA4F;LRP4;GDI1;SEMA4C;NGFR;SEMA3B
5165,GO:0015711,0.000345029882705602,0.999819915024066,47,264,organic anion transport,BP,SLC16A3;SLC6A8;APOE;OSBPL5;PITPNC1;SLCO4A1;SLC2A9;SLC7A8;SLC2A3;PLTP;CPT2;SLC16A5;SLC6A6;AKT1;PITPNM1;BSG;STK39;SLC15A4;LDLR;CEACAM1;ABCD1;SERINC2;SLC43A1;SLC38A10;NTSR1;OSBPL10;VAMP2;SLC22A17;PRKCD;SV2A;SLC13A5;PPARA;ABCG1;ABCA7;MIF;SLC25A29;PLA2G6;PITPNM3;SLC27A1;SLC13A3;ATP8B2;PRAF2;SLC16A13;MFSD10;SLC23A2;APBA1;SLC26A11
12774,GO:0051058,0.000345415106241534,0.999910144472364,14,47,negative regulation of small GTPase mediated signal transduction,BP,SPRY2;SPRY4;SYNGAP1;EPHB2;TIMP2;ARHGAP25;RASA3;ARAP3;RASA4;ARHGAP44;SH3BP1;ARHGAP12;ITGA3;KCTD13
4382,GO:0010035,0.000347693752459995,0.999806013371014,57,345,response to inorganic substance,BP,ERCC1;CST3;PRNP;NDRG1;ITPR3;EGFR;NFATC4;SDC1;TXNRD3;ENDOG;FOS;STAT6;ERCC6;CYBRD1;D2HGDH;AKT1;UROS;ENTPD6;BSG;IMPACT;ANK3;CCND1;MAPK13;GSN;IGFBP2;CCS;BNIP3;PKD2;ADAMTS13;ATP7B;ANKZF1;TRAP1;KDM6B;CD9;ADA;AREG;NET1;TRPC1;RASA4;PRKCD;CARF;MT2A;GDI1;CPNE7;STK25;EEF2K;DNM2;CAT;CYP2R1;MAPK3;ADCY1;DNMT3A;PDCD6;GCH1;HFE;ITPKB;LRP11
3448,GO:0007264,0.000349582267742242,0.999790532799764,73,456,small GTPase mediated signal transduction,BP,DOCK4;APOE;F2R;OBSCN;NISCH;SPRY2;APPL2;SHC1;SPRY4;RAPGEF3;ARAP1;ARHGAP23;PIK3R2;SHC2;ASAP2;RAB31;RAC2;RALGDS;DOCK6;SYNGAP1;RAB3B;PLEKHG2;MAPKAPK3;ARHGAP22;BCR;RGL2;AGAP1;PAK6;RASGEF1A;CDC42EP5;EPHB2;TIMP2;ARHGAP25;RASA3;ARAP3;FARP1;RHOD;PLEKHG4;RHOF;PLEKHG3;RHOBTB2;ADAP1;PLEKHG5;NET1;RASA4;ARHGAP44;SH3BP1;LIMK1;GDI1;GIT1;RAB12;RAC3;ARHGAP12;ACAP3;DNM2;IQSEC1;ARHGEF4;ARHGEF1;DOCK9;RALGAPA1;VANGL2;PAK1;ITGA3;RRAS;KCTD13;TRIP10;RAB28;RAP1GAP2;RGS19;RAB40B;NGFR;CELSR1;ITPKB
147,GO:0000302,0.000354455687393261,0.999841313292794,32,165,response to reactive oxygen species,BP,CST3;APOE;EGFR;SDC1;TXNRD3;ENDOG;FOS;STAT6;ERCC6;PRDX5;AKT1;IMPACT;MAPK13;CCS;BNIP3;PKD2;ANKZF1;TRAP1;KDM6B;ADA;AREG;NET1;PRKCD;SESN2;STK25;DNM2;CAT;MAPK3;CAMKK2;HYAL1;PXN;GCH1
17568,GO:1901137,0.000367605088112839,0.999771125776334,84,551,carbohydrate derivative biosynthetic process,BP,TNIP1;NT5E;PGM1;APOE;PYGL;ACOT7;NOS1;SDC1;LMF1;TK2;ST6GALNAC2;NME4;CRYL1;SRD5A3;PIGQ;HBEGF;ADORA2B;HK1;VEGFB;PTHLH;PFKL;B4GAT1;PIGV;B3GAT3;PFKP;DHTKD1;PHLDA1;PANK4;NPR2;CEMIP;APRT;MVD;ADAMTS13;TIMP2;TGFB1;GPC1;ADAMTS7;B3GNT3;MGAT4B;ST6GALNAC6;B4GALT2;AGRN;B4GALT6;PFKFB2;RFNG;MLXIPL;ADA;MPI;UCKL1;NECAB3;JAK3;MCFD2;CYC1;XYLT2;PPCS;DDIT4;LTB4R2;MFNG;ALDOC;ST3GAL3;PPARA;COG7;ABCA7;NUDT14;UPP1;INSR;TAZ;PFKM;ADCY1;TSTA3;VANGL2;PFKFB3;GABBR1;HYAL1;NDST2;GAL3ST4;ADCY7;ALG12;ST3GAL2;CHST14;ST3GAL5;CHPF;ADCY6;SDC2
12850,GO:0051179,0.000379276632864476,0.99969647464874,514,4334,localization,BP,XDH;ZMYND8;SEMA4B;FHL1;NR1D1;SLC16A3;EDEM1;DLG4;PLAT;CST3;CYP27B1;MRC2;MARVELD1;APLN;PGF;KCNG1;ACVR2B;DOCK4;PRNP;PYGB;BBS2;SLC6A8;POSTN;VEGFA;PGM1;WNT7A;APOE;PYGL;TSPAN1;F2R;LRP5;OSBPL5;ITGA6;PITPNC1;OBSCN;IDH2;SLCO4A1;ITPR3;PKN1;ARRDC1;EVI5L;NISCH;FCGRT;EGFR;SERPINE2;SCN4B;OBSL1;NOS1;VAT1;TMEM129;SLC2A9;HADH;SPRY2;LRP3;LTBP4;PRSS8;SYTL1;SDC1;ETV5;LMF1;ORAI3;APPL2;SHC1;ORAI1;LTBP2;VPS11;LTBP1;TBC1D14;ARL2;HEXB;SLC7A8;SLC12A7;SLC2A3;RIN1;MMP1;PHLDA2;SNX9;NUDCD3;RAPGEF3;ZFP36L1;GAA;GLUL;ARAP1;MAP2K2;NME4;LPAR3;MDFI;PLTP;MAP2K1;NAPRT;CPT2;MCTP1;SSH1;POU2F2;EXOC2;MARK4;SLC16A5;KCNJ15;SMURF2;KLC2;FBLN1;SMAD3;SHANK2;PIK3R2;LRP1;GJC2;DVL1;HBEGF;FAM110C;AP2A2;ITGB4;SH3PXD2B;NLGN2;STOM;MBOAT7;ADORA2B;ADARB1;SYT8;SLC6A6;AKT1;TPCN1;GRB7;KCNC4;CORO1B;TTYH3;HDAC5;S100A6;PPM1F;MMP28;PITPNM1;RHBDF2;BSG;STK39;HK1;SERPING1;ASAP2;DYSF;EPHA1;PTPRU;VEGFB;SLC15A4;ATG16L2;ZFYVE21;LRRC8A;CNTN1;BRSK1;IFT140;MFSD3;RAB31;FGFR4;PEAR1;LDLR;FGFR1;FUCA1;MAPKBP1;ELMO3;SIGMAR1;RAC2;KCNAB2;PFKL;MXI1;NPHP4;SYNE3;PACS2;TOMM34;SORL1;CEACAM1;B3GAT3;LZTS2;RAB11FIP4;ZNF385A;ABCD1;ANK3;TTC7B;TRAPPC9;CCND1;EFS;TWF2;STRADB;SYNGAP1;CEP250;EDNRA;PLAU;GAS6;PTK6;SEMA3F;CSNK1E;BRI3;CTSB;RAB3B;CARD11;LAMA5;GSN;MAPKAPK3;PCSK9;ANO8;BCR;ANTXR2;XPOT;EHD4;SEPT10;WIPF1;AIP;STON1;ARPIN;ARHGAP27;ALOX15B;SPTB;AGAP1;PEX10;CCS;CORO7;SLC20A1;UNC119B;SNTA1;PLXNB3;BNIP3;PAK6;MVB12B;SERINC2;FYCO1;CEMIP;PROCR;PKD2;RASGEF1A;CTSZ;AP3D1;ABCA2;PRSS3;EPHB2;GRIN3B;ADAM8;ASIC1;APRT;LTA4H;PLCG1;KIF17;CD81;SLC29A4;TIMP2;WNT3;DPP7;TMED4;TGFB1;SNPH;CLTCL1;SCYL1;ABHD17C;SLC43A1;UNK;GPC1;MOAP1;TBC1D9B;SLC38A10;NTSR1;TMEM173;ARHGAP25;ATP7B;SHANK3;PODXL2;RASA3;MIPEP;GALNS;CLCA2;NSMF;ARAP3;SCART1;TUB;CROCC;RHOD;TNS1;SNX17;DNAH1;VGF;SNX33;PI4K2A;SEMA4F;RHOF;SLC48A1;LLGL1;RHOBTB2;RIMS3;BBS1;PTPN1;PEX1;PCK2;AGRN;CD320;OSBPL10;LRP4;LRP10;ESYT2;ZDHHC24;CEP131;ADAP1;PFKFB2;YPEL5;PRKCZ;PRKACA;MINK1;OXA1L;ACTR1B;TOM1L2;CD9;EPN2;ADA;AREG;MICALL2;PLEKHG5;BOK;SDCCAG8;NEURL1B;ERBB2;ULK1;NINL;VAMP2;MMP10;TFDP2;NECAB3;RILPL1;JAK3;NET1;BNIP3L;CYFIP2;FSCN1;TRPC1;SLC22A17;CYGB;ARHGAP44;MCFD2;PRKCD;REEP6;CACNB3;USP20;BAX;CYC1;SV2A;SLC13A5;ITGA1;OLFM2;SH3BP1;EREG;TIMM17B;DDIT4;IER2;RASL10B;ZDHHC8;FCHO1;LIMK1;TGFBR3;GDI1;LTB4R2;SLC2A11;LEMD2;DNM1;WASH3P;RGS14;SCN8A;GSTO1;GIT1;ALDOC;LPCAT1;LRSAM1;ADAM15;REEP2;EHD3;WDR60;TMEM231;LONP2;SYMPK;TGFA;HDAC7;FHOD1;INPP5D;CACFD1;PPARA;COG7;SESN2;ABCG1;MYO1D;ABCA7;RAB12;BCAP31;MIF;SLC25A29;DOPEY2;SLC9A7;PLA2G6;DDT;SYNGR1;ECM1;WFS1;QSOX1;CD68;SLC22A18;NBPF3;FYN;PITPNM3;STK25;RAC3;TMCO6;EEF2K;SUN1;ICAM5;ARHGAP12;ACAP3;ARID5B;DNM2;GLB1;SNX15;CHKA;CAT;KIAA1147;SLC27A1;SLC50A1;KIF26A;ZDHHC1;SLC12A4;MAPK3;INSR;SLC13A3;RTN2;PFKM;TNS4;C12ORF66;RERE;STX10;ATP8B2;PDXK;PRAF2;GLRX;CEP72;VANGL2;PAK1;MALL;RNASET2;PPP3CB;LGALS3BP;ROBO4;SLC37A2;MICAL1;HYAL1;SEMA4C;ITGA3;BIN1;VPS16;MAN2B1;SLC16A13;MAP2K3;BCL2L1;DLG3;SGSM2;RRAS;DNASE1L1;PROX1;MDGA1;TBC1D16;LMNA;PKD1;KCTD13;RABGAP1;FAM129B;ITGA4;TRIP10;MAPRE3;AZIN2;RAB28;SERPINB1;ICA1;SLC25A37;LAMB1;SOCS7;NDE1;RAB40B;NGFR;TOLLIP;PDCD6;ATP6V1F;PCLO;PXN;GRB10;TBC1D8;PLEKHM1;LURAP1;KIF13B;TCTN1;NBEAL2;CAMK1;SLC39A3;SIRT3;HFE;WIPI2;BTG1;ZP3;VPS51;TMCO3;CELSR1;SEMA3B;SEPT6;PFN2;SLC35F3;MFSD10;TST;CCDC88C;BLOC1S4;TRIM46;HOMER2;SLC23A2;PKN3;APBA1;SRSF5;SLC26A11;KLHL24;SDC2
81,GO:0000165,0.000382852559075385,0.999756747668496,91,607,MAPK cascade,BP,TNIP1;DUSP6;XDH;DUSP5;DLG4;PDCD4;VEGFA;WNT7A;APOE;F2R;PKN1;EGFR;SPRY2;MST1R;SHC1;SPRY4;ZFP36L1;MAP2K2;LPAR3;MAP2K1;FBLN1;PIK3R2;ERCC6;HBEGF;SHC2;ADORA2B;AKT1;STK39;EPHA1;FGFR4;FGFR1;SORL1;CEACAM1;IGFBP4;SYNGAP1;MAPK13;GAS6;DUSP7;MAPKAPK3;ERRFI1;SPTB;PAK6;RASGEF1A;CDC42EP5;EPHB2;ADAM8;PLCG1;CD81;TIMP2;TGFB1;SHANK3;RASA3;PTPN1;CAMK2N1;TRIB2;PRKCZ;MINK1;ERBB2;JAK3;RASA4;PRKCD;ITGA1;EREG;DUSP4;LEMD2;RPS6KA6;RGS14;MAPK12;IRAK1;TGFA;ABCA7;MIF;DDT;FYN;STK25;MAPK3;INSR;VANGL2;PAK1;CAMKK2;SEMA4C;MAP2K3;RRAS;TNFRSF25;MAP3K10;NGFR;SIRT3;FGFR3;NDRG2;CBLC;ITPKB
10375,GO:0043202,0.000390596560757224,0.999873904725591,18,71,lysosomal lumen,CC,NAGLU;SDC1;HEXB;GAA;FUCA1;CTSB;GPC1;GALNS;TPP1;AGRN;IDUA;GLB1;RNASET2;CTSF;HYAL1;MAN2B1;MAN2B2;SDC2
13262,GO:0051960,0.000392451545432475,0.999754518270609,85,551,regulation of nervous system development,BP,ZMYND8;ADGRL1;SEMA4B;DLG4;VEGFA;WNT7A;APOE;IDH2;SERPINE2;OBSL1;NOS1;PTPRS;NFATC4;ETV5;LPAR3;MAP2K1;SSH1;SHANK2;LRP1;GJC2;DVL1;NLGN2;AKT1;IMPACT;CNTN1;LDLR;FGFR1;PRKACB;SORL1;HMG20B;TWF2;SYNGAP1;PTK6;SEMA3F;CSNK1E;SLITRK6;PLXNB3;CTSZ;CRTC1;FBXW8;EPHB2;TIMP2;WNT3;TGFB1;ULK2;SHANK3;EFNB3;NSMF;SEMA4F;WASF3;AGRN;LRP4;ADGRB2;ARHGAP44;DGUOK;LIMK1;GDI1;RGS14;FYN;STK25;RAC3;EEF2K;DNM2;TPBG;VANGL2;PAK1;CUL7;SEMA4C;CAPRIN2;ITGA3;BIN1;PPP2R5B;PROX1;SIRT2;CDH4;RAP1GAP2;NGFR;KIF13B;CAMK1;CELSR1;SEMA3B;SSH3;PLAG1;ADCY6;SDC2
6628,GO:0023014,0.000394156110036766,0.999748082721345,93,623,signal transduction by protein phosphorylation,BP,TNIP1;DUSP6;XDH;DUSP5;DLG4;PDCD4;ACVR2B;VEGFA;WNT7A;APOE;F2R;PKN1;EGFR;SPRY2;MST1R;SHC1;SPRY4;ZFP36L1;MAP2K2;LPAR3;MAP2K1;FBLN1;PIK3R2;ERCC6;HBEGF;SHC2;ADORA2B;AKT1;STK39;EPHA1;FGFR4;FGFR1;SORL1;CEACAM1;IGFBP4;STRADB;SYNGAP1;MAPK13;GAS6;DUSP7;MAPKAPK3;ERRFI1;SPTB;PAK6;RASGEF1A;CDC42EP5;EPHB2;ADAM8;PLCG1;CD81;TIMP2;TGFB1;SHANK3;RASA3;PTPN1;CAMK2N1;TRIB2;PRKCZ;MINK1;ERBB2;JAK3;RASA4;PRKCD;ITGA1;EREG;DUSP4;LEMD2;RPS6KA6;RGS14;MAPK12;IRAK1;TGFA;ABCA7;MIF;DDT;FYN;STK25;MAPK3;INSR;VANGL2;PAK1;CAMKK2;SEMA4C;MAP2K3;RRAS;TNFRSF25;MAP3K10;NGFR;SIRT3;FGFR3;NDRG2;CBLC;ITPKB
10499,GO:0043408,0.000402143141862683,0.999755924780116,75,477,regulation of MAPK cascade,BP,TNIP1;DUSP6;XDH;DUSP5;PDCD4;VEGFA;WNT7A;APOE;F2R;PKN1;EGFR;SPRY2;MST1R;SHC1;SPRY4;MAP2K2;LPAR3;MAP2K1;FBLN1;PIK3R2;ERCC6;SHC2;ADORA2B;AKT1;STK39;EPHA1;FGFR4;FGFR1;SORL1;CEACAM1;IGFBP4;SYNGAP1;GAS6;DUSP7;MAPKAPK3;ERRFI1;PAK6;EPHB2;ADAM8;PLCG1;CD81;TIMP2;TGFB1;PTPN1;CAMK2N1;TRIB2;PRKCZ;MINK1;ERBB2;PRKCD;ITGA1;DUSP4;LEMD2;RPS6KA6;RGS14;IRAK1;TGFA;ABCA7;MIF;DDT;STK25;MAPK3;INSR;VANGL2;PAK1;SEMA4C;MAP2K3;RRAS;TNFRSF25;MAP3K10;NGFR;SIRT3;FGFR3;NDRG2;CBLC
12297,GO:0048646,0.000405676314242798,0.999734580966651,103,695,anatomical structure formation involved in morphogenesis,BP,DUSP6;ERCC1;DUSP5;SDK2;HTRA1;APLN;PGF;ACVR2B;VEGFA;WNT7A;ITGA6;HMGA2;OBSCN;ELK3;PKN1;OBSL1;NOS1;SPRY2;CAPN2;NFATC4;SHC1;RAPGEF3;PLCD3;MAP2K1;SMAD3;DVL1;EPAS1;THBS3;ITGB4;MBOAT7;TMOD2;HDAC5;SH2D2A;EPHA1;VEGFB;FGFR4;WNT2B;FGFR1;PRKACB;CEACAM1;ZNF385A;TNNT1;EDNRA;LAMA5;ARHGAP22;ANGPTL4;ITGB5;SH3PXD2A;EPHB2;ADAM8;PLCG1;WNT3;TGFB1;RFX2;GPC1;DEAF1;FHOD3;KIF26B;RNH1;KDM6B;CD9;EPN2;ADA;SDCCAG8;ERBB2;ADGRB2;FAM20C;EREG;DUSP4;AHNAK2;TGFBR3;LEMD2;CHAD;ADAM15;HDAC7;ZFPM1;PPARA;SOX7;ECM1;MAPK3;VANGL2;PPP3CB;ROBO4;HYAL1;SEMA4C;HES7;ITGA3;RRAS;PROX1;FAM129B;ITGA4;EDA;LAMB1;SOCS7;NGFR;PDCD6;TCTN1;NBEAL2;CAMK1;COL6A1;BTG1;ZP3;CELSR1
12911,GO:0051270,0.000411208175975325,0.999737355649984,92,613,regulation of cellular component movement,BP,ZMYND8;SEMA4B;PGF;DOCK4;BBS2;POSTN;VEGFA;WNT7A;APOE;F2R;ITGA6;IDH2;PKN1;NISCH;EGFR;SERPINE2;SPRY2;PHLDA2;ARAP1;MCTP1;SSH1;SMURF2;FBLN1;SMAD3;LRP1;HBEGF;FAM110C;ADARB1;AKT1;GRB7;CORO1B;HDAC5;PPM1F;MMP28;EPHA1;PTPRU;VEGFB;FGFR1;RAC2;SORL1;CEACAM1;PLAU;GAS6;SEMA3F;LAMA5;BCR;ARPIN;ALOX15B;PLXNB3;CEMIP;ADAM8;PLCG1;CD81;WNT3;TGFB1;NSMF;ARAP3;RHOD;SEMA4F;RHOF;RHOBTB2;MINK1;CD9;ADA;ERBB2;MMP10;CYGB;SH3BP1;EREG;TGFBR3;ADAM15;HDAC7;MIF;DDT;ECM1;MAPK3;INSR;PAK1;ROBO4;HYAL1;SEMA4C;ITGA3;MAP2K3;RRAS;PROX1;LMNA;ITGA4;LAMB1;PDCD6;ZP3;SEMA3B;PFN2
5378,GO:0016192,0.000438801636333534,0.999679051746848,192,1449,vesicle-mediated transport,BP,DLG4;CST3;MRC2;APLN;PYGB;BBS2;VEGFA;PGM1;APOE;PYGL;TSPAN1;LRP5;OSBPL5;EVI5L;FCGRT;VAT1;LRP3;SYTL1;SDC1;LMF1;APPL2;VPS11;TBC1D14;HEXB;SLC2A3;RIN1;SNX9;GAA;ARAP1;MAP2K2;MAP2K1;NAPRT;MCTP1;EXOC2;KLC2;PIK3R2;LRP1;AP2A2;NLGN2;STOM;ADORA2B;SYT8;SERPING1;ASAP2;DYSF;VEGFB;SLC15A4;ZFYVE21;RAB31;PEAR1;LDLR;FUCA1;ELMO3;RAC2;KCNAB2;PFKL;SORL1;CEACAM1;RAB11FIP4;ANK3;TRAPPC9;PLAU;GAS6;CSNK1E;BRI3;CTSB;RAB3B;GSN;MAPKAPK3;PCSK9;BCR;EHD4;WIPF1;STON1;ARHGAP27;SPTB;AGAP1;CORO7;MVB12B;CTSZ;AP3D1;PRSS3;ADAM8;APRT;LTA4H;PLCG1;KIF17;CD81;TIMP2;DPP7;TMED4;TGFB1;SNPH;CLTCL1;SCYL1;TBC1D9B;TMEM173;ARHGAP25;GALNS;ARAP3;SCART1;TUB;SNX17;SNX33;PI4K2A;RHOF;LLGL1;RIMS3;BBS1;PTPN1;LRP4;LRP10;ESYT2;ADAP1;YPEL5;ACTR1B;CD9;EPN2;AREG;MICALL2;NEURL1B;VAMP2;CYFIP2;ARHGAP44;MCFD2;PRKCD;USP20;SH3BP1;FCHO1;LIMK1;DNM1;WASH3P;GIT1;ALDOC;LPCAT1;LRSAM1;EHD3;TGFA;CACFD1;COG7;MYO1D;ABCA7;RAB12;BCAP31;MIF;DOPEY2;PLA2G6;SYNGR1;ECM1;QSOX1;CD68;FYN;RAC3;EEF2K;ICAM5;ARHGAP12;ACAP3;DNM2;GLB1;CAT;KIF26A;MAPK3;STX10;PDXK;PAK1;RNASET2;PPP3CB;LGALS3BP;MICAL1;BIN1;VPS16;MAN2B1;BCL2L1;SGSM2;DNASE1L1;TBC1D16;RABGAP1;ITGA4;TRIP10;SERPINB1;RAB40B;TOLLIP;PDCD6;PCLO;TBC1D8;NBEAL2;HFE;ZP3;VPS51;PFN2;BLOC1S4;TRIM46
17202,GO:0106027,0.000445556398134556,0.999873149563218,15,54,neuron projection organization,BP,ZMYND8;DLG4;PRNP;WNT7A;APOE;SHANK2;DVL1;EPHB2;SHANK3;ARHGAP44;FYN;EEF2K;INSR;CAPRIN2;ITGA3
12615,GO:0050808,0.000451775970872576,0.99978681209428,35,181,synapse organization,BP,SDK2;ZMYND8;ADGRL1;DLG4;PRNP;WNT7A;APOE;F2R;NFATC4;ETV5;SSH1;SHANK2;DVL1;NLGN2;ANK3;SLITRK6;EPHB2;SHANK3;FARP1;LAMB2;AGRN;LRP4;ERBB2;ADGRB2;ARHGAP44;CACNB3;FYN;EEF2K;TPBG;INSR;CAPRIN2;ITGA3;ADGRF1;PCLO;CAMK1
9829,GO:0042060,0.000454396365948582,0.999744957254145,56,340,wound healing,BP,PLAT;POSTN;WNT7A;APOE;DGKA;F2R;ELK3;ITPR3;EGFR;SERPINE2;SDC1;FBLN1;SMAD3;HBEGF;AKT1;CORO1B;F12;SERPING1;DYSF;PRKACB;RAC2;CEACAM1;HMG20B;DOCK6;PLAU;GAS6;SH2B3;GSN;DGKQ;TFPI2;PROCR;ENTPD2;ADAMTS13;TGFB1;PHF21A;PRKACA;CD9;ERBB2;C6ORF89;PRKCD;EREG;ADAM15;EHD3;ZFPM1;PPARA;FYN;MAPK3;DOCK9;VANGL2;PAK1;MICAL1;DCBLD2;MAFF;CELSR1;BLOC1S4;AK3
15816,GO:0072522,0.000458277784238653,0.999783168026506,35,186,purine-containing compound biosynthetic process,BP,NT5E;PGM1;APOE;ACOT7;NOS1;NME4;ADORA2B;HK1;PTHLH;PFKL;PFKP;DHTKD1;PANK4;NPR2;APRT;TIMP2;TGFB1;PFKFB2;MLXIPL;ADA;CYC1;PPCS;DGUOK;DDIT4;LTB4R2;ALDOC;PPARA;INSR;TAZ;PFKM;ADCY1;PFKFB3;GABBR1;ADCY7;ADCY6
11822,GO:0046777,0.00046903255030163,0.99978104753281,34,173,protein autophosphorylation,BP,VEGFA;EGFR;MAP2K2;AKT1;STK39;EPHA1;IMPACT;FGFR4;FGFR1;PTK6;MAPKAPK3;BCR;ERRFI1;ULK2;MKNK2;MINK1;PIM2;ERBB2;ULK1;JAK3;IRAK1;CHEK2;FYN;STK25;EEF2K;MAPK3;INSR;PAK1;CAMKK2;SRMS;PPP2R5B;MAP3K10;FGFR3;CLK3
15474,GO:0071825,0.000476847944259924,0.999918483221196,9,24,protein-lipid complex subunit organization,BP,APOE;SNX9;PLTP;PRKACB;PRKACA;ZDHHC8;ABCG1;ABCA7;BIN1
10515,GO:0043436,0.000480189378130211,0.999676200288818,116,818,oxoacid metabolic process,BP,NR1D1;SLC16A3;TYSND1;NAGS;SLC6A8;PGM1;IDH2;CRAT;ACOT7;ACSF2;NOS1;HADH;CRTAP;HEXB;SLC7A8;SLC2A3;ALDH4A1;GLUL;PC;CRYL1;CPT2;HSD17B8;PRODH;D2HGDH;SLC6A6;AKT1;UROS;PYCR2;BSG;HK1;GGT1;FGFR4;ACOT1;PFKL;GAMT;B4GAT1;BPHL;CEACAM1;B3GAT3;CBR4;ABCD1;AIG1;PFKP;DHTKD1;HLCS;ALOX15B;HAGH;CEMIP;ACY1;LTA4H;CBS;TGFB1;B3GNT3;PODXL2;SDHA;MDH2;GALNS;ABHD14B;ERO1B;PHGDH;HMGCL;PCK2;B4GALT2;B4GALT6;IDUA;PFKFB2;MLXIPL;GRHPR;AHCY;PDK1;ACAD10;CYGB;XYLT2;DDIT4;ACADS;CES2;GSTO1;ALDOC;ST3GAL3;LONP2;MTHFR;DECR2;PPARA;SESN2;MIF;ACO2;PHYH;DALRD3;ETFB;CKMT1A;GLB1;SLC27A1;MAPK3;INSR;PFKM;GPT2;PFKFB3;MLYCD;HYAL1;WDTC1;NDST2;ABHD10;PROX1;IARS2;ALDH7A1;NMNAT2;AZIN2;ST3GAL2;CHST14;PHYKPL;GCH1;PTGR2;PM20D2;SLC23A2;CHPF;AARS
6300,GO:0019932,0.000484779104448264,0.999778844165318,32,164,second-messenger-mediated signaling,BP,ADGRL1;PRNP;APOE;ITPR3;EGFR;NOS1;NFATC4;RAPGEF3;MCTP1;ADORA2B;PTHLH;DGKQ;PKD2;PLCG1;GNAL;MC1R;PRKACA;ADA;ADGRB2;TMBIM4;GSTO1;CDC34;BCAP31;ADCY1;CAMKK2;PPP3CB;ADGRF1;ADCY7;GPR3;PCLO;HOMER2;ADCY6
14717,GO:0070373,0.000488064332810788,0.999867347092474,14,49,negative regulation of ERK1 and ERK2 cascade,BP,TNIP1;DUSP6;SPRY2;SPRY4;FBLN1;ERRFI1;EPHB2;PTPN1;CAMK2N1;DUSP4;RPS6KA6;RGS14;SIRT3;NDRG2
11643,GO:0046390,0.000514884432746949,0.999754627336064,35,187,ribose phosphate biosynthetic process,BP,PGM1;APOE;PYGL;ACOT7;NOS1;NME4;ADORA2B;HK1;PTHLH;PFKL;PFKP;DHTKD1;PANK4;NPR2;APRT;TIMP2;TGFB1;PFKFB2;MLXIPL;UCKL1;CYC1;PPCS;DDIT4;LTB4R2;ALDOC;PPARA;UPP1;INSR;TAZ;PFKM;ADCY1;PFKFB3;GABBR1;ADCY7;ADCY6
12670,GO:0050890,0.000545810289901726,0.999752758898104,31,157,cognition,BP,DLG4;PRNP;APOE;ITPR3;EGFR;FOS;SHANK2;TMOD2;LDLR;RAG1;ZNF385A;SYNGAP1;CRTC1;EPHB2;ASIC1;CEBPB;DEAF1;NTSR1;SHANK3;B4GALT2;PRKCZ;RGS14;ABCA7;DOPEY2;PLA2G6;FYN;INSR;ADCY1;PPP3CB;ITGA3;ADGRF1
6050,GO:0019199,0.000545879716124548,0.999849857361576,14,49,transmembrane receptor protein kinase activity,MF,ACVR2B;EGFR;MST1R;LTBP4;LTBP1;EPHA1;FGFR4;FGFR1;EPHB2;EFNB3;ERBB2;TGFBR3;INSR;FGFR3
18440,GO:1903510,0.000551407316712668,0.999809282007495,19,78,mucopolysaccharide metabolic process,BP,HEXB;AKT1;B4GAT1;B3GAT3;CEMIP;TGFB1;B3GNT3;GALNS;B4GALT2;B4GALT6;IDUA;XYLT2;ST3GAL3;GLB1;HYAL1;NDST2;ST3GAL2;CHST14;CHPF
16970,GO:0098984,0.000563270985388628,0.999744578283318,31,155,neuron to neuron synapse,CC,DLG4;PRNP;SH2D5;NOS1;PTPRS;SHANK2;DVL1;NLGN2;SIGMAR1;KCNAB2;SYNGAP1;BCR;BNIP3;SHARPIN;ABHD17C;NTSR1;SHANK3;NSMF;CAMK2N1;LRP4;MINK1;ARHGAP44;DNM1;RGS14;FYN;EEF2K;DNM2;SEMA4C;DLG3;PCLO;HOMER2
16449,GO:0097113,0.000570138110676659,0.999986867450317,4,5,AMPA glutamate receptor clustering,BP,DLG4;APOE;SSH1;SHANK3
16706,GO:0097688,0.000570138110676659,0.999986867450317,4,5,glutamate receptor clustering,BP,DLG4;APOE;SSH1;SHANK3
6857,GO:0030334,0.000575580369684089,0.999637768302671,82,539,regulation of cell migration,BP,ZMYND8;SEMA4B;PGF;DOCK4;POSTN;VEGFA;WNT7A;APOE;F2R;ITGA6;IDH2;NISCH;EGFR;SERPINE2;SPRY2;PHLDA2;MCTP1;SSH1;SMURF2;SMAD3;LRP1;HBEGF;FAM110C;ADARB1;AKT1;GRB7;CORO1B;HDAC5;PPM1F;MMP28;EPHA1;PTPRU;VEGFB;FGFR1;RAC2;SORL1;CEACAM1;PLAU;GAS6;SEMA3F;LAMA5;BCR;ARPIN;ALOX15B;PLXNB3;CEMIP;ADAM8;PLCG1;TGFB1;NSMF;ARAP3;RHOD;SEMA4F;RHOF;RHOBTB2;MINK1;ADA;MMP10;CYGB;SH3BP1;ADAM15;HDAC7;MIF;DDT;ECM1;MAPK3;INSR;PAK1;ROBO4;HYAL1;SEMA4C;ITGA3;MAP2K3;RRAS;PROX1;LMNA;ITGA4;LAMB1;PDCD6;ZP3;SEMA3B;PFN2
13898,GO:0060560,0.000577445044958631,0.999737610577759,31,156,developmental growth involved in morphogenesis,BP,SEMA4B;POSTN;VEGFA;APOE;PTPRS;SPRY2;LPAR3;DVL1;IMPACT;TWF2;SEMA3F;PLXNB3;WNT3;TGFB1;ULK2;KIF26B;LAMB2;SEMA4F;PRKCZ;AREG;ULK1;CYFIP2;LIMK1;GDI1;DNM2;VANGL2;PAK1;PPP3CB;SEMA4C;CDH4;SEMA3B
11731,GO:0046578,0.000588588747431257,0.999714444645692,36,189,regulation of Ras protein signal transduction,BP,APOE;F2R;OBSCN;SPRY2;APPL2;SPRY4;ARAP1;ASAP2;SYNGAP1;PLEKHG2;BCR;RGL2;AGAP1;RASGEF1A;EPHB2;TIMP2;RASA3;ARAP3;FARP1;PLEKHG4;PLEKHG3;ADAP1;PLEKHG5;NET1;RASA4;ARHGAP44;SH3BP1;GIT1;ACAP3;DNM2;IQSEC1;ARHGEF4;ARHGEF1;ITGA3;KCTD13;ITPKB
10681,GO:0043954,0.000599685927109457,0.999894002217231,9,24,cellular component maintenance,BP,ZMYND8;PRNP;APOE;F2R;NLGN2;MTHFR;FYN;INSR;ITGA3
16879,GO:0098815,0.000605316636717568,0.999892860436287,9,24,modulation of excitatory postsynaptic potential,BP,ZMYND8;DLG4;WNT7A;SSH1;SHANK2;DVL1;NLGN2;SHANK3;PRKCZ
1876,GO:0004553,0.000609214545723334,0.999811203706904,16,61,hydrolase activity, hydrolyzing O-glycosyl compounds,MF,EDEM1;NAGLU;HEXB;GAA;CTBS;FUCA1;CEMIP;HEXDC;IDUA;NAGA;GLB1L2;GLB1;HYAL1;MAN2B1;ABHD10;MAN2B2
12412,GO:0048871,0.00061350714240867,0.999697929379857,37,200,multicellular organismal homeostasis,BP,NR1D1;APLN;BBS2;VEGFA;F2R;EGFR;ACP5;ERCC6;EPAS1;STK39;PRKACB;RAC2;NPHP4;CRTC1;IL20RB;ADAM8;NTSR1;TUB;CROCC;BBS1;TPP1;PRKACA;BAX;PPP1R13L;LPCAT1;INPP5D;WFS1;RAC3;SLC27A1;ADCY1;ADCY7;PLEKHM1;HFE;BBS10;HOMER2;ADCY6;LRRK1
17037,GO:0099503,0.000615913062283149,0.999602764802034,90,616,secretory vesicle,CC,DLG4;PLAT;CST3;PYGB;VEGFA;PGM1;PYGL;ITPR3;SERPINE2;LOXL1;VAT1;PTPRS;SYTL1;HEXB;SLC2A3;GAA;NAPRT;MCTP1;AP2A2;STOM;LY6K;SYT8;BSG;SERPING1;VEGFB;SLC15A4;BRSK1;RAB31;FUCA1;KCNAB2;PFKL;CEACAM1;PLAU;GAS6;BRI3;CTSB;RAB3B;GSN;DBNDD1;PCSK1;CTSZ;PRSS3;ADAM8;APRT;LTA4H;TIMP2;DPP7;TGFB1;TMEM173;GALNS;PI4K2A;RHOF;CEP131;YPEL5;PRKACA;ACTR1B;CD9;VAMP2;RNPEP;PRKCD;SV2A;ITGA1;PCSK1N;DNM1;ALDOC;LPCAT1;ADAM15;MIF;SYNGR1;ECM1;QSOX1;CD68;SUN1;GLB1;CAT;PDXK;RNASET2;LGALS3BP;SEMA4C;MAN2B1;BCL2L1;DNASE1L1;SERPINB1;ICA1;RAB40B;TOLLIP;NBEAL2;SEPT6;CLK3;APBA1
10251,GO:0042995,0.000619368723075023,0.999548361902434,177,1319,cell projection,CC,ZMYND8;ADGRL1;NR1D1;DLG4;CST3;FBXO2;PRR7;DOCK4;PRNP;PARVB;BBS2;APOE;ESPN;ITGA6;NOS1;PTPRS;ANKS6;SPRY2;CAPN2;SYTL1;ACTA2;SNX9;SPRY4;RAPGEF3;GLUL;LPAR3;SSH1;MARK4;FOS;SHANK2;LRP1;GJC2;DVL1;S100A4;CYBRD1;SH3PXD2B;AKT1;GRB7;KCNC4;TMOD2;CORO1B;S100A6;HK1;DYSF;EPHA1;IFT140;PRKACB;SIGMAR1;RAC2;KCNAB2;NPHP4;CEACAM1;TENM2;ZNF385A;ANK3;EVC;TWF2;SYNGAP1;CEP250;PTK6;GSN;WIPF1;ARPIN;RSPH3;UNC119B;BNIP3;SHARPIN;PKD2;CTSZ;CRTC1;AP3D1;SH3PXD2A;EPHB2;PLCG1;KIF17;TIMP2;SYNJ2;TGFB1;SNPH;ABHD17C;NTSR1;SHANK3;PIP5KL1;NSMF;ARAP3;FARP1;TUB;CROCC;DNAH1;HTR7;PI4K2A;WASF3;LLGL1;KIF7;BBS1;CAMK2N1;LRP4;CEP131;PRKCZ;PRKACA;MINK1;ADA;MICALL2;PLEKHG5;ULK1;AHCY;VAMP2;PLEK2;RILPL1;CYFIP2;FSCN1;CYGB;ARHGAP44;REEP6;SV2A;ITGA1;NUBP2;SH3BP1;LIMK1;GDI1;DNM1;WASH3P;RGS14;SCN8A;ADAM15;EHD3;WDR60;TMEM231;FHOD1;MYO1D;ABCA7;SYNGR1;WFS1;FYN;PITPNM3;RAC3;EEF2K;DNM2;ATXN10;ARHGEF4;MAPK3;INSR;PFKM;MORN4;PAK1;CAMKK2;GABBR1;MICAL1;ITGA3;BIN1;VPS16;DLG3;PKD1;SIRT2;TRIP10;AFAP1L1;AZIN2;RAB28;RAP1GAP2;NGFR;PXN;GCH1;KIF13B;TCTN1;BBS10;SEPT6;PFN2;MFSD10;NDRG2;BLOC1S4;TRIM46;HOMER2;APBA1;TTLL3;ADCY6;KLHL24;STRN4
1488,GO:0003824,0.00063260674555755,0.999489252401996,517,4372,catalytic activity,MF,DUSP6;NT5E;XDH;ERCC1;DUSP5;GID4;HTRA1;THSD4;B4GALNT4;H6PD;EDEM1;DLG4;PLAT;CYP27B1;TYSND1;FBXO2;NAGS;ACVR2B;PYGB;PGM1;PYGL;DGKA;NAGLU;PLD3;LPCAT4;ISYNA1;HMGA2;OBSCN;IDH2;NEK9;CRAT;PKN1;MTA1;ACOT7;ACSF2;AKR7A2;EGFR;RPS6KA2;DNPH1;LOXL1;NOS1;VAT1;PTPRS;TMEM129;HADH;CTSO;CAPN2;MST1R;LTBP4;PRSS8;KLHL29;DDB2;LTBP1;ARL2;HEXB;GTPBP1;PTPRE;NPEPL1;ALDH4A1;TK2;MMP1;TXNRD3;ST6GALNAC2;GAA;GLUL;RNPEPL1;MAP2K2;KDSR;NME4;MARCH9;CTBS;PLCD3;FKBP9;SMARCA1;RBCK1;SUGCT;PGLS;PC;RNF44;MAP2K1;NAPRT;CRYL1;ACP5;CPT2;SSH1;ENDOG;MARK4;TMEM8A;GALE;SMURF2;KLC2;PIK3R2;ERCC6;SRD5A3;PIGQ;HSD17B8;HBEGF;RPUSD3;CYBRD1;PPP2R3B;PRDX5;NLGN2;PRODH;MBOAT7;CDK18;FBXW5;RNF187;NMRK1;ADARB1;PLCXD2;D2HGDH;AKT1;HDAC5;UROS;FBXO41;NT5DC1;F12;PPM1F;MMP28;ENTPD6;RHBDF2;HAGHL;PYCR2;STK39;HK1;EPHA1;GGT1;PTPRU;ASH2L;MARCH4;ZFYVE21;BRSK1;RAB31;FGFR4;POLD4;ACOT1;FGFR1;PRKACB;FUCA1;RAC2;KCNAB2;PFKL;OPLAH;HLTF;PPM1J;RAG1;GAMT;B4GAT1;BPHL;PIGV;NAT14;B3GAT3;CBR4;HMG20B;ABCD1;CCND1;LHPP;TNNT1;AIG1;STRADB;PLCH2;MAPK13;EDNRA;PLAU;PTK6;PFKP;CSNK1E;CTSB;RAB3B;CARD11;DUSP7;MAPKAPK3;PCSK9;DHTKD1;BCR;SEPT10;NADK;PANK4;HLCS;PRSS22;CDC25B;ALOX15B;AGAP1;COMTD1;CCS;GGACT;RSAD1;RRNAD1;NPR2;DGKQ;HAGH;PAK6;SHARPIN;CEMIP;ACY1;GPX3;PCSK1;RETSAT;CTSZ;FBXW8;ABCA2;ZNF598;PRSS3;EPHB2;ADAM8;APRT;CTBP1;JOSD2;LTA4H;PTPDC1;GRK6;PLCG1;FBXL8;CBS;KIF17;MVD;RNF135;ENTPD2;ADAMTS13;ZNF862;SYNJ2;DPP7;GNAL;LACTB2;SCYL1;ABHD17C;ULK2;MKNK2;ADAMTS7;B3GNT3;ATP7B;SDHA;MSRB2;EFNB3;MIPEP;PIP5KL1;MGAT4B;KIF26B;MDH2;MPG;GALNS;FBXO17;CLCA2;HEXDC;ABHD8;RHOD;ABHD14B;DNAH1;ERO1B;ST6GALNAC6;POLL;FBXO44;POLM;PI4K2A;RHOF;ANKZF1;PHGDH;PHF21A;KIF7;PLPP6;RHOBTB2;ADAM19;TUBG2;ZER1;HMGCL;PTPN1;PEX1;TPP1;PCK2;B4GALT2;MBD3;ZDHHC24;ACP6;B4GALT6;VHL;MYH16;IDUA;PFKFB2;RFNG;PRKCZ;KDM6B;PRKACA;MINK1;GRHPR;RABGGTA;ADA;PIM2;MPI;UCKL1;ALAS1;NEURL1B;ERBB2;ULK1;CNDP2;AHCY;PRIMPOL;MMP10;STK17A;JAK3;RNPEP;PDK1;ACAD10;CYGB;THOP1;PRKCD;FAM20C;MIB2;USP20;STUB1;CYC1;SBF1;DTD1;XYLT2;TRIM4;PPCS;FBXW4;EREG;RPS6KA5;DGUOK;DUSP4;MBTPS2;ACADS;TOP3B;HSD17B7;RASL10B;CES2;NAGA;ZDHHC8;TMX4;LIMK1;TGFBR3;NTPCR;PDIA5;PADI3;DIP2A;RPS6KA6;DNM1;MFNG;GSTO1;ALDOC;LPCAT1;LRSAM1;ADAM15;ASB1;WDR60;ST3GAL3;FAHD2B;LONP2;MAPK12;IRAK1;PPOX;HDAC7;INPP5D;MTHFR;CHD2;PI4K2B;PCMTD2;CHEK2;DECR2;ABHD15;COQ2;SESN2;FGGY;ABCG1;MYO1D;JADE2;MYH15;CDC34;RNF123;ABCA7;RAB12;SPATA20;SPEG;MIF;ACO2;SMOX;EEF2KMT;KDM4B;PHYH;PLA2G6;DDT;NUDT14;NARF;QSOX1;DTX3;TRPT1;DALRD3;SPPL2B;HSD11B1L;FYN;UPP1;STK25;RAC3;ETFB;GLB1L2;EEF2K;CERS4;ARID5B;DNM2;CKMT1A;CYP3A5;GLB1;PELI1;CHKA;CAT;NEIL1;SLC27A1;APOBEC3C;KIF26A;ASMTL;ZDHHC1;PLCB3;APOBEC3F;DDX50;CYP2R1;TUBB6;MAPK3;INSR;PAN2;TAZ;PFKM;ADCY1;TSTA3;ATP8B2;GPT2;PDXK;GLRX;PAK1;CDYL2;KLHL36;CAMKK2;RNASET2;PPP3CB;RNF144A;ALPK1;CTSF;USP21;PFKFB3;MLYCD;REV1;MICAL1;HYAL1;STK32C;DNMT3A;SAMD8;MAN2B1;SRMS;TSTD1;NSUN7;MAP2K3;NDST2;DLG3;ABHD10;NDUFV3;RRAS;DNASE1L1;IARS2;ALDH7A1;ZYG11B;KCTD13;SIRT2;GAL3ST4;NMNAT2;BACH1;NT5C1B;ADCY7;ALG12;AZIN2;TEP1;RAB28;ST3GAL2;YDJC;MAP3K10;HSD11B1;PELI3;RAB40B;PDCD6;ATP6V1F;CHST14;FAM86B1;RNASE7;PHYKPL;DUSP23;GCH1;KIF13B;CAMK1;CAMKK1;EZH1;SIRT3;TERC;SEPT6;CDK11B;PFN2;SSH3;FGFR3;TST;ST3GAL5;MAN2B2;CBLC;ITPKB;PTGR2;SPTLC2;CDC42BPG;PRSS21;CLK3;DHX32;KDM3A;PM20D2;PKN3;TTLL3;PI4KAP2;AK3;CHPF;ADCY6;LRRK1;AARS;KLHL24
2649,GO:0005996,0.000647688983675762,0.999680004642129,37,201,monosaccharide metabolic process,BP,NR1D1;H6PD;PGM1;LRP5;NISCH;SLC2A3;PHLDA2;GAA;PC;CRYL1;GALE;AKT1;HK1;FUCA1;PFKL;IGFBP4;PFKP;DGKQ;MDH2;PCK2;PFKFB2;MPI;PDK1;GSTO1;ALDOC;PPARA;FGGY;GLB1;INSR;PFKM;PFKFB3;MLYCD;WDTC1;MAN2B1;ABHD10;MAN2B2;SLC23A2
18633,GO:1903909,0.000657768658357174,0.99998422966574,4,5,regulation of receptor clustering,BP,SSH1;GSN;TGFB1;LRP4
7484,GO:0031659,0.00066409948681164,0.999984034986845,4,5,positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,EGFR;AKT1;PKD2;PKD1
7352,GO:0031401,0.000687619748257842,0.999533480267874,113,792,positive regulation of protein modification process,BP,TNIP1;DUSP6;XDH;DUSP5;EGR1;DLG4;ACVR2B;PRNP;VEGFA;WNT7A;F2R;PKN1;MTA1;EGFR;NOS1;SPRY2;MST1R;SHC1;SNX9;RAPGEF3;MAP2K2;LPAR3;MAP2K1;ERCC6;DVL1;HBEGF;SHC2;ADORA2B;AKT1;STK39;EPHA1;CNTN1;FGFR4;FGFR1;PRKACB;IGFBP4;CCND1;STRADB;GAS6;PTK6;DUSP7;MAPKAPK3;EHD4;CDC25B;DGKQ;PAK6;CEMIP;PKD2;EPHB2;ADAM8;CTBP1;PLCG1;CD81;TIMP2;TGFB1;NAB2;TNFSF15;NSMF;PTPN1;IFNE;LRP4;PRKCZ;PRKACA;MINK1;AREG;ERBB2;C6ORF89;PRKCD;STUB1;BAX;ITGA1;EREG;RPS6KA5;SYMPK;IRAK1;TGFA;CHEK2;ABCA7;MIF;PLA2G6;DDT;WFS1;FYN;STK25;PELI1;SLC27A1;MAPK3;INSR;ADCY1;ETAA1;VANGL2;PAK1;CAMKK2;SEMA4C;CAPRIN2;MAP2K3;DLG3;PROX1;PKD1;TNFRSF25;ADCY7;MAPRE3;MAP3K10;NGFR;TOLLIP;PDCD6;CAMK1;CAMKK1;HFE;PFN2;FGFR3;ADCY6;LRRK1
2750,GO:0006164,0.000691555194107526,0.999672428803036,33,176,purine nucleotide biosynthetic process,BP,PGM1;APOE;ACOT7;NOS1;NME4;ADORA2B;HK1;PTHLH;PFKL;PFKP;DHTKD1;PANK4;NPR2;APRT;TIMP2;TGFB1;PFKFB2;MLXIPL;ADA;CYC1;PPCS;DDIT4;LTB4R2;ALDOC;PPARA;INSR;TAZ;PFKM;ADCY1;PFKFB3;GABBR1;ADCY7;ADCY6
2383,GO:0005520,0.000699460710043592,0.999910192210724,7,16,insulin-like growth factor binding,MF,HTRA1;ITGA6;ITGB4;IGFBP4;IGFBP2;IGFBP7;INSR
4129,GO:0009190,0.000704771164165901,0.999838634643076,11,35,cyclic nucleotide biosynthetic process,BP,APOE;NOS1;ADORA2B;PTHLH;NPR2;TIMP2;LTB4R2;ADCY1;GABBR1;ADCY7;ADCY6
13372,GO:0052652,0.000704771164165901,0.999838634643076,11,35,cyclic purine nucleotide metabolic process,BP,APOE;NOS1;ADORA2B;PTHLH;NPR2;TIMP2;LTB4R2;ADCY1;GABBR1;ADCY7;ADCY6
9196,GO:0035584,0.000714705613645315,0.99995115019886,5,9,calcium-mediated signaling using intracellular calcium source,BP,ADGRL1;PRNP;PRKACA;BCAP31;HOMER2
772,GO:0002028,0.000738361592190547,0.999776865914912,15,57,regulation of sodium ion transport,BP,SERPINE2;SCN4B;NOS1;PRSS8;STOM;AKT1;STK39;CNTN1;ANK3;PCSK9;SNTA1;TGFB1;DNM2;GLRX;KLHL24
10486,GO:0043393,0.000739211701670243,0.999653014975295,32,169,regulation of protein binding,BP,CTNNBIP1;APOE;NFATC4;PHLDA2;LRP1;DVL1;AKT1;HDAC5;SORL1;CSNK1E;PCSK9;CTSZ;GPSM1;TMEM173;RFNG;PRKACA;PIM2;PRKCD;STUB1;BAX;TGFBR3;MFNG;ADAM15;ZFPM1;PPARA;MAPK3;CAPRIN2;PKD1;ITGA4;MAPRE3;CAMK1;HFE
6594,GO:0022617,0.000750072584113327,0.999772959523272,15,57,extracellular matrix disassembly,BP,HTRA1;CST3;CAPN2;MMP1;LRP1;SH3PXD2B;BSG;FGFR4;ADAM8;TIMP2;TGFB1;MMP10;FSCN1;NID1;ADAM15
10791,GO:0044273,0.000770057650032442,0.999838455438942,10,30,sulfur compound catabolic process,BP,ACOT7;HEXB;GGT1;CBS;GALNS;IDUA;AHCY;GLB1;MLYCD;HYAL1
5328,GO:0016054,0.000770158169458541,0.99962369254402,35,190,organic acid catabolic process,BP,TYSND1;CRAT;NOS1;HADH;HEXB;ALDH4A1;GLUL;CRYL1;CPT2;PRODH;AKT1;ABCD1;AIG1;CEMIP;CBS;TGFB1;HMGCL;PCK2;IDUA;AHCY;ACAD10;ACADS;LONP2;DECR2;PPARA;SESN2;PHYH;ETFB;GPT2;MLYCD;HYAL1;ABHD10;ALDH7A1;PHYKPL;PM20D2
11646,GO:0046395,0.000770158169458541,0.99962369254402,35,190,carboxylic acid catabolic process,BP,TYSND1;CRAT;NOS1;HADH;HEXB;ALDH4A1;GLUL;CRYL1;CPT2;PRODH;AKT1;ABCD1;AIG1;CEMIP;CBS;TGFB1;HMGCL;PCK2;IDUA;AHCY;ACAD10;ACADS;LONP2;DECR2;PPARA;SESN2;PHYH;ETFB;GPT2;MLYCD;HYAL1;ABHD10;ALDH7A1;PHYKPL;PM20D2
4181,GO:0009260,0.000770641165426449,0.99962775794398,34,184,ribonucleotide biosynthetic process,BP,PGM1;APOE;ACOT7;NOS1;NME4;ADORA2B;HK1;PTHLH;PFKL;PFKP;DHTKD1;PANK4;NPR2;APRT;TIMP2;TGFB1;PFKFB2;MLXIPL;UCKL1;CYC1;PPCS;DDIT4;LTB4R2;ALDOC;PPARA;UPP1;INSR;TAZ;PFKM;ADCY1;PFKFB3;GABBR1;ADCY7;ADCY6
12568,GO:0050731,0.000778449924886345,0.999695452941823,22,101,positive regulation of peptidyl-tyrosine phosphorylation,BP,DLG4;PRNP;VEGFA;ERCC6;HBEGF;CNTN1;GAS6;PTK6;EHD4;DGKQ;CD81;TGFB1;PTPN1;LRP4;AREG;EREG;TGFA;MIF;FYN;DLG3;FGFR3;LRRK1
12766,GO:0051050,0.000781026836253141,0.999492038080072,90,612,positive regulation of transport,BP,FHL1;EDEM1;APLN;PRNP;POSTN;VEGFA;APOE;TSPAN1;F2R;EGFR;SCN4B;NOS1;PRSS8;SDC1;ORAI1;VPS11;RAPGEF3;GLUL;LPAR3;PLTP;PIK3R2;LRP1;GJC2;NLGN2;STOM;ADORA2B;AKT1;STK39;HK1;CNTN1;LDLR;FGFR1;RAC2;SORL1;B3GAT3;ANK3;GAS6;RAB3B;PCSK9;BCR;ALOX15B;CEMIP;PKD2;EPHB2;ADAM8;PLCG1;TGFB1;CLTCL1;NTSR1;TMEM173;SHANK3;TUB;PCK2;CEP131;PFKFB2;PRKCZ;MICALL2;BOK;ERBB2;VAMP2;TFDP2;TRPC1;PRKCD;BAX;RASL10B;ZDHHC8;DNM1;GSTO1;EHD3;ABCG1;ABCA7;BCAP31;MIF;PLA2G6;WFS1;NBPF3;FYN;EEF2K;DNM2;MAPK3;INSR;PFKM;GLRX;PAK1;PPP3CB;AZIN2;CAMK1;SIRT3;HFE;ZP3
680,GO:0001891,0.000785908475770873,0.99989697797885,7,16,phagocytic cup,CC,PEAR1;ARHGAP25;SH3BP1;ABCA7;ARHGAP12;DNM2;TRIP10
3187,GO:0006814,0.000791317857854653,0.999668346137117,25,119,sodium ion transport,BP,SLC6A8;SERPINE2;SCN4B;NOS1;PRSS8;STOM;AKT1;STK39;CNTN1;ANK3;PCSK9;SLC20A1;SNTA1;PKD2;ASIC1;TGFB1;SLC38A10;SLC13A5;SCN8A;SLC9A7;DNM2;SLC13A3;GLRX;SLC23A2;KLHL24
2637,GO:0005975,0.000795922707174625,0.99951213870355,70,450,carbohydrate metabolic process,BP,NR1D1;H6PD;PYGB;PGM1;PYGL;LRP5;ISYNA1;IDH2;NISCH;AKR7A2;HEXB;SLC2A3;PHLDA2;ST6GALNAC2;GAA;CTBS;PGLS;PC;CRYL1;GALE;PIGQ;AKT1;HK1;FUCA1;PFKL;B3GAT3;IGFBP4;PFKP;DHTKD1;DGKQ;TGFB1;NTSR1;B3GNT3;MGAT4B;MDH2;HEXDC;ST6GALNAC6;PCK2;B4GALT2;B4GALT6;IDUA;PFKFB2;MLXIPL;MPI;PDK1;DDIT4;NAGA;GSTO1;ALDOC;ST3GAL3;PPARA;COQ2;FGGY;GLB1L2;GLB1;INSR;PFKM;PFKFB3;MLYCD;HYAL1;WDTC1;MAN2B1;ABHD10;GAL3ST4;ST3GAL2;YDJC;CHST14;ST3GAL5;MAN2B2;SLC23A2
10260,GO:0043005,0.000802688041915067,0.999456425418261,109,760,neuron projection,CC,ZMYND8;ADGRL1;NR1D1;DLG4;CST3;FBXO2;PRR7;DOCK4;PRNP;BBS2;APOE;ESPN;NOS1;PTPRS;CAPN2;GLUL;LPAR3;SSH1;MARK4;FOS;SHANK2;LRP1;GJC2;DVL1;S100A4;KCNC4;TMOD2;EPHA1;IFT140;SIGMAR1;KCNAB2;NPHP4;TENM2;ZNF385A;ANK3;TWF2;SYNGAP1;BNIP3;SHARPIN;CTSZ;CRTC1;AP3D1;EPHB2;KIF17;TIMP2;SYNJ2;TGFB1;SNPH;ABHD17C;NTSR1;SHANK3;NSMF;FARP1;HTR7;PI4K2A;LLGL1;CAMK2N1;LRP4;PRKCZ;MINK1;ADA;MICALL2;ULK1;AHCY;VAMP2;CYFIP2;FSCN1;CYGB;ARHGAP44;REEP6;SV2A;ITGA1;LIMK1;GDI1;DNM1;RGS14;SCN8A;MYO1D;SYNGR1;WFS1;FYN;RAC3;EEF2K;DNM2;ATXN10;INSR;MORN4;PAK1;GABBR1;MICAL1;ITGA3;BIN1;VPS16;DLG3;SIRT2;AZIN2;RAP1GAP2;NGFR;GCH1;KIF13B;SEPT6;PFN2;NDRG2;BLOC1S4;TRIM46;HOMER2;APBA1;KLHL24;STRN4
3262,GO:0006936,0.000838124218724158,0.999603276628509,32,170,muscle contraction,BP,DOCK4;BBS2;SLC6A8;F2R;SCN4B;OBSL1;NOS1;ACTA2;GAA;ADORA2B;TMOD2;DYSF;VEGFB;GAMT;TNNT1;EDNRA;SNTA1;ITGB5;HTR7;PRKACA;ADA;SMTN;ITGA1;PPP1R13L;TPM2;GSTO1;EHD3;PLA2G6;TAZ;MAP2K3;LTB4R;PXN
4259,GO:0009605,0.000849065567554585,0.999376178473275,176,1337,response to external stimulus,BP,TNIP1;NT5E;ERCC1;SEMA4B;HTRA1;NR1D1;PLAT;CST3;CYP27B1;PGF;PDCD4;DOCK4;XPC;BBS2;POSTN;VEGFA;TNFRSF6B;APOE;F2R;ITGA6;HMGA2;MTA1;EGFR;SERPINE2;LOXL1;NOS1;PTPRS;MST1R;SHC1;ACTA2;GLUL;CMTM7;MAP2K1;ACP5;SSH1;ENDOG;FOS;SMAD3;DVL1;HBEGF;ADORA2B;ADARB1;AKT1;GRB7;CORO1B;HDAC5;F12;PPM1F;MMP28;PITPNM1;STK39;SERPING1;GGT1;VEGFB;IMPACT;IFNGR2;DAP;WNT2B;FNDC4;LDLR;FGFR1;MAPKBP1;RAC2;B4GAT1;KLF7;CEACAM1;CCND1;MAPK13;PLAU;GAS6;SEMA3F;GSN;CMTM4;MAPKAPK3;IGFBP2;PCSK9;BCR;WIPF1;HLCS;SLITRK6;SPTB;DGKQ;PLXNB3;BNIP3;SHARPIN;PKD2;FAM3A;CRTC1;IL20RB;AP3D1;PRSS3;EPHB2;ADAM8;PLCG1;CBS;CD81;CEBPB;ADAMTS13;WNT3;TGFB1;ULK2;GPC1;NTSR1;TMEM173;SHANK3;EFNB3;LAMB2;VGF;SEMA4F;HMGCL;PCK2;WDR59;MBD3;IFNE;CD9;ADA;PIM2;PLEKHG5;ERBB2;ULK1;AHCY;BNIP3L;CYFIP2;PRKCD;REEP6;ITGA1;RPS6KA5;DDIT4;PPL;PCSK1N;LTB4R2;LRSAM1;IRAK1;MTHFR;PPARA;SESN2;MIF;PLA2G6;DDT;FYN;UPP1;RAC3;SUN1;BHLHE40;PELI1;CAT;APOBEC3C;SATB1;KIF26A;APOBEC3F;MAPK3;C12ORF66;VANGL2;HYAL1;SEMA4C;DNMT3A;BCL2L1;PROX1;PKD1;TNFRSF25;SIRT2;FAM129B;CDH4;NGFR;RNASE7;GRB10;GCH1;NR2F6;HFE;WIPI2;GAS2L1;ZP3;SEMA3B;LRP11;DOK4;GSDMA
5278,GO:0015929,0.000849629523837308,0.999914008587627,6,12,hexosaminidase activity,MF,NAGLU;HEXB;CEMIP;HEXDC;NAGA;HYAL1
20304,GO:2001257,0.000890252390456726,0.999677022391083,19,82,regulation of cation channel activity,BP,DLG4;KCNG1;NOS1;SHANK2;NLGN2;STOM;ANK3;PKD2;EPHB2;NTSR1;SHANK3;PRKACA;MINK1;VAMP2;CACNB3;GSTO1;EHD3;PLA2G6;KLHL24
6669,GO:0030036,0.000907126979033434,0.999434999755496,73,474,actin cytoskeleton organization,BP,PARVB;ESPN;OBSCN;NISCH;OBSL1;SHC1;RAPGEF3;ARAP1;SSH1;SMAD3;LRP1;SH3PXD2B;TMOD2;CORO1B;PPM1F;EPHA1;FMNL2;RAC2;NPHP4;EFS;TNNT1;TWF2;GSN;PLEKHG2;BCR;WIPF1;ARPIN;SPTB;CORO7;PAK6;CDC42EP5;ITGB5;TGFB1;ARHGAP25;FHOD3;SHANK3;MSRB2;RHOD;RHOF;WASF3;LLGL1;RHOBTB2;PTPN1;PRKCZ;MINK1;MICALL2;CAPG;PLEK2;FSCN1;ARHGAP44;PRKCD;SH3BP1;LIMK1;TPM2;WASH3P;FHOD1;RAC3;ARHGAP12;INF2;IQSEC1;VANGL2;PAK1;MICAL1;PROX1;KCTD13;TRIP10;PXN;LURAP1;CELSR1;PFN2;SSH3;CDC42BPG;PI4KAP2
4263,GO:0009611,0.000912040122838654,0.999450512638595,64,413,response to wounding,BP,PLAT;CST3;POSTN;WNT7A;APOE;DGKA;F2R;ELK3;ITPR3;EGFR;SERPINE2;PTPRS;SDC1;ZFP36L1;MAP2K1;FBLN1;SMAD3;HBEGF;ITGB4;AKT1;CORO1B;F12;SERPING1;DYSF;PRKACB;RAC2;CEACAM1;HMG20B;DOCK6;PLAU;GAS6;SH2B3;GSN;DGKQ;TFPI2;PROCR;ENTPD2;ADAMTS13;TGFB1;LAMB2;PHF21A;PRKACA;CD9;ERBB2;C6ORF89;PRKCD;BAX;EREG;ADAM15;EHD3;ZFPM1;PPARA;FYN;MAPK3;DOCK9;MORN4;VANGL2;PAK1;MICAL1;DCBLD2;MAFF;CELSR1;BLOC1S4;AK3
7350,GO:0031399,0.000926378123513105,0.999321862926381,169,1267,regulation of protein modification process,BP,TNIP1;DUSP6;XDH;DUSP5;EGR1;DLG4;FBXO2;PDCD4;ACVR2B;PRNP;VEGFA;WNT7A;APOE;F2R;LRP5;PKN1;MTA1;EGFR;WWTR1;NOS1;SPRY2;MST1R;CRTAP;SHC1;SNX9;SPRY4;RAPGEF3;MAP2K2;LPAR3;PPP1R35;MAP2K1;FBLN1;PIK3R2;ERCC6;GJC2;DVL1;HBEGF;PPP1R14A;PPP2R3B;SHC2;ADORA2B;ADARB1;AKT1;PPM1F;STK39;EPHA1;IMPACT;CNTN1;FGFR4;FGFR1;PRKACB;RAC2;SORL1;CEACAM1;B3GAT3;HMG20B;IGFBP4;CCND1;PODNL1;STRADB;SYNGAP1;GAS6;PTK6;DUSP7;MAPKAPK3;EHD4;ERRFI1;CDC25B;SNTA1;DGKQ;PAK6;CEMIP;PKD2;EPHB2;ADAM8;CTBP1;CDKN1C;PLCG1;CD81;TIMP2;TGFB1;NAB2;TNFSF15;NSMF;ZER1;PTPN1;IFNE;CAMK2N1;LRP4;MLXIPL;TRIB2;PRKCZ;PRKACA;MINK1;AREG;ERBB2;C6ORF89;PRKCD;STUB1;BAX;ITGA1;EREG;RPS6KA5;DUSP4;DDIT4;LIMK1;LEMD2;RPS6KA6;RGS14;CHAD;SYMPK;IRAK1;TGFA;MTHFR;CHEK2;SESN2;ABCA7;MIF;PLA2G6;DDT;WFS1;TRPT1;FYN;STK25;EEF2K;PELI1;TSPYL2;ELFN2;SLC27A1;MAPK3;INSR;ADCY1;ETAA1;VANGL2;PAK1;CAMKK2;MICAL1;SEMA4C;CAPRIN2;PPP2R5B;MAP2K3;DLG3;RRAS;PROX1;ZYG11B;PKD1;TNFRSF25;SIRT2;ADCY7;MAPRE3;SOCS7;MAP3K10;NGFR;TOLLIP;PDCD6;CAMK1;CAMKK1;SIRT3;HFE;PFN2;FGFR3;PPP1R16A;CCDC88C;NDRG2;CBLC;ITPKB;KDM3A;ADCY6;LRRK1
3308,GO:0007015,0.000930673131407416,0.999484738518892,48,284,actin filament organization,BP,ESPN;OBSL1;RAPGEF3;ARAP1;SSH1;SMAD3;SH3PXD2B;TMOD2;CORO1B;PPM1F;EPHA1;RAC2;EFS;TWF2;GSN;PLEKHG2;WIPF1;ARPIN;SPTB;CORO7;CDC42EP5;ITGB5;ARHGAP25;FHOD3;SHANK3;MSRB2;RHOD;RHOF;WASF3;RHOBTB2;MICALL2;CAPG;FSCN1;PRKCD;SH3BP1;LIMK1;TPM2;WASH3P;FHOD1;RAC3;ARHGAP12;PAK1;MICAL1;PROX1;KCTD13;PXN;PFN2;SSH3
16866,GO:0098797,0.000935467986276874,0.99948194950129,48,284,plasma membrane protein complex,CC,DLG4;KCNG1;LRP5;ITGA6;EGFR;SCN4B;NOS1;SHC1;SHANK2;LRP1;GJC2;AP2A2;ITGB4;KCNC4;KCNAB2;CEACAM1;EVC;CARD11;COL13A1;SNTA1;ITGB5;ABCA2;GRIN3B;ADAM8;GNAL;SNTB2;SHANK3;SDHA;LRP4;VAMP2;CACNB3;ITGA1;OLFM2;GJB4;TGFBR3;SCN8A;IRAK1;ABCA7;INSR;HLA-G;GABBR1;ITGA3;DLG3;CDH4;ITGA4;RGS19;TOLLIP;HFE
4096,GO:0009152,0.000942601762608504,0.999550112850816,32,172,purine ribonucleotide biosynthetic process,BP,PGM1;APOE;ACOT7;NOS1;NME4;ADORA2B;HK1;PTHLH;PFKL;PFKP;DHTKD1;PANK4;NPR2;APRT;TIMP2;TGFB1;PFKFB2;MLXIPL;CYC1;PPCS;DDIT4;LTB4R2;ALDOC;PPARA;INSR;TAZ;PFKM;ADCY1;PFKFB3;GABBR1;ADCY7;ADCY6
12567,GO:0050730,0.000950377378718458,0.999565680247198,29,149,regulation of peptidyl-tyrosine phosphorylation,BP,DLG4;PRNP;VEGFA;EGFR;SHC1;ERCC6;HBEGF;CNTN1;GAS6;PTK6;EHD4;ERRFI1;DGKQ;CD81;TGFB1;PTPN1;LRP4;PRKCZ;AREG;PRKCD;EREG;TGFA;MIF;FYN;PPP2R5B;DLG3;FGFR3;CBLC;LRRK1
1992,GO:0004713,0.000955950749385793,0.999601921930534,24,113,protein tyrosine kinase activity,MF,EGFR;MST1R;MAP2K2;MAP2K1;HBEGF;EPHA1;FGFR4;FGFR1;PTK6;BCR;EPHB2;SCYL1;EFNB3;ERBB2;JAK3;PRKCD;EREG;FYN;INSR;CAMKK2;SRMS;MAP2K3;FGFR3;CLK3
10497,GO:0043406,0.000970411786558048,0.999513807740078,36,197,positive regulation of MAP kinase activity,BP,DUSP6;DUSP5;VEGFA;F2R;PKN1;EGFR;MST1R;SHC1;MAP2K2;LPAR3;MAP2K1;ERCC6;SHC2;ADORA2B;STK39;FGFR1;DUSP7;MAPKAPK3;ADAM8;PLCG1;CD81;TGFB1;PTPN1;MINK1;ERBB2;ITGA1;IRAK1;TGFA;MIF;STK25;MAPK3;INSR;VANGL2;PAK1;MAP2K3;MAP3K10
5683,GO:0016798,0.000983030378883882,0.999639735181651,19,83,hydrolase activity, acting on glycosyl bonds,MF,EDEM1;NAGLU;DNPH1;HEXB;GAA;CTBS;FUCA1;CEMIP;MPG;HEXDC;IDUA;NAGA;GLB1L2;GLB1;NEIL1;HYAL1;MAN2B1;ABHD10;MAN2B2
12623,GO:0050819,0.00100194556667289,0.999780385164437,10,31,negative regulation of coagulation,BP,PLAT;APOE;SERPINE2;F12;SERPING1;CEACAM1;PLAU;PROCR;CD9;PRKCD
12073,GO:0048037,0.00100301551645317,0.999415174490609,56,352,cofactor binding,MF,XDH;NR1D1;H6PD;CYP27B1;PYGB;PYGL;IDH2;ACOT7;NOS1;HADH;TXNRD3;PC;CRYL1;HSD17B8;PRODH;D2HGDH;UROS;HEBP1;CBR4;ACBD4;DHTKD1;HLCS;RSAD1;CTBP1;CBS;SDHA;SLC48A1;PHGDH;HMGCL;CD320;GRHPR;ALAS1;AHCY;ACAD10;CYGB;CYC1;NUBP2;ACADS;PPOX;MTHFR;ACO2;PHYH;NARF;CYP3A5;CAT;CYP2R1;TSTA3;GPT2;PDXK;MICAL1;SIRT2;BACH1;PHYKPL;GCH1;SIRT3;SPTLC2
7845,GO:0032412,0.00100453243024604,0.999562066206164,26,129,regulation of ion transmembrane transporter activity,BP,FHL1;DLG4;KCNG1;PRNP;SCN4B;NOS1;SHANK2;NLGN2;STOM;STK39;ANK3;PCSK9;PKD2;EPHB2;NTSR1;SHANK3;PRKACA;MINK1;VAMP2;CACNB3;GSTO1;EHD3;PLA2G6;DNM2;GLRX;KLHL24
4805,GO:0012505,0.00102399276827396,0.999180195004814,384,3177,endomembrane system,CC,XDH;H1F0;B4GALNT4;SLC16A3;H6PD;EDEM1;DLG4;PLAT;CST3;HS1BP3;EPN3;FBXO2;DOCK4;PRNP;PYGB;POSTN;VEGFA;PGM1;WNT7A;APOE;PYGL;F2R;LRP5;PLD3;OSBPL5;LPCAT4;NDRG1;CRAT;ITPR3;PKN1;MTA1;ANGEL1;EVI5L;NISCH;AKR7A2;EGFR;SERPINE2;LOXL1;OBSL1;NOS1;VAT1;PTPRS;TMEM129;SLC2A9;LRP3;CAPN2;CRTAP;SYTL1;SDC1;LMF1;APPL2;VPS11;LTBP1;TBC1D14;ARL2;HEXB;SLC2A3;SNX9;RAPGEF3;TXNRD3;ST6GALNAC2;GAA;GLUL;ARAP1;MAP2K2;KDSR;MARCH9;FKBP9;MAP2K1;NAPRT;MCTP1;SLC9A3R2;FOS;SMAD3;STAT6;LRP1;SRD5A3;PIGQ;AP2A2;STOM;MBOAT7;REEP4;LY6K;SYT8;TPCN1;HDAC5;S100A6;F12;PITPNM1;ENTPD6;RHBDF2;BSG;SERPING1;ASAP2;DYSF;VEGFB;MARCH4;SLC15A4;ZFYVE21;IFNGR2;BRSK1;PTHLH;RAB31;FGFR4;FNDC4;LDLR;FUCA1;SIGMAR1;RAC2;KCNAB2;PFKL;SYNE3;B4GAT1;PACS2;PHF7;PIGV;SORL1;CEACAM1;B3GAT3;RAB11FIP4;TENM2;ANK3;IGFBP4;TRAPPC9;AIG1;CARD19;PLAU;GAS6;BRI3;CTSB;RAB3B;MPLKIP;GSN;PCSK9;ANO8;ANTXR2;XPOT;EHD4;DBNDD1;SPTB;COL13A1;CORO7;DGKQ;BNIP3;MVB12B;FYCO1;CEMIP;PKD2;PCSK1;RETSAT;CTSZ;CDC42EP5;FBXW8;GPSM1;AP3D1;ABCA2;PRSS3;ADAM8;ASIC1;APRT;TMEM9;LTA4H;ENTPD2;ADAMTS13;TIMP2;WNT3;DPP7;TMED4;TGFB1;CLTCL1;SCYL1;ABHD17C;SNTB2;GPC1;ADAMTS7;TBC1D9B;SLC38A10;NTSR1;B3GNT3;TMEM173;ATP7B;PODXL2;MGAT4B;GALNS;CLCA2;GOLGA2P5;NSMF;RHOD;LAMB2;SNX17;ERO1B;ST6GALNAC6;VGF;SNX33;PI4K2A;SEMA4F;C1ORF210;RHOF;YIPF3;SLC48A1;LLGL1;UBXN4;ADAM19;PTPN1;B4GALT2;AGRN;CD320;LRP10;ESYT2;ZDHHC24;B4GALT6;VHL;TMCC3;CEP131;RFNG;YPEL5;PRKCZ;PRKACA;MINK1;ACTR1B;CD9;AREG;MICALL2;BOK;NEURL1B;ERBB2;ULK1;VAMP2;CERCAM;C6ORF89;NECAB3;JAK3;RNPEP;BNIP3L;ARHGAP44;EHBP1L1;MCFD2;PRKCD;FAM20C;MIB2;REEP6;STUB1;BAX;SV2A;SBF1;XYLT2;ITGA1;KLHDC2;TMBIM4;MBTPS2;HSD17B7;PCSK1N;CES2;ZDHHC8;TMX4;FCHO1;LIMK1;PDIA5;GDI1;LEMD2;DNM1;WASH3P;TMEM8B;MFNG;ALDOC;MSLN;LPCAT1;ADAM15;REEP2;EHD3;ST3GAL3;IRAK1;TGFA;PI4K2B;CHEK2;COG7;ABCG1;MYO1D;RNF123;ABCA7;RAB12;BCAP31;MIF;SMOX;DOPEY2;SLC9A7;SYNGR1;ECM1;WFS1;QSOX1;CD68;SLC22A18;SPPL2B;FYN;PITPNM3;VWA1;STK25;RAC3;CERS4;SUN1;DNM2;CYP3A5;GLB1;CAT;IGFBP7;SLC27A1;TPBG;SLC50A1;ZDHHC1;CYP2R1;MAPK3;CBLN3;INSR;RTN2;GRINA;PDZD2;HLA-G;DOCK9;STX10;ATP8B2;PDXK;PRAF2;PAK1;MALL;RNASET2;RNF144A;LGALS3BP;CUL7;SLC37A2;SEMA4C;SAMD8;BIN1;VPS16;MAN2B1;SLC16A13;NDST2;BCL2L1;SGSM2;DNASE1L1;TBC1D16;LMNA;PKD1;RABGAP1;EDA;ANKRD13D;GAL3ST4;NMNAT2;TRIP10;ALG12;AZIN2;RAB28;SERPINB1;ST3GAL2;ICA1;RAP1GAP2;LAMB1;RGS19;HSD11B1;RAB40B;NGFR;TOLLIP;PDCD6;CHST14;TBC1D8;PLEKHM1;GCH1;NBEAL2;HFE;COL6A1;VPS51;SEMA3B;SEPT6;FGFR3;ST3GAL5;TNRC18;NDRG2;SPTLC2;CLK3;TMEM187;PKN3;APBA1;CHPF;SLC26A11;SDC2
12104,GO:0048167,0.00102490817798216,0.999600380214216,21,95,regulation of synaptic plasticity,BP,DLG4;PRNP;APOE;ITPR3;SERPINE2;NFATC4;MCTP1;SSH1;SHANK2;SYNGAP1;CRTC1;EPHB2;SHANK3;NSMF;VGF;RIMS3;PRKCZ;VAMP2;RGS14;SYNGR1;PPP3CB
18039,GO:1902532,0.00102613132285007,0.99938401734024,62,393,negative regulation of intracellular signal transduction,BP,TNIP1;DUSP6;XDH;DUSP5;PDCD4;PRNP;APOE;SERPINE2;SPRY2;SPRY4;FBLN1;PIK3R2;AKT1;WWC3;MAPKBP1;SORL1;ZNF385A;PODNL1;SYNGAP1;CARD19;DUSP7;ERRFI1;PKD2;EPHB2;TIMP2;ARHGAP25;RASA3;ARAP3;TNFAIP8L1;PTPN1;CAMK2N1;VHL;TRAP1;RASA4;ARHGAP44;PRKCD;SH3BP1;DUSP4;DDIT4;LEMD2;RPS6KA6;RGS14;GSTO1;CHAD;HDAC7;TMEM161A;SESN2;CDC34;MIF;WFS1;ARHGAP12;GRINA;C12ORF66;ITGA3;PPP2R5B;BCL2L1;KCTD13;SOCS7;PDCD6;SIRT3;NDRG2;CBLC
4641,GO:0010765,0.00104712658241239,0.999822738190036,8,21,positive regulation of sodium ion transport,BP,SCN4B;NOS1;PRSS8;AKT1;CNTN1;ANK3;DNM2;GLRX
12791,GO:0051094,0.00105372528728854,0.999270479923314,117,831,positive regulation of developmental process,BP,ZMYND8;ADGRL1;EGR1;DLG4;CYP27B1;PGF;CTNNBIP1;ACVR2B;BBS2;VEGFA;FAM210B;WNT7A;APOE;LRP5;HMGA2;SERPINE2;WWTR1;OBSL1;ETV5;RAPGEF3;ZFP36L1;LPAR3;MAP2K1;SMURF2;FOS;SMAD3;STAT6;SHANK2;GJC2;DVL1;SH3PXD2B;NLGN2;AKT1;CORO1B;EPHA1;VEGFB;IMPACT;CNTN1;WNT2B;FGFR1;RAG1;CEACAM1;HMG20B;ZNF385A;CCND1;TWF2;GAS6;PTK6;CSNK1E;ANGPTL4;CCDC71L;SLITRK6;ALOX15B;PLXNB3;BNIP3;YPEL3;CRTC1;FBXW8;AP3D1;EPHB2;ADAM8;PLCG1;CEBPB;TIMP2;WNT3;TGFB1;GPC1;SHANK3;NSMF;WASF3;AGRN;VHL;PRKCZ;ADA;ADGRB2;NET1;FAM20C;BAX;OLFM2;PPP1R13L;LIMK1;TGFBR3;GDI1;ZHX3;RGS14;MAPK12;HDAC7;INPP5D;ECM1;FYN;STK25;RAC3;EEF2K;DNM2;TPBG;INSR;HLA-G;PAK1;CUL7;HYAL1;CAPRIN2;ITGA3;BIN1;PPP2R5B;RRAS;PROX1;LMNA;SIRT2;FAM129B;CDH4;NGFR;PDCD6;CAMK1;BTG1;ZP3;ITPKB;PLAG1
14445,GO:0061771,0.00105548845439986,1,3,3,response to caloric restriction,BP,APOE;LDLR;SIRT2
18714,GO:1904064,0.00105976592974653,0.999649469196413,16,66,positive regulation of cation transmembrane transport,BP,F2R;NOS1;GJC2;ANK3;CEMIP;PKD2;EPHB2;PLCG1;NTSR1;SHANK3;TRPC1;BAX;GSTO1;EHD3;DNM2;GLRX
8919,GO:0034767,0.00107485897862395,0.99962917976635,17,72,positive regulation of ion transmembrane transport,BP,F2R;NOS1;GJC2;STK39;ANK3;CEMIP;PKD2;EPHB2;PLCG1;NTSR1;SHANK3;TRPC1;BAX;GSTO1;EHD3;DNM2;GLRX
11126,GO:0045178,0.00108166389572257,0.999736812369193,11,36,basal part of cell,CC,ITGA6;EGFR;MST1R;CEACAM1;ANK3;PKD2;CLCA2;ERBB2;ITGA1;HFE;SLC23A2
17724,GO:1901628,0.00108788317831892,1,3,3,positive regulation of postsynaptic membrane organization,BP,APOE;SSH1;LRP4
12662,GO:0050878,0.0011178347323658,0.999366529342523,50,307,regulation of body fluid levels,BP,XDH;PLAT;APLN;VEGFA;APOE;DGKA;F2R;ITPR3;SERPINE2;FBLN1;AKT1;F12;STK39;SERPING1;PRKACB;RAC2;CEACAM1;HMG20B;ZNF385A;DOCK6;CCND1;PLAU;GAS6;SH2B3;DGKQ;TFPI2;PROCR;EPHB2;APRT;ENTPD2;ADAMTS13;ATP7B;PHF21A;PRKACA;CD9;ADA;PRKCD;EHD3;ZFPM1;WFS1;FYN;MAPK3;ADCY1;DOCK9;MICAL1;ADCY7;MAFF;BLOC1S4;AK3;ADCY6
3391,GO:0007173,0.00113818874177693,0.999529151712897,23,109,epidermal growth factor receptor signaling pathway,BP,EGFR;SPRY2;SHC1;ARAP1;HBEGF;PAG1;AKT1;GRB7;FAM83A;RHBDF2;CEACAM1;PTK6;ERRFI1;MVB12B;PLCG1;TGFB1;AREG;ITGA1;EREG;RPS6KA5;TGFA;PXN;CBLC
1259,GO:0003012,0.00114401286823179,0.99940292555998,39,223,muscle system process,BP,DOCK4;BBS2;SLC6A8;F2R;SCN4B;OBSL1;NOS1;ACTA2;GAA;SMAD3;ADORA2B;TMOD2;DYSF;VEGFB;GAMT;TNNT1;EDNRA;GSN;ERRFI1;SNTA1;GTF2IRD1;ITGB5;HTR7;PRKACA;ADA;SMTN;ITGA1;PPP1R13L;TPM2;GSTO1;EHD3;PLA2G6;CAMTA2;TAZ;PAK1;MAP2K3;LMNA;LTB4R;PXN
8723,GO:0034380,0.00114526050927859,0.999912627386906,5,9,high-density lipoprotein particle assembly,BP,APOE;PRKACB;PRKACA;ZDHHC8;ABCA7
12668,GO:0050885,0.00115516172639687,0.999769770569717,9,26,neuromuscular process controlling balance,BP,DLG4;HEXB;GAA;NLGN2;BCR;TPP1;RAC3;BLOC1S4;AARS
5931,GO:0018209,0.00116312876778038,0.999387297735767,40,227,peptidyl-serine modification,BP,VEGFA;HMGA2;PKN1;EGFR;SPRY2;RAPGEF3;MAP2K2;AKT1;PPM1F;STK39;MAPK13;GAS6;CSNK1E;MAPKAPK3;DGKQ;TGFB1;MKNK2;IFNE;MLXIPL;PRKCZ;PRKACA;ULK1;PRKCD;BAX;RPS6KA5;DDIT4;MAPK12;CHEK2;MIF;MAPK3;PAK1;CAMKK2;CAPRIN2;STK32C;PKD1;MAP3K10;CAMK1;CAMKK1;PFN2;PKN3
17755,GO:1901681,0.00118791276144545,0.99946533445183,27,139,sulfur compound binding,MF,PGF;POSTN;VEGFA;APOE;ACOT7;SERPINE2;PTPRS;LTBP2;PC;LRP1;THBS3;HBEGF;VEGFB;FGFR4;FGFR1;SMOC2;ACBD4;FGFBP1;DHTKD1;HLCS;COL13A1;CBS;GPC1;HMGCL;AGRN;TGFBR3;GAL3ST4
4471,GO:0010469,0.00119010698823683,0.99938844998177,37,214,regulation of signaling receptor activity,BP,DLG4;APLN;PGF;VEGFA;WNT7A;SHC1;PHLDA2;CMTM7;SHANK2;HBEGF;NLGN2;VEGFB;PTHLH;PLAU;GAS6;CMTM4;PCSK9;ERRFI1;EPHB2;WNT3;TGFB1;SHANK3;TNFSF15;VGF;IFNE;CD320;MINK1;AREG;PRKCD;EREG;TGFA;MIF;PPP2R5B;HFE;ZP3;CBLC;KLHL24
14860,GO:0070640,0.00122236855752584,1,3,3,vitamin D3 metabolic process,BP,CYP27B1;FGFR1;CYP2R1
7030,GO:0030810,0.00122282949713689,0.999722528609422,10,32,positive regulation of nucleotide biosynthetic process,BP,APOE;NOS1;ADORA2B;PTHLH;TIMP2;PFKFB2;MLXIPL;INSR;TAZ;PFKFB3
17484,GO:1900373,0.00122282949713689,0.999722528609422,10,32,positive regulation of purine nucleotide biosynthetic process,BP,APOE;NOS1;ADORA2B;PTHLH;TIMP2;PFKFB2;MLXIPL;INSR;TAZ;PFKFB3
4383,GO:0010038,0.00123024409803536,0.999360905502125,38,218,response to metal ion,BP,ERCC1;PRNP;NDRG1;ITPR3;EGFR;NFATC4;SDC1;ENDOG;FOS;CYBRD1;D2HGDH;AKT1;UROS;ENTPD6;BSG;ANK3;CCND1;GSN;IGFBP2;BNIP3;PKD2;ADAMTS13;ATP7B;TRPC1;RASA4;CARF;MT2A;GDI1;CPNE7;EEF2K;CAT;CYP2R1;MAPK3;ADCY1;DNMT3A;PDCD6;HFE;ITPKB
18004,GO:1902430,0.00123417561313342,0.999904171918887,5,9,negative regulation of amyloid-beta formation,BP,PRNP;APOE;SORL1;ABCA7;BIN1
11330,GO:0045664,0.00123541883890969,0.99924297994986,65,416,regulation of neuron differentiation,BP,ZMYND8;SEMA4B;DLG4;VEGFA;WNT7A;APOE;OBSL1;PTPRS;NFATC4;ETV5;LPAR3;MAP2K1;SSH1;SHANK2;LRP1;DVL1;AKT1;IMPACT;CNTN1;FGFR1;HMG20B;TWF2;SYNGAP1;PTK6;SEMA3F;CSNK1E;PLXNB3;CTSZ;CRTC1;FBXW8;EPHB2;TIMP2;WNT3;ULK2;SHANK3;EFNB3;NSMF;SEMA4F;LRP4;ARHGAP44;DGUOK;LIMK1;GDI1;FYN;STK25;RAC3;EEF2K;DNM2;PAK1;CUL7;SEMA4C;CAPRIN2;ITGA3;BIN1;PPP2R5B;PROX1;CDH4;RAP1GAP2;NGFR;KIF13B;CAMK1;SEMA3B;SSH3;ADCY6;SDC2
17761,GO:1901700,0.0012405896843182,0.999111890113486,138,1021,response to oxygen-containing compound,BP,TNIP1;ERCC1;EGR1;NR1D1;EDEM1;CST3;CYP27B1;PDCD4;ACVR2B;PRNP;POSTN;FAM210B;TNFRSF6B;WNT7A;APOE;F2R;LRP5;EGFR;LOXL1;NOS1;HADH;CAPN2;NFATC4;SDC1;SHC1;PTPRE;RAPGEF3;TXNRD3;ZFP36L1;GLUL;ACP5;SSH1;ENDOG;FOS;STAT6;PIK3R2;ERCC6;LRP1;PRDX5;AKT1;HDAC5;BSG;IMPACT;RAB31;LDLR;PRKACB;PFKL;CEACAM1;CCND1;TWF2;MAPK13;GAS6;PTK6;GSN;MAPKAPK3;IGFBP2;PCSK9;BCR;ERRFI1;HLCS;CCS;DGKQ;BNIP3;PKD2;GPX3;ABCA2;APRT;CEBPB;ADAMTS13;WNT3;TGFB1;NSMF;VGF;ANKZF1;HMGCL;PTPN1;PCK2;AGRN;MBD3;TRAP1;PFKFB2;MLXIPL;PRKCZ;KDM6B;PRKACA;CD9;ADA;AREG;VAMP2;JAK3;NET1;PRKCD;CYC1;EREG;DDIT4;TGFBR3;IRAK1;MTHFR;CHEK2;PPARA;TMEM161A;SESN2;MIF;PLA2G6;FYN;STK25;EEF2K;DNM2;GLB1;PELI1;CAT;IGFBP7;SLC27A1;MAPK3;INSR;ADCY1;PAK1;CAMKK2;PPP3CB;HYAL1;WDTC1;DNMT3A;BCL2L1;TNFRSF25;SIRT2;ADCY7;SOCS7;NGFR;ATP6V1F;PXN;GRB10;GCH1;COL6A1;BTG1;LRP11;HOMER2;SRSF5;ADCY6
6736,GO:0030160,0.00127860796741632,1,3,3,GKAP/Homer scaffold activity,MF,SHANK2;SHANK3;HOMER2
18634,GO:1903911,0.00131024560183183,1,3,3,positive regulation of receptor clustering,BP,SSH1;TGFB1;LRP4
5837,GO:0017124,0.00131157810286685,0.999476819128359,21,97,SH3 domain binding,MF,DOCK4;ESPN;SHANK2;SH2D2A;ELMO3;EFS;SYNGAP1;ERRFI1;WIPF1;ARHGAP27;SH3BP2;SHANK3;ADAM19;KHDRBS3;SH3BP1;ADAM15;INPP5D;DNM2;MICAL1;SOCS7;CBLC
1708,GO:0004252,0.00132189039022613,0.999517097165335,18,79,serine-type endopeptidase activity,MF,HTRA1;PLAT;TYSND1;PRSS8;MMP1;F12;RHBDF2;PLAU;CTSB;PCSK9;PRSS22;PCSK1;PRSS3;ADAM8;TPP1;MMP10;LONP2;PRSS21
96,GO:0000187,0.00132312968687424,0.999458099627045,22,104,activation of MAPK activity,BP,DUSP6;DUSP5;PKN1;SHC1;MAP2K2;LPAR3;MAP2K1;ERCC6;SHC2;ADORA2B;STK39;DUSP7;MAPKAPK3;CD81;PTPN1;ITGA1;IRAK1;TGFA;MAPK3;INSR;MAP2K3;MAP3K10
1512,GO:0003872,0.00132701527906335,1,3,3,6-phosphofructokinase activity,MF,PFKL;PFKP;PFKM
7451,GO:0031594,0.00136427724997449,0.999656025928614,11,37,neuromuscular junction,CC,DLG4;POSTN;F2R;SERPINE2;KCNC4;ANK3;SNTA1;LRP4;SV2A;SYNGR1;DLG3
9787,GO:0040012,0.00137357995312814,0.99908795728923,90,619,regulation of locomotion,BP,ZMYND8;SEMA4B;PGF;DOCK4;BBS2;POSTN;VEGFA;WNT7A;APOE;F2R;ITGA6;IDH2;PKN1;NISCH;EGFR;SERPINE2;SPRY2;PHLDA2;PC;MCTP1;SSH1;SMURF2;FBLN1;SMAD3;LRP1;HBEGF;FAM110C;ADARB1;AKT1;GRB7;CORO1B;HDAC5;PPM1F;MMP28;EPHA1;PTPRU;VEGFB;FGFR1;RAC2;SORL1;CEACAM1;PLAU;GAS6;SEMA3F;LAMA5;BCR;ARPIN;ALOX15B;PLXNB3;CEMIP;ADAM8;PLCG1;CD81;WNT3;TGFB1;NSMF;ARAP3;RHOD;SEMA4F;RHOF;RHOBTB2;MINK1;ADA;ERBB2;MMP10;CYGB;SH3BP1;EREG;ADAM15;HDAC7;MIF;DDT;ECM1;MAPK3;INSR;PAK1;ROBO4;HYAL1;SEMA4C;ITGA3;MAP2K3;RRAS;PROX1;LMNA;ITGA4;LAMB1;PDCD6;ZP3;SEMA3B;PFN2
16423,GO:0097062,0.00138101197716948,0.999838574342119,6,13,dendritic spine maintenance,BP,ZMYND8;PRNP;APOE;FYN;INSR;ITGA3
7315,GO:0031331,0.00138197380663758,0.999223832007972,47,281,positive regulation of cellular catabolic process,BP,EDEM1;APOE;TRIM65;VPS11;GTPBP1;SNX9;RAPGEF3;ZFP36L1;ENDOG;LRP1;DVL1;AKT1;TPCN1;LDLR;CSNK1E;PCSK9;RAD23A;SH3D19;BNIP3;FYCO1;GPSM1;MAGEF1;ADAM8;CD81;SNX33;PTPN1;PFKFB2;MLXIPL;TRIB2;PIM2;ULK1;BNIP3L;PRKCD;STUB1;BAX;LRSAM1;PPARA;SESN2;RAB12;BCAP31;MAPK3;INSR;CAMKK2;RNF144A;PFKFB3;SIRT2;SPTLC2
12614,GO:0050807,0.0013892548411834,0.999443115959795,21,97,regulation of synapse organization,BP,ZMYND8;ADGRL1;PRNP;WNT7A;APOE;NFATC4;ETV5;SSH1;NLGN2;SLITRK6;EPHB2;SHANK3;AGRN;LRP4;ADGRB2;ARHGAP44;FYN;EEF2K;TPBG;CAPRIN2;CAMK1
6625,GO:0022898,0.00139818478481413,0.999374288438932,26,132,regulation of transmembrane transporter activity,BP,FHL1;DLG4;KCNG1;PRNP;SCN4B;NOS1;SHANK2;NLGN2;STOM;STK39;ANK3;PCSK9;PKD2;EPHB2;NTSR1;SHANK3;PRKACA;MINK1;VAMP2;CACNB3;GSTO1;EHD3;PLA2G6;DNM2;GLRX;KLHL24
14017,GO:0060753,0.00140006294078355,0.999937789069744,4,6,regulation of mast cell chemotaxis,BP,PGF;VEGFA;VEGFB;RAC2
12889,GO:0051240,0.00141302972367453,0.998989537066798,134,982,positive regulation of multicellular organismal process,BP,ZMYND8;ADGRL1;EGR1;DLG4;CYP27B1;APLN;PGF;CTNNBIP1;ACVR2B;BBS2;POSTN;VEGFA;FAM210B;WNT7A;APOE;F2R;HMGA2;EGFR;SERPINE2;WWTR1;OBSL1;NOS1;NFATC4;ETV5;RAPGEF3;ZFP36L1;LPAR3;MAP2K1;SMURF2;FOS;SMAD3;STAT6;SHANK2;LRP1;GJC2;DVL1;HBEGF;SH3PXD2B;NLGN2;ADORA2B;AKT1;F12;PPM1F;HK1;EPHA1;VEGFB;IMPACT;CNTN1;WNT2B;LDLR;FGFR1;RAG1;CEACAM1;HMG20B;CCND1;TWF2;MAPK13;GAS6;PTK6;CSNK1E;CARD11;ANGPTL4;SLITRK6;ALOX15B;PLXNB3;CRTC1;IL20RB;FBXW8;AP3D1;EPHB2;ADAM8;PLCG1;CEBPB;RNF135;TIMP2;WNT3;TGFB1;GPC1;TMEM173;SHANK3;NSMF;WASF3;AGRN;PRKCZ;ADA;ADGRB2;FAM20C;BAX;EREG;LIMK1;TGFBR3;GDI1;ZHX3;RGS14;GSTO1;IRAK1;HDAC7;INPP5D;ZFPM1;ABCA7;MIF;DDT;ECM1;FYN;STK25;EEF2K;PELI1;SLC27A1;TPBG;MAPK3;HLA-G;PAK1;CUL7;HYAL1;CAPRIN2;ITGA3;BIN1;PPP2R5B;MAP2K3;RRAS;PROX1;SIRT2;FAM129B;CDH4;NGFR;PDCD6;PLEKHM1;GCH1;LURAP1;CAMK1;BTG1;ZP3;ITPKB;PLAG1
3555,GO:0007599,0.00141652997369069,0.999264471374847,37,214,hemostasis,BP,PLAT;APOE;DGKA;F2R;ITPR3;SERPINE2;FBLN1;AKT1;F12;SERPING1;PRKACB;RAC2;CEACAM1;HMG20B;ZNF385A;DOCK6;PLAU;GAS6;SH2B3;DGKQ;TFPI2;PROCR;ENTPD2;ADAMTS13;PHF21A;PRKACA;CD9;PRKCD;EHD3;ZFPM1;FYN;MAPK3;DOCK9;MICAL1;MAFF;BLOC1S4;AK3
5319,GO:0016042,0.0014315908842264,0.999264191916063,36,204,lipid catabolic process,BP,CYP27B1;TYSND1;APOE;PLD3;CRAT;HADH;HEXB;PLCD3;CPT2;SRD5A3;PLCXD2;AKT1;LDLR;FUCA1;ABCD1;AIG1;PLCH2;PLCG1;SNX17;PCK2;ACAD10;PRKCD;ACADS;CES2;NAGA;LONP2;DECR2;PPARA;SESN2;PHYH;PLA2G6;ETFB;PLCB3;MLYCD;SIRT2;HSD11B1
1265,GO:0003018,0.00143468164797372,0.999454666028067,19,85,vascular process in circulatory system,BP,APLN;CTNNBIP1;DOCK4;BBS2;APOE;F2R;EGFR;NOS1;ADORA2B;AKT1;CEACAM1;EDNRA;BCR;TGFB1;HTR7;ITGA1;PLA2G6;GCH1;ADCY6
4564,GO:0010647,0.00144049604109837,0.998947875993259,153,1151,positive regulation of cell communication,BP,DUSP6;XDH;DUSP5;DLG4;CYP27B1;APLN;PDCD4;ACVR2B;PRNP;VEGFA;WNT7A;APOE;F2R;ITPR3;PKN1;EGFR;SERPINE2;NOS1;SPRY2;MST1R;NFATC4;SHC1;GLUL;ARAP1;MAP2K2;LPAR3;RBCK1;MAP2K1;SSH1;SMURF2;SMAD3;SHANK2;PIK3R2;ERCC6;DVL1;HBEGF;FAM110C;S100A4;SHC2;NLGN2;PAG1;ADORA2B;AKT1;GRB7;TMOD2;SH2D2A;STK39;EPHA1;FGFR4;WNT2B;FGFR1;ZNF385A;ANK3;IGFBP4;EVC;GAS6;PTK6;FGFBP1;CSNK1E;RAB3B;CARD11;SH2B3;DUSP7;GSN;MAPKAPK3;RGL2;ALOX15B;SLC20A1;BNIP3;SHARPIN;PKD2;RASGEF1A;CRTC1;EPHB2;ADAM8;CDKN1C;PLCG1;SH3BP2;CD81;TIMP2;WNT3;TMED4;TGFB1;MOAP1;NTSR1;SHANK3;TNFSF15;MC1R;KIF7;RIMS3;PTPN1;PCK2;WDR59;PFKFB2;RFNG;PRKCZ;MINK1;EPN2;ADA;PIM2;PLEKHG5;BOK;ERBB2;VAMP2;TFDP2;CYFIP2;PRKCD;MIB2;BAX;ITGA1;EREG;RASL10B;TGFBR3;RGS14;MFNG;GSTO1;IRAK1;TGFA;ABCA7;BCAP31;MIF;PLA2G6;DDT;ECM1;FYN;STK25;PELI1;CAT;MAPK3;INSR;PFKM;TMEM101;VANGL2;PAK1;PPP3CB;SEMA4C;CAPRIN2;PPP2R5B;MAP2K3;BCL2L1;KCTD13;TNFRSF25;EDA;MAP3K10;NGFR;GRB10;LURAP1;SIRT3;HFE;FGFR3;ITPKB;DEDD2;LRRK1
13729,GO:0060312,0.0014544099989146,0.99993467132081,4,6,regulation of blood vessel remodeling,BP,CST3;CEACAM1;BCR;TGFB1
7003,GO:0030695,0.0014689295630198,0.999195958503169,43,250,GTPase regulator activity,MF,DOCK4;EVI5L;APPL2;TBC1D14;ARL2;RIN1;ARAP1;ARHGAP23;PIK3R2;ASAP2;RALGDS;SYNGAP1;ARHGAP22;BCR;ERRFI1;ARHGAP27;AGAP1;CDC42EP5;GPSM1;TBC1D9B;ARHGAP25;RASA3;ARAP3;LLGL1;ADAP1;RASA4;ARHGAP44;SH3BP1;GDI1;RGS14;GIT1;SESN2;ARHGAP12;ACAP3;ARHGEF1;RALGAPA1;SGSM2;TBC1D16;RABGAP1;TRIP10;RAP1GAP2;RGS19;TBC1D8
16615,GO:0097458,0.00147737634271088,0.99894722611613,130,947,neuron part,CC,ZMYND8;ADGRL1;NR1D1;DLG4;CST3;FBXO2;PRR7;DOCK4;PRNP;BBS2;WNT7A;APOE;ESPN;ITPR3;SH2D5;NOS1;PTPRS;CAPN2;SYTL1;GLUL;LPAR3;MCTP1;SSH1;ENDOG;MARK4;FOS;SHANK2;LRP1;GJC2;DVL1;S100A4;NLGN2;SYT8;KCNC4;TMOD2;EPHA1;BRSK1;IFT140;LDLR;SIGMAR1;KCNAB2;NPHP4;TENM2;ZNF385A;ANK3;TWF2;SYNGAP1;RAB3B;BCR;DBNDD1;BNIP3;SHARPIN;CTSZ;CRTC1;AP3D1;EPHB2;GRIN3B;KIF17;TIMP2;SYNJ2;TGFB1;SNPH;ABHD17C;NTSR1;SHANK3;NSMF;FARP1;CROCC;HTR7;PI4K2A;LLGL1;RIMS3;CAMK2N1;LRP4;PRKCZ;MINK1;ADA;MICALL2;ULK1;AHCY;VAMP2;CYFIP2;FSCN1;CYGB;ARHGAP44;REEP6;SV2A;ITGA1;LIMK1;GDI1;DNM1;RGS14;SCN8A;MYO1D;SYNGR1;WFS1;FYN;RAC3;EEF2K;DNM2;ATXN10;INSR;MORN4;PAK1;GABBR1;MICAL1;SEMA4C;ITGA3;BIN1;VPS16;BCL2L1;DLG3;SIRT2;AZIN2;ICA1;RAP1GAP2;RAB40B;NGFR;PCLO;GCH1;KIF13B;SEPT6;PFN2;NDRG2;BLOC1S4;TRIM46;HOMER2;APBA1;KLHL24;STRN4
10891,GO:0044444,0.00148587704679699,0.998782792748089,806,7192,cytoplasmic part,CC,TNIP1;DUSP6;NT5E;XDH;ERCC1;H1F0;HTRA1;FHL1;B4GALNT4;H6PD;EDEM1;DLG4;PLAT;CST3;CYP27B1;TYSND1;HS1BP3;BTBD2;EPN3;FBXO2;APLN;PRR7;PDCD4;CTNNBIP1;NAGS;DOCK4;XPC;PRNP;PARVB;PYGB;BBS2;FLNC;POSTN;VEGFA;FAM210B;PGM1;WNT7A;APOE;PYGL;DGKA;TSPAN1;NAGLU;F2R;LRP5;PLD3;OSBPL5;LPCAT4;ISYNA1;PITPNC1;OBSCN;NDRG1;IDH2;NEK9;CRAT;ELK3;ITPR3;PKN1;MTA1;GRAMD4;ACOT7;ARRDC1;ANGEL1;ACSF2;NISCH;AKR7A2;EGFR;RPS6KA2;SERPINE2;DNPH1;WWTR1;LOXL1;OBSL1;NOS1;VAT1;PTPRS;TMEM129;HADH;CTSO;SPRY2;CAPN2;MST1R;NFATC4;TRIM65;CRTAP;SYTL1;SDC1;LMF1;APPL2;SHC1;VPS11;LTBP1;TBC1D14;ARL2;HEXB;GTPBP1;SLC2A3;ALDH4A1;TK2;RIN1;ACTA2;CLIP2;SNX9;SPRY4;RAPGEF3;TXNRD3;ST6GALNAC2;ZFP36L1;GAA;GLUL;ARAP1;MAP2K2;KDSR;NME4;MARCH9;CTBS;PLCD3;FKBP9;PTOV1;RBCK1;SUGCT;PGLS;PC;MAP2K1;NAPRT;CRYL1;ACP5;CPT2;MCTP1;SSH1;EXOC2;ENDOG;MARK4;MPRIP;TMEM8A;GALE;SMURF2;KLC2;ARMCX2;OXLD1;FOS;SMAD3;ARHGAP23;STAT6;SHANK2;PIK3R2;LRP1;SRD5A3;DVL1;EPAS1;DNAJB5;PIGQ;HSD17B8;THBS3;HBEGF;FAM110C;RPUSD3;AP2A2;S100A4;CYBRD1;PPP1R14A;PRDX5;SHC2;STOM;PRODH;MBOAT7;REEP4;LY6K;FBXW5;RNF187;NMRK1;ADARB1;D2HGDH;SYT8;AKT1;TPCN1;GRB7;TMOD2;CORO1B;HDAC5;UROS;FBXO41;S100A6;F12;SH2D2A;PPM1F;PITPNM1;ENTPD6;RHBDF2;PYCR2;BSG;STK39;HK1;SERPING1;ASAP2;DYSF;NFKBIZ;VEGFB;FMNL2;MARCH4;SLC15A4;WWC3;ATG16L2;ZFYVE21;IFNGR2;BRSK1;IFT140;PTHLH;MYZAP;RAB31;FGFR4;POLD4;ACOT1;FNDC4;LDLR;FGFR1;PRKACB;FUCA1;SIGMAR1;RAC2;KCNAB2;PFKL;SEC14L2;OPLAH;MXI1;NPHP4;SYNE3;GAMT;B4GAT1;PACS2;PHF7;TOMM34;BPHL;PIGV;RALGDS;SORL1;CEACAM1;B3GAT3;ASB13;CIRBP;CBR4;LZTS2;RAB11FIP4;TENM2;DOCK6;ABCD1;ANK3;NIPSNAP1;IGFBP4;TTC7B;TRAPPC9;CCND1;PCBP4;LHPP;TNNT1;TWF2;STRADB;SYNGAP1;MAPK13;CEP250;CARD19;PLAU;GAS6;PTK6;PFKP;CSNK1E;BRI3;CTSB;RAB3B;CARD11;SH2B3;DUSP7;MPLKIP;GSN;PLEKHG2;MAPKAPK3;IGFBP2;PCSK9;ARHGAP22;RAD23A;DHTKD1;PHLDA1;ANO8;BCR;ANTXR2;XPOT;MRPS6;EHD4;ERRFI1;SEPT10;WIPF1;NADK;HLCS;AIP;DBNDD1;SH3D19;CCDC113;CDC25B;SH3GLB2;ARHGAP27;ALOX15B;SPTB;AGAP1;COMTD1;PEX10;CCS;RSAD1;COL13A1;CORO7;NPR2;UNC119B;DGKQ;HAGH;BNIP3;NOL4L;GTF2IRD1;SHARPIN;MVB12B;FYCO1;CEMIP;PKD2;ACY1;PCSK1;RETSAT;RASGEF1A;CTSZ;CDC42EP5;CRTC1;FBXW8;GPSM1;AP3D1;ITGB5;ABCA2;PRSS3;SH3PXD2A;C19ORF33;EPHB2;ADAM8;ASIC1;APRT;TMEM9;CTBP1;JOSD2;LTA4H;GRIP2;PLCG1;FBXL8;ZMIZ2;CBS;KIF17;MVD;RNF135;ENTPD2;LGALS9B;ADAMTS13;ZNF217;TIMP2;SYNJ2;WNT3;DPP7;TMED4;TGFB1;LACTB2;SNPH;CLTCL1;SCYL1;ABHD17C;SNTB2;ULK2;GPC1;ADAMTS7;MOAP1;SLC38A10;NTSR1;B3GNT3;TMEM173;ARHGAP25;TMEM134;ATP7B;FHOD3;SHANK3;PODXL2;SDHA;MSRB2;RASA3;PNRC1;MIPEP;PIP5KL1;MGAT4B;MDH2;MPG;GALNS;FBXO17;CLCA2;GOLGA2P5;ENKD1;NSMF;PEG3;ARAP3;FARP1;TUB;DIRC2;CROCC;RHOD;ABHD14B;LAMB2;ABTB1;SNX17;RNH1;DNAH1;ERO1B;ST6GALNAC6;VGF;FBXO44;SNX33;PI4K2A;SEMA4F;C1ORF210;RHOF;YIPF3;ANKZF1;ATG2A;SLC48A1;LLGL1;PHGDH;MIF4GD;COA5;RHOBTB2;UBXN4;ADAM19;TUBG2;RIMS3;BBS1;HMGCL;PTPN1;PEX1;TPP1;PCK2;B4GALT2;WDR59;AGRN;CD320;OSBPL10;ESYT2;ZDHHC24;ACP6;B4GALT6;VHL;CEP131;TRAP1;IDUA;ADAP1;PFKFB2;RFNG;MLXIPL;YPEL5;PRKCZ;PRKACA;MINK1;CENPH;GRHPR;OXA1L;RHPN1;RABGGTA;RCCD1;ACTR1B;CD9;EPN2;ADA;AREG;MPI;MICALL2;UCKL1;LGALS9C;PLEKHG5;BOK;TDRKH;CAPG;SDCCAG8;ALAS1;NEURL1B;ERBB2;ULK1;CNDP2;NINL;AHCY;VAMP2;CERCAM;PRIMPOL;TMEM143;TFDP2;C6ORF89;MZT2A;NECAB3;RILPL1;JAK3;RNPEP;NET1;BNIP3L;CYFIP2;FSCN1;SLC22A17;RASA4;PDK1;ACAD10;CYGB;ARHGAP44;THOP1;EHBP1L1;MCFD2;PRKCD;FAM20C;MIB2;REEP6;RBL2;CACNB3;USP20;STUB1;IFI6;BAX;CYC1;SV2A;SBF1;DTD1;XYLT2;TRIM4;ITGA1;ZNF395;HIST3H2BB;CCDC92;NUBP2;PPCS;SH3BP1;FBXW4;DGUOK;TIMM17B;CUL9;TMBIM4;DDIT4;MBTPS2;ACADS;PPL;PPP1R13L;HSD17B7;AHNAK2;PCSK1N;MT2A;CES2;NAGA;ZDHHC8;TMX4;MZT2B;FCHO1;LIMK1;PDIA5;GDI1;TPM2;PADI3;RPL39L;LEMD2;RPS6KA6;DNM1;WASH3P;TMEM8B;SCN8A;MFNG;GSTO1;GIT1;ALDOC;MRPS26;MSLN;LPCAT1;LRSAM1;ADAM15;REEP2;ASB1;EHD3;WDR60;ST3GAL3;LONP2;SYMPK;MAPK12;IRAK1;PPOX;TGFA;HDAC7;FHOD1;INPP5D;MTHFR;PI4K2B;CBX7;CHEK2;DECR2;COG7;COQ2;SESN2;ABCG1;MYO1D;MYH15;CDC34;RNF123;SNN;ABCA7;RAB12;BCAP31;MIF;ACO2;SMOX;EEF2KMT;SLC25A29;DOPEY2;PHYH;MEX3A;SLC9A7;PLA2G6;SYNGR1;NUDT14;ECM1;WFS1;QSOX1;CD68;SPPL2B;FYN;PITPNM3;VWA1;UPP1;STK25;RAC3;ETFB;GLB1L2;EEF2K;CERS4;SUN1;ARHGAP12;FLYWCH1;ACAP3;DNM2;CKMT1A;CYP3A5;GLB1;PELI1;ATXN10;SNX15;INF2;CHKA;CAT;IGFBP7;ARMCX1;SLC27A1;TPBG;APOBEC3C;SLC50A1;KIF26A;ASMTL;ZDHHC1;SLC12A4;PLCB3;APOBEC3F;ARHGEF4;CYP2R1;MAPK3;CBLN3;INSR;RTN2;ARHGEF1;PAN2;GRINA;PDZD2;TAZ;PFKM;ADCY1;TNS4;C12ORF66;HLA-G;DOCK9;STX10;TSTA3;ATP8B2;GPT2;PDXK;PRAF2;GLRX;CEP72;VANGL2;PAK1;TRIM45;MALL;CAMKK2;RNASET2;PPP3CB;RNF144A;LGALS3BP;CTSF;USP21;PFKFB3;MLYCD;CUL7;SLC37A2;MICAL1;HYAL1;SEMA4C;CAPRIN2;WDTC1;ITGA3;SAMD8;BIN1;VPS16;MAN2B1;SRMS;TSTD1;PPP2R5B;SLC16A13;MAP2K3;NDST2;BCL2L1;DLG3;SGSM2;ABHD10;NDUFV3;DNASE1L1;IARS2;TBC1D16;ALDH7A1;LMNA;PKD1;TNFRSF25;RABGAP1;SIRT2;FAM129B;EDA;ANKRD13D;GAL3ST4;NMNAT2;BACH1;NT5C1B;TRIP10;ADCY7;ALG12;AZIN2;SERPINB1;ST3GAL2;ICA1;SLC25A37;RAP1GAP2;LAMB1;SOCS7;HSDL1;RGS19;NDE1;HSD11B1;PELI3;RAB40B;NGFR;TOLLIP;PDCD6;ATP6V1F;PCLO;CHST14;PXN;GRB10;PHYKPL;PLEKHM1;DUSP23;GCH1;MSS51;KIF13B;MAFF;TCTN1;NBEAL2;CAMKK1;SIRT3;HFE;WIPI2;COL6A1;VPS51;SEMA3B;SEPT6;C2CD2;FGFR3;MFSD10;TST;ST3GAL5;TNRC18;NDRG2;MAN2B2;BLOC1S4;ITPKB;SPTLC2;CDC42BPG;DOK4;GSDMA;CLK3;TRIM46;DHX32;TMEM187;HOMER2;PKN3;APBA1;TTLL3;AK3;SRSF5;CHPF;ADCY6;SLC26A11;LRRK1;AARS;SDC2
11529,GO:0046068,0.00149750356790406,0.999727260304046,8,22,cGMP metabolic process,BP,VEGFA;APOE;NOS1;ADORA2B;NPR2;ADCY1;ADCY7;ADCY6
10808,GO:0044304,0.00150645956294446,0.999615208140088,11,37,main axon,CC,DLG4;GJC2;KCNAB2;ANK3;DNM1;SCN8A;MYO1D;BIN1;SIRT2;KIF13B;TRIM46
17738,GO:1901658,0.00150714992372507,0.999681563606711,9,28,glycosyl compound catabolic process,BP,NT5E;FUCA1;ADA;AHCY;NAGA;UPP1;APOBEC3C;APOBEC3F;ABHD10
12051,GO:0048010,0.00151117550509371,0.99946027918764,17,73,vascular endothelial growth factor receptor signaling pathway,BP,PGF;VEGFA;PIK3R2;SHC2;SH2D2A;VEGFB;MAPK13;MAPKAPK3;PTPN1;EPN2;CYFIP2;MAPK12;FYN;FAM129B;PDCD6;PXN;GRB10
12695,GO:0050922,0.00154203007989478,0.999636249393255,10,33,negative regulation of chemotaxis,BP,SEMA4B;CORO1B;MMP28;SEMA3F;WNT3;SEMA4F;MIF;DDT;SEMA4C;SEMA3B
14507,GO:0065005,0.00154226374890849,0.999760805322084,7,18,protein-lipid complex assembly,BP,APOE;SNX9;PRKACB;PRKACA;ZDHHC8;ABCA7;BIN1
10513,GO:0043434,0.00154547582037795,0.999115147355612,49,299,response to peptide hormone,BP,EGR1;LRP5;HADH;SHC1;PTPRE;ZFP36L1;PIK3R2;AKT1;HDAC5;BSG;RAB31;PRKACB;CEACAM1;PCSK9;ERRFI1;APRT;TGFB1;VGF;PTPN1;PCK2;PRKCZ;PRKACA;AREG;VAMP2;JAK3;PRKCD;CYC1;EREG;TGFBR3;PPARA;SESN2;FYN;EEF2K;CAT;SLC27A1;MAPK3;INSR;ADCY1;PAK1;WDTC1;ADCY7;SOCS7;NGFR;ATP6V1F;PXN;GRB10;BTG1;SRSF5;ADCY6
9956,GO:0042339,0.00154595027133428,0.999674936370024,9,27,keratan sulfate metabolic process,BP,HEXB;B4GAT1;B3GNT3;GALNS;B4GALT2;B4GALT6;ST3GAL3;GLB1;ST3GAL2
3261,GO:0006935,0.00154664683185634,0.999078999813886,56,357,chemotaxis,BP,SEMA4B;PGF;DOCK4;VEGFA;SHC1;CMTM7;MAP2K1;SMAD3;DVL1;HBEGF;GRB7;CORO1B;PPM1F;MMP28;VEGFB;FGFR1;RAC2;B4GAT1;KLF7;PLAU;GAS6;SEMA3F;CMTM4;SPTB;PLXNB3;EPHB2;ADAM8;PLCG1;WNT3;TGFB1;GPC1;SHANK3;EFNB3;LAMB2;SEMA4F;PLEKHG5;ERBB2;CYFIP2;PRKCD;ITGA1;RPS6KA5;LTB4R2;MIF;PLA2G6;DDT;FYN;RAC3;MAPK3;VANGL2;SEMA4C;FAM129B;CDH4;NGFR;GRB10;SEMA3B;DOK4
9954,GO:0042330,0.00154664683185634,0.999078999813886,56,357,taxis,BP,SEMA4B;PGF;DOCK4;VEGFA;SHC1;CMTM7;MAP2K1;SMAD3;DVL1;HBEGF;GRB7;CORO1B;PPM1F;MMP28;VEGFB;FGFR1;RAC2;B4GAT1;KLF7;PLAU;GAS6;SEMA3F;CMTM4;SPTB;PLXNB3;EPHB2;ADAM8;PLCG1;WNT3;TGFB1;GPC1;SHANK3;EFNB3;LAMB2;SEMA4F;PLEKHG5;ERBB2;CYFIP2;PRKCD;ITGA1;RPS6KA5;LTB4R2;MIF;PLA2G6;DDT;FYN;RAC3;MAPK3;VANGL2;SEMA4C;FAM129B;CDH4;NGFR;GRB10;SEMA3B;DOK4
2655,GO:0006002,0.0015748564512582,0.999927640828483,4,6,fructose 6-phosphate metabolic process,BP,PFKL;PFKP;MPI;PFKM
10885,GO:0044433,0.00158718286717489,0.998852727758736,140,1046,cytoplasmic vesicle part,CC,DLG4;CST3;PYGB;VEGFA;PGM1;WNT7A;APOE;PYGL;NDRG1;ITPR3;EGFR;VAT1;PTPRS;APPL2;VPS11;HEXB;SLC2A3;SNX9;GAA;NAPRT;MCTP1;LRP1;HBEGF;AP2A2;STOM;SYT8;TPCN1;BSG;SERPING1;DYSF;VEGFB;SLC15A4;ZFYVE21;IFNGR2;RAB31;LDLR;FUCA1;RAC2;KCNAB2;PFKL;SORL1;CEACAM1;RAB11FIP4;PLAU;GAS6;BRI3;CTSB;RAB3B;GSN;PCSK9;ANTXR2;EHD4;DBNDD1;MVB12B;CEMIP;PKD2;PCSK1;CTSZ;AP3D1;ABCA2;PRSS3;ADAM8;APRT;TMEM9;LTA4H;TIMP2;WNT3;DPP7;TGFB1;CLTCL1;SCYL1;ABHD17C;SNTB2;ULK2;TMEM173;GALNS;RHOD;SNX17;SNX33;PI4K2A;RHOF;SLC48A1;LLGL1;CD320;YPEL5;ACTR1B;CD9;EPN2;ADA;AREG;BOK;ERBB2;VAMP2;MCFD2;PRKCD;SV2A;AHNAK2;ZDHHC8;WASH3P;ALDOC;LPCAT1;EHD3;IRAK1;TGFA;ABCA7;RAB12;MIF;SLC9A7;SYNGR1;ECM1;QSOX1;CD68;SPPL2B;SUN1;DNM2;GLB1;SNX15;CAT;INSR;HLA-G;PDXK;PRAF2;RNASET2;RNF144A;LGALS3BP;SEMA4C;VPS16;MAN2B1;BCL2L1;DNASE1L1;PKD1;SERPINB1;ICA1;RAB40B;TOLLIP;PDCD6;PLEKHM1;NBEAL2;VPS51;MFSD10
18191,GO:1902950,0.00158977338131882,0.999926758857145,4,6,regulation of dendritic spine maintenance,BP,ZMYND8;PRNP;APOE;FYN
15856,GO:0072578,0.00160695483535383,0.999925739983717,4,6,neurotransmitter-gated ion channel clustering,BP,DLG4;APOE;SSH1;SHANK3
4855,GO:0014069,0.00161357546844338,0.999234347796845,29,151,postsynaptic density,CC,DLG4;PRNP;SH2D5;NOS1;PTPRS;SHANK2;DVL1;SIGMAR1;KCNAB2;SYNGAP1;BCR;BNIP3;SHARPIN;ABHD17C;SHANK3;NSMF;CAMK2N1;LRP4;MINK1;ARHGAP44;DNM1;RGS14;FYN;EEF2K;DNM2;SEMA4C;DLG3;PCLO;HOMER2
17252,GO:0120025,0.00162525073261856,0.998793118874654,168,1270,plasma membrane bounded cell projection,CC,ZMYND8;ADGRL1;NR1D1;DLG4;CST3;FBXO2;PRR7;DOCK4;PRNP;PARVB;BBS2;APOE;ESPN;ITGA6;NOS1;PTPRS;ANKS6;SPRY2;CAPN2;SYTL1;ACTA2;SNX9;SPRY4;RAPGEF3;GLUL;LPAR3;SSH1;MARK4;FOS;SHANK2;LRP1;GJC2;DVL1;S100A4;CYBRD1;AKT1;KCNC4;TMOD2;CORO1B;S100A6;HK1;DYSF;EPHA1;IFT140;PRKACB;SIGMAR1;RAC2;KCNAB2;NPHP4;CEACAM1;TENM2;ZNF385A;ANK3;EVC;TWF2;SYNGAP1;CEP250;PTK6;GSN;WIPF1;ARPIN;UNC119B;BNIP3;SHARPIN;PKD2;CTSZ;CRTC1;AP3D1;EPHB2;PLCG1;KIF17;TIMP2;SYNJ2;TGFB1;SNPH;ABHD17C;NTSR1;SHANK3;NSMF;ARAP3;FARP1;TUB;CROCC;DNAH1;HTR7;PI4K2A;WASF3;LLGL1;KIF7;BBS1;CAMK2N1;LRP4;CEP131;PRKCZ;PRKACA;MINK1;ADA;MICALL2;PLEKHG5;ULK1;AHCY;VAMP2;PLEK2;RILPL1;CYFIP2;FSCN1;CYGB;ARHGAP44;REEP6;SV2A;ITGA1;NUBP2;SH3BP1;LIMK1;GDI1;DNM1;WASH3P;RGS14;SCN8A;EHD3;WDR60;TMEM231;FHOD1;MYO1D;ABCA7;SYNGR1;WFS1;FYN;RAC3;EEF2K;DNM2;ATXN10;ARHGEF4;MAPK3;INSR;PFKM;MORN4;PAK1;GABBR1;MICAL1;ITGA3;BIN1;VPS16;DLG3;PKD1;SIRT2;AFAP1L1;AZIN2;RAB28;RAP1GAP2;NGFR;PXN;GCH1;KIF13B;TCTN1;BBS10;SEPT6;PFN2;MFSD10;NDRG2;BLOC1S4;TRIM46;HOMER2;APBA1;TTLL3;ADCY6;KLHL24;STRN4
15515,GO:0071900,0.00167481257634633,0.998975878774129,61,393,regulation of protein serine/threonine kinase activity,BP,DUSP6;DUSP5;PDCD4;VEGFA;APOE;F2R;LRP5;PKN1;EGFR;SPRY2;MST1R;SHC1;SPRY4;MAP2K2;LPAR3;MAP2K1;ERCC6;SHC2;ADORA2B;AKT1;STK39;FGFR1;SORL1;CCND1;DUSP7;MAPKAPK3;CEMIP;PKD2;EPHB2;ADAM8;CDKN1C;PLCG1;CD81;TGFB1;TNFSF15;PTPN1;TRIB2;MINK1;ERBB2;PRKCD;ITGA1;DUSP4;RGS14;IRAK1;TGFA;SESN2;MIF;STK25;SLC27A1;MAPK3;INSR;ETAA1;VANGL2;PAK1;MAP2K3;PROX1;PKD1;MAPRE3;MAP3K10;CAMK1;CBLC
17077,GO:0099572,0.00179388710956649,0.999142017426864,29,152,postsynaptic specialization,CC,DLG4;PRNP;SH2D5;NOS1;PTPRS;SHANK2;DVL1;SIGMAR1;KCNAB2;SYNGAP1;BCR;BNIP3;SHARPIN;ABHD17C;SHANK3;NSMF;CAMK2N1;LRP4;MINK1;ARHGAP44;DNM1;RGS14;FYN;EEF2K;DNM2;SEMA4C;DLG3;PCLO;HOMER2
8188,GO:0032940,0.00179392023811778,0.998718360454723,127,940,secretion by cell,BP,NR1D1;CST3;APLN;ACVR2B;PYGB;POSTN;VEGFA;PGM1;WNT7A;PYGL;F2R;LRP5;IDH2;ITPR3;NISCH;EGFR;SERPINE2;VAT1;HADH;LTBP4;SYTL1;SDC1;LMF1;LTBP2;VPS11;ARL2;HEXB;SLC2A3;RAPGEF3;GAA;GLUL;NAPRT;MCTP1;POU2F2;EXOC2;DVL1;AP2A2;NLGN2;STOM;ADORA2B;SYT8;KCNC4;RHBDF2;HK1;SERPING1;VEGFB;SLC15A4;BRSK1;RAB31;FGFR1;FUCA1;MAPKBP1;RAC2;KCNAB2;PFKL;CEACAM1;PLAU;GAS6;BRI3;CTSB;RAB3B;CARD11;GSN;BCR;ALOX15B;CTSZ;PRSS3;ADAM8;ASIC1;APRT;LTA4H;TIMP2;DPP7;TGFB1;SNPH;NTSR1;TMEM173;GALNS;VGF;PI4K2A;RHOF;LLGL1;RIMS3;PCK2;PFKFB2;YPEL5;PRKCZ;ACTR1B;CD9;VAMP2;NECAB3;ARHGAP44;PRKCD;OLFM2;RASL10B;ALDOC;LPCAT1;MIF;PLA2G6;SYNGR1;ECM1;QSOX1;CD68;GLB1;CAT;MAPK3;PFKM;PDXK;PAK1;RNASET2;PPP3CB;LGALS3BP;MICAL1;MAN2B1;DNASE1L1;FAM129B;SERPINB1;ICA1;RAB40B;TOLLIP;PCLO;NBEAL2;SIRT3;HFE;ZP3;PFN2;APBA1
13522,GO:0055114,0.00180169821415098,0.998769532503842,98,716,oxidation-reduction process,BP,XDH;NR1D1;H6PD;CYP27B1;TYSND1;PYGB;PGM1;PYGL;IDH2;CRAT;AKR7A2;LOXL1;NOS1;VAT1;HADH;NFATC4;ALDH4A1;PHLDA2;TXNRD3;GAA;KDSR;CRYL1;CPT2;SRD5A3;HSD17B8;CYBRD1;SH3PXD2B;PRDX5;PRODH;D2HGDH;AKT1;PYCR2;HK1;KCNAB2;PFKL;CBR4;ABCD1;PFKP;DHTKD1;ALOX15B;CCS;RSAD1;BNIP3;GPX3;RETSAT;SH3PXD2A;CTBP1;CBS;SDHA;MSRB2;MDH2;ERO1B;PHGDH;PCK2;TRAP1;KDM6B;GRHPR;OXA1L;ACAD10;CYGB;CYC1;ACADS;HSD17B7;TMX4;PDIA5;GSTO1;ALDOC;LONP2;PPOX;MTHFR;DECR2;PPARA;SESN2;ACO2;SMOX;KDM4B;PHYH;NARF;QSOX1;HSD11B1L;ETFB;CYP3A5;CAT;CYP2R1;INSR;TAZ;PFKM;TSTA3;GLRX;MLYCD;MICAL1;TSTD1;NDUFV3;ALDH7A1;HSD11B1;SIRT3;PTGR2;KDM3A
7938,GO:0032535,0.00181321338474874,0.998987014449588,44,264,regulation of cellular component size,BP,SEMA4B;VEGFA;WNT7A;APOE;PTPRS;SLC12A7;LPAR3;SSH1;AKT1;TMOD2;CORO1B;LRRC8A;RAC2;TWF2;SEMA3F;RAB3B;GSN;PLEKHG2;WIPF1;ARPIN;SPTB;CDC42EP5;WNT3;ULK2;FHOD3;SHANK3;SEMA4F;CAPG;PRKCD;SH3BP1;LIMK1;GDI1;WASH3P;RAC3;DNM2;SLC12A4;PAK1;SEMA4C;WDTC1;CDH4;RAP1GAP2;SEMA3B;PFN2;SSH3
9707,GO:0038127,0.00181758991323303,0.99918494578098,25,126,ERBB signaling pathway,BP,EGFR;SPRY2;SHC1;ARAP1;HBEGF;PAG1;AKT1;GRB7;FAM83A;RHBDF2;CEACAM1;PTK6;ERRFI1;MVB12B;PLCG1;TGFB1;AREG;ERBB2;STUB1;ITGA1;EREG;RPS6KA5;TGFA;PXN;CBLC
1598,GO:0004016,0.00181923196228817,0.999912894359614,4,6,adenylate cyclase activity,MF,NPR2;ADCY1;ADCY7;ADCY6
1776,GO:0004383,0.00181923196228817,0.999912894359614,4,6,guanylate cyclase activity,MF,NPR2;ADCY1;ADCY7;ADCY6
3617,GO:0008074,0.00181923196228817,0.999912894359614,4,6,guanylate cyclase complex, soluble,CC,NPR2;ADCY1;ADCY7;ADCY6
12810,GO:0051124,0.00181923196228892,0.999912894359614,4,6,synaptic growth at neuromuscular junction,BP,SHANK2;SHANK3;AGRN;LRP4
14285,GO:0061387,0.00188596555807563,0.999310526589978,17,74,regulation of extent of cell growth,BP,SEMA4B;VEGFA;APOE;PTPRS;LPAR3;TWF2;SEMA3F;WNT3;ULK2;SEMA4F;LIMK1;GDI1;DNM2;PAK1;SEMA4C;CDH4;SEMA3B
5326,GO:0016052,0.00190048483646594,0.999128689697686,26,134,carbohydrate catabolic process,BP,PYGB;PGM1;PYGL;LRP5;HEXB;GAA;CTBS;CRYL1;GALE;HK1;PFKL;PFKP;DHTKD1;PFKFB2;MLXIPL;DDIT4;NAGA;ALDOC;PPARA;GLB1;INSR;PFKM;PFKFB3;MAN2B1;ABHD10;MAN2B2
13138,GO:0051716,0.00190926435785009,0.998425986400833,545,4685,cellular response to stimulus,BP,TNIP1;DUSP6;XDH;ERCC1;DUSP5;ZMYND8;ADGRL1;SEMA4B;HTRA1;EGR1;NR1D1;EDEM1;DLG4;PLAT;CST3;CYP27B1;MRC2;FBXO2;APLN;PGF;PDCD4;CTNNBIP1;ACVR2B;DOCK4;XPC;PRNP;BBS2;DDIT4L;POSTN;VEGFA;FAM210B;TNFRSF6B;WNT7A;APOE;DGKA;TSPAN1;F2R;LRP5;ITGA6;PITPNC1;HMGA2;OBSCN;NDRG1;ELK3;ITPR3;PKN1;MTA1;ARRDC1;NISCH;AKR7A2;FCGRT;EGFR;RPS6KA2;SERPINE2;WWTR1;NOS1;PTPRS;TMEM129;SPRY2;CAPN2;MST1R;NFATC4;LTBP4;SDC1;ETV5;APPL2;SHC1;DDB2;LTBP2;LTBP1;GTPBP1;PTPRE;RIN1;MMP1;PHLDA2;SPRY4;RAPGEF3;TXNRD3;ZFP36L1;GLUL;ARAP1;MAP2K2;LPAR3;PLCD3;MDFI;CMTM7;RBCK1;MAP2K1;MCTP1;SSH1;ENDOG;SMURF2;FOS;FBLN1;SMAD3;ARHGAP23;STAT6;SHANK2;PIK3R2;ERCC6;LRP1;DVL1;EPAS1;HBEGF;FAM110C;AP2A2;S100A4;ITGB4;PPP1R14A;PRDX5;SHC2;NLGN2;PRODH;SALL2;PAG1;ADORA2B;PLCXD2;AKT1;GRB7;TMOD2;CORO1B;HDAC5;UROS;FAM83A;S100A6;SH2D2A;PPM1F;MMP28;PITPNM1;PLEKHH3;RHBDF2;PYCR2;BSG;STK39;ASAP2;EPHA1;GGT1;PTPRU;VEGFB;ASH2L;IMPACT;WWC3;LRRC8A;CNTN1;IFNGR2;BRSK1;DAP;IFT140;PTHLH;MYZAP;RAB31;FGFR4;HEBP1;PEAR1;WNT2B;POLD4;LDLR;FGFR1;PRKACB;MAPKBP1;SIGMAR1;RAC2;SMOC2;NPHP4;BPHL;RALGDS;SORL1;CEACAM1;ASB13;LZTS2;TENM2;ZNF385A;DOCK6;NSMCE4A;ANK3;IGFBP4;EVC;CCND1;PODNL1;EFS;PCBP4;TWF2;STRADB;SYNGAP1;PLCH2;MAPK13;EDNRA;CARD19;PLAU;GAS6;PTK6;SEMA3F;PFKP;FGFBP1;CSNK1E;CTSB;RAB3B;CARD11;SH2B3;LAMA5;DUSP7;GSN;CMTM4;PLEKHG2;MAPKAPK3;IGFBP2;PCSK9;ARHGAP22;RAD23A;BCR;ANTXR2;EHD4;ERRFI1;WIPF1;AIP;RGL2;TSPAN18;PAQR6;ARHGAP27;ALOX15B;SPTB;AGAP1;NXPH4;CCS;SLC20A1;NPR2;DGKQ;PLXNB3;BNIP3;PAK6;TFPI2;SHARPIN;MVB12B;PKD2;ACY1;GPX3;YPEL3;RASGEF1A;CDC42EP5;IL20RB;AP3D1;ITGB5;MAGEF1;EPOR;EPHB2;GRIN3B;ADAM8;ASIC1;APRT;MNT;GRK6;CDKN1C;PLCG1;CBS;SH3BP2;NYAP1;CD81;CEBPB;ENTPD2;ADAMTS13;ZNF217;TIMP2;WNT3;GNAL;TMED4;TGFB1;CLTCL1;RFX2;ULK2;GPC1;MKNK2;ADAMTS7;MOAP1;NTSR1;TMEM173;ARHGAP25;SHANK3;EFNB3;RASA3;TNFSF15;MPG;NSMF;ARAP3;FARP1;MC1R;RHOD;LAMB2;SNX17;HTR7;VGF;POLL;POLM;PLEKHG4;SEMA4F;RHOF;ANKZF1;LLGL1;PLEKHG3;KIF7;RHOBTB2;UBXN4;GIGYF1;TNFAIP8L1;PTPN1;TPP1;PCK2;WDR59;AGRN;MBD3;IFNE;CD320;CAMK2N1;LRP4;GPR153;VHL;TRAP1;ADAP1;RFNG;MLXIPL;TRIB2;PRKCZ;KDM6B;PRKACA;MINK1;ZNF516;RHPN1;TOM1L2;CD9;EPN2;ADA;AREG;PIM2;PLEKHG5;BOK;NEURL1B;ERBB2;ADGRB2;ULK1;VAMP2;PRIMPOL;TFDP2;PLEK2;STK17A;JAK3;NET1;BNIP3L;CYFIP2;FSCN1;SLC22A17;RASA4;PDK1;CYGB;ARHGAP44;PRKCD;FAM20C;MIB2;RBL2;CACNB3;USP20;STUB1;IFI6;BAX;ITGA1;SH3BP1;FBXW4;EREG;RPS6KA5;DUSP4;TMBIM4;DDIT4;MBTPS2;SPRED3;PPP1R13L;CARF;PCSK1N;MT2A;RASL10B;CES2;TMX4;LIMK1;TGFBR3;PDIA5;GDI1;LTB4R2;CPNE7;LEMD2;RPS6KA6;DNM1;RGS14;MFNG;GSTO1;GIT1;CHAD;MRPS26;LRSAM1;ADAM15;ASB1;TMEM231;MAPK12;IRAK1;TGFA;HDAC7;INPP5D;CHD2;CHEK2;PPARA;TMEM161A;SESN2;ABCG1;CDC34;SOX7;ABCA7;RAB12;BCAP31;MIF;BCAM;PLA2G6;DDT;SYNGR1;ECM1;WFS1;CD68;DTX3;SPPL2B;FYN;UPP1;STK25;RAC3;EEF2K;ARHGAP12;ACAP3;ARID5B;DNM2;CYP3A5;PELI1;SNX15;CHKA;CAT;NEIL1;TSPYL2;IGFBP7;SLC27A1;KIF26A;PLCB3;IQSEC1;ARHGEF4;CYP2R1;MAPK3;INSR;ARHGEF1;GRINA;ADCY1;C12ORF66;HLA-G;DOCK9;INO80C;TMEM101;RALGAPA1;ETAA1;VANGL2;PAK1;CAMKK2;PPP3CB;LGALS3BP;CUL7;GABBR1;REV1;MICAL1;HYAL1;SEMA4C;CAPRIN2;WDTC1;HES7;ITGA3;STK32C;DNMT3A;SRMS;PPP2R5B;MAP2K3;BCL2L1;RRAS;LRCH4;ADGRF1;LMNA;PKD1;KCTD13;TNFRSF25;SIRT2;FAM129B;ITGA4;EDA;UVSSA;DCBLD2;BACH1;TRIP10;ADCY7;LTB4R;RAB28;RAP1GAP2;SOCS7;MAP3K10;RGS19;GPR3;PELI3;RAB40B;NGFR;TOLLIP;PDCD6;ATP6V1F;PCLO;PXN;GRB10;PLEKHM1;GCH1;LURAP1;KIF13B;NR2F6;TCTN1;CAMK1;CAMKK1;SIRT3;HFE;TERC;GAS2L1;COL6A1;ZP3;CELSR1;IL17RE;SEMA3B;FGFR3;CCDC88C;NDRG2;CBLC;ITPKB;CDC42BPG;KDM3A;HOMER2;PKN3;DEDD2;PI4KAP2;SRSF5;ADCY6;LRRK1;KLHL24;SDC2
7756,GO:0032279,0.00199128197407856,0.999040099640044,29,153,asymmetric synapse,CC,DLG4;PRNP;SH2D5;NOS1;PTPRS;SHANK2;DVL1;SIGMAR1;KCNAB2;SYNGAP1;BCR;BNIP3;SHARPIN;ABHD17C;SHANK3;NSMF;CAMK2N1;LRP4;MINK1;ARHGAP44;DNM1;RGS14;FYN;EEF2K;DNM2;SEMA4C;DLG3;PCLO;HOMER2
3552,GO:0007596,0.00204614599345375,0.998922853895556,36,211,blood coagulation,BP,PLAT;APOE;DGKA;F2R;ITPR3;SERPINE2;FBLN1;AKT1;F12;SERPING1;PRKACB;RAC2;CEACAM1;HMG20B;DOCK6;PLAU;GAS6;SH2B3;DGKQ;TFPI2;PROCR;ENTPD2;ADAMTS13;PHF21A;PRKACA;CD9;PRKCD;EHD3;ZFPM1;FYN;MAPK3;DOCK9;MICAL1;MAFF;BLOC1S4;AK3
3199,GO:0006836,0.00204821452478701,0.999071868096459,25,128,neurotransmitter transport,BP,APLN;SLC6A8;WNT7A;NOS1;SYTL1;GLUL;MCTP1;DVL1;SYT8;SLC6A6;KCNC4;BRSK1;RAB3B;ASIC1;SNPH;NTSR1;RIMS3;ADA;VAMP2;SV2A;PRAF2;ICA1;PCLO;PFN2;APBA1
7601,GO:0031994,0.00209046879722867,0.999801298628734,5,10,insulin-like growth factor I binding,MF,ITGA6;ITGB4;IGFBP4;IGFBP2;INSR
12582,GO:0050767,0.00210376968173203,0.998634041349458,75,503,regulation of neurogenesis,BP,ZMYND8;SEMA4B;DLG4;VEGFA;WNT7A;APOE;IDH2;SERPINE2;OBSL1;NOS1;PTPRS;NFATC4;ETV5;LPAR3;MAP2K1;SSH1;SHANK2;LRP1;GJC2;DVL1;AKT1;IMPACT;CNTN1;LDLR;FGFR1;SORL1;HMG20B;TWF2;SYNGAP1;PTK6;SEMA3F;CSNK1E;PLXNB3;CTSZ;CRTC1;FBXW8;EPHB2;TIMP2;WNT3;TGFB1;ULK2;SHANK3;EFNB3;NSMF;SEMA4F;LRP4;ARHGAP44;DGUOK;LIMK1;GDI1;RGS14;FYN;STK25;RAC3;EEF2K;DNM2;PAK1;CUL7;SEMA4C;CAPRIN2;ITGA3;BIN1;PPP2R5B;PROX1;SIRT2;CDH4;RAP1GAP2;NGFR;KIF13B;CAMK1;SEMA3B;SSH3;PLAG1;ADCY6;SDC2
683,GO:0001894,0.00219354519957,0.999018935294107,24,122,tissue homeostasis,BP,BBS2;VEGFA;F2R;EGFR;ACP5;ERCC6;EPAS1;STK39;RAC2;NPHP4;IL20RB;ADAM8;TUB;CROCC;BBS1;TPP1;BAX;LPCAT1;INPP5D;RAC3;PLEKHM1;BBS10;HOMER2;LRRK1
12621,GO:0050817,0.00223358749888704,0.998817363277383,36,212,coagulation,BP,PLAT;APOE;DGKA;F2R;ITPR3;SERPINE2;FBLN1;AKT1;F12;SERPING1;PRKACB;RAC2;CEACAM1;HMG20B;DOCK6;PLAU;GAS6;SH2B3;DGKQ;TFPI2;PROCR;ENTPD2;ADAMTS13;PHF21A;PRKACA;CD9;PRKCD;EHD3;ZFPM1;FYN;MAPK3;DOCK9;MICAL1;MAFF;BLOC1S4;AK3
18290,GO:1903169,0.00223892438939357,0.999165045232552,17,76,regulation of calcium ion transmembrane transport,BP,PRNP;F2R;NOS1;GJC2;CEMIP;PKD2;PLCG1;TGFB1;NTSR1;PRKACA;TRPC1;CACNB3;BAX;GSTO1;EHD3;PLA2G6;FYN
7842,GO:0032409,0.00224661551288513,0.998938266582147,27,143,regulation of transporter activity,BP,FHL1;DLG4;KCNG1;PRNP;SCN4B;NOS1;SHANK2;NLGN2;STOM;STK39;ANK3;PCSK9;PKD2;EPHB2;NTSR1;SHANK3;PRKACA;MINK1;VAMP2;PRKCD;CACNB3;GSTO1;EHD3;PLA2G6;DNM2;GLRX;KLHL24
12917,GO:0051281,0.00225179425387439,0.999550528117282,8,24,positive regulation of release of sequestered calcium ion into cytosol,BP,F2R;CEMIP;PKD2;PLCG1;NTSR1;TRPC1;BAX;GSTO1
16666,GO:0097553,0.00228248674873726,0.999177999173648,16,70,calcium ion transmembrane import into cytosol,BP,PRNP;F2R;ITPR3;NOS1;TPCN1;CEMIP;PKD2;PLCG1;TGFB1;NTSR1;RASA3;PRKACA;TRPC1;BAX;GSTO1;FYN
7329,GO:0031346,0.00230832625664024,0.998701984057181,43,258,positive regulation of cell projection organization,BP,ZMYND8;DLG4;VEGFA;APOE;ESPN;OBSL1;ARAP1;LPAR3;MAP2K1;SHANK2;DVL1;CORO1B;CNTN1;FGFR1;RAC2;TENM2;TWF2;PTK6;PLXNB3;CDC42EP5;CRTC1;FBXW8;WNT3;SHANK3;CROCC;AGRN;PLEK2;FSCN1;LIMK1;GDI1;FYN;STK25;EEF2K;DNM2;PAK1;CUL7;CAPRIN2;ITGA3;PPP2R5B;CDH4;NGFR;PLEKHM1;CAMK1
3405,GO:0007190,0.00230905313137904,0.999689131729233,6,14,activation of adenylate cyclase activity,BP,ADORA2B;EDNRA;GNAL;ADCY1;ADCY7;ADCY6
16807,GO:0098655,0.0023138211359849,0.998550854477989,63,419,cation transmembrane transport,BP,FHL1;DLG4;KCNG1;PRNP;F2R;ITPR3;SCN4B;NOS1;SLC2A9;ORAI3;ORAI1;SLC12A7;KCNJ15;SHANK2;GJC2;NLGN2;STOM;TPCN1;KCNC4;STK39;SLC15A4;MFSD3;KCNAB2;ANK3;GAS6;PCSK9;SLC20A1;SNTA1;CEMIP;PKD2;EPHB2;GRIN3B;ASIC1;PLCG1;TGFB1;NTSR1;ATP7B;SHANK3;RASA3;PRKACA;MINK1;VAMP2;TRPC1;CACNB3;BAX;CYC1;SCN8A;GSTO1;EHD3;SLC25A29;SLC9A7;PLA2G6;FYN;DNM2;SLC12A4;GLRX;PKD1;SLC25A37;ATP6V1F;SLC39A3;HFE;TMCO3;KLHL24
8653,GO:0034220,0.00233086371325719,0.998441959963261,84,586,ion transmembrane transport,BP,FHL1;SLC16A3;DLG4;KCNG1;PRNP;SLC6A8;F2R;ITPR3;SCN4B;NOS1;SLC2A9;ORAI3;ORAI1;SLC7A8;SLC12A7;CPT2;KCNJ15;SHANK2;GJC2;NLGN2;STOM;SLC6A6;AKT1;TPCN1;KCNC4;TTYH3;S100A6;STK39;SLC15A4;LRRC8A;MFSD3;KCNAB2;ANK3;GAS6;PCSK9;ANO8;SLC20A1;SNTA1;CEMIP;PKD2;EPHB2;GRIN3B;ASIC1;PLCG1;TGFB1;SLC43A1;SLC38A10;NTSR1;ATP7B;SHANK3;RASA3;CLCA2;PRKACA;MINK1;VAMP2;TRPC1;CACNB3;BAX;CYC1;SLC13A5;SCN8A;GSTO1;EHD3;SLC25A29;SLC9A7;PLA2G6;FYN;DNM2;SLC12A4;SLC13A3;ATP8B2;PRAF2;GLRX;SLC37A2;DLG3;PKD1;SLC25A37;ATP6V1F;SLC39A3;HFE;TMCO3;SLC23A2;SLC26A11;KLHL24
7132,GO:0030971,0.00233244199160439,0.999314246450495,12,45,receptor tyrosine kinase binding,MF,DOCK4;SHC1;PIK3R2;SHC2;PAG1;PITPNM1;GAS6;PLCG1;PTPN1;LRP4;PITPNM3;CBLC
2669,GO:0006024,0.00235921942132264,0.999086933066937,18,81,glycosaminoglycan biosynthetic process,BP,SDC1;B4GAT1;B3GAT3;CEMIP;TGFB1;GPC1;B3GNT3;B4GALT2;AGRN;B4GALT6;XYLT2;ST3GAL3;HYAL1;NDST2;ST3GAL2;CHST14;CHPF;SDC2
2380,GO:0005516,0.00237164314503502,0.998912879058096,25,128,calmodulin binding,MF,OBSCN;EGFR;NOS1;ORAI1;MARCKSL1;CEACAM1;MAPKAPK3;SNTA1;SNTB2;MKNK2;VAMP2;MYO1D;MYH15;PLA2G6;WFS1;EEF2K;PLCB3;ADCY1;CAMKK2;PPP3CB;NGFR;CAMK1;CAMKK1;ITPKB;STRN4
606,GO:0001775,0.00237651141039048,0.998309330683981,117,864,cell activation,BP,ERCC1;EGR1;CST3;PRNP;PYGB;PGM1;WNT7A;APOE;PYGL;DGKA;F2R;NDRG1;ITPR3;PKN1;EGFR;SERPINE2;VAT1;HEXB;SLC2A3;ZFP36L1;GAA;CMTM7;NAPRT;POU2F2;SMAD3;STAT6;LRP1;AP2A2;STOM;PAG1;ADORA2B;AKT1;HDAC5;SLC15A4;LRRC8A;RAB31;LDLR;FUCA1;RAC2;KCNAB2;PFKL;RAG1;CEACAM1;PLAU;GAS6;BRI3;CTSB;CARD11;SOX13;GSN;IGFBP2;BCR;DGKQ;CTSZ;IL20RB;AP3D1;PRSS3;ADAM8;APRT;LTA4H;CD81;CEBPB;ENTPD2;ADAMTS13;TIMP2;DPP7;TGFB1;TMEM173;EFNB3;GALNS;POLM;PI4K2A;RHOF;IFNE;CD320;YPEL5;PRKCZ;ACTR1B;CD9;ADA;ERBB2;VAMP2;JAK3;CYGB;PRKCD;BAX;MFNG;ALDOC;LPCAT1;INPP5D;ZFPM1;MIF;SYNGR1;QSOX1;CD68;FYN;GLB1;PELI1;CAT;SATB1;MAPK3;HLA-G;PDXK;PAK1;RNASET2;PPP3CB;MAN2B1;DNASE1L1;ITGA4;SERPINB1;TOLLIP;KIF13B;NBEAL2;HFE;ZP3;BLOC1S4;ITPKB
6642,GO:0023056,0.00242497653208194,0.998203281863735,152,1157,positive regulation of signaling,BP,DUSP6;XDH;DUSP5;DLG4;CYP27B1;APLN;PDCD4;ACVR2B;PRNP;VEGFA;WNT7A;APOE;F2R;ITPR3;PKN1;EGFR;SERPINE2;NOS1;SPRY2;MST1R;NFATC4;SHC1;GLUL;ARAP1;MAP2K2;LPAR3;RBCK1;MAP2K1;SSH1;SMURF2;SMAD3;SHANK2;PIK3R2;ERCC6;DVL1;HBEGF;FAM110C;S100A4;SHC2;NLGN2;PAG1;ADORA2B;AKT1;GRB7;TMOD2;SH2D2A;STK39;EPHA1;FGFR4;WNT2B;FGFR1;ZNF385A;IGFBP4;EVC;GAS6;PTK6;FGFBP1;CSNK1E;RAB3B;CARD11;SH2B3;DUSP7;GSN;MAPKAPK3;RGL2;ALOX15B;SLC20A1;BNIP3;SHARPIN;PKD2;RASGEF1A;CRTC1;EPHB2;ADAM8;CDKN1C;PLCG1;SH3BP2;CD81;TIMP2;WNT3;TMED4;TGFB1;MOAP1;NTSR1;SHANK3;TNFSF15;MC1R;KIF7;RIMS3;PTPN1;PCK2;WDR59;PFKFB2;RFNG;PRKCZ;MINK1;EPN2;ADA;PIM2;PLEKHG5;BOK;ERBB2;VAMP2;TFDP2;CYFIP2;PRKCD;MIB2;BAX;ITGA1;EREG;RASL10B;TGFBR3;RGS14;MFNG;GSTO1;IRAK1;TGFA;ABCA7;BCAP31;MIF;PLA2G6;DDT;ECM1;FYN;STK25;PELI1;CAT;MAPK3;INSR;PFKM;TMEM101;VANGL2;PAK1;PPP3CB;SEMA4C;CAPRIN2;PPP2R5B;MAP2K3;BCL2L1;KCTD13;TNFRSF25;EDA;MAP3K10;NGFR;GRB10;LURAP1;SIRT3;HFE;FGFR3;ITPKB;DEDD2;LRRK1
4636,GO:0010760,0.0024263162573675,0.99994393467557,3,4,negative regulation of macrophage chemotaxis,BP,MMP28;MIF;DDT
19299,GO:1905522,0.0024263162573675,0.99994393467557,3,4,negative regulation of macrophage migration,BP,MMP28;MIF;DDT
3135,GO:0006732,0.00243001231241407,0.998590621940632,47,294,coenzyme metabolic process,BP,NT5E;H6PD;PGM1;IDH2;ACOT7;ACSF2;SLC2A3;PGLS;PC;NAPRT;HSD17B8;NMRK1;HK1;ACOT1;KCNAB2;PFKL;GAMT;CBR4;PFKP;DHTKD1;NADK;PANK4;HLCS;MVD;MDH2;HMGCL;PCK2;PFKFB2;MLXIPL;AHCY;PDK1;PPCS;DDIT4;GSTO1;ALDOC;MTHFR;PPARA;COQ2;INSR;PFKM;PDXK;PFKFB3;MLYCD;NMNAT2;GCH1;PM20D2;SLC23A2
16992,GO:0099068,0.00243225651089429,0.999760259530765,5,10,postsynapse assembly,BP,WNT7A;SHANK2;NLGN2;SHANK3;LRP4
11842,GO:0046834,0.00245432046023294,0.999077511378029,17,75,lipid phosphorylation,BP,DGKA;EGFR;PIK3R2;HBEGF;ZFYVE21;FGFR4;FGFR1;TTC7B;DGKQ;PIP5KL1;PI4K2A;ERBB2;EREG;PI4K2B;FYN;FGFR3;PI4KAP2
5267,GO:0015914,0.00246037778457898,0.999269333747719,12,46,phospholipid transport,BP,APOE;OSBPL5;PITPNC1;PLTP;PITPNM1;LDLR;OSBPL10;PRKCD;ABCG1;ABCA7;PITPNM3;ATP8B2
3450,GO:0007266,0.00247263418541668,0.998805307470959,28,149,Rho protein signal transduction,BP,APOE;F2R;OBSCN;ARAP1;RAC2;PLEKHG2;BCR;PAK6;CDC42EP5;ARAP3;FARP1;RHOD;PLEKHG4;RHOF;PLEKHG3;RHOBTB2;PLEKHG5;NET1;LIMK1;RAC3;ARHGEF4;ARHGEF1;VANGL2;PAK1;ITGA3;KCTD13;NGFR;CELSR1
3185,GO:0006812,0.00249158325528839,0.998333912628357,83,582,cation transport,BP,FHL1;DLG4;CYP27B1;KCNG1;PRNP;SLC6A8;F2R;ITPR3;SERPINE2;SCN4B;NOS1;SLC2A9;PRSS8;ORAI3;ORAI1;SLC7A8;SLC12A7;LPAR3;KCNJ15;SHANK2;GJC2;NLGN2;STOM;AKT1;TPCN1;KCNC4;STK39;SLC15A4;CNTN1;MFSD3;KCNAB2;ANK3;GAS6;RAB3B;PCSK9;CCS;SLC20A1;SNTA1;SERINC2;CEMIP;PKD2;EPHB2;GRIN3B;ASIC1;PLCG1;TGFB1;SLC38A10;NTSR1;ATP7B;SHANK3;RASA3;PRKACA;MINK1;ADA;VAMP2;TRPC1;CACNB3;BAX;CYC1;SLC13A5;SCN8A;GSTO1;EHD3;SLC25A29;SLC9A7;PLA2G6;WFS1;SLC22A18;FYN;DNM2;SLC12A4;SLC13A3;GLRX;PKD1;AZIN2;SLC25A37;ATP6V1F;SLC39A3;HFE;TMCO3;HOMER2;SLC23A2;KLHL24
8644,GO:0034199,0.00249509673492243,0.999752550336623,5,10,activation of protein kinase A activity,BP,PRKACB;PRKACA;ADCY1;ADCY7;ADCY6
6756,GO:0030195,0.00249640562016863,0.999425781408844,9,29,negative regulation of blood coagulation,BP,PLAT;APOE;SERPINE2;F12;SERPING1;CEACAM1;PLAU;CD9;PRKCD
17361,GO:1900047,0.00249640562016863,0.999425781408844,9,29,negative regulation of hemostasis,BP,PLAT;APOE;SERPINE2;F12;SERPING1;CEACAM1;PLAU;CD9;PRKCD
2210,GO:0005096,0.00254044739115202,0.998608585144101,39,227,GTPase activator activity,MF,DOCK4;EVI5L;APPL2;TBC1D14;RIN1;ARAP1;ARHGAP23;PIK3R2;ASAP2;SYNGAP1;ARHGAP22;BCR;ERRFI1;ARHGAP27;AGAP1;CDC42EP5;TBC1D9B;ARHGAP25;RASA3;ARAP3;LLGL1;ADAP1;RASA4;ARHGAP44;SH3BP1;GDI1;RGS14;GIT1;ARHGAP12;ACAP3;ARHGEF1;RALGAPA1;SGSM2;TBC1D16;RABGAP1;TRIP10;RAP1GAP2;RGS19;TBC1D8
3286,GO:0006979,0.00254114961346402,0.998495162419382,50,321,response to oxidative stress,BP,ERCC1;CST3;PRNP;APOE;EGFR;SDC1;ETV5;TXNRD3;NAPRT;MCTP1;ENDOG;FOS;STAT6;ERCC6;EPAS1;PRDX5;PRODH;AKT1;PYCR2;IMPACT;MAPK13;CCS;BNIP3;PKD2;GPX3;MSRB2;ANKZF1;TRAP1;KDM6B;ADA;AREG;NET1;PDK1;CYGB;PRKCD;RGS14;TMEM161A;SESN2;STK25;DNM2;CAT;NEIL1;MAPK3;CAMKK2;HYAL1;SIRT2;PXN;GCH1;BTG1;SLC23A2
6051,GO:0019200,0.00254266153386823,0.999559852991901,7,19,carbohydrate kinase activity,MF,HK1;PFKL;PFKP;PFKFB2;FGGY;PFKM;PFKFB3
3705,GO:0008217,0.00256268215159664,0.998997819840363,18,83,regulation of blood pressure,BP,APLN;POSTN;F2R;LRP5;NISCH;NOS1;SMAD3;STK39;EDNRA;GAS6;NPR2;CTSZ;NTSR1;RNPEP;RASL10B;PPARA;PLCB3;GCH1
16735,GO:0097755,0.00257251361458267,0.999340035069926,10,35,positive regulation of blood vessel diameter,BP,APLN;DOCK4;BBS2;APOE;EGFR;NOS1;ADORA2B;ITGA1;PLA2G6;GCH1
9609,GO:0036477,0.00257860166480949,0.998331198052854,71,478,somatodendritic compartment,CC,ZMYND8;NR1D1;DLG4;CST3;FBXO2;PRR7;PRNP;APOE;ITPR3;NOS1;PTPRS;CAPN2;GLUL;ENDOG;SHANK2;LRP1;GJC2;DVL1;KCNC4;LDLR;TENM2;ZNF385A;ANK3;SYNGAP1;BNIP3;SHARPIN;CRTC1;EPHB2;GRIN3B;KIF17;TIMP2;TGFB1;SNPH;ABHD17C;NTSR1;SHANK3;NSMF;FARP1;HTR7;PI4K2A;CAMK2N1;LRP4;PRKCZ;MINK1;ADA;CYGB;ARHGAP44;SV2A;ITGA1;GDI1;DNM1;RGS14;MYO1D;WFS1;FYN;RAC3;EEF2K;DNM2;ATXN10;INSR;PAK1;GABBR1;VPS16;DLG3;SIRT2;AZIN2;KIF13B;HOMER2;APBA1;KLHL24;STRN4
12954,GO:0051345,0.00258562671896467,0.998277675472191,81,561,positive regulation of hydrolase activity,BP,XDH;DOCK4;VEGFA;F2R;ITGA6;GRAMD4;EVI5L;EGFR;LMF1;TBC1D14;RIN1;SNX9;RAPGEF3;ARAP1;FBLN1;SMAD3;ARHGAP23;PIK3R2;AKT1;PPM1F;ASAP2;EPHA1;DAP;FGFR1;SYNGAP1;EDNRA;GSN;ARHGAP22;BCR;ERRFI1;ARHGAP27;AGAP1;CDC42EP5;TBC1D9B;ARHGAP25;RASA3;TNFSF15;ARAP3;PLEKHG4;LLGL1;PTPN1;AGRN;ADAP1;PRKCZ;BOK;ERBB2;C6ORF89;NET1;CYFIP2;RASA4;ARHGAP44;PRKCD;BAX;ITGA1;SH3BP1;GDI1;RGS14;GIT1;MAPK12;SOX7;BCAP31;FYN;ARHGAP12;ACAP3;DNM2;IQSEC1;MAPK3;ARHGEF1;DOCK9;RALGAPA1;SGSM2;TBC1D16;RABGAP1;TRIP10;RAP1GAP2;RGS19;NGFR;PDCD6;TBC1D8;PFN2;FGFR3
4786,GO:0010977,0.00258869764115022,0.998899057296344,21,103,negative regulation of neuron projection development,BP,SEMA4B;APOE;PTPRS;NFATC4;LRP1;SYNGAP1;SEMA3F;CTSZ;EPHB2;WNT3;ULK2;EFNB3;SEMA4F;LRP4;DGUOK;GDI1;SEMA4C;RAP1GAP2;NGFR;SEMA3B;ADCY6
3501,GO:0007411,0.00260000784764813,0.998686592196061,31,170,axon guidance,BP,SEMA4B;VEGFA;SHC1;DVL1;GRB7;B4GAT1;KLF7;SEMA3F;SPTB;PLXNB3;EPHB2;PLCG1;WNT3;GPC1;SHANK3;EFNB3;LAMB2;SEMA4F;ERBB2;CYFIP2;RPS6KA5;FYN;MAPK3;VANGL2;SEMA4C;FAM129B;CDH4;NGFR;GRB10;SEMA3B;DOK4
3451,GO:0007267,0.0026798069498975,0.998068065606743,124,918,cell-cell signaling,BP,ZMYND8;EGR1;NR1D1;DLG4;APLN;PGF;CTNNBIP1;ACVR2B;PRNP;WNT7A;APOE;F2R;LRP5;HMGA2;ITPR3;NISCH;EGFR;SERPINE2;WWTR1;SCN4B;NOS1;HADH;NFATC4;LTBP4;SYTL1;SDC1;ETV5;ARL2;SLC12A7;RAPGEF3;GLUL;LPAR3;MDFI;MCTP1;SSH1;SMURF2;SMAD3;SHANK2;LRP1;GJC2;DVL1;AP2A2;NLGN2;ADARB1;SYT8;AKT1;KCNC4;TMOD2;PTPRU;BRSK1;PTHLH;WNT2B;FGFR1;PFKL;NPHP4;LZTS2;IGFBP4;CCND1;SYNGAP1;FGFBP1;CSNK1E;RAB3B;IGFBP2;PCSK1;CRTC1;EPHB2;GRIN3B;ASIC1;GRK6;WNT3;SNPH;NTSR1;SHANK3;EFNB3;MYCBPAP;NSMF;HTR7;VGF;SEMA4F;RIMS3;PCK2;LRP4;PFKFB2;PRKCZ;MINK1;AREG;VAMP2;CACNB3;SV2A;FBXW4;EREG;RASL10B;DNM1;RGS14;SOX7;PLA2G6;SYNGR1;RAC3;SLC12A4;PLCB3;PFKM;VANGL2;PPP3CB;CAPRIN2;ITGA3;DLG3;KCTD13;FAM129B;EDA;GAL3ST4;ICA1;TOLLIP;PCLO;GRB10;SIRT3;HFE;CELSR1;SEMA3B;PFN2;FGFR3;CCDC88C;NDRG2;APBA1;LRRK1
8822,GO:0034614,0.00268874094249408,0.998797904121249,23,120,cellular response to reactive oxygen species,BP,CST3;EGFR;ENDOG;FOS;STAT6;PRDX5;AKT1;IMPACT;MAPK13;CCS;BNIP3;PKD2;ANKZF1;TRAP1;KDM6B;NET1;PRKCD;STK25;DNM2;MAPK3;CAMKK2;PXN;GCH1
10577,GO:0043547,0.00272419226511653,0.998392203134194,49,303,positive regulation of GTPase activity,BP,DOCK4;F2R;ITGA6;EVI5L;TBC1D14;RIN1;SNX9;RAPGEF3;ARAP1;ARHGAP23;PIK3R2;ASAP2;EPHA1;SYNGAP1;ARHGAP22;BCR;ERRFI1;ARHGAP27;AGAP1;CDC42EP5;TBC1D9B;ARHGAP25;RASA3;ARAP3;PLEKHG4;LLGL1;AGRN;ADAP1;ERBB2;NET1;RASA4;ARHGAP44;SH3BP1;GDI1;RGS14;GIT1;ARHGAP12;ACAP3;IQSEC1;ARHGEF1;DOCK9;RALGAPA1;SGSM2;TBC1D16;RABGAP1;TRIP10;RAP1GAP2;RGS19;TBC1D8
11246,GO:0045494,0.00274616563107369,0.999517758602468,7,19,photoreceptor cell maintenance,BP,BBS2;ERCC6;NPHP4;TUB;CROCC;BBS1;BBS10
12743,GO:0051020,0.00280356058716702,0.998146733313983,77,523,GTPase binding,MF,DLG4;DOCK4;OBSCN;NDRG1;PKN1;EVI5L;EGFR;SYTL1;APPL2;SHC1;TBC1D14;RIN1;RAPGEF3;ARAP1;EXOC2;DVL1;HBEGF;SHC2;ASAP2;FMNL2;FGFR4;FGFR1;RALGDS;SORL1;RAB11FIP4;DOCK6;TRAPPC9;PLEKHG2;BCR;XPOT;ERRFI1;RGL2;SPTB;AGAP1;BNIP3;PAK6;RASGEF1A;CDC42EP5;TBC1D9B;ARAP3;FARP1;PLEKHG4;LLGL1;PLEKHG3;RIMS3;ADAP1;RABGGTA;MICALL2;PLEKHG5;ERBB2;ULK1;RILPL1;JAK3;NET1;ARHGAP44;SBF1;SH3BP1;EREG;GDI1;GIT1;FYN;ACAP3;INF2;IQSEC1;ARHGEF4;ARHGEF1;DOCK9;PAK1;MICAL1;SGSM2;TBC1D16;KCTD13;RABGAP1;NGFR;TBC1D8;FGFR3;PKN3
10796,GO:0044283,0.0028121587241176,0.998134408674824,78,543,small molecule biosynthetic process,BP,NT5E;XDH;EGR1;NR1D1;CYP27B1;NAGS;PGM1;APOE;ISYNA1;ACOT7;DNPH1;TK2;RAPGEF3;GLUL;NME4;PLTP;PC;SRD5A3;HSD17B8;UROS;PYCR2;HK1;GGT1;FGFR4;PFKL;SEC14L2;GAMT;CEACAM1;CBR4;PFKP;DHTKD1;ALOX15B;DGKQ;CEMIP;APRT;LTA4H;CBS;MVD;ENTPD2;TGFB1;NTSR1;MDH2;PHGDH;PLPP6;HMGCL;PCK2;PFKFB2;MLXIPL;ADA;UCKL1;AHCY;DDIT4;MBTPS2;HSD17B7;ALDOC;DECR2;PPARA;COQ2;ABCG1;MIF;UPP1;NEIL1;CYP2R1;INSR;PFKM;GPT2;PDXK;PFKFB3;MLYCD;HYAL1;WDTC1;PROX1;NT5C1B;CHST14;GCH1;ITPKB;SPTLC2;KDM3A
5232,GO:0015849,0.00282527275944219,0.99856350329015,31,172,organic acid transport,BP,SLC16A3;SLC6A8;APOE;SLC7A8;CPT2;SLC16A5;SLC6A6;AKT1;BSG;STK39;SLC15A4;CEACAM1;ABCD1;SERINC2;SLC43A1;SLC38A10;NTSR1;VAMP2;SV2A;SLC13A5;PPARA;MIF;SLC25A29;PLA2G6;SLC27A1;SLC13A3;PRAF2;SLC16A13;SLC23A2;APBA1;SLC26A11
11899,GO:0046942,0.00282527275944219,0.99856350329015,31,172,carboxylic acid transport,BP,SLC16A3;SLC6A8;APOE;SLC7A8;CPT2;SLC16A5;SLC6A6;AKT1;BSG;STK39;SLC15A4;CEACAM1;ABCD1;SERINC2;SLC43A1;SLC38A10;NTSR1;VAMP2;SV2A;SLC13A5;PPARA;MIF;SLC25A29;PLA2G6;SLC27A1;SLC13A3;PRAF2;SLC16A13;SLC23A2;APBA1;SLC26A11
16626,GO:0097485,0.00285743495762887,0.998546496381759,31,171,neuron projection guidance,BP,SEMA4B;VEGFA;SHC1;DVL1;GRB7;B4GAT1;KLF7;SEMA3F;SPTB;PLXNB3;EPHB2;PLCG1;WNT3;GPC1;SHANK3;EFNB3;LAMB2;SEMA4F;ERBB2;CYFIP2;RPS6KA5;FYN;MAPK3;VANGL2;SEMA4C;FAM129B;CDH4;NGFR;GRB10;SEMA3B;DOK4
3792,GO:0008361,0.0028961527207747,0.998674379120523,24,123,regulation of cell size,BP,SEMA4B;VEGFA;APOE;PTPRS;SLC12A7;LPAR3;AKT1;LRRC8A;TWF2;SEMA3F;WNT3;ULK2;SHANK3;SEMA4F;LIMK1;GDI1;DNM2;SLC12A4;PAK1;SEMA4C;WDTC1;CDH4;RAP1GAP2;SEMA3B
8725,GO:0034382,0.00292344024754456,0.999927677042607,3,4,chylomicron remnant clearance,BP,APOE;LMF1;LDLR
15477,GO:0071830,0.00292344024754456,0.999927677042607,3,4,triglyceride-rich lipoprotein particle clearance,BP,APOE;LMF1;LDLR
9862,GO:0042127,0.00294922584333331,0.997834268054548,137,1036,regulation of cell proliferation,BP,XDH;MEF2D;HTRA1;EGR1;NR1D1;CST3;CYP27B1;FBXO2;APLN;PGF;PDCD4;CTNNBIP1;PRNP;VEGFA;TNFRSF6B;WNT7A;APOE;F2R;LRP5;HMGA2;NDRG1;IDH2;PKN1;EGFR;RPS6KA2;SERPINE2;WWTR1;SPRY2;MST1R;ETV5;SHC1;TCFL5;PHLDA2;TRNP1;ZFP36L1;GLUL;PLCD3;TP53I11;MAP2K1;MXD4;MARCKSL1;FBLN1;SMAD3;STAT6;GJC2;HBEGF;RNF187;ADARB1;AKT1;S100A6;EPHA1;PTPRU;VEGFB;ASH2L;PTHLH;FGFR4;FGFR1;RAC2;MXI1;CEACAM1;LZTS2;CCND1;PLAU;GAS6;PTK6;FGFBP1;CARD11;LAMA5;IGFBP2;ERRFI1;CDC25B;ALOX15B;PLXNB3;PKD2;CTSZ;IL20RB;CTBP1;MNT;CDKN1C;CD81;CEBPB;MVD;TIMP2;WNT3;TGFB1;DEAF1;CGREF1;CD320;CAMK2N1;VHL;CEP131;MLXIPL;PRKCZ;CD9;ADA;AREG;PIM2;BOK;ERBB2;JAK3;BAX;ITGA1;FBXW4;EREG;TGFBR3;IRAK1;TGFA;INPP5D;SOX7;SPEG;SIX5;MIF;ECM1;FYN;PELI1;IGFBP7;INSR;HLA-G;PAK1;HYAL1;SRMS;BCL2L1;DLG3;PROX1;LMNA;TNFRSF25;SIRT2;FAM129B;LAMB1;NGFR;PDCD6;TBC1D8;BTG1;ZP3;FGFR3;NDRG2;PLAG1
16873,GO:0098805,0.00297272673522873,0.997772576430844,158,1207,whole membrane,CC,DLG4;CYP27B1;MARVELD1;PRNP;FAM210B;WNT7A;APOE;TSPAN1;F2R;NDRG1;ITPR3;EGFR;NOS1;VAT1;PTPRS;CAPN2;APPL2;VPS11;SLC2A3;GAA;MAP2K2;MARCH9;MCTP1;TMEM8A;SMURF2;ARMCX2;STAT6;LRP1;HBEGF;AP2A2;CYBRD1;STOM;LY6K;PAG1;SYT8;TPCN1;BSG;HK1;SLC15A4;ATG16L2;ZFYVE21;CNTN1;RAB31;LDLR;SIGMAR1;RAC2;KCNAB2;SYNE3;TOMM34;BPHL;SORL1;CEACAM1;RAB11FIP4;ABCD1;PLAU;BRI3;RAB3B;CARD11;PCSK9;ANTXR2;EHD4;DBNDD1;PEX10;BNIP3;MVB12B;CEMIP;RETSAT;AP3D1;ABCA2;ADAM8;TMEM9;SYNJ2;WNT3;CLTCL1;SCYL1;ABHD17C;SNTB2;ULK2;GPC1;MOAP1;NTSR1;TMEM173;DIRC2;RHOD;SNX17;PI4K2A;RHOF;ANKZF1;ATG2A;SLC48A1;LLGL1;PEX1;WDR59;CD320;LRP4;PRKCZ;PRKACA;CD9;EPN2;AREG;BOK;ERBB2;ULK1;VAMP2;BNIP3L;SLC22A17;MCFD2;BAX;SV2A;ITGA1;WASH3P;LPCAT1;EHD3;IRAK1;TGFA;INPP5D;PI4K2B;DECR2;MYO1D;SNN;ABCA7;RAB12;SLC9A7;SYNGR1;CD68;SPPL2B;FYN;SUN1;DNM2;CAT;ARMCX1;SLC12A4;MAPK3;INSR;ADCY1;C12ORF66;HLA-G;PRAF2;MALL;RNF144A;SEMA4C;VPS16;MAN2B1;BCL2L1;PKD1;LTB4R;ICA1;RGS19;RAB40B;PDCD6;ATP6V1F;PLEKHM1;NBEAL2;WIPI2;COL6A1;MAN2B2;CBLC;SLC26A11
16776,GO:0098590,0.00297779261136796,0.997963255280579,90,629,plasma membrane region,CC,ADGRL1;DLG4;PRR7;BBS2;F2R;ITGA6;PKN1;SH2D5;EGFR;NOS1;PTPRS;SLC2A9;SPRY2;MST1R;SYTL1;SLC7A8;SPRY4;PLCD3;SSH1;SLC9A3R2;SHANK2;LRP1;CYBRD1;NLGN2;KCNC4;PITPNM1;STK39;LDLR;SIGMAR1;CEACAM1;RAB11FIP4;TENM2;ANK3;NIPSNAP1;EVC;IGFBP2;BCR;COL13A1;PKD2;GRIN3B;KIF17;CD81;SLC29A4;SNPH;ABHD17C;ATP7B;SHANK3;CLCA2;NSMF;PI4K2A;SEMA4F;RIMS3;BBS1;CAMK2N1;LRP4;PRKCZ;PRKACA;MINK1;CD9;ERBB2;PLEK2;FSCN1;CACNB3;OLFM2;DNM1;RGS14;EHD3;TMEM231;TGFA;MYO1D;ABCA7;SLC22A18;DNM2;ARHGEF4;MAPK3;INSR;PFKM;VANGL2;PAK1;GABBR1;SEMA4C;ITGA3;DLG3;LRCH4;PKD1;NDE1;SEPT6;MFSD10;HOMER2;SLC23A2
13802,GO:0060402,0.00299490997438153,0.998846867806316,17,78,calcium ion transport into cytosol,BP,PRNP;F2R;ITPR3;NOS1;TPCN1;CEMIP;PKD2;PLCG1;TGFB1;NTSR1;RASA3;PRKACA;TRPC1;CACNB3;BAX;GSTO1;FYN
13937,GO:0060627,0.00302812392451099,0.998153094539858,54,347,regulation of vesicle-mediated transport,BP,DLG4;APLN;VEGFA;APOE;TSPAN1;EVI5L;SYTL1;SDC1;VPS11;TBC1D14;MAP2K2;MAP2K1;MCTP1;LRP1;ADORA2B;SYT8;LDLR;RAC2;SORL1;CEACAM1;GAS6;RAB3B;PCSK9;BCR;EHD4;STON1;TGFB1;TBC1D9B;ARAP3;TUB;SNX17;SNX33;LLGL1;RIMS3;PTPN1;VAMP2;LRSAM1;ABCA7;PLA2G6;EEF2K;DNM2;MAPK3;MICAL1;BIN1;VPS16;SGSM2;TBC1D16;RABGAP1;RAB40B;PCLO;TBC1D8;HFE;ZP3;PFN2
9470,GO:0036094,0.00306507584673179,0.997597708432138,230,1821,small molecule binding,MF,NT5E;XDH;H6PD;NAGS;ACVR2B;PYGB;APOE;PYGL;DGKA;OSBPL5;OBSCN;IDH2;NEK9;ITPR3;PKN1;ACSF2;EGFR;RPS6KA2;NOS1;HADH;MST1R;VPS11;ARL2;GTPBP1;SLC2A3;TK2;ACTA2;RAPGEF3;TXNRD3;GLUL;MAP2K2;NME4;SMARCA1;PC;MAP2K1;CRYL1;MARK4;ERCC6;HSD17B8;PRODH;CDK18;NMRK1;D2HGDH;AKT1;BSG;STK39;HK1;EPHA1;BRSK1;RAB31;FGFR4;FGFR1;PRKACB;RAC2;PFKL;TTLL12;SEC14L2;OPLAH;HLTF;CBR4;ABCD1;TWF2;STRADB;MAPK13;PTK6;PFKP;CSNK1E;RAB3B;MAPKAPK3;DHTKD1;BCR;EHD4;SEPT10;NADK;PANK4;HLCS;AGAP1;NPR2;DGKQ;PAK6;FYCO1;CEMIP;ABCA2;EPHB2;GRIN3B;APRT;CTBP1;GRK6;CBS;KIF17;MVD;ENTPD2;GNAL;SCYL1;ULK2;MKNK2;TMEM173;ATP7B;SDHA;PIP5KL1;KIF26B;RHOD;DNAH1;PI4K2A;RHOF;PHGDH;ARL10;KIF7;RHOBTB2;TUBG2;HMGCL;PEX1;PCK2;AGRN;MBD3;CD320;OSBPL10;TRAP1;ADAP1;PFKFB2;PRKCZ;PRKACA;MINK1;GRHPR;ACTR1B;ADA;PIM2;UCKL1;ALAS1;ERBB2;ULK1;AHCY;STK17A;JAK3;TRPC1;PDK1;ACAD10;PRKCD;FAM20C;NUBP2;RPS6KA5;DGUOK;CUL9;ACADS;RASL10B;LIMK1;NTPCR;RPS6KA6;DNM1;SCN8A;EHD3;LONP2;MAPK12;IRAK1;PPOX;MTHFR;CHD2;PI4K2B;CHEK2;PPARA;SESN2;ABCG1;MYO1D;MYH15;CDC34;ABCA7;RAB12;SPEG;PHYH;DALRD3;FYN;STK25;RAC3;EEF2K;DNM2;CKMT1A;CHKA;CAT;SLC27A1;KIF26A;DDX50;TUBB6;MAPK3;INSR;PFKM;ADCY1;ATP8B2;GPT2;PDXK;PAK1;CAMKK2;ALPK1;PFKFB3;MICAL1;STK32C;SRMS;MAP2K3;RRAS;IARS2;SIRT2;GAL3ST4;NMNAT2;NT5C1B;ADCY7;LTB4R;TEP1;RAB28;MAP3K10;RAB40B;PHYKPL;GCH1;KIF13B;CAMK1;CAMKK1;SIRT3;BBS10;SEPT6;CDK11B;FGFR3;ITPKB;SPTLC2;CDC42BPG;CLK3;DHX32;PKN3;TTLL3;AK3;ADCY6;LRRK1;AARS
9830,GO:0042063,0.00308037931221268,0.998423211012583,31,174,gliogenesis,BP,NDRG1;IDH2;EGFR;SERPINE2;ETV5;HEXB;MAP2K1;LRP1;GJC2;MBOAT7;AKT1;LDLR;GSN;BNIP3;TGFB1;GPC1;NAB2;LAMB2;WASF3;CD9;AREG;BOK;ERBB2;AHNAK2;SUN1;MAPK3;BIN1;SIRT2;LAMB1;SOCS7;PLAG1
12379,GO:0048813,0.00309670205394783,0.998661903733145,21,103,dendrite morphogenesis,BP,DLG4;WNT7A;OBSL1;NFATC4;SHANK2;DVL1;KLF7;FBXW8;EPHB2;SHANK3;NSMF;FARP1;LRP4;MINK1;ARHGAP44;FYN;EEF2K;RERE;CUL7;CAPRIN2;SDC2
5589,GO:0016614,0.0031115087260315,0.998717366283567,19,94,oxidoreductase activity, acting on CH-OH group of donors,MF,XDH;H6PD;IDH2;AKR7A2;HADH;KDSR;CRYL1;HSD17B8;D2HGDH;KCNAB2;CBR4;CTBP1;MDH2;PHGDH;GRHPR;HSD17B7;TSTA3;HSD11B1;PTGR2
15818,GO:0072524,0.00312740859191225,0.99853141185173,25,132,pyridine-containing compound metabolic process,BP,NT5E;H6PD;PGM1;IDH2;PGLS;NAPRT;NMRK1;HK1;KCNAB2;PFKL;PFKP;DHTKD1;NADK;MDH2;PCK2;PFKFB2;MLXIPL;DDIT4;ALDOC;PPARA;INSR;PFKM;PDXK;PFKFB3;NMNAT2
13264,GO:0051962,0.00316269159033345,0.998086603681957,52,329,positive regulation of nervous system development,BP,ZMYND8;ADGRL1;DLG4;VEGFA;WNT7A;APOE;SERPINE2;OBSL1;ETV5;LPAR3;MAP2K1;SHANK2;GJC2;DVL1;NLGN2;IMPACT;CNTN1;FGFR1;HMG20B;TWF2;PTK6;CSNK1E;SLITRK6;PLXNB3;CRTC1;FBXW8;EPHB2;TIMP2;WNT3;SHANK3;NSMF;WASF3;AGRN;ADGRB2;LIMK1;GDI1;RGS14;FYN;STK25;EEF2K;TPBG;PAK1;CUL7;CAPRIN2;ITGA3;BIN1;PPP2R5B;PROX1;CDH4;NGFR;CAMK1;PLAG1
6195,GO:0019674,0.00317421599040997,0.99902322960403,12,47,NAD metabolic process,BP,NT5E;NAPRT;NMRK1;HK1;PFKL;PFKP;NADK;MDH2;PCK2;ALDOC;PFKM;NMNAT2
8196,GO:0032956,0.00319688609338252,0.998206961191557,40,242,regulation of actin cytoskeleton organization,BP,RAPGEF3;ARAP1;SSH1;SMAD3;LRP1;SH3PXD2B;TMOD2;CORO1B;PPM1F;EPHA1;RAC2;TWF2;GSN;PLEKHG2;WIPF1;ARPIN;SPTB;CDC42EP5;TGFB1;FHOD3;SHANK3;RHOD;RHOF;RHOBTB2;CAPG;FSCN1;ARHGAP44;PRKCD;SH3BP1;LIMK1;WASH3P;FHOD1;RAC3;VANGL2;PAK1;PROX1;PXN;CELSR1;PFN2;SSH3
11878,GO:0046903,0.00320481354471549,0.997650578179817,133,1005,secretion,BP,XDH;NR1D1;CST3;APLN;ACVR2B;PYGB;POSTN;VEGFA;PGM1;WNT7A;PYGL;F2R;LRP5;IDH2;ITPR3;NISCH;EGFR;SERPINE2;VAT1;HADH;LTBP4;SYTL1;SDC1;LMF1;LTBP2;VPS11;ARL2;HEXB;SLC2A3;RAPGEF3;GAA;GLUL;NAPRT;MCTP1;POU2F2;EXOC2;DVL1;AP2A2;NLGN2;STOM;ADORA2B;SYT8;KCNC4;RHBDF2;STK39;HK1;SERPING1;VEGFB;SLC15A4;BRSK1;RAB31;FGFR1;FUCA1;MAPKBP1;RAC2;KCNAB2;PFKL;CEACAM1;CCND1;PLAU;GAS6;BRI3;CTSB;RAB3B;CARD11;GSN;BCR;ALOX15B;CTSZ;PRSS3;ADAM8;ASIC1;APRT;LTA4H;TIMP2;DPP7;TGFB1;SNPH;NTSR1;TMEM173;ATP7B;GALNS;VGF;PI4K2A;RHOF;LLGL1;RIMS3;PCK2;PFKFB2;YPEL5;PRKCZ;ACTR1B;CD9;ADA;VAMP2;NECAB3;ARHGAP44;PRKCD;SV2A;OLFM2;RASL10B;ALDOC;LPCAT1;MIF;PLA2G6;SYNGR1;ECM1;QSOX1;CD68;GLB1;CAT;MAPK3;PFKM;PDXK;PAK1;RNASET2;PPP3CB;LGALS3BP;MICAL1;MAN2B1;DNASE1L1;FAM129B;SERPINB1;ICA1;RAB40B;TOLLIP;PCLO;NBEAL2;SIRT3;HFE;ZP3;PFN2;APBA1
11196,GO:0045334,0.00322362365552031,0.999141345406092,10,36,clathrin-coated endocytic vesicle,CC,APOE;EGFR;HBEGF;AP2A2;LDLR;CEMIP;CLTCL1;CD9;EPN2;DNM2
12912,GO:0051271,0.00326069971935957,0.99826615349257,34,197,negative regulation of cellular component movement,BP,ZMYND8;SEMA4B;APOE;IDH2;NISCH;MCTP1;FBLN1;LRP1;ADARB1;CORO1B;HDAC5;MMP28;EPHA1;PTPRU;SEMA3F;BCR;ARPIN;ALOX15B;PLXNB3;WNT3;TGFB1;ARAP3;SEMA4F;CD9;ADA;CYGB;TGFBR3;ADAM15;MIF;DDT;SEMA4C;RRAS;SEMA3B;PFN2
13712,GO:0060291,0.00326151755164051,0.999059694500454,11,41,long-term synaptic potentiation,BP,PRNP;APOE;ITPR3;SERPINE2;SHANK2;CRTC1;EPHB2;SHANK3;PRKCZ;VAMP2;RGS14
4201,GO:0009311,0.00331144575978367,0.99891385557802,13,53,oligosaccharide metabolic process,BP,HEXB;ST6GALNAC2;GAA;CTBS;ST6GALNAC6;IDUA;NAGA;ST3GAL3;MAN2B1;GAL3ST4;ST3GAL2;ST3GAL5;MAN2B2
11490,GO:0045981,0.0033305663991586,0.999033476048207,11,42,positive regulation of nucleotide metabolic process,BP,APOE;NOS1;RAPGEF3;ADORA2B;PTHLH;TIMP2;PFKFB2;MLXIPL;INSR;TAZ;PFKFB3
17508,GO:1900544,0.0033305663991586,0.999033476048207,11,42,positive regulation of purine nucleotide metabolic process,BP,APOE;NOS1;RAPGEF3;ADORA2B;PTHLH;TIMP2;PFKFB2;MLXIPL;INSR;TAZ;PFKFB3
1483,GO:0003779,0.00333227774385894,0.99803369224402,47,293,actin binding,MF,PARVB;FLNC;ESPN;EGFR;OBSL1;SSH1;MARCKSL1;MPRIP;S100A4;TMOD2;CORO1B;FMNL2;IMPACT;SYNE3;CEACAM1;TWF2;GSN;WIPF1;SPTB;CORO7;SNTA1;TAGLN3;SNTB2;FHOD3;SHANK3;MSRB2;CROCC;TNS1;WASF3;MICALL2;CAPG;SMTN;FSCN1;MIB2;TPM2;WASH3P;FHOD1;MYO1D;MYH15;INF2;TNS4;MICAL1;BIN1;VPS16;PFN2;SSH3;HOMER2
12603,GO:0050793,0.00336716844605677,0.997380846869682,209,1661,regulation of developmental process,BP,DUSP6;XDH;ZMYND8;ADGRL1;SEMA4B;EGR1;NR1D1;DLG4;CST3;CYP27B1;PGF;PDCD4;CTNNBIP1;ACVR2B;PARVB;BBS2;POSTN;VEGFA;FAM210B;WNT7A;APOE;LRP5;HMGA2;IDH2;PKN1;EGFR;SERPINE2;WWTR1;OBSL1;NOS1;VAT1;PTPRS;SPRY2;NFATC4;LTBP4;ETV5;HEXB;TCFL5;PHLDA2;RAPGEF3;ZFP36L1;ARAP1;LPAR3;MAP2K1;SSH1;SMURF2;FOS;FBLN1;SMAD3;STAT6;SHANK2;LRP1;GJC2;DVL1;AP2A2;SH3PXD2B;NLGN2;AKT1;CORO1B;HDAC5;EPHA1;VEGFB;FMNL2;ASH2L;IMPACT;WWC3;CNTN1;PTHLH;WNT2B;LDLR;FGFR1;PRKACB;SYNE3;RAG1;GAMT;SORL1;CEACAM1;HMG20B;ZNF385A;CCND1;TWF2;SYNGAP1;GAS6;PTK6;SEMA3F;CSNK1E;CARD11;SOX13;LAMA5;BCR;ANGPTL4;ERRFI1;WIPF1;CCDC71L;SH3D19;SLITRK6;ARPIN;ALOX15B;NPR2;PLXNB3;BNIP3;YPEL3;CTSZ;CDC42EP5;CRTC1;FBXW8;AP3D1;EPHB2;ADAM8;PLCG1;CEBPB;TIMP2;WNT3;TGFB1;ULK2;GPC1;ADAMTS7;DEAF1;NAB2;SHANK3;EFNB3;NSMF;ARAP3;RHOD;RNH1;SEMA4F;RHOF;WASF3;RHOBTB2;AGRN;LRP4;VHL;TRIB2;PRKCZ;PRKACA;EPN2;ADA;AREG;ERBB2;ADGRB2;JAK3;NET1;ARHGAP44;FAM20C;BAX;OLFM2;CHADL;EREG;DGUOK;PPP1R13L;LIMK1;TGFBR3;GDI1;RPS6KA6;ZHX3;RGS14;CHAD;MAPK12;HDAC7;INPP5D;ZFPM1;PPARA;ABCG1;MIF;ECM1;FYN;STK25;RAC3;EEF2K;DNM2;INF2;ZMYM3;TPBG;INSR;HLA-G;VANGL2;PAK1;CUL7;HYAL1;SEMA4C;CAPRIN2;HES7;ITGA3;BIN1;PPP2R5B;RRAS;PROX1;LMNA;SIRT2;FAM129B;CDH4;RAP1GAP2;NGFR;PDCD6;KIF13B;MAFF;CAMK1;TERC;BTG1;ZP3;CELSR1;SEMA3B;SSH3;FGFR3;ITPKB;PLAG1;KDM3A;ADCY6;SDC2
5185,GO:0015749,0.00342135245886905,0.998712215646315,16,71,monosaccharide transmembrane transport,BP,SLC2A9;SLC2A3;PIK3R2;AKT1;EDNRA;CLTCL1;PRKCZ;SLC2A11;SESN2;SLC50A1;INSR;RTN2;PAK1;NGFR;GRB10;SLC23A2
17723,GO:1901626,0.003430726460213,0.999763257914628,4,7,regulation of postsynaptic membrane organization,BP,ZMYND8;APOE;SSH1;LRP4
3504,GO:0007416,0.00344447889139585,0.998656377378534,17,77,synapse assembly,BP,SDK2;ADGRL1;WNT7A;SHANK2;DVL1;NLGN2;SLITRK6;EPHB2;SHANK3;FARP1;AGRN;LRP4;ADGRB2;EEF2K;TPBG;ADGRF1;PCLO
4495,GO:0010522,0.00344699456019524,0.998861166357857,13,54,regulation of calcium ion transport into cytosol,BP,PRNP;F2R;NOS1;CEMIP;PKD2;PLCG1;TGFB1;NTSR1;PRKACA;TRPC1;BAX;GSTO1;FYN
3385,GO:0007166,0.00345336894077649,0.997281380118535,233,1874,cell surface receptor signaling pathway,BP,DUSP6;XDH;ZMYND8;ADGRL1;SEMA4B;HTRA1;EGR1;DLG4;PLAT;APLN;PGF;PDCD4;CTNNBIP1;ACVR2B;PRNP;BBS2;POSTN;VEGFA;TNFRSF6B;WNT7A;APOE;TSPAN1;LRP5;ITGA6;ARRDC1;FCGRT;EGFR;SERPINE2;WWTR1;SPRY2;MST1R;NFATC4;LTBP4;SDC1;SHC1;LTBP2;LTBP1;PTPRE;MMP1;SPRY4;ARAP1;MDFI;RBCK1;SSH1;SMURF2;FOS;SMAD3;STAT6;SHANK2;PIK3R2;LRP1;DVL1;HBEGF;AP2A2;ITGB4;SHC2;NLGN2;PAG1;ADORA2B;AKT1;GRB7;FAM83A;SH2D2A;RHBDF2;BSG;EPHA1;PTPRU;VEGFB;CNTN1;IFNGR2;IFT140;FGFR4;PEAR1;WNT2B;FGFR1;PRKACB;NPHP4;CEACAM1;LZTS2;IGFBP4;EVC;CCND1;PODNL1;EFS;STRADB;MAPK13;GAS6;PTK6;SEMA3F;FGFBP1;CSNK1E;CARD11;LAMA5;MAPKAPK3;IGFBP2;BCR;ERRFI1;WIPF1;AIP;TSPAN18;NPR2;DGKQ;PLXNB3;SHARPIN;MVB12B;IL20RB;ITGB5;EPOR;EPHB2;GRIN3B;GRK6;CDKN1C;PLCG1;CD81;ADAMTS13;WNT3;TGFB1;GPC1;MKNK2;MOAP1;NTSR1;SHANK3;EFNB3;TNFSF15;SEMA4F;LLGL1;KIF7;GIGYF1;PTPN1;IFNE;LRP4;ADAP1;RFNG;PRKCZ;PRKACA;MINK1;CD9;EPN2;ADA;AREG;BOK;NEURL1B;ERBB2;ADGRB2;JAK3;CYFIP2;FSCN1;PRKCD;FAM20C;MIB2;CACNB3;STUB1;IFI6;BAX;ITGA1;SH3BP1;FBXW4;EREG;RPS6KA5;DDIT4;MT2A;LIMK1;TGFBR3;LEMD2;DNM1;RGS14;MFNG;GSTO1;GIT1;CHAD;ADAM15;TMEM231;MAPK12;IRAK1;TGFA;INPP5D;SOX7;ABCA7;MIF;PLA2G6;ECM1;DTX3;SPPL2B;FYN;ARID5B;DNM2;PELI1;SLC27A1;PLCB3;MAPK3;INSR;HLA-G;VANGL2;PAK1;PPP3CB;SEMA4C;CAPRIN2;HES7;ITGA3;SRMS;PPP2R5B;BCL2L1;ADGRF1;LMNA;TNFRSF25;SIRT2;FAM129B;ITGA4;EDA;SOCS7;MAP3K10;PELI3;NGFR;TOLLIP;PDCD6;ATP6V1F;PXN;GRB10;TCTN1;HFE;CELSR1;IL17RE;SEMA3B;FGFR3;CCDC88C;NDRG2;CBLC;ITPKB;HOMER2;DEDD2;LRRK1;KLHL24;SDC2
2519,GO:0005775,0.00351643849900276,0.998360850804853,24,127,vacuolar lumen,CC,PYGB;NAGLU;VAT1;SDC1;HEXB;GAA;NAPRT;FUCA1;CTSB;DPP7;GPC1;GALNS;TPP1;AGRN;IDUA;PRKCD;GLB1;RNASET2;CTSF;HYAL1;MAN2B1;TOLLIP;MAN2B2;SDC2
16203,GO:0090238,0.0035562212464437,0.999905434548696,3,4,positive regulation of arachidonic acid secretion,BP,NTSR1;MIF;PLA2G6
11853,GO:0046854,0.00355999556703979,0.998705759458059,15,65,phosphatidylinositol phosphorylation,BP,EGFR;PIK3R2;HBEGF;ZFYVE21;FGFR4;FGFR1;TTC7B;PIP5KL1;PI4K2A;ERBB2;EREG;PI4K2B;FYN;FGFR3;PI4KAP2
19639,GO:1990782,0.00356620151323669,0.998819652836829,13,53,protein tyrosine kinase binding,MF,DOCK4;SHC1;PIK3R2;SHC2;PAG1;PITPNM1;CEACAM1;GAS6;PLCG1;PTPN1;LRP4;PITPNM3;CBLC
12416,GO:0048875,0.00358064410281911,0.999749816743179,4,7,chemical homeostasis within a tissue,BP,VEGFA;EPAS1;LPCAT1;HOMER2
7808,GO:0032368,0.00360878643087952,0.99879831216427,13,55,regulation of lipid transport,BP,APOE;PLTP;LRP1;AKT1;PCSK9;ABCA2;NTSR1;PRKCD;PPARA;ABCG1;ABCA7;MIF;PLA2G6
18583,GO:1903800,0.00363032652279893,0.999745324484227,4,7,positive regulation of production of miRNAs involved in gene silencing by miRNA,BP,EGFR;MAP2K2;MAP2K1;TGFB1
11733,GO:0046580,0.00364497704305772,0.998933036803616,11,41,negative regulation of Ras protein signal transduction,BP,SPRY2;SPRY4;SYNGAP1;EPHB2;TIMP2;RASA3;ARAP3;RASA4;ARHGAP44;ITGA3;KCTD13
17737,GO:1901657,0.00366432334380618,0.998349483646137,22,116,glycosyl compound metabolic process,BP,NT5E;DLG4;AKR7A2;GTPBP1;TK2;NME4;FUCA1;GAMT;CBR4;CARD11;APRT;ADA;UCKL1;AHCY;DGUOK;NAGA;UPP1;APOBEC3C;APOBEC3F;DLG3;ABHD10;AK3
6723,GO:0030141,0.0036679383720235,0.997544593462218,77,546,secretory granule,CC,PLAT;CST3;PYGB;VEGFA;PGM1;PYGL;ITPR3;SERPINE2;LOXL1;VAT1;HEXB;SLC2A3;GAA;NAPRT;AP2A2;STOM;LY6K;SYT8;BSG;SERPING1;VEGFB;SLC15A4;RAB31;FUCA1;KCNAB2;PFKL;CEACAM1;PLAU;GAS6;BRI3;CTSB;RAB3B;GSN;PCSK1;CTSZ;PRSS3;ADAM8;APRT;LTA4H;TIMP2;DPP7;TGFB1;TMEM173;GALNS;RHOF;CEP131;YPEL5;PRKACA;ACTR1B;CD9;VAMP2;RNPEP;PRKCD;ITGA1;PCSK1N;ALDOC;LPCAT1;ADAM15;MIF;SYNGR1;ECM1;QSOX1;CD68;SUN1;GLB1;CAT;PDXK;RNASET2;LGALS3BP;MAN2B1;DNASE1L1;SERPINB1;ICA1;RAB40B;TOLLIP;NBEAL2;CLK3
5866,GO:0017171,0.00369074212116861,0.998413751938282,20,100,serine hydrolase activity,MF,HTRA1;PLAT;TYSND1;PRSS8;MMP1;F12;RHBDF2;PLAU;CTSB;PCSK9;PRSS22;PCSK1;PRSS3;ADAM8;DPP7;TPP1;MMP10;LONP2;PLA2G6;PRSS21
19035,GO:1904861,0.00373507776901158,0.99973579224973,4,7,excitatory synapse assembly,BP,WNT7A;SHANK2;NLGN2;SHANK3
12946,GO:0051336,0.00374724437528631,0.997281357430252,120,899,regulation of hydrolase activity,BP,XDH;CST3;DOCK4;VEGFA;TNFRSF6B;F2R;ITGA6;GRAMD4;EVI5L;EGFR;SERPINE2;NOS1;SPRY2;LMF1;TBC1D14;ARL2;RIN1;SNX9;RAPGEF3;ARAP1;PPP1R35;FBLN1;SMAD3;ARHGAP23;PIK3R2;LRP1;PPP1R14A;PPP2R3B;PRDX5;AKT1;PPM1F;SERPING1;ASAP2;EPHA1;DAP;FGFR1;RAG1;SORL1;B3GAT3;SYNGAP1;EDNRA;GAS6;GSN;ARHGAP22;BCR;ANGPTL4;ERRFI1;AIP;ARHGAP27;AGAP1;PLXNB3;TFPI2;CDC42EP5;GPSM1;TIMP2;TBC1D9B;ARHGAP25;RASA3;TNFSF15;ARAP3;FARP1;PLEKHG4;LLGL1;PTPN1;AGRN;ADAP1;PRKCZ;OXA1L;BOK;ERBB2;C6ORF89;NET1;CYFIP2;RASA4;ARHGAP44;PRKCD;IFI6;BAX;SBF1;ITGA1;SH3BP1;PCSK1N;GDI1;TPM2;RGS14;GIT1;MAPK12;MYO1D;SOX7;BCAP31;ECM1;FYN;ARHGAP12;ACAP3;DNM2;NEIL1;ELFN2;IQSEC1;MAPK3;ARHGEF1;DOCK9;RALGAPA1;MICAL1;BIN1;PPP2R5B;DLG3;SGSM2;TBC1D16;RABGAP1;TRIP10;SERPINB1;RAP1GAP2;RGS19;NDE1;NGFR;PDCD6;TBC1D8;PFN2;FGFR3;PPP1R16A
10729,GO:0044092,0.00375154151615031,0.997345229760322,103,758,negative regulation of molecular function,BP,DUSP6;DUSP5;CST3;CYP27B1;PDCD4;CTNNBIP1;PRNP;VEGFA;TNFRSF6B;APOE;LRP5;HMGA2;PKN1;SERPINE2;WWTR1;NOS1;SPRY2;NFATC4;ARL2;SPRY4;MDFI;PPP1R35;RBCK1;DVL1;PPP1R14A;PRDX5;ADARB1;AKT1;PPM1F;STK39;SERPING1;EPHA1;DAP;MXI1;RAG1;SORL1;CEACAM1;ANK3;PODNL1;GAS6;PTK6;CSNK1E;DUSP7;PCSK9;ANGPTL4;ERRFI1;AIP;PLXNB3;TFPI2;PKD2;CTSZ;GPSM1;EPHB2;CDKN1C;TIMP2;FARP1;RNH1;PTPN1;CAMK2N1;TRIB2;PRKCZ;OXA1L;PIM2;RASA4;PRKCD;STUB1;IFI6;BAX;DUSP4;PCSK1N;LIMK1;LTB4R2;RGS14;GSTO1;CHAD;ADAM15;IRAK1;ZFPM1;PPARA;MYO1D;ECM1;WFS1;BHLHE40;PELI1;CAT;NEIL1;ELFN2;MAPK3;GABBR1;MICAL1;WDTC1;BIN1;DLG3;PROX1;PKD1;ITGA4;SERPINB1;SOCS7;MAP3K10;NGFR;CAMK1;HFE;CBLC
2110,GO:0004888,0.00376853954999338,0.997709171321105,51,327,transmembrane signaling receptor activity,MF,ADGRL1;MRC2;ACVR2B;TNFRSF6B;F2R;LRP5;FCGRT;EGFR;MST1R;LTBP4;LTBP1;PTPRE;LPAR3;ADORA2B;EPHA1;PTPRU;IFNGR2;FGFR4;FGFR1;SIGMAR1;SORL1;EDNRA;ANTXR2;PLXNB3;IL20RB;EPOR;EPHB2;GRIN3B;NTSR1;EFNB3;MC1R;HTR7;LRP4;GPR153;ERBB2;ADGRB2;SLC22A17;TGFBR3;LTB4R2;ABCA7;BCAM;INSR;GABBR1;ADGRF1;TNFRSF25;LTB4R;GPR3;NGFR;CELSR1;IL17RE;FGFR3
9784,GO:0040008,0.00380708778891151,0.997532004719228,66,449,regulation of growth,BP,DUSP6;SEMA4B;HTRA1;FHL1;CYP27B1;BBS2;VEGFA;APOE;HMGA2;EGFR;SERPINE2;DNPH1;PTPRS;LTBP4;SHC1;PHLDA2;LPAR3;SMAD3;HBEGF;SH3PXD2B;AKT1;PPM1F;WWC3;FGFR1;GAMT;CEACAM1;IGFBP4;TWF2;GAS6;PTK6;SEMA3F;IGFBP2;ALOX15B;WNT3;TGFB1;ULK2;SEMA4F;AGRN;ERBB2;NET1;MT2A;LIMK1;TGFBR3;GDI1;TMEM8B;ADAM15;SESN2;WFS1;DNM2;TSPYL2;IGFBP7;KIF26A;INSR;PAK1;HYAL1;SEMA4C;CAPRIN2;PROX1;CDH4;DCBLD2;SOCS7;BTG1;ZP3;SEMA3B;CDK11B;FGFR3
6113,GO:0019362,0.00381274472167791,0.99821075517104,24,127,pyridine nucleotide metabolic process,BP,NT5E;H6PD;PGM1;IDH2;PGLS;NAPRT;NMRK1;HK1;KCNAB2;PFKL;PFKP;DHTKD1;NADK;MDH2;PCK2;PFKFB2;MLXIPL;DDIT4;ALDOC;PPARA;INSR;PFKM;PFKFB3;NMNAT2
11694,GO:0046496,0.00381274472167791,0.99821075517104,24,127,nicotinamide nucleotide metabolic process,BP,NT5E;H6PD;PGM1;IDH2;PGLS;NAPRT;NMRK1;HK1;KCNAB2;PFKL;PFKP;DHTKD1;NADK;MDH2;PCK2;PFKFB2;MLXIPL;DDIT4;ALDOC;PPARA;INSR;PFKM;PFKFB3;NMNAT2
3065,GO:0006635,0.00382661469376692,0.998652222894958,14,61,fatty acid beta-oxidation,BP,TYSND1;CRAT;HADH;CPT2;AKT1;ABCD1;ACAD10;ACADS;LONP2;DECR2;PPARA;SESN2;ETFB;MLYCD
18214,GO:1902992,0.00383510658255391,0.999554164382066,5,11,negative regulation of amyloid precursor protein catabolic process,BP,PRNP;APOE;SORL1;ABCA7;BIN1
3402,GO:0007187,0.00387881358189246,0.998464532751802,17,79,G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,BP,NOS1;LPAR3;ADORA2B;PTHLH;PRKACB;EDNRA;GNAL;MC1R;HTR7;LTB4R2;ADCY1;GABBR1;ADGRF1;ADCY7;LTB4R;GPR3;ADCY6
6217,GO:0019752,0.00393329660619035,0.997216212074526,102,751,carboxylic acid metabolic process,BP,NR1D1;SLC16A3;TYSND1;NAGS;SLC6A8;PGM1;IDH2;CRAT;ACOT7;ACSF2;NOS1;HADH;CRTAP;HEXB;SLC7A8;SLC2A3;ALDH4A1;GLUL;PC;CRYL1;CPT2;HSD17B8;PRODH;D2HGDH;SLC6A6;AKT1;UROS;PYCR2;BSG;HK1;GGT1;FGFR4;ACOT1;PFKL;GAMT;BPHL;CEACAM1;CBR4;ABCD1;AIG1;PFKP;DHTKD1;HLCS;ALOX15B;HAGH;CEMIP;ACY1;LTA4H;CBS;TGFB1;SDHA;MDH2;ERO1B;PHGDH;HMGCL;PCK2;IDUA;PFKFB2;MLXIPL;GRHPR;AHCY;PDK1;ACAD10;CYGB;DDIT4;ACADS;CES2;GSTO1;ALDOC;LONP2;MTHFR;DECR2;PPARA;SESN2;MIF;ACO2;PHYH;DALRD3;ETFB;CKMT1A;SLC27A1;MAPK3;INSR;PFKM;GPT2;PFKFB3;MLYCD;HYAL1;WDTC1;ABHD10;PROX1;IARS2;ALDH7A1;NMNAT2;AZIN2;CHST14;PHYKPL;GCH1;PTGR2;PM20D2;SLC23A2;AARS
4126,GO:0009187,0.00393937165134832,0.998610382663374,14,60,cyclic nucleotide metabolic process,BP,VEGFA;APOE;NOS1;RAPGEF3;ADORA2B;PTHLH;NPR2;PKD2;TIMP2;LTB4R2;ADCY1;GABBR1;ADCY7;ADCY6
1991,GO:0004712,0.00400929058838128,0.998897447437491,10,36,protein serine/threonine/tyrosine kinase activity,MF,ACVR2B;RPS6KA2;MAP2K2;MAP2K1;AKT1;MAPKAPK3;PRKACA;MAPK3;MAP2K3;CLK3
13240,GO:0051928,0.00404036404809371,0.998635812621853,13,55,positive regulation of calcium ion transport,BP,F2R;ORAI1;LPAR3;GJC2;CEMIP;PKD2;PLCG1;NTSR1;TRPC1;BAX;GSTO1;EHD3;WFS1
6096,GO:0019318,0.00406686217206325,0.997874721073674,31,177,hexose metabolic process,BP,NR1D1;H6PD;PGM1;LRP5;NISCH;PHLDA2;GAA;PC;GALE;AKT1;HK1;FUCA1;PFKL;IGFBP4;PFKP;DGKQ;MDH2;PCK2;PFKFB2;MPI;PDK1;ALDOC;PPARA;GLB1;INSR;PFKM;PFKFB3;MLYCD;WDTC1;MAN2B1;MAN2B2
9059,GO:0035296,0.00408800128510801,0.998485695780151,15,67,regulation of tube diameter,BP,APLN;DOCK4;BBS2;APOE;F2R;EGFR;NOS1;ADORA2B;AKT1;EDNRA;HTR7;ITGA1;PLA2G6;GCH1;ADCY6
16730,GO:0097746,0.00408800128510801,0.998485695780151,15,67,regulation of blood vessel diameter,BP,APLN;DOCK4;BBS2;APOE;F2R;EGFR;NOS1;ADORA2B;AKT1;EDNRA;HTR7;ITGA1;PLA2G6;GCH1;ADCY6
6284,GO:0019897,0.0041080592105239,0.998175004084066,21,106,extrinsic component of plasma membrane,CC,DLG4;EPN3;SERPINE2;PRSS8;SYTL1;SNX9;S100A6;MYZAP;KCNAB2;PTK6;PCSK9;ERRFI1;PRSS22;GNAL;FARP1;ESYT2;JAK3;FYN;SRMS;CDH4;RGS19
16871,GO:0098802,0.00411070118571386,0.998262823316909,19,92,plasma membrane receptor complex,CC,DLG4;ITGA6;SHANK2;ITGB4;CEACAM1;CARD11;ITGB5;GRIN3B;SHANK3;ITGA1;OLFM2;IRAK1;INSR;GABBR1;ITGA3;DLG3;ITGA4;TOLLIP;HFE
16862,GO:0098793,0.00413053367533399,0.997744183982165,35,208,presynapse,CC,ADGRL1;DLG4;WNT7A;PTPRS;SYTL1;GLUL;MCTP1;DVL1;NLGN2;SYT8;KCNC4;BRSK1;KCNAB2;RAB3B;DBNDD1;AP3D1;SNPH;NTSR1;PI4K2A;RIMS3;VAMP2;ARHGAP44;SV2A;DNM1;SYNGR1;GABBR1;MICAL1;SEMA4C;BCL2L1;ICA1;RAB40B;PCLO;SEPT6;PFN2;APBA1
14950,GO:0070848,0.0041323877063978,0.997284683812875,69,471,response to growth factor,BP,DUSP6;XDH;HTRA1;EGR1;APLN;PDCD4;ACVR2B;POSTN;VEGFA;WNT7A;EGFR;NOS1;SPRY2;LTBP4;SHC1;LTBP2;LTBP1;SPRY4;ZFP36L1;SMURF2;FOS;SMAD3;AKT1;CORO1B;FGFR4;FNDC4;FGFR1;TWF2;GAS6;FGFBP1;EHD4;ERRFI1;ITGB5;CDKN1C;PLCG1;TGFB1;GPC1;ADAMTS7;PTPN1;LRP4;PRKCZ;EPN2;ERBB2;CYFIP2;FAM20C;STUB1;DDIT4;IER2;TGFBR3;LEMD2;CDC34;FYN;EEF2K;DNM2;CAT;MAPK3;INSR;HYAL1;ITGA3;PPP2R5B;MAP2K3;SIRT2;FAM129B;NGFR;PDCD6;PXN;GRB10;HFE;FGFR3
7033,GO:0030813,0.00413951690964663,0.999509696899384,5,11,positive regulation of nucleotide catabolic process,BP,RAPGEF3;PFKFB2;MLXIPL;INSR;PFKFB3
7605,GO:0031998,0.00415451840996193,0.999507483391934,5,11,regulation of fatty acid beta-oxidation,BP,TYSND1;AKT1;LONP2;PPARA;MLYCD
10501,GO:0043410,0.00419141703249853,0.997424072052466,52,336,positive regulation of MAPK cascade,BP,DUSP6;XDH;DUSP5;VEGFA;WNT7A;F2R;PKN1;EGFR;SPRY2;MST1R;SHC1;MAP2K2;LPAR3;MAP2K1;ERCC6;SHC2;ADORA2B;STK39;EPHA1;FGFR4;FGFR1;IGFBP4;GAS6;DUSP7;MAPKAPK3;EPHB2;ADAM8;PLCG1;CD81;TIMP2;TGFB1;PTPN1;PRKCZ;MINK1;ERBB2;ITGA1;IRAK1;TGFA;ABCA7;MIF;DDT;STK25;MAPK3;INSR;VANGL2;PAK1;SEMA4C;MAP2K3;TNFRSF25;MAP3K10;NGFR;FGFR3
6663,GO:0030029,0.00420821756773007,0.997183156664838,75,518,actin filament-based process,BP,PARVB;ESPN;OBSCN;NISCH;SCN4B;OBSL1;SHC1;RAPGEF3;ARAP1;SSH1;SMAD3;LRP1;SH3PXD2B;TMOD2;CORO1B;PPM1F;EPHA1;FMNL2;RAC2;NPHP4;EFS;TNNT1;TWF2;GSN;PLEKHG2;BCR;WIPF1;ARPIN;SPTB;CORO7;SNTA1;PAK6;CDC42EP5;ITGB5;TGFB1;ARHGAP25;FHOD3;SHANK3;MSRB2;RHOD;RHOF;WASF3;LLGL1;RHOBTB2;PTPN1;PRKCZ;MINK1;MICALL2;CAPG;PLEK2;FSCN1;ARHGAP44;PRKCD;SH3BP1;LIMK1;TPM2;WASH3P;FHOD1;RAC3;ARHGAP12;INF2;IQSEC1;VANGL2;PAK1;MICAL1;PROX1;KCTD13;TRIP10;PXN;LURAP1;CELSR1;PFN2;SSH3;CDC42BPG;PI4KAP2
16256,GO:0090313,0.00430975023770715,0.999021317754555,8,26,regulation of protein targeting to membrane,BP,PRNP;STOM;ANK3;CEMIP;ERBB2;GDI1;FYN;PAK1
1693,GO:0004167,0.00434763864387569,1,2,2,dopachrome isomerase activity,MF,MIF;DDT
5723,GO:0016862,0.00434763864387569,1,2,2,intramolecular oxidoreductase activity, interconverting keto- and enol-groups,MF,MIF;DDT
12443,GO:0050178,0.00434763864387569,1,2,2,phenylpyruvate tautomerase activity,MF,MIF;DDT
7596,GO:0031983,0.00435232180733878,0.997566421066052,37,232,vesicle lumen,CC,PYGB;VEGFA;APOE;PYGL;EGFR;VAT1;HEXB;NAPRT;SERPING1;VEGFB;FUCA1;PFKL;GAS6;GSN;PCSK1;CTSZ;APRT;TIMP2;DPP7;TGFB1;GALNS;ACTR1B;ADA;PRKCD;ALDOC;MIF;ECM1;QSOX1;GLB1;CAT;PDXK;RNASET2;LGALS3BP;MAN2B1;DNASE1L1;SERPINB1;TOLLIP
12869,GO:0051208,0.00437169387121242,0.998365832158941,15,68,sequestering of calcium ion,BP,F2R;ITPR3;NOS1;TPCN1;CEMIP;PKD2;PLCG1;TGFB1;NTSR1;ATP7B;RASA3;PRKACA;TRPC1;BAX;GSTO1
7446,GO:0031589,0.00442861432130587,0.997505070344412,38,229,cell-substrate adhesion,BP,PARVB;POSTN;VEGFA;ITGA6;ARL2;FBLN1;SMAD3;THBS3;ITGB4;PPM1F;EPHA1;RAC2;SMOC2;PLAU;GAS6;LAMA5;COL13A1;ITGB5;ADAMTS13;RHOD;PRKCZ;MINK1;MICALL2;NET1;ITGA1;NID1;TMEM8B;MSLN;ADAM15;BCAM;RAC3;DNM2;ITGA3;PKD1;ITGA4;EDA;LAMB1;PXN
707,GO:0001933,0.00445028436272258,0.997269483318725,51,330,negative regulation of protein phosphorylation,BP,TNIP1;DUSP6;XDH;DUSP5;PDCD4;PRNP;APOE;LRP5;PKN1;WWTR1;SPRY2;SPRY4;FBLN1;PIK3R2;DVL1;ADARB1;AKT1;PPM1F;STK39;EPHA1;IMPACT;SORL1;CEACAM1;PODNL1;PTK6;DUSP7;ERRFI1;DGKQ;EPHB2;CDKN1C;TGFB1;PTPN1;CAMK2N1;MLXIPL;TRIB2;PRKCZ;PRKCD;BAX;DUSP4;DDIT4;LEMD2;RPS6KA6;RGS14;CHAD;MICAL1;SIRT2;SOCS7;SIRT3;NDRG2;CBLC;LRRK1
3657,GO:0008144,0.00445393546606543,0.996601670027334,166,1272,drug binding,MF,ACVR2B;PYGB;PYGL;DGKA;OBSCN;NEK9;ITPR3;PKN1;ACSF2;EGFR;RPS6KA2;NOS1;MST1R;TK2;ACTA2;GLUL;MAP2K2;NME4;CTBS;FKBP9;SMARCA1;PC;MAP2K1;MARK4;ERCC6;CDK18;NMRK1;AKT1;STK39;HK1;EPHA1;BRSK1;FGFR4;FGFR1;PRKACB;SIGMAR1;PFKL;TTLL12;OPLAH;HLTF;ABCD1;TWF2;STRADB;MAPK13;PTK6;PFKP;CSNK1E;MAPKAPK3;BCR;EHD4;NADK;PANK4;HLCS;NPR2;DGKQ;PAK6;FYCO1;ABCA2;EPHB2;GRIN3B;APRT;GRK6;CBS;KIF17;MVD;ENTPD2;SCYL1;ULK2;MKNK2;TMEM173;ATP7B;PIP5KL1;KIF26B;DNAH1;PI4K2A;KIF7;PEX1;CD320;TRAP1;PFKFB2;PRKCZ;PRKACA;MINK1;ACTR1B;PIM2;UCKL1;ALAS1;ERBB2;ULK1;STK17A;JAK3;FSCN1;PDK1;CYGB;PRKCD;FAM20C;NUBP2;RPS6KA5;DGUOK;CUL9;MT2A;LIMK1;NTPCR;RPS6KA6;SCN8A;EHD3;LONP2;MAPK12;IRAK1;CHD2;PI4K2B;CHEK2;PPARA;ABCG1;MYO1D;MYH15;CDC34;ABCA7;SPEG;DALRD3;FYN;STK25;EEF2K;CKMT1A;CYP3A5;CHKA;KIF26A;DDX50;MAPK3;INSR;PFKM;ADCY1;ATP8B2;GPT2;PDXK;PAK1;CAMKK2;PPP3CB;ALPK1;PFKFB3;STK32C;SRMS;MAP2K3;IARS2;NMNAT2;ADCY7;TEP1;MAP3K10;PHYKPL;KIF13B;CAMK1;CAMKK1;BBS10;CDK11B;FGFR3;ITPKB;SPTLC2;CDC42BPG;CLK3;DHX32;PKN3;TTLL3;AK3;ADCY6;LRRK1;AARS
17305,GO:0140096,0.00448013492216125,0.996477245912946,216,1713,catalytic activity, acting on a protein,MF,DUSP6;DUSP5;GID4;HTRA1;THSD4;B4GALNT4;PLAT;TYSND1;FBXO2;ACVR2B;HMGA2;OBSCN;NEK9;PKN1;MTA1;EGFR;RPS6KA2;LOXL1;PTPRS;TMEM129;CTSO;CAPN2;MST1R;LTBP4;PRSS8;KLHL29;DDB2;LTBP1;PTPRE;NPEPL1;MMP1;RNPEPL1;MAP2K2;FKBP9;RBCK1;RNF44;MAP2K1;SSH1;MARK4;SMURF2;HBEGF;PPP2R3B;CDK18;FBXW5;RNF187;AKT1;HDAC5;FBXO41;F12;PPM1F;MMP28;RHBDF2;STK39;EPHA1;GGT1;PTPRU;ASH2L;MARCH4;BRSK1;FGFR4;FGFR1;PRKACB;HLTF;PPM1J;RAG1;HMG20B;CCND1;LHPP;STRADB;MAPK13;PLAU;PTK6;CSNK1E;CTSB;DUSP7;MAPKAPK3;PCSK9;BCR;HLCS;PRSS22;CDC25B;NPR2;PAK6;SHARPIN;ACY1;PCSK1;CTSZ;FBXW8;ZNF598;PRSS3;EPHB2;ADAM8;JOSD2;LTA4H;PTPDC1;GRK6;FBXL8;RNF135;ADAMTS13;ZNF862;DPP7;SCYL1;ABHD17C;ULK2;MKNK2;ADAMTS7;B3GNT3;EFNB3;MIPEP;MGAT4B;FBXO17;CLCA2;ERO1B;FBXO44;ANKZF1;PHF21A;ADAM19;ZER1;PTPN1;TPP1;MBD3;ZDHHC24;VHL;PRKCZ;KDM6B;PRKACA;MINK1;RABGGTA;PIM2;ERBB2;ULK1;CNDP2;MMP10;STK17A;JAK3;RNPEP;PDK1;THOP1;PRKCD;FAM20C;MIB2;USP20;STUB1;SBF1;XYLT2;FBXW4;EREG;RPS6KA5;DUSP4;MBTPS2;ZDHHC8;TMX4;LIMK1;TGFBR3;PDIA5;RPS6KA6;LRSAM1;ADAM15;ASB1;LONP2;MAPK12;IRAK1;HDAC7;PCMTD2;CHEK2;CDC34;RNF123;SPEG;EEF2KMT;KDM4B;QSOX1;SPPL2B;FYN;STK25;EEF2K;ARID5B;PELI1;ZDHHC1;MAPK3;INSR;PAK1;KLHL36;CAMKK2;PPP3CB;RNF144A;ALPK1;CTSF;USP21;STK32C;SRMS;MAP2K3;ZYG11B;KCTD13;SIRT2;BACH1;MAP3K10;PELI3;PDCD6;DUSP23;CAMK1;CAMKK1;EZH1;SIRT3;CDK11B;SSH3;FGFR3;CBLC;CDC42BPG;PRSS21;CLK3;KDM3A;PM20D2;PKN3;TTLL3;LRRK1;KLHL24
18813,GO:1904352,0.00451163010155223,0.999868937476456,3,4,positive regulation of protein catabolic process in the vacuole,BP,LRP1;LDLR;CD81
16813,GO:0098662,0.00451789523949628,0.997157390551414,56,376,inorganic cation transmembrane transport,BP,FHL1;KCNG1;PRNP;F2R;ITPR3;SCN4B;NOS1;SLC2A9;ORAI3;ORAI1;SLC12A7;KCNJ15;GJC2;STOM;TPCN1;KCNC4;STK39;SLC15A4;MFSD3;KCNAB2;ANK3;GAS6;PCSK9;SLC20A1;SNTA1;CEMIP;PKD2;GRIN3B;ASIC1;PLCG1;TGFB1;NTSR1;ATP7B;RASA3;PRKACA;VAMP2;TRPC1;CACNB3;BAX;CYC1;SCN8A;GSTO1;EHD3;SLC9A7;PLA2G6;FYN;DNM2;SLC12A4;GLRX;PKD1;SLC25A37;ATP6V1F;SLC39A3;HFE;TMCO3;KLHL24
16152,GO:0090170,0.00453421691223147,0.999868035490302,3,4,regulation of Golgi inheritance,BP,MAP2K2;MAP2K1;MAPK3
5144,GO:0015672,0.00453460153260329,0.997396697836417,40,252,monovalent inorganic cation transport,BP,FHL1;KCNG1;PRNP;SLC6A8;SERPINE2;SCN4B;NOS1;SLC2A9;PRSS8;SLC12A7;KCNJ15;STOM;AKT1;KCNC4;STK39;SLC15A4;CNTN1;MFSD3;KCNAB2;ANK3;PCSK9;SLC20A1;SNTA1;PKD2;ASIC1;TGFB1;SLC38A10;VAMP2;CYC1;SLC13A5;SCN8A;SLC9A7;DNM2;SLC12A4;SLC13A3;GLRX;ATP6V1F;TMCO3;SLC23A2;KLHL24
3578,GO:0007626,0.00456086163721013,0.997998992188829,20,101,locomotory behavior,BP,DLG4;APOE;ESPN;NAGLU;MTA1;ETV5;HEXB;GAA;NLGN2;ZNF385A;SLITRK6;NTSR1;EFNB3;B4GALT2;OLFM2;ZDHHC8;DNM1;PPP3CB;CELSR1;APBA1
8652,GO:0034219,0.00459101139162347,0.998211351484148,16,73,carbohydrate transmembrane transport,BP,SLC2A9;SLC2A3;PIK3R2;AKT1;EDNRA;CLTCL1;PRKCZ;SLC2A11;SESN2;SLC50A1;INSR;RTN2;PAK1;NGFR;GRB10;SLC23A2
6665,GO:0030031,0.0046303774300489,0.996981048030375,65,440,cell projection assembly,BP,ZMYND8;PARVB;BBS2;ESPN;ITGA6;EVI5L;WWTR1;NUDCD3;ARAP1;LPAR3;SSH1;MARK4;FAM110C;IFT140;DNAAF5;RAC2;NPHP4;TENM2;TWF2;CEP250;CSNK1E;LAMA5;GSN;SEPT10;CCDC113;UNC119B;PLXNB3;CDC42EP5;PTPDC1;KIF17;RFX2;CROCC;RHOD;DNAH1;WASF3;BBS1;AGRN;CEP131;PRKACA;SDCCAG8;NINL;RILPL1;CYFIP2;FSCN1;PRKCD;SH3BP1;EHD3;WDR60;TMEM231;DNAAF3;RAC3;DNM2;ATXN10;ARHGEF4;CEP72;VANGL2;NDE1;PLEKHM1;MSS51;TCTN1;BBS10;SEPT6;PFN2;SSH3;TTLL3
2668,GO:0006023,0.00463491636854968,0.998071674386405,18,86,aminoglycan biosynthetic process,BP,SDC1;B4GAT1;B3GAT3;CEMIP;TGFB1;GPC1;B3GNT3;B4GALT2;AGRN;B4GALT6;XYLT2;ST3GAL3;HYAL1;NDST2;ST3GAL2;CHST14;CHPF;SDC2
5787,GO:0017016,0.00464033403287191,0.99701827644265,61,406,Ras GTPase binding,MF,DLG4;DOCK4;OBSCN;NDRG1;PKN1;EVI5L;EGFR;SYTL1;SHC1;TBC1D14;RIN1;RAPGEF3;EXOC2;DVL1;HBEGF;SHC2;FMNL2;FGFR4;FGFR1;RAB11FIP4;TRAPPC9;PLEKHG2;BCR;XPOT;RGL2;SPTB;PAK6;RASGEF1A;CDC42EP5;TBC1D9B;FARP1;PLEKHG4;LLGL1;PLEKHG3;RIMS3;RABGGTA;MICALL2;PLEKHG5;ERBB2;ULK1;JAK3;NET1;ARHGAP44;SBF1;SH3BP1;EREG;GDI1;FYN;INF2;ARHGEF4;ARHGEF1;PAK1;MICAL1;SGSM2;TBC1D16;KCTD13;RABGAP1;NGFR;TBC1D8;FGFR3;PKN3
5451,GO:0016323,0.00468853234488845,0.997761272444021,24,127,basolateral plasma membrane,CC,DLG4;ITGA6;EGFR;SLC2A9;MST1R;SLC7A8;LRP1;STK39;LDLR;CEACAM1;ANK3;PKD2;CD81;ATP7B;CLCA2;ERBB2;TGFA;MYO1D;VANGL2;ITGA3;DLG3;LRCH4;PKD1;SLC23A2
17026,GO:0099175,0.00469590568304048,0.99867210605639,10,37,regulation of postsynapse organization,BP,ZMYND8;PRNP;APOE;SSH1;SHANK3;LRP4;ARHGAP44;FYN;EEF2K;CAPRIN2
6918,GO:0030516,0.00469875709040526,0.998231880029044,15,67,regulation of axon extension,BP,SEMA4B;VEGFA;APOE;PTPRS;TWF2;SEMA3F;WNT3;SEMA4F;LIMK1;GDI1;DNM2;PAK1;SEMA4C;CDH4;SEMA3B
3272,GO:0006954,0.004711155029362,0.99704268397826,55,367,inflammatory response,BP,TNIP1;NT5E;PDCD4;CTNNBIP1;TNFRSF6B;APOE;F2R;EGFR;NFATC4;SDC1;ACP5;FOS;SMAD3;PRDX5;ADORA2B;AKT1;HDAC5;F12;STK39;SERPING1;GGT1;NFKBIZ;FNDC4;LDLR;IGFBP4;MAPK13;BCR;SHARPIN;IL20RB;ADAM8;CD81;CEBPB;TGFB1;PRKCZ;KDM6B;ADA;AHCY;JAK3;PRKCD;RPS6KA5;LTB4R2;PPARA;MIF;DDT;ECM1;HYAL1;MAP2K3;TNFRSF25;LTB4R;NGFR;TOLLIP;PNMA1;HFE;ZP3;IL17RE
9897,GO:0042221,0.00476161501418366,0.996107130866015,332,2790,response to chemical,BP,TNIP1;DUSP6;XDH;ERCC1;SEMA4B;HTRA1;EGR1;NR1D1;EDEM1;CST3;CYP27B1;FBXO2;APLN;PGF;PDCD4;ACVR2B;DOCK4;XPC;PRNP;BBS2;SLC6A8;POSTN;VEGFA;FAM210B;TNFRSF6B;WNT7A;APOE;F2R;LRP5;ITGA6;HMGA2;NDRG1;ITPR3;AKR7A2;EGFR;LOXL1;NOS1;TMEM129;HADH;SPRY2;CAPN2;MST1R;NFATC4;LTBP4;SDC1;ETV5;SHC1;LTBP2;LTBP1;SLC7A8;PTPRE;MMP1;SPRY4;RAPGEF3;TXNRD3;ZFP36L1;GLUL;MAP2K2;CMTM7;RBCK1;MAP2K1;ACP5;SSH1;ENDOG;SMURF2;FOS;SMAD3;STAT6;PIK3R2;ERCC6;LRP1;GJC2;DVL1;EPAS1;DNAJB5;HBEGF;CYBRD1;PPP1R14A;PRDX5;PRODH;D2HGDH;AKT1;GRB7;CORO1B;HDAC5;UROS;F12;PPM1F;MMP28;ENTPD6;PYCR2;BSG;STK39;GGT1;PTPRU;VEGFB;IMPACT;IFNGR2;RAB31;FGFR4;FNDC4;LDLR;FGFR1;PRKACB;RAC2;PFKL;B4GAT1;BPHL;KLF7;CEACAM1;ANK3;CCND1;PODNL1;TWF2;MAPK13;PLAU;GAS6;PTK6;SEMA3F;PFKP;FGFBP1;CTSB;RAB3B;LAMA5;GSN;CMTM4;MAPKAPK3;IGFBP2;PCSK9;BCR;EHD4;ERRFI1;HLCS;AIP;PAQR6;SPTB;CCS;NPR2;DGKQ;PLXNB3;BNIP3;SHARPIN;PKD2;ACY1;GPX3;IL20RB;ITGB5;ABCA2;EPOR;EPHB2;ADAM8;APRT;CDKN1C;PLCG1;CD81;CEBPB;ADAMTS13;TIMP2;WNT3;TGFB1;RFX2;GPC1;MKNK2;ADAMTS7;NTSR1;TMEM173;ATP7B;SHANK3;EFNB3;TNFSF15;NSMF;TUB;LAMB2;VGF;SEMA4F;ANKZF1;UBXN4;HMGCL;PTPN1;TPP1;PCK2;AGRN;MBD3;IFNE;CD320;LRP4;VHL;DNAJC4;TRAP1;PFKFB2;MLXIPL;PRKCZ;KDM6B;PRKACA;CD9;EPN2;ADA;AREG;PLEKHG5;BOK;ERBB2;AHCY;VAMP2;JAK3;NET1;BNIP3L;CYFIP2;FSCN1;TRPC1;RASA4;PDK1;CYGB;PRKCD;FAM20C;STUB1;IFI6;BAX;CYC1;SLC13A5;ITGA1;GJB4;EREG;RPS6KA5;DDIT4;MBTPS2;CARF;MT2A;IER2;CES2;TGFBR3;PDIA5;GDI1;LTB4R2;CPNE7;LEMD2;GSTO1;CHAD;LONP2;MAPK12;IRAK1;PPOX;INPP5D;MTHFR;CHEK2;PPARA;TMEM161A;SESN2;ABCG1;CDC34;SNN;RAB12;BCAP31;MIF;SLC25A29;PLA2G6;DDT;SYNGR1;ECM1;WFS1;CD68;SLC22A18;SPPL2B;FYN;STK25;RAC3;EEF2K;ARID5B;DNM2;CYP3A5;GLB1;PELI1;CHKA;CAT;TSPYL2;IGFBP7;SLC27A1;CYP2R1;MAPK3;INSR;SLC13A3;ADCY1;HLA-G;PRAF2;VANGL2;PAK1;CAMKK2;PPP3CB;CUL7;HYAL1;SEMA4C;WDTC1;ITGA3;DNMT3A;PPP2R5B;MAP2K3;BCL2L1;LMNA;TNFRSF25;SIRT2;FAM129B;CDH4;ITGA4;EDA;BACH1;ADCY7;SOCS7;PELI3;NGFR;TOLLIP;PDCD6;ATP6V1F;PXN;GRB10;GCH1;NR2F6;HFE;TERC;GAS2L1;COL6A1;BTG1;IL17RE;SEMA3B;SLC35F3;FGFR3;MFSD10;ITPKB;LRP11;DOK4;KDM3A;HOMER2;SRSF5;ADCY6
3403,GO:0007188,0.00482621004611369,0.99810696966774,16,74,adenylate cyclase-modulating G-protein coupled receptor signaling pathway,BP,NOS1;ADORA2B;PTHLH;PRKACB;EDNRA;GNAL;MC1R;HTR7;LTB4R2;ADCY1;GABBR1;ADGRF1;ADCY7;LTB4R;GPR3;ADCY6
5591,GO:0016616,0.0048596960873657,0.998019723081097,17,84,oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,H6PD;IDH2;AKR7A2;HADH;KDSR;CRYL1;HSD17B8;KCNAB2;CBR4;CTBP1;MDH2;PHGDH;GRHPR;HSD17B7;TSTA3;HSD11B1;PTGR2
16443,GO:0097107,0.00487249252955196,0.999854322374376,3,4,postsynaptic density assembly,BP,SHANK2;NLGN2;SHANK3
16819,GO:0098698,0.00487249252955196,0.999854322374376,3,4,postsynaptic specialization assembly,BP,SHANK2;NLGN2;SHANK3
13031,GO:0051496,0.00487320150568363,0.998614358275251,10,37,positive regulation of stress fiber assembly,BP,RAPGEF3;SMAD3;SH3PXD2B;PPM1F;EPHA1;LIMK1;FHOD1;PAK1;PXN;PFN2
12268,GO:0048588,0.00489615998028103,0.997573444396165,26,142,developmental cell growth,BP,SEMA4B;POSTN;VEGFA;APOE;PTPRS;LPAR3;DVL1;IMPACT;TWF2;SEMA3F;PLXNB3;WNT3;ULK2;LAMB2;SEMA4F;PRKCZ;ULK1;CYFIP2;LIMK1;GDI1;DNM2;PAK1;PPP3CB;SEMA4C;CDH4;SEMA3B
16811,GO:0098660,0.00489985927240857,0.996852501685574,60,409,inorganic ion transmembrane transport,BP,FHL1;KCNG1;PRNP;F2R;ITPR3;SCN4B;NOS1;SLC2A9;ORAI3;ORAI1;SLC12A7;KCNJ15;GJC2;STOM;TPCN1;KCNC4;TTYH3;STK39;SLC15A4;MFSD3;KCNAB2;ANK3;GAS6;PCSK9;SLC20A1;SNTA1;CEMIP;PKD2;GRIN3B;ASIC1;PLCG1;TGFB1;NTSR1;ATP7B;RASA3;CLCA2;PRKACA;VAMP2;TRPC1;CACNB3;BAX;CYC1;SCN8A;GSTO1;EHD3;SLC9A7;PLA2G6;FYN;DNM2;SLC12A4;GLRX;SLC37A2;PKD1;SLC25A37;ATP6V1F;SLC39A3;HFE;TMCO3;SLC26A11;KLHL24
15806,GO:0072507,0.0049122810690951,0.997234292374707,37,227,divalent inorganic cation homeostasis,BP,DLG4;CYP27B1;PRNP;APOE;F2R;ITPR3;EGFR;NOS1;HEXB;LPAR3;SMAD3;TPCN1;ANK3;EDNRA;BNIP3;CEMIP;PKD2;AP3D1;PLCG1;TGFB1;NTSR1;ATP7B;RASA3;PRKACA;BOK;TRPC1;CACNB3;BAX;SV2A;MT2A;GSTO1;BCAP31;PLA2G6;WFS1;FYN;GRINA;PKD1
16573,GO:0097367,0.00505326722997653,0.996041710492284,202,1590,carbohydrate derivative binding,MF,PGF;ACVR2B;PRNP;POSTN;VEGFA;APOE;PYGL;DGKA;OBSCN;NEK9;PKN1;ACSF2;EGFR;RPS6KA2;SERPINE2;NOS1;PTPRS;MST1R;LTBP4;LTBP2;ARL2;GTPBP1;TK2;ACTA2;RAPGEF3;GLUL;MAP2K2;NME4;CTBS;SMARCA1;PC;MAP2K1;MARK4;ERCC6;LRP1;THBS3;HBEGF;CDK18;NMRK1;AKT1;STK39;HK1;EPHA1;VEGFB;BRSK1;RAB31;FGFR4;FGFR1;PRKACB;RAC2;SMOC2;PFKL;TTLL12;OPLAH;HLTF;ABCD1;TWF2;STRADB;MAPK13;PTK6;PFKP;FGFBP1;CSNK1E;CTSB;RAB3B;MAPKAPK3;BCR;EHD4;SEPT10;NADK;PANK4;HLCS;AGAP1;COL13A1;NPR2;DGKQ;PAK6;FYCO1;CEMIP;ABCA2;EPHB2;APRT;GRK6;KIF17;MVD;ENTPD2;GNAL;SCYL1;ULK2;GPC1;MKNK2;TMEM173;ATP7B;PODXL2;PIP5KL1;KIF26B;RHOD;DNAH1;PI4K2A;RHOF;ARL10;KIF7;RHOBTB2;TUBG2;PEX1;PCK2;AGRN;TRAP1;PFKFB2;PRKCZ;PRKACA;MINK1;ACTR1B;ADA;PIM2;UCKL1;ERBB2;ULK1;STK17A;JAK3;PDK1;PRKCD;FAM20C;NUBP2;RPS6KA5;DGUOK;CUL9;RASL10B;NID1;LIMK1;TGFBR3;NTPCR;RPS6KA6;DNM1;SCN8A;EHD3;LONP2;MAPK12;IRAK1;CHD2;PI4K2B;CHEK2;ABCG1;MYO1D;MYH15;CDC34;ABCA7;RAB12;SPEG;DALRD3;FYN;STK25;RAC3;EEF2K;DNM2;CKMT1A;GLB1;CHKA;KIF26A;DDX50;TUBB6;MAPK3;INSR;PFKM;ADCY1;ATP8B2;PDXK;PAK1;CAMKK2;ALPK1;PFKFB3;STK32C;SRMS;MAP2K3;RRAS;IARS2;GAL3ST4;NMNAT2;ADCY7;TEP1;RAB28;MAP3K10;RAB40B;RNASE7;GCH1;KIF13B;CAMK1;CAMKK1;BBS10;SEPT6;CDK11B;FGFR3;ITPKB;CDC42BPG;CLK3;DHX32;PKN3;TTLL3;AK3;ADCY6;LRRK1;AARS
6303,GO:0019935,0.00506607659551043,0.998071545310211,15,69,cyclic-nucleotide-mediated signaling,BP,APOE;NOS1;RAPGEF3;ADORA2B;PTHLH;DGKQ;GNAL;MC1R;CDC34;ADCY1;ADGRF1;ADCY7;GPR3;PCLO;ADCY6
7747,GO:0032270,0.00511565655360497,0.996160853662642,141,1083,positive regulation of cellular protein metabolic process,BP,TNIP1;DUSP6;XDH;DUSP5;EGR1;EDEM1;DLG4;ACVR2B;PRNP;VEGFA;WNT7A;APOE;F2R;PKN1;MTA1;GRAMD4;EGFR;NOS1;SPRY2;MST1R;SHC1;VPS11;SNX9;RAPGEF3;MAP2K2;LPAR3;MAP2K1;FBLN1;SMAD3;ERCC6;LRP1;DVL1;HBEGF;SHC2;ADORA2B;AKT1;F12;PPM1F;STK39;EPHA1;IMPACT;CNTN1;DAP;FGFR4;LDLR;FGFR1;PRKACB;CIRBP;IGFBP4;CCND1;STRADB;GAS6;PTK6;CSNK1E;DUSP7;GSN;MAPKAPK3;PCSK9;RAD23A;EHD4;SH3D19;CDC25B;DGKQ;PAK6;CEMIP;PKD2;MAGEF1;EPHB2;ADAM8;CTBP1;PLCG1;CD81;TIMP2;TGFB1;NAB2;TNFSF15;NSMF;SNX33;PTPN1;IFNE;LRP4;TRIB2;PRKCZ;PRKACA;MINK1;AREG;BOK;ERBB2;C6ORF89;CYFIP2;PRKCD;STUB1;BAX;ITGA1;EREG;RPS6KA5;SYMPK;MAPK12;IRAK1;TGFA;CHEK2;SOX7;ABCA7;BCAP31;MIF;PLA2G6;DDT;WFS1;FYN;STK25;PELI1;SLC27A1;MAPK3;INSR;ADCY1;ETAA1;VANGL2;PAK1;CAMKK2;RNF144A;SEMA4C;CAPRIN2;MAP2K3;DLG3;PROX1;PKD1;TNFRSF25;SIRT2;ADCY7;MAPRE3;MAP3K10;NGFR;TOLLIP;PDCD6;CAMK1;CAMKK1;HFE;PFN2;FGFR3;ADCY6;LRRK1
7810,GO:0032370,0.00517022498258214,0.998633172308709,9,33,positive regulation of lipid transport,BP,APOE;PLTP;LRP1;NTSR1;PRKCD;ABCG1;ABCA7;MIF;PLA2G6
18846,GO:1904427,0.00517290760215108,0.998509777700836,10,38,positive regulation of calcium ion transmembrane transport,BP,F2R;GJC2;CEMIP;PKD2;PLCG1;NTSR1;TRPC1;BAX;GSTO1;EHD3
12653,GO:0050866,0.00520724816482102,0.997684793256815,20,102,negative regulation of cell activation,BP,PRNP;APOE;PKN1;SERPINE2;PAG1;LDLR;CEACAM1;BCR;IL20RB;CEBPB;TGFB1;CD9;ERBB2;JAK3;CYGB;PRKCD;INPP5D;PELI1;HLA-G;HFE
4497,GO:0010524,0.00524710591358084,0.998757377604947,8,27,positive regulation of calcium ion transport into cytosol,BP,F2R;CEMIP;PKD2;PLCG1;NTSR1;TRPC1;BAX;GSTO1
6424,GO:0021695,0.00525242576135583,0.998615306533112,9,32,cerebellar cortex development,BP,WNT7A;NAGLU;SERPINE2;TRNP1;MAP2K1;B4GALT2;RERE;PROX1;AARS
17497,GO:1900449,0.00526537287937947,0.998924144717086,7,21,regulation of glutamate receptor signaling pathway,BP,DLG4;SHANK2;NLGN2;EPHB2;SHANK3;MINK1;KLHL24
546,GO:0001666,0.00527324896209572,0.99694240442704,40,255,response to hypoxia,BP,EGR1;PLAT;CST3;PGF;POSTN;VEGFA;NDRG1;NOS1;CAPN2;ZFP36L1;ENDOG;SMAD3;EPAS1;AKT1;VEGFB;EDNRA;PLAU;ANGPTL4;BNIP3;ADAM8;TGFB1;VHL;ADA;AHCY;BNIP3L;PDK1;CYGB;STUB1;DDIT4;TGFBR3;IRAK1;MTHFR;PPARA;CAT;PAK1;DNMT3A;LMNA;SIRT2;BACH1;TERC
17073,GO:0099565,0.0052747910170191,0.998256122273082,12,49,chemical synaptic transmission, postsynaptic,BP,ZMYND8;DLG4;WNT7A;SSH1;SHANK2;DVL1;NLGN2;AKT1;GRIN3B;NTSR1;SHANK3;PRKCZ
3378,GO:0007159,0.00534735961006534,0.99711315505574,32,190,leukocyte cell-cell adhesion,BP,TNIP1;NT5E;PRNP;PAG1;AKT1;RAC2;RAG1;CEACAM1;CARD11;IGFBP2;IL20RB;AP3D1;ADAM8;CEBPB;TGFB1;PODXL2;EFNB3;PRKCZ;ADA;ERBB2;CERCAM;JAK3;PPARA;FYN;PELI1;HLA-G;TSTA3;PAK1;ITGA4;HFE;ZP3;ITPKB
18040,GO:1902533,0.00536868324879304,0.996230111874193,91,661,positive regulation of intracellular signal transduction,BP,DUSP6;XDH;DUSP5;PDCD4;VEGFA;WNT7A;F2R;PKN1;EGFR;NOS1;SPRY2;MST1R;SHC1;MAP2K2;LPAR3;RBCK1;MAP2K1;PIK3R2;ERCC6;HBEGF;FAM110C;S100A4;SHC2;ADORA2B;AKT1;STK39;EPHA1;FGFR4;FGFR1;ZNF385A;IGFBP4;GAS6;PTK6;CARD11;DUSP7;MAPKAPK3;RGL2;SLC20A1;SHARPIN;PKD2;RASGEF1A;EPHB2;ADAM8;PLCG1;CD81;TIMP2;TMED4;TGFB1;TNFSF15;MC1R;PTPN1;WDR59;PRKCZ;MINK1;ADA;PIM2;PLEKHG5;BOK;ERBB2;MIB2;BAX;ITGA1;EREG;GSTO1;IRAK1;TGFA;ABCA7;BCAP31;MIF;PLA2G6;DDT;ECM1;FYN;STK25;PELI1;CAT;MAPK3;INSR;TMEM101;VANGL2;PAK1;SEMA4C;MAP2K3;BCL2L1;TNFRSF25;MAP3K10;NGFR;LURAP1;FGFR3;ITPKB;LRRK1
13222,GO:0051896,0.00540288972990153,0.997431664749525,23,123,regulation of protein kinase B signaling,BP,XDH;EGFR;SPRY2;MST1R;PIK3R2;HBEGF;FAM110C;AKT1;FGFR4;FGFR1;GAS6;ADAM8;TGFB1;MC1R;ERBB2;EREG;LEMD2;FYN;INSR;PPP2R5B;RRAS;PDCD6;FGFR3
13504,GO:0055086,0.00545662003259455,0.996299807283301,75,548,nucleobase-containing small molecule metabolic process,BP,NT5E;XDH;H6PD;DLG4;VEGFA;PGM1;APOE;IDH2;ACOT7;DNPH1;NOS1;GTPBP1;TK2;RAPGEF3;NME4;PGLS;NAPRT;NMRK1;ADORA2B;ENTPD6;HK1;PTHLH;KCNAB2;PFKL;GAMT;LHPP;PFKP;CARD11;DHTKD1;NADK;PANK4;NPR2;PKD2;APRT;ENTPD2;TIMP2;TGFB1;PODXL2;SDHA;MDH2;ABHD14B;PCK2;PFKFB2;MLXIPL;ADA;MPI;UCKL1;AHCY;FAM20C;CYC1;PPCS;DGUOK;DDIT4;LTB4R2;ALDOC;PPARA;UPP1;NEIL1;APOBEC3C;APOBEC3F;INSR;TAZ;PFKM;ADCY1;TSTA3;GLRX;PFKFB3;GABBR1;DLG3;NDUFV3;NMNAT2;NT5C1B;ADCY7;AK3;ADCY6
9536,GO:0036293,0.00547788214485604,0.996792746889552,41,263,response to decreased oxygen levels,BP,EGR1;PLAT;CST3;PGF;POSTN;VEGFA;NDRG1;NOS1;CAPN2;ZFP36L1;ENDOG;SMAD3;EPAS1;AKT1;VEGFB;EDNRA;PLAU;ANGPTL4;BNIP3;ADAM8;TGFB1;VHL;ADA;AHCY;BNIP3L;PDK1;CYGB;STUB1;DDIT4;TGFBR3;IRAK1;MTHFR;PPARA;EEF2K;CAT;PAK1;DNMT3A;LMNA;SIRT2;BACH1;TERC
3150,GO:0006753,0.00549566479159936,0.996357634218417,67,482,nucleoside phosphate metabolic process,BP,NT5E;XDH;H6PD;DLG4;VEGFA;PGM1;APOE;IDH2;ACOT7;DNPH1;NOS1;GTPBP1;TK2;RAPGEF3;NME4;PGLS;NAPRT;NMRK1;ADORA2B;HK1;PTHLH;KCNAB2;PFKL;LHPP;PFKP;CARD11;DHTKD1;NADK;PANK4;NPR2;PKD2;APRT;ENTPD2;TIMP2;TGFB1;PODXL2;SDHA;MDH2;ABHD14B;PCK2;PFKFB2;MLXIPL;ADA;UCKL1;FAM20C;CYC1;PPCS;DGUOK;DDIT4;LTB4R2;ALDOC;PPARA;UPP1;NEIL1;INSR;TAZ;PFKM;ADCY1;PFKFB3;GABBR1;DLG3;NDUFV3;NMNAT2;NT5C1B;ADCY7;AK3;ADCY6
4711,GO:0010875,0.00550293422642209,0.999271817398631,5,12,positive regulation of cholesterol efflux,BP,APOE;PLTP;LRP1;ABCG1;ABCA7
12760,GO:0051044,0.0055945054385324,0.999256669676169,5,12,positive regulation of membrane protein ectodomain proteolysis,BP,APOE;SNX9;SH3D19;ADAM8;SNX33
14541,GO:0070062,0.00560436071414211,0.995515674296827,242,2047,extracellular exosome,CC,NT5E;HTRA1;THSD4;PLAT;CST3;EPN3;FBXO2;XPC;PRNP;PYGB;PGM1;WNT7A;APOE;PYGL;TSPAN1;NAGLU;PLD3;NDRG1;IDH2;ACOT7;ARRDC1;AKR7A2;DNPH1;VAT1;PTPRS;CAPN2;LTBP4;PRSS8;SYTL1;SDC1;APPL2;LTBP2;ARL2;HEXB;SLC7A8;SLC2A3;ACTA2;SNX9;RAPGEF3;GAA;GLUL;CTBS;PGLS;MAP2K1;NAPRT;CRYL1;ACP5;MARCKSL1;TMEM8A;GALE;SLC9A3R2;FBLN1;ARHGAP23;S100A4;ITGB4;CYBRD1;PRDX5;STOM;CORO1B;TTYH3;S100A6;F12;ENTPD6;BSG;SERPING1;DYSF;GGT1;CNTN1;HEBP1;PRKACB;FUCA1;RAC2;PFKL;SEC14L2;GAMT;H2AFJ;B4GAT1;BPHL;SORL1;CEACAM1;B3GAT3;TWF2;CEP250;PLAU;GAS6;PFKP;CTSB;RAB3B;CARD11;LAMA5;GSN;IGFBP2;BCR;EHD4;ALOX15B;GGACT;OAF;HAGH;MVB12B;SERINC2;PROCR;PKD2;ACY1;GPX3;CTSZ;ITGB5;MAGEF1;PRSS3;CADM4;APRT;LTA4H;CD81;ENTPD2;TIMP2;NUDCD2;WNT3;DPP7;GNAL;TMED4;CLTCL1;SNTB2;GPC1;MDH2;GALNS;ABHD8;CROCC;ABHD14B;LAMB2;RNH1;RHOF;WASF3;PHGDH;PEX1;TPP1;PCK2;AGRN;CD320;TRAP1;IDUA;RFNG;PRKCZ;PRKACA;MINK1;GRHPR;ACTR1B;TOM1L2;CD9;MPI;CAPG;CNDP2;AHCY;VAMP2;RNPEP;CYFIP2;FSCN1;PRKCD;FAM20C;RBL2;STUB1;BAX;ITGA1;PPCS;PPL;PCSK1N;HPCAL1;NAGA;NID1;TGFBR3;NTPCR;CPNE7;DNM1;GSTO1;ALDOC;ADAM15;REEP2;WDR60;CHD2;MYO1D;JADE2;MIF;DOPEY2;BCAM;DDT;NUDT14;ECM1;QSOX1;VWA1;EFEMP2;STK25;RAC3;ETFB;DNM2;CKMT1A;GLB1;CAT;IGFBP7;ZDHHC1;TUBB6;MAPK3;INSR;SLC13A3;PFKM;ADCY1;TSTA3;PDXK;GLRX;RNASET2;LGALS3BP;CTSF;ROBO4;SLC37A2;HYAL1;ITGA3;MAN2B1;RRAS;DNASE1L1;ALDH7A1;PKD1;FAM129B;ITGA4;GAL3ST4;TRIP10;SERPINB1;LAMB1;TOLLIP;PDCD6;ATP6V1F;PCLO;CHST14;RNASE7;DUSP23;COL6A1;SEMA3B;PFN2;TST;NDRG2;MAN2B2;CBLC;PTGR2;PM20D2;SLC26A11;AARS
16758,GO:0098552,0.00561577610120446,0.996686823927397,42,265,side of membrane,CC,DLG4;PRNP;ITGA6;SERPINE2;SDC1;SNX9;MAP2K2;S100A6;MYZAP;LDLR;KCNAB2;SYNGAP1;PTK6;PCSK9;ANTXR2;ERRFI1;SPTB;PKD2;GNAL;NTSR1;RASA3;SCART1;FARP1;PTPN1;ESYT2;CD9;ADA;JAK3;RASA4;ITGA1;TGFBR3;ABCG1;BCAP31;BCAM;SPPL2B;FYN;INSR;HLA-G;ITGA3;SRMS;RGS19;HFE
10392,GO:0043230,0.00565504392857216,0.995472397290451,243,2056,extracellular organelle,CC,NT5E;HTRA1;THSD4;PLAT;CST3;EPN3;FBXO2;XPC;PRNP;PYGB;PGM1;WNT7A;APOE;PYGL;TSPAN1;NAGLU;PLD3;NDRG1;IDH2;ACOT7;ARRDC1;AKR7A2;SERPINE2;DNPH1;VAT1;PTPRS;CAPN2;LTBP4;PRSS8;SYTL1;SDC1;APPL2;LTBP2;ARL2;HEXB;SLC7A8;SLC2A3;ACTA2;SNX9;RAPGEF3;GAA;GLUL;CTBS;PGLS;MAP2K1;NAPRT;CRYL1;ACP5;MARCKSL1;TMEM8A;GALE;SLC9A3R2;FBLN1;ARHGAP23;S100A4;ITGB4;CYBRD1;PRDX5;STOM;CORO1B;TTYH3;S100A6;F12;ENTPD6;BSG;SERPING1;DYSF;GGT1;CNTN1;HEBP1;PRKACB;FUCA1;RAC2;PFKL;SEC14L2;GAMT;H2AFJ;B4GAT1;BPHL;SORL1;CEACAM1;B3GAT3;TWF2;CEP250;PLAU;GAS6;PFKP;CTSB;RAB3B;CARD11;LAMA5;GSN;IGFBP2;BCR;EHD4;ALOX15B;GGACT;OAF;HAGH;MVB12B;SERINC2;PROCR;PKD2;ACY1;GPX3;CTSZ;ITGB5;MAGEF1;PRSS3;CADM4;APRT;LTA4H;CD81;ENTPD2;TIMP2;NUDCD2;WNT3;DPP7;GNAL;TMED4;CLTCL1;SNTB2;GPC1;MDH2;GALNS;ABHD8;CROCC;ABHD14B;LAMB2;RNH1;RHOF;WASF3;PHGDH;PEX1;TPP1;PCK2;AGRN;CD320;TRAP1;IDUA;RFNG;PRKCZ;PRKACA;MINK1;GRHPR;ACTR1B;TOM1L2;CD9;MPI;CAPG;CNDP2;AHCY;VAMP2;RNPEP;CYFIP2;FSCN1;PRKCD;FAM20C;RBL2;STUB1;BAX;ITGA1;PPCS;PPL;PCSK1N;HPCAL1;NAGA;NID1;TGFBR3;NTPCR;CPNE7;DNM1;GSTO1;ALDOC;ADAM15;REEP2;WDR60;CHD2;MYO1D;JADE2;MIF;DOPEY2;BCAM;DDT;NUDT14;ECM1;QSOX1;VWA1;EFEMP2;STK25;RAC3;ETFB;DNM2;CKMT1A;GLB1;CAT;IGFBP7;ZDHHC1;TUBB6;MAPK3;INSR;SLC13A3;PFKM;ADCY1;TSTA3;PDXK;GLRX;RNASET2;LGALS3BP;CTSF;ROBO4;SLC37A2;HYAL1;ITGA3;MAN2B1;RRAS;DNASE1L1;ALDH7A1;PKD1;FAM129B;ITGA4;GAL3ST4;TRIP10;SERPINB1;LAMB1;TOLLIP;PDCD6;ATP6V1F;PCLO;CHST14;RNASE7;DUSP23;COL6A1;SEMA3B;PFN2;TST;NDRG2;MAN2B2;CBLC;PTGR2;PM20D2;SLC26A11;AARS
18475,GO:1903561,0.00565504392857216,0.995472397290451,243,2056,extracellular vesicle,CC,NT5E;HTRA1;THSD4;PLAT;CST3;EPN3;FBXO2;XPC;PRNP;PYGB;PGM1;WNT7A;APOE;PYGL;TSPAN1;NAGLU;PLD3;NDRG1;IDH2;ACOT7;ARRDC1;AKR7A2;SERPINE2;DNPH1;VAT1;PTPRS;CAPN2;LTBP4;PRSS8;SYTL1;SDC1;APPL2;LTBP2;ARL2;HEXB;SLC7A8;SLC2A3;ACTA2;SNX9;RAPGEF3;GAA;GLUL;CTBS;PGLS;MAP2K1;NAPRT;CRYL1;ACP5;MARCKSL1;TMEM8A;GALE;SLC9A3R2;FBLN1;ARHGAP23;S100A4;ITGB4;CYBRD1;PRDX5;STOM;CORO1B;TTYH3;S100A6;F12;ENTPD6;BSG;SERPING1;DYSF;GGT1;CNTN1;HEBP1;PRKACB;FUCA1;RAC2;PFKL;SEC14L2;GAMT;H2AFJ;B4GAT1;BPHL;SORL1;CEACAM1;B3GAT3;TWF2;CEP250;PLAU;GAS6;PFKP;CTSB;RAB3B;CARD11;LAMA5;GSN;IGFBP2;BCR;EHD4;ALOX15B;GGACT;OAF;HAGH;MVB12B;SERINC2;PROCR;PKD2;ACY1;GPX3;CTSZ;ITGB5;MAGEF1;PRSS3;CADM4;APRT;LTA4H;CD81;ENTPD2;TIMP2;NUDCD2;WNT3;DPP7;GNAL;TMED4;CLTCL1;SNTB2;GPC1;MDH2;GALNS;ABHD8;CROCC;ABHD14B;LAMB2;RNH1;RHOF;WASF3;PHGDH;PEX1;TPP1;PCK2;AGRN;CD320;TRAP1;IDUA;RFNG;PRKCZ;PRKACA;MINK1;GRHPR;ACTR1B;TOM1L2;CD9;MPI;CAPG;CNDP2;AHCY;VAMP2;RNPEP;CYFIP2;FSCN1;PRKCD;FAM20C;RBL2;STUB1;BAX;ITGA1;PPCS;PPL;PCSK1N;HPCAL1;NAGA;NID1;TGFBR3;NTPCR;CPNE7;DNM1;GSTO1;ALDOC;ADAM15;REEP2;WDR60;CHD2;MYO1D;JADE2;MIF;DOPEY2;BCAM;DDT;NUDT14;ECM1;QSOX1;VWA1;EFEMP2;STK25;RAC3;ETFB;DNM2;CKMT1A;GLB1;CAT;IGFBP7;ZDHHC1;TUBB6;MAPK3;INSR;SLC13A3;PFKM;ADCY1;TSTA3;PDXK;GLRX;RNASET2;LGALS3BP;CTSF;ROBO4;SLC37A2;HYAL1;ITGA3;MAN2B1;RRAS;DNASE1L1;ALDH7A1;PKD1;FAM129B;ITGA4;GAL3ST4;TRIP10;SERPINB1;LAMB1;TOLLIP;PDCD6;ATP6V1F;PCLO;CHST14;RNASE7;DUSP23;COL6A1;SEMA3B;PFN2;TST;NDRG2;MAN2B2;CBLC;PTGR2;PM20D2;SLC26A11;AARS
3691,GO:0008201,0.0056663541547296,0.99772967646452,16,77,heparin binding,MF,PGF;POSTN;VEGFA;APOE;SERPINE2;PTPRS;LTBP2;THBS3;HBEGF;VEGFB;FGFR4;FGFR1;SMOC2;FGFBP1;COL13A1;TGFBR3
10500,GO:0043409,0.00569438276662693,0.997231405726164,24,130,negative regulation of MAPK cascade,BP,TNIP1;DUSP6;DUSP5;PDCD4;APOE;SPRY2;SPRY4;FBLN1;PIK3R2;AKT1;SORL1;DUSP7;ERRFI1;EPHB2;PTPN1;CAMK2N1;PRKCD;DUSP4;LEMD2;RPS6KA6;RGS14;SIRT3;NDRG2;CBLC
9847,GO:0042100,0.00570632488533928,0.99819849429702,11,45,B cell proliferation,BP,PKN1;CARD11;CD81;IFNE;CD320;ADA;PRKCD;BAX;INPP5D;MIF;PELI1
13074,GO:0051592,0.00572520556481839,0.997631340345876,17,82,response to calcium ion,BP,ITPR3;EGFR;SDC1;ENDOG;FOS;ENTPD6;CCND1;PKD2;TRPC1;RASA4;CARF;GDI1;CPNE7;EEF2K;ADCY1;PDCD6;ITPKB
3713,GO:0008236,0.00572932581498131,0.997488203835215,19,97,serine-type peptidase activity,MF,HTRA1;PLAT;TYSND1;PRSS8;MMP1;F12;RHBDF2;PLAU;CTSB;PCSK9;PRSS22;PCSK1;PRSS3;ADAM8;DPP7;TPP1;MMP10;LONP2;PRSS21
2326,GO:0005342,0.00573118132947219,0.997558782086651,18,88,organic acid transmembrane transporter activity,MF,SLC16A3;SLC6A8;SLC7A8;SLC16A5;SLC6A6;BSG;SLC15A4;CEACAM1;SERINC2;SLC43A1;SLC38A10;SLC13A5;SLC25A29;SLC27A1;SLC13A3;SLC16A13;SLC23A2;SLC26A11
11900,GO:0046943,0.00573118132947219,0.997558782086651,18,88,carboxylic acid transmembrane transporter activity,MF,SLC16A3;SLC6A8;SLC7A8;SLC16A5;SLC6A6;BSG;SLC15A4;CEACAM1;SERINC2;SLC43A1;SLC38A10;SLC13A5;SLC25A29;SLC27A1;SLC13A3;SLC16A13;SLC23A2;SLC26A11
4598,GO:0010715,0.00575803908017867,0.999229458762099,5,12,regulation of extracellular matrix disassembly,BP,CST3;LRP1;FGFR4;TGFB1;FSCN1
10777,GO:0044242,0.00576766605664584,0.997097206576309,26,147,cellular lipid catabolic process,BP,TYSND1;APOE;CRAT;HADH;HEXB;CPT2;SRD5A3;AKT1;LDLR;FUCA1;ABCD1;AIG1;PLCG1;PCK2;ACAD10;PRKCD;ACADS;NAGA;LONP2;DECR2;PPARA;SESN2;PHYH;ETFB;MLYCD;SIRT2
15476,GO:0071827,0.00579323024680265,0.998780500012655,7,22,plasma lipoprotein particle organization,BP,APOE;PLTP;PRKACB;PRKACA;ZDHHC8;ABCG1;ABCA7
8094,GO:0032787,0.00583004814035164,0.996207852159113,61,417,monocarboxylic acid metabolic process,BP,NR1D1;SLC16A3;TYSND1;PGM1;IDH2;CRAT;ACOT7;ACSF2;HADH;ALDH4A1;PC;CRYL1;CPT2;HSD17B8;D2HGDH;AKT1;BSG;HK1;GGT1;FGFR4;ACOT1;PFKL;CEACAM1;CBR4;ABCD1;AIG1;PFKP;DHTKD1;HLCS;ALOX15B;HAGH;PCK2;IDUA;PFKFB2;MLXIPL;GRHPR;PDK1;ACAD10;CYGB;DDIT4;ACADS;CES2;ALDOC;LONP2;DECR2;PPARA;SESN2;MIF;PHYH;ETFB;SLC27A1;MAPK3;INSR;PFKM;PFKFB3;MLYCD;WDTC1;ABHD10;PROX1;CHST14;PTGR2
14182,GO:0061098,0.00584525058918122,0.998589343420185,8,27,positive regulation of protein tyrosine kinase activity,BP,DLG4;PRNP;ERCC6;GAS6;PTPN1;EREG;TGFA;DLG3
16257,GO:0090314,0.00589273317680049,0.998755472895458,7,22,positive regulation of protein targeting to membrane,BP,PRNP;STOM;ANK3;CEMIP;ERBB2;FYN;PAK1
15210,GO:0071363,0.00594783507422769,0.996060605725712,66,454,cellular response to growth factor stimulus,BP,DUSP6;XDH;HTRA1;EGR1;APLN;PDCD4;ACVR2B;POSTN;VEGFA;WNT7A;EGFR;NOS1;SPRY2;LTBP4;SHC1;LTBP2;LTBP1;SPRY4;ZFP36L1;SMURF2;FOS;SMAD3;AKT1;CORO1B;FGFR4;FGFR1;TWF2;GAS6;FGFBP1;EHD4;ERRFI1;ITGB5;CDKN1C;PLCG1;TGFB1;GPC1;ADAMTS7;PTPN1;LRP4;PRKCZ;EPN2;ERBB2;CYFIP2;FAM20C;STUB1;DDIT4;TGFBR3;LEMD2;FYN;EEF2K;DNM2;CAT;MAPK3;INSR;HYAL1;ITGA3;PPP2R5B;MAP2K3;SIRT2;FAM129B;NGFR;PDCD6;PXN;GRB10;HFE;FGFR3
2659,GO:0006007,0.00599456035593489,0.998729772309532,7,22,glucose catabolic process,BP,LRP5;HK1;PFKL;PFKP;PFKFB2;ALDOC;PFKM
717,GO:0001944,0.00604104072254237,0.995983448779434,67,460,vasculature development,BP,XDH;EGR1;APLN;PGF;PDCD4;ACVR2B;VEGFA;WNT7A;APOE;LRP5;HMGA2;ELK3;LOXL1;SPRY2;NFATC4;SHC1;LTBP1;ACTA2;RAPGEF3;ZFP36L1;PLCD3;MAP2K1;LRP1;EPAS1;AKT1;HDAC5;SH2D2A;EPHA1;VEGFB;FGFR4;FGFR1;CEACAM1;EDNRA;LAMA5;ARHGAP22;ANGPTL4;ERRFI1;PKD2;FBXW8;EPHB2;ADAM8;PLCG1;TGFB1;SNX17;RNH1;EPN2;ERBB2;ADGRB2;BAX;EREG;TGFBR3;ADAM15;TMEM231;HDAC7;ECM1;DNM2;PPP3CB;ROBO4;CUL7;HYAL1;RRAS;PROX1;PKD1;FAM129B;NGFR;PDCD6;BTG1
2535,GO:0005794,0.00607029407925926,0.995386175676509,149,1148,Golgi apparatus,CC,H1F0;B4GALNT4;EDEM1;DOCK4;PRNP;POSTN;WNT7A;APOE;F2R;ANGEL1;AKR7A2;EGFR;OBSL1;CAPN2;SDC1;LMF1;TBC1D14;ARL2;SNX9;ST6GALNAC2;ARAP1;MAP2K2;MARCH9;MAP2K1;HDAC5;PITPNM1;ENTPD6;BSG;ASAP2;MARCH4;IFNGR2;PTHLH;RAB31;FGFR4;LDLR;B4GAT1;PHF7;SORL1;B3GAT3;TENM2;ANK3;TRAPPC9;GAS6;MPLKIP;PCSK9;SPTB;CORO7;FYCO1;CTSZ;FBXW8;GPSM1;AP3D1;ASIC1;WNT3;DPP7;TMED4;TGFB1;CLTCL1;SCYL1;GPC1;SLC38A10;NTSR1;B3GNT3;TMEM173;ATP7B;PODXL2;MGAT4B;GOLGA2P5;SNX17;ST6GALNAC6;VGF;PI4K2A;YIPF3;LLGL1;ADAM19;B4GALT2;AGRN;ZDHHC24;B4GALT6;RFNG;MINK1;AREG;BOK;VAMP2;C6ORF89;NECAB3;MCFD2;FAM20C;XYLT2;TMBIM4;MBTPS2;PCSK1N;ZDHHC8;LIMK1;GDI1;DNM1;MFNG;MSLN;LPCAT1;ST3GAL3;TGFA;PI4K2B;CHEK2;COG7;ABCG1;ABCA7;RAB12;BCAP31;DOPEY2;SLC9A7;QSOX1;SPPL2B;STK25;DNM2;GLB1;CAT;SLC50A1;ZDHHC1;MAPK3;CBLN3;GRINA;HLA-G;STX10;ATP8B2;MALL;RNF144A;CUL7;SAMD8;SLC16A13;NDST2;PKD1;GAL3ST4;NMNAT2;TRIP10;AZIN2;ST3GAL2;ICA1;RGS19;PDCD6;CHST14;VPS51;FGFR3;ST3GAL5;NDRG2;PKN3;APBA1;CHPF;SLC26A11;SDC2
17695,GO:1901564,0.0060804647006708,0.994874819260566,558,4931,organonitrogen compound metabolic process,BP,TNIP1;DUSP6;NT5E;XDH;DUSP5;GID4;ZMYND8;HTRA1;THSD4;EGR1;NR1D1;H6PD;EDEM1;DLG4;PLAT;CST3;TYSND1;BTBD2;FBXO2;PDCD4;NAGS;ACVR2B;PRNP;SLC6A8;VEGFA;TNFRSF6B;PGM1;WNT7A;APOE;NAGLU;F2R;LRP5;OSBPL5;LPCAT4;HMGA2;OBSCN;IDH2;NEK9;CRAT;PKN1;MTA1;GRAMD4;ACOT7;ARRDC1;EGFR;RPS6KA2;SERPINE2;DNPH1;WWTR1;LOXL1;OBSL1;NOS1;PTPRS;TMEM129;SLC2A9;CTSO;SPRY2;CAPN2;MST1R;CRTAP;LTBP4;PRSS8;SDC1;KLHL29;LMF1;SHC1;DDB2;VPS11;LTBP1;HEXB;GTPBP1;SLC7A8;PTPRE;NPEPL1;ALDH4A1;TK2;MMP1;SNX9;SPRY4;RAPGEF3;ST6GALNAC2;ZFP36L1;GLUL;RNPEPL1;MAP2K2;KDSR;NME4;LPAR3;MARCH9;CTBS;FKBP9;PPP1R35;RBCK1;PGLS;PC;RNF44;MAP2K1;NAPRT;ACP5;SSH1;MARK4;SMURF2;FBLN1;SMAD3;PIK3R2;ERCC6;LRP1;GJC2;SRD5A3;DVL1;EPAS1;PIGQ;HBEGF;AP2A2;PPP1R14A;PPP2R3B;PRDX5;SHC2;PRODH;CDK18;LY6K;FBXW5;RNF187;NMRK1;ADORA2B;ADARB1;D2HGDH;SLC6A6;AKT1;GRB7;HDAC5;UROS;FBXO41;F12;PPM1F;MMP28;RHBDF2;PYCR2;STK39;HK1;SERPING1;EPHA1;GGT1;PTPRU;VEGFB;ASH2L;IMPACT;MARCH4;CNTN1;BRSK1;DAP;PTHLH;FGFR4;LDLR;FGFR1;PRKACB;FUCA1;RAC2;KCNAB2;PFKL;TTLL12;OPLAH;HLTF;PPM1J;RAG1;GAMT;B4GAT1;BPHL;PIGV;SORL1;CEACAM1;B3GAT3;ASB13;CIRBP;HMG20B;TENM2;ZNF385A;IGFBP4;CCND1;PODNL1;LHPP;STRADB;SYNGAP1;MAPK13;PLAU;GAS6;PTK6;PFKP;CSNK1E;CTSB;RAB3B;CARD11;DUSP7;GSN;MAPKAPK3;IGFBP2;PCSK9;RAD23A;DHTKD1;PHLDA1;ANO8;BCR;MRPS6;EHD4;ERRFI1;NADK;PANK4;HLCS;PRSS22;AIP;SH3D19;CDC25B;SPTB;PEX10;GGACT;RSAD1;NPR2;SNTA1;DGKQ;HAGH;BNIP3;PAK6;TFPI2;SHARPIN;MVB12B;SERINC2;CEMIP;PKD2;ACY1;PCSK1;RASGEF1A;CTSZ;CDC42EP5;FBXW8;ZNF598;MAGEF1;PRSS3;EPHB2;ADAM8;APRT;CTBP1;JOSD2;LTA4H;PTPDC1;GRK6;CDKN1C;PLCG1;FBXL8;CBS;CD81;CEBPB;MVD;RNF135;ADAMTS13;TIMP2;ZNF862;DPP7;C8ORF88;TGFB1;SCYL1;ABHD17C;UNK;ULK2;GPC1;MKNK2;ADAMTS7;B3GNT3;NAB2;SHANK3;PODXL2;SDHA;MSRB2;RASA3;MIPEP;TNFSF15;MGAT4B;MDH2;GALNS;FBXO17;CLCA2;NSMF;LCE1E;ABHD14B;LAMB2;ABTB1;ERO1B;ST6GALNAC6;VGF;FBXO44;SNX33;ANKZF1;PHGDH;PHF21A;MIF4GD;UBXN4;ADAM19;ZER1;HMGCL;PTPN1;TPP1;PCK2;B4GALT2;AGRN;MBD3;IFNE;CD320;CAMK2N1;OSBPL10;LRP4;ESYT2;ZDHHC24;B4GALT6;VHL;TRAP1;IDUA;PFKFB2;RFNG;MLXIPL;TRIB2;PRKCZ;KDM6B;PRKACA;MINK1;RABGGTA;ADA;AREG;PIM2;MPI;UCKL1;BOK;ALAS1;NEURL1B;ERBB2;ULK1;CNDP2;AHCY;MMP10;C6ORF89;NECAB3;STK17A;JAK3;RNPEP;BNIP3L;CYFIP2;RASA4;PDK1;THOP1;MCFD2;PRKCD;FAM20C;MIB2;USP20;STUB1;IFI6;BAX;CYC1;SBF1;XYLT2;TRIM4;ITGA1;PPCS;FBXW4;EREG;RPS6KA5;DGUOK;DUSP4;CUL9;DDIT4;MBTPS2;PCSK1N;NAGA;ZDHHC8;LIMK1;TGFBR3;PADI3;LTB4R2;RPL39L;LEMD2;RPS6KA6;RGS14;MFNG;GSTO1;ALDOC;CHAD;MRPS26;MSLN;LPCAT1;LRSAM1;ADAM15;ASB1;ST3GAL3;LONP2;SYMPK;MAPK12;IRAK1;PPOX;TGFA;HDAC7;INPP5D;MTHFR;PCMTD2;CHEK2;ZFPM1;PPARA;COG7;SESN2;ABCG1;JADE2;CDC34;RNF123;SOX7;ABCA7;RAB12;SPEG;BCAP31;MIF;SMOX;EEF2KMT;KDM4B;MEX3A;PLA2G6;DDT;NUDT14;ECM1;WFS1;QSOX1;DTX3;TRPT1;DALRD3;SPPL2B;FYN;VWA1;UPP1;STK25;ETFB;EEF2K;CERS4;ARID5B;CKMT1A;CYP3A5;GLB1;PELI1;CHKA;CAT;NEIL1;TSPYL2;IGFBP7;ELFN2;SLC27A1;APOBEC3C;SATB1;ZDHHC1;APOBEC3F;MAPK3;INSR;TAZ;PFKM;ADCY1;INO80C;GPT2;PDXK;ETAA1;GLRX;VANGL2;PAK1;DCAF10;KLHL36;CAMKK2;PPP3CB;RNF144A;ALPK1;CTSF;USP21;PFKFB3;CUL7;GABBR1;MICAL1;HYAL1;SEMA4C;CAPRIN2;WDTC1;STK32C;SAMD8;BIN1;MAN2B1;SRMS;PPP2R5B;MAP2K3;NDST2;DLG3;NDUFV3;RRAS;PROX1;IARS2;MDGA1;ALDH7A1;ZYG11B;PKD1;KCTD13;TNFRSF25;SIRT2;UVSSA;GAL3ST4;NMNAT2;BACH1;NT5C1B;ADCY7;ALG12;MAPRE3;AZIN2;SERPINB1;ST3GAL2;LAMB1;SOCS7;MAP3K10;PELI3;RAB40B;NGFR;TOLLIP;PDCD6;CHST14;PHYKPL;DUSP23;GCH1;CAMK1;CAMKK1;EZH1;SIRT3;HFE;WIPI2;BTG1;CDK11B;PFN2;SSH3;FGFR3;PPP1R16A;TST;CCDC88C;ST3GAL5;NDRG2;MAN2B2;CBLC;ITPKB;SPTLC2;CDC42BPG;PRSS21;CLK3;KDM3A;PM20D2;PKN3;TTLL3;AK3;CHPF;ADCY6;LRRK1;AARS;KLHL24;SDC2
1122,GO:0002710,0.006092265633232,0.999447040031012,4,8,negative regulation of T cell mediated immunity,BP,CEACAM1;IL20RB;PPP3CB;HFE
7468,GO:0031639,0.00609757405630246,0.999172325743484,5,12,plasminogen activation,BP,PLAT;SERPINE2;F12;PLAU;CTSZ
9895,GO:0042219,0.00616168364709427,0.998904325356522,6,17,cellular modified amino acid catabolic process,BP,ALDH4A1;PRODH;GGT1;GGACT;AHCY;PM20D2
12870,GO:0051209,0.00616538819986835,0.997690183771512,14,64,release of sequestered calcium ion into cytosol,BP,F2R;ITPR3;NOS1;TPCN1;CEMIP;PKD2;PLCG1;TGFB1;NTSR1;RASA3;PRKACA;TRPC1;BAX;GSTO1
12919,GO:0051283,0.00616538819986835,0.997690183771512,14,64,negative regulation of sequestering of calcium ion,BP,F2R;ITPR3;NOS1;TPCN1;CEMIP;PKD2;PLCG1;TGFB1;NTSR1;RASA3;PRKACA;TRPC1;BAX;GSTO1
4369,GO:0009991,0.00617971510119192,0.996136113180885,51,338,response to extracellular stimulus,BP,ERCC1;CST3;CYP27B1;BBS2;POSTN;APOE;ITGA6;EGFR;GLUL;SSH1;FOS;ADORA2B;AKT1;IMPACT;DAP;WNT2B;LDLR;CCND1;GAS6;GSN;IGFBP2;PCSK9;HLCS;DGKQ;CBS;TGFB1;ULK2;VGF;HMGCL;PCK2;WDR59;MBD3;ADA;ULK1;AHCY;PCSK1N;MTHFR;PPARA;SESN2;FYN;UPP1;CAT;KIF26A;MAPK3;C12ORF66;DNMT3A;PROX1;SIRT2;HFE;GAS2L1;LRP11
1988,GO:0004708,0.00621139815941183,0.999152984861291,5,12,MAP kinase kinase activity,MF,MAP2K2;MAP2K1;MAPKAPK3;MAPK3;MAP2K3
6131,GO:0019395,0.00621230877601267,0.997485536000206,16,77,fatty acid oxidation,BP,TYSND1;CRAT;HADH;CPT2;AKT1;ABCD1;ACAD10;CYGB;ACADS;LONP2;DECR2;PPARA;SESN2;PHYH;ETFB;MLYCD
13598,GO:0060079,0.00623766618389085,0.998011842172124,11,44,excitatory postsynaptic potential,BP,ZMYND8;DLG4;WNT7A;SSH1;SHANK2;DVL1;NLGN2;AKT1;GRIN3B;SHANK3;PRKCZ
17963,GO:1902305,0.00623913007238364,0.998144176069775,10,39,regulation of sodium ion transmembrane transport,BP,SCN4B;NOS1;STOM;STK39;ANK3;PCSK9;SNTA1;DNM2;GLRX;KLHL24
7424,GO:0031532,0.00625390013746039,0.997466830334837,16,77,actin cytoskeleton reorganization,BP,PARVB;SHC1;RAPGEF3;ARAP1;RAC2;EFS;GSN;TGFB1;RHOD;PTPN1;PRKCZ;MINK1;MICALL2;RAC3;PAK1;CDC42BPG
10397,GO:0043236,0.00626456329638037,0.998661198106532,7,22,laminin binding,MF,ITGA6;GPC1;AGRN;NID1;BCAM;ECM1;ITGA3
13597,GO:0060078,0.00627962510589351,0.99786981915491,12,50,regulation of postsynaptic membrane potential,BP,ZMYND8;DLG4;WNT7A;SSH1;SHANK2;DVL1;NLGN2;AKT1;GRIN3B;NTSR1;SHANK3;PRKCZ
6301,GO:0019933,0.00628908517515116,0.997638189284745,14,64,cAMP-mediated signaling,BP,NOS1;RAPGEF3;ADORA2B;PTHLH;DGKQ;GNAL;MC1R;CDC34;ADCY1;ADGRF1;ADCY7;GPR3;PCLO;ADCY6
1993,GO:0004714,0.00629203541973771,0.99813328921961,10,38,transmembrane receptor protein tyrosine kinase activity,MF,EGFR;MST1R;EPHA1;FGFR4;FGFR1;EPHB2;EFNB3;ERBB2;INSR;FGFR3
13238,GO:0051924,0.00635475610341732,0.996990041309424,22,118,regulation of calcium ion transport,BP,PRNP;F2R;NOS1;ORAI1;LPAR3;GJC2;CEMIP;PKD2;GRIN3B;PLCG1;TGFB1;NTSR1;PRKACA;TRPC1;CACNB3;BAX;GSTO1;EHD3;PLA2G6;WFS1;FYN;HOMER2
12890,GO:0051241,0.00635749877014172,0.995494993542586,92,679,negative regulation of multicellular organismal process,BP,XDH;SEMA4B;PLAT;CST3;APLN;PDCD4;DOCK4;PRNP;BBS2;WNT7A;APOE;F2R;LRP5;IDH2;EGFR;SERPINE2;PTPRS;SPRY2;NFATC4;ZFP36L1;ACP5;SMAD3;LRP1;ADORA2B;HDAC5;F12;STK39;SERPING1;WWC3;PTHLH;LDLR;FGFR1;PRKACB;MAPKBP1;SORL1;CEACAM1;TNNT1;SYNGAP1;PLAU;GAS6;SEMA3F;PCSK9;BCR;ERRFI1;NPR2;PROCR;CTSZ;IL20RB;EPHB2;RNF135;WNT3;TGFB1;ULK2;ADAMTS7;EFNB3;MC1R;SEMA4F;LRP4;TRIB2;CD9;EPN2;ADA;AREG;ERBB2;ADGRB2;JAK3;PRKCD;CHADL;RPS6KA5;DGUOK;GDI1;RPS6KA6;CHAD;ASB1;HDAC7;INPP5D;ZFPM1;ECM1;HLA-G;PAK1;SEMA4C;LMNA;SIRT2;FAM129B;RAP1GAP2;NGFR;HFE;SEMA3B;PFN2;NDRG2;ITPKB;ADCY6
15140,GO:0071248,0.00638045995793315,0.997170506852257,19,98,cellular response to metal ion,BP,PRNP;EGFR;NFATC4;ENDOG;FOS;AKT1;ANK3;GSN;BNIP3;PKD2;RASA4;CARF;MT2A;CPNE7;EEF2K;MAPK3;ADCY1;HFE;ITPKB
15760,GO:0072359,0.00639336142065975,0.995453960254134,94,682,circulatory system development,BP,DUSP6;XDH;MEF2D;EGR1;APLN;PGF;PDCD4;ACVR2B;VEGFA;WNT7A;APOE;LRP5;HMGA2;ELK3;EGFR;LOXL1;OBSL1;SPRY2;NFATC4;SHC1;LTBP1;ACTA2;RAPGEF3;ZFP36L1;GAA;PLCD3;MAP2K1;SMAD3;LRP1;DVL1;EPAS1;SH3PXD2B;AKT1;HDAC5;SH2D2A;EPHA1;VEGFB;IFT140;FGFR4;FGFR1;CEACAM1;TCF25;EDNRA;LAMA5;ARHGAP22;ANGPTL4;ERRFI1;PKD2;FBXW8;EPOR;EPHB2;ADAM8;PLCG1;TGFB1;FHOD3;SNX17;RNH1;ADAM19;MBD3;KDM6B;EPN2;ERBB2;ADGRB2;TFDP2;BAX;EREG;PPP1R13L;TGFBR3;LEMD2;ADAM15;TMEM231;HDAC7;ZFPM1;PPARA;ECM1;DNM2;MAPK3;INSR;TAZ;VANGL2;PAK1;PPP3CB;ROBO4;CUL7;HYAL1;ITGA3;RRAS;PROX1;LMNA;PKD1;FAM129B;NGFR;PDCD6;BTG1
3173,GO:0006790,0.00639866332612074,0.996189818770585,42,273,sulfur compound metabolic process,BP,ACOT7;ACSF2;HEXB;PC;HSD17B8;GGT1;ACOT1;OPLAH;GAMT;B4GAT1;B3GAT3;CBR4;HLCS;HAGH;CBS;MVD;B3GNT3;PODXL2;GALNS;ABHD14B;HMGCL;B4GALT2;B4GALT6;IDUA;CNDP2;AHCY;PDK1;XYLT2;NUBP2;GSTO1;ST3GAL3;MTHFR;GLB1;MLYCD;MICAL1;HYAL1;TSTD1;NDST2;GAL3ST4;ST3GAL2;CHST14;CHPF
8294,GO:0033135,0.0064417086211012,0.997295686142172,17,84,regulation of peptidyl-serine phosphorylation,BP,VEGFA;EGFR;SPRY2;RAPGEF3;AKT1;PPM1F;GAS6;TGFB1;IFNE;MLXIPL;BAX;DDIT4;MIF;PAK1;CAPRIN2;CAMK1;PFN2
7118,GO:0030948,0.00645039806562831,0.999404531730759,4,8,negative regulation of vascular endothelial growth factor receptor signaling pathway,BP,PTPN1;EPN2;FAM129B;PDCD6
6098,GO:0019320,0.00646522682819062,0.998066560541713,10,39,hexose catabolic process,BP,PGM1;LRP5;GALE;HK1;PFKL;PFKP;PFKFB2;ALDOC;GLB1;PFKM
16269,GO:0090331,0.00651515963365188,0.999396765682483,4,8,negative regulation of platelet aggregation,BP,SERPINE2;CEACAM1;CD9;PRKCD
4342,GO:0009896,0.00661943991912012,0.995866599426234,50,328,positive regulation of catabolic process,BP,EDEM1;APOE;TRIM65;VPS11;GTPBP1;SNX9;RAPGEF3;ZFP36L1;ENDOG;SMURF2;LRP1;DVL1;AKT1;TPCN1;LDLR;SORL1;CSNK1E;PCSK9;RAD23A;SH3D19;BNIP3;FYCO1;GPSM1;MAGEF1;ADAM8;CD81;SNX33;PTPN1;PFKFB2;MLXIPL;TRIB2;PIM2;ULK1;BNIP3L;PRKCD;STUB1;BAX;LPCAT1;LRSAM1;PPARA;SESN2;RAB12;BCAP31;MAPK3;INSR;CAMKK2;RNF144A;PFKFB3;SIRT2;SPTLC2
534,GO:0001653,0.0066473612041995,0.998347472123144,8,28,peptide receptor activity,MF,F2R;SIGMAR1;EDNRA;NPR2;NTSR1;MC1R;LTB4R2;LTB4R
6363,GO:0021549,0.00680822863716723,0.997535864624977,13,57,cerebellum development,BP,WNT7A;NAGLU;SERPINE2;PTPRS;TRNP1;MAP2K1;CNTN1;B4GALT2;RERE;PAK1;SEMA4C;PROX1;AARS
3404,GO:0007189,0.00684787973241553,0.99793421438806,10,39,adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,NOS1;ADORA2B;PTHLH;GNAL;MC1R;ADCY1;ADGRF1;ADCY7;GPR3;ADCY6
2424,GO:0005605,0.00685429332637588,0.998752626451272,6,17,basal lamina,CC,LAMA5;ENTPD2;LAMB2;AGRN;NID1;LAMB1
5323,GO:0016049,0.00686812962822302,0.995659000889244,52,347,cell growth,BP,SEMA4B;HTRA1;FHL1;CYP27B1;POSTN;VEGFA;APOE;EGFR;SERPINE2;DNPH1;PTPRS;LTBP4;LPAR3;SMAD3;DVL1;HBEGF;AKT1;IMPACT;CEACAM1;IGFBP4;TWF2;SEMA3F;IGFBP2;PLXNB3;WNT3;TGFB1;ULK2;LAMB2;SEMA4F;PRKCZ;ERBB2;ULK1;NET1;CYFIP2;LIMK1;GDI1;ADAM15;SESN2;DNM2;TSPYL2;IGFBP7;KIF26A;PAK1;PPP3CB;HYAL1;SEMA4C;CAPRIN2;CDH4;DCBLD2;BTG1;SEMA3B;CDK11B
13021,GO:0051480,0.00693146823984883,0.996509982128504,25,141,regulation of cytosolic calcium ion concentration,BP,DLG4;PRNP;F2R;ITPR3;NOS1;LPAR3;SMAD3;TPCN1;EDNRA;CEMIP;PKD2;PLCG1;TGFB1;NTSR1;RASA3;PRKACA;BOK;TRPC1;CACNB3;BAX;GSTO1;BCAP31;PLA2G6;FYN;PKD1
12915,GO:0051279,0.00696420169436853,0.997732137271813,11,46,regulation of release of sequestered calcium ion into cytosol,BP,F2R;NOS1;CEMIP;PKD2;PLCG1;TGFB1;NTSR1;PRKACA;TRPC1;BAX;GSTO1
3379,GO:0007160,0.00696946183107777,0.996387900988834,27,153,cell-matrix adhesion,BP,POSTN;VEGFA;ITGA6;SMAD3;THBS3;ITGB4;PPM1F;EPHA1;PLAU;LAMA5;COL13A1;ITGB5;ADAMTS13;RHOD;PRKCZ;MINK1;ITGA1;NID1;TMEM8B;MSLN;ADAM15;BCAM;ITGA3;PKD1;ITGA4;EDA;PXN
16442,GO:0097106,0.00697230357813019,0.999341275261491,4,8,postsynaptic density organization,BP,ZMYND8;SHANK2;NLGN2;SHANK3
17003,GO:0099084,0.00697230357813019,0.999341275261491,4,8,postsynaptic specialization organization,BP,ZMYND8;SHANK2;NLGN2;SHANK3
12815,GO:0051129,0.00697246352631617,0.99528789688661,70,491,negative regulation of cellular component organization,BP,ERCC1;SEMA4B;DLG4;CST3;CTNNBIP1;PRNP;POSTN;APOE;ESPN;EVI5L;VAT1;PTPRS;SPRY2;NFATC4;RAPGEF3;ARAP1;MCTP1;FBLN1;LRP1;AKT1;TMOD2;CORO1B;IMPACT;LDLR;SORL1;TWF2;SYNGAP1;SEMA3F;GSN;PCSK9;ARPIN;SPTB;PLXNB3;BNIP3;CTSZ;EPHB2;CTBP1;WNT3;TGFB1;ULK2;FHOD3;SHANK3;EFNB3;EML2;SNX33;SEMA4F;LRP4;PRKCZ;TOM1L2;BOK;CAPG;ULK1;PRKCD;CHADL;DGUOK;GDI1;LRSAM1;FYN;DNM2;SEMA4C;ITGA3;BCL2L1;LMNA;SIRT2;RAP1GAP2;NGFR;SEMA3B;PFN2;KDM3A;ADCY6
13666,GO:0060205,0.00702519776755134,0.995974183509445,36,231,cytoplasmic vesicle lumen,CC,PYGB;VEGFA;APOE;PYGL;VAT1;HEXB;NAPRT;SERPING1;VEGFB;FUCA1;PFKL;GAS6;GSN;PCSK1;CTSZ;APRT;TIMP2;DPP7;TGFB1;GALNS;ACTR1B;ADA;PRKCD;ALDOC;MIF;ECM1;QSOX1;GLB1;CAT;PDXK;RNASET2;LGALS3BP;MAN2B1;DNASE1L1;SERPINB1;TOLLIP
4496,GO:0010523,0.00705136591069926,0.998975781188085,5,13,negative regulation of calcium ion transport into cytosol,BP,NOS1;PKD2;TGFB1;NTSR1;GSTO1
8758,GO:0034440,0.00705388893462009,0.99710098318543,16,78,lipid oxidation,BP,TYSND1;CRAT;HADH;CPT2;AKT1;ABCD1;ACAD10;CYGB;ACADS;LONP2;DECR2;PPARA;SESN2;PHYH;ETFB;MLYCD
10367,GO:0043194,0.00706123405682988,0.999330346444371,4,8,axon initial segment,CC,ANK3;SCN8A;BIN1;TRIM46
15819,GO:0072525,0.0070732093214066,0.99683325662722,19,97,pyridine-containing compound biosynthetic process,BP,PGM1;IDH2;NAPRT;NMRK1;HK1;PFKL;PFKP;DHTKD1;NADK;PFKFB2;MLXIPL;DDIT4;ALDOC;PPARA;INSR;PFKM;PDXK;PFKFB3;NMNAT2
3183,GO:0006810,0.0070898638174904,0.994090613745142,393,3370,transport,BP,XDH;FHL1;NR1D1;SLC16A3;EDEM1;DLG4;CST3;CYP27B1;MRC2;APLN;KCNG1;ACVR2B;PRNP;PYGB;BBS2;SLC6A8;POSTN;VEGFA;PGM1;WNT7A;APOE;PYGL;TSPAN1;F2R;LRP5;OSBPL5;PITPNC1;IDH2;SLCO4A1;ITPR3;ARRDC1;EVI5L;NISCH;FCGRT;EGFR;SERPINE2;SCN4B;NOS1;VAT1;TMEM129;SLC2A9;HADH;LRP3;LTBP4;PRSS8;SYTL1;SDC1;LMF1;ORAI3;APPL2;ORAI1;LTBP2;VPS11;TBC1D14;ARL2;HEXB;SLC7A8;SLC12A7;SLC2A3;RIN1;SNX9;RAPGEF3;ZFP36L1;GAA;GLUL;ARAP1;MAP2K2;NME4;LPAR3;PLTP;MAP2K1;NAPRT;CPT2;MCTP1;POU2F2;EXOC2;SLC16A5;KCNJ15;KLC2;SHANK2;PIK3R2;LRP1;GJC2;DVL1;AP2A2;NLGN2;STOM;ADORA2B;SYT8;SLC6A6;AKT1;TPCN1;KCNC4;TTYH3;S100A6;PITPNM1;RHBDF2;BSG;STK39;HK1;SERPING1;ASAP2;DYSF;VEGFB;SLC15A4;ATG16L2;ZFYVE21;LRRC8A;CNTN1;BRSK1;IFT140;MFSD3;RAB31;PEAR1;LDLR;FGFR1;FUCA1;MAPKBP1;ELMO3;SIGMAR1;RAC2;KCNAB2;PFKL;TOMM34;SORL1;CEACAM1;B3GAT3;RAB11FIP4;ABCD1;ANK3;TRAPPC9;CCND1;STRADB;EDNRA;PLAU;GAS6;CSNK1E;BRI3;CTSB;RAB3B;CARD11;GSN;MAPKAPK3;PCSK9;ANO8;BCR;ANTXR2;XPOT;EHD4;WIPF1;AIP;STON1;ARHGAP27;ALOX15B;SPTB;AGAP1;PEX10;CCS;CORO7;SLC20A1;UNC119B;SNTA1;BNIP3;MVB12B;SERINC2;FYCO1;CEMIP;PKD2;CTSZ;AP3D1;ABCA2;PRSS3;EPHB2;GRIN3B;ADAM8;ASIC1;APRT;LTA4H;PLCG1;KIF17;CD81;SLC29A4;TIMP2;DPP7;TMED4;TGFB1;SNPH;CLTCL1;SCYL1;SLC43A1;MOAP1;TBC1D9B;SLC38A10;NTSR1;TMEM173;ARHGAP25;ATP7B;SHANK3;RASA3;MIPEP;GALNS;CLCA2;ARAP3;SCART1;TUB;RHOD;SNX17;VGF;SNX33;PI4K2A;RHOF;SLC48A1;LLGL1;RIMS3;BBS1;PTPN1;PEX1;PCK2;CD320;OSBPL10;LRP4;LRP10;ESYT2;ZDHHC24;CEP131;ADAP1;PFKFB2;YPEL5;PRKCZ;PRKACA;MINK1;ACTR1B;TOM1L2;CD9;EPN2;ADA;AREG;MICALL2;BOK;NEURL1B;ERBB2;VAMP2;TFDP2;NECAB3;RILPL1;BNIP3L;CYFIP2;TRPC1;SLC22A17;CYGB;ARHGAP44;MCFD2;PRKCD;REEP6;CACNB3;USP20;BAX;CYC1;SV2A;SLC13A5;OLFM2;SH3BP1;TIMM17B;RASL10B;ZDHHC8;FCHO1;LIMK1;GDI1;SLC2A11;DNM1;WASH3P;RGS14;SCN8A;GSTO1;GIT1;ALDOC;LPCAT1;LRSAM1;REEP2;EHD3;WDR60;LONP2;SYMPK;TGFA;FHOD1;CACFD1;PPARA;COG7;SESN2;ABCG1;MYO1D;ABCA7;RAB12;BCAP31;MIF;SLC25A29;DOPEY2;SLC9A7;PLA2G6;SYNGR1;ECM1;WFS1;QSOX1;CD68;SLC22A18;NBPF3;FYN;PITPNM3;RAC3;TMCO6;EEF2K;SUN1;ICAM5;ARHGAP12;ACAP3;DNM2;GLB1;SNX15;CHKA;CAT;SLC27A1;SLC50A1;KIF26A;ZDHHC1;SLC12A4;MAPK3;INSR;SLC13A3;RTN2;PFKM;RERE;STX10;ATP8B2;PDXK;PRAF2;GLRX;PAK1;RNASET2;PPP3CB;LGALS3BP;SLC37A2;MICAL1;BIN1;VPS16;MAN2B1;SLC16A13;BCL2L1;DLG3;SGSM2;DNASE1L1;TBC1D16;PKD1;RABGAP1;FAM129B;ITGA4;TRIP10;AZIN2;RAB28;SERPINB1;ICA1;SLC25A37;NDE1;RAB40B;NGFR;TOLLIP;PDCD6;ATP6V1F;PCLO;GRB10;TBC1D8;PLEKHM1;KIF13B;NBEAL2;CAMK1;SLC39A3;SIRT3;HFE;ZP3;VPS51;TMCO3;PFN2;SLC35F3;MFSD10;TST;CCDC88C;BLOC1S4;TRIM46;HOMER2;SLC23A2;APBA1;SRSF5;SLC26A11;KLHL24
15740,GO:0072329,0.0070975109164621,0.996816433048233,19,99,monocarboxylic acid catabolic process,BP,TYSND1;CRAT;HADH;CRYL1;CPT2;AKT1;ABCD1;AIG1;PCK2;IDUA;ACAD10;ACADS;LONP2;DECR2;PPARA;SESN2;PHYH;ETFB;MLYCD
5844,GO:0017134,0.00710804022987907,0.998675154026358,6,18,fibroblast growth factor binding,MF,FGFR4;FGFR1;FGFBP1;GPC1;TGFBR3;FGFR3
12918,GO:0051282,0.00715021158991299,0.997268479338027,14,65,regulation of sequestering of calcium ion,BP,F2R;ITPR3;NOS1;TPCN1;CEMIP;PKD2;PLCG1;TGFB1;NTSR1;RASA3;PRKACA;TRPC1;BAX;GSTO1
9951,GO:0042326,0.00716434593601782,0.995440610154129,53,354,negative regulation of phosphorylation,BP,TNIP1;DUSP6;XDH;DUSP5;PDCD4;PRNP;APOE;LRP5;PKN1;WWTR1;SPRY2;SPRY4;FBLN1;PIK3R2;DVL1;ADARB1;AKT1;PPM1F;STK39;EPHA1;IMPACT;SORL1;CEACAM1;PODNL1;PTK6;DUSP7;ERRFI1;DGKQ;EPHB2;CDKN1C;TGFB1;PTPN1;CAMK2N1;MLXIPL;TRIB2;PRKCZ;PRKCD;BAX;DUSP4;DDIT4;LEMD2;RPS6KA6;RGS14;CHAD;PPARA;MICAL1;SIRT2;SOCS7;GRB10;SIRT3;NDRG2;CBLC;LRRK1
6986,GO:0030672,0.00717356743232376,0.997511114061471,12,52,synaptic vesicle membrane,CC,PTPRS;MCTP1;SYT8;RAB3B;DBNDD1;PI4K2A;VAMP2;SV2A;SYNGR1;SEMA4C;BCL2L1;ICA1
17036,GO:0099501,0.00717356743232376,0.997511114061471,12,52,exocytic vesicle membrane,CC,PTPRS;MCTP1;SYT8;RAB3B;DBNDD1;PI4K2A;VAMP2;SV2A;SYNGR1;SEMA4C;BCL2L1;ICA1
9001,GO:0035150,0.00727780927149146,0.997103603087701,15,71,regulation of tube size,BP,APLN;DOCK4;BBS2;APOE;F2R;EGFR;NOS1;ADORA2B;AKT1;EDNRA;HTR7;ITGA1;PLA2G6;GCH1;ADCY6
12664,GO:0050880,0.00727780927149146,0.997103603087701,15,71,regulation of blood vessel size,BP,APLN;DOCK4;BBS2;APOE;F2R;EGFR;NOS1;ADORA2B;AKT1;EDNRA;HTR7;ITGA1;PLA2G6;GCH1;ADCY6
12888,GO:0051239,0.0073140470847817,0.994148832764862,225,1834,regulation of multicellular organismal process,BP,DUSP6;XDH;ZMYND8;ADGRL1;SEMA4B;EGR1;DLG4;PLAT;CST3;CYP27B1;APLN;PGF;PDCD4;CTNNBIP1;ACVR2B;DOCK4;PRNP;BBS2;POSTN;VEGFA;FAM210B;WNT7A;APOE;F2R;LRP5;HMGA2;IDH2;ITPR3;EGFR;SERPINE2;WWTR1;SCN4B;OBSL1;NOS1;PTPRS;SPRY2;NFATC4;ETV5;PHLDA2;RAPGEF3;ZFP36L1;GAA;LPAR3;MAP2K1;ACP5;SSH1;SMURF2;FOS;SMAD3;STAT6;SHANK2;LRP1;GJC2;DVL1;EPAS1;HBEGF;AP2A2;SH3PXD2B;NLGN2;ADORA2B;AKT1;HDAC5;F12;PPM1F;STK39;HK1;SERPING1;EPHA1;VEGFB;ASH2L;IMPACT;WWC3;CNTN1;PTHLH;WNT2B;LDLR;FGFR1;PRKACB;MAPKBP1;RAG1;GAMT;SORL1;CEACAM1;HMG20B;CCND1;TNNT1;TWF2;SYNGAP1;MAPK13;PLAU;GAS6;PTK6;SEMA3F;CSNK1E;CARD11;SOX13;LAMA5;PCSK9;BCR;ANGPTL4;ERRFI1;SLITRK6;ALOX15B;NPR2;SNTA1;PLXNB3;GTF2IRD1;PROCR;CTSZ;CRTC1;IL20RB;FBXW8;AP3D1;EPHB2;ADAM8;PLCG1;CEBPB;RNF135;TIMP2;WNT3;TGFB1;ULK2;GPC1;ADAMTS7;DEAF1;NTSR1;TMEM173;SHANK3;EFNB3;NSMF;MC1R;RNH1;SEMA4F;WASF3;AGRN;LRP4;TRIB2;PRKCZ;PRKACA;CD9;EPN2;ADA;AREG;ERBB2;ADGRB2;JAK3;TRPC1;ARHGAP44;PRKCD;FAM20C;CACNB3;BAX;SH3BP1;CHADL;EREG;RPS6KA5;DGUOK;LIMK1;TGFBR3;GDI1;RPS6KA6;ZHX3;RGS14;GSTO1;CHAD;ASB1;EHD3;IRAK1;HDAC7;INPP5D;ZFPM1;ABCA7;MIF;DDT;ECM1;FYN;STK25;RAC3;EEF2K;DNM2;PELI1;SLC27A1;TPBG;MAPK3;INSR;HLA-G;VANGL2;PAK1;CUL7;HYAL1;SEMA4C;CAPRIN2;HES7;ITGA3;BIN1;PPP2R5B;MAP2K3;RRAS;PROX1;LMNA;SIRT2;FAM129B;CDH4;RAP1GAP2;NGFR;PDCD6;PLEKHM1;GCH1;LURAP1;KIF13B;MAFF;CAMK1;HFE;BTG1;ZP3;CELSR1;SEMA3B;PFN2;SSH3;NDRG2;ITPKB;PLAG1;KDM3A;ADCY6;SDC2
9944,GO:0042311,0.00733536540454168,0.998623372457186,6,18,vasodilation,BP,BBS2;APOE;NOS1;ADORA2B;ITGA1;GCH1
3945,GO:0008645,0.00737544055907278,0.997064078837677,15,70,hexose transmembrane transport,BP,SLC2A9;SLC2A3;PIK3R2;AKT1;EDNRA;CLTCL1;PRKCZ;SLC2A11;SESN2;SLC50A1;INSR;RTN2;PAK1;NGFR;GRB10
13267,GO:0051965,0.00738598169406677,0.997931217374639,9,33,positive regulation of synapse assembly,BP,ADGRL1;WNT7A;NLGN2;SLITRK6;EPHB2;AGRN;ADGRB2;EEF2K;TPBG
6773,GO:0030215,0.00741897048922525,0.998626308636955,6,17,semaphorin receptor binding,MF,SEMA4B;SEMA3F;SEMA4F;SH3BP1;SEMA4C;SEMA3B
9731,GO:0038191,0.0074201012692243,0.998626053402426,6,17,neuropilin binding,MF,SEMA4B;SEMA3F;SEMA4F;SEMA4C;PXN;SEMA3B
8296,GO:0033138,0.00747694037519625,0.997251094187957,13,59,positive regulation of peptidyl-serine phosphorylation,BP,VEGFA;EGFR;SPRY2;RAPGEF3;AKT1;GAS6;TGFB1;IFNE;MIF;PAK1;CAPRIN2;CAMK1;PFN2
6645,GO:0023061,0.00754704495601901,0.995555882948769,39,246,signal release,BP,NR1D1;APLN;ACVR2B;WNT7A;LRP5;ITPR3;EGFR;HADH;LTBP4;SYTL1;ARL2;RAPGEF3;GLUL;MCTP1;DVL1;NLGN2;SYT8;KCNC4;BRSK1;FGFR1;PFKL;ASIC1;SNPH;VGF;RIMS3;PCK2;PFKFB2;VAMP2;RASL10B;PLA2G6;PFKM;PPP3CB;FAM129B;ICA1;PCLO;SIRT3;HFE;PFN2;APBA1
12797,GO:0051100,0.00757977501682843,0.996343467865425,22,122,negative regulation of binding,BP,CTNNBIP1;HMGA2;NFATC4;MDFI;DVL1;AKT1;SORL1;CSNK1E;PCSK9;CTSZ;GPSM1;PIM2;PRKCD;STUB1;BAX;ADAM15;ZFPM1;PPARA;MAPK3;ITGA4;CAMK1;HFE
17732,GO:1901652,0.00758212129015311,0.995203346628879,51,340,response to peptide,BP,EGR1;PRNP;LRP5;HADH;SHC1;PTPRE;ZFP36L1;PIK3R2;LRP1;AKT1;HDAC5;BSG;RAB31;PRKACB;CEACAM1;PCSK9;ERRFI1;APRT;TGFB1;VGF;PTPN1;PCK2;PRKCZ;PRKACA;AREG;VAMP2;JAK3;PRKCD;CYC1;EREG;TGFBR3;PPARA;SESN2;FYN;EEF2K;CAT;SLC27A1;MAPK3;INSR;ADCY1;PAK1;WDTC1;ADCY7;SOCS7;NGFR;ATP6V1F;PXN;GRB10;BTG1;SRSF5;ADCY6
11895,GO:0046934,0.00758225709855567,0.997867078819442,9,33,phosphatidylinositol-4,5-bisphosphate 3-kinase activity,MF,EGFR;PIK3R2;HBEGF;FGFR4;FGFR1;ERBB2;EREG;FYN;FGFR3
5361,GO:0016137,0.00762356331991219,0.998870843615561,5,13,glycoside metabolic process,BP,AKR7A2;FUCA1;CBR4;NAGA;ABHD10
10722,GO:0044070,0.0077003802364823,0.997456154677919,11,46,regulation of anion transport,BP,PRNP;APOE;AKT1;STK39;FGFR1;NTSR1;PRKCD;SV2A;ABCA7;MIF;PLA2G6
3136,GO:0006733,0.00775923923829838,0.996053868848132,25,142,oxidoreduction coenzyme metabolic process,BP,NT5E;H6PD;PGM1;IDH2;PGLS;NAPRT;NMRK1;HK1;KCNAB2;PFKL;PFKP;DHTKD1;NADK;MDH2;PCK2;PFKFB2;MLXIPL;DDIT4;ALDOC;PPARA;COQ2;INSR;PFKM;PFKFB3;NMNAT2
8135,GO:0032868,0.00785529374792585,0.995635323262705,32,193,response to insulin,BP,EGR1;HADH;SHC1;PTPRE;ZFP36L1;PIK3R2;AKT1;HDAC5;RAB31;CEACAM1;PCSK9;ERRFI1;APRT;VGF;PTPN1;PCK2;PRKCZ;VAMP2;PRKCD;PPARA;SESN2;EEF2K;CAT;SLC27A1;INSR;PAK1;WDTC1;SOCS7;NGFR;ATP6V1F;GRB10;SRSF5
15759,GO:0072358,0.00798399083642404,0.994617474592145,67,466,cardiovascular system development,BP,XDH;EGR1;APLN;PGF;PDCD4;ACVR2B;VEGFA;WNT7A;APOE;LRP5;HMGA2;ELK3;LOXL1;SPRY2;NFATC4;SHC1;LTBP1;ACTA2;RAPGEF3;ZFP36L1;PLCD3;MAP2K1;LRP1;EPAS1;AKT1;HDAC5;SH2D2A;EPHA1;VEGFB;FGFR4;FGFR1;CEACAM1;EDNRA;LAMA5;ARHGAP22;ANGPTL4;ERRFI1;PKD2;FBXW8;EPHB2;ADAM8;PLCG1;TGFB1;SNX17;RNH1;EPN2;ERBB2;ADGRB2;BAX;EREG;TGFBR3;ADAM15;TMEM231;HDAC7;ECM1;DNM2;PPP3CB;ROBO4;CUL7;HYAL1;RRAS;PROX1;PKD1;FAM129B;NGFR;PDCD6;BTG1
12633,GO:0050840,0.00819331424799879,0.997654336588884,9,34,extracellular matrix binding,MF,VEGFA;ITGA6;GPC1;AGRN;OLFML2A;NID1;BCAM;ECM1;ITGA3
11635,GO:0046365,0.00819382381267343,0.997261652600432,11,47,monosaccharide catabolic process,BP,PGM1;LRP5;CRYL1;GALE;HK1;PFKL;PFKP;PFKFB2;ALDOC;GLB1;PFKM
11560,GO:0046122,0.0083113581219538,1,2,2,purine deoxyribonucleoside metabolic process,BP,ADA;DGUOK
10632,GO:0043648,0.00832385605970155,0.99651100550432,16,79,dicarboxylic acid metabolic process,BP,NAGS;IDH2;ALDH4A1;GLUL;PRODH;D2HGDH;GGT1;SDHA;MDH2;PCK2;GRHPR;MTHFR;PHYH;GPT2;NMNAT2;PM20D2
10537,GO:0043491,0.0083466081949553,0.995665343787287,26,149,protein kinase B signaling,BP,XDH;EGFR;SPRY2;MST1R;ZFP36L1;PIK3R2;HBEGF;FAM110C;AKT1;FGFR4;FGFR1;GAS6;ADAM8;TGFB1;MC1R;ERBB2;EREG;LEMD2;SESN2;FYN;INSR;PPP2R5B;RRAS;SIRT2;PDCD6;FGFR3
6646,GO:0030001,0.00841886374218556,0.994342919440622,65,455,metal ion transport,BP,FHL1;CYP27B1;KCNG1;PRNP;SLC6A8;F2R;ITPR3;SERPINE2;SCN4B;NOS1;PRSS8;ORAI3;ORAI1;SLC12A7;LPAR3;KCNJ15;GJC2;STOM;AKT1;TPCN1;KCNC4;STK39;CNTN1;KCNAB2;ANK3;GAS6;PCSK9;CCS;SLC20A1;SNTA1;CEMIP;PKD2;GRIN3B;ASIC1;PLCG1;TGFB1;SLC38A10;NTSR1;ATP7B;RASA3;PRKACA;VAMP2;TRPC1;CACNB3;BAX;SLC13A5;SCN8A;GSTO1;EHD3;SLC9A7;PLA2G6;WFS1;FYN;DNM2;SLC12A4;SLC13A3;GLRX;PKD1;SLC25A37;ATP6V1F;SLC39A3;HFE;HOMER2;SLC23A2;KLHL24
3681,GO:0008188,0.00845756496839417,0.999548266066935,3,5,neuropeptide receptor activity,MF,NTSR1;LTB4R2;LTB4R
4503,GO:0010544,0.00852025053638755,0.998702235325397,5,13,negative regulation of platelet activation,BP,APOE;SERPINE2;CEACAM1;CD9;PRKCD
9660,GO:0038023,0.00852349103762763,0.994429719250551,57,388,signaling receptor activity,MF,ADGRL1;NR1D1;MRC2;ACVR2B;TNFRSF6B;F2R;LRP5;FCGRT;EGFR;MST1R;LTBP4;LTBP1;PTPRE;LPAR3;ADORA2B;EPHA1;PTPRU;IFNGR2;FGFR4;FGFR1;SIGMAR1;SORL1;EDNRA;ANTXR2;PAQR6;NPR2;PLXNB3;IL20RB;EPOR;EPHB2;GRIN3B;NTSR1;EFNB3;MC1R;HTR7;LRP4;GPR153;ERBB2;ADGRB2;SLC22A17;TGFBR3;LTB4R2;PPARA;ABCA7;BCAM;INSR;GABBR1;ADGRF1;TNFRSF25;ITGA4;LTB4R;GPR3;NGFR;NR2F6;CELSR1;IL17RE;FGFR3
13606,GO:0060089,0.00852349103762763,0.994429719250551,57,388,molecular transducer activity,MF,ADGRL1;NR1D1;MRC2;ACVR2B;TNFRSF6B;F2R;LRP5;FCGRT;EGFR;MST1R;LTBP4;LTBP1;PTPRE;LPAR3;ADORA2B;EPHA1;PTPRU;IFNGR2;FGFR4;FGFR1;SIGMAR1;SORL1;EDNRA;ANTXR2;PAQR6;NPR2;PLXNB3;IL20RB;EPOR;EPHB2;GRIN3B;NTSR1;EFNB3;MC1R;HTR7;LRP4;GPR153;ERBB2;ADGRB2;SLC22A17;TGFBR3;LTB4R2;PPARA;ABCA7;BCAM;INSR;GABBR1;ADGRF1;TNFRSF25;ITGA4;LTB4R;GPR3;NGFR;NR2F6;CELSR1;IL17RE;FGFR3
13503,GO:0055085,0.00860206491364856,0.993609608059419,115,881,transmembrane transport,BP,FHL1;SLC16A3;DLG4;KCNG1;PRNP;SLC6A8;F2R;SLCO4A1;ITPR3;SCN4B;NOS1;SLC2A9;ORAI3;ORAI1;SLC7A8;SLC12A7;SLC2A3;CPT2;SLC16A5;KCNJ15;SHANK2;PIK3R2;GJC2;NLGN2;STOM;SLC6A6;AKT1;TPCN1;KCNC4;TTYH3;S100A6;STK39;SLC15A4;LRRC8A;MFSD3;KCNAB2;ABCD1;ANK3;EDNRA;GAS6;PCSK9;ANO8;BCR;PEX10;SLC20A1;SNTA1;CEMIP;PKD2;ABCA2;EPHB2;GRIN3B;ASIC1;PLCG1;SLC29A4;TGFB1;CLTCL1;SLC43A1;SLC38A10;NTSR1;ATP7B;SHANK3;RASA3;CLCA2;PEX1;PRKCZ;PRKACA;MINK1;VAMP2;TRPC1;SLC22A17;CACNB3;BAX;CYC1;SV2A;SLC13A5;TIMM17B;SLC2A11;SCN8A;GSTO1;EHD3;SESN2;ABCG1;ABCA7;SLC25A29;SLC9A7;PLA2G6;SLC22A18;FYN;DNM2;SLC50A1;SLC12A4;INSR;SLC13A3;RTN2;ATP8B2;PRAF2;GLRX;PAK1;SLC37A2;SLC16A13;DLG3;PKD1;AZIN2;SLC25A37;NGFR;ATP6V1F;GRB10;SLC39A3;HFE;TMCO3;MFSD10;TST;SLC23A2;SLC26A11;KLHL24
18115,GO:1902743,0.00860880014212168,0.997515166487814,9,34,regulation of lamellipodium organization,BP,SSH1;CORO1B;RAC2;TWF2;ARPIN;PLXNB3;FSCN1;DNM2;SSH3
16226,GO:0090277,0.00862601225463876,0.996924844901964,12,53,positive regulation of peptide hormone secretion,BP,APLN;EGFR;GLUL;NLGN2;PCK2;PFKFB2;RASL10B;PLA2G6;PFKM;PPP3CB;SIRT3;HFE
11189,GO:0045321,0.00871469314390068,0.993637852477141,102,772,leukocyte activation,BP,ERCC1;EGR1;CST3;PRNP;PYGB;PGM1;PYGL;NDRG1;PKN1;VAT1;HEXB;SLC2A3;ZFP36L1;GAA;CMTM7;NAPRT;POU2F2;SMAD3;STAT6;AP2A2;STOM;PAG1;ADORA2B;AKT1;HDAC5;SLC15A4;LRRC8A;RAB31;LDLR;FUCA1;RAC2;KCNAB2;PFKL;RAG1;CEACAM1;PLAU;GAS6;BRI3;CTSB;CARD11;SOX13;GSN;IGFBP2;BCR;CTSZ;IL20RB;AP3D1;PRSS3;ADAM8;APRT;LTA4H;CD81;CEBPB;TIMP2;DPP7;TGFB1;TMEM173;EFNB3;GALNS;POLM;PI4K2A;RHOF;IFNE;CD320;YPEL5;PRKCZ;ACTR1B;ADA;ERBB2;VAMP2;JAK3;PRKCD;BAX;MFNG;ALDOC;LPCAT1;INPP5D;ZFPM1;MIF;SYNGR1;QSOX1;CD68;FYN;GLB1;PELI1;CAT;SATB1;HLA-G;PDXK;PAK1;RNASET2;PPP3CB;MAN2B1;DNASE1L1;ITGA4;SERPINB1;TOLLIP;KIF13B;NBEAL2;HFE;ZP3;ITPKB
13494,GO:0055074,0.00873325503172482,0.995058045728334,33,203,calcium ion homeostasis,BP,DLG4;CYP27B1;PRNP;APOE;F2R;ITPR3;NOS1;HEXB;LPAR3;SMAD3;TPCN1;EDNRA;BNIP3;CEMIP;PKD2;PLCG1;TGFB1;NTSR1;ATP7B;RASA3;PRKACA;BOK;TRPC1;CACNB3;BAX;SV2A;GSTO1;BCAP31;PLA2G6;WFS1;FYN;GRINA;PKD1
3652,GO:0008138,0.00876212217521436,0.9974522179733,9,35,protein tyrosine/serine/threonine phosphatase activity,MF,DUSP6;DUSP5;SSH1;DUSP7;PTPDC1;SBF1;DUSP4;DUSP23;SSH3
8023,GO:0032673,0.00877048802330014,0.998654317656562,5,13,regulation of interleukin-4 production,BP,IL20RB;CEBPB;PRKCZ;ZFPM1;ZP3
16202,GO:0090237,0.0087847871910658,0.999523996098776,3,5,regulation of arachidonic acid secretion,BP,NTSR1;MIF;PLA2G6
4930,GO:0014888,0.00887511331112942,0.997949227389454,7,23,striated muscle adaptation,BP,SMAD3;TNNT1;GSN;ERRFI1;GTF2IRD1;CAMTA2;LMNA
9802,GO:0040036,0.00889679759374893,0.997943225300217,7,23,regulation of fibroblast growth factor receptor signaling pathway,BP,DUSP6;APLN;SPRY2;SPRY4;FGFBP1;GPC1;FAM20C
7280,GO:0031279,0.0089163450113427,0.998253445923138,6,18,regulation of cyclase activity,BP,NOS1;ADORA2B;TIMP2;LTB4R2;MAPK3;GABBR1
11276,GO:0045597,0.00896921087282366,0.993666783746839,83,600,positive regulation of cell differentiation,BP,ZMYND8;DLG4;CYP27B1;CTNNBIP1;ACVR2B;VEGFA;FAM210B;APOE;LRP5;SERPINE2;WWTR1;OBSL1;ETV5;ZFP36L1;LPAR3;MAP2K1;FOS;SMAD3;SHANK2;GJC2;DVL1;SH3PXD2B;AKT1;IMPACT;CNTN1;FGFR1;RAG1;CEACAM1;HMG20B;ZNF385A;TWF2;GAS6;PTK6;CSNK1E;CCDC71L;ALOX15B;PLXNB3;CRTC1;FBXW8;AP3D1;EPHB2;ADAM8;CEBPB;TIMP2;WNT3;TGFB1;GPC1;SHANK3;NSMF;VHL;PRKCZ;ADA;NET1;FAM20C;OLFM2;PPP1R13L;LIMK1;GDI1;ZHX3;RGS14;MAPK12;INPP5D;FYN;STK25;RAC3;EEF2K;DNM2;HLA-G;PAK1;CUL7;CAPRIN2;ITGA3;BIN1;PPP2R5B;PROX1;SIRT2;FAM129B;CDH4;NGFR;CAMK1;BTG1;ITPKB;PLAG1
11106,GO:0045136,0.00904785987982584,0.999010020757325,4,9,development of secondary sexual characteristics,BP,TGFB1;AREG;BAX;IRF2BPL
12814,GO:0051128,0.00905901062034007,0.992717089928623,223,1811,regulation of cellular component organization,BP,ERCC1;ZMYND8;ADGRL1;SEMA4B;HTRA1;FHL1;DLG4;CST3;CYP27B1;APLN;CTNNBIP1;PRNP;PARVB;POSTN;VEGFA;WNT7A;APOE;TSPAN1;ESPN;LRP5;EVI5L;EGFR;SERPINE2;DNPH1;OBSL1;NOS1;VAT1;PTPRS;SPRY2;CAPN2;NFATC4;LTBP4;SDC1;ETV5;DDB2;VPS11;TBC1D14;ARL2;HEXB;MMP1;SNX9;RAPGEF3;ARAP1;MAP2K2;LPAR3;MAP2K1;MCTP1;SSH1;ENDOG;FBLN1;SMAD3;SHANK2;LRP1;DVL1;HBEGF;FAM110C;SH3PXD2B;NLGN2;FBXW5;AKT1;TMOD2;CORO1B;PPM1F;EPHA1;FMNL2;IMPACT;CNTN1;IFT140;FGFR4;LDLR;FGFR1;RAC2;NPHP4;SYNE3;SORL1;CEACAM1;TENM2;IGFBP4;TWF2;SYNGAP1;CEP250;GAS6;PTK6;SEMA3F;CSNK1E;GSN;PLEKHG2;IGFBP2;PCSK9;BCR;EHD4;WIPF1;STON1;SH3D19;SLITRK6;ARPIN;SPTB;PLXNB3;BNIP3;FYCO1;CTSZ;CDC42EP5;CRTC1;FBXW8;EPHB2;CTBP1;WNT3;TGFB1;ULK2;MOAP1;TBC1D9B;FHOD3;SHANK3;EFNB3;EML2;NSMF;ARAP3;TUB;CROCC;RHOD;SNX17;SNX33;SEMA4F;RHOF;WASF3;RHOBTB2;PTPN1;AGRN;LRP4;CEP131;PRKCZ;PRKACA;TOM1L2;MICALL2;BOK;CAPG;ERBB2;ADGRB2;ULK1;TFDP2;PLEK2;C6ORF89;NET1;BNIP3L;FSCN1;ARHGAP44;PRKCD;STUB1;BAX;SH3BP1;CHADL;EREG;RPS6KA5;DGUOK;CUL9;ZDHHC8;LIMK1;GDI1;WASH3P;LRSAM1;ADAM15;EHD3;TGFA;FHOD1;MTHFR;SESN2;CDC34;ABCA7;PLA2G6;NBPF3;FYN;STK25;RAC3;EEF2K;DNM2;INF2;TSPYL2;IGFBP7;ZMYM3;TPBG;KIF26A;MAPK3;INSR;VANGL2;PAK1;CAMKK2;CUL7;HYAL1;SEMA4C;CAPRIN2;ITGA3;BIN1;VPS16;PPP2R5B;BCL2L1;SGSM2;PROX1;TBC1D16;LMNA;PKD1;RABGAP1;SIRT2;CDH4;DCBLD2;RAP1GAP2;GPR3;NGFR;PXN;TBC1D8;PLEKHM1;KIF13B;CAMK1;HFE;BTG1;BBS10;CELSR1;SEMA3B;CDK11B;PFN2;SSH3;KDM3A;ADCY6;SDC2
3220,GO:0006874,0.00912867337179589,0.994867006641733,32,196,cellular calcium ion homeostasis,BP,DLG4;PRNP;APOE;F2R;ITPR3;NOS1;HEXB;LPAR3;SMAD3;TPCN1;EDNRA;BNIP3;CEMIP;PKD2;PLCG1;TGFB1;NTSR1;ATP7B;RASA3;PRKACA;BOK;TRPC1;CACNB3;BAX;SV2A;GSTO1;BCAP31;PLA2G6;WFS1;FYN;GRINA;PKD1
2327,GO:0005343,0.00912883821818684,0.9985850660798,5,13,organic acid:sodium symporter activity,MF,SLC6A8;SLC6A6;SLC13A5;SLC13A3;SLC23A2
13223,GO:0051897,0.00914773715595866,0.996003459730772,17,86,positive regulation of protein kinase B signaling,BP,EGFR;SPRY2;MST1R;PIK3R2;HBEGF;FAM110C;FGFR4;FGFR1;GAS6;ADAM8;TGFB1;MC1R;ERBB2;EREG;FYN;INSR;FGFR3
5062,GO:0015276,0.00915507504160474,0.997102209400212,10,40,ligand-gated ion channel activity,MF,DLG4;ITPR3;KCNJ15;TPCN1;PKD2;GRIN3B;ASIC1;RASA3;CLCA2;DLG3
6607,GO:0022834,0.00915507504160474,0.997102209400212,10,40,ligand-gated channel activity,MF,DLG4;ITPR3;KCNJ15;TPCN1;PKD2;GRIN3B;ASIC1;RASA3;CLCA2;DLG3
10305,GO:0043087,0.00916222399057976,0.994062343065025,54,363,regulation of GTPase activity,BP,DOCK4;F2R;ITGA6;EVI5L;SPRY2;TBC1D14;ARL2;RIN1;SNX9;RAPGEF3;ARAP1;ARHGAP23;PIK3R2;ASAP2;EPHA1;SYNGAP1;ARHGAP22;BCR;ERRFI1;ARHGAP27;AGAP1;PLXNB3;CDC42EP5;GPSM1;TBC1D9B;ARHGAP25;RASA3;ARAP3;PLEKHG4;LLGL1;AGRN;ADAP1;ERBB2;NET1;RASA4;ARHGAP44;SBF1;SH3BP1;GDI1;RGS14;GIT1;ARHGAP12;ACAP3;IQSEC1;ARHGEF1;DOCK9;RALGAPA1;SGSM2;TBC1D16;RABGAP1;TRIP10;RAP1GAP2;RGS19;TBC1D8
13708,GO:0060284,0.00922147280808632,0.993523206602858,80,575,regulation of cell development,BP,ZMYND8;SEMA4B;DLG4;POSTN;VEGFA;WNT7A;APOE;IDH2;SERPINE2;OBSL1;NOS1;PTPRS;NFATC4;ETV5;LPAR3;MAP2K1;SSH1;FBLN1;SHANK2;LRP1;GJC2;DVL1;AKT1;IMPACT;CNTN1;LDLR;FGFR1;SORL1;HMG20B;TWF2;SYNGAP1;PTK6;SEMA3F;CSNK1E;NPR2;PLXNB3;CTSZ;CRTC1;FBXW8;EPHB2;TIMP2;WNT3;TGFB1;ULK2;SHANK3;EFNB3;NSMF;SEMA4F;LRP4;NET1;ARHGAP44;DGUOK;LIMK1;GDI1;RGS14;FYN;STK25;RAC3;EEF2K;DNM2;PAK1;CUL7;SEMA4C;CAPRIN2;ITGA3;BIN1;PPP2R5B;PROX1;SIRT2;FAM129B;CDH4;RAP1GAP2;NGFR;KIF13B;CAMK1;SEMA3B;SSH3;PLAG1;ADCY6;SDC2
13270,GO:0051968,0.00925106076738716,0.998561279386626,5,13,positive regulation of synaptic transmission, glutamatergic,BP,EGFR;GLUL;SHANK2;NLGN2;SHANK3
11939,GO:0047025,0.00925223666993071,1,2,2,3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity,MF,HSD17B8;CBR4
16235,GO:0090287,0.00930912028423958,0.994927210819405,29,172,regulation of cellular response to growth factor stimulus,BP,DUSP6;XDH;HTRA1;APLN;VEGFA;SPRY2;LTBP4;LTBP1;SPRY4;SMURF2;SMAD3;FGFR1;FGFBP1;CDKN1C;TGFB1;GPC1;PTPN1;EPN2;CYFIP2;FAM20C;STUB1;TGFBR3;LEMD2;DNM2;ITGA3;PPP2R5B;FAM129B;PDCD6;GRB10
11872,GO:0046890,0.00931426694082143,0.995337523851843,23,129,regulation of lipid biosynthetic process,BP,EGR1;NR1D1;CYP27B1;APOE;AKT1;FGFR4;LDLR;SEC14L2;CEACAM1;DGKQ;MVD;MLXIPL;PRKCD;MBTPS2;LPCAT1;ABCG1;PLA2G6;IGFBP7;SLC27A1;WDTC1;SAMD8;PROX1;ZP3
3415,GO:0007204,0.00932073256718179,0.995331840696776,23,130,positive regulation of cytosolic calcium ion concentration,BP,DLG4;PRNP;F2R;ITPR3;NOS1;LPAR3;TPCN1;EDNRA;CEMIP;PKD2;PLCG1;TGFB1;NTSR1;RASA3;PRKACA;TRPC1;CACNB3;BAX;GSTO1;BCAP31;PLA2G6;FYN;PKD1
5804,GO:0017057,0.00939131553466205,1,2,2,6-phosphogluconolactonase activity,MF,H6PD;PGLS
8362,GO:0033267,0.00942659800450726,0.994405205948325,38,241,axon part,CC,ADGRL1;DLG4;GLUL;SSH1;SHANK2;GJC2;DVL1;KCNC4;TMOD2;SIGMAR1;KCNAB2;TENM2;ANK3;TWF2;CTSZ;AP3D1;TIMP2;NTSR1;PRKCZ;FSCN1;SV2A;DNM1;SCN8A;MYO1D;SYNGR1;RAC3;DNM2;MICAL1;ITGA3;BIN1;DLG3;SIRT2;KIF13B;SEPT6;PFN2;NDRG2;BLOC1S4;TRIM46
17253,GO:0120031,0.00946226475674941,0.993666691067398,62,430,plasma membrane bounded cell projection assembly,BP,ZMYND8;PARVB;BBS2;ESPN;ITGA6;EVI5L;WWTR1;NUDCD3;ARAP1;LPAR3;SSH1;MARK4;IFT140;DNAAF5;RAC2;NPHP4;TENM2;TWF2;CEP250;CSNK1E;LAMA5;GSN;SEPT10;CCDC113;UNC119B;PLXNB3;CDC42EP5;PTPDC1;KIF17;RFX2;CROCC;RHOD;DNAH1;WASF3;BBS1;AGRN;CEP131;PRKACA;SDCCAG8;NINL;RILPL1;FSCN1;PRKCD;SH3BP1;EHD3;WDR60;TMEM231;DNAAF3;DNM2;ATXN10;ARHGEF4;CEP72;VANGL2;NDE1;PLEKHM1;MSS51;TCTN1;BBS10;SEPT6;PFN2;SSH3;TTLL3
14018,GO:0060754,0.00946964160802841,0.999472053016989,3,5,positive regulation of mast cell chemotaxis,BP,PGF;VEGFA;VEGFB
4065,GO:0009117,0.00949453170729687,0.993573275289569,65,477,nucleotide metabolic process,BP,NT5E;XDH;H6PD;DLG4;VEGFA;PGM1;APOE;IDH2;ACOT7;DNPH1;NOS1;GTPBP1;TK2;RAPGEF3;NME4;PGLS;NAPRT;NMRK1;ADORA2B;HK1;PTHLH;KCNAB2;PFKL;PFKP;CARD11;DHTKD1;NADK;PANK4;NPR2;PKD2;APRT;TIMP2;TGFB1;PODXL2;SDHA;MDH2;ABHD14B;PCK2;PFKFB2;MLXIPL;ADA;UCKL1;FAM20C;CYC1;PPCS;DGUOK;DDIT4;LTB4R2;ALDOC;PPARA;UPP1;NEIL1;INSR;TAZ;PFKM;ADCY1;PFKFB3;GABBR1;DLG3;NDUFV3;NMNAT2;NT5C1B;ADCY7;AK3;ADCY6
4785,GO:0010976,0.00959914588927874,0.994638923374982,31,187,positive regulation of neuron projection development,BP,ZMYND8;DLG4;VEGFA;APOE;OBSL1;LPAR3;MAP2K1;SHANK2;DVL1;CNTN1;FGFR1;TWF2;PTK6;PLXNB3;CRTC1;FBXW8;WNT3;SHANK3;LIMK1;GDI1;FYN;STK25;EEF2K;PAK1;CUL7;CAPRIN2;ITGA3;PPP2R5B;CDH4;NGFR;CAMK1
10361,GO:0043183,0.00969416938492733,1,2,2,vascular endothelial growth factor receptor 1 binding,MF,VEGFA;VEGFB
3556,GO:0007600,0.00976042578884938,0.994377171695311,34,213,sensory perception,BP,BBS2;ESPN;F2R;ITPR3;SERPINE2;SPRY2;HEXB;EPAS1;NLGN2;FGFR1;NIPSNAP1;SLITRK6;CEMIP;ASIC1;GNAL;NTSR1;EML2;TUB;LAMB2;BBS1;RABGGTA;REEP6;OLFM2;GJB4;DNM1;REEP2;WFS1;FYN;MAPK3;ALDH7A1;NR2F6;ZNF513;BBS10;HOMER2
16981,GO:0099024,0.0097879872106801,0.997101112713586,9,35,plasma membrane invagination,BP,SNX9;RAC2;GSN;ARHGAP25;SNX33;SH3BP1;ABCA7;RAC3;ARHGAP12
1039,GO:0002551,0.00981902930243616,0.998898873576047,4,9,mast cell chemotaxis,BP,PGF;VEGFA;VEGFB;RAC2
12391,GO:0048843,0.00982741320582041,0.998033052548566,6,18,negative regulation of axon extension involved in axon guidance,BP,SEMA4B;SEMA3F;WNT3;SEMA4F;SEMA4C;SEMA3B
8111,GO:0032805,0.00989297992515784,1,2,2,positive regulation of low-density lipoprotein particle receptor catabolic process,BP,APOE;PCSK9
18193,GO:1902952,0.009892979925158,1,2,2,positive regulation of dendritic spine maintenance,BP,ZMYND8;APOE
18216,GO:1902994,0.009892979925158,1,2,2,regulation of phospholipid efflux,BP,APOE;ABCA7
18217,GO:1902995,0.009892979925158,1,2,2,positive regulation of phospholipid efflux,BP,APOE;ABCA7
16450,GO:0097114,0.00989297992515804,1,2,2,NMDA glutamate receptor clustering,BP,APOE;SHANK3
17725,GO:1901629,0.00989297992515804,1,2,2,regulation of presynaptic membrane organization,BP,APOE;LRP4
4028,GO:0009062,0.00996842261133394,0.995595733121066,17,88,fatty acid catabolic process,BP,TYSND1;CRAT;HADH;CPT2;AKT1;ABCD1;AIG1;PCK2;ACAD10;ACADS;LONP2;DECR2;PPARA;SESN2;PHYH;ETFB;MLYCD
16434,GO:0097090,0.0100254507876627,0.999428790487157,3,5,presynaptic membrane organization,BP,APOE;NLGN2;LRP4
20043,GO:2000646,0.0100254507876716,0.999428790487157,3,5,positive regulation of receptor catabolic process,BP,APOE;PCSK9;PTPN1
17580,GO:1901184,0.0100869659610813,0.99567392387147,16,80,regulation of ERBB signaling pathway,BP,EGFR;SPRY2;SHC1;ARAP1;HBEGF;AKT1;RHBDF2;CEACAM1;PTK6;ERRFI1;MVB12B;ERBB2;ITGA1;EREG;TGFA;CBLC
16522,GO:0097237,0.0101328128763399,0.994633922221095,26,158,cellular response to toxic substance,BP,EGR1;CST3;APOE;TXNRD3;ENDOG;STAT6;PRDX5;IMPACT;MAPK13;CCS;BNIP3;GPX3;ANKZF1;TRAP1;KDM6B;NET1;CYGB;PRKCD;GSTO1;SESN2;STK25;DNM2;CAT;DNMT3A;ADCY7;GCH1
10353,GO:0043173,0.0101386090317071,0.998345362218166,5,14,nucleotide salvage,BP,NAPRT;APRT;ADA;UCKL1;UPP1
9506,GO:0036159,0.0101558900946539,0.99941849745694,3,5,inner dynein arm assembly,BP,DNAAF5;DNAH1;MSS51
3876,GO:0008509,0.010183115372504,0.994286887094403,31,187,anion transmembrane transporter activity,MF,SLC16A3;SLC6A8;SLCO4A1;SLC2A9;SLC7A8;SLC12A7;SLC2A3;SLC16A5;SLC6A6;TTYH3;BSG;SLC15A4;LRRC8A;CEACAM1;ANO8;SLC20A1;SERINC2;SLC43A1;SLC38A10;CLCA2;SLC22A17;SLC13A5;SLC25A29;SLC27A1;SLC12A4;SLC13A3;SLC37A2;SLC16A13;MFSD10;SLC23A2;SLC26A11
3741,GO:0008283,0.0101876410218349,0.992017902621119,167,1333,cell proliferation,BP,XDH;ERCC1;MEF2D;HTRA1;EGR1;NR1D1;CST3;CYP27B1;FBXO2;APLN;PGF;PDCD4;CTNNBIP1;PRNP;VEGFA;TNFRSF6B;WNT7A;APOE;TSPAN1;F2R;LRP5;HMGA2;NDRG1;IDH2;PKN1;EGFR;RPS6KA2;SERPINE2;DNPH1;WWTR1;SPRY2;MST1R;ETV5;APPL2;SHC1;TCFL5;PHLDA2;TRNP1;RAPGEF3;ZFP36L1;GLUL;PLCD3;TP53I11;MAP2K1;MXD4;MARCKSL1;FBLN1;SMAD3;STAT6;LRP1;GJC2;HBEGF;RNF187;ADARB1;AKT1;FAM83A;S100A6;SH2D2A;EPHA1;PTPRU;VEGFB;ASH2L;PTHLH;FGFR4;WNT2B;FGFR1;RAC2;MXI1;CEACAM1;LZTS2;IGFBP4;CCND1;EDNRA;PLAU;GAS6;PTK6;FGFBP1;CARD11;LAMA5;IGFBP2;ERRFI1;HLCS;CDC25B;ALOX15B;PLXNB3;PKD2;CTSZ;IL20RB;FBXW8;CTBP1;MNT;CDKN1C;CD81;CEBPB;MVD;TIMP2;WNT3;TGFB1;DEAF1;NAB2;CGREF1;IFNE;CD320;CAMK2N1;VHL;CEP131;MLXIPL;PRKCZ;CD9;ADA;AREG;PIM2;BOK;ERBB2;C6ORF89;JAK3;FSCN1;PDK1;PRKCD;BAX;ITGA1;FBXW4;EREG;DDIT4;TGFBR3;IRAK1;TGFA;INPP5D;SOX7;SPEG;SIX5;MIF;ECM1;FYN;PELI1;IGFBP7;SATB1;INSR;ARHGEF1;RERE;HLA-G;PDXK;PAK1;PPP3CB;HYAL1;BIN1;SRMS;BCL2L1;DLG3;PROX1;LMNA;TNFRSF25;SIRT2;FAM129B;LAMB1;NDE1;NGFR;PDCD6;TBC1D8;BTG1;ZP3;TACC1;CDK11B;FGFR3;NDRG2;ITPKB;PLAG1
15815,GO:0072521,0.0102733631552022,0.99325839834383,55,396,purine-containing compound metabolic process,BP,NT5E;XDH;DLG4;VEGFA;PGM1;APOE;ACOT7;DNPH1;NOS1;SLC2A9;GTPBP1;RAPGEF3;NME4;ADORA2B;HK1;PTHLH;PFKL;GAMT;PFKP;CARD11;DHTKD1;NADK;PANK4;NPR2;PKD2;APRT;TIMP2;TGFB1;PODXL2;SDHA;ABHD14B;PFKFB2;MLXIPL;ADA;AHCY;FAM20C;CYC1;PPCS;DGUOK;DDIT4;LTB4R2;ALDOC;PPARA;INSR;TAZ;PFKM;ADCY1;PFKFB3;GABBR1;DLG3;NDUFV3;NT5C1B;ADCY7;AK3;ADCY6
623,GO:0001807,0.0103149703177678,1,2,2,regulation of type IV hypersensitivity,BP,IL20RB;ZP3
8067,GO:0032753,0.010391649384093,0.998814534756133,4,9,positive regulation of interleukin-4 production,BP,IL20RB;CEBPB;PRKCZ;ZP3
17449,GO:1900221,0.0104186643606315,0.998810518833207,4,9,regulation of amyloid-beta clearance,BP,APOE;LRP1;LDLR;ABCA7
5064,GO:0015279,0.0104664142503361,0.999393783448328,3,5,store-operated calcium channel activity,MF,ORAI3;ORAI1;TRPC1
11050,GO:0045055,0.0104969264623144,0.992738178635674,71,518,regulated exocytosis,BP,CST3;PYGB;VEGFA;PGM1;PYGL;VAT1;SYTL1;HEXB;SLC2A3;GAA;NAPRT;AP2A2;STOM;ADORA2B;SYT8;SERPING1;VEGFB;SLC15A4;RAB31;FUCA1;RAC2;KCNAB2;PFKL;CEACAM1;PLAU;GAS6;BRI3;CTSB;GSN;BCR;CTSZ;PRSS3;ADAM8;APRT;LTA4H;TIMP2;DPP7;TGFB1;SNPH;TMEM173;GALNS;PI4K2A;RHOF;RIMS3;YPEL5;ACTR1B;CD9;VAMP2;PRKCD;ALDOC;LPCAT1;MIF;SYNGR1;ECM1;QSOX1;CD68;GLB1;CAT;PDXK;RNASET2;PPP3CB;LGALS3BP;MICAL1;MAN2B1;DNASE1L1;SERPINB1;TOLLIP;PCLO;NBEAL2;ZP3;PFN2
10329,GO:0043129,0.010502514649017,0.999390891220997,3,5,surfactant homeostasis,BP,VEGFA;EPAS1;LPCAT1
2203,GO:0005088,0.0106137912224002,0.994153573468945,29,173,Ras guanyl-nucleotide exchange factor activity,MF,DLG4;OBSCN;EGFR;SHC1;RIN1;RAPGEF3;HBEGF;SHC2;FGFR4;FGFR1;TRAPPC9;PLEKHG2;BCR;RGL2;SPTB;RASGEF1A;FARP1;PLEKHG4;PLEKHG3;PLEKHG5;ERBB2;JAK3;NET1;SBF1;EREG;FYN;ARHGEF4;ARHGEF1;FGFR3
11957,GO:0047184,0.0106894341055563,0.999375852998789,3,5,1-acylglycerophosphocholine O-acyltransferase activity,MF,LPCAT4;LPCAT1;TAZ
7282,GO:0031281,0.0107171210232816,0.998765933659006,4,9,positive regulation of cyclase activity,BP,NOS1;ADORA2B;TIMP2;MAPK3
8588,GO:0034103,0.0107362529086147,0.996494029762785,10,42,regulation of tissue remodeling,BP,CST3;LRP5;EGFR;CEACAM1;BCR;ADAM8;TGFB1;BAX;INPP5D;PLEKHM1
9368,GO:0035897,0.0107438372510254,0.999371456374697,3,5,proteolysis in other organism,BP,MAP2K2;MAP2K1;MAP2K3
6112,GO:0019359,0.0108274019114414,0.995044842275922,18,94,nicotinamide nucleotide biosynthetic process,BP,PGM1;IDH2;NAPRT;NMRK1;HK1;PFKL;PFKP;DHTKD1;NADK;PFKFB2;MLXIPL;DDIT4;ALDOC;PPARA;INSR;PFKM;PFKFB3;NMNAT2
6114,GO:0019363,0.0108274019114414,0.995044842275922,18,94,pyridine nucleotide biosynthetic process,BP,PGM1;IDH2;NAPRT;NMRK1;HK1;PFKL;PFKP;DHTKD1;NADK;PFKFB2;MLXIPL;DDIT4;ALDOC;PPARA;INSR;PFKM;PFKFB3;NMNAT2
15868,GO:0072593,0.0108520467159672,0.994145032067541,27,164,reactive oxygen species metabolic process,BP,XDH;EGFR;NOS1;ACP5;SMAD3;SH3PXD2B;PRDX5;AKT1;RAC2;BCR;CCS;BNIP3;PKD2;GPX3;SH3PXD2A;TGFB1;TRAP1;STK17A;PRKCD;DDIT4;SESN2;DNM2;CAT;INSR;SIRT2;GCH1;SIRT3
524,GO:0001631,0.0108592348406745,1,2,2,cysteinyl leukotriene receptor activity,MF,LTB4R2;LTB4R
525,GO:0001632,0.0108592348406745,1,2,2,leukotriene B4 receptor activity,MF,LTB4R2;LTB4R
2153,GO:0004974,0.0108592348406745,1,2,2,leukotriene receptor activity,MF,LTB4R2;LTB4R
14425,GO:0061737,0.0108592348406745,1,2,2,leukotriene signaling pathway,BP,LTB4R2;LTB4R
18188,GO:1902947,0.0108840687412977,0.999360082721425,3,5,regulation of tau-protein kinase activity,BP,EGR1;SORL1;NAB2
1982,GO:0004702,0.0108851986641396,0.995152139089044,17,86,signal transducer, downstream of receptor, with serine/threonine kinase activity,MF,ACVR2B;EGFR;MST1R;EPHA1;FGFR4;FGFR1;MAPK13;EPHB2;MINK1;ERBB2;MAPK12;IRAK1;STK25;MAPK3;INSR;MAP3K10;FGFR3
14588,GO:0070141,0.0109097104672813,0.999357996688294,3,5,response to UV-A,BP,EGFR;AKT1;CCND1
12790,GO:0051093,0.0109265712277307,0.992314188979309,77,563,negative regulation of developmental process,BP,XDH;SEMA4B;CST3;PDCD4;BBS2;POSTN;WNT7A;APOE;LRP5;HMGA2;IDH2;EGFR;WWTR1;VAT1;PTPRS;SPRY2;NFATC4;RAPGEF3;ZFP36L1;FBLN1;SMAD3;LRP1;HDAC5;WWC3;PTHLH;LDLR;PRKACB;SORL1;CEACAM1;CCND1;SYNGAP1;GAS6;SEMA3F;BCR;ARPIN;NPR2;BNIP3;CTSZ;EPHB2;WNT3;TGFB1;ULK2;ADAMTS7;EFNB3;SEMA4F;LRP4;TRIB2;EPN2;AREG;ERBB2;ADGRB2;JAK3;CHADL;EREG;DGUOK;GDI1;RPS6KA6;CHAD;HDAC7;INPP5D;ZFPM1;PPARA;ABCG1;MIF;ECM1;HLA-G;PAK1;SEMA4C;SIRT2;FAM129B;RAP1GAP2;NGFR;TERC;SEMA3B;FGFR3;ITPKB;ADCY6
13801,GO:0060401,0.0109828492398532,0.995095168054307,17,88,cytosolic calcium ion transport,BP,PRNP;F2R;ITPR3;NOS1;TPCN1;CEMIP;PKD2;PLCG1;TGFB1;NTSR1;RASA3;PRKACA;TRPC1;CACNB3;BAX;GSTO1;FYN
12892,GO:0051247,0.0110349961613433,0.991464581042506,146,1151,positive regulation of protein metabolic process,BP,TNIP1;DUSP6;XDH;DUSP5;EGR1;EDEM1;DLG4;ACVR2B;PRNP;VEGFA;WNT7A;APOE;F2R;PKN1;MTA1;GRAMD4;EGFR;NOS1;SPRY2;MST1R;SHC1;VPS11;SNX9;RAPGEF3;MAP2K2;LPAR3;MAP2K1;SMURF2;FBLN1;SMAD3;ERCC6;LRP1;DVL1;HBEGF;SHC2;ADORA2B;AKT1;F12;PPM1F;STK39;EPHA1;IMPACT;CNTN1;DAP;FGFR4;LDLR;FGFR1;PRKACB;SORL1;CIRBP;IGFBP4;CCND1;STRADB;GAS6;PTK6;CSNK1E;CARD11;DUSP7;GSN;MAPKAPK3;PCSK9;RAD23A;EHD4;SH3D19;CDC25B;DGKQ;PAK6;CEMIP;PKD2;MAGEF1;EPHB2;ADAM8;CTBP1;PLCG1;CD81;TIMP2;TGFB1;NAB2;TNFSF15;NSMF;SNX33;PTPN1;IFNE;LRP4;TRIB2;PRKCZ;PRKACA;MINK1;AREG;BOK;ERBB2;C6ORF89;CYFIP2;PRKCD;STUB1;BAX;ITGA1;EREG;RPS6KA5;LPCAT1;SYMPK;MAPK12;IRAK1;TGFA;CHEK2;ZFPM1;SOX7;ABCA7;BCAP31;MIF;PLA2G6;DDT;WFS1;FYN;STK25;PELI1;SLC27A1;MAPK3;INSR;ADCY1;ETAA1;VANGL2;PAK1;CAMKK2;RNF144A;SEMA4C;CAPRIN2;MAP2K3;DLG3;PROX1;PKD1;TNFRSF25;SIRT2;ADCY7;MAPRE3;MAP3K10;NGFR;TOLLIP;PDCD6;CAMK1;CAMKK1;HFE;PFN2;FGFR3;ADCY6;LRRK1
82,GO:0000166,0.011047949391596,0.991142927683477,204,1638,nucleotide binding,MF,NT5E;XDH;H6PD;ACVR2B;PYGL;DGKA;OBSCN;IDH2;NEK9;PKN1;ACSF2;EGFR;RPS6KA2;NOS1;HADH;MST1R;VPS11;ARL2;GTPBP1;TK2;ACTA2;RAPGEF3;TXNRD3;GLUL;MAP2K2;NME4;SMARCA1;PC;MAP2K1;CRYL1;MARK4;ERCC6;HSD17B8;PRODH;CDK18;NMRK1;D2HGDH;AKT1;STK39;HK1;EPHA1;BRSK1;RAB31;FGFR4;FGFR1;PRKACB;RAC2;PFKL;TTLL12;OPLAH;HLTF;CBR4;ABCD1;TWF2;STRADB;MAPK13;PTK6;PFKP;CSNK1E;RAB3B;MAPKAPK3;BCR;EHD4;SEPT10;NADK;PANK4;HLCS;AGAP1;NPR2;DGKQ;PAK6;FYCO1;ABCA2;EPHB2;APRT;CTBP1;GRK6;KIF17;MVD;ENTPD2;GNAL;SCYL1;ULK2;MKNK2;TMEM173;ATP7B;SDHA;PIP5KL1;KIF26B;RHOD;DNAH1;PI4K2A;RHOF;PHGDH;ARL10;KIF7;RHOBTB2;TUBG2;PEX1;PCK2;MBD3;TRAP1;PFKFB2;PRKCZ;PRKACA;MINK1;GRHPR;ACTR1B;PIM2;UCKL1;ERBB2;ULK1;AHCY;STK17A;JAK3;PDK1;ACAD10;PRKCD;FAM20C;NUBP2;RPS6KA5;DGUOK;CUL9;ACADS;RASL10B;LIMK1;NTPCR;RPS6KA6;DNM1;SCN8A;EHD3;LONP2;MAPK12;IRAK1;PPOX;MTHFR;CHD2;PI4K2B;CHEK2;ABCG1;MYO1D;MYH15;CDC34;ABCA7;RAB12;SPEG;DALRD3;FYN;STK25;RAC3;EEF2K;DNM2;CKMT1A;CHKA;CAT;SLC27A1;KIF26A;DDX50;TUBB6;MAPK3;INSR;PFKM;ADCY1;ATP8B2;PDXK;PAK1;CAMKK2;ALPK1;PFKFB3;MICAL1;STK32C;SRMS;MAP2K3;RRAS;IARS2;SIRT2;GAL3ST4;NMNAT2;NT5C1B;ADCY7;LTB4R;TEP1;RAB28;MAP3K10;RAB40B;GCH1;KIF13B;CAMK1;CAMKK1;SIRT3;BBS10;SEPT6;CDK11B;FGFR3;ITPKB;CDC42BPG;CLK3;DHX32;PKN3;TTLL3;AK3;ADCY6;LRRK1;AARS
19523,GO:1990393,0.0110550384762157,0.999346137027582,3,5,3M complex,CC,OBSL1;FBXW8;CUL7
12759,GO:0051043,0.011055594282835,0.997697523078704,6,19,regulation of membrane protein ectodomain proteolysis,BP,APOE;SNX9;SH3D19;ADAM8;TIMP2;SNX33
4422,GO:0010243,0.0110896869046147,0.992013777442445,88,652,response to organonitrogen compound,BP,EGR1;EDEM1;FBXO2;PRNP;APOE;LRP5;EGFR;TMEM129;HADH;CAPN2;SDC1;SHC1;PTPRE;RAPGEF3;ZFP36L1;SSH1;FOS;PIK3R2;LRP1;AKT1;HDAC5;UROS;BSG;IMPACT;RAB31;LDLR;PRKACB;CEACAM1;CCND1;MAPK13;GSN;PCSK9;ERRFI1;HLCS;DGKQ;PKD2;APRT;CD81;CEBPB;ADAMTS13;TGFB1;NSMF;VGF;ANKZF1;UBXN4;PTPN1;PCK2;PRKCZ;PRKACA;CD9;ADA;AREG;VAMP2;JAK3;PRKCD;STUB1;CYC1;EREG;TGFBR3;MTHFR;PPARA;SESN2;BCAP31;WFS1;FYN;EEF2K;DNM2;CAT;SLC27A1;MAPK3;INSR;ADCY1;PAK1;WDTC1;DNMT3A;BCL2L1;SIRT2;ADCY7;SOCS7;NGFR;ATP6V1F;PXN;GRB10;COL6A1;BTG1;HOMER2;SRSF5;ADCY6
9571,GO:0036378,0.0111231060192009,1,2,2,calcitriol biosynthetic process from calciol,BP,CYP27B1;CYP2R1
10370,GO:0043197,0.0111356648492797,0.994762507903536,19,101,dendritic spine,CC,ZMYND8;NR1D1;DLG4;FBXO2;NOS1;SHANK2;DVL1;TENM2;ABHD17C;NTSR1;SHANK3;FARP1;ARHGAP44;DNM1;RGS14;EEF2K;DNM2;APBA1;STRN4
505,GO:0001568,0.011144931668274,0.992450697306707,63,440,blood vessel development,BP,XDH;EGR1;APLN;PGF;ACVR2B;VEGFA;WNT7A;APOE;LRP5;HMGA2;ELK3;LOXL1;SPRY2;NFATC4;SHC1;LTBP1;ACTA2;RAPGEF3;ZFP36L1;PLCD3;MAP2K1;LRP1;EPAS1;AKT1;HDAC5;SH2D2A;EPHA1;VEGFB;FGFR4;FGFR1;CEACAM1;EDNRA;LAMA5;ARHGAP22;ANGPTL4;PKD2;FBXW8;EPHB2;ADAM8;PLCG1;TGFB1;SNX17;RNH1;EPN2;ERBB2;ADGRB2;BAX;EREG;TGFBR3;ADAM15;HDAC7;ECM1;DNM2;ROBO4;CUL7;HYAL1;RRAS;PROX1;PKD1;FAM129B;NGFR;PDCD6;BTG1
5715,GO:0016849,0.0111671587881098,0.998697959629897,4,9,phosphorus-oxygen lyase activity,MF,NPR2;ADCY1;ADCY7;ADCY6
16606,GO:0097443,0.0111741520681788,0.999336370215205,3,5,sorting endosome,CC,LDLR;CLTCL1;PTPN1
4842,GO:0014051,0.0111845100177968,0.999335518939815,3,5,gamma-aminobutyric acid secretion,BP,NTSR1;SV2A;APBA1
2171,GO:0005007,0.0111845100178013,0.999335518939816,3,5,fibroblast growth factor-activated receptor activity,MF,FGFR4;FGFR1;FGFR3
4541,GO:0010616,0.011184510017806,0.999335518939816,3,5,negative regulation of cardiac muscle adaptation,BP,SMAD3;ERRFI1;LMNA
18326,GO:1903243,0.011184510017806,0.999335518939816,3,5,negative regulation of cardiac muscle hypertrophy in response to stress,BP,SMAD3;ERRFI1;LMNA
17611,GO:1901265,0.0112635418085974,0.99096494317129,204,1639,nucleoside phosphate binding,MF,NT5E;XDH;H6PD;ACVR2B;PYGL;DGKA;OBSCN;IDH2;NEK9;PKN1;ACSF2;EGFR;RPS6KA2;NOS1;HADH;MST1R;VPS11;ARL2;GTPBP1;TK2;ACTA2;RAPGEF3;TXNRD3;GLUL;MAP2K2;NME4;SMARCA1;PC;MAP2K1;CRYL1;MARK4;ERCC6;HSD17B8;PRODH;CDK18;NMRK1;D2HGDH;AKT1;STK39;HK1;EPHA1;BRSK1;RAB31;FGFR4;FGFR1;PRKACB;RAC2;PFKL;TTLL12;OPLAH;HLTF;CBR4;ABCD1;TWF2;STRADB;MAPK13;PTK6;PFKP;CSNK1E;RAB3B;MAPKAPK3;BCR;EHD4;SEPT10;NADK;PANK4;HLCS;AGAP1;NPR2;DGKQ;PAK6;FYCO1;ABCA2;EPHB2;APRT;CTBP1;GRK6;KIF17;MVD;ENTPD2;GNAL;SCYL1;ULK2;MKNK2;TMEM173;ATP7B;SDHA;PIP5KL1;KIF26B;RHOD;DNAH1;PI4K2A;RHOF;PHGDH;ARL10;KIF7;RHOBTB2;TUBG2;PEX1;PCK2;MBD3;TRAP1;PFKFB2;PRKCZ;PRKACA;MINK1;GRHPR;ACTR1B;PIM2;UCKL1;ERBB2;ULK1;AHCY;STK17A;JAK3;PDK1;ACAD10;PRKCD;FAM20C;NUBP2;RPS6KA5;DGUOK;CUL9;ACADS;RASL10B;LIMK1;NTPCR;RPS6KA6;DNM1;SCN8A;EHD3;LONP2;MAPK12;IRAK1;PPOX;MTHFR;CHD2;PI4K2B;CHEK2;ABCG1;MYO1D;MYH15;CDC34;ABCA7;RAB12;SPEG;DALRD3;FYN;STK25;RAC3;EEF2K;DNM2;CKMT1A;CHKA;CAT;SLC27A1;KIF26A;DDX50;TUBB6;MAPK3;INSR;PFKM;ADCY1;ATP8B2;PDXK;PAK1;CAMKK2;ALPK1;PFKFB3;MICAL1;STK32C;SRMS;MAP2K3;RRAS;IARS2;SIRT2;GAL3ST4;NMNAT2;NT5C1B;ADCY7;LTB4R;TEP1;RAB28;MAP3K10;RAB40B;GCH1;KIF13B;CAMK1;CAMKK1;SIRT3;BBS10;SEPT6;CDK11B;FGFR3;ITPKB;CDC42BPG;CLK3;DHX32;PKN3;TTLL3;AK3;ADCY6;LRRK1;AARS
7019,GO:0030799,0.0113017546570459,0.996279600652516,10,42,regulation of cyclic nucleotide metabolic process,BP,VEGFA;APOE;NOS1;RAPGEF3;ADORA2B;PTHLH;PKD2;TIMP2;LTB4R2;GABBR1
18253,GO:1903053,0.0113277609672734,0.99722809547179,7,24,regulation of extracellular matrix organization,BP,CST3;SMAD3;LRP1;FGFR4;TGFB1;FSCN1;CHADL
15803,GO:0072503,0.0113413654004767,0.993390265398774,34,216,cellular divalent inorganic cation homeostasis,BP,DLG4;PRNP;APOE;F2R;ITPR3;NOS1;HEXB;LPAR3;SMAD3;TPCN1;EDNRA;BNIP3;CEMIP;PKD2;AP3D1;PLCG1;TGFB1;NTSR1;ATP7B;RASA3;PRKACA;BOK;TRPC1;CACNB3;BAX;SV2A;MT2A;GSTO1;BCAP31;PLA2G6;WFS1;FYN;GRINA;PKD1
19250,GO:1905384,0.0113484020826461,1,2,2,regulation of protein localization to presynapse,BP,WNT7A;DVL1
19251,GO:1905386,0.0113484020826461,1,2,2,positive regulation of protein localization to presynapse,BP,WNT7A;DVL1
11847,GO:0046847,0.0113659785330414,0.996266696016649,10,41,filopodium assembly,BP,ZMYND8;ESPN;ITGA6;ARAP1;TENM2;AGRN;FSCN1;PRKCD;SH3BP1;ARHGEF4
13408,GO:0052813,0.0113690975007091,0.996547226121235,9,35,phosphatidylinositol bisphosphate kinase activity,MF,EGFR;PIK3R2;HBEGF;FGFR4;FGFR1;ERBB2;EREG;FYN;FGFR3
4203,GO:0009313,0.0113998350721046,0.99866247115199,4,9,oligosaccharide catabolic process,BP,HEXB;CTBS;MAN2B1;MAN2B2
11469,GO:0045936,0.0114296039835801,0.992245717313128,63,444,negative regulation of phosphate metabolic process,BP,TNIP1;DUSP6;XDH;DUSP5;PDCD4;PRNP;APOE;LRP5;PKN1;WWTR1;SPRY2;SPRY4;PPP1R35;FBLN1;PIK3R2;DVL1;PPP1R14A;ADARB1;AKT1;PPM1F;STK39;EPHA1;IMPACT;SORL1;CEACAM1;PODNL1;PTK6;DUSP7;ERRFI1;DGKQ;EPHB2;CDKN1C;TGFB1;FARP1;PTPN1;CAMK2N1;MLXIPL;TRIB2;PRKCZ;PRKCD;BAX;DUSP4;DDIT4;LTB4R2;LEMD2;RPS6KA6;RGS14;CHAD;LPCAT1;PPARA;MYO1D;ELFN2;SLC27A1;GABBR1;MICAL1;DLG3;SIRT2;SOCS7;GRB10;SIRT3;NDRG2;CBLC;LRRK1
2184,GO:0005041,0.0114742882894382,0.998651066356715,4,9,low-density lipoprotein particle receptor activity,MF,LRP1;LDLR;SORL1;LRP10
4066,GO:0009119,0.011496122435806,0.994975479532212,16,84,ribonucleoside metabolic process,BP,NT5E;DLG4;GTPBP1;NME4;GAMT;CARD11;APRT;ADA;UCKL1;AHCY;DGUOK;UPP1;APOBEC3C;APOBEC3F;DLG3;AK3
6886,GO:0030424,0.0114991040627344,0.99247865640265,53,362,axon,CC,ADGRL1;DLG4;CST3;PTPRS;GLUL;LPAR3;SSH1;SHANK2;GJC2;DVL1;KCNC4;TMOD2;SIGMAR1;KCNAB2;TENM2;ANK3;TWF2;CTSZ;AP3D1;EPHB2;TIMP2;SYNJ2;TGFB1;NTSR1;LLGL1;PRKCZ;MINK1;ULK1;FSCN1;SV2A;GDI1;DNM1;SCN8A;MYO1D;SYNGR1;RAC3;DNM2;INSR;PAK1;MICAL1;ITGA3;BIN1;VPS16;DLG3;SIRT2;AZIN2;KIF13B;SEPT6;PFN2;NDRG2;BLOC1S4;TRIM46;KLHL24
12056,GO:0048015,0.0115426812692745,0.994550728487194,19,101,phosphatidylinositol-mediated signaling,BP,F2R;EGFR;SERPINE2;ZFP36L1;PIK3R2;AKT1;FGFR1;CEACAM1;GSN;RGL2;NYAP1;ERBB2;FYN;CAT;MAPK3;PPP2R5B;SIRT2;ZP3;PI4KAP2
7117,GO:0030947,0.0115685390826368,0.997566140337372,6,19,regulation of vascular endothelial growth factor receptor signaling pathway,BP,VEGFA;PTPN1;EPN2;FAM129B;PDCD6;GRB10
4364,GO:0009975,0.0115867703990288,0.998633791573969,4,9,cyclase activity,MF,NPR2;ADCY1;ADCY7;ADCY6
5080,GO:0015318,0.0116951612318467,0.992217720366758,57,398,inorganic molecular entity transmembrane transporter activity,MF,SLC16A3;DLG4;KCNG1;SLC6A8;ITPR3;SCN4B;SLC2A9;ORAI3;ORAI1;SLC7A8;SLC12A7;SLC16A5;KCNJ15;SLC6A6;TPCN1;KCNC4;TTYH3;BSG;SLC15A4;LRRC8A;MFSD3;KCNAB2;CEACAM1;GAS6;ANO8;SLC20A1;SERINC2;PKD2;GRIN3B;ASIC1;SLC43A1;SLC38A10;ATP7B;RASA3;CLCA2;TRPC1;SLC22A17;CACNB3;SLC13A5;SCN8A;ABCG1;SLC25A29;SLC9A7;SLC22A18;SLC27A1;SLC12A4;SLC13A3;SLC37A2;SLC16A13;DLG3;PKD1;SLC25A37;ATP6V1F;SLC39A3;TMCO3;SLC23A2;SLC26A11
2711,GO:0006090,0.0117905494475055,0.994417588744101,19,102,pyruvate metabolic process,BP,SLC16A3;PGM1;PC;BSG;HK1;PFKL;PFKP;DHTKD1;HAGH;PCK2;PFKFB2;MLXIPL;PDK1;DDIT4;ALDOC;PPARA;INSR;PFKM;PFKFB3
11332,GO:0045666,0.0118555062010025,0.992902490401934,37,235,positive regulation of neuron differentiation,BP,ZMYND8;DLG4;VEGFA;APOE;OBSL1;ETV5;LPAR3;MAP2K1;SHANK2;DVL1;IMPACT;CNTN1;FGFR1;HMG20B;TWF2;PTK6;CSNK1E;PLXNB3;CRTC1;FBXW8;TIMP2;WNT3;SHANK3;LIMK1;GDI1;FYN;STK25;EEF2K;PAK1;CUL7;CAPRIN2;ITGA3;PPP2R5B;PROX1;CDH4;NGFR;CAMK1
18192,GO:1902951,0.0118628935099702,1,2,2,negative regulation of dendritic spine maintenance,BP,PRNP;FYN
19347,GO:1905664,0.0118628935099702,1,2,2,regulation of calcium ion import across plasma membrane,BP,PRNP;FYN
18082,GO:1902652,0.0118650632712122,0.994374913302414,19,103,secondary alcohol metabolic process,BP,CYP27B1;APOE;LRP5;OSBPL5;LMF1;LDLR;FGFR1;SEC14L2;SORL1;PCSK9;DGKQ;MVD;SNX17;PLPP6;MBTPS2;HSD17B7;ABCG1;CAT;CYP2R1
4710,GO:0010874,0.0118983136559648,0.997977213993463,5,14,regulation of cholesterol efflux,BP,APOE;PLTP;LRP1;ABCG1;ABCA7
3013,GO:0006562,0.0119688495979421,1,2,2,proline catabolic process,BP,ALDH4A1;PRODH
4399,GO:0010133,0.0119688495979421,1,2,2,proline catabolic process to glutamate,BP,ALDH4A1;PRODH
19632,GO:1990769,0.0119797533680033,1,2,2,proximal neuron projection,CC,GJC2;TRIM46
4511,GO:0010563,0.011980695808624,0.991851221856945,63,445,negative regulation of phosphorus metabolic process,BP,TNIP1;DUSP6;XDH;DUSP5;PDCD4;PRNP;APOE;LRP5;PKN1;WWTR1;SPRY2;SPRY4;PPP1R35;FBLN1;PIK3R2;DVL1;PPP1R14A;ADARB1;AKT1;PPM1F;STK39;EPHA1;IMPACT;SORL1;CEACAM1;PODNL1;PTK6;DUSP7;ERRFI1;DGKQ;EPHB2;CDKN1C;TGFB1;FARP1;PTPN1;CAMK2N1;MLXIPL;TRIB2;PRKCZ;PRKCD;BAX;DUSP4;DDIT4;LTB4R2;LEMD2;RPS6KA6;RGS14;CHAD;LPCAT1;PPARA;MYO1D;ELFN2;SLC27A1;GABBR1;MICAL1;DLG3;SIRT2;SOCS7;GRB10;SIRT3;NDRG2;CBLC;LRRK1
15984,GO:0080184,0.0120048199392099,1,2,2,response to phenylpropanoid,BP,EGFR;CAT
12389,GO:0048841,0.0120128926178961,0.997025562341041,7,24,regulation of axon extension involved in axon guidance,BP,SEMA4B;VEGFA;SEMA3F;WNT3;SEMA4F;SEMA4C;SEMA3B
14114,GO:0060988,0.0120195494744185,1,2,2,lipid tube assembly,BP,SNX9;BIN1
18201,GO:1902960,0.0120195494744185,1,2,2,negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,SORL1;BIN1
19192,GO:1905246,0.0120195494744185,1,2,2,negative regulation of aspartic-type peptidase activity,BP,SORL1;BIN1
12237,GO:0048522,0.0120250731694397,0.989841916916166,407,3490,positive regulation of cellular process,BP,TNIP1;DUSP6;XDH;ERCC1;DUSP5;MEF2D;ZMYND8;ADGRL1;CITED4;SEMA4B;HTRA1;EGR1;NR1D1;EDEM1;DLG4;CST3;CYP27B1;APLN;PGF;PDCD4;CTNNBIP1;ACVR2B;DOCK4;PRNP;POSTN;VEGFA;FAM210B;WNT7A;APOE;TSPAN1;ESPN;F2R;LRP5;ITGA6;HMGA2;OBSCN;NDRG1;ELK3;ITPR3;PKN1;MTA1;GRAMD4;EGFR;RPS6KA2;SERPINE2;DNPH1;WWTR1;OBSL1;NOS1;SPRY2;MST1R;NFATC4;TRIM65;SDC1;ETV5;SHC1;DDB2;VPS11;ARL2;HEXB;GTPBP1;MMP1;ETV4;SNX9;RAPGEF3;ZFP36L1;GLUL;ARAP1;MAP2K2;LPAR3;SMARCA1;RBCK1;MAP2K1;SSH1;POU2F2;ENDOG;MARK4;MARCKSL1;SMURF2;FOS;FBLN1;SMAD3;STAT6;SHANK2;PIK3R2;ERCC6;LRP1;GJC2;DVL1;EPAS1;HBEGF;FAM110C;S100A4;SH3PXD2B;SHC2;NLGN2;PRODH;SALL2;PAG1;ZXDC;RNF187;ADORA2B;AKT1;TPCN1;GRB7;TMOD2;CORO1B;HDAC5;S100A6;F12;SH2D2A;PPM1F;STK39;HK1;EPHA1;VEGFB;ASH2L;IMPACT;CNTN1;DAP;PTHLH;FGFR4;WNT2B;LDLR;FGFR1;PRKACB;RAC2;SEC14L2;HLTF;NPHP4;RAG1;KLF7;SORL1;NAT14;CEACAM1;CIRBP;HMG20B;RAB11FIP4;TENM2;ZNF385A;NSMCE4A;ANK3;IGFBP4;EVC;CCND1;PCBP4;TWF2;STRADB;PLAU;GAS6;PTK6;SEMA3F;FGFBP1;CSNK1E;RAB3B;CARD11;SH2B3;DUSP7;GSN;PLEKHG2;MAPKAPK3;IGFBP2;PCSK9;RAD23A;BCR;EHD4;WIPF1;CCDC71L;SH3D19;CDC25B;RGL2;SLITRK6;ARPIN;ALOX15B;SLC20A1;DGKQ;PLXNB3;BNIP3;PAK6;SHARPIN;FYCO1;CEMIP;PKD2;YPEL3;RASGEF1A;CTSZ;CDC42EP5;CRTC1;FBXW8;GPSM1;AP3D1;MAGEF1;EPHB2;ADAM8;CTBP1;CDKN1C;PLCG1;ZMIZ2;SH3BP2;CD81;CEBPB;MVD;TIMP2;WNT3;TMED4;TGFB1;RFX2;GPC1;DEAF1;MOAP1;NTSR1;NAB2;TMEM173;SHANK3;EFNB3;TNFSF15;NSMF;PEG3;MC1R;TUB;CROCC;RHOD;ABHD14B;SNX33;SEMA4F;WASF3;KIF7;RIMS3;PTPN1;PCK2;WDR59;AGRN;IFNE;CD320;LRP4;VHL;CEP131;PFKFB2;RFNG;MLXIPL;TRIB2;PRKCZ;KDM6B;PRKACA;MINK1;ZNF516;EPN2;ADA;AREG;PIM2;MICALL2;PLEKHG5;BOK;ERBB2;ADGRB2;ULK1;VAMP2;TFDP2;PLEK2;C6ORF89;STK17A;JAK3;NET1;BNIP3L;CYFIP2;FSCN1;PBX2;TRPC1;PRKCD;FAM20C;MIB2;RBL2;STUB1;BAX;ITGA1;OLFM2;FBXW4;EREG;RPS6KA5;SOX12;DDIT4;MBTPS2;PPP1R13L;CARF;IER2;RASL10B;ZDHHC8;LIMK1;TGFBR3;GDI1;ZHX3;WASH3P;RGS14;MFNG;GSTO1;LRSAM1;SYMPK;MAPK12;IRAK1;TGFA;HDAC7;FHOD1;INPP5D;CHEK2;ZFPM1;PPARA;TMEM161A;SESN2;CDC34;SOX7;ABCA7;RAB12;SIX5;BCAP31;MIF;PLA2G6;DDT;SSBP4;ECM1;WFS1;NBPF3;FYN;STK25;RAC3;EEF2K;DNM2;PELI1;CAT;SLC27A1;TPBG;ARHGEF4;MAPK3;INSR;ARHGEF1;CAMTA2;TAZ;PFKM;ADCY1;RERE;HLA-G;TMEM101;ETAA1;VANGL2;PAK1;CAMKK2;PPP3CB;RNF144A;USP21;PFKFB3;MLYCD;CUL7;HYAL1;SEMA4C;CAPRIN2;ITGA3;DNMT3A;BIN1;PPP2R5B;MAP2K3;BCL2L1;DLG3;PROX1;LMNA;PKD1;KCTD13;TNFRSF25;SIRT2;FAM129B;CDH4;ITGA4;EDA;BACH1;ADCY7;E2F5;MAPRE3;LAMB1;MAP3K10;NGFR;TOLLIP;PDCD6;PXN;GRB10;TBC1D8;PLEKHM1;LURAP1;MAFF;PNMA1;CAMK1;CAMKK1;EZH1;SIRT3;HFE;BTG1;ZP3;SEMA3B;PFN2;FGFR3;ITPKB;SPTLC2;TCEA2;PLAG1;IRF2BPL;KDM3A;DEDD2;SRSF5;ADCY6;LRRK1
8923,GO:0034774,0.0120385957935983,0.992943739785227,34,223,secretory granule lumen,CC,PYGB;VEGFA;PYGL;VAT1;HEXB;NAPRT;SERPING1;VEGFB;FUCA1;PFKL;GAS6;GSN;PCSK1;CTSZ;APRT;TIMP2;DPP7;TGFB1;GALNS;ACTR1B;PRKCD;ALDOC;MIF;ECM1;QSOX1;GLB1;CAT;PDXK;RNASET2;LGALS3BP;MAN2B1;DNASE1L1;SERPINB1;TOLLIP
18557,GO:1903756,0.0120439040632399,1,2,2,regulation of transcription from RNA polymerase II promoter by histone modification,BP,ZMYND8;CTBP1
18558,GO:1903758,0.0120439040632399,1,2,2,negative regulation of transcription from RNA polymerase II promoter by histone modification,BP,ZMYND8;CTBP1
16396,GO:0097017,0.0120700558121445,1,2,2,renal protein absorption,BP,GAS6;GSN
7960,GO:0032571,0.0120703173404419,1,2,2,response to vitamin K,BP,POSTN;GAS6
15169,GO:0071307,0.0120703173404419,1,2,2,cellular response to vitamin K,BP,POSTN;GAS6
14754,GO:0070435,0.0120775320037022,1,2,2,Shc-EGFR complex,CC,EGFR;SHC1
3678,GO:0008184,0.0120864202912361,1,2,2,glycogen phosphorylase activity,MF,PYGB;PYGL
17136,GO:0102250,0.0120864202912361,1,2,2,linear malto-oligosaccharide phosphorylase activity,MF,PYGB;PYGL
17158,GO:0102499,0.0120864202912361,1,2,2,SHG alpha-glucan phosphorylase activity,MF,PYGB;PYGL
19474,GO:1990164,0.0120864203424605,1,2,2,histone H2A phosphorylation,BP,HMGA2;RPS6KA5
2622,GO:0005945,0.0120864203424654,1,2,2,6-phosphofructokinase complex,CC,PFKL;PFKM
4293,GO:0009726,0.0120864203424655,1,2,2,detection of endogenous stimulus,BP,PKD2;ABCG1
19788,GO:2000182,0.012086420342467,1,2,2,regulation of progesterone biosynthetic process,BP,EGR1;DGKQ
13736,GO:0060319,0.0120864203424674,1,2,2,primitive erythrocyte differentiation,BP,VEGFA;ZFPM1
7522,GO:0031749,0.0120864203424677,1,2,2,D2 dopamine receptor binding,MF,DNM1;DNM2
19600,GO:1990666,0.0120864203424694,1,2,2,PCSK9-LDLR complex,CC,LDLR;PCSK9
11147,GO:0045210,0.0120864203424696,1,2,2,FasL biosynthetic process,BP,PHLDA1;JAK3
13860,GO:0060488,0.0120864203424696,1,2,2,orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis,BP,VANGL2;CELSR1
13861,GO:0060489,0.0120864203424696,1,2,2,planar dichotomous subdivision of terminal units involved in lung branching morphogenesis,BP,VANGL2;CELSR1
13862,GO:0060490,0.0120864203424696,1,2,2,lateral sprouting involved in lung morphogenesis,BP,VANGL2;CELSR1
18835,GO:1904398,0.0120864203424696,1,2,2,positive regulation of neuromuscular junction development,BP,AGRN;LRP4
832,GO:0002133,0.0120864203424696,1,2,2,polycystin complex,CC,PKD2;PKD1
15565,GO:0072021,0.0120864203424696,1,2,2,ascending thin limb development,BP,PKD2;PKD1
15656,GO:0072177,0.0120864203424696,1,2,2,mesonephric duct development,BP,PKD2;PKD1
15687,GO:0072218,0.0120864203424696,1,2,2,metanephric ascending thin limb development,BP,PKD2;PKD1
19167,GO:1905167,0.0120864203424696,1,2,2,positive regulation of lysosomal protein catabolic process,BP,LRP1;LDLR
2749,GO:0006163,0.0121319101973301,0.992060470034029,52,375,purine nucleotide metabolic process,BP,NT5E;XDH;DLG4;VEGFA;PGM1;APOE;ACOT7;DNPH1;NOS1;GTPBP1;RAPGEF3;NME4;ADORA2B;HK1;PTHLH;PFKL;PFKP;CARD11;DHTKD1;NADK;PANK4;NPR2;PKD2;APRT;TIMP2;TGFB1;PODXL2;SDHA;ABHD14B;PFKFB2;MLXIPL;ADA;FAM20C;CYC1;PPCS;DGUOK;DDIT4;LTB4R2;ALDOC;PPARA;INSR;TAZ;PFKM;ADCY1;PFKFB3;GABBR1;DLG3;NDUFV3;NT5C1B;ADCY7;AK3;ADCY6
16853,GO:0098772,0.0121924054370809,0.990559145066794,143,1136,molecular function regulator,MF,SEMA4B;DLG4;CST3;APLN;PGF;DOCK4;VEGFA;WNT7A;APOE;OBSCN;EVI5L;EGFR;SERPINE2;SCN4B;NOS1;SPRY2;PRSS8;APPL2;SHC1;TBC1D14;ARL2;RIN1;RAPGEF3;ARAP1;MAP2K2;PPP1R35;CMTM7;MAP2K1;FBLN1;ARHGAP23;PIK3R2;ERCC6;HBEGF;PPP1R14A;SH3PXD2B;PPP2R3B;PRDX5;SHC2;AKT1;SERPING1;ASAP2;VEGFB;PTHLH;FGFR4;FGFR1;RAC2;KCNAB2;RALGDS;B3GAT3;DOCK6;TRAPPC9;CCND1;PODNL1;SYNGAP1;GAS6;SEMA3F;CMTM4;PLEKHG2;PCSK9;ARHGAP22;BCR;ANGPTL4;ERRFI1;RGL2;ARHGAP27;SPTB;AGAP1;CCS;SNTA1;DGKQ;TFPI2;RASGEF1A;CDC42EP5;GPSM1;SH3PXD2A;CDKN1C;TIMP2;WNT3;TGFB1;TBC1D9B;ARHGAP25;RASA3;TNFSF15;ARAP3;FARP1;RNH1;VGF;PLEKHG4;SEMA4F;LLGL1;PLEKHG3;IFNE;CD320;CAMK2N1;ADAP1;TRIB2;PRKCZ;AREG;PLEKHG5;ERBB2;JAK3;NET1;RASA4;ARHGAP44;PRKCD;SBF1;SH3BP1;EREG;PCSK1N;GDI1;RGS14;GIT1;CHAD;TGFA;SESN2;MIF;FYN;ARHGAP12;ACAP3;ELFN2;IQSEC1;ARHGEF4;ARHGEF1;DOCK9;RALGAPA1;ETAA1;SEMA4C;WDTC1;PPP2R5B;SGSM2;TBC1D16;RABGAP1;TRIP10;AZIN2;SERPINB1;RAP1GAP2;SOCS7;RGS19;TBC1D8;ZP3;SEMA3B;FGFR3;PPP1R16A
6658,GO:0030018,0.012217068683903,0.994984345773032,14,69,Z disc,CC,PARVB;FLNC;OBSCN;OBSL1;NOS1;MYZAP;ANK3;FHOD3;STUB1;AHNAK2;SCN8A;PAK1;PPP3CB;BIN1
12170,GO:0048306,0.0122575360421877,0.996186655647099,9,38,calcium-dependent protein binding,MF,S100A4;SYT8;S100A6;NSMF;VAMP2;MYO1D;WFS1;RAC3;PDCD6
501,GO:0001558,0.0122796489990514,0.992324321955557,43,287,regulation of cell growth,BP,SEMA4B;HTRA1;FHL1;CYP27B1;VEGFA;APOE;EGFR;SERPINE2;DNPH1;PTPRS;LTBP4;LPAR3;SMAD3;HBEGF;AKT1;CEACAM1;IGFBP4;TWF2;SEMA3F;IGFBP2;WNT3;TGFB1;ULK2;SEMA4F;ERBB2;NET1;LIMK1;GDI1;ADAM15;SESN2;DNM2;TSPYL2;IGFBP7;KIF26A;PAK1;HYAL1;SEMA4C;CAPRIN2;CDH4;DCBLD2;BTG1;SEMA3B;CDK11B
890,GO:0002260,0.0123080669151419,0.99588167011056,10,43,lymphocyte homeostasis,BP,PKN1;AKT1;RAG1;TGFB1;ADA;JAK3;BAX;MIF;PPP3CB;SLC39A3
6984,GO:0030669,0.0123731111939176,0.996894024470043,7,25,clathrin-coated endocytic vesicle membrane,CC,APOE;EGFR;HBEGF;AP2A2;LDLR;CD9;EPN2
10436,GO:0043299,0.0124116575825892,0.991803790966494,54,383,leukocyte degranulation,BP,CST3;PYGB;PGM1;PYGL;VAT1;HEXB;SLC2A3;GAA;NAPRT;AP2A2;STOM;ADORA2B;SLC15A4;RAB31;FUCA1;RAC2;KCNAB2;PFKL;CEACAM1;PLAU;BRI3;CTSB;GSN;BCR;CTSZ;PRSS3;ADAM8;APRT;LTA4H;TIMP2;DPP7;TMEM173;GALNS;PI4K2A;RHOF;YPEL5;ACTR1B;VAMP2;PRKCD;ALDOC;LPCAT1;MIF;SYNGR1;QSOX1;CD68;GLB1;CAT;PDXK;RNASET2;MAN2B1;DNASE1L1;SERPINB1;TOLLIP;NBEAL2
9520,GO:0036230,0.0124252088740609,0.991862313011216,52,367,granulocyte activation,BP,CST3;PYGB;PGM1;PYGL;VAT1;HEXB;SLC2A3;GAA;NAPRT;AP2A2;STOM;SLC15A4;RAB31;FUCA1;KCNAB2;PFKL;CEACAM1;PLAU;BRI3;CTSB;GSN;BCR;CTSZ;PRSS3;ADAM8;APRT;LTA4H;TIMP2;DPP7;TMEM173;GALNS;PI4K2A;RHOF;YPEL5;ACTR1B;VAMP2;PRKCD;ALDOC;LPCAT1;MIF;SYNGR1;QSOX1;CD68;GLB1;CAT;PDXK;RNASET2;MAN2B1;DNASE1L1;SERPINB1;TOLLIP;NBEAL2
5519,GO:0016485,0.012438291254131,0.99330011905601,26,156,protein processing,BP,PLAT;TYSND1;PRNP;SERPINE2;CAPN2;F12;RHBDF2;SERPING1;GGT1;PRKACB;PLAU;GAS6;GSN;PCSK9;PCSK1;CTSZ;PRSS3;ADAM8;CD81;ADAMTS13;MIPEP;ERO1B;CYFIP2;PCSK1N;LONP2;SPPL2B
5069,GO:0015293,0.0125257945436943,0.994662509701018,15,74,symporter activity,MF,SLC16A3;SLC6A8;SLC2A9;SLC12A7;SLC16A5;SLC6A6;SLC15A4;MFSD3;SLC20A1;SLC13A5;SLC22A18;SLC12A4;SLC13A3;SLC16A13;SLC23A2
12884,GO:0051234,0.0125618981160274,0.989387695413367,399,3454,establishment of localization,BP,XDH;FHL1;NR1D1;SLC16A3;EDEM1;DLG4;CST3;CYP27B1;MRC2;APLN;KCNG1;ACVR2B;PRNP;PYGB;BBS2;SLC6A8;POSTN;VEGFA;PGM1;WNT7A;APOE;PYGL;TSPAN1;F2R;LRP5;OSBPL5;PITPNC1;IDH2;SLCO4A1;ITPR3;ARRDC1;EVI5L;NISCH;FCGRT;EGFR;SERPINE2;SCN4B;NOS1;VAT1;TMEM129;SLC2A9;HADH;SPRY2;LRP3;LTBP4;PRSS8;SYTL1;SDC1;LMF1;ORAI3;APPL2;ORAI1;LTBP2;VPS11;TBC1D14;ARL2;HEXB;SLC7A8;SLC12A7;SLC2A3;RIN1;SNX9;RAPGEF3;ZFP36L1;GAA;GLUL;ARAP1;MAP2K2;NME4;LPAR3;PLTP;MAP2K1;NAPRT;CPT2;MCTP1;POU2F2;EXOC2;SLC16A5;KCNJ15;KLC2;SHANK2;PIK3R2;LRP1;GJC2;DVL1;AP2A2;NLGN2;STOM;ADORA2B;SYT8;SLC6A6;AKT1;TPCN1;KCNC4;TTYH3;S100A6;PITPNM1;RHBDF2;BSG;STK39;HK1;SERPING1;ASAP2;DYSF;VEGFB;SLC15A4;ATG16L2;ZFYVE21;LRRC8A;CNTN1;BRSK1;IFT140;MFSD3;RAB31;PEAR1;LDLR;FGFR1;FUCA1;MAPKBP1;ELMO3;SIGMAR1;RAC2;KCNAB2;PFKL;SYNE3;TOMM34;SORL1;CEACAM1;B3GAT3;RAB11FIP4;ABCD1;ANK3;TRAPPC9;CCND1;STRADB;EDNRA;PLAU;GAS6;CSNK1E;BRI3;CTSB;RAB3B;CARD11;GSN;MAPKAPK3;PCSK9;ANO8;BCR;ANTXR2;XPOT;EHD4;WIPF1;AIP;STON1;ARHGAP27;ALOX15B;SPTB;AGAP1;PEX10;CCS;CORO7;SLC20A1;UNC119B;SNTA1;BNIP3;MVB12B;SERINC2;FYCO1;CEMIP;PKD2;CTSZ;AP3D1;ABCA2;PRSS3;EPHB2;GRIN3B;ADAM8;ASIC1;APRT;LTA4H;PLCG1;KIF17;CD81;SLC29A4;TIMP2;DPP7;TMED4;TGFB1;SNPH;CLTCL1;SCYL1;SLC43A1;MOAP1;TBC1D9B;SLC38A10;NTSR1;TMEM173;ARHGAP25;ATP7B;SHANK3;RASA3;MIPEP;GALNS;CLCA2;ARAP3;SCART1;TUB;CROCC;RHOD;SNX17;VGF;SNX33;PI4K2A;RHOF;SLC48A1;LLGL1;RIMS3;BBS1;PTPN1;PEX1;PCK2;CD320;OSBPL10;LRP4;LRP10;ESYT2;ZDHHC24;CEP131;ADAP1;PFKFB2;YPEL5;PRKCZ;PRKACA;MINK1;OXA1L;ACTR1B;TOM1L2;CD9;EPN2;ADA;AREG;MICALL2;BOK;NEURL1B;ERBB2;VAMP2;TFDP2;NECAB3;RILPL1;BNIP3L;CYFIP2;TRPC1;SLC22A17;CYGB;ARHGAP44;MCFD2;PRKCD;REEP6;CACNB3;USP20;BAX;CYC1;SV2A;SLC13A5;OLFM2;SH3BP1;TIMM17B;RASL10B;ZDHHC8;FCHO1;LIMK1;GDI1;SLC2A11;LEMD2;DNM1;WASH3P;RGS14;SCN8A;GSTO1;GIT1;ALDOC;LPCAT1;LRSAM1;REEP2;EHD3;WDR60;LONP2;SYMPK;TGFA;FHOD1;CACFD1;PPARA;COG7;SESN2;ABCG1;MYO1D;ABCA7;RAB12;BCAP31;MIF;SLC25A29;DOPEY2;SLC9A7;PLA2G6;SYNGR1;ECM1;WFS1;QSOX1;CD68;SLC22A18;NBPF3;FYN;PITPNM3;STK25;RAC3;TMCO6;EEF2K;SUN1;ICAM5;ARHGAP12;ACAP3;DNM2;GLB1;SNX15;CHKA;CAT;SLC27A1;SLC50A1;KIF26A;ZDHHC1;SLC12A4;MAPK3;INSR;SLC13A3;RTN2;PFKM;RERE;STX10;ATP8B2;PDXK;PRAF2;GLRX;PAK1;RNASET2;PPP3CB;LGALS3BP;SLC37A2;MICAL1;BIN1;VPS16;MAN2B1;SLC16A13;BCL2L1;DLG3;SGSM2;DNASE1L1;TBC1D16;PKD1;RABGAP1;FAM129B;ITGA4;TRIP10;AZIN2;RAB28;SERPINB1;ICA1;SLC25A37;NDE1;RAB40B;NGFR;TOLLIP;PDCD6;ATP6V1F;PCLO;GRB10;TBC1D8;PLEKHM1;KIF13B;NBEAL2;CAMK1;SLC39A3;SIRT3;HFE;ZP3;VPS51;TMCO3;PFN2;SLC35F3;MFSD10;TST;CCDC88C;BLOC1S4;TRIM46;HOMER2;SLC23A2;APBA1;SRSF5;SLC26A11;KLHL24
12676,GO:0050900,0.0126196472759913,0.992521290305599,35,226,leukocyte migration,BP,SLC16A3;PGF;VEGFA;ITGA6;SDC1;SHC1;SLC7A8;MMP1;PIK3R2;GRB7;MMP28;BSG;VEGFB;RAC2;CEACAM1;GAS6;BCR;PROCR;ADAM8;PLCG1;TGFB1;GPC1;PODXL2;ADA;ITGA1;INPP5D;MIF;DDT;ECM1;FYN;MAPK3;ITGA3;ITGA4;ZP3;SDC2
12916,GO:0051280,0.0126808035663611,0.99838699372973,4,10,negative regulation of release of sequestered calcium ion into cytosol,BP,PKD2;TGFB1;NTSR1;GSTO1
12920,GO:0051284,0.0126808035663611,0.99838699372973,4,10,positive regulation of sequestering of calcium ion,BP,PKD2;TGFB1;NTSR1;GSTO1
12622,GO:0050818,0.0127232200905561,0.995443694474736,11,49,regulation of coagulation,BP,PLAT;APOE;F2R;SERPINE2;F12;SERPING1;CEACAM1;PLAU;PROCR;CD9;PRKCD
9034,GO:0035254,0.0127430581219727,0.996394890704073,8,30,glutamate receptor binding,MF,DLG4;PRNP;SHANK2;PLCG1;SHANK3;FYN;DLG3;HOMER2
2756,GO:0006171,0.0128119429733253,0.9967611986176,7,25,cAMP biosynthetic process,BP,PTHLH;TIMP2;LTB4R2;ADCY1;GABBR1;ADCY7;ADCY6
3794,GO:0008373,0.0128483634812751,0.997772114412233,5,14,sialyltransferase activity,MF,ST6GALNAC2;ST6GALNAC6;ST3GAL3;ST3GAL2;ST3GAL5
16640,GO:0097503,0.0128483634812751,0.997772114412233,5,14,sialylation,BP,ST6GALNAC2;ST6GALNAC6;ST3GAL3;ST3GAL2;ST3GAL5
14797,GO:0070528,0.0128910799644681,0.997221096686701,6,19,protein kinase C signaling,BP,VEGFA;DGKQ;MC1R;PRKCZ;ADAM15;PLA2G6
1797,GO:0004435,0.0129594666978249,0.997747853371703,5,14,phosphatidylinositol phospholipase C activity,MF,PLCD3;PLCH2;EDNRA;PLCG1;PLCB3
16236,GO:0090288,0.0130134261829798,0.993915743725239,18,96,negative regulation of cellular response to growth factor stimulus,BP,XDH;HTRA1;APLN;SPRY2;LTBP1;SPRY4;SMURF2;SMAD3;TGFB1;GPC1;PTPN1;EPN2;STUB1;TGFBR3;LEMD2;DNM2;FAM129B;PDCD6
6735,GO:0030159,0.0130447276669247,0.997180444005063,6,19,receptor signaling complex scaffold activity,MF,SHANK2;GRIP2;SHANK3;RGS14;HOMER2;DEDD2
742,GO:0001974,0.0130756231472571,0.996680915701199,7,25,blood vessel remodeling,BP,CST3;ACVR2B;EPAS1;CEACAM1;BCR;TGFB1;BAX
18088,GO:1902668,0.0130792510099291,0.997171293887771,6,19,negative regulation of axon guidance,BP,SEMA4B;SEMA3F;WNT3;SEMA4F;SEMA4C;SEMA3B
7467,GO:0031638,0.0131512264664172,0.996238319001182,8,31,zymogen activation,BP,PLAT;SERPINE2;F12;GGT1;PLAU;CTSZ;PRSS3;CYFIP2
7374,GO:0031434,0.0131748612178765,0.995556804126999,10,42,mitogen-activated protein kinase kinase binding,MF,EGFR;MST1R;EPHA1;FGFR4;FGFR1;EPHB2;TRIB2;ERBB2;INSR;FGFR3
6840,GO:0030315,0.013198150296664,0.996241911106269,8,30,T-tubule,CC,NOS1;DYSF;ANK3;CACNB3;AHNAK2;RTN2;PPP3CB;BIN1
3401,GO:0007186,0.0133008469362077,0.991150782624953,55,385,G-protein coupled receptor signaling pathway,BP,ADGRL1;APLN;APOE;DGKA;F2R;OBSCN;ITPR3;NOS1;LPAR3;LRP1;ADORA2B;AKT1;TMOD2;PTHLH;HEBP1;PRKACB;SIGMAR1;RAC2;EDNRA;PLEKHG2;NXPH4;DGKQ;GRK6;ENTPD2;GNAL;NTSR1;MC1R;HTR7;AGRN;GPR153;ADA;AREG;PLEKHG5;ADGRB2;NET1;USP20;EREG;PCSK1N;LTB4R2;RGS14;GIT1;PLCB3;ARHGEF4;INSR;ARHGEF1;ADCY1;GABBR1;ADGRF1;ADCY7;LTB4R;RGS19;GPR3;CELSR1;HOMER2;ADCY6
18577,GO:1903793,0.0133254908093224,0.997072049603671,6,20,positive regulation of anion transport,BP,APOE;NTSR1;PRKCD;ABCA7;MIF;PLA2G6
12805,GO:0051119,0.0133368233471255,0.997665031175994,5,14,sugar transmembrane transporter activity,MF,SLC2A9;SLC2A3;SLC2A11;SLC50A1;SLC23A2
9543,GO:0036303,0.0133740164960388,0.99765683313317,5,14,lymph vessel morphogenesis,BP,ACVR2B;VEGFA;PPP3CB;PROX1;PKD1
3758,GO:0008305,0.0134197991139446,0.99708072660401,6,19,integrin complex,CC,ITGA6;ITGB4;ITGB5;ITGA1;ITGA3;ITGA4
16793,GO:0098636,0.0134197991139446,0.99708072660401,6,19,protein complex involved in cell adhesion,CC,ITGA6;ITGB4;ITGB5;ITGA1;ITGA3;ITGA4
2658,GO:0006006,0.0135950304064308,0.992828843342675,24,140,glucose metabolic process,BP,NR1D1;H6PD;PGM1;LRP5;NISCH;PHLDA2;GAA;PC;AKT1;HK1;PFKL;IGFBP4;PFKP;DGKQ;MDH2;PCK2;PFKFB2;PDK1;ALDOC;PPARA;INSR;PFKM;MLYCD;WDTC1
5067,GO:0015291,0.0136155932977323,0.993051411143163,22,124,secondary active transmembrane transporter activity,MF,SLC16A3;SLC6A8;SLCO4A1;SLC2A9;SLC7A8;SLC12A7;SLC16A5;SLC6A6;SLC15A4;MFSD3;SLC20A1;SLC22A17;SLC13A5;SLC9A7;SLC22A18;SLC12A4;SLC13A3;SLC37A2;SLC16A13;TMCO3;SLC23A2;SLC26A11
9708,GO:0038128,0.0136444569075047,0.996070645005764,8,31,ERBB2 signaling pathway,BP,EGFR;SHC1;HBEGF;GRB7;PTK6;ERBB2;STUB1;EREG
10813,GO:0044309,0.0136930262277876,0.99340972458964,19,103,neuron spine,CC,ZMYND8;NR1D1;DLG4;FBXO2;NOS1;SHANK2;DVL1;TENM2;ABHD17C;NTSR1;SHANK3;FARP1;ARHGAP44;DNM1;RGS14;EEF2K;DNM2;APBA1;STRN4
7731,GO:0032233,0.013764059941798,0.995312226065599,10,43,positive regulation of actin filament bundle assembly,BP,RAPGEF3;SMAD3;SH3PXD2B;PPM1F;EPHA1;LIMK1;FHOD1;PAK1;PXN;PFN2
3246,GO:0006909,0.0137833302936911,0.992511183995034,26,155,phagocytosis,BP,PIK3R2;LRP1;PEAR1;ELMO3;RAC2;GAS6;GSN;BCR;WIPF1;PLCG1;TGFB1;ARHGAP25;TUB;CYFIP2;PRKCD;SH3BP1;LIMK1;ABCA7;PLA2G6;FYN;RAC3;ICAM5;ARHGAP12;DNM2;MAPK3;PAK1
11879,GO:0046906,0.0138308255819137,0.99445307510847,13,63,tetrapyrrole binding,MF,NR1D1;CYP27B1;NOS1;HEBP1;CBS;SLC48A1;CD320;CYGB;CYC1;CYP3A5;CAT;CYP2R1;BACH1
17696,GO:1901565,0.013837758739182,0.989413518273163,125,982,organonitrogen compound catabolic process,BP,NT5E;XDH;GID4;NR1D1;EDEM1;CST3;BTBD2;FBXO2;APOE;NAGLU;MTA1;ARRDC1;EGFR;SERPINE2;DNPH1;WWTR1;NOS1;TMEM129;CTSO;CAPN2;SDC1;VPS11;HEXB;ALDH4A1;SNX9;RAPGEF3;GLUL;RNPEPL1;CTBS;RBCK1;RNF44;SMURF2;SMAD3;LRP1;DVL1;AP2A2;PRODH;FBXW5;RNF187;AKT1;GGT1;LDLR;FUCA1;SORL1;CEACAM1;CSNK1E;CTSB;PCSK9;RAD23A;SH3D19;GGACT;BNIP3;SHARPIN;MVB12B;CEMIP;CTSZ;MAGEF1;ADAM8;LTA4H;CBS;CD81;ADAMTS13;TIMP2;TGFB1;ABHD17C;GPC1;ADAMTS7;GALNS;ABTB1;FBXO44;SNX33;ANKZF1;UBXN4;HMGCL;TPP1;AGRN;IDUA;TRIB2;PRKACA;ADA;AHCY;RNPEP;BNIP3L;PRKCD;USP20;STUB1;FBXW4;CUL9;NAGA;LPCAT1;LRSAM1;LONP2;CHEK2;CDC34;RNF123;RAB12;BCAP31;SMOX;WFS1;FYN;UPP1;CYP3A5;GLB1;NEIL1;APOBEC3C;APOBEC3F;GPT2;RNF144A;CTSF;USP21;CUL7;HYAL1;ALDH7A1;PKD1;KCTD13;SIRT2;NT5C1B;AZIN2;TOLLIP;PHYKPL;HFE;TST;CBLC;PM20D2;SDC2
7811,GO:0032371,0.013901557603568,0.996402206744303,7,26,regulation of sterol transport,BP,APOE;PLTP;LRP1;PCSK9;ABCA2;ABCG1;ABCA7
7814,GO:0032374,0.013901557603568,0.996402206744303,7,26,regulation of cholesterol transport,BP,APOE;PLTP;LRP1;PCSK9;ABCA2;ABCG1;ABCA7
10307,GO:0043094,0.0139135586708764,0.995959475337122,8,32,cellular metabolic compound salvage,BP,TK2;NAPRT;APRT;ADA;UCKL1;DGUOK;UPP1;PDXK
10016,GO:0042454,0.0140366871403012,0.997458985809527,5,15,ribonucleoside catabolic process,BP,ADA;AHCY;UPP1;APOBEC3C;APOBEC3F
6566,GO:0022037,0.0140478620275166,0.994362527426816,13,62,metencephalon development,BP,WNT7A;NAGLU;SERPINE2;PTPRS;TRNP1;MAP2K1;CNTN1;B4GALT2;RERE;PAK1;SEMA4C;PROX1;AARS
15216,GO:0071375,0.014111087316224,0.99157137582096,35,224,cellular response to peptide hormone stimulus,BP,SHC1;PTPRE;ZFP36L1;PIK3R2;AKT1;HDAC5;RAB31;PRKACB;CEACAM1;PCSK9;ERRFI1;APRT;TGFB1;PTPN1;PCK2;PRKCZ;PRKACA;VAMP2;JAK3;PRKCD;FYN;EEF2K;MAPK3;INSR;ADCY1;PAK1;WDTC1;ADCY7;SOCS7;NGFR;ATP6V1F;PXN;GRB10;SRSF5;ADCY6
4524,GO:0010591,0.0141615913188548,0.996346650778,7,25,regulation of lamellipodium assembly,BP,SSH1;RAC2;TWF2;PLXNB3;FSCN1;DNM2;SSH3
12885,GO:0051235,0.0141796301163906,0.991591174599803,34,220,maintenance of location,BP,APOE;F2R;ITPR3;NOS1;LTBP1;ARL2;HEXB;GAA;MDFI;AKT1;TPCN1;HK1;MXI1;SYNE3;SORL1;ANK3;TWF2;GSN;CEMIP;PKD2;AP3D1;PLCG1;TGFB1;NTSR1;ATP7B;RASA3;PRKACA;TRPC1;BAX;GSTO1;PPARA;ABCG1;SUN1;PKD1
6206,GO:0019722,0.014287831288254,0.993411634788659,17,91,calcium-mediated signaling,BP,ADGRL1;PRNP;EGFR;NOS1;NFATC4;MCTP1;PKD2;PLCG1;PRKACA;ADA;ADGRB2;TMBIM4;GSTO1;BCAP31;CAMKK2;PPP3CB;HOMER2
7259,GO:0031234,0.014289243601286,0.994015259029161,14,69,extrinsic component of cytoplasmic side of plasma membrane,CC,DLG4;SNX9;S100A6;MYZAP;KCNAB2;PTK6;ERRFI1;GNAL;FARP1;ESYT2;JAK3;FYN;SRMS;RGS19
17083,GO:0099601,0.0143729632313702,0.996280930272959,7,25,regulation of neurotransmitter receptor activity,BP,DLG4;SHANK2;NLGN2;EPHB2;SHANK3;MINK1;KLHL24
9982,GO:0042391,0.0144704397276812,0.991641109625897,31,194,regulation of membrane potential,BP,ZMYND8;FHL1;DLG4;WNT7A;SCN4B;SSH1;SHANK2;DVL1;NLGN2;AKT1;TPCN1;ANK3;SNTA1;BNIP3;CRTC1;GRIN3B;ASIC1;NTSR1;SHANK3;RIMS3;PRKCZ;BOK;BNIP3L;CACNB3;IFI6;BAX;SCN8A;EHD3;GLRX;BCL2L1;SLC26A11
9282,GO:0035725,0.0145811552849502,0.99365620584546,15,76,sodium ion transmembrane transport,BP,SCN4B;NOS1;STOM;STK39;ANK3;PCSK9;SLC20A1;SNTA1;PKD2;ASIC1;SCN8A;SLC9A7;DNM2;GLRX;KLHL24
12523,GO:0050673,0.014617003792647,0.990982941286021,39,257,epithelial cell proliferation,BP,XDH;HTRA1;NR1D1;APLN;PGF;VEGFA;WNT7A;APOE;EGFR;ZFP36L1;GLUL;MAP2K1;SMAD3;STAT6;AKT1;VEGFB;FGFR1;CEACAM1;IGFBP4;CCND1;ERRFI1;PLXNB3;CDKN1C;CEBPB;TGFB1;DEAF1;AREG;ERBB2;C6ORF89;BAX;EREG;TGFBR3;TGFA;ECM1;HYAL1;PROX1;LAMB1;NGFR;PDCD6
3880,GO:0008514,0.0146478912376722,0.992341974717403,23,132,organic anion transmembrane transporter activity,MF,SLC16A3;SLC6A8;SLCO4A1;SLC2A9;SLC7A8;SLC2A3;SLC16A5;SLC6A6;BSG;SLC15A4;CEACAM1;SERINC2;SLC43A1;SLC38A10;SLC22A17;SLC13A5;SLC25A29;SLC27A1;SLC13A3;SLC16A13;MFSD10;SLC23A2;SLC26A11
12105,GO:0048168,0.014782582481298,0.995679216050997,8,31,regulation of neuronal synaptic plasticity,BP,DLG4;APOE;MCTP1;SYNGAP1;EPHB2;SHANK3;NSMF;SYNGR1
2575,GO:0005865,0.0148731977378196,0.99801357376638,4,10,striated muscle thin filament,CC,TMOD2;TNNT1;FHOD3;TPM2
17240,GO:0110053,0.0149165783519024,0.991447381905585,30,187,regulation of actin filament organization,BP,RAPGEF3;ARAP1;SSH1;SMAD3;SH3PXD2B;TMOD2;CORO1B;PPM1F;EPHA1;RAC2;TWF2;GSN;PLEKHG2;WIPF1;ARPIN;SPTB;CDC42EP5;FHOD3;SHANK3;CAPG;PRKCD;SH3BP1;LIMK1;WASH3P;FHOD1;RAC3;PAK1;PXN;PFN2;SSH3
3073,GO:0006644,0.0149323571000143,0.990205001929147,50,343,phospholipid metabolic process,BP,DGKA;OSBPL5;LPCAT4;ISYNA1;EGFR;HEXB;PIK3R2;SRD5A3;PIGQ;HBEGF;MBOAT7;PITPNM1;ZFYVE21;FGFR4;LDLR;FGFR1;PIGV;TTC7B;PLCH2;PCSK9;DGKQ;SERINC2;PLCG1;CD81;MVD;SYNJ2;TGFB1;PIP5KL1;PI4K2A;OSBPL10;ACP6;ERBB2;PRKCD;SBF1;EREG;CPNE7;LPCAT1;INPP5D;PI4K2B;PLA2G6;FYN;PITPNM3;CHKA;SLC27A1;TAZ;SAMD8;ZP3;FGFR3;SPTLC2;PI4KAP2
3565,GO:0007612,0.0149905351534716,0.993455795966345,15,76,learning,BP,DLG4;FOS;SHANK2;RAG1;SYNGAP1;EPHB2;ASIC1;DEAF1;NTSR1;SHANK3;B4GALT2;RGS14;FYN;INSR;PPP3CB
13916,GO:0060589,0.0150497757890862,0.990468552141955,43,285,nucleoside-triphosphatase regulator activity,MF,DOCK4;EVI5L;APPL2;TBC1D14;ARL2;RIN1;ARAP1;ARHGAP23;PIK3R2;ASAP2;RALGDS;SYNGAP1;ARHGAP22;BCR;ERRFI1;ARHGAP27;AGAP1;CDC42EP5;GPSM1;TBC1D9B;ARHGAP25;RASA3;ARAP3;LLGL1;ADAP1;RASA4;ARHGAP44;SH3BP1;GDI1;RGS14;GIT1;SESN2;ARHGAP12;ACAP3;ARHGEF1;RALGAPA1;SGSM2;TBC1D16;RABGAP1;TRIP10;RAP1GAP2;RGS19;TBC1D8
14839,GO:0070588,0.0150676563475512,0.991746197107831,26,156,calcium ion transmembrane transport,BP,PRNP;F2R;ITPR3;NOS1;ORAI3;ORAI1;GJC2;TPCN1;GAS6;CEMIP;PKD2;GRIN3B;ASIC1;PLCG1;TGFB1;NTSR1;RASA3;PRKACA;TRPC1;CACNB3;BAX;GSTO1;EHD3;PLA2G6;FYN;PKD1
8508,GO:0033700,0.0150709029805081,0.998817488353419,3,6,phospholipid efflux,BP,APOE;ABCG1;ABCA7
7024,GO:0030804,0.0151002335919724,0.997214251152933,5,15,positive regulation of cyclic nucleotide biosynthetic process,BP,APOE;NOS1;ADORA2B;PTHLH;TIMP2
6327,GO:0020037,0.0151067631687041,0.994133734018166,12,57,heme binding,MF,NR1D1;CYP27B1;NOS1;HEBP1;CBS;SLC48A1;CYGB;CYC1;CYP3A5;CAT;CYP2R1;BACH1
14120,GO:0060997,0.0151136837594409,0.995144375774583,9,37,dendritic spine morphogenesis,BP,DLG4;WNT7A;SHANK2;DVL1;EPHB2;SHANK3;ARHGAP44;EEF2K;CAPRIN2
9827,GO:0042058,0.0151502074912176,0.993598925991829,14,70,regulation of epidermal growth factor receptor signaling pathway,BP,EGFR;SPRY2;SHC1;ARAP1;AKT1;RHBDF2;CEACAM1;PTK6;ERRFI1;MVB12B;ITGA1;EREG;TGFA;CBLC
12740,GO:0051017,0.0151880073901731,0.992447613998851,20,111,actin filament bundle assembly,BP,ESPN;RAPGEF3;ARAP1;SMAD3;SH3PXD2B;CORO1B;PPM1F;EPHA1;ITGB5;SHANK3;RHOD;RHOF;RHOBTB2;FSCN1;LIMK1;FHOD1;PAK1;KCTD13;PXN;PFN2
897,GO:0002275,0.0152453495523339,0.989808853750396,54,387,myeloid cell activation involved in immune response,BP,CST3;PYGB;PGM1;PYGL;VAT1;HEXB;SLC2A3;GAA;NAPRT;AP2A2;STOM;ADORA2B;SLC15A4;RAB31;FUCA1;RAC2;KCNAB2;PFKL;CEACAM1;PLAU;BRI3;CTSB;GSN;BCR;CTSZ;PRSS3;ADAM8;APRT;LTA4H;TIMP2;DPP7;TMEM173;GALNS;PI4K2A;RHOF;YPEL5;ACTR1B;VAMP2;PRKCD;ALDOC;LPCAT1;MIF;SYNGR1;QSOX1;CD68;GLB1;CAT;PDXK;RNASET2;MAN2B1;DNASE1L1;SERPINB1;TOLLIP;NBEAL2
11097,GO:0045121,0.0152537884555818,0.990988953646923,33,208,membrane raft,CC,MARVELD1;PRNP;F2R;EGFR;NOS1;CAPN2;SMURF2;STAT6;STOM;LY6K;PAG1;BSG;HK1;CNTN1;CARD11;SYNJ2;GPC1;NTSR1;PI4K2A;LRP4;PRKCZ;PRKACA;ITGA1;INPP5D;MYO1D;FYN;MAPK3;INSR;ADCY1;MALL;LTB4R;RGS19;CBLC
16654,GO:0097531,0.0152819417266335,0.997941890916328,4,10,mast cell migration,BP,PGF;VEGFA;VEGFB;RAC2
3423,GO:0007215,0.0152980040087561,0.995074899338844,9,37,glutamate receptor signaling pathway,BP,DLG4;SHANK2;NLGN2;EPHB2;GRIN3B;SHANK3;MINK1;HOMER2;KLHL24
4069,GO:0009124,0.0153097090916232,0.991949162929909,23,136,nucleoside monophosphate biosynthetic process,BP,PGM1;TK2;HK1;PFKL;LHPP;PFKP;DHTKD1;APRT;TGFB1;PFKFB2;MLXIPL;ADA;UCKL1;CYC1;DGUOK;DDIT4;ALDOC;PPARA;UPP1;INSR;TAZ;PFKM;PFKFB3
4646,GO:0010770,0.0154205018096118,0.992315685194361,20,112,positive regulation of cell morphogenesis involved in differentiation,BP,VEGFA;OBSL1;LPAR3;MAP2K1;TWF2;PLXNB3;FBXW8;WNT3;NET1;LIMK1;GDI1;STK25;RAC3;EEF2K;DNM2;PAK1;CUL7;CAPRIN2;CDH4;NGFR
4851,GO:0014065,0.0154537859969483,0.993013557757512,16,83,phosphatidylinositol 3-kinase signaling,BP,F2R;EGFR;SERPINE2;ZFP36L1;PIK3R2;AKT1;FGFR1;CEACAM1;RGL2;NYAP1;ERBB2;FYN;CAT;MAPK3;PPP2R5B;SIRT2
15244,GO:0071417,0.0154754055231071,0.989654454667171,54,376,cellular response to organonitrogen compound,BP,EGR1;PRNP;EGFR;CAPN2;SHC1;PTPRE;RAPGEF3;ZFP36L1;SSH1;PIK3R2;LRP1;AKT1;HDAC5;UROS;IMPACT;RAB31;PRKACB;CEACAM1;MAPK13;PCSK9;ERRFI1;PKD2;APRT;CEBPB;TGFB1;NSMF;PTPN1;PCK2;PRKCZ;PRKACA;VAMP2;JAK3;PRKCD;SESN2;FYN;EEF2K;DNM2;MAPK3;INSR;ADCY1;PAK1;WDTC1;DNMT3A;BCL2L1;SIRT2;ADCY7;SOCS7;NGFR;ATP6V1F;PXN;GRB10;COL6A1;SRSF5;ADCY6
20233,GO:2001138,0.0156349814925253,0.9987557010724,3,6,regulation of phospholipid transport,BP,APOE;PRKCD;ABCA7
20234,GO:2001140,0.0156349814925253,0.9987557010724,3,6,positive regulation of phospholipid transport,BP,APOE;PRKCD;ABCA7
12058,GO:0048017,0.0156421484527684,0.992359372620808,19,104,inositol lipid-mediated signaling,BP,F2R;EGFR;SERPINE2;ZFP36L1;PIK3R2;AKT1;FGFR1;CEACAM1;GSN;RGL2;NYAP1;ERBB2;FYN;CAT;MAPK3;PPP2R5B;SIRT2;ZP3;PI4KAP2
8815,GO:0034599,0.0156559846860437,0.990720273266571,33,215,cellular response to oxidative stress,BP,CST3;EGFR;ETV5;ENDOG;FOS;STAT6;EPAS1;PRDX5;PRODH;AKT1;PYCR2;IMPACT;MAPK13;CCS;BNIP3;PKD2;GPX3;ANKZF1;TRAP1;KDM6B;NET1;PDK1;PRKCD;TMEM161A;SESN2;STK25;DNM2;CAT;MAPK3;CAMKK2;SIRT2;PXN;GCH1
7022,GO:0030802,0.0156907399678694,0.995837860857071,7,26,regulation of cyclic nucleotide biosynthetic process,BP,APOE;NOS1;ADORA2B;PTHLH;TIMP2;LTB4R2;GABBR1
536,GO:0001655,0.0157006739522049,0.990624018986321,34,216,urogenital system development,BP,EGR1;PGF;CTNNBIP1;ACVR2B;VEGFA;ITGA6;WWTR1;SDC1;ACTA2;SMAD3;ITGB4;IFT140;WNT2B;FGFR1;LZTS2;LAMA5;PCSK9;ALOX15B;PKD2;EPHB2;TGFB1;KIF26B;LAMB2;LRP4;BAX;NID1;WFS1;ARID5B;CAT;VANGL2;ITGA3;PROX1;PKD1;PLAG1
3239,GO:0006898,0.0157878490427028,0.991202422010358,27,165,receptor-mediated endocytosis,BP,DLG4;APLN;VEGFA;APOE;LRP3;SNX9;LRP1;AP2A2;RAB31;LDLR;SORL1;CEACAM1;PCSK9;ARHGAP27;CD81;CLTCL1;ARAP3;SCART1;SNX17;LRP10;CD9;FCHO1;DNM1;DNM2;LGALS3BP;ITGA4;HFE
8208,GO:0032970,0.0158869058013926,0.990076382833361,40,266,regulation of actin filament-based process,BP,RAPGEF3;ARAP1;SSH1;SMAD3;LRP1;SH3PXD2B;TMOD2;CORO1B;PPM1F;EPHA1;RAC2;TWF2;GSN;PLEKHG2;WIPF1;ARPIN;SPTB;CDC42EP5;TGFB1;FHOD3;SHANK3;RHOD;RHOF;RHOBTB2;CAPG;FSCN1;ARHGAP44;PRKCD;SH3BP1;LIMK1;WASH3P;FHOD1;RAC3;VANGL2;PAK1;PROX1;PXN;CELSR1;PFN2;SSH3
2194,GO:0005057,0.0160997420583114,0.991790237612949,21,118,signal transducer activity, downstream of receptor,MF,ACVR2B;EGFR;MST1R;MAP2K1;SMAD3;EPHA1;FGFR4;FGFR1;MAPK13;EPHB2;PLCG1;MINK1;ERBB2;RGS14;MAPK12;IRAK1;STK25;MAPK3;INSR;MAP3K10;FGFR3
6588,GO:0022610,0.0161265751918742,0.987875756057213,105,803,biological adhesion,BP,TNIP1;NT5E;SDK2;ADGRL1;PRNP;PARVB;POSTN;VEGFA;ITGA6;EGFR;SERPINE2;PTPRS;SHC1;ARL2;ZFP36L1;FBLN1;SMAD3;THBS3;ITGB4;NLGN2;PAG1;AKT1;PPM1F;EPHA1;PTPRU;CNTN1;RAC2;SMOC2;NPHP4;RAG1;CEACAM1;TENM2;ANK3;EFS;PLAU;GAS6;CARD11;LAMA5;GSN;IGFBP2;COL13A1;PLXNB3;IL20RB;AP3D1;ITGB5;ADAM8;CADM4;CD81;CEBPB;ADAMTS13;TGFB1;PODXL2;EFNB3;KIF26B;CLCA2;RHOD;CGREF1;LAMB2;PRKCZ;MINK1;CD9;ADA;MICALL2;ERBB2;CERCAM;JAK3;NET1;CYFIP2;PRKCD;ITGA1;NID1;TMEM8B;MSLN;ADAM15;SYMPK;PPARA;BCAM;FYN;RAC3;ICAM5;DNM2;PELI1;IGFBP7;TPBG;PDZD2;HLA-G;TSTA3;PAK1;LGALS3BP;HYAL1;ITGA3;PKD1;CDH4;ITGA4;EDA;LAMB1;ARVCF;PXN;HFE;COL6A1;ZP3;CELSR1;BLOC1S4;ITPKB;APBA1
4107,GO:0009164,0.0161579566449008,0.996253210725978,6,21,nucleoside catabolic process,BP,NT5E;ADA;AHCY;UPP1;APOBEC3C;APOBEC3F
15646,GO:0072163,0.0161842312625068,0.993370033007297,13,63,mesonephric epithelium development,BP,PGF;CTNNBIP1;VEGFA;SDC1;SMAD3;WNT2B;FGFR1;LAMA5;PKD2;TGFB1;KIF26B;CAT;PKD1
15647,GO:0072164,0.0161842312625068,0.993370033007297,13,63,mesonephric tubule development,BP,PGF;CTNNBIP1;VEGFA;SDC1;SMAD3;WNT2B;FGFR1;LAMA5;PKD2;TGFB1;KIF26B;CAT;PKD1
10498,GO:0043407,0.0162187851231936,0.993344666883809,13,64,negative regulation of MAP kinase activity,BP,DUSP6;DUSP5;PDCD4;APOE;SPRY2;SPRY4;SORL1;DUSP7;PTPN1;PRKCD;DUSP4;RGS14;CBLC
6666,GO:0030032,0.0162636773273846,0.993944245349827,11,50,lamellipodium assembly,BP,PARVB;SSH1;RAC2;TWF2;PLXNB3;RHOD;WASF3;FSCN1;DNM2;ARHGEF4;SSH3
10448,GO:0043312,0.0162989565843424,0.989239187478109,50,356,neutrophil degranulation,BP,CST3;PYGB;PGM1;PYGL;VAT1;HEXB;SLC2A3;GAA;NAPRT;AP2A2;STOM;SLC15A4;RAB31;FUCA1;KCNAB2;PFKL;CEACAM1;PLAU;BRI3;CTSB;GSN;BCR;CTSZ;PRSS3;ADAM8;APRT;LTA4H;TIMP2;DPP7;TMEM173;GALNS;RHOF;YPEL5;ACTR1B;PRKCD;ALDOC;LPCAT1;MIF;SYNGR1;QSOX1;CD68;GLB1;CAT;PDXK;RNASET2;MAN2B1;DNASE1L1;SERPINB1;TOLLIP;NBEAL2
4067,GO:0009120,0.0163174932015533,0.998679734546059,3,6,deoxyribonucleoside metabolic process,BP,TK2;ADA;DGUOK
16902,GO:0098857,0.0163176462048977,0.990308109937528,33,209,membrane microdomain,CC,MARVELD1;PRNP;F2R;EGFR;NOS1;CAPN2;SMURF2;STAT6;STOM;LY6K;PAG1;BSG;HK1;CNTN1;CARD11;SYNJ2;GPC1;NTSR1;PI4K2A;LRP4;PRKCZ;PRKACA;ITGA1;INPP5D;MYO1D;FYN;MAPK3;INSR;ADCY1;MALL;LTB4R;RGS19;CBLC
14181,GO:0061097,0.0163304753398339,0.993587687867216,12,57,regulation of protein tyrosine kinase activity,BP,DLG4;PRNP;SHC1;ERCC6;GAS6;PTK6;ERRFI1;PTPN1;EREG;TGFA;DLG3;CBLC
10416,GO:0043266,0.0163371374542997,0.994265619074035,10,44,regulation of potassium ion transport,BP,FHL1;KCNG1;PRNP;NOS1;STK39;KCNAB2;ANK3;VAMP2;DNM2;KLHL24
8707,GO:0034362,0.0163586984358747,0.998675106533601,3,6,low-density lipoprotein particle,CC,APOE;LDLR;SORL1
3771,GO:0008328,0.0163838832706911,0.996227006040867,6,20,ionotropic glutamate receptor complex,CC,DLG4;SHANK2;GRIN3B;SHANK3;OLFM2;DLG3
16912,GO:0098878,0.0163838832706911,0.996227006040867,6,20,neurotransmitter receptor complex,CC,DLG4;SHANK2;GRIN3B;SHANK3;OLFM2;DLG3
4053,GO:0009100,0.0164716878744703,0.989384393254633,45,306,glycoprotein metabolic process,BP,TNIP1;EDEM1;CST3;FBXO2;LMF1;HEXB;ST6GALNAC2;SRD5A3;HBEGF;VEGFB;B4GAT1;B3GAT3;PHLDA1;MVD;ADAMTS13;GPC1;ADAMTS7;B3GNT3;MGAT4B;ST6GALNAC6;B4GALT2;B4GALT6;IDUA;RFNG;MPI;NECAB3;JAK3;MCFD2;XYLT2;MFNG;ST3GAL3;COG7;ABCA7;NUDT14;VANGL2;HYAL1;MAN2B1;NDST2;GAL3ST4;ALG12;ST3GAL2;CHST14;ST3GAL5;MAN2B2;CHPF
8593,GO:0034111,0.0165835813578289,0.997709518223585,4,10,negative regulation of homotypic cell-cell adhesion,BP,SERPINE2;CEACAM1;CD9;PRKCD
1285,GO:0003091,0.0166814814002355,0.99614259548318,6,20,renal water homeostasis,BP,PRKACB;PRKACA;WFS1;ADCY1;ADCY7;ADCY6
4596,GO:0010713,0.0166887115793358,0.998637871389008,3,6,negative regulation of collagen metabolic process,BP,CST3;ERRFI1;CYGB
14351,GO:0061572,0.0166921796295665,0.991613109534748,20,112,actin filament bundle organization,BP,ESPN;RAPGEF3;ARAP1;SMAD3;SH3PXD2B;CORO1B;PPM1F;EPHA1;ITGB5;SHANK3;RHOD;RHOF;RHOBTB2;FSCN1;LIMK1;FHOD1;PAK1;KCTD13;PXN;PFN2
10488,GO:0043395,0.0166958384484916,0.997689192039325,4,10,heparan sulfate proteoglycan binding,MF,PTPRS;LRP1;GPC1;AGRN
20046,GO:2000649,0.0167015963668581,0.994982213427963,8,32,regulation of sodium ion transmembrane transporter activity,BP,SCN4B;STOM;STK39;ANK3;PCSK9;DNM2;GLRX;KLHL24
15551,GO:0072001,0.0167356455436622,0.99021926799153,31,194,renal system development,BP,EGR1;PGF;CTNNBIP1;ACVR2B;VEGFA;ITGA6;WWTR1;SDC1;ACTA2;SMAD3;ITGB4;IFT140;WNT2B;FGFR1;LZTS2;LAMA5;PCSK9;PKD2;TGFB1;KIF26B;LAMB2;LRP4;BAX;NID1;WFS1;ARID5B;CAT;VANGL2;ITGA3;PROX1;PKD1
6689,GO:0030072,0.0167368742441179,0.990986379592707,24,144,peptide hormone secretion,BP,NR1D1;APLN;ACVR2B;LRP5;ITPR3;EGFR;HADH;LTBP4;ARL2;RAPGEF3;GLUL;NLGN2;PFKL;VGF;PCK2;PFKFB2;RASL10B;PLA2G6;PFKM;PPP3CB;ICA1;PCLO;SIRT3;HFE
7665,GO:0032101,0.0167388740434773,0.988473124444446,61,440,regulation of response to external stimulus,BP,TNIP1;NT5E;SEMA4B;HTRA1;PLAT;CYP27B1;PGF;PDCD4;BBS2;VEGFA;APOE;F2R;EGFR;SERPINE2;PTPRS;MAP2K1;ACP5;SMAD3;DVL1;ADORA2B;CORO1B;F12;PPM1F;MMP28;STK39;SERPING1;GGT1;VEGFB;FNDC4;LDLR;FGFR1;MAPKBP1;RAC2;CEACAM1;MAPK13;PLAU;GAS6;SEMA3F;BCR;SHARPIN;FAM3A;IL20RB;ADAM8;CD81;WNT3;TGFB1;TMEM173;SEMA4F;CD9;ADA;PRKCD;LRSAM1;PPARA;MIF;DDT;APOBEC3F;MAPK3;SEMA4C;SIRT2;ZP3;SEMA3B
9985,GO:0042398,0.0167999758478753,0.994925083953634,8,33,cellular modified amino acid biosynthetic process,BP,GGT1;OPLAH;GAMT;HAGH;CNDP2;SLC27A1;ALDH7A1;GCH1
11461,GO:0045926,0.0168076973614223,0.990577571883619,27,167,negative regulation of growth,BP,SEMA4B;FHL1;CYP27B1;BBS2;SERPINE2;PTPRS;SMAD3;WWC3;PTK6;SEMA3F;ALOX15B;WNT3;TGFB1;ULK2;SEMA4F;MT2A;ADAM15;SESN2;TSPYL2;PAK1;HYAL1;SEMA4C;CAPRIN2;DCBLD2;BTG1;SEMA3B;FGFR3
19856,GO:2000311,0.0168614889987012,0.997659116700111,4,10,regulation of AMPA receptor activity,BP,SHANK2;NLGN2;SHANK3;MINK1
2530,GO:0005788,0.0168840818730705,0.99021838435626,30,188,endoplasmic reticulum lumen,CC,H6PD;CST3;WNT7A;APOE;CRTAP;LTBP1;IGFBP4;GAS6;PCSK9;ANO8;COL13A1;CTSZ;ADAMTS13;WNT3;ADAMTS7;LAMB2;VGF;CERCAM;FAM20C;CES2;PDIA5;MSLN;WFS1;QSOX1;VWA1;IGFBP7;RNASET2;LAMB1;COL6A1;SDC2
3248,GO:0006911,0.0170631863599928,0.995395271209791,7,26,phagocytosis, engulfment,BP,RAC2;GSN;ARHGAP25;SH3BP1;ABCA7;RAC3;ARHGAP12
6752,GO:0030183,0.0170909263452537,0.992401098942879,15,78,B cell differentiation,BP,ZFP36L1;CMTM7;POU2F2;HDAC5;LRRC8A;RAG1;CARD11;POLM;IFNE;ADA;JAK3;BAX;MFNG;INPP5D;ITGA4
903,GO:0002283,0.0171563738888668,0.98863637037262,50,357,neutrophil activation involved in immune response,BP,CST3;PYGB;PGM1;PYGL;VAT1;HEXB;SLC2A3;GAA;NAPRT;AP2A2;STOM;SLC15A4;RAB31;FUCA1;KCNAB2;PFKL;CEACAM1;PLAU;BRI3;CTSB;GSN;BCR;CTSZ;PRSS3;ADAM8;APRT;LTA4H;TIMP2;DPP7;TMEM173;GALNS;RHOF;YPEL5;ACTR1B;PRKCD;ALDOC;LPCAT1;MIF;SYNGR1;QSOX1;CD68;GLB1;CAT;PDXK;RNASET2;MAN2B1;DNASE1L1;SERPINB1;TOLLIP;NBEAL2
13268,GO:0051966,0.017187320213362,0.995354844510235,7,26,regulation of synaptic transmission, glutamatergic,BP,EGFR;SERPINE2;GLUL;SHANK2;NLGN2;SHANK3;PLA2G6
7489,GO:0031667,0.017282866715723,0.988767266560875,46,316,response to nutrient levels,BP,ERCC1;CST3;CYP27B1;BBS2;POSTN;APOE;EGFR;GLUL;SSH1;AKT1;IMPACT;DAP;WNT2B;LDLR;CCND1;GAS6;GSN;IGFBP2;PCSK9;HLCS;DGKQ;TGFB1;ULK2;VGF;HMGCL;PCK2;WDR59;MBD3;ADA;ULK1;AHCY;PCSK1N;MTHFR;PPARA;SESN2;FYN;UPP1;CAT;MAPK3;C12ORF66;DNMT3A;PROX1;SIRT2;HFE;GAS2L1;LRP11
16526,GO:0097242,0.0173028714409592,0.996692446985152,5,15,amyloid-beta clearance,BP,APOE;LRP1;LDLR;ABCA7;INSR
3230,GO:0006887,0.0173169161612383,0.987460178845109,80,605,exocytosis,BP,CST3;PYGB;VEGFA;PGM1;PYGL;VAT1;SYTL1;SDC1;VPS11;HEXB;SLC2A3;GAA;NAPRT;EXOC2;AP2A2;STOM;ADORA2B;SYT8;SERPING1;VEGFB;SLC15A4;RAB31;FUCA1;RAC2;KCNAB2;PFKL;CEACAM1;PLAU;GAS6;BRI3;CTSB;RAB3B;GSN;BCR;CTSZ;PRSS3;ADAM8;APRT;LTA4H;TIMP2;DPP7;TGFB1;SNPH;TMEM173;GALNS;PI4K2A;RHOF;LLGL1;RIMS3;YPEL5;ACTR1B;CD9;VAMP2;ARHGAP44;PRKCD;ALDOC;LPCAT1;MIF;PLA2G6;SYNGR1;ECM1;QSOX1;CD68;GLB1;CAT;PDXK;PAK1;RNASET2;PPP3CB;LGALS3BP;MICAL1;MAN2B1;DNASE1L1;SERPINB1;RAB40B;TOLLIP;PCLO;NBEAL2;ZP3;PFN2
12059,GO:0048018,0.0173466155815159,0.990349679633704,26,166,receptor ligand activity,MF,SEMA4B;APLN;PGF;VEGFA;WNT7A;CMTM7;HBEGF;VEGFB;PTHLH;GAS6;SEMA3F;CMTM4;WNT3;TGFB1;TNFSF15;VGF;SEMA4F;IFNE;CD320;AREG;EREG;TGFA;MIF;SEMA4C;ZP3;SEMA3B
18254,GO:1903054,0.0174857441125969,0.998546715968587,3,6,negative regulation of extracellular matrix organization,BP,CST3;TGFB1;CHADL
6784,GO:0030228,0.0175111822257095,0.997540233578646,4,10,lipoprotein particle receptor activity,MF,LRP1;LDLR;SORL1;LRP10
16389,GO:0097006,0.0175360856450594,0.993368868518556,11,52,regulation of plasma lipoprotein particle levels,BP,APOE;LMF1;PLTP;AP2A2;LDLR;PRKACB;PCSK9;PRKACA;ZDHHC8;ABCG1;ABCA7
6836,GO:0030308,0.0175459770111167,0.990956930410948,21,122,negative regulation of cell growth,BP,SEMA4B;FHL1;CYP27B1;SERPINE2;PTPRS;SMAD3;SEMA3F;WNT3;TGFB1;ULK2;SEMA4F;ADAM15;SESN2;TSPYL2;PAK1;HYAL1;SEMA4C;CAPRIN2;DCBLD2;BTG1;SEMA3B
988,GO:0002444,0.01756420481762,0.988157866023372,54,390,myeloid leukocyte mediated immunity,BP,CST3;PYGB;PGM1;PYGL;VAT1;HEXB;SLC2A3;GAA;NAPRT;AP2A2;STOM;ADORA2B;SLC15A4;RAB31;FUCA1;RAC2;KCNAB2;PFKL;CEACAM1;PLAU;BRI3;CTSB;GSN;BCR;CTSZ;PRSS3;ADAM8;APRT;LTA4H;TIMP2;DPP7;TMEM173;GALNS;PI4K2A;RHOF;YPEL5;ACTR1B;VAMP2;PRKCD;ALDOC;LPCAT1;MIF;SYNGR1;QSOX1;CD68;GLB1;CAT;PDXK;RNASET2;MAN2B1;DNASE1L1;SERPINB1;TOLLIP;NBEAL2
11403,GO:0045821,0.0176141264848357,0.997521262523576,4,10,positive regulation of glycolytic process,BP,PFKFB2;MLXIPL;INSR;PFKFB3
12865,GO:0051197,0.0176141264848357,0.997521262523576,4,10,positive regulation of coenzyme metabolic process,BP,PFKFB2;MLXIPL;INSR;PFKFB3
1930,GO:0004629,0.0177941205031343,0.996573453491635,5,15,phospholipase C activity,MF,PLCD3;PLCH2;EDNRA;PLCG1;PLCB3
598,GO:0001766,0.0178626189643927,0.998503018252336,3,6,membrane raft polarization,BP,MARVELD1;GSN;MALL
7439,GO:0031580,0.0178626189643927,0.998503018252336,3,6,membrane raft distribution,BP,MARVELD1;GSN;MALL
18374,GO:1903358,0.017875334347797,0.996553692549652,5,15,regulation of Golgi organization,BP,MAP2K2;MAP2K1;EHD3;DNM2;MAPK3
11410,GO:0045834,0.0178781014836784,0.992006230499746,15,78,positive regulation of lipid metabolic process,BP,NR1D1;APOE;AKT1;LDLR;CD81;TGFB1;MLXIPL;PRKCD;PPARA;ABCG1;PLA2G6;TAZ;MLYCD;ZP3;FGFR3
6931,GO:0030545,0.0178886249229165,0.989781446321478,28,182,receptor regulator activity,MF,SEMA4B;APLN;PGF;VEGFA;WNT7A;CMTM7;HBEGF;VEGFB;PTHLH;GAS6;SEMA3F;CMTM4;PCSK9;DGKQ;WNT3;TGFB1;TNFSF15;VGF;SEMA4F;IFNE;CD320;AREG;EREG;TGFA;MIF;SEMA4C;ZP3;SEMA3B
7021,GO:0030801,0.0179689026240352,0.995730661649694,6,21,positive regulation of cyclic nucleotide metabolic process,BP,APOE;NOS1;RAPGEF3;ADORA2B;PTHLH;TIMP2
10845,GO:0044351,0.0179892970984508,0.99848824552192,3,6,macropinocytosis,BP,MAPKAPK3;SNX33;DNM2
14304,GO:0061448,0.0179945011256761,0.990249848007344,24,142,connective tissue development,BP,MEF2D;EGR1;BBS2;WNT7A;LRP5;HMGA2;ACTA2;SMAD3;THBS3;SH3PXD2B;PTHLH;WNT2B;FGFR1;EVC;TGFB1;ADAMTS7;ZNF516;FBXW4;CHADL;ARID5B;MAPK3;HYAL1;PKD1;FGFR3
4361,GO:0009967,0.0180774396619177,0.985910185493213,134,1066,positive regulation of signal transduction,BP,DUSP6;XDH;DUSP5;DLG4;CYP27B1;PDCD4;ACVR2B;VEGFA;WNT7A;F2R;PKN1;EGFR;NOS1;SPRY2;MST1R;NFATC4;SHC1;ARAP1;MAP2K2;LPAR3;RBCK1;MAP2K1;SSH1;SMURF2;SMAD3;SHANK2;PIK3R2;ERCC6;DVL1;HBEGF;FAM110C;S100A4;SHC2;NLGN2;PAG1;ADORA2B;AKT1;GRB7;TMOD2;SH2D2A;STK39;EPHA1;FGFR4;WNT2B;FGFR1;ZNF385A;IGFBP4;EVC;GAS6;PTK6;FGFBP1;CSNK1E;CARD11;SH2B3;DUSP7;GSN;MAPKAPK3;RGL2;ALOX15B;SLC20A1;BNIP3;SHARPIN;PKD2;RASGEF1A;EPHB2;ADAM8;CDKN1C;PLCG1;SH3BP2;CD81;TIMP2;WNT3;TMED4;TGFB1;MOAP1;NTSR1;SHANK3;TNFSF15;MC1R;KIF7;PTPN1;WDR59;RFNG;PRKCZ;MINK1;EPN2;ADA;PIM2;PLEKHG5;BOK;ERBB2;TFDP2;CYFIP2;PRKCD;MIB2;BAX;ITGA1;EREG;TGFBR3;MFNG;GSTO1;IRAK1;TGFA;ABCA7;BCAP31;MIF;PLA2G6;DDT;ECM1;FYN;STK25;PELI1;CAT;MAPK3;INSR;TMEM101;VANGL2;PAK1;SEMA4C;CAPRIN2;PPP2R5B;MAP2K3;BCL2L1;TNFRSF25;EDA;MAP3K10;NGFR;GRB10;LURAP1;HFE;FGFR3;ITPKB;DEDD2;LRRK1
12179,GO:0048333,0.0181091295827591,0.996496666181618,5,15,mesodermal cell differentiation,BP,HMGA2;ITGB4;FGFR1;KDM6B;ITGA3
9856,GO:0042113,0.0181282589226048,0.990163493268217,24,144,B cell activation,BP,ERCC1;PKN1;ZFP36L1;CMTM7;POU2F2;STAT6;HDAC5;LRRC8A;RAG1;CARD11;CD81;TGFB1;POLM;IFNE;CD320;ADA;JAK3;PRKCD;BAX;MFNG;INPP5D;MIF;PELI1;ITGA4
6858,GO:0030335,0.0182237841065306,0.988114865428642,46,316,positive regulation of cell migration,BP,SEMA4B;PGF;DOCK4;POSTN;VEGFA;WNT7A;F2R;ITGA6;EGFR;SPRY2;SSH1;SMURF2;SMAD3;HBEGF;FAM110C;AKT1;GRB7;PPM1F;EPHA1;VEGFB;FGFR1;RAC2;PLAU;GAS6;SEMA3F;CEMIP;ADAM8;PLCG1;TGFB1;NSMF;RHOD;SEMA4F;HDAC7;MAPK3;INSR;PAK1;HYAL1;SEMA4C;ITGA3;MAP2K3;PROX1;ITGA4;LAMB1;PDCD6;ZP3;SEMA3B
633,GO:0001823,0.0182888859080176,0.992371010891607,13,64,mesonephros development,BP,PGF;CTNNBIP1;VEGFA;SDC1;SMAD3;WNT2B;FGFR1;LAMA5;PKD2;TGFB1;KIF26B;CAT;PKD1
6887,GO:0030425,0.0183153225402681,0.987727199887917,52,363,dendrite,CC,ZMYND8;NR1D1;DLG4;FBXO2;PRR7;PRNP;APOE;NOS1;CAPN2;SHANK2;LRP1;DVL1;KCNC4;TENM2;ZNF385A;ANK3;SYNGAP1;BNIP3;SHARPIN;CRTC1;EPHB2;KIF17;ABHD17C;NTSR1;SHANK3;NSMF;FARP1;HTR7;PI4K2A;CAMK2N1;LRP4;MINK1;ADA;ARHGAP44;SV2A;DNM1;RGS14;MYO1D;WFS1;FYN;EEF2K;DNM2;ATXN10;INSR;PAK1;GABBR1;DLG3;AZIN2;KIF13B;HOMER2;APBA1;STRN4
16608,GO:0097447,0.0183153225402681,0.987727199887917,52,363,dendritic tree,CC,ZMYND8;NR1D1;DLG4;FBXO2;PRR7;PRNP;APOE;NOS1;CAPN2;SHANK2;LRP1;DVL1;KCNC4;TENM2;ZNF385A;ANK3;SYNGAP1;BNIP3;SHARPIN;CRTC1;EPHB2;KIF17;ABHD17C;NTSR1;SHANK3;NSMF;FARP1;HTR7;PI4K2A;CAMK2N1;LRP4;MINK1;ADA;ARHGAP44;SV2A;DNM1;RGS14;MYO1D;WFS1;FYN;EEF2K;DNM2;ATXN10;INSR;PAK1;GABBR1;DLG3;AZIN2;KIF13B;HOMER2;APBA1;STRN4
14648,GO:0070244,0.0183355281651189,0.998447653674588,3,6,negative regulation of thymocyte apoptotic process,BP,RAG1;ADA;JAK3
11688,GO:0046487,0.0183950925578546,0.998440638715402,3,6,glyoxylate metabolic process,BP,IDH2;ALDH4A1;GRHPR
7046,GO:0030828,0.0184007972006281,0.998439966387709,3,6,positive regulation of cGMP biosynthetic process,BP,APOE;NOS1;ADORA2B
6620,GO:0022857,0.0184034451087661,0.986838509988887,73,541,transmembrane transporter activity,MF,SLC16A3;DLG4;KCNG1;SLC6A8;SLCO4A1;ITPR3;SCN4B;SLC2A9;ORAI3;ORAI1;SLC7A8;SLC12A7;SLC2A3;SLC16A5;KCNJ15;GJC2;SLC6A6;TPCN1;KCNC4;TTYH3;S100A6;BSG;SLC15A4;LRRC8A;MFSD3;KCNAB2;CEACAM1;ABCD1;GAS6;ANO8;SLC20A1;SERINC2;PKD2;ABCA2;GRIN3B;ASIC1;SLC29A4;SLC43A1;SLC38A10;ATP7B;RASA3;CLCA2;SLC48A1;TRPC1;SLC22A17;CACNB3;BAX;SV2A;SLC13A5;TIMM17B;SLC2A11;SCN8A;ABCG1;ABCA7;SLC25A29;SLC9A7;SLC22A18;SLC27A1;SLC50A1;SLC12A4;SLC13A3;SLC37A2;SLC16A13;DLG3;PKD1;AZIN2;SLC25A37;ATP6V1F;SLC39A3;TMCO3;MFSD10;SLC23A2;SLC26A11
14774,GO:0070482,0.0185587838412575,0.988196234453968,41,283,response to oxygen levels,BP,EGR1;PLAT;CST3;PGF;POSTN;VEGFA;NDRG1;NOS1;CAPN2;ZFP36L1;ENDOG;SMAD3;EPAS1;AKT1;VEGFB;EDNRA;PLAU;ANGPTL4;BNIP3;ADAM8;TGFB1;VHL;ADA;AHCY;BNIP3L;PDK1;CYGB;STUB1;DDIT4;TGFBR3;IRAK1;MTHFR;PPARA;EEF2K;CAT;PAK1;DNMT3A;LMNA;SIRT2;BACH1;TERC
3891,GO:0008528,0.0186739918438749,0.994833808556066,7,27,G-protein coupled peptide receptor activity,MF,F2R;SIGMAR1;EDNRA;NTSR1;MC1R;LTB4R2;LTB4R
5901,GO:0018107,0.0189692450955689,0.990956069079655,17,92,peptidyl-threonine phosphorylation,BP,PKN1;SPRY2;MAP2K1;AKT1;STK39;DGKQ;CEMIP;TGFB1;ULK1;PRKCD;DDIT4;CHEK2;CAMKK2;SIRT2;MAP3K10;CAMK1;CAMKK1
12233,GO:0048518,0.0190417830988732,0.98367619045096,448,3907,positive regulation of biological process,BP,TNIP1;DUSP6;XDH;ERCC1;DUSP5;MEF2D;ZMYND8;ADGRL1;CITED4;SEMA4B;HTRA1;FHL1;EGR1;NR1D1;EDEM1;DLG4;CST3;CYP27B1;APLN;PGF;PDCD4;CTNNBIP1;ACVR2B;DOCK4;PRNP;BBS2;POSTN;VEGFA;FAM210B;WNT7A;APOE;TSPAN1;ESPN;F2R;LRP5;ITGA6;HMGA2;OBSCN;NDRG1;ELK3;ITPR3;PKN1;MTA1;GRAMD4;EGFR;RPS6KA2;SERPINE2;DNPH1;WWTR1;SCN4B;OBSL1;NOS1;PTPRS;SPRY2;MST1R;NFATC4;TRIM65;PRSS8;SDC1;ETV5;SHC1;DDB2;ORAI1;VPS11;ARL2;HEXB;GTPBP1;ACTA2;MMP1;ETV4;SNX9;RAPGEF3;ZFP36L1;GLUL;ARAP1;MAP2K2;LPAR3;SMARCA1;RBCK1;PLTP;PC;MAP2K1;SSH1;POU2F2;ENDOG;MARK4;MARCKSL1;SMURF2;FOS;FBLN1;SMAD3;STAT6;SHANK2;PIK3R2;ERCC6;LRP1;GJC2;DVL1;EPAS1;HBEGF;FAM110C;S100A4;SH3PXD2B;SHC2;NLGN2;STOM;PRODH;SALL2;PAG1;ZXDC;RNF187;ADORA2B;ADARB1;AKT1;TPCN1;GRB7;TMOD2;CORO1B;HDAC5;S100A6;F12;SH2D2A;PPM1F;STK39;HK1;SERPING1;EPHA1;VEGFB;ASH2L;IMPACT;CNTN1;DAP;PTHLH;FGFR4;WNT2B;LDLR;FGFR1;PRKACB;RAC2;SMOC2;SEC14L2;HLTF;NPHP4;RAG1;KLF7;SORL1;NAT14;CEACAM1;B3GAT3;CIRBP;HMG20B;RAB11FIP4;TENM2;ZNF385A;NSMCE4A;ANK3;IGFBP4;EVC;TRAPPC9;CCND1;PCBP4;TWF2;STRADB;MAPK13;CEP250;PLAU;GAS6;PTK6;SEMA3F;FGFBP1;CSNK1E;CTSB;RAB3B;CARD11;SH2B3;DUSP7;GSN;PLEKHG2;MAPKAPK3;IGFBP2;PCSK9;RAD23A;BCR;ANGPTL4;EHD4;WIPF1;CCDC71L;SH3D19;CDC25B;RGL2;SLITRK6;ARPIN;ALOX15B;CCS;SLC20A1;DGKQ;PLXNB3;BNIP3;PAK6;SHARPIN;MVB12B;FYCO1;CEMIP;PKD2;YPEL3;RASGEF1A;CTSZ;CDC42EP5;CRTC1;IL20RB;FBXW8;GPSM1;AP3D1;MAGEF1;EPHB2;ADAM8;CTBP1;CDKN1C;PLCG1;ZMIZ2;SH3BP2;CD81;CEBPB;MVD;RNF135;TIMP2;WNT3;TMED4;TGFB1;CLTCL1;RFX2;ABHD17C;GPC1;DEAF1;MOAP1;NTSR1;NAB2;TMEM173;SHANK3;EFNB3;TNFSF15;KIF26B;NSMF;PEG3;MC1R;TUB;CROCC;RHOD;ABHD14B;SNX33;SEMA4F;WASF3;KIF7;RIMS3;PTPN1;PCK2;WDR59;AGRN;IFNE;CD320;CAMK2N1;LRP4;VHL;CEP131;PFKFB2;RFNG;MLXIPL;TRIB2;PRKCZ;KDM6B;PRKACA;MINK1;ZNF516;EPN2;ADA;AREG;PIM2;MICALL2;PLEKHG5;BOK;ERBB2;ADGRB2;ULK1;VAMP2;TFDP2;PLEK2;C6ORF89;STK17A;JAK3;NET1;BNIP3L;CYFIP2;FSCN1;PBX2;TRPC1;NELFCD;PRKCD;FAM20C;MIB2;RBL2;CACNB3;STUB1;BAX;ITGA1;OLFM2;FBXW4;EREG;RPS6KA5;SOX12;DDIT4;MBTPS2;PPP1R13L;CARF;IER2;RASL10B;ZDHHC8;NID1;LIMK1;TGFBR3;GDI1;ZHX3;DNM1;WASH3P;RGS14;MFNG;GSTO1;LPCAT1;LRSAM1;EHD3;SYMPK;MAPK12;IRAK1;TGFA;HDAC7;FHOD1;INPP5D;CHEK2;ZFPM1;PPARA;TMEM161A;SESN2;ABCG1;CDC34;SOX7;ABCA7;RAB12;SIX5;BCAP31;MIF;PLA2G6;DDT;SSBP4;ECM1;WFS1;NBPF3;FYN;STK25;RAC3;EEF2K;ARID5B;DNM2;PELI1;CAT;SLC27A1;TPBG;SLC50A1;ARHGEF4;MAPK3;INSR;ARHGEF1;CAMTA2;TAZ;PFKM;ADCY1;RERE;HLA-G;TMEM101;ETAA1;GLRX;VANGL2;PAK1;CAMKK2;PPP3CB;RNF144A;USP21;PFKFB3;MLYCD;CUL7;HYAL1;SEMA4C;CAPRIN2;ITGA3;DNMT3A;BIN1;PPP2R5B;MAP2K3;BCL2L1;DLG3;RRAS;PROX1;ADGRF1;LMNA;PKD1;KCTD13;TNFRSF25;SIRT2;FAM129B;CDH4;ITGA4;EDA;BACH1;ADCY7;E2F5;MAPRE3;AZIN2;LAMB1;MAP3K10;NGFR;TOLLIP;PDCD6;PXN;GRB10;TBC1D8;PLEKHM1;GCH1;LURAP1;MAFF;PNMA1;CAMK1;CAMKK1;EZH1;SIRT3;HFE;BTG1;ZP3;SEMA3B;PFN2;FGFR3;ITPKB;SPTLC2;TCEA2;PLAG1;IRF2BPL;KDM3A;DEDD2;SRSF5;ADCY6;LRRK1
10710,GO:0044033,0.0192067942766268,0.998344127284013,3,6,multi-organism metabolic process,BP,MAP2K2;MAP2K1;MAP2K3
9036,GO:0035256,0.0192420671347423,0.998339894938119,3,6,G-protein coupled glutamate receptor binding,MF,PRNP;FYN;HOMER2
3011,GO:0006560,0.0192785589818043,0.998335512987837,3,6,proline metabolic process,BP,ALDH4A1;PRODH;PYCR2
3374,GO:0007155,0.0193115857597155,0.985388205388439,104,800,cell adhesion,BP,TNIP1;NT5E;SDK2;ADGRL1;PRNP;PARVB;POSTN;VEGFA;ITGA6;EGFR;SERPINE2;PTPRS;SHC1;ARL2;ZFP36L1;FBLN1;SMAD3;THBS3;ITGB4;NLGN2;PAG1;AKT1;PPM1F;EPHA1;PTPRU;CNTN1;RAC2;SMOC2;NPHP4;RAG1;CEACAM1;TENM2;ANK3;EFS;PLAU;GAS6;CARD11;LAMA5;GSN;IGFBP2;COL13A1;PLXNB3;IL20RB;AP3D1;ITGB5;ADAM8;CADM4;CEBPB;ADAMTS13;TGFB1;PODXL2;EFNB3;KIF26B;CLCA2;RHOD;CGREF1;LAMB2;PRKCZ;MINK1;CD9;ADA;MICALL2;ERBB2;CERCAM;JAK3;NET1;CYFIP2;PRKCD;ITGA1;NID1;TMEM8B;MSLN;ADAM15;SYMPK;PPARA;BCAM;FYN;RAC3;ICAM5;DNM2;PELI1;IGFBP7;TPBG;PDZD2;HLA-G;TSTA3;PAK1;LGALS3BP;HYAL1;ITGA3;PKD1;CDH4;ITGA4;EDA;LAMB1;ARVCF;PXN;HFE;COL6A1;ZP3;CELSR1;BLOC1S4;ITPKB;APBA1
5275,GO:0015925,0.0193908376770392,0.998322009267965,3,6,galactosidase activity,MF,NAGA;GLB1L2;GLB1
18590,GO:1903825,0.0194007369036338,0.991235773116163,15,78,organic acid transmembrane transport,BP,SLC16A3;SLC6A8;SLC7A8;CPT2;SLC6A6;AKT1;STK39;SLC43A1;SLC38A10;NTSR1;SLC13A5;SLC25A29;SLC13A3;PRAF2;SLC23A2
19120,GO:1905039,0.0194007369036338,0.991235773116163,15,78,carboxylic acid transmembrane transport,BP,SLC16A3;SLC6A8;SLC7A8;CPT2;SLC6A6;AKT1;STK39;SLC43A1;SLC38A10;NTSR1;SLC13A5;SLC25A29;SLC13A3;PRAF2;SLC23A2
10218,GO:0042895,0.0194231227876487,0.998318120416454,3,6,antibiotic transmembrane transporter activity,MF,SLC13A5;SLC13A3;MFSD10
14152,GO:0061045,0.0194384778432591,0.99296408639154,10,45,negative regulation of wound healing,BP,PLAT;APOE;SERPINE2;SMAD3;F12;SERPING1;CEACAM1;PLAU;CD9;PRKCD
12230,GO:0048513,0.0196010856071464,0.983721076206535,254,2143,animal organ development,BP,DUSP6;XDH;ERCC1;SDK2;MEF2D;SEMA4B;HTRA1;FHL1;EGR1;CST3;CYP27B1;APLN;PGF;PDCD4;CTNNBIP1;ACVR2B;BBS2;VEGFA;FAM210B;WNT7A;NAGLU;LRP5;ITGA6;HMGA2;PKN1;EGFR;SERPINE2;WWTR1;OBSL1;PTPRS;SPRY2;NFATC4;PRSS8;SDC1;ETV5;SHC1;LTBP1;ACTA2;PHLDA2;TRNP1;SPRY4;ZFP36L1;GAA;PLCD3;MDFI;SMARCA1;CMTM7;FOXQ1;MAP2K1;ACP5;POU2F2;SMURF2;FOS;SMAD3;STAT6;SHANK2;LRP1;GJC2;DVL1;EPAS1;THBS3;HBEGF;AP2A2;S100A4;ITGB4;SH3PXD2B;SALL2;MBOAT7;ADARB1;AKT1;HDAC5;PITPNM1;BSG;PTPRU;VEGFB;ASH2L;LRRC8A;CNTN1;IFT140;PTHLH;WNT2B;FGFR1;KCNAB2;NPHP4;RAG1;GAMT;CEACAM1;HMG20B;LZTS2;RAB11FIP4;ZNF385A;EVC;TSHZ1;TRAPPC9;CCND1;TCF25;EDNRA;GAS6;SEMA3F;CSNK1E;CTSB;CARD11;SH2B3;SOX13;LAMA5;PCSK9;DHTKD1;BCR;ERRFI1;SLITRK6;ALOX15B;COL13A1;NPR2;BNIP3;SHARPIN;PKD2;CTSZ;FBXW8;AP3D1;SH3PXD2A;EPOR;EPHB2;ADAM8;APRT;CEBPB;WNT3;TGFB1;SNPH;GPC1;MKNK2;ADAMTS7;DEAF1;SLC38A10;NAB2;ATP7B;FHOD3;SHANK3;KIF26B;TUB;LCE1E;LAMB2;SNX17;VGF;POLM;SEMA4F;PHGDH;ADAM19;HMGCL;PCK2;B4GALT2;MBD3;IFNE;LRP4;LRP10;RFNG;PRKCZ;KDM6B;ZNF516;CD9;ADA;AREG;BOK;ERBB2;TFDP2;SMTN;JAK3;FAM20C;BAX;FBXW4;CHADL;EREG;SOX12;DDIT4;PPL;PPP1R13L;NID1;TGFBR3;LEMD2;MFNG;CHAD;MSLN;LPCAT1;ADAM15;ASB1;WDR60;TMEM231;MAPK12;INPP5D;CHD2;ZFPM1;PPARA;MYO1D;MYH15;SPEG;SIX5;ACO2;ECM1;WFS1;FYN;RAC3;SUN1;ARID5B;DNM2;CAT;SATB1;MAPK3;INSR;TAZ;ADCY1;RERE;HLA-G;VANGL2;PAK1;TRIM45;PPP3CB;PFKFB3;CUL7;HYAL1;SEMA4C;ITGA3;BCL2L1;RRAS;PROX1;MDGA1;LMNA;PKD1;SIRT2;FAM129B;ITGA4;EDA;E2F5;LAMB1;SOCS7;NDE1;HSD11B1;PDCD6;MAFF;TCTN1;NBEAL2;SLC39A3;EZH1;HFE;ZNF513;ZP3;CELSR1;TACC1;SEMA3B;FGFR3;NDRG2;ITPKB;PLAG1;SRSF5;LRRK1;AARS
16075,GO:0090037,0.0196546305795755,0.998290157144529,3,6,positive regulation of protein kinase C signaling,BP,VEGFA;MC1R;PLA2G6
13084,GO:0051604,0.0197137818334023,0.988194000529773,32,212,protein maturation,BP,PLAT;TYSND1;PRNP;SERPINE2;CAPN2;LMF1;F12;RHBDF2;SERPING1;GGT1;PRKACB;SORL1;PLAU;GAS6;GSN;PCSK9;AIP;PCSK1;CTSZ;MAGEF1;PRSS3;ADAM8;CD81;ADAMTS13;MIPEP;ERO1B;CYFIP2;STUB1;PCSK1N;LONP2;WFS1;SPPL2B
1495,GO:0003836,0.0197278876736158,0.998281280392997,3,6,beta-galactoside (CMP) alpha-2,3-sialyltransferase activity,MF,ST3GAL3;ST3GAL2;ST3GAL5
17451,GO:1900223,0.0197321270202322,0.998280766286507,3,6,positive regulation of amyloid-beta clearance,BP,LRP1;LDLR;ABCA7
3137,GO:0006734,0.0197555945194564,0.994470385173184,7,27,NADH metabolic process,BP,HK1;PFKL;PFKP;MDH2;PCK2;ALDOC;PFKM
11777,GO:0046651,0.0197795128664164,0.989163867588547,24,148,lymphocyte proliferation,BP,PRNP;PKN1;RAC2;CARD11;IGFBP2;IL20RB;CD81;CEBPB;TGFB1;IFNE;CD320;ADA;ERBB2;JAK3;PRKCD;BAX;INPP5D;MIF;FYN;PELI1;SATB1;HLA-G;PPP3CB;ZP3
15191,GO:0071340,0.0197864705328827,0.998274172030533,3,6,skeletal muscle acetylcholine-gated channel clustering,BP,ETV5;DVL1;LRP4
11689,GO:0046488,0.0198413201828403,0.988849440300688,26,159,phosphatidylinositol metabolic process,BP,EGFR;PIK3R2;PIGQ;HBEGF;MBOAT7;PITPNM1;ZFYVE21;FGFR4;FGFR1;PIGV;TTC7B;PLCH2;SYNJ2;PIP5KL1;PI4K2A;ERBB2;SBF1;EREG;INPP5D;PI4K2B;FYN;PITPNM3;SLC27A1;ZP3;FGFR3;PI4KAP2
6415,GO:0021683,0.0199026389929433,0.99826005080244,3,6,cerebellar granular layer morphogenesis,BP,WNT7A;SERPINE2;PROX1
14217,GO:0061180,0.0199364954010251,0.992311720195302,11,52,mammary gland epithelium development,BP,LRP5;ETV5;STAT6;AKT1;CCND1;CEBPB;WNT3;TGFB1;DEAF1;AREG;BAX
7954,GO:0032559,0.0199430203123414,0.984216431167525,149,1175,adenyl ribonucleotide binding,MF,ACVR2B;PYGL;DGKA;OBSCN;NEK9;PKN1;ACSF2;EGFR;RPS6KA2;MST1R;TK2;ACTA2;RAPGEF3;GLUL;MAP2K2;NME4;SMARCA1;PC;MAP2K1;MARK4;ERCC6;CDK18;NMRK1;AKT1;STK39;HK1;EPHA1;BRSK1;FGFR4;FGFR1;PRKACB;PFKL;TTLL12;OPLAH;HLTF;ABCD1;TWF2;STRADB;MAPK13;PTK6;PFKP;CSNK1E;MAPKAPK3;BCR;EHD4;NADK;PANK4;HLCS;NPR2;DGKQ;PAK6;FYCO1;ABCA2;EPHB2;APRT;GRK6;KIF17;MVD;ENTPD2;SCYL1;ULK2;MKNK2;TMEM173;ATP7B;PIP5KL1;KIF26B;DNAH1;PI4K2A;KIF7;PEX1;TRAP1;PFKFB2;PRKCZ;PRKACA;MINK1;ACTR1B;PIM2;UCKL1;ERBB2;ULK1;STK17A;JAK3;PDK1;PRKCD;FAM20C;NUBP2;RPS6KA5;DGUOK;CUL9;LIMK1;NTPCR;RPS6KA6;SCN8A;EHD3;LONP2;MAPK12;IRAK1;CHD2;PI4K2B;CHEK2;ABCG1;MYO1D;MYH15;CDC34;ABCA7;SPEG;DALRD3;FYN;STK25;EEF2K;CKMT1A;CHKA;KIF26A;DDX50;MAPK3;INSR;PFKM;ADCY1;ATP8B2;PDXK;PAK1;CAMKK2;ALPK1;PFKFB3;STK32C;SRMS;MAP2K3;IARS2;GAL3ST4;NMNAT2;ADCY7;TEP1;MAP3K10;KIF13B;CAMK1;CAMKK1;BBS10;CDK11B;FGFR3;ITPKB;CDC42BPG;CLK3;DHX32;PKN3;TTLL3;AK3;ADCY6;LRRK1;AARS
18016,GO:1902474,0.0199745037522166,0.998251298107814,3,6,positive regulation of protein localization to synapse,BP,WNT7A;DVL1;NLGN2
17653,GO:1901379,0.0199935373911102,0.993211460158404,9,39,regulation of potassium ion transmembrane transport,BP,FHL1;KCNG1;PRNP;STK39;KCNAB2;ANK3;VAMP2;DNM2;KLHL24
8720,GO:0034377,0.0200578981684115,0.995946925260485,5,16,plasma lipoprotein particle assembly,BP,APOE;PRKACB;PRKACA;ZDHHC8;ABCA7
5479,GO:0016413,0.0202359019772521,0.998219352558489,3,6,O-acetyltransferase activity,MF,LPCAT4;CRAT;LPCAT1
10769,GO:0044224,0.0202679375588105,0.998215425774648,3,6,juxtaparanode region of axon,CC,DLG4;KCNAB2;SIRT2
12858,GO:0051188,0.0202698972311813,0.987448024356553,36,240,cofactor biosynthetic process,BP,PGM1;IDH2;ACOT7;NAPRT;HSD17B8;NMRK1;UROS;HK1;GGT1;PFKL;OPLAH;CBR4;PFKP;DHTKD1;NADK;PANK4;RSAD1;HAGH;PFKFB2;MLXIPL;ALAS1;CNDP2;PDK1;PPCS;DDIT4;ALDOC;PPOX;PPARA;COQ2;INSR;PFKM;PDXK;PFKFB3;MLYCD;NMNAT2;GCH1
5167,GO:0015718,0.0202921571405291,0.990496236148504,16,86,monocarboxylic acid transport,BP,SLC16A3;APOE;CPT2;SLC16A5;AKT1;BSG;CEACAM1;ABCD1;NTSR1;SV2A;PPARA;MIF;PLA2G6;SLC27A1;SLC16A13;APBA1
14589,GO:0070142,0.0202970353962908,0.998211856877545,3,6,synaptic vesicle budding,BP,AP3D1;DNM1;DNM2
5212,GO:0015812,0.0203147095087198,0.998209688092889,3,6,gamma-aminobutyric acid transport,BP,NTSR1;SV2A;APBA1
1796,GO:0004430,0.0204468353834379,0.998193450440002,3,6,1-phosphatidylinositol 4-kinase activity,MF,PI4K2A;PI4K2B;PI4KAP2
5147,GO:0015680,0.0204675709057586,0.999385644447945,2,3,intracellular copper ion transport,BP,CCS;ATP7B
14956,GO:0070857,0.0204768724276187,0.998189752999924,3,6,regulation of bile acid biosynthetic process,BP,NR1D1;FGFR4;PROX1
3025,GO:0006575,0.020487723875424,0.989068188500927,22,134,cellular modified amino acid metabolic process,BP,SLC6A8;OSBPL5;LPCAT4;CRTAP;ALDH4A1;PRODH;GGT1;OPLAH;GAMT;HAGH;SERINC2;ERO1B;OSBPL10;CNDP2;AHCY;GSTO1;MTHFR;CKMT1A;SLC27A1;ALDH7A1;GCH1;PM20D2
1995,GO:0004716,0.0205429005379715,0.998181617368865,3,6,signal transducer, downstream of receptor, with protein tyrosine kinase activity,MF,EGFR;ERBB2;INSR
6743,GO:0030169,0.0205488534615804,0.998180883352601,3,6,low-density lipoprotein particle binding,MF,LDLR;SORL1;PCSK9
2177,GO:0005024,0.0205497886094271,0.99818076803766,3,6,transforming growth factor beta-activated receptor activity,MF,LTBP4;LTBP1;TGFBR3
4537,GO:0010612,0.0205497886094341,0.998180768037661,3,6,regulation of cardiac muscle adaptation,BP,SMAD3;ERRFI1;LMNA
18325,GO:1903242,0.0205497886094341,0.998180768037661,3,6,regulation of cardiac muscle hypertrophy in response to stress,BP,SMAD3;ERRFI1;LMNA
17759,GO:1901698,0.0205560062750906,0.984575140994876,96,737,response to nitrogen compound,BP,EGR1;EDEM1;FBXO2;PRNP;APOE;LRP5;EGFR;TMEM129;HADH;CAPN2;SDC1;SHC1;PTPRE;RAPGEF3;ZFP36L1;MAP2K2;MAP2K1;SSH1;FOS;SMAD3;STAT6;PIK3R2;LRP1;AKT1;HDAC5;UROS;BSG;IMPACT;RAB31;LDLR;PRKACB;CEACAM1;CCND1;MAPK13;GSN;PCSK9;ERRFI1;HLCS;DGKQ;PKD2;APRT;CD81;CEBPB;ADAMTS13;TGFB1;TMEM173;NSMF;VGF;ANKZF1;UBXN4;PTPN1;PCK2;AGRN;IFNE;PRKCZ;PRKACA;CD9;ADA;AREG;VAMP2;JAK3;PRKCD;STUB1;CYC1;EREG;TGFBR3;MTHFR;PPARA;SESN2;BCAP31;WFS1;FYN;EEF2K;DNM2;PELI1;CAT;SLC27A1;MAPK3;INSR;ADCY1;PAK1;WDTC1;DNMT3A;BCL2L1;SIRT2;ADCY7;SOCS7;NGFR;ATP6V1F;PXN;GRB10;COL6A1;BTG1;HOMER2;SRSF5;ADCY6
12584,GO:0050769,0.0205641630192831,0.986618622001875,44,299,positive regulation of neurogenesis,BP,ZMYND8;DLG4;VEGFA;APOE;SERPINE2;OBSL1;ETV5;LPAR3;MAP2K1;SHANK2;GJC2;DVL1;IMPACT;CNTN1;FGFR1;HMG20B;TWF2;PTK6;CSNK1E;PLXNB3;CRTC1;FBXW8;EPHB2;TIMP2;WNT3;SHANK3;NSMF;LIMK1;GDI1;RGS14;FYN;STK25;EEF2K;PAK1;CUL7;CAPRIN2;ITGA3;BIN1;PPP2R5B;PROX1;CDH4;NGFR;CAMK1;PLAG1
14164,GO:0061061,0.0205830830899951,0.985997880598897,54,382,muscle structure development,BP,MEF2D;FHL1;EGR1;PDCD4;FLNC;VEGFA;OBSCN;OBSL1;NOS1;CAPN2;NFATC4;SDC1;ZFP36L1;FOS;SMAD3;EPAS1;HBEGF;ADARB1;AKT1;TMOD2;HDAC5;FGFR1;HMG20B;EVC;TNNT1;LAMA5;MYEF2;TGFB1;GPC1;FHOD3;KDM6B;SMTN;OLFM2;EREG;TGFBR3;LEMD2;MAPK12;CHD2;ZFPM1;MYH15;SPEG;ARID5B;TAZ;VANGL2;PAK1;SEMA4C;BIN1;PROX1;LMNA;SIRT2;FAM129B;MAFF;CAMK1;BTG1
5057,GO:0015267,0.0205935477371594,0.988246223650363,27,167,channel activity,MF,DLG4;KCNG1;ITPR3;SCN4B;ORAI3;ORAI1;KCNJ15;GJC2;TPCN1;KCNC4;TTYH3;LRRC8A;KCNAB2;GAS6;ANO8;PKD2;GRIN3B;ASIC1;RASA3;CLCA2;TRPC1;CACNB3;BAX;SCN8A;DLG3;PKD1;SLC26A11
6601,GO:0022803,0.0205935477371594,0.988246223650363,27,167,passive transmembrane transporter activity,MF,DLG4;KCNG1;ITPR3;SCN4B;ORAI3;ORAI1;KCNJ15;GJC2;TPCN1;KCNC4;TTYH3;LRRC8A;KCNAB2;GAS6;ANO8;PKD2;GRIN3B;ASIC1;RASA3;CLCA2;TRPC1;CACNB3;BAX;SCN8A;DLG3;PKD1;SLC26A11
14646,GO:0070242,0.0207611459818597,0.995766405869911,5,16,thymocyte apoptotic process,BP,RAG1;ADAM8;ADA;JAK3;BAX
17615,GO:1901292,0.0208923973201955,0.988838939277776,22,132,nucleoside phosphate catabolic process,BP,NT5E;XDH;PGM1;DNPH1;RAPGEF3;HK1;PFKL;PFKP;DHTKD1;ENTPD2;PFKFB2;MLXIPL;ADA;DDIT4;ALDOC;PPARA;UPP1;NEIL1;INSR;PFKM;PFKFB3;NT5C1B
3426,GO:0007218,0.0209003356662679,0.995670130327114,5,17,neuropeptide signaling pathway,BP,NXPH4;NTSR1;PCSK1N;LTB4R2;LTB4R
7813,GO:0032373,0.0209580140389514,0.995715560059574,5,16,positive regulation of sterol transport,BP,APOE;PLTP;LRP1;ABCG1;ABCA7
7816,GO:0032376,0.0209580140389514,0.995715560059574,5,16,positive regulation of cholesterol transport,BP,APOE;PLTP;LRP1;ABCG1;ABCA7
4235,GO:0009435,0.0210779084975687,0.993353921760093,8,33,NAD biosynthetic process,BP,NAPRT;NMRK1;HK1;PFKL;PFKP;ALDOC;PFKM;NMNAT2
4234,GO:0009416,0.0210974797531483,0.987094465722743,34,223,response to light stimulus,BP,ERCC1;XPC;MTA1;EGFR;NFATC4;DDB2;FOS;ERCC6;AKT1;PITPNM1;IMPACT;BRSK1;NPHP4;RAG1;CIRBP;CCND1;SYNGAP1;MAPK13;CRTC1;DEAF1;MC1R;B4GALT2;PRIMPOL;REEP6;BAX;RGS14;TMEM161A;DNM2;BHLHE40;CAT;REV1;HYAL1;UVSSA;NR2F6
4079,GO:0009135,0.0211266200121673,0.989785006126634,17,94,purine nucleoside diphosphate metabolic process,BP,DLG4;PGM1;HK1;PFKL;PFKP;CARD11;DHTKD1;ENTPD2;PFKFB2;MLXIPL;DDIT4;ALDOC;PPARA;INSR;PFKM;PFKFB3;DLG3
4118,GO:0009179,0.0211266200121673,0.989785006126634,17,94,purine ribonucleoside diphosphate metabolic process,BP,DLG4;PGM1;HK1;PFKL;PFKP;CARD11;DHTKD1;ENTPD2;PFKFB2;MLXIPL;DDIT4;ALDOC;PPARA;INSR;PFKM;PFKFB3;DLG3
6065,GO:0019216,0.021129279799274,0.986610115532131,39,262,regulation of lipid metabolic process,BP,EGR1;NR1D1;CYP27B1;TYSND1;APOE;LMF1;CPT2;PIK3R2;AKT1;FGFR4;LDLR;SEC14L2;CEACAM1;ANGPTL4;DGKQ;CD81;MVD;TGFB1;MLXIPL;ALAS1;PDK1;PRKCD;RBL2;STUB1;MBTPS2;LPCAT1;LONP2;PPARA;ABCG1;PLA2G6;IGFBP7;SLC27A1;TAZ;MLYCD;WDTC1;SAMD8;PROX1;ZP3;FGFR3
17055,GO:0099531,0.0212626823056424,0.990264298632151,15,80,presynaptic process involved in chemical synaptic transmission,BP,WNT7A;SYTL1;MCTP1;DVL1;SYT8;KCNC4;BRSK1;RAB3B;ASIC1;SNPH;RIMS3;VAMP2;PCLO;PFN2;APBA1
14990,GO:0070914,0.0213502560850859,0.996694145922473,4,11,UV-damage excision repair,BP,ERCC1;XPC;DDB2;MC1R
8190,GO:0032943,0.021391005637678,0.988189269502475,24,149,mononuclear cell proliferation,BP,PRNP;PKN1;RAC2;CARD11;IGFBP2;IL20RB;CD81;CEBPB;TGFB1;IFNE;CD320;ADA;ERBB2;JAK3;PRKCD;BAX;INPP5D;MIF;FYN;PELI1;SATB1;HLA-G;PPP3CB;ZP3
892,GO:0002263,0.021407709315705,0.984911353602982,64,477,cell activation involved in immune response,BP,ERCC1;CST3;PYGB;PGM1;PYGL;VAT1;HEXB;SLC2A3;GAA;NAPRT;STAT6;LRP1;AP2A2;STOM;ADORA2B;SLC15A4;RAB31;FUCA1;RAC2;KCNAB2;PFKL;CEACAM1;PLAU;BRI3;CTSB;GSN;BCR;CTSZ;PRSS3;ADAM8;APRT;LTA4H;TIMP2;DPP7;TGFB1;TMEM173;GALNS;PI4K2A;RHOF;IFNE;YPEL5;PRKCZ;ACTR1B;ADA;VAMP2;JAK3;PRKCD;MFNG;ALDOC;LPCAT1;ZFPM1;MIF;SYNGR1;QSOX1;CD68;GLB1;CAT;PDXK;RNASET2;MAN2B1;DNASE1L1;SERPINB1;TOLLIP;NBEAL2
2272,GO:0005216,0.0214420053067552,0.98801498838551,25,152,ion channel activity,MF,DLG4;KCNG1;ITPR3;SCN4B;ORAI3;ORAI1;KCNJ15;TPCN1;KCNC4;TTYH3;LRRC8A;KCNAB2;GAS6;ANO8;PKD2;GRIN3B;ASIC1;RASA3;CLCA2;TRPC1;CACNB3;SCN8A;DLG3;PKD1;SLC26A11
6940,GO:0030554,0.0216101852741176,0.982834417969305,150,1187,adenyl nucleotide binding,MF,ACVR2B;PYGL;DGKA;OBSCN;NEK9;PKN1;ACSF2;EGFR;RPS6KA2;MST1R;TK2;ACTA2;RAPGEF3;GLUL;MAP2K2;NME4;SMARCA1;PC;MAP2K1;MARK4;ERCC6;CDK18;NMRK1;AKT1;STK39;HK1;EPHA1;BRSK1;FGFR4;FGFR1;PRKACB;PFKL;TTLL12;OPLAH;HLTF;ABCD1;TWF2;STRADB;MAPK13;PTK6;PFKP;CSNK1E;MAPKAPK3;BCR;EHD4;NADK;PANK4;HLCS;NPR2;DGKQ;PAK6;FYCO1;ABCA2;EPHB2;APRT;GRK6;KIF17;MVD;ENTPD2;SCYL1;ULK2;MKNK2;TMEM173;ATP7B;PIP5KL1;KIF26B;DNAH1;PI4K2A;KIF7;PEX1;TRAP1;PFKFB2;PRKCZ;PRKACA;MINK1;ACTR1B;PIM2;UCKL1;ERBB2;ULK1;AHCY;STK17A;JAK3;PDK1;PRKCD;FAM20C;NUBP2;RPS6KA5;DGUOK;CUL9;LIMK1;NTPCR;RPS6KA6;SCN8A;EHD3;LONP2;MAPK12;IRAK1;CHD2;PI4K2B;CHEK2;ABCG1;MYO1D;MYH15;CDC34;ABCA7;SPEG;DALRD3;FYN;STK25;EEF2K;CKMT1A;CHKA;KIF26A;DDX50;MAPK3;INSR;PFKM;ADCY1;ATP8B2;PDXK;PAK1;CAMKK2;ALPK1;PFKFB3;STK32C;SRMS;MAP2K3;IARS2;GAL3ST4;NMNAT2;ADCY7;TEP1;MAP3K10;KIF13B;CAMK1;CAMKK1;BBS10;CDK11B;FGFR3;ITPKB;CDC42BPG;CLK3;DHX32;PKN3;TTLL3;AK3;ADCY6;LRRK1;AARS
16783,GO:0098609,0.0216153011874513,0.984898096683603,61,442,cell-cell adhesion,BP,TNIP1;NT5E;SDK2;ADGRL1;PRNP;ITGA6;EGFR;SERPINE2;SHC1;ZFP36L1;NLGN2;PAG1;AKT1;PTPRU;RAC2;NPHP4;RAG1;CEACAM1;TENM2;ANK3;GAS6;CARD11;IGFBP2;COL13A1;PLXNB3;IL20RB;AP3D1;ITGB5;ADAM8;CADM4;CEBPB;TGFB1;PODXL2;EFNB3;KIF26B;PRKCZ;MINK1;CD9;ADA;ERBB2;CERCAM;JAK3;CYFIP2;PRKCD;PPARA;FYN;ICAM5;PELI1;HLA-G;TSTA3;PAK1;PKD1;CDH4;ITGA4;LAMB1;ARVCF;HFE;ZP3;CELSR1;BLOC1S4;ITPKB
6754,GO:0030193,0.0216206581925021,0.992017500744715,10,46,regulation of blood coagulation,BP,PLAT;APOE;F2R;SERPINE2;F12;SERPING1;CEACAM1;PLAU;CD9;PRKCD
17360,GO:1900046,0.0216206581925021,0.992017500744715,10,46,regulation of hemostasis,BP,PLAT;APOE;F2R;SERPINE2;F12;SERPING1;CEACAM1;PLAU;CD9;PRKCD
6067,GO:0019218,0.0217978934968947,0.989978715597606,15,81,regulation of steroid metabolic process,BP,EGR1;NR1D1;CYP27B1;APOE;LMF1;FGFR4;LDLR;SEC14L2;DGKQ;MVD;STUB1;MBTPS2;ABCG1;IGFBP7;PROX1
9572,GO:0036379,0.021817266164699,0.996598837889815,4,11,myofilament,CC,TMOD2;TNNT1;FHOD3;TPM2
10906,GO:0044463,0.0218616758730605,0.983150696138959,115,898,cell projection part,CC,ZMYND8;ADGRL1;NR1D1;DLG4;FBXO2;PRR7;PRNP;BBS2;APOE;ESPN;NOS1;SPRY2;CAPN2;SYTL1;SPRY4;GLUL;SSH1;MARK4;SHANK2;LRP1;GJC2;DVL1;CYBRD1;AKT1;KCNC4;TMOD2;HK1;IFT140;PRKACB;SIGMAR1;KCNAB2;NPHP4;CEACAM1;TENM2;ZNF385A;ANK3;EVC;TWF2;SYNGAP1;UNC119B;BNIP3;SHARPIN;PKD2;CTSZ;CRTC1;AP3D1;EPHB2;KIF17;TIMP2;ABHD17C;NTSR1;SHANK3;NSMF;FARP1;CROCC;DNAH1;HTR7;PI4K2A;KIF7;BBS1;CAMK2N1;LRP4;CEP131;PRKCZ;PRKACA;MINK1;ADA;VAMP2;PLEK2;RILPL1;FSCN1;ARHGAP44;SV2A;DNM1;RGS14;SCN8A;EHD3;WDR60;TMEM231;MYO1D;ABCA7;SYNGR1;WFS1;FYN;RAC3;EEF2K;DNM2;ATXN10;ARHGEF4;INSR;PFKM;MORN4;PAK1;GABBR1;MICAL1;ITGA3;BIN1;DLG3;PKD1;SIRT2;AZIN2;RAB28;GCH1;KIF13B;TCTN1;SEPT6;PFN2;MFSD10;NDRG2;BLOC1S4;TRIM46;HOMER2;APBA1;TTLL3;STRN4
17259,GO:0120038,0.0218616758730605,0.983150696138959,115,898,plasma membrane bounded cell projection part,CC,ZMYND8;ADGRL1;NR1D1;DLG4;FBXO2;PRR7;PRNP;BBS2;APOE;ESPN;NOS1;SPRY2;CAPN2;SYTL1;SPRY4;GLUL;SSH1;MARK4;SHANK2;LRP1;GJC2;DVL1;CYBRD1;AKT1;KCNC4;TMOD2;HK1;IFT140;PRKACB;SIGMAR1;KCNAB2;NPHP4;CEACAM1;TENM2;ZNF385A;ANK3;EVC;TWF2;SYNGAP1;UNC119B;BNIP3;SHARPIN;PKD2;CTSZ;CRTC1;AP3D1;EPHB2;KIF17;TIMP2;ABHD17C;NTSR1;SHANK3;NSMF;FARP1;CROCC;DNAH1;HTR7;PI4K2A;KIF7;BBS1;CAMK2N1;LRP4;CEP131;PRKCZ;PRKACA;MINK1;ADA;VAMP2;PLEK2;RILPL1;FSCN1;ARHGAP44;SV2A;DNM1;RGS14;SCN8A;EHD3;WDR60;TMEM231;MYO1D;ABCA7;SYNGR1;WFS1;FYN;RAC3;EEF2K;DNM2;ATXN10;ARHGEF4;INSR;PFKM;MORN4;PAK1;GABBR1;MICAL1;ITGA3;BIN1;DLG3;PKD1;SIRT2;AZIN2;RAB28;GCH1;KIF13B;TCTN1;SEPT6;PFN2;MFSD10;NDRG2;BLOC1S4;TRIM46;HOMER2;APBA1;TTLL3;STRN4
12709,GO:0050954,0.0218721059700346,0.990260811803457,14,74,sensory perception of mechanical stimulus,BP,ESPN;SERPINE2;SPRY2;HEXB;FGFR1;SLITRK6;CEMIP;EML2;TUB;DNM1;WFS1;FYN;ALDH7A1;HOMER2
14669,GO:0070286,0.0220514483885837,0.996550789901891,4,11,axonemal dynein complex assembly,BP,DNAAF5;DNAH1;DNAAF3;MSS51
6744,GO:0030170,0.0220792330157076,0.992976127684603,8,33,pyridoxal phosphate binding,MF,PYGB;PYGL;CBS;ALAS1;GPT2;PDXK;PHYKPL;SPTLC2
14666,GO:0070279,0.0220792330157076,0.992976127684603,8,33,vitamin B6 binding,MF,PYGB;PYGL;CBS;ALAS1;GPT2;PDXK;PHYKPL;SPTLC2
4604,GO:0010721,0.0221093967723482,0.986764173222539,31,200,negative regulation of cell development,BP,SEMA4B;POSTN;WNT7A;APOE;IDH2;PTPRS;NFATC4;FBLN1;LRP1;LDLR;SORL1;SYNGAP1;SEMA3F;NPR2;CTSZ;EPHB2;WNT3;TGFB1;ULK2;EFNB3;SEMA4F;LRP4;DGUOK;GDI1;PAK1;SEMA4C;SIRT2;RAP1GAP2;NGFR;SEMA3B;ADCY6
6919,GO:0030517,0.0221185156706231,0.99366115532272,7,27,negative regulation of axon extension,BP,SEMA4B;PTPRS;SEMA3F;WNT3;SEMA4F;SEMA4C;SEMA3B
7495,GO:0031674,0.0221704090863166,0.990110156663291,14,74,I band,CC,PARVB;FLNC;OBSCN;OBSL1;NOS1;MYZAP;ANK3;FHOD3;STUB1;AHNAK2;SCN8A;PAK1;PPP3CB;BIN1
12289,GO:0048638,0.0221994360722467,0.986708449403637,31,199,regulation of developmental growth,BP,DUSP6;SEMA4B;BBS2;VEGFA;APOE;PTPRS;PHLDA2;LPAR3;SH3PXD2B;AKT1;WWC3;FGFR1;GAMT;TWF2;SEMA3F;WNT3;ULK2;SEMA4F;AGRN;LIMK1;TGFBR3;GDI1;DNM2;INSR;PAK1;SEMA4C;PROX1;CDH4;ZP3;SEMA3B;FGFR3
1101,GO:0002689,0.0222907067818914,0.997765005063661,3,7,negative regulation of leukocyte chemotaxis,BP,MMP28;MIF;DDT
18546,GO:1903725,0.0223218838008224,0.99171505119737,10,46,regulation of phospholipid metabolic process,BP,PIK3R2;LDLR;CD81;TGFB1;PRKCD;LPCAT1;SLC27A1;TAZ;ZP3;FGFR3
466,GO:0001505,0.0223910417581909,0.987117223350712,27,169,regulation of neurotransmitter levels,BP,WNT7A;NOS1;SYTL1;GLUL;ACP5;MCTP1;SMAD3;DVL1;SYT8;AKT1;KCNC4;BRSK1;RAB3B;PKD2;ASIC1;SNPH;NTSR1;RIMS3;VAMP2;DNM2;CHKA;INSR;ALDH7A1;PCLO;GCH1;PFN2;APBA1
1098,GO:0002686,0.0223992164291914,0.995273704040356,5,17,negative regulation of leukocyte migration,BP,MMP28;BCR;ADA;MIF;DDT
6200,GO:0019693,0.0224571909581212,0.984735131605547,52,387,ribose phosphate metabolic process,BP,NT5E;H6PD;DLG4;VEGFA;PGM1;APOE;PYGL;ACOT7;NOS1;GTPBP1;RAPGEF3;NME4;PGLS;ADORA2B;HK1;PTHLH;PFKL;PFKP;CARD11;DHTKD1;NADK;PANK4;NPR2;PKD2;APRT;TIMP2;TGFB1;PODXL2;SDHA;ABHD14B;PFKFB2;MLXIPL;UCKL1;FAM20C;CYC1;PPCS;DDIT4;LTB4R2;ALDOC;PPARA;UPP1;INSR;TAZ;PFKM;ADCY1;PFKFB3;GABBR1;DLG3;NDUFV3;ADCY7;AK3;ADCY6
4966,GO:0015075,0.022516981135058,0.984228759712746,61,445,ion transmembrane transporter activity,MF,SLC16A3;DLG4;KCNG1;SLC6A8;SLCO4A1;ITPR3;SCN4B;SLC2A9;ORAI3;ORAI1;SLC7A8;SLC12A7;SLC2A3;SLC16A5;KCNJ15;SLC6A6;TPCN1;KCNC4;TTYH3;S100A6;BSG;SLC15A4;LRRC8A;MFSD3;KCNAB2;CEACAM1;GAS6;ANO8;SLC20A1;SERINC2;PKD2;GRIN3B;ASIC1;SLC43A1;SLC38A10;ATP7B;RASA3;CLCA2;TRPC1;SLC22A17;CACNB3;SLC13A5;SCN8A;SLC25A29;SLC9A7;SLC22A18;SLC27A1;SLC12A4;SLC13A3;SLC37A2;SLC16A13;DLG3;PKD1;AZIN2;SLC25A37;ATP6V1F;SLC39A3;TMCO3;MFSD10;SLC23A2;SLC26A11
2423,GO:0005604,0.022655243668962,0.990239578712985,13,66,basement membrane,CC,CST3;ITGA6;LOXL1;FBLN1;SMOC2;LAMA5;ENTPD2;LAMB2;AGRN;NID1;VWA1;EFEMP2;LAMB1
9860,GO:0042119,0.0226917933492158,0.984696966915912,50,363,neutrophil activation,BP,CST3;PYGB;PGM1;PYGL;VAT1;HEXB;SLC2A3;GAA;NAPRT;AP2A2;STOM;SLC15A4;RAB31;FUCA1;KCNAB2;PFKL;CEACAM1;PLAU;BRI3;CTSB;GSN;BCR;CTSZ;PRSS3;ADAM8;APRT;LTA4H;TIMP2;DPP7;TMEM173;GALNS;RHOF;YPEL5;ACTR1B;PRKCD;ALDOC;LPCAT1;MIF;SYNGR1;QSOX1;CD68;GLB1;CAT;PDXK;RNASET2;MAN2B1;DNASE1L1;SERPINB1;TOLLIP;NBEAL2
14647,GO:0070243,0.0227279057327984,0.996411050730715,4,11,regulation of thymocyte apoptotic process,BP,RAG1;ADAM8;ADA;JAK3
4603,GO:0010720,0.022732184826279,0.9847481696086,49,342,positive regulation of cell development,BP,ZMYND8;DLG4;VEGFA;APOE;SERPINE2;OBSL1;ETV5;LPAR3;MAP2K1;SHANK2;GJC2;DVL1;IMPACT;CNTN1;FGFR1;HMG20B;TWF2;PTK6;CSNK1E;PLXNB3;CRTC1;FBXW8;EPHB2;TIMP2;WNT3;SHANK3;NSMF;NET1;LIMK1;GDI1;RGS14;FYN;STK25;RAC3;EEF2K;DNM2;PAK1;CUL7;CAPRIN2;ITGA3;BIN1;PPP2R5B;PROX1;SIRT2;FAM129B;CDH4;NGFR;CAMK1;PLAG1
2386,GO:0005523,0.0228015268006787,0.997693394371218,3,7,tropomyosin binding,MF,TMOD2;S100A6;TNNT1
5184,GO:0015748,0.0228138927863364,0.990149680751292,13,67,organophosphate ester transport,BP,APOE;OSBPL5;PITPNC1;PLTP;PITPNM1;LDLR;OSBPL10;PRKCD;ABCG1;ABCA7;PITPNM3;ATP8B2;SLC37A2
14718,GO:0070374,0.0228226719107614,0.988116271240396,20,117,positive regulation of ERK1 and ERK2 cascade,BP,F2R;EGFR;SPRY2;MST1R;SHC1;MAP2K1;EPHA1;FGFR4;FGFR1;GAS6;EPHB2;TGFB1;PRKCZ;ERBB2;ABCA7;MIF;DDT;MAPK3;INSR;FGFR3
5464,GO:0016358,0.0229539960220425,0.986767208738028,27,168,dendrite development,BP,ZMYND8;DLG4;WNT7A;APOE;OBSL1;PTPRS;NFATC4;SHANK2;DVL1;KLF7;SYNGAP1;CRTC1;FBXW8;EPHB2;SHANK3;NSMF;FARP1;LRP4;MINK1;ARHGAP44;FYN;EEF2K;RERE;CUL7;CAPRIN2;CAMK1;SDC2
7999,GO:0032633,0.0230141464468618,0.995176615928466,5,16,interleukin-4 production,BP,IL20RB;CEBPB;PRKCZ;ZFPM1;ZP3
3661,GO:0008154,0.023021483958296,0.987202951372637,24,148,actin polymerization or depolymerization,BP,SSH1;TMOD2;CORO1B;RAC2;TWF2;GSN;PLEKHG2;WIPF1;ARPIN;SPTB;CORO7;CDC42EP5;FHOD3;MSRB2;WASF3;MICALL2;CAPG;PRKCD;SH3BP1;WASH3P;RAC3;MICAL1;PFN2;SSH3
15135,GO:0071241,0.0230555770043564,0.987976241696802,20,118,cellular response to inorganic substance,BP,PRNP;EGFR;NFATC4;ENDOG;FOS;AKT1;ANK3;GSN;BNIP3;PKD2;RASA4;CARF;MT2A;CPNE7;EEF2K;DNM2;MAPK3;ADCY1;HFE;ITPKB
18029,GO:1902512,0.0230764313145977,0.999260255501358,2,3,positive regulation of apoptotic DNA fragmentation,BP,ENDOG;BAX
9685,GO:0038083,0.0230772737097949,0.992596040379176,8,33,peptidyl-tyrosine autophosphorylation,BP,VEGFA;EGFR;PTK6;JAK3;FYN;MAPK3;INSR;SRMS
19380,GO:1905809,0.0231858217825733,0.996315666556606,4,11,negative regulation of synapse organization,BP,PRNP;APOE;NFATC4;FYN
19714,GO:2000026,0.0232687756185919,0.981373396943936,157,1279,regulation of multicellular organismal development,BP,DUSP6;XDH;ZMYND8;ADGRL1;SEMA4B;EGR1;DLG4;CYP27B1;PGF;PDCD4;CTNNBIP1;ACVR2B;VEGFA;FAM210B;WNT7A;APOE;HMGA2;IDH2;EGFR;SERPINE2;WWTR1;OBSL1;NOS1;PTPRS;SPRY2;NFATC4;ETV5;PHLDA2;RAPGEF3;ZFP36L1;LPAR3;MAP2K1;SSH1;SMURF2;FOS;SMAD3;STAT6;SHANK2;LRP1;GJC2;DVL1;AP2A2;SH3PXD2B;NLGN2;AKT1;HDAC5;EPHA1;VEGFB;ASH2L;IMPACT;CNTN1;PTHLH;WNT2B;LDLR;FGFR1;PRKACB;RAG1;SORL1;CEACAM1;HMG20B;CCND1;TWF2;SYNGAP1;GAS6;PTK6;SEMA3F;CSNK1E;CARD11;SOX13;LAMA5;ANGPTL4;ERRFI1;SLITRK6;ALOX15B;PLXNB3;CTSZ;CRTC1;FBXW8;AP3D1;EPHB2;ADAM8;PLCG1;CEBPB;TIMP2;WNT3;TGFB1;ULK2;GPC1;ADAMTS7;DEAF1;SHANK3;EFNB3;NSMF;RNH1;SEMA4F;WASF3;AGRN;LRP4;PRKCZ;EPN2;ADA;ERBB2;ADGRB2;JAK3;ARHGAP44;FAM20C;BAX;CHADL;DGUOK;LIMK1;TGFBR3;GDI1;RPS6KA6;RGS14;CHAD;HDAC7;INPP5D;ZFPM1;ECM1;FYN;STK25;RAC3;EEF2K;DNM2;TPBG;INSR;HLA-G;VANGL2;PAK1;CUL7;HYAL1;SEMA4C;CAPRIN2;HES7;ITGA3;BIN1;PPP2R5B;RRAS;PROX1;SIRT2;FAM129B;CDH4;RAP1GAP2;NGFR;PDCD6;KIF13B;MAFF;CAMK1;BTG1;ZP3;CELSR1;SEMA3B;SSH3;ITPKB;PLAG1;ADCY6;SDC2
2397,GO:0005543,0.0233665025320113,0.984735255353719,43,295,phospholipid binding,MF,HS1BP3;APOE;DGKA;OSBPL5;PITPNC1;ITPR3;NISCH;SYTL1;SHC1;SNX9;ARAP1;NME4;LPAR3;PLTP;MCTP1;SH3PXD2B;SYT8;AKT1;GRB7;PITPNM1;DYSF;SEC14L2;TWF2;GAS6;AGAP1;SH3PXD2A;ARAP3;TUB;SNX17;SNX33;OSBPL10;ESYT2;ADAP1;VAMP2;PLEK2;RASA4;ARHGAP44;ABCG1;SNX15;PCLO;WIPI2;PFN2;GSDMA
18161,GO:1902893,0.023383099535181,0.993219883791653,7,27,regulation of pri-miRNA transcription by RNA polymerase II,BP,APLN;NFATC4;FOS;SMAD3;TGFB1;PPARA;NGFR
16672,GO:0097581,0.0233846637989932,0.989880451326668,13,66,lamellipodium organization,BP,PARVB;SSH1;CORO1B;RAC2;TWF2;ARPIN;PLXNB3;RHOD;WASF3;FSCN1;DNM2;ARHGEF4;SSH3
11564,GO:0046128,0.0234680184412174,0.990214127310223,12,62,purine ribonucleoside metabolic process,BP,NT5E;DLG4;GTPBP1;NME4;GAMT;CARD11;APRT;ADA;AHCY;DGUOK;DLG3;AK3
10276,GO:0043029,0.0235126491898283,0.993136280124168,7,28,T cell homeostasis,BP,AKT1;RAG1;TGFB1;JAK3;BAX;PPP3CB;SLC39A3
3944,GO:0008643,0.0236112047915113,0.988432323198891,17,94,carbohydrate transport,BP,SLC2A9;SLC2A3;PIK3R2;AKT1;EDNRA;CLTCL1;PRKCZ;SLC2A11;SESN2;SLC50A1;INSR;RTN2;PAK1;SLC37A2;NGFR;GRB10;SLC23A2
3516,GO:0007492,0.0236239069364871,0.990180983277257,12,59,endoderm development,BP,DUSP6;DUSP5;HMGA2;ZFP36L1;SMAD3;ITGB5;TGFB1;DUSP4;SOX7;ITGA4;LAMB1;COL6A1
3273,GO:0006955,0.0237337185551621,0.981073931491787,150,1232,immune response,BP,TNIP1;ERCC1;EGR1;NR1D1;CST3;CYP27B1;APLN;PRR7;PRNP;PYGB;TNFRSF6B;PGM1;PYGL;PKN1;FCGRT;VAT1;PTPRS;MST1R;SHC1;ORAI1;HEXB;GTPBP1;SLC2A3;GAA;RBCK1;NAPRT;POU2F2;FOS;SMAD3;STAT6;PIK3R2;LRP1;AP2A2;STOM;PAG1;ADORA2B;ADARB1;F12;HK1;SERPING1;SLC15A4;IFNGR2;RAB31;PRKACB;FUCA1;RAC2;KCNAB2;PFKL;RAG1;CEACAM1;PLAU;GAS6;PTK6;BRI3;CTSB;CARD11;GSN;MAPKAPK3;BCR;WIPF1;FAM3A;CTSZ;IL20RB;PRSS3;ADAM8;APRT;LTA4H;PLCG1;CD81;CEBPB;RNF135;ADAMTS13;TIMP2;DPP7;TGFB1;TMEM173;TNFSF15;GALNS;SCART1;PI4K2A;RHOF;PTPN1;IFNE;YPEL5;PRKCZ;KDM6B;PRKACA;TBKBP1;ACTR1B;ADA;AHCY;VAMP2;JAK3;CYFIP2;PRKCD;CACNB3;IFI6;BAX;TRIM4;EREG;RPS6KA5;MT2A;LIMK1;TGFBR3;MFNG;ALDOC;LPCAT1;ADAM15;IRAK1;INPP5D;ZFPM1;RAB12;MIF;PLA2G6;SYNGR1;ECM1;QSOX1;CD68;SPPL2B;FYN;ICAM5;GLB1;PELI1;CAT;APOBEC3C;APOBEC3F;MAPK3;HLA-G;PDXK;PAK1;RNASET2;PPP3CB;MAN2B1;SRMS;DNASE1L1;TNFRSF25;SIRT2;ITGA4;EDA;LTB4R;SERPINB1;PELI3;NGFR;TOLLIP;RNASE7;GCH1;NBEAL2;PNMA1;HFE;ZP3
18935,GO:1904659,0.0237552134041248,0.989697352491606,13,66,glucose transmembrane transport,BP,SLC2A9;SLC2A3;PIK3R2;AKT1;EDNRA;CLTCL1;PRKCZ;SESN2;INSR;RTN2;PAK1;NGFR;GRB10
3591,GO:0008021,0.0238068788752999,0.988030329724035,18,104,synaptic vesicle,CC,DLG4;PTPRS;MCTP1;SYT8;BRSK1;RAB3B;DBNDD1;PI4K2A;VAMP2;SV2A;DNM1;SYNGR1;SEMA4C;BCL2L1;ICA1;RAB40B;SEPT6;APBA1
4273,GO:0009636,0.0238542215720719,0.984218611266171,45,322,response to toxic substance,BP,EGR1;CST3;APOE;SDC1;SLC7A8;TXNRD3;ENDOG;FOS;STAT6;ERCC6;GJC2;PRDX5;IMPACT;BPHL;CCND1;MAPK13;GSN;CCS;BNIP3;GPX3;ADAMTS13;ANKZF1;TRAP1;KDM6B;ADA;AREG;NET1;CYGB;PRKCD;BAX;MT2A;GSTO1;PPARA;SESN2;SNN;FYN;STK25;DNM2;CHKA;CAT;MAPK3;DNMT3A;BCL2L1;ADCY7;GCH1
19772,GO:2000147,0.0238837717141717,0.984133406170587,46,322,positive regulation of cell motility,BP,SEMA4B;PGF;DOCK4;POSTN;VEGFA;WNT7A;F2R;ITGA6;EGFR;SPRY2;SSH1;SMURF2;SMAD3;HBEGF;FAM110C;AKT1;GRB7;PPM1F;EPHA1;VEGFB;FGFR1;RAC2;PLAU;GAS6;SEMA3F;CEMIP;ADAM8;PLCG1;TGFB1;NSMF;RHOD;SEMA4F;HDAC7;MAPK3;INSR;PAK1;HYAL1;SEMA4C;ITGA3;MAP2K3;PROX1;ITGA4;LAMB1;PDCD6;ZP3;SEMA3B
9788,GO:0040013,0.023901133610929,0.98546832334348,32,209,negative regulation of locomotion,BP,ZMYND8;SEMA4B;APOE;IDH2;NISCH;MCTP1;FBLN1;LRP1;ADARB1;CORO1B;HDAC5;MMP28;EPHA1;PTPRU;SEMA3F;BCR;ARPIN;ALOX15B;PLXNB3;WNT3;TGFB1;ARAP3;SEMA4F;ADA;CYGB;ADAM15;MIF;DDT;SEMA4C;RRAS;SEMA3B;PFN2
6611,GO:0022839,0.0239203810667464,0.987725522200329,19,109,ion gated channel activity,MF,DLG4;KCNG1;ITPR3;SCN4B;KCNJ15;TPCN1;KCNC4;TTYH3;KCNAB2;GAS6;ANO8;PKD2;GRIN3B;ASIC1;RASA3;CLCA2;CACNB3;SCN8A;DLG3
6127,GO:0019377,0.0239994366231778,0.996144641641959,4,11,glycolipid catabolic process,BP,HEXB;FUCA1;PRKCD;NAGA
8099,GO:0032793,0.0240083740740687,0.996142752066028,4,11,positive regulation of CREB transcription factor activity,BP,VEGFA;CRTC1;RPS6KA5;ADGRF1
4353,GO:0009950,0.0240796719479734,0.996127669695658,4,11,dorsal/ventral axis specification,BP,LRP5;MDFI;WNT3;LRP4
12525,GO:0050679,0.0242015476004738,0.987306563626524,20,119,positive regulation of epithelial cell proliferation,BP,HTRA1;APLN;PGF;VEGFA;WNT7A;EGFR;GLUL;AKT1;VEGFB;FGFR1;CCND1;PLXNB3;TGFB1;ERBB2;TGFA;ECM1;HYAL1;PROX1;LAMB1;PDCD6
3218,GO:0006869,0.024355290545214,0.985298577335394,31,201,lipid transport,BP,APOE;OSBPL5;PITPNC1;NME4;PLTP;CPT2;LRP1;AKT1;PITPNM1;LDLR;SIGMAR1;SORL1;CEACAM1;ABCD1;PCSK9;ABCA2;NTSR1;OSBPL10;LRP10;ESYT2;PRKCD;PPARA;ABCG1;ABCA7;MIF;PLA2G6;PITPNM3;CHKA;SLC27A1;ATP8B2;VPS51
11607,GO:0046320,0.0243678849692763,0.99481416584342,5,16,regulation of fatty acid oxidation,BP,TYSND1;AKT1;LONP2;PPARA;MLYCD
3604,GO:0008047,0.0243816701638778,0.983176702576276,55,394,enzyme activator activity,MF,DOCK4;APOE;EVI5L;SPRY2;APPL2;TBC1D14;RIN1;ARAP1;MAP2K2;MAP2K1;FBLN1;ARHGAP23;PIK3R2;ERCC6;SH3PXD2B;ASAP2;B3GAT3;SYNGAP1;GAS6;ARHGAP22;BCR;ERRFI1;ARHGAP27;AGAP1;CCS;DGKQ;CDC42EP5;SH3PXD2A;TGFB1;TBC1D9B;ARHGAP25;RASA3;ARAP3;LLGL1;ADAP1;RASA4;ARHGAP44;PRKCD;SH3BP1;GDI1;RGS14;GIT1;ARHGAP12;ACAP3;ARHGEF1;RALGAPA1;ETAA1;SGSM2;TBC1D16;RABGAP1;TRIP10;AZIN2;RAP1GAP2;RGS19;TBC1D8
8974,GO:0035082,0.0245025853117472,0.993687606578069,6,22,axoneme assembly,BP,BBS2;DNAAF5;DNAH1;DNAAF3;MSS51;TTLL3
678,GO:0001889,0.0245398590887462,0.987625687110307,18,103,liver development,BP,EGFR;SMAD3;CEACAM1;CCND1;PCSK9;PKD2;CEBPB;TGFB1;HMGCL;PCK2;ADA;TGFBR3;ACO2;ARID5B;PROX1;PKD1;HFE;SRSF5
548,GO:0001669,0.0245467715252514,0.990188070472187,11,54,acrosomal vesicle,CC,LOXL1;HEXB;LY6K;SYT8;BSG;CEP131;PRKACA;ITGA1;ADAM15;SUN1;CLK3
12524,GO:0050678,0.024675350101644,0.98482769023066,33,219,regulation of epithelial cell proliferation,BP,XDH;HTRA1;NR1D1;APLN;PGF;VEGFA;WNT7A;APOE;EGFR;ZFP36L1;GLUL;SMAD3;AKT1;VEGFB;FGFR1;CEACAM1;CCND1;ERRFI1;PLXNB3;CDKN1C;TGFB1;DEAF1;ERBB2;BAX;EREG;TGFBR3;TGFA;ECM1;HYAL1;PROX1;LAMB1;NGFR;PDCD6
9115,GO:0035418,0.0247527097028455,0.993607905314352,6,22,protein localization to synapse,BP,DLG4;WNT7A;DVL1;NLGN2;ARHGAP44;PCLO
9058,GO:0035295,0.0248391893356696,0.981462613450446,87,659,tube development,BP,XDH;APLN;PGF;CTNNBIP1;ACVR2B;VEGFA;WNT7A;APOE;LRP5;ITGA6;HMGA2;ELK3;EGFR;SERPINE2;WWTR1;SPRY2;NFATC4;SDC1;ETV5;SHC1;RAPGEF3;ZFP36L1;PLCD3;MAP2K1;SMAD3;LRP1;DVL1;EPAS1;ITGB4;SALL2;HDAC5;SH2D2A;EPHA1;VEGFB;IFT140;FGFR4;WNT2B;FGFR1;PRKACB;CEACAM1;EDNRA;PTK6;LAMA5;ARHGAP22;ANGPTL4;ERRFI1;PKD2;CTSZ;EPHB2;ADAM8;PLCG1;TGFB1;DEAF1;KIF26B;RNH1;EPN2;ADA;AREG;SDCCAG8;ERBB2;ADGRB2;BAX;EREG;TGFBR3;ADAM15;HDAC7;ECM1;CAT;MAPK3;VANGL2;PAK1;ROBO4;CUL7;HYAL1;SEMA4C;ITGA3;RRAS;PROX1;PKD1;FAM129B;EDA;HSD11B1;NGFR;PDCD6;TCTN1;BTG1;CELSR1
2148,GO:0004966,0.0249139410665367,0.999166921237321,2,3,galanin receptor activity,MF,LTB4R2;LTB4R
562,GO:0001704,0.0249419112618671,0.98834342473641,15,80,formation of primary germ layer,BP,DUSP6;DUSP5;HMGA2;SMAD3;ITGB4;FGFR1;ITGB5;WNT3;KDM6B;DUSP4;SOX7;ITGA3;ITGA4;LAMB1;COL6A1
2296,GO:0005262,0.0249897755848932,0.990000189215586,11,53,calcium channel activity,MF,ITPR3;ORAI3;ORAI1;TPCN1;GAS6;PKD2;GRIN3B;RASA3;TRPC1;CACNB3;PKD1
16986,GO:0099054,0.0250096977326293,0.995929572859058,4,11,presynapse assembly,BP,WNT7A;DVL1;NLGN2;LRP4
15554,GO:0072006,0.0250846225107806,0.987922390328721,16,88,nephron development,BP,EGR1;PGF;CTNNBIP1;VEGFA;WWTR1;ACTA2;WNT2B;LAMA5;PKD2;TGFB1;KIF26B;LAMB2;NID1;VANGL2;ITGA3;PKD1
1966,GO:0004675,0.0250969615481282,0.99591085707995,4,11,transmembrane receptor protein serine/threonine kinase activity,MF,ACVR2B;LTBP4;LTBP1;TGFBR3
13569,GO:0060047,0.0251502215496854,0.986521566870797,21,126,heart contraction,BP,APLN;ITPR3;SCN4B;NOS1;GAA;EPAS1;HBEGF;VEGFB;TNNT1;NPR2;SNTA1;PRKACA;ADA;TRPC1;CACNB3;PPP1R13L;GSTO1;EHD3;TAZ;MAP2K3;GCH1
3568,GO:0007616,0.0252137039930555,0.993460479510186,6,22,long-term memory,BP,PRNP;APOE;LDLR;PRKCZ;RGS14;ADCY1
4124,GO:0009185,0.0252300114240244,0.98752437768282,17,96,ribonucleoside diphosphate metabolic process,BP,DLG4;PGM1;HK1;PFKL;PFKP;CARD11;DHTKD1;ENTPD2;PFKFB2;MLXIPL;DDIT4;ALDOC;PPARA;INSR;PFKM;PFKFB3;DLG3
990,GO:0002446,0.0252457549470191,0.982855416472719,50,365,neutrophil mediated immunity,BP,CST3;PYGB;PGM1;PYGL;VAT1;HEXB;SLC2A3;GAA;NAPRT;AP2A2;STOM;SLC15A4;RAB31;FUCA1;KCNAB2;PFKL;CEACAM1;PLAU;BRI3;CTSB;GSN;BCR;CTSZ;PRSS3;ADAM8;APRT;LTA4H;TIMP2;DPP7;TMEM173;GALNS;RHOF;YPEL5;ACTR1B;PRKCD;ALDOC;LPCAT1;MIF;SYNGR1;QSOX1;CD68;GLB1;CAT;PDXK;RNASET2;MAN2B1;DNASE1L1;SERPINB1;TOLLIP;NBEAL2
15154,GO:0071277,0.0252570451331094,0.991034752689556,9,40,cellular response to calcium ion,BP,ENDOG;FOS;PKD2;RASA4;CARF;CPNE7;EEF2K;ADCY1;ITPKB
16775,GO:0098589,0.025303134453893,0.984417890995717,33,216,membrane region,CC,MARVELD1;PRNP;F2R;EGFR;NOS1;CAPN2;SMURF2;STAT6;STOM;LY6K;PAG1;BSG;HK1;CNTN1;CARD11;SYNJ2;GPC1;NTSR1;PI4K2A;LRP4;PRKCZ;PRKACA;ITGA1;INPP5D;MYO1D;FYN;MAPK3;INSR;ADCY1;MALL;LTB4R;RGS19;CBLC
17338,GO:1900006,0.0253308917299342,0.989842056058648,11,53,positive regulation of dendrite development,BP,ZMYND8;APOE;OBSL1;SHANK2;CRTC1;FBXW8;SHANK3;EEF2K;CUL7;CAPRIN2;CAMK1
1261,GO:0003014,0.025333895457272,0.989344991821249,12,60,renal system process,BP,F2R;PKN1;PRKACB;GAS6;GSN;BCR;PRKACA;WFS1;ADCY1;ITGA3;ADCY7;ADCY6
4100,GO:0009156,0.0253985819600489,0.986368788874658,21,127,ribonucleoside monophosphate biosynthetic process,BP,PGM1;HK1;PFKL;LHPP;PFKP;DHTKD1;APRT;TGFB1;PFKFB2;MLXIPL;ADA;UCKL1;CYC1;DDIT4;ALDOC;PPARA;UPP1;INSR;TAZ;PFKM;PFKFB3
7260,GO:0031235,0.0254838514936849,0.995827616778547,4,11,intrinsic component of the cytoplasmic side of the plasma membrane,CC,SYNGAP1;SPTB;RASA3;RASA4
4667,GO:0010817,0.0255212860229377,0.983396082363788,41,284,regulation of hormone levels,BP,EGR1;NR1D1;CYP27B1;APLN;ACVR2B;LRP5;SLCO4A1;ITPR3;EGFR;HADH;LTBP4;ARL2;RAPGEF3;GLUL;SRD5A3;HSD17B8;NLGN2;FGFR1;PFKL;DGKQ;PCSK1;RETSAT;CTSZ;ERO1B;VGF;PCK2;PFKFB2;STUB1;HSD17B7;PCSK1N;RASL10B;PLA2G6;CYP2R1;PFKM;PPP3CB;FAM129B;ICA1;HSD11B1;PCLO;SIRT3;HFE
4109,GO:0009166,0.0256361684028004,0.986227738868902,21,127,nucleotide catabolic process,BP,NT5E;XDH;PGM1;DNPH1;RAPGEF3;HK1;PFKL;PFKP;DHTKD1;PFKFB2;MLXIPL;ADA;DDIT4;ALDOC;PPARA;UPP1;NEIL1;INSR;PFKM;PFKFB3;NT5C1B
3714,GO:0008237,0.0257190289043119,0.986968016768863,18,102,metallopeptidase activity,MF,NPEPL1;MMP1;RNPEPL1;MMP28;ACY1;ADAM8;LTA4H;ADAMTS13;ADAMTS7;MIPEP;CLCA2;ADAM19;CNDP2;MMP10;RNPEP;THOP1;MBTPS2;ADAM15
5070,GO:0015294,0.0257225632555561,0.989660037241403,11,53,solute:cation symporter activity,MF,SLC6A8;SLC2A9;SLC12A7;SLC6A6;SLC15A4;MFSD3;SLC20A1;SLC13A5;SLC12A4;SLC13A3;SLC23A2
5517,GO:0016480,0.025727428163953,0.999124311671395,2,3,negative regulation of transcription by RNA polymerase III,BP,PRDX5;NAB2
11645,GO:0046394,0.0258857408643599,0.983141751133699,41,284,carboxylic acid biosynthetic process,BP,NR1D1;NAGS;PGM1;ACOT7;GLUL;HSD17B8;UROS;PYCR2;HK1;GGT1;FGFR4;PFKL;GAMT;CEACAM1;CBR4;PFKP;DHTKD1;ALOX15B;CEMIP;LTA4H;CBS;TGFB1;PHGDH;PFKFB2;MLXIPL;AHCY;DDIT4;ALDOC;DECR2;PPARA;MIF;INSR;PFKM;GPT2;PFKFB3;MLYCD;HYAL1;WDTC1;PROX1;CHST14;GCH1
5909,GO:0018146,0.0260359704865945,0.993195829969878,6,22,keratan sulfate biosynthetic process,BP,B4GAT1;B3GNT3;B4GALT2;B4GALT6;ST3GAL3;ST3GAL2
6609,GO:0022836,0.0261287347586529,0.986451959198872,19,110,gated channel activity,MF,DLG4;KCNG1;ITPR3;SCN4B;KCNJ15;TPCN1;KCNC4;TTYH3;KCNAB2;GAS6;ANO8;PKD2;GRIN3B;ASIC1;RASA3;CLCA2;CACNB3;SCN8A;DLG3
987,GO:0002443,0.0261636681697281,0.981198573576165,67,508,leukocyte mediated immunity,BP,ERCC1;CST3;PYGB;PGM1;PYGL;VAT1;HEXB;SLC2A3;GAA;NAPRT;POU2F2;STAT6;AP2A2;STOM;ADORA2B;SERPING1;SLC15A4;RAB31;FUCA1;RAC2;KCNAB2;PFKL;CEACAM1;PLAU;BRI3;CTSB;GSN;BCR;CTSZ;IL20RB;PRSS3;ADAM8;APRT;LTA4H;TIMP2;DPP7;TGFB1;TMEM173;GALNS;SCART1;PI4K2A;RHOF;YPEL5;PRKCZ;ACTR1B;VAMP2;JAK3;PRKCD;ALDOC;LPCAT1;INPP5D;MIF;SYNGR1;QSOX1;CD68;GLB1;CAT;PDXK;RNASET2;PPP3CB;MAN2B1;DNASE1L1;SERPINB1;TOLLIP;NBEAL2;HFE;ZP3
1970,GO:0004683,0.0261656630351951,0.993153892622364,6,22,calmodulin-dependent protein kinase activity,MF,MAPKAPK3;MKNK2;EEF2K;CAMKK2;CAMK1;CAMKK1
8182,GO:0032928,0.0263354183850887,0.99552255327273,4,12,regulation of superoxide anion generation,BP,EGFR;ACP5;TGFB1;PRKCD
1707,GO:0004222,0.0263694162970675,0.988843006436475,12,60,metalloendopeptidase activity,MF,MMP1;MMP28;ADAM8;ADAMTS13;ADAMTS7;MIPEP;CLCA2;ADAM19;MMP10;THOP1;MBTPS2;ADAM15
12693,GO:0050920,0.0263775721934814,0.986022957611545,20,121,regulation of chemotaxis,BP,SEMA4B;PGF;VEGFA;SMAD3;CORO1B;PPM1F;MMP28;VEGFB;FGFR1;RAC2;GAS6;SEMA3F;WNT3;TGFB1;SEMA4F;MIF;DDT;MAPK3;SEMA4C;SEMA3B
948,GO:0002366,0.026461111588274,0.981173535115009,63,474,leukocyte activation involved in immune response,BP,ERCC1;CST3;PYGB;PGM1;PYGL;VAT1;HEXB;SLC2A3;GAA;NAPRT;STAT6;AP2A2;STOM;ADORA2B;SLC15A4;RAB31;FUCA1;RAC2;KCNAB2;PFKL;CEACAM1;PLAU;BRI3;CTSB;GSN;BCR;CTSZ;PRSS3;ADAM8;APRT;LTA4H;TIMP2;DPP7;TGFB1;TMEM173;GALNS;PI4K2A;RHOF;IFNE;YPEL5;PRKCZ;ACTR1B;ADA;VAMP2;JAK3;PRKCD;MFNG;ALDOC;LPCAT1;ZFPM1;MIF;SYNGR1;QSOX1;CD68;GLB1;CAT;PDXK;RNASET2;MAN2B1;DNASE1L1;SERPINB1;TOLLIP;NBEAL2
6610,GO:0022838,0.0264684177139574,0.984893417915583,25,155,substrate-specific channel activity,MF,DLG4;KCNG1;ITPR3;SCN4B;ORAI3;ORAI1;KCNJ15;TPCN1;KCNC4;TTYH3;LRRC8A;KCNAB2;GAS6;ANO8;PKD2;GRIN3B;ASIC1;RASA3;CLCA2;TRPC1;CACNB3;SCN8A;DLG3;PKD1;SLC26A11
7088,GO:0030890,0.026505057495757,0.992990052705297,6,23,positive regulation of B cell proliferation,BP,CARD11;CD81;CD320;ADA;MIF;PELI1
16774,GO:0098588,0.026506587997639,0.978350036706499,185,1522,bounding membrane of organelle,CC,B4GALNT4;EDEM1;DLG4;CYP27B1;BBS2;FAM210B;WNT7A;APOE;TSPAN1;NDRG1;ITPR3;EGFR;NOS1;VAT1;PTPRS;APPL2;VPS11;SLC2A3;ST6GALNAC2;GAA;ARAP1;MAP2K2;MARCH9;MCTP1;TMEM8A;ARMCX2;SHANK2;LRP1;HBEGF;AP2A2;CYBRD1;STOM;SYT8;TPCN1;PITPNM1;ENTPD6;BSG;HK1;ASAP2;MARCH4;SLC15A4;ATG16L2;ZFYVE21;IFNGR2;RAB31;LDLR;SIGMAR1;RAC2;KCNAB2;SYNE3;B4GAT1;TOMM34;BPHL;SORL1;CEACAM1;B3GAT3;RAB11FIP4;ABCD1;EVC;TRAPPC9;PLAU;BRI3;RAB3B;PCSK9;ANTXR2;EHD4;DBNDD1;PEX10;CORO7;BNIP3;MVB12B;CEMIP;PKD2;RETSAT;CTSZ;GPSM1;AP3D1;ABCA2;ADAM8;TMEM9;WNT3;CLTCL1;SCYL1;ABHD17C;SNTB2;MOAP1;B3GNT3;TMEM173;ATP7B;SHANK3;MGAT4B;GOLGA2P5;DIRC2;RHOD;SNX17;ST6GALNAC6;PI4K2A;RHOF;ANKZF1;SLC48A1;LLGL1;BBS1;PEX1;B4GALT2;WDR59;CD320;B4GALT6;RFNG;CD9;EPN2;AREG;BOK;ERBB2;ULK1;VAMP2;C6ORF89;BNIP3L;SLC22A17;MCFD2;BAX;SV2A;XYLT2;TMBIM4;MBTPS2;WASH3P;MFNG;LPCAT1;EHD3;ST3GAL3;TMEM231;IRAK1;TGFA;PI4K2B;DECR2;COG7;ABCG1;SNN;ABCA7;RAB12;BCAP31;DOPEY2;SLC9A7;SYNGR1;QSOX1;CD68;SPPL2B;STK25;SUN1;DNM2;CAT;ARMCX1;SLC50A1;SLC12A4;INSR;C12ORF66;HLA-G;STX10;PRAF2;MALL;RNF144A;SEMA4C;SAMD8;VPS16;MAN2B1;SLC16A13;NDST2;BCL2L1;PKD1;GAL3ST4;NMNAT2;AZIN2;ST3GAL2;ICA1;RAB40B;PDCD6;ATP6V1F;CHST14;PLEKHM1;NBEAL2;COL6A1;VPS51;ST3GAL5;MAN2B2;CHPF;SLC26A11
19249,GO:1905383,0.0265305398177021,0.999081481902289,2,3,protein localization to presynapse,BP,WNT7A;DVL1
7086,GO:0030888,0.0265582248550958,0.991178198151389,8,35,regulation of B cell proliferation,BP,PKN1;CARD11;CD81;CD320;ADA;INPP5D;MIF;PELI1
789,GO:0002054,0.0265807230431738,0.999078780644344,2,3,nucleobase binding,MF,PYGL;APRT
791,GO:0002060,0.0265807230431738,0.999078780644344,2,3,purine nucleobase binding,MF,PYGL;APRT
3178,GO:0006801,0.0266435460723979,0.991114360355165,8,36,superoxide metabolic process,BP,EGFR;ACP5;SH3PXD2B;CCS;SH3PXD2A;TGFB1;PRKCD;GCH1
6684,GO:0030060,0.0266544564486403,0.999074806417678,2,3,L-malate dehydrogenase activity,MF,MDH2;PHGDH
8947,GO:0035004,0.0268024042107767,0.990384130790459,9,40,phosphatidylinositol 3-kinase activity,MF,EGFR;PIK3R2;HBEGF;FGFR4;FGFR1;ERBB2;EREG;FYN;FGFR3
13730,GO:0060313,0.0268929172615299,0.999061910180391,2,3,negative regulation of blood vessel remodeling,BP,CST3;BCR
7614,GO:0032011,0.0269074227661954,0.990339645546045,9,40,ARF protein signal transduction,BP,APPL2;ARAP1;ASAP2;AGAP1;ARAP3;ADAP1;GIT1;ACAP3;IQSEC1
7615,GO:0032012,0.0269074227661954,0.990339645546045,9,40,regulation of ARF protein signal transduction,BP,APPL2;ARAP1;ASAP2;AGAP1;ARAP3;ADAP1;GIT1;ACAP3;IQSEC1
4064,GO:0009116,0.0269855239324001,0.986515052900328,17,100,nucleoside metabolic process,BP,NT5E;DLG4;GTPBP1;TK2;NME4;GAMT;CARD11;APRT;ADA;UCKL1;AHCY;DGUOK;UPP1;APOBEC3C;APOBEC3F;DLG3;AK3
5798,GO:0017048,0.0271019079279259,0.984911194152628,23,139,Rho GTPase binding,MF,DOCK4;OBSCN;PKN1;DVL1;FMNL2;PLEKHG2;BCR;RGL2;PAK6;CDC42EP5;FARP1;PLEKHG4;PLEKHG3;PLEKHG5;NET1;ARHGAP44;SH3BP1;INF2;ARHGEF4;ARHGEF1;PAK1;KCTD13;PKN3
6212,GO:0019740,0.0271593136404984,0.999047425285517,2,3,nitrogen utilization,BP,GLUL;BAX
8742,GO:0034404,0.0271650738176468,0.984245730234076,26,168,nucleobase-containing small molecule biosynthetic process,BP,NT5E;XDH;PGM1;DNPH1;TK2;RAPGEF3;NME4;HK1;PFKL;PFKP;DHTKD1;APRT;ENTPD2;PFKFB2;MLXIPL;ADA;UCKL1;DDIT4;ALDOC;PPARA;UPP1;NEIL1;INSR;PFKM;PFKFB3;NT5C1B
12307,GO:0048668,0.0272857359241753,0.993930320843397,5,17,collateral sprouting,BP,PTPRS;LPAR3;DVL1;WNT3;ULK2
5327,GO:0016053,0.0272897976910644,0.982157294097244,41,285,organic acid biosynthetic process,BP,NR1D1;NAGS;PGM1;ACOT7;GLUL;HSD17B8;UROS;PYCR2;HK1;GGT1;FGFR4;PFKL;GAMT;CEACAM1;CBR4;PFKP;DHTKD1;ALOX15B;CEMIP;LTA4H;CBS;TGFB1;PHGDH;PFKFB2;MLXIPL;AHCY;DDIT4;ALDOC;DECR2;PPARA;MIF;INSR;PFKM;GPT2;PFKFB3;MLYCD;HYAL1;WDTC1;PROX1;CHST14;GCH1
16225,GO:0090276,0.0273197908118906,0.985474363450529,20,120,regulation of peptide hormone secretion,BP,NR1D1;APLN;LRP5;ITPR3;EGFR;HADH;ARL2;RAPGEF3;GLUL;NLGN2;PFKL;PCK2;PFKFB2;RASL10B;PLA2G6;PFKM;PPP3CB;ICA1;SIRT3;HFE
11523,GO:0046058,0.0273727296001541,0.990114988131935,9,41,cAMP metabolic process,BP,RAPGEF3;PTHLH;PKD2;TIMP2;LTB4R2;ADCY1;GABBR1;ADCY7;ADCY6
17395,GO:1900119,0.0273819263212248,0.995286725242533,4,12,positive regulation of execution phase of apoptosis,BP,ENDOG;BOK;BAX;SIRT2
8851,GO:0034656,0.0274459844315472,0.990793814010877,8,36,nucleobase-containing small molecule catabolic process,BP,NT5E;ENTPD6;ENTPD2;ADA;AHCY;UPP1;APOBEC3C;APOBEC3F
12369,GO:0048771,0.0274774825224738,0.98626409910874,17,97,tissue remodeling,BP,CST3;ACVR2B;F2R;LRP5;EGFR;ACP5;EPAS1;RAC2;CEACAM1;BCR;ADAM8;TGFB1;TPP1;BAX;INPP5D;PLEKHM1;LRRK1
16764,GO:0098562,0.0274814082478277,0.984662688317742,23,142,cytoplasmic side of membrane,CC,DLG4;SNX9;MAP2K2;S100A6;MYZAP;KCNAB2;SYNGAP1;PTK6;ERRFI1;SPTB;PKD2;GNAL;NTSR1;RASA3;FARP1;PTPN1;ESYT2;JAK3;RASA4;SPPL2B;FYN;SRMS;RGS19
10021,GO:0042471,0.0276255122309854,0.988213500109808,12,61,ear morphogenesis,BP,NAGLU;SPRY2;DVL1;FGFR1;TSHZ1;BCR;SLITRK6;EPHB2;MAPK3;VANGL2;PROX1;CELSR1
13026,GO:0051491,0.0276838184870751,0.992659102439903,6,22,positive regulation of filopodium assembly,BP,ZMYND8;ESPN;ARAP1;TENM2;AGRN;FSCN1
13695,GO:0060263,0.0276896030280255,0.996975704164686,3,7,regulation of respiratory burst,BP,RAC2;BCR;INSR
11361,GO:0045737,0.027719908473947,0.99157824295546,7,29,positive regulation of cyclin-dependent protein serine/threonine kinase activity,BP,EGFR;AKT1;CCND1;PKD2;PROX1;PKD1;MAPRE3
3167,GO:0006782,0.0277609596332241,0.996964807732917,3,7,protoporphyrinogen IX biosynthetic process,BP,UROS;ALAS1;PPOX
14695,GO:0070326,0.0278415465523969,0.999009957099185,2,3,very-low-density lipoprotein particle receptor binding,MF,APOE;PCSK9
14723,GO:0070382,0.0279166717082209,0.985394588928337,19,113,exocytic vesicle,CC,DLG4;PTPRS;SYTL1;MCTP1;SYT8;BRSK1;RAB3B;DBNDD1;PI4K2A;VAMP2;SV2A;DNM1;SYNGR1;SEMA4C;BCL2L1;ICA1;RAB40B;SEPT6;APBA1
12394,GO:0048846,0.0280223862873006,0.991509362220886,7,28,axon extension involved in axon guidance,BP,SEMA4B;VEGFA;SEMA3F;WNT3;SEMA4F;SEMA4C;SEMA3B
17954,GO:1902284,0.0280223862873006,0.991509362220886,7,28,neuron projection extension involved in neuron projection guidance,BP,SEMA4B;VEGFA;SEMA3F;WNT3;SEMA4F;SEMA4C;SEMA3B
15153,GO:0071276,0.0280268378396286,0.992436936656822,6,24,cellular response to cadmium ion,BP,EGFR;FOS;AKT1;GSN;MT2A;MAPK3
3453,GO:0007269,0.0281365719235798,0.987026044133158,14,75,neurotransmitter secretion,BP,WNT7A;SYTL1;MCTP1;DVL1;SYT8;KCNC4;BRSK1;ASIC1;SNPH;RIMS3;VAMP2;PCLO;PFN2;APBA1
17106,GO:0099643,0.0281365719235798,0.987026044133158,14,75,signal release from synapse,BP,WNT7A;SYTL1;MCTP1;DVL1;SYT8;KCNC4;BRSK1;ASIC1;SNPH;RIMS3;VAMP2;PCLO;PFN2;APBA1
14501,GO:0062013,0.0281542105967085,0.985884297341426,17,97,positive regulation of small molecule metabolic process,BP,NR1D1;APOE;NOS1;RAPGEF3;ADORA2B;AKT1;PTHLH;TIMP2;NTSR1;PFKFB2;MLXIPL;PPARA;ABCG1;INSR;TAZ;PFKFB3;MLYCD
2938,GO:0006469,0.0282234867173325,0.982736940116702,31,205,negative regulation of protein kinase activity,BP,DUSP6;DUSP5;PDCD4;APOE;LRP5;PKN1;WWTR1;SPRY2;SPRY4;DVL1;ADARB1;AKT1;PPM1F;EPHA1;SORL1;CEACAM1;PODNL1;PTK6;DUSP7;ERRFI1;EPHB2;CDKN1C;PTPN1;CAMK2N1;TRIB2;PRKCD;DUSP4;RGS14;CHAD;SOCS7;CBLC
5690,GO:0016810,0.0283238888368688,0.985157213389894,19,113,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds,MF,MTA1;ADARB1;HDAC5;OPLAH;HMG20B;ACY1;PHF21A;MBD3;ADA;PADI3;HDAC7;CAT;APOBEC3C;APOBEC3F;NDST2;SIRT2;GCH1;SIRT3;PM20D2
13754,GO:0060341,0.0283444459672988,0.978924875528086,81,619,regulation of cellular localization,BP,ZMYND8;NR1D1;EDEM1;PRNP;F2R;LRP5;EGFR;NOS1;VPS11;RAPGEF3;ZFP36L1;MAP2K2;MAP2K1;MCTP1;SSH1;LRP1;DVL1;NLGN2;STOM;ADORA2B;AKT1;KCNC4;RAC2;KCNAB2;SORL1;B3GAT3;LZTS2;ANK3;CEP250;GAS6;CSNK1E;RAB3B;GSN;PCSK9;CEMIP;PKD2;ABCA2;EPHB2;ASIC1;PLCG1;TGFB1;ABHD17C;NTSR1;TMEM173;CROCC;SNX33;RIMS3;PTPN1;LRP4;CEP131;PRKACA;MICALL2;ERBB2;VAMP2;TFDP2;BNIP3L;TRPC1;PRKCD;REEP6;BAX;ZDHHC8;GDI1;DNM1;GSTO1;REEP2;SESN2;BCAP31;PLA2G6;NBPF3;FYN;MAPK3;CEP72;PAK1;PPP3CB;ITGA3;BCL2L1;LMNA;NGFR;CAMK1;HFE;PFN2
7633,GO:0032050,0.0283538030233685,0.996873827323315,3,7,clathrin heavy chain binding,MF,LRP1;LDLR;CEMIP
2438,GO:0005640,0.0283720327772446,0.993621714219532,5,17,nuclear outer membrane,CC,ITPR3;SIGMAR1;SYNE3;RETSAT;BOK
7602,GO:0031995,0.0283824413359571,0.996869412060086,3,7,insulin-like growth factor II binding,MF,IGFBP4;IGFBP2;INSR
17067,GO:0099550,0.0284398131857893,0.998976661880018,2,3,trans-synaptic signaling, modulating synaptic transmission,BP,F2R;EPHB2
18232,GO:1903019,0.0285151698751563,0.9950279096817,4,12,negative regulation of glycoprotein metabolic process,BP,CST3;HBEGF;JAK3;ABCA7
20250,GO:2001171,0.0285625698307687,0.993567228014023,5,17,positive regulation of ATP biosynthetic process,BP,PFKFB2;MLXIPL;INSR;TAZ;PFKFB3
2779,GO:0006213,0.0285700900928735,0.990311061336149,8,37,pyrimidine nucleoside metabolic process,BP,NT5E;TK2;NME4;UCKL1;UPP1;APOBEC3C;APOBEC3F;AK3
9242,GO:0035641,0.0285786360905088,0.996839113994284,3,7,locomotory exploration behavior,BP,DLG4;APOE;NLGN2
6942,GO:0030574,0.0286390924725618,0.98957277717738,9,41,collagen catabolic process,BP,CST3;MRC2;MMP1;CTSB;COL13A1;MMP10;ADAM15;PHYKPL;COL6A1
8718,GO:0034374,0.0286419282401728,0.998965321585727,2,3,low-density lipoprotein particle remodeling,BP,APOE;ABCG1
2822,GO:0006290,0.0287249021337775,0.996816469605839,3,7,pyrimidine dimer repair,BP,ERCC1;DDB2;ERCC6
8466,GO:0033619,0.0287658126884439,0.988190708479536,11,55,membrane protein proteolysis,BP,APOE;SNX9;SH3D19;ADAM8;TIMP2;TGFB1;SNX33;ADAM19;MBTPS2;SPPL2B;NGFR
12722,GO:0050994,0.0288511257055673,0.991159289933445,7,29,regulation of lipid catabolic process,BP,TYSND1;AKT1;LDLR;PRKCD;LONP2;PPARA;MLYCD
10273,GO:0043025,0.0288569960810123,0.981271045173697,39,269,neuronal cell body,CC,CST3;APOE;ITPR3;PTPRS;GLUL;ENDOG;SHANK2;LRP1;GJC2;DVL1;KCNC4;ZNF385A;CRTC1;EPHB2;GRIN3B;TIMP2;TGFB1;SNPH;NTSR1;NSMF;PI4K2A;CAMK2N1;LRP4;PRKCZ;ADA;CYGB;SV2A;ITGA1;GDI1;MYO1D;RAC3;ATXN10;INSR;VPS16;DLG3;SIRT2;AZIN2;HOMER2;KLHL24
12309,GO:0048670,0.0288731169591825,0.99494542892342,4,12,regulation of collateral sprouting,BP,PTPRS;LPAR3;WNT3;ULK2
12417,GO:0048878,0.0290545756070506,0.978287475867448,83,643,chemical homeostasis,BP,FHL1;NR1D1;DLG4;CYP27B1;PRNP;VEGFA;APOE;PYGL;F2R;LRP5;ITPR3;EGFR;NOS1;HEXB;SLC7A8;SLC12A7;LPAR3;ENDOG;SMAD3;PIK3R2;EPAS1;CYBRD1;AKT1;TPCN1;HK1;FGFR4;LDLR;PRKACB;ANK3;EDNRA;GAS6;PCSK9;ANGPTL4;BNIP3;CEMIP;PKD2;AP3D1;ABCA2;PLCG1;TGFB1;NTSR1;ATP7B;RASA3;ERO1B;VGF;PCK2;MLXIPL;PRKACA;BOK;TRPC1;SLC22A17;CACNB3;IFI6;BAX;SV2A;MT2A;GSTO1;LPCAT1;SESN2;ABCG1;BCAP31;SLC9A7;PLA2G6;WFS1;FYN;SLC12A4;MAPK3;INSR;GRINA;PFKM;ADCY1;MALL;PPP3CB;WDTC1;PKD1;ADCY7;SLC25A37;NGFR;ATP6V1F;HFE;HOMER2;ADCY6;SLC26A11
3215,GO:0006865,0.0291348980363287,0.986501493020319,14,75,amino acid transport,BP,SLC6A8;SLC7A8;SLC6A6;STK39;SLC15A4;SERINC2;SLC43A1;SLC38A10;NTSR1;VAMP2;SV2A;SLC25A29;PRAF2;APBA1
1650,GO:0004096,0.0291826129073631,0.998934757552231,2,3,catalase activity,MF,CYGB;CAT
2387,GO:0005524,0.0291914017148406,0.976632661747446,145,1155,ATP binding,MF,ACVR2B;PYGL;DGKA;OBSCN;NEK9;PKN1;ACSF2;EGFR;RPS6KA2;MST1R;TK2;ACTA2;GLUL;MAP2K2;NME4;SMARCA1;PC;MAP2K1;MARK4;ERCC6;CDK18;NMRK1;AKT1;STK39;HK1;EPHA1;BRSK1;FGFR4;FGFR1;PRKACB;PFKL;TTLL12;OPLAH;HLTF;ABCD1;TWF2;STRADB;MAPK13;PTK6;PFKP;CSNK1E;MAPKAPK3;BCR;EHD4;NADK;PANK4;HLCS;NPR2;DGKQ;PAK6;FYCO1;ABCA2;EPHB2;GRK6;KIF17;MVD;ENTPD2;SCYL1;ULK2;MKNK2;ATP7B;PIP5KL1;KIF26B;DNAH1;PI4K2A;KIF7;PEX1;TRAP1;PFKFB2;PRKCZ;PRKACA;MINK1;ACTR1B;PIM2;UCKL1;ERBB2;ULK1;STK17A;JAK3;PDK1;PRKCD;FAM20C;NUBP2;RPS6KA5;DGUOK;CUL9;LIMK1;NTPCR;RPS6KA6;SCN8A;EHD3;LONP2;MAPK12;IRAK1;CHD2;PI4K2B;CHEK2;ABCG1;MYO1D;MYH15;CDC34;ABCA7;SPEG;DALRD3;FYN;STK25;EEF2K;CKMT1A;CHKA;KIF26A;DDX50;MAPK3;INSR;PFKM;ADCY1;ATP8B2;PDXK;PAK1;CAMKK2;ALPK1;PFKFB3;STK32C;SRMS;MAP2K3;IARS2;NMNAT2;ADCY7;TEP1;MAP3K10;KIF13B;CAMK1;CAMKK1;BBS10;CDK11B;FGFR3;ITPKB;CDC42BPG;CLK3;DHX32;PKN3;TTLL3;AK3;ADCY6;LRRK1;AARS
12225,GO:0048499,0.029202038824396,0.998933653298681,2,3,synaptic vesicle membrane organization,BP,AP3D1;SYNGR1
6695,GO:0030100,0.0292238279048555,0.983141839430948,25,159,regulation of endocytosis,BP,DLG4;APLN;VEGFA;APOE;TSPAN1;MCTP1;LRP1;LDLR;GAS6;PCSK9;BCR;EHD4;STON1;TGFB1;ARAP3;TUB;SNX17;SNX33;PTPN1;LRSAM1;ABCA7;EEF2K;DNM2;BIN1;HFE
11794,GO:0046686,0.0293274283409424,0.989197302471383,9,44,response to cadmium ion,BP,ERCC1;PRNP;EGFR;FOS;AKT1;GSN;MT2A;CAT;MAPK3
9926,GO:0042278,0.0293368415652457,0.987321273956114,12,64,purine nucleoside metabolic process,BP,NT5E;DLG4;GTPBP1;NME4;GAMT;CARD11;APRT;ADA;AHCY;DGUOK;DLG3;AK3
12106,GO:0048169,0.0293451766682023,0.99334233312392,5,17,regulation of long-term neuronal synaptic plasticity,BP,DLG4;SYNGAP1;EPHB2;SHANK3;SYNGR1
14129,GO:0061008,0.0293723807403858,0.984858502479346,18,105,hepaticobiliary system development,BP,EGFR;SMAD3;CEACAM1;CCND1;PCSK9;PKD2;CEBPB;TGFB1;HMGCL;PCK2;ADA;TGFBR3;ACO2;ARID5B;PROX1;PKD1;HFE;SRSF5
11721,GO:0046543,0.029379201673402,0.996714583266765,3,7,development of secondary female sexual characteristics,BP,TGFB1;AREG;IRF2BPL
13114,GO:0051665,0.029438036414717,0.9967053745941,3,7,membrane raft localization,BP,MARVELD1;GSN;MALL
1262,GO:0003015,0.0295520072256709,0.98387548894482,21,128,heart process,BP,APLN;ITPR3;SCN4B;NOS1;GAA;EPAS1;HBEGF;VEGFB;TNNT1;NPR2;SNTA1;PRKACA;ADA;TRPC1;CACNB3;PPP1R13L;GSTO1;EHD3;TAZ;MAP2K3;GCH1
18379,GO:1903365,0.0296264750234786,0.998909420637641,2,3,regulation of fear response,BP,APOE;RAG1
20149,GO:2000822,0.0296264750234786,0.998909420637641,2,3,regulation of behavioral fear response,BP,APOE;RAG1
8136,GO:0032869,0.0296698558925663,0.98286411672534,25,158,cellular response to insulin stimulus,BP,SHC1;PTPRE;ZFP36L1;PIK3R2;AKT1;HDAC5;RAB31;CEACAM1;PCSK9;ERRFI1;APRT;PTPN1;PCK2;PRKCZ;VAMP2;PRKCD;EEF2K;INSR;PAK1;WDTC1;SOCS7;NGFR;ATP6V1F;GRB10;SRSF5
1711,GO:0004301,0.0297130387909916,0.996662229528902,3,7,epoxide hydrolase activity,MF,AKR7A2;LTA4H;RNPEP
17847,GO:1902003,0.0297192604269567,0.993234215007266,5,17,regulation of amyloid-beta formation,BP,PRNP;APOE;SORL1;ABCA7;BIN1
15771,GO:0072378,0.0297874483100325,0.996650526513344,3,7,blood coagulation, fibrin clot formation,BP,FBLN1;F12;SERPING1
2001,GO:0004725,0.0297920107010106,0.98614179088349,14,76,protein tyrosine phosphatase activity,MF,DUSP6;DUSP5;PTPRS;PTPRE;MAP2K1;SSH1;PTPRU;DUSP7;CDC25B;PTPDC1;PTPN1;DUSP4;DUSP23;SSH3
5592,GO:0016618,0.0299220046295341,0.998892428516554,2,3,hydroxypyruvate reductase activity,MF,CTBP1;GRHPR
6807,GO:0030267,0.0299220046295341,0.998892428516554,2,3,glyoxylate reductase (NADP) activity,MF,CTBP1;GRHPR
13987,GO:0060712,0.0299761376729514,0.994689092576134,4,12,spongiotrophoblast layer development,BP,PHLDA2;ZFP36L1;AKT1;FBXW8
7482,GO:0031657,0.030022667698128,0.994678207883691,4,12,regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,EGFR;AKT1;PKD2;PKD1
7045,GO:0030826,0.0301674841132054,0.996590563704889,3,7,regulation of cGMP biosynthetic process,BP,APOE;NOS1;ADORA2B
10726,GO:0044089,0.0301882225619131,0.979032790853239,53,383,positive regulation of cellular component biogenesis,BP,ERCC1;ZMYND8;ADGRL1;VEGFA;WNT7A;ESPN;SDC1;DDB2;ARL2;MMP1;SNX9;RAPGEF3;ARAP1;SMAD3;SH3PXD2B;NLGN2;CORO1B;PPM1F;EPHA1;RAC2;NPHP4;TENM2;TWF2;GSN;WIPF1;SLITRK6;ARPIN;CDC42EP5;EPHB2;TGFB1;CROCC;AGRN;ADGRB2;ULK1;FSCN1;STUB1;BAX;LIMK1;WASH3P;LRSAM1;FHOD1;CDC34;RAC3;EEF2K;DNM2;TPBG;PAK1;HYAL1;PPP2R5B;PROX1;PXN;PLEKHM1;PFN2
10304,GO:0043086,0.0302750913031104,0.977858105924536,71,543,negative regulation of catalytic activity,BP,DUSP6;DUSP5;CST3;CYP27B1;PDCD4;PRNP;VEGFA;TNFRSF6B;APOE;LRP5;PKN1;SERPINE2;WWTR1;NOS1;SPRY2;ARL2;SPRY4;PPP1R35;DVL1;PPP1R14A;PRDX5;ADARB1;AKT1;PPM1F;SERPING1;EPHA1;RAG1;SORL1;CEACAM1;PODNL1;GAS6;PTK6;DUSP7;ANGPTL4;ERRFI1;AIP;PLXNB3;TFPI2;GPSM1;EPHB2;CDKN1C;TIMP2;FARP1;RNH1;PTPN1;CAMK2N1;TRIB2;PRKCZ;OXA1L;RASA4;PRKCD;IFI6;DUSP4;PCSK1N;LIMK1;LTB4R2;RGS14;CHAD;MYO1D;ECM1;NEIL1;ELFN2;GABBR1;MICAL1;WDTC1;BIN1;DLG3;SERPINB1;SOCS7;NGFR;CBLC
11240,GO:0045453,0.0302800821061214,0.989680648773595,8,35,bone resorption,BP,EGFR;ACP5;RAC2;ADAM8;TPP1;INPP5D;PLEKHM1;LRRK1
622,GO:0001806,0.0304040493500723,0.998864503230878,2,3,type IV hypersensitivity,BP,IL20RB;ZP3
1214,GO:0002883,0.0304040493500727,0.998864503230878,2,3,regulation of hypersensitivity,BP,IL20RB;ZP3
2541,GO:0005802,0.030557320995156,0.982084842735068,26,167,trans-Golgi network,CC,POSTN;SNX9;ARAP1;MARCH9;MARCH4;RAB31;SORL1;TRAPPC9;CORO7;CLTCL1;ATP7B;PI4K2A;LLGL1;BOK;VAMP2;PCSK1N;PI4K2B;COG7;RAB12;DOPEY2;SLC9A7;DNM2;STX10;NMNAT2;AZIN2;VPS51
6848,GO:0030324,0.0307669479930066,0.983732107781201,19,112,lung development,BP,ACVR2B;VEGFA;EGFR;SPRY2;MAP2K1;EPAS1;WNT2B;FGFR1;LAMA5;ERRFI1;CTSZ;ADA;MAPK3;VANGL2;ITGA3;PROX1;PKD1;HSD11B1;CELSR1
7257,GO:0031232,0.03076773440143,0.998843263796364,2,3,extrinsic component of external side of plasma membrane,CC,SERPINE2;PCSK9
1618,GO:0004046,0.0307852630421283,0.998842236413286,2,3,aminoacylase activity,MF,ACY1;CAT
18728,GO:1904154,0.03084349539283,0.998838820878805,2,3,positive regulation of retrograde protein transport, ER to cytosol,BP,EDEM1;BCAP31
4631,GO:0010755,0.0308757071039839,0.996477970189393,3,7,regulation of plasminogen activation,BP,SERPINE2;F12;CTSZ
17733,GO:1901653,0.0308860932203376,0.980094341182283,37,254,cellular response to peptide,BP,PRNP;SHC1;PTPRE;ZFP36L1;PIK3R2;LRP1;AKT1;HDAC5;RAB31;PRKACB;CEACAM1;PCSK9;ERRFI1;APRT;TGFB1;PTPN1;PCK2;PRKCZ;PRKACA;VAMP2;JAK3;PRKCD;FYN;EEF2K;MAPK3;INSR;ADCY1;PAK1;WDTC1;ADCY7;SOCS7;NGFR;ATP6V1F;PXN;GRB10;SRSF5;ADCY6
9241,GO:0035640,0.0310399021395431,0.994438823582973,4,12,exploration behavior,BP,DLG4;APOE;NLGN2;ITGA3
13225,GO:0051899,0.031071204883097,0.987733144035943,10,49,membrane depolarization,BP,FHL1;SCN4B;TPCN1;ANK3;NTSR1;PRKCZ;BOK;CACNB3;IFI6;SCN8A
13197,GO:0051835,0.0310748896690908,0.998825211778705,2,3,positive regulation of synapse structural plasticity,BP,SHANK3;CAMK1
5362,GO:0016139,0.0310952016222237,0.996442852201352,3,7,glycoside catabolic process,BP,FUCA1;NAGA;ABHD10
8192,GO:0032945,0.031186822615862,0.98843814453738,9,42,negative regulation of mononuclear cell proliferation,BP,PRNP;PKN1;IL20RB;CEBPB;TGFB1;ERBB2;INPP5D;PELI1;HLA-G
12522,GO:0050672,0.031186822615862,0.98843814453738,9,42,negative regulation of lymphocyte proliferation,BP,PRNP;PKN1;IL20RB;CEBPB;TGFB1;ERBB2;INPP5D;PELI1;HLA-G
13836,GO:0060448,0.0312703218301347,0.998813671759448,2,3,dichotomous subdivision of terminal units involved in lung branching,BP,VANGL2;CELSR1
13489,GO:0055065,0.0312784168015086,0.9789131880496,45,324,metal ion homeostasis,BP,DLG4;CYP27B1;PRNP;APOE;F2R;ITPR3;EGFR;NOS1;HEXB;SLC7A8;SLC12A7;LPAR3;SMAD3;EPAS1;CYBRD1;TPCN1;ANK3;EDNRA;BNIP3;CEMIP;PKD2;AP3D1;PLCG1;TGFB1;NTSR1;ATP7B;RASA3;PRKACA;BOK;TRPC1;SLC22A17;CACNB3;BAX;SV2A;MT2A;GSTO1;BCAP31;PLA2G6;WFS1;FYN;SLC12A4;GRINA;PKD1;SLC25A37;HFE
1158,GO:0002765,0.0313134876191128,0.998811117207756,2,3,immune response-inhibiting signal transduction,BP,IL20RB;HLA-G
11831,GO:0046813,0.0313651725221447,0.998808055800178,2,3,receptor-mediated virion attachment to host cell,BP,GAS6;CD81
607,GO:0001776,0.0314125836587468,0.98690121204013,11,56,leukocyte homeostasis,BP,PKN1;AKT1;RAG1;TGFB1;ADA;JAK3;BAX;MIF;PPP3CB;SLC39A3;ITPKB
3283,GO:0006975,0.0314336115089365,0.996388503259326,3,7,DNA damage induced protein phosphorylation,BP,MAPK12;CHEK2;MAPK3
16893,GO:0098839,0.0314605664443155,0.996384163604601,3,7,postsynaptic density membrane,CC,DLG4;PTPRS;DLG3
10217,GO:0042891,0.0315461517317507,0.996370374250188,3,7,antibiotic transport,BP,SLC13A5;SLC13A3;MFSD10
14540,GO:0070061,0.0315653412954354,0.99879617169328,2,3,fructose binding,MF,PFKL;PFKM
11554,GO:0046110,0.0315698985742796,0.998795900613824,2,3,xanthine metabolic process,BP,XDH;ADA
10352,GO:0043171,0.0316302379518144,0.991274741813113,6,23,peptide catabolic process,BP,RNPEPL1;GGT1;LTA4H;ADAMTS13;TPP1;RNPEP
15507,GO:0071889,0.0316414989098622,0.99127088919281,6,23,14-3-3 protein binding,MF,ZFP36L1;AKT1;PRKCZ;DDIT4;HDAC7;KIF13B
15461,GO:0071804,0.0316690312224963,0.984691258138972,15,83,cellular potassium ion transport,BP,FHL1;KCNG1;PRNP;SLC12A7;KCNJ15;KCNC4;STK39;KCNAB2;ANK3;PKD2;VAMP2;SLC9A7;DNM2;SLC12A4;KLHL24
15462,GO:0071805,0.0316690312224963,0.984691258138972,15,83,potassium ion transmembrane transport,BP,FHL1;KCNG1;PRNP;SLC12A7;KCNJ15;KCNC4;STK39;KCNAB2;ANK3;PKD2;VAMP2;SLC9A7;DNM2;SLC12A4;KLHL24
2697,GO:0006066,0.031794619464269,0.979875511475376,34,231,alcohol metabolic process,BP,CYP27B1;APOE;LRP5;OSBPL5;ISYNA1;LMF1;PLCD3;SRD5A3;LDLR;FGFR1;SEC14L2;SORL1;PLCH2;PCSK9;DGKQ;RETSAT;PLCG1;MVD;NTSR1;SNX17;PLPP6;PCK2;MBTPS2;HSD17B7;INPP5D;COQ2;ABCG1;CHKA;CAT;PLCB3;CYP2R1;GCH1;ITPKB;SPTLC2
13070,GO:0051588,0.0318367583489498,0.987378626680967,10,49,regulation of neurotransmitter transport,BP,APLN;NOS1;MCTP1;KCNC4;RAB3B;ASIC1;NTSR1;RIMS3;SV2A;PFN2
8366,GO:0033273,0.0318452846869693,0.986082268326859,12,63,response to vitamin,BP,CYP27B1;POSTN;EGFR;CCND1;GAS6;GSN;HLCS;TGFB1;ADA;MTHFR;CAT;DNMT3A
5685,GO:0016801,0.0318568957584704,0.99424461131597,4,12,hydrolase activity, acting on ether bonds,MF,AKR7A2;LTA4H;AHCY;RNPEP
11248,GO:0045499,0.0319278722042777,0.992587899594395,5,17,chemorepellent activity,MF,SEMA4B;SEMA3F;SEMA4F;SEMA4C;SEMA3B
14730,GO:0070403,0.0319516412955576,0.994221977654271,4,12,NAD+ binding,MF,HADH;CRYL1;SIRT2;SIRT3
3306,GO:0007010,0.031966555027259,0.974743517126537,124,986,cytoskeleton organization,BP,PARVB;BBS2;APOE;ESPN;OBSCN;NISCH;OBSL1;SPRY2;CAPN2;SHC1;ARL2;RAPGEF3;ARAP1;SSH1;MARK4;SMAD3;LRP1;DVL1;SH3PXD2B;FBXW5;TMOD2;CORO1B;PPM1F;EPHA1;FMNL2;BRSK1;DNAAF5;RAC2;NPHP4;SYNE3;ANK3;EFS;TNNT1;TWF2;CEP250;LAMA5;GSN;PLEKHG2;BCR;SEPT10;WIPF1;SH3D19;ARPIN;SPTB;CORO7;PAK6;PKD2;CDC42EP5;ITGB5;TGFB1;ARHGAP25;FHOD3;SHANK3;MSRB2;EML2;GOLGA2P5;ARAP3;CROCC;RHOD;DNAH1;RHOF;WASF3;LLGL1;RHOBTB2;TUBG2;PTPN1;AGRN;CEP131;PRKCZ;MINK1;MICALL2;CAPG;SDCCAG8;NINL;PLEK2;FSCN1;ARHGAP44;PRKCD;SH3BP1;CUL9;PPL;LIMK1;TPM2;WASH3P;RGS14;FHOD1;CHEK2;EML3;DNAAF3;RAC3;SUN1;ARHGAP12;INF2;ZMYM3;IQSEC1;TUBB6;MAPK3;CEP72;VANGL2;PAK1;CUL7;MICAL1;BIN1;PROX1;LMNA;PKD1;KCTD13;TRIP10;NDE1;PCLO;PXN;MSS51;LURAP1;CELSR1;TACC1;SEPT6;PFN2;SSH3;CCDC88C;CDC42BPG;TRIM46;TTLL3;PI4KAP2;KLHL24
8523,GO:0033829,0.0320070688649902,0.998769790825084,2,3,O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity,MF,RFNG;MFNG
9263,GO:0035690,0.0320464412254551,0.979554984081825,35,240,cellular response to drug,BP,EGR1;CST3;PRNP;HMGA2;EGFR;SSH1;ENDOG;STAT6;PPP1R14A;PPM1F;IMPACT;MAPK13;GAS6;ERRFI1;BNIP3;TGFB1;ANKZF1;PCK2;AGRN;TRAP1;KDM6B;NET1;PRKCD;DDIT4;MT2A;CHEK2;FYN;STK25;DNM2;MAPK3;ADCY1;PPP3CB;DNMT3A;ADCY7;ADCY6
5646,GO:0016740,0.0320529243036306,0.973212601406115,227,1900,transferase activity,MF,GID4;B4GALNT4;DLG4;FBXO2;NAGS;ACVR2B;PYGB;PYGL;DGKA;LPCAT4;HMGA2;OBSCN;NEK9;CRAT;PKN1;EGFR;RPS6KA2;DNPH1;TMEM129;MST1R;LTBP4;KLHL29;DDB2;LTBP1;HEXB;TK2;ST6GALNAC2;MAP2K2;NME4;MARCH9;RBCK1;SUGCT;RNF44;MAP2K1;NAPRT;CPT2;MARK4;SMURF2;PIK3R2;PIGQ;HBEGF;MBOAT7;CDK18;FBXW5;RNF187;NMRK1;AKT1;FBXO41;STK39;HK1;EPHA1;GGT1;ASH2L;MARCH4;ZFYVE21;BRSK1;FGFR4;POLD4;FGFR1;PRKACB;PFKL;HLTF;RAG1;GAMT;B4GAT1;PIGV;NAT14;B3GAT3;CCND1;STRADB;MAPK13;PTK6;PFKP;CSNK1E;CARD11;MAPKAPK3;BCR;NADK;PANK4;COMTD1;RRNAD1;NPR2;DGKQ;PAK6;SHARPIN;FBXW8;ZNF598;EPHB2;APRT;GRK6;FBXL8;RNF135;ZNF862;SCYL1;ULK2;MKNK2;B3GNT3;EFNB3;PIP5KL1;MGAT4B;FBXO17;ST6GALNAC6;POLL;FBXO44;POLM;PI4K2A;ZER1;B4GALT2;ZDHHC24;B4GALT6;VHL;PFKFB2;RFNG;PRKCZ;PRKACA;MINK1;RABGGTA;PIM2;UCKL1;ALAS1;NEURL1B;ERBB2;ULK1;PRIMPOL;STK17A;JAK3;PDK1;PRKCD;FAM20C;MIB2;STUB1;XYLT2;TRIM4;FBXW4;EREG;RPS6KA5;DGUOK;ZDHHC8;LIMK1;TGFBR3;RPS6KA6;MFNG;GSTO1;LPCAT1;LRSAM1;ASB1;ST3GAL3;MAPK12;IRAK1;HDAC7;PI4K2B;PCMTD2;CHEK2;COQ2;FGGY;JADE2;CDC34;RNF123;SPEG;EEF2KMT;DTX3;TRPT1;FYN;UPP1;STK25;EEF2K;CERS4;CKMT1A;PELI1;CHKA;ASMTL;ZDHHC1;MAPK3;INSR;TAZ;PFKM;GPT2;PDXK;PAK1;KLHL36;CAMKK2;RNF144A;ALPK1;PFKFB3;REV1;HYAL1;STK32C;DNMT3A;SAMD8;SRMS;TSTD1;NSUN7;MAP2K3;NDST2;DLG3;ZYG11B;KCTD13;GAL3ST4;NMNAT2;BACH1;ALG12;TEP1;ST3GAL2;MAP3K10;PELI3;CHST14;FAM86B1;PHYKPL;CAMK1;CAMKK1;EZH1;TERC;CDK11B;FGFR3;TST;ST3GAL5;CBLC;ITPKB;SPTLC2;CDC42BPG;CLK3;PKN3;PI4KAP2;AK3;CHPF;LRRK1;KLHL24
19620,GO:1990743,0.0320557455643311,0.998766870709763,2,3,protein sialylation,BP,ST6GALNAC2;ST3GAL2
14869,GO:0070661,0.0322206845767758,0.981448630742542,24,155,leukocyte proliferation,BP,PRNP;PKN1;RAC2;CARD11;IGFBP2;IL20RB;CD81;CEBPB;TGFB1;IFNE;CD320;ADA;ERBB2;JAK3;PRKCD;BAX;INPP5D;MIF;FYN;PELI1;SATB1;HLA-G;PPP3CB;ZP3
7858,GO:0032426,0.0322396493888784,0.996258057604523,3,7,stereocilium tip,CC,ESPN;MORN4;HOMER2
2967,GO:0006509,0.0322797518814336,0.988822345873123,8,36,membrane protein ectodomain proteolysis,BP,APOE;SNX9;SH3D19;ADAM8;TIMP2;SNX33;ADAM19;SPPL2B
18015,GO:1902473,0.0322861096882141,0.996250496196312,3,7,regulation of protein localization to synapse,BP,WNT7A;DVL1;NLGN2
18774,GO:1904251,0.0322913184805064,0.996249648178582,3,7,regulation of bile acid metabolic process,BP,NR1D1;FGFR4;PROX1
6105,GO:0019344,0.0322946818129381,0.998752499467319,2,3,cysteine biosynthetic process,BP,GGT1;CBS
6718,GO:0030135,0.0323205064789404,0.979988760069908,31,208,coated vesicle,CC,EPN3;APOE;EGFR;VPS11;SNX9;LRP1;DVL1;HBEGF;AP2A2;LDLR;PCSK9;CEMIP;CTSZ;TMED4;CLTCL1;SCYL1;IDUA;CD9;EPN2;AREG;VAMP2;MCFD2;TGFA;BCAP31;DNM2;HLA-G;VANGL2;MALL;VPS16;RGS19;PDCD6
11191,GO:0045323,0.0324107851979188,0.998745493787882,2,3,interleukin-1 receptor complex,CC,IRAK1;TOLLIP
538,GO:0001657,0.0324162192532858,0.985812251145306,12,62,ureteric bud development,BP,PGF;CTNNBIP1;VEGFA;SDC1;SMAD3;WNT2B;FGFR1;LAMA5;PKD2;TGFB1;KIF26B;CAT
6671,GO:0030038,0.032431374874754,0.985244231736857,13,69,contractile actin filament bundle assembly,BP,RAPGEF3;ARAP1;SMAD3;SH3PXD2B;PPM1F;EPHA1;ITGB5;LIMK1;FHOD1;PAK1;KCTD13;PXN;PFN2
10341,GO:0043149,0.032431374874754,0.985244231736857,13,69,stress fiber assembly,BP,RAPGEF3;ARAP1;SMAD3;SH3PXD2B;PPM1F;EPHA1;ITGB5;LIMK1;FHOD1;PAK1;KCTD13;PXN;PFN2
12210,GO:0048471,0.0324449313874744,0.976347409467584,68,514,perinuclear region of cytoplasm,CC,CST3;EPN3;APLN;PRR7;TSPAN1;NDRG1;ANGEL1;EGFR;OBSL1;NOS1;CAPN2;MAP2K2;PTOV1;THBS3;S100A4;PRDX5;STOM;CORO1B;S100A6;PPM1F;PRKACB;RAB11FIP4;DOCK6;ABCD1;TWF2;CEP250;CTSB;RAB3B;GSN;PCSK9;EHD4;FBXW8;TMEM173;TMEM134;ATP7B;PRKCZ;PRKACA;PLEKHG5;ERBB2;VAMP2;CYFIP2;PRKCD;USP20;MT2A;EHD3;TGFA;BCAP31;RAC3;DNM2;GLB1;ATXN10;INF2;STX10;CUL7;ITGA3;TSTD1;SIRT2;TRIP10;AZIN2;RAP1GAP2;LAMB1;RAB40B;TOLLIP;HFE;NDRG2;GSDMA;PKN3;APBA1
9957,GO:0042340,0.0325194915776069,0.996212443657485,3,7,keratan sulfate catabolic process,BP,HEXB;GALNS;GLB1
8365,GO:0033270,0.0325690818393708,0.99620434310173,3,7,paranode region of axon,CC,GJC2;SIRT2;KIF13B
694,GO:0001915,0.0325855845295275,0.998734918767494,2,3,negative regulation of T cell mediated cytotoxicity,BP,CEACAM1;PPP3CB
17131,GO:0102148,0.0326181596694066,0.998732944368597,2,3,N-acetyl-beta-D-galactosaminidase activity,MF,HEXB;HEXDC
18244,GO:1903038,0.0326689012992415,0.985666696901857,12,63,negative regulation of leukocyte cell-cell adhesion,BP,PRNP;PAG1;CEACAM1;IL20RB;CEBPB;TGFB1;ERBB2;JAK3;PPARA;PELI1;HLA-G;HFE
18429,GO:1903463,0.0327640434513007,0.998724088152305,2,3,regulation of mitotic cell cycle DNA replication,BP,FGFR1;CHEK2
12974,GO:0051386,0.0328117230555281,0.996164632406421,3,7,regulation of neurotrophin TRK receptor signaling pathway,BP,SPRY2;CYFIP2;PPP2R5B
4998,GO:0015141,0.0328211196196871,0.998720616935601,2,3,succinate transmembrane transporter activity,MF,SLC13A5;SLC13A3
5181,GO:0015744,0.0328211196196871,0.998720616935601,2,3,succinate transport,BP,SLC13A5;SLC13A3
15248,GO:0071422,0.0328211196196871,0.998720616935601,2,3,succinate transmembrane transport,BP,SLC13A5;SLC13A3
11960,GO:0047192,0.0328851991785546,0.998716715590566,2,3,1-alkylglycerophosphocholine O-acetyltransferase activity,MF,LPCAT4;LPCAT1
487,GO:0001540,0.0328972704597972,0.987654591501583,9,43,amyloid-beta binding,MF,CST3;FBXO2;PRNP;APOE;LDLR;SORL1;EPHB2;INSR;APBA1
4947,GO:0014916,0.0329713695071439,0.998711462295488,2,3,regulation of lung blood pressure,BP,SMAD3;GCH1
18971,GO:1904724,0.0329715554905931,0.988465689435875,8,38,tertiary granule lumen,CC,CST3;PGM1;PRSS3;LTA4H;TIMP2;YPEL5;ALDOC;QSOX1
5788,GO:0017017,0.0330081391534666,0.993968044507144,4,12,MAP kinase tyrosine/serine/threonine phosphatase activity,MF,DUSP6;DUSP5;DUSP7;DUSP4
15465,GO:0071813,0.0331467632429546,0.993934516436328,4,12,lipoprotein particle binding,MF,APOE;LDLR;SORL1;PCSK9
15466,GO:0071814,0.0331467632429546,0.993934516436328,4,12,protein-lipid complex binding,MF,APOE;LDLR;SORL1;PCSK9
4466,GO:0010464,0.0331495218823567,0.99075179053288,6,23,regulation of mesenchymal cell proliferation,BP,CTNNBIP1;VEGFA;LRP5;FGFR1;FBXW4;LMNA
7533,GO:0031802,0.0332058494695527,0.998697126833141,2,3,type 5 metabotropic glutamate receptor binding,MF,PRNP;FYN
12689,GO:0050916,0.0332276769583072,0.998695789342225,2,3,sensory perception of sweet taste,BP,ITPR3;REEP2
12053,GO:0048012,0.0332595505927539,0.993907201766389,4,12,hepatocyte growth factor receptor signaling pathway,BP,MST1R;PTPN1;PAK1;SIRT2
16490,GO:0097187,0.0332775763715381,0.998692729800428,2,3,dentinogenesis,BP,HTRA1;FAM20C
6533,GO:0021942,0.0333211320465941,0.998690057026923,2,3,radial glia guided migration of Purkinje cell,BP,RERE;SOCS7
2402,GO:0005548,0.0333728918103064,0.987473244356958,9,42,phospholipid transporter activity,MF,OSBPL5;PITPNC1;PLTP;PITPNM1;OSBPL10;ABCG1;ABCA7;PITPNM3;ATP8B2
10151,GO:0042737,0.0334047233546418,0.984689329200237,13,72,drug catabolic process,BP,NT5E;NOS1;CTBS;PRDX5;GPX3;PCK2;IDUA;ADA;SMOX;CYP3A5;CAT;CYP2R1;PM20D2
18087,GO:1902667,0.0334491174682296,0.989418121029224,7,29,regulation of axon guidance,BP,SEMA4B;VEGFA;SEMA3F;WNT3;SEMA4F;SEMA4C;SEMA3B
10950,GO:0044706,0.0334836171544615,0.981185596095682,22,137,multi-multicellular organism process,BP,CST3;CYP27B1;PGF;SERPINE2;HEXB;SMURF2;FOS;FBLN1;SH3PXD2B;AKT1;BSG;PTHLH;CTSB;IGFBP2;EPOR;TGFB1;PLA2G6;IGFBP7;ITGA3;ADCY7;MAFF;HFE
12310,GO:0048671,0.0335172340898133,0.998677998023145,2,3,negative regulation of collateral sprouting,BP,PTPRS;ULK2
14089,GO:0060935,0.0335402260789719,0.99867658145611,2,3,cardiac fibroblast cell differentiation,BP,PDCD4;TGFBR3
14090,GO:0060936,0.0335402260789719,0.99867658145611,2,3,cardiac fibroblast cell development,BP,PDCD4;TGFBR3
14091,GO:0060938,0.0335402260789719,0.99867658145611,2,3,epicardium-derived cardiac fibroblast cell differentiation,BP,PDCD4;TGFBR3
14092,GO:0060939,0.0335402260789719,0.99867658145611,2,3,epicardium-derived cardiac fibroblast cell development,BP,PDCD4;TGFBR3
1513,GO:0003873,0.0336044971287902,0.998672618618118,2,3,6-phosphofructo-2-kinase activity,MF,PFKFB2;PFKFB3
6783,GO:0030226,0.0336044971287903,0.998672618618118,2,3,apolipoprotein receptor activity,MF,LRP1;ABCA7
4822,GO:0014022,0.033604497128804,0.998672618618119,2,3,neural plate elongation,BP,DVL1;VANGL2
6555,GO:0022007,0.033604497128804,0.998672618618119,2,3,convergent extension involved in neural plate elongation,BP,DVL1;VANGL2
10413,GO:0043259,0.033604497128805,0.998672618618118,2,3,laminin-10 complex,CC,LAMA5;LAMB1
10414,GO:0043260,0.033604497128805,0.998672618618118,2,3,laminin-11 complex,CC,LAMA5;LAMB2
15694,GO:0072235,0.033604497128805,0.998672618618118,2,3,metanephric distal tubule development,BP,PKD2;PKD1
15695,GO:0072236,0.033604497128805,0.998672618618118,2,3,metanephric loop of Henle development,BP,PKD2;PKD1
4843,GO:0014052,0.033604497128805,0.998672618618118,2,3,regulation of gamma-aminobutyric acid secretion,BP,NTSR1;SV2A
16949,GO:0098936,0.033604497128805,0.998672618618118,2,3,intrinsic component of postsynaptic membrane,CC,PTPRS;NLGN2
16987,GO:0099055,0.033604497128805,0.998672618618118,2,3,integral component of postsynaptic membrane,CC,PTPRS;NLGN2
17030,GO:0099240,0.033604497128805,0.998672618618118,2,3,intrinsic component of synaptic membrane,CC,PTPRS;NLGN2
17107,GO:0099699,0.033604497128805,0.998672618618118,2,3,integral component of synaptic membrane,CC,PTPRS;NLGN2
18834,GO:1904396,0.0336044971288196,0.998672618618118,2,3,regulation of neuromuscular junction development,BP,AGRN;LRP4
4334,GO:0009888,0.0336617093371699,0.972787811722654,151,1239,tissue development,BP,DUSP6;XDH;DUSP5;MEF2D;SEMA4B;EGR1;CST3;CYP27B1;PGF;PDCD4;CTNNBIP1;ACVR2B;BBS2;POSTN;VEGFA;WNT7A;LRP5;ITGA6;HMGA2;EGFR;SERPINE2;DNPH1;WWTR1;OBSL1;PTPRS;SPRY2;NFATC4;PRSS8;SDC1;ETV5;ACTA2;PHLDA2;RAPGEF3;ZFP36L1;GAA;FOXQ1;MAP2K1;SMURF2;FOS;SMAD3;STAT6;DVL1;THBS3;HBEGF;AP2A2;S100A4;ITGB4;SH3PXD2B;SALL2;ADARB1;AKT1;BSG;IFT140;PTHLH;WNT2B;FGFR1;PRKACB;CEACAM1;HMG20B;EVC;CCND1;EDNRA;GAS6;PTK6;SEMA3F;CTSB;LAMA5;GSN;ERRFI1;SLITRK6;ALOX15B;SHARPIN;PKD2;CTSZ;FBXW8;ITGB5;EPOR;CEBPB;WNT3;TGFB1;GPC1;ADAMTS7;DEAF1;NAB2;FHOD3;KIF26B;LCE1E;LAMB2;SEMA4F;TPP1;PCK2;MBD3;LRP4;KDM6B;ZNF516;ADA;AREG;RILPL1;FAM20C;BAX;SH3BP1;FBXW4;CHADL;EREG;DUSP4;PPL;PPP1R13L;TGFBR3;LEMD2;RPS6KA6;ALDOC;ADAM15;TMEM231;ZFPM1;PPARA;MYH15;SOX7;ECM1;ARHGAP12;ARID5B;CAT;SATB1;MAPK3;INSR;TAZ;VANGL2;PAK1;CUL7;HYAL1;SEMA4C;HES7;ITGA3;DLG3;PROX1;LMNA;PKD1;SIRT2;FAM129B;ITGA4;EDA;LAMB1;TOLLIP;PDCD6;MAFF;TCTN1;COL6A1;BTG1;CELSR1;SEMA3B;FGFR3;TST
15311,GO:0071526,0.033917007864831,0.989237641502335,7,29,semaphorin-plexin signaling pathway,BP,SEMA4B;SEMA3F;PLXNB3;SEMA4F;SH3BP1;SEMA4C;SEMA3B
12816,GO:0051130,0.0339684631503549,0.973346355437031,114,908,positive regulation of cellular component organization,BP,ERCC1;ZMYND8;ADGRL1;DLG4;APLN;VEGFA;WNT7A;APOE;TSPAN1;ESPN;LRP5;OBSL1;NOS1;SDC1;DDB2;VPS11;ARL2;MMP1;SNX9;RAPGEF3;ARAP1;LPAR3;MAP2K1;SSH1;ENDOG;SMAD3;SHANK2;LRP1;DVL1;SH3PXD2B;NLGN2;CORO1B;PPM1F;EPHA1;CNTN1;LDLR;FGFR1;RAC2;NPHP4;TENM2;TWF2;GAS6;PTK6;GSN;PCSK9;BCR;WIPF1;SLITRK6;ARPIN;PLXNB3;BNIP3;FYCO1;CDC42EP5;CRTC1;FBXW8;EPHB2;CTBP1;WNT3;TGFB1;MOAP1;SHANK3;TUB;CROCC;AGRN;LRP4;MICALL2;BOK;ADGRB2;ULK1;TFDP2;PLEK2;C6ORF89;NET1;FSCN1;PRKCD;STUB1;BAX;EREG;RPS6KA5;ZDHHC8;LIMK1;GDI1;WASH3P;LRSAM1;TGFA;FHOD1;CDC34;ABCA7;PLA2G6;NBPF3;FYN;STK25;RAC3;EEF2K;DNM2;TPBG;MAPK3;INSR;PAK1;CAMKK2;CUL7;HYAL1;CAPRIN2;ITGA3;PPP2R5B;PROX1;SIRT2;CDH4;NGFR;PXN;PLEKHM1;CAMK1;HFE;PFN2
10025,GO:0042475,0.0340732969746227,0.98560438102938,11,56,odontogenesis of dentin-containing tooth,BP,HTRA1;ACVR2B;ITGA6;ITGB4;BSG;LAMA5;LRP4;FAM20C;BAX;PPARA;EDA
18241,GO:1903035,0.0340971570476803,0.985592668405584,11,56,negative regulation of response to wounding,BP,PLAT;APOE;SERPINE2;PTPRS;SMAD3;F12;SERPING1;CEACAM1;PLAU;CD9;PRKCD
564,GO:0001706,0.0341640478363001,0.98712087027241,9,42,endoderm formation,BP,DUSP6;DUSP5;HMGA2;ITGB5;DUSP4;SOX7;ITGA4;LAMB1;COL6A1
12875,GO:0051222,0.0342812763378942,0.977076289444754,42,298,positive regulation of protein transport,BP,EDEM1;PRNP;POSTN;F2R;EGFR;VPS11;RAPGEF3;GLUL;LRP1;NLGN2;STOM;HK1;RAC2;SORL1;B3GAT3;ANK3;GAS6;ALOX15B;CEMIP;ADAM8;TGFB1;TMEM173;PCK2;CEP131;PFKFB2;PRKCZ;MICALL2;ERBB2;VAMP2;PRKCD;ZDHHC8;BCAP31;MIF;PLA2G6;NBPF3;FYN;MAPK3;PFKM;PAK1;PPP3CB;CAMK1;SIRT3
12583,GO:0050768,0.0343926438072847,0.979378829235231,27,176,negative regulation of neurogenesis,BP,SEMA4B;WNT7A;APOE;IDH2;PTPRS;NFATC4;LRP1;LDLR;SORL1;SYNGAP1;SEMA3F;CTSZ;EPHB2;WNT3;TGFB1;ULK2;EFNB3;SEMA4F;LRP4;DGUOK;GDI1;SEMA4C;SIRT2;RAP1GAP2;NGFR;SEMA3B;ADCY6
8223,GO:0032994,0.0343998423399324,0.991669120555602,5,19,protein-lipid complex,CC,APOE;PLTP;LDLR;SORL1;BIN1
5848,GO:0017144,0.0344596638640723,0.97477411410664,68,533,drug metabolic process,BP,NT5E;EGR1;CYP27B1;SLC6A8;PGM1;IDH2;AKR7A2;EGFR;NOS1;CTBS;PC;ACP5;SMAD3;PRDX5;AKT1;PYCR2;HK1;GGT1;RAC2;PFKL;GAMT;CBR4;ABCD1;PFKP;DHTKD1;NADK;HLCS;DGKQ;PKD2;GPX3;PRSS3;APRT;CBS;TGFB1;SDHA;MDH2;HMGCL;PCK2;CD320;IDUA;PFKFB2;MLXIPL;ADA;AHCY;FAM20C;CYC1;DDIT4;ALDOC;MTHFR;PPARA;ACO2;SMOX;DNM2;CKMT1A;CYP3A5;CAT;CYP2R1;INSR;TAZ;PFKM;PDXK;PFKFB3;NDUFV3;CHST14;GCH1;KDM3A;PM20D2;AK3
7052,GO:0030837,0.0344787834853951,0.987866336917387,8,37,negative regulation of actin filament polymerization,BP,TMOD2;TWF2;GSN;SPTB;FHOD3;CAPG;PRKCD;PFN2
10874,GO:0044420,0.034523703397406,0.983105428128071,15,84,extracellular matrix component,CC,THSD4;CST3;ITGA6;LOXL1;LTBP1;FBLN1;SMOC2;LAMA5;ENTPD2;LAMB2;AGRN;NID1;VWA1;EFEMP2;LAMB1
16259,GO:0090316,0.034545476347148,0.979975815324872,24,154,positive regulation of intracellular protein transport,BP,EDEM1;PRNP;VPS11;RAPGEF3;STOM;RAC2;SORL1;B3GAT3;ANK3;GAS6;CEMIP;TGFB1;TMEM173;CEP131;MICALL2;ERBB2;VAMP2;PRKCD;ZDHHC8;BCAP31;NBPF3;FYN;PAK1;CAMK1
4438,GO:0010324,0.0345570865724594,0.986913889003341,9,43,membrane invagination,BP,SNX9;RAC2;GSN;ARHGAP25;SNX33;SH3BP1;ABCA7;RAC3;ARHGAP12
547,GO:0001667,0.0346435704489055,0.977193289480013,39,272,ameboidal-type cell migration,BP,SEMA4B;VEGFA;WNT7A;APOE;LRP5;PKN1;SMURF2;HBEGF;AKT1;CORO1B;HDAC5;PPM1F;FGFR1;CEACAM1;SEMA3F;LAMA5;PRSS3;PLCG1;TGFB1;TNS1;SEMA4F;PLEKHG5;CYGB;SH3BP1;LTB4R2;HDAC7;ARID5B;PAK1;HYAL1;SEMA4C;ITGA3;MAP2K3;PROX1;ITGA4;PDCD6;PXN;SEMA3B;PFN2;PKN3
9435,GO:0036017,0.0346867643595589,0.998054527470629,2,4,response to erythropoietin,BP,EPOR;MT2A
9436,GO:0036018,0.0346867643595589,0.998054527470629,2,4,cellular response to erythropoietin,BP,EPOR;MT2A
12719,GO:0050982,0.0347204917253393,0.993550536920875,4,12,detection of mechanical stimulus,BP,SERPINE2;PKD2;FYN;PKD1
1979,GO:0004697,0.0348288197857141,0.993523881093828,4,12,protein kinase C activity,MF,PKN1;PRKCZ;PRKCD;PKN3
12359,GO:0048754,0.0349412516820499,0.981602781601968,18,106,branching morphogenesis of an epithelial tube,BP,PGF;CTNNBIP1;VEGFA;LRP5;SPRY2;NFATC4;ETV5;WNT2B;EDNRA;LAMA5;PKD2;CTSZ;TGFB1;AREG;VANGL2;PAK1;PKD1;CELSR1
4072,GO:0009127,0.0349549544785941,0.981209218161207,19,116,purine nucleoside monophosphate biosynthetic process,BP,PGM1;HK1;PFKL;LHPP;PFKP;DHTKD1;APRT;TGFB1;PFKFB2;MLXIPL;ADA;CYC1;DDIT4;ALDOC;PPARA;INSR;TAZ;PFKM;PFKFB3
4111,GO:0009168,0.0349549544785941,0.981209218161207,19,116,purine ribonucleoside monophosphate biosynthetic process,BP,PGM1;HK1;PFKL;LHPP;PFKP;DHTKD1;APRT;TGFB1;PFKFB2;MLXIPL;ADA;CYC1;DDIT4;ALDOC;PPARA;INSR;TAZ;PFKM;PFKFB3
1390,GO:0003299,0.0349717074090087,0.993488677542388,4,12,muscle hypertrophy in response to stress,BP,SMAD3;ERRFI1;CAMTA2;LMNA
4929,GO:0014887,0.0349717074090087,0.993488677542388,4,12,cardiac muscle adaptation,BP,SMAD3;ERRFI1;CAMTA2;LMNA
4937,GO:0014898,0.0349717074090087,0.993488677542388,4,12,cardiac muscle hypertrophy in response to stress,BP,SMAD3;ERRFI1;CAMTA2;LMNA
11869,GO:0046887,0.0349797094656925,0.983875351929062,13,71,positive regulation of hormone secretion,BP,APLN;EGFR;GLUL;NLGN2;FGFR1;PCK2;PFKFB2;RASL10B;PLA2G6;PFKM;PPP3CB;SIRT3;HFE
679,GO:0001890,0.0351864282331867,0.981078696241115,19,115,placenta development,BP,HTRA1;CYP27B1;EGFR;PHLDA2;ZFP36L1;PLCD3;MDFI;MAP2K1;EPAS1;AKT1;BSG;CTSB;PKD2;FBXW8;EPOR;CEBPB;ADA;CUL7;PKD1
4231,GO:0009411,0.0353164646300409,0.980655065172318,20,123,response to UV,BP,ERCC1;XPC;EGFR;NFATC4;DDB2;ERCC6;AKT1;IMPACT;BRSK1;CIRBP;CCND1;MAPK13;MC1R;PRIMPOL;BAX;TMEM161A;CAT;REV1;HYAL1;UVSSA
9021,GO:0035239,0.0355295620675492,0.973736245159298,72,543,tube morphogenesis,BP,XDH;APLN;PGF;CTNNBIP1;ACVR2B;VEGFA;WNT7A;APOE;LRP5;HMGA2;ELK3;EGFR;SPRY2;NFATC4;ETV5;SHC1;RAPGEF3;ZFP36L1;PLCD3;SMAD3;LRP1;DVL1;EPAS1;HDAC5;SH2D2A;EPHA1;VEGFB;FGFR4;WNT2B;FGFR1;PRKACB;CEACAM1;EDNRA;LAMA5;ARHGAP22;ANGPTL4;PKD2;CTSZ;EPHB2;ADAM8;PLCG1;TGFB1;DEAF1;KIF26B;RNH1;EPN2;AREG;SDCCAG8;ERBB2;ADGRB2;BAX;EREG;TGFBR3;ADAM15;HDAC7;ECM1;VANGL2;PAK1;ROBO4;CUL7;HYAL1;SEMA4C;RRAS;PROX1;PKD1;FAM129B;EDA;NGFR;PDCD6;TCTN1;BTG1;CELSR1
3138,GO:0006735,0.0355527046381732,0.991399187141069,5,18,NADH regeneration,BP,HK1;PFKL;PFKP;ALDOC;PFKM
14374,GO:0061621,0.0355527046381732,0.991399187141069,5,18,canonical glycolysis,BP,HK1;PFKL;PFKP;ALDOC;PFKM
14415,GO:0061718,0.0355527046381732,0.991399187141069,5,18,glucose catabolic process to pyruvate,BP,HK1;PFKL;PFKP;ALDOC;PFKM
159,GO:0000323,0.0355963206378114,0.97385227006492,69,523,lytic vacuole,CC,CST3;PYGB;TSPAN1;NAGLU;VAT1;CTSO;CAPN2;SDC1;VPS11;HEXB;GAA;MARCH9;CTBS;NAPRT;ACP5;TMEM8A;LRP1;AP2A2;CYBRD1;STOM;TPCN1;SLC15A4;LDLR;FUCA1;ANK3;BRI3;CTSB;PCSK9;FYCO1;CTSZ;AP3D1;ABCA2;ADAM8;TMEM9;DPP7;GPC1;GALNS;DIRC2;PI4K2A;SLC48A1;TPP1;WDR59;AGRN;IDUA;ADA;PRKCD;NAGA;LPCAT1;PI4K2B;RAB12;SYNGR1;CD68;SPPL2B;GLB1;CAT;SLC12A4;C12ORF66;RNASET2;CTSF;HYAL1;VPS16;MAN2B1;TRIP10;TOLLIP;PLEKHM1;COL6A1;MAN2B2;SLC26A11;SDC2
2509,GO:0005764,0.0355963206378114,0.97385227006492,69,523,lysosome,CC,CST3;PYGB;TSPAN1;NAGLU;VAT1;CTSO;CAPN2;SDC1;VPS11;HEXB;GAA;MARCH9;CTBS;NAPRT;ACP5;TMEM8A;LRP1;AP2A2;CYBRD1;STOM;TPCN1;SLC15A4;LDLR;FUCA1;ANK3;BRI3;CTSB;PCSK9;FYCO1;CTSZ;AP3D1;ABCA2;ADAM8;TMEM9;DPP7;GPC1;GALNS;DIRC2;PI4K2A;SLC48A1;TPP1;WDR59;AGRN;IDUA;ADA;PRKCD;NAGA;LPCAT1;PI4K2B;RAB12;SYNGR1;CD68;SPPL2B;GLB1;CAT;SLC12A4;C12ORF66;RNASET2;CTSF;HYAL1;VPS16;MAN2B1;TRIP10;TOLLIP;PLEKHM1;COL6A1;MAN2B2;SLC26A11;SDC2
3075,GO:0006650,0.0356105442663516,0.976509638267144,39,271,glycerophospholipid metabolic process,BP,DGKA;OSBPL5;LPCAT4;EGFR;PIK3R2;PIGQ;HBEGF;MBOAT7;PITPNM1;ZFYVE21;FGFR4;LDLR;FGFR1;PIGV;TTC7B;PLCH2;DGKQ;SERINC2;SYNJ2;PIP5KL1;PI4K2A;OSBPL10;ACP6;ERBB2;SBF1;EREG;CPNE7;LPCAT1;INPP5D;PI4K2B;PLA2G6;FYN;PITPNM3;CHKA;SLC27A1;TAZ;ZP3;FGFR3;PI4KAP2
17703,GO:1901575,0.0357386165708443,0.970408731164251,192,1631,organic substance catabolic process,BP,NT5E;XDH;GID4;H1F0;NR1D1;EDEM1;CST3;CYP27B1;TYSND1;BTBD2;FBXO2;PYGB;PGM1;APOE;PYGL;NAGLU;LRP5;PLD3;CRAT;MTA1;ACOT7;ARRDC1;EGFR;SERPINE2;DNPH1;WWTR1;NOS1;TMEM129;HADH;CTSO;CAPN2;SDC1;VPS11;HEXB;GTPBP1;ALDH4A1;SNX9;RAPGEF3;ZFP36L1;GAA;GLUL;RNPEPL1;CTBS;PLCD3;RBCK1;RNF44;CRYL1;CPT2;ENDOG;GALE;SMURF2;SMAD3;LRP1;SRD5A3;DVL1;AP2A2;PRODH;FBXW5;RNF187;PLCXD2;AKT1;ENTPD6;HK1;GGT1;LDLR;FUCA1;PFKL;SORL1;CEACAM1;CIRBP;ABCD1;PCBP4;AIG1;PLCH2;PFKP;CSNK1E;CTSB;PCSK9;RAD23A;DHTKD1;SH3D19;GGACT;HAGH;BNIP3;SHARPIN;MVB12B;CEMIP;CTSZ;MAGEF1;ADAM8;LTA4H;PLCG1;CBS;CD81;ENTPD2;ADAMTS13;TIMP2;TGFB1;ABHD17C;GPC1;ADAMTS7;NTSR1;PNRC1;GALNS;ABTB1;SNX17;RNH1;FBXO44;SNX33;ANKZF1;UBXN4;HMGCL;PTPN1;TPP1;PCK2;AGRN;IDUA;PFKFB2;MLXIPL;TRIB2;PRKACA;ADA;AHCY;RNPEP;BNIP3L;ACAD10;PRKCD;USP20;STUB1;BAX;FBXW4;CUL9;DDIT4;ACADS;CES2;NAGA;ALDOC;LPCAT1;LRSAM1;LONP2;CHEK2;DECR2;PPARA;SESN2;CDC34;RNF123;RAB12;BCAP31;SMOX;PHYH;PLA2G6;WFS1;FYN;UPP1;ETFB;CYP3A5;GLB1;NEIL1;APOBEC3C;PLCB3;APOBEC3F;INSR;PAN2;PFKM;GPT2;RNASET2;RNF144A;CTSF;USP21;PFKFB3;MLYCD;CUL7;HYAL1;MAN2B1;ABHD10;DNASE1L1;ALDH7A1;PKD1;KCTD13;SIRT2;NT5C1B;AZIN2;HSD11B1;TOLLIP;PHYKPL;HFE;TST;MAN2B2;CBLC;PM20D2;DEDD2;SDC2
11236,GO:0045444,0.0358629288050221,0.979411621579699,23,145,fat cell differentiation,BP,NR1D1;BBS2;LRP5;ITGA6;HMGA2;WWTR1;ZFP36L1;SMAD3;SH3PXD2B;AKT1;ZNF385A;CCND1;CCDC71L;BNIP3;CTBP1;CEBPB;TGFB1;TRIB2;ZNF516;ZFPM1;ARID5B;SIRT2;SOCS7
10192,GO:0042802,0.0359239491530343,0.971059971995219,142,1168,identical protein binding,MF,TNIP1;XDH;MEF2D;HTRA1;CST3;PGF;PRNP;VEGFA;APOE;PYGL;ACOT7;ARRDC1;NISCH;EGFR;DNPH1;WWTR1;SDC1;ORAI1;HEXB;ALDH4A1;SNX9;GLUL;MDFI;PC;CRYL1;MPRIP;GALE;SMURF2;FBLN1;SMAD3;STAT6;DVL1;S100A4;NLGN2;STOM;AKT1;TPCN1;GRB7;CORO1B;S100A6;PHC2;PTPRU;VEGFB;LRRC8A;LDLR;FGFR1;PFKL;RAG1;CEACAM1;RAB11FIP4;TENM2;ABCD1;LHPP;PTK6;BRI3;ANGPTL4;HLCS;SH3GLB2;NPR2;BNIP3;SHARPIN;PKD2;ACY1;PCSK1;EPOR;EPHB2;CADM4;CTBP1;CBS;CEBPB;MVD;RNF135;UHRF1BP1;TGFB1;NTSR1;NAB2;TMEM173;SNX33;KHDRBS3;HMGCL;OLFML2A;LRP4;ESYT2;CEP131;GRHPR;OXA1L;BOK;ALAS1;ERBB2;ULK1;AHCY;BNIP3L;STUB1;BAX;PPP1R13L;NAGA;TPM2;PADI3;ZHX3;DNM1;IRAK1;FHOD1;CHEK2;ABCG1;MIF;SLC9A7;NUDT14;SPPL2B;FYN;VWA1;STK25;BHLHE40;ATXN10;CHKA;CAT;SLC27A1;APOBEC3F;MAPK3;PFKM;HLA-G;TSTA3;PDXK;CEP72;MLYCD;DNMT3A;BIN1;BCL2L1;KCTD13;CDH4;TRIP10;MAPRE3;MAP3K10;NDE1;PDCD6;PHYKPL;GCH1;ZP3;FGFR3;CLK3;HOMER2;LRRK1;SDC2
18243,GO:1903037,0.0359603014498304,0.978569376770433,26,170,regulation of leukocyte cell-cell adhesion,BP,PRNP;PAG1;AKT1;RAG1;CEACAM1;CARD11;IGFBP2;IL20RB;AP3D1;ADAM8;CEBPB;TGFB1;EFNB3;PRKCZ;ADA;ERBB2;JAK3;PPARA;FYN;PELI1;HLA-G;PAK1;ITGA4;HFE;ZP3;ITPKB
6602,GO:0022804,0.0359917778039413,0.977696694169325,30,200,active transmembrane transporter activity,MF,SLC16A3;SLC6A8;SLCO4A1;SLC2A9;SLC7A8;SLC12A7;SLC16A5;SLC6A6;SLC15A4;MFSD3;ABCD1;SLC20A1;ABCA2;SLC29A4;ATP7B;SLC22A17;SLC13A5;TIMM17B;ABCG1;ABCA7;SLC9A7;SLC22A18;SLC12A4;SLC13A3;SLC37A2;SLC16A13;ATP6V1F;TMCO3;SLC23A2;SLC26A11
12913,GO:0051272,0.0360533321563139,0.975341974865594,46,331,positive regulation of cellular component movement,BP,SEMA4B;PGF;DOCK4;POSTN;VEGFA;WNT7A;F2R;ITGA6;EGFR;SPRY2;SSH1;SMURF2;SMAD3;HBEGF;FAM110C;AKT1;GRB7;PPM1F;EPHA1;VEGFB;FGFR1;RAC2;PLAU;GAS6;SEMA3F;CEMIP;ADAM8;PLCG1;TGFB1;NSMF;RHOD;SEMA4F;HDAC7;MAPK3;INSR;PAK1;HYAL1;SEMA4C;ITGA3;MAP2K3;PROX1;ITGA4;LAMB1;PDCD6;ZP3;SEMA3B
8719,GO:0034375,0.0363835896027307,0.99529573024244,3,8,high-density lipoprotein particle remodeling,BP,APOE;PLTP;ABCG1
16602,GO:0097435,0.0365268502134659,0.973522966246977,63,470,supramolecular fiber organization,BP,CST3;APOE;ESPN;OBSCN;LOXL1;OBSL1;LTBP2;ARL2;RAPGEF3;ARAP1;SSH1;SMAD3;DVL1;SH3PXD2B;TMOD2;CORO1B;PPM1F;EPHA1;LDLR;RAC2;EFS;TNNT1;TWF2;GSN;PLEKHG2;WIPF1;ARPIN;SPTB;CORO7;CDC42EP5;ITGB5;ARHGAP25;FHOD3;SHANK3;MSRB2;EML2;RHOD;RHOF;WASF3;RHOBTB2;TUBG2;MICALL2;CAPG;FSCN1;PRKCD;SH3BP1;CHADL;LIMK1;TPM2;WASH3P;FHOD1;RAC3;ARHGAP12;PAK1;MICAL1;PROX1;KCTD13;NDE1;PXN;PFN2;SSH3;CCDC88C;KLHL24
1698,GO:0004175,0.0365551660993912,0.976577028866345,34,236,endopeptidase activity,MF,HTRA1;PLAT;TYSND1;CTSO;CAPN2;PRSS8;MMP1;F12;MMP28;RHBDF2;PLAU;CTSB;PCSK9;PRSS22;PCSK1;CTSZ;PRSS3;ADAM8;ADAMTS13;ADAMTS7;MIPEP;CLCA2;ADAM19;TPP1;MMP10;THOP1;USP20;MBTPS2;ADAM15;LONP2;SPPL2B;CTSF;PDCD6;PRSS21
13570,GO:0060048,0.0366335646690234,0.983622648040899,12,64,cardiac muscle contraction,BP,SCN4B;NOS1;GAA;VEGFB;TNNT1;SNTA1;PRKACA;PPP1R13L;GSTO1;EHD3;TAZ;MAP2K3
4180,GO:0009259,0.0367054667935285,0.974520450610389,49,373,ribonucleotide metabolic process,BP,NT5E;DLG4;VEGFA;PGM1;APOE;ACOT7;NOS1;GTPBP1;RAPGEF3;NME4;ADORA2B;HK1;PTHLH;PFKL;PFKP;CARD11;DHTKD1;NADK;PANK4;NPR2;PKD2;APRT;TIMP2;TGFB1;PODXL2;SDHA;ABHD14B;PFKFB2;MLXIPL;UCKL1;FAM20C;CYC1;PPCS;DDIT4;LTB4R2;ALDOC;PPARA;UPP1;INSR;TAZ;PFKM;ADCY1;PFKFB3;GABBR1;DLG3;NDUFV3;ADCY7;AK3;ADCY6
9818,GO:0042036,0.0367101703166732,0.99104034140935,5,18,negative regulation of cytokine biosynthetic process,BP,ERRFI1;TRIB2;ASB1;INPP5D;ZFPM1
16808,GO:0098656,0.0367252212225873,0.978591852626337,24,152,anion transmembrane transport,BP,SLC16A3;PRNP;SLC6A8;SLC7A8;SLC12A7;CPT2;SLC6A6;AKT1;TTYH3;STK39;LRRC8A;SLC20A1;SLC43A1;SLC38A10;NTSR1;CLCA2;SLC13A5;SLC25A29;SLC12A4;SLC13A3;PRAF2;SLC37A2;SLC23A2;SLC26A11
4830,GO:0014037,0.0368678103603434,0.988032286024652,7,30,Schwann cell differentiation,BP,NDRG1;AKT1;GPC1;NAB2;LAMB2;AHNAK2;SIRT2
6719,GO:0030136,0.0370124507590599,0.979618311851854,20,123,clathrin-coated vesicle,CC,EPN3;APOE;EGFR;VPS11;SNX9;LRP1;DVL1;HBEGF;AP2A2;LDLR;CEMIP;CLTCL1;CD9;EPN2;VAMP2;BCAP31;DNM2;MALL;VPS16;RGS19
11274,GO:0045595,0.0371377176167481,0.970064675726031,141,1157,regulation of cell differentiation,BP,DUSP6;XDH;ZMYND8;SEMA4B;NR1D1;DLG4;CYP27B1;PDCD4;CTNNBIP1;ACVR2B;POSTN;VEGFA;FAM210B;WNT7A;APOE;LRP5;IDH2;EGFR;SERPINE2;WWTR1;OBSL1;NOS1;PTPRS;SPRY2;NFATC4;LTBP4;ETV5;TCFL5;ZFP36L1;LPAR3;MAP2K1;SSH1;FOS;FBLN1;SMAD3;SHANK2;LRP1;GJC2;DVL1;SH3PXD2B;AKT1;HDAC5;ASH2L;IMPACT;CNTN1;PTHLH;LDLR;FGFR1;RAG1;SORL1;CEACAM1;HMG20B;ZNF385A;CCND1;TWF2;SYNGAP1;GAS6;PTK6;SEMA3F;CSNK1E;CARD11;SOX13;ERRFI1;CCDC71L;ALOX15B;NPR2;PLXNB3;CTSZ;CRTC1;FBXW8;AP3D1;EPHB2;ADAM8;CEBPB;TIMP2;WNT3;TGFB1;ULK2;GPC1;ADAMTS7;SHANK3;EFNB3;NSMF;SEMA4F;LRP4;VHL;TRIB2;PRKCZ;PRKACA;ADA;AREG;ERBB2;JAK3;NET1;ARHGAP44;FAM20C;OLFM2;CHADL;EREG;DGUOK;PPP1R13L;LIMK1;GDI1;ZHX3;RGS14;MAPK12;HDAC7;INPP5D;ZFPM1;PPARA;ABCG1;FYN;STK25;RAC3;EEF2K;DNM2;HLA-G;PAK1;CUL7;SEMA4C;CAPRIN2;ITGA3;BIN1;PPP2R5B;PROX1;SIRT2;FAM129B;CDH4;RAP1GAP2;NGFR;KIF13B;MAFF;CAMK1;BTG1;SEMA3B;SSH3;ITPKB;PLAG1;KDM3A;ADCY6;SDC2
1177,GO:0002823,0.0374405949598527,0.990812149887458,5,18,negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,CEACAM1;IL20RB;JAK3;PPP3CB;HFE
2524,GO:0005782,0.0375647581356325,0.987704968234237,7,31,peroxisomal matrix,CC,CRAT;PRDX5;GRHPR;LONP2;PHYH;CAT;MLYCD
7558,GO:0031907,0.0375647581356325,0.987704968234237,7,31,microbody lumen,CC,CRAT;PRDX5;GRHPR;LONP2;PHYH;CAT;MLYCD
7844,GO:0032411,0.0376323484392066,0.983795540678564,11,58,positive regulation of transporter activity,BP,STK39;ANK3;PKD2;EPHB2;NTSR1;SHANK3;PRKCD;GSTO1;EHD3;DNM2;GLRX
5679,GO:0016791,0.037657723079314,0.976370657952315,31,208,phosphatase activity,MF,DUSP6;NT5E;DUSP5;PTPRS;PTPRE;MAP2K1;ACP5;SSH1;PPP2R3B;NT5DC1;PPM1F;PTPRU;PPM1J;LHPP;DUSP7;CDC25B;PTPDC1;SYNJ2;PLPP6;PTPN1;ACP6;PFKFB2;SBF1;DUSP4;NTPCR;INPP5D;PPP3CB;PFKFB3;NT5C1B;DUSP23;SSH3
11383,GO:0045776,0.03769086171456,0.989078721564642,6,24,negative regulation of blood pressure,BP,APLN;NOS1;NTSR1;RNPEP;PPARA;GCH1
7847,GO:0032414,0.0377263637695364,0.98454494890258,10,51,positive regulation of ion transmembrane transporter activity,BP,STK39;ANK3;PKD2;EPHB2;NTSR1;SHANK3;GSTO1;EHD3;DNM2;GLRX
19292,GO:1905477,0.0378718743760034,0.980708261806151,16,94,positive regulation of protein localization to membrane,BP,PRNP;EGFR;SSH1;LRP1;STOM;AKT1;ANK3;CEMIP;EPHB2;TGFB1;LRP4;ERBB2;TFDP2;FYN;PAK1;ITGA3
10377,GO:0043204,0.0378748206167331,0.983696737545116,11,57,perikaryon,CC,PTPRS;GLUL;ENDOG;GJC2;NTSR1;NSMF;PI4K2A;ITGA1;SIRT2;AZIN2;KLHL24
2200,GO:0005085,0.0379970710352471,0.975591417034678,34,231,guanyl-nucleotide exchange factor activity,MF,DLG4;DOCK4;OBSCN;EGFR;SHC1;RIN1;RAPGEF3;HBEGF;SHC2;FGFR4;FGFR1;RALGDS;DOCK6;TRAPPC9;PLEKHG2;BCR;RGL2;SPTB;RASGEF1A;FARP1;PLEKHG4;PLEKHG3;PLEKHG5;ERBB2;JAK3;NET1;SBF1;EREG;FYN;IQSEC1;ARHGEF4;ARHGEF1;DOCK9;FGFR3
18548,GO:1903727,0.0380878130226583,0.988935469399283,6,24,positive regulation of phospholipid metabolic process,BP,CD81;TGFB1;PRKCD;TAZ;ZP3;FGFR3
14107,GO:0060976,0.0381591849758724,0.987519164384437,7,30,coronary vasculature development,BP,APLN;VEGFA;LTBP1;VEGFB;SNX17;TGFBR3;DNM2
4373,GO:0010001,0.0382455565504847,0.978513493491895,21,131,glial cell differentiation,BP,NDRG1;EGFR;SERPINE2;MAP2K1;LRP1;AKT1;LDLR;GSN;BNIP3;TGFB1;GPC1;NAB2;LAMB2;WASF3;CD9;BOK;ERBB2;AHNAK2;MAPK3;BIN1;SIRT2
11275,GO:0045596,0.0382773170496887,0.972715111458603,56,420,negative regulation of cell differentiation,BP,XDH;SEMA4B;PDCD4;POSTN;WNT7A;APOE;LRP5;IDH2;EGFR;WWTR1;PTPRS;NFATC4;ZFP36L1;FBLN1;SMAD3;LRP1;HDAC5;PTHLH;LDLR;SORL1;CEACAM1;CCND1;SYNGAP1;SEMA3F;NPR2;CTSZ;EPHB2;WNT3;TGFB1;ULK2;ADAMTS7;EFNB3;SEMA4F;LRP4;TRIB2;AREG;ERBB2;JAK3;CHADL;EREG;DGUOK;GDI1;HDAC7;INPP5D;ZFPM1;PPARA;ABCG1;HLA-G;PAK1;SEMA4C;SIRT2;RAP1GAP2;NGFR;SEMA3B;ITPKB;ADCY6
12652,GO:0050865,0.0383917856238361,0.973979604503003,43,308,regulation of cell activation,BP,PRNP;APOE;PKN1;SERPINE2;ZFP36L1;STAT6;PAG1;ADORA2B;AKT1;LDLR;RAC2;RAG1;CEACAM1;GAS6;CARD11;SOX13;GSN;IGFBP2;BCR;IL20RB;AP3D1;ADAM8;CD81;CEBPB;TGFB1;EFNB3;CD320;PRKCZ;CD9;ADA;ERBB2;JAK3;CYGB;PRKCD;INPP5D;MIF;FYN;PELI1;HLA-G;PAK1;HFE;ZP3;ITPKB
3692,GO:0008202,0.0384510250574249,0.97622087829313,29,197,steroid metabolic process,BP,EGR1;NR1D1;CYP27B1;APOE;LRP5;OSBPL5;LMF1;SRD5A3;HSD17B8;FGFR4;LDLR;FGFR1;SEC14L2;SORL1;PCSK9;DGKQ;MVD;SNX17;PLPP6;STUB1;MBTPS2;HSD17B7;ABCG1;CYP3A5;CAT;IGFBP7;CYP2R1;PROX1;HSD11B1
956,GO:0002376,0.0384818517775098,0.967750592424451,217,1860,immune system process,BP,TNIP1;ERCC1;HTRA1;EGR1;NR1D1;SLC16A3;CST3;CYP27B1;APLN;PRR7;PGF;CTNNBIP1;PRNP;PYGB;VEGFA;FAM210B;TNFRSF6B;PGM1;PYGL;LRP5;ITGA6;NDRG1;PKN1;FCGRT;VAT1;PTPRS;MST1R;SDC1;SHC1;ORAI1;HEXB;GTPBP1;SLC7A8;SLC2A3;MMP1;ZFP36L1;GAA;CMTM7;RBCK1;MAP2K1;NAPRT;POU2F2;KLC2;FOS;SMAD3;STAT6;PIK3R2;LRP1;EPAS1;AP2A2;STOM;PAG1;ADORA2B;ADARB1;AKT1;GRB7;HDAC5;F12;MMP28;BSG;HK1;SERPING1;GGT1;VEGFB;ASH2L;SLC15A4;LRRC8A;IFNGR2;RAB31;WNT2B;LDLR;PRKACB;FUCA1;RAC2;KCNAB2;PFKL;RAG1;CEACAM1;ZNF385A;PLAU;GAS6;PTK6;BRI3;CTSB;RAB3B;CARD11;SH2B3;SOX13;GSN;MAPKAPK3;IGFBP2;DHTKD1;BCR;WIPF1;BNIP3;PROCR;FAM3A;CTSZ;IL20RB;AP3D1;ITGB5;PRSS3;SH3PXD2A;ADAM8;APRT;LTA4H;PLCG1;CD81;CEBPB;RNF135;ADAMTS13;TIMP2;DPP7;TGFB1;GPC1;MKNK2;TMEM173;PODXL2;EFNB3;TNFSF15;GALNS;SCART1;POLL;POLM;PI4K2A;PTMS;RHOF;PTPN1;IFNE;CD320;YPEL5;PRKCZ;KDM6B;PRKACA;TBKBP1;ACTR1B;ADA;ERBB2;AHCY;VAMP2;JAK3;BNIP3L;CYFIP2;PRKCD;FAM20C;CACNB3;IFI6;BAX;TRIM4;ITGA1;EREG;RPS6KA5;DDIT4;MT2A;LIMK1;TGFBR3;MFNG;ALDOC;LPCAT1;ADAM15;IRAK1;INPP5D;CHD2;ZFPM1;RAB12;BCAP31;MIF;PLA2G6;DDT;SYNGR1;ECM1;QSOX1;CD68;SPPL2B;FYN;ICAM5;DNM2;GLB1;PELI1;CAT;APOBEC3C;SATB1;KIF26A;APOBEC3F;MAPK3;TAZ;HLA-G;PDXK;PAK1;RNASET2;PPP3CB;CTSF;ITGA3;MAN2B1;SRMS;RRAS;DNASE1L1;TNFRSF25;SIRT2;ITGA4;EDA;LTB4R;SERPINB1;PELI3;NGFR;TOLLIP;RNASE7;GCH1;KIF13B;NBEAL2;PNMA1;SLC39A3;HFE;ZP3;ITPKB;LRRK1;SDC2
632,GO:0001822,0.0385870715665459,0.976374720005809,28,184,kidney development,BP,EGR1;PGF;CTNNBIP1;ACVR2B;VEGFA;WWTR1;SDC1;ACTA2;SMAD3;WNT2B;FGFR1;LZTS2;LAMA5;PCSK9;PKD2;TGFB1;KIF26B;LAMB2;LRP4;BAX;NID1;WFS1;ARID5B;CAT;VANGL2;ITGA3;PROX1;PKD1
12872,GO:0051216,0.0387154928523091,0.979351250348709,18,107,cartilage development,BP,MEF2D;BBS2;WNT7A;HMGA2;SMAD3;THBS3;PTHLH;WNT2B;FGFR1;EVC;TGFB1;ADAMTS7;FBXW4;CHADL;MAPK3;HYAL1;PKD1;FGFR3
6285,GO:0019898,0.0387705812530155,0.976022900914998,29,193,extrinsic component of membrane,CC,DLG4;EPN3;PRNP;SERPINE2;PRSS8;SYTL1;SNX9;PIK3R2;S100A6;STK39;MYZAP;KCNAB2;PTK6;PCSK9;ERRFI1;PRSS22;ALOX15B;GNAL;FARP1;SNX33;ATG2A;ESYT2;ULK1;JAK3;FYN;SRMS;CDH4;RGS19;WIPI2
18167,GO:1902903,0.0389017725019951,0.974609799983471,36,251,regulation of supramolecular fiber organization,BP,APOE;ARL2;RAPGEF3;ARAP1;SSH1;SMAD3;SH3PXD2B;TMOD2;CORO1B;PPM1F;EPHA1;LDLR;RAC2;TWF2;GSN;PLEKHG2;WIPF1;ARPIN;SPTB;CDC42EP5;FHOD3;SHANK3;EML2;CAPG;PRKCD;SH3BP1;CHADL;LIMK1;WASH3P;FHOD1;RAC3;PAK1;PROX1;PXN;PFN2;SSH3
2604,GO:0005905,0.0391332258530517,0.983064577922183,11,57,clathrin-coated pit,CC,EPN3;EGFR;LRP3;LRP1;AP2A2;LDLR;CEMIP;CLTCL1;LRP10;FCHO1;DNM2
12231,GO:0048514,0.039134793728631,0.972445314535657,52,379,blood vessel morphogenesis,BP,XDH;APLN;PGF;VEGFA;WNT7A;APOE;LRP5;HMGA2;ELK3;SPRY2;NFATC4;SHC1;RAPGEF3;ZFP36L1;PLCD3;LRP1;EPAS1;HDAC5;SH2D2A;EPHA1;VEGFB;FGFR4;FGFR1;CEACAM1;EDNRA;LAMA5;ARHGAP22;ANGPTL4;PKD2;EPHB2;ADAM8;PLCG1;TGFB1;RNH1;EPN2;ERBB2;ADGRB2;BAX;EREG;TGFBR3;ADAM15;HDAC7;ECM1;ROBO4;CUL7;HYAL1;RRAS;PROX1;FAM129B;NGFR;PDCD6;BTG1
696,GO:0001917,0.0392029115648833,0.98853094975212,6,24,photoreceptor inner segment,CC,NOS1;SHANK2;CROCC;REEP6;DNM1;DNM2
4076,GO:0009132,0.03924378133772,0.979004568464754,18,110,nucleoside diphosphate metabolic process,BP,DLG4;PGM1;NME4;HK1;PFKL;PFKP;CARD11;DHTKD1;ENTPD2;PFKFB2;MLXIPL;DDIT4;ALDOC;PPARA;INSR;PFKM;PFKFB3;DLG3
3123,GO:0006706,0.039267944043148,0.992244114425816,4,13,steroid catabolic process,BP,CYP27B1;APOE;SNX17;HSD11B1
4347,GO:0009914,0.0392773204371526,0.976134938819708,27,179,hormone transport,BP,NR1D1;APLN;ACVR2B;LRP5;SLCO4A1;ITPR3;EGFR;HADH;LTBP4;ARL2;RAPGEF3;GLUL;NLGN2;FGFR1;PFKL;VGF;PCK2;PFKFB2;RASL10B;PLA2G6;PFKM;PPP3CB;FAM129B;ICA1;PCLO;SIRT3;HFE
18695,GO:1904031,0.0392846015075385,0.987015052888745,7,31,positive regulation of cyclin-dependent protein kinase activity,BP,EGFR;AKT1;CCND1;PKD2;PROX1;PKD1;MAPRE3
10487,GO:0043394,0.0392877980703483,0.988500029909018,6,24,proteoglycan binding,MF,PTPRS;LRP1;CTSB;GPC1;AGRN;NID1
5401,GO:0016239,0.0393119624892708,0.982974489339901,11,57,positive regulation of macroautophagy,BP,BNIP3;FYCO1;GPSM1;PIM2;ULK1;BNIP3L;LRSAM1;SESN2;RAB12;MAPK3;SPTLC2
6742,GO:0030168,0.0394516764872695,0.979330989958461,17,101,platelet activation,BP,APOE;DGKA;F2R;ITPR3;SERPINE2;AKT1;RAC2;CEACAM1;GAS6;DGKQ;ENTPD2;ADAMTS13;CD9;PRKCD;FYN;MAPK3;BLOC1S4
14792,GO:0070513,0.0395267687521021,0.994715371814141,3,8,death domain binding,MF,DAP;BAX;BCL2L1
5264,GO:0015909,0.0395350199370894,0.985700472031676,8,37,long-chain fatty acid transport,BP,APOE;CPT2;AKT1;ABCD1;NTSR1;MIF;PLA2G6;SLC27A1
11611,GO:0046324,0.0395716995375688,0.984633356485043,9,43,regulation of glucose import,BP,PIK3R2;AKT1;CLTCL1;PRKCZ;INSR;RTN2;PAK1;NGFR;GRB10
14119,GO:0060996,0.039643950549373,0.98138564103224,13,71,dendritic spine development,BP,ZMYND8;DLG4;WNT7A;APOE;PTPRS;SHANK2;DVL1;EPHB2;SHANK3;ARHGAP44;EEF2K;CAPRIN2;CAMK1
4138,GO:0009201,0.039702829110259,0.978719101615862,18,111,ribonucleoside triphosphate biosynthetic process,BP,PGM1;NME4;HK1;PFKL;PFKP;DHTKD1;TGFB1;PFKFB2;MLXIPL;UCKL1;CYC1;DDIT4;ALDOC;PPARA;INSR;TAZ;PFKM;PFKFB3
13024,GO:0051489,0.0398047709545179,0.986859278620582,7,30,regulation of filopodium assembly,BP,ZMYND8;ESPN;ARAP1;TENM2;AGRN;FSCN1;PRKCD
14872,GO:0070664,0.0398343661162858,0.984477578008279,9,44,negative regulation of leukocyte proliferation,BP,PRNP;PKN1;IL20RB;CEBPB;TGFB1;ERBB2;INPP5D;PELI1;HLA-G
14502,GO:0062014,0.0398377685497456,0.981936500182748,12,65,negative regulation of small molecule metabolic process,BP,CYP27B1;APOE;AKT1;CEACAM1;TGFB1;MLXIPL;DDIT4;LTB4R2;PPARA;GABBR1;WDTC1;PROX1
19427,GO:1905954,0.0398736764072078,0.984426472337736,9,45,positive regulation of lipid localization,BP,APOE;PLTP;LRP1;NTSR1;PRKCD;ABCG1;ABCA7;MIF;PLA2G6
2295,GO:0005261,0.0399709955031476,0.978598736671707,18,107,cation channel activity,MF,KCNG1;ITPR3;SCN4B;ORAI3;ORAI1;KCNJ15;TPCN1;KCNC4;KCNAB2;GAS6;PKD2;GRIN3B;ASIC1;RASA3;TRPC1;CACNB3;SCN8A;PKD1
5521,GO:0016491,0.040092780874661,0.97052045196167,66,526,oxidoreductase activity,MF,XDH;H6PD;CYP27B1;IDH2;AKR7A2;LOXL1;NOS1;VAT1;HADH;ALDH4A1;TXNRD3;KDSR;CRYL1;SRD5A3;HSD17B8;CYBRD1;PRDX5;PRODH;D2HGDH;PYCR2;KCNAB2;CBR4;DHTKD1;ALOX15B;CCS;RSAD1;GPX3;RETSAT;CTBP1;CBS;SDHA;MSRB2;MDH2;ERO1B;PHGDH;KDM6B;GRHPR;ACAD10;CYGB;CYC1;ACADS;HSD17B7;PDIA5;GSTO1;PPOX;MTHFR;DECR2;SESN2;SMOX;KDM4B;PHYH;NARF;QSOX1;HSD11B1L;ETFB;CYP3A5;CAT;CYP2R1;TSTA3;GLRX;MICAL1;NDUFV3;ALDH7A1;HSD11B1;PTGR2;KDM3A
2206,GO:0005092,0.0401492555570443,0.992012388109193,4,13,GDP-dissociation inhibitor activity,MF,GPSM1;GDI1;RGS14;SESN2
17232,GO:0110020,0.0401516747396236,0.981792687084156,12,64,regulation of actomyosin structure organization,BP,RAPGEF3;ARAP1;SMAD3;SH3PXD2B;PPM1F;EPHA1;LIMK1;FHOD1;PAK1;PROX1;PXN;PFN2
7774,GO:0032305,0.0404415472744963,0.994542652172833,3,8,positive regulation of icosanoid secretion,BP,NTSR1;MIF;PLA2G6
19791,GO:2000193,0.0404415472744963,0.994542652172833,3,8,positive regulation of fatty acid transport,BP,NTSR1;MIF;PLA2G6
12346,GO:0048732,0.0405071669784573,0.97257200958748,42,299,gland development,BP,XDH;CST3;APLN;VEGFA;LRP5;EGFR;SERPINE2;ETV5;MAP2K1;SMAD3;STAT6;AKT1;FGFR1;RAG1;CEACAM1;CCND1;LAMA5;PCSK9;ALOX15B;PKD2;APRT;CEBPB;WNT3;TGFB1;DEAF1;ATP7B;HMGCL;PCK2;ADA;AREG;BAX;TGFBR3;ACO2;ARID5B;MAPK3;INSR;PROX1;PKD1;EDA;HFE;PLAG1;SRSF5
4333,GO:0009887,0.0408767080589944,0.96891061707834,83,646,animal organ morphogenesis,BP,SDK2;MEF2D;HTRA1;FHL1;PGF;PDCD4;CTNNBIP1;ACVR2B;BBS2;VEGFA;WNT7A;NAGLU;LRP5;ITGA6;EGFR;WWTR1;SPRY2;SDC1;ETV5;ACTA2;PHLDA2;GAA;MDFI;MAP2K1;ACP5;SMURF2;SMAD3;STAT6;SHANK2;DVL1;THBS3;AP2A2;ITGB4;SH3PXD2B;ADARB1;BSG;IFT140;WNT2B;FGFR1;GAMT;CEACAM1;TSHZ1;LAMA5;BCR;ERRFI1;SLITRK6;COL13A1;PKD2;CTSZ;EPHB2;CEBPB;TGFB1;NAB2;SHANK3;KIF26B;LRP4;RFNG;AREG;FAM20C;BAX;EREG;PPP1R13L;TGFBR3;LEMD2;CHAD;ADAM15;WDR60;ZFPM1;PPARA;ARID5B;MAPK3;INSR;VANGL2;HYAL1;PROX1;PKD1;EDA;E2F5;LAMB1;SLC39A3;CELSR1;FGFR3;PLAG1
10636,GO:0043652,0.0408928674905346,0.994456815939219,3,8,engulfment of apoptotic cell,BP,RAC2;ABCA7;RAC3
4094,GO:0009150,0.0409331058845676,0.971591952395885,47,359,purine ribonucleotide metabolic process,BP,NT5E;DLG4;VEGFA;PGM1;APOE;ACOT7;NOS1;GTPBP1;RAPGEF3;NME4;ADORA2B;HK1;PTHLH;PFKL;PFKP;CARD11;DHTKD1;NADK;PANK4;NPR2;PKD2;APRT;TIMP2;TGFB1;PODXL2;SDHA;ABHD14B;PFKFB2;MLXIPL;FAM20C;CYC1;PPCS;DDIT4;LTB4R2;ALDOC;PPARA;INSR;TAZ;PFKM;ADCY1;PFKFB3;GABBR1;DLG3;NDUFV3;ADCY7;AK3;ADCY6
17715,GO:1901615,0.0410410589032898,0.971785990679675,45,326,organic hydroxy compound metabolic process,BP,NR1D1;CYP27B1;APOE;LRP5;OSBPL5;ISYNA1;LMF1;PLCD3;PLTP;SRD5A3;EPAS1;D2HGDH;FGFR4;LDLR;FGFR1;SEC14L2;SORL1;PLCH2;PCSK9;DGKQ;HAGH;RETSAT;PLCG1;MVD;NTSR1;SNX17;PLPP6;PCK2;PFKFB2;TRPC1;MBTPS2;HSD17B7;INPP5D;COQ2;ABCG1;DDT;CHKA;CAT;PLCB3;CYP2R1;PDXK;PROX1;GCH1;ITPKB;SPTLC2
595,GO:0001763,0.0410570678457315,0.976412151613314,22,138,morphogenesis of a branching structure,BP,PGF;CTNNBIP1;VEGFA;LRP5;SPRY2;NFATC4;ETV5;WNT2B;FGFR1;EDNRA;LAMA5;COL13A1;PKD2;CTSZ;TGFB1;AREG;RERE;VANGL2;PAK1;PROX1;PKD1;CELSR1
4344,GO:0009898,0.0410632065151469,0.977118181294341,20,123,cytoplasmic side of plasma membrane,CC,DLG4;SNX9;MAP2K2;S100A6;MYZAP;KCNAB2;SYNGAP1;PTK6;ERRFI1;SPTB;GNAL;NTSR1;RASA3;FARP1;ESYT2;JAK3;RASA4;FYN;SRMS;RGS19
2257,GO:0005172,0.0410738433744213,0.994422281459057,3,8,vascular endothelial growth factor receptor binding,MF,PGF;VEGFA;VEGFB
3508,GO:0007422,0.0411172627994195,0.982901104469313,10,51,peripheral nervous system development,BP,NDRG1;AKT1;GPC1;NAB2;LAMB2;ERBB2;ADGRB2;AHNAK2;SCN8A;SIRT2
896,GO:0002274,0.0412212647740753,0.970376441140352,57,435,myeloid leukocyte activation,BP,CST3;PYGB;PGM1;PYGL;NDRG1;VAT1;HEXB;SLC2A3;GAA;NAPRT;AP2A2;STOM;ADORA2B;SLC15A4;RAB31;LDLR;FUCA1;RAC2;KCNAB2;PFKL;CEACAM1;PLAU;BRI3;CTSB;GSN;BCR;CTSZ;PRSS3;ADAM8;APRT;LTA4H;TIMP2;DPP7;TGFB1;TMEM173;GALNS;PI4K2A;RHOF;YPEL5;ACTR1B;VAMP2;PRKCD;ALDOC;LPCAT1;MIF;SYNGR1;QSOX1;CD68;GLB1;CAT;PDXK;RNASET2;MAN2B1;DNASE1L1;SERPINB1;TOLLIP;NBEAL2
12703,GO:0050930,0.0414817445770587,0.994344204176739,3,8,induction of positive chemotaxis,BP,PGF;VEGFA;VEGFB
6063,GO:0019213,0.0414923379897281,0.982717632439446,10,51,deacetylase activity,MF,MTA1;HDAC5;HMG20B;PHF21A;MBD3;CES2;HDAC7;NDST2;SIRT2;SIRT3
8451,GO:0033598,0.0415246312026422,0.98760460822933,6,25,mammary gland epithelial cell proliferation,BP,STAT6;CCND1;CEBPB;DEAF1;AREG;BAX
3042,GO:0006600,0.041658891459452,0.994310192803074,3,8,creatine metabolic process,BP,SLC6A8;GAMT;CKMT1A
4229,GO:0009409,0.0417626123753101,0.986008278998045,7,31,response to cold,BP,FOS;CIRBP;VGF;ZNF516;PCSK1N;SLC27A1;LRP11
19425,GO:1905952,0.0417781173582009,0.980174994300261,13,74,regulation of lipid localization,BP,APOE;PLTP;LRP1;AKT1;PCSK9;ABCA2;NTSR1;PRKCD;PPARA;ABCG1;ABCA7;MIF;PLA2G6
6672,GO:0030041,0.0418814141611355,0.976582498901553,20,126,actin filament polymerization,BP,TMOD2;CORO1B;RAC2;TWF2;GSN;PLEKHG2;WIPF1;ARPIN;SPTB;CORO7;CDC42EP5;FHOD3;MSRB2;WASF3;MICALL2;CAPG;PRKCD;WASH3P;RAC3;PFN2
7201,GO:0031099,0.0421179068644749,0.976838489986185,19,118,regeneration,BP,PGF;POSTN;WNT7A;APOE;EGFR;PTPRS;MAP2K1;PTPRU;CCND1;GAS6;GSN;CEBPB;TGFB1;LAMB2;ULK1;TGFBR3;ADAM15;HFE;SRSF5
18455,GO:1903530,0.0422947917323678,0.969850980695695,54,402,regulation of secretion by cell,BP,NR1D1;APLN;POSTN;F2R;LRP5;IDH2;ITPR3;EGFR;HADH;SYTL1;SDC1;ARL2;RAPGEF3;GLUL;MCTP1;NLGN2;ADORA2B;SYT8;KCNC4;RHBDF2;HK1;FGFR1;MAPKBP1;RAC2;PFKL;CEACAM1;GAS6;RAB3B;BCR;ALOX15B;ADAM8;ASIC1;TGFB1;NTSR1;LLGL1;RIMS3;PCK2;PFKFB2;PRKCZ;VAMP2;RASL10B;MIF;PLA2G6;MAPK3;PFKM;PPP3CB;MICAL1;ICA1;RAB40B;PCLO;SIRT3;HFE;ZP3;PFN2
12762,GO:0051046,0.0423432069907819,0.969528777812876,57,428,regulation of secretion,BP,NR1D1;APLN;POSTN;F2R;LRP5;IDH2;ITPR3;EGFR;HADH;SYTL1;SDC1;ARL2;RAPGEF3;GLUL;MCTP1;NLGN2;ADORA2B;SYT8;KCNC4;RHBDF2;STK39;HK1;FGFR1;MAPKBP1;RAC2;PFKL;CEACAM1;GAS6;RAB3B;BCR;ALOX15B;ADAM8;ASIC1;TGFB1;NTSR1;LLGL1;RIMS3;PCK2;PFKFB2;PRKCZ;ADA;VAMP2;SV2A;RASL10B;MIF;PLA2G6;MAPK3;PFKM;PPP3CB;MICAL1;ICA1;RAB40B;PCLO;SIRT3;HFE;ZP3;PFN2
6847,GO:0030323,0.0424389354198198,0.976660559112766,19,116,respiratory tube development,BP,ACVR2B;VEGFA;EGFR;SPRY2;MAP2K1;EPAS1;WNT2B;FGFR1;LAMA5;ERRFI1;CTSZ;ADA;MAPK3;VANGL2;ITGA3;PROX1;PKD1;HSD11B1;CELSR1
3524,GO:0007507,0.0424931375274864,0.970240255156268,49,355,heart development,BP,DUSP6;MEF2D;APLN;PDCD4;ACVR2B;VEGFA;EGFR;OBSL1;NFATC4;SHC1;LTBP1;ZFP36L1;GAA;MAP2K1;SMAD3;DVL1;SH3PXD2B;VEGFB;IFT140;FGFR1;TCF25;EDNRA;PKD2;EPOR;TGFB1;FHOD3;SNX17;ADAM19;MBD3;KDM6B;ERBB2;TFDP2;PPP1R13L;TGFBR3;LEMD2;ADAM15;ZFPM1;PPARA;DNM2;MAPK3;INSR;TAZ;VANGL2;PAK1;PPP3CB;ITGA3;PROX1;LMNA;PKD1
18023,GO:1902495,0.0425626865674493,0.97658440143468,19,116,transmembrane transporter complex,CC,DLG4;KCNG1;SCN4B;NOS1;SHANK2;KCNC4;TTYH3;LRRC8A;KCNAB2;ABCA2;GRIN3B;SHANK3;PRKACA;VAMP2;CACNB3;OLFM2;SCN8A;ABCA7;DLG3
5604,GO:0016645,0.042596526312862,0.98905587598657,5,19,oxidoreductase activity, acting on the CH-NH group of donors,MF,ALDH4A1;PRODH;PYCR2;MTHFR;SMOX
6456,GO:0021782,0.042653597809388,0.980430788444901,12,66,glial cell development,BP,NDRG1;EGFR;LRP1;AKT1;LDLR;GSN;TGFB1;LAMB2;WASF3;CD9;AHNAK2;SIRT2
17533,GO:1901016,0.0428983395361901,0.985541970030301,7,31,regulation of potassium ion transmembrane transporter activity,BP,FHL1;KCNG1;STK39;ANK3;VAMP2;DNM2;KLHL24
17023,GO:0099172,0.042959644709393,0.991261635075394,4,13,presynapse organization,BP,WNT7A;DVL1;NLGN2;LRP4
11293,GO:0045621,0.0430678094820659,0.981913973260166,10,52,positive regulation of lymphocyte differentiation,BP,RAG1;GAS6;AP3D1;ADAM8;TGFB1;PRKCZ;ADA;INPP5D;HLA-G;ITPKB
12948,GO:0051339,0.0430780401384598,0.9888973208953,5,19,regulation of lyase activity,BP,NOS1;ADORA2B;TIMP2;LTB4R2;GABBR1
6128,GO:0019388,0.0430945381314114,0.994032264701575,3,8,galactose catabolic process,BP,PGM1;GALE;GLB1
2517,GO:0005773,0.0431509572085044,0.967366264067963,78,605,vacuole,CC,CST3;PYGB;TSPAN1;NAGLU;VAT1;CTSO;CAPN2;MST1R;SDC1;VPS11;TBC1D14;HEXB;GAA;MARCH9;CTBS;NAPRT;ACP5;TMEM8A;LRP1;AP2A2;CYBRD1;STOM;TPCN1;SLC15A4;ATG16L2;LDLR;FUCA1;ANK3;BRI3;CTSB;PCSK9;FYCO1;CTSZ;AP3D1;ABCA2;ADAM8;TMEM9;DPP7;GPC1;GALNS;PEG3;DIRC2;PI4K2A;SLC48A1;TPP1;WDR59;AGRN;IDUA;ADA;ULK1;SLC22A17;PRKCD;NAGA;WASH3P;LPCAT1;PI4K2B;RAB12;SYNGR1;CD68;SPPL2B;GLB1L2;GLB1;CAT;SLC12A4;C12ORF66;RNASET2;CTSF;HYAL1;VPS16;MAN2B1;TRIP10;TOLLIP;ATP6V1F;PLEKHM1;COL6A1;MAN2B2;SLC26A11;SDC2
14370,GO:0061615,0.0432290072144794,0.988847499318086,5,19,glycolytic process through fructose-6-phosphate,BP,HK1;PFKL;PFKP;ALDOC;PFKM
14373,GO:0061620,0.0432290072144794,0.988847499318086,5,19,glycolytic process through glucose-6-phosphate,BP,HK1;PFKL;PFKP;ALDOC;PFKM
11849,GO:0046849,0.0433120773334743,0.981822981267442,10,51,bone remodeling,BP,LRP5;EGFR;ACP5;RAC2;ADAM8;TGFB1;TPP1;INPP5D;PLEKHM1;LRRK1
6413,GO:0021681,0.0433210548164699,0.993988043114667,3,8,cerebellar granular layer development,BP,WNT7A;SERPINE2;PROX1
7043,GO:0030823,0.0433219214219071,0.991163572678034,4,13,regulation of cGMP metabolic process,BP,VEGFA;APOE;NOS1;ADORA2B
17334,GO:0150034,0.0433627022061341,0.973399825995203,27,179,distal axon,CC,ADGRL1;GLUL;SSH1;SHANK2;DVL1;KCNC4;TMOD2;SIGMAR1;KCNAB2;TENM2;TWF2;CTSZ;AP3D1;TIMP2;NTSR1;FSCN1;SV2A;SYNGR1;RAC3;DNM2;MICAL1;ITGA3;DLG3;SIRT2;SEPT6;PFN2;NDRG2
17760,GO:1901699,0.0434583348389313,0.968409603506626,60,450,cellular response to nitrogen compound,BP,EGR1;PRNP;EGFR;CAPN2;SHC1;PTPRE;RAPGEF3;ZFP36L1;MAP2K2;MAP2K1;SSH1;SMAD3;STAT6;PIK3R2;LRP1;AKT1;HDAC5;UROS;IMPACT;RAB31;PRKACB;CEACAM1;MAPK13;PCSK9;ERRFI1;PKD2;APRT;CEBPB;TGFB1;TMEM173;NSMF;PTPN1;PCK2;AGRN;PRKCZ;PRKACA;VAMP2;JAK3;PRKCD;SESN2;FYN;EEF2K;DNM2;MAPK3;INSR;ADCY1;PAK1;WDTC1;DNMT3A;BCL2L1;SIRT2;ADCY7;SOCS7;NGFR;ATP6V1F;PXN;GRB10;COL6A1;SRSF5;ADCY6
17965,GO:1902307,0.0435320828391599,0.991106552718554,4,13,positive regulation of sodium ion transmembrane transport,BP,NOS1;ANK3;DNM2;GLRX
7571,GO:0031941,0.0435719944084495,0.986766709414005,6,26,filamentous actin,CC,ESPN;PKD2;PRKCZ;FSCN1;RAC3;PAK1
2286,GO:0005245,0.0435847589106256,0.991092245674258,4,13,voltage-gated calcium channel activity,MF,TPCN1;GAS6;PKD2;CACNB3
3487,GO:0007369,0.0436102720605572,0.975529718628749,20,123,gastrulation,BP,DUSP6;DUSP5;APLN;ACVR2B;LRP5;HMGA2;SMAD3;DVL1;ITGB4;FGFR1;ITGB5;WNT3;KDM6B;DUSP4;SOX7;VANGL2;ITGA3;ITGA4;LAMB1;COL6A1
12922,GO:0051287,0.043645403394215,0.981628358284032,10,52,NAD binding,MF,IDH2;HADH;CRYL1;HSD17B8;CTBP1;PHGDH;GRHPR;AHCY;SIRT2;SIRT3
12981,GO:0051400,0.0436968861587559,0.993914450782685,3,8,BH domain binding,MF,BOK;BAX;BCL2L1
12958,GO:0051349,0.0438454051611228,0.99388529317772,3,8,positive regulation of lyase activity,BP,NOS1;ADORA2B;TIMP2
8424,GO:0033549,0.0438967619653541,0.991007379430409,4,13,MAP kinase phosphatase activity,MF,DUSP6;DUSP5;DUSP7;DUSP4
7853,GO:0032420,0.0439118190461443,0.986710294296274,6,25,stereocilium,CC,DOCK4;BBS2;ESPN;TWF2;MORN4;HOMER2
12894,GO:0051249,0.0440245559433269,0.97114601601145,35,246,regulation of lymphocyte activation,BP,PRNP;PKN1;ZFP36L1;STAT6;PAG1;AKT1;RAC2;RAG1;CEACAM1;GAS6;CARD11;SOX13;GSN;IGFBP2;IL20RB;AP3D1;ADAM8;CD81;CEBPB;TGFB1;EFNB3;CD320;PRKCZ;ADA;ERBB2;JAK3;INPP5D;MIF;FYN;PELI1;HLA-G;PAK1;HFE;ZP3;ITPKB
7351,GO:0031400,0.0440369692832098,0.967870474921835,61,462,negative regulation of protein modification process,BP,TNIP1;DUSP6;XDH;DUSP5;PDCD4;PRNP;APOE;LRP5;PKN1;WWTR1;SPRY2;CRTAP;SPRY4;PPP1R35;FBLN1;PIK3R2;DVL1;PPP1R14A;ADARB1;AKT1;PPM1F;STK39;EPHA1;IMPACT;SORL1;CEACAM1;HMG20B;PODNL1;PTK6;DUSP7;ERRFI1;SNTA1;DGKQ;EPHB2;CTBP1;CDKN1C;TGFB1;PTPN1;CAMK2N1;MLXIPL;TRIB2;PRKCZ;PRKCD;BAX;DUSP4;DDIT4;LIMK1;LEMD2;RPS6KA6;RGS14;CHAD;FYN;ELFN2;MICAL1;SIRT2;SOCS7;SIRT3;NDRG2;CBLC;KDM3A;LRRK1
3151,GO:0006754,0.0440379303035678,0.977092907234274,16,96,ATP biosynthetic process,BP,PGM1;HK1;PFKL;PFKP;DHTKD1;TGFB1;PFKFB2;MLXIPL;CYC1;DDIT4;ALDOC;PPARA;INSR;TAZ;PFKM;PFKFB3
14122,GO:0060999,0.0440515729352328,0.985065406238424,7,31,positive regulation of dendritic spine development,BP,ZMYND8;APOE;SHANK2;SHANK3;EEF2K;CAPRIN2;CAMK1
12333,GO:0048705,0.044117420260822,0.974807779237339,21,132,skeletal system morphogenesis,BP,MEF2D;ACVR2B;WNT7A;LRP5;MDFI;ACP5;SMAD3;THBS3;SH3PXD2B;IFT140;FGFR1;COL13A1;TGFB1;NAB2;CHAD;WDR60;ARID5B;HYAL1;PKD1;SLC39A3;FGFR3
7950,GO:0032555,0.0441541630112837,0.963475332508771,174,1431,purine ribonucleotide binding,MF,ACVR2B;PYGL;DGKA;OBSCN;NEK9;PKN1;ACSF2;EGFR;RPS6KA2;MST1R;ARL2;GTPBP1;TK2;ACTA2;RAPGEF3;GLUL;MAP2K2;NME4;SMARCA1;PC;MAP2K1;MARK4;ERCC6;CDK18;NMRK1;AKT1;STK39;HK1;EPHA1;BRSK1;RAB31;FGFR4;FGFR1;PRKACB;RAC2;PFKL;TTLL12;OPLAH;HLTF;ABCD1;TWF2;STRADB;MAPK13;PTK6;PFKP;CSNK1E;RAB3B;MAPKAPK3;BCR;EHD4;SEPT10;NADK;PANK4;HLCS;AGAP1;NPR2;DGKQ;PAK6;FYCO1;ABCA2;EPHB2;APRT;GRK6;KIF17;MVD;ENTPD2;GNAL;SCYL1;ULK2;MKNK2;TMEM173;ATP7B;PIP5KL1;KIF26B;RHOD;DNAH1;PI4K2A;RHOF;ARL10;KIF7;RHOBTB2;TUBG2;PEX1;PCK2;TRAP1;PFKFB2;PRKCZ;PRKACA;MINK1;ACTR1B;PIM2;UCKL1;ERBB2;ULK1;STK17A;JAK3;PDK1;PRKCD;FAM20C;NUBP2;RPS6KA5;DGUOK;CUL9;RASL10B;LIMK1;NTPCR;RPS6KA6;DNM1;SCN8A;EHD3;LONP2;MAPK12;IRAK1;CHD2;PI4K2B;CHEK2;ABCG1;MYO1D;MYH15;CDC34;ABCA7;RAB12;SPEG;DALRD3;FYN;STK25;RAC3;EEF2K;DNM2;CKMT1A;CHKA;KIF26A;DDX50;TUBB6;MAPK3;INSR;PFKM;ADCY1;ATP8B2;PDXK;PAK1;CAMKK2;ALPK1;PFKFB3;STK32C;SRMS;MAP2K3;RRAS;IARS2;GAL3ST4;NMNAT2;ADCY7;TEP1;RAB28;MAP3K10;RAB40B;GCH1;KIF13B;CAMK1;CAMKK1;BBS10;SEPT6;CDK11B;FGFR3;ITPKB;CDC42BPG;CLK3;DHX32;PKN3;TTLL3;AK3;ADCY6;LRRK1;AARS
8153,GO:0032890,0.0442094317042631,0.986597870073102,6,25,regulation of organic acid transport,BP,AKT1;STK39;NTSR1;SV2A;MIF;PLA2G6
12565,GO:0050728,0.0443905017400545,0.979484199772987,12,67,negative regulation of inflammatory response,BP,NT5E;PDCD4;APOE;ACP5;SMAD3;FNDC4;BCR;SHARPIN;IL20RB;ADA;PRKCD;PPARA
18514,GO:1903649,0.0444190195149372,0.988452944864061,5,19,regulation of cytoplasmic transport,BP,VPS11;MAP2K2;MAP2K1;SORL1;MAPK3
12291,GO:0048640,0.0445838786576041,0.979424723341566,12,65,negative regulation of developmental growth,BP,SEMA4B;BBS2;PTPRS;WWC3;SEMA3F;WNT3;ULK2;SEMA4F;PAK1;SEMA4C;SEMA3B;FGFR3
1225,GO:0002901,0.0445891579613038,0.997121750441905,2,4,mature B cell apoptotic process,BP,ADA;MIF
1229,GO:0002905,0.0445891579613038,0.997121750441905,2,4,regulation of mature B cell apoptotic process,BP,ADA;MIF
1230,GO:0002906,0.0445891579613038,0.997121750441905,2,4,negative regulation of mature B cell apoptotic process,BP,ADA;MIF
7044,GO:0030825,0.0446209242146483,0.993732347187214,3,8,positive regulation of cGMP metabolic process,BP,APOE;NOS1;ADORA2B
11427,GO:0045869,0.0446970294816077,0.993717275315203,3,8,negative regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,HMGA2;APOBEC3C;APOBEC3F
7760,GO:0032287,0.0446974269701353,0.993717196567367,3,8,peripheral nervous system myelin maintenance,BP,NDRG1;AKT1;AHNAK2
3407,GO:0007193,0.0447339286047292,0.984781993710428,7,31,adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,BP,EDNRA;GNAL;HTR7;ADCY1;GABBR1;ADCY7;ADCY6
7598,GO:0031985,0.0447755299300571,0.977252912748647,15,87,Golgi cisterna,CC,B4GALNT4;ARAP1;PITPNM1;ASAP2;SORL1;GOLGA2P5;LLGL1;B4GALT2;B4GALT6;NECAB3;ST3GAL3;BCAP31;GAL3ST4;ST3GAL2;CHPF
6772,GO:0030214,0.044884320218981,0.990737357931814,4,13,hyaluronan catabolic process,BP,HEXB;CEMIP;TGFB1;HYAL1
13263,GO:0051961,0.0449035139999301,0.972087733894497,28,188,negative regulation of nervous system development,BP,SEMA4B;WNT7A;APOE;IDH2;PTPRS;NFATC4;LRP1;LDLR;PRKACB;SORL1;SYNGAP1;SEMA3F;CTSZ;EPHB2;WNT3;TGFB1;ULK2;EFNB3;SEMA4F;LRP4;DGUOK;GDI1;SEMA4C;SIRT2;RAP1GAP2;NGFR;SEMA3B;ADCY6
10057,GO:0042552,0.0449915930638916,0.977749702375815,14,80,myelination,BP,MARVELD1;NDRG1;HEXB;AKT1;TGFB1;GPC1;NAB2;WASF3;CD9;ERBB2;AHNAK2;SCN8A;MALL;SIRT2
6574,GO:0022407,0.0450471559254686,0.970821038023111,33,229,regulation of cell-cell adhesion,BP,PRNP;ITGA6;SERPINE2;PAG1;AKT1;RAG1;CEACAM1;ANK3;CARD11;IGFBP2;IL20RB;AP3D1;ADAM8;CEBPB;TGFB1;EFNB3;KIF26B;PRKCZ;MINK1;CD9;ADA;ERBB2;JAK3;PRKCD;PPARA;FYN;PELI1;HLA-G;PAK1;ITGA4;HFE;ZP3;ITPKB
6859,GO:0030336,0.0450620852093245,0.972821537221307,25,165,negative regulation of cell migration,BP,ZMYND8;APOE;IDH2;NISCH;MCTP1;LRP1;ADARB1;CORO1B;HDAC5;MMP28;EPHA1;PTPRU;BCR;ARPIN;ALOX15B;PLXNB3;TGFB1;ARAP3;ADA;CYGB;ADAM15;MIF;DDT;RRAS;PFN2
4143,GO:0009206,0.0450828952844902,0.975928577844017,17,105,purine ribonucleoside triphosphate biosynthetic process,BP,PGM1;NME4;HK1;PFKL;PFKP;DHTKD1;TGFB1;PFKFB2;MLXIPL;CYC1;DDIT4;ALDOC;PPARA;INSR;TAZ;PFKM;PFKFB3
15134,GO:0071236,0.0451127980712946,0.975922463785276,17,104,cellular response to antibiotic,BP,EGR1;CST3;ENDOG;STAT6;IMPACT;MAPK13;BNIP3;ANKZF1;TRAP1;KDM6B;NET1;PRKCD;STK25;ADCY1;DNMT3A;ADCY7;ADCY6
2521,GO:0005777,0.0451673831207013,0.975877703099793,17,105,peroxisome,CC,XDH;TYSND1;IDH2;CRAT;MAP2K2;PRDX5;ABCD1;PEX10;TMEM173;HMGCL;PEX1;GRHPR;LONP2;DECR2;PHYH;CAT;MLYCD
10074,GO:0042579,0.0451673831207013,0.975877703099793,17,105,microbody,CC,XDH;TYSND1;IDH2;CRAT;MAP2K2;PRDX5;ABCD1;PEX10;TMEM173;HMGCL;PEX1;GRHPR;LONP2;DECR2;PHYH;CAT;MLYCD
10026,GO:0042476,0.0451827797726786,0.977641536188275,14,80,odontogenesis,BP,HTRA1;ACVR2B;ITGA6;SDC1;ITGB4;BSG;LAMA5;TGFB1;LRP4;FAM20C;BAX;PPARA;EDA;LAMB1
3743,GO:0008285,0.0452138561441224,0.966868967438053,62,472,negative regulation of cell proliferation,BP,XDH;CYP27B1;FBXO2;APLN;PDCD4;CTNNBIP1;PRNP;APOE;F2R;NDRG1;IDH2;PKN1;RPS6KA2;SERPINE2;SPRY2;TP53I11;MAP2K1;MXD4;FBLN1;SMAD3;ADARB1;PTPRU;PTHLH;MXI1;CEACAM1;LZTS2;FGFBP1;ALOX15B;PKD2;IL20RB;CTBP1;MNT;CDKN1C;CEBPB;TIMP2;TGFB1;CGREF1;CAMK2N1;VHL;CD9;PIM2;ERBB2;BAX;ITGA1;EREG;TGFBR3;INPP5D;SOX7;SPEG;SIX5;PELI1;IGFBP7;HLA-G;PAK1;DLG3;PROX1;LMNA;SIRT2;FAM129B;NGFR;BTG1;NDRG2
9803,GO:0040037,0.045226354509202,0.990643344449666,4,13,negative regulation of fibroblast growth factor receptor signaling pathway,BP,APLN;SPRY2;SPRY4;GPC1
15238,GO:0071402,0.045234131526984,0.988180832272481,5,19,cellular response to lipoprotein particle stimulus,BP,APOE;LDLR;CD81;CD9;ABCG1
2662,GO:0006013,0.045335215063866,0.993590451267582,3,8,mannose metabolic process,BP,MPI;MAN2B1;MAN2B2
1107,GO:0002695,0.0455622586667314,0.976782070451814,15,88,negative regulation of leukocyte activation,BP,PRNP;PKN1;PAG1;LDLR;CEACAM1;BCR;IL20RB;CEBPB;TGFB1;ERBB2;JAK3;INPP5D;PELI1;HLA-G;HFE
10073,GO:0042578,0.0457393660771813,0.969383699345229,38,268,phosphoric ester hydrolase activity,MF,DUSP6;NT5E;DUSP5;PLD3;PTPRS;PTPRE;PLCD3;MAP2K1;ACP5;SSH1;PPP2R3B;PLCXD2;NT5DC1;PPM1F;PTPRU;PPM1J;LHPP;PLCH2;EDNRA;DUSP7;CDC25B;PTPDC1;PLCG1;SYNJ2;PLPP6;PTPN1;ACP6;PFKFB2;SBF1;DUSP4;NTPCR;INPP5D;PLCB3;PPP3CB;PFKFB3;NT5C1B;DUSP23;SSH3
12862,GO:0051194,0.045755380068139,0.990497437194513,4,13,positive regulation of cofactor metabolic process,BP,PFKFB2;MLXIPL;INSR;PFKFB3
6657,GO:0030017,0.0457603069009779,0.975532350988029,17,104,sarcomere,CC,PARVB;FLNC;OBSCN;OBSL1;NOS1;TMOD2;MYZAP;ANK3;TNNT1;FHOD3;STUB1;AHNAK2;TPM2;SCN8A;PAK1;PPP3CB;BIN1
645,GO:0001836,0.0459107824463426,0.98148232701615,9,48,release of cytochrome c from mitochondria,BP,AKT1;BNIP3;MOAP1;BOK;IFI6;BAX;PLA2G6;BCL2L1;LMNA
13265,GO:0051963,0.0459166076744982,0.981622070646105,9,44,regulation of synapse assembly,BP,ADGRL1;WNT7A;NLGN2;SLITRK6;EPHB2;AGRN;ADGRB2;EEF2K;TPBG
11655,GO:0046434,0.0460056843458062,0.971884621126647,26,174,organophosphate catabolic process,BP,NT5E;XDH;PGM1;DNPH1;RAPGEF3;HK1;LDLR;PFKL;PFKP;DHTKD1;PLCG1;ENTPD2;NTSR1;PFKFB2;MLXIPL;ADA;PRKCD;DDIT4;ALDOC;PPARA;UPP1;NEIL1;INSR;PFKM;PFKFB3;NT5C1B
4634,GO:0010758,0.0461443166002661,0.990222737262191,4,14,regulation of macrophage chemotaxis,BP,MMP28;MIF;DDT;MAPK3
17255,GO:0120033,0.0462519360243338,0.987838959747351,5,19,negative regulation of plasma membrane bounded cell projection assembly,BP,EVI5L;PLXNB3;PRKCD;DNM2;PFN2
13863,GO:0060491,0.0462525530274123,0.973839695039346,20,126,regulation of cell projection assembly,BP,ZMYND8;ESPN;EVI5L;ARAP1;SSH1;FAM110C;IFT140;RAC2;TENM2;TWF2;PLXNB3;CDC42EP5;CROCC;AGRN;FSCN1;PRKCD;DNM2;PLEKHM1;PFN2;SSH3
7458,GO:0031623,0.0463101276926522,0.979336120283341,11,59,receptor internalization,BP,DLG4;APLN;VEGFA;LRP1;RAB31;CEACAM1;PCSK9;CD81;CD9;DNM1;DNM2
7948,GO:0032553,0.0463203160276311,0.961596187585016,175,1442,ribonucleotide binding,MF,ACVR2B;PYGL;DGKA;OBSCN;NEK9;PKN1;ACSF2;EGFR;RPS6KA2;NOS1;MST1R;ARL2;GTPBP1;TK2;ACTA2;RAPGEF3;GLUL;MAP2K2;NME4;SMARCA1;PC;MAP2K1;MARK4;ERCC6;CDK18;NMRK1;AKT1;STK39;HK1;EPHA1;BRSK1;RAB31;FGFR4;FGFR1;PRKACB;RAC2;PFKL;TTLL12;OPLAH;HLTF;ABCD1;TWF2;STRADB;MAPK13;PTK6;PFKP;CSNK1E;RAB3B;MAPKAPK3;BCR;EHD4;SEPT10;NADK;PANK4;HLCS;AGAP1;NPR2;DGKQ;PAK6;FYCO1;ABCA2;EPHB2;APRT;GRK6;KIF17;MVD;ENTPD2;GNAL;SCYL1;ULK2;MKNK2;TMEM173;ATP7B;PIP5KL1;KIF26B;RHOD;DNAH1;PI4K2A;RHOF;ARL10;KIF7;RHOBTB2;TUBG2;PEX1;PCK2;TRAP1;PFKFB2;PRKCZ;PRKACA;MINK1;ACTR1B;PIM2;UCKL1;ERBB2;ULK1;STK17A;JAK3;PDK1;PRKCD;FAM20C;NUBP2;RPS6KA5;DGUOK;CUL9;RASL10B;LIMK1;NTPCR;RPS6KA6;DNM1;SCN8A;EHD3;LONP2;MAPK12;IRAK1;CHD2;PI4K2B;CHEK2;ABCG1;MYO1D;MYH15;CDC34;ABCA7;RAB12;SPEG;DALRD3;FYN;STK25;RAC3;EEF2K;DNM2;CKMT1A;CHKA;KIF26A;DDX50;TUBB6;MAPK3;INSR;PFKM;ADCY1;ATP8B2;PDXK;PAK1;CAMKK2;ALPK1;PFKFB3;STK32C;SRMS;MAP2K3;RRAS;IARS2;GAL3ST4;NMNAT2;ADCY7;TEP1;RAB28;MAP3K10;RAB40B;GCH1;KIF13B;CAMK1;CAMKK1;BBS10;SEPT6;CDK11B;FGFR3;ITPKB;CDC42BPG;CLK3;DHX32;PKN3;TTLL3;AK3;ADCY6;LRRK1;AARS
4054,GO:0009101,0.0463343320252474,0.96931248874273,36,253,glycoprotein biosynthetic process,BP,TNIP1;LMF1;ST6GALNAC2;SRD5A3;HBEGF;VEGFB;B4GAT1;B3GAT3;PHLDA1;MVD;ADAMTS13;ADAMTS7;B3GNT3;MGAT4B;ST6GALNAC6;B4GALT2;B4GALT6;RFNG;MPI;NECAB3;JAK3;MCFD2;XYLT2;MFNG;ST3GAL3;COG7;ABCA7;NUDT14;VANGL2;NDST2;GAL3ST4;ALG12;ST3GAL2;CHST14;ST3GAL5;CHPF
15080,GO:0071071,0.04641116540753,0.993374870782501,3,8,regulation of phospholipid biosynthetic process,BP,LPCAT1;SLC27A1;ZP3
12093,GO:0048143,0.04642190382681,0.993372708121588,3,8,astrocyte activation,BP,EGFR;LRP1;LDLR
6976,GO:0030658,0.046518985389534,0.973661858838721,20,127,transport vesicle membrane,CC,PTPRS;MCTP1;SYT8;CEACAM1;RAB3B;DBNDD1;CLTCL1;SNTB2;PI4K2A;AREG;VAMP2;MCFD2;SV2A;TGFA;SYNGR1;HLA-G;SEMA4C;BCL2L1;ICA1;PDCD6
11687,GO:0046486,0.0465222738878868,0.967863254710467,44,318,glycerolipid metabolic process,BP,APOE;DGKA;OSBPL5;LPCAT4;EGFR;LMF1;PIK3R2;PIGQ;HBEGF;MBOAT7;PITPNM1;ZFYVE21;FGFR4;LDLR;FGFR1;PIGV;TTC7B;PLCH2;PCSK9;DGKQ;SERINC2;SYNJ2;PIP5KL1;PI4K2A;PCK2;OSBPL10;ACP6;ERBB2;SBF1;EREG;CPNE7;LPCAT1;INPP5D;PI4K2B;PLA2G6;FYN;PITPNM3;CHKA;CAT;SLC27A1;TAZ;ZP3;FGFR3;PI4KAP2
18117,GO:1902745,0.0465898970571835,0.987724931525114,5,19,positive regulation of lamellipodium organization,BP,CORO1B;RAC2;TWF2;FSCN1;DNM2
1174,GO:0002820,0.0466274929467905,0.987712231033075,5,19,negative regulation of adaptive immune response,BP,CEACAM1;IL20RB;JAK3;PPP3CB;HFE
14962,GO:0070863,0.0466288936600868,0.993330978848052,3,8,positive regulation of protein exit from endoplasmic reticulum,BP,EDEM1;SORL1;BCAP31
17100,GO:0099634,0.04664850263727,0.993327021468261,3,8,postsynaptic specialization membrane,CC,DLG4;PTPRS;DLG3
3596,GO:0008028,0.0467299534485624,0.985637663643375,6,25,monocarboxylic acid transmembrane transporter activity,MF,SLC16A3;SLC16A5;BSG;CEACAM1;SLC27A1;SLC16A13
4290,GO:0009719,0.0467402699467211,0.962246068771169,131,1068,response to endogenous stimulus,BP,DUSP6;HTRA1;EGR1;NR1D1;CST3;APLN;PGF;PDCD4;ACVR2B;PRNP;BBS2;POSTN;FAM210B;WNT7A;APOE;LRP5;EGFR;NOS1;HADH;SPRY2;CAPN2;LTBP4;SDC1;SHC1;LTBP2;LTBP1;PTPRE;SPRY4;RAPGEF3;ZFP36L1;SSH1;ENDOG;SMURF2;FOS;SMAD3;PIK3R2;LRP1;AKT1;CORO1B;HDAC5;UROS;BSG;PTPRU;IMPACT;RAB31;FGFR4;FNDC4;LDLR;FGFR1;PRKACB;CEACAM1;CCND1;MAPK13;FGFBP1;CTSB;IGFBP2;PCSK9;ERRFI1;PAQR6;PKD2;ITGB5;ABCA2;APRT;CDKN1C;PLCG1;CD81;CEBPB;TIMP2;TGFB1;GPC1;ADAMTS7;NSMF;TUB;VGF;PTPN1;PCK2;AGRN;MBD3;LRP4;PRKCZ;PRKACA;CD9;AREG;ERBB2;VAMP2;JAK3;PRKCD;FAM20C;STUB1;CYC1;EREG;DDIT4;IER2;TGFBR3;LEMD2;CHEK2;PPARA;SESN2;ABCG1;FYN;EEF2K;DNM2;GLB1;CAT;IGFBP7;SLC27A1;MAPK3;INSR;ADCY1;PAK1;HYAL1;WDTC1;ITGA3;DNMT3A;BCL2L1;SIRT2;ADCY7;SOCS7;NGFR;ATP6V1F;PXN;GRB10;NR2F6;HFE;GAS2L1;COL6A1;BTG1;FGFR3;KDM3A;SRSF5;ADCY6
11571,GO:0046135,0.0467890557371918,0.990040638836304,4,14,pyrimidine nucleoside catabolic process,BP,NT5E;UPP1;APOBEC3C;APOBEC3F
11858,GO:0046873,0.0468158074738845,0.970277027738521,30,202,metal ion transmembrane transporter activity,MF,KCNG1;SLC6A8;ITPR3;SCN4B;ORAI3;ORAI1;SLC12A7;KCNJ15;SLC6A6;TPCN1;KCNC4;KCNAB2;GAS6;SLC20A1;PKD2;GRIN3B;ASIC1;ATP7B;RASA3;TRPC1;CACNB3;SLC13A5;SCN8A;SLC9A7;SLC12A4;SLC13A3;PKD1;SLC25A37;SLC39A3;SLC23A2
12655,GO:0050868,0.0468249808347945,0.979067707452104,11,59,negative regulation of T cell activation,BP,PRNP;PAG1;CEACAM1;IL20RB;CEBPB;TGFB1;ERBB2;JAK3;PELI1;HLA-G;HFE
18811,GO:1904350,0.0468480709142728,0.993286704384419,3,8,regulation of protein catabolic process in the vacuole,BP,LRP1;LDLR;CD81
10011,GO:0042446,0.0469618927491816,0.981046471176396,9,46,hormone biosynthetic process,BP,EGR1;CYP27B1;SRD5A3;HSD17B8;DGKQ;HSD17B7;CYP2R1;HSD11B1;HFE
19673,GO:1990909,0.0470177073038095,0.993252375162645,3,8,Wnt signalosome,CC,LRP5;DVL1;WNT3
3235,GO:0006893,0.0470489754731928,0.98104204709027,9,45,Golgi to plasma membrane transport,BP,BBS2;OSBPL5;EXOC2;RAB31;ANK3;LLGL1;BBS1;VAMP2;DNM2
13701,GO:0060271,0.0471276652329003,0.968029493912269,40,286,cilium assembly,BP,BBS2;EVI5L;WWTR1;NUDCD3;MARK4;IFT140;DNAAF5;NPHP4;CEP250;CSNK1E;LAMA5;GSN;SEPT10;CCDC113;UNC119B;PTPDC1;KIF17;RFX2;CROCC;DNAH1;BBS1;CEP131;PRKACA;SDCCAG8;NINL;RILPL1;EHD3;WDR60;TMEM231;DNAAF3;DNM2;ATXN10;CEP72;VANGL2;NDE1;MSS51;TCTN1;BBS10;SEPT6;TTLL3
16261,GO:0090322,0.0471298365013419,0.987433762511066,5,20,regulation of superoxide metabolic process,BP,EGFR;ACP5;TGFB1;PRKCD;GCH1
3505,GO:0007417,0.0471712793227022,0.964279964877774,76,588,central nervous system development,BP,CST3;BBS2;WNT7A;NAGLU;EGFR;SERPINE2;PTPRS;TRNP1;SMARCA1;MAP2K1;SHANK2;LRP1;GJC2;MBOAT7;ADARB1;AKT1;PITPNM1;CNTN1;FGFR4;WNT2B;LDLR;FGFR1;TRAPPC9;SEMA3F;CSNK1E;GSN;BCR;BNIP3;SHARPIN;TAGLN3;PKD2;EPOR;EPHB2;TIMP2;WNT3;TGFB1;SNPH;SHANK3;LAMB2;WASF3;PHGDH;TPP1;B4GALT2;MBD3;KDM6B;CD9;BOK;ERBB2;BAX;SOX12;DDIT4;RPS6KA6;MYO1D;FYN;RAC3;SUN1;MAPK3;ADCY1;RERE;PAK1;PFKFB3;SEMA4C;BIN1;PROX1;MDGA1;PKD1;SIRT2;LAMB1;SOCS7;NDE1;TCTN1;EZH1;CELSR1;TACC1;NDRG2;AARS
8428,GO:0033555,0.0471773113015053,0.983697513969465,7,32,multicellular organismal response to stress,BP,APOE;NOS1;RAG1;DEAF1;VWA1;GCH1;LRP11
2672,GO:0006029,0.0472244014180365,0.978886628960212,11,58,proteoglycan metabolic process,BP,HEXB;B3GAT3;GPC1;IDUA;XYLT2;VANGL2;HYAL1;NDST2;GAL3ST4;CHST14;CHPF
12587,GO:0050772,0.0474409563151761,0.97786587645519,12,66,positive regulation of axonogenesis,BP,VEGFA;LPAR3;MAP2K1;TWF2;PLXNB3;WNT3;LIMK1;GDI1;STK25;PAK1;CDH4;NGFR
7632,GO:0032049,0.0474619840406025,0.993162210751645,3,8,cardiolipin biosynthetic process,BP,PLA2G6;SLC27A1;TAZ
6766,GO:0030207,0.0474935505735947,0.993155790343723,3,8,chondroitin sulfate catabolic process,BP,HEXB;IDUA;HYAL1
9943,GO:0042310,0.0475257835810654,0.982103151132428,8,38,vasoconstriction,BP,APLN;DOCK4;BBS2;F2R;EGFR;AKT1;EDNRA;HTR7
4057,GO:0009108,0.0476889617884444,0.970173345034918,28,190,coenzyme biosynthetic process,BP,PGM1;IDH2;ACOT7;NAPRT;HSD17B8;NMRK1;HK1;PFKL;CBR4;PFKP;DHTKD1;NADK;PANK4;PFKFB2;MLXIPL;PDK1;PPCS;DDIT4;ALDOC;PPARA;COQ2;INSR;PFKM;PDXK;PFKFB3;MLYCD;NMNAT2;GCH1
401,GO:0001078,0.0477322322543714,0.974365453008189,17,102,transcriptional repressor activity, RNA polymerase II proximal promoter sequence-specific DNA binding,MF,NR1D1;HMGA2;NFATC4;TCFL5;FOXQ1;TSHZ1;MYEF2;HES2;CEBPB;ZNF217;MLXIPL;RBL2;ZFPM1;PPARA;BHLHE40;PROX1;BACH1
12857,GO:0051187,0.0477682711139197,0.983335646324678,7,34,cofactor catabolic process,BP,ACOT7;PRDX5;GGT1;GPX3;AHCY;CAT;PM20D2
6662,GO:0030027,0.0478059316559961,0.971322908433721,24,157,lamellipodium,CC,PARVB;ACTA2;RAPGEF3;SSH1;CORO1B;DYSF;RAC2;TWF2;GSN;ARPIN;PKD2;PLCG1;ARAP3;WASF3;PLEKHG5;PLEK2;FSCN1;SH3BP1;LIMK1;WASH3P;RAC3;DNM2;PAK1;PXN
18507,GO:1903626,0.0478960934642312,0.996780618869926,2,4,positive regulation of DNA catabolic process,BP,ENDOG;BAX
10085,GO:0042592,0.0479406134515292,0.96119655515481,132,1096,homeostatic process,BP,ERCC1;FHL1;NR1D1;DLG4;CYP27B1;APLN;PRNP;BBS2;VEGFA;FAM210B;APOE;PYGL;F2R;LRP5;ITPR3;PKN1;EGFR;NOS1;HEXB;SLC7A8;SLC12A7;TXNRD3;ZFP36L1;GAA;LPAR3;ACP5;ENDOG;SMAD3;PIK3R2;ERCC6;EPAS1;CYBRD1;PRDX5;AKT1;TPCN1;STK39;HK1;LRRC8A;FGFR4;POLD4;LDLR;PRKACB;RAC2;NPHP4;RAG1;ANK3;EDNRA;GAS6;CARD11;PCSK9;BCR;ANGPTL4;BNIP3;CEMIP;PKD2;CRTC1;IL20RB;AP3D1;ABCA2;ADAM8;PLCG1;TGFB1;NTSR1;ATP7B;SHANK3;RASA3;TUB;CROCC;ERO1B;VGF;BBS1;TPP1;PCK2;MLXIPL;PRKACA;ADA;BOK;JAK3;TRPC1;SLC22A17;CACNB3;IFI6;BAX;SV2A;PPP1R13L;MT2A;TMX4;TGFBR3;PDIA5;GSTO1;LPCAT1;INPP5D;ZFPM1;SESN2;FGGY;ABCG1;BCAP31;MIF;SLC9A7;PLA2G6;WFS1;QSOX1;FYN;RAC3;SLC27A1;SLC12A4;MAPK3;INSR;GRINA;PFKM;ADCY1;GLRX;MALL;PPP3CB;WDTC1;PKD1;ADCY7;TEP1;SLC25A37;NGFR;ATP6V1F;PLEKHM1;SLC39A3;HFE;TERC;BBS10;ITPKB;HOMER2;DEDD2;ADCY6;SLC26A11;LRRK1
11567,GO:0046131,0.0479483849838135,0.985015030483148,6,27,pyrimidine ribonucleoside metabolic process,BP,NME4;UCKL1;UPP1;APOBEC3C;APOBEC3F;AK3
20306,GO:2001259,0.0480571544768921,0.983324485663161,7,32,positive regulation of cation channel activity,BP,ANK3;PKD2;EPHB2;NTSR1;SHANK3;GSTO1;EHD3
3148,GO:0006750,0.048065219285611,0.989677583027044,4,14,glutathione biosynthetic process,BP,GGT1;OPLAH;HAGH;CNDP2
12667,GO:0050884,0.0481822994993088,0.993015240020336,3,8,neuromuscular process controlling posture,BP,GAA;ADARB1;GCH1
12136,GO:0048251,0.0481944250368639,0.993012757683735,3,8,elastic fiber assembly,BP,THSD4;LOXL1;EFEMP2
3889,GO:0008526,0.0481951589160326,0.993012607435421,3,8,phosphatidylinositol transporter activity,MF,PITPNC1;PITPNM1;PITPNM3
18168,GO:1902904,0.0483394669704322,0.975148201600506,15,89,negative regulation of supramolecular fiber organization,BP,ARAP1;TMOD2;CORO1B;LDLR;TWF2;GSN;ARPIN;SPTB;FHOD3;SHANK3;EML2;CAPG;PRKCD;CHADL;PFN2
1989,GO:0004709,0.0484669519667169,0.979249552234418,10,51,MAP kinase kinase kinase activity,MF,EGFR;MST1R;EPHA1;FGFR4;FGFR1;EPHB2;ERBB2;INSR;MAP3K10;FGFR3
7729,GO:0032231,0.0485393812140647,0.977270775077302,12,66,regulation of actin filament bundle assembly,BP,RAPGEF3;ARAP1;SMAD3;SH3PXD2B;PPM1F;EPHA1;SHANK3;LIMK1;FHOD1;PAK1;PXN;PFN2
11388,GO:0045785,0.0485642766574848,0.968109421558814,34,239,positive regulation of cell adhesion,BP,VEGFA;ITGA6;ARL2;SMAD3;AKT1;PPM1F;EPHA1;SMOC2;RAG1;ANK3;CARD11;IGFBP2;AP3D1;ADAM8;TGFB1;EFNB3;KIF26B;RHOD;PRKCZ;ADA;ERBB2;JAK3;NET1;NID1;FYN;RAC3;DNM2;HLA-G;PAK1;HYAL1;ITGA3;ITGA4;ZP3;ITPKB
7620,GO:0032026,0.0486412284497831,0.992921097672141,3,8,response to magnesium ion,BP,ENTPD6;ANK3;CCND1
10411,GO:0043256,0.0486415466943188,0.99292103225344,3,8,laminin complex,CC,LAMA5;LAMB2;LAMB1
5001,GO:0015144,0.0487822007689704,0.986979162596656,5,19,carbohydrate transmembrane transporter activity,MF,SLC2A9;SLC2A3;SLC2A11;SLC50A1;SLC23A2
4089,GO:0009145,0.048783514436439,0.973675194717011,17,106,purine nucleoside triphosphate biosynthetic process,BP,PGM1;NME4;HK1;PFKL;PFKP;DHTKD1;TGFB1;PFKFB2;MLXIPL;CYC1;DDIT4;ALDOC;PPARA;INSR;TAZ;PFKM;PFKFB3
10886,GO:0044437,0.0488458243547915,0.964220237359329,60,456,vacuolar part,CC,PYGB;TSPAN1;NAGLU;VAT1;SDC1;VPS11;HEXB;GAA;MARCH9;NAPRT;TMEM8A;LRP1;AP2A2;CYBRD1;STOM;TPCN1;SLC15A4;ATG16L2;LDLR;FUCA1;BRI3;CTSB;PCSK9;AP3D1;ABCA2;TMEM9;DPP7;GPC1;GALNS;DIRC2;PI4K2A;SLC48A1;TPP1;WDR59;AGRN;IDUA;ULK1;SLC22A17;PRKCD;LPCAT1;PI4K2B;RAB12;SYNGR1;CD68;SPPL2B;GLB1;SLC12A4;C12ORF66;RNASET2;CTSF;HYAL1;VPS16;MAN2B1;TOLLIP;ATP6V1F;PLEKHM1;COL6A1;MAN2B2;SLC26A11;SDC2
7155,GO:0031032,0.0489039070826683,0.972169504695988,20,125,actomyosin structure organization,BP,OBSCN;OBSL1;RAPGEF3;ARAP1;SMAD3;SH3PXD2B;TMOD2;PPM1F;EPHA1;TNNT1;ITGB5;FHOD3;LIMK1;FHOD1;PAK1;PROX1;KCTD13;PXN;LURAP1;PFN2
5814,GO:0017076,0.0489310443621762,0.959347637778751,175,1445,purine nucleotide binding,MF,ACVR2B;PYGL;DGKA;OBSCN;NEK9;PKN1;ACSF2;EGFR;RPS6KA2;MST1R;ARL2;GTPBP1;TK2;ACTA2;RAPGEF3;GLUL;MAP2K2;NME4;SMARCA1;PC;MAP2K1;MARK4;ERCC6;CDK18;NMRK1;AKT1;STK39;HK1;EPHA1;BRSK1;RAB31;FGFR4;FGFR1;PRKACB;RAC2;PFKL;TTLL12;OPLAH;HLTF;ABCD1;TWF2;STRADB;MAPK13;PTK6;PFKP;CSNK1E;RAB3B;MAPKAPK3;BCR;EHD4;SEPT10;NADK;PANK4;HLCS;AGAP1;NPR2;DGKQ;PAK6;FYCO1;ABCA2;EPHB2;APRT;GRK6;KIF17;MVD;ENTPD2;GNAL;SCYL1;ULK2;MKNK2;TMEM173;ATP7B;PIP5KL1;KIF26B;RHOD;DNAH1;PI4K2A;RHOF;ARL10;KIF7;RHOBTB2;TUBG2;PEX1;PCK2;TRAP1;PFKFB2;PRKCZ;PRKACA;MINK1;ACTR1B;PIM2;UCKL1;ERBB2;ULK1;AHCY;STK17A;JAK3;PDK1;PRKCD;FAM20C;NUBP2;RPS6KA5;DGUOK;CUL9;RASL10B;LIMK1;NTPCR;RPS6KA6;DNM1;SCN8A;EHD3;LONP2;MAPK12;IRAK1;CHD2;PI4K2B;CHEK2;ABCG1;MYO1D;MYH15;CDC34;ABCA7;RAB12;SPEG;DALRD3;FYN;STK25;RAC3;EEF2K;DNM2;CKMT1A;CHKA;KIF26A;DDX50;TUBB6;MAPK3;INSR;PFKM;ADCY1;ATP8B2;PDXK;PAK1;CAMKK2;ALPK1;PFKFB3;STK32C;SRMS;MAP2K3;RRAS;IARS2;GAL3ST4;NMNAT2;ADCY7;TEP1;RAB28;MAP3K10;RAB40B;GCH1;KIF13B;CAMK1;CAMKK1;BBS10;SEPT6;CDK11B;FGFR3;ITPKB;CDC42BPG;CLK3;DHX32;PKN3;TTLL3;AK3;ADCY6;LRRK1;AARS
13508,GO:0055090,0.0489561339538569,0.989422084585717,4,14,acylglycerol homeostasis,BP,APOE;ANGPTL4;MLXIPL;SESN2
14697,GO:0070328,0.0489561339538569,0.989422084585717,4,14,triglyceride homeostasis,BP,APOE;ANGPTL4;MLXIPL;SESN2
19904,GO:2000377,0.0490422031948294,0.972996844847958,18,113,regulation of reactive oxygen species metabolic process,BP,XDH;EGFR;ACP5;SMAD3;AKT1;RAC2;BCR;BNIP3;PKD2;TGFB1;TRAP1;STK17A;PRKCD;DNM2;INSR;SIRT2;GCH1;SIRT3
9693,GO:0038094,0.0492636740933082,0.977788962665497,11,59,Fc-gamma receptor signaling pathway,BP,FCGRT;PIK3R2;WIPF1;PLCG1;CYFIP2;PRKCD;LIMK1;PLA2G6;FYN;MAPK3;PAK1
8880,GO:0034702,0.0493036382585456,0.973397066479709,17,103,ion channel complex,CC,DLG4;KCNG1;SCN4B;NOS1;SHANK2;KCNC4;TTYH3;LRRC8A;KCNAB2;GRIN3B;SHANK3;PRKACA;VAMP2;CACNB3;OLFM2;SCN8A;DLG3
12650,GO:0050863,0.0493907350689742,0.969288373367098,27,183,regulation of T cell activation,BP,PRNP;PAG1;AKT1;RAC2;RAG1;CEACAM1;CARD11;SOX13;GSN;IGFBP2;IL20RB;AP3D1;ADAM8;CEBPB;TGFB1;EFNB3;PRKCZ;ADA;ERBB2;JAK3;FYN;PELI1;HLA-G;PAK1;HFE;ZP3;ITPKB
3253,GO:0006921,0.0495115728288881,0.984478574415325,6,26,cellular component disassembly involved in execution phase of apoptosis,BP,H1F0;ENDOG;SHARPIN;BOK;BAX;DEDD2
18163,GO:1902895,0.0495342295207702,0.986720942621572,5,19,positive regulation of pri-miRNA transcription by RNA polymerase II,BP,APLN;FOS;SMAD3;TGFB1;NGFR
13027,GO:0051492,0.0495955136793783,0.977614034974104,11,59,regulation of stress fiber assembly,BP,RAPGEF3;ARAP1;SMAD3;SH3PXD2B;PPM1F;EPHA1;LIMK1;FHOD1;PAK1;PXN;PFN2
12616,GO:0050810,0.0497228035051325,0.976602757162308,12,67,regulation of steroid biosynthetic process,BP,EGR1;NR1D1;CYP27B1;APOE;FGFR4;SEC14L2;DGKQ;MVD;MBTPS2;ABCG1;IGFBP7;PROX1
6581,GO:0022417,0.0498405817503021,0.992366479938667,3,9,protein maturation by protein folding,BP,AIP;ERO1B;WFS1
1116,GO:0002704,0.0499472940701397,0.984307662294503,6,26,negative regulation of leukocyte mediated immunity,BP,CEACAM1;BCR;IL20RB;JAK3;PPP3CB;HFE
13647,GO:0060170,0.0501787627265592,0.979530713220085,9,45,ciliary membrane,CC,BBS2;SHANK2;EVC;PKD2;SHANK3;BBS1;EHD3;TMEM231;PKD1
9792,GO:0040017,0.0505696284452802,0.964397138325282,47,347,positive regulation of locomotion,BP,SEMA4B;PGF;DOCK4;POSTN;VEGFA;WNT7A;F2R;ITGA6;EGFR;SPRY2;PC;SSH1;SMURF2;SMAD3;HBEGF;FAM110C;AKT1;GRB7;PPM1F;EPHA1;VEGFB;FGFR1;RAC2;PLAU;GAS6;SEMA3F;CEMIP;ADAM8;PLCG1;TGFB1;NSMF;RHOD;SEMA4F;HDAC7;MAPK3;INSR;PAK1;HYAL1;SEMA4C;ITGA3;MAP2K3;PROX1;ITGA4;LAMB1;PDCD6;ZP3;SEMA3B
1205,GO:0002864,0.0506782473845021,0.996482566861678,2,4,regulation of acute inflammatory response to antigenic stimulus,BP,IL20RB;ZP3
4296,GO:0009743,0.0507055098286177,0.970121512368889,22,145,response to carbohydrate,BP,ERCC1;EGR1;NR1D1;CST3;ACVR2B;LRP5;ZFP36L1;GLUL;ENDOG;PFKL;MAPK13;GAS6;TGFB1;PCK2;PFKFB2;MLXIPL;PRKACA;VAMP2;SESN2;PLA2G6;CAT;PPP3CB
1097,GO:0002685,0.0507738894653904,0.973025656164159,16,100,regulation of leukocyte migration,BP,PGF;VEGFA;MMP28;VEGFB;RAC2;GAS6;BCR;ADAM8;TGFB1;ADA;MIF;DDT;ECM1;MAPK3;ITGA4;ZP3
16904,GO:0098862,0.0507893423835804,0.974399868383311,14,82,cluster of actin-based cell projections,CC,DOCK4;BBS2;ESPN;ITPR3;SHANK2;CYBRD1;RALGDS;TWF2;SCART1;MYO1D;MORN4;RGS19;MFSD10;HOMER2
8954,GO:0035023,0.0508758615965773,0.973037401355773,16,95,regulation of Rho protein signal transduction,BP,APOE;F2R;OBSCN;ARAP1;PLEKHG2;BCR;ARAP3;FARP1;PLEKHG4;PLEKHG3;PLEKHG5;NET1;ARHGEF4;ARHGEF1;ITGA3;KCTD13
19771,GO:2000146,0.0508977764237946,0.96857032898374,26,175,negative regulation of cell motility,BP,ZMYND8;APOE;IDH2;NISCH;MCTP1;FBLN1;LRP1;ADARB1;CORO1B;HDAC5;MMP28;EPHA1;PTPRU;BCR;ARPIN;ALOX15B;PLXNB3;TGFB1;ARAP3;ADA;CYGB;ADAM15;MIF;DDT;RRAS;PFN2
5701,GO:0016829,0.050945634740804,0.970816513396333,20,130,lyase activity,MF,HMGA2;GLUL;UROS;GGACT;NPR2;CBS;MVD;POLL;HMGCL;PCK2;ALDOC;ACO2;DDT;NEIL1;ADCY1;MLYCD;ADCY7;AZIN2;PHYKPL;ADCY6
12207,GO:0048408,0.0510244085653635,0.996444785544983,2,4,epidermal growth factor binding,MF,EGFR;SHC1
11610,GO:0046323,0.0511486106170813,0.977853558365972,10,52,glucose import,BP,PIK3R2;AKT1;CLTCL1;PRKCZ;SESN2;INSR;RTN2;PAK1;NGFR;GRB10
6737,GO:0030162,0.0511744938700302,0.961825953097502,66,521,regulation of proteolysis,BP,TNIP1;XDH;EDEM1;PLAT;CST3;BTBD2;PRNP;VEGFA;TNFRSF6B;APOE;F2R;GRAMD4;SERPINE2;LTBP4;SNX9;FBLN1;SMAD3;DVL1;PRDX5;AKT1;F12;PPM1F;SERPING1;DAP;FGFR4;PRKACB;RAG1;SORL1;GAS6;CSNK1E;GSN;RAD23A;SH3D19;TFPI2;CTSZ;MAGEF1;ADAM8;CD81;TIMP2;TNFSF15;ABTB1;SNX33;CAMK2N1;TRIB2;PRKACA;BOK;CYFIP2;STUB1;IFI6;BAX;PCSK1N;MAPK12;SOX7;BCAP31;ECM1;FYN;MAPK3;RNF144A;MICAL1;BIN1;PKD1;SIRT2;SERPINB1;NGFR;PDCD6;HFE
11575,GO:0046148,0.051482254797451,0.980190425226737,8,40,pigment biosynthetic process,BP,UROS;AP3D1;APRT;ADA;ALAS1;TRPC1;PPOX;DDT
10035,GO:0042493,0.0514943829394382,0.960730750667317,77,607,response to drug,BP,DUSP6;EGR1;CST3;PGF;XPC;PRNP;SLC6A8;HMGA2;EGFR;NOS1;HADH;SDC1;SSH1;ENDOG;FOS;STAT6;PPP1R14A;HDAC5;PPM1F;STK39;VEGFB;IMPACT;PRKACB;CCND1;MAPK13;GAS6;RAB3B;GSN;IGFBP2;ERRFI1;HLCS;DGKQ;BNIP3;ABCA2;TIMP2;TGFB1;NTSR1;ANKZF1;PCK2;AGRN;CD320;TRAP1;KDM6B;ADA;AREG;NET1;CYGB;PRKCD;SLC13A5;DDIT4;MT2A;PPOX;MTHFR;CHEK2;PPARA;SLC25A29;SLC22A18;FYN;STK25;DNM2;CHKA;CAT;IGFBP7;CYP2R1;MAPK3;SLC13A3;ADCY1;PRAF2;PPP3CB;ITGA3;DNMT3A;BCL2L1;ADCY7;SLC35F3;MFSD10;HOMER2;ADCY6
8713,GO:0034368,0.0515958799584627,0.991984285767915,3,9,protein-lipid complex remodeling,BP,APOE;PLTP;ABCG1
8714,GO:0034369,0.0515958799584627,0.991984285767915,3,9,plasma lipoprotein particle remodeling,BP,APOE;PLTP;ABCG1
684,GO:0001895,0.0516308566745614,0.981729364089479,7,33,retina homeostasis,BP,BBS2;ERCC6;NPHP4;TUB;CROCC;BBS1;BBS10
8184,GO:0032930,0.0516801969765874,0.991965781569498,3,9,positive regulation of superoxide anion generation,BP,EGFR;TGFB1;PRKCD
9669,GO:0038034,0.0519617671591948,0.977370037529832,10,54,signal transduction in absence of ligand,BP,AKT1;FGFR1;STRADB;MKNK2;MOAP1;BOK;IFI6;BAX;FYN;BCL2L1
16493,GO:0097192,0.0519617671591948,0.977370037529832,10,54,extrinsic apoptotic signaling pathway in absence of ligand,BP,AKT1;FGFR1;STRADB;MKNK2;MOAP1;BOK;IFI6;BAX;FYN;BCL2L1
13481,GO:0055037,0.0520434032051074,0.969252634757993,22,144,recycling endosome,CC,NDRG1;NISCH;TBC1D14;MCTP1;SORL1;RAB11FIP4;EHD4;ABHD17C;C1ORF210;MICALL2;BOK;ULK1;ARHGAP44;WASH3P;EHD3;ABCG1;RAB12;SLC9A7;HLA-G;VPS16;HFE;VPS51
17717,GO:1901617,0.0521155994500156,0.968427462559005,24,160,organic hydroxy compound biosynthetic process,BP,NR1D1;CYP27B1;APOE;ISYNA1;PLTP;SRD5A3;FGFR4;SEC14L2;DGKQ;MVD;NTSR1;PLPP6;PCK2;TRPC1;MBTPS2;HSD17B7;ABCG1;DDT;CYP2R1;PDXK;PROX1;GCH1;ITPKB;SPTLC2
6656,GO:0030016,0.0522497431592144,0.970477764046292,19,121,myofibril,CC,PARVB;FLNC;OBSCN;OBSL1;NOS1;TMOD2;MYZAP;ANK3;TNNT1;TWF2;FHOD3;STUB1;AHNAK2;TPM2;SCN8A;MYH15;PAK1;PPP3CB;BIN1
2243,GO:0005154,0.0522990172058277,0.983378231385156,6,26,epidermal growth factor receptor binding,MF,SHC1;HBEGF;AREG;EREG;TGFA;CBLC
19789,GO:2000191,0.0523304142127503,0.988439470950308,4,14,regulation of fatty acid transport,BP,AKT1;NTSR1;MIF;PLA2G6
11861,GO:0046879,0.0523321565530087,0.967586566234764,26,176,hormone secretion,BP,NR1D1;APLN;ACVR2B;LRP5;ITPR3;EGFR;HADH;LTBP4;ARL2;RAPGEF3;GLUL;NLGN2;FGFR1;PFKL;VGF;PCK2;PFKFB2;RASL10B;PLA2G6;PFKM;PPP3CB;FAM129B;ICA1;PCLO;SIRT3;HFE
6257,GO:0019852,0.0523441695108383,0.991819604429903,3,9,L-ascorbic acid metabolic process,BP,SLC2A3;GSTO1;SLC23A2
8592,GO:0034110,0.052718389677634,0.985490386551536,5,20,regulation of homotypic cell-cell adhesion,BP,SERPINE2;CEACAM1;ANK3;CD9;PRKCD
9283,GO:0035726,0.0528492308349107,0.996243092559745,2,4,common myeloid progenitor cell proliferation,BP,CEACAM1;ITPKB
17762,GO:1901701,0.0528541033291891,0.958869507180781,89,711,cellular response to oxygen-containing compound,BP,TNIP1;EGR1;NR1D1;CST3;CYP27B1;PDCD4;PRNP;FAM210B;LRP5;EGFR;CAPN2;NFATC4;SHC1;PTPRE;RAPGEF3;ZFP36L1;SSH1;ENDOG;FOS;STAT6;PIK3R2;LRP1;PRDX5;AKT1;HDAC5;IMPACT;RAB31;LDLR;PRKACB;CEACAM1;TWF2;MAPK13;GAS6;PTK6;PCSK9;BCR;ERRFI1;CCS;BNIP3;PKD2;APRT;CEBPB;ADAMTS13;WNT3;TGFB1;NSMF;ANKZF1;PTPN1;PCK2;AGRN;TRAP1;MLXIPL;PRKCZ;KDM6B;PRKACA;VAMP2;JAK3;NET1;PRKCD;DDIT4;IRAK1;CHEK2;SESN2;MIF;PLA2G6;FYN;STK25;EEF2K;DNM2;MAPK3;INSR;ADCY1;PAK1;CAMKK2;PPP3CB;WDTC1;DNMT3A;BCL2L1;SIRT2;ADCY7;SOCS7;NGFR;ATP6V1F;PXN;GRB10;GCH1;COL6A1;SRSF5;ADCY6
14555,GO:0070086,0.0528562619901213,0.996242307248798,2,4,ubiquitin-dependent endocytosis,BP,NEURL1B;LRSAM1
4599,GO:0010716,0.0529400571835263,0.996232943335964,2,4,negative regulation of extracellular matrix disassembly,BP,CST3;TGFB1
13042,GO:0051541,0.0531105755292984,0.996213860906737,2,4,elastin metabolic process,BP,CST3;HBEGF
12700,GO:0050927,0.0531646006857272,0.988192970239009,4,14,positive regulation of positive chemotaxis,BP,PGF;VEGFA;SMAD3;VEGFB
14679,GO:0070301,0.053197099885177,0.97464596546901,12,69,cellular response to hydrogen peroxide,BP,CST3;ENDOG;STAT6;IMPACT;MAPK13;BNIP3;ANKZF1;TRAP1;KDM6B;NET1;PRKCD;STK25
6038,GO:0019136,0.0532173275713535,0.99620189576321,2,4,deoxynucleoside kinase activity,MF,TK2;DGUOK
17945,GO:1902262,0.053295435593112,0.996193132027256,2,4,apoptotic process involved in blood vessel morphogenesis,BP,LRP5;BAX
2384,GO:0005521,0.0534937208701693,0.988095331109036,4,14,lamin binding,MF,PRNP;BNIP3L;NARF;SUN1
12999,GO:0051434,0.0535417439650299,0.996165445776436,2,4,BH3 domain binding,MF,BAX;BCL2L1
10193,GO:0042803,0.0536461162135137,0.959698294965181,68,533,protein homodimerization activity,MF,XDH;MEF2D;PGF;VEGFA;APOE;PYGL;ACOT7;DNPH1;WWTR1;HEXB;SNX9;CRYL1;GALE;SMAD3;STOM;AKT1;S100A6;VEGFB;FGFR1;RAG1;CEACAM1;RAB11FIP4;TENM2;ABCD1;LHPP;HLCS;BNIP3;PKD2;CADM4;CTBP1;CBS;CEBPB;MVD;TGFB1;NTSR1;TMEM173;HMGCL;OLFML2A;LRP4;CEP131;GRHPR;OXA1L;BOK;BNIP3L;STUB1;BAX;NAGA;TPM2;ZHX3;IRAK1;CHEK2;ABCG1;SLC9A7;SPPL2B;STK25;BHLHE40;CHKA;CAT;SLC27A1;PFKM;HLA-G;PDXK;BCL2L1;CDH4;MAP3K10;PDCD6;GCH1;HOMER2
12174,GO:0048313,0.0536827284599635,0.988039160807753,4,14,Golgi inheritance,BP,MAP2K2;MAP2K1;STK25;MAPK3
12658,GO:0050871,0.0537212822422303,0.977711750931217,9,47,positive regulation of B cell activation,BP,STAT6;CARD11;CD81;TGFB1;CD320;ADA;INPP5D;MIF;PELI1
7749,GO:0032272,0.0537663394633136,0.977689449929541,9,47,negative regulation of protein polymerization,BP,TMOD2;TWF2;GSN;SPTB;FHOD3;EML2;CAPG;PRKCD;PFN2
7651,GO:0032079,0.0538921888586201,0.996125922332591,2,4,positive regulation of endodeoxyribonuclease activity,BP,AKT1;PRKCD
3456,GO:0007272,0.0539492613627505,0.972566037645597,14,82,ensheathment of neurons,BP,MARVELD1;NDRG1;HEXB;AKT1;TGFB1;GPC1;NAB2;WASF3;CD9;ERBB2;AHNAK2;SCN8A;MALL;SIRT2
3793,GO:0008366,0.0539492613627505,0.972566037645597,14,82,axon ensheathment,BP,MARVELD1;NDRG1;HEXB;AKT1;TGFB1;GPC1;NAB2;WASF3;CD9;ERBB2;AHNAK2;SCN8A;MALL;SIRT2
19290,GO:1905475,0.0540867648943735,0.9688076816031,20,129,regulation of protein localization to membrane,BP,ZMYND8;PRNP;EGFR;SSH1;LRP1;STOM;AKT1;ANK3;GSN;CEMIP;EPHB2;TGFB1;LRP4;ERBB2;TFDP2;GDI1;FYN;PAK1;ITGA3;BCL2L1
9078,GO:0035335,0.0542231060025463,0.973212171332993,13,75,peptidyl-tyrosine dephosphorylation,BP,DUSP6;DUSP5;PTPRS;PTPRE;SSH1;PTPRU;DUSP7;CDC25B;PTPDC1;PTPN1;DUSP4;DUSP23;SSH3
7331,GO:0031348,0.0543138010422265,0.969695768739583,18,114,negative regulation of defense response,BP,NT5E;HTRA1;PDCD4;APOE;ACP5;SMAD3;SERPING1;FNDC4;MAPKBP1;CEACAM1;BCR;SHARPIN;FAM3A;IL20RB;ADA;PRKCD;PPARA;SIRT2
10431,GO:0043292,0.0543581791935073,0.968621981462394,20,130,contractile fiber,CC,CST3;PARVB;FLNC;OBSCN;OBSL1;NOS1;TMOD2;MYZAP;ANK3;TNNT1;TWF2;FHOD3;STUB1;AHNAK2;TPM2;SCN8A;MYH15;PAK1;PPP3CB;BIN1
11871,GO:0046889,0.0543919277928813,0.977421003222356,9,46,positive regulation of lipid biosynthetic process,BP,NR1D1;APOE;AKT1;LDLR;MLXIPL;PRKCD;ABCG1;PLA2G6;ZP3
12520,GO:0050670,0.0545498989534398,0.969534910158626,18,115,regulation of lymphocyte proliferation,BP,PRNP;PKN1;RAC2;CARD11;IGFBP2;IL20RB;CD81;CEBPB;TGFB1;CD320;ADA;ERBB2;JAK3;INPP5D;MIF;PELI1;HLA-G;ZP3
2204,GO:0005089,0.0545615138540378,0.974970623009142,11,59,Rho guanyl-nucleotide exchange factor activity,MF,OBSCN;PLEKHG2;BCR;RGL2;FARP1;PLEKHG4;PLEKHG3;PLEKHG5;NET1;ARHGEF4;ARHGEF1
12511,GO:0050660,0.0546238147421923,0.974906331125878,11,60,flavin adenine dinucleotide binding,MF,XDH;NOS1;TXNRD3;PRODH;D2HGDH;SDHA;ACAD10;ACADS;PPOX;MTHFR;MICAL1
4400,GO:0010138,0.0546356151158566,0.996041567101808,2,4,pyrimidine ribonucleotide salvage,BP,UCKL1;UPP1
10754,GO:0044206,0.0546356151158566,0.996041567101808,2,4,UMP salvage,BP,UCKL1;UPP1
6291,GO:0019904,0.0547595097310095,0.958479088468134,72,564,protein domain specific binding,MF,ERCC1;DLG4;EPN3;CTNNBIP1;DOCK4;ESPN;HMGA2;ANGEL1;VPS11;RAPGEF3;MAP2K2;POU2F2;SHANK2;AP2A2;SH3PXD2B;PAG1;ZXDC;SH2D2A;DAP;ELMO3;EFS;SYNGAP1;CEP250;CARD19;CARD11;ERRFI1;WIPF1;AIP;ARHGAP27;SNTA1;PLXNB3;PKD2;FAM189B;CTBP1;SH3BP2;WNT3;SHANK3;ADAM19;KHDRBS3;PRKCZ;BOK;CAPG;TFDP2;STUB1;BAX;SH3BP1;TGFBR3;ADAM15;FHOD1;INPP5D;PPARA;MYO1D;FYN;DNM2;BHLHE40;ARHGEF4;INSR;MICAL1;ITGA3;BCL2L1;DLG3;PROX1;PKD1;KCTD13;ICA1;SOCS7;NDE1;CCDC88C;CBLC;HOMER2;STRN4;SDC2
4539,GO:0010614,0.0548254250592248,0.987698053588977,4,14,negative regulation of cardiac muscle hypertrophy,BP,SMAD3;ERRFI1;PAK1;LMNA
11776,GO:0046649,0.0548413415838101,0.960455759575965,52,392,lymphocyte activation,BP,ERCC1;EGR1;PRNP;PKN1;ZFP36L1;CMTM7;POU2F2;SMAD3;STAT6;PAG1;AKT1;HDAC5;LRRC8A;RAC2;RAG1;CEACAM1;GAS6;CARD11;SOX13;GSN;IGFBP2;IL20RB;AP3D1;ADAM8;CD81;CEBPB;TGFB1;EFNB3;POLM;IFNE;CD320;PRKCZ;ADA;ERBB2;JAK3;PRKCD;BAX;MFNG;INPP5D;ZFPM1;MIF;FYN;PELI1;SATB1;HLA-G;PAK1;PPP3CB;ITGA4;KIF13B;HFE;ZP3;ITPKB
13956,GO:0060674,0.0548810649696258,0.982344506925262,6,26,placenta blood vessel development,BP,PLCD3;MAP2K1;AKT1;PKD2;FBXW8;PKD1
2513,GO:0005768,0.0550011839448707,0.957294073830944,86,682,endosome,CC,CST3;APOE;F2R;NDRG1;PKN1;NISCH;EGFR;APPL2;VPS11;TBC1D14;SNX9;MAP2K2;MAP2K1;MCTP1;LRP1;AP2A2;TPCN1;DYSF;ZFYVE21;RAB31;FGFR4;LDLR;SORL1;RAB11FIP4;CTSB;PCSK9;ANTXR2;EHD4;DGKQ;MVB12B;FYCO1;AP3D1;ABCA2;TMEM9;CLTCL1;ABHD17C;GPC1;ATP7B;RHOD;SNX17;SNX33;PI4K2A;C1ORF210;SLC48A1;LLGL1;PTPN1;CD320;PRKCZ;MICALL2;BOK;NEURL1B;ERBB2;ULK1;JAK3;ARHGAP44;EHBP1L1;MIB2;WASH3P;EHD3;IRAK1;PI4K2B;ABCG1;MYO1D;ABCA7;RAB12;DOPEY2;SLC9A7;CD68;SPPL2B;FYN;DNM2;MAPK3;INSR;HLA-G;PRAF2;RNF144A;VPS16;TBC1D16;ANKRD13D;NMNAT2;RAB40B;NGFR;PDCD6;PLEKHM1;HFE;VPS51
8487,GO:0033673,0.0550786744278658,0.96417969520521,31,217,negative regulation of kinase activity,BP,DUSP6;DUSP5;PDCD4;APOE;LRP5;PKN1;WWTR1;SPRY2;SPRY4;DVL1;ADARB1;AKT1;PPM1F;EPHA1;SORL1;CEACAM1;PODNL1;PTK6;DUSP7;ERRFI1;EPHB2;CDKN1C;PTPN1;CAMK2N1;TRIB2;PRKCD;DUSP4;RGS14;CHAD;SOCS7;CBLC
11569,GO:0046133,0.055083271656203,0.991207995196478,3,9,pyrimidine ribonucleoside catabolic process,BP,UPP1;APOBEC3C;APOBEC3F
20291,GO:2001239,0.0550897970437349,0.980153208918737,7,34,regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,AKT1;FGFR1;STRADB;IFI6;BAX;FYN;BCL2L1
5932,GO:0018210,0.055106355628135,0.969817317289207,17,104,peptidyl-threonine modification,BP,PKN1;SPRY2;MAP2K1;AKT1;STK39;DGKQ;CEMIP;TGFB1;ULK1;PRKCD;DDIT4;CHEK2;CAMKK2;SIRT2;MAP3K10;CAMK1;CAMKK1
4525,GO:0010592,0.0551127869536421,0.987611866042333,4,14,positive regulation of lamellipodium assembly,BP,RAC2;TWF2;FSCN1;DNM2
1400,GO:0003333,0.0551131731883847,0.977063194651986,9,46,amino acid transmembrane transport,BP,SLC6A8;SLC7A8;SLC6A6;STK39;SLC43A1;SLC38A10;NTSR1;SLC25A29;PRAF2
11277,GO:0045598,0.0552631806508763,0.971798267365268,14,82,regulation of fat cell differentiation,BP,NR1D1;LRP5;WWTR1;ZFP36L1;SMAD3;SH3PXD2B;AKT1;ZNF385A;CCDC71L;CEBPB;TGFB1;TRIB2;ZFPM1;SIRT2
2714,GO:0006096,0.0554196924784204,0.972528909937831,13,75,glycolytic process,BP,PGM1;HK1;PFKL;PFKP;DHTKD1;PFKFB2;MLXIPL;DDIT4;ALDOC;PPARA;INSR;PFKM;PFKFB3
13830,GO:0060441,0.0554336154072649,0.984522568486201,5,20,epithelial tube branching involved in lung morphogenesis,BP,SPRY2;WNT2B;CTSZ;VANGL2;CELSR1
1504,GO:0003857,0.055444161382617,0.991126393360209,3,9,3-hydroxyacyl-CoA dehydrogenase activity,MF,HADH;CRYL1;HSD17B8
6255,GO:0019842,0.0554772273044224,0.971633517845059,14,84,vitamin binding,MF,PYGB;PYGL;PC;SEC14L2;DHTKD1;HLCS;CBS;CD320;ALAS1;PHYH;GPT2;PDXK;PHYKPL;SPTLC2
14930,GO:0070820,0.0555731395849915,0.969471330840171,17,108,tertiary granule,CC,CST3;PGM1;SLC2A3;GAA;AP2A2;STOM;KCNAB2;CEACAM1;PLAU;PRSS3;ADAM8;LTA4H;TIMP2;YPEL5;ALDOC;QSOX1;NBEAL2
12335,GO:0048708,0.0556479683991819,0.97823821198289,8,40,astrocyte differentiation,BP,EGFR;SERPINE2;MAP2K1;LRP1;LDLR;LAMB2;MAPK3;BIN1
2273,GO:0005217,0.0557777279675958,0.987411809338753,4,14,intracellular ligand-gated ion channel activity,MF,ITPR3;TPCN1;PKD2;RASA3
5063,GO:0015278,0.0557777279675958,0.987411809338753,4,14,calcium-release channel activity,MF,ITPR3;TPCN1;PKD2;RASA3
17845,GO:1901998,0.0558368197412207,0.979886380151114,7,33,toxin transport,BP,SLC7A8;ANTXR2;BNIP3;DNM1;ABCG1;RAB28;RAB40B
12290,GO:0048639,0.0561534727837159,0.969152927345992,17,105,positive regulation of developmental growth,BP,BBS2;VEGFA;LPAR3;SH3PXD2B;AKT1;FGFR1;TWF2;WNT3;AGRN;LIMK1;TGFBR3;GDI1;INSR;PAK1;PROX1;CDH4;ZP3
718,GO:0001945,0.0562383308505651,0.984232860162986,5,20,lymph vessel development,BP,ACVR2B;VEGFA;PPP3CB;PROX1;PKD1
3124,GO:0006707,0.0564056645380105,0.995837941201496,2,4,cholesterol catabolic process,BP,APOE;SNX17
5356,GO:0016127,0.0564056645380105,0.995837941201496,2,4,sterol catabolic process,BP,APOE;SNX17
16595,GO:0097421,0.0565096322464684,0.981597003850994,6,27,liver regeneration,BP,EGFR;CCND1;CEBPB;TGFB1;HFE;SRSF5
5799,GO:0017049,0.0565228186052259,0.98413013021059,5,20,GTP-Rho binding,MF,PKN1;CDC42EP5;NET1;KCTD13;PKN3
3186,GO:0006813,0.0566299842667108,0.969515032117158,16,97,potassium ion transport,BP,FHL1;KCNG1;PRNP;NOS1;SLC12A7;KCNJ15;KCNC4;STK39;KCNAB2;ANK3;PKD2;VAMP2;SLC9A7;DNM2;SLC12A4;KLHL24
8463,GO:0033613,0.0566308924622041,0.974950206010135,10,54,activating transcription factor binding,MF,MEF2D;FOS;SMAD3;DGKQ;ZNF516;RBL2;HDAC7;ZFPM1;WFS1;BHLHE40
8202,GO:0032963,0.0566334629225861,0.971833240361376,13,75,collagen metabolic process,BP,CST3;MRC2;F2R;MMP1;CTSB;ERRFI1;COL13A1;TGFB1;MMP10;CYGB;ADAM15;PHYKPL;COL6A1
6763,GO:0030204,0.0568211496573469,0.981558879667258,6,26,chondroitin sulfate metabolic process,BP,HEXB;B3GAT3;IDUA;XYLT2;HYAL1;CHPF
6693,GO:0030098,0.0569397420666692,0.963435471703584,29,201,lymphocyte differentiation,BP,EGR1;ZFP36L1;CMTM7;POU2F2;STAT6;HDAC5;LRRC8A;RAG1;GAS6;CARD11;SOX13;AP3D1;ADAM8;TGFB1;POLM;IFNE;PRKCZ;ADA;ERBB2;JAK3;BAX;MFNG;INPP5D;ZFPM1;SATB1;HLA-G;PPP3CB;ITGA4;ITPKB
544,GO:0001664,0.0572190666720142,0.967260862229535,19,125,G-protein coupled receptor binding,MF,DLG4;APLN;PRNP;WNT7A;ARAP1;DVL1;ITGB4;WNT2B;WNT3;GNAL;BBS1;USP20;STUB1;DNM1;REEP2;FYN;DNM2;ARHGEF1;HOMER2
9190,GO:0035578,0.0572822936963498,0.972345251133596,12,70,azurophil granule lumen,CC,PYGB;VAT1;HEXB;NAPRT;FUCA1;DPP7;GALNS;PRKCD;GLB1;RNASET2;MAN2B1;TOLLIP
7772,GO:0032303,0.0573217963426576,0.990698055769682,3,9,regulation of icosanoid secretion,BP,NTSR1;MIF;PLA2G6
14051,GO:0060840,0.0574393675623994,0.974563736172728,10,53,artery development,BP,ACVR2B;VEGFA;APOE;LOXL1;LTBP1;LRP1;PKD2;SNX17;DNM2;PROX1
18581,GO:1903798,0.0574926608519679,0.986891864219565,4,14,regulation of production of miRNAs involved in gene silencing by miRNA,BP,EGFR;MAP2K2;MAP2K1;TGFB1
6425,GO:0021696,0.057516092103892,0.983770190635008,5,20,cerebellar cortex morphogenesis,BP,WNT7A;SERPINE2;TRNP1;MAP2K1;PROX1
6878,GO:0030388,0.0575666234570738,0.995702270942949,2,4,fructose 1,6-bisphosphate metabolic process,BP,PFKL;ALDOC
9881,GO:0042165,0.0575720128436263,0.98374986807356,5,20,neurotransmitter binding,MF,NIPSNAP1;GRIN3B;CBS;HTR7;CHKA
2935,GO:0006464,0.0576372015538912,0.949669600658869,353,3098,cellular protein modification process,BP,TNIP1;DUSP6;XDH;DUSP5;GID4;ZMYND8;EGR1;EDEM1;DLG4;PLAT;CST3;FBXO2;PDCD4;ACVR2B;PRNP;VEGFA;WNT7A;APOE;F2R;LRP5;HMGA2;OBSCN;NEK9;PKN1;MTA1;ARRDC1;EGFR;RPS6KA2;WWTR1;LOXL1;OBSL1;NOS1;PTPRS;TMEM129;SPRY2;MST1R;CRTAP;KLHL29;LMF1;SHC1;DDB2;LTBP1;PTPRE;SNX9;SPRY4;RAPGEF3;ST6GALNAC2;ZFP36L1;MAP2K2;LPAR3;MARCH9;FKBP9;PPP1R35;RBCK1;RNF44;MAP2K1;SSH1;MARK4;SMURF2;FBLN1;SMAD3;PIK3R2;ERCC6;GJC2;SRD5A3;DVL1;EPAS1;PIGQ;HBEGF;PPP1R14A;PPP2R3B;SHC2;CDK18;LY6K;FBXW5;RNF187;ADORA2B;ADARB1;AKT1;HDAC5;FBXO41;PPM1F;STK39;EPHA1;PTPRU;VEGFB;ASH2L;IMPACT;MARCH4;CNTN1;BRSK1;FGFR4;FGFR1;PRKACB;RAC2;TTLL12;HLTF;PPM1J;RAG1;B4GAT1;PIGV;SORL1;CEACAM1;B3GAT3;ASB13;HMG20B;IGFBP4;CCND1;PODNL1;LHPP;STRADB;SYNGAP1;MAPK13;GAS6;PTK6;CSNK1E;RAB3B;DUSP7;MAPKAPK3;PCSK9;RAD23A;ANO8;BCR;EHD4;ERRFI1;HLCS;CDC25B;SPTB;PEX10;NPR2;SNTA1;DGKQ;PAK6;SHARPIN;CEMIP;PKD2;RASGEF1A;CDC42EP5;FBXW8;ZNF598;MAGEF1;EPHB2;ADAM8;CTBP1;JOSD2;PTPDC1;GRK6;CDKN1C;PLCG1;FBXL8;CD81;MVD;RNF135;ADAMTS13;TIMP2;ZNF862;TGFB1;SCYL1;ABHD17C;ULK2;MKNK2;ADAMTS7;B3GNT3;NAB2;SHANK3;RASA3;TNFSF15;MGAT4B;MDH2;FBXO17;NSMF;LCE1E;LAMB2;ERO1B;ST6GALNAC6;VGF;FBXO44;PHF21A;ZER1;PTPN1;B4GALT2;MBD3;IFNE;CAMK2N1;LRP4;ZDHHC24;B4GALT6;VHL;RFNG;MLXIPL;TRIB2;PRKCZ;KDM6B;PRKACA;MINK1;RABGGTA;AREG;PIM2;MPI;NEURL1B;ERBB2;ULK1;C6ORF89;STK17A;JAK3;RASA4;PDK1;THOP1;MCFD2;PRKCD;FAM20C;MIB2;USP20;STUB1;BAX;SBF1;TRIM4;ITGA1;FBXW4;EREG;RPS6KA5;DGUOK;DUSP4;CUL9;DDIT4;ZDHHC8;LIMK1;TGFBR3;PADI3;LEMD2;RPS6KA6;RGS14;MFNG;CHAD;MSLN;LRSAM1;ASB1;ST3GAL3;SYMPK;MAPK12;IRAK1;TGFA;HDAC7;MTHFR;PCMTD2;CHEK2;COG7;SESN2;JADE2;CDC34;RNF123;ABCA7;SPEG;MIF;EEF2KMT;KDM4B;PLA2G6;DDT;NUDT14;WFS1;QSOX1;DTX3;TRPT1;FYN;VWA1;STK25;ETFB;EEF2K;ARID5B;PELI1;TSPYL2;IGFBP7;ELFN2;SLC27A1;SATB1;ZDHHC1;MAPK3;INSR;ADCY1;INO80C;ETAA1;GLRX;VANGL2;PAK1;DCAF10;KLHL36;CAMKK2;PPP3CB;RNF144A;ALPK1;USP21;CUL7;MICAL1;SEMA4C;CAPRIN2;WDTC1;STK32C;MAN2B1;SRMS;PPP2R5B;MAP2K3;DLG3;RRAS;PROX1;MDGA1;ZYG11B;PKD1;KCTD13;TNFRSF25;SIRT2;UVSSA;BACH1;ADCY7;ALG12;MAPRE3;ST3GAL2;LAMB1;SOCS7;MAP3K10;PELI3;RAB40B;NGFR;TOLLIP;PDCD6;DUSP23;CAMK1;CAMKK1;EZH1;SIRT3;HFE;WIPI2;BTG1;CDK11B;PFN2;SSH3;FGFR3;PPP1R16A;CCDC88C;ST3GAL5;NDRG2;MAN2B2;CBLC;ITPKB;CDC42BPG;PRSS21;CLK3;KDM3A;PKN3;TTLL3;ADCY6;LRRK1;KLHL24;SDC2
9512,GO:0036211,0.0576372015538912,0.949669600658869,353,3098,protein modification process,BP,TNIP1;DUSP6;XDH;DUSP5;GID4;ZMYND8;EGR1;EDEM1;DLG4;PLAT;CST3;FBXO2;PDCD4;ACVR2B;PRNP;VEGFA;WNT7A;APOE;F2R;LRP5;HMGA2;OBSCN;NEK9;PKN1;MTA1;ARRDC1;EGFR;RPS6KA2;WWTR1;LOXL1;OBSL1;NOS1;PTPRS;TMEM129;SPRY2;MST1R;CRTAP;KLHL29;LMF1;SHC1;DDB2;LTBP1;PTPRE;SNX9;SPRY4;RAPGEF3;ST6GALNAC2;ZFP36L1;MAP2K2;LPAR3;MARCH9;FKBP9;PPP1R35;RBCK1;RNF44;MAP2K1;SSH1;MARK4;SMURF2;FBLN1;SMAD3;PIK3R2;ERCC6;GJC2;SRD5A3;DVL1;EPAS1;PIGQ;HBEGF;PPP1R14A;PPP2R3B;SHC2;CDK18;LY6K;FBXW5;RNF187;ADORA2B;ADARB1;AKT1;HDAC5;FBXO41;PPM1F;STK39;EPHA1;PTPRU;VEGFB;ASH2L;IMPACT;MARCH4;CNTN1;BRSK1;FGFR4;FGFR1;PRKACB;RAC2;TTLL12;HLTF;PPM1J;RAG1;B4GAT1;PIGV;SORL1;CEACAM1;B3GAT3;ASB13;HMG20B;IGFBP4;CCND1;PODNL1;LHPP;STRADB;SYNGAP1;MAPK13;GAS6;PTK6;CSNK1E;RAB3B;DUSP7;MAPKAPK3;PCSK9;RAD23A;ANO8;BCR;EHD4;ERRFI1;HLCS;CDC25B;SPTB;PEX10;NPR2;SNTA1;DGKQ;PAK6;SHARPIN;CEMIP;PKD2;RASGEF1A;CDC42EP5;FBXW8;ZNF598;MAGEF1;EPHB2;ADAM8;CTBP1;JOSD2;PTPDC1;GRK6;CDKN1C;PLCG1;FBXL8;CD81;MVD;RNF135;ADAMTS13;TIMP2;ZNF862;TGFB1;SCYL1;ABHD17C;ULK2;MKNK2;ADAMTS7;B3GNT3;NAB2;SHANK3;RASA3;TNFSF15;MGAT4B;MDH2;FBXO17;NSMF;LCE1E;LAMB2;ERO1B;ST6GALNAC6;VGF;FBXO44;PHF21A;ZER1;PTPN1;B4GALT2;MBD3;IFNE;CAMK2N1;LRP4;ZDHHC24;B4GALT6;VHL;RFNG;MLXIPL;TRIB2;PRKCZ;KDM6B;PRKACA;MINK1;RABGGTA;AREG;PIM2;MPI;NEURL1B;ERBB2;ULK1;C6ORF89;STK17A;JAK3;RASA4;PDK1;THOP1;MCFD2;PRKCD;FAM20C;MIB2;USP20;STUB1;BAX;SBF1;TRIM4;ITGA1;FBXW4;EREG;RPS6KA5;DGUOK;DUSP4;CUL9;DDIT4;ZDHHC8;LIMK1;TGFBR3;PADI3;LEMD2;RPS6KA6;RGS14;MFNG;CHAD;MSLN;LRSAM1;ASB1;ST3GAL3;SYMPK;MAPK12;IRAK1;TGFA;HDAC7;MTHFR;PCMTD2;CHEK2;COG7;SESN2;JADE2;CDC34;RNF123;ABCA7;SPEG;MIF;EEF2KMT;KDM4B;PLA2G6;DDT;NUDT14;WFS1;QSOX1;DTX3;TRPT1;FYN;VWA1;STK25;ETFB;EEF2K;ARID5B;PELI1;TSPYL2;IGFBP7;ELFN2;SLC27A1;SATB1;ZDHHC1;MAPK3;INSR;ADCY1;INO80C;ETAA1;GLRX;VANGL2;PAK1;DCAF10;KLHL36;CAMKK2;PPP3CB;RNF144A;ALPK1;USP21;CUL7;MICAL1;SEMA4C;CAPRIN2;WDTC1;STK32C;MAN2B1;SRMS;PPP2R5B;MAP2K3;DLG3;RRAS;PROX1;MDGA1;ZYG11B;PKD1;KCTD13;TNFRSF25;SIRT2;UVSSA;BACH1;ADCY7;ALG12;MAPRE3;ST3GAL2;LAMB1;SOCS7;MAP3K10;PELI3;RAB40B;NGFR;TOLLIP;PDCD6;DUSP23;CAMK1;CAMKK1;EZH1;SIRT3;HFE;WIPI2;BTG1;CDK11B;PFN2;SSH3;FGFR3;PPP1R16A;CCDC88C;ST3GAL5;NDRG2;MAN2B2;CBLC;ITPKB;CDC42BPG;PRSS21;CLK3;KDM3A;PKN3;TTLL3;ADCY6;LRRK1;KLHL24;SDC2
981,GO:0002437,0.0576877538551892,0.983584758740937,5,21,inflammatory response to antigenic stimulus,BP,IL20RB;KDM6B;AHCY;PNMA1;ZP3
15257,GO:0071437,0.0577355480380294,0.986817763413981,4,14,invadopodium,CC,FSCN1;PAK1;ITGA3;AFAP1L1
11613,GO:0046326,0.0577542434301244,0.981178355286912,6,26,positive regulation of glucose import,BP,PIK3R2;AKT1;CLTCL1;PRKCZ;INSR;PAK1
2642,GO:0005980,0.0578112090799265,0.983662870335764,5,20,glycogen catabolic process,BP,PYGB;PGM1;PYGL;GAA;PFKM
4175,GO:0009251,0.0578112090799265,0.983662870335764,5,20,glucan catabolic process,BP,PYGB;PGM1;PYGL;GAA;PFKM
15986,GO:0085029,0.0578256245347246,0.981149174620411,6,26,extracellular matrix assembly,BP,THSD4;LOXL1;SMAD3;GAS6;TGFB1;EFEMP2
17713,GO:1901611,0.0579420915941524,0.990555166844097,3,9,phosphatidylglycerol binding,MF,PITPNC1;NME4;PLTP
1024,GO:0002524,0.058031936986762,0.995647426757136,2,4,hypersensitivity,BP,IL20RB;ZP3
4712,GO:0010876,0.0580895175928089,0.961758148420206,32,225,lipid localization,BP,APOE;OSBPL5;PITPNC1;HEXB;NME4;PLTP;CPT2;LRP1;AKT1;PITPNM1;LDLR;SIGMAR1;SORL1;CEACAM1;ABCD1;PCSK9;ABCA2;NTSR1;OSBPL10;LRP10;ESYT2;PRKCD;PPARA;ABCG1;ABCA7;MIF;PLA2G6;PITPNM3;CHKA;SLC27A1;ATP8B2;VPS51
3382,GO:0007163,0.0581356122787341,0.964373796790483,24,159,establishment or maintenance of cell polarity,BP,DLG4;PARVB;WNT7A;SPRY2;MARK4;BRSK1;GSN;KIF26B;RHOD;RHOF;LLGL1;RHOBTB2;PRKCZ;SDCCAG8;FSCN1;SH3BP1;STK25;VANGL2;PAK1;DLG3;LRCH4;LMNA;PKD1;NDE1
9459,GO:0036066,0.0582004143364786,0.986675624049968,4,14,protein O-linked fucosylation,BP,ADAMTS13;ADAMTS7;RFNG;MFNG
3155,GO:0006766,0.0582423569604365,0.969189394524847,15,93,vitamin metabolic process,BP,CYP27B1;SLC2A3;PLTP;PC;ACP5;FGFR1;HLCS;PRSS3;CD320;GSTO1;MTHFR;CYP2R1;PDXK;PM20D2;SLC23A2
825,GO:0002102,0.0583291325722789,0.980943055687078,6,26,podosome,CC,SH3PXD2B;GSN;SH3PXD2A;ADAM8;FSCN1;AFAP1L1
6831,GO:0030301,0.0584582459600549,0.975302961103503,9,48,cholesterol transport,BP,APOE;OSBPL5;PLTP;LRP1;LDLR;PCSK9;ABCA2;ABCG1;ABCA7
10165,GO:0042758,0.0585804525023312,0.995582433713306,2,4,long-chain fatty acid catabolic process,BP,ABCD1;AIG1
16512,GO:0097223,0.0585812394791869,0.969002195740646,15,92,sperm part,CC,LOXL1;HEXB;LY6K;SYT8;BSG;HK1;DNAH1;CEP131;PRKACA;ITGA1;ADAM15;SUN1;PFKM;SEPT6;CLK3
14022,GO:0060762,0.0586208517178629,0.995577632233877,2,4,regulation of branching involved in mammary gland duct morphogenesis,BP,ETV5;TGFB1
494,GO:0001547,0.0586305393064723,0.99557648055831,2,4,antral ovarian follicle growth,BP,EREG;ZP3
3693,GO:0008203,0.0586455599802772,0.968245377902553,16,99,cholesterol metabolic process,BP,APOE;LRP5;OSBPL5;LMF1;LDLR;SEC14L2;SORL1;PCSK9;DGKQ;MVD;SNX17;PLPP6;MBTPS2;HSD17B7;ABCG1;CAT
8191,GO:0032944,0.0586878752954013,0.966904971587558,18,116,regulation of mononuclear cell proliferation,BP,PRNP;PKN1;RAC2;CARD11;IGFBP2;IL20RB;CD81;CEBPB;TGFB1;CD320;ADA;ERBB2;JAK3;INPP5D;MIF;PELI1;HLA-G;ZP3
9029,GO:0035249,0.0587107149088638,0.978606782545747,7,33,synaptic transmission, glutamatergic,BP,EGFR;SERPINE2;GLUL;SHANK2;NLGN2;SHANK3;PLA2G6
10784,GO:0044262,0.0588499361927813,0.962415117600105,28,192,cellular carbohydrate metabolic process,BP,NR1D1;PYGB;PGM1;PYGL;ISYNA1;IDH2;PHLDA2;GAA;AKT1;HK1;IGFBP4;DGKQ;NTSR1;B3GNT3;PCK2;IDUA;PFKFB2;PDK1;DDIT4;PPARA;COQ2;FGGY;GLB1;INSR;PFKM;PFKFB3;MLYCD;ABHD10
160,GO:0000332,0.0589279660051842,1,1,1,template for synthesis of G-rich strand of telomere DNA activity,MF,TERC
238,GO:0000496,0.0589279660051842,1,1,1,base pairing,MF,TERC
239,GO:0000497,0.0589279660051842,1,1,1,base pairing with DNA,MF,TERC
1467,GO:0003721,0.0589279660051842,1,1,1,telomerase RNA reverse transcriptase activity,MF,TERC
13192,GO:0051823,0.0589395807054238,0.995539680812058,2,4,regulation of synapse structural plasticity,BP,SHANK3;CAMK1
3118,GO:0006701,0.05902662396441,0.995529294819381,2,4,progesterone biosynthetic process,BP,EGR1;DGKQ
19298,GO:1905521,0.0590327273365018,0.986227388602354,4,15,regulation of macrophage migration,BP,MMP28;MIF;DDT;MAPK3
545,GO:0001665,0.059046843769482,0.995526880865597,2,4,alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity,MF,ST6GALNAC2;ST6GALNAC6
7317,GO:0031333,0.0591122764020267,0.968681008078607,15,92,negative regulation of protein complex assembly,BP,CTNNBIP1;TMOD2;IMPACT;SORL1;TWF2;GSN;SPTB;FHOD3;EML2;PRKCZ;CAPG;ULK1;PRKCD;SIRT2;PFN2
4633,GO:0010757,0.0591551724954178,0.995513939446049,2,4,negative regulation of plasminogen activation,BP,SERPINE2;CTSZ
10734,GO:0044107,0.0591559246356212,0.995513849541881,2,4,cellular alcohol metabolic process,BP,CYP27B1;CYP2R1
10735,GO:0044108,0.0591559246356212,0.995513849541881,2,4,cellular alcohol biosynthetic process,BP,CYP27B1;CYP2R1
10316,GO:0043112,0.0591634005719745,0.965500673925841,20,130,receptor metabolic process,BP,NR1D1;DLG4;APLN;VEGFA;APOE;ARAP1;LRP1;AP2A2;RAB31;CEACAM1;PCSK9;CD81;TGFB1;PTPN1;CD9;DNM1;EHD3;PPARA;DNM2;TBC1D16
11699,GO:0046501,0.0591810964124791,0.990267716556381,3,9,protoporphyrinogen IX metabolic process,BP,UROS;ALAS1;PPOX
2262,GO:0005178,0.059304480414928,0.970293325291638,13,75,integrin binding,MF,ITGA6;NISCH;EGFR;LTBP4;LAMA5;ADAMTS13;TIMP2;LAMB2;CD9;ADAM15;ICAM5;ITGA3;PXN
6011,GO:0019062,0.0593061304809613,0.995495881389353,2,4,virion attachment to host cell,BP,GAS6;CD81
10945,GO:0044650,0.0593061304809613,0.995495881389353,2,4,adhesion of symbiont to host cell,BP,GAS6;CD81
12052,GO:0048011,0.0593451744579048,0.983102283386649,5,20,neurotrophin TRK receptor signaling pathway,BP,SPRY2;CYFIP2;DDIT4;PPP2R5B;NGFR
9267,GO:0035694,0.0595889958718887,0.99546196910859,2,4,mitochondrial protein catabolic process,BP,BNIP3;BNIP3L
3927,GO:0008610,0.0597374278130852,0.955024469369384,66,513,lipid biosynthetic process,BP,EGR1;NR1D1;CYP27B1;APOE;DGKA;LPCAT4;ISYNA1;ACOT7;HEXB;KDSR;PIK3R2;SRD5A3;PIGQ;HSD17B8;MBOAT7;AKT1;PITPNM1;FGFR4;LDLR;FGFR1;SEC14L2;PIGV;CEACAM1;CBR4;ALOX15B;DGKQ;MVD;SYNJ2;ST6GALNAC6;PI4K2A;PLPP6;PCK2;ACP6;B4GALT6;MLXIPL;PRKCD;SBF1;MBTPS2;HSD17B7;CPNE7;LPCAT1;INPP5D;PI4K2B;DECR2;COQ2;ABCG1;MIF;PLA2G6;PITPNM3;CERS4;CHKA;IGFBP7;SLC27A1;CYP2R1;TAZ;MLYCD;WDTC1;SAMD8;PROX1;GAL3ST4;ST3GAL2;HSD11B1;ZP3;FGFR3;ST3GAL5;SPTLC2
10058,GO:0042554,0.0599087506617868,0.98595343872791,4,15,superoxide anion generation,BP,EGFR;ACP5;TGFB1;PRKCD
18549,GO:1903729,0.0599108150856403,0.990097158345031,3,9,regulation of plasma membrane organization,BP,GSN;PRKCD;DNM2
3202,GO:0006842,0.0599909743780298,0.995413608388756,2,4,tricarboxylic acid transport,BP,SLC13A5;SLC13A3
4996,GO:0015137,0.0599909743780298,0.995413608388756,2,4,citrate transmembrane transporter activity,MF,SLC13A5;SLC13A3
4999,GO:0015142,0.0599909743780298,0.995413608388756,2,4,tricarboxylic acid transmembrane transporter activity,MF,SLC13A5;SLC13A3
5182,GO:0015746,0.0599909743780298,0.995413608388756,2,4,citrate transport,BP,SLC13A5;SLC13A3
3447,GO:0007263,0.0600098205861549,0.990073945879933,3,9,nitric oxide mediated signal transduction,BP,APOE;EGFR;NOS1
14292,GO:0061428,0.060048297745589,0.995406695938054,2,4,negative regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,VHL;SIRT2
14318,GO:0061502,0.0601136404331134,0.995398811575584,2,4,early endosome to recycling endosome transport,BP,SORL1;MYO1D
510,GO:0001574,0.0601528535335262,0.995394077555801,2,4,ganglioside biosynthetic process,BP,ST6GALNAC6;ST3GAL5
7963,GO:0032580,0.0601651842292316,0.970774532124839,12,68,Golgi cisterna membrane,CC,B4GALNT4;ARAP1;PITPNM1;ASAP2;GOLGA2P5;B4GALT2;B4GALT6;ST3GAL3;BCAP31;GAL3ST4;ST3GAL2;CHPF
9240,GO:0035639,0.0602413072930411,0.94966550642715,170,1411,purine ribonucleoside triphosphate binding,MF,ACVR2B;PYGL;DGKA;OBSCN;NEK9;PKN1;ACSF2;EGFR;RPS6KA2;MST1R;ARL2;GTPBP1;TK2;ACTA2;GLUL;MAP2K2;NME4;SMARCA1;PC;MAP2K1;MARK4;ERCC6;CDK18;NMRK1;AKT1;STK39;HK1;EPHA1;BRSK1;RAB31;FGFR4;FGFR1;PRKACB;RAC2;PFKL;TTLL12;OPLAH;HLTF;ABCD1;TWF2;STRADB;MAPK13;PTK6;PFKP;CSNK1E;RAB3B;MAPKAPK3;BCR;EHD4;SEPT10;NADK;PANK4;HLCS;AGAP1;NPR2;DGKQ;PAK6;FYCO1;ABCA2;EPHB2;GRK6;KIF17;MVD;ENTPD2;GNAL;SCYL1;ULK2;MKNK2;ATP7B;PIP5KL1;KIF26B;RHOD;DNAH1;PI4K2A;RHOF;ARL10;KIF7;RHOBTB2;TUBG2;PEX1;PCK2;TRAP1;PFKFB2;PRKCZ;PRKACA;MINK1;ACTR1B;PIM2;UCKL1;ERBB2;ULK1;STK17A;JAK3;PDK1;PRKCD;FAM20C;NUBP2;RPS6KA5;DGUOK;CUL9;RASL10B;LIMK1;NTPCR;RPS6KA6;DNM1;SCN8A;EHD3;LONP2;MAPK12;IRAK1;CHD2;PI4K2B;CHEK2;ABCG1;MYO1D;MYH15;CDC34;ABCA7;RAB12;SPEG;DALRD3;FYN;STK25;RAC3;EEF2K;DNM2;CKMT1A;CHKA;KIF26A;DDX50;TUBB6;MAPK3;INSR;PFKM;ADCY1;ATP8B2;PDXK;PAK1;CAMKK2;ALPK1;PFKFB3;STK32C;SRMS;MAP2K3;RRAS;IARS2;NMNAT2;ADCY7;TEP1;RAB28;MAP3K10;RAB40B;GCH1;KIF13B;CAMK1;CAMKK1;BBS10;SEPT6;CDK11B;FGFR3;ITPKB;CDC42BPG;CLK3;DHX32;PKN3;TTLL3;AK3;ADCY6;LRRK1;AARS
17393,GO:1900117,0.060426462157171,0.982574381640932,5,21,regulation of execution phase of apoptosis,BP,ENDOG;BOK;BAX;BCL2L1;SIRT2
2436,GO:0005638,0.0604764910713593,0.995354934739302,2,4,lamin filament,CC,NARF;LMNA
2124,GO:0004920,0.0605586199247259,0.995344981261366,2,4,interleukin-10 receptor activity,MF,IFNGR2;IL20RB
6416,GO:0021684,0.0605665980206702,0.995344013931236,2,4,cerebellar granular layer formation,BP,WNT7A;PROX1
6431,GO:0021707,0.0605665980206702,0.995344013931236,2,4,cerebellar granule cell differentiation,BP,WNT7A;PROX1
2537,GO:0005796,0.0606000348319975,0.974217685426739,9,48,Golgi lumen,CC,WNT7A;SDC1;GAS6;WNT3;TGFB1;GPC1;PODXL2;AGRN;SDC2
7202,GO:0031100,0.0606615892819488,0.97279124759146,10,55,animal organ regeneration,BP,PGF;EGFR;PTPRU;CCND1;GAS6;CEBPB;TGFB1;TGFBR3;HFE;SRSF5
3142,GO:0006741,0.0606701159787751,0.995331455542108,2,4,NADP biosynthetic process,BP,IDH2;NADK
3153,GO:0006757,0.060687098415849,0.969466934779915,13,76,ATP generation from ADP,BP,PGM1;HK1;PFKL;PFKP;DHTKD1;PFKFB2;MLXIPL;DDIT4;ALDOC;PPARA;INSR;PFKM;PFKFB3
14116,GO:0060993,0.0608362975239365,0.971497332586244,11,61,kidney morphogenesis,BP,PGF;CTNNBIP1;VEGFA;WWTR1;WNT2B;LAMA5;PKD2;TGFB1;KIF26B;VANGL2;PKD1
13957,GO:0060675,0.0608561827671509,0.9757498275593,8,40,ureteric bud morphogenesis,BP,PGF;CTNNBIP1;VEGFA;WNT2B;LAMA5;PKD2;TGFB1;KIF26B
15650,GO:0072171,0.0608561827671509,0.9757498275593,8,40,mesonephric tubule morphogenesis,BP,PGF;CTNNBIP1;VEGFA;WNT2B;LAMA5;PKD2;TGFB1;KIF26B
18190,GO:1902949,0.0609634849582001,0.995295794420236,2,4,positive regulation of tau-protein kinase activity,BP,EGR1;NAB2
6811,GO:0030276,0.0609710928108071,0.97407359514785,9,47,clathrin binding,MF,SYTL1;LRP1;AP2A2;SYT8;LDLR;CEMIP;CLTCL1;TOM1L2;BIN1
3270,GO:0006952,0.0609739357360674,0.950973535078263,111,922,defense response,BP,TNIP1;NT5E;HTRA1;EGR1;NR1D1;CST3;CYP27B1;PDCD4;CTNNBIP1;TNFRSF6B;APOE;F2R;EGFR;PTPRS;MST1R;NFATC4;SDC1;SHC1;ACP5;FOS;SMAD3;PRDX5;ADORA2B;ADARB1;AKT1;HDAC5;F12;STK39;SERPING1;GGT1;NFKBIZ;IFNGR2;FNDC4;LDLR;PRKACB;MAPKBP1;RAG1;CEACAM1;IGFBP4;MAPK13;PTK6;CTSB;CARD11;GSN;MAPKAPK3;BCR;BNIP3;SHARPIN;FAM3A;IL20RB;ADAM8;CD81;CEBPB;RNF135;ADAMTS13;TGFB1;DEAF1;TMEM173;VGF;PTPN1;IFNE;PRKCZ;KDM6B;PRKACA;TBKBP1;ADA;AHCY;JAK3;BNIP3L;PRKCD;IFI6;TRIM4;EREG;RPS6KA5;DDIT4;MT2A;LTB4R2;LRSAM1;ADAM15;IRAK1;PPARA;RAB12;MIF;PLA2G6;DDT;ECM1;FYN;PELI1;APOBEC3C;APOBEC3F;MAPK3;HLA-G;PAK1;LGALS3BP;HYAL1;SRMS;MAP2K3;TNFRSF25;SIRT2;LTB4R;NGFR;TOLLIP;RNASE7;GCH1;PNMA1;HFE;WIPI2;ZP3;MLF2;IL17RE;GSDMA
9968,GO:0042362,0.0609758980506112,0.989846546714217,3,9,fat-soluble vitamin biosynthetic process,BP,CYP27B1;PLTP;CYP2R1
7283,GO:0031282,0.060990480729487,0.995292507636575,2,4,regulation of guanylate cyclase activity,BP,NOS1;ADORA2B
7284,GO:0031284,0.060990480729487,0.995292507636575,2,4,positive regulation of guanylate cyclase activity,BP,NOS1;ADORA2B
15454,GO:0071797,0.0610226057759194,0.995288595201614,2,4,LUBAC complex,CC,RBCK1;SHARPIN
5687,GO:0016803,0.0611480880629141,0.989805845721894,3,9,ether hydrolase activity,MF,AKR7A2;LTA4H;RNPEP
4707,GO:0010871,0.0611743366405165,0.995270099323677,2,4,negative regulation of receptor biosynthetic process,BP,NR1D1;PPARA
18713,GO:1904063,0.0612560148883874,0.975501312756465,8,41,negative regulation of cation transmembrane transport,BP,STK39;ANK3;PCSK9;PKD2;EPHB2;TGFB1;NTSR1;GSTO1
8825,GO:0034618,0.0613448113140877,0.995249285277403,2,4,arginine binding,MF,NAGS;NOS1
1307,GO:0003150,0.0615629300932147,0.995222602778129,2,4,muscular septum morphogenesis,BP,TGFBR3;VANGL2
3560,GO:0007605,0.0616255211341474,0.969891784028765,12,70,sensory perception of sound,BP,ESPN;SPRY2;HEXB;FGFR1;SLITRK6;CEMIP;EML2;TUB;DNM1;WFS1;ALDH7A1;HOMER2
3722,GO:0008253,0.0617844231977938,0.989654988558944,3,9,5'-nucleotidase activity,MF,NT5E;NT5DC1;NT5C1B
10978,GO:0044782,0.0618329025140674,0.957104386449281,40,292,cilium organization,BP,BBS2;EVI5L;WWTR1;NUDCD3;MARK4;IFT140;DNAAF5;NPHP4;CEP250;CSNK1E;LAMA5;GSN;SEPT10;CCDC113;UNC119B;PTPDC1;KIF17;RFX2;CROCC;DNAH1;BBS1;CEP131;PRKACA;SDCCAG8;NINL;RILPL1;EHD3;WDR60;TMEM231;DNAAF3;DNM2;ATXN10;CEP72;VANGL2;NDE1;MSS51;TCTN1;BBS10;SEPT6;TTLL3
4896,GO:0014824,0.0618345933702497,0.995189289624114,2,4,artery smooth muscle contraction,BP,BBS2;EDNRA
6151,GO:0019470,0.0619938704033205,0.995169716504839,2,4,4-hydroxyproline catabolic process,BP,ALDH4A1;PRODH
6005,GO:0019049,0.0620288901769842,0.995165408908243,2,4,evasion or tolerance of host defenses by virus,BP,SMAD3;TGFB1
10868,GO:0044413,0.0620288901769842,0.995165408908243,2,4,avoidance of host defenses,BP,SMAD3;TGFB1
10870,GO:0044415,0.0620288901769842,0.995165408908243,2,4,evasion or tolerance of host defenses,BP,SMAD3;TGFB1
13194,GO:0051832,0.0620288901769842,0.995165408908243,2,4,avoidance of defenses of other organism involved in symbiotic interaction,BP,SMAD3;TGFB1
13196,GO:0051834,0.0620288901769842,0.995165408908243,2,4,evasion or tolerance of defenses of other organism involved in symbiotic interaction,BP,SMAD3;TGFB1
4943,GO:0014909,0.0620371369991105,0.973530407503815,9,47,smooth muscle cell migration,BP,PLAT;DOCK4;POSTN;SSH1;LRP1;CORO1B;SORL1;PLAU;PAK1
8952,GO:0035021,0.0621044669687016,0.995156107558337,2,4,negative regulation of Rac protein signal transduction,BP,ARAP3;ARHGAP44
12107,GO:0048170,0.0621302535166681,0.99515293239016,2,4,positive regulation of long-term neuronal synaptic plasticity,BP,EPHB2;SHANK3
5371,GO:0016176,0.0621906082528986,0.995145497606869,2,4,superoxide-generating NADPH oxidase activator activity,MF,SH3PXD2B;SH3PXD2A
1884,GO:0004565,0.0622606634337073,0.995136862361098,2,4,beta-galactosidase activity,MF,GLB1L2;GLB1
6202,GO:0019695,0.0622671480304716,0.995136062747509,2,4,choline metabolic process,BP,CHKA;ALDH7A1
3612,GO:0008063,0.0622932565414122,0.995132842801656,2,4,Toll signaling pathway,BP,PELI1;PELI3
6795,GO:0030246,0.0623064898021936,0.964009725745098,19,122,carbohydrate binding,MF,ADGRL1;MRC2;FBXO2;PYGL;SLC2A3;GAA;BSG;HK1;CNTN1;PFKL;LGALS9B;KLRG2;LGALS9C;PHYH;PFKM;MAN2B1;PKD1;ZP3;MAN2B2
18449,GO:1903522,0.0623077950754484,0.963439332421872,20,130,regulation of blood circulation,BP,APLN;DOCK4;F2R;ITPR3;EGFR;SCN4B;NOS1;GAA;EPAS1;HBEGF;AKT1;NPR2;SNTA1;PRKACA;ADA;TRPC1;CACNB3;GSTO1;EHD3;GCH1
17342,GO:1900019,0.0623153714659948,0.995130114738672,2,4,regulation of protein kinase C activity,BP,EGFR;CEMIP
17343,GO:1900020,0.0623153714659948,0.995130114738672,2,4,positive regulation of protein kinase C activity,BP,EGFR;CEMIP
20041,GO:2000644,0.0623231833522581,0.98952671776704,3,9,regulation of receptor catabolic process,BP,APOE;PCSK9;PTPN1
10999,GO:0044821,0.0623309257121338,0.99512819563731,2,4,meiotic telomere tethering at nuclear periphery,BP,LEMD2;SUN1
14622,GO:0070197,0.0623309257121338,0.99512819563731,2,4,meiotic attachment of telomere to nuclear envelope,BP,LEMD2;SUN1
16524,GO:0097240,0.0623309257121338,0.99512819563731,2,4,chromosome attachment to the nuclear envelope,BP,LEMD2;SUN1
17770,GO:1901727,0.0623319016808858,0.995128075211392,2,4,positive regulation of histone deacetylase activity,BP,VEGFA;C6ORF89
6338,GO:0021516,0.0623351052874901,0.995127679906563,2,4,dorsal spinal cord development,BP,PROX1;MDGA1
12976,GO:0051388,0.0623353203656149,0.995127653366846,2,4,positive regulation of neurotrophin TRK receptor signaling pathway,BP,CYFIP2;PPP2R5B
19570,GO:1990535,0.0623357658684972,0.995127598393502,2,4,neuron projection maintenance,BP,PRNP;INSR
5855,GO:0017153,0.062336280362804,0.995127534906587,2,4,sodium:dicarboxylate symporter activity,MF,SLC13A5;SLC13A3
15081,GO:0071072,0.0623364105980029,0.995127518835947,2,4,negative regulation of phospholipid biosynthetic process,BP,LPCAT1;SLC27A1
13735,GO:0060318,0.0623365027023425,0.995127507470519,2,4,definitive erythrocyte differentiation,BP,TGFBR3;ZFPM1
9711,GO:0038132,0.0623365027023468,0.995127507470515,2,4,neuregulin binding,MF,ITGA6;ITGB4
5374,GO:0016185,0.0623365027023664,0.995127507470521,2,4,synaptic vesicle budding from presynaptic endocytic zone membrane,BP,DNM1;DNM2
16897,GO:0098844,0.0623365027023664,0.995127507470521,2,4,postsynaptic endocytic zone membrane,CC,DNM1;DNM2
16915,GO:0098884,0.0623365027023664,0.995127507470521,2,4,postsynaptic neurotransmitter receptor internalization,BP,DNM1;DNM2
6170,GO:0019534,0.0623365027023708,0.995127507470517,2,4,toxin transmembrane transporter activity,MF,SLC7A8;ABCG1
1734,GO:0004331,0.0623365027023925,0.995127507470521,2,4,fructose-2,6-bisphosphate 2-phosphatase activity,MF,PFKFB2;PFKFB3
2656,GO:0006003,0.0623365027023925,0.995127507470521,2,4,fructose 2,6-bisphosphate metabolic process,BP,PFKFB2;PFKFB3
13555,GO:0060029,0.0623365027023925,0.995127507470521,2,4,convergent extension involved in organogenesis,BP,DVL1;VANGL2
18116,GO:1902744,0.0623365027023968,0.995127507470517,2,4,negative regulation of lamellipodium organization,BP,ARPIN;PLXNB3
10301,GO:0043083,0.0623365027023968,0.995127507470517,2,4,synaptic cleft,CC,LAMA5;LAMB2
12992,GO:0051425,0.0623365027023968,0.995127507470517,2,4,PTB domain binding,MF,INPP5D;INSR
6761,GO:0030202,0.062336502702399,0.995127507470515,2,4,heparin metabolic process,BP,XYLT2;NDST2
6769,GO:0030210,0.062336502702399,0.995127507470515,2,4,heparin biosynthetic process,BP,XYLT2;NDST2
12090,GO:0048104,0.062336502702399,0.995127507470515,2,4,establishment of body hair or bristle planar orientation,BP,VANGL2;CELSR1
12091,GO:0048105,0.062336502702399,0.995127507470515,2,4,establishment of body hair planar orientation,BP,VANGL2;CELSR1
15942,GO:0075044,0.062336502702399,0.995127507470515,2,4,autophagy of host cells involved in interaction with symbiont,BP,ULK2;ULK1
15943,GO:0075071,0.062336502702399,0.995127507470515,2,4,autophagy involved in symbiotic interaction,BP,ULK2;ULK1
12372,GO:0048788,0.062336502702399,0.995127507470515,2,4,cytoskeleton of presynaptic active zone,CC,RIMS3;PCLO
17075,GO:0099569,0.062336502702399,0.995127507470515,2,4,presynaptic cytoskeleton,CC,RIMS3;PCLO
932,GO:0002329,0.0623365027024491,0.995127507470517,2,4,pre-B cell differentiation,BP,LRRC8A;RAG1
7757,GO:0032280,0.0623365027024491,0.995127507470517,2,4,symmetric synapse,CC,NLGN2;NTSR1
16441,GO:0097105,0.0623365027024491,0.995127507470517,2,4,presynaptic membrane assembly,BP,NLGN2;LRP4
5385,GO:0016209,0.0623452718592985,0.973126686644109,9,53,antioxidant activity,MF,APOE;TXNRD3;PRDX5;CCS;GPX3;CYGB;GSTO1;SESN2;CAT
14369,GO:0061614,0.0624677898681767,0.976910003105452,7,33,pri-miRNA transcription by RNA polymerase II,BP,APLN;NFATC4;FOS;SMAD3;TGFB1;PPARA;NGFR
6055,GO:0019205,0.0626380326206387,0.974776394668481,8,42,nucleobase-containing compound kinase activity,MF,DLG4;TK2;NME4;CARD11;UCKL1;DGUOK;DLG3;AK3
12795,GO:0051098,0.0627991577240878,0.956793669586797,38,281,regulation of binding,BP,CTNNBIP1;APOE;HMGA2;NFATC4;PHLDA2;MDFI;SMAD3;LRP1;DVL1;AKT1;HDAC5;SORL1;CSNK1E;PCSK9;CTSZ;GPSM1;TGFB1;TMEM173;RFNG;PRKACA;PIM2;PRKCD;STUB1;BAX;TGFBR3;MFNG;ADAM15;ZFPM1;PPARA;MAPK3;CAPRIN2;PKD1;SIRT2;FAM129B;ITGA4;MAPRE3;CAMK1;HFE
5615,GO:0016667,0.0628490648515132,0.972982777605069,9,50,oxidoreductase activity, acting on a sulfur group of donors,MF,TXNRD3;CCS;MSRB2;ERO1B;PDIA5;GSTO1;SESN2;QSOX1;GLRX
17192,GO:0106003,0.0630672937956735,0.989348736524097,3,9,amyloid-beta complex,CC,PRNP;APOE;INSR
18489,GO:1903580,0.0632565206700913,0.981515076960962,5,21,positive regulation of ATP metabolic process,BP,PFKFB2;MLXIPL;INSR;TAZ;PFKFB3
11397,GO:0045807,0.0633108936873534,0.966965116235823,14,85,positive regulation of endocytosis,BP,APLN;VEGFA;APOE;TSPAN1;LRP1;LDLR;GAS6;PCSK9;BCR;TUB;ABCA7;EEF2K;DNM2;HFE
11226,GO:0045408,0.063494400956381,0.98924615035361,3,9,regulation of interleukin-6 biosynthetic process,BP,CEBPB;EREG;INPP5D
792,GO:0002062,0.0636436922063581,0.969947922341102,11,61,chondrocyte differentiation,BP,MEF2D;WNT7A;HMGA2;SMAD3;PTHLH;WNT2B;FGFR1;TGFB1;ADAMTS7;CHADL;FGFR3
13394,GO:0052742,0.063699104908845,0.976348158284628,7,33,phosphatidylinositol kinase activity,MF,PIK3R2;FGFR4;FGFR1;PI4K2A;PI4K2B;FGFR3;PI4KAP2
6615,GO:0022843,0.0639942173503792,0.974226084024033,8,40,voltage-gated cation channel activity,MF,KCNG1;KCNJ15;TPCN1;KCNC4;KCNAB2;GAS6;PKD2;CACNB3
14170,GO:0061078,0.0640811793188924,1,1,1,positive regulation of prostaglandin secretion involved in immune response,BP,MIF
16262,GO:0090323,0.0640811793188924,1,1,1,prostaglandin secretion involved in immune response,BP,MIF
2442,GO:0005652,0.0642827890238007,0.989055972584854,3,9,nuclear lamina,CC,HLCS;NARF;LMNA
9852,GO:0042107,0.0644436647732901,0.969469998753151,11,62,cytokine metabolic process,BP,EGR1;CARD11;ERRFI1;CEBPB;TNFSF15;TRIB2;EREG;ASB1;INPP5D;ZFPM1;MAP2K3
3188,GO:0006816,0.0644806845091057,0.95774360334102,30,211,calcium ion transport,BP,CYP27B1;PRNP;F2R;ITPR3;NOS1;ORAI3;ORAI1;LPAR3;GJC2;TPCN1;GAS6;CEMIP;PKD2;GRIN3B;ASIC1;PLCG1;TGFB1;NTSR1;RASA3;PRKACA;TRPC1;CACNB3;BAX;GSTO1;EHD3;PLA2G6;WFS1;FYN;PKD1;HOMER2
5702,GO:0016830,0.0645312660631278,0.973904932812704,8,41,carbon-carbon lyase activity,MF,GLUL;MVD;HMGCL;PCK2;ALDOC;DDT;MLYCD;AZIN2
14993,GO:0070920,0.0645549843060406,0.984476255328232,4,15,regulation of production of small RNA involved in gene silencing by RNA,BP,EGFR;MAP2K2;MAP2K1;TGFB1
4292,GO:0009725,0.0647860895439386,0.949536236779792,82,652,response to hormone,BP,EGR1;NR1D1;CST3;PGF;BBS2;POSTN;FAM210B;WNT7A;LRP5;EGFR;NOS1;HADH;SDC1;SHC1;PTPRE;ZFP36L1;ENDOG;FOS;PIK3R2;AKT1;HDAC5;BSG;PTPRU;RAB31;PRKACB;CEACAM1;CCND1;CTSB;IGFBP2;PCSK9;ERRFI1;PAQR6;ABCA2;APRT;TIMP2;TGFB1;NSMF;TUB;VGF;PTPN1;PCK2;AGRN;MBD3;PRKCZ;PRKACA;AREG;VAMP2;JAK3;PRKCD;CYC1;EREG;DDIT4;TGFBR3;CHEK2;PPARA;SESN2;ABCG1;FYN;EEF2K;GLB1;CAT;IGFBP7;SLC27A1;MAPK3;INSR;ADCY1;PAK1;WDTC1;ITGA3;DNMT3A;ADCY7;SOCS7;NGFR;ATP6V1F;PXN;GRB10;NR2F6;GAS2L1;BTG1;KDM3A;SRSF5;ADCY6
9855,GO:0042110,0.0649989777901806,0.955398915712438,37,270,T cell activation,BP,EGR1;PRNP;ZFP36L1;SMAD3;STAT6;PAG1;AKT1;RAC2;RAG1;CEACAM1;CARD11;SOX13;GSN;IGFBP2;IL20RB;AP3D1;ADAM8;CEBPB;TGFB1;EFNB3;IFNE;PRKCZ;ADA;ERBB2;JAK3;BAX;ZFPM1;FYN;PELI1;SATB1;HLA-G;PAK1;PPP3CB;KIF13B;HFE;ZP3;ITPKB
12462,GO:0050337,0.0651646781292241,1,1,1,thiosulfate-thiol sulfurtransferase activity,MF,TSTD1
4761,GO:0010942,0.0651861843402056,0.95096491150224,63,496,positive regulation of cell death,BP,DUSP6;XDH;EGR1;PDCD4;PRNP;F2R;ITGA6;HMGA2;OBSCN;GRAMD4;RPS6KA2;NFATC4;RBCK1;SSH1;ENDOG;MARK4;FOS;SMAD3;LRP1;PRODH;AKT1;PPM1F;DAP;GSN;PLEKHG2;PCSK9;BNIP3;CTSZ;ADAM8;TGFB1;MOAP1;NTSR1;TNFSF15;PLEKHG5;BOK;TFDP2;STK17A;NET1;BNIP3L;PRKCD;BAX;ITGA1;DDIT4;INPP5D;CHEK2;CDC34;SOX7;BCAP31;PLA2G6;FYN;DNM2;ARHGEF4;ARHGEF1;DNMT3A;BIN1;BCL2L1;SIRT2;MAP3K10;NGFR;PDCD6;PNMA1;BTG1;DEDD2
5583,GO:0016601,0.0652425145948958,0.975563813188244,7,34,Rac protein signal transduction,BP,NISCH;RAC2;ARAP3;ARHGAP44;SH3BP1;RAC3;DNM2
2461,GO:0005677,0.06532230290416,0.988803606948869,3,9,chromatin silencing complex,CC,BAHCC1;SIRT2;TNRC18
17470,GO:1900271,0.0654159337863992,0.98069661806881,5,21,regulation of long-term synaptic potentiation,BP,PRNP;APOE;CRTC1;EPHB2;SHANK3
4022,GO:0009056,0.0654603768275976,0.943948442713677,228,1989,catabolic process,BP,NT5E;XDH;GID4;H1F0;NR1D1;EDEM1;CST3;CYP27B1;MRC2;TYSND1;BTBD2;FBXO2;PYGB;PGM1;APOE;PYGL;NAGLU;LRP5;PLD3;CRAT;MTA1;ACOT7;ARRDC1;EGFR;SERPINE2;DNPH1;WWTR1;NOS1;TMEM129;HADH;CTSO;CAPN2;TRIM65;SDC1;VPS11;TBC1D14;HEXB;GTPBP1;ALDH4A1;MMP1;SNX9;RAPGEF3;ZFP36L1;GAA;GLUL;RNPEPL1;CTBS;PLCD3;RBCK1;RNF44;CRYL1;CPT2;ENDOG;GALE;SMURF2;SMAD3;PIK3R2;LRP1;SRD5A3;DVL1;AP2A2;ITGB4;PRDX5;PRODH;FBXW5;RNF187;PLCXD2;AKT1;TPCN1;ENTPD6;HK1;GGT1;ATG16L2;DAP;LDLR;FUCA1;PFKL;PACS2;SORL1;CEACAM1;CIRBP;ABCD1;PCBP4;AIG1;PLCH2;PFKP;CSNK1E;CTSB;PCSK9;RAD23A;DHTKD1;SH3D19;GGACT;COL13A1;HAGH;BNIP3;SHARPIN;MVB12B;FYCO1;CEMIP;GPX3;CTSZ;GPSM1;MAGEF1;ADAM8;LTA4H;PLCG1;CBS;CD81;ENTPD2;ADAMTS13;TIMP2;TGFB1;ABHD17C;ULK2;GPC1;ADAMTS7;NTSR1;PNRC1;GALNS;ABTB1;SNX17;RNH1;FBXO44;SNX33;ANKZF1;ATG2A;UBXN4;HMGCL;PTPN1;TPP1;PCK2;AGRN;IDUA;PFKFB2;MLXIPL;TRIB2;PRKACA;ADA;PIM2;BOK;ULK1;AHCY;MMP10;RNPEP;BNIP3L;ACAD10;PRKCD;USP20;STUB1;BAX;FBXW4;CUL9;DDIT4;ACADS;CES2;NAGA;ZDHHC8;GSTO1;ALDOC;LPCAT1;LRSAM1;ADAM15;LONP2;CHEK2;DECR2;PPARA;SESN2;CDC34;RNF123;RAB12;BCAP31;SMOX;PHYH;PLA2G6;WFS1;QSOX1;FYN;UPP1;ETFB;CYP3A5;GLB1;CAT;NEIL1;APOBEC3C;PLCB3;APOBEC3F;CYP2R1;MAPK3;INSR;PAN2;PFKM;GPT2;CAMKK2;RNASET2;RNF144A;CTSF;USP21;PFKFB3;MLYCD;CUL7;HYAL1;VPS16;MAN2B1;ABHD10;DNASE1L1;ALDH7A1;PKD1;KCTD13;SIRT2;NT5C1B;AZIN2;RGS19;HSD11B1;TOLLIP;PHYKPL;PLEKHM1;HFE;WIPI2;COL6A1;VPS51;TST;MAN2B2;CBLC;SPTLC2;PM20D2;DEDD2;SDC2
7028,GO:0030808,0.0660188168219619,0.965334712683049,14,85,regulation of nucleotide biosynthetic process,BP,APOE;NOS1;ADORA2B;PTHLH;TIMP2;PFKFB2;MLXIPL;DDIT4;LTB4R2;PPARA;INSR;TAZ;PFKFB3;GABBR1
17482,GO:1900371,0.0660188168219619,0.965334712683049,14,85,regulation of purine nucleotide biosynthetic process,BP,APOE;NOS1;ADORA2B;PTHLH;TIMP2;PFKFB2;MLXIPL;DDIT4;LTB4R2;PPARA;INSR;TAZ;PFKFB3;GABBR1
16335,GO:0090568,0.0661648181123617,0.977566839759201,6,27,nuclear transcriptional repressor complex,CC,BAHCC1;APPL2;SALL2;MBD3;SIRT2;TNRC18
12896,GO:0051251,0.0662163040908908,0.959248252907956,23,157,positive regulation of lymphocyte activation,BP,STAT6;AKT1;RAG1;GAS6;CARD11;IGFBP2;AP3D1;ADAM8;CD81;TGFB1;EFNB3;CD320;PRKCZ;ADA;JAK3;INPP5D;MIF;FYN;PELI1;HLA-G;PAK1;ZP3;ITPKB
10214,GO:0042866,0.0662697590840683,0.966168761017033,13,77,pyruvate biosynthetic process,BP,PGM1;HK1;PFKL;PFKP;DHTKD1;PFKFB2;MLXIPL;DDIT4;ALDOC;PPARA;INSR;PFKM;PFKFB3
11952,GO:0047144,0.0663615082280902,0.98854949648519,3,9,2-acylglycerol-3-phosphate O-acyltransferase activity,MF,LPCAT4;MBOAT7;LPCAT1
5178,GO:0015740,0.0664660602658928,0.988523830744947,3,9,C4-dicarboxylate transport,BP,NTSR1;SLC13A5;SLC13A3
2392,GO:0005536,0.0665040135465357,0.988514509338252,3,9,glucose binding,MF,PYGL;SLC2A3;HK1
2289,GO:0005248,0.0665599041086611,0.988500778111262,3,9,voltage-gated sodium channel activity,MF,SCN4B;PKD2;SCN8A
6580,GO:0022414,0.0665638445821873,0.946739315304632,102,829,reproductive process,BP,ERCC1;HTRA1;EGR1;CST3;CYP27B1;PGF;BBS2;VEGFA;WNT7A;EGFR;SERPINE2;MST1R;CRTAP;SDC1;ETV5;HEXB;TCFL5;PHLDA2;TXNRD3;ZFP36L1;PLCD3;MDFI;MAP2K1;SMURF2;FOS;FBLN1;EPAS1;SH3PXD2B;SYT8;AKT1;BSG;SCMH1;GGT1;PHC2;PTHLH;WNT2B;PRKACB;GAMT;CCNI;MICALCL;CCND1;CTSB;IGFBP2;ANTXR2;CDC25B;ALOX15B;NPR2;PKD2;FBXW8;EPOR;CEBPB;WNT3;TGFB1;RFX2;DEAF1;MYCBPAP;DNAH1;VGF;TUBG2;CEP131;PRKACA;CD9;ADA;AREG;PIM2;BOK;TDRKH;FAM50A;BAX;SBF1;EREG;RPL39L;LEMD2;ADAM15;ASB1;SPATA20;SIX5;BCAP31;PLA2G6;SUN1;ARID5B;DNM2;IGFBP7;INSR;CUL7;ITGA3;DNMT3A;BCL2L1;PKD1;SIRT2;ADCY7;AZIN2;GPR3;MAFF;HFE;BTG1;ZP3;SEPT6;PRSS21;PLAG1;IRF2BPL;KDM3A
18213,GO:1902991,0.066597221903695,0.980245221595708,5,21,regulation of amyloid precursor protein catabolic process,BP,PRNP;APOE;SORL1;ABCA7;BIN1
5596,GO:0016627,0.066604327901074,0.97108429402518,9,49,oxidoreductase activity, acting on the CH-CH group of donors,MF,SRD5A3;RSAD1;RETSAT;SDHA;ACAD10;ACADS;PPOX;DECR2;PTGR2
12505,GO:0050654,0.0666765661845062,0.977348346770771,6,27,chondroitin sulfate proteoglycan metabolic process,BP,HEXB;B3GAT3;IDUA;XYLT2;HYAL1;CHPF
4343,GO:0009897,0.0667279008607759,0.962442762145585,17,108,external side of plasma membrane,CC,PRNP;ITGA6;SERPINE2;SDC1;LDLR;PCSK9;ANTXR2;SCART1;CD9;ADA;ITGA1;TGFBR3;ABCG1;BCAM;INSR;ITGA3;HFE
4639,GO:0010763,0.0667283080026546,0.988459372974396,3,9,positive regulation of fibroblast migration,BP,AKT1;TGFB1;PAK1
9817,GO:0042035,0.0668457184535566,0.969476184397879,10,55,regulation of cytokine biosynthetic process,BP,EGR1;CARD11;ERRFI1;CEBPB;TRIB2;EREG;ASB1;INPP5D;ZFPM1;MAP2K3
9981,GO:0042383,0.0669351702375396,0.965775139472362,13,77,sarcolemma,CC,FLNC;OBSCN;NOS1;BSG;DYSF;ANK3;SNTA1;CACNB3;AHNAK2;RTN2;PPP3CB;BIN1;COL6A1
14935,GO:0070828,0.066948016132475,0.98369986242976,4,15,heterochromatin organization,BP,HMGA2;BAHCC1;MTHFR;TNRC18
11150,GO:0045214,0.0669585625371473,0.980106632630498,5,21,sarcomere organization,BP,OBSCN;OBSL1;TNNT1;FHOD3;PROX1
8363,GO:0033268,0.0670387105597936,0.988382930832363,3,9,node of Ranvier,CC,ANK3;SCN8A;BIN1
12699,GO:0050926,0.0670924465088798,0.983652670825672,4,15,regulation of positive chemotaxis,BP,PGF;VEGFA;SMAD3;VEGFB
18986,GO:1904754,0.0670986265094044,0.988368156963447,3,9,positive regulation of vascular associated smooth muscle cell migration,BP,DOCK4;SSH1;PAK1
7078,GO:0030879,0.0671091498755959,0.9629607303033,16,100,mammary gland development,BP,XDH;APLN;VEGFA;LRP5;ETV5;STAT6;AKT1;CCND1;APRT;CEBPB;WNT3;TGFB1;DEAF1;ATP7B;AREG;BAX
16322,GO:0090527,0.0671407544931764,0.988357765608179,3,9,actin filament reorganization,BP,ARAP1;EFS;GSN
13458,GO:0055003,0.0671411550367679,0.988357666795285,3,9,cardiac myofibril assembly,BP,OBSL1;FHOD3;PROX1
4310,GO:0009790,0.0672000732859544,0.947321423148445,85,674,embryo development,BP,DUSP6;ERCC1;DUSP5;DLG4;APLN;ACVR2B;VEGFA;WNT7A;NAGLU;LRP5;HMGA2;EGFR;SPRY2;CAPN2;PHLDA2;ZFP36L1;PLCD3;MDFI;MAP2K1;ENDOG;SMAD3;DVL1;EPAS1;ITGB4;SALL2;AKT1;IFT140;WNT2B;FGFR1;PRKACB;TSHZ1;EDNRA;SEMA3F;SH2B3;LAMA5;BCR;SLITRK6;GTF2IRD1;PKD2;FBXW8;ITGB5;EPHB2;PLCG1;CEBPB;WNT3;TGFB1;DEAF1;MBD3;LRP4;KDM6B;ADA;PBX2;BAX;FBXW4;DUSP4;PPP1R13L;RPS6KA6;WDR60;TMEM231;ZFPM1;SOX7;MAPK3;INSR;VANGL2;HYAL1;SEMA4C;WDTC1;HES7;ITGA3;DNMT3A;BCL2L1;DLG3;PROX1;PKD1;FAM129B;ITGA4;LAMB1;PDCD6;MAFF;TCTN1;SLC39A3;COL6A1;ZP3;CELSR1;APBA1
4465,GO:0010463,0.0672372585378341,0.977108409686115,6,27,mesenchymal cell proliferation,BP,CTNNBIP1;VEGFA;LRP5;FGFR1;FBXW4;LMNA
4890,GO:0014812,0.0673404517659404,0.969208155707928,10,55,muscle cell migration,BP,PLAT;DOCK4;POSTN;SSH1;LRP1;CORO1B;SORL1;PLAU;NET1;PAK1
12171,GO:0048308,0.0676839993047077,0.983458992804203,4,15,organelle inheritance,BP,MAP2K2;MAP2K1;STK25;MAPK3
16495,GO:0097194,0.0677125484870121,0.966370769659795,12,71,execution phase of apoptosis,BP,H1F0;ENDOG;AKT1;SHARPIN;BOK;PRKCD;BAX;BCAP31;SATB1;BCL2L1;SIRT2;DEDD2
681,GO:0001892,0.0677176535587942,0.966396928063522,12,70,embryonic placenta development,BP,EGFR;PHLDA2;ZFP36L1;PLCD3;MDFI;MAP2K1;EPAS1;AKT1;PKD2;FBXW8;CEBPB;PKD1
8549,GO:0033981,0.0678384205108901,1,1,1,D-dopachrome decarboxylase activity,MF,DDT
1253,GO:0003006,0.067845261032874,0.95002224876545,54,413,developmental process involved in reproduction,BP,ERCC1;HTRA1;CST3;CYP27B1;BBS2;VEGFA;WNT7A;EGFR;SERPINE2;SDC1;ETV5;HEXB;PHLDA2;ZFP36L1;PLCD3;MDFI;MAP2K1;EPAS1;AKT1;BSG;WNT2B;CCND1;CTSB;CDC25B;ALOX15B;NPR2;PKD2;FBXW8;EPOR;CEBPB;TGFB1;RFX2;DEAF1;DNAH1;VGF;PRKACA;ADA;AREG;BOK;BAX;EREG;ADAM15;ASB1;SIX5;ARID5B;INSR;CUL7;BCL2L1;PKD1;SIRT2;ZP3;PLAG1;IRF2BPL;KDM3A
17254,GO:0120032,0.0682076262104124,0.960122607319906,19,124,regulation of plasma membrane bounded cell projection assembly,BP,ZMYND8;ESPN;EVI5L;ARAP1;SSH1;IFT140;RAC2;TENM2;TWF2;PLXNB3;CDC42EP5;CROCC;AGRN;FSCN1;PRKCD;DNM2;PLEKHM1;PFN2;SSH3
15593,GO:0072078,0.0682758721538887,0.970260812844527,9,48,nephron tubule morphogenesis,BP,PGF;CTNNBIP1;VEGFA;WNT2B;LAMA5;PKD2;TGFB1;KIF26B;PKD1
2,GO:0000003,0.0682822701385391,0.945292324240887,102,830,reproduction,BP,ERCC1;HTRA1;EGR1;CST3;CYP27B1;PGF;BBS2;VEGFA;WNT7A;EGFR;SERPINE2;MST1R;CRTAP;SDC1;ETV5;HEXB;TCFL5;PHLDA2;TXNRD3;ZFP36L1;PLCD3;MDFI;MAP2K1;SMURF2;FOS;FBLN1;EPAS1;SH3PXD2B;SYT8;AKT1;BSG;SCMH1;GGT1;PHC2;PTHLH;WNT2B;PRKACB;GAMT;CCNI;MICALCL;CCND1;CTSB;IGFBP2;ANTXR2;CDC25B;ALOX15B;NPR2;PKD2;FBXW8;EPOR;CEBPB;WNT3;TGFB1;RFX2;DEAF1;MYCBPAP;DNAH1;VGF;TUBG2;CEP131;PRKACA;CD9;ADA;AREG;PIM2;BOK;TDRKH;FAM50A;BAX;SBF1;EREG;RPL39L;LEMD2;ADAM15;ASB1;SPATA20;SIX5;BCAP31;PLA2G6;SUN1;ARID5B;DNM2;IGFBP7;INSR;CUL7;ITGA3;DNMT3A;BCL2L1;PKD1;SIRT2;ADCY7;AZIN2;GPR3;MAFF;HFE;BTG1;ZP3;SEPT6;PRSS21;PLAG1;IRF2BPL;KDM3A
8881,GO:0034703,0.0683413409204148,0.964941042828795,13,77,cation channel complex,CC,DLG4;KCNG1;SCN4B;NOS1;KCNC4;KCNAB2;GRIN3B;PRKACA;VAMP2;CACNB3;OLFM2;SCN8A;DLG3
4502,GO:0010543,0.068465880042697,0.979525944445146,5,21,regulation of platelet activation,BP,APOE;SERPINE2;CEACAM1;CD9;PRKCD
5691,GO:0016811,0.068482737776575,0.96592432787364,12,71,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides,MF,MTA1;HDAC5;HMG20B;ACY1;PHF21A;MBD3;HDAC7;CAT;NDST2;SIRT2;SIRT3;PM20D2
8951,GO:0035020,0.0686860652724611,0.983129477108346,4,15,regulation of Rac protein signal transduction,BP,ARAP3;ARHGAP44;SH3BP1;DNM2
10802,GO:0044297,0.06871801201561,0.951453239340125,42,313,cell body,CC,CST3;APOE;ITPR3;PTPRS;ACTA2;GLUL;ENDOG;SHANK2;LRP1;GJC2;DVL1;KCNC4;PITPNM1;ZNF385A;CRTC1;EPHB2;GRIN3B;TIMP2;TGFB1;SNPH;NTSR1;NSMF;PI4K2A;CAMK2N1;LRP4;PRKCZ;ADA;CYGB;SV2A;ITGA1;GDI1;MYO1D;PITPNM3;RAC3;ATXN10;INSR;VPS16;DLG3;SIRT2;AZIN2;HOMER2;KLHL24
4962,GO:0015038,0.0688305127239979,0.99344963807421,2,5,glutathione disulfide oxidoreductase activity,MF,GSTO1;GLRX
12895,GO:0051250,0.0688594020181451,0.964606736314904,13,78,negative regulation of lymphocyte activation,BP,PRNP;PKN1;PAG1;CEACAM1;IL20RB;CEBPB;TGFB1;ERBB2;JAK3;INPP5D;PELI1;HLA-G;HFE
11583,GO:0046173,0.0689540383234203,0.971659285797182,8,42,polyol biosynthetic process,BP,CYP27B1;ISYNA1;NTSR1;PCK2;CYP2R1;GCH1;ITPKB;SPTLC2
4878,GO:0014741,0.0689871396703734,0.983030122359875,4,15,negative regulation of muscle hypertrophy,BP,SMAD3;ERRFI1;PAK1;LMNA
11705,GO:0046513,0.0690519081803052,0.971670098298112,8,41,ceramide biosynthetic process,BP,ST6GALNAC6;B4GALT6;PRKCD;PLA2G6;CERS4;SAMD8;ST3GAL5;SPTLC2
4944,GO:0014910,0.0692226164212524,0.971585008952687,8,41,regulation of smooth muscle cell migration,BP,DOCK4;POSTN;SSH1;LRP1;CORO1B;SORL1;PLAU;PAK1
15588,GO:0072073,0.0692784616277451,0.962446217279495,15,92,kidney epithelium development,BP,PGF;CTNNBIP1;VEGFA;WWTR1;SDC1;SMAD3;WNT2B;FGFR1;LAMA5;PKD2;TGFB1;KIF26B;LAMB2;CAT;PKD1
10146,GO:0042730,0.0692873000300446,0.982930908599318,4,15,fibrinolysis,BP,PLAT;F12;SERPING1;PLAU
6977,GO:0030659,0.069449344535253,0.947315030460265,65,510,cytoplasmic vesicle membrane,CC,DLG4;WNT7A;APOE;ITPR3;EGFR;PTPRS;SLC2A3;SNX9;GAA;MCTP1;LRP1;HBEGF;AP2A2;STOM;SYT8;BSG;DYSF;SLC15A4;IFNGR2;RAB31;LDLR;RAC2;KCNAB2;CEACAM1;PLAU;BRI3;RAB3B;DBNDD1;CEMIP;PKD2;ADAM8;WNT3;CLTCL1;SCYL1;SNTB2;ULK2;TMEM173;SNX17;SNX33;PI4K2A;RHOF;CD9;EPN2;AREG;VAMP2;MCFD2;SV2A;AHNAK2;ZDHHC8;LPCAT1;TGFA;SYNGR1;CD68;SUN1;DNM2;SNX15;HLA-G;RNF144A;SEMA4C;BCL2L1;ICA1;RAB40B;PDCD6;NBEAL2;MFSD10
131,GO:0000272,0.0695348575139761,0.979111630970076,5,21,polysaccharide catabolic process,BP,PYGB;PGM1;PYGL;GAA;PFKM
10778,GO:0044247,0.0695348575139761,0.979111630970076,5,21,cellular polysaccharide catabolic process,BP,PYGB;PGM1;PYGL;GAA;PFKM
10810,GO:0044306,0.0695967245844133,0.964167282278453,13,78,neuron projection terminus,CC,DLG4;GLUL;KCNC4;KCNAB2;AP3D1;NTSR1;VAMP2;SV2A;SYNGR1;MICAL1;GCH1;SEPT6;PFN2
6731,GO:0030155,0.069596910972719,0.948492752403485,55,421,regulation of cell adhesion,BP,PRNP;POSTN;VEGFA;ITGA6;SERPINE2;ARL2;FBLN1;SMAD3;PAG1;AKT1;PPM1F;EPHA1;RAC2;SMOC2;RAG1;CEACAM1;ANK3;PLAU;CARD11;LAMA5;GSN;IGFBP2;PLXNB3;IL20RB;AP3D1;ADAM8;CEBPB;TGFB1;EFNB3;KIF26B;RHOD;PRKCZ;MINK1;CD9;ADA;ERBB2;JAK3;NET1;PRKCD;NID1;ADAM15;PPARA;FYN;RAC3;DNM2;PELI1;HLA-G;PAK1;HYAL1;ITGA3;PKD1;ITGA4;HFE;ZP3;ITPKB
13123,GO:0051693,0.069602870244616,0.979085201082235,5,21,actin filament capping,BP,TMOD2;TWF2;GSN;SPTB;CAPG
11266,GO:0045582,0.069609941755287,0.971331576400939,8,42,positive regulation of T cell differentiation,BP,RAG1;AP3D1;ADAM8;TGFB1;PRKCZ;ADA;HLA-G;ITPKB
4806,GO:0012506,0.0696962151403137,0.946892366485789,67,527,vesicle membrane,CC,DLG4;WNT7A;APOE;ITPR3;EGFR;NOS1;PTPRS;SLC2A3;SNX9;GAA;MCTP1;LRP1;HBEGF;AP2A2;STOM;SYT8;BSG;DYSF;SLC15A4;IFNGR2;RAB31;LDLR;RAC2;KCNAB2;CEACAM1;PLAU;BRI3;RAB3B;DBNDD1;DGKQ;CEMIP;PKD2;ADAM8;WNT3;CLTCL1;SCYL1;SNTB2;ULK2;TMEM173;SNX17;SNX33;PI4K2A;RHOF;CD9;EPN2;AREG;VAMP2;MCFD2;SV2A;AHNAK2;ZDHHC8;LPCAT1;TGFA;SYNGR1;CD68;SUN1;DNM2;SNX15;HLA-G;RNF144A;SEMA4C;BCL2L1;ICA1;RAB40B;PDCD6;NBEAL2;MFSD10
3574,GO:0007622,0.0697553767831561,0.978887667862133,5,22,rhythmic behavior,BP,CST3;NAGLU;MTA1;ADA;AHCY
12229,GO:0048512,0.0697553767831561,0.978887667862133,5,22,circadian behavior,BP,CST3;NAGLU;MTA1;ADA;AHCY
10101,GO:0042624,0.0698091115191604,1,1,1,ATPase activity, uncoupled,MF,ATP6V1F
15699,GO:0072243,0.0699154269063892,0.982722772566219,4,15,metanephric nephron epithelium development,BP,WWTR1;PKD2;LAMB2;PKD1
16736,GO:0097756,0.0699730318827067,0.971210372363034,8,41,negative regulation of blood vessel diameter,BP,APLN;DOCK4;BBS2;F2R;EGFR;AKT1;EDNRA;HTR7
4661,GO:0010811,0.0700242602857601,0.963912083626281,13,78,positive regulation of cell-substrate adhesion,BP,VEGFA;ITGA6;ARL2;SMAD3;PPM1F;EPHA1;SMOC2;PRKCZ;NET1;NID1;RAC3;DNM2;ITGA3
19831,GO:2000273,0.0701880939018365,0.978718185991169,5,22,positive regulation of signaling receptor activity,BP,EPHB2;SHANK3;EREG;TGFA;HFE
4655,GO:0010801,0.0701891660350344,0.982631847862863,4,15,negative regulation of peptidyl-threonine phosphorylation,BP,SPRY2;DGKQ;DDIT4;SIRT2
17565,GO:1901099,0.0702668101197191,0.978687319197577,5,22,negative regulation of signal transduction in absence of ligand,BP,AKT1;STRADB;IFI6;FYN;BCL2L1
20292,GO:2001240,0.0702668101197191,0.978687319197577,5,22,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,AKT1;STRADB;IFI6;FYN;BCL2L1
8712,GO:0034367,0.070313943799371,0.98719045546811,3,10,protein-containing complex remodeling,BP,APOE;PLTP;ABCG1
6216,GO:0019751,0.0703653252664036,0.96267070433766,14,86,polyol metabolic process,BP,CYP27B1;ISYNA1;PLCD3;PLCH2;PLCG1;NTSR1;PCK2;INPP5D;COQ2;PLCB3;CYP2R1;GCH1;ITPKB;SPTLC2
16489,GO:0097186,0.0704893183720572,0.982531997721884,4,15,amelogenesis,BP,ITGA6;ITGB4;FAM20C;PPARA
3742,GO:0008284,0.0705016487314518,0.946120793615499,68,541,positive regulation of cell proliferation,BP,MEF2D;HTRA1;EGR1;CST3;APLN;PGF;VEGFA;WNT7A;F2R;LRP5;HMGA2;EGFR;WWTR1;MST1R;ETV5;SHC1;GLUL;MARCKSL1;GJC2;HBEGF;RNF187;AKT1;S100A6;EPHA1;VEGFB;ASH2L;PTHLH;FGFR4;FGFR1;RAC2;CCND1;GAS6;FGFBP1;CARD11;IGFBP2;CDC25B;PLXNB3;CTSZ;CD81;MVD;TGFB1;CD320;CEP131;MLXIPL;PRKCZ;ADA;AREG;ERBB2;JAK3;FBXW4;EREG;TGFBR3;IRAK1;TGFA;MIF;ECM1;PELI1;INSR;PAK1;HYAL1;BCL2L1;PROX1;LAMB1;PDCD6;TBC1D8;ZP3;FGFR3;PLAG1
7176,GO:0031065,0.0705420989505054,0.982514423054691,4,15,positive regulation of histone deacetylation,BP,VEGFA;CTBP1;TGFB1;C6ORF89
19513,GO:1990351,0.0707588927570093,0.958438019746723,19,124,transporter complex,CC,DLG4;KCNG1;SCN4B;NOS1;SHANK2;KCNC4;TTYH3;LRRC8A;KCNAB2;ABCA2;GRIN3B;SHANK3;PRKACA;VAMP2;CACNB3;OLFM2;SCN8A;ABCA7;DLG3
3081,GO:0006658,0.0708066393789234,0.978616044654483,5,21,phosphatidylserine metabolic process,BP,OSBPL5;LPCAT4;SERINC2;OSBPL10;SLC27A1
9372,GO:0035904,0.070840727225257,0.97295201431594,7,34,aorta development,BP,LOXL1;LTBP1;LRP1;PKD2;SNX17;DNM2;PROX1
17710,GO:1901605,0.0708443109021663,0.956586078356133,22,149,alpha-amino acid metabolic process,BP,NAGS;SLC6A8;NOS1;CRTAP;ALDH4A1;GLUL;PRODH;PYCR2;GGT1;GAMT;CBS;ERO1B;PHGDH;HMGCL;AHCY;MTHFR;CKMT1A;GPT2;ALDH7A1;NMNAT2;AZIN2;PHYKPL
17594,GO:1901216,0.0711160171236848,0.965651076361957,11,64,positive regulation of neuron death,BP,EGR1;PRNP;SSH1;FOS;PCSK9;CTSZ;BAX;ITGA1;DDIT4;CDC34;FYN
8395,GO:0033344,0.0711944464982372,0.97832273346529,5,22,cholesterol efflux,BP,APOE;PLTP;LRP1;ABCG1;ABCA7
5703,GO:0016831,0.0712895045007436,0.975251451552648,6,28,carboxy-lyase activity,MF,GLUL;MVD;PCK2;DDT;MLYCD;AZIN2
16268,GO:0090330,0.0713874666396225,0.982232268302396,4,15,regulation of platelet aggregation,BP,SERPINE2;CEACAM1;CD9;PRKCD
14198,GO:0061138,0.0713978003753822,0.957388030966931,20,131,morphogenesis of a branching epithelium,BP,PGF;CTNNBIP1;VEGFA;LRP5;SPRY2;NFATC4;ETV5;WNT2B;FGFR1;EDNRA;LAMA5;PKD2;CTSZ;TGFB1;AREG;VANGL2;PAK1;PROX1;PKD1;CELSR1
7321,GO:0031338,0.07141777335043,0.968611976405229,9,48,regulation of vesicle fusion,BP,EVI5L;VPS11;TBC1D14;TBC1D9B;VPS16;SGSM2;TBC1D16;RABGAP1;TBC1D8
10053,GO:0042542,0.0714435332379598,0.960147101420279,16,104,response to hydrogen peroxide,BP,CST3;SDC1;ENDOG;STAT6;IMPACT;MAPK13;BNIP3;ANKZF1;TRAP1;KDM6B;ADA;AREG;NET1;PRKCD;STK25;CAT
6690,GO:0030073,0.0715755590205438,0.957868769982022,19,126,insulin secretion,BP,NR1D1;ACVR2B;LRP5;ITPR3;HADH;ARL2;RAPGEF3;GLUL;NLGN2;PFKL;VGF;PCK2;PFKFB2;PLA2G6;PFKM;PPP3CB;ICA1;PCLO;SIRT3
10108,GO:0042632,0.0717192210904074,0.972458046449539,7,35,cholesterol homeostasis,BP,APOE;LRP5;LDLR;PCSK9;ABCA2;ABCG1;MALL
13510,GO:0055092,0.0717192210904074,0.972458046449539,7,35,sterol homeostasis,BP,APOE;LRP5;LDLR;PCSK9;ABCA2;ABCG1;MALL
10354,GO:0043174,0.0717299668263928,0.98190675097403,4,16,nucleoside salvage,BP,TK2;APRT;UCKL1;UPP1
790,GO:0002055,0.0719618128421074,1,1,1,adenine binding,MF,APRT
1589,GO:0003999,0.0719618128421074,1,1,1,adenine phosphoribosyltransferase activity,MF,APRT
1168,GO:0002790,0.0721883934730708,0.947959703375803,46,349,peptide secretion,BP,NR1D1;APLN;ACVR2B;POSTN;F2R;LRP5;IDH2;ITPR3;EGFR;HADH;LTBP4;LMF1;LTBP2;ARL2;RAPGEF3;GLUL;POU2F2;NLGN2;RHBDF2;HK1;MAPKBP1;PFKL;GAS6;RAB3B;CARD11;ALOX15B;ADAM8;TGFB1;VGF;LLGL1;PCK2;PFKFB2;PRKCZ;NECAB3;OLFM2;RASL10B;MIF;PLA2G6;MAPK3;PFKM;PPP3CB;ICA1;RAB40B;PCLO;SIRT3;HFE
6412,GO:0021680,0.0723719056860989,0.981902119052832,4,15,cerebellar Purkinje cell layer development,BP,NAGLU;B4GALT2;RERE;AARS
12738,GO:0051015,0.072400600703023,0.957349347048496,19,124,actin filament binding,MF,FLNC;ESPN;EGFR;OBSL1;CORO1B;SYNE3;TWF2;GSN;WIPF1;SPTB;TAGLN3;MICALL2;CAPG;FSCN1;TPM2;MYO1D;MYH15;BIN1;VPS16
15887,GO:0072657,0.072674957506366,0.945834387945547,56,458,protein localization to membrane,BP,ZMYND8;DLG4;PRNP;BBS2;APOE;EGFR;ETV5;SSH1;LRP1;DVL1;SH3PXD2B;NLGN2;STOM;AKT1;BSG;RAB31;SYNE3;PACS2;ANK3;TTC7B;SYNGAP1;GAS6;LAMA5;GSN;CEMIP;AP3D1;EPHB2;GRIN3B;TGFB1;MOAP1;SHANK3;TUB;BBS1;AGRN;LRP4;ZDHHC24;PRKCZ;OXA1L;ERBB2;VAMP2;TFDP2;RILPL1;ARHGAP44;CACNB3;BAX;GDI1;REEP2;EHD3;FYN;ZDHHC1;PAK1;ITGA3;BCL2L1;DLG3;ITGA4;RAB40B
10425,GO:0043277,0.0728694973967134,0.974558246778275,6,28,apoptotic cell clearance,BP,LRP1;PEAR1;RAC2;GAS6;ABCA7;RAC3
15137,GO:0071243,0.0729258256487059,0.981500378001424,4,16,cellular response to arsenic-containing substance,BP,UROS;MAPK13;MKNK2;GSTO1
16275,GO:0090343,0.0731782208732268,0.98644140164367,3,10,positive regulation of cell aging,BP,HMGA2;YPEL3;LMNA
2298,GO:0005272,0.0733805932876423,0.981562088129375,4,15,sodium channel activity,MF,SCN4B;PKD2;ASIC1;SCN8A
4594,GO:0010711,0.0734444340953886,1,1,1,negative regulation of collagen catabolic process,BP,CST3
13726,GO:0060309,0.0734444340953886,1,1,1,elastin catabolic process,BP,CST3
13727,GO:0060310,0.0734444340953886,1,1,1,regulation of elastin catabolic process,BP,CST3
13728,GO:0060311,0.0734444340953886,1,1,1,negative regulation of elastin catabolic process,BP,CST3
2751,GO:0006165,0.073706488991994,0.960596708194257,14,87,nucleoside diphosphate phosphorylation,BP,PGM1;NME4;HK1;PFKL;PFKP;DHTKD1;PFKFB2;MLXIPL;DDIT4;ALDOC;PPARA;INSR;PFKM;PFKFB3
4889,GO:0014810,0.0738223414578061,1,1,1,positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,BP,GSTO1
6791,GO:0030239,0.073952292584408,0.974080675596635,6,28,myofibril assembly,BP,OBSCN;OBSL1;TMOD2;TNNT1;FHOD3;PROX1
4086,GO:0009142,0.0741046127170036,0.956863874299621,18,120,nucleoside triphosphate biosynthetic process,BP,PGM1;NME4;HK1;PFKL;PFKP;DHTKD1;TGFB1;PFKFB2;MLXIPL;UCKL1;CYC1;DDIT4;ALDOC;PPARA;INSR;TAZ;PFKM;PFKFB3
3128,GO:0006720,0.0743195182748299,0.962480002042999,12,72,isoprenoid metabolic process,BP,APOE;EGFR;SDC1;LRP1;SRD5A3;RETSAT;MVD;GPC1;AGRN;COQ2;PHYH;SDC2
596,GO:0001764,0.0744557428833667,0.960183283024343,14,85,neuron migration,BP,VEGFA;FGFR1;GAS6;UNK;NSMF;SDCCAG8;BAX;DDIT4;FYN;ITGA3;MDGA1;NDE1;CELSR1;TRIM46
13887,GO:0060541,0.0745117020902861,0.95527978134893,20,132,respiratory system development,BP,ACVR2B;VEGFA;EGFR;SPRY2;MAP2K1;EPAS1;WNT2B;FGFR1;LAMA5;ERRFI1;CTSZ;ADA;MAPK3;VANGL2;ITGA3;PROX1;PKD1;EDA;HSD11B1;CELSR1
15100,GO:0071156,0.0745712158458144,0.95905253030908,15,96,regulation of cell cycle arrest,BP,HMGA2;ZNF385A;CCND1;PCBP4;PKD2;TGFB1;MLXIPL;PRKACA;TFDP2;RBL2;BAX;CHEK2;MIF;BIN1;PPP2R5B
10790,GO:0044272,0.0747395338087497,0.954467395644074,21,143,sulfur compound biosynthetic process,BP,HSD17B8;GGT1;OPLAH;B4GAT1;CBR4;HAGH;CBS;B3GNT3;B4GALT2;B4GALT6;CNDP2;AHCY;PDK1;XYLT2;GSTO1;ST3GAL3;MLYCD;NDST2;ST3GAL2;CHST14;CHPF
17396,GO:1900120,0.0748834197437515,0.980829774021703,4,16,regulation of receptor binding,BP,PHLDA2;PCSK9;ADAM15;HFE
14871,GO:0070663,0.0749873883481743,0.956281735627639,18,120,regulation of leukocyte proliferation,BP,PRNP;PKN1;RAC2;CARD11;IGFBP2;IL20RB;CD81;CEBPB;TGFB1;CD320;ADA;ERBB2;JAK3;INPP5D;MIF;PELI1;HLA-G;ZP3
608,GO:0001777,0.0749891056520614,1,1,1,T cell homeostatic proliferation,BP,BAX
945,GO:0002358,0.0749891056520614,1,1,1,B cell homeostatic proliferation,BP,BAX
8209,GO:0032976,0.0749891056520614,1,1,1,release of matrix enzymes from mitochondria,BP,BAX
16463,GO:0097144,0.0749891056520614,1,1,1,BAX complex,CC,BAX
19463,GO:1990117,0.0749891056520614,1,1,1,B cell receptor apoptotic signaling pathway,BP,BAX
4708,GO:0010872,0.0752701711312054,0.992455632977115,2,5,regulation of cholesterol esterification,BP,APOE;ABCG1
5815,GO:0017080,0.0753526020140833,0.976669806637546,5,22,sodium channel regulator activity,MF,SCN4B;NOS1;PRSS8;PCSK9;SNTA1
7667,GO:0032103,0.0753789016897816,0.952868057496038,23,162,positive regulation of response to external stimulus,BP,TNIP1;CYP27B1;PGF;PDCD4;VEGFA;EGFR;SMAD3;ADORA2B;F12;PPM1F;VEGFB;LDLR;FGFR1;RAC2;MAPK13;GAS6;ADAM8;TGFB1;LRSAM1;MIF;DDT;MAPK3;ZP3
16852,GO:0098771,0.0757051320346109,0.944445697120522,50,388,inorganic ion homeostasis,BP,DLG4;CYP27B1;PRNP;APOE;F2R;ITPR3;EGFR;NOS1;HEXB;SLC7A8;SLC12A7;LPAR3;SMAD3;EPAS1;CYBRD1;TPCN1;FGFR4;ANK3;EDNRA;BNIP3;CEMIP;PKD2;AP3D1;PLCG1;TGFB1;NTSR1;ATP7B;RASA3;PRKACA;BOK;TRPC1;SLC22A17;CACNB3;BAX;SV2A;MT2A;GSTO1;BCAP31;SLC9A7;PLA2G6;WFS1;FYN;SLC12A4;MAPK3;GRINA;PKD1;SLC25A37;ATP6V1F;HFE;SLC26A11
9865,GO:0042130,0.0757727745367633,0.970521880443221,7,35,negative regulation of T cell proliferation,BP,PRNP;IL20RB;CEBPB;TGFB1;ERBB2;PELI1;HLA-G
8036,GO:0032692,0.0759249045206267,0.980470299037526,4,16,negative regulation of interleukin-1 production,BP,ACP5;CEACAM1;GAS6;ERRFI1
6046,GO:0019184,0.0761434729518205,0.980394622441305,4,16,nonribosomal peptide biosynthetic process,BP,GGT1;OPLAH;HAGH;CNDP2
462,GO:0001501,0.0762463433690306,0.945679032694697,42,312,skeletal system development,BP,MEF2D;ACVR2B;BBS2;POSTN;WNT7A;LRP5;HMGA2;HEXB;MDFI;ACP5;SMAD3;THBS3;SH3PXD2B;IFT140;PTHLH;WNT2B;FGFR1;ZNF385A;IGFBP4;EVC;COL13A1;NPR2;TGFB1;ADAMTS7;DEAF1;SLC38A10;NAB2;FAM20C;FBXW4;CHADL;CHAD;WDR60;ZFPM1;ARID5B;MAPK3;TRIM45;HYAL1;HES7;PKD1;SLC39A3;FGFR3;LRRK1
7648,GO:0032075,0.0765091812362962,0.980267817752411,4,16,positive regulation of nuclease activity,BP,AKT1;PTPN1;PRKCD;BAX
10883,GO:0044431,0.0767390632490503,0.939056690965383,89,718,Golgi apparatus part,CC,B4GALNT4;EDEM1;POSTN;WNT7A;ANGEL1;EGFR;SDC1;SNX9;ST6GALNAC2;ARAP1;MARCH9;PITPNM1;ENTPD6;BSG;ASAP2;MARCH4;IFNGR2;RAB31;B4GAT1;SORL1;B3GAT3;TRAPPC9;GAS6;CORO7;CTSZ;GPSM1;AP3D1;WNT3;TGFB1;CLTCL1;SCYL1;GPC1;B3GNT3;ATP7B;PODXL2;MGAT4B;GOLGA2P5;ST6GALNAC6;PI4K2A;LLGL1;B4GALT2;AGRN;B4GALT6;RFNG;AREG;BOK;VAMP2;C6ORF89;NECAB3;MCFD2;XYLT2;TMBIM4;MBTPS2;PCSK1N;MFNG;LPCAT1;ST3GAL3;TGFA;PI4K2B;COG7;ABCG1;ABCA7;RAB12;BCAP31;DOPEY2;SLC9A7;QSOX1;SPPL2B;STK25;DNM2;SLC50A1;HLA-G;STX10;MALL;SAMD8;SLC16A13;NDST2;PKD1;GAL3ST4;NMNAT2;AZIN2;ST3GAL2;ICA1;PDCD6;CHST14;VPS51;ST3GAL5;CHPF;SDC2
11095,GO:0045117,0.0768218734924333,0.980159214594606,4,16,azole transport,BP,SLC15A4;ADA;SLC25A29;SLC35F3
13499,GO:0055080,0.0768250837460354,0.94374357750457,49,380,cation homeostasis,BP,DLG4;CYP27B1;PRNP;APOE;F2R;ITPR3;EGFR;NOS1;HEXB;SLC7A8;SLC12A7;LPAR3;SMAD3;EPAS1;CYBRD1;TPCN1;ANK3;EDNRA;BNIP3;CEMIP;PKD2;AP3D1;PLCG1;TGFB1;NTSR1;ATP7B;RASA3;PRKACA;BOK;TRPC1;SLC22A17;CACNB3;BAX;SV2A;MT2A;GSTO1;BCAP31;SLC9A7;PLA2G6;WFS1;FYN;SLC12A4;MAPK3;GRINA;PKD1;SLC25A37;ATP6V1F;HFE;SLC26A11
9661,GO:0038024,0.076835163433407,0.96767372255841,8,42,cargo receptor activity,MF,LRP1;AP2A2;LDLR;SORL1;SCART1;LRP10;ABCA7;LGALS3BP
10309,GO:0043096,0.0769375687214849,0.992189456073181,2,5,purine nucleobase salvage,BP,APRT;ADA
15218,GO:0071377,0.0769569995728911,0.976024002811373,5,22,cellular response to glucagon stimulus,BP,PRKACB;PRKACA;ADCY1;ADCY7;ADCY6
2536,GO:0005795,0.0770409715674692,0.954971820723047,18,117,Golgi stack,CC,B4GALNT4;ARAP1;MARCH9;PITPNM1;ASAP2;MARCH4;SORL1;GOLGA2P5;LLGL1;B4GALT2;B4GALT6;NECAB3;TMBIM4;ST3GAL3;BCAP31;GAL3ST4;ST3GAL2;CHPF
8648,GO:0034205,0.077052003176139,0.975985623434772,5,22,amyloid-beta formation,BP,PRNP;APOE;SORL1;ABCA7;BIN1
11698,GO:0046500,0.0771571620418538,0.985378510506305,3,10,S-adenosylmethionine metabolic process,BP,GAMT;AHCY;MTHFR
3967,GO:0008768,0.0771998966772622,1,1,1,UDP-sugar diphosphatase activity,MF,NUDT14
1785,GO:0004407,0.07724572430208,0.967463290637919,8,42,histone deacetylase activity,MF,MTA1;HDAC5;HMG20B;PHF21A;MBD3;HDAC7;SIRT2;SIRT3
7099,GO:0030902,0.0772634199195532,0.958420265483796,14,86,hindbrain development,BP,WNT7A;NAGLU;SERPINE2;PTPRS;TRNP1;MAP2K1;CNTN1;B4GALT2;RERE;PAK1;SEMA4C;PROX1;SOCS7;AARS
11414,GO:0045838,0.0775054825475598,0.985284243335294,3,10,positive regulation of membrane potential,BP,AKT1;ANK3;GLRX
710,GO:0001936,0.0776022059147143,0.95928677339822,13,80,regulation of endothelial cell proliferation,BP,XDH;APLN;PGF;VEGFA;APOE;AKT1;VEGFB;FGFR1;PLXNB3;ECM1;PROX1;NGFR;PDCD6
12608,GO:0050801,0.0777910662405224,0.942104741715373,54,423,ion homeostasis,BP,FHL1;DLG4;CYP27B1;PRNP;APOE;F2R;ITPR3;EGFR;NOS1;HEXB;SLC7A8;SLC12A7;LPAR3;SMAD3;EPAS1;CYBRD1;TPCN1;FGFR4;ANK3;EDNRA;BNIP3;CEMIP;PKD2;AP3D1;PLCG1;TGFB1;NTSR1;ATP7B;RASA3;MLXIPL;PRKACA;BOK;TRPC1;SLC22A17;CACNB3;IFI6;BAX;SV2A;MT2A;GSTO1;ABCG1;BCAP31;SLC9A7;PLA2G6;WFS1;FYN;SLC12A4;MAPK3;GRINA;PKD1;SLC25A37;ATP6V1F;HFE;SLC26A11
6673,GO:0030042,0.0777917368353747,0.969547251797972,7,35,actin filament depolymerization,BP,TMOD2;TWF2;GSN;SPTB;CAPG;SH3BP1;MICAL1
1106,GO:0002694,0.0778257102688068,0.945450366983515,38,283,regulation of leukocyte activation,BP,PRNP;PKN1;ZFP36L1;STAT6;PAG1;ADORA2B;AKT1;LDLR;RAC2;RAG1;CEACAM1;GAS6;CARD11;SOX13;GSN;IGFBP2;BCR;IL20RB;AP3D1;ADAM8;CD81;CEBPB;TGFB1;EFNB3;CD320;PRKCZ;ADA;ERBB2;JAK3;INPP5D;MIF;FYN;PELI1;HLA-G;PAK1;HFE;ZP3;ITPKB
3520,GO:0007498,0.0778614815227229,0.960414558117211,12,71,mesoderm development,BP,ACVR2B;VEGFA;HMGA2;ZFP36L1;SMAD3;ITGB4;FGFR1;WNT3;KDM6B;RPS6KA6;HES7;ITGA3
767,GO:0002021,0.0779607196332209,0.985160747156454,3,10,response to dietary excess,BP,APOE;VGF;PCSK1N
17397,GO:1900121,0.0780071398134584,0.985148135668038,3,10,negative regulation of receptor binding,BP,PCSK9;ADAM15;HFE
7410,GO:0031507,0.0781549182672549,0.985107964054474,3,10,heterochromatin assembly,BP,HMGA2;BAHCC1;TNRC18
8705,GO:0034358,0.0784013972758989,0.97940382918317,4,17,plasma lipoprotein particle,CC,APOE;PLTP;LDLR;SORL1
19637,GO:1990777,0.0784013972758989,0.97940382918317,4,17,lipoprotein particle,CC,APOE;PLTP;LDLR;SORL1
11508,GO:0046033,0.0786302241253079,0.984978521456719,3,10,AMP metabolic process,BP,NT5E;APRT;AK3
15277,GO:0071466,0.0787550831756929,0.955439145310849,16,105,cellular response to xenobiotic stimulus,BP,EGR1;AKR7A2;EGFR;GGT1;BPHL;ERRFI1;AIP;ACY1;TGFB1;PCK2;DDIT4;CES2;GSTO1;CHEK2;CYP3A5;CYP2R1
453,GO:0001227,0.0787739656147249,0.950021949699673,24,164,transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding,MF,NR1D1;HMGA2;NFATC4;TCFL5;FOXQ1;MXI1;TSHZ1;MYEF2;HES2;MNT;CEBPB;ZNF217;DEAF1;MLXIPL;RBL2;ZFPM1;PPARA;ARID5B;BHLHE40;SATB1;HES6;PROX1;BACH1;NR2F6
14014,GO:0060749,0.079023363976996,0.984871182803611,3,10,mammary gland alveolus development,BP,VEGFA;CCND1;AREG
14281,GO:0061377,0.079023363976996,0.984871182803611,3,10,mammary gland lobule development,BP,VEGFA;CCND1;AREG
10022,GO:0042472,0.0790569472939491,0.964479650971676,9,49,inner ear morphogenesis,BP,SPRY2;DVL1;FGFR1;BCR;SLITRK6;EPHB2;VANGL2;PROX1;CELSR1
11364,GO:0045740,0.0793410669615791,0.966319431729324,8,43,positive regulation of DNA replication,BP,CST3;EGFR;SHC1;FGFR1;AREG;EREG;INSR;KCTD13
7396,GO:0031467,0.0794753164210935,0.991777476056366,2,5,Cul7-RING ubiquitin ligase complex,CC,FBXW8;CUL7
6969,GO:0030638,0.0797566663078367,0.99173129384791,2,5,polyketide metabolic process,BP,AKR7A2;CBR4
6973,GO:0030647,0.0797566663078367,0.99173129384791,2,5,aminoglycoside antibiotic metabolic process,BP,AKR7A2;CBR4
10931,GO:0044597,0.0797566663078367,0.99173129384791,2,5,daunorubicin metabolic process,BP,AKR7A2;CBR4
10932,GO:0044598,0.0797566663078367,0.99173129384791,2,5,doxorubicin metabolic process,BP,AKR7A2;CBR4
734,GO:0001965,0.0798696747486694,0.979091983810844,4,16,G-protein alpha-subunit binding,MF,F2R;LPAR3;RGS14;RGS19
12406,GO:0048864,0.0798851569208842,0.962186417843258,10,57,stem cell development,BP,SEMA4B;WNT7A;EDNRA;SEMA3F;LAMA5;SEMA4F;MAPK3;SEMA4C;PDCD6;SEMA3B
507,GO:0001570,0.0798908756162978,0.964028480248229,9,49,vasculogenesis,BP,XDH;VEGFA;WNT7A;ZFP36L1;CEACAM1;TGFB1;TGFBR3;HDAC7;CUL7
5132,GO:0015629,0.0799818080718579,0.941875731403211,46,349,actin cytoskeleton,CC,H1F0;PARVB;PGM1;ESPN;OBSL1;CAPN2;MST1R;RAPGEF3;MPRIP;SH3PXD2B;TMOD2;CORO1B;MYZAP;RAC2;TNNT1;TWF2;GSN;WIPF1;SPTB;PKD2;SH3PXD2A;ADAM8;FHOD3;CROCC;LLGL1;MYH16;PRKCZ;ACTR1B;MICALL2;CAPG;SMTN;FSCN1;TPM2;FHOD1;MYO1D;MYH15;SPPL2B;FYN;RAC3;VANGL2;PAK1;BIN1;AFAP1L1;PXN;LURAP1;HFE
4233,GO:0009415,0.0800380101177636,0.98459301714919,3,10,response to water,BP,PKD2;CD9;LRP11
2381,GO:0005518,0.0801024078636021,0.965991622890163,8,42,collagen binding,MF,MRC2;SMAD3;CTSB;ITGA1;CHADL;NID1;PAK1;ITGA3
774,GO:0002031,0.080182537770034,0.984553261740477,3,10,G-protein coupled receptor internalization,BP,APLN;DNM1;DNM2
4269,GO:0009628,0.0803369001729045,0.934885202335039,105,868,response to abiotic stimulus,BP,ERCC1;EGR1;PLAT;CST3;PGF;XPC;POSTN;VEGFA;LRP5;HMGA2;NDRG1;PKN1;MTA1;EGFR;SERPINE2;NOS1;CAPN2;NFATC4;DDB2;ZFP36L1;ENDOG;FOS;SMAD3;ERCC6;EPAS1;AKT1;PITPNM1;STK39;VEGFB;IMPACT;LRRC8A;BRSK1;NPHP4;RAG1;CIRBP;CCND1;SYNGAP1;MAPK13;EDNRA;PLAU;IGFBP2;ANGPTL4;ERRFI1;SLITRK6;BNIP3;PKD2;CRTC1;ADAM8;ASIC1;TGFB1;DEAF1;NTSR1;SHANK3;NSMF;MC1R;VGF;B4GALT2;VHL;PRKACA;ZNF516;CD9;ADA;AHCY;PRIMPOL;NET1;BNIP3L;PDK1;CYGB;REEP6;STUB1;BAX;DDIT4;PPL;PCSK1N;TGFBR3;RGS14;IRAK1;MTHFR;CHEK2;PPARA;TMEM161A;FYN;EEF2K;SUN1;DNM2;BHLHE40;CAT;IGFBP7;SLC27A1;CYP2R1;MAPK3;PAK1;REV1;HYAL1;DNMT3A;BCL2L1;LMNA;PKD1;SIRT2;UVSSA;BACH1;PDCD6;NR2F6;TERC;LRP11
6332,GO:0021510,0.0805101648374005,0.963692738174271,9,49,spinal cord development,BP,PTPRS;ADARB1;AKT1;PKD2;SOX12;PROX1;MDGA1;PKD1;TCTN1
3266,GO:0006941,0.0805918966876378,0.957459263613463,13,80,striated muscle contraction,BP,SCN4B;OBSL1;NOS1;GAA;VEGFB;TNNT1;SNTA1;PRKACA;PPP1R13L;GSTO1;EHD3;TAZ;MAP2K3
5284,GO:0015937,0.0806824629645989,0.98441549140379,3,10,coenzyme A biosynthetic process,BP,ACOT7;PANK4;PPCS
2704,GO:0006081,0.0807875919297926,0.961632937316367,10,58,cellular aldehyde metabolic process,BP,H6PD;IDH2;AKR7A2;ALDH4A1;PGLS;HAGH;GRHPR;PDXK;ALDH7A1;KDM3A
2971,GO:0006516,0.0807950498649745,0.978764860909851,4,16,glycoprotein catabolic process,BP,EDEM1;CST3;FBXO2;GPC1
7034,GO:0030814,0.0808613260893045,0.970873591499482,6,29,regulation of cAMP metabolic process,BP,RAPGEF3;PTHLH;PKD2;TIMP2;LTB4R2;GABBR1
17256,GO:0120034,0.0809423731910719,0.958542316098061,12,72,positive regulation of plasma membrane bounded cell projection assembly,BP,ZMYND8;ESPN;ARAP1;RAC2;TENM2;TWF2;CDC42EP5;CROCC;AGRN;FSCN1;DNM2;PLEKHM1
12050,GO:0048009,0.0810790787870663,0.974344715597691,5,22,insulin-like growth factor receptor signaling pathway,BP,AKT1;IGFBP4;IGFBP2;GIGYF1;GRB10
5547,GO:0016540,0.0810929923823479,0.984302061283807,3,10,protein autoprocessing,BP,CAPN2;F12;PCSK9
12588,GO:0050773,0.0811650532384159,0.953938079612342,16,102,regulation of dendrite development,BP,ZMYND8;APOE;OBSL1;PTPRS;NFATC4;SHANK2;CRTC1;FBXW8;SHANK3;NSMF;ARHGAP44;EEF2K;CUL7;CAPRIN2;CAMK1;SDC2
4619,GO:0010739,0.0812578450052866,0.991483177892324,2,5,positive regulation of protein kinase A signaling,BP,MC1R;MIF
2588,GO:0005884,0.0812771025234294,0.958308719814212,12,73,actin filament,CC,ESPN;CORO1B;RAC2;TWF2;WIPF1;PKD2;PRKCZ;FSCN1;TPM2;FYN;RAC3;PAK1
9846,GO:0042098,0.0812901558609608,0.953796036397238,16,105,T cell proliferation,BP,PRNP;RAC2;CARD11;IGFBP2;IL20RB;CEBPB;TGFB1;ERBB2;JAK3;BAX;FYN;PELI1;SATB1;HLA-G;PPP3CB;ZP3
10949,GO:0044703,0.0813365856374026,0.93715015539015,69,550,multi-organism reproductive process,BP,ERCC1;CST3;CYP27B1;PGF;BBS2;SERPINE2;MST1R;CRTAP;ETV5;HEXB;TCFL5;TXNRD3;SMURF2;FOS;FBLN1;SH3PXD2B;SYT8;AKT1;BSG;SCMH1;GGT1;PHC2;PTHLH;GAMT;CCNI;MICALCL;CTSB;IGFBP2;CDC25B;NPR2;EPOR;WNT3;TGFB1;RFX2;DEAF1;MYCBPAP;DNAH1;VGF;CEP131;PRKACA;CD9;ADA;PIM2;TDRKH;FAM50A;BAX;SBF1;EREG;RPL39L;SPATA20;SIX5;BCAP31;PLA2G6;SUN1;DNM2;IGFBP7;ITGA3;DNMT3A;BCL2L1;SIRT2;ADCY7;AZIN2;MAFF;HFE;BTG1;ZP3;SEPT6;PRSS21;KDM3A
13973,GO:0060696,0.0814143180200831,0.991457150995776,2,5,regulation of phospholipid catabolic process,BP,LDLR;PRKCD
7650,GO:0032077,0.081606618938731,0.991425122111097,2,5,positive regulation of deoxyribonuclease activity,BP,AKT1;PRKCD
12771,GO:0051055,0.0818431860157684,0.967485540372736,7,36,negative regulation of lipid biosynthetic process,BP,CYP27B1;APOE;CEACAM1;LPCAT1;SLC27A1;WDTC1;PROX1
10362,GO:0043184,0.082156362173683,0.991333300393882,2,5,vascular endothelial growth factor receptor 2 binding,MF,VEGFA;VEGFB
11132,GO:0045185,0.0822272423297442,0.955242421525279,14,89,maintenance of protein location,BP,LTBP1;ARL2;MDFI;AKT1;HK1;MXI1;SYNE3;SORL1;ANK3;TWF2;GSN;PKD2;SUN1;PKD1
13925,GO:0060600,0.0822282491488698,0.98398700394402,3,10,dichotomous subdivision of an epithelial terminal unit,BP,AREG;VANGL2;CELSR1
11940,GO:0047035,0.0822570367962179,1,1,1,testosterone dehydrogenase (NAD+) activity,MF,HSD17B8
7854,GO:0032421,0.0822872830315299,0.970222843212831,6,29,stereocilium bundle,CC,DOCK4;BBS2;ESPN;TWF2;MORN4;HOMER2
3043,GO:0006601,0.082748118778134,1,1,1,creatine biosynthetic process,BP,GAMT
7013,GO:0030731,0.082748118778134,1,1,1,guanidinoacetate N-methyltransferase activity,MF,GAMT
7096,GO:0030899,0.0828233562335269,1,1,1,calcium-dependent ATPase activity,MF,TNNT1
7148,GO:0031014,0.0828233562335269,1,1,1,troponin T binding,MF,TNNT1
7384,GO:0031444,0.0828233562335269,1,1,1,slow-twitch skeletal muscle fiber contraction,BP,TNNT1
7799,GO:0032355,0.082879347507122,0.956023560849392,13,81,response to estradiol,BP,CST3;POSTN;FAM210B;WNT7A;EGFR;ENDOG;CCND1;IGFBP2;TGFB1;MBD3;AREG;CAT;DNMT3A
11331,GO:0045665,0.0828931896305503,0.948858940614644,21,143,negative regulation of neuron differentiation,BP,SEMA4B;APOE;PTPRS;NFATC4;LRP1;SYNGAP1;SEMA3F;CTSZ;EPHB2;WNT3;ULK2;EFNB3;SEMA4F;LRP4;DGUOK;GDI1;SEMA4C;RAP1GAP2;NGFR;SEMA3B;ADCY6
11082,GO:0045091,0.0829165534844433,0.983794999047272,3,10,regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,HMGA2;APOBEC3C;APOBEC3F
1675,GO:0004138,0.082936054852859,1,1,1,deoxyguanosine kinase activity,MF,DGUOK
3933,GO:0008617,0.082936054852859,1,1,1,guanosine metabolic process,BP,DGUOK
11506,GO:0046031,0.0829584997402967,0.956003759815584,13,80,ADP metabolic process,BP,PGM1;HK1;PFKL;PFKP;DHTKD1;PFKFB2;MLXIPL;DDIT4;ALDOC;PPARA;INSR;PFKM;PFKFB3
2316,GO:0005319,0.0830209528553311,0.9559652453217,13,80,lipid transporter activity,MF,APOE;OSBPL5;PITPNC1;PLTP;PITPNM1;CEACAM1;ABCD1;OSBPL10;ABCG1;ABCA7;PITPNM3;SLC27A1;ATP8B2
12262,GO:0048568,0.0833977639461966,0.941490131437851,37,273,embryonic organ development,BP,ERCC1;VEGFA;NAGLU;EGFR;SPRY2;PHLDA2;ZFP36L1;PLCD3;MDFI;MAP2K1;SMAD3;DVL1;EPAS1;AKT1;IFT140;FGFR1;TSHZ1;SH2B3;BCR;SLITRK6;PKD2;FBXW8;EPHB2;CEBPB;TGFB1;MBD3;ADA;PPP1R13L;WDR60;ZFPM1;MAPK3;VANGL2;HYAL1;PROX1;PKD1;SLC39A3;CELSR1
3746,GO:0008289,0.0835190820831329,0.936867677973131,58,455,lipid binding,MF,HS1BP3;EPN3;APOE;DGKA;OSBPL5;PITPNC1;ITPR3;NISCH;SYTL1;SHC1;SNX9;ARAP1;NME4;LPAR3;PLTP;MCTP1;AP2A2;SH3PXD2B;SYT8;AKT1;GRB7;PITPNM1;DYSF;SEC14L2;TWF2;ACBD4;GAS6;PAQR6;ALOX15B;AGAP1;UNC119B;MVB12B;SH3PXD2A;ARAP3;TUB;SNX17;SNX33;OSBPL10;ESYT2;ADAP1;EPN2;VAMP2;PLEK2;RASA4;ARHGAP44;BAX;PPARA;ABCG1;PITPNM3;SNX15;IQSEC1;TRIP10;HSD11B1;PCLO;RNASE7;WIPI2;PFN2;GSDMA
10887,GO:0044438,0.0835267475082115,0.956922013706959,12,74,microbody part,CC,CRAT;MAP2K2;PRDX5;ABCD1;PEX10;PEX1;GRHPR;LONP2;DECR2;PHYH;CAT;MLYCD
10888,GO:0044439,0.0835267475082115,0.956922013706959,12,74,peroxisomal part,CC,CRAT;MAP2K2;PRDX5;ABCD1;PEX10;PEX1;GRHPR;LONP2;DECR2;PHYH;CAT;MLYCD
17942,GO:1902259,0.0835630902291345,0.983613969898605,3,10,regulation of delayed rectifier potassium channel activity,BP,KCNG1;ANK3;VAMP2
3063,GO:0006631,0.0835876544896378,0.941940294067826,35,261,fatty acid metabolic process,BP,TYSND1;CRAT;ACOT7;ACSF2;HADH;CRYL1;CPT2;HSD17B8;AKT1;GGT1;ACOT1;CEACAM1;CBR4;ABCD1;AIG1;ALOX15B;PCK2;MLXIPL;PDK1;ACAD10;CYGB;ACADS;CES2;LONP2;DECR2;PPARA;SESN2;MIF;PHYH;ETFB;SLC27A1;MAPK3;MLYCD;WDTC1;PTGR2
3245,GO:0006907,0.083785714497305,0.977697939191477,4,16,pinocytosis,BP,MAPKAPK3;EHD4;SNX33;DNM2
16906,GO:0098869,0.0838567748196972,0.959684120158214,10,63,cellular oxidant detoxification,BP,APOE;TXNRD3;PRDX5;CCS;GPX3;CYGB;GSTO1;SESN2;CAT;GCH1
8764,GO:0034451,0.0839825166945213,0.973144862789524,5,22,centriolar satellite,CC,CCDC113;CEP131;SDCCAG8;CEP72;MSS51
15132,GO:0071230,0.0841214183506893,0.961665901809897,9,50,cellular response to amino acid stimulus,BP,EGFR;CAPN2;CEBPB;NSMF;SESN2;FYN;DNMT3A;BCL2L1;COL6A1
9900,GO:0042226,0.084130314066902,0.983454610933083,3,10,interleukin-6 biosynthetic process,BP,CEBPB;EREG;INPP5D
7122,GO:0030952,0.0841632791909152,0.9775621963387,4,16,establishment or maintenance of cytoskeleton polarity,BP,RHOD;RHOF;RHOBTB2;LMNA
13351,GO:0052547,0.0842293109007346,0.940782074558064,37,287,regulation of peptidase activity,BP,XDH;CST3;VEGFA;TNFRSF6B;F2R;GRAMD4;SERPINE2;FBLN1;SMAD3;PRDX5;AKT1;PPM1F;SERPING1;DAP;RAG1;SORL1;GAS6;GSN;TFPI2;TIMP2;TNFSF15;BOK;CYFIP2;IFI6;BAX;PCSK1N;MAPK12;SOX7;BCAP31;ECM1;FYN;MAPK3;MICAL1;BIN1;SERPINB1;NGFR;PDCD6
14135,GO:0061024,0.0842541127022166,0.933346743882374,82,666,membrane organization,BP,ZMYND8;DLG4;MARVELD1;APOE;NDRG1;NEK9;EVI5L;EGFR;VAT1;SYTL1;ETV5;VPS11;TBC1D14;SNX9;SSH1;DVL1;AP2A2;NLGN2;REEP4;SYT8;AKT1;DYSF;LDLR;RAC2;ANK3;TRAPPC9;GAS6;GSN;BNIP3;CTSZ;AP3D1;GRIN3B;SYNJ2;CLTCL1;MOAP1;TBC1D9B;ARHGAP25;SHANK3;SNX33;AGRN;LRP4;OXA1L;CD9;EPN2;AREG;BOK;VAMP2;TFDP2;RILPL1;BNIP3L;ARHGAP44;MCFD2;PRKCD;BAX;SH3BP1;AHNAK2;FCHO1;LEMD2;DNM1;REEP2;TGFA;ABCA7;SYNGR1;RAC3;SUN1;ARHGAP12;DNM2;TAZ;STX10;ATP8B2;MALL;BIN1;VPS16;BCL2L1;SGSM2;TBC1D16;LMNA;RABGAP1;TRIP10;AZIN2;PDCD6;TBC1D8
12216,GO:0048484,0.0843602720284335,0.990961352331167,2,5,enteric nervous system development,BP,EDNRA;KIF26A
11684,GO:0046479,0.0845432908640104,0.983338271839581,3,10,glycosphingolipid catabolic process,BP,HEXB;PRKCD;NAGA
14258,GO:0061333,0.0845923627441721,0.96140727493651,9,50,renal tubule morphogenesis,BP,PGF;CTNNBIP1;VEGFA;WNT2B;LAMA5;PKD2;TGFB1;KIF26B;PKD1
15599,GO:0072088,0.0845923627441868,0.961407274936495,9,50,nephron epithelium morphogenesis,BP,PGF;CTNNBIP1;VEGFA;WNT2B;LAMA5;PKD2;TGFB1;KIF26B;PKD1
7741,GO:0032262,0.0846013290986884,0.990920298261076,2,5,pyrimidine nucleotide salvage,BP,UCKL1;UPP1
20048,GO:2000651,0.0846183727021926,0.983317092161702,3,10,positive regulation of sodium ion transmembrane transporter activity,BP,ANK3;DNM2;GLRX
6512,GO:0021894,0.0847496503481873,1,1,1,cerebral cortex GABAergic interneuron development,BP,RAC3
12506,GO:0050655,0.0849612070146988,0.983220271525606,3,10,dermatan sulfate proteoglycan metabolic process,BP,B3GAT3;IDUA;CHST14
6245,GO:0019825,0.0853119590918909,0.983121026173528,3,10,oxygen binding,MF,CBS;CYGB;CYP3A5
16623,GO:0097479,0.085332750864974,0.954535827951343,13,80,synaptic vesicle localization,BP,SYTL1;NLGN2;SYT8;AP3D1;SNPH;RIMS3;VAMP2;DNM1;DNM2;PCLO;PFN2;BLOC1S4;TRIM46
15886,GO:0072656,0.0853384576956076,0.990794305876293,2,5,maintenance of protein location in mitochondrion,BP,AKT1;HK1
509,GO:0001573,0.085401253449555,0.983095729887969,3,10,ganglioside metabolic process,BP,HEXB;ST6GALNAC6;ST3GAL5
2720,GO:0006103,0.0854748367144274,0.977088854866321,4,16,2-oxoglutarate metabolic process,BP,IDH2;D2HGDH;PHYH;GPT2
4882,GO:0014745,0.0854789984521113,0.983073695379773,3,10,negative regulation of muscle adaptation,BP,SMAD3;ERRFI1;LMNA
16910,GO:0098876,0.0854903414195942,0.957287708507999,11,65,vesicle-mediated transport to the plasma membrane,BP,BBS2;OSBPL5;EXOC2;RAB31;ANK3;SNX17;LLGL1;BBS1;VAMP2;ARHGAP44;DNM2
17180,GO:0102991,0.0856635728163322,0.990738519401552,2,5,myristoyl-CoA hydrolase activity,MF,ACOT7;ACOT1
1527,GO:0003905,0.0856907658748517,1,1,1,alkylbase DNA N-glycosylase activity,MF,MPG
3958,GO:0008725,0.0856907658748517,1,1,1,DNA-3-methyladenine glycosylase activity,MF,MPG
10649,GO:0043733,0.0856907658748517,1,1,1,DNA-3-methylbase glycosylase activity,MF,MPG
10668,GO:0043916,0.0856907658748517,1,1,1,DNA-7-methylguanine glycosylase activity,MF,MPG
13410,GO:0052821,0.0856907658748517,1,1,1,DNA-7-methyladenine glycosylase activity,MF,MPG
13411,GO:0052822,0.0856907658748517,1,1,1,DNA-3-methylguanine glycosylase activity,MF,MPG
17085,GO:0099604,0.0856948080469188,0.977009193200911,4,16,ligand-gated calcium channel activity,MF,ITPR3;TPCN1;PKD2;RASA3
15852,GO:0072574,0.0857878204599467,0.982986076640506,3,10,hepatocyte proliferation,BP,CEACAM1;CEBPB;PROX1
15853,GO:0072575,0.0857878204599467,0.982986076640506,3,10,epithelial cell proliferation involved in liver morphogenesis,BP,CEACAM1;CEBPB;PROX1
10130,GO:0042695,0.0862673227063905,0.990634570578802,2,5,thelarche,BP,TGFB1;AREG
14010,GO:0060744,0.0862673227063905,0.990634570578802,2,5,mammary gland branching involved in thelarche,BP,TGFB1;AREG
13228,GO:0051902,0.08626741049529,0.990634555430821,2,5,negative regulation of mitochondrial depolarization,BP,BOK;IFI6
18737,GO:1904180,0.08626741049529,0.990634555430821,2,5,negative regulation of membrane depolarization,BP,BOK;IFI6
12595,GO:0050780,0.0862976417750821,0.982841108171142,3,10,dopamine receptor binding,MF,DLG4;DNM1;DNM2
5845,GO:0017136,0.0863965190347671,0.97675454772774,4,16,NAD-dependent histone deacetylase activity,MF,HDAC5;HDAC7;SIRT2;SIRT3
12564,GO:0050727,0.0864372833596456,0.943944947464747,25,180,regulation of inflammatory response,BP,TNIP1;NT5E;PDCD4;APOE;EGFR;ACP5;SMAD3;ADORA2B;F12;STK39;SERPING1;GGT1;FNDC4;LDLR;MAPK13;BCR;SHARPIN;IL20RB;ADAM8;CD81;ADA;PRKCD;PPARA;DDT;ZP3
8430,GO:0033558,0.086533855609903,0.962559466202434,8,43,protein deacetylase activity,MF,MTA1;HDAC5;HMG20B;PHF21A;MBD3;HDAC7;SIRT2;SIRT3
3078,GO:0006655,0.0867077317032324,0.982724207614395,3,10,phosphatidylglycerol biosynthetic process,BP,PLA2G6;SLC27A1;TAZ
13380,GO:0052689,0.0868613452979695,0.952313827953065,14,89,carboxylic ester hydrolase activity,MF,H6PD;ACOT7;PGLS;TMEM8A;NLGN2;ACOT1;BPHL;DTD1;CES2;PLA2G6;CHKA;ABHD10;IARS2;AARS
10408,GO:0043252,0.0869905771708984,0.982643428612846,3,10,sodium-independent organic anion transport,BP,SLCO4A1;SLC22A17;MFSD10
14973,GO:0070887,0.0870053232765418,0.92447346171941,242,2126,cellular response to chemical stimulus,BP,TNIP1;DUSP6;XDH;HTRA1;EGR1;NR1D1;EDEM1;CST3;CYP27B1;APLN;PGF;PDCD4;ACVR2B;DOCK4;PRNP;BBS2;POSTN;VEGFA;FAM210B;TNFRSF6B;WNT7A;APOE;LRP5;ITGA6;HMGA2;NDRG1;AKR7A2;EGFR;NOS1;SPRY2;CAPN2;MST1R;NFATC4;LTBP4;SDC1;ETV5;SHC1;LTBP2;LTBP1;PTPRE;MMP1;SPRY4;RAPGEF3;TXNRD3;ZFP36L1;MAP2K2;RBCK1;MAP2K1;SSH1;ENDOG;SMURF2;FOS;SMAD3;STAT6;PIK3R2;LRP1;EPAS1;HBEGF;PPP1R14A;PRDX5;PRODH;AKT1;CORO1B;HDAC5;UROS;PPM1F;MMP28;PYCR2;GGT1;VEGFB;IMPACT;IFNGR2;RAB31;FGFR4;LDLR;FGFR1;PRKACB;RAC2;BPHL;CEACAM1;ANK3;CCND1;PODNL1;TWF2;MAPK13;GAS6;PTK6;PFKP;FGFBP1;CTSB;LAMA5;GSN;IGFBP2;PCSK9;BCR;EHD4;ERRFI1;AIP;PAQR6;CCS;NPR2;PLXNB3;BNIP3;SHARPIN;PKD2;ACY1;GPX3;IL20RB;ITGB5;EPOR;ADAM8;APRT;CDKN1C;PLCG1;CEBPB;ADAMTS13;WNT3;TGFB1;RFX2;GPC1;MKNK2;ADAMTS7;TMEM173;TNFSF15;NSMF;ANKZF1;PTPN1;TPP1;PCK2;AGRN;IFNE;LRP4;VHL;TRAP1;MLXIPL;PRKCZ;KDM6B;PRKACA;EPN2;PLEKHG5;BOK;ERBB2;VAMP2;JAK3;NET1;BNIP3L;CYFIP2;FSCN1;RASA4;PDK1;CYGB;PRKCD;FAM20C;STUB1;IFI6;BAX;ITGA1;EREG;RPS6KA5;DDIT4;MBTPS2;CARF;MT2A;CES2;TGFBR3;PDIA5;CPNE7;LEMD2;GSTO1;CHAD;MAPK12;IRAK1;INPP5D;CHEK2;PPARA;TMEM161A;SESN2;CDC34;RAB12;MIF;PLA2G6;DDT;SYNGR1;ECM1;WFS1;CD68;SPPL2B;FYN;STK25;EEF2K;ARID5B;DNM2;CYP3A5;PELI1;CAT;TSPYL2;IGFBP7;SLC27A1;CYP2R1;MAPK3;INSR;ADCY1;HLA-G;PAK1;CAMKK2;PPP3CB;CUL7;HYAL1;WDTC1;ITGA3;DNMT3A;PPP2R5B;MAP2K3;BCL2L1;LMNA;TNFRSF25;SIRT2;FAM129B;ITGA4;EDA;BACH1;ADCY7;SOCS7;PELI3;NGFR;TOLLIP;PDCD6;ATP6V1F;PXN;GRB10;GCH1;NR2F6;HFE;TERC;GAS2L1;COL6A1;IL17RE;FGFR3;ITPKB;KDM3A;SRSF5;ADCY6
10156,GO:0042745,0.0870781683029842,0.982220281292562,3,11,circadian sleep/wake cycle,BP,CST3;ADA;AHCY
7660,GO:0032096,0.0871400076114891,0.99048351258869,2,5,negative regulation of response to food,BP,BBS2;PPARA
7663,GO:0032099,0.0871400076114891,0.99048351258869,2,5,negative regulation of appetite,BP,BBS2;PPARA
539,GO:0001658,0.0874114719303866,0.964720757182733,7,36,branching involved in ureteric bud morphogenesis,BP,PGF;CTNNBIP1;VEGFA;WNT2B;LAMA5;PKD2;TGFB1
16861,GO:0098792,0.0875028708265144,0.982496807578048,3,10,xenophagy,BP,LRSAM1;MAPK3;WIPI2
13797,GO:0060397,0.0875137500824035,0.982493689511831,3,10,JAK-STAT cascade involved in growth hormone signaling pathway,BP,PTPN1;JAK3;MAPK3
8109,GO:0032803,0.0875296413661449,0.990415761483657,2,5,regulation of low-density lipoprotein particle receptor catabolic process,BP,APOE;PCSK9
3221,GO:0006875,0.087573058243149,0.938246376078715,37,281,cellular metal ion homeostasis,BP,DLG4;PRNP;APOE;F2R;ITPR3;NOS1;HEXB;LPAR3;SMAD3;CYBRD1;TPCN1;EDNRA;BNIP3;CEMIP;PKD2;AP3D1;PLCG1;TGFB1;NTSR1;ATP7B;RASA3;PRKACA;BOK;TRPC1;SLC22A17;CACNB3;BAX;SV2A;MT2A;GSTO1;BCAP31;PLA2G6;WFS1;FYN;GRINA;PKD1;HFE
3553,GO:0007597,0.0875812078167691,0.990406780706525,2,5,blood coagulation, intrinsic pathway,BP,F12;SERPING1
11801,GO:0046697,0.0877520429493762,0.976260388613718,4,16,decidualization,BP,CYP27B1;BSG;CTSB;EPOR
18169,GO:1902905,0.0878063883841855,0.945413751621973,21,145,positive regulation of supramolecular fiber organization,BP,APOE;ARL2;RAPGEF3;SMAD3;SH3PXD2B;CORO1B;PPM1F;EPHA1;RAC2;GSN;WIPF1;ARPIN;CDC42EP5;LIMK1;WASH3P;FHOD1;RAC3;PAK1;PROX1;PXN;PFN2
10587,GO:0043560,0.0879899451699703,0.982357031115112,3,10,insulin receptor substrate binding,MF,PRKCZ;PRKCD;INSR
18492,GO:1903587,0.0880060447285368,0.990332665246651,2,5,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,VEGFA;NGFR
6350,GO:0021535,0.0880355342278541,0.982343929757334,3,10,cell migration in hindbrain,BP,RERE;SEMA4C;SOCS7
6716,GO:0030133,0.0880997824164225,0.938848886131948,34,253,transport vesicle,CC,DLG4;PTPRS;SYTL1;MCTP1;SYT8;BRSK1;FGFR4;CEACAM1;RAB3B;DBNDD1;PCSK1;CLTCL1;SNTB2;VGF;PI4K2A;YIPF3;AREG;VAMP2;MCFD2;SV2A;DNM1;TGFA;SYNGR1;HLA-G;SEMA4C;BCL2L1;AZIN2;ICA1;RAB40B;PDCD6;SEPT6;FGFR3;TMEM187;APBA1
14115,GO:0060992,0.0881040144870957,0.982324243961934,3,10,response to fungicide,BP,IMPACT;KDM6B;BCL2L1
16993,GO:0099072,0.0881239280050534,0.976124300948496,4,16,regulation of postsynaptic membrane neurotransmitter receptor levels,BP,DLG4;ARHGAP44;DNM1;DNM2
5946,GO:0018279,0.08814501473384,0.964183187069731,7,38,protein N-linked glycosylation via asparagine,BP,ST6GALNAC2;ST6GALNAC6;MCFD2;ST3GAL3;NUDT14;ST3GAL2;ST3GAL5
2719,GO:0006102,0.0882167681006988,0.990295819804034,2,5,isocitrate metabolic process,BP,IDH2;ACO2
2278,GO:0005229,0.0882893790263675,0.982270921837398,3,10,intracellular calcium activated chloride channel activity,MF,TTYH3;ANO8;CLCA2
14447,GO:0061778,0.0882893790263675,0.982270921837398,3,10,intracellular chloride channel activity,MF,TTYH3;ANO8;CLCA2
8566,GO:0034045,0.0884091055632527,0.976019792981678,4,16,phagophore assembly site membrane,CC,ULK2;ATG2A;ULK1;WIPI2
14931,GO:0070821,0.0884509508027853,0.961473914938927,8,44,tertiary granule membrane,CC,SLC2A3;GAA;STOM;KCNAB2;CEACAM1;PLAU;ADAM8;NBEAL2
2504,GO:0005759,0.0885037198327983,0.934625401690655,48,392,mitochondrial matrix,CC,NAGS;IDH2;ACSF2;HADH;SHC1;ARL2;ALDH4A1;TK2;NME4;PC;HSD17B8;RPUSD3;PRDX5;PRODH;D2HGDH;PYCR2;CBR4;DHTKD1;MRPS6;HAGH;LACTB2;MIPEP;MDH2;MPG;HMGCL;PCK2;ACP6;TRAP1;ALAS1;PRIMPOL;PDK1;ACAD10;DGUOK;ACADS;MRPS26;ACO2;ETFB;GPT2;MLYCD;BCL2L1;ABHD10;IARS2;ALDH7A1;PHYKPL;SIRT3;TST;AK3;CHPF
11426,GO:0045862,0.088697945670927,0.937380944706277,37,281,positive regulation of proteolysis,BP,TNIP1;XDH;EDEM1;APOE;F2R;GRAMD4;SNX9;FBLN1;SMAD3;DVL1;AKT1;F12;PPM1F;DAP;FGFR4;CSNK1E;GSN;RAD23A;SH3D19;MAGEF1;ADAM8;TNFSF15;SNX33;TRIB2;BOK;CYFIP2;STUB1;BAX;MAPK12;SOX7;BCAP31;FYN;MAPK3;RNF144A;SIRT2;NGFR;PDCD6
10249,GO:0042989,0.0887541607093118,0.989415921334124,2,6,sequestering of actin monomers,BP,TWF2;GSN
11291,GO:0045619,0.0888473748533845,0.949899487452024,15,97,regulation of lymphocyte differentiation,BP,ZFP36L1;RAG1;GAS6;CARD11;SOX13;AP3D1;ADAM8;TGFB1;PRKCZ;ADA;ERBB2;JAK3;INPP5D;HLA-G;ITPKB
8708,GO:0034363,0.0888978116932242,1,1,1,intermediate-density lipoprotein particle,CC,APOE
8710,GO:0034365,0.0888978116932242,1,1,1,discoidal high-density lipoprotein particle,CC,APOE
8716,GO:0034371,0.0888978116932242,1,1,1,chylomicron remodeling,BP,APOE
11881,GO:0046911,0.0888978116932242,1,1,1,metal chelating activity,MF,APOE
16380,GO:0090731,0.0888978116932242,1,1,1,cellular response to very-low-density lipoprotein particle stimulus,BP,APOE
17726,GO:1901630,0.0888978116932242,1,1,1,negative regulation of presynaptic membrane organization,BP,APOE
18221,GO:1903000,0.0888978116932242,1,1,1,regulation of lipid transport across blood brain barrier,BP,APOE
18222,GO:1903002,0.0888978116932242,1,1,1,positive regulation of lipid transport across blood brain barrier,BP,APOE
19388,GO:1905853,0.0888978116932242,1,1,1,regulation of heparan sulfate binding,BP,APOE
19389,GO:1905855,0.0888978116932242,1,1,1,positive regulation of heparan sulfate binding,BP,APOE
19390,GO:1905858,0.0888978116932242,1,1,1,regulation of heparan sulfate proteoglycan binding,BP,APOE
19391,GO:1905860,0.0888978116932242,1,1,1,positive regulation of heparan sulfate proteoglycan binding,BP,APOE
19399,GO:1905890,0.0888978116932242,1,1,1,regulation of cellular response to very-low-density lipoprotein particle stimulus,BP,APOE
3394,GO:0007176,0.089137385998961,0.970814278405328,5,23,regulation of epidermal growth factor-activated receptor activity,BP,SHC1;ERRFI1;EREG;TGFA;CBLC
6624,GO:0022890,0.0891670552213246,0.937348892891107,36,271,inorganic cation transmembrane transporter activity,MF,KCNG1;SLC6A8;ITPR3;SCN4B;SLC2A9;ORAI3;ORAI1;SLC12A7;KCNJ15;SLC6A6;TPCN1;KCNC4;SLC15A4;MFSD3;KCNAB2;GAS6;SLC20A1;PKD2;GRIN3B;ASIC1;ATP7B;RASA3;TRPC1;CACNB3;SLC13A5;SCN8A;SLC9A7;SLC22A18;SLC12A4;SLC13A3;PKD1;SLC25A37;ATP6V1F;SLC39A3;TMCO3;SLC23A2
13460,GO:0055006,0.0891675764719028,0.961162932398302,8,43,cardiac cell development,BP,PDCD4;VEGFA;OBSL1;FHOD3;TGFBR3;PAK1;PROX1;LMNA
9481,GO:0036120,0.0891795782086201,0.975736790927002,4,16,cellular response to platelet-derived growth factor stimulus,BP,CORO1B;ERRFI1;FYN;HYAL1
7291,GO:0031296,0.0892177042064023,1,1,1,B cell costimulation,BP,CD320
3628,GO:0008092,0.0893602058084853,0.928967371736464,83,671,cytoskeletal protein binding,MF,PRNP;PARVB;FLNC;APOE;ESPN;OBSCN;NDRG1;EGFR;OBSL1;CAPN2;CLIP2;SSH1;MARK4;MARCKSL1;MPRIP;KLC2;FAM110C;S100A4;REEP4;TMOD2;CORO1B;S100A6;FMNL2;IMPACT;BRSK1;SYNE3;CEACAM1;ANK3;TNNT1;TWF2;RAB3B;GSN;WIPF1;SPTB;CORO7;SNTA1;TAGLN3;PKD2;KIF17;SNTB2;FHOD3;SHANK3;MSRB2;EML2;KIF26B;FARP1;CROCC;TNS1;WASF3;KIF7;MICALL2;CAPG;SMTN;FSCN1;MIB2;TPM2;DNM1;WASH3P;RGS14;ALDOC;FHOD1;MYO1D;MYH15;EML3;FYN;DNM2;INF2;KIF26A;TNS4;MICAL1;BIN1;VPS16;RABGAP1;CDH4;MAPRE3;NDE1;PXN;KIF13B;GAS2L1;PFN2;SSH3;CCDC88C;HOMER2
4595,GO:0010712,0.0895648219216494,0.97063198206214,5,23,regulation of collagen metabolic process,BP,CST3;F2R;ERRFI1;TGFB1;CYGB
13796,GO:0060396,0.0896782496820939,0.975553119752048,4,16,growth hormone receptor signaling pathway,BP,PTPN1;JAK3;MAPK3;PXN
2511,GO:0005766,0.089709728630177,0.946374078309725,18,123,primary lysosome,CC,PYGB;VAT1;HEXB;GAA;NAPRT;STOM;FUCA1;BRI3;DPP7;GALNS;PRKCD;LPCAT1;SYNGR1;CD68;GLB1;RNASET2;MAN2B1;TOLLIP
10076,GO:0042582,0.089709728630177,0.946374078309725,18,123,azurophil granule,CC,PYGB;VAT1;HEXB;GAA;NAPRT;STOM;FUCA1;BRI3;DPP7;GALNS;PRKCD;LPCAT1;SYNGR1;CD68;GLB1;RNASET2;MAN2B1;TOLLIP
2271,GO:0005215,0.0897824391293455,0.928505405921816,84,686,transporter activity,MF,SLC16A3;DLG4;KCNG1;SLC6A8;APOE;OSBPL5;PITPNC1;SLCO4A1;ITPR3;SCN4B;SLC2A9;ORAI3;ORAI1;SLC7A8;SLC12A7;SLC2A3;PLTP;SLC16A5;KCNJ15;LRP1;GJC2;SLC6A6;TPCN1;KCNC4;TTYH3;S100A6;PITPNM1;BSG;SLC15A4;LRRC8A;MFSD3;KCNAB2;CEACAM1;ABCD1;GAS6;ANO8;SLC20A1;SERINC2;PKD2;AP3D1;ABCA2;GRIN3B;ASIC1;SLC29A4;SLC43A1;SLC38A10;ATP7B;RASA3;CLCA2;SLC48A1;OSBPL10;TRPC1;SLC22A17;CACNB3;BAX;SV2A;SLC13A5;TIMM17B;CPNE7;SLC2A11;SCN8A;ABCG1;ABCA7;SLC25A29;SLC9A7;SLC22A18;PITPNM3;SLC27A1;SLC50A1;SLC12A4;SLC13A3;ATP8B2;SLC37A2;SLC16A13;DLG3;PKD1;AZIN2;SLC25A37;ATP6V1F;SLC39A3;TMCO3;MFSD10;SLC23A2;SLC26A11
18594,GO:1903829,0.0897827250999875,0.936253248837171,38,286,positive regulation of cellular protein localization,BP,EDEM1;PRNP;EGFR;VPS11;RAPGEF3;SSH1;LRP1;STOM;AKT1;RAC2;SORL1;B3GAT3;ANK3;CEP250;GAS6;CEMIP;EPHB2;TGFB1;ABHD17C;TMEM173;CROCC;SNX33;LRP4;CEP131;MICALL2;ERBB2;VAMP2;TFDP2;PRKCD;ZDHHC8;SESN2;BCAP31;NBPF3;FYN;PAK1;ITGA3;NGFR;CAMK1
6589,GO:0022612,0.0899335476453698,0.950384356268968,14,88,gland morphogenesis,BP,LRP5;EGFR;ETV5;STAT6;FGFR1;CEACAM1;LAMA5;CEBPB;TGFB1;AREG;BAX;PROX1;EDA;PLAG1
13731,GO:0060314,0.0899600261603866,0.975206912930312,4,17,regulation of ryanodine-sensitive calcium-release channel activity,BP,NOS1;PKD2;PRKACA;GSTO1
11113,GO:0045153,0.0899996862165251,1,1,1,electron transporter, transferring electrons within CoQH2-cytochrome c reductase complex activity,MF,CYC1
10895,GO:0044448,0.0902074283422045,0.945268663788657,19,127,cell cortex part,CC,DLG4;CAPN2;RAPGEF3;EXOC2;MYZAP;GSN;SEPT10;WIPF1;SPTB;PKD2;CTSZ;NSMF;LLGL1;RIMS3;PRKCZ;SH3BP1;PCLO;HFE;SEPT6
14016,GO:0060751,0.090255062651719,0.989936570506236,2,5,branch elongation involved in mammary gland duct branching,BP,TGFB1;AREG
4678,GO:0010828,0.0903965587577927,0.966459956031213,6,29,positive regulation of glucose transmembrane transport,BP,PIK3R2;AKT1;CLTCL1;PRKCZ;INSR;PAK1
741,GO:0001973,0.0905890779548609,0.989877208959998,2,5,adenosine receptor signaling pathway,BP,ADORA2B;ADA
9428,GO:0036004,0.0907195586789387,1,1,1,GAF domain binding,MF,AIP
6575,GO:0022408,0.0907562882501766,0.948658268819855,15,97,negative regulation of cell-cell adhesion,BP,PRNP;SERPINE2;PAG1;CEACAM1;IL20RB;CEBPB;TGFB1;CD9;ERBB2;JAK3;PRKCD;PPARA;PELI1;HLA-G;HFE
13923,GO:0060598,0.0908167993337512,1,1,1,dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis,BP,AREG
4971,GO:0015085,0.0909093725802925,0.954070033488937,11,65,calcium ion transmembrane transporter activity,MF,ITPR3;ORAI3;ORAI1;TPCN1;GAS6;PKD2;GRIN3B;RASA3;TRPC1;CACNB3;PKD1
3849,GO:0008465,0.0909138168984941,1,1,1,glycerate dehydrogenase activity,MF,GRHPR
13942,GO:0060638,0.0911895871727543,0.9897701387166,2,5,mesenchymal-epithelial cell signaling,BP,WNT2B;FGFR1
883,GO:0002248,0.0912289612512847,0.989763102783031,2,5,connective tissue replacement involved in inflammatory response wound healing,BP,F2R;TGFB1
8541,GO:0033897,0.0912676321194086,1,1,1,ribonuclease T2 activity,MF,RNASET2
2140,GO:0004953,0.091296502298389,0.989751029105077,2,5,icosanoid receptor activity,MF,LTB4R2;LTB4R
980,GO:0002433,0.091312885705068,0.95560329087509,10,58,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,BP,PIK3R2;WIPF1;PLCG1;CYFIP2;PRKCD;LIMK1;PLA2G6;FYN;MAPK3;PAK1
9695,GO:0038096,0.091312885705068,0.95560329087509,10,58,Fc-gamma receptor signaling pathway involved in phagocytosis,BP,PIK3R2;WIPF1;PLCG1;CYFIP2;PRKCD;LIMK1;PLA2G6;FYN;MAPK3;PAK1
3156,GO:0006767,0.091530348921303,0.953615721272485,11,67,water-soluble vitamin metabolic process,BP,SLC2A3;PC;ACP5;HLCS;PRSS3;CD320;GSTO1;MTHFR;PDXK;PM20D2;SLC23A2
8276,GO:0033089,0.0915855870015574,0.989699288492071,2,5,positive regulation of T cell differentiation in thymus,BP,ADAM8;ADA
1933,GO:0004632,0.0916977201939226,1,1,1,phosphopantothenate--cysteine ligase activity,MF,PPCS
12133,GO:0048246,0.0918641643097156,0.974277119194291,4,18,macrophage chemotaxis,BP,MMP28;MIF;DDT;MAPK3
4554,GO:0010637,0.0919493954325319,0.989634027185456,2,5,negative regulation of mitochondrial fusion,BP,VAT1;BNIP3
6946,GO:0030579,0.0920598043395665,0.989614189335697,2,5,ubiquitin-dependent SMAD protein catabolic process,BP,SMURF2;STUB1
16538,GO:0097283,0.092557573232781,0.989524565573143,2,5,keratinocyte apoptotic process,BP,ZFP36L1;GSN
17899,GO:1902172,0.092557573232781,0.989524565573143,2,5,regulation of keratinocyte apoptotic process,BP,ZFP36L1;GSN
8516,GO:0033762,0.0925620215597399,0.965315963742786,6,30,response to glucagon,BP,PRKACB;PRKACA;CYC1;ADCY1;ADCY7;ADCY6
3234,GO:0006892,0.0925803051562794,0.948661098400103,14,89,post-Golgi vesicle-mediated transport,BP,BBS2;OSBPL5;EXOC2;RAB31;SORL1;ANK3;CORO7;AP3D1;LLGL1;BBS1;VAMP2;EHD3;DOPEY2;DNM2
10247,GO:0042987,0.0925868636466342,0.965304157322695,6,30,amyloid precursor protein catabolic process,BP,PRNP;APOE;SORL1;ABCG1;ABCA7;BIN1
12727,GO:0050999,0.0926166348129195,0.965290007066528,6,30,regulation of nitric-oxide synthase activity,BP,APOE;EGFR;AKT1;CYGB;DNM2;GCH1
8205,GO:0032966,0.0926897906235965,0.989500708407801,2,5,negative regulation of collagen biosynthetic process,BP,ERRFI1;CYGB
19082,GO:1904951,0.0927710949298195,0.93249742852111,43,330,positive regulation of establishment of protein localization,BP,EDEM1;PRNP;POSTN;F2R;EGFR;VPS11;RAPGEF3;GLUL;LRP1;NLGN2;STOM;HK1;RAC2;SORL1;B3GAT3;ANK3;GAS6;ALOX15B;CEMIP;ADAM8;TGFB1;TMEM173;PCK2;CEP131;PFKFB2;PRKCZ;MICALL2;ERBB2;VAMP2;TFDP2;PRKCD;ZDHHC8;BCAP31;MIF;PLA2G6;NBPF3;FYN;MAPK3;PFKM;PAK1;PPP3CB;CAMK1;SIRT3
10866,GO:0044406,0.0928269124912764,0.989475943552767,2,5,adhesion of symbiont to host,BP,GAS6;CD81
8040,GO:0032700,0.0928731651708935,0.989467584882104,2,5,negative regulation of interleukin-17 production,BP,PRNP;TGFB1
7193,GO:0031089,0.092973097886138,0.989449516300138,2,5,platelet dense granule lumen,CC,ECM1;LGALS3BP
4836,GO:0014044,0.093026441568869,0.969145001130508,5,23,Schwann cell development,BP,NDRG1;AKT1;LAMB2;AHNAK2;SIRT2
11727,GO:0046554,0.0930520632489627,1,1,1,malate dehydrogenase (NADP+) activity,MF,MDH2
1069,GO:0002634,0.0931899790954596,0.989410260298583,2,5,regulation of germinal center formation,BP,PKN1;ADA
10438,GO:0043301,0.0932772531118119,0.989394447179367,2,5,negative regulation of leukocyte degranulation,BP,CEACAM1;BCR
16177,GO:0090199,0.0933821258427143,0.96143958924239,7,39,regulation of release of cytochrome c from mitochondria,BP,AKT1;BNIP3;MOAP1;BAX;PLA2G6;BCL2L1;LMNA
15567,GO:0072028,0.0935541799865935,0.95636244727163,9,51,nephron morphogenesis,BP,PGF;CTNNBIP1;VEGFA;WNT2B;LAMA5;PKD2;TGFB1;KIF26B;PKD1
4105,GO:0009162,0.0935803881850081,0.980288434865859,3,11,deoxyribonucleoside monophosphate metabolic process,BP,DNPH1;TK2;DGUOK
9626,GO:0036498,0.0937518789512401,0.952281093775903,11,67,IRE1-mediated unfolded protein response,BP,EDEM1;SHC1;PTPN1;TPP1;BAX;PDIA5;WFS1;TSPYL2;CUL7;PPP2R5B;LMNA
15271,GO:0071458,0.0938659930691291,0.989287529272409,2,5,integral component of cytoplasmic side of endoplasmic reticulum membrane,CC,PKD2;SPPL2B
6054,GO:0019203,0.0938716634293963,0.989286497439026,2,5,carbohydrate phosphatase activity,MF,PFKFB2;PFKFB3
12457,GO:0050308,0.0938716634293963,0.989286497439026,2,5,sugar-phosphatase activity,MF,PFKFB2;PFKFB3
16124,GO:0090118,0.0938748803110787,0.989285912046731,2,5,receptor-mediated endocytosis involved in cholesterol transport,BP,LDLR;PCSK9
1943,GO:0004645,0.0940234388476718,0.98925886425765,2,5,phosphorylase activity,MF,PYGB;PYGL
7560,GO:0031915,0.0940479913971818,0.989254391410579,2,5,positive regulation of synaptic plasticity,BP,SSH1;EPHB2
465,GO:0001504,0.0941168662680607,0.973644791994466,4,17,neurotransmitter uptake,BP,NOS1;GLUL;RAB3B;NTSR1
15491,GO:0071868,0.0941444683875871,0.968660727162996,5,23,cellular response to monoamine stimulus,BP,PRKACA;DNM2;MAPK3;SIRT2;ADCY6
15493,GO:0071870,0.0941444683875871,0.968660727162996,5,23,cellular response to catecholamine stimulus,BP,PRKACA;DNM2;MAPK3;SIRT2;ADCY6
1787,GO:0004415,0.0941482137936004,0.989236125779761,2,5,hyalurononglucosaminidase activity,MF,CEMIP;HYAL1
9309,GO:0035771,0.0941616174563903,0.989233682014774,2,5,interleukin-4-mediated signaling pathway,BP,STAT6;JAK3
17495,GO:1900425,0.0943132878111744,0.989206014017493,2,5,negative regulation of defense response to bacterium,BP,MAPKBP1;SIRT2
18874,GO:1904502,0.0944125905785493,0.989187883735184,2,5,regulation of lipophagy,BP,SESN2;SPTLC2
18875,GO:1904504,0.0944125905785493,0.989187883735184,2,5,positive regulation of lipophagy,BP,SESN2;SPTLC2
2088,GO:0004852,0.0945772660688376,1,1,1,uroporphyrinogen-III synthase activity,MF,UROS
15245,GO:0071418,0.0945772660688376,1,1,1,cellular response to amine stimulus,BP,UROS
15966,GO:0080058,0.0946356720429323,1,1,1,protein deglutathionylation,BP,GLRX
16667,GO:0097573,0.0946356720429323,1,1,1,glutathione oxidoreductase activity,MF,GLRX
6035,GO:0019118,0.094752161926478,1,1,1,phenanthrene-epoxide hydrolase activity,MF,AKR7A2
6036,GO:0019119,0.094752161926478,1,1,1,phenanthrene-9,10-epoxide hydrolase activity,MF,AKR7A2
9963,GO:0042356,0.094752161926478,1,1,1,GDP-4-dehydro-D-rhamnose reductase activity,MF,TSTA3
12496,GO:0050577,0.094752161926478,1,1,1,GDP-L-fucose synthase activity,MF,TSTA3
12266,GO:0048584,0.0947558750292786,0.919392667941437,168,1443,positive regulation of response to stimulus,BP,TNIP1;DUSP6;XDH;DUSP5;NR1D1;EDEM1;DLG4;CYP27B1;PGF;PDCD4;ACVR2B;PRNP;VEGFA;WNT7A;F2R;HMGA2;PKN1;EGFR;NOS1;PTPRS;SPRY2;MST1R;NFATC4;SHC1;ARAP1;MAP2K2;LPAR3;RBCK1;MAP2K1;SSH1;ENDOG;SMURF2;SMAD3;STAT6;SHANK2;PIK3R2;ERCC6;DVL1;HBEGF;FAM110C;S100A4;SHC2;NLGN2;PAG1;ADORA2B;AKT1;GRB7;TMOD2;F12;SH2D2A;PPM1F;STK39;HK1;SERPING1;EPHA1;VEGFB;FGFR4;WNT2B;LDLR;FGFR1;PRKACB;RAC2;CEACAM1;ZNF385A;NSMCE4A;IGFBP4;EVC;MAPK13;GAS6;PTK6;FGFBP1;CSNK1E;CTSB;RAB3B;CARD11;SH2B3;DUSP7;GSN;MAPKAPK3;WIPF1;RGL2;ALOX15B;SLC20A1;BNIP3;SHARPIN;PKD2;YPEL3;RASGEF1A;EPHB2;ADAM8;CDKN1C;PLCG1;SH3BP2;CD81;TIMP2;WNT3;TMED4;TGFB1;MOAP1;NTSR1;TMEM173;SHANK3;TNFSF15;MC1R;KIF7;PTPN1;WDR59;RFNG;PRKCZ;PRKACA;MINK1;EPN2;ADA;PIM2;PLEKHG5;BOK;ERBB2;TFDP2;CYFIP2;PRKCD;MIB2;CACNB3;BAX;ITGA1;EREG;RPS6KA5;LIMK1;TGFBR3;MFNG;GSTO1;LRSAM1;IRAK1;TGFA;INPP5D;TMEM161A;ABCA7;BCAP31;MIF;PLA2G6;DDT;ECM1;FYN;STK25;PELI1;CAT;MAPK3;INSR;TMEM101;VANGL2;PAK1;PPP3CB;SEMA4C;CAPRIN2;PPP2R5B;MAP2K3;BCL2L1;TNFRSF25;EDA;MAP3K10;NGFR;GRB10;LURAP1;HFE;ZP3;FGFR3;ITPKB;DEDD2;LRRK1
11462,GO:0045927,0.0948170211677374,0.938465310743846,24,171,positive regulation of growth,BP,BBS2;VEGFA;EGFR;DNPH1;LPAR3;HBEGF;SH3PXD2B;AKT1;PPM1F;FGFR1;TWF2;WNT3;AGRN;ERBB2;LIMK1;TGFBR3;GDI1;WFS1;INSR;PAK1;HYAL1;PROX1;CDH4;ZP3
1883,GO:0004563,0.0948692955003898,0.989104344858827,2,5,beta-N-acetylhexosaminidase activity,MF,HEXB;HEXDC
16409,GO:0097039,0.0948763919211787,0.989103044790158,2,5,protein linear polyubiquitination,BP,RBCK1;SHARPIN
15510,GO:0071895,0.0949312312287988,0.989092996115516,2,5,odontoblast differentiation,BP,CEBPB;FAM20C
17434,GO:1900193,0.0949729738296821,0.98908534479399,2,5,regulation of oocyte maturation,BP,NPR2;SIRT2
10817,GO:0044317,0.0949838497537462,1,1,1,rod spherule,CC,REEP6
14756,GO:0070444,0.0951088360409582,0.989060426796562,2,5,oligodendrocyte progenitor proliferation,BP,GJC2;SIRT2
14757,GO:0070445,0.0951088360409582,0.989060426796562,2,5,regulation of oligodendrocyte progenitor proliferation,BP,GJC2;SIRT2
648,GO:0001839,0.095184861001002,0.98904647347449,2,5,neural plate morphogenesis,BP,DVL1;VANGL2
887,GO:0002252,0.0951991235847282,0.923251070526242,91,758,immune effector process,BP,ERCC1;HTRA1;CST3;PYGB;PGM1;PYGL;PKN1;VAT1;HEXB;SLC2A3;GAA;NAPRT;POU2F2;STAT6;PIK3R2;LRP1;AP2A2;STOM;ADORA2B;ADARB1;HK1;SERPING1;SLC15A4;RAB31;FUCA1;RAC2;KCNAB2;PFKL;CEACAM1;PLAU;BRI3;CTSB;GSN;BCR;WIPF1;BNIP3;CTSZ;IL20RB;PRSS3;ADAM8;APRT;LTA4H;PLCG1;CD81;TIMP2;DPP7;TGFB1;TMEM173;GALNS;SCART1;PI4K2A;RHOF;IFNE;YPEL5;PRKCZ;ACTR1B;ADA;VAMP2;JAK3;BNIP3L;CYFIP2;PRKCD;DDIT4;LIMK1;MFNG;ALDOC;LPCAT1;INPP5D;ZFPM1;MIF;PLA2G6;SYNGR1;QSOX1;CD68;FYN;GLB1;CAT;APOBEC3C;APOBEC3F;MAPK3;PDXK;PAK1;RNASET2;PPP3CB;MAN2B1;DNASE1L1;SERPINB1;TOLLIP;NBEAL2;HFE;ZP3
2988,GO:0006536,0.0952099382880451,0.968197412899709,5,23,glutamate metabolic process,BP,NAGS;ALDH4A1;GLUL;PRODH;GGT1
16454,GO:0097119,0.0952988566286643,0.989025537911763,2,5,postsynaptic density protein 95 clustering,BP,ZMYND8;NLGN2
10024,GO:0042474,0.0954021874736733,0.97973557720315,3,11,middle ear morphogenesis,BP,NAGLU;FGFR1;TSHZ1
14323,GO:0061512,0.0954799284141482,0.963922758008287,6,30,protein localization to cilium,BP,BBS2;IFT140;TUB;CROCC;BBS1;TCTN1
8918,GO:0034766,0.0955033065585406,0.955202056331005,9,52,negative regulation of ion transmembrane transport,BP,AKT1;STK39;ANK3;PCSK9;PKD2;EPHB2;TGFB1;NTSR1;GSTO1
12718,GO:0050974,0.095525122384842,0.988983936586521,2,5,detection of mechanical stimulus involved in sensory perception,BP,SERPINE2;FYN
625,GO:0001809,0.0955271609814865,1,1,1,positive regulation of type IV hypersensitivity,BP,ZP3
13849,GO:0060467,0.0955271609814865,1,1,1,negative regulation of fertilization,BP,ZP3
19893,GO:2000359,0.0955271609814865,1,1,1,regulation of binding of sperm to zona pellucida,BP,ZP3
19894,GO:2000360,0.0955271609814865,1,1,1,negative regulation of binding of sperm to zona pellucida,BP,ZP3
19913,GO:2000387,0.0955271609814865,1,1,1,regulation of antral ovarian follicle growth,BP,ZP3
19914,GO:2000388,0.0955271609814865,1,1,1,positive regulation of antral ovarian follicle growth,BP,ZP3
9378,GO:0035914,0.0956113246844065,0.960467071977512,7,37,skeletal muscle cell differentiation,BP,MEF2D;EGR1;FOS;HMG20B;GPC1;LEMD2;MAFF
17499,GO:1900451,0.0956920366076048,0.988953207534979,2,5,positive regulation of glutamate receptor signaling pathway,BP,EPHB2;SHANK3
3268,GO:0006949,0.0957201159342336,0.963807500400531,6,30,syncytium formation,BP,ERCC1;NOS1;CAPN2;RAPGEF3;SH3PXD2A;CAMK1
13062,GO:0051575,0.0959408922697374,0.988907329762637,2,5,5'-deoxyribose-5-phosphate lyase activity,MF,HMGA2;POLL
8334,GO:0033192,0.0960636761231634,0.988884666076597,2,5,calmodulin-dependent protein phosphatase activity,MF,PPM1F;PPP3CB
10310,GO:0043097,0.0960740912315932,0.97953041038285,3,11,pyrimidine nucleoside salvage,BP,TK2;UCKL1;UPP1
14794,GO:0070524,0.0960745071322799,1,1,1,11-beta-hydroxysteroid dehydrogenase (NADP+) activity,MF,HSD11B1
3539,GO:0007565,0.0961251802241136,0.942012877478675,18,122,female pregnancy,BP,CST3;CYP27B1;PGF;SMURF2;FOS;FBLN1;AKT1;BSG;PTHLH;CTSB;IGFBP2;EPOR;TGFB1;PLA2G6;IGFBP7;ITGA3;ADCY7;HFE
11657,GO:0046439,0.0961987110254725,0.988859719808369,2,5,L-cysteine metabolic process,BP,CBS;AHCY
2624,GO:0005952,0.0962497247212888,0.988850289773945,2,5,cAMP-dependent protein kinase complex,CC,PRKACB;PRKACA
10564,GO:0043533,0.096255469510674,0.988849227633383,2,5,inositol 1,3,4,5 tetrakisphosphate binding,MF,ITPR3;ADAP1
4213,GO:0009374,0.096344268441352,0.988832804684493,2,5,biotin binding,MF,PC;HLCS
14687,GO:0070314,0.0963757114227372,0.988826987144059,2,5,G1 to G0 transition,BP,CYP27B1;RAB11FIP4
4453,GO:0010421,0.0963968741998311,0.979431606469984,3,11,hydrogen peroxide-mediated programmed cell death,BP,ENDOG;TRAP1;STK25
16618,GO:0097468,0.0963968741998311,0.979431606469984,3,11,programmed cell death in response to reactive oxygen species,BP,ENDOG;TRAP1;STK25
13671,GO:0060215,0.0964145082429406,0.988819807342802,2,5,primitive hemopoiesis,BP,VEGFA;ZFPM1
8739,GO:0034398,0.0964312136170475,0.988816715253976,2,5,telomere tethering at nuclear periphery,BP,LEMD2;SUN1
12965,GO:0051371,0.0964378327822768,0.988815489982351,2,5,muscle alpha-actinin binding,MF,OBSL1;PKD2
9823,GO:0042048,0.096437832782286,0.988815489982342,2,5,olfactory behavior,BP,GJB4;WFS1
8944,GO:0034992,0.0964378327823097,0.988815489982357,2,5,microtubule organizing center attachment site,CC,SYNE3;SUN1
8945,GO:0034993,0.0964378327823097,0.988815489982357,2,5,meiotic nuclear membrane microtubule tethering complex,CC,SYNE3;SUN1
16234,GO:0090286,0.0964378327823097,0.988815489982357,2,5,cytoskeletal anchoring at nuclear membrane,BP,SYNE3;SUN1
17222,GO:0106083,0.0964378327823097,0.988815489982357,2,5,nuclear membrane protein complex,CC,SYNE3;SUN1
17225,GO:0106094,0.0964378327823097,0.988815489982357,2,5,nuclear membrane microtubule tethering complex,CC,SYNE3;SUN1
16440,GO:0097104,0.0964378327823102,0.988815489982357,2,5,postsynaptic membrane assembly,BP,NLGN2;LRP4
16888,GO:0098831,0.0964378327823102,0.988815489982357,2,5,presynaptic active zone cytoplasmic component,CC,RIMS3;PCLO
7059,GO:0030853,0.096437832782315,0.988815489982352,2,5,negative regulation of granulocyte differentiation,BP,CEACAM1;INPP5D
10831,GO:0044332,0.0964378327823151,0.988815489982351,2,5,Wnt signaling pathway involved in dorsal/ventral axis specification,BP,LRP5;LRP4
12279,GO:0048617,0.0964378327823928,0.988815489982352,2,5,embryonic foregut morphogenesis,BP,ACVR2B;SMAD3
13737,GO:0060322,0.0964496227683894,0.925829239191413,61,482,head development,BP,CST3;BBS2;WNT7A;NAGLU;EGFR;SERPINE2;PTPRS;TRNP1;SMARCA1;MAP2K1;SHANK2;LRP1;GJC2;MBOAT7;PITPNM1;CNTN1;WNT2B;FGFR1;TRAPPC9;EDNRA;CSNK1E;BCR;BNIP3;SHARPIN;EPOR;EPHB2;WNT3;TGFB1;SNPH;SHANK3;PHGDH;B4GALT2;MBD3;KDM6B;CD9;BOK;BAX;DDIT4;MYO1D;FYN;RAC3;SUN1;ARID5B;MAPK3;ADCY1;RERE;PAK1;PFKFB3;SEMA4C;RRAS;PROX1;MDGA1;SIRT2;LAMB1;SOCS7;NDE1;TCTN1;EZH1;TACC1;NDRG2;AARS
11865,GO:0046883,0.0965017174336927,0.939267003092069,21,147,regulation of hormone secretion,BP,NR1D1;APLN;LRP5;ITPR3;EGFR;HADH;ARL2;RAPGEF3;GLUL;NLGN2;FGFR1;PFKL;PCK2;PFKFB2;RASL10B;PLA2G6;PFKM;PPP3CB;ICA1;SIRT3;HFE
4953,GO:0015018,0.096909477658358,1,1,1,galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity,MF,B3GAT3
13625,GO:0060135,0.0969215955658688,0.956914812276414,8,44,maternal process involved in female pregnancy,BP,CYP27B1;AKT1;BSG;CTSB;EPOR;PLA2G6;ITGA3;ADCY7
513,GO:0001578,0.0972130860118221,0.956756080308816,8,44,microtubule bundle formation,BP,BBS2;MARK4;DNAAF5;DNAH1;DNAAF3;MSS51;TRIM46;TTLL3
6549,GO:0021987,0.0972478227616507,0.946989653874289,13,82,cerebral cortex development,BP,BBS2;EGFR;PTPRS;LRP1;MBOAT7;TRAPPC9;BNIP3;BAX;SUN1;LAMB1;SOCS7;NDE1;TACC1
4677,GO:0010827,0.097516622990269,0.95411977196809,9,51,regulation of glucose transmembrane transport,BP,PIK3R2;AKT1;CLTCL1;PRKCZ;INSR;RTN2;PAK1;NGFR;GRB10
3613,GO:0008064,0.0975323814855152,0.940137059942614,19,131,regulation of actin polymerization or depolymerization,BP,SSH1;TMOD2;CORO1B;RAC2;TWF2;GSN;PLEKHG2;WIPF1;ARPIN;SPTB;CDC42EP5;FHOD3;CAPG;PRKCD;SH3BP1;WASH3P;RAC3;PFN2;SSH3
7806,GO:0032366,0.0976086476762011,0.972311688803559,4,17,intracellular sterol transport,BP,LDLR;PCSK9;ABCA2;ABCG1
7807,GO:0032367,0.0976086476762011,0.972311688803559,4,17,intracellular cholesterol transport,BP,LDLR;PCSK9;ABCA2;ABCG1
9437,GO:0036019,0.0977226029239041,0.972267864714638,4,17,endolysosome,CC,AP2A2;LDLR;CTSB;PCSK9
5777,GO:0016999,0.0977703734130834,0.945198097289419,14,93,antibiotic metabolic process,BP,IDH2;AKR7A2;EGFR;PRDX5;RAC2;CBR4;DHTKD1;GPX3;SDHA;MDH2;PCK2;ACO2;CAT;KDM3A
12972,GO:0051384,0.0978002709991312,0.945233555667396,14,91,response to glucocorticoid,BP,EGFR;SDC1;ZFP36L1;FOS;PTPRU;CCND1;IGFBP2;ERRFI1;TGFB1;PCK2;AREG;DDIT4;GLB1;IGFBP7
20038,GO:2000641,0.0979569848370814,0.972177664996001,4,17,regulation of early endosome to late endosome transport,BP,VPS11;MAP2K2;MAP2K1;MAPK3
8589,GO:0034104,0.0980126064203323,0.978934680871848,3,11,negative regulation of tissue remodeling,BP,CST3;BCR;INPP5D
6208,GO:0019725,0.0981559210256022,0.923467859142544,67,547,cellular homeostasis,BP,NR1D1;DLG4;PRNP;APOE;F2R;LRP5;ITPR3;NOS1;HEXB;SLC12A7;TXNRD3;GAA;LPAR3;ENDOG;SMAD3;PIK3R2;CYBRD1;PRDX5;TPCN1;HK1;LRRC8A;POLD4;EDNRA;GAS6;BNIP3;CEMIP;PKD2;AP3D1;PLCG1;TGFB1;NTSR1;ATP7B;SHANK3;RASA3;ERO1B;PCK2;MLXIPL;PRKACA;BOK;TRPC1;SLC22A17;CACNB3;BAX;SV2A;MT2A;TMX4;PDIA5;GSTO1;FGGY;BCAP31;SLC9A7;PLA2G6;WFS1;QSOX1;FYN;SLC12A4;MAPK3;GRINA;PFKM;GLRX;PPP3CB;WDTC1;PKD1;ATP6V1F;HFE;DEDD2;SLC26A11
1088,GO:0002675,0.0982432913383965,0.978863414011844,3,11,positive regulation of acute inflammatory response,BP,F12;ADAM8;ZP3
12326,GO:0048696,0.0983486368526146,1,1,1,regulation of collateral sprouting in absence of injury,BP,WNT3
12327,GO:0048697,0.0983486368526146,1,1,1,positive regulation of collateral sprouting in absence of injury,BP,WNT3
13584,GO:0060064,0.0983486368526146,1,1,1,Spemann organizer formation at the anterior end of the primitive streak,BP,WNT3
19289,GO:1905474,0.0983486368526146,1,1,1,canonical Wnt signaling pathway involved in stem cell proliferation,BP,WNT3
10327,GO:0043126,0.0984499063962071,1,1,1,regulation of 1-phosphatidylinositol 4-kinase activity,BP,CD81
10328,GO:0043128,0.0984499063962071,1,1,1,positive regulation of 1-phosphatidylinositol 4-kinase activity,BP,CD81
12433,GO:0050104,0.0984751509972325,1,1,1,L-gulonate 3-dehydrogenase activity,MF,CRYL1
1790,GO:0004419,0.0985381349460231,1,1,1,hydroxymethylglutaryl-CoA lyase activity,MF,HMGCL
6056,GO:0019206,0.0986623262914447,0.978733755915644,3,11,nucleoside kinase activity,MF,TK2;UCKL1;DGUOK
5520,GO:0016486,0.09870211830783,0.971890346641284,4,17,peptide hormone processing,BP,PCSK1;CTSZ;ERO1B;PCSK1N
3182,GO:0006809,0.0988936541453896,0.955763607164826,8,45,nitric oxide biosynthetic process,BP,NOS1;ACP5;SMAD3;AKT1;PKD2;DNM2;INSR;GCH1
11706,GO:0046514,0.0990159098821173,0.978624146236502,3,11,ceramide catabolic process,BP,HEXB;PRKCD;NAGA
5921,GO:0018196,0.0991821079069074,0.958439355168928,7,39,peptidyl-asparagine modification,BP,ST6GALNAC2;ST6GALNAC6;MCFD2;ST3GAL3;NUDT14;ST3GAL2;ST3GAL5
9475,GO:0036114,0.0992066838096337,1,1,1,medium-chain fatty-acyl-CoA catabolic process,BP,ACOT7
9476,GO:0036115,0.0992066838096337,1,1,1,fatty-acyl-CoA catabolic process,BP,ACOT7
9477,GO:0036116,0.0992066838096337,1,1,1,long-chain fatty-acyl-CoA catabolic process,BP,ACOT7
17504,GO:1900533,0.0992066838096337,1,1,1,palmitic acid metabolic process,BP,ACOT7
17505,GO:1900535,0.0992066838096337,1,1,1,palmitic acid biosynthetic process,BP,ACOT7
12380,GO:0048814,0.099264789161717,0.950891848624642,10,59,regulation of dendrite morphogenesis,BP,OBSL1;NFATC4;FBXW8;SHANK3;NSMF;ARHGAP44;EEF2K;CUL7;CAPRIN2;SDC2
1071,GO:0002636,0.0993885718809777,1,1,1,positive regulation of germinal center formation,BP,ADA
2748,GO:0006157,0.0993885718809777,1,1,1,deoxyadenosine catabolic process,BP,ADA
9948,GO:0042321,0.0993885718809777,1,1,1,negative regulation of circadian sleep/wake cycle, sleep,BP,ADA
9949,GO:0042323,0.0993885718809777,1,1,1,negative regulation of circadian sleep/wake cycle, non-REM sleep,BP,ADA
11544,GO:0046090,0.0993885718809777,1,1,1,deoxyadenosine metabolic process,BP,ADA
11555,GO:0046111,0.0993885718809777,1,1,1,xanthine biosynthetic process,BP,ADA
11561,GO:0046124,0.0993885718809777,1,1,1,purine deoxyribonucleoside catabolic process,BP,ADA
13645,GO:0060167,0.0993885718809777,1,1,1,regulation of adenosine receptor signaling pathway,BP,ADA
13646,GO:0060169,0.0993885718809777,1,1,1,negative regulation of adenosine receptor signaling pathway,BP,ADA
13805,GO:0060407,0.0993885718809777,1,1,1,negative regulation of penile erection,BP,ADA
14653,GO:0070256,0.0993885718809777,1,1,1,negative regulation of mucus secretion,BP,ADA
12957,GO:0051348,0.0994007877601681,0.930985217480535,32,240,negative regulation of transferase activity,BP,DUSP6;DUSP5;PDCD4;APOE;LRP5;PKN1;WWTR1;SPRY2;SPRY4;DVL1;ADARB1;AKT1;PPM1F;EPHA1;SORL1;CEACAM1;PODNL1;PTK6;DUSP7;ERRFI1;EPHB2;CDKN1C;PTPN1;CAMK2N1;TRIB2;PRKCD;DUSP4;LIMK1;RGS14;CHAD;SOCS7;CBLC
13512,GO:0055094,0.099515791887248,0.971575627981988,4,17,response to lipoprotein particle,BP,APOE;LDLR;CD81;CD9
13069,GO:0051586,0.0996046274826902,1,1,1,positive regulation of dopamine uptake involved in synaptic transmission,BP,RAB3B
13251,GO:0051944,0.0996046274826902,1,1,1,positive regulation of catecholamine uptake involved in synaptic transmission,BP,RAB3B
8336,GO:0033197,0.0997198456259615,0.978405374810605,3,11,response to vitamin E,BP,CCND1;ADA;CAT
4059,GO:0009110,0.100227784077478,0.971299408887768,4,17,vitamin biosynthetic process,BP,CYP27B1;PLTP;CYP2R1;PDXK
17711,GO:1901606,0.100371615758789,0.950184476672003,10,60,alpha-amino acid catabolic process,BP,NOS1;ALDH4A1;GLUL;PRODH;CBS;HMGCL;AHCY;GPT2;ALDH7A1;PHYKPL
1086,GO:0002673,0.100394359877277,0.961423577627361,6,31,regulation of acute inflammatory response,BP,F12;SERPING1;IL20RB;ADAM8;CD81;ZP3
20267,GO:2001199,0.100398875709173,1,1,1,negative regulation of dendritic cell differentiation,BP,HLA-G
2710,GO:0006089,0.100402300185773,0.978192576957428,3,11,lactate metabolic process,BP,D2HGDH;HAGH;PFKFB2
16129,GO:0090131,0.100410294636923,1,1,1,mesenchyme migration,BP,ACTA2
12891,GO:0051246,0.100496357450758,0.912550575214962,230,2024,regulation of protein metabolic process,BP,TNIP1;DUSP6;XDH;DUSP5;EGR1;EDEM1;DLG4;PLAT;CST3;BTBD2;FBXO2;PDCD4;ACVR2B;PRNP;VEGFA;TNFRSF6B;WNT7A;APOE;F2R;LRP5;PKN1;MTA1;GRAMD4;EGFR;SERPINE2;WWTR1;NOS1;SPRY2;MST1R;CRTAP;LTBP4;SHC1;VPS11;SNX9;SPRY4;RAPGEF3;ZFP36L1;MAP2K2;LPAR3;PPP1R35;MAP2K1;SSH1;SMURF2;FBLN1;SMAD3;PIK3R2;ERCC6;LRP1;GJC2;DVL1;HBEGF;PPP1R14A;PPP2R3B;PRDX5;SHC2;ADORA2B;ADARB1;AKT1;GRB7;F12;PPM1F;STK39;SERPING1;EPHA1;IMPACT;CNTN1;DAP;FGFR4;LDLR;FGFR1;PRKACB;RAC2;RAG1;SORL1;CEACAM1;B3GAT3;CIRBP;HMG20B;ZNF385A;IGFBP4;CCND1;PODNL1;STRADB;SYNGAP1;GAS6;PTK6;CSNK1E;CARD11;DUSP7;GSN;MAPKAPK3;PCSK9;RAD23A;EHD4;ERRFI1;SH3D19;CDC25B;SNTA1;DGKQ;PAK6;TFPI2;CEMIP;PKD2;CTSZ;ZNF598;MAGEF1;EPHB2;ADAM8;CTBP1;CDKN1C;PLCG1;CD81;CEBPB;TIMP2;C8ORF88;TGFB1;UNK;MKNK2;NAB2;TNFSF15;NSMF;ABTB1;SNX33;MIF4GD;ZER1;PTPN1;IFNE;CAMK2N1;LRP4;TRAP1;MLXIPL;TRIB2;PRKCZ;PRKACA;MINK1;AREG;BOK;ERBB2;C6ORF89;NECAB3;JAK3;CYFIP2;PRKCD;STUB1;IFI6;BAX;ITGA1;EREG;RPS6KA5;DUSP4;DDIT4;PCSK1N;LIMK1;LEMD2;RPS6KA6;RGS14;CHAD;LPCAT1;ASB1;SYMPK;MAPK12;IRAK1;TGFA;INPP5D;MTHFR;CHEK2;ZFPM1;SESN2;SOX7;ABCA7;BCAP31;MIF;MEX3A;PLA2G6;DDT;ECM1;WFS1;TRPT1;FYN;STK25;EEF2K;PELI1;TSPYL2;ELFN2;SLC27A1;MAPK3;INSR;ADCY1;ETAA1;VANGL2;PAK1;CAMKK2;RNF144A;MICAL1;SEMA4C;CAPRIN2;BIN1;PPP2R5B;MAP2K3;DLG3;RRAS;PROX1;ZYG11B;PKD1;TNFRSF25;SIRT2;ADCY7;MAPRE3;AZIN2;SERPINB1;SOCS7;MAP3K10;NGFR;TOLLIP;PDCD6;CAMK1;CAMKK1;SIRT3;HFE;PFN2;FGFR3;PPP1R16A;CCDC88C;NDRG2;CBLC;ITPKB;KDM3A;PM20D2;ADCY6;LRRK1
7989,GO:0032613,0.100622368472077,0.965643042422448,5,24,interleukin-10 production,BP,IL20RB;TRIB2;PRKCZ;JAK3;PRKCD
9371,GO:0035902,0.100664434953935,0.971129627175072,4,17,response to immobilization stress,BP,ERCC1;FOS;TGFB1;LRP11
15457,GO:0071800,0.100726406047786,0.971105507640382,4,17,podosome assembly,BP,SH3PXD2B;GSN;SH3PXD2A;FSCN1
6804,GO:0030262,0.100949236537391,0.965497199392875,5,24,apoptotic nuclear changes,BP,H1F0;ENDOG;SHARPIN;BAX;DEDD2
1568,GO:0003974,0.101114240755585,1,1,1,UDP-N-acetylglucosamine 4-epimerase activity,MF,GALE
1572,GO:0003978,0.101114240755585,1,1,1,UDP-glucose 4-epimerase activity,MF,GALE
4407,GO:0010164,0.101179687228396,1,1,1,response to cesium ion,BP,CYP2R1
6862,GO:0030343,0.101179687228396,1,1,1,vitamin D3 25-hydroxylase activity,MF,CYP2R1
14861,GO:0070643,0.101179687228396,1,1,1,vitamin D 25-hydroxylase activity,MF,CYP2R1
7618,GO:0032024,0.101237549103293,0.954475443396378,8,45,positive regulation of insulin secretion,BP,GLUL;NLGN2;PCK2;PFKFB2;PLA2G6;PFKM;PPP3CB;SIRT3
7029,GO:0030809,0.101602930318845,0.970763734763827,4,17,negative regulation of nucleotide biosynthetic process,BP,DDIT4;LTB4R2;PPARA;GABBR1
17483,GO:1900372,0.101602930318845,0.970763734763827,4,17,negative regulation of purine nucleotide biosynthetic process,BP,DDIT4;LTB4R2;PPARA;GABBR1
500,GO:0001556,0.101640823241199,0.970748933362693,4,17,oocyte maturation,BP,CDC25B;NPR2;EREG;SIRT2
809,GO:0002083,0.101714164996923,1,1,1,4-hydroxybenzoate decaprenyltransferase activity,MF,COQ2
11975,GO:0047293,0.101714164996923,1,1,1,4-hydroxybenzoate nonaprenyltransferase activity,MF,COQ2
3227,GO:0006884,0.101953779763902,0.97062660596785,4,17,cell volume homeostasis,BP,SLC12A7;LRRC8A;SHANK3;SLC12A4
3077,GO:0006654,0.10198061955903,0.960772905519792,6,30,phosphatidic acid biosynthetic process,BP,DGKA;LPCAT4;DGKQ;ACP6;LPCAT1;SLC27A1
2661,GO:0006012,0.10200081363671,0.977691443043822,3,11,galactose metabolic process,BP,PGM1;GALE;GLB1
5263,GO:0015908,0.102035979020904,0.951471256810445,9,52,fatty acid transport,BP,APOE;CPT2;AKT1;ABCD1;NTSR1;PPARA;MIF;PLA2G6;SLC27A1
12131,GO:0048244,0.102208766235928,1,1,1,phytanoyl-CoA dioxygenase activity,MF,PHYH
16433,GO:0097089,0.102208766235928,1,1,1,methyl-branched fatty acid metabolic process,BP,PHYH
16168,GO:0090190,0.10221538153061,0.977623889038676,3,11,positive regulation of branching involved in ureteric bud morphogenesis,BP,VEGFA;WNT2B;TGFB1
4106,GO:0009163,0.102330817429066,0.956703878589351,7,40,nucleoside biosynthetic process,BP,NT5E;TK2;NME4;APRT;ADA;UCKL1;UPP1
4414,GO:0010189,0.102459116778098,1,1,1,vitamin E biosynthetic process,BP,PLTP
9966,GO:0042360,0.102459116778098,1,1,1,vitamin E metabolic process,BP,PLTP
18722,GO:1904121,0.102459116778098,1,1,1,phosphatidylethanolamine transporter activity,MF,PLTP
1480,GO:0003756,0.102512107463562,0.970408001171169,4,17,protein disulfide isomerase activity,MF,ERO1B;TMX4;PDIA5;QSOX1
5725,GO:0016864,0.102512107463562,0.970408001171169,4,17,intramolecular oxidoreductase activity, transposing S-S bonds,MF,ERO1B;TMX4;PDIA5;QSOX1
14121,GO:0060998,0.102607699191381,0.951141986667361,9,52,regulation of dendritic spine development,BP,ZMYND8;APOE;PTPRS;SHANK2;SHANK3;ARHGAP44;EEF2K;CAPRIN2;CAMK1
4509,GO:0010561,0.102695767918989,0.977472399795147,3,11,negative regulation of glycoprotein biosynthetic process,BP,HBEGF;JAK3;ABCA7
9121,GO:0035438,0.102704456069829,1,1,1,cyclic-di-GMP binding,MF,TMEM173
14320,GO:0061507,0.102704456069829,1,1,1,cyclic-GMP-AMP binding,MF,TMEM173
17420,GO:1900154,0.102762588200974,1,1,1,regulation of bone trabecula formation,BP,CHAD
17421,GO:1900155,0.102762588200974,1,1,1,negative regulation of bone trabecula formation,BP,CHAD
728,GO:0001958,0.102823373591345,0.970285925433981,4,17,endochondral ossification,BP,MEF2D;COL13A1;NAB2;FGFR3
9462,GO:0036075,0.102823373591345,0.970285925433981,4,17,replacement ossification,BP,MEF2D;COL13A1;NAB2;FGFR3
12015,GO:0047658,0.102839644997026,1,1,1,alpha-amino-acid esterase activity,MF,BPHL
9048,GO:0035272,0.102852556395672,0.956607304274779,7,38,exocrine system development,BP,CST3;EGFR;FGFR1;LAMA5;TGFB1;INSR;EDA
4961,GO:0015037,0.103020719028077,0.976964406825914,3,12,peptide disulfide oxidoreductase activity,MF,PDIA5;GSTO1;GLRX
4642,GO:0010766,0.103030079986265,0.977366774748581,3,11,negative regulation of sodium ion transport,BP,SERPINE2;STK39;PCSK9
17506,GO:1900542,0.103074210182829,0.938205741756659,17,115,regulation of purine nucleotide metabolic process,BP,VEGFA;APOE;NOS1;RAPGEF3;ADORA2B;PTHLH;PKD2;TIMP2;PFKFB2;MLXIPL;DDIT4;LTB4R2;PPARA;INSR;TAZ;PFKFB3;GABBR1
9249,GO:0035659,0.103142677799559,1,1,1,Wnt signaling pathway involved in wound healing, spreading of epidermal cells,BP,WNT7A
11120,GO:0045167,0.103142677799559,1,1,1,asymmetric protein localization involved in cell fate determination,BP,WNT7A
19055,GO:1904889,0.103142677799559,1,1,1,regulation of excitatory synapse assembly,BP,WNT7A
19056,GO:1904891,0.103142677799559,1,1,1,positive regulation of excitatory synapse assembly,BP,WNT7A
4322,GO:0009822,0.103161340401748,1,1,1,alkaloid catabolic process,BP,CYP3A5
7047,GO:0030832,0.103411128319146,0.936010501600352,19,132,regulation of actin filament length,BP,SSH1;TMOD2;CORO1B;RAC2;TWF2;GSN;PLEKHG2;WIPF1;ARPIN;SPTB;CDC42EP5;FHOD3;CAPG;PRKCD;SH3BP1;WASH3P;RAC3;PFN2;SSH3
15678,GO:0072207,0.103429868547039,0.97004764461294,4,17,metanephric epithelium development,BP,WWTR1;PKD2;LAMB2;PKD1
18861,GO:1904464,0.103545679516378,1,1,1,regulation of matrix metallopeptidase secretion,BP,IDH2
18862,GO:1904465,0.103545679516378,1,1,1,negative regulation of matrix metallopeptidase secretion,BP,IDH2
19634,GO:1990773,0.103545679516378,1,1,1,matrix metallopeptidase secretion,BP,IDH2
14847,GO:0070613,0.103611522184003,0.950500281105928,9,53,regulation of protein processing,BP,PRNP;SERPINE2;F12;SERPING1;PRKACB;GSN;CTSZ;ADAM8;CD81
2005,GO:0004729,0.103732395596731,1,1,1,oxygen-dependent protoporphyrinogen oxidase activity,MF,PPOX
14929,GO:0070818,0.103732395596731,1,1,1,protoporphyrinogen oxidase activity,MF,PPOX
15544,GO:0071963,0.103741195660379,1,1,1,establishment or maintenance of cell polarity regulating cell shape,BP,PARVB
3828,GO:0008430,0.103984232198778,1,1,1,selenium binding,MF,GPX3
8937,GO:0034979,0.104004302435166,0.969821450341602,4,17,NAD-dependent protein deacetylase activity,MF,HDAC5;HDAC7;SIRT2;SIRT3
970,GO:0002416,0.104026951256717,1,1,1,IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor,BP,FCGRT
6220,GO:0019770,0.104026951256717,1,1,1,IgG receptor activity,MF,FCGRT
6267,GO:0019864,0.104026951256717,1,1,1,IgG binding,MF,FCGRT
17,GO:0000032,0.104220828167916,1,1,1,cell wall mannoprotein biosynthetic process,BP,MPI
1823,GO:0004476,0.104220828167916,1,1,1,mannose-6-phosphate isomerase activity,MF,MPI
2688,GO:0006056,0.104220828167916,1,1,1,mannoprotein metabolic process,BP,MPI
2689,GO:0006057,0.104220828167916,1,1,1,mannoprotein biosynthetic process,BP,MPI
7409,GO:0031506,0.104220828167916,1,1,1,cell wall glycoprotein biosynthetic process,BP,MPI
10055,GO:0042546,0.104220828167916,1,1,1,cell wall biogenesis,BP,MPI
10713,GO:0044038,0.104220828167916,1,1,1,cell wall macromolecule biosynthetic process,BP,MPI
14368,GO:0061611,0.104220828167916,1,1,1,mannose to fructose-6-phosphate metabolic process,BP,MPI
14840,GO:0070589,0.104220828167916,1,1,1,cellular component macromolecule biosynthetic process,BP,MPI
9775,GO:0039692,0.104348130694797,0.976948743296267,3,11,single stranded viral RNA replication via double stranded DNA intermediate,BP,HMGA2;APOBEC3C;APOBEC3F
6467,GO:0021801,0.104361810983312,0.969680424745503,4,17,cerebral cortex radial glia guided migration,BP,MBOAT7;SUN1;LAMB1;SOCS7
6565,GO:0022030,0.104361810983312,0.969680424745503,4,17,telencephalon glial cell migration,BP,MBOAT7;SUN1;LAMB1;SOCS7
2653,GO:0006000,0.104522530762503,0.976893240335728,3,11,fructose metabolic process,BP,PFKFB2;ALDOC;PFKFB3
7745,GO:0032268,0.104542338620317,0.909197444372869,217,1908,regulation of cellular protein metabolic process,BP,TNIP1;DUSP6;XDH;DUSP5;EGR1;EDEM1;DLG4;PLAT;CST3;FBXO2;PDCD4;ACVR2B;PRNP;VEGFA;TNFRSF6B;WNT7A;APOE;F2R;LRP5;PKN1;MTA1;GRAMD4;EGFR;SERPINE2;WWTR1;NOS1;SPRY2;MST1R;CRTAP;SHC1;VPS11;SNX9;SPRY4;RAPGEF3;ZFP36L1;MAP2K2;LPAR3;PPP1R35;MAP2K1;SSH1;FBLN1;SMAD3;PIK3R2;ERCC6;LRP1;GJC2;DVL1;HBEGF;PPP1R14A;PPP2R3B;PRDX5;SHC2;ADORA2B;ADARB1;AKT1;GRB7;F12;PPM1F;STK39;SERPING1;EPHA1;IMPACT;CNTN1;DAP;FGFR4;LDLR;FGFR1;PRKACB;RAC2;RAG1;SORL1;CEACAM1;B3GAT3;CIRBP;HMG20B;ZNF385A;IGFBP4;CCND1;PODNL1;STRADB;SYNGAP1;GAS6;PTK6;CSNK1E;DUSP7;GSN;MAPKAPK3;PCSK9;RAD23A;EHD4;ERRFI1;SH3D19;CDC25B;SNTA1;DGKQ;PAK6;TFPI2;CEMIP;PKD2;CTSZ;ZNF598;MAGEF1;EPHB2;ADAM8;CTBP1;CDKN1C;PLCG1;CD81;TIMP2;C8ORF88;TGFB1;UNK;MKNK2;NAB2;TNFSF15;NSMF;SNX33;MIF4GD;ZER1;PTPN1;IFNE;CAMK2N1;LRP4;TRAP1;MLXIPL;TRIB2;PRKCZ;PRKACA;MINK1;AREG;BOK;ERBB2;C6ORF89;CYFIP2;PRKCD;STUB1;IFI6;BAX;ITGA1;EREG;RPS6KA5;DUSP4;DDIT4;PCSK1N;LIMK1;LEMD2;RPS6KA6;RGS14;CHAD;SYMPK;MAPK12;IRAK1;TGFA;MTHFR;CHEK2;SESN2;SOX7;ABCA7;BCAP31;MIF;MEX3A;PLA2G6;DDT;ECM1;WFS1;TRPT1;FYN;STK25;EEF2K;PELI1;TSPYL2;ELFN2;SLC27A1;MAPK3;INSR;ADCY1;ETAA1;VANGL2;PAK1;CAMKK2;RNF144A;MICAL1;SEMA4C;CAPRIN2;BIN1;PPP2R5B;MAP2K3;DLG3;RRAS;PROX1;ZYG11B;PKD1;TNFRSF25;SIRT2;ADCY7;MAPRE3;SERPINB1;SOCS7;MAP3K10;NGFR;TOLLIP;PDCD6;CAMK1;CAMKK1;SIRT3;HFE;PFN2;FGFR3;PPP1R16A;CCDC88C;NDRG2;CBLC;ITPKB;KDM3A;PM20D2;ADCY6;LRRK1
1690,GO:0004163,0.104643439425019,1,1,1,diphosphomevalonate decarboxylase activity,MF,MVD
2087,GO:0004850,0.104815782042922,1,1,1,uridine phosphorylase activity,MF,UPP1
2782,GO:0006218,0.104815782042922,1,1,1,uridine catabolic process,BP,UPP1
11553,GO:0046108,0.104815782042922,1,1,1,uridine metabolic process,BP,UPP1
13368,GO:0052642,0.104846710239807,1,1,1,lysophosphatidic acid phosphatase activity,MF,ACP6
20324,GO:2001311,0.104846710239807,1,1,1,lysobisphosphatidic acid metabolic process,BP,ACP6
3721,GO:0008252,0.104960689401005,0.97675360004559,3,11,nucleotidase activity,MF,NT5E;NT5DC1;NT5C1B
2114,GO:0004900,0.105410981458177,1,1,1,erythropoietin receptor activity,MF,EPOR
9717,GO:0038162,0.105410981458177,1,1,1,erythropoietin-mediated signaling pathway,BP,EPOR
712,GO:0001938,0.105435628138147,0.947108749045751,10,61,positive regulation of endothelial cell proliferation,BP,APLN;PGF;VEGFA;AKT1;VEGFB;FGFR1;PLXNB3;ECM1;PROX1;PDCD6
1108,GO:0002696,0.105441672521183,0.930673736439811,24,174,positive regulation of leukocyte activation,BP,STAT6;ADORA2B;AKT1;RAG1;GAS6;CARD11;IGFBP2;AP3D1;ADAM8;CD81;TGFB1;EFNB3;CD320;PRKCZ;ADA;JAK3;INPP5D;MIF;FYN;PELI1;HLA-G;PAK1;ZP3;ITPKB
16812,GO:0098661,0.105467940371597,0.952131234395584,8,45,inorganic anion transmembrane transport,BP,PRNP;SLC12A7;TTYH3;SLC20A1;CLCA2;SLC12A4;SLC37A2;SLC26A11
12606,GO:0050796,0.10547377465821,0.937647527474981,16,108,regulation of insulin secretion,BP,NR1D1;LRP5;ITPR3;HADH;ARL2;RAPGEF3;GLUL;NLGN2;PFKL;PCK2;PFKFB2;PLA2G6;PFKM;PPP3CB;ICA1;SIRT3
1777,GO:0004385,0.10554526681538,0.97656686045496,3,11,guanylate kinase activity,MF,DLG4;CARD11;DLG3
3866,GO:0008493,0.105587072494841,1,1,1,tetracycline transmembrane transporter activity,MF,MFSD10
5262,GO:0015904,0.105587072494841,1,1,1,tetracycline transport,BP,MFSD10
7758,GO:0032281,0.105608012776513,0.976546787070681,3,11,AMPA glutamate receptor complex,CC,DLG4;OLFM2;DLG3
5000,GO:0015143,0.105649333649039,1,1,1,urate transmembrane transporter activity,MF,SLC2A9
5183,GO:0015747,0.105649333649039,1,1,1,urate transport,BP,SLC2A9
15791,GO:0072428,0.105649333649039,1,1,1,signal transduction involved in intra-S DNA damage checkpoint,BP,CHEK2
17763,GO:1901702,0.105649333649039,1,1,1,salt transmembrane transporter activity,MF,SLC2A9
18643,GO:1903925,0.105649333649039,1,1,1,response to bisphenol A,BP,CHEK2
18644,GO:1903926,0.105649333649039,1,1,1,cellular response to bisphenol A,BP,CHEK2
2167,GO:0005003,0.10574292495532,0.976503607215131,3,11,ephrin receptor activity,MF,EPHA1;EPHB2;EFNB3
2169,GO:0005005,0.10574292495532,0.976503607215131,3,11,transmembrane-ephrin receptor activity,MF,EPHA1;EPHB2;EFNB3
20052,GO:2000656,0.105799031096364,1,1,1,regulation of apolipoprotein binding,BP,MAPK3
20053,GO:2000657,0.105799031096364,1,1,1,negative regulation of apolipoprotein binding,BP,MAPK3
1037,GO:0002545,0.105839246867971,1,1,1,chronic inflammatory response to non-antigenic stimulus,BP,ADORA2B
1212,GO:0002880,0.105839246867971,1,1,1,regulation of chronic inflammatory response to non-antigenic stimulus,BP,ADORA2B
1213,GO:0002882,0.105839246867971,1,1,1,positive regulation of chronic inflammatory response to non-antigenic stimulus,BP,ADORA2B
3577,GO:0007625,0.105859294598873,0.985988738971449,2,6,grooming behavior,BP,DLG4;APRT
11375,GO:0045761,0.105908543482078,0.976450563313002,3,11,regulation of adenylate cyclase activity,BP,TIMP2;LTB4R2;GABBR1
664,GO:0001868,0.105977959198102,1,1,1,regulation of complement activation, lectin pathway,BP,SERPING1
665,GO:0001869,0.105977959198102,1,1,1,negative regulation of complement activation, lectin pathway,BP,SERPING1
15329,GO:0071556,0.105987989170851,0.968776882644851,4,18,integral component of lumenal side of endoplasmic reticulum membrane,CC,PKD2;BCAP31;SPPL2B;HLA-G
16759,GO:0098553,0.105987989170851,0.968776882644851,4,18,lumenal side of endoplasmic reticulum membrane,CC,PKD2;BCAP31;SPPL2B;HLA-G
15935,GO:0072740,0.105997517277563,1,1,1,cellular response to anisomycin,BP,MAPK13
10128,GO:0042692,0.106048164686149,0.927868107988234,28,204,muscle cell differentiation,BP,PDCD4;FLNC;VEGFA;OBSCN;OBSL1;NOS1;CAPN2;NFATC4;SDC1;AKT1;TMOD2;HDAC5;TNNT1;MYEF2;TGFB1;FHOD3;KDM6B;OLFM2;EREG;MAPK12;SPEG;PAK1;SEMA4C;BIN1;PROX1;LMNA;FAM129B;CAMK1
3606,GO:0008049,0.106176979560401,1,1,1,male courtship behavior,BP,HEXB
10318,GO:0043114,0.106198223725499,0.968953009382475,4,17,regulation of vascular permeability,BP,CTNNBIP1;CEACAM1;BCR;TGFB1
11955,GO:0047166,0.106277053617745,1,1,1,1-alkenylglycerophosphoethanolamine O-acyltransferase activity,MF,LPCAT4
13659,GO:0060193,0.106278409562996,0.958524505958993,6,31,positive regulation of lipase activity,BP,EGFR;LMF1;FGFR1;EDNRA;PRKCZ;FGFR3
1643,GO:0004085,0.106338694897534,1,1,1,butyryl-CoA dehydrogenase activity,MF,ACADS
6183,GO:0019605,0.106338694897534,1,1,1,butyrate metabolic process,BP,ACADS
11631,GO:0046359,0.106338694897534,1,1,1,butyrate catabolic process,BP,ACADS
13437,GO:0052890,0.106338694897534,1,1,1,oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor,MF,ACADS
10645,GO:0043687,0.106351083582552,0.922274274035267,41,321,post-translational protein modification,BP,CST3;FBXO2;APOE;OBSL1;CRTAP;DDB2;LTBP1;EPAS1;LY6K;FBXW5;FBXO41;ASB13;IGFBP4;GAS6;PCSK9;ANO8;FBXW8;FBXL8;FBXO17;LAMB2;VGF;FBXO44;VHL;RABGGTA;FAM20C;FBXW4;CUL9;MSLN;ASB1;WFS1;QSOX1;VWA1;IGFBP7;DCAF10;CUL7;WDTC1;MDGA1;LAMB1;WIPI2;PRSS21;SDC2
12100,GO:0048156,0.106469219553466,0.976270695408872,3,11,tau protein binding,MF,APOE;FYN;BIN1
10155,GO:0042744,0.106558713314218,0.975817912279756,3,12,hydrogen peroxide catabolic process,BP,PRDX5;GPX3;CAT
1067,GO:0002625,0.10663661063354,1,1,1,regulation of T cell antigen processing and presentation,BP,HFE
1068,GO:0002626,0.10663661063354,1,1,1,negative regulation of T cell antigen processing and presentation,BP,HFE
4395,GO:0010106,0.10663661063354,1,1,1,cellular response to iron ion starvation,BP,HFE
18786,GO:1904282,0.10663661063354,1,1,1,regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,HFE
18787,GO:1904283,0.10663661063354,1,1,1,negative regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,HFE
20261,GO:2001186,0.10663661063354,1,1,1,negative regulation of CD8-positive, alpha-beta T cell activation,BP,HFE
11917,GO:0046970,0.106648174805101,1,1,1,NAD-dependent histone deacetylase activity (H4-K16 specific),MF,SIRT2
14294,GO:0061433,0.106648174805101,1,1,1,cellular response to caloric restriction,BP,SIRT2
14758,GO:0070446,0.106648174805101,1,1,1,negative regulation of oligodendrocyte progenitor proliferation,BP,SIRT2
2328,GO:0005344,0.106682706495048,1,1,1,oxygen carrier activity,MF,CYGB
12038,GO:0047888,0.106682706495048,1,1,1,fatty acid peroxidase activity,MF,CYGB
11843,GO:0046835,0.106708715472356,0.962901258098555,5,24,carbohydrate phosphorylation,BP,HK1;PFKFB2;FGGY;PFKM;PFKFB3
1541,GO:0003933,0.106722689474925,1,1,1,GTP cyclohydrolase activity,MF,GCH1
1542,GO:0003934,0.106722689474925,1,1,1,GTP cyclohydrolase I activity,MF,GCH1
9424,GO:0035998,0.106722689474925,1,1,1,7,8-dihydroneopterin 3'-triphosphate biosynthetic process,BP,GCH1
3305,GO:0007009,0.106745829129021,0.946373380571415,10,60,plasma membrane organization,BP,NDRG1;SNX9;AKT1;DYSF;ANK3;GSN;SNX33;PRKCD;AHNAK2;DNM2
4967,GO:0015077,0.106829246242644,0.930313636771584,23,168,monovalent inorganic cation transmembrane transporter activity,MF,KCNG1;SLC6A8;SCN4B;SLC2A9;SLC12A7;KCNJ15;SLC6A6;KCNC4;SLC15A4;MFSD3;KCNAB2;SLC20A1;PKD2;ASIC1;SLC13A5;SCN8A;SLC9A7;SLC22A18;SLC12A4;SLC13A3;ATP6V1F;TMCO3;SLC23A2
1918,GO:0004611,0.106879374265166,1,1,1,phosphoenolpyruvate carboxykinase activity,MF,PCK2
1919,GO:0004613,0.106879374265166,1,1,1,phosphoenolpyruvate carboxykinase (GTP) activity,MF,PCK2
6174,GO:0019543,0.106879374265166,1,1,1,propionate catabolic process,BP,PCK2
11614,GO:0046327,0.106879374265166,1,1,1,glycerol biosynthetic process from pyruvate,BP,PCK2
3769,GO:0008324,0.107022294722528,0.922078204162612,40,309,cation transmembrane transporter activity,MF,KCNG1;SLC6A8;ITPR3;SCN4B;SLC2A9;ORAI3;ORAI1;SLC7A8;SLC12A7;KCNJ15;SLC6A6;TPCN1;KCNC4;SLC15A4;MFSD3;KCNAB2;GAS6;SLC20A1;SERINC2;PKD2;GRIN3B;ASIC1;ATP7B;RASA3;TRPC1;CACNB3;SLC13A5;SCN8A;SLC25A29;SLC9A7;SLC22A18;SLC12A4;SLC13A3;PKD1;AZIN2;SLC25A37;ATP6V1F;SLC39A3;TMCO3;SLC23A2
16539,GO:0097284,0.107037794637584,0.976087827514543,3,11,hepatocyte apoptotic process,BP,GSN;DNMT3A;BCL2L1
9480,GO:0036119,0.107059822355164,0.968609994757703,4,17,response to platelet-derived growth factor,BP,CORO1B;ERRFI1;FYN;HYAL1
3510,GO:0007431,0.107072244949625,0.958129551009964,6,31,salivary gland development,BP,CST3;EGFR;FGFR1;LAMA5;TGFB1;EDA
12726,GO:0050998,0.107135197001478,0.976056453477667,3,11,nitric-oxide synthase binding,MF,SNTA1;DNM1;DNM2
16903,GO:0098858,0.107144330471795,0.93436443683383,18,123,actin-based cell projection,CC,DOCK4;BBS2;ESPN;ITGA6;SYTL1;ACTA2;RAPGEF3;CEACAM1;TENM2;TWF2;TGFB1;FARP1;FSCN1;WASH3P;MORN4;ITGA3;KIF13B;HOMER2
6539,GO:0021956,0.107203079698291,1,1,1,central nervous system interneuron axonogenesis,BP,TCTN1
6827,GO:0030296,0.107371373258556,0.975980322277944,3,11,protein tyrosine kinase activator activity,MF,ERCC6;GAS6;DGKQ
1923,GO:0004617,0.107431628302589,1,1,1,phosphoglycerate dehydrogenase activity,MF,PHGDH
16844,GO:0098754,0.107516598860411,0.943534614579083,11,75,detoxification,BP,APOE;TXNRD3;PRDX5;CCS;GPX3;CYGB;MT2A;GSTO1;SESN2;CAT;GCH1
12518,GO:0050667,0.107573182987443,0.975915205133433,3,11,homocysteine metabolic process,BP,CBS;AHCY;MTHFR
15219,GO:0071378,0.107604203321269,0.968392701856365,4,17,cellular response to growth hormone stimulus,BP,PTPN1;JAK3;MAPK3;PXN
624,GO:0001808,0.107628983774173,1,1,1,negative regulation of type IV hypersensitivity,BP,IL20RB
1206,GO:0002865,0.107628983774173,1,1,1,negative regulation of acute inflammatory response to antigenic stimulus,BP,IL20RB
1215,GO:0002884,0.107628983774173,1,1,1,negative regulation of hypersensitivity,BP,IL20RB
2986,GO:0006534,0.107713310886896,0.975869955967291,3,11,cysteine metabolic process,BP,GGT1;CBS;AHCY
15101,GO:0071157,0.107753281414742,0.968068121005426,4,18,negative regulation of cell cycle arrest,BP,CCND1;MLXIPL;CHEK2;MIF
1034,GO:0002542,0.107772284344352,1,1,1,Factor XII activation,BP,F12
13235,GO:0051919,0.107772284344352,1,1,1,positive regulation of fibrinolysis,BP,F12
6041,GO:0019150,0.10778541078392,1,1,1,D-ribulokinase activity,MF,FGGY
1582,GO:0003991,0.107901205730402,1,1,1,acetylglutamate kinase activity,MF,NAGS
1614,GO:0004042,0.107901205730402,1,1,1,acetyl-CoA:L-glutamate N-acetyltransferase activity,MF,NAGS
17182,GO:0103045,0.107901205730402,1,1,1,methione N-acyltransferase activity,MF,NAGS
13438,GO:0052894,0.107905414007484,1,1,1,norspermine:oxygen oxidoreductase activity,MF,SMOX
13439,GO:0052895,0.107905414007484,1,1,1,N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity,MF,SMOX
1813,GO:0004463,0.107909616577919,1,1,1,leukotriene-A4 hydrolase activity,MF,LTA4H
10095,GO:0042610,0.107934712380481,1,1,1,CD8 receptor binding,MF,FYN
19267,GO:1905429,0.107934712380481,1,1,1,response to glycine,BP,FYN
19268,GO:1905430,0.107934712380481,1,1,1,cellular response to glycine,BP,FYN
10008,GO:0042440,0.10797483646858,0.950577672911723,8,47,pigment metabolic process,BP,UROS;AP3D1;APRT;ADA;ALAS1;TRPC1;PPOX;DDT
7549,GO:0031883,0.108128189741668,1,1,1,taste receptor binding,MF,REEP2
13657,GO:0060191,0.108153652673258,0.95055189217143,8,46,regulation of lipase activity,BP,EGFR;LMF1;LRP1;FGFR1;EDNRA;ANGPTL4;PRKCZ;FGFR3
5721,GO:0016860,0.10840665180862,0.953476243561311,7,40,intramolecular oxidoreductase activity,MF,ERO1B;MPI;TMX4;PDIA5;MIF;DDT;QSOX1
3279,GO:0006970,0.108478575513681,0.947670089044364,9,53,response to osmotic stress,BP,PKN1;EGFR;ZFP36L1;STK39;LRRC8A;MAPK13;ERRFI1;PKD2;BAX
6771,GO:0030213,0.108568379407582,0.975593228287752,3,11,hyaluronan biosynthetic process,BP,CEMIP;TGFB1;HYAL1
804,GO:0002076,0.108718900011691,0.97554440577786,3,11,osteoblast development,BP,LRP5;SMAD3;PTHLH
12432,GO:0050080,0.10875643379727,1,1,1,malonyl-CoA decarboxylase activity,MF,MLYCD
20322,GO:2001294,0.10875643379727,1,1,1,malonyl-CoA catabolic process,BP,MLYCD
1546,GO:0003940,0.108762330787496,1,1,1,L-iduronidase activity,MF,IDUA
6768,GO:0030209,0.108762330787496,1,1,1,dermatan sulfate catabolic process,BP,IDUA
12276,GO:0048608,0.108772509985079,0.921033011068546,39,299,reproductive structure development,BP,ERCC1;HTRA1;CST3;CYP27B1;VEGFA;WNT7A;EGFR;SERPINE2;SDC1;PHLDA2;ZFP36L1;PLCD3;MDFI;MAP2K1;EPAS1;AKT1;BSG;WNT2B;CCND1;CTSB;ALOX15B;PKD2;FBXW8;EPOR;CEBPB;VGF;ADA;BOK;BAX;EREG;ADAM15;ASB1;ARID5B;INSR;CUL7;BCL2L1;PKD1;ZP3;PLAG1
4319,GO:0009814,0.108803077743526,1,1,1,defense response, incompatible interaction,BP,TGFB1
4320,GO:0009817,0.108803077743526,1,1,1,defense response to fungus, incompatible interaction,BP,TGFB1
19219,GO:1905313,0.108803077743526,1,1,1,transforming growth factor beta receptor signaling pathway involved in heart development,BP,TGFB1
19526,GO:1990402,0.108803077743526,1,1,1,embryonic liver development,BP,TGFB1
1953,GO:0004657,0.10890364145736,1,1,1,proline dehydrogenase activity,MF,PRODH
3641,GO:0008118,0.108933179272938,1,1,1,N-acetyllactosaminide alpha-2,3-sialyltransferase activity,MF,ST3GAL3
4852,GO:0014066,0.10901152518395,0.94500615434063,10,60,regulation of phosphatidylinositol 3-kinase signaling,BP,F2R;EGFR;SERPINE2;FGFR1;CEACAM1;RGL2;FYN;CAT;MAPK3;PPP2R5B
15854,GO:0072576,0.109059956686879,0.975433660647707,3,11,liver morphogenesis,BP,CEACAM1;CEBPB;PROX1
1586,GO:0003996,0.109063049764744,1,1,1,acyl-CoA ligase activity,MF,ACSF2
15490,GO:0071867,0.109096664155699,0.961810610331879,5,24,response to monoamine,BP,PRKACA;DNM2;MAPK3;SIRT2;ADCY6
15492,GO:0071869,0.109096664155699,0.961810610331879,5,24,response to catecholamine,BP,PRKACA;DNM2;MAPK3;SIRT2;ADCY6
10105,GO:0042628,0.109117902696251,1,1,1,mating plug formation,BP,SERPINE2
11186,GO:0045297,0.109117902696251,1,1,1,post-mating behavior,BP,SERPINE2
14188,GO:0061107,0.109117902696251,1,1,1,seminal vesicle development,BP,SERPINE2
14189,GO:0061108,0.109117902696251,1,1,1,seminal vesicle epithelium development,BP,SERPINE2
1849,GO:0004512,0.109124891002215,1,1,1,inositol-3-phosphate synthase activity,MF,ISYNA1
5728,GO:0016872,0.109124891002215,1,1,1,intramolecular lyase activity,MF,ISYNA1
6159,GO:0019510,0.109252641213378,1,1,1,S-adenosylhomocysteine catabolic process,BP,AHCY
15151,GO:0071268,0.109252641213378,1,1,1,homocysteine biosynthetic process,BP,AHCY
4751,GO:0010927,0.109271849850777,0.944848646096876,10,60,cellular component assembly involved in morphogenesis,BP,OBSCN;OBSL1;TMOD2;TNNT1;RFX2;GPC1;FHOD3;CD9;AHNAK2;PROX1
4217,GO:0009386,0.109317308046683,1,1,1,translational attenuation,BP,TRAP1
1850,GO:0004513,0.109325109323013,1,1,1,neolactotetraosylceramide alpha-2,3-sialyltransferase activity,MF,ST3GAL5
11974,GO:0047291,0.109325109323013,1,1,1,lactosylceramide alpha-2,3-sialyltransferase activity,MF,ST3GAL5
14113,GO:0060987,0.109366917235583,1,1,1,lipid tube,CC,BIN1
1511,GO:0003870,0.109431401398416,1,1,1,5-aminolevulinate synthase activity,MF,ALAS1
5654,GO:0016749,0.109431401398416,1,1,1,N-succinyltransferase activity,MF,ALAS1
13044,GO:0051543,0.109494350650571,1,1,1,regulation of elastin biosynthetic process,BP,HBEGF
13045,GO:0051545,0.109494350650571,1,1,1,negative regulation of elastin biosynthetic process,BP,HBEGF
1900,GO:0004584,0.109510068655088,1,1,1,dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity,MF,PIGV
5945,GO:0018277,0.109510068655088,1,1,1,protein deamination,BP,LOXL1
24,GO:0000048,0.109517797777063,1,1,1,peptidyltransferase activity,MF,GGT1
1251,GO:0002951,0.109517797777063,1,1,1,leukotriene-C(4) hydrolase,MF,GGT1
10661,GO:0043890,0.109534500000513,1,1,1,N-acetylgalactosamine-6-sulfatase activity,MF,GALNS
3,GO:0000009,0.109549327192674,1,1,1,alpha-1,6-mannosyltransferase activity,MF,ALG12
13449,GO:0052917,0.109549327192674,1,1,1,dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity,MF,ALG12
8760,GO:0034446,0.109551622459897,0.942556300200451,11,68,substrate adhesion-dependent cell spreading,BP,PARVB;POSTN;FBLN1;EPHA1;LAMA5;MICALL2;NET1;RAC3;DNM2;ITGA4;LAMB1
16074,GO:0090036,0.109604494635904,0.975256495684671,3,11,regulation of protein kinase C signaling,BP,VEGFA;MC1R;PLA2G6
4027,GO:0009061,0.109607980655812,1,1,1,anaerobic respiration,BP,SDHA
11175,GO:0045274,0.109607980655812,1,1,1,plasma membrane respiratory chain complex II,CC,SDHA
11179,GO:0045282,0.109607980655812,1,1,1,plasma membrane succinate dehydrogenase complex,CC,SDHA
4393,GO:0010070,0.109653758487364,1,1,1,zygote asymmetric cell division,BP,RGS14
11387,GO:0045780,0.109698374374373,0.975225908900106,3,11,positive regulation of bone resorption,BP,EGFR;ADAM8;PLEKHM1
11852,GO:0046852,0.109698374374373,0.975225908900106,3,11,positive regulation of bone remodeling,BP,EGFR;ADAM8;PLEKHM1
10896,GO:0044449,0.10971059153395,0.933586662260056,17,117,contractile fiber part,CC,PARVB;FLNC;OBSCN;OBSL1;NOS1;TMOD2;MYZAP;ANK3;TNNT1;FHOD3;STUB1;AHNAK2;TPM2;SCN8A;PAK1;PPP3CB;BIN1
18966,GO:1904719,0.1097234142744,1,1,1,positive regulation of AMPA glutamate receptor clustering,BP,SSH1
66,GO:0000137,0.109754461818517,0.975207629110164,3,11,Golgi cis cisterna,CC,GOLGA2P5;LLGL1;NECAB3
7251,GO:0031225,0.109776633059553,0.94228281533604,11,71,anchored component of membrane,CC,NT5E;PRNP;PRSS8;LY6K;CNTN1;RAB3B;PRSS22;GPC1;MSLN;MDGA1;PRSS21
1842,GO:0004498,0.109805499696759,1,1,1,calcidiol 1-monooxygenase activity,MF,CYP27B1
8078,GO:0032768,0.109824037619348,0.952809019160962,7,39,regulation of monooxygenase activity,BP,CYP27B1;APOE;EGFR;AKT1;CYGB;DNM2;GCH1
16397,GO:0097018,0.109829715858986,1,1,1,renal albumin absorption,BP,GAS6
17409,GO:1900141,0.109829715858986,1,1,1,regulation of oligodendrocyte apoptotic process,BP,GAS6
17410,GO:1900142,0.109829715858986,1,1,1,negative regulation of oligodendrocyte apoptotic process,BP,GAS6
19979,GO:2000532,0.109829715858986,1,1,1,regulation of renal albumin absorption,BP,GAS6
19980,GO:2000533,0.109829715858986,1,1,1,negative regulation of renal albumin absorption,BP,GAS6
12987,GO:0051413,0.109835389191242,1,1,1,response to cortisone,BP,GLB1
8152,GO:0032889,0.109855359017144,1,1,1,regulation of vacuole fusion, non-autophagic,BP,VPS16
16791,GO:0098633,0.109863993529194,1,1,1,collagen fibril binding,MF,CHADL
18691,GO:1904027,0.109863993529194,1,1,1,negative regulation of collagen fibril organization,BP,CHADL
580,GO:0001733,0.109869902553183,1,1,1,galactosylceramide sulfotransferase activity,MF,GAL3ST4
12539,GO:0050694,0.109869902553183,1,1,1,galactose 3-O-sulfotransferase activity,MF,GAL3ST4
12540,GO:0050698,0.109869902553183,1,1,1,proteoglycan sulfotransferase activity,MF,GAL3ST4
9529,GO:0036266,0.109883760166892,1,1,1,Cdc48p-Npl4p-Vms1p AAA ATPase complex,CC,ANKZF1
15896,GO:0072671,0.109883760166892,1,1,1,mitochondria-associated ubiquitin-dependent protein catabolic process,BP,ANKZF1
4627,GO:0010750,0.109895395754931,1,1,1,positive regulation of nitric oxide mediated signal transduction,BP,EGFR
8448,GO:0033594,0.109895395754931,1,1,1,response to hydroxyisoflavone,BP,EGFR
10261,GO:0043006,0.109895395754931,1,1,1,activation of phospholipase A2 activity by calcium-mediated signaling,BP,EGFR
16629,GO:0097489,0.109895395754931,1,1,1,multivesicular body, internal vesicle lumen,CC,EGFR
11020,GO:0044877,0.109904824712443,0.911740455906957,81,669,protein-containing complex binding,MF,DLG4;MRC2;ACVR2B;PRNP;FLNC;APOE;ESPN;ITGA6;HMGA2;NISCH;FCGRT;EGFR;OBSL1;CRTAP;LTBP4;SHC1;DDB2;SNX9;SMARCA1;FBLN1;SMAD3;ERCC6;LRP1;CORO1B;IMPACT;LDLR;SYNE3;SORL1;TWF2;CTSB;LAMA5;GSN;PCSK9;WIPF1;SPTB;SMARCD2;TAGLN3;ZNF598;EPHB2;CDKN1C;CD81;RNF135;ADAMTS13;TIMP2;GNAL;LAMB2;PI4K2A;PTPN1;PEX1;MBD3;IFNE;CEP131;CENPH;OXA1L;CD9;MICALL2;CAPG;ULK1;FSCN1;ITGA1;CHADL;FCHO1;NID1;TGFBR3;TPM2;ADAM15;MTHFR;MYO1D;MYH15;FYN;ICAM5;INSR;PAK1;ITGA3;BIN1;VPS16;UVSSA;PXN;GRB10;TERC;STRN4
1809,GO:0004458,0.109920318289002,1,1,1,D-lactate dehydrogenase (cytochrome) activity,MF,D2HGDH
2004,GO:0004728,0.109920318289002,1,1,1,signal transducer, downstream of receptor, with protein tyrosine phosphatase activity,MF,MAP2K1
5750,GO:0016898,0.109920318289002,1,1,1,oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor,MF,D2HGDH
6161,GO:0019516,0.109920318289002,1,1,1,lactate oxidation,BP,D2HGDH
18954,GO:1904700,0.109926153173842,1,1,1,granulosa cell apoptotic process,BP,BOK
18959,GO:1904708,0.109926153173842,1,1,1,regulation of granulosa cell apoptotic process,BP,BOK
1664,GO:0004122,0.109928232032617,1,1,1,cystathionine beta-synthase activity,MF,CBS
2987,GO:0006535,0.109928232032617,1,1,1,cysteine biosynthetic process from serine,BP,CBS
4050,GO:0009093,0.109928232032617,1,1,1,cysteine catabolic process,BP,CBS
5614,GO:0016662,0.109928232032617,1,1,1,oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor,MF,CBS
6149,GO:0019448,0.109928232032617,1,1,1,L-cysteine catabolic process,BP,CBS
12470,GO:0050421,0.109928232032617,1,1,1,nitrite reductase (NO-forming) activity,MF,CBS
14522,GO:0070025,0.109928232032617,1,1,1,carbon monoxide binding,MF,CBS
16875,GO:0098809,0.109928232032617,1,1,1,nitrite reductase activity,MF,CBS
19488,GO:1990188,0.109942565204659,1,1,1,euchromatin binding,MF,ASH2L
5368,GO:0016165,0.109943367964749,1,1,1,linoleate 13S-lipoxygenase activity,MF,ALOX15B
9580,GO:0036403,0.109943367964749,1,1,1,arachidonate 8(S)-lipoxygenase activity,MF,ALOX15B
6129,GO:0019389,0.109950706209099,1,1,1,glucuronoside metabolic process,BP,ABHD10
6130,GO:0019391,0.109950706209099,1,1,1,glucuronoside catabolic process,BP,ABHD10
17148,GO:0102390,0.109950706209099,1,1,1,mycophenolic acid acyl-glucuronide esterase activity,MF,ABHD10
5347,GO:0016095,0.109957962497338,1,1,1,polyprenol catabolic process,BP,SRD5A3
17147,GO:0102389,0.109957962497338,1,1,1,polyprenol reductase activity,MF,SRD5A3
3029,GO:0006580,0.109967770742507,1,1,1,ethanolamine metabolic process,BP,CHKA
18287,GO:1903165,0.109967770742507,1,1,1,response to polycyclic arene,BP,CHKA
18943,GO:1904681,0.109967770742507,1,1,1,response to 3-methylcholanthrene,BP,CHKA
11012,GO:0044855,0.109973901049395,1,1,1,plasma membrane raft distribution,BP,GSN
11013,GO:0044856,0.109973901049395,1,1,1,plasma membrane raft localization,BP,GSN
11015,GO:0044858,0.109973901049395,1,1,1,plasma membrane raft polarization,BP,GSN
18632,GO:1903906,0.109973901049395,1,1,1,regulation of plasma membrane raft polarization,BP,GSN
3994,GO:0008894,0.109974036636284,1,1,1,guanosine-5'-triphosphate,3'-diphosphate diphosphatase activity,MF,ENTPD6
9509,GO:0036179,0.109975334702257,1,1,1,osteoclast maturation,BP,FAM20C
15324,GO:0071547,0.109975716276003,1,1,1,piP-body,CC,TDRKH
1882,GO:0004561,0.109976114334766,1,1,1,alpha-N-acetylglucosaminidase activity,MF,NAGLU
13974,GO:0060697,0.109976223676986,1,1,1,positive regulation of phospholipid catabolic process,BP,PRKCD
17422,GO:1900161,0.109976223676986,1,1,1,regulation of phospholipid scramblase activity,BP,PRKCD
17423,GO:1900163,0.109976223676986,1,1,1,positive regulation of phospholipid scramblase activity,BP,PRKCD
20106,GO:2000752,0.109976223676986,1,1,1,regulation of glucosylceramide catabolic process,BP,PRKCD
20107,GO:2000753,0.109976223676986,1,1,1,positive regulation of glucosylceramide catabolic process,BP,PRKCD
20108,GO:2000754,0.109976223676986,1,1,1,regulation of sphingomyelin catabolic process,BP,PRKCD
20109,GO:2000755,0.109976223676986,1,1,1,positive regulation of sphingomyelin catabolic process,BP,PRKCD
5215,GO:0015817,0.109976234569714,1,1,1,histidine transport,BP,SLC15A4
1648,GO:0004092,0.1099762819384,1,1,1,carnitine O-acetyltransferase activity,MF,CRAT
17708,GO:1901585,0.109976281938401,1,1,1,regulation of acid-sensing ion channel activity,BP,STOM
1299,GO:0003131,0.109976281938401,1,1,1,mesodermal-endodermal cell signaling,BP,HMGA2
7162,GO:0031049,0.109976281938401,1,1,1,programmed DNA elimination,BP,HMGA2
7164,GO:0031052,0.109976281938401,1,1,1,chromosome breakage,BP,HMGA2
9145,GO:0035501,0.109976281938401,1,1,1,MH1 domain binding,MF,HMGA2
9410,GO:0035978,0.109976281938401,1,1,1,histone H2A-S139 phosphorylation,BP,HMGA2
20075,GO:2000685,0.109976281938401,1,1,1,positive regulation of cellular response to X-ray,BP,HMGA2
18025,GO:1902499,0.109976281938404,1,1,1,positive regulation of protein autoubiquitination,BP,MTA1
13984,GO:0060709,0.109976281938406,1,1,1,glycogen cell differentiation involved in embryonic placenta development,BP,AKT1
17109,GO:0100002,0.109976281938406,1,1,1,negative regulation of protein kinase activity by protein phosphorylation,BP,AKT1
1853,GO:0004516,0.109976281938409,1,1,1,nicotinate phosphoribosyltransferase activity,MF,NAPRT
3841,GO:0008453,0.109976281938409,1,1,1,alanine-glyoxylate transaminase activity,MF,PHYKPL
3972,GO:0008792,0.109976281938409,1,1,1,arginine decarboxylase activity,MF,AZIN2
4103,GO:0009159,0.109976281938409,1,1,1,deoxyribonucleoside monophosphate catabolic process,BP,DNPH1
5031,GO:0015203,0.109976281938409,1,1,1,polyamine transmembrane transporter activity,MF,AZIN2
5121,GO:0015489,0.109976281938409,1,1,1,putrescine transmembrane transporter activity,MF,AZIN2
5231,GO:0015847,0.109976281938409,1,1,1,putrescine transport,BP,AZIN2
6110,GO:0019357,0.109976281938409,1,1,1,nicotinate nucleotide biosynthetic process,BP,NAPRT
6111,GO:0019358,0.109976281938409,1,1,1,nicotinate nucleotide salvage,BP,NAPRT
6116,GO:0019365,0.109976281938409,1,1,1,pyridine nucleotide salvage,BP,NAPRT
8259,GO:0033058,0.109976281938409,1,1,1,directional locomotion,BP,ARPIN
8460,GO:0033608,0.109976281938409,1,1,1,formyl-CoA transferase activity,MF,SUGCT
8703,GO:0034355,0.109976281938409,1,1,1,NAD salvage,BP,NAPRT
10232,GO:0042946,0.109976281938409,1,1,1,glucoside transport,BP,SLC50A1
10233,GO:0042947,0.109976281938409,1,1,1,glucoside transmembrane transporter activity,MF,SLC50A1
10963,GO:0044736,0.109976281938409,1,1,1,acid-sensing ion channel activity,MF,ASIC1
11695,GO:0046497,0.109976281938409,1,1,1,nicotinate nucleotide metabolic process,BP,NAPRT
11983,GO:0047369,0.109976281938409,1,1,1,succinate-hydroxymethylglutarate CoA-transferase activity,MF,SUGCT
12439,GO:0050144,0.109976281938409,1,1,1,nucleoside deoxyribosyltransferase activity,MF,DNPH1
12451,GO:0050262,0.109976281938409,1,1,1,ribosylnicotinamide kinase activity,MF,NMRK1
12688,GO:0050915,0.109976281938409,1,1,1,sensory perception of sour taste,BP,ASIC1
14288,GO:0061400,0.109976281938409,1,1,1,positive regulation of transcription from RNA polymerase II promoter in response to calcium ion,BP,CARF
14443,GO:0061769,0.109976281938409,1,1,1,ribosylnicotinate kinase activity,MF,NMRK1
14888,GO:0070694,0.109976281938409,1,1,1,deoxyribonucleoside 5'-monophosphate N-glycosidase activity,MF,DNPH1
16788,GO:0098629,0.109976281938409,1,1,1,trans-Golgi network membrane organization,BP,AZIN2
14438,GO:0061760,0.109976281938414,1,1,1,antifungal innate immune response,BP,FAM3A
19116,GO:1905034,0.109976281938414,1,1,1,regulation of antifungal innate immune response,BP,FAM3A
19117,GO:1905035,0.109976281938414,1,1,1,negative regulation of antifungal innate immune response,BP,FAM3A
19548,GO:1990439,0.109976281938416,1,1,1,MAP kinase serine/threonine phosphatase activity,MF,DUSP4
5765,GO:0016938,0.109976281938417,1,1,1,kinesin I complex,CC,KLC2
4291,GO:0009720,0.109976281938421,1,1,1,detection of hormone stimulus,BP,ABCG1
8565,GO:0034041,0.109976281938421,1,1,1,sterol-transporting ATPase activity,MF,ABCG1
7694,GO:0032173,0.109976281938422,1,1,1,septin collar,CC,SEPT6
1409,GO:0003342,0.109976281938424,1,1,1,proepicardium development,BP,ZFP36L1
1410,GO:0003343,0.109976281938424,1,1,1,septum transversum development,BP,ZFP36L1
16589,GO:0097403,0.109976281938424,1,1,1,cellular response to raffinose,BP,ZFP36L1
17687,GO:1901545,0.109976281938424,1,1,1,response to raffinose,BP,ZFP36L1
3829,GO:0008431,0.109976281938427,1,1,1,vitamin E binding,MF,SEC14L2
2422,GO:0005600,0.109976281938428,1,1,1,collagen type XIII trimer,CC,COL13A1
7114,GO:0030936,0.109976281938428,1,1,1,transmembrane collagen trimer,CC,COL13A1
863,GO:0002194,0.109976281938429,1,1,1,hepatocyte cell migration,BP,PROX1
10292,GO:0043049,0.109976281938429,1,1,1,otic placode formation,BP,PROX1
14192,GO:0061114,0.109976281938429,1,1,1,branching involved in pancreas morphogenesis,BP,PROX1
14957,GO:0070858,0.109976281938429,1,1,1,negative regulation of bile acid biosynthetic process,BP,PROX1
16303,GO:0090425,0.109976281938429,1,1,1,acinar cell differentiation,BP,PROX1
18775,GO:1904252,0.109976281938429,1,1,1,negative regulation of bile acid metabolic process,BP,PROX1
20182,GO:2000979,0.109976281938429,1,1,1,positive regulation of forebrain neuron differentiation,BP,PROX1
2156,GO:0004980,0.109976281938431,1,1,1,melanocyte-stimulating hormone receptor activity,MF,MC1R
10697,GO:0043990,0.109976281938431,1,1,1,histone H2A-S1 phosphorylation,BP,RPS6KA5
9898,GO:0042222,0.109976281938434,1,1,1,interleukin-1 biosynthetic process,BP,EGR1
11219,GO:0045360,0.109976281938434,1,1,1,regulation of interleukin-1 biosynthetic process,BP,EGR1
11220,GO:0045362,0.109976281938434,1,1,1,positive regulation of interleukin-1 biosynthetic process,BP,EGR1
12561,GO:0050720,0.109976281938434,1,1,1,interleukin-1 beta biosynthetic process,BP,EGR1
12562,GO:0050722,0.109976281938434,1,1,1,regulation of interleukin-1 beta biosynthetic process,BP,EGR1
12563,GO:0050725,0.109976281938434,1,1,1,positive regulation of interleukin-1 beta biosynthetic process,BP,EGR1
15726,GO:0072303,0.109976281938434,1,1,1,positive regulation of glomerular metanephric mesangial cell proliferation,BP,EGR1
16847,GO:0098758,0.109976281938434,1,1,1,response to interleukin-8,BP,EGR1
16848,GO:0098759,0.109976281938434,1,1,1,cellular response to interleukin-8,BP,EGR1
7676,GO:0032127,0.109976281938435,1,1,1,dense core granule membrane,CC,ADAM8
15079,GO:0071065,0.109976281938435,1,1,1,alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex,CC,ADAM8
15093,GO:0071133,0.109976281938435,1,1,1,alpha9-beta1 integrin-ADAM8 complex,CC,ADAM8
15827,GO:0072535,0.109976281938435,1,1,1,tumor necrosis factor (ligand) superfamily member 11 production,BP,ADAM8
15905,GO:0072680,0.109976281938435,1,1,1,extracellular matrix-dependent thymocyte migration,BP,ADAM8
15906,GO:0072681,0.109976281938435,1,1,1,fibronectin-dependent thymocyte migration,BP,ADAM8
19853,GO:2000307,0.109976281938435,1,1,1,regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,ADAM8
19854,GO:2000309,0.109976281938435,1,1,1,positive regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,ADAM8
19930,GO:2000410,0.109976281938435,1,1,1,regulation of thymocyte migration,BP,ADAM8
19931,GO:2000412,0.109976281938435,1,1,1,positive regulation of thymocyte migration,BP,ADAM8
19932,GO:2000413,0.109976281938435,1,1,1,regulation of fibronectin-dependent thymocyte migration,BP,ADAM8
19933,GO:2000415,0.109976281938435,1,1,1,positive regulation of fibronectin-dependent thymocyte migration,BP,ADAM8
15043,GO:0070995,0.109976281938435,1,1,1,NADPH oxidation,BP,KCNAB2
19440,GO:1990031,0.109976281938435,1,1,1,pinceau fiber,CC,KCNAB2
14560,GO:0070095,0.109976281938437,1,1,1,fructose-6-phosphate binding,MF,PFKL
1269,GO:0003050,0.109976281938438,1,1,1,regulation of systemic arterial blood pressure by atrial natriuretic peptide,BP,RASL10B
1961,GO:0004668,0.109976281938439,1,1,1,protein-arginine deiminase activity,MF,PADI3
5897,GO:0018101,0.109976281938439,1,1,1,protein citrullination,BP,PADI3
9582,GO:0036414,0.109976281938439,1,1,1,histone citrullination,BP,PADI3
16385,GO:0093001,0.109976281938439,1,1,1,glycolysis from storage polysaccharide through glucose-1-phosphate,BP,PFKM
7511,GO:0031704,0.10997628193844,1,1,1,apelin receptor binding,MF,APLN
10489,GO:0043396,0.10997628193844,1,1,1,corticotropin-releasing hormone secretion,BP,APLN
10490,GO:0043397,0.10997628193844,1,1,1,regulation of corticotropin-releasing hormone secretion,BP,APLN
13020,GO:0051466,0.10997628193844,1,1,1,positive regulation of corticotropin-releasing hormone secretion,BP,APLN
13654,GO:0060183,0.10997628193844,1,1,1,apelin receptor signaling pathway,BP,APLN
18687,GO:1904022,0.10997628193844,1,1,1,positive regulation of G-protein coupled receptor internalization,BP,APLN
19569,GO:1990523,0.10997628193844,1,1,1,bone regeneration,BP,POSTN
1338,GO:0003195,0.109976281938441,1,1,1,tricuspid valve formation,BP,ZFPM1
9845,GO:0042097,0.109976281938441,1,1,1,interleukin-4 biosynthetic process,BP,ZFPM1
11224,GO:0045402,0.109976281938441,1,1,1,regulation of interleukin-4 biosynthetic process,BP,ZFPM1
11225,GO:0045403,0.109976281938441,1,1,1,negative regulation of interleukin-4 biosynthetic process,BP,ZFPM1
13778,GO:0060375,0.109976281938441,1,1,1,regulation of mast cell differentiation,BP,ZFPM1
13779,GO:0060377,0.109976281938441,1,1,1,negative regulation of mast cell differentiation,BP,ZFPM1
1498,GO:0003842,0.109976281938441,1,1,1,1-pyrroline-5-carboxylate dehydrogenase activity,MF,ALDH4A1
9169,GO:0035538,0.109976281938442,1,1,1,carbohydrate response element binding,MF,MLXIPL
15987,GO:0085032,0.109976281938443,1,1,1,modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade,BP,TNIP1
2315,GO:0005316,0.109976281938444,1,1,1,high-affinity inorganic phosphate:sodium symporter activity,MF,SLC20A1
19261,GO:1905407,0.109976281938444,1,1,1,regulation of creatine transmembrane transporter activity,BP,STK39
19262,GO:1905408,0.109976281938444,1,1,1,negative regulation of creatine transmembrane transporter activity,BP,STK39
13171,GO:0051786,0.109976281938445,1,1,1,all-trans-retinol 13,14-reductase activity,MF,RETSAT
4920,GO:0014859,0.109976281938446,1,1,1,negative regulation of skeletal muscle cell proliferation,BP,SIX5
18104,GO:1902723,0.109976281938446,1,1,1,negative regulation of skeletal muscle satellite cell proliferation,BP,SIX5
5895,GO:0018094,0.109976281938449,1,1,1,protein polyglycylation,BP,TTLL3
14903,GO:0070735,0.109976281938449,1,1,1,protein-glycine ligase activity,MF,TTLL3
14904,GO:0070736,0.109976281938449,1,1,1,protein-glycine ligase activity, initiating,MF,TTLL3
5767,GO:0016941,0.10997628193845,1,1,1,natriuretic peptide receptor activity,MF,NPR2
13707,GO:0060283,0.10997628193845,1,1,1,negative regulation of oocyte development,BP,NPR2
17435,GO:1900194,0.10997628193845,1,1,1,negative regulation of oocyte maturation,BP,NPR2
19397,GO:1905880,0.10997628193845,1,1,1,negative regulation of oogenesis,BP,NPR2
3964,GO:0008753,0.109976281938451,1,1,1,NADPH dehydrogenase (quinone) activity,MF,CBR4
10453,GO:0043317,0.109976281938451,1,1,1,regulation of cytotoxic T cell degranulation,BP,CEACAM1
10454,GO:0043318,0.109976281938451,1,1,1,negative regulation of cytotoxic T cell degranulation,BP,CEACAM1
3706,GO:0008218,0.109976281938452,1,1,1,bioluminescence,BP,SDC2
17849,GO:1902010,0.109976281938452,1,1,1,negative regulation of translation in response to endoplasmic reticulum stress,BP,SESN2
9688,GO:0038086,0.109976281938453,1,1,1,VEGF-activated platelet-derived growth factor receptor signaling pathway,BP,VEGFA
9690,GO:0038091,0.109976281938453,1,1,1,positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway,BP,VEGFA
16655,GO:0097532,0.109976281938453,1,1,1,stress response to acid chemical,BP,VEGFA
16656,GO:0097533,0.109976281938453,1,1,1,cellular stress response to acid chemical,BP,VEGFA
18482,GO:1903570,0.109976281938453,1,1,1,regulation of protein kinase D signaling,BP,VEGFA
18483,GO:1903572,0.109976281938453,1,1,1,positive regulation of protein kinase D signaling,BP,VEGFA
19438,GO:1990026,0.109976281938453,1,1,1,hippocampal mossy fiber expansion,CC,MICAL1
2309,GO:0005308,0.109976281938453,1,1,1,creatine transmembrane transporter activity,MF,SLC6A8
2310,GO:0005309,0.109976281938453,1,1,1,creatine:sodium symporter activity,MF,SLC6A8
5253,GO:0015881,0.109976281938453,1,1,1,creatine transmembrane transport,BP,SLC6A8
1615,GO:0004043,0.109976281938454,1,1,1,L-aminoadipate-semialdehyde dehydrogenase activity,MF,ALDH7A1
3976,GO:0008802,0.109976281938454,1,1,1,betaine-aldehyde dehydrogenase activity,MF,ALDH7A1
6091,GO:0019285,0.109976281938454,1,1,1,glycine betaine biosynthetic process from choline,BP,ALDH7A1
7387,GO:0031455,0.109976281938454,1,1,1,glycine betaine metabolic process,BP,ALDH7A1
7388,GO:0031456,0.109976281938454,1,1,1,glycine betaine biosynthetic process,BP,ALDH7A1
812,GO:0002086,0.109976281938455,1,1,1,diaphragm contraction,BP,GAA
1892,GO:0004574,0.109976281938455,1,1,1,oligo-1,6-glucosidase activity,MF,GAA
2645,GO:0005985,0.109976281938455,1,1,1,sucrose metabolic process,BP,GAA
10360,GO:0043181,0.109976281938455,1,1,1,vacuolar sequestering,BP,GAA
11083,GO:0045092,0.109976281938455,1,1,1,interleukin-18 receptor complex,CC,TOLLIP
54,GO:0000111,0.109976281938455,1,1,1,nucleotide-excision repair factor 2 complex,CC,XPC
11073,GO:0045081,0.109976281938455,1,1,1,negative regulation of interleukin-10 biosynthetic process,BP,TRIB2
7818,GO:0032378,0.109976281938455,1,1,1,negative regulation of intracellular lipid transport,BP,PCSK9
7821,GO:0032381,0.109976281938455,1,1,1,negative regulation of intracellular sterol transport,BP,PCSK9
7824,GO:0032384,0.109976281938455,1,1,1,negative regulation of intracellular cholesterol transport,BP,PCSK9
15138,GO:0071245,0.109976281938455,1,1,1,cellular response to carbon monoxide,BP,DNM2
18400,GO:1903406,0.109976281938455,1,1,1,regulation of sodium:potassium-exchanging ATPase activity,BP,DNM2
18401,GO:1903408,0.109976281938455,1,1,1,positive regulation of sodium:potassium-exchanging ATPase activity,BP,DNM2
19326,GO:1905596,0.109976281938455,1,1,1,negative regulation of low-density lipoprotein particle receptor binding,BP,PCSK9
19328,GO:1905598,0.109976281938455,1,1,1,negative regulation of low-density lipoprotein receptor activity,BP,PCSK9
19331,GO:1905601,0.109976281938455,1,1,1,negative regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,PCSK9
3844,GO:0008456,0.109976281938456,1,1,1,alpha-N-acetylgalactosaminidase activity,MF,NAGA
15940,GO:0072755,0.109976281938456,1,1,1,cellular response to benomyl,BP,IMPACT
17693,GO:1901561,0.109976281938456,1,1,1,response to benomyl,BP,IMPACT
1603,GO:0004021,0.109976281938456,1,1,1,L-alanine:2-oxoglutarate aminotransferase activity,MF,GPT2
2146,GO:0004962,0.109976281938456,1,1,1,endothelin receptor activity,MF,EDNRA
2976,GO:0006522,0.109976281938456,1,1,1,alanine metabolic process,BP,GPT2
2977,GO:0006524,0.109976281938456,1,1,1,alanine catabolic process,BP,GPT2
4040,GO:0009078,0.109976281938456,1,1,1,pyruvate family amino acid metabolic process,BP,GPT2
4041,GO:0009080,0.109976281938456,1,1,1,pyruvate family amino acid catabolic process,BP,GPT2
4845,GO:0014054,0.109976281938456,1,1,1,positive regulation of gamma-aminobutyric acid secretion,BP,NTSR1
5522,GO:0016492,0.109976281938456,1,1,1,G-protein coupled neurotensin receptor activity,MF,NTSR1
7534,GO:0031811,0.109976281938456,1,1,1,G-protein coupled nucleotide receptor binding,MF,DLG4
7535,GO:0031812,0.109976281938456,1,1,1,P2Y1 nucleotide receptor binding,MF,DLG4
10212,GO:0042851,0.109976281938456,1,1,1,L-alanine metabolic process,BP,GPT2
10213,GO:0042853,0.109976281938456,1,1,1,L-alanine catabolic process,BP,GPT2
11954,GO:0047159,0.109976281938456,1,1,1,1-alkenylglycerophosphocholine O-acyltransferase activity,MF,LPCAT1
11959,GO:0047191,0.109976281938456,1,1,1,1-alkylglycerophosphocholine O-acyltransferase activity,MF,LPCAT1
12014,GO:0047635,0.109976281938456,1,1,1,alanine-oxo-acid transaminase activity,MF,GPT2
15312,GO:0071528,0.109976281938456,1,1,1,tRNA re-export from nucleus,BP,XPOT
16054,GO:0086100,0.109976281938456,1,1,1,endothelin receptor signaling pathway,BP,EDNRA
17069,GO:0099552,0.109976281938456,1,1,1,trans-synaptic signaling by lipid, modulating synaptic transmission,BP,F2R
17070,GO:0099553,0.109976281938456,1,1,1,trans-synaptic signaling by endocannabinoid, modulating synaptic transmission,BP,F2R
17405,GO:1900134,0.109976281938456,1,1,1,negative regulation of renin secretion into blood stream,BP,F2R
20298,GO:2001246,0.109976281938456,1,1,1,negative regulation of phosphatidylcholine biosynthetic process,BP,LPCAT1
55,GO:0000117,0.109976281938457,1,1,1,regulation of transcription involved in G2/M transition of mitotic cell cycle,BP,BACH1
495,GO:0001550,0.109976281938457,1,1,1,ovarian cumulus expansion,BP,EREG
508,GO:0001572,0.109976281938457,1,1,1,lactosylceramide biosynthetic process,BP,B4GALT6
959,GO:0002380,0.109976281938457,1,1,1,immunoglobulin secretion involved in immune response,BP,POU2F2
1042,GO:0002560,0.109976281938457,1,1,1,basophil mediated immunity,BP,PI4K2A
1043,GO:0002561,0.109976281938457,1,1,1,basophil degranulation,BP,PI4K2A
1295,GO:0003127,0.109976281938457,1,1,1,detection of nodal flow,BP,PKD2
1422,GO:0003366,0.109976281938457,1,1,1,cell-matrix adhesion involved in ameboidal cell migration,BP,ITGA4
1635,GO:0004077,0.109976281938457,1,1,1,biotin-[acetyl-CoA-carboxylase] ligase activity,MF,HLCS
1636,GO:0004078,0.109976281938457,1,1,1,biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity,MF,HLCS
1637,GO:0004079,0.109976281938457,1,1,1,biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity,MF,HLCS
1638,GO:0004080,0.109976281938457,1,1,1,biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity,MF,HLCS
1744,GO:0004344,0.109976281938457,1,1,1,glucose dehydrogenase activity,MF,H6PD
1754,GO:0004356,0.109976281938457,1,1,1,glutamate-ammonia ligase activity,MF,GLUL
1834,GO:0004489,0.109976281938457,1,1,1,methylenetetrahydrofolate reductase (NAD(P)H) activity,MF,MTHFR
1971,GO:0004686,0.109976281938457,1,1,1,elongation factor-2 kinase activity,MF,EEF2K
2010,GO:0004736,0.109976281938457,1,1,1,pyruvate carboxylase activity,MF,PC
2091,GO:0004855,0.109976281938457,1,1,1,xanthine oxidase activity,MF,XDH
2173,GO:0005009,0.109976281938457,1,1,1,insulin-activated receptor activity,MF,INSR
2175,GO:0005011,0.109976281938457,1,1,1,macrophage colony-stimulating factor receptor activity,MF,MST1R
2338,GO:0005368,0.109976281938457,1,1,1,taurine transmembrane transporter activity,MF,SLC6A6
2339,GO:0005369,0.109976281938457,1,1,1,taurine:sodium symporter activity,MF,SLC6A6
2993,GO:0006542,0.109976281938457,1,1,1,glutamine biosynthetic process,BP,GLUL
3089,GO:0006666,0.109976281938457,1,1,1,3-keto-sphinganine metabolic process,BP,KDSR
3132,GO:0006726,0.109976281938457,1,1,1,eye pigment biosynthetic process,BP,AP3D1
3466,GO:0007290,0.109976281938457,1,1,1,spermatid nucleus elongation,BP,KDM3A
3728,GO:0008267,0.109976281938457,1,1,1,poly-glutamine tract binding,MF,RERE
3750,GO:0008294,0.109976281938457,1,1,1,calcium- and calmodulin-responsive adenylate cyclase activity,MF,ADCY1
3857,GO:0008478,0.109976281938457,1,1,1,pyridoxal kinase activity,MF,PDXK
3869,GO:0008496,0.109976281938457,1,1,1,mannan endo-1,6-alpha-mannosidase activity,MF,MAN2B2
3885,GO:0008520,0.109976281938457,1,1,1,L-ascorbate:sodium symporter activity,MF,SLC23A2
4196,GO:0009305,0.109976281938457,1,1,1,protein biotinylation,BP,HLCS
4242,GO:0009443,0.109976281938457,1,1,1,pyridoxal 5'-phosphate salvage,BP,PDXK
4567,GO:0010650,0.109976281938457,1,1,1,positive regulation of cell communication by electrical coupling,BP,ANK3
5045,GO:0015229,0.109976281938457,1,1,1,L-ascorbic acid transmembrane transporter activity,MF,SLC23A2
5091,GO:0015362,0.109976281938457,1,1,1,high-affinity sodium:dicarboxylate symporter activity,MF,SLC13A3
5176,GO:0015734,0.109976281938457,1,1,1,taurine transport,BP,SLC6A6
5254,GO:0015882,0.109976281938457,1,1,1,L-ascorbic acid transmembrane transport,BP,SLC23A2
5373,GO:0016182,0.109976281938457,1,1,1,synaptic vesicle budding from endosome,BP,AP3D1
5386,GO:0016211,0.109976281938457,1,1,1,ammonia ligase activity,MF,GLUL
5642,GO:0016727,0.109976281938457,1,1,1,oxidoreductase activity, acting on CH or CH2 groups, oxygen as acceptor,MF,XDH
5769,GO:0016964,0.109976281938457,1,1,1,alpha-2 macroglobulin receptor activity,MF,LRP1
5838,GO:0017125,0.109976281938457,1,1,1,deoxycytidyl transferase activity,MF,REV1
5864,GO:0017168,0.109976281938457,1,1,1,5-oxoprolinase (ATP-hydrolyzing) activity,MF,OPLAH
5943,GO:0018271,0.109976281938457,1,1,1,biotin-protein ligase activity,MF,HLCS
5968,GO:0018400,0.109976281938457,1,1,1,peptidyl-proline hydroxylation to 3-hydroxy-L-proline,BP,CRTAP
6196,GO:0019676,0.109976281938457,1,1,1,ammonia assimilation cycle,BP,GLUL
6375,GO:0021566,0.109976281938457,1,1,1,hypoglossal nerve development,BP,ADARB1
6397,GO:0021618,0.109976281938457,1,1,1,hypoglossal nerve morphogenesis,BP,ADARB1
6468,GO:0021812,0.109976281938457,1,1,1,neuronal-glial interaction involved in cerebral cortex radial glia guided migration,BP,LAMB1
6670,GO:0030037,0.109976281938457,1,1,1,actin filament reorganization involved in cell cycle,BP,ARAP1
7027,GO:0030807,0.109976281938457,1,1,1,positive regulation of cyclic nucleotide catabolic process,BP,RAPGEF3
7042,GO:0030822,0.109976281938457,1,1,1,positive regulation of cAMP catabolic process,BP,RAPGEF3
7586,GO:0031962,0.109976281938457,1,1,1,mineralocorticoid receptor binding,MF,SMAD3
8244,GO:0033030,0.109976281938457,1,1,1,negative regulation of neutrophil apoptotic process,BP,ITPKB
8286,GO:0033123,0.109976281938457,1,1,1,positive regulation of purine nucleotide catabolic process,BP,RAPGEF3
8367,GO:0033274,0.109976281938457,1,1,1,response to vitamin B2,BP,MTHFR
8480,GO:0033644,0.109976281938457,1,1,1,host cell membrane,CC,PI4K2A
8629,GO:0034164,0.109976281938457,1,1,1,negative regulation of toll-like receptor 9 signaling pathway,BP,PTPRS
8860,GO:0034669,0.109976281938457,1,1,1,integrin alpha4-beta7 complex,CC,ITGA4
8863,GO:0034676,0.109976281938457,1,1,1,integrin alpha6-beta4 complex,CC,ITGA6
9327,GO:0035811,0.109976281938457,1,1,1,negative regulation of urine volume,BP,ADCY6
9672,GO:0038039,0.109976281938457,1,1,1,G-protein coupled receptor heterodimeric complex,CC,GABBR1
10009,GO:0042441,0.109976281938457,1,1,1,eye pigment metabolic process,BP,AP3D1
10133,GO:0042700,0.109976281938457,1,1,1,luteinizing hormone signaling pathway,BP,EREG
10412,GO:0043257,0.109976281938457,1,1,1,laminin-8 complex,CC,LAMB1
10458,GO:0043324,0.109976281938457,1,1,1,pigment metabolic process involved in developmental pigmentation,BP,AP3D1
10527,GO:0043474,0.109976281938457,1,1,1,pigment metabolic process involved in pigmentation,BP,AP3D1
10766,GO:0044218,0.109976281938457,1,1,1,other organism cell membrane,CC,PI4K2A
10768,GO:0044221,0.109976281938457,1,1,1,host cell synapse,CC,PI4K2A
10771,GO:0044231,0.109976281938457,1,1,1,host cell presynaptic membrane,CC,PI4K2A
10793,GO:0044279,0.109976281938457,1,1,1,other organism membrane,CC,PI4K2A
11154,GO:0045219,0.109976281938457,1,1,1,regulation of FasL biosynthetic process,BP,JAK3
11155,GO:0045221,0.109976281938457,1,1,1,negative regulation of FasL biosynthetic process,BP,JAK3
11434,GO:0045887,0.109976281938457,1,1,1,positive regulation of synaptic growth at neuromuscular junction,BP,AGRN
11545,GO:0046092,0.109976281938457,1,1,1,deoxycytidine metabolic process,BP,TK2
11600,GO:0046293,0.109976281938457,1,1,1,formaldehyde biosynthetic process,BP,KDM3A
11683,GO:0046478,0.109976281938457,1,1,1,lactosylceramide metabolic process,BP,B4GALT6
12006,GO:0047560,0.109976281938457,1,1,1,3-dehydrosphinganine reductase activity,MF,KDSR
12042,GO:0047936,0.109976281938457,1,1,1,glucose 1-dehydrogenase [NAD(P)] activity,MF,H6PD
12101,GO:0048160,0.109976281938457,1,1,1,primary follicle stage,BP,EREG
12103,GO:0048165,0.109976281938457,1,1,1,fused antrum stage,BP,EREG
12314,GO:0048677,0.109976281938457,1,1,1,axon extension involved in regeneration,BP,LAMB2
12363,GO:0048763,0.109976281938457,1,1,1,calcium-induced calcium release activity,MF,PKD2
13534,GO:0060005,0.109976281938457,1,1,1,vestibular reflex,BP,SLITRK6
13535,GO:0060007,0.109976281938457,1,1,1,linear vestibuloocular reflex,BP,SLITRK6
13711,GO:0060290,0.109976281938457,1,1,1,transdifferentiation,BP,SMAD3
13780,GO:0060378,0.109976281938457,1,1,1,regulation of brood size,BP,SH3PXD2B
13948,GO:0060665,0.109976281938457,1,1,1,regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling,BP,FGFR1
14441,GO:0061767,0.109976281938457,1,1,1,negative regulation of lung blood pressure,BP,SMAD3
14478,GO:0061889,0.109976281938457,1,1,1,negative regulation of astrocyte activation,BP,LDLR
14576,GO:0070123,0.109976281938457,1,1,1,transforming growth factor beta receptor activity, type III,MF,TGFBR3
14848,GO:0070615,0.109976281938457,1,1,1,nucleosome-dependent ATPase activity,MF,SMARCA1
14923,GO:0070781,0.109976281938457,1,1,1,response to biotin,BP,HLCS
14976,GO:0070890,0.109976281938457,1,1,1,sodium-dependent L-ascorbate transmembrane transporter activity,MF,SLC23A2
14987,GO:0070904,0.109976281938457,1,1,1,transepithelial L-ascorbic acid transport,BP,SLC23A2
15092,GO:0071110,0.109976281938457,1,1,1,histone biotinylation,BP,HLCS
15268,GO:0071454,0.109976281938457,1,1,1,cellular response to anoxia,BP,EEF2K
15276,GO:0071464,0.109976281938457,1,1,1,cellular response to hydrostatic pressure,BP,PKD2
15433,GO:0071713,0.109976281938457,1,1,1,para-aminobenzoyl-glutamate hydrolase activity,MF,PM20D2
15581,GO:0072055,0.109976281938457,1,1,1,renal cortex development,BP,PKD2
15582,GO:0072059,0.109976281938457,1,1,1,cortical collecting duct development,BP,PKD2
15668,GO:0072194,0.109976281938457,1,1,1,kidney smooth muscle tissue development,BP,PKD2
15679,GO:0072208,0.109976281938457,1,1,1,metanephric smooth muscle tissue development,BP,PKD2
15683,GO:0072214,0.109976281938457,1,1,1,metanephric cortex development,BP,PKD2
15688,GO:0072219,0.109976281938457,1,1,1,metanephric cortical collecting duct development,BP,PKD2
15700,GO:0072244,0.109976281938457,1,1,1,metanephric glomerular epithelium development,BP,LAMB2
15701,GO:0072248,0.109976281938457,1,1,1,metanephric glomerular visceral epithelial cell differentiation,BP,LAMB2
15702,GO:0072249,0.109976281938457,1,1,1,metanephric glomerular visceral epithelial cell development,BP,LAMB2
15713,GO:0072274,0.109976281938457,1,1,1,metanephric glomerular basement membrane development,BP,LAMB2
15719,GO:0072287,0.109976281938457,1,1,1,metanephric distal tubule morphogenesis,BP,PKD1
15734,GO:0072312,0.109976281938457,1,1,1,metanephric glomerular epithelial cell differentiation,BP,LAMB2
15735,GO:0072313,0.109976281938457,1,1,1,metanephric glomerular epithelial cell development,BP,LAMB2
15763,GO:0072363,0.109976281938457,1,1,1,regulation of glycolytic process by positive regulation of transcription from RNA polymerase II promoter,BP,PPARA
15766,GO:0072366,0.109976281938457,1,1,1,regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter,BP,PPARA
15839,GO:0072556,0.109976281938457,1,1,1,other organism presynaptic membrane,CC,PI4K2A
15888,GO:0072658,0.109976281938457,1,1,1,maintenance of protein location in membrane,BP,ANK3
15890,GO:0072660,0.109976281938457,1,1,1,maintenance of protein location in plasma membrane,BP,ANK3
16212,GO:0090251,0.109976281938457,1,1,1,protein localization involved in establishment of planar polarity,BP,CELSR1
16224,GO:0090272,0.109976281938457,1,1,1,negative regulation of fibroblast growth factor production,BP,FGFR1
16325,GO:0090537,0.109976281938457,1,1,1,CERF complex,CC,SMARCA1
16451,GO:0097116,0.109976281938457,1,1,1,gephyrin clustering involved in postsynaptic density assembly,BP,NLGN2
16452,GO:0097117,0.109976281938457,1,1,1,guanylate kinase-associated protein clustering,BP,SHANK3
16555,GO:0097338,0.109976281938457,1,1,1,response to clozapine,BP,PRKACB
16887,GO:0098830,0.109976281938457,1,1,1,presynaptic endosome,CC,AP3D1
16942,GO:0098923,0.109976281938457,1,1,1,retrograde trans-synaptic signaling by soluble gas,BP,NOS1
16943,GO:0098924,0.109976281938457,1,1,1,retrograde trans-synaptic signaling by nitric oxide,BP,NOS1
16991,GO:0099061,0.109976281938457,1,1,1,integral component of postsynaptic density membrane,CC,PTPRS
17019,GO:0099146,0.109976281938457,1,1,1,intrinsic component of postsynaptic density membrane,CC,PTPRS
17021,GO:0099163,0.109976281938457,1,1,1,synaptic signaling by nitric oxide,BP,NOS1
17063,GO:0099543,0.109976281938457,1,1,1,trans-synaptic signaling by soluble gas,BP,NOS1
17064,GO:0099545,0.109976281938457,1,1,1,trans-synaptic signaling by trans-synaptic complex,BP,EPHB2
17066,GO:0099548,0.109976281938457,1,1,1,trans-synaptic signaling by nitric oxide,BP,NOS1
17071,GO:0099557,0.109976281938457,1,1,1,trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission,BP,EPHB2
17122,GO:0102008,0.109976281938457,1,1,1,cytosolic dipeptidase activity,MF,CNDP2
17183,GO:0103046,0.109976281938457,1,1,1,alanylglutamate dipeptidase activity,MF,CNDP2
17203,GO:0106028,0.109976281938457,1,1,1,neuron projection retraction,BP,EPHB2
17322,GO:0140196,0.109976281938457,1,1,1,positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,NOS1
17498,GO:1900450,0.109976281938457,1,1,1,negative regulation of glutamate receptor signaling pathway,BP,EPHB2
17528,GO:1900827,0.109976281938457,1,1,1,positive regulation of membrane depolarization during cardiac muscle cell action potential,BP,ANK3
17552,GO:1901074,0.109976281938457,1,1,1,regulation of engulfment of apoptotic cell,BP,ABCA7
17553,GO:1901076,0.109976281938457,1,1,1,positive regulation of engulfment of apoptotic cell,BP,ABCA7
17727,GO:1901631,0.109976281938457,1,1,1,positive regulation of presynaptic membrane organization,BP,LRP4
17905,GO:1902178,0.109976281938457,1,1,1,fibroblast growth factor receptor apoptotic signaling pathway,BP,FGFR3
18079,GO:1902630,0.109976281938457,1,1,1,regulation of membrane hyperpolarization,BP,CRTC1
18080,GO:1902631,0.109976281938457,1,1,1,negative regulation of membrane hyperpolarization,BP,CRTC1
18124,GO:1902769,0.109976281938457,1,1,1,regulation of choline O-acetyltransferase activity,BP,SORL1
18125,GO:1902771,0.109976281938457,1,1,1,positive regulation of choline O-acetyltransferase activity,BP,SORL1
18189,GO:1902948,0.109976281938457,1,1,1,negative regulation of tau-protein kinase activity,BP,SORL1
18196,GO:1902955,0.109976281938457,1,1,1,positive regulation of early endosome to recycling endosome transport,BP,SORL1
18219,GO:1902997,0.109976281938457,1,1,1,negative regulation of neurofibrillary tangle assembly,BP,SORL1
18426,GO:1903450,0.109976281938457,1,1,1,regulation of G1 to G0 transition,BP,RAB11FIP4
18427,GO:1903452,0.109976281938457,1,1,1,positive regulation of G1 to G0 transition,BP,RAB11FIP4
18431,GO:1903465,0.109976281938457,1,1,1,positive regulation of mitotic cell cycle DNA replication,BP,FGFR1
18673,GO:1903979,0.109976281938457,1,1,1,negative regulation of microglial cell activation,BP,LDLR
18832,GO:1904393,0.109976281938457,1,1,1,regulation of skeletal muscle acetylcholine-gated channel clustering,BP,LRP4
18833,GO:1904395,0.109976281938457,1,1,1,positive regulation of skeletal muscle acetylcholine-gated channel clustering,BP,LRP4
18999,GO:1904782,0.109976281938457,1,1,1,negative regulation of NMDA glutamate receptor activity,BP,EPHB2
19484,GO:1990175,0.109976281938457,1,1,1,EH domain binding,MF,EPN3
19609,GO:1990715,0.109976281938457,1,1,1,mRNA CDS binding,MF,UNK
19633,GO:1990771,0.109976281938457,1,1,1,clathrin-dependent extracellular exosome endocytosis,BP,ITGA4
19845,GO:2000297,0.109976281938457,1,1,1,negative regulation of synapse maturation,BP,NFATC4
20155,GO:2000830,0.109976281938457,1,1,1,positive regulation of parathyroid hormone secretion,BP,FGFR1
20276,GO:2001213,0.109976281938457,1,1,1,negative regulation of vasculogenesis,BP,XDH
8976,GO:0035088,0.109994080854978,0.956668123442091,6,31,establishment or maintenance of apical/basal cell polarity,BP,DLG4;FSCN1;SH3BP1;VANGL2;DLG3;LRCH4
14235,GO:0061245,0.109994080854978,0.956668123442091,6,31,establishment or maintenance of bipolar cell polarity,BP,DLG4;FSCN1;SH3BP1;VANGL2;DLG3;LRCH4
5002,GO:0015145,0.11012926494541,0.975085358842657,3,11,monosaccharide transmembrane transporter activity,MF,SLC2A9;SLC2A3;SLC23A2
719,GO:0001946,0.110234034918848,0.975051144165251,3,11,lymphangiogenesis,BP,ACVR2B;PPP3CB;PROX1
4970,GO:0015081,0.110433808317966,0.942053988725675,11,67,sodium ion transmembrane transporter activity,MF,SLC6A8;SCN4B;SLC6A6;SLC20A1;PKD2;ASIC1;SLC13A5;SCN8A;SLC9A7;SLC13A3;SLC23A2
11897,GO:0046939,0.110539723720425,0.936803140585553,14,93,nucleotide phosphorylation,BP,PGM1;NME4;HK1;PFKL;PFKP;DHTKD1;PFKFB2;MLXIPL;DDIT4;ALDOC;PPARA;INSR;PFKM;PFKFB3
9306,GO:0035767,0.110621277296769,0.966906784119587,4,18,endothelial cell chemotaxis,BP,VEGFA;CORO1B;FGFR1;PLEKHG5
2569,GO:0005856,0.111109339754606,0.9043163149997,182,1563,cytoskeleton,CC,H1F0;DLG4;MARVELD1;PARVB;BBS2;FLNC;PGM1;ESPN;NDRG1;NEK9;MTA1;OBSL1;NOS1;SPRY2;CAPN2;MST1R;ARL2;RIN1;ACTA2;CLIP2;NUDCD3;RAPGEF3;MAP2K2;MAP2K1;SSH1;MARK4;MPRIP;KLC2;SHANK2;DVL1;FAM110C;SH3PXD2B;STOM;REEP4;AKT1;TMOD2;CORO1B;PITPNM1;PLEKHH3;STK39;DYSF;BRSK1;IFT140;MYZAP;PRKACB;MAPKBP1;RAC2;KCNAB2;NPHP4;LZTS2;RAB11FIP4;ANK3;EVC;TNNT1;TWF2;CEP250;MPLKIP;GSN;RAD23A;SEPT10;WIPF1;CCDC113;CDC25B;ALOX15B;SPTB;RSPH3;SNTA1;DGKQ;PROCR;PKD2;CDC42EP5;ABCA2;SH3PXD2A;ADAM8;KIF17;NUDCD2;SYNJ2;SNPH;CLTCL1;SCYL1;SNTB2;FHOD3;EML2;KIF26B;ENKD1;NSMF;ARAP3;FARP1;CROCC;TNS1;DNAH1;RHOF;WASF3;LLGL1;KIF7;SAC3D1;TUBG2;RIMS3;BBS1;OSBPL10;MYH16;CEP131;TRIB2;PRKCZ;PRKACA;ACTR1B;MICALL2;CAPG;SDCCAG8;ADGRB2;NINL;SMTN;PLEK2;MZT2A;RILPL1;JAK3;FSCN1;USP20;CCDC92;NUBP2;PLEKHH1;PPL;MZT2B;TPM2;DNM1;WASH3P;RGS14;ALDOC;REEP2;WDR60;SYMPK;FHOD1;INPP5D;MYO1D;MYH15;EML3;PLA2G6;NARF;SPPL2B;FYN;RAC3;DNM2;NEIL1;KIF26A;TUBB6;MAPK3;TNS4;CEP72;VANGL2;PAK1;CUL7;MICAL1;CAPRIN2;BIN1;BCL2L1;LMNA;RABGAP1;SIRT2;EDA;TRIP10;AFAP1L1;MAPRE3;RAB28;RAP1GAP2;NDE1;PCLO;PXN;MSS51;LURAP1;KIF13B;TCTN1;HFE;GAS2L1;TACC1;SEPT6;PFN2;SSH3;CCDC88C;CDC42BPG;CLK3;TRIM46;TTLL3
10250,GO:0042994,0.111319969586387,0.966622029407326,4,18,cytoplasmic sequestering of transcription factor,BP,MDFI;MXI1;PKD2;PKD1
12566,GO:0050729,0.111326285481544,0.94344271015854,10,63,positive regulation of inflammatory response,BP,TNIP1;PDCD4;EGFR;ADORA2B;F12;LDLR;MAPK13;ADAM8;DDT;ZP3
15376,GO:0071625,0.111615282857563,0.974598600379326,3,11,vocalization behavior,BP,DLG4;SHANK2;SHANK3
7050,GO:0030835,0.111910113030292,0.960515003820006,5,24,negative regulation of actin filament depolymerization,BP,TMOD2;TWF2;GSN;SPTB;CAPG
8013,GO:0032652,0.111930559177609,0.948344447044145,8,47,regulation of interleukin-1 production,BP,EGR1;F2R;ACP5;SMAD3;HK1;CEACAM1;GAS6;ERRFI1
12221,GO:0048489,0.11204027594324,0.939086853550487,12,76,synaptic vesicle transport,BP,SYTL1;SYT8;AP3D1;SNPH;RIMS3;VAMP2;DNM1;DNM2;PCLO;PFN2;BLOC1S4;TRIM46
16624,GO:0097480,0.11204027594324,0.939086853550487,12,76,establishment of synaptic vesicle localization,BP,SYTL1;SYT8;AP3D1;SNPH;RIMS3;VAMP2;DNM1;DNM2;PCLO;PFN2;BLOC1S4;TRIM46
5354,GO:0016125,0.11208439441493,0.933106757334591,16,109,sterol metabolic process,BP,APOE;LRP5;OSBPL5;LMF1;LDLR;SEC14L2;SORL1;PCSK9;DGKQ;MVD;SNX17;PLPP6;MBTPS2;HSD17B7;ABCG1;CAT
6077,GO:0019233,0.112156354006482,0.951554027117087,7,39,sensory perception of pain,BP,F2R;NLGN2;NIPSNAP1;NTSR1;FYN;MAPK3;NR2F6
11279,GO:0045600,0.11243225615445,0.95150621551367,7,38,positive regulation of fat cell differentiation,BP,LRP5;ZFP36L1;SH3PXD2B;AKT1;ZNF385A;CCDC71L;CEBPB
18378,GO:1903364,0.11243686396558,0.9317152906001,17,116,positive regulation of cellular protein catabolic process,BP,EDEM1;APOE;VPS11;LRP1;DVL1;AKT1;LDLR;CSNK1E;PCSK9;RAD23A;MAGEF1;CD81;TRIB2;STUB1;BCAP31;RNF144A;SIRT2
3106,GO:0006687,0.113040296904359,0.944989444170025,9,53,glycosphingolipid metabolic process,BP,HEXB;ST6GALNAC6;ESYT2;B4GALT6;PRKCD;BAX;NAGA;GLB1;ST3GAL5
1121,GO:0002709,0.113296744836905,0.954869953567074,6,32,regulation of T cell mediated immunity,BP,CEACAM1;IL20RB;PRKCZ;PPP3CB;HFE;ZP3
12950,GO:0051341,0.113492877957637,0.944592970238409,9,55,regulation of oxidoreductase activity,BP,CYP27B1;APOE;EGFR;AKT1;CCS;OXA1L;CYGB;DNM2;GCH1
19750,GO:2000107,0.113561869432377,0.95473517629137,6,32,negative regulation of leukocyte apoptotic process,BP,RAG1;GAS6;ADA;JAK3;MIF;ITPKB
11264,GO:0045580,0.113588205600279,0.938052502794012,12,77,regulation of T cell differentiation,BP,RAG1;CARD11;SOX13;AP3D1;ADAM8;TGFB1;PRKCZ;ADA;ERBB2;JAK3;HLA-G;ITPKB
18357,GO:1903317,0.113648241486787,0.944564223641951,9,54,regulation of protein maturation,BP,PRNP;SERPINE2;F12;SERPING1;PRKACB;GSN;CTSZ;ADAM8;CD81
12955,GO:0051346,0.113811008533408,0.918109661610766,36,281,negative regulation of hydrolase activity,BP,CST3;VEGFA;TNFRSF6B;SERPINE2;NOS1;SPRY2;ARL2;PPP1R35;PPP1R14A;PRDX5;AKT1;SERPING1;RAG1;SORL1;GAS6;ANGPTL4;AIP;PLXNB3;TFPI2;GPSM1;TIMP2;FARP1;PRKCZ;OXA1L;RASA4;IFI6;PCSK1N;MYO1D;ECM1;NEIL1;ELFN2;MICAL1;BIN1;DLG3;SERPINB1;NGFR
12274,GO:0048598,0.113903900397462,0.913954726575218,49,383,embryonic morphogenesis,BP,DUSP6;DUSP5;APLN;ACVR2B;WNT7A;NAGLU;LRP5;HMGA2;SPRY2;ZFP36L1;MDFI;SMAD3;DVL1;ITGB4;IFT140;WNT2B;FGFR1;PRKACB;TSHZ1;LAMA5;BCR;SLITRK6;PKD2;ITGB5;EPHB2;WNT3;TGFB1;DEAF1;LRP4;KDM6B;PBX2;BAX;FBXW4;DUSP4;WDR60;TMEM231;SOX7;MAPK3;VANGL2;HYAL1;SEMA4C;ITGA3;PROX1;ITGA4;LAMB1;TCTN1;SLC39A3;COL6A1;CELSR1
18458,GO:1903533,0.113973168599395,0.934483224142881,14,94,regulation of protein targeting,BP,PRNP;VPS11;STOM;RAC2;ANK3;CEMIP;MICALL2;ERBB2;BNIP3L;ZDHHC8;GDI1;NBPF3;FYN;PAK1
9838,GO:0042089,0.114591590535231,0.941554518557214,10,61,cytokine biosynthetic process,BP,EGR1;CARD11;ERRFI1;CEBPB;TRIB2;EREG;ASB1;INPP5D;ZFPM1;MAP2K3
17882,GO:1902107,0.114694309009312,0.935599548408466,13,85,positive regulation of leukocyte differentiation,BP,CTNNBIP1;ZFP36L1;FOS;RAG1;GAS6;AP3D1;ADAM8;TGFB1;PRKCZ;ADA;INPP5D;HLA-G;ITPKB
7922,GO:0032504,0.114703663265455,0.911242251934615,58,465,multicellular organism reproduction,BP,ERCC1;EGR1;CYP27B1;BBS2;EGFR;SERPINE2;CRTAP;ETV5;HEXB;TCFL5;TXNRD3;SH3PXD2B;AKT1;BSG;SCMH1;GGT1;PHC2;GAMT;CCNI;MICALCL;CTSB;CDC25B;NPR2;EPOR;WNT3;TGFB1;RFX2;DEAF1;MYCBPAP;DNAH1;CEP131;PRKACA;CD9;ADA;PIM2;TDRKH;FAM50A;BAX;SBF1;EREG;RPL39L;SPATA20;SIX5;BCAP31;PLA2G6;SUN1;DNM2;ITGA3;DNMT3A;BCL2L1;SIRT2;ADCY7;AZIN2;BTG1;ZP3;SEPT6;PRSS21;KDM3A
16760,GO:0098554,0.114716812771383,0.97271688373505,3,13,cytoplasmic side of endoplasmic reticulum membrane,CC,PKD2;PTPN1;SPPL2B
12636,GO:0050849,0.114963698481893,0.973020987561652,3,12,negative regulation of calcium-mediated signaling,BP,PRNP;PKD2;GSTO1
12982,GO:0051402,0.115067757353473,0.925042947417804,22,159,neuron apoptotic process,BP,PRNP;APOE;F2R;LRP1;ADARB1;SIGMAR1;SYNGAP1;PCSK9;BNIP3;CTSZ;ADAM8;CEBPB;NSMF;BOK;BAX;ITGA1;CDC34;WFS1;FYN;BCL2L1;NGFR;AARS
15817,GO:0072523,0.115202325115046,0.949805861958582,7,40,purine-containing compound catabolic process,BP,NT5E;XDH;DNPH1;RAPGEF3;ADA;AHCY;NT5C1B
7245,GO:0031210,0.115324679218398,0.972898583353085,3,12,phosphatidylcholine binding,MF,PLTP;PITPNM1;ESYT2
12725,GO:0050997,0.115324679218398,0.972898583353085,3,12,quaternary ammonium group binding,MF,PLTP;PITPNM1;ESYT2
11678,GO:0046473,0.11549114444747,0.953886103798177,6,31,phosphatidic acid metabolic process,BP,DGKA;LPCAT4;DGKQ;ACP6;LPCAT1;SLC27A1
12851,GO:0051180,0.11553806489494,0.964887813226693,4,18,vitamin transport,BP,SLC2A3;CD320;SLC35F3;SLC23A2
11366,GO:0045742,0.115576605093716,0.958623396314677,5,25,positive regulation of epidermal growth factor receptor signaling pathway,BP,ARAP1;AKT1;PTK6;EREG;TGFA
5095,GO:0015370,0.11563824503514,0.953811080824449,6,31,solute:sodium symporter activity,MF,SLC6A8;SLC6A6;SLC20A1;SLC13A5;SLC13A3;SLC23A2
19623,GO:1990748,0.115662670654784,0.940593031112211,10,67,cellular detoxification,BP,APOE;TXNRD3;PRDX5;CCS;GPX3;CYGB;GSTO1;SESN2;CAT;GCH1
11696,GO:0046498,0.115782937647794,0.983828760845362,2,6,S-adenosylhomocysteine metabolic process,BP,GAMT;AHCY
456,GO:0001302,0.116239137854235,0.983726487795004,2,6,replicative cell aging,BP,ERCC1;CHEK2
4960,GO:0015036,0.116257810820949,0.953114483036701,6,34,disulfide oxidoreductase activity,MF,TXNRD3;CCS;ERO1B;PDIA5;GSTO1;GLRX
13166,GO:0051781,0.116466751835936,0.942890828227134,9,54,positive regulation of cell division,BP,PGF;VEGFA;VEGFB;CDC25B;TGFB1;EREG;TGFA;CAT;SIRT2
3561,GO:0007606,0.116587796525666,0.953063173313779,6,33,sensory perception of chemical stimulus,BP,ITPR3;ASIC1;GNAL;BBS1;GJB4;REEP2
1370,GO:0003254,0.116665867048301,0.958111004534164,5,25,regulation of membrane depolarization,BP,FHL1;ANK3;NTSR1;BOK;IFI6
628,GO:0001818,0.116947968829267,0.923646715065158,22,160,negative regulation of cytokine production,BP,PDCD4;PRNP;PTPRS;ACP5;FGFR1;MAPKBP1;CEACAM1;GAS6;ERRFI1;IL20RB;RNF135;TGFB1;MC1R;TRIB2;JAK3;RPS6KA5;ASB1;HDAC7;INPP5D;ZFPM1;HFE;NDRG2
6576,GO:0022409,0.117069839976737,0.925322645799683,20,142,positive regulation of cell-cell adhesion,BP,ITGA6;AKT1;RAG1;ANK3;CARD11;IGFBP2;AP3D1;ADAM8;TGFB1;EFNB3;KIF26B;PRKCZ;ADA;JAK3;FYN;HLA-G;PAK1;ITGA4;ZP3;ITPKB
9505,GO:0036158,0.117102343602434,0.983532259030431,2,6,outer dynein arm assembly,BP,DNAAF5;MSS51
3949,GO:0008654,0.11722169720043,0.917727913313756,31,232,phospholipid biosynthetic process,BP,DGKA;LPCAT4;ISYNA1;HEXB;PIK3R2;SRD5A3;PIGQ;MBOAT7;PITPNM1;FGFR4;FGFR1;PIGV;DGKQ;MVD;SYNJ2;PI4K2A;ACP6;SBF1;CPNE7;LPCAT1;INPP5D;PI4K2B;PLA2G6;PITPNM3;CHKA;SLC27A1;TAZ;SAMD8;ZP3;FGFR3;SPTLC2
4959,GO:0015035,0.117495293131247,0.963583080205547,4,20,protein disulfide oxidoreductase activity,MF,TXNRD3;CCS;ERO1B;GLRX
15595,GO:0072080,0.117579776056507,0.939719308313462,10,61,nephron tubule development,BP,PGF;CTNNBIP1;VEGFA;WWTR1;WNT2B;LAMA5;PKD2;TGFB1;KIF26B;PKD1
9612,GO:0036481,0.117720243595853,0.98339265517618,2,6,intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,TRAP1;STK25
5694,GO:0016814,0.118045929574063,0.95745941485181,5,25,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines,MF,ADARB1;ADA;APOBEC3C;APOBEC3F;GCH1
3950,GO:0008655,0.118273771785295,0.971891625486094,3,12,pyrimidine-containing compound salvage,BP,TK2;UCKL1;UPP1
14694,GO:0070325,0.118508770420739,0.963651023488842,4,18,lipoprotein particle receptor binding,MF,APOE;LRP1;PCSK9;SNX17
978,GO:0002431,0.118640132353484,0.939065477405204,10,61,Fc receptor mediated stimulatory signaling pathway,BP,PIK3R2;WIPF1;PLCG1;CYFIP2;PRKCD;LIMK1;PLA2G6;FYN;MAPK3;PAK1
19758,GO:2000116,0.119004045531179,0.919808306756836,25,190,regulation of cysteine-type endopeptidase activity,BP,XDH;CST3;VEGFA;TNFRSF6B;F2R;GRAMD4;SMAD3;PRDX5;AKT1;PPM1F;DAP;RAG1;GAS6;GSN;TNFSF15;BOK;CYFIP2;IFI6;BAX;SOX7;BCAP31;FYN;MICAL1;NGFR;PDCD6
3588,GO:0008016,0.119042754385001,0.928301209138914,16,109,regulation of heart contraction,BP,APLN;ITPR3;SCN4B;NOS1;GAA;EPAS1;HBEGF;NPR2;SNTA1;PRKACA;ADA;TRPC1;CACNB3;GSTO1;EHD3;GCH1
16255,GO:0090312,0.119313711703851,0.963313728492142,4,18,positive regulation of protein deacetylation,BP,VEGFA;CTBP1;TGFB1;C6ORF89
3113,GO:0006694,0.119359035460178,0.925670319396603,18,127,steroid biosynthetic process,BP,EGR1;NR1D1;CYP27B1;APOE;SRD5A3;HSD17B8;FGFR4;SEC14L2;DGKQ;MVD;PLPP6;MBTPS2;HSD17B7;ABCG1;IGFBP7;CYP2R1;PROX1;HSD11B1
14306,GO:0061458,0.119589702103311,0.912399377100657,39,302,reproductive system development,BP,ERCC1;HTRA1;CST3;CYP27B1;VEGFA;WNT7A;EGFR;SERPINE2;SDC1;PHLDA2;ZFP36L1;PLCD3;MDFI;MAP2K1;EPAS1;AKT1;BSG;WNT2B;CCND1;CTSB;ALOX15B;PKD2;FBXW8;EPOR;CEBPB;VGF;ADA;BOK;BAX;EREG;ADAM15;ASB1;ARID5B;INSR;CUL7;BCL2L1;PKD1;ZP3;PLAG1
5270,GO:0015918,0.119673608594194,0.94090801631226,9,55,sterol transport,BP,APOE;OSBPL5;PLTP;LRP1;LDLR;PCSK9;ABCA2;ABCG1;ABCA7
16896,GO:0098843,0.119737036328346,0.982933686380775,2,6,postsynaptic endocytic zone,CC,DNM1;DNM2
3105,GO:0006686,0.119796235795715,0.982920137712818,2,6,sphingomyelin biosynthetic process,BP,SAMD8;SPTLC2
4264,GO:0009612,0.11984592002449,0.924310574316563,19,133,response to mechanical stimulus,BP,XPC;POSTN;EGFR;SERPINE2;ENDOG;FOS;AKT1;IGFBP2;SLITRK6;BNIP3;PKD2;TGFB1;SHANK3;PPL;FYN;SUN1;MAPK3;PKD1;LRP11
10716,GO:0044057,0.119862353550493,0.914685394999186,33,250,regulation of system process,BP,APLN;DOCK4;F2R;ITPR3;EGFR;SCN4B;NOS1;GAA;SMAD3;EPAS1;HBEGF;NLGN2;ADORA2B;AKT1;STK39;FGFR1;TNNT1;GAS6;ERRFI1;NPR2;SNTA1;GTF2IRD1;NTSR1;WASF3;PRKACA;ADA;TRPC1;CACNB3;GSTO1;EHD3;PAK1;LMNA;GCH1
4660,GO:0010810,0.119875984019753,0.923307407279117,20,141,regulation of cell-substrate adhesion,BP,POSTN;VEGFA;ITGA6;ARL2;FBLN1;SMAD3;PPM1F;EPHA1;RAC2;SMOC2;PLAU;RHOD;PRKCZ;MINK1;NET1;NID1;ADAM15;RAC3;DNM2;ITGA3
13817,GO:0060425,0.120035284582147,0.947260292869899,7,39,lung morphogenesis,BP,SPRY2;MAP2K1;WNT2B;CTSZ;MAPK3;VANGL2;CELSR1
4826,GO:0014032,0.120053875145686,0.940746712647494,9,54,neural crest cell development,BP,SEMA4B;EDNRA;SEMA3F;LAMA5;SEMA4F;MAPK3;SEMA4C;PDCD6;SEMA3B
10017,GO:0042455,0.12036746214747,0.950988048072562,6,34,ribonucleoside biosynthetic process,BP,NT5E;NME4;APRT;ADA;UCKL1;UPP1
5392,GO:0016229,0.120370801014254,0.962601435824431,4,19,steroid dehydrogenase activity,MF,SRD5A3;HSD17B8;HSD17B7;HSD11B1
17507,GO:1900543,0.120382599167902,0.956350076279777,5,25,negative regulation of purine nucleotide metabolic process,BP,MLXIPL;DDIT4;LTB4R2;PPARA;GABBR1
12831,GO:0051150,0.120423198292489,0.962847307851711,4,18,regulation of smooth muscle cell differentiation,BP,PDCD4;TGFB1;OLFM2;EREG
464,GO:0001503,0.120824095257918,0.914418583955897,32,241,ossification,BP,MEF2D;CYP27B1;MRC2;CTNNBIP1;ACVR2B;LRP5;EGFR;WWTR1;SMAD3;THBS3;SH3PXD2B;AKT1;PTHLH;MN1;COL13A1;NPR2;CEBPB;WNT3;TGFB1;NAB2;LRP4;PRKACA;AREG;FAM20C;ZHX3;HDAC7;ECM1;SUN1;CAT;MAPK3;COL6A1;FGFR3
14493,GO:0061951,0.120896323884237,0.94678606895434,7,39,establishment of protein localization to plasma membrane,BP,BBS2;RAB31;ANK3;BBS1;VAMP2;RILPL1;ARHGAP44
15681,GO:0072210,0.120908742601793,0.956099237565397,5,25,metanephric nephron development,BP,EGR1;PKD2;KIF26B;LAMB2;PKD1
413,GO:0001101,0.121174386699577,0.915163724205849,30,226,response to acid chemical,BP,EGR1;VEGFA;EGFR;CAPN2;NFATC4;AKT1;LDLR;TWF2;PTK6;GSN;IGFBP2;HLCS;PKD2;CEBPB;WNT3;NSMF;HMGCL;CD9;TGFBR3;MTHFR;TMEM161A;SESN2;FYN;CAT;IGFBP7;DNMT3A;BCL2L1;COL6A1;LRP11;ADCY6
4232,GO:0009414,0.121235808173269,0.982589330982081,2,6,response to water deprivation,BP,CD9;LRP11
5590,GO:0016615,0.121400607389166,0.982551296920122,2,6,malate dehydrogenase activity,MF,MDH2;PHGDH
10502,GO:0043412,0.121629834057057,0.891177038626861,364,3258,macromolecule modification,BP,TNIP1;DUSP6;XDH;DUSP5;GID4;ZMYND8;EGR1;EDEM1;DLG4;PLAT;CST3;FBXO2;PDCD4;ACVR2B;PRNP;VEGFA;WNT7A;APOE;F2R;LRP5;HMGA2;OBSCN;NEK9;PKN1;MTA1;ARRDC1;EGFR;RPS6KA2;WWTR1;LOXL1;OBSL1;NOS1;PTPRS;TMEM129;SPRY2;MST1R;CRTAP;KLHL29;LMF1;SHC1;DDB2;LTBP1;PTPRE;SNX9;SPRY4;RAPGEF3;ST6GALNAC2;ZFP36L1;MAP2K2;LPAR3;MARCH9;FKBP9;PPP1R35;RBCK1;RNF44;MAP2K1;SSH1;MARK4;SMURF2;FOS;FBLN1;SMAD3;PIK3R2;ERCC6;GJC2;SRD5A3;DVL1;EPAS1;PIGQ;HBEGF;RPUSD3;PPP1R14A;PPP2R3B;SHC2;CDK18;LY6K;FBXW5;RNF187;ADORA2B;ADARB1;AKT1;HDAC5;FBXO41;PPM1F;STK39;EPHA1;PTPRU;VEGFB;ASH2L;IMPACT;MARCH4;CNTN1;BRSK1;FGFR4;FGFR1;PRKACB;RAC2;TTLL12;HLTF;PPM1J;RAG1;B4GAT1;PIGV;SORL1;CEACAM1;B3GAT3;ASB13;HMG20B;IGFBP4;CCND1;PODNL1;LHPP;STRADB;SYNGAP1;MAPK13;GAS6;PTK6;CSNK1E;RAB3B;DUSP7;MAPKAPK3;PCSK9;RAD23A;ANO8;BCR;EHD4;ERRFI1;HLCS;CDC25B;SPTB;PEX10;RRNAD1;NPR2;SNTA1;DGKQ;PAK6;SHARPIN;CEMIP;PKD2;RASGEF1A;CDC42EP5;FBXW8;ZNF598;MAGEF1;EPHB2;ADAM8;CTBP1;JOSD2;PTPDC1;GRK6;CDKN1C;PLCG1;FBXL8;CD81;MVD;RNF135;ADAMTS13;TIMP2;ZNF862;TGFB1;SCYL1;ABHD17C;ULK2;MKNK2;ADAMTS7;B3GNT3;NAB2;SHANK3;RASA3;TNFSF15;MGAT4B;MDH2;MPG;FBXO17;NSMF;LCE1E;LAMB2;ERO1B;ST6GALNAC6;VGF;FBXO44;PHF21A;ZER1;PTPN1;B4GALT2;MBD3;IFNE;CAMK2N1;LRP4;ZDHHC24;B4GALT6;VHL;RFNG;MLXIPL;TRIB2;PRKCZ;KDM6B;PRKACA;MINK1;RABGGTA;AREG;PIM2;MPI;TDRKH;NEURL1B;ERBB2;ULK1;C6ORF89;STK17A;JAK3;RASA4;PDK1;THOP1;MCFD2;PRKCD;FAM20C;MIB2;USP20;STUB1;BAX;SBF1;TRIM4;ITGA1;FBXW4;EREG;RPS6KA5;DGUOK;DUSP4;CUL9;DDIT4;ZDHHC8;LIMK1;TGFBR3;PADI3;LEMD2;RPS6KA6;RGS14;MFNG;CHAD;MSLN;LRSAM1;ASB1;ST3GAL3;SYMPK;MAPK12;IRAK1;TGFA;HDAC7;MTHFR;PCMTD2;CHEK2;COG7;SESN2;JADE2;CDC34;RNF123;ABCA7;SPEG;MIF;EEF2KMT;KDM4B;PLA2G6;DDT;NUDT14;WFS1;QSOX1;DTX3;TRPT1;FYN;VWA1;STK25;ETFB;EEF2K;ARID5B;PELI1;NEIL1;TSPYL2;IGFBP7;ELFN2;SLC27A1;APOBEC3C;SATB1;ZDHHC1;APOBEC3F;MAPK3;INSR;ADCY1;INO80C;ETAA1;GLRX;VANGL2;PAK1;DCAF10;KLHL36;CAMKK2;PPP3CB;RNF144A;ALPK1;USP21;CUL7;MICAL1;SEMA4C;CAPRIN2;WDTC1;STK32C;DNMT3A;MAN2B1;SRMS;PPP2R5B;MAP2K3;DLG3;RRAS;PROX1;MDGA1;ZYG11B;PKD1;KCTD13;TNFRSF25;SIRT2;FAM129B;UVSSA;BACH1;ADCY7;ALG12;MAPRE3;ST3GAL2;LAMB1;SOCS7;MAP3K10;PELI3;RAB40B;NGFR;TOLLIP;PDCD6;DUSP23;CAMK1;CAMKK1;EZH1;SIRT3;HFE;WIPI2;BTG1;CDK11B;PFN2;SSH3;FGFR3;PPP1R16A;CCDC88C;ST3GAL5;NDRG2;MAN2B2;CBLC;ITPKB;CDC42BPG;PRSS21;CLK3;KDM3A;PKN3;TTLL3;ADCY6;LRRK1;AARS;KLHL24;SDC2
1583,GO:0003993,0.121721709440375,0.98247709299079,2,6,acid phosphatase activity,MF,ACP5;ACP6
17640,GO:1901342,0.121842120599094,0.917070841249966,26,191,regulation of vasculature development,BP,XDH;EGR1;PGF;PDCD4;VEGFA;HMGA2;SPRY2;RAPGEF3;HDAC5;EPHA1;VEGFB;CEACAM1;ANGPTL4;PLCG1;RNH1;EPN2;ERBB2;ADGRB2;HDAC7;ECM1;HYAL1;RRAS;FAM129B;NGFR;PDCD6;BTG1
9348,GO:0035864,0.121872262711375,0.982442257430897,2,6,response to potassium ion,BP,ADAMTS13;CARF
17471,GO:1900272,0.121895699253251,0.982436832073566,2,6,negative regulation of long-term synaptic potentiation,BP,PRNP;APOE
4468,GO:0010466,0.121935496442297,0.922672301620196,19,140,negative regulation of peptidase activity,BP,CST3;VEGFA;TNFRSF6B;SERPINE2;PRDX5;AKT1;SERPING1;RAG1;SORL1;GAS6;TFPI2;TIMP2;IFI6;PCSK1N;ECM1;MICAL1;BIN1;SERPINB1;NGFR
2746,GO:0006152,0.122012913483335,0.982409687780831,2,6,purine nucleoside catabolic process,BP,ADA;AHCY
11566,GO:0046130,0.122012913483335,0.982409687780831,2,6,purine ribonucleoside catabolic process,BP,ADA;AHCY
4893,GO:0014820,0.122068851936813,0.982396727641441,2,6,tonic smooth muscle contraction,BP,BBS2;EDNRA
16462,GO:0097136,0.122177237610675,0.982371605204588,2,6,Bcl-2 family protein complex,CC,BAX;BCL2L1
14951,GO:0070849,0.122266285647891,0.946029553971694,7,39,response to epidermal growth factor,BP,EGFR;ZFP36L1;AKT1;ERRFI1;PLCG1;ERBB2;MAPK3
10595,GO:0043574,0.122705866106108,0.961882203105826,4,18,peroxisomal transport,BP,ABCD1;PEX10;PEX1;LONP2
11098,GO:0045123,0.122737037396118,0.955224611605775,5,25,cellular extravasation,BP,BCR;ADAM8;PODXL2;ITGA1;ITGA4
4491,GO:0010518,0.122855867118003,0.955167605346619,5,25,positive regulation of phospholipase activity,BP,EGFR;FGFR1;EDNRA;PRKCZ;FGFR3
14601,GO:0070167,0.122906951657974,0.945674928912176,7,39,regulation of biomineral tissue development,BP,CYP27B1;ACVR2B;SMAD3;GAS6;TGFB1;FAM20C;ECM1
10015,GO:0042451,0.12303635536872,0.961221992741127,4,20,purine nucleoside biosynthetic process,BP,NT5E;NME4;APRT;ADA
11565,GO:0046129,0.12303635536872,0.961221992741127,4,20,purine ribonucleoside biosynthetic process,BP,NT5E;NME4;APRT;ADA
11365,GO:0045741,0.123132462813489,0.982149567325588,2,6,positive regulation of epidermal growth factor-activated receptor activity,BP,EREG;TGFA
16175,GO:0090197,0.123346582252502,0.982099641370139,2,6,positive regulation of chemokine secretion,BP,POSTN;ALOX15B
13563,GO:0060041,0.123457982574472,0.931648545949089,12,77,retina development in camera-type eye,BP,SDK2;ACVR2B;LRP5;IFT140;NPHP4;RAB11FIP4;TUB;LAMB2;BAX;LPCAT1;PROX1;ZNF513
5349,GO:0016101,0.12346300252006,0.941717305367735,8,47,diterpenoid metabolic process,BP,APOE;EGFR;SDC1;LRP1;RETSAT;GPC1;AGRN;SDC2
8155,GO:0032892,0.123471905615002,0.970086794450953,3,12,positive regulation of organic acid transport,BP,NTSR1;MIF;PLA2G6
7080,GO:0030881,0.1234763782489,0.982069349415671,2,6,beta-2-microglobulin binding,MF,FCGRT;HFE
11273,GO:0045591,0.123670023149946,0.982024117623696,2,6,positive regulation of regulatory T cell differentiation,BP,TGFB1;HLA-G
19127,GO:1905049,0.124062988443343,0.98193218596942,2,6,negative regulation of metallopeptidase activity,BP,SORL1;TIMP2
12482,GO:0050482,0.124064003886979,0.969878807985895,3,12,arachidonic acid secretion,BP,NTSR1;MIF;PLA2G6
18660,GO:1903963,0.124064003886979,0.969878807985895,3,12,arachidonate transport,BP,NTSR1;MIF;PLA2G6
9438,GO:0036020,0.124157145295202,0.96984604563039,3,12,endolysosome membrane,CC,AP2A2;LDLR;PCSK9
14517,GO:0070011,0.124203944347763,0.906319362748772,46,366,peptidase activity, acting on L-amino acid peptides,MF,HTRA1;PLAT;TYSND1;CTSO;CAPN2;PRSS8;NPEPL1;MMP1;RNPEPL1;F12;MMP28;RHBDF2;GGT1;PLAU;CTSB;PCSK9;PRSS22;ACY1;PCSK1;CTSZ;PRSS3;ADAM8;JOSD2;LTA4H;ADAMTS13;DPP7;ADAMTS7;MIPEP;CLCA2;ANKZF1;ADAM19;TPP1;CNDP2;MMP10;RNPEP;THOP1;USP20;MBTPS2;ADAM15;LONP2;SPPL2B;CTSF;USP21;PDCD6;PRSS21;PM20D2
11579,GO:0046165,0.124469016914072,0.924465692409163,16,111,alcohol biosynthetic process,BP,CYP27B1;APOE;ISYNA1;SRD5A3;SEC14L2;MVD;NTSR1;PLPP6;PCK2;MBTPS2;HSD17B7;ABCG1;CYP2R1;GCH1;ITPKB;SPTLC2
882,GO:0002246,0.125082739826073,0.98169273266238,2,6,wound healing involved in inflammatory response,BP,F2R;TGFB1
7049,GO:0030834,0.125101587924183,0.948775620935971,6,32,regulation of actin filament depolymerization,BP,TMOD2;TWF2;GSN;SPTB;CAPG;SH3BP1
15044,GO:0070997,0.125449015943957,0.911283330569083,31,236,neuron death,BP,EGR1;PRNP;APOE;F2R;SSH1;ENDOG;FOS;LRP1;ADARB1;AKT1;SIGMAR1;SORL1;SYNGAP1;PCSK9;BNIP3;CTSZ;ADAM8;CEBPB;NSMF;BOK;RILPL1;BAX;ITGA1;DDIT4;PPARA;CDC34;WFS1;FYN;BCL2L1;NGFR;AARS
8422,GO:0033539,0.125489021808724,0.969376237243162,3,12,fatty acid beta-oxidation using acyl-CoA dehydrogenase,BP,ACAD10;ACADS;ETFB
13073,GO:0051591,0.125646837796051,0.934651074482853,10,62,response to cAMP,BP,SDC1;RAPGEF3;ZFP36L1;FOS;BSG;DGKQ;PKD2;VGF;AREG;EEF2K
788,GO:0002053,0.125798600945936,0.960562904475408,4,18,positive regulation of mesenchymal cell proliferation,BP,VEGFA;LRP5;FGFR1;FBXW4
11235,GO:0045429,0.126130445768448,0.953589047512988,5,25,positive regulation of nitric oxide biosynthetic process,BP,SMAD3;AKT1;PKD2;DNM2;INSR
18838,GO:1904407,0.126130445768448,0.953589047512988,5,25,positive regulation of nitric oxide metabolic process,BP,SMAD3;AKT1;PKD2;DNM2;INSR
565,GO:0001707,0.126287802165564,0.943794748139153,7,39,mesoderm formation,BP,HMGA2;SMAD3;ITGB4;FGFR1;WNT3;KDM6B;ITGA3
11359,GO:0045732,0.126411739929683,0.915020636189584,24,176,positive regulation of protein catabolic process,BP,EDEM1;APOE;VPS11;SNX9;SMURF2;LRP1;DVL1;AKT1;LDLR;SORL1;CSNK1E;PCSK9;RAD23A;SH3D19;MAGEF1;ADAM8;CD81;SNX33;TRIB2;STUB1;LPCAT1;BCAP31;RNF144A;SIRT2
773,GO:0002029,0.126497697947051,0.969018793037091,3,12,desensitization of G-protein coupled receptor protein signaling pathway,BP,APLN;DNM1;DNM2
6569,GO:0022401,0.126497697947051,0.969018793037091,3,12,negative adaptation of signaling pathway,BP,APLN;DNM1;DNM2
13500,GO:0055081,0.126530078676668,0.948025422059969,6,32,anion homeostasis,BP,APOE;SLC12A7;FGFR4;MLXIPL;ABCG1;SLC12A4
16080,GO:0090045,0.126635694225313,0.981325612525801,2,6,positive regulation of deacetylase activity,BP,VEGFA;C6ORF89
3542,GO:0007568,0.126767021300826,0.911964276688149,28,212,aging,BP,ERCC1;PDCD4;PRNP;HMGA2;MAP2K1;ENDOG;FOS;LRP1;AKT1;SERPING1;GSN;IGFBP2;YPEL3;MNT;TIMP2;TGFB1;MBD3;ADA;PRKCD;IRAK1;INPP5D;CHEK2;MIF;CAT;DNMT3A;LMNA;SIRT3;TERC
18291,GO:1903170,0.126831526240987,0.959833620808566,4,19,negative regulation of calcium ion transmembrane transport,BP,PKD2;TGFB1;NTSR1;GSTO1
17739,GO:1901659,0.126905621123161,0.943140321660217,7,42,glycosyl compound biosynthetic process,BP,NT5E;TK2;NME4;APRT;ADA;UCKL1;UPP1
10558,GO:0043523,0.127002291378504,0.919078905791228,19,136,regulation of neuron apoptotic process,BP,PRNP;APOE;F2R;LRP1;SIGMAR1;SYNGAP1;PCSK9;CTSZ;ADAM8;CEBPB;NSMF;BOK;BAX;ITGA1;CDC34;WFS1;FYN;BCL2L1;AARS
3264,GO:0006939,0.127075811802297,0.936432804847042,9,55,smooth muscle contraction,BP,DOCK4;BBS2;F2R;ADORA2B;EDNRA;HTR7;ADA;SMTN;PLA2G6
4204,GO:0009314,0.127122925003628,0.904895985990699,43,338,response to radiation,BP,ERCC1;EGR1;XPC;LRP5;HMGA2;MTA1;EGFR;NFATC4;DDB2;FOS;ERCC6;AKT1;PITPNM1;IMPACT;BRSK1;NPHP4;RAG1;CIRBP;CCND1;SYNGAP1;MAPK13;CRTC1;TGFB1;DEAF1;MC1R;B4GALT2;PRIMPOL;NET1;REEP6;BAX;RGS14;CHEK2;TMEM161A;DNM2;BHLHE40;CAT;CYP2R1;REV1;HYAL1;DNMT3A;BCL2L1;UVSSA;NR2F6
4355,GO:0009953,0.127293032323553,0.93947906533704,8,47,dorsal/ventral pattern formation,BP,DUSP6;WNT7A;LRP5;MDFI;PRKACB;WNT3;LRP4;TCTN1
13306,GO:0052173,0.127353423397697,0.98115493753028,2,6,response to defenses of other organism involved in symbiotic interaction,BP,SMAD3;TGFB1
13311,GO:0052200,0.127353423397697,0.98115493753028,2,6,response to host defenses,BP,SMAD3;TGFB1
15948,GO:0075136,0.127353423397697,0.98115493753028,2,6,response to host,BP,SMAD3;TGFB1
10724,GO:0044087,0.127415822782867,0.896716936974715,81,668,regulation of cellular component biogenesis,BP,ERCC1;ZMYND8;ADGRL1;CTNNBIP1;VEGFA;WNT7A;APOE;ESPN;EVI5L;SDC1;DDB2;VPS11;TBC1D14;ARL2;MMP1;SNX9;RAPGEF3;ARAP1;SSH1;SMAD3;FAM110C;SH3PXD2B;NLGN2;TMOD2;CORO1B;PPM1F;EPHA1;IMPACT;IFT140;RAC2;NPHP4;SORL1;TENM2;TWF2;GSN;PLEKHG2;WIPF1;SLITRK6;ARPIN;SPTB;PLXNB3;CDC42EP5;EPHB2;TGFB1;FHOD3;SHANK3;EML2;CROCC;RHOD;AGRN;PRKCZ;PRKACA;CAPG;ADGRB2;ULK1;FSCN1;PRKCD;STUB1;BAX;LIMK1;WASH3P;LRSAM1;FHOD1;CDC34;PLA2G6;RAC3;EEF2K;DNM2;TPBG;PAK1;HYAL1;SAMD8;VPS16;PPP2R5B;PROX1;SIRT2;PXN;PLEKHM1;BBS10;PFN2;SSH3
6384,GO:0021587,0.127425514455377,0.952960692501718,5,25,cerebellum morphogenesis,BP,WNT7A;SERPINE2;TRNP1;MAP2K1;PROX1
9007,GO:0035176,0.127496294710819,0.947516464510293,6,32,social behavior,BP,DLG4;SHANK2;DVL1;SHANK3;PPP3CB;MSS51
13128,GO:0051703,0.127496294710819,0.947516464510293,6,32,intraspecies interaction between organisms,BP,DLG4;SHANK2;DVL1;SHANK3;PPP3CB;MSS51
10023,GO:0042473,0.127567209825607,0.981103976986034,2,6,outer ear morphogenesis,BP,FGFR1;MAPK3
14257,GO:0061326,0.127586797146418,0.933434359341206,10,62,renal tubule development,BP,PGF;CTNNBIP1;VEGFA;WWTR1;WNT2B;LAMA5;PKD2;TGFB1;KIF26B;PKD1
7120,GO:0030950,0.127629007325387,0.968616212206586,3,12,establishment or maintenance of actin cytoskeleton polarity,BP,RHOD;RHOF;RHOBTB2
7590,GO:0031968,0.127877635159297,0.91551993480624,22,162,organelle outer membrane,CC,CYP27B1;FAM210B;ITPR3;VAT1;ARMCX2;HK1;SIGMAR1;SYNE3;TOMM34;BPHL;BNIP3;RETSAT;MOAP1;TMEM173;ANKZF1;BOK;ULK1;BNIP3L;BAX;SNN;ARMCX1;BCL2L1
4809,GO:0014002,0.12797775432868,0.959336453293945,4,19,astrocyte development,BP,EGFR;LRP1;LDLR;LAMB2
6770,GO:0030212,0.128034663194432,0.952664350375965,5,25,hyaluronan metabolic process,BP,HEXB;AKT1;CEMIP;TGFB1;HYAL1
3435,GO:0007229,0.128037131725951,0.933151290127069,10,62,integrin-mediated signaling pathway,BP,ITGA6;ITGB4;CEACAM1;LAMA5;ITGB5;ADAMTS13;ITGA1;ADAM15;ITGA3;ITGA4
10154,GO:0042743,0.128066130442679,0.952281471463924,5,27,hydrogen peroxide metabolic process,BP,EGFR;PRDX5;RAC2;GPX3;CAT
17007,GO:0099094,0.128087823887969,0.947204266984092,6,32,ligand-gated cation channel activity,MF,ITPR3;KCNJ15;TPCN1;PKD2;ASIC1;RASA3
11806,GO:0046710,0.128099601891932,0.96844822755488,3,12,GDP metabolic process,BP,DLG4;CARD11;DLG3
11677,GO:0046471,0.128136125235297,0.952614941616495,5,25,phosphatidylglycerol metabolic process,BP,LPCAT4;LPCAT1;PLA2G6;SLC27A1;TAZ
4281,GO:0009650,0.12826496653206,0.968389125881749,3,12,UV protection,BP,ERCC1;MC1R;CAT
9879,GO:0042159,0.12840135904478,0.968340350480226,3,12,lipoprotein catabolic process,BP,APOE;LDLR;ABHD17C
3507,GO:0007420,0.128422255829675,0.900218822239423,56,449,brain development,BP,CST3;BBS2;WNT7A;NAGLU;EGFR;SERPINE2;PTPRS;TRNP1;SMARCA1;MAP2K1;SHANK2;LRP1;GJC2;MBOAT7;PITPNM1;CNTN1;WNT2B;FGFR1;TRAPPC9;CSNK1E;BCR;BNIP3;SHARPIN;EPOR;EPHB2;WNT3;SNPH;SHANK3;PHGDH;B4GALT2;MBD3;KDM6B;CD9;BOK;BAX;DDIT4;MYO1D;FYN;RAC3;SUN1;ADCY1;RERE;PAK1;PFKFB3;SEMA4C;PROX1;MDGA1;SIRT2;LAMB1;SOCS7;NDE1;TCTN1;EZH1;TACC1;NDRG2;AARS
19558,GO:1990459,0.128563959017622,0.980865639438195,2,6,transferrin receptor binding,MF,CD81;HFE
16715,GO:0097709,0.12856906154186,0.980864416210305,2,6,connective tissue replacement,BP,F2R;TGFB1
11323,GO:0045657,0.128588358046994,0.980859789971387,2,6,positive regulation of monocyte differentiation,BP,CTNNBIP1;ZFP36L1
12186,GO:0048365,0.128607625302448,0.935570297067824,9,54,Rac GTPase binding,MF,DOCK4;PKN1;DVL1;PAK6;FARP1;ARHGAP44;SH3BP1;ARHGEF4;PAK1
4723,GO:0010887,0.128696490912657,0.980833857211234,2,6,negative regulation of cholesterol storage,BP,PPARA;ABCG1
14630,GO:0070207,0.128728815484116,0.959009695169084,4,19,protein homotrimerization,BP,SIGMAR1;ASIC1;MIF;ATXN10
12277,GO:0048609,0.129007280959081,0.899492212667028,57,460,multicellular organismal reproductive process,BP,ERCC1;EGR1;CYP27B1;BBS2;EGFR;SERPINE2;CRTAP;ETV5;HEXB;TCFL5;TXNRD3;SH3PXD2B;AKT1;BSG;SCMH1;GGT1;PHC2;GAMT;CCNI;MICALCL;CTSB;CDC25B;NPR2;EPOR;WNT3;TGFB1;RFX2;DEAF1;MYCBPAP;DNAH1;CEP131;PRKACA;ADA;PIM2;TDRKH;FAM50A;BAX;SBF1;EREG;RPL39L;SPATA20;SIX5;BCAP31;PLA2G6;SUN1;DNM2;ITGA3;DNMT3A;BCL2L1;SIRT2;ADCY7;AZIN2;BTG1;ZP3;SEPT6;PRSS21;KDM3A
10234,GO:0042953,0.129060208886496,0.980746523944658,2,6,lipoprotein transport,BP,LRP1;UNC119B
11019,GO:0044872,0.129060208886496,0.980746523944658,2,6,lipoprotein localization,BP,LRP1;UNC119B
7939,GO:0032536,0.129125185502048,0.980730905155378,2,6,regulation of cell projection size,BP,WNT7A;TWF2
11402,GO:0045820,0.129424127527379,0.980658980095108,2,6,negative regulation of glycolytic process,BP,DDIT4;PPARA
12866,GO:0051198,0.129424127527379,0.980658980095108,2,6,negative regulation of coenzyme metabolic process,BP,DDIT4;PPARA
6081,GO:0019239,0.129493946766223,0.951758243033851,5,26,deaminase activity,MF,RPUSD3;ADARB1;ADA;APOBEC3C;APOBEC3F
12812,GO:0051126,0.129564040129941,0.980625279663682,2,6,negative regulation of actin nucleation,BP,CORO1B;ARPIN
6760,GO:0030201,0.129575273456228,0.951912621388337,5,25,heparan sulfate proteoglycan metabolic process,BP,B3GAT3;GPC1;XYLT2;VANGL2;NDST2
11682,GO:0046477,0.129610497571503,0.980614084258152,2,6,glycosylceramide catabolic process,BP,PRKCD;NAGA
17082,GO:0099590,0.129693074283255,0.980594178229787,2,6,neurotransmitter receptor internalization,BP,DNM1;DNM2
3325,GO:0007039,0.12971882300649,0.967867890142108,3,12,protein catabolic process in the vacuole,BP,LRP1;LDLR;CD81
4252,GO:0009581,0.129737588935955,0.938040991293559,8,47,detection of external stimulus,BP,SERPINE2;PITPNM1;PKD2;NTSR1;REEP6;FYN;PKD1;NR2F6
11782,GO:0046658,0.129772112519299,0.951621720503022,5,26,anchored component of plasma membrane,CC,PRNP;PRSS8;PRSS22;GPC1;MDGA1
15557,GO:0072009,0.129840157200613,0.929568003780489,11,70,nephron epithelium development,BP,PGF;CTNNBIP1;VEGFA;WWTR1;WNT2B;LAMA5;PKD2;TGFB1;KIF26B;LAMB2;PKD1
13457,GO:0055002,0.129842190063528,0.927402841380506,12,78,striated muscle cell development,BP,FLNC;VEGFA;OBSCN;OBSL1;SDC1;TMOD2;TNNT1;FHOD3;PAK1;PROX1;LMNA;FAM129B
6152,GO:0019471,0.129878671842928,0.967810403495561,3,12,4-hydroxyproline metabolic process,BP,ALDH4A1;PRODH;ERO1B
11541,GO:0046085,0.129973075623815,0.980526618605951,2,6,adenosine metabolic process,BP,NT5E;ADA
11443,GO:0045906,0.129986655953626,0.980523339457654,2,6,negative regulation of vasoconstriction,BP,APLN;DOCK4
12414,GO:0048873,0.130030350463282,0.958441594349766,4,19,homeostasis of number of cells within a tissue,BP,F2R;IL20RB;BAX;RAC3
8590,GO:0034105,0.130411601260278,0.958274740171652,4,19,positive regulation of tissue remodeling,BP,EGFR;ADAM8;BAX;PLEKHM1
5010,GO:0015171,0.130467687695104,0.937610069862741,8,47,amino acid transmembrane transporter activity,MF,SLC6A8;SLC7A8;SLC6A6;SLC15A4;SERINC2;SLC43A1;SLC38A10;SLC25A29
5598,GO:0016634,0.130491416696955,0.980401298131032,2,6,oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor,MF,RSAD1;PPOX
1590,GO:0004000,0.130735442107788,0.980342185659772,2,6,adenosine deaminase activity,MF,ADARB1;ADA
936,GO:0002335,0.130791453378953,0.958108298516138,4,19,mature B cell differentiation,BP,CMTM7;POU2F2;ADA;MFNG
7689,GO:0032153,0.130847347615838,0.928915380605104,11,70,cell division site,CC,PKN1;PLCD3;SSH1;PITPNM1;RAB11FIP4;SEPT10;RHOD;RHOF;RHOBTB2;NDE1;SEPT6
12739,GO:0051016,0.130903144462368,0.967441136745935,3,12,barbed-end actin filament capping,BP,TWF2;GSN;CAPG
12651,GO:0050864,0.130935794154803,0.928806771941437,11,71,regulation of B cell activation,BP,PKN1;ZFP36L1;STAT6;CARD11;CD81;TGFB1;CD320;ADA;INPP5D;MIF;PELI1
10381,GO:0043217,0.130942212431925,0.967427026319359,3,12,myelin maintenance,BP,NDRG1;AKT1;AHNAK2
13829,GO:0060440,0.131005926050119,0.980276578729031,2,6,trachea formation,BP,MAP2K1;MAPK3
1987,GO:0004707,0.131031644237174,0.967394717778585,3,12,MAP kinase activity,MF,MAPK13;MAPK12;MAPK3
3222,GO:0006878,0.131102146544708,0.966906191943526,3,13,cellular copper ion homeostasis,BP,PRNP;ATP7B;MT2A
6371,GO:0021561,0.131164999731423,0.980237952981795,2,6,facial nerve development,BP,ADARB1;SEMA3F
6394,GO:0021610,0.131164999731423,0.980237952981795,2,6,facial nerve morphogenesis,BP,ADARB1;SEMA3F
3888,GO:0008525,0.131310052671508,0.980202704719933,2,6,phosphatidylcholine transporter activity,MF,PLTP;ABCA7
9417,GO:0035988,0.131345009203333,0.980194206338336,2,6,chondrocyte proliferation,BP,HMGA2;FGFR3
10839,GO:0044342,0.131373200801926,0.96727122449454,3,12,type B pancreatic cell proliferation,BP,NR1D1;IGFBP4;ERRFI1
6889,GO:0030427,0.131535707323237,0.916956771002024,18,126,site of polarized growth,CC,ADGRL1;SSH1;SHANK2;DVL1;TMOD2;SIGMAR1;TENM2;TWF2;CTSZ;TIMP2;PI4K2A;FSCN1;RAC3;DNM2;ITGA3;DLG3;SIRT2;NDRG2
2639,GO:0005977,0.131589289496431,0.933671705491628,9,55,glycogen metabolic process,BP,NR1D1;PYGB;PGM1;PYGL;PHLDA2;GAA;AKT1;INSR;PFKM
2703,GO:0006073,0.131589289496431,0.933671705491628,9,55,cellular glucan metabolic process,BP,NR1D1;PYGB;PGM1;PYGL;PHLDA2;GAA;AKT1;INSR;PFKM
10714,GO:0044042,0.131589289496431,0.933671705491628,9,55,glucan metabolic process,BP,NR1D1;PYGB;PGM1;PYGL;PHLDA2;GAA;AKT1;INSR;PFKM
2290,GO:0005249,0.131633280787334,0.950903436738175,5,25,voltage-gated potassium channel activity,MF,KCNG1;KCNJ15;KCNC4;KCNAB2;PKD2
1130,GO:0002718,0.131687371139471,0.940541279322273,7,41,regulation of cytokine production involved in immune response,BP,HK1;TGFB1;PRKCZ;JAK3;MIF;MAPK3;HFE
12728,GO:0051000,0.131698686910841,0.967153392762604,3,12,positive regulation of nitric-oxide synthase activity,BP,APOE;AKT1;GCH1
14417,GO:0061724,0.131782984931167,0.980087602162325,2,6,lipophagy,BP,SESN2;SPTLC2
16126,GO:0090128,0.131806057185886,0.980081979825879,2,6,regulation of synapse maturation,BP,ADGRL1;NFATC4
13811,GO:0060416,0.131850011558614,0.950796827296404,5,25,response to growth hormone,BP,AKT1;PTPN1;JAK3;MAPK3;PXN
1975,GO:0004691,0.132074468872084,0.980016524409469,2,6,cAMP-dependent protein kinase activity,MF,PRKACB;PRKACA
13546,GO:0060020,0.132392425026227,0.979938873061407,2,6,Bergmann glial cell differentiation,BP,MAP2K1;MAPK3
14047,GO:0060836,0.132427011217916,0.979930418962855,2,6,lymphatic endothelial cell differentiation,BP,ACVR2B;PROX1
17472,GO:1900273,0.132453876896041,0.966879441566345,3,12,positive regulation of long-term synaptic potentiation,BP,CRTC1;EPHB2;SHANK3
15673,GO:0072201,0.13245655364078,0.979923196584121,2,6,negative regulation of mesenchymal cell proliferation,BP,CTNNBIP1;LMNA
3189,GO:0006817,0.132459428592739,0.966877424753266,3,12,phosphate ion transport,BP,FGFR1;SLC20A1;SLC37A2
11593,GO:0046209,0.132636308278869,0.936237984905171,8,48,nitric oxide metabolic process,BP,NOS1;ACP5;SMAD3;AKT1;PKD2;DNM2;INSR;GCH1
1450,GO:0003680,0.132650386894267,0.979875782790547,2,6,AT DNA binding,MF,H1F0;HMGA2
13705,GO:0060281,0.132750626634913,0.979851245022551,2,6,regulation of oocyte development,BP,NPR2;SIRT2
19396,GO:1905879,0.132750626634913,0.979851245022551,2,6,regulation of oogenesis,BP,NPR2;SIRT2
4869,GO:0014731,0.132832242593906,0.979831257123323,2,6,spectrin-associated cytoskeleton,CC,ANK3;SPTB
11489,GO:0045980,0.132841216412607,0.950108501530726,5,26,negative regulation of nucleotide metabolic process,BP,MLXIPL;DDIT4;LTB4R2;PPARA;GABBR1
7037,GO:0030817,0.132850882039985,0.957202449427735,4,19,regulation of cAMP biosynthetic process,BP,PTHLH;TIMP2;LTB4R2;GABBR1
3592,GO:0008022,0.132853205255456,0.91181461294663,22,161,protein C-terminus binding,MF,ERCC1;DLG4;SDC1;MAP2K1;SLC9A3R2;FBLN1;ERCC6;CEP250;CTBP1;SHANK3;EML2;SNX17;MIF4GD;PEX1;ERBB2;DNM1;BCAM;ECM1;NEIL1;PFKM;DLG3;MAPRE3
4767,GO:0010954,0.132876302151407,0.966725863049021,3,12,positive regulation of protein processing,BP,F12;GSN;ADAM8
18842,GO:1904415,0.1329261510262,0.979808248712032,2,6,regulation of xenophagy,BP,LRSAM1;MAPK3
18843,GO:1904417,0.1329261510262,0.979808248712032,2,6,positive regulation of xenophagy,BP,LRSAM1;MAPK3
3247,GO:0006910,0.132982855008468,0.979794350512626,2,6,phagocytosis, recognition,BP,PEAR1;TUB
846,GO:0002161,0.13302283961207,0.966672530344962,3,12,aminoacyl-tRNA editing activity,MF,DTD1;IARS2;AARS
17218,GO:0106074,0.13302283961207,0.966672530344962,3,12,aminoacyl-tRNA metabolism involved in translational fidelity,BP,DTD1;IARS2;AARS
9099,GO:0035374,0.133100984955372,0.979765384145731,2,6,chondroitin sulfate binding,MF,PTPRS;AGRN
8939,GO:0034983,0.133236790908851,0.979732062440391,2,6,peptidyl-lysine deacetylation,BP,SIRT2;SIRT3
15131,GO:0071229,0.13345854478255,0.91439136389668,19,135,cellular response to acid chemical,BP,EGR1;VEGFA;EGFR;CAPN2;NFATC4;AKT1;LDLR;TWF2;PTK6;PKD2;CEBPB;WNT3;NSMF;SESN2;FYN;DNMT3A;BCL2L1;COL6A1;ADCY6
15326,GO:0071549,0.13346163054794,0.949801072231831,5,26,cellular response to dexamethasone stimulus,BP,EGFR;ERRFI1;TGFB1;PCK2;DDIT4
4800,GO:0010996,0.133495409911468,0.966500337268526,3,12,response to auditory stimulus,BP,XPC;SLITRK6;SHANK3
3759,GO:0008306,0.133637464238284,0.939542090652784,7,40,associative learning,BP,FOS;RAG1;SYNGAP1;ASIC1;DEAF1;B4GALT2;RGS14
16821,GO:0098703,0.13367769426489,0.979623726097398,2,6,calcium ion import across plasma membrane,BP,PRNP;FYN
18084,GO:1902656,0.13367769426489,0.979623726097398,2,6,calcium ion import into cytosol,BP,PRNP;FYN
18451,GO:1903524,0.133779034187704,0.944029378006574,6,33,positive regulation of blood circulation,BP,APLN;F2R;EGFR;AKT1;ADA;GCH1
8635,GO:0034185,0.1337982413413,0.96638983260854,3,12,apolipoprotein binding,MF,LRP1;PCSK9;LRP4
14309,GO:0061469,0.133798959638173,0.979593887856197,2,6,regulation of type B pancreatic cell proliferation,BP,NR1D1;ERRFI1
19165,GO:1905165,0.13392752737752,0.979562233226917,2,6,regulation of lysosomal protein catabolic process,BP,LRP1;LDLR
2644,GO:0005984,0.133963433297393,0.979553389238987,2,6,disaccharide metabolic process,BP,GAA;IDUA
13257,GO:0051955,0.133970068098631,0.966327076557489,3,12,regulation of amino acid transport,BP,STK39;NTSR1;SV2A
16502,GO:0097201,0.134112911182909,0.96627487552756,3,12,negative regulation of transcription from RNA polymerase II promoter in response to stress,BP,IMPACT;VHL;SIRT2
18997,GO:1904779,0.1342739259132,0.979476846228821,2,6,regulation of protein localization to centrosome,BP,CEP250;CEP72
17569,GO:1901142,0.13428348954167,0.979474486726009,2,6,insulin metabolic process,BP,CEACAM1;ERO1B
9171,GO:0035542,0.1343401386182,0.979460508190592,2,6,regulation of SNARE complex assembly,BP,VPS11;VPS16
17768,GO:1901725,0.134375780933285,0.97945171120823,2,6,regulation of histone deacetylase activity,BP,VEGFA;C6ORF89
5473,GO:0016406,0.13437881060631,0.979450963374494,2,6,carnitine O-acyltransferase activity,MF,CRAT;CPT2
15691,GO:0072224,0.134381857050507,0.979450211389767,2,6,metanephric glomerulus development,BP,EGR1;LAMB2
11152,GO:0045217,0.134381857050516,0.979450211389758,2,6,cell-cell junction maintenance,BP,F2R;NLGN2
6834,GO:0030306,0.134381857050536,0.979450211389738,2,6,ADP-ribosylation factor binding,MF,SORL1;RAB11FIP4
474,GO:0001518,0.134381857050569,0.979450211389757,2,6,voltage-gated sodium channel complex,CC,SCN4B;SCN8A
930,GO:0002327,0.134381857050569,0.979450211389757,2,6,immature B cell differentiation,BP,LRRC8A;RAG1
5098,GO:0015377,0.134381857050571,0.979450211389755,2,6,cation:chloride symporter activity,MF,SLC12A7;SLC12A4
5100,GO:0015379,0.134381857050571,0.979450211389755,2,6,potassium:chloride symporter activity,MF,SLC12A7;SLC12A4
10366,GO:0043190,0.134381857050611,0.979450211389767,2,6,ATP-binding cassette (ABC) transporter complex,CC,ABCA2;ABCA7
2253,GO:0005168,0.134381857050621,0.979450211389757,2,6,neurotrophin TRKA receptor binding,MF,SHC1;PLCG1
14884,GO:0070679,0.134381857050621,0.979450211389757,2,6,inositol 1,4,5 trisphosphate binding,MF,ITPR3;TRPC1
3513,GO:0007440,0.134381857050621,0.979450211389757,2,6,foregut morphogenesis,BP,ACVR2B;SMAD3
13599,GO:0060080,0.134381857050621,0.979450211389757,2,6,inhibitory postsynaptic potential,BP,NLGN2;NTSR1
16467,GO:0097151,0.134381857050621,0.979450211389757,2,6,positive regulation of inhibitory postsynaptic potential,BP,NLGN2;NTSR1
16885,GO:0098828,0.134381857050621,0.979450211389757,2,6,modulation of inhibitory postsynaptic potential,BP,NLGN2;NTSR1
3442,GO:0007256,0.134381857050631,0.979450211389747,2,6,activation of JNKK activity,BP,ERCC6;MAP3K10
6682,GO:0030056,0.134381857050638,0.97945021138974,2,6,hemidesmosome,CC,ITGA6;ITGB4
7249,GO:0031223,0.134381857050691,0.979450211389739,2,6,auditory behavior,BP,SLITRK6;SHANK3
4490,GO:0010517,0.134663421906453,0.943554129508504,6,33,regulation of phospholipase activity,BP,EGFR;LRP1;FGFR1;EDNRA;PRKCZ;FGFR3
5075,GO:0015299,0.134846865385122,0.966006218547553,3,12,solute:proton antiporter activity,MF,SLC9A7;SLC22A18;TMCO3
8042,GO:0032703,0.135118096994582,0.965906751196841,3,12,negative regulation of interleukin-2 production,BP,PRNP;IL20RB;HDAC7
11500,GO:0045995,0.135468556678058,0.921659175524804,13,86,regulation of embryonic development,BP,DUSP6;PHLDA2;DVL1;WNT2B;FGFR1;PRKACB;LAMA5;RPS6KA6;INSR;VANGL2;HES7;FAM129B;CELSR1
2741,GO:0006140,0.135478426652022,0.915306937013132,17,120,regulation of nucleotide metabolic process,BP,VEGFA;APOE;NOS1;RAPGEF3;ADORA2B;PTHLH;PKD2;TIMP2;PFKFB2;MLXIPL;DDIT4;LTB4R2;PPARA;INSR;TAZ;PFKFB3;GABBR1
10596,GO:0043576,0.135487183247736,0.965771237406627,3,12,regulation of respiratory gaseous exchange,BP,APLN;NLGN2;NTSR1
4154,GO:0009218,0.135546018066986,0.955732815843053,4,20,pyrimidine ribonucleotide metabolic process,BP,NME4;UCKL1;UPP1;AK3
6286,GO:0019899,0.135953213749975,0.880918935704869,209,1827,enzyme binding,MF,TNIP1;MEF2D;EGR1;DLG4;CST3;TYSND1;BTBD2;DOCK4;PRNP;OBSCN;NDRG1;NEK9;PKN1;ARRDC1;EVI5L;EGFR;SPRY2;MST1R;SYTL1;APPL2;SHC1;TBC1D14;SLC12A7;RIN1;ACTA2;SNX9;RAPGEF3;ARAP1;PPP1R35;EXOC2;SLC9A3R2;SMAD3;STAT6;PIK3R2;LRP1;DVL1;EPAS1;HBEGF;AP2A2;SHC2;STOM;FBXW5;PAG1;AKT1;GRB7;HDAC5;FAM83A;PITPNM1;STK39;ASAP2;EPHA1;FMNL2;WWC3;BRSK1;FGFR4;LDLR;FGFR1;PRKACB;RAC2;PFKL;HLTF;RALGDS;SORL1;CEACAM1;RAB11FIP4;DOCK6;MICALCL;ABCD1;TRAPPC9;CCND1;TWF2;CEP250;GAS6;PLEKHG2;MAPKAPK3;RAD23A;BCR;XPOT;ERRFI1;HLCS;CDC25B;RGL2;SPTB;AGAP1;SNTA1;DGKQ;BNIP3;PAK6;PKD2;RASGEF1A;CDC42EP5;EPHB2;PLCG1;CBS;CEBPB;TIMP2;UHRF1BP1;TGFB1;MOAP1;TBC1D9B;TMEM173;ARAP3;FARP1;MC1R;RHOD;ABTB1;PLEKHG4;RHOF;LLGL1;PLEKHG3;RHOBTB2;RIMS3;PTPN1;CAMK2N1;LRP4;VHL;TRAP1;ADAP1;PFKFB2;TRIB2;PRKCZ;PRKACA;RABGGTA;TOM1L2;MICALL2;PLEKHG5;BOK;ERBB2;ULK1;RILPL1;JAK3;NET1;ARHGAP44;PRKCD;CACNB3;STUB1;SV2A;SBF1;ITGA1;SH3BP1;EREG;CUL9;GDI1;DNM1;RGS14;GIT1;LONP2;HDAC7;CHEK2;PPARA;CDC34;MIF;PLA2G6;ECM1;WFS1;SLC22A18;FYN;PITPNM3;RAC3;ACAP3;DNM2;ATXN10;INF2;CAT;SLC12A4;IQSEC1;ARHGEF4;MAPK3;INSR;ARHGEF1;CAMTA2;PFKM;DOCK9;PAK1;PPP3CB;RNF144A;CUL7;MICAL1;WDTC1;ITGA3;BIN1;MAP2K3;BCL2L1;DLG3;SGSM2;TBC1D16;PKD1;KCTD13;RABGAP1;SIRT2;UVSSA;MAPRE3;TEP1;NGFR;TOLLIP;PXN;TBC1D8;GCH1;KIF13B;SIRT3;TERC;BTG1;ZP3;FGFR3;CBLC;PKN3;SRSF5;ADCY6;STRN4
14052,GO:0060841,0.136161998332914,0.96552299354773,3,12,venous blood vessel development,BP,ACVR2B;VEGFA;PROX1
18974,GO:1904738,0.13617504446865,0.965518188180471,3,12,vascular associated smooth muscle cell migration,BP,DOCK4;SSH1;PAK1
18984,GO:1904752,0.13617504446865,0.965518188180471,3,12,regulation of vascular associated smooth muscle cell migration,BP,DOCK4;SSH1;PAK1
4900,GO:0014829,0.136210078995833,0.965505282544314,3,12,vascular smooth muscle contraction,BP,DOCK4;BBS2;EDNRA
590,GO:0001755,0.13626450449449,0.942691187903106,6,33,neural crest cell migration,BP,SEMA4B;SEMA3F;LAMA5;SEMA4F;SEMA4C;SEMA3B
3551,GO:0007595,0.136451343495949,0.942590272401813,6,33,lactation,BP,XDH;APLN;VEGFA;CCND1;APRT;ATP7B
9498,GO:0036150,0.136466104713314,0.965410920034835,3,12,phosphatidylserine acyl-chain remodeling,BP,OSBPL5;LPCAT4;OSBPL10
18255,GO:1903055,0.13649566844676,0.965400018105749,3,12,positive regulation of extracellular matrix organization,BP,SMAD3;TGFB1;FSCN1
4760,GO:0010941,0.136570907595457,0.883561298031765,137,1187,regulation of cell death,BP,DUSP6;XDH;EGR1;CST3;HS1BP3;PDCD4;PRNP;VEGFA;TNFRSF6B;WNT7A;APOE;F2R;LRP5;ITGA6;HMGA2;OBSCN;NDRG1;GRAMD4;EGFR;RPS6KA2;SPRY2;MST1R;NFATC4;SHC1;ZFP36L1;MAP2K2;NME4;RBCK1;MAP2K1;SSH1;ENDOG;MARK4;FOS;SMAD3;LRP1;PRDX5;PRODH;AKT1;PPM1F;STK39;EPHA1;IMPACT;DAP;FGFR4;FGFR1;SIGMAR1;RAG1;SORL1;ZNF385A;STRADB;SYNGAP1;GAS6;CTSB;CARD11;GSN;PLEKHG2;PCSK9;ANGPTL4;RGL2;BNIP3;PAK6;CTSZ;EPHB2;ADAM8;MNT;CEBPB;TGFB1;MOAP1;NTSR1;TNFSF15;NSMF;TNFAIP8L1;PTPN1;VHL;TRAP1;PRKCZ;MINK1;RABGGTA;ADA;PIM2;PLEKHG5;BOK;ERBB2;TFDP2;STK17A;RILPL1;JAK3;NET1;BNIP3L;PRKCD;IFI6;BAX;ITGA1;TMBIM4;DDIT4;DIP2A;IRAK1;INPP5D;CHEK2;PPARA;TMEM161A;CDC34;SOX7;BCAP31;MIF;PLA2G6;WFS1;FYN;STK25;EEF2K;DNM2;CAT;BEX2;ARHGEF4;INSR;ARHGEF1;GRINA;PAK1;MICAL1;DNMT3A;BIN1;MAP2K3;BCL2L1;LMNA;TNFRSF25;SIRT2;FAM129B;MAP3K10;PELI3;NGFR;PDCD6;PNMA1;BTG1;FGFR3;ITPKB;DEDD2;AARS
18932,GO:1904645,0.136800421714295,0.955448980191177,4,19,response to amyloid-beta,BP,PRNP;LRP1;FYN;NGFR
16158,GO:0090179,0.136816350876629,0.965281687032456,3,12,planar cell polarity pathway involved in neural tube closure,BP,DVL1;VANGL2;CELSR1
3782,GO:0008347,0.136875930314678,0.942360778478799,6,33,glial cell migration,BP,IDH2;HEXB;MBOAT7;SUN1;LAMB1;SOCS7
488,GO:0001541,0.137559371824444,0.937190663103825,7,41,ovarian follicle development,BP,VEGFA;CEBPB;VGF;BAX;EREG;BCL2L1;ZP3
12903,GO:0051258,0.137904898190514,0.903970434971763,27,205,protein polymerization,BP,ARL2;TMOD2;CORO1B;RAC2;TWF2;GSN;PLEKHG2;WIPF1;ARPIN;SPTB;CORO7;CDC42EP5;FHOD3;MSRB2;EML2;WASF3;TUBG2;MICALL2;CAPG;PRKCD;DNM1;WASH3P;RAC3;DNM2;PAK1;NDE1;PFN2
17112,GO:0101002,0.137947924102801,0.909881866955125,20,149,ficolin-1-rich granule,CC,CST3;PGM1;PYGL;SLC2A3;GAA;AP2A2;PFKL;CTSB;GSN;CTSZ;ADAM8;LTA4H;TIMP2;YPEL5;ACTR1B;ALDOC;MIF;GLB1;CAT;NBEAL2
1022,GO:0002521,0.138346487137969,0.897652601104245,38,297,leukocyte differentiation,BP,EGR1;CTNNBIP1;VEGFA;ZFP36L1;CMTM7;POU2F2;FOS;STAT6;HDAC5;LRRC8A;RAG1;CEACAM1;GAS6;CARD11;SOX13;AP3D1;SH3PXD2A;ADAM8;CEBPB;TGFB1;POLM;IFNE;PRKCZ;ADA;ERBB2;JAK3;FAM20C;BAX;MFNG;INPP5D;ZFPM1;SATB1;HLA-G;PPP3CB;RRAS;ITGA4;ITPKB;LRRK1
4197,GO:0009306,0.138402124393693,0.896004435964661,42,333,protein secretion,BP,NR1D1;ACVR2B;POSTN;F2R;LRP5;IDH2;ITPR3;EGFR;HADH;LMF1;LTBP2;ARL2;RAPGEF3;GLUL;POU2F2;NLGN2;RHBDF2;HK1;MAPKBP1;PFKL;GAS6;RAB3B;CARD11;ALOX15B;ADAM8;TGFB1;VGF;LLGL1;PCK2;PFKFB2;PRKCZ;NECAB3;OLFM2;MIF;PLA2G6;MAPK3;PFKM;PPP3CB;ICA1;RAB40B;PCLO;SIRT3
13243,GO:0051932,0.13847648689847,0.954698450862982,4,19,synaptic transmission, GABAergic,BP,NISCH;NLGN2;DNM1;RAC3
1171,GO:0002793,0.138534924525156,0.908479332836986,21,154,positive regulation of peptide secretion,BP,APLN;POSTN;F2R;EGFR;GLUL;NLGN2;HK1;ALOX15B;ADAM8;TGFB1;PCK2;PFKFB2;PRKCZ;RASL10B;MIF;PLA2G6;MAPK3;PFKM;PPP3CB;SIRT3;HFE
1998,GO:0004721,0.138759336733456,0.909374658023654,20,144,phosphoprotein phosphatase activity,MF,DUSP6;DUSP5;PTPRS;PTPRE;MAP2K1;SSH1;PPP2R3B;PPM1F;PTPRU;PPM1J;LHPP;DUSP7;CDC25B;PTPDC1;PTPN1;SBF1;DUSP4;PPP3CB;DUSP23;SSH3
19906,GO:2000379,0.138847815312668,0.929034879408441,9,57,positive regulation of reactive oxygen species metabolic process,BP,XDH;EGFR;SMAD3;AKT1;PKD2;TGFB1;PRKCD;DNM2;INSR
13456,GO:0055001,0.139169757091817,0.919092763140659,13,87,muscle cell development,BP,FLNC;VEGFA;OBSCN;OBSL1;NFATC4;SDC1;TMOD2;TNNT1;FHOD3;PAK1;PROX1;LMNA;FAM129B
4068,GO:0009123,0.139229040628266,0.899176587915289,33,271,nucleoside monophosphate metabolic process,BP,NT5E;DLG4;PGM1;DNPH1;TK2;HK1;PFKL;LHPP;PFKP;CARD11;DHTKD1;NADK;APRT;TGFB1;SDHA;PFKFB2;MLXIPL;ADA;UCKL1;FAM20C;CYC1;DGUOK;DDIT4;ALDOC;PPARA;UPP1;INSR;TAZ;PFKM;PFKFB3;DLG3;NDUFV3;AK3
13482,GO:0055038,0.139242607585692,0.925906733393063,10,64,recycling endosome membrane,CC,NDRG1;RAB11FIP4;EHD4;ABHD17C;BOK;WASH3P;EHD3;RAB12;SLC9A7;HLA-G
8572,GO:0034061,0.139750827183787,0.940655859133471,6,34,DNA polymerase activity,MF,POLD4;POLL;POLM;PRIMPOL;TEP1;TERC
14732,GO:0070405,0.140105317121106,0.946281863267889,5,27,ammonium ion binding,MF,PLTP;PITPNM1;HTR7;ESYT2;CHKA
10567,GO:0043536,0.140244323560445,0.93564440744045,7,41,positive regulation of blood vessel endothelial cell migration,BP,VEGFA;AKT1;FGFR1;PLCG1;TGFB1;HDAC7;MAP2K3
12413,GO:0048872,0.140248910297454,0.905304480848665,23,171,homeostasis of number of cells,BP,VEGFA;FAM210B;F2R;PKN1;ZFP36L1;EPAS1;AKT1;RAG1;CARD11;BCR;IL20RB;TGFB1;ADA;JAK3;BAX;TGFBR3;INPP5D;ZFPM1;MIF;RAC3;PPP3CB;SLC39A3;ITPKB
8414,GO:0033500,0.140334131903087,0.908143531779051,20,147,carbohydrate homeostasis,BP,NR1D1;PYGL;LRP5;ENDOG;PIK3R2;AKT1;HK1;FGFR4;GAS6;ERO1B;VGF;PCK2;MLXIPL;PRKACA;PLA2G6;WFS1;INSR;PFKM;PPP3CB;NGFR
10086,GO:0042593,0.140334131903087,0.908143531779051,20,147,glucose homeostasis,BP,NR1D1;PYGL;LRP5;ENDOG;PIK3R2;AKT1;HK1;FGFR4;GAS6;ERO1B;VGF;PCK2;MLXIPL;PRKACA;PLA2G6;WFS1;INSR;PFKM;PPP3CB;NGFR
10824,GO:0044325,0.140347932724698,0.920297729696066,12,80,ion channel binding,MF,FHL1;PRNP;SCN4B;NOS1;PACS2;ANK3;SNTA1;PKD2;RIMS3;FYN;GRINA;PKD1
3737,GO:0008277,0.140371503031149,0.92028185175602,12,80,regulation of G-protein coupled receptor protein signaling pathway,BP,APLN;NOS1;TMOD2;DGKQ;GRK6;ADA;USP20;DNM1;RGS14;GIT1;DNM2;HOMER2
3416,GO:0007205,0.140415570990574,0.953825409432671,4,19,protein kinase C-activating G-protein coupled receptor signaling pathway,BP,DGKA;F2R;LRP1;DGKQ
6270,GO:0019867,0.14071965257339,0.905837275077526,22,164,outer membrane,CC,CYP27B1;FAM210B;ITPR3;VAT1;ARMCX2;HK1;SIGMAR1;SYNE3;TOMM34;BPHL;BNIP3;RETSAT;MOAP1;TMEM173;ANKZF1;BOK;ULK1;BNIP3L;BAX;SNN;ARMCX1;BCL2L1
5539,GO:0016528,0.140723557090083,0.935367490525373,7,41,sarcoplasm,CC,XDH;FLNC;ITPR3;NOS1;ANK3;GSN;RTN2
5563,GO:0016575,0.14077779443048,0.920054148404896,12,79,histone deacetylation,BP,VEGFA;MTA1;HDAC5;HMG20B;CTBP1;TGFB1;PHF21A;MBD3;C6ORF89;HDAC7;SIRT2;SIRT3
10311,GO:0043101,0.140984275109059,0.963221139043637,3,13,purine-containing compound salvage,BP,APRT;ADA;DGUOK
16179,GO:0090201,0.141040000094993,0.963199981602221,3,13,negative regulation of release of cytochrome c from mitochondria,BP,AKT1;BCL2L1;LMNA
11358,GO:0045730,0.141235128835054,0.96312586275999,3,13,respiratory burst,BP,RAC2;BCR;INSR
16945,GO:0098927,0.141632156646665,0.93484170365624,7,41,vesicle-mediated transport between endosomal compartments,BP,VPS11;MAP2K2;MAP2K1;SORL1;WASH3P;MYO1D;MAPK3
286,GO:0000791,0.141688961258975,0.945478391358519,5,27,euchromatin,CC,H1F0;TRNP1;ASH2L;NSMF;DNMT3A
2602,GO:0005902,0.141863000047878,0.93061594702308,8,49,microvillus,CC,BBS2;ESPN;SYTL1;RAPGEF3;CEACAM1;TGFB1;FSCN1;KIF13B
10018,GO:0042461,0.1418803879346,0.953162546339552,4,19,photoreceptor cell development,BP,VEGFA;NAGLU;IFT140;NPHP4
7265,GO:0031252,0.141905730560133,0.894342102259565,39,304,cell leading edge,CC,PARVB;SPRY2;ACTA2;SNX9;SPRY4;RAPGEF3;SSH1;ITGB4;KCNC4;CORO1B;S100A6;DYSF;RAC2;TWF2;PTK6;GSN;WIPF1;ARPIN;PKD2;PLCG1;ARAP3;WASF3;PRKCZ;PLEKHG5;PLEK2;FSCN1;ARHGAP44;SH3BP1;LIMK1;WASH3P;MYO1D;ABCA7;RAC3;DNM2;ARHGEF4;INSR;PAK1;PXN;CDC42BPG
4253,GO:0009582,0.142032597241443,0.93060371212844,8,48,detection of abiotic stimulus,BP,SERPINE2;PITPNM1;PKD2;NTSR1;REEP6;FYN;PKD1;NR2F6
4825,GO:0014031,0.142305669082843,0.926944150495496,9,56,mesenchymal cell development,BP,SEMA4B;EDNRA;SEMA3F;LAMA5;SEMA4F;MAPK3;SEMA4C;PDCD6;SEMA3B
11382,GO:0045773,0.14239955976521,0.939354314155913,6,33,positive regulation of axon extension,BP,VEGFA;TWF2;LIMK1;GDI1;PAK1;CDH4
6814,GO:0030279,0.142535281876259,0.934318090385385,7,41,negative regulation of ossification,BP,LRP5;SMAD3;TGFB1;LRP4;AREG;HDAC7;ECM1
10342,GO:0043153,0.142621277167701,0.952826181971773,4,19,entrainment of circadian clock by photoperiod,BP,MTA1;CRTC1;BHLHE40;NR2F6
479,GO:0001525,0.142636887648133,0.892924700832619,41,322,angiogenesis,BP,APLN;PGF;VEGFA;WNT7A;HMGA2;ELK3;SPRY2;NFATC4;SHC1;RAPGEF3;PLCD3;EPAS1;HDAC5;SH2D2A;EPHA1;VEGFB;FGFR4;FGFR1;CEACAM1;EDNRA;LAMA5;ARHGAP22;ANGPTL4;EPHB2;ADAM8;PLCG1;RNH1;EPN2;ERBB2;ADGRB2;EREG;ADAM15;HDAC7;ECM1;ROBO4;HYAL1;RRAS;FAM129B;NGFR;PDCD6;BTG1
14780,GO:0070491,0.142687957797539,0.92670424406825,9,56,repressing transcription factor binding,MF,ZMYND8;BBS2;MTA1;HDAC5;CTBP1;BBS1;HDAC7;PPARA;BBS10
10380,GO:0043209,0.143096310139941,0.907205832840202,19,139,myelin sheath,CC,NDRG1;ITPR3;GLUL;GJC2;CNTN1;GSN;TAGLN3;SDHA;MDH2;PRKCZ;ERBB2;FSCN1;GDI1;DNM1;EHD3;MYO1D;MIF;ACO2;SIRT2
682,GO:0001893,0.143118300698163,0.944950325247409,5,26,maternal placenta development,BP,CYP27B1;AKT1;BSG;CTSB;EPOR
4653,GO:0010799,0.143133110361596,0.938952151680447,6,33,regulation of peptidyl-threonine phosphorylation,BP,SPRY2;DGKQ;CEMIP;TGFB1;DDIT4;SIRT2
13676,GO:0060228,0.143143234150113,0.994478856126228,1,2,phosphatidylcholine-sterol O-acyltransferase activator activity,MF,APOE
5676,GO:0016787,0.143326641721537,0.874176540801365,209,1838,hydrolase activity,MF,DUSP6;NT5E;ERCC1;DUSP5;HTRA1;THSD4;H6PD;EDEM1;PLAT;TYSND1;NAGLU;PLD3;MTA1;ACOT7;AKR7A2;DNPH1;PTPRS;CTSO;CAPN2;PRSS8;ARL2;HEXB;GTPBP1;PTPRE;NPEPL1;MMP1;GAA;RNPEPL1;CTBS;PLCD3;SMARCA1;PGLS;MAP2K1;ACP5;SSH1;ENDOG;TMEM8A;KLC2;ERCC6;RPUSD3;PPP2R3B;NLGN2;ADARB1;PLCXD2;HDAC5;NT5DC1;F12;PPM1F;MMP28;ENTPD6;RHBDF2;HAGHL;GGT1;PTPRU;RAB31;ACOT1;FUCA1;RAC2;OPLAH;HLTF;PPM1J;RAG1;BPHL;HMG20B;ABCD1;LHPP;TNNT1;AIG1;PLCH2;EDNRA;PLAU;CTSB;RAB3B;DUSP7;PCSK9;SEPT10;PRSS22;CDC25B;AGAP1;HAGH;CEMIP;ACY1;PCSK1;CTSZ;ABCA2;PRSS3;ADAM8;JOSD2;LTA4H;PTPDC1;PLCG1;KIF17;ENTPD2;ADAMTS13;SYNJ2;DPP7;GNAL;LACTB2;ABHD17C;ADAMTS7;ATP7B;MIPEP;KIF26B;MPG;GALNS;CLCA2;HEXDC;ABHD8;RHOD;ABHD14B;DNAH1;RHOF;ANKZF1;PHF21A;KIF7;PLPP6;RHOBTB2;ADAM19;TUBG2;PTPN1;PEX1;TPP1;MBD3;ACP6;MYH16;IDUA;PFKFB2;ADA;CNDP2;AHCY;MMP10;RNPEP;ACAD10;THOP1;USP20;SBF1;DTD1;DUSP4;MBTPS2;RASL10B;CES2;NAGA;NTPCR;PADI3;DNM1;ADAM15;WDR60;FAHD2B;LONP2;HDAC7;INPP5D;CHD2;ABHD15;ABCG1;MYO1D;MYH15;ABCA7;RAB12;PLA2G6;NUDT14;SPPL2B;RAC3;GLB1L2;DNM2;GLB1;CHKA;CAT;NEIL1;APOBEC3C;KIF26A;ASMTL;PLCB3;APOBEC3F;DDX50;TUBB6;PAN2;ATP8B2;RNASET2;PPP3CB;CTSF;USP21;PFKFB3;HYAL1;MAN2B1;NDST2;ABHD10;RRAS;DNASE1L1;IARS2;SIRT2;NT5C1B;RAB28;YDJC;RAB40B;PDCD6;ATP6V1F;RNASE7;DUSP23;GCH1;KIF13B;SIRT3;SEPT6;PFN2;SSH3;MAN2B2;PRSS21;DHX32;PM20D2;AARS
6429,GO:0021700,0.143483242535317,0.905832405141967,20,145,developmental maturation,BP,ADGRL1;DLG4;VEGFA;FAM210B;NFATC4;POU2F2;EPAS1;THBS3;FGFR1;CDC25B;NPR2;AP3D1;AGRN;PRKACA;FAM20C;EREG;RAC3;RERE;SIRT2;FGFR3
8108,GO:0032802,0.143574607126597,0.962233214344572,3,13,low-density lipoprotein particle receptor catabolic process,BP,APOE;AP2A2;PCSK9
8753,GO:0034433,0.14371533309869,0.975972551521163,2,7,steroid esterification,BP,APOE;ABCG1
8754,GO:0034434,0.14371533309869,0.975972551521163,2,7,sterol esterification,BP,APOE;ABCG1
8755,GO:0034435,0.14371533309869,0.975972551521163,2,7,cholesterol esterification,BP,APOE;ABCG1
1280,GO:0003073,0.143768411450658,0.93360155180636,7,41,regulation of systemic arterial blood pressure,BP,POSTN;F2R;GAS6;CTSZ;NTSR1;RASL10B;PLCB3
6171,GO:0019538,0.144069967671424,0.869486711904012,461,4231,protein metabolic process,BP,TNIP1;DUSP6;XDH;DUSP5;GID4;ZMYND8;HTRA1;THSD4;EGR1;NR1D1;EDEM1;DLG4;PLAT;CST3;TYSND1;BTBD2;FBXO2;PDCD4;ACVR2B;PRNP;VEGFA;TNFRSF6B;WNT7A;APOE;F2R;LRP5;HMGA2;OBSCN;NEK9;PKN1;MTA1;GRAMD4;ARRDC1;EGFR;RPS6KA2;SERPINE2;WWTR1;LOXL1;OBSL1;NOS1;PTPRS;TMEM129;CTSO;SPRY2;CAPN2;MST1R;CRTAP;LTBP4;PRSS8;KLHL29;LMF1;SHC1;DDB2;VPS11;LTBP1;HEXB;GTPBP1;PTPRE;NPEPL1;MMP1;SNX9;SPRY4;RAPGEF3;ST6GALNAC2;ZFP36L1;RNPEPL1;MAP2K2;LPAR3;MARCH9;FKBP9;PPP1R35;RBCK1;RNF44;MAP2K1;SSH1;MARK4;SMURF2;FBLN1;SMAD3;PIK3R2;ERCC6;LRP1;GJC2;SRD5A3;DVL1;EPAS1;PIGQ;HBEGF;AP2A2;PPP1R14A;PPP2R3B;PRDX5;SHC2;CDK18;LY6K;FBXW5;RNF187;ADORA2B;ADARB1;D2HGDH;AKT1;GRB7;HDAC5;FBXO41;F12;PPM1F;MMP28;RHBDF2;STK39;SERPING1;EPHA1;GGT1;PTPRU;VEGFB;ASH2L;IMPACT;MARCH4;CNTN1;BRSK1;DAP;FGFR4;LDLR;FGFR1;PRKACB;RAC2;TTLL12;HLTF;PPM1J;RAG1;B4GAT1;PIGV;SORL1;CEACAM1;B3GAT3;ASB13;CIRBP;HMG20B;TENM2;ZNF385A;IGFBP4;CCND1;PODNL1;LHPP;STRADB;SYNGAP1;MAPK13;PLAU;GAS6;PTK6;CSNK1E;CTSB;RAB3B;CARD11;DUSP7;GSN;MAPKAPK3;IGFBP2;PCSK9;RAD23A;PHLDA1;ANO8;BCR;MRPS6;EHD4;ERRFI1;HLCS;PRSS22;AIP;SH3D19;CDC25B;SPTB;PEX10;NPR2;SNTA1;DGKQ;BNIP3;PAK6;TFPI2;SHARPIN;MVB12B;CEMIP;PKD2;ACY1;PCSK1;RASGEF1A;CTSZ;CDC42EP5;FBXW8;ZNF598;MAGEF1;PRSS3;EPHB2;ADAM8;CTBP1;JOSD2;LTA4H;PTPDC1;GRK6;CDKN1C;PLCG1;FBXL8;CD81;CEBPB;MVD;RNF135;ADAMTS13;TIMP2;ZNF862;DPP7;C8ORF88;TGFB1;SCYL1;ABHD17C;UNK;ULK2;GPC1;MKNK2;ADAMTS7;B3GNT3;NAB2;SHANK3;MSRB2;RASA3;MIPEP;TNFSF15;MGAT4B;MDH2;FBXO17;CLCA2;NSMF;LCE1E;LAMB2;ABTB1;ERO1B;ST6GALNAC6;VGF;FBXO44;SNX33;ANKZF1;PHF21A;MIF4GD;UBXN4;ADAM19;ZER1;PTPN1;TPP1;B4GALT2;MBD3;IFNE;CAMK2N1;LRP4;ZDHHC24;B4GALT6;VHL;TRAP1;IDUA;RFNG;MLXIPL;TRIB2;PRKCZ;KDM6B;PRKACA;MINK1;RABGGTA;AREG;PIM2;MPI;BOK;NEURL1B;ERBB2;ULK1;CNDP2;MMP10;C6ORF89;NECAB3;STK17A;JAK3;RNPEP;BNIP3L;CYFIP2;RASA4;PDK1;THOP1;MCFD2;PRKCD;FAM20C;MIB2;USP20;STUB1;IFI6;BAX;SBF1;XYLT2;TRIM4;ITGA1;FBXW4;EREG;RPS6KA5;DGUOK;DUSP4;CUL9;DDIT4;MBTPS2;PCSK1N;ZDHHC8;LIMK1;TGFBR3;PADI3;RPL39L;LEMD2;RPS6KA6;RGS14;MFNG;CHAD;MRPS26;MSLN;LPCAT1;LRSAM1;ADAM15;ASB1;ST3GAL3;LONP2;SYMPK;MAPK12;IRAK1;TGFA;HDAC7;INPP5D;MTHFR;PCMTD2;CHEK2;ZFPM1;PPARA;COG7;SESN2;ABCG1;JADE2;CDC34;RNF123;SOX7;ABCA7;RAB12;SPEG;BCAP31;MIF;EEF2KMT;KDM4B;MEX3A;PLA2G6;DDT;NUDT14;ECM1;WFS1;QSOX1;DTX3;TRPT1;DALRD3;SPPL2B;FYN;VWA1;STK25;ETFB;EEF2K;ARID5B;PELI1;CAT;TSPYL2;IGFBP7;ELFN2;SLC27A1;SATB1;ZDHHC1;MAPK3;INSR;ADCY1;INO80C;ETAA1;GLRX;VANGL2;PAK1;DCAF10;KLHL36;CAMKK2;PPP3CB;RNF144A;ALPK1;CTSF;USP21;CUL7;MICAL1;HYAL1;SEMA4C;CAPRIN2;WDTC1;STK32C;BIN1;MAN2B1;SRMS;PPP2R5B;MAP2K3;NDST2;DLG3;RRAS;PROX1;IARS2;MDGA1;ZYG11B;PKD1;KCTD13;TNFRSF25;SIRT2;UVSSA;GAL3ST4;BACH1;ADCY7;ALG12;MAPRE3;AZIN2;SERPINB1;ST3GAL2;LAMB1;SOCS7;MAP3K10;PELI3;RAB40B;NGFR;TOLLIP;PDCD6;CHST14;DUSP23;CAMK1;CAMKK1;EZH1;SIRT3;HFE;WIPI2;BTG1;CDK11B;PFN2;SSH3;FGFR3;PPP1R16A;CCDC88C;ST3GAL5;NDRG2;MAN2B2;CBLC;ITPKB;CDC42BPG;PRSS21;CLK3;KDM3A;PM20D2;PKN3;TTLL3;CHPF;ADCY6;LRRK1;AARS;KLHL24;SDC2
10297,GO:0043067,0.144207841787942,0.877324170770328,128,1109,regulation of programmed cell death,BP,DUSP6;XDH;EGR1;CST3;HS1BP3;PDCD4;PRNP;VEGFA;TNFRSF6B;WNT7A;APOE;F2R;LRP5;ITGA6;HMGA2;OBSCN;NDRG1;GRAMD4;EGFR;RPS6KA2;SPRY2;MST1R;NFATC4;SHC1;ZFP36L1;MAP2K2;NME4;RBCK1;MAP2K1;ENDOG;MARK4;SMAD3;LRP1;PRDX5;AKT1;PPM1F;STK39;EPHA1;DAP;FGFR4;FGFR1;SIGMAR1;RAG1;ZNF385A;STRADB;SYNGAP1;GAS6;CTSB;CARD11;GSN;PLEKHG2;PCSK9;ANGPTL4;RGL2;BNIP3;PAK6;CTSZ;EPHB2;ADAM8;MNT;CEBPB;TGFB1;MOAP1;NTSR1;TNFSF15;NSMF;TNFAIP8L1;PTPN1;VHL;TRAP1;PRKCZ;MINK1;RABGGTA;ADA;PIM2;PLEKHG5;BOK;ERBB2;TFDP2;STK17A;JAK3;NET1;BNIP3L;PRKCD;IFI6;BAX;ITGA1;TMBIM4;DIP2A;IRAK1;INPP5D;CHEK2;TMEM161A;CDC34;SOX7;BCAP31;MIF;PLA2G6;WFS1;FYN;STK25;EEF2K;DNM2;CAT;BEX2;ARHGEF4;INSR;ARHGEF1;GRINA;PAK1;MICAL1;BIN1;MAP2K3;BCL2L1;LMNA;TNFRSF25;SIRT2;FAM129B;MAP3K10;PELI3;NGFR;PDCD6;PNMA1;BTG1;FGFR3;ITPKB;DEDD2;AARS
14148,GO:0061041,0.14426598029831,0.917650452360702,12,80,regulation of wound healing,BP,PLAT;APOE;F2R;SERPINE2;SMAD3;HBEGF;F12;SERPING1;CEACAM1;PLAU;CD9;PRKCD
1497,GO:0003841,0.144548262567198,0.951947895538598,4,19,1-acylglycerol-3-phosphate O-acyltransferase activity,MF,LPCAT4;MBOAT7;LPCAT1;TAZ
2717,GO:0006099,0.144550697755994,0.944018185130229,5,27,tricarboxylic acid cycle,BP,IDH2;DHTKD1;SDHA;MDH2;ACO2
7896,GO:0032471,0.144639071697299,0.975722558689598,2,7,negative regulation of endoplasmic reticulum calcium ion concentration,BP,BAX;BCAP31
20035,GO:2000637,0.144808106551868,0.951829084575063,4,19,positive regulation of gene silencing by miRNA,BP,EGFR;MAP2K2;MAP2K1;TGFB1
6194,GO:0019673,0.144914262405458,0.975647877201394,2,7,GDP-mannose metabolic process,BP,MPI;TSTA3
8676,GO:0034284,0.145191847238116,0.90687411862438,18,131,response to monosaccharide,BP,EGR1;NR1D1;ACVR2B;LRP5;GLUL;ENDOG;PFKL;GAS6;TGFB1;PCK2;PFKFB2;MLXIPL;PRKACA;VAMP2;SESN2;PLA2G6;CAT;PPP3CB
13106,GO:0051651,0.145327547379568,0.919193241592647,11,74,maintenance of location in cell,BP,APOE;ARL2;GAA;AKT1;HK1;SYNE3;SORL1;ANK3;TWF2;GSN;SUN1
12654,GO:0050867,0.145475304553561,0.900405247267412,24,181,positive regulation of cell activation,BP,STAT6;ADORA2B;AKT1;RAG1;GAS6;CARD11;IGFBP2;AP3D1;ADAM8;CD81;TGFB1;EFNB3;CD320;PRKCZ;ADA;JAK3;INPP5D;MIF;FYN;PELI1;HLA-G;PAK1;ZP3;ITPKB
14684,GO:0070306,0.145581100082298,0.951475110639272,4,19,lens fiber cell differentiation,BP,WNT7A;SMAD3;TGFB1;PROX1
18027,GO:1902510,0.145770532988071,0.975414896696179,2,7,regulation of apoptotic DNA fragmentation,BP,ENDOG;BAX
4637,GO:0010761,0.145772955781073,0.937499309151368,6,33,fibroblast migration,BP,AKT1;TGFB1;TNS1;CYGB;ARID5B;PAK1
18245,GO:1903039,0.146021463684221,0.907616425038456,17,122,positive regulation of leukocyte cell-cell adhesion,BP,AKT1;RAG1;CARD11;IGFBP2;AP3D1;ADAM8;TGFB1;EFNB3;PRKCZ;ADA;JAK3;FYN;HLA-G;PAK1;ITGA4;ZP3;ITPKB
13759,GO:0060348,0.146038044252421,0.907684390837775,17,119,bone development,BP,MEF2D;LRP5;ACP5;THBS3;SH3PXD2B;ZNF385A;COL13A1;NPR2;TGFB1;SLC38A10;NAB2;FAM20C;CHAD;ZFPM1;TRIM45;FGFR3;LRRK1
7036,GO:0030816,0.146347889373091,0.961165495098601,3,13,positive regulation of cAMP metabolic process,BP,RAPGEF3;PTHLH;TIMP2
6120,GO:0019370,0.146645303393656,0.975175937536666,2,7,leukotriene biosynthetic process,BP,GGT1;LTA4H
17581,GO:1901185,0.146853697191676,0.927578777263089,8,49,negative regulation of ERBB signaling pathway,BP,EGFR;SPRY2;HBEGF;ERRFI1;ERBB2;ITGA1;EREG;CBLC
16128,GO:0090130,0.147012574543871,0.896855626598094,27,205,tissue migration,BP,VEGFA;WNT7A;APOE;PKN1;ACTA2;HBEGF;AKT1;CORO1B;HDAC5;PPM1F;FGFR1;CEACAM1;PRSS3;PLCG1;TGFB1;PLEKHG5;SH3BP1;LTB4R2;HDAC7;HYAL1;ITGA3;MAP2K3;PROX1;PDCD6;PXN;PFN2;PKN3
3796,GO:0008375,0.147021349568274,0.927476248056872,8,49,acetylglucosaminyltransferase activity,MF,HEXB;PIGQ;B4GAT1;B3GNT3;MGAT4B;RFNG;XYLT2;MFNG
7357,GO:0031406,0.147143026247741,0.909800673669439,15,107,carboxylic acid binding,MF,NAGS;PYGL;NOS1;GLUL;PC;HLCS;CEMIP;GRIN3B;HMGCL;AGRN;GRHPR;PPARA;SESN2;PHYH;AARS
736,GO:0001968,0.147237578928376,0.950713896406882,4,19,fibronectin binding,MF,VEGFA;FBLN1;ITGA3;ITGA4
16159,GO:0090181,0.147779737387535,0.927012044839891,8,49,regulation of cholesterol metabolic process,BP,APOE;LMF1;LDLR;SEC14L2;DGKQ;MVD;MBTPS2;ABCG1
10570,GO:0043539,0.147951566673343,0.942269112331772,5,27,protein serine/threonine kinase activator activity,MF,SPRY2;MAP2K2;MAP2K1;TGFB1;ETAA1
17836,GO:1901985,0.148197227817979,0.936002837518322,6,34,positive regulation of protein acetylation,BP,NOS1;RAPGEF3;TGFB1;RPS6KA5;MAPK3;CAMK1
3699,GO:0008211,0.148206748215739,0.960444057588785,3,13,glucocorticoid metabolic process,BP,DGKQ;STUB1;HSD11B1
3623,GO:0008083,0.148272977656201,0.919875182802228,10,67,growth factor activity,MF,PGF;VEGFA;HBEGF;VEGFB;TGFB1;VGF;CD320;AREG;EREG;TGFA
10987,GO:0044794,0.148302086109414,0.960406931666104,3,13,positive regulation by host of viral process,BP,APOE;PC;STOM
17592,GO:1901214,0.148499999186512,0.895675008595027,27,206,regulation of neuron death,BP,EGR1;PRNP;APOE;F2R;SSH1;FOS;LRP1;AKT1;SIGMAR1;SORL1;SYNGAP1;PCSK9;CTSZ;ADAM8;CEBPB;NSMF;BOK;RILPL1;BAX;ITGA1;DDIT4;PPARA;CDC34;WFS1;FYN;BCL2L1;AARS
13029,GO:0051494,0.148547775663392,0.910612613464099,14,97,negative regulation of cytoskeleton organization,BP,ESPN;ARAP1;TMOD2;CORO1B;TWF2;GSN;ARPIN;SPTB;FHOD3;SHANK3;EML2;CAPG;PRKCD;PFN2
7289,GO:0031294,0.148621016086182,0.935767037204805,6,34,lymphocyte costimulation,BP,AKT1;CARD11;EFNB3;CD320;FYN;PAK1
13028,GO:0051493,0.148732454135125,0.88503590182191,49,396,regulation of cytoskeleton organization,BP,ESPN;CAPN2;ARL2;RAPGEF3;ARAP1;SSH1;SMAD3;LRP1;SH3PXD2B;FBXW5;TMOD2;CORO1B;PPM1F;EPHA1;RAC2;TWF2;CEP250;GSN;PLEKHG2;WIPF1;ARPIN;SPTB;CDC42EP5;TGFB1;FHOD3;SHANK3;EML2;RHOD;RHOF;RHOBTB2;CEP131;CAPG;FSCN1;ARHGAP44;PRKCD;SH3BP1;LIMK1;WASH3P;FHOD1;RAC3;MAPK3;VANGL2;PAK1;PROX1;PKD1;PXN;CELSR1;PFN2;SSH3
10566,GO:0043535,0.148883156309999,0.919598132642699,10,65,regulation of blood vessel endothelial cell migration,BP,VEGFA;APOE;AKT1;HDAC5;FGFR1;PLCG1;TGFB1;SH3BP1;HDAC7;MAP2K3
1712,GO:0004303,0.148912674227308,0.974552123865039,2,7,estradiol 17-beta-dehydrogenase activity,MF,HSD17B8;HSD17B7
4484,GO:0010508,0.149124542074231,0.910242631883911,14,96,positive regulation of autophagy,BP,TRIM65;TPCN1;BNIP3;FYCO1;GPSM1;PIM2;ULK1;BNIP3L;LRSAM1;SESN2;RAB12;MAPK3;CAMKK2;SPTLC2
4145,GO:0009208,0.149172174677262,0.95960503321946,3,14,pyrimidine ribonucleoside triphosphate metabolic process,BP,NME4;UCKL1;AK3
17582,GO:1901186,0.149493598104949,0.941471147947062,5,27,positive regulation of ERBB signaling pathway,BP,ARAP1;AKT1;PTK6;EREG;TGFA
2781,GO:0006216,0.149520691729725,0.974383753686838,2,7,cytidine catabolic process,BP,APOBEC3C;APOBEC3F
4363,GO:0009972,0.149520691729725,0.974383753686838,2,7,cytidine deamination,BP,APOBEC3C;APOBEC3F
11543,GO:0046087,0.149520691729725,0.974383753686838,2,7,cytidine metabolic process,BP,APOBEC3C;APOBEC3F
12590,GO:0050775,0.149541173058693,0.94165674329652,5,26,positive regulation of dendrite morphogenesis,BP,OBSL1;FBXW8;EEF2K;CUL7;CAPRIN2
19297,GO:1905517,0.149850082077997,0.948916461055038,4,21,macrophage migration,BP,MMP28;MIF;DDT;MAPK3
3103,GO:0006684,0.149911855660003,0.959778233720862,3,13,sphingomyelin metabolic process,BP,PRKCD;SAMD8;SPTLC2
18683,GO:1904018,0.1499250789247,0.906265012711434,16,113,positive regulation of vasculature development,BP,EGR1;PGF;VEGFA;HMGA2;RAPGEF3;EPHA1;VEGFB;CEACAM1;ANGPTL4;PLCG1;HDAC7;ECM1;HYAL1;RRAS;PDCD6;BTG1
12826,GO:0051145,0.15003539517497,0.934978458718378,6,34,smooth muscle cell differentiation,BP,PDCD4;VEGFA;NFATC4;TGFB1;OLFM2;EREG
12362,GO:0048762,0.150099138684045,0.902038226092613,19,137,mesenchymal cell differentiation,BP,SEMA4B;PDCD4;HMGA2;WWTR1;SMAD3;S100A4;FGFR1;EDNRA;SEMA3F;LAMA5;TGFB1;SEMA4F;TGFBR3;ADAM15;MAPK3;CUL7;SEMA4C;PDCD6;SEMA3B
1176,GO:0002822,0.150198128718593,0.915992126865065,11,73,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,PKN1;STAT6;CEACAM1;IL20RB;TGFB1;PRKCZ;ADA;JAK3;PPP3CB;HFE;ZP3
6787,GO:0030234,0.150293483007662,0.875959474165197,87,738,enzyme regulator activity,MF,CST3;DOCK4;APOE;EVI5L;EGFR;SERPINE2;SPRY2;APPL2;TBC1D14;ARL2;RIN1;ARAP1;MAP2K2;PPP1R35;MAP2K1;FBLN1;ARHGAP23;PIK3R2;ERCC6;PPP1R14A;SH3PXD2B;PPP2R3B;PRDX5;AKT1;SERPING1;ASAP2;RAC2;RALGDS;B3GAT3;CCND1;PODNL1;SYNGAP1;GAS6;ARHGAP22;BCR;ANGPTL4;ERRFI1;ARHGAP27;AGAP1;CCS;DGKQ;TFPI2;CDC42EP5;GPSM1;SH3PXD2A;CDKN1C;TIMP2;TGFB1;TBC1D9B;ARHGAP25;RASA3;ARAP3;RNH1;LLGL1;CAMK2N1;ADAP1;TRIB2;RASA4;ARHGAP44;PRKCD;SBF1;SH3BP1;PCSK1N;GDI1;RGS14;GIT1;CHAD;SESN2;ARHGAP12;ACAP3;ELFN2;ARHGEF1;RALGAPA1;ETAA1;WDTC1;PPP2R5B;SGSM2;TBC1D16;RABGAP1;TRIP10;AZIN2;SERPINB1;RAP1GAP2;SOCS7;RGS19;TBC1D8;PPP1R16A
14640,GO:0070231,0.150339977600938,0.934661187497247,6,35,T cell apoptotic process,BP,AKT1;RAG1;ADAM8;ADA;JAK3;BAX
7740,GO:0032261,0.150490254741766,0.974114314332668,2,7,purine nucleotide salvage,BP,APRT;ADA
12238,GO:0048523,0.15084590377672,0.864035806035673,365,3298,negative regulation of cellular process,BP,TNIP1;DUSP6;XDH;ERCC1;DUSP5;ZMYND8;SEMA4B;HTRA1;FHL1;EGR1;NR1D1;DLG4;PLAT;CST3;CYP27B1;FBXO2;APLN;PDCD4;CTNNBIP1;ACVR2B;XPC;PRNP;DDIT4L;POSTN;VEGFA;TNFRSF6B;WNT7A;APOE;ESPN;F2R;LRP5;ITGA6;HMGA2;NDRG1;IDH2;ELK3;ITPR3;PKN1;MTA1;ARRDC1;EVI5L;NISCH;EGFR;RPS6KA2;SERPINE2;WWTR1;NOS1;VAT1;PTPRS;HADH;SPRY2;MST1R;NFATC4;BAHCC1;CRTAP;SHC1;LTBP1;TBC1D14;TCFL5;PTPRE;SPRY4;RAPGEF3;ZFP36L1;ARAP1;MAP2K2;ZC3H6;MDFI;PPP1R35;RBCK1;TP53I11;FOXQ1;MAP2K1;ACP5;MCTP1;MXD4;SMURF2;FBLN1;SMAD3;STAT6;SHANK2;PIK3R2;LRP1;GJC2;DVL1;DNAJB5;HBEGF;PPP1R14A;PPP2R3B;PRDX5;SALL2;PAG1;ADARB1;AKT1;TPCN1;GRB7;TMOD2;CORO1B;HDAC5;PPM1F;MMP28;RHBDF2;STK39;SERPING1;SCMH1;EPHA1;PTPRU;IMPACT;WWC3;BRSK1;DAP;PTHLH;FGFR4;PEAR1;LDLR;FGFR1;PRKACB;MAPKBP1;PFKL;MXI1;NPHP4;RAG1;H2AFJ;SORL1;CEACAM1;CIRBP;HMG20B;LZTS2;TENM2;ZNF385A;ANK3;IGFBP4;TSHZ1;CCND1;PODNL1;PCBP4;TCF25;TWF2;STRADB;SYNGAP1;CARD19;GAS6;PTK6;SEMA3F;FGFBP1;DUSP7;GSN;IGFBP2;PCSK9;BCR;ANGPTL4;ERRFI1;RGL2;ARPIN;ALOX15B;SPTB;NPR2;SNTA1;DGKQ;PLXNB3;BNIP3;TFPI2;TAGLN3;CEMIP;PKD2;CTSZ;HES2;IL20RB;MAGEF1;EPHB2;ADAM8;ASIC1;CTBP1;MNT;CDKN1C;PLCG1;CEBPB;ZNF217;TIMP2;WNT3;C8ORF88;TGFB1;UNK;ULK2;GPC1;ADAMTS7;DEAF1;NTSR1;NAB2;ARHGAP25;FHOD3;SHANK3;EFNB3;RASA3;EML2;PEG3;ARAP3;FARP1;CGREF1;SNX33;SEMA4F;PHF21A;KIF7;TNFAIP8L1;PTPN1;MBD3;CAMK2N1;LRP4;VHL;TRAP1;MLXIPL;TRIB2;PRKCZ;PRKACA;TOM1L2;CD9;EPN2;ADA;AREG;PIM2;BOK;CAPG;ERBB2;ULK1;TFDP2;JAK3;BNIP3L;TRPC1;NELFCD;RASA4;CYGB;ARHGAP44;PRKCD;RBL2;STUB1;IFI6;BAX;ITGA1;SH3BP1;CHADL;EREG;RPS6KA5;DGUOK;DUSP4;TMBIM4;DDIT4;PPP1R13L;PCSK1N;LIMK1;TGFBR3;GDI1;LTB4R2;LEMD2;RPS6KA6;ZHX3;DNM1;RGS14;GSTO1;CHAD;LPCAT1;LRSAM1;ADAM15;ASB1;MAPK12;IRAK1;HDAC7;INPP5D;CBX7;CHEK2;ZFPM1;PPARA;TMEM161A;SESN2;ABCG1;MYO1D;CDC34;SOX7;ABCA7;SPEG;SIX5;MIF;MEX3A;PLA2G6;DDT;ECM1;WFS1;QSOX1;FYN;EEF2K;ARHGAP12;ARID5B;DNM2;BHLHE40;PELI1;CAT;NEIL1;TSPYL2;IGFBP7;ELFN2;SLC27A1;APOBEC3C;SATB1;KIF26A;APOBEC3F;INSR;GRINA;C12ORF66;RERE;HLA-G;ETAA1;BCL7A;PAK1;GABBR1;MICAL1;HYAL1;SEMA4C;CAPRIN2;WDTC1;HES7;ITGA3;DNMT3A;BIN1;SRMS;PPP2R5B;HES6;BCL2L1;DLG3;RRAS;PROX1;LMNA;PKD1;KCTD13;SIRT2;FAM129B;DCBLD2;BACH1;SERPINB1;RAP1GAP2;SOCS7;MAP3K10;RGS19;PELI3;NGFR;PDCD6;GRB10;NR2F6;CBX6;SIRT3;HFE;TERC;GAS2L1;BTG1;ZP3;SEMA3B;PFN2;FGFR3;TNRC18;NDRG2;CBLC;ITPKB;IRF2BPL;KDM3A;DEDD2;ADCY6;LRRK1;AARS
19126,GO:1905048,0.15114662269642,0.959293654793243,3,13,regulation of metallopeptidase activity,BP,SORL1;TIMP2;MAPK3
11278,GO:0045599,0.151277115840024,0.934284117287609,6,34,negative regulation of fat cell differentiation,BP,WWTR1;SMAD3;TGFB1;TRIB2;ZFPM1;SIRT2
5548,GO:0016553,0.151376287072925,0.959203300467713,3,13,base conversion or substitution editing,BP,ADARB1;APOBEC3C;APOBEC3F
17933,GO:1902236,0.151674455192663,0.95908589097054,3,13,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,PTPN1;WFS1;GRINA
16167,GO:0090189,0.151711592160982,0.959071259301634,3,13,regulation of branching involved in ureteric bud morphogenesis,BP,VEGFA;WNT2B;TGFB1
7894,GO:0032469,0.151963124568643,0.948205906583324,4,20,endoplasmic reticulum calcium ion homeostasis,BP,BAX;BCAP31;WFS1;GRINA
8423,GO:0033540,0.152007719422592,0.958954522044213,3,13,fatty acid beta-oxidation using acyl-CoA oxidase,BP,CRAT;ABCD1;DECR2
14952,GO:0070851,0.152094898040966,0.912265403012536,12,81,growth factor receptor binding,MF,PGF;VEGFA;SHC1;HBEGF;VEGFB;AREG;EREG;TGFA;ECM1;FYN;TOLLIP;CBLC
12209,GO:0048469,0.152218170394792,0.909989677018052,13,89,cell maturation,BP,VEGFA;FAM210B;POU2F2;EPAS1;FGFR1;CDC25B;NPR2;AGRN;PRKACA;FAM20C;EREG;RAC3;SIRT2
10642,GO:0043679,0.152268809648906,0.917379863686187,10,65,axon terminus,CC,GLUL;KCNC4;KCNAB2;AP3D1;NTSR1;SV2A;SYNGR1;MICAL1;SEPT6;PFN2
11769,GO:0046638,0.152925267453974,0.947753688798347,4,20,positive regulation of alpha-beta T cell differentiation,BP,AP3D1;PRKCZ;ADA;ITPKB
17381,GO:1900103,0.153013174247278,0.958557290883166,3,13,positive regulation of endoplasmic reticulum unfolded protein response,BP,PTPN1;BOK;BAX
6644,GO:0023058,0.153072226986212,0.958533918912888,3,13,adaptation of signaling pathway,BP,APLN;DNM1;DNM2
16140,GO:0090153,0.153130608852346,0.958510807922385,3,13,regulation of sphingolipid biosynthetic process,BP,PRKCD;PLA2G6;SAMD8
19119,GO:1905038,0.153130608852346,0.958510807922385,3,13,regulation of membrane lipid metabolic process,BP,PRKCD;PLA2G6;SAMD8
19851,GO:2000303,0.153130608852346,0.958510807922385,3,13,regulation of ceramide biosynthetic process,BP,PRKCD;PLA2G6;SAMD8
12178,GO:0048332,0.153656317627534,0.927790154225739,7,41,mesoderm morphogenesis,BP,HMGA2;SMAD3;ITGB4;FGFR1;WNT3;KDM6B;ITGA3
7048,GO:0030833,0.153745727944713,0.903428879937967,16,115,regulation of actin filament polymerization,BP,TMOD2;CORO1B;RAC2;TWF2;GSN;PLEKHG2;WIPF1;ARPIN;SPTB;CDC42EP5;FHOD3;CAPG;PRKCD;WASH3P;RAC3;PFN2
12592,GO:0050777,0.153922652184283,0.910962506728215,12,82,negative regulation of immune response,BP,STAT6;SERPING1;CEACAM1;BCR;FAM3A;IL20RB;TGFB1;JAK3;INPP5D;HLA-G;PPP3CB;HFE
4620,GO:0010742,0.153951981996663,0.947269785772618,4,20,macrophage derived foam cell differentiation,BP,ALOX15B;TGFB1;PPARA;ABCG1
16095,GO:0090077,0.153951981996663,0.947269785772618,4,20,foam cell differentiation,BP,ALOX15B;TGFB1;PPARA;ABCG1
1103,GO:0002691,0.15435821339801,0.958023805162534,3,13,regulation of cellular extravasation,BP,BCR;ADAM8;ITGA4
19792,GO:2000194,0.154487949004867,0.972991035214827,2,7,regulation of female gonad development,BP,INSR;ZP3
17038,GO:0099504,0.154522387083177,0.91064638239109,12,80,synaptic vesicle cycle,BP,WNT7A;SYTL1;NLGN2;SYT8;AP3D1;SNPH;RIMS3;VAMP2;DNM1;DNM2;PCLO;PFN2
13600,GO:0060081,0.154592545939179,0.972961379358202,2,7,membrane hyperpolarization,BP,CRTC1;PRKCZ
13352,GO:0052548,0.154623499874848,0.886796978528348,33,269,regulation of endopeptidase activity,BP,XDH;CST3;VEGFA;TNFRSF6B;F2R;GRAMD4;SERPINE2;SMAD3;PRDX5;AKT1;PPM1F;SERPING1;DAP;RAG1;SORL1;GAS6;GSN;TFPI2;TIMP2;TNFSF15;BOK;CYFIP2;IFI6;BAX;PCSK1N;SOX7;BCAP31;FYN;MICAL1;BIN1;SERPINB1;NGFR;PDCD6
14611,GO:0070181,0.154625047545106,0.972043072052115,2,8,small ribosomal subunit rRNA binding,MF,CIRBP;MRPS6
18179,GO:1902931,0.154660784163039,0.97294202480498,2,7,negative regulation of alcohol biosynthetic process,BP,CYP27B1;APOE
6066,GO:0019217,0.154693791096097,0.919006883781185,9,57,regulation of fatty acid metabolic process,BP,TYSND1;AKT1;CEACAM1;MLXIPL;PDK1;LONP2;PPARA;MLYCD;WDTC1
478,GO:0001523,0.154712707815541,0.927042033525946,7,42,retinoid metabolic process,BP,APOE;SDC1;LRP1;RETSAT;GPC1;AGRN;SDC2
12657,GO:0050870,0.154766567680757,0.902684457557304,16,115,positive regulation of T cell activation,BP,AKT1;RAG1;CARD11;IGFBP2;AP3D1;ADAM8;TGFB1;EFNB3;PRKCZ;ADA;JAK3;FYN;HLA-G;PAK1;ZP3;ITPKB
20218,GO:2001056,0.154911472532834,0.902492723725782,16,118,positive regulation of cysteine-type endopeptidase activity,BP,XDH;F2R;GRAMD4;SMAD3;PPM1F;DAP;GSN;TNFSF15;BOK;CYFIP2;BAX;SOX7;BCAP31;FYN;NGFR;PDCD6
7668,GO:0032104,0.155400794812484,0.957608639145434,3,13,regulation of response to extracellular stimulus,BP,CYP27B1;BBS2;PPARA
7671,GO:0032107,0.155400794812484,0.957608639145434,3,13,regulation of response to nutrient levels,BP,CYP27B1;BBS2;PPARA
6740,GO:0030166,0.155670705881859,0.926592078939643,7,41,proteoglycan biosynthetic process,BP,B3GAT3;XYLT2;VANGL2;NDST2;GAL3ST4;CHST14;CHPF
7182,GO:0031077,0.155735395982751,0.972636470064433,2,7,post-embryonic camera-type eye development,BP,VEGFA;BAX
6712,GO:0030128,0.155785684874812,0.957455009737986,3,13,clathrin coat of endocytic vesicle,CC,EGFR;AP2A2;EPN2
10357,GO:0043177,0.155795366037048,0.903555687252311,15,108,organic acid binding,MF,NAGS;PYGL;NOS1;GLUL;PC;HLCS;CEMIP;GRIN3B;HMGCL;AGRN;GRHPR;PPARA;SESN2;PHYH;AARS
12035,GO:0047844,0.156001964465641,0.972560452831135,2,7,deoxycytidine deaminase activity,MF,APOBEC3C;APOBEC3F
7784,GO:0032331,0.156058696660762,0.957345918318883,3,13,negative regulation of chondrocyte differentiation,BP,PTHLH;ADAMTS7;CHADL
15240,GO:0071404,0.156261936760045,0.957264642854924,3,13,cellular response to low-density lipoprotein particle stimulus,BP,LDLR;CD81;CD9
7068,GO:0030863,0.156328490140906,0.90940207778227,12,80,cortical cytoskeleton,CC,DLG4;CAPN2;RAPGEF3;MYZAP;GSN;WIPF1;SPTB;NSMF;LLGL1;RIMS3;PCLO;HFE
7882,GO:0032456,0.156433502303332,0.93138064575292,6,34,endocytic recycling,BP,SORL1;RAB11FIP4;EHD4;MICALL2;EHD3;VPS51
1119,GO:0002707,0.156494892541454,0.946065362250136,4,20,negative regulation of lymphocyte mediated immunity,BP,CEACAM1;IL20RB;PPP3CB;HFE
15823,GO:0072529,0.156533788730337,0.937585608218992,5,28,pyrimidine-containing compound catabolic process,BP,NT5E;UPP1;NEIL1;APOBEC3C;APOBEC3F
10539,GO:0043495,0.156622039722277,0.972383286148098,2,7,protein membrane anchor,MF,SUN1;PDCD6
5858,GO:0017157,0.156669330963481,0.899797313504113,17,122,regulation of exocytosis,BP,SYTL1;SDC1;ADORA2B;SYT8;RAC2;CEACAM1;RAB3B;BCR;LLGL1;RIMS3;VAMP2;PLA2G6;MICAL1;RAB40B;PCLO;ZP3;PFN2
11759,GO:0046627,0.156693884863186,0.93770516359055,5,27,negative regulation of insulin receptor signaling pathway,BP,PTPRE;PTPN1;PRKCZ;PRKCD;GRB10
12049,GO:0048008,0.156813932494311,0.925910028444552,7,41,platelet-derived growth factor receptor signaling pathway,BP,PLAT;VEGFA;LRP1;BCR;PTPN1;RGS14;ARID5B
709,GO:0001935,0.157047392593733,0.90656479856883,13,90,endothelial cell proliferation,BP,XDH;APLN;PGF;VEGFA;APOE;AKT1;VEGFB;FGFR1;PLXNB3;ECM1;PROX1;NGFR;PDCD6
16392,GO:0097011,0.157091125659164,0.972248943935271,2,7,cellular response to granulocyte macrophage colony-stimulating factor stimulus,BP,AKT1;NPR2
16393,GO:0097012,0.157091125659164,0.972248943935271,2,7,response to granulocyte macrophage colony-stimulating factor,BP,AKT1;NPR2
7645,GO:0032071,0.157316938750631,0.972184175999866,2,7,regulation of endodeoxyribonuclease activity,BP,AKT1;PRKCD
3460,GO:0007281,0.157391604964432,0.897825661917034,18,131,germ cell development,BP,ERCC1;BBS2;ETV5;HEXB;AKT1;CDC25B;NPR2;RFX2;DEAF1;DNAH1;PRKACA;BAX;EREG;SIX5;BCL2L1;SIRT2;ZP3;KDM3A
2285,GO:0005244,0.157430019909142,0.913974877514947,10,65,voltage-gated ion channel activity,MF,KCNG1;SCN4B;KCNJ15;TPCN1;KCNC4;KCNAB2;GAS6;PKD2;CACNB3;SCN8A
6606,GO:0022832,0.157430019909142,0.913974877514947,10,65,voltage-gated channel activity,MF,KCNG1;SCN4B;KCNJ15;TPCN1;KCNC4;KCNAB2;GAS6;PKD2;CACNB3;SCN8A
6426,GO:0021697,0.157521517443197,0.956759725420349,3,13,cerebellar cortex formation,BP,WNT7A;MAP2K1;PROX1
530,GO:0001649,0.157633827400542,0.896338048631629,19,139,osteoblast differentiation,BP,MEF2D;MRC2;CTNNBIP1;ACVR2B;LRP5;WWTR1;SMAD3;SH3PXD2B;AKT1;PTHLH;CEBPB;WNT3;PRKACA;AREG;FAM20C;ZHX3;HDAC7;CAT;COL6A1
6891,GO:0030431,0.157781950630767,0.956156971029681,3,14,sleep,BP,CST3;FOS;ADA
11409,GO:0045833,0.157849325205408,0.920689931546888,8,50,negative regulation of lipid metabolic process,BP,CYP27B1;APOE;AKT1;CEACAM1;LPCAT1;SLC27A1;WDTC1;PROX1
5657,GO:0016757,0.158100397563416,0.888083123968169,27,207,transferase activity, transferring glycosyl groups,MF,B4GALNT4;PYGB;PYGL;DNPH1;HEXB;ST6GALNAC2;NAPRT;PIGQ;B4GAT1;PIGV;B3GAT3;APRT;B3GNT3;MGAT4B;ST6GALNAC6;B4GALT2;B4GALT6;RFNG;XYLT2;MFNG;ST3GAL3;UPP1;HYAL1;ALG12;ST3GAL2;ST3GAL5;CHPF
827,GO:0002115,0.158371066509672,0.956417996065546,3,13,store-operated calcium entry,BP,ORAI3;ORAI1;HOMER2
13857,GO:0060485,0.158547281261956,0.892229288026309,22,163,mesenchyme development,BP,SEMA4B;PDCD4;HMGA2;WWTR1;ACTA2;ZFP36L1;SMAD3;S100A4;FGFR1;EDNRA;SEMA3F;LAMA5;PKD2;TGFB1;SEMA4F;TGFBR3;ADAM15;MAPK3;CUL7;SEMA4C;PDCD6;SEMA3B
3710,GO:0008233,0.158679990846294,0.877307260051171,47,383,peptidase activity,MF,HTRA1;THSD4;PLAT;TYSND1;CTSO;CAPN2;PRSS8;NPEPL1;MMP1;RNPEPL1;F12;MMP28;RHBDF2;GGT1;PLAU;CTSB;PCSK9;PRSS22;ACY1;PCSK1;CTSZ;PRSS3;ADAM8;JOSD2;LTA4H;ADAMTS13;DPP7;ADAMTS7;MIPEP;CLCA2;ANKZF1;ADAM19;TPP1;CNDP2;MMP10;RNPEP;THOP1;USP20;MBTPS2;ADAM15;LONP2;SPPL2B;CTSF;USP21;PDCD6;PRSS21;PM20D2
7861,GO:0032429,0.158765531708124,0.971767190700576,2,7,regulation of phospholipase A2 activity,BP,EGFR;LRP1
3107,GO:0006688,0.158833789738608,0.956231468005525,3,13,glycosphingolipid biosynthetic process,BP,ST6GALNAC6;B4GALT6;ST3GAL5
6185,GO:0019626,0.158859593980342,0.971740024764871,2,7,short-chain fatty acid catabolic process,BP,PCK2;ACADS
15278,GO:0071467,0.159170811360459,0.95609543466395,3,13,cellular response to pH,BP,IMPACT;ASIC1;HYAL1
11321,GO:0045655,0.159198213615028,0.956084367639255,3,13,regulation of monocyte differentiation,BP,CTNNBIP1;ZFP36L1;INPP5D
6357,GO:0021543,0.159600821553892,0.899177158678761,16,114,pallium development,BP,BBS2;EGFR;PTPRS;LRP1;MBOAT7;TRAPPC9;BNIP3;KDM6B;BAX;SUN1;PROX1;LAMB1;SOCS7;NDE1;EZH1;TACC1
12635,GO:0050848,0.159603676118607,0.923996828781464,7,43,regulation of calcium-mediated signaling,BP,PRNP;NOS1;PKD2;PRKACA;ADA;TMBIM4;GSTO1
6975,GO:0030656,0.159644363722327,0.971512951354981,2,7,regulation of vitamin metabolic process,BP,CYP27B1;CD320
9723,GO:0038179,0.159723299833901,0.93610117301029,5,27,neurotrophin signaling pathway,BP,SPRY2;CYFIP2;DDIT4;PPP2R5B;NGFR
14724,GO:0070383,0.159803828011284,0.971466717402448,2,7,DNA cytosine deamination,BP,APOBEC3C;APOBEC3F
3140,GO:0006739,0.159933546386633,0.935780359251102,5,28,NADP metabolic process,BP,H6PD;IDH2;PGLS;KCNAB2;NADK
18359,GO:1903319,0.159935725293566,0.955786137131205,3,13,positive regulation of protein maturation,BP,F12;GSN;ADAM8
2479,GO:0005719,0.160038483088164,0.944071541063767,4,21,nuclear euchromatin,CC,H1F0;TRNP1;ASH2L;NSMF
3511,GO:0007435,0.160422923469709,0.935729113691871,5,27,salivary gland morphogenesis,BP,EGFR;FGFR1;LAMA5;TGFB1;EDA
11396,GO:0045806,0.160454213051851,0.928936337942772,6,35,negative regulation of endocytosis,BP,DLG4;MCTP1;PCSK9;TGFB1;SNX33;LRSAM1
5849,GO:0017145,0.160621482886698,0.935623408980769,5,27,stem cell division,BP,WNT7A;WWTR1;ETV5;FGFR1;VANGL2
4031,GO:0009065,0.160649360492992,0.944079595989608,4,20,glutamine family amino acid catabolic process,BP,NOS1;ALDH4A1;GLUL;PRODH
8204,GO:0032965,0.160681390847039,0.94406419944928,4,20,regulation of collagen biosynthetic process,BP,F2R;ERRFI1;TGFB1;CYGB
4955,GO:0015020,0.160819623032606,0.955427773716336,3,13,glucuronosyltransferase activity,MF,B4GAT1;B3GAT3;CHPF
6380,GO:0021575,0.160847895264662,0.935502816704823,5,27,hindbrain morphogenesis,BP,WNT7A;SERPINE2;TRNP1;MAP2K1;PROX1
2769,GO:0006195,0.161070744103559,0.928434477404581,6,36,purine nucleotide catabolic process,BP,NT5E;XDH;DNPH1;RAPGEF3;ADA;NT5C1B
6788,GO:0030235,0.161145057842755,0.971076609464403,2,7,nitric-oxide synthase regulator activity,MF,EGFR;AKT1
6909,GO:0030506,0.161148847956303,0.95529403309259,3,13,ankyrin binding,MF,FLNC;OBSCN;SPTB
10208,GO:0042834,0.16124679297986,0.971046928454163,2,7,peptidoglycan binding,MF,HK1;RNASE7
10241,GO:0042981,0.161436219715597,0.861987990844865,126,1097,regulation of apoptotic process,BP,DUSP6;XDH;EGR1;HS1BP3;PDCD4;PRNP;VEGFA;TNFRSF6B;WNT7A;APOE;F2R;LRP5;ITGA6;HMGA2;OBSCN;NDRG1;GRAMD4;EGFR;RPS6KA2;SPRY2;MST1R;NFATC4;SHC1;ZFP36L1;MAP2K2;NME4;RBCK1;MAP2K1;ENDOG;SMAD3;LRP1;PRDX5;AKT1;PPM1F;STK39;EPHA1;DAP;FGFR4;FGFR1;SIGMAR1;RAG1;ZNF385A;STRADB;SYNGAP1;GAS6;CTSB;CARD11;GSN;PLEKHG2;PCSK9;ANGPTL4;RGL2;BNIP3;PAK6;CTSZ;EPHB2;ADAM8;MNT;CEBPB;TGFB1;MOAP1;NTSR1;TNFSF15;NSMF;TNFAIP8L1;PTPN1;VHL;TRAP1;PRKCZ;MINK1;RABGGTA;ADA;PIM2;PLEKHG5;BOK;ERBB2;TFDP2;STK17A;JAK3;NET1;BNIP3L;PRKCD;IFI6;BAX;ITGA1;TMBIM4;DIP2A;IRAK1;INPP5D;CHEK2;TMEM161A;CDC34;SOX7;BCAP31;MIF;PLA2G6;WFS1;FYN;STK25;EEF2K;DNM2;CAT;BEX2;ARHGEF4;INSR;ARHGEF1;GRINA;PAK1;MICAL1;BIN1;MAP2K3;BCL2L1;LMNA;TNFRSF25;SIRT2;FAM129B;MAP3K10;PELI3;NGFR;PDCD6;PNMA1;BTG1;FGFR3;ITPKB;DEDD2;AARS
2199,GO:0005080,0.161723028465113,0.928209458390201,6,35,protein kinase C binding,MF,PKN1;AKT1;HDAC5;TWF2;HDAC7;ADCY6
2603,GO:0005903,0.161745522579463,0.914375074542606,9,58,brush border,CC,ESPN;ITPR3;SHANK2;CYBRD1;RALGDS;SCART1;MYO1D;RGS19;MFSD10
18623,GO:1903896,0.161788419781467,0.97088869527872,2,7,positive regulation of IRE1-mediated unfolded protein response,BP,PTPN1;BAX
7817,GO:0032377,0.162145893913436,0.97078406326332,2,7,regulation of intracellular lipid transport,BP,PCSK9;ABCA2
7820,GO:0032380,0.162145893913436,0.97078406326332,2,7,regulation of intracellular sterol transport,BP,PCSK9;ABCA2
7823,GO:0032383,0.162145893913436,0.97078406326332,2,7,regulation of intracellular cholesterol transport,BP,PCSK9;ABCA2
7659,GO:0032095,0.162173489624562,0.970775979505216,2,7,regulation of response to food,BP,BBS2;PPARA
7662,GO:0032098,0.162173489624562,0.970775979505216,2,7,regulation of appetite,BP,BBS2;PPARA
3269,GO:0006950,0.162193688825609,0.854549254533454,295,2666,response to stress,BP,TNIP1;DUSP6;NT5E;XDH;ERCC1;HTRA1;EGR1;NR1D1;EDEM1;PLAT;CST3;CYP27B1;BTBD2;FBXO2;PGF;PDCD4;CTNNBIP1;XPC;PRNP;POSTN;VEGFA;TNFRSF6B;WNT7A;APOE;DGKA;F2R;HMGA2;NDRG1;ELK3;ITPR3;PKN1;MTA1;EGFR;RPS6KA2;SERPINE2;NOS1;PTPRS;TMEM129;CAPN2;MST1R;NFATC4;SDC1;ETV5;SHC1;DDB2;TXNRD3;ZFP36L1;GLUL;MAP2K2;MAP2K1;NAPRT;ACP5;MCTP1;ENDOG;FOS;FBLN1;SMAD3;STAT6;PIK3R2;ERCC6;EPAS1;DNAJB5;HBEGF;ITGB4;PRDX5;PRODH;ADORA2B;ADARB1;AKT1;CORO1B;HDAC5;F12;PYCR2;STK39;SERPING1;DYSF;GGT1;NFKBIZ;VEGFB;ASH2L;IMPACT;LRRC8A;IFNGR2;BRSK1;DAP;WNT2B;POLD4;FNDC4;LDLR;PRKACB;MAPKBP1;RAC2;RAG1;CEACAM1;CIRBP;HMG20B;ZNF385A;DOCK6;NSMCE4A;IGFBP4;CCND1;PCBP4;STRADB;MAPK13;EDNRA;PLAU;GAS6;PTK6;CSNK1E;CTSB;CARD11;SH2B3;GSN;MAPKAPK3;PCSK9;RAD23A;BCR;ANGPTL4;ERRFI1;CCS;DGKQ;BNIP3;PAK6;TFPI2;SHARPIN;PROCR;PKD2;FAM3A;GPX3;YPEL3;CDC42EP5;IL20RB;MAGEF1;ADAM8;CBS;CD81;CEBPB;RNF135;ENTPD2;ADAMTS13;TGFB1;ULK2;DEAF1;MOAP1;TMEM173;MSRB2;MPG;MC1R;LAMB2;ABTB1;VGF;POLL;POLM;ANKZF1;PHF21A;UBXN4;HMGCL;PTPN1;TPP1;PCK2;WDR59;IFNE;VHL;DNAJC4;TRAP1;PRKCZ;KDM6B;PRKACA;MINK1;ZNF516;TBKBP1;CD9;ADA;AREG;BOK;ERBB2;ULK1;AHCY;PRIMPOL;TFDP2;C6ORF89;JAK3;NET1;BNIP3L;PDK1;CYGB;PRKCD;RBL2;STUB1;IFI6;BAX;TRIM4;EREG;RPS6KA5;DDIT4;MBTPS2;PCSK1N;MT2A;TMX4;TGFBR3;PDIA5;LTB4R2;RPS6KA6;RGS14;MRPS26;LRSAM1;ADAM15;EHD3;MAPK12;IRAK1;MTHFR;CHD2;CHEK2;ZFPM1;PPARA;TMEM161A;SESN2;RAB12;BCAP31;MIF;ACO2;PLA2G6;DDT;ECM1;WFS1;FYN;VWA1;UPP1;STK25;EEF2K;DNM2;PELI1;CAT;NEIL1;TSPYL2;IGFBP7;SLC27A1;APOBEC3C;APOBEC3F;MAPK3;GRINA;CAMTA2;C12ORF66;HLA-G;DOCK9;INO80C;MORN4;ETAA1;VANGL2;PAK1;CAMKK2;LGALS3BP;MLYCD;CUL7;REV1;MICAL1;HYAL1;SEMA4C;DNMT3A;SRMS;PPP2R5B;MAP2K3;BCL2L1;LMNA;PKD1;TNFRSF25;SIRT2;UVSSA;DCBLD2;BACH1;LTB4R;MAP3K10;NGFR;TOLLIP;PDCD6;RNASE7;PXN;GCH1;MAFF;PNMA1;HFE;TERC;WIPI2;GAS2L1;BTG1;ZP3;CELSR1;MLF2;IL17RE;CCDC88C;BLOC1S4;LRP11;GSDMA;SLC23A2;AK3
15997,GO:0086010,0.162272272605339,0.943297824659414,4,20,membrane depolarization during action potential,BP,SCN4B;TPCN1;ANK3;SCN8A
12680,GO:0050906,0.162348267191491,0.934292947268512,5,29,detection of stimulus involved in sensory perception,BP,SERPINE2;NTSR1;REEP6;FYN;NR2F6
10421,GO:0043271,0.16235032214682,0.907712137307023,11,74,negative regulation of ion transport,BP,SERPINE2;NOS1;AKT1;STK39;ANK3;PCSK9;PKD2;EPHB2;TGFB1;NTSR1;GSTO1
161,GO:0000333,0.162428393929845,0.992812902860371,1,2,telomerase catalytic core complex,CC,TERC
414,GO:0001102,0.162517861315666,0.927753135536596,6,35,RNA polymerase II activating transcription factor binding,MF,MEF2D;FOS;SMAD3;RBL2;ZFPM1;BHLHE40
6295,GO:0019911,0.162593996385237,0.970652682198917,2,7,structural constituent of myelin sheath,MF,MARVELD1;MALL
6888,GO:0030426,0.162730597515995,0.89530196716444,17,122,growth cone,CC,ADGRL1;SSH1;SHANK2;DVL1;TMOD2;SIGMAR1;TENM2;TWF2;CTSZ;TIMP2;FSCN1;RAC3;DNM2;ITGA3;DLG3;SIRT2;NDRG2
7669,GO:0032105,0.163073449229403,0.970511835593781,2,7,negative regulation of response to extracellular stimulus,BP,BBS2;PPARA
7672,GO:0032108,0.163073449229403,0.970511835593781,2,7,negative regulation of response to nutrient levels,BP,BBS2;PPARA
16174,GO:0090196,0.163077240733539,0.970510720653715,2,7,regulation of chemokine secretion,BP,POSTN;ALOX15B
12691,GO:0050918,0.163132405484092,0.927248822369263,6,36,positive chemotaxis,BP,PGF;VEGFA;SMAD3;VEGFB;PLXNB3;MIF
5322,GO:0016048,0.163173043013749,0.970482542900321,2,7,detection of temperature stimulus,BP,NTSR1;NR2F6
12713,GO:0050961,0.163173043013749,0.970482542900321,2,7,detection of temperature stimulus involved in sensory perception,BP,NTSR1;NR2F6
12715,GO:0050965,0.163173043013749,0.970482542900321,2,7,detection of temperature stimulus involved in sensory perception of pain,BP,NTSR1;NR2F6
6559,GO:0022011,0.16336420704575,0.942769927039075,4,20,myelination in peripheral nervous system,BP,NDRG1;AKT1;AHNAK2;SIRT2
7765,GO:0032292,0.16336420704575,0.942769927039075,4,20,peripheral nervous system axon ensheathment,BP,NDRG1;AKT1;AHNAK2;SIRT2
13003,GO:0051445,0.163477325544262,0.93409766600036,5,27,regulation of meiotic cell cycle,BP,PRKACB;NPR2;INSR;SIRT2;GPR3
7286,GO:0031290,0.163518165094708,0.954327374664261,3,13,retinal ganglion cell axon guidance,BP,VEGFA;EPHB2;SEMA4F
4299,GO:0009749,0.163661008741172,0.894525090755836,17,125,response to glucose,BP,EGR1;NR1D1;ACVR2B;LRP5;GLUL;ENDOG;PFKL;GAS6;TGFB1;PCK2;PFKFB2;MLXIPL;PRKACA;VAMP2;SESN2;PLA2G6;PPP3CB
13833,GO:0060444,0.163802657073606,0.942557527741673,4,20,branching involved in mammary gland duct morphogenesis,BP,LRP5;ETV5;TGFB1;AREG
1553,GO:0003951,0.163806241041818,0.954209343488954,3,13,NAD+ kinase activity,MF,DGKA;NADK;DGKQ
9972,GO:0042368,0.163923541017939,0.97026141257093,2,7,vitamin D biosynthetic process,BP,CYP27B1;CYP2R1
4956,GO:0015026,0.163940970366094,0.942490473282473,4,20,coreceptor activity,MF,LRP5;TGFBR3;ITGA4;NGFR
1880,GO:0004559,0.163980771980921,0.954137781696794,3,13,alpha-mannosidase activity,MF,EDEM1;MAN2B1;MAN2B2
16104,GO:0090087,0.164017580432065,0.869181268077594,59,491,regulation of peptide transport,BP,NR1D1;EDEM1;APLN;PRNP;POSTN;F2R;LRP5;IDH2;ITPR3;EGFR;HADH;VPS11;ARL2;RAPGEF3;GLUL;LRP1;NLGN2;STOM;RHBDF2;HK1;MAPKBP1;RAC2;PFKL;SORL1;B3GAT3;ANK3;GAS6;ALOX15B;CEMIP;ADAM8;TGFB1;TMEM173;LLGL1;PTPN1;PCK2;CEP131;PFKFB2;PRKCZ;MICALL2;ERBB2;VAMP2;BNIP3L;PRKCD;RASL10B;ZDHHC8;GDI1;BCAP31;MIF;PLA2G6;NBPF3;FYN;MAPK3;PFKM;PAK1;PPP3CB;ICA1;CAMK1;SIRT3;HFE
11234,GO:0045428,0.164147023725209,0.926815465130321,6,35,regulation of nitric oxide biosynthetic process,BP,ACP5;SMAD3;AKT1;PKD2;DNM2;INSR
16156,GO:0090177,0.164150841132165,0.954068011208337,3,13,establishment of planar polarity involved in neural tube closure,BP,DVL1;VANGL2;CELSR1
16157,GO:0090178,0.164150841132165,0.954068011208337,3,13,regulation of establishment of planar polarity involved in neural tube closure,BP,DVL1;VANGL2;CELSR1
1438,GO:0003416,0.164275504994058,0.954016844235454,3,13,endochondral bone growth,BP,THBS3;EVC;FGFR3
911,GO:0002295,0.164469957236811,0.970099977948625,2,7,T-helper cell lineage commitment,BP,STAT6;ZFPM1
10474,GO:0043373,0.164469957236811,0.970099977948625,2,7,CD4-positive, alpha-beta T cell lineage commitment,BP,STAT6;ZFPM1
3408,GO:0007194,0.164591892114694,0.970063903076045,2,7,negative regulation of adenylate cyclase activity,BP,LTB4R2;GABBR1
7281,GO:0031280,0.164591892114694,0.970063903076045,2,7,negative regulation of cyclase activity,BP,LTB4R2;GABBR1
9338,GO:0035845,0.164601988203967,0.97006091529213,2,7,photoreceptor cell outer segment organization,BP,IFT140;NPHP4
12632,GO:0050839,0.164659211421949,0.871897252487207,48,394,cell adhesion molecule binding,MF,ADGRL1;POSTN;ITGA6;NDRG1;NISCH;EGFR;LTBP4;SNX9;MPRIP;KLC2;SLC9A3R2;NLGN2;CORO1B;BSG;FMNL2;TENM2;ANK3;TWF2;PFKP;LAMA5;EHD4;SH3GLB2;CCS;PAK6;ADAM8;CADM4;ADAMTS13;TIMP2;SCYL1;LAMB2;PTPN1;ESYT2;CD9;EPN2;CAPG;FSCN1;PPL;PPP1R13L;ADAM15;ICAM5;PLCB3;H1FX;DOCK9;ITGA3;FAM129B;CDH4;ITGA4;PXN
11850,GO:0046850,0.164739852072326,0.933419941494751,5,27,regulation of bone remodeling,BP,LRP5;EGFR;ADAM8;INPP5D;PLEKHM1
16504,GO:0097205,0.164854045248739,0.953779123914678,3,13,renal filtration,BP,F2R;GAS6;ITGA3
5619,GO:0016672,0.164892458444352,0.992582750122115,1,2,oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor,MF,GSTO1
11123,GO:0045174,0.164892458444352,0.992582750122115,1,2,glutathione dehydrogenase (ascorbate) activity,MF,GSTO1
12497,GO:0050610,0.164892458444352,0.992582750122115,1,2,methylarsonate reductase activity,MF,GSTO1
13967,GO:0060688,0.164905209904916,0.926378014282416,6,35,regulation of morphogenesis of a branching structure,BP,PGF;VEGFA;ETV5;WNT2B;FGFR1;TGFB1
2250,GO:0005165,0.16491408964755,0.969968491794373,2,7,neurotrophin receptor binding,MF,SHC1;PLCG1
2252,GO:0005167,0.16491408964755,0.969968491794373,2,7,neurotrophin TRK receptor binding,MF,SHC1;PLCG1
16340,GO:0090594,0.164945786924073,0.969959098489249,2,7,inflammatory response to wounding,BP,F2R;TGFB1
2712,GO:0006091,0.16524949395985,0.873181590383444,43,366,generation of precursor metabolites and energy,BP,XDH;NR1D1;PYGB;PGM1;PYGL;IDH2;AKR7A2;NFATC4;ALDH4A1;PHLDA2;TXNRD3;GAA;D2HGDH;AKT1;HK1;PFKL;PFKP;DHTKD1;BNIP3;SDHA;MDH2;VGF;PHGDH;HMGCL;TRAP1;PFKFB2;MLXIPL;OXA1L;CYC1;DDIT4;ALDOC;PPARA;ACO2;ETFB;CAT;INSR;TAZ;PFKM;TSTA3;GLRX;PFKFB3;NDUFV3;SIRT3
3948,GO:0008652,0.165681959110483,0.911809294416981,9,58,cellular amino acid biosynthetic process,BP,NAGS;GLUL;PYCR2;GGT1;GAMT;CBS;PHGDH;AHCY;GPT2
4230,GO:0009410,0.165708886698162,0.886591295452321,22,168,response to xenobiotic stimulus,BP,EGR1;AKR7A2;EGFR;HDAC5;GGT1;PRKACB;BPHL;ERRFI1;AIP;ACY1;TGFB1;PCK2;ADA;DDIT4;CES2;GSTO1;CHEK2;DNM2;CYP3A5;CYP2R1;DNMT3A;HOMER2
15516,GO:0071901,0.16579428261371,0.894552821711752,16,116,negative regulation of protein serine/threonine kinase activity,BP,DUSP6;DUSP5;PDCD4;APOE;LRP5;SPRY2;SPRY4;AKT1;SORL1;DUSP7;CDKN1C;PTPN1;PRKCD;DUSP4;RGS14;CBLC
20305,GO:2001258,0.165835155085819,0.94125501229871,4,21,negative regulation of cation channel activity,BP,ANK3;PKD2;EPHB2;GSTO1
615,GO:0001784,0.166045272165031,0.932717126677684,5,27,phosphotyrosine residue binding,MF,SHC1;PIK3R2;SH3BP2;MAPK3;CBLC
9886,GO:0042171,0.166282831752503,0.941351425841745,4,20,lysophosphatidic acid acyltransferase activity,MF,LPCAT4;MBOAT7;LPCAT1;TAZ
15370,GO:0071617,0.166282831752503,0.941351425841745,4,20,lysophospholipid acyltransferase activity,MF,LPCAT4;MBOAT7;LPCAT1;TAZ
4827,GO:0014033,0.166443828985631,0.911310811232688,9,58,neural crest cell differentiation,BP,SEMA4B;EDNRA;SEMA3F;LAMA5;SEMA4F;MAPK3;SEMA4C;PDCD6;SEMA3B
13632,GO:0060148,0.166557991952484,0.941217132730586,4,20,positive regulation of posttranscriptional gene silencing,BP,EGFR;MAP2K2;MAP2K1;TGFB1
18469,GO:1903547,0.166639473566952,0.992417165063925,1,2,regulation of growth hormone activity,BP,PHLDA2
9465,GO:0036089,0.166646814588417,0.969453197531537,2,7,cleavage furrow formation,BP,SNX9;SNX33
12581,GO:0050766,0.166844026401056,0.932066666043726,5,28,positive regulation of phagocytosis,BP,GAS6;BCR;TUB;ABCA7;DNM2
3581,GO:0007632,0.166893359023538,0.925227682788575,6,35,visual behavior,BP,NPHP4;RAG1;SYNGAP1;DEAF1;B4GALT2;RGS14
3087,GO:0006664,0.166929700671901,0.897372648283025,14,100,glycolipid metabolic process,BP,HEXB;PIGQ;FUCA1;PIGV;ST6GALNAC6;ESYT2;B4GALT6;PRKCD;BAX;NAGA;GLB1;GAL3ST4;ST3GAL2;ST3GAL5
18439,GO:1903509,0.166929700671901,0.897372648283025,14,100,liposaccharide metabolic process,BP,HEXB;PIGQ;FUCA1;PIGV;ST6GALNAC6;ESYT2;B4GALT6;PRKCD;BAX;NAGA;GLB1;GAL3ST4;ST3GAL2;ST3GAL5
16455,GO:0097120,0.167288055930502,0.940860354897774,4,20,receptor localization to synapse,BP,DLG4;KIF17;ARHGAP44;DLG3
9445,GO:0036037,0.167288183699,0.969261525816832,2,7,CD8-positive, alpha-beta T cell activation,BP,SATB1;HFE
17893,GO:1902162,0.167390109480681,0.992345403188225,1,2,regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,ZNF385A
17894,GO:1902164,0.167390109480681,0.992345403188225,1,2,positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,ZNF385A
5444,GO:0016311,0.167393634639454,0.870714303427121,45,362,dephosphorylation,BP,DUSP6;NT5E;DUSP5;PTPRS;PTPRE;PPP1R35;ACP5;SSH1;SMAD3;PPP1R14A;PPP2R3B;NT5DC1;PPM1F;PTPRU;PPM1J;B3GAT3;LHPP;DUSP7;CDC25B;PTPDC1;SYNJ2;TGFB1;NSMF;FARP1;PLPP6;PTPN1;ACP6;PFKFB2;PRKCD;SBF1;ITGA1;DUSP4;NTPCR;SYMPK;INPP5D;MYO1D;ELFN2;PPP3CB;PFKFB3;PPP2R5B;DLG3;NT5C1B;DUSP23;SSH3;PPP1R16A
7828,GO:0032388,0.167402134401753,0.882349560908437,25,192,positive regulation of intracellular transport,BP,EDEM1;PRNP;VPS11;RAPGEF3;STOM;ADORA2B;RAC2;SORL1;B3GAT3;ANK3;GAS6;CEMIP;TGFB1;TMEM173;CEP131;MICALL2;ERBB2;VAMP2;PRKCD;ZDHHC8;BCAP31;NBPF3;FYN;PAK1;CAMK1
3191,GO:0006821,0.167523342689349,0.91919247485151,7,43,chloride transport,BP,PRNP;SLC12A7;TTYH3;ANO8;CLCA2;SLC12A4;SLC26A11
3806,GO:0008395,0.167549710251744,0.969183224235308,2,7,steroid hydroxylase activity,MF,CYP3A5;CYP2R1
10857,GO:0044387,0.167572014864398,0.969176542303194,2,7,negative regulation of protein kinase activity by regulation of protein phosphorylation,BP,ADARB1;PPM1F
6981,GO:0030665,0.167610283521681,0.907040484140762,10,67,clathrin-coated vesicle membrane,CC,APOE;EGFR;HBEGF;AP2A2;LDLR;CEMIP;CLTCL1;CD9;EPN2;VAMP2
4949,GO:0015012,0.167626409116394,0.940694773905211,4,20,heparan sulfate proteoglycan biosynthetic process,BP,B3GAT3;XYLT2;VANGL2;NDST2
4765,GO:0010951,0.167963025753649,0.889707062385978,18,138,negative regulation of endopeptidase activity,BP,CST3;VEGFA;TNFRSF6B;SERPINE2;PRDX5;AKT1;SERPING1;RAG1;SORL1;GAS6;TFPI2;TIMP2;IFI6;PCSK1N;MICAL1;BIN1;SERPINB1;NGFR
9848,GO:0042101,0.16810699583143,0.96901609175165,2,7,T cell receptor complex,CC,CEACAM1;CARD11
8311,GO:0033157,0.168123396855303,0.88005805030549,27,210,regulation of intracellular protein transport,BP,EDEM1;PRNP;VPS11;RAPGEF3;STOM;RAC2;SORL1;B3GAT3;ANK3;GAS6;CEMIP;TGFB1;TMEM173;PTPN1;CEP131;MICALL2;ERBB2;VAMP2;BNIP3L;PRKCD;ZDHHC8;GDI1;BCAP31;NBPF3;FYN;PAK1;CAMK1
12832,GO:0051151,0.16845140933831,0.968912610019513,2,7,negative regulation of smooth muscle cell differentiation,BP,PDCD4;EREG
1025,GO:0002526,0.168461945369193,0.909829132781053,9,60,acute inflammatory response,BP,CTNNBIP1;F12;SERPING1;IL20RB;ADAM8;CD81;CEBPB;HFE;ZP3
20275,GO:2001212,0.168594861544595,0.968869465748846,2,7,regulation of vasculogenesis,BP,XDH;CEACAM1
5580,GO:0016597,0.16885572876062,0.924087699677476,6,35,amino acid binding,MF,NAGS;NOS1;GLUL;GRIN3B;SESN2;AARS
15741,GO:0072330,0.168918765169188,0.880260369840918,26,201,monocarboxylic acid biosynthetic process,BP,NR1D1;PGM1;ACOT7;HSD17B8;HK1;FGFR4;PFKL;CEACAM1;CBR4;PFKP;DHTKD1;ALOX15B;PFKFB2;MLXIPL;DDIT4;ALDOC;DECR2;PPARA;MIF;INSR;PFKM;PFKFB3;MLYCD;WDTC1;PROX1;CHST14
3095,GO:0006672,0.168955508396979,0.906201123059266,10,66,ceramide metabolic process,BP,HEXB;ST6GALNAC6;B4GALT6;PRKCD;NAGA;PLA2G6;CERS4;SAMD8;ST3GAL5;SPTLC2
15844,GO:0072562,0.169168885708961,0.918185285284672,7,43,blood microparticle,CC,APOE;STOM;SERPING1;GSN;ANGPTL4;TGFB1;LGALS3BP
6648,GO:0030003,0.169209444218637,0.870791190352621,41,335,cellular cation homeostasis,BP,DLG4;PRNP;APOE;F2R;ITPR3;NOS1;HEXB;LPAR3;SMAD3;CYBRD1;TPCN1;EDNRA;BNIP3;CEMIP;PKD2;AP3D1;PLCG1;TGFB1;NTSR1;ATP7B;RASA3;PRKACA;BOK;TRPC1;SLC22A17;CACNB3;BAX;SV2A;MT2A;GSTO1;BCAP31;SLC9A7;PLA2G6;WFS1;FYN;MAPK3;GRINA;PKD1;ATP6V1F;HFE;SLC26A11
12096,GO:0048146,0.169311427015545,0.923665116785535,6,36,positive regulation of fibroblast proliferation,BP,EGFR;S100A6;GAS6;TGFB1;EREG;MIF
1100,GO:0002688,0.169317254166851,0.909190937552629,9,61,regulation of leukocyte chemotaxis,BP,PGF;VEGFA;MMP28;VEGFB;RAC2;GAS6;MIF;DDT;MAPK3
14636,GO:0070227,0.169506557104865,0.91313981217068,8,52,lymphocyte apoptotic process,BP,PKN1;AKT1;RAG1;ADAM8;ADA;JAK3;BAX;MIF
3164,GO:0006779,0.169513385697965,0.939445525461191,4,21,porphyrin-containing compound biosynthetic process,BP,UROS;RSAD1;ALAS1;PPOX
10242,GO:0042982,0.169544946164481,0.917954681001139,7,43,amyloid precursor protein metabolic process,BP,PRNP;APOE;SORL1;NECAB3;ABCG1;ABCA7;BIN1
8915,GO:0034763,0.169660969948317,0.90565676293292,10,67,negative regulation of transmembrane transport,BP,AKT1;STK39;ANK3;PCSK9;PKD2;EPHB2;TGFB1;NTSR1;GSTO1;GRB10
16975,GO:0099003,0.169775103135624,0.897541132774712,13,90,vesicle-mediated transport in synapse,BP,SYTL1;NLGN2;SYT8;AP3D1;SNPH;RIMS3;VAMP2;DNM1;DNM2;PCLO;PFN2;BLOC1S4;TRIM46
12370,GO:0048786,0.170253276559629,0.93940431395748,4,20,presynaptic active zone,CC,RIMS3;ARHGAP44;SV2A;PCLO
19907,GO:2000380,0.170577835899036,0.968270486569736,2,7,regulation of mesoderm development,BP,FGFR1;RPS6KA6
7119,GO:0030949,0.170699870209009,0.968233467317055,2,7,positive regulation of vascular endothelial growth factor receptor signaling pathway,BP,VEGFA;GRB10
5688,GO:0016805,0.17079414350619,0.968204856906729,2,7,dipeptidase activity,MF,CNDP2;PM20D2
10792,GO:0044275,0.170889033448001,0.922901744052538,6,35,cellular carbohydrate catabolic process,BP,PYGB;PGM1;PYGL;GAA;PFKM;ABHD10
14059,GO:0060850,0.170958501994918,0.96815495074013,2,7,regulation of transcription involved in cell fate commitment,BP,CEBPB;PROX1
8012,GO:0032651,0.171293103385321,0.922506279220528,6,36,regulation of interleukin-1 beta production,BP,EGR1;F2R;ACP5;SMAD3;HK1;ERRFI1
540,GO:0001659,0.171302481408513,0.938559178865438,4,21,temperature homeostasis,BP,NR1D1;APLN;NTSR1;SLC27A1
2954,GO:0006489,0.171307277535407,0.968048938150965,2,7,dolichyl diphosphate biosynthetic process,BP,SRD5A3;MVD
11672,GO:0046465,0.171307277535407,0.968048938150965,2,7,dolichyl diphosphate metabolic process,BP,SRD5A3;MVD
5127,GO:0015556,0.171357956027082,0.968033521694999,2,7,C4-dicarboxylate transmembrane transporter activity,MF,SLC13A5;SLC13A3
20219,GO:2001057,0.171430275027986,0.912005514135473,8,51,reactive nitrogen species metabolic process,BP,NOS1;ACP5;SMAD3;AKT1;PKD2;DNM2;INSR;GCH1
19431,GO:1990000,0.171461500086704,0.950477574833055,3,14,amyloid fibril formation,BP,APOE;LDLR;GSN
14782,GO:0070493,0.171647625290998,0.967945343590213,2,7,thrombin-activated receptor signaling pathway,BP,F2R;DGKQ
10631,GO:0043647,0.171886338879832,0.911814134708723,8,50,inositol phosphate metabolic process,BP,ISYNA1;PLCD3;PLCH2;PLCG1;NTSR1;INPP5D;PLCB3;ITPKB
9965,GO:0042359,0.171922836100681,0.950281789564899,3,14,vitamin D metabolic process,BP,CYP27B1;FGFR1;CYP2R1
10757,GO:0044209,0.17195974149231,0.991900526546805,1,2,AMP salvage,BP,APRT
2217,GO:0005114,0.172036197213362,0.967826897182893,2,7,type II transforming growth factor beta receptor binding,MF,TGFB1;TGFBR3
1974,GO:0004690,0.172445700773337,0.967701870201233,2,7,cyclic nucleotide-dependent protein kinase activity,MF,PRKACB;PRKACA
1202,GO:0002861,0.172475256485783,0.966619874563103,2,8,regulation of inflammatory response to antigenic stimulus,BP,IL20RB;ZP3
1146,GO:0002741,0.172725114141854,0.967616443686216,2,7,positive regulation of cytokine secretion involved in immune response,BP,HK1;MAPK3
12512,GO:0050661,0.172765589750503,0.921642235874414,6,36,NADP binding,MF,H6PD;NOS1;CBR4;GRHPR;MTHFR;CAT
1990,GO:0004711,0.172830396956851,0.967584230229791,2,7,ribosomal protein S6 kinase activity,MF,RPS6KA2;RPS6KA6
15655,GO:0072176,0.172854442640436,0.967576871052002,2,7,nephric duct development,BP,PKD2;PKD1
17108,GO:0099738,0.172860045903935,0.928785905535602,5,28,cell cortex region,CC,PKD2;CTSZ;RIMS3;PRKCZ;PCLO
15531,GO:0071933,0.172901703087973,0.967562404936881,2,7,Arp2/3 complex binding,MF,SNX9;CORO1B
2195,GO:0005068,0.172907868279161,0.967560517610441,2,7,transmembrane receptor protein tyrosine kinase adaptor activity,MF,SHC1;PAG1
10119,GO:0042659,0.172952807807645,0.967546759038764,2,7,regulation of cell fate specification,BP,DUSP6;FGFR1
11465,GO:0045932,0.173064542569565,0.949796079612256,3,14,negative regulation of muscle contraction,BP,DOCK4;ADORA2B;TNNT1
4351,GO:0009931,0.173359155574513,0.967422240426655,2,7,calcium-dependent protein serine/threonine kinase activity,MF,MAPKAPK3;MKNK2
3715,GO:0008238,0.1734128718544,0.903183762384317,10,66,exopeptidase activity,MF,NPEPL1;RNPEPL1;GGT1;CTSZ;LTA4H;DPP7;TPP1;CNDP2;RNPEP;PM20D2
12630,GO:0050832,0.173470912878806,0.949141420981642,3,15,defense response to fungus,BP,FAM3A;TGFB1;RNASE7
18592,GO:1903827,0.173499908977937,0.863360470243475,51,419,regulation of cellular protein localization,BP,ZMYND8;EDEM1;PRNP;EGFR;VPS11;RAPGEF3;SSH1;LRP1;DVL1;STOM;AKT1;RAC2;KCNAB2;SORL1;B3GAT3;LZTS2;ANK3;CEP250;GAS6;CSNK1E;GSN;CEMIP;EPHB2;TGFB1;ABHD17C;TMEM173;CROCC;SNX33;PTPN1;LRP4;CEP131;MICALL2;ERBB2;VAMP2;TFDP2;BNIP3L;PRKCD;ZDHHC8;GDI1;SESN2;BCAP31;NBPF3;FYN;CEP72;PAK1;ITGA3;BCL2L1;LMNA;NGFR;CAMK1;HFE
5605,GO:0016646,0.173650792513038,0.949546019834532,3,14,oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor,MF,ALDH4A1;PYCR2;MTHFR
14602,GO:0070168,0.173689065966185,0.967320996179365,2,7,negative regulation of biomineral tissue development,BP,GAS6;ECM1
6819,GO:0030285,0.173727068337055,0.96730932530329,2,7,integral component of synaptic vesicle membrane,CC,PTPRS;SV2A
10289,GO:0043046,0.174118783532752,0.967188923016643,2,7,DNA methylation involved in gamete generation,BP,TDRKH;DNMT3A
17574,GO:1901160,0.174155664209666,0.967177577260673,2,7,primary amino compound metabolic process,BP,CHKA;AZIN2
9684,GO:0038066,0.174174684965424,0.928063124632699,5,28,p38MAPK cascade,BP,XDH;VEGFA;ZFP36L1;MINK1;MAP2K3
9359,GO:0035878,0.174212412855924,0.967160116189245,2,7,nail development,BP,ITGA6;ITGB4
4986,GO:0015114,0.174249217975064,0.967148789464093,2,7,phosphate ion transmembrane transporter activity,MF,SLC20A1;SLC37A2
2292,GO:0005251,0.174297063242096,0.967134062671632,2,7,delayed rectifier potassium channel activity,MF,KCNG1;KCNC4
6525,GO:0021932,0.174377903291293,0.967109173709981,2,7,hindbrain radial glia guided cell migration,BP,RERE;SOCS7
2000,GO:0004723,0.174467526044689,0.967081571394698,2,7,calcium-dependent protein serine/threonine phosphatase activity,MF,PPM1F;PPP3CB
19829,GO:2000271,0.174476106305029,0.967078928302152,2,7,positive regulation of fibroblast apoptotic process,BP,STK17A;BTG1
8700,GO:0034350,0.174576150689629,0.967048103644973,2,7,regulation of glial cell apoptotic process,BP,GAS6;PRKCD
8701,GO:0034351,0.174576150689629,0.967048103644973,2,7,negative regulation of glial cell apoptotic process,BP,GAS6;PRKCD
18422,GO:1903441,0.174716862112247,0.967004728359399,2,7,protein localization to ciliary membrane,BP,BBS2;TUB
733,GO:0001964,0.174760402799682,0.966991301731023,2,7,startle response,BP,DVL1;SLITRK6
8115,GO:0032809,0.174774702952735,0.966986891491463,2,7,neuronal cell body membrane,CC,KCNC4;INSR
10803,GO:0044298,0.174774702952735,0.966986891491463,2,7,cell body membrane,CC,KCNC4;INSR
8397,GO:0033363,0.174796404950921,0.936816576909035,4,21,secretory granule organization,BP,F2R;SERPINE2;ZNF385A;RFX2
269,GO:0000768,0.174814862156124,0.927710402164333,5,28,syncytium formation by plasma membrane fusion,BP,NOS1;CAPN2;RAPGEF3;SH3PXD2A;CAMK1
3686,GO:0008194,0.17488056705378,0.891635700428242,14,99,UDP-glycosyltransferase activity,MF,B4GALNT4;HEXB;PIGQ;B4GAT1;B3GAT3;B3GNT3;MGAT4B;B4GALT2;B4GALT6;RFNG;XYLT2;MFNG;HYAL1;CHPF
4773,GO:0010960,0.174882562079648,0.966953619135474,2,7,magnesium ion homeostasis,BP,EGFR;ANK3
13553,GO:0060027,0.17489389669389,0.966950121810558,2,7,convergent extension involved in gastrulation,BP,DVL1;VANGL2
11244,GO:0045475,0.174912309287268,0.966944440221755,2,7,locomotor rhythm,BP,NAGLU;MTA1
15096,GO:0071141,0.174912371057964,0.966944421160481,2,7,SMAD protein complex,CC,HMGA2;SMAD3
15208,GO:0071361,0.174912371057984,0.966944421160461,2,7,cellular response to ethanol,BP,DNMT3A;ADCY7
17327,GO:0150011,0.174912371057995,0.96694442116045,2,7,regulation of neuron projection arborization,BP,DLG4;DVL1
17328,GO:0150012,0.174912371057995,0.96694442116045,2,7,positive regulation of neuron projection arborization,BP,DLG4;DVL1
7198,GO:0031094,0.174912371058045,0.966944421160465,2,7,platelet dense tubular network,CC,F2R;ITPR3
5072,GO:0015296,0.174912371058071,0.966944421160438,2,7,anion:cation symporter activity,MF,SLC12A7;SLC12A4
8688,GO:0034331,0.174912371058106,0.966944421160468,2,7,cell junction maintenance,BP,F2R;NLGN2
3287,GO:0006982,0.174988854035737,0.991598002255447,1,2,response to lipid hydroperoxide,BP,GPX3
8715,GO:0034370,0.174993415933701,0.991597542042785,1,2,triglyceride-rich lipoprotein particle remodeling,BP,APOE
8717,GO:0034372,0.174993415933701,0.991597542042785,1,2,very-low-density lipoprotein particle remodeling,BP,APOE
19014,GO:1904813,0.175287164554002,0.889171285813215,15,112,ficolin-1-rich granule lumen,CC,CST3;PGM1;PYGL;PFKL;CTSB;GSN;CTSZ;LTA4H;TIMP2;YPEL5;ACTR1B;ALDOC;MIF;GLB1;CAT
2265,GO:0005184,0.175449257043936,0.991551485961179,1,2,neuropeptide hormone activity,MF,VGF
17367,GO:1900077,0.175486422170405,0.927339856702721,5,28,negative regulation of cellular response to insulin stimulus,BP,PTPRE;PTPN1;PRKCZ;PRKCD;GRB10
938,GO:0002339,0.17559589155644,0.991536641213584,1,2,B cell selection,BP,BAX
942,GO:0002352,0.17559589155644,0.991536641213584,1,2,B cell negative selection,BP,BAX
4618,GO:0010738,0.175634503218439,0.948696596112712,3,14,regulation of protein kinase A signaling,BP,AIP;MC1R;MIF
9618,GO:0036488,0.175813823879451,0.991514552013886,1,2,CHOP-C/EBP complex,CC,CEBPB
5150,GO:0015688,0.176024488912951,0.991493169264288,1,2,iron chelate transport,BP,SLC22A17
5260,GO:0015891,0.176024488912951,0.991493169264288,1,2,siderophore transport,BP,SLC22A17
10618,GO:0043621,0.176060002657128,0.913934443529937,7,43,protein self-association,MF,PCSK9;ADAM8;SHANK3;MDH2;VAMP2;FHOD1;CCDC88C
4239,GO:0009439,0.176361047112522,0.99145894668527,1,2,cyanate metabolic process,BP,TST
4240,GO:0009440,0.176361047112522,0.99145894668527,1,2,cyanate catabolic process,BP,TST
9416,GO:0035987,0.176382025958626,0.919673796094022,6,35,endodermal cell differentiation,BP,DUSP6;HMGA2;ITGB5;ITGA4;LAMB1;COL6A1
2228,GO:0005132,0.176521270037637,0.991442627978615,1,2,type I interferon receptor binding,MF,IFNE
3445,GO:0007259,0.176644163146798,0.892517023455981,13,92,JAK-STAT cascade,BP,PODNL1;PTK6;PKD2;PTPN1;IFNE;VHL;JAK3;CHAD;FYN;MAPK3;PKD1;SOCS7;FGFR3
3181,GO:0006808,0.176724322789665,0.991421922390984,1,2,regulation of nitrogen utilization,BP,BAX
11785,GO:0046666,0.176724322789665,0.991421922390984,1,2,retinal cell programmed cell death,BP,BAX
20148,GO:2000821,0.176871686735824,0.99140687820225,1,2,regulation of grooming behavior,BP,DLG4
5996,GO:0019005,0.177332446132849,0.908109584992757,8,52,SCF ubiquitin ligase complex,CC,BTBD2;FBXO2;FBXW5;FBXW8;FBXO17;ABTB1;FBXO44;FBXW4
3546,GO:0007584,0.177664003225808,0.880977899010621,19,143,response to nutrient,BP,ERCC1;CYP27B1;POSTN;EGFR;SSH1;CCND1;GAS6;GSN;IGFBP2;HLCS;DGKQ;TGFB1;HMGCL;ADA;AHCY;MTHFR;FYN;CAT;DNMT3A
10637,GO:0043653,0.177866148061785,0.964903373076531,2,8,mitochondrial fragmentation involved in apoptotic process,BP,BNIP3;BAX
12275,GO:0048599,0.177891180205043,0.926008532345446,5,28,oocyte development,BP,CDC25B;NPR2;EREG;SIRT2;ZP3
10010,GO:0042445,0.177924081334272,0.885454906509554,16,118,hormone metabolic process,BP,EGR1;CYP27B1;SRD5A3;HSD17B8;FGFR1;DGKQ;PCSK1;RETSAT;CTSZ;ERO1B;STUB1;HSD17B7;PCSK1N;CYP2R1;HSD11B1;HFE
14629,GO:0070206,0.178067208526408,0.918510462821137,6,36,protein trimerization,BP,SIGMAR1;ASIC1;TRIM4;MIF;ATXN10;COL6A1
11379,GO:0045765,0.178158877347408,0.875787540742189,23,175,regulation of angiogenesis,BP,PGF;VEGFA;HMGA2;SPRY2;RAPGEF3;HDAC5;EPHA1;VEGFB;CEACAM1;ANGPTL4;PLCG1;RNH1;EPN2;ERBB2;ADGRB2;HDAC7;ECM1;HYAL1;RRAS;FAM129B;NGFR;PDCD6;BTG1
10924,GO:0044550,0.178260346945601,0.94756441917544,3,14,secondary metabolite biosynthetic process,BP,CBS;TRPC1;DDT
18240,GO:1903034,0.178480747311798,0.88896141968454,14,100,regulation of response to wounding,BP,PLAT;APOE;F2R;SERPINE2;PTPRS;MAP2K1;SMAD3;HBEGF;F12;SERPING1;CEACAM1;PLAU;CD9;PRKCD
5624,GO:0016684,0.178705728277679,0.924769727448236,5,32,oxidoreductase activity, acting on peroxide as acceptor,MF,PRDX5;GPX3;CYGB;SESN2;CAT
7779,GO:0032311,0.179032833187443,0.991184578519066,1,2,angiogenin-PRI complex,CC,RNH1
7884,GO:0032459,0.179066288850985,0.925135867471681,5,29,regulation of protein oligomerization,BP,APOE;MMP1;SNX9;SORL1;BAX
3319,GO:0007030,0.179123269110024,0.884652685408132,16,115,Golgi organization,BP,OBSL1;MAP2K2;MAP2K1;FBXW8;TMED4;GOLGA2P5;PI4K2A;EHD3;PI4K2B;COG7;STK25;DNM2;MAPK3;ATP8B2;CUL7;VPS51
13732,GO:0060315,0.179209973325645,0.964469834557232,2,8,negative regulation of ryanodine-sensitive calcium-release channel activity,BP,PKD2;GSTO1
11781,GO:0046657,0.179337477890817,0.991152990159474,1,2,folic acid catabolic process,BP,PM20D2
17489,GO:1900390,0.179856768300946,0.991099001556676,1,2,regulation of iron ion import,BP,HFE
18851,GO:1904432,0.179856768300946,0.991099001556676,1,2,regulation of ferrous iron binding,BP,HFE
18852,GO:1904434,0.179856768300946,0.991099001556676,1,2,positive regulation of ferrous iron binding,BP,HFE
18853,GO:1904435,0.179856768300946,0.991099001556676,1,2,regulation of transferrin receptor binding,BP,HFE
18854,GO:1904437,0.179856768300946,0.991099001556676,1,2,positive regulation of transferrin receptor binding,BP,HFE
4583,GO:0010675,0.179900355964466,0.892707919831146,12,83,regulation of cellular carbohydrate metabolic process,BP,NR1D1;PHLDA2;AKT1;IGFBP4;DGKQ;NTSR1;PFKFB2;PDK1;DDIT4;PPARA;INSR;MLYCD
4279,GO:0009648,0.179918880831404,0.934234023574049,4,21,photoperiodism,BP,MTA1;CRTC1;BHLHE40;NR2F6
14230,GO:0061213,0.180349966055075,0.946657118755336,3,14,positive regulation of mesonephros development,BP,VEGFA;WNT2B;TGFB1
15102,GO:0071158,0.180548366387671,0.894938148616866,11,77,positive regulation of cell cycle arrest,BP,HMGA2;ZNF385A;PCBP4;PKD2;TGFB1;PRKACA;TFDP2;RBL2;BAX;CHEK2;PPP2R5B
13993,GO:0060720,0.180576650743781,0.99102385807419,1,2,spongiotrophoblast cell proliferation,BP,PHLDA2
13994,GO:0060721,0.180576650743781,0.99102385807419,1,2,regulation of spongiotrophoblast cell proliferation,BP,PHLDA2
13995,GO:0060722,0.180576650743781,0.99102385807419,1,2,cell proliferation involved in embryonic placenta development,BP,PHLDA2
13996,GO:0060723,0.180576650743781,0.99102385807419,1,2,regulation of cell proliferation involved in embryonic placenta development,BP,PHLDA2
16189,GO:0090214,0.180576650743781,0.99102385807419,1,2,spongiotrophoblast layer developmental growth,BP,PHLDA2
4298,GO:0009746,0.180842548757309,0.881534041167913,17,127,response to hexose,BP,EGR1;NR1D1;ACVR2B;LRP5;GLUL;ENDOG;PFKL;GAS6;TGFB1;PCK2;PFKFB2;MLXIPL;PRKACA;VAMP2;SESN2;PLA2G6;PPP3CB
9864,GO:0042129,0.180937830753438,0.891863932499833,12,85,regulation of T cell proliferation,BP,PRNP;RAC2;CARD11;IGFBP2;IL20RB;CEBPB;TGFB1;ERBB2;JAK3;PELI1;HLA-G;ZP3
18696,GO:1904035,0.181022340242224,0.910840739605628,7,43,regulation of epithelial cell apoptotic process,BP,PDCD4;ZFP36L1;GAS6;GSN;ANGPTL4;BOK;WFS1
13210,GO:0051881,0.181107198365956,0.910422070782183,7,46,regulation of mitochondrial membrane potential,BP,AKT1;BNIP3;BOK;BNIP3L;IFI6;BAX;BCL2L1
7174,GO:0031063,0.181128173793639,0.933619564351322,4,21,regulation of histone deacetylation,BP,VEGFA;CTBP1;TGFB1;C6ORF89
6075,GO:0019229,0.181199056203323,0.924165888187676,5,28,regulation of vasoconstriction,BP,APLN;DOCK4;F2R;EGFR;AKT1
1140,GO:0002731,0.181310005533075,0.990946949339849,1,2,negative regulation of dendritic cell cytokine production,BP,JAK3
11998,GO:0047496,0.181366722463788,0.916545033125338,6,36,vesicle transport along microtubule,BP,FYCO1;AP3D1;PRKCZ;NDE1;BLOC1S4;TRIM46
2966,GO:0006508,0.181523855679867,0.842450463636419,143,1263,proteolysis,BP,TNIP1;XDH;GID4;HTRA1;THSD4;NR1D1;EDEM1;PLAT;CST3;TYSND1;BTBD2;FBXO2;PRNP;VEGFA;TNFRSF6B;APOE;F2R;MTA1;GRAMD4;ARRDC1;SERPINE2;WWTR1;TMEM129;CTSO;CAPN2;LTBP4;PRSS8;DDB2;NPEPL1;MMP1;SNX9;RNPEPL1;MAP2K2;RBCK1;RNF44;MAP2K1;SMURF2;FBLN1;SMAD3;DVL1;PRDX5;FBXW5;RNF187;AKT1;F12;PPM1F;MMP28;RHBDF2;SERPING1;GGT1;DAP;FGFR4;PRKACB;RAG1;SORL1;TENM2;PLAU;GAS6;CSNK1E;CTSB;GSN;PCSK9;RAD23A;PRSS22;SH3D19;TFPI2;SHARPIN;MVB12B;ACY1;PCSK1;CTSZ;MAGEF1;PRSS3;ADAM8;JOSD2;LTA4H;CD81;RNF135;ADAMTS13;TIMP2;DPP7;TGFB1;ADAMTS7;MIPEP;TNFSF15;CLCA2;ABTB1;ERO1B;FBXO44;SNX33;ANKZF1;UBXN4;ADAM19;TPP1;CAMK2N1;VHL;TRIB2;PRKACA;BOK;CNDP2;MMP10;RNPEP;CYFIP2;THOP1;USP20;STUB1;IFI6;BAX;FBXW4;CUL9;MBTPS2;PCSK1N;ADAM15;LONP2;MAPK12;CDC34;RNF123;SOX7;BCAP31;ECM1;WFS1;SPPL2B;FYN;MAPK3;INO80C;RNF144A;CTSF;USP21;CUL7;MICAL1;BIN1;MAP2K3;PKD1;KCTD13;SIRT2;SERPINB1;NGFR;TOLLIP;PDCD6;HFE;CBLC;PRSS21;PM20D2
6826,GO:0030295,0.181703078054456,0.905271888709798,8,52,protein kinase activator activity,MF,SPRY2;MAP2K2;MAP2K1;ERCC6;GAS6;DGKQ;TGFB1;ETAA1
6215,GO:0019748,0.181957597649142,0.916031939678346,6,37,secondary metabolic process,BP,AKR7A2;CBR4;CBS;TRPC1;GSTO1;DDT
14523,GO:0070026,0.181991415772017,0.990875163023634,1,2,nitric oxide binding,MF,CBS
7924,GO:0032507,0.18207665473574,0.900697342500508,9,61,maintenance of protein location in cell,BP,ARL2;AKT1;HK1;SYNE3;SORL1;ANK3;TWF2;GSN;SUN1
5846,GO:0017137,0.182083967151048,0.874978015360764,21,158,Rab GTPase binding,MF,NDRG1;EVI5L;SYTL1;TBC1D14;RIN1;RAB11FIP4;TRAPPC9;TBC1D9B;LLGL1;RIMS3;RABGGTA;MICALL2;ULK1;SBF1;GDI1;MICAL1;SGSM2;TBC1D16;RABGAP1;NGFR;TBC1D8
16554,GO:0097332,0.182172888674539,0.990855992056712,1,2,response to antipsychotic drug,BP,PRKACB
3825,GO:0008427,0.182209746207528,0.99085209567434,1,2,calcium-dependent protein kinase inhibitor activity,MF,CAMK2N1
4698,GO:0010858,0.182209746207528,0.99085209567434,1,2,calcium-dependent protein kinase regulator activity,MF,CAMK2N1
12683,GO:0050909,0.182262793276113,0.945308047955712,3,15,sensory perception of taste,BP,ITPR3;ASIC1;REEP2
7863,GO:0032431,0.182576912118478,0.990813230721422,1,2,activation of phospholipase A2 activity,BP,EGFR
3952,GO:0008670,0.182785797949732,0.990791079230538,1,2,2,4-dienoyl-CoA reductase (NADPH) activity,MF,DECR2
7700,GO:0032190,0.183088039044339,0.990758975546687,1,2,acrosin binding,MF,ZP3
9324,GO:0035803,0.183088039044339,0.990758975546687,1,2,egg coat formation,BP,ZP3
7974,GO:0032594,0.183112591124119,0.932607313765836,4,21,protein transport within lipid bilayer,BP,AP3D1;RILPL1;ARHGAP44;REEP2
15505,GO:0071887,0.183444769595593,0.896107003071527,10,69,leukocyte apoptotic process,BP,PKN1;AKT1;RAG1;GAS6;ADAM8;ADA;JAK3;BAX;MIF;ITPKB
45,GO:0000097,0.183518746543052,0.945270589407568,3,14,sulfur amino acid biosynthetic process,BP,GGT1;CBS;AHCY
3557,GO:0007601,0.183571593427829,0.890083379836645,12,83,visual perception,BP,BBS2;EPAS1;SLITRK6;EML2;LAMB2;BBS1;RABGGTA;REEP6;OLFM2;WFS1;ZNF513;BBS10
12708,GO:0050953,0.183571593427829,0.890083379836645,12,83,sensory perception of light stimulus,BP,BBS2;EPAS1;SLITRK6;EML2;LAMB2;BBS1;RABGGTA;REEP6;OLFM2;WFS1;ZNF513;BBS10
103,GO:0000215,0.183647317633569,0.990699406584377,1,2,tRNA 2'-phosphotransferase activity,MF,TRPT1
1257,GO:0003010,0.183697536878614,0.990694047349962,1,2,voluntary skeletal muscle contraction,BP,TNNT1
2572,GO:0005861,0.183697536878614,0.990694047349962,1,2,troponin complex,CC,TNNT1
4867,GO:0014721,0.183697536878614,0.990694047349962,1,2,twitch skeletal muscle contraction,BP,TNNT1
4983,GO:0015108,0.183725077422157,0.915132600270399,6,36,chloride transmembrane transporter activity,MF,SLC12A7;TTYH3;ANO8;CLCA2;SLC12A4;SLC26A11
8965,GO:0035051,0.183729992912201,0.88996986279275,12,83,cardiocyte differentiation,BP,PDCD4;VEGFA;EGFR;OBSL1;TGFB1;FHOD3;KDM6B;TGFBR3;MAPK3;PAK1;PROX1;LMNA
6778,GO:0030220,0.184511994114005,0.944833345612606,3,14,platelet formation,BP,ZNF385A;ZFPM1;NBEAL2
7643,GO:0032069,0.184547183001029,0.922060349047917,5,29,regulation of nuclease activity,BP,AKT1;PTPN1;PRKCD;BAX;NEIL1
13832,GO:0060443,0.184736418555972,0.914524962956603,6,36,mammary gland morphogenesis,BP,LRP5;ETV5;STAT6;TGFB1;AREG;BAX
8128,GO:0032835,0.184915000367501,0.914417546211543,6,36,glomerulus development,BP,EGR1;WWTR1;ACTA2;LAMB2;NID1;VANGL2
18012,GO:1902463,0.185030272107114,0.990551197323511,1,2,protein localization to cell leading edge,BP,CORO1B
15693,GO:0072234,0.185585174968151,0.944359500941324,3,14,metanephric nephron tubule development,BP,WWTR1;PKD2;PKD1
19827,GO:2000269,0.185633055260206,0.944338326043976,3,14,regulation of fibroblast apoptotic process,BP,GAS6;STK17A;BTG1
3096,GO:0006677,0.185946893066594,0.944199460101736,3,14,glycosylceramide metabolic process,BP,ST6GALNAC6;PRKCD;NAGA
10417,GO:0043267,0.186039110872062,0.944158632041579,3,14,negative regulation of potassium ion transport,BP,NOS1;STK39;ANK3
18505,GO:1903624,0.186502225720656,0.962077985595988,2,8,regulation of DNA catabolic process,BP,ENDOG;BAX
16710,GO:0097696,0.186529791123318,0.885292465783034,13,93,STAT cascade,BP,PODNL1;PTK6;PKD2;PTPN1;IFNE;VHL;JAK3;CHAD;FYN;MAPK3;PKD1;SOCS7;FGFR3
4418,GO:0010224,0.186572465477682,0.943922285037921,3,14,response to UV-B,BP,XPC;ERCC6;HYAL1
7631,GO:0032048,0.186602859730382,0.94390880544822,3,14,cardiolipin metabolic process,BP,PLA2G6;SLC27A1;TAZ
11516,GO:0046041,0.186687780403328,0.990371852836842,1,2,ITP metabolic process,BP,AK3
1169,GO:0002791,0.186822712409256,0.85976148004146,34,274,regulation of peptide secretion,BP,NR1D1;APLN;POSTN;F2R;LRP5;IDH2;ITPR3;EGFR;HADH;ARL2;RAPGEF3;GLUL;NLGN2;RHBDF2;HK1;MAPKBP1;PFKL;GAS6;ALOX15B;ADAM8;TGFB1;LLGL1;PCK2;PFKFB2;PRKCZ;RASL10B;MIF;PLA2G6;MAPK3;PFKM;PPP3CB;ICA1;SIRT3;HFE
3827,GO:0008429,0.186863644010717,0.961957718761532,2,8,phosphatidylethanolamine binding,MF,PLTP;ESYT2
9002,GO:0035162,0.186994061640722,0.943735205935489,3,14,embryonic hemopoiesis,BP,VEGFA;SH2B3;ZFPM1
2193,GO:0005055,0.187084458820995,0.990328654385016,1,2,laminin receptor activity,MF,BCAM
4420,GO:0010226,0.187086352207306,0.943694222775541,3,14,response to lithium ion,BP,NFATC4;IGFBP2;ADCY1
9834,GO:0042078,0.187105487518198,0.990326361357249,1,2,germ-line stem cell division,BP,ETV5
12092,GO:0048133,0.187105487518198,0.990326361357249,1,2,male germ-line stem cell asymmetric division,BP,ETV5
16831,GO:0098728,0.187105487518198,0.990326361357249,1,2,germline stem cell asymmetric division,BP,ETV5
6982,GO:0030666,0.187222716393662,0.880275847174287,15,112,endocytic vesicle membrane,CC,DLG4;WNT7A;APOE;EGFR;LRP1;HBEGF;AP2A2;RAB31;LDLR;RAC2;WNT3;CD9;EPN2;DNM2;HLA-G
949,GO:0002367,0.187252062443507,0.901539488866746,8,53,cytokine production involved in immune response,BP,HK1;GAS6;TGFB1;PRKCZ;JAK3;MIF;MAPK3;HFE
3527,GO:0007517,0.18727396210431,0.862944231428463,29,227,muscle organ development,BP,MEF2D;FHL1;EGR1;FOS;SMAD3;HBEGF;ADARB1;FGFR1;HMG20B;EVC;LAMA5;TGFB1;GPC1;SMTN;TGFBR3;LEMD2;MAPK12;CHD2;ZFPM1;MYH15;SPEG;ARID5B;TAZ;VANGL2;PAK1;PROX1;SIRT2;FAM129B;MAFF
2952,GO:0006487,0.187403701956718,0.890046324981036,11,78,protein N-linked glycosylation,BP,ST6GALNAC2;SRD5A3;MVD;MGAT4B;ST6GALNAC6;MCFD2;ST3GAL3;NUDT14;ALG12;ST3GAL2;ST3GAL5
4045,GO:0009084,0.187448787021702,0.943533172871042,3,14,glutamine family amino acid biosynthetic process,BP,NAGS;GLUL;PYCR2
9959,GO:0042351,0.187500957115962,0.990283182087476,1,2,'de novo' GDP-L-fucose biosynthetic process,BP,TSTA3
12692,GO:0050919,0.187587278285859,0.920570463870691,5,28,negative chemotaxis,BP,SEMA4B;SEMA3F;SEMA4F;SEMA4C;SEMA3B
19881,GO:2000343,0.187626921395234,0.961703194015763,2,8,positive regulation of chemokine (C-X-C motif) ligand 2 production,BP,POSTN;MIF
9552,GO:0036324,0.187822774206119,0.990247965808442,1,2,vascular endothelial growth factor receptor-2 signaling pathway,BP,PDCD6
8841,GO:0034644,0.187935663070723,0.892997574958852,10,69,cellular response to UV,BP,ERCC1;XPC;NFATC4;DDB2;IMPACT;MAPK13;MC1R;BAX;TMEM161A;HYAL1
19516,GO:1990379,0.187973948454588,0.990231398483072,1,2,lipid transport across blood brain barrier,BP,APOE
15211,GO:0071364,0.188011884669195,0.912549031254847,6,36,cellular response to epidermal growth factor stimulus,BP,EGFR;ZFP36L1;AKT1;ERRFI1;PLCG1;ERBB2
17440,GO:1900208,0.188024487284378,0.990225856405555,1,2,regulation of cardiolipin metabolic process,BP,TAZ
17441,GO:1900210,0.188024487284378,0.990225856405555,1,2,positive regulation of cardiolipin metabolic process,BP,TAZ
4713,GO:0010877,0.188337050100413,0.990191542071904,1,2,lipid transport involved in lipid storage,BP,APOE
6465,GO:0021799,0.188357180536658,0.929908585200909,4,21,cerebral cortex radially oriented cell migration,BP,MBOAT7;SUN1;LAMB1;SOCS7
11380,GO:0045766,0.188469223394817,0.88155169017851,14,101,positive regulation of angiogenesis,BP,PGF;VEGFA;HMGA2;RAPGEF3;EPHA1;VEGFB;ANGPTL4;PLCG1;HDAC7;ECM1;HYAL1;RRAS;PDCD6;BTG1
11099,GO:0045124,0.188506076765808,0.929831471880876,4,21,regulation of bone resorption,BP,EGFR;ADAM8;INPP5D;PLEKHM1
4036,GO:0009070,0.188541159994476,0.943046761885441,3,14,serine family amino acid biosynthetic process,BP,GGT1;CBS;PHGDH
14941,GO:0070838,0.18879777056943,0.860169903543341,31,245,divalent metal ion transport,BP,CYP27B1;PRNP;F2R;ITPR3;NOS1;ORAI3;ORAI1;LPAR3;GJC2;TPCN1;GAS6;CEMIP;PKD2;GRIN3B;ASIC1;PLCG1;TGFB1;NTSR1;RASA3;PRKACA;TRPC1;CACNB3;BAX;GSTO1;EHD3;PLA2G6;WFS1;FYN;PKD1;SLC39A3;HOMER2
4548,GO:0010631,0.188801165409399,0.864242730767116,26,203,epithelial cell migration,BP,VEGFA;WNT7A;APOE;PKN1;HBEGF;AKT1;CORO1B;HDAC5;PPM1F;FGFR1;CEACAM1;PRSS3;PLCG1;TGFB1;PLEKHG5;SH3BP1;LTB4R2;HDAC7;HYAL1;ITGA3;MAP2K3;PROX1;PDCD6;PXN;PFN2;PKN3
614,GO:0001783,0.188813234544604,0.929341397671917,4,22,B cell apoptotic process,BP,PKN1;ADA;BAX;MIF
3412,GO:0007198,0.188832851593491,0.990136974147799,1,2,adenylate cyclase-inhibiting serotonin receptor signaling pathway,BP,HTR7
16228,GO:0090279,0.188850378690501,0.942908798215307,3,14,regulation of calcium ion import,BP,PRNP;PKD2;FYN
19905,GO:2000378,0.188989266175028,0.911790609322327,6,37,negative regulation of reactive oxygen species metabolic process,BP,ACP5;BCR;BNIP3;TRAP1;SIRT2;SIRT3
16549,GO:0097320,0.189043045273217,0.942822775113519,3,14,plasma membrane tubulation,BP,SNX9;SNX33;DNM2
14206,GO:0061152,0.189269445663649,0.990088783385645,1,2,trachea submucosa development,BP,EDA
14207,GO:0061153,0.189269445663649,0.990088783385645,1,2,trachea gland development,BP,EDA
4945,GO:0014911,0.189462944590308,0.929335259823185,4,21,positive regulation of smooth muscle cell migration,BP,DOCK4;POSTN;SSH1;PAK1
10429,GO:0043281,0.189558291419863,0.867701610207824,22,175,regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,XDH;VEGFA;TNFRSF6B;F2R;GRAMD4;SMAD3;PRDX5;AKT1;PPM1F;DAP;RAG1;GAS6;GSN;TNFSF15;BOK;IFI6;BAX;SOX7;BCAP31;MICAL1;NGFR;PDCD6
11985,GO:0047374,0.189642228426871,0.990047532780907,1,2,methylumbelliferyl-acetate deacetylase activity,MF,CES2
4883,GO:0014802,0.189666720568132,0.990044819249654,1,2,terminal cisterna,CC,RTN2
3682,GO:0008190,0.189730079995161,0.960998120938685,2,8,eukaryotic initiation factor 4E binding,MF,ANGEL1;C8ORF88
3120,GO:0006703,0.189809913942821,0.960971248720367,2,8,estrogen biosynthetic process,BP,HSD17B8;HSD17B7
11114,GO:0045155,0.190085135757357,0.989998398740193,1,2,electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity,MF,CYC1
573,GO:0001725,0.190122920407133,0.904962550270934,7,44,stress fiber,CC,MST1R;CORO1B;MICALL2;FSCN1;FHOD1;VANGL2;PXN
16647,GO:0097517,0.190122920407133,0.904962550270934,7,44,contractile actin filament bundle,CC,MST1R;CORO1B;MICALL2;FSCN1;FHOD1;VANGL2;PXN
16860,GO:0098791,0.190696947420435,0.841656664252223,78,660,Golgi subcompartment,CC,B4GALNT4;EDEM1;POSTN;EGFR;SNX9;ST6GALNAC2;ARAP1;MARCH9;PITPNM1;ENTPD6;BSG;ASAP2;MARCH4;IFNGR2;RAB31;B4GAT1;SORL1;B3GAT3;TRAPPC9;CORO7;CTSZ;GPSM1;AP3D1;CLTCL1;B3GNT3;ATP7B;MGAT4B;GOLGA2P5;ST6GALNAC6;PI4K2A;LLGL1;B4GALT2;B4GALT6;RFNG;AREG;BOK;VAMP2;C6ORF89;NECAB3;MCFD2;XYLT2;TMBIM4;MBTPS2;PCSK1N;MFNG;LPCAT1;ST3GAL3;TGFA;PI4K2B;COG7;ABCG1;ABCA7;RAB12;BCAP31;DOPEY2;SLC9A7;QSOX1;SPPL2B;STK25;DNM2;SLC50A1;HLA-G;STX10;MALL;SAMD8;SLC16A13;NDST2;PKD1;GAL3ST4;NMNAT2;AZIN2;ST3GAL2;ICA1;PDCD6;CHST14;VPS51;ST3GAL5;CHPF
11927,GO:0046983,0.190707578392283,0.838702196255036,96,858,protein dimerization activity,MF,XDH;MEF2D;PGF;VEGFA;APOE;PYGL;ACOT7;EGFR;DNPH1;WWTR1;CAPN2;HEXB;TCFL5;SNX9;CRYL1;MXD4;GALE;FOS;SMAD3;PIK3R2;EPAS1;PRDX5;STOM;AKT1;S100A6;VEGFB;FGFR1;MXI1;RAG1;H2AFJ;CEACAM1;HMG20B;RAB11FIP4;TENM2;ABCD1;LHPP;HLCS;BNIP3;PKD2;HES2;CADM4;CTBP1;MNT;CBS;CEBPB;MVD;ZNF862;TGFB1;NTSR1;TMEM173;HMGCL;OLFML2A;LRP4;CEP131;MLXIPL;GRHPR;OXA1L;RABGGTA;BOK;ERBB2;RILPL1;BNIP3L;STUB1;BAX;HIST3H2BB;NAGA;LIMK1;TPM2;ZHX3;DNM1;IRAK1;CHEK2;ABCG1;SLC9A7;SPPL2B;STK25;BHLHE40;CHKA;CAT;SLC27A1;PFKM;HLA-G;RALGAPA1;PDXK;PPP3CB;HES7;ITGA3;HES6;BCL2L1;CDH4;E2F5;MAP3K10;PDCD6;GCH1;CELSR1;HOMER2
8979,GO:0035091,0.190741234110759,0.864682255210864,24,184,phosphatidylinositol binding,MF,HS1BP3;OSBPL5;PITPNC1;ITPR3;NISCH;SNX9;ARAP1;SH3PXD2B;AKT1;GRB7;PITPNM1;TWF2;SH3PXD2A;ARAP3;TUB;SNX17;SNX33;ESYT2;ADAP1;PLEK2;SNX15;WIPI2;PFN2;GSDMA
8876,GO:0034695,0.190745224764771,0.942060730375432,3,14,response to prostaglandin E,BP,AKT1;TGFBR3;ADCY6
9035,GO:0035255,0.19079656848566,0.92864179410343,4,21,ionotropic glutamate receptor binding,MF,DLG4;SHANK2;SHANK3;DLG3
8247,GO:0033033,0.190888088111064,0.960607558210163,2,8,negative regulation of myeloid cell apoptotic process,BP,MIF;ITPKB
10160,GO:0042752,0.191035969160118,0.890911175881168,10,68,regulation of circadian rhythm,BP,NR1D1;MTA1;CSNK1E;CRTC1;ADA;PPARA;BHLHE40;ADCY1;PROX1;NR2F6
10578,GO:0043548,0.191093533271559,0.928487079607083,4,21,phosphatidylinositol 3-kinase binding,MF,FAM83A;FYN;DNM2;INSR
1735,GO:0004332,0.191222286515816,0.989871632470555,1,2,fructose-bisphosphate aldolase activity,MF,ALDOC
8279,GO:0033106,0.19145214484892,0.989845900656524,1,2,cis-Golgi network membrane,CC,BOK
19541,GO:1990425,0.191582437109405,0.98983129878186,1,2,ryanodine receptor complex,CC,NOS1
1500,GO:0003845,0.191728257782164,0.989814942795789,1,2,11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity,MF,HSD11B1
7197,GO:0031093,0.191815774128655,0.910070005248744,6,37,platelet alpha granule lumen,CC,VEGFA;SERPING1;VEGFB;GAS6;TGFB1;QSOX1
13851,GO:0060478,0.19193159185911,0.989792111404042,1,2,acrosomal vesicle exocytosis,BP,ZP3
19897,GO:2000367,0.19193159185911,0.989792111404042,1,2,regulation of acrosomal vesicle exocytosis,BP,ZP3
19898,GO:2000368,0.19193159185911,0.989792111404042,1,2,positive regulation of acrosomal vesicle exocytosis,BP,ZP3
11768,GO:0046637,0.192051439655723,0.917791719116599,5,29,regulation of alpha-beta T cell differentiation,BP,AP3D1;PRKCZ;ADA;JAK3;ITPKB
19408,GO:1905906,0.192451539608756,0.96007760879031,2,8,regulation of amyloid fibril formation,BP,APOE;LDLR
11789,GO:0046677,0.192522012108558,0.860240282085678,27,216,response to antibiotic,BP,EGR1;CST3;SDC1;ENDOG;STAT6;UROS;IMPACT;CCND1;MAPK13;GSN;BNIP3;ANKZF1;TRAP1;KDM6B;ADA;AREG;NET1;PRKCD;FYN;STK25;CAT;ADCY1;HYAL1;DNMT3A;BCL2L1;ADCY7;ADCY6
11673,GO:0046466,0.192584574822012,0.927369796902371,4,22,membrane lipid catabolic process,BP,HEXB;FUCA1;PRKCD;NAGA
937,GO:0002337,0.192638330431513,0.989712533883326,1,2,B-1a B cell differentiation,BP,CMTM7
10820,GO:0044321,0.192725287305112,0.941169666573323,3,14,response to leptin,BP,NR1D1;BBS2;CCND1
2729,GO:0006112,0.192729545316573,0.893564980486912,9,60,energy reserve metabolic process,BP,NR1D1;PYGB;PGM1;PYGL;PHLDA2;GAA;AKT1;INSR;PFKM
5273,GO:0015923,0.19273910893275,0.941163429172764,3,14,mannosidase activity,MF,EDEM1;MAN2B1;MAN2B2
9907,GO:0042249,0.192918087502384,0.94108263823357,3,14,establishment of planar polarity of embryonic epithelium,BP,DVL1;VANGL2;CELSR1
3165,GO:0006780,0.192921652082939,0.989680535781411,1,2,uroporphyrinogen III biosynthetic process,BP,UROS
11700,GO:0046502,0.192921652082939,0.989680535781411,1,2,uroporphyrinogen III metabolic process,BP,UROS
6681,GO:0030055,0.192976060908024,0.849700662903562,43,363,cell-substrate junction,CC,FHL1;MRC2;PARVB;FLNC;ITGA6;EGFR;CAPN2;ARL2;SPRY4;MAP2K2;MAP2K1;MPRIP;SLC9A3R2;LRP1;ITGB4;GRB7;CORO1B;BSG;ZFYVE21;RAC2;PLAU;GSN;ARHGAP22;PROCR;ITGB5;CD81;SNTB2;TNS1;CD9;ITGA1;LIMK1;GIT1;EHD3;DNM2;CAT;MAPK3;TNS4;PAK1;ITGA3;RRAS;ITGA4;PXN;FGFR3
16905,GO:0098868,0.193049273362063,0.941023395229638,3,14,bone growth,BP,THBS3;EVC;FGFR3
13672,GO:0060216,0.19310845337469,0.940996662661019,3,14,definitive hemopoiesis,BP,BCR;TGFBR3;ZFPM1
7846,GO:0032413,0.193302258854813,0.909161532197468,6,37,negative regulation of ion transmembrane transporter activity,BP,STK39;ANK3;PCSK9;PKD2;EPHB2;GSTO1
4737,GO:0010906,0.193328079287986,0.889310646488312,10,68,regulation of glucose metabolic process,BP,NR1D1;PHLDA2;AKT1;IGFBP4;DGKQ;PFKFB2;PDK1;PPARA;INSR;MLYCD
8014,GO:0032653,0.193335616717935,0.926975081113264,4,22,regulation of interleukin-10 production,BP,IL20RB;TRIB2;PRKCZ;JAK3
14024,GO:0060764,0.19339513547438,0.989626937485609,1,2,cell-cell signaling involved in mammary gland development,BP,LRP5
1466,GO:0003720,0.193446271402217,0.959738853602998,2,8,telomerase activity,MF,TEP1;TERC
1564,GO:0003964,0.193446271402217,0.959738853602998,2,8,RNA-directed DNA polymerase activity,MF,TEP1;TERC
7988,GO:0032612,0.193494922749333,0.897312221348955,8,54,interleukin-1 production,BP,EGR1;F2R;ACP5;SMAD3;HK1;CEACAM1;GAS6;ERRFI1
8743,GO:0034405,0.193558075532418,0.916926725296115,5,29,response to fluid shear stress,BP,AKT1;TFPI2;PKD2;TGFB1;PKD1
17546,GO:1901068,0.193584050555081,0.902497584539872,7,46,guanosine-containing compound metabolic process,BP,DLG4;GTPBP1;NME4;CARD11;DGUOK;DLG3;AK3
613,GO:0001782,0.193638665849519,0.926815615937326,4,22,B cell homeostasis,BP,PKN1;ADA;BAX;MIF
12477,GO:0050435,0.193988863884714,0.916678912031457,5,29,amyloid-beta metabolic process,BP,PRNP;APOE;SORL1;ABCA7;BIN1
415,GO:0001103,0.19401826125149,0.916661993141532,5,29,RNA polymerase II repressing transcription factor binding,MF,BBS2;MTA1;BBS1;PPARA;BBS10
4489,GO:0010513,0.194083069157744,0.989548787831589,1,2,positive regulation of phosphatidylinositol biosynthetic process,BP,ZP3
8591,GO:0034109,0.194263629225255,0.896901057581866,8,53,homotypic cell-cell adhesion,BP,SERPINE2;PTPRU;CEACAM1;ANK3;GAS6;CD9;PRKCD;BLOC1S4
14375,GO:0061622,0.194289391475065,0.989525285803703,1,2,glycolytic process through glucose-1-phosphate,BP,PFKM
7805,GO:0032365,0.194337068755112,0.916478446974258,5,29,intracellular lipid transport,BP,CPT2;LDLR;PCSK9;ABCA2;ABCG1
13033,GO:0051499,0.19436697707193,0.989516440474764,1,2,D-aminoacyl-tRNA deacylase activity,MF,DTD1
13034,GO:0051500,0.19436697707193,0.989516440474764,1,2,D-tyrosyl-tRNA(Tyr) deacylase activity,MF,DTD1
4026,GO:0009060,0.194605166557096,0.891738332762509,9,67,aerobic respiration,BP,IDH2;DHTKD1;BNIP3;SDHA;MDH2;OXA1L;ACO2;CAT;SIRT3
7585,GO:0031960,0.194759890473026,0.876782821247628,14,103,response to corticosteroid,BP,EGFR;SDC1;ZFP36L1;FOS;PTPRU;CCND1;IGFBP2;ERRFI1;TGFB1;PCK2;AREG;DDIT4;GLB1;IGFBP7
6830,GO:0030299,0.19477711429992,0.989469612684077,1,2,intestinal cholesterol absorption,BP,LDLR
10776,GO:0044241,0.19477711429992,0.989469612684077,1,2,lipid digestion,BP,LDLR
16901,GO:0098856,0.19477711429992,0.989469612684077,1,2,intestinal lipid absorption,BP,LDLR
12135,GO:0048250,0.194812132762483,0.989465609030297,1,2,iron import into the mitochondrion,BP,SLC25A37
3397,GO:0007181,0.194878682904983,0.989457998028501,1,2,transforming growth factor beta receptor complex assembly,BP,TGFBR3
14500,GO:0062012,0.194945827447371,0.849005951537541,41,339,regulation of small molecule metabolic process,BP,EGR1;NR1D1;CYP27B1;TYSND1;VEGFA;APOE;NOS1;LMF1;PHLDA2;RAPGEF3;ADORA2B;AKT1;PTHLH;FGFR4;LDLR;SEC14L2;CEACAM1;IGFBP4;DGKQ;PKD2;MVD;TIMP2;TGFB1;NTSR1;CD320;PFKFB2;MLXIPL;PDK1;DDIT4;MBTPS2;LTB4R2;LONP2;PPARA;ABCG1;INSR;TAZ;PFKFB3;MLYCD;GABBR1;WDTC1;PROX1
12282,GO:0048627,0.19500509771112,0.989443532172407,1,2,myoblast development,BP,SDC1
1216,GO:0002885,0.195005097711122,0.989443532172406,1,2,positive regulation of hypersensitivity,BP,ZP3
19794,GO:2000196,0.195005097711122,0.989443532172406,1,2,positive regulation of female gonad development,BP,ZP3
19912,GO:2000386,0.195005097711122,0.989443532172406,1,2,positive regulation of ovarian follicle development,BP,ZP3
4060,GO:0009111,0.195079597132877,0.959179962155279,2,8,vitamin catabolic process,BP,CYP27B1;PM20D2
5432,GO:0016290,0.195168116820095,0.95914957793245,2,8,palmitoyl-CoA hydrolase activity,MF,ACOT7;ACOT1
15809,GO:0072511,0.195257716843641,0.854804486442381,31,246,divalent inorganic cation transport,BP,CYP27B1;PRNP;F2R;ITPR3;NOS1;ORAI3;ORAI1;LPAR3;GJC2;TPCN1;GAS6;CEMIP;PKD2;GRIN3B;ASIC1;PLCG1;TGFB1;NTSR1;RASA3;PRKACA;TRPC1;CACNB3;BAX;GSTO1;EHD3;PLA2G6;WFS1;FYN;PKD1;SLC39A3;HOMER2
9537,GO:0036294,0.195303421210629,0.865684168392787,20,158,cellular response to decreased oxygen levels,BP,EGR1;VEGFA;NDRG1;ZFP36L1;ENDOG;EPAS1;AKT1;BNIP3;ADAM8;VHL;BNIP3L;PDK1;STUB1;IRAK1;EEF2K;DNMT3A;LMNA;SIRT2;BACH1;TERC
13117,GO:0051673,0.19534417476913,0.98940467641456,1,2,membrane disruption in other organism,BP,RNASE7
3572,GO:0007620,0.195497185884539,0.959036540339089,2,8,copulation,BP,SERPINE2;ADA
149,GO:0000305,0.195522808877985,0.925509684583109,4,23,response to oxygen radical,BP,TXNRD3;ERCC6;CCS;GCH1
3376,GO:0007157,0.195544073057525,0.925810415608466,4,22,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,BP,ADGRL1;TENM2;CADM4;CDH4
5764,GO:0016936,0.195598921949448,0.989375431885365,1,2,galactoside binding,MF,GLB1
16952,GO:0098943,0.195628010402403,0.989372089723192,1,2,neurotransmitter receptor transport, postsynaptic endosome to lysosome,BP,AP3D1
13506,GO:0055088,0.195658612659647,0.887604921760327,10,69,lipid homeostasis,BP,APOE;LRP5;LDLR;PCSK9;ANGPTL4;ABCA2;MLXIPL;SESN2;ABCG1;MALL
1878,GO:0004557,0.195726249862153,0.989360798018271,1,2,alpha-galactosidase activity,MF,NAGA
12222,GO:0048490,0.195908645916478,0.939162182593324,3,15,anterograde synaptic vesicle transport,BP,AP3D1;BLOC1S4;TRIM46
17041,GO:0099514,0.195908645916478,0.939162182593324,3,15,synaptic vesicle cytoskeletal transport,BP,AP3D1;BLOC1S4;TRIM46
17044,GO:0099517,0.195908645916478,0.939162182593324,3,15,synaptic vesicle transport along microtubule,BP,AP3D1;BLOC1S4;TRIM46
16130,GO:0090132,0.195930068718719,0.858428714593616,26,204,epithelium migration,BP,VEGFA;WNT7A;APOE;PKN1;HBEGF;AKT1;CORO1B;HDAC5;PPM1F;FGFR1;CEACAM1;PRSS3;PLCG1;TGFB1;PLEKHG5;SH3BP1;LTB4R2;HDAC7;HYAL1;ITGA3;MAP2K3;PROX1;PDCD6;PXN;PFN2;PKN3
10871,GO:0044416,0.196162382025115,0.989310587969024,1,2,induction by symbiont of host defense response,BP,TGFB1
11818,GO:0046730,0.196162382025115,0.989310587969024,1,2,induction of host immune response by virus,BP,TGFB1
11819,GO:0046732,0.196162382025115,0.989310587969024,1,2,active induction of host immune response by virus,BP,TGFB1
13321,GO:0052251,0.196162382025115,0.989310587969024,1,2,induction by organism of defense response of other organism involved in symbiotic interaction,BP,TGFB1
13348,GO:0052509,0.196162382025115,0.989310587969024,1,2,positive regulation by symbiont of host defense response,BP,TGFB1
13349,GO:0052510,0.196162382025115,0.989310587969024,1,2,positive regulation by organism of defense response of other organism involved in symbiotic interaction,BP,TGFB1
11139,GO:0045197,0.19619211844193,0.915408093082863,5,29,establishment or maintenance of epithelial cell apical/basal polarity,BP,DLG4;SH3BP1;VANGL2;DLG3;LRCH4
17416,GO:1900150,0.196450355055034,0.9892773625707,1,2,regulation of defense response to fungus,BP,FAM3A
4745,GO:0010917,0.196531629733508,0.958680326698902,2,8,negative regulation of mitochondrial membrane potential,BP,BNIP3;BNIP3L
11413,GO:0045837,0.196531629733508,0.958680326698902,2,8,negative regulation of membrane potential,BP,BNIP3;BNIP3L
266,GO:0000737,0.196678783792445,0.925209693209066,4,22,DNA catabolic process, endonucleolytic,BP,H1F0;ENDOG;BAX;DNASE1L1
7481,GO:0031652,0.196692000087002,0.958624983902045,2,8,positive regulation of heat generation,BP,APLN;SLC27A1
10166,GO:0042759,0.196983315076732,0.958524371355767,2,8,long-chain fatty acid biosynthetic process,BP,ACOT7;ALOX15B
5549,GO:0016554,0.197267750921456,0.958426033157043,2,8,cytidine to uridine editing,BP,APOBEC3C;APOBEC3F
19084,GO:1904954,0.197516470270743,0.98915385666465,1,2,canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,WNT3
10835,GO:0044338,0.197516470270743,0.989153856664649,1,2,canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation,BP,WNT3
13583,GO:0060061,0.197516470270743,0.989153856664649,1,2,Spemann organizer formation,BP,WNT3
4371,GO:0009994,0.19758940589901,0.914599220830513,5,29,oocyte differentiation,BP,CDC25B;NPR2;EREG;SIRT2;ZP3
982,GO:0002438,0.197600826707389,0.958310751134003,2,8,acute inflammatory response to antigenic stimulus,BP,IL20RB;ZP3
17536,GO:1901019,0.197643542000495,0.900010033586324,7,45,regulation of calcium ion transmembrane transporter activity,BP,NOS1;PKD2;PRKACA;CACNB3;GSTO1;EHD3;PLA2G6
19247,GO:1905371,0.197673941632661,0.989135547202172,1,2,ceramide phosphoethanolamine metabolic process,BP,SAMD8
19248,GO:1905373,0.197673941632661,0.989135547202172,1,2,ceramide phosphoethanolamine biosynthetic process,BP,SAMD8
12776,GO:0051066,0.197775321465024,0.989123750474069,1,2,dihydrobiopterin metabolic process,BP,GCH1
2009,GO:0004735,0.197845483717563,0.989115582091134,1,2,pyrroline-5-carboxylate reductase activity,MF,PYCR2
13065,GO:0051582,0.197876113183815,0.989112015094234,1,2,positive regulation of neurotransmitter uptake,BP,RAB3B
8183,GO:0032929,0.198001207664153,0.989097440268129,1,2,negative regulation of superoxide anion generation,BP,ACP5
14172,GO:0061082,0.19800459119227,0.938197261073485,3,15,myeloid leukocyte cytokine production,BP,GAS6;TGFB1;MIF
920,GO:0002314,0.198036047574409,0.989093379112925,1,2,germinal center B cell differentiation,BP,ADA
5560,GO:0016572,0.19809087294787,0.914308374753847,5,29,histone phosphorylation,BP,HMGA2;PKN1;PRKCD;RPS6KA5;MAPK3
18547,GO:1903726,0.198199300487765,0.958103265707308,2,8,negative regulation of phospholipid metabolic process,BP,LPCAT1;SLC27A1
9474,GO:0036112,0.198271843702832,0.989065871056022,1,2,medium-chain fatty-acyl-CoA metabolic process,BP,ACOT7
2747,GO:0006154,0.198376002314266,0.989053707553901,1,2,adenosine catabolic process,BP,ADA
11551,GO:0046103,0.198376002314266,0.989053707553901,1,2,inosine biosynthetic process,BP,ADA
1099,GO:0002687,0.198390258420265,0.885542409413322,10,71,positive regulation of leukocyte migration,BP,PGF;VEGFA;VEGFB;RAC2;GAS6;ADAM8;TGFB1;MAPK3;ITGA4;ZP3
3461,GO:0007283,0.198431990437322,0.850025838797726,34,276,spermatogenesis,BP,ERCC1;BBS2;CRTAP;ETV5;TCFL5;TXNRD3;SCMH1;GGT1;PHC2;GAMT;CCNI;MICALCL;RFX2;MYCBPAP;DNAH1;CEP131;PRKACA;TDRKH;FAM50A;BAX;SBF1;RPL39L;SPATA20;SIX5;BCAP31;SUN1;DNM2;DNMT3A;BCL2L1;AZIN2;BTG1;SEPT6;PRSS21;KDM3A
11135,GO:0045188,0.198442107750922,0.989045983932152,1,2,regulation of circadian sleep/wake cycle, non-REM sleep,BP,ADA
1131,GO:0002719,0.198589239709867,0.937927113937952,3,15,negative regulation of cytokine production involved in immune response,BP,TGFB1;JAK3;HFE
5077,GO:0015307,0.198602514921604,0.989027229641188,1,2,drug:proton antiporter activity,MF,SLC22A18
11750,GO:0046618,0.198602514921604,0.989027229641188,1,2,drug export,BP,SLC22A18
18494,GO:1903589,0.198698041504838,0.989016052465995,1,2,positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,VEGFA
13670,GO:0060214,0.198782500792474,0.989006164934835,1,2,endocardium formation,BP,PROX1
16560,GO:0097344,0.198824570163991,0.989001238077783,1,2,Rix1 complex,CC,WDR18
8903,GO:0034739,0.198881632245629,0.988994553413352,1,2,histone deacetylase activity (H4-K16 specific),MF,SIRT2
1788,GO:0004416,0.199002169792595,0.988980425314877,1,2,hydroxyacylglutathione hydrolase activity,MF,HAGH
6084,GO:0019243,0.199002169792595,0.988980425314877,1,2,methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione,BP,HAGH
13077,GO:0051596,0.199002169792595,0.988980425314877,1,2,methylglyoxal catabolic process,BP,HAGH
14419,GO:0061727,0.199002169792595,0.988980425314877,1,2,methylglyoxal catabolic process to lactate,BP,HAGH
1159,GO:0002767,0.1993413706594,0.988940613526543,1,2,immune response-inhibiting cell surface receptor signaling pathway,BP,HLA-G
11472,GO:0045940,0.199401533565644,0.937551063693782,3,15,positive regulation of steroid metabolic process,BP,NR1D1;APOE;ABCG1
5606,GO:0016647,0.199655846894404,0.988903631964042,1,2,oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor,MF,SMOX
11738,GO:0046592,0.199655846894404,0.988903631964042,1,2,polyamine oxidase activity,MF,SMOX
13441,GO:0052901,0.199655846894404,0.988903631964042,1,2,spermine:oxygen oxidoreductase (spermidine-forming) activity,MF,SMOX
2049,GO:0004797,0.199663242306104,0.988902761452957,1,2,thymidine kinase activity,MF,TK2
6747,GO:0030175,0.199743399413221,0.884804405215104,10,68,filopodium,CC,ITGA6;ACTA2;RAPGEF3;TENM2;TWF2;FARP1;FSCN1;WASH3P;MORN4;ITGA3
9260,GO:0035674,0.199782141969835,0.988888760578952,1,2,tricarboxylic acid transmembrane transport,BP,SLC13A5
16072,GO:0090034,0.199782141969922,0.98888876057895,1,2,regulation of chaperone-mediated protein complex assembly,BP,STUB1
16073,GO:0090035,0.199782141969922,0.98888876057895,1,2,positive regulation of chaperone-mediated protein complex assembly,BP,STUB1
13760,GO:0060349,0.199848881731383,0.893277616037013,8,52,bone morphogenesis,BP,MEF2D;LRP5;ACP5;THBS3;COL13A1;TGFB1;NAB2;FGFR3
7572,GO:0031943,0.199985364407545,0.957481414169369,2,8,regulation of glucocorticoid metabolic process,BP,DGKQ;STUB1
7886,GO:0032461,0.200206841135438,0.937177426815002,3,15,positive regulation of protein oligomerization,BP,MMP1;SNX9;BAX
1062,GO:0002589,0.200379211017559,0.98881830424694,1,2,regulation of antigen processing and presentation of peptide antigen via MHC class I,BP,HFE
1063,GO:0002590,0.200379211017559,0.98881830424694,1,2,negative regulation of antigen processing and presentation of peptide antigen via MHC class I,BP,HFE
1652,GO:0004103,0.200391862747507,0.988816808602019,1,2,choline kinase activity,MF,CHKA
19325,GO:1905595,0.2004465440694,0.988810343073834,1,2,regulation of low-density lipoprotein particle receptor binding,BP,PCSK9
19601,GO:1990667,0.2004465440694,0.988810343073834,1,2,PCSK9-AnxA2 complex,CC,PCSK9
19830,GO:2000272,0.20050117504349,0.923174574662149,4,22,negative regulation of signaling receptor activity,BP,ERRFI1;EPHB2;HFE;CBLC
820,GO:0002094,0.200512098420701,0.988802589162423,1,2,polyprenyltransferase activity,MF,COQ2
9715,GO:0038158,0.200734247774782,0.988776290512658,1,2,granulocyte colony-stimulating factor signaling pathway,BP,CEACAM1
10560,GO:0043525,0.200936556214476,0.904289602153182,6,38,positive regulation of neuron apoptotic process,BP,PRNP;PCSK9;CTSZ;BAX;ITGA1;CDC34
2713,GO:0006094,0.2010045229859,0.892394190098203,8,53,gluconeogenesis,BP,NR1D1;PGM1;PC;DGKQ;MDH2;PCK2;ALDOC;PPARA
13492,GO:0055070,0.201240306057221,0.936192329954953,3,16,copper ion homeostasis,BP,PRNP;ATP7B;MT2A
10006,GO:0042438,0.20130166529008,0.957020589345638,2,8,melanin biosynthetic process,BP,TRPC1;DDT
11519,GO:0046051,0.201373507529396,0.955967406150415,2,9,UTP metabolic process,BP,NME4;AK3
11714,GO:0046530,0.201495208282731,0.912326190110728,5,29,photoreceptor cell differentiation,BP,SDK2;VEGFA;NAGLU;IFT140;NPHP4
16446,GO:0097110,0.201502180389234,0.897511350348413,7,45,scaffold protein binding,MF,DLG4;NOS1;MAP2K2;MAP2K1;SHANK3;LRP4;MAPK3
3129,GO:0006721,0.201511109306275,0.892053629677555,8,53,terpenoid metabolic process,BP,APOE;EGFR;SDC1;LRP1;RETSAT;GPC1;AGRN;SDC2
6343,GO:0021523,0.201571128079284,0.988676908315528,1,2,somatic motor neuron differentiation,BP,TCTN1
1805,GO:0004450,0.201635026244819,0.988669300057835,1,2,isocitrate dehydrogenase (NADP+) activity,MF,IDH2
2715,GO:0006097,0.201635026244819,0.988669300057835,1,2,glyoxylate cycle,BP,IDH2
9427,GO:0036003,0.201695734558184,0.922534932064269,4,22,positive regulation of transcription from RNA polymerase II promoter in response to stress,BP,VEGFA;CEBPB;MBTPS2;SESN2
1241,GO:0002933,0.201761269223511,0.988654260090133,1,2,lipid hydroxylation,BP,CYP3A5
17116,GO:0101020,0.201761269223511,0.988654260090133,1,2,estrogen 16-alpha-hydroxylase activity,MF,CYP3A5
19434,GO:1990005,0.201766964803953,0.988653581283436,1,2,granular vesicle,CC,AZIN2
13586,GO:0060066,0.201783605298964,0.98865159791735,1,2,oviduct development,BP,WNT7A
7227,GO:0031133,0.201783605298965,0.98865159791735,1,2,regulation of axon diameter,BP,WNT7A
10013,GO:0042448,0.201811246917048,0.956841613191214,2,8,progesterone metabolic process,BP,EGR1;DGKQ
1286,GO:0003093,0.201961577370376,0.956788752425289,2,8,regulation of glomerular filtration,BP,F2R;GAS6
17901,GO:1902174,0.20223554562136,0.988597657332107,1,2,positive regulation of keratinocyte apoptotic process,BP,GSN
6104,GO:0019343,0.202249750588313,0.988595959600733,1,2,cysteine biosynthetic process via cystathionine,BP,CBS
18907,GO:1904580,0.202253471111799,0.988595514912512,1,2,regulation of intracellular mRNA localization,BP,ZFP36L1
18908,GO:1904582,0.202253471111799,0.988595514912512,1,2,positive regulation of intracellular mRNA localization,BP,ZFP36L1
11972,GO:0047288,0.202331984354152,0.988586128507999,1,2,monosialoganglioside sialyltransferase activity,MF,ST3GAL2
8146,GO:0032880,0.202397014495204,0.83062400319018,81,695,regulation of protein localization,BP,ZMYND8;NR1D1;EDEM1;PRNP;POSTN;WNT7A;F2R;LRP5;IDH2;ITPR3;EGFR;HADH;VPS11;ARL2;RAPGEF3;GLUL;SSH1;LRP1;DVL1;NLGN2;STOM;AKT1;RHBDF2;HK1;MAPKBP1;RAC2;KCNAB2;PFKL;SORL1;B3GAT3;LZTS2;ANK3;CEP250;GAS6;CSNK1E;GSN;ALOX15B;CEMIP;EPHB2;ADAM8;TGFB1;ABHD17C;TMEM173;CROCC;SNX33;LLGL1;PTPN1;PCK2;LRP4;CEP131;PFKFB2;PRKCZ;MICALL2;ERBB2;VAMP2;TFDP2;BNIP3L;PRKCD;ZDHHC8;GDI1;TMEM231;SESN2;BCAP31;MIF;PLA2G6;NBPF3;FYN;MAPK3;PFKM;STX10;CEP72;PAK1;PPP3CB;ITGA3;BCL2L1;LMNA;ICA1;NGFR;CAMK1;SIRT3;HFE
19691,GO:1990967,0.202517404799933,0.988563943983707,1,2,multi-organism toxin transport,BP,RAB40B
2578,GO:0005871,0.202527587180068,0.896981301499782,7,44,kinesin complex,CC,KLC2;KIF17;KIF26B;KIF7;KIF26A;NDE1;KIF13B
12263,GO:0048569,0.202554432979507,0.93608356058552,3,15,post-embryonic animal organ development,BP,ERCC1;VEGFA;BAX
6219,GO:0019763,0.202570689360713,0.988557564320672,1,2,immunoglobulin receptor activity,MF,FCGRT
2239,GO:0005150,0.202861052649568,0.988522764639627,1,2,interleukin-1, Type I receptor binding,MF,TOLLIP
8272,GO:0033084,0.202875648001533,0.988521013842466,1,2,regulation of immature T cell proliferation in thymus,BP,ERBB2
8275,GO:0033088,0.202875648001533,0.988521013842466,1,2,negative regulation of immature T cell proliferation in thymus,BP,ERBB2
11860,GO:0046875,0.203011364718895,0.921828462862457,4,22,ephrin receptor binding,MF,SHC1;EFNB3;PTPN1;FYN
12163,GO:0048295,0.20308408368975,0.988495994450097,1,2,positive regulation of isotype switching to IgE isotypes,BP,STAT6
13689,GO:0060252,0.203110978148414,0.95638366299459,2,8,positive regulation of glial cell proliferation,BP,ETV5;PLAG1
10123,GO:0042663,0.203115116504367,0.988492266844179,1,2,regulation of endodermal cell fate specification,BP,DUSP6
10646,GO:0043691,0.20319183315241,0.956355105242129,2,8,reverse cholesterol transport,BP,APOE;ABCG1
17712,GO:1901607,0.203197416195594,0.890918117101718,8,53,alpha-amino acid biosynthetic process,BP,NAGS;GLUL;PYCR2;GGT1;GAMT;CBS;PHGDH;AHCY
19538,GO:1990418,0.203210474165378,0.988480808420048,1,2,response to insulin-like growth factor stimulus,BP,AKT1
12213,GO:0048477,0.203361214814501,0.896301916787553,7,45,oogenesis,BP,ERCC1;HEXB;CDC25B;NPR2;EREG;SIRT2;ZP3
3291,GO:0006987,0.203400988498511,0.956281194625662,2,8,activation of signaling protein activity involved in unfolded protein response,BP,PTPN1;BAX
7092,GO:0030895,0.203407982176405,0.988457055023784,1,2,apolipoprotein B mRNA editing enzyme complex,CC,APOBEC3F
17633,GO:1901329,0.203569580616386,0.988437599916676,1,2,regulation of odontoblast differentiation,BP,CEBPB
3204,GO:0006844,0.203645463162589,0.988428457955395,1,2,acyl carnitine transport,BP,SLC25A29
5043,GO:0015227,0.203645463162589,0.988428457955395,1,2,acyl carnitine transmembrane transporter activity,MF,SLC25A29
16370,GO:0090677,0.20392832204121,0.988394344808834,1,2,reversible differentiation,BP,OLFM2
16371,GO:0090678,0.20392832204121,0.988394344808834,1,2,cell dedifferentiation involved in phenotypic switching,BP,OLFM2
19172,GO:1905174,0.20392832204121,0.988394344808834,1,2,regulation of vascular smooth muscle cell dedifferentiation,BP,OLFM2
19685,GO:1990936,0.20392832204121,0.988394344808834,1,2,vascular smooth muscle cell dedifferentiation,BP,OLFM2
17520,GO:1900745,0.203964429210125,0.935423238949614,3,15,positive regulation of p38MAPK cascade,BP,XDH;VEGFA;MINK1
2154,GO:0004977,0.203977871099749,0.988388363335435,1,2,melanocortin receptor activity,MF,MC1R
9840,GO:0042091,0.204002488232535,0.98838539095712,1,2,interleukin-10 biosynthetic process,BP,TRIB2
11066,GO:0045074,0.204002488232535,0.98838539095712,1,2,regulation of interleukin-10 biosynthetic process,BP,TRIB2
18430,GO:1903464,0.204014757549676,0.988383909347827,1,2,negative regulation of mitotic cell cycle DNA replication,BP,CHEK2
18238,GO:1903031,0.204020523925403,0.988383212979429,1,2,regulation of microtubule plus-end binding,BP,MAPRE3
18239,GO:1903033,0.204020523925403,0.988383212979429,1,2,positive regulation of microtubule plus-end binding,BP,MAPRE3
17436,GO:1900195,0.204025493156158,0.988382612858353,1,2,positive regulation of oocyte maturation,BP,SIRT2
8269,GO:0033081,0.20411716127917,0.935351562449263,3,15,regulation of T cell differentiation in thymus,BP,ADAM8;ADA;ERBB2
3090,GO:0006667,0.204153983971372,0.988367089323601,1,2,sphinganine metabolic process,BP,SPTLC2
11703,GO:0046511,0.204153983971372,0.988367089323601,1,2,sphinganine biosynthetic process,BP,SPTLC2
20154,GO:2000828,0.204307264211043,0.988348555671238,1,2,regulation of parathyroid hormone secretion,BP,FGFR1
15920,GO:0072709,0.204324672682078,0.988346449705912,1,2,cellular response to sorbitol,BP,MAPK13
15934,GO:0072739,0.204324672682248,0.988346449705917,1,2,response to anisomycin,BP,MAPK13
6775,GO:0030217,0.204389184396988,0.861673381005726,18,136,T cell differentiation,BP,EGR1;ZFP36L1;STAT6;RAG1;CARD11;SOX13;AP3D1;ADAM8;TGFB1;PRKCZ;ADA;ERBB2;JAK3;ZFPM1;SATB1;HLA-G;PPP3CB;ITPKB
20123,GO:2000777,0.204498305850029,0.988325432999416,1,2,positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia,BP,SIRT2
5143,GO:0015671,0.20451526302277,0.988323379350808,1,2,oxygen transport,BP,CYGB
18411,GO:1903429,0.204617285915706,0.935116651227443,3,15,regulation of cell maturation,BP,NPR2;RAC3;SIRT2
1881,GO:0004560,0.204653164808327,0.988306670826031,1,2,alpha-L-fucosidase activity,MF,FUCA1
5277,GO:0015928,0.204653164808327,0.988306670826031,1,2,fucosidase activity,MF,FUCA1
889,GO:0002254,0.204734926582756,0.988296758039103,1,2,kinin cascade,BP,F12
943,GO:0002353,0.204734926582756,0.988296758039103,1,2,plasma kallikrein-kinin cascade,BP,F12
12707,GO:0050951,0.204775071454176,0.955794278960681,2,8,sensory perception of temperature stimulus,BP,NTSR1;NR2F6
4001,GO:0008941,0.2048061647758,0.98828811728996,1,2,nitric oxide dioxygenase activity,MF,CYGB
5629,GO:0016708,0.2048061647758,0.98828811728996,1,2,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor,MF,CYGB
19597,GO:1990641,0.204893523933482,0.988277516286483,1,2,response to iron ion starvation,BP,HFE
10219,GO:0042903,0.204903817098412,0.988276266860297,1,2,tubulin deacetylase activity,MF,SIRT2
5454,GO:0016328,0.204926757551725,0.895280605010257,7,45,lateral plasma membrane,CC,ARL2;DVL1;CEACAM1;ANK3;SNTA1;VANGL2;PKD1
19965,GO:2000490,0.204934553444268,0.988272535513286,1,2,negative regulation of hepatic stellate cell activation,BP,CYGB
13075,GO:0051593,0.204959846545756,0.955728624343431,2,8,response to folic acid,BP,GSN;MTHFR
14524,GO:0070032,0.204961739445886,0.988269234617855,1,2,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex,CC,VAMP2
14525,GO:0070033,0.204961739445886,0.988269234617855,1,2,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex,CC,VAMP2
8662,GO:0034242,0.205035465745082,0.988260280226692,1,2,negative regulation of syncytium formation by plasma membrane fusion,BP,RAPGEF3
2732,GO:0006116,0.205109605650713,0.988251271736748,1,2,NADH oxidation,BP,PCK2
19786,GO:2000179,0.205131286852873,0.920685706256539,4,22,positive regulation of neural precursor cell proliferation,BP,VEGFA;GJC2;CTSZ;PROX1
16296,GO:0090402,0.205196844800631,0.988240666638455,1,2,oncogene-induced cell senescence,BP,HMGA2
9478,GO:0036117,0.205282343125758,0.988230267953359,1,2,hyaluranon cable,CC,HYAL1
8295,GO:0033137,0.205387331319629,0.92054731719737,4,22,negative regulation of peptidyl-serine phosphorylation,BP,PPM1F;MLXIPL;BAX;DDIT4
2117,GO:0004906,0.205420470707525,0.988213457371219,1,2,interferon-gamma receptor activity,MF,IFNGR2
5320,GO:0016043,0.205433134708397,0.811396709321582,500,4613,cellular component organization,BP,ERCC1;SDK2;ZMYND8;ADGRL1;H1F0;SEMA4B;HTRA1;FHL1;THSD4;DLG4;CST3;CYP27B1;TYSND1;MARVELD1;APLN;CTNNBIP1;KCNG1;XPC;PRNP;PARVB;BBS2;FLNC;POSTN;VEGFA;WNT7A;APOE;TSPAN1;ESPN;NAGLU;F2R;LRP5;ITGA6;HMGA2;OBSCN;NDRG1;IDH2;NEK9;ITPR3;PKN1;MTA1;EVI5L;NISCH;EGFR;SERPINE2;DNPH1;WWTR1;LOXL1;OBSL1;NOS1;VAT1;PTPRS;SPRY2;CAPN2;NFATC4;BAHCC1;LTBP4;SYTL1;SDC1;ETV5;SHC1;DDB2;LTBP2;VPS11;TBC1D14;ARL2;HEXB;SLC12A7;MMP1;SNX9;NUDCD3;RAPGEF3;GAA;GLUL;ARAP1;MAP2K2;LPAR3;SMARCA1;PLTP;MAP2K1;MCTP1;SSH1;EXOC2;ENDOG;MARK4;SLC9A3R2;FBLN1;SMAD3;SHANK2;LRP1;DVL1;EPAS1;HSD17B8;THBS3;HBEGF;FAM110C;AP2A2;ITGB4;SH3PXD2B;NLGN2;STOM;BRD3;REEP4;FBXW5;ADARB1;SYT8;AKT1;GRB7;KCNC4;TMOD2;CORO1B;HDAC5;S100A6;PPM1F;BSG;SCMH1;DYSF;EPHA1;FMNL2;ASH2L;IMPACT;ATG16L2;LRRC8A;CNTN1;BRSK1;IFT140;RAB31;DNAAF5;FGFR4;POLD4;LDLR;FGFR1;PRKACB;SIGMAR1;RAC2;SMOC2;PFKL;HLTF;NPHP4;SYNE3;RAG1;H2AFJ;B4GAT1;PACS2;TOMM34;KLF7;SORL1;CEACAM1;CIRBP;CBR4;HMG20B;TENM2;ZNF385A;ABCD1;ANK3;IGFBP4;TRAPPC9;EFS;TNNT1;TWF2;STRADB;SYNGAP1;CEP250;GAS6;PTK6;SEMA3F;CSNK1E;RAB3B;LAMA5;GSN;PLEKHG2;IGFBP2;PCSK9;BCR;ANGPTL4;MRPS6;EHD4;SEPT10;WIPF1;HLCS;AIP;DBNDD1;STON1;SH3D19;CCDC113;CDC25B;SLITRK6;ARPIN;SPTB;SMARCD2;PEX10;COL13A1;CORO7;UNC119B;DGKQ;PLXNB3;BNIP3;PAK6;SHARPIN;FYCO1;PKD2;GPX3;CTSZ;CDC42EP5;CRTC1;FBXW8;AP3D1;ITGB5;SH3PXD2A;EPHB2;GRIN3B;ADAM8;ASIC1;CTBP1;PTPDC1;PLCG1;KIF17;NYAP1;TIMP2;SYNJ2;WNT3;TMED4;TGFB1;CLTCL1;RFX2;UNK;ULK2;GPC1;MOAP1;TBC1D9B;ARHGAP25;FHOD3;SHANK3;MSRB2;EFNB3;MIPEP;EML2;GOLGA2P5;NSMF;ARAP3;FARP1;TUB;CROCC;RHOD;LAMB2;TNS1;SNX17;DNAH1;ERO1B;SNX33;PI4K2A;SEMA4F;RHOF;WASF3;ATG2A;LLGL1;PHF21A;COA5;RHOBTB2;ADAM19;KHDRBS3;TUBG2;BBS1;HMGCL;PTPN1;PEX1;TPP1;AGRN;MBD3;OLFML2A;LRP4;VHL;CEP131;PRKCZ;KDM6B;PRKACA;MINK1;CENPH;GRHPR;OXA1L;RABGGTA;RCCD1;TOM1L2;CD9;EPN2;AREG;PIM2;MICALL2;BOK;WDR18;TDRKH;CAPG;SDCCAG8;ALAS1;ERBB2;ADGRB2;ULK1;NINL;VAMP2;PRIMPOL;PSMG4;MMP10;TFDP2;PLEK2;C6ORF89;RILPL1;NET1;BNIP3L;CYFIP2;FSCN1;ARHGAP44;MCFD2;PRKCD;RBL2;CACNB3;STUB1;IFI6;BAX;TRIM4;ITGA1;HIST3H2BB;NUBP2;SH3BP1;CHADL;EREG;RPS6KA5;DGUOK;TIMM17B;CUL9;SOX12;TOP3B;PPL;AHNAK2;ZDHHC8;FCHO1;NID1;LIMK1;TGFBR3;GDI1;TPM2;PADI3;LEMD2;DNM1;WASH3P;RGS14;MRPS26;LRSAM1;ADAM15;REEP2;EHD3;WDR60;TMEM231;LONP2;IRAK1;TGFA;HDAC7;FHOD1;MTHFR;CHD2;PI4K2B;CBX7;CHEK2;ZFPM1;COG7;SESN2;ABCG1;JADE2;CDC34;ABCA7;EML3;MIF;KDM4B;DOPEY2;PLA2G6;SYNGR1;DNAAF3;NBPF3;FYN;VWA1;EFEMP2;STK25;RAC3;EEF2K;SUN1;ICAM5;ARHGAP12;ARID5B;DNM2;ATXN10;INF2;CAT;TSPYL2;IGFBP7;ZMYM3;TPBG;SATB1;KIF26A;SLC12A4;H1FX;IQSEC1;ARHGEF4;TUBB6;MAPK3;INSR;TAZ;PFKM;ADCY1;RERE;STX10;INO80C;ATP8B2;CEP72;VANGL2;PAK1;MALL;CAMKK2;PPP3CB;USP21;CUL7;MICAL1;HYAL1;SEMA4C;CAPRIN2;WDTC1;ITGA3;DNMT3A;BIN1;VPS16;PPP2R5B;BCL2L1;SGSM2;NDUFV3;PROX1;TBC1D16;ADGRF1;LMNA;PKD1;KCTD13;RABGAP1;SIRT2;FAM129B;CDH4;ITGA4;DCBLD2;TRIP10;E2F5;AZIN2;TEP1;RAP1GAP2;LAMB1;NDE1;GPR3;NGFR;BCORL1;PDCD6;ATP6V1F;PCLO;PXN;GRB10;TBC1D8;PLEKHM1;GCH1;MSS51;LURAP1;KIF13B;CBX6;TCTN1;NBEAL2;CAMK1;SLC39A3;EZH1;SIRT3;HFE;TERC;WIPI2;COL6A1;BTG1;BBS10;VPS51;CELSR1;TACC1;SEMA3B;SEPT6;CDK11B;PFN2;SSH3;CCDC88C;TNRC18;BLOC1S4;CDC42BPG;DOK4;TRIM46;KDM3A;APBA1;TTLL3;DEDD2;PI4KAP2;SRSF5;ADCY6;KLHL24;SDC2
1033,GO:0002541,0.205457110521589,0.988208995926329,1,2,activation of plasma proteins involved in acute inflammatory response,BP,F12
14642,GO:0070233,0.205499205165813,0.934701644509649,3,15,negative regulation of T cell apoptotic process,BP,RAG1;ADA;JAK3
9200,GO:0035588,0.205502760153929,0.955535470772793,2,8,G-protein coupled purinergic receptor signaling pathway,BP,ADORA2B;ADA
5283,GO:0015936,0.205532237622812,0.934686081402514,3,15,coenzyme A metabolic process,BP,ACOT7;PANK4;PPCS
19265,GO:1905424,0.205550136554801,0.988197664361209,1,2,regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,BP,CSNK1E
19266,GO:1905426,0.205550136554801,0.988197664361209,1,2,positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,BP,CSNK1E
4415,GO:0010193,0.205605479380578,0.988190920116342,1,2,response to ozone,BP,CAT
18231,GO:1903018,0.205721343010465,0.909609157627735,5,30,regulation of glycoprotein metabolic process,BP,CST3;HBEGF;NECAB3;JAK3;ABCA7
11542,GO:0046086,0.205880869194383,0.988157328132335,1,2,adenosine biosynthetic process,BP,NT5E
20309,GO:2001269,0.205916860997156,0.934504766985822,3,15,positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,SMAD3;GSN;BAX
12975,GO:0051387,0.20595564506818,0.988148197745639,1,2,negative regulation of neurotrophin TRK receptor signaling pathway,BP,SPRY2
12126,GO:0048232,0.206033149143451,0.842952777042413,35,286,male gamete generation,BP,ERCC1;BBS2;CRTAP;ETV5;TCFL5;TXNRD3;SCMH1;GGT1;PHC2;GAMT;CCNI;MICALCL;RFX2;MYCBPAP;DNAH1;CEP131;PRKACA;PIM2;TDRKH;FAM50A;BAX;SBF1;RPL39L;SPATA20;SIX5;BCAP31;SUN1;DNM2;DNMT3A;BCL2L1;AZIN2;BTG1;SEPT6;PRSS21;KDM3A
12716,GO:0050966,0.206048952522511,0.988136799052325,1,2,detection of mechanical stimulus involved in sensory perception of pain,BP,FYN
11238,GO:0045446,0.206211318274059,0.880145019128876,10,69,endothelial cell differentiation,BP,XDH;ACVR2B;WNT7A;PTPRS;RAPGEF3;CEACAM1;LAMA5;KDM6B;PROX1;BTG1
1811,GO:0004461,0.206235002369793,0.988114052338073,1,2,lactose synthase activity,MF,B4GALT2
13826,GO:0060437,0.206248761808379,0.988112369118701,1,2,lung growth,BP,SPRY2
7023,GO:0030803,0.206256933403522,0.955266551457798,2,8,negative regulation of cyclic nucleotide biosynthetic process,BP,LTB4R2;GABBR1
7038,GO:0030818,0.206256933403522,0.955266551457798,2,8,negative regulation of cAMP biosynthetic process,BP,LTB4R2;GABBR1
14821,GO:0070564,0.206274707268477,0.988109194795187,1,2,positive regulation of vitamin D receptor signaling pathway,BP,CYP27B1
898,GO:0002276,0.206286200015268,0.988107788551442,1,2,basophil activation involved in immune response,BP,PI4K2A
11259,GO:0045575,0.206286200015268,0.988107788551442,1,2,basophil activation,BP,PI4K2A
13124,GO:0051694,0.206349494580896,0.988100042204037,1,2,pointed-end actin filament capping,BP,TMOD2
12852,GO:0051181,0.206398313964691,0.909209227663167,5,30,cofactor transport,BP,SLC48A1;CD320;SLC22A17;SLC25A29;SLC23A2
13501,GO:0055082,0.206418766415451,0.834820117480876,51,432,cellular chemical homeostasis,BP,NR1D1;DLG4;PRNP;APOE;F2R;LRP5;ITPR3;NOS1;HEXB;LPAR3;ENDOG;SMAD3;PIK3R2;CYBRD1;TPCN1;HK1;EDNRA;GAS6;BNIP3;CEMIP;PKD2;AP3D1;PLCG1;TGFB1;NTSR1;ATP7B;RASA3;PCK2;MLXIPL;PRKACA;BOK;TRPC1;SLC22A17;CACNB3;BAX;SV2A;MT2A;GSTO1;BCAP31;SLC9A7;PLA2G6;WFS1;FYN;MAPK3;GRINA;PPP3CB;WDTC1;PKD1;ATP6V1F;HFE;SLC26A11
15696,GO:0072237,0.206470957721958,0.988085168926533,1,2,metanephric proximal tubule development,BP,PKD1
5233,GO:0015850,0.206492072097941,0.867908740367434,14,104,organic hydroxy compound transport,BP,SLC16A3;APOE;OSBPL5;NISCH;NOS1;PLTP;LRP1;LDLR;CEACAM1;RAB3B;PCSK9;ABCA2;ABCG1;ABCA7
15270,GO:0071456,0.206516733733313,0.858226466869675,19,151,cellular response to hypoxia,BP,EGR1;VEGFA;NDRG1;ZFP36L1;ENDOG;EPAS1;AKT1;BNIP3;ADAM8;VHL;BNIP3L;PDK1;STUB1;IRAK1;DNMT3A;LMNA;SIRT2;BACH1;TERC
542,GO:0001661,0.206568056880245,0.988073271540949,1,2,conditioned taste aversion,BP,FOS
13662,GO:0060199,0.206568056880245,0.988073271540949,1,2,clathrin-sculpted glutamate transport vesicle,CC,VAMP2
13665,GO:0060203,0.206568056880245,0.988073271540949,1,2,clathrin-sculpted glutamate transport vesicle membrane,CC,VAMP2
3562,GO:0007608,0.206712921326662,0.934128909118217,3,15,sensory perception of smell,BP,GNAL;BBS1;GJB4
485,GO:0001537,0.206775093376287,0.988047881468927,1,2,N-acetylgalactosamine 4-O-sulfotransferase activity,MF,CHST14
8129,GO:0032836,0.206788562606363,0.955076562751854,2,8,glomerular basement membrane development,BP,LAMB2;NID1
535,GO:0001654,0.206798832749812,0.847648046845322,28,221,eye development,BP,SDK2;CST3;ACVR2B;VEGFA;WNT7A;NAGLU;LRP5;EGFR;SMAD3;SH3PXD2B;SALL2;IFT140;WNT2B;NPHP4;RAB11FIP4;SLITRK6;EPHB2;TGFB1;TUB;LAMB2;BAX;PPP1R13L;LPCAT1;TMEM231;MYH15;SIX5;PROX1;ZNF513
16416,GO:0097055,0.206806434124077,0.988044035331496,1,2,agmatine biosynthetic process,BP,AZIN2
17575,GO:1901162,0.206806434124077,0.988044035331496,1,2,primary amino compound biosynthetic process,BP,AZIN2
10674,GO:0043932,0.206821876574153,0.988042139978114,1,2,ossification involved in bone remodeling,BP,TGFB1
14759,GO:0070447,0.207000153753428,0.988020246631997,1,2,positive regulation of oligodendrocyte progenitor proliferation,BP,GJC2
19504,GO:1990264,0.20701811056621,0.988018040197274,1,2,peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity,BP,PTPN1
13815,GO:0060423,0.20702033753744,0.988017766543354,1,2,foregut regionalization,BP,WNT2B
13816,GO:0060424,0.20702033753744,0.988017766543354,1,2,lung field specification,BP,WNT2B
13864,GO:0060492,0.20702033753744,0.988017766543354,1,2,lung induction,BP,WNT2B
16525,GO:0097241,0.207082143670192,0.988010170302827,1,2,hematopoietic stem cell migration to bone marrow,BP,GAS6
1508,GO:0003865,0.207087854905076,0.988009468230941,1,2,3-oxo-5-alpha-steroid 4-dehydrogenase activity,MF,SRD5A3
8518,GO:0033765,0.207087854905076,0.988009468230941,1,2,steroid dehydrogenase activity, acting on the CH-CH group of donors,MF,SRD5A3
9257,GO:0035671,0.207087854905076,0.988009468230941,1,2,enone reductase activity,MF,SRD5A3
12028,GO:0047751,0.207087854905076,0.988009468230941,1,2,cholestenone 5-alpha-reductase activity,MF,SRD5A3
18750,GO:1904207,0.207108319590249,0.988006952354306,1,2,regulation of chemokine (C-C motif) ligand 2 secretion,BP,POSTN
18751,GO:1904209,0.207108319590249,0.988006952354306,1,2,positive regulation of chemokine (C-C motif) ligand 2 secretion,BP,POSTN
3387,GO:0007168,0.207128809480404,0.988004433082061,1,2,receptor guanylyl cyclase signaling pathway,BP,NPR2
480,GO:0001527,0.207134357067742,0.954952798188012,2,8,microfibril,CC,THSD4;LTBP1
12893,GO:0051248,0.207194074686284,0.823130055647898,101,894,negative regulation of protein metabolic process,BP,TNIP1;DUSP6;XDH;DUSP5;PLAT;CST3;PDCD4;PRNP;VEGFA;TNFRSF6B;APOE;LRP5;PKN1;EGFR;SERPINE2;WWTR1;SPRY2;CRTAP;SPRY4;ZFP36L1;MAP2K2;PPP1R35;MAP2K1;FBLN1;SMAD3;PIK3R2;DVL1;HBEGF;PPP1R14A;PRDX5;ADARB1;AKT1;GRB7;PPM1F;STK39;SERPING1;EPHA1;IMPACT;LDLR;RAG1;SORL1;CEACAM1;CIRBP;HMG20B;PODNL1;GAS6;PTK6;DUSP7;ERRFI1;SNTA1;DGKQ;TFPI2;CTSZ;EPHB2;CTBP1;CDKN1C;TIMP2;C8ORF88;TGFB1;UNK;PTPN1;CAMK2N1;MLXIPL;TRIB2;PRKCZ;JAK3;PRKCD;IFI6;BAX;DUSP4;DDIT4;PCSK1N;LIMK1;LEMD2;RPS6KA6;RGS14;CHAD;ASB1;INPP5D;ZFPM1;SESN2;ABCA7;MIF;MEX3A;ECM1;FYN;ELFN2;MICAL1;CAPRIN2;BIN1;SIRT2;AZIN2;SERPINB1;SOCS7;NGFR;SIRT3;HFE;NDRG2;CBLC;KDM3A;LRRK1
2207,GO:0005093,0.207250441369924,0.987989472084262,1,2,Rab GDP-dissociation inhibitor activity,MF,GDI1
2317,GO:0005324,0.207256637808873,0.987988709627886,1,2,long-chain fatty acid transporter activity,MF,ABCD1
5265,GO:0015910,0.207256637808873,0.987988709627886,1,2,peroxisomal long-chain fatty acid import,BP,ABCD1
17793,GO:1901856,0.207279588224158,0.987985885399678,1,2,negative regulation of cellular respiration,BP,TRAP1
13283,GO:0051990,0.207312639787179,0.987981817490903,1,2,(R)-2-hydroxyglutarate dehydrogenase activity,MF,D2HGDH
9657,GO:0038016,0.207313759039586,0.987981679722413,1,2,insulin receptor internalization,BP,CEACAM1
1189,GO:0002835,0.20732704656402,0.987980044096591,1,2,negative regulation of response to tumor cell,BP,CEACAM1
1192,GO:0002838,0.20732704656402,0.987980044096591,1,2,negative regulation of immune response to tumor cell,BP,CEACAM1
1197,GO:0002856,0.20732704656402,0.987980044096591,1,2,negative regulation of natural killer cell mediated immune response to tumor cell,BP,CEACAM1
1200,GO:0002859,0.20732704656402,0.987980044096591,1,2,negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,CEACAM1
14975,GO:0070889,0.207363847006638,0.987975513499129,1,2,platelet alpha granule organization,BP,ZNF385A
4535,GO:0010609,0.207380157678378,0.987973505143505,1,2,mRNA localization resulting in posttranscriptional regulation of gene expression,BP,ZNF385A
5653,GO:0016748,0.207381141660994,0.987973383978348,1,2,succinyltransferase activity,MF,ALAS1
1745,GO:0004345,0.207385732861066,0.987972818620335,1,2,glucose-6-phosphate dehydrogenase activity,MF,H6PD
5307,GO:0016013,0.207393320275053,0.987971884277398,1,2,syntrophin complex,CC,SNTA1
13043,GO:0051542,0.207437172207663,0.987966483385306,1,2,elastin biosynthetic process,BP,HBEGF
16058,GO:0089709,0.207461969609612,0.98796342868466,1,2,L-histidine transmembrane transport,BP,SLC25A29
2302,GO:0005287,0.20746213330293,0.987963408518433,1,2,high-affinity basic amino acid transmembrane transporter activity,MF,SLC25A29
2303,GO:0005289,0.20746213330293,0.987963408518433,1,2,high-affinity arginine transmembrane transporter activity,MF,SLC25A29
2305,GO:0005292,0.20746213330293,0.987963408518433,1,2,high-affinity lysine transmembrane transporter activity,MF,SLC25A29
19579,GO:1990575,0.20746213330293,0.987963408518433,1,2,mitochondrial L-ornithine transmembrane transport,BP,SLC25A29
1751,GO:0004351,0.207470233106333,0.987962410638181,1,2,glutamate decarboxylase activity,MF,GLUL
1548,GO:0003943,0.207472908772144,0.987962080991103,1,2,N-acetylgalactosamine-4-sulfatase activity,MF,GALNS
11298,GO:0045626,0.207519030181377,0.987956397948901,1,2,negative regulation of T-helper 1 cell differentiation,BP,JAK3
14093,GO:0060940,0.207573614882556,0.987949670120011,1,2,epithelial to mesenchymal transition involved in cardiac fibroblast development,BP,PDCD4
8436,GO:0033566,0.207587629983601,0.987947942350385,1,2,gamma-tubulin complex localization,BP,CEP72
1653,GO:0004104,0.207629781366936,0.987942745125413,1,2,cholinesterase activity,MF,CHKA
8361,GO:0033265,0.207629781366936,0.987942745125413,1,2,choline binding,MF,CHKA
12319,GO:0048682,0.207635494009989,0.987942040665167,1,2,sprouting of injured axon,BP,LAMB2
17227,GO:0106104,0.207641059615634,0.987941354314747,1,2,regulation of glutamate receptor clustering,BP,SSH1
18965,GO:1904717,0.207641059615634,0.987941354314747,1,2,regulation of AMPA glutamate receptor clustering,BP,SSH1
1854,GO:0004517,0.207674242267603,0.987937261775071,1,2,nitric-oxide synthase activity,MF,NOS1
14300,GO:0061441,0.207705465340052,0.987933410205185,1,2,renal artery morphogenesis,BP,PKD2
9730,GO:0038190,0.207705465340229,0.987933410205185,1,2,VEGF-activated neuropilin signaling pathway,BP,VEGFA
17972,GO:1902336,0.207705465340229,0.987933410205185,1,2,positive regulation of retinal ganglion cell axon guidance,BP,VEGFA
4769,GO:0010956,0.207714123087814,0.987932342093137,1,2,negative regulation of calcidiol 1-monooxygenase activity,BP,CYP27B1
9973,GO:0042369,0.2077141230879,0.987932342093139,1,2,vitamin D catabolic process,BP,CYP27B1
4787,GO:0010979,0.207714123087903,0.987932342093137,1,2,regulation of vitamin D 24-hydroxylase activity,BP,CYP27B1
4788,GO:0010980,0.207714123087903,0.987932342093137,1,2,positive regulation of vitamin D 24-hydroxylase activity,BP,CYP27B1
1656,GO:0004109,0.20772537204815,0.987930954222173,1,2,coproporphyrinogen oxidase activity,MF,RSAD1
20064,GO:2000669,0.207735677668994,0.987929682659556,1,2,negative regulation of dendritic cell apoptotic process,BP,GAS6
11763,GO:0046632,0.207742692047433,0.88784321149866,8,53,alpha-beta T cell differentiation,BP,STAT6;AP3D1;PRKCZ;ADA;JAK3;ZFPM1;SATB1;ITPKB
19745,GO:2000097,0.207755091532,0.987927287068915,1,2,regulation of smooth muscle cell-matrix adhesion,BP,PLAU
9873,GO:0042144,0.207758502405768,0.987926866153535,1,2,vacuole fusion, non-autophagic,BP,VPS16
16670,GO:0097576,0.207758502405768,0.987926866153535,1,2,vacuole fusion,BP,VPS16
18690,GO:1904026,0.207766187904893,0.987925917702282,1,2,regulation of collagen fibril organization,BP,CHADL
15540,GO:0071953,0.207786699178262,0.987923386244239,1,2,elastic fiber,CC,FBLN1
2170,GO:0005006,0.207791440088886,0.987922801088632,1,2,epidermal growth factor-activated receptor activity,MF,EGFR
12690,GO:0050917,0.207791526101909,0.987922790472178,1,2,sensory perception of umami taste,BP,ITPR3
7941,GO:0032542,0.207792403882674,0.987922682128665,1,2,sulfiredoxin activity,MF,SESN2
1983,GO:0004703,0.207799179573197,0.987921845794373,1,2,G-protein coupled receptor kinase activity,MF,GRK6
12020,GO:0047696,0.207799179573197,0.987921845794373,1,2,beta-adrenergic receptor kinase activity,MF,GRK6
14533,GO:0070051,0.207811100800901,0.987920374259205,1,2,fibrinogen binding,MF,FBLN1
16568,GO:0097360,0.207821515626669,0.987919088589152,1,2,chorionic trophoblast cell proliferation,BP,BOK
17656,GO:1901382,0.207821515626669,0.987919088589152,1,2,regulation of chorionic trophoblast cell proliferation,BP,BOK
1674,GO:0004137,0.207825164492123,0.987918638132618,1,2,deoxycytidine kinase activity,MF,TK2
6086,GO:0019254,0.207830256067212,0.987918009556203,1,2,carnitine metabolic process, CoA-linked,BP,CRAT
18619,GO:1903892,0.207834660096734,0.987917465845348,1,2,negative regulation of ATF6-mediated unfolded protein response,BP,WFS1
12481,GO:0050473,0.207836838352078,0.987917196918123,1,2,arachidonate 15-lipoxygenase activity,MF,ALOX15B
19936,GO:2000418,0.207840023144612,0.987916803717826,1,2,positive regulation of eosinophil migration,BP,ADAM8
11874,GO:0046899,0.207843370055162,0.98791639049445,1,2,nucleoside triphosphate adenylate kinase activity,MF,AK3
3756,GO:0008300,0.20784982880992,0.987915593047457,1,2,isoprenoid catabolic process,BP,SRD5A3
6138,GO:0019408,0.20784982880992,0.987915593047457,1,2,dolichol biosynthetic process,BP,SRD5A3
19000,GO:1904783,0.207850459943352,0.987915515121338,1,2,positive regulation of NMDA glutamate receptor activity,BP,EPHB2
9107,GO:0035402,0.207856587041191,0.987914758593132,1,2,histone kinase activity (H3-T11 specific),MF,PKN1
9112,GO:0035407,0.207856587041191,0.987914758593132,1,2,histone H3-T11 phosphorylation,BP,PKN1
3842,GO:0008454,0.20785776568314,0.987914613060215,1,2,alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity,MF,MGAT4B
18183,GO:1902938,0.207863624564343,0.987913889619625,1,2,regulation of intracellular calcium activated chloride channel activity,BP,PRNP
17526,GO:1900756,0.207864015566592,0.987913841338725,1,2,protein processing in phagocytic vesicle,BP,GSN
18640,GO:1903921,0.207864015566592,0.987913841338725,1,2,regulation of protein processing in phagocytic vesicle,BP,GSN
18641,GO:1903923,0.207864015566592,0.987913841338725,1,2,positive regulation of protein processing in phagocytic vesicle,BP,GSN
1584,GO:0003994,0.207865151392865,0.987913701086491,1,2,aconitate hydratase activity,MF,ACO2
15323,GO:0071546,0.207865631282886,0.987913641829227,1,2,pi-body,CC,TDRKH
13603,GO:0060086,0.207865746957677,0.987913627545585,1,2,circadian temperature homeostasis,BP,NR1D1
2304,GO:0005290,0.207865929001549,0.987913605066596,1,2,L-histidine transmembrane transporter activity,MF,SLC15A4
5088,GO:0015349,0.207866011851403,0.987913594836185,1,2,thyroid hormone transmembrane transporter activity,MF,SLCO4A1
10452,GO:0043316,0.207866129503483,0.987913580308321,1,2,cytotoxic T cell degranulation,BP,CEACAM1
5537,GO:0016524,0.207866134773657,0.98791357965754,1,2,latrotoxin receptor activity,MF,ADGRL1
6017,GO:0019075,0.207866134773657,0.98791357965754,1,2,virus maturation,BP,MVB12B
5119,GO:0015467,0.207866134773746,0.987913579657541,1,2,G-protein activated inward rectifier potassium channel activity,MF,KCNJ15
6211,GO:0019732,0.207866134773747,0.98791357965754,1,2,antifungal humoral response,BP,FAM3A
1321,GO:0003169,0.207866134773756,0.987913579657531,1,2,coronary vein morphogenesis,BP,VEGFA
14095,GO:0060948,0.207866134773756,0.987913579657531,1,2,cardiac vascular smooth muscle cell development,BP,VEGFA
11325,GO:0045659,0.207866134773756,0.987913579657531,1,2,negative regulation of neutrophil differentiation,BP,INPP5D
20074,GO:2000683,0.207866134773836,0.98791357965754,1,2,regulation of cellular response to X-ray,BP,HMGA2
15308,GO:0071505,0.207866134773837,0.987913579657538,1,2,response to mycophenolic acid,BP,EGR1
15309,GO:0071506,0.207866134773837,0.987913579657538,1,2,cellular response to mycophenolic acid,BP,EGR1
9144,GO:0035500,0.207866134773839,0.987913579657537,1,2,MH2 domain binding,MF,HMGA2
19133,GO:1905064,0.207866134773839,0.987913579657536,1,2,negative regulation of vascular smooth muscle cell differentiation,BP,PDCD4
7606,GO:0031999,0.207866134773839,0.987913579657536,1,2,negative regulation of fatty acid beta-oxidation,BP,AKT1
17801,GO:1901873,0.20786613477384,0.987913579657536,1,2,regulation of post-translational protein modification,BP,CRTAP
17802,GO:1901874,0.20786613477384,0.987913579657536,1,2,negative regulation of post-translational protein modification,BP,CRTAP
15769,GO:0072369,0.207866134773841,0.987913579657535,1,2,regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter,BP,PPARA
8757,GO:0034437,0.207866134773841,0.987913579657535,1,2,glycoprotein transporter activity,MF,ABCG1
12194,GO:0048382,0.207866134773841,0.987913579657534,1,2,mesendoderm development,BP,ZFP36L1
1887,GO:0004568,0.207866134773841,0.987913579657534,1,2,chitinase activity,MF,CTBS
2673,GO:0006030,0.207866134773841,0.987913579657534,1,2,chitin metabolic process,BP,CTBS
2674,GO:0006032,0.207866134773841,0.987913579657534,1,2,chitin catabolic process,BP,CTBS
3611,GO:0008061,0.207866134773841,0.987913579657534,1,2,chitin binding,MF,CTBS
15904,GO:0072679,0.207866134773841,0.987913579657534,1,2,thymocyte migration,BP,ADAM8
14191,GO:0061113,0.207866134773842,0.987913579657534,1,2,pancreas morphogenesis,BP,PROX1
14058,GO:0060849,0.207866134773842,0.987913579657534,1,2,regulation of transcription involved in lymphatic endothelial cell fate commitment,BP,PROX1
6792,GO:0030240,0.207866134773842,0.987913579657534,1,2,skeletal muscle thin filament assembly,BP,PROX1
13459,GO:0055005,0.207866134773842,0.987913579657534,1,2,ventricular cardiac myofibril assembly,BP,PROX1
11751,GO:0046619,0.207866134773842,0.987913579657534,1,2,optic placode formation involved in camera-type eye formation,BP,PROX1
13809,GO:0060414,0.207866134773842,0.987913579657534,1,2,aorta smooth muscle tissue morphogenesis,BP,PROX1
15723,GO:0072300,0.207866134773842,0.987913579657533,1,2,positive regulation of metanephric glomerulus development,BP,EGR1
13014,GO:0051458,0.207866134773843,0.987913579657532,1,2,corticotropin secretion,BP,APLN
13015,GO:0051459,0.207866134773843,0.987913579657532,1,2,regulation of corticotropin secretion,BP,APLN
13016,GO:0051461,0.207866134773843,0.987913579657532,1,2,positive regulation of corticotropin secretion,BP,APLN
11227,GO:0045409,0.207866134773843,0.987913579657532,1,2,negative regulation of interleukin-6 biosynthetic process,BP,INPP5D
4928,GO:0014886,0.207866134773843,0.987913579657532,1,2,transition between slow and fast fiber,BP,GTF2IRD1
2353,GO:0005436,0.207866134773843,0.987913579657532,1,2,sodium:phosphate symporter activity,MF,SLC20A1
5081,GO:0015319,0.207866134773843,0.987913579657532,1,2,sodium:inorganic phosphate symporter activity,MF,SLC20A1
5082,GO:0015321,0.207866134773843,0.987913579657532,1,2,sodium-dependent phosphate transmembrane transporter activity,MF,SLC20A1
10910,GO:0044501,0.207866134773843,0.987913579657532,1,2,modulation of signal transduction in other organism,BP,TNIP1
13286,GO:0052027,0.207866134773843,0.987913579657532,1,2,modulation by symbiont of host signal transduction pathway,BP,TNIP1
13320,GO:0052250,0.207866134773843,0.987913579657532,1,2,modulation of signal transduction in other organism involved in symbiotic interaction,BP,TNIP1
8524,GO:0033842,0.207866134773844,0.987913579657532,1,2,N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity,MF,B4GALNT4
8869,GO:0034684,0.207866134773844,0.987913579657531,1,2,integrin alphav-beta5 complex,CC,ITGB5
19884,GO:2000346,0.207866134773844,0.987913579657531,1,2,negative regulation of hepatocyte proliferation,BP,CEACAM1
17570,GO:1901143,0.207866134773844,0.987913579657531,1,2,insulin catabolic process,BP,CEACAM1
18391,GO:1903385,0.207866134773844,0.987913579657531,1,2,regulation of homophilic cell adhesion,BP,CEACAM1
8638,GO:0034189,0.207866134773845,0.987913579657531,1,2,very-low-density lipoprotein particle binding,MF,PCSK9
6140,GO:0019417,0.207866134773845,0.987913579657531,1,2,sulfur oxidation,BP,MICAL1
3717,GO:0008240,0.207866134773845,0.987913579657531,1,2,tripeptidyl-peptidase activity,MF,TPP1
16614,GO:0097457,0.207866134773845,0.987913579657531,1,2,hippocampal mossy fiber,CC,MICAL1
15275,GO:0071462,0.207866134773845,0.987913579657531,1,2,cellular response to water stimulus,BP,PKD2
12,GO:0000023,0.207866134773845,0.987913579657531,1,2,maltose metabolic process,BP,GAA
1258,GO:0003011,0.207866134773845,0.987913579657531,1,2,involuntary skeletal muscle contraction,BP,GAA
1879,GO:0004558,0.207866134773845,0.987913579657531,1,2,alpha-1,4-glucosidase activity,MF,GAA
7876,GO:0032450,0.207866134773845,0.987913579657531,1,2,maltose alpha-glucosidase activity,MF,GAA
11376,GO:0045762,0.207866134773845,0.987913579657531,1,2,positive regulation of adenylate cyclase activity,BP,TIMP2
14919,GO:0070777,0.207866134773845,0.987913579657531,1,2,D-aspartate transport,BP,NTSR1
14921,GO:0070779,0.207866134773845,0.987913579657531,1,2,D-aspartate import across plasma membrane,BP,NTSR1
18147,GO:1902856,0.207866134773845,0.987913579657531,1,2,negative regulation of non-motile cilium assembly,BP,DNM2
10707,GO:0044028,0.207866134773845,0.987913579657531,1,2,DNA hypomethylation,BP,FAM129B
10708,GO:0044029,0.207866134773845,0.987913579657531,1,2,hypomethylation of CpG island,BP,FAM129B
12188,GO:0048369,0.207866134773845,0.987913579657531,1,2,lateral mesoderm morphogenesis,BP,FGFR1
12189,GO:0048370,0.207866134773845,0.987913579657531,1,2,lateral mesoderm formation,BP,FGFR1
12190,GO:0048371,0.207866134773845,0.987913579657531,1,2,lateral mesodermal cell differentiation,BP,FGFR1
12191,GO:0048372,0.207866134773845,0.987913579657531,1,2,lateral mesodermal cell fate commitment,BP,FGFR1
12192,GO:0048377,0.207866134773845,0.987913579657531,1,2,lateral mesodermal cell fate specification,BP,FGFR1
12193,GO:0048378,0.207866134773845,0.987913579657531,1,2,regulation of lateral mesodermal cell fate specification,BP,FGFR1
3533,GO:0007529,0.207866134773845,0.98791357965753,1,2,establishment of synaptic specificity at neuromuscular junction,BP,F2R
12353,GO:0048743,0.207866134773845,0.98791357965753,1,2,positive regulation of skeletal muscle fiber development,BP,FAM129B
8856,GO:0034665,0.207866134773845,0.98791357965753,1,2,integrin alpha1-beta1 complex,CC,ITGA1
8858,GO:0034667,0.207866134773845,0.98791357965753,1,2,integrin alpha3-beta1 complex,CC,ITGA3
16962,GO:0098971,0.207866134773845,0.98791357965753,1,2,anterograde dendritic transport of neurotransmitter receptor complex,BP,KIF17
18203,GO:1902962,0.207866134773845,0.98791357965753,1,2,regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,BP,SORL1
18204,GO:1902963,0.207866134773845,0.98791357965753,1,2,negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,BP,SORL1
933,GO:0002331,0.207866134773845,0.98791357965753,1,2,pre-B cell allelic exclusion,BP,RAG1
18195,GO:1902954,0.207866134773845,0.98791357965753,1,2,regulation of early endosome to recycling endosome transport,BP,SORL1
157,GO:0000320,0.207866134773845,0.98791357965753,1,2,re-entry into mitotic cell cycle,BP,CCND1
502,GO:0001560,0.207866134773845,0.98791357965753,1,2,regulation of cell growth by extracellular stimulus,BP,KIF26A
912,GO:0002296,0.207866134773845,0.98791357965753,1,2,T-helper 1 cell lineage commitment,BP,STAT6
1471,GO:0003726,0.207866134773845,0.98791357965753,1,2,double-stranded RNA adenosine deaminase activity,MF,ADARB1
1594,GO:0004008,0.207866134773845,0.98791357965753,1,2,copper-exporting ATPase activity,MF,ATP7B
2090,GO:0004854,0.207866134773845,0.98791357965753,1,2,xanthine dehydrogenase activity,MF,XDH
2147,GO:0004965,0.207866134773845,0.98791357965753,1,2,G-protein coupled GABA receptor activity,MF,GABBR1
2413,GO:0005589,0.207866134773845,0.98791357965753,1,2,collagen type VI trimer,CC,COL6A1
2426,GO:0005607,0.207866134773845,0.98791357965753,1,2,laminin-2 complex,CC,LAMB1
2427,GO:0005608,0.207866134773845,0.98791357965753,1,2,laminin-3 complex,CC,LAMB2
2770,GO:0006196,0.207866134773845,0.98791357965753,1,2,AMP catabolic process,BP,NT5E
4063,GO:0009115,0.207866134773845,0.98791357965753,1,2,xanthine catabolic process,BP,XDH
4526,GO:0010593,0.207866134773845,0.98791357965753,1,2,negative regulation of lamellipodium assembly,BP,PLXNB3
4952,GO:0015016,0.207866134773845,0.98791357965753,1,2,[heparan sulfate]-glucosamine N-sulfotransferase activity,MF,NDST2
5446,GO:0016314,0.207866134773845,0.98791357965753,1,2,phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity,MF,INPP5D
5641,GO:0016726,0.207866134773845,0.98791357965753,1,2,oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor,MF,XDH
6015,GO:0019072,0.207866134773845,0.98791357965753,1,2,viral genome packaging,BP,PC
6016,GO:0019074,0.207866134773845,0.98791357965753,1,2,viral RNA genome packaging,BP,PC
6346,GO:0021527,0.207866134773845,0.98791357965753,1,2,spinal cord association neuron differentiation,BP,MDGA1
6386,GO:0021590,0.207866134773845,0.98791357965753,1,2,cerebellum maturation,BP,RERE
6420,GO:0021691,0.207866134773845,0.98791357965753,1,2,cerebellar Purkinje cell layer maturation,BP,RERE
6428,GO:0021699,0.207866134773845,0.98791357965753,1,2,cerebellar cortex maturation,BP,RERE
6487,GO:0021847,0.207866134773845,0.98791357965753,1,2,ventricular zone neuroblast division,BP,FGFR1
7264,GO:0031251,0.207866134773845,0.98791357965753,1,2,PAN complex,CC,PAN2
8172,GO:0032916,0.207866134773845,0.98791357965753,1,2,positive regulation of transforming growth factor beta3 production,BP,SMAD3
8503,GO:0033691,0.207866134773845,0.98791357965753,1,2,sialic acid binding,MF,AGRN
8637,GO:0034188,0.207866134773845,0.98791357965753,1,2,apolipoprotein A-I receptor activity,MF,ABCA7
8790,GO:0034499,0.207866134773845,0.98791357965753,1,2,late endosome to Golgi transport,BP,SGSM2
8862,GO:0034673,0.207866134773845,0.98791357965753,1,2,inhibin-betaglycan-ActRII complex,CC,TGFBR3
9215,GO:0035607,0.207866134773845,0.98791357965753,1,2,fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development,BP,FGFR1
9335,GO:0035838,0.207866134773845,0.98791357965753,1,2,growing cell tip,CC,PI4K2A
9602,GO:0036466,0.207866134773845,0.98791357965753,1,2,synaptic vesicle recycling via endosome,BP,AP3D1
9703,GO:0038113,0.207866134773845,0.98791357965753,1,2,interleukin-9-mediated signaling pathway,BP,JAK3
10450,GO:0043314,0.207866134773845,0.98791357965753,1,2,negative regulation of neutrophil degranulation,BP,BCR
10643,GO:0043682,0.207866134773845,0.98791357965753,1,2,copper-transporting ATPase activity,MF,ATP7B
12435,GO:0050119,0.207866134773845,0.98791357965753,1,2,N-acetylglucosamine deacetylase activity,MF,NDST2
12478,GO:0050436,0.207866134773845,0.98791357965753,1,2,microfibril binding,MF,LTBP1
12977,GO:0051389,0.207866134773845,0.98791357965753,1,2,inactivation of MAPKK activity,BP,EPHB2
13036,GO:0051525,0.207866134773845,0.98791357965753,1,2,NFAT protein binding,MF,PPARA
13532,GO:0060003,0.207866134773845,0.98791357965753,1,2,copper ion export,BP,ATP7B
13634,GO:0060151,0.207866134773845,0.98791357965753,1,2,peroxisome localization,BP,PEX1
13635,GO:0060152,0.207866134773845,0.98791357965753,1,2,microtubule-based peroxisome localization,BP,PEX1
13656,GO:0060187,0.207866134773845,0.98791357965753,1,2,cell pole,CC,VANGL2
14261,GO:0061341,0.207866134773845,0.98791357965753,1,2,non-canonical Wnt signaling pathway involved in heart development,BP,VANGL2
14263,GO:0061346,0.207866134773845,0.98791357965753,1,2,planar cell polarity pathway involved in heart morphogenesis,BP,VANGL2
14439,GO:0061762,0.207866134773845,0.98791357965753,1,2,CAMKK-AMPK signaling cascade,BP,CAMKK2
15086,GO:0071104,0.207866134773845,0.98791357965753,1,2,response to interleukin-9,BP,JAK3
15161,GO:0071286,0.207866134773845,0.98791357965753,1,2,cellular response to magnesium ion,BP,ANK3
15203,GO:0071355,0.207866134773845,0.98791357965753,1,2,cellular response to interleukin-9,BP,JAK3
15521,GO:0071910,0.207866134773845,0.98791357965753,1,2,determination of liver left/right asymmetry,BP,PKD2
15541,GO:0071955,0.207866134773845,0.98791357965753,1,2,recycling endosome to Golgi transport,BP,TBC1D14
15993,GO:0086006,0.207866134773845,0.98791357965753,1,2,voltage-gated sodium channel activity involved in cardiac muscle cell action potential,MF,SCN4B
16097,GO:0090080,0.207866134773845,0.98791357965753,1,2,positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway,BP,FGFR1
16329,GO:0090554,0.207866134773845,0.98791357965753,1,2,phosphatidylcholine-translocating ATPase activity,MF,ABCA7
16330,GO:0090556,0.207866134773845,0.98791357965753,1,2,phosphatidylserine-translocating ATPase activity,MF,ABCA7
16376,GO:0090722,0.207866134773845,0.98791357965753,1,2,receptor-receptor interaction,MF,FGFR1
16445,GO:0097109,0.207866134773845,0.98791357965753,1,2,neuroligin family protein binding,MF,DLG4
16686,GO:0097635,0.207866134773845,0.98791357965753,1,2,extrinsic component of autophagosome membrane,CC,ULK1
16803,GO:0098647,0.207866134773845,0.98791357965753,1,2,collagen beaded filament,CC,COL6A1
16954,GO:0098948,0.207866134773845,0.98791357965753,1,2,intrinsic component of postsynaptic specialization membrane,CC,PTPRS
16968,GO:0098982,0.207866134773845,0.98791357965753,1,2,GABA-ergic synapse,CC,NLGN2
16969,GO:0098983,0.207866134773845,0.98791357965753,1,2,symmetric, GABA-ergic, inhibitory synapse,CC,NLGN2
16976,GO:0099004,0.207866134773845,0.98791357965753,1,2,calmodulin dependent kinase signaling pathway,BP,CAMKK2
16990,GO:0099060,0.207866134773845,0.98791357965753,1,2,integral component of postsynaptic specialization membrane,CC,PTPRS
18051,GO:1902564,0.207866134773845,0.98791357965753,1,2,negative regulation of neutrophil activation,BP,BCR
18324,GO:1903238,0.207866134773845,0.98791357965753,1,2,positive regulation of leukocyte tethering or rolling,BP,ITGA4
19031,GO:1904849,0.207866134773845,0.98791357965753,1,2,positive regulation of cell chemotaxis to fibroblast growth factor,BP,FGFR1
19036,GO:1904862,0.207866134773845,0.98791357965753,1,2,inhibitory synapse assembly,BP,NLGN2
19073,GO:1904928,0.207866134773845,0.98791357965753,1,2,coreceptor activity involved in canonical Wnt signaling pathway,MF,LRP5
19376,GO:1905793,0.207866134773845,0.98791357965753,1,2,protein localization to pericentriolar material,BP,NUDCD3
19988,GO:2000546,0.207866134773845,0.98791357965753,1,2,positive regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,FGFR1
20297,GO:2001245,0.207866134773845,0.98791357965753,1,2,regulation of phosphatidylcholine biosynthetic process,BP,LPCAT1
15706,GO:0072262,0.207866134773927,0.987913579657537,1,2,metanephric glomerular mesangial cell proliferation involved in metanephros development,BP,EGR1
15724,GO:0072301,0.207866134773927,0.987913579657537,1,2,regulation of metanephric glomerular mesangial cell proliferation,BP,EGR1
18218,GO:1902996,0.207866134773928,0.987913579657536,1,2,regulation of neurofibrillary tangle assembly,BP,SORL1
5258,GO:0015888,0.207866134773929,0.987913579657536,1,2,thiamine transport,BP,SLC35F3
5734,GO:0016880,0.207866134773929,0.987913579657536,1,2,acid-ammonia (or amide) ligase activity,MF,GLUL
7636,GO:0032053,0.207866134773929,0.987913579657536,1,2,ciliary basal body organization,BP,CROCC
10239,GO:0042978,0.207866134773929,0.987913579657536,1,2,ornithine decarboxylase activator activity,MF,AZIN2
16685,GO:0097632,0.207866134773929,0.987913579657536,1,2,extrinsic component of phagophore assembly site membrane,CC,ULK1
16917,GO:0098886,0.207866134773929,0.987913579657536,1,2,modification of dendritic spine,BP,ARHGAP44
17736,GO:1901656,0.207866134773929,0.987913579657536,1,2,glycoside transport,BP,SLC50A1
17949,GO:1902269,0.207866134773929,0.987913579657536,1,2,positive regulation of polyamine transmembrane transport,BP,AZIN2
19918,GO:2000393,0.207866134773929,0.987913579657536,1,2,negative regulation of lamellipodium morphogenesis,BP,ARPIN
15239,GO:0071403,0.20786613477393,0.987913579657535,1,2,cellular response to high density lipoprotein particle stimulus,BP,ABCG1
1026,GO:0002528,0.20786613477393,0.987913579657535,1,2,regulation of vascular permeability involved in acute inflammatory response,BP,CTNNBIP1
18685,GO:1904020,0.207866134773931,0.987913579657533,1,2,regulation of G-protein coupled receptor internalization,BP,APLN
7354,GO:0031403,0.207866134773933,0.987913579657531,1,2,lithium ion binding,MF,PDXK
2219,GO:0005119,0.207866134773933,0.987913579657531,1,2,smoothened binding,MF,BBS1
2069,GO:0004822,0.207866134773933,0.987913579657531,1,2,isoleucine-tRNA ligase activity,MF,IARS2
2914,GO:0006428,0.207866134773933,0.987913579657531,1,2,isoleucyl-tRNA aminoacylation,BP,IARS2
8381,GO:0033300,0.207866134773934,0.987913579657531,1,2,dehydroascorbic acid transmembrane transporter activity,MF,SLC2A3
14940,GO:0070837,0.207866134773934,0.987913579657531,1,2,dehydroascorbic acid transport,BP,SLC2A3
3913,GO:0008582,0.207866134773934,0.98791357965753,1,2,regulation of synaptic growth at neuromuscular junction,BP,AGRN
6542,GO:0021965,0.207866134773934,0.98791357965753,1,2,spinal cord ventral commissure morphogenesis,BP,ADARB1
14936,GO:0070829,0.207866134773934,0.98791357965753,1,2,heterochromatin maintenance,BP,MTHFR
15097,GO:0071144,0.207866134773934,0.98791357965753,1,2,heteromeric SMAD protein complex,CC,SMAD3
15761,GO:0072361,0.207866134773934,0.98791357965753,1,2,regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter,BP,PPARA
15764,GO:0072364,0.207866134773934,0.98791357965753,1,2,regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter,BP,PPARA
16815,GO:0098679,0.207866134773934,0.98791357965753,1,2,regulation of carbohydrate catabolic process by regulation of transcription from RNA polymerase II promoter,BP,PPARA
17056,GO:0099532,0.207866134773934,0.98791357965753,1,2,synaptic vesicle endosomal processing,BP,AP3D1
17319,GO:0140192,0.207866134773934,0.98791357965753,1,2,regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,NOS1
9503,GO:0036156,0.207866134773934,0.98791357965753,1,2,inner dynein arm,CC,DNAH1
5466,GO:0016362,0.207866134773934,0.98791357965753,1,2,activin receptor activity, type II,MF,ACVR2B
15602,GO:0072092,0.207866134773934,0.98791357965753,1,2,ureteric bud invasion,BP,KIF26B
18988,GO:1904761,0.207866134773934,0.987913579657531,1,2,negative regulation of myofibroblast differentiation,BP,PDCD4
18453,GO:1903526,0.207866134773934,0.987913579657531,1,2,negative regulation of membrane tubulation,BP,DNM2
514,GO:0001579,0.207866134774018,0.987913579657535,1,2,medium-chain fatty acid transport,BP,SLC27A1
6629,GO:0023016,0.207866134774022,0.987913579657532,1,2,signal transduction by trans-phosphorylation,BP,STK39
10202,GO:0042823,0.207866134774022,0.987913579657531,1,2,pyridoxal phosphate biosynthetic process,BP,PDXK
10002,GO:0042426,0.207866134774022,0.987913579657531,1,2,choline catabolic process,BP,ALDH7A1
14001,GO:0060733,0.207866134774023,0.987913579657531,1,2,regulation of eIF2 alpha phosphorylation by amino acid starvation,BP,IMPACT
15146,GO:0071262,0.207866134774023,0.987913579657531,1,2,regulation of translational initiation in response to starvation,BP,IMPACT
15147,GO:0071264,0.207866134774023,0.987913579657531,1,2,positive regulation of translational initiation in response to starvation,BP,IMPACT
153,GO:0000309,0.207866134774023,0.98791357965753,1,2,nicotinamide-nucleotide adenylyltransferase activity,MF,NMNAT2
6109,GO:0019355,0.207866134774023,0.98791357965753,1,2,nicotinamide nucleotide biosynthetic process from aspartate,BP,NMNAT2
8830,GO:0034627,0.207866134774023,0.98791357965753,1,2,'de novo' NAD biosynthetic process,BP,NMNAT2
8831,GO:0034628,0.207866134774023,0.98791357965753,1,2,'de novo' NAD biosynthetic process from aspartate,BP,NMNAT2
9544,GO:0036309,0.207866134774023,0.98791357965753,1,2,protein localization to M-band,BP,OBSCN
16946,GO:0098928,0.207866134774023,0.98791357965753,1,2,presynaptic signal transduction,BP,PCLO
17051,GO:0099526,0.207866134774023,0.98791357965753,1,2,presynapse to nucleus signaling pathway,BP,PCLO
20073,GO:2000679,0.208112131561873,0.933466352309955,3,15,positive regulation of transcription regulatory region DNA binding,BP,HMGA2;TGFB1;FAM129B
11457,GO:0045922,0.208339164792608,0.933358616060561,3,15,negative regulation of fatty acid metabolic process,BP,AKT1;CEACAM1;WDTC1
68,GO:0000139,0.208345333290221,0.827829102152117,69,583,Golgi membrane,CC,B4GALNT4;EDEM1;EGFR;ST6GALNAC2;ARAP1;MARCH9;PITPNM1;ENTPD6;BSG;ASAP2;MARCH4;IFNGR2;RAB31;B4GAT1;SORL1;B3GAT3;TRAPPC9;CORO7;CTSZ;GPSM1;AP3D1;B3GNT3;ATP7B;MGAT4B;GOLGA2P5;ST6GALNAC6;LLGL1;B4GALT2;B4GALT6;RFNG;AREG;BOK;C6ORF89;MCFD2;XYLT2;TMBIM4;MBTPS2;MFNG;LPCAT1;ST3GAL3;TGFA;COG7;ABCG1;ABCA7;RAB12;BCAP31;DOPEY2;SLC9A7;QSOX1;SPPL2B;STK25;DNM2;SLC50A1;HLA-G;STX10;MALL;SAMD8;SLC16A13;NDST2;PKD1;GAL3ST4;NMNAT2;ST3GAL2;ICA1;PDCD6;CHST14;VPS51;ST3GAL5;CHPF
379,GO:0001012,0.208556304392712,0.832290637598543,53,438,RNA polymerase II regulatory region DNA binding,MF,MEF2D;ZMYND8;EGR1;NR1D1;HMGA2;ELK3;NFATC4;ETV5;TCFL5;ETV4;ZC3H6;FOXQ1;POU2F2;FOS;SMAD3;STAT6;SALL2;HLTF;MXI1;KLF7;SOX13;MYEF2;SMARCD2;HES2;MNT;CEBPB;ZNF217;RFX2;DEAF1;PHF21A;MBD3;MLXIPL;KDM6B;TFDP2;PBX2;RBL2;ZNF395;CARF;IER2;ZHX3;ZFPM1;PPARA;SIX5;SSBP4;ARID5B;BHLHE40;SATB1;HES7;HES6;BACH1;NR2F6;PLAG1;KDM3A
18488,GO:1903579,0.208565177282127,0.933251300154677,3,15,negative regulation of ATP metabolic process,BP,MLXIPL;DDIT4;PPARA
3583,GO:0007635,0.20863588252314,0.954413665439195,2,8,chemosensory behavior,BP,GJB4;WFS1
5203,GO:0015802,0.20870671593382,0.954388163322569,2,8,basic amino acid transport,BP,SLC15A4;SLC25A29
4551,GO:0010634,0.209200524597119,0.865896351260067,14,103,positive regulation of epithelial cell migration,BP,VEGFA;WNT7A;HBEGF;AKT1;PPM1F;FGFR1;PLCG1;TGFB1;HDAC7;HYAL1;ITGA3;MAP2K3;PROX1;PDCD6
9601,GO:0036465,0.209246934450204,0.899262907434218,6,37,synaptic vesicle recycling,BP,WNT7A;NLGN2;SYT8;AP3D1;DNM1;DNM2
12833,GO:0051152,0.209432371575827,0.954126548335321,2,8,positive regulation of smooth muscle cell differentiation,BP,TGFB1;OLFM2
9192,GO:0035580,0.209445104506378,0.898798010992218,6,39,specific granule lumen,CC,CTSZ;TIMP2;QSOX1;PDXK;DNASE1L1;TOLLIP
10826,GO:0044327,0.209509017044202,0.954098877900065,2,8,dendritic spine head,CC,DNM1;DNM2
7248,GO:0031214,0.209544956532117,0.877766799369307,10,69,biomineral tissue development,BP,CYP27B1;ACVR2B;SMAD3;PTHLH;GAS6;TGFB1;FAM20C;PPARA;ECM1;FGFR3
814,GO:0002088,0.209622870965501,0.89220163419337,7,45,lens development in camera-type eye,BP,WNT7A;SMAD3;WNT2B;SLITRK6;TGFB1;SIX5;PROX1
3198,GO:0006835,0.209867073501084,0.892040896268951,7,45,dicarboxylic acid transport,BP,NTSR1;VAMP2;SLC13A5;SLC13A3;PRAF2;APBA1;SLC26A11
9043,GO:0035265,0.209918216468083,0.867964458966878,13,93,organ growth,BP,DUSP6;ACVR2B;SPRY2;THBS3;AKT1;WWC3;FGFR1;EVC;TGFBR3;PAK1;PROX1;FGFR3;PLAG1
15889,GO:0072659,0.210115641966767,0.848892417400834,24,188,protein localization to plasma membrane,BP,PRNP;BBS2;EGFR;LRP1;AKT1;BSG;RAB31;PACS2;ANK3;TTC7B;GAS6;LAMA5;EPHB2;TGFB1;BBS1;PRKCZ;VAMP2;RILPL1;ARHGAP44;CACNB3;EHD3;ITGA3;BCL2L1;RAB40B
3121,GO:0006704,0.210142690908989,0.953869831454648,2,8,glucocorticoid biosynthetic process,BP,DGKQ;HSD11B1
15447,GO:0071774,0.210151212100409,0.86285656563191,15,112,response to fibroblast growth factor,BP,DUSP6;APLN;POSTN;SPRY2;SPRY4;ZFP36L1;FGFR4;FGFR1;FGFBP1;GPC1;FAM20C;IER2;MAPK3;HYAL1;FGFR3
7688,GO:0032148,0.210202241459516,0.917590189991802,4,23,activation of protein kinase B activity,BP,AKT1;GAS6;PRKCZ;INSR
8289,GO:0033129,0.210221198222501,0.953841419778455,2,8,positive regulation of histone phosphorylation,BP,RPS6KA5;MAPK3
14296,GO:0061437,0.210420573276743,0.932367901855581,3,15,renal system vasculature development,BP,EGR1;ACTA2;PKD2
14299,GO:0061440,0.210420573276743,0.932367901855581,3,15,kidney vasculature development,BP,EGR1;ACTA2;PKD2
18200,GO:1902959,0.210485714615857,0.953745635578044,2,8,regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,SORL1;BIN1
19191,GO:1905245,0.210485714615857,0.953745635578044,2,8,regulation of aspartic-type peptidase activity,BP,SORL1;BIN1
16141,GO:0090154,0.210530969673523,0.953729239569023,2,8,positive regulation of sphingolipid biosynthetic process,BP,PRKCD;PLA2G6
19852,GO:2000304,0.210530969673523,0.953729239569023,2,8,positive regulation of ceramide biosynthetic process,BP,PRKCD;PLA2G6
971,GO:0002418,0.210816013646195,0.953625909263829,2,8,immune response to tumor cell,BP,CEACAM1;ADAM15
13469,GO:0055015,0.210818639315601,0.953624956974284,2,8,ventricular cardiac muscle cell development,BP,PROX1;LMNA
10152,GO:0042738,0.210976349669194,0.953567742237888,2,8,exogenous drug catabolic process,BP,NOS1;CYP2R1
13827,GO:0060438,0.211015900897286,0.932083540882603,3,15,trachea development,BP,MAP2K1;MAPK3;EDA
7195,GO:0031091,0.211119874698078,0.885436261609727,8,54,platelet alpha granule,CC,VEGFA;SERPINE2;SERPING1;VEGFB;GAS6;TGFB1;CD9;QSOX1
3550,GO:0007589,0.21122594540263,0.885363845975449,8,54,body fluid secretion,BP,XDH;APLN;VEGFA;STK39;CCND1;APRT;ATP7B;ADA
4552,GO:0010635,0.211402199172916,0.953413097301812,2,8,regulation of mitochondrial fusion,BP,VAT1;BNIP3
9042,GO:0035264,0.211402965489367,0.864220894647401,14,103,multicellular organism growth,BP,ERCC1;BBS2;WWTR1;ZFP36L1;ERCC6;SH3PXD2B;ADARB1;GAMT;SLITRK6;PPP1R13L;ARID5B;WDTC1;PLAG1;APBA1
16765,GO:0098563,0.211439273836831,0.931881045663585,3,15,intrinsic component of synaptic vesicle membrane,CC,PTPRS;RAB3B;SV2A
7032,GO:0030812,0.21148615774387,0.9533825817295,2,8,negative regulation of nucleotide catabolic process,BP,DDIT4;PPARA
10418,GO:0043268,0.211569162321056,0.931818876406723,3,15,positive regulation of potassium ion transport,BP,FHL1;STK39;DNM2
19083,GO:1904953,0.211592960815461,0.953343750496974,2,8,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,CSNK1E;WNT3
8517,GO:0033764,0.211702535777725,0.931216236598593,3,16,steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,HSD17B8;HSD17B7;HSD11B1
750,GO:0001991,0.21172362741497,0.953296223823158,2,8,regulation of systemic arterial blood pressure by circulatory renin-angiotensin,BP,F2R;CTSZ
357,GO:0000976,0.212196656321614,0.826815277676431,60,500,transcription regulatory region sequence-specific DNA binding,MF,MEF2D;ZMYND8;EGR1;NR1D1;HMGA2;ELK3;MTA1;NFATC4;BAHCC1;ETV5;TCFL5;ETV4;ZC3H6;FOXQ1;POU2F2;FOS;SMAD3;STAT6;SALL2;HLTF;MXI1;KLF7;SOX13;MYEF2;SMARCD2;HES2;MNT;CEBPB;ZNF217;RFX2;DEAF1;PHF21A;MBD3;MLXIPL;KDM6B;ZNF516;TFDP2;PBX2;ZNF395;SOX12;CARF;IER2;ZHX3;CHD2;ZFPM1;PPARA;SIX5;SSBP4;ARID5B;BHLHE40;SATB1;HES7;HES6;PROX1;BACH1;ZNF704;NR2F6;TNRC18;PLAG1;KDM3A
1493,GO:0003831,0.21227708869876,0.953094682095991,2,8,beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity,MF,B4GALT2;B4GALT6
3219,GO:0006873,0.212293138400664,0.834103684685615,41,343,cellular ion homeostasis,BP,DLG4;PRNP;APOE;F2R;ITPR3;NOS1;HEXB;LPAR3;SMAD3;CYBRD1;TPCN1;EDNRA;BNIP3;CEMIP;PKD2;AP3D1;PLCG1;TGFB1;NTSR1;ATP7B;RASA3;PRKACA;BOK;TRPC1;SLC22A17;CACNB3;BAX;SV2A;MT2A;GSTO1;BCAP31;SLC9A7;PLA2G6;WFS1;FYN;MAPK3;GRINA;PKD1;ATP6V1F;HFE;SLC26A11
9559,GO:0036344,0.212660212559259,0.931295830032431,3,15,platelet morphogenesis,BP,ZNF385A;ZFPM1;NBEAL2
12295,GO:0048644,0.212720577044459,0.89015809069751,7,45,muscle organ morphogenesis,BP,ADARB1;TGFB1;TGFBR3;ZFPM1;ARID5B;VANGL2;PROX1
14145,GO:0061037,0.212835334670002,0.9312117387404,3,15,negative regulation of cartilage development,BP,PTHLH;ADAMTS7;CHADL
6914,GO:0030512,0.212979036485614,0.88416537463506,8,54,negative regulation of transforming growth factor beta receptor signaling pathway,BP,HTRA1;LTBP1;SMURF2;SMAD3;TGFB1;STUB1;TGFBR3;DNM2
10371,GO:0043198,0.212992789948759,0.916400746849282,4,22,dendritic shaft,CC,ZMYND8;SYNGAP1;NTSR1;DLG3
4701,GO:0010863,0.213119436955845,0.93107523531279,3,15,positive regulation of phospholipase C activity,BP,EGFR;FGFR1;EDNRA
7190,GO:0031086,0.213124722606124,0.952785283588533,2,8,nuclear-transcribed mRNA catabolic process, deadenylation-independent decay,BP,ZFP36L1;PNRC1
19749,GO:2000106,0.213386080167846,0.88378103066231,8,55,regulation of leukocyte apoptotic process,BP,RAG1;GAS6;ADAM8;ADA;JAK3;BAX;MIF;ITPKB
2614,GO:0005925,0.213438370643289,0.832558864190784,42,358,focal adhesion,CC,FHL1;MRC2;PARVB;FLNC;ITGA6;EGFR;CAPN2;ARL2;SPRY4;MAP2K2;MAP2K1;MPRIP;SLC9A3R2;LRP1;GRB7;CORO1B;BSG;ZFYVE21;RAC2;PLAU;GSN;ARHGAP22;PROCR;ITGB5;CD81;SNTB2;TNS1;CD9;ITGA1;LIMK1;GIT1;EHD3;DNM2;CAT;MAPK3;TNS4;PAK1;ITGA3;RRAS;ITGA4;PXN;FGFR3
13757,GO:0060346,0.213812815204789,0.952533466468138,2,8,bone trabecula formation,BP,THBS3;CHAD
10512,GO:0043433,0.213851325482199,0.85787130475037,16,121,negative regulation of DNA binding transcription factor activity,BP,CTNNBIP1;PRNP;MDFI;RBCK1;DAP;MXI1;GAS6;PKD2;IRAK1;WFS1;BHLHE40;PELI1;CAT;PROX1;PKD1;MAP3K10
12811,GO:0051125,0.213919351723022,0.915890844078757,4,22,regulation of actin nucleation,BP,CORO1B;GSN;WIPF1;ARPIN
3005,GO:0006554,0.213992979405043,0.952467436125291,2,8,lysine catabolic process,BP,ALDH7A1;PHYKPL
770,GO:0002026,0.214094303366292,0.930606073815778,3,15,regulation of the force of heart contraction,BP,APLN;NOS1;GAA
11241,GO:0045454,0.214256988759973,0.88298385303502,8,57,cell redox homeostasis,BP,NOS1;TXNRD3;PRDX5;ERO1B;TMX4;PDIA5;QSOX1;GLRX
9701,GO:0038110,0.214334322085668,0.952342223647943,2,8,interleukin-2-mediated signaling pathway,BP,SHC1;JAK3
4766,GO:0010952,0.214420550616619,0.851936415052209,19,151,positive regulation of peptidase activity,BP,XDH;F2R;GRAMD4;FBLN1;SMAD3;PPM1F;DAP;GSN;TNFSF15;BOK;CYFIP2;BAX;MAPK12;SOX7;BCAP31;FYN;MAPK3;NGFR;PDCD6
6577,GO:0022410,0.214459661839022,0.951165920637898,2,9,circadian sleep/wake cycle process,BP,CST3;ADA
12609,GO:0050802,0.214459661839022,0.951165920637898,2,9,circadian sleep/wake cycle, sleep,BP,CST3;ADA
10428,GO:0043280,0.214483881113578,0.861659350749599,14,108,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,XDH;F2R;GRAMD4;SMAD3;PPM1F;DAP;GSN;TNFSF15;BOK;BAX;SOX7;BCAP31;NGFR;PDCD6
818,GO:0002092,0.21462253604556,0.9303513635487,3,15,positive regulation of receptor internalization,BP,APLN;VEGFA;PCSK9
9119,GO:0035435,0.214775461058304,0.952180190114693,2,8,phosphate ion transmembrane transport,BP,SLC20A1;SLC37A2
11608,GO:0046321,0.214829335636094,0.952160385102721,2,8,positive regulation of fatty acid oxidation,BP,PPARA;MLYCD
5013,GO:0015174,0.21486236989421,0.952148239494526,2,8,basic amino acid transmembrane transporter activity,MF,SLC15A4;SLC25A29
14355,GO:0061577,0.214996834734925,0.952098787276783,2,8,calcium ion transmembrane transport via high voltage-gated calcium channel,BP,NOS1;CACNB3
1105,GO:0002693,0.215112148435714,0.952056360476065,2,8,positive regulation of cellular extravasation,BP,ADAM8;ITGA4
7077,GO:0030878,0.215158838684707,0.93009240662144,3,15,thyroid gland development,BP,MAP2K1;SMAD3;MAPK3
15649,GO:0072170,0.215175050459341,0.930084573095195,3,15,metanephric tubule development,BP,WWTR1;PKD2;PKD1
6764,GO:0030205,0.2152475946378,0.952006505422606,2,8,dermatan sulfate metabolic process,BP,IDUA;CHST14
18017,GO:1902475,0.215284270803779,0.903911191475425,5,30,L-alpha-amino acid transmembrane transport,BP,SLC7A8;SLC43A1;NTSR1;SLC25A29;PRAF2
15495,GO:0071872,0.215372758984098,0.951960414746998,2,8,cellular response to epinephrine stimulus,BP,PRKACA;SIRT2
4697,GO:0010857,0.215382318019097,0.951956893919632,2,8,calcium-dependent protein kinase activity,MF,MAPKAPK3;MKNK2
18804,GO:1904321,0.215420908593956,0.951942678914477,2,8,response to forskolin,BP,ADCY1;ADCY6
18805,GO:1904322,0.215420908593956,0.951942678914477,2,8,cellular response to forskolin,BP,ADCY1;ADCY6
649,GO:0001840,0.215453779650279,0.951930569266315,2,8,neural plate development,BP,DVL1;VANGL2
1132,GO:0002720,0.215591596673308,0.91461758050428,4,23,positive regulation of cytokine production involved in immune response,BP,HK1;PRKCZ;MIF;MAPK3
12660,GO:0050873,0.215752447244361,0.914528327029529,4,23,brown fat cell differentiation,BP,ITGA6;BNIP3;CEBPB;ZNF516
20047,GO:2000650,0.215966359637601,0.951741562692217,2,8,negative regulation of sodium ion transmembrane transporter activity,BP,STK39;PCSK9
5087,GO:0015347,0.216038303687055,0.951715008346742,2,8,sodium-independent organic anion transmembrane transporter activity,MF,SLCO4A1;SLC22A17
13927,GO:0060602,0.216058359300053,0.929657264138606,3,15,branch elongation of an epithelium,BP,SPRY2;TGFB1;AREG
10298,GO:0043068,0.216063138757141,0.824921865799265,55,470,positive regulation of programmed cell death,BP,DUSP6;XDH;PDCD4;PRNP;F2R;ITGA6;HMGA2;OBSCN;GRAMD4;RPS6KA2;NFATC4;RBCK1;ENDOG;MARK4;SMAD3;AKT1;PPM1F;DAP;GSN;PLEKHG2;PCSK9;BNIP3;CTSZ;ADAM8;TGFB1;MOAP1;NTSR1;TNFSF15;PLEKHG5;BOK;TFDP2;STK17A;NET1;BNIP3L;PRKCD;BAX;ITGA1;INPP5D;CHEK2;CDC34;SOX7;BCAP31;PLA2G6;DNM2;ARHGEF4;ARHGEF1;BIN1;BCL2L1;SIRT2;MAP3K10;NGFR;PDCD6;PNMA1;BTG1;DEDD2
2437,GO:0005639,0.216065668220365,0.951704906494498,2,8,integral component of nuclear inner membrane,CC,LEMD2;SUN1
7255,GO:0031229,0.216065668220365,0.951704906494498,2,8,intrinsic component of nuclear inner membrane,CC,LEMD2;SUN1
10900,GO:0044453,0.216065668220365,0.951704906494498,2,8,nuclear membrane part,CC,LEMD2;SUN1
11570,GO:0046134,0.216101237382406,0.914015462281391,4,24,pyrimidine nucleoside biosynthetic process,BP,TK2;NME4;UCKL1;UPP1
10262,GO:0043008,0.216191911742598,0.951658290625379,2,8,ATP-dependent protein binding,MF,PRNP;PLA2G6
3459,GO:0007276,0.216336596100325,0.828672277477657,45,375,gamete generation,BP,ERCC1;BBS2;CRTAP;ETV5;HEXB;TCFL5;TXNRD3;AKT1;SCMH1;GGT1;PHC2;GAMT;CCNI;MICALCL;CDC25B;NPR2;WNT3;TGFB1;RFX2;DEAF1;MYCBPAP;DNAH1;CEP131;PRKACA;PIM2;TDRKH;FAM50A;BAX;SBF1;EREG;RPL39L;SPATA20;SIX5;BCAP31;SUN1;DNM2;DNMT3A;BCL2L1;SIRT2;AZIN2;BTG1;ZP3;SEPT6;PRSS21;KDM3A
8154,GO:0032891,0.216362430350059,0.951595294736198,2,8,negative regulation of organic acid transport,BP,AKT1;STK39
17718,GO:1901618,0.216388487308406,0.929497312471685,3,15,organic hydroxy compound transmembrane transporter activity,MF,SLC16A3;CEACAM1;ABCG1
17589,GO:1901203,0.21655396370287,0.95152449234689,2,8,positive regulation of extracellular matrix assembly,BP,SMAD3;TGFB1
9065,GO:0035307,0.216633740507844,0.903098751633284,5,30,positive regulation of protein dephosphorylation,BP,TGFB1;NSMF;PRKCD;ITGA1;SYMPK
766,GO:0002020,0.216848335487397,0.865394784655541,12,89,protease binding,MF,CST3;TYSND1;PRNP;LRP1;LDLR;RAD23A;TIMP2;LONP2;MIF;ECM1;ITGA3;BIN1
11108,GO:0045141,0.216902990053198,0.951395354305385,2,8,meiotic telomere clustering,BP,LEMD2;SUN1
16192,GO:0090220,0.216902990053198,0.951395354305385,2,8,chromosome localization to nuclear envelope involved in homologous chromosome segregation,BP,LEMD2;SUN1
15410,GO:0071679,0.216933570628014,0.951384032465139,2,8,commissural neuron axon guidance,BP,VEGFA;EPHB2
19511,GO:1990316,0.216935468476922,0.951383329786796,2,8,Atg1/ULK1 kinase complex,CC,ULK1;SESN2
1679,GO:0004143,0.21700218252546,0.951358626087733,2,8,diacylglycerol kinase activity,MF,DGKA;DGKQ
17490,GO:1900402,0.217002482322235,0.951358515062875,2,8,regulation of carbohydrate metabolic process by regulation of transcription from RNA polymerase II promoter,BP,NR1D1;PPARA
1423,GO:0003373,0.217002649079692,0.951358453306938,2,8,dynamin family protein polymerization involved in membrane fission,BP,DNM1;DNM2
1424,GO:0003374,0.217002649079692,0.951358453306938,2,8,dynamin family protein polymerization involved in mitochondrial fission,BP,DNM1;DNM2
8884,GO:0034706,0.217002649079709,0.951358453306921,2,8,sodium channel complex,CC,SCN4B;SCN8A
3584,GO:0007638,0.217002649079785,0.951358453306921,2,8,mechanosensory behavior,BP,SLITRK6;SHANK3
2429,GO:0005614,0.217002649079804,0.951358453306903,2,8,interstitial matrix,CC,SMOC2;VWA1
335,GO:0000931,0.217002649079806,0.9513584533069,2,8,gamma-tubulin large complex,CC,MZT2A;MZT2B
3734,GO:0008274,0.217002649079806,0.9513584533069,2,8,gamma-tubulin ring complex,CC,MZT2A;MZT2B
2276,GO:0005225,0.217002649079879,0.951358453306905,2,8,volume-sensitive anion channel activity,MF,TTYH3;LRRC8A
15563,GO:0072017,0.217002649079927,0.951358453306856,2,8,distal tubule development,BP,PKD2;PKD1
9405,GO:0035970,0.217246299755137,0.92908105680107,3,15,peptidyl-threonine dephosphorylation,BP,DUSP5;PPM1F;DUSP4
13790,GO:0060390,0.217265734859457,0.929071615271658,3,15,regulation of SMAD protein signal transduction,BP,WWTR1;SMAD3;TGFB1
18571,GO:1903779,0.217519165681584,0.893835810810392,6,38,regulation of cardiac conduction,BP,ITPR3;NOS1;NPR2;PRKACA;TRPC1;EHD3
984,GO:0002440,0.217545073215317,0.857109910573603,15,113,production of molecular mediator of immune response,BP,ERCC1;PKN1;POU2F2;STAT6;HK1;GAS6;CARD11;TGFB1;POLL;POLM;PRKCZ;JAK3;MIF;MAPK3;HFE
4151,GO:0009215,0.218053163724107,0.949809794808271,2,9,purine deoxyribonucleoside triphosphate metabolic process,BP,ADA;DGUOK
6391,GO:0021602,0.218140525698545,0.928646157920468,3,15,cranial nerve morphogenesis,BP,ADARB1;SEMA3F;EPHB2
5296,GO:0015980,0.218176923059237,0.84085814723812,25,215,energy derivation by oxidation of organic compounds,BP,NR1D1;PYGB;PGM1;PYGL;IDH2;NFATC4;PHLDA2;GAA;D2HGDH;AKT1;DHTKD1;BNIP3;SDHA;MDH2;TRAP1;OXA1L;CYC1;ACO2;ETFB;CAT;INSR;TAZ;PFKM;NDUFV3;SIRT3
2613,GO:0005924,0.218703132334772,0.827993976563767,42,359,cell-substrate adherens junction,CC,FHL1;MRC2;PARVB;FLNC;ITGA6;EGFR;CAPN2;ARL2;SPRY4;MAP2K2;MAP2K1;MPRIP;SLC9A3R2;LRP1;GRB7;CORO1B;BSG;ZFYVE21;RAC2;PLAU;GSN;ARHGAP22;PROCR;ITGB5;CD81;SNTB2;TNS1;CD9;ITGA1;LIMK1;GIT1;EHD3;DNM2;CAT;MAPK3;TNS4;PAK1;ITGA3;RRAS;ITGA4;PXN;FGFR3
10257,GO:0043001,0.219031129430891,0.901650339810936,5,30,Golgi to plasma membrane protein transport,BP,BBS2;RAB31;ANK3;BBS1;VAMP2
12876,GO:0051223,0.219273050828588,0.821762161958283,56,476,regulation of protein transport,BP,NR1D1;EDEM1;PRNP;POSTN;F2R;LRP5;IDH2;ITPR3;EGFR;HADH;VPS11;ARL2;RAPGEF3;GLUL;LRP1;NLGN2;STOM;RHBDF2;HK1;MAPKBP1;RAC2;PFKL;SORL1;B3GAT3;ANK3;GAS6;ALOX15B;CEMIP;ADAM8;TGFB1;TMEM173;LLGL1;PTPN1;PCK2;CEP131;PFKFB2;PRKCZ;MICALL2;ERBB2;VAMP2;BNIP3L;PRKCD;ZDHHC8;GDI1;BCAP31;MIF;PLA2G6;NBPF3;FYN;MAPK3;PFKM;PAK1;PPP3CB;ICA1;CAMK1;SIRT3
13502,GO:0055083,0.219303616703056,0.928079013085126,3,15,monovalent inorganic anion homeostasis,BP,SLC12A7;FGFR4;SLC12A4
7915,GO:0032496,0.220209658363509,0.83938137780216,25,202,response to lipopolysaccharide,BP,TNIP1;NR1D1;CYP27B1;PDCD4;TNFRSF6B;F2R;LOXL1;NOS1;ACP5;FOS;AKT1;HDAC5;MAPKAPK3;BCR;CEBPB;ADAMTS13;TGFB1;PCK2;IRAK1;MIF;PELI1;MAPK3;TNFRSF25;NGFR;GCH1
12057,GO:0048016,0.220610294504852,0.900692725137461,5,30,inositol phosphate-mediated signaling,BP,PRNP;ITPR3;NFATC4;ADGRB2;PPP3CB
17039,GO:0099512,0.221123287921796,0.816385996332334,69,589,supramolecular fiber,CC,THSD4;CST3;PARVB;FLNC;ESPN;OBSCN;NDRG1;MTA1;OBSL1;NOS1;SPRY2;LTBP1;CLIP2;MAP2K2;KLC2;SHANK2;DVL1;FAM110C;REEP4;TMOD2;CORO1B;MYZAP;RAC2;KCNAB2;LZTS2;ANK3;TNNT1;TWF2;WIPF1;PKD2;KIF17;SNPH;SNTB2;FHOD3;EML2;KIF26B;ENKD1;DNAH1;KIF7;TUBG2;PRKCZ;NINL;FSCN1;STUB1;AHNAK2;TPM2;DNM1;RGS14;SCN8A;REEP2;MYH15;EML3;NARF;FYN;RAC3;DNM2;KIF26A;TUBB6;PAK1;PPP3CB;MICAL1;BIN1;LMNA;SIRT2;MAPRE3;NDE1;KIF13B;COL6A1;TTLL3
11249,GO:0045503,0.221503525329976,0.927001707049716,3,15,dynein light chain binding,MF,GLUL;DNAH1;WDR60
5569,GO:0016581,0.221849187755017,0.926831889036781,3,15,NuRD complex,CC,APPL2;SALL2;MBD3
16328,GO:0090545,0.221849187755017,0.926831889036781,3,15,CHD-type complex,CC,APPL2;SALL2;MBD3
2718,GO:0006101,0.222037575859681,0.899584398930939,5,31,citrate metabolic process,BP,IDH2;DHTKD1;SDHA;MDH2;ACO2
10194,GO:0042805,0.222112727390108,0.926702317079036,3,15,actinin binding,MF,OBSL1;PKD2;MICALL2
13761,GO:0060350,0.22215760318813,0.899751705101801,5,30,endochondral bone morphogenesis,BP,MEF2D;THBS3;COL13A1;NAB2;FGFR3
14495,GO:0061971,0.22215760318813,0.899751705101801,5,30,replacement bone morphogenesis,BP,MEF2D;THBS3;COL13A1;NAB2;FGFR3
879,GO:0002237,0.222188053511627,0.836669289151241,26,211,response to molecule of bacterial origin,BP,TNIP1;NR1D1;CYP27B1;PDCD4;TNFRSF6B;F2R;LOXL1;NOS1;ACP5;FOS;AKT1;HDAC5;MAPKAPK3;BCR;CEBPB;ADAMTS13;TGFB1;PCK2;IRAK1;MIF;PELI1;MAPK3;TNFRSF25;SIRT2;NGFR;GCH1
3940,GO:0008631,0.222295554645323,0.890593737913483,6,39,intrinsic apoptotic signaling pathway in response to oxidative stress,BP,PRODH;AKT1;TRAP1;PDK1;PRKCD;STK25
14515,GO:0070006,0.222757295654857,0.926385045971157,3,15,metalloaminopeptidase activity,MF,RNPEPL1;LTA4H;RNPEP
17697,GO:1901566,0.223175068773658,0.802454115005547,165,1523,organonitrogen compound biosynthetic process,BP,TNIP1;NT5E;EGR1;NAGS;PGM1;APOE;IDH2;ACOT7;EGFR;NOS1;SDC1;LMF1;GTPBP1;TK2;ST6GALNAC2;ZFP36L1;GLUL;MAP2K2;KDSR;NME4;MAP2K1;NAPRT;SRD5A3;PIGQ;HBEGF;LY6K;NMRK1;ADORA2B;AKT1;GRB7;UROS;PYCR2;HK1;GGT1;VEGFB;IMPACT;PTHLH;PFKL;OPLAH;GAMT;B4GAT1;PIGV;B3GAT3;CIRBP;ZNF385A;PFKP;CARD11;DHTKD1;PHLDA1;MRPS6;NADK;PANK4;RSAD1;NPR2;HAGH;CEMIP;PCSK1;ZNF598;APRT;CBS;CEBPB;MVD;ADAMTS13;TIMP2;C8ORF88;TGFB1;ABHD17C;UNK;GPC1;MKNK2;ADAMTS7;B3GNT3;MGAT4B;ABTB1;ST6GALNAC6;PHGDH;MIF4GD;B4GALT2;AGRN;ZDHHC24;B4GALT6;TRAP1;PFKFB2;RFNG;MLXIPL;TRIB2;ADA;MPI;UCKL1;ALAS1;ERBB2;CNDP2;AHCY;NECAB3;JAK3;CYFIP2;MCFD2;PRKCD;CYC1;XYLT2;PPCS;EREG;DGUOK;DDIT4;ZDHHC8;LTB4R2;RPL39L;MFNG;GSTO1;ALDOC;MRPS26;MSLN;LPCAT1;ST3GAL3;PPOX;INPP5D;ZFPM1;PPARA;COG7;SESN2;ABCA7;SMOX;MEX3A;PLA2G6;NUDT14;DALRD3;UPP1;EEF2K;CERS4;CHKA;SLC27A1;ZDHHC1;MAPK3;INSR;TAZ;PFKM;ADCY1;GPT2;PDXK;VANGL2;PFKFB3;GABBR1;HYAL1;CAPRIN2;SAMD8;NDST2;IARS2;MDGA1;ALDH7A1;GAL3ST4;NMNAT2;ADCY7;ALG12;AZIN2;ST3GAL2;CHST14;GCH1;WIPI2;ST3GAL5;SPTLC2;PRSS21;CHPF;ADCY6;AARS;SDC2
12473,GO:0050431,0.22330411595464,0.926115485257921,3,15,transforming growth factor beta binding,MF,LTBP4;LTBP1;TGFBR3
10856,GO:0044381,0.223610076834872,0.925964497181417,3,15,glucose import in response to insulin stimulus,BP,PIK3R2;PAK1;NGFR
20313,GO:2001273,0.223610076834872,0.925964497181417,3,15,regulation of glucose import in response to insulin stimulus,BP,PIK3R2;PAK1;NGFR
6461,GO:0021795,0.223612560863407,0.898864395174645,5,30,cerebral cortex cell migration,BP,EGFR;MBOAT7;SUN1;LAMB1;SOCS7
12069,GO:0048029,0.223736754786291,0.88266673476852,7,46,monosaccharide binding,MF,PYGL;SLC2A3;BSG;HK1;PFKL;PHYH;PFKM
3160,GO:0006775,0.224041957160397,0.909553865053359,4,24,fat-soluble vitamin metabolic process,BP,CYP27B1;PLTP;FGFR1;CYP2R1
6904,GO:0030500,0.224160950583158,0.889565454401544,6,38,regulation of bone mineralization,BP,CYP27B1;ACVR2B;SMAD3;TGFB1;FAM20C;ECM1
3209,GO:0006855,0.224745447387306,0.881987114743023,7,46,drug transmembrane transport,BP,SLC6A8;NTSR1;SLC13A5;SLC25A29;SLC22A18;SLC13A3;PRAF2
4104,GO:0009161,0.225003978225997,0.830386456986085,30,259,ribonucleoside monophosphate metabolic process,BP,NT5E;DLG4;PGM1;HK1;PFKL;LHPP;PFKP;CARD11;DHTKD1;NADK;APRT;TGFB1;SDHA;PFKFB2;MLXIPL;ADA;UCKL1;FAM20C;CYC1;DDIT4;ALDOC;PPARA;UPP1;INSR;TAZ;PFKM;PFKFB3;DLG3;NDUFV3;AK3
6721,GO:0030139,0.22521814770952,0.834159008660858,26,210,endocytic vesicle,CC,DLG4;WNT7A;APOE;EGFR;VPS11;LRP1;HBEGF;AP2A2;DYSF;RAB31;LDLR;RAC2;RAB11FIP4;GSN;CEMIP;ITGB5;ADAM8;WNT3;CLTCL1;CD9;EPN2;PLEKHG5;EHD3;RAB12;DNM2;HLA-G
16876,GO:0098810,0.22562339164607,0.946899917058021,2,9,neurotransmitter reuptake,BP,NOS1;RAB3B
4813,GO:0014009,0.225714285900883,0.908940767242215,4,23,glial cell proliferation,BP,IDH2;ETV5;AREG;PLAG1
13741,GO:0060326,0.226023388089285,0.844255081405147,18,145,cell chemotaxis,BP,PGF;DOCK4;VEGFA;HBEGF;CORO1B;MMP28;VEGFB;FGFR1;RAC2;GAS6;PLXNB3;ADAM8;PLEKHG5;PRKCD;ITGA1;MIF;DDT;MAPK3
13467,GO:0055013,0.226127861588654,0.888291781015683,6,38,cardiac muscle cell development,BP,VEGFA;OBSL1;FHOD3;PAK1;PROX1;LMNA
13239,GO:0051926,0.226220284056867,0.897022718871825,5,31,negative regulation of calcium ion transport,BP,NOS1;PKD2;TGFB1;NTSR1;GSTO1
18684,GO:1904019,0.226426740986957,0.869823109971281,9,62,epithelial cell apoptotic process,BP,PDCD4;ZFP36L1;GAS6;GSN;ANGPTL4;BOK;WFS1;DNMT3A;BCL2L1
16478,GO:0097164,0.226532799450778,0.84582507829368,17,132,ammonium ion metabolic process,BP,LPCAT4;CRAT;AKR7A2;KDSR;LDLR;CBR4;PRKCD;LPCAT1;SMOX;PLA2G6;CHKA;SLC27A1;SAMD8;ALDH7A1;AZIN2;GCH1;SPTLC2
12962,GO:0051353,0.226695466138147,0.896501373674134,5,32,positive regulation of oxidoreductase activity,BP,CYP27B1;APOE;AKT1;CCS;GCH1
16351,GO:0090630,0.226762433567824,0.86524026429385,10,70,activation of GTPase activity,BP,EVI5L;TBC1D14;EPHA1;TBC1D9B;PLEKHG4;RALGAPA1;SGSM2;TBC1D16;RABGAP1;TBC1D8
10087,GO:0042594,0.227094500952392,0.843599047509262,18,138,response to starvation,BP,GLUL;IMPACT;DAP;WNT2B;GAS6;PCSK9;ULK2;HMGCL;PCK2;WDR59;ULK1;SESN2;UPP1;MAPK3;C12ORF66;HFE;GAS2L1;LRP11
97,GO:0000188,0.227432601630033,0.90796509557372,4,23,inactivation of MAPK activity,BP,DUSP6;DUSP5;DUSP7;DUSP4
20121,GO:2000774,0.228037443604789,0.945956878719712,2,9,positive regulation of cellular senescence,BP,HMGA2;YPEL3
3795,GO:0008374,0.228141177441985,0.886983798425843,6,38,O-acyltransferase activity,MF,LPCAT4;CRAT;CPT2;MBOAT7;LPCAT1;TAZ
18410,GO:1903428,0.228327786864673,0.895724568396413,5,31,positive regulation of reactive oxygen species biosynthetic process,BP,SMAD3;AKT1;PKD2;DNM2;INSR
1666,GO:0004126,0.228544595576653,0.945757833098742,2,9,cytidine deaminase activity,MF,APOBEC3C;APOBEC3F
6905,GO:0030501,0.228637008925422,0.907279150289606,4,23,positive regulation of bone mineralization,BP,ACVR2B;SMAD3;TGFB1;FAM20C
14603,GO:0070169,0.228637008925422,0.907279150289606,4,23,positive regulation of biomineral tissue development,BP,ACVR2B;SMAD3;TGFB1;FAM20C
14796,GO:0070527,0.228871808371647,0.886326754209453,6,39,platelet aggregation,BP,SERPINE2;CEACAM1;GAS6;CD9;PRKCD;BLOC1S4
5384,GO:0016208,0.228927692204111,0.94560726250535,2,9,AMP binding,MF,PYGL;APRT
11448,GO:0045913,0.229127838114259,0.879022440399671,7,46,positive regulation of carbohydrate metabolic process,BP,AKT1;NTSR1;PFKFB2;MLXIPL;PPARA;INSR;PFKFB3
7288,GO:0031293,0.229383984244567,0.906852867882657,4,23,membrane protein intracellular domain proteolysis,BP,TGFB1;MBTPS2;SPPL2B;NGFR
15770,GO:0072376,0.229699470249255,0.906672629765442,4,23,protein activation cascade,BP,FBLN1;F12;SERPING1;CD81
14637,GO:0070228,0.229799425532122,0.885549098897143,6,40,regulation of lymphocyte apoptotic process,BP,RAG1;ADAM8;ADA;JAK3;BAX;MIF
20201,GO:2001028,0.230533676270315,0.944974050365466,2,9,positive regulation of endothelial cell chemotaxis,BP,VEGFA;FGFR1
2223,GO:0005126,0.230554064595375,0.842493217625197,17,136,cytokine receptor binding,MF,PGF;VEGFA;SHC1;SMURF2;SMAD3;VEGFB;PLCG1;TGFB1;TNFSF15;IFNE;TRAP1;TGFBR3;MIF;DDT;ECM1;EDA;TOLLIP
6954,GO:0030613,0.230909028213297,0.980127288975921,1,3,oxidoreductase activity, acting on phosphorus or arsenic in donors,MF,GSTO1
6955,GO:0030614,0.230909028213297,0.980127288975921,1,3,oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor,MF,GSTO1
12311,GO:0048672,0.230956465464801,0.944806813861284,2,9,positive regulation of collateral sprouting,BP,LPAR3;WNT3
4621,GO:0010743,0.230988232870458,0.921685201877001,3,16,regulation of macrophage derived foam cell differentiation,BP,ALOX15B;PPARA;ABCG1
2214,GO:0005109,0.231606883747382,0.905580426462486,4,23,frizzled binding,MF,WNT7A;DVL1;WNT2B;WNT3
13030,GO:0051495,0.231795438565887,0.836381783163456,20,158,positive regulation of cytoskeleton organization,BP,ARL2;RAPGEF3;SMAD3;SH3PXD2B;CORO1B;PPM1F;EPHA1;RAC2;GSN;WIPF1;ARPIN;CDC42EP5;LIMK1;WASH3P;FHOD1;RAC3;PAK1;PROX1;PXN;PFN2
4280,GO:0009649,0.231900465685097,0.905411939090536,4,23,entrainment of circadian clock,BP,MTA1;CRTC1;BHLHE40;NR2F6
7057,GO:0030851,0.232308100784023,0.921016054169556,3,16,granulocyte differentiation,BP,CEACAM1;INPP5D;ZFPM1
8320,GO:0033173,0.232488631446404,0.905074084989115,4,23,calcineurin-NFAT signaling cascade,BP,PRNP;NFATC4;ADGRB2;PPP3CB
12605,GO:0050795,0.232547622830863,0.904692128839895,4,24,regulation of behavior,BP,DLG4;APOE;RAG1;ADA
15821,GO:0072527,0.232712548198981,0.864944274722857,9,66,pyrimidine-containing compound metabolic process,BP,NT5E;TK2;NME4;UCKL1;UPP1;NEIL1;APOBEC3C;APOBEC3F;AK3
11765,GO:0046634,0.233467066175407,0.883317922482587,6,39,regulation of alpha-beta T cell activation,BP,AP3D1;PRKCZ;ADA;JAK3;HFE;ITPKB
56,GO:0000118,0.234085226589538,0.869384333198026,8,55,histone deacetylase complex,CC,APPL2;SALL2;HDAC5;ZNF217;PHF21A;MBD3;HDAC7;RERE
7454,GO:0031616,0.234433371943952,0.943423000769087,2,9,spindle pole centrosome,CC,NUBP2;NDE1
7644,GO:0032070,0.234919491864351,0.943228315979059,2,9,regulation of deoxyribonuclease activity,BP,AKT1;PRKCD
10348,GO:0043167,0.23525733866608,0.783105104061343,484,4402,ion binding,MF,NT5E;XDH;ZMYND8;FHL1;EGR1;NR1D1;EDEM1;CYP27B1;HS1BP3;PGF;NAGS;ACVR2B;PRNP;PYGB;POSTN;VEGFA;PGM1;APOE;PYGL;DGKA;OSBPL5;ITGA6;PITPNC1;OBSCN;IDH2;ZKSCAN1;NEK9;ITPR3;PKN1;MTA1;ACOT7;ACSF2;NISCH;EGFR;RPS6KA2;SERPINE2;LOXL1;NOS1;VAT1;PTPRS;TMEM129;HADH;CAPN2;MST1R;TRIM65;LTBP4;SYTL1;SHC1;LTBP2;VPS11;LTBP1;ARL2;GTPBP1;NPEPL1;TK2;ACTA2;MMP1;SNX9;RAPGEF3;TXNRD3;ZFP36L1;GLUL;RNPEPL1;ARAP1;MAP2K2;NME4;ZC3H6;LPAR3;MARCH9;PLCD3;FKBP9;SMARCA1;RBCK1;PLTP;PC;RNF44;MAP2K1;CRYL1;ACP5;MCTP1;ENDOG;MARK4;FBLN1;SMAD3;ERCC6;LRP1;HSD17B8;THBS3;HBEGF;S100A4;CYBRD1;SH3PXD2B;PPP2R3B;PRODH;SALL2;CDK18;ZXDC;RNF187;NMRK1;ADARB1;D2HGDH;SYT8;AKT1;GRB7;HDAC5;NT5DC1;S100A6;F12;PPM1F;MMP28;PITPNM1;HAGHL;STK39;HK1;ASAP2;DYSF;EPHA1;PHC2;VEGFB;ASH2L;MARCH4;ZFYVE21;BRSK1;RAB31;FGFR4;LDLR;FGFR1;PRKACB;RAC2;SMOC2;PFKL;TTLL12;SEC14L2;OPLAH;HLTF;RAG1;B4GAT1;PHF7;KLF7;B3GAT3;CBR4;RAB11FIP4;TENM2;ZNF385A;ABCD1;TSHZ1;LHPP;TNNT1;TWF2;STRADB;PLCH2;MAPK13;ACBD4;GAS6;PTK6;PFKP;FGFBP1;CSNK1E;RAB3B;GSN;MAPKAPK3;DHTKD1;BCR;ANTXR2;EHD4;GLI4;SEPT10;NADK;PANK4;HLCS;ZSCAN18;ALOX15B;AGAP1;PEX10;CCS;RSAD1;COL13A1;NPR2;DGKQ;HAGH;PAK6;SHARPIN;FYCO1;CEMIP;PKD2;ACY1;YPEL3;ABCA2;ZNF598;PRSS3;SH3PXD2A;EPHB2;GRIN3B;ADAM8;APRT;LTA4H;GRK6;PLCG1;ZMIZ2;CBS;KIF17;MVD;RNF135;ENTPD2;ADAMTS13;ZNF217;TIMP2;ZNF862;GNAL;LACTB2;SCYL1;UNK;ULK2;GPC1;MKNK2;ADAMTS7;DEAF1;TBC1D9B;TMEM173;ZSCAN30;ATP7B;SHANK3;SDHA;MSRB2;RASA3;MIPEP;PIP5KL1;MGAT4B;KIF26B;GALNS;CLCA2;PEG3;ARAP3;TUB;RHOD;CGREF1;SNX17;DNAH1;HTR7;POLL;POLM;SNX33;PI4K2A;RHOF;ANKZF1;ARL10;PHF21A;KIF7;RHOBTB2;ADAM19;TUBG2;HMGCL;PTPN1;PEX1;TPP1;PCK2;B4GALT2;AGRN;CD320;OSBPL10;LRP4;ESYT2;B4GALT6;TRAP1;ADAP1;PFKFB2;RFNG;YPEL5;PRKCZ;KDM6B;PRKACA;MINK1;ZNF516;GRHPR;RABGGTA;ACTR1B;ADA;PIM2;MPI;MICALL2;UCKL1;ALAS1;NEURL1B;ERBB2;ULK1;CNDP2;NINL;VAMP2;PRIMPOL;MMP10;PLEK2;NECAB3;STK17A;JAK3;IRF2BP2;RNPEP;TRPC1;RASA4;PDK1;ACAD10;CYGB;ARHGAP44;THOP1;MCFD2;PRKCD;FAM20C;MIB2;USP20;CYC1;DTD1;TRIM4;ITGA1;ZNF395;NUBP2;RPS6KA5;DGUOK;ZNF524;CUL9;MBTPS2;ACADS;MT2A;HPCAL1;RASL10B;NID1;LIMK1;TGFBR3;NTPCR;PADI3;RPS6KA6;ZHX3;DNM1;SCN8A;MFNG;GIT1;LPCAT1;LRSAM1;ADAM15;EHD3;FAHD2B;LONP2;MAPK12;IRAK1;PPOX;HDAC7;RNF215;MTHFR;CHD2;PI4K2B;CHEK2;DTNB;ZFPM1;PPARA;SESN2;ABCG1;MYO1D;JADE2;MYH15;CDC34;RNF123;SNN;ABCA7;RAB12;SPEG;ACO2;KDM4B;PHYH;ZNF414;MEX3A;LENG9;NUDT14;ZNF444;DTX3;DALRD3;FYN;PITPNM3;EFEMP2;STK25;RAC3;EEF2K;FLYWCH1;ACAP3;DNM2;CKMT1A;CYP3A5;SNX15;CHKA;CAT;NEIL1;ZMYM3;APOBEC3C;KIF26A;PLCB3;ZNF606;APOBEC3F;DDX50;CYP2R1;TUBB6;MAPK3;INSR;PAN2;PFKM;ADCY1;RERE;ATP8B2;GPT2;PDXK;PAK1;TRIM45;CAMKK2;PPP3CB;RNF144A;ALPK1;USP21;PFKFB3;REV1;MICAL1;CAPRIN2;ZBTB10;ITGA3;STK32C;DNMT3A;MAN2B1;SRMS;MAP2K3;RRAS;IARS2;SIRT2;CDH4;ITGA4;GAL3ST4;NMNAT2;NT5C1B;ADCY7;ZBTB22;TEP1;RAB28;ZNF704;YDJC;MAP3K10;RAB40B;PDCD6;PCLO;CHST14;ZNF837;PXN;PHYKPL;PLEKHM1;GCH1;MSS51;KIF13B;NR2F6;CAMK1;CAMKK1;SIRT3;ZNF513;WIPI2;BBS10;CELSR1;SEPT6;CDK11B;PFN2;FGFR3;MAN2B2;CBLC;ITPKB;SPTLC2;TCEA2;CDC42BPG;ZBTB47;PLAG1;GSDMA;CLK3;IRF2BPL;TRIM46;DHX32;KDM3A;MEGF6;PKN3;TTLL3;AK3;CHPF;ADCY6;LRRK1;AARS
6652,GO:0030010,0.235922603325493,0.845257734055701,14,104,establishment of cell polarity,BP,WNT7A;SPRY2;MARK4;BRSK1;GSN;KIF26B;LLGL1;PRKCZ;SDCCAG8;FSCN1;SH3BP1;PAK1;PKD1;NDE1
1429,GO:0003401,0.236020923681753,0.903036534348306,4,23,axis elongation,BP,SPRY2;TGFB1;AREG;VANGL2
5724,GO:0016863,0.236054423071926,0.941749919496686,2,10,intramolecular oxidoreductase activity, transposing C=C bonds,MF,MIF;DDT
4101,GO:0009157,0.236109458034188,0.942750498517481,2,9,deoxyribonucleoside monophosphate biosynthetic process,BP,TK2;DGUOK
4528,GO:0010595,0.236414482305689,0.857981946177302,10,72,positive regulation of endothelial cell migration,BP,VEGFA;WNT7A;AKT1;FGFR1;PLCG1;TGFB1;HDAC7;MAP2K3;PROX1;PDCD6
10104,GO:0042627,0.236487375425427,0.979092891023437,1,3,chylomicron,CC,APOE
4709,GO:0010873,0.236666452453476,0.979059193954724,1,3,positive regulation of cholesterol esterification,BP,APOE
6926,GO:0030534,0.236732034021,0.862209199102146,9,64,adult behavior,BP,BBS2;SHANK2;SLITRK6;NTSR1;SHANK3;EFNB3;DNM1;PPARA;HOMER2
5478,GO:0016411,0.236783390073051,0.902594799836059,4,23,acylglycerol O-acyltransferase activity,MF,LPCAT4;MBOAT7;LPCAT1;TAZ
749,GO:0001990,0.23683063341051,0.918706909029495,3,16,regulation of systemic arterial blood pressure by hormone,BP,F2R;CTSZ;RASL10B
13051,GO:0051561,0.237045587367672,0.942373357607493,2,9,positive regulation of mitochondrial calcium ion concentration,BP,BNIP3;BCAP31
8643,GO:0034198,0.237301179625566,0.880790435223878,6,39,cellular response to amino acid starvation,BP,IMPACT;DAP;WDR59;SESN2;MAPK3;C12ORF66
7039,GO:0030819,0.237384669333981,0.942236479433913,2,9,positive regulation of cAMP biosynthetic process,BP,PTHLH;TIMP2
2514,GO:0005769,0.237659734634898,0.818137683131156,32,261,early endosome,CC,APOE;F2R;NISCH;EGFR;APPL2;VPS11;MAP2K2;MAP2K1;LRP1;DYSF;RAB31;LDLR;SORL1;PCSK9;EHD4;MVB12B;RHOD;SNX17;PI4K2A;C1ORF210;LLGL1;PTPN1;BOK;NEURL1B;MIB2;WASH3P;ABCA7;MAPK3;HLA-G;VPS16;TBC1D16;HFE
3760,GO:0008307,0.237795839859769,0.901649904292449,4,24,structural constituent of muscle,MF,OBSCN;OBSL1;SMTN;TPM2
14232,GO:0061217,0.237896538983992,0.918158999497981,3,16,regulation of mesonephros development,BP,VEGFA;WNT2B;TGFB1
14641,GO:0070232,0.238167792096976,0.901433072089173,4,24,regulation of T cell apoptotic process,BP,RAG1;ADAM8;ADA;JAK3
17620,GO:1901298,0.238223437057665,0.941897271743268,2,9,regulation of hydrogen peroxide-mediated programmed cell death,BP,ENDOG;TRAP1
10149,GO:0042733,0.238278087319017,0.872623748726732,7,47,embryonic digit morphogenesis,BP,WNT7A;LRP5;IFT140;LRP4;BAX;FBXW4;TMEM231
4729,GO:0010894,0.238356319003558,0.917922225831519,3,16,negative regulation of steroid biosynthetic process,BP,CYP27B1;APOE;PROX1
11471,GO:0045939,0.238356319003558,0.917922225831519,3,16,negative regulation of steroid metabolic process,BP,CYP27B1;APOE;PROX1
358,GO:0000977,0.238359116654767,0.806324232333424,52,435,RNA polymerase II regulatory region sequence-specific DNA binding,MF,MEF2D;ZMYND8;EGR1;NR1D1;HMGA2;ELK3;NFATC4;ETV5;TCFL5;ETV4;ZC3H6;FOXQ1;POU2F2;FOS;SMAD3;STAT6;SALL2;HLTF;MXI1;KLF7;SOX13;MYEF2;SMARCD2;HES2;MNT;CEBPB;ZNF217;RFX2;DEAF1;PHF21A;MBD3;MLXIPL;KDM6B;TFDP2;PBX2;ZNF395;CARF;IER2;ZHX3;ZFPM1;PPARA;SIX5;SSBP4;ARID5B;BHLHE40;SATB1;HES7;HES6;BACH1;NR2F6;PLAG1;KDM3A
12234,GO:0048519,0.238563871949425,0.780861697569361,395,3646,negative regulation of biological process,BP,TNIP1;DUSP6;NT5E;XDH;ERCC1;DUSP5;ZMYND8;SEMA4B;HTRA1;FHL1;EGR1;NR1D1;DLG4;PLAT;CST3;CYP27B1;FBXO2;APLN;PDCD4;CTNNBIP1;ACVR2B;DOCK4;XPC;PRNP;BBS2;DDIT4L;POSTN;VEGFA;TNFRSF6B;WNT7A;APOE;ESPN;F2R;LRP5;ITGA6;HMGA2;NDRG1;IDH2;ELK3;ITPR3;PKN1;MTA1;ARRDC1;EVI5L;NISCH;EGFR;RPS6KA2;SERPINE2;WWTR1;NOS1;VAT1;PTPRS;HADH;SPRY2;MST1R;NFATC4;BAHCC1;CRTAP;SHC1;LTBP1;TBC1D14;ARL2;GTPBP1;TCFL5;PTPRE;SPRY4;RAPGEF3;ZFP36L1;ARAP1;MAP2K2;ZC3H6;MDFI;PPP1R35;RBCK1;PC;TP53I11;FOXQ1;MAP2K1;ACP5;MCTP1;MXD4;SMURF2;FBLN1;SMAD3;STAT6;SHANK2;PIK3R2;LRP1;GJC2;DVL1;DNAJB5;HBEGF;PPP1R14A;PPP2R3B;PRDX5;SALL2;PAG1;ADORA2B;ADARB1;AKT1;TPCN1;GRB7;TMOD2;CORO1B;HDAC5;F12;PPM1F;MMP28;RHBDF2;STK39;SERPING1;SCMH1;EPHA1;PTPRU;IMPACT;WWC3;BRSK1;DAP;PTHLH;FGFR4;PEAR1;FNDC4;LDLR;FGFR1;PRKACB;MAPKBP1;PFKL;MXI1;NPHP4;RAG1;H2AFJ;SORL1;CEACAM1;CIRBP;HMG20B;LZTS2;TENM2;ZNF385A;ANK3;IGFBP4;TSHZ1;CCND1;PODNL1;PCBP4;TCF25;TNNT1;TWF2;STRADB;SYNGAP1;CARD19;PLAU;GAS6;PTK6;SEMA3F;FGFBP1;DUSP7;GSN;IGFBP2;PCSK9;BCR;ANGPTL4;ERRFI1;RGL2;ARPIN;ALOX15B;SPTB;NPR2;SNTA1;DGKQ;PLXNB3;BNIP3;TFPI2;SHARPIN;TAGLN3;CEMIP;PROCR;PKD2;FAM3A;CTSZ;HES2;CRTC1;IL20RB;GPSM1;MAGEF1;EPHB2;ADAM8;ASIC1;CTBP1;MNT;CDKN1C;PLCG1;CEBPB;RNF135;ZNF217;TIMP2;WNT3;C8ORF88;TGFB1;ABHD17C;UNK;ULK2;GPC1;ADAMTS7;DEAF1;NTSR1;NAB2;ARHGAP25;FHOD3;SHANK3;EFNB3;RASA3;PNRC1;EML2;PEG3;ARAP3;FARP1;MC1R;CGREF1;RNH1;SNX33;SEMA4F;PHF21A;KIF7;TNFAIP8L1;PTPN1;MBD3;CAMK2N1;LRP4;VHL;TRAP1;MLXIPL;TRIB2;PRKCZ;PRKACA;OXA1L;TOM1L2;CD9;EPN2;ADA;AREG;PIM2;BOK;TDRKH;CAPG;ERBB2;ADGRB2;ULK1;TFDP2;JAK3;BNIP3L;TRPC1;NELFCD;RASA4;CYGB;ARHGAP44;PRKCD;RBL2;STUB1;IFI6;BAX;ITGA1;SH3BP1;CHADL;EREG;RPS6KA5;DGUOK;DUSP4;TMBIM4;DDIT4;PPP1R13L;PCSK1N;MT2A;LIMK1;TGFBR3;GDI1;DIP2A;LTB4R2;LEMD2;RPS6KA6;ZHX3;DNM1;RGS14;GSTO1;CHAD;LPCAT1;LRSAM1;ADAM15;ASB1;MAPK12;IRAK1;HDAC7;INPP5D;CBX7;CHEK2;ZFPM1;PPARA;TMEM161A;SESN2;ABCG1;MYO1D;CDC34;SOX7;ABCA7;SPEG;SIX5;MIF;MEX3A;PLA2G6;DDT;ECM1;WFS1;QSOX1;FYN;EEF2K;ARHGAP12;ARID5B;DNM2;BHLHE40;PELI1;CAT;NEIL1;TSPYL2;IGFBP7;ELFN2;SLC27A1;APOBEC3C;SATB1;KIF26A;APOBEC3F;INSR;PAN2;GRINA;C12ORF66;RERE;HLA-G;ETAA1;BCL7A;PAK1;PPP3CB;GABBR1;MICAL1;HYAL1;SEMA4C;CAPRIN2;WDTC1;HES7;ITGA3;DNMT3A;BIN1;SRMS;PPP2R5B;HES6;BCL2L1;DLG3;RRAS;PROX1;LMNA;PKD1;KCTD13;SIRT2;FAM129B;DCBLD2;BACH1;AZIN2;SERPINB1;RAP1GAP2;SOCS7;MAP3K10;RGS19;PELI3;NGFR;PDCD6;GRB10;NR2F6;CBX6;SIRT3;HFE;TERC;GAS2L1;BTG1;ZP3;SEMA3B;PFN2;FGFR3;TNRC18;NDRG2;CBLC;ITPKB;PLAG1;IRF2BPL;KDM3A;DEDD2;ADCY6;LRRK1;AARS
3179,GO:0006805,0.23861534407257,0.860661322908962,9,66,xenobiotic metabolic process,BP,AKR7A2;GGT1;BPHL;AIP;ACY1;CES2;GSTO1;CYP3A5;CYP2R1
4673,GO:0010823,0.238630216119877,0.879731727826996,6,40,negative regulation of mitochondrion organization,BP,VAT1;AKT1;BNIP3;BOK;BCL2L1;LMNA
19295,GO:1905515,0.238874193880532,0.872213143748434,7,47,non-motile cilium assembly,BP,BBS2;IFT140;CEP250;BBS1;DNM2;VANGL2;BBS10
10572,GO:0043542,0.238890795385873,0.833998371276918,18,141,endothelial cell migration,BP,VEGFA;WNT7A;APOE;AKT1;CORO1B;HDAC5;FGFR1;CEACAM1;PRSS3;PLCG1;TGFB1;PLEKHG5;SH3BP1;HDAC7;MAP2K3;PROX1;PDCD6;PXN
7479,GO:0031650,0.239077409359791,0.941551007946661,2,9,regulation of heat generation,BP,APLN;SLC27A1
14712,GO:0070365,0.239097285048406,0.941542937965696,2,9,hepatocyte differentiation,BP,PCK2;PROX1
7390,GO:0031461,0.23924037673211,0.830290674783916,20,158,cullin-RING ubiquitin ligase complex,CC,BTBD2;FBXO2;KLHL29;DDB2;FBXW5;FBXW8;FBXO17;ABTB1;FBXO44;ZER1;FBXW4;CUL9;DCAF10;KLHL36;CUL7;ZYG11B;KCTD13;BACH1;PDCD6;KLHL24
9458,GO:0036065,0.239475925413873,0.901029444771881,4,23,fucosylation,BP,ADAMTS13;ADAMTS7;RFNG;MFNG
10115,GO:0042641,0.23980046399532,0.86533634395383,8,55,actomyosin,CC,MST1R;CORO1B;MICALL2;FSCN1;FHOD1;VANGL2;PXN;LURAP1
3900,GO:0008542,0.240104209635244,0.888379759702187,5,31,visual learning,BP,RAG1;SYNGAP1;DEAF1;B4GALT2;RGS14
8616,GO:0034142,0.240118222998531,0.917012485583885,3,16,toll-like receptor 4 signaling pathway,BP,NR1D1;IRAK1;PELI1
12994,GO:0051428,0.240262706444701,0.941068883359257,2,9,peptide hormone receptor binding,MF,PTHLH;FYN
1487,GO:0003823,0.24042124619854,0.900115949904431,4,24,antigen binding,MF,SLC7A8;TGFB1;HLA-G;ITGA4
17366,GO:1900076,0.240542905227139,0.864808200243052,8,55,regulation of cellular response to insulin stimulus,BP,PTPRE;PIK3R2;PTPN1;PRKCZ;PRKCD;PAK1;NGFR;GRB10
15319,GO:0071542,0.240640920053097,0.916741861747608,3,16,dopaminergic neuron differentiation,BP,VEGFA;CSNK1E;WNT3
8234,GO:0033014,0.24065963260741,0.89997626869027,4,24,tetrapyrrole biosynthetic process,BP,UROS;RSAD1;ALAS1;PPOX
1173,GO:0002819,0.240836751969627,0.850691005450952,11,81,regulation of adaptive immune response,BP,PKN1;STAT6;CEACAM1;IL20RB;TGFB1;PRKCZ;ADA;JAK3;PPP3CB;HFE;ZP3
12959,GO:0051350,0.241297726803833,0.940646441884122,2,9,negative regulation of lyase activity,BP,LTB4R2;GABBR1
9064,GO:0035306,0.241674261240962,0.877888834781436,6,39,positive regulation of dephosphorylation,BP,SMAD3;TGFB1;NSMF;PRKCD;ITGA1;SYMPK
6579,GO:0022412,0.241798867579649,0.823837208488816,23,184,cellular process involved in reproduction in multicellular organism,BP,ERCC1;BBS2;ETV5;HEXB;AKT1;CDC25B;NPR2;TGFB1;RFX2;DEAF1;DNAH1;PRKACA;CD9;PIM2;TDRKH;BAX;EREG;SIX5;DNMT3A;BCL2L1;SIRT2;ZP3;KDM3A
8531,GO:0033866,0.241815368757315,0.916132570800836,3,16,nucleoside bisphosphate biosynthetic process,BP,ACOT7;PANK4;PPCS
8555,GO:0034030,0.241815368757315,0.916132570800836,3,16,ribonucleoside bisphosphate biosynthetic process,BP,ACOT7;PANK4;PPCS
8558,GO:0034033,0.241815368757315,0.916132570800836,3,16,purine nucleoside bisphosphate biosynthetic process,BP,ACOT7;PANK4;PPCS
12687,GO:0050913,0.241916543008043,0.939332271833545,2,10,sensory perception of bitter taste,BP,ITPR3;REEP2
2638,GO:0005976,0.241944017453034,0.849921012098245,11,80,polysaccharide metabolic process,BP,NR1D1;PYGB;PGM1;PYGL;PHLDA2;GAA;AKT1;TGFB1;B3GNT3;INSR;PFKM
6816,GO:0030282,0.242150591440412,0.863662758644451,8,55,bone mineralization,BP,CYP27B1;ACVR2B;SMAD3;PTHLH;TGFB1;FAM20C;ECM1;FGFR3
13756,GO:0060343,0.24218057312764,0.915942761104216,3,16,trabecula formation,BP,THBS3;TGFBR3;CHAD
13527,GO:0055123,0.242186632362611,0.849737235046979,11,80,digestive system development,BP,ACVR2B;ITGA6;EGFR;SMAD3;ITGB4;PTK6;TGFB1;ADA;INSR;VANGL2;PKD1
19203,GO:1905276,0.242455016428865,0.915800015254167,3,16,regulation of epithelial tube formation,BP,DVL1;VANGL2;CELSR1
19549,GO:1990440,0.242469070425339,0.940166737762227,2,9,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,BP,CEBPB;MBTPS2
3618,GO:0008076,0.242629925851731,0.886784522634541,5,31,voltage-gated potassium channel complex,CC,DLG4;KCNG1;KCNC4;KCNAB2;VAMP2
745,GO:0001977,0.242860408048851,0.940006088013496,2,9,renal system process involved in regulation of blood volume,BP,F2R;GAS6
10358,GO:0043178,0.243032590180235,0.869060792182712,7,49,alcohol binding,MF,APOE;OSBPL5;ITPR3;OSBPL10;ADAP1;TRPC1;ABCG1
10264,GO:0043010,0.243033901056315,0.821561886327474,24,191,camera-type eye development,BP,SDK2;ACVR2B;VEGFA;WNT7A;LRP5;EGFR;SMAD3;IFT140;WNT2B;NPHP4;RAB11FIP4;SLITRK6;EPHB2;TGFB1;TUB;LAMB2;BAX;PPP1R13L;LPCAT1;TMEM231;MYH15;SIX5;PROX1;ZNF513
4070,GO:0009125,0.243090027693032,0.939911736292796,2,9,nucleoside monophosphate catabolic process,BP,NT5E;DNPH1
3941,GO:0008635,0.243097341273671,0.939908730022253,2,9,activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c,BP,BOK;BAX
11890,GO:0046928,0.243118022981953,0.886475431724282,5,31,regulation of neurotransmitter secretion,BP,MCTP1;KCNC4;ASIC1;RIMS3;PFN2
13130,GO:0051705,0.243187201350952,0.876880324861245,6,39,multi-organism behavior,BP,DLG4;SHANK2;DVL1;SHANK3;PPP3CB;MSS51
13990,GO:0060716,0.243197302824547,0.915413466935404,3,16,labyrinthine layer blood vessel development,BP,PLCD3;AKT1;FBXW8
18600,GO:1903845,0.243290627581486,0.86273366385283,8,56,negative regulation of cellular response to transforming growth factor beta stimulus,BP,HTRA1;LTBP1;SMURF2;SMAD3;TGFB1;STUB1;TGFBR3;DNM2
3030,GO:0006582,0.243799950441791,0.939619607026491,2,9,melanin metabolic process,BP,TRPC1;DDT
17964,GO:1902306,0.243833752755706,0.939605681773185,2,9,negative regulation of sodium ion transmembrane transport,BP,STK39;PCSK9
12147,GO:0048265,0.244069099563014,0.939508688154704,2,9,response to pain,BP,VWA1;GCH1
6709,GO:0030125,0.244789101158126,0.897546120302907,4,24,clathrin vesicle coat,CC,EGFR;AP2A2;CLTCL1;EPN2
2939,GO:0006470,0.244818526110695,0.813681874809759,30,245,protein dephosphorylation,BP,DUSP6;DUSP5;PTPRS;PTPRE;PPP1R35;SSH1;PPP1R14A;PPP2R3B;PPM1F;PTPRU;PPM1J;B3GAT3;LHPP;DUSP7;CDC25B;PTPDC1;TGFB1;NSMF;PTPN1;PRKCD;SBF1;ITGA1;DUSP4;SYMPK;ELFN2;PPP3CB;PPP2R5B;DUSP23;SSH3;PPP1R16A
6097,GO:0019319,0.244940500366711,0.861553077526966,8,56,hexose biosynthetic process,BP,NR1D1;PGM1;PC;DGKQ;MDH2;PCK2;ALDOC;PPARA
12874,GO:0051220,0.245056913951288,0.897387829946158,4,24,cytoplasmic sequestering of protein,BP,MDFI;MXI1;PKD2;PKD1
10785,GO:0044264,0.245072862462561,0.851540348846605,10,72,cellular polysaccharide metabolic process,BP,NR1D1;PYGB;PGM1;PYGL;PHLDA2;GAA;AKT1;B3GNT3;INSR;PFKM
784,GO:0002043,0.245112274974055,0.939077925903597,2,9,blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,VEGFA;NGFR
11766,GO:0046635,0.245153388489006,0.897330788380658,4,24,positive regulation of alpha-beta T cell activation,BP,AP3D1;PRKCZ;ADA;ITPKB
15299,GO:0071495,0.245203192057618,0.787924329933224,104,909,cellular response to endogenous stimulus,BP,DUSP6;HTRA1;EGR1;NR1D1;APLN;PGF;PDCD4;ACVR2B;PRNP;BBS2;POSTN;FAM210B;WNT7A;EGFR;SPRY2;CAPN2;LTBP4;SHC1;LTBP2;LTBP1;PTPRE;SPRY4;RAPGEF3;ZFP36L1;SSH1;SMURF2;FOS;SMAD3;PIK3R2;LRP1;AKT1;CORO1B;HDAC5;UROS;IMPACT;RAB31;FGFR4;FGFR1;PRKACB;CEACAM1;MAPK13;FGFBP1;CTSB;IGFBP2;PCSK9;ERRFI1;PAQR6;PKD2;ITGB5;APRT;CDKN1C;PLCG1;CEBPB;TGFB1;GPC1;ADAMTS7;NSMF;PTPN1;PCK2;AGRN;LRP4;PRKCZ;PRKACA;ERBB2;VAMP2;JAK3;PRKCD;FAM20C;STUB1;DDIT4;TGFBR3;LEMD2;CHEK2;PPARA;SESN2;FYN;EEF2K;DNM2;IGFBP7;SLC27A1;MAPK3;INSR;ADCY1;PAK1;HYAL1;WDTC1;ITGA3;DNMT3A;BCL2L1;SIRT2;ADCY7;SOCS7;NGFR;ATP6V1F;PXN;GRB10;NR2F6;HFE;GAS2L1;COL6A1;FGFR3;KDM3A;SRSF5;ADCY6
12579,GO:0050764,0.245859228256033,0.874908726398399,6,40,regulation of phagocytosis,BP,GAS6;BCR;TGFB1;TUB;ABCA7;DNM2
10295,GO:0043065,0.245901465114166,0.798741690697966,54,467,positive regulation of apoptotic process,BP,DUSP6;XDH;PDCD4;PRNP;F2R;ITGA6;HMGA2;OBSCN;GRAMD4;RPS6KA2;NFATC4;RBCK1;ENDOG;SMAD3;AKT1;PPM1F;DAP;GSN;PLEKHG2;PCSK9;BNIP3;CTSZ;ADAM8;TGFB1;MOAP1;NTSR1;TNFSF15;PLEKHG5;BOK;TFDP2;STK17A;NET1;BNIP3L;PRKCD;BAX;ITGA1;INPP5D;CHEK2;CDC34;SOX7;BCAP31;PLA2G6;DNM2;ARHGEF4;ARHGEF1;BIN1;BCL2L1;SIRT2;MAP3K10;NGFR;PDCD6;PNMA1;BTG1;DEDD2
8265,GO:0033077,0.246021254838617,0.867118638894363,7,48,T cell differentiation in thymus,BP,ZFP36L1;RAG1;CARD11;ADAM8;ADA;ERBB2;ITPKB
17752,GO:1901678,0.246026654168389,0.938699223480556,2,9,iron coordination entity transport,BP,SLC48A1;SLC22A17
15332,GO:0071559,0.246231870868271,0.822959641581576,21,167,response to transforming growth factor beta,BP,HTRA1;POSTN;WNT7A;LTBP4;LTBP2;LTBP1;ZFP36L1;SMURF2;FOS;SMAD3;FNDC4;ITGB5;CDKN1C;TGFB1;PRKCZ;STUB1;TGFBR3;FYN;DNM2;ITGA3;PXN
13786,GO:0060384,0.246446933794291,0.913713241939808,3,16,innervation,BP,SERPINE2;ADARB1;SLITRK6
5786,GO:0017015,0.246474777264051,0.846411295351847,11,81,regulation of transforming growth factor beta receptor signaling pathway,BP,HTRA1;LTBP4;LTBP1;SMURF2;SMAD3;CDKN1C;TGFB1;STUB1;TGFBR3;DNM2;ITGA3
19426,GO:1905953,0.246494982395072,0.896536435948487,4,24,negative regulation of lipid localization,BP,AKT1;PCSK9;PPARA;ABCG1
17880,GO:1902105,0.24670024659449,0.824150145783778,20,158,regulation of leukocyte differentiation,BP,CTNNBIP1;ZFP36L1;FOS;RAG1;CEACAM1;GAS6;CARD11;SOX13;AP3D1;ADAM8;CEBPB;TGFB1;PRKCZ;ADA;ERBB2;JAK3;INPP5D;ZFPM1;HLA-G;ITPKB
18007,GO:1902445,0.246941093860941,0.977074211076729,1,3,regulation of mitochondrial membrane permeability involved in programmed necrotic cell death,BP,BAX
4969,GO:0015079,0.246958439266127,0.860222648827945,8,55,potassium ion transmembrane transporter activity,MF,KCNG1;SLC12A7;KCNJ15;KCNC4;KCNAB2;PKD2;SLC9A7;SLC12A4
2785,GO:0006222,0.247222192187799,0.93820249039638,2,9,UMP biosynthetic process,BP,UCKL1;UPP1
4114,GO:0009173,0.247222192187799,0.93820249039638,2,9,pyrimidine ribonucleoside monophosphate metabolic process,BP,UCKL1;UPP1
4115,GO:0009174,0.247222192187799,0.93820249039638,2,9,pyrimidine ribonucleoside monophosphate biosynthetic process,BP,UCKL1;UPP1
11518,GO:0046049,0.247222192187799,0.93820249039638,2,9,UMP metabolic process,BP,UCKL1;UPP1
16173,GO:0090195,0.247250202130279,0.938190831032221,2,9,chemokine secretion,BP,POSTN;ALOX15B
947,GO:0002363,0.247314993966739,0.938163857129535,2,9,alpha-beta T cell lineage commitment,BP,STAT6;ZFPM1
5667,GO:0016776,0.247385393231973,0.883274486379022,5,33,phosphotransferase activity, phosphate group as acceptor,MF,DLG4;NME4;CARD11;DLG3;AK3
11122,GO:0045171,0.247704855229097,0.865944126630398,7,48,intercellular bridge,CC,PRKACB;CEP131;PRKACA;NINL;PPP1R13L;QSOX1;TRIM45
1226,GO:0002902,0.247790554903181,0.912431219048347,3,17,regulation of B cell apoptotic process,BP,ADA;BAX;MIF
6781,GO:0030224,0.247889110477893,0.895708763215337,4,24,monocyte differentiation,BP,CTNNBIP1;VEGFA;ZFP36L1;INPP5D
18278,GO:1903131,0.247889110477893,0.895708763215337,4,24,mononuclear cell differentiation,BP,CTNNBIP1;VEGFA;ZFP36L1;INPP5D
5271,GO:0015919,0.24809841436806,0.912844210103857,3,16,peroxisomal membrane transport,BP,ABCD1;PEX10;PEX1
18207,GO:1902969,0.248267955296635,0.93776651414154,2,9,mitotic DNA replication,BP,FGFR1;CHEK2
9109,GO:0035404,0.248676301721119,0.937595902218006,2,9,histone-serine phosphorylation,BP,HMGA2;RPS6KA5
17000,GO:0099081,0.249240458168322,0.790997018887444,69,595,supramolecular polymer,CC,THSD4;CST3;PARVB;FLNC;ESPN;OBSCN;NDRG1;MTA1;OBSL1;NOS1;SPRY2;LTBP1;CLIP2;MAP2K2;KLC2;SHANK2;DVL1;FAM110C;REEP4;TMOD2;CORO1B;MYZAP;RAC2;KCNAB2;LZTS2;ANK3;TNNT1;TWF2;WIPF1;PKD2;KIF17;SNPH;SNTB2;FHOD3;EML2;KIF26B;ENKD1;DNAH1;KIF7;TUBG2;PRKCZ;NINL;FSCN1;STUB1;AHNAK2;TPM2;DNM1;RGS14;SCN8A;REEP2;MYH15;EML3;NARF;FYN;RAC3;DNM2;KIF26A;TUBB6;PAK1;PPP3CB;MICAL1;BIN1;LMNA;SIRT2;MAPRE3;NDE1;KIF13B;COL6A1;TTLL3
4871,GO:0014733,0.249409620578369,0.937288986685072,2,9,regulation of skeletal muscle adaptation,BP,TNNT1;GTF2IRD1
17851,GO:1902018,0.249443918331298,0.937274615513171,2,9,negative regulation of cilium assembly,BP,EVI5L;DNM2
11444,GO:0045907,0.249466450840542,0.912121796992975,3,16,positive regulation of vasoconstriction,BP,F2R;EGFR;AKT1
17053,GO:0099528,0.249502282183155,0.937250156955569,2,9,G-protein coupled neurotransmitter receptor activity,MF,HTR7;GABBR1
4623,GO:0010745,0.249542969924281,0.937233103397111,2,9,negative regulation of macrophage derived foam cell differentiation,BP,PPARA;ABCG1
7058,GO:0030852,0.24962271420526,0.937199673931416,2,9,regulation of granulocyte differentiation,BP,CEACAM1;INPP5D
13828,GO:0060439,0.24972996199484,0.937154702156542,2,9,trachea morphogenesis,BP,MAP2K1;MAPK3
5543,GO:0016532,0.249762244436747,0.97651129999453,1,3,superoxide dismutase copper chaperone activity,MF,CCS
5677,GO:0016788,0.24976919159637,0.791628976601835,65,560,hydrolase activity, acting on ester bonds,MF,DUSP6;NT5E;ERCC1;DUSP5;H6PD;PLD3;ACOT7;PTPRS;PTPRE;PLCD3;PGLS;MAP2K1;ACP5;SSH1;ENDOG;TMEM8A;PPP2R3B;NLGN2;PLCXD2;NT5DC1;PPM1F;PTPRU;ACOT1;PPM1J;RAG1;BPHL;LHPP;PLCH2;EDNRA;DUSP7;CDC25B;HAGH;PTPDC1;PLCG1;SYNJ2;LACTB2;ABHD17C;GALNS;PLPP6;PTPN1;ACP6;PFKFB2;SBF1;DTD1;DUSP4;CES2;NTPCR;INPP5D;ABHD15;PLA2G6;CHKA;NEIL1;PLCB3;PAN2;RNASET2;PPP3CB;PFKFB3;ABHD10;DNASE1L1;IARS2;NT5C1B;RNASE7;DUSP23;SSH3;AARS
15445,GO:0071772,0.24990518343389,0.837058076856929,13,97,response to BMP,BP,HTRA1;EGR1;PDCD4;ACVR2B;SMURF2;TGFB1;ADAMTS7;LRP4;TGFBR3;LEMD2;MAPK3;ITGA3;HFE
15446,GO:0071773,0.24990518343389,0.837058076856929,13,97,cellular response to BMP stimulus,BP,HTRA1;EGR1;PDCD4;ACVR2B;SMURF2;TGFB1;ADAMTS7;LRP4;TGFBR3;LEMD2;MAPK3;ITGA3;HFE
8107,GO:0032801,0.249974057357529,0.881851179467588,5,32,receptor catabolic process,BP,APOE;AP2A2;PCSK9;TGFB1;PTPN1
12827,GO:0051146,0.250014910346116,0.8231231964901,19,149,striated muscle cell differentiation,BP,FLNC;VEGFA;OBSCN;OBSL1;NOS1;CAPN2;SDC1;AKT1;TMOD2;HDAC5;TNNT1;MYEF2;TGFB1;FHOD3;KDM6B;PAK1;PROX1;LMNA;FAM129B
7864,GO:0032432,0.25054047564309,0.863959623460181,7,48,actin filament bundle,CC,MST1R;CORO1B;MICALL2;FSCN1;FHOD1;VANGL2;PXN
2754,GO:0006168,0.250585048734147,0.976345660349155,1,3,adenine salvage,BP,APRT
11539,GO:0046083,0.250585048734147,0.976345660349155,1,3,adenine metabolic process,BP,APRT
11540,GO:0046084,0.250585048734147,0.976345660349155,1,3,adenine biosynthetic process,BP,APRT
1256,GO:0003009,0.250652380864709,0.910909910615935,3,17,skeletal muscle contraction,BP,GAA;TNNT1;GSTO1
2962,GO:0006501,0.250797973739026,0.881082844537187,5,33,C-terminal protein lipidation,BP,LY6K;MSLN;MDGA1;WIPI2;PRSS21
12215,GO:0048483,0.250998794874486,0.893854467265281,4,24,autonomic nervous system development,BP,ADARB1;EDNRA;SEMA3F;KIF26A
19157,GO:1905146,0.251163587752631,0.936552156615944,2,9,lysosomal protein catabolic process,BP,LRP1;LDLR
12731,GO:0051005,0.251169839201959,0.976227532734871,1,3,negative regulation of lipoprotein lipase activity,BP,ANGPTL4
15586,GO:0072070,0.251239580148593,0.936520145252848,2,9,loop of Henle development,BP,PKD2;PKD1
10368,GO:0043195,0.25131359960885,0.871233752163583,6,40,terminal bouton,CC,AP3D1;NTSR1;SV2A;SYNGR1;MICAL1;PFN2
404,GO:0001085,0.251516810009409,0.832835095520807,14,107,RNA polymerase II transcription factor binding,MF,ERCC1;MEF2D;BBS2;MTA1;FOS;SMAD3;HDAC5;BBS1;RBL2;ZFPM1;PPARA;BHLHE40;RERE;BBS10
7490,GO:0031668,0.25175803704225,0.815471632963184,23,185,cellular response to extracellular stimulus,BP,CYP27B1;POSTN;ITGA6;GLUL;SSH1;FOS;ADORA2B;IMPACT;DAP;WNT2B;GAS6;PCSK9;CBS;WDR59;ULK1;SESN2;FYN;UPP1;KIF26A;MAPK3;C12ORF66;HFE;GAS2L1
10243,GO:0042983,0.251821583555064,0.936274738753566,2,9,amyloid precursor protein biosynthetic process,BP,NECAB3;ABCA7
10244,GO:0042984,0.251821583555064,0.936274738753566,2,9,regulation of amyloid precursor protein biosynthetic process,BP,NECAB3;ABCA7
10150,GO:0042734,0.251838621582274,0.871067660252276,6,39,presynaptic membrane,CC,ADGRL1;NLGN2;SNPH;PI4K2A;RIMS3;GABBR1
7794,GO:0032350,0.251916523952323,0.893305086739328,4,24,regulation of hormone metabolic process,BP,EGR1;CYP27B1;DGKQ;STUB1
15617,GO:0072109,0.252002928065322,0.936198186276721,2,9,glomerular mesangium development,BP,EGR1;ACTA2
5632,GO:0016712,0.252016533893861,0.936192441065741,2,9,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen,MF,CYP3A5;CYP2R1
12273,GO:0048597,0.252117231924896,0.976035448196867,1,3,post-embryonic camera-type eye morphogenesis,BP,BAX
9433,GO:0036015,0.252339409343967,0.975990274103525,1,3,response to interleukin-3,BP,MT2A
9434,GO:0036016,0.252339409343967,0.975990274103525,1,3,cellular response to interleukin-3,BP,MT2A
12089,GO:0048103,0.252435736764137,0.910545925790015,3,16,somatic stem cell division,BP,WNT7A;FGFR1;VANGL2
4030,GO:0009064,0.252719884680144,0.862428991459058,7,48,glutamine family amino acid metabolic process,BP,NAGS;NOS1;ALDH4A1;GLUL;PRODH;PYCR2;GGT1
4514,GO:0010566,0.252806532407639,0.935858456079008,2,9,regulation of ketone biosynthetic process,BP,EGR1;DGKQ
13724,GO:0060306,0.252878862907601,0.910309821850036,3,16,regulation of membrane repolarization,BP,SCN4B;SNTA1;CACNB3
10616,GO:0043619,0.253215127104026,0.935685407741631,2,9,regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,EPAS1;SESN2
4888,GO:0014809,0.253270159390453,0.975800502853926,1,3,regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,BP,GSTO1
4721,GO:0010885,0.253369910206214,0.935619799010648,2,9,regulation of cholesterol storage,BP,PPARA;ABCG1
14268,GO:0061351,0.25342849889231,0.84109610429005,11,81,neural precursor cell proliferation,BP,VEGFA;WNT7A;TRNP1;GJC2;FGFR1;CTSZ;TGFB1;RERE;PROX1;SIRT2;NDE1
12502,GO:0050651,0.253457036895115,0.93558285489726,2,9,dermatan sulfate proteoglycan biosynthetic process,BP,B3GAT3;CHST14
8775,GO:0034464,0.25349207867973,0.935567993522118,2,9,BBSome,CC,BBS2;BBS1
12854,GO:0051184,0.253679598918857,0.909882568418515,3,16,cofactor transmembrane transporter activity,MF,SLC6A8;SLC48A1;SLC23A2
9386,GO:0035928,0.253769810499534,0.975698277286683,1,3,rRNA import into mitochondrion,BP,TST
18018,GO:1902476,0.253865187867247,0.879344209083422,5,32,chloride transmembrane transport,BP,SLC12A7;TTYH3;CLCA2;SLC12A4;SLC26A11
12863,GO:0051195,0.253887431707873,0.93540021547514,2,9,negative regulation of cofactor metabolic process,BP,DDIT4;PPARA
14410,GO:0061700,0.25389508709181,0.935396964777906,2,9,GATOR2 complex,CC,WDR59;SESN2
14685,GO:0070307,0.253906339729608,0.935392186448619,2,9,lens fiber cell development,BP,WNT7A;PROX1
16999,GO:0099080,0.254084967150066,0.78659119482681,69,596,supramolecular complex,CC,THSD4;CST3;PARVB;FLNC;ESPN;OBSCN;NDRG1;MTA1;OBSL1;NOS1;SPRY2;LTBP1;CLIP2;MAP2K2;KLC2;SHANK2;DVL1;FAM110C;REEP4;TMOD2;CORO1B;MYZAP;RAC2;KCNAB2;LZTS2;ANK3;TNNT1;TWF2;WIPF1;PKD2;KIF17;SNPH;SNTB2;FHOD3;EML2;KIF26B;ENKD1;DNAH1;KIF7;TUBG2;PRKCZ;NINL;FSCN1;STUB1;AHNAK2;TPM2;DNM1;RGS14;SCN8A;REEP2;MYH15;EML3;NARF;FYN;RAC3;DNM2;KIF26A;TUBB6;PAK1;PPP3CB;MICAL1;BIN1;LMNA;SIRT2;MAPRE3;NDE1;KIF13B;COL6A1;TTLL3
20249,GO:2001170,0.254199016848522,0.935267847812256,2,9,negative regulation of ATP biosynthetic process,BP,DDIT4;PPARA
3251,GO:0006915,0.254435151545573,0.773970243086896,155,1395,apoptotic process,BP,DUSP6;XDH;MEF2D;H1F0;EGR1;CST3;HS1BP3;PDCD4;PRNP;VEGFA;TNFRSF6B;WNT7A;APOE;F2R;LRP5;ITGA6;HMGA2;OBSCN;NDRG1;PKN1;GRAMD4;NISCH;EGFR;RPS6KA2;SPRY2;MST1R;NFATC4;SHC1;PHLDA2;ZFP36L1;MAP2K2;NME4;RBCK1;MAP2K1;ENDOG;SMAD3;ERCC6;LRP1;PRDX5;PRODH;ADARB1;AKT1;PPM1F;STK39;EPHA1;DAP;FGFR4;FGFR1;ELMO3;SIGMAR1;RAG1;PACS2;ZNF385A;STRADB;SYNGAP1;GAS6;CTSB;CARD11;GSN;PLEKHG2;PCSK9;PHLDA1;ANGPTL4;RGL2;ALOX15B;BNIP3;PAK6;SHARPIN;CTSZ;EPHB2;ADAM8;MNT;CEBPB;TGFB1;MKNK2;MOAP1;NTSR1;TMEM173;TNFSF15;NSMF;PEG3;TNFAIP8L1;PTPN1;VHL;TRAP1;PRKCZ;MINK1;RABGGTA;ADA;PIM2;PLEKHG5;BOK;ERBB2;TFDP2;STK17A;JAK3;NET1;BNIP3L;CYFIP2;PDK1;PRKCD;IFI6;BAX;ITGA1;TMBIM4;DDIT4;PPP1R13L;DIP2A;IRAK1;INPP5D;CHEK2;TMEM161A;CDC34;SOX7;BCAP31;MIF;PLA2G6;WFS1;FYN;STK25;EEF2K;DNM2;CAT;BEX2;SATB1;ARHGEF4;MAPK3;INSR;ARHGEF1;GRINA;TNS4;PAK1;MICAL1;DNMT3A;BIN1;MAP2K3;BCL2L1;LMNA;TNFRSF25;SIRT2;FAM129B;MAP3K10;PELI3;NGFR;PDCD6;PNMA1;BTG1;CDK11B;FGFR3;MFSD10;ITPKB;PLAG1;GSDMA;DEDD2;AARS
9281,GO:0035723,0.254594320114711,0.935099739109548,2,9,interleukin-15-mediated signaling pathway,BP,SHC1;JAK3
15198,GO:0071350,0.254594320114711,0.935099739109548,2,9,cellular response to interleukin-15,BP,SHC1;JAK3
13488,GO:0055064,0.254697695385234,0.935055744759019,2,9,chloride ion homeostasis,BP,SLC12A7;SLC12A4
16719,GO:0097720,0.254896915475655,0.891514212815097,4,24,calcineurin-mediated signaling,BP,PRNP;NFATC4;ADGRB2;PPP3CB
4733,GO:0010899,0.255024373463374,0.975440517664349,1,3,regulation of phosphatidylcholine catabolic process,BP,LDLR
18265,GO:1903078,0.255030046994932,0.86871210973296,6,40,positive regulation of protein localization to plasma membrane,BP,PRNP;EGFR;LRP1;AKT1;EPHB2;ITGA3
18624,GO:1903897,0.255199729133584,0.934841898368536,2,9,regulation of PERK-mediated unfolded protein response,BP,PTPN1;BOK
12868,GO:0051205,0.255238233387896,0.868388799201831,6,41,protein insertion into membrane,BP,EGFR;GRIN3B;MOAP1;OXA1L;TFDP2;BAX
14600,GO:0070166,0.255263303371083,0.934814795635989,2,9,enamel mineralization,BP,FAM20C;PPARA
11525,GO:0046061,0.255274644881781,0.975388911799669,1,3,dATP catabolic process,BP,ADA
9033,GO:0035253,0.2553753025026,0.934767036202034,2,9,ciliary rootlet,CC,CROCC;RAB28
8194,GO:0032947,0.255479311930321,0.843711724226322,10,72,protein-containing complex scaffold activity,MF,SLC9A3R2;SHANK2;WWC3;SEPT10;GRIP2;SHANK3;RGS14;SEPT6;HOMER2;DEDD2
11124,GO:0045176,0.255564020919298,0.934686525874572,2,9,apical protein localization,BP,VANGL2;CELSR1
14313,GO:0061478,0.25619550411422,0.934416798795283,2,9,response to platelet aggregation inhibitor,BP,ADCY1;ADCY6
4095,GO:0009151,0.256293200778537,0.933218453044937,2,10,purine deoxyribonucleotide metabolic process,BP,ADA;DGUOK
7690,GO:0032154,0.256388781642302,0.859841745236272,7,48,cleavage furrow,CC,PKN1;PLCD3;SSH1;PITPNM1;RAB11FIP4;NDE1;SEPT6
3464,GO:0007288,0.25650455406662,0.934284610426756,2,9,sperm axoneme assembly,BP,BBS2;DNAH1
7935,GO:0032530,0.256512137914905,0.934281365113352,2,9,regulation of microvillus organization,BP,TWF2;FSCN1
2334,GO:0005355,0.25672966630772,0.934188248577304,2,9,glucose transmembrane transporter activity,MF,SLC2A9;SLC2A3
3004,GO:0006553,0.256756858260737,0.934176604432105,2,9,lysine metabolic process,BP,ALDH7A1;PHYKPL
13593,GO:0060074,0.256907456236874,0.934112098463054,2,9,synapse maturation,BP,ADGRL1;NFATC4
9316,GO:0035791,0.257104327467053,0.934027729078958,2,9,platelet-derived growth factor receptor-beta signaling pathway,BP,LRP1;PTPN1
14877,GO:0070669,0.257104464702157,0.934027670249789,2,9,response to interleukin-2,BP,SHC1;JAK3
15200,GO:0071352,0.257104464702157,0.934027670249789,2,9,cellular response to interleukin-2,BP,SHC1;JAK3
12569,GO:0050732,0.257285031137069,0.867175144974766,6,40,negative regulation of peptidyl-tyrosine phosphorylation,BP,PTK6;ERRFI1;PRKCZ;PRKCD;CBLC;LRRK1
13004,GO:0051446,0.257525813465146,0.933846936609202,2,9,positive regulation of meiotic cell cycle,BP,INSR;SIRT2
12393,GO:0048845,0.257567196778828,0.933829173557609,2,9,venous blood vessel morphogenesis,BP,VEGFA;PROX1
15494,GO:0071871,0.25789127310119,0.933689994940648,2,9,response to epinephrine,BP,PRKACA;SIRT2
18402,GO:1903409,0.257899599661227,0.846448385840007,9,66,reactive oxygen species biosynthetic process,BP,NOS1;ACP5;SMAD3;AKT1;PKD2;TRAP1;DNM2;INSR;GCH1
9820,GO:0042043,0.257948319352222,0.93366548201893,2,9,neurexin family protein binding,MF,SYTL1;NLGN2
14431,GO:0061744,0.257952385686721,0.974832887669814,1,3,motor behavior,BP,ADARB1
13891,GO:0060546,0.258013317159791,0.933637547294714,2,9,negative regulation of necroptotic process,BP,RBCK1;BOK
19855,GO:2000310,0.258116785638442,0.93359306768245,2,9,regulation of NMDA receptor activity,BP,DLG4;EPHB2
19497,GO:1990253,0.258187328520287,0.933562734576674,2,9,cellular response to leucine starvation,BP,IMPACT;SESN2
19917,GO:2000392,0.258366912906406,0.933485485835492,2,9,regulation of lamellipodium morphogenesis,BP,CORO1B;ARPIN
15029,GO:0070977,0.258397354851553,0.933472387116308,2,9,bone maturation,BP,THBS3;FGFR3
2837,GO:0006309,0.258462358376272,0.906707086450003,3,17,apoptotic DNA fragmentation,BP,H1F0;ENDOG;BAX
5785,GO:0017014,0.258591733529211,0.932216628913678,2,10,protein nitrosylation,BP,NOS1;SNTA1
5905,GO:0018119,0.258591733529211,0.932216628913678,2,10,peptidyl-cysteine S-nitrosylation,BP,NOS1;SNTA1
33,GO:0000062,0.258910532218488,0.906463639842571,3,17,fatty-acyl-CoA binding,MF,ACOT7;ACBD4;HMGCL
8961,GO:0035035,0.25925534058698,0.888876825101902,4,24,histone acetyltransferase binding,MF,EGR1;EPAS1;CEBPB;SIRT2
1207,GO:0002866,0.259371595941329,0.974535312084408,1,3,positive regulation of acute inflammatory response to antigenic stimulus,BP,ZP3
8738,GO:0034397,0.259718840585106,0.932902645409395,2,9,telomere localization,BP,LEMD2;SUN1
8452,GO:0033599,0.259723157650551,0.906021596863992,3,17,regulation of mammary gland epithelial cell proliferation,BP,CCND1;DEAF1;BAX
9546,GO:0036312,0.259745354397354,0.932891191790232,2,9,phosphatidylinositol 3-kinase regulatory subunit binding,MF,FAM83A;DNM2
14238,GO:0061298,0.259749950232345,0.932889206359591,2,9,retina vasculature development in camera-type eye,BP,ACVR2B;LRP5
2619,GO:0005940,0.259772403550751,0.932879505997282,2,9,septin ring,CC,SEPT10;SEPT6
7206,GO:0031105,0.259772403550751,0.932879505997282,2,9,septin complex,CC,SEPT10;SEPT6
7693,GO:0032160,0.259772403550751,0.932879505997282,2,9,septin filament array,CC,SEPT10;SEPT6
18516,GO:1903651,0.25980761358141,0.932864293155126,2,9,positive regulation of cytoplasmic transport,BP,VPS11;SORL1
19348,GO:1905666,0.259820222506504,0.932858844964089,2,9,regulation of protein localization to endosome,BP,SORL1;ABHD17C
19349,GO:1905668,0.259820222506504,0.932858844964089,2,9,positive regulation of protein localization to endosome,BP,SORL1;ABHD17C
11355,GO:0045725,0.259820222506539,0.932858844964055,2,9,positive regulation of glycogen biosynthetic process,BP,AKT1;INSR
20256,GO:2001181,0.259936244926338,0.974416361608975,1,3,positive regulation of interleukin-10 secretion,BP,PRKCZ
7200,GO:0031098,0.259951986082133,0.802589808560119,28,229,stress-activated protein kinase signaling cascade,BP,XDH;PDCD4;VEGFA;WNT7A;PKN1;EGFR;ZFP36L1;MAP2K2;MAP2K1;ERCC6;ADORA2B;AKT1;STK39;STRADB;MAPK13;PAK6;CDC42EP5;PTPN1;MINK1;IRAK1;STK25;MAPK3;VANGL2;PAK1;SEMA4C;MAP2K3;MAP3K10;CCDC88C
4029,GO:0009063,0.259985791580086,0.840126718557259,10,74,cellular amino acid catabolic process,BP,NOS1;ALDH4A1;GLUL;PRODH;CBS;HMGCL;AHCY;GPT2;ALDH7A1;PHYKPL
1228,GO:0002904,0.260266065738108,0.974346733868054,1,3,positive regulation of B cell apoptotic process,BP,BAX
14308,GO:0061462,0.260305066874745,0.875158910426306,5,32,protein localization to lysosome,BP,SORL1;AP3D1;CD81;WASH3P;C12ORF66
11762,GO:0046631,0.26037584748854,0.844694708864219,9,65,alpha-beta T cell activation,BP,STAT6;AP3D1;PRKCZ;ADA;JAK3;ZFPM1;SATB1;HFE;ITPKB
6586,GO:0022605,0.261306294389304,0.974126423507743,1,3,mammalian oogenesis stage,BP,EREG
5840,GO:0017127,0.261332891606775,0.93101309615845,2,10,cholesterol transporter activity,MF,APOE;ABCG1
1911,GO:0004601,0.261340216643593,0.886321402941146,4,28,peroxidase activity,MF,PRDX5;GPX3;CYGB;CAT
2944,GO:0006476,0.261787656685808,0.830904715746416,12,90,protein deacetylation,BP,VEGFA;MTA1;HDAC5;HMG20B;CTBP1;TGFB1;PHF21A;MBD3;C6ORF89;HDAC7;SIRT2;SIRT3
7152,GO:0031021,0.262656542426554,0.973838843400153,1,3,interphase microtubule organizing center,CC,WDR60
16403,GO:0097028,0.262960945749692,0.904252312821295,3,17,dendritic cell differentiation,BP,GAS6;TGFB1;HLA-G
1293,GO:0003105,0.263174269000308,0.973728092923539,1,3,negative regulation of glomerular filtration,BP,F2R
6979,GO:0030662,0.263354184230636,0.818140384851768,16,127,coated vesicle membrane,CC,APOE;EGFR;HBEGF;AP2A2;LDLR;CEMIP;CLTCL1;SCYL1;CD9;EPN2;AREG;VAMP2;MCFD2;TGFA;HLA-G;PDCD6
12260,GO:0048565,0.26356424385453,0.837479882667806,10,73,digestive tract development,BP,ACVR2B;ITGA6;EGFR;SMAD3;ITGB4;PTK6;TGFB1;ADA;VANGL2;PKD1
11589,GO:0046189,0.26357182488521,0.90391706025999,3,17,phenol-containing compound biosynthetic process,BP,TRPC1;DDT;GCH1
15754,GO:0072350,0.263743328138561,0.872653678785275,5,33,tricarboxylic acid metabolic process,BP,IDH2;DHTKD1;SDHA;MDH2;ACO2
7748,GO:0032271,0.264000105931745,0.81142760880296,19,153,regulation of protein polymerization,BP,ARL2;TMOD2;CORO1B;RAC2;TWF2;GSN;PLEKHG2;WIPF1;ARPIN;SPTB;CDC42EP5;FHOD3;EML2;CAPG;PRKCD;WASH3P;RAC3;PAK1;PFN2
9987,GO:0042402,0.264045549695589,0.929812658252117,2,10,cellular biogenic amine catabolic process,BP,SMOX;ALDH7A1
8883,GO:0034705,0.264254495466058,0.872569901871296,5,32,potassium channel complex,CC,DLG4;KCNG1;KCNC4;KCNAB2;VAMP2
15712,GO:0072273,0.264392513247369,0.90346594502037,3,17,metanephric nephron morphogenesis,BP,PKD2;KIF26B;PKD1
7777,GO:0032309,0.264504442534411,0.903404355985561,3,17,icosanoid secretion,BP,NTSR1;MIF;PLA2G6
4156,GO:0009220,0.264801447791792,0.902690521513946,3,18,pyrimidine ribonucleotide biosynthetic process,BP,NME4;UCKL1;UPP1
11568,GO:0046132,0.264801447791792,0.902690521513946,3,18,pyrimidine ribonucleoside biosynthetic process,BP,NME4;UCKL1;UPP1
4638,GO:0010762,0.264833373363221,0.885469489002058,4,24,regulation of fibroblast migration,BP,AKT1;TGFB1;CYGB;PAK1
7129,GO:0030968,0.265050501512348,0.819259758377192,15,117,endoplasmic reticulum unfolded protein response,BP,EDEM1;SHC1;CCND1;PTPN1;TPP1;BOK;STUB1;BAX;MBTPS2;PDIA5;WFS1;TSPYL2;CUL7;PPP2R5B;LMNA
8530,GO:0033865,0.265327376784315,0.871609770550401,5,33,nucleoside bisphosphate metabolic process,BP,ACOT7;PANK4;PODXL2;ABHD14B;PPCS
8536,GO:0033875,0.265327376784315,0.871609770550401,5,33,ribonucleoside bisphosphate metabolic process,BP,ACOT7;PANK4;PODXL2;ABHD14B;PPCS
8557,GO:0034032,0.265327376784315,0.871609770550401,5,33,purine nucleoside bisphosphate metabolic process,BP,ACOT7;PANK4;PODXL2;ABHD14B;PPCS
14731,GO:0070404,0.265884189513442,0.973144010712923,1,3,NADH binding,MF,HSD17B8
4593,GO:0010710,0.26605437627694,0.973107083340042,1,3,regulation of collagen catabolic process,BP,CST3
13699,GO:0060267,0.266120188912772,0.973092795402773,1,3,positive regulation of respiratory burst,BP,INSR
10559,GO:0043524,0.266338870064368,0.827202846918504,12,92,negative regulation of neuron apoptotic process,BP,APOE;F2R;LRP1;SYNGAP1;ADAM8;CEBPB;BOK;BAX;WFS1;FYN;BCL2L1;AARS
17932,GO:1902235,0.266568507912609,0.884030011085896,4,25,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,PTPN1;BOK;WFS1;GRINA
17928,GO:1902230,0.266584805630201,0.883678957747401,4,26,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,ZNF385A;TMEM161A;MIF;BCL2L1
2045,GO:0004792,0.266759849319774,0.972953697801545,1,3,thiosulfate sulfurtransferase activity,MF,TST
8033,GO:0032689,0.266906004647546,0.90207920658544,3,17,negative regulation of interferon-gamma production,BP,PRNP;GAS6;IL20RB
7226,GO:0031128,0.266940508556328,0.902060116409072,3,17,developmental induction,BP,WNT2B;FGFR1;WNT3
13539,GO:0060011,0.26727816469578,0.972840684935544,1,3,Sertoli cell proliferation,BP,BAX
13579,GO:0060057,0.267278164695781,0.972840684935544,1,3,apoptotic process involved in mammary gland involution,BP,BAX
13580,GO:0060058,0.267278164695781,0.972840684935544,1,3,positive regulation of apoptotic process involved in mammary gland involution,BP,BAX
17946,GO:1902263,0.267278164695781,0.972840684935544,1,3,apoptotic process involved in embryonic digit morphogenesis,BP,BAX
17975,GO:1902339,0.267278164695781,0.972840684935544,1,3,positive regulation of apoptotic process involved in morphogenesis,BP,BAX
18447,GO:1903519,0.267278164695781,0.972840684935544,1,3,regulation of mammary gland involution,BP,BAX
18448,GO:1903521,0.267278164695781,0.972840684935544,1,3,positive regulation of mammary gland involution,BP,BAX
18979,GO:1904747,0.267278164695781,0.972840684935544,1,3,positive regulation of apoptotic process involved in development,BP,BAX
1795,GO:0004427,0.267298778086865,0.972836184815282,1,3,inorganic diphosphatase activity,MF,LHPP
18103,GO:1902722,0.2673427428559,0.972826585411348,1,3,positive regulation of prolactin secretion,BP,EGFR
9971,GO:0042365,0.267361336377142,0.972822525057675,1,3,water-soluble vitamin catabolic process,BP,PM20D2
18322,GO:1903236,0.267376560464311,0.972819200243155,1,3,regulation of leukocyte tethering or rolling,BP,ITGA4
10459,GO:0043325,0.267398434842736,0.901806619060818,3,17,phosphatidylinositol-3,4-bisphosphate binding,MF,AKT1;ARAP3;PLEK2
9246,GO:0035651,0.267541564722816,0.972783149678555,1,3,AP-3 adaptor complex binding,MF,PI4K2A
13072,GO:0051590,0.267669220998654,0.901656597530694,3,17,positive regulation of neurotransmitter transport,BP,APLN;RAB3B;NTSR1
13700,GO:0060268,0.26773194731709,0.972741520248068,1,3,negative regulation of respiratory burst,BP,BCR
9209,GO:0035601,0.268076196210262,0.822570367946761,13,99,protein deacylation,BP,VEGFA;MTA1;HDAC5;HMG20B;CTBP1;TGFB1;ABHD17C;PHF21A;MBD3;C6ORF89;HDAC7;SIRT2;SIRT3
3333,GO:0007050,0.268136138141701,0.797689995079848,26,215,cell cycle arrest,BP,PRNP;HMGA2;MAP2K1;SMAD3;PPP2R3B;ZNF385A;CCND1;PCBP4;STRADB;GAS6;PKD2;CDKN1C;TGFB1;CGREF1;MLXIPL;PRKACA;TFDP2;RBL2;BAX;MAPK12;CHEK2;MIF;BIN1;PPP2R5B;PKD1;GAS2L1
18933,GO:1904646,0.26840632627489,0.901247770832638,3,17,cellular response to amyloid-beta,BP,PRNP;LRP1;NGFR
10841,GO:0044344,0.268429810417311,0.819205291244705,14,109,cellular response to fibroblast growth factor stimulus,BP,DUSP6;APLN;POSTN;SPRY2;SPRY4;ZFP36L1;FGFR4;FGFR1;FGFBP1;GPC1;FAM20C;MAPK3;HYAL1;FGFR3
10580,GO:0043550,0.268541886047361,0.869740251453728,5,32,regulation of lipid kinase activity,BP,PIK3R2;CD81;TGFB1;RBL2;FGFR3
13254,GO:0051952,0.268720307242619,0.882698264958509,4,25,regulation of amine transport,BP,STK39;RAB3B;NTSR1;SV2A
11027,GO:0045007,0.268911620503595,0.972482754313342,1,3,depurination,BP,MPG
15403,GO:0071672,0.268948864953016,0.972474561686826,1,3,negative regulation of smooth muscle cell chemotaxis,BP,CORO1B
11592,GO:0046208,0.269174171452531,0.97242497129935,1,3,spermine catabolic process,BP,SMOX
15325,GO:0071548,0.269203005932719,0.869044257428984,5,33,response to dexamethasone,BP,EGFR;ERRFI1;TGFB1;PCK2;DDIT4
997,GO:0002460,0.269337910749415,0.811000705590873,17,135,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,ERCC1;PKN1;POU2F2;STAT6;SERPING1;CEACAM1;IL20RB;TGFB1;SCART1;PRKCZ;ADA;JAK3;PRKCD;INPP5D;PPP3CB;HFE;ZP3
12337,GO:0048710,0.269518121868139,0.90062987046221,3,17,regulation of astrocyte differentiation,BP,SERPINE2;LDLR;BIN1
4221,GO:0009397,0.26960409270172,0.972330202237468,1,3,folic acid-containing compound catabolic process,BP,PM20D2
10062,GO:0042560,0.26960409270172,0.972330202237468,1,3,pteridine-containing compound catabolic process,BP,PM20D2
13688,GO:0060251,0.26985923080349,0.900439990234629,3,17,regulation of glial cell proliferation,BP,IDH2;ETV5;PLAG1
9668,GO:0038033,0.269984346052066,0.972246225617512,1,3,positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway,BP,VEGFA
8910,GO:0034756,0.270066304802686,0.972228106333535,1,3,regulation of iron ion transport,BP,HFE
12574,GO:0050750,0.270248203143672,0.900223293077155,3,17,low-density lipoprotein particle receptor binding,MF,APOE;PCSK9;SNX17
6306,GO:0019953,0.270278141745614,0.778076393650399,51,439,sexual reproduction,BP,ERCC1;BBS2;SERPINE2;MST1R;CRTAP;ETV5;HEXB;TCFL5;TXNRD3;SYT8;AKT1;SCMH1;GGT1;PHC2;GAMT;CCNI;MICALCL;CDC25B;NPR2;WNT3;TGFB1;RFX2;DEAF1;MYCBPAP;DNAH1;VGF;CEP131;PRKACA;CD9;ADA;PIM2;TDRKH;FAM50A;BAX;SBF1;EREG;RPL39L;SPATA20;SIX5;BCAP31;SUN1;DNM2;DNMT3A;BCL2L1;SIRT2;AZIN2;BTG1;ZP3;SEPT6;PRSS21;KDM3A
9671,GO:0038037,0.270330999916134,0.972169541525391,1,3,G-protein coupled receptor dimeric complex,CC,GABBR1
16697,GO:0097648,0.270330999916134,0.972169541525391,1,3,G-protein coupled receptor complex,CC,GABBR1
8709,GO:0034364,0.270384763691193,0.925963741330165,2,11,high-density lipoprotein particle,CC,APOE;PLTP
5259,GO:0015889,0.270448887232769,0.972143435633352,1,3,cobalamin transport,BP,CD320
10469,GO:0043368,0.270835423794311,0.899895801260784,3,17,positive T cell selection,BP,STAT6;ZFPM1;ITPKB
9349,GO:0035865,0.270956638159069,0.972030834104516,1,3,cellular response to potassium ion,BP,CARF
4019,GO:0009051,0.271010301052078,0.972018918245302,1,3,pentose-phosphate shunt, oxidative branch,BP,PGLS
6268,GO:0019865,0.271094832549395,0.972000142072621,1,3,immunoglobulin binding,MF,FCGRT
20180,GO:2000977,0.27117918622267,0.971981398163235,1,3,regulation of forebrain neuron differentiation,BP,PROX1
18279,GO:1903135,0.271202705902632,0.971976170655713,1,3,cupric ion binding,MF,PRNP
2489,GO:0005739,0.27147619026456,0.758051409100559,153,1427,mitochondrion,CC,CYP27B1;HS1BP3;NAGS;XPC;FAM210B;LRP5;IDH2;CRAT;ELK3;GRAMD4;ACOT7;ACSF2;NOS1;VAT1;HADH;SHC1;ARL2;ALDH4A1;TK2;TXNRD3;GLUL;MAP2K2;NME4;SUGCT;PC;MAP2K1;CPT2;ENDOG;KLC2;ARMCX2;OXLD1;HSD17B8;RPUSD3;PRDX5;STOM;PRODH;D2HGDH;AKT1;UROS;PYCR2;BSG;HK1;POLD4;PACS2;TOMM34;BPHL;CBR4;ABCD1;NIPSNAP1;CARD19;CTSB;DHTKD1;MRPS6;HLCS;COMTD1;RSAD1;HAGH;BNIP3;ZMIZ2;ZNF217;LACTB2;SNPH;MOAP1;NTSR1;TMEM173;ATP7B;SDHA;MSRB2;MIPEP;MDH2;MPG;PI4K2A;ANKZF1;COA5;HMGCL;TPP1;PCK2;ACP6;VHL;TRAP1;PRKACA;OXA1L;BOK;TDRKH;ALAS1;ULK1;PRIMPOL;TMEM143;TFDP2;BNIP3L;PDK1;ACAD10;THOP1;IFI6;BAX;CYC1;DGUOK;TIMM17B;DDIT4;ACADS;PPL;ZDHHC8;RPS6KA6;DNM1;TMEM8B;ALDOC;MRPS26;MAPK12;PPOX;COQ2;SESN2;ABCG1;SNN;BCAP31;ACO2;SLC25A29;PHYH;PLA2G6;FYN;ETFB;DNM2;CKMT1A;CAT;ARMCX1;SLC27A1;MAPK3;TAZ;GPT2;GLRX;MLYCD;CAPRIN2;TSTD1;BCL2L1;ABHD10;NDUFV3;IARS2;ALDH7A1;TNFRSF25;SIRT2;AZIN2;SLC25A37;HSDL1;PHYKPL;MAFF;SIRT3;TST;TNRC18;SPTLC2;DHX32;AK3;CHPF;LRRK1;AARS
13614,GO:0060119,0.271784520708704,0.880792659540441,4,25,inner ear receptor cell development,BP,NAGLU;FGFR1;SLITRK6;VANGL2
17884,GO:1902109,0.271940595330982,0.971811881098807,1,3,negative regulation of mitochondrial membrane permeability involved in apoptotic process,BP,BNIP3
18351,GO:1903305,0.27197266885797,0.830940669226111,10,74,regulation of regulated secretory pathway,BP,SYTL1;ADORA2B;SYT8;RAC2;CEACAM1;BCR;RIMS3;MICAL1;ZP3;PFN2
19879,GO:2000341,0.272278369724286,0.926111929155839,2,10,regulation of chemokine (C-X-C motif) ligand 2 production,BP,POSTN;MIF
12669,GO:0050886,0.272455122047819,0.856505870844416,6,41,endocrine process,BP,APLN;F2R;FGFR1;CTSZ;RASL10B;FAM129B
18425,GO:1903445,0.272459103708019,0.971696104960073,1,3,protein transport from ciliary membrane to plasma membrane,BP,RILPL1
7862,GO:0032430,0.272487460965221,0.9716897652623,1,3,positive regulation of phospholipase A2 activity,BP,EGFR
16485,GO:0097177,0.272540887426717,0.971677818736329,1,3,mitochondrial ribosome binding,MF,OXA1L
18599,GO:1903844,0.272628236521241,0.826066440694526,11,83,regulation of cellular response to transforming growth factor beta stimulus,BP,HTRA1;LTBP4;LTBP1;SMURF2;SMAD3;CDKN1C;TGFB1;STUB1;TGFBR3;DNM2;ITGA3
18450,GO:1903523,0.27265778864319,0.898876789835884,3,17,negative regulation of blood circulation,BP,APLN;DOCK4;F2R
19759,GO:2000117,0.272680588261653,0.830153204283047,10,77,negative regulation of cysteine-type endopeptidase activity,BP,CST3;VEGFA;TNFRSF6B;PRDX5;AKT1;RAG1;GAS6;IFI6;MICAL1;NGFR
17115,GO:0101006,0.272688979059878,0.971644689226549,1,3,protein histidine phosphatase activity,MF,LHPP
16628,GO:0097487,0.272866688437701,0.971604904454121,1,3,multivesicular body, internal vesicle,CC,EGFR
8724,GO:0034381,0.272874353250489,0.866354226931022,5,34,plasma lipoprotein particle clearance,BP,APOE;LMF1;AP2A2;LDLR;PCSK9
8756,GO:0034436,0.27294606064393,0.971587124567077,1,3,glycoprotein transport,BP,ABCG1
2817,GO:0006285,0.273465942666233,0.92557096337621,2,10,base-excision repair, AP site formation,BP,MPG;NEIL1
4071,GO:0009126,0.273585804032985,0.790508213671395,28,248,purine nucleoside monophosphate metabolic process,BP,NT5E;DLG4;PGM1;HK1;PFKL;LHPP;PFKP;CARD11;DHTKD1;NADK;APRT;TGFB1;SDHA;PFKFB2;MLXIPL;ADA;FAM20C;CYC1;DDIT4;ALDOC;PPARA;INSR;TAZ;PFKM;PFKFB3;DLG3;NDUFV3;AK3
4110,GO:0009167,0.273585804032985,0.790508213671395,28,248,purine ribonucleoside monophosphate metabolic process,BP,NT5E;DLG4;PGM1;HK1;PFKL;LHPP;PFKP;CARD11;DHTKD1;NADK;APRT;TGFB1;SDHA;PFKFB2;MLXIPL;ADA;FAM20C;CYC1;DDIT4;ALDOC;PPARA;INSR;TAZ;PFKM;PFKFB3;DLG3;NDUFV3;AK3
6059,GO:0019209,0.273706868799806,0.84031589196796,8,58,kinase activator activity,MF,SPRY2;MAP2K2;MAP2K1;ERCC6;GAS6;DGKQ;TGFB1;ETAA1
18181,GO:1902936,0.273730153260301,0.834532456669203,9,66,phosphatidylinositol bisphosphate binding,MF,SH3PXD2B;AKT1;TWF2;ARAP3;ADAP1;PLEK2;WIPI2;PFN2;GSDMA
6510,GO:0021892,0.273810852801573,0.971392989250335,1,3,cerebral cortex GABAergic interneuron differentiation,BP,RAC3
6813,GO:0030278,0.273822714848954,0.812115986818911,15,117,regulation of ossification,BP,CYP27B1;CTNNBIP1;ACVR2B;LRP5;SMAD3;CEBPB;TGFB1;LRP4;PRKACA;AREG;FAM20C;ZHX3;HDAC7;ECM1;MAPK3
2525,GO:0005783,0.274082273638829,0.756150435395294,147,1329,endoplasmic reticulum,CC,XDH;H6PD;EDEM1;DLG4;CST3;HS1BP3;FBXO2;PRNP;WNT7A;APOE;LRP5;PLD3;OSBPL5;LPCAT4;CRAT;ITPR3;ANGEL1;EGFR;NOS1;TMEM129;CAPN2;CRTAP;LMF1;LTBP1;TXNRD3;GLUL;MAP2K2;KDSR;FKBP9;MAP2K1;MCTP1;FOS;SRD5A3;PIGQ;STOM;MBOAT7;REEP4;F12;PITPNM1;RHBDF2;IFNGR2;FGFR4;FNDC4;SIGMAR1;SYNE3;PACS2;PIGV;SORL1;TENM2;ANK3;IGFBP4;TRAPPC9;CARD19;GAS6;PCSK9;ANO8;ANTXR2;EHD4;COL13A1;BNIP3;CEMIP;PKD2;RETSAT;CTSZ;GPSM1;ENTPD2;ADAMTS13;WNT3;TMED4;ADAMTS7;NTSR1;B3GNT3;TMEM173;LAMB2;ERO1B;VGF;SEMA4F;UBXN4;PTPN1;CD320;ESYT2;ZDHHC24;VHL;AREG;BOK;ULK1;CERCAM;NECAB3;BNIP3L;MCFD2;PRKCD;FAM20C;REEP6;STUB1;BAX;SV2A;SBF1;XYLT2;MBTPS2;HSD17B7;CES2;TMX4;PDIA5;LEMD2;TMEM8B;MSLN;LPCAT1;REEP2;TGFA;ABCG1;MYO1D;BCAP31;WFS1;QSOX1;SPPL2B;VWA1;CERS4;CYP3A5;CAT;IGFBP7;SLC27A1;TPBG;ZDHHC1;CYP2R1;CBLN3;RTN2;GRINA;PDZD2;HLA-G;ATP8B2;RNASET2;SLC37A2;SAMD8;BCL2L1;DNASE1L1;EDA;ALG12;LAMB1;HSD11B1;PDCD6;NBEAL2;COL6A1;SEMA3B;FGFR3;SPTLC2;SLC26A11;SDC2
12905,GO:0051260,0.274327425421304,0.79231596646661,26,217,protein homooligomerization,BP,TYSND1;KCNG1;PRNP;APOE;ITPR3;GLUL;STOM;KCNC4;SIGMAR1;PFKL;CBR4;ANGPTL4;EHD4;SHARPIN;PKD2;GPX3;CRTC1;ASIC1;BAX;EHD3;MIF;ATXN10;CAT;KCTD13;GCH1;CCDC88C
7658,GO:0032094,0.274380814617674,0.897909595272932,3,17,response to food,BP,BBS2;AKT1;PPARA
6725,GO:0030145,0.274516927534086,0.855062579137746,6,41,manganese ion binding,MF,NPEPL1;GLUL;HMGCL;PCK2;PRIMPOL;FAM20C
17473,GO:1900274,0.274596363033669,0.897788345305531,3,17,regulation of phospholipase C activity,BP,EGFR;FGFR1;EDNRA
20266,GO:2001198,0.274677071119401,0.971197768462363,1,3,regulation of dendritic cell differentiation,BP,HLA-G
10759,GO:0044211,0.27491270595981,0.971144530442922,1,3,CTP salvage,BP,UCKL1
16664,GO:0097546,0.274981617465038,0.87879294794332,4,25,ciliary base,CC,PRKACB;NPHP4;PRKACA;WDR60
9415,GO:0035986,0.275297149331929,0.97105754952497,1,3,senescence-associated heterochromatin focus assembly,BP,HMGA2
4527,GO:0010594,0.275363016797044,0.813594059992405,14,109,regulation of endothelial cell migration,BP,VEGFA;WNT7A;APOE;AKT1;HDAC5;FGFR1;CEACAM1;PLCG1;TGFB1;SH3BP1;HDAC7;MAP2K3;PROX1;PDCD6
6092,GO:0019287,0.275380902200274,0.971038580241334,1,3,isopentenyl diphosphate biosynthetic process, mevalonate pathway,BP,MVD
15535,GO:0071942,0.275528480772399,0.971005137524494,1,3,XPC complex,CC,XPC
10313,GO:0043103,0.275548763071595,0.971000539618248,1,3,hypoxanthine salvage,BP,ADA
4464,GO:0010460,0.275585266868168,0.924601085032891,2,10,positive regulation of heart rate,BP,ADA;GCH1
6006,GO:0019050,0.275814933521868,0.970940160925554,1,3,suppression by virus of host apoptotic process,BP,BCL2L1
9757,GO:0039526,0.275814933521868,0.970940160925554,1,3,modulation by virus of host apoptotic process,BP,BCL2L1
13636,GO:0060154,0.275815518793829,0.970940028081183,1,3,cellular process regulating host cell cycle in response to virus,BP,BCL2L1
11458,GO:0045923,0.27583731764673,0.897089182005158,3,17,positive regulation of fatty acid metabolic process,BP,MLXIPL;PPARA;MLYCD
11679,GO:0046474,0.275926436408638,0.793552621783257,24,195,glycerophospholipid biosynthetic process,BP,DGKA;LPCAT4;PIK3R2;PIGQ;PITPNM1;FGFR4;FGFR1;PIGV;DGKQ;SYNJ2;PI4K2A;ACP6;SBF1;CPNE7;LPCAT1;INPP5D;PI4K2B;PLA2G6;PITPNM3;CHKA;SLC27A1;TAZ;ZP3;FGFR3
9353,GO:0035869,0.276018142095282,0.845475634911751,7,50,ciliary transition zone,CC,IFT140;NPHP4;UNC119B;KIF17;CEP131;TMEM231;TCTN1
17379,GO:1900101,0.276089596535857,0.878097202503068,4,25,regulation of endoplasmic reticulum unfolded protein response,BP,PTPN1;BOK;BAX;WFS1
13818,GO:0060426,0.27612497352581,0.970869739244442,1,3,lung vasculature development,BP,ERRFI1
3575,GO:0007623,0.276221038889211,0.805296942111653,17,135,circadian rhythm,BP,NR1D1;CST3;NAGLU;MTA1;EGFR;HEBP1;CSNK1E;CRTC1;HTR7;ADA;AHCY;PPARA;BHLHE40;ADCY1;PROX1;NGFR;NR2F6
7987,GO:0032611,0.276221416030723,0.853679536081988,6,42,interleukin-1 beta production,BP,EGR1;F2R;ACP5;SMAD3;HK1;ERRFI1
10843,GO:0044346,0.276330355057194,0.896810879102342,3,17,fibroblast apoptotic process,BP,GAS6;STK17A;BTG1
1057,GO:0002584,0.276342969850564,0.970820165125752,1,3,negative regulation of antigen processing and presentation of peptide antigen,BP,HFE
7290,GO:0031295,0.276814625270119,0.863958590126565,5,33,T cell costimulation,BP,AKT1;CARD11;EFNB3;FYN;PAK1
14554,GO:0070085,0.276839351539227,0.791415921409569,25,206,glycosylation,BP,LMF1;ST6GALNAC2;SRD5A3;VEGFB;B4GAT1;PIGV;B3GAT3;MVD;ADAMTS13;ADAMTS7;B3GNT3;MGAT4B;ST6GALNAC6;B4GALT2;B4GALT6;RFNG;MPI;MCFD2;MFNG;ST3GAL3;COG7;NUDT14;ALG12;ST3GAL2;ST3GAL5
9958,GO:0042350,0.276870272280592,0.9707000507467,1,3,GDP-L-fucose biosynthetic process,BP,TSTA3
8037,GO:0032693,0.27691866919327,0.923987928460445,2,10,negative regulation of interleukin-10 production,BP,TRIB2;JAK3
12730,GO:0051004,0.276972106261365,0.923963308352715,2,10,regulation of lipoprotein lipase activity,BP,LMF1;ANGPTL4
3059,GO:0006625,0.277132992471998,0.896357182745587,3,17,protein targeting to peroxisome,BP,PEX10;PEX1;LONP2
15891,GO:0072662,0.277132992471998,0.896357182745587,3,17,protein localization to peroxisome,BP,PEX10;PEX1;LONP2
15892,GO:0072663,0.277132992471998,0.896357182745587,3,17,establishment of protein localization to peroxisome,BP,PEX10;PEX1;LONP2
1557,GO:0003955,0.277151620012383,0.970635845701248,1,3,NAD(P)H dehydrogenase (quinone) activity,MF,CBR4
2161,GO:0004993,0.2772287989546,0.970618218848464,1,3,G-protein coupled serotonin receptor activity,MF,HTR7
3419,GO:0007210,0.2772287989546,0.970618218848464,1,3,serotonin receptor signaling pathway,BP,HTR7
10356,GO:0043176,0.2772287989546,0.970618218848464,1,3,amine binding,MF,HTR7
12967,GO:0051378,0.2772287989546,0.970618218848464,1,3,serotonin binding,MF,HTR7
16814,GO:0098664,0.2772287989546,0.970618218848464,1,3,G-protein coupled serotonin receptor signaling pathway,BP,HTR7
17081,GO:0099589,0.2772287989546,0.970618218848464,1,3,serotonin receptor activity,MF,HTR7
7559,GO:0031914,0.277265102480169,0.970609925391901,1,3,negative regulation of synaptic plasticity,BP,RGS14
11032,GO:0045017,0.277272740916682,0.789841863932665,26,213,glycerolipid biosynthetic process,BP,DGKA;LPCAT4;PIK3R2;PIGQ;PITPNM1;FGFR4;LDLR;FGFR1;PIGV;DGKQ;SYNJ2;PI4K2A;PCK2;ACP6;SBF1;CPNE7;LPCAT1;INPP5D;PI4K2B;PLA2G6;PITPNM3;CHKA;SLC27A1;TAZ;ZP3;FGFR3
12694,GO:0050921,0.277313712627139,0.826563624618384,10,77,positive regulation of chemotaxis,BP,PGF;VEGFA;SMAD3;PPM1F;VEGFB;FGFR1;RAC2;GAS6;TGFB1;MAPK3
9869,GO:0042136,0.277314363374606,0.837626088550806,8,58,neurotransmitter biosynthetic process,BP,NOS1;ACP5;SMAD3;AKT1;PKD2;DNM2;INSR;GCH1
13039,GO:0051538,0.277430388995901,0.970572148952237,1,3,3 iron, 4 sulfur cluster binding,MF,ACO2
1091,GO:0002678,0.277697659162634,0.970511004615943,1,3,positive regulation of chronic inflammatory response,BP,ADORA2B
10164,GO:0042756,0.277790148034557,0.970489828508104,1,3,drinking behavior,BP,APLN
5476,GO:0016409,0.277928564778557,0.863209096750615,5,33,palmitoyltransferase activity,MF,CPT2;ZDHHC24;ZDHHC8;ZDHHC1;SPTLC2
4866,GO:0014719,0.278047785716766,0.970430793801609,1,3,skeletal muscle satellite cell activation,BP,WNT7A
13269,GO:0051967,0.278055769217327,0.970428963383734,1,3,negative regulation of synaptic transmission, glutamatergic,BP,PLA2G6
8721,GO:0034378,0.278247622071644,0.970384956578246,1,3,chylomicron assembly,BP,APOE
13929,GO:0060605,0.278444374240279,0.970339786632818,1,3,tube lumen cavitation,BP,EDA
13946,GO:0060662,0.278444374240279,0.970339786632818,1,3,salivary gland cavitation,BP,EDA
11599,GO:0046292,0.278756525508257,0.970268041825961,1,3,formaldehyde metabolic process,BP,KDM3A
13063,GO:0051580,0.278856341071808,0.923092846399113,2,10,regulation of neurotransmitter uptake,BP,NOS1;RAB3B
10491,GO:0043398,0.278908070057654,0.970233174655094,1,3,HLH domain binding,MF,PKD2
10281,GO:0043034,0.279109848460921,0.895236397894876,3,17,costamere,CC,FLNC;ANK3;AHNAK2
3211,GO:0006858,0.279255069515674,0.970153248334347,1,3,extracellular transport,BP,ARRDC1
5332,GO:0016064,0.279335112291099,0.836114185276439,8,58,immunoglobulin mediated immune response,BP,ERCC1;POU2F2;STAT6;SERPING1;TGFB1;PRKCD;INPP5D;ZP3
6207,GO:0019724,0.279335112291099,0.836114185276439,8,58,B cell mediated immunity,BP,ERCC1;POU2F2;STAT6;SERPING1;TGFB1;PRKCD;INPP5D;ZP3
18541,GO:1903719,0.279605973613199,0.970072296378223,1,3,regulation of I-kappaB phosphorylation,BP,AKT1
18542,GO:1903721,0.279605973613199,0.970072296378223,1,3,positive regulation of I-kappaB phosphorylation,BP,AKT1
6911,GO:0030509,0.279649752118401,0.816699782213742,12,91,BMP signaling pathway,BP,HTRA1;EGR1;PDCD4;ACVR2B;SMURF2;TGFB1;LRP4;TGFBR3;LEMD2;MAPK3;ITGA3;HFE
8905,GO:0034751,0.27966103708787,0.970059581958608,1,3,aryl hydrocarbon receptor complex,CC,AIP
16832,GO:0098732,0.27972136572515,0.813163949144597,13,100,macromolecule deacylation,BP,VEGFA;MTA1;HDAC5;HMG20B;CTBP1;TGFB1;ABHD17C;PHF21A;MBD3;C6ORF89;HDAC7;SIRT2;SIRT3
12953,GO:0051344,0.279740729543587,0.970041175048754,1,3,negative regulation of cyclic-nucleotide phosphodiesterase activity,BP,AIP
816,GO:0002090,0.27981087818077,0.875750184156111,4,25,regulation of receptor internalization,BP,DLG4;APLN;VEGFA;PCSK9
2398,GO:0005544,0.279874402300328,0.861896685279903,5,33,calcium-dependent phospholipid binding,MF,SYTL1;SYT8;DYSF;ESYT2;PCLO
10696,GO:0043988,0.279894631788884,0.970005609031963,1,3,histone H3-S28 phosphorylation,BP,RPS6KA5
9488,GO:0036132,0.280154600584455,0.969945476041702,1,3,13-prostaglandin reductase activity,MF,PTGR2
12002,GO:0047522,0.280154600584455,0.969945476041702,1,3,15-oxoprostaglandin 13-oxidase activity,MF,PTGR2
13537,GO:0060009,0.280274071217177,0.922434898604961,2,10,Sertoli cell development,BP,CST3;SDC1
2724,GO:0006107,0.280305559420113,0.92242025615877,2,10,oxaloacetate metabolic process,BP,MDH2;PCK2
17744,GO:1901664,0.280446831552659,0.969877797201721,1,3,regulation of NAD+ ADP-ribosyltransferase activity,BP,TGFB1
17745,GO:1901666,0.280446831552659,0.969877797201721,1,3,positive regulation of NAD+ ADP-ribosyltransferase activity,BP,TGFB1
1281,GO:0003081,0.280518889304341,0.922321021372638,2,10,regulation of systemic arterial blood pressure by renin-angiotensin,BP,F2R;CTSZ
7266,GO:0031253,0.280531462968404,0.788267035147303,25,204,cell projection membrane,CC,BBS2;SPRY2;SYTL1;SPRY4;SHANK2;CYBRD1;KCNC4;CEACAM1;EVC;PKD2;SHANK3;BBS1;PLEK2;FSCN1;EHD3;TMEM231;MYO1D;ABCA7;DNM2;ARHGEF4;INSR;PAK1;ITGA3;PKD1;MFSD10
11333,GO:0045667,0.280622234405837,0.824151749369315,10,75,regulation of osteoblast differentiation,BP,CTNNBIP1;ACVR2B;LRP5;SMAD3;CEBPB;PRKACA;AREG;FAM20C;ZHX3;HDAC7
8955,GO:0035024,0.280815180044848,0.894265723046656,3,17,negative regulation of Rho protein signal transduction,BP,ARAP3;ITGA3;KCTD13
3509,GO:0007423,0.280997405513111,0.776354278814364,37,311,sensory organ development,BP,SDK2;CST3;ACVR2B;VEGFA;WNT7A;NAGLU;LRP5;EGFR;SPRY2;SMAD3;DVL1;SH3PXD2B;SALL2;IFT140;WNT2B;FGFR1;NPHP4;RAB11FIP4;TSHZ1;BCR;SLITRK6;EPHB2;TGFB1;TUB;LAMB2;LRP10;BAX;PPP1R13L;LPCAT1;TMEM231;MYH15;SIX5;MAPK3;VANGL2;PROX1;ZNF513;CELSR1
12904,GO:0051259,0.281047493953527,0.772297861548817,43,381,protein complex oligomerization,BP,TYSND1;KCNG1;PRNP;APOE;ITPR3;MMP1;SNX9;GLUL;HSD17B8;STOM;KCNC4;SIGMAR1;PFKL;SORL1;CBR4;ANGPTL4;EHD4;SHARPIN;PKD2;GPX3;CRTC1;ASIC1;KHDRBS3;HMGCL;LRP4;PRKCZ;GRHPR;OXA1L;BOK;BAX;TRIM4;DNM1;EHD3;IRAK1;MIF;ATXN10;CAT;INSR;PFKM;KCTD13;GCH1;COL6A1;CCDC88C
9457,GO:0036064,0.281076426744074,0.815495724819978,12,92,ciliary basal body,CC,BBS2;MARK4;AKT1;IFT140;NPHP4;EVC;PKD2;KIF17;KIF7;BBS1;RILPL1;RAB28
14484,GO:0061900,0.281094023324888,0.894106667868262,3,17,glial cell activation,BP,EGFR;LRP1;LDLR
18493,GO:1903588,0.281149333918901,0.96971474094838,1,3,negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,NGFR
6983,GO:0030667,0.28117807060331,0.788970269367547,24,198,secretory granule membrane,CC,ITPR3;SLC2A3;GAA;AP2A2;STOM;BSG;SLC15A4;RAB31;KCNAB2;CEACAM1;PLAU;BRI3;ADAM8;TMEM173;RHOF;CD9;VAMP2;LPCAT1;SYNGR1;CD68;SUN1;ICA1;RAB40B;NBEAL2
4979,GO:0015101,0.281189520866532,0.894052173243126,3,17,organic cation transmembrane transporter activity,MF,SLC7A8;SLC25A29;AZIN2
12550,GO:0050708,0.281301761103818,0.780971162531024,31,261,regulation of protein secretion,BP,NR1D1;POSTN;F2R;LRP5;IDH2;ITPR3;EGFR;HADH;ARL2;RAPGEF3;GLUL;NLGN2;RHBDF2;HK1;MAPKBP1;PFKL;GAS6;ALOX15B;ADAM8;TGFB1;LLGL1;PCK2;PFKFB2;PRKCZ;MIF;PLA2G6;MAPK3;PFKM;PPP3CB;ICA1;SIRT3
11559,GO:0046121,0.281337553342975,0.96967096704904,1,3,deoxyribonucleoside catabolic process,BP,ADA
2263,GO:0005179,0.281345522111436,0.893368769627332,3,18,hormone activity,MF,APLN;PTHLH;VGF
13932,GO:0060612,0.281370488690411,0.874761830831881,4,25,adipose tissue development,BP,LRP5;SH3PXD2B;ZNF516;ARID5B
254,GO:0000720,0.281394227562785,0.969657779231228,1,3,pyrimidine dimer repair by nucleotide-excision repair,BP,ERCC1
702,GO:0001923,0.281442961187142,0.96964643649277,1,3,B-1 B cell differentiation,BP,CMTM7
983,GO:0002439,0.281469588741187,0.969640237897755,1,3,chronic inflammatory response to antigenic stimulus,BP,AHCY
3349,GO:0007084,0.281517394827862,0.921855770537234,2,10,mitotic nuclear envelope reassembly,BP,REEP4;LMNA
10712,GO:0044036,0.281545835244747,0.969622484508832,1,3,cell wall macromolecule metabolic process,BP,MPI
15328,GO:0071554,0.281545835244747,0.969622484508832,1,3,cell wall organization or biogenesis,BP,MPI
1905,GO:0004591,0.282045183700537,0.969506066360456,1,3,oxoglutarate dehydrogenase (succinyl-transferring) activity,MF,DHTKD1
7194,GO:0031090,0.282088287835844,0.742960274744245,242,2227,organelle membrane,CC,B4GALNT4;SLC16A3;EDEM1;DLG4;CST3;CYP27B1;FBXO2;PRNP;BBS2;FAM210B;WNT7A;APOE;TSPAN1;NDRG1;IDH2;CRAT;ITPR3;GRAMD4;EGFR;NOS1;VAT1;PTPRS;HADH;APPL2;VPS11;SLC2A3;SNX9;ST6GALNAC2;GAA;ARAP1;MAP2K2;NME4;MARCH9;CPT2;MCTP1;TMEM8A;ARMCX2;SMAD3;STAT6;SHANK2;LRP1;HBEGF;AP2A2;CYBRD1;STOM;PRODH;SYT8;TPCN1;PITPNM1;ENTPD6;BSG;HK1;ASAP2;DYSF;MARCH4;SLC15A4;ATG16L2;ZFYVE21;IFNGR2;RAB31;LDLR;SIGMAR1;RAC2;KCNAB2;SYNE3;B4GAT1;TOMM34;BPHL;SORL1;CEACAM1;B3GAT3;RAB11FIP4;ABCD1;NIPSNAP1;EVC;TRAPPC9;CARD19;PLAU;BRI3;RAB3B;PCSK9;ANTXR2;MRPS6;EHD4;DBNDD1;PEX10;CORO7;DGKQ;BNIP3;MVB12B;CEMIP;PKD2;RETSAT;CTSZ;GPSM1;AP3D1;ABCA2;ADAM8;TMEM9;WNT3;SNPH;CLTCL1;SCYL1;ABHD17C;SNTB2;ULK2;MOAP1;B3GNT3;TMEM173;ATP7B;SHANK3;SDHA;MGAT4B;MDH2;CLCA2;GOLGA2P5;NSMF;DIRC2;RHOD;SNX17;ST6GALNAC6;SNX33;PI4K2A;RHOF;ANKZF1;SLC48A1;LLGL1;BBS1;HMGCL;PEX1;B4GALT2;WDR59;CD320;B4GALT6;TRAP1;RFNG;OXA1L;CD9;EPN2;AREG;BOK;ERBB2;ULK1;VAMP2;C6ORF89;BNIP3L;SLC22A17;MCFD2;BAX;CYC1;SV2A;XYLT2;KLHDC2;TIMM17B;TMBIM4;MBTPS2;AHNAK2;ZDHHC8;LEMD2;DNM1;WASH3P;MFNG;MRPS26;LPCAT1;EHD3;ST3GAL3;TMEM231;IRAK1;PPOX;TGFA;PI4K2B;DECR2;COG7;COQ2;ABCG1;RNF123;SNN;ABCA7;RAB12;BCAP31;SMOX;SLC25A29;DOPEY2;SLC9A7;SYNGR1;QSOX1;CD68;SPPL2B;STK25;CERS4;SUN1;DNM2;CKMT1A;CYP3A5;SNX15;CAT;ARMCX1;SLC50A1;SLC12A4;CYP2R1;INSR;TAZ;C12ORF66;HLA-G;STX10;PRAF2;PAK1;MALL;RNF144A;SEMA4C;SAMD8;VPS16;MAN2B1;SLC16A13;NDST2;BCL2L1;NDUFV3;LMNA;PKD1;GAL3ST4;NMNAT2;AZIN2;ST3GAL2;ICA1;SLC25A37;RAP1GAP2;RAB40B;PDCD6;ATP6V1F;CHST14;PLEKHM1;GCH1;NBEAL2;COL6A1;VPS51;MFSD10;TST;ST3GAL5;TNRC18;MAN2B2;CHPF;SLC26A11
1134,GO:0002725,0.282152004949782,0.969481128495856,1,3,negative regulation of T cell cytokine production,BP,HFE
12678,GO:0050904,0.282329642809881,0.96943963200614,1,3,diapedesis,BP,ITGA4
13103,GO:0051648,0.28233821701389,0.787990600647393,24,197,vesicle localization,BP,BBS2;SYTL1;NLGN2;SYT8;TRAPPC9;FYCO1;CTSZ;AP3D1;SNPH;RIMS3;PRKCZ;AREG;VAMP2;MCFD2;DNM1;TGFA;DNM2;ITGA4;NDE1;PDCD6;PCLO;PFN2;BLOC1S4;TRIM46
17808,GO:1901890,0.28237289505847,0.874125121987323,4,25,positive regulation of cell junction assembly,BP,VEGFA;SMAD3;PPM1F;NPHP4
14477,GO:0061888,0.282400286683759,0.969423120389941,1,3,regulation of astrocyte activation,BP,LDLR
19515,GO:1990357,0.282592822770249,0.969378092587377,1,3,terminal web,CC,HFE
9776,GO:0039694,0.282707523328612,0.873912317396882,4,25,viral RNA genome replication,BP,HMGA2;ATG16L2;APOBEC3C;APOBEC3F
15082,GO:0071073,0.282728898189139,0.969346245865856,1,3,positive regulation of phospholipid biosynthetic process,BP,ZP3
14806,GO:0070541,0.282797020418371,0.969330295506675,1,3,response to platinum ion,BP,UROS
11491,GO:0045986,0.282984336919085,0.921169934414743,2,10,negative regulation of smooth muscle contraction,BP,DOCK4;ADORA2B
2491,GO:0005741,0.283094915869546,0.79730650339454,18,147,mitochondrial outer membrane,CC,CYP27B1;FAM210B;VAT1;ARMCX2;HK1;TOMM34;BPHL;BNIP3;MOAP1;TMEM173;ANKZF1;BOK;ULK1;BNIP3L;BAX;SNN;ARMCX1;BCL2L1
16408,GO:0097038,0.283168987274641,0.92108340966943,2,10,perinuclear endoplasmic reticulum,CC,CAPN2;BCAP31
135,GO:0000285,0.28339190107768,0.969190803477992,1,3,1-phosphatidylinositol-3-phosphate 5-kinase activity,MF,ZFYVE21
5906,GO:0018125,0.283421195869416,0.969183924721673,1,3,peptidyl-cysteine methylation,BP,RAB3B
3016,GO:0006565,0.283529410424132,0.969158506959506,1,3,L-serine catabolic process,BP,CBS
3285,GO:0006978,0.283634975901154,0.892052423613902,3,18,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,ZNF385A;RPS6KA6;CHEK2
3168,GO:0006783,0.283756116920929,0.891982593928144,3,18,heme biosynthetic process,BP,UROS;ALAS1;PPOX
6044,GO:0019166,0.283788575179571,0.969097584074914,1,3,trans-2-enoyl-CoA reductase (NADPH) activity,MF,DECR2
5719,GO:0016857,0.283962872760344,0.920710906919013,2,10,racemase and epimerase activity, acting on carbohydrates and derivatives,MF,GALE;TSTA3
2445,GO:0005656,0.284054061797746,0.96903510266708,1,3,nuclear pre-replicative complex,CC,WDR18
2804,GO:0006267,0.284054061797746,0.96903510266708,1,3,pre-replicative complex assembly involved in nuclear cell cycle DNA replication,BP,WDR18
9573,GO:0036387,0.284054061797746,0.96903510266708,1,3,pre-replicative complex,CC,WDR18
9574,GO:0036388,0.284054061797746,0.96903510266708,1,3,pre-replicative complex assembly,BP,WDR18
17960,GO:1902299,0.284054061797746,0.96903510266708,1,3,pre-replicative complex assembly involved in cell cycle DNA replication,BP,WDR18
16955,GO:0098953,0.284104023504137,0.969023336145832,1,3,receptor diffusion trapping,BP,DLG4
16961,GO:0098970,0.284104023504137,0.969023336145832,1,3,postsynaptic neurotransmitter receptor diffusion trapping,BP,DLG4
17096,GO:0099628,0.284104023504137,0.969023336145832,1,3,neurotransmitter receptor diffusion trapping,BP,DLG4
2158,GO:0004985,0.284127971389026,0.969017695239699,1,3,opioid receptor activity,MF,SIGMAR1
14638,GO:0070229,0.284398492328103,0.872467725294385,4,26,negative regulation of lymphocyte apoptotic process,BP,RAG1;ADA;JAK3;MIF
15224,GO:0071385,0.284485432010251,0.84783155434817,6,42,cellular response to glucocorticoid stimulus,BP,EGFR;ZFP36L1;ERRFI1;TGFB1;PCK2;DDIT4
1525,GO:0003896,0.284545184858204,0.968919325144004,1,3,DNA primase activity,MF,PRIMPOL
12521,GO:0050671,0.284571779763482,0.825953360366537,9,69,positive regulation of lymphocyte proliferation,BP,CARD11;IGFBP2;CD81;CD320;ADA;JAK3;MIF;PELI1;ZP3
13288,GO:0052031,0.284579658333269,0.96891118892394,1,3,modulation by symbiont of host defense response,BP,TGFB1
13322,GO:0052255,0.284579658333269,0.96891118892394,1,3,modulation by organism of defense response of other organism involved in symbiotic interaction,BP,TGFB1
13354,GO:0052552,0.284579658333269,0.96891118892394,1,3,modulation by organism of immune response of other organism involved in symbiotic interaction,BP,TGFB1
13355,GO:0052553,0.284579658333269,0.96891118892394,1,3,modulation by symbiont of host immune response,BP,TGFB1
15955,GO:0075528,0.284579658333269,0.96891118892394,1,3,modulation by virus of host immune response,BP,TGFB1
8080,GO:0032770,0.284601060590238,0.891495041963043,3,18,positive regulation of monooxygenase activity,BP,APOE;AKT1;GCH1
18930,GO:1904636,0.284704809283783,0.96888164115463,1,3,response to ionomycin,BP,NFATC4
18931,GO:1904637,0.284704809283783,0.96888164115463,1,3,cellular response to ionomycin,BP,NFATC4
4768,GO:0010955,0.284721128041029,0.872261327860647,4,26,negative regulation of protein processing,BP,PRNP;SERPINE2;SERPING1;CTSZ
18358,GO:1903318,0.284721128041029,0.872261327860647,4,26,negative regulation of protein maturation,BP,PRNP;SERPINE2;SERPING1;CTSZ
10048,GO:0042536,0.284778094176006,0.968864331234965,1,3,negative regulation of tumor necrosis factor biosynthetic process,BP,ERRFI1
8233,GO:0033013,0.284822633337891,0.84740877750828,6,43,tetrapyrrole metabolic process,BP,UROS;RSAD1;PRSS3;CD320;ALAS1;PPOX
10321,GO:0043120,0.284824591210785,0.968853345716538,1,3,tumor necrosis factor binding,MF,TNFRSF25
18657,GO:1903959,0.284877774232153,0.891938998647627,3,17,regulation of anion transmembrane transport,BP,PRNP;AKT1;STK39
13928,GO:0060603,0.285035643058682,0.872428229653593,4,25,mammary gland duct morphogenesis,BP,LRP5;ETV5;TGFB1;AREG
8274,GO:0033087,0.285092076865406,0.968790105058004,1,3,negative regulation of immature T cell proliferation,BP,ERBB2
15352,GO:0071593,0.28521302027255,0.968761486367313,1,3,lymphocyte aggregation,BP,RAC2
4408,GO:0010165,0.285391477450587,0.858153542288776,5,33,response to X-ray,BP,ERCC1;HMGA2;ERCC6;CCND1;DNM2
12963,GO:0051354,0.285601415144037,0.91993952081221,2,10,negative regulation of oxidoreductase activity,BP,CYP27B1;OXA1L
12308,GO:0048669,0.285784908460454,0.968625954557532,1,3,collateral sprouting in absence of injury,BP,WNT3
10836,GO:0044339,0.285784908460455,0.968625954557531,1,3,canonical Wnt signaling pathway involved in osteoblast differentiation,BP,WNT3
12677,GO:0050901,0.28579894681416,0.919846294829228,2,10,leukocyte tethering or rolling,BP,PODXL2;ITGA4
4861,GO:0014704,0.285799810687518,0.857875209314085,5,33,intercalated disc,CC,SCN4B;OBSL1;ANK3;FHOD1;PAK1
15442,GO:0071733,0.285825070211393,0.968616423798796,1,3,transcriptional activation by promoter-enhancer looping,BP,ZFPM1
16180,GO:0090202,0.285825070211393,0.968616423798796,1,3,gene looping,BP,ZFPM1
16339,GO:0090579,0.285825070211393,0.968616423798796,1,3,dsDNA loop formation,BP,ZFPM1
5141,GO:0015669,0.285882714223924,0.96860274139366,1,3,gas transport,BP,CYGB
1250,GO:0002950,0.285925070937748,0.968592685376784,1,3,ceramide phosphoethanolamine synthase activity,MF,SAMD8
8332,GO:0033188,0.285925070937748,0.968592685376784,1,3,sphingomyelin synthase activity,MF,SAMD8
11997,GO:0047493,0.285925070937748,0.968592685376784,1,3,ceramide cholinephosphotransferase activity,MF,SAMD8
10591,GO:0043567,0.286002852709109,0.919750007932145,2,10,regulation of insulin-like growth factor receptor signaling pathway,BP,IGFBP4;IGFBP2
2581,GO:0005875,0.286114315173933,0.801924031568006,15,119,microtubule associated complex,CC,CLIP2;NUDCD3;KLC2;KIF17;EML2;KIF26B;DNAH1;KIF7;ACTR1B;WDR60;KIF26A;RABGAP1;NDE1;PXN;KIF13B
4266,GO:0009617,0.286272158213951,0.773822640747856,34,298,response to bacterium,BP,TNIP1;NR1D1;CYP27B1;PDCD4;TNFRSF6B;F2R;LOXL1;NOS1;SHC1;ACP5;FOS;AKT1;HDAC5;MAPKBP1;MAPKAPK3;BCR;CEBPB;ADAMTS13;TGFB1;VGF;PCK2;IFNE;PRKCD;IRAK1;MIF;PLA2G6;PELI1;MAPK3;TNFRSF25;SIRT2;NGFR;RNASE7;GCH1;GSDMA
11550,GO:0046102,0.286289428776861,0.968506104872441,1,3,inosine metabolic process,BP,ADA
8050,GO:0032722,0.286347416726238,0.85724393119394,5,34,positive regulation of chemokine production,BP,EGR1;POSTN;ADORA2B;ALOX15B;MIF
3937,GO:0008626,0.286471493719478,0.968462789744683,1,3,granzyme-mediated apoptotic signaling pathway,BP,BNIP3
6026,GO:0019087,0.286576184096776,0.968437867138478,1,3,transformation of host cell by virus,BP,INSR
10158,GO:0042748,0.28660880199765,0.968430099775796,1,3,circadian sleep/wake cycle, non-REM sleep,BP,ADA
13803,GO:0060405,0.286608801997761,0.968430099775801,1,3,regulation of penile erection,BP,ADA
1851,GO:0004514,0.286798873785582,0.968384815495032,1,3,nicotinate-nucleotide diphosphorylase (carboxylating) activity,MF,NAPRT
19627,GO:1990756,0.28710380460709,0.968312087320164,1,3,protein binding, bridging involved in substrate recognition for ubiquitination,MF,ARRDC1
16178,GO:0090200,0.287104599180405,0.870391620599591,4,27,positive regulation of release of cytochrome c from mitochondria,BP,BNIP3;MOAP1;BAX;PLA2G6
2594,GO:0005891,0.287105721385696,0.919228293866902,2,10,voltage-gated calcium channel complex,CC,NOS1;CACNB3
10093,GO:0042608,0.287155726396385,0.968299693911754,1,3,T cell receptor binding,MF,FYN
9628,GO:0036500,0.287229983728115,0.919169413363661,2,10,ATF6-mediated unfolded protein response,BP,MBTPS2;WFS1
690,GO:0001911,0.287312348577765,0.919130374643462,2,10,negative regulation of leukocyte mediated cytotoxicity,BP,CEACAM1;PPP3CB
968,GO:0002414,0.287406807877523,0.968239722514324,1,3,immunoglobulin transcytosis in epithelial cells,BP,FCGRT
15555,GO:0072007,0.287418266615262,0.9682369839937,1,3,mesangial cell differentiation,BP,ACTA2
15556,GO:0072008,0.287418266615262,0.9682369839937,1,3,glomerular mesangial cell differentiation,BP,ACTA2
15639,GO:0072143,0.287418266615262,0.9682369839937,1,3,mesangial cell development,BP,ACTA2
15640,GO:0072144,0.287418266615262,0.9682369839937,1,3,glomerular mesangial cell development,BP,ACTA2
18768,GO:1904238,0.287418266615262,0.9682369839937,1,3,pericyte cell differentiation,BP,ACTA2
8444,GO:0033590,0.287426713020008,0.968234965301638,1,3,response to cobalamin,BP,EGFR
53,GO:0000110,0.287481424392931,0.968221887466186,1,3,nucleotide-excision repair factor 1 complex,CC,ERCC1
10369,GO:0043196,0.287544285831422,0.968206857625243,1,3,varicosity,CC,DNM1
3414,GO:0007202,0.287560227503489,0.919012834100455,2,10,activation of phospholipase C activity,BP,EGFR;EDNRA
11552,GO:0046104,0.287695712126199,0.968170635400243,1,3,thymidine metabolic process,BP,TK2
11562,GO:0046125,0.287695712126199,0.968170635400243,1,3,pyrimidine deoxyribonucleoside metabolic process,BP,TK2
4755,GO:0010934,0.287849745921538,0.918875448721871,2,10,macrophage cytokine production,BP,GAS6;TGFB1
52,GO:0000109,0.287978934079409,0.918814110204329,2,10,nucleotide-excision repair complex,CC,ERCC1;XPC
5229,GO:0015844,0.288135028737788,0.870070107999466,4,26,monoamine transport,BP,NISCH;NOS1;RAB3B;SLC29A4
8464,GO:0033615,0.288199661690678,0.968049914141915,1,3,mitochondrial proton-transporting ATP synthase complex assembly,BP,OXA1L
7936,GO:0032532,0.288233005036696,0.96804191734541,1,3,regulation of microvillus length,BP,TWF2
19330,GO:1905600,0.288392915006447,0.968003549638891,1,3,regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,PCSK9
18670,GO:1903976,0.288659839738275,0.967939445789796,1,3,negative regulation of glial cell migration,BP,IDH2
18810,GO:1904340,0.288735867563644,0.967921173495117,1,3,positive regulation of dopaminergic neuron differentiation,BP,CSNK1E
19087,GO:1904958,0.288735867563644,0.967921173495117,1,3,positive regulation of midbrain dopaminergic neuron differentiation,BP,CSNK1E
9226,GO:0035620,0.289041455034301,0.967847668335272,1,3,ceramide transporter activity,MF,PLTP
12251,GO:0048546,0.289215567384911,0.869748182759228,4,25,digestive tract morphogenesis,BP,ACVR2B;EGFR;SMAD3;VANGL2
9712,GO:0038145,0.289217482752055,0.967805282609449,1,3,macrophage colony-stimulating factor signaling pathway,BP,MST1R
4632,GO:0010756,0.289249951341141,0.967797460940666,1,3,positive regulation of plasminogen activation,BP,F12
3477,GO:0007341,0.289283466874883,0.967789385901626,1,3,penetration of zona pellucida,BP,HEXB
521,GO:0001609,0.28928497955334,0.967789021417794,1,3,G-protein coupled adenosine receptor activity,MF,ADORA2B
2061,GO:0004814,0.289361776713715,0.967770513781672,1,3,arginine-tRNA ligase activity,MF,DALRD3
2906,GO:0006420,0.289361776713715,0.967770513781672,1,3,arginyl-tRNA aminoacylation,BP,DALRD3
18626,GO:1903899,0.289408749429673,0.967759190596065,1,3,positive regulation of PERK-mediated unfolded protein response,BP,BOK
17909,GO:1902202,0.289448776426019,0.967749539907607,1,3,regulation of hepatocyte growth factor receptor signaling pathway,BP,PTPN1
9888,GO:0042176,0.289533494142551,0.770192872139294,35,300,regulation of protein catabolic process,BP,EDEM1;CST3;APOE;EGFR;SERPINE2;VPS11;SNX9;SMURF2;SMAD3;LRP1;DVL1;AKT1;LDLR;SORL1;CSNK1E;PCSK9;RAD23A;SH3D19;MAGEF1;ADAM8;CD81;TIMP2;SNX33;TRIB2;PRKACA;STUB1;LPCAT1;CHEK2;BCAP31;FYN;RNF144A;PKD1;SIRT2;AZIN2;HFE
4903,GO:0014834,0.289559392505151,0.967722861118212,1,3,skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration,BP,WNT7A
19596,GO:1990637,0.289568197736649,0.967720736887712,1,3,response to prolactin,BP,EEF2K
13576,GO:0060054,0.289583009140664,0.967717163505849,1,3,positive regulation of epithelial cell proliferation involved in wound healing,BP,WNT7A
13025,GO:0051490,0.289597748154378,0.96771360736001,1,3,negative regulation of filopodium assembly,BP,PRKCD
13089,GO:0051611,0.289707859840685,0.967687033008535,1,3,regulation of serotonin uptake,BP,NOS1
13090,GO:0051612,0.289707859840685,0.967687033008535,1,3,negative regulation of serotonin uptake,BP,NOS1
14154,GO:0061047,0.289797448229401,0.967665402344049,1,3,positive regulation of branching involved in lung morphogenesis,BP,WNT2B
1996,GO:0004719,0.289916501727047,0.967636644417114,1,3,protein-L-isoaspartate (D-aspartate) O-methyltransferase activity,MF,PCMTD2
6457,GO:0021783,0.289976013838875,0.917863166509534,2,10,preganglionic parasympathetic fiber development,BP,ADARB1;SEMA3F
9199,GO:0035587,0.289987175665259,0.917857837196358,2,10,purinergic receptor signaling pathway,BP,ADORA2B;ADA
7670,GO:0032106,0.290112636429424,0.967589234653239,1,3,positive regulation of response to extracellular stimulus,BP,CYP27B1
7673,GO:0032109,0.290112636429424,0.967589234653239,1,3,positive regulation of response to nutrient levels,BP,CYP27B1
18756,GO:1904217,0.290133099906206,0.967584285881194,1,3,regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,BP,SERINC2
18757,GO:1904219,0.290133099906206,0.967584285881194,1,3,positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,BP,SERINC2
18759,GO:1904222,0.290133099906206,0.967584285881194,1,3,positive regulation of serine C-palmitoyltransferase activity,BP,SERINC2
6759,GO:0030200,0.290316912980868,0.967539813805565,1,3,heparan sulfate proteoglycan catabolic process,BP,GPC1
7578,GO:0031952,0.290401464007615,0.85472627484252,5,33,regulation of protein autophosphorylation,BP,VEGFA;IMPACT;ERRFI1;EEF2K;PPP2R5B
16843,GO:0098751,0.290436393422479,0.86896166936001,4,25,bone cell development,BP,ZNF385A;FAM20C;ZFPM1;LRRK1
8268,GO:0033080,0.290555016567795,0.967482153708553,1,3,immature T cell proliferation in thymus,BP,ERBB2
9146,GO:0035502,0.290593837216694,0.967472747088381,1,3,metanephric part of ureteric bud development,BP,PKD2
14552,GO:0070081,0.29079647509746,0.967423620194998,1,3,clathrin-sculpted monoamine transport vesicle,CC,VAMP2
14553,GO:0070083,0.29079647509746,0.967423620194998,1,3,clathrin-sculpted monoamine transport vesicle membrane,CC,VAMP2
18403,GO:1903416,0.290804442540505,0.967421687709293,1,3,response to glycoside,BP,CHEK2
3523,GO:0007501,0.290809530115845,0.96742045369406,1,3,mesodermal cell fate specification,BP,FGFR1
10121,GO:0042661,0.290809530115845,0.96742045369406,1,3,regulation of mesodermal cell fate specification,BP,FGFR1
19368,GO:1905770,0.290809530115845,0.96742045369406,1,3,regulation of mesodermal cell differentiation,BP,FGFR1
19406,GO:1905902,0.290809530115845,0.96742045369406,1,3,regulation of mesoderm formation,BP,FGFR1
9495,GO:0036146,0.290883930897952,0.967402404321048,1,3,cellular response to mycotoxin,BP,EGR1
8511,GO:0033745,0.290896244192726,0.967399416595665,1,3,L-methionine-(R)-S-oxide reductase activity,MF,MSRB2
16131,GO:0090135,0.290943892546484,0.967387853587152,1,3,actin filament branching,BP,CORO1B
13683,GO:0060244,0.290957431104997,0.967384567696864,1,3,negative regulation of cell proliferation involved in contact inhibition,BP,PAK1
3815,GO:0008410,0.291077989037911,0.967355299035639,1,3,CoA-transferase activity,MF,SUGCT
2731,GO:0006114,0.29124664612751,0.967314327308589,1,3,glycerol biosynthetic process,BP,PCK2
3774,GO:0008331,0.291260821565025,0.967310882315013,1,3,high voltage-gated calcium channel activity,MF,CACNB3
10542,GO:0043500,0.291283314107377,0.826976885948178,8,59,muscle adaptation,BP,SMAD3;TNNT1;GSN;ERRFI1;GTF2IRD1;CAMTA2;PAK1;LMNA
19656,GO:1990837,0.29133151194825,0.754665545313922,62,533,sequence-specific double-stranded DNA binding,MF,MEF2D;ZMYND8;H1F0;EGR1;NR1D1;HMGA2;ELK3;MTA1;NFATC4;BAHCC1;ETV5;TCFL5;ETV4;ZC3H6;FOXQ1;POU2F2;FOS;SMAD3;STAT6;SALL2;HLTF;MXI1;KLF7;SOX13;MYEF2;SMARCD2;HES2;MNT;CEBPB;ZNF217;RFX2;DEAF1;PHF21A;MBD3;MLXIPL;KDM6B;ZNF516;TFDP2;PBX2;ZNF395;SOX12;CARF;IER2;ZHX3;CHD2;ZFPM1;PPARA;SIX5;SSBP4;ARID5B;BHLHE40;TSPYL2;SATB1;HES7;HES6;PROX1;BACH1;ZNF704;NR2F6;TNRC18;PLAG1;KDM3A
1994,GO:0004715,0.291360447878278,0.854067194732005,5,33,non-membrane spanning protein tyrosine kinase activity,MF,PTK6;JAK3;PRKCD;FYN;SRMS
17853,GO:1902022,0.29142124866912,0.967271879658909,1,3,L-lysine transport,BP,SLC25A29
18398,GO:1903401,0.29142124866912,0.967271879658909,1,3,L-lysine transmembrane transport,BP,SLC25A29
13652,GO:0060179,0.291434099424254,0.967268754239598,1,3,male mating behavior,BP,HEXB
12537,GO:0050692,0.291453085159096,0.967264136419289,1,3,DBD domain binding,MF,PROX1
9508,GO:0036166,0.291491982553044,0.967254674382375,1,3,phenotypic switching,BP,OLFM2
17457,GO:1900239,0.291491982553044,0.967254674382375,1,3,regulation of phenotypic switching,BP,OLFM2
7330,GO:0031347,0.291560239559379,0.758275082682877,52,457,regulation of defense response,BP,TNIP1;NT5E;HTRA1;NR1D1;PDCD4;APOE;EGFR;PTPRS;ACP5;SMAD3;ADORA2B;F12;STK39;SERPING1;GGT1;IFNGR2;FNDC4;LDLR;PRKACB;MAPKBP1;RAG1;CEACAM1;MAPK13;CTSB;CARD11;MAPKAPK3;BCR;SHARPIN;FAM3A;IL20RB;ADAM8;CD81;RNF135;TGFB1;TMEM173;PTPN1;PRKACA;ADA;PRKCD;EREG;RPS6KA5;LRSAM1;IRAK1;PPARA;DDT;FYN;PELI1;APOBEC3F;MAPK3;PAK1;SIRT2;ZP3
5564,GO:0016576,0.291569105037776,0.967235909130632,1,3,histone dephosphorylation,BP,PPM1F
13706,GO:0060282,0.291578472786707,0.967233629365849,1,3,positive regulation of oocyte development,BP,SIRT2
19398,GO:1905881,0.291578472786707,0.967233629365849,1,3,positive regulation of oogenesis,BP,SIRT2
10470,GO:0043369,0.291579570343052,0.917095890728119,2,10,CD4-positive or CD8-positive, alpha-beta T cell lineage commitment,BP,STAT6;ZFPM1
11405,GO:0045823,0.291638915075362,0.887400161100706,3,18,positive regulation of heart contraction,BP,APLN;ADA;GCH1
5779,GO:0017001,0.291656066956823,0.867448780985776,4,27,antibiotic catabolic process,BP,PRDX5;GPX3;PCK2;CAT
7020,GO:0030800,0.291710221084852,0.917033230601044,2,10,negative regulation of cyclic nucleotide metabolic process,BP,LTB4R2;GABBR1
7035,GO:0030815,0.291710221084852,0.917033230601044,2,10,negative regulation of cAMP metabolic process,BP,LTB4R2;GABBR1
3571,GO:0007619,0.291740830125051,0.967194102863376,1,3,courtship behavior,BP,HEXB
8824,GO:0034617,0.291795370263144,0.967180818620061,1,3,tetrahydrobiopterin binding,MF,NOS1
9369,GO:0035898,0.291829272048338,0.967172559640836,1,3,parathyroid hormone secretion,BP,FGFR1
11451,GO:0045916,0.291829272048569,0.96717255964084,1,3,negative regulation of complement activation,BP,SERPING1
19825,GO:2000258,0.291829272048569,0.96717255964084,1,3,negative regulation of protein activation cascade,BP,SERPING1
16279,GO:0090360,0.291871935522022,0.967162164459914,1,3,platelet-derived growth factor production,BP,NDRG2
16280,GO:0090361,0.291871935522022,0.967162164459914,1,3,regulation of platelet-derived growth factor production,BP,NDRG2
3826,GO:0008428,0.291875604508718,0.967161270402103,1,3,ribonuclease inhibitor activity,MF,RNH1
2060,GO:0004813,0.291890947217549,0.967157531540807,1,3,alanine-tRNA ligase activity,MF,AARS
2905,GO:0006419,0.291890947217549,0.967157531540807,1,3,alanyl-tRNA aminoacylation,BP,AARS
10075,GO:0042581,0.291961337107045,0.803055868922293,13,103,specific granule,CC,SLC2A3;STOM;SLC15A4;KCNAB2;CEACAM1;PLAU;CTSZ;ADAM8;TIMP2;QSOX1;PDXK;DNASE1L1;TOLLIP
7619,GO:0032025,0.292054272972936,0.916868118053759,2,10,response to cobalt ion,BP,D2HGDH;BNIP3
18408,GO:1903426,0.292055431206133,0.833543695479012,7,51,regulation of reactive oxygen species biosynthetic process,BP,ACP5;SMAD3;AKT1;PKD2;TRAP1;DNM2;INSR
2128,GO:0004930,0.292074854088663,0.791927723929835,17,138,G-protein coupled receptor activity,MF,ADGRL1;F2R;LPAR3;ADORA2B;SIGMAR1;EDNRA;NTSR1;MC1R;HTR7;GPR153;ADGRB2;LTB4R2;GABBR1;ADGRF1;LTB4R;GPR3;CELSR1
18165,GO:1902897,0.292076041791981,0.967112406298989,1,3,regulation of postsynaptic density protein 95 clustering,BP,ZMYND8
19394,GO:1905874,0.292076041791981,0.967112406298989,1,3,regulation of postsynaptic density organization,BP,ZMYND8
9637,GO:0036510,0.292093949110778,0.967108038654165,1,3,trimming of terminal mannose on C branch,BP,EDEM1
19964,GO:2000489,0.292387610693428,0.967036365453832,1,3,regulation of hepatic stellate cell activation,BP,CYGB
2229,GO:0005134,0.292424651359859,0.967027318566043,1,3,interleukin-2 receptor binding,MF,ECM1
18704,GO:1904047,0.292439227239639,0.967023758125975,1,3,S-adenosyl-L-methionine binding,MF,CBS
3014,GO:0006563,0.292458461537787,0.916673950765211,2,10,L-serine metabolic process,BP,CBS;PHGDH
6172,GO:0019541,0.292543421446337,0.966998300139234,1,3,propionate metabolic process,BP,PCK2
4380,GO:0010033,0.292604838610856,0.733113742755659,237,2173,response to organic substance,BP,TNIP1;DUSP6;XDH;ERCC1;HTRA1;EGR1;NR1D1;EDEM1;CST3;CYP27B1;FBXO2;APLN;PGF;PDCD4;ACVR2B;PRNP;BBS2;POSTN;VEGFA;FAM210B;TNFRSF6B;WNT7A;APOE;F2R;LRP5;ITGA6;EGFR;LOXL1;NOS1;TMEM129;HADH;SPRY2;CAPN2;MST1R;NFATC4;LTBP4;SDC1;SHC1;LTBP2;LTBP1;PTPRE;MMP1;SPRY4;RAPGEF3;ZFP36L1;GLUL;MAP2K2;RBCK1;MAP2K1;ACP5;SSH1;ENDOG;SMURF2;FOS;SMAD3;STAT6;PIK3R2;LRP1;DNAJB5;AKT1;CORO1B;HDAC5;UROS;F12;BSG;PTPRU;IMPACT;IFNGR2;RAB31;FGFR4;FNDC4;LDLR;FGFR1;PRKACB;PFKL;CEACAM1;CCND1;PODNL1;TWF2;MAPK13;GAS6;PTK6;PFKP;FGFBP1;CTSB;LAMA5;GSN;MAPKAPK3;IGFBP2;PCSK9;BCR;EHD4;ERRFI1;HLCS;AIP;PAQR6;NPR2;DGKQ;SHARPIN;PKD2;GPX3;IL20RB;ITGB5;ABCA2;EPOR;APRT;CDKN1C;PLCG1;CD81;CEBPB;ADAMTS13;TIMP2;WNT3;TGFB1;RFX2;GPC1;ADAMTS7;NTSR1;TMEM173;TNFSF15;NSMF;TUB;VGF;ANKZF1;UBXN4;HMGCL;PTPN1;TPP1;PCK2;AGRN;MBD3;IFNE;LRP4;DNAJC4;PFKFB2;MLXIPL;PRKCZ;PRKACA;CD9;EPN2;ADA;AREG;BOK;ERBB2;VAMP2;JAK3;CYFIP2;FSCN1;PRKCD;FAM20C;STUB1;IFI6;BAX;CYC1;EREG;RPS6KA5;DDIT4;MBTPS2;MT2A;IER2;TGFBR3;PDIA5;LEMD2;GSTO1;CHAD;LONP2;MAPK12;IRAK1;INPP5D;MTHFR;CHEK2;PPARA;TMEM161A;SESN2;ABCG1;CDC34;RAB12;BCAP31;MIF;PLA2G6;SYNGR1;ECM1;WFS1;CD68;SPPL2B;FYN;EEF2K;ARID5B;DNM2;GLB1;PELI1;CHKA;CAT;TSPYL2;IGFBP7;SLC27A1;MAPK3;INSR;ADCY1;HLA-G;PAK1;PPP3CB;CUL7;HYAL1;WDTC1;ITGA3;DNMT3A;PPP2R5B;MAP2K3;BCL2L1;LMNA;TNFRSF25;SIRT2;FAM129B;ITGA4;EDA;ADCY7;SOCS7;PELI3;NGFR;TOLLIP;PDCD6;ATP6V1F;PXN;GRB10;GCH1;NR2F6;HFE;GAS2L1;COL6A1;BTG1;IL17RE;FGFR3;KDM3A;HOMER2;SRSF5;ADCY6
6446,GO:0021769,0.292650818959328,0.966972047471856,1,3,orbitofrontal cortex development,BP,FGFR1
5341,GO:0016079,0.292685265422667,0.833224767542805,7,50,synaptic vesicle exocytosis,BP,SYTL1;SYT8;SNPH;RIMS3;VAMP2;PCLO;PFN2
9479,GO:0036118,0.292697171896042,0.96696071301177,1,3,hyaluranon cable assembly,BP,HYAL1
17382,GO:1900104,0.292697171896042,0.96696071301177,1,3,regulation of hyaluranon cable assembly,BP,HYAL1
17383,GO:1900106,0.292697171896042,0.96696071301177,1,3,positive regulation of hyaluranon cable assembly,BP,HYAL1
12484,GO:0050501,0.292697171896276,0.966960713011773,1,3,hyaluronan synthase activity,MF,HYAL1
11324,GO:0045658,0.292750917953773,0.966947567903362,1,3,regulation of neutrophil differentiation,BP,INPP5D
10201,GO:0042822,0.292832118688,0.966927702188636,1,3,pyridoxal phosphate metabolic process,BP,PDXK
6473,GO:0021819,0.292911387191854,0.916456120679326,2,10,layer formation in cerebral cortex,BP,MBOAT7;SOCS7
1524,GO:0003887,0.292970195744062,0.866943934110435,4,26,DNA-directed DNA polymerase activity,MF,POLD4;POLL;POLM;PRIMPOL
4992,GO:0015129,0.293078731974992,0.966867325629776,1,3,lactate transmembrane transporter activity,MF,SLC16A3
9360,GO:0035879,0.293078731975229,0.966867325629775,1,3,plasma membrane lactate transport,BP,SLC16A3
20177,GO:2000969,0.293100838155496,0.9668619103901,1,3,positive regulation of AMPA receptor activity,BP,SHANK3
5665,GO:0016774,0.293119333870152,0.966857379190859,1,3,phosphotransferase activity, carboxyl group as acceptor,MF,NAGS
7878,GO:0032452,0.293132659057277,0.86721859817924,4,25,histone demethylase activity,MF,KDM6B;KDM4B;ARID5B;KDM3A
9808,GO:0042015,0.29313729331289,0.966852979024499,1,3,interleukin-20 binding,MF,IL20RB
12556,GO:0050714,0.293140478556707,0.788859114329393,18,146,positive regulation of protein secretion,BP,POSTN;F2R;EGFR;GLUL;NLGN2;HK1;ALOX15B;ADAM8;TGFB1;PCK2;PFKFB2;PRKCZ;MIF;PLA2G6;MAPK3;PFKM;PPP3CB;SIRT3
3540,GO:0007566,0.293169596119194,0.852309175002529,5,35,embryo implantation,BP,CST3;SMURF2;FBLN1;BSG;IGFBP7
2611,GO:0005922,0.293189201034336,0.916322378070532,2,10,connexin complex,CC,GJC2;GJB4
14532,GO:0070050,0.293235511091354,0.96682890906832,1,3,neuron cellular homeostasis,BP,FGGY
1901,GO:0004586,0.293326135718548,0.9668066908878,1,3,ornithine decarboxylase activity,MF,AZIN2
8404,GO:0033387,0.293326135718548,0.9668066908878,1,3,putrescine biosynthetic process from ornithine,BP,AZIN2
1182,GO:0002828,0.293344414967638,0.886398734289556,3,18,regulation of type 2 immune response,BP,STAT6;PRKCZ;ECM1
6012,GO:0019064,0.293352784071605,0.966800155933291,1,3,fusion of virus membrane with host plasma membrane,BP,GAS6
9773,GO:0039663,0.293352784071605,0.966800155933291,1,3,membrane fusion involved in viral entry into host cell,BP,GAS6
10991,GO:0044800,0.293352784071605,0.966800155933291,1,3,multi-organism membrane fusion,BP,GAS6
4770,GO:0010957,0.293366114332729,0.966796886681884,1,3,negative regulation of vitamin D biosynthetic process,BP,CYP27B1
11573,GO:0046137,0.293366114332729,0.966796886681884,1,3,negative regulation of vitamin metabolic process,BP,CYP27B1
17045,GO:0099518,0.293399744736909,0.841446331357889,6,42,vesicle cytoskeletal trafficking,BP,FYCO1;AP3D1;PRKCZ;NDE1;BLOC1S4;TRIM46
3543,GO:0007569,0.293444881843725,0.80936215434602,11,86,cell aging,BP,ERCC1;PDCD4;HMGA2;MAP2K1;YPEL3;MNT;PRKCD;CHEK2;MIF;LMNA;TERC
6717,GO:0030134,0.293496171852966,0.819046181467271,9,69,COPII-coated ER to Golgi transport vesicle,CC,PCSK9;CTSZ;TMED4;AREG;MCFD2;TGFA;HLA-G;VANGL2;PDCD6
13719,GO:0060298,0.293511078536626,0.966761322009654,1,3,positive regulation of sarcomere organization,BP,PROX1
4989,GO:0015119,0.29356954115428,0.966746972835307,1,3,hexose phosphate transmembrane transporter activity,MF,SLC37A2
5078,GO:0015315,0.29356954115428,0.966746972835307,1,3,organophosphate:inorganic phosphate antiporter activity,MF,SLC37A2
5125,GO:0015526,0.29356954115428,0.966746972835307,1,3,hexose-phosphate:inorganic phosphate antiporter activity,MF,SLC37A2
14324,GO:0061513,0.29356954115428,0.966746972835307,1,3,glucose 6-phosphate:inorganic phosphate antiporter activity,MF,SLC37A2
3893,GO:0008532,0.293609982899754,0.916119619656814,2,10,N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity,MF,B4GAT1;B3GNT3
14456,GO:0061819,0.293611621360182,0.966736642350393,1,3,telomeric DNA-containing double minutes formation,BP,ERCC1
19364,GO:1905764,0.293611621360182,0.966736642350393,1,3,regulation of protection from non-homologous end joining at telomere,BP,ERCC1
19365,GO:1905765,0.293611621360182,0.966736642350393,1,3,negative regulation of protection from non-homologous end joining at telomere,BP,ERCC1
19587,GO:1990599,0.293611621360182,0.966736642350393,1,3,3' overhang single-stranded DNA endodeoxyribonuclease activity,MF,ERCC1
10199,GO:0042819,0.293649946329086,0.966727232125889,1,3,vitamin B6 biosynthetic process,BP,PDXK
19991,GO:2000553,0.293658688799688,0.966725085301935,1,3,positive regulation of T-helper 2 cell cytokine production,BP,PRKCZ
20059,GO:2000664,0.293658688799806,0.966725085301936,1,3,positive regulation of interleukin-5 secretion,BP,PRKCZ
20062,GO:2000667,0.293658688799806,0.966725085301936,1,3,positive regulation of interleukin-13 secretion,BP,PRKCZ
13258,GO:0051956,0.293670286359776,0.966722237249684,1,3,negative regulation of amino acid transport,BP,STK39
7141,GO:0030997,0.293721645115221,0.96670962319333,1,3,regulation of centriole-centriole cohesion,BP,CEP250
2664,GO:0006015,0.293767196159647,0.966698433211525,1,3,5-phosphoribose 1-diphosphate biosynthetic process,BP,PYGL
11644,GO:0046391,0.293767196159647,0.966698433211525,1,3,5-phosphoribose 1-diphosphate metabolic process,BP,PYGL
7855,GO:0032422,0.293785884369735,0.966693841665938,1,3,purine-rich negative regulatory element binding,MF,ELK3
9774,GO:0039689,0.293846826016,0.966678866214081,1,3,negative stranded viral RNA replication,BP,ATG16L2
6449,GO:0021773,0.293923875778363,0.966659926812495,1,3,striatal medium spiny neuron differentiation,BP,SHANK3
17534,GO:1901017,0.293938042914928,0.915961381949227,2,10,negative regulation of potassium ion transmembrane transporter activity,BP,STK39;ANK3
17654,GO:1901380,0.293938042914928,0.915961381949227,2,10,negative regulation of potassium ion transmembrane transport,BP,STK39;ANK3
8163,GO:0032907,0.293948771482919,0.966653805919395,1,3,transforming growth factor beta3 production,BP,SMAD3
8166,GO:0032910,0.293948771482919,0.966653805919395,1,3,regulation of transforming growth factor beta3 production,BP,SMAD3
7149,GO:0031016,0.293991253285916,0.841019820582801,6,42,pancreas development,BP,ACVR2B;AKT1;MSLN;WFS1;INSR;PROX1
17215,GO:0106071,0.293992606469206,0.966643026991033,1,3,positive regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,NOS1
15501,GO:0071879,0.293992606469206,0.966643026991033,1,3,positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway,BP,NOS1
20321,GO:2001293,0.294030528358689,0.966633700437391,1,3,malonyl-CoA metabolic process,BP,MLYCD
1144,GO:0002739,0.294059644224583,0.915902693064525,2,10,regulation of cytokine secretion involved in immune response,BP,HK1;MAPK3
1017,GO:0002513,0.294067482179465,0.966624610505096,1,3,tolerance induction to self antigen,BP,TGFB1
10320,GO:0043117,0.294067482179467,0.966624610505094,1,3,positive regulation of vascular permeability,BP,TGFB1
8890,GO:0034714,0.294067482179467,0.966624610505094,1,3,type III transforming growth factor beta receptor binding,MF,TGFB1
17400,GO:1900126,0.294067482179707,0.966624610505091,1,3,negative regulation of hyaluronan biosynthetic process,BP,TGFB1
1180,GO:0002826,0.294207963146071,0.966590041664896,1,3,negative regulation of T-helper 1 type immune response,BP,JAK3
803,GO:0002074,0.294214029011451,0.966588548536415,1,3,extraocular skeletal muscle development,BP,MYH15
13822,GO:0060431,0.29424412860025,0.966581138867421,1,3,primary lung bud formation,BP,WNT2B
6631,GO:0023021,0.294251228217407,0.96657939100208,1,3,termination of signal transduction,BP,PRKCD
5918,GO:0018193,0.294255575343357,0.741930087252008,106,944,peptidyl-amino acid modification,BP,EGR1;DLG4;PRNP;VEGFA;HMGA2;PKN1;MTA1;EGFR;NOS1;SPRY2;MST1R;CRTAP;SHC1;RAPGEF3;ST6GALNAC2;MAP2K2;FKBP9;MAP2K1;ERCC6;HBEGF;AKT1;PPM1F;STK39;EPHA1;ASH2L;CNTN1;FGFR4;FGFR1;HMG20B;MAPK13;GAS6;PTK6;CSNK1E;RAB3B;MAPKAPK3;BCR;EHD4;ERRFI1;SNTA1;DGKQ;CEMIP;EPHB2;CTBP1;CD81;TGFB1;SCYL1;MKNK2;ST6GALNAC6;PTPN1;MBD3;IFNE;LRP4;ZDHHC24;MLXIPL;PRKCZ;PRKACA;AREG;ERBB2;ULK1;JAK3;MCFD2;PRKCD;BAX;EREG;RPS6KA5;DDIT4;PADI3;ST3GAL3;MAPK12;TGFA;HDAC7;CHEK2;JADE2;MIF;EEF2KMT;NUDT14;FYN;ZDHHC1;MAPK3;INSR;PAK1;CAMKK2;CAPRIN2;STK32C;SRMS;PPP2R5B;MAP2K3;DLG3;PKD1;SIRT2;ST3GAL2;MAP3K10;TOLLIP;CAMK1;CAMKK1;EZH1;SIRT3;PFN2;FGFR3;ST3GAL5;CBLC;CLK3;KDM3A;PKN3;TTLL3;LRRK1
9272,GO:0035701,0.294299141091288,0.96656759386268,1,3,hematopoietic stem cell migration,BP,GAS6
703,GO:0001927,0.294303867010023,0.966566430111928,1,3,exocyst assembly,BP,EXOC2
14958,GO:0070859,0.294317692407207,0.966563025491637,1,3,positive regulation of bile acid biosynthetic process,BP,NR1D1
18776,GO:1904253,0.294317692407207,0.966563025491637,1,3,positive regulation of bile acid metabolic process,BP,NR1D1
17830,GO:1901978,0.294341337160901,0.915766665327238,2,10,positive regulation of cell cycle checkpoint,BP,NDRG1;PROX1
1596,GO:0004013,0.29442365031225,0.966536925735732,1,3,adenosylhomocysteinase activity,MF,AHCY
5686,GO:0016802,0.29442365031225,0.966536925735732,1,3,trialkylsulfonium hydrolase activity,MF,AHCY
2013,GO:0004740,0.294433500896146,0.966534498715734,1,3,pyruvate dehydrogenase (acetyl-transferring) kinase activity,MF,PDK1
2633,GO:0005967,0.294433500896146,0.966534498715734,1,3,mitochondrial pyruvate dehydrogenase complex,CC,PDK1
7613,GO:0032010,0.294475317397769,0.966524194679914,1,3,phagolysosome,CC,ADAM8
9468,GO:0036092,0.294514575519501,0.851892552857125,5,33,phosphatidylinositol-3-phosphate biosynthetic process,BP,PIK3R2;FGFR4;FGFR1;SYNJ2;FGFR3
19857,GO:2000312,0.294551463814209,0.966505426618866,1,3,regulation of kainate selective glutamate receptor activity,BP,KLHL24
9569,GO:0036374,0.294563552789055,0.966502446442987,1,3,glutathione hydrolase activity,MF,GGT1
17178,GO:0102953,0.294563552789055,0.966502446442987,1,3,hypoglycin A gamma-glutamyl transpeptidase activity,MF,GGT1
17187,GO:0103068,0.294563552789055,0.966502446442987,1,3,leukotriene C4 gamma-glutamyl transferase activity,MF,GGT1
17775,GO:1901748,0.294563552789055,0.966502446442987,1,3,leukotriene D4 metabolic process,BP,GGT1
17776,GO:1901750,0.294563552789055,0.966502446442987,1,3,leukotriene D4 biosynthetic process,BP,GGT1
8571,GO:0034059,0.29457071661122,0.966500680343386,1,3,response to anoxia,BP,EEF2K
9877,GO:0042157,0.294631048452522,0.792102438503104,16,131,lipoprotein metabolic process,BP,APOE;LRP1;PIGQ;LY6K;LDLR;PIGV;PCSK9;ABHD17C;ZDHHC24;ZDHHC8;MSLN;PPARA;ZDHHC1;MDGA1;WIPI2;PRSS21
18397,GO:1903400,0.294637362799371,0.966484247424955,1,3,L-arginine transmembrane transport,BP,SLC25A29
18478,GO:1903566,0.294642179939119,0.966483059482462,1,3,positive regulation of protein localization to cilium,BP,CROCC
6828,GO:0030297,0.294670181680597,0.966476153557255,1,3,transmembrane receptor protein tyrosine kinase activator activity,MF,DGKQ
3099,GO:0006680,0.294719609008352,0.96646396151916,1,3,glucosylceramide catabolic process,BP,PRKCD
10507,GO:0043418,0.294720304323496,0.966463789990095,1,3,homocysteine catabolic process,BP,CBS
5770,GO:0016971,0.294721684609722,0.966463449482311,1,3,flavin-linked sulfhydryl oxidase activity,MF,QSOX1
4297,GO:0009744,0.294747172427518,0.966457161436452,1,3,response to sucrose,BP,ERCC1
8677,GO:0034285,0.294747172427518,0.966457161436452,1,3,response to disaccharide,BP,ERCC1
6687,GO:0030070,0.294771035754294,0.966451273540217,1,3,insulin processing,BP,ERO1B
11873,GO:0046898,0.294819444286969,0.966439327648223,1,3,response to cycloheximide,BP,BCL2L1
11856,GO:0046870,0.294826157039696,0.966437670929405,1,3,cadmium ion binding,MF,NOS1
16527,GO:0097252,0.294835285498037,0.966435417933569,1,3,oligodendrocyte apoptotic process,BP,GAS6
9699,GO:0038108,0.294835331967805,0.966435406464133,1,3,negative regulation of appetite by leptin-mediated signaling pathway,BP,BBS2
16215,GO:0090259,0.294853948114514,0.966430811535709,1,3,regulation of retinal ganglion cell axon guidance,BP,VEGFA
16622,GO:0097475,0.294853948114752,0.966430811535709,1,3,motor neuron migration,BP,VEGFA
9057,GO:0035290,0.294853948114752,0.966430811535709,1,3,trunk segmentation,BP,SEMA3F
9615,GO:0036484,0.294853948114752,0.966430811535709,1,3,trunk neural crest cell migration,BP,SEMA3F
9616,GO:0036486,0.294853948114752,0.966430811535709,1,3,ventral trunk neural crest cell migration,BP,SEMA3F
17579,GO:1901166,0.294853948114752,0.966430811535709,1,3,neural crest cell migration involved in autonomic nervous system development,BP,SEMA3F
4795,GO:0010989,0.294859117105921,0.966429535634889,1,3,negative regulation of low-density lipoprotein particle clearance,BP,PCSK9
12807,GO:0051121,0.294860359231419,0.966429229027416,1,3,hepoxilin metabolic process,BP,ALOX15B
12808,GO:0051122,0.294860359231419,0.966429229027416,1,3,hepoxilin biosynthetic process,BP,ALOX15B
11962,GO:0047223,0.294860685023456,0.966429148608392,1,3,beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity,MF,B3GNT3
4964,GO:0015057,0.294869078336764,0.966427076749341,1,3,thrombin-activated receptor activity,MF,F2R
11725,GO:0046548,0.294874920693459,0.966425634540557,1,3,retinal rod cell development,BP,NAGLU
17425,GO:1900165,0.294877024951907,0.966425115087237,1,3,negative regulation of interleukin-6 secretion,BP,GAS6
8313,GO:0033159,0.294880839545783,0.966424173411656,1,3,negative regulation of protein import into nucleus, translocation,BP,GAS6
14242,GO:0061302,0.294898119463424,0.966419907475338,1,3,smooth muscle cell-matrix adhesion,BP,PLAU
11026,GO:0045006,0.294906919314641,0.914347990851995,2,11,DNA deamination,BP,APOBEC3C;APOBEC3F
15378,GO:0071630,0.294923656319133,0.966413602547634,1,3,nuclear protein quality control by the ubiquitin-proteasome system,BP,ANKZF1
16637,GO:0097500,0.294931330491348,0.966411707695816,1,3,receptor localization to non-motile cilium,BP,TUB
4626,GO:0010749,0.294932874650145,0.966411326415594,1,3,regulation of nitric oxide mediated signal transduction,BP,EGFR
10230,GO:0042940,0.294947005459475,0.966407837150394,1,3,D-amino acid transport,BP,NTSR1
2405,GO:0005577,0.294947972269707,0.96640759841201,1,3,fibrinogen complex,CC,FBLN1
18630,GO:1903903,0.294972978291425,0.966401423228089,1,3,regulation of establishment of T cell polarity,BP,GSN
19934,GO:2000416,0.294973715508997,0.966401241163688,1,3,regulation of eosinophil migration,BP,ADAM8
5346,GO:0016094,0.294982443348516,0.96639908567908,1,3,polyprenol biosynthetic process,BP,SRD5A3
8879,GO:0034699,0.294985222195247,0.96639839937987,1,3,response to luteinizing hormone,BP,TGFBR3
18369,GO:1903348,0.29498687563948,0.966397991020384,1,3,positive regulation of bicellular tight junction assembly,BP,NPHP4
10638,GO:0043654,0.294988257985035,0.966397649613336,1,3,recognition of apoptotic cell,BP,PEAR1
141,GO:0000293,0.294989416223902,0.966397363553869,1,3,ferric-chelate reductase activity,MF,CYBRD1
19556,GO:1990454,0.294991992771494,0.966396727198166,1,3,L-type voltage-gated calcium channel complex,CC,CACNB3
14049,GO:0060838,0.294993697510769,0.966396306157783,1,3,lymphatic endothelial cell fate commitment,BP,PROX1
17061,GO:0099541,0.294994148136106,0.966396194860879,1,3,trans-synaptic signaling by lipid,BP,F2R
17062,GO:0099542,0.294994148136106,0.966396194860879,1,3,trans-synaptic signaling by endocannabinoid,BP,F2R
14971,GO:0070885,0.294994722692251,0.966396052954671,1,3,negative regulation of calcineurin-NFAT signaling cascade,BP,PRNP
17211,GO:0106057,0.294994722692251,0.966396052954671,1,3,negative regulation of calcineurin-mediated signaling,BP,PRNP
9312,GO:0035787,0.29499667769694,0.96639557009728,1,3,cell migration involved in kidney development,BP,VANGL2
6668,GO:0030035,0.294996751723593,0.966395551813677,1,3,microspike assembly,BP,FSCN1
10862,GO:0044393,0.294996751723945,0.966395551813682,1,3,microspike,CC,FSCN1
14696,GO:0070327,0.294996847571927,0.966395528140482,1,3,thyroid hormone transport,BP,SLCO4A1
1981,GO:0004699,0.294996910825255,0.966395512517779,1,3,calcium-independent protein kinase C activity,MF,PRKCD
5086,GO:0015333,0.294996919455122,0.966395510386337,1,3,peptide:proton symporter activity,MF,SLC15A4
310,GO:0000822,0.294996956476595,0.966395501242528,1,3,inositol hexakisphosphate binding,MF,ITPR3
699,GO:0001920,0.294996956982774,0.96639550111742,1,3,negative regulation of receptor recycling,BP,PCSK9
7025,GO:0030805,0.294996956982776,0.966395501117418,1,3,regulation of cyclic nucleotide catabolic process,BP,RAPGEF3
7040,GO:0030820,0.294996956982776,0.966395501117418,1,3,regulation of cAMP catabolic process,BP,RAPGEF3
8284,GO:0033121,0.294996956982776,0.966395501117418,1,3,regulation of purine nucleotide catabolic process,BP,RAPGEF3
10807,GO:0044302,0.294996956982779,0.966395501117415,1,3,dentate gyrus mossy fiber,CC,MICAL1
186,GO:0000404,0.294996956982781,0.966395501117413,1,3,heteroduplex DNA loop binding,MF,XPC
5757,GO:0016917,0.294996956982782,0.966395501117413,1,3,GABA receptor activity,MF,GABBR1
6675,GO:0030046,0.294996956982782,0.966395501117412,1,3,parallel actin filament bundle assembly,BP,ESPN
16056,GO:0089700,0.294996956982782,0.966395501117412,1,3,protein kinase D signaling,BP,VEGFA
7905,GO:0032484,0.294996956982783,0.966395501117411,1,3,Ral protein signal transduction,BP,RGL2
7906,GO:0032485,0.294996956982783,0.966395501117411,1,3,regulation of Ral protein signal transduction,BP,RGL2
8628,GO:0034163,0.294996956982784,0.966395501117411,1,3,regulation of toll-like receptor 9 signaling pathway,BP,PTPRS
6472,GO:0021817,0.294996956982786,0.966395501117409,1,3,nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration,BP,SUN1
16834,GO:0098735,0.294996956982786,0.966395501117408,1,3,positive regulation of the force of heart contraction,BP,NOS1
10960,GO:0044729,0.294996956982893,0.96639550111742,1,3,hemi-methylated DNA-binding,MF,EGR1
15721,GO:0072298,0.294996956982893,0.96639550111742,1,3,regulation of metanephric glomerulus development,BP,EGR1
8564,GO:0034040,0.294996956982896,0.966395501117417,1,3,lipid-transporting ATPase activity,MF,ABCG1
19455,GO:1990075,0.294996956982898,0.966395501117416,1,3,periciliary membrane compartment,CC,KIF17
14427,GO:0061739,0.2949969569829,0.966395501117413,1,3,protein lipidation involved in autophagosome assembly,BP,WIPI2
6323,GO:0020016,0.294996956982904,0.96639550111741,1,3,ciliary pocket,CC,EHD3
6324,GO:0020018,0.294996956982904,0.96639550111741,1,3,ciliary pocket membrane,CC,EHD3
6311,GO:0019960,0.294996956982905,0.966395501117408,1,3,C-X3-C chemokine binding,MF,ITGA4
15603,GO:0072093,0.294996956982905,0.966395501117408,1,3,metanephric renal vesicle formation,BP,KIF26B
16948,GO:0098935,0.294996956982905,0.966395501117408,1,3,dendritic transport,BP,KIF17
16950,GO:0098937,0.294996956982905,0.966395501117408,1,3,anterograde dendritic transport,BP,KIF17
9195,GO:0035583,0.294996956982905,0.966395501117408,1,3,sequestering of TGFbeta in extracellular matrix,BP,LTBP1
15690,GO:0072223,0.294996956983002,0.966395501117431,1,3,metanephric glomerular mesangium development,BP,EGR1
15697,GO:0072239,0.294996956983002,0.966395501117431,1,3,metanephric glomerulus vasculature development,BP,EGR1
17404,GO:1900133,0.294996956983009,0.966395501117423,1,3,regulation of renin secretion into blood stream,BP,F2R
18720,GO:1904116,0.294996956983011,0.966395501117421,1,3,response to vasopressin,BP,ADCY6
18721,GO:1904117,0.294996956983011,0.966395501117421,1,3,cellular response to vasopressin,BP,ADCY6
5065,GO:0015280,0.294996956983012,0.96639550111742,1,3,ligand-gated sodium channel activity,MF,ASIC1
18024,GO:1902498,0.294996956983012,0.966395501117419,1,3,regulation of protein autoubiquitination,BP,MTA1
18211,GO:1902988,0.294996956983012,0.966395501117419,1,3,neurofibrillary tangle assembly,BP,SORL1
9003,GO:0035166,0.294996956983013,0.96639550111742,1,3,post-embryonic hemopoiesis,BP,ERCC1
6734,GO:0030158,0.294996956983013,0.966395501117419,1,3,protein xylosyltransferase activity,MF,XYLT2
16977,GO:0099010,0.294996956983014,0.966395501117418,1,3,modification of postsynaptic structure,BP,ARHGAP44
17522,GO:1900747,0.294996956983014,0.966395501117418,1,3,negative regulation of vascular endothelial growth factor signaling pathway,BP,XDH
18952,GO:1904694,0.294996956983014,0.966395501117418,1,3,negative regulation of vascular smooth muscle contraction,BP,DOCK4
13624,GO:0060134,0.294996956983015,0.966395501117417,1,3,prepulse inhibition,BP,DVL1
587,GO:0001743,0.294996956983016,0.966395501117416,1,3,optic placode formation,BP,PROX1
7104,GO:0030910,0.294996956983016,0.966395501117416,1,3,olfactory placode formation,BP,PROX1
15422,GO:0071698,0.294996956983016,0.966395501117416,1,3,olfactory placode development,BP,PROX1
15423,GO:0071699,0.294996956983016,0.966395501117416,1,3,olfactory placode morphogenesis,BP,PROX1
19660,GO:1990851,0.294996956983019,0.966395501117412,1,3,Wnt-Frizzled-LRP5/6 complex,CC,LRP5
4902,GO:0014832,0.294996956983019,0.966395501117413,1,3,urinary bladder smooth muscle contraction,BP,PLA2G6
4911,GO:0014848,0.294996956983019,0.966395501117413,1,3,urinary tract smooth muscle contraction,BP,PLA2G6
1336,GO:0003192,0.29499695698302,0.966395501117411,1,3,mitral valve formation,BP,ZFPM1
2281,GO:0005234,0.294996956983021,0.966395501117411,1,3,extracellularly glutamate-gated ion channel activity,MF,GRIN3B
15738,GO:0072320,0.294996956983021,0.96639550111741,1,3,volume-sensitive chloride channel activity,MF,TTYH3
20232,GO:2001137,0.294996956983022,0.96639550111741,1,3,positive regulation of endocytic recycling,BP,SORL1
17373,GO:1900086,0.294996956983023,0.966395501117409,1,3,positive regulation of peptidyl-tyrosine autophosphorylation,BP,VEGFA
893,GO:0002265,0.294996956983023,0.966395501117409,1,3,astrocyte activation involved in immune response,BP,LRP1
1852,GO:0004515,0.294996956983023,0.966395501117408,1,3,nicotinate-nucleotide adenylyltransferase activity,MF,NMNAT2
12046,GO:0048003,0.294996956983023,0.966395501117408,1,3,antigen processing and presentation of lipid antigen via MHC class Ib,BP,AP3D1
12048,GO:0048007,0.294996956983023,0.966395501117408,1,3,antigen processing and presentation, exogenous lipid antigen via MHC class Ib,BP,AP3D1
6382,GO:0021578,0.294996956983023,0.966395501117408,1,3,hindbrain maturation,BP,RERE
6400,GO:0021626,0.294996956983023,0.966395501117408,1,3,central nervous system maturation,BP,RERE
7908,GO:0032487,0.294996956983024,0.966395501117409,1,3,regulation of Rap protein signal transduction,BP,TIMP2
71,GO:0000147,0.294996956983024,0.966395501117408,1,3,actin cortical patch assembly,BP,WIPF1
2425,GO:0005606,0.294996956983024,0.966395501117408,1,3,laminin-1 complex,CC,LAMB1
9305,GO:0035766,0.294996956983024,0.966395501117408,1,3,cell chemotaxis to fibroblast growth factor,BP,FGFR1
9307,GO:0035768,0.294996956983024,0.966395501117408,1,3,endothelial cell chemotaxis to fibroblast growth factor,BP,FGFR1
10864,GO:0044396,0.294996956983024,0.966395501117408,1,3,actin cortical patch organization,BP,WIPF1
11269,GO:0045586,0.294996956983024,0.966395501117408,1,3,regulation of gamma-delta T cell differentiation,BP,SOX13
12822,GO:0051138,0.294996956983024,0.966395501117408,1,3,positive regulation of NK T cell differentiation,BP,AP3D1
13115,GO:0051666,0.294996956983024,0.966395501117408,1,3,actin cortical patch localization,BP,WIPF1
16221,GO:0090269,0.294996956983024,0.966395501117408,1,3,fibroblast growth factor production,BP,FGFR1
16222,GO:0090270,0.294996956983024,0.966395501117408,1,3,regulation of fibroblast growth factor production,BP,FGFR1
17659,GO:1901387,0.294996956983024,0.966395501117408,1,3,positive regulation of voltage-gated calcium channel activity,BP,EHD3
19030,GO:1904847,0.294996956983024,0.966395501117408,1,3,regulation of cell chemotaxis to fibroblast growth factor,BP,FGFR1
19987,GO:2000544,0.294996956983024,0.966395501117408,1,3,regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,FGFR1
20141,GO:2000809,0.294996956983024,0.966395501117408,1,3,positive regulation of synaptic vesicle clustering,BP,NLGN2
3195,GO:0006828,0.294996956983024,0.966395501117408,1,3,manganese ion transport,BP,TRPC1
4841,GO:0014049,0.294996956983024,0.966395501117408,1,3,positive regulation of glutamate secretion,BP,NTSR1
18735,GO:1904177,0.294996956983024,0.966395501117408,1,3,regulation of adipose tissue development,BP,SH3PXD2B
18736,GO:1904179,0.294996956983024,0.966395501117408,1,3,positive regulation of adipose tissue development,BP,SH3PXD2B
4606,GO:0010724,0.294996956983129,0.966395501117422,1,3,regulation of definitive erythrocyte differentiation,BP,ZFPM1
2314,GO:0005315,0.29499695698314,0.966395501117411,1,3,inorganic phosphate transmembrane transporter activity,MF,SLC20A1
10838,GO:0044341,0.29499695698314,0.966395501117411,1,3,sodium-dependent phosphate transport,BP,SLC20A1
9589,GO:0036446,0.294996956983142,0.966395501117409,1,3,myofibroblast differentiation,BP,PDCD4
18987,GO:1904760,0.294996956983142,0.966395501117409,1,3,regulation of myofibroblast differentiation,BP,PDCD4
1523,GO:0003886,0.294996956983143,0.966395501117408,1,3,DNA (cytosine-5-)-methyltransferase activity,MF,DNMT3A
4778,GO:0010966,0.294996956983143,0.966395501117408,1,3,regulation of phosphate transport,BP,FGFR1
6401,GO:0021631,0.294996956983143,0.966395501117408,1,3,optic nerve morphogenesis,BP,EPHB2
6495,GO:0021869,0.294996956983143,0.966395501117408,1,3,forebrain ventricular zone progenitor cell division,BP,FGFR1
8085,GO:0032776,0.294996956983143,0.966395501117408,1,3,DNA methylation on cytosine,BP,DNMT3A
10805,GO:0044300,0.294996956983143,0.966395501117408,1,3,cerebellar mossy fiber,CC,DLG4
11896,GO:0046935,0.294996956983143,0.966395501117408,1,3,1-phosphatidylinositol-3-kinase regulator activity,MF,PIK3R2
13022,GO:0051481,0.294996956983143,0.966395501117408,1,3,negative regulation of cytosolic calcium ion concentration,BP,SMAD3
14455,GO:0061817,0.294996956983143,0.966395501117408,1,3,endoplasmic reticulum-plasma membrane tethering,BP,ESYT2
16123,GO:0090116,0.294996956983143,0.966395501117408,1,3,C-5 methylation of cytosine,BP,DNMT3A
19943,GO:2000427,0.294996956983143,0.966395501117408,1,3,positive regulation of apoptotic cell clearance,BP,ABCA7
19915,GO:2000389,0.294996956983248,0.966395501117422,1,3,regulation of neutrophil extravasation,BP,ADAM8
19916,GO:2000391,0.294996956983248,0.966395501117422,1,3,positive regulation of neutrophil extravasation,BP,ADAM8
1968,GO:0004677,0.29499695698325,0.96639550111742,1,3,DNA-dependent protein kinase activity,MF,HMGA2
13777,GO:0060374,0.294996956983252,0.966395501117417,1,3,mast cell differentiation,BP,ZFPM1
1986,GO:0004706,0.29499695698326,0.96639550111741,1,3,JUN kinase kinase kinase activity,MF,MAP3K10
6785,GO:0030229,0.294996956983261,0.966395501117409,1,3,very-low-density lipoprotein particle receptor activity,MF,LDLR
10597,GO:0043578,0.294996956983261,0.966395501117409,1,3,nuclear matrix organization,BP,SUN1
16240,GO:0090292,0.294996956983261,0.966395501117409,1,3,nuclear matrix anchoring at nuclear membrane,BP,SUN1
1741,GO:0004340,0.294996956983261,0.966395501117409,1,3,glucokinase activity,MF,HK1
1782,GO:0004396,0.294996956983261,0.966395501117409,1,3,hexokinase activity,MF,HK1
3988,GO:0008865,0.294996956983261,0.966395501117409,1,3,fructokinase activity,MF,HK1
6043,GO:0019158,0.294996956983261,0.966395501117409,1,3,mannokinase activity,MF,HK1
2428,GO:0005610,0.294996956983262,0.966395501117408,1,3,laminin-5 complex,CC,LAMA5
2599,GO:0005899,0.294996956983262,0.966395501117408,1,3,insulin receptor complex,CC,INSR
7444,GO:0031587,0.294996956983262,0.966395501117408,1,3,positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,BP,PKD2
7763,GO:0032290,0.294996956983262,0.966395501117408,1,3,peripheral nervous system myelin formation,BP,AHNAK2
14110,GO:0060979,0.294996956983262,0.966395501117408,1,3,vasculogenesis involved in coronary vascular morphogenesis,BP,TGFBR3
15415,GO:0071688,0.294996956983262,0.966395501117408,1,3,striated muscle myosin thick filament assembly,BP,OBSL1
15642,GO:0072156,0.294996956983262,0.966395501117408,1,3,distal tubule morphogenesis,BP,PKD1
2275,GO:0005220,0.294996956983262,0.966395501117408,1,3,inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,MF,ITPR3
18536,GO:1903708,0.295080845284873,0.797342369955157,14,111,positive regulation of hemopoiesis,BP,CTNNBIP1;FAM210B;ZFP36L1;FOS;RAG1;GAS6;AP3D1;ADAM8;TGFB1;PRKCZ;ADA;INPP5D;HLA-G;ITPKB
19079,GO:1904948,0.29511816020953,0.915391012133949,2,10,midbrain dopaminergic neuron differentiation,BP,CSNK1E;WNT3
13892,GO:0060547,0.295183003722027,0.915359620149072,2,10,negative regulation of necrotic cell death,BP,RBCK1;BOK
12299,GO:0048660,0.29538822243899,0.807875470351334,11,85,regulation of smooth muscle cell proliferation,BP,MEF2D;APLN;PDCD4;CTNNBIP1;EGFR;HBEGF;AKT1;EREG;IRAK1;PAK1;NDRG2
5207,GO:0015807,0.295568731199279,0.839880658264747,6,42,L-amino acid transport,BP,SLC7A8;SERINC2;SLC43A1;NTSR1;SLC25A29;PRAF2
19405,GO:1905898,0.295684265542238,0.850816768231137,5,34,positive regulation of response to endoplasmic reticulum stress,BP,EDEM1;PTPN1;BOK;BAX;BCAP31
2181,GO:0005031,0.296265603160063,0.884675233948501,3,18,tumor necrosis factor-activated receptor activity,MF,TNFRSF6B;TNFRSF25;NGFR
2183,GO:0005035,0.296265603160063,0.884675233948501,3,18,death receptor activity,MF,TNFRSF6B;TNFRSF25;NGFR
13224,GO:0051898,0.296306297887836,0.850385286972713,5,34,negative regulation of protein kinase B signaling,BP,XDH;AKT1;LEMD2;PPP2R5B;PDCD6
939,GO:0002347,0.296381150412109,0.914778598060337,2,10,response to tumor cell,BP,CEACAM1;ADAM15
13466,GO:0055012,0.29638405720943,0.914777186202386,2,10,ventricular cardiac muscle cell differentiation,BP,PROX1;LMNA
14678,GO:0070300,0.296552112806612,0.884505632195882,3,18,phosphatidic acid binding,MF,PITPNC1;PLTP;PITPNM1
8617,GO:0034143,0.296617580984776,0.914663725938063,2,10,regulation of toll-like receptor 4 signaling pathway,BP,NR1D1;PELI1
5857,GO:0017156,0.296701966620949,0.816746455494464,9,67,calcium ion regulated exocytosis,BP,SYTL1;SYT8;SNPH;RIMS3;VAMP2;PPP3CB;PCLO;ZP3;PFN2
13105,GO:0051650,0.296859209022797,0.776808627196253,23,190,establishment of vesicle localization,BP,BBS2;SYTL1;SYT8;TRAPPC9;FYCO1;CTSZ;AP3D1;SNPH;RIMS3;PRKCZ;AREG;VAMP2;MCFD2;DNM1;TGFA;DNM2;ITGA4;NDE1;PDCD6;PCLO;PFN2;BLOC1S4;TRIM46
999,GO:0002467,0.296900748743311,0.914526051110773,2,10,germinal center formation,BP,PKN1;ADA
4810,GO:0014003,0.297177044376111,0.864202364243712,4,26,oligodendrocyte development,BP,GSN;TGFB1;WASF3;CD9
12986,GO:0051412,0.297177720065098,0.914391288794698,2,10,response to corticosterone,BP,FOS;CCND1
15280,GO:0071470,0.297297199752743,0.864123764453437,4,26,cellular response to osmotic stress,BP,ZFP36L1;STK39;ERRFI1;PKD2
463,GO:0001502,0.297413530769502,0.914276475380496,2,10,cartilage condensation,BP,WNT7A;PKD1
16838,GO:0098743,0.297413530769502,0.914276475380496,2,10,cell aggregation,BP,WNT7A;PKD1
12724,GO:0050996,0.297429896061234,0.914268504650387,2,10,positive regulation of lipid catabolic process,BP,PRKCD;PPARA
14880,GO:0070672,0.297459565104944,0.91425405343377,2,10,response to interleukin-15,BP,SHC1;JAK3
10983,GO:0044788,0.297500363378554,0.883943592524965,3,18,modulation by host of viral process,BP,APOE;PC;STOM
20044,GO:2000647,0.297520920717128,0.914224164696204,2,10,negative regulation of stem cell proliferation,BP,FBLN1;TGFB1
2929,GO:0006450,0.297671017210649,0.883277221160673,3,19,regulation of translational fidelity,BP,DTD1;IARS2;AARS
10409,GO:0043254,0.297693797988505,0.759929813356828,39,335,regulation of protein complex assembly,BP,ERCC1;CTNNBIP1;VEGFA;APOE;DDB2;VPS11;ARL2;MMP1;SNX9;TMOD2;CORO1B;IMPACT;RAC2;SORL1;TWF2;GSN;PLEKHG2;WIPF1;ARPIN;SPTB;CDC42EP5;TGFB1;FHOD3;EML2;PRKCZ;CAPG;ULK1;FSCN1;PRKCD;STUB1;BAX;WASH3P;RAC3;PAK1;VPS16;PPP2R5B;SIRT2;BBS10;PFN2
7826,GO:0032386,0.297889155053678,0.761188414856342,37,317,regulation of intracellular transport,BP,EDEM1;PRNP;VPS11;RAPGEF3;MAP2K2;MAP2K1;STOM;ADORA2B;RAC2;SORL1;B3GAT3;ANK3;GAS6;PCSK9;CEMIP;ABCA2;TGFB1;TMEM173;RIMS3;PTPN1;CEP131;MICALL2;ERBB2;VAMP2;BNIP3L;PRKCD;REEP6;ZDHHC8;GDI1;REEP2;BCAP31;NBPF3;FYN;MAPK3;PAK1;CAMK1;PFN2
3915,GO:0008585,0.297912966148846,0.815700169926138,9,68,female gonad development,BP,VEGFA;CEBPB;VGF;BAX;EREG;ARID5B;INSR;BCL2L1;ZP3
6348,GO:0021533,0.298012259387787,0.913984638859668,2,10,cell differentiation in hindbrain,BP,WNT7A;PROX1
7087,GO:0030889,0.298090144814736,0.913946641355088,2,10,negative regulation of B cell proliferation,BP,PKN1;INPP5D
806,GO:0002080,0.298293123413175,0.913847578550429,2,10,acrosomal membrane,CC,BSG;SUN1
3570,GO:0007618,0.298477230463642,0.883363443213105,3,18,mating,BP,SERPINE2;HEXB;ADA
14108,GO:0060977,0.298511248377785,0.913741064281111,2,10,coronary vasculature morphogenesis,BP,VEGFA;TGFBR3
3084,GO:0006661,0.298733905679942,0.791437440853508,15,119,phosphatidylinositol biosynthetic process,BP,PIK3R2;PIGQ;PITPNM1;FGFR4;FGFR1;PIGV;SYNJ2;PI4K2A;SBF1;INPP5D;PI4K2B;PITPNM3;SLC27A1;ZP3;FGFR3
10179,GO:0042776,0.298843176807114,0.961494147936129,1,4,mitochondrial ATP synthesis coupled proton transport,BP,CYC1
11791,GO:0046683,0.298857792254522,0.805087082534808,11,85,response to organophosphorus,BP,SDC1;RAPGEF3;ZFP36L1;SSH1;FOS;BSG;DGKQ;PKD2;VGF;AREG;EEF2K
13926,GO:0060601,0.29893753214812,0.913532724878974,2,10,lateral sprouting from an epithelium,BP,VANGL2;CELSR1
2385,GO:0005522,0.299218585505197,0.913395236040556,2,10,profilin binding,MF,WIPF1;PCLO
15333,GO:0071560,0.299372810676586,0.779589991229681,20,164,cellular response to transforming growth factor beta stimulus,BP,HTRA1;POSTN;WNT7A;LTBP4;LTBP2;LTBP1;ZFP36L1;SMURF2;FOS;SMAD3;ITGB5;CDKN1C;TGFB1;PRKCZ;STUB1;TGFBR3;FYN;DNM2;ITGA3;PXN
19313,GO:1905564,0.299456589745122,0.913278726595031,2,10,positive regulation of vascular endothelial cell proliferation,BP,APLN;FGFR1
5003,GO:0015149,0.299508879004988,0.913253119789458,2,10,hexose transmembrane transporter activity,MF,SLC2A9;SLC2A3
2526,GO:0005784,0.299759696347753,0.961238635234678,1,4,Sec61 translocon complex,CC,BCAP31
15142,GO:0071256,0.299759696347753,0.961238635234678,1,4,translocon complex,CC,BCAP31
2951,GO:0006486,0.300011332894515,0.772586978658219,24,200,protein glycosylation,BP,LMF1;ST6GALNAC2;SRD5A3;VEGFB;B4GAT1;B3GAT3;MVD;ADAMTS13;ADAMTS7;B3GNT3;MGAT4B;ST6GALNAC6;B4GALT2;B4GALT6;RFNG;MPI;MCFD2;MFNG;ST3GAL3;COG7;NUDT14;ALG12;ST3GAL2;ST3GAL5
10503,GO:0043413,0.300011332894515,0.772586978658219,24,200,macromolecule glycosylation,BP,LMF1;ST6GALNAC2;SRD5A3;VEGFB;B4GAT1;B3GAT3;MVD;ADAMTS13;ADAMTS7;B3GNT3;MGAT4B;ST6GALNAC6;B4GALT2;B4GALT6;RFNG;MPI;MCFD2;MFNG;ST3GAL3;COG7;NUDT14;ALG12;ST3GAL2;ST3GAL5
8193,GO:0032946,0.300036697013067,0.813844967026507,9,70,positive regulation of mononuclear cell proliferation,BP,CARD11;IGFBP2;CD81;CD320;ADA;JAK3;MIF;PELI1;ZP3
10703,GO:0044003,0.300126870466633,0.847726080924009,5,34,modification by symbiont of host morphology or physiology,BP,TNIP1;SMAD3;TGFB1;INSR;BCL2L1
7143,GO:0031005,0.300995912559998,0.912523417692536,2,10,filamin binding,MF,CEACAM1;MICALL2
13005,GO:0051447,0.301177985574243,0.912433876070383,2,10,negative regulation of meiotic cell cycle,BP,PRKACB;NPR2
5159,GO:0015698,0.301246863694118,0.803161499831828,11,85,inorganic anion transport,BP,PRNP;SLC12A7;TTYH3;LRRC8A;FGFR1;ANO8;SLC20A1;CLCA2;SLC12A4;SLC37A2;SLC26A11
2319,GO:0005328,0.301616626905354,0.912217980610906,2,10,neurotransmitter:sodium symporter activity,MF,SLC6A8;SLC6A6
3901,GO:0008543,0.301829343391598,0.802618696518609,11,86,fibroblast growth factor receptor signaling pathway,BP,DUSP6;APLN;SPRY2;SPRY4;FGFR4;FGFR1;FGFBP1;GPC1;FAM20C;MAPK3;FGFR3
4854,GO:0014068,0.301858717425924,0.846515573170286,5,34,positive regulation of phosphatidylinositol 3-kinase signaling,BP,F2R;FGFR1;RGL2;FYN;CAT
4980,GO:0015103,0.301991907456977,0.807227271371588,10,76,inorganic anion transmembrane transporter activity,MF,SLC12A7;TTYH3;LRRC8A;ANO8;SLC20A1;CLCA2;SLC22A17;SLC12A4;SLC37A2;SLC26A11
18658,GO:1903960,0.3020443185667,0.912007234658525,2,10,negative regulation of anion transmembrane transport,BP,AKT1;STK39
3784,GO:0008349,0.302107491873951,0.911976085805771,2,10,MAP kinase kinase kinase kinase activity,MF,MINK1;STK25
13533,GO:0060004,0.302196772849557,0.911932055236577,2,10,reflex,BP,SLITRK6;SATB1
2166,GO:0005001,0.30235385448627,0.911854562457048,2,10,transmembrane receptor protein tyrosine phosphatase activity,MF,PTPRE;PTPRU
6049,GO:0019198,0.30235385448627,0.911854562457048,2,10,transmembrane receptor protein phosphatase activity,MF,PTPRE;PTPRU
9499,GO:0036151,0.302390883087546,0.881027485365543,3,18,phosphatidylcholine acyl-chain remodeling,BP,LPCAT4;LPCAT1;PLA2G6
3457,GO:0007274,0.302480097115134,0.911792260265211,2,10,neuromuscular synaptic transmission,BP,ETV5;ADARB1
13725,GO:0060307,0.302489578290289,0.911787580362731,2,10,regulation of ventricular cardiac muscle cell membrane repolarization,BP,SCN4B;SNTA1
7579,GO:0031953,0.302640810935323,0.911712916278568,2,10,negative regulation of protein autophosphorylation,BP,IMPACT;ERRFI1
330,GO:0000921,0.302648736539151,0.911709002563385,2,10,septin ring assembly,BP,SEPT10;SEPT6
7692,GO:0032156,0.302648736539151,0.911709002563385,2,10,septin cytoskeleton,CC,SEPT10;SEPT6
18162,GO:1902894,0.302675096550586,0.911695985231564,2,10,negative regulation of pri-miRNA transcription by RNA polymerase II,BP,NFATC4;PPARA
14520,GO:0070016,0.302696621039102,0.911685355152433,2,10,armadillo repeat domain binding,MF,CTNNBIP1;STRN4
14965,GO:0070875,0.302696621039369,0.911685355152458,2,10,positive regulation of glycogen metabolic process,BP,AKT1;INSR
6359,GO:0021545,0.303334679938229,0.860153226076835,4,26,cranial nerve development,BP,ADARB1;SEMA3F;SLITRK6;EPHB2
13810,GO:0060415,0.303339615531837,0.834232682069592,6,42,muscle tissue morphogenesis,BP,ADARB1;TGFB1;TGFBR3;ZFPM1;VANGL2;PROX1
4764,GO:0010950,0.303646529687033,0.784399124415894,16,134,positive regulation of endopeptidase activity,BP,XDH;F2R;GRAMD4;SMAD3;PPM1F;DAP;GSN;TNFSF15;BOK;CYFIP2;BAX;SOX7;BCAP31;FYN;NGFR;PDCD6
3396,GO:0007179,0.303788094642652,0.784474339085259,16,129,transforming growth factor beta receptor signaling pathway,BP,HTRA1;LTBP4;LTBP2;LTBP1;SMURF2;FOS;SMAD3;ITGB5;CDKN1C;TGFB1;PRKCZ;STUB1;TGFBR3;DNM2;ITGA3;PXN
7309,GO:0031325,0.30385594387739,0.722220771526136,240,2181,positive regulation of cellular metabolic process,BP,TNIP1;DUSP6;XDH;ERCC1;DUSP5;MEF2D;CITED4;EGR1;NR1D1;EDEM1;DLG4;CST3;APLN;ACVR2B;PRNP;VEGFA;WNT7A;APOE;F2R;LRP5;ITGA6;HMGA2;ELK3;PKN1;MTA1;GRAMD4;EGFR;WWTR1;NOS1;SPRY2;MST1R;NFATC4;TRIM65;ETV5;SHC1;VPS11;HEXB;GTPBP1;ETV4;SNX9;RAPGEF3;ZFP36L1;ARAP1;MAP2K2;LPAR3;SMARCA1;MAP2K1;POU2F2;ENDOG;FOS;FBLN1;SMAD3;STAT6;PIK3R2;ERCC6;LRP1;DVL1;EPAS1;HBEGF;SHC2;SALL2;ZXDC;RNF187;ADORA2B;AKT1;TPCN1;HDAC5;F12;PPM1F;STK39;EPHA1;ASH2L;IMPACT;CNTN1;DAP;PTHLH;FGFR4;LDLR;FGFR1;PRKACB;SEC14L2;HLTF;KLF7;NAT14;CIRBP;IGFBP4;CCND1;STRADB;GAS6;PTK6;CSNK1E;CARD11;DUSP7;GSN;MAPKAPK3;PCSK9;RAD23A;EHD4;SH3D19;CDC25B;DGKQ;BNIP3;PAK6;FYCO1;CEMIP;PKD2;CRTC1;GPSM1;MAGEF1;EPHB2;ADAM8;CTBP1;CDKN1C;PLCG1;ZMIZ2;CD81;CEBPB;TIMP2;TGFB1;RFX2;DEAF1;NTSR1;NAB2;TMEM173;TNFSF15;NSMF;PEG3;MC1R;ABHD14B;SNX33;PTPN1;AGRN;IFNE;LRP4;VHL;PFKFB2;MLXIPL;TRIB2;PRKCZ;KDM6B;PRKACA;MINK1;ZNF516;AREG;PIM2;BOK;ERBB2;ULK1;TFDP2;C6ORF89;BNIP3L;CYFIP2;PBX2;PRKCD;STUB1;BAX;ITGA1;EREG;RPS6KA5;SOX12;MBTPS2;CARF;IER2;LRSAM1;SYMPK;MAPK12;IRAK1;TGFA;FHOD1;CHEK2;ZFPM1;PPARA;TMEM161A;SESN2;SOX7;ABCA7;RAB12;SIX5;BCAP31;MIF;PLA2G6;DDT;SSBP4;WFS1;FYN;STK25;DNM2;PELI1;SLC27A1;MAPK3;INSR;CAMTA2;TAZ;PFKM;ADCY1;RERE;ETAA1;VANGL2;PAK1;CAMKK2;PPP3CB;RNF144A;USP21;PFKFB3;MLYCD;SEMA4C;CAPRIN2;PPP2R5B;MAP2K3;DLG3;PROX1;PKD1;KCTD13;TNFRSF25;SIRT2;FAM129B;BACH1;ADCY7;E2F5;MAPRE3;MAP3K10;NGFR;TOLLIP;PDCD6;MAFF;CAMK1;CAMKK1;EZH1;HFE;ZP3;PFN2;FGFR3;SPTLC2;TCEA2;PLAG1;IRF2BPL;KDM3A;SRSF5;ADCY6;LRRK1
11052,GO:0045058,0.304345702398925,0.859484283686678,4,26,T cell selection,BP,STAT6;CARD11;ZFPM1;ITPKB
2247,GO:0005160,0.30446422148228,0.859405789646854,4,26,transforming growth factor beta receptor binding,MF,SMURF2;SMAD3;TGFB1;TGFBR3
2375,GO:0005506,0.304555623034532,0.800413992280001,11,86,iron ion binding,MF,XDH;CYP27B1;NOS1;ACP5;ALOX15B;CYGB;ACO2;PHYH;CYP3A5;CYP2R1;KDM3A
4172,GO:0009247,0.306102221760435,0.82272354602874,7,53,glycolipid biosynthetic process,BP,PIGQ;PIGV;ST6GALNAC6;B4GALT6;GAL3ST4;ST3GAL2;ST3GAL5
18457,GO:1903532,0.306640267975916,0.764065545738046,26,219,positive regulation of secretion by cell,BP,APLN;POSTN;F2R;EGFR;SDC1;GLUL;NLGN2;ADORA2B;HK1;FGFR1;ALOX15B;ADAM8;TGFB1;NTSR1;PCK2;PFKFB2;PRKCZ;RASL10B;MIF;PLA2G6;MAPK3;PFKM;PPP3CB;SIRT3;HFE;ZP3
4200,GO:0009310,0.306688747366317,0.908489981861611,2,11,amine catabolic process,BP,SMOX;ALDH7A1
7843,GO:0032410,0.306875131354059,0.831446292018418,6,43,negative regulation of transporter activity,BP,STK39;ANK3;PCSK9;PKD2;EPHB2;GSTO1
14124,GO:0061001,0.307097463524945,0.857657708257911,4,26,regulation of dendritic spine morphogenesis,BP,SHANK3;ARHGAP44;EEF2K;CAPRIN2
4717,GO:0010881,0.30734613565929,0.908157794171308,2,11,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,BP,PRKACA;GSTO1
4058,GO:0009109,0.307659130865293,0.907999434826138,2,11,coenzyme catabolic process,BP,ACOT7;PM20D2
3110,GO:0006691,0.307660931184464,0.90799852358776,2,11,leukotriene metabolic process,BP,GGT1;LTA4H
4091,GO:0009147,0.307827238073159,0.876636776516887,3,20,pyrimidine nucleoside triphosphate metabolic process,BP,NME4;UCKL1;AK3
10175,GO:0042772,0.308671053481314,0.87664852597259,3,19,DNA damage response, signal transduction resulting in transcription,BP,ZNF385A;RPS6KA6;CHEK2
12829,GO:0051148,0.308852810470601,0.856488049488924,4,26,negative regulation of muscle cell differentiation,BP,PDCD4;HDAC5;EREG;PAK1
11754,GO:0046622,0.308901712105741,0.856455414316243,4,26,positive regulation of organ growth,BP,AKT1;FGFR1;TGFBR3;PROX1
7295,GO:0031301,0.308988385879618,0.777518793733252,17,140,integral component of organelle membrane,CC,PTPRS;B4GAT1;ABCD1;PEX10;BNIP3;RFNG;OXA1L;SLC22A17;SV2A;TIMM17B;LEMD2;MFNG;PPOX;COQ2;QSOX1;SUN1;SAMD8
7407,GO:0031501,0.309093804695724,0.958580149961386,1,4,mannosyltransferase complex,CC,PIGV
5071,GO:0015295,0.309525982340608,0.876720575347562,3,18,solute:proton symporter activity,MF,SLC2A9;SLC15A4;MFSD3
8875,GO:0034694,0.310010281090733,0.876425986664121,3,18,response to prostaglandin,BP,AKT1;TGFBR3;ADCY6
6289,GO:0019902,0.310097576600387,0.774431900084791,18,145,phosphatase binding,MF,DLG4;EGFR;PPP1R35;SLC9A3R2;SMAD3;STAT6;PIK3R2;AKT1;CEACAM1;PTPN1;ERBB2;JAK3;ITGA1;PPARA;MAPK3;PPP3CB;DLG3;STRN4
1700,GO:0004177,0.310369009313222,0.840520961856356,5,34,aminopeptidase activity,MF,NPEPL1;RNPEPL1;LTA4H;DPP7;RNPEP
7783,GO:0032330,0.310477785193117,0.85540214837468,4,26,regulation of chondrocyte differentiation,BP,SMAD3;PTHLH;ADAMTS7;CHADL
15914,GO:0072698,0.310525484506171,0.828956337074592,6,42,protein localization to microtubule cytoskeleton,BP,NUDCD3;DVL1;CEP250;ABHD17C;CEP131;CEP72
12742,GO:0051019,0.310735785632723,0.85522946228922,4,26,mitogen-activated protein kinase binding,MF,TNIP1;MICALCL;MAPKAPK3;GCH1
6290,GO:0019903,0.310750265134684,0.787628980940127,13,102,protein phosphatase binding,MF,DLG4;EGFR;STAT6;PIK3R2;AKT1;CEACAM1;PTPN1;ERBB2;JAK3;ITGA1;PPP3CB;DLG3;STRN4
6564,GO:0022029,0.310851358748983,0.840178901569583,5,34,telencephalon cell migration,BP,EGFR;MBOAT7;SUN1;LAMB1;SOCS7
4791,GO:0010984,0.311005637528797,0.90629826988029,2,11,regulation of lipoprotein particle clearance,BP,LDLR;PCSK9
5156,GO:0015695,0.311156693935566,0.854947575941368,4,26,organic cation transport,BP,SLC7A8;SLC25A29;SLC22A18;AZIN2
627,GO:0001817,0.311192135921301,0.742772165428167,47,412,regulation of cytokine production,BP,EGR1;PDCD4;PRNP;POSTN;F2R;PTPRS;NFATC4;ACP5;SMAD3;STAT6;ADORA2B;HK1;FGFR1;MAPKBP1;CEACAM1;MAPK13;GAS6;CARD11;ERRFI1;ALOX15B;IL20RB;ADAM8;CEBPB;RNF135;TGFB1;TMEM173;MC1R;TRIB2;PRKCZ;JAK3;EREG;RPS6KA5;ASB1;IRAK1;HDAC7;INPP5D;ZFPM1;MIF;DDT;PELI1;MAPK3;HLA-G;MAP2K3;LURAP1;HFE;ZP3;NDRG2
8049,GO:0032720,0.311491738192513,0.854348786648301,4,27,negative regulation of tumor necrosis factor production,BP,ACP5;GAS6;ERRFI1;MC1R
11867,GO:0046885,0.311539907249094,0.875493664382094,3,18,regulation of hormone biosynthetic process,BP,EGR1;CYP27B1;DGKQ
12373,GO:0048791,0.312002199211684,0.875211329905263,3,18,calcium ion-regulated exocytosis of neurotransmitter,BP,SYTL1;SYT8;RIMS3
16190,GO:0090218,0.312855942717817,0.87468923818683,3,18,positive regulation of lipid kinase activity,BP,CD81;TGFB1;FGFR3
2042,GO:0004784,0.313069811778195,0.957416338452013,1,4,superoxide dismutase activity,MF,CCS
5636,GO:0016721,0.313069811778195,0.957416338452013,1,4,oxidoreductase activity, acting on superoxide radicals as acceptor,MF,CCS
5540,GO:0016529,0.313810318070071,0.837809102497284,5,35,sarcoplasmic reticulum,CC,XDH;ITPR3;NOS1;ANK3;RTN2
8761,GO:0034447,0.313828955017749,0.957191980456962,1,4,very-low-density lipoprotein particle clearance,BP,APOE
4839,GO:0014047,0.314158590592363,0.873890909237795,3,18,glutamate secretion,BP,NTSR1;VAMP2;APBA1
8035,GO:0032691,0.314176218696434,0.904673009208754,2,11,negative regulation of interleukin-1 beta production,BP,ACP5;ERRFI1
4396,GO:0010107,0.314642710564129,0.873593686841655,3,18,potassium ion import,BP,SLC12A7;KCNJ15;SLC12A4
12542,GO:0050700,0.314700660924328,0.904402906474743,2,11,CARD domain binding,MF,CARD19;CARD11
9403,GO:0035966,0.315154752834192,0.764058605436776,21,175,response to topologically incorrect protein,BP,EDEM1;TMEM129;SHC1;DNAJB5;F12;CCND1;ANKZF1;UBXN4;PTPN1;TPP1;DNAJC4;BOK;STUB1;BAX;MBTPS2;PDIA5;WFS1;TSPYL2;CUL7;PPP2R5B;LMNA
13102,GO:0051647,0.315331319551037,0.873170425757282,3,18,nucleus localization,BP,FHOD1;SUN1;BIN1
13226,GO:0051900,0.315642564480076,0.903916893073205,2,11,regulation of mitochondrial depolarization,BP,BOK;IFI6
6141,GO:0019418,0.316085576363874,0.956520968052501,1,4,sulfide oxidation,BP,TSTD1
14635,GO:0070221,0.316085576363874,0.956520968052501,1,4,sulfide oxidation, using sulfide:quinone oxidoreductase,BP,TSTD1
2245,GO:0005158,0.316327466488856,0.872557106433312,3,18,insulin receptor binding,MF,SHC1;PTPN1;GRB10
15156,GO:0071280,0.316470461163929,0.902445599931326,2,12,cellular response to copper ion,BP,PRNP;MT2A
15316,GO:0071539,0.316562807553751,0.851309195175375,4,26,protein localization to centrosome,BP,NUDCD3;CEP250;CEP131;CEP72
9432,GO:0036010,0.316570174360286,0.872407489273252,3,18,protein localization to endosome,BP,SORL1;ABHD17C;TOLLIP
8105,GO:0032799,0.316587213185978,0.871786617793457,3,19,low-density lipoprotein receptor particle metabolic process,BP,APOE;AP2A2;PCSK9
6849,GO:0030325,0.316776804031446,0.903330090320447,2,11,adrenal gland development,BP,ARID5B;INSR
4432,GO:0010273,0.316796852745711,0.953685130958069,1,5,detoxification of copper ion,BP,MT2A
19479,GO:1990169,0.316796852745711,0.953685130958069,1,5,stress response to copper ion,BP,MT2A
4021,GO:0009055,0.316884166764067,0.794344856249527,10,88,electron transfer activity,MF,XDH;AKR7A2;ALDH4A1;TXNRD3;SDHA;PHGDH;CYC1;ETFB;TSTA3;GLRX
12218,GO:0048486,0.317053386392246,0.903186743215236,2,11,parasympathetic nervous system development,BP,ADARB1;SEMA3F
18519,GO:1903670,0.317128282732389,0.823859615423431,6,43,regulation of sprouting angiogenesis,BP,VEGFA;HDAC5;CEACAM1;EPN2;HDAC7;NGFR
13901,GO:0060563,0.317343387221603,0.835281951806114,5,35,neuroepithelial cell differentiation,BP,FGFR1;SLITRK6;CEBPB;FAM20C;TMEM231
1926,GO:0004620,0.318493974579769,0.805827111497311,8,60,phospholipase activity,MF,PLD3;PLCD3;TMEM8A;PLCH2;EDNRA;PLCG1;PLA2G6;PLCB3
13170,GO:0051785,0.318747074683214,0.822458157277987,6,44,positive regulation of nuclear division,BP,LRP5;TGFB1;EREG;TGFA;INSR;SIRT2
11334,GO:0045668,0.318797456964879,0.849411453802203,4,27,negative regulation of osteoblast differentiation,BP,LRP5;SMAD3;AREG;HDAC7
2793,GO:0006241,0.318832098417422,0.901207897137751,2,12,CTP biosynthetic process,BP,NME4;UCKL1
11511,GO:0046036,0.318832098417422,0.901207897137751,2,12,CTP metabolic process,BP,NME4;UCKL1
19784,GO:2000177,0.31905511098317,0.822422248069951,6,43,regulation of neural precursor cell proliferation,BP,VEGFA;GJC2;CTSZ;TGFB1;PROX1;SIRT2
5439,GO:0016303,0.319084225959408,0.849600923193745,4,26,1-phosphatidylinositol-3-kinase activity,MF,PIK3R2;FGFR4;FGFR1;FGFR3
148,GO:0000303,0.319350040793337,0.869521630976292,3,20,response to superoxide,BP,ERCC6;CCS;GCH1
8018,GO:0032660,0.319529690929921,0.901898843575941,2,11,regulation of interleukin-17 production,BP,PRNP;TGFB1
10343,GO:0043154,0.319532090970187,0.798305679582158,9,71,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,VEGFA;TNFRSF6B;PRDX5;AKT1;RAG1;GAS6;IFI6;MICAL1;NGFR
10153,GO:0042742,0.319711377602575,0.787383692545184,11,96,defense response to bacterium,BP,SHC1;ACP5;MAPKBP1;CEBPB;VGF;IFNE;PRKCD;PLA2G6;SIRT2;RNASE7;GSDMA
16276,GO:0090344,0.320053729070843,0.869633416831902,3,19,negative regulation of cell aging,BP,HMGA2;MIF;TERC
2376,GO:0005507,0.320430128763105,0.832340915947642,5,38,copper ion binding,MF,PRNP;LOXL1;CCS;GPC1;ATP7B
2605,GO:0005911,0.320751692926305,0.74135062595124,36,306,cell-cell junction,CC,ITGA6;NDRG1;SCN4B;OBSL1;MAP2K2;GJC2;AKT1;PTPRU;FGFR4;NPHP4;CEACAM1;ANK3;CCND1;COL13A1;PKD2;CADM4;PLCG1;PRKCZ;MICALL2;PLEKHG5;SDCCAG8;FSCN1;PRKCD;SV2A;SH3BP1;GJB4;PPL;SYMPK;FHOD1;PDZD2;VANGL2;PAK1;DLG3;SIRT2;CDH4;KLHL24
9891,GO:0042180,0.321049395800657,0.762559078118018,19,163,cellular ketone metabolic process,BP,EGR1;NR1D1;TYSND1;AKR7A2;KDSR;AKT1;FGFR4;CEACAM1;CBR4;DGKQ;HAGH;MLXIPL;PDK1;LONP2;PPARA;COQ2;MLYCD;WDTC1;PROX1
2694,GO:0006063,0.321612647129362,0.900809272137808,2,11,uronic acid metabolic process,BP,CRYL1;ABHD10
6182,GO:0019585,0.321612647129362,0.900809272137808,2,11,glucuronate metabolic process,BP,CRYL1;ABHD10
11634,GO:0046364,0.321918655684823,0.803009256431291,8,61,monosaccharide biosynthetic process,BP,NR1D1;PGM1;PC;DGKQ;MDH2;PCK2;ALDOC;PPARA
8971,GO:0035066,0.322137505334713,0.847134050428271,4,27,positive regulation of histone acetylation,BP,NOS1;TGFB1;RPS6KA5;MAPK3
15267,GO:0071453,0.322354532395539,0.759443403802713,20,172,cellular response to oxygen levels,BP,EGR1;VEGFA;NDRG1;ZFP36L1;ENDOG;EPAS1;AKT1;BNIP3;ADAM8;VHL;BNIP3L;PDK1;STUB1;IRAK1;EEF2K;DNMT3A;LMNA;SIRT2;BACH1;TERC
18957,GO:1904706,0.322798852139219,0.90018622694349,2,11,negative regulation of vascular smooth muscle cell proliferation,BP,APLN;PDCD4
11531,GO:0046070,0.323146251503628,0.954381694391871,1,4,dGTP metabolic process,BP,DGUOK
12298,GO:0048659,0.323436786901681,0.784909454538278,11,87,smooth muscle cell proliferation,BP,MEF2D;APLN;PDCD4;CTNNBIP1;EGFR;HBEGF;AKT1;EREG;IRAK1;PAK1;NDRG2
1203,GO:0002862,0.324056061398818,0.954101625677124,1,4,negative regulation of inflammatory response to antigenic stimulus,BP,IL20RB
14807,GO:0070542,0.32406588057537,0.809123938256013,7,52,response to fatty acid,BP,NFATC4;AKT1;LDLR;HMGCL;TGFBR3;CAT;ADCY6
594,GO:0001759,0.324070438363628,0.899516275240925,2,11,organ induction,BP,WNT2B;FGFR1
4549,GO:0010632,0.324120208822155,0.760068417541037,19,157,regulation of epithelial cell migration,BP,VEGFA;WNT7A;APOE;HBEGF;AKT1;HDAC5;PPM1F;FGFR1;CEACAM1;PLCG1;TGFB1;SH3BP1;HDAC7;HYAL1;ITGA3;MAP2K3;PROX1;PDCD6;PFN2
3478,GO:0007342,0.324215025898022,0.95405258744448,1,4,fusion of sperm to egg plasma membrane involved in single fertilization,BP,CD9
20194,GO:2001021,0.324235425100841,0.801059814007224,8,62,negative regulation of response to DNA damage stimulus,BP,ERCC1;HMGA2;ZNF385A;MAGEF1;CHEK2;TMEM161A;MIF;BCL2L1
10206,GO:0042827,0.324291196054661,0.899399748839798,2,11,platelet dense granule,CC,ECM1;LGALS3BP
771,GO:0002027,0.324335807964807,0.81826669713874,6,44,regulation of heart rate,BP,SCN4B;EPAS1;SNTA1;PRKACA;ADA;GCH1
3290,GO:0006986,0.324472934954572,0.759729402585242,19,158,response to unfolded protein,BP,EDEM1;TMEM129;SHC1;DNAJB5;CCND1;UBXN4;PTPN1;TPP1;DNAJC4;BOK;STUB1;BAX;MBTPS2;PDIA5;WFS1;TSPYL2;CUL7;PPP2R5B;LMNA
4507,GO:0010559,0.324532275057252,0.84549340584605,4,27,regulation of glycoprotein biosynthetic process,BP,HBEGF;NECAB3;JAK3;ABCA7
7069,GO:0030864,0.324537212842219,0.801066311611771,8,60,cortical actin cytoskeleton,CC,CAPN2;RAPGEF3;MYZAP;GSN;WIPF1;SPTB;LLGL1;HFE
13256,GO:0051954,0.324694237742191,0.899186838344638,2,11,positive regulation of amine transport,BP,RAB3B;NTSR1
14766,GO:0070470,0.324894590872479,0.953842602850347,1,4,plasma membrane respiratory chain,CC,SDHA
6727,GO:0030149,0.325510191459709,0.866214343538971,3,19,sphingolipid catabolic process,BP,HEXB;PRKCD;NAGA
15425,GO:0071702,0.326163922249109,0.702181563621571,210,1942,organic substance transport,BP,NR1D1;SLC16A3;EDEM1;APLN;ACVR2B;PRNP;BBS2;SLC6A8;POSTN;APOE;F2R;LRP5;OSBPL5;PITPNC1;IDH2;SLCO4A1;ITPR3;ARRDC1;EVI5L;NISCH;EGFR;NOS1;TMEM129;SLC2A9;HADH;LTBP4;SYTL1;LMF1;LTBP2;VPS11;TBC1D14;ARL2;SLC7A8;SLC2A3;SNX9;RAPGEF3;ZFP36L1;GLUL;NME4;PLTP;CPT2;POU2F2;EXOC2;SLC16A5;PIK3R2;LRP1;AP2A2;NLGN2;STOM;SLC6A6;AKT1;PITPNM1;RHBDF2;BSG;STK39;HK1;SLC15A4;ATG16L2;RAB31;LDLR;MAPKBP1;SIGMAR1;RAC2;PFKL;TOMM34;SORL1;CEACAM1;B3GAT3;ABCD1;ANK3;STRADB;EDNRA;GAS6;RAB3B;CARD11;PCSK9;BCR;XPOT;AIP;ALOX15B;AGAP1;PEX10;CORO7;UNC119B;MVB12B;SERINC2;CEMIP;AP3D1;ABCA2;ADAM8;KIF17;SLC29A4;TMED4;TGFB1;CLTCL1;SLC43A1;TBC1D9B;SLC38A10;NTSR1;TMEM173;MIPEP;RHOD;SNX17;VGF;SNX33;SLC48A1;LLGL1;BBS1;PTPN1;PEX1;PCK2;CD320;OSBPL10;LRP10;ESYT2;ZDHHC24;CEP131;PFKFB2;PRKCZ;TOM1L2;ADA;MICALL2;NEURL1B;ERBB2;VAMP2;NECAB3;RILPL1;BNIP3L;SLC22A17;ARHGAP44;MCFD2;PRKCD;SV2A;SLC13A5;OLFM2;TIMM17B;RASL10B;ZDHHC8;GDI1;SLC2A11;WASH3P;LRSAM1;REEP2;EHD3;LONP2;SYMPK;PPARA;COG7;SESN2;ABCG1;ABCA7;RAB12;BCAP31;MIF;SLC25A29;DOPEY2;PLA2G6;SYNGR1;SLC22A18;NBPF3;FYN;PITPNM3;TMCO6;DNM2;SNX15;CHKA;SLC27A1;SLC50A1;ZDHHC1;MAPK3;INSR;SLC13A3;RTN2;PFKM;RERE;STX10;ATP8B2;PRAF2;PAK1;PPP3CB;SLC37A2;VPS16;SLC16A13;SGSM2;TBC1D16;PKD1;RABGAP1;AZIN2;RAB28;ICA1;RAB40B;NGFR;PDCD6;ATP6V1F;PCLO;GRB10;TBC1D8;PLEKHM1;KIF13B;CAMK1;SIRT3;HFE;VPS51;SLC35F3;MFSD10;TST;SLC23A2;APBA1;SRSF5;SLC26A11
5961,GO:0018345,0.3263069902531,0.844273367498033,4,27,protein palmitoylation,BP,ABHD17C;ZDHHC24;ZDHHC8;ZDHHC1
1278,GO:0003071,0.326807038048826,0.89806722170907,2,11,renal system process involved in regulation of systemic arterial blood pressure,BP,F2R;GAS6
8038,GO:0032695,0.326831515968042,0.898054215783554,2,11,negative regulation of interleukin-12 production,BP,ACP5;JAK3
13023,GO:0051482,0.327090012454436,0.897916819718851,2,11,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,BP,F2R;LPAR3
14136,GO:0061025,0.327134416282161,0.753531621894445,21,176,membrane fusion,BP,EVI5L;VAT1;SYTL1;VPS11;TBC1D14;SYT8;DYSF;GAS6;BNIP3;TBC1D9B;CD9;VAMP2;BAX;DNM1;DNM2;STX10;VPS16;SGSM2;TBC1D16;RABGAP1;TBC1D8
15434,GO:0071715,0.32729342436861,0.86508903626359,3,19,icosanoid transport,BP,NTSR1;MIF;PLA2G6
17702,GO:1901571,0.32729342436861,0.86508903626359,3,19,fatty acid derivative transport,BP,NTSR1;MIF;PLA2G6
18371,GO:1903350,0.32741060536545,0.897746295403959,2,11,response to dopamine,BP,DNM2;MAPK3
18372,GO:1903351,0.32741060536545,0.897746295403959,2,11,cellular response to dopamine,BP,DNM2;MAPK3
16540,GO:0097286,0.327495805132014,0.897700954533084,2,11,iron ion import,BP,SLC25A37;HFE
7438,GO:0031579,0.327627437305791,0.864877823885448,3,19,membrane raft organization,BP,MARVELD1;GSN;MALL
9448,GO:0036042,0.327665389616423,0.952980566789962,1,4,long-chain fatty acyl-CoA binding,MF,ACOT7
6352,GO:0021537,0.328096826878171,0.75656672774682,19,158,telencephalon development,BP,BBS2;EGFR;PTPRS;LRP1;MBOAT7;TRAPPC9;BNIP3;EPHB2;SHANK3;KDM6B;BAX;SUN1;PROX1;LAMB1;SOCS7;NDE1;TCTN1;EZH1;TACC1
122,GO:0000253,0.328127357800245,0.952835923587502,1,4,3-keto sterol reductase activity,MF,HSD17B7
2701,GO:0006071,0.328196596150629,0.897327649309918,2,11,glycerol metabolic process,BP,PCK2;COQ2
2742,GO:0006144,0.328296599177437,0.864454268857451,3,19,purine nucleobase metabolic process,BP,XDH;APRT;ADA
16184,GO:0090207,0.328401971493832,0.864387521942991,3,19,regulation of triglyceride metabolic process,BP,APOE;LMF1;LDLR
543,GO:0001662,0.328458041106351,0.864351999719129,3,19,behavioral fear response,BP,APOE;RAG1;DEAF1
869,GO:0002209,0.328458041106351,0.864351999719129,3,19,behavioral defense response,BP,APOE;RAG1;DEAF1
10089,GO:0042596,0.328458041106351,0.864351999719129,3,19,fear response,BP,APOE;RAG1;DEAF1
12111,GO:0048185,0.328523624803696,0.897153221622059,2,11,activin binding,MF,ACVR2B;TGFBR3
4584,GO:0010676,0.328610266633827,0.827134988214695,5,35,positive regulation of cellular carbohydrate metabolic process,BP,AKT1;NTSR1;PFKFB2;PPARA;INSR
11723,GO:0046545,0.328689542347635,0.791038658994202,9,70,development of primary female sexual characteristics,BP,VEGFA;CEBPB;VGF;BAX;EREG;ARID5B;INSR;BCL2L1;ZP3
16870,GO:0098801,0.328794522348602,0.897008625452207,2,11,regulation of renal system process,BP,F2R;GAS6
13943,GO:0060644,0.328976603011909,0.896911382206051,2,11,mammary gland epithelial cell differentiation,BP,AKT1;CEBPB
15287,GO:0071478,0.329001057805756,0.760272962860808,17,141,cellular response to radiation,BP,ERCC1;EGR1;XPC;HMGA2;NFATC4;DDB2;IMPACT;MAPK13;TGFB1;MC1R;NET1;BAX;CHEK2;TMEM161A;DNM2;HYAL1;BCL2L1
18035,GO:1902527,0.329249803658009,0.952483387153468,1,4,positive regulation of protein monoubiquitination,BP,PDCD6
7325,GO:0031342,0.32981971443445,0.896460532015188,2,11,negative regulation of cell killing,BP,CEACAM1;PPP3CB
16162,GO:0090184,0.329861132926624,0.841819327196014,4,27,positive regulation of kidney development,BP,EGR1;VEGFA;WNT2B;TGFB1
8203,GO:0032964,0.32987381693494,0.841810543610652,4,27,collagen biosynthetic process,BP,F2R;ERRFI1;TGFB1;CYGB
15118,GO:0071214,0.329953692832835,0.742024727382086,27,230,cellular response to abiotic stimulus,BP,ERCC1;EGR1;XPC;HMGA2;EGFR;NFATC4;DDB2;ZFP36L1;AKT1;STK39;IMPACT;MAPK13;ERRFI1;BNIP3;PKD2;ASIC1;TGFB1;NSMF;MC1R;NET1;BAX;CHEK2;TMEM161A;DNM2;MAPK3;HYAL1;BCL2L1
17189,GO:0104004,0.329953692832835,0.742024727382086,27,230,cellular response to environmental stimulus,BP,ERCC1;EGR1;XPC;HMGA2;EGFR;NFATC4;DDB2;ZFP36L1;AKT1;STK39;IMPACT;MAPK13;ERRFI1;BNIP3;PKD2;ASIC1;TGFB1;NSMF;MC1R;NET1;BAX;CHEK2;TMEM161A;DNM2;MAPK3;HYAL1;BCL2L1
12846,GO:0051173,0.330313453737572,0.6972077483826,230,2097,positive regulation of nitrogen compound metabolic process,BP,TNIP1;DUSP6;XDH;ERCC1;DUSP5;MEF2D;CITED4;EGR1;NR1D1;EDEM1;DLG4;CST3;APLN;ACVR2B;PRNP;VEGFA;WNT7A;APOE;F2R;LRP5;ITGA6;HMGA2;ELK3;PKN1;MTA1;GRAMD4;EGFR;WWTR1;NOS1;SPRY2;MST1R;NFATC4;ETV5;SHC1;VPS11;HEXB;GTPBP1;ETV4;SNX9;RAPGEF3;ZFP36L1;MAP2K2;LPAR3;SMARCA1;MAP2K1;POU2F2;ENDOG;SMURF2;FOS;FBLN1;SMAD3;STAT6;PIK3R2;ERCC6;LRP1;DVL1;EPAS1;HBEGF;SHC2;SALL2;ZXDC;RNF187;ADORA2B;AKT1;HDAC5;F12;PPM1F;STK39;EPHA1;ASH2L;IMPACT;CNTN1;DAP;PTHLH;FGFR4;LDLR;FGFR1;PRKACB;SEC14L2;HLTF;KLF7;SORL1;NAT14;CIRBP;IGFBP4;CCND1;STRADB;GAS6;PTK6;CSNK1E;CARD11;DUSP7;GSN;MAPKAPK3;PCSK9;RAD23A;EHD4;SH3D19;CDC25B;DGKQ;PAK6;CEMIP;PKD2;CRTC1;MAGEF1;EPHB2;ADAM8;CTBP1;CDKN1C;PLCG1;ZMIZ2;CD81;CEBPB;TIMP2;TGFB1;RFX2;DEAF1;NAB2;TMEM173;TNFSF15;NSMF;PEG3;MC1R;ABHD14B;SNX33;PTPN1;AGRN;IFNE;LRP4;VHL;PFKFB2;MLXIPL;TRIB2;PRKCZ;KDM6B;PRKACA;MINK1;ZNF516;AREG;PIM2;BOK;ERBB2;TFDP2;C6ORF89;CYFIP2;PBX2;PRKCD;STUB1;BAX;ITGA1;EREG;RPS6KA5;SOX12;MBTPS2;CARF;IER2;LPCAT1;SYMPK;MAPK12;IRAK1;TGFA;FHOD1;CHEK2;ZFPM1;PPARA;TMEM161A;SESN2;SOX7;ABCA7;SIX5;BCAP31;MIF;PLA2G6;DDT;SSBP4;WFS1;FYN;STK25;DNM2;PELI1;SLC27A1;MAPK3;INSR;CAMTA2;TAZ;PFKM;ADCY1;RERE;ETAA1;VANGL2;PAK1;CAMKK2;PPP3CB;RNF144A;USP21;PFKFB3;SEMA4C;CAPRIN2;PPP2R5B;MAP2K3;DLG3;PROX1;PKD1;KCTD13;TNFRSF25;SIRT2;FAM129B;BACH1;ADCY7;E2F5;MAPRE3;MAP3K10;NGFR;TOLLIP;PDCD6;MAFF;CAMK1;CAMKK1;EZH1;HFE;ZP3;PFN2;FGFR3;TCEA2;PLAG1;IRF2BPL;KDM3A;SRSF5;ADCY6;LRRK1
5518,GO:0016482,0.330647206644775,0.761459945670227,16,131,cytosolic transport,BP,VPS11;TBC1D14;MAP2K2;MAP2K1;ZFYVE21;SORL1;CORO7;CLTCL1;WASH3P;EHD3;MYO1D;DOPEY2;MAPK3;STX10;SGSM2;VPS51
2297,GO:0005267,0.331132533889108,0.825292840643489,5,35,potassium channel activity,MF,KCNG1;KCNJ15;KCNC4;KCNAB2;PKD2
12338,GO:0048711,0.33126275753667,0.895686685275497,2,11,positive regulation of astrocyte differentiation,BP,SERPINE2;BIN1
12296,GO:0048645,0.331362738694081,0.82486000764583,5,36,animal organ formation,BP,MAP2K1;WNT2B;FGFR1;LEMD2;MAPK3
10947,GO:0044666,0.331659154844742,0.895473629756708,2,11,MLL3/4 complex,CC,ASH2L;KDM6B
9896,GO:0042220,0.331761504667222,0.840501301957134,4,27,response to cocaine,BP,HDAC5;DNM2;DNMT3A;HOMER2
11512,GO:0046037,0.331844783474908,0.862199211910253,3,19,GMP metabolic process,BP,DLG4;CARD11;DLG3
3547,GO:0007585,0.331935093416417,0.824440446969684,5,36,respiratory gaseous exchange,BP,APLN;GAA;NLGN2;EDNRA;NTSR1
10324,GO:0043123,0.33200771977268,0.757627686971747,17,142,positive regulation of I-kappaB kinase/NF-kappaB signaling,BP,F2R;RBCK1;S100A4;AKT1;CARD11;SLC20A1;SHARPIN;TMED4;PIM2;PLEKHG5;MIB2;IRAK1;ECM1;FYN;PELI1;TMEM101;LURAP1
3399,GO:0007183,0.332045626671844,0.8952657083049,2,11,SMAD protein complex assembly,BP,SMAD3;TGFB1
3026,GO:0006576,0.332082813318552,0.839907356775549,4,28,cellular biogenic amine metabolic process,BP,SMOX;CHKA;ALDH7A1;AZIN2
15999,GO:0086012,0.332104565429567,0.895233981897215,2,11,membrane depolarization during cardiac muscle cell action potential,BP,SCN4B;ANK3
1056,GO:0002583,0.333095279754236,0.951263788283219,1,4,regulation of antigen processing and presentation of peptide antigen,BP,HFE
4561,GO:0010644,0.333235517121202,0.861311109332657,3,19,cell communication by electrical coupling,BP,GJC2;ANK3;PRKACA
15430,GO:0071709,0.333649967425436,0.861045987597072,3,19,membrane assembly,BP,NLGN2;ANK3;LRP4
334,GO:0000930,0.333700708300958,0.861013514412901,3,19,gamma-tubulin complex,CC,TUBG2;MZT2A;MZT2B
7053,GO:0030838,0.333750125842579,0.786836912032997,9,71,positive regulation of actin filament polymerization,BP,CORO1B;RAC2;GSN;WIPF1;ARPIN;CDC42EP5;WASH3P;RAC3;PFN2
14960,GO:0070861,0.333923476321432,0.860870909718132,3,19,regulation of protein exit from endoplasmic reticulum,BP,EDEM1;SORL1;BCAP31
5684,GO:0016799,0.333935931286663,0.860281623502309,3,20,hydrolase activity, hydrolyzing N-glycosyl compounds,MF,DNPH1;MPG;NEIL1
8333,GO:0033189,0.3341506518378,0.894129725905608,2,11,response to vitamin A,BP,CAT;DNMT3A
13507,GO:0055089,0.334310819712171,0.89404304993318,2,11,fatty acid homeostasis,BP,APOE;MLXIPL
14033,GO:0060788,0.334328234826264,0.894033623566558,2,11,ectodermal placode formation,BP,PROX1;EDA
15421,GO:0071697,0.334328234826264,0.894033623566558,2,11,ectodermal placode morphogenesis,BP,PROX1;EDA
8147,GO:0032881,0.334577225100674,0.83854090597771,4,27,regulation of polysaccharide metabolic process,BP,PHLDA2;AKT1;TGFB1;INSR
6538,GO:0021955,0.334692140669397,0.860378381691641,3,19,central nervous system neuron axonogenesis,BP,ADARB1;EPHB2;TCTN1
4227,GO:0009407,0.33482612825594,0.950708852026231,1,4,toxin catabolic process,BP,GSTO1
13067,GO:0051584,0.334916384854734,0.950679811939552,1,4,regulation of dopamine uptake involved in synaptic transmission,BP,RAB3B
13249,GO:0051940,0.334916384854734,0.950679811939552,1,4,regulation of catecholamine uptake involved in synaptic transmission,BP,RAB3B
18473,GO:1903556,0.335002254888904,0.837869905501297,4,28,negative regulation of tumor necrosis factor superfamily cytokine production,BP,ACP5;GAS6;ERRFI1;MC1R
3157,GO:0006768,0.335057643723534,0.893638450683061,2,11,biotin metabolic process,BP,PC;HLCS
1204,GO:0002863,0.335102238052291,0.950619981593414,1,4,positive regulation of inflammatory response to antigenic stimulus,BP,ZP3
6409,GO:0021675,0.335275214162178,0.809973035783661,6,44,nerve development,BP,SERPINE2;ADARB1;SEMA3F;SLITRK6;EPHB2;AHNAK2
4868,GO:0014722,0.335410498061575,0.950520650631201,1,4,regulation of skeletal muscle contraction by calcium ion signaling,BP,GSTO1
5304,GO:0016010,0.335501247027133,0.893397773154944,2,11,dystrophin-associated glycoprotein complex,CC,SNTA1;SNTB2
16361,GO:0090665,0.335501247027133,0.893397773154944,2,11,glycoprotein complex,CC,SNTA1;SNTB2
1496,GO:0003839,0.335655720223046,0.950441547646328,1,4,gamma-glutamylcyclotransferase activity,MF,GGACT
10882,GO:0044430,0.335768862019318,0.699134836290831,132,1189,cytoskeletal part,CC,BBS2;ESPN;NDRG1;NEK9;MTA1;OBSL1;SPRY2;CAPN2;MST1R;ARL2;CLIP2;NUDCD3;RAPGEF3;MAP2K2;MAP2K1;MARK4;KLC2;SHANK2;DVL1;FAM110C;SH3PXD2B;REEP4;AKT1;TMOD2;CORO1B;PITPNM1;DYSF;BRSK1;IFT140;MYZAP;PRKACB;MAPKBP1;RAC2;KCNAB2;NPHP4;LZTS2;RAB11FIP4;EVC;TNNT1;TWF2;CEP250;MPLKIP;GSN;RAD23A;SEPT10;WIPF1;CCDC113;CDC25B;SPTB;PROCR;PKD2;ABCA2;SH3PXD2A;ADAM8;KIF17;NUDCD2;SNPH;CLTCL1;SCYL1;SNTB2;FHOD3;EML2;KIF26B;ENKD1;CROCC;DNAH1;LLGL1;KIF7;SAC3D1;TUBG2;BBS1;MYH16;CEP131;PRKCZ;PRKACA;ACTR1B;MICALL2;CAPG;SDCCAG8;ADGRB2;NINL;MZT2A;RILPL1;FSCN1;USP20;CCDC92;NUBP2;MZT2B;TPM2;DNM1;WASH3P;RGS14;REEP2;WDR60;FHOD1;MYO1D;MYH15;EML3;PLA2G6;NARF;SPPL2B;FYN;RAC3;DNM2;NEIL1;KIF26A;TUBB6;CEP72;VANGL2;PAK1;CUL7;MICAL1;CAPRIN2;BCL2L1;LMNA;RABGAP1;SIRT2;AFAP1L1;MAPRE3;RAB28;RAP1GAP2;NDE1;PXN;MSS51;LURAP1;KIF13B;HFE;TACC1;SEPT6;CCDC88C;CDC42BPG;TTLL3
9385,GO:0035927,0.335855225676282,0.950377136365528,1,4,RNA import into mitochondrion,BP,TST
15180,GO:0071322,0.335959849308705,0.774298885735407,11,90,cellular response to carbohydrate stimulus,BP,NR1D1;LRP5;ZFP36L1;ENDOG;MAPK13;GAS6;PCK2;MLXIPL;PRKACA;PLA2G6;PPP3CB
11055,GO:0045061,0.335993430035779,0.893130432321713,2,11,thymic T cell selection,BP,CARD11;ITPKB
5542,GO:0016531,0.336052273133077,0.947354615993964,1,5,copper chaperone activity,MF,CCS
9039,GO:0035259,0.336188179044693,0.893024560795607,2,11,glucocorticoid receptor binding,MF,SMAD3;CEBPB
1110,GO:0002698,0.336337308335909,0.784731662193215,9,71,negative regulation of immune effector process,BP,HTRA1;SERPING1;CEACAM1;BCR;IL20RB;TGFB1;JAK3;PPP3CB;HFE
7426,GO:0031536,0.336374836661491,0.950209143847552,1,4,positive regulation of exit from mitosis,BP,TGFB1
19925,GO:2000404,0.336395447783578,0.858697794781927,3,20,regulation of T cell migration,BP,ADAM8;ECM1;ITGA4
10779,GO:0044248,0.336487095121174,0.693162234523959,194,1802,cellular catabolic process,BP,NT5E;XDH;GID4;H1F0;NR1D1;EDEM1;CST3;CYP27B1;TYSND1;BTBD2;FBXO2;PYGB;PGM1;APOE;PYGL;CRAT;MTA1;ACOT7;ARRDC1;DNPH1;WWTR1;NOS1;TMEM129;HADH;CTSO;CAPN2;TRIM65;VPS11;TBC1D14;HEXB;GTPBP1;ALDH4A1;SNX9;RAPGEF3;ZFP36L1;GAA;GLUL;RNPEPL1;CTBS;RBCK1;RNF44;CRYL1;CPT2;ENDOG;SMURF2;PIK3R2;LRP1;SRD5A3;DVL1;AP2A2;ITGB4;PRDX5;PRODH;FBXW5;RNF187;AKT1;TPCN1;ENTPD6;HK1;GGT1;ATG16L2;DAP;LDLR;FUCA1;PFKL;PACS2;CIRBP;ABCD1;PCBP4;AIG1;PFKP;CSNK1E;CTSB;PCSK9;RAD23A;DHTKD1;SH3D19;HAGH;BNIP3;SHARPIN;MVB12B;FYCO1;CEMIP;GPX3;CTSZ;GPSM1;MAGEF1;ADAM8;LTA4H;PLCG1;CBS;CD81;ENTPD2;ADAMTS13;TIMP2;TGFB1;ULK2;GPC1;ADAMTS7;PNRC1;GALNS;ABTB1;RNH1;FBXO44;SNX33;ANKZF1;ATG2A;UBXN4;HMGCL;PTPN1;TPP1;PCK2;IDUA;PFKFB2;MLXIPL;TRIB2;PRKACA;ADA;PIM2;BOK;ULK1;AHCY;RNPEP;BNIP3L;ACAD10;PRKCD;USP20;STUB1;BAX;FBXW4;CUL9;DDIT4;ACADS;NAGA;ZDHHC8;GSTO1;ALDOC;LRSAM1;LONP2;CHEK2;DECR2;PPARA;SESN2;CDC34;RNF123;RAB12;BCAP31;SMOX;PHYH;WFS1;QSOX1;UPP1;ETFB;CYP3A5;GLB1;CAT;NEIL1;APOBEC3C;APOBEC3F;CYP2R1;MAPK3;INSR;PAN2;PFKM;GPT2;CAMKK2;RNASET2;RNF144A;CTSF;USP21;PFKFB3;MLYCD;CUL7;HYAL1;VPS16;ABHD10;DNASE1L1;ALDH7A1;PKD1;KCTD13;SIRT2;NT5C1B;RGS19;TOLLIP;PHYKPL;PLEKHM1;HFE;WIPI2;VPS51;TST;CBLC;SPTLC2;PM20D2;DEDD2
7812,GO:0032372,0.336980063694025,0.950013045238854,1,4,negative regulation of sterol transport,BP,PCSK9
7815,GO:0032375,0.336980063694025,0.950013045238854,1,4,negative regulation of cholesterol transport,BP,PCSK9
3116,GO:0006699,0.337037523377615,0.858871067673201,3,19,bile acid biosynthetic process,BP,NR1D1;FGFR4;PROX1
16359,GO:0090661,0.337142309738592,0.946981911574357,1,5,box H/ACA telomerase RNP complex,CC,TERC
5673,GO:0016783,0.337355403378346,0.891243635913599,2,12,sulfurtransferase activity,MF,TSTD1;TST
7440,GO:0031581,0.337385334588831,0.892372641315065,2,11,hemidesmosome assembly,BP,ITGA6;ITGB4
16427,GO:0097067,0.337594782300831,0.89225838892895,2,11,cellular response to thyroid hormone stimulus,BP,CTSB;GAS2L1
13604,GO:0060087,0.337727265305679,0.949770312524562,1,4,relaxation of vascular smooth muscle,BP,ADORA2B
1186,GO:0002832,0.337907277212529,0.820042022285236,5,36,negative regulation of response to biotic stimulus,BP,HTRA1;MAPKBP1;CEACAM1;FAM3A;SIRT2
16583,GO:0097386,0.338177346252105,0.891940296661837,2,11,glial cell projection,CC,GLUL;SIRT2
3609,GO:0008053,0.338199453788442,0.857531356176777,3,20,mitochondrial fusion,BP,VAT1;BNIP3;BAX
4714,GO:0010878,0.33837676524935,0.89183130575567,2,11,cholesterol storage,BP,PPARA;ABCG1
8670,GO:0034260,0.338709823901545,0.819448099643453,5,36,negative regulation of GTPase activity,BP,SPRY2;ARL2;PLXNB3;GPSM1;RASA4
11587,GO:0046184,0.338845482216583,0.891574923401335,2,11,aldehyde biosynthetic process,BP,PDXK;KDM3A
18178,GO:1902930,0.338856236135353,0.797425712478774,7,53,regulation of alcohol biosynthetic process,BP,CYP27B1;APOE;SEC14L2;MVD;NTSR1;MBTPS2;ABCG1
7089,GO:0030891,0.33890144234253,0.949387458620131,1,4,VCB complex,CC,VHL
616,GO:0001786,0.338958868597373,0.835472402133251,4,27,phosphatidylserine binding,MF,OSBPL5;GAS6;OSBPL10;GSDMA
2606,GO:0005912,0.338972420652787,0.715499240749973,50,450,adherens junction,CC,FHL1;MRC2;PARVB;FLNC;ITGA6;NDRG1;EGFR;CAPN2;ARL2;SPRY4;MAP2K2;MAP2K1;MPRIP;SLC9A3R2;LRP1;GRB7;CORO1B;BSG;ZFYVE21;RAC2;CEACAM1;PLAU;GSN;ARHGAP22;PROCR;ITGB5;CADM4;CD81;SNTB2;TNS1;CD9;ITGA1;SH3BP1;LIMK1;GIT1;ADAM15;EHD3;DNM2;CAT;MAPK3;TNS4;PAK1;ITGA3;RRAS;FAM129B;CDH4;ITGA4;PXN;FGFR3;KLHL24
18779,GO:1904262,0.339006124250643,0.891486986806353,2,11,negative regulation of TORC1 signaling,BP,SESN2;C12ORF66
19638,GO:1990778,0.339007364626614,0.736573811243882,25,212,protein localization to cell periphery,BP,PRNP;BBS2;EGFR;LRP1;AKT1;BSG;RAB31;PACS2;ANK3;TTC7B;GAS6;LAMA5;EPHB2;TGFB1;TUB;BBS1;PRKCZ;VAMP2;RILPL1;ARHGAP44;CACNB3;EHD3;ITGA3;BCL2L1;RAB40B
3225,GO:0006882,0.339013412065553,0.856472545940869,3,21,cellular zinc ion homeostasis,BP,AP3D1;ATP7B;MT2A
13491,GO:0055069,0.339013412065553,0.856472545940869,3,21,zinc ion homeostasis,BP,AP3D1;ATP7B;MT2A
3320,GO:0007031,0.339024130302814,0.835047270402611,4,28,peroxisome organization,BP,ABCD1;PEX10;PEX1;LONP2
6842,GO:0030317,0.33946358918236,0.834737738938761,4,28,flagellated sperm motility,BP,BBS2;PLTP;NPHP4;DNAH1
3074,GO:0006646,0.33975480135574,0.891076701617201,2,11,phosphatidylethanolamine biosynthetic process,BP,CHKA;SLC27A1
15223,GO:0071384,0.340003224259026,0.806155395044258,6,45,cellular response to corticosteroid stimulus,BP,EGFR;ZFP36L1;ERRFI1;TGFB1;PCK2;DDIT4
6745,GO:0030173,0.340096259165015,0.818420476265573,5,36,integral component of Golgi membrane,CC,B4GAT1;RFNG;MFNG;QSOX1;SAMD8
17117,GO:0101023,0.340171921592504,0.890847789685988,2,11,vascular endothelial cell proliferation,BP,APLN;FGFR1
19311,GO:1905562,0.340171921592504,0.890847789685988,2,11,regulation of vascular endothelial cell proliferation,BP,APLN;FGFR1
12236,GO:0048521,0.340237391350525,0.948949748346889,1,4,negative regulation of behavior,BP,ADA
3278,GO:0006968,0.340812874106879,0.856430534071013,3,19,cellular defense response,BP,ADORA2B;HLA-G;LGALS3BP
3629,GO:0008093,0.341048391657976,0.890366033859859,2,11,cytoskeletal adaptor activity,MF,OBSL1;GAS2L1
762,GO:0002011,0.341184084449779,0.805444179357535,6,44,morphogenesis of an epithelial sheet,BP,WNT7A;DVL1;HBEGF;CEACAM1;ARHGAP12;VANGL2
7761,GO:0032288,0.341316092730139,0.856103908332712,3,19,myelin assembly,BP,GPC1;CD9;AHNAK2
3569,GO:0007617,0.341446869678097,0.890146669346403,2,11,mating behavior,BP,SERPINE2;HEXB
9557,GO:0036342,0.341519439244809,0.890106696536763,2,11,post-anal tail morphogenesis,BP,VANGL2;HES7
995,GO:0002456,0.341538783838487,0.795157731451761,7,54,T cell mediated immunity,BP,CEACAM1;IL20RB;SCART1;PRKCZ;PPP3CB;HFE;ZP3
7183,GO:0031078,0.341539891712464,0.890095429625927,2,11,histone deacetylase activity (H3-K14 specific),MF,HDAC5;HDAC7
7627,GO:0032041,0.341539891712464,0.890095429625927,2,11,NAD-dependent histone deacetylase activity (H3-K14 specific),MF,HDAC5;HDAC7
14293,GO:0061430,0.341883140481434,0.889906256410546,2,11,bone trabecula morphogenesis,BP,THBS3;CHAD
13203,GO:0051865,0.341979797378904,0.79496100169448,7,53,protein autoubiquitination,BP,MTA1;DDB2;RNF187;RAG1;STUB1;LRSAM1;KLHL24
19409,GO:1905907,0.342018635091085,0.948362640616462,1,4,negative regulation of amyloid fibril formation,BP,LDLR
14639,GO:0070230,0.34203295381846,0.888655094279271,2,12,positive regulation of lymphocyte apoptotic process,BP,ADAM8;BAX
2347,GO:0005402,0.342038189406189,0.889820753340376,2,11,carbohydrate:cation symporter activity,MF,SLC2A9;SLC23A2
8293,GO:0033133,0.342068637961655,0.948346101541665,1,4,positive regulation of glucokinase activity,BP,PFKFB2
19294,GO:1905508,0.342659638376675,0.832863774739475,4,27,protein localization to microtubule organizing center,BP,NUDCD3;CEP250;CEP131;CEP72
12671,GO:0050891,0.342700679084067,0.804276240072916,6,44,multicellular organismal water homeostasis,BP,PRKACB;PRKACA;WFS1;ADCY1;ADCY7;ADCY6
7150,GO:0031017,0.342784449042104,0.948108991170868,1,4,exocrine pancreas development,BP,INSR
16274,GO:0090342,0.34282790433783,0.816132299895757,5,37,regulation of cell aging,BP,HMGA2;YPEL3;MIF;LMNA;TERC
12980,GO:0051393,0.343000029304874,0.889289620337089,2,11,alpha-actinin binding,MF,OBSL1;PKD2
17380,GO:1900102,0.343044428609524,0.889265072937988,2,11,negative regulation of endoplasmic reticulum unfolded protein response,BP,PTPN1;WFS1
18412,GO:1903430,0.343069994831232,0.948014223877043,1,4,negative regulation of cell maturation,BP,NPR2
2502,GO:0005757,0.343193627165533,0.947973160565365,1,4,mitochondrial permeability transition pore complex,CC,BAX
13734,GO:0060317,0.343282351241964,0.85482467091839,3,19,cardiac epithelial to mesenchymal transition,BP,PDCD4;TGFBR3;ADAM15
78,GO:0000159,0.343424393864974,0.854732074175027,3,19,protein phosphatase type 2A complex,CC,PPP2R3B;PPP2R5B;STRN4
20307,GO:2001267,0.34358490069319,0.854025377134152,3,20,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,SMAD3;GSN;BAX
15859,GO:0072583,0.343632650077579,0.815790158365101,5,36,clathrin-dependent endocytosis,BP,AP2A2;ARAP3;FCHO1;DNM1;ITGA4
9496,GO:0036148,0.343650723229481,0.888929602086622,2,11,phosphatidylglycerol acyl-chain remodeling,BP,LPCAT4;LPCAT1
4617,GO:0010737,0.343654218544398,0.853980017503052,3,20,protein kinase A signaling,BP,AIP;MC1R;MIF
20198,GO:2001025,0.343831993766409,0.887651699124503,2,12,positive regulation of response to drug,BP,ENDOG;RAB3B
14873,GO:0070665,0.343873029539739,0.77836884251189,9,73,positive regulation of leukocyte proliferation,BP,CARD11;IGFBP2;CD81;CD320;ADA;JAK3;MIF;PELI1;ZP3
17310,GO:0140103,0.344136000998826,0.854267807206734,3,19,catalytic activity, acting on a glycoprotein,MF,B4GALNT4;B3GNT3;MGAT4B
12501,GO:0050650,0.344166685288214,0.854247774109072,3,19,chondroitin sulfate proteoglycan biosynthetic process,BP,B3GAT3;XYLT2;CHPF
20129,GO:2000786,0.344189290002463,0.888631193392531,2,11,positive regulation of autophagosome assembly,BP,ULK1;LRSAM1
10423,GO:0043274,0.34445060541062,0.888486264030124,2,11,phospholipase binding,MF,DGKQ;PRKCZ
17587,GO:1901201,0.344456023300529,0.888483258221215,2,11,regulation of extracellular matrix assembly,BP,SMAD3;TGFB1
4461,GO:0010457,0.344481198523427,0.888469290661678,2,11,centriole-centriole cohesion,BP,CEP250;CROCC
15290,GO:0071481,0.344502835148805,0.888457285686595,2,11,cellular response to X-ray,BP,HMGA2;DNM2
16603,GO:0097440,0.344612703759453,0.888396315954325,2,11,apical dendrite,CC,NSMF;MYO1D
17094,GO:0099625,0.344896643888687,0.888238673290808,2,11,ventricular cardiac muscle cell membrane repolarization,BP,SCN4B;SNTA1
17092,GO:0099623,0.344896643888917,0.88823867329079,2,11,regulation of cardiac muscle cell membrane repolarization,BP,SCN4B;SNTA1
6739,GO:0030165,0.344958618476586,0.784607613405895,8,61,PDZ domain binding,MF,DLG4;DOCK4;MAP2K2;SNTA1;TGFBR3;DLG3;CCDC88C;SDC2
17956,GO:1902287,0.345031817604789,0.888163587328129,2,11,semaphorin-plexin signaling pathway involved in axon guidance,BP,SEMA3F;PLXNB3
13552,GO:0060026,0.345060506079873,0.888147648375907,2,11,convergent extension,BP,DVL1;VANGL2
8137,GO:0032870,0.34508970018328,0.707942592072184,54,475,cellular response to hormone stimulus,BP,NR1D1;PGF;BBS2;FAM210B;EGFR;SHC1;PTPRE;ZFP36L1;FOS;PIK3R2;AKT1;HDAC5;RAB31;PRKACB;CEACAM1;CTSB;IGFBP2;PCSK9;ERRFI1;PAQR6;APRT;TGFB1;NSMF;PTPN1;PCK2;AGRN;PRKCZ;PRKACA;VAMP2;JAK3;PRKCD;DDIT4;CHEK2;PPARA;FYN;EEF2K;IGFBP7;SLC27A1;MAPK3;INSR;ADCY1;PAK1;WDTC1;ADCY7;SOCS7;NGFR;ATP6V1F;PXN;GRB10;NR2F6;GAS2L1;KDM3A;SRSF5;ADCY6
5565,GO:0016577,0.345172354642491,0.831083743710281,4,27,histone demethylation,BP,KDM6B;KDM4B;ARID5B;KDM3A
15298,GO:0071494,0.345351961790029,0.947253163851082,1,4,cellular response to UV-C,BP,IMPACT
4819,GO:0014015,0.345375830198949,0.81448876818342,5,36,positive regulation of gliogenesis,BP,SERPINE2;ETV5;GJC2;BIN1;PLAG1
5618,GO:0016671,0.345611821614592,0.886654739917987,2,12,oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor,MF,MSRB2;ERO1B
1036,GO:0002544,0.345627710807376,0.886645820501931,2,12,chronic inflammatory response,BP,ADORA2B;AHCY
8776,GO:0034465,0.345995248900852,0.947037424246523,1,4,response to carbon monoxide,BP,DNM2
11368,GO:0045744,0.346025298376294,0.830089998683839,4,28,negative regulation of G-protein coupled receptor protein signaling pathway,BP,APLN;ADA;DNM1;DNM2
10157,GO:0042747,0.346150133823993,0.946985401627905,1,4,circadian sleep/wake cycle, REM sleep,BP,CST3
589,GO:0001754,0.346222203821023,0.852903126456326,3,19,eye photoreceptor cell differentiation,BP,SDK2;VEGFA;NAGLU
10468,GO:0043367,0.346418835231964,0.813708574048705,5,36,CD4-positive, alpha-beta T cell differentiation,BP,STAT6;PRKCZ;JAK3;ZFPM1;SATB1
10621,GO:0043625,0.346593315041698,0.946836377286675,1,4,delta DNA polymerase complex,CC,POLD4
2736,GO:0006121,0.347074558115188,0.946674270388257,1,4,mitochondrial electron transport, succinate to ubiquinone,BP,SDHA
1087,GO:0002674,0.347111613881652,0.946661775878179,1,4,negative regulation of acute inflammatory response,BP,IL20RB
12301,GO:0048662,0.347399230762467,0.829110647694205,4,28,negative regulation of smooth muscle cell proliferation,BP,APLN;PDCD4;CTNNBIP1;NDRG2
7868,GO:0032436,0.347703724731812,0.775415906125707,9,71,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,DVL1;AKT1;CSNK1E;RAD23A;TRIB2;STUB1;BCAP31;RNF144A;SIRT2
8299,GO:0033141,0.347717815109765,0.946457127041113,1,4,positive regulation of peptidyl-serine phosphorylation of STAT protein,BP,IFNE
7610,GO:0032007,0.347793641590141,0.812678437150445,5,36,negative regulation of TOR signaling,BP,TNFAIP8L1;DDIT4;SESN2;C12ORF66;PDCD6
1104,GO:0002692,0.347966261568657,0.946373117700659,1,4,negative regulation of cellular extravasation,BP,BCR
11425,GO:0045861,0.348063818536912,0.729695443768433,24,213,negative regulation of proteolysis,BP,PLAT;CST3;PRNP;VEGFA;TNFRSF6B;SERPINE2;PRDX5;AKT1;SERPING1;RAG1;SORL1;GAS6;TFPI2;CTSZ;TIMP2;CAMK2N1;IFI6;PCSK1N;ECM1;MICAL1;BIN1;SERPINB1;NGFR;HFE
20112,GO:2000758,0.348208372885701,0.82853288293002,4,28,positive regulation of peptidyl-lysine acetylation,BP,NOS1;TGFB1;RPS6KA5;MAPK3
17527,GO:1900825,0.348402468224053,0.946225428309343,1,4,regulation of membrane depolarization during cardiac muscle cell action potential,BP,ANK3
16161,GO:0090183,0.348610265498369,0.812065603599526,5,36,regulation of kidney development,BP,EGR1;VEGFA;WWTR1;WNT2B;TGFB1
4191,GO:0009298,0.349044978569973,0.946007445484748,1,4,GDP-mannose biosynthetic process,BP,MPI
15402,GO:0071671,0.349365730163134,0.945898426895014,1,4,regulation of smooth muscle cell chemotaxis,BP,CORO1B
5672,GO:0016782,0.349406227873682,0.798691137005719,6,46,transferase activity, transferring sulfur-containing groups,MF,SUGCT;TSTD1;NDST2;GAL3ST4;CHST14;TST
1112,GO:0002700,0.349519979851841,0.773815014726935,9,72,regulation of production of molecular mediator of immune response,BP,PKN1;STAT6;HK1;TGFB1;PRKCZ;JAK3;MIF;MAPK3;HFE
7391,GO:0031462,0.349764473196229,0.884312075747762,2,12,Cul2-RING ubiquitin ligase complex,CC,ZER1;ZYG11B
7746,GO:0032269,0.349999620330901,0.691445814464511,93,856,negative regulation of cellular protein metabolic process,BP,TNIP1;DUSP6;XDH;DUSP5;PLAT;CST3;PDCD4;PRNP;VEGFA;TNFRSF6B;APOE;LRP5;PKN1;EGFR;SERPINE2;WWTR1;SPRY2;CRTAP;SPRY4;ZFP36L1;MAP2K2;PPP1R35;MAP2K1;FBLN1;SMAD3;PIK3R2;DVL1;PPP1R14A;PRDX5;ADARB1;AKT1;GRB7;PPM1F;STK39;SERPING1;EPHA1;IMPACT;RAG1;SORL1;CEACAM1;CIRBP;HMG20B;PODNL1;GAS6;PTK6;DUSP7;ERRFI1;SNTA1;DGKQ;TFPI2;CTSZ;EPHB2;CTBP1;CDKN1C;TIMP2;C8ORF88;TGFB1;UNK;PTPN1;CAMK2N1;MLXIPL;TRIB2;PRKCZ;PRKCD;IFI6;BAX;DUSP4;DDIT4;PCSK1N;LIMK1;LEMD2;RPS6KA6;RGS14;CHAD;SESN2;MIF;MEX3A;ECM1;FYN;ELFN2;MICAL1;CAPRIN2;BIN1;SIRT2;SERPINB1;SOCS7;NGFR;SIRT3;HFE;NDRG2;CBLC;KDM3A;LRRK1
19608,GO:1990712,0.35036033505104,0.945559536265873,1,4,HFE-transferrin receptor complex,CC,HFE
19882,GO:2000344,0.350449301353791,0.945529160955971,1,4,positive regulation of acrosome reaction,BP,ZP3
13176,GO:0051792,0.350650545441062,0.945460413672466,1,4,medium-chain fatty acid biosynthetic process,BP,ACOT7
16217,GO:0090261,0.350653719565771,0.945459328937873,1,4,positive regulation of inclusion body assembly,BP,CDC34
18956,GO:1904705,0.350663223596232,0.826775463865209,4,28,regulation of vascular smooth muscle cell proliferation,BP,MEF2D;APLN;PDCD4;PAK1
19664,GO:1990874,0.350663223596232,0.826775463865209,4,28,vascular smooth muscle cell proliferation,BP,MEF2D;APLN;PDCD4;PAK1
18553,GO:1903750,0.350880670333234,0.945381736540213,1,4,regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,TRAP1
18554,GO:1903751,0.350880670333234,0.945381736540213,1,4,negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,TRAP1
19420,GO:1905939,0.351269965537682,0.883457027124486,2,12,regulation of gonad development,BP,INSR;ZP3
9414,GO:0035985,0.351484912078502,0.945174828614743,1,4,senescence-associated heterochromatin focus,CC,HMGA2
3395,GO:0007178,0.351505722701201,0.725293392497127,25,213,transmembrane receptor protein serine/threonine kinase signaling pathway,BP,HTRA1;EGR1;PDCD4;ACVR2B;WWTR1;LTBP4;LTBP2;LTBP1;SMURF2;FOS;SMAD3;ITGB5;CDKN1C;TGFB1;LRP4;PRKCZ;STUB1;TGFBR3;LEMD2;IRAK1;DNM2;MAPK3;ITGA3;PXN;HFE
953,GO:0002371,0.35151164922918,0.945165662264258,1,4,dendritic cell cytokine production,BP,JAK3
1139,GO:0002730,0.35151164922918,0.945165662264258,1,4,regulation of dendritic cell cytokine production,BP,JAK3
8445,GO:0033591,0.351603792078656,0.945134065692408,1,4,response to L-ascorbic acid,BP,CAT
10437,GO:0043300,0.351663246896907,0.826057591557647,4,28,regulation of leukocyte degranulation,BP,ADORA2B;RAC2;CEACAM1;BCR
11188,GO:0045309,0.351729160502967,0.809718584942484,5,36,protein phosphorylated amino acid binding,MF,SHC1;PIK3R2;SH3BP2;MAPK3;CBLC
1227,GO:0002903,0.351798010748342,0.883156397024982,2,12,negative regulation of B cell apoptotic process,BP,ADA;MIF
13687,GO:0060249,0.352061134772468,0.716209528253571,32,285,anatomical structure homeostasis,BP,ERCC1;BBS2;VEGFA;F2R;EGFR;GAA;ACP5;ERCC6;EPAS1;STK39;POLD4;RAC2;NPHP4;IL20RB;ADAM8;TUB;CROCC;BBS1;TPP1;BAX;LPCAT1;INPP5D;FGGY;RAC3;MAPK3;PFKM;TEP1;PLEKHM1;TERC;BBS10;HOMER2;LRRK1
13813,GO:0060420,0.352184727489404,0.809374907609307,5,36,regulation of heart growth,BP,DUSP6;FGFR1;TGFBR3;PAK1;PROX1
1240,GO:0002931,0.352573471707326,0.825403195416549,4,28,response to ischemia,BP,EGR1;STUB1;EEF2K;MLYCD
16470,GO:0097154,0.352709457241097,0.944754069892399,1,4,GABAergic neuron differentiation,BP,RAC3
5716,GO:0016853,0.35286982828991,0.747921628782089,14,120,isomerase activity,MF,PGM1;ISYNA1;FKBP9;GALE;RPUSD3;ERO1B;MPI;TOP3B;TMX4;PDIA5;MIF;DDT;QSOX1;TSTA3
9382,GO:0035924,0.352920935685329,0.825153142112661,4,28,cellular response to vascular endothelial growth factor stimulus,BP,XDH;VEGFA;AKT1;MAP2K3
1113,GO:0002701,0.352943860377082,0.847847469506844,3,20,negative regulation of production of molecular mediator of immune response,BP,TGFB1;JAK3;HFE
12607,GO:0050798,0.353010969121387,0.824721610637686,4,29,activated T cell proliferation,BP,PRNP;IGFBP2;FYN;SATB1
8763,GO:0034450,0.353019749416449,0.882459383638662,2,12,ubiquitin-ubiquitin ligase activity,MF,STUB1;PELI1
16938,GO:0098917,0.353027946984984,0.94464431842509,1,4,retrograde trans-synaptic signaling,BP,NOS1
5923,GO:0018198,0.353249783113388,0.808054831747881,5,38,peptidyl-cysteine modification,BP,NOS1;RAB3B;SNTA1;ZDHHC24;ZDHHC1
4927,GO:0014883,0.353403148787485,0.944514855856985,1,4,transition between fast and slow fiber,BP,TNNT1
19733,GO:2000060,0.353686122930723,0.764566318037306,10,80,positive regulation of ubiquitin-dependent protein catabolic process,BP,DVL1;AKT1;CSNK1E;RAD23A;MAGEF1;TRIB2;STUB1;BCAP31;RNF144A;SIRT2
3039,GO:0006596,0.353865911256855,0.88197545660144,2,12,polyamine biosynthetic process,BP,SMOX;AZIN2
2573,GO:0005862,0.353893959769294,0.944345227791701,1,4,muscle thin filament tropomyosin,CC,TPM2
15480,GO:0071839,0.354055221012421,0.944289426631963,1,4,apoptotic process in bone marrow,BP,BCL2L1
15836,GO:0072553,0.35406130740088,0.944287319902269,1,4,terminal button organization,BP,NLGN2
17113,GO:0101003,0.354098772789991,0.807662457930311,5,37,ficolin-1-rich granule membrane,CC,SLC2A3;GAA;AP2A2;ADAM8;NBEAL2
560,GO:0001701,0.35415696103013,0.717676647027808,29,249,in utero embryonic development,BP,VEGFA;EGFR;CAPN2;PHLDA2;ZFP36L1;PLCD3;MDFI;MAP2K1;ENDOG;SMAD3;EPAS1;AKT1;FGFR1;EDNRA;PKD2;FBXW8;PLCG1;CEBPB;MBD3;ADA;TMEM231;WDTC1;BCL2L1;PKD1;MAFF;TCTN1;SLC39A3;ZP3;APBA1
11549,GO:0046101,0.354193008542942,0.944241721400033,1,4,hypoxanthine biosynthetic process,BP,ADA
670,GO:0001881,0.35421001975625,0.824224252727736,4,28,receptor recycling,BP,ARAP1;PCSK9;EHD3;TBC1D16
10240,GO:0042979,0.354217737137014,0.94423315718671,1,4,ornithine decarboxylase regulator activity,MF,AZIN2
17947,GO:1902267,0.354217737137014,0.94423315718671,1,4,regulation of polyamine transmembrane transport,BP,AZIN2
15479,GO:0071838,0.354217867566055,0.944233112013364,1,4,cell proliferation in bone marrow,BP,HMGA2
8348,GO:0033233,0.354441912117176,0.846848542725327,3,20,regulation of protein sumoylation,BP,EGR1;HMG20B;TOLLIP
17622,GO:1901300,0.35444573974348,0.944154156103293,1,4,positive regulation of hydrogen peroxide-mediated programmed cell death,BP,ENDOG
19972,GO:2000508,0.354564502421136,0.944112979108042,1,4,regulation of dendritic cell chemotaxis,BP,GAS6
19973,GO:2000510,0.354564502421136,0.944112979108042,1,4,positive regulation of dendritic cell chemotaxis,BP,GAS6
3799,GO:0008379,0.354588777674603,0.940802727148366,1,5,thioredoxin peroxidase activity,MF,PRDX5
1114,GO:0002702,0.354651047417331,0.7945944415378,6,46,positive regulation of production of molecular mediator of immune response,BP,STAT6;HK1;TGFB1;PRKCZ;MIF;MAPK3
19891,GO:2000354,0.354997358879405,0.943962745839012,1,4,regulation of ovarian follicle development,BP,ZP3
1657,GO:0004111,0.355152415505272,0.943908870595424,1,4,creatine kinase activity,MF,CKMT1A
11302,GO:0045630,0.355412528826634,0.943818422793501,1,4,positive regulation of T-helper 2 cell differentiation,BP,PRKCZ
8486,GO:0033668,0.355477041698534,0.943795976490902,1,4,negative regulation by symbiont of host apoptotic process,BP,BCL2L1
13291,GO:0052041,0.355477041698534,0.943795976490902,1,4,negative regulation by symbiont of host programmed cell death,BP,BCL2L1
13345,GO:0052490,0.355477041698534,0.943795976490902,1,4,negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction,BP,BCL2L1
3599,GO:0008037,0.355564400361996,0.775723384271422,8,63,cell recognition,BP,PEAR1;LAMA5;EPHB2;CADM4;EFNB3;TUB;ST6GALNAC6;ZP3
17698,GO:1901567,0.355613879577528,0.84550196060776,3,21,fatty acid derivative binding,MF,ACOT7;ACBD4;HMGCL
4081,GO:0009137,0.355617403850132,0.943747120883585,1,4,purine nucleoside diphosphate catabolic process,BP,ENTPD2
4120,GO:0009181,0.355617403850132,0.943747120883585,1,4,purine ribonucleoside diphosphate catabolic process,BP,ENTPD2
15964,GO:0080025,0.355747693561547,0.845975558476307,3,20,phosphatidylinositol-3,5-bisphosphate binding,MF,SH3PXD2B;PLEK2;WIPI2
1051,GO:0002578,0.355947033086376,0.943632286819231,1,4,negative regulation of antigen processing and presentation,BP,HFE
1808,GO:0004457,0.356098698177366,0.943579403315737,1,4,lactate dehydrogenase activity,MF,D2HGDH
2196,GO:0005070,0.356128493405221,0.806390632058925,5,36,SH3/SH2 adaptor activity,MF,PAG1;GRB7;SH2D2A;SH3BP2;GRB10
90,GO:0000179,0.356139403112549,0.943565204983918,1,4,rRNA (adenine-N6,N6-)-dimethyltransferase activity,MF,RRNAD1
3529,GO:0007519,0.356191535139321,0.757321612834659,11,89,skeletal muscle tissue development,BP,MEF2D;EGR1;FOS;HMG20B;TGFB1;GPC1;LEMD2;MYH15;TAZ;FAM129B;MAFF
11636,GO:0046368,0.356416371220847,0.943468538251619,1,4,GDP-L-fucose metabolic process,BP,TSTA3
4267,GO:0009620,0.356476111548177,0.844922837161119,3,21,response to fungus,BP,FAM3A;TGFB1;RNASE7
1959,GO:0004663,0.356503651752136,0.943438055143834,1,4,Rab geranylgeranyltransferase activity,MF,RABGGTA
17943,GO:1902260,0.356534850908319,0.943427156297703,1,4,negative regulation of delayed rectifier potassium channel activity,BP,ANK3
10326,GO:0043125,0.356702806478094,0.943368462380293,1,4,ErbB-3 class receptor binding,MF,ERBB2
15848,GO:0072567,0.356960304715641,0.880197486528412,2,12,chemokine (C-X-C motif) ligand 2 production,BP,POSTN;MIF
10598,GO:0043583,0.357040296243879,0.744546715897335,14,115,ear development,BP,NAGLU;SPRY2;DVL1;FGFR1;TSHZ1;BCR;SLITRK6;EPHB2;TGFB1;LRP10;MAPK3;VANGL2;PROX1;CELSR1
1405,GO:0003338,0.357065494156367,0.845092397165282,3,20,metanephros morphogenesis,BP,PKD2;KIF26B;PKD1
16186,GO:0090209,0.357156732340372,0.943209649309249,1,4,negative regulation of triglyceride metabolic process,BP,APOE
8006,GO:0032642,0.357305965519094,0.792510405212969,6,46,regulation of chemokine production,BP,EGR1;POSTN;ADORA2B;ALOX15B;ZFPM1;MIF
571,GO:0001714,0.35736204886435,0.943137727981354,1,4,endodermal cell fate specification,BP,DUSP6
8510,GO:0033743,0.357496729261418,0.94309052029811,1,4,peptide-methionine (R)-S-oxide reductase activity,MF,MSRB2
7910,GO:0032489,0.357556353729215,0.943069613397347,1,4,regulation of Cdc42 protein signal transduction,BP,APOE
15155,GO:0071279,0.357580741343943,0.943061060716466,1,4,cellular response to cobalt ion,BP,BNIP3
5658,GO:0016758,0.357613139346548,0.732679005138242,18,152,transferase activity, transferring hexosyl groups,MF,B4GALNT4;PYGB;PYGL;HEXB;PIGQ;B4GAT1;PIGV;B3GAT3;B3GNT3;MGAT4B;B4GALT2;B4GALT6;RFNG;XYLT2;MFNG;HYAL1;ALG12;CHPF
16591,GO:0097411,0.357638971559136,0.943040636377217,1,4,hypoxia-inducible factor-1alpha signaling pathway,BP,PDK1
11385,GO:0045778,0.357672831773641,0.782282920190633,7,54,positive regulation of ossification,BP,CTNNBIP1;ACVR2B;SMAD3;CEBPB;TGFB1;FAM20C;ZHX3
19410,GO:1905908,0.357686655145282,0.943023907992798,1,4,positive regulation of amyloid fibril formation,BP,APOE
20199,GO:2001026,0.35790248039831,0.879653553382875,2,12,regulation of endothelial cell chemotaxis,BP,VEGFA;FGFR1
1311,GO:0003158,0.358119621721688,0.760835377889487,10,80,endothelium development,BP,XDH;ACVR2B;WNT7A;PTPRS;RAPGEF3;CEACAM1;LAMA5;KDM6B;PROX1;BTG1
14243,GO:0061303,0.358423857511635,0.94276490486326,1,4,cornea development in camera-type eye,BP,WNT2B
18870,GO:1904491,0.358485132447716,0.942743345063063,1,4,protein localization to ciliary transition zone,BP,TCTN1
5971,GO:0018410,0.358727024284303,0.803891604815013,5,38,C-terminal protein amino acid modification,BP,LY6K;MSLN;MDGA1;WIPI2;PRSS21
1083,GO:0002666,0.358823104017006,0.942624340475359,1,4,positive regulation of T cell tolerance induction,BP,HLA-G
3791,GO:0008360,0.358928217194224,0.739654381565,15,124,regulation of cell shape,BP,PARVB;VEGFA;HEXB;ARAP1;SYNE3;CSNK1E;WIPF1;PLXNB3;CDC42EP5;ARAP3;RHOD;RHOF;WASF3;RHOBTB2;FYN
14015,GO:0060750,0.35903986063725,0.942547938843481,1,4,epithelial cell proliferation involved in mammary gland duct elongation,BP,AREG
16206,GO:0090241,0.359078988213577,0.942534140746319,1,4,negative regulation of histone H4 acetylation,BP,CTBP1
16150,GO:0090168,0.359137733974257,0.942513420659666,1,4,Golgi reassembly,BP,STK25
6133,GO:0019401,0.359208891161411,0.942488316923697,1,4,alditol biosynthetic process,BP,PCK2
10520,GO:0043461,0.359251459564998,0.942473295936835,1,4,proton-transporting ATP synthase complex assembly,BP,OXA1L
4049,GO:0009092,0.359451243162884,0.942402767226664,1,4,homoserine metabolic process,BP,CBS
6106,GO:0019346,0.359451243162884,0.942402767226664,1,4,transsulfuration,BP,CBS
14926,GO:0070814,0.359451243162884,0.942402767226664,1,4,hydrogen sulfide biosynthetic process,BP,CBS
11796,GO:0046688,0.359618585534641,0.84228948988765,3,22,response to copper ion,BP,PRNP;ATP7B;MT2A
11707,GO:0046519,0.359690032018747,0.878618255925877,2,12,sphingoid metabolic process,BP,KDSR;SPTLC2
19815,GO:2000242,0.359703630036329,0.819870233833009,4,29,negative regulation of reproductive process,BP,PRKACB;NPR2;ADA;ZP3
10383,GO:0043219,0.359976506016113,0.942217086865608,1,4,lateral loop,CC,SIRT2
11838,GO:0046827,0.360081833422268,0.843062807746345,3,20,positive regulation of protein export from nucleus,BP,RAPGEF3;GAS6;CAMK1
5678,GO:0016790,0.360519624516882,0.819275258381483,4,29,thiolester hydrolase activity,MF,ACOT7;ACOT1;HAGH;ABHD17C
10565,GO:0043534,0.360548532894119,0.758696270802183,10,81,blood vessel endothelial cell migration,BP,VEGFA;APOE;AKT1;HDAC5;FGFR1;PLCG1;TGFB1;SH3BP1;HDAC7;MAP2K3
4146,GO:0009209,0.360692791973766,0.876981512694423,2,13,pyrimidine ribonucleoside triphosphate biosynthetic process,BP,NME4;UCKL1
2953,GO:0006488,0.360821094033967,0.842563662703037,3,20,dolichol-linked oligosaccharide biosynthetic process,BP,SRD5A3;MVD;ALG12
9129,GO:0035458,0.360837526265677,0.877951370256125,2,12,cellular response to interferon-beta,BP,TMEM173;CDC34
900,GO:0002278,0.361278336270042,0.941755331779295,1,4,eosinophil activation involved in immune response,BP,VAMP2
991,GO:0002447,0.361278336270042,0.941755331779295,1,4,eosinophil mediated immunity,BP,VAMP2
10444,GO:0043307,0.361278336270042,0.941755331779295,1,4,eosinophil activation,BP,VAMP2
10445,GO:0043308,0.361278336270042,0.941755331779295,1,4,eosinophil degranulation,BP,VAMP2
18672,GO:1903978,0.361338490976682,0.941733941354935,1,4,regulation of microglial cell activation,BP,LDLR
17500,GO:1900452,0.361338490976955,0.941733941354937,1,4,regulation of long term synaptic depression,BP,SHANK3
6835,GO:0030307,0.361519606316492,0.74048381624572,14,118,positive regulation of cell growth,BP,VEGFA;EGFR;DNPH1;LPAR3;HBEGF;AKT1;TWF2;WNT3;ERBB2;LIMK1;GDI1;PAK1;HYAL1;CDH4
4990,GO:0015125,0.361596696702452,0.941642071953173,1,4,bile acid transmembrane transporter activity,MF,CEACAM1
4487,GO:0010511,0.361630726388153,0.941629957685456,1,4,regulation of phosphatidylinositol biosynthetic process,BP,ZP3
12682,GO:0050908,0.361978321799062,0.941506129629852,1,4,detection of light stimulus involved in visual perception,BP,REEP6
12714,GO:0050962,0.361978321799062,0.941506129629852,1,4,detection of light stimulus involved in sensory perception,BP,REEP6
15561,GO:0072014,0.362214676835504,0.941421839337244,1,4,proximal tubule development,BP,PKD1
12009,GO:0047617,0.362216018930238,0.877147864845731,2,12,acyl-CoA hydrolase activity,MF,ACOT7;ACOT1
19989,GO:2000551,0.362298122294679,0.941392062989093,1,4,regulation of T-helper 2 cell cytokine production,BP,PRKCZ
16542,GO:0097296,0.362373280105246,0.877056034773408,2,12,activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,SMAD3;BAX
3012,GO:0006561,0.362516087816477,0.941314241816118,1,4,proline biosynthetic process,BP,PYCR2
13528,GO:0055129,0.362516087816477,0.941314241816118,1,4,L-proline biosynthetic process,BP,PYCR2
759,GO:0002002,0.362737392844461,0.941235164353807,1,4,regulation of angiotensin levels in blood,BP,CTSZ
760,GO:0002003,0.362737392844461,0.941235164353807,1,4,angiotensin maturation,BP,CTSZ
13630,GO:0060143,0.362738680149069,0.876842535222682,2,12,positive regulation of syncytium formation by plasma membrane fusion,BP,RAPGEF3;CAMK1
16633,GO:0097494,0.362825264435179,0.941203747895204,1,4,regulation of vesicle size,BP,RAB3B
663,GO:0001867,0.362835228034042,0.941200184998756,1,4,complement activation, lectin pathway,BP,SERPING1
6052,GO:0019201,0.362863189747356,0.841181323396229,3,20,nucleotide kinase activity,MF,DLG4;CARD11;DLG3
9655,GO:0038003,0.362876256832758,0.941185512078569,1,4,opioid receptor signaling pathway,BP,SIGMAR1
2634,GO:0005968,0.363005449019514,0.941139295252699,1,4,Rab-protein geranylgeranyltransferase complex,CC,RABGGTA
17854,GO:1902023,0.36318175966679,0.941076186930086,1,4,L-arginine transport,BP,SLC25A29
11793,GO:0046685,0.363309296333865,0.817235480152784,4,29,response to arsenic-containing substance,BP,UROS;MAPK13;MKNK2;GSTO1
15209,GO:0071362,0.363389684713823,0.941001709962218,1,4,cellular response to ether,BP,NFATC4
7294,GO:0031300,0.363414383588782,0.727443330237505,18,154,intrinsic component of organelle membrane,CC,PTPRS;B4GAT1;ABCD1;RAB3B;PEX10;BNIP3;RFNG;OXA1L;SLC22A17;SV2A;TIMM17B;LEMD2;MFNG;PPOX;COQ2;QSOX1;SUN1;SAMD8
17716,GO:1901616,0.363686544339616,0.800352376309983,5,37,organic hydroxy compound catabolic process,BP,CYP27B1;APOE;SRD5A3;NTSR1;SNX17
8271,GO:0033083,0.363693820354529,0.94089266852094,1,4,regulation of immature T cell proliferation,BP,ERBB2
14991,GO:0070915,0.363814746883153,0.9408492789571,1,4,lysophosphatidic acid receptor activity,MF,LPAR3
2666,GO:0006021,0.363867717072054,0.940830266683531,1,4,inositol biosynthetic process,BP,ISYNA1
12983,GO:0051403,0.363896266012177,0.715523333848794,24,206,stress-activated MAPK cascade,BP,XDH;PDCD4;VEGFA;WNT7A;PKN1;EGFR;ZFP36L1;MAP2K2;MAP2K1;ERCC6;ADORA2B;AKT1;MAPK13;CDC42EP5;PTPN1;MINK1;IRAK1;STK25;MAPK3;VANGL2;PAK1;SEMA4C;MAP2K3;MAP3K10
12732,GO:0051006,0.363931796438138,0.940807262110665,1,4,positive regulation of lipoprotein lipase activity,BP,LMF1
14275,GO:0061365,0.363931796438138,0.940807262110665,1,4,positive regulation of triglyceride lipase activity,BP,LMF1
5597,GO:0016628,0.364049666006386,0.839796385641216,3,21,oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor,MF,SRD5A3;DECR2;PTGR2
19908,GO:2000381,0.364184945656875,0.940716328224188,1,4,negative regulation of mesoderm development,BP,RPS6KA6
3773,GO:0008330,0.364725464848687,0.940521884714623,1,4,protein tyrosine/threonine phosphatase activity,MF,DUSP4
4321,GO:0009820,0.36484377446147,0.9404792731405,1,4,alkaloid metabolic process,BP,CYP3A5
10373,GO:0043200,0.364867559413438,0.755037325773184,10,81,response to amino acid,BP,EGFR;CAPN2;CEBPB;NSMF;MTHFR;SESN2;FYN;DNMT3A;BCL2L1;COL6A1
20260,GO:2001185,0.364895748252304,0.940460547889441,1,4,regulation of CD8-positive, alpha-beta T cell activation,BP,HFE
15026,GO:0070973,0.364964703471765,0.940435699012516,1,4,protein localization to endoplasmic reticulum exit site,BP,BCAP31
905,GO:0002286,0.365006701081438,0.786426402742045,6,46,T cell activation involved in immune response,BP,STAT6;CEACAM1;IFNE;PRKCZ;JAK3;ZFPM1
1313,GO:0003160,0.365011446897629,0.940418850857663,1,4,endocardium morphogenesis,BP,PROX1
18538,GO:1903715,0.365033214081682,0.940411004128892,1,4,regulation of aerobic respiration,BP,BNIP3
20192,GO:2001016,0.365067343283598,0.940398699824925,1,4,positive regulation of skeletal muscle cell differentiation,BP,GPC1
13549,GO:0060023,0.365067343740147,0.940398699660352,1,4,soft palate development,BP,TSHZ1
10302,GO:0043084,0.365084377116714,0.940392558189074,1,4,penile erection,BP,ADA
10278,GO:0043031,0.36519705882737,0.940351920552304,1,4,negative regulation of macrophage activation,BP,LDLR
19704,GO:2000008,0.365201817489151,0.815846654187436,4,29,regulation of protein localization to cell surface,BP,AKT1;KCNAB2;SNX33;HFE
11349,GO:0045717,0.365204377923898,0.875397089356393,2,12,negative regulation of fatty acid biosynthetic process,BP,CEACAM1;WDTC1
19706,GO:2000010,0.365263443840948,0.87536236177823,2,12,positive regulation of protein localization to cell surface,BP,AKT1;SNX33
555,GO:0001678,0.365271003865692,0.749343557411401,11,92,cellular glucose homeostasis,BP,NR1D1;LRP5;ENDOG;PIK3R2;HK1;GAS6;PCK2;MLXIPL;PRKACA;PLA2G6;PPP3CB
1218,GO:0002887,0.365287137568028,0.940319422389677,1,4,negative regulation of myeloid leukocyte mediated immunity,BP,BCR
5166,GO:0015712,0.365382514152366,0.940285001193784,1,4,hexose phosphate transport,BP,SLC37A2
5186,GO:0015760,0.365382514152366,0.940285001193784,1,4,glucose-6-phosphate transport,BP,SLC37A2
418,GO:0001106,0.365394739252489,0.83946046737985,3,20,RNA polymerase II transcription corepressor activity,MF,ZMYND8;CTBP1;RERE
17348,GO:1900028,0.365410548303001,0.940274881442037,1,4,negative regulation of ruffle assembly,BP,PFN2
4932,GO:0014891,0.365417109240617,0.940272512928401,1,4,striated muscle atrophy,BP,GSN
2811,GO:0006275,0.36543411979888,0.744783877441894,12,99,regulation of DNA replication,BP,CST3;EGFR;SHC1;FGFR1;TGFB1;AREG;WDR18;EREG;CHEK2;TSPYL2;INSR;KCTD13
16720,GO:0097722,0.365547525928312,0.81559251635623,4,29,sperm motility,BP,BBS2;PLTP;NPHP4;DNAH1
19147,GO:1905098,0.365788186894157,0.94013846026913,1,4,negative regulation of guanyl-nucleotide exchange factor activity,BP,GPSM1
6801,GO:0030259,0.365819205932902,0.940127246310937,1,4,lipid glycosylation,BP,ST3GAL2
7031,GO:0030811,0.365892396170483,0.775631165107098,7,54,regulation of nucleotide catabolic process,BP,RAPGEF3;PFKFB2;MLXIPL;DDIT4;PPARA;INSR;PFKFB3
4793,GO:0010986,0.366149852968298,0.940007632051037,1,4,positive regulation of lipoprotein particle clearance,BP,LDLR
4425,GO:0010256,0.366159801528851,0.695661732525617,41,359,endomembrane system organization,BP,F2R;NDRG1;NEK9;SERPINE2;OBSL1;VPS11;SNX9;MAP2K2;MAP2K1;REEP4;AKT1;DYSF;ZNF385A;ANK3;GSN;FBXW8;AP3D1;TMED4;RFX2;GOLGA2P5;SNX33;PI4K2A;PRKCD;AHNAK2;LEMD2;DNM1;WASH3P;REEP2;EHD3;PI4K2B;COG7;DOPEY2;SYNGR1;STK25;SUN1;DNM2;MAPK3;ATP8B2;CUL7;LMNA;VPS51
12248,GO:0048539,0.366177228178734,0.939997722351148,1,4,bone marrow development,BP,LRP5
10904,GO:0044458,0.366278326779759,0.874764920130758,2,12,motile cilium assembly,BP,DNAAF3;MSS51
10695,GO:0043987,0.366322553116073,0.939945098757808,1,4,histone H3-S10 phosphorylation,BP,RPS6KA5
15749,GO:0072344,0.366393361078795,0.939919448349922,1,4,rescue of stalled ribosome,BP,ZNF598
3243,GO:0006904,0.366419600439663,0.798250893792742,5,37,vesicle docking involved in exocytosis,BP,VPS11;EXOC2;RAB3B;SNPH;RAB40B
1714,GO:0004305,0.36659948055664,0.939844743066506,1,4,ethanolamine kinase activity,MF,CHKA
13064,GO:0051581,0.366653077989394,0.939825308151546,1,4,negative regulation of neurotransmitter uptake,BP,NOS1
17543,GO:1901031,0.366767787828412,0.814694388682007,4,29,regulation of response to reactive oxygen species,BP,ENDOG;TRAP1;SESN2;GCH1
9584,GO:0036438,0.366812700293104,0.939767405076051,1,4,maintenance of lens transparency,BP,STK39
13986,GO:0060711,0.366877550371706,0.797898001820632,5,37,labyrinthine layer development,BP,ZFP36L1;PLCD3;MAP2K1;AKT1;FBXW8
19086,GO:1904956,0.366977620170918,0.939707544782332,1,4,regulation of midbrain dopaminergic neuron differentiation,BP,CSNK1E
14531,GO:0070044,0.366987995450692,0.939703777702124,1,4,synaptobrevin 2-SNAP-25-syntaxin-1a complex,CC,VAMP2
17896,GO:1902166,0.367035259740274,0.873237509826451,2,13,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,ZNF385A;MIF
18726,GO:1904152,0.367081183616175,0.874291295834382,2,12,regulation of retrograde protein transport, ER to cytosol,BP,EDEM1;BCAP31
17279,GO:0140007,0.367120084553385,0.939655805997435,1,4,KICSTOR complex,CC,C12ORF66
4339,GO:0009893,0.367186850839467,0.660353379162745,256,2365,positive regulation of metabolic process,BP,TNIP1;DUSP6;XDH;ERCC1;DUSP5;MEF2D;CITED4;EGR1;NR1D1;EDEM1;DLG4;CST3;CYP27B1;APLN;ACVR2B;PRNP;VEGFA;WNT7A;APOE;F2R;LRP5;ITGA6;HMGA2;ELK3;PKN1;MTA1;GRAMD4;EGFR;WWTR1;NOS1;SPRY2;MST1R;NFATC4;TRIM65;ETV5;SHC1;VPS11;HEXB;GTPBP1;ACTA2;ETV4;SNX9;RAPGEF3;ZFP36L1;ARAP1;MAP2K2;LPAR3;SMARCA1;MAP2K1;POU2F2;ENDOG;SMURF2;FOS;FBLN1;SMAD3;STAT6;PIK3R2;ERCC6;LRP1;GJC2;DVL1;EPAS1;HBEGF;SH3PXD2B;SHC2;SALL2;ZXDC;RNF187;ADORA2B;AKT1;TPCN1;HDAC5;F12;PPM1F;STK39;EPHA1;ASH2L;IMPACT;CNTN1;DAP;PTHLH;FGFR4;LDLR;FGFR1;PRKACB;SEC14L2;HLTF;KLF7;SORL1;NAT14;CIRBP;ANK3;IGFBP4;CCND1;STRADB;GAS6;PTK6;CSNK1E;CARD11;DUSP7;GSN;MAPKAPK3;PCSK9;RAD23A;EHD4;SH3D19;CDC25B;CCS;DGKQ;BNIP3;PAK6;FYCO1;CEMIP;PKD2;CRTC1;GPSM1;MAGEF1;EPHB2;ADAM8;CTBP1;CDKN1C;PLCG1;ZMIZ2;CD81;CEBPB;TIMP2;WNT3;TGFB1;RFX2;DEAF1;NTSR1;NAB2;TMEM173;TNFSF15;NSMF;PEG3;MC1R;ABHD14B;SNX33;PTPN1;AGRN;IFNE;CAMK2N1;LRP4;VHL;PFKFB2;MLXIPL;TRIB2;PRKCZ;KDM6B;PRKACA;MINK1;ZNF516;AREG;PIM2;BOK;ERBB2;ULK1;TFDP2;C6ORF89;BNIP3L;CYFIP2;PBX2;PRKCD;STUB1;BAX;ITGA1;EREG;RPS6KA5;SOX12;MBTPS2;CARF;IER2;LPCAT1;LRSAM1;SYMPK;MAPK12;IRAK1;TGFA;FHOD1;CHEK2;ZFPM1;PPARA;TMEM161A;SESN2;ABCG1;SOX7;ABCA7;RAB12;SIX5;BCAP31;MIF;PLA2G6;DDT;SSBP4;WFS1;FYN;STK25;DNM2;PELI1;SLC27A1;SLC50A1;MAPK3;INSR;CAMTA2;TAZ;PFKM;ADCY1;RERE;ETAA1;VANGL2;PAK1;CAMKK2;PPP3CB;RNF144A;USP21;PFKFB3;MLYCD;SEMA4C;CAPRIN2;ITGA3;PPP2R5B;MAP2K3;DLG3;PROX1;PKD1;KCTD13;TNFRSF25;SIRT2;FAM129B;EDA;BACH1;ADCY7;E2F5;MAPRE3;MAP3K10;NGFR;TOLLIP;PDCD6;GCH1;MAFF;CAMK1;CAMKK1;EZH1;HFE;ZP3;PFN2;FGFR3;SPTLC2;TCEA2;PLAG1;IRF2BPL;KDM3A;SRSF5;ADCY6;LRRK1
727,GO:0001957,0.367625527876882,0.939472026649493,1,4,intramembranous ossification,BP,MN1
9461,GO:0036072,0.367625527876882,0.939472026649493,1,4,direct ossification,BP,MN1
9189,GO:0035577,0.367634709637375,0.784144555405735,6,47,azurophil granule membrane,CC,GAA;STOM;BRI3;LPCAT1;SYNGR1;CD68
9008,GO:0035184,0.367684396332831,0.939450599985871,1,4,histone threonine kinase activity,MF,PKN1
9110,GO:0035405,0.367684396332831,0.939450599985871,1,4,histone-threonine phosphorylation,BP,PKN1
11261,GO:0045577,0.367709178511077,0.837880218319164,3,20,regulation of B cell differentiation,BP,ZFP36L1;CARD11;INPP5D
14146,GO:0061038,0.367731637651978,0.939433401980155,1,4,uterus morphogenesis,BP,WNT7A
4837,GO:0014045,0.367731637651999,0.939433401980134,1,4,establishment of endothelial blood-brain barrier,BP,WNT7A
6557,GO:0022009,0.367731637651999,0.939433401980134,1,4,central nervous system vasculogenesis,BP,WNT7A
9467,GO:0036091,0.367789204287631,0.939412441074762,1,4,positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,SESN2
13088,GO:0051610,0.367842763828954,0.939392935257126,1,4,serotonin uptake,BP,NOS1
4390,GO:0010046,0.368024345893715,0.939326776596336,1,4,response to mycotoxin,BP,EGR1
18758,GO:1904220,0.368221258312396,0.939254982805528,1,4,regulation of serine C-palmitoyltransferase activity,BP,SERINC2
13220,GO:0051894,0.368251892817042,0.837508699348761,3,20,positive regulation of focal adhesion assembly,BP,VEGFA;SMAD3;PPM1F
1906,GO:0004594,0.368354447002504,0.939206393274081,1,4,pantothenate kinase activity,MF,PANK4
6741,GO:0030167,0.368384865266468,0.939195292854092,1,4,proteoglycan catabolic process,BP,GPC1
3108,GO:0006689,0.368388652668162,0.939193910646011,1,4,ganglioside catabolic process,BP,HEXB
1550,GO:0003945,0.368454290682671,0.939169953089947,1,4,N-acetyllactosamine synthase activity,MF,B4GALT2
8177,GO:0032922,0.368464388303071,0.783877727147739,6,45,circadian regulation of gene expression,BP,NR1D1;MTA1;CSNK1E;PPARA;BHLHE40;NGFR
14297,GO:0061438,0.368468705023065,0.939164691157497,1,4,renal system vasculature morphogenesis,BP,PKD2
14298,GO:0061439,0.368468705023065,0.939164691157497,1,4,kidney vasculature morphogenesis,BP,PKD2
14686,GO:0070309,0.368538752918549,0.939139116343616,1,4,lens fiber cell morphogenesis,BP,PROX1
3655,GO:0008142,0.368573646076381,0.939126374250197,1,4,oxysterol binding,MF,OSBPL5
2109,GO:0004887,0.368592786223321,0.939119384067033,1,4,thyroid hormone receptor activity,MF,NR2F6
15717,GO:0072284,0.368596794705409,0.939117920065208,1,4,metanephric S-shaped body morphogenesis,BP,PKD2
12744,GO:0051021,0.368680034268951,0.939087513979448,1,4,GDP-dissociation inhibitor binding,MF,PLXNB3
12745,GO:0051022,0.368680034268951,0.939087513979448,1,4,Rho GDP-dissociation inhibitor binding,MF,PLXNB3
8685,GO:0034316,0.368687954748504,0.939084620273632,1,4,negative regulation of Arp2/3 complex-mediated actin nucleation,BP,CORO1B
3832,GO:0008440,0.368722498223734,0.939071999018043,1,4,inositol-1,4,5-trisphosphate 3-kinase activity,MF,ITPKB
12158,GO:0048289,0.368761925226645,0.939057591510509,1,4,isotype switching to IgE isotypes,BP,STAT6
12161,GO:0048293,0.368761925226645,0.939057591510509,1,4,regulation of isotype switching to IgE isotypes,BP,STAT6
13080,GO:0051599,0.368778738799794,0.939051446825329,1,4,response to hydrostatic pressure,BP,PKD2
18317,GO:1903224,0.368786510578272,0.939048606425291,1,4,regulation of endodermal cell differentiation,BP,DUSP6
12300,GO:0048661,0.36879642800709,0.773109967224868,7,55,positive regulation of smooth muscle cell proliferation,BP,MEF2D;EGFR;HBEGF;AKT1;EREG;IRAK1;PAK1
7485,GO:0031663,0.36898387995662,0.796010662995111,5,38,lipopolysaccharide-mediated signaling pathway,BP,AKT1;TGFB1;IRAK1;MIF;MAPK3
19886,GO:2000348,0.368987398927182,0.938975158587066,1,4,regulation of CD40 signaling pathway,BP,SHARPIN
1358,GO:0003228,0.368989289451109,0.938974467127373,1,4,atrial cardiac muscle tissue development,BP,PROX1
13463,GO:0055009,0.368989289451109,0.938974467127373,1,4,atrial cardiac muscle tissue morphogenesis,BP,PROX1
15624,GO:0072126,0.369030128182189,0.93895952918382,1,4,positive regulation of glomerular mesangial cell proliferation,BP,EGR1
16258,GO:0090315,0.369157705972134,0.938912849605659,1,4,negative regulation of protein targeting to membrane,BP,GDI1
5630,GO:0016709,0.369229502975337,0.836838543403463,3,20,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen,MF,CYP27B1;NOS1;MICAL1
18591,GO:1903826,0.369367803967825,0.938835929315147,1,4,arginine transmembrane transport,BP,SLC25A29
18194,GO:1902953,0.369443270042983,0.938808285585609,1,4,positive regulation of ER to Golgi vesicle-mediated transport,BP,SORL1
11416,GO:0045840,0.369459714561506,0.795642368169207,5,38,positive regulation of mitotic nuclear division,BP,LRP5;TGFB1;EREG;TGFA;INSR
18058,GO:1902576,0.369499239656522,0.938787778633462,1,4,negative regulation of nuclear cell cycle DNA replication,BP,CHEK2
15911,GO:0072687,0.369507291766884,0.938784828041442,1,4,meiotic spindle,CC,SIRT2
14908,GO:0070742,0.369638004072521,0.87277708353262,2,12,C2H2 zinc finger domain binding,MF,HMGA2;ZXDC
15919,GO:0072708,0.369736048728495,0.938700966855964,1,4,response to sorbitol,BP,MAPK13
5225,GO:0015837,0.369759283172118,0.812485445064831,4,29,amine transport,BP,STK39;RAB3B;NTSR1;SV2A
3872,GO:0008504,0.369844526907299,0.938661174868479,1,4,monoamine transmembrane transporter activity,MF,SLC29A4
1533,GO:0003917,0.369933132433943,0.938628660912837,1,4,DNA topoisomerase type I activity,MF,TOP3B
9409,GO:0035977,0.369966555990333,0.93861639335591,1,4,protein deglycosylation involved in glycoprotein catabolic process,BP,EDEM1
16617,GO:0097466,0.369966555990333,0.93861639335591,1,4,ubiquitin-dependent glycoprotein ERAD pathway,BP,EDEM1
18827,GO:1904382,0.369966555990333,0.93861639335591,1,4,mannose trimming involved in glycoprotein ERAD pathway,BP,EDEM1
18911,GO:1904587,0.369966555990333,0.93861639335591,1,4,response to glycoprotein,BP,EDEM1
9664,GO:0038027,0.369968023566614,0.938615854672322,1,4,apolipoprotein A-I-mediated signaling pathway,BP,ABCA7
18468,GO:1903546,0.370023794071935,0.938595381610581,1,4,protein localization to photoreceptor outer segment,BP,TUB
3754,GO:0008298,0.370030259402541,0.872543987086456,2,12,intracellular mRNA localization,BP,ZFP36L1;ZNF385A
8639,GO:0034190,0.370104408296171,0.938565781206047,1,4,apolipoprotein receptor binding,MF,PCSK9
10511,GO:0043426,0.370162622805087,0.938544400262213,1,4,MRF binding,MF,BHLHE40
996,GO:0002457,0.37019543091842,0.938532348548905,1,4,T cell antigen processing and presentation,BP,HFE
17454,GO:1900226,0.370203585543886,0.938529352810365,1,4,negative regulation of NLRP3 inflammasome complex assembly,BP,SIRT2
9290,GO:0035733,0.370227936012616,0.938520406728174,1,4,hepatic stellate cell activation,BP,CYGB
4921,GO:0014866,0.370307882463874,0.938491029749981,1,4,skeletal myofibril assembly,BP,PROX1
1717,GO:0004308,0.37032199092599,0.938485844593457,1,4,exo-alpha-sialidase activity,MF,GLB1
5775,GO:0016997,0.37032199092599,0.938485844593457,1,4,alpha-sialidase activity,MF,GLB1
7134,GO:0030976,0.370407095446774,0.938454561248823,1,4,thiamine pyrophosphate binding,MF,DHTKD1
885,GO:0002250,0.370431394619544,0.711176284242614,23,198,adaptive immune response,BP,ERCC1;PRR7;PKN1;ORAI1;POU2F2;STAT6;PAG1;SERPING1;RAG1;CEACAM1;IL20RB;TGFB1;SCART1;IFNE;PRKCZ;ADA;JAK3;PRKCD;INPP5D;FYN;PPP3CB;HFE;ZP3
1920,GO:0004614,0.370470783205329,0.93843114410122,1,4,phosphoglucomutase activity,MF,PGM1
11115,GO:0045159,0.370636138156281,0.938370319951336,1,4,myosin II binding,MF,GSN
5172,GO:0015727,0.370843083841136,0.938294145548439,1,4,lactate transport,BP,SLC16A3
9357,GO:0035873,0.370843083841136,0.938294145548439,1,4,lactate transmembrane transport,BP,SLC16A3
12166,GO:0048298,0.370852483352174,0.938290684333069,1,4,positive regulation of isotype switching to IgA isotypes,BP,TGFB1
13768,GO:0060364,0.370906883720266,0.938270649969035,1,4,frontal suture morphogenesis,BP,TGFB1
12507,GO:0050656,0.370957873723895,0.938251867966197,1,4,3'-phosphoadenosine 5'-phosphosulfate binding,MF,GAL3ST4
9866,GO:0042133,0.370976398280714,0.749836690659651,10,81,neurotransmitter metabolic process,BP,NOS1;ACP5;SMAD3;AKT1;PKD2;DNM2;CHKA;INSR;ALDH7A1;GCH1
11105,GO:0045134,0.370988487192517,0.938240589922288,1,4,uridine-diphosphatase activity,MF,ENTPD6
3443,GO:0007257,0.370995304417694,0.811956759524162,4,28,activation of JUN kinase activity,BP,PKN1;ERCC6;PTPN1;MAP3K10
10992,GO:0044803,0.371087009975907,0.938204285480226,1,4,multi-organism membrane organization,BP,GAS6
19188,GO:1905232,0.371110804020598,0.938195515717486,1,4,cellular response to L-glutamate,BP,FYN
5015,GO:0015179,0.371194763242522,0.794560355665855,5,37,L-amino acid transmembrane transporter activity,MF,SLC7A8;SLC15A4;SERINC2;SLC43A1;SLC25A29
13718,GO:0060297,0.371227903464213,0.93815234537392,1,4,regulation of sarcomere organization,BP,PROX1
14159,GO:0061052,0.371275364249149,0.938134843064738,1,4,negative regulation of cell growth involved in cardiac muscle cell development,BP,PAK1
12130,GO:0048243,0.371279939408759,0.938133155704851,1,4,norepinephrine secretion,BP,NISCH
18876,GO:1904505,0.371317393825617,0.938119341126489,1,4,regulation of telomere maintenance in response to DNA damage,BP,ERCC1
18877,GO:1904506,0.371317393825617,0.938119341126489,1,4,negative regulation of telomere maintenance in response to DNA damage,BP,ERCC1
14793,GO:0070522,0.371317393825643,0.938119341126463,1,4,ERCC4-ERCC1 complex,CC,ERCC1
1771,GO:0004376,0.371324408872215,0.938116753508174,1,4,glycolipid mannosyltransferase activity,MF,PIGV
15873,GO:0072603,0.371359287239661,0.938103887055423,1,4,interleukin-5 secretion,BP,PRKCZ
20057,GO:2000662,0.371359287239661,0.938103887055423,1,4,regulation of interleukin-5 secretion,BP,PRKCZ
17674,GO:1901522,0.371377300145628,0.835362034951432,3,20,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus,BP,VEGFA;CARF;SESN2
9729,GO:0038189,0.371454375663894,0.938068801142236,1,4,neuropilin signaling pathway,BP,VEGFA
15899,GO:0072674,0.371469569895999,0.938063193622357,1,4,multinuclear osteoclast differentiation,BP,SH3PXD2A
15900,GO:0072675,0.371469569895999,0.938063193622357,1,4,osteoclast fusion,BP,SH3PXD2A
3082,GO:0006659,0.37150103657187,0.938051579679064,1,4,phosphatidylserine biosynthetic process,BP,SLC27A1
18471,GO:1903553,0.371547124743038,0.93803456673648,1,4,positive regulation of extracellular exosome assembly,BP,SDC1
9303,GO:0035754,0.371561519109463,0.938029252630936,1,4,B cell chemotaxis,BP,GAS6
16966,GO:0098976,0.371676877811585,0.937986654530124,1,4,excitatory chemical synaptic transmission,BP,SSH1
3499,GO:0007406,0.371723142806397,0.937969565408528,1,4,negative regulation of neuroblast proliferation,BP,TGFB1
11609,GO:0046322,0.37180224795735,0.93794033931594,1,4,negative regulation of fatty acid oxidation,BP,AKT1
11811,GO:0046716,0.371837387722298,0.871467378065205,2,12,muscle cell cellular homeostasis,BP,GAA;PFKM
150,GO:0000306,0.371846317050641,0.937924053964233,1,4,extrinsic component of vacuolar membrane,CC,ULK1
18562,GO:1903763,0.371864380513121,0.937917378015946,1,4,gap junction channel activity involved in cell communication by electrical coupling,MF,GJC2
8787,GO:0034485,0.371878606556773,0.937912120004319,1,4,phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,MF,INPP5D
12460,GO:0050321,0.371916885263481,0.871419913816022,2,12,tau-protein kinase activity,MF,MARK4;BRSK1
12281,GO:0048625,0.37194270577907,0.937888425269611,1,4,myoblast fate commitment,BP,EPAS1
3473,GO:0007320,0.371945145554278,0.937887523280582,1,4,insemination,BP,SERPINE2
8396,GO:0033353,0.372040158096062,0.937852390770471,1,4,S-adenosylmethionine cycle,BP,AHCY
14671,GO:0070290,0.372063314351533,0.937843826514636,1,4,N-acylphosphatidylethanolamine-specific phospholipase D activity,MF,PLD3
972,GO:0002420,0.372103679777441,0.937828895791164,1,4,natural killer cell mediated cytotoxicity directed against tumor cell target,BP,CEACAM1
973,GO:0002423,0.372103679777441,0.937828895791164,1,4,natural killer cell mediated immune response to tumor cell,BP,CEACAM1
1196,GO:0002855,0.372103679777441,0.937828895791164,1,4,regulation of natural killer cell mediated immune response to tumor cell,BP,CEACAM1
1199,GO:0002858,0.372103679777441,0.937828895791164,1,4,regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,CEACAM1
8983,GO:0035095,0.372158703228991,0.937808539706619,1,4,behavioral response to nicotine,BP,PPARA
1699,GO:0004176,0.372212838885604,0.937788508100635,1,4,ATP-dependent peptidase activity,MF,LONP2
14575,GO:0070122,0.372227136535397,0.937783216940844,1,4,isopeptidase activity,MF,GGT1
5219,GO:0015822,0.372230377595377,0.937782017477245,1,4,ornithine transport,BP,SLC25A29
18373,GO:1903352,0.372230377595377,0.937782017477245,1,4,L-ornithine transmembrane transport,BP,SLC25A29
14998,GO:0070932,0.372231445011369,0.834773251607992,3,20,histone H3 deacetylation,BP,HDAC5;HDAC7;SIRT2
18476,GO:1903564,0.372234665196077,0.937780430684029,1,4,regulation of protein localization to cilium,BP,CROCC
19529,GO:1990405,0.372247297801346,0.93777575535486,1,4,protein antigen binding,MF,ITGA4
7640,GO:0032058,0.372257563794091,0.93777195575145,1,4,positive regulation of translational initiation in response to stress,BP,IMPACT
1102,GO:0002690,0.372277564032546,0.780248409862547,6,48,positive regulation of leukocyte chemotaxis,BP,PGF;VEGFA;VEGFB;RAC2;GAS6;MAPK3
5771,GO:0016972,0.372305430075446,0.937754237830865,1,4,thiol oxidase activity,MF,QSOX1
13941,GO:0060633,0.372332311518593,0.937744286194824,1,4,negative regulation of transcription initiation from RNA polymerase II promoter,BP,CTNNBIP1
19768,GO:2000143,0.372332311518593,0.937744286194824,1,4,negative regulation of DNA-templated transcription, initiation,BP,CTNNBIP1
16586,GO:0097396,0.372372638652845,0.937729355082512,1,4,response to interleukin-17,BP,IL17RE
16587,GO:0097398,0.372372638652845,0.937729355082512,1,4,cellular response to interleukin-17,BP,IL17RE
16588,GO:0097400,0.372372638652845,0.937729355082512,1,4,interleukin-17-mediated signaling pathway,BP,IL17RE
7505,GO:0031697,0.372373583383083,0.937729005270298,1,4,beta-1 adrenergic receptor binding,MF,DLG4
18520,GO:1903671,0.372378576545856,0.834671738235012,3,20,negative regulation of sprouting angiogenesis,BP,HDAC5;EPN2;NGFR
8045,GO:0032713,0.37240928910961,0.937715783366337,1,4,negative regulation of interleukin-4 production,BP,ZFPM1
18618,GO:1903891,0.372412758497356,0.937714498553837,1,4,regulation of ATF6-mediated unfolded protein response,BP,WFS1
14934,GO:0070827,0.372421986219398,0.937711081188151,1,4,chromatin maintenance,BP,MTHFR
6372,GO:0021562,0.372423154112742,0.937710648665996,1,4,vestibulocochlear nerve development,BP,SLITRK6
6402,GO:0021636,0.372423154112961,0.937710648665918,1,4,trigeminal nerve morphogenesis,BP,SEMA3F
6403,GO:0021637,0.372423154112961,0.937710648665918,1,4,trigeminal nerve structural organization,BP,SEMA3F
16630,GO:0097490,0.372423154112961,0.937710648665918,1,4,sympathetic neuron projection extension,BP,SEMA3F
16631,GO:0097491,0.372423154112961,0.937710648665918,1,4,sympathetic neuron projection guidance,BP,SEMA3F
9969,GO:0042363,0.372430013096623,0.937708108446736,1,4,fat-soluble vitamin catabolic process,BP,CYP27B1
1292,GO:0003104,0.372447089421442,0.937701783968678,1,4,positive regulation of glomerular filtration,BP,GAS6
16411,GO:0097048,0.372447089421538,0.937701783968724,1,4,dendritic cell apoptotic process,BP,GAS6
20063,GO:2000668,0.372447089421538,0.937701783968724,1,4,regulation of dendritic cell apoptotic process,BP,GAS6
18681,GO:1904016,0.372451090041265,0.93770030222129,1,4,response to Thyroglobulin triiodothyronine,BP,GLB1
12054,GO:0048013,0.372460421849268,0.75453908180346,9,73,ephrin receptor signaling pathway,BP,AP2A2;EPHA1;EPHB2;EFNB3;DNM1;GIT1;FYN;PAK1;SDC2
16516,GO:0097227,0.372463827926779,0.937695584227406,1,4,sperm annulus,CC,SEPT6
17371,GO:1900084,0.372540223601222,0.937667283412645,1,4,regulation of peptidyl-tyrosine autophosphorylation,BP,VEGFA
1649,GO:0004095,0.372544216117425,0.937665804167555,1,4,carnitine O-palmitoyltransferase activity,MF,CPT2
5482,GO:0016416,0.372544216117425,0.937665804167555,1,4,O-palmitoyltransferase activity,MF,CPT2
16108,GO:0090091,0.372547358433893,0.93766463991032,1,4,positive regulation of extracellular matrix disassembly,BP,FSCN1
18578,GO:1903795,0.372548453615075,0.937664234132313,1,4,regulation of inorganic anion transmembrane transport,BP,PRNP
6897,GO:0030478,0.372548763381606,0.937664119359824,1,4,actin cap,CC,GSN
8618,GO:0034144,0.372550135052705,0.937663611136338,1,4,negative regulation of toll-like receptor 4 signaling pathway,BP,NR1D1
11965,GO:0047238,0.372550442294548,0.937663497298441,1,4,glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,MF,CHPF
7617,GO:0032021,0.372550442294661,0.93766349729847,1,4,NELF complex,CC,NELFCD
16342,GO:0090599,0.372550442294663,0.937663497298468,1,4,alpha-glucosidase activity,MF,GAA
9704,GO:0038114,0.372550442294668,0.937663497298463,1,4,interleukin-21-mediated signaling pathway,BP,JAK3
16845,GO:0098756,0.372550442294668,0.937663497298463,1,4,response to interleukin-21,BP,JAK3
16846,GO:0098757,0.372550442294668,0.937663497298463,1,4,cellular response to interleukin-21,BP,JAK3
18945,GO:1904684,0.372550442294668,0.937663497298463,1,4,negative regulation of metalloendopeptidase activity,BP,SORL1
19622,GO:1990745,0.372550442294687,0.937663497298444,1,4,EARP complex,CC,VPS51
757,GO:0001999,0.372550442294687,0.937663497298444,1,4,renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure,BP,F2R
758,GO:0002001,0.372550442294687,0.937663497298444,1,4,renin secretion into blood stream,BP,F2R
337,GO:0000938,0.372550442294687,0.937663497298444,1,4,GARP complex,CC,VPS51
18850,GO:1904431,0.372550442294688,0.937663497298444,1,4,positive regulation of t-circle formation,BP,ERCC1
18137,GO:1902816,0.372550442294688,0.937663497298444,1,4,regulation of protein localization to microtubule,BP,ABHD17C
18138,GO:1902817,0.372550442294688,0.937663497298444,1,4,negative regulation of protein localization to microtubule,BP,ABHD17C
7121,GO:0030951,0.372550442294689,0.937663497298442,1,4,establishment or maintenance of microtubule cytoskeleton polarity,BP,LMNA
14094,GO:0060947,0.372550442294689,0.937663497298442,1,4,cardiac vascular smooth muscle cell differentiation,BP,VEGFA
609,GO:0001778,0.372550442294692,0.937663497298439,1,4,plasma membrane repair,BP,DYSF
1430,GO:0003402,0.372550442294692,0.937663497298439,1,4,planar cell polarity pathway involved in axis elongation,BP,VANGL2
2743,GO:0006145,0.372550442294692,0.937663497298439,1,4,purine nucleobase catabolic process,BP,XDH
3603,GO:0008046,0.372550442294692,0.937663497298439,1,4,axon guidance receptor activity,MF,EPHB2
9642,GO:0036515,0.372550442294692,0.937663497298439,1,4,serotonergic neuron axon guidance,BP,VANGL2
11393,GO:0045794,0.372550442294692,0.937663497298439,1,4,negative regulation of cell volume,BP,SHANK3
12487,GO:0050510,0.372550442294692,0.937663497298439,1,4,N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity,MF,CHPF
14244,GO:0061304,0.372550442294692,0.937663497298439,1,4,retinal blood vessel morphogenesis,BP,LRP5
3400,GO:0007185,0.372550442294692,0.937663497298439,1,4,transmembrane receptor protein tyrosine phosphatase signaling pathway,BP,PTPRU
7157,GO:0031034,0.372550442294692,0.937663497298439,1,4,myosin filament assembly,BP,OBSL1
15767,GO:0072367,0.372550442294692,0.937663497298439,1,4,regulation of lipid transport by regulation of transcription from RNA polymerase II promoter,BP,PPARA
2627,GO:0005955,0.372550442294692,0.937663497298439,1,4,calcineurin complex,CC,PPP3CB
1335,GO:0003190,0.372550442294692,0.937663497298439,1,4,atrioventricular valve formation,BP,ZFPM1
9936,GO:0042297,0.372550442294694,0.937663497298437,1,4,vocal learning,BP,SHANK3
16779,GO:0098596,0.372550442294694,0.937663497298437,1,4,imitative learning,BP,SHANK3
16781,GO:0098598,0.372550442294694,0.937663497298437,1,4,learned vocalization behavior or vocal learning,BP,SHANK3
12205,GO:0048406,0.372550442294696,0.937663497298435,1,4,nerve growth factor binding,MF,NGFR
661,GO:0001865,0.372550442294696,0.937663497298435,1,4,NK T cell differentiation,BP,AP3D1
11774,GO:0046643,0.372550442294696,0.937663497298435,1,4,regulation of gamma-delta T cell activation,BP,SOX13
12821,GO:0051136,0.372550442294696,0.937663497298435,1,4,regulation of NK T cell differentiation,BP,AP3D1
20139,GO:2000807,0.372550442294696,0.937663497298435,1,4,regulation of synaptic vesicle clustering,BP,NLGN2
19941,GO:2000425,0.372550442294742,0.937663497298389,1,4,regulation of apoptotic cell clearance,BP,ABCA7
16016,GO:0086036,0.372550442294828,0.937663497298444,1,4,regulation of cardiac muscle cell membrane potential,BP,EHD3
18044,GO:1902548,0.372550442294833,0.937663497298439,1,4,negative regulation of cellular response to vascular endothelial growth factor stimulus,BP,XDH
7443,GO:0031585,0.372550442294833,0.937663497298439,1,4,regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,BP,PKD2
20069,GO:2000675,0.372550442294833,0.937663497298439,1,4,negative regulation of type B pancreatic cell apoptotic process,BP,WFS1
4840,GO:0014048,0.372550442294833,0.937663497298439,1,4,regulation of glutamate secretion,BP,NTSR1
10398,GO:0043237,0.372550442294833,0.937663497298439,1,4,laminin-1 binding,MF,NID1
1325,GO:0003175,0.372550442294859,0.937663497298413,1,4,tricuspid valve development,BP,ZFPM1
1333,GO:0003186,0.372550442294859,0.937663497298413,1,4,tricuspid valve morphogenesis,BP,ZFPM1
9117,GO:0035426,0.372550442294883,0.937663497298389,1,4,extracellular matrix-cell signaling,BP,LRP5
14312,GO:0061476,0.372550442294922,0.937663497298492,1,4,response to anticoagulant,BP,EGR1
15306,GO:0071503,0.372550442294922,0.937663497298492,1,4,response to heparin,BP,EGR1
15307,GO:0071504,0.372550442294922,0.937663497298492,1,4,cellular response to heparin,BP,EGR1
4624,GO:0010746,0.372550442294944,0.93766349729847,1,4,regulation of plasma membrane long-chain fatty acid transport,BP,AKT1
4625,GO:0010748,0.372550442294944,0.93766349729847,1,4,negative regulation of plasma membrane long-chain fatty acid transport,BP,AKT1
249,GO:0000710,0.372550442294944,0.93766349729847,1,4,meiotic mismatch repair,BP,ERCC1
13509,GO:0055091,0.372550442294969,0.937663497298444,1,4,phospholipid homeostasis,BP,ABCG1
11117,GO:0045162,0.372550442294972,0.937663497298441,1,4,clustering of voltage-gated sodium channels,BP,AGRN
7109,GO:0030916,0.372550442294974,0.937663497298439,1,4,otic vesicle formation,BP,PROX1
15357,GO:0071600,0.372550442294974,0.937663497298439,1,4,otic vesicle morphogenesis,BP,PROX1
786,GO:0002051,0.372550442294974,0.937663497298439,1,4,osteoblast fate commitment,BP,SH3PXD2B
6958,GO:0030618,0.372550442294974,0.937663497298439,1,4,transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity,MF,SMAD3
2151,GO:0004970,0.372550442294976,0.937663497298437,1,4,ionotropic glutamate receptor activity,MF,GRIN3B
13111,GO:0051660,0.372550442294976,0.937663497298437,1,4,establishment of centrosome localization,BP,FHOD1
16795,GO:0098639,0.372550442295002,0.937663497298411,1,4,collagen binding involved in cell-matrix adhesion,MF,ITGA1
3380,GO:0007161,0.372550442295026,0.937663497298387,1,4,calcium-independent cell-matrix adhesion,BP,PKD1
6706,GO:0030122,0.372629510009499,0.870994050902099,2,12,AP-2 adaptor complex,CC,EGFR;AP2A2
10543,GO:0043501,0.372658337610785,0.870976808893331,2,12,skeletal muscle adaptation,BP,TNNT1;GTF2IRD1
3252,GO:0006919,0.373151140683649,0.753658831136276,9,76,activation of cysteine-type endopeptidase activity involved in apoptotic process,BP,XDH;F2R;SMAD3;DAP;TNFSF15;BOK;BAX;NGFR;PDCD6
5261,GO:0015893,0.373752675376169,0.737496883247183,12,100,drug transport,BP,SLC6A8;RAB3B;NTSR1;CD320;CYGB;SLC13A5;SLC25A29;SLC22A18;SLC13A3;PRAF2;SLC35F3;MFSD10
12392,GO:0048844,0.373904704859739,0.792455275596384,5,37,artery morphogenesis,BP,VEGFA;APOE;LRP1;PKD2;PROX1
4034,GO:0009068,0.374000500335357,0.870172784764471,2,12,aspartate family amino acid catabolic process,BP,ALDH7A1;PHYKPL
7656,GO:0032092,0.374226740340338,0.753044362134315,9,73,positive regulation of protein binding,BP,APOE;LRP1;TMEM173;RFNG;MFNG;CAPRIN2;PKD1;MAPRE3;HFE
698,GO:0001919,0.374275643980203,0.833360435567233,3,20,regulation of receptor recycling,BP,ARAP1;PCSK9;TBC1D16
2246,GO:0005159,0.374439399965194,0.869909323177002,2,12,insulin-like growth factor receptor binding,MF,SHC1;INSR
13613,GO:0060117,0.37482457058149,0.86967789520975,2,12,auditory receptor cell development,BP,FGFR1;SLITRK6
2294,GO:0005254,0.375077452388713,0.808533309051873,4,29,chloride channel activity,MF,TTYH3;ANO8;CLCA2;SLC26A11
18822,GO:1904377,0.375110917226952,0.778355220475675,6,46,positive regulation of protein localization to cell periphery,BP,PRNP;EGFR;LRP1;AKT1;EPHB2;ITGA3
3586,GO:0008013,0.375145083413611,0.759522957436195,8,63,beta-catenin binding,MF,CTNNBIP1;SLC9A3R2;SMAD3;DVL1;PTPRU;ASH2L;KDM6B;PXN
7229,GO:0031143,0.375458722606562,0.869296422344055,2,12,pseudopodium,CC,CAPN2;MAPK3
12155,GO:0048284,0.375693081448896,0.718959627844393,17,145,organelle fusion,BP,EVI5L;VAT1;SYTL1;VPS11;TBC1D14;SYT8;DYSF;BNIP3;TBC1D9B;VAMP2;BAX;STX10;VPS16;SGSM2;TBC1D16;RABGAP1;TBC1D8
15122,GO:0071219,0.375769142076485,0.731574503003686,13,110,cellular response to molecule of bacterial origin,BP,TNIP1;NR1D1;PDCD4;AKT1;HDAC5;BCR;CEBPB;ADAMTS13;TGFB1;IRAK1;MIF;MAPK3;SIRT2
15164,GO:0071295,0.37577597135087,0.832320185425133,3,20,cellular response to vitamin,BP,CYP27B1;POSTN;GAS6
15420,GO:0071696,0.375991827606234,0.868975304964733,2,12,ectodermal placode development,BP,PROX1;EDA
5074,GO:0015298,0.376249835567152,0.831991047382514,3,20,solute:cation antiporter activity,MF,SLC9A7;SLC22A18;TMCO3
4456,GO:0010447,0.376376977380497,0.868743064834694,2,12,response to acidic pH,BP,IMPACT;ASIC1
17735,GO:1901655,0.376387571838261,0.758356054737236,8,64,cellular response to ketone,BP,EGFR;AKT1;ERRFI1;TGFB1;PCK2;DDIT4;ADCY1;ADCY6
2518,GO:0005774,0.37640293793815,0.687529326970273,39,345,vacuolar membrane,CC,TSPAN1;VPS11;GAA;MARCH9;TMEM8A;LRP1;AP2A2;CYBRD1;STOM;TPCN1;SLC15A4;ATG16L2;LDLR;BRI3;PCSK9;AP3D1;ABCA2;TMEM9;DIRC2;PI4K2A;SLC48A1;WDR59;ULK1;SLC22A17;LPCAT1;PI4K2B;RAB12;SYNGR1;CD68;SPPL2B;SLC12A4;C12ORF66;VPS16;MAN2B1;ATP6V1F;PLEKHM1;COL6A1;MAN2B2;SLC26A11
12600,GO:0050789,0.376419800204353,0.646526667529409,805,7543,regulation of biological process,BP,TNIP1;DUSP6;NT5E;XDH;ERCC1;DUSP5;MEF2D;ZMYND8;ADGRL1;CITED4;SEMA4B;HTRA1;FHL1;EGR1;NR1D1;CCNG2;EDEM1;DLG4;PLAT;CST3;CYP27B1;MRC2;TYSND1;HS1BP3;BTBD2;FBXO2;APLN;PGF;PDCD4;CTNNBIP1;KCNG1;ACVR2B;DOCK4;XPC;PRNP;PARVB;BBS2;DDIT4L;POSTN;VEGFA;FAM210B;TNFRSF6B;WNT7A;APOE;DGKA;TSPAN1;ESPN;F2R;LRP5;ITGA6;PITPNC1;HMGA2;OBSCN;NDRG1;IDH2;ZKSCAN1;ELK3;ITPR3;PKN1;MTA1;GRAMD4;ARRDC1;EVI5L;NISCH;FCGRT;EGFR;RPS6KA2;SERPINE2;DNPH1;WWTR1;SCN4B;OBSL1;NOS1;VAT1;PTPRS;HADH;SPRY2;CAPN2;MST1R;NFATC4;TRIM65;BAHCC1;CRTAP;LTBP4;PRSS8;SYTL1;SDC1;ETV5;LMF1;APPL2;SHC1;DDB2;ORAI1;LTBP2;VPS11;LTBP1;TBC1D14;ARL2;HEXB;GTPBP1;TCFL5;PTPRE;RIN1;ACTA2;MMP1;ETV4;PHLDA2;SNX9;TRNP1;SPRY4;RAPGEF3;TXNRD3;ZFP36L1;GAA;GLUL;ARAP1;MAP2K2;NME4;ZC3H6;LPAR3;PLCD3;MDFI;PTOV1;SMARCA1;PPP1R35;CMTM7;RBCK1;PLTP;PC;TP53I11;FOXQ1;MAP2K1;ACP5;CPT2;MCTP1;MXD4;SSH1;POU2F2;EXOC2;ENDOG;MARK4;KCNJ15;MARCKSL1;SMURF2;TSC22D1;FOS;FBLN1;SMAD3;ARHGAP23;STAT6;SHANK2;PIK3R2;ERCC6;LRP1;GJC2;DVL1;EPAS1;DNAJB5;HBEGF;FAM110C;AP2A2;S100A4;ITGB4;PPP1R14A;SH3PXD2B;PPP2R3B;PRDX5;SHC2;NLGN2;STOM;BRD3;PRODH;SALL2;FBXW5;PAG1;ZXDC;RNF187;ADORA2B;ADARB1;PLCXD2;SYT8;AKT1;TPCN1;GRB7;KCNC4;TMOD2;CORO1B;HDAC5;FAM83A;S100A6;F12;SH2D2A;PPM1F;MMP28;PITPNM1;PLEKHH3;RHBDF2;BSG;STK39;HK1;SERPING1;ASAP2;SCMH1;EPHA1;GGT1;NFKBIZ;PTPRU;VEGFB;FMNL2;ASH2L;IMPACT;WWC3;LRRC8A;CNTN1;IFNGR2;BRSK1;DAP;IFT140;PTHLH;MYZAP;RAB31;FGFR4;HEBP1;PEAR1;WNT2B;FNDC4;LDLR;FGFR1;PRKACB;MAPKBP1;SIGMAR1;RAC2;KCNAB2;SMOC2;PFKL;SEC14L2;HLTF;MXI1;NPHP4;SYNE3;RAG1;GAMT;H2AFJ;KLF7;RALGDS;SORL1;NAT14;CEACAM1;CCNI;B3GAT3;ASB13;CIRBP;HMG20B;LZTS2;RAB11FIP4;TENM2;ZNF385A;DOCK6;NSMCE4A;ANK3;IGFBP4;EVC;TSHZ1;TRAPPC9;CCND1;PODNL1;EFS;PCBP4;TCF25;TNNT1;TWF2;STRADB;SYNGAP1;PLCH2;MAPK13;CEP250;EDNRA;CARD19;PLAU;GAS6;PTK6;SEMA3F;FGFBP1;CSNK1E;CTSB;RAB3B;CARD11;SH2B3;SOX13;LAMA5;DUSP7;GSN;CMTM4;PLEKHG2;MAPKAPK3;IGFBP2;PCSK9;ARHGAP22;RAD23A;BCR;ANTXR2;ANGPTL4;EHD4;ERRFI1;GLI4;WIPF1;ZSCAN18;AIP;STON1;CCDC71L;MYEF2;MN1;SH3D19;CDC25B;RGL2;SLITRK6;TSPAN18;PAQR6;ARPIN;ARHGAP27;ALOX15B;SPTB;SMARCD2;AGAP1;NXPH4;CCS;SLC20A1;NPR2;SNTA1;DGKQ;PLXNB3;BNIP3;PAK6;TFPI2;GTF2IRD1;SHARPIN;MVB12B;TAGLN3;FYCO1;CEMIP;PROCR;PKD2;FAM3A;YPEL3;RASGEF1A;CTSZ;CDC42EP5;HES2;CRTC1;IL20RB;FBXW8;GPSM1;AP3D1;ITGB5;ABCA2;ZNF598;MAGEF1;EPOR;EPHB2;GRIN3B;ADAM8;ASIC1;CTBP1;MNT;GRK6;CDKN1C;PLCG1;ZMIZ2;SH3BP2;NYAP1;CD81;CEBPB;MVD;RNF135;ENTPD2;ADAMTS13;ZNF217;TIMP2;ZNF862;WNT3;GNAL;C8ORF88;TMED4;TGFB1;CLTCL1;RFX2;SCYL1;ABHD17C;UNK;ULK2;GPC1;MKNK2;ADAMTS7;DEAF1;MOAP1;TBC1D9B;NTSR1;NAB2;TMEM173;ARHGAP25;ZSCAN30;FHOD3;SHANK3;MSRB2;EFNB3;RASA3;PNRC1;TNFSF15;EML2;KIF26B;NSMF;PEG3;ARAP3;FARP1;MC1R;TUB;CROCC;RHOD;CGREF1;ABHD14B;ABTB1;SNX17;RNH1;ERO1B;HTR7;VGF;PLEKHG4;SNX33;SEMA4F;RHOF;WASF3;LLGL1;PHF21A;PLEKHG3;MIF4GD;KIF7;RHOBTB2;KHDRBS3;ZER1;GIGYF1;RIMS3;TNFAIP8L1;PTPN1;TPP1;PCK2;WDR59;AGRN;MBD3;IFNE;CD320;CAMK2N1;LRP4;GPR153;VHL;CEP131;TRAP1;ADAP1;PFKFB2;RFNG;MLXIPL;TRIB2;PRKCZ;KDM6B;PRKACA;MINK1;ZNF516;OXA1L;RHPN1;RABGGTA;TOM1L2;CD9;EPN2;ADA;AREG;PIM2;MICALL2;PLEKHG5;BOK;WDR18;TDRKH;CAPG;SDCCAG8;ALAS1;NEURL1B;ERBB2;ADGRB2;ULK1;NINL;VAMP2;MMP10;TFDP2;PLEK2;C6ORF89;NECAB3;STK17A;RILPL1;JAK3;IRF2BP2;NET1;BNIP3L;CYFIP2;FSCN1;PBX2;TRPC1;NELFCD;SLC22A17;RASA4;PDK1;CYGB;ARHGAP44;PRKCD;FAM20C;MIB2;REEP6;RBL2;CACNB3;USP20;STUB1;IFI6;BAX;SV2A;ITGA1;OLFM2;ZNF395;SH3BP1;FBXW4;CHADL;EREG;RPS6KA5;DGUOK;DUSP4;ZNF524;CUL9;SOX12;TMBIM4;DDIT4;MBTPS2;SPRED3;PPP1R13L;CARF;AHNAK2;PCSK1N;MT2A;IER2;RASL10B;ZDHHC8;TMX4;NID1;LIMK1;TGFBR3;PDIA5;GDI1;DIP2A;LTB4R2;LEMD2;RPS6KA6;ZHX3;DNM1;WASH3P;RGS14;TMEM8B;SCN8A;MFNG;GSTO1;GIT1;CHAD;LPCAT1;LRSAM1;ADAM15;REEP2;ASB1;EHD3;TMEM231;LONP2;SYMPK;MAPK12;IRAK1;TGFA;HDAC7;FHOD1;INPP5D;MTHFR;CHD2;CBX7;CHEK2;ZFPM1;PPARA;TMEM161A;SESN2;ABCG1;MYO1D;CDC34;SOX7;ABCA7;RAB12;SPEG;SIX5;BCAP31;MIF;KDM4B;ZNF414;MEX3A;BCAM;PLA2G6;DDT;SSBP4;SYNGR1;ECM1;WFS1;QSOX1;ZNF444;DTX3;TRPT1;NBPF3;SPPL2B;FYN;STK25;RAC3;EEF2K;ICAM5;ARHGAP12;ACAP3;ARID5B;HOXC5;DNM2;BHLHE40;PELI1;SNX15;INF2;CHKA;CAT;BEX2;NEIL1;TSPYL2;IGFBP7;ELFN2;SLC27A1;ZMYM3;TPBG;APOBEC3C;SATB1;SLC50A1;KIF26A;PLCB3;IQSEC1;ZNF606;APOBEC3F;ARHGEF4;MAPK3;INSR;RTN2;ARHGEF1;PAN2;GRINA;CAMTA2;TAZ;PFKM;ADCY1;C12ORF66;RERE;HLA-G;DOCK9;STX10;INO80C;TMEM101;RALGAPA1;ETAA1;GLRX;BCL7A;CEP72;VANGL2;PAK1;CAMKK2;PPP3CB;RNF144A;LGALS3BP;ROBO4;USP21;PFKFB3;MLYCD;CUL7;GABBR1;MICAL1;HYAL1;SEMA4C;CAPRIN2;ZBTB10;WDTC1;HES7;ITGA3;STK32C;DNMT3A;SAMD8;BIN1;VPS16;SRMS;PPP2R5B;HES6;MAP2K3;BCL2L1;DLG3;SGSM2;RRAS;PROX1;LRCH4;TBC1D16;ADGRF1;LMNA;ZYG11B;PKD1;KCTD13;TNFRSF25;RABGAP1;SIRT2;FAM129B;CDH4;ITGA4;EDA;DCBLD2;BACH1;TRIP10;ADCY7;E2F5;ZBTB22;LTB4R;MAPRE3;AZIN2;RAB28;ZNF704;SERPINB1;ICA1;RAP1GAP2;LAMB1;SOCS7;MAP3K10;RGS19;NDE1;GPR3;PELI3;GTF2IRD2;RAB40B;NGFR;TOLLIP;BCORL1;PDCD6;ATP6V1F;PCLO;ZNF837;PXN;GRB10;TBC1D8;PLEKHM1;GCH1;LURAP1;KIF13B;MAFF;NR2F6;CBX6;TCTN1;PNMA1;CAMK1;CAMKK1;EZH1;SIRT3;HFE;TERC;ZNF513;GAS2L1;BTG1;BBS10;ZP3;CELSR1;MLF2;IL17RE;SEMA3B;CDK11B;PFN2;SSH3;FGFR3;PPP1R16A;CCDC88C;TNRC18;NDRG2;CBLC;ITPKB;SPTLC2;TCEA2;CDC42BPG;ZBTB47;PLAG1;CLK3;IRF2BPL;KDM3A;PM20D2;HOMER2;PKN3;APBA1;DEDD2;PI4KAP2;SRSF5;ADCY6;LRRK1;AARS;KLHL24;SDC2
8225,GO:0033002,0.377059973444066,0.726868652629084,14,117,muscle cell proliferation,BP,MEF2D;APLN;PDCD4;CTNNBIP1;EGFR;HBEGF;AKT1;FGFR1;EREG;TGFBR3;IRAK1;SIX5;PAK1;NDRG2
2311,GO:0005310,0.377345010865306,0.831229282302755,3,20,dicarboxylic acid transmembrane transporter activity,MF,SLC13A5;SLC13A3;SLC26A11
2249,GO:0005164,0.377400085683338,0.830585816050332,3,21,tumor necrosis factor receptor binding,MF,TNFSF15;TRAP1;EDA
4892,GO:0014819,0.377438056118185,0.932085173776497,1,5,regulation of skeletal muscle contraction,BP,GSTO1
11195,GO:0045333,0.377455098918038,0.719497860032188,16,153,cellular respiration,BP,IDH2;NFATC4;D2HGDH;DHTKD1;BNIP3;SDHA;MDH2;TRAP1;OXA1L;CYC1;ACO2;ETFB;CAT;TAZ;NDUFV3;SIRT3
11432,GO:0045879,0.377771016134839,0.830932562641035,3,20,negative regulation of smoothened signaling pathway,BP,SERPINE2;PRKACB;KIF7
3163,GO:0006778,0.377796572697076,0.806134156582384,4,30,porphyrin-containing compound metabolic process,BP,UROS;RSAD1;ALAS1;PPOX
3942,GO:0008637,0.377799642104731,0.733772905237873,12,103,apoptotic mitochondrial changes,BP,AKT1;BNIP3;MOAP1;PIM2;BOK;TFDP2;BNIP3L;IFI6;BAX;PLA2G6;BCL2L1;LMNA
8287,GO:0033127,0.377882542791995,0.867833263622468,2,12,regulation of histone phosphorylation,BP,RPS6KA5;MAPK3
5552,GO:0016558,0.378150500166013,0.867671010754599,2,12,protein import into peroxisome matrix,BP,PEX10;PEX1
955,GO:0002374,0.378240680593272,0.867616382603474,2,12,cytokine secretion involved in immune response,BP,HK1;MAPK3
8359,GO:0033262,0.378358010985675,0.86754529111751,2,12,regulation of nuclear cell cycle DNA replication,BP,FGFR1;CHEK2
10462,GO:0043331,0.378429614439562,0.749477301615663,9,73,response to dsRNA,BP,EGFR;MAP2K2;MAP2K1;SMAD3;TGFB1;TMEM173;IFNE;PELI1;MAPK3
3919,GO:0008593,0.378462713375598,0.749449151555845,9,73,regulation of Notch signaling pathway,BP,POSTN;ARRDC1;EGFR;PEAR1;LLGL1;RFNG;EPN2;MFNG;FAM129B
10410,GO:0043255,0.378546929781286,0.76526828463373,7,54,regulation of carbohydrate biosynthetic process,BP,NR1D1;AKT1;DGKQ;TGFB1;NTSR1;PPARA;INSR
1016,GO:0002507,0.378656528872282,0.867364330734582,2,12,tolerance induction,BP,TGFB1;HLA-G
16114,GO:0090101,0.378754638746009,0.749200834705927,9,73,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,HTRA1;LTBP1;SMURF2;SMAD3;TGFB1;STUB1;TGFBR3;LEMD2;DNM2
17368,GO:1900078,0.378868774831222,0.830166908473511,3,20,positive regulation of cellular response to insulin stimulus,BP,PIK3R2;PRKCZ;PAK1
4728,GO:0010893,0.378986064761206,0.867164424198362,2,12,positive regulation of steroid biosynthetic process,BP,NR1D1;ABCG1
6505,GO:0021885,0.379008665860556,0.788469527926116,5,37,forebrain cell migration,BP,EGFR;MBOAT7;SUN1;LAMB1;SOCS7
8909,GO:0034755,0.379168022412074,0.867053978735464,2,12,iron ion transmembrane transport,BP,SLC25A37;HFE
9912,GO:0042262,0.379226214649157,0.931372253720696,1,5,DNA protection,BP,CBS
8987,GO:0035102,0.379408287963998,0.86690807107861,2,12,PRC1 complex,CC,PHC2;CBX7
7203,GO:0031102,0.379451449621751,0.787853785878313,5,38,neuron projection regeneration,BP,APOE;PTPRS;MAP2K1;LAMB2;ULK1
3861,GO:0008483,0.379702384702696,0.866729364217711,2,12,transaminase activity,MF,GPT2;PHYKPL
2401,GO:0005547,0.380303221648193,0.804618428792683,4,29,phosphatidylinositol-3,4,5-trisphosphate binding,MF,ARAP1;AKT1;ARAP3;ADAP1
14674,GO:0070293,0.380479794079157,0.866256397273919,2,12,renal absorption,BP,GAS6;GSN
3549,GO:0007588,0.380504347059501,0.82841225098874,3,21,excretion,BP,ADORA2B;GRHPR;SLC22A18
2222,GO:0005125,0.380611005510766,0.747224750749815,9,77,cytokine activity,MF,VEGFA;WNT7A;CMTM7;CMTM4;TGFB1;TNFSF15;IFNE;AREG;MIF
6678,GO:0030049,0.380694042855772,0.864986724558279,2,13,muscle filament sliding,BP,TNNT1;TPM2
8368,GO:0033275,0.380694042855772,0.864986724558279,2,13,actin-myosin filament sliding,BP,TNNT1;TPM2
17870,GO:1902074,0.380839129278581,0.86603749887494,2,12,response to salt,BP,MAPK13;TGFB1
11057,GO:0045063,0.380890132467922,0.866006414448758,2,12,T-helper 1 cell differentiation,BP,STAT6;JAK3
724,GO:0001954,0.380961088501078,0.786667881197411,5,38,positive regulation of cell-matrix adhesion,BP,VEGFA;SMAD3;PPM1F;EPHA1;PRKCZ
18352,GO:1903306,0.381024500667741,0.865924505080859,2,12,negative regulation of regulated secretory pathway,BP,CEACAM1;BCR
2540,GO:0005801,0.381070034713314,0.773349406634961,6,47,cis-Golgi network,CC,ANGEL1;B3GAT3;SCYL1;GOLGA2P5;BOK;AZIN2
16116,GO:0090103,0.381406192782551,0.865691693229398,2,12,cochlea morphogenesis,BP,DVL1;VANGL2
11030,GO:0045010,0.381480972662636,0.786258927795929,5,38,actin nucleation,BP,CORO1B;GSN;WIPF1;ARPIN;WASH3P
16341,GO:0090596,0.381612564643529,0.713680706075353,17,144,sensory organ morphogenesis,BP,SDK2;VEGFA;NAGLU;LRP5;SPRY2;DVL1;WNT2B;FGFR1;TSHZ1;BCR;SLITRK6;EPHB2;BAX;MAPK3;VANGL2;PROX1;CELSR1
8794,GO:0034505,0.382194021955768,0.865210520362079,2,12,tooth mineralization,BP,FAM20C;PPARA
3939,GO:0008630,0.382491867124905,0.73431003428588,11,94,intrinsic apoptotic signaling pathway in response to DNA damage,BP,NFATC4;ERCC6;ZNF385A;MOAP1;BOK;BAX;DDIT4;CHEK2;TMEM161A;MIF;BCL2L1
11034,GO:0045022,0.382529383285602,0.785433356614112,5,38,early endosome to late endosome transport,BP,VPS11;MAP2K2;MAP2K1;WASH3P;MAPK3
15600,GO:0072089,0.382555403526734,0.746068140940897,9,72,stem cell proliferation,BP,VEGFA;HMGA2;ZFP36L1;FBLN1;WNT2B;FGFR1;WNT3;TGFB1;NDE1
10727,GO:0044090,0.382589074110313,0.864968914880635,2,12,positive regulation of vacuole organization,BP,ULK1;LRSAM1
17163,GO:0102567,0.382866411274085,0.864799171918659,2,12,phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine),MF,TMEM8A;PLA2G6
17164,GO:0102568,0.382866411274085,0.864799171918659,2,12,phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine),MF,TMEM8A;PLA2G6
8788,GO:0034497,0.383077580385418,0.864669855179041,2,12,protein localization to phagophore assembly site,BP,PACS2;WIPI2
1268,GO:0003044,0.383211237391042,0.826507060924145,3,21,regulation of systemic arterial blood pressure mediated by a chemical signal,BP,F2R;CTSZ;RASL10B
957,GO:0002377,0.383314465876126,0.752535132034998,8,64,immunoglobulin production,BP,ERCC1;PKN1;POU2F2;STAT6;CARD11;TGFB1;POLL;POLM
16136,GO:0090148,0.38333664369255,0.864511124148795,2,12,membrane fission,BP,DNM1;DNM2
13567,GO:0060045,0.383366857749321,0.864492605581012,2,12,positive regulation of cardiac muscle cell proliferation,BP,FGFR1;TGFBR3
17898,GO:1902170,0.383557958466598,0.864375448210796,2,12,cellular response to reactive nitrogen species,BP,STAT6;DNM2
16213,GO:0090257,0.383599884345209,0.720962536899977,14,119,regulation of muscle system process,BP,DOCK4;F2R;NOS1;SMAD3;ADORA2B;TNNT1;ERRFI1;GTF2IRD1;PRKACA;ADA;GSTO1;EHD3;PAK1;LMNA
17345,GO:1900025,0.384046059050206,0.864075979895653,2,12,negative regulation of substrate adhesion-dependent cell spreading,BP,POSTN;FBLN1
13791,GO:0060391,0.384064602521401,0.864064596238496,2,12,positive regulation of SMAD protein signal transduction,BP,SMAD3;TGFB1
12387,GO:0048839,0.384282031986086,0.728350526412009,12,99,inner ear development,BP,NAGLU;SPRY2;DVL1;FGFR1;BCR;SLITRK6;EPHB2;TGFB1;LRP10;VANGL2;PROX1;CELSR1
5120,GO:0015485,0.38460836764138,0.800996766022617,4,30,cholesterol binding,MF,APOE;OSBPL5;OSBPL10;ABCG1
15221,GO:0071380,0.38493447926275,0.863530049897066,2,12,cellular response to prostaglandin E stimulus,BP,AKT1;ADCY6
19961,GO:2000482,0.38494668657592,0.86236508600732,2,13,regulation of interleukin-8 secretion,BP,F2R;MAPKBP1
12013,GO:0047631,0.385063214487496,0.929013484961672,1,5,ADP-ribose diphosphatase activity,MF,NUDT14
12375,GO:0048799,0.385239585658784,0.863342310126542,2,12,animal organ maturation,BP,THBS3;FGFR3
12604,GO:0050794,0.385325344845628,0.637469521683083,765,7150,regulation of cellular process,BP,TNIP1;DUSP6;XDH;ERCC1;DUSP5;MEF2D;ZMYND8;ADGRL1;CITED4;SEMA4B;HTRA1;FHL1;EGR1;NR1D1;CCNG2;EDEM1;DLG4;PLAT;CST3;CYP27B1;MRC2;TYSND1;HS1BP3;FBXO2;APLN;PGF;PDCD4;CTNNBIP1;KCNG1;ACVR2B;DOCK4;XPC;PRNP;PARVB;BBS2;DDIT4L;POSTN;VEGFA;FAM210B;TNFRSF6B;WNT7A;APOE;DGKA;TSPAN1;ESPN;F2R;LRP5;ITGA6;PITPNC1;HMGA2;OBSCN;NDRG1;IDH2;ZKSCAN1;ELK3;ITPR3;PKN1;MTA1;GRAMD4;ARRDC1;EVI5L;NISCH;FCGRT;EGFR;RPS6KA2;SERPINE2;DNPH1;WWTR1;OBSL1;NOS1;VAT1;PTPRS;HADH;SPRY2;CAPN2;MST1R;NFATC4;TRIM65;BAHCC1;CRTAP;LTBP4;SYTL1;SDC1;ETV5;LMF1;APPL2;SHC1;DDB2;LTBP2;VPS11;LTBP1;TBC1D14;ARL2;HEXB;GTPBP1;TCFL5;PTPRE;RIN1;MMP1;ETV4;PHLDA2;SNX9;TRNP1;SPRY4;RAPGEF3;TXNRD3;ZFP36L1;GLUL;ARAP1;MAP2K2;NME4;ZC3H6;LPAR3;PLCD3;MDFI;PTOV1;SMARCA1;PPP1R35;CMTM7;RBCK1;TP53I11;FOXQ1;MAP2K1;ACP5;MCTP1;MXD4;SSH1;POU2F2;ENDOG;MARK4;MARCKSL1;SMURF2;TSC22D1;FOS;FBLN1;SMAD3;ARHGAP23;STAT6;SHANK2;PIK3R2;ERCC6;LRP1;GJC2;DVL1;EPAS1;DNAJB5;HBEGF;FAM110C;AP2A2;S100A4;ITGB4;PPP1R14A;SH3PXD2B;PPP2R3B;PRDX5;SHC2;NLGN2;BRD3;PRODH;SALL2;FBXW5;PAG1;ZXDC;RNF187;ADORA2B;ADARB1;PLCXD2;SYT8;AKT1;TPCN1;GRB7;KCNC4;TMOD2;CORO1B;HDAC5;FAM83A;S100A6;F12;SH2D2A;PPM1F;MMP28;PITPNM1;PLEKHH3;RHBDF2;BSG;STK39;HK1;SERPING1;ASAP2;SCMH1;EPHA1;NFKBIZ;PTPRU;VEGFB;FMNL2;ASH2L;IMPACT;WWC3;LRRC8A;CNTN1;IFNGR2;BRSK1;DAP;IFT140;PTHLH;MYZAP;RAB31;FGFR4;HEBP1;PEAR1;WNT2B;LDLR;FGFR1;PRKACB;MAPKBP1;SIGMAR1;RAC2;KCNAB2;SMOC2;PFKL;SEC14L2;HLTF;MXI1;NPHP4;SYNE3;RAG1;H2AFJ;KLF7;RALGDS;SORL1;NAT14;CEACAM1;CCNI;B3GAT3;ASB13;CIRBP;HMG20B;LZTS2;RAB11FIP4;TENM2;ZNF385A;DOCK6;NSMCE4A;ANK3;IGFBP4;EVC;TSHZ1;TRAPPC9;CCND1;PODNL1;EFS;PCBP4;TCF25;TWF2;STRADB;SYNGAP1;PLCH2;MAPK13;CEP250;EDNRA;CARD19;PLAU;GAS6;PTK6;SEMA3F;FGFBP1;CSNK1E;CTSB;RAB3B;CARD11;SH2B3;SOX13;LAMA5;DUSP7;GSN;CMTM4;PLEKHG2;MAPKAPK3;IGFBP2;PCSK9;ARHGAP22;RAD23A;BCR;ANTXR2;ANGPTL4;EHD4;ERRFI1;GLI4;WIPF1;ZSCAN18;AIP;STON1;CCDC71L;MYEF2;MN1;SH3D19;CDC25B;RGL2;SLITRK6;TSPAN18;PAQR6;ARPIN;ARHGAP27;ALOX15B;SPTB;SMARCD2;AGAP1;NXPH4;SLC20A1;NPR2;SNTA1;DGKQ;PLXNB3;BNIP3;PAK6;TFPI2;GTF2IRD1;SHARPIN;MVB12B;TAGLN3;FYCO1;CEMIP;PKD2;YPEL3;RASGEF1A;CTSZ;CDC42EP5;HES2;CRTC1;IL20RB;FBXW8;GPSM1;AP3D1;ITGB5;ABCA2;ZNF598;MAGEF1;EPOR;EPHB2;GRIN3B;ADAM8;ASIC1;CTBP1;MNT;GRK6;CDKN1C;PLCG1;ZMIZ2;SH3BP2;NYAP1;CD81;CEBPB;MVD;ENTPD2;ADAMTS13;ZNF217;TIMP2;ZNF862;WNT3;GNAL;C8ORF88;TMED4;TGFB1;CLTCL1;RFX2;SCYL1;UNK;ULK2;GPC1;MKNK2;ADAMTS7;DEAF1;MOAP1;TBC1D9B;NTSR1;NAB2;TMEM173;ARHGAP25;ZSCAN30;FHOD3;SHANK3;MSRB2;EFNB3;RASA3;PNRC1;TNFSF15;EML2;NSMF;PEG3;ARAP3;FARP1;MC1R;TUB;CROCC;RHOD;CGREF1;ABHD14B;SNX17;ERO1B;HTR7;VGF;PLEKHG4;SNX33;SEMA4F;RHOF;WASF3;LLGL1;PHF21A;PLEKHG3;MIF4GD;KIF7;RHOBTB2;KHDRBS3;ZER1;GIGYF1;RIMS3;TNFAIP8L1;PTPN1;TPP1;PCK2;WDR59;AGRN;MBD3;IFNE;CD320;CAMK2N1;LRP4;GPR153;VHL;CEP131;TRAP1;ADAP1;PFKFB2;RFNG;MLXIPL;TRIB2;PRKCZ;KDM6B;PRKACA;MINK1;ZNF516;RHPN1;RABGGTA;TOM1L2;CD9;EPN2;ADA;AREG;PIM2;MICALL2;PLEKHG5;BOK;WDR18;CAPG;SDCCAG8;NEURL1B;ERBB2;ADGRB2;ULK1;NINL;VAMP2;MMP10;TFDP2;PLEK2;C6ORF89;NECAB3;STK17A;RILPL1;JAK3;IRF2BP2;NET1;BNIP3L;CYFIP2;FSCN1;PBX2;TRPC1;NELFCD;SLC22A17;RASA4;PDK1;CYGB;ARHGAP44;PRKCD;FAM20C;MIB2;RBL2;CACNB3;USP20;STUB1;IFI6;BAX;ITGA1;OLFM2;ZNF395;SH3BP1;FBXW4;CHADL;EREG;RPS6KA5;DGUOK;DUSP4;ZNF524;CUL9;SOX12;TMBIM4;DDIT4;MBTPS2;SPRED3;PPP1R13L;CARF;AHNAK2;PCSK1N;MT2A;IER2;RASL10B;ZDHHC8;TMX4;LIMK1;TGFBR3;PDIA5;GDI1;DIP2A;LTB4R2;LEMD2;RPS6KA6;ZHX3;DNM1;WASH3P;RGS14;TMEM8B;MFNG;GSTO1;GIT1;CHAD;LPCAT1;LRSAM1;ADAM15;ASB1;EHD3;TMEM231;LONP2;SYMPK;MAPK12;IRAK1;TGFA;HDAC7;FHOD1;INPP5D;MTHFR;CHD2;CBX7;CHEK2;ZFPM1;PPARA;TMEM161A;SESN2;ABCG1;MYO1D;CDC34;SOX7;ABCA7;RAB12;SPEG;SIX5;BCAP31;MIF;KDM4B;ZNF414;MEX3A;BCAM;PLA2G6;DDT;SSBP4;SYNGR1;ECM1;WFS1;QSOX1;ZNF444;DTX3;TRPT1;NBPF3;SPPL2B;FYN;STK25;RAC3;EEF2K;ARHGAP12;ACAP3;ARID5B;HOXC5;DNM2;BHLHE40;PELI1;SNX15;INF2;CHKA;CAT;BEX2;NEIL1;TSPYL2;IGFBP7;ELFN2;SLC27A1;ZMYM3;TPBG;APOBEC3C;SATB1;KIF26A;PLCB3;IQSEC1;ZNF606;APOBEC3F;ARHGEF4;MAPK3;INSR;ARHGEF1;GRINA;CAMTA2;TAZ;PFKM;ADCY1;C12ORF66;RERE;HLA-G;DOCK9;INO80C;TMEM101;RALGAPA1;ETAA1;GLRX;BCL7A;CEP72;VANGL2;PAK1;CAMKK2;PPP3CB;RNF144A;LGALS3BP;ROBO4;USP21;PFKFB3;MLYCD;CUL7;GABBR1;MICAL1;HYAL1;SEMA4C;CAPRIN2;ZBTB10;WDTC1;HES7;ITGA3;STK32C;DNMT3A;SAMD8;BIN1;VPS16;SRMS;PPP2R5B;HES6;MAP2K3;BCL2L1;DLG3;SGSM2;RRAS;PROX1;LRCH4;TBC1D16;ADGRF1;LMNA;ZYG11B;PKD1;KCTD13;TNFRSF25;RABGAP1;SIRT2;FAM129B;CDH4;ITGA4;EDA;DCBLD2;BACH1;TRIP10;ADCY7;E2F5;ZBTB22;LTB4R;MAPRE3;RAB28;ZNF704;SERPINB1;ICA1;RAP1GAP2;LAMB1;SOCS7;MAP3K10;RGS19;NDE1;GPR3;PELI3;GTF2IRD2;RAB40B;NGFR;TOLLIP;BCORL1;PDCD6;ATP6V1F;PCLO;ZNF837;PXN;GRB10;TBC1D8;PLEKHM1;GCH1;LURAP1;KIF13B;MAFF;NR2F6;CBX6;TCTN1;PNMA1;CAMK1;CAMKK1;EZH1;SIRT3;HFE;TERC;ZNF513;GAS2L1;BTG1;BBS10;ZP3;CELSR1;MLF2;IL17RE;SEMA3B;CDK11B;PFN2;SSH3;FGFR3;PPP1R16A;CCDC88C;TNRC18;NDRG2;CBLC;ITPKB;SPTLC2;TCEA2;CDC42BPG;ZBTB47;PLAG1;CLK3;IRF2BPL;KDM3A;PM20D2;HOMER2;PKN3;DEDD2;PI4KAP2;SRSF5;ADCY6;LRRK1;AARS;KLHL24;SDC2
3427,GO:0007219,0.385426851907235,0.716031511503981,15,127,Notch signaling pathway,BP,POSTN;ARRDC1;EGFR;CNTN1;PEAR1;TGFB1;LLGL1;RFNG;EPN2;NEURL1B;MIB2;MFNG;DTX3;HES7;FAM129B
8056,GO:0032731,0.385902512428896,0.824603741253387,3,21,positive regulation of interleukin-1 beta production,BP,EGR1;SMAD3;HK1
9342,GO:0035855,0.386074995367011,0.862827597870923,2,12,megakaryocyte development,BP,ZNF385A;ZFPM1
7207,GO:0031106,0.386128721791998,0.862794462702215,2,12,septin ring organization,BP,SEPT10;SEPT6
15300,GO:0071496,0.38642177776534,0.690427784761865,27,236,cellular response to external stimulus,BP,CYP27B1;POSTN;ITGA6;EGFR;GLUL;SSH1;FOS;ADORA2B;AKT1;IMPACT;DAP;WNT2B;GAS6;PCSK9;BNIP3;CBS;TGFB1;WDR59;ULK1;SESN2;FYN;UPP1;KIF26A;MAPK3;C12ORF66;HFE;GAS2L1
17955,GO:1902285,0.386551821498761,0.862533380153533,2,12,semaphorin-plexin signaling pathway involved in neuron projection guidance,BP,SEMA3F;PLXNB3
1287,GO:0003094,0.386564633762529,0.862525470185439,2,12,glomerular filtration,BP,F2R;GAS6
12813,GO:0051127,0.386619062658571,0.862491864609902,2,12,positive regulation of actin nucleation,BP,GSN;WIPF1
7880,GO:0032454,0.386619961483737,0.862491309621295,2,12,histone demethylase activity (H3-K9 specific),MF,KDM4B;KDM3A
20315,GO:2001275,0.386619961483858,0.862491309621287,2,12,positive regulation of glucose import in response to insulin stimulus,BP,PIK3R2;PAK1
4817,GO:0014013,0.386752971137076,0.749630049720034,8,64,regulation of gliogenesis,BP,IDH2;SERPINE2;ETV5;GJC2;LDLR;BIN1;SIRT2;PLAG1
17293,GO:0140056,0.387091353262041,0.706106052728959,18,155,organelle localization by membrane tethering,BP,VPS11;EXOC2;MARK4;NPHP4;CEP250;CSNK1E;RAB3B;SNPH;ESYT2;CEP131;PRKACA;SDCCAG8;NINL;STX10;CEP72;NDE1;RAB40B;TCTN1
3147,GO:0006749,0.387220398443334,0.780770115673677,5,42,glutathione metabolic process,BP,GGT1;OPLAH;HAGH;CNDP2;GSTO1
2836,GO:0006308,0.387263184182496,0.798980171808308,4,30,DNA catabolic process,BP,H1F0;ENDOG;BAX;DNASE1L1
4818,GO:0014014,0.387387230748527,0.823549823546026,3,21,negative regulation of gliogenesis,BP,IDH2;LDLR;SIRT2
7187,GO:0031083,0.387767937182013,0.86061194882607,2,13,BLOC-1 complex,CC,PI4K2A;BLOC1S4
14626,GO:0070201,0.387783195384969,0.66623350653184,57,515,regulation of establishment of protein localization,BP,NR1D1;EDEM1;PRNP;POSTN;F2R;LRP5;IDH2;ITPR3;EGFR;HADH;VPS11;ARL2;RAPGEF3;GLUL;LRP1;NLGN2;STOM;RHBDF2;HK1;MAPKBP1;RAC2;PFKL;SORL1;B3GAT3;ANK3;GAS6;ALOX15B;CEMIP;ADAM8;TGFB1;TMEM173;LLGL1;PTPN1;PCK2;CEP131;PFKFB2;PRKCZ;MICALL2;ERBB2;VAMP2;TFDP2;BNIP3L;PRKCD;ZDHHC8;GDI1;BCAP31;MIF;PLA2G6;NBPF3;FYN;MAPK3;PFKM;PAK1;PPP3CB;ICA1;CAMK1;SIRT3
13900,GO:0060562,0.388162802392165,0.69024614733446,26,225,epithelial tube morphogenesis,BP,PGF;CTNNBIP1;VEGFA;LRP5;SPRY2;NFATC4;ETV5;SMAD3;DVL1;WNT2B;PRKACB;EDNRA;LAMA5;PKD2;CTSZ;TGFB1;DEAF1;KIF26B;AREG;VANGL2;PAK1;SEMA4C;PROX1;PKD1;TCTN1;CELSR1
3669,GO:0008171,0.388371589010042,0.82284955390863,3,21,O-methyltransferase activity,MF,COMTD1;PCMTD2;ASMTL
3041,GO:0006598,0.388411174798842,0.927638551750966,1,5,polyamine catabolic process,BP,SMOX
1528,GO:0003906,0.388545117102036,0.860127051380496,2,13,DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,HMGA2;NEIL1
12220,GO:0048488,0.388587999619429,0.798347954203762,4,29,synaptic vesicle endocytosis,BP,NLGN2;SYT8;DNM1;DNM2
10159,GO:0042749,0.388875248102826,0.927446693441246,1,5,regulation of circadian sleep/wake cycle,BP,ADA
11134,GO:0045187,0.388875248102826,0.927446693441246,1,5,regulation of circadian sleep/wake cycle, sleep,BP,ADA
13211,GO:0051882,0.389543122449074,0.859503136725775,2,13,mitochondrial depolarization,BP,BOK;IFI6
11524,GO:0046060,0.390131767719446,0.926925658341641,1,5,dATP metabolic process,BP,ADA
12873,GO:0051219,0.391579853055827,0.745534531744964,8,64,phosphoprotein binding,MF,PLAT;SHC1;PIK3R2;PKD2;SH3BP2;MAPK3;CBLC;LRP11
14595,GO:0070161,0.391585202808899,0.66546501971938,51,467,anchoring junction,CC,FHL1;MRC2;PARVB;FLNC;ITGA6;NDRG1;EGFR;CAPN2;ARL2;SPRY4;MAP2K2;MAP2K1;MPRIP;SLC9A3R2;LRP1;GRB7;CORO1B;BSG;ZFYVE21;RAC2;CEACAM1;PLAU;GSN;ARHGAP22;PROCR;ITGB5;CADM4;CD81;SNTB2;TNS1;CD9;ITGA1;SH3BP1;PPL;LIMK1;GIT1;ADAM15;EHD3;DNM2;CAT;MAPK3;TNS4;PAK1;ITGA3;RRAS;FAM129B;CDH4;ITGA4;PXN;FGFR3;KLHL24
10787,GO:0044267,0.3919130773232,0.632108232769726,417,3938,cellular protein metabolic process,BP,TNIP1;DUSP6;XDH;DUSP5;GID4;ZMYND8;EGR1;NR1D1;EDEM1;DLG4;PLAT;CST3;BTBD2;FBXO2;PDCD4;ACVR2B;PRNP;VEGFA;TNFRSF6B;WNT7A;APOE;F2R;LRP5;HMGA2;OBSCN;NEK9;PKN1;MTA1;GRAMD4;ARRDC1;EGFR;RPS6KA2;SERPINE2;WWTR1;LOXL1;OBSL1;NOS1;PTPRS;TMEM129;CTSO;SPRY2;CAPN2;MST1R;CRTAP;KLHL29;LMF1;SHC1;DDB2;VPS11;LTBP1;HEXB;GTPBP1;PTPRE;MMP1;SNX9;SPRY4;RAPGEF3;ST6GALNAC2;ZFP36L1;MAP2K2;LPAR3;MARCH9;FKBP9;PPP1R35;RBCK1;RNF44;MAP2K1;SSH1;MARK4;SMURF2;FBLN1;SMAD3;PIK3R2;ERCC6;LRP1;GJC2;SRD5A3;DVL1;EPAS1;PIGQ;HBEGF;AP2A2;PPP1R14A;PPP2R3B;PRDX5;SHC2;CDK18;LY6K;FBXW5;RNF187;ADORA2B;ADARB1;D2HGDH;AKT1;GRB7;HDAC5;FBXO41;F12;PPM1F;STK39;SERPING1;EPHA1;GGT1;PTPRU;VEGFB;ASH2L;IMPACT;MARCH4;CNTN1;BRSK1;DAP;FGFR4;LDLR;FGFR1;PRKACB;RAC2;TTLL12;HLTF;PPM1J;RAG1;B4GAT1;PIGV;SORL1;CEACAM1;B3GAT3;ASB13;CIRBP;HMG20B;ZNF385A;IGFBP4;CCND1;PODNL1;LHPP;STRADB;SYNGAP1;MAPK13;GAS6;PTK6;CSNK1E;CTSB;RAB3B;DUSP7;GSN;MAPKAPK3;IGFBP2;PCSK9;RAD23A;ANO8;BCR;MRPS6;EHD4;ERRFI1;HLCS;SH3D19;CDC25B;SPTB;PEX10;NPR2;SNTA1;DGKQ;BNIP3;PAK6;TFPI2;SHARPIN;MVB12B;CEMIP;PKD2;RASGEF1A;CTSZ;CDC42EP5;FBXW8;ZNF598;MAGEF1;EPHB2;ADAM8;CTBP1;JOSD2;LTA4H;PTPDC1;GRK6;CDKN1C;PLCG1;FBXL8;CD81;MVD;RNF135;ADAMTS13;TIMP2;ZNF862;C8ORF88;TGFB1;SCYL1;ABHD17C;UNK;ULK2;MKNK2;ADAMTS7;B3GNT3;NAB2;SHANK3;MSRB2;RASA3;MIPEP;TNFSF15;MGAT4B;MDH2;FBXO17;NSMF;LCE1E;LAMB2;ABTB1;ERO1B;ST6GALNAC6;VGF;FBXO44;SNX33;ANKZF1;PHF21A;MIF4GD;UBXN4;ZER1;PTPN1;B4GALT2;MBD3;IFNE;CAMK2N1;LRP4;ZDHHC24;B4GALT6;VHL;TRAP1;RFNG;MLXIPL;TRIB2;PRKCZ;KDM6B;PRKACA;MINK1;RABGGTA;AREG;PIM2;MPI;BOK;NEURL1B;ERBB2;ULK1;C6ORF89;STK17A;JAK3;BNIP3L;CYFIP2;RASA4;PDK1;THOP1;MCFD2;PRKCD;FAM20C;MIB2;USP20;STUB1;IFI6;BAX;SBF1;TRIM4;ITGA1;FBXW4;EREG;RPS6KA5;DGUOK;DUSP4;CUL9;DDIT4;PCSK1N;ZDHHC8;LIMK1;TGFBR3;PADI3;RPL39L;LEMD2;RPS6KA6;RGS14;MFNG;CHAD;MRPS26;MSLN;LRSAM1;ASB1;ST3GAL3;LONP2;SYMPK;MAPK12;IRAK1;TGFA;HDAC7;MTHFR;PCMTD2;CHEK2;COG7;SESN2;JADE2;CDC34;RNF123;SOX7;ABCA7;RAB12;SPEG;BCAP31;MIF;EEF2KMT;KDM4B;MEX3A;PLA2G6;DDT;NUDT14;ECM1;WFS1;QSOX1;DTX3;TRPT1;DALRD3;SPPL2B;FYN;VWA1;STK25;ETFB;EEF2K;ARID5B;PELI1;TSPYL2;IGFBP7;ELFN2;SLC27A1;SATB1;ZDHHC1;MAPK3;INSR;ADCY1;INO80C;ETAA1;GLRX;VANGL2;PAK1;DCAF10;KLHL36;CAMKK2;PPP3CB;RNF144A;ALPK1;CTSF;USP21;CUL7;MICAL1;SEMA4C;CAPRIN2;WDTC1;STK32C;BIN1;MAN2B1;SRMS;PPP2R5B;MAP2K3;DLG3;RRAS;PROX1;IARS2;MDGA1;ZYG11B;PKD1;KCTD13;TNFRSF25;SIRT2;UVSSA;BACH1;ADCY7;ALG12;MAPRE3;SERPINB1;ST3GAL2;LAMB1;SOCS7;MAP3K10;PELI3;RAB40B;NGFR;TOLLIP;PDCD6;DUSP23;CAMK1;CAMKK1;EZH1;SIRT3;HFE;WIPI2;BTG1;CDK11B;PFN2;SSH3;FGFR3;PPP1R16A;CCDC88C;ST3GAL5;NDRG2;MAN2B2;CBLC;ITPKB;CDC42BPG;PRSS21;CLK3;KDM3A;PM20D2;PKN3;TTLL3;ADCY6;LRRK1;AARS;KLHL24;SDC2
693,GO:0001914,0.392020149524653,0.857948561506108,2,13,regulation of T cell mediated cytotoxicity,BP,CEACAM1;PPP3CB
2955,GO:0006490,0.392035988356411,0.820231979028899,3,21,oligosaccharide-lipid intermediate biosynthetic process,BP,SRD5A3;MVD;ALG12
9446,GO:0036038,0.392287013648049,0.857780564500319,2,13,MKS complex,CC,TMEM231;TCTN1
9238,GO:0035637,0.392615466042996,0.725675482100554,11,91,multicellular organismal signaling,BP,ITPR3;SCN4B;NOS1;ANK3;NPR2;PRKACA;TRPC1;CACNB3;AHNAK2;SCN8A;EHD3
3088,GO:0006665,0.393004667661487,0.709229747877623,15,127,sphingolipid metabolic process,BP,HEXB;KDSR;SERINC2;ST6GALNAC6;ESYT2;B4GALT6;PRKCD;BAX;NAGA;PLA2G6;CERS4;GLB1;SAMD8;ST3GAL5;SPTLC2
8335,GO:0033194,0.393638953630502,0.856927949892428,2,13,response to hydroperoxide,BP,GPX3;PRKCD
3476,GO:0007340,0.393859753056871,0.856788456350478,2,13,acrosome reaction,BP,SYT8;ZP3
19228,GO:1905332,0.394227443893738,0.818658470167032,3,21,positive regulation of morphogenesis of an epithelium,BP,VEGFA;WNT2B;TGFB1
6210,GO:0019731,0.394333885133682,0.853185081441942,2,17,antibacterial humoral response,BP,PLA2G6;RNASE7
9062,GO:0035304,0.394356676330975,0.719322864568247,12,101,regulation of protein dephosphorylation,BP,PPP1R35;PPP1R14A;PPP2R3B;B3GAT3;TGFB1;NSMF;PRKCD;ITGA1;SYMPK;ELFN2;PPP2R5B;PPP1R16A
672,GO:0001883,0.394547055004769,0.67682271042405,32,285,purine nucleoside binding,MF,ARL2;GTPBP1;RAB31;RAC2;RAB3B;EHD4;SEPT10;AGAP1;NPR2;GNAL;RHOD;RHOF;ARL10;RHOBTB2;TUBG2;PCK2;ADA;RASL10B;DNM1;EHD3;RAB12;RAC3;DNM2;TUBB6;INSR;RRAS;RAB28;RAB40B;GCH1;SEPT6;AK3;LRRK1
15538,GO:0071949,0.394584781295999,0.818401319464268,3,21,FAD binding,MF,PRODH;D2HGDH;MICAL1
5801,GO:0017053,0.394639162710404,0.735582281505119,9,73,transcriptional repressor complex,CC,BAHCC1;APPL2;SALL2;CCND1;CTBP1;MBD3;ZFPM1;SIRT2;TNRC18
4199,GO:0009309,0.395036648225173,0.856043776567798,2,13,amine biosynthetic process,BP,SMOX;AZIN2
9986,GO:0042401,0.395036648225173,0.856043776567798,2,13,cellular biogenic amine biosynthetic process,BP,SMOX;AZIN2
7993,GO:0032620,0.395718997899467,0.855611126783683,2,13,interleukin-17 production,BP,PRNP;TGFB1
14729,GO:0070402,0.395955206294107,0.855461203884281,2,13,NADPH binding,MF,CBR4;GRHPR
5717,GO:0016854,0.39602924950459,0.855414192016431,2,13,racemase and epimerase activity,MF,GALE;TSTA3
10718,GO:0044060,0.39631991350672,0.81715037087087,3,21,regulation of endocrine process,BP,APLN;F2R;FGFR1
17430,GO:1900180,0.396445740074605,0.727650796063029,10,83,regulation of protein localization to nucleus,BP,AKT1;LZTS2;GAS6;TGFB1;TMEM173;PRKCD;SESN2;FYN;LMNA;NGFR
2618,GO:0005938,0.396570915277566,0.682424613089828,26,226,cell cortex,CC,DLG4;CAPN2;RAPGEF3;EXOC2;FAM110C;MYZAP;GSN;SEPT10;WIPF1;SPTB;PKD2;CTSZ;GPSM1;NSMF;RHOD;RHOF;LLGL1;RHOBTB2;RIMS3;PRKCZ;SH3BP1;TRIP10;PCLO;PXN;HFE;SEPT6
2186,GO:0005044,0.396660028828687,0.816904717268173,3,21,scavenger receptor activity,MF,LRP1;SCART1;LGALS3BP
2950,GO:0006482,0.3968109016082,0.792046559237473,4,29,protein demethylation,BP,KDM6B;KDM4B;ARID5B;KDM3A
3702,GO:0008214,0.3968109016082,0.792046559237473,4,29,protein dealkylation,BP,KDM6B;KDM4B;ARID5B;KDM3A
2783,GO:0006220,0.396812961907434,0.773317456092503,5,41,pyrimidine nucleotide metabolic process,BP,NME4;UCKL1;UPP1;NEIL1;AK3
711,GO:0001937,0.396890844432386,0.816737923694259,3,21,negative regulation of endothelial cell proliferation,BP,XDH;APOE;NGFR
4759,GO:0010940,0.397130487505504,0.92398155660091,1,5,positive regulation of necrotic cell death,BP,BNIP3
11280,GO:0045601,0.39717483090156,0.81653261487958,3,21,regulation of endothelial cell differentiation,BP,XDH;CEACAM1;BTG1
2545,GO:0005815,0.397204673099821,0.652961267551634,68,612,microtubule organizing center,CC,BBS2;NDRG1;NEK9;OBSL1;ARL2;MAP2K1;MARK4;FAM110C;AKT1;PITPNM1;DYSF;BRSK1;IFT140;PRKACB;NPHP4;LZTS2;RAB11FIP4;EVC;CEP250;MPLKIP;RAD23A;CCDC113;CDC25B;PROCR;PKD2;ABCA2;KIF17;NUDCD2;SCYL1;CROCC;KIF7;SAC3D1;TUBG2;BBS1;CEP131;PRKCZ;PRKACA;ACTR1B;CAPG;SDCCAG8;ADGRB2;NINL;MZT2A;RILPL1;USP20;CCDC92;NUBP2;MZT2B;WASH3P;RGS14;WDR60;PLA2G6;SPPL2B;DNM2;NEIL1;CEP72;CUL7;CAPRIN2;BCL2L1;RABGAP1;SIRT2;RAB28;RAP1GAP2;NDE1;MSS51;TACC1;CCDC88C;CDC42BPG
9319,GO:0035795,0.397475041066223,0.92383476704035,1,5,negative regulation of mitochondrial membrane permeability,BP,BNIP3
19357,GO:1905709,0.397475041066223,0.92383476704035,1,5,negative regulation of membrane permeability,BP,BNIP3
3265,GO:0006940,0.397534416445212,0.791102127608165,4,30,regulation of smooth muscle contraction,BP,DOCK4;F2R;ADORA2B;ADA
17432,GO:1900182,0.398381352894549,0.748400607020115,7,56,positive regulation of protein localization to nucleus,BP,AKT1;TGFB1;TMEM173;PRKCD;SESN2;FYN;NGFR
19150,GO:1905114,0.398811070103413,0.660295267095311,48,433,cell surface receptor signaling pathway involved in cell-cell signaling,BP,ZMYND8;EGR1;DLG4;CTNNBIP1;WNT7A;APOE;LRP5;WWTR1;NFATC4;SDC1;MDFI;SSH1;SMURF2;SMAD3;SHANK2;LRP1;DVL1;AP2A2;NLGN2;AKT1;PTPRU;WNT2B;NPHP4;LZTS2;IGFBP4;CCND1;CSNK1E;IGFBP2;GRIN3B;GRK6;WNT3;NTSR1;SHANK3;LRP4;PRKCZ;FBXW4;SOX7;PLCB3;VANGL2;PPP3CB;CAPRIN2;ITGA3;EDA;GRB10;CELSR1;CCDC88C;NDRG2;LRRK1
14963,GO:0070873,0.398830688482451,0.815333473818258,3,21,regulation of glycogen metabolic process,BP,PHLDA2;AKT1;INSR
4167,GO:0009235,0.398922301109395,0.853571264324941,2,13,cobalamin metabolic process,BP,PRSS3;CD320
13814,GO:0060421,0.398934181882338,0.815258410475161,3,21,positive regulation of heart growth,BP,FGFR1;TGFBR3;PROX1
12637,GO:0050850,0.399091859533969,0.814560790896238,3,22,positive regulation of calcium-mediated signaling,BP,PKD2;ADA;GSTO1
4513,GO:0010565,0.399135682047376,0.706808041788797,14,124,regulation of cellular ketone metabolic process,BP,EGR1;NR1D1;TYSND1;AKT1;FGFR4;CEACAM1;DGKQ;MLXIPL;PDK1;LONP2;PPARA;MLYCD;WDTC1;PROX1
10633,GO:0043649,0.399173361484357,0.853410776550641,2,13,dicarboxylic acid catabolic process,BP,GLUL;PM20D2
14143,GO:0061035,0.399212063211491,0.772140523364286,5,38,regulation of cartilage development,BP,SMAD3;PTHLH;TGFB1;ADAMTS7;CHADL
9013,GO:0035196,0.399229496694751,0.77212647844567,5,38,production of miRNAs involved in gene silencing by miRNA,BP,EGFR;MAP2K2;MAP2K1;SMAD3;TGFB1
12315,GO:0048678,0.399330839056899,0.75800579013776,6,49,response to axon injury,BP,CST3;PTPRS;MAP2K1;LAMB2;BAX;MORN4
3689,GO:0008199,0.399534558060214,0.92295371433593,1,5,ferric iron binding,MF,ACP5
11578,GO:0046164,0.399617659446759,0.789489508592594,4,30,alcohol catabolic process,BP,APOE;SRD5A3;NTSR1;SNX17
8594,GO:0034112,0.399772548347844,0.922851500379705,1,5,positive regulation of homotypic cell-cell adhesion,BP,ANK3
11666,GO:0046459,0.400287977653374,0.852697192665312,2,13,short-chain fatty acid metabolic process,BP,PCK2;ACADS
1095,GO:0002683,0.400331720195414,0.674724565346938,29,264,negative regulation of immune system process,BP,HTRA1;NR1D1;PRNP;PKN1;PTPRS;ZFP36L1;STAT6;PAG1;MMP28;SERPING1;LDLR;CEACAM1;BCR;FAM3A;IL20RB;CEBPB;TGFB1;ADA;ERBB2;JAK3;INPP5D;ZFPM1;MIF;DDT;PELI1;HLA-G;PPP3CB;HFE;ITPKB
6567,GO:0022038,0.400577900166534,0.852511294303896,2,13,corpus callosum development,BP,PTPRS;EPHB2
7370,GO:0031430,0.401318137758221,0.852036113654576,2,13,M band,CC,OBSCN;OBSL1
5666,GO:0016775,0.40135213589835,0.922170966580179,1,5,phosphotransferase activity, nitrogenous group as acceptor,MF,CKMT1A
14171,GO:0061081,0.401723702019329,0.922010348603346,1,5,positive regulation of myeloid leukocyte cytokine production involved in immune response,BP,MIF
4062,GO:0009113,0.402162125964509,0.8514933846174,2,13,purine nucleobase biosynthetic process,BP,APRT;ADA
7775,GO:0032306,0.402283288400137,0.921768068588164,1,5,regulation of prostaglandin secretion,BP,MIF
7776,GO:0032308,0.402283288400137,0.921768068588164,1,5,positive regulation of prostaglandin secretion,BP,MIF
8576,GO:0034067,0.402504793831509,0.812660338756183,3,21,protein localization to Golgi apparatus,BP,OBSL1;SORL1;COG7
13629,GO:0060142,0.402508738360792,0.8512702018065,2,13,regulation of syncytium formation by plasma membrane fusion,BP,RAPGEF3;CAMK1
17494,GO:1900424,0.402623199169947,0.851196463341634,2,13,regulation of defense response to bacterium,BP,MAPKBP1;SIRT2
18034,GO:1902525,0.40303820932909,0.92144048010259,1,5,regulation of protein monoubiquitination,BP,PDCD6
4792,GO:0010985,0.403328434096195,0.921314315516659,1,5,negative regulation of lipoprotein particle clearance,BP,PCSK9
722,GO:0001952,0.403625607681471,0.72135236239423,10,83,regulation of cell-matrix adhesion,BP,POSTN;VEGFA;SMAD3;PPM1F;EPHA1;PLAU;RHOD;PRKCZ;MINK1;ADAM15
6698,GO:0030104,0.403818146299389,0.754667200484778,6,47,water homeostasis,BP,PRKACB;PRKACA;WFS1;ADCY1;ADCY7;ADCY6
12763,GO:0051047,0.403870829347699,0.67551987547539,26,231,positive regulation of secretion,BP,APLN;POSTN;F2R;EGFR;SDC1;GLUL;NLGN2;ADORA2B;HK1;FGFR1;ALOX15B;ADAM8;TGFB1;NTSR1;PCK2;PFKFB2;PRKCZ;RASL10B;MIF;PLA2G6;MAPK3;PFKM;PPP3CB;SIRT3;HFE;ZP3
10510,GO:0043425,0.403963533511076,0.811594262238337,3,21,bHLH transcription factor binding,MF,SMAD3;BHLHE40;MAP3K10
9606,GO:0036474,0.404096489605315,0.810905098145479,3,22,cell death in response to hydrogen peroxide,BP,ENDOG;TRAP1;STK25
7478,GO:0031649,0.404230766146388,0.850158863362479,2,13,heat generation,BP,APLN;SLC27A1
19962,GO:2000483,0.40444311618805,0.920828584049186,1,5,negative regulation of interleukin-8 secretion,BP,MAPKBP1
10635,GO:0043651,0.404456221284107,0.850013050251195,2,13,linoleic acid metabolic process,BP,ABCD1;ALOX15B
2695,GO:0006064,0.404548992784059,0.920782351319133,1,5,glucuronate catabolic process,BP,CRYL1
6188,GO:0019640,0.404548992784059,0.920782351319133,1,5,glucuronate catabolic process to xylulose 5-phosphate,BP,CRYL1
12840,GO:0051167,0.404548992784059,0.920782351319133,1,5,xylulose 5-phosphate metabolic process,BP,CRYL1
17573,GO:1901159,0.404548992784059,0.920782351319133,1,5,xylulose 5-phosphate biosynthetic process,BP,CRYL1
2752,GO:0006166,0.404906393294223,0.920626163246901,1,5,purine ribonucleoside salvage,BP,APRT
11255,GO:0045541,0.405736265057986,0.920262765214599,1,5,negative regulation of cholesterol biosynthetic process,BP,APOE
16183,GO:0090206,0.405736265057986,0.920262765214599,1,5,negative regulation of cholesterol metabolic process,BP,APOE
363,GO:0000982,0.40602128589559,0.667212677144505,31,271,transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding,MF,MEF2D;EGR1;NR1D1;HMGA2;ELK3;NFATC4;TCFL5;ETV4;FOXQ1;POU2F2;FOS;EPAS1;HLTF;KLF7;TSHZ1;MYEF2;HES2;CEBPB;ZNF217;MLXIPL;RBL2;SOX12;CARF;ZFPM1;PPARA;SSBP4;BHLHE40;CAMTA2;PROX1;BACH1;PLAG1
2552,GO:0005829,0.40613567060199,0.617858843259671,437,4113,cytosol,CC,TNIP1;DUSP6;NT5E;XDH;ERCC1;HTRA1;FHL1;DLG4;BTBD2;FBXO2;PDCD4;CTNNBIP1;DOCK4;PRNP;PARVB;BBS2;FLNC;PGM1;PYGL;DGKA;OSBPL5;ISYNA1;PITPNC1;OBSCN;NDRG1;IDH2;NEK9;PKN1;MTA1;ACOT7;ANGEL1;NISCH;AKR7A2;RPS6KA2;SERPINE2;DNPH1;WWTR1;OBSL1;NOS1;SPRY2;CAPN2;NFATC4;TRIM65;APPL2;SHC1;TBC1D14;ARL2;GTPBP1;RIN1;ACTA2;SNX9;SPRY4;ZFP36L1;GLUL;ARAP1;MAP2K2;PLCD3;RBCK1;PGLS;PC;MAP2K1;NAPRT;CRYL1;ACP5;SSH1;EXOC2;ENDOG;MARK4;MPRIP;GALE;SMURF2;KLC2;FOS;SMAD3;ARHGAP23;STAT6;SHANK2;PIK3R2;DVL1;EPAS1;DNAJB5;AP2A2;PPP1R14A;PRDX5;SHC2;FBXW5;RNF187;NMRK1;ADARB1;AKT1;GRB7;CORO1B;HDAC5;UROS;FBXO41;S100A6;SH2D2A;PPM1F;PITPNM1;STK39;HK1;ASAP2;FMNL2;WWC3;ZFYVE21;PTHLH;RAB31;POLD4;ACOT1;FGFR1;PRKACB;RAC2;KCNAB2;PFKL;SEC14L2;OPLAH;MXI1;NPHP4;GAMT;PHF7;TOMM34;RALGDS;ASB13;LZTS2;DOCK6;ABCD1;ANK3;TTC7B;TRAPPC9;CCND1;PCBP4;LHPP;TNNT1;STRADB;SYNGAP1;MAPK13;CEP250;CARD19;PTK6;PFKP;CSNK1E;RAB3B;CARD11;SH2B3;DUSP7;GSN;PLEKHG2;MAPKAPK3;ARHGAP22;RAD23A;DHTKD1;PHLDA1;BCR;XPOT;ERRFI1;WIPF1;NADK;HLCS;AIP;SH3D19;CCDC113;CDC25B;SH3GLB2;ARHGAP27;ALOX15B;SPTB;AGAP1;CCS;CORO7;NPR2;UNC119B;DGKQ;HAGH;NOL4L;GTF2IRD1;SHARPIN;MVB12B;FYCO1;ACY1;RASGEF1A;CDC42EP5;CRTC1;FBXW8;GPSM1;SH3PXD2A;C19ORF33;EPHB2;APRT;CTBP1;JOSD2;LTA4H;GRIP2;PLCG1;FBXL8;CBS;KIF17;MVD;RNF135;LGALS9B;SYNJ2;DPP7;CLTCL1;SCYL1;ULK2;GPC1;MOAP1;ARHGAP25;SHANK3;MSRB2;RASA3;PIP5KL1;FBXO17;CLCA2;ARAP3;FARP1;TUB;CROCC;RHOD;ABHD14B;ABTB1;SNX17;RNH1;FBXO44;SNX33;PI4K2A;RHOF;ATG2A;PHGDH;MIF4GD;RHOBTB2;UBXN4;TUBG2;BBS1;PTPN1;PEX1;PCK2;AGRN;OSBPL10;VHL;CEP131;ADAP1;PFKFB2;MLXIPL;PRKCZ;PRKACA;MINK1;CENPH;GRHPR;RHPN1;RABGGTA;RCCD1;ACTR1B;EPN2;ADA;MPI;MICALL2;UCKL1;LGALS9C;PLEKHG5;SDCCAG8;ALAS1;ERBB2;ULK1;CNDP2;NINL;AHCY;VAMP2;MZT2A;RILPL1;JAK3;NET1;BNIP3L;CYFIP2;FSCN1;RASA4;CYGB;ARHGAP44;THOP1;PRKCD;MIB2;RBL2;CACNB3;USP20;STUB1;BAX;SBF1;DTD1;TRIM4;ZNF395;HIST3H2BB;PPCS;SH3BP1;FBXW4;DGUOK;CUL9;DDIT4;PPL;PPP1R13L;AHNAK2;MT2A;ZDHHC8;MZT2B;FCHO1;LIMK1;GDI1;TPM2;PADI3;RPL39L;RPS6KA6;WASH3P;GSTO1;GIT1;ALDOC;LRSAM1;ASB1;EHD3;SYMPK;MAPK12;IRAK1;HDAC7;FHOD1;INPP5D;MTHFR;PI4K2B;CBX7;SESN2;MYO1D;CDC34;RNF123;RAB12;BCAP31;MIF;SMOX;EEF2KMT;DOPEY2;MEX3A;PLA2G6;NUDT14;FYN;PITPNM3;UPP1;RAC3;ETFB;EEF2K;ARHGAP12;FLYWCH1;ACAP3;DNM2;PELI1;ATXN10;SNX15;CHKA;CAT;SLC27A1;KIF26A;ASMTL;PLCB3;ARHGEF4;MAPK3;ARHGEF1;PAN2;TAZ;PFKM;ADCY1;TNS4;DOCK9;STX10;TSTA3;PDXK;GLRX;CEP72;PAK1;TRIM45;CAMKK2;PPP3CB;USP21;PFKFB3;MLYCD;CUL7;MICAL1;CAPRIN2;WDTC1;SAMD8;BIN1;SRMS;TSTD1;PPP2R5B;MAP2K3;BCL2L1;DLG3;ABHD10;IARS2;TBC1D16;ALDH7A1;LMNA;TNFRSF25;RABGAP1;SIRT2;FAM129B;BACH1;NT5C1B;TRIP10;ADCY7;AZIN2;ICA1;RAP1GAP2;SOCS7;NDE1;PELI3;NGFR;TOLLIP;ATP6V1F;PXN;GRB10;DUSP23;GCH1;KIF13B;TCTN1;CAMKK1;WIPI2;VPS51;C2CD2;TNRC18;NDRG2;BLOC1S4;ITPKB;CDC42BPG;DOK4;GSDMA;HOMER2;APBA1;TTLL3;SRSF5;CHPF;ADCY6;LRRK1;AARS
18621,GO:1903894,0.406187745149506,0.848890776240615,2,13,regulation of IRE1-mediated unfolded protein response,BP,PTPN1;BAX
44,GO:0000096,0.40631465453607,0.78427158762349,4,30,sulfur amino acid metabolic process,BP,GGT1;CBS;AHCY;MTHFR
3914,GO:0008584,0.406866941925381,0.712844075557084,11,94,male gonad development,BP,ERCC1;CST3;SDC1;WNT2B;CCND1;BOK;BAX;ADAM15;ARID5B;INSR;BCL2L1
19814,GO:2000241,0.407064094943105,0.724466587287198,9,76,regulation of reproductive process,BP,PHLDA2;SMURF2;PRKACB;NPR2;ADA;INSR;SIRT2;GPR3;ZP3
7420,GO:0031528,0.407126659569083,0.848280440256557,2,13,microvillus membrane,CC,SYTL1;CEACAM1
15996,GO:0086009,0.407163088310598,0.809246480230854,3,21,membrane repolarization,BP,SCN4B;SNTA1;CACNB3
12837,GO:0051156,0.407250293985326,0.808585011544151,3,22,glucose 6-phosphate metabolic process,BP,H6PD;PGLS;HK1
16517,GO:0097228,0.407300479928806,0.848167311427376,2,13,sperm principal piece,CC,HK1;PFKM
6004,GO:0019048,0.407656096776753,0.78322019595842,4,30,modulation by virus of host morphology or physiology,BP,SMAD3;TGFB1;INSR;BCL2L1
4498,GO:0010528,0.407782663953105,0.847853262288056,2,13,regulation of transposition,BP,APOBEC3C;APOBEC3F
4499,GO:0010529,0.407782663953105,0.847853262288056,2,13,negative regulation of transposition,BP,APOBEC3C;APOBEC3F
18693,GO:1904029,0.407801529854025,0.723821190247197,9,76,regulation of cyclin-dependent protein kinase activity,BP,EGFR;AKT1;CCND1;PKD2;CDKN1C;CAMK2N1;PROX1;PKD1;MAPRE3
2753,GO:0006167,0.408290455946597,0.919137832419819,1,5,AMP biosynthetic process,BP,APRT
4153,GO:0009217,0.40841618017719,0.919082207703449,1,5,purine deoxyribonucleoside triphosphate catabolic process,BP,ADA
13241,GO:0051930,0.408571990039763,0.847338453523833,2,13,regulation of sensory perception of pain,BP,F2R;NTSR1
13242,GO:0051931,0.408571990039763,0.847338453523833,2,13,regulation of sensory perception,BP,F2R;NTSR1
7394,GO:0031465,0.408628724370638,0.918988116877143,1,5,Cul4B-RING E3 ubiquitin ligase complex,CC,DDB2
15560,GO:0072012,0.408972531956408,0.847076874520821,2,13,glomerulus vasculature development,BP,EGR1;ACTA2
5830,GO:0017110,0.409084338476024,0.84700381692206,2,13,nucleoside-diphosphatase activity,MF,ENTPD6;ENTPD2
5541,GO:0016530,0.409093215580293,0.915876969335938,1,6,metallochaperone activity,MF,CCS
1115,GO:0002703,0.409507783626978,0.705673403354398,12,103,regulation of leukocyte mediated immunity,BP,STAT6;ADORA2B;RAC2;CEACAM1;BCR;IL20RB;TGFB1;PRKCZ;JAK3;PPP3CB;HFE;ZP3
15458,GO:0071801,0.409597755033008,0.846668106341042,2,13,regulation of podosome assembly,BP,GSN;FSCN1
7750,GO:0032273,0.409618777418142,0.710392242088793,11,94,positive regulation of protein polymerization,BP,ARL2;CORO1B;RAC2;GSN;WIPF1;ARPIN;CDC42EP5;WASH3P;RAC3;PAK1;PFN2
16561,GO:0097345,0.409852323829292,0.749230023590411,6,49,mitochondrial outer membrane permeabilization,BP,BNIP3;MOAP1;BOK;TFDP2;BNIP3L;BAX
1133,GO:0002724,0.409859501233204,0.84649681181865,2,13,regulation of T cell cytokine production,BP,PRKCZ;HFE
8878,GO:0034698,0.410177421243607,0.807022672939366,3,21,response to gonadotropin,BP,NSMF;TGFBR3;ITGA3
3697,GO:0008209,0.410242445258122,0.846246025247591,2,13,androgen metabolic process,BP,SRD5A3;HSD17B8
14761,GO:0070459,0.410539374617107,0.918139231768011,1,5,prolactin secretion,BP,EGFR
10925,GO:0044557,0.410583741914377,0.918119454737802,1,5,relaxation of smooth muscle,BP,ADORA2B
7436,GO:0031573,0.410845399257094,0.845850730778944,2,13,intra-S DNA damage checkpoint,BP,XPC;CHEK2
14436,GO:0061756,0.410963494977599,0.845773246695066,2,13,leukocyte adhesion to vascular endothelial cell,BP,PODXL2;ITGA4
4724,GO:0010888,0.411007455036557,0.845744398847608,2,13,negative regulation of lipid storage,BP,PPARA;ABCG1
20254,GO:2001179,0.411112151972248,0.917883684020785,1,5,regulation of interleukin-10 secretion,BP,PRKCZ
3244,GO:0006906,0.411366542530424,0.695948087648367,14,120,vesicle fusion,BP,EVI5L;SYTL1;VPS11;TBC1D14;SYT8;DYSF;TBC1D9B;VAMP2;STX10;VPS16;SGSM2;TBC1D16;RABGAP1;TBC1D8
14925,GO:0070813,0.411448773948721,0.917733267249558,1,5,hydrogen sulfide metabolic process,BP,CBS
7956,GO:0032561,0.411484591547343,0.660853865342504,32,287,guanyl ribonucleotide binding,MF,ARL2;GTPBP1;RAB31;RAC2;RAB3B;EHD4;SEPT10;AGAP1;NPR2;GNAL;TMEM173;RHOD;RHOF;ARL10;RHOBTB2;TUBG2;PCK2;RASL10B;DNM1;EHD3;RAB12;RAC3;DNM2;TUBB6;INSR;RRAS;RAB28;RAB40B;GCH1;SEPT6;AK3;LRRK1
4858,GO:0014074,0.411897189939127,0.708433943089645,11,93,response to purine-containing compound,BP,SDC1;RAPGEF3;ZFP36L1;SSH1;FOS;BSG;DGKQ;PKD2;VGF;AREG;EEF2K
1482,GO:0003777,0.412185015437481,0.71379021439559,10,83,microtubule motor activity,MF,KLC2;KIF17;KIF26B;DNAH1;KIF7;WDR60;MYO1D;MYH15;KIF26A;KIF13B
4458,GO:0010453,0.41222359348057,0.84494523620988,2,13,regulation of cell fate commitment,BP,DUSP6;FGFR1
10855,GO:0044380,0.412292601199116,0.74757711290315,6,47,protein localization to cytoskeleton,BP,NUDCD3;DVL1;CEP250;ABHD17C;CEP131;CEP72
4657,GO:0010804,0.412683932728094,0.843559600198582,2,14,negative regulation of tumor necrosis factor-mediated signaling pathway,BP,GAS6;PELI3
7488,GO:0031666,0.412696317085327,0.917174319049485,1,5,positive regulation of lipopolysaccharide-mediated signaling pathway,BP,MIF
16652,GO:0097529,0.412697359650991,0.712905698786305,10,88,myeloid leukocyte migration,BP,PGF;VEGFA;MMP28;VEGFB;RAC2;ADAM8;ITGA1;MIF;DDT;MAPK3
3755,GO:0008299,0.412952624606362,0.804357913335211,3,22,isoprenoid biosynthetic process,BP,SRD5A3;MVD;COQ2
3789,GO:0008356,0.413127279759394,0.844350022249308,2,13,asymmetric cell division,BP,ETV5;RGS14
4238,GO:0009438,0.413463393991701,0.916829468624274,1,5,methylglyoxal metabolic process,BP,HAGH
13885,GO:0060538,0.413677650170035,0.70684165378858,11,93,skeletal muscle organ development,BP,MEF2D;EGR1;FOS;HMG20B;TGFB1;GPC1;LEMD2;MYH15;TAZ;FAM129B;MAFF
2100,GO:0004866,0.413839220888174,0.718132820526226,9,80,endopeptidase inhibitor activity,MF,CST3;SERPINE2;PRDX5;SERPING1;GAS6;TFPI2;TIMP2;PCSK1N;SERPINB1
6882,GO:0030414,0.413839220888174,0.718132820526226,9,80,peptidase inhibitor activity,MF,CST3;SERPINE2;PRDX5;SERPING1;GAS6;TFPI2;TIMP2;PCSK1N;SERPINB1
7635,GO:0032052,0.414017896542877,0.916579628305688,1,5,bile acid binding,MF,PYGL
5662,GO:0016769,0.414091259774459,0.843713803527593,2,13,transferase activity, transferring nitrogenous groups,MF,GPT2;PHYKPL
18350,GO:1903301,0.414447852185742,0.916385583269846,1,5,positive regulation of hexokinase activity,BP,PFKFB2
1585,GO:0003995,0.414538520717265,0.843418161640439,2,13,acyl-CoA dehydrogenase activity,MF,ACAD10;ACADS
9841,GO:0042092,0.414738264937981,0.803025684653518,3,22,type 2 immune response,BP,STAT6;PRKCZ;ECM1
9364,GO:0035886,0.414884373518317,0.843189353909438,2,13,vascular smooth muscle cell differentiation,BP,PDCD4;VEGFA
4304,GO:0009757,0.414935674838145,0.916165081766271,1,5,hexose mediated signaling,BP,MLXIPL
4413,GO:0010182,0.414935674838145,0.916165081766271,1,5,sugar mediated signaling pathway,BP,MLXIPL
4424,GO:0010255,0.414935674838145,0.916165081766271,1,5,glucose mediated signaling pathway,BP,MLXIPL
9408,GO:0035976,0.414958547489831,0.91615473417637,1,5,transcription factor AP-1 complex,CC,FOS
9191,GO:0035579,0.414981390721248,0.73410651381029,7,57,specific granule membrane,CC,SLC2A3;STOM;SLC15A4;KCNAB2;CEACAM1;PLAU;ADAM8
4170,GO:0009240,0.415071693356432,0.916103535277,1,5,isopentenyl diphosphate biosynthetic process,BP,MVD
11690,GO:0046490,0.415071693356432,0.916103535277,1,5,isopentenyl diphosphate metabolic process,BP,MVD
946,GO:0002360,0.415090208580652,0.843053096824871,2,13,T cell lineage commitment,BP,STAT6;ZFPM1
9203,GO:0035591,0.415342676415565,0.733955641040551,7,56,signaling adaptor activity,MF,SHC1;PAG1;GRB7;SH2D2A;SH2B3;SH3BP2;GRB10
13807,GO:0060412,0.415808324316071,0.776785934641722,4,30,ventricular septum morphogenesis,BP,TGFBR3;ZFPM1;VANGL2;PROX1
5201,GO:0015800,0.415966387559868,0.776660420490985,4,30,acidic amino acid transport,BP,NTSR1;VAMP2;PRAF2;APBA1
441,GO:0001190,0.416042656038383,0.744211847686549,6,48,transcriptional activator activity, RNA polymerase II transcription factor binding,MF,CITED4;FOS;KDM6B;SOX12;PPARA;RERE
11623,GO:0046339,0.41612694703014,0.842365877947427,2,13,diacylglycerol metabolic process,BP,DGKA;DGKQ
3038,GO:0006595,0.416975375806798,0.840703853408377,2,14,polyamine metabolic process,BP,SMOX;AZIN2
12787,GO:0051090,0.417010940942131,0.653547851905065,34,306,regulation of DNA binding transcription factor activity,BP,CTNNBIP1;PRNP;VEGFA;LRP5;MDFI;RBCK1;FOS;AKT1;HDAC5;DAP;MXI1;TRAPPC9;GAS6;CARD11;PKD2;CRTC1;ADAM8;TGFB1;PRKCZ;RPS6KA5;MBTPS2;IRAK1;WFS1;ARID5B;BHLHE40;PELI1;CAT;MAPK3;PPP2R5B;PROX1;ADGRF1;PKD1;EDA;MAP3K10
18738,GO:1904181,0.417294534930534,0.91509373448484,1,5,positive regulation of membrane depolarization,BP,ANK3
17741,GO:1901661,0.417516672345304,0.800387378645848,3,23,quinone metabolic process,BP,AKR7A2;CBR4;COQ2
50,GO:0000104,0.417607035410443,0.914951165686952,1,5,succinate dehydrogenase activity,MF,SDHA
2498,GO:0005749,0.417607035410443,0.914951165686952,1,5,mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone),CC,SDHA
3675,GO:0008177,0.417607035410443,0.914951165686952,1,5,succinate dehydrogenase (ubiquinone) activity,MF,SDHA
11169,GO:0045257,0.417607035410443,0.914951165686952,1,5,succinate dehydrogenase complex (ubiquinone),CC,SDHA
11174,GO:0045273,0.417607035410443,0.914951165686952,1,5,respiratory chain complex II,CC,SDHA
11178,GO:0045281,0.417607035410443,0.914951165686952,1,5,succinate dehydrogenase complex,CC,SDHA
11180,GO:0045283,0.417607035410443,0.914951165686952,1,5,fumarate reductase complex,CC,SDHA
11797,GO:0046689,0.417611370695459,0.914949186796049,1,5,response to mercury ion,BP,BSG
17538,GO:1901021,0.417709481477233,0.8007998661198,3,22,positive regulation of calcium ion transmembrane transporter activity,BP,PKD2;GSTO1;EHD3
7997,GO:0032627,0.417747060919163,0.914887234865796,1,5,interleukin-23 production,BP,TGFB1
8021,GO:0032667,0.417747060919163,0.914887234865796,1,5,regulation of interleukin-23 production,BP,TGFB1
6107,GO:0019348,0.417802582324729,0.914861877409966,1,5,dolichol metabolic process,BP,SRD5A3
3154,GO:0006760,0.417947285940436,0.800621230787582,3,22,folic acid-containing compound metabolic process,BP,MTHFR;GCH1;PM20D2
9343,GO:0035859,0.418329842848377,0.84090051153188,2,13,Seh1-associated complex,CC,WDR59;SESN2
12907,GO:0051262,0.418547480428286,0.696765903175863,12,116,protein tetramerization,BP,HSD17B8;PFKL;CBR4;PKD2;GPX3;CRTC1;HMGCL;LRP4;OXA1L;DNM1;CAT;INSR
3622,GO:0008081,0.418581397419082,0.731006367191807,7,57,phosphoric diester hydrolase activity,MF,PLD3;PLCD3;PLCXD2;PLCH2;EDNRA;PLCG1;PLCB3
6074,GO:0019228,0.418622195360257,0.840705512407875,2,13,neuronal action potential,BP,ANK3;SCN8A
14538,GO:0070059,0.418920343219777,0.741578971065949,6,49,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,CEBPB;PTPN1;BOK;BAX;WFS1;GRINA
11370,GO:0045746,0.419262746361934,0.773656645263864,4,31,negative regulation of Notch signaling pathway,BP,ARRDC1;EGFR;PEAR1;FAM129B
5213,GO:0015813,0.419302104131653,0.840251535852458,2,13,L-glutamate transmembrane transport,BP,NTSR1;PRAF2
13046,GO:0051546,0.419772982318376,0.839936737913489,2,13,keratinocyte migration,BP,HBEGF;LTB4R2
18180,GO:1902932,0.419833222426883,0.839896442241178,2,13,positive regulation of alcohol biosynthetic process,BP,NTSR1;ABCG1
5993,GO:0019001,0.419859915374379,0.652907459707043,32,288,guanyl nucleotide binding,MF,ARL2;GTPBP1;RAB31;RAC2;RAB3B;EHD4;SEPT10;AGAP1;NPR2;GNAL;TMEM173;RHOD;RHOF;ARL10;RHOBTB2;TUBG2;PCK2;RASL10B;DNM1;EHD3;RAB12;RAC3;DNM2;TUBB6;INSR;RRAS;RAB28;RAB40B;GCH1;SEPT6;AK3;LRRK1
9140,GO:0035493,0.419910044970369,0.839845046671669,2,13,SNARE complex assembly,BP,VPS11;VPS16
14658,GO:0070265,0.419911807948892,0.754442920388348,5,41,necrotic cell death,BP,PYGL;RBCK1;BNIP3;BOK;BAX
1460,GO:0003705,0.419963054932738,0.729813359259416,7,57,transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding,MF,MEF2D;GTF2IRD1;CEBPB;SOX7;BHLHE40;PROX1;BACH1
13173,GO:0051788,0.419999163187437,0.799076871634898,3,22,response to misfolded protein,BP,F12;ANKZF1;STUB1
16924,GO:0098902,0.420085378246588,0.913815198651038,1,5,regulation of membrane depolarization during action potential,BP,ANK3
3072,GO:0006643,0.420159189553205,0.670947890693725,20,177,membrane lipid metabolic process,BP,HEXB;KDSR;PIGQ;FUCA1;PIGV;SERINC2;ST6GALNAC6;ESYT2;B4GALT6;PRKCD;BAX;NAGA;PLA2G6;CERS4;GLB1;SAMD8;GAL3ST4;ST3GAL2;ST3GAL5;SPTLC2
15037,GO:0070988,0.420162410482737,0.729641077142393,7,57,demethylation,BP,KDM6B;KDM4B;ARID5B;CYP3A5;APOBEC3C;APOBEC3F;KDM3A
13189,GO:0051817,0.420358334326578,0.712762160707194,9,76,modification of morphology or physiology of other organism involved in symbiotic interaction,BP,TNIP1;APOE;HMGA2;PC;SMAD3;STOM;TGFB1;INSR;BCL2L1
9893,GO:0042182,0.420413125684504,0.913664267057791,1,5,ketone catabolic process,BP,HAGH
425,GO:0001133,0.420733517673797,0.839293593365339,2,13,RNA polymerase II transcription factor activity, sequence-specific transcription regulatory region DNA binding,MF,NR1D1;PPARA
19785,GO:2000178,0.420762791993216,0.839273971227536,2,13,negative regulation of neural precursor cell proliferation,BP,TGFB1;SIRT2
16716,GO:0097711,0.420805329951832,0.700365849962652,11,94,ciliary basal body-plasma membrane docking,BP,MARK4;NPHP4;CEP250;CSNK1E;CEP131;PRKACA;SDCCAG8;NINL;CEP72;NDE1;TCTN1
15401,GO:0071670,0.420942744411572,0.913420021897363,1,5,smooth muscle cell chemotaxis,BP,CORO1B
18793,GO:1904294,0.420946161043553,0.839151033473174,2,13,positive regulation of ERAD pathway,BP,EDEM1;BCAP31
4088,GO:0009144,0.421008537645756,0.66059997217884,25,240,purine nucleoside triphosphate metabolic process,BP,PGM1;GTPBP1;NME4;HK1;PFKL;PFKP;DHTKD1;NADK;TGFB1;SDHA;PFKFB2;MLXIPL;ADA;FAM20C;CYC1;DGUOK;DDIT4;ALDOC;PPARA;INSR;TAZ;PFKM;PFKFB3;NDUFV3;AK3
17099,GO:0099632,0.42113129869327,0.839026860587699,2,13,protein transport within plasma membrane,BP,AP3D1;ARHGAP44
17101,GO:0099637,0.42113129869327,0.839026860587699,2,13,neurotransmitter receptor transport,BP,AP3D1;ARHGAP44
14259,GO:0061337,0.421279328947006,0.719620851288239,8,66,cardiac conduction,BP,ITPR3;SCN4B;NOS1;NPR2;PRKACA;TRPC1;CACNB3;EHD3
6437,GO:0021756,0.42135785497203,0.838874840447228,2,13,striatum development,BP,BBS2;SHANK3
11724,GO:0046546,0.421473564422183,0.699688362987154,11,95,development of primary male sexual characteristics,BP,ERCC1;CST3;SDC1;WNT2B;CCND1;BOK;BAX;ADAM15;ARID5B;INSR;BCL2L1
5659,GO:0016763,0.421671678233241,0.753232977789086,5,40,transferase activity, transferring pentosyl groups,MF,DNPH1;NAPRT;APRT;XYLT2;UPP1
9689,GO:0038089,0.421763077969527,0.913040854147908,1,5,positive regulation of cell migration by vascular endothelial growth factor signaling pathway,BP,VEGFA
8379,GO:0033293,0.421775226630695,0.770956804656055,4,33,monocarboxylic acid binding,MF,PYGL;PC;HLCS;PPARA
13568,GO:0060046,0.421907193532254,0.912974135046113,1,5,regulation of acrosome reaction,BP,ZP3
19296,GO:1905516,0.421907193532254,0.912974135046113,1,5,positive regulation of fertilization,BP,ZP3
9828,GO:0042059,0.422264391018007,0.752740424979964,5,40,negative regulation of epidermal growth factor receptor signaling pathway,BP,EGFR;SPRY2;ERRFI1;ITGA1;CBLC
15263,GO:0071447,0.422286059931799,0.912798583814228,1,5,cellular response to hydroperoxide,BP,PRKCD
17621,GO:1901299,0.422291140064581,0.912796228379496,1,5,negative regulation of hydrogen peroxide-mediated programmed cell death,BP,TRAP1
17593,GO:1901215,0.422322721417708,0.682360289305048,15,131,negative regulation of neuron death,BP,APOE;F2R;LRP1;AKT1;SORL1;SYNGAP1;ADAM8;CEBPB;BOK;BAX;PPARA;WFS1;FYN;BCL2L1;AARS
3149,GO:0006751,0.422412755238571,0.912739828909011,1,5,glutathione catabolic process,BP,GGT1
13461,GO:0055007,0.422719400697501,0.718356862278531,8,66,cardiac muscle cell differentiation,BP,VEGFA;OBSL1;TGFB1;FHOD3;KDM6B;PAK1;PROX1;LMNA
11548,GO:0046100,0.422960041082886,0.912485740227739,1,5,hypoxanthine metabolic process,BP,ADA
9444,GO:0036035,0.423218146755395,0.837623763806077,2,13,osteoclast development,BP,FAM20C;LRRK1
3069,GO:0006639,0.423450997596554,0.717587241784499,8,67,acylglycerol metabolic process,BP,APOE;DGKA;LMF1;LDLR;PCSK9;DGKQ;PCK2;CAT
16751,GO:0098533,0.423756124172214,0.837261029161915,2,13,ATPase dependent transmembrane transport complex,CC,ABCA2;ABCA7
10019,GO:0042462,0.423787542786059,0.837239831973759,2,13,eye photoreceptor cell development,BP,VEGFA;NAGLU
9068,GO:0035313,0.423834526338568,0.837208130917258,2,13,wound healing, spreading of epidermal cells,BP,WNT7A;HBEGF
8977,GO:0035089,0.424073712276877,0.837046696060874,2,13,establishment of apical/basal cell polarity,BP,FSCN1;SH3BP1
18263,GO:1903076,0.42412050225032,0.716998396492262,8,67,regulation of protein localization to plasma membrane,BP,PRNP;EGFR;LRP1;AKT1;EPHB2;TGFB1;ITGA3;BCL2L1
13607,GO:0060090,0.424135223144695,0.674669997530336,17,148,molecular adaptor activity,MF,ARRDC1;OBSL1;SHC1;VPS11;AP2A2;PAG1;GRB7;SH2D2A;ANK3;GAS6;SH2B3;SH3BP2;FSCN1;STUB1;PDCD6;GRB10;GAS2L1
7442,GO:0031584,0.42415902276029,0.911927468147903,1,5,activation of phospholipase D activity,BP,PRKCZ
4251,GO:0009566,0.424298741204169,0.716718650029987,8,68,fertilization,BP,MST1R;HEXB;SYT8;CD9;TDRKH;BAX;BCL2L1;ZP3
19180,GO:1905208,0.424307713833678,0.836888679872966,2,13,negative regulation of cardiocyte differentiation,BP,EGFR;PAK1
8699,GO:0034349,0.42439085859228,0.836832514854001,2,13,glial cell apoptotic process,BP,GAS6;PRKCD
11889,GO:0046923,0.424412510465312,0.911809153421879,1,5,ER retention sequence binding,MF,CEMIP
1803,GO:0004448,0.424459107440016,0.911787393557847,1,5,isocitrate dehydrogenase activity,MF,IDH2
17578,GO:1901165,0.424467401379628,0.911783520095794,1,5,positive regulation of trophoblast cell migration,BP,SMURF2
7907,GO:0032486,0.424661302533729,0.83664975807329,2,13,Rap protein signal transduction,BP,RAPGEF3;TIMP2
10094,GO:0042609,0.424743557588125,0.911654487890712,1,5,CD4 receptor binding,MF,FYN
3027,GO:0006577,0.424810541837276,0.836548861712581,2,13,amino-acid betaine metabolic process,BP,CRAT;ALDH7A1
1049,GO:0002576,0.424849778773344,0.708671695729459,9,77,platelet degranulation,BP,VEGFA;SERPING1;VEGFB;GAS6;TGFB1;CD9;ECM1;QSOX1;LGALS3BP
12354,GO:0048745,0.424883700219116,0.836499389623382,2,13,smooth muscle tissue development,BP,PKD2;PROX1
8273,GO:0033085,0.424897411570417,0.911582549251527,1,5,negative regulation of T cell differentiation in thymus,BP,ERBB2
74,GO:0000151,0.425011988112867,0.650322502144013,30,268,ubiquitin ligase complex,CC,BTBD2;FBXO2;KLHL29;DDB2;RBCK1;SMURF2;FBXW5;PHC2;SHARPIN;FBXW8;FBXO17;ABTB1;FBXO44;ZER1;VHL;MIB2;STUB1;FBXW4;CUL9;ASB1;CBX7;DCAF10;KLHL36;RNF144A;CUL7;ZYG11B;KCTD13;BACH1;PDCD6;KLHL24
5375,GO:0016188,0.425122113815454,0.911477417505272,1,5,synaptic vesicle maturation,BP,DLG4
17344,GO:1900024,0.425139288122207,0.750346026365051,5,40,regulation of substrate adhesion-dependent cell spreading,BP,POSTN;FBLN1;NET1;RAC3;DNM2
15875,GO:0072606,0.425141697340798,0.835196031692871,2,14,interleukin-8 secretion,BP,F2R;MAPKBP1
9483,GO:0036123,0.425205347938615,0.911438454724673,1,5,histone H3-K9 dimethylation,BP,KDM3A
17866,GO:1902047,0.425261346419617,0.911412235185512,1,5,polyamine transmembrane transport,BP,AZIN2
15486,GO:0071863,0.425261462522381,0.91141218081243,1,5,regulation of cell proliferation in bone marrow,BP,HMGA2
15487,GO:0071864,0.425261462522381,0.91141218081243,1,5,positive regulation of cell proliferation in bone marrow,BP,HMGA2
17834,GO:1901983,0.425309291205937,0.725023680379192,7,58,regulation of protein acetylation,BP,NOS1;RAPGEF3;CTBP1;TGFB1;RPS6KA5;MAPK3;CAMK1
9905,GO:0042246,0.425336624820499,0.768782659200324,4,31,tissue regeneration,BP,POSTN;WNT7A;GSN;ADAM15
19178,GO:1905206,0.425464283509636,0.911317175377445,1,5,positive regulation of hydrogen peroxide-induced cell death,BP,ENDOG
9097,GO:0035372,0.425572221328243,0.836033407665767,2,13,protein localization to microtubule,BP,DVL1;ABHD17C
2086,GO:0004849,0.42560136306282,0.911252928321348,1,5,uridine kinase activity,MF,UCKL1
12258,GO:0048562,0.425667420249405,0.668135874119647,19,166,embryonic organ morphogenesis,BP,NAGLU;SPRY2;MDFI;SMAD3;DVL1;IFT140;FGFR1;TSHZ1;BCR;SLITRK6;PKD2;EPHB2;WDR60;MAPK3;VANGL2;HYAL1;PROX1;SLC39A3;CELSR1
4804,GO:0012501,0.425677027246037,0.609193578213238,159,1485,programmed cell death,BP,DUSP6;XDH;MEF2D;H1F0;EGR1;CST3;HS1BP3;PDCD4;PRNP;VEGFA;TNFRSF6B;WNT7A;APOE;PYGL;F2R;LRP5;ITGA6;HMGA2;OBSCN;NDRG1;PKN1;GRAMD4;NISCH;EGFR;RPS6KA2;SPRY2;MST1R;NFATC4;PRSS8;SHC1;PHLDA2;ZFP36L1;MAP2K2;NME4;RBCK1;MAP2K1;ENDOG;MARK4;SMAD3;ERCC6;LRP1;PRDX5;PRODH;ADARB1;AKT1;PPM1F;STK39;EPHA1;DAP;FGFR4;FGFR1;ELMO3;SIGMAR1;RAG1;PACS2;ZNF385A;STRADB;SYNGAP1;GAS6;CTSB;CARD11;GSN;PLEKHG2;PCSK9;PHLDA1;ANGPTL4;RGL2;ALOX15B;BNIP3;PAK6;SHARPIN;CTSZ;EPHB2;ADAM8;MNT;CEBPB;TGFB1;MKNK2;MOAP1;NTSR1;TMEM173;TNFSF15;NSMF;PEG3;TNFAIP8L1;PTPN1;VHL;TRAP1;PRKCZ;MINK1;RABGGTA;ADA;PIM2;PLEKHG5;BOK;ERBB2;TFDP2;STK17A;JAK3;NET1;BNIP3L;CYFIP2;PDK1;PRKCD;IFI6;BAX;ITGA1;TMBIM4;DDIT4;PPL;PPP1R13L;DIP2A;IRAK1;INPP5D;CHEK2;TMEM161A;CDC34;SOX7;BCAP31;MIF;PLA2G6;WFS1;FYN;STK25;EEF2K;DNM2;CAT;BEX2;SATB1;ARHGEF4;MAPK3;INSR;ARHGEF1;GRINA;TNS4;PAK1;MICAL1;DNMT3A;BIN1;MAP2K3;BCL2L1;LMNA;TNFRSF25;SIRT2;FAM129B;MAP3K10;PELI3;NGFR;PDCD6;PNMA1;BTG1;CDK11B;FGFR3;MFSD10;ITPKB;PLAG1;GSDMA;DEDD2;AARS
6349,GO:0021534,0.42590707527777,0.91110954046369,1,5,cell proliferation in hindbrain,BP,RERE
6523,GO:0021924,0.42590707527777,0.91110954046369,1,5,cell proliferation in external granule layer,BP,RERE
6524,GO:0021930,0.42590707527777,0.91110954046369,1,5,cerebellar granule cell precursor proliferation,BP,RERE
11752,GO:0046620,0.42594059890496,0.724631550945914,7,57,regulation of organ growth,BP,DUSP6;AKT1;WWC3;FGFR1;TGFBR3;PAK1;PROX1
1607,GO:0004029,0.426073464918654,0.835693738639791,2,13,aldehyde dehydrogenase (NAD) activity,MF,ALDH4A1;ALDH7A1
2101,GO:0004867,0.426130526852373,0.749023971239694,5,42,serine-type endopeptidase inhibitor activity,MF,SERPINE2;SERPING1;TFPI2;PCSK1N;SERPINB1
8343,GO:0033211,0.426275583667592,0.910936505998897,1,5,adiponectin-activated signaling pathway,BP,SLC27A1
18576,GO:1903792,0.42632097897932,0.835525875141683,2,13,negative regulation of anion transport,BP,AKT1;STK39
17294,GO:0140058,0.426346023312211,0.835508885157857,2,13,neuron projection arborization,BP,DLG4;DVL1
13302,GO:0052150,0.42638220900069,0.910886400238091,1,5,modulation by symbiont of host apoptotic process,BP,BCL2L1
8574,GO:0034063,0.426408990526036,0.835466164392395,2,13,stress granule assembly,BP,GRB7;CIRBP
7699,GO:0032185,0.426457399100254,0.835433317160819,2,13,septin cytoskeleton organization,BP,SEPT10;SEPT6
8812,GO:0034595,0.426563504068346,0.835361308580648,2,13,phosphatidylinositol phosphate 5-phosphatase activity,MF,SYNJ2;INPP5D
7062,GO:0030856,0.426578436738177,0.695154161286156,11,94,regulation of epithelial cell differentiation,BP,XDH;CYP27B1;WWTR1;ZFP36L1;CEACAM1;CCND1;ERRFI1;ALOX15B;CEBPB;MAFF;BTG1
16093,GO:0090074,0.426624433873397,0.910772507213619,1,5,negative regulation of protein homodimerization activity,BP,ITGA4
11281,GO:0045602,0.426627829929599,0.910770909754251,1,5,negative regulation of endothelial cell differentiation,BP,XDH
8131,GO:0032839,0.426755378795717,0.79395344236914,3,22,dendrite cytoplasm,CC,DLG4;KIF17;ADA
2293,GO:0005253,0.426775129906589,0.748979653069626,5,40,anion channel activity,MF,TTYH3;LRRC8A;ANO8;CLCA2;SLC26A11
10623,GO:0043627,0.426776531261838,0.734884637330131,6,49,response to estrogen,BP,CITED4;CYP27B1;WNT7A;ASH2L;CCND1;IGFBP2
6989,GO:0030676,0.426807060245194,0.835195956105952,2,13,Rac guanyl-nucleotide exchange factor activity,MF,FARP1;ARHGEF4
12988,GO:0051414,0.42682845103734,0.910676508318967,1,5,response to cortisol,BP,IGFBP7
17927,GO:1902229,0.426846395723511,0.76686715863265,4,33,regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,ZNF385A;TMEM161A;MIF;BCL2L1
8318,GO:0033169,0.426907170613832,0.835127965203595,2,13,histone H3-K9 demethylation,BP,KDM4B;KDM3A
1595,GO:0004012,0.426934407590309,0.835109464425476,2,13,phospholipid-translocating ATPase activity,MF,ABCA7;ATP8B2
14126,GO:0061003,0.426934407590358,0.835109464425547,2,13,positive regulation of dendritic spine morphogenesis,BP,EEF2K;CAPRIN2
4375,GO:0010008,0.426959210023072,0.638014446544542,41,371,endosome membrane,CC,NDRG1;EGFR;APPL2;VPS11;AP2A2;TPCN1;ZFYVE21;RAB31;LDLR;SORL1;RAB11FIP4;PCSK9;ANTXR2;EHD4;MVB12B;AP3D1;ABCA2;TMEM9;ABHD17C;RHOD;SNX17;PI4K2A;SLC48A1;LLGL1;CD320;BOK;ERBB2;WASH3P;EHD3;IRAK1;ABCA7;RAB12;SLC9A7;CD68;SPPL2B;INSR;HLA-G;PRAF2;RNF144A;VPS16;PLEKHM1
1957,GO:0004661,0.427294075740515,0.910457168581689,1,5,protein geranylgeranyltransferase activity,MF,RABGGTA
18586,GO:1903817,0.427314400227834,0.910447586710862,1,5,negative regulation of voltage-gated potassium channel activity,BP,ANK3
5613,GO:0016661,0.427523228114877,0.910349098558707,1,5,oxidoreductase activity, acting on other nitrogenous compounds as donors,MF,CBS
5705,GO:0016833,0.427735426160348,0.910248951186922,1,5,oxo-acid-lyase activity,MF,HMGCL
11367,GO:0045743,0.427798728776877,0.910219061748767,1,5,positive regulation of fibroblast growth factor receptor signaling pathway,BP,FGFBP1
4757,GO:0010936,0.428058625442231,0.910096281329466,1,5,negative regulation of macrophage cytokine production,BP,TGFB1
8031,GO:0032687,0.42824987677974,0.910005862894522,1,5,negative regulation of interferon-alpha production,BP,PTPRS
13098,GO:0051642,0.428274669763688,0.792793203425355,3,22,centrosome localization,BP,FHOD1;SUN1;NDE1
12339,GO:0048712,0.428284074703534,0.909989689013516,1,5,negative regulation of astrocyte differentiation,BP,LDLR
6302,GO:0019934,0.428348907526158,0.909959021369234,1,5,cGMP-mediated signaling,BP,APOE
3003,GO:0006552,0.428393614574243,0.909937869914169,1,5,leucine catabolic process,BP,HMGCL
1383,GO:0003281,0.428396707722131,0.733697524068766,6,48,ventricular septum development,BP,LTBP1;TGFBR3;ZFPM1;DNM2;VANGL2;PROX1
15125,GO:0071222,0.428431380959343,0.688419746405632,12,105,cellular response to lipopolysaccharide,BP,TNIP1;NR1D1;PDCD4;AKT1;HDAC5;BCR;CEBPB;ADAMTS13;TGFB1;IRAK1;MIF;MAPK3
2388,GO:0005525,0.428461237952063,0.645826980258805,31,280,GTP binding,MF,ARL2;GTPBP1;RAB31;RAC2;RAB3B;EHD4;SEPT10;AGAP1;NPR2;GNAL;RHOD;RHOF;ARL10;RHOBTB2;TUBG2;PCK2;RASL10B;DNM1;EHD3;RAB12;RAC3;DNM2;TUBB6;INSR;RRAS;RAB28;RAB40B;GCH1;SEPT6;AK3;LRRK1
7875,GO:0032449,0.428475872606518,0.90989894445844,1,5,CBM complex,CC,CARD11
13358,GO:0052564,0.428565778798778,0.909856387689814,1,5,response to immune response of other organism involved in symbiotic interaction,BP,TGFB1
13360,GO:0052572,0.428565778798778,0.909856387689814,1,5,response to host immune response,BP,TGFB1
1984,GO:0004704,0.429062020186541,0.909621265943952,1,5,NF-kappaB-inducing kinase activity,MF,IRAK1
13896,GO:0060558,0.429309221803989,0.909503996580505,1,5,regulation of calcidiol 1-monooxygenase activity,BP,CYP27B1
1019,GO:0002517,0.429360420127857,0.909479696769015,1,5,T cell tolerance induction,BP,HLA-G
1076,GO:0002645,0.429360420127857,0.909479696769015,1,5,positive regulation of tolerance induction,BP,HLA-G
1082,GO:0002664,0.429360420127857,0.909479696769015,1,5,regulation of T cell tolerance induction,BP,HLA-G
3381,GO:0007162,0.429413228828355,0.664603125838267,19,167,negative regulation of cell adhesion,BP,PRNP;POSTN;SERPINE2;FBLN1;PAG1;CEACAM1;PLXNB3;IL20RB;CEBPB;TGFB1;CD9;ERBB2;JAK3;PRKCD;ADAM15;PPARA;PELI1;HLA-G;HFE
7724,GO:0032226,0.429571258827442,0.909379584899343,1,5,positive regulation of synaptic transmission, dopaminergic,BP,RAB3B
13819,GO:0060428,0.429606281491602,0.791773832369455,3,22,lung epithelium development,BP,MAP2K1;ERRFI1;PKD1
8978,GO:0035090,0.429796074147675,0.909272759741123,1,5,maintenance of apical/basal cell polarity,BP,LRCH4
11141,GO:0045199,0.429796074147675,0.909272759741123,1,5,maintenance of epithelial cell apical/basal polarity,BP,LRCH4
9737,GO:0038202,0.429859010563435,0.765125762535651,4,31,TORC1 signaling,BP,CARD11;DGKQ;SESN2;C12ORF66
4224,GO:0009403,0.429919504304771,0.909214075890284,1,5,toxin biosynthetic process,BP,CBS
4012,GO:0009008,0.430136067084759,0.909111055110273,1,5,DNA-methyltransferase activity,MF,DNMT3A
20205,GO:2001033,0.430136390388718,0.909110901258639,1,5,negative regulation of double-strand break repair via nonhomologous end joining,BP,HMGA2
2819,GO:0006287,0.430162579332305,0.909098437948396,1,5,base-excision repair, gap-filling,BP,POLL
7254,GO:0031228,0.430176819166675,0.746129156157771,5,40,intrinsic component of Golgi membrane,CC,B4GAT1;RFNG;MFNG;QSOX1;SAMD8
18395,GO:1903393,0.430177754953648,0.791335655231819,3,22,positive regulation of adherens junction organization,BP,VEGFA;SMAD3;PPM1F
9100,GO:0035376,0.430468215998928,0.908952905893278,1,5,sterol import,BP,LDLR
14788,GO:0070508,0.430468215998928,0.908952905893278,1,5,cholesterol import,BP,LDLR
13738,GO:0060323,0.430623595581998,0.764505143441269,4,31,head morphogenesis,BP,WNT3;TGFB1;ARID5B;RRAS
20277,GO:2001214,0.430682909006202,0.908850589841712,1,5,positive regulation of vasculogenesis,BP,CEACAM1
12336,GO:0048709,0.431091860413104,0.719980957425558,7,58,oligodendrocyte differentiation,BP,GSN;BNIP3;TGFB1;WASF3;CD9;BOK;ERBB2
2115,GO:0004904,0.431162990372216,0.908621535612385,1,5,interferon receptor activity,MF,IFNGR2
17895,GO:1902165,0.431240162753841,0.830031772788253,2,15,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,ZNF385A;MIF
4035,GO:0009069,0.431322752842745,0.763937034430304,4,31,serine family amino acid metabolic process,BP,GGT1;CBS;PHGDH;AHCY
3526,GO:0007512,0.431368120583594,0.908523554247394,1,5,adult heart development,BP,MEF2D
13856,GO:0060484,0.431374517307784,0.908520497755574,1,5,lung-associated mesenchyme development,BP,FGFR1
12246,GO:0048537,0.431475534952227,0.908472220859302,1,5,mucosal-associated lymphoid tissue development,BP,ADA
12249,GO:0048541,0.431475534952227,0.908472220859302,1,5,Peyer's patch development,BP,ADA
17828,GO:1901976,0.431534364269237,0.763764974233026,4,31,regulation of cell cycle checkpoint,BP,NDRG1;CHEK2;ETAA1;PROX1
15897,GO:0072672,0.431543310142203,0.908439821710577,1,5,neutrophil extravasation,BP,ADAM8
9853,GO:0042108,0.431857202720936,0.763502374995921,4,31,positive regulation of cytokine biosynthetic process,BP,EGR1;CARD11;EREG;ZFPM1
629,GO:0001819,0.43187118299064,0.646259724721732,28,254,positive regulation of cytokine production,BP,EGR1;POSTN;F2R;NFATC4;SMAD3;STAT6;ADORA2B;HK1;MAPK13;CARD11;ALOX15B;IL20RB;ADAM8;CEBPB;RNF135;TGFB1;TMEM173;PRKCZ;EREG;IRAK1;ZFPM1;MIF;DDT;PELI1;MAPK3;HLA-G;LURAP1;ZP3
5431,GO:0016289,0.431884132256673,0.830575382587898,2,14,CoA hydrolase activity,MF,ACOT7;ACOT1
8020,GO:0032663,0.432004694743614,0.763382363297315,4,31,regulation of interleukin-2 production,BP,PRNP;CARD11;IL20RB;HDAC7
11812,GO:0046717,0.432167985188366,0.730255110000011,6,49,acid secretion,BP,NTSR1;VAMP2;SV2A;MIF;PLA2G6;APBA1
15751,GO:0072347,0.432362018273564,0.744291501661895,5,40,response to anesthetic,BP,HDAC5;ADA;DNM2;DNMT3A;HOMER2
11297,GO:0045625,0.432507348652094,0.907978190325363,1,5,regulation of T-helper 1 cell differentiation,BP,JAK3
10552,GO:0043515,0.432524477363146,0.907969974955715,1,5,kinetochore binding,MF,CENPH
14153,GO:0061046,0.432561108903996,0.907952403996871,1,5,regulation of branching involved in lung morphogenesis,BP,WNT2B
16479,GO:0097165,0.432633988860625,0.907917439524278,1,5,nuclear stress granule,CC,SYMPK
19630,GO:1990763,0.432661613740133,0.907904184180542,1,5,arrestin family protein binding,MF,ARRDC1
612,GO:0001781,0.432792131815133,0.907841540936709,1,5,neutrophil apoptotic process,BP,ITPKB
8243,GO:0033029,0.432792131815133,0.907841540936709,1,5,regulation of neutrophil apoptotic process,BP,ITPKB
14649,GO:0070245,0.432925290092949,0.907777602775424,1,5,positive regulation of thymocyte apoptotic process,BP,ADAM8
10376,GO:0043203,0.433073925112676,0.907706200121293,1,5,axon hillock,CC,PRKCZ
2806,GO:0006269,0.433298511191862,0.907598245164196,1,5,DNA replication, synthesis of RNA primer,BP,PRIMPOL
15258,GO:0071438,0.433343499571213,0.907576610377109,1,5,invadopodium membrane,CC,ITGA3
19817,GO:2000249,0.433355899192011,0.7883093208085,3,23,regulation of actin cytoskeleton reorganization,BP,RAPGEF3;TGFB1;RHOD
12001,GO:0047499,0.433383256161361,0.907557488884115,1,5,calcium-independent phospholipase A2 activity,MF,PLA2G6
10092,GO:0042605,0.433553180859968,0.829421284434365,2,14,peptide antigen binding,MF,SLC7A8;HLA-G
8267,GO:0033079,0.433695669225842,0.907407142396176,1,5,immature T cell proliferation,BP,ERBB2
17700,GO:1901569,0.433823497308272,0.907345581548209,1,5,fatty acid derivative catabolic process,BP,ACOT7
2816,GO:0006284,0.433951839360641,0.742693285876323,5,41,base-excision repair,BP,HMGA2;ERCC6;MPG;POLL;NEIL1
11335,GO:0045669,0.433976850711028,0.742930211777342,5,40,positive regulation of osteoblast differentiation,BP,CTNNBIP1;ACVR2B;CEBPB;FAM20C;ZHX3
1931,GO:0004630,0.43420878329626,0.90715987485443,1,5,phospholipase D activity,MF,PLD3
10837,GO:0044340,0.434280647056049,0.907125210726204,1,5,canonical Wnt signaling pathway involved in regulation of cell proliferation,BP,WNT3
16746,GO:0098519,0.434675250462404,0.906934724385323,1,5,nucleotide phosphatase activity, acting on free nucleotides,MF,NTPCR
136,GO:0000287,0.434987297668115,0.661814813677597,18,159,magnesium ion binding,MF,PGM1;IDH2;RPS6KA2;GLUL;BRSK1;PRKACB;LHPP;PI4K2A;HMGCL;RPS6KA5;RPS6KA6;MAPK12;ATP8B2;PDXK;NT5C1B;YDJC;PDCD6;CDC42BPG
4244,GO:0009446,0.435010108106303,0.906772885392018,1,5,putrescine biosynthetic process,BP,AZIN2
18647,GO:1903936,0.435248018042034,0.906657793781425,1,5,cellular response to sodium arsenite,BP,MAPK13
16166,GO:0090188,0.43526214686433,0.906650955975767,1,5,negative regulation of pancreatic juice secretion,BP,STK39
10475,GO:0043374,0.435284232666405,0.90664026666583,1,5,CD8-positive, alpha-beta T cell differentiation,BP,SATB1
10034,GO:0042492,0.435284232666405,0.90664026666614,1,5,gamma-delta T cell differentiation,BP,SOX13
12538,GO:0050693,0.435296057272963,0.906634543359768,1,5,LBD domain binding,MF,PROX1
2979,GO:0006526,0.435391681382673,0.906588251515242,1,5,arginine biosynthetic process,BP,NAGS
10613,GO:0043615,0.435587406014782,0.90649345550502,1,5,astrocyte cell migration,BP,HEXB
6393,GO:0021604,0.435679959337874,0.906448607628361,1,5,cranial nerve structural organization,BP,SEMA3F
6395,GO:0021612,0.435679959337874,0.906448607628361,1,5,facial nerve structural organization,BP,SEMA3F
8058,GO:0032733,0.435741380070595,0.827902000135427,2,14,positive regulation of interleukin-10 production,BP,IL20RB;PRKCZ
17550,GO:1901072,0.435810627172577,0.906385267718987,1,5,glucosamine-containing compound catabolic process,BP,CTBS
20295,GO:2001243,0.435930865270696,0.698558837195648,9,79,negative regulation of intrinsic apoptotic signaling pathway,BP,AKT1;ZNF385A;PTPN1;TRAP1;TMEM161A;MIF;WFS1;GRINA;BCL2L1
9439,GO:0036021,0.435947996276387,0.906318650171901,1,5,endolysosome lumen,CC,CTSB
15417,GO:0071692,0.435958423579848,0.906313592194596,1,5,protein localization to extracellular region,BP,LTBP1
15418,GO:0071694,0.435958423579848,0.906313592194596,1,5,maintenance of protein location in extracellular region,BP,LTBP1
7980,GO:0032602,0.435970731821713,0.726590280307084,6,51,chemokine production,BP,EGR1;POSTN;ADORA2B;ALOX15B;ZFPM1;MIF
15752,GO:0072348,0.436040627258451,0.786815805241549,3,22,sulfur compound transport,BP,SLC6A6;SLC35F3;SLC26A11
4682,GO:0010832,0.436287981732458,0.906153644210218,1,5,negative regulation of myotube differentiation,BP,HDAC5
9092,GO:0035360,0.436290005841159,0.9061526612973,1,5,positive regulation of peroxisome proliferator activated receptor signaling pathway,BP,ALOX15B
17666,GO:1901474,0.436417452752851,0.906090759379624,1,5,azole transmembrane transporter activity,MF,SLC15A4
7521,GO:0031748,0.436649868149417,0.905977806928188,1,5,D1 dopamine receptor binding,MF,DLG4
19104,GO:1904996,0.436716107856813,0.905945599095713,1,5,positive regulation of leukocyte adhesion to vascular endothelial cell,BP,ITGA4
20281,GO:2001225,0.436739633794773,0.905934158360906,1,5,regulation of chloride transport,BP,PRNP
16127,GO:0090129,0.436863024563602,0.905874138624632,1,5,positive regulation of synapse maturation,BP,ADGRL1
19291,GO:1905476,0.436892329066002,0.786155483996431,3,22,negative regulation of protein localization to membrane,BP,TGFB1;GDI1;BCL2L1
7976,GO:0032596,0.436959651715005,0.905827120308531,1,5,protein transport into membrane raft,BP,REEP2
9429,GO:0036005,0.43700000512483,0.905807480130633,1,5,response to macrophage colony-stimulating factor,BP,MST1R
9430,GO:0036006,0.43700000512483,0.905807480130633,1,5,cellular response to macrophage colony-stimulating factor stimulus,BP,MST1R
8442,GO:0033578,0.437072713980844,0.905772085860641,1,5,protein glycosylation in Golgi,BP,LMF1
3104,GO:0006685,0.437168892256248,0.905725253865323,1,5,sphingomyelin catabolic process,BP,PRKCD
20009,GO:2000587,0.437183017797685,0.905718374488584,1,5,negative regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,LRP1
13281,GO:0051987,0.437333795556148,0.905644923337909,1,5,positive regulation of attachment of spindle microtubules to kinetochore,BP,SIRT2
16682,GO:0097629,0.437474529681022,0.90557633223362,1,5,extrinsic component of omegasome membrane,CC,ULK1
4727,GO:0010891,0.437478027087566,0.905574627256626,1,5,negative regulation of sequestering of triglyceride,BP,PPARA
19132,GO:1905063,0.437648651141729,0.905491425048266,1,5,regulation of vascular smooth muscle cell differentiation,BP,PDCD4
11650,GO:0046415,0.4377461710925,0.90544385008208,1,5,urate metabolic process,BP,SLC2A9
3263,GO:0006937,0.437801710644944,0.696974072224824,9,78,regulation of muscle contraction,BP,DOCK4;F2R;NOS1;ADORA2B;TNNT1;PRKACA;ADA;GSTO1;EHD3
19698,GO:2000002,0.437804571344152,0.905415352324764,1,5,negative regulation of DNA damage checkpoint,BP,CHEK2
10647,GO:0043696,0.437894570447842,0.905371424526534,1,5,dedifferentiation,BP,OLFM2
10648,GO:0043697,0.437894570447842,0.905371424526534,1,5,cell dedifferentiation,BP,OLFM2
17214,GO:0106070,0.43803727959147,0.905301742903255,1,5,regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,NOS1
13959,GO:0060677,0.4380596271485,0.905290828151726,1,5,ureteric bud elongation,BP,KIF26B
15677,GO:0072205,0.4380596271485,0.905290828151412,1,5,metanephric collecting duct development,BP,PKD1
10007,GO:0042439,0.438064523282559,0.905288436729637,1,5,ethanolamine-containing compound metabolic process,BP,CHKA
9402,GO:0035965,0.438077227507613,0.905282231418997,1,5,cardiolipin acyl-chain remodeling,BP,TAZ
5780,GO:0017002,0.438080150281144,0.905280803764674,1,5,activin-activated receptor activity,MF,ACVR2B
13159,GO:0051766,0.438171511201421,0.905236170979564,1,5,inositol trisphosphate kinase activity,MF,ITPKB
19648,GO:1990822,0.438339983262859,0.905153831915242,1,5,basic amino acid transmembrane transport,BP,SLC25A29
5017,GO:0015181,0.438462432173315,0.905093957750269,1,5,arginine transmembrane transporter activity,MF,SLC25A29
5024,GO:0015189,0.438462432173315,0.905093957750269,1,5,L-lysine transmembrane transporter activity,MF,SLC25A29
2728,GO:0006111,0.43850784424897,0.784900381634869,3,22,regulation of gluconeogenesis,BP,NR1D1;DGKQ;PPARA
1234,GO:0002921,0.438514584845836,0.905068449247466,1,5,negative regulation of humoral immune response,BP,SERPING1
16263,GO:0090324,0.438522447305105,0.905064603242796,1,5,negative regulation of oxidative phosphorylation,BP,MLXIPL
18625,GO:1903898,0.438530739330397,0.905060547011909,1,5,negative regulation of PERK-mediated unfolded protein response,BP,PTPN1
15747,GO:0072341,0.438586563466782,0.724321882942565,6,51,modified amino acid binding,MF,OSBPL5;GAS6;CBS;OSBPL10;MTHFR;GSDMA
15878,GO:0072611,0.438662945167711,0.904995860626217,1,5,interleukin-13 secretion,BP,PRKCZ
20060,GO:2000665,0.438662945167711,0.904995860626217,1,5,regulation of interleukin-13 secretion,BP,PRKCZ
6273,GO:0019871,0.438695306166968,0.904980022613058,1,5,sodium channel inhibitor activity,MF,PCSK9
16412,GO:0097049,0.438704292846003,0.904975624085284,1,5,motor neuron apoptotic process,BP,ADARB1
13915,GO:0060586,0.438770262201939,0.904943331431722,1,5,multicellular organismal iron ion homeostasis,BP,HFE
13610,GO:0060099,0.43877109550969,0.904942923471978,1,5,regulation of phagocytosis, engulfment,BP,ABCA7
13611,GO:0060100,0.43877109550969,0.904942923471978,1,5,positive regulation of phagocytosis, engulfment,BP,ABCA7
19162,GO:1905155,0.43877109550969,0.904942923471978,1,5,positive regulation of membrane invagination,BP,ABCA7
19209,GO:1905288,0.43877109550969,0.904942923472291,1,5,vascular associated smooth muscle cell apoptotic process,BP,PDCD4
19282,GO:1905459,0.43877109550969,0.904942923472291,1,5,regulation of vascular associated smooth muscle cell apoptotic process,BP,PDCD4
19283,GO:1905461,0.43877109550969,0.904942923472291,1,5,positive regulation of vascular associated smooth muscle cell apoptotic process,BP,PDCD4
10198,GO:0042816,0.438793190168356,0.90493210632782,1,5,vitamin B6 metabolic process,BP,PDXK
5794,GO:0017034,0.438806294416652,0.904925690366095,1,5,Rap guanyl-nucleotide exchange factor activity,MF,RAPGEF3
7496,GO:0031681,0.438836849883761,0.904910729042173,1,5,G-protein beta-subunit binding,MF,F2R
14226,GO:0061200,0.438860765999774,0.904899017599043,1,5,clathrin-sculpted gamma-aminobutyric acid transport vesicle,CC,VAMP2
14227,GO:0061202,0.438860765999774,0.904899017599043,1,5,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,CC,VAMP2
2026,GO:0004758,0.438961034266944,0.904849907443663,1,5,serine C-palmitoyltransferase activity,MF,SPTLC2
5506,GO:0016454,0.438961034266944,0.904849907443663,1,5,C-palmitoyltransferase activity,MF,SPTLC2
12164,GO:0048296,0.439058739047209,0.904802037370635,1,5,regulation of isotype switching to IgA isotypes,BP,TGFB1
3277,GO:0006959,0.439070537848527,0.695022741673207,9,87,humoral immune response,BP,POU2F2;SERPING1;FAM3A;PRSS3;CD81;IFNE;PLA2G6;RNASE7;ZP3
6893,GO:0030433,0.439141447579792,0.70355745119141,8,68,ubiquitin-dependent ERAD pathway,BP,EDEM1;FBXO2;TMEM129;ANKZF1;UBXN4;STUB1;BCAP31;WFS1
19919,GO:2000394,0.439233419488426,0.904716415298518,1,5,positive regulation of lamellipodium morphogenesis,BP,CORO1B
10679,GO:0043950,0.439255259496498,0.904705706682478,1,5,positive regulation of cAMP-mediated signaling,BP,NOS1
1270,GO:0003056,0.439279001573703,0.904694064563058,1,5,regulation of vascular smooth muscle contraction,BP,DOCK4
4447,GO:0010385,0.439303215961755,0.90468218992133,1,5,double-stranded methylated DNA binding,MF,EGR1
10028,GO:0042482,0.43948115129107,0.904594902309533,1,5,positive regulation of odontogenesis,BP,TGFB1
15829,GO:0072537,0.439511445637542,0.904580036126953,1,5,fibroblast activation,BP,CYGB
2877,GO:0006382,0.439582603008263,0.904545111653512,1,5,adenosine to inosine editing,BP,ADARB1
11322,GO:0045656,0.439618475941573,0.904527501920133,1,5,negative regulation of monocyte differentiation,BP,INPP5D
6132,GO:0019400,0.439675370518146,0.825152827803031,2,14,alditol metabolic process,BP,PCK2;COQ2
1481,GO:0003774,0.439838807636698,0.6830092730158,11,95,motor activity,MF,KLC2;KIF17;KIF26B;DNAH1;KIF7;MYH16;WDR60;MYO1D;MYH15;KIF26A;KIF13B
3114,GO:0006695,0.43992252803747,0.7120649801509,7,59,cholesterol biosynthetic process,BP,APOE;SEC14L2;MVD;PLPP6;MBTPS2;HSD17B7;ABCG1
20209,GO:2001038,0.439959864493018,0.783177474803946,3,23,regulation of cellular response to drug,BP,HMGA2;ENDOG;TRAP1
18575,GO:1903789,0.439998058148949,0.904341041730068,1,5,regulation of amino acid transmembrane transport,BP,STK39
11420,GO:0045844,0.440010210498845,0.737819371918992,5,40,positive regulation of striated muscle tissue development,BP,FGFR1;TGFB1;GPC1;TGFBR3;FAM129B
12288,GO:0048636,0.440010210498845,0.737819371918992,5,40,positive regulation of muscle organ development,BP,FGFR1;TGFB1;GPC1;TGFBR3;FAM129B
17800,GO:1901863,0.440010210498845,0.737819371918992,5,40,positive regulation of muscle tissue development,BP,FGFR1;TGFB1;GPC1;TGFBR3;FAM129B
12082,GO:0048069,0.440082286363376,0.904299635425412,1,5,eye pigmentation,BP,AP3D1
7691,GO:0032155,0.440116226759679,0.712048973662879,7,58,cell division site part,CC,PKN1;PLCD3;SSH1;PITPNM1;RAB11FIP4;NDE1;SEPT6
16009,GO:0086023,0.440116816669547,0.904282657152186,1,5,adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,NOS1
12143,GO:0048261,0.440140129128625,0.824826530275395,2,14,negative regulation of receptor-mediated endocytosis,BP,DLG4;PCSK9
13484,GO:0055056,0.440349461756287,0.904168217595181,1,5,D-glucose transmembrane transporter activity,MF,SLC2A3
2216,GO:0005113,0.440359955739185,0.904163053498902,1,5,patched binding,MF,BBS1
18407,GO:1903423,0.440438147261001,0.904124569778562,1,5,positive regulation of synaptic vesicle recycling,BP,DNM1
15750,GO:0072345,0.440442974629741,0.90412219356533,1,5,NAADP-sensitive calcium-release channel activity,MF,TPCN1
5248,GO:0015874,0.440447794758817,0.904119820871661,1,5,norepinephrine transport,BP,NISCH
7156,GO:0031033,0.440452598015851,0.904117456439087,1,5,myosin filament organization,BP,OBSL1
11127,GO:0045179,0.44051841931484,0.904085051880027,1,5,apical cortex,CC,PRKCZ
5050,GO:0015245,0.440518653115066,0.904084936768578,1,5,fatty acid transmembrane transporter activity,MF,SLC27A1
13992,GO:0060718,0.440527607141603,0.904080528053099,1,5,chorionic trophoblast cell differentiation,BP,HTRA1
10167,GO:0042760,0.44059283414835,0.904048408247649,1,5,very long-chain fatty acid catabolic process,BP,ABCD1
11557,GO:0046113,0.440782955569941,0.903954747550835,1,5,nucleobase catabolic process,BP,XDH
3068,GO:0006638,0.440787685531024,0.702085777061722,8,68,neutral lipid metabolic process,BP,APOE;DGKA;LMF1;LDLR;PCSK9;DGKQ;PCK2;CAT
10592,GO:0043568,0.440930572508986,0.903881986073544,1,5,positive regulation of insulin-like growth factor receptor signaling pathway,BP,IGFBP4
1801,GO:0004445,0.440980646053762,0.903857296502753,1,5,inositol-polyphosphate 5-phosphatase activity,MF,INPP5D
8811,GO:0034594,0.440980646053762,0.903857296502752,1,5,phosphatidylinositol trisphosphate phosphatase activity,MF,INPP5D
12360,GO:0048755,0.440984819647285,0.903855238457465,1,5,branching morphogenesis of a nerve,BP,RERE
3119,GO:0006702,0.441022927318344,0.903836445892823,1,5,androgen biosynthetic process,BP,SRD5A3
9384,GO:0035926,0.44104425607554,0.903825926729713,1,5,chemokine (C-C motif) ligand 2 secretion,BP,POSTN
13259,GO:0051957,0.441050067098258,0.903823060654055,1,5,positive regulation of amino acid transport,BP,NTSR1
4588,GO:0010694,0.441117864755608,0.903789617933014,1,5,positive regulation of alkaline phosphatase activity,BP,SMAD3
5436,GO:0016298,0.441164026483796,0.69414893726881,9,76,lipase activity,MF,PLD3;PLCD3;TMEM8A;PLCH2;EDNRA;PLCG1;CES2;PLA2G6;PLCB3
12352,GO:0048742,0.441194993481133,0.903751563468753,1,5,regulation of skeletal muscle fiber development,BP,FAM129B
6951,GO:0030594,0.441242729124385,0.782173979041804,3,23,neurotransmitter receptor activity,MF,GRIN3B;HTR7;GABBR1
17872,GO:1902083,0.441245221508263,0.903726776359522,1,5,negative regulation of peptidyl-cysteine S-nitrosylation,BP,SNTA1
19778,GO:2000169,0.441245221508263,0.903726776359522,1,5,regulation of peptidyl-cysteine S-nitrosylation,BP,SNTA1
14291,GO:0061419,0.441275838030016,0.903711665381145,1,5,positive regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,VEGFA
1997,GO:0004720,0.441286008493902,0.903706645346671,1,5,protein-lysine 6-oxidase activity,MF,LOXL1
5266,GO:0015911,0.441299455831439,0.903700007630592,1,5,plasma membrane long-chain fatty acid transport,BP,AKT1
16918,GO:0098887,0.441339024364212,0.903680474589316,1,5,neurotransmitter receptor transport, endosome to postsynaptic membrane,BP,ARHGAP44
1560,GO:0003958,0.441353090616676,0.903673530168106,1,5,NADPH-hemoprotein reductase activity,MF,NOS1
5059,GO:0015271,0.441379230692893,0.90366062412787,1,5,outward rectifier potassium channel activity,MF,PKD2
15601,GO:0072091,0.441385854302935,0.736648588491923,5,40,regulation of stem cell proliferation,BP,VEGFA;HMGA2;ZFP36L1;FBLN1;TGFB1
1416,GO:0003352,0.441450579419174,0.903625391791618,1,5,regulation of cilium movement,BP,BBS2
1417,GO:0003356,0.441450579419174,0.903625391791618,1,5,regulation of cilium beat frequency,BP,BBS2
13716,GO:0060295,0.441450579419174,0.903625391791618,1,5,regulation of cilium movement involved in cell motility,BP,BBS2
13717,GO:0060296,0.441450579419174,0.903625391791618,1,5,regulation of cilium beat frequency involved in ciliary motility,BP,BBS2
17852,GO:1902019,0.441450579419174,0.903625391791618,1,5,regulation of cilium-dependent cell motility,BP,BBS2
16003,GO:0086016,0.441451313959038,0.903625029025997,1,5,AV node cell action potential,BP,SCN4B
16012,GO:0086027,0.441451313959038,0.903625029025997,1,5,AV node cell to bundle of His cell signaling,BP,SCN4B
16059,GO:0089717,0.441477313976938,0.903612188023279,1,5,spanning component of membrane,CC,NLGN2
11256,GO:0045542,0.441488423562199,0.903606700840118,1,5,positive regulation of cholesterol biosynthetic process,BP,ABCG1
17720,GO:1901621,0.441518555239146,0.90359181738192,1,5,negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,PRKACB
13554,GO:0060028,0.441543497025637,0.903579496351565,1,5,convergent extension involved in axis elongation,BP,VANGL2
10235,GO:0042954,0.441555542598411,0.903573545582829,1,5,lipoprotein transporter activity,MF,LRP1
600,GO:0001768,0.44155962556518,0.903571528463244,1,5,establishment of T cell polarity,BP,GSN
2031,GO:0004771,0.441563126324277,0.903569798949195,1,5,sterol esterase activity,MF,CES2
3731,GO:0008271,0.441566079301459,0.903568340040469,1,5,secondary active sulfate transmembrane transporter activity,MF,SLC26A11
6168,GO:0019531,0.441566079301459,0.903568340040469,1,5,oxalate transmembrane transporter activity,MF,SLC26A11
6169,GO:0019532,0.441566079301459,0.903568340040469,1,5,oxalate transport,BP,SLC26A11
11048,GO:0045053,0.441570185050258,0.903566311588481,1,5,protein retention in Golgi apparatus,BP,SORL1
813,GO:0002087,0.441575265046277,0.903563801765804,1,5,regulation of respiratory gaseous exchange by neurological system process,BP,NLGN2
8846,GO:0034650,0.441577699025873,0.903562599226717,1,5,cortisol metabolic process,BP,DGKQ
8847,GO:0034651,0.441577699025873,0.903562599226717,1,5,cortisol biosynthetic process,BP,DGKQ
19734,GO:2000064,0.441577699025873,0.903562599226717,1,5,regulation of cortisol biosynthetic process,BP,DGKQ
15143,GO:0071257,0.441578244287855,0.903562329828169,1,5,cellular response to electrical stimulus,BP,NSMF
9397,GO:0035947,0.441578348505155,0.903562278340555,1,5,regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter,BP,NR1D1
5380,GO:0016198,0.441578621956632,0.903562143243395,1,5,axon choice point recognition,BP,EFNB3
5692,GO:0016812,0.441578621956632,0.903562143243394,1,5,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides,MF,OPLAH
6470,GO:0021815,0.441578621956632,0.903562143243394,1,5,modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration,BP,SUN1
10586,GO:0043559,0.441578621956632,0.903562143243394,1,5,insulin binding,MF,INSR
12921,GO:0051286,0.441578621956632,0.903562143243395,1,5,cell tip,CC,PI4K2A
13581,GO:0060059,0.441578621956632,0.903562143243551,1,5,embryonic retina morphogenesis in camera-type eye,BP,PROX1
446,GO:0001206,0.441578621956632,0.903562143243081,1,5,transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding,MF,BACH1
3615,GO:0008066,0.441578621956632,0.903562143243237,1,5,glutamate receptor activity,MF,GRIN3B
4581,GO:0010668,0.441578621956632,0.903562143243237,1,5,ectodermal cell differentiation,BP,ITGA6
5850,GO:0017146,0.441578621956632,0.903562143243237,1,5,NMDA selective glutamate receptor complex,CC,GRIN3B
6895,GO:0030473,0.441578621956632,0.903562143243237,1,5,nuclear migration along microtubule,BP,SUN1
6898,GO:0030479,0.441578621956632,0.903562143243081,1,5,actin cortical patch,CC,WIPF1
7607,GO:0032000,0.441578621956632,0.903562143243081,1,5,positive regulation of fatty acid beta-oxidation,BP,PPARA
7634,GO:0032051,0.441578621956632,0.903562143242924,1,5,clathrin light chain binding,MF,CLTCL1
9641,GO:0036514,0.441578621956632,0.903562143243237,1,5,dopaminergic neuron axon guidance,BP,VANGL2
10449,GO:0043313,0.441578621956632,0.903562143243237,1,5,regulation of neutrophil degranulation,BP,BCR
10656,GO:0043813,0.441578621956632,0.903562143243395,1,5,phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity,MF,SYNJ2
10984,GO:0044789,0.441578621956632,0.903562143243237,1,5,modulation by host of viral release from host cell,BP,PC
10985,GO:0044791,0.441578621956632,0.903562143243237,1,5,positive regulation by host of viral release from host cell,BP,PC
11070,GO:0045078,0.441578621956632,0.903562143242924,1,5,positive regulation of interferon-gamma biosynthetic process,BP,ZFPM1
11128,GO:0045180,0.441578621956632,0.903562143243081,1,5,basal cortex,CC,PKD2
13099,GO:0051643,0.441578621956632,0.903562143242924,1,5,endoplasmic reticulum localization,BP,ESYT2
14389,GO:0061645,0.441578621956632,0.903562143243081,1,5,endocytic patch,CC,WIPF1
15330,GO:0071557,0.441578621956632,0.903562143242924,1,5,histone H3-K27 demethylation,BP,KDM6B
15331,GO:0071558,0.441578621956632,0.903562143242924,1,5,histone demethylase activity (H3-K27 specific),MF,KDM6B
16435,GO:0097091,0.441578621956632,0.903562143243237,1,5,synaptic vesicle clustering,BP,NLGN2
16619,GO:0097470,0.441578621956632,0.903562143242924,1,5,ribbon synapse,CC,NPHP4
16780,GO:0098597,0.441578621956632,0.903562143243237,1,5,observational learning,BP,SHANK3
16792,GO:0098634,0.441578621956632,0.903562143243395,1,5,cell-matrix adhesion mediator activity,MF,ITGA1
18050,GO:1902563,0.441578621956632,0.903562143243237,1,5,regulation of neutrophil activation,BP,BCR
18452,GO:1903525,0.441578621956632,0.903562143243237,1,5,regulation of membrane tubulation,BP,DNM2
18998,GO:1904781,0.441578621956632,0.903562143242924,1,5,positive regulation of protein localization to centrosome,BP,CEP250
19077,GO:1904938,0.441578621956632,0.903562143243237,1,5,planar cell polarity pathway involved in axon guidance,BP,VANGL2
10322,GO:0043121,0.441578621956632,0.903562143243237,1,5,neurotrophin binding,MF,NGFR
19790,GO:2000192,0.441578621956632,0.903562143243237,1,5,negative regulation of fatty acid transport,BP,AKT1
12455,GO:0050291,0.441578621964758,0.903562143235111,1,5,sphingosine N-acyltransferase activity,MF,CERS4
13097,GO:0051641,0.442599308028207,0.5874813588234,233,2191,cellular localization,BP,ZMYND8;NR1D1;EDEM1;DLG4;MARVELD1;PRNP;BBS2;WNT7A;APOE;F2R;LRP5;OBSCN;ITPR3;EVI5L;EGFR;OBSL1;NOS1;TMEM129;SPRY2;SYTL1;ETV5;LMF1;LTBP2;VPS11;TBC1D14;ARL2;SNX9;NUDCD3;RAPGEF3;ZFP36L1;GAA;MAP2K2;MAP2K1;CPT2;MCTP1;SSH1;EXOC2;MARK4;LRP1;DVL1;AP2A2;SH3PXD2B;NLGN2;STOM;ADORA2B;SYT8;AKT1;TPCN1;KCNC4;CORO1B;BSG;HK1;PTPRU;ZFYVE21;BRSK1;IFT140;RAB31;LDLR;RAC2;KCNAB2;NPHP4;SYNE3;PACS2;TOMM34;SORL1;B3GAT3;LZTS2;RAB11FIP4;ZNF385A;ABCD1;ANK3;TTC7B;TRAPPC9;TWF2;STRADB;SYNGAP1;CEP250;GAS6;CSNK1E;RAB3B;LAMA5;GSN;PCSK9;BCR;XPOT;EHD4;SEPT10;WIPF1;AIP;SPTB;PEX10;CCS;CORO7;MVB12B;FYCO1;CEMIP;PKD2;CTSZ;AP3D1;ABCA2;EPHB2;GRIN3B;ASIC1;PLCG1;KIF17;CD81;TMED4;TGFB1;SNPH;CLTCL1;ABHD17C;MOAP1;TBC1D9B;NTSR1;TMEM173;ATP7B;SHANK3;RASA3;MIPEP;TUB;CROCC;RHOD;SNX17;SNX33;LLGL1;RIMS3;BBS1;PTPN1;PEX1;AGRN;LRP4;ESYT2;ZDHHC24;CEP131;PRKCZ;PRKACA;OXA1L;TOM1L2;AREG;MICALL2;SDCCAG8;NEURL1B;ERBB2;NINL;VAMP2;TFDP2;RILPL1;BNIP3L;TRPC1;ARHGAP44;MCFD2;PRKCD;REEP6;CACNB3;BAX;CYC1;TIMM17B;ZDHHC8;GDI1;LEMD2;DNM1;WASH3P;RGS14;GSTO1;LRSAM1;REEP2;EHD3;WDR60;LONP2;SYMPK;TGFA;FHOD1;COG7;SESN2;ABCG1;MYO1D;ABCA7;RAB12;BCAP31;DOPEY2;PLA2G6;SYNGR1;NBPF3;FYN;STK25;TMCO6;SUN1;DNM2;SNX15;ZDHHC1;MAPK3;RTN2;C12ORF66;RERE;STX10;CEP72;PAK1;MALL;PPP3CB;ITGA3;BIN1;VPS16;BCL2L1;DLG3;SGSM2;TBC1D16;LMNA;PKD1;RABGAP1;ITGA4;RAB28;NDE1;RAB40B;NGFR;TOLLIP;PDCD6;PCLO;TBC1D8;PLEKHM1;KIF13B;TCTN1;CAMK1;HFE;WIPI2;VPS51;CELSR1;SEPT6;PFN2;CCDC88C;BLOC1S4;TRIM46;APBA1;SRSF5
3067,GO:0006637,0.442685974399722,0.692564175882749,9,78,acyl-CoA metabolic process,BP,ACOT7;ACSF2;HSD17B8;ACOT1;CBR4;MVD;HMGCL;PDK1;MLYCD
9102,GO:0035383,0.442685974399722,0.692564175882749,9,78,thioester metabolic process,BP,ACOT7;ACSF2;HSD17B8;ACOT1;CBR4;MVD;HMGCL;PDK1;MLYCD
7809,GO:0032369,0.443933638529893,0.822151194677703,2,14,negative regulation of lipid transport,BP,AKT1;PCSK9
9874,GO:0042147,0.444078251257375,0.699136977534907,8,68,retrograde transport, endosome to Golgi,BP,TBC1D14;ZFYVE21;CLTCL1;WASH3P;EHD3;STX10;SGSM2;VPS51
255,GO:0000722,0.444238747957383,0.821935089295073,2,14,telomere maintenance via recombination,BP,ERCC1;TEP1
15178,GO:0071320,0.444518470372568,0.753107189094511,4,31,cellular response to cAMP,BP,RAPGEF3;ZFP36L1;PKD2;EEF2K
8826,GO:0034620,0.444596272565334,0.661659187852841,15,132,cellular response to unfolded protein,BP,EDEM1;SHC1;CCND1;PTPN1;TPP1;BOK;STUB1;BAX;MBTPS2;PDIA5;WFS1;TSPYL2;CUL7;PPP2R5B;LMNA
6755,GO:0030194,0.444695398305822,0.82161139011888,2,14,positive regulation of blood coagulation,BP,F2R;F12
17362,GO:1900048,0.444695398305822,0.82161139011888,2,14,positive regulation of hemostasis,BP,F2R;F12
12924,GO:0051290,0.444891721961727,0.749512351740045,4,43,protein heterotetramerization,BP,HSD17B8;CBR4;LRP4;INSR
4074,GO:0009129,0.44526275799015,0.821208780929044,2,14,pyrimidine nucleoside monophosphate metabolic process,BP,UCKL1;UPP1
4075,GO:0009130,0.44526275799015,0.821208780929044,2,14,pyrimidine nucleoside monophosphate biosynthetic process,BP,UCKL1;UPP1
13536,GO:0060008,0.445302429219097,0.821180611514043,2,14,Sertoli cell differentiation,BP,CST3;SDC1
7990,GO:0032615,0.445410344646275,0.751991641792675,4,32,interleukin-12 production,BP,ACP5;JAK3;PRKCD;HLA-G
12647,GO:0050860,0.445511505519373,0.82103211356233,2,14,negative regulation of T cell receptor signaling pathway,BP,PRNP;CEACAM1
16810,GO:0098659,0.44558518457265,0.752222776978318,4,31,inorganic cation import across plasma membrane,BP,PRNP;SLC9A7;FYN;HFE
17080,GO:0099587,0.44558518457265,0.752222776978318,4,31,inorganic ion import across plasma membrane,BP,PRNP;SLC9A7;FYN;HFE
3393,GO:0007175,0.445684167339033,0.820909430079646,2,14,negative regulation of epidermal growth factor-activated receptor activity,BP,ERRFI1;CBLC
2726,GO:0006109,0.446106898982734,0.660294627204919,15,131,regulation of carbohydrate metabolic process,BP,NR1D1;PHLDA2;AKT1;IGFBP4;DGKQ;TGFB1;NTSR1;PFKFB2;MLXIPL;PDK1;DDIT4;PPARA;INSR;PFKFB3;MLYCD
20120,GO:2000773,0.446205639320743,0.820538632133242,2,14,negative regulation of cellular senescence,BP,HMGA2;TERC
20196,GO:2001023,0.446238976444762,0.731986287291674,5,42,regulation of response to drug,BP,HMGA2;ENDOG;STK39;RAB3B;TRAP1
1023,GO:0002523,0.446635615839937,0.897573032463777,1,6,leukocyte migration involved in inflammatory response,BP,ADAM8
4895,GO:0014823,0.446779341070588,0.731773700905583,5,41,response to activity,BP,POSTN;HADH;HDAC5;KDM6B;CAT
8736,GO:0034394,0.446784239679619,0.73176949705033,5,41,protein localization to cell surface,BP,AKT1;PTPRU;KCNAB2;SNX33;HFE
11119,GO:0045165,0.44679101692696,0.66322409493904,14,122,cell fate commitment,BP,DUSP6;WNT7A;SPRY2;STAT6;EPAS1;SH3PXD2B;WNT2B;FGFR1;CEBPB;WNT3;KDM6B;SOX12;ZFPM1;PROX1
18280,GO:1903136,0.446891474211041,0.897440456872514,1,6,cuprous ion binding,MF,PRNP
11290,GO:0045618,0.446951486701787,0.820007583836174,2,14,positive regulation of keratinocyte differentiation,BP,CYP27B1;ALOX15B
17641,GO:1901343,0.447091870797284,0.696555810328037,8,67,negative regulation of vasculature development,BP,XDH;PDCD4;SPRY2;HDAC5;EPN2;ADGRB2;FAM129B;NGFR
15291,GO:0071482,0.447682507276628,0.681437238669204,10,87,cellular response to light stimulus,BP,ERCC1;XPC;NFATC4;DDB2;IMPACT;MAPK13;MC1R;BAX;TMEM161A;HYAL1
8882,GO:0034704,0.44770493150663,0.7770862611732,3,23,calcium channel complex,CC,NOS1;PRKACA;CACNB3
1233,GO:0002920,0.447763286842697,0.777040067941672,3,23,regulation of humoral immune response,BP,SERPING1;CD81;ZP3
20071,GO:2000677,0.448010441776079,0.749475058699126,4,33,regulation of transcription regulatory region DNA binding,BP,HMGA2;TGFB1;PPARA;FAM129B
1465,GO:0003714,0.448488769620074,0.644278285461087,20,178,transcription corepressor activity,MF,ZMYND8;NR1D1;ELK3;MTA1;WWTR1;MXD4;MXI1;CCND1;CTBP1;MNT;NAB2;GRHPR;PPP1R13L;ZHX3;HDAC7;BHLHE40;RERE;CDYL2;PROX1;MAP3K10
11254,GO:0045540,0.448704532783948,0.730119556519539,5,41,regulation of cholesterol biosynthetic process,BP,APOE;SEC14L2;MVD;MBTPS2;ABCG1
6726,GO:0030148,0.448769427111553,0.687147651201896,9,77,sphingolipid biosynthetic process,BP,KDSR;ST6GALNAC6;B4GALT6;PRKCD;PLA2G6;CERS4;SAMD8;ST3GAL5;SPTLC2
9884,GO:0042168,0.449140574871337,0.775396934226578,3,24,heme metabolic process,BP,UROS;ALAS1;PPOX
13261,GO:0051959,0.449247366620482,0.775863785413843,3,23,dynein light intermediate chain binding,MF,DNAH1;RILPL1;CCDC88C
18472,GO:1903555,0.4492485570621,0.694239746378155,8,70,regulation of tumor necrosis factor superfamily cytokine production,BP,NFATC4;ACP5;GAS6;ERRFI1;ADAM8;MC1R;MIF;DDT
6535,GO:0021952,0.449554907863339,0.81814740793987,2,14,central nervous system projection neuron axonogenesis,BP,ADARB1;EPHB2
7730,GO:0032232,0.449604987067468,0.818111526196544,2,14,negative regulation of actin filament bundle assembly,BP,ARAP1;SHANK3
15674,GO:0072202,0.449657485501949,0.818073907036257,2,14,cell differentiation involved in metanephros development,BP,WWTR1;LAMB2
2434,GO:0005635,0.450046697721577,0.615723341720192,41,375,nuclear envelope,CC,SLC16A3;CST3;PRNP;ITPR3;MTA1;EGFR;SLC2A9;SMAD3;STAT6;S100A6;SIGMAR1;RAC2;SYNE3;SORL1;XPOT;BNIP3;RETSAT;CLCA2;NSMF;UBXN4;PRKCZ;BOK;BNIP3L;BAX;KLHDC2;LEMD2;RNF123;SMOX;SLC22A18;CERS4;SUN1;MAPK3;INSR;PAK1;BIN1;BCL2L1;LMNA;RAP1GAP2;RAB40B;GCH1;TNRC18
16254,GO:0090311,0.450103118461152,0.748081943768089,4,32,regulation of protein deacetylation,BP,VEGFA;CTBP1;TGFB1;C6ORF89
6203,GO:0019706,0.450118664226196,0.775171842650096,3,23,protein-cysteine S-palmitoyltransferase activity,MF,ZDHHC24;ZDHHC8;ZDHHC1
6204,GO:0019707,0.450118664226196,0.775171842650096,3,23,protein-cysteine S-acyltransferase activity,MF,ZDHHC24;ZDHHC8;ZDHHC1
17885,GO:1902110,0.450141593252704,0.71421996014084,6,51,positive regulation of mitochondrial membrane permeability involved in apoptotic process,BP,BNIP3;MOAP1;BOK;TFDP2;BNIP3L;BAX
20248,GO:2001169,0.450645962851967,0.702539662451466,7,59,regulation of ATP biosynthetic process,BP,PFKFB2;MLXIPL;DDIT4;PPARA;INSR;TAZ;PFKFB3
10568,GO:0043537,0.450867863964779,0.774576063709116,3,23,negative regulation of blood vessel endothelial cell migration,BP,APOE;HDAC5;TGFB1
6033,GO:0019104,0.450941173373904,0.816101845939655,2,15,DNA N-glycosylase activity,MF,MPG;NEIL1
12751,GO:0051029,0.451102340830921,0.895242876636568,1,6,rRNA transport,BP,TST
17519,GO:1900744,0.45139615101307,0.774155513806082,3,23,regulation of p38MAPK cascade,BP,XDH;VEGFA;MINK1
11784,GO:0046661,0.451618882879267,0.667011491600418,12,106,male sex differentiation,BP,ERCC1;CST3;SDC1;WNT2B;CCND1;BOK;BAX;ADAM15;ASB1;ARID5B;INSR;BCL2L1
4032,GO:0009066,0.451715171211886,0.72752475267751,5,41,aspartate family amino acid metabolic process,BP,AHCY;MTHFR;ALDH7A1;NMNAT2;PHYKPL
12598,GO:0050786,0.452510829585942,0.890114833281747,1,8,RAGE receptor binding,MF,S100A4
13071,GO:0051589,0.452828914271863,0.81579364411115,2,14,negative regulation of neurotransmitter transport,BP,NOS1;ASIC1
15863,GO:0072588,0.453120627959159,0.889780866111496,1,8,box H/ACA RNP complex,CC,TERC
4519,GO:0010574,0.453361294463557,0.772587899349901,3,23,regulation of vascular endothelial growth factor production,BP,ADORA2B;TGFB1;NDRG2
10401,GO:0043243,0.453486939548386,0.772487497387199,3,23,positive regulation of protein complex disassembly,BP,BNIP3;FYCO1;INSR
16100,GO:0090083,0.453494577539568,0.815313112226934,2,14,regulation of inclusion body assembly,BP,SORL1;CDC34
3911,GO:0008574,0.453776568581876,0.772255977631597,3,23,ATP-dependent microtubule motor activity, plus-end-directed,MF,KIF17;KIF7;WDR60
2957,GO:0006493,0.453945072709339,0.675686564439823,10,87,protein O-linked glycosylation,BP,ST6GALNAC2;VEGFB;B4GAT1;ADAMTS13;ADAMTS7;B3GNT3;RFNG;MFNG;ST3GAL3;ST3GAL2
12095,GO:0048145,0.454036104567725,0.699205077474353,7,61,regulation of fibroblast proliferation,BP,EGFR;S100A6;GAS6;TGFB1;BAX;EREG;MIF
7945,GO:0032550,0.454073523032234,0.621238993223002,31,283,purine ribonucleoside binding,MF,ARL2;GTPBP1;RAB31;RAC2;RAB3B;EHD4;SEPT10;AGAP1;NPR2;GNAL;RHOD;RHOF;ARL10;RHOBTB2;TUBG2;PCK2;RASL10B;DNM1;EHD3;RAB12;RAC3;DNM2;TUBB6;INSR;RRAS;RAB28;RAB40B;GCH1;SEPT6;AK3;LRRK1
14995,GO:0070925,0.454502505073167,0.597005724805737,69,639,organelle assembly,BP,BBS2;OBSCN;EVI5L;WWTR1;OBSL1;SDC1;VPS11;TBC1D14;NUDCD3;MARK4;SHANK2;SH3PXD2B;NLGN2;GRB7;TMOD2;ATG16L2;IFT140;DNAAF5;NPHP4;PACS2;CIRBP;TNNT1;CEP250;CSNK1E;LAMA5;GSN;SEPT10;CCDC113;UNC119B;SH3PXD2A;PTPDC1;KIF17;RFX2;ULK2;FHOD3;SHANK3;GOLGA2P5;CROCC;DNAH1;ATG2A;TUBG2;BBS1;CEP131;PRKACA;CENPH;WDR18;SDCCAG8;ULK1;NINL;RILPL1;FSCN1;LRSAM1;EHD3;WDR60;TMEM231;CHEK2;DNAAF3;DNM2;ATXN10;CEP72;VANGL2;PROX1;NDE1;MSS51;TCTN1;WIPI2;BBS10;SEPT6;TTLL3
3413,GO:0007200,0.454514610874794,0.744382822435177,4,32,phospholipase C-activating G-protein coupled receptor signaling pathway,BP,F2R;LPAR3;LTB4R2;LTB4R
4758,GO:0010939,0.45454316400741,0.77108358379483,3,24,regulation of necrotic cell death,BP,RBCK1;BNIP3;BOK
11060,GO:0045066,0.45466167740896,0.814468988637984,2,14,regulatory T cell differentiation,BP,TGFB1;HLA-G
11271,GO:0045589,0.45466167740896,0.814468988637984,2,14,regulation of regulatory T cell differentiation,BP,TGFB1;HLA-G
5440,GO:0016307,0.454896986383861,0.814298548681654,2,14,phosphatidylinositol phosphate kinase activity,MF,ZFYVE21;PIP5KL1
7163,GO:0031050,0.45493853069984,0.724735728741861,5,41,dsRNA fragmentation,BP,EGFR;MAP2K2;MAP2K1;SMAD3;TGFB1
14992,GO:0070918,0.45493853069984,0.724735728741861,5,41,production of small RNA involved in gene silencing by RNA,BP,EGFR;MAP2K2;MAP2K1;SMAD3;TGFB1
3602,GO:0008045,0.455039288572521,0.814195435211974,2,14,motor neuron axon guidance,BP,SEMA3F;ERBB2
6738,GO:0030163,0.45541305954019,0.592679843001442,80,744,protein catabolic process,BP,GID4;NR1D1;EDEM1;CST3;BTBD2;FBXO2;APOE;MTA1;ARRDC1;EGFR;SERPINE2;WWTR1;TMEM129;CTSO;CAPN2;VPS11;SNX9;RBCK1;RNF44;SMURF2;SMAD3;LRP1;DVL1;AP2A2;FBXW5;RNF187;AKT1;LDLR;SORL1;CEACAM1;CSNK1E;CTSB;PCSK9;RAD23A;SH3D19;BNIP3;SHARPIN;MVB12B;CTSZ;MAGEF1;ADAM8;CD81;TIMP2;ABHD17C;GPC1;ADAMTS7;ABTB1;FBXO44;SNX33;ANKZF1;UBXN4;TPP1;TRIB2;PRKACA;BNIP3L;USP20;STUB1;FBXW4;CUL9;LPCAT1;LRSAM1;LONP2;CHEK2;CDC34;RNF123;RAB12;BCAP31;WFS1;FYN;RNF144A;CTSF;USP21;CUL7;PKD1;KCTD13;SIRT2;AZIN2;TOLLIP;HFE;CBLC
13066,GO:0051583,0.455422150268276,0.892957533447453,1,6,dopamine uptake involved in synaptic transmission,BP,RAB3B
13245,GO:0051934,0.455422150268276,0.892957533447453,1,6,catecholamine uptake involved in synaptic transmission,BP,RAB3B
16311,GO:0090493,0.455422150268276,0.892957533447453,1,6,catecholamine uptake,BP,RAB3B
16312,GO:0090494,0.455422150268276,0.892957533447453,1,6,dopamine uptake,BP,RAB3B
12228,GO:0048511,0.455899920436124,0.635048119591375,21,188,rhythmic process,BP,EGR1;NR1D1;CST3;NAGLU;MTA1;EGFR;HEBP1;CSNK1E;CRTC1;HTR7;ADA;AHCY;EREG;PPARA;BHLHE40;ADCY1;HES7;PROX1;NGFR;NR2F6;ZP3
8100,GO:0032794,0.45596463270329,0.813524176046354,2,14,GTPase activating protein binding,MF,AKT1;RGS14
12928,GO:0051294,0.455980166033167,0.77049085852808,3,23,establishment of spindle orientation,BP,SPRY2;LLGL1;NDE1
11758,GO:0046626,0.456164465847242,0.723672025606497,5,41,regulation of insulin receptor signaling pathway,BP,PTPRE;PTPN1;PRKCZ;PRKCD;GRB10
5324,GO:0016050,0.456206040115472,0.614936713951488,35,319,vesicle organization,BP,DLG4;F2R;EVI5L;SERPINE2;SYTL1;SDC1;VPS11;TBC1D14;SNX9;SYT8;DYSF;ZNF385A;TRAPPC9;CTSZ;AP3D1;RFX2;TBC1D9B;SNX33;PI4K2A;AREG;VAMP2;MCFD2;DNM1;WASH3P;TGFA;PI4K2B;DNM2;STX10;VPS16;SGSM2;TBC1D16;RABGAP1;PDCD6;TBC1D8;BLOC1S4
7628,GO:0032042,0.456255569642941,0.813312858347172,2,14,mitochondrial DNA metabolic process,BP,PRIMPOL;SESN2
906,GO:0002287,0.456308052745865,0.742872383522039,4,32,alpha-beta T cell activation involved in immune response,BP,STAT6;PRKCZ;JAK3;ZFPM1
909,GO:0002293,0.456308052745865,0.742872383522039,4,32,alpha-beta T cell differentiation involved in immune response,BP,STAT6;PRKCZ;JAK3;ZFPM1
910,GO:0002294,0.456308052745865,0.742872383522039,4,32,CD4-positive, alpha-beta T cell differentiation involved in immune response,BP,STAT6;PRKCZ;JAK3;ZFPM1
9842,GO:0042093,0.456308052745865,0.742872383522039,4,32,T-helper cell differentiation,BP,STAT6;PRKCZ;JAK3;ZFPM1
1841,GO:0004497,0.45638331336549,0.723481967247957,5,41,monooxygenase activity,MF,CYP27B1;NOS1;CYP3A5;CYP2R1;MICAL1
16115,GO:0090102,0.456760467570421,0.769864280741154,3,23,cochlea development,BP,DVL1;SLITRK6;VANGL2
8345,GO:0033218,0.4571948735243,0.631698281780635,22,201,amide binding,MF,CST3;FBXO2;PRNP;APOE;SLC7A8;RNPEPL1;PLTP;PC;TMEM158;LDLR;SORL1;HLCS;NPR2;CEMIP;EPHB2;LTA4H;TPP1;RNPEP;THOP1;INSR;HLA-G;APBA1
14404,GO:0061687,0.457266818919447,0.889403249130777,1,7,detoxification of inorganic compound,BP,MT2A
16638,GO:0097501,0.457266818919447,0.889403249130777,1,7,stress response to metal ion,BP,MT2A
8682,GO:0034312,0.457368364425007,0.811431831369941,2,15,diol biosynthetic process,BP,GCH1;SPTLC2
12376,GO:0048806,0.457976934156856,0.768885853015168,3,23,genitalia development,BP,BAX;ASB1;PKD1
3237,GO:0006896,0.457990736872219,0.812049884805011,2,14,Golgi to vacuole transport,BP,AP3D1;EHD3
11783,GO:0046660,0.458054454465468,0.678557947654391,9,78,female sex differentiation,BP,VEGFA;CEBPB;VGF;BAX;EREG;ARID5B;INSR;BCL2L1;ZP3
4189,GO:0009268,0.458086117512276,0.768797938608631,3,23,response to pH,BP,IMPACT;ASIC1;HYAL1
18083,GO:1902653,0.458215063664032,0.695597149712951,7,60,secondary alcohol biosynthetic process,BP,APOE;SEC14L2;MVD;PLPP6;MBTPS2;HSD17B7;ABCG1
17657,GO:1901385,0.458260833617533,0.811852879572945,2,14,regulation of voltage-gated calcium channel activity,BP,CACNB3;EHD3
5503,GO:0016446,0.458530103256715,0.811656367487118,2,14,somatic hypermutation of immunoglobulin genes,BP,POLL;POLM
1610,GO:0004032,0.458536275429767,0.891290465003399,1,6,alditol:NADP+ 1-oxidoreductase activity,MF,AKR7A2
12079,GO:0048050,0.458537765173439,0.891289663565869,1,6,post-embryonic eye morphogenesis,BP,BAX
2522,GO:0005778,0.458632296728649,0.706711834309291,6,51,peroxisomal membrane,CC,MAP2K2;ABCD1;PEX10;PEX1;DECR2;CAT
7554,GO:0031903,0.458632296728649,0.706711834309291,6,51,microbody membrane,CC,MAP2K2;ABCD1;PEX10;PEX1;DECR2;CAT
14485,GO:0061912,0.459172515589353,0.721055122660699,5,41,selective autophagy,BP,LRSAM1;SESN2;MAPK3;WIPI2;SPTLC2
671,GO:0001882,0.459414032274578,0.614930511034953,32,293,nucleoside binding,MF,ARL2;GTPBP1;RAB31;RAC2;RAB3B;EHD4;SEPT10;AGAP1;NPR2;GNAL;RHOD;RHOF;ARL10;RHOBTB2;TUBG2;PCK2;ADA;RASL10B;DNM1;EHD3;RAB12;RAC3;DNM2;TUBB6;INSR;RRAS;RAB28;RAB40B;GCH1;SEPT6;AK3;LRRK1
4090,GO:0009146,0.459436427355355,0.89080551720436,1,6,purine nucleoside triphosphate catabolic process,BP,ADA
11447,GO:0045912,0.459752630268154,0.767454096098732,3,23,negative regulation of carbohydrate metabolic process,BP,TGFB1;DDIT4;PPARA
377,GO:0001010,0.459825483702295,0.810709464910036,2,14,transcription factor activity, sequence-specific DNA binding transcription factor recruiting,MF,NR1D1;PPARA
4188,GO:0009267,0.459857584677797,0.654921933751246,13,114,cellular response to starvation,BP,GLUL;IMPACT;DAP;WNT2B;GAS6;PCSK9;WDR59;SESN2;UPP1;MAPK3;C12ORF66;HFE;GAS2L1
15220,GO:0071379,0.460111524655778,0.810500029919547,2,14,cellular response to prostaglandin stimulus,BP,AKT1;ADCY6
8186,GO:0032934,0.460260575272863,0.739167007048414,4,33,sterol binding,MF,APOE;OSBPL5;OSBPL10;ABCG1
3281,GO:0006972,0.460293574580457,0.810366670857812,2,14,hyperosmotic response,BP,PKN1;ERRFI1
12294,GO:0048643,0.460376598031809,0.810305836029615,2,14,positive regulation of skeletal muscle tissue development,BP,GPC1;FAM129B
3537,GO:0007548,0.460381305835608,0.635217807771877,19,171,sex differentiation,BP,ERCC1;CST3;VEGFA;WNT7A;SDC1;WNT2B;CCND1;CEBPB;VGF;BOK;BAX;EREG;ADAM15;ASB1;ARID5B;INSR;BCL2L1;PKD1;ZP3
8836,GO:0034638,0.460831923184337,0.890050971791668,1,6,phosphatidylcholine catabolic process,BP,LDLR
11621,GO:0046337,0.460898116167704,0.809923457629535,2,14,phosphatidylethanolamine metabolic process,BP,CHKA;SLC27A1
14663,GO:0070273,0.461234630864811,0.766255935765309,3,23,phosphatidylinositol-4-phosphate binding,MF,OSBPL5;SH3PXD2B;GSDMA
9030,GO:0035250,0.461393821492005,0.766127060106249,3,23,UDP-galactosyltransferase activity,MF,B3GNT3;B4GALT2;B4GALT6
127,GO:0000266,0.461776734658138,0.738243015785951,4,32,mitochondrial fission,BP,BNIP3;DNM1;DNM2;INF2
9370,GO:0035900,0.462048980211541,0.889390185866501,1,6,response to isolation stress,BP,ACO2
8500,GO:0033688,0.462168252082221,0.80899045854256,2,14,regulation of osteoblast proliferation,BP,LRP5;SMAD3
20286,GO:2001234,0.462459122038412,0.635644193811805,18,165,negative regulation of apoptotic signaling pathway,BP,ITGA6;AKT1;ZNF385A;STRADB;MNT;PTPN1;TRAP1;BOK;IFI6;BAX;TMEM161A;MIF;WFS1;FYN;GRINA;BCL2L1;LMNA;PELI3
13495,GO:0055075,0.462742099589045,0.808568123147576,2,14,potassium ion homeostasis,BP,SLC12A7;SLC12A4
16310,GO:0090482,0.462909724975577,0.808444660851328,2,14,vitamin transmembrane transporter activity,MF,SLC2A3;SLC23A2
3812,GO:0008406,0.462940122062635,0.640996317641911,16,144,gonad development,BP,ERCC1;CST3;VEGFA;SDC1;WNT2B;CCND1;CEBPB;VGF;BOK;BAX;EREG;ADAM15;ARID5B;INSR;BCL2L1;ZP3
6486,GO:0021846,0.463398092814396,0.808084715403106,2,14,cell proliferation in forebrain,BP,WNT7A;FGFR1
5813,GO:0017075,0.463447011565129,0.80804864038151,2,14,syntaxin-1 binding,MF,SNPH;VAMP2
8627,GO:0034162,0.463625855965052,0.807916720883739,2,14,toll-like receptor 9 signaling pathway,BP,PTPRS;IRAK1
3703,GO:0008215,0.463803637122073,0.888433038004255,1,6,spermine metabolic process,BP,SMOX
506,GO:0001569,0.464233688946719,0.763822302925028,3,23,branching involved in blood vessel morphogenesis,BP,VEGFA;NFATC4;EDNRA
19927,GO:2000406,0.464314471213451,0.80631437119504,2,15,positive regulation of T cell migration,BP,ADAM8;ITGA4
10709,GO:0044030,0.464602053935062,0.807195794707063,2,14,regulation of DNA methylation,BP,MBD3;FAM129B
12181,GO:0048339,0.464936579244418,0.80694841118995,2,14,paraxial mesoderm development,BP,SMAD3;FGFR1
5472,GO:0016405,0.464953905712324,0.806935593497412,2,14,CoA-ligase activity,MF,ACSF2;SLC27A1
13595,GO:0060076,0.465179770130019,0.806768462557706,2,14,excitatory synapse,CC,DLG4;ITGA3
8291,GO:0033131,0.465228436335152,0.887651920753423,1,6,regulation of glucokinase activity,BP,PFKFB2
7094,GO:0030897,0.465336845163161,0.806652187070602,2,14,HOPS complex,CC,VPS11;VPS16
18697,GO:1904036,0.46538763826209,0.762882715105327,3,23,negative regulation of epithelial cell apoptotic process,BP,GAS6;ANGPTL4;WFS1
15419,GO:0071695,0.465497120809548,0.659195785002839,11,96,anatomical structure maturation,BP,FAM210B;THBS3;CDC25B;NPR2;AGRN;FAM20C;EREG;RAC3;RERE;SIRT2;FGFR3
2044,GO:0004791,0.465559545194959,0.887469894786626,1,6,thioredoxin-disulfide reductase activity,MF,TXNRD3
11194,GO:0045332,0.465807462477161,0.80630358437211,2,14,phospholipid translocation,BP,ABCA7;ATP8B2
2523,GO:0005779,0.466291667354872,0.80484423323397,2,15,integral component of peroxisomal membrane,CC,ABCD1;PEX10
7256,GO:0031231,0.466291667354872,0.80484423323397,2,15,intrinsic component of peroxisomal membrane,CC,ABCD1;PEX10
19888,GO:2000351,0.466497069658303,0.761977695099367,3,23,regulation of endothelial cell apoptotic process,BP,PDCD4;GAS6;ANGPTL4
1359,GO:0003229,0.466869845554754,0.73389945595717,4,32,ventricular cardiac muscle tissue development,BP,TGFB1;PPP1R13L;TGFBR3;PROX1
4099,GO:0009155,0.466961315706076,0.886697172956715,1,6,purine deoxyribonucleotide catabolic process,BP,ADA
2098,GO:0004864,0.467096136444222,0.76091199487365,3,24,protein phosphatase inhibitor activity,MF,PPP1R35;PPP1R14A;ELFN2
14508,GO:0065007,0.467109656954167,0.557555521773637,843,7938,biological regulation,BP,TNIP1;DUSP6;NT5E;XDH;ERCC1;DUSP5;MEF2D;ZMYND8;ADGRL1;CITED4;SEMA4B;HTRA1;FHL1;EGR1;NR1D1;CCNG2;EDEM1;DLG4;PLAT;CST3;CYP27B1;MRC2;TYSND1;HS1BP3;BTBD2;FBXO2;APLN;PGF;PDCD4;CTNNBIP1;KCNG1;ACVR2B;DOCK4;XPC;PRNP;PARVB;BBS2;DDIT4L;POSTN;VEGFA;FAM210B;TNFRSF6B;WNT7A;APOE;PYGL;DGKA;TSPAN1;ESPN;F2R;LRP5;ITGA6;PITPNC1;HMGA2;OBSCN;NDRG1;IDH2;ZKSCAN1;SLCO4A1;ELK3;ITPR3;PKN1;MTA1;GRAMD4;ARRDC1;EVI5L;NISCH;FCGRT;EGFR;RPS6KA2;SERPINE2;DNPH1;WWTR1;SCN4B;OBSL1;NOS1;VAT1;PTPRS;HADH;SPRY2;CAPN2;MST1R;NFATC4;TRIM65;BAHCC1;CRTAP;LTBP4;PRSS8;SYTL1;SDC1;ETV5;LMF1;APPL2;SHC1;DDB2;ORAI1;LTBP2;VPS11;LTBP1;TBC1D14;ARL2;HEXB;GTPBP1;SLC7A8;TCFL5;PTPRE;SLC12A7;RIN1;ACTA2;MMP1;ETV4;PHLDA2;SNX9;TRNP1;SPRY4;RAPGEF3;TXNRD3;ZFP36L1;GAA;GLUL;ARAP1;MAP2K2;NME4;ZC3H6;LPAR3;PLCD3;MDFI;PTOV1;SMARCA1;PPP1R35;CMTM7;RBCK1;PLTP;PC;TP53I11;FOXQ1;MAP2K1;ACP5;CPT2;MCTP1;MXD4;SSH1;POU2F2;EXOC2;ENDOG;MARK4;KCNJ15;MARCKSL1;SMURF2;TSC22D1;FOS;FBLN1;SMAD3;ARHGAP23;STAT6;SHANK2;PIK3R2;ERCC6;LRP1;GJC2;SRD5A3;DVL1;EPAS1;DNAJB5;HSD17B8;HBEGF;FAM110C;AP2A2;S100A4;ITGB4;CYBRD1;PPP1R14A;SH3PXD2B;PPP2R3B;PRDX5;SHC2;NLGN2;STOM;BRD3;PRODH;SALL2;FBXW5;PAG1;ZXDC;RNF187;ADORA2B;ADARB1;PLCXD2;SYT8;AKT1;TPCN1;GRB7;KCNC4;TMOD2;CORO1B;HDAC5;FAM83A;S100A6;F12;SH2D2A;PPM1F;MMP28;PITPNM1;PLEKHH3;RHBDF2;BSG;STK39;HK1;SERPING1;ASAP2;SCMH1;EPHA1;GGT1;NFKBIZ;PTPRU;VEGFB;FMNL2;ASH2L;IMPACT;WWC3;LRRC8A;CNTN1;IFNGR2;BRSK1;DAP;IFT140;PTHLH;MYZAP;RAB31;FGFR4;HEBP1;PEAR1;WNT2B;POLD4;FNDC4;LDLR;FGFR1;PRKACB;MAPKBP1;SIGMAR1;RAC2;KCNAB2;SMOC2;PFKL;SEC14L2;HLTF;MXI1;NPHP4;SYNE3;RAG1;GAMT;H2AFJ;KLF7;RALGDS;SORL1;NAT14;CEACAM1;CCNI;B3GAT3;ASB13;CIRBP;HMG20B;LZTS2;RAB11FIP4;TENM2;ZNF385A;DOCK6;NSMCE4A;ANK3;IGFBP4;EVC;TSHZ1;TRAPPC9;CCND1;PODNL1;EFS;PCBP4;TCF25;TNNT1;TWF2;STRADB;SYNGAP1;PLCH2;MAPK13;CEP250;EDNRA;CARD19;PLAU;GAS6;PTK6;SEMA3F;FGFBP1;CSNK1E;CTSB;RAB3B;CARD11;SH2B3;SOX13;LAMA5;DUSP7;GSN;CMTM4;PLEKHG2;MAPKAPK3;IGFBP2;PCSK9;ARHGAP22;RAD23A;BCR;ANTXR2;ANGPTL4;EHD4;ERRFI1;GLI4;WIPF1;ZSCAN18;AIP;STON1;CCDC71L;MYEF2;MN1;SH3D19;CDC25B;RGL2;SLITRK6;TSPAN18;PAQR6;ARPIN;ARHGAP27;ALOX15B;SPTB;SMARCD2;AGAP1;NXPH4;CCS;SLC20A1;NPR2;SNTA1;DGKQ;PLXNB3;BNIP3;PAK6;TFPI2;GTF2IRD1;SHARPIN;MVB12B;SERINC2;TAGLN3;FYCO1;CEMIP;PROCR;PKD2;FAM3A;PCSK1;RETSAT;YPEL3;RASGEF1A;CTSZ;CDC42EP5;HES2;CRTC1;IL20RB;FBXW8;GPSM1;AP3D1;ITGB5;ABCA2;ZNF598;MAGEF1;SH3PXD2A;EPOR;EPHB2;GRIN3B;ADAM8;ASIC1;APRT;CTBP1;MNT;GRK6;CDKN1C;PLCG1;ZMIZ2;SH3BP2;NYAP1;CD81;CEBPB;MVD;RNF135;ENTPD2;ADAMTS13;ZNF217;TIMP2;ZNF862;WNT3;GNAL;C8ORF88;TMED4;TGFB1;SNPH;CLTCL1;RFX2;SCYL1;ABHD17C;UNK;ULK2;GPC1;MKNK2;ADAMTS7;DEAF1;MOAP1;TBC1D9B;NTSR1;NAB2;TMEM173;ARHGAP25;ZSCAN30;ATP7B;FHOD3;SHANK3;MSRB2;EFNB3;RASA3;PNRC1;TNFSF15;EML2;KIF26B;NSMF;PEG3;ARAP3;FARP1;MC1R;TUB;CROCC;RHOD;CGREF1;ABHD14B;ABTB1;SNX17;RNH1;ERO1B;HTR7;VGF;PLEKHG4;SNX33;SEMA4F;RHOF;WASF3;LLGL1;PHF21A;PLEKHG3;MIF4GD;KIF7;RHOBTB2;KHDRBS3;ZER1;GIGYF1;RIMS3;BBS1;TNFAIP8L1;PTPN1;TPP1;PCK2;WDR59;AGRN;MBD3;IFNE;CD320;CAMK2N1;LRP4;GPR153;VHL;CEP131;TRAP1;ADAP1;PFKFB2;RFNG;MLXIPL;TRIB2;PRKCZ;KDM6B;PRKACA;MINK1;ZNF516;OXA1L;RHPN1;RABGGTA;TOM1L2;CD9;EPN2;ADA;AREG;PIM2;MICALL2;PLEKHG5;BOK;WDR18;TDRKH;CAPG;SDCCAG8;ALAS1;NEURL1B;ERBB2;ADGRB2;ULK1;NINL;VAMP2;MMP10;TFDP2;PLEK2;C6ORF89;NECAB3;STK17A;RILPL1;JAK3;IRF2BP2;RNPEP;NET1;BNIP3L;CYFIP2;FSCN1;PBX2;TRPC1;NELFCD;SLC22A17;RASA4;PDK1;CYGB;ARHGAP44;PRKCD;FAM20C;MIB2;REEP6;RBL2;CACNB3;USP20;STUB1;IFI6;BAX;SV2A;SBF1;DTD1;ITGA1;OLFM2;ZNF395;SH3BP1;FBXW4;CHADL;EREG;RPS6KA5;DGUOK;DUSP4;ZNF524;CUL9;SOX12;TMBIM4;DDIT4;MBTPS2;SPRED3;PPP1R13L;CARF;HSD17B7;AHNAK2;PCSK1N;MT2A;IER2;RASL10B;ZDHHC8;TMX4;NID1;LIMK1;TGFBR3;PDIA5;GDI1;TPM2;DIP2A;LTB4R2;LEMD2;RPS6KA6;ZHX3;DNM1;WASH3P;RGS14;TMEM8B;SCN8A;MFNG;GSTO1;GIT1;CHAD;LPCAT1;LRSAM1;ADAM15;REEP2;ASB1;EHD3;TMEM231;LONP2;SYMPK;MAPK12;IRAK1;TGFA;HDAC7;FHOD1;INPP5D;MTHFR;CHD2;CBX7;CHEK2;ZFPM1;PPARA;COG7;TMEM161A;SESN2;FGGY;ABCG1;MYO1D;CDC34;SOX7;ABCA7;RAB12;SPEG;SIX5;BCAP31;MIF;KDM4B;ZNF414;MEX3A;BCAM;SLC9A7;PLA2G6;DDT;SSBP4;SYNGR1;ECM1;WFS1;QSOX1;ZNF444;DTX3;TRPT1;NBPF3;SPPL2B;FYN;STK25;RAC3;EEF2K;SUN1;ICAM5;ARHGAP12;ACAP3;ARID5B;HOXC5;DNM2;BHLHE40;PELI1;SNX15;INF2;CHKA;CAT;BEX2;NEIL1;TSPYL2;IGFBP7;ELFN2;SLC27A1;ZMYM3;TPBG;APOBEC3C;SATB1;SLC50A1;KIF26A;SLC12A4;PLCB3;IQSEC1;ZNF606;APOBEC3F;ARHGEF4;CYP2R1;MAPK3;INSR;RTN2;ARHGEF1;PAN2;GRINA;CAMTA2;TAZ;PFKM;ADCY1;C12ORF66;RERE;HLA-G;DOCK9;STX10;INO80C;ATP8B2;TMEM101;RALGAPA1;ETAA1;GLRX;BCL7A;CEP72;VANGL2;PAK1;MALL;CAMKK2;PPP3CB;RNF144A;LGALS3BP;ROBO4;USP21;PFKFB3;MLYCD;CUL7;GABBR1;MICAL1;HYAL1;SEMA4C;CAPRIN2;ZBTB10;WDTC1;HES7;ITGA3;STK32C;DNMT3A;SAMD8;BIN1;VPS16;SRMS;PPP2R5B;HES6;MAP2K3;BCL2L1;DLG3;SGSM2;RRAS;PROX1;IARS2;LRCH4;TBC1D16;ADGRF1;ALDH7A1;LMNA;ZYG11B;PKD1;KCTD13;TNFRSF25;RABGAP1;SIRT2;FAM129B;CDH4;ITGA4;EDA;DCBLD2;BACH1;TRIP10;ADCY7;E2F5;ZBTB22;LTB4R;MAPRE3;AZIN2;TEP1;RAB28;ZNF704;SERPINB1;ICA1;SLC25A37;RAP1GAP2;LAMB1;SOCS7;MAP3K10;RGS19;NDE1;GPR3;HSD11B1;PELI3;GTF2IRD2;RAB40B;NGFR;TOLLIP;BCORL1;PDCD6;ATP6V1F;PCLO;ZNF837;PXN;GRB10;TBC1D8;PLEKHM1;GCH1;LURAP1;KIF13B;MAFF;NR2F6;CBX6;TCTN1;PNMA1;CAMK1;CAMKK1;SLC39A3;EZH1;SIRT3;HFE;TERC;ZNF513;GAS2L1;BTG1;BBS10;ZP3;CELSR1;MLF2;IL17RE;SEMA3B;CDK11B;PFN2;SSH3;FGFR3;PPP1R16A;CCDC88C;TNRC18;NDRG2;BLOC1S4;CBLC;ITPKB;SPTLC2;TCEA2;CDC42BPG;ZBTB47;PLAG1;CLK3;IRF2BPL;KDM3A;PM20D2;HOMER2;PKN3;APBA1;DEDD2;PI4KAP2;AK3;SRSF5;ADCY6;SLC26A11;LRRK1;AARS;KLHL24;SDC2
11674,GO:0046467,0.467163431001413,0.647867445429596,13,117,membrane lipid biosynthetic process,BP,KDSR;PIGQ;PIGV;ST6GALNAC6;B4GALT6;PRKCD;PLA2G6;CERS4;SAMD8;GAL3ST4;ST3GAL2;ST3GAL5;SPTLC2
10323,GO:0043122,0.467268713707697,0.626238695530024,20,182,regulation of I-kappaB kinase/NF-kappaB signaling,BP,TNIP1;F2R;RBCK1;S100A4;AKT1;MAPKBP1;CARD19;CARD11;SLC20A1;SHARPIN;TMED4;PIM2;PLEKHG5;MIB2;IRAK1;ECM1;FYN;PELI1;TMEM101;LURAP1
19802,GO:2000210,0.467863507096085,0.886198039372261,1,6,positive regulation of anoikis,BP,CHEK2
4718,GO:0010882,0.468000692140063,0.803568663614258,2,15,regulation of cardiac muscle contraction by calcium ion signaling,BP,PRKACA;GSTO1
8138,GO:0032872,0.468022708802223,0.630471362809564,18,161,regulation of stress-activated MAPK cascade,BP,XDH;PDCD4;VEGFA;WNT7A;PKN1;EGFR;MAP2K2;MAP2K1;ERCC6;AKT1;PTPN1;MINK1;STK25;MAPK3;VANGL2;PAK1;SEMA4C;MAP3K10
7778,GO:0032310,0.468042957569321,0.886098590455989,1,6,prostaglandin secretion,BP,MIF
4716,GO:0010880,0.468514076532441,0.803184611148234,2,15,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,PRKACA;GSTO1
4738,GO:0010907,0.468547324829143,0.760300855677665,3,23,positive regulation of glucose metabolic process,BP,AKT1;PPARA;INSR
189,GO:0000407,0.469084650309494,0.732000904190792,4,32,phagophore assembly site,CC,ULK2;ATG2A;ULK1;WIPI2
19816,GO:2000243,0.469185598057977,0.731544386760449,4,33,positive regulation of reproductive process,BP,SMURF2;INSR;SIRT2;ZP3
3712,GO:0008235,0.470108205563927,0.731121504551926,4,32,metalloexopeptidase activity,MF,NPEPL1;RNPEPL1;LTA4H;RNPEP
2510,GO:0005765,0.470425887080061,0.603170418476312,33,301,lysosomal membrane,CC,TSPAN1;VPS11;GAA;MARCH9;TMEM8A;LRP1;AP2A2;CYBRD1;STOM;TPCN1;SLC15A4;LDLR;BRI3;PCSK9;AP3D1;ABCA2;TMEM9;DIRC2;PI4K2A;SLC48A1;WDR59;LPCAT1;PI4K2B;RAB12;SYNGR1;CD68;SPPL2B;SLC12A4;C12ORF66;VPS16;PLEKHM1;COL6A1;SLC26A11
16900,GO:0098852,0.470425887080061,0.603170418476312,33,301,lytic vacuole membrane,CC,TSPAN1;VPS11;GAA;MARCH9;TMEM8A;LRP1;AP2A2;CYBRD1;STOM;TPCN1;SLC15A4;LDLR;BRI3;PCSK9;AP3D1;ABCA2;TMEM9;DIRC2;PI4K2A;SLC48A1;WDR59;LPCAT1;PI4K2B;RAB12;SYNGR1;CD68;SPPL2B;SLC12A4;C12ORF66;VPS16;PLEKHM1;COL6A1;SLC26A11
3061,GO:0006627,0.471029861494705,0.884435046390124,1,6,protein processing involved in protein targeting to mitochondrion,BP,MIPEP
442,GO:0001191,0.471106374407699,0.729891414738735,4,33,transcriptional repressor activity, RNA polymerase II transcription factor binding,MF,ZMYND8;CTBP1;BHLHE40;RERE
5733,GO:0016879,0.471777368043393,0.709718466309,5,42,ligase activity, forming carbon-nitrogen bonds,MF,GLUL;NAPRT;HLCS;PPCS;TTLL3
2341,GO:0005375,0.472125816040446,0.88382074619554,1,6,copper ion transmembrane transporter activity,MF,ATP7B
9118,GO:0035434,0.472125816040446,0.88382074619554,1,6,copper ion transmembrane transport,BP,ATP7B
12094,GO:0048144,0.472476535512457,0.68235755930226,7,62,fibroblast proliferation,BP,EGFR;S100A6;GAS6;TGFB1;BAX;EREG;MIF
6864,GO:0030346,0.473061448577086,0.88329464078337,1,6,protein phosphatase 2B binding,MF,PPP3CB
3109,GO:0006690,0.47317556482439,0.681718002427915,7,62,icosanoid metabolic process,BP,GGT1;ALOX15B;LTA4H;CES2;MIF;MAPK3;PTGR2
6587,GO:0022607,0.473227162286601,0.557112255629945,234,2220,cellular component assembly,BP,ERCC1;SDK2;ZMYND8;ADGRL1;H1F0;THSD4;DLG4;TYSND1;CTNNBIP1;KCNG1;XPC;PRNP;PARVB;BBS2;FLNC;VEGFA;WNT7A;APOE;ESPN;ITGA6;HMGA2;OBSCN;ITPR3;EVI5L;WWTR1;LOXL1;OBSL1;BAHCC1;SDC1;DDB2;VPS11;TBC1D14;ARL2;MMP1;SNX9;NUDCD3;RAPGEF3;GLUL;ARAP1;LPAR3;SSH1;EXOC2;MARK4;SLC9A3R2;SMAD3;SHANK2;DVL1;HSD17B8;FAM110C;ITGB4;SH3PXD2B;NLGN2;STOM;GRB7;KCNC4;TMOD2;CORO1B;PPM1F;EPHA1;ASH2L;IMPACT;ATG16L2;IFT140;DNAAF5;PRKACB;SIGMAR1;RAC2;PFKL;NPHP4;PACS2;SORL1;CIRBP;CBR4;TENM2;ANK3;TRAPPC9;TNNT1;TWF2;CEP250;GAS6;CSNK1E;LAMA5;GSN;PLEKHG2;ANGPTL4;EHD4;SEPT10;WIPF1;CCDC113;SLITRK6;ARPIN;SPTB;CORO7;UNC119B;DGKQ;PLXNB3;SHARPIN;PKD2;GPX3;CTSZ;CDC42EP5;CRTC1;ITGB5;SH3PXD2A;EPHB2;ASIC1;PTPDC1;KIF17;TGFB1;CLTCL1;RFX2;ULK2;GPC1;FHOD3;SHANK3;MSRB2;EML2;GOLGA2P5;FARP1;CROCC;RHOD;TNS1;DNAH1;RHOF;WASF3;ATG2A;LLGL1;COA5;RHOBTB2;KHDRBS3;TUBG2;BBS1;HMGCL;AGRN;LRP4;CEP131;PRKCZ;PRKACA;CENPH;GRHPR;OXA1L;RABGGTA;CD9;AREG;MICALL2;BOK;WDR18;CAPG;SDCCAG8;ADGRB2;ULK1;NINL;VAMP2;PSMG4;RILPL1;CYFIP2;FSCN1;MCFD2;PRKCD;STUB1;BAX;TRIM4;HIST3H2BB;NUBP2;SH3BP1;SOX12;AHNAK2;ZDHHC8;FCHO1;LIMK1;TGFBR3;DNM1;WASH3P;LRSAM1;EHD3;WDR60;TMEM231;IRAK1;TGFA;HDAC7;FHOD1;CHEK2;CDC34;ABCA7;MIF;DNAAF3;EFEMP2;STK25;RAC3;EEF2K;DNM2;ATXN10;CAT;TSPYL2;TPBG;H1FX;ARHGEF4;MAPK3;INSR;TAZ;PFKM;CEP72;VANGL2;PAK1;HYAL1;BIN1;VPS16;PPP2R5B;NDUFV3;PROX1;ADGRF1;KCTD13;SIRT2;CDH4;NDE1;PDCD6;PCLO;PXN;PLEKHM1;GCH1;MSS51;TCTN1;HFE;WIPI2;COL6A1;BBS10;SEPT6;PFN2;SSH3;CCDC88C;TNRC18;APBA1;TTLL3;SRSF5
16153,GO:0090174,0.47347430149936,0.637922290239739,14,125,organelle membrane fusion,BP,EVI5L;SYTL1;VPS11;TBC1D14;SYT8;DYSF;TBC1D9B;VAMP2;STX10;VPS16;SGSM2;TBC1D16;RABGAP1;TBC1D8
5073,GO:0015297,0.473668658707069,0.693237340371533,6,51,antiporter activity,MF,SLC7A8;SLC9A7;SLC22A18;SLC37A2;TMCO3;SLC26A11
12643,GO:0050856,0.473811081074056,0.755384433694643,3,24,regulation of T cell receptor signaling pathway,BP,PRNP;CEACAM1;ADA
11835,GO:0046824,0.474019453324193,0.692920251439847,6,51,positive regulation of nucleocytoplasmic transport,BP,RAPGEF3;GAS6;TGFB1;TMEM173;PRKCD;CAMK1
19449,GO:1990050,0.474112603809054,0.882701739942056,1,6,phosphatidic acid transporter activity,MF,PLTP
12142,GO:0048260,0.474172932881146,0.727243223936153,4,33,positive regulation of receptor-mediated endocytosis,BP,APLN;VEGFA;PCSK9;HFE
12767,GO:0051051,0.474274048919346,0.604080159015439,29,268,negative regulation of transport,BP,DLG4;F2R;IDH2;SERPINE2;NOS1;HADH;MCTP1;AKT1;RHBDF2;STK39;MAPKBP1;PFKL;CEACAM1;ANK3;GAS6;PCSK9;BCR;PKD2;EPHB2;ASIC1;TGFB1;NTSR1;SNX33;ADA;BOK;GDI1;GSTO1;LRSAM1;GRB10
6704,GO:0030120,0.474534977176357,0.692262134639519,6,52,vesicle coat,CC,EGFR;AP2A2;CLTCL1;SCYL1;EPN2;PDCD6
1089,GO:0002676,0.474668568525736,0.882387362315433,1,6,regulation of chronic inflammatory response,BP,ADORA2B
6573,GO:0022406,0.475139598243394,0.623574649197148,18,163,membrane docking,BP,VPS11;EXOC2;MARK4;NPHP4;CEP250;CSNK1E;RAB3B;SNPH;ESYT2;CEP131;PRKACA;SDCCAG8;NINL;STX10;CEP72;NDE1;RAB40B;TCTN1
919,GO:0002313,0.475382864187346,0.798007104937259,2,15,mature B cell differentiation involved in immune response,BP,ADA;MFNG
1706,GO:0004198,0.47583534587142,0.797663472581355,2,15,calcium-dependent cysteine-type endopeptidase activity,MF,CAPN2;PDCD6
15876,GO:0072608,0.475901136867459,0.881688443253515,1,6,interleukin-10 secretion,BP,PRKCZ
6281,GO:0019888,0.476085814948369,0.679198006955664,7,61,protein phosphatase regulator activity,MF,PPP1R35;PPP1R14A;PPP2R3B;B3GAT3;ELFN2;PPP2R5B;PPP1R16A
17714,GO:1901612,0.47617664912304,0.881531848477647,1,6,cardiolipin binding,MF,NME4
6780,GO:0030223,0.476429213013825,0.881388178904209,1,6,neutrophil differentiation,BP,INPP5D
11237,GO:0045445,0.476537254256442,0.690448163544089,6,52,myoblast differentiation,BP,SDC1;ZFP36L1;EPAS1;TGFB1;MAPK12;BTG1
13612,GO:0060113,0.47659348108357,0.725144902708467,4,33,inner ear receptor cell differentiation,BP,NAGLU;FGFR1;SLITRK6;VANGL2
12149,GO:0048268,0.476740776885274,0.796974897558711,2,15,clathrin coat assembly,BP,CLTCL1;FCHO1
9019,GO:0035234,0.476780801861763,0.88118799126942,1,6,ectopic germ cell programmed cell death,BP,BAX
4137,GO:0009200,0.476975308131097,0.795812634787312,2,16,deoxyribonucleoside triphosphate metabolic process,BP,ADA;DGUOK
10664,GO:0043901,0.477092817259359,0.638343225129184,13,119,negative regulation of multi-organism process,BP,TNIP1;HTRA1;HMGA2;MAPKBP1;GSN;NPR2;FAM3A;ADA;APOBEC3C;APOBEC3F;PROX1;SIRT2;ZP3
5116,GO:0015450,0.477174705758556,0.878166151431777,1,7,P-P-bond-hydrolysis-driven protein transmembrane transporter activity,MF,TIMM17B
2727,GO:0006110,0.477567973907228,0.689705648094458,6,51,regulation of glycolytic process,BP,PFKFB2;MLXIPL;DDIT4;PPARA;INSR;PFKFB3
4423,GO:0010248,0.477706564395407,0.880659831437432,1,6,establishment or maintenance of transmembrane electrochemical gradient,BP,BAX
11778,GO:0046653,0.477897906301261,0.796093051087819,2,15,tetrahydrofolate metabolic process,BP,MTHFR;GCH1
1235,GO:0002922,0.477931016127294,0.880531549418798,1,6,positive regulation of humoral immune response,BP,ZP3
4130,GO:0009191,0.478086081756925,0.880442871669171,1,6,ribonucleoside diphosphate catabolic process,BP,ENTPD2
4303,GO:0009756,0.479128047594543,0.879845889986648,1,6,carbohydrate mediated signaling,BP,MLXIPL
14680,GO:0070302,0.479260150351354,0.619644847097744,18,162,regulation of stress-activated protein kinase signaling cascade,BP,XDH;PDCD4;VEGFA;WNT7A;PKN1;EGFR;MAP2K2;MAP2K1;ERCC6;AKT1;PTPN1;MINK1;STK25;MAPK3;VANGL2;PAK1;SEMA4C;MAP3K10
2970,GO:0006515,0.479571985046953,0.750593754550159,3,24,protein quality control for misfolded or incompletely synthesized proteins,BP,ANKZF1;STUB1;LONP2
2725,GO:0006108,0.479597663161031,0.879576196835294,1,6,malate metabolic process,BP,MDH2
10728,GO:0044091,0.479776839640978,0.750422572934599,3,24,membrane biogenesis,BP,NLGN2;ANK3;LRP4
3356,GO:0007096,0.479880886063563,0.79457697326004,2,15,regulation of exit from mitosis,BP,TGFB1;SIRT2
10914,GO:0044531,0.479903226287824,0.879400505145774,1,6,modulation of programmed cell death in other organism,BP,BCL2L1
10915,GO:0044532,0.479903226287824,0.879400505145774,1,6,modulation of apoptotic process in other organism,BP,BCL2L1
13290,GO:0052040,0.479903226287824,0.879400505145774,1,6,modulation by symbiont of host programmed cell death,BP,BCL2L1
13319,GO:0052248,0.479903226287824,0.879400505145774,1,6,modulation of programmed cell death in other organism involved in symbiotic interaction,BP,BCL2L1
13343,GO:0052433,0.479903226287824,0.879400505145774,1,6,modulation by organism of apoptotic process in other organism involved in symbiotic interaction,BP,BCL2L1
17398,GO:1900122,0.480202073174896,0.879228513831393,1,6,positive regulation of receptor binding,BP,HFE
11294,GO:0045622,0.480245452228838,0.794297577928871,2,15,regulation of T-helper cell differentiation,BP,PRKCZ;JAK3
5599,GO:0016635,0.480453283647069,0.879083814565645,1,6,oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor,MF,SDHA
13884,GO:0060537,0.480652629563127,0.603792160975062,25,226,muscle tissue development,BP,MEF2D;EGR1;VEGFA;OBSL1;FOS;SMAD3;FGFR1;HMG20B;PKD2;TGFB1;GPC1;FHOD3;KDM6B;PPP1R13L;TGFBR3;LEMD2;ZFPM1;MYH15;TAZ;PAK1;PROX1;LMNA;SIRT2;FAM129B;MAFF
8297,GO:0033139,0.480792380956707,0.878888312760735,1,6,regulation of peptidyl-serine phosphorylation of STAT protein,BP,IFNE
4862,GO:0014706,0.481129593481086,0.605005034314631,24,217,striated muscle tissue development,BP,MEF2D;EGR1;VEGFA;OBSL1;FOS;SMAD3;FGFR1;HMG20B;TGFB1;GPC1;FHOD3;KDM6B;PPP1R13L;TGFBR3;LEMD2;ZFPM1;MYH15;TAZ;PAK1;PROX1;LMNA;SIRT2;FAM129B;MAFF
9332,GO:0035821,0.4811522388157,0.649825982469724,10,93,modification of morphology or physiology of other organism,BP,TNIP1;APOE;HMGA2;PC;SMAD3;STOM;TGFB1;INSR;BCL2L1;RNASE7
7830,GO:0032391,0.481404204133517,0.749060681621811,3,24,photoreceptor connecting cilium,CC,IFT140;NPHP4;KIF17
9826,GO:0042056,0.481406020542861,0.791539031356905,2,17,chemoattractant activity,MF,VEGFA;MIF
4282,GO:0009651,0.481500359595973,0.793334256174334,2,15,response to salt stress,BP,ZFP36L1;BAX
5745,GO:0016892,0.481683054196653,0.878373826984806,1,6,endoribonuclease activity, producing 3'-phosphomonoesters,MF,RNASET2
5345,GO:0016093,0.48185599978959,0.878273762353811,1,6,polyprenol metabolic process,BP,SRD5A3
4260,GO:0009607,0.481861697718097,0.5744539177222,58,551,response to biotic stimulus,BP,TNIP1;HTRA1;NR1D1;CYP27B1;PDCD4;TNFRSF6B;F2R;HMGA2;LOXL1;NOS1;MST1R;SHC1;ACTA2;ACP5;FOS;SMAD3;ADARB1;AKT1;HDAC5;IFNGR2;MAPKBP1;CEACAM1;MAPKAPK3;BCR;WIPF1;BNIP3;FAM3A;PRSS3;CEBPB;ADAMTS13;TGFB1;TMEM173;VGF;PCK2;IFNE;PIM2;BNIP3L;PRKCD;DDIT4;LRSAM1;ADAM15;IRAK1;MIF;PLA2G6;WFS1;PELI1;APOBEC3C;APOBEC3F;MAPK3;HYAL1;BCL2L1;TNFRSF25;SIRT2;NGFR;RNASE7;GCH1;WIPI2;GSDMA
18414,GO:1903432,0.481934619484285,0.748616015396794,3,24,regulation of TORC1 signaling,BP,DGKQ;SESN2;C12ORF66
12951,GO:0051342,0.482025554979876,0.878175607293437,1,6,regulation of cyclic-nucleotide phosphodiesterase activity,BP,AIP
1160,GO:0002768,0.482040274975224,0.599233975429801,27,251,immune response-regulating cell surface receptor signaling pathway,BP,PRNP;FCGRT;SHC1;RBCK1;FOS;PIK3R2;PAG1;PRKACB;CEACAM1;CARD11;WIPF1;PLCG1;PRKACA;ADA;CYFIP2;PRKCD;CACNB3;BAX;RPS6KA5;LIMK1;INPP5D;PLA2G6;FYN;MAPK3;HLA-G;PAK1;PPP3CB
12148,GO:0048266,0.482256386849586,0.878041896376266,1,6,behavioral response to pain,BP,VWA1
6019,GO:0019079,0.482552131031922,0.642832842281563,11,100,viral genome replication,BP,TNIP1;HMGA2;STOM;ADARB1;ATG16L2;GAS6;RAD23A;CTBP1;APOBEC3C;APOBEC3F;PROX1
13588,GO:0060068,0.482764641983059,0.87774714882655,1,6,vagina development,BP,BAX
12624,GO:0050820,0.482802091021623,0.792332384682557,2,15,positive regulation of coagulation,BP,F2R;F12
9247,GO:0035655,0.482807387854205,0.877722338452904,1,6,interleukin-18-mediated signaling pathway,BP,AKT1
15199,GO:0071351,0.482807387854205,0.877722338452904,1,6,cellular response to interleukin-18,BP,AKT1
4518,GO:0010573,0.482968785102205,0.747747936188063,3,24,vascular endothelial growth factor production,BP,ADORA2B;TGFB1;NDRG2
15578,GO:0072050,0.482985713042192,0.877618800294404,1,6,S-shaped body morphogenesis,BP,PKD2
14196,GO:0061135,0.483000525657343,0.654712592911449,9,85,endopeptidase regulator activity,MF,CST3;SERPINE2;PRDX5;SERPING1;GAS6;TFPI2;TIMP2;PCSK1N;SERPINB1
2978,GO:0006525,0.48302385194261,0.792161442576624,2,15,arginine metabolic process,BP,NAGS;NOS1
1002,GO:0002475,0.483048826649503,0.877582141923066,1,6,antigen processing and presentation via MHC class Ib,BP,AP3D1
4780,GO:0010968,0.483132503354071,0.877533528816169,1,6,regulation of microtubule nucleation,BP,EML2
5754,GO:0016903,0.483302846273629,0.71929164003111,4,33,oxidoreductase activity, acting on the aldehyde or oxo group of donors,MF,XDH;ALDH4A1;DHTKD1;ALDH7A1
9878,GO:0042158,0.483514714657032,0.636740852307056,12,110,lipoprotein biosynthetic process,BP,APOE;PIGQ;LY6K;PIGV;ABHD17C;ZDHHC24;ZDHHC8;MSLN;ZDHHC1;MDGA1;WIPI2;PRSS21
17734,GO:1901654,0.483603135813312,0.628144104689345,14,127,response to ketone,BP,EGFR;FOS;AKT1;CCND1;ERRFI1;TGFB1;PCK2;DDIT4;TGFBR3;GLB1;IGFBP7;ADCY1;BCL2L1;ADCY6
6365,GO:0021554,0.48363461984041,0.877241552772253,1,6,optic nerve development,BP,EPHB2
3370,GO:0007144,0.483671897541298,0.877219858037522,1,6,female meiosis I,BP,CDC25B
10721,GO:0044068,0.483692201842359,0.747139833818862,3,24,modulation by symbiont of host cellular process,BP,TNIP1;TGFB1;BCL2L1
13739,GO:0060324,0.483906171525229,0.698893120930343,5,42,face development,BP,MAP2K1;TGFB1;ARID5B;MAPK3;RRAS
15902,GO:0072677,0.484090205753185,0.876976240876978,1,6,eosinophil migration,BP,ADAM8
5693,GO:0016813,0.48429952137624,0.876854219806781,1,6,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines,MF,PADI3
6209,GO:0019730,0.484311487066026,0.715631170562432,4,43,antimicrobial humoral response,BP,FAM3A;PRSS3;PLA2G6;RNASE7
17804,GO:1901880,0.484435251277855,0.698417203829485,5,42,negative regulation of protein depolymerization,BP,TMOD2;TWF2;GSN;SPTB;CAPG
16082,GO:0090050,0.484766671879565,0.790815319658237,2,15,positive regulation of cell migration involved in sprouting angiogenesis,BP,VEGFA;HDAC7
5014,GO:0015175,0.484972820954955,0.746061598635406,3,24,neutral amino acid transmembrane transporter activity,MF,SLC7A8;SERINC2;SLC43A1
8727,GO:0034384,0.485097036892428,0.876388581524438,1,6,high-density lipoprotein particle clearance,BP,APOE
15980,GO:0080154,0.485509333886109,0.876147406744445,1,6,regulation of fertilization,BP,ZP3
10889,GO:0044440,0.485520060404374,0.579558658110692,43,398,endosomal part,CC,NDRG1;EGFR;APPL2;VPS11;AP2A2;TPCN1;ZFYVE21;RAB31;LDLR;SORL1;RAB11FIP4;CTSB;PCSK9;ANTXR2;EHD4;MVB12B;AP3D1;ABCA2;TMEM9;ABHD17C;RHOD;SNX17;PI4K2A;SLC48A1;LLGL1;CD320;BOK;ERBB2;WASH3P;EHD3;IRAK1;ABCA7;RAB12;SLC9A7;CD68;SPPL2B;INSR;HLA-G;PRAF2;RNF144A;VPS16;PLEKHM1;VPS51
19472,GO:1990144,0.485828282013118,0.875960625816537,1,6,intrinsic apoptotic signaling pathway in response to hypoxia,BP,BNIP3
8390,GO:0033327,0.485846579785677,0.875949904780712,1,6,Leydig cell differentiation,BP,CCND1
8476,GO:0033632,0.486070734018898,0.875818519007614,1,6,regulation of cell-cell adhesion mediated by integrin,BP,ADA
15715,GO:0072282,0.48622357334537,0.87572888157711,1,6,metanephric nephron tubule morphogenesis,BP,PKD1
4085,GO:0009141,0.486423699206917,0.596166502862907,26,257,nucleoside triphosphate metabolic process,BP,PGM1;GTPBP1;NME4;HK1;PFKL;PFKP;DHTKD1;NADK;TGFB1;SDHA;PFKFB2;MLXIPL;ADA;UCKL1;FAM20C;CYC1;DGUOK;DDIT4;ALDOC;PPARA;INSR;TAZ;PFKM;PFKFB3;NDUFV3;AK3
15903,GO:0072678,0.486480745377922,0.7442383474354,3,25,T cell migration,BP,ADAM8;ECM1;ITGA4
13172,GO:0051787,0.486562554153697,0.744719985132823,3,24,misfolded protein binding,MF,EDEM1;F12;STUB1
14112,GO:0060986,0.486605141667109,0.744683997008338,3,24,endocrine hormone secretion,BP,APLN;FGFR1;FAM129B
13933,GO:0060613,0.486754394118398,0.875417236178338,1,6,fat pad development,BP,ARID5B
10071,GO:0042575,0.486762410191335,0.788256989993644,2,16,DNA polymerase complex,CC,POLD4;TERC
10378,GO:0043207,0.486789663512411,0.57101696273854,55,524,response to external biotic stimulus,BP,TNIP1;HTRA1;NR1D1;CYP27B1;PDCD4;TNFRSF6B;F2R;HMGA2;LOXL1;NOS1;MST1R;SHC1;ACTA2;ACP5;FOS;SMAD3;ADARB1;AKT1;HDAC5;IFNGR2;MAPKBP1;MAPKAPK3;BCR;WIPF1;BNIP3;FAM3A;PRSS3;CEBPB;ADAMTS13;TGFB1;TMEM173;VGF;PCK2;IFNE;PIM2;BNIP3L;PRKCD;DDIT4;LRSAM1;IRAK1;MIF;PLA2G6;PELI1;APOBEC3C;APOBEC3F;MAPK3;HYAL1;BCL2L1;TNFRSF25;SIRT2;NGFR;RNASE7;GCH1;WIPI2;GSDMA
13131,GO:0051707,0.486789663512411,0.57101696273854,55,524,response to other organism,BP,TNIP1;HTRA1;NR1D1;CYP27B1;PDCD4;TNFRSF6B;F2R;HMGA2;LOXL1;NOS1;MST1R;SHC1;ACTA2;ACP5;FOS;SMAD3;ADARB1;AKT1;HDAC5;IFNGR2;MAPKBP1;MAPKAPK3;BCR;WIPF1;BNIP3;FAM3A;PRSS3;CEBPB;ADAMTS13;TGFB1;TMEM173;VGF;PCK2;IFNE;PIM2;BNIP3L;PRKCD;DDIT4;LRSAM1;IRAK1;MIF;PLA2G6;PELI1;APOBEC3C;APOBEC3F;MAPK3;HYAL1;BCL2L1;TNFRSF25;SIRT2;NGFR;RNASE7;GCH1;WIPI2;GSDMA
5033,GO:0015205,0.486846963270077,0.875362836413851,1,6,nucleobase transmembrane transporter activity,MF,SLC23A2
7159,GO:0031045,0.486892495923657,0.87533607270775,1,6,dense core granule,CC,ADAM8
4794,GO:0010988,0.486978324331571,0.875285613268675,1,6,regulation of low-density lipoprotein particle clearance,BP,PCSK9
8181,GO:0032927,0.487128364362718,0.875197371010173,1,6,positive regulation of activin receptor signaling pathway,BP,ACVR2B
14464,GO:0061842,0.487161119890154,0.744213945895137,3,24,microtubule organizing center localization,BP,FHOD1;SUN1;NDE1
14034,GO:0060789,0.487204059280716,0.8751528374388,1,6,hair follicle placode formation,BP,EDA
5495,GO:0016433,0.487334074180968,0.875076321533256,1,6,rRNA (adenine) methyltransferase activity,MF,RRNAD1
6522,GO:0021915,0.487801097734855,0.624219238244083,14,125,neural tube development,BP,ZFP36L1;DVL1;SALL2;IFT140;PRKACB;PKD2;TGFB1;DEAF1;VANGL2;SEMA4C;PROX1;PKD1;TCTN1;CELSR1
13477,GO:0055025,0.487838004037615,0.743641103906821,3,24,positive regulation of cardiac muscle tissue development,BP,FGFR1;TGFB1;TGFBR3
1955,GO:0004659,0.487924893181723,0.788363783465249,2,15,prenyltransferase activity,MF,RABGGTA;COQ2
11653,GO:0046426,0.487990671138165,0.715169514039951,4,33,negative regulation of JAK-STAT cascade,BP,PODNL1;VHL;CHAD;SOCS7
19058,GO:1904893,0.487990671138165,0.715169514039951,4,33,negative regulation of STAT cascade,BP,PODNL1;VHL;CHAD;SOCS7
17699,GO:1901568,0.488067938460851,0.637589050941474,11,100,fatty acid derivative metabolic process,BP,ACOT7;HSD17B8;GGT1;CBR4;ALOX15B;LTA4H;HMGCL;CES2;MIF;MAPK3;PTGR2
5230,GO:0015846,0.48807385089319,0.874640366063661,1,6,polyamine transport,BP,AZIN2
7944,GO:0032549,0.488230863875079,0.587962689151611,31,287,ribonucleoside binding,MF,ARL2;GTPBP1;RAB31;RAC2;RAB3B;EHD4;SEPT10;AGAP1;NPR2;GNAL;RHOD;RHOF;ARL10;RHOBTB2;TUBG2;PCK2;RASL10B;DNM1;EHD3;RAB12;RAC3;DNM2;TUBB6;INSR;RRAS;RAB28;RAB40B;GCH1;SEPT6;AK3;LRRK1
9925,GO:0042277,0.488393056554223,0.608130864347972,19,175,peptide binding,MF,CST3;FBXO2;PRNP;APOE;SLC7A8;RNPEPL1;TMEM158;LDLR;SORL1;NPR2;CEMIP;EPHB2;LTA4H;TPP1;RNPEP;THOP1;INSR;HLA-G;APBA1
6894,GO:0030449,0.488541471589106,0.787883334234531,2,15,regulation of complement activation,BP,SERPING1;CD81
19824,GO:2000257,0.488541471589106,0.787883334234531,2,15,regulation of protein activation cascade,BP,SERPING1;CD81
16431,GO:0097084,0.488585299928875,0.874338383556573,1,6,vascular smooth muscle cell development,BP,VEGFA
20211,GO:2001040,0.488675341630418,0.874285169573227,1,6,positive regulation of cellular response to drug,BP,ENDOG
10402,GO:0043244,0.488848116937978,0.64978727024396,9,79,regulation of protein complex disassembly,BP,TMOD2;TWF2;GSN;SPTB;BNIP3;FYCO1;CAPG;SH3BP1;INSR
6952,GO:0030595,0.489251567526804,0.636247627660034,11,103,leukocyte chemotaxis,BP,PGF;VEGFA;MMP28;VEGFB;RAC2;GAS6;ADAM8;ITGA1;MIF;DDT;MAPK3
11053,GO:0045059,0.48967560108224,0.873693029349155,1,6,positive thymic T cell selection,BP,ITPKB
18094,GO:1902686,0.489887412895325,0.678060468179436,6,53,mitochondrial outer membrane permeabilization involved in programmed cell death,BP,BNIP3;MOAP1;BOK;TFDP2;BNIP3L;BAX
4597,GO:0010714,0.489907288790423,0.786816922372191,2,15,positive regulation of collagen metabolic process,BP,F2R;TGFB1
8206,GO:0032967,0.489907288790423,0.786816922372191,2,15,positive regulation of collagen biosynthetic process,BP,F2R;TGFB1
16828,GO:0098722,0.489988285373699,0.873507549767223,1,6,asymmetric stem cell division,BP,ETV5
4574,GO:0010661,0.490171656043681,0.786610166633301,2,15,positive regulation of muscle cell apoptotic process,BP,PDCD4;BNIP3
7933,GO:0032527,0.490213930401754,0.712844179941808,4,34,protein exit from endoplasmic reticulum,BP,EDEM1;TMEM129;SORL1;BCAP31
20116,GO:2000766,0.490263117089263,0.873344376205536,1,6,negative regulation of cytoplasmic translation,BP,UNK
5960,GO:0018344,0.490303957734559,0.873320116446838,1,6,protein geranylgeranylation,BP,RABGGTA
6932,GO:0030546,0.490463404930586,0.873225373970044,1,6,receptor activator activity,MF,DGKQ
15288,GO:0071479,0.490742251502073,0.66549334006303,7,62,cellular response to ionizing radiation,BP,EGR1;HMGA2;TGFB1;NET1;CHEK2;DNM2;BCL2L1
15120,GO:0071216,0.490891813576127,0.621086974096036,14,128,cellular response to biotic stimulus,BP,TNIP1;NR1D1;PDCD4;AKT1;HDAC5;BCR;CEBPB;ADAMTS13;TGFB1;IRAK1;MIF;WFS1;MAPK3;SIRT2
13894,GO:0060556,0.491020067761256,0.872894243804804,1,6,regulation of vitamin D biosynthetic process,BP,CYP27B1
7364,GO:0031419,0.491066758603099,0.872866444024837,1,6,cobalamin binding,MF,CD320
5209,GO:0015809,0.491106497308569,0.872842780405551,1,6,arginine transport,BP,SLC25A29
16353,GO:0090647,0.491128844788505,0.872829471648436,1,6,modulation of age-related behavioral decline,BP,PRNP
14165,GO:0061072,0.49126235329523,0.872749943308425,1,6,iris morphogenesis,BP,WNT2B
5797,GO:0017046,0.491331721821187,0.785701594587104,2,15,peptide hormone binding,MF,NPR2;INSR
10544,GO:0043502,0.491409979673119,0.676846211875833,6,52,regulation of muscle adaptation,BP,SMAD3;TNNT1;ERRFI1;GTF2IRD1;PAK1;LMNA
3314,GO:0007021,0.491663894059766,0.869541259608933,1,7,tubulin complex assembly,BP,ARL2
3747,GO:0008290,0.491673710977485,0.872504700331076,1,6,F-actin capping protein complex,CC,CAPG
11369,GO:0045745,0.4917307720405,0.785388561678809,2,15,positive regulation of G-protein coupled receptor protein signaling pathway,BP,NOS1;TMOD2
13713,GO:0060292,0.491997697670435,0.785179032004106,2,15,long term synaptic depression,BP,SHANK2;SHANK3
17881,GO:1902106,0.492423717939458,0.675910842427756,6,52,negative regulation of leukocyte differentiation,BP,CEACAM1;ERBB2;JAK3;INPP5D;ZFPM1;HLA-G
6850,GO:0030326,0.492537387697659,0.639370866413534,10,89,embryonic limb morphogenesis,BP,WNT7A;LRP5;IFT140;FGFR1;WNT3;LRP4;PBX2;BAX;FBXW4;TMEM231
8991,GO:0035113,0.492537387697659,0.639370866413534,10,89,embryonic appendage morphogenesis,BP,WNT7A;LRP5;IFT140;FGFR1;WNT3;LRP4;PBX2;BAX;FBXW4;TMEM231
16636,GO:0097499,0.49263970803312,0.871927571761854,1,6,protein localization to non-motile cilium,BP,TUB
3454,GO:0007270,0.492685737421829,0.871900029013916,1,6,neuron-neuron synaptic transmission,BP,TMOD2
7726,GO:0032228,0.492807777848738,0.784542446505528,2,15,regulation of synaptic transmission, GABAergic,BP,NISCH;NLGN2
1408,GO:0003341,0.492853237117444,0.738818620190572,3,25,cilium movement,BP,BBS2;DNAAF5;DNAH1
19828,GO:2000270,0.493013601156786,0.871703731428546,1,6,negative regulation of fibroblast apoptotic process,BP,GAS6
13558,GO:0060033,0.493079635339953,0.871664171712037,1,6,anatomical structure regression,BP,LRP5
9691,GO:0038092,0.493108896172535,0.871646639589721,1,6,nodal signaling pathway,BP,SMAD3
11051,GO:0045056,0.493133991368365,0.784285803158171,2,15,transcytosis,BP,FCGRT;LRP1
8232,GO:0033010,0.493246411463012,0.871564223847533,1,6,paranodal junction,CC,SIRT2
11228,GO:0045410,0.493349559826682,0.871502382058381,1,6,positive regulation of interleukin-6 biosynthetic process,BP,EREG
2342,GO:0005381,0.493797669268624,0.871233494049696,1,6,iron ion transmembrane transporter activity,MF,SLC25A37
11167,GO:0045252,0.493885431138696,0.871180789213653,1,6,oxoglutarate dehydrogenase complex,CC,DHTKD1
5441,GO:0016308,0.493910619293719,0.871165660001633,1,6,1-phosphatidylinositol-4-phosphate 5-kinase activity,MF,PIP5KL1
17431,GO:1900181,0.493923677738655,0.783663828109867,2,15,negative regulation of protein localization to nucleus,BP,LZTS2;GAS6
7679,GO:0032135,0.49407769419517,0.871065277206776,1,6,DNA insertion or deletion binding,MF,XPC
8619,GO:0034145,0.494237721808706,0.870969080319832,1,6,positive regulation of toll-like receptor 4 signaling pathway,BP,PELI1
503,GO:0001561,0.49448707477253,0.870819093360079,1,6,fatty acid alpha-oxidation,BP,PHYH
7637,GO:0032055,0.494620381452516,0.870738861689217,1,6,negative regulation of translation in response to stress,BP,SESN2
7969,GO:0032589,0.494622501182926,0.737864685146935,3,24,neuron projection membrane,CC,KCNC4;MYO1D;INSR
9296,GO:0035745,0.494628543101618,0.870733948466172,1,6,T-helper 2 cell cytokine production,BP,PRKCZ
11386,GO:0045779,0.494676513678545,0.87070506824586,1,6,negative regulation of bone resorption,BP,INPP5D
18252,GO:1903052,0.494767586711897,0.63126261574782,11,99,positive regulation of proteolysis involved in cellular protein catabolic process,BP,EDEM1;DVL1;AKT1;CSNK1E;RAD23A;MAGEF1;TRIB2;STUB1;BCAP31;RNF144A;SIRT2
18223,GO:1903003,0.49478441785277,0.87064009004053,1,6,positive regulation of protein deubiquitination,BP,TNIP1
10245,GO:0042985,0.494869899776156,0.870588598889768,1,6,negative regulation of amyloid precursor protein biosynthetic process,BP,ABCA7
5735,GO:0016881,0.494931388835211,0.782868687929498,2,15,acid-amino acid ligase activity,MF,PPCS;TTLL3
9779,GO:0039706,0.495025279692679,0.870494969194564,1,6,co-receptor binding,MF,HFE
12227,GO:0048505,0.495124227160674,0.870435321610861,1,6,regulation of timing of cell differentiation,BP,SERPINE2
2832,GO:0006304,0.495143248906822,0.643620356638482,9,81,DNA modification,BP,FOS;MPG;MBD3;TDRKH;NEIL1;APOBEC3C;APOBEC3F;DNMT3A;FAM129B
18669,GO:1903975,0.495206515831519,0.870385702509933,1,6,regulation of glial cell migration,BP,IDH2
11078,GO:0045086,0.495261030595069,0.870352823850915,1,6,positive regulation of interleukin-2 biosynthetic process,BP,CARD11
7970,GO:0032590,0.495263783202896,0.782606054791925,2,15,dendrite membrane,CC,KCNC4;INSR
3424,GO:0007216,0.495365140410329,0.870290018404545,1,6,G-protein coupled glutamate receptor signaling pathway,BP,HOMER2
11905,GO:0046951,0.495489259435145,0.87021511597147,1,6,ketone body biosynthetic process,BP,HMGCL
8726,GO:0034383,0.495560889996608,0.736498898943145,3,25,low-density lipoprotein particle clearance,BP,AP2A2;LDLR;PCSK9
3659,GO:0008150,0.495605487848985,0.550541829038057,1192,11291,biological_process,BP,TNIP1;DUSP6;NT5E;XDH;ERCC1;DUSP5;SDK2;MEF2D;GID4;ZMYND8;ADGRL1;H1F0;CITED4;SEMA4B;HTRA1;FHL1;THSD4;EGR1;NR1D1;SLC16A3;H6PD;CCNG2;EDEM1;DLG4;PLAT;CST3;CYP27B1;MRC2;TYSND1;HS1BP3;BTBD2;MARVELD1;FBXO2;APLN;PRR7;PGF;PDCD4;CTNNBIP1;NAGS;KCNG1;ACVR2B;DOCK4;XPC;PRNP;PARVB;PYGB;BBS2;FLNC;SLC6A8;DDIT4L;POSTN;VEGFA;FAM210B;TNFRSF6B;PGM1;WNT7A;APOE;PYGL;DGKA;TSPAN1;ESPN;NAGLU;F2R;LRP5;PLD3;OSBPL5;LPCAT4;ITGA6;ISYNA1;PITPNC1;HMGA2;OBSCN;NDRG1;IDH2;ZKSCAN1;NEK9;CRAT;SLCO4A1;ELK3;ITPR3;PKN1;MTA1;GRAMD4;ACOT7;ARRDC1;ACSF2;EVI5L;NISCH;AKR7A2;FCGRT;EGFR;RPS6KA2;SERPINE2;DNPH1;WWTR1;LOXL1;SCN4B;OBSL1;NOS1;VAT1;PTPRS;TMEM129;SLC2A9;HADH;CTSO;SPRY2;LRP3;CAPN2;MST1R;NFATC4;TRIM65;BAHCC1;CRTAP;LTBP4;PRSS8;SYTL1;SDC1;KLHL29;SH3TC1;ETV5;LMF1;ORAI3;APPL2;SHC1;DDB2;ORAI1;LTBP2;VPS11;LTBP1;TBC1D14;ARL2;HEXB;GTPBP1;SLC7A8;TCFL5;PTPRE;SLC12A7;NPEPL1;SLC2A3;ALDH4A1;TK2;RIN1;ACTA2;MMP1;ETV4;PHLDA2;SNX9;NUDCD3;TRNP1;SPRY4;RAPGEF3;TXNRD3;ST6GALNAC2;ZFP36L1;GAA;GLUL;RNPEPL1;ARAP1;MAP2K2;KDSR;NME4;ZC3H6;LPAR3;MARCH9;CTBS;PLCD3;FKBP9;MDFI;PTOV1;SMARCA1;PPP1R35;CMTM7;RBCK1;SUGCT;PLTP;PGLS;PC;TP53I11;FOXQ1;RNF44;MAP2K1;NAPRT;CRYL1;ACP5;CPT2;NYNRIN;MCTP1;MXD4;SSH1;POU2F2;EXOC2;ENDOG;MARK4;SLC16A5;KCNJ15;MARCKSL1;TMEM8A;GALE;SMURF2;KLC2;TSC22D1;SLC9A3R2;FOS;FBLN1;SMAD3;ARHGAP23;STAT6;SHANK2;PIK3R2;ERCC6;LRP1;GJC2;SRD5A3;DVL1;EPAS1;DNAJB5;PIGQ;HSD17B8;THBS3;HBEGF;FAM110C;RPUSD3;AP2A2;S100A4;ITGB4;CYBRD1;PPP1R14A;SH3PXD2B;PPP2R3B;PRDX5;SHC2;NLGN2;STOM;BRD3;PRODH;SALL2;MBOAT7;CDK18;REEP4;LY6K;FBXW5;PAG1;ZXDC;RNF187;NMRK1;ADORA2B;ADARB1;PLCXD2;D2HGDH;SYT8;SLC6A6;AKT1;TPCN1;GRB7;KCNC4;TMOD2;CORO1B;TTYH3;HDAC5;UROS;FBXO41;FAM83A;NT5DC1;S100A6;F12;SH2D2A;PPM1F;MMP28;PITPNM1;ENTPD6;PLEKHH3;RHBDF2;PYCR2;BSG;STK39;HK1;SERPING1;ASAP2;SCMH1;DYSF;EPHA1;GGT1;PHC2;NFKBIZ;PTPRU;VEGFB;FMNL2;ASH2L;IMPACT;MARCH4;SLC15A4;WWC3;ATG16L2;ZFYVE21;LRRC8A;CNTN1;IFNGR2;BRSK1;DAP;IFT140;PTHLH;MYZAP;MFSD3;RAB31;DNAAF5;FGFR4;HEBP1;PEAR1;WNT2B;POLD4;ACOT1;FNDC4;LDLR;FGFR1;PRKACB;FUCA1;MAPKBP1;ELMO3;SIGMAR1;RAC2;KCNAB2;SMOC2;PFKL;TTLL12;SEC14L2;OPLAH;HLTF;MXI1;PPM1J;NPHP4;SYNE3;RAG1;GAMT;H2AFJ;B4GAT1;PACS2;TOMM34;BPHL;PIGV;KLF7;RALGDS;SORL1;NAT14;CEACAM1;CCNI;B3GAT3;ASB13;CIRBP;CBR4;HMG20B;LZTS2;RAB11FIP4;TENM2;ZNF385A;DOCK6;NSMCE4A;MICALCL;ABCD1;ANK3;NIPSNAP1;IGFBP4;TTC7B;EVC;TSHZ1;TRAPPC9;CCND1;PODNL1;EFS;PCBP4;TCF25;LHPP;TNNT1;TWF2;AIG1;STRADB;SYNGAP1;PLCH2;MAPK13;CEP250;EDNRA;CARD19;PLAU;GAS6;PTK6;SEMA3F;PFKP;FGFBP1;CSNK1E;BRI3;CTSB;CYYR1;RAB3B;CARD11;SH2B3;SOX13;LAMA5;DUSP7;MPLKIP;GSN;CMTM4;PLEKHG2;MAPKAPK3;IGFBP2;PCSK9;ARHGAP22;RAD23A;DHTKD1;PHLDA1;ANO8;BCR;ANTXR2;XPOT;ANGPTL4;MRPS6;EHD4;ERRFI1;GLI4;SEPT10;WIPF1;NADK;PANK4;HLCS;ZSCAN18;PRSS22;AIP;DBNDD1;STON1;CCDC71L;MYEF2;MN1;SH3D19;CCDC113;CDC25B;RGL2;SLITRK6;TSPAN18;PAQR6;ARPIN;TMEM132B;ARHGAP27;ALOX15B;SPTB;SMARCD2;KHNYN;AGAP1;COMTD1;NXPH4;PEX10;CCS;GGACT;RSAD1;COL13A1;CORO7;SLC20A1;RRNAD1;NPR2;UNC119B;SNTA1;DGKQ;HAGH;PLXNB3;BNIP3;PAK6;TFPI2;GTF2IRD1;SHARPIN;MVB12B;SERINC2;TAGLN3;FYCO1;CEMIP;PROCR;PKD2;ACY1;FAM3A;GPX3;PCSK1;RETSAT;YPEL3;RASGEF1A;CTSZ;CDC42EP5;HES2;CRTC1;IL20RB;FBXW8;GPSM1;AP3D1;ITGB5;ABCA2;FAM189B;ZNF598;MAGEF1;PRSS3;SH3PXD2A;C19ORF33;EPOR;EPHB2;GRIN3B;ADAM8;ASIC1;CADM4;APRT;TMEM9;CTBP1;JOSD2;LTA4H;MNT;PTPDC1;GRK6;CDKN1C;PLCG1;FBXL8;ZMIZ2;CBS;KIF17;SH3BP2;NYAP1;CD81;CEBPB;MVD;RNF135;ENTPD2;ADAMTS13;SLC29A4;ZNF217;TIMP2;ZNF862;NUDCD2;SYNJ2;WNT3;DPP7;GNAL;C8ORF88;TMED4;TGFB1;LACTB2;SNPH;CLTCL1;RFX2;SCYL1;ABHD17C;SLC43A1;UNK;ULK2;GPC1;MKNK2;ADAMTS7;DEAF1;MOAP1;TBC1D9B;SLC38A10;NTSR1;B3GNT3;NAB2;TMEM173;ARHGAP25;ZSCAN30;ATP7B;FHOD3;SHANK3;PODXL2;SDHA;MSRB2;EFNB3;RASA3;PNRC1;MIPEP;PIP5KL1;TNFSF15;MYCBPAP;MGAT4B;EML2;KIF26B;MDH2;MPG;GALNS;FBXO17;CLCA2;HEXDC;GOLGA2P5;NSMF;PEG3;ARAP3;SCART1;FARP1;MC1R;TUB;LCE1E;CROCC;RHOD;CGREF1;ABHD14B;LAMB2;TNS1;ABTB1;SNX17;RNH1;DNAH1;ERO1B;ST6GALNAC6;HTR7;VGF;POLL;FBXO44;POLM;PLEKHG4;SNX33;PI4K2A;SEMA4F;PTMS;RHOF;YIPF3;ANKZF1;WASF3;ATG2A;SLC48A1;LLGL1;PHGDH;PHF21A;PLEKHG3;MIF4GD;KIF7;COA5;PLPP6;RHOBTB2;UBXN4;ADAM19;KHDRBS3;SAC3D1;TUBG2;ZER1;GIGYF1;RIMS3;BBS1;TNFAIP8L1;HMGCL;PTPN1;PEX1;TPP1;PCK2;B4GALT2;WDR59;AGRN;MBD3;OLFML2A;IFNE;CD320;CAMK2N1;OSBPL10;LRP4;LRP10;ESYT2;ZDHHC24;GPR153;ACP6;B4GALT6;VHL;DNAJC4;CEP131;TRAP1;IDUA;ADAP1;PFKFB2;RFNG;MLXIPL;YPEL5;TRIB2;PRKCZ;KDM6B;PRKACA;MINK1;ZNF516;CENPH;GRHPR;OXA1L;RHPN1;RABGGTA;RCCD1;TBKBP1;ACTR1B;TOM1L2;CD9;EPN2;ADA;AREG;PIM2;MPI;MICALL2;UCKL1;PLEKHG5;BOK;WDR18;TDRKH;CAPG;SDCCAG8;ALAS1;NEURL1B;ERBB2;ADGRB2;ULK1;CNDP2;NINL;AHCY;VAMP2;CERCAM;PRIMPOL;TMEM143;RTL1;PSMG4;MMP10;TFDP2;SMTN;PLEK2;C6ORF89;NECAB3;STK17A;RILPL1;FAM50A;JAK3;IRF2BP2;RNPEP;NET1;BNIP3L;CYFIP2;FSCN1;PBX2;TRPC1;NELFCD;SLC22A17;RASA4;PDK1;ACAD10;CYGB;ARHGAP44;THOP1;EHBP1L1;MCFD2;PRKCD;FAM20C;MIB2;REEP6;RBL2;CACNB3;USP20;STUB1;IFI6;BAX;CYC1;SV2A;SBF1;DTD1;XYLT2;SLC13A5;TRIM4;ITGA1;OLFM2;ZNF395;HIST3H2BB;NUBP2;PPCS;SH3BP1;FBXW4;GJB4;CHADL;EREG;RPS6KA5;DGUOK;DUSP4;TIMM17B;ZNF524;CUL9;SOX12;TMBIM4;DDIT4;MBTPS2;ACADS;TOP3B;SPRED3;PPL;PPP1R13L;CARF;HSD17B7;AHNAK2;PCSK1N;MT2A;IER2;RASL10B;CES2;NAGA;ZDHHC8;TMX4;FCHO1;NID1;LIMK1;TGFBR3;NTPCR;PDIA5;GDI1;TPM2;PADI3;DIP2A;LTB4R2;CPNE7;SLC2A11;RPL39L;LEMD2;RPS6KA6;ZHX3;DNM1;WASH3P;RGS14;TMEM8B;SCN8A;MFNG;GSTO1;GIT1;ALDOC;CHAD;MRPS26;MSLN;LPCAT1;LRSAM1;ADAM15;REEP2;ASB1;EHD3;WDR60;ST3GAL3;TMEM231;FAHD2B;LONP2;SYMPK;MAPK12;IRAK1;PPOX;TGFA;HDAC7;FHOD1;INPP5D;MTHFR;CHD2;PI4K2B;CBX7;PCMTD2;CHEK2;DECR2;CACFD1;ZFPM1;PPARA;COG7;ABHD15;COQ2;TMEM161A;SESN2;FGGY;ABCG1;MYO1D;JADE2;MYH15;CDC34;RNF123;SNN;PRR15;SOX7;ABCA7;RAB12;SPATA20;EML3;SPEG;SIX5;BCAP31;MIF;ACO2;SMOX;EEF2KMT;KDM4B;SLC25A29;DOPEY2;PHYH;ZNF414;MEX3A;BCAM;SLC9A7;PLA2G6;DDT;SSBP4;SYNGR1;NUDT14;ECM1;NARF;WFS1;QSOX1;DNAAF3;CD68;ZNF444;SLC22A18;DTX3;TRPT1;NBPF3;DALRD3;SPPL2B;HSD11B1L;FYN;PITPNM3;VWA1;UPP1;EFEMP2;STK25;RAC3;ETFB;TMCO6;GLB1L2;EEF2K;CERS4;SUN1;ICAM5;ARHGAP12;ACAP3;ARID5B;HOXC5;DNM2;CKMT1A;CYP3A5;BHLHE40;GLB1;PELI1;ATXN10;SNX15;INF2;CHKA;CAT;BEX2;NEIL1;TSPYL2;KIAA1147;IGFBP7;ELFN2;SLC27A1;ZMYM3;TPBG;APOBEC3C;SATB1;SLC50A1;KIF26A;ASMTL;ZDHHC1;SLC12A4;PLCB3;H1FX;IQSEC1;ZNF606;APOBEC3F;ARHGEF4;DDX50;CYP2R1;TUBB6;MAPK3;INSR;SLC13A3;RTN2;ARHGEF1;PAN2;GRINA;TMEM54;PDZD2;CAMTA2;TAZ;PFKM;ADCY1;TNS4;C12ORF66;RERE;HLA-G;DOCK9;STX10;TSTA3;INO80C;ATP8B2;GPT2;TMEM101;RALGAPA1;MORN4;PDXK;ETAA1;PRAF2;GLRX;BCL7A;CEP72;VANGL2;PAK1;TRIM45;CDYL2;DCAF10;KLHL36;MALL;CAMKK2;RNASET2;PPP3CB;RNF144A;LGALS3BP;ALPK1;CTSF;ROBO4;USP21;PFKFB3;MLYCD;CUL7;SLC37A2;GABBR1;REV1;MICAL1;HYAL1;SEMA4C;CAPRIN2;ZBTB10;WDTC1;HES7;ITGA3;STK32C;DNMT3A;SAMD8;BIN1;VPS16;MAN2B1;SRMS;TSTD1;NSUN7;PPP2R5B;HES6;SLC16A13;MAP2K3;NDST2;BCL2L1;DLG3;SGSM2;ABHD10;NDUFV3;RRAS;DNASE1L1;PROX1;IARS2;LRCH4;MDGA1;TBC1D16;ADGRF1;ALDH7A1;LMNA;ZYG11B;PKD1;KCTD13;TNFRSF25;RABGAP1;SIRT2;FAM129B;CDH4;ITGA4;EDA;UVSSA;GAL3ST4;DCBLD2;NMNAT2;BACH1;NT5C1B;TRIP10;ADCY7;E2F5;ZBTB22;ALG12;LTB4R;MAPRE3;AZIN2;TEP1;RAB28;ZNF704;SERPINB1;ST3GAL2;ICA1;SLC25A37;RAP1GAP2;YDJC;LAMB1;SOCS7;MAP3K10;RGS19;NDE1;GPR3;HSD11B1;PELI3;GTF2IRD2;RAB40B;NGFR;TOLLIP;BCORL1;PDCD6;ATP6V1F;PCLO;ARVCF;CHST14;FAM86B1;ZNF837;RNASE7;PXN;GRB10;TBC1D8;PHYKPL;PLEKHM1;DUSP23;GCH1;MSS51;LURAP1;KIF13B;MAFF;NR2F6;CBX6;TCTN1;NBEAL2;PNMA1;CAMK1;CAMKK1;SLC39A3;EZH1;SIRT3;HFE;TERC;ZNF513;WIPI2;GAS2L1;COL6A1;BTG1;BBS10;ZP3;VPS51;TMCO3;CELSR1;TACC1;MLF2;IL17RE;SEMA3B;SEPT6;CDK11B;PFN2;SLC35F3;SSH3;FGFR3;MFSD10;PPP1R16A;TST;CCDC88C;ST3GAL5;TNRC18;NDRG2;MAN2B2;BLOC1S4;CBLC;ITPKB;PTGR2;SPTLC2;TCEA2;CDC42BPG;PRSS21;ZBTB47;PLAG1;LRP11;DOK4;GSDMA;CLK3;IRF2BPL;TRIM46;DHX32;KDM3A;PM20D2;MEGF6;TMEM187;TBL3;HOMER2;SLC23A2;PKN3;APBA1;TTLL3;DEDD2;PI4KAP2;AK3;SRSF5;CHPF;ADCY6;SLC26A11;LRRK1;AARS;KLHL24;STRN4;SDC2
8431,GO:0033559,0.495714237908106,0.660700968551057,7,63,unsaturated fatty acid metabolic process,BP,ABCD1;ALOX15B;CES2;DECR2;MIF;MAPK3;PTGR2
7392,GO:0031463,0.495752188676036,0.672832246546907,6,52,Cul3-RING ubiquitin ligase complex,CC,KLHL29;KLHL36;KCTD13;BACH1;PDCD6;KLHL24
2936,GO:0006465,0.495824594784284,0.781126289003377,2,16,signal peptide processing,BP,GAS6;SPPL2B
17903,GO:1902176,0.495961729829094,0.781017378607602,2,16,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,AKT1;TRAP1
11767,GO:0046636,0.496071431982066,0.781967175663607,2,15,negative regulation of alpha-beta T cell activation,BP,JAK3;HFE
1045,GO:0002566,0.496089375854595,0.781952969575884,2,15,somatic diversification of immune receptors via somatic mutation,BP,POLL;POLM
16164,GO:0090186,0.496214125634739,0.869777109294325,1,6,regulation of pancreatic juice secretion,BP,STK39
12663,GO:0050879,0.496232962874523,0.735921548723846,3,25,multicellular organismal movement,BP,GAA;TNNT1;GSTO1
12665,GO:0050881,0.496232962874523,0.735921548723846,3,25,musculoskeletal movement,BP,GAA;TNNT1;GSTO1
15545,GO:0071971,0.496285532002734,0.869733908701462,1,6,extracellular exosome assembly,BP,SDC1
18470,GO:1903551,0.496285532002734,0.869733908701462,1,6,regulation of extracellular exosome assembly,BP,SDC1
9274,GO:0035710,0.496302385012047,0.687399609226223,5,43,CD4-positive, alpha-beta T cell activation,BP,STAT6;PRKCZ;JAK3;ZFPM1;SATB1
6062,GO:0019212,0.496325512117602,0.735841994590702,3,25,phosphatase inhibitor activity,MF,PPP1R35;PPP1R14A;ELFN2
3015,GO:0006564,0.496449442883736,0.86963470744569,1,6,L-serine biosynthetic process,BP,PHGDH
15799,GO:0072497,0.496522387807311,0.86959054408833,1,6,mesenchymal stem cell differentiation,BP,WNT3
6746,GO:0030174,0.496777232310503,0.869436175001844,1,6,regulation of DNA-dependent DNA replication initiation,BP,WDR18
3406,GO:0007191,0.496803644818663,0.869420169036883,1,6,adenylate cyclase-activating dopamine receptor signaling pathway,BP,GNAL
4270,GO:0009629,0.496862696230293,0.86938437923851,1,6,response to gravity,BP,FOS
17781,GO:1901800,0.496865681850471,0.635154167546162,10,90,positive regulation of proteasomal protein catabolic process,BP,EDEM1;DVL1;AKT1;CSNK1E;RAD23A;TRIB2;STUB1;BCAP31;RNF144A;SIRT2
568,GO:0001710,0.496914657622183,0.869352881189666,1,6,mesodermal cell fate commitment,BP,FGFR1
4576,GO:0010663,0.497062799974974,0.869263052470951,1,6,positive regulation of striated muscle cell apoptotic process,BP,BNIP3
4579,GO:0010666,0.497062799974974,0.869263052470951,1,6,positive regulation of cardiac muscle cell apoptotic process,BP,BNIP3
9232,GO:0035627,0.497162377365277,0.86920264906559,1,6,ceramide transport,BP,PLTP
9032,GO:0035252,0.497183945661866,0.869189563361393,1,6,UDP-xylosyltransferase activity,MF,XYLT2
9930,GO:0042285,0.497183945661866,0.869189563361393,1,6,xylosyltransferase activity,MF,XYLT2
8615,GO:0034141,0.497198241677154,0.869180889344503,1,6,positive regulation of toll-like receptor 3 signaling pathway,BP,PELI1
17871,GO:1902075,0.497341678145085,0.86909383918337,1,6,cellular response to salt,BP,MAPK13
18646,GO:1903935,0.497383400290395,0.869068511251852,1,6,response to sodium arsenite,BP,MAPK13
18881,GO:1904528,0.497456894494207,0.869023887833686,1,6,positive regulation of microtubule binding,BP,MAPRE3
6638,GO:0023035,0.497475112594527,0.869012824810399,1,6,CD40 signaling pathway,BP,SHARPIN
11756,GO:0046624,0.497596676878951,0.868938988553757,1,6,sphingolipid transporter activity,MF,PLTP
13971,GO:0060693,0.49762637556723,0.868920945854865,1,6,regulation of branching involved in salivary gland morphogenesis,BP,FGFR1
19146,GO:1905097,0.49766089287337,0.86889997366952,1,6,regulation of guanyl-nucleotide exchange factor activity,BP,GPSM1
8060,GO:0032736,0.497883664307782,0.868764567814088,1,6,positive regulation of interleukin-13 production,BP,PRKCZ
4886,GO:0014807,0.497939792570719,0.868730437135374,1,6,regulation of somitogenesis,BP,HES7
4640,GO:0010764,0.497944930554619,0.868727312517687,1,6,negative regulation of fibroblast migration,BP,CYGB
16171,GO:0090193,0.497949877191148,0.868724304219411,1,6,positive regulation of glomerulus development,BP,EGR1
10040,GO:0042500,0.497965692737189,0.86871468569285,1,6,aspartic endopeptidase activity, intramembrane cleaving,MF,SPPL2B
9193,GO:0035581,0.498015699563532,0.868684270006614,1,6,sequestering of extracellular ligand from receptor,BP,LTBP1
11107,GO:0045137,0.498034196549357,0.60714567384501,16,147,development of primary sexual characteristics,BP,ERCC1;CST3;VEGFA;SDC1;WNT2B;CCND1;CEBPB;VGF;BOK;BAX;EREG;ADAM15;ARID5B;INSR;BCL2L1;ZP3
15822,GO:0072528,0.49805904198083,0.705192011495711,4,36,pyrimidine-containing compound biosynthetic process,BP,TK2;NME4;UCKL1;UPP1
15898,GO:0072673,0.498062074583256,0.780388049147175,2,15,lamellipodium morphogenesis,BP,CORO1B;ARPIN
389,GO:0001042,0.498103910015771,0.868630606359784,1,6,RNA polymerase I core binding,MF,ERBB2
15297,GO:0071493,0.498205760033496,0.868568626929306,1,6,cellular response to UV-B,BP,HYAL1
15279,GO:0071468,0.498224649972545,0.86855712959355,1,6,cellular response to acidic pH,BP,IMPACT
13661,GO:0060198,0.498444878348176,0.86842303883309,1,6,clathrin-sculpted vesicle,CC,VAMP2
3422,GO:0007214,0.498500819748894,0.868388963319027,1,6,gamma-aminobutyric acid signaling pathway,BP,GABBR1
12398,GO:0048854,0.498568970993771,0.734475404535994,3,24,brain morphogenesis,BP,BBS2;SHANK2;SHANK3
18808,GO:1904338,0.498603167109464,0.868326605509479,1,6,regulation of dopaminergic neuron differentiation,BP,CSNK1E
13233,GO:0051917,0.498678898541619,0.868280451581451,1,6,regulation of fibrinolysis,BP,F12
13837,GO:0060449,0.498679285397685,0.868280215786643,1,6,bud elongation involved in lung branching,BP,SPRY2
12737,GO:0051014,0.498828369113062,0.868189326525912,1,6,actin filament severing,BP,GSN
11664,GO:0046456,0.499114329634787,0.73291980079855,3,26,icosanoid biosynthetic process,BP,GGT1;LTA4H;MIF
15111,GO:0071203,0.499162839295029,0.867985265074077,1,6,WASH complex,CC,WASH3P
2983,GO:0006531,0.499215219310653,0.86795328893483,1,6,aspartate metabolic process,BP,NMNAT2
3398,GO:0007182,0.499226366986989,0.867946483010131,1,6,common-partner SMAD protein phosphorylation,BP,TGFB1
17537,GO:1901020,0.499305366950218,0.778352598975474,2,16,negative regulation of calcium ion transmembrane transporter activity,BP,PKD2;GSTO1
8502,GO:0033690,0.499308957906125,0.867896052066078,1,6,positive regulation of osteoblast proliferation,BP,LRP5
6080,GO:0019238,0.499335500208413,0.867879842323392,1,6,cyclohydrolase activity,MF,GCH1
18370,GO:1903349,0.499365115604396,0.867861754254305,1,6,omegasome membrane,CC,ULK1
9533,GO:0036289,0.499365338145241,0.867861618326235,1,6,peptidyl-serine autophosphorylation,BP,MAP2K2
19537,GO:1990416,0.499475557008023,0.867794285992531,1,6,cellular response to brain-derived neurotrophic factor stimulus,BP,EEF2K
8730,GO:0034388,0.499608746684802,0.867712890584344,1,6,Pwp2p-containing subcomplex of 90S preribosome,CC,TBL3
10288,GO:0043045,0.499619925714778,0.867706057302438,1,6,DNA methylation involved in embryo development,BP,DNMT3A
17686,GO:1901538,0.499619925714778,0.867706057302438,1,6,changes to DNA methylation involved in embryo development,BP,DNMT3A
17829,GO:1901977,0.499651948901839,0.867686481550907,1,6,negative regulation of cell cycle checkpoint,BP,CHEK2
4092,GO:0009148,0.499666609432067,0.777147546834615,2,17,pyrimidine nucleoside triphosphate biosynthetic process,BP,NME4;UCKL1
5137,GO:0015651,0.499690567250383,0.867662871635852,1,6,quaternary ammonium group transmembrane transporter activity,MF,SLC25A29
12350,GO:0048739,0.499771859246623,0.867613163423729,1,6,cardiac muscle fiber development,BP,VEGFA
8140,GO:0032874,0.499785474356978,0.621268039098199,12,108,positive regulation of stress-activated MAPK cascade,BP,XDH;VEGFA;WNT7A;PKN1;ERCC6;PTPN1;MINK1;STK25;VANGL2;PAK1;SEMA4C;MAP3K10
1393,GO:0003306,0.499795417622172,0.867598755701152,1,6,Wnt signaling pathway involved in heart development,BP,VANGL2
4531,GO:0010604,0.499802285348726,0.530582472806621,236,2219,positive regulation of macromolecule metabolic process,BP,TNIP1;DUSP6;XDH;ERCC1;DUSP5;MEF2D;CITED4;EGR1;NR1D1;EDEM1;DLG4;CST3;APLN;ACVR2B;PRNP;VEGFA;WNT7A;APOE;F2R;LRP5;ITGA6;HMGA2;ELK3;PKN1;MTA1;GRAMD4;EGFR;WWTR1;NOS1;SPRY2;MST1R;NFATC4;ETV5;SHC1;VPS11;HEXB;GTPBP1;ACTA2;ETV4;SNX9;RAPGEF3;ZFP36L1;ARAP1;MAP2K2;LPAR3;SMARCA1;MAP2K1;POU2F2;ENDOG;SMURF2;FOS;FBLN1;SMAD3;STAT6;PIK3R2;ERCC6;LRP1;GJC2;DVL1;EPAS1;HBEGF;SH3PXD2B;SHC2;SALL2;ZXDC;RNF187;ADORA2B;AKT1;HDAC5;F12;PPM1F;STK39;EPHA1;ASH2L;IMPACT;CNTN1;DAP;FGFR4;LDLR;FGFR1;PRKACB;SEC14L2;HLTF;KLF7;SORL1;NAT14;CIRBP;ANK3;IGFBP4;CCND1;STRADB;GAS6;PTK6;CSNK1E;CARD11;DUSP7;GSN;MAPKAPK3;PCSK9;RAD23A;EHD4;SH3D19;CDC25B;DGKQ;PAK6;CEMIP;PKD2;CRTC1;MAGEF1;EPHB2;ADAM8;CTBP1;CDKN1C;PLCG1;ZMIZ2;CD81;CEBPB;TIMP2;WNT3;TGFB1;RFX2;DEAF1;NAB2;TMEM173;TNFSF15;NSMF;PEG3;MC1R;ABHD14B;SNX33;PTPN1;AGRN;IFNE;CAMK2N1;LRP4;VHL;MLXIPL;TRIB2;PRKCZ;KDM6B;PRKACA;MINK1;ZNF516;AREG;PIM2;BOK;ERBB2;TFDP2;C6ORF89;CYFIP2;PBX2;PRKCD;STUB1;BAX;ITGA1;EREG;RPS6KA5;SOX12;MBTPS2;CARF;IER2;LPCAT1;SYMPK;MAPK12;IRAK1;TGFA;FHOD1;CHEK2;ZFPM1;PPARA;TMEM161A;SESN2;SOX7;ABCA7;SIX5;BCAP31;MIF;PLA2G6;DDT;SSBP4;WFS1;FYN;STK25;DNM2;PELI1;SLC27A1;SLC50A1;MAPK3;INSR;CAMTA2;PFKM;ADCY1;RERE;ETAA1;VANGL2;PAK1;CAMKK2;PPP3CB;RNF144A;USP21;SEMA4C;CAPRIN2;ITGA3;PPP2R5B;MAP2K3;DLG3;PROX1;PKD1;KCTD13;TNFRSF25;SIRT2;FAM129B;EDA;BACH1;ADCY7;E2F5;MAPRE3;MAP3K10;NGFR;TOLLIP;PDCD6;MAFF;CAMK1;CAMKK1;EZH1;HFE;ZP3;PFN2;FGFR3;TCEA2;PLAG1;IRF2BPL;KDM3A;SRSF5;ADCY6;LRRK1
19889,GO:2000352,0.499815412974298,0.778991905875522,2,15,negative regulation of endothelial cell apoptotic process,BP,GAS6;ANGPTL4
7131,GO:0030970,0.499820365658781,0.732829189483261,3,25,retrograde protein transport, ER to cytosol,BP,EDEM1;TMEM129;BCAP31
18441,GO:1903513,0.499820365658781,0.732829189483261,3,25,endoplasmic reticulum to cytosol transport,BP,EDEM1;TMEM129;BCAP31
6280,GO:0019887,0.499931428043808,0.605299513916797,16,147,protein kinase regulator activity,MF,SPRY2;MAP2K2;MAP2K1;ERCC6;RAC2;CCND1;PODNL1;GAS6;DGKQ;CDKN1C;TGFB1;CAMK2N1;TRIB2;CHAD;ETAA1;SOCS7
17767,GO:1901724,0.499965519837102,0.86749469459441,1,6,positive regulation of cell proliferation involved in kidney development,BP,EGR1
7638,GO:0032056,0.500305198836874,0.867286731867754,1,6,positive regulation of translation in response to stress,BP,IMPACT
9500,GO:0036152,0.500310582018787,0.778596719330261,2,15,phosphatidylethanolamine acyl-chain remodeling,BP,LPCAT4;PLA2G6
14213,GO:0061162,0.50042333947044,0.778506674247434,2,15,establishment of monopolar cell polarity,BP,FSCN1;SH3BP1
14260,GO:0061339,0.50042333947044,0.778506674247434,2,15,establishment or maintenance of monopolar cell polarity,BP,FSCN1;SH3BP1
22,GO:0000041,0.500482951525208,0.646349102635118,8,74,transition metal ion transport,BP,CCS;ATP7B;TRPC1;DNM2;SLC25A37;ATP6V1F;SLC39A3;HFE
11412,GO:0045836,0.500493270416489,0.867171495341188,1,6,positive regulation of meiotic nuclear division,BP,SIRT2
69,GO:0000145,0.500495537413916,0.778449008153969,2,15,exocyst,CC,EXOC2;SH3BP1
19160,GO:1905153,0.500519128721278,0.86715564608153,1,6,regulation of membrane invagination,BP,ABCA7
14178,GO:0061088,0.500520590227869,0.867154750248234,1,6,regulation of sequestering of zinc ion,BP,AP3D1
3028,GO:0006578,0.5005330425264,0.867147117419336,1,6,amino-acid betaine biosynthetic process,BP,ALDH7A1
17846,GO:1902001,0.500544655757229,0.778409771450698,2,15,fatty acid transmembrane transport,BP,CPT2;AKT1
4887,GO:0014808,0.500614024811033,0.777304751425793,2,16,release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,PRKACA;GSTO1
18442,GO:1903514,0.500614024811033,0.777304751425793,2,16,release of sequestered calcium ion into cytosol by endoplasmic reticulum,BP,PRKACA;GSTO1
3070,GO:0006641,0.500669290278253,0.66807165416564,6,53,triglyceride metabolic process,BP,APOE;LMF1;LDLR;PCSK9;PCK2;CAT
486,GO:0001539,0.500708112245159,0.778279171205884,2,15,cilium or flagellum-dependent cell motility,BP,BBS2;DNAH1
13709,GO:0060285,0.500708112245159,0.778279171205884,2,15,cilium-dependent cell motility,BP,BBS2;DNAH1
1356,GO:0003223,0.500751392038367,0.867013229438225,1,6,ventricular compact myocardium morphogenesis,BP,TGFBR3
4987,GO:0015116,0.500754881424187,0.867011089085577,1,6,sulfate transmembrane transporter activity,MF,SLC26A11
17977,GO:1902358,0.500754881424187,0.867011089085577,1,6,sulfate transmembrane transport,BP,SLC26A11
12159,GO:0048290,0.500775146857476,0.866998658027293,1,6,isotype switching to IgA isotypes,BP,TGFB1
13255,GO:0051953,0.500778986028754,0.866996302945177,1,6,negative regulation of amine transport,BP,STK39
5577,GO:0016594,0.500782533352807,0.866994126868431,1,6,glycine binding,MF,GRIN3B
8290,GO:0033130,0.500788030982219,0.86699075434999,1,6,acetylcholine receptor binding,MF,DLG4
7647,GO:0032074,0.500799789968538,0.866983540613148,1,6,negative regulation of nuclease activity,BP,NEIL1
1532,GO:0003916,0.500944535491415,0.866894722908744,1,6,DNA topoisomerase activity,MF,TOP3B
14819,GO:0070562,0.500962730379754,0.866883555512984,1,6,regulation of vitamin D receptor signaling pathway,BP,CYP27B1
13382,GO:0052695,0.501079034003036,0.866812157702626,1,6,cellular glucuronidation,BP,ABHD10
16824,GO:0098711,0.501152329284597,0.866767149324261,1,6,iron ion import across plasma membrane,BP,HFE
13985,GO:0060710,0.501186007939107,0.866746464916578,1,6,chorio-allantoic fusion,BP,ZFP36L1
6906,GO:0030502,0.501241413798873,0.866712431694903,1,6,negative regulation of bone mineralization,BP,ECM1
2324,GO:0005337,0.501344017739783,0.866649391695913,1,6,nucleoside transmembrane transporter activity,MF,SLC29A4
5237,GO:0015858,0.501344017739783,0.866649391695913,1,6,nucleoside transport,BP,SLC29A4
17731,GO:1901642,0.501344017739783,0.866649391695913,1,6,nucleoside transmembrane transport,BP,SLC29A4
2853,GO:0006346,0.501374055388557,0.777746643830751,2,15,methylation-dependent chromatin silencing,BP,MBD3;DNMT3A
5706,GO:0016835,0.501376740235831,0.667227829461969,6,54,carbon-oxygen lyase activity,MF,HMGA2;UROS;CBS;POLL;ACO2;NEIL1
14900,GO:0070728,0.501433874295756,0.86659416749046,1,6,leucine binding,MF,SESN2
3389,GO:0007171,0.501449955150966,0.866584282888326,1,6,activation of transmembrane receptor protein tyrosine kinase activity,BP,DGKQ
13487,GO:0055062,0.501502793188762,0.866551800918028,1,6,phosphate ion homeostasis,BP,FGFR4
15804,GO:0072505,0.501502793188762,0.866551800918028,1,6,divalent inorganic anion homeostasis,BP,FGFR4
15805,GO:0072506,0.501502793188762,0.866551800918028,1,6,trivalent inorganic anion homeostasis,BP,FGFR4
9937,GO:0042301,0.501568284061966,0.866511533401772,1,6,phosphate ion binding,MF,CHST14
13248,GO:0051938,0.501611191042779,0.866485147379028,1,6,L-glutamate import,BP,NTSR1
16825,GO:0098712,0.501611191042779,0.866485147379028,1,6,L-glutamate import across plasma membrane,BP,NTSR1
17564,GO:1901098,0.501680989650659,0.866442216725369,1,6,positive regulation of autophagosome maturation,BP,FYCO1
2990,GO:0006538,0.501723081639609,0.866416323014502,1,6,glutamate catabolic process,BP,GLUL
3064,GO:0006633,0.50175846668798,0.63029750176243,10,92,fatty acid biosynthetic process,BP,ACOT7;HSD17B8;CEACAM1;CBR4;ALOX15B;MLXIPL;DECR2;MIF;MLYCD;WDTC1
12855,GO:0051185,0.501909864040119,0.866301380021299,1,6,coenzyme transmembrane transporter activity,MF,SLC23A2
19981,GO:2000535,0.501955534883502,0.866273264922452,1,6,regulation of entry of bacterium into host cell,BP,EXOC2
5343,GO:0016081,0.502011480628384,0.866238819220874,1,6,synaptic vesicle docking,BP,SNPH
8162,GO:0032906,0.502057841974684,0.866210270161168,1,6,transforming growth factor beta2 production,BP,SMAD3
8165,GO:0032909,0.502057841974684,0.866210270161168,1,6,regulation of transforming growth factor beta2 production,BP,SMAD3
8068,GO:0032754,0.502074340240446,0.866200109648737,1,6,positive regulation of interleukin-5 production,BP,PRKCZ
9298,GO:0035748,0.502074340240446,0.866200109648402,1,6,myelin sheath abaxonal region,CC,PRKCZ
11374,GO:0045760,0.502105481956864,0.866180929518713,1,6,positive regulation of action potential,BP,ANK3
11064,GO:0045072,0.502261328350773,0.866084916610085,1,6,regulation of interferon-gamma biosynthetic process,BP,ZFPM1
1188,GO:0002834,0.502312902292843,0.866053133189663,1,6,regulation of response to tumor cell,BP,CEACAM1
1191,GO:0002837,0.502312902292843,0.866053133189663,1,6,regulation of immune response to tumor cell,BP,CEACAM1
17399,GO:1900125,0.502362587809251,0.866022508813487,1,6,regulation of hyaluronan biosynthetic process,BP,TGFB1
13049,GO:0051549,0.502451850138547,0.86596747905114,1,6,positive regulation of keratinocyte migration,BP,HBEGF
4136,GO:0009199,0.50247793964905,0.5836570365815,24,239,ribonucleoside triphosphate metabolic process,BP,PGM1;GTPBP1;NME4;HK1;PFKL;PFKP;DHTKD1;NADK;TGFB1;SDHA;PFKFB2;MLXIPL;UCKL1;FAM20C;CYC1;DDIT4;ALDOC;PPARA;INSR;TAZ;PFKM;PFKFB3;NDUFV3;AK3
3117,GO:0006700,0.502517218218112,0.775775935111077,2,16,C21-steroid hormone biosynthetic process,BP,EGR1;DGKQ
18944,GO:1904683,0.502542362972475,0.865911663051399,1,6,regulation of metalloendopeptidase activity,BP,SORL1
14738,GO:0070412,0.50257444056576,0.776784938835831,2,15,R-SMAD binding,MF,FOS;SMAD3
10576,GO:0043546,0.502703851888919,0.865812040376698,1,6,molybdopterin cofactor binding,MF,XDH
15675,GO:0072203,0.502755794896847,0.86577998624526,1,6,cell proliferation involved in metanephros development,BP,EGR1
5578,GO:0016595,0.502769504324119,0.865771525290808,1,6,glutamate binding,MF,GLUL
17102,GO:0099638,0.502804722437161,0.865749788323108,1,6,endosome to plasma membrane protein transport,BP,ARHGAP44
17103,GO:0099639,0.502804722437161,0.865749788323108,1,6,neurotransmitter receptor transport, endosome to plasma membrane,BP,ARHGAP44
13674,GO:0060219,0.502809249858258,0.865746993788142,1,6,camera-type eye photoreceptor cell differentiation,BP,SDK2
6869,GO:0030368,0.502877120440725,0.865705096244023,1,6,interleukin-17 receptor activity,MF,IL17RE
16035,GO:0086067,0.502904666151832,0.865688089376839,1,6,AV node cell to bundle of His cell communication,BP,SCN4B
6369,GO:0021559,0.502914194449481,0.865682206223965,1,6,trigeminal nerve development,BP,SEMA3F
6459,GO:0021785,0.502917138951528,0.865680388137864,1,6,branchiomotor neuron axon guidance,BP,SEMA3F
12390,GO:0048842,0.502917138951528,0.865680388137864,1,6,positive regulation of axon extension involved in axon guidance,BP,VEGFA
14339,GO:0061549,0.502917138951528,0.865680388138032,1,6,sympathetic ganglion development,BP,SEMA3F
14239,GO:0061299,0.502917138951528,0.865680388137696,1,6,retina vasculature morphogenesis in camera-type eye,BP,LRP5
16182,GO:0090205,0.50293769564887,0.865667694916447,1,6,positive regulation of cholesterol metabolic process,BP,ABCG1
599,GO:0001767,0.503001069241992,0.865628558365163,1,6,establishment of lymphocyte polarity,BP,GSN
16925,GO:0098903,0.503006381349594,0.865625277514416,1,6,regulation of membrane repolarization during action potential,BP,CACNB3
9833,GO:0042074,0.503014069258486,0.865620529235059,1,6,cell migration involved in gastrulation,BP,LRP5
8501,GO:0033689,0.503014669305223,0.865620158627968,1,6,negative regulation of osteoblast proliferation,BP,SMAD3
4443,GO:0010359,0.503016401589875,0.865619088698057,1,6,regulation of anion channel activity,BP,PRNP
7575,GO:0031946,0.503017155568051,0.86561862300605,1,6,regulation of glucocorticoid biosynthetic process,BP,DGKQ
7937,GO:0032534,0.503017832299645,0.8656182050288,1,6,regulation of microvillus assembly,BP,FSCN1
15568,GO:0072033,0.503017977034488,0.865618115633028,1,6,renal vesicle formation,BP,KIF26B
3377,GO:0007158,0.503017977034488,0.865618115633028,1,6,neuron cell-cell adhesion,BP,NLGN2
3627,GO:0008091,0.503017977034488,0.865618115633028,1,6,spectrin,CC,SPTB
4516,GO:0010571,0.503017977034488,0.86561811562934,1,6,positive regulation of nuclear cell cycle DNA replication,BP,FGFR1
6499,GO:0021873,0.503017977034488,0.865618115633028,1,6,forebrain neuroblast division,BP,FGFR1
10222,GO:0042908,0.503017977034488,0.865618115633028,1,6,xenobiotic transport,BP,SLC6A6
10223,GO:0042910,0.503017977034488,0.865618115633028,1,6,xenobiotic transmembrane transporter activity,MF,SLC6A6
15705,GO:0072257,0.503017977034488,0.865618115633196,1,6,metanephric nephron tubule epithelial cell differentiation,BP,WWTR1
15729,GO:0072307,0.503017977034488,0.865618115633196,1,6,regulation of metanephric nephron tubule epithelial cell differentiation,BP,WWTR1
18205,GO:1902965,0.503017977034488,0.865618115633364,1,6,regulation of protein localization to early endosome,BP,SORL1
18206,GO:1902966,0.503017977034488,0.865618115633364,1,6,positive regulation of protein localization to early endosome,BP,SORL1
5640,GO:0016725,0.50301797704172,0.865618115625796,1,6,oxidoreductase activity, acting on CH or CH2 groups,MF,XDH
8949,GO:0035014,0.50301797704172,0.865618115625796,1,6,phosphatidylinositol 3-kinase regulator activity,MF,PIK3R2
16529,GO:0097264,0.50301797704172,0.865618115626132,1,6,self proteolysis,BP,TENM2
17637,GO:1901339,0.50301797704172,0.865618115625796,1,6,regulation of store-operated calcium channel activity,BP,PLA2G6
7199,GO:0031095,0.50301797704172,0.865618115626132,1,6,platelet dense tubular network membrane,CC,ITPR3
14000,GO:0060732,0.50301797704172,0.86561811562563,1,6,positive regulation of inositol phosphate biosynthetic process,BP,NTSR1
17089,GO:0099612,0.50301797704172,0.865618115626132,1,6,protein localization to axon,BP,TRIM46
8647,GO:0034204,0.503068390853134,0.776388528223609,2,15,lipid translocation,BP,ABCA7;ATP8B2
17311,GO:0140104,0.503081183936759,0.728996822208605,3,27,molecular carrier activity,MF,CCS;CYGB;TMCO6
5859,GO:0017158,0.503350597406694,0.680933547730929,5,43,regulation of calcium ion-dependent exocytosis,BP,SYTL1;SYT8;RIMS3;ZP3;PFN2
6536,GO:0021953,0.503943027406971,0.62836919920822,10,90,central nervous system neuron differentiation,BP,WNT7A;ADARB1;CSNK1E;EPHB2;WNT3;SHANK3;RAC3;PROX1;MDGA1;TCTN1
2099,GO:0004865,0.504286879475591,0.861709914408551,1,7,protein serine/threonine phosphatase inhibitor activity,MF,PPP1R14A
19687,GO:1990939,0.504886064797655,0.699718521000281,4,34,ATP-dependent microtubule motor activity,MF,KIF17;DNAH1;KIF7;WDR60
4384,GO:0010039,0.505046942430039,0.72829187140021,3,25,response to iron ion,BP,CYBRD1;CCND1;HFE
6691,GO:0030091,0.505120880753293,0.861181869296997,1,7,protein repair,BP,MSRB2
908,GO:0002292,0.505980407928137,0.698728869268065,4,34,T cell differentiation involved in immune response,BP,STAT6;PRKCZ;JAK3;ZFPM1
11288,GO:0045616,0.506477710404479,0.698278650176972,4,34,regulation of keratinocyte differentiation,BP,CYP27B1;ZFP36L1;ERRFI1;ALOX15B
3698,GO:0008210,0.506770596380793,0.772338075020214,2,16,estrogen metabolic process,BP,HSD17B8;HSD17B7
17883,GO:1902108,0.506911109974861,0.662048348236764,6,54,regulation of mitochondrial membrane permeability involved in apoptotic process,BP,BNIP3;MOAP1;BOK;TFDP2;BNIP3L;BAX
8706,GO:0034361,0.507260655344539,0.859820980328499,1,7,very-low-density lipoprotein particle,CC,APOE
8728,GO:0034385,0.507260655344539,0.859820980328499,1,7,triglyceride-rich plasma lipoprotein particle,CC,APOE
7097,GO:0030900,0.508038075565782,0.576868452033401,25,230,forebrain development,BP,BBS2;WNT7A;EGFR;PTPRS;LRP1;MBOAT7;WNT2B;FGFR1;TRAPPC9;BNIP3;EPHB2;SHANK3;KDM6B;BAX;MYO1D;FYN;RAC3;SUN1;PROX1;LAMB1;SOCS7;NDE1;TCTN1;EZH1;TACC1
626,GO:0001816,0.50900621948774,0.552924109651994,48,452,cytokine production,BP,EGR1;PDCD4;PRNP;POSTN;F2R;PTPRS;NFATC4;ACP5;SMAD3;STAT6;ADORA2B;HK1;FGFR1;MAPKBP1;CEACAM1;MAPK13;GAS6;CARD11;ERRFI1;ALOX15B;IL20RB;ADAM8;CEBPB;RNF135;TGFB1;TMEM173;MC1R;TRIB2;PRKCZ;JAK3;PRKCD;EREG;RPS6KA5;ASB1;IRAK1;HDAC7;INPP5D;ZFPM1;MIF;DDT;PELI1;MAPK3;HLA-G;MAP2K3;LURAP1;HFE;ZP3;NDRG2
11926,GO:0046982,0.509059707669713,0.562762371375229,35,351,protein heterodimerization activity,MF,MEF2D;PGF;VEGFA;EGFR;CAPN2;HEXB;FOS;SMAD3;PIK3R2;EPAS1;VEGFB;H2AFJ;HMG20B;TENM2;BNIP3;CEBPB;TGFB1;NTSR1;MLXIPL;RABGGTA;BOK;ERBB2;BNIP3L;BAX;HIST3H2BB;LIMK1;TPM2;ZHX3;IRAK1;ABCG1;BHLHE40;RALGAPA1;ITGA3;BCL2L1;HOMER2
554,GO:0001676,0.509237703203157,0.647941794985052,7,63,long-chain fatty acid metabolic process,BP,ACOT7;ACOT1;ABCD1;AIG1;ALOX15B;SLC27A1;MAPK3
9404,GO:0035967,0.509548771448186,0.595904737027231,16,147,cellular response to topologically incorrect protein,BP,EDEM1;SHC1;CCND1;ANKZF1;PTPN1;TPP1;BOK;STUB1;BAX;MBTPS2;PDIA5;WFS1;TSPYL2;CUL7;PPP2R5B;LMNA
5867,GO:0017176,0.509698157548391,0.858260000963366,1,7,phosphatidylinositol N-acetylglucosaminyltransferase activity,MF,PIGQ
6058,GO:0019208,0.510127599596434,0.637389971347482,8,72,phosphatase regulator activity,MF,PPP1R35;PPP1R14A;PPP2R3B;B3GAT3;SBF1;ELFN2;PPP2R5B;PPP1R16A
15170,GO:0071310,0.510934290896578,0.522141693368416,191,1806,cellular response to organic substance,BP,TNIP1;DUSP6;XDH;HTRA1;EGR1;NR1D1;EDEM1;CYP27B1;APLN;PGF;PDCD4;ACVR2B;PRNP;BBS2;POSTN;VEGFA;FAM210B;TNFRSF6B;WNT7A;LRP5;ITGA6;EGFR;NOS1;SPRY2;CAPN2;MST1R;NFATC4;LTBP4;SDC1;SHC1;LTBP2;LTBP1;PTPRE;MMP1;SPRY4;RAPGEF3;ZFP36L1;MAP2K2;RBCK1;MAP2K1;SSH1;ENDOG;SMURF2;FOS;SMAD3;STAT6;PIK3R2;LRP1;AKT1;CORO1B;HDAC5;UROS;IMPACT;IFNGR2;RAB31;FGFR4;LDLR;FGFR1;PRKACB;CEACAM1;CCND1;PODNL1;TWF2;MAPK13;GAS6;PTK6;PFKP;FGFBP1;CTSB;LAMA5;GSN;IGFBP2;PCSK9;BCR;EHD4;ERRFI1;AIP;PAQR6;NPR2;SHARPIN;PKD2;IL20RB;ITGB5;EPOR;APRT;CDKN1C;PLCG1;CEBPB;ADAMTS13;WNT3;TGFB1;RFX2;GPC1;ADAMTS7;TMEM173;TNFSF15;NSMF;ANKZF1;PTPN1;TPP1;PCK2;AGRN;IFNE;LRP4;MLXIPL;PRKCZ;PRKACA;EPN2;BOK;ERBB2;VAMP2;JAK3;CYFIP2;FSCN1;PRKCD;FAM20C;STUB1;IFI6;BAX;EREG;RPS6KA5;DDIT4;MBTPS2;MT2A;TGFBR3;PDIA5;LEMD2;GSTO1;CHAD;MAPK12;IRAK1;INPP5D;CHEK2;PPARA;SESN2;CDC34;RAB12;MIF;PLA2G6;SYNGR1;ECM1;WFS1;CD68;SPPL2B;FYN;EEF2K;ARID5B;DNM2;PELI1;CAT;TSPYL2;IGFBP7;SLC27A1;MAPK3;INSR;ADCY1;HLA-G;PAK1;PPP3CB;CUL7;HYAL1;WDTC1;ITGA3;DNMT3A;PPP2R5B;MAP2K3;BCL2L1;LMNA;TNFRSF25;SIRT2;FAM129B;ITGA4;EDA;ADCY7;SOCS7;PELI3;NGFR;TOLLIP;PDCD6;ATP6V1F;PXN;GRB10;NR2F6;HFE;GAS2L1;COL6A1;IL17RE;FGFR3;KDM3A;SRSF5;ADCY6
10267,GO:0043015,0.510967571559494,0.723105935319233,3,25,gamma-tubulin binding,MF,NDRG1;MARK4;BRSK1
14183,GO:0061099,0.511104220181162,0.722985662693817,3,25,negative regulation of protein tyrosine kinase activity,BP,PTK6;ERRFI1;CBLC
7491,GO:0031669,0.511367595873844,0.588275879723501,18,165,cellular response to nutrient levels,BP,CYP27B1;POSTN;GLUL;SSH1;IMPACT;DAP;WNT2B;GAS6;PCSK9;WDR59;ULK1;SESN2;FYN;UPP1;MAPK3;C12ORF66;HFE;GAS2L1
15485,GO:0071855,0.51197163494701,0.856793701642197,1,7,neuropeptide receptor binding,MF,APLN
1477,GO:0003746,0.511993845505847,0.768076063387594,2,16,translation elongation factor activity,MF,GTPBP1;ABTB1
6070,GO:0019221,0.512012922771833,0.545953220794024,55,532,cytokine-mediated signaling pathway,BP,EGR1;PDCD4;BBS2;VEGFA;TNFRSF6B;MST1R;SDC1;SHC1;MMP1;RBCK1;FOS;STAT6;AKT1;IFNGR2;CEACAM1;CCND1;PODNL1;GAS6;LAMA5;AIP;SHARPIN;IL20RB;EPOR;TGFB1;TNFSF15;PTPN1;IFNE;PRKACA;JAK3;FSCN1;PRKCD;IFI6;EREG;RPS6KA5;MT2A;GSTO1;CHAD;IRAK1;INPP5D;MIF;ECM1;SPPL2B;FYN;PELI1;SLC27A1;MAPK3;HLA-G;BCL2L1;TNFRSF25;EDA;SOCS7;PELI3;NGFR;TOLLIP;IL17RE
2863,GO:0006359,0.512114457333591,0.722095677180115,3,25,regulation of transcription by RNA polymerase III,BP,PRDX5;NAB2;ERBB2
7470,GO:0031641,0.51275117098174,0.721534014997203,3,25,regulation of myelination,BP,AKT1;WASF3;SIRT2
3327,GO:0007041,0.513195847508323,0.619436619026393,10,90,lysosomal transport,BP,VPS11;SORL1;PCSK9;AP3D1;WASH3P;EHD3;RAB12;BIN1;VPS16;VPS51
2368,GO:0005496,0.513271938377584,0.656056073623982,6,54,steroid binding,MF,APOE;OSBPL5;PAQR6;OSBPL10;ABCG1;HSD11B1
14682,GO:0070304,0.513435963137603,0.607958521648875,12,109,positive regulation of stress-activated protein kinase signaling cascade,BP,XDH;VEGFA;WNT7A;PKN1;ERCC6;PTPN1;MINK1;STK25;VANGL2;PAK1;SEMA4C;MAP3K10
5049,GO:0015238,0.51346930093965,0.644063148420316,7,62,drug transmembrane transporter activity,MF,SLC6A8;SLC15A4;SLC13A5;SLC25A29;SLC22A18;SLC13A3;MFSD10
10818,GO:0044319,0.513799771842501,0.720607770040579,3,25,wound healing, spreading of cells,BP,WNT7A;HBEGF;CEACAM1
16319,GO:0090505,0.513799771842501,0.720607770040579,3,25,epiboly involved in wound healing,BP,WNT7A;HBEGF;CEACAM1
15186,GO:0071333,0.514131698693487,0.625135037710347,9,84,cellular response to glucose stimulus,BP,NR1D1;LRP5;ENDOG;GAS6;PCK2;MLXIPL;PRKACA;PLA2G6;PPP3CB
1118,GO:0002706,0.514297324188924,0.633269337533949,8,73,regulation of lymphocyte mediated immunity,BP,STAT6;CEACAM1;IL20RB;TGFB1;PRKCZ;PPP3CB;HFE;ZP3
16836,GO:0098739,0.514613652831314,0.670484567667565,5,43,import across plasma membrane,BP,PRNP;NTSR1;SLC9A7;FYN;HFE
15163,GO:0071294,0.514654805094461,0.852636001889293,1,8,cellular response to zinc ion,BP,MT2A
16818,GO:0098693,0.514693550142551,0.690796055240804,4,34,regulation of synaptic vesicle cycle,BP,NLGN2;RIMS3;DNM1;PFN2
15289,GO:0071480,0.514710681088157,0.719265394500547,3,26,cellular response to gamma radiation,BP,EGR1;CHEK2;BCL2L1
3683,GO:0008191,0.51474980332168,0.854988240477919,1,7,metalloendopeptidase inhibitor activity,MF,TIMP2
4061,GO:0009112,0.514973407050571,0.690185450614288,4,35,nucleobase metabolic process,BP,XDH;APRT;ADA;UCKL1
10519,GO:0043457,0.515120701455378,0.765503281085459,2,16,regulation of cellular respiration,BP,BNIP3;TRAP1
15428,GO:0071706,0.515279631342556,0.632207600789257,8,74,tumor necrosis factor superfamily cytokine production,BP,NFATC4;ACP5;GAS6;ERRFI1;ADAM8;MC1R;MIF;DDT
14215,GO:0061178,0.515331206348577,0.689524071776888,4,36,regulation of insulin secretion involved in cellular response to glucose stimulus,BP,NR1D1;LRP5;PLA2G6;PPP3CB
5379,GO:0016197,0.515332513553631,0.581726690011351,19,176,endosomal transport,BP,TBC1D14;SNX9;ZFYVE21;SORL1;RAB11FIP4;EHD4;MVB12B;AP3D1;CLTCL1;SNX17;SNX33;MICALL2;ARHGAP44;WASH3P;EHD3;STX10;VPS16;SGSM2;VPS51
3133,GO:0006729,0.515738230663657,0.854342246557279,1,7,tetrahydrobiopterin biosynthetic process,BP,GCH1
11574,GO:0046146,0.515738230663657,0.854342246557279,1,7,tetrahydrobiopterin metabolic process,BP,GCH1
6143,GO:0019430,0.516693854614341,0.763245435611186,2,17,removal of superoxide radicals,BP,CCS;GCH1
4141,GO:0009204,0.516900184595023,0.853580390609519,1,7,deoxyribonucleoside triphosphate catabolic process,BP,ADA
8312,GO:0033158,0.517099406689919,0.763866888282074,2,16,regulation of protein import into nucleus, translocation,BP,GAS6;TMEM173
16492,GO:0097191,0.517220402303314,0.582368048062701,18,169,extrinsic apoptotic signaling pathway,BP,ITGA6;RBCK1;SMAD3;AKT1;FGFR1;STRADB;TGFB1;MKNK2;MOAP1;BOK;IFI6;BAX;FYN;BCL2L1;LMNA;PELI3;FGFR3;DEDD2
7418,GO:0031526,0.517258341744443,0.717541748051779,3,25,brush border membrane,CC,SHANK2;CYBRD1;MFSD10
8936,GO:0034976,0.5174868047569,0.56585731656465,26,242,response to endoplasmic reticulum stress,BP,EDEM1;FBXO2;TMEM129;SHC1;PIK3R2;CCND1;CEBPB;ANKZF1;UBXN4;PTPN1;TPP1;BOK;STUB1;BAX;MBTPS2;TMX4;PDIA5;SESN2;BCAP31;PLA2G6;WFS1;TSPYL2;GRINA;CUL7;PPP2R5B;LMNA
4394,GO:0010092,0.518269370593665,0.762896285407226,2,16,specification of animal organ identity,BP,WNT2B;FGFR1
12645,GO:0050858,0.518646582720056,0.762582867346972,2,16,negative regulation of antigen receptor-mediated signaling pathway,BP,PRNP;CEACAM1
19787,GO:2000181,0.518876260115954,0.638890886089104,7,62,negative regulation of blood vessel morphogenesis,BP,XDH;SPRY2;HDAC5;EPN2;ADGRB2;FAM129B;NGFR
10617,GO:0043620,0.518903592860412,0.607410274394932,11,106,regulation of DNA-templated transcription in response to stress,BP,EGR1;VEGFA;EPAS1;IMPACT;CEBPB;VHL;MBTPS2;RGS14;SESN2;SIRT2;BACH1
13637,GO:0060155,0.519338072751363,0.85197330046631,1,7,platelet dense granule organization,BP,F2R
10032,GO:0042490,0.519423803286568,0.686092677608068,4,35,mechanoreceptor differentiation,BP,NAGLU;FGFR1;SLITRK6;VANGL2
10881,GO:0044429,0.519461104592594,0.527477908965783,86,851,mitochondrial part,CC,CYP27B1;NAGS;FAM210B;IDH2;CRAT;GRAMD4;ACSF2;VAT1;HADH;SHC1;ARL2;ALDH4A1;TK2;NME4;PC;CPT2;ARMCX2;HSD17B8;RPUSD3;PRDX5;PRODH;D2HGDH;PYCR2;HK1;TOMM34;BPHL;CBR4;NIPSNAP1;CARD19;DHTKD1;MRPS6;HAGH;BNIP3;LACTB2;SNPH;MOAP1;TMEM173;SDHA;MIPEP;MDH2;MPG;ANKZF1;HMGCL;PCK2;ACP6;TRAP1;OXA1L;BOK;ALAS1;ULK1;PRIMPOL;BNIP3L;PDK1;ACAD10;THOP1;BAX;CYC1;DGUOK;TIMM17B;ACADS;DNM1;MRPS26;PPOX;COQ2;SNN;ACO2;SLC25A29;ETFB;DNM2;CKMT1A;CAT;ARMCX1;TAZ;GPT2;MLYCD;BCL2L1;ABHD10;NDUFV3;IARS2;ALDH7A1;SLC25A37;PHYKPL;SIRT3;TST;AK3;CHPF
3498,GO:0007405,0.519634502201521,0.686255358343528,4,34,neuroblast proliferation,BP,VEGFA;FGFR1;TGFB1;NDE1
9686,GO:0038084,0.519713399694707,0.761695194613931,2,16,vascular endothelial growth factor signaling pathway,BP,XDH;VEGFA
9605,GO:0036473,0.520136115548104,0.637383834572412,7,64,cell death in response to oxidative stress,BP,ENDOG;PRODH;AKT1;TRAP1;PDK1;PRKCD;STK25
3744,GO:0008286,0.52038151597859,0.606316723078025,11,101,insulin receptor signaling pathway,BP,SHC1;PTPRE;PIK3R2;AKT1;PTPN1;PRKCZ;PRKCD;INSR;SOCS7;ATP6V1F;GRB10
7108,GO:0030915,0.520614222557811,0.851127357609759,1,7,Smc5-Smc6 complex,CC,NSMCE4A
17213,GO:0106068,0.520614222557811,0.851127357609759,1,7,SUMO ligase complex,CC,NSMCE4A
4946,GO:0014912,0.520679008457806,0.760890107523062,2,16,negative regulation of smooth muscle cell migration,BP,LRP1;CORO1B
1611,GO:0004033,0.520897709745262,0.759740010863055,2,17,aldo-keto reductase (NADP) activity,MF,AKR7A2;KCNAB2
7702,GO:0032196,0.5216553220557,0.760074520560476,2,16,transposition,BP,APOBEC3C;APOBEC3F
15684,GO:0072215,0.521821313274309,0.759935698161742,2,16,regulation of metanephros development,BP,EGR1;WWTR1
13733,GO:0060316,0.522070597131459,0.850157994614657,1,7,positive regulation of ryanodine-sensitive calcium-release channel activity,BP,GSTO1
11408,GO:0045830,0.522752355044552,0.759156195622952,2,16,positive regulation of isotype switching,BP,STAT6;TGFB1
12591,GO:0050776,0.522792053176822,0.53246789736331,61,579,regulation of immune response,BP,TNIP1;NR1D1;PRNP;PKN1;FCGRT;PTPRS;SHC1;RBCK1;FOS;SMAD3;STAT6;PIK3R2;PAG1;ADORA2B;HK1;SERPING1;IFNGR2;PRKACB;RAC2;CEACAM1;CTSB;CARD11;MAPKAPK3;BCR;WIPF1;FAM3A;IL20RB;ADAM8;PLCG1;CD81;RNF135;TGFB1;TMEM173;PTPN1;PRKCZ;PRKACA;ADA;JAK3;CYFIP2;PRKCD;CACNB3;BAX;EREG;RPS6KA5;LIMK1;IRAK1;INPP5D;MIF;PLA2G6;ECM1;SPPL2B;FYN;ICAM5;PELI1;MAPK3;HLA-G;PAK1;PPP3CB;ITGA4;HFE;ZP3
8835,GO:0034637,0.522926937459678,0.634845307268989,7,63,cellular carbohydrate biosynthetic process,BP,NR1D1;PGM1;ISYNA1;AKT1;B3GNT3;PCK2;INSR
12764,GO:0051048,0.523793806023626,0.597620238688167,12,112,negative regulation of secretion,BP,F2R;IDH2;HADH;RHBDF2;STK39;MAPKBP1;PFKL;CEACAM1;GAS6;BCR;ASIC1;ADA
5711,GO:0016842,0.523843828674452,0.848972024705936,1,7,amidine-lyase activity,MF,GGACT
12129,GO:0048240,0.524048809955188,0.848834524254103,1,7,sperm capacitation,BP,PRKACA
18348,GO:1903299,0.524067794937565,0.848821784967573,1,7,regulation of hexokinase activity,BP,PFKFB2
8681,GO:0034311,0.524099910055216,0.757050142693717,2,17,diol metabolic process,BP,GCH1;SPTLC2
13564,GO:0060042,0.52415184755155,0.711379980721229,3,25,retina morphogenesis in camera-type eye,BP,SDK2;LRP5;PROX1
10959,GO:0044728,0.524667692844606,0.633166776274924,7,63,DNA methylation or demethylation,BP,FOS;MBD3;TDRKH;APOBEC3C;APOBEC3F;DNMT3A;FAM129B
16426,GO:0097066,0.524868138642425,0.75737940815121,2,16,response to thyroid hormone,BP,CTSB;GAS2L1
9892,GO:0042181,0.52490716336756,0.710153240186698,3,26,ketone biosynthetic process,BP,EGR1;DGKQ;COQ2
8148,GO:0032885,0.525384503418405,0.710271020798744,3,25,regulation of polysaccharide biosynthetic process,BP,AKT1;TGFB1;INSR
17545,GO:1901033,0.525477636237429,0.847873735455444,1,7,positive regulation of response to reactive oxygen species,BP,ENDOG
365,GO:0000987,0.525480525728013,0.549956552407275,32,295,proximal promoter sequence-specific DNA binding,MF,MEF2D;NR1D1;HMGA2;ELK3;NFATC4;TCFL5;ETV4;FOXQ1;POU2F2;FOS;SMAD3;STAT6;HLTF;KLF7;MYEF2;SMARCD2;HES2;CEBPB;ZNF217;RFX2;MBD3;MLXIPL;KDM6B;ZNF516;ZNF395;CARF;ZFPM1;PPARA;SIX5;SSBP4;BHLHE40;PLAG1
2974,GO:0006520,0.52552137457833,0.553440126249899,29,277,cellular amino acid metabolic process,BP,NAGS;SLC6A8;NOS1;CRTAP;SLC7A8;ALDH4A1;GLUL;PRODH;SLC6A6;PYCR2;GGT1;GAMT;BPHL;ACY1;CBS;ERO1B;PHGDH;HMGCL;AHCY;MTHFR;DALRD3;CKMT1A;GPT2;IARS2;ALDH7A1;NMNAT2;AZIN2;PHYKPL;AARS
7318,GO:0031334,0.525602546022318,0.566868246812176,21,197,positive regulation of protein complex assembly,BP,ERCC1;VEGFA;DDB2;ARL2;MMP1;SNX9;CORO1B;RAC2;GSN;WIPF1;ARPIN;CDC42EP5;TGFB1;FSCN1;STUB1;BAX;WASH3P;RAC3;PAK1;PPP2R5B;PFN2
94,GO:0000185,0.525619224152436,0.756746864218965,2,16,activation of MAPKKK activity,BP,MINK1;STK25
13236,GO:0051920,0.525625711581657,0.845257477352653,1,8,peroxiredoxin activity,MF,PRDX5
9318,GO:0035794,0.52576478805624,0.64398069673849,6,55,positive regulation of mitochondrial membrane permeability,BP,BNIP3;MOAP1;BOK;TFDP2;BNIP3L;BAX
19358,GO:1905710,0.52576478805624,0.64398069673849,6,55,positive regulation of membrane permeability,BP,BNIP3;MOAP1;BOK;TFDP2;BNIP3L;BAX
13903,GO:0060571,0.52581529630339,0.756581582113155,2,16,morphogenesis of an epithelial fold,BP,EGFR;WNT2B
4243,GO:0009445,0.525984343302222,0.847532024921507,1,7,putrescine metabolic process,BP,AZIN2
32,GO:0000060,0.526187466043241,0.67948533691946,4,36,protein import into nucleus, translocation,BP,AKT1;GAS6;TGFB1;TMEM173
15301,GO:0071498,0.526416981744849,0.75607397980834,2,16,cellular response to fluid shear stress,BP,TFPI2;PKD2
5355,GO:0016126,0.526941974840433,0.630821766708836,7,64,sterol biosynthetic process,BP,APOE;SEC14L2;MVD;PLPP6;MBTPS2;HSD17B7;ABCG1
19465,GO:1990126,0.527022198966205,0.755562785622386,2,16,retrograde transport, endosome to plasma membrane,BP,SNX17;ARHGAP44
6231,GO:0019784,0.527174523884078,0.84672736481166,1,7,NEDD8-specific protease activity,MF,USP21
11466,GO:0045933,0.527221458308106,0.708064412160325,3,26,positive regulation of muscle contraction,BP,F2R;ADA;GSTO1
3867,GO:0008494,0.52726450012396,0.846666417395523,1,7,translation activator activity,MF,MIF4GD
6292,GO:0019905,0.527401660757379,0.630524513725139,7,63,syntaxin binding,MF,SYTL1;VPS11;SYT8;SNPH;LLGL1;VAMP2;STX10
19763,GO:2000134,0.527403949756539,0.60532307205422,10,93,negative regulation of G1/S transition of mitotic cell cycle,BP,FHL1;GJC2;ZNF385A;CCND1;PCBP4;PKD2;TFDP2;RBL2;BAX;CHEK2
4622,GO:0010744,0.528019145065131,0.846154598429358,1,7,positive regulation of macrophage derived foam cell differentiation,BP,ALOX15B
19697,GO:2000001,0.528466863411249,0.754340069591042,2,16,regulation of DNA damage checkpoint,BP,CHEK2;ETAA1
16544,GO:0097300,0.528767657741762,0.677077535115792,4,36,programmed necrotic cell death,BP,PYGL;RBCK1;BOK;BAX
16109,GO:0090092,0.529108614678042,0.579929688102768,15,139,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,HTRA1;ACVR2B;WWTR1;LTBP4;LTBP1;SMURF2;SMAD3;CDKN1C;TGFB1;STUB1;TGFBR3;LEMD2;DNM2;ITGA3;HFE
14548,GO:0070076,0.529125788906338,0.706891817968018,3,25,histone lysine demethylation,BP,KDM6B;KDM4B;KDM3A
8062,GO:0032740,0.529202686848349,0.845349571834114,1,7,positive regulation of interleukin-17 production,BP,TGFB1
15235,GO:0071398,0.529336009780104,0.676887153940134,4,35,cellular response to fatty acid,BP,NFATC4;AKT1;LDLR;ADCY6
2571,GO:0005859,0.52937062993279,0.845235109720673,1,7,muscle myosin complex,CC,OBSL1
2403,GO:0005575,0.529448198526218,0.53898019017677,1242,11768,cellular_component,CC,TNIP1;DUSP6;NT5E;XDH;ERCC1;DUSP5;SDK2;MEF2D;ZMYND8;ADGRL1;H1F0;CITED4;SEMA4B;HTRA1;FHL1;THSD4;EGR1;B4GALNT4;NR1D1;SLC16A3;H6PD;CCNG2;EDEM1;DLG4;PLAT;CST3;CYP27B1;MRC2;TYSND1;HS1BP3;BTBD2;MARVELD1;EPN3;FBXO2;APLN;PRR7;PGF;PDCD4;CTNNBIP1;NAGS;KCNG1;ACVR2B;DOCK4;XPC;PRNP;PARVB;PYGB;BBS2;FLNC;SLC6A8;DDIT4L;POSTN;VEGFA;FAM210B;TNFRSF6B;THEM6;MXRA7;PGM1;WNT7A;APOE;PYGL;DGKA;TSPAN1;ESPN;NAGLU;F2R;LRP5;PLD3;OSBPL5;LPCAT4;ITGA6;ISYNA1;PITPNC1;HMGA2;OBSCN;NDRG1;IDH2;ZKSCAN1;NEK9;CRAT;SLCO4A1;ELK3;ITPR3;PKN1;MTA1;GRAMD4;ACOT7;ARRDC1;ANGEL1;ACSF2;EVI5L;NISCH;AKR7A2;FCGRT;SH2D5;EGFR;RPS6KA2;SERPINE2;DNPH1;WWTR1;LOXL1;SCN4B;OBSL1;NOS1;VAT1;PTPRS;TMEM129;SLC2A9;ANKS6;HADH;CTSO;SPRY2;LRP3;CAPN2;MST1R;NFATC4;TRIM65;BAHCC1;CRTAP;LTBP4;PRSS8;SYTL1;SDC1;KLHL29;SH3TC1;ETV5;LMF1;ORAI3;APPL2;SHC1;DDB2;ORAI1;LTBP2;VPS11;LTBP1;TBC1D14;ARL2;HEXB;GTPBP1;SLC7A8;TCFL5;PTPRE;SLC12A7;NPEPL1;SLC2A3;ALDH4A1;TK2;RIN1;ACTA2;MMP1;CLIP2;ETV4;PHLDA2;KIAA1549L;SNX9;NUDCD3;TRNP1;SPRY4;RAPGEF3;TXNRD3;ST6GALNAC2;ZFP36L1;GAA;GLUL;RNPEPL1;ARAP1;MAP2K2;KDSR;NME4;ZC3H6;LPAR3;MARCH9;CTBS;PLCD3;FKBP9;MDFI;PTOV1;CSMD2;SMARCA1;CMTM7;RBCK1;SUGCT;PLTP;PGLS;PC;TP53I11;FOXQ1;RNF44;MAP2K1;NAPRT;CRYL1;ACP5;CPT2;NYNRIN;VWA5A;MCTP1;MXD4;SSH1;POU2F2;EXOC2;ENDOG;MARK4;SLC16A5;KCNJ15;TMTC4;MARCKSL1;MPRIP;TMEM8A;GALE;SMURF2;KLC2;TSC22D1;ARMCX2;OXLD1;SLC9A3R2;FOS;FBLN1;SMAD3;ARHGAP23;STAT6;SHANK2;PIK3R2;ERCC6;LRP1;GJC2;SRD5A3;DVL1;EPAS1;DNAJB5;PIGQ;HSD17B8;THBS3;HBEGF;FAM110C;RPUSD3;AP2A2;S100A4;ITGB4;CYBRD1;PPP1R14A;SH3PXD2B;PPP2R3B;PRDX5;TMEM158;SHC2;NLGN2;STOM;BRD3;PRODH;SALL2;MBOAT7;CDK18;REEP4;LY6K;FBXW5;PAG1;ZXDC;RNF187;NMRK1;ADORA2B;ADARB1;PLCXD2;D2HGDH;SYT8;SLC6A6;AKT1;TPCN1;GRB7;KCNC4;TMOD2;CORO1B;TTYH3;HDAC5;UROS;FBXO41;FAM83A;S100A6;F12;SH2D2A;PPM1F;MMP28;PITPNM1;ENTPD6;PLEKHH3;RHBDF2;PYCR2;BSG;STK39;HK1;SERPING1;ASAP2;SCMH1;DYSF;EPHA1;GGT1;PHC2;NFKBIZ;PTPRU;VEGFB;FMNL2;ASH2L;IMPACT;MARCH4;SLC15A4;WWC3;ATG16L2;ZFYVE21;LRRC8A;CNTN1;IFNGR2;BRSK1;IFT140;PTHLH;MYZAP;MFSD3;RAB31;DNAAF5;FGFR4;HEBP1;PEAR1;WNT2B;POLD4;ACOT1;FNDC4;LDLR;FAM131A;FGFR1;PRKACB;FUCA1;MAPKBP1;ELMO3;SIGMAR1;RAC2;KCNAB2;SMOC2;PFKL;SEC14L2;OPLAH;HLTF;MXI1;NPHP4;SYNE3;RAG1;GAMT;H2AFJ;B4GAT1;PACS2;PHF7;TOMM34;BPHL;PIGV;KLF7;RALGDS;SORL1;NAT14;CEACAM1;B3GAT3;ASB13;CIRBP;CBR4;HMG20B;LZTS2;RAB11FIP4;TENM2;ZNF385A;DOCK6;NSMCE4A;MICALCL;ABCD1;ANK3;NIPSNAP1;IGFBP4;TTC7B;EVC;TSHZ1;TRAPPC9;CCND1;PODNL1;EFS;PCBP4;TCF25;LHPP;TNNT1;TWF2;AIG1;STRADB;SYNGAP1;PLCH2;MAPK13;CEP250;EDNRA;CARD19;PLAU;GAS6;PTK6;SEMA3F;PFKP;FGFBP1;CSNK1E;R3HDM4;BRI3;CTSB;CYYR1;RAB3B;CARD11;SH2B3;SOX13;LAMA5;DUSP7;MPLKIP;GSN;CMTM4;PLEKHG2;MAPKAPK3;IGFBP2;PCSK9;ARHGAP22;RAD23A;DHTKD1;PHLDA1;ANO8;BCR;ANTXR2;XPOT;ANGPTL4;MRPS6;EHD4;ERRFI1;GLI4;SEPT10;WIPF1;NADK;PANK4;HLCS;ZSCAN18;PRSS22;AIP;DBNDD1;STON1;TMEM200A;MYEF2;MN1;SH3D19;CCDC113;CDC25B;RGL2;SLITRK6;TSPAN18;PAQR6;ARPIN;SH3GLB2;TMEM132B;ARHGAP27;ALOX15B;SPTB;SMARCD2;KHNYN;AGAP1;COMTD1;NXPH4;RSPH3;PEX10;CCS;GGACT;RSAD1;COL13A1;CORO7;SLC20A1;RRNAD1;OAF;NPR2;UNC119B;SNTA1;DGKQ;HAGH;PLXNB3;BNIP3;PAK6;TFPI2;NOL4L;GTF2IRD1;SHARPIN;MVB12B;SERINC2;TAGLN3;FYCO1;CEMIP;PROCR;PKD2;ACY1;FAM3A;GPX3;PCSK1;RETSAT;YPEL3;RASGEF1A;CTSZ;CDC42EP5;HES2;CRTC1;IL20RB;FBXW8;GPSM1;AP3D1;ITGB5;ABCA2;FAM189B;MAGEF1;PRSS3;SH3PXD2A;C19ORF33;EPOR;EPHB2;GRIN3B;ADAM8;ASIC1;CADM4;APRT;TMEM9;CTBP1;JOSD2;LTA4H;MNT;PTPDC1;GRIP2;GRK6;CDKN1C;PLCG1;FBXL8;ZMIZ2;CBS;KIF17;NYAP1;CD81;CEBPB;MVD;RNF135;ENTPD2;LGALS9B;ADAMTS13;SLC29A4;ZNF217;TIMP2;ZNF862;NUDCD2;SYNJ2;WNT3;DPP7;GNAL;C8ORF88;TMED4;TGFB1;LACTB2;SNPH;CLTCL1;RFX2;SCYL1;ABHD17C;SLC43A1;UNK;SNTB2;ULK2;GPC1;MKNK2;ADAMTS7;DEAF1;MOAP1;TBC1D9B;SLC38A10;NTSR1;B3GNT3;NAB2;OGFRL1;TMEM173;ARHGAP25;TMEM134;ZSCAN30;ATP7B;FHOD3;SHANK3;PODXL2;SDHA;MSRB2;EFNB3;RASA3;PNRC1;MIPEP;PIP5KL1;TNFSF15;MYCBPAP;MGAT4B;EML2;KIF26B;MDH2;MPG;GALNS;FBXO17;CLCA2;HEXDC;GOLGA2P5;ABHD8;ENKD1;NSMF;PEG3;ARAP3;SCART1;FARP1;MC1R;TUB;DIRC2;LCE1E;CROCC;KLRG2;RHOD;CGREF1;ABHD14B;LAMB2;TNS1;ABTB1;SNX17;RNH1;DNAH1;ERO1B;ST6GALNAC6;HTR7;VGF;POLL;FBXO44;POLM;SNX33;TP73-AS1;PI4K2A;SEMA4F;C1ORF210;PTMS;RHOF;YIPF3;ANKZF1;WASF3;ATG2A;SLC48A1;LLGL1;PHGDH;ARL10;PHF21A;MIF4GD;KIF7;COA5;PLPP6;RHOBTB2;UBXN4;ADAM19;KHDRBS3;SAC3D1;TUBG2;ZER1;GIGYF1;RIMS3;BBS1;TNFAIP8L1;HMGCL;PTPN1;PEX1;TPP1;PCK2;B4GALT2;WDR59;AGRN;MBD3;OLFML2A;IFNE;CD320;CAMK2N1;OSBPL10;LRP4;LRP10;ESYT2;ZDHHC24;GPR153;ACP6;B4GALT6;VHL;DNAJC4;TMCC3;MYH16;CEP131;TRAP1;IDUA;APCDD1L;ADAP1;PFKFB2;RFNG;MLXIPL;YPEL5;C14ORF132;TRIB2;PRKCZ;KDM6B;PRKACA;MINK1;ZNF516;CENPH;GRHPR;OXA1L;RHPN1;RABGGTA;RCCD1;ACTR1B;TOM1L2;CD9;EPN2;ADA;AREG;PIM2;MPI;MICALL2;UCKL1;LGALS9C;PLEKHG5;BOK;WDR18;TDRKH;CAPG;SDCCAG8;ALAS1;NEURL1B;ERBB2;ADGRB2;ULK1;CNDP2;NINL;AHCY;VAMP2;CERCAM;PRIMPOL;TMEM143;RTL1;MMP10;TFDP2;SMTN;PLEK2;C6ORF89;MZT2A;NECAB3;STK17A;RILPL1;FAM50A;JAK3;IRF2BP2;RNPEP;NET1;LRRC37A2;BNIP3L;CYFIP2;FSCN1;PBX2;TRPC1;NELFCD;SLC22A17;RASA4;GLCCI1;PDK1;ACAD10;CYGB;ARHGAP44;THOP1;EHBP1L1;MCFD2;PRKCD;FAM20C;MIB2;REEP6;RBL2;CACNB3;USP20;STUB1;IFI6;BAX;CYC1;GRAMD1C;SV2A;SBF1;DTD1;XYLT2;SLC13A5;TRIM4;ITGA1;OLFM2;ZNF395;HIST3H2BB;CCDC92;NUBP2;PPCS;SH3BP1;FBXW4;GJB4;CHADL;EREG;RPS6KA5;DGUOK;TMEM25;DUSP4;KLHDC2;TIMM17B;ZNF524;CUL9;SOX12;PLEKHH1;TMBIM4;DDIT4;MBTPS2;ACADS;TOP3B;SPRED3;PPL;PPP1R13L;CARF;HSD17B7;AHNAK2;PCSK1N;GRAMD1A;MT2A;IER2;HPCAL1;RASL10B;CES2;NAGA;ZDHHC8;TMX4;MZT2B;FCHO1;NID1;LIMK1;TGFBR3;NTPCR;PDIA5;GDI1;TPM2;PADI3;DIP2A;LTB4R2;CPNE7;SLC2A11;RPL39L;LEMD2;RPS6KA6;TMEM92;ZHX3;DNM1;WASH3P;RGS14;TMEM8B;SCN8A;MFNG;GSTO1;GIT1;ALDOC;CHAD;MRPS26;MSLN;LPCAT1;LRSAM1;ADAM15;REEP2;ASB1;EHD3;WDR60;ST3GAL3;TMEM231;LONP2;SYMPK;MAPK12;TMEM94;IRAK1;PPOX;TGFA;HDAC7;FHOD1;INPP5D;RNF215;MTHFR;CHD2;PI4K2B;CBX7;PCMTD2;CHEK2;DTNB;DECR2;CACFD1;ZFPM1;PPARA;COG7;ABHD15;COQ2;TMEM161A;SESN2;FGGY;ABCG1;MYO1D;JADE2;MYH15;CDC34;RNF123;SNN;SOX7;ABCA7;RAB12;SPATA20;EML3;SPEG;SIX5;BCAP31;MIF;ACO2;SMOX;EEF2KMT;KDM4B;SLC25A29;DOPEY2;PHYH;ZNF414;MEX3A;BCAM;SLC9A7;PLA2G6;DDT;SSBP4;SYNGR1;NUDT14;ECM1;NARF;WFS1;QSOX1;DNAAF3;CD68;ZNF444;SLC22A18;DTX3;NBPF3;SPPL2B;HSD11B1L;FYN;PITPNM3;VWA1;UPP1;EFEMP2;STK25;RAC3;ETFB;TMCO6;GLB1L2;EEF2K;CERS4;SUN1;ICAM5;ARHGAP12;FLYWCH1;ACAP3;ARID5B;HOXC5;DNM2;CKMT1A;CYP3A5;BHLHE40;GLB1;PELI1;ATXN10;SNX15;INF2;CHKA;CAT;BEX2;NEIL1;TSPYL2;KIAA1147;IGFBP7;ARMCX1;ELFN2;SLC27A1;ZMYM3;TPBG;APOBEC3C;SATB1;SLC50A1;KIF26A;ASMTL;ZDHHC1;SLC12A4;PLCB3;H1FX;IQSEC1;ZNF606;APOBEC3F;ARHGEF4;DDX50;CYP2R1;TUBB6;MAPK3;CBLN3;INSR;SLC13A3;RTN2;ARHGEF1;PAN2;GRINA;TMEM54;PDZD2;CAMTA2;TAZ;PFKM;ADCY1;TNS4;C12ORF66;RERE;HLA-G;DOCK9;STX10;TSTA3;INO80C;ATP8B2;GPT2;TMEM101;RALGAPA1;MORN4;PDXK;ETAA1;PRAF2;GLRX;BCL7A;CEP72;VANGL2;PAK1;TRIM45;CDYL2;DCAF10;KLHL36;MALL;CAMKK2;RNASET2;PPP3CB;RNF144A;LGALS3BP;ALPK1;CTSF;ROBO4;USP21;PFKFB3;MLYCD;CUL7;SLC37A2;GABBR1;REV1;MICAL1;HYAL1;SEMA4C;CAPRIN2;ZBTB10;WDTC1;HES7;ITGA3;STK32C;DNMT3A;SAMD8;BIN1;VPS16;MAN2B1;SRMS;TSTD1;PPP2R5B;HES6;SLC16A13;MAP2K3;NDST2;BCL2L1;DLG3;SGSM2;ABHD10;NDUFV3;RRAS;DNASE1L1;PROX1;IGIP;IARS2;LRCH4;MDGA1;TBC1D16;ADGRF1;ALDH7A1;LMNA;ZYG11B;PKD1;KCTD13;TNFRSF25;RABGAP1;SIRT2;FAM129B;CDH4;ITGA4;EDA;UVSSA;ANKRD13D;GAL3ST4;DCBLD2;NMNAT2;BACH1;NT5C1B;TRIP10;ADCY7;E2F5;ZBTB22;ALG12;LTB4R;AFAP1L1;MAPRE3;AZIN2;TMEM154;TEP1;FAM171A2;RAB28;ZNF704;SERPINB1;ST3GAL2;ICA1;SLC25A37;RAP1GAP2;LAMB1;SOCS7;MAP3K10;HSDL1;RGS19;NDE1;GPR3;HSD11B1;PELI3;GTF2IRD2;RAB40B;NGFR;TOLLIP;BCORL1;PDCD6;ATP6V1F;PCLO;ARVCF;CHST14;BIVM;ZNF837;RNASE7;PXN;GRB10;TBC1D8;PHYKPL;PLEKHM1;DUSP23;GCH1;MSS51;LURAP1;KIF13B;MAFF;NR2F6;CBX6;TCTN1;NBEAL2;PNMA1;CAMK1;CAMKK1;SLC39A3;EZH1;SIRT3;HFE;TERC;ZNF513;WIPI2;GAS2L1;COL6A1;BTG1;BBS10;ZP3;VPS51;TMCO3;FAM117A;CELSR1;TACC1;MLF2;IL17RE;SEMA3B;SEPT6;CDK11B;PFN2;C2CD2;SLC35F3;SSH3;FGFR3;MFSD10;PPP1R16A;TST;CCDC88C;KRTCAP3;ST3GAL5;TNRC18;NDRG2;MAN2B2;BLOC1S4;CBLC;ITPKB;PTGR2;SPTLC2;TCEA2;CDC42BPG;PRSS21;ZBTB47;PLAG1;LRP11;DOK4;GSDMA;CLK3;IRF2BPL;TRIM46;DHX32;KDM3A;PM20D2;MEGF6;TMEM229B;TMEM187;FAM214B;TBL3;HOMER2;SLC23A2;PKN3;APBA1;TTLL3;DEDD2;PI4KAP2;AK3;SRSF5;CHPF;ADCY6;SLC26A11;LRRK1;AARS;KLHL24;STRN4;SDC2
960,GO:0002381,0.529610294461419,0.676630651026971,4,35,immunoglobulin production involved in immunoglobulin mediated immune response,BP,ERCC1;POU2F2;STAT6;TGFB1
15182,GO:0071326,0.529768260417238,0.609822135887265,9,85,cellular response to monosaccharide stimulus,BP,NR1D1;LRP5;ENDOG;GAS6;PCK2;MLXIPL;PRKACA;PLA2G6;PPP3CB
15184,GO:0071331,0.529768260417238,0.609822135887265,9,85,cellular response to hexose stimulus,BP,NR1D1;LRP5;ENDOG;GAS6;PCK2;MLXIPL;PRKACA;PLA2G6;PPP3CB
4536,GO:0010611,0.530142672988003,0.676132512697197,4,35,regulation of cardiac muscle hypertrophy,BP,SMAD3;ERRFI1;PAK1;LMNA
10296,GO:0043066,0.530197679452483,0.523416797501603,65,616,negative regulation of apoptotic process,BP,PDCD4;PRNP;VEGFA;TNFRSF6B;WNT7A;APOE;F2R;ITGA6;HMGA2;EGFR;SPRY2;MST1R;SHC1;SMAD3;LRP1;PRDX5;AKT1;EPHA1;FGFR4;FGFR1;RAG1;ZNF385A;STRADB;SYNGAP1;GAS6;ANGPTL4;RGL2;BNIP3;EPHB2;ADAM8;MNT;CEBPB;NTSR1;PTPN1;VHL;TRAP1;PRKCZ;ADA;PIM2;BOK;ERBB2;JAK3;BNIP3L;PRKCD;IFI6;BAX;TMBIM4;IRAK1;TMEM161A;MIF;WFS1;FYN;EEF2K;CAT;INSR;GRINA;MICAL1;BCL2L1;LMNA;FAM129B;PELI3;NGFR;FGFR3;ITPKB;AARS
10461,GO:0043330,0.530273864099331,0.705297622386956,3,26,response to exogenous dsRNA,BP,TMEM173;IFNE;MAPK3
7218,GO:0031119,0.530286923548009,0.844609599086058,1,7,tRNA pseudouridine synthesis,BP,RPUSD3
11063,GO:0045071,0.530554343716163,0.654474216965884,5,47,negative regulation of viral genome replication,BP,TNIP1;HMGA2;APOBEC3C;APOBEC3F;PROX1
11514,GO:0046039,0.53102288971803,0.704106640268261,3,27,GTP metabolic process,BP,GTPBP1;NME4;AK3
2956,GO:0006491,0.53112563652739,0.75208058865758,2,16,N-glycan processing,BP,EDEM1;MGAT4B
5410,GO:0016254,0.531271174154121,0.750964007663459,2,17,preassembly of GPI anchor in ER membrane,BP,PIGQ;PIGV
19422,GO:1905941,0.531662994331745,0.843667013353366,1,7,positive regulation of gonad development,BP,ZP3
2833,GO:0006305,0.531701381867312,0.65409367307091,5,44,DNA alkylation,BP,FOS;MBD3;TDRKH;DNMT3A;FAM129B
2834,GO:0006306,0.531701381867312,0.65409367307091,5,44,DNA methylation,BP,FOS;MBD3;TDRKH;DNMT3A;FAM129B
14652,GO:0070255,0.532123986363859,0.843350378573879,1,7,regulation of mucus secretion,BP,ADA
9795,GO:0040020,0.532481568054686,0.750923693546089,2,16,regulation of meiotic nuclear division,BP,SIRT2;GPR3
14248,GO:0061311,0.532852583273083,0.75060659713725,2,16,cell surface receptor signaling pathway involved in heart development,BP,TGFB1;VANGL2
16980,GO:0099023,0.533185449462679,0.624761797851554,7,64,tethering complex,CC,VPS11;EXOC2;TRAPPC9;SH3BP1;COG7;VPS16;VPS51
6358,GO:0021544,0.533201709156042,0.750307995888011,2,16,subpallium development,BP,BBS2;SHANK3
3438,GO:0007250,0.533378346197367,0.750156842587662,2,16,activation of NF-kappaB-inducing kinase activity,BP,TNFSF15;IRAK1
12923,GO:0051289,0.533411215388855,0.636441005274203,6,56,protein homotetramerization,BP,PFKL;CBR4;PKD2;GPX3;CRTC1;CAT
10330,GO:0043130,0.533440702162106,0.624369527603831,7,65,ubiquitin binding,MF,RBCK1;MARK4;SMAD3;SHARPIN;UBTD1;SIRT2;TOLLIP
2788,GO:0006228,0.533576982868726,0.839757884505266,1,8,UTP biosynthetic process,BP,NME4
17541,GO:1901029,0.533837990889329,0.842169296305276,1,7,negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,BOK
4543,GO:0010623,0.534349960825128,0.841815342186739,1,7,programmed cell death involved in cell development,BP,BAX
381,GO:0001016,0.534411578160007,0.841772706328931,1,7,RNA polymerase III regulatory region DNA binding,MF,PRDX5
7492,GO:0031670,0.53476535702232,0.650914350879366,5,45,cellular response to nutrient,BP,CYP27B1;POSTN;SSH1;GAS6;FYN
4142,GO:0009205,0.534812496593927,0.553288836534259,23,233,purine ribonucleoside triphosphate metabolic process,BP,PGM1;GTPBP1;NME4;HK1;PFKL;PFKP;DHTKD1;NADK;TGFB1;SDHA;PFKFB2;MLXIPL;FAM20C;CYC1;DDIT4;ALDOC;PPARA;INSR;TAZ;PFKM;PFKFB3;NDUFV3;AK3
15201,GO:0071353,0.53496707620138,0.701017340935289,3,26,cellular response to interleukin-4,BP,STAT6;ADAMTS13;JAK3
8281,GO:0033116,0.535074447778846,0.635009133151299,6,55,endoplasmic reticulum-Golgi intermediate compartment membrane,CC,CTSZ;AREG;MCFD2;TGFA;BCAP31;AZIN2
13843,GO:0060457,0.535188970900954,0.841234122806594,1,7,negative regulation of digestive system process,BP,STK39
10364,GO:0043186,0.535219465787828,0.841212970397203,1,7,P granule,CC,TDRKH
11247,GO:0045495,0.535219465787828,0.841212970397203,1,7,pole plasm,CC,TDRKH
13714,GO:0060293,0.535219465787828,0.841212970397203,1,7,germ plasm,CC,TDRKH
18097,GO:1902692,0.535222126702019,0.748575905095617,2,16,regulation of neuroblast proliferation,BP,VEGFA;TGFB1
16545,GO:0097305,0.535343193978839,0.586211969853225,12,112,response to alcohol,BP,AKT1;CCND1;GSN;ABCA2;TGFB1;TGFBR3;FYN;CAT;DNMT3A;BCL2L1;ADCY7;ADCY6
10760,GO:0044212,0.535355737311452,0.51791772764145,66,612,transcription regulatory region DNA binding,MF,MEF2D;ZMYND8;EGR1;NR1D1;HMGA2;ELK3;MTA1;NFATC4;BAHCC1;ETV5;TCFL5;ETV4;ZC3H6;FOXQ1;POU2F2;FOS;SMAD3;STAT6;PRDX5;SALL2;HDAC5;ASH2L;HLTF;MXI1;KLF7;SOX13;MYEF2;SMARCD2;HES2;MNT;CEBPB;ZNF217;RFX2;DEAF1;PHF21A;MBD3;MLXIPL;KDM6B;ZNF516;TFDP2;PBX2;RBL2;ZNF395;SOX12;CARF;IER2;ZHX3;CHD2;ZFPM1;PPARA;SOX7;SIX5;SSBP4;ARID5B;BHLHE40;SATB1;HES7;HES6;PROX1;BACH1;ZNF704;NR2F6;ZNF513;TNRC18;PLAG1;KDM3A
12649,GO:0050862,0.535407247040459,0.841082676038527,1,7,positive regulation of T cell receptor signaling pathway,BP,ADA
17091,GO:0099622,0.535467507882877,0.748365068851773,2,16,cardiac muscle cell membrane repolarization,BP,SCN4B;SNTA1
4078,GO:0009134,0.535511713061348,0.841010159573922,1,7,nucleoside diphosphate catabolic process,BP,ENTPD2
11010,GO:0044853,0.535604604366694,0.622552384896105,7,63,plasma membrane raft,CC,F2R;NOS1;LRP4;PRKACA;MYO1D;MAPK3;INSR
3111,GO:0006692,0.535643344727123,0.699883473880324,3,27,prostanoid metabolic process,BP,CES2;MIF;PTGR2
3112,GO:0006693,0.535643344727123,0.699883473880324,3,27,prostaglandin metabolic process,BP,CES2;MIF;PTGR2
15157,GO:0071281,0.535750126910358,0.840844577314048,1,7,cellular response to iron ion,BP,HFE
3688,GO:0008198,0.535803097674607,0.747073106689178,2,17,ferrous iron binding,MF,ACP5;PHYH
3271,GO:0006953,0.536033576063227,0.746874296667553,2,17,acute-phase response,BP,CEBPB;HFE
4746,GO:0010918,0.536061710833358,0.840628000751426,1,7,positive regulation of mitochondrial membrane potential,BP,AKT1
19924,GO:2000403,0.536089295644113,0.746826219535005,2,17,positive regulation of lymphocyte migration,BP,ADAM8;ITGA4
14677,GO:0070296,0.536189726894403,0.74673954999343,2,17,sarcoplasmic reticulum calcium ion transport,BP,PRKACA;GSTO1
19102,GO:1904994,0.536365090410218,0.840416934592271,1,7,regulation of leukocyte adhesion to vascular endothelial cell,BP,ITGA4
5234,GO:0015851,0.536510889508628,0.840315432221226,1,7,nucleobase transport,BP,SLC23A2
13682,GO:0060242,0.536582499038705,0.840265563057027,1,7,contact inhibition,BP,PAK1
3695,GO:0008206,0.536597231980535,0.699523147514582,3,26,bile acid metabolic process,BP,NR1D1;FGFR4;PROX1
10890,GO:0044441,0.536778392206037,0.542257701234429,29,272,ciliary part,CC,BBS2;MARK4;SHANK2;AKT1;HK1;IFT140;PRKACB;NPHP4;EVC;UNC119B;PKD2;KIF17;SHANK3;CROCC;DNAH1;KIF7;BBS1;CEP131;PRKACA;RILPL1;EHD3;WDR60;TMEM231;PFKM;PKD1;RAB28;TCTN1;SEPT6;TTLL3
2716,GO:0006098,0.536820199580164,0.746195076007059,2,17,pentose-phosphate shunt,BP,H6PD;PGLS
3357,GO:0007097,0.537281798783143,0.746803011634769,2,16,nuclear migration,BP,FHOD1;SUN1
866,GO:0002200,0.537332589800641,0.633004847448541,6,54,somatic diversification of immune receptors,BP,ERCC1;STAT6;RAG1;TGFB1;POLL;POLM
5508,GO:0016459,0.537368533132572,0.668990004210177,4,36,myosin complex,CC,OBSL1;MYH16;MYO1D;MYH15
10197,GO:0042813,0.537642192794128,0.746492053170741,2,16,Wnt-activated receptor activity,MF,LRP5;LRP4
10897,GO:0044450,0.537786511737382,0.567924289003094,16,148,microtubule organizing center part,CC,CEP250;CCDC113;CROCC;TUBG2;CEP131;CAPG;SDCCAG8;MZT2A;CCDC92;NUBP2;MZT2B;WASH3P;WDR60;CEP72;SIRT2;MSS51
7877,GO:0032451,0.537908721964212,0.668824726309066,4,35,demethylase activity,MF,KDM6B;KDM4B;ARID5B;KDM3A
12761,GO:0051045,0.538058195210157,0.83923552312505,1,7,negative regulation of membrane protein ectodomain proteolysis,BP,TIMP2
14832,GO:0070577,0.538259008937818,0.745959331181825,2,16,lysine-acetylated histone binding,MF,ZMYND8;BRD3
17286,GO:0140033,0.538259008937818,0.745959331181825,2,16,acetylation-dependent protein binding,MF,ZMYND8;BRD3
4807,GO:0012507,0.538342977602652,0.647239598265373,5,46,ER to Golgi transport vesicle membrane,CC,AREG;MCFD2;TGFA;HLA-G;PDCD6
6790,GO:0030238,0.538456761739497,0.838956549534738,1,7,male sex determination,BP,INSR
11300,GO:0045628,0.538467763185073,0.838948844488199,1,7,regulation of T-helper 2 cell differentiation,BP,PRKCZ
5572,GO:0016589,0.538826967175155,0.838697131996382,1,7,NURF complex,CC,SMARCA1
8079,GO:0032769,0.538835467307999,0.838691172282914,1,7,negative regulation of monooxygenase activity,BP,CYP27B1
15481,GO:0071840,0.538858073324885,0.485193111541596,505,4822,cellular component organization or biogenesis,BP,ERCC1;SDK2;ZMYND8;ADGRL1;H1F0;SEMA4B;HTRA1;FHL1;THSD4;DLG4;CST3;CYP27B1;TYSND1;MARVELD1;APLN;CTNNBIP1;KCNG1;XPC;PRNP;PARVB;BBS2;FLNC;POSTN;VEGFA;WNT7A;APOE;TSPAN1;ESPN;NAGLU;F2R;LRP5;ITGA6;HMGA2;OBSCN;NDRG1;IDH2;NEK9;ITPR3;PKN1;MTA1;ARRDC1;EVI5L;NISCH;EGFR;SERPINE2;DNPH1;WWTR1;LOXL1;OBSL1;NOS1;VAT1;PTPRS;SPRY2;CAPN2;NFATC4;BAHCC1;LTBP4;SYTL1;SDC1;ETV5;SHC1;DDB2;LTBP2;VPS11;TBC1D14;ARL2;HEXB;SLC12A7;MMP1;SNX9;NUDCD3;RAPGEF3;GAA;GLUL;ARAP1;MAP2K2;LPAR3;SMARCA1;PLTP;MAP2K1;MCTP1;SSH1;EXOC2;ENDOG;MARK4;SLC9A3R2;FBLN1;SMAD3;SHANK2;LRP1;DVL1;EPAS1;HSD17B8;THBS3;HBEGF;FAM110C;AP2A2;ITGB4;SH3PXD2B;NLGN2;STOM;BRD3;REEP4;FBXW5;ADARB1;SYT8;AKT1;GRB7;KCNC4;TMOD2;CORO1B;HDAC5;S100A6;PPM1F;BSG;SCMH1;DYSF;EPHA1;FMNL2;ASH2L;IMPACT;ATG16L2;LRRC8A;CNTN1;BRSK1;IFT140;RAB31;DNAAF5;FGFR4;POLD4;LDLR;FGFR1;PRKACB;SIGMAR1;RAC2;SMOC2;PFKL;HLTF;NPHP4;SYNE3;RAG1;H2AFJ;B4GAT1;PACS2;TOMM34;KLF7;SORL1;CEACAM1;CIRBP;CBR4;HMG20B;TENM2;ZNF385A;ABCD1;ANK3;IGFBP4;TRAPPC9;EFS;TNNT1;TWF2;STRADB;SYNGAP1;CEP250;GAS6;PTK6;SEMA3F;CSNK1E;RAB3B;LAMA5;GSN;PLEKHG2;IGFBP2;PCSK9;BCR;ANGPTL4;MRPS6;EHD4;SEPT10;WIPF1;HLCS;AIP;DBNDD1;STON1;SH3D19;CCDC113;CDC25B;SLITRK6;ARPIN;SPTB;SMARCD2;PEX10;COL13A1;CORO7;RRNAD1;UNC119B;DGKQ;PLXNB3;BNIP3;PAK6;SHARPIN;FYCO1;PKD2;GPX3;CTSZ;CDC42EP5;CRTC1;FBXW8;AP3D1;ITGB5;SH3PXD2A;EPHB2;GRIN3B;ADAM8;ASIC1;CTBP1;PTPDC1;PLCG1;KIF17;NYAP1;TIMP2;SYNJ2;WNT3;TMED4;TGFB1;CLTCL1;RFX2;UNK;ULK2;GPC1;MOAP1;TBC1D9B;ARHGAP25;FHOD3;SHANK3;MSRB2;EFNB3;MIPEP;EML2;GOLGA2P5;NSMF;ARAP3;FARP1;TUB;CROCC;RHOD;LAMB2;TNS1;SNX17;DNAH1;ERO1B;SNX33;PI4K2A;SEMA4F;RHOF;WASF3;ATG2A;LLGL1;PHF21A;COA5;RHOBTB2;ADAM19;KHDRBS3;TUBG2;BBS1;HMGCL;PTPN1;PEX1;TPP1;AGRN;MBD3;OLFML2A;LRP4;VHL;CEP131;PRKCZ;KDM6B;PRKACA;MINK1;CENPH;GRHPR;OXA1L;RABGGTA;RCCD1;TOM1L2;CD9;EPN2;AREG;PIM2;MPI;MICALL2;BOK;WDR18;TDRKH;CAPG;SDCCAG8;ALAS1;ERBB2;ADGRB2;ULK1;NINL;VAMP2;PRIMPOL;PSMG4;MMP10;TFDP2;PLEK2;C6ORF89;RILPL1;NET1;BNIP3L;CYFIP2;FSCN1;ARHGAP44;MCFD2;PRKCD;RBL2;CACNB3;STUB1;IFI6;BAX;TRIM4;ITGA1;HIST3H2BB;NUBP2;SH3BP1;CHADL;EREG;RPS6KA5;DGUOK;TIMM17B;CUL9;SOX12;TOP3B;PPL;AHNAK2;ZDHHC8;FCHO1;NID1;LIMK1;TGFBR3;GDI1;TPM2;PADI3;LEMD2;DNM1;WASH3P;RGS14;MRPS26;LRSAM1;ADAM15;REEP2;EHD3;WDR60;TMEM231;LONP2;IRAK1;TGFA;HDAC7;FHOD1;MTHFR;CHD2;PI4K2B;CBX7;CHEK2;ZFPM1;COG7;SESN2;ABCG1;JADE2;CDC34;ABCA7;EML3;MIF;KDM4B;DOPEY2;PLA2G6;SYNGR1;DNAAF3;NBPF3;FYN;VWA1;EFEMP2;STK25;RAC3;EEF2K;SUN1;ICAM5;ARHGAP12;ARID5B;DNM2;ATXN10;INF2;CAT;TSPYL2;IGFBP7;ZMYM3;TPBG;SATB1;KIF26A;SLC12A4;H1FX;IQSEC1;ARHGEF4;TUBB6;MAPK3;INSR;TAZ;PFKM;ADCY1;RERE;STX10;INO80C;ATP8B2;CEP72;VANGL2;PAK1;MALL;CAMKK2;PPP3CB;USP21;CUL7;MICAL1;HYAL1;SEMA4C;CAPRIN2;WDTC1;ITGA3;DNMT3A;SAMD8;BIN1;VPS16;PPP2R5B;BCL2L1;SGSM2;NDUFV3;PROX1;TBC1D16;ADGRF1;LMNA;PKD1;KCTD13;RABGAP1;SIRT2;FAM129B;CDH4;ITGA4;DCBLD2;TRIP10;E2F5;AZIN2;TEP1;RAP1GAP2;LAMB1;NDE1;GPR3;NGFR;BCORL1;PDCD6;ATP6V1F;PCLO;PXN;GRB10;TBC1D8;PLEKHM1;GCH1;MSS51;LURAP1;KIF13B;CBX6;TCTN1;NBEAL2;CAMK1;SLC39A3;EZH1;SIRT3;HFE;TERC;WIPI2;COL6A1;BTG1;BBS10;VPS51;CELSR1;TACC1;SEMA3B;SEPT6;CDK11B;PFN2;SSH3;CCDC88C;TNRC18;BLOC1S4;CDC42BPG;DOK4;TRIM46;KDM3A;TBL3;APBA1;TTLL3;DEDD2;PI4KAP2;SRSF5;ADCY6;KLHL24;SDC2
6988,GO:0030674,0.538990140753006,0.57381698018314,14,130,protein binding, bridging,MF,ARRDC1;OBSL1;SHC1;VPS11;AP2A2;PAG1;GRB7;SH2D2A;ANK3;SH3BP2;FSCN1;STUB1;GRB10;GAS2L1
9995,GO:0042416,0.539125443306474,0.838487770902607,1,7,dopamine biosynthetic process,BP,GCH1
15285,GO:0071476,0.539223490391528,0.838418957039925,1,7,cellular hypotonic response,BP,STK39
2784,GO:0006221,0.539427248483886,0.695923349321859,3,28,pyrimidine nucleotide biosynthetic process,BP,NME4;UCKL1;UPP1
4225,GO:0009404,0.539965585011006,0.743468592793038,2,17,toxin metabolic process,BP,CBS;GSTO1
4218,GO:0009394,0.54008204461697,0.695318171794455,3,28,2'-deoxyribonucleotide metabolic process,BP,ADA;DGUOK;NEIL1
12086,GO:0048087,0.540306216113468,0.837657722235136,1,7,positive regulation of developmental pigmentation,BP,BAX
17973,GO:1902337,0.540306216113468,0.837657722235136,1,7,regulation of apoptotic process involved in morphogenesis,BP,BAX
18980,GO:1904748,0.540306216113468,0.837657722235136,1,7,regulation of apoptotic process involved in development,BP,BAX
2269,GO:0005201,0.540554897974407,0.666316997246208,4,35,extracellular matrix structural constituent,MF,FBLN1;TFPI2;EFEMP2;LAMB1
16405,GO:0097035,0.540649742936177,0.695791872800853,3,26,regulation of membrane lipid distribution,BP,PRKCD;ABCA7;ATP8B2
2520,GO:0005776,0.540691202070647,0.599259508641443,9,83,autophagosome,CC,VPS11;TBC1D14;ATG16L2;FYCO1;PEG3;ULK1;WASH3P;RAB12;VPS16
12119,GO:0048207,0.540801862097041,0.629264505478331,6,56,vesicle targeting, rough ER to cis-Golgi,BP,TRAPPC9;CTSZ;AREG;MCFD2;TGFA;PDCD6
12120,GO:0048208,0.540801862097041,0.629264505478331,6,56,COPII vesicle coating,BP,TRAPPC9;CTSZ;AREG;MCFD2;TGFA;PDCD6
13740,GO:0060325,0.540895270314084,0.695565037760453,3,26,face morphogenesis,BP,TGFB1;ARID5B;RRAS
9339,GO:0035850,0.541030416781052,0.695440142550841,3,26,epithelial cell differentiation involved in kidney development,BP,WWTR1;ACTA2;LAMB2
324,GO:0000910,0.541089590558578,0.567949613742879,15,140,cytokinesis,BP,SNX9;RAB11FIP4;ANK3;SEPT10;CDC25B;PAK6;RHOD;SNX33;RHOF;RHOBTB2;GIT1;PAK1;CUL7;BCL2L1;SEPT6
523,GO:0001618,0.541130592340206,0.644792986938988,5,45,virus receptor activity,MF,EGFR;LDLR;ITGB5;CD81;EFNB3
17190,GO:0104005,0.541130592340206,0.644792986938988,5,45,hijacked molecular function,MF,EGFR;LDLR;ITGB5;CD81;EFNB3
8125,GO:0032825,0.541165084436455,0.837052138831155,1,7,positive regulation of natural killer cell differentiation,BP,GAS6
5595,GO:0016624,0.541175838649458,0.837044546342504,1,7,oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor,MF,DHTKD1
395,GO:0001067,0.541176024489591,0.512057437906384,66,613,regulatory region nucleic acid binding,MF,MEF2D;ZMYND8;EGR1;NR1D1;HMGA2;ELK3;MTA1;NFATC4;BAHCC1;ETV5;TCFL5;ETV4;ZC3H6;FOXQ1;POU2F2;FOS;SMAD3;STAT6;PRDX5;SALL2;HDAC5;ASH2L;HLTF;MXI1;KLF7;SOX13;MYEF2;SMARCD2;HES2;MNT;CEBPB;ZNF217;RFX2;DEAF1;PHF21A;MBD3;MLXIPL;KDM6B;ZNF516;TFDP2;PBX2;RBL2;ZNF395;SOX12;CARF;IER2;ZHX3;CHD2;ZFPM1;PPARA;SOX7;SIX5;SSBP4;ARID5B;BHLHE40;SATB1;HES7;HES6;PROX1;BACH1;ZNF704;NR2F6;ZNF513;TNRC18;PLAG1;KDM3A
5205,GO:0015804,0.54161192660588,0.694902437002109,3,26,neutral amino acid transport,BP,SLC7A8;SERINC2;SLC43A1
16318,GO:0090504,0.541685986113721,0.694833920746141,3,26,epiboly,BP,WNT7A;HBEGF;CEACAM1
3200,GO:0006837,0.541702644322198,0.836672324915879,1,7,serotonin transport,BP,NOS1
3916,GO:0008589,0.541760173808768,0.628695971084559,6,54,regulation of smoothened signaling pathway,BP,SERPINE2;IFT140;PRKACB;EVC;KIF7;TCTN1
15833,GO:0072542,0.541923842679721,0.83651586143202,1,7,protein phosphatase activator activity,MF,B3GAT3
8551,GO:0033993,0.541936287527014,0.512831757674215,62,587,response to lipid,BP,TNIP1;NR1D1;CST3;CYP27B1;PDCD4;POSTN;FAM210B;TNFRSF6B;WNT7A;F2R;EGFR;LOXL1;NOS1;NFATC4;SDC1;ZFP36L1;ACP5;ENDOG;FOS;AKT1;HDAC5;PTPRU;LDLR;CCND1;TWF2;PTK6;MAPKAPK3;IGFBP2;BCR;ERRFI1;PAQR6;ABCA2;CEBPB;ADAMTS13;WNT3;TGFB1;NTSR1;HMGCL;PCK2;MBD3;AREG;DDIT4;TGFBR3;IRAK1;PPARA;TMEM161A;ABCG1;MIF;GLB1;PELI1;CAT;IGFBP7;MAPK3;ADCY1;PAK1;DNMT3A;TNFRSF25;NGFR;GCH1;NR2F6;KDM3A;ADCY6
9801,GO:0040034,0.542004043557486,0.836459106493373,1,7,regulation of development, heterochronic,BP,SERPINE2
6278,GO:0019885,0.542056034706556,0.836422307256255,1,7,antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,HFE
10523,GO:0043467,0.542197102102228,0.590715878123517,10,93,regulation of generation of precursor metabolites and energy,BP,PHLDA2;AKT1;BNIP3;TRAP1;PFKFB2;MLXIPL;DDIT4;PPARA;INSR;PFKFB3
13175,GO:0051791,0.542209538935395,0.836313624247606,1,7,medium-chain fatty acid metabolic process,BP,ACOT7
4833,GO:0014041,0.542464905554692,0.836132712054092,1,7,regulation of neuron maturation,BP,RAC3
3707,GO:0008219,0.542610765387217,0.492454197573873,165,1572,cell death,BP,DUSP6;XDH;MEF2D;H1F0;EGR1;CST3;HS1BP3;PDCD4;PRNP;VEGFA;TNFRSF6B;WNT7A;APOE;PYGL;F2R;LRP5;ITGA6;HMGA2;OBSCN;NDRG1;PKN1;GRAMD4;NISCH;EGFR;RPS6KA2;SPRY2;MST1R;NFATC4;PRSS8;SHC1;PHLDA2;ZFP36L1;MAP2K2;NME4;RBCK1;MAP2K1;SSH1;ENDOG;MARK4;FOS;SMAD3;ERCC6;LRP1;PRDX5;PRODH;ADARB1;AKT1;PPM1F;STK39;EPHA1;IMPACT;DAP;FGFR4;FGFR1;ELMO3;SIGMAR1;RAG1;PACS2;SORL1;ZNF385A;STRADB;SYNGAP1;GAS6;CTSB;CARD11;GSN;PLEKHG2;PCSK9;PHLDA1;ANGPTL4;RGL2;ALOX15B;BNIP3;PAK6;SHARPIN;CTSZ;EPHB2;ADAM8;MNT;CEBPB;TGFB1;MKNK2;MOAP1;NTSR1;TMEM173;TNFSF15;NSMF;PEG3;TNFAIP8L1;PTPN1;VHL;TRAP1;PRKCZ;MINK1;RABGGTA;ADA;PIM2;PLEKHG5;BOK;ERBB2;TFDP2;STK17A;RILPL1;JAK3;NET1;BNIP3L;CYFIP2;PDK1;PRKCD;IFI6;BAX;ITGA1;TMBIM4;DDIT4;PPL;PPP1R13L;DIP2A;IRAK1;INPP5D;CHEK2;PPARA;TMEM161A;CDC34;SOX7;BCAP31;MIF;PLA2G6;WFS1;FYN;STK25;EEF2K;DNM2;CAT;BEX2;SATB1;ARHGEF4;MAPK3;INSR;ARHGEF1;GRINA;TNS4;PAK1;MICAL1;DNMT3A;BIN1;MAP2K3;BCL2L1;LMNA;TNFRSF25;SIRT2;FAM129B;MAP3K10;PELI3;NGFR;PDCD6;PNMA1;BTG1;CDK11B;FGFR3;MFSD10;ITPKB;PLAG1;GSDMA;DEDD2;AARS
11779,GO:0046654,0.542753468318157,0.835928117972599,1,7,tetrahydrofolate biosynthetic process,BP,GCH1
15652,GO:0072173,0.542754471199679,0.835927406617087,1,7,metanephric tubule morphogenesis,BP,PKD1
4037,GO:0009071,0.542791787577127,0.835900936088214,1,7,serine family amino acid catabolic process,BP,CBS
3002,GO:0006551,0.542829989564261,0.835873834322534,1,7,leucine metabolic process,BP,HMGCL
11072,GO:0045080,0.542832656417373,0.835871942253619,1,7,positive regulation of chemokine biosynthetic process,BP,EGR1
12557,GO:0050715,0.542931501228279,0.615079642639119,7,65,positive regulation of cytokine secretion,BP,POSTN;F2R;HK1;ALOX15B;PRKCZ;MIF;MAPK3
11877,GO:0046902,0.542996096703586,0.614875632414049,7,66,regulation of mitochondrial membrane permeability,BP,BNIP3;MOAP1;BOK;TFDP2;BNIP3L;BAX;BCL2L1
12088,GO:0048102,0.543062570099224,0.835708767904595,1,7,autophagic cell death,BP,BNIP3
8025,GO:0032675,0.54313582155195,0.615023914096677,7,64,regulation of interleukin-6 production,BP,F2R;ADORA2B;MAPK13;GAS6;CEBPB;EREG;INPP5D
3080,GO:0006657,0.543252139186754,0.835574143531477,1,7,CDP-choline pathway,BP,CHKA
11002,GO:0044829,0.543315210011537,0.835529336436164,1,7,positive regulation by host of viral genome replication,BP,STOM
359,GO:0000978,0.543406417148505,0.533116210012902,31,288,RNA polymerase II proximal promoter sequence-specific DNA binding,MF,MEF2D;NR1D1;HMGA2;ELK3;NFATC4;TCFL5;ETV4;FOXQ1;POU2F2;FOS;SMAD3;STAT6;HLTF;KLF7;MYEF2;SMARCD2;HES2;CEBPB;ZNF217;RFX2;MBD3;MLXIPL;KDM6B;ZNF395;CARF;ZFPM1;PPARA;SIX5;SSBP4;BHLHE40;PLAG1
1252,GO:0003002,0.543454993687972,0.549044586433703,21,196,regionalization,BP,DUSP6;CTNNBIP1;ACVR2B;WNT7A;LRP5;MDFI;SMAD3;SCMH1;IFT140;WNT2B;FGFR1;PRKACB;TSHZ1;SEMA3F;WNT3;LRP4;PBX2;VANGL2;HES7;TCTN1;CELSR1
4931,GO:0014889,0.543556337488148,0.835357956452672,1,7,muscle atrophy,BP,GSN
18499,GO:1903599,0.544315380493966,0.739670139130098,2,17,positive regulation of autophagy of mitochondrion,BP,BNIP3;CAMKK2
9941,GO:0042307,0.544342077883014,0.69237131691298,3,26,positive regulation of protein import into nucleus,BP,TGFB1;TMEM173;PRKCD
6498,GO:0021872,0.54439909097865,0.662308486435656,4,36,forebrain generation of neurons,BP,FGFR1;SHANK3;RAC3;PROX1
5704,GO:0016832,0.544460971587778,0.834713903909078,1,7,aldehyde-lyase activity,MF,ALDOC
19922,GO:2000401,0.544643906752058,0.691567727122732,3,27,regulation of lymphocyte migration,BP,ADAM8;ECM1;ITGA4
4367,GO:0009987,0.544688722515673,0.489984005954811,1111,10538,cellular process,BP,TNIP1;DUSP6;NT5E;XDH;ERCC1;DUSP5;SDK2;MEF2D;GID4;ZMYND8;ADGRL1;H1F0;CITED4;SEMA4B;HTRA1;FHL1;THSD4;EGR1;NR1D1;SLC16A3;H6PD;CCNG2;EDEM1;DLG4;PLAT;CST3;CYP27B1;MRC2;TYSND1;HS1BP3;BTBD2;MARVELD1;FBXO2;APLN;PGF;PDCD4;CTNNBIP1;NAGS;KCNG1;ACVR2B;DOCK4;XPC;PRNP;PARVB;PYGB;BBS2;FLNC;SLC6A8;DDIT4L;POSTN;VEGFA;FAM210B;TNFRSF6B;PGM1;WNT7A;APOE;PYGL;DGKA;TSPAN1;ESPN;NAGLU;F2R;LRP5;OSBPL5;LPCAT4;ITGA6;ISYNA1;PITPNC1;HMGA2;OBSCN;NDRG1;IDH2;ZKSCAN1;NEK9;CRAT;ELK3;ITPR3;PKN1;MTA1;GRAMD4;ACOT7;ARRDC1;ACSF2;EVI5L;NISCH;AKR7A2;FCGRT;EGFR;RPS6KA2;SERPINE2;DNPH1;WWTR1;LOXL1;SCN4B;OBSL1;NOS1;VAT1;PTPRS;TMEM129;SLC2A9;HADH;CTSO;SPRY2;CAPN2;MST1R;NFATC4;TRIM65;BAHCC1;CRTAP;LTBP4;PRSS8;SYTL1;SDC1;KLHL29;ETV5;LMF1;APPL2;SHC1;DDB2;LTBP2;VPS11;LTBP1;TBC1D14;ARL2;HEXB;GTPBP1;SLC7A8;TCFL5;PTPRE;SLC12A7;SLC2A3;ALDH4A1;TK2;RIN1;ACTA2;MMP1;ETV4;PHLDA2;SNX9;NUDCD3;TRNP1;SPRY4;RAPGEF3;TXNRD3;ST6GALNAC2;ZFP36L1;GAA;GLUL;RNPEPL1;ARAP1;MAP2K2;KDSR;NME4;ZC3H6;LPAR3;MARCH9;CTBS;PLCD3;FKBP9;MDFI;PTOV1;SMARCA1;PPP1R35;CMTM7;RBCK1;PLTP;PGLS;PC;TP53I11;FOXQ1;RNF44;MAP2K1;NAPRT;CRYL1;ACP5;CPT2;NYNRIN;MCTP1;MXD4;SSH1;POU2F2;EXOC2;ENDOG;MARK4;KCNJ15;MARCKSL1;SMURF2;KLC2;TSC22D1;SLC9A3R2;FOS;FBLN1;SMAD3;ARHGAP23;STAT6;SHANK2;PIK3R2;ERCC6;LRP1;GJC2;SRD5A3;DVL1;EPAS1;DNAJB5;PIGQ;HSD17B8;THBS3;HBEGF;FAM110C;RPUSD3;AP2A2;S100A4;ITGB4;CYBRD1;PPP1R14A;SH3PXD2B;PPP2R3B;PRDX5;SHC2;NLGN2;STOM;BRD3;PRODH;SALL2;MBOAT7;CDK18;REEP4;LY6K;FBXW5;PAG1;ZXDC;RNF187;NMRK1;ADORA2B;ADARB1;PLCXD2;D2HGDH;SYT8;SLC6A6;AKT1;TPCN1;GRB7;KCNC4;TMOD2;CORO1B;HDAC5;UROS;FBXO41;FAM83A;NT5DC1;S100A6;F12;SH2D2A;PPM1F;MMP28;PITPNM1;ENTPD6;PLEKHH3;RHBDF2;PYCR2;BSG;STK39;HK1;SERPING1;ASAP2;SCMH1;DYSF;EPHA1;GGT1;NFKBIZ;PTPRU;VEGFB;FMNL2;ASH2L;IMPACT;MARCH4;SLC15A4;WWC3;ATG16L2;ZFYVE21;LRRC8A;CNTN1;IFNGR2;BRSK1;DAP;IFT140;PTHLH;MYZAP;RAB31;DNAAF5;FGFR4;HEBP1;PEAR1;WNT2B;POLD4;ACOT1;LDLR;FGFR1;PRKACB;FUCA1;MAPKBP1;ELMO3;SIGMAR1;RAC2;KCNAB2;SMOC2;PFKL;TTLL12;SEC14L2;OPLAH;HLTF;MXI1;PPM1J;NPHP4;SYNE3;RAG1;GAMT;H2AFJ;B4GAT1;PACS2;TOMM34;BPHL;PIGV;KLF7;RALGDS;SORL1;NAT14;CEACAM1;CCNI;B3GAT3;ASB13;CIRBP;CBR4;HMG20B;LZTS2;RAB11FIP4;TENM2;ZNF385A;DOCK6;NSMCE4A;MICALCL;ABCD1;ANK3;IGFBP4;TTC7B;EVC;TSHZ1;TRAPPC9;CCND1;PODNL1;EFS;PCBP4;TCF25;LHPP;TNNT1;TWF2;AIG1;STRADB;SYNGAP1;PLCH2;MAPK13;CEP250;EDNRA;CARD19;PLAU;GAS6;PTK6;SEMA3F;PFKP;FGFBP1;CSNK1E;BRI3;CTSB;RAB3B;CARD11;SH2B3;SOX13;LAMA5;DUSP7;MPLKIP;GSN;CMTM4;PLEKHG2;MAPKAPK3;IGFBP2;PCSK9;ARHGAP22;RAD23A;DHTKD1;PHLDA1;ANO8;BCR;ANTXR2;ANGPTL4;MRPS6;EHD4;ERRFI1;GLI4;SEPT10;WIPF1;NADK;PANK4;HLCS;ZSCAN18;AIP;DBNDD1;STON1;CCDC71L;MYEF2;MN1;SH3D19;CCDC113;CDC25B;RGL2;SLITRK6;TSPAN18;PAQR6;ARPIN;ARHGAP27;ALOX15B;SPTB;SMARCD2;AGAP1;NXPH4;PEX10;CCS;RSAD1;COL13A1;CORO7;SLC20A1;RRNAD1;NPR2;UNC119B;SNTA1;DGKQ;HAGH;PLXNB3;BNIP3;PAK6;TFPI2;GTF2IRD1;SHARPIN;MVB12B;SERINC2;TAGLN3;FYCO1;CEMIP;PROCR;PKD2;ACY1;GPX3;PCSK1;RETSAT;YPEL3;RASGEF1A;CTSZ;CDC42EP5;HES2;CRTC1;IL20RB;FBXW8;GPSM1;AP3D1;ITGB5;ABCA2;ZNF598;MAGEF1;PRSS3;SH3PXD2A;EPOR;EPHB2;GRIN3B;ADAM8;ASIC1;CADM4;APRT;CTBP1;JOSD2;LTA4H;MNT;PTPDC1;GRK6;CDKN1C;PLCG1;FBXL8;ZMIZ2;CBS;KIF17;SH3BP2;NYAP1;CD81;CEBPB;MVD;RNF135;ENTPD2;ADAMTS13;ZNF217;TIMP2;ZNF862;NUDCD2;SYNJ2;WNT3;DPP7;GNAL;C8ORF88;TMED4;TGFB1;LACTB2;SNPH;CLTCL1;RFX2;SCYL1;ABHD17C;UNK;ULK2;GPC1;MKNK2;ADAMTS7;DEAF1;MOAP1;TBC1D9B;NTSR1;B3GNT3;NAB2;TMEM173;ARHGAP25;ZSCAN30;ATP7B;FHOD3;SHANK3;PODXL2;SDHA;MSRB2;EFNB3;RASA3;PNRC1;MIPEP;PIP5KL1;TNFSF15;MYCBPAP;MGAT4B;EML2;KIF26B;MDH2;MPG;GALNS;FBXO17;GOLGA2P5;NSMF;PEG3;ARAP3;FARP1;MC1R;TUB;LCE1E;CROCC;RHOD;CGREF1;ABHD14B;LAMB2;TNS1;ABTB1;SNX17;RNH1;DNAH1;ERO1B;ST6GALNAC6;HTR7;VGF;POLL;FBXO44;POLM;PLEKHG4;SNX33;PI4K2A;SEMA4F;PTMS;RHOF;YIPF3;ANKZF1;WASF3;ATG2A;LLGL1;PHGDH;PHF21A;PLEKHG3;MIF4GD;KIF7;COA5;PLPP6;RHOBTB2;UBXN4;ADAM19;KHDRBS3;SAC3D1;TUBG2;ZER1;GIGYF1;RIMS3;BBS1;TNFAIP8L1;HMGCL;PTPN1;PEX1;TPP1;PCK2;B4GALT2;WDR59;AGRN;MBD3;OLFML2A;IFNE;CD320;CAMK2N1;OSBPL10;LRP4;ESYT2;ZDHHC24;GPR153;ACP6;B4GALT6;VHL;DNAJC4;CEP131;TRAP1;IDUA;ADAP1;PFKFB2;RFNG;MLXIPL;YPEL5;TRIB2;PRKCZ;KDM6B;PRKACA;MINK1;ZNF516;CENPH;GRHPR;OXA1L;RHPN1;RABGGTA;RCCD1;ACTR1B;TOM1L2;CD9;EPN2;ADA;AREG;PIM2;MPI;MICALL2;UCKL1;PLEKHG5;BOK;WDR18;TDRKH;CAPG;SDCCAG8;ALAS1;NEURL1B;ERBB2;ADGRB2;ULK1;CNDP2;NINL;AHCY;VAMP2;PRIMPOL;PSMG4;MMP10;TFDP2;PLEK2;C6ORF89;NECAB3;STK17A;RILPL1;JAK3;IRF2BP2;RNPEP;NET1;BNIP3L;CYFIP2;FSCN1;PBX2;TRPC1;NELFCD;SLC22A17;RASA4;PDK1;ACAD10;CYGB;ARHGAP44;THOP1;MCFD2;PRKCD;FAM20C;MIB2;RBL2;CACNB3;USP20;STUB1;IFI6;BAX;CYC1;SV2A;SBF1;DTD1;XYLT2;TRIM4;ITGA1;OLFM2;ZNF395;HIST3H2BB;NUBP2;PPCS;SH3BP1;FBXW4;GJB4;CHADL;EREG;RPS6KA5;DGUOK;DUSP4;TIMM17B;ZNF524;CUL9;SOX12;TMBIM4;DDIT4;MBTPS2;ACADS;TOP3B;SPRED3;PPL;PPP1R13L;CARF;HSD17B7;AHNAK2;PCSK1N;MT2A;IER2;RASL10B;CES2;NAGA;ZDHHC8;TMX4;FCHO1;NID1;LIMK1;TGFBR3;NTPCR;PDIA5;GDI1;TPM2;PADI3;DIP2A;LTB4R2;CPNE7;RPL39L;LEMD2;RPS6KA6;ZHX3;DNM1;WASH3P;RGS14;TMEM8B;SCN8A;MFNG;GSTO1;GIT1;ALDOC;CHAD;MRPS26;MSLN;LPCAT1;LRSAM1;ADAM15;REEP2;ASB1;EHD3;WDR60;ST3GAL3;TMEM231;LONP2;SYMPK;MAPK12;IRAK1;PPOX;TGFA;HDAC7;FHOD1;INPP5D;MTHFR;CHD2;PI4K2B;CBX7;PCMTD2;CHEK2;DECR2;ZFPM1;PPARA;COG7;ABHD15;COQ2;TMEM161A;SESN2;FGGY;ABCG1;MYO1D;JADE2;MYH15;CDC34;RNF123;SOX7;ABCA7;RAB12;SPATA20;EML3;SPEG;SIX5;BCAP31;MIF;ACO2;SMOX;EEF2KMT;KDM4B;DOPEY2;PHYH;ZNF414;MEX3A;BCAM;SLC9A7;PLA2G6;DDT;SSBP4;SYNGR1;NUDT14;ECM1;WFS1;QSOX1;DNAAF3;CD68;ZNF444;DTX3;TRPT1;NBPF3;DALRD3;SPPL2B;FYN;PITPNM3;VWA1;UPP1;EFEMP2;STK25;RAC3;ETFB;EEF2K;CERS4;SUN1;ICAM5;ARHGAP12;ACAP3;ARID5B;HOXC5;DNM2;CKMT1A;CYP3A5;BHLHE40;GLB1;PELI1;ATXN10;SNX15;INF2;CHKA;CAT;BEX2;NEIL1;TSPYL2;IGFBP7;ELFN2;SLC27A1;ZMYM3;TPBG;APOBEC3C;SATB1;KIF26A;ZDHHC1;SLC12A4;PLCB3;H1FX;IQSEC1;ZNF606;APOBEC3F;ARHGEF4;DDX50;CYP2R1;TUBB6;MAPK3;INSR;ARHGEF1;PAN2;GRINA;CAMTA2;TAZ;PFKM;ADCY1;TNS4;C12ORF66;RERE;HLA-G;DOCK9;STX10;TSTA3;INO80C;ATP8B2;GPT2;TMEM101;RALGAPA1;PDXK;ETAA1;GLRX;BCL7A;CEP72;VANGL2;PAK1;DCAF10;KLHL36;MALL;CAMKK2;RNASET2;PPP3CB;RNF144A;LGALS3BP;ALPK1;CTSF;ROBO4;USP21;PFKFB3;MLYCD;CUL7;GABBR1;REV1;MICAL1;HYAL1;SEMA4C;CAPRIN2;ZBTB10;WDTC1;HES7;ITGA3;STK32C;DNMT3A;SAMD8;BIN1;VPS16;MAN2B1;SRMS;TSTD1;PPP2R5B;HES6;MAP2K3;NDST2;BCL2L1;DLG3;SGSM2;ABHD10;NDUFV3;RRAS;DNASE1L1;PROX1;IARS2;LRCH4;MDGA1;TBC1D16;ADGRF1;ALDH7A1;LMNA;ZYG11B;PKD1;KCTD13;TNFRSF25;RABGAP1;SIRT2;FAM129B;CDH4;ITGA4;EDA;UVSSA;GAL3ST4;DCBLD2;NMNAT2;BACH1;NT5C1B;TRIP10;ADCY7;E2F5;ZBTB22;ALG12;LTB4R;MAPRE3;AZIN2;TEP1;RAB28;ZNF704;SERPINB1;ST3GAL2;ICA1;RAP1GAP2;LAMB1;SOCS7;MAP3K10;RGS19;NDE1;GPR3;PELI3;GTF2IRD2;RAB40B;NGFR;TOLLIP;BCORL1;PDCD6;ATP6V1F;PCLO;CHST14;ZNF837;RNASE7;PXN;GRB10;TBC1D8;PHYKPL;PLEKHM1;DUSP23;GCH1;MSS51;LURAP1;KIF13B;MAFF;NR2F6;CBX6;TCTN1;NBEAL2;PNMA1;CAMK1;CAMKK1;SLC39A3;EZH1;SIRT3;HFE;TERC;ZNF513;WIPI2;GAS2L1;COL6A1;BTG1;BBS10;ZP3;VPS51;CELSR1;TACC1;MLF2;IL17RE;SEMA3B;SEPT6;CDK11B;PFN2;SSH3;FGFR3;MFSD10;PPP1R16A;TST;CCDC88C;ST3GAL5;TNRC18;NDRG2;MAN2B2;BLOC1S4;CBLC;ITPKB;PTGR2;SPTLC2;TCEA2;CDC42BPG;PRSS21;ZBTB47;PLAG1;DOK4;GSDMA;CLK3;IRF2BPL;TRIM46;DHX32;KDM3A;PM20D2;TBL3;HOMER2;SLC23A2;PKN3;APBA1;TTLL3;DEDD2;PI4KAP2;AK3;SRSF5;CHPF;ADCY6;SLC26A11;LRRK1;AARS;KLHL24;SDC2
19128,GO:1905050,0.544714753696588,0.834532914973013,1,7,positive regulation of metallopeptidase activity,BP,MAPK3
3193,GO:0006825,0.544721524381352,0.738409900989797,2,18,copper ion transport,BP,CCS;ATP7B
4635,GO:0010759,0.544821350248138,0.834456853416848,1,7,positive regulation of macrophage chemotaxis,BP,MAPK3
3313,GO:0007020,0.544982784589895,0.6917757324134,3,26,microtubule nucleation,BP,EML2;TUBG2;NDE1
5502,GO:0016445,0.545127483887032,0.640925056346801,5,45,somatic diversification of immunoglobulins,BP,ERCC1;STAT6;TGFB1;POLL;POLM
20289,GO:2001237,0.545289905950235,0.602789989542554,8,75,negative regulation of extrinsic apoptotic signaling pathway,BP,ITGA6;AKT1;STRADB;IFI6;FYN;BCL2L1;LMNA;PELI3
6700,GO:0030111,0.54541973568229,0.536258771939705,27,259,regulation of Wnt signaling pathway,BP,EGR1;CTNNBIP1;WNT7A;APOE;LRP5;WWTR1;NFATC4;MDFI;SMURF2;LRP1;DVL1;WNT2B;NPHP4;LZTS2;IGFBP4;CCND1;CSNK1E;IGFBP2;WNT3;LRP4;SOX7;VANGL2;CAPRIN2;ITGA3;EDA;GRB10;LRRK1
17394,GO:1900118,0.545620552341075,0.833885822837553,1,7,negative regulation of execution phase of apoptosis,BP,BCL2L1
4441,GO:0010340,0.545814946633851,0.833746724172883,1,7,carboxyl-O-methyltransferase activity,MF,PCMTD2
13285,GO:0051998,0.545814946633851,0.833746724172883,1,7,protein carboxyl O-methyltransferase activity,MF,PCMTD2
9844,GO:0042095,0.545988013987963,0.833622818824637,1,7,interferon-gamma biosynthetic process,BP,ZFPM1
10083,GO:0042589,0.546061802869628,0.833569971379084,1,7,zymogen granule membrane,CC,VAMP2
13119,GO:0051683,0.546167926592397,0.833493945612339,1,7,establishment of Golgi localization,BP,STK25
3766,GO:0008318,0.546386200958394,0.833337501617071,1,7,protein prenyltransferase activity,MF,RABGGTA
1178,GO:0002824,0.546813605313404,0.639044976690913,5,46,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,STAT6;TGFB1;PRKCZ;ADA;ZP3
9152,GO:0035510,0.546878935221104,0.689484365464352,3,27,DNA dealkylation,BP,MPG;APOBEC3C;APOBEC3F
9198,GO:0035586,0.547289252373246,0.832689185155024,1,7,purinergic receptor activity,MF,ADORA2B
6715,GO:0030132,0.547321836358034,0.73702567043138,2,17,clathrin coat of coated pit,CC,EGFR;AP2A2
3036,GO:0006591,0.54733712181225,0.832654770627372,1,7,ornithine metabolic process,BP,AZIN2
13140,GO:0051721,0.547528660644975,0.689403176532147,3,26,protein phosphatase 2A binding,MF,AKT1;PTPN1;STRN4
11068,GO:0045076,0.547614064101657,0.832455574576186,1,7,regulation of interleukin-2 biosynthetic process,BP,CARD11
1484,GO:0003785,0.547614355270169,0.735857556452017,2,18,actin monomer binding,MF,TWF2;PFN2
7106,GO:0030913,0.548138916937577,0.832077617576562,1,7,paranodal junction assembly,BP,CD9
10299,GO:0043069,0.548383662745305,0.504712897940766,66,629,negative regulation of programmed cell death,BP,PDCD4;PRNP;VEGFA;TNFRSF6B;WNT7A;APOE;F2R;ITGA6;HMGA2;EGFR;SPRY2;MST1R;SHC1;RBCK1;SMAD3;LRP1;PRDX5;AKT1;EPHA1;FGFR4;FGFR1;RAG1;ZNF385A;STRADB;SYNGAP1;GAS6;ANGPTL4;RGL2;BNIP3;EPHB2;ADAM8;MNT;CEBPB;NTSR1;PTPN1;VHL;TRAP1;PRKCZ;ADA;PIM2;BOK;ERBB2;JAK3;BNIP3L;PRKCD;IFI6;BAX;TMBIM4;IRAK1;TMEM161A;MIF;WFS1;FYN;EEF2K;CAT;INSR;GRINA;MICAL1;BCL2L1;LMNA;FAM129B;PELI3;NGFR;FGFR3;ITPKB;AARS
11243,GO:0045472,0.548584872395614,0.831756016287691,1,7,response to ether,BP,NFATC4
6440,GO:0021761,0.5486166624201,0.609471736888001,7,65,limbic system development,BP,BBS2;PTPRS;FGFR1;KDM6B;BAX;PROX1;EZH1
7968,GO:0032588,0.548639586192221,0.609449058925002,7,65,trans-Golgi network membrane,CC,RAB31;ATP7B;LLGL1;BOK;COG7;STX10;VPS51
9942,GO:0042308,0.548640477970223,0.831715886612422,1,7,negative regulation of protein import into nucleus,BP,GAS6
18913,GO:1904590,0.548640477970223,0.831715886612422,1,7,negative regulation of protein import,BP,GAS6
9994,GO:0042415,0.548754344863668,0.831633690130782,1,7,norepinephrine metabolic process,BP,EPAS1
7372,GO:0031432,0.548754799343243,0.831633362003591,1,7,titin binding,MF,OBSCN
12817,GO:0051131,0.549261844483433,0.735310919819955,2,17,chaperone-mediated protein complex assembly,BP,STUB1;BBS10
4856,GO:0014070,0.54927851358806,0.503458942945236,67,633,response to organic cyclic compound,BP,DUSP6;EGR1;NR1D1;CST3;CYP27B1;POSTN;FAM210B;WNT7A;ITGA6;EGFR;NFATC4;SDC1;RAPGEF3;ZFP36L1;MAP2K2;MAP2K1;SSH1;ENDOG;FOS;SMAD3;AKT1;HDAC5;BSG;PTPRU;IMPACT;PRKACB;CCND1;GSN;IGFBP2;ERRFI1;HLCS;PAQR6;DGKQ;PKD2;ABCA2;CEBPB;TGFB1;TMEM173;VGF;PCK2;MBD3;IFNE;PRKACA;ADA;AREG;DDIT4;LONP2;MTHFR;CHEK2;PPARA;EEF2K;DNM2;GLB1;PELI1;CHKA;CAT;IGFBP7;MAPK3;ADCY1;PAK1;DNMT3A;BCL2L1;SIRT2;NR2F6;KDM3A;HOMER2;ADCY6
8057,GO:0032732,0.549702855821514,0.686841541641961,3,27,positive regulation of interleukin-1 production,BP,EGR1;SMAD3;HK1
12108,GO:0048172,0.549707944728752,0.830944236350865,1,7,regulation of short-term neuronal synaptic plasticity,BP,SYNGR1
15283,GO:0071474,0.549901437692699,0.830804104158324,1,7,cellular hyperosmotic response,BP,ERRFI1
15282,GO:0071472,0.549901437692699,0.830804104158844,1,7,cellular response to salt stress,BP,ZFP36L1
6916,GO:0030514,0.550087220274305,0.687009154831537,3,26,negative regulation of BMP signaling pathway,BP,HTRA1;SMURF2;LEMD2
5325,GO:0016051,0.550211508076836,0.552265172834667,17,160,carbohydrate biosynthetic process,BP,NR1D1;PGM1;ISYNA1;PC;AKT1;DGKQ;TGFB1;NTSR1;B3GNT3;MDH2;ST6GALNAC6;PCK2;ALDOC;PPARA;INSR;ST3GAL2;CHST14
11851,GO:0046851,0.550277974109647,0.8305311784945,1,7,negative regulation of bone remodeling,BP,INPP5D
10692,GO:0043983,0.550432504154055,0.83041908253558,1,7,histone H4-K12 acetylation,BP,JADE2
7061,GO:0030855,0.550708956168471,0.512323041450344,46,442,epithelial cell differentiation,BP,XDH;CST3;CYP27B1;ACVR2B;VEGFA;WNT7A;DNPH1;WWTR1;PTPRS;PRSS8;SDC1;ACTA2;RAPGEF3;ZFP36L1;MAP2K1;SMAD3;AKT1;FGFR1;CEACAM1;CCND1;PTK6;CTSB;LAMA5;ERRFI1;SLITRK6;ALOX15B;SHARPIN;CEBPB;TGFB1;LCE1E;LAMB2;TPP1;PCK2;KDM6B;RILPL1;FAM20C;SH3BP1;EREG;PPL;ALDOC;TMEM231;PROX1;TOLLIP;MAFF;BTG1;TST
11676,GO:0046470,0.550760039249991,0.619502155775571,6,56,phosphatidylcholine metabolic process,BP,LPCAT4;LDLR;LPCAT1;PLA2G6;CHKA;SLC27A1
11904,GO:0046950,0.551001354361555,0.830005999258631,1,7,cellular ketone body metabolic process,BP,HMGCL
17923,GO:1902224,0.551001354361555,0.830005999258631,1,7,ketone body metabolic process,BP,HMGCL
17346,GO:1900026,0.55117919570969,0.685455183515025,3,27,positive regulation of substrate adhesion-dependent cell spreading,BP,NET1;RAC3;DNM2
11312,GO:0045646,0.55126443476996,0.655722128579198,4,36,regulation of erythrocyte differentiation,BP,FAM210B;ZFP36L1;INPP5D;ZFPM1
10319,GO:0043116,0.551298772793411,0.829789746605491,1,7,negative regulation of vascular permeability,BP,CEACAM1
17850,GO:1902017,0.551358931679099,0.655298587284108,4,37,regulation of cilium assembly,BP,EVI5L;IFT140;CROCC;DNM2
18260,GO:1903071,0.551374212232186,0.829734864545601,1,7,positive regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,BCAP31
3097,GO:0006678,0.551404619291717,0.829712740016845,1,7,glucosylceramide metabolic process,BP,PRKCD
3158,GO:0006771,0.551419638476586,0.82970181115454,1,7,riboflavin metabolic process,BP,ACP5
8087,GO:0032780,0.55154340077635,0.829611735851377,1,7,negative regulation of ATPase activity,BP,OXA1L
14736,GO:0070410,0.551620413209188,0.829555668949135,1,7,co-SMAD binding,MF,SMAD3
6733,GO:0030157,0.551646517787797,0.829536661306479,1,7,pancreatic juice secretion,BP,STK39
15160,GO:0071285,0.551709578221123,0.829490738799644,1,7,cellular response to lithium ion,BP,NFATC4
10274,GO:0043027,0.551923338530389,0.732947782797515,2,17,cysteine-type endopeptidase inhibitor activity involved in apoptotic process,MF,PRDX5;GAS6
11168,GO:0045254,0.551987157881848,0.829288495560176,1,7,pyruvate dehydrogenase complex,CC,PDK1
2542,GO:0005811,0.552055862660176,0.606063496411904,7,65,lipid droplet,CC,PITPNM1;SIGMAR1;ATG2A;LPCAT1;IRAK1;BCAP31;EDA
4185,GO:0009264,0.552141999447015,0.731833628037287,2,18,deoxyribonucleotide catabolic process,BP,ADA;NEIL1
817,GO:0002091,0.552155277287198,0.829165924175478,1,7,negative regulation of receptor internalization,BP,DLG4
5028,GO:0015194,0.552163415823375,0.829159989049208,1,7,L-serine transmembrane transporter activity,MF,SERINC2
5221,GO:0015825,0.552163415823375,0.829159989049208,1,7,L-serine transport,BP,SERINC2
6623,GO:0022889,0.552163415823375,0.829159989049208,1,7,serine transmembrane transporter activity,MF,SERINC2
14111,GO:0060982,0.552335120438626,0.8290347381645,1,7,coronary artery morphogenesis,BP,VEGFA
15618,GO:0072110,0.552416753515191,0.828975168260966,1,7,glomerular mesangial cell proliferation,BP,EGR1
15622,GO:0072124,0.552416753515191,0.828975168260966,1,7,regulation of glomerular mesangial cell proliferation,BP,EGR1
7191,GO:0031087,0.552631525177353,0.828818375097867,1,7,deadenylation-independent decapping of nuclear-transcribed mRNA,BP,PNRC1
6626,GO:0022900,0.552722438016041,0.563179390997324,13,142,electron transport chain,BP,XDH;AKR7A2;ALDH4A1;TXNRD3;D2HGDH;SDHA;PHGDH;CYC1;ETFB;TAZ;TSTA3;GLRX;NDUFV3
3716,GO:0008239,0.552752781779801,0.828729808445585,1,7,dipeptidyl-peptidase activity,MF,DPP7
12293,GO:0048642,0.552791616787874,0.828701436405085,1,7,negative regulation of skeletal muscle tissue development,BP,TGFB1
12612,GO:0050805,0.552932393545282,0.654112659937989,4,36,negative regulation of synaptic transmission,BP,SHANK2;ASIC1;SHANK3;PLA2G6
1187,GO:0002833,0.553054774720194,0.683689255806284,3,27,positive regulation of response to biotic stimulus,BP,LRSAM1;MIF;MAPK3
7728,GO:0032230,0.553226876630781,0.828383222844635,1,7,positive regulation of synaptic transmission, GABAergic,BP,NLGN2
5854,GO:0017151,0.553391629995598,0.828262667161946,1,7,DEAD/H-box RNA helicase binding,MF,SMAD3
11061,GO:0045069,0.553392790335507,0.594507201941662,8,77,regulation of viral genome replication,BP,TNIP1;HMGA2;STOM;ADARB1;RAD23A;APOBEC3C;APOBEC3F;PROX1
19883,GO:2000345,0.553511070939061,0.828175231592248,1,7,regulation of hepatocyte proliferation,BP,CEACAM1
9090,GO:0035358,0.553512674410204,0.828174057579705,1,7,regulation of peroxisome proliferator activated receptor signaling pathway,BP,ALOX15B
4880,GO:0014743,0.55361744334047,0.653450576257801,4,36,regulation of muscle hypertrophy,BP,SMAD3;ERRFI1;PAK1;LMNA
13767,GO:0060363,0.553714671370175,0.828026117059626,1,7,cranial suture morphogenesis,BP,TGFB1
7641,GO:0032059,0.553966139389012,0.827841821569669,1,7,bleb,CC,FHOD1
11780,GO:0046655,0.554041582644001,0.73105813749175,2,17,folic acid metabolic process,BP,MTHFR;PM20D2
20008,GO:2000586,0.55422010724017,0.827655555616498,1,7,regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,LRP1
46,GO:0000098,0.55436857735371,0.827546599704738,1,7,sulfur amino acid catabolic process,BP,CBS
3006,GO:0006555,0.554378400024314,0.73075694333919,2,17,methionine metabolic process,BP,AHCY;MTHFR
19560,GO:1990462,0.554451039257581,0.827486063867534,1,7,omegasome,CC,ULK1
11391,GO:0045792,0.554586721171849,0.827386426907893,1,7,negative regulation of cell size,BP,AKT1
2439,GO:0005641,0.554699550806962,0.827303541063934,1,7,nuclear envelope lumen,CC,SORL1
18031,GO:1902514,0.555090858509492,0.827015869142282,1,7,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,NOS1
7181,GO:0031076,0.555334630769679,0.682068790453847,3,26,embryonic camera-type eye development,BP,IFT140;PPP1R13L;PROX1
95,GO:0000186,0.555486000400913,0.630813264641711,5,45,activation of MAPKK activity,BP,F2R;EGFR;ERCC6;PLCG1;MAP3K10
3390,GO:0007172,0.555495291925931,0.82671819980275,1,7,signal complex assembly,BP,PXN
4705,GO:0010869,0.555509229065089,0.729744255738229,2,17,regulation of receptor biosynthetic process,BP,NR1D1;PPARA
18413,GO:1903431,0.555556853585808,0.826672858409864,1,7,positive regulation of cell maturation,BP,SIRT2
13991,GO:0060717,0.555599641760472,0.82664133923432,1,7,chorion development,BP,HTRA1
10581,GO:0043551,0.555626009566402,0.681793258355598,3,26,regulation of phosphatidylinositol 3-kinase activity,BP,PIK3R2;TGFB1;FGFR3
16575,GO:0097371,0.555682210441327,0.826580505222966,1,7,MDM2/MDM4 family protein binding,MF,PPARA
3732,GO:0008272,0.555687992288145,0.826576244785324,1,7,sulfate transport,BP,SLC26A11
7510,GO:0031702,0.55579431734298,0.826497884742132,1,7,type 1 angiotensin receptor binding,MF,ARAP1
9497,GO:0036149,0.555799685524089,0.826493927819375,1,7,phosphatidylinositol acyl-chain remodeling,BP,MBOAT7
1889,GO:0004571,0.555880359589629,0.826434454903342,1,7,mannosyl-oligosaccharide 1,2-alpha-mannosidase activity,MF,EDEM1
17938,GO:1902254,0.555937537278741,0.728432729367037,2,18,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,ZNF385A;MIF
6767,GO:0030208,0.556021422554582,0.826330429409248,1,7,dermatan sulfate biosynthetic process,BP,CHST14
7,GO:0000014,0.556104637163938,0.826269043386663,1,7,single-stranded DNA endodeoxyribonuclease activity,MF,ERCC1
4906,GO:0014841,0.556121027538193,0.826256950713104,1,7,skeletal muscle satellite cell proliferation,BP,SIX5
4907,GO:0014842,0.556121027538193,0.826256950713104,1,7,regulation of skeletal muscle satellite cell proliferation,BP,SIX5
4917,GO:0014856,0.556121027538193,0.826256950713104,1,7,skeletal muscle cell proliferation,BP,SIX5
4918,GO:0014857,0.556121027538193,0.826256950713104,1,7,regulation of skeletal muscle cell proliferation,BP,SIX5
2301,GO:0005283,0.55632296666206,0.826107913994129,1,7,amino acid:sodium symporter activity,MF,SLC6A8
18089,GO:1902669,0.556327721474072,0.826104403744014,1,7,positive regulation of axon guidance,BP,VEGFA
4275,GO:0009642,0.556355225574638,0.826084097821451,1,7,response to light intensity,BP,CAT
17803,GO:1901879,0.556478857262747,0.61402988593715,6,55,regulation of protein depolymerization,BP,TMOD2;TWF2;GSN;SPTB;CAPG;SH3BP1
7751,GO:0032274,0.556602517038808,0.825901451994006,1,7,gonadotropin secretion,BP,FAM129B
12853,GO:0051182,0.556715977645612,0.825817607240456,1,7,coenzyme transport,BP,SLC23A2
8342,GO:0033210,0.556798493409676,0.825756612446726,1,7,leptin-mediated signaling pathway,BP,BBS2
13511,GO:0055093,0.556874062661663,0.728519009655125,2,17,response to hyperoxia,BP,BNIP3;CAT
5525,GO:0016500,0.556900110778969,0.82568147762263,1,7,protein-hormone receptor activity,MF,INSR
6469,GO:0021814,0.556928093826575,0.825660783308937,1,7,cell motility involved in cerebral cortex radial glia guided migration,BP,SUN1
7582,GO:0031957,0.556955315801131,0.825640650201061,1,7,very long-chain fatty acid-CoA ligase activity,MF,SLC27A1
2283,GO:0005242,0.55697863960433,0.825623398862191,1,7,inward rectifier potassium channel activity,MF,KCNJ15
3787,GO:0008354,0.55701793710784,0.825594329975746,1,7,germ cell migration,BP,TGFB1
10072,GO:0042577,0.557138722250674,0.825504962590185,1,7,lipid phosphatase activity,MF,PLPP6
5102,GO:0015386,0.55714983278754,0.8254967404526,1,7,potassium:proton antiporter activity,MF,SLC9A7
5617,GO:0016670,0.557204531049624,0.825456258152093,1,7,oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor,MF,QSOX1
14050,GO:0060839,0.557371570778401,0.825332591417964,1,7,endothelial cell fate commitment,BP,PROX1
17719,GO:1901620,0.557451562909158,0.825273348298026,1,7,regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,PRKACB
5047,GO:0015232,0.557517800892501,0.825224281121352,1,7,heme transporter activity,MF,SLC48A1
5256,GO:0015886,0.557517800892501,0.825224281121352,1,7,heme transport,BP,SLC48A1
187,GO:0000405,0.557532018416939,0.82521374794622,1,7,bubble DNA binding,MF,XPC
2587,GO:0005883,0.55761249650068,0.82515411678015,1,7,neurofilament,CC,SHANK2
7795,GO:0032351,0.557616601446622,0.825151074797528,1,7,negative regulation of hormone metabolic process,BP,CYP27B1
7797,GO:0032353,0.557616601446622,0.825151074797528,1,7,negative regulation of hormone biosynthetic process,BP,CYP27B1
3517,GO:0007494,0.557662029659927,0.825117407605337,1,7,midgut development,BP,EGFR
5276,GO:0015926,0.557700818784107,0.825088657141452,1,7,glucosidase activity,MF,GAA
12206,GO:0048407,0.557702071524493,0.825087728556214,1,7,platelet-derived growth factor binding,MF,COL6A1
847,GO:0002162,0.557702246797288,0.825087598637474,1,7,dystroglycan binding,MF,AGRN
8215,GO:0032982,0.557702246797288,0.825087598637649,1,7,myosin filament,CC,MYH15
16632,GO:0097493,0.557702246797288,0.825087598637475,1,7,structural molecule activity conferring elasticity,MF,OBSL1
4747,GO:0010919,0.557702246803725,0.825087598631038,1,7,regulation of inositol phosphate biosynthetic process,BP,NTSR1
12182,GO:0048340,0.557702246803725,0.825087598631038,1,7,paraxial mesoderm morphogenesis,BP,SMAD3
15356,GO:0071599,0.557702246803725,0.825087598630864,1,7,otic vesicle development,BP,PROX1
15774,GO:0072383,0.557702246803725,0.825087598631038,1,7,plus-end-directed vesicle transport along microtubule,BP,FYCO1
18848,GO:1904429,0.557702246803725,0.825087598631386,1,7,regulation of t-circle formation,BP,ERCC1
14004,GO:0060736,0.557702246803725,0.825087598631038,1,7,prostate gland growth,BP,PLAG1
12141,GO:0048259,0.55786447401814,0.612471787819168,6,56,regulation of receptor-mediated endocytosis,BP,DLG4;APLN;VEGFA;PCSK9;ARAP3;HFE
18076,GO:1902624,0.558179623590675,0.726411849610584,2,18,positive regulation of neutrophil migration,BP,RAC2;ADAM8
6072,GO:0019226,0.558370402006042,0.678655913133418,3,27,transmission of nerve impulse,BP,ANK3;AHNAK2;SCN8A
9070,GO:0035325,0.558652272218077,0.821547755439648,1,8,Toll-like receptor binding,MF,TOLLIP
5157,GO:0015696,0.558722779039622,0.627145913606562,5,47,ammonium transport,BP,NOS1;RAB3B;ADA;SLC25A29;AZIN2
18820,GO:1904375,0.559110497370361,0.589011037652582,8,75,regulation of protein localization to cell periphery,BP,PRNP;EGFR;LRP1;AKT1;EPHB2;TGFB1;ITGA3;BCL2L1
7675,GO:0032119,0.559506139061763,0.820903841772803,1,8,sequestering of zinc ion,BP,AP3D1
11619,GO:0046332,0.559910399523771,0.610620277053745,6,55,SMAD binding,MF,HMGA2;SMURF2;FOS;SMAD3;STUB1;TGFBR3
9876,GO:0042149,0.559938996662574,0.6473118082419,4,36,cellular response to glucose starvation,BP,IMPACT;SESN2;UPP1;C12ORF66
19779,GO:2000171,0.56003146038166,0.725671908854572,2,17,negative regulation of dendrite development,BP,PTPRS;NFATC4
5297,GO:0015985,0.560086080784497,0.820465584447799,1,8,energy coupled proton transport, down electrochemical gradient,BP,CYC1
5298,GO:0015986,0.560086080784497,0.820465584447799,1,8,ATP synthesis coupled proton transport,BP,CYC1
12153,GO:0048278,0.560330881980515,0.610018214812489,6,56,vesicle docking,BP,VPS11;EXOC2;RAB3B;SNPH;STX10;RAB40B
13475,GO:0055023,0.560669053303158,0.725094830080363,2,17,positive regulation of cardiac muscle tissue growth,BP,FGFR1;TGFBR3
10678,GO:0043949,0.561033324174532,0.7247648077658,2,17,regulation of cAMP-mediated signaling,BP,NOS1;CDC34
6937,GO:0030551,0.561218328005392,0.724597107475343,2,17,cyclic nucleotide binding,MF,RAPGEF3;TMEM173
13462,GO:0055008,0.561270615024962,0.646011962130058,4,36,cardiac muscle tissue morphogenesis,BP,TGFB1;TGFBR3;ZFPM1;PROX1
7335,GO:0031369,0.561455386614448,0.67521774653535,3,28,translation initiation factor binding,MF,ANGEL1;C8ORF88;GCH1
2854,GO:0006348,0.562015308432671,0.819002342538759,1,8,chromatin silencing at telomere,BP,SIRT2
14878,GO:0070670,0.562132800316393,0.675067725419675,3,27,response to interleukin-4,BP,STAT6;ADAMTS13;JAK3
2102,GO:0004869,0.562167276279993,0.674075051104785,3,29,cysteine-type endopeptidase inhibitor activity,MF,CST3;PRDX5;GAS6
1461,GO:0003707,0.562615210543458,0.644697061929623,4,36,steroid hormone receptor activity,MF,NR1D1;PAQR6;PPARA;NR2F6
11732,GO:0046579,0.562733986829387,0.674492400377679,3,27,positive regulation of Ras protein signal transduction,BP,F2R;RASGEF1A;ITPKB
5483,GO:0016417,0.563034857902953,0.674204267133323,3,27,S-acyltransferase activity,MF,ZDHHC24;ZDHHC8;ZDHHC1
14035,GO:0060795,0.563088722328963,0.722898226473249,2,17,cell fate commitment involved in formation of primary germ layer,BP,DUSP6;FGFR1
11455,GO:0045920,0.563161677630873,0.722831834587107,2,17,negative regulation of exocytosis,BP,CEACAM1;BCR
7561,GO:0031929,0.563276041988579,0.569497256882628,10,94,TOR signaling,BP,AKT1;GAS6;CARD11;DGKQ;TNFAIP8L1;WDR59;DDIT4;SESN2;C12ORF66;PDCD6
1263,GO:0003016,0.563399350042182,0.722615478379623,2,17,respiratory system process,BP,GAA;NLGN2
3240,GO:0006900,0.563505083504899,0.576156009745421,9,86,vesicle budding from membrane,BP,TRAPPC9;CTSZ;AP3D1;AREG;MCFD2;DNM1;TGFA;DNM2;PDCD6
12830,GO:0051149,0.563505886979485,0.606849911029636,6,56,positive regulation of muscle cell differentiation,BP,TGFB1;OLFM2;MAPK12;PROX1;FAM129B;CAMK1
993,GO:0002449,0.563549866283944,0.548893766348894,14,134,lymphocyte mediated immunity,BP,ERCC1;POU2F2;STAT6;SERPING1;CEACAM1;IL20RB;TGFB1;SCART1;PRKCZ;PRKCD;INPP5D;PPP3CB;HFE;ZP3
18133,GO:1902807,0.564188596466137,0.568409325494189,10,96,negative regulation of cell cycle G1/S phase transition,BP,FHL1;GJC2;ZNF385A;CCND1;PCBP4;PKD2;TFDP2;RBL2;BAX;CHEK2
17074,GO:0099568,0.564514584486979,0.506310744885834,36,341,cytoplasmic region,CC,DLG4;CAPN2;RAPGEF3;EXOC2;FAM110C;IFT140;MYZAP;GSN;SEPT10;WIPF1;SPTB;PKD2;CTSZ;GPSM1;AP3D1;KIF17;NSMF;RHOD;DNAH1;RHOF;LLGL1;RHOBTB2;RIMS3;BBS1;PRKCZ;PRKACA;ADA;SH3BP1;TRIP10;PCLO;PXN;HFE;SEPT6;BLOC1S4;TRIM46;TTLL3
2610,GO:0005921,0.564817023183107,0.721322853377605,2,17,gap junction,CC,GJC2;GJB4
18698,GO:1904037,0.564949750359149,0.721201649337751,2,17,positive regulation of epithelial cell apoptotic process,BP,PDCD4;GSN
646,GO:0001837,0.565689837295863,0.567052790464467,10,94,epithelial to mesenchymal transition,BP,PDCD4;HMGA2;WWTR1;SMAD3;S100A4;TGFB1;TGFBR3;ADAM15;CUL7;PDCD6
8198,GO:0032958,0.565738209121208,0.72048099178551,2,17,inositol phosphate biosynthetic process,BP,NTSR1;ITPKB
14651,GO:0070254,0.565832957831325,0.816082474476735,1,8,mucus secretion,BP,ADA
8499,GO:0033687,0.566069008868999,0.720178305889377,2,17,osteoblast proliferation,BP,LRP5;SMAD3
14897,GO:0070723,0.566077657356147,0.720170389778902,2,17,response to cholesterol,BP,ABCA2;TGFB1
631,GO:0001821,0.566258943653455,0.815754650356365,1,8,histamine secretion,BP,ADA
19721,GO:2000045,0.566325045868738,0.546023877066506,14,135,regulation of G1/S transition of mitotic cell cycle,BP,FHL1;EGFR;GJC2;AKT1;ZNF385A;CCND1;PCBP4;PKD2;TFDP2;RBL2;BAX;CHEK2;HYAL1;PKD1
287,GO:0000792,0.566613362703651,0.591360357914182,7,66,heterochromatin,CC,HMGA2;PHC2;MBD3;SATB1;DNMT3A;SIRT2;CBX6
12828,GO:0051147,0.567094540758498,0.565627925029356,10,94,regulation of muscle cell differentiation,BP,PDCD4;HDAC5;TGFB1;OLFM2;EREG;MAPK12;PAK1;PROX1;FAM129B;CAMK1
8585,GO:0034097,0.567561928314418,0.479579018330799,84,814,response to cytokine,BP,EGR1;CYP27B1;PDCD4;BBS2;POSTN;VEGFA;TNFRSF6B;SPRY2;MST1R;SDC1;SHC1;MMP1;ZFP36L1;RBCK1;ACP5;ENDOG;FOS;SMAD3;STAT6;AKT1;IFNGR2;CEACAM1;CCND1;PODNL1;MAPK13;GAS6;PFKP;LAMA5;GSN;MAPKAPK3;AIP;NPR2;SHARPIN;IL20RB;EPOR;CEBPB;ADAMTS13;TIMP2;TGFB1;RFX2;ADAMTS7;TMEM173;TNFSF15;PTPN1;PCK2;IFNE;PRKACA;JAK3;FSCN1;PRKCD;IFI6;EREG;RPS6KA5;MT2A;GSTO1;CHAD;IRAK1;INPP5D;MTHFR;CDC34;RAB12;MIF;SYNGR1;ECM1;SPPL2B;FYN;ARID5B;PELI1;SLC27A1;MAPK3;HLA-G;PPP3CB;HYAL1;BCL2L1;TNFRSF25;ITGA4;EDA;SOCS7;PELI3;NGFR;TOLLIP;GCH1;IL17RE;KDM3A
12656,GO:0050869,0.567790262208932,0.718600161822312,2,17,negative regulation of B cell activation,BP,PKN1;INPP5D
12355,GO:0048747,0.568095092155043,0.669337724392383,3,27,muscle fiber development,BP,FLNC;VEGFA;FAM129B
1452,GO:0003684,0.568140267255031,0.589820517370623,7,66,damaged DNA binding,MF,ERCC1;XPC;DDB2;RAD23A;MPG;NEIL1;REV1
7995,GO:0032623,0.568374022472456,0.6386975937281,4,37,interleukin-2 production,BP,PRNP;CARD11;IL20RB;HDAC7
18264,GO:1903077,0.568454503342153,0.717989720209311,2,17,negative regulation of protein localization to plasma membrane,BP,TGFB1;BCL2L1
537,GO:0001656,0.568990459085062,0.601350755201806,6,56,metanephros development,BP,EGR1;WWTR1;PKD2;KIF26B;LAMB2;PKD1
14305,GO:0061450,0.569185355772704,0.813491576677591,1,8,trophoblast cell migration,BP,SMURF2
17576,GO:1901163,0.569185355772704,0.813491576677591,1,8,regulation of trophoblast cell migration,BP,SMURF2
3066,GO:0006636,0.569196061388063,0.667769641973257,3,28,unsaturated fatty acid biosynthetic process,BP,ALOX15B;DECR2;MIF
13834,GO:0060445,0.569328519851386,0.717185280358543,2,17,branching involved in salivary gland morphogenesis,BP,FGFR1;LAMA5
20142,GO:2000810,0.569351466159858,0.717164142112112,2,17,regulation of bicellular tight junction assembly,BP,NPHP4;PRKACA
8325,GO:0033180,0.569617134550622,0.813156038269757,1,8,proton-transporting V-type ATPase, V1 domain,CC,ATP6V1F
10060,GO:0042558,0.569702354145094,0.667279316753512,3,28,pteridine-containing compound metabolic process,BP,MTHFR;GCH1;PM20D2
16639,GO:0097502,0.569887547899448,0.667099866052321,3,28,mannosylation,BP,B4GAT1;PIGV;ALG12
12259,GO:0048563,0.571137488833735,0.811971204880976,1,8,post-embryonic animal organ morphogenesis,BP,BAX
10582,GO:0043552,0.571280349134665,0.715383838798245,2,17,positive regulation of phosphatidylinositol 3-kinase activity,BP,TGFB1;FGFR3
2640,GO:0005978,0.571281362724901,0.635822505729577,4,37,glycogen biosynthetic process,BP,NR1D1;PGM1;AKT1;INSR
4174,GO:0009250,0.571281362724901,0.635822505729577,4,37,glucan biosynthetic process,BP,NR1D1;PGM1;AKT1;INSR
6765,GO:0030206,0.571472799271982,0.715205842890164,2,17,chondroitin sulfate biosynthetic process,BP,XYLT2;CHPF
18409,GO:1903427,0.571476602747336,0.714242766083396,2,18,negative regulation of reactive oxygen species biosynthetic process,BP,ACP5;TRAP1
10798,GO:0044291,0.571684435791494,0.614494026827459,5,46,cell-cell contact zone,CC,SCN4B;OBSL1;ANK3;FHOD1;PAK1
3798,GO:0008378,0.57177449220564,0.665774695818548,3,27,galactosyltransferase activity,MF,B3GNT3;B4GALT2;B4GALT6
19054,GO:1904888,0.572443977709435,0.613732572426411,5,46,cranial skeletal system development,BP,SMAD3;SH3PXD2B;IFT140;TGFB1;SLC39A3
7186,GO:0031082,0.57285684362248,0.712961371759545,2,18,BLOC complex,CC,PI4K2A;BLOC1S4
15265,GO:0071450,0.572963463328254,0.712007056456332,2,19,cellular response to oxygen radical,BP,CCS;GCH1
15266,GO:0071451,0.572963463328254,0.712007056456332,2,19,cellular response to superoxide,BP,CCS;GCH1
8246,GO:0033032,0.572976047971713,0.712850541930621,2,18,regulation of myeloid cell apoptotic process,BP,MIF;ITPKB
17701,GO:1901570,0.573041563671665,0.596916586350031,6,58,fatty acid derivative biosynthetic process,BP,HSD17B8;GGT1;CBR4;LTA4H;HMGCL;MIF
6057,GO:0019207,0.573315951148003,0.528692637699944,17,163,kinase regulator activity,MF,SPRY2;MAP2K2;MAP2K1;PIK3R2;ERCC6;RAC2;CCND1;PODNL1;GAS6;DGKQ;CDKN1C;TGFB1;CAMK2N1;TRIB2;CHAD;ETAA1;SOCS7
8010,GO:0032649,0.573364933405312,0.612340582627508,5,48,regulation of interferon-gamma production,BP,PRNP;GAS6;IL20RB;ZFPM1;ZP3
15870,GO:0072595,0.573663485730618,0.633134714288563,4,38,maintenance of protein localization in organelle,BP,ARL2;AKT1;HK1;SUN1
1050,GO:0002577,0.573738662927759,0.809931905798304,1,8,regulation of antigen processing and presentation,BP,HFE
14899,GO:0070727,0.573777939038655,0.4621051925692,153,1477,cellular macromolecule localization,BP,ZMYND8;EDEM1;DLG4;PRNP;BBS2;APOE;OBSCN;EVI5L;EGFR;OBSL1;TMEM129;SYTL1;ETV5;LTBP2;VPS11;TBC1D14;ARL2;SNX9;NUDCD3;RAPGEF3;ZFP36L1;SSH1;LRP1;DVL1;AP2A2;SH3PXD2B;NLGN2;STOM;AKT1;CORO1B;BSG;HK1;PTPRU;IFT140;RAB31;RAC2;KCNAB2;SYNE3;PACS2;TOMM34;SORL1;B3GAT3;LZTS2;ZNF385A;ANK3;TTC7B;TWF2;STRADB;SYNGAP1;CEP250;GAS6;CSNK1E;RAB3B;LAMA5;GSN;BCR;XPOT;SEPT10;AIP;PEX10;CEMIP;AP3D1;EPHB2;GRIN3B;CD81;TMED4;TGFB1;CLTCL1;ABHD17C;MOAP1;TBC1D9B;TMEM173;SHANK3;MIPEP;TUB;CROCC;RHOD;SNX17;SNX33;BBS1;PTPN1;PEX1;AGRN;LRP4;ZDHHC24;CEP131;PRKCZ;OXA1L;TOM1L2;MICALL2;NEURL1B;ERBB2;VAMP2;TFDP2;RILPL1;BNIP3L;ARHGAP44;PRKCD;CACNB3;BAX;TIMM17B;ZDHHC8;GDI1;LEMD2;WASH3P;LRSAM1;REEP2;EHD3;LONP2;SYMPK;COG7;SESN2;ABCA7;RAB12;BCAP31;SYNGR1;NBPF3;FYN;TMCO6;SUN1;SNX15;ZDHHC1;RTN2;C12ORF66;RERE;STX10;CEP72;PAK1;ITGA3;VPS16;BCL2L1;DLG3;SGSM2;TBC1D16;LMNA;PKD1;RABGAP1;ITGA4;RAB28;RAB40B;NGFR;TOLLIP;PDCD6;TBC1D8;KIF13B;TCTN1;CAMK1;HFE;WIPI2;CELSR1;SEPT6;APBA1;SRSF5
11283,GO:0045604,0.573873313166304,0.612058341976097,5,47,regulation of epidermal cell differentiation,BP,CYP27B1;ZFP36L1;ERRFI1;ALOX15B;MAFF
6347,GO:0021532,0.573879289585153,0.663727151788306,3,27,neural tube patterning,BP,IFT140;PRKACB;TCTN1
8028,GO:0032680,0.573901609463187,0.583712950628117,7,68,regulation of tumor necrosis factor production,BP,NFATC4;ACP5;GAS6;ERRFI1;MC1R;MIF;DDT
3781,GO:0008344,0.57407935511205,0.632721017501025,4,38,adult locomotory behavior,BP,SLITRK6;NTSR1;EFNB3;DNM1
878,GO:0002230,0.574544798831167,0.711389591385958,2,18,positive regulation of defense response to virus by host,BP,TMEM173;APOBEC3F
8189,GO:0032941,0.57464104682552,0.711299811282395,2,18,secretion by tissue,BP,STK39;ADA
7397,GO:0031468,0.574971882281713,0.710991079155161,2,18,nuclear envelope reassembly,BP,REEP4;LMNA
14465,GO:0061844,0.575149848356191,0.706794488980873,2,24,antimicrobial humoral immune response mediated by antimicrobial peptide,BP,FAM3A;RNASE7
15413,GO:0071682,0.576165373694655,0.808015456764482,1,8,endocytic vesicle lumen,CC,APOE
2577,GO:0005869,0.576434755462218,0.807801884668212,1,8,dynactin complex,CC,ACTR1B
8472,GO:0033628,0.576677027674292,0.660484692077822,3,28,regulation of cell adhesion mediated by integrin,BP,PLAU;ADA;RAC3
7434,GO:0031571,0.576704367831663,0.580862851129953,7,68,mitotic G1 DNA damage checkpoint,BP,ZNF385A;CCND1;PCBP4;TFDP2;RBL2;BAX;CHEK2
10998,GO:0044819,0.576704367831663,0.580862851129953,7,68,mitotic G1/S transition checkpoint,BP,ZNF385A;CCND1;PCBP4;TFDP2;RBL2;BAX;CHEK2
20197,GO:2001024,0.577068455194631,0.709029929180213,2,18,negative regulation of response to drug,BP,STK39;TRAP1
6122,GO:0019372,0.57727558472398,0.807134181844245,1,8,lipoxygenase pathway,BP,ALOX15B
9000,GO:0035148,0.578343409315856,0.54269873881075,12,114,tube formation,BP,VEGFA;DVL1;PRKACB;TGFB1;DEAF1;SDCCAG8;VANGL2;SEMA4C;PROX1;EDA;TCTN1;CELSR1
20002,GO:2000574,0.578596544289448,0.806081915036356,1,8,regulation of microtubule motor activity,BP,NDE1
5175,GO:0015732,0.57866731193413,0.806025428267276,1,8,prostaglandin transport,BP,MIF
15630,GO:0072132,0.578741297910502,0.658971323685117,3,27,mesenchyme morphogenesis,BP,ACTA2;SMAD3;FGFR1
17040,GO:0099513,0.57886633416747,0.481857891263864,49,466,polymeric cytoskeletal fiber,CC,ESPN;NDRG1;MTA1;SPRY2;CLIP2;MAP2K2;KLC2;SHANK2;DVL1;FAM110C;REEP4;CORO1B;RAC2;KCNAB2;LZTS2;TWF2;WIPF1;PKD2;KIF17;SNPH;SNTB2;EML2;KIF26B;ENKD1;DNAH1;KIF7;TUBG2;PRKCZ;NINL;FSCN1;TPM2;DNM1;RGS14;REEP2;EML3;NARF;FYN;RAC3;DNM2;KIF26A;TUBB6;PAK1;MICAL1;LMNA;SIRT2;MAPRE3;NDE1;KIF13B;TTLL3
19404,GO:1905897,0.57890612469746,0.578754455123558,7,67,regulation of response to endoplasmic reticulum stress,BP,EDEM1;PTPN1;BOK;BAX;BCAP31;WFS1;GRINA
10615,GO:0043618,0.579033586294403,0.552898391791296,10,101,regulation of transcription from RNA polymerase II promoter in response to stress,BP,EGR1;VEGFA;EPAS1;IMPACT;CEBPB;VHL;MBTPS2;SESN2;SIRT2;BACH1
12788,GO:0051091,0.579136162444829,0.517235450177388,19,184,positive regulation of DNA binding transcription factor activity,BP,VEGFA;LRP5;RBCK1;AKT1;HDAC5;TRAPPC9;CARD11;CRTC1;ADAM8;TGFB1;PRKCZ;RPS6KA5;MBTPS2;IRAK1;ARID5B;CAT;PPP2R5B;ADGRF1;EDA
14504,GO:0065002,0.579295143349089,0.6059311032574,5,50,intracellular protein transmembrane transport,BP,BCR;PEX10;PEX1;TIMM17B;RTN2
8249,GO:0033036,0.579464352440423,0.450383749644775,238,2279,macromolecule localization,BP,ZMYND8;NR1D1;EDEM1;DLG4;MARVELD1;ACVR2B;PRNP;BBS2;POSTN;WNT7A;APOE;F2R;LRP5;OSBPL5;PITPNC1;OBSCN;IDH2;ITPR3;ARRDC1;EVI5L;EGFR;OBSL1;TMEM129;HADH;SYTL1;ETV5;LMF1;LTBP2;VPS11;LTBP1;TBC1D14;ARL2;HEXB;SNX9;NUDCD3;RAPGEF3;ZFP36L1;GLUL;NME4;MDFI;PLTP;CPT2;SSH1;POU2F2;EXOC2;PIK3R2;LRP1;DVL1;AP2A2;SH3PXD2B;NLGN2;STOM;AKT1;CORO1B;PITPNM1;RHBDF2;BSG;HK1;PTPRU;SLC15A4;ATG16L2;IFT140;RAB31;LDLR;MAPKBP1;SIGMAR1;RAC2;KCNAB2;PFKL;MXI1;SYNE3;PACS2;TOMM34;SORL1;CEACAM1;B3GAT3;LZTS2;ZNF385A;ABCD1;ANK3;TTC7B;TWF2;STRADB;SYNGAP1;CEP250;GAS6;CSNK1E;RAB3B;CARD11;LAMA5;GSN;PCSK9;BCR;XPOT;SEPT10;AIP;ALOX15B;AGAP1;PEX10;CORO7;UNC119B;MVB12B;CEMIP;PKD2;AP3D1;ABCA2;EPHB2;GRIN3B;ADAM8;KIF17;CD81;TMED4;TGFB1;CLTCL1;ABHD17C;MOAP1;TBC1D9B;NTSR1;TMEM173;SHANK3;MIPEP;TUB;CROCC;RHOD;SNX17;VGF;SNX33;LLGL1;BBS1;PTPN1;PEX1;PCK2;AGRN;OSBPL10;LRP4;LRP10;ESYT2;ZDHHC24;CEP131;PFKFB2;PRKCZ;OXA1L;TOM1L2;MICALL2;NEURL1B;ERBB2;ULK1;VAMP2;TFDP2;NECAB3;RILPL1;BNIP3L;ARHGAP44;MCFD2;PRKCD;CACNB3;BAX;OLFM2;TIMM17B;ZDHHC8;GDI1;LEMD2;WASH3P;LRSAM1;REEP2;EHD3;TMEM231;LONP2;SYMPK;PPARA;COG7;SESN2;ABCG1;ABCA7;RAB12;BCAP31;MIF;DOPEY2;PLA2G6;SYNGR1;NBPF3;FYN;PITPNM3;TMCO6;SUN1;DNM2;SNX15;CHKA;SLC27A1;ZDHHC1;MAPK3;RTN2;PFKM;TNS4;C12ORF66;RERE;STX10;ATP8B2;PRAF2;CEP72;VANGL2;PAK1;MALL;PPP3CB;ITGA3;VPS16;BCL2L1;DLG3;SGSM2;TBC1D16;LMNA;PKD1;RABGAP1;ITGA4;MAPRE3;RAB28;ICA1;RAB40B;NGFR;TOLLIP;PDCD6;ATP6V1F;PCLO;TBC1D8;PLEKHM1;KIF13B;TCTN1;CAMK1;SIRT3;HFE;WIPI2;VPS51;CELSR1;SEPT6;TST;TRIM46;APBA1;SRSF5
8337,GO:0033198,0.579577569605862,0.706672291201223,2,18,response to ATP,BP,SSH1;DGKQ
994,GO:0002455,0.579863022967426,0.706403337196237,2,18,humoral immune response mediated by circulating immunoglobulin,BP,SERPING1;ZP3
4725,GO:0010889,0.58049853136275,0.804559712889224,1,8,regulation of sequestering of triglyceride,BP,PPARA
1361,GO:0003231,0.58070528188276,0.567115237484247,8,75,cardiac ventricle development,BP,LTBP1;TGFB1;PPP1R13L;TGFBR3;ZFPM1;DNM2;VANGL2;PROX1
8560,GO:0034035,0.580800226950348,0.705519247759981,2,18,purine ribonucleoside bisphosphate metabolic process,BP,PODXL2;ABHD14B
12471,GO:0050427,0.580800226950348,0.705519247759981,2,18,3'-phosphoadenosine 5'-phosphosulfate metabolic process,BP,PODXL2;ABHD14B
14662,GO:0070269,0.580878442926073,0.804254654951651,1,8,pyroptosis,BP,GSDMA
19963,GO:2000484,0.581154564976895,0.80403272621752,1,8,positive regulation of interleukin-8 secretion,BP,F2R
11494,GO:0045989,0.581213857944934,0.803985047279224,1,8,positive regulation of striated muscle contraction,BP,GSTO1
13085,GO:0051606,0.581230953364048,0.539489002708213,12,118,detection of stimulus,BP,HMGA2;SERPINE2;PITPNM1;POLD4;PKD2;NTSR1;REEP6;MRPS26;ABCG1;FYN;PKD1;NR2F6
5467,GO:0016363,0.581247131828015,0.551092568857838,10,95,nuclear matrix,CC,XPOT;HLCS;DGKQ;CEBPB;NSMF;PRKCZ;PRKCD;SATB1;DNMT3A;TEP1
2763,GO:0006183,0.581488207442453,0.801403936972137,1,9,GTP biosynthetic process,BP,NME4
11509,GO:0046034,0.581606414501921,0.511919263761631,20,208,ATP metabolic process,BP,PGM1;HK1;PFKL;PFKP;DHTKD1;NADK;TGFB1;SDHA;PFKFB2;MLXIPL;FAM20C;CYC1;DDIT4;ALDOC;PPARA;INSR;TAZ;PFKM;PFKFB3;NDUFV3
8970,GO:0035065,0.581633788502086,0.604222434700268,5,47,regulation of histone acetylation,BP,NOS1;CTBP1;TGFB1;RPS6KA5;MAPK3
13899,GO:0060561,0.581875418214614,0.704502993597211,2,18,apoptotic process involved in morphogenesis,BP,LRP5;BAX
6501,GO:0021879,0.582180567695247,0.655070308307015,3,28,forebrain neuron differentiation,BP,SHANK3;RAC3;PROX1
9939,GO:0042304,0.582283588565515,0.65496850818709,3,28,regulation of fatty acid biosynthetic process,BP,CEACAM1;MLXIPL;WDTC1
13795,GO:0060395,0.582408895768664,0.624713037032664,4,37,SMAD protein signal transduction,BP,WWTR1;FOS;SMAD3;TGFB1
5722,GO:0016861,0.58246965737524,0.802973302481125,1,8,intramolecular oxidoreductase activity, interconverting aldoses and ketoses,MF,MPI
5938,GO:0018230,0.582950796774897,0.703484422874056,2,18,peptidyl-L-cysteine S-palmitoylation,BP,ZDHHC24;ZDHHC1
5939,GO:0018231,0.582950796774897,0.703484422874056,2,18,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine,BP,ZDHHC24;ZDHHC1
12553,GO:0050711,0.583088334489772,0.802473505911906,1,8,negative regulation of interleukin-1 secretion,BP,GAS6
567,GO:0001709,0.58322259038137,0.703226647728103,2,18,cell fate determination,BP,WNT7A;PROX1
11704,GO:0046512,0.583357973194941,0.802255398761245,1,8,sphingosine biosynthetic process,BP,SPTLC2
3624,GO:0008088,0.583905543169585,0.601683445339289,5,48,axo-dendritic transport,BP,AP3D1;KIF17;BLOC1S4;TRIM46;APBA1
11125,GO:0045177,0.584013013698721,0.50365880343042,23,219,apical part of cell,CC,PLAT;ITPR3;EGFR;SLC2A9;SLC9A3R2;SHANK2;STK39;LDLR;CEACAM1;IGFBP2;SLC29A4;PRKCZ;CD9;ERBB2;REEP6;CACNB3;SLC22A18;PFKM;VANGL2;EDA;HFE;HOMER2;SLC23A2
12316,GO:0048679,0.584377815400936,0.702129476358349,2,18,regulation of axon regeneration,BP,PTPRS;MAP2K1
3369,GO:0007143,0.584501851295945,0.702011526228106,2,18,female meiotic nuclear division,BP,CDC25B;EREG
10471,GO:0043370,0.584561313519057,0.701954971345397,2,18,regulation of CD4-positive, alpha-beta T cell differentiation,BP,PRKCZ;JAK3
12861,GO:0051193,0.584632634900723,0.562966701229531,8,76,regulation of cofactor metabolic process,BP,RAC2;PFKFB2;MLXIPL;PDK1;DDIT4;PPARA;INSR;PFKFB3
17596,GO:1901223,0.584710295828223,0.801158951157443,1,8,negative regulation of NIK/NF-kappaB signaling,BP,HDAC7
13578,GO:0060056,0.58498501518119,0.800935686875005,1,8,mammary gland involution,BP,BAX
11642,GO:0046386,0.585071415530642,0.70059248224181,2,19,deoxyribose phosphate catabolic process,BP,ADA;NEIL1
8687,GO:0034330,0.585358844328114,0.504251110128561,22,208,cell junction organization,BP,SDK2;FLNC;VEGFA;F2R;ITGA6;ARL2;SMAD3;ITGB4;NLGN2;PPM1F;NPHP4;LAMA5;TGFB1;RHOD;TNS1;PRKACA;CD9;MICALL2;FSCN1;SH3BP1;HDAC7;CDH4
11028,GO:0045008,0.585417662856006,0.800583714198644,1,8,depyrimidination,BP,NEIL1
6978,GO:0030660,0.585584073757782,0.553440703491034,9,88,Golgi-associated vesicle membrane,CC,CLTCL1;SCYL1;AREG;MCFD2;TGFA;SPPL2B;HLA-G;PKD1;PDCD6
8439,GO:0033572,0.585597220813465,0.651205990786991,3,29,transferrin transport,BP,DNM2;ATP6V1F;HFE
3254,GO:0006924,0.585722085581148,0.800335792327521,1,8,activation-induced cell death of T cells,BP,AKT1
1217,GO:0002886,0.58594070254487,0.651344003543475,3,28,regulation of myeloid leukocyte mediated immunity,BP,ADORA2B;RAC2;BCR
2958,GO:0006497,0.586315904743749,0.539555012726034,11,108,protein lipidation,BP,PIGQ;LY6K;PIGV;ABHD17C;ZDHHC24;ZDHHC8;MSLN;ZDHHC1;MDGA1;WIPI2;PRSS21
4219,GO:0009395,0.586318843584493,0.650968041280469,3,28,phospholipid catabolic process,BP,LDLR;PLCG1;PRKCD
10045,GO:0042533,0.586491699819176,0.799708043586836,1,8,tumor necrosis factor biosynthetic process,BP,ERRFI1
10046,GO:0042534,0.586491699819176,0.799708043586836,1,8,regulation of tumor necrosis factor biosynthetic process,BP,ERRFI1
9280,GO:0035722,0.586564653798939,0.619586506707114,4,40,interleukin-12-mediated signaling pathway,BP,PDCD4;AIP;GSTO1;MIF
15197,GO:0071349,0.586564653798939,0.619586506707114,4,40,cellular response to interleukin-12,BP,PDCD4;AIP;GSTO1;MIF
1185,GO:0002831,0.58686473824106,0.545144482057835,10,97,regulation of response to biotic stimulus,BP,HTRA1;MAPKBP1;CEACAM1;FAM3A;TMEM173;LRSAM1;MIF;APOBEC3F;MAPK3;SIRT2
4073,GO:0009128,0.586878739401285,0.799391819577249,1,8,purine nucleoside monophosphate catabolic process,BP,NT5E
4102,GO:0009158,0.586878739401285,0.799391819577249,1,8,ribonucleoside monophosphate catabolic process,BP,NT5E
4112,GO:0009169,0.586878739401285,0.799391819577249,1,8,purine ribonucleoside monophosphate catabolic process,BP,NT5E
13050,GO:0051560,0.586976250535672,0.699652543591621,2,18,mitochondrial calcium ion homeostasis,BP,BNIP3;BCAP31
9425,GO:0035999,0.587070901066318,0.799234685603724,1,8,tetrahydrofolate interconversion,BP,MTHFR
65,GO:0000132,0.58736434585617,0.699281513894487,2,18,establishment of mitotic spindle orientation,BP,SPRY2;NDE1
8231,GO:0033008,0.587402845201958,0.798963043164617,1,8,positive regulation of mast cell activation involved in immune response,BP,ADORA2B
10443,GO:0043306,0.587402845201958,0.798963043164617,1,8,positive regulation of mast cell degranulation,BP,ADORA2B
16974,GO:0098993,0.587442602824629,0.798930490499593,1,8,anchored component of synaptic vesicle membrane,CC,RAB3B
11492,GO:0045987,0.587539681470319,0.699113795884904,2,18,positive regulation of smooth muscle contraction,BP,F2R;ADA
4416,GO:0010212,0.587864720487638,0.5239336340551,14,135,response to ionizing radiation,BP,ERCC1;EGR1;HMGA2;MTA1;ERCC6;CCND1;TGFB1;NET1;BAX;CHEK2;DNM2;CYP2R1;DNMT3A;BCL2L1
19761,GO:2000121,0.588024891345333,0.798453296280915,1,8,regulation of removal of superoxide radicals,BP,GCH1
3658,GO:0008146,0.588399951542578,0.648894908850256,3,28,sulfotransferase activity,MF,NDST2;GAL3ST4;CHST14
14325,GO:0061515,0.588402853871049,0.597327189354279,5,47,myeloid cell development,BP,FAM210B;ZNF385A;FAM20C;ZFPM1;LRRK1
2570,GO:0005858,0.588501934917122,0.798061752428002,1,8,axonemal dynein complex,CC,DNAH1
9627,GO:0036499,0.588546876980946,0.698149243815386,2,18,PERK-mediated unfolded protein response,BP,PTPN1;BOK
16134,GO:0090140,0.588691234032098,0.698010842903432,2,18,regulation of mitochondrial fission,BP,BNIP3;INF2
18474,GO:1903557,0.588783227190667,0.617631242816414,4,39,positive regulation of tumor necrosis factor superfamily cytokine production,BP,NFATC4;ADAM8;MIF;DDT
7477,GO:0031648,0.588804756722626,0.617921181064473,4,38,protein destabilization,BP,PRNP;GSN;RAD23A;CCDC88C
3274,GO:0006956,0.588887372859779,0.697822734084485,2,18,complement activation,BP,SERPING1;CD81
1009,GO:0002483,0.589017352231435,0.797638104827359,1,8,antigen processing and presentation of endogenous peptide antigen,BP,HFE
4756,GO:0010935,0.58925315969428,0.797444072059209,1,8,regulation of macrophage cytokine production,BP,TGFB1
3284,GO:0006977,0.589363006033146,0.580105537063203,6,59,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,BP,ZNF385A;PCBP4;TFDP2;RBL2;BAX;CHEK2
303,GO:0000813,0.589504769480391,0.797236890456162,1,8,ESCRT I complex,CC,MVB12B
16081,GO:0090049,0.589544814340657,0.647751529860858,3,28,regulation of cell migration involved in sprouting angiogenesis,BP,VEGFA;HDAC5;HDAC7
3654,GO:0008140,0.589670721313159,0.797100159159763,1,8,cAMP response element binding protein binding,MF,CRTC1
11065,GO:0045073,0.589678081769727,0.797094093200446,1,8,regulation of chemokine biosynthetic process,BP,EGR1
9294,GO:0035743,0.589750458621972,0.797034438522847,1,8,CD4-positive, alpha-beta T cell cytokine production,BP,PRKCZ
3280,GO:0006971,0.589926862810203,0.796888989795558,1,8,hypotonic response,BP,STK39
11884,GO:0046915,0.590124137290847,0.647172170697848,3,28,transition metal ion transmembrane transporter activity,MF,ATP7B;SLC25A37;SLC39A3
8993,GO:0035116,0.590290120641681,0.696475309449934,2,18,embryonic hindlimb morphogenesis,BP,WNT7A;WNT3
13758,GO:0060347,0.590426193500637,0.79647687930435,1,8,heart trabecula formation,BP,TGFBR3
10584,GO:0043555,0.590439815101887,0.696331300340906,2,18,regulation of translation in response to stress,BP,IMPACT;SESN2
3718,GO:0008242,0.590694098497981,0.796255525000905,1,8,omega peptidase activity,MF,GGT1
11479,GO:0045953,0.590966444177203,0.796030325783762,1,8,negative regulation of natural killer cell mediated cytotoxicity,BP,CEACAM1
17340,GO:1900016,0.591344903158889,0.795717088214927,1,8,negative regulation of cytokine production involved in inflammatory response,BP,PDCD4
6199,GO:0019692,0.591387984643145,0.644973684068429,3,30,deoxyribose phosphate metabolic process,BP,ADA;DGUOK;NEIL1
1109,GO:0002697,0.591516010135292,0.499827877103277,21,204,regulation of immune effector process,BP,HTRA1;PKN1;STAT6;ADORA2B;HK1;SERPING1;RAC2;CEACAM1;BCR;IL20RB;CD81;TGFB1;TMEM173;PRKCZ;JAK3;MIF;APOBEC3F;MAPK3;PPP3CB;HFE;ZP3
13007,GO:0051451,0.591937126076914,0.795226237187856,1,8,myoblast migration,BP,NET1
7934,GO:0032528,0.591981325262399,0.694845880323003,2,18,microvillus organization,BP,TWF2;FSCN1
819,GO:0002093,0.592360262770335,0.794875014462147,1,8,auditory receptor cell morphogenesis,BP,SLITRK6
10993,GO:0044804,0.592478745267174,0.694365602820246,2,18,autophagy of nucleus,BP,ATG2A;WIPI2
12098,GO:0048148,0.592670917193573,0.794616883500702,1,8,behavioral response to cocaine,BP,HOMER2
9325,GO:0035809,0.592967331318423,0.794370368963169,1,8,regulation of urine volume,BP,ADCY6
1183,GO:0002829,0.593068148786991,0.794286475376302,1,8,negative regulation of type 2 immune response,BP,STAT6
18958,GO:1904707,0.593142812562091,0.693723692121697,2,18,positive regulation of vascular smooth muscle cell proliferation,BP,MEF2D;PAK1
12113,GO:0048193,0.593169337470747,0.48105235066228,32,309,Golgi vesicle transport,BP,BBS2;OSBPL5;LMF1;TBC1D14;EXOC2;KLC2;RAB31;SORL1;ANK3;TRAPPC9;GAS6;SPTB;CORO7;CTSZ;AP3D1;TMED4;SCYL1;LLGL1;BBS1;AREG;VAMP2;MCFD2;EHD3;TGFA;COG7;BCAP31;DOPEY2;DNM2;KIF26A;SGSM2;PDCD6;VPS51
11626,GO:0046348,0.593424659729773,0.793989614524863,1,8,amino sugar catabolic process,BP,CTBS
10979,GO:0044783,0.593449886055037,0.563530195373448,7,69,G1 DNA damage checkpoint,BP,ZNF385A;CCND1;PCBP4;TFDP2;RBL2;BAX;CHEK2
2395,GO:0005540,0.593540117803331,0.793893408869348,1,8,hyaluronic acid binding,MF,CEMIP
4578,GO:0010665,0.593960771999976,0.692931876520183,2,18,regulation of cardiac muscle cell apoptotic process,BP,RGL2;BNIP3
5076,GO:0015301,0.594017870809455,0.692876555376549,2,18,anion:anion antiporter activity,MF,SLC37A2;SLC26A11
1701,GO:0004180,0.594042039158417,0.692853137602739,2,18,carboxypeptidase activity,MF,CTSZ;CNDP2
14943,GO:0070841,0.59410414569448,0.692792954773364,2,18,inclusion body assembly,BP,SORL1;CDC34
8950,GO:0035019,0.594223420852681,0.590895607607475,5,49,somatic stem cell population maintenance,BP,WNT7A;LRP5;EPAS1;EPHA1;VANGL2
17595,GO:1901222,0.594480909143224,0.590853679950645,5,48,regulation of NIK/NF-kappaB signaling,BP,PDCD4;EGFR;TNFSF15;IRAK1;HDAC7
17521,GO:1900746,0.594490309087201,0.793100439645381,1,8,regulation of vascular endothelial growth factor signaling pathway,BP,XDH
7337,GO:0031371,0.594646830585151,0.792969607715284,1,8,ubiquitin conjugating enzyme complex,CC,STUB1
3708,GO:0008227,0.594778548016695,0.792859462938485,1,8,G-protein coupled amine receptor activity,MF,HTR7
10384,GO:0043220,0.594871534590852,0.792781680434858,1,8,Schmidt-Lanterman incisure,CC,SIRT2
19300,GO:1905523,0.594909165307606,0.792750196705743,1,8,positive regulation of macrophage migration,BP,MAPK3
17597,GO:1901224,0.594954381234671,0.611652363983919,4,38,positive regulation of NIK/NF-kappaB signaling,BP,PDCD4;EGFR;TNFSF15;IRAK1
5460,GO:0016339,0.595296845255104,0.691635777971434,2,18,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,BP,CDH4;ARVCF
10974,GO:0044773,0.595356106554029,0.536267133902812,10,98,mitotic DNA damage checkpoint,BP,XPC;HMGA2;BRSK1;ZNF385A;CCND1;PCBP4;TFDP2;RBL2;BAX;CHEK2
4915,GO:0014854,0.595417319059837,0.792324714571117,1,8,response to inactivity,BP,CAT
5862,GO:0017162,0.595441185312692,0.792304715754394,1,8,aryl hydrocarbon receptor binding,MF,AIP
5805,GO:0017059,0.595786225811252,0.792015433617102,1,8,serine C-palmitoyltransferase complex,CC,SPTLC2
7246,GO:0031211,0.595786225811252,0.792015433617102,1,8,endoplasmic reticulum palmitoyltransferase complex,CC,SPTLC2
19430,GO:1905961,0.595786225811252,0.792015433617102,1,8,protein-cysteine S-palmitoyltransferase complex,CC,SPTLC2
11502,GO:0046007,0.595797506580332,0.792005970944524,1,8,negative regulation of activated T cell proliferation,BP,PRNP
11313,GO:0045647,0.595814195126251,0.791991971486855,1,8,negative regulation of erythrocyte differentiation,BP,ZFP36L1
14245,GO:0061307,0.595869419017574,0.791945641219135,1,8,cardiac neural crest cell differentiation involved in heart development,BP,MAPK3
14246,GO:0061308,0.595869419017574,0.791945641219135,1,8,cardiac neural crest cell development involved in heart development,BP,MAPK3
1455,GO:0003690,0.595949830947746,0.457104529002467,64,605,double-stranded DNA binding,MF,MEF2D;ZMYND8;H1F0;EGR1;NR1D1;XPC;HMGA2;ELK3;MTA1;EGFR;NFATC4;BAHCC1;ETV5;TCFL5;ETV4;ZC3H6;FOXQ1;POU2F2;FOS;SMAD3;STAT6;SALL2;HLTF;MXI1;KLF7;SOX13;MYEF2;SMARCD2;HES2;MNT;CEBPB;ZNF217;RFX2;DEAF1;PHF21A;MBD3;MLXIPL;KDM6B;ZNF516;TFDP2;PBX2;ZNF395;SOX12;CARF;IER2;ZHX3;CHD2;ZFPM1;PPARA;SIX5;SSBP4;ARID5B;BHLHE40;TSPYL2;SATB1;HES7;HES6;PROX1;BACH1;ZNF704;NR2F6;TNRC18;PLAG1;KDM3A
12551,GO:0050709,0.595957020759468,0.560929479934482,7,69,negative regulation of protein secretion,BP,F2R;IDH2;HADH;RHBDF2;MAPKBP1;PFKL;GAS6
15259,GO:0071439,0.59604880578004,0.791795093071818,1,8,clathrin complex,CC,CLTCL1
7414,GO:0031514,0.596337230117501,0.550635102170669,8,78,motile cilium,CC,BBS2;HK1;PKD2;DNAH1;PRKACA;PFKM;PKD1;SEPT6
6307,GO:0019955,0.596565256752163,0.572834086022437,6,58,cytokine binding,MF,LTBP4;LTBP1;IL20RB;TGFBR3;TNFRSF25;ITGA4
12835,GO:0051154,0.596691152913049,0.69027956826857,2,18,negative regulation of striated muscle cell differentiation,BP,HDAC5;PAK1
7630,GO:0032045,0.59671718485913,0.791233476516423,1,8,guanyl-nucleotide exchange factor complex,CC,ULK1
6320,GO:0019992,0.596744688306214,0.791210343046564,1,8,diacylglycerol binding,MF,PLTP
16198,GO:0090232,0.596784519464906,0.791176837336267,1,8,positive regulation of spindle checkpoint,BP,NDRG1
433,GO:0001162,0.596962917475216,0.79102672277533,1,8,RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding,MF,ZC3H6
9291,GO:0035735,0.597089427245121,0.609148721131768,4,39,intraciliary transport involved in cilium assembly,BP,IFT140;KIF17;CEP131;WDR60
19179,GO:1905207,0.597250851829426,0.640001512140316,3,28,regulation of cardiocyte differentiation,BP,EGFR;TGFB1;PAK1
7903,GO:0032482,0.597270003156374,0.5719333355187,6,59,Rab protein signal transduction,BP,RAB31;RAB3B;GDI1;RAB12;RAB28;RAB40B
13702,GO:0060272,0.597484041311019,0.790587775162903,1,8,embryonic skeletal joint morphogenesis,BP,HYAL1
10547,GO:0043507,0.597515643191467,0.572023943878252,6,57,positive regulation of JUN kinase activity,BP,PKN1;ERCC6;PTPN1;VANGL2;PAK1;MAP3K10
15574,GO:0072044,0.597608526984234,0.790482821850516,1,8,collecting duct development,BP,PKD1
8047,GO:0032715,0.597681091665511,0.689314428974101,2,18,negative regulation of interleukin-6 production,BP,GAS6;INPP5D
11868,GO:0046886,0.597735013806083,0.790376142704657,1,8,positive regulation of hormone biosynthetic process,BP,EGR1
8889,GO:0034713,0.597747876929107,0.790365291746164,1,8,type I transforming growth factor beta receptor binding,MF,TGFB1
10725,GO:0044088,0.5977831710944,0.608751095996695,4,38,regulation of vacuole organization,BP,TBC1D14;ULK1;LRSAM1;VPS16
10131,GO:0042698,0.597888755322422,0.608642590160562,4,38,ovulation cycle,BP,EGR1;EGFR;EREG;ZP3
8789,GO:0034498,0.597916910856232,0.790222662141744,1,8,early endosome to Golgi transport,BP,EHD3
15206,GO:0071359,0.598331995589165,0.570999987351435,6,58,cellular response to dsRNA,BP,EGFR;MAP2K2;MAP2K1;SMAD3;TGFB1;TMEM173
16055,GO:0086103,0.598386787125747,0.789825817818085,1,8,G-protein coupled receptor signaling pathway involved in heart process,BP,NOS1
17277,GO:0120111,0.59862812123105,0.570522463382359,6,59,neuron projection cytoplasm,CC,DLG4;AP3D1;KIF17;ADA;BLOC1S4;TRIM46
15775,GO:0072384,0.59874776546741,0.55816077839819,7,68,organelle transport along microtubule,BP,FYCO1;AP3D1;PRKCZ;SUN1;NDE1;BLOC1S4;TRIM46
15860,GO:0072584,0.59879229826486,0.789482901123586,1,8,caveolin-mediated endocytosis,BP,MAPK3
5145,GO:0015677,0.598951594798056,0.789348083564024,1,8,copper ion import,BP,ATP7B
3884,GO:0008519,0.598959007083873,0.688065758030568,2,18,ammonium transmembrane transporter activity,MF,SLC25A29;AZIN2
6326,GO:0020027,0.598978831062406,0.789325026461298,1,8,hemoglobin metabolic process,BP,CAT
6337,GO:0021515,0.598991889399188,0.68803358696013,2,18,cell differentiation in spinal cord,BP,MDGA1;TCTN1
553,GO:0001675,0.599014929694099,0.789294464049183,1,8,acrosome assembly,BP,RFX2
12332,GO:0048704,0.599298651281173,0.569994956174304,6,58,embryonic skeletal system morphogenesis,BP,MDFI;SMAD3;IFT140;WDR60;HYAL1;SLC39A3
5732,GO:0016878,0.599366777707262,0.687666661010626,2,18,acid-thiol ligase activity,MF,ACSF2;SLC27A1
19053,GO:1904886,0.599476597188254,0.687559122993777,2,18,beta-catenin destruction complex disassembly,BP,LRP5;DVL1
16387,GO:0097001,0.59963240031201,0.78877119717752,1,8,ceramide binding,MF,PLTP
9127,GO:0035456,0.599826151245646,0.685505736420646,2,20,response to interferon-beta,BP,TMEM173;CDC34
6519,GO:0021904,0.59996617564444,0.687079433893802,2,18,dorsal/ventral neural tube patterning,BP,PRKACB;TCTN1
19510,GO:1990314,0.600016231398231,0.788445454119117,1,8,cellular response to insulin-like growth factor stimulus,BP,TGFB1
8306,GO:0033148,0.600024934398486,0.788438064020646,1,8,positive regulation of intracellular estrogen receptor signaling pathway,BP,PAK1
2708,GO:0006085,0.600100560549637,0.68694768305756,2,18,acetyl-CoA biosynthetic process,BP,PDK1;MLYCD
11813,GO:0046718,0.600108691500977,0.546596006924613,8,79,viral entry into host cell,BP,EGFR;LDLR;GAS6;CTSB;GSN;ITGB5;CD81;EFNB3
6029,GO:0019098,0.600178476414047,0.686871278534135,2,18,reproductive behavior,BP,SERPINE2;HEXB
9545,GO:0036310,0.600178490648258,0.788307642123086,1,8,annealing helicase activity,MF,SMARCA1
9970,GO:0042364,0.600218094625069,0.788273995384987,1,8,water-soluble vitamin biosynthetic process,BP,PDXK
20303,GO:2001256,0.600312861128342,0.78819346805052,1,8,regulation of store-operated calcium entry,BP,HOMER2
2393,GO:0005537,0.600388424440312,0.788129242727615,1,8,mannose binding,MF,BSG
12187,GO:0048368,0.600402262973556,0.788117479093977,1,8,lateral mesoderm development,BP,FGFR1
1306,GO:0003149,0.600756099458756,0.787816535819524,1,8,membranous septum morphogenesis,BP,VANGL2
10143,GO:0042726,0.600781879312032,0.787794597641362,1,8,flavin-containing compound metabolic process,BP,ACP5
10097,GO:0042612,0.600874018837973,0.785203858820488,1,9,MHC class I protein complex,CC,HLA-G
13766,GO:0060359,0.600883674654032,0.555933722658724,7,68,response to ammonium ion,BP,HDAC5;AGRN;ADA;DNM2;MAPK3;DNMT3A;HOMER2
3776,GO:0008333,0.600938216978562,0.584172401221851,5,48,endosome to lysosome transport,BP,VPS11;AP3D1;RAB12;BIN1;VPS16
18246,GO:1903044,0.600963863400045,0.787639686067793,1,8,protein localization to membrane raft,BP,REEP2
13464,GO:0055010,0.601048724335616,0.636147133564771,3,28,ventricular cardiac muscle tissue morphogenesis,BP,TGFB1;TGFBR3;PROX1
13650,GO:0060174,0.601228006386479,0.787414692883309,1,8,limb bud formation,BP,WNT3
14699,GO:0070330,0.6013438401762,0.787315973173037,1,8,aromatase activity,MF,CYP3A5
7782,GO:0032329,0.601415616710928,0.787254784820309,1,8,serine transport,BP,SERINC2
14123,GO:0061000,0.601607700417199,0.787090974104639,1,8,negative regulation of dendritic spine development,BP,PTPRS
1331,GO:0003183,0.601607721629779,0.78709095601029,1,8,mitral valve morphogenesis,BP,ZFPM1
1334,GO:0003188,0.601607721629779,0.787090956009936,1,8,heart valve formation,BP,ZFPM1
3210,GO:0006857,0.601743391323586,0.786975200890015,1,8,oligopeptide transport,BP,SLC15A4
8613,GO:0034139,0.60176339836657,0.786958126784048,1,8,regulation of toll-like receptor 3 signaling pathway,BP,PELI1
19890,GO:2000353,0.602210751590514,0.786576095666214,1,8,positive regulation of endothelial cell apoptotic process,BP,PDCD4
7105,GO:0030911,0.602310432454343,0.786490902839067,1,8,TPR domain binding,MF,STUB1
19527,GO:1990403,0.602356199817007,0.786451779282181,1,8,embryonic brain development,BP,IFT140
8786,GO:0034483,0.602392948011456,0.786420361882453,1,8,heparan sulfate sulfotransferase activity,MF,NDST2
10720,GO:0044065,0.602507291047544,0.786322584437713,1,8,regulation of respiratory system process,BP,NLGN2
1347,GO:0003209,0.602561404776435,0.6845289313743,2,18,cardiac atrium morphogenesis,BP,ZFPM1;PROX1
20230,GO:2001135,0.602576489210499,0.786263395758992,1,8,regulation of endocytic recycling,BP,SORL1
4586,GO:0010692,0.602617493735126,0.786228316937574,1,8,regulation of alkaline phosphatase activity,BP,SMAD3
7609,GO:0032006,0.602634098742982,0.544178597332742,8,77,regulation of TOR signaling,BP,GAS6;DGKQ;TNFAIP8L1;WDR59;DDIT4;SESN2;C12ORF66;PDCD6
16413,GO:0097050,0.60269666319754,0.786160576769779,1,8,type B pancreatic cell apoptotic process,BP,WFS1
20068,GO:2000674,0.60269666319754,0.786160576769779,1,8,regulation of type B pancreatic cell apoptotic process,BP,WFS1
9131,GO:0035461,0.602740263490036,0.786123264216975,1,8,vitamin transmembrane transport,BP,SLC23A2
921,GO:0002315,0.602945345718351,0.785947694518251,1,8,marginal zone B cell differentiation,BP,MFNG
9096,GO:0035371,0.602982087812242,0.684114275738975,2,18,microtubule plus-end,CC,CLIP2;MAPRE3
12934,GO:0051302,0.603220270433806,0.516740070121687,12,117,regulation of cell division,BP,PGF;VEGFA;VEGFB;RAB11FIP4;CDC25B;TGFB1;EREG;GIT1;TGFA;CAT;BCL2L1;SIRT2
13866,GO:0060502,0.603255838268986,0.785681685670644,1,8,epithelial cell proliferation involved in lung morphogenesis,BP,MAP2K1
11891,GO:0046929,0.60326129513909,0.785677008463899,1,8,negative regulation of neurotransmitter secretion,BP,ASIC1
5738,GO:0016885,0.603345856584168,0.785604519502124,1,8,ligase activity, forming carbon-carbon bonds,MF,PC
2333,GO:0005351,0.60358794758888,0.785396892897051,1,8,carbohydrate:proton symporter activity,MF,SLC2A9
11116,GO:0045161,0.603665919949853,0.785329989870475,1,8,neuronal ion channel clustering,BP,AGRN
5158,GO:0015697,0.603737745819739,0.785268347420216,1,8,quaternary ammonium group transport,BP,SLC25A29
15382,GO:0071636,0.603753266883924,0.785255025238839,1,8,positive regulation of transforming growth factor beta production,BP,SMAD3
15562,GO:0072015,0.603891977778949,0.78513593913526,1,8,glomerular visceral epithelial cell development,BP,LAMB2
15732,GO:0072310,0.603891977778949,0.78513593913526,1,8,glomerular epithelial cell development,BP,LAMB2
11282,GO:0045603,0.603892469770226,0.785135516665735,1,8,positive regulation of endothelial cell differentiation,BP,BTG1
561,GO:0001702,0.60390270458393,0.683205655893747,2,18,gastrulation with mouth forming second,BP,ACVR2B;LRP5
11390,GO:0045787,0.603984709343266,0.470988701517404,31,302,positive regulation of cell cycle,BP,LRP5;HMGA2;EGFR;AKT1;FGFR1;RAB11FIP4;ZNF385A;CCND1;PCBP4;PTK6;RAD23A;CDC25B;PKD2;TGFB1;MLXIPL;PRKACA;TFDP2;C6ORF89;RBL2;BAX;EREG;TGFA;CHEK2;MIF;INSR;HYAL1;PPP2R5B;PROX1;PKD1;SIRT2;MAPRE3
13369,GO:0052646,0.604099385180441,0.784957786670572,1,8,alditol phosphate metabolic process,BP,ACP6
7509,GO:0031701,0.604157906322755,0.78490750066298,1,8,angiotensin receptor binding,MF,ARAP1
9619,GO:0036490,0.604224638753764,0.784850148495255,1,8,regulation of translation in response to endoplasmic reticulum stress,BP,SESN2
16145,GO:0090160,0.604229618590013,0.784845868208122,1,8,Golgi to lysosome transport,BP,EHD3
19717,GO:2000036,0.60423676780033,0.682875540440926,2,18,regulation of stem cell population maintenance,BP,HMGA2;KDM3A
5582,GO:0016600,0.604244680487391,0.784832921774464,1,8,flotillin complex,CC,LRP4
11327,GO:0045661,0.604289291420086,0.632347229451004,3,29,regulation of myoblast differentiation,BP,ZFP36L1;TGFB1;BTG1
2284,GO:0005243,0.604395728177188,0.784703057798433,1,8,gap junction channel activity,MF,GJC2
18610,GO:1903867,0.604502228855189,0.784611459268746,1,8,extraembryonic membrane development,BP,HTRA1
7353,GO:0031402,0.604528028494549,0.78458926541363,1,8,sodium ion binding,MF,PDXK
10673,GO:0043931,0.604752998453914,0.784395667405013,1,8,ossification involved in bone maturation,BP,THBS3
10405,GO:0043249,0.604788887486734,0.78436477144527,1,8,erythrocyte maturation,BP,FAM210B
11760,GO:0046628,0.604910815988782,0.78425978236322,1,8,positive regulation of insulin receptor signaling pathway,BP,PRKCZ
9310,GO:0035773,0.60502229550607,0.600656805169666,4,40,insulin secretion involved in cellular response to glucose stimulus,BP,NR1D1;LRP5;PLA2G6;PPP3CB
13095,GO:0051639,0.605063130278343,0.784128577011874,1,8,actin filament network formation,BP,FHOD3
18582,GO:1903799,0.605093996761382,0.784101981220975,1,8,negative regulation of production of miRNAs involved in gene silencing by miRNA,BP,TGFB1
15133,GO:0071233,0.605118741707596,0.784080658279314,1,8,cellular response to leucine,BP,SESN2
8454,GO:0033601,0.605423884581397,0.783817588625093,1,8,positive regulation of mammary gland epithelial cell proliferation,BP,CCND1
9311,GO:0035774,0.605520404271243,0.680691791310402,2,19,positive regulation of insulin secretion involved in cellular response to glucose stimulus,BP,PLA2G6;PPP3CB
8001,GO:0032635,0.605540950899661,0.55106074277011,7,68,interleukin-6 production,BP,F2R;ADORA2B;MAPK13;GAS6;CEBPB;EREG;INPP5D
18815,GO:1904354,0.605599808920318,0.783665815417758,1,8,negative regulation of telomere capping,BP,ERCC1
8000,GO:0032634,0.605626099527985,0.783643127397015,1,8,interleukin-5 production,BP,PRKCZ
8024,GO:0032674,0.605626099527985,0.783643127397015,1,8,regulation of interleukin-5 production,BP,PRKCZ
15901,GO:0072676,0.6056282372483,0.600027287382171,4,40,lymphocyte migration,BP,GAS6;ADAM8;ECM1;ITGA4
10524,GO:0043470,0.60563727147814,0.563377938148356,6,58,regulation of carbohydrate catabolic process,BP,PFKFB2;MLXIPL;DDIT4;PPARA;INSR;PFKFB3
1439,GO:0003417,0.605790760232486,0.783500990869788,1,8,growth plate cartilage development,BP,THBS3
9220,GO:0035612,0.605858251145118,0.783442712606112,1,8,AP-2 adaptor complex binding,MF,FCHO1
9075,GO:0035331,0.605867069932,0.783435096762626,1,8,negative regulation of hippo signaling,BP,WWC3
5101,GO:0015385,0.605881952469246,0.78342224386623,1,8,sodium:proton antiporter activity,MF,SLC9A7
13047,GO:0051547,0.60592515144631,0.783384933120011,1,8,regulation of keratinocyte migration,BP,HBEGF
1799,GO:0004439,0.605925672641447,0.783384482938784,1,8,phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity,MF,SYNJ2
7599,GO:0031987,0.605954215703222,0.783359827844973,1,8,locomotion involved in locomotory behavior,BP,PPP3CB
7459,GO:0031624,0.606026603076017,0.631060017733156,3,28,ubiquitin conjugating enzyme binding,MF,PPARA;RNF144A;TOLLIP
1391,GO:0003300,0.60608135730884,0.578813217772974,5,48,cardiac muscle hypertrophy,BP,SMAD3;ERRFI1;CAMTA2;PAK1;LMNA
7472,GO:0031643,0.606191092163771,0.783155138875232,1,8,positive regulation of myelination,BP,WASF3
2197,GO:0005072,0.606226545794118,0.783124490742762,1,8,transforming growth factor beta receptor, cytoplasmic mediator activity,MF,SMAD3
15023,GO:0070970,0.606229814583519,0.783121664857353,1,8,interleukin-2 secretion,BP,CARD11
12134,GO:0048247,0.60623631663042,0.679162922227718,2,20,lymphocyte chemotaxis,BP,GAS6;ADAM8
14338,GO:0061548,0.606257074485216,0.783098097494471,1,8,ganglion development,BP,SEMA3F
18187,GO:1902946,0.606293739095185,0.783066396426645,1,8,protein localization to early endosome,BP,SORL1
16069,GO:0090030,0.60630937264601,0.783052878276598,1,8,regulation of steroid hormone biosynthetic process,BP,DGKQ
6799,GO:0030252,0.606321218824685,0.783042634618319,1,8,growth hormone secretion,BP,LTBP4
7139,GO:0030991,0.606336962790591,0.783029019911069,1,8,intraciliary transport particle A,CC,IFT140
8807,GO:0034587,0.606341685190789,0.783024936062085,1,8,piRNA metabolic process,BP,TDRKH
20040,GO:2000643,0.606359288171648,0.783009712818696,1,8,positive regulation of early endosome to late endosome transport,BP,VPS11
14968,GO:0070878,0.606360528811851,0.783008639870173,1,8,primary miRNA binding,MF,SMAD3
9180,GO:0035562,0.606372908243209,0.782997933506151,1,8,negative regulation of chromatin binding,BP,NFATC4
3309,GO:0007016,0.606373619955782,0.782997317968863,1,8,cytoskeletal anchoring at plasma membrane,BP,ANK3
7244,GO:0031209,0.606373619955782,0.782997317968863,1,8,SCAR complex,CC,CYFIP2
8197,GO:0032957,0.606373619955782,0.782997317968509,1,8,inositol trisphosphate metabolic process,BP,ITPKB
8813,GO:0034596,0.606373619955782,0.782997317969218,1,8,phosphatidylinositol phosphate 4-phosphatase activity,MF,SYNJ2
13202,GO:0051864,0.606373619955782,0.782997317969217,1,8,histone demethylase activity (H3-K36 specific),MF,KDM4B
14070,GO:0060900,0.606373619955782,0.782997317968509,1,8,embryonic camera-type eye formation,BP,PROX1
14808,GO:0070544,0.606373619955782,0.782997317969217,1,8,histone H3-K36 demethylation,BP,KDM4B
15533,GO:0071936,0.606373619955782,0.78299731796904,1,8,coreceptor activity involved in Wnt signaling pathway,MF,LRP5
15777,GO:0072386,0.606373619955782,0.782997317968863,1,8,plus-end-directed organelle transport along microtubule,BP,FYCO1
16331,GO:0090557,0.606373619955782,0.782997317968863,1,8,establishment of endothelial intestinal barrier,BP,PTPRS
16246,GO:0090303,0.606715555163282,0.629858316132746,3,29,positive regulation of wound healing,BP,F2R;HBEGF;F12
10400,GO:0043242,0.606734174677337,0.57813057482862,5,48,negative regulation of protein complex disassembly,BP,TMOD2;TWF2;GSN;SPTB;CAPG
241,GO:0000506,0.60711686091208,0.779791970601308,1,9,glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex,CC,PIGQ
15793,GO:0072431,0.607143632169884,0.561462856510251,6,60,signal transduction involved in mitotic G1 DNA damage checkpoint,BP,ZNF385A;PCBP4;TFDP2;RBL2;BAX;CHEK2
17993,GO:1902400,0.607143632169884,0.561462856510251,6,60,intracellular signal transduction involved in G1 DNA damage checkpoint,BP,ZNF385A;PCBP4;TFDP2;RBL2;BAX;CHEK2
8821,GO:0034613,0.607224529471708,0.428259457725185,151,1467,cellular protein localization,BP,ZMYND8;EDEM1;DLG4;PRNP;BBS2;APOE;OBSCN;EVI5L;EGFR;OBSL1;TMEM129;SYTL1;ETV5;LTBP2;VPS11;TBC1D14;ARL2;SNX9;NUDCD3;RAPGEF3;SSH1;LRP1;DVL1;AP2A2;SH3PXD2B;NLGN2;STOM;AKT1;CORO1B;BSG;HK1;PTPRU;IFT140;RAB31;RAC2;KCNAB2;SYNE3;PACS2;TOMM34;SORL1;B3GAT3;LZTS2;ANK3;TTC7B;TWF2;STRADB;SYNGAP1;CEP250;GAS6;CSNK1E;RAB3B;LAMA5;GSN;BCR;XPOT;SEPT10;AIP;PEX10;CEMIP;AP3D1;EPHB2;GRIN3B;CD81;TMED4;TGFB1;CLTCL1;ABHD17C;MOAP1;TBC1D9B;TMEM173;SHANK3;MIPEP;TUB;CROCC;RHOD;SNX17;SNX33;BBS1;PTPN1;PEX1;AGRN;LRP4;ZDHHC24;CEP131;PRKCZ;OXA1L;TOM1L2;MICALL2;NEURL1B;ERBB2;VAMP2;TFDP2;RILPL1;BNIP3L;ARHGAP44;PRKCD;CACNB3;BAX;TIMM17B;ZDHHC8;GDI1;LEMD2;WASH3P;LRSAM1;REEP2;EHD3;LONP2;SYMPK;COG7;SESN2;ABCA7;RAB12;BCAP31;SYNGR1;NBPF3;FYN;TMCO6;SUN1;SNX15;ZDHHC1;RTN2;C12ORF66;RERE;STX10;CEP72;PAK1;ITGA3;VPS16;BCL2L1;DLG3;SGSM2;TBC1D16;LMNA;PKD1;RABGAP1;ITGA4;RAB28;RAB40B;NGFR;TOLLIP;PDCD6;TBC1D8;KIF13B;TCTN1;CAMK1;HFE;WIPI2;CELSR1;SEPT6;APBA1;SRSF5
3330,GO:0007044,0.607778211514784,0.538782875499612,8,77,cell-substrate junction assembly,BP,VEGFA;ITGA6;SMAD3;ITGB4;PPM1F;LAMA5;RHOD;TNS1
12271,GO:0048593,0.60780377196365,0.548684686594541,7,68,camera-type eye morphogenesis,BP,SDK2;VEGFA;LRP5;WNT2B;EPHB2;BAX;PROX1
11285,GO:0045606,0.607814422148769,0.678409310522589,2,19,positive regulation of epidermal cell differentiation,BP,CYP27B1;ALOX15B
3079,GO:0006656,0.607891462824456,0.628648608193734,3,29,phosphatidylcholine biosynthetic process,BP,LPCAT1;CHKA;SLC27A1
904,GO:0002285,0.608380817552536,0.522646232225384,10,98,lymphocyte activation involved in immune response,BP,ERCC1;STAT6;CEACAM1;TGFB1;IFNE;PRKCZ;ADA;JAK3;MFNG;ZFPM1
11652,GO:0046425,0.608414896060942,0.537890323489536,8,79,regulation of JAK-STAT cascade,BP,PODNL1;PTK6;IFNE;VHL;CHAD;FYN;SOCS7;FGFR3
716,GO:0001942,0.608707475373175,0.547734213747803,7,68,hair follicle development,BP,EGFR;FOXQ1;LAMA5;LRP4;VANGL2;EDA;CELSR1
8471,GO:0033627,0.608749513875169,0.59707834961239,4,39,cell adhesion mediated by integrin,BP,ITGA6;PLAU;ADA;RAC3
360,GO:0000979,0.608815028162631,0.627696918280316,3,29,RNA polymerase II core promoter sequence-specific DNA binding,MF,FOS;CEBPB;KDM3A
1007,GO:0002480,0.60890400996904,0.778224766161824,1,9,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent,BP,HLA-G
13889,GO:0060544,0.608931677459305,0.677293962080949,2,19,regulation of necroptotic process,BP,RBCK1;BOK
20288,GO:2001236,0.609449419367591,0.510088302372601,12,119,regulation of extrinsic apoptotic signaling pathway,BP,ITGA6;RBCK1;AKT1;FGFR1;STRADB;IFI6;BAX;FYN;BCL2L1;LMNA;PELI3;DEDD2
17313,GO:0140112,0.610264650335573,0.675960072330848,2,19,extracellular vesicle biogenesis,BP,ARRDC1;SDC1
10485,GO:0043392,0.610413549921589,0.59503750345278,4,40,negative regulation of DNA binding,BP,CTNNBIP1;HMGA2;MDFI;PPARA
9890,GO:0042178,0.610451672174171,0.776861066646602,1,9,xenobiotic catabolic process,BP,GSTO1
12864,GO:0051196,0.610626501950937,0.545712936453897,7,68,regulation of coenzyme metabolic process,BP,PFKFB2;MLXIPL;PDK1;DDIT4;PPARA;INSR;PFKFB3
11991,GO:0047429,0.610930487508768,0.77643793764245,1,9,nucleoside-triphosphate diphosphatase activity,MF,ASMTL
2555,GO:0005834,0.611225091238786,0.674996812821648,2,19,heterotrimeric G-protein complex,CC,GNAL;RGS19
19241,GO:1905360,0.611225091238786,0.674996812821648,2,19,GTPase complex,CC,GNAL;RGS19
3241,GO:0006901,0.611406416813865,0.556977986731617,6,60,vesicle coating,BP,TRAPPC9;CTSZ;AREG;MCFD2;TGFA;PDCD6
18914,GO:1904591,0.611642276874379,0.624774918858455,3,29,positive regulation of protein import,BP,TGFB1;TMEM173;PRKCD
2576,GO:0005868,0.611667674844121,0.673726268391925,2,20,cytoplasmic dynein complex,CC,NUDCD3;WDR60
467,GO:0001508,0.612142760819408,0.544113058890216,7,68,action potential,BP,SCN4B;TPCN1;ANK3;SNTA1;NTSR1;CACNB3;SCN8A
951,GO:0002369,0.612297933940803,0.673918679314104,2,19,T cell cytokine production,BP,PRKCZ;HFE
15193,GO:0071345,0.612676638804856,0.435659968720845,76,748,cellular response to cytokine stimulus,BP,EGR1;PDCD4;BBS2;POSTN;VEGFA;TNFRSF6B;SPRY2;MST1R;SDC1;SHC1;MMP1;ZFP36L1;RBCK1;FOS;SMAD3;STAT6;AKT1;IFNGR2;CEACAM1;CCND1;PODNL1;MAPK13;GAS6;PFKP;LAMA5;GSN;AIP;NPR2;SHARPIN;IL20RB;EPOR;CEBPB;ADAMTS13;TGFB1;RFX2;ADAMTS7;TMEM173;TNFSF15;PTPN1;PCK2;IFNE;PRKACA;JAK3;FSCN1;PRKCD;IFI6;EREG;RPS6KA5;MT2A;GSTO1;CHAD;IRAK1;INPP5D;CDC34;RAB12;MIF;SYNGR1;ECM1;SPPL2B;FYN;ARID5B;PELI1;SLC27A1;MAPK3;HLA-G;HYAL1;BCL2L1;TNFRSF25;ITGA4;EDA;SOCS7;PELI3;NGFR;TOLLIP;IL17RE;KDM3A
13547,GO:0060021,0.612861837116492,0.555779022161419,6,58,roof of mouth development,BP,ACVR2B;WNT7A;TSHZ1;EPHB2;TGFBR3;ARID5B
13087,GO:0051608,0.613989582595805,0.773720852348655,1,9,histamine transport,BP,ADA
12348,GO:0048736,0.614097918350355,0.500685183979257,13,126,appendage development,BP,WNT7A;LRP5;ITGA6;ITGB4;IFT140;FGFR1;WNT3;LRP4;PBX2;BAX;FBXW4;TMEM231;SLC39A3
13649,GO:0060173,0.614097918350355,0.500685183979257,13,126,limb development,BP,WNT7A;LRP5;ITGA6;ITGB4;IFT140;FGFR1;WNT3;LRP4;PBX2;BAX;FBXW4;TMEM231;SLC39A3
7493,GO:0031672,0.6142111261173,0.671990425363413,2,19,A band,CC,OBSCN;OBSL1
8106,GO:0032800,0.61469184853129,0.671504782086557,2,19,receptor biosynthetic process,BP,NR1D1;PPARA
11556,GO:0046112,0.615064980831171,0.671127515025572,2,19,nucleobase biosynthetic process,BP,APRT;ADA
4439,GO:0010332,0.615093489366115,0.568895335896727,5,50,response to gamma radiation,BP,EGR1;ERCC6;BAX;CHEK2;BCL2L1
8229,GO:0033006,0.615260871575997,0.670929343199293,2,19,regulation of mast cell activation involved in immune response,BP,ADORA2B;RAC2
10441,GO:0043304,0.615260871575997,0.670929343199293,2,19,regulation of mast cell degranulation,BP,ADORA2B;RAC2
3631,GO:0008097,0.615428933439552,0.770348405472652,1,10,5S rRNA binding,MF,TST
653,GO:0001844,0.616529426912254,0.619227584707897,3,30,protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,MOAP1;TFDP2;BAX
4968,GO:0015078,0.617323728584551,0.537759012365338,7,75,proton transmembrane transporter activity,MF,SLC2A9;SLC15A4;MFSD3;SLC9A7;SLC22A18;ATP6V1F;TMCO3
2707,GO:0006084,0.61783068307288,0.61833329456987,3,29,acetyl-CoA metabolic process,BP,MVD;PDK1;MLYCD
9486,GO:0036126,0.618318741565011,0.586722886037449,4,40,sperm flagellum,CC,HK1;DNAH1;PFKM;SEPT6
16722,GO:0097729,0.618318741565011,0.586722886037449,4,40,9+2 motile cilium,CC,HK1;DNAH1;PFKM;SEPT6
12349,GO:0048738,0.618329625540301,0.49621637836784,13,126,cardiac muscle tissue development,BP,VEGFA;OBSL1;FGFR1;TGFB1;FHOD3;KDM6B;PPP1R13L;TGFBR3;ZFPM1;TAZ;PAK1;PROX1;LMNA
1126,GO:0002714,0.618676711737159,0.66746147460737,2,19,positive regulation of B cell mediated immunity,BP,STAT6;TGFB1
1222,GO:0002891,0.618676711737159,0.66746147460737,2,19,positive regulation of immunoglobulin mediated immune response,BP,STAT6;TGFB1
16599,GO:0097428,0.61895882749987,0.767147968709928,1,10,protein maturation by iron-sulfur cluster transfer,BP,MAGEF1
14643,GO:0070234,0.619457272360248,0.768804650240232,1,9,positive regulation of T cell apoptotic process,BP,ADAM8
9794,GO:0040019,0.619476123971547,0.666646528625997,2,19,positive regulation of embryonic development,BP,WNT2B;FAM129B
9793,GO:0040018,0.619477615432848,0.666645006989558,2,19,positive regulation of multicellular organism growth,BP,BBS2;SH3PXD2B
15874,GO:0072604,0.619686528405002,0.666431823330422,2,19,interleukin-6 secretion,BP,F2R;GAS6
12796,GO:0051099,0.619828261652725,0.490320147265908,14,139,positive regulation of binding,BP,APOE;HMGA2;LRP1;GPSM1;TGFB1;TMEM173;RFNG;MFNG;CAPRIN2;PKD1;SIRT2;FAM129B;MAPRE3;HFE
1175,GO:0002821,0.620466065110275,0.563196692773163,5,50,positive regulation of adaptive immune response,BP,STAT6;TGFB1;PRKCZ;ADA;ZP3
12984,GO:0051409,0.620783788341437,0.767600258959823,1,9,response to nitrosative stress,BP,DUSP6
11446,GO:0045911,0.620849275367184,0.665243710065222,2,19,positive regulation of DNA recombination,BP,STAT6;TGFB1
8004,GO:0032640,0.621377584004838,0.533918984496665,7,71,tumor necrosis factor production,BP,NFATC4;ACP5;GAS6;ERRFI1;MC1R;MIF;DDT
692,GO:0001913,0.621548901630356,0.663686382716222,2,20,T cell mediated cytotoxicity,BP,CEACAM1;PPP3CB
18456,GO:1903531,0.621654481038913,0.508451821468285,10,100,negative regulation of secretion by cell,BP,F2R;IDH2;HADH;RHBDF2;MAPKBP1;PFKL;CEACAM1;GAS6;BCR;ASIC1
19751,GO:2000108,0.621717498643875,0.663513390760497,2,20,positive regulation of leukocyte apoptotic process,BP,ADAM8;BAX
16922,GO:0098900,0.62194171714663,0.614018973366981,3,29,regulation of action potential,BP,ANK3;NTSR1;CACNB3
11296,GO:0045624,0.622539123203515,0.765999463456177,1,9,positive regulation of T-helper cell differentiation,BP,PRKCZ
19057,GO:1904892,0.622777156122223,0.522564316218632,8,80,regulation of STAT cascade,BP,PODNL1;PTK6;IFNE;VHL;CHAD;FYN;SOCS7;FGFR3
1155,GO:0002762,0.622829694662486,0.613083382340522,3,29,negative regulation of myeloid leukocyte differentiation,BP,CEACAM1;INPP5D;ZFPM1
927,GO:0002323,0.623480011026616,0.765138085410691,1,9,natural killer cell activation involved in immune response,BP,IFNE
15786,GO:0072413,0.624494337426988,0.542913558800032,6,61,signal transduction involved in mitotic cell cycle checkpoint,BP,ZNF385A;PCBP4;TFDP2;RBL2;BAX;CHEK2
17994,GO:1902402,0.624494337426988,0.542913558800032,6,61,signal transduction involved in mitotic DNA damage checkpoint,BP,ZNF385A;PCBP4;TFDP2;RBL2;BAX;CHEK2
17995,GO:1902403,0.624494337426988,0.542913558800032,6,61,signal transduction involved in mitotic DNA integrity checkpoint,BP,ZNF385A;PCBP4;TFDP2;RBL2;BAX;CHEK2
4220,GO:0009396,0.624728553533208,0.763991453379033,1,9,folic acid-containing compound biosynthetic process,BP,GCH1
15855,GO:0072577,0.624877142878548,0.610921111462727,3,29,endothelial cell apoptotic process,BP,PDCD4;GAS6;ANGPTL4
16491,GO:0097190,0.624935645054713,0.435419481437776,47,466,apoptotic signaling pathway,BP,TNFRSF6B;ITGA6;NFATC4;RBCK1;SMAD3;ERCC6;PRODH;AKT1;PPM1F;DAP;FGFR1;ZNF385A;STRADB;GSN;BNIP3;MNT;CEBPB;TGFB1;MKNK2;MOAP1;PTPN1;TRAP1;BOK;TFDP2;BNIP3L;PDK1;PRKCD;IFI6;BAX;DDIT4;CHEK2;TMEM161A;BCAP31;MIF;PLA2G6;WFS1;FYN;STK25;GRINA;BCL2L1;LMNA;TNFRSF25;PELI3;NGFR;PDCD6;FGFR3;DEDD2
4936,GO:0014897,0.625095725990889,0.558475743961236,5,49,striated muscle hypertrophy,BP,SMAD3;ERRFI1;CAMTA2;PAK1;LMNA
9816,GO:0042033,0.625730445043066,0.763068363069803,1,9,chemokine biosynthetic process,BP,EGR1
12575,GO:0050755,0.625730445043066,0.763068363069803,1,9,chemokine metabolic process,BP,EGR1
1170,GO:0002792,0.625874943330656,0.529112180278203,7,71,negative regulation of peptide secretion,BP,F2R;IDH2;HADH;RHBDF2;MAPKBP1;PFKL;GAS6
20126,GO:2000780,0.626135672024839,0.659807677870159,2,19,negative regulation of double-strand break repair,BP,HMGA2;MAGEF1
3696,GO:0008207,0.626181390201413,0.658912312149372,2,20,C21-steroid hormone metabolic process,BP,EGR1;DGKQ
6841,GO:0030316,0.626398672465311,0.541201565565867,6,59,osteoclast differentiation,BP,FOS;SH3PXD2A;CEBPB;FAM20C;INPP5D;LRRK1
16333,GO:0090559,0.626417623298272,0.528530646331529,7,71,regulation of membrane permeability,BP,BNIP3;MOAP1;BOK;TFDP2;BNIP3L;BAX;BCL2L1
10484,GO:0043388,0.626684228902558,0.577534097413428,4,41,positive regulation of DNA binding,BP,HMGA2;TGFB1;SIRT2;FAM129B
12292,GO:0048641,0.62697862428891,0.608694443690576,3,29,regulation of skeletal muscle tissue development,BP,TGFB1;GPC1;FAM129B
6854,GO:0030330,0.627012751723967,0.502663123843682,10,101,DNA damage response, signal transduction by p53 class mediator,BP,NDRG1;ZNF385A;PCBP4;TFDP2;RBL2;BAX;RPS6KA6;CHEK2;SESN2;MIF
13690,GO:0060253,0.627137803495754,0.761767204025939,1,9,negative regulation of glial cell proliferation,BP,IDH2
5052,GO:0015248,0.627185450304508,0.657871842476882,2,20,sterol transporter activity,MF,APOE;ABCG1
9375,GO:0035909,0.627774421188942,0.658111051958888,2,19,aorta morphogenesis,BP,LRP1;PROX1
8123,GO:0032823,0.627938987044539,0.761024125818239,1,9,regulation of natural killer cell differentiation,BP,GAS6
17833,GO:1901981,0.628034142624468,0.495745139119328,11,108,phosphatidylinositol phosphate binding,MF,OSBPL5;ARAP1;SH3PXD2B;AKT1;TWF2;ARAP3;ADAP1;PLEK2;WIPI2;PFN2;GSDMA
3632,GO:0008104,0.628353218421511,0.401856773682606,214,2069,protein localization,BP,ZMYND8;NR1D1;EDEM1;DLG4;MARVELD1;ACVR2B;PRNP;BBS2;POSTN;WNT7A;APOE;F2R;LRP5;OBSCN;IDH2;ITPR3;ARRDC1;EVI5L;EGFR;OBSL1;TMEM129;HADH;SYTL1;ETV5;LMF1;LTBP2;VPS11;LTBP1;TBC1D14;ARL2;SNX9;NUDCD3;RAPGEF3;GLUL;MDFI;SSH1;POU2F2;EXOC2;PIK3R2;LRP1;DVL1;AP2A2;SH3PXD2B;NLGN2;STOM;AKT1;CORO1B;PITPNM1;RHBDF2;BSG;HK1;PTPRU;SLC15A4;ATG16L2;IFT140;RAB31;MAPKBP1;RAC2;KCNAB2;PFKL;MXI1;SYNE3;PACS2;TOMM34;SORL1;B3GAT3;LZTS2;ANK3;TTC7B;TWF2;STRADB;SYNGAP1;CEP250;GAS6;CSNK1E;RAB3B;CARD11;LAMA5;GSN;BCR;XPOT;SEPT10;AIP;ALOX15B;AGAP1;PEX10;CORO7;UNC119B;MVB12B;CEMIP;PKD2;AP3D1;EPHB2;GRIN3B;ADAM8;KIF17;CD81;TMED4;TGFB1;CLTCL1;ABHD17C;MOAP1;TBC1D9B;TMEM173;SHANK3;MIPEP;TUB;CROCC;RHOD;SNX17;VGF;SNX33;LLGL1;BBS1;PTPN1;PEX1;PCK2;AGRN;LRP4;ZDHHC24;CEP131;PFKFB2;PRKCZ;OXA1L;TOM1L2;MICALL2;NEURL1B;ERBB2;ULK1;VAMP2;TFDP2;NECAB3;RILPL1;BNIP3L;ARHGAP44;MCFD2;PRKCD;CACNB3;BAX;OLFM2;TIMM17B;ZDHHC8;GDI1;LEMD2;WASH3P;LRSAM1;REEP2;EHD3;TMEM231;LONP2;SYMPK;COG7;SESN2;ABCG1;ABCA7;RAB12;BCAP31;MIF;DOPEY2;PLA2G6;SYNGR1;NBPF3;FYN;TMCO6;SUN1;DNM2;SNX15;ZDHHC1;MAPK3;RTN2;PFKM;TNS4;C12ORF66;RERE;STX10;PRAF2;CEP72;VANGL2;PAK1;MALL;PPP3CB;ITGA3;VPS16;BCL2L1;DLG3;SGSM2;TBC1D16;LMNA;PKD1;RABGAP1;ITGA4;MAPRE3;RAB28;ICA1;RAB40B;NGFR;TOLLIP;PDCD6;ATP6V1F;PCLO;TBC1D8;PLEKHM1;KIF13B;TCTN1;CAMK1;SIRT3;HFE;WIPI2;VPS51;CELSR1;SEPT6;TRIM46;APBA1;SRSF5
9548,GO:0036314,0.628718430684377,0.657131218700995,2,19,response to sterol,BP,ABCA2;TGFB1
10205,GO:0042826,0.628819962805207,0.507906594282632,9,89,histone deacetylase binding,MF,MEF2D;PKN1;HDAC5;CCND1;CEBPB;UHRF1BP1;CAMTA2;WDTC1;SIRT2
3355,GO:0007095,0.629181833791683,0.656649564218821,2,19,mitotic G2 DNA damage checkpoint,BP,HMGA2;BRSK1
11708,GO:0046520,0.629208246256087,0.759843413545325,1,9,sphingoid biosynthetic process,BP,SPTLC2
1184,GO:0002830,0.629313250780001,0.759745541519087,1,9,positive regulation of type 2 immune response,BP,PRKCZ
14879,GO:0070671,0.629411683326957,0.57433290707637,4,42,response to interleukin-12,BP,PDCD4;AIP;GSTO1;MIF
17756,GO:1901682,0.629421598430041,0.656400183964698,2,19,sulfur compound transmembrane transporter activity,MF,SLC6A6;SLC26A11
6750,GO:0030178,0.629612771676883,0.476014345212939,15,154,negative regulation of Wnt signaling pathway,BP,EGR1;CTNNBIP1;APOE;WWTR1;NFATC4;MDFI;LRP1;DVL1;NPHP4;LZTS2;IGFBP4;CCND1;IGFBP2;LRP4;GRB10
11185,GO:0045296,0.629675134300039,0.445274952890118,30,299,cadherin binding,MF,ITGA6;NDRG1;EGFR;SNX9;MPRIP;KLC2;SLC9A3R2;CORO1B;BSG;FMNL2;ANK3;TWF2;PFKP;EHD4;SH3GLB2;CCS;PAK6;SCYL1;PTPN1;ESYT2;EPN2;CAPG;FSCN1;PPL;PPP1R13L;PLCB3;H1FX;DOCK9;FAM129B;CDH4
10540,GO:0043496,0.629964351336701,0.654981473693975,2,20,regulation of protein homodimerization activity,BP,BAX;ITGA4
19848,GO:2000300,0.630378096728558,0.655404154603584,2,19,regulation of synaptic vesicle exocytosis,BP,RIMS3;PFN2
2980,GO:0006527,0.63050732378742,0.758630497766527,1,9,arginine catabolic process,BP,NOS1
11260,GO:0045576,0.630540193116848,0.604429709755665,3,30,mast cell activation,BP,NDRG1;ADORA2B;RAC2
2641,GO:0005979,0.630615583875877,0.655156561779908,2,19,regulation of glycogen biosynthetic process,BP,AKT1;INSR
4775,GO:0010962,0.630615583875877,0.655156561779908,2,19,regulation of glucan biosynthetic process,BP,AKT1;INSR
11588,GO:0046185,0.630706660652471,0.758443981123985,1,9,aldehyde catabolic process,BP,HAGH
14367,GO:0061608,0.630818412204165,0.758339370070584,1,9,nuclear import signal receptor activity,MF,TMCO6
18821,GO:1904376,0.630840173014605,0.654922309340974,2,19,negative regulation of protein localization to cell periphery,BP,TGFB1;BCL2L1
15716,GO:0072283,0.631391699247251,0.757802185497828,1,9,metanephric renal vesicle morphogenesis,BP,KIF26B
113,GO:0000242,0.6314050399244,0.654332680284911,2,19,pericentriolar material,CC,TUBG2;WDR60
6444,GO:0021766,0.63160985979574,0.551256407000015,5,50,hippocampus development,BP,BBS2;PTPRS;KDM6B;PROX1;EZH1
17535,GO:1901018,0.631820291650594,0.757400005118596,1,9,positive regulation of potassium ion transmembrane transporter activity,BP,DNM2
18309,GO:1903205,0.631951956550984,0.652904457001062,2,20,regulation of hydrogen peroxide-induced cell death,BP,ENDOG;TRAP1
3236,GO:0006895,0.632190032203853,0.653512186897147,2,19,Golgi to endosome transport,BP,CORO7;DOPEY2
11846,GO:0046839,0.632246480287138,0.603079918168003,3,29,phospholipid dephosphorylation,BP,SYNJ2;PLPP6;INPP5D
10541,GO:0043497,0.632340704277374,0.756910996704414,1,9,regulation of protein heterodimerization activity,BP,BAX
11058,GO:0045064,0.632672122072791,0.756599196929246,1,9,T-helper 2 cell differentiation,BP,PRKCZ
8228,GO:0033005,0.632796787264519,0.756481834321068,1,9,positive regulation of mast cell activation,BP,ADORA2B
10265,GO:0043011,0.632880792166087,0.756402726509161,1,9,myeloid dendritic cell differentiation,BP,TGFB1
408,GO:0001094,0.632956672880541,0.756331252864776,1,9,TFIID-class transcription factor binding,MF,ERCC1
918,GO:0002312,0.632977720358041,0.549779490224557,5,50,B cell activation involved in immune response,BP,ERCC1;STAT6;TGFB1;ADA;MFNG
11008,GO:0044849,0.633193106076623,0.756108451491873,1,9,estrous cycle,BP,EGR1
12589,GO:0050774,0.633700519658971,0.755629782034849,1,9,negative regulation of dendrite morphogenesis,BP,NFATC4
7333,GO:0031362,0.633728041917597,0.755603798903556,1,9,anchored component of external side of plasma membrane,CC,PRNP
134,GO:0000281,0.63389213284582,0.532964875745088,6,60,mitotic cytokinesis,BP,SNX9;ANK3;SEPT10;SNX33;CUL7;SEPT6
5727,GO:0016868,0.634154788562184,0.755200654095667,1,9,intramolecular transferase activity, phosphotransferases,MF,PGM1
7015,GO:0030742,0.634166539433727,0.650580687785146,2,20,GTP-dependent protein binding,MF,RAB3B;GCH1
7278,GO:0031272,0.634476114754819,0.754896772806469,1,9,regulation of pseudopodium assembly,BP,CDC42EP5
7279,GO:0031274,0.634476114754819,0.754896772806469,1,9,positive regulation of pseudopodium assembly,BP,CDC42EP5
18155,GO:1902882,0.634486198326679,0.5321602725001,6,61,regulation of response to oxidative stress,BP,MCTP1;ENDOG;AKT1;TRAP1;SESN2;GCH1
14893,GO:0070700,0.634489716343755,0.754883903459861,1,9,BMP receptor binding,MF,TGFB1
7095,GO:0030898,0.634635986237501,0.754745476208063,1,9,actin-dependent ATPase activity,MF,MYO1D
4289,GO:0009713,0.634977077659734,0.754422447096645,1,9,catechol-containing compound biosynthetic process,BP,GCH1
10000,GO:0042423,0.634977077659734,0.754422447096645,1,9,catecholamine biosynthetic process,BP,GCH1
12973,GO:0051385,0.635368699150855,0.649315018260193,2,20,response to mineralocorticoid,BP,FOS;CCND1
14881,GO:0070673,0.635409316236992,0.754012642217703,1,9,response to interleukin-18,BP,AKT1
6776,GO:0030218,0.635550581832631,0.508849871866806,8,80,erythrocyte differentiation,BP,VEGFA;FAM210B;ZFP36L1;EPAS1;JAK3;TGFBR3;INPP5D;ZFPM1
1128,GO:0002716,0.635980002984327,0.75347079419048,1,9,negative regulation of natural killer cell mediated immunity,BP,CEACAM1
12580,GO:0050765,0.636191102301225,0.753270137072357,1,9,negative regulation of phagocytosis,BP,TGFB1
10680,GO:0043951,0.636529846869004,0.752947894152036,1,9,negative regulation of cAMP-mediated signaling,BP,CDC34
1123,GO:0002711,0.636554660283701,0.64806346936807,2,20,positive regulation of T cell mediated immunity,BP,PRKCZ;ZP3
16077,GO:0090042,0.636578177789354,0.752901892038955,1,9,tubulin deacetylation,BP,SIRT2
4935,GO:0014896,0.636910123748957,0.545519681122397,5,50,muscle hypertrophy,BP,SMAD3;ERRFI1;CAMTA2;PAK1;LMNA
1284,GO:0003085,0.637120597476873,0.752385169905636,1,9,negative regulation of systemic arterial blood pressure,BP,NTSR1
6356,GO:0021542,0.637286665513537,0.752226808247608,1,9,dentate gyrus development,BP,PROX1
14157,GO:0061050,0.637322407238562,0.752192715225091,1,9,regulation of cell growth involved in cardiac muscle cell development,BP,PAK1
1135,GO:0002726,0.637610027172775,0.751918235078635,1,9,positive regulation of T cell cytokine production,BP,PRKCZ
10263,GO:0043009,0.637843818242294,0.424682115959875,43,416,chordate embryonic development,BP,VEGFA;EGFR;CAPN2;PHLDA2;ZFP36L1;PLCD3;MDFI;MAP2K1;ENDOG;SMAD3;DVL1;EPAS1;SALL2;AKT1;IFT140;FGFR1;PRKACB;EDNRA;PKD2;FBXW8;PLCG1;CEBPB;TGFB1;DEAF1;MBD3;ADA;WDR60;TMEM231;VANGL2;HYAL1;SEMA4C;WDTC1;HES7;BCL2L1;PROX1;PKD1;PDCD6;MAFF;TCTN1;SLC39A3;ZP3;CELSR1;APBA1
16293,GO:0090398,0.638144636531322,0.543965504899739,5,51,cellular senescence,BP,HMGA2;MAP2K1;YPEL3;PRKCD;TERC
11353,GO:0045723,0.638206519555081,0.751348268956107,1,9,positive regulation of fatty acid biosynthetic process,BP,MLXIPL
4656,GO:0010803,0.638752603513655,0.543100055356554,5,52,regulation of tumor necrosis factor-mediated signaling pathway,BP,RBCK1;GAS6;SHARPIN;SPPL2B;PELI3
10082,GO:0042588,0.638777776526214,0.750801498544472,1,9,zymogen granule,CC,VAMP2
8735,GO:0034393,0.638831931564789,0.75074961818616,1,9,positive regulation of smooth muscle cell apoptotic process,BP,PDCD4
18258,GO:1903069,0.638850887694795,0.75073145636319,1,9,regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,BCAP31
130,GO:0000271,0.638926754424727,0.527504830497463,6,60,polysaccharide biosynthetic process,BP,NR1D1;PGM1;AKT1;TGFB1;B3GNT3;INSR
18043,GO:1902547,0.639116339857243,0.750477023207277,1,9,regulation of cellular response to vascular endothelial growth factor stimulus,BP,XDH
2093,GO:0004857,0.639375360337903,0.445426881360973,23,235,enzyme inhibitor activity,MF,CST3;SERPINE2;SPRY2;ARL2;PPP1R35;PPP1R14A;PRDX5;SERPING1;PODNL1;GAS6;ANGPTL4;TFPI2;CDKN1C;TIMP2;RNH1;CAMK2N1;TRIB2;PCSK1N;CHAD;ELFN2;WDTC1;SERPINB1;SOCS7
13060,GO:0051573,0.639419256456129,0.750186443307363,1,9,negative regulation of histone H3-K9 methylation,BP,KDM3A
11761,GO:0046629,0.639589623361776,0.750022903531715,1,9,gamma-delta T cell activation,BP,SOX13
3194,GO:0006826,0.639704662034555,0.563197425907179,4,42,iron ion transport,BP,DNM2;SLC25A37;ATP6V1F;HFE
1540,GO:0003924,0.639751560583792,0.445152578787881,23,229,GTPase activity,MF,ARL2;GTPBP1;RAB31;RAC2;RAB3B;SEPT10;AGAP1;GNAL;RHOD;RHOF;RHOBTB2;TUBG2;RASL10B;DNM1;RAB12;RAC3;DNM2;TUBB6;RRAS;RAB28;RAB40B;GCH1;SEPT6
5418,GO:0016266,0.640252214219374,0.56317621158701,4,40,O-glycan processing,BP,ST6GALNAC2;B3GNT3;ST3GAL3;ST3GAL2
4183,GO:0009262,0.640289028633894,0.593073621140567,3,32,deoxyribonucleotide metabolic process,BP,ADA;DGUOK;NEIL1
6837,GO:0030309,0.640402153423118,0.749241830226845,1,9,poly-N-acetyllactosamine metabolic process,BP,B3GNT3
6838,GO:0030311,0.640402153423118,0.749241830226845,1,9,poly-N-acetyllactosamine biosynthetic process,BP,B3GNT3
2238,GO:0005149,0.640434375232083,0.749210818210354,1,9,interleukin-1 receptor binding,MF,TOLLIP
6571,GO:0022404,0.640516007863309,0.513436445643883,7,70,molting cycle process,BP,EGFR;FOXQ1;LAMA5;LRP4;VANGL2;EDA;CELSR1
6572,GO:0022405,0.640516007863309,0.513436445643883,7,70,hair cycle process,BP,EGFR;FOXQ1;LAMA5;LRP4;VANGL2;EDA;CELSR1
16854,GO:0098773,0.640516007863461,0.513436445643591,7,70,skin epidermis development,BP,EGFR;FOXQ1;LAMA5;LRP4;VANGL2;EDA;CELSR1
3375,GO:0007156,0.640629670167058,0.513445924233429,7,69,homophilic cell adhesion via plasma membrane adhesion molecules,BP,SDK2;CEACAM1;PLXNB3;CADM4;PKD1;CDH4;CELSR1
10670,GO:0043922,0.640632054254915,0.749020498252171,1,9,negative regulation by host of viral transcription,BP,HMGA2
5958,GO:0018342,0.640728714732926,0.748927396765817,1,9,protein prenylation,BP,RABGGTA
16565,GO:0097354,0.640728714732926,0.748927396765817,1,9,prenylation,BP,RABGGTA
6653,GO:0030011,0.641107867796436,0.748561953797049,1,9,maintenance of cell polarity,BP,LRCH4
13820,GO:0060429,0.641293414860861,0.40387787522451,84,821,epithelium development,BP,XDH;CST3;CYP27B1;PGF;CTNNBIP1;ACVR2B;VEGFA;WNT7A;LRP5;EGFR;SERPINE2;DNPH1;WWTR1;PTPRS;SPRY2;NFATC4;PRSS8;SDC1;ETV5;ACTA2;RAPGEF3;ZFP36L1;FOXQ1;MAP2K1;SMURF2;SMAD3;STAT6;DVL1;HBEGF;AP2A2;SALL2;AKT1;IFT140;WNT2B;FGFR1;PRKACB;CEACAM1;CCND1;EDNRA;PTK6;CTSB;LAMA5;ERRFI1;SLITRK6;ALOX15B;SHARPIN;PKD2;CTSZ;CEBPB;WNT3;TGFB1;DEAF1;KIF26B;LCE1E;LAMB2;TPP1;PCK2;LRP4;KDM6B;AREG;RILPL1;FAM20C;BAX;SH3BP1;EREG;PPL;ALDOC;TMEM231;ARHGAP12;CAT;VANGL2;PAK1;SEMA4C;HES7;DLG3;PROX1;PKD1;EDA;TOLLIP;MAFF;TCTN1;BTG1;CELSR1;TST
4566,GO:0010649,0.641533750965377,0.748150994660043,1,9,regulation of cell communication by electrical coupling,BP,ANK3
1075,GO:0002643,0.641781685508775,0.747911516271217,1,9,regulation of tolerance induction,BP,HLA-G
9790,GO:0040015,0.641796702667675,0.7478970058028,1,9,negative regulation of multicellular organism growth,BP,BBS2
6630,GO:0023019,0.641886202979313,0.747810512294055,1,9,signal transduction involved in regulation of gene expression,BP,SMAD3
17867,GO:1902065,0.642122150166631,0.747582385021578,1,9,response to L-glutamate,BP,FYN
14835,GO:0070584,0.642128490252904,0.641358371172308,2,21,mitochondrion morphogenesis,BP,BAX;BCL2L1
3289,GO:0006984,0.64220240459045,0.561047941610276,4,40,ER-nucleus signaling pathway,BP,PTPN1;BOK;MBTPS2;WFS1
810,GO:0002084,0.642249288665314,0.747459395974349,1,9,protein depalmitoylation,BP,ABHD17C
9932,GO:0042288,0.642395202197047,0.747318189170499,1,9,MHC class I protein binding,MF,BCAP31
17888,GO:1902117,0.642446737227938,0.523668952783798,6,60,positive regulation of organelle assembly,BP,SDC1;CROCC;ULK1;FSCN1;LRSAM1;PROX1
11612,GO:0046325,0.642488388079162,0.747227978140614,1,9,negative regulation of glucose import,BP,GRB10
15121,GO:0071218,0.642712668586854,0.641517737934006,2,20,cellular response to misfolded protein,BP,ANKZF1;STUB1
6707,GO:0030123,0.642771034388407,0.746954206910214,1,9,AP-3 adaptor complex,CC,AP3D1
9061,GO:0035303,0.643063115520261,0.458526024387855,16,158,regulation of dephosphorylation,BP,PPP1R35;SMAD3;PPP1R14A;PPP2R3B;B3GAT3;TGFB1;NSMF;FARP1;PRKCD;ITGA1;SYMPK;MYO1D;ELFN2;PPP2R5B;DLG3;PPP1R16A
4436,GO:0010310,0.643321948400788,0.74641995081017,1,9,regulation of hydrogen peroxide metabolic process,BP,RAC2
2802,GO:0006265,0.64333592426215,0.746406386509247,1,9,DNA topological change,BP,TOP3B
14776,GO:0070486,0.643485796832767,0.743996457681015,1,10,leukocyte aggregation,BP,RAC2
12927,GO:0051293,0.643643329805925,0.590288741563202,3,30,establishment of spindle localization,BP,SPRY2;LLGL1;NDE1
16170,GO:0090192,0.643888729147947,0.745869422530255,1,9,regulation of glomerulus development,BP,EGR1
11295,GO:0045623,0.644022964171532,0.745738905039489,1,9,negative regulation of T-helper cell differentiation,BP,JAK3
4434,GO:0010288,0.644034973710526,0.640101789963496,2,20,response to lead ion,BP,CAT;DNMT3A
265,GO:0000733,0.644155973909814,0.745609529122516,1,9,DNA strand renaturation,BP,SMARCA1
164,GO:0000340,0.644167381628552,0.745598430754823,1,9,RNA 7-methylguanosine cap binding,MF,CYFIP2
611,GO:0001780,0.644178973246751,0.74558715310027,1,9,neutrophil homeostasis,BP,ITPKB
8314,GO:0033160,0.644320445641629,0.745449482205304,1,9,positive regulation of protein import into nucleus, translocation,BP,TMEM173
14499,GO:0062009,0.644328613543601,0.745441532069518,1,9,secondary palate development,BP,TSHZ1
574,GO:0001726,0.644390942935082,0.464097271222554,14,139,ruffle,CC,SPRY2;SNX9;SPRY4;S100A6;PTK6;GSN;WIPF1;PLCG1;ARAP3;FSCN1;ABCA7;DNM2;ARHGEF4;PAK1
2616,GO:0005929,0.644491149882119,0.424269117165766,35,343,cilium,CC,BBS2;ANKS6;MARK4;SHANK2;AKT1;HK1;IFT140;PRKACB;NPHP4;EVC;CEP250;UNC119B;PKD2;KIF17;SHANK3;TUB;CROCC;DNAH1;KIF7;BBS1;CEP131;PRKACA;RILPL1;NUBP2;EHD3;WDR60;TMEM231;PFKM;PKD1;RAB28;TCTN1;BBS10;SEPT6;TTLL3;ADCY6
4703,GO:0010867,0.644504455109499,0.745270333294991,1,9,positive regulation of triglyceride biosynthetic process,BP,LDLR
10546,GO:0043506,0.644506430815463,0.509087042719135,7,70,regulation of JUN kinase activity,BP,PDCD4;PKN1;ERCC6;PTPN1;VANGL2;PAK1;MAP3K10
20119,GO:2000772,0.644740707968521,0.588642110303025,3,31,regulation of cellular senescence,BP,HMGA2;YPEL3;TERC
18376,GO:1903362,0.644754707187232,0.44589151929193,20,201,regulation of cellular protein catabolic process,BP,EDEM1;APOE;VPS11;LRP1;DVL1;AKT1;LDLR;CSNK1E;PCSK9;RAD23A;MAGEF1;CD81;TRIB2;PRKACA;STUB1;BCAP31;RNF144A;PKD1;SIRT2;HFE
14826,GO:0070570,0.644827345172393,0.639251533012797,2,20,regulation of neuron projection regeneration,BP,PTPRS;MAP2K1
8016,GO:0032656,0.644898674150288,0.744886207671629,1,9,regulation of interleukin-13 production,BP,PRKCZ
14999,GO:0070933,0.644977894550403,0.744808962946847,1,9,histone H4 deacetylation,BP,SIRT2
1310,GO:0003157,0.645317525070506,0.744477602602874,1,9,endocardium development,BP,PROX1
1324,GO:0003174,0.64545102597918,0.744347263716285,1,9,mitral valve development,BP,ZFPM1
7214,GO:0031115,0.645507974456174,0.74429164883133,1,9,negative regulation of microtubule polymerization,BP,EML2
10162,GO:0042754,0.645521413760854,0.744278522911063,1,9,negative regulation of circadian rhythm,BP,ADA
10237,GO:0042975,0.645570159199437,0.744230909877581,1,9,peroxisome proliferator activated receptor binding,MF,NFATC4
3530,GO:0007520,0.645695624062112,0.638318295270042,2,20,myoblast fusion,BP,NOS1;CAPN2
5656,GO:0016755,0.645724832844962,0.744079785175697,1,9,transferase activity, transferring amino-acyl groups,MF,GGT1
18879,GO:1904526,0.645771946177964,0.744033739462237,1,9,regulation of microtubule binding,BP,MAPRE3
2585,GO:0005881,0.6457745296748,0.535627295497708,5,51,cytoplasmic microtubule,CC,CLIP2;SNPH;ENKD1;TUBG2;REEP2
14061,GO:0060856,0.645777586417555,0.744028226614653,1,9,establishment of blood-brain barrier,BP,WNT7A
20296,GO:2001244,0.645860675038347,0.555939451823829,4,44,positive regulation of intrinsic apoptotic signaling pathway,BP,BOK;BAX;BCAP31;BCL2L1
18844,GO:1904424,0.645915768910698,0.743893137175946,1,9,regulation of GTP binding,BP,GPSM1
1929,GO:0004623,0.645954029124835,0.638040249038639,2,20,phospholipase A2 activity,MF,TMEM8A;PLA2G6
13893,GO:0060548,0.646281430487525,0.40274359810804,70,686,negative regulation of cell death,BP,CST3;PDCD4;PRNP;VEGFA;TNFRSF6B;WNT7A;APOE;F2R;ITGA6;HMGA2;EGFR;SPRY2;MST1R;SHC1;RBCK1;SMAD3;LRP1;PRDX5;AKT1;EPHA1;IMPACT;FGFR4;FGFR1;RAG1;SORL1;ZNF385A;STRADB;SYNGAP1;GAS6;ANGPTL4;RGL2;BNIP3;EPHB2;ADAM8;MNT;CEBPB;NTSR1;PTPN1;VHL;TRAP1;PRKCZ;ADA;PIM2;BOK;ERBB2;JAK3;BNIP3L;PRKCD;IFI6;BAX;TMBIM4;IRAK1;PPARA;TMEM161A;MIF;WFS1;FYN;EEF2K;CAT;INSR;GRINA;MICAL1;BCL2L1;LMNA;FAM129B;PELI3;NGFR;FGFR3;ITPKB;AARS
11251,GO:0045505,0.646696157349796,0.63645129626039,2,21,dynein intermediate chain binding,MF,DNAAF5;DNAH1
19720,GO:2000042,0.646728143679346,0.743097857883271,1,9,negative regulation of double-strand break repair via homologous recombination,BP,MAGEF1
7445,GO:0031588,0.64677264797832,0.743054236310343,1,9,nucleotide-activated protein kinase complex,CC,SESN2
11352,GO:0045722,0.64684137528272,0.74298686119365,1,9,positive regulation of gluconeogenesis,BP,PPARA
13715,GO:0060294,0.646942331678947,0.742887866878384,1,9,cilium movement involved in cell motility,BP,BBS2
13596,GO:0060077,0.646962410146774,0.742868175199605,1,9,inhibitory synapse,CC,NLGN2
8479,GO:0033643,0.647003971827674,0.742827410537704,1,9,host cell part,CC,PI4K2A
12659,GO:0050872,0.647006229142456,0.742825196371251,1,9,white fat cell differentiation,BP,CTBP1
15590,GO:0072075,0.647317803951524,0.742519438997731,1,9,metanephric mesenchyme development,BP,PKD2
15502,GO:0071880,0.647322372510125,0.742514953696117,1,9,adenylate cyclase-activating adrenergic receptor signaling pathway,BP,NOS1
6537,GO:0021954,0.647383243249431,0.555068880578242,4,41,central nervous system neuron development,BP,ADARB1;EPHB2;RAC3;TCTN1
4853,GO:0014067,0.647421548566582,0.74241757045361,1,9,negative regulation of phosphatidylinositol 3-kinase signaling,BP,SERPINE2
11265,GO:0045581,0.647625295988898,0.636238519566726,2,20,negative regulation of T cell differentiation,BP,ERBB2;JAK3
17937,GO:1902253,0.647699933881612,0.634652028326214,2,22,regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,ZNF385A;MIF
781,GO:0002040,0.647713379289366,0.505578375704455,7,70,sprouting angiogenesis,BP,PGF;VEGFA;HDAC5;CEACAM1;EPN2;HDAC7;NGFR
2280,GO:0005231,0.647952802773396,0.741895445512072,1,9,excitatory extracellular ligand-gated ion channel activity,MF,GRIN3B
1999,GO:0004722,0.648033150870044,0.517386612813454,6,61,protein serine/threonine phosphatase activity,MF,PPP2R3B;PPM1F;PPM1J;DUSP4;PPP3CB;DUSP23
7124,GO:0030955,0.648050173816825,0.741799660985078,1,9,potassium ion binding,MF,PDXK
5538,GO:0016525,0.648221286545974,0.517342993651292,6,60,negative regulation of angiogenesis,BP,SPRY2;HDAC5;EPN2;ADGRB2;FAM129B;NGFR
14818,GO:0070561,0.648241401115444,0.741611471175978,1,9,vitamin D receptor signaling pathway,BP,CYP27B1
5274,GO:0015924,0.648249583073592,0.741603416866745,1,9,mannosyl-oligosaccharide mannosidase activity,MF,EDEM1
10920,GO:0044546,0.648379633732708,0.741475369646989,1,9,NLRP3 inflammasome complex assembly,BP,SIRT2
17453,GO:1900225,0.648379633732708,0.741475369646989,1,9,regulation of NLRP3 inflammasome complex assembly,BP,SIRT2
2350,GO:0005416,0.648600195707185,0.741258095646799,1,9,amino acid:cation symporter activity,MF,SLC6A8
19080,GO:1904949,0.648693220979918,0.494453470587319,8,81,ATPase complex,CC,APPL2;SMARCA1;SALL2;SMARCD2;ABCA2;MBD3;ABCA7;INO80C
14989,GO:0070911,0.648705200880614,0.583874423983576,3,32,global genome nucleotide-excision repair,BP,ERCC1;XPC;DDB2
16960,GO:0098969,0.648846907393223,0.741014897972387,1,9,neurotransmitter receptor transport to postsynaptic membrane,BP,ARHGAP44
18461,GO:1903539,0.648846907393223,0.741014897972387,1,9,protein localization to postsynaptic membrane,BP,ARHGAP44
18462,GO:1903540,0.648846907393223,0.741014897972387,1,9,establishment of protein localization to postsynaptic membrane,BP,ARHGAP44
18628,GO:1903901,0.648911993310435,0.51611064634851,6,63,negative regulation of viral life cycle,BP,TNIP1;HMGA2;GSN;APOBEC3C;APOBEC3F;PROX1
6604,GO:0022824,0.648912250716261,0.74095045637377,1,9,transmitter-gated ion channel activity,MF,GRIN3B
6608,GO:0022835,0.648912250716261,0.74095045637377,1,9,transmitter-gated channel activity,MF,GRIN3B
603,GO:0001772,0.648928917423779,0.634828997975139,2,20,immunological synapse,CC,CARD11;CD81
15659,GO:0072182,0.649171697624307,0.740694469923159,1,9,regulation of nephron tubule epithelial cell differentiation,BP,WWTR1
6603,GO:0022821,0.649255200272371,0.740612040268105,1,9,potassium ion antiporter activity,MF,SLC9A7
16827,GO:0098719,0.649255200272371,0.740612040268105,1,9,sodium ion import across plasma membrane,BP,SLC9A7
2354,GO:0005451,0.649255200272371,0.740612040268283,1,9,monovalent cation:proton antiporter activity,MF,SLC9A7
13378,GO:0052659,0.64931754720321,0.740550481538081,1,9,inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity,MF,INPP5D
6928,GO:0030539,0.649355631284722,0.74051287347662,1,9,male genitalia development,BP,ASB1
6987,GO:0030673,0.649383110873505,0.740485734793923,1,9,axolemma,CC,MYO1D
1817,GO:0004467,0.649391332219025,0.740477615022823,1,9,long-chain fatty acid-CoA ligase activity,MF,SLC27A1
10604,GO:0043589,0.649515267416953,0.740355187709399,1,9,skin morphogenesis,BP,ERRFI1
9128,GO:0035457,0.649563825158542,0.740307208823344,1,9,cellular response to interferon-alpha,BP,GAS6
2105,GO:0004879,0.649663325300373,0.583691887254353,3,30,nuclear receptor activity,MF,NR1D1;PPARA;NR2F6
16749,GO:0098531,0.649663325300373,0.583691887254353,3,30,transcription factor activity, direct ligand regulated sequence-specific DNA binding,MF,NR1D1;PPARA;NR2F6
3779,GO:0008340,0.649670153429305,0.740202124618473,1,9,determination of adult lifespan,BP,INPP5D
15753,GO:0072349,0.649692796611879,0.740179742203726,1,9,modified amino acid transmembrane transporter activity,MF,SLC6A8
16494,GO:0097193,0.649757520968324,0.432621371311792,24,244,intrinsic apoptotic signaling pathway,BP,NFATC4;ERCC6;PRODH;AKT1;PPM1F;ZNF385A;BNIP3;CEBPB;MOAP1;PTPN1;TRAP1;BOK;PDK1;PRKCD;BAX;DDIT4;CHEK2;TMEM161A;BCAP31;MIF;WFS1;STK25;GRINA;BCL2L1
18074,GO:1902622,0.649896658743089,0.632986579246422,2,21,regulation of neutrophil migration,BP,RAC2;ADAM8
12232,GO:0048515,0.6499520237394,0.502866867499872,7,72,spermatid differentiation,BP,BBS2;RFX2;DNAH1;PRKACA;BAX;SIX5;KDM3A
20110,GO:2000756,0.650006828922964,0.530968003545701,5,51,regulation of peptidyl-lysine acetylation,BP,NOS1;CTBP1;TGFB1;RPS6KA5;MAPK3
5403,GO:0016241,0.650013981322515,0.454300256632502,15,150,regulation of macroautophagy,BP,TBC1D14;AKT1;BNIP3;FYCO1;GPSM1;PRKACA;PIM2;ULK1;BNIP3L;LRSAM1;SESN2;RAB12;QSOX1;MAPK3;SPTLC2
20285,GO:2001233,0.650025645756586,0.423699280467883,30,304,regulation of apoptotic signaling pathway,BP,ITGA6;NFATC4;RBCK1;SMAD3;AKT1;FGFR1;ZNF385A;STRADB;GSN;BNIP3;MNT;MOAP1;PTPN1;TRAP1;BOK;TFDP2;PRKCD;IFI6;BAX;TMEM161A;BCAP31;MIF;PLA2G6;WFS1;FYN;GRINA;BCL2L1;LMNA;PELI3;DEDD2
6007,GO:0019054,0.650163966422454,0.633490263231022,2,20,modulation by virus of host process,BP,TGFB1;BCL2L1
11062,GO:0045070,0.651515891800195,0.581196674934019,3,31,positive regulation of viral genome replication,BP,STOM;ADARB1;RAD23A
4585,GO:0010677,0.651519604326542,0.632017044382485,2,20,negative regulation of cellular carbohydrate metabolic process,BP,DDIT4;PPARA
3311,GO:0007018,0.651852691643685,0.432249451792353,23,229,microtubule-based movement,BP,BBS2;KLC2;AP2A2;IFT140;DNAAF5;FYCO1;AP3D1;KIF17;KIF26B;DNAH1;KIF7;CEP131;PRKCZ;WDR60;MYO1D;MYH15;SUN1;KIF26A;NDE1;KIF13B;BLOC1S4;TRIM46;APBA1
8323,GO:0033178,0.651868750273655,0.735703701497544,1,10,proton-transporting two-sector ATPase complex, catalytic domain,CC,ATP6V1F
9940,GO:0042306,0.651964127568607,0.550009660038479,4,41,regulation of protein import into nucleus,BP,GAS6;TGFB1;TMEM173;PRKCD
5382,GO:0016202,0.652186993975738,0.490729258078869,8,80,regulation of striated muscle tissue development,BP,SMAD3;FGFR1;TGFB1;GPC1;TGFBR3;PAK1;SIRT2;FAM129B
5148,GO:0015682,0.652264881938381,0.579946146196299,3,32,ferric iron transport,BP,DNM2;ATP6V1F;HFE
15810,GO:0072512,0.652264881938381,0.579946146196299,3,32,trivalent inorganic cation transport,BP,DNM2;ATP6V1F;HFE
8015,GO:0032655,0.652435999597859,0.580179287386447,3,31,regulation of interleukin-12 production,BP,ACP5;JAK3;HLA-G
9938,GO:0042303,0.652798263584509,0.489951793783651,8,81,molting cycle,BP,EGFR;FOXQ1;LAMA5;LRP4;PPP1R13L;VANGL2;EDA;CELSR1
10109,GO:0042633,0.652798263584509,0.489951793783651,8,81,hair cycle,BP,EGFR;FOXQ1;LAMA5;LRP4;PPP1R13L;VANGL2;EDA;CELSR1
4575,GO:0010662,0.653416363438673,0.629949120797691,2,20,regulation of striated muscle cell apoptotic process,BP,RGL2;BNIP3
4572,GO:0010659,0.653436583593309,0.629927034070851,2,20,cardiac muscle cell apoptotic process,BP,RGL2;BNIP3
1977,GO:0004693,0.654386446054145,0.578017644872132,3,31,cyclin-dependent protein serine/threonine kinase activity,MF,CDK18;CCND1;CDK11B
445,GO:0001205,0.65453373744436,0.628727270853729,2,20,transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific DNA binding,MF,MEF2D;BACH1
10174,GO:0042771,0.654590959299804,0.546540817430372,4,43,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,ZNF385A;DDIT4;CHEK2;MIF
8740,GO:0034399,0.654751324811873,0.461533505938672,12,120,nuclear periphery,CC,XPOT;HLCS;DGKQ;CEBPB;NSMF;PRKCZ;PRKCD;NARF;SATB1;DNMT3A;LMNA;TEP1
13164,GO:0051775,0.654770595959092,0.732786304734803,1,10,response to redox state,BP,SIRT2
15406,GO:0071675,0.654777047138862,0.627660981853163,2,21,regulation of mononuclear cell migration,BP,TGFB1;MAPK3
15885,GO:0072655,0.654874312820702,0.448768504811448,15,157,establishment of protein localization to mitochondrion,BP,VPS11;AKT1;HK1;RAC2;TOMM34;AIP;MOAP1;MIPEP;MICALL2;TFDP2;BNIP3L;BAX;TIMM17B;ZDHHC8;NBPF3
481,GO:0001530,0.654896536158994,0.732659138395267,1,10,lipopolysaccharide binding,MF,RNASE7
4520,GO:0010575,0.654934043834848,0.628288876136896,2,20,positive regulation of vascular endothelial growth factor production,BP,ADORA2B;TGFB1
2083,GO:0004842,0.655551044061024,0.40903290932919,39,381,ubiquitin-protein transferase activity,MF,GID4;FBXO2;TMEM129;KLHL29;DDB2;RBCK1;RNF44;SMURF2;FBXW5;RNF187;FBXO41;MARCH4;HLTF;RAG1;SHARPIN;FBXW8;ZNF598;FBXL8;RNF135;FBXO17;FBXO44;ZER1;VHL;MIB2;STUB1;FBXW4;LRSAM1;ASB1;CDC34;RNF123;PELI1;KLHL36;RNF144A;ZYG11B;KCTD13;BACH1;PELI3;CBLC;KLHL24
1154,GO:0002761,0.656249606428715,0.496051248548386,7,71,regulation of myeloid leukocyte differentiation,BP,CTNNBIP1;ZFP36L1;FOS;CEACAM1;CEBPB;INPP5D;ZFPM1
20294,GO:2001242,0.656421074865989,0.459331923305993,12,127,regulation of intrinsic apoptotic signaling pathway,BP,AKT1;ZNF385A;PTPN1;TRAP1;BOK;BAX;TMEM161A;BCAP31;MIF;WFS1;GRINA;BCL2L1
13658,GO:0060192,0.656774643293317,0.730757276960149,1,10,negative regulation of lipase activity,BP,ANGPTL4
18942,GO:1904680,0.656919935210245,0.624580874393572,2,22,peptide transmembrane transporter activity,MF,SLC15A4;TIMM17B
2828,GO:0006298,0.656973879786873,0.575139550302031,3,31,mismatch repair,BP,ERCC1;XPC;POLD4
8908,GO:0034754,0.657315791326612,0.506820789691809,6,63,cellular hormone metabolic process,BP,EGR1;SRD5A3;HSD17B8;DGKQ;RETSAT;HSD17B7
11497,GO:0045992,0.657336826268099,0.625650142173994,2,20,negative regulation of embryonic development,BP,PRKACB;RPS6KA6
14659,GO:0070266,0.657398502888612,0.574666079831111,3,31,necroptotic process,BP,PYGL;RBCK1;BOK
2835,GO:0006307,0.657784982065733,0.729729905120427,1,10,DNA dealkylation involved in DNA repair,BP,MPG
14937,GO:0070830,0.657811109407313,0.54350511325434,4,41,bicellular tight junction assembly,BP,ARL2;NPHP4;PRKACA;MICALL2
12930,GO:0051298,0.65783446785899,0.506555459492344,6,61,centrosome duplication,BP,FBXW5;BRSK1;PKD2;CEP131;CEP72;NDE1
17303,GO:0140078,0.658108180350225,0.729400627644174,1,10,class I DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,NEIL1
17304,GO:0140080,0.658108180350225,0.729400627644174,1,10,class III/IV DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,NEIL1
13247,GO:0051937,0.658132070317084,0.623969972239674,2,21,catecholamine transport,BP,NISCH;RAB3B
2095,GO:0004860,0.658417703180619,0.493524802457743,7,72,protein kinase inhibitor activity,MF,SPRY2;PODNL1;CDKN1C;CAMK2N1;TRIB2;CHAD;SOCS7
2512,GO:0005767,0.658540175346946,0.728960028914591,1,10,secondary lysosome,CC,ADAM8
18129,GO:1902803,0.658853543390955,0.623977989372563,2,20,regulation of synaptic vesicle transport,BP,RIMS3;PFN2
9692,GO:0038093,0.659014685048218,0.444349408834144,15,155,Fc receptor signaling pathway,BP,FCGRT;SHC1;FOS;PIK3R2;CARD11;WIPF1;PLCG1;CYFIP2;PRKCD;LIMK1;PLA2G6;FYN;MAPK3;PAK1;PPP3CB
7473,GO:0031644,0.659014716888354,0.572860972713812,3,31,regulation of neurological system process,BP,F2R;NTSR1;WASF3
39,GO:0000079,0.659146294061214,0.49259453741948,7,73,regulation of cyclin-dependent protein serine/threonine kinase activity,BP,EGFR;AKT1;CCND1;PKD2;PROX1;PKD1;MAPRE3
16138,GO:0090150,0.659275213284776,0.422048351849304,24,266,establishment of protein localization to membrane,BP,PRNP;BBS2;EGFR;STOM;RAB31;SYNE3;ANK3;CEMIP;GRIN3B;MOAP1;BBS1;ZDHHC24;OXA1L;ERBB2;VAMP2;TFDP2;RILPL1;ARHGAP44;BAX;GDI1;REEP2;FYN;ZDHHC1;PAK1
8938,GO:0034982,0.660098873215593,0.727365728720165,1,10,mitochondrial protein processing,BP,MIPEP
12867,GO:0051204,0.660247086667719,0.57105535312692,3,32,protein insertion into mitochondrial membrane,BP,MOAP1;TFDP2;BAX
6198,GO:0019682,0.660404082693213,0.62145645948136,2,21,glyceraldehyde-3-phosphate metabolic process,BP,H6PD;PGLS
8242,GO:0033028,0.660705287178014,0.621122387587379,2,21,myeloid cell apoptotic process,BP,MIF;ITPKB
8686,GO:0034329,0.660978134948093,0.433409482509281,18,178,cell junction assembly,BP,FLNC;VEGFA;ITGA6;ARL2;SMAD3;ITGB4;PPM1F;NPHP4;LAMA5;RHOD;TNS1;PRKACA;CD9;MICALL2;FSCN1;SH3BP1;HDAC7;CDH4
2475,GO:0005697,0.661038876791209,0.620022121537193,2,22,telomerase holoenzyme complex,CC,TEP1;TERC
15463,GO:0071806,0.661039467319458,0.517927490050268,5,55,protein transmembrane transport,BP,BCR;PEX10;PEX1;TIMM17B;RTN2
12773,GO:0051057,0.66109725062726,0.570528090596196,3,31,positive regulation of small GTPase mediated signal transduction,BP,F2R;RASGEF1A;ITPKB
12343,GO:0048729,0.66158411381091,0.397616471909108,46,452,tissue morphogenesis,BP,PGF;CTNNBIP1;VEGFA;WNT7A;LRP5;HMGA2;EGFR;SPRY2;NFATC4;ETV5;ACTA2;FOXQ1;SMURF2;SMAD3;DVL1;HBEGF;AP2A2;ITGB4;ADARB1;WNT2B;FGFR1;PRKACB;CEACAM1;EDNRA;LAMA5;PKD2;CTSZ;WNT3;TGFB1;DEAF1;KIF26B;KDM6B;AREG;SH3BP1;TGFBR3;ZFPM1;ARHGAP12;VANGL2;PAK1;SEMA4C;ITGA3;DLG3;PROX1;PKD1;TCTN1;CELSR1
2379,GO:0005515,0.661862665382555,0.361671133245095,874,8345,protein binding,MF,TNIP1;XDH;ERCC1;DUSP5;MEF2D;ZMYND8;ADGRL1;H1F0;SEMA4B;HTRA1;FHL1;EGR1;NR1D1;SLC16A3;EDEM1;DLG4;PLAT;CST3;MRC2;TYSND1;BTBD2;EPN3;FBXO2;APLN;PGF;PDCD4;CTNNBIP1;ACVR2B;DOCK4;XPC;PRNP;PARVB;PYGB;BBS2;FLNC;DDIT4L;POSTN;VEGFA;TNFRSF6B;PGM1;WNT7A;APOE;PYGL;TSPAN1;ESPN;F2R;LRP5;PLD3;ITGA6;ISYNA1;PITPNC1;HMGA2;LRRC20;OBSCN;NDRG1;ZKSCAN1;NEK9;CRAT;ELK3;ITPR3;PKN1;MTA1;ACOT7;ARRDC1;ANGEL1;ACSF2;EVI5L;NISCH;AKR7A2;FCGRT;EGFR;RPS6KA2;SERPINE2;DNPH1;WWTR1;SCN4B;OBSL1;NOS1;PTPRS;ANKS6;SPRY2;CAPN2;MST1R;NFATC4;LTBP4;PRSS8;SYTL1;SDC1;ETV5;ORAI3;APPL2;SHC1;DDB2;ORAI1;LTBP2;VPS11;LTBP1;TBC1D14;ARL2;HEXB;SLC7A8;KIAA0930;TCFL5;PTPRE;SLC12A7;ALDH4A1;RIN1;ACTA2;CLIP2;ETV4;SNX9;NUDCD3;SPRY4;RAPGEF3;ZFP36L1;GLUL;ARAP1;MAP2K2;NME4;LPAR3;MDFI;SMARCA1;PPP1R35;CMTM7;RBCK1;PGLS;PC;MAP2K1;NAPRT;CRYL1;MXD4;SSH1;POU2F2;EXOC2;ENDOG;MARK4;KCNJ15;MARCKSL1;MPRIP;TMEM8A;GALE;SMURF2;KLC2;TSC22D1;SLC9A3R2;FOS;FBLN1;SMAD3;STAT6;SHANK2;PIK3R2;ERCC6;LRP1;DVL1;EPAS1;DNAJB5;HSD17B8;HBEGF;FAM110C;RPUSD3;AP2A2;S100A4;ITGB4;CYBRD1;SH3PXD2B;PPP2R3B;PRDX5;SHC2;NLGN2;STOM;BRD3;SALL2;MBOAT7;CDK18;REEP4;FBXW5;PAG1;ZXDC;RNF187;NMRK1;ADARB1;SYT8;AKT1;TPCN1;GRB7;TMOD2;CORO1B;HDAC5;FAM83A;S100A6;F12;SH2D2A;PPM1F;PITPNM1;RHBDF2;BSG;STK39;HK1;SERPING1;ASAP2;SCMH1;DYSF;EPHA1;GGT1;PHC2;NFKBIZ;PTPRU;VEGFB;FMNL2;ASH2L;IMPACT;SLC15A4;WWC3;ZFYVE21;LRRC8A;CNTN1;BRSK1;DAP;IFT140;PTHLH;MYZAP;DNAAF5;FGFR4;WNT2B;POLD4;LDLR;FGFR1;PRKACB;MAPKBP1;ELMO3;RAC2;PFKL;HLTF;MXI1;NPHP4;SYNE3;RAG1;H2AFJ;B4GAT1;PACS2;PHF7;TOMM34;RALGDS;SORL1;CEACAM1;B3GAT3;ASB13;CIRBP;CBR4;HMG20B;LZTS2;RAB11FIP4;TENM2;ZNF385A;DOCK6;NSMCE4A;MICALCL;ABCD1;ANK3;NIPSNAP1;IGFBP4;TTC7B;TRAPPC9;CCND1;EFS;TCF25;LHPP;TNNT1;TWF2;AIG1;STRADB;SYNGAP1;MAPK13;CEP250;EDNRA;CARD19;PLAU;GAS6;PTK6;SEMA3F;PFKP;FGFBP1;CSNK1E;BRI3;CTSB;RAB3B;CARD11;SH2B3;SOX13;LAMA5;DUSP7;MPLKIP;GSN;CMTM4;PLEKHG2;MAPKAPK3;IGFBP2;PCSK9;ARHGAP22;RAD23A;PHLDA1;BCR;ANTXR2;XPOT;ANGPTL4;MRPS6;EHD4;ERRFI1;SEPT10;WIPF1;NADK;HLCS;AIP;SH3D19;CCDC113;CDC25B;RGL2;ARPIN;SH3GLB2;ARHGAP27;SPTB;SMARCD2;AGAP1;COMTD1;NXPH4;RSPH3;PEX10;CCS;GGACT;COL13A1;CORO7;NPR2;UNC119B;SNTA1;DGKQ;HAGH;PLXNB3;BNIP3;PAK6;NOL4L;GTF2IRD1;SHARPIN;MVB12B;TAGLN3;FYCO1;CEMIP;PROCR;PKD2;ACY1;GPX3;PCSK1;RASGEF1A;CTSZ;CDC42EP5;HES2;CRTC1;IL20RB;FBXW8;GPSM1;ITGB5;FAM189B;ZNF598;MAGEF1;PRSS3;SH3PXD2A;EPOR;EPHB2;ADAM8;ASIC1;CADM4;CTBP1;LTA4H;MNT;GRIP2;GRK6;CDKN1C;PLCG1;FBXL8;ZMIZ2;CBS;KIF17;SH3BP2;CD81;CEBPB;MVD;RNF135;LGALS9B;ADAMTS13;ZNF217;TIMP2;ZNF862;NUDCD2;UHRF1BP1;SYNJ2;WNT3;PCED1A;GNAL;C8ORF88;TGFB1;LACTB2;SNPH;CLTCL1;RFX2;SCYL1;SNTB2;ULK2;GPC1;MKNK2;ADAMTS7;DEAF1;MOAP1;TBC1D9B;NTSR1;NAB2;TMEM173;TMEM134;ATP7B;FHOD3;SHANK3;PODXL2;SDHA;MSRB2;EFNB3;PNRC1;TNFSF15;MYCBPAP;JMJD7;EML2;KIF26B;MDH2;MPG;FBXO17;ENKD1;NSMF;ARAP3;FARP1;MC1R;CROCC;RHOD;ABHD14B;LAMB2;TNS1;ABTB1;SNX17;RNH1;DNAH1;ERO1B;VGF;FBXO44;POLM;PLEKHG4;SNX33;PI4K2A;SEMA4F;RHOF;YIPF3;ANKZF1;WASF3;ATG2A;SLC48A1;LLGL1;PHF21A;PLEKHG3;MIF4GD;KIF7;COA5;RHOBTB2;UBXN4;ADAM19;KHDRBS3;SAC3D1;GIGYF1;RIMS3;BBS1;TNFAIP8L1;HMGCL;PTPN1;PEX1;TPP1;PCK2;WDR59;AGRN;MBD3;OLFML2A;IFNE;CD320;CAMK2N1;LRP4;ESYT2;ZDHHC24;VHL;DNAJC4;TMCC3;PCED1B;CEP131;TRAP1;IDUA;ADAP1;PFKFB2;MLXIPL;YPEL5;TRIB2;PRKCZ;KDM6B;PRKACA;MINK1;ZNF516;CENPH;GRHPR;OXA1L;RHPN1;RABGGTA;TBKBP1;ACTR1B;TOM1L2;CD9;EPN2;ADA;AREG;PIM2;MICALL2;UCKL1;LGALS9C;PLEKHG5;BOK;WDR18;CAPG;SDCCAG8;ALAS1;NEURL1B;ERBB2;ADGRB2;ULK1;NINL;AHCY;VAMP2;PRIMPOL;TFDP2;SMTN;C6ORF89;NECAB3;RILPL1;JAK3;NET1;BNIP3L;CYFIP2;FSCN1;PBX2;TRPC1;NELFCD;PDK1;CYGB;ARHGAP44;MCFD2;PRKCD;FAM20C;MIB2;REEP6;RBL2;CACNB3;USP20;STUB1;IFI6;BAX;GRAMD1C;SV2A;SBF1;ITGA1;OLFM2;HIST3H2BB;CCDC92;NUBP2;SH3BP1;FBXW4;EREG;RPS6KA5;TMEM25;TIMM17B;ZNF524;CUL9;TMBIM4;DDIT4;TOP3B;PPL;PPP1R13L;AHNAK2;PCSK1N;GRAMD1A;MT2A;HPCAL1;NAGA;MZT2B;FCHO1;NID1;LIMK1;TGFBR3;PDIA5;GDI1;TPM2;PADI3;DIP2A;CPNE7;UBTD1;RPL39L;LEMD2;ZHX3;DNM1;WASH3P;RGS14;TMEM8B;SCN8A;GSTO1;GIT1;ALDOC;MSLN;LRSAM1;ADAM15;REEP2;ASB1;EHD3;WDR60;TMEM231;GPATCH2L;LONP2;SYMPK;MAPK12;IRAK1;TGFA;HDAC7;FHOD1;INPP5D;CHD2;CBX7;CHEK2;DTNB;DECR2;CACFD1;ZFPM1;PPARA;COG7;SESN2;ABCG1;MYO1D;JADE2;MYH15;CDC34;SOX7;RAB12;EML3;SPEG;SIX5;BCAP31;MIF;EEF2KMT;PHYH;ZNF414;BCAM;SLC9A7;PLA2G6;DDT;SSBP4;SYNGR1;NUDT14;ECM1;NARF;WFS1;SLC22A18;DTX3;DALRD3;SPPL2B;FYN;C11ORF68;PITPNM3;VWA1;EFEMP2;STK25;RAC3;ETFB;TMCO6;EEF2K;SUN1;ICAM5;ACAP3;ARID5B;DNM2;BHLHE40;GLB1;PELI1;ATXN10;SNX15;INF2;CHKA;CAT;BEX2;NEIL1;TSPYL2;IGFBP7;ARMCX1;SLC27A1;APOBEC3C;SATB1;KIF26A;ASMTL;SLC12A4;PLCB3;H1FX;IQSEC1;APOBEC3F;ARHGEF4;MAPK3;INSR;RTN2;ARHGEF1;PAN2;GRINA;CAMTA2;PFKM;ADCY1;TNS4;RERE;HLA-G;DOCK9;STX10;TSTA3;RALGAPA1;MORN4;PDXK;ETAA1;PRAF2;GLRX;BCL7A;CEP72;VANGL2;PAK1;CDYL2;MALL;CAMKK2;PPP3CB;RNF144A;LGALS3BP;USP21;MLYCD;CUL7;GABBR1;REV1;MICAL1;HYAL1;SEMA4C;CAPRIN2;ZBTB10;WDTC1;HES7;ITGA3;ERICH2;DNMT3A;BIN1;VPS16;MAN2B1;SRMS;PPP2R5B;HES6;MAP2K3;FAM214A;BCL2L1;DLG3;SGSM2;KIAA0040;RRAS;PROX1;LRCH4;TBC1D16;ALDH7A1;LMNA;PKD1;KCTD13;TNFRSF25;NATD1;RABGAP1;SIRT2;FAM129B;CDH4;ITGA4;EDA;UVSSA;DCBLD2;BACH1;TRIP10;E2F5;ZBTB22;AFAP1L1;MAPRE3;AZIN2;TEP1;ICA1;RAP1GAP2;LAMB1;SOCS7;MAP3K10;RGS19;NDE1;GPR3;PELI3;GTF2IRD2;NGFR;TOLLIP;PDCD6;ATP6V1F;PCLO;ARVCF;PXN;GRB10;TBC1D8;PHYKPL;DUSP23;GCH1;LURAP1;KIF13B;MAFF;NR2F6;CBX6;PNMA1;CAMK1;CAMKK1;SIRT3;HFE;TERC;ZNF513;WIPI2;GAS2L1;COL6A1;BTG1;BBS10;ZP3;VPS51;CELSR1;TACC1;MLF2;IL17RE;SEMA3B;SEPT6;CDK11B;PFN2;SSH3;FGFR3;PPP1R16A;CCDC88C;NDRG2;BLOC1S4;CBLC;FAM102A;ITPKB;TCEA2;CDC42BPG;PRSS21;LRP11;DOK4;CLK3;DHX32;KDM3A;MEGF6;FAM214B;TYMSOS;TBL3;HOMER2;PKN3;APBA1;DEDD2;AK3;SRSF5;ADCY6;LRRK1;KLHL24;STRN4;SDC2
3474,GO:0007338,0.662022450100043,0.517200152747075,5,53,single fertilization,BP,MST1R;HEXB;SYT8;CD9;ZP3
8144,GO:0032878,0.66207645743405,0.620407993658468,2,20,regulation of establishment or maintenance of cell polarity,BP,GSN;LLGL1
1309,GO:0003156,0.662370753564547,0.619271574911507,2,21,regulation of animal organ formation,BP,WNT2B;FGFR1
3093,GO:0006670,0.662456792858843,0.724940319381119,1,10,sphingosine metabolic process,BP,SPTLC2
13523,GO:0055117,0.662899374535353,0.53751582075684,4,42,regulation of cardiac muscle contraction,BP,NOS1;PRKACA;GSTO1;EHD3
11033,GO:0045019,0.663497553164873,0.723864520317636,1,10,negative regulation of nitric oxide biosynthetic process,BP,ACP5
18837,GO:1904406,0.663497553164873,0.723864520317636,1,10,negative regulation of nitric oxide metabolic process,BP,ACP5
15970,GO:0080111,0.663561064057504,0.61794503974918,2,21,DNA demethylation,BP,APOBEC3C;APOBEC3F
16122,GO:0090114,0.663906222199958,0.499472993683481,6,63,COPII-coated vesicle budding,BP,TRAPPC9;CTSZ;AREG;MCFD2;TGFA;PDCD6
10473,GO:0043372,0.664005054584703,0.72333876202573,1,10,positive regulation of CD4-positive, alpha-beta T cell differentiation,BP,PRKCZ
10041,GO:0042501,0.664253841494164,0.723080744271875,1,10,serine phosphorylation of STAT protein,BP,IFNE
4162,GO:0009226,0.664257765228172,0.617167147138932,2,21,nucleotide-sugar biosynthetic process,BP,MPI;TSTA3
2823,GO:0006293,0.664536203656811,0.616855958717679,2,21,nucleotide-excision repair, preincision complex stabilization,BP,ERCC1;DDB2
2825,GO:0006295,0.664536203656811,0.616855958717679,2,21,nucleotide-excision repair, DNA incision, 3'-to lesion,BP,ERCC1;DDB2
13812,GO:0060419,0.664666468575988,0.51463803574326,5,51,heart growth,BP,DUSP6;FGFR1;TGFBR3;PAK1;PROX1
1446,GO:0003674,0.66505380549715,0.379998673668036,1198,11379,molecular_function,MF,TNIP1;DUSP6;NT5E;XDH;ERCC1;DUSP5;MEF2D;GID4;ZMYND8;ADGRL1;H1F0;CITED4;SEMA4B;HTRA1;FHL1;THSD4;EGR1;B4GALNT4;NR1D1;SLC16A3;H6PD;EDEM1;DLG4;PLAT;CST3;CYP27B1;MRC2;TYSND1;HS1BP3;BTBD2;MARVELD1;EPN3;FBXO2;APLN;PGF;PDCD4;CTNNBIP1;NAGS;KCNG1;ACVR2B;DOCK4;XPC;PRNP;PARVB;PYGB;BBS2;FLNC;SLC6A8;DDIT4L;POSTN;VEGFA;TNFRSF6B;PGM1;WNT7A;APOE;PYGL;DGKA;TSPAN1;ESPN;NAGLU;F2R;LRP5;PLD3;OSBPL5;LPCAT4;ITGA6;ISYNA1;PITPNC1;HMGA2;LRRC20;OBSCN;NDRG1;IDH2;ZKSCAN1;NEK9;CRAT;SLCO4A1;ELK3;ITPR3;PKN1;MTA1;GRAMD4;ACOT7;ARRDC1;ANGEL1;ACSF2;EVI5L;NISCH;AKR7A2;FCGRT;EGFR;RPS6KA2;SERPINE2;DNPH1;WWTR1;LOXL1;SCN4B;OBSL1;NOS1;VAT1;PTPRS;TMEM129;SLC2A9;ANKS6;HADH;CTSO;SPRY2;CAPN2;MST1R;NFATC4;TRIM65;BAHCC1;CRTAP;LTBP4;PRSS8;SYTL1;SDC1;KLHL29;ETV5;ORAI3;APPL2;SHC1;DDB2;ORAI1;LTBP2;VPS11;LTBP1;TBC1D14;ARL2;HEXB;GTPBP1;SLC7A8;KIAA0930;TCFL5;PTPRE;SLC12A7;NPEPL1;SLC2A3;ALDH4A1;TK2;RIN1;ACTA2;MMP1;CLIP2;ETV4;SNX9;NUDCD3;TRNP1;SPRY4;RAPGEF3;TXNRD3;ST6GALNAC2;ZFP36L1;GAA;GLUL;RNPEPL1;ARAP1;MAP2K2;KDSR;NME4;ZC3H6;LPAR3;MARCH9;CTBS;PLCD3;FKBP9;MDFI;SMARCA1;PPP1R35;CMTM7;RBCK1;SUGCT;PLTP;PGLS;PC;FOXQ1;RNF44;MAP2K1;NAPRT;CRYL1;ACP5;CPT2;NYNRIN;MCTP1;MXD4;SSH1;POU2F2;EXOC2;ENDOG;MARK4;SLC16A5;KCNJ15;MARCKSL1;MPRIP;TMEM8A;GALE;SMURF2;KLC2;TSC22D1;SLC9A3R2;FOS;FBLN1;SMAD3;ARHGAP23;STAT6;SHANK2;PIK3R2;ERCC6;LRP1;GJC2;SRD5A3;DVL1;EPAS1;DNAJB5;PIGQ;HSD17B8;THBS3;HBEGF;FAM110C;RPUSD3;AP2A2;S100A4;ITGB4;CYBRD1;PPP1R14A;SH3PXD2B;PPP2R3B;PRDX5;TMEM158;SHC2;NLGN2;STOM;BRD3;PRODH;SALL2;MBOAT7;CDK18;REEP4;FBXW5;PAG1;ZXDC;RNF187;NMRK1;ADORA2B;ADARB1;PLCXD2;D2HGDH;SYT8;SLC6A6;AKT1;TPCN1;GRB7;KCNC4;TMOD2;CORO1B;TTYH3;HDAC5;UROS;FBXO41;FAM83A;NT5DC1;S100A6;F12;SH2D2A;PPM1F;MMP28;PITPNM1;ENTPD6;RHBDF2;HAGHL;PYCR2;BSG;STK39;HK1;SERPING1;ASAP2;SCMH1;DYSF;EPHA1;GGT1;PHC2;NFKBIZ;PTPRU;VEGFB;FMNL2;ASH2L;IMPACT;MARCH4;SLC15A4;WWC3;ZFYVE21;LRRC8A;CNTN1;IFNGR2;BRSK1;DAP;IFT140;PTHLH;MYZAP;MFSD3;RAB31;DNAAF5;FGFR4;HEBP1;WNT2B;POLD4;ACOT1;LDLR;FGFR1;PRKACB;FUCA1;MAPKBP1;ELMO3;SIGMAR1;RAC2;KCNAB2;SMOC2;PFKL;TTLL12;SEC14L2;OPLAH;HLTF;MXI1;PPM1J;NPHP4;SYNE3;RAG1;GAMT;H2AFJ;B4GAT1;PACS2;PHF7;TOMM34;BPHL;PIGV;KLF7;RALGDS;SORL1;NAT14;CEACAM1;B3GAT3;ASB13;CIRBP;CBR4;HMG20B;LZTS2;RAB11FIP4;TENM2;ZNF385A;DOCK6;NSMCE4A;MICALCL;ABCD1;ANK3;NIPSNAP1;IGFBP4;TTC7B;TSHZ1;TRAPPC9;CCND1;PODNL1;EFS;PCBP4;TCF25;LHPP;TNNT1;TWF2;AIG1;STRADB;SYNGAP1;PLCH2;MAPK13;ACBD4;CEP250;EDNRA;CARD19;PLAU;GAS6;PTK6;SEMA3F;PFKP;FGFBP1;CSNK1E;R3HDM4;BRI3;CTSB;CYYR1;RAB3B;CARD11;SH2B3;SOX13;LAMA5;DUSP7;MPLKIP;GSN;CMTM4;PLEKHG2;MAPKAPK3;IGFBP2;PCSK9;ARHGAP22;RAD23A;DHTKD1;PHLDA1;ANO8;BCR;ANTXR2;XPOT;ANGPTL4;MRPS6;EHD4;ERRFI1;GLI4;SEPT10;WIPF1;NADK;PANK4;HLCS;ZSCAN18;PRSS22;AIP;MYEF2;MN1;SH3D19;CCDC113;CDC25B;RGL2;PAQR6;ARPIN;SH3GLB2;TMEM132B;ARHGAP27;ALOX15B;SPTB;SMARCD2;KHNYN;AGAP1;COMTD1;NXPH4;RSPH3;PEX10;CCS;GGACT;RSAD1;COL13A1;CORO7;SLC20A1;RRNAD1;NPR2;UNC119B;SNTA1;DGKQ;HAGH;PLXNB3;BNIP3;PAK6;TFPI2;NOL4L;GTF2IRD1;SHARPIN;MVB12B;SERINC2;TAGLN3;FYCO1;CEMIP;PROCR;PKD2;ACY1;FAM3A;GPX3;PCSK1;RETSAT;YPEL3;RASGEF1A;CTSZ;CDC42EP5;HES2;CRTC1;IL20RB;FBXW8;GPSM1;AP3D1;ITGB5;ABCA2;FAM189B;ZNF598;MAGEF1;PRSS3;SH3PXD2A;EPOR;EPHB2;GRIN3B;ADAM8;ASIC1;CADM4;APRT;TMEM9;CTBP1;JOSD2;LTA4H;MNT;PTPDC1;GRIP2;GRK6;CDKN1C;PLCG1;FBXL8;ZMIZ2;CBS;KIF17;SH3BP2;CD81;CEBPB;MVD;RNF135;ENTPD2;LGALS9B;ADAMTS13;SLC29A4;ZNF217;TIMP2;ZNF862;NUDCD2;UHRF1BP1;SYNJ2;WNT3;DPP7;PCED1A;GNAL;C8ORF88;TMED4;TGFB1;LACTB2;SNPH;CLTCL1;RFX2;SCYL1;ABHD17C;SLC43A1;UNK;SNTB2;ULK2;GPC1;MKNK2;ADAMTS7;DEAF1;MOAP1;TBC1D9B;SLC38A10;NTSR1;B3GNT3;NAB2;TMEM173;ARHGAP25;TMEM134;ZSCAN30;ATP7B;FHOD3;SHANK3;PODXL2;SDHA;MSRB2;EFNB3;RASA3;PNRC1;MIPEP;PIP5KL1;TNFSF15;MYCBPAP;JMJD7;MGAT4B;EML2;KIF26B;MDH2;MPG;GALNS;FBXO17;CLCA2;HEXDC;ABHD8;ENKD1;NSMF;PEG3;ARAP3;SCART1;FARP1;MC1R;TUB;LCE1E;CROCC;KLRG2;RHOD;CGREF1;ABHD14B;LAMB2;TNS1;ABTB1;SNX17;RNH1;DNAH1;ERO1B;ST6GALNAC6;HTR7;VGF;POLL;FBXO44;POLM;PLEKHG4;SNX33;PI4K2A;SEMA4F;RHOF;YIPF3;ANKZF1;WASF3;ATG2A;SLC48A1;LLGL1;PHGDH;ARL10;PHF21A;PLEKHG3;MIF4GD;KIF7;COA5;PLPP6;RHOBTB2;UBXN4;ADAM19;KHDRBS3;SAC3D1;TUBG2;ZER1;GIGYF1;RIMS3;BBS1;TNFAIP8L1;HMGCL;PTPN1;PEX1;TPP1;PCK2;B4GALT2;WDR59;AGRN;MBD3;OLFML2A;IFNE;CD320;CAMK2N1;OSBPL10;LRP4;LRP10;ESYT2;ZDHHC24;GPR153;ACP6;B4GALT6;VHL;DNAJC4;TMCC3;MYH16;PCED1B;CEP131;TRAP1;IDUA;ADAP1;PFKFB2;RFNG;MLXIPL;YPEL5;TRIB2;PRKCZ;KDM6B;PRKACA;MINK1;ZNF516;CENPH;GRHPR;OXA1L;RHPN1;RABGGTA;TBKBP1;ACTR1B;TOM1L2;CD9;EPN2;ADA;AREG;PIM2;MPI;MICALL2;UCKL1;LGALS9C;PLEKHG5;BOK;WDR18;TDRKH;CAPG;SDCCAG8;ALAS1;NEURL1B;ERBB2;ADGRB2;ULK1;CNDP2;NINL;AHCY;VAMP2;PRIMPOL;TMEM143;MMP10;TFDP2;SMTN;PLEK2;C6ORF89;NECAB3;STK17A;RILPL1;FAM50A;JAK3;IRF2BP2;RNPEP;NET1;BNIP3L;CYFIP2;FSCN1;PBX2;TRPC1;NELFCD;SLC22A17;RASA4;PDK1;ACAD10;CYGB;ARHGAP44;THOP1;EHBP1L1;MCFD2;PRKCD;FAM20C;MIB2;REEP6;RBL2;CACNB3;USP20;STUB1;IFI6;BAX;CYC1;GRAMD1C;SV2A;SBF1;DTD1;XYLT2;SLC13A5;TRIM4;ITGA1;OLFM2;ZNF395;HIST3H2BB;CCDC92;NUBP2;PPCS;SH3BP1;FBXW4;CHADL;EREG;RPS6KA5;DGUOK;TMEM25;DUSP4;TIMM17B;ZNF524;CUL9;SOX12;TMBIM4;DDIT4;MBTPS2;ACADS;TOP3B;PPL;PPP1R13L;CARF;HSD17B7;AHNAK2;PCSK1N;GRAMD1A;MT2A;IER2;HPCAL1;RASL10B;CES2;NAGA;ZDHHC8;TMX4;MZT2B;FCHO1;NID1;LIMK1;TGFBR3;NTPCR;PDIA5;GDI1;TPM2;PADI3;DIP2A;LTB4R2;CPNE7;SLC2A11;UBTD1;RPL39L;LEMD2;RPS6KA6;ZHX3;DNM1;WASH3P;RGS14;TMEM8B;SCN8A;MFNG;GSTO1;GIT1;ALDOC;CHAD;MRPS26;MSLN;LPCAT1;LRSAM1;ADAM15;REEP2;ASB1;EHD3;WDR60;ST3GAL3;TMEM231;FAHD2B;GPATCH2L;LONP2;SYMPK;MAPK12;IRAK1;PPOX;TGFA;HDAC7;FHOD1;INPP5D;RNF215;MTHFR;CHD2;PI4K2B;CBX7;PCMTD2;CHEK2;DTNB;DECR2;CACFD1;ZFPM1;PPARA;COG7;ABHD15;COQ2;SESN2;FGGY;ABCG1;MYO1D;JADE2;MYH15;CDC34;RNF123;SNN;SOX7;ABCA7;RAB12;SPATA20;EML3;SPEG;SIX5;BCAP31;MIF;ACO2;SMOX;EEF2KMT;KDM4B;SLC25A29;DOPEY2;PHYH;ZNF414;MEX3A;LENG9;BCAM;SLC9A7;PLA2G6;DDT;SSBP4;SYNGR1;NUDT14;ECM1;NARF;WFS1;QSOX1;ZNF444;SLC22A18;DTX3;TRPT1;DALRD3;SPPL2B;HSD11B1L;FYN;C11ORF68;PITPNM3;VWA1;UPP1;EFEMP2;STK25;RAC3;ETFB;TMCO6;GLB1L2;EEF2K;CERS4;SUN1;ICAM5;ARHGAP12;FLYWCH1;ACAP3;ARID5B;HOXC5;DNM2;CKMT1A;CYP3A5;BHLHE40;GLB1;PELI1;ATXN10;SNX15;INF2;CHKA;CAT;BEX2;NEIL1;TSPYL2;IGFBP7;ARMCX1;ELFN2;SLC27A1;ZMYM3;APOBEC3C;SATB1;SLC50A1;KIF26A;ASMTL;ZDHHC1;SLC12A4;PLCB3;H1FX;IQSEC1;ZNF606;APOBEC3F;ARHGEF4;DDX50;CYP2R1;TUBB6;MAPK3;INSR;SLC13A3;RTN2;ARHGEF1;PAN2;GRINA;TMEM54;CAMTA2;TAZ;PFKM;ADCY1;TNS4;RERE;HLA-G;DOCK9;STX10;TSTA3;INO80C;ATP8B2;GPT2;TMEM101;RALGAPA1;MORN4;PDXK;ETAA1;PRAF2;GLRX;BCL7A;CEP72;VANGL2;PAK1;TRIM45;CDYL2;KLHL36;MALL;CAMKK2;RNASET2;PPP3CB;RNF144A;LGALS3BP;ALPK1;CTSF;USP21;PFKFB3;MLYCD;CUL7;SLC37A2;GABBR1;REV1;MICAL1;HYAL1;SEMA4C;CAPRIN2;ZBTB10;WDTC1;HES7;ITGA3;ERICH2;STK32C;DNMT3A;SAMD8;BIN1;VPS16;MAN2B1;SRMS;TSTD1;NSUN7;PPP2R5B;HES6;SLC16A13;MAP2K3;FAM214A;NDST2;BCL2L1;DLG3;SGSM2;ABHD10;NDUFV3;KIAA0040;RRAS;DNASE1L1;PROX1;IARS2;LRCH4;MDGA1;TBC1D16;ADGRF1;ALDH7A1;LMNA;ZYG11B;PKD1;KCTD13;TNFRSF25;NATD1;RABGAP1;SIRT2;FAM129B;CDH4;ITGA4;EDA;UVSSA;GAL3ST4;DCBLD2;NMNAT2;BACH1;NT5C1B;TRIP10;ADCY7;E2F5;ZBTB22;ALG12;LTB4R;AFAP1L1;MAPRE3;AZIN2;TEP1;RAB28;ZNF704;SERPINB1;ST3GAL2;ICA1;SLC25A37;RAP1GAP2;YDJC;LAMB1;SOCS7;MAP3K10;RGS19;NDE1;GPR3;HSD11B1;PELI3;GTF2IRD2;RAB40B;NGFR;TOLLIP;PDCD6;ATP6V1F;PCLO;ARVCF;CHST14;FAM86B1;ZNF837;RNASE7;PXN;GRB10;TBC1D8;PHYKPL;PLEKHM1;DUSP23;GCH1;MSS51;LURAP1;KIF13B;MAFF;NR2F6;CBX6;PNMA1;CAMK1;CAMKK1;SLC39A3;EZH1;SIRT3;HFE;TERC;ZNF513;WIPI2;GAS2L1;COL6A1;BTG1;BBS10;ZP3;VPS51;TMCO3;CELSR1;TACC1;MLF2;IL17RE;SEMA3B;SEPT6;CDK11B;PFN2;SSH3;FGFR3;MFSD10;PPP1R16A;TST;CCDC88C;ST3GAL5;TNRC18;NDRG2;MAN2B2;BLOC1S4;CBLC;FAM102A;ITPKB;PTGR2;SPTLC2;TCEA2;CDC42BPG;PRSS21;ZBTB47;PLAG1;LRP11;DOK4;GSDMA;CLK3;IRF2BPL;TRIM46;DHX32;KDM3A;PM20D2;MEGF6;TMEM187;FAM214B;TYMSOS;TBL3;HOMER2;SLC23A2;PKN3;APBA1;TTLL3;DEDD2;PI4KAP2;AK3;SRSF5;CHPF;ADCY6;SLC26A11;LRRK1;AARS;KLHL24;STRN4;SDC2
3326,GO:0007040,0.665091398382291,0.513953008305757,5,52,lysosome organization,BP,NAGLU;VPS11;HEXB;GAA;TPP1
15982,GO:0080171,0.665091398382291,0.513953008305757,5,52,lytic vacuole organization,BP,NAGLU;VPS11;HEXB;GAA;TPP1
12535,GO:0050690,0.665204715810954,0.616108111750245,2,21,regulation of defense response to virus by virus,BP,AP2A2;FYN
795,GO:0002065,0.665497692509591,0.485647337887287,7,72,columnar/cuboidal epithelial cell differentiation,BP,FGFR1;PTK6;SLITRK6;CEBPB;FAM20C;TMEM231;PROX1
9244,GO:0035646,0.666145046823849,0.721113307504702,1,10,endosome to melanosome transport,BP,AP3D1
10531,GO:0043485,0.666145046823849,0.721113307504702,1,10,endosome to pigment granule transport,BP,AP3D1
12361,GO:0048757,0.666145046823849,0.721113307504702,1,10,pigment granule maturation,BP,AP3D1
12286,GO:0048634,0.666311271666179,0.475003179222163,8,81,regulation of muscle organ development,BP,SMAD3;FGFR1;TGFB1;GPC1;TGFBR3;PAK1;SIRT2;FAM129B
17798,GO:1901861,0.666311271666225,0.475003179222245,8,81,regulation of muscle tissue development,BP,SMAD3;FGFR1;TGFB1;GPC1;TGFBR3;PAK1;SIRT2;FAM129B
8992,GO:0035115,0.666890246968946,0.614218128042864,2,21,embryonic forelimb morphogenesis,BP,WNT7A;WNT3
15893,GO:0072665,0.667066182995798,0.511728806464742,5,52,protein localization to vacuole,BP,SORL1;AP3D1;CD81;WASH3P;C12ORF66
1346,GO:0003208,0.667308867687577,0.53282522382541,4,41,cardiac ventricle morphogenesis,BP,TGFB1;PPP1R13L;TGFBR3;PROX1
12770,GO:0051054,0.667627467827045,0.426097962270194,18,181,positive regulation of DNA metabolic process,BP,ERCC1;CST3;EGFR;SHC1;ENDOG;STAT6;AKT1;FGFR4;FGFR1;TGFB1;AREG;PRKCD;BAX;EREG;TMEM161A;MAPK3;INSR;KCTD13
16865,GO:0098796,0.668351517421476,0.378622426989718,73,733,membrane protein complex,CC,DLG4;KCNG1;LRP5;ITGA6;EGFR;SCN4B;NOS1;SHC1;VPS11;SHANK2;PIK3R2;LRP1;GJC2;PIGQ;AP2A2;ITGB4;KCNC4;TTYH3;LRRC8A;KCNAB2;SYNE3;CEACAM1;EVC;CARD11;COL13A1;SNTA1;MVB12B;AP3D1;ITGB5;ABCA2;GRIN3B;ADAM8;GNAL;CLTCL1;SCYL1;SNTB2;SHANK3;SDHA;ANKZF1;LRP4;PRKACA;EPN2;VAMP2;CACNB3;BAX;CYC1;ITGA1;OLFM2;GJB4;TIMM17B;TGFBR3;DNM1;SCN8A;IRAK1;ABCA7;BCAP31;SUN1;INSR;HLA-G;STX10;GABBR1;ITGA3;VPS16;DLG3;NDUFV3;CDH4;ITGA4;RGS19;TOLLIP;PDCD6;ATP6V1F;HFE;SPTLC2
7591,GO:0031970,0.668415386370095,0.481698457423211,7,78,organelle envelope lumen,CC,ARL2;NME4;SORL1;TRAP1;THOP1;PPOX;CAT
6635,GO:0023026,0.66860213534736,0.71854109552911,1,10,MHC class II protein complex binding,MF,CD81
13473,GO:0055021,0.669218556514941,0.561354984981027,3,31,regulation of cardiac muscle tissue growth,BP,FGFR1;TGFBR3;PAK1
1074,GO:0002639,0.669811330709532,0.610927646572855,2,21,positive regulation of immunoglobulin production,BP,STAT6;TGFB1
8350,GO:0033235,0.67002210397337,0.717046256598877,1,10,positive regulation of protein sumoylation,BP,TOLLIP
966,GO:0002407,0.670190900769267,0.716868151627787,1,10,dendritic cell chemotaxis,BP,GAS6
8608,GO:0034134,0.670313084683209,0.716739175769671,1,10,toll-like receptor 2 signaling pathway,BP,IRAK1
5106,GO:0015399,0.671161860724821,0.479060424119246,7,74,primary active transmembrane transporter activity,MF,ABCD1;ABCA2;ATP7B;TIMM17B;ABCG1;ABCA7;ATP6V1F
5107,GO:0015405,0.671161860724821,0.479060424119246,7,74,P-P-bond-hydrolysis-driven transmembrane transporter activity,MF,ABCD1;ABCA2;ATP7B;TIMM17B;ABCG1;ABCA7;ATP6V1F
15460,GO:0071803,0.671355743449984,0.715636703468017,1,10,positive regulation of podosome assembly,BP,FSCN1
390,GO:0001046,0.671358138790214,0.479081701094139,7,72,core promoter sequence-specific DNA binding,MF,NR1D1;MTA1;FOS;CEBPB;CHD2;PROX1;KDM3A
17934,GO:1902237,0.671395600035958,0.715594494491699,1,10,positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,BOK
2499,GO:0005750,0.671545152446339,0.713450522562493,1,11,mitochondrial respiratory chain complex III,CC,CYC1
11176,GO:0045275,0.671545152446339,0.713450522562493,1,11,respiratory chain complex III,CC,CYC1
1179,GO:0002825,0.671699090752333,0.715272931781282,1,10,regulation of T-helper 1 type immune response,BP,JAK3
15685,GO:0072216,0.671804361342879,0.715161326709125,1,10,positive regulation of metanephros development,BP,EGR1
7642,GO:0032060,0.671843435250735,0.71511989294993,1,10,bleb assembly,BP,LPAR3
8226,GO:0033003,0.671931459819977,0.608527362897641,2,21,regulation of mast cell activation,BP,ADORA2B;RAC2
2464,GO:0005682,0.671954865008443,0.607758885798696,2,22,U5 snRNP,CC,MAPKBP1;TEP1
9843,GO:0042094,0.671979919235153,0.714975129336985,1,10,interleukin-2 biosynthetic process,BP,CARD11
3421,GO:0007213,0.67202132055138,0.714931205166798,1,10,G-protein coupled acetylcholine receptor signaling pathway,BP,AGRN
252,GO:0000717,0.67248929505293,0.607151630334964,2,22,nucleotide-excision repair, DNA duplex unwinding,BP,XPC;DDB2
16546,GO:0097306,0.673152844818531,0.52618266817745,4,41,cellular response to alcohol,BP,AKT1;DNMT3A;ADCY7;ADCY6
18487,GO:1903578,0.67332668664529,0.476744268603808,7,73,regulation of ATP metabolic process,BP,PFKFB2;MLXIPL;DDIT4;PPARA;INSR;TAZ;PFKFB3
2617,GO:0005930,0.673327352841017,0.488872246354367,6,63,axoneme,CC,IFT140;KIF17;DNAH1;BBS1;PRKACA;TTLL3
10975,GO:0044774,0.673543028844461,0.451682781445662,10,104,mitotic DNA integrity checkpoint,BP,XPC;HMGA2;BRSK1;ZNF385A;CCND1;PCBP4;TFDP2;RBL2;BAX;CHEK2
11362,GO:0045738,0.673605920123,0.606624435241425,2,21,negative regulation of DNA repair,BP,HMGA2;MAGEF1
1048,GO:0002573,0.673608662818492,0.440704815288494,12,122,myeloid leukocyte differentiation,BP,CTNNBIP1;VEGFA;ZFP36L1;FOS;CEACAM1;SH3PXD2A;CEBPB;TGFB1;FAM20C;INPP5D;ZFPM1;LRRK1
26,GO:0000050,0.67365082791907,0.713198217143496,1,10,urea cycle,BP,NAGS
6186,GO:0019627,0.67365082791907,0.713198217143496,1,10,urea metabolic process,BP,NAGS
11263,GO:0045579,0.673765492273257,0.713075963164067,1,10,positive regulation of B cell differentiation,BP,INPP5D
891,GO:0002262,0.67388765536995,0.451298911059991,10,104,myeloid cell homeostasis,BP,VEGFA;FAM210B;ZFP36L1;EPAS1;JAK3;BAX;TGFBR3;INPP5D;ZFPM1;ITPKB
6513,GO:0021895,0.673919105923991,0.712912118245249,1,10,cerebral cortex neuron differentiation,BP,RAC3
10033,GO:0042491,0.67400089351418,0.606174640560546,2,21,inner ear auditory receptor cell differentiation,BP,FGFR1;SLITRK6
8349,GO:0033234,0.674275412590472,0.712531799606139,1,10,negative regulation of protein sumoylation,BP,HMG20B
4824,GO:0014029,0.674310913811117,0.712493884420775,1,10,neural crest formation,BP,PDCD6
15800,GO:0072498,0.674373027136532,0.712427538221482,1,10,embryonic skeletal joint development,BP,HYAL1
551,GO:0001673,0.674487068492132,0.712305694158368,1,10,male germ cell nucleus,CC,TCFL5
10020,GO:0042470,0.674653724323085,0.457284434106911,9,94,melanosome,CC,SYTL1;STOM;BSG;CTSB;TPP1;CAPG;AHCY;SYNGR1;SGSM2
12368,GO:0048770,0.674653724323085,0.457284434106911,9,94,pigment granule,CC,SYTL1;STOM;BSG;CTSB;TPP1;CAPG;AHCY;SYNGR1;SGSM2
2972,GO:0006517,0.674724548447069,0.554634551499948,3,32,protein deglycosylation,BP,EDEM1;MAN2B1;MAN2B2
18146,GO:1902855,0.674745940056864,0.712028961261423,1,10,regulation of non-motile cilium assembly,BP,DNM2
7144,GO:0031010,0.674832715291357,0.711936152380746,1,10,ISWI-type complex,CC,SMARCA1
4427,GO:0010259,0.675029052159237,0.605002106325272,2,21,multicellular organism aging,BP,ERCC1;INPP5D
5995,GO:0019003,0.675185578903738,0.50232576879382,5,53,GDP binding,MF,RAB31;RAB3B;RAB12;RRAS;RAB28
6929,GO:0030540,0.675226444311172,0.711514753561264,1,10,female genitalia development,BP,BAX
16,GO:0000030,0.675432512197696,0.603795716212912,2,22,mannosyltransferase activity,MF,PIGV;ALG12
3134,GO:0006730,0.675764026784706,0.604162443713025,2,21,one-carbon metabolic process,BP,AHCY;MTHFR
13981,GO:0060706,0.675994108007286,0.603899335932462,2,21,cell differentiation involved in embryonic placenta development,BP,MDFI;AKT1
1157,GO:0002764,0.676075284075123,0.390563134117665,35,352,immune response-regulating signaling pathway,BP,TNIP1;NR1D1;PRNP;FCGRT;PTPRS;SHC1;RBCK1;FOS;PIK3R2;PAG1;PRKACB;CEACAM1;CTSB;CARD11;MAPKAPK3;WIPF1;IL20RB;PLCG1;PRKACA;ADA;CYFIP2;PRKCD;CACNB3;BAX;RPS6KA5;LIMK1;IRAK1;INPP5D;PLA2G6;FYN;PELI1;MAPK3;HLA-G;PAK1;PPP3CB
7991,GO:0032616,0.676102519333279,0.710575385308575,1,10,interleukin-13 production,BP,PRKCZ
3329,GO:0007043,0.676272630428439,0.463750068381574,8,82,cell-cell junction assembly,BP,ARL2;NPHP4;PRKACA;CD9;MICALL2;FSCN1;HDAC7;CDH4
4437,GO:0010314,0.676478913957908,0.710171064764868,1,10,phosphatidylinositol-5-phosphate binding,MF,SH3PXD2B
16620,GO:0097472,0.676624049694512,0.552451266698872,3,32,cyclin-dependent protein kinase activity,MF,CDK18;CCND1;CDK11B
3493,GO:0007389,0.676733489793786,0.402061295104859,25,249,pattern specification process,BP,DUSP6;CTNNBIP1;ACVR2B;WNT7A;LRP5;MDFI;SMAD3;SCMH1;IFT140;WNT2B;FGFR1;PRKACB;TSHZ1;SYNGAP1;SEMA3F;PKD2;WNT3;LRP4;RFNG;PBX2;MFNG;VANGL2;HES7;TCTN1;CELSR1
639,GO:0001829,0.676765930834685,0.709862456700725,1,10,trophectodermal cell differentiation,BP,ADA
7870,GO:0032438,0.677006203178842,0.601993247580787,2,22,melanosome organization,BP,AP3D1;BLOC1S4
6061,GO:0019211,0.677093226342827,0.709510226570117,1,10,phosphatase activator activity,MF,B3GAT3
12115,GO:0048199,0.677116970984846,0.484426891412304,6,64,vesicle targeting, to, from or within Golgi,BP,TRAPPC9;CTSZ;AREG;MCFD2;TGFA;PDCD6
3288,GO:0006983,0.677178820992081,0.709418055857172,1,10,ER overload response,BP,WFS1
11329,GO:0045663,0.677213402537883,0.709380810994577,1,10,positive regulation of myoblast differentiation,BP,BTG1
8475,GO:0033631,0.677613370318897,0.708949768021515,1,10,cell-cell adhesion mediated by integrin,BP,ADA
4410,GO:0010171,0.677624652130833,0.520774374940098,4,42,body morphogenesis,BP,WNT3;TGFB1;ARID5B;RRAS
10508,GO:0043422,0.678411717839142,0.708087897254439,1,10,protein kinase B binding,MF,SRSF5
11883,GO:0046914,0.678822205830972,0.367064069079204,75,738,transition metal ion binding,MF,XDH;EGR1;NR1D1;CYP27B1;PRNP;MTA1;LOXL1;NOS1;VAT1;TRIM65;NPEPL1;MMP1;GLUL;RNPEPL1;MARCH9;ACP5;SMAD3;S100A4;S100A6;MMP28;PHC2;MARCH4;HLTF;RAG1;KLF7;ZNF385A;ALOX15B;PEX10;CCS;ADAM8;LTA4H;ZMIZ2;ADAMTS13;TIMP2;LACTB2;GPC1;ATP7B;SHANK3;MSRB2;HMGCL;PTPN1;PCK2;RABGGTA;ADA;MPI;PRIMPOL;MMP10;RNPEP;CYGB;FAM20C;MIB2;USP20;TRIM4;MT2A;DTNB;PPARA;ACO2;PHYH;CYP3A5;NEIL1;ZMYM3;APOBEC3C;APOBEC3F;CYP2R1;RERE;PDXK;TRIM45;SIRT2;GCH1;NR2F6;SIRT3;CBLC;TCEA2;TRIM46;KDM3A
13982,GO:0060707,0.678865266228524,0.707597371028248,1,10,trophoblast giant cell differentiation,BP,MDFI
7204,GO:0031103,0.678883453775644,0.54984547560211,3,32,axon regeneration,BP,PTPRS;MAP2K1;LAMB2
3854,GO:0008474,0.679465706273729,0.706946983298866,1,10,palmitoyl-(protein) hydrolase activity,MF,ABHD17C
16782,GO:0098599,0.679465706273729,0.706946983298866,1,10,palmitoyl hydrolase activity,MF,ABHD17C
16833,GO:0098734,0.679465706273729,0.706946983298866,1,10,macromolecule depalmitoylation,BP,ABHD17C
569,GO:0001711,0.679603054768888,0.706798050111441,1,10,endodermal cell fate commitment,BP,DUSP6
9080,GO:0035337,0.679818089038802,0.548764733868409,3,32,fatty-acyl-CoA metabolic process,BP,ACOT7;HSD17B8;CBR4
11164,GO:0045240,0.679880459469382,0.706497066521423,1,10,dihydrolipoyl dehydrogenase complex,CC,DHTKD1
3455,GO:0007271,0.680083977600951,0.706276095533383,1,10,synaptic transmission, cholinergic,BP,APOE
3322,GO:0007033,0.680791014994662,0.42415950046719,14,143,vacuole organization,BP,NAGLU;VPS11;TBC1D14;HEXB;GAA;ATG16L2;PACS2;ULK2;ATG2A;TPP1;ULK1;LRSAM1;VPS16;WIPI2
432,GO:0001161,0.680793357289494,0.705504860851076,1,10,intronic transcription regulatory region sequence-specific DNA binding,MF,ZC3H6
10761,GO:0044213,0.680793357289494,0.705504860851076,1,10,intronic transcription regulatory region DNA binding,MF,ZC3H6
6802,GO:0030260,0.681093632843737,0.449976769968955,9,95,entry into host cell,BP,EGFR;EXOC2;LDLR;GAS6;CTSB;GSN;ITGB5;CD81;EFNB3
10867,GO:0044409,0.681093632843737,0.449976769968955,9,95,entry into host,BP,EGFR;EXOC2;LDLR;GAS6;CTSB;GSN;ITGB5;CD81;EFNB3
13186,GO:0051806,0.681093632843737,0.449976769968955,9,95,entry into cell of other organism involved in symbiotic interaction,BP,EGFR;EXOC2;LDLR;GAS6;CTSB;GSN;ITGB5;CD81;EFNB3
13193,GO:0051828,0.681093632843737,0.449976769968955,9,95,entry into other organism involved in symbiotic interaction,BP,EGFR;EXOC2;LDLR;GAS6;CTSB;GSN;ITGB5;CD81;EFNB3
4356,GO:0009954,0.681261300903156,0.597842715366325,2,21,proximal/distal pattern formation,BP,LRP4;PBX2
4802,GO:0010998,0.681346915876805,0.70490192951721,1,10,regulation of translational initiation by eIF2 alpha phosphorylation,BP,IMPACT
7796,GO:0032352,0.681404965004298,0.704838646711267,1,10,positive regulation of hormone metabolic process,BP,EGR1
11250,GO:0045504,0.681427975625959,0.704813558510475,1,10,dynein heavy chain binding,MF,WDR60
7587,GO:0031965,0.681549785976626,0.396799773064559,25,251,nuclear membrane,CC,SLC16A3;CST3;PRNP;ITPR3;EGFR;SMAD3;STAT6;SIGMAR1;SYNE3;RETSAT;CLCA2;NSMF;BOK;KLHDC2;LEMD2;RNF123;SMOX;CERS4;SUN1;PAK1;BCL2L1;LMNA;RAP1GAP2;GCH1;TNRC18
2801,GO:0006264,0.681991711137597,0.704198400301646,1,10,mitochondrial DNA replication,BP,PRIMPOL
3056,GO:0006622,0.682050842233062,0.59692929911261,2,21,protein targeting to lysosome,BP,SORL1;WASH3P
3541,GO:0007567,0.682129234958699,0.704048178887768,1,10,parturition,BP,MAFF
11100,GO:0045125,0.682219205503139,0.703949868854599,1,10,bioactive lipid receptor activity,MF,LPAR3
7985,GO:0032609,0.682333395367456,0.493952072469113,5,54,interferon-gamma production,BP,PRNP;GAS6;IL20RB;ZFPM1;ZP3
5638,GO:0016723,0.682365266599084,0.703790214404915,1,10,oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor,MF,CYBRD1
12845,GO:0051172,0.682369573607503,0.348143787402751,183,1786,negative regulation of nitrogen compound metabolic process,BP,TNIP1;DUSP6;XDH;ERCC1;DUSP5;ZMYND8;EGR1;NR1D1;PLAT;CST3;PDCD4;CTNNBIP1;ACVR2B;PRNP;VEGFA;TNFRSF6B;APOE;LRP5;HMGA2;ELK3;PKN1;MTA1;EGFR;SERPINE2;WWTR1;SPRY2;NFATC4;BAHCC1;CRTAP;SHC1;TCFL5;SPRY4;ZFP36L1;MAP2K2;ZC3H6;MDFI;PPP1R35;FOXQ1;MAP2K1;ACP5;MXD4;SMURF2;FBLN1;SMAD3;STAT6;PIK3R2;DVL1;DNAJB5;HBEGF;PPP1R14A;PRDX5;SALL2;ADARB1;AKT1;GRB7;HDAC5;PPM1F;STK39;SERPING1;SCMH1;EPHA1;IMPACT;WWC3;DAP;LDLR;FGFR1;MXI1;RAG1;H2AFJ;SORL1;CEACAM1;CIRBP;HMG20B;TENM2;TSHZ1;CCND1;PODNL1;TCF25;GAS6;PTK6;DUSP7;ERRFI1;SNTA1;DGKQ;TFPI2;TAGLN3;CTSZ;HES2;MAGEF1;EPHB2;CTBP1;MNT;CDKN1C;CEBPB;ZNF217;TIMP2;C8ORF88;TGFB1;UNK;DEAF1;NAB2;PEG3;PHF21A;PTPN1;MBD3;CAMK2N1;VHL;MLXIPL;TRIB2;PRKCZ;TFDP2;JAK3;NELFCD;PRKCD;IFI6;BAX;EREG;RPS6KA5;DUSP4;DDIT4;PPP1R13L;PCSK1N;LIMK1;LTB4R2;LEMD2;RPS6KA6;ZHX3;RGS14;CHAD;LPCAT1;ASB1;HDAC7;INPP5D;CBX7;CHEK2;ZFPM1;PPARA;SESN2;SOX7;ABCA7;SIX5;MIF;MEX3A;ECM1;WFS1;FYN;ARID5B;BHLHE40;NEIL1;TSPYL2;ELFN2;SATB1;RERE;BCL7A;GABBR1;MICAL1;CAPRIN2;WDTC1;HES7;DNMT3A;BIN1;HES6;PROX1;SIRT2;FAM129B;BACH1;AZIN2;SERPINB1;SOCS7;MAP3K10;NGFR;NR2F6;CBX6;SIRT3;HFE;ZP3;TNRC18;NDRG2;CBLC;IRF2BPL;KDM3A;DEDD2;LRRK1
13013,GO:0051457,0.682488588456225,0.595669283262277,2,22,maintenance of protein location in nucleus,BP,ARL2;SUN1
9020,GO:0035235,0.68290016088934,0.703204960465093,1,10,ionotropic glutamate receptor signaling pathway,BP,GRIN3B
4654,GO:0010800,0.683020139497167,0.595805935699593,2,21,positive regulation of peptidyl-threonine phosphorylation,BP,CEMIP;TGFB1
2553,GO:0005832,0.683145510579727,0.702936206737206,1,10,chaperonin-containing T-complex,CC,FYCO1
10472,GO:0043371,0.683201686601224,0.702874645072031,1,10,negative regulation of CD4-positive, alpha-beta T cell differentiation,BP,JAK3
6233,GO:0019787,0.683470986031939,0.377705095584625,41,405,ubiquitin-like protein transferase activity,MF,GID4;FBXO2;TMEM129;KLHL29;DDB2;RBCK1;RNF44;SMURF2;FBXW5;RNF187;FBXO41;MARCH4;HLTF;RAG1;SHARPIN;FBXW8;ZNF598;FBXL8;RNF135;ZNF862;FBXO17;FBXO44;ZER1;VHL;MIB2;STUB1;FBXW4;LRSAM1;ASB1;HDAC7;CDC34;RNF123;PELI1;KLHL36;RNF144A;ZYG11B;KCTD13;BACH1;PELI3;CBLC;KLHL24
10043,GO:0042531,0.683521562635293,0.54405860204291,3,33,positive regulation of tyrosine phosphorylation of STAT protein,BP,PTK6;FYN;FGFR3
18132,GO:1902806,0.683720683370986,0.42078435910974,14,146,regulation of cell cycle G1/S phase transition,BP,FHL1;EGFR;GJC2;AKT1;ZNF385A;CCND1;PCBP4;PKD2;TFDP2;RBL2;BAX;CHEK2;HYAL1;PKD1
2665,GO:0006020,0.683931625340661,0.702073811278434,1,10,inositol metabolic process,BP,ISYNA1
9286,GO:0035729,0.683997226767843,0.702001755015177,1,10,cellular response to hepatocyte growth factor stimulus,BP,SIRT2
4965,GO:0015074,0.684077508453578,0.701913555317138,1,10,DNA integration,BP,NYNRIN
4412,GO:0010181,0.684200824976516,0.701778036209278,1,10,FMN binding,MF,NOS1
100,GO:0000212,0.684382408736674,0.701578395577977,1,10,meiotic spindle organization,BP,TUBG2
12549,GO:0050707,0.684445110316603,0.446198204410517,9,95,regulation of cytokine secretion,BP,POSTN;F2R;HK1;MAPKBP1;GAS6;ALOX15B;PRKCZ;MIF;MAPK3
15960,GO:0080008,0.684694573906273,0.543098999014345,3,32,Cul4-RING E3 ubiquitin ligase complex,CC,DDB2;FBXW5;DCAF10
91,GO:0000182,0.684876825043442,0.701034278981343,1,10,rDNA binding,MF,TSPYL2
7165,GO:0031053,0.684933436541013,0.700971926736926,1,10,primary miRNA processing,BP,SMAD3
12242,GO:0048532,0.684953437636496,0.700949894954002,1,10,anatomical structure arrangement,BP,SEMA3F
4671,GO:0010821,0.685034288890201,0.40687188058835,18,187,regulation of mitochondrion organization,BP,VAT1;VPS11;AKT1;RAC2;BNIP3;MOAP1;MICALL2;BOK;TFDP2;BNIP3L;BAX;ZDHHC8;PLA2G6;NBPF3;INF2;CAMKK2;BCL2L1;LMNA
11475,GO:0045945,0.685081454967629,0.700808849783678,1,10,positive regulation of transcription by RNA polymerase III,BP,ERBB2
15441,GO:0071732,0.685394834093843,0.700463357308829,1,10,cellular response to nitric oxide,BP,DNM2
19727,GO:2000052,0.685457813065482,0.700393886548771,1,10,positive regulation of non-canonical Wnt signaling pathway,BP,CSNK1E
11140,GO:0045198,0.685503924804526,0.700343013593706,1,10,establishment of epithelial cell apical/basal polarity,BP,SH3BP1
14836,GO:0070585,0.685709080601499,0.414858994401956,15,160,protein localization to mitochondrion,BP,VPS11;AKT1;HK1;RAC2;TOMM34;AIP;MOAP1;MIPEP;MICALL2;TFDP2;BNIP3L;BAX;TIMM17B;ZDHHC8;NBPF3
3208,GO:0006853,0.685787160171028,0.700030383173857,1,10,carnitine shuttle,BP,CPT2
400,GO:0001077,0.685960240775512,0.408724511478122,17,171,transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding,MF,MEF2D;EGR1;HMGA2;ELK3;ETV4;POU2F2;FOS;EPAS1;HLTF;KLF7;CEBPB;SOX12;CARF;PPARA;SSBP4;CAMTA2;PLAG1
7540,GO:0031848,0.686260484541456,0.699507359723195,1,10,protection from non-homologous end joining at telomere,BP,ERCC1
16101,GO:0090084,0.686310261826654,0.699452313898015,1,10,negative regulation of inclusion body assembly,BP,SORL1
17562,GO:1901096,0.686564476096101,0.699171068489365,1,10,regulation of autophagosome maturation,BP,FYCO1
20287,GO:2001235,0.686602598804715,0.417460712686427,14,149,positive regulation of apoptotic signaling pathway,BP,NFATC4;RBCK1;SMAD3;GSN;BNIP3;MOAP1;BOK;TFDP2;PRKCD;BAX;BCAP31;PLA2G6;BCL2L1;DEDD2
4940,GO:0014902,0.686656759433145,0.489159680771796,5,53,myotube differentiation,BP,NOS1;CAPN2;HDAC5;MYEF2;FAM129B
4859,GO:0014075,0.686715109251867,0.590746192436548,2,22,response to amine,BP,UROS;ADAMTS13
5851,GO:0017147,0.686857704683543,0.591336775148976,2,21,Wnt-protein binding,MF,LRP5;LRP4
5407,GO:0016247,0.686964916058866,0.461035585379211,7,75,channel regulator activity,MF,SCN4B;NOS1;PRSS8;KCNAB2;PCSK9;SNTA1;PRKCZ
10922,GO:0044548,0.687050533897448,0.696566611869078,1,11,S100 protein binding,MF,S100A6
7866,GO:0032434,0.687143085910837,0.436373374768333,10,105,regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,DVL1;AKT1;CSNK1E;RAD23A;TRIB2;STUB1;BCAP31;RNF144A;SIRT2;HFE
9889,GO:0042177,0.687216148284334,0.442908484153714,9,97,negative regulation of protein catabolic process,BP,CST3;EGFR;SERPINE2;SMAD3;TIMP2;FYN;SIRT2;AZIN2;HFE
10374,GO:0043201,0.687253894557441,0.698407293143047,1,10,response to leucine,BP,SESN2
2055,GO:0004806,0.687304252843879,0.698351443314758,1,10,triglyceride lipase activity,MF,CES2
7076,GO:0030877,0.687369067073517,0.69827954906376,1,10,beta-catenin destruction complex,CC,CTNNBIP1
16911,GO:0098877,0.687495074479389,0.698139738277481,1,10,neurotransmitter receptor transport to plasma membrane,BP,ARHGAP44
336,GO:0000932,0.687518503792117,0.460402664034158,7,75,P-body,CC,BTBD2;ZFP36L1;PNRC1;MEX3A;APOBEC3C;APOBEC3F;PAN2
10819,GO:0044320,0.68760900999816,0.698013277555908,1,10,cellular response to leptin stimulus,BP,BBS2
6099,GO:0019321,0.687629925761406,0.695920917204568,1,11,pentose metabolic process,BP,FGGY
6060,GO:0019210,0.687717996376272,0.46029047048943,7,74,kinase inhibitor activity,MF,SPRY2;PODNL1;CDKN1C;CAMK2N1;TRIB2;CHAD;SOCS7
5136,GO:0015645,0.687721321513535,0.697888578244179,1,10,fatty acid ligase activity,MF,SLC27A1
15643,GO:0072160,0.687784142879533,0.697818809960614,1,10,nephron tubule epithelial cell differentiation,BP,WWTR1
8570,GO:0034058,0.68779498643214,0.697806766012752,1,10,endosomal vesicle fusion,BP,VPS11
14631,GO:0070208,0.687826393302007,0.697771880209406,1,10,protein heterotrimerization,BP,COL6A1
5602,GO:0016641,0.6878281877818,0.697769886859182,1,10,oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor,MF,LOXL1
8704,GO:0034356,0.687851363542787,0.697744141740484,1,10,NAD biosynthesis via nicotinamide riboside salvage pathway,BP,NAPRT
17199,GO:0106019,0.687893093867342,0.697697780636223,1,10,phosphatidylinositol-4,5-bisphosphate phosphatase activity,MF,SYNJ2
13808,GO:0060413,0.687990947674804,0.697589045944293,1,10,atrial septum morphogenesis,BP,ZFPM1
7785,GO:0032332,0.6881744265372,0.697385081430307,1,10,positive regulation of chondrocyte differentiation,BP,SMAD3
828,GO:0002116,0.688184652606435,0.697373710395049,1,10,semaphorin receptor complex,CC,PLXNB3
5856,GO:0017154,0.688184652606435,0.697373710395049,1,10,semaphorin receptor activity,MF,PLXNB3
8504,GO:0033692,0.688189689708223,0.487385610962655,5,53,cellular polysaccharide biosynthetic process,BP,NR1D1;PGM1;AKT1;B3GNT3;INSR
5863,GO:0017166,0.688228311340686,0.697325159579151,1,10,vinculin binding,MF,PXN
2248,GO:0005161,0.688247805534151,0.697303479010989,1,10,platelet-derived growth factor receptor binding,MF,VEGFA
2771,GO:0006198,0.688247929115416,0.697303341566169,1,10,cAMP catabolic process,BP,RAPGEF3
9588,GO:0036445,0.688247929115416,0.697303341566345,1,10,neuronal stem cell division,BP,FGFR1
13485,GO:0055057,0.688247929115416,0.697303341566345,1,10,neuroblast division,BP,FGFR1
4087,GO:0009143,0.688438141515472,0.695018398420405,1,11,nucleoside triphosphate catabolic process,BP,ADA
11885,GO:0046916,0.688501360805513,0.458949195668217,7,78,cellular transition metal ion homeostasis,BP,PRNP;CYBRD1;AP3D1;ATP7B;SLC22A17;MT2A;HFE
4159,GO:0009223,0.688642061440283,0.694790350415909,1,11,pyrimidine deoxyribonucleotide catabolic process,BP,NEIL1
11855,GO:0046856,0.688773795988345,0.589092320320019,2,21,phosphatidylinositol dephosphorylation,BP,SYNJ2;INPP5D
16394,GO:0097014,0.688832063517391,0.471023325275974,6,64,ciliary plasm,CC,IFT140;KIF17;DNAH1;BBS1;PRKACA;TTLL3
12887,GO:0051238,0.689396978417994,0.692224332391927,1,12,sequestering of metal ion,BP,AP3D1
16552,GO:0097327,0.689683468302992,0.458039777651591,7,74,response to antineoplastic agent,BP,EGR1;EGFR;MAPK13;ERRFI1;TGFB1;PCK2;DDIT4
11419,GO:0045843,0.690524354298049,0.536265764105403,3,32,negative regulation of striated muscle tissue development,BP,TGFB1;PAK1;SIRT2
14789,GO:0070509,0.690777053595451,0.535968079374156,3,32,calcium ion import,BP,PRNP;PKD2;FYN
12329,GO:0048701,0.690894281446575,0.535829940416392,3,32,embryonic cranial skeleton morphogenesis,BP,SMAD3;IFT140;SLC39A3
4023,GO:0009057,0.691004113281695,0.346282335090565,113,1129,macromolecule catabolic process,BP,GID4;H1F0;NR1D1;EDEM1;CST3;BTBD2;FBXO2;PYGB;PGM1;APOE;PYGL;NAGLU;MTA1;ARRDC1;EGFR;SERPINE2;WWTR1;TMEM129;CTSO;CAPN2;SDC1;VPS11;HEXB;GTPBP1;SNX9;ZFP36L1;GAA;CTBS;RBCK1;RNF44;ENDOG;SMURF2;SMAD3;LRP1;DVL1;AP2A2;FBXW5;RNF187;AKT1;LDLR;FUCA1;SORL1;CEACAM1;CIRBP;PCBP4;CSNK1E;CTSB;PCSK9;RAD23A;SH3D19;BNIP3;SHARPIN;MVB12B;CEMIP;CTSZ;MAGEF1;ADAM8;CD81;TIMP2;TGFB1;ABHD17C;GPC1;ADAMTS7;PNRC1;GALNS;ABTB1;RNH1;FBXO44;SNX33;ANKZF1;UBXN4;PTPN1;TPP1;AGRN;IDUA;TRIB2;PRKACA;BNIP3L;PRKCD;USP20;STUB1;BAX;FBXW4;CUL9;LPCAT1;LRSAM1;LONP2;CHEK2;CDC34;RNF123;RAB12;BCAP31;WFS1;FYN;GLB1;PAN2;PFKM;RNASET2;RNF144A;CTSF;USP21;CUL7;HYAL1;DNASE1L1;PKD1;KCTD13;SIRT2;AZIN2;TOLLIP;HFE;CBLC;DEDD2;SDC2
7268,GO:0031256,0.691011408428101,0.426318823181431,11,113,leading edge membrane,CC,SPRY2;SPRY4;KCNC4;PLEK2;ARHGAP44;MYO1D;ABCA7;DNM2;ARHGEF4;INSR;PAK1
23,GO:0000045,0.691284088671652,0.44653529190259,8,84,autophagosome assembly,BP,TBC1D14;ATG16L2;PACS2;ULK2;ATG2A;ULK1;LRSAM1;WIPI2
635,GO:0001825,0.691859288165894,0.584697295426301,2,22,blastocyst formation,BP,ADA;ZP3
251,GO:0000715,0.691974909598253,0.583868149898884,2,23,nucleotide-excision repair, DNA damage recognition,BP,XPC;DDB2
12723,GO:0050995,0.692001577365149,0.691013824876474,1,11,negative regulation of lipid catabolic process,BP,AKT1
2480,GO:0005720,0.692240059172787,0.533831844664427,3,33,nuclear heterochromatin,CC,SATB1;DNMT3A;SIRT2
3446,GO:0007260,0.693084341810534,0.502278673233343,4,44,tyrosine phosphorylation of STAT protein,BP,PTK6;JAK3;FYN;FGFR3
8117,GO:0032813,0.693240194935234,0.532649260376675,3,33,tumor necrosis factor receptor superfamily binding,MF,TNFSF15;TRAP1;EDA
3467,GO:0007292,0.693478518264932,0.453680333448862,7,74,female gamete generation,BP,ERCC1;HEXB;CDC25B;NPR2;EREG;SIRT2;ZP3
976,GO:0002429,0.694238288433029,0.387946072344312,22,228,immune response-activating cell surface receptor signaling pathway,BP,PRNP;RBCK1;PIK3R2;PAG1;PRKACB;CEACAM1;CARD11;WIPF1;PLCG1;PRKACA;ADA;CYFIP2;PRKCD;CACNB3;BAX;RPS6KA5;LIMK1;INPP5D;PLA2G6;FYN;MAPK3;PAK1
7215,GO:0031116,0.694304218240248,0.581800215960422,2,22,positive regulation of microtubule polymerization,BP,ARL2;PAK1
9103,GO:0035384,0.694817344748631,0.500503406958198,4,43,thioester biosynthetic process,BP,HSD17B8;CBR4;PDK1;MLYCD
15369,GO:0071616,0.694817344748631,0.500503406958198,4,43,acyl-CoA biosynthetic process,BP,HSD17B8;CBR4;PDK1;MLYCD
2539,GO:0005798,0.694874228380215,0.412254984344968,13,137,Golgi-associated vesicle,CC,PCSK9;CTSZ;TMED4;CLTCL1;SCYL1;AREG;MCFD2;TGFA;SPPL2B;HLA-G;VANGL2;PKD1;PDCD6
19571,GO:1990542,0.694989425395124,0.463485627040378,6,67,mitochondrial transmembrane transport,BP,CPT2;CYC1;TIMM17B;SLC25A29;SLC25A37;TST
18313,GO:1903209,0.695334374960888,0.687230693295442,1,11,positive regulation of oxidative stress-induced cell death,BP,ENDOG
8178,GO:0032924,0.695590647561104,0.580270102135358,2,22,activin receptor signaling pathway,BP,ACVR2B;SMAD3
2601,GO:0005901,0.695667766241341,0.478680899768857,5,53,caveola,CC,F2R;NOS1;LRP4;MAPK3;INSR
1705,GO:0004197,0.695796097666606,0.450893159071397,7,75,cysteine-type endopeptidase activity,MF,CTSO;CAPN2;CTSB;CTSZ;USP20;CTSF;PDCD6
18064,GO:1902600,0.69585524613985,0.450097498811972,7,82,proton transmembrane transport,BP,SLC2A9;SLC15A4;MFSD3;CYC1;SLC9A7;ATP6V1F;TMCO3
3649,GO:0008134,0.696138841240768,0.357943711847533,51,507,transcription factor binding,MF,ERCC1;MEF2D;ZMYND8;NR1D1;BBS2;HMGA2;PKN1;MTA1;NFATC4;MDFI;SMARCA1;FOS;SMAD3;EPAS1;HDAC5;CCND1;AIP;DGKQ;GPX3;HES2;CRTC1;CTBP1;CEBPB;NAB2;TMEM173;BBS1;VHL;MLXIPL;TRIB2;ZNF516;TFDP2;PBX2;RBL2;PPP1R13L;HDAC7;ZFPM1;PPARA;WFS1;BHLHE40;CAMTA2;RERE;HYAL1;HES7;HES6;PROX1;SIRT2;E2F5;MAP3K10;GAS2L1;BBS10;KDM3A
10554,GO:0043517,0.696191615318429,0.686251667306178,1,11,positive regulation of DNA damage response, signal transduction by p53 class mediator,BP,ZNF385A
18114,GO:1902742,0.696328003859289,0.579391265672895,2,22,apoptotic process involved in development,BP,LRP5;BAX
4332,GO:0009886,0.696361581019401,0.686057264177699,1,11,post-embryonic animal morphogenesis,BP,BAX
2112,GO:0004896,0.696475355134821,0.498548788006842,4,43,cytokine receptor activity,MF,IFNGR2;IL20RB;EPOR;IL17RE
5709,GO:0016840,0.696484745088289,0.685916331515146,1,11,carbon-nitrogen lyase activity,MF,GGACT
8988,GO:0035107,0.696784902930556,0.425523089087067,10,104,appendage morphogenesis,BP,WNT7A;LRP5;IFT140;FGFR1;WNT3;LRP4;PBX2;BAX;FBXW4;TMEM231
8989,GO:0035108,0.696784902930556,0.425523089087067,10,104,limb morphogenesis,BP,WNT7A;LRP5;IFT140;FGFR1;WNT3;LRP4;PBX2;BAX;FBXW4;TMEM231
5513,GO:0016471,0.696931223625852,0.685405015837673,1,11,vacuolar proton-transporting V-type ATPase complex,CC,ATP6V1F
10063,GO:0042562,0.697137037706424,0.497504147815629,4,44,hormone binding,MF,EGFR;SHC1;NPR2;INSR
5616,GO:0016668,0.697222497312315,0.685071084470415,1,11,oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor,MF,TXNRD3
7012,GO:0030730,0.697878714803302,0.684317721337563,1,11,sequestering of triglyceride,BP,PPARA
430,GO:0001158,0.697889958505551,0.460533020933629,6,64,enhancer sequence-specific DNA binding,MF,SMARCD2;MBD3;ZNF395;BACH1;ZNF704;NR2F6
3589,GO:0008017,0.697924798335456,0.385938197405222,21,213,microtubule binding,MF,PRNP;NDRG1;CLIP2;MARK4;REEP4;KIF17;EML2;KIF26B;KIF7;DNM1;RGS14;MYO1D;MYH15;EML3;DNM2;KIF26A;MAPRE3;NDE1;KIF13B;GAS2L1;CCDC88C
2209,GO:0005095,0.698149634866321,0.684006273383482,1,11,GTPase inhibitor activity,MF,ARL2
12836,GO:0051155,0.698218684458021,0.526733326837522,3,33,positive regulation of striated muscle cell differentiation,BP,TGFB1;PROX1;FAM129B
6489,GO:0021854,0.698460929120504,0.683648107138745,1,11,hypothalamus development,BP,BAX
76,GO:0000153,0.698499714648409,0.683603458801237,1,11,cytoplasmic ubiquitin ligase complex,CC,VHL
11892,GO:0046930,0.69871140350113,0.683359681946789,1,11,pore complex,CC,BAX
15136,GO:0071242,0.698925125759669,0.525889893303634,3,33,cellular response to ammonium ion,BP,AGRN;DNM2;MAPK3
2096,GO:0004861,0.69963201981155,0.682297762054876,1,11,cyclin-dependent protein serine/threonine kinase inhibitor activity,MF,CDKN1C
18285,GO:1903146,0.699654707708115,0.494523983721662,4,44,regulation of autophagy of mitochondrion,BP,BNIP3;BNIP3L;ZDHHC8;CAMKK2
2840,GO:0006312,0.699663176466565,0.575399641481511,2,22,mitotic recombination,BP,ERCC1;TEP1
15229,GO:0071392,0.699822950863834,0.575207737350277,2,22,cellular response to estradiol stimulus,BP,FAM210B;EGFR
6820,GO:0030286,0.700342182950133,0.523808047086525,3,34,dynein complex,CC,NUDCD3;DNAH1;WDR60
9782,GO:0040001,0.700541176604892,0.574344307220555,2,22,establishment of mitotic spindle localization,BP,SPRY2;NDE1
4312,GO:0009792,0.700603244966373,0.357875702682608,43,426,embryo development ending in birth or egg hatching,BP,VEGFA;EGFR;CAPN2;PHLDA2;ZFP36L1;PLCD3;MDFI;MAP2K1;ENDOG;SMAD3;DVL1;EPAS1;SALL2;AKT1;IFT140;FGFR1;PRKACB;EDNRA;PKD2;FBXW8;PLCG1;CEBPB;TGFB1;DEAF1;MBD3;ADA;WDR60;TMEM231;VANGL2;HYAL1;SEMA4C;WDTC1;HES7;BCL2L1;PROX1;PKD1;PDCD6;MAFF;TCTN1;SLC39A3;ZP3;CELSR1;APBA1
6913,GO:0030511,0.701016931964841,0.57377167047671,2,22,positive regulation of transforming growth factor beta receptor signaling pathway,BP,CDKN1C;TGFBR3
18601,GO:1903846,0.701016931964841,0.57377167047671,2,22,positive regulation of cellular response to transforming growth factor beta stimulus,BP,CDKN1C;TGFBR3
3662,GO:0008156,0.701208019008316,0.523157509418575,3,33,negative regulation of DNA replication,BP,TGFB1;CHEK2;TSPYL2
14078,GO:0060914,0.701238254008837,0.68043813164178,1,11,heart formation,BP,LEMD2
19705,GO:2000009,0.701328247121982,0.680333682629545,1,11,negative regulation of protein localization to cell surface,BP,SNX33
417,GO:0001105,0.701337043981891,0.523002769323923,3,33,RNA polymerase II transcription coactivator activity,MF,CITED4;SOX12;RERE
1156,GO:0002763,0.701394922605653,0.522933344465793,3,33,positive regulation of myeloid leukocyte differentiation,BP,CTNNBIP1;ZFP36L1;FOS
16102,GO:0090085,0.701554089879191,0.680071440785517,1,11,regulation of protein deubiquitination,BP,TNIP1
6145,GO:0019433,0.701821620291878,0.679760568048771,1,11,triglyceride catabolic process,BP,APOE
2435,GO:0005637,0.70204237169844,0.491687670147273,4,44,nuclear inner membrane,CC,SMAD3;SIGMAR1;LEMD2;SUN1
10096,GO:0042611,0.702150671088087,0.677603111460842,1,12,MHC protein complex,CC,HLA-G
17902,GO:1902175,0.702192641099716,0.571652802317002,2,23,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,AKT1;TRAP1
12358,GO:0048753,0.702487089856233,0.571297011203334,2,23,pigment granule organization,BP,AP3D1;BLOC1S4
10404,GO:0043248,0.702550553732718,0.677135850123322,1,12,proteasome assembly,BP,PSMG4
4314,GO:0009798,0.702740435648504,0.470176794788374,5,54,axis specification,BP,WNT7A;LRP5;MDFI;WNT3;LRP4
13496,GO:0055076,0.702741637533675,0.424976048454195,9,100,transition metal ion homeostasis,BP,PRNP;EPAS1;CYBRD1;AP3D1;ATP7B;SLC22A17;MT2A;SLC25A37;HFE
20093,GO:2000725,0.70285553829587,0.571553415289896,2,22,regulation of cardiac muscle cell differentiation,BP,TGFB1;PAK1
8998,GO:0035137,0.702892827658603,0.571508339792909,2,22,hindlimb morphogenesis,BP,WNT7A;WNT3
7723,GO:0032225,0.70304839607782,0.678331919950181,1,11,regulation of synaptic transmission, dopaminergic,BP,RAB3B
6713,GO:0030130,0.703161668296701,0.678199749049412,1,11,clathrin coat of trans-Golgi network vesicle,CC,CLTCL1
4529,GO:0010596,0.703272423596989,0.520677656655326,3,33,negative regulation of endothelial cell migration,BP,APOE;HDAC5;TGFB1
7401,GO:0031490,0.703802282674308,0.431441462358601,8,92,chromatin DNA binding,MF,H1F0;HMGA2;SMAD3;SMARCD2;MBD3;KDM6B;LEMD2;KDM3A
2580,GO:0005874,0.703923448175307,0.362424841966699,33,331,microtubule,CC,NDRG1;MTA1;SPRY2;CLIP2;MAP2K2;KLC2;DVL1;FAM110C;REEP4;KCNAB2;LZTS2;KIF17;SNPH;SNTB2;EML2;KIF26B;ENKD1;DNAH1;KIF7;TUBG2;NINL;DNM1;RGS14;REEP2;EML3;DNM2;KIF26A;TUBB6;SIRT2;MAPRE3;NDE1;KIF13B;TTLL3
17349,GO:1900029,0.703966680710327,0.677259160503958,1,11,positive regulation of ruffle assembly,BP,PLEKHM1
17672,GO:1901505,0.704496887394128,0.51920272863199,3,33,carbohydrate derivative transmembrane transporter activity,MF,SLC29A4;SLC50A1;SLC37A2
6276,GO:0019883,0.704872953802246,0.676197596703083,1,11,antigen processing and presentation of endogenous antigen,BP,HFE
16204,GO:0090239,0.70496018381612,0.676095270737629,1,11,regulation of histone H4 acetylation,BP,CTBP1
14128,GO:0061005,0.705510527439746,0.517979458491239,3,33,cell differentiation involved in kidney development,BP,WWTR1;ACTA2;LAMB2
11314,GO:0045648,0.705687455892526,0.568120368285862,2,22,positive regulation of erythrocyte differentiation,BP,FAM210B;INPP5D
4571,GO:0010658,0.705732496560806,0.568065605673845,2,22,striated muscle cell apoptotic process,BP,RGL2;BNIP3
10860,GO:0044390,0.705804748778577,0.517624000149808,3,33,ubiquitin-like protein conjugating enzyme binding,MF,PPARA;RNF144A;TOLLIP
11433,GO:0045880,0.705832701090951,0.567943754025327,2,22,positive regulation of smoothened signaling pathway,BP,EVC;KIF7
8372,GO:0033280,0.705847771287521,0.567925426056184,2,22,response to vitamin D,BP,CYP27B1;TGFB1
9472,GO:0036109,0.705929420980477,0.674956533290655,1,11,alpha-linolenic acid metabolic process,BP,ABCD1
9631,GO:0036503,0.705989184503054,0.429422653069681,8,86,ERAD pathway,BP,EDEM1;FBXO2;TMEM129;ANKZF1;UBXN4;STUB1;BCAP31;WFS1
3580,GO:0007631,0.706193785903005,0.516765138693327,3,34,feeding behavior,BP,APLN;FOS;FYN
1874,GO:0004550,0.707149439910952,0.671722671974402,1,12,nucleoside diphosphate kinase activity,MF,NME4
15177,GO:0071318,0.707453137655916,0.673159780774887,1,11,cellular response to ATP,BP,SSH1
3465,GO:0007289,0.707517457990997,0.673083757657007,1,11,spermatid nucleus differentiation,BP,KDM3A
12169,GO:0048305,0.707530346862134,0.67306852198657,1,11,immunoglobulin secretion,BP,POU2F2
3625,GO:0008089,0.707682754725321,0.514962010653587,3,34,anterograde axonal transport,BP,AP3D1;BLOC1S4;TRIM46
14856,GO:0070633,0.707749766969999,0.672809061348501,1,11,transepithelial transport,BP,SLC23A2
12644,GO:0050857,0.70779756960411,0.67275251330878,1,11,positive regulation of antigen receptor-mediated signaling pathway,BP,ADA
15038,GO:0070989,0.707934988114301,0.672589910039794,1,11,oxidative demethylation,BP,CYP3A5
15592,GO:0072077,0.708065866125905,0.672434984818244,1,11,renal vesicle morphogenesis,BP,KIF26B
15598,GO:0072087,0.708065866125905,0.672434984818244,1,11,renal vesicle development,BP,KIF26B
14195,GO:0061134,0.708191674689474,0.411962927213609,10,112,peptidase regulator activity,MF,CST3;SERPINE2;FBLN1;PRDX5;SERPING1;GAS6;TFPI2;TIMP2;PCSK1N;SERPINB1
867,GO:0002204,0.708248071002272,0.51466535235523,3,33,somatic recombination of immunoglobulin genes involved in immune response,BP,ERCC1;STAT6;TGFB1
868,GO:0002208,0.708248071002272,0.51466535235523,3,33,somatic diversification of immunoglobulins involved in immune response,BP,ERCC1;STAT6;TGFB1
11136,GO:0045190,0.708248071002272,0.51466535235523,3,33,isotype switching,BP,ERCC1;STAT6;TGFB1
12541,GO:0050699,0.708307225519972,0.564220238905517,2,23,WW domain binding,MF,FAM189B;DNM2
17655,GO:1901381,0.708405365374797,0.672032828586639,1,11,positive regulation of potassium ion transmembrane transport,BP,DNM2
8603,GO:0034122,0.708415707483174,0.564794070709149,2,22,negative regulation of toll-like receptor signaling pathway,BP,NR1D1;PTPRS
10382,GO:0043218,0.708687952550509,0.67169778139999,1,11,compact myelin,CC,SIRT2
8069,GO:0032755,0.708889399496192,0.483499323090406,4,44,positive regulation of interleukin-6 production,BP,F2R;ADORA2B;MAPK13;EREG
2389,GO:0005527,0.708946505887696,0.669587549594193,1,12,macrolide binding,MF,FKBP9
2390,GO:0005528,0.708946505887696,0.669587549594193,1,12,FK506 binding,MF,FKBP9
7170,GO:0031058,0.709143324362601,0.435376188597501,7,75,positive regulation of histone modification,BP,VEGFA;NOS1;CTBP1;TGFB1;C6ORF89;RPS6KA5;MAPK3
15534,GO:0071941,0.709387403981833,0.670867282708461,1,11,nitrogen cycle metabolic process,BP,NAGS
20078,GO:2000696,0.709463298906923,0.670777065402359,1,11,regulation of epithelial cell differentiation involved in kidney development,BP,WWTR1
586,GO:0001741,0.709618588474688,0.670592407768157,1,11,XY body,CC,DNMT3A
20095,GO:2000727,0.709621072237056,0.670589453594094,1,11,positive regulation of cardiac muscle cell differentiation,BP,TGFB1
14890,GO:0070696,0.710078978774953,0.670044452554546,1,11,transmembrane receptor protein serine/threonine kinase binding,MF,TGFB1
12318,GO:0048681,0.710244387104998,0.669847402445255,1,11,negative regulation of axon regeneration,BP,PTPRS
17391,GO:1900115,0.71024627639403,0.669845151190112,1,11,extracellular regulation of signal transduction,BP,LTBP1
17392,GO:1900116,0.71024627639403,0.669845151190112,1,11,extracellular negative regulation of signal transduction,BP,LTBP1
9223,GO:0035615,0.710462584065438,0.669587318514017,1,11,clathrin adaptor activity,MF,AP2A2
16841,GO:0098748,0.710462584065438,0.669587318514017,1,11,endocytic adaptor activity,MF,AP2A2
9046,GO:0035269,0.710475261329902,0.667762338558377,1,12,protein O-linked mannosylation,BP,B4GAT1
3267,GO:0006942,0.710506361916996,0.481301530971201,4,45,regulation of striated muscle contraction,BP,NOS1;PRKACA;GSTO1;EHD3
7277,GO:0031269,0.7105091107974,0.66953183846879,1,11,pseudopodium assembly,BP,CDC42EP5
2722,GO:0006105,0.710771304681709,0.669219047304459,1,11,succinate metabolic process,BP,SDHA
13565,GO:0060043,0.710787601723652,0.561887033137568,2,22,regulation of cardiac muscle cell proliferation,BP,FGFR1;TGFBR3
1360,GO:0003230,0.710957165070839,0.561678668263548,2,22,cardiac atrium development,BP,ZFPM1;PROX1
17799,GO:1901862,0.711002969870175,0.511314797939777,3,33,negative regulation of muscle tissue development,BP,TGFB1;PAK1;SIRT2
12287,GO:0048635,0.711002969870415,0.511314797939537,3,33,negative regulation of muscle organ development,BP,TGFB1;PAK1;SIRT2
10641,GO:0043666,0.711256630552644,0.423297606059458,8,86,regulation of phosphoprotein phosphatase activity,BP,PPP1R35;PPP1R14A;PPP2R3B;B3GAT3;ITGA1;ELFN2;PPP2R5B;PPP1R16A
6308,GO:0019956,0.711441770620991,0.668418096314907,1,11,chemokine binding,MF,ITGA4
1382,GO:0003279,0.711453630084608,0.432782800670278,7,74,cardiac septum development,BP,LTBP1;SNX17;TGFBR3;ZFPM1;DNM2;VANGL2;PROX1
9071,GO:0035326,0.711742352730694,0.432327832496158,7,75,enhancer binding,MF,SMAD3;SMARCD2;MBD3;ZNF395;BACH1;ZNF704;NR2F6
3437,GO:0007249,0.711833790694358,0.372451452071012,20,208,I-kappaB kinase/NF-kappaB signaling,BP,TNIP1;F2R;RBCK1;S100A4;AKT1;MAPKBP1;CARD19;CARD11;SLC20A1;SHARPIN;TMED4;PIM2;PLEKHG5;MIB2;IRAK1;ECM1;FYN;PELI1;TMEM101;LURAP1
2503,GO:0005758,0.712014142884633,0.443029180502386,6,71,mitochondrial intermembrane space,CC,ARL2;NME4;TRAP1;THOP1;PPOX;CAT
11753,GO:0046621,0.712326192250351,0.559993689565952,2,22,negative regulation of organ growth,BP,WWC3;PAK1
18242,GO:1903036,0.712591248201108,0.508985827061189,3,34,positive regulation of response to wounding,BP,F2R;HBEGF;F12
3600,GO:0008038,0.712710556109247,0.559519762775494,2,22,neuron recognition,BP,EPHB2;EFNB3
14137,GO:0061028,0.712929888149407,0.50896197833631,3,33,establishment of endothelial barrier,BP,WNT7A;PTPRS;RAPGEF3
16088,GO:0090068,0.71311733620146,0.368969239444518,21,218,positive regulation of cell cycle process,BP,LRP5;HMGA2;FGFR1;RAB11FIP4;ZNF385A;CCND1;PCBP4;CDC25B;PKD2;TGFB1;PRKACA;TFDP2;RBL2;BAX;EREG;TGFA;CHEK2;INSR;HYAL1;PPP2R5B;SIRT2
9837,GO:0042088,0.713202157123745,0.558202655845285,2,23,T-helper 1 type immune response,BP,STAT6;JAK3
7909,GO:0032488,0.713231105828986,0.666272748416495,1,11,Cdc42 protein signal transduction,BP,APOE
16868,GO:0098799,0.713839050085194,0.663717285119356,1,12,outer mitochondrial membrane protein complex,CC,ANKZF1
852,GO:0002178,0.713881178195858,0.665490522946998,1,11,palmitoyltransferase complex,CC,SPTLC2
16294,GO:0090399,0.713984312935702,0.665366283754108,1,11,replicative senescence,BP,CHEK2
10277,GO:0043030,0.714166587058283,0.557009861157372,2,23,regulation of macrophage activation,BP,LDLR;MIF
11740,GO:0046597,0.714254300560863,0.663215154549138,1,12,negative regulation of viral entry into host cell,BP,GSN
6902,GO:0030496,0.714280180295448,0.382979234681417,15,156,midbody,CC,PKN1;SSH1;EXOC2;PITPNM1;RAB11FIP4;MPLKIP;CAPG;C6ORF89;GDI1;DNM2;MICAL1;SIRT2;MAPRE3;TACC1;SEPT6
15408,GO:0071677,0.714989360515163,0.662324796501293,1,12,positive regulation of mononuclear cell migration,BP,TGFB1
3870,GO:0008499,0.715205537239181,0.663892275652251,1,11,UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity,MF,B3GNT3
652,GO:0001843,0.715345004798347,0.428087652966832,7,75,neural tube closure,BP,DVL1;PRKACB;TGFB1;DEAF1;VANGL2;SEMA4C;CELSR1
13930,GO:0060606,0.715345004798347,0.428087652966832,7,75,tube closure,BP,DVL1;PRKACB;TGFB1;DEAF1;VANGL2;SEMA4C;CELSR1
18314,GO:1903214,0.715531415578954,0.439355354105527,6,67,regulation of protein targeting to mitochondrion,BP,VPS11;RAC2;MICALL2;BNIP3L;ZDHHC8;NBPF3
17119,GO:0101031,0.715615700442423,0.663396015753725,1,11,chaperone complex,CC,FYCO1
14290,GO:0061418,0.715746495371819,0.438599612950226,6,71,regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,EGR1;VEGFA;EPAS1;VHL;SIRT2;BACH1
8587,GO:0034101,0.715930422235438,0.417743726903259,8,87,erythrocyte homeostasis,BP,VEGFA;FAM210B;ZFP36L1;EPAS1;JAK3;TGFBR3;INPP5D;ZFPM1
20204,GO:2001032,0.716409468062467,0.662433916043371,1,11,regulation of double-strand break repair via nonhomologous end joining,BP,HMGA2
11406,GO:0045824,0.716734136458425,0.50390313412565,3,34,negative regulation of innate immune response,BP,SERPING1;CEACAM1;FAM3A
2516,GO:0005771,0.716992273368727,0.552850745364738,2,24,multivesicular body,CC,CST3;EGFR
4187,GO:0009266,0.717182482962924,0.373680541427327,17,177,response to temperature stimulus,BP,NOS1;FOS;AKT1;CIRBP;NTSR1;VGF;PRKACA;ZNF516;STUB1;PCSK1N;IRAK1;IGFBP7;SLC27A1;MAPK3;PDCD6;NR2F6;LRP11
3910,GO:0008569,0.717273301252363,0.66138431774172,1,11,ATP-dependent microtubule motor activity, minus-end-directed,MF,DNAH1
2849,GO:0006338,0.717284808272601,0.382691781462646,14,155,chromatin remodeling,BP,HMGA2;BAHCC1;SMARCA1;HDAC5;SCMH1;HMG20B;SMARCD2;MBD3;KDM6B;CENPH;SATB1;RERE;INO80C;TNRC18
17347,GO:1900027,0.717288729067428,0.553132086785472,2,23,regulation of ruffle assembly,BP,PLEKHM1;PFN2
11757,GO:0046625,0.717566857125716,0.661027021043382,1,11,sphingolipid binding,MF,PLTP
3367,GO:0007140,0.71760766611053,0.552734546545853,2,23,male meiotic nuclear division,BP,PIM2;TDRKH
12514,GO:0050663,0.717700475136537,0.401229618960826,10,108,cytokine secretion,BP,POSTN;F2R;HK1;MAPKBP1;GAS6;CARD11;ALOX15B;PRKCZ;MIF;MAPK3
16185,GO:0090208,0.717803778161388,0.660738429566863,1,11,positive regulation of triglyceride metabolic process,BP,LDLR
18912,GO:1904589,0.717977698174243,0.472250528854665,4,45,regulation of protein import,BP,GAS6;TGFB1;TMEM173;PRKCD
9868,GO:0042135,0.718045584231813,0.660443678440828,1,11,neurotransmitter catabolic process,BP,ALDH7A1
11770,GO:0046639,0.718071392612502,0.660412206652471,1,11,negative regulation of alpha-beta T cell differentiation,BP,JAK3
17610,GO:1901264,0.718129108483659,0.451460840424997,5,56,carbohydrate derivative transport,BP,SLC29A4;ADA;ABCG1;SLC50A1;SLC37A2
10599,GO:0043584,0.718307388710218,0.660124311588782,1,11,nose development,BP,PROX1
9142,GO:0035497,0.718604700384232,0.659761329595904,1,11,cAMP response element binding,MF,HMGA2
14253,GO:0061318,0.718650174192894,0.659705783259657,1,11,renal filtration cell differentiation,BP,LAMB2
15620,GO:0072112,0.718650174192894,0.659705783259657,1,11,glomerular visceral epithelial cell differentiation,BP,LAMB2
15733,GO:0072311,0.718650174192894,0.659705783259657,1,11,glomerular epithelial cell differentiation,BP,LAMB2
4486,GO:0010510,0.71897647342201,0.659306988142833,1,11,regulation of acetyl-CoA biosynthetic process from pyruvate,BP,PDK1
12906,GO:0051261,0.718981973104053,0.423789630758596,7,75,protein depolymerization,BP,TMOD2;TWF2;GSN;SPTB;CAPG;SH3BP1;MICAL1
17765,GO:1901722,0.719096477992767,0.659160224205186,1,11,regulation of cell proliferation involved in kidney development,BP,EGR1
13904,GO:0060572,0.719239836920404,0.65898482962576,1,11,morphogenesis of an epithelial bud,BP,WNT2B
20190,GO:2001014,0.719251801580523,0.658970187909479,1,11,regulation of skeletal muscle cell differentiation,BP,GPC1
12641,GO:0050854,0.71931084776446,0.500723855495945,3,34,regulation of antigen receptor-mediated signaling pathway,BP,PRNP;CEACAM1;ADA
4559,GO:0010642,0.719524741867987,0.658636036687909,1,11,negative regulation of platelet-derived growth factor receptor signaling pathway,BP,LRP1
18121,GO:1902751,0.7195384421392,0.550322299622183,2,23,positive regulation of cell cycle G2/M phase transition,BP,CCND1;CDC25B
10027,GO:0042481,0.719627770155322,0.658509832302354,1,11,regulation of odontogenesis,BP,TGFB1
15998,GO:0086011,0.719687698719097,0.658436405100647,1,11,membrane repolarization during action potential,BP,CACNB3
14138,GO:0061029,0.719993440984265,0.658061592147454,1,11,eyelid development in camera-type eye,BP,EGFR
15440,GO:0071731,0.720023309460845,0.658024957772276,1,11,response to nitric oxide,BP,DNM2
16436,GO:0097094,0.720060450205098,0.657979399257708,1,11,craniofacial suture morphogenesis,BP,TGFB1
9383,GO:0035925,0.720141609553197,0.657879828023797,1,11,mRNA 3'-UTR AU-rich region binding,MF,ZFP36L1
14212,GO:0061158,0.720141787577337,0.657879609587818,1,11,3'-UTR-mediated mRNA destabilization,BP,ZFP36L1
7308,GO:0031324,0.720194889128887,0.308011945714002,194,1901,negative regulation of cellular metabolic process,BP,TNIP1;DUSP6;XDH;ERCC1;DUSP5;ZMYND8;EGR1;NR1D1;DLG4;PLAT;CST3;CYP27B1;PDCD4;CTNNBIP1;ACVR2B;PRNP;VEGFA;TNFRSF6B;APOE;LRP5;HMGA2;ELK3;PKN1;MTA1;EGFR;SERPINE2;WWTR1;SPRY2;NFATC4;BAHCC1;CRTAP;SHC1;TBC1D14;TCFL5;SPRY4;ZFP36L1;MAP2K2;ZC3H6;MDFI;PPP1R35;FOXQ1;MAP2K1;ACP5;MXD4;SMURF2;FBLN1;SMAD3;STAT6;PIK3R2;DVL1;DNAJB5;HBEGF;PPP1R14A;PRDX5;SALL2;ADARB1;AKT1;GRB7;HDAC5;PPM1F;STK39;SERPING1;SCMH1;EPHA1;IMPACT;WWC3;DAP;FGFR1;MXI1;RAG1;H2AFJ;SORL1;CEACAM1;CIRBP;HMG20B;TENM2;TSHZ1;CCND1;PODNL1;TCF25;GAS6;PTK6;DUSP7;PCSK9;BCR;ERRFI1;SNTA1;DGKQ;BNIP3;TFPI2;TAGLN3;CTSZ;HES2;MAGEF1;EPHB2;CTBP1;MNT;CDKN1C;CEBPB;ZNF217;TIMP2;C8ORF88;TGFB1;UNK;DEAF1;NAB2;PEG3;FARP1;PHF21A;PTPN1;MBD3;CAMK2N1;VHL;TRAP1;MLXIPL;TRIB2;PRKCZ;TFDP2;JAK3;NELFCD;PRKCD;IFI6;BAX;EREG;RPS6KA5;DUSP4;DDIT4;PPP1R13L;PCSK1N;LIMK1;LTB4R2;LEMD2;RPS6KA6;ZHX3;RGS14;CHAD;LPCAT1;ASB1;HDAC7;INPP5D;CBX7;CHEK2;ZFPM1;PPARA;SESN2;MYO1D;SOX7;ABCA7;SIX5;MIF;MEX3A;ECM1;WFS1;QSOX1;FYN;ARID5B;BHLHE40;NEIL1;TSPYL2;ELFN2;SLC27A1;SATB1;RERE;BCL7A;GABBR1;MICAL1;CAPRIN2;WDTC1;HES7;DNMT3A;BIN1;HES6;DLG3;PROX1;SIRT2;FAM129B;BACH1;SERPINB1;SOCS7;MAP3K10;NGFR;GRB10;NR2F6;CBX6;SIRT3;HFE;ZP3;TNRC18;NDRG2;CBLC;IRF2BPL;KDM3A;DEDD2;LRRK1
13002,GO:0051444,0.720227467354108,0.654367252852305,1,13,negative regulation of ubiquitin-protein transferase activity,BP,LIMK1
16060,GO:0089718,0.720330218960243,0.657648337696921,1,11,amino acid import across plasma membrane,BP,NTSR1
20094,GO:2000726,0.720346095095714,0.657628846148651,1,11,negative regulation of cardiac muscle cell differentiation,BP,PAK1
6497,GO:0021871,0.720515022355059,0.657421392731447,1,11,forebrain regionalization,BP,WNT2B
59,GO:0000122,0.721102080242899,0.326715670297196,61,604,negative regulation of transcription by RNA polymerase II,BP,ZMYND8;EGR1;NR1D1;CTNNBIP1;ACVR2B;VEGFA;HMGA2;WWTR1;NFATC4;TCFL5;MDFI;FOXQ1;MXD4;SMURF2;SMAD3;STAT6;DNAJB5;SALL2;HDAC5;IMPACT;WWC3;FGFR1;MXI1;TENM2;TSHZ1;CCND1;TCF25;TAGLN3;HES2;CTBP1;MNT;CEBPB;ZNF217;TGFB1;DEAF1;PEG3;PHF21A;MBD3;VHL;MLXIPL;PPP1R13L;ZHX3;HDAC7;CBX7;ZFPM1;PPARA;WFS1;ARID5B;BHLHE40;SATB1;RERE;WDTC1;HES7;DNMT3A;HES6;PROX1;SIRT2;BACH1;NR2F6;CBX6;IRF2BPL
2279,GO:0005230,0.721184299249295,0.656598452769303,1,11,extracellular ligand-gated ion channel activity,MF,GRIN3B
1072,GO:0002637,0.721216371466731,0.498363745112257,3,34,regulation of immunoglobulin production,BP,PKN1;STAT6;TGFB1
11505,GO:0046030,0.721664702596108,0.656006739659143,1,11,inositol trisphosphate phosphatase activity,MF,INPP5D
6160,GO:0019511,0.721708833820307,0.655952340752949,1,11,peptidyl-proline hydroxylation,BP,CRTAP
7419,GO:0031527,0.722184183653861,0.655365941405261,1,11,filopodium membrane,CC,ITGA3
9074,GO:0035330,0.722205461711596,0.655339673027742,1,11,regulation of hippo signaling,BP,WWC3
13395,GO:0052743,0.72226534022387,0.655265742336566,1,11,inositol tetrakisphosphate phosphatase activity,MF,INPP5D
18156,GO:1902883,0.722274594967544,0.496681230891415,3,35,negative regulation of response to oxidative stress,BP,MCTP1;AKT1;TRAP1
13367,GO:0052629,0.722406641880532,0.655091227977066,1,11,phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity,MF,SYNJ2
4982,GO:0015106,0.722556347834277,0.654906253737094,1,11,bicarbonate transmembrane transporter activity,MF,SLC26A11
2794,GO:0006244,0.722913517062336,0.652602811640967,1,12,pyrimidine nucleotide catabolic process,BP,NEIL1
18521,GO:1903672,0.723540513053123,0.545291295330183,2,23,positive regulation of sprouting angiogenesis,BP,VEGFA;HDAC7
10266,GO:0043014,0.723850905697692,0.544899343932783,2,23,alpha-tubulin binding,MF,FAM110C;WASH3P
17548,GO:1901070,0.723936645317948,0.649761432431514,1,13,guanosine-containing compound biosynthetic process,BP,NME4
11137,GO:0045191,0.724262087378082,0.544379728775447,2,23,regulation of isotype switching,BP,STAT6;TGFB1
17542,GO:1901030,0.724689923033303,0.493672751378223,3,35,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,BOK;TFDP2;BAX
20128,GO:2000785,0.725732614575137,0.492739337041265,3,34,regulation of autophagosome assembly,BP,TBC1D14;ULK1;LRSAM1
20293,GO:2001241,0.725946842271679,0.648820472054604,1,12,positive regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,BAX
10427,GO:0043279,0.726148480376365,0.426782845897932,6,66,response to alkaloid,BP,HDAC5;ADA;DNM2;DNMT3A;BCL2L1;HOMER2
9279,GO:0035721,0.726375194466722,0.648283593938867,1,12,intraciliary retrograde transport,BP,IFT140
17493,GO:1900409,0.72650753977869,0.648117579598425,1,12,positive regulation of cellular response to oxidative stress,BP,ENDOG
18157,GO:1902884,0.72650753977869,0.648117579598425,1,12,positive regulation of response to oxidative stress,BP,ENDOG
6702,GO:0030118,0.727394036921259,0.460700061490505,4,45,clathrin coat,CC,EGFR;AP2A2;CLTCL1;EPN2
18535,GO:1903707,0.727616724467556,0.403390090126872,8,94,negative regulation of hemopoiesis,BP,ZFP36L1;CEACAM1;ERBB2;JAK3;INPP5D;ZFPM1;HLA-G;ITPKB
13107,GO:0051653,0.728209560904185,0.489636078592579,3,34,spindle localization,BP,SPRY2;LLGL1;NDE1
7071,GO:0030866,0.728269359829574,0.489560995622206,3,34,cortical actin cytoskeleton organization,BP,FMNL2;WIPF1;LLGL1
20195,GO:2001022,0.728323372613937,0.424024327158064,6,67,positive regulation of response to DNA damage stimulus,BP,HMGA2;EGFR;ZNF385A;NSMCE4A;PRKCD;TMEM161A
17283,GO:0140029,0.728501627911022,0.438879184744389,5,56,exocytic process,BP,VPS11;EXOC2;RAB3B;SNPH;RAB40B
6651,GO:0030008,0.728618959072663,0.643874595879198,1,13,TRAPP complex,CC,TRAPPC9
20115,GO:2000765,0.728702223788144,0.538740097044852,2,23,regulation of cytoplasmic translation,BP,ZNF385A;UNK
1120,GO:0002708,0.728977520596059,0.458500196145146,4,46,positive regulation of lymphocyte mediated immunity,BP,STAT6;TGFB1;PRKCZ;ZP3
8820,GO:0034612,0.729118288672224,0.352862542687793,20,216,response to tumor necrosis factor,BP,POSTN;TNFRSF6B;ZFP36L1;RBCK1;ENDOG;AKT1;GAS6;SHARPIN;ADAMTS13;ADAMTS7;TNFSF15;PCK2;SPPL2B;MAPK3;HYAL1;TNFRSF25;EDA;PELI3;NGFR;GCH1
7064,GO:0030858,0.729171789546305,0.48805717519452,3,35,positive regulation of epithelial cell differentiation,BP,CYP27B1;ALOX15B;BTG1
7923,GO:0032506,0.729389746697079,0.537862134822531,2,23,cytokinetic process,BP,SNX9;SNX33
19118,GO:1905037,0.729468412854801,0.401766390723892,8,87,autophagosome organization,BP,TBC1D14;ATG16L2;PACS2;ULK2;ATG2A;ULK1;LRSAM1;WIPI2
8120,GO:0032816,0.729784081236782,0.643986530673928,1,12,positive regulation of natural killer cell activation,BP,GAS6
4098,GO:0009154,0.729887657572018,0.536566198370753,2,24,purine ribonucleotide catabolic process,BP,NT5E;RAPGEF3
13126,GO:0051701,0.73000489159886,0.364907220780014,15,160,interaction with host,BP,TNIP1;EGFR;PC;EXOC2;SMAD3;LDLR;GAS6;CTSB;GSN;ITGB5;CD81;TGFB1;EFNB3;INSR;BCL2L1
3057,GO:0006623,0.730045191607456,0.487327748923552,3,34,protein targeting to vacuole,BP,SORL1;AP3D1;WASH3P
20045,GO:2000648,0.730061496527393,0.537003087874653,2,23,positive regulation of stem cell proliferation,BP,VEGFA;HMGA2
7297,GO:0031304,0.730192264111484,0.486424382771582,3,36,intrinsic component of mitochondrial inner membrane,CC,TIMM17B;PPOX;COQ2
7298,GO:0031305,0.730192264111484,0.486424382771582,3,36,integral component of mitochondrial inner membrane,CC,TIMM17B;PPOX;COQ2
12112,GO:0048188,0.730764458889209,0.642742602702718,1,12,Set1C/COMPASS complex,CC,ASH2L
1044,GO:0002562,0.730817189463437,0.456460728615542,4,45,somatic diversification of immune receptors via germline recombination within a single locus,BP,ERCC1;STAT6;RAG1;TGFB1
5501,GO:0016444,0.730817189463437,0.456460728615542,4,45,somatic cell DNA recombination,BP,ERCC1;STAT6;RAG1;TGFB1
155,GO:0000314,0.731100699115184,0.532865556523804,2,28,organellar small ribosomal subunit,CC,MRPS6;MRPS26
2508,GO:0005763,0.731100699115184,0.532865556523804,2,28,mitochondrial small ribosomal subunit,CC,MRPS6;MRPS26
11339,GO:0045682,0.731127358199765,0.420631558558105,6,67,regulation of epidermis development,BP,CYP27B1;ZFP36L1;ERRFI1;ALOX15B;NAB2;MAFF
10555,GO:0043518,0.731184798292212,0.64220814788059,1,12,negative regulation of DNA damage response, signal transduction by p53 class mediator,BP,MIF
4749,GO:0010922,0.731403665873304,0.535283052311953,2,23,positive regulation of phosphatase activity,BP,SMAD3;ITGA1
10538,GO:0043492,0.731556151112342,0.408571511265051,7,77,ATPase activity, coupled to movement of substances,MF,ABCD1;ABCA2;ATP7B;ABCG1;ABCA7;ATP8B2;ATP6V1F
8474,GO:0033630,0.73155948727341,0.641731170065342,1,12,positive regulation of cell adhesion mediated by integrin,BP,RAC3
7460,GO:0031625,0.732025630838862,0.33955170858289,26,270,ubiquitin protein ligase binding,MF,BTBD2;ARRDC1;EGFR;SNX9;SMAD3;PRKACB;HLTF;CBS;MOAP1;TMEM173;MC1R;ABTB1;TRIB2;PRKACA;BOK;STUB1;CUL9;CHEK2;CDC34;WFS1;SLC22A18;CUL7;DLG3;NGFR;TOLLIP;PXN
3358,GO:0007098,0.732081570568757,0.384432700113685,10,108,centrosome cycle,BP,ARL2;FBXW5;BRSK1;CEP250;PKD2;CROCC;CEP131;SDCCAG8;CEP72;NDE1
14844,GO:0070603,0.73216627186901,0.419371506915622,6,67,SWI/SNF superfamily-type complex,CC,APPL2;SMARCA1;SALL2;SMARCD2;MBD3;INO80C
11788,GO:0046676,0.732177960147408,0.533627781142701,2,24,negative regulation of insulin secretion,BP,HADH;PFKL
8048,GO:0032717,0.732365383363596,0.640703452939899,1,12,negative regulation of interleukin-8 production,BP,MAPKBP1
4472,GO:0010470,0.732411359177598,0.533988456905533,2,23,regulation of gastrulation,BP,DUSP6;FGFR1
16789,GO:0098631,0.732415623795873,0.483965714819902,3,35,cell adhesion mediator activity,MF,PLXNB3;ITGA1;BCAM
13219,GO:0051893,0.73282024315885,0.453969964304346,4,45,regulation of focal adhesion assembly,BP,VEGFA;SMAD3;PPM1F;RHOD
16119,GO:0090109,0.73282024315885,0.453969964304346,4,45,regulation of cell-substrate junction assembly,BP,VEGFA;SMAD3;PPM1F;RHOD
426,GO:0001134,0.732933331309755,0.533316789899287,2,23,transcription factor activity, transcription factor recruiting,MF,NR1D1;PPARA
9849,GO:0042102,0.733232270265343,0.45298428322274,4,47,positive regulation of T cell proliferation,BP,CARD11;IGFBP2;JAK3;ZP3
10103,GO:0042626,0.733540346971868,0.41770246118599,6,67,ATPase activity, coupled to transmembrane movement of substances,MF,ABCD1;ABCA2;ATP7B;ABCG1;ABCA7;ATP6V1F
3745,GO:0008287,0.733662683897104,0.452920156465313,4,45,protein serine/threonine phosphatase complex,CC,PPP2R3B;PPP3CB;PPP2R5B;STRN4
18343,GO:1903293,0.733662683897104,0.452920156465313,4,45,phosphatase complex,CC,PPP2R3B;PPP3CB;PPP2R5B;STRN4
3797,GO:0008376,0.733675426752632,0.482741078898451,3,34,acetylgalactosaminyltransferase activity,MF,B4GALNT4;B3GNT3;CHPF
15427,GO:0071705,0.733763197241955,0.295211394044766,172,1710,nitrogen compound transport,BP,NR1D1;EDEM1;APLN;ACVR2B;PRNP;BBS2;SLC6A8;POSTN;APOE;F2R;LRP5;IDH2;ITPR3;ARRDC1;EVI5L;NISCH;EGFR;NOS1;TMEM129;SLC2A9;HADH;LTBP4;SYTL1;LMF1;LTBP2;VPS11;TBC1D14;ARL2;SLC7A8;SNX9;RAPGEF3;ZFP36L1;GLUL;PLTP;POU2F2;EXOC2;PIK3R2;LRP1;AP2A2;NLGN2;STOM;SLC6A6;AKT1;PITPNM1;RHBDF2;STK39;HK1;SLC15A4;ATG16L2;RAB31;MAPKBP1;RAC2;PFKL;TOMM34;SORL1;B3GAT3;ANK3;STRADB;GAS6;RAB3B;CARD11;BCR;XPOT;AIP;ALOX15B;AGAP1;PEX10;CORO7;UNC119B;MVB12B;SERINC2;CEMIP;AP3D1;ADAM8;KIF17;SLC29A4;TMED4;TGFB1;CLTCL1;SLC43A1;TBC1D9B;SLC38A10;NTSR1;TMEM173;MIPEP;RHOD;SNX17;VGF;SNX33;SLC48A1;LLGL1;BBS1;PTPN1;PEX1;PCK2;CD320;ZDHHC24;CEP131;PFKFB2;PRKCZ;TOM1L2;ADA;MICALL2;NEURL1B;ERBB2;VAMP2;NECAB3;RILPL1;BNIP3L;ARHGAP44;MCFD2;PRKCD;SV2A;OLFM2;TIMM17B;RASL10B;ZDHHC8;GDI1;WASH3P;LRSAM1;REEP2;EHD3;LONP2;SYMPK;COG7;ABCG1;RAB12;BCAP31;MIF;SLC25A29;DOPEY2;PLA2G6;SYNGR1;NBPF3;FYN;TMCO6;DNM2;SNX15;ZDHHC1;MAPK3;RTN2;PFKM;RERE;STX10;PRAF2;PAK1;PPP3CB;VPS16;SGSM2;TBC1D16;PKD1;RABGAP1;AZIN2;RAB28;ICA1;RAB40B;NGFR;PDCD6;ATP6V1F;PCLO;TBC1D8;PLEKHM1;KIF13B;CAMK1;SIRT3;HFE;VPS51;SLC35F3;TST;SLC23A2;APBA1;SRSF5
7258,GO:0031233,0.734150482022469,0.638418155643417,1,12,intrinsic component of external side of plasma membrane,CC,PRNP
8253,GO:0033043,0.734339741605456,0.302101467520775,103,1017,regulation of organelle organization,BP,ERCC1;ZMYND8;VEGFA;ESPN;LRP5;EVI5L;OBSL1;NOS1;VAT1;CAPN2;SDC1;VPS11;TBC1D14;ARL2;RAPGEF3;ARAP1;MAP2K2;MAP2K1;SSH1;SMAD3;LRP1;SH3PXD2B;FBXW5;AKT1;TMOD2;CORO1B;PPM1F;EPHA1;IFT140;RAC2;TWF2;CEP250;GSN;PLEKHG2;WIPF1;ARPIN;SPTB;BNIP3;FYCO1;CDC42EP5;CTBP1;TGFB1;MOAP1;TBC1D9B;FHOD3;SHANK3;EML2;CROCC;RHOD;RHOF;RHOBTB2;CEP131;TOM1L2;MICALL2;BOK;CAPG;ULK1;TFDP2;C6ORF89;BNIP3L;FSCN1;ARHGAP44;PRKCD;BAX;SH3BP1;EREG;RPS6KA5;CUL9;ZDHHC8;LIMK1;WASH3P;LRSAM1;EHD3;TGFA;FHOD1;MTHFR;PLA2G6;NBPF3;RAC3;DNM2;INF2;MAPK3;INSR;VANGL2;PAK1;CAMKK2;CUL7;VPS16;BCL2L1;SGSM2;PROX1;TBC1D16;LMNA;PKD1;RABGAP1;SIRT2;GPR3;PXN;TBC1D8;CELSR1;PFN2;SSH3;KDM3A
16503,GO:0097202,0.734408112214792,0.638087324080091,1,12,activation of cysteine-type endopeptidase activity,BP,CYFIP2
5329,GO:0016055,0.73457299626775,0.324357855205189,38,390,Wnt signaling pathway,BP,EGR1;CTNNBIP1;WNT7A;APOE;LRP5;WWTR1;NFATC4;SDC1;MDFI;SMURF2;SMAD3;LRP1;DVL1;AP2A2;PTPRU;WNT2B;NPHP4;LZTS2;IGFBP4;CCND1;CSNK1E;IGFBP2;GRK6;WNT3;LRP4;FBXW4;SOX7;PLCB3;VANGL2;PPP3CB;CAPRIN2;ITGA3;EDA;GRB10;CELSR1;CCDC88C;NDRG2;LRRK1
17806,GO:1901888,0.735178642445161,0.415843495810636,6,66,regulation of cell junction assembly,BP,VEGFA;SMAD3;PPM1F;NPHP4;RHOD;PRKACA
7276,GO:0031268,0.735307843616433,0.636929939647691,1,12,pseudopodium organization,BP,CDC42EP5
10528,GO:0043476,0.73559496867102,0.636559932751633,1,12,pigment accumulation,BP,AP3D1
10529,GO:0043482,0.73559496867102,0.636559932751633,1,12,cellular pigment accumulation,BP,AP3D1
650,GO:0001841,0.735664371405839,0.394376368886022,8,87,neural tube formation,BP,DVL1;PRKACB;TGFB1;DEAF1;VANGL2;SEMA4C;TCTN1;CELSR1
13000,GO:0051438,0.735818470782966,0.449534564621536,4,48,regulation of ubiquitin-protein transferase activity,BP,ZER1;STUB1;LIMK1;ZYG11B
4387,GO:0010042,0.735945165213648,0.636108215687177,1,12,response to manganese ion,BP,D2HGDH
8885,GO:0034707,0.736541211520788,0.635338283525855,1,12,chloride channel complex,CC,TTYH3
6014,GO:0019068,0.736558008090558,0.478358358385573,3,36,virion assembly,BP,APOE;PC;LRSAM1
6297,GO:0019915,0.736631430941226,0.448968206540048,4,46,lipid storage,BP,APOE;HEXB;PPARA;ABCG1
12334,GO:0048706,0.737130066263736,0.401854493537174,7,77,embryonic skeletal system development,BP,MDFI;SMAD3;IFT140;DEAF1;WDR60;HYAL1;SLC39A3
6632,GO:0023023,0.737200048894245,0.634485634167165,1,12,MHC protein complex binding,MF,CD81
2374,GO:0005504,0.737798185184546,0.630714838701949,1,14,fatty acid binding,MF,PPARA
2737,GO:0006122,0.738108815184509,0.631688896314965,1,13,mitochondrial electron transport, ubiquinol to cytochrome c,BP,CYC1
16135,GO:0090141,0.738611895285892,0.632652754348235,1,12,positive regulation of mitochondrial fission,BP,BNIP3
13907,GO:0060575,0.738648498146272,0.63260513218296,1,12,intestinal epithelial cell differentiation,BP,PTK6
2515,GO:0005770,0.739083827949603,0.346119692321562,18,191,late endosome,CC,CST3;F2R;EGFR;VPS11;MAP2K2;MAP2K1;DYSF;LDLR;PCSK9;MVB12B;FYCO1;TMEM9;CLTCL1;ATP7B;MAPK3;VPS16;ANKRD13D;NMNAT2
18593,GO:1903828,0.739327062982383,0.399089360889573,7,78,negative regulation of cellular protein localization,BP,LZTS2;GAS6;TGFB1;ABHD17C;SNX33;GDI1;BCL2L1
10172,GO:0042769,0.739357874673759,0.474452979950465,3,37,DNA damage response, detection of DNA damage,BP,HMGA2;POLD4;MRPS26
11482,GO:0045956,0.739482989792482,0.631517988913221,1,12,positive regulation of calcium ion-dependent exocytosis,BP,ZP3
10665,GO:0043902,0.7397333609382,0.360676140405149,13,143,positive regulation of multi-organism process,BP,APOE;PC;SMURF2;STOM;ADARB1;RAD23A;MVB12B;NELFCD;LRSAM1;MIF;MAPK3;SIRT2;ZP3
10548,GO:0043508,0.73977510082649,0.631136790672617,1,12,negative regulation of JUN kinase activity,BP,PDCD4
16386,GO:0095500,0.739833266642936,0.631060845464076,1,12,acetylcholine receptor signaling pathway,BP,AGRN
18596,GO:1903831,0.739833266642936,0.631060845464076,1,12,signal transduction involved in cellular response to ammonium ion,BP,AGRN
19155,GO:1905144,0.739833266642936,0.631060845464076,1,12,response to acetylcholine,BP,AGRN
19156,GO:1905145,0.739833266642936,0.631060845464076,1,12,cellular response to acetylcholine,BP,AGRN
11371,GO:0045747,0.739924555049265,0.474406017988047,3,35,positive regulation of Notch signaling pathway,BP,RFNG;EPN2;MFNG
11151,GO:0045216,0.740029840837927,0.347665830628809,17,177,cell-cell junction organization,BP,SDK2;VEGFA;F2R;ARL2;SMAD3;NLGN2;PPM1F;NPHP4;LAMA5;TGFB1;RHOD;PRKACA;CD9;MICALL2;FSCN1;HDAC7;CDH4
15207,GO:0071360,0.740145285898297,0.630653224324374,1,12,cellular response to exogenous dsRNA,BP,TMEM173
12083,GO:0048070,0.740316731862575,0.630429084176985,1,12,regulation of developmental pigmentation,BP,BAX
9539,GO:0036296,0.740328699116768,0.5230545381133,2,24,response to increased oxygen levels,BP,BNIP3;CAT
3534,GO:0007530,0.740509203176408,0.630177318137593,1,12,sex determination,BP,INSR
8462,GO:0033612,0.740663647601124,0.629975188029834,1,12,receptor serine/threonine kinase binding,MF,TGFB1
3463,GO:0007286,0.740667115125179,0.408869567723645,6,68,spermatid development,BP,BBS2;RFX2;DNAH1;PRKACA;SIX5;KDM3A
7196,GO:0031092,0.740879635412015,0.629692354340694,1,12,platelet alpha granule membrane,CC,CD9
19974,GO:2000514,0.741095671996025,0.522050167645848,2,24,regulation of CD4-positive, alpha-beta T cell activation,BP,PRKCZ;JAK3
7498,GO:0031683,0.74125089115185,0.629205767209112,1,12,G-protein beta/gamma-subunit complex binding,MF,GNAL
7211,GO:0031112,0.741350674437376,0.521715871787246,2,24,positive regulation of microtubule polymerization or depolymerization,BP,ARL2;PAK1
12244,GO:0048535,0.74191675275456,0.628331684214458,1,12,lymph node development,BP,TGFB1
10300,GO:0043073,0.741917749249987,0.628330374784265,1,12,germ cell nucleus,CC,TCFL5
11501,GO:0046006,0.742465054398034,0.519642179232078,2,25,regulation of activated T cell proliferation,BP,PRNP;IGFBP2
10325,GO:0043124,0.742465452162921,0.471142738803891,3,35,negative regulation of I-kappaB kinase/NF-kappaB signaling,BP,TNIP1;MAPKBP1;CARD19
11343,GO:0045686,0.742890455475552,0.627050319019976,1,12,negative regulation of glial cell differentiation,BP,LDLR
4781,GO:0010970,0.742902896223474,0.361242333889282,12,131,transport along microtubule,BP,IFT140;FYCO1;AP3D1;KIF17;CEP131;PRKCZ;WDR60;SUN1;NDE1;BLOC1S4;TRIM46;APBA1
17011,GO:0099111,0.742902896223474,0.361242333889282,12,131,microtubule-based transport,BP,IFT140;FYCO1;AP3D1;KIF17;CEP131;PRKCZ;WDR60;SUN1;NDE1;BLOC1S4;TRIM46;APBA1
15745,GO:0072337,0.743005895196221,0.626898152857757,1,12,modified amino acid transport,BP,SLC6A8
3276,GO:0006958,0.743028377976164,0.626868511125135,1,12,complement activation, classical pathway,BP,SERPING1
1148,GO:0002755,0.743078817445847,0.519445561659491,2,24,MyD88-dependent toll-like receptor signaling pathway,BP,TNIP1;IRAK1
4388,GO:0010043,0.74309542253195,0.518251226018506,2,26,response to zinc ion,BP,D2HGDH;MT2A
1,GO:0000002,0.743350772617016,0.519087522899204,2,24,mitochondrial genome maintenance,BP,PRIMPOL;SESN2
4679,GO:0010829,0.74343884235467,0.626326991672311,1,12,negative regulation of glucose transmembrane transport,BP,GRB10
7929,GO:0032515,0.743488595862444,0.469474647920297,3,36,negative regulation of phosphoprotein phosphatase activity,BP,PPP1R35;PPP1R14A;ELFN2
3579,GO:0007628,0.743962916824966,0.625634607738726,1,12,adult walking behavior,BP,EFNB3
17778,GO:1901797,0.744198453605416,0.517358628878494,2,25,negative regulation of signal transduction by p53 class mediator,BP,ZNF385A;MIF
14546,GO:0070071,0.744203833171143,0.625315950213312,1,12,proton-transporting two-sector ATPase complex assembly,BP,OXA1L
1389,GO:0003298,0.744381861697832,0.625080324003038,1,12,physiological muscle hypertrophy,BP,PAK1
1392,GO:0003301,0.744381861697832,0.625080324003038,1,12,physiological cardiac muscle hypertrophy,BP,PAK1
14156,GO:0061049,0.744381861697832,0.625080324003038,1,12,cell growth involved in cardiac muscle cell development,BP,PAK1
14099,GO:0060965,0.744483613899064,0.624945594645551,1,12,negative regulation of gene silencing by miRNA,BP,TGFB1
8308,GO:0033151,0.744560548506962,0.624843698451276,1,12,V(D)J recombination,BP,RAG1
15641,GO:0072148,0.744564199872891,0.624838861800743,1,12,epithelial cell fate commitment,BP,PROX1
11163,GO:0045239,0.744777928927943,0.624555659829305,1,12,tricarboxylic acid cycle enzyme complex,CC,DHTKD1
11000,GO:0044827,0.744836506474253,0.624478009471159,1,12,modulation by host of viral genome replication,BP,STOM
12925,GO:0051291,0.744951356817939,0.382214293506288,8,100,protein heterooligomerization,BP,ITPR3;HSD17B8;CBR4;LRP4;PRKCZ;INSR;GCH1;COL6A1
15322,GO:0071545,0.744967766847695,0.624303960635416,1,12,inositol phosphate catabolic process,BP,NTSR1
2494,GO:0005744,0.74511658066763,0.622465190965819,1,13,mitochondrial inner membrane presequence translocase complex,CC,TIMM17B
7865,GO:0032433,0.745125528926522,0.624094679170347,1,12,filopodium tip,CC,MORN4
4272,GO:0009635,0.745496102622459,0.623602694720982,1,12,response to herbicide,BP,MAPK13
3767,GO:0008320,0.745566343471275,0.620466053189491,1,14,protein transmembrane transporter activity,MF,TIMM17B
21,GO:0000038,0.745596931056362,0.516122394079191,2,24,very long-chain fatty acid metabolic process,BP,ACOT1;ABCD1
19958,GO:2000479,0.745905774573052,0.623058156885431,1,12,regulation of cAMP-dependent protein kinase activity,BP,SESN2
17335,GO:0198738,0.746034930790768,0.311683223679761,38,392,cell-cell signaling by wnt,BP,EGR1;CTNNBIP1;WNT7A;APOE;LRP5;WWTR1;NFATC4;SDC1;MDFI;SMURF2;SMAD3;LRP1;DVL1;AP2A2;PTPRU;WNT2B;NPHP4;LZTS2;IGFBP4;CCND1;CSNK1E;IGFBP2;GRK6;WNT3;LRP4;FBXW4;SOX7;PLCB3;VANGL2;PPP3CB;CAPRIN2;ITGA3;EDA;GRB10;CELSR1;CCDC88C;NDRG2;LRRK1
13199,GO:0051851,0.746060104408382,0.436842099993169,4,47,modification by host of symbiont morphology or physiology,BP,APOE;HMGA2;PC;STOM
5610,GO:0016653,0.746066210156833,0.622844720246669,1,12,oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor,MF,NOS1
4580,GO:0010667,0.746208156097526,0.622655794571243,1,12,negative regulation of cardiac muscle cell apoptotic process,BP,RGL2
13100,GO:0051645,0.746661391171377,0.62205200610245,1,12,Golgi localization,BP,STK25
15498,GO:0071875,0.746692485376269,0.622010552641516,1,12,adrenergic receptor signaling pathway,BP,NOS1
10553,GO:0043516,0.74674775460201,0.513984822441457,2,25,regulation of DNA damage response, signal transduction by p53 class mediator,BP,ZNF385A;MIF
11309,GO:0045639,0.746891048743299,0.415963348830267,5,57,positive regulation of myeloid cell differentiation,BP,CTNNBIP1;FAM210B;ZFP36L1;FOS;INPP5D
13096,GO:0051640,0.746999959614896,0.302360718768664,52,526,organelle localization,BP,BBS2;SPRY2;SYTL1;VPS11;EXOC2;MARK4;NLGN2;ADORA2B;SYT8;RAC2;NPHP4;TRAPPC9;CEP250;CSNK1E;RAB3B;FYCO1;CTSZ;AP3D1;SNPH;CROCC;LLGL1;RIMS3;PEX1;ESYT2;CEP131;PRKCZ;PRKACA;AREG;SDCCAG8;NINL;VAMP2;MCFD2;LEMD2;DNM1;TGFA;FHOD1;STK25;SUN1;DNM2;STX10;CEP72;BIN1;ITGA4;NDE1;RAB40B;PDCD6;PCLO;PLEKHM1;TCTN1;PFN2;BLOC1S4;TRIM46
8956,GO:0035025,0.747040018605789,0.621546969051105,1,12,positive regulation of Rho protein signal transduction,BP,F2R
2826,GO:0006296,0.747246842321565,0.464281753808321,3,37,nucleotide-excision repair, DNA incision, 5'-to lesion,BP,ERCC1;DDB2;POLD4
41,GO:0000083,0.747323886031381,0.513832929388026,2,24,regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,TFDP2;BACH1
1912,GO:0004602,0.747440856034059,0.61674432998219,1,15,glutathione peroxidase activity,MF,GPX3
14282,GO:0061383,0.747597359491677,0.464507240013261,3,35,trabecula morphogenesis,BP,THBS3;TGFBR3;CHAD
19975,GO:2000515,0.748273111983787,0.619898147589367,1,12,negative regulation of CD4-positive, alpha-beta T cell activation,BP,JAK3
12546,GO:0050704,0.748328313120725,0.511883800277752,2,25,regulation of interleukin-1 secretion,BP,HK1;GAS6
7552,GO:0031901,0.74835491100563,0.365078242737462,10,109,early endosome membrane,CC,EGFR;APPL2;RAB31;EHD4;PI4K2A;LLGL1;BOK;WASH3P;ABCA7;HLA-G
12672,GO:0050892,0.749010880804883,0.618908676870747,1,12,intestinal absorption,BP,LDLR
1111,GO:0002699,0.749136632940744,0.370328495966072,9,101,positive regulation of immune effector process,BP,STAT6;ADORA2B;HK1;RAC2;TGFB1;PRKCZ;MIF;MAPK3;ZP3
12526,GO:0050680,0.749200140800567,0.377970061292855,8,88,negative regulation of epithelial cell proliferation,BP,XDH;APOE;CEACAM1;CDKN1C;TGFB1;EREG;TGFBR3;NGFR
7010,GO:0030728,0.749489690676656,0.618265319667786,1,12,ovulation,BP,EREG
9285,GO:0035728,0.749550357140654,0.618183737444386,1,12,response to hepatocyte growth factor,BP,SIRT2
15589,GO:0072074,0.74962031852269,0.618089636956925,1,12,kidney mesenchyme development,BP,PKD2
6930,GO:0030544,0.74984580974395,0.461230406946332,3,36,Hsp70 protein binding,MF,MVD;STUB1;BAX
12618,GO:0050812,0.749911195268475,0.617698181851213,1,12,regulation of acyl-CoA biosynthetic process,BP,PDK1
720,GO:0001947,0.750004187080326,0.461374465206372,3,35,heart looping,BP,SMAD3;PKD2;VANGL2
3633,GO:0008106,0.750087389516374,0.615803074174784,1,13,alcohol dehydrogenase (NADP+) activity,MF,AKR7A2
10859,GO:0044389,0.750108018069939,0.317873310192295,27,283,ubiquitin-like protein ligase binding,MF,BTBD2;ARRDC1;EGFR;SNX9;SMAD3;PRKACB;HLTF;CBS;CEBPB;MOAP1;TMEM173;MC1R;ABTB1;TRIB2;PRKACA;BOK;STUB1;CUL9;CHEK2;CDC34;WFS1;SLC22A18;CUL7;DLG3;NGFR;TOLLIP;PXN
3481,GO:0007350,0.75030281906132,0.617170593671922,1,12,blastoderm segmentation,BP,SEMA3F
13282,GO:0051988,0.750389552899869,0.617053662003685,1,12,regulation of attachment of spindle microtubules to kinetochore,BP,SIRT2
787,GO:0002052,0.750517902182166,0.616880568855651,1,12,positive regulation of neuroblast proliferation,BP,VEGFA
9989,GO:0042405,0.750580977111115,0.61679548045765,1,12,nuclear inclusion body,CC,STUB1
7098,GO:0030901,0.750582164182517,0.411163160165439,5,58,midbrain development,BP,FGFR1;CSNK1E;WNT3;SIRT2;NDRG2
10306,GO:0043090,0.750651390644715,0.616700472844796,1,12,amino acid import,BP,NTSR1
13938,GO:0060628,0.75105854414268,0.616150706969472,1,12,regulation of ER to Golgi vesicle-mediated transport,BP,SORL1
1351,GO:0003215,0.751082190457152,0.616118757079649,1,12,cardiac right ventricle morphogenesis,BP,PPP1R13L
8823,GO:0034616,0.751278386460877,0.615853576199891,1,12,response to laminar fluid shear stress,BP,TGFB1
5988,GO:0018958,0.751363974929505,0.430074823622635,4,47,phenol-containing compound metabolic process,BP,EPAS1;TRPC1;DDT;GCH1
13476,GO:0055024,0.75140224075519,0.43025664982707,4,46,regulation of cardiac muscle tissue development,BP,FGFR1;TGFB1;TGFBR3;PAK1
4237,GO:0009437,0.75149035019199,0.615566904386507,1,12,carnitine metabolic process,BP,CRAT
17072,GO:0099563,0.751702865273103,0.615279300000025,1,12,modification of synaptic structure,BP,ARHGAP44
5835,GO:0017119,0.751707330760122,0.615273254683695,1,12,Golgi transport complex,CC,COG7
4182,GO:0009261,0.751797339804753,0.50724733915604,2,25,ribonucleotide catabolic process,BP,NT5E;RAPGEF3
12157,GO:0048286,0.751878586502005,0.507753658891461,2,24,lung alveolus development,BP,ERRFI1;ADA
7403,GO:0031492,0.752267303189828,0.456330651586101,3,42,nucleosomal DNA binding,MF,HMGA2;SMARCD2;MBD3
7798,GO:0032354,0.752282038761706,0.614494532065916,1,12,response to follicle-stimulating hormone,BP,TGFBR3
2355,GO:0005452,0.752396544511337,0.614339214150631,1,12,inorganic anion exchanger activity,MF,SLC22A17
7007,GO:0030705,0.752421165415012,0.342176003292263,14,152,cytoskeleton-dependent intracellular transport,BP,IFT140;FYCO1;AP3D1;KIF17;CEP131;PRKCZ;WDR60;SUN1;NDE1;KIF13B;CCDC88C;BLOC1S4;TRIM46;APBA1
9047,GO:0035270,0.752462161848582,0.394294433862876,6,68,endocrine system development,BP,MAP2K1;SMAD3;AKT1;ARID5B;MAPK3;INSR
2408,GO:0005581,0.752707446646651,0.457839849414901,3,35,collagen trimer,CC,COL13A1;EDA;COL6A1
16132,GO:0090136,0.752721429646592,0.613898236356718,1,12,epithelial cell-cell adhesion,BP,ITGB5
7212,GO:0031113,0.75273187342853,0.457456964074269,3,36,regulation of microtubule polymerization,BP,ARL2;EML2;PAK1
1870,GO:0004535,0.75275069428688,0.61385849286932,1,12,poly(A)-specific ribonuclease activity,MF,PAN2
5600,GO:0016638,0.752770344215165,0.613831804853047,1,12,oxidoreductase activity, acting on the CH-NH2 group of donors,MF,LOXL1
6938,GO:0030552,0.752953080349491,0.613583540356655,1,12,cAMP binding,MF,RAPGEF3
2399,GO:0005545,0.753078886423282,0.613412539853608,1,12,1-phosphatidylinositol binding,MF,SNX9
4150,GO:0009214,0.753102822442306,0.613379997612339,1,12,cyclic nucleotide catabolic process,BP,RAPGEF3
10964,GO:0044743,0.753775293580659,0.455444821066573,3,38,protein transmembrane import into intracellular organelle,BP,PEX10;PEX1;TIMM17B
16227,GO:0090278,0.753929345772442,0.504380574812595,2,25,negative regulation of peptide hormone secretion,BP,HADH;PFKL
16113,GO:0090100,0.754177927117049,0.39215598158343,6,68,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,ACVR2B;SMAD3;CDKN1C;TGFB1;TGFBR3;HFE
18627,GO:1903900,0.754411339717046,0.357582638475195,10,113,regulation of viral life cycle,BP,TNIP1;HMGA2;PC;STOM;ADARB1;GSN;RAD23A;APOBEC3C;APOBEC3F;PROX1
11242,GO:0045471,0.754509105225289,0.391495384995956,6,70,response to ethanol,BP,CCND1;GSN;FYN;CAT;DNMT3A;ADCY7
18719,GO:1904115,0.754657231294731,0.454597958003571,3,37,axon cytoplasm,CC,AP3D1;BLOC1S4;TRIM46
18484,GO:1903573,0.755067301479853,0.454389240706281,3,36,negative regulation of response to endoplasmic reticulum stress,BP,PTPN1;WFS1;GRINA
199,GO:0000421,0.755529356327184,0.502220434256585,2,25,autophagosome membrane,CC,ATG16L2;ULK1
2318,GO:0005326,0.755987994426077,0.502217056332228,2,24,neurotransmitter transporter activity,MF,SLC6A8;SLC6A6
8303,GO:0033145,0.756295484296467,0.607339782645034,1,13,positive regulation of intracellular steroid hormone receptor signaling pathway,BP,PAK1
17544,GO:1901032,0.756967734139796,0.606413637554509,1,13,negative regulation of response to reactive oxygen species,BP,TRAP1
18310,GO:1903206,0.756967734139796,0.606413637554509,1,13,negative regulation of hydrogen peroxide-induced cell death,BP,TRAP1
20210,GO:2001039,0.756967734139796,0.606413637554509,1,13,negative regulation of cellular response to drug,BP,TRAP1
5726,GO:0016866,0.757078923177985,0.500121226844648,2,25,intramolecular transferase activity,MF,PGM1;RPUSD3
12270,GO:0048592,0.757706671567935,0.367504247625606,8,89,eye morphogenesis,BP,SDK2;VEGFA;NAGLU;LRP5;WNT2B;EPHB2;BAX;PROX1
7332,GO:0031349,0.75797521741164,0.307679821453258,28,299,positive regulation of defense response,BP,TNIP1;NR1D1;PDCD4;EGFR;PTPRS;ADORA2B;F12;LDLR;PRKACB;MAPK13;CTSB;CARD11;MAPKAPK3;ADAM8;TGFB1;TMEM173;PRKACA;PRKCD;EREG;RPS6KA5;LRSAM1;IRAK1;DDT;FYN;PELI1;MAPK3;PAK1;ZP3
15989,GO:0086002,0.7581279242883,0.499314257647176,2,24,cardiac muscle cell action potential involved in contraction,BP,SCN4B;SNTA1
4808,GO:0012510,0.758202158067935,0.604708007177186,1,13,trans-Golgi network transport vesicle membrane,CC,CLTCL1
6683,GO:0030057,0.758214698739354,0.499196262240165,2,24,desmosome,CC,PPL;KLHL24
5509,GO:0016460,0.758747957283246,0.603951797305731,1,13,myosin II complex,CC,OBSL1
7416,GO:0031519,0.759236151347372,0.419927443367195,4,47,PcG protein complex,CC,PHC2;CBX7;CBX6;EZH1
3321,GO:0007032,0.759815655271232,0.384970794117902,6,69,endosome organization,BP,VPS11;SNX33;PI4K2A;DNM1;WASH3P;PI4K2B
14385,GO:0061640,0.759998405834367,0.384741091036782,6,69,cytoskeleton-dependent cytokinesis,BP,SNX9;ANK3;SEPT10;SNX33;CUL7;SEPT6
15743,GO:0072332,0.76019904168588,0.384135533402988,6,72,intrinsic apoptotic signaling pathway by p53 class mediator,BP,ZNF385A;BOK;BAX;DDIT4;CHEK2;MIF
4573,GO:0010660,0.760869993780001,0.446711281212122,3,36,regulation of muscle cell apoptotic process,BP,PDCD4;RGL2;BNIP3
8997,GO:0035136,0.761446973220338,0.494165466481623,2,25,forelimb morphogenesis,BP,WNT7A;WNT3
16837,GO:0098742,0.7614554672868,0.349258899056247,10,110,cell-cell adhesion via plasma-membrane adhesion molecules,BP,SDK2;ADGRL1;CEACAM1;TENM2;PLXNB3;CADM4;PKD1;CDH4;ARVCF;CELSR1
5707,GO:0016836,0.76146086284603,0.445593701600585,3,37,hydro-lyase activity,MF,UROS;CBS;ACO2
4365,GO:0009982,0.761947959965039,0.599492471653054,1,13,pseudouridine synthase activity,MF,RPUSD3
12834,GO:0051153,0.761950995042376,0.396737869041,5,58,regulation of striated muscle cell differentiation,BP,HDAC5;TGFB1;PAK1;PROX1;FAM129B
11903,GO:0046949,0.762275453118588,0.49302940795506,2,25,fatty-acyl-CoA biosynthetic process,BP,HSD17B8;CBR4
5625,GO:0016701,0.76251162370931,0.598702408138935,1,13,oxidoreductase activity, acting on single donors with incorporation of molecular oxygen,MF,ALOX15B
5626,GO:0016702,0.76251162370931,0.598702408138935,1,13,oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen,MF,ALOX15B
13037,GO:0051536,0.762558277371251,0.395500550940298,5,61,iron-sulfur cluster binding,MF,XDH;RSAD1;NUBP2;ACO2;NARF
13041,GO:0051540,0.762558277371251,0.395500550940298,5,61,metal cluster binding,MF,XDH;RSAD1;NUBP2;ACO2;NARF
11292,GO:0045620,0.76275274752222,0.49237397565741,2,25,negative regulation of lymphocyte differentiation,BP,ERBB2;JAK3
16390,GO:0097009,0.762962438469029,0.598069527340593,1,13,energy homeostasis,BP,CRTC1
3255,GO:0006925,0.763142857468174,0.597815996629194,1,13,inflammatory cell apoptotic process,BP,ITPKB
19976,GO:2000516,0.763193071404484,0.597745409137759,1,13,positive regulation of CD4-positive, alpha-beta T cell activation,BP,PRKCZ
7400,GO:0031489,0.763669488316546,0.59707514636075,1,13,myosin V binding,MF,RAB3B
1254,GO:0003007,0.764711750953226,0.327751017726486,14,150,heart morphogenesis,BP,PDCD4;VEGFA;GAA;SMAD3;PKD2;TGFB1;PPP1R13L;TGFBR3;LEMD2;ADAM15;ZFPM1;INSR;VANGL2;PROX1
8130,GO:0032838,0.764741589650365,0.33982567386367,11,123,plasma membrane bounded cell projection cytoplasm,CC,DLG4;IFT140;AP3D1;KIF17;DNAH1;BBS1;PRKACA;ADA;BLOC1S4;TRIM46;TTLL3
20072,GO:2000678,0.764833261189605,0.593980339394784,1,14,negative regulation of transcription regulatory region DNA binding,BP,PPARA
4419,GO:0010225,0.764847312472719,0.5954138280872,1,13,response to UV-C,BP,IMPACT
19522,GO:1990391,0.764969532695013,0.441238236960997,3,36,DNA repair complex,CC,ERCC1;XPC;PHF21A
8604,GO:0034123,0.76503676117244,0.595146043510008,1,13,positive regulation of toll-like receptor signaling pathway,BP,PELI1
3480,GO:0007346,0.7655909638957,0.280187230145725,56,576,regulation of mitotic cell cycle,BP,FHL1;XPC;LRP5;HMGA2;EGFR;OBSL1;ZFP36L1;MAP2K2;MAP2K1;SMAD3;GJC2;FBXW5;AKT1;STK39;BRSK1;FGFR1;ZNF385A;CCND1;PCBP4;STRADB;CEP250;CSNK1E;CDC25B;PAK6;PKD2;CDKN1C;TIMP2;TGFB1;CEP131;PRKACA;MINK1;TOM1L2;PIM2;SDCCAG8;NINL;TFDP2;RBL2;BAX;EREG;CUL9;TMEM8B;TGFA;CHEK2;STK25;INSR;CEP72;PAK1;CUL7;HYAL1;MAP2K3;BCL2L1;PKD1;SIRT2;NDE1;BTG1;CDK11B
7885,GO:0032460,0.765802065069136,0.59406268473389,1,13,negative regulation of protein oligomerization,BP,SORL1
7501,GO:0031690,0.766057145971768,0.593701020727519,1,13,adrenergic receptor binding,MF,DLG4
8032,GO:0032688,0.766248961277707,0.593428868080266,1,13,negative regulation of interferon-beta production,BP,PTPRS
2533,GO:0005791,0.766303225912422,0.390551785176589,5,62,rough endoplasmic reticulum,CC,GLUL;F12;SYNE3;PCSK9;BCAP31
15988,GO:0086001,0.766409742231678,0.439305808269793,3,36,cardiac muscle cell action potential,BP,SCN4B;ANK3;SNTA1
10717,GO:0044058,0.766482391188761,0.593097452245278,1,13,regulation of digestive system process,BP,STK39
5747,GO:0016894,0.766562957334496,0.486545781268249,2,26,endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters,MF,NEIL1;RNASET2
15195,GO:0071347,0.766673072988942,0.337303071283594,11,127,cellular response to interleukin-1,BP,EGR1;MAPK13;CEBPB;ADAMTS7;RPS6KA5;IRAK1;PELI1;MAPK3;HYAL1;PELI3;TOLLIP
448,GO:0001222,0.766824345131875,0.592611522553964,1,13,transcription corepressor binding,MF,NR1D1
4368,GO:0009988,0.766857657258036,0.486137227510287,2,26,cell-cell recognition,BP,ST6GALNAC6;ZP3
12074,GO:0048038,0.767210492378201,0.590602509682048,1,14,quinone binding,MF,CBR4
17043,GO:0099516,0.767266746316458,0.438153496118555,3,36,ion antiporter activity,MF,SLC9A7;SLC37A2;SLC26A11
3439,GO:0007252,0.767790370057579,0.591235962928167,1,13,I-kappaB phosphorylation,BP,AKT1
5475,GO:0016408,0.767987991104005,0.59095405183055,1,13,C-acyltransferase activity,MF,SPTLC2
9832,GO:0042073,0.768259829007349,0.407709874050665,4,49,intraciliary transport,BP,IFT140;KIF17;CEP131;WDR60
2543,GO:0005813,0.76832575241773,0.283551054620155,43,441,centrosome,CC,NDRG1;NEK9;OBSL1;ARL2;MARK4;BRSK1;IFT140;PRKACB;NPHP4;RAB11FIP4;CEP250;MPLKIP;CCDC113;CDC25B;PROCR;CROCC;TUBG2;BBS1;CEP131;PRKACA;ACTR1B;SDCCAG8;ADGRB2;MZT2A;RILPL1;USP20;CCDC92;NUBP2;MZT2B;RGS14;WDR60;SPPL2B;DNM2;CEP72;CUL7;CAPRIN2;BCL2L1;RABGAP1;SIRT2;RAP1GAP2;NDE1;MSS51;CCDC88C
5168,GO:0015721,0.768329238674678,0.590466844541161,1,13,bile acid and bile salt transport,BP,CEACAM1
13032,GO:0051497,0.768762870698365,0.589846988278866,1,13,negative regulation of stress fiber assembly,BP,ARAP1
15145,GO:0071260,0.769181500095989,0.387283420733833,5,59,cellular response to mechanical stimulus,BP,EGFR;AKT1;BNIP3;TGFB1;MAPK3
7564,GO:0031932,0.769286538505218,0.589097309716607,1,13,TORC2 complex,CC,SESN2
4555,GO:0010638,0.76931217912509,0.278709423616802,50,513,positive regulation of organelle organization,BP,ERCC1;VEGFA;LRP5;NOS1;SDC1;VPS11;ARL2;RAPGEF3;SMAD3;SH3PXD2B;CORO1B;PPM1F;EPHA1;RAC2;GSN;WIPF1;ARPIN;BNIP3;FYCO1;CDC42EP5;CTBP1;TGFB1;MOAP1;CROCC;MICALL2;BOK;ULK1;TFDP2;C6ORF89;FSCN1;BAX;EREG;RPS6KA5;ZDHHC8;LIMK1;WASH3P;LRSAM1;TGFA;FHOD1;PLA2G6;NBPF3;RAC3;MAPK3;INSR;PAK1;CAMKK2;PROX1;SIRT2;PXN;PFN2
4329,GO:0009880,0.769494213263445,0.435150024852433,3,36,embryonic pattern specification,BP,WNT7A;SMAD3;SEMA3F
4702,GO:0010866,0.769711687423346,0.58848776646022,1,13,regulation of triglyceride biosynthetic process,BP,LDLR
4445,GO:0010369,0.769722032647129,0.588472924229807,1,13,chromocenter,CC,SCMH1
6144,GO:0019432,0.769894157752543,0.482484312093712,2,25,triglyceride biosynthetic process,BP,LDLR;PCK2
15373,GO:0071622,0.769938652550532,0.481322298819322,2,27,regulation of granulocyte chemotaxis,BP,RAC2;MAPK3
8072,GO:0032760,0.770129247655313,0.433647037628746,3,38,positive regulation of tumor necrosis factor production,BP,NFATC4;MIF;DDT
12217,GO:0048485,0.770202955703603,0.587782416082652,1,13,sympathetic nervous system development,BP,SEMA3F
8358,GO:0033260,0.770334416198772,0.40497620058481,4,49,nuclear DNA replication,BP,POLD4;FGFR1;WDR18;CHEK2
14827,GO:0070571,0.770429989112759,0.587456080596681,1,13,negative regulation of neuron projection regeneration,BP,PTPRS
7063,GO:0030857,0.770544128147431,0.481576409862137,2,25,negative regulation of epithelial cell differentiation,BP,XDH;CCND1
18814,GO:1904353,0.770647904121333,0.481431330038505,2,25,regulation of telomere capping,BP,ERCC1;MAPK3
10056,GO:0042551,0.770835660467303,0.481168759510077,2,25,neuron maturation,BP,AGRN;RAC3
17757,GO:1901685,0.770881616968324,0.582966280513479,1,16,glutathione derivative metabolic process,BP,GSTO1
17758,GO:1901687,0.770881616968324,0.582966280513479,1,16,glutathione derivative biosynthetic process,BP,GSTO1
19731,GO:2000058,0.77090747551337,0.332316620577826,11,124,regulation of ubiquitin-dependent protein catabolic process,BP,DVL1;AKT1;CSNK1E;RAD23A;MAGEF1;TRIB2;STUB1;BCAP31;RNF144A;SIRT2;HFE
1096,GO:0002684,0.771001631646733,0.272722609325644,60,617,positive regulation of immune system process,BP,TNIP1;NR1D1;PGF;CTNNBIP1;PRNP;VEGFA;FAM210B;PTPRS;ZFP36L1;RBCK1;FOS;STAT6;PIK3R2;PAG1;ADORA2B;AKT1;HK1;SERPING1;VEGFB;PRKACB;RAC2;RAG1;CEACAM1;GAS6;CTSB;CARD11;MAPKAPK3;IGFBP2;WIPF1;AP3D1;ADAM8;PLCG1;CD81;TGFB1;TMEM173;EFNB3;CD320;PRKCZ;PRKACA;ADA;JAK3;CYFIP2;PRKCD;CACNB3;BAX;EREG;RPS6KA5;LIMK1;IRAK1;INPP5D;MIF;PLA2G6;FYN;PELI1;MAPK3;HLA-G;PAK1;ITGA4;ZP3;ITPKB
730,GO:0001960,0.771314259601792,0.432042293365918,3,38,negative regulation of cytokine-mediated signaling pathway,BP,GAS6;ECM1;PELI3
7475,GO:0031646,0.771482379218988,0.585940349439958,1,13,positive regulation of neurological system process,BP,WASF3
10061,GO:0042559,0.771484979553001,0.584465712641478,1,14,pteridine-containing compound biosynthetic process,BP,GCH1
19518,GO:1990381,0.771487694044646,0.585932681927681,1,13,ubiquitin-specific protease binding,MF,RAD23A
1117,GO:0002705,0.771509636641827,0.384117152797044,5,60,positive regulation of leukocyte mediated immunity,BP,STAT6;ADORA2B;TGFB1;PRKCZ;ZP3
3360,GO:0007100,0.771624059672223,0.585735908258873,1,13,mitotic centrosome separation,BP,NDE1
8732,GO:0034390,0.772011527384936,0.585176337946576,1,13,smooth muscle cell apoptotic process,BP,PDCD4
8733,GO:0034391,0.772011527384936,0.585176337946576,1,13,regulation of smooth muscle cell apoptotic process,BP,PDCD4
16358,GO:0090659,0.772149112236201,0.584977477803992,1,13,walking behavior,BP,EFNB3
2881,GO:0006388,0.772206755005979,0.583421374009753,1,14,tRNA splicing, via endonucleolytic cleavage and ligation,BP,TRPT1
12241,GO:0048531,0.772252142939224,0.584828504684171,1,13,beta-1,3-galactosyltransferase activity,MF,B3GNT3
4462,GO:0010458,0.772253696780774,0.478609123569492,2,26,exit from mitosis,BP,TGFB1;SIRT2
2612,GO:0005923,0.772394201481363,0.349262050309463,8,90,bicellular tight junction,CC,NPHP4;ANK3;CCND1;PRKCZ;MICALL2;SH3BP1;SYMPK;DLG3
12351,GO:0048741,0.772525027028055,0.584433705770225,1,13,skeletal muscle fiber development,BP,FAM129B
6583,GO:0022602,0.772863823440548,0.47832541839157,2,25,ovulation cycle process,BP,EREG;ZP3
15558,GO:0072010,0.773177635098448,0.583488161177359,1,13,glomerular epithelium development,BP,LAMB2
13789,GO:0060389,0.77342894104231,0.429482884313008,3,37,pathway-restricted SMAD protein phosphorylation,BP,TGFB1;TGFBR3;HFE
16083,GO:0090051,0.773543498580057,0.582957222559436,1,13,negative regulation of cell migration involved in sprouting angiogenesis,BP,HDAC5
6622,GO:0022884,0.773576398082209,0.58016020459224,1,15,macromolecule transmembrane transporter activity,MF,TIMM17B
13589,GO:0060070,0.773683947613071,0.298084081762725,22,239,canonical Wnt signaling pathway,BP,EGR1;WNT7A;APOE;LRP5;WWTR1;SDC1;SMURF2;SMAD3;DVL1;PTPRU;WNT2B;NPHP4;LZTS2;IGFBP4;CCND1;IGFBP2;WNT3;LRP4;SOX7;CAPRIN2;EDA;LRRK1
4821,GO:0014020,0.774043155629,0.355935174396293,7,80,primary neural tube formation,BP,DVL1;PRKACB;TGFB1;DEAF1;VANGL2;SEMA4C;CELSR1
19748,GO:2000105,0.774221910037686,0.581971096381815,1,13,positive regulation of DNA-dependent DNA replication,BP,FGFR1
18405,GO:1903421,0.774310389691141,0.581842328570792,1,13,regulation of synaptic vesicle recycling,BP,DNM1
7136,GO:0030983,0.774447562765268,0.581642624354698,1,13,mismatched DNA binding,MF,XPC
4550,GO:0010633,0.774621414447871,0.399508394727065,4,48,negative regulation of epithelial cell migration,BP,APOE;HDAC5;TGFB1;PFN2
15204,GO:0071356,0.774710594270286,0.304551302136865,18,202,cellular response to tumor necrosis factor,BP,POSTN;TNFRSF6B;ZFP36L1;RBCK1;AKT1;GAS6;SHARPIN;ADAMTS13;ADAMTS7;TNFSF15;PCK2;SPPL2B;MAPK3;HYAL1;TNFRSF25;EDA;PELI3;NGFR
12114,GO:0048194,0.774736389949065,0.36579754078977,6,71,Golgi vesicle budding,BP,TRAPPC9;CTSZ;AREG;MCFD2;TGFA;PDCD6
1328,GO:0003179,0.774837919031215,0.475545450311886,2,25,heart valve morphogenesis,BP,TGFB1;ZFPM1
10782,GO:0044257,0.775011979904401,0.26762515983803,62,636,cellular protein catabolic process,BP,GID4;NR1D1;EDEM1;BTBD2;FBXO2;APOE;MTA1;ARRDC1;WWTR1;TMEM129;CTSO;CAPN2;VPS11;RBCK1;RNF44;SMURF2;LRP1;DVL1;AP2A2;FBXW5;RNF187;AKT1;LDLR;CSNK1E;CTSB;PCSK9;RAD23A;BNIP3;SHARPIN;MVB12B;CTSZ;MAGEF1;CD81;ADAMTS7;ABTB1;FBXO44;ANKZF1;UBXN4;TRIB2;PRKACA;BNIP3L;USP20;STUB1;FBXW4;CUL9;LONP2;CHEK2;CDC34;RNF123;RAB12;BCAP31;WFS1;RNF144A;CTSF;USP21;CUL7;PKD1;KCTD13;SIRT2;TOLLIP;HFE;CBLC
11826,GO:0046785,0.775114338384598,0.379583772244086,5,59,microtubule polymerization,BP,ARL2;EML2;TUBG2;PAK1;NDE1
3031,GO:0006584,0.775298117191351,0.474321694895763,2,26,catecholamine metabolic process,BP,EPAS1;GCH1
4288,GO:0009712,0.775298117191351,0.474321694895763,2,26,catechol-containing compound metabolic process,BP,EPAS1;GCH1
5533,GO:0016514,0.775504574131027,0.580100866463385,1,13,SWI/SNF complex,CC,SMARCD2
6701,GO:0030117,0.775688512598345,0.344989537754619,8,92,membrane coat,CC,EGFR;AP2A2;AP3D1;CLTCL1;SCYL1;EPN2;DNM1;PDCD6
12211,GO:0048475,0.775688512598345,0.344989537754619,8,92,coated membrane,CC,EGFR;AP2A2;AP3D1;CLTCL1;SCYL1;EPN2;DNM1;PDCD6
4582,GO:0010669,0.775956546616084,0.579440046921833,1,13,epithelial structure maintenance,BP,CROCC
10403,GO:0043247,0.775959049354765,0.579436385092027,1,13,telomere maintenance in response to DNA damage,BP,ERCC1
3757,GO:0008301,0.776146733671818,0.579161696132622,1,13,DNA binding, bending,MF,HMGA2
8602,GO:0034121,0.776349871024863,0.425496863119666,3,37,regulation of toll-like receptor signaling pathway,BP,NR1D1;PTPRS;PELI1
605,GO:0001774,0.776354327943902,0.578857677661733,1,13,microglial cell activation,BP,LDLR
9422,GO:0035994,0.776497179718945,0.578648357581691,1,13,response to muscle stretch,BP,FOS
16676,GO:0097617,0.776790749728505,0.578217893645733,1,13,annealing activity,MF,SMARCA1
783,GO:0002042,0.777118544815249,0.424444306488696,3,37,cell migration involved in sprouting angiogenesis,BP,VEGFA;HDAC5;HDAC7
9885,GO:0042169,0.777121146572234,0.472314735470776,2,25,SH2 domain binding,MF,SH3PXD2B;PAG1
732,GO:0001963,0.777328704600944,0.575942108813064,1,14,synaptic transmission, dopaminergic,BP,RAB3B
19625,GO:1990752,0.777370461180562,0.471960953116238,2,25,microtubule end,CC,CLIP2;MAPRE3
2709,GO:0006086,0.777443015856803,0.577260037838066,1,13,acetyl-CoA biosynthetic process from pyruvate,BP,PDK1
5504,GO:0016447,0.777615187203029,0.423763446178987,3,37,somatic recombination of immunoglobulin gene segments,BP,ERCC1;STAT6;TGFB1
13129,GO:0051704,0.777709008023654,0.249748921732058,157,1589,multi-organism process,BP,TNIP1;ERCC1;HTRA1;NR1D1;DLG4;CST3;CYP27B1;PGF;PDCD4;BBS2;TNFRSF6B;APOE;F2R;HMGA2;EGFR;SERPINE2;LOXL1;NOS1;MST1R;CRTAP;ETV5;SHC1;HEXB;TCFL5;ACTA2;MMP1;TXNRD3;MAP2K2;RBCK1;PC;MAP2K1;ACP5;EXOC2;SMURF2;FOS;FBLN1;SMAD3;SHANK2;DVL1;AP2A2;SH3PXD2B;STOM;ADARB1;SYT8;AKT1;HDAC5;BSG;SCMH1;GGT1;PHC2;ATG16L2;IFNGR2;PTHLH;LDLR;MAPKBP1;GAMT;PACS2;CCNI;RAB11FIP4;MICALCL;GAS6;CTSB;GSN;MAPKAPK3;IGFBP2;RAD23A;BCR;WIPF1;CDC25B;NPR2;BNIP3;MVB12B;FAM3A;CRTC1;ITGB5;PRSS3;EPOR;CTBP1;PLCG1;CD81;CEBPB;ADAMTS13;WNT3;TGFB1;RFX2;ULK2;DEAF1;TMEM173;SHANK3;EFNB3;MYCBPAP;DNAH1;VGF;PCK2;IFNE;CEP131;PRKACA;TBKBP1;CD9;ADA;PIM2;UCKL1;TDRKH;ULK1;FAM50A;BNIP3L;NELFCD;PRKCD;BAX;SBF1;EREG;DDIT4;RPL39L;LRSAM1;IRAK1;SPATA20;SIX5;BCAP31;MIF;PLA2G6;FYN;SUN1;DNM2;PELI1;IGFBP7;APOBEC3C;SATB1;APOBEC3F;MAPK3;INSR;PPP3CB;CUL7;HYAL1;ITGA3;DNMT3A;BIN1;MAP2K3;BCL2L1;PROX1;TNFRSF25;SIRT2;ADCY7;AZIN2;RAB40B;NGFR;RNASE7;GCH1;MSS51;MAFF;HFE;WIPI2;BTG1;ZP3;SEPT6;PRSS21;GSDMA;KDM3A
13585,GO:0060065,0.777930560267267,0.576542782834281,1,13,uterus development,BP,WNT7A
700,GO:0001921,0.777935209267383,0.576535938081417,1,13,positive regulation of receptor recycling,BP,ARAP1
12247,GO:0048538,0.778023706335958,0.42320292439263,3,37,thymus development,BP,MAP2K1;RAG1;MAPK3
3145,GO:0006744,0.778793290423988,0.573781194212562,1,14,ubiquinone biosynthetic process,BP,COQ2
17743,GO:1901663,0.778793290423988,0.573781194212562,1,14,quinone biosynthetic process,BP,COQ2
2855,GO:0006349,0.778836736117681,0.575206704578441,1,13,regulation of gene expression by genetic imprinting,BP,DNMT3A
16755,GO:0098542,0.778851636021396,0.288904569714812,24,266,defense response to other organism,BP,HTRA1;SHC1;ACP5;ADARB1;MAPKBP1;BNIP3;FAM3A;CEBPB;TGFB1;TMEM173;VGF;IFNE;BNIP3L;PRKCD;DDIT4;LRSAM1;PLA2G6;APOBEC3C;APOBEC3F;MAPK3;SIRT2;RNASE7;WIPI2;GSDMA
18393,GO:1903391,0.778908111956075,0.393791215243243,4,48,regulation of adherens junction organization,BP,VEGFA;SMAD3;PPM1F;RHOD
4202,GO:0009312,0.779158458680955,0.468842903793016,2,26,oligosaccharide biosynthetic process,BP,ST6GALNAC6;ST3GAL2
3862,GO:0008484,0.779222352260503,0.574636979826084,1,13,sulfuric ester hydrolase activity,MF,GALNS
7365,GO:0031420,0.779252899314025,0.574591818538079,1,13,alkali metal ion binding,MF,PDXK
604,GO:0001773,0.779362456898342,0.572938717706181,1,14,myeloid dendritic cell activation,BP,TGFB1
2657,GO:0006004,0.779391490034157,0.574386868563626,1,13,fucose metabolic process,BP,FUCA1
13762,GO:0060351,0.77966911123989,0.573976046570636,1,13,cartilage development involved in endochondral bone morphogenesis,BP,THBS3
15212,GO:0071371,0.779909573836853,0.57361991836789,1,13,cellular response to gonadotropin stimulus,BP,NSMF
14046,GO:0060831,0.780158930820167,0.573250329584406,1,13,smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,PRKACB
7697,GO:0032183,0.78025891386613,0.573102055574806,1,13,SUMO binding,MF,TOLLIP
12733,GO:0051010,0.780274991477033,0.573078208208278,1,13,microtubule plus-end binding,MF,CLIP2
7450,GO:0031593,0.780496763036558,0.419800550888865,3,37,polyubiquitin modification-dependent protein binding,MF,TNIP1;RAD23A;SHARPIN
8496,GO:0033683,0.780542313715897,0.419129012078276,3,39,nucleotide-excision repair, DNA incision,BP,ERCC1;DDB2;POLD4
3420,GO:0007212,0.780922364485466,0.466323542080272,2,26,dopamine receptor signaling pathway,BP,GNAL;ADCY6
454,GO:0001228,0.780942806459328,0.285299094452554,25,262,transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding,MF,MEF2D;EGR1;HMGA2;ELK3;ETV5;ETV4;POU2F2;FOS;STAT6;EPAS1;SALL2;HLTF;KLF7;CEBPB;TFDP2;PBX2;SOX12;CARF;IER2;PPARA;SSBP4;CAMTA2;BACH1;MAFF;PLAG1
7696,GO:0032182,0.781418825453733,0.346386658322673,7,82,ubiquitin-like protein binding,MF,RBCK1;MARK4;SMAD3;SHARPIN;UBTD1;SIRT2;TOLLIP
19199,GO:1905269,0.782211178847218,0.345468049921351,7,81,positive regulation of chromatin organization,BP,VEGFA;NOS1;CTBP1;TGFB1;C6ORF89;RPS6KA5;MAPK3
13806,GO:0060411,0.7825367770248,0.388920341731878,4,48,cardiac septum morphogenesis,BP,TGFBR3;ZFPM1;VANGL2;PROX1
12789,GO:0051092,0.782628563176626,0.323058707476905,10,115,positive regulation of NF-kappaB transcription factor activity,BP,RBCK1;TRAPPC9;CARD11;ADAM8;TGFB1;PRKCZ;RPS6KA5;IRAK1;CAT;EDA
14280,GO:0061371,0.782633597961943,0.416848030023727,3,37,determination of heart left/right asymmetry,BP,SMAD3;PKD2;VANGL2
10350,GO:0043169,0.782749142234729,0.237973657091127,310,2998,cation binding,MF,NT5E;XDH;ZMYND8;FHL1;EGR1;NR1D1;EDEM1;CYP27B1;NAGS;ACVR2B;PRNP;POSTN;PGM1;APOE;PYGL;DGKA;ITGA6;OBSCN;IDH2;ZKSCAN1;NEK9;ITPR3;MTA1;RPS6KA2;LOXL1;NOS1;VAT1;TMEM129;CAPN2;TRIM65;LTBP4;SYTL1;LTBP2;VPS11;LTBP1;NPEPL1;MMP1;ZFP36L1;GLUL;RNPEPL1;ARAP1;MAP2K2;NME4;ZC3H6;MARCH9;PLCD3;FKBP9;RBCK1;PLTP;PC;RNF44;ACP5;MCTP1;ENDOG;FBLN1;SMAD3;LRP1;THBS3;S100A4;CYBRD1;PPP2R3B;SALL2;ZXDC;RNF187;NMRK1;ADARB1;SYT8;HDAC5;NT5DC1;S100A6;F12;PPM1F;MMP28;PITPNM1;HAGHL;ASAP2;DYSF;PHC2;ASH2L;MARCH4;ZFYVE21;BRSK1;LDLR;PRKACB;SMOC2;PFKL;HLTF;RAG1;B4GAT1;PHF7;KLF7;B3GAT3;RAB11FIP4;TENM2;ZNF385A;TSHZ1;LHPP;TNNT1;PLCH2;GAS6;PFKP;GSN;DHTKD1;ANTXR2;EHD4;GLI4;NADK;ZSCAN18;ALOX15B;AGAP1;PEX10;CCS;RSAD1;DGKQ;HAGH;SHARPIN;FYCO1;PKD2;ACY1;YPEL3;ZNF598;PRSS3;GRIN3B;ADAM8;APRT;LTA4H;PLCG1;ZMIZ2;CBS;RNF135;ADAMTS13;ZNF217;TIMP2;ZNF862;GNAL;LACTB2;UNK;GPC1;MKNK2;ADAMTS7;DEAF1;TBC1D9B;ZSCAN30;ATP7B;SHANK3;MSRB2;RASA3;MIPEP;MGAT4B;GALNS;CLCA2;PEG3;ARAP3;CGREF1;HTR7;POLL;POLM;PI4K2A;ANKZF1;PHF21A;ADAM19;HMGCL;PTPN1;TPP1;PCK2;B4GALT2;AGRN;CD320;LRP4;ESYT2;B4GALT6;ADAP1;RFNG;YPEL5;PRKCZ;KDM6B;ZNF516;RABGGTA;ADA;MPI;MICALL2;NEURL1B;CNDP2;NINL;PRIMPOL;MMP10;NECAB3;IRF2BP2;RNPEP;RASA4;CYGB;THOP1;MCFD2;PRKCD;FAM20C;MIB2;USP20;CYC1;DTD1;TRIM4;ITGA1;ZNF395;NUBP2;RPS6KA5;ZNF524;CUL9;MBTPS2;MT2A;HPCAL1;NID1;LIMK1;PADI3;RPS6KA6;ZHX3;MFNG;GIT1;LPCAT1;LRSAM1;ADAM15;EHD3;FAHD2B;MAPK12;HDAC7;RNF215;CHEK2;DTNB;ZFPM1;PPARA;SESN2;JADE2;RNF123;SNN;ACO2;KDM4B;PHYH;ZNF414;MEX3A;LENG9;NUDT14;ZNF444;DTX3;FYN;PITPNM3;EFEMP2;STK25;EEF2K;FLYWCH1;ACAP3;CYP3A5;CHKA;CAT;NEIL1;ZMYM3;APOBEC3C;PLCB3;ZNF606;APOBEC3F;CYP2R1;PAN2;PFKM;ADCY1;RERE;ATP8B2;PDXK;TRIM45;CAMKK2;PPP3CB;RNF144A;USP21;REV1;MICAL1;CAPRIN2;ZBTB10;ITGA3;STK32C;DNMT3A;MAN2B1;SIRT2;CDH4;ITGA4;NT5C1B;ADCY7;ZBTB22;ZNF704;YDJC;PDCD6;PCLO;ZNF837;PXN;PLEKHM1;GCH1;MSS51;NR2F6;SIRT3;ZNF513;CELSR1;MAN2B2;CBLC;TCEA2;CDC42BPG;ZBTB47;PLAG1;IRF2BPL;TRIM46;KDM3A;MEGF6;CHPF;ADCY6;LRRK1;AARS
15405,GO:0071674,0.783271071879568,0.462422167172513,2,27,mononuclear cell migration,BP,TGFB1;MAPK3
5288,GO:0015949,0.78350467364836,0.461594723446901,2,28,nucleobase-containing small molecule interconversion,BP,NME4;GLRX
15784,GO:0072401,0.783554337872023,0.354317586457975,6,72,signal transduction involved in DNA integrity checkpoint,BP,ZNF385A;PCBP4;TFDP2;RBL2;BAX;CHEK2
15788,GO:0072422,0.783554337872023,0.354317586457975,6,72,signal transduction involved in DNA damage checkpoint,BP,ZNF385A;PCBP4;TFDP2;RBL2;BAX;CHEK2
13633,GO:0060149,0.784011841479575,0.565999449591804,1,14,negative regulation of posttranscriptional gene silencing,BP,TGFB1
14101,GO:0060967,0.784011841479575,0.565999449591804,1,14,negative regulation of gene silencing by RNA,BP,TGFB1
6318,GO:0019985,0.784027008286365,0.414307851186528,3,39,translesion synthesis,BP,POLD4;PRIMPOL;REV1
18791,GO:1904292,0.784457757908178,0.461243499369653,2,26,regulation of ERAD pathway,BP,EDEM1;BCAP31
14650,GO:0070252,0.784760693984909,0.385711574850184,4,49,actin-mediated cell contraction,BP,SCN4B;TNNT1;SNTA1;TPM2
5134,GO:0015631,0.785375850774222,0.27881195551152,26,276,tubulin binding,MF,PRNP;NDRG1;CLIP2;MARK4;FAM110C;REEP4;BRSK1;KIF17;EML2;KIF26B;KIF7;DNM1;WASH3P;RGS14;MYO1D;MYH15;EML3;FYN;DNM2;KIF26A;RABGAP1;MAPRE3;NDE1;KIF13B;GAS2L1;CCDC88C
11468,GO:0045935,0.785757743329781,0.243650154368544,129,1276,positive regulation of nucleobase-containing compound metabolic process,BP,TNIP1;ERCC1;MEF2D;CITED4;EGR1;NR1D1;CST3;APLN;VEGFA;WNT7A;APOE;F2R;LRP5;ITGA6;HMGA2;ELK3;EGFR;WWTR1;NOS1;NFATC4;ETV5;SHC1;HEXB;GTPBP1;ETV4;RAPGEF3;ZFP36L1;MAP2K2;SMARCA1;MAP2K1;POU2F2;ENDOG;FOS;SMAD3;STAT6;PIK3R2;ERCC6;DVL1;EPAS1;SALL2;ZXDC;RNF187;ADORA2B;AKT1;HDAC5;ASH2L;PTHLH;FGFR4;FGFR1;SEC14L2;HLTF;KLF7;NAT14;PKD2;CRTC1;CDKN1C;ZMIZ2;CD81;CEBPB;TIMP2;TGFB1;RFX2;DEAF1;TMEM173;PEG3;MC1R;ABHD14B;PTPN1;AGRN;VHL;PFKFB2;MLXIPL;KDM6B;ZNF516;AREG;PIM2;ERBB2;TFDP2;PBX2;PRKCD;BAX;EREG;RPS6KA5;SOX12;MBTPS2;CARF;IER2;IRAK1;FHOD1;CHEK2;ZFPM1;PPARA;TMEM161A;SESN2;SOX7;SIX5;SSBP4;DNM2;MAPK3;INSR;CAMTA2;TAZ;PFKM;RERE;CAMKK2;PPP3CB;USP21;PFKFB3;CAPRIN2;PPP2R5B;MAP2K3;PROX1;PKD1;KCTD13;SIRT2;FAM129B;BACH1;E2F5;MAPRE3;NGFR;MAFF;CAMK1;EZH1;ZP3;TCEA2;PLAG1;IRF2BPL;KDM3A;SRSF5
4700,GO:0010862,0.786142695678528,0.458807936412696,2,26,positive regulation of pathway-restricted SMAD protein phosphorylation,BP,TGFB1;HFE
16327,GO:0090543,0.786246225449251,0.458657978311398,2,26,Flemming body,CC,EXOC2;CAPG
5452,GO:0016324,0.78635869453297,0.29581832755203,16,174,apical plasma membrane,CC,EGFR;SLC2A9;SLC9A3R2;SHANK2;STK39;CEACAM1;IGFBP2;SLC29A4;PRKCZ;CD9;ERBB2;CACNB3;SLC22A18;PFKM;VANGL2;SLC23A2
4916,GO:0014855,0.786794730076516,0.411064263072155,3,37,striated muscle cell proliferation,BP,FGFR1;TGFBR3;SIX5
11617,GO:0046330,0.787334096169635,0.330314543600507,8,92,positive regulation of JNK cascade,BP,WNT7A;PKN1;ERCC6;PTPN1;MINK1;VANGL2;PAK1;MAP3K10
12240,GO:0048525,0.787970215671885,0.348465375156739,6,73,negative regulation of viral process,BP,TNIP1;HMGA2;GSN;APOBEC3C;APOBEC3F;PROX1
5778,GO:0017000,0.78820878752388,0.559646433132834,1,14,antibiotic biosynthetic process,BP,KDM3A
7932,GO:0032526,0.788249385856322,0.348209782477436,6,72,response to retinoic acid,BP,TWF2;PTK6;IGFBP2;WNT3;TMEM161A;IGFBP7
10435,GO:0043297,0.788272807075171,0.380952303602118,4,49,apical junction assembly,BP,ARL2;NPHP4;PRKACA;MICALL2
11308,GO:0045638,0.788296114407036,0.361160717371115,5,67,negative regulation of myeloid cell differentiation,BP,ZFP36L1;CEACAM1;INPP5D;ZFPM1;ITPKB
18829,GO:1904385,0.788652881357199,0.558969179306436,1,14,cellular response to angiotensin,BP,PRKCD
1219,GO:0002888,0.788710019677,0.558881971701401,1,14,positive regulation of myeloid leukocyte mediated immunity,BP,ADORA2B
10521,GO:0043462,0.788813212712769,0.379826213847154,4,51,regulation of ATPase activity,BP,OXA1L;TPM2;DNM2;PFN2
3902,GO:0008544,0.788866837705699,0.275915532858396,25,276,epidermis development,BP,CYP27B1;EGFR;PRSS8;ZFP36L1;FOXQ1;MAP2K1;PTHLH;FGFR1;LAMA5;ERRFI1;SLITRK6;ALOX15B;SHARPIN;NAB2;LCE1E;LRP4;EREG;PPL;PPARA;SATB1;INSR;VANGL2;EDA;MAFF;CELSR1
11344,GO:0045687,0.788986561654824,0.454675732728728,2,26,positive regulation of glial cell differentiation,BP,SERPINE2;BIN1
11436,GO:0045893,0.789136245263449,0.242760835937252,106,1055,positive regulation of transcription, DNA-templated,BP,TNIP1;MEF2D;CITED4;EGR1;NR1D1;APLN;VEGFA;WNT7A;F2R;LRP5;ITGA6;HMGA2;ELK3;EGFR;WWTR1;NOS1;NFATC4;ETV5;SHC1;HEXB;ETV4;MAP2K2;SMARCA1;MAP2K1;POU2F2;FOS;SMAD3;STAT6;PIK3R2;ERCC6;DVL1;EPAS1;SALL2;ZXDC;RNF187;AKT1;HDAC5;ASH2L;SEC14L2;HLTF;KLF7;NAT14;PKD2;CRTC1;CDKN1C;ZMIZ2;CD81;CEBPB;TGFB1;RFX2;DEAF1;TMEM173;PEG3;MC1R;ABHD14B;AGRN;VHL;MLXIPL;KDM6B;ZNF516;PIM2;ERBB2;TFDP2;PBX2;RPS6KA5;SOX12;MBTPS2;CARF;IER2;IRAK1;FHOD1;CHEK2;ZFPM1;PPARA;SESN2;SOX7;SIX5;SSBP4;DNM2;MAPK3;INSR;CAMTA2;PFKM;RERE;CAMKK2;PPP3CB;USP21;CAPRIN2;PPP2R5B;MAP2K3;PROX1;PKD1;SIRT2;FAM129B;BACH1;E2F5;MAPRE3;NGFR;MAFF;CAMK1;EZH1;ZP3;TCEA2;PLAG1;IRF2BPL;KDM3A
18438,GO:1903508,0.789136245263449,0.242760835937252,106,1055,positive regulation of nucleic acid-templated transcription,BP,TNIP1;MEF2D;CITED4;EGR1;NR1D1;APLN;VEGFA;WNT7A;F2R;LRP5;ITGA6;HMGA2;ELK3;EGFR;WWTR1;NOS1;NFATC4;ETV5;SHC1;HEXB;ETV4;MAP2K2;SMARCA1;MAP2K1;POU2F2;FOS;SMAD3;STAT6;PIK3R2;ERCC6;DVL1;EPAS1;SALL2;ZXDC;RNF187;AKT1;HDAC5;ASH2L;SEC14L2;HLTF;KLF7;NAT14;PKD2;CRTC1;CDKN1C;ZMIZ2;CD81;CEBPB;TGFB1;RFX2;DEAF1;TMEM173;PEG3;MC1R;ABHD14B;AGRN;VHL;MLXIPL;KDM6B;ZNF516;PIM2;ERBB2;TFDP2;PBX2;RPS6KA5;SOX12;MBTPS2;CARF;IER2;IRAK1;FHOD1;CHEK2;ZFPM1;PPARA;SESN2;SOX7;SIX5;SSBP4;DNM2;MAPK3;INSR;CAMTA2;PFKM;RERE;CAMKK2;PPP3CB;USP21;CAPRIN2;PPP2R5B;MAP2K3;PROX1;PKD1;SIRT2;FAM129B;BACH1;E2F5;MAPRE3;NGFR;MAFF;CAMK1;EZH1;ZP3;TCEA2;PLAG1;IRF2BPL;KDM3A
4912,GO:0014850,0.789361473338365,0.557886552660456,1,14,response to muscle activity,BP,POSTN
11836,GO:0046825,0.789490368962847,0.406685157158998,3,39,regulation of protein export from nucleus,BP,RAPGEF3;GAS6;CAMK1
10663,GO:0043900,0.789679808902986,0.273720615611576,26,284,regulation of multi-organism process,BP,TNIP1;HTRA1;APOE;HMGA2;PC;EXOC2;SMURF2;STOM;ADARB1;MAPKBP1;GSN;RAD23A;NPR2;MVB12B;FAM3A;TMEM173;ADA;NELFCD;LRSAM1;MIF;APOBEC3C;APOBEC3F;MAPK3;PROX1;SIRT2;ZP3
18463,GO:1903541,0.789747447427729,0.557295799072806,1,14,regulation of exosomal secretion,BP,SDC1
18465,GO:1903543,0.789747447427729,0.557295799072806,1,14,positive regulation of exosomal secretion,BP,SDC1
7421,GO:0031529,0.789771932250237,0.406585578128801,3,38,ruffle organization,BP,CORO1B;PLEKHM1;PFN2
4354,GO:0009952,0.790183836609091,0.308741234333377,11,123,anterior/posterior pattern specification,BP,CTNNBIP1;ACVR2B;LRP5;SMAD3;SCMH1;WNT2B;TSHZ1;WNT3;VANGL2;HES7;CELSR1
7292,GO:0031297,0.790351880722318,0.45268225133156,2,26,replication fork processing,BP,PRIMPOL;ETAA1
4748,GO:0010921,0.790528990420739,0.303896554606087,12,134,regulation of phosphatase activity,BP,PPP1R35;SMAD3;PPP1R14A;PPP2R3B;B3GAT3;FARP1;ITGA1;MYO1D;ELFN2;PPP2R5B;DLG3;PPP1R16A
610,GO:0001779,0.790582249957416,0.556015571407784,1,14,natural killer cell differentiation,BP,GAS6
10997,GO:0044818,0.790981730324376,0.451760494302404,2,26,mitotic G2/M transition checkpoint,BP,HMGA2;BRSK1
5593,GO:0016620,0.791048937292022,0.451662060480182,2,26,oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor,MF,ALDH4A1;ALDH7A1
12560,GO:0050718,0.791316569243912,0.554886584649878,1,14,positive regulation of interleukin-1 beta secretion,BP,HK1
10439,GO:0043302,0.791691367670095,0.554309312736905,1,14,positive regulation of leukocyte degranulation,BP,ADORA2B
13940,GO:0060632,0.791980993709026,0.553862745111259,1,14,regulation of microtubule-based movement,BP,BBS2
808,GO:0002082,0.792007671068807,0.553821590843351,1,14,regulation of oxidative phosphorylation,BP,MLXIPL
4483,GO:0010507,0.79201113589693,0.357133349424736,5,60,negative regulation of autophagy,BP,TBC1D14;AKT1;DAP;QSOX1;SIRT2
4672,GO:0010822,0.792053052216122,0.301860717372689,12,138,positive regulation of mitochondrion organization,BP,VPS11;RAC2;BNIP3;MOAP1;MICALL2;BOK;TFDP2;BAX;ZDHHC8;PLA2G6;NBPF3;CAMKK2
15654,GO:0072175,0.792343144875573,0.316927212580958,9,103,epithelial tube formation,BP,DVL1;PRKACB;TGFB1;DEAF1;VANGL2;SEMA4C;PROX1;TCTN1;CELSR1
18091,GO:1902680,0.792388638352558,0.23923116456313,106,1056,positive regulation of RNA biosynthetic process,BP,TNIP1;MEF2D;CITED4;EGR1;NR1D1;APLN;VEGFA;WNT7A;F2R;LRP5;ITGA6;HMGA2;ELK3;EGFR;WWTR1;NOS1;NFATC4;ETV5;SHC1;HEXB;ETV4;MAP2K2;SMARCA1;MAP2K1;POU2F2;FOS;SMAD3;STAT6;PIK3R2;ERCC6;DVL1;EPAS1;SALL2;ZXDC;RNF187;AKT1;HDAC5;ASH2L;SEC14L2;HLTF;KLF7;NAT14;PKD2;CRTC1;CDKN1C;ZMIZ2;CD81;CEBPB;TGFB1;RFX2;DEAF1;TMEM173;PEG3;MC1R;ABHD14B;AGRN;VHL;MLXIPL;KDM6B;ZNF516;PIM2;ERBB2;TFDP2;PBX2;RPS6KA5;SOX12;MBTPS2;CARF;IER2;IRAK1;FHOD1;CHEK2;ZFPM1;PPARA;SESN2;SOX7;SIX5;SSBP4;DNM2;MAPK3;INSR;CAMTA2;PFKM;RERE;CAMKK2;PPP3CB;USP21;CAPRIN2;PPP2R5B;MAP2K3;PROX1;PKD1;SIRT2;FAM129B;BACH1;E2F5;MAPRE3;NGFR;MAFF;CAMK1;EZH1;ZP3;TCEA2;PLAG1;IRF2BPL;KDM3A
18656,GO:1903955,0.792550545550886,0.356126624918194,5,62,positive regulation of protein targeting to mitochondrion,BP,VPS11;RAC2;MICALL2;ZDHHC8;NBPF3
9066,GO:0035308,0.792781896179729,0.402054328236581,3,39,negative regulation of protein dephosphorylation,BP,PPP1R35;PPP1R14A;ELFN2
9555,GO:0036336,0.792825326778254,0.552558493756783,1,14,dendritic cell migration,BP,GAS6
14594,GO:0070160,0.793159317151203,0.322897010784309,8,92,occluding junction,CC,NPHP4;ANK3;CCND1;PRKCZ;MICALL2;SH3BP1;SYMPK;DLG3
13104,GO:0051649,0.793428392660851,0.232305287951304,166,1674,establishment of localization in cell,BP,NR1D1;EDEM1;PRNP;BBS2;WNT7A;APOE;F2R;LRP5;ITPR3;EVI5L;NOS1;TMEM129;SPRY2;SYTL1;LMF1;LTBP2;VPS11;TBC1D14;SNX9;RAPGEF3;MAP2K2;MAP2K1;CPT2;MCTP1;DVL1;AP2A2;NLGN2;STOM;ADORA2B;SYT8;AKT1;TPCN1;KCNC4;ZFYVE21;BRSK1;IFT140;RAB31;LDLR;RAC2;TOMM34;SORL1;B3GAT3;RAB11FIP4;ABCD1;ANK3;TRAPPC9;STRADB;GAS6;RAB3B;PCSK9;BCR;XPOT;EHD4;AIP;SPTB;PEX10;CCS;CORO7;MVB12B;FYCO1;CEMIP;PKD2;CTSZ;AP3D1;ABCA2;ASIC1;PLCG1;KIF17;TMED4;TGFB1;SNPH;CLTCL1;MOAP1;TBC1D9B;NTSR1;TMEM173;ATP7B;RASA3;MIPEP;RHOD;SNX17;SNX33;LLGL1;RIMS3;PTPN1;PEX1;ZDHHC24;CEP131;PRKCZ;PRKACA;TOM1L2;AREG;MICALL2;ERBB2;VAMP2;TFDP2;RILPL1;BNIP3L;TRPC1;ARHGAP44;MCFD2;PRKCD;REEP6;CACNB3;BAX;CYC1;TIMM17B;ZDHHC8;GDI1;LEMD2;DNM1;WASH3P;RGS14;GSTO1;REEP2;EHD3;WDR60;LONP2;SYMPK;TGFA;FHOD1;COG7;ABCG1;MYO1D;RAB12;BCAP31;DOPEY2;PLA2G6;SYNGR1;NBPF3;FYN;STK25;TMCO6;SUN1;DNM2;SNX15;ZDHHC1;MAPK3;RTN2;RERE;STX10;PAK1;PPP3CB;BIN1;VPS16;SGSM2;TBC1D16;PKD1;RABGAP1;ITGA4;RAB28;NDE1;RAB40B;NGFR;PDCD6;PCLO;TBC1D8;KIF13B;CAMK1;VPS51;PFN2;CCDC88C;BLOC1S4;TRIM46;APBA1;SRSF5
11338,GO:0045672,0.793475861460963,0.551551166111261,1,14,positive regulation of osteoclast differentiation,BP,FOS
16064,GO:0090023,0.793479543274876,0.550230518590563,1,15,positive regulation of neutrophil chemotaxis,BP,RAC2
5860,GO:0017160,0.793632004586315,0.551309067750954,1,14,Ral GTPase binding,MF,EXOC2
10601,GO:0043586,0.793737636037284,0.551145217582183,1,14,tongue development,BP,EGFR
1343,GO:0003205,0.793751044676632,0.315211410532293,9,102,cardiac chamber development,BP,LTBP1;TGFB1;SNX17;PPP1R13L;TGFBR3;ZFPM1;DNM2;VANGL2;PROX1
17417,GO:1900151,0.794276420774746,0.550308606047687,1,14,regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,ZFP36L1
17419,GO:1900153,0.794276420774746,0.550308606047687,1,14,positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,ZFP36L1
6711,GO:0030127,0.794668563666454,0.549698773753735,1,14,COPII vesicle coat,CC,PDCD6
5729,GO:0016874,0.79476245309167,0.298682351203672,12,134,ligase activity,MF,ACSF2;GLUL;PC;NAPRT;HLCS;NEURL1B;PPCS;DALRD3;SLC27A1;IARS2;TTLL3;AARS
16197,GO:0090231,0.794763728030567,0.549550663601865,1,14,regulation of spindle checkpoint,BP,NDRG1
14970,GO:0070884,0.794876459339611,0.549375153539705,1,14,regulation of calcineurin-NFAT signaling cascade,BP,PRNP
17210,GO:0106056,0.794876459339611,0.549375153539705,1,14,regulation of calcineurin-mediated signaling,BP,PRNP
901,GO:0002279,0.794879114746496,0.445493656412438,2,27,mast cell activation involved in immune response,BP,ADORA2B;RAC2
10440,GO:0043303,0.794879114746496,0.445493656412438,2,27,mast cell degranulation,BP,ADORA2B;RAC2
15782,GO:0072395,0.795087734190058,0.33913487758788,6,73,signal transduction involved in cell cycle checkpoint,BP,ZNF385A;PCBP4;TFDP2;RBL2;BAX;CHEK2
6605,GO:0022829,0.795233083304378,0.548819505218109,1,14,wide pore channel activity,MF,GJC2
3060,GO:0006626,0.795577979886916,0.306670155746352,10,120,protein targeting to mitochondrion,BP,VPS11;RAC2;TOMM34;AIP;MIPEP;MICALL2;BNIP3L;TIMM17B;ZDHHC8;NBPF3
10585,GO:0043558,0.795757985006818,0.548000491007671,1,14,regulation of translational initiation in response to stress,BP,IMPACT
11336,GO:0045670,0.795966748803946,0.397840585862374,3,38,regulation of osteoclast differentiation,BP,FOS;CEBPB;INPP5D
75,GO:0000152,0.796118543702148,0.397050799574323,3,40,nuclear ubiquitin ligase complex,CC,PHC2;CBX7;CUL7
12970,GO:0051382,0.796247561826707,0.547235329709811,1,14,kinetochore assembly,BP,CENPH
5637,GO:0016722,0.796303767118535,0.547147407975585,1,14,oxidoreductase activity, oxidizing metal ions,MF,CYBRD1
13436,GO:0052866,0.796367368669745,0.443823500312664,2,26,phosphatidylinositol phosphate phosphatase activity,MF,SYNJ2;INPP5D
9004,GO:0035173,0.796386923526033,0.547017297103734,1,14,histone kinase activity,MF,PKN1
5889,GO:0018027,0.796446396022424,0.54692422163808,1,14,peptidyl-lysine dimethylation,BP,KDM3A
12931,GO:0051299,0.796767250288997,0.546421767133447,1,14,centrosome separation,BP,NDE1
10830,GO:0044331,0.796942475307743,0.546147143978906,1,14,cell-cell adhesion mediated by cadherin,BP,CDH4
5338,GO:0016075,0.797009234473672,0.544720543369273,1,15,rRNA catabolic process,BP,DEDD2
88,GO:0000177,0.797893031188417,0.543330972848623,1,15,cytoplasmic exosome (RNase complex),CC,GTPBP1
18629,GO:1903902,0.79808958294507,0.36711132872192,4,51,positive regulation of viral life cycle,BP,PC;STOM;ADARB1;RAD23A
4601,GO:0010718,0.798286267234956,0.394539213087493,3,38,positive regulation of epithelial to mesenchymal transition,BP,WWTR1;SMAD3;TGFB1
12871,GO:0051213,0.798305147798068,0.334994233517821,6,72,dioxygenase activity,MF,ALOX15B;KDM6B;CYGB;KDM4B;PHYH;KDM3A
5546,GO:0016538,0.798970664730289,0.43892385832187,2,28,cyclin-dependent protein serine/threonine kinase regulator activity,MF,CCND1;CDKN1C
8972,GO:0035067,0.799176247848355,0.54263239720182,1,14,negative regulation of histone acetylation,BP,CTBP1
12639,GO:0050852,0.799310652308614,0.292782898738423,12,141,T cell receptor signaling pathway,BP,PRNP;RBCK1;PIK3R2;PAG1;CEACAM1;CARD11;PLCG1;ADA;CACNB3;INPP5D;FYN;PAK1
7930,GO:0032516,0.79987201372778,0.541532366017952,1,14,positive regulation of phosphoprotein phosphatase activity,BP,ITGA1
9991,GO:0042407,0.800310832216269,0.539508956672006,1,15,cristae formation,BP,TAZ
13127,GO:0051702,0.800384035894443,0.363935530968717,4,51,interaction with symbiont,BP,APOE;HMGA2;PC;STOM
15251,GO:0071425,0.800463065647203,0.540595911479061,1,14,hematopoietic stem cell proliferation,BP,WNT2B
1704,GO:0004190,0.800473775714027,0.540578925780203,1,14,aspartic-type endopeptidase activity,MF,SPPL2B
14512,GO:0070001,0.800473775714027,0.540578925780203,1,14,aspartic-type peptidase activity,MF,SPPL2B
5627,GO:0016705,0.800783994525656,0.313034512523756,8,93,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,MF,CYP27B1;NOS1;CYGB;KDM4B;PHYH;CYP3A5;CYP2R1;MICAL1
7145,GO:0031011,0.800989789701282,0.538430216445532,1,15,Ino80 complex,CC,INO80C
8338,GO:0033202,0.800989789701282,0.538430216445532,1,15,DNA helicase complex,CC,INO80C
5247,GO:0015872,0.801016332802498,0.538387995407358,1,15,dopamine transport,BP,RAB3B
7154,GO:0031023,0.801273648295258,0.299747973566398,10,115,microtubule organizing center organization,BP,ARL2;FBXW5;BRSK1;CEP250;PKD2;CROCC;CEP131;SDCCAG8;CEP72;NDE1
9089,GO:0035357,0.801627688423698,0.538745352964651,1,14,peroxisome proliferator activated receptor signaling pathway,BP,ALOX15B
1330,GO:0003181,0.80194339567062,0.538242474974191,1,14,atrioventricular valve morphogenesis,BP,ZFPM1
815,GO:0002089,0.801981809967414,0.538181250512342,1,14,lens morphogenesis in camera-type eye,BP,PROX1
15619,GO:0072111,0.802030600412143,0.538103477407904,1,14,cell proliferation involved in kidney development,BP,EGR1
9073,GO:0035329,0.802092484277718,0.389089378968583,3,38,hippo signaling,BP,WWTR1;WWC3;NPHP4
11667,GO:0046460,0.802094033303702,0.434739320347205,2,27,neutral lipid biosynthetic process,BP,LDLR;PCK2
11670,GO:0046463,0.802094033303702,0.434739320347205,2,27,acylglycerol biosynthetic process,BP,LDLR;PCK2
15167,GO:0071305,0.802137825948334,0.537932513336855,1,14,cellular response to vitamin D,BP,CYP27B1
8684,GO:0034315,0.802595102482353,0.53720273516097,1,14,regulation of Arp2/3 complex-mediated actin nucleation,BP,CORO1B
11654,GO:0046427,0.802825790592366,0.387461948825491,3,40,positive regulation of JAK-STAT cascade,BP,PTK6;FYN;FGFR3
1384,GO:0003283,0.802873455877391,0.536757963689979,1,14,atrial septum development,BP,ZFPM1
1124,GO:0002712,0.803008076582556,0.433363765583635,2,27,regulation of B cell mediated immunity,BP,STAT6;TGFB1
1220,GO:0002889,0.803008076582556,0.433363765583635,2,27,regulation of immunoglobulin mediated immune response,BP,STAT6;TGFB1
13474,GO:0055022,0.803098802252168,0.536397590012359,1,14,negative regulation of cardiac muscle tissue growth,BP,PAK1
14193,GO:0061117,0.803098802252168,0.536397590012359,1,14,negative regulation of heart growth,BP,PAK1
3144,GO:0006743,0.803147829543538,0.534985444599963,1,15,ubiquinone metabolic process,BP,COQ2
4556,GO:0010639,0.803372740014012,0.257807418875133,26,280,negative regulation of organelle organization,BP,ERCC1;ESPN;EVI5L;VAT1;ARAP1;AKT1;TMOD2;CORO1B;TWF2;GSN;ARPIN;SPTB;BNIP3;CTBP1;FHOD3;SHANK3;EML2;TOM1L2;BOK;CAPG;PRKCD;DNM2;BCL2L1;LMNA;PFN2;KDM3A
13561,GO:0060039,0.803415616640149,0.535890485626524,1,14,pericardium development,BP,SMAD3
10424,GO:0043276,0.803418044457887,0.432745829331748,2,27,anoikis,BP,AKT1;CHEK2
3503,GO:0007413,0.803475770572498,0.535794140943146,1,14,axonal fasciculation,BP,EPHB2
17204,GO:0106030,0.803475770572498,0.535794140943146,1,14,neuron projection fasciculation,BP,EPHB2
9069,GO:0035315,0.803596423251071,0.432476774479824,2,27,hair cell differentiation,BP,FGFR1;SLITRK6
8935,GO:0034975,0.803657677759143,0.535502674984785,1,14,protein folding in endoplasmic reticulum,BP,ERO1B
17306,GO:0140097,0.803914108478444,0.274511778609435,16,179,catalytic activity, acting on DNA,MF,ERCC1;HMGA2;SMARCA1;ENDOG;POLD4;MPG;POLL;POLM;PRIMPOL;TOP3B;CHD2;NEIL1;DNMT3A;DNASE1L1;TEP1;TERC
11110,GO:0045143,0.804320055578742,0.431384122553931,2,27,homologous chromosome segregation,BP,LEMD2;SUN1
17198,GO:0106018,0.804364067535371,0.53436917272304,1,14,phosphatidylinositol-3,5-bisphosphate phosphatase activity,MF,SYNJ2
1798,GO:0004438,0.804364067535371,0.53436917272304,1,14,phosphatidylinositol-3-phosphatase activity,MF,SYNJ2
13396,GO:0052744,0.804364067535371,0.53436917272304,1,14,phosphatidylinositol monophosphate phosphatase activity,MF,SYNJ2
3441,GO:0007254,0.804421629015485,0.279567944586649,14,157,JNK cascade,BP,PDCD4;WNT7A;PKN1;EGFR;ERCC6;ADORA2B;AKT1;CDC42EP5;PTPN1;MINK1;IRAK1;VANGL2;PAK1;MAP3K10
20280,GO:2001224,0.804473996178153,0.534192537530015,1,14,positive regulation of neuron migration,BP,NSMF
5117,GO:0015459,0.804496548853481,0.43111733987193,2,27,potassium channel regulator activity,MF,KCNAB2;PRKCZ
3475,GO:0007339,0.80536412851194,0.531422047539723,1,15,binding of sperm to zona pellucida,BP,ZP3
6119,GO:0019369,0.805516164931776,0.429573913268753,2,27,arachidonic acid metabolic process,BP,ALOX15B;MAPK3
11328,GO:0045662,0.807081103270218,0.528643419479155,1,15,negative regulation of myoblast differentiation,BP,TGFB1
17779,GO:1901798,0.807276527000564,0.527158277085382,1,16,positive regulation of signal transduction by p53 class mediator,BP,ZNF385A
4570,GO:0010657,0.808010303332885,0.380241088798872,3,39,muscle cell apoptotic process,BP,PDCD4;RGL2;BNIP3
11680,GO:0046475,0.808388752078439,0.526516540871775,1,15,glycerophospholipid catabolic process,BP,LDLR
13519,GO:0055106,0.808773136793657,0.524719373520955,1,16,ubiquitin-protein transferase regulator activity,MF,TRIB2
6710,GO:0030126,0.808991644525796,0.525532812416519,1,15,COPI vesicle coat,CC,SCYL1
5925,GO:0018200,0.809041103761071,0.52545202271461,1,15,peptidyl-glutamic acid modification,BP,TTLL3
723,GO:0001953,0.809164463311593,0.42402038315428,2,27,negative regulation of cell-matrix adhesion,BP,POSTN;ADAM15
6933,GO:0030547,0.809641633798363,0.524470013823461,1,15,receptor inhibitor activity,MF,PCSK9
14815,GO:0070555,0.809987399961724,0.279403819932537,12,143,response to interleukin-1,BP,EGR1;MAPK13;CEBPB;ADAMTS7;RPS6KA5;IRAK1;MTHFR;PELI1;MAPK3;HYAL1;PELI3;TOLLIP
12474,GO:0050432,0.810062802515344,0.523780124709869,1,15,catecholamine secretion,BP,NISCH
2824,GO:0006294,0.810844956162576,0.420493489371627,2,29,nucleotide-excision repair, preincision complex assembly,BP,XPC;DDB2
361,GO:0000980,0.81114239182372,0.348876278972698,4,51,RNA polymerase II distal enhancer sequence-specific DNA binding,MF,SMARCD2;MBD3;BACH1;NR2F6
3302,GO:0007006,0.811745192880579,0.298397297738662,8,99,mitochondrial membrane organization,BP,BNIP3;MOAP1;BOK;TFDP2;BNIP3L;BAX;TAZ;BCL2L1
5133,GO:0015630,0.811757884383279,0.21953888641966,96,967,microtubule cytoskeleton,CC,BBS2;NDRG1;NEK9;MTA1;OBSL1;SPRY2;ARL2;CLIP2;NUDCD3;MAP2K2;MAP2K1;MARK4;KLC2;DVL1;FAM110C;REEP4;AKT1;PITPNM1;DYSF;BRSK1;IFT140;PRKACB;MAPKBP1;KCNAB2;NPHP4;LZTS2;RAB11FIP4;EVC;CEP250;MPLKIP;RAD23A;SEPT10;CCDC113;CDC25B;PROCR;PKD2;ABCA2;KIF17;NUDCD2;SNPH;CLTCL1;SCYL1;SNTB2;EML2;KIF26B;ENKD1;CROCC;DNAH1;KIF7;SAC3D1;TUBG2;BBS1;CEP131;PRKCZ;PRKACA;ACTR1B;CAPG;SDCCAG8;ADGRB2;NINL;MZT2A;RILPL1;USP20;CCDC92;NUBP2;MZT2B;DNM1;WASH3P;RGS14;REEP2;WDR60;EML3;PLA2G6;SPPL2B;DNM2;NEIL1;KIF26A;TUBB6;CEP72;CUL7;CAPRIN2;BCL2L1;RABGAP1;SIRT2;MAPRE3;RAB28;RAP1GAP2;NDE1;PXN;MSS51;KIF13B;TACC1;SEPT6;CCDC88C;CDC42BPG;TTLL3
3548,GO:0007586,0.811799685356506,0.374433197281583,3,40,digestion,BP,STK39;LDLR;PRSS3
18248,GO:1903046,0.812066173367113,0.285981786957176,10,116,meiotic cell cycle process,BP,ERCC1;CDC25B;TUBG2;PIM2;TDRKH;EREG;LEMD2;SUN1;SIRT2;GPR3
992,GO:0002448,0.812088975587767,0.419039103557005,2,28,mast cell mediated immunity,BP,ADORA2B;RAC2
6758,GO:0030199,0.812143830764636,0.419448741908683,2,27,collagen fibril organization,BP,LOXL1;CHADL
15975,GO:0080134,0.812782469867647,0.218242790457753,97,988,regulation of response to stress,BP,TNIP1;NT5E;XDH;ERCC1;HTRA1;NR1D1;EDEM1;PLAT;PDCD4;VEGFA;WNT7A;APOE;F2R;HMGA2;PKN1;EGFR;SERPINE2;PTPRS;MAP2K2;MAP2K1;ACP5;MCTP1;ENDOG;SMAD3;ERCC6;HBEGF;ADORA2B;AKT1;F12;STK39;SERPING1;GGT1;IMPACT;IFNGR2;FNDC4;LDLR;PRKACB;MAPKBP1;RAG1;CEACAM1;ZNF385A;NSMCE4A;MAPK13;PLAU;CTSB;CARD11;MAPKAPK3;BCR;ERRFI1;SHARPIN;FAM3A;YPEL3;IL20RB;MAGEF1;ADAM8;CD81;RNF135;TGFB1;TMEM173;PTPN1;TRAP1;PRKACA;MINK1;CD9;ADA;BOK;PRKCD;BAX;EREG;RPS6KA5;LRSAM1;IRAK1;CHEK2;PPARA;TMEM161A;SESN2;BCAP31;MIF;DDT;WFS1;FYN;STK25;PELI1;APOBEC3F;MAPK3;GRINA;ETAA1;VANGL2;PAK1;SEMA4C;BCL2L1;LMNA;SIRT2;MAP3K10;GCH1;TERC;ZP3
13040,GO:0051539,0.812912166532701,0.372538864968912,3,41,4 iron, 4 sulfur cluster binding,MF,RSAD1;NUBP2;ACO2
7967,GO:0032587,0.813421121491798,0.314665330349602,6,73,ruffle membrane,CC,SPRY2;SPRY4;ABCA7;DNM2;ARHGEF4;PAK1
11474,GO:0045944,0.81347374855587,0.220891922342401,78,791,positive regulation of transcription by RNA polymerase II,BP,TNIP1;MEF2D;CITED4;EGR1;NR1D1;APLN;VEGFA;WNT7A;LRP5;ITGA6;HMGA2;ELK3;EGFR;WWTR1;NOS1;NFATC4;ETV5;HEXB;ETV4;POU2F2;FOS;SMAD3;STAT6;PIK3R2;EPAS1;SALL2;AKT1;HDAC5;ASH2L;HLTF;KLF7;PKD2;CRTC1;ZMIZ2;CD81;CEBPB;TGFB1;RFX2;TMEM173;PEG3;MC1R;ABHD14B;AGRN;MLXIPL;KDM6B;TFDP2;PBX2;RPS6KA5;SOX12;MBTPS2;CARF;IER2;FHOD1;ZFPM1;PPARA;SESN2;SIX5;SSBP4;MAPK3;CAMTA2;PFKM;RERE;PPP3CB;CAPRIN2;PPP2R5B;PROX1;PKD1;SIRT2;BACH1;E2F5;NGFR;MAFF;CAMK1;EZH1;TCEA2;PLAG1;IRF2BPL;KDM3A
17908,GO:1902188,0.814839052015625,0.515887727933439,1,15,positive regulation of viral release from host cell,BP,PC
1761,GO:0004364,0.815146849097707,0.512241042700236,1,18,glutathione transferase activity,MF,GSTO1
15894,GO:0072666,0.815151896057547,0.369506002945147,3,40,establishment of protein localization to vacuole,BP,SORL1;AP3D1;WASH3P
9850,GO:0042104,0.81518110672209,0.514137788672963,1,16,positive regulation of activated T cell proliferation,BP,IGFBP2
2201,GO:0005086,0.815702814538591,0.514446780030409,1,15,ARF guanyl-nucleotide exchange factor activity,MF,IQSEC1
18694,GO:1904030,0.815723694915642,0.413417626233796,2,28,negative regulation of cyclin-dependent protein kinase activity,BP,CDKN1C;CAMK2N1
5455,GO:0016331,0.816008454331746,0.280929548304602,10,116,morphogenesis of embryonic epithelium,BP,DVL1;WNT2B;PRKACB;LAMA5;TGFB1;DEAF1;VANGL2;SEMA4C;TCTN1;CELSR1
19059,GO:1904894,0.816321818490772,0.367516216046636,3,41,positive regulation of STAT cascade,BP,PTK6;FYN;FGFR3
6578,GO:0022411,0.816800364592116,0.228146147425874,44,477,cellular component disassembly,BP,H1F0;HTRA1;CST3;LRP5;NEK9;CAPN2;MMP1;ENDOG;LRP1;DVL1;SH3PXD2B;TMOD2;BSG;FGFR4;TWF2;GSN;MRPS6;SPTB;SMARCD2;BNIP3;SHARPIN;FYCO1;ADAM8;TIMP2;TGFB1;ATG2A;BOK;CAPG;MMP10;BNIP3L;FSCN1;BAX;SH3BP1;ZDHHC8;NID1;MRPS26;ADAM15;INSR;CAMKK2;MICAL1;VPS16;LMNA;WIPI2;DEDD2
10526,GO:0043473,0.817584149434851,0.308816761293297,6,75,pigmentation,BP,BBS2;AP3D1;MC1R;BAX;EDA;BLOC1S4
4941,GO:0014904,0.817799379984444,0.510931599652862,1,15,myotube cell development,BP,FAM129B
19181,GO:1905209,0.817883749011834,0.51078961721484,1,15,positive regulation of cardiocyte differentiation,BP,TGFB1
3331,GO:0007045,0.818005248191552,0.321410167945435,5,62,cell-substrate adherens junction assembly,BP,VEGFA;SMAD3;PPM1F;LAMA5;RHOD
12077,GO:0048041,0.818005248191552,0.321410167945435,5,62,focal adhesion assembly,BP,VEGFA;SMAD3;PPM1F;LAMA5;RHOD
7972,GO:0032592,0.818219422175962,0.320729100306226,5,65,integral component of mitochondrial membrane,CC,BNIP3;OXA1L;TIMM17B;PPOX;COQ2
11616,GO:0046329,0.818584221722741,0.408958225239492,2,28,negative regulation of JNK cascade,BP,PDCD4;AKT1
6279,GO:0019886,0.819019883110322,0.30686138017834,6,75,antigen processing and presentation of exogenous peptide antigen via MHC class II,BP,KLC2;AP2A2;ACTR1B;DNM2;KIF26A;CTSF
16006,GO:0086019,0.819258853726997,0.508469710508879,1,15,cell-cell signaling involved in cardiac conduction,BP,SCN4B
364,GO:0000983,0.819365438261908,0.508289438122567,1,15,transcription factor activity, RNA polymerase II core promoter sequence-specific DNA binding,MF,SMAD3
6667,GO:0030033,0.819367212094422,0.508286437383454,1,15,microvillus assembly,BP,FSCN1
6714,GO:0030131,0.819974441961953,0.406779571121243,2,28,clathrin adaptor complex,CC,EGFR;AP2A2
12261,GO:0048566,0.820157550063253,0.506947629852492,1,15,embryonic digestive tract development,BP,ADA
15449,GO:0071786,0.820228840837181,0.506826686985041,1,15,endoplasmic reticulum tubular network organization,BP,REEP2
15024,GO:0070971,0.820638674600681,0.506130840482548,1,15,endoplasmic reticulum exit site,CC,PDCD6
16947,GO:0098930,0.820856095029232,0.360782727780898,3,41,axonal transport,BP,AP3D1;BLOC1S4;TRIM46
16662,GO:0097542,0.820914339173945,0.360695826393128,3,41,ciliary tip,CC,IFT140;KIF7;WDR60
4577,GO:0010664,0.821127282632564,0.505299963406416,1,15,negative regulation of striated muscle cell apoptotic process,BP,RGL2
16260,GO:0090317,0.821599150122099,0.403766034785025,2,29,negative regulation of intracellular protein transport,BP,GAS6;GDI1
15375,GO:0071624,0.821916578407961,0.50172092597163,1,17,positive regulation of granulocyte chemotaxis,BP,RAC2
5910,GO:0018149,0.822165365146962,0.400699440331587,2,35,peptide cross-linking,BP,LCE1E;ABCA7
3946,GO:0008649,0.822215045858631,0.502255510290478,1,16,rRNA methyltransferase activity,MF,RRNAD1
17309,GO:0140102,0.822215045858631,0.502255510290478,1,16,catalytic activity, acting on a rRNA,MF,RRNAD1
4254,GO:0009583,0.822215572626225,0.403251581979761,2,28,detection of light stimulus,BP,PITPNM1;REEP6
10690,GO:0043981,0.822239934623724,0.503402677951554,1,15,histone H4-K5 acetylation,BP,JADE2
10691,GO:0043982,0.822239934623724,0.503402677951554,1,15,histone H4-K8 acetylation,BP,JADE2
4689,GO:0010842,0.822685806768269,0.502640334880629,1,15,retina layer formation,BP,SDK2
5819,GO:0017085,0.822875771304932,0.502315180629475,1,15,response to insecticide,BP,MAPK13
11834,GO:0046823,0.823506227654284,0.500043109232814,1,16,negative regulation of nucleocytoplasmic transport,BP,GAS6
10169,GO:0042762,0.82358984545473,0.501091018199767,1,15,regulation of sulfur metabolic process,BP,PDK1
19899,GO:2000369,0.823830093773936,0.500678471437296,1,15,regulation of clathrin-dependent endocytosis,BP,ARAP3
12536,GO:0050691,0.82385300763045,0.400203755852535,2,29,regulation of defense response to virus by host,BP,TMEM173;APOBEC3F
19491,GO:1990204,0.824400351333976,0.298505546953518,6,87,oxidoreductase complex,CC,CBR4;DHTKD1;SDHA;PDK1;CYC1;NDUFV3
7065,GO:0030859,0.824438938844751,0.499631442565673,1,15,polarized epithelial cell differentiation,BP,SH3BP1
2344,GO:0005385,0.824465144987506,0.49958632629891,1,15,zinc ion transmembrane transporter activity,MF,SLC39A3
15342,GO:0071577,0.824465144987506,0.49958632629891,1,15,zinc ion transmembrane transport,BP,SLC39A3
7827,GO:0032387,0.824695035185142,0.354784944396547,3,42,negative regulation of intracellular transport,BP,GAS6;PCSK9;GDI1
11037,GO:0045026,0.824869811624201,0.497695926225436,1,16,plasma membrane fusion,BP,CD9
10605,GO:0043596,0.825087834354582,0.354441576597379,3,41,nuclear replication fork,CC,POLD4;ZMIZ2;ETAA1
1304,GO:0003143,0.825175074599958,0.354570890440695,3,40,embryonic heart tube morphogenesis,BP,SMAD3;PKD2;VANGL2
10216,GO:0042887,0.825428427878557,0.397276373886883,2,30,amide transmembrane transporter activity,MF,SLC15A4;TIMM17B
8658,GO:0034237,0.825543174994668,0.497726835684054,1,15,protein kinase A regulatory subunit binding,MF,PRKACA
5462,GO:0016342,0.825675207670839,0.4974986134422,1,15,catenin complex,CC,CDH4
3494,GO:0007398,0.825853460098343,0.497190332579837,1,15,ectoderm development,BP,ITGA6
15992,GO:0086005,0.825896161562513,0.497116453591729,1,15,ventricular cardiac muscle cell action potential,BP,SNTA1
14044,GO:0060828,0.825927689186388,0.245029790156405,17,197,regulation of canonical Wnt signaling pathway,BP,EGR1;WNT7A;APOE;LRP5;WWTR1;SMURF2;DVL1;WNT2B;NPHP4;LZTS2;IGFBP4;IGFBP2;LRP4;SOX7;CAPRIN2;EDA;LRRK1
459,GO:0001325,0.825994092243583,0.496946979491704,1,15,formation of extrachromosomal circular DNA,BP,ERCC1
16356,GO:0090656,0.825994092243583,0.496946979491704,1,15,t-circle formation,BP,ERCC1
16383,GO:0090737,0.825994092243583,0.496946979491704,1,15,telomere maintenance via telomere trimming,BP,ERCC1
70,GO:0000146,0.826002972348995,0.496931609150973,1,15,microfilament motor activity,MF,MYO1D
5731,GO:0016877,0.826050598015669,0.397168498217343,2,28,ligase activity, forming carbon-sulfur bonds,MF,ACSF2;SLC27A1
7486,GO:0031664,0.826068083981494,0.495624135523858,1,16,regulation of lipopolysaccharide-mediated signaling pathway,BP,MIF
16724,GO:0097731,0.826672728771132,0.326448407055997,4,52,9+0 non-motile cilium,CC,SHANK2;IFT140;NPHP4;KIF17
16726,GO:0097733,0.826672728771132,0.326448407055997,4,52,photoreceptor cell cilium,CC,SHANK2;IFT140;NPHP4;KIF17
1322,GO:0003170,0.82673423192232,0.39607795367182,2,28,heart valve development,BP,TGFB1;ZFPM1
6251,GO:0019835,0.827168617040267,0.492663166182697,1,17,cytolysis,BP,TSTA3
15052,GO:0071011,0.827402109465911,0.393731747611293,2,31,precatalytic spliceosome,CC,MAPKBP1;TEP1
6810,GO:0030275,0.827519729677948,0.493102689510959,1,16,LRR domain binding,MF,ZXDC
7959,GO:0032570,0.828023198530372,0.393559407383414,2,29,response to progesterone,BP,FOS;TGFB1
4340,GO:0009894,0.828123653611679,0.205407942755002,74,768,regulation of catabolic process,BP,EDEM1;CST3;TYSND1;APOE;EGFR;SERPINE2;TRIM65;VPS11;TBC1D14;GTPBP1;SNX9;RAPGEF3;ZFP36L1;ENDOG;SMURF2;SMAD3;PIK3R2;LRP1;DVL1;AKT1;TPCN1;DAP;LDLR;SORL1;CIRBP;PCBP4;CSNK1E;PCSK9;RAD23A;SH3D19;BNIP3;FYCO1;GPSM1;MAGEF1;ADAM8;CD81;TIMP2;ULK2;SNX33;PTPN1;PFKFB2;MLXIPL;TRIB2;PRKACA;PIM2;BOK;ULK1;BNIP3L;PRKCD;STUB1;BAX;DDIT4;ZDHHC8;LPCAT1;LRSAM1;LONP2;CHEK2;PPARA;SESN2;RAB12;BCAP31;QSOX1;FYN;MAPK3;INSR;CAMKK2;RNF144A;PFKFB3;MLYCD;PKD1;SIRT2;AZIN2;HFE;SPTLC2
10946,GO:0044665,0.828161412948381,0.393337992984343,2,29,MLL1/2 complex,CC,ASH2L;INO80C
15190,GO:0071339,0.828161412948381,0.393337992984343,2,29,MLL1 complex,CC,ASH2L;INO80C
8683,GO:0034314,0.828192504007096,0.393288175581549,2,29,Arp2/3 complex-mediated actin nucleation,BP,CORO1B;WASH3P
4750,GO:0010923,0.828710231418189,0.293552777510079,6,75,negative regulation of phosphatase activity,BP,PPP1R35;PPP1R14A;FARP1;MYO1D;ELFN2;DLG3
13616,GO:0060122,0.828851276681171,0.490778604723517,1,16,inner ear receptor cell stereocilium organization,BP,VANGL2
14021,GO:0060761,0.829021908138917,0.34824942398897,3,42,negative regulation of response to cytokine stimulus,BP,GAS6;ECM1;PELI3
16766,GO:0098573,0.829037292307468,0.305425046692672,5,66,intrinsic component of mitochondrial membrane,CC,BNIP3;OXA1L;TIMM17B;PPOX;COQ2
13493,GO:0055072,0.829069201384399,0.305379855009009,5,66,iron ion homeostasis,BP,EPAS1;CYBRD1;SLC22A17;SLC25A37;HFE
18353,GO:1903307,0.829130153184731,0.391783928718683,2,29,positive regulation of regulated secretory pathway,BP,ADORA2B;ZP3
5224,GO:0015833,0.829578530698604,0.194481457498361,149,1526,peptide transport,BP,NR1D1;EDEM1;APLN;ACVR2B;PRNP;BBS2;POSTN;APOE;F2R;LRP5;IDH2;ITPR3;ARRDC1;EVI5L;EGFR;TMEM129;HADH;LTBP4;SYTL1;LMF1;LTBP2;VPS11;TBC1D14;ARL2;SNX9;RAPGEF3;GLUL;POU2F2;EXOC2;PIK3R2;LRP1;AP2A2;NLGN2;STOM;AKT1;PITPNM1;RHBDF2;HK1;SLC15A4;ATG16L2;RAB31;MAPKBP1;RAC2;PFKL;TOMM34;SORL1;B3GAT3;ANK3;STRADB;GAS6;RAB3B;CARD11;BCR;XPOT;AIP;ALOX15B;AGAP1;PEX10;CORO7;UNC119B;MVB12B;CEMIP;AP3D1;ADAM8;KIF17;TMED4;TGFB1;CLTCL1;TBC1D9B;TMEM173;MIPEP;RHOD;SNX17;VGF;SNX33;LLGL1;BBS1;PTPN1;PEX1;PCK2;ZDHHC24;CEP131;PFKFB2;PRKCZ;TOM1L2;MICALL2;NEURL1B;ERBB2;VAMP2;NECAB3;RILPL1;BNIP3L;ARHGAP44;MCFD2;PRKCD;OLFM2;TIMM17B;RASL10B;ZDHHC8;GDI1;WASH3P;LRSAM1;REEP2;EHD3;LONP2;SYMPK;COG7;ABCG1;RAB12;BCAP31;MIF;DOPEY2;PLA2G6;SYNGR1;NBPF3;FYN;TMCO6;DNM2;SNX15;ZDHHC1;MAPK3;RTN2;PFKM;RERE;STX10;PRAF2;PAK1;PPP3CB;VPS16;SGSM2;TBC1D16;PKD1;RABGAP1;RAB28;ICA1;RAB40B;NGFR;PDCD6;ATP6V1F;PCLO;TBC1D8;PLEKHM1;KIF13B;CAMK1;SIRT3;HFE;VPS51;APBA1;SRSF5
3431,GO:0007224,0.829665323799591,0.274823251860809,8,97,smoothened signaling pathway,BP,SERPINE2;IFT140;PRKACB;EVC;KIF7;TMEM231;MAP3K10;TCTN1
6912,GO:0030510,0.830425501919702,0.320977753824896,4,52,regulation of BMP signaling pathway,BP,HTRA1;SMURF2;LEMD2;ITGA3
7652,GO:0032088,0.830928584644813,0.302859631309083,5,65,negative regulation of NF-kappaB transcription factor activity,BP,RBCK1;DAP;IRAK1;PELI1;CAT
19649,GO:1990823,0.831128120735087,0.290201306716488,6,75,response to leukemia inhibitory factor,BP,SPRY2;PFKP;RFX2;SYNGR1;ARID5B;KDM3A
19652,GO:1990830,0.831128120735087,0.290201306716488,6,75,cellular response to leukemia inhibitory factor,BP,SPRY2;PFKP;RFX2;SYNGR1;ARID5B;KDM3A
10042,GO:0042509,0.831201259001343,0.344935041553867,3,42,regulation of tyrosine phosphorylation of STAT protein,BP,PTK6;FYN;FGFR3
12543,GO:0050701,0.831303562789929,0.387858639989714,2,30,interleukin-1 secretion,BP,HK1;GAS6
200,GO:0000422,0.831328554503312,0.28973708562685,6,77,autophagy of mitochondrion,BP,BNIP3;ATG2A;BNIP3L;ZDHHC8;CAMKK2;WIPI2
14418,GO:0061726,0.831328554503312,0.28973708562685,6,77,mitochondrion disassembly,BP,BNIP3;ATG2A;BNIP3L;ZDHHC8;CAMKK2;WIPI2
14542,GO:0070063,0.831482124390401,0.319260858436582,4,53,RNA polymerase binding,MF,STOM;ERBB2;BIN1;UVSSA
10191,GO:0042800,0.831656669256887,0.485846442025357,1,16,histone methyltransferase activity (H3-K4 specific),MF,ASH2L
8179,GO:0032925,0.832140359931379,0.484991134425322,1,16,regulation of activin receptor signaling pathway,BP,ACVR2B
19636,GO:1990776,0.832632104923516,0.484120085950561,1,16,response to angiotensin,BP,PRKCD
14197,GO:0061136,0.83268996028681,0.247180346721549,13,153,regulation of proteasomal protein catabolic process,BP,EDEM1;DVL1;AKT1;CSNK1E;RAD23A;TRIB2;PRKACA;STUB1;BCAP31;RNF144A;PKD1;SIRT2;HFE
17017,GO:0099132,0.832761017910889,0.385500531457746,2,30,ATP hydrolysis coupled cation transmembrane transport,BP,ATP7B;ATP6V1F
3323,GO:0007034,0.833040082585968,0.258689613484667,10,119,vacuolar transport,BP,VPS11;SORL1;PCSK9;AP3D1;WASH3P;EHD3;RAB12;BIN1;VPS16;VPS51
9917,GO:0042269,0.833287064263199,0.482957574709404,1,16,regulation of natural killer cell mediated cytotoxicity,BP,CEACAM1
2848,GO:0006337,0.833292468969093,0.482947970482289,1,16,nucleosome disassembly,BP,SMARCD2
4680,GO:0010830,0.833387224686184,0.384909044717536,2,29,regulation of myotube differentiation,BP,HDAC5;FAM129B
6504,GO:0021884,0.833401160423144,0.482754785463922,1,16,forebrain neuron development,BP,RAC3
6235,GO:0019789,0.834111540864387,0.4814903413692,1,16,SUMO transferase activity,MF,HDAC7
10894,GO:0044447,0.834153466029958,0.481415616893686,1,16,axoneme part,CC,DNAH1
6823,GO:0030291,0.834734966835035,0.382292673330021,2,30,protein serine/threonine kinase inhibitor activity,MF,SPRY2;CDKN1C
10173,GO:0042770,0.83479483964327,0.256298388348,10,121,signal transduction in response to DNA damage,BP,NDRG1;ZNF385A;PCBP4;TFDP2;RBL2;BAX;RPS6KA6;CHEK2;SESN2;MIF
406,GO:0001091,0.834856858232917,0.480160278727877,1,16,RNA polymerase II basal transcription factor binding,MF,ERCC1
11342,GO:0045685,0.835352056743677,0.338824998705767,3,41,regulation of glial cell differentiation,BP,SERPINE2;LDLR;BIN1
3770,GO:0008327,0.835652911035099,0.478735775104714,1,16,methyl-CpG binding,MF,MBD3
16032,GO:0086064,0.835680712416679,0.478685952622093,1,16,cell communication by electrical coupling involved in cardiac conduction,BP,PRKACA
12798,GO:0051101,0.835736707906636,0.273979235764491,7,90,regulation of DNA binding,BP,CTNNBIP1;HMGA2;MDFI;TGFB1;PPARA;SIRT2;FAM129B
20124,GO:2000778,0.835742702281857,0.47857484363097,1,16,positive regulation of interleukin-6 secretion,BP,F2R
761,GO:0002009,0.835779524708148,0.210223328454698,37,398,morphogenesis of an epithelium,BP,PGF;CTNNBIP1;VEGFA;WNT7A;LRP5;EGFR;SPRY2;NFATC4;ETV5;FOXQ1;SMURF2;SMAD3;DVL1;HBEGF;AP2A2;WNT2B;FGFR1;PRKACB;CEACAM1;EDNRA;LAMA5;PKD2;CTSZ;TGFB1;DEAF1;KIF26B;AREG;SH3BP1;ARHGAP12;VANGL2;PAK1;SEMA4C;DLG3;PROX1;PKD1;TCTN1;CELSR1
4450,GO:0010390,0.835866113639649,0.380871048352313,2,29,histone monoubiquitination,BP,DDB2;RAG1
1012,GO:0002495,0.83589415552072,0.28337372677654,6,77,antigen processing and presentation of peptide antigen via MHC class II,BP,KLC2;AP2A2;ACTR1B;DNM2;KIF26A;CTSF
689,GO:0001910,0.836045313160531,0.380154205546254,2,30,regulation of leukocyte mediated cytotoxicity,BP,CEACAM1;PPP3CB
16723,GO:0097730,0.836126965011899,0.295560941657308,5,64,non-motile cilium,CC,SHANK2;IFT140;NPHP4;PKD2;KIF17
449,GO:0001223,0.836387821091354,0.477417089632339,1,16,transcription coactivator binding,MF,PPARA
12552,GO:0050710,0.836584618860064,0.37927195775742,2,30,negative regulation of cytokine secretion,BP,MAPKBP1;GAS6
9736,GO:0038201,0.836936991309097,0.476429423461962,1,16,TOR complex,CC,SESN2
9931,GO:0042287,0.836939880595982,0.476424222034826,1,16,MHC protein binding,MF,BCAP31
3242,GO:0006903,0.837319651459098,0.281377581204916,6,77,vesicle targeting,BP,TRAPPC9;CTSZ;AREG;MCFD2;TGFA;PDCD6
5404,GO:0016242,0.837366598841337,0.378414200847633,2,29,negative regulation of macroautophagy,BP,AKT1;QSOX1
472,GO:0001516,0.837859284134775,0.473704990587704,1,17,prostaglandin biosynthetic process,BP,MIF
11665,GO:0046457,0.837859284134775,0.473704990587704,1,17,prostanoid biosynthetic process,BP,MIF
18816,GO:1904355,0.838200034081828,0.474150493171711,1,16,positive regulation of telomere capping,BP,MAPK3
8054,GO:0032729,0.838360217102587,0.376358516928472,2,30,positive regulation of interferon-gamma production,BP,ZFPM1;ZP3
1556,GO:0003954,0.838810537854885,0.372593647822332,2,40,NADH dehydrogenase activity,MF,NARF;NDUFV3
11435,GO:0045892,0.838852643008033,0.191110460614384,86,897,negative regulation of transcription, DNA-templated,BP,ZMYND8;EGR1;NR1D1;PDCD4;CTNNBIP1;ACVR2B;VEGFA;HMGA2;ELK3;WWTR1;NFATC4;BAHCC1;SHC1;TCFL5;ZC3H6;MDFI;FOXQ1;MXD4;SMURF2;SMAD3;STAT6;DNAJB5;PRDX5;SALL2;HDAC5;PPM1F;SCMH1;IMPACT;WWC3;DAP;FGFR1;MXI1;H2AFJ;TENM2;TSHZ1;CCND1;TCF25;GAS6;TAGLN3;HES2;CTBP1;MNT;CDKN1C;CEBPB;ZNF217;TGFB1;DEAF1;NAB2;PEG3;PHF21A;MBD3;VHL;MLXIPL;TFDP2;NELFCD;EREG;RPS6KA5;PPP1R13L;ZHX3;HDAC7;CBX7;ZFPM1;PPARA;SOX7;SIX5;WFS1;ARID5B;BHLHE40;SATB1;RERE;BCL7A;WDTC1;HES7;DNMT3A;HES6;PROX1;SIRT2;FAM129B;BACH1;MAP3K10;NR2F6;CBX6;ZP3;TNRC18;IRF2BPL;DEDD2
181,GO:0000394,0.839415245800177,0.470885336398243,1,17,RNA splicing, via endonucleolytic cleavage and ligation,BP,TRPT1
11615,GO:0046328,0.839645475559653,0.245552536169245,11,130,regulation of JNK cascade,BP,PDCD4;WNT7A;PKN1;EGFR;ERCC6;AKT1;PTPN1;MINK1;VANGL2;PAK1;MAP3K10
2821,GO:0006289,0.83968585618275,0.254889091458704,9,113,nucleotide-excision repair,BP,ERCC1;XPC;DDB2;ERCC6;POLD4;RAD23A;POLL;NEIL1;UVSSA
10215,GO:0042886,0.839762658877529,0.183319845661521,150,1540,amide transport,BP,NR1D1;EDEM1;APLN;ACVR2B;PRNP;BBS2;POSTN;APOE;F2R;LRP5;IDH2;ITPR3;ARRDC1;EVI5L;EGFR;TMEM129;HADH;LTBP4;SYTL1;LMF1;LTBP2;VPS11;TBC1D14;ARL2;SNX9;RAPGEF3;GLUL;PLTP;POU2F2;EXOC2;PIK3R2;LRP1;AP2A2;NLGN2;STOM;AKT1;PITPNM1;RHBDF2;HK1;SLC15A4;ATG16L2;RAB31;MAPKBP1;RAC2;PFKL;TOMM34;SORL1;B3GAT3;ANK3;STRADB;GAS6;RAB3B;CARD11;BCR;XPOT;AIP;ALOX15B;AGAP1;PEX10;CORO7;UNC119B;MVB12B;CEMIP;AP3D1;ADAM8;KIF17;TMED4;TGFB1;CLTCL1;TBC1D9B;TMEM173;MIPEP;RHOD;SNX17;VGF;SNX33;LLGL1;BBS1;PTPN1;PEX1;PCK2;ZDHHC24;CEP131;PFKFB2;PRKCZ;TOM1L2;MICALL2;NEURL1B;ERBB2;VAMP2;NECAB3;RILPL1;BNIP3L;ARHGAP44;MCFD2;PRKCD;OLFM2;TIMM17B;RASL10B;ZDHHC8;GDI1;WASH3P;LRSAM1;REEP2;EHD3;LONP2;SYMPK;COG7;ABCG1;RAB12;BCAP31;MIF;DOPEY2;PLA2G6;SYNGR1;NBPF3;FYN;TMCO6;DNM2;SNX15;ZDHHC1;MAPK3;RTN2;PFKM;RERE;STX10;PRAF2;PAK1;PPP3CB;VPS16;SGSM2;TBC1D16;PKD1;RABGAP1;RAB28;ICA1;RAB40B;NGFR;PDCD6;ATP6V1F;PCLO;TBC1D8;PLEKHM1;KIF13B;CAMK1;SIRT3;HFE;VPS51;APBA1;SRSF5
7172,GO:0031061,0.839839802329446,0.471176354943111,1,16,negative regulation of histone methylation,BP,KDM3A
2400,GO:0005546,0.839907707588501,0.331539071692995,3,42,phosphatidylinositol-4,5-bisphosphate binding,MF,TWF2;PFN2;GSDMA
12625,GO:0050821,0.83995044868891,0.245040464435254,11,133,protein stabilization,BP,TSPAN1;CRTAP;SMAD3;DVL1;VHL;PIM2;PRKCD;CHEK2;COG7;WFS1;PFN2
25,GO:0000049,0.840414856942311,0.305898145659427,4,54,tRNA binding,MF,XPOT;DTD1;IARS2;AARS
11089,GO:0045109,0.841091547902573,0.468894119190839,1,16,intermediate filament organization,BP,KLHL24
13750,GO:0060337,0.84113574170429,0.287894431501934,5,68,type I interferon signaling pathway,BP,EGR1;PTPN1;IFI6;IRAK1;HLA-G
15205,GO:0071357,0.84113574170429,0.287894431501934,5,68,cellular response to type I interferon,BP,EGR1;PTPN1;IFI6;IRAK1;HLA-G
17549,GO:1901071,0.841252487370903,0.46859993647207,1,16,glucosamine-containing compound metabolic process,BP,CTBS
17540,GO:1901028,0.841477432455167,0.328865295739471,3,43,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,BOK;TFDP2;BAX
7887,GO:0032462,0.841615624957967,0.466870864390543,1,17,regulation of protein homooligomerization,BP,APOE
14785,GO:0070498,0.841694831767249,0.265576326420377,7,93,interleukin-1-mediated signaling pathway,BP,EGR1;RPS6KA5;IRAK1;PELI1;MAPK3;PELI3;TOLLIP
4311,GO:0009791,0.8419434352644,0.274961481495035,6,76,post-embryonic development,BP,ERCC1;ACVR2B;VEGFA;BAX;PPP1R13L;ARID5B
15990,GO:0086003,0.841958339634769,0.370835677333162,2,29,cardiac muscle cell contraction,BP,SCN4B;SNTA1
6342,GO:0021522,0.841996661290073,0.46723741847758,1,16,spinal cord motor neuron differentiation,BP,TCTN1
4719,GO:0010883,0.84258985662654,0.369363674337168,2,30,regulation of lipid storage,BP,PPARA;ABCG1
1323,GO:0003171,0.842984377060354,0.465423294324286,1,16,atrioventricular valve development,BP,ZFPM1
4557,GO:0010640,0.843378662134092,0.464697291217789,1,16,regulation of platelet-derived growth factor receptor signaling pathway,BP,LRP1
8985,GO:0035098,0.843526667627146,0.464424496698107,1,16,ESC/E(Z) complex,CC,EZH1
19725,GO:2000050,0.843715757197019,0.464075763971398,1,16,regulation of non-canonical Wnt signaling pathway,BP,CSNK1E
12081,GO:0048066,0.843729463470582,0.367465649389505,2,30,developmental pigmentation,BP,AP3D1;BAX
10884,GO:0044432,0.843833067443242,0.184482586267772,93,960,endoplasmic reticulum part,CC,H6PD;EDEM1;CST3;WNT7A;APOE;PLD3;OSBPL5;LPCAT4;ITPR3;EGFR;NOS1;TMEM129;CAPN2;CRTAP;LMF1;LTBP1;KDSR;MCTP1;SRD5A3;PIGQ;MBOAT7;REEP4;PITPNM1;RHBDF2;IFNGR2;SIGMAR1;PIGV;IGFBP4;CARD19;GAS6;PCSK9;ANO8;ANTXR2;COL13A1;PKD2;RETSAT;CTSZ;GPSM1;ENTPD2;ADAMTS13;WNT3;TMED4;ADAMTS7;TMEM173;LAMB2;ERO1B;VGF;UBXN4;PTPN1;ESYT2;AREG;BOK;ULK1;CERCAM;NECAB3;MCFD2;FAM20C;REEP6;BAX;SBF1;XYLT2;MBTPS2;HSD17B7;CES2;PDIA5;MSLN;LPCAT1;REEP2;TGFA;ABCG1;BCAP31;WFS1;QSOX1;SPPL2B;VWA1;CERS4;CYP3A5;IGFBP7;CYP2R1;RTN2;HLA-G;ATP8B2;RNASET2;SLC37A2;SAMD8;EDA;ALG12;LAMB1;HSD11B1;PDCD6;COL6A1;SPTLC2;SDC2
6387,GO:0021591,0.843841091175382,0.462777982571909,1,17,ventricular system development,BP,MBOAT7
15431,GO:0071711,0.84398443984748,0.463579825277059,1,16,basement membrane organization,BP,NID1
2620,GO:0005942,0.844208956068992,0.463165035808964,1,16,phosphatidylinositol 3-kinase complex,CC,PIK3R2
17491,GO:1900407,0.844301822667732,0.299929930987996,4,55,regulation of cellular response to oxidative stress,BP,ENDOG;AKT1;TRAP1;GCH1
12272,GO:0048596,0.844496851686566,0.462632655137562,1,16,embryonic camera-type eye morphogenesis,BP,PROX1
11337,GO:0045671,0.844672703286628,0.462307191596474,1,16,negative regulation of osteoclast differentiation,BP,INPP5D
2850,GO:0006342,0.844803831323394,0.260505268216556,7,107,chromatin silencing,BP,BAHCC1;HDAC5;H2AFJ;MBD3;DNMT3A;SIRT2;TNRC18
7138,GO:0030990,0.84489483267815,0.365518765574745,2,30,intraciliary transport particle,CC,IFT140;KIF17
1015,GO:0002504,0.845157248653175,0.270234323135051,6,78,antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,KLC2;AP2A2;ACTR1B;DNM2;KIF26A;CTSF
12629,GO:0050830,0.84516746851075,0.363045262423018,2,36,defense response to Gram-positive bacterium,BP,ACP5;RNASE7
17887,GO:1902116,0.845282236694877,0.364870222296328,2,30,negative regulation of organelle assembly,BP,EVI5L;DNM2
12558,GO:0050716,0.845509761446047,0.459687281084878,1,17,positive regulation of interleukin-1 secretion,BP,HK1
7555,GO:0031904,0.845517259740501,0.459673350189974,1,17,endosome lumen,CC,CTSB
1474,GO:0003730,0.845627160162587,0.298091185989911,4,54,mRNA 3'-UTR binding,MF,ZFP36L1;CIRBP;ZNF385A;PCBP4
19505,GO:1990266,0.846135126237993,0.321142055555687,3,45,neutrophil migration,BP,RAC2;ADAM8;ITGA1
1344,GO:0003206,0.847158120942076,0.26756486337024,6,76,cardiac chamber morphogenesis,BP,TGFB1;PPP1R13L;TGFBR3;ZFPM1;VANGL2;PROX1
6627,GO:0022904,0.84720558236456,0.266203231872162,6,94,respiratory electron transport chain,BP,D2HGDH;SDHA;CYC1;ETFB;TAZ;NDUFV3
11739,GO:0046596,0.847306129166616,0.455392667362805,1,18,regulation of viral entry into host cell,BP,GSN
477,GO:0001522,0.847309846003353,0.455385713914081,1,18,pseudouridine synthesis,BP,RPUSD3
11341,GO:0045684,0.847326037095411,0.361044937424588,2,31,positive regulation of epidermis development,BP,CYP27B1;ALOX15B
5920,GO:0018195,0.847437550585388,0.456093039101056,1,17,peptidyl-arginine modification,BP,PADI3
7070,GO:0030865,0.847936467882313,0.318958085924825,3,42,cortical cytoskeleton organization,BP,FMNL2;WIPF1;LLGL1
163,GO:0000339,0.848286732891724,0.4545016819314,1,17,RNA cap binding,MF,CYFIP2
10970,GO:0044769,0.848465982134923,0.45321819821524,1,18,ATPase activity, coupled to transmembrane movement of ions, rotational mechanism,MF,ATP6V1F
11909,GO:0046961,0.848465982134923,0.45321819821524,1,18,proton-transporting ATPase activity, rotational mechanism,MF,ATP6V1F
12243,GO:0048534,0.848504386119132,0.18668154203728,57,616,hematopoietic or lymphoid organ development,BP,ERCC1;EGR1;CTNNBIP1;VEGFA;FAM210B;LRP5;PKN1;ZFP36L1;CMTM7;MAP2K1;POU2F2;FOS;STAT6;EPAS1;HDAC5;ASH2L;LRRC8A;WNT2B;KCNAB2;RAG1;CEACAM1;ZNF385A;GAS6;CARD11;SH2B3;SOX13;DHTKD1;BCR;AP3D1;SH3PXD2A;ADAM8;CEBPB;TGFB1;MKNK2;POLM;IFNE;PRKCZ;ADA;ERBB2;JAK3;FAM20C;BAX;TGFBR3;MFNG;INPP5D;CHD2;ZFPM1;SATB1;MAPK3;TAZ;HLA-G;PPP3CB;RRAS;ITGA4;NBEAL2;ITPKB;LRRK1
6441,GO:0021762,0.848537850634133,0.359001074592378,2,31,substantia nigra development,BP,SIRT2;NDRG2
647,GO:0001838,0.848861466654185,0.248667738320574,8,99,embryonic epithelial tube formation,BP,DVL1;PRKACB;TGFB1;DEAF1;VANGL2;SEMA4C;TCTN1;CELSR1
7611,GO:0032008,0.849080238334074,0.358476276170703,2,30,positive regulation of TOR signaling,BP,GAS6;WDR59
16727,GO:0097734,0.849801859845576,0.451649909710128,1,17,extracellular exosome biogenesis,BP,SDC1
19487,GO:1990182,0.849801859845576,0.451649909710128,1,17,exosomal secretion,BP,SDC1
6728,GO:0030150,0.84981374928536,0.450679721828728,1,18,protein import into mitochondrial matrix,BP,TIMM17B
16094,GO:0090075,0.850013701108144,0.451249903607603,1,17,relaxation of muscle,BP,ADORA2B
10603,GO:0043588,0.850140616725106,0.207943125075223,21,244,skin development,BP,CYP27B1;ITGA6;EGFR;PRSS8;ZFP36L1;FOXQ1;MAP2K1;ITGB4;LAMA5;ERRFI1;ALOX15B;SHARPIN;LCE1E;LRP4;EREG;PPL;VANGL2;ITGA3;PKD1;EDA;CELSR1
2773,GO:0006206,0.850182913976519,0.450930163605676,1,17,pyrimidine nucleobase metabolic process,BP,UCKL1
12779,GO:0051082,0.850361474526138,0.246435110990592,8,102,unfolded protein binding,MF,NUDCD3;DNAJB5;AIP;FYCO1;NUDCD2;ERO1B;DNAJC4;TRAP1
11668,GO:0046461,0.850908456884302,0.449556912949957,1,17,neutral lipid catabolic process,BP,APOE
11671,GO:0046464,0.850908456884302,0.449556912949957,1,17,acylglycerol catabolic process,BP,APOE
16096,GO:0090079,0.851107236163245,0.449180030850853,1,17,translation regulator activity, nucleic acid binding,MF,MIF4GD
16718,GO:0097718,0.851234532722405,0.354820244813694,2,30,disordered domain specific binding,MF,AP2A2;FYN
20111,GO:2000757,0.851510769691478,0.448414077923146,1,17,negative regulation of peptidyl-lysine acetylation,BP,CTBP1
7406,GO:0031498,0.851650499843355,0.44814858490462,1,17,chromatin disassembly,BP,SMARCD2
11701,GO:0046503,0.851957339845113,0.353197466601099,2,31,glycerolipid catabolic process,BP,APOE;LDLR
13109,GO:0051656,0.852170384865689,0.19423091386613,32,351,establishment of organelle localization,BP,BBS2;SPRY2;SYTL1;ADORA2B;SYT8;RAC2;TRAPPC9;FYCO1;CTSZ;AP3D1;SNPH;CROCC;LLGL1;RIMS3;PRKCZ;AREG;VAMP2;MCFD2;LEMD2;DNM1;TGFA;FHOD1;STK25;SUN1;DNM2;ITGA4;NDE1;PDCD6;PCLO;PFN2;BLOC1S4;TRIM46
13057,GO:0051570,0.85242162774897,0.446680911998117,1,17,regulation of histone H3-K9 methylation,BP,KDM3A
871,GO:0002220,0.852837696441035,0.249975353252288,7,94,innate immune response activating cell surface receptor signaling pathway,BP,PRKACB;CARD11;PRKACA;PRKCD;RPS6KA5;FYN;PAK1
873,GO:0002223,0.852837696441035,0.249975353252288,7,94,stimulatory C-type lectin receptor signaling pathway,BP,PRKACB;CARD11;PRKACA;PRKCD;RPS6KA5;FYN;PAK1
4155,GO:0009219,0.852865755813596,0.444884230743482,1,18,pyrimidine deoxyribonucleotide metabolic process,BP,NEIL1
4958,GO:0015031,0.853398879446963,0.168667406172931,146,1507,protein transport,BP,NR1D1;EDEM1;ACVR2B;PRNP;BBS2;POSTN;APOE;F2R;LRP5;IDH2;ITPR3;ARRDC1;EVI5L;EGFR;TMEM129;HADH;SYTL1;LMF1;LTBP2;VPS11;TBC1D14;ARL2;SNX9;RAPGEF3;GLUL;POU2F2;EXOC2;PIK3R2;LRP1;AP2A2;NLGN2;STOM;AKT1;PITPNM1;RHBDF2;HK1;SLC15A4;ATG16L2;RAB31;MAPKBP1;RAC2;PFKL;TOMM34;SORL1;B3GAT3;ANK3;STRADB;GAS6;RAB3B;CARD11;BCR;XPOT;AIP;ALOX15B;AGAP1;PEX10;CORO7;UNC119B;MVB12B;CEMIP;AP3D1;ADAM8;KIF17;TMED4;TGFB1;CLTCL1;TBC1D9B;TMEM173;MIPEP;RHOD;SNX17;VGF;SNX33;LLGL1;BBS1;PTPN1;PEX1;PCK2;ZDHHC24;CEP131;PFKFB2;PRKCZ;TOM1L2;MICALL2;NEURL1B;ERBB2;VAMP2;NECAB3;RILPL1;BNIP3L;ARHGAP44;MCFD2;PRKCD;OLFM2;TIMM17B;ZDHHC8;GDI1;WASH3P;LRSAM1;REEP2;EHD3;LONP2;SYMPK;COG7;ABCG1;RAB12;BCAP31;MIF;DOPEY2;PLA2G6;SYNGR1;NBPF3;FYN;TMCO6;DNM2;SNX15;ZDHHC1;MAPK3;RTN2;PFKM;RERE;STX10;PRAF2;PAK1;PPP3CB;VPS16;SGSM2;TBC1D16;PKD1;RABGAP1;RAB28;ICA1;RAB40B;NGFR;PDCD6;ATP6V1F;PCLO;TBC1D8;PLEKHM1;KIF13B;CAMK1;SIRT3;HFE;VPS51;APBA1;SRSF5
4857,GO:0014072,0.853672524039309,0.444291062010106,1,17,response to isoquinoline alkaloid,BP,ADA
10426,GO:0043278,0.853672524039309,0.444291062010106,1,17,response to morphine,BP,ADA
16063,GO:0090022,0.854060370589513,0.442597718177445,1,18,regulation of neutrophil chemotaxis,BP,RAC2
12945,GO:0051321,0.854153928400381,0.219499549615817,13,153,meiotic cell cycle,BP,ERCC1;PRKACB;CDC25B;NPR2;TUBG2;PIM2;TDRKH;EREG;LEMD2;SUN1;INSR;SIRT2;GPR3
8962,GO:0035036,0.854827607514175,0.441123795481738,1,18,sperm-egg recognition,BP,ZP3
2964,GO:0006506,0.855113766901558,0.347427413869832,2,32,GPI anchor biosynthetic process,BP,PIGQ;PIGV
9159,GO:0035518,0.855149720044342,0.441454334089288,1,17,histone H2A monoubiquitination,BP,DDB2
9045,GO:0035268,0.856209103064029,0.438459060782934,1,18,protein mannosylation,BP,B4GAT1
7984,GO:0032608,0.856220139464169,0.305510281548218,3,43,interferon-beta production,BP,PTPRS;RNF135;TMEM173
14612,GO:0070182,0.856592247851251,0.43771755287995,1,18,DNA polymerase binding,MF,TERC
6703,GO:0030119,0.856759425262068,0.304641008558992,3,43,AP-type membrane coat adaptor complex,CC,EGFR;AP2A2;AP3D1
11476,GO:0045947,0.857766951704099,0.435437394017311,1,18,negative regulation of translational initiation,BP,C8ORF88
5660,GO:0016765,0.858197339040909,0.30151438809646,3,47,transferase activity, transferring alkyl or aryl (other than methyl) groups,MF,RABGGTA;GSTO1;COQ2
8612,GO:0034138,0.858924203802702,0.434133404476404,1,17,toll-like receptor 3 signaling pathway,BP,PELI1
16625,GO:0097484,0.85905493152848,0.433877951927867,1,17,dendrite extension,BP,CYFIP2
7476,GO:0031647,0.859139542495451,0.201475776666057,18,211,regulation of protein stability,BP,PRNP;TSPAN1;CRTAP;VPS11;SMAD3;DVL1;GSN;RAD23A;CD81;VHL;PIM2;PRKCD;STUB1;CHEK2;COG7;WFS1;PFN2;CCDC88C
12593,GO:0050778,0.85918039836321,0.1804435880611,41,450,positive regulation of immune response,BP,TNIP1;NR1D1;PRNP;PTPRS;RBCK1;STAT6;PIK3R2;PAG1;ADORA2B;HK1;SERPING1;PRKACB;CEACAM1;CTSB;CARD11;MAPKAPK3;WIPF1;ADAM8;PLCG1;CD81;TGFB1;TMEM173;PRKCZ;PRKACA;ADA;CYFIP2;PRKCD;CACNB3;BAX;EREG;RPS6KA5;LIMK1;IRAK1;INPP5D;MIF;PLA2G6;FYN;PELI1;MAPK3;PAK1;ZP3
8118,GO:0032814,0.859186197811842,0.432668926456096,1,18,regulation of natural killer cell activation,BP,GAS6
2992,GO:0006541,0.859273975141114,0.433449635664021,1,17,glutamine metabolic process,BP,GLUL
6339,GO:0021517,0.859396824402238,0.433209259423541,1,17,ventral spinal cord development,BP,TCTN1
16033,GO:0086065,0.859807741607512,0.339665616840118,2,31,cell communication involved in cardiac conduction,BP,SCN4B;PRKACA
14902,GO:0070734,0.860517728817391,0.430057857391164,1,18,histone H3-K27 methylation,BP,EZH1
6910,GO:0030507,0.860637817091216,0.430774658018935,1,17,spectrin binding,MF,ANK3
17886,GO:1902115,0.860638921262034,0.214071879998573,12,144,regulation of organelle assembly,BP,EVI5L;SDC1;VPS11;TBC1D14;IFT140;GSN;CROCC;ULK1;FSCN1;LRSAM1;DNM2;PROX1
15380,GO:0071634,0.860923697786719,0.430212159840082,1,17,regulation of transforming growth factor beta production,BP,SMAD3
3196,GO:0006829,0.860996786771308,0.430068250402452,1,17,zinc ion transport,BP,SLC39A3
13038,GO:0051537,0.861120924851489,0.428021324705767,1,19,2 iron, 2 sulfur cluster binding,MF,XDH
10275,GO:0043028,0.861144464678432,0.336969322647797,2,32,cysteine-type endopeptidase regulator activity involved in apoptotic process,MF,PRDX5;GAS6
8217,GO:0032986,0.861218715964492,0.428677877867233,1,18,protein-DNA complex disassembly,BP,SMARCD2
4426,GO:0010257,0.861418312274257,0.295053000601434,3,55,NADH dehydrogenase complex assembly,BP,OXA1L;TAZ;NDUFV3
8214,GO:0032981,0.861418312274257,0.295053000601434,3,55,mitochondrial respiratory chain complex I assembly,BP,OXA1L;TAZ;NDUFV3
16050,GO:0086091,0.861486934820746,0.429102115949242,1,17,regulation of heart rate by cardiac conduction,BP,SCN4B
6980,GO:0030663,0.861628911615555,0.427868626389059,1,18,COPI-coated vesicle membrane,CC,SCYL1
11857,GO:0046872,0.861877355595742,0.153966080023561,301,2954,metal ion binding,MF,NT5E;XDH;ZMYND8;FHL1;EGR1;NR1D1;EDEM1;CYP27B1;ACVR2B;PRNP;POSTN;PGM1;APOE;DGKA;ITGA6;OBSCN;IDH2;ZKSCAN1;NEK9;ITPR3;MTA1;RPS6KA2;LOXL1;NOS1;VAT1;TMEM129;CAPN2;TRIM65;LTBP4;SYTL1;LTBP2;VPS11;LTBP1;NPEPL1;MMP1;ZFP36L1;GLUL;RNPEPL1;ARAP1;MAP2K2;NME4;ZC3H6;MARCH9;PLCD3;FKBP9;RBCK1;PC;RNF44;ACP5;MCTP1;ENDOG;FBLN1;SMAD3;LRP1;THBS3;S100A4;CYBRD1;PPP2R3B;SALL2;ZXDC;RNF187;NMRK1;ADARB1;SYT8;HDAC5;NT5DC1;S100A6;F12;PPM1F;MMP28;PITPNM1;HAGHL;ASAP2;DYSF;PHC2;ASH2L;MARCH4;ZFYVE21;BRSK1;LDLR;PRKACB;SMOC2;PFKL;HLTF;RAG1;B4GAT1;PHF7;KLF7;B3GAT3;RAB11FIP4;TENM2;ZNF385A;TSHZ1;LHPP;TNNT1;PLCH2;GAS6;PFKP;GSN;ANTXR2;EHD4;GLI4;NADK;ZSCAN18;ALOX15B;AGAP1;PEX10;CCS;RSAD1;DGKQ;HAGH;SHARPIN;FYCO1;PKD2;ACY1;YPEL3;ZNF598;PRSS3;ADAM8;LTA4H;PLCG1;ZMIZ2;CBS;RNF135;ADAMTS13;ZNF217;TIMP2;ZNF862;GNAL;LACTB2;UNK;GPC1;MKNK2;ADAMTS7;DEAF1;TBC1D9B;ZSCAN30;ATP7B;SHANK3;MSRB2;RASA3;MIPEP;MGAT4B;GALNS;CLCA2;PEG3;ARAP3;CGREF1;POLL;POLM;PI4K2A;ANKZF1;PHF21A;ADAM19;HMGCL;PTPN1;TPP1;PCK2;B4GALT2;AGRN;CD320;LRP4;ESYT2;B4GALT6;ADAP1;RFNG;YPEL5;PRKCZ;KDM6B;ZNF516;RABGGTA;ADA;MPI;MICALL2;NEURL1B;CNDP2;NINL;PRIMPOL;MMP10;NECAB3;IRF2BP2;RNPEP;RASA4;CYGB;THOP1;MCFD2;PRKCD;FAM20C;MIB2;USP20;CYC1;DTD1;TRIM4;ITGA1;ZNF395;NUBP2;RPS6KA5;ZNF524;CUL9;MBTPS2;MT2A;HPCAL1;NID1;LIMK1;PADI3;RPS6KA6;ZHX3;MFNG;GIT1;LPCAT1;LRSAM1;ADAM15;EHD3;FAHD2B;MAPK12;HDAC7;RNF215;CHEK2;DTNB;ZFPM1;PPARA;JADE2;RNF123;SNN;ACO2;KDM4B;PHYH;ZNF414;MEX3A;LENG9;NUDT14;ZNF444;DTX3;FYN;PITPNM3;EFEMP2;STK25;EEF2K;FLYWCH1;ACAP3;CYP3A5;CAT;NEIL1;ZMYM3;APOBEC3C;PLCB3;ZNF606;APOBEC3F;CYP2R1;PAN2;PFKM;ADCY1;RERE;ATP8B2;PDXK;TRIM45;CAMKK2;PPP3CB;RNF144A;USP21;REV1;MICAL1;CAPRIN2;ZBTB10;ITGA3;STK32C;DNMT3A;MAN2B1;SIRT2;CDH4;ITGA4;NT5C1B;ADCY7;ZBTB22;ZNF704;YDJC;PDCD6;PCLO;ZNF837;PXN;PLEKHM1;GCH1;MSS51;NR2F6;SIRT3;ZNF513;CELSR1;MAN2B2;CBLC;TCEA2;CDC42BPG;ZBTB47;PLAG1;IRF2BPL;TRIM46;KDM3A;MEGF6;CHPF;ADCY6;LRRK1;AARS
16653,GO:0097530,0.862131879947194,0.272139460888231,4,59,granulocyte migration,BP,RAC2;ADAM8;ITGA1;MAPK3
2496,GO:0005746,0.862422906387513,0.270362438296381,4,72,mitochondrial respiratory chain,CC,SDHA;OXA1L;CYC1;NDUFV3
14544,GO:0070069,0.862598642009489,0.423029014736579,1,22,cytochrome complex,CC,CYC1
9789,GO:0040014,0.862821460758844,0.294580028781099,3,44,regulation of multicellular organism growth,BP,BBS2;SH3PXD2B;GAMT
15165,GO:0071300,0.862881976127274,0.294481036446934,3,44,cellular response to retinoic acid,BP,TWF2;PTK6;WNT3
14382,GO:0061630,0.862950457585359,0.198498506139065,17,198,ubiquitin protein ligase activity,MF,GID4;TMEM129;RNF44;SMURF2;HLTF;RAG1;ZNF598;VHL;MIB2;STUB1;LRSAM1;ASB1;CDC34;PELI1;RNF144A;PELI3;CBLC
10346,GO:0043162,0.863117442795732,0.424921184931491,1,18,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,BP,MVB12B
17835,GO:1901984,0.863399124159016,0.424361510790037,1,18,negative regulation of protein acetylation,BP,CTBP1
7313,GO:0031329,0.863567061117856,0.167286682303543,65,690,regulation of cellular catabolic process,BP,EDEM1;CST3;TYSND1;APOE;TRIM65;VPS11;TBC1D14;GTPBP1;SNX9;RAPGEF3;ZFP36L1;ENDOG;PIK3R2;LRP1;DVL1;AKT1;TPCN1;DAP;LDLR;CIRBP;PCBP4;CSNK1E;PCSK9;RAD23A;SH3D19;BNIP3;FYCO1;GPSM1;MAGEF1;ADAM8;CD81;TIMP2;ULK2;SNX33;PTPN1;PFKFB2;MLXIPL;TRIB2;PRKACA;PIM2;BOK;ULK1;BNIP3L;PRKCD;STUB1;BAX;DDIT4;ZDHHC8;LRSAM1;LONP2;PPARA;SESN2;RAB12;BCAP31;QSOX1;MAPK3;INSR;CAMKK2;RNF144A;PFKFB3;MLYCD;PKD1;SIRT2;HFE;SPTLC2
1127,GO:0002715,0.864487934436075,0.422192369859304,1,18,regulation of natural killer cell mediated immunity,BP,CEACAM1
7744,GO:0032266,0.864961553580092,0.330618456744865,2,31,phosphatidylinositol-3-phosphate binding,MF,SH3PXD2B;WIPI2
283,GO:0000786,0.865379643527877,0.264918033681534,4,84,nucleosome,CC,H1F0;H2AFJ;HIST3H2BB;H1FX
20290,GO:2001238,0.865444163268457,0.290073888071167,3,45,positive regulation of extrinsic apoptotic signaling pathway,BP,RBCK1;BAX;DEDD2
10982,GO:0044786,0.865768514608687,0.26672152428685,4,57,cell cycle DNA replication,BP,POLD4;FGFR1;WDR18;CHEK2
16267,GO:0090329,0.865771599314188,0.289737422414648,3,44,regulation of DNA-dependent DNA replication,BP,FGFR1;WDR18;CHEK2
1433,GO:0003407,0.866193270802708,0.328436443929489,2,31,neural retina development,BP,SDK2;RAB11FIP4
9996,GO:0042417,0.866263896976988,0.418634413156112,1,18,dopamine metabolic process,BP,GCH1
8059,GO:0032735,0.866325819277378,0.418509910542205,1,18,positive regulation of interleukin-12 production,BP,HLA-G
17317,GO:0140142,0.866366981573368,0.418427131764938,1,18,nucleocytoplasmic carrier activity,MF,TMCO6
4482,GO:0010506,0.866627900601985,0.183789693735059,24,271,regulation of autophagy,BP,TRIM65;TBC1D14;PIK3R2;AKT1;TPCN1;DAP;BNIP3;FYCO1;GPSM1;ULK2;PRKACA;PIM2;BOK;ULK1;BNIP3L;ZDHHC8;LRSAM1;SESN2;RAB12;QSOX1;MAPK3;CAMKK2;SIRT2;SPTLC2
5670,GO:0016780,0.867043162140642,0.417065388102334,1,18,phosphotransferase activity, for other substituted phosphate groups,MF,SAMD8
4681,GO:0010831,0.867519824336823,0.416103265838463,1,18,positive regulation of myotube differentiation,BP,FAM129B
2963,GO:0006505,0.867578584594161,0.325276345936379,2,33,GPI anchor metabolic process,BP,PIGQ;PIGV
9237,GO:0035635,0.867605072296454,0.415931005484472,1,18,entry of bacterium into host cell,BP,EXOC2
674,GO:0001885,0.868075750172429,0.285931187491571,3,44,endothelial cell development,BP,WNT7A;PTPRS;RAPGEF3
2534,GO:0005793,0.868301411430702,0.221344421630611,8,103,endoplasmic reticulum-Golgi intermediate compartment,CC,CTSZ;TMED4;SCYL1;AREG;MCFD2;TGFA;BCAP31;AZIN2
11456,GO:0045921,0.868383313128219,0.262611282135633,4,57,positive regulation of exocytosis,BP,SDC1;ADORA2B;PLA2G6;ZP3
13560,GO:0060038,0.868419738499192,0.324472408858068,2,31,cardiac muscle cell proliferation,BP,FGFR1;TGFBR3
1150,GO:0002757,0.868633770621808,0.17658503939732,29,328,immune response-activating signal transduction,BP,TNIP1;NR1D1;PRNP;PTPRS;RBCK1;PIK3R2;PAG1;PRKACB;CEACAM1;CTSB;CARD11;MAPKAPK3;WIPF1;PLCG1;PRKACA;ADA;CYFIP2;PRKCD;CACNB3;BAX;RPS6KA5;LIMK1;IRAK1;INPP5D;PLA2G6;FYN;PELI1;MAPK3;PAK1
11464,GO:0045931,0.868787618746147,0.215136841243352,9,114,positive regulation of mitotic cell cycle,BP,LRP5;FGFR1;CCND1;CDC25B;TGFB1;EREG;TGFA;INSR;HYAL1
9126,GO:0035455,0.869431976642816,0.411374293077516,1,19,response to interferon-alpha,BP,GAS6
9308,GO:0035770,0.869511501380205,0.196443712000405,14,170,ribonucleoprotein granule,CC,BTBD2;ZFP36L1;GRB7;PITPNM1;NFKBIZ;CIRBP;PNRC1;TDRKH;SYMPK;MEX3A;APOBEC3C;APOBEC3F;PAN2;TSTD1
11354,GO:0045724,0.86954195984843,0.412001420691808,1,18,positive regulation of cilium assembly,BP,CROCC
2059,GO:0004812,0.869704395409141,0.283227919336804,3,44,aminoacyl-tRNA ligase activity,MF,DALRD3;IARS2;AARS
5730,GO:0016875,0.869704395409141,0.283227919336804,3,44,ligase activity, forming carbon-oxygen bonds,MF,DALRD3;IARS2;AARS
2268,GO:0005200,0.869797556585265,0.234367388364931,6,80,structural constituent of cytoskeleton,MF,ANK3;SPTB;TUBG2;AGRN;PPL;TUBB6
12638,GO:0050851,0.869890805415258,0.198526118250918,13,162,antigen receptor-mediated signaling pathway,BP,PRNP;RBCK1;PIK3R2;PAG1;CEACAM1;CARD11;PLCG1;ADA;CACNB3;BAX;INPP5D;FYN;PAK1
13082,GO:0051602,0.870227057292351,0.410604222712075,1,18,response to electrical stimulus,BP,NSMF
9924,GO:0042276,0.870344462320037,0.409513225568411,1,19,error-prone translesion synthesis,BP,REV1
10772,GO:0044232,0.870413856063687,0.410222599010096,1,18,organelle membrane contact site,CC,ESYT2
13988,GO:0060713,0.870414964270289,0.410220334131204,1,18,labyrinthine layer morphogenesis,BP,ZFP36L1
12877,GO:0051224,0.870911495573591,0.21754543519333,8,105,negative regulation of protein transport,BP,F2R;IDH2;HADH;RHBDF2;MAPKBP1;PFKL;GAS6;GDI1
1857,GO:0004520,0.871188034054863,0.2805554501822,3,45,endodeoxyribonuclease activity,MF,ERCC1;NEIL1;DNASE1L1
16486,GO:0097178,0.871269468128921,0.319002871528548,2,32,ruffle assembly,BP,PLEKHM1;PFN2
17492,GO:1900408,0.871380498512439,0.318467703020404,2,33,negative regulation of cellular response to oxidative stress,BP,AKT1;TRAP1
18306,GO:1903202,0.871380498512439,0.318467703020404,2,33,negative regulation of oxidative stress-induced cell death,BP,AKT1;TRAP1
11584,GO:0046174,0.871541090153269,0.407913630062706,1,18,polyol catabolic process,BP,NTSR1
10068,GO:0042572,0.871702106766356,0.407582958771555,1,18,retinol metabolic process,BP,RETSAT
9063,GO:0035305,0.872083679591996,0.230976636686121,6,80,negative regulation of dephosphorylation,BP,PPP1R35;PPP1R14A;FARP1;MYO1D;ELFN2;DLG3
5391,GO:0016226,0.872165878086587,0.405014768567773,1,20,iron-sulfur cluster assembly,BP,NUBP2
7234,GO:0031163,0.872165878086587,0.405014768567773,1,20,metallo-sulfur cluster assembly,BP,NUBP2
4336,GO:0009890,0.873099908767505,0.149002309548604,118,1225,negative regulation of biosynthetic process,BP,ZMYND8;EGR1;NR1D1;CYP27B1;PDCD4;CTNNBIP1;ACVR2B;VEGFA;APOE;HMGA2;ELK3;MTA1;EGFR;WWTR1;NFATC4;BAHCC1;SHC1;TCFL5;ZFP36L1;MAP2K2;ZC3H6;MDFI;FOXQ1;MAP2K1;ACP5;MXD4;SMURF2;SMAD3;STAT6;DNAJB5;HBEGF;PRDX5;SALL2;GRB7;HDAC5;PPM1F;SCMH1;IMPACT;WWC3;DAP;FGFR1;MXI1;H2AFJ;CEACAM1;CIRBP;TENM2;TSHZ1;CCND1;TCF25;GAS6;ERRFI1;TAGLN3;HES2;CTBP1;MNT;CDKN1C;CEBPB;ZNF217;C8ORF88;TGFB1;UNK;DEAF1;NAB2;PEG3;PHF21A;MBD3;VHL;TRAP1;MLXIPL;TRIB2;TFDP2;JAK3;NELFCD;CYGB;EREG;RPS6KA5;DDIT4;PPP1R13L;LTB4R2;ZHX3;LPCAT1;ASB1;HDAC7;INPP5D;CBX7;CHEK2;ZFPM1;PPARA;SESN2;SOX7;ABCA7;SIX5;MEX3A;WFS1;ARID5B;BHLHE40;TSPYL2;SLC27A1;SATB1;RERE;BCL7A;GABBR1;CAPRIN2;WDTC1;HES7;DNMT3A;HES6;PROX1;SIRT2;FAM129B;BACH1;MAP3K10;NR2F6;CBX6;ZP3;TNRC18;IRF2BPL;DEDD2
6873,GO:0030374,0.874095364437689,0.253551398459408,4,57,ligand-dependent nuclear receptor transcription coactivator activity,MF,NR1D1;PKN1;ZMIZ2;PPARA
7363,GO:0031418,0.874132701743787,0.40256520286786,1,18,L-ascorbic acid binding,MF,PHYH
3044,GO:0006605,0.874290770825273,0.168703939999285,30,366,protein targeting,BP,PRNP;LTBP2;VPS11;STOM;RAC2;TOMM34;SORL1;ANK3;AIP;PEX10;CEMIP;AP3D1;MIPEP;RHOD;PEX1;ZDHHC24;MICALL2;ERBB2;BNIP3L;TIMM17B;ZDHHC8;GDI1;WASH3P;LONP2;SYNGR1;NBPF3;FYN;ZDHHC1;PAK1;KIF13B
11025,GO:0045005,0.874510368866107,0.31313879208104,2,32,DNA-dependent DNA replication maintenance of fidelity,BP,PRIMPOL;ETAA1
8260,GO:0033059,0.874635864783708,0.274587099334861,3,46,cellular pigmentation,BP,BBS2;AP3D1;BLOC1S4
3363,GO:0007129,0.874672702903321,0.40144369360013,1,18,synapsis,BP,SUN1
7253,GO:0031227,0.874845573805245,0.202108662504005,10,126,intrinsic component of endoplasmic reticulum membrane,CC,EDEM1;PKD2;ESYT2;BCAP31;WFS1;SPPL2B;RTN2;HLA-G;SLC37A2;SAMD8
17281,GO:0140013,0.874860175126421,0.21201613607044,8,103,meiotic nuclear division,BP,CDC25B;PIM2;TDRKH;EREG;LEMD2;SUN1;SIRT2;GPR3
11197,GO:0045335,0.87530376427299,0.211284630905871,8,105,phagocytic vesicle,CC,RAB31;RAC2;GSN;ITGB5;ADAM8;RAB12;DNM2;HLA-G
15310,GO:0071514,0.87545544363757,0.399813662162005,1,18,genetic imprinting,BP,DNMT3A
7177,GO:0031069,0.875552170157425,0.39961187069622,1,18,hair follicle morphogenesis,BP,FOXQ1
3223,GO:0006879,0.875583632320351,0.272809354918135,3,47,cellular iron ion homeostasis,BP,CYBRD1;SLC22A17;HFE
1094,GO:0002682,0.875784043200943,0.149354090290491,87,927,regulation of immune system process,BP,TNIP1;HTRA1;NR1D1;PGF;CTNNBIP1;PRNP;VEGFA;FAM210B;PKN1;FCGRT;PTPRS;SHC1;ZFP36L1;RBCK1;FOS;SMAD3;STAT6;PIK3R2;PAG1;ADORA2B;AKT1;MMP28;HK1;SERPING1;GGT1;VEGFB;ASH2L;IFNGR2;LDLR;PRKACB;RAC2;RAG1;CEACAM1;GAS6;CTSB;CARD11;SOX13;GSN;MAPKAPK3;IGFBP2;BCR;WIPF1;FAM3A;IL20RB;AP3D1;ADAM8;PLCG1;CD81;CEBPB;RNF135;TGFB1;TMEM173;EFNB3;PTPN1;CD320;PRKCZ;PRKACA;ADA;ERBB2;JAK3;CYFIP2;PRKCD;CACNB3;BAX;EREG;RPS6KA5;LIMK1;IRAK1;INPP5D;ZFPM1;MIF;PLA2G6;DDT;ECM1;SPPL2B;FYN;ICAM5;PELI1;APOBEC3F;MAPK3;HLA-G;PAK1;PPP3CB;ITGA4;HFE;ZP3;ITPKB
888,GO:0002253,0.875932901652854,0.165463495655055,32,361,activation of immune response,BP,TNIP1;NR1D1;PRNP;PTPRS;RBCK1;PIK3R2;PAG1;SERPING1;PRKACB;CEACAM1;CTSB;CARD11;MAPKAPK3;WIPF1;PLCG1;CD81;TMEM173;PRKACA;ADA;CYFIP2;PRKCD;CACNB3;BAX;RPS6KA5;LIMK1;IRAK1;INPP5D;PLA2G6;FYN;PELI1;MAPK3;PAK1
3201,GO:0006839,0.875971933136238,0.175496647418199,21,250,mitochondrial transport,BP,VPS11;CPT2;RAC2;TOMM34;AIP;BNIP3;MOAP1;MIPEP;MICALL2;BOK;TFDP2;BNIP3L;BAX;CYC1;TIMM17B;ZDHHC8;SLC25A29;NBPF3;BCL2L1;SLC25A37;TST
15360,GO:0071604,0.876240942264289,0.39817263928779,1,18,transforming growth factor beta production,BP,SMAD3
15807,GO:0072509,0.876305987148008,0.39803651410686,1,18,divalent inorganic cation transmembrane transporter activity,MF,SLC39A3
3231,GO:0006888,0.876731315023004,0.186861617710909,14,171,ER to Golgi vesicle-mediated transport,BP,LMF1;SORL1;ANK3;TRAPPC9;GAS6;SPTB;CTSZ;TMED4;AREG;MCFD2;TGFA;COG7;BCAP31;PDCD6
4161,GO:0009225,0.87686627606479,0.30850768328028,2,33,nucleotide-sugar metabolic process,BP,MPI;TSTA3
5122,GO:0015491,0.876952643691523,0.396681220495085,1,18,cation:cation antiporter activity,MF,SLC9A7
19757,GO:2000114,0.877138755181174,0.396290491243387,1,18,regulation of establishment of cell polarity,BP,GSN
16286,GO:0090382,0.877386083500569,0.30724367743778,2,34,phagosome maturation,BP,RAB31;ATP6V1F
8321,GO:0033176,0.877455570040672,0.394010239325796,1,20,proton-transporting V-type ATPase complex,CC,ATP6V1F
7169,GO:0031057,0.877523215591457,0.307636063969887,2,32,negative regulation of histone modification,BP,CTBP1;KDM3A
874,GO:0002224,0.877847559594742,0.214137227841504,7,93,toll-like receptor signaling pathway,BP,TNIP1;NR1D1;PTPRS;CTSB;MAPKAPK3;IRAK1;PELI1
3486,GO:0007368,0.878008939786943,0.232669044695948,5,69,determination of left/right symmetry,BP,ACVR2B;SMAD3;IFT140;PKD2;VANGL2
12899,GO:0051254,0.878139467631331,0.144194684341743,109,1117,positive regulation of RNA metabolic process,BP,TNIP1;MEF2D;CITED4;EGR1;NR1D1;APLN;VEGFA;WNT7A;F2R;LRP5;ITGA6;HMGA2;ELK3;EGFR;WWTR1;NOS1;NFATC4;ETV5;SHC1;HEXB;GTPBP1;ETV4;ZFP36L1;MAP2K2;SMARCA1;MAP2K1;POU2F2;FOS;SMAD3;STAT6;PIK3R2;ERCC6;DVL1;EPAS1;SALL2;ZXDC;RNF187;AKT1;HDAC5;ASH2L;SEC14L2;HLTF;KLF7;NAT14;PKD2;CRTC1;CDKN1C;ZMIZ2;CD81;CEBPB;TGFB1;RFX2;DEAF1;TMEM173;PEG3;MC1R;ABHD14B;AGRN;VHL;MLXIPL;KDM6B;ZNF516;PIM2;ERBB2;TFDP2;PBX2;RPS6KA5;SOX12;MBTPS2;CARF;IER2;IRAK1;FHOD1;CHEK2;ZFPM1;PPARA;SESN2;SOX7;SIX5;SSBP4;DNM2;MAPK3;INSR;CAMTA2;PFKM;RERE;CAMKK2;PPP3CB;USP21;CAPRIN2;PPP2R5B;MAP2K3;PROX1;PKD1;SIRT2;FAM129B;BACH1;E2F5;MAPRE3;NGFR;MAFF;CAMK1;EZH1;ZP3;TCEA2;PLAG1;IRF2BPL;KDM3A;SRSF5
9600,GO:0036464,0.878155076706945,0.187496391790673,13,161,cytoplasmic ribonucleoprotein granule,CC,BTBD2;ZFP36L1;GRB7;PITPNM1;NFKBIZ;CIRBP;PNRC1;TDRKH;MEX3A;APOBEC3C;APOBEC3F;PAN2;TSTD1
12239,GO:0048524,0.878714522623338,0.212753090632146,7,95,positive regulation of viral process,BP,APOE;PC;STOM;ADARB1;RAD23A;MVB12B;NELFCD
4662,GO:0010812,0.878883069173588,0.267589603512803,3,45,negative regulation of cell-substrate adhesion,BP,POSTN;FBLN1;ADAM15
18825,GO:1904380,0.87891627175256,0.39169241270159,1,19,endoplasmic reticulum mannose trimming,BP,EDEM1
6677,GO:0030048,0.87919599014099,0.230828627406249,5,69,actin filament-based movement,BP,SCN4B;TNNT1;WIPF1;SNTA1;TPM2
7140,GO:0030992,0.879905445315002,0.389595413946208,1,19,intraciliary transport particle B,CC,KIF17
5301,GO:0015991,0.880006097117384,0.388618683959432,1,20,ATP hydrolysis coupled proton transport,BP,ATP6V1F
8465,GO:0033617,0.880031794847322,0.388564072062286,1,20,mitochondrial respiratory chain complex IV assembly,BP,COA5
3430,GO:0007223,0.880412856782077,0.302310818405485,2,32,Wnt signaling pathway, calcium modulating pathway,BP,PLCB3;PPP3CB
72,GO:0000149,0.880953842417216,0.209571509902605,7,93,SNARE binding,MF,SYTL1;VPS11;SYT8;SNPH;LLGL1;VAMP2;STX10
1308,GO:0003151,0.880980861493516,0.264010739625322,3,45,outflow tract morphogenesis,BP,VEGFA;TGFBR3;ZFPM1
16564,GO:0097352,0.881228588086367,0.3001591180461,2,34,autophagosome maturation,BP,FYCO1;VPS16
6692,GO:0030097,0.88134915384557,0.149718945735836,53,587,hemopoiesis,BP,ERCC1;EGR1;CTNNBIP1;VEGFA;FAM210B;ZFP36L1;CMTM7;POU2F2;FOS;STAT6;EPAS1;HDAC5;ASH2L;LRRC8A;WNT2B;KCNAB2;RAG1;CEACAM1;ZNF385A;GAS6;CARD11;SH2B3;SOX13;DHTKD1;BCR;AP3D1;SH3PXD2A;ADAM8;CEBPB;TGFB1;MKNK2;POLM;IFNE;PRKCZ;ADA;ERBB2;JAK3;FAM20C;BAX;TGFBR3;MFNG;INPP5D;CHD2;ZFPM1;SATB1;TAZ;HLA-G;PPP3CB;RRAS;ITGA4;NBEAL2;ITPKB;LRRK1
6249,GO:0019829,0.881762415346863,0.299168258174488,2,34,cation-transporting ATPase activity,MF,ATP7B;ATP6V1F
11131,GO:0045184,0.88187840766863,0.136824798698798,153,1589,establishment of protein localization,BP,NR1D1;EDEM1;DLG4;ACVR2B;PRNP;BBS2;POSTN;APOE;F2R;LRP5;IDH2;ITPR3;ARRDC1;EVI5L;EGFR;TMEM129;HADH;SYTL1;LMF1;LTBP2;VPS11;TBC1D14;ARL2;SNX9;RAPGEF3;GLUL;POU2F2;EXOC2;PIK3R2;LRP1;AP2A2;NLGN2;STOM;AKT1;PITPNM1;RHBDF2;HK1;SLC15A4;ATG16L2;RAB31;MAPKBP1;RAC2;PFKL;SYNE3;TOMM34;SORL1;B3GAT3;ANK3;STRADB;GAS6;RAB3B;CARD11;BCR;XPOT;AIP;ALOX15B;AGAP1;PEX10;CORO7;UNC119B;MVB12B;CEMIP;AP3D1;GRIN3B;ADAM8;KIF17;TMED4;TGFB1;CLTCL1;MOAP1;TBC1D9B;TMEM173;MIPEP;RHOD;SNX17;VGF;SNX33;LLGL1;BBS1;PTPN1;PEX1;PCK2;ZDHHC24;CEP131;PFKFB2;PRKCZ;OXA1L;TOM1L2;MICALL2;NEURL1B;ERBB2;VAMP2;TFDP2;NECAB3;RILPL1;BNIP3L;ARHGAP44;MCFD2;PRKCD;BAX;OLFM2;TIMM17B;ZDHHC8;GDI1;WASH3P;LRSAM1;REEP2;EHD3;LONP2;SYMPK;COG7;ABCG1;RAB12;BCAP31;MIF;DOPEY2;PLA2G6;SYNGR1;NBPF3;FYN;TMCO6;DNM2;SNX15;ZDHHC1;MAPK3;RTN2;PFKM;RERE;STX10;PRAF2;PAK1;PPP3CB;VPS16;SGSM2;TBC1D16;PKD1;RABGAP1;RAB28;ICA1;RAB40B;NGFR;PDCD6;ATP6V1F;PCLO;TBC1D8;PLEKHM1;KIF13B;CAMK1;SIRT3;HFE;VPS51;APBA1;SRSF5
9607,GO:0036475,0.881955915249079,0.385220924677747,1,19,neuron death in response to oxidative stress,BP,ENDOG
14543,GO:0070064,0.881975858904708,0.385178192251787,1,19,proline-rich region binding,MF,CCND1
10270,GO:0043022,0.882054634871511,0.261806458334574,3,47,ribosome binding,MF,IMPACT;ZNF598;OXA1L
10495,GO:0043403,0.882095980511715,0.384920737115332,1,19,skeletal muscle tissue regeneration,BP,WNT7A
12602,GO:0050792,0.882838696558388,0.181110368828989,13,164,regulation of viral process,BP,TNIP1;APOE;HMGA2;PC;STOM;ADARB1;GSN;RAD23A;MVB12B;NELFCD;APOBEC3C;APOBEC3F;PROX1
19801,GO:2000209,0.882918293649006,0.383154788945609,1,19,regulation of anoikis,BP,CHEK2
4782,GO:0010971,0.882956219246108,0.38307319475822,1,19,positive regulation of G2/M transition of mitotic cell cycle,BP,CCND1
8064,GO:0032743,0.883019545717241,0.382936923340293,1,19,positive regulation of interleukin-2 production,BP,CARD11
8236,GO:0033017,0.883278309651669,0.382379714166796,1,19,sarcoplasmic reticulum membrane,CC,NOS1
2366,GO:0005484,0.883651326500066,0.295648971600049,2,34,SNAP receptor activity,MF,VAMP2;STX10
109,GO:0000226,0.884425963725746,0.151283924225175,39,427,microtubule cytoskeleton organization,BP,BBS2;OBSL1;SPRY2;ARL2;MARK4;DVL1;FBXW5;BRSK1;DNAAF5;CEP250;PKD2;EML2;GOLGA2P5;CROCC;DNAH1;LLGL1;TUBG2;CEP131;PRKCZ;SDCCAG8;NINL;CUL9;RGS14;CHEK2;EML3;DNAAF3;SUN1;TUBB6;CEP72;PAK1;CUL7;LMNA;PKD1;NDE1;MSS51;TACC1;CCDC88C;TRIM46;TTLL3
19747,GO:2000104,0.884477157319104,0.379790206135159,1,19,negative regulation of DNA-dependent DNA replication,BP,CHEK2
8693,GO:0034340,0.884574039029349,0.222084193355453,5,73,response to type I interferon,BP,EGR1;PTPN1;IFI6;IRAK1;HLA-G
10614,GO:0043616,0.884746297048491,0.293907135674386,2,33,keratinocyte proliferation,BP,ZFP36L1;EREG
3593,GO:0008023,0.884850840032908,0.257171770923447,3,46,transcription elongation factor complex,CC,ERCC6;NELFCD;TCEA2
9079,GO:0035336,0.884879950917068,0.37891721391984,1,19,long-chain fatty-acyl-CoA metabolic process,BP,ACOT7
12971,GO:0051383,0.885677320266536,0.37718461889143,1,19,kinetochore organization,BP,CENPH
16923,GO:0098901,0.886662655223072,0.375035425092398,1,19,regulation of cardiac muscle cell action potential,BP,ANK3
5161,GO:0015701,0.886875834745554,0.374569246239242,1,19,bicarbonate transport,BP,SLC26A11
16466,GO:0097150,0.88720374061871,0.373851350669846,1,19,neuronal stem cell population maintenance,BP,PROX1
634,GO:0001824,0.887214114202538,0.252900352040494,3,47,blastocyst development,BP,CAPN2;ADA;ZP3
5760,GO:0016922,0.887232700618321,0.373787898867569,1,19,ligand-dependent nuclear receptor binding,MF,PROX1
14395,GO:0061659,0.887353862475725,0.166732749821853,17,203,ubiquitin-like protein ligase activity,MF,GID4;TMEM129;RNF44;SMURF2;HLTF;RAG1;ZNF598;VHL;MIB2;STUB1;LRSAM1;ASB1;CDC34;PELI1;RNF144A;PELI3;CBLC
5742,GO:0016889,0.887496925491309,0.37244752320195,1,20,endodeoxyribonuclease activity, producing 3'-phosphomonoesters,MF,NEIL1
18250,GO:1903050,0.88753789280433,0.17232545344478,14,174,regulation of proteolysis involved in cellular protein catabolic process,BP,EDEM1;DVL1;AKT1;CSNK1E;RAD23A;MAGEF1;TRIB2;PRKACA;STUB1;BCAP31;RNF144A;PKD1;SIRT2;HFE
5608,GO:0016651,0.887664495911904,0.21650982992474,5,83,oxidoreductase activity, acting on NAD(P)H,MF,NOS1;TXNRD3;CBR4;NARF;NDUFV3
14974,GO:0070888,0.887684745685481,0.37279643437845,1,19,E-box binding,MF,BHLHE40
11870,GO:0046888,0.888082045461242,0.287311670868479,2,34,negative regulation of hormone secretion,BP,HADH;PFKL
3350,GO:0007088,0.888225435960878,0.179688261412506,11,140,regulation of mitotic nuclear division,BP,LRP5;OBSL1;FBXW5;TGFB1;TOM1L2;EREG;CUL9;TGFA;INSR;CUL7;SIRT2
5299,GO:0015988,0.888909036092017,0.368655285728519,1,21,energy coupled proton transmembrane transport, against electrochemical gradient,BP,ATP6V1F
13397,GO:0052745,0.889131107913064,0.369611101904942,1,19,inositol phosphate phosphatase activity,MF,INPP5D
14505,GO:0065003,0.8891449655667,0.129839806964065,134,1421,protein-containing complex assembly,BP,ERCC1;H1F0;DLG4;TYSND1;CTNNBIP1;KCNG1;XPC;PRNP;VEGFA;APOE;ITPR3;OBSL1;DDB2;VPS11;ARL2;MMP1;SNX9;GLUL;EXOC2;SLC9A3R2;SMAD3;HSD17B8;SH3PXD2B;STOM;GRB7;KCNC4;TMOD2;CORO1B;ASH2L;IMPACT;DNAAF5;PRKACB;SIGMAR1;RAC2;PFKL;SORL1;CIRBP;CBR4;TRAPPC9;TWF2;GSN;PLEKHG2;ANGPTL4;EHD4;SEPT10;WIPF1;ARPIN;SPTB;CORO7;DGKQ;SHARPIN;PKD2;GPX3;CTSZ;CDC42EP5;CRTC1;SH3PXD2A;ASIC1;TGFB1;CLTCL1;FHOD3;MSRB2;EML2;DNAH1;WASF3;LLGL1;COA5;KHDRBS3;TUBG2;HMGCL;LRP4;PRKCZ;PRKACA;CENPH;GRHPR;OXA1L;RABGGTA;AREG;MICALL2;BOK;WDR18;CAPG;ULK1;VAMP2;PSMG4;FSCN1;MCFD2;PRKCD;STUB1;BAX;TRIM4;HIST3H2BB;SOX12;ZDHHC8;FCHO1;TGFBR3;DNM1;WASH3P;EHD3;IRAK1;TGFA;ABCA7;MIF;DNAAF3;RAC3;DNM2;ATXN10;CAT;TSPYL2;H1FX;MAPK3;INSR;TAZ;PFKM;PAK1;BIN1;VPS16;PPP2R5B;NDUFV3;KCTD13;SIRT2;NDE1;PDCD6;PXN;GCH1;MSS51;HFE;COL6A1;BBS10;SEPT6;PFN2;CCDC88C;APBA1;SRSF5
6008,GO:0019058,0.889591273124592,0.156943496401544,22,259,viral life cycle,BP,TNIP1;APOE;HMGA2;EGFR;PC;STOM;ADARB1;ATG16L2;LDLR;GAS6;CTSB;GSN;RAD23A;MVB12B;ITGB5;CTBP1;CD81;EFNB3;LRSAM1;APOBEC3C;APOBEC3F;PROX1
7435,GO:0031572,0.889799858693416,0.284352168231694,2,33,G2 DNA damage checkpoint,BP,HMGA2;BRSK1
5652,GO:0016747,0.889966665343607,0.169083516885082,14,172,transferase activity, transferring acyl groups other than amino-acyl groups,MF,NAGS;LPCAT4;CRAT;CPT2;MBOAT7;NAT14;ZDHHC24;ALAS1;ZDHHC8;LPCAT1;CERS4;ZDHHC1;TAZ;SPTLC2
9694,GO:0038095,0.890010661497559,0.189771980712675,8,110,Fc-epsilon receptor signaling pathway,BP,SHC1;FOS;PIK3R2;CARD11;PLCG1;MAPK3;PAK1;PPP3CB
7597,GO:0031984,0.890044997082343,0.129617276939203,123,1271,organelle subcompartment,CC,B4GALNT4;EDEM1;POSTN;PLD3;OSBPL5;LPCAT4;ITPR3;EGFR;NOS1;TMEM129;LMF1;SNX9;ST6GALNAC2;ARAP1;KDSR;MARCH9;MCTP1;SRD5A3;PIGQ;MBOAT7;REEP4;PITPNM1;ENTPD6;RHBDF2;BSG;ASAP2;MARCH4;IFNGR2;RAB31;SIGMAR1;B4GAT1;PIGV;SORL1;B3GAT3;TRAPPC9;CARD19;ANTXR2;CORO7;PKD2;RETSAT;CTSZ;GPSM1;AP3D1;ENTPD2;TMED4;CLTCL1;B3GNT3;TMEM173;ATP7B;MGAT4B;GOLGA2P5;ERO1B;ST6GALNAC6;PI4K2A;LLGL1;UBXN4;PTPN1;B4GALT2;ESYT2;B4GALT6;RFNG;AREG;BOK;ULK1;VAMP2;C6ORF89;NECAB3;MCFD2;REEP6;BAX;SBF1;XYLT2;TMBIM4;MBTPS2;HSD17B7;PCSK1N;PDIA5;MFNG;LPCAT1;REEP2;ST3GAL3;TGFA;PI4K2B;COG7;ABCG1;ABCA7;RAB12;BCAP31;DOPEY2;SLC9A7;WFS1;QSOX1;SPPL2B;STK25;CERS4;DNM2;CYP3A5;SLC50A1;CYP2R1;RTN2;HLA-G;STX10;ATP8B2;MALL;SLC37A2;SAMD8;SLC16A13;NDST2;PKD1;EDA;GAL3ST4;NMNAT2;ALG12;AZIN2;ST3GAL2;ICA1;HSD11B1;PDCD6;CHST14;VPS51;ST3GAL5;SPTLC2;CHPF
14144,GO:0061036,0.890090669848095,0.367486785137915,1,19,positive regulation of cartilage development,BP,SMAD3
15372,GO:0071621,0.890322912596838,0.246995698364351,3,50,granulocyte chemotaxis,BP,RAC2;ITGA1;MAPK3
19658,GO:1990841,0.890409027081412,0.283189894737333,2,33,promoter-specific chromatin binding,MF,EGR1;RBL2
13470,GO:0055017,0.890443634506892,0.247437408584077,3,46,cardiac muscle tissue growth,BP,FGFR1;TGFBR3;PAK1
18305,GO:1903201,0.891502576992077,0.245237768636362,3,48,regulation of oxidative stress-induced cell death,BP,ENDOG;AKT1;TRAP1
12548,GO:0050706,0.891519167044439,0.363548270353999,1,20,regulation of interleukin-1 beta secretion,BP,HK1
13793,GO:0060393,0.891730506446512,0.280357225984473,2,34,regulation of pathway-restricted SMAD protein phosphorylation,BP,TGFB1;HFE
1856,GO:0004519,0.892139457173131,0.186728229523491,8,108,endonuclease activity,MF,ERCC1;ENDOG;RAG1;LACTB2;NEIL1;RNASET2;DNASE1L1;RNASE7
6619,GO:0022853,0.892161998287068,0.279244362689421,2,35,active ion transmembrane transporter activity,MF,ATP7B;ATP6V1F
10102,GO:0042625,0.892161998287068,0.279244362689421,2,35,ATPase coupled ion transmembrane transporter activity,MF,ATP7B;ATP6V1F
6871,GO:0030371,0.892187322734422,0.362054782887388,1,20,translation repressor activity,MF,CIRBP
2462,GO:0005680,0.892284450870827,0.361153049125224,1,21,anaphase-promoting complex,CC,CUL7
2932,GO:0006457,0.892382455046314,0.159986888872971,17,210,protein folding,BP,CRTAP;LTBP4;NUDCD3;FKBP9;DNAJB5;TOMM34;AIP;FYCO1;NUDCD2;ERO1B;DNAJC4;TRAP1;TMX4;PDIA5;WFS1;QSOX1;ALG12
16287,GO:0090383,0.892687113876862,0.360250671209521,1,21,phagosome acidification,BP,ATP6V1F
16360,GO:0090662,0.893223224930751,0.359046745647835,1,21,ATP hydrolysis coupled transmembrane transport,BP,ATP6V1F
17016,GO:0099131,0.893223224930751,0.359046745647835,1,21,ATP hydrolysis coupled ion transmembrane transport,BP,ATP6V1F
566,GO:0001708,0.893363693701366,0.277217329596662,2,34,cell fate specification,BP,DUSP6;FGFR1
13743,GO:0060330,0.893789775787567,0.358454926434383,1,20,regulation of response to interferon-gamma,BP,IFNGR2
13747,GO:0060334,0.893789775787567,0.358454926434383,1,20,regulation of interferon-gamma-mediated signaling pathway,BP,IFNGR2
4044,GO:0009083,0.894229031673572,0.35746367897146,1,20,branched-chain amino acid catabolic process,BP,HMGCL
6985,GO:0030670,0.894311750596442,0.2199627155498,4,62,phagocytic vesicle membrane,CC,RAB31;RAC2;DNM2;HLA-G
14526,GO:0070034,0.894561586369852,0.356028744103229,1,21,telomerase RNA binding,MF,TEP1
8156,GO:0032897,0.894628463101525,0.356560616748492,1,20,negative regulation of viral transcription,BP,HMGA2
10434,GO:0043296,0.895159859661959,0.182399376819083,8,105,apical junction complex,CC,NPHP4;ANK3;CCND1;PRKCZ;MICALL2;SH3BP1;SYMPK;DLG3
2486,GO:0005732,0.895223961079462,0.352832081937719,1,24,small nucleolar ribonucleoprotein complex,CC,TERC
6950,GO:0030593,0.895428097606785,0.272423790963389,2,37,neutrophil chemotaxis,BP,RAC2;ITGA1
5426,GO:0016279,0.895555971785192,0.238237020099399,3,47,protein-lysine N-methyltransferase activity,MF,ASH2L;EEF2KMT;EZH1
19081,GO:1904950,0.89577910131069,0.181313653435553,8,109,negative regulation of establishment of protein localization,BP,F2R;IDH2;HADH;RHBDF2;MAPKBP1;PFKL;GAS6;GDI1
3353,GO:0007093,0.896035555019295,0.16569994627443,12,153,mitotic cell cycle checkpoint,BP,XPC;HMGA2;BRSK1;ZNF385A;CCND1;PCBP4;TGFB1;TFDP2;RBL2;BAX;CHEK2;BCL2L1
4192,GO:0009299,0.896130745643665,0.353149672787374,1,20,mRNA transcription,BP,EREG
15171,GO:0071312,0.896471151070814,0.352373576591808,1,20,cellular response to alkaloid,BP,BCL2L1
7402,GO:0031491,0.896538852391889,0.215846490784944,4,66,nucleosome binding,MF,HMGA2;SMARCA1;SMARCD2;MBD3
18090,GO:1902679,0.896704706374631,0.12543888985788,87,930,negative regulation of RNA biosynthetic process,BP,ZMYND8;EGR1;NR1D1;PDCD4;CTNNBIP1;ACVR2B;VEGFA;HMGA2;ELK3;MTA1;WWTR1;NFATC4;BAHCC1;SHC1;TCFL5;ZC3H6;MDFI;FOXQ1;MXD4;SMURF2;SMAD3;STAT6;DNAJB5;PRDX5;SALL2;HDAC5;PPM1F;SCMH1;IMPACT;WWC3;DAP;FGFR1;MXI1;H2AFJ;TENM2;TSHZ1;CCND1;TCF25;GAS6;TAGLN3;HES2;CTBP1;MNT;CDKN1C;CEBPB;ZNF217;TGFB1;DEAF1;NAB2;PEG3;PHF21A;MBD3;VHL;MLXIPL;TFDP2;NELFCD;EREG;RPS6KA5;PPP1R13L;ZHX3;HDAC7;CBX7;ZFPM1;PPARA;SOX7;SIX5;WFS1;ARID5B;BHLHE40;SATB1;RERE;BCL7A;WDTC1;HES7;DNMT3A;HES6;PROX1;SIRT2;FAM129B;BACH1;MAP3K10;NR2F6;CBX6;ZP3;TNRC18;IRF2BPL;DEDD2
18437,GO:1903507,0.896704706374631,0.12543888985788,87,930,negative regulation of nucleic acid-templated transcription,BP,ZMYND8;EGR1;NR1D1;PDCD4;CTNNBIP1;ACVR2B;VEGFA;HMGA2;ELK3;MTA1;WWTR1;NFATC4;BAHCC1;SHC1;TCFL5;ZC3H6;MDFI;FOXQ1;MXD4;SMURF2;SMAD3;STAT6;DNAJB5;PRDX5;SALL2;HDAC5;PPM1F;SCMH1;IMPACT;WWC3;DAP;FGFR1;MXI1;H2AFJ;TENM2;TSHZ1;CCND1;TCF25;GAS6;TAGLN3;HES2;CTBP1;MNT;CDKN1C;CEBPB;ZNF217;TGFB1;DEAF1;NAB2;PEG3;PHF21A;MBD3;VHL;MLXIPL;TFDP2;NELFCD;EREG;RPS6KA5;PPP1R13L;ZHX3;HDAC7;CBX7;ZFPM1;PPARA;SOX7;SIX5;WFS1;ARID5B;BHLHE40;SATB1;RERE;BCL7A;WDTC1;HES7;DNMT3A;HES6;PROX1;SIRT2;FAM129B;BACH1;MAP3K10;NR2F6;CBX6;ZP3;TNRC18;IRF2BPL;DEDD2
2829,GO:0006301,0.896903867411507,0.235515987086763,3,49,postreplication repair,BP,POLD4;PRIMPOL;REV1
12385,GO:0048821,0.896934684308024,0.35131484141915,1,20,erythrocyte development,BP,FAM210B
3295,GO:0006996,0.897064995983726,0.115762805900383,308,3101,organelle organization,BP,ERCC1;ZMYND8;H1F0;DLG4;XPC;PARVB;BBS2;VEGFA;APOE;ESPN;NAGLU;F2R;LRP5;HMGA2;OBSCN;IDH2;NEK9;PKN1;MTA1;EVI5L;NISCH;SERPINE2;WWTR1;OBSL1;NOS1;VAT1;SPRY2;CAPN2;BAHCC1;SYTL1;SDC1;SHC1;DDB2;VPS11;TBC1D14;ARL2;HEXB;SNX9;NUDCD3;RAPGEF3;GAA;ARAP1;MAP2K2;SMARCA1;MAP2K1;SSH1;MARK4;SMAD3;SHANK2;LRP1;DVL1;EPAS1;SH3PXD2B;NLGN2;BRD3;REEP4;FBXW5;SYT8;AKT1;GRB7;TMOD2;CORO1B;HDAC5;PPM1F;SCMH1;DYSF;EPHA1;FMNL2;ASH2L;ATG16L2;BRSK1;IFT140;RAB31;DNAAF5;POLD4;RAC2;HLTF;NPHP4;SYNE3;RAG1;H2AFJ;PACS2;TOMM34;CIRBP;HMG20B;ZNF385A;ABCD1;ANK3;TRAPPC9;EFS;TNNT1;TWF2;CEP250;CSNK1E;LAMA5;GSN;PLEKHG2;BCR;SEPT10;WIPF1;HLCS;AIP;SH3D19;CCDC113;CDC25B;ARPIN;SPTB;SMARCD2;PEX10;CORO7;UNC119B;BNIP3;PAK6;SHARPIN;FYCO1;PKD2;CTSZ;CDC42EP5;FBXW8;AP3D1;ITGB5;SH3PXD2A;CTBP1;PTPDC1;KIF17;TMED4;TGFB1;RFX2;ULK2;MOAP1;TBC1D9B;ARHGAP25;FHOD3;SHANK3;MSRB2;MIPEP;EML2;GOLGA2P5;ARAP3;CROCC;RHOD;DNAH1;SNX33;PI4K2A;RHOF;WASF3;ATG2A;LLGL1;PHF21A;COA5;RHOBTB2;TUBG2;BBS1;HMGCL;PTPN1;PEX1;TPP1;AGRN;MBD3;CEP131;PRKCZ;KDM6B;PRKACA;MINK1;CENPH;OXA1L;RCCD1;TOM1L2;AREG;PIM2;MICALL2;BOK;WDR18;TDRKH;CAPG;SDCCAG8;ALAS1;ULK1;NINL;VAMP2;PRIMPOL;TFDP2;PLEK2;C6ORF89;RILPL1;BNIP3L;FSCN1;ARHGAP44;MCFD2;PRKCD;RBL2;IFI6;BAX;HIST3H2BB;SH3BP1;EREG;RPS6KA5;TIMM17B;CUL9;TOP3B;PPL;ZDHHC8;LIMK1;TPM2;PADI3;LEMD2;DNM1;WASH3P;RGS14;LRSAM1;REEP2;EHD3;WDR60;TMEM231;LONP2;TGFA;HDAC7;FHOD1;MTHFR;CHD2;PI4K2B;CBX7;CHEK2;ZFPM1;COG7;SESN2;JADE2;EML3;KDM4B;DOPEY2;PLA2G6;DNAAF3;NBPF3;STK25;RAC3;SUN1;ARHGAP12;ARID5B;DNM2;ATXN10;INF2;TSPYL2;ZMYM3;SATB1;H1FX;IQSEC1;TUBB6;MAPK3;INSR;TAZ;RERE;STX10;INO80C;ATP8B2;CEP72;VANGL2;PAK1;CAMKK2;USP21;CUL7;MICAL1;DNMT3A;BIN1;VPS16;BCL2L1;SGSM2;NDUFV3;PROX1;TBC1D16;LMNA;PKD1;KCTD13;RABGAP1;SIRT2;TRIP10;TEP1;NDE1;GPR3;BCORL1;PDCD6;ATP6V1F;PCLO;PXN;TBC1D8;MSS51;LURAP1;CBX6;TCTN1;EZH1;SIRT3;TERC;WIPI2;BBS10;VPS51;CELSR1;TACC1;SEPT6;PFN2;SSH3;CCDC88C;TNRC18;BLOC1S4;CDC42BPG;TRIM46;KDM3A;TTLL3;PI4KAP2;KLHL24
7838,GO:0032402,0.897259269873759,0.350572148782651,1,20,melanosome transport,BP,BBS2
7236,GO:0031167,0.897476058614037,0.349393915365197,1,21,rRNA methylation,BP,RRNAD1
17339,GO:1900015,0.897537819256563,0.349933921676191,1,20,regulation of cytokine production involved in inflammatory response,BP,PDCD4
8690,GO:0034333,0.897742450709905,0.201293362102707,5,71,adherens junction assembly,BP,VEGFA;SMAD3;PPM1F;LAMA5;RHOD
362,GO:0000981,0.897750787098886,0.127075949891009,68,719,RNA polymerase II transcription factor activity, sequence-specific DNA binding,MF,MEF2D;EGR1;NR1D1;HMGA2;ELK3;NFATC4;ETV5;TCFL5;ETV4;ZFP36L1;FOXQ1;MXD4;POU2F2;TSC22D1;FOS;SMAD3;STAT6;EPAS1;SALL2;HLTF;MXI1;KLF7;ZNF385A;TSHZ1;SOX13;ZSCAN18;MYEF2;GTF2IRD1;HES2;MNT;CEBPB;ZNF217;RFX2;DEAF1;PEG3;MLXIPL;TFDP2;PBX2;RBL2;ZNF395;ZNF524;SOX12;CARF;IER2;ZHX3;ZFPM1;PPARA;SOX7;SIX5;SSBP4;ZNF444;ARID5B;HOXC5;BHLHE40;ZMYM3;SATB1;CAMTA2;RERE;HES7;HES6;PROX1;BACH1;E2F5;GTF2IRD2;MAFF;NR2F6;EZH1;PLAG1
6256,GO:0019843,0.898182679917639,0.232303916350019,3,56,rRNA binding,MF,CIRBP;MRPS6;TST
8964,GO:0035050,0.898502986638068,0.232975066021543,3,47,embryonic heart tube development,BP,SMAD3;PKD2;VANGL2
5398,GO:0016235,0.898548563281966,0.267135640914738,2,34,aggresome,CC,EDEM1;STRADB
1021,GO:0002520,0.898762376504581,0.127636074901837,59,653,immune system development,BP,ERCC1;EGR1;CTNNBIP1;VEGFA;FAM210B;LRP5;PKN1;ZFP36L1;CMTM7;MAP2K1;POU2F2;FOS;SMAD3;STAT6;EPAS1;HDAC5;ASH2L;LRRC8A;WNT2B;KCNAB2;RAG1;CEACAM1;ZNF385A;GAS6;CARD11;SH2B3;SOX13;DHTKD1;BCR;AP3D1;SH3PXD2A;ADAM8;CEBPB;TGFB1;MKNK2;POLL;POLM;IFNE;PRKCZ;ADA;ERBB2;JAK3;FAM20C;BAX;TGFBR3;MFNG;INPP5D;CHD2;ZFPM1;SATB1;MAPK3;TAZ;HLA-G;PPP3CB;RRAS;ITGA4;NBEAL2;ITPKB;LRRK1
3303,GO:0007007,0.898947411762164,0.34539444847788,1,22,inner mitochondrial membrane organization,BP,TAZ
7269,GO:0031258,0.899044590515643,0.346467478937704,1,20,lamellipodium membrane,CC,PLEK2
11996,GO:0047485,0.899095104312229,0.182178226975493,7,97,protein N-terminus binding,MF,ZMYND8;MAP2K1;EXOC2;ERCC6;TGFB1;NTSR1;GLRX
391,GO:0001047,0.899155301979681,0.171692491957267,9,117,core promoter binding,MF,NR1D1;HMGA2;MTA1;FOS;HDAC5;CEBPB;CHD2;PROX1;KDM3A
7324,GO:0031341,0.899512308329932,0.264698658039314,2,36,regulation of cell killing,BP,CEACAM1;PPP3CB
13168,GO:0051783,0.899536956856995,0.160806099210969,12,153,regulation of nuclear division,BP,LRP5;OBSL1;FBXW5;TGFB1;TOM1L2;EREG;CUL9;TGFA;INSR;CUL7;SIRT2;GPR3
18550,GO:1903747,0.899567372198983,0.181410293331356,7,98,regulation of establishment of protein localization to mitochondrion,BP,VPS11;RAC2;MICALL2;TFDP2;BNIP3L;ZDHHC8;NBPF3
18360,GO:1903320,0.89994864201765,0.153370764427455,15,188,regulation of protein modification by small protein conjugation or removal,BP,TNIP1;EGR1;FBXO2;MTA1;AKT1;HMG20B;ZER1;STUB1;LIMK1;WFS1;FYN;PELI1;ZYG11B;TOLLIP;PDCD6
7300,GO:0031307,0.899977839341611,0.34362845643381,1,21,integral component of mitochondrial outer membrane,CC,BNIP3
6282,GO:0019894,0.900195530598635,0.263896121867495,2,34,kinesin binding,MF,KLC2;CROCC
9702,GO:0038111,0.900350764138979,0.340172195628774,1,26,interleukin-7-mediated signaling pathway,BP,JAK3
16849,GO:0098760,0.900350764138979,0.340172195628774,1,26,response to interleukin-7,BP,JAK3
16850,GO:0098761,0.900350764138979,0.340172195628774,1,26,cellular response to interleukin-7,BP,JAK3
8678,GO:0034308,0.900428617974904,0.263156907478217,2,35,primary alcohol metabolic process,BP,RETSAT;CHKA
12628,GO:0050829,0.900474886257422,0.340316969025608,1,25,defense response to Gram-negative bacterium,BP,RNASE7
7580,GO:0031954,0.900673513346526,0.342693025333745,1,20,positive regulation of protein autophosphorylation,BP,VEGFA
10666,GO:0043903,0.901128482304867,0.153729130530028,14,179,regulation of symbiosis, encompassing mutualism through parasitism,BP,TNIP1;APOE;HMGA2;PC;EXOC2;STOM;ADARB1;GSN;RAD23A;MVB12B;NELFCD;APOBEC3C;APOBEC3F;PROX1
12344,GO:0048730,0.901457934697503,0.340865264165342,1,20,epidermis morphogenesis,BP,FOXQ1
3046,GO:0006607,0.901472982534792,0.34083013656332,1,20,NLS-bearing protein import into nucleus,BP,RERE
7311,GO:0031327,0.90149620039784,0.117267102641139,115,1209,negative regulation of cellular biosynthetic process,BP,ZMYND8;EGR1;NR1D1;CYP27B1;PDCD4;CTNNBIP1;ACVR2B;VEGFA;HMGA2;ELK3;MTA1;EGFR;WWTR1;NFATC4;BAHCC1;SHC1;TCFL5;ZFP36L1;MAP2K2;ZC3H6;MDFI;FOXQ1;MAP2K1;ACP5;MXD4;SMURF2;SMAD3;STAT6;DNAJB5;HBEGF;PRDX5;SALL2;GRB7;HDAC5;PPM1F;SCMH1;IMPACT;WWC3;DAP;FGFR1;MXI1;H2AFJ;CEACAM1;CIRBP;TENM2;TSHZ1;CCND1;TCF25;GAS6;ERRFI1;TAGLN3;HES2;CTBP1;MNT;CDKN1C;CEBPB;ZNF217;C8ORF88;TGFB1;UNK;DEAF1;NAB2;PEG3;PHF21A;MBD3;VHL;MLXIPL;TRIB2;TFDP2;JAK3;NELFCD;EREG;RPS6KA5;DDIT4;PPP1R13L;LTB4R2;ZHX3;LPCAT1;ASB1;HDAC7;INPP5D;CBX7;CHEK2;ZFPM1;PPARA;SESN2;SOX7;ABCA7;SIX5;MEX3A;WFS1;ARID5B;BHLHE40;TSPYL2;SLC27A1;SATB1;RERE;BCL7A;GABBR1;CAPRIN2;WDTC1;HES7;DNMT3A;HES6;PROX1;SIRT2;FAM129B;BACH1;MAP3K10;NR2F6;CBX6;ZP3;TNRC18;IRF2BPL;DEDD2
447,GO:0001221,0.901595962132512,0.260848699692835,2,35,transcription cofactor binding,MF,NR1D1;PPARA
7312,GO:0031328,0.901855554424743,0.116034021257702,127,1308,positive regulation of cellular biosynthetic process,BP,TNIP1;MEF2D;CITED4;EGR1;NR1D1;CST3;APLN;VEGFA;WNT7A;APOE;F2R;LRP5;ITGA6;HMGA2;ELK3;EGFR;WWTR1;NOS1;NFATC4;ETV5;SHC1;HEXB;ETV4;RAPGEF3;MAP2K2;SMARCA1;MAP2K1;POU2F2;FOS;SMAD3;STAT6;PIK3R2;ERCC6;DVL1;EPAS1;SALL2;ZXDC;RNF187;ADORA2B;AKT1;HDAC5;ASH2L;IMPACT;PTHLH;FGFR4;LDLR;FGFR1;SEC14L2;HLTF;KLF7;NAT14;CIRBP;CARD11;PKD2;CRTC1;CDKN1C;ZMIZ2;CD81;CEBPB;TIMP2;TGFB1;RFX2;DEAF1;NTSR1;TMEM173;PEG3;MC1R;ABHD14B;AGRN;VHL;PFKFB2;MLXIPL;KDM6B;ZNF516;AREG;PIM2;ERBB2;TFDP2;PBX2;PRKCD;EREG;RPS6KA5;SOX12;MBTPS2;CARF;IER2;IRAK1;FHOD1;CHEK2;ZFPM1;PPARA;SESN2;SOX7;SIX5;PLA2G6;SSBP4;DNM2;MAPK3;INSR;CAMTA2;TAZ;PFKM;RERE;CAMKK2;PPP3CB;USP21;PFKFB3;CAPRIN2;PPP2R5B;MAP2K3;PROX1;PKD1;KCTD13;SIRT2;FAM129B;BACH1;E2F5;MAPRE3;NGFR;MAFF;CAMK1;EZH1;ZP3;TCEA2;PLAG1;IRF2BPL;KDM3A
7168,GO:0031056,0.902376601382045,0.166931049493638,9,118,regulation of histone modification,BP,VEGFA;NOS1;CTBP1;TGFB1;C6ORF89;RPS6KA5;MTHFR;MAPK3;KDM3A
10355,GO:0043175,0.902411534520557,0.259230522052444,2,35,RNA polymerase core enzyme binding,MF,ERBB2;UVSSA
5907,GO:0018126,0.902612259438085,0.338163458804159,1,20,protein hydroxylation,BP,CRTAP
5832,GO:0017112,0.902789289141406,0.22492854721679,3,49,Rab guanyl-nucleotide exchange factor activity,MF,RIN1;TRAPPC9;SBF1
3310,GO:0007017,0.902924978441662,0.123420844548165,56,607,microtubule-based process,BP,BBS2;OBSL1;SPRY2;ARL2;MARK4;KLC2;DVL1;AP2A2;FBXW5;BRSK1;IFT140;DNAAF5;CEP250;FYCO1;PKD2;AP3D1;KIF17;EML2;KIF26B;GOLGA2P5;CROCC;DNAH1;LLGL1;KIF7;TUBG2;PEX1;CEP131;PRKCZ;SDCCAG8;ERBB2;NINL;CUL9;RGS14;WDR60;CHEK2;MYO1D;MYH15;EML3;DNAAF3;SUN1;KIF26A;TUBB6;CEP72;PAK1;CUL7;LMNA;PKD1;NDE1;MSS51;KIF13B;TACC1;CCDC88C;BLOC1S4;TRIM46;APBA1;TTLL3
3730,GO:0008270,0.902960975710168,0.124107271554483,53,580,zinc ion binding,MF,EGR1;NR1D1;MTA1;VAT1;TRIM65;MMP1;RNPEPL1;MARCH9;SMAD3;S100A6;MMP28;PHC2;MARCH4;HLTF;RAG1;KLF7;ZNF385A;PEX10;CCS;ADAM8;LTA4H;ZMIZ2;ADAMTS13;TIMP2;LACTB2;SHANK3;MSRB2;PTPN1;RABGGTA;ADA;MPI;MMP10;RNPEP;MIB2;USP20;TRIM4;MT2A;DTNB;PPARA;NEIL1;ZMYM3;APOBEC3C;APOBEC3F;RERE;PDXK;TRIM45;SIRT2;GCH1;NR2F6;SIRT3;CBLC;TCEA2;TRIM46
6582,GO:0022600,0.903107128113251,0.25784676568981,2,35,digestive system process,BP,STK39;LDLR
7851,GO:0032418,0.903206630197287,0.224170907142787,3,49,lysosome localization,BP,ADORA2B;RAC2;PLEKHM1
2831,GO:0006303,0.903253314085348,0.204392686134911,4,67,double-strand break repair via nonhomologous end joining,BP,ERCC1;HMGA2;POLL;POLM
5425,GO:0016278,0.903660349207848,0.223498983475036,3,48,lysine N-methyltransferase activity,MF,ASH2L;EEF2KMT;EZH1
89,GO:0000178,0.903889714368836,0.333865884975869,1,22,exosome (RNase complex),CC,GTPBP1
19238,GO:1905354,0.903889714368836,0.333865884975869,1,22,exoribonuclease complex,CC,GTPBP1
9586,GO:0036442,0.904026140345442,0.333543887470038,1,22,proton-exporting ATPase activity,MF,ATP6V1F
5822,GO:0017091,0.90417067328845,0.333815705166575,1,21,AU-rich element binding,MF,ZFP36L1
1871,GO:0004536,0.904545373435549,0.202641947763473,4,62,deoxyribonuclease activity,MF,ERCC1;ENDOG;NEIL1;DNASE1L1
5566,GO:0016578,0.904626849266318,0.332736449283966,1,21,histone deubiquitination,BP,USP21
15002,GO:0070936,0.906097122396364,0.218897784200075,3,49,protein K48-linked ubiquitination,BP,RNF187;CDC34;PELI1
10287,GO:0043044,0.906302010724156,0.199004636508355,4,69,ATP-dependent chromatin remodeling,BP,SMARCA1;SMARCD2;MBD3;CENPH
8694,GO:0034341,0.906742937790669,0.160318404813651,9,123,response to interferon-gamma,BP,CYP27B1;IFNGR2;GSN;ADAMTS13;PRKCD;MT2A;RAB12;HLA-G;GCH1
14765,GO:0070469,0.906750230014228,0.197610523703716,4,78,respiratory chain,CC,SDHA;OXA1L;CYC1;NDUFV3
8341,GO:0033209,0.906770860883582,0.15639344435209,10,139,tumor necrosis factor-mediated signaling pathway,BP,TNFRSF6B;RBCK1;GAS6;SHARPIN;TNFSF15;SPPL2B;TNFRSF25;EDA;PELI3;NGFR
13490,GO:0055067,0.907066641759899,0.176803193058951,6,86,monovalent inorganic cation homeostasis,BP,SLC12A7;SLC9A7;SLC12A4;MAPK3;ATP6V1F;SLC26A11
2904,GO:0006418,0.907322824694865,0.216647955846887,3,49,tRNA aminoacylation for protein translation,BP,DALRD3;IARS2;AARS
8832,GO:0034629,0.907556868192388,0.32574841451186,1,21,cellular protein-containing complex localization,BP,CEP72
13746,GO:0060333,0.907900703769144,0.196766032703131,4,63,interferon-gamma-mediated signaling pathway,BP,IFNGR2;PRKCD;MT2A;HLA-G
12532,GO:0050687,0.908279803855219,0.324009099683723,1,21,negative regulation of defense response to virus,BP,HTRA1
4337,GO:0009891,0.90844812878031,0.108509539994755,128,1322,positive regulation of biosynthetic process,BP,TNIP1;MEF2D;CITED4;EGR1;NR1D1;CST3;APLN;VEGFA;WNT7A;APOE;F2R;LRP5;ITGA6;HMGA2;ELK3;EGFR;WWTR1;NOS1;NFATC4;ETV5;SHC1;HEXB;ETV4;RAPGEF3;MAP2K2;SMARCA1;MAP2K1;POU2F2;FOS;SMAD3;STAT6;PIK3R2;ERCC6;DVL1;EPAS1;SALL2;ZXDC;RNF187;ADORA2B;AKT1;HDAC5;ASH2L;IMPACT;PTHLH;FGFR4;LDLR;FGFR1;SEC14L2;HLTF;KLF7;NAT14;CIRBP;CARD11;PKD2;CRTC1;CDKN1C;ZMIZ2;CD81;CEBPB;TIMP2;TGFB1;RFX2;DEAF1;NTSR1;TMEM173;PEG3;MC1R;ABHD14B;AGRN;VHL;PFKFB2;MLXIPL;KDM6B;ZNF516;AREG;PIM2;ERBB2;TFDP2;PBX2;PRKCD;EREG;RPS6KA5;SOX12;MBTPS2;CARF;IER2;IRAK1;FHOD1;CHEK2;ZFPM1;PPARA;SESN2;ABCG1;SOX7;SIX5;PLA2G6;SSBP4;DNM2;MAPK3;INSR;CAMTA2;TAZ;PFKM;RERE;CAMKK2;PPP3CB;USP21;PFKFB3;CAPRIN2;PPP2R5B;MAP2K3;PROX1;PKD1;KCTD13;SIRT2;FAM129B;BACH1;E2F5;MAPRE3;NGFR;MAFF;CAMK1;EZH1;ZP3;TCEA2;PLAG1;IRF2BPL;KDM3A
7837,GO:0032401,0.90857720999066,0.323291804292952,1,21,establishment of melanosome localization,BP,BBS2
13230,GO:0051904,0.90857720999066,0.323291804292952,1,21,pigment granule transport,BP,BBS2
11473,GO:0045943,0.909316081979702,0.321505283015681,1,21,positive regulation of transcription by RNA polymerase I,BP,ERBB2
2878,GO:0006383,0.909501903870805,0.212347126449849,3,51,transcription by RNA polymerase III,BP,PRDX5;NAB2;ERBB2
4569,GO:0010656,0.909578244853156,0.320869854645693,1,21,negative regulation of muscle cell apoptotic process,BP,RGL2
3257,GO:0006929,0.909651579307639,0.32069196182314,1,21,substrate-dependent cell migration,BP,ADAM8
8008,GO:0032647,0.910298157313817,0.319120749543732,1,21,regulation of interferon-alpha production,BP,PTPRS
4328,GO:0009855,0.91082904172562,0.179603899106717,5,74,determination of bilateral symmetry,BP,ACVR2B;SMAD3;IFT140;PKD2;VANGL2
2532,GO:0005790,0.910946687195854,0.316932383004549,1,22,smooth endoplasmic reticulum,CC,MYO1D
7299,GO:0031306,0.910996556249038,0.316810653601287,1,22,intrinsic component of mitochondrial outer membrane,CC,BNIP3
2432,GO:0005623,0.911230956176145,0.106950470065469,1166,11160,cell,CC,TNIP1;DUSP6;NT5E;XDH;ERCC1;DUSP5;SDK2;MEF2D;ZMYND8;ADGRL1;H1F0;CITED4;SEMA4B;HTRA1;FHL1;EGR1;B4GALNT4;NR1D1;SLC16A3;H6PD;CCNG2;EDEM1;DLG4;PLAT;CST3;CYP27B1;MRC2;TYSND1;HS1BP3;BTBD2;MARVELD1;EPN3;FBXO2;APLN;PRR7;PDCD4;CTNNBIP1;NAGS;KCNG1;ACVR2B;DOCK4;XPC;PRNP;PARVB;PYGB;BBS2;FLNC;SLC6A8;DDIT4L;POSTN;VEGFA;FAM210B;TNFRSF6B;PGM1;WNT7A;APOE;PYGL;DGKA;TSPAN1;ESPN;NAGLU;F2R;LRP5;PLD3;OSBPL5;LPCAT4;ITGA6;ISYNA1;PITPNC1;HMGA2;OBSCN;NDRG1;IDH2;ZKSCAN1;NEK9;CRAT;SLCO4A1;ELK3;ITPR3;PKN1;MTA1;GRAMD4;ACOT7;ARRDC1;ANGEL1;ACSF2;EVI5L;NISCH;AKR7A2;FCGRT;SH2D5;EGFR;RPS6KA2;SERPINE2;DNPH1;WWTR1;LOXL1;SCN4B;OBSL1;NOS1;VAT1;PTPRS;TMEM129;SLC2A9;ANKS6;HADH;CTSO;SPRY2;LRP3;CAPN2;MST1R;NFATC4;TRIM65;BAHCC1;CRTAP;PRSS8;SYTL1;SDC1;KLHL29;ETV5;LMF1;APPL2;SHC1;DDB2;ORAI1;LTBP2;VPS11;LTBP1;TBC1D14;ARL2;HEXB;GTPBP1;SLC7A8;TCFL5;PTPRE;SLC12A7;NPEPL1;SLC2A3;ALDH4A1;TK2;RIN1;ACTA2;CLIP2;ETV4;PHLDA2;SNX9;NUDCD3;TRNP1;SPRY4;RAPGEF3;TXNRD3;ST6GALNAC2;ZFP36L1;GAA;GLUL;RNPEPL1;ARAP1;MAP2K2;KDSR;NME4;ZC3H6;LPAR3;MARCH9;CTBS;PLCD3;FKBP9;MDFI;PTOV1;CSMD2;SMARCA1;RBCK1;SUGCT;PGLS;PC;FOXQ1;RNF44;MAP2K1;NAPRT;CRYL1;ACP5;CPT2;VWA5A;MCTP1;MXD4;SSH1;POU2F2;EXOC2;ENDOG;MARK4;SLC16A5;KCNJ15;MARCKSL1;MPRIP;TMEM8A;GALE;SMURF2;KLC2;TSC22D1;ARMCX2;OXLD1;SLC9A3R2;FOS;SMAD3;ARHGAP23;STAT6;SHANK2;PIK3R2;ERCC6;LRP1;GJC2;SRD5A3;DVL1;EPAS1;DNAJB5;PIGQ;HSD17B8;THBS3;HBEGF;FAM110C;RPUSD3;AP2A2;S100A4;ITGB4;CYBRD1;PPP1R14A;SH3PXD2B;PPP2R3B;PRDX5;SHC2;NLGN2;STOM;BRD3;PRODH;SALL2;MBOAT7;CDK18;REEP4;LY6K;FBXW5;PAG1;ZXDC;RNF187;NMRK1;ADORA2B;ADARB1;PLCXD2;D2HGDH;SYT8;SLC6A6;AKT1;TPCN1;GRB7;KCNC4;TMOD2;CORO1B;TTYH3;HDAC5;UROS;FBXO41;FAM83A;S100A6;F12;SH2D2A;PPM1F;MMP28;PITPNM1;ENTPD6;PLEKHH3;RHBDF2;PYCR2;BSG;STK39;HK1;SERPING1;ASAP2;SCMH1;DYSF;EPHA1;GGT1;PHC2;NFKBIZ;PTPRU;VEGFB;FMNL2;ASH2L;IMPACT;MARCH4;SLC15A4;WWC3;ATG16L2;ZFYVE21;LRRC8A;CNTN1;IFNGR2;BRSK1;IFT140;PTHLH;MYZAP;MFSD3;RAB31;DNAAF5;FGFR4;HEBP1;PEAR1;WNT2B;POLD4;ACOT1;FNDC4;LDLR;FGFR1;PRKACB;FUCA1;MAPKBP1;ELMO3;SIGMAR1;RAC2;KCNAB2;PFKL;SEC14L2;OPLAH;HLTF;MXI1;NPHP4;SYNE3;RAG1;GAMT;H2AFJ;B4GAT1;PACS2;PHF7;TOMM34;BPHL;PIGV;KLF7;RALGDS;SORL1;NAT14;CEACAM1;B3GAT3;ASB13;CIRBP;CBR4;HMG20B;LZTS2;RAB11FIP4;TENM2;ZNF385A;DOCK6;NSMCE4A;MICALCL;ABCD1;ANK3;NIPSNAP1;IGFBP4;TTC7B;EVC;TSHZ1;TRAPPC9;CCND1;PODNL1;EFS;PCBP4;TCF25;LHPP;TNNT1;TWF2;AIG1;STRADB;SYNGAP1;PLCH2;MAPK13;CEP250;EDNRA;CARD19;PLAU;GAS6;PTK6;PFKP;FGFBP1;CSNK1E;R3HDM4;BRI3;CTSB;RAB3B;CARD11;SH2B3;SOX13;LAMA5;DUSP7;MPLKIP;GSN;PLEKHG2;MAPKAPK3;IGFBP2;PCSK9;ARHGAP22;RAD23A;DHTKD1;PHLDA1;ANO8;BCR;ANTXR2;XPOT;MRPS6;EHD4;ERRFI1;GLI4;SEPT10;WIPF1;NADK;PANK4;HLCS;ZSCAN18;PRSS22;AIP;DBNDD1;STON1;MYEF2;SH3D19;CCDC113;CDC25B;RGL2;SLITRK6;TSPAN18;PAQR6;ARPIN;SH3GLB2;ARHGAP27;ALOX15B;SPTB;SMARCD2;AGAP1;COMTD1;RSPH3;PEX10;CCS;RSAD1;COL13A1;CORO7;SLC20A1;NPR2;UNC119B;SNTA1;DGKQ;HAGH;PLXNB3;BNIP3;PAK6;NOL4L;GTF2IRD1;SHARPIN;MVB12B;TAGLN3;FYCO1;CEMIP;PROCR;PKD2;ACY1;PCSK1;RETSAT;YPEL3;RASGEF1A;CTSZ;CDC42EP5;HES2;CRTC1;IL20RB;FBXW8;GPSM1;AP3D1;ITGB5;ABCA2;PRSS3;SH3PXD2A;C19ORF33;EPOR;EPHB2;GRIN3B;ADAM8;ASIC1;CADM4;APRT;TMEM9;CTBP1;JOSD2;LTA4H;MNT;PTPDC1;GRIP2;GRK6;CDKN1C;PLCG1;FBXL8;ZMIZ2;CBS;KIF17;NYAP1;CD81;CEBPB;MVD;RNF135;ENTPD2;LGALS9B;ADAMTS13;SLC29A4;ZNF217;TIMP2;ZNF862;NUDCD2;SYNJ2;WNT3;DPP7;GNAL;C8ORF88;TMED4;TGFB1;LACTB2;SNPH;CLTCL1;RFX2;SCYL1;ABHD17C;SLC43A1;UNK;SNTB2;ULK2;GPC1;MKNK2;ADAMTS7;DEAF1;MOAP1;TBC1D9B;SLC38A10;NTSR1;B3GNT3;NAB2;TMEM173;ARHGAP25;TMEM134;ZSCAN30;ATP7B;FHOD3;SHANK3;PODXL2;SDHA;MSRB2;EFNB3;RASA3;PNRC1;MIPEP;PIP5KL1;TNFSF15;MYCBPAP;MGAT4B;EML2;KIF26B;MDH2;MPG;GALNS;FBXO17;CLCA2;HEXDC;GOLGA2P5;ENKD1;NSMF;PEG3;ARAP3;SCART1;FARP1;MC1R;TUB;DIRC2;LCE1E;CROCC;RHOD;ABHD14B;LAMB2;TNS1;ABTB1;SNX17;RNH1;DNAH1;ERO1B;ST6GALNAC6;HTR7;VGF;POLL;FBXO44;POLM;SNX33;PI4K2A;SEMA4F;C1ORF210;PTMS;RHOF;YIPF3;ANKZF1;WASF3;ATG2A;SLC48A1;LLGL1;PHGDH;ARL10;PHF21A;MIF4GD;KIF7;COA5;PLPP6;RHOBTB2;UBXN4;ADAM19;KHDRBS3;SAC3D1;TUBG2;ZER1;RIMS3;BBS1;TNFAIP8L1;HMGCL;PTPN1;PEX1;TPP1;PCK2;B4GALT2;WDR59;AGRN;MBD3;CD320;CAMK2N1;OSBPL10;LRP4;LRP10;ESYT2;ZDHHC24;GPR153;ACP6;B4GALT6;VHL;TMCC3;MYH16;CEP131;TRAP1;IDUA;ADAP1;PFKFB2;RFNG;MLXIPL;YPEL5;TRIB2;PRKCZ;KDM6B;PRKACA;MINK1;ZNF516;CENPH;GRHPR;OXA1L;RHPN1;RABGGTA;RCCD1;ACTR1B;TOM1L2;CD9;EPN2;ADA;AREG;PIM2;MPI;MICALL2;UCKL1;LGALS9C;PLEKHG5;BOK;WDR18;TDRKH;CAPG;SDCCAG8;ALAS1;NEURL1B;ERBB2;ADGRB2;ULK1;CNDP2;NINL;AHCY;VAMP2;CERCAM;PRIMPOL;TMEM143;TFDP2;SMTN;PLEK2;C6ORF89;MZT2A;NECAB3;STK17A;RILPL1;FAM50A;JAK3;IRF2BP2;RNPEP;NET1;BNIP3L;CYFIP2;FSCN1;PBX2;TRPC1;NELFCD;SLC22A17;RASA4;GLCCI1;PDK1;ACAD10;CYGB;ARHGAP44;THOP1;EHBP1L1;MCFD2;PRKCD;FAM20C;MIB2;REEP6;RBL2;CACNB3;USP20;STUB1;IFI6;BAX;CYC1;SV2A;SBF1;DTD1;XYLT2;SLC13A5;TRIM4;ITGA1;OLFM2;ZNF395;HIST3H2BB;CCDC92;NUBP2;PPCS;SH3BP1;FBXW4;GJB4;EREG;RPS6KA5;DGUOK;TMEM25;DUSP4;KLHDC2;TIMM17B;ZNF524;CUL9;SOX12;PLEKHH1;TMBIM4;DDIT4;MBTPS2;ACADS;TOP3B;PPL;PPP1R13L;CARF;HSD17B7;AHNAK2;PCSK1N;MT2A;IER2;RASL10B;CES2;NAGA;ZDHHC8;TMX4;MZT2B;FCHO1;NID1;LIMK1;TGFBR3;PDIA5;GDI1;TPM2;PADI3;DIP2A;LTB4R2;CPNE7;SLC2A11;RPL39L;LEMD2;RPS6KA6;TMEM92;ZHX3;DNM1;WASH3P;RGS14;TMEM8B;SCN8A;MFNG;GSTO1;GIT1;ALDOC;CHAD;MRPS26;MSLN;LPCAT1;LRSAM1;ADAM15;REEP2;ASB1;EHD3;WDR60;ST3GAL3;TMEM231;LONP2;SYMPK;MAPK12;IRAK1;PPOX;TGFA;HDAC7;FHOD1;INPP5D;MTHFR;CHD2;PI4K2B;CBX7;PCMTD2;CHEK2;DTNB;DECR2;ZFPM1;PPARA;COG7;COQ2;SESN2;FGGY;ABCG1;MYO1D;JADE2;MYH15;CDC34;RNF123;SNN;SOX7;ABCA7;RAB12;EML3;SPEG;SIX5;BCAP31;MIF;ACO2;SMOX;EEF2KMT;KDM4B;SLC25A29;DOPEY2;PHYH;ZNF414;MEX3A;BCAM;SLC9A7;PLA2G6;DDT;SSBP4;SYNGR1;NUDT14;ECM1;NARF;WFS1;QSOX1;DNAAF3;CD68;ZNF444;SLC22A18;DTX3;NBPF3;SPPL2B;HSD11B1L;FYN;PITPNM3;VWA1;UPP1;STK25;RAC3;ETFB;TMCO6;GLB1L2;EEF2K;CERS4;SUN1;ICAM5;ARHGAP12;FLYWCH1;ACAP3;ARID5B;HOXC5;DNM2;CKMT1A;CYP3A5;BHLHE40;GLB1;PELI1;ATXN10;SNX15;INF2;CHKA;CAT;BEX2;NEIL1;TSPYL2;KIAA1147;IGFBP7;ARMCX1;SLC27A1;ZMYM3;TPBG;APOBEC3C;SATB1;SLC50A1;KIF26A;ASMTL;ZDHHC1;SLC12A4;PLCB3;H1FX;IQSEC1;ZNF606;APOBEC3F;ARHGEF4;DDX50;CYP2R1;TUBB6;MAPK3;CBLN3;INSR;SLC13A3;RTN2;ARHGEF1;PAN2;GRINA;PDZD2;CAMTA2;TAZ;PFKM;ADCY1;TNS4;C12ORF66;RERE;HLA-G;DOCK9;STX10;TSTA3;INO80C;ATP8B2;GPT2;RALGAPA1;MORN4;PDXK;ETAA1;PRAF2;GLRX;CEP72;VANGL2;PAK1;TRIM45;CDYL2;DCAF10;KLHL36;MALL;CAMKK2;RNASET2;PPP3CB;RNF144A;LGALS3BP;ALPK1;CTSF;USP21;PFKFB3;MLYCD;CUL7;SLC37A2;GABBR1;REV1;MICAL1;HYAL1;SEMA4C;CAPRIN2;ZBTB10;WDTC1;HES7;ITGA3;STK32C;DNMT3A;SAMD8;BIN1;VPS16;MAN2B1;SRMS;TSTD1;PPP2R5B;HES6;SLC16A13;MAP2K3;NDST2;BCL2L1;DLG3;SGSM2;ABHD10;NDUFV3;RRAS;DNASE1L1;PROX1;IARS2;LRCH4;MDGA1;TBC1D16;ADGRF1;ALDH7A1;LMNA;ZYG11B;PKD1;KCTD13;TNFRSF25;RABGAP1;SIRT2;FAM129B;CDH4;ITGA4;EDA;UVSSA;ANKRD13D;GAL3ST4;DCBLD2;NMNAT2;BACH1;NT5C1B;TRIP10;ADCY7;E2F5;ZBTB22;ALG12;LTB4R;AFAP1L1;MAPRE3;AZIN2;TEP1;RAB28;ZNF704;SERPINB1;ST3GAL2;ICA1;SLC25A37;RAP1GAP2;LAMB1;SOCS7;MAP3K10;HSDL1;RGS19;NDE1;GPR3;HSD11B1;PELI3;GTF2IRD2;RAB40B;NGFR;TOLLIP;BCORL1;PDCD6;ATP6V1F;PCLO;ARVCF;CHST14;BIVM;ZNF837;RNASE7;PXN;GRB10;TBC1D8;PHYKPL;PLEKHM1;DUSP23;GCH1;MSS51;LURAP1;KIF13B;MAFF;NR2F6;CBX6;TCTN1;NBEAL2;PNMA1;CAMK1;CAMKK1;SLC39A3;EZH1;SIRT3;HFE;TERC;ZNF513;WIPI2;GAS2L1;COL6A1;BTG1;BBS10;ZP3;VPS51;FAM117A;CELSR1;TACC1;MLF2;IL17RE;SEMA3B;SEPT6;CDK11B;PFN2;C2CD2;SSH3;FGFR3;MFSD10;PPP1R16A;TST;CCDC88C;ST3GAL5;TNRC18;NDRG2;MAN2B2;BLOC1S4;CBLC;ITPKB;PTGR2;SPTLC2;TCEA2;CDC42BPG;PRSS21;ZBTB47;PLAG1;LRP11;DOK4;GSDMA;CLK3;IRF2BPL;TRIM46;DHX32;KDM3A;PM20D2;TMEM187;FAM214B;TBL3;HOMER2;SLC23A2;PKN3;APBA1;TTLL3;DEDD2;PI4KAP2;AK3;SRSF5;CHPF;ADCY6;SLC26A11;LRRK1;AARS;KLHL24;STRN4;SDC2
9179,GO:0035561,0.911321335539281,0.316624183242569,1,21,regulation of chromatin binding,BP,NFATC4
4338,GO:0009892,0.911546840914338,0.101757157243579,210,2174,negative regulation of metabolic process,BP,TNIP1;DUSP6;XDH;ERCC1;DUSP5;ZMYND8;EGR1;NR1D1;DLG4;PLAT;CST3;CYP27B1;APLN;PDCD4;CTNNBIP1;ACVR2B;PRNP;BBS2;VEGFA;TNFRSF6B;APOE;LRP5;HMGA2;ELK3;PKN1;MTA1;EGFR;SERPINE2;WWTR1;SPRY2;NFATC4;BAHCC1;CRTAP;SHC1;TBC1D14;GTPBP1;TCFL5;SPRY4;ZFP36L1;MAP2K2;ZC3H6;MDFI;PPP1R35;PC;FOXQ1;MAP2K1;ACP5;MXD4;SMURF2;FBLN1;SMAD3;STAT6;PIK3R2;DVL1;DNAJB5;HBEGF;PPP1R14A;PRDX5;SALL2;ADARB1;AKT1;GRB7;HDAC5;PPM1F;STK39;SERPING1;SCMH1;EPHA1;IMPACT;WWC3;DAP;LDLR;FGFR1;MXI1;RAG1;H2AFJ;SORL1;CEACAM1;CIRBP;HMG20B;TENM2;TSHZ1;CCND1;PODNL1;PCBP4;TCF25;GAS6;PTK6;DUSP7;PCSK9;BCR;ERRFI1;SNTA1;DGKQ;BNIP3;TFPI2;TAGLN3;CTSZ;HES2;MAGEF1;EPHB2;CTBP1;MNT;CDKN1C;CEBPB;ZNF217;TIMP2;C8ORF88;TGFB1;UNK;DEAF1;NAB2;PNRC1;PEG3;FARP1;RNH1;PHF21A;PTPN1;MBD3;CAMK2N1;VHL;TRAP1;MLXIPL;TRIB2;PRKCZ;OXA1L;TDRKH;TFDP2;JAK3;NELFCD;CYGB;PRKCD;RBL2;IFI6;BAX;EREG;RPS6KA5;DUSP4;DDIT4;PPP1R13L;PCSK1N;LIMK1;DIP2A;LTB4R2;LEMD2;RPS6KA6;ZHX3;RGS14;CHAD;LPCAT1;ASB1;HDAC7;INPP5D;CBX7;CHEK2;ZFPM1;PPARA;SESN2;MYO1D;SOX7;ABCA7;SIX5;MIF;MEX3A;ECM1;WFS1;QSOX1;FYN;ARID5B;BHLHE40;NEIL1;TSPYL2;ELFN2;SLC27A1;SATB1;PAN2;RERE;BCL7A;GABBR1;MICAL1;CAPRIN2;WDTC1;HES7;DNMT3A;BIN1;HES6;DLG3;PROX1;SIRT2;FAM129B;BACH1;AZIN2;SERPINB1;SOCS7;MAP3K10;NGFR;GRB10;NR2F6;CBX6;SIRT3;HFE;ZP3;TNRC18;NDRG2;CBLC;PLAG1;IRF2BPL;KDM3A;DEDD2;LRRK1
8668,GO:0034249,0.911553898940805,0.132745691576473,18,233,negative regulation of cellular amide metabolic process,BP,PRNP;APOE;EGFR;ZFP36L1;MAP2K2;MAP2K1;SMAD3;GRB7;SORL1;CIRBP;C8ORF88;TGFB1;UNK;SESN2;ABCA7;MEX3A;CAPRIN2;BIN1
5587,GO:0016605,0.912305082908798,0.168408210797801,6,86,PML body,CC,TENM2;MKNK2;RGS14;CHEK2;SATB1;LRCH4
14211,GO:0061157,0.912366166703542,0.314061746078929,1,21,mRNA destabilization,BP,ZFP36L1
13478,GO:0055026,0.912483362608664,0.31377349553996,1,21,negative regulation of cardiac muscle tissue development,BP,PAK1
11445,GO:0045910,0.912527582019203,0.313664691531385,1,21,negative regulation of DNA recombination,BP,MAGEF1
7902,GO:0032481,0.912711237429379,0.188390511291948,4,63,positive regulation of type I interferon production,BP,STAT6;RNF135;TMEM173;IRAK1
588,GO:0001750,0.913082864397978,0.237366499218509,2,36,photoreceptor outer segment,CC,SHANK2;IFT140
7056,GO:0030850,0.913564851092914,0.236370796676898,2,36,prostate gland development,BP,ALOX15B;PLAG1
14133,GO:0061014,0.914274532043835,0.234901433135565,2,36,positive regulation of mRNA catabolic process,BP,GTPBP1;ZFP36L1
14618,GO:0070192,0.914318923647524,0.234809391681643,2,36,chromosome organization involved in meiotic cell cycle,BP,LEMD2;SUN1
9634,GO:0036507,0.914684766500351,0.307723984334321,1,22,protein demannosylation,BP,EDEM1
9635,GO:0036508,0.914684766500351,0.307723984334321,1,22,protein alpha-1,2-demannosylation,BP,EDEM1
14103,GO:0060969,0.914775230524722,0.307498997176319,1,22,negative regulation of gene silencing,BP,TGFB1
5557,GO:0016569,0.915091807339743,0.115339259119132,35,397,covalent chromatin modification,BP,ZMYND8;VEGFA;HMGA2;PKN1;MTA1;NOS1;DDB2;HDAC5;PPM1F;ASH2L;RAG1;HMG20B;HLCS;CTBP1;TGFB1;PHF21A;MBD3;KDM6B;C6ORF89;PRKCD;RPS6KA5;PADI3;HDAC7;MTHFR;JADE2;KDM4B;ARID5B;SATB1;MAPK3;USP21;DNMT3A;SIRT2;EZH1;SIRT3;KDM3A
10178,GO:0042775,0.915270026190018,0.18273421293159,4,79,mitochondrial ATP synthesis coupled electron transport,BP,SDHA;CYC1;TAZ;NDUFV3
15107,GO:0071168,0.916170111599499,0.304016817879769,1,22,protein localization to chromatin,BP,LEMD2
11747,GO:0046605,0.91623084051078,0.199900022622004,3,50,regulation of centrosome cycle,BP,FBXW5;CEP250;CEP131
4315,GO:0009799,0.916429287540907,0.17014326311527,5,75,specification of symmetry,BP,ACVR2B;SMAD3;IFT140;PKD2;VANGL2
6748,GO:0030176,0.917053480415604,0.144882585093199,9,123,integral component of endoplasmic reticulum membrane,CC,EDEM1;PKD2;BCAP31;WFS1;SPPL2B;RTN2;HLA-G;SLC37A2;SAMD8
1426,GO:0003382,0.917059006703747,0.301784856878985,1,22,epithelial cell morphogenesis,BP,RILPL1
6970,GO:0030641,0.917065346891542,0.180623178920327,4,64,regulation of cellular pH,BP,SLC9A7;MAPK3;ATP6V1F;SLC26A11
16562,GO:0097346,0.917886918551418,0.299151114773121,1,23,INO80-type complex,CC,INO80C
2827,GO:0006297,0.917909483596087,0.299094106279461,1,23,nucleotide-excision repair, DNA gap filling,BP,POLD4
5130,GO:0015605,0.91819293627106,0.298922816070345,1,22,organophosphate ester transmembrane transporter activity,MF,SLC37A2
16872,GO:0098803,0.918197831645899,0.194557512716447,3,66,respiratory chain complex,CC,SDHA;CYC1;NDUFV3
8982,GO:0035094,0.918598126199272,0.297896046703126,1,22,response to nicotine,BP,PPARA
13231,GO:0051905,0.918649225499184,0.297766405633247,1,22,establishment of pigment granule localization,BP,BBS2
3229,GO:0006886,0.918704670010817,0.100346379526764,83,920,intracellular protein transport,BP,EDEM1;PRNP;EVI5L;TMEM129;SYTL1;LTBP2;VPS11;TBC1D14;SNX9;RAPGEF3;AP2A2;STOM;AKT1;RAB31;RAC2;TOMM34;SORL1;B3GAT3;ANK3;STRADB;GAS6;RAB3B;BCR;XPOT;AIP;PEX10;CEMIP;AP3D1;TMED4;TGFB1;CLTCL1;TBC1D9B;TMEM173;MIPEP;RHOD;SNX17;SNX33;PTPN1;PEX1;ZDHHC24;CEP131;TOM1L2;MICALL2;ERBB2;VAMP2;RILPL1;BNIP3L;ARHGAP44;PRKCD;TIMM17B;ZDHHC8;GDI1;WASH3P;REEP2;LONP2;SYMPK;COG7;RAB12;BCAP31;SYNGR1;NBPF3;FYN;TMCO6;SNX15;ZDHHC1;RTN2;RERE;STX10;PAK1;VPS16;SGSM2;TBC1D16;PKD1;RABGAP1;RAB28;RAB40B;NGFR;PDCD6;TBC1D8;KIF13B;CAMK1;APBA1;SRSF5
10996,GO:0044815,0.918711385983789,0.176071038750351,4,91,DNA packaging complex,CC,H1F0;H2AFJ;HIST3H2BB;H1FX
13952,GO:0060669,0.918752284881792,0.297504835032841,1,22,embryonic placenta morphogenesis,BP,ZFP36L1
10907,GO:0044464,0.91885050197053,0.0981340575690191,1165,11155,cell part,CC,TNIP1;DUSP6;NT5E;XDH;ERCC1;DUSP5;SDK2;MEF2D;ZMYND8;ADGRL1;H1F0;CITED4;SEMA4B;HTRA1;FHL1;EGR1;B4GALNT4;NR1D1;SLC16A3;H6PD;CCNG2;EDEM1;DLG4;PLAT;CST3;CYP27B1;MRC2;TYSND1;HS1BP3;BTBD2;MARVELD1;EPN3;FBXO2;APLN;PRR7;PDCD4;CTNNBIP1;NAGS;KCNG1;ACVR2B;DOCK4;XPC;PRNP;PARVB;PYGB;BBS2;FLNC;SLC6A8;DDIT4L;POSTN;VEGFA;FAM210B;TNFRSF6B;PGM1;WNT7A;APOE;PYGL;DGKA;TSPAN1;ESPN;NAGLU;F2R;LRP5;PLD3;OSBPL5;LPCAT4;ITGA6;ISYNA1;PITPNC1;HMGA2;OBSCN;NDRG1;IDH2;ZKSCAN1;NEK9;CRAT;SLCO4A1;ELK3;ITPR3;PKN1;MTA1;GRAMD4;ACOT7;ARRDC1;ANGEL1;ACSF2;EVI5L;NISCH;AKR7A2;FCGRT;SH2D5;EGFR;RPS6KA2;SERPINE2;DNPH1;WWTR1;LOXL1;SCN4B;OBSL1;NOS1;VAT1;PTPRS;TMEM129;SLC2A9;ANKS6;HADH;CTSO;SPRY2;LRP3;CAPN2;MST1R;NFATC4;TRIM65;BAHCC1;CRTAP;PRSS8;SYTL1;SDC1;KLHL29;ETV5;LMF1;APPL2;SHC1;DDB2;ORAI1;LTBP2;VPS11;LTBP1;TBC1D14;ARL2;HEXB;GTPBP1;SLC7A8;TCFL5;PTPRE;SLC12A7;NPEPL1;SLC2A3;ALDH4A1;TK2;RIN1;ACTA2;CLIP2;ETV4;PHLDA2;SNX9;NUDCD3;TRNP1;SPRY4;RAPGEF3;TXNRD3;ST6GALNAC2;ZFP36L1;GAA;GLUL;RNPEPL1;ARAP1;MAP2K2;KDSR;NME4;ZC3H6;LPAR3;MARCH9;CTBS;PLCD3;FKBP9;MDFI;PTOV1;CSMD2;SMARCA1;RBCK1;SUGCT;PGLS;PC;FOXQ1;RNF44;MAP2K1;NAPRT;CRYL1;ACP5;CPT2;VWA5A;MCTP1;MXD4;SSH1;POU2F2;EXOC2;ENDOG;MARK4;SLC16A5;KCNJ15;MARCKSL1;MPRIP;TMEM8A;GALE;SMURF2;KLC2;TSC22D1;ARMCX2;OXLD1;SLC9A3R2;FOS;SMAD3;ARHGAP23;STAT6;SHANK2;PIK3R2;ERCC6;LRP1;GJC2;SRD5A3;DVL1;EPAS1;DNAJB5;PIGQ;HSD17B8;THBS3;HBEGF;FAM110C;RPUSD3;AP2A2;S100A4;ITGB4;CYBRD1;PPP1R14A;SH3PXD2B;PPP2R3B;PRDX5;SHC2;NLGN2;STOM;BRD3;PRODH;SALL2;MBOAT7;CDK18;REEP4;LY6K;FBXW5;PAG1;ZXDC;RNF187;NMRK1;ADORA2B;ADARB1;PLCXD2;D2HGDH;SYT8;SLC6A6;AKT1;TPCN1;GRB7;KCNC4;TMOD2;CORO1B;TTYH3;HDAC5;UROS;FBXO41;FAM83A;S100A6;F12;SH2D2A;PPM1F;MMP28;PITPNM1;ENTPD6;PLEKHH3;RHBDF2;PYCR2;BSG;STK39;HK1;SERPING1;ASAP2;SCMH1;DYSF;EPHA1;GGT1;PHC2;NFKBIZ;PTPRU;VEGFB;FMNL2;ASH2L;IMPACT;MARCH4;SLC15A4;WWC3;ATG16L2;ZFYVE21;LRRC8A;CNTN1;IFNGR2;BRSK1;IFT140;PTHLH;MYZAP;MFSD3;RAB31;DNAAF5;FGFR4;HEBP1;PEAR1;WNT2B;POLD4;ACOT1;FNDC4;LDLR;FGFR1;PRKACB;FUCA1;MAPKBP1;ELMO3;SIGMAR1;RAC2;KCNAB2;PFKL;SEC14L2;OPLAH;HLTF;MXI1;NPHP4;SYNE3;RAG1;GAMT;H2AFJ;B4GAT1;PACS2;PHF7;TOMM34;BPHL;PIGV;KLF7;RALGDS;SORL1;NAT14;CEACAM1;B3GAT3;ASB13;CIRBP;CBR4;HMG20B;LZTS2;RAB11FIP4;TENM2;ZNF385A;DOCK6;NSMCE4A;MICALCL;ABCD1;ANK3;NIPSNAP1;IGFBP4;TTC7B;EVC;TSHZ1;TRAPPC9;CCND1;PODNL1;EFS;PCBP4;TCF25;LHPP;TNNT1;TWF2;AIG1;STRADB;SYNGAP1;PLCH2;MAPK13;CEP250;EDNRA;CARD19;PLAU;GAS6;PTK6;PFKP;FGFBP1;CSNK1E;R3HDM4;BRI3;CTSB;RAB3B;CARD11;SH2B3;SOX13;LAMA5;DUSP7;MPLKIP;GSN;PLEKHG2;MAPKAPK3;IGFBP2;PCSK9;ARHGAP22;RAD23A;DHTKD1;PHLDA1;ANO8;BCR;ANTXR2;XPOT;MRPS6;EHD4;ERRFI1;GLI4;SEPT10;WIPF1;NADK;PANK4;HLCS;ZSCAN18;PRSS22;AIP;DBNDD1;STON1;MYEF2;SH3D19;CCDC113;CDC25B;RGL2;SLITRK6;TSPAN18;PAQR6;ARPIN;SH3GLB2;ARHGAP27;ALOX15B;SPTB;SMARCD2;AGAP1;COMTD1;RSPH3;PEX10;CCS;RSAD1;COL13A1;CORO7;SLC20A1;NPR2;UNC119B;SNTA1;DGKQ;HAGH;PLXNB3;BNIP3;PAK6;NOL4L;GTF2IRD1;SHARPIN;MVB12B;TAGLN3;FYCO1;CEMIP;PROCR;PKD2;ACY1;PCSK1;RETSAT;YPEL3;RASGEF1A;CTSZ;CDC42EP5;HES2;CRTC1;IL20RB;FBXW8;GPSM1;AP3D1;ITGB5;ABCA2;PRSS3;SH3PXD2A;C19ORF33;EPOR;EPHB2;GRIN3B;ADAM8;ASIC1;CADM4;APRT;TMEM9;CTBP1;JOSD2;LTA4H;MNT;PTPDC1;GRIP2;GRK6;CDKN1C;PLCG1;FBXL8;ZMIZ2;CBS;KIF17;NYAP1;CD81;CEBPB;MVD;RNF135;ENTPD2;LGALS9B;ADAMTS13;SLC29A4;ZNF217;TIMP2;ZNF862;NUDCD2;SYNJ2;WNT3;DPP7;GNAL;C8ORF88;TMED4;TGFB1;LACTB2;SNPH;CLTCL1;RFX2;SCYL1;ABHD17C;SLC43A1;UNK;SNTB2;ULK2;GPC1;MKNK2;ADAMTS7;DEAF1;MOAP1;TBC1D9B;SLC38A10;NTSR1;B3GNT3;NAB2;TMEM173;ARHGAP25;TMEM134;ZSCAN30;ATP7B;FHOD3;SHANK3;PODXL2;SDHA;MSRB2;EFNB3;RASA3;PNRC1;MIPEP;PIP5KL1;TNFSF15;MYCBPAP;MGAT4B;EML2;KIF26B;MDH2;MPG;GALNS;FBXO17;CLCA2;HEXDC;GOLGA2P5;ENKD1;NSMF;PEG3;ARAP3;SCART1;FARP1;MC1R;TUB;DIRC2;LCE1E;CROCC;RHOD;ABHD14B;LAMB2;TNS1;ABTB1;SNX17;RNH1;DNAH1;ERO1B;ST6GALNAC6;HTR7;VGF;POLL;FBXO44;POLM;SNX33;PI4K2A;SEMA4F;C1ORF210;PTMS;RHOF;YIPF3;ANKZF1;WASF3;ATG2A;SLC48A1;LLGL1;PHGDH;ARL10;PHF21A;MIF4GD;KIF7;COA5;PLPP6;RHOBTB2;UBXN4;ADAM19;KHDRBS3;SAC3D1;TUBG2;ZER1;RIMS3;BBS1;TNFAIP8L1;HMGCL;PTPN1;PEX1;TPP1;PCK2;B4GALT2;WDR59;AGRN;MBD3;CD320;CAMK2N1;OSBPL10;LRP4;LRP10;ESYT2;ZDHHC24;GPR153;ACP6;B4GALT6;VHL;TMCC3;MYH16;CEP131;TRAP1;IDUA;ADAP1;PFKFB2;RFNG;MLXIPL;YPEL5;TRIB2;PRKCZ;KDM6B;PRKACA;MINK1;ZNF516;CENPH;GRHPR;OXA1L;RHPN1;RABGGTA;RCCD1;ACTR1B;TOM1L2;CD9;EPN2;ADA;AREG;PIM2;MPI;MICALL2;UCKL1;LGALS9C;PLEKHG5;BOK;WDR18;TDRKH;CAPG;SDCCAG8;ALAS1;NEURL1B;ERBB2;ADGRB2;ULK1;CNDP2;NINL;AHCY;VAMP2;CERCAM;PRIMPOL;TMEM143;TFDP2;SMTN;PLEK2;C6ORF89;MZT2A;NECAB3;STK17A;RILPL1;FAM50A;JAK3;IRF2BP2;RNPEP;NET1;BNIP3L;CYFIP2;FSCN1;PBX2;TRPC1;NELFCD;SLC22A17;RASA4;GLCCI1;PDK1;ACAD10;CYGB;ARHGAP44;THOP1;EHBP1L1;MCFD2;PRKCD;FAM20C;MIB2;REEP6;RBL2;CACNB3;USP20;STUB1;IFI6;BAX;CYC1;SV2A;SBF1;DTD1;XYLT2;SLC13A5;TRIM4;ITGA1;OLFM2;ZNF395;HIST3H2BB;CCDC92;NUBP2;PPCS;SH3BP1;FBXW4;GJB4;EREG;RPS6KA5;DGUOK;TMEM25;DUSP4;KLHDC2;TIMM17B;ZNF524;CUL9;SOX12;PLEKHH1;TMBIM4;DDIT4;MBTPS2;ACADS;TOP3B;PPL;PPP1R13L;CARF;HSD17B7;AHNAK2;PCSK1N;MT2A;IER2;RASL10B;CES2;NAGA;ZDHHC8;TMX4;MZT2B;FCHO1;NID1;LIMK1;TGFBR3;PDIA5;GDI1;TPM2;PADI3;DIP2A;LTB4R2;CPNE7;SLC2A11;RPL39L;LEMD2;RPS6KA6;TMEM92;ZHX3;DNM1;WASH3P;RGS14;TMEM8B;SCN8A;MFNG;GSTO1;GIT1;ALDOC;CHAD;MRPS26;MSLN;LPCAT1;LRSAM1;ADAM15;REEP2;ASB1;EHD3;WDR60;ST3GAL3;TMEM231;LONP2;SYMPK;MAPK12;IRAK1;PPOX;TGFA;HDAC7;FHOD1;INPP5D;MTHFR;CHD2;PI4K2B;CBX7;PCMTD2;CHEK2;DTNB;DECR2;ZFPM1;PPARA;COG7;COQ2;SESN2;ABCG1;MYO1D;JADE2;MYH15;CDC34;RNF123;SNN;SOX7;ABCA7;RAB12;EML3;SPEG;SIX5;BCAP31;MIF;ACO2;SMOX;EEF2KMT;KDM4B;SLC25A29;DOPEY2;PHYH;ZNF414;MEX3A;BCAM;SLC9A7;PLA2G6;DDT;SSBP4;SYNGR1;NUDT14;ECM1;NARF;WFS1;QSOX1;DNAAF3;CD68;ZNF444;SLC22A18;DTX3;NBPF3;SPPL2B;HSD11B1L;FYN;PITPNM3;VWA1;UPP1;STK25;RAC3;ETFB;TMCO6;GLB1L2;EEF2K;CERS4;SUN1;ICAM5;ARHGAP12;FLYWCH1;ACAP3;ARID5B;HOXC5;DNM2;CKMT1A;CYP3A5;BHLHE40;GLB1;PELI1;ATXN10;SNX15;INF2;CHKA;CAT;BEX2;NEIL1;TSPYL2;KIAA1147;IGFBP7;ARMCX1;SLC27A1;ZMYM3;TPBG;APOBEC3C;SATB1;SLC50A1;KIF26A;ASMTL;ZDHHC1;SLC12A4;PLCB3;H1FX;IQSEC1;ZNF606;APOBEC3F;ARHGEF4;DDX50;CYP2R1;TUBB6;MAPK3;CBLN3;INSR;SLC13A3;RTN2;ARHGEF1;PAN2;GRINA;PDZD2;CAMTA2;TAZ;PFKM;ADCY1;TNS4;C12ORF66;RERE;HLA-G;DOCK9;STX10;TSTA3;INO80C;ATP8B2;GPT2;RALGAPA1;MORN4;PDXK;ETAA1;PRAF2;GLRX;CEP72;VANGL2;PAK1;TRIM45;CDYL2;DCAF10;KLHL36;MALL;CAMKK2;RNASET2;PPP3CB;RNF144A;LGALS3BP;ALPK1;CTSF;USP21;PFKFB3;MLYCD;CUL7;SLC37A2;GABBR1;REV1;MICAL1;HYAL1;SEMA4C;CAPRIN2;ZBTB10;WDTC1;HES7;ITGA3;STK32C;DNMT3A;SAMD8;BIN1;VPS16;MAN2B1;SRMS;TSTD1;PPP2R5B;HES6;SLC16A13;MAP2K3;NDST2;BCL2L1;DLG3;SGSM2;ABHD10;NDUFV3;RRAS;DNASE1L1;PROX1;IARS2;LRCH4;MDGA1;TBC1D16;ADGRF1;ALDH7A1;LMNA;ZYG11B;PKD1;KCTD13;TNFRSF25;RABGAP1;SIRT2;FAM129B;CDH4;ITGA4;EDA;UVSSA;ANKRD13D;GAL3ST4;DCBLD2;NMNAT2;BACH1;NT5C1B;TRIP10;ADCY7;E2F5;ZBTB22;ALG12;LTB4R;AFAP1L1;MAPRE3;AZIN2;TEP1;RAB28;ZNF704;SERPINB1;ST3GAL2;ICA1;SLC25A37;RAP1GAP2;LAMB1;SOCS7;MAP3K10;HSDL1;RGS19;NDE1;GPR3;HSD11B1;PELI3;GTF2IRD2;RAB40B;NGFR;TOLLIP;BCORL1;PDCD6;ATP6V1F;PCLO;ARVCF;CHST14;BIVM;ZNF837;RNASE7;PXN;GRB10;TBC1D8;PHYKPL;PLEKHM1;DUSP23;GCH1;MSS51;LURAP1;KIF13B;MAFF;NR2F6;CBX6;TCTN1;NBEAL2;PNMA1;CAMK1;CAMKK1;SLC39A3;EZH1;SIRT3;HFE;TERC;ZNF513;WIPI2;GAS2L1;COL6A1;BTG1;BBS10;ZP3;VPS51;FAM117A;CELSR1;TACC1;MLF2;IL17RE;SEMA3B;SEPT6;CDK11B;PFN2;C2CD2;SSH3;FGFR3;MFSD10;PPP1R16A;TST;CCDC88C;ST3GAL5;TNRC18;NDRG2;MAN2B2;BLOC1S4;CBLC;ITPKB;PTGR2;SPTLC2;TCEA2;CDC42BPG;PRSS21;ZBTB47;PLAG1;LRP11;DOK4;GSDMA;CLK3;IRF2BPL;TRIM46;DHX32;KDM3A;PM20D2;TMEM187;FAM214B;TBL3;HOMER2;SLC23A2;PKN3;APBA1;TTLL3;DEDD2;PI4KAP2;AK3;SRSF5;CHPF;ADCY6;SLC26A11;LRRK1;AARS;KLHL24;STRN4;SDC2
10723,GO:0044085,0.918865581031552,0.0929677741171085,240,2484,cellular component biogenesis,BP,ERCC1;SDK2;ZMYND8;ADGRL1;H1F0;THSD4;DLG4;TYSND1;CTNNBIP1;KCNG1;XPC;PRNP;PARVB;BBS2;FLNC;VEGFA;WNT7A;APOE;ESPN;ITGA6;HMGA2;OBSCN;ITPR3;ARRDC1;EVI5L;WWTR1;LOXL1;OBSL1;BAHCC1;SDC1;DDB2;VPS11;TBC1D14;ARL2;MMP1;SNX9;NUDCD3;RAPGEF3;GLUL;ARAP1;LPAR3;SSH1;EXOC2;MARK4;SLC9A3R2;SMAD3;SHANK2;DVL1;HSD17B8;FAM110C;ITGB4;SH3PXD2B;NLGN2;STOM;GRB7;KCNC4;TMOD2;CORO1B;PPM1F;EPHA1;ASH2L;IMPACT;ATG16L2;IFT140;DNAAF5;PRKACB;SIGMAR1;RAC2;PFKL;NPHP4;PACS2;SORL1;CIRBP;CBR4;TENM2;ANK3;TRAPPC9;TNNT1;TWF2;CEP250;GAS6;CSNK1E;LAMA5;GSN;PLEKHG2;ANGPTL4;EHD4;SEPT10;WIPF1;CCDC113;SLITRK6;ARPIN;SPTB;CORO7;RRNAD1;UNC119B;DGKQ;PLXNB3;SHARPIN;PKD2;GPX3;CTSZ;CDC42EP5;CRTC1;ITGB5;SH3PXD2A;EPHB2;ASIC1;PTPDC1;KIF17;TGFB1;CLTCL1;RFX2;ULK2;GPC1;FHOD3;SHANK3;MSRB2;EML2;GOLGA2P5;FARP1;CROCC;RHOD;TNS1;DNAH1;RHOF;WASF3;ATG2A;LLGL1;COA5;RHOBTB2;KHDRBS3;TUBG2;BBS1;HMGCL;AGRN;LRP4;CEP131;PRKCZ;PRKACA;CENPH;GRHPR;OXA1L;RABGGTA;CD9;AREG;MPI;MICALL2;BOK;WDR18;CAPG;SDCCAG8;ADGRB2;ULK1;NINL;VAMP2;PSMG4;RILPL1;CYFIP2;FSCN1;MCFD2;PRKCD;STUB1;BAX;TRIM4;HIST3H2BB;NUBP2;SH3BP1;SOX12;AHNAK2;ZDHHC8;FCHO1;LIMK1;TGFBR3;DNM1;WASH3P;LRSAM1;EHD3;WDR60;TMEM231;IRAK1;TGFA;HDAC7;FHOD1;CHEK2;CDC34;ABCA7;MIF;PLA2G6;DNAAF3;EFEMP2;STK25;RAC3;EEF2K;DNM2;ATXN10;CAT;TSPYL2;TPBG;H1FX;ARHGEF4;MAPK3;INSR;TAZ;PFKM;CEP72;VANGL2;PAK1;HYAL1;SAMD8;BIN1;VPS16;PPP2R5B;NDUFV3;PROX1;ADGRF1;KCTD13;SIRT2;CDH4;NDE1;PDCD6;PCLO;PXN;PLEKHM1;GCH1;MSS51;TCTN1;HFE;WIPI2;COL6A1;BBS10;SEPT6;PFN2;SSH3;CCDC88C;TNRC18;TBL3;APBA1;TTLL3;SRSF5
7983,GO:0032607,0.919021227872728,0.296821582372105,1,22,interferon-alpha production,BP,PTPRS
4674,GO:0010824,0.919208978713527,0.224340893136218,2,37,regulation of centrosome duplication,BP,FBXW5;CEP131
5140,GO:0015662,0.919232075816936,0.296285251799055,1,22,ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism,MF,ATP7B
14690,GO:0070317,0.919291330938705,0.224166935996368,2,37,negative regulation of G0 to G1 transition,BP,TFDP2;PPP2R5B
8139,GO:0032873,0.919469612397222,0.223790149836545,2,37,negative regulation of stress-activated MAPK cascade,BP,PDCD4;AKT1
14681,GO:0070303,0.919469612397222,0.223790149836545,2,37,negative regulation of stress-activated protein kinase signaling cascade,BP,PDCD4;AKT1
7072,GO:0030867,0.91989335570431,0.293103975931361,1,25,rough endoplasmic reticulum membrane,CC,BCAP31
4255,GO:0009584,0.920004205679787,0.294316150663222,1,22,detection of visible light,BP,REEP6
5512,GO:0016469,0.920152941019229,0.292896621570073,1,24,proton-transporting two-sector ATPase complex,CC,ATP6V1F
8854,GO:0034661,0.920189953881205,0.293298226105591,1,23,ncRNA catabolic process,BP,DEDD2
5651,GO:0016746,0.920463977148545,0.125014768090023,15,190,transferase activity, transferring acyl groups,MF,NAGS;LPCAT4;CRAT;CPT2;MBOAT7;GGT1;NAT14;ZDHHC24;ALAS1;ZDHHC8;LPCAT1;CERS4;ZDHHC1;TAZ;SPTLC2
11821,GO:0046755,0.920615328182785,0.292209478710237,1,23,viral budding,BP,LRSAM1
5558,GO:0016570,0.920628031375071,0.108795249238809,34,389,histone modification,BP,ZMYND8;VEGFA;HMGA2;PKN1;MTA1;NOS1;DDB2;HDAC5;PPM1F;ASH2L;RAG1;HMG20B;HLCS;CTBP1;TGFB1;PHF21A;MBD3;KDM6B;C6ORF89;PRKCD;RPS6KA5;PADI3;HDAC7;MTHFR;JADE2;KDM4B;ARID5B;SATB1;MAPK3;USP21;SIRT2;EZH1;SIRT3;KDM3A
4546,GO:0010628,0.92066629532323,0.0944908402091348,130,1363,positive regulation of gene expression,BP,TNIP1;MEF2D;CITED4;EGR1;NR1D1;APLN;VEGFA;WNT7A;F2R;LRP5;ITGA6;HMGA2;ELK3;EGFR;WWTR1;NOS1;SPRY2;NFATC4;ETV5;SHC1;HEXB;ACTA2;ETV4;MAP2K2;SMARCA1;MAP2K1;POU2F2;FOS;SMAD3;STAT6;PIK3R2;ERCC6;GJC2;DVL1;EPAS1;SH3PXD2B;SALL2;ZXDC;RNF187;AKT1;HDAC5;F12;PPM1F;ASH2L;IMPACT;CNTN1;FGFR4;LDLR;SEC14L2;HLTF;KLF7;NAT14;CIRBP;ANK3;GAS6;GSN;DGKQ;PKD2;CRTC1;EPHB2;ADAM8;CDKN1C;ZMIZ2;CD81;CEBPB;WNT3;TGFB1;RFX2;DEAF1;TMEM173;PEG3;MC1R;ABHD14B;AGRN;CAMK2N1;VHL;MLXIPL;KDM6B;ZNF516;PIM2;ERBB2;TFDP2;PBX2;RPS6KA5;SOX12;MBTPS2;CARF;IER2;IRAK1;FHOD1;CHEK2;ZFPM1;PPARA;SESN2;SOX7;SIX5;SSBP4;DNM2;SLC50A1;MAPK3;INSR;CAMTA2;PFKM;RERE;CAMKK2;PPP3CB;USP21;CAPRIN2;ITGA3;PPP2R5B;MAP2K3;PROX1;PKD1;SIRT2;FAM129B;EDA;BACH1;E2F5;MAPRE3;NGFR;MAFF;CAMK1;EZH1;HFE;ZP3;TCEA2;PLAG1;IRF2BPL;KDM3A;SRSF5
38,GO:0000077,0.920733650867779,0.132994472537528,11,146,DNA damage checkpoint,BP,XPC;HMGA2;BRSK1;ZNF385A;CCND1;PCBP4;TFDP2;RBL2;BAX;CHEK2;ETAA1
18552,GO:1903749,0.920849335862006,0.154290695836068,6,90,positive regulation of establishment of protein localization to mitochondrion,BP,VPS11;RAC2;MICALL2;TFDP2;ZDHHC8;NBPF3
5611,GO:0016655,0.920880412568648,0.218784571595233,2,49,oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor,MF,CBR4;NDUFV3
242,GO:0000578,0.921051833113491,0.291631681301135,1,22,embryonic axis specification,BP,WNT7A
794,GO:0002064,0.921159584378459,0.132388505086103,11,145,epithelial cell development,BP,CST3;WNT7A;PTPRS;SDC1;ACTA2;RAPGEF3;FGFR1;SLITRK6;LAMB2;RILPL1;PROX1
10176,GO:0042773,0.921336146024826,0.171913882312486,4,80,ATP synthesis coupled electron transport,BP,SDHA;CYC1;TAZ;NDUFV3
7380,GO:0031440,0.921584558247206,0.290260905594017,1,22,regulation of mRNA 3'-end processing,BP,ZFP36L1
2803,GO:0006266,0.921743443479315,0.289310224135468,1,23,DNA ligation,BP,POLD4
11079,GO:0045087,0.921755947282962,0.102331937174572,49,561,innate immune response,BP,TNIP1;EGR1;NR1D1;CYP27B1;PTPRS;MST1R;ADARB1;F12;SERPING1;IFNGR2;PRKACB;CEACAM1;PTK6;CTSB;CARD11;GSN;MAPKAPK3;FAM3A;ADAM8;RNF135;ADAMTS13;TGFB1;TMEM173;PTPN1;IFNE;PRKACA;TBKBP1;JAK3;PRKCD;IFI6;TRIM4;EREG;RPS6KA5;MT2A;ADAM15;IRAK1;RAB12;MIF;FYN;PELI1;APOBEC3C;APOBEC3F;HLA-G;PAK1;SRMS;SIRT2;TOLLIP;RNASE7;GCH1
6720,GO:0030137,0.921826072292137,0.289097187518521,1,23,COPI-coated vesicle,CC,SCYL1
12594,GO:0050779,0.922021038117075,0.289134889374629,1,22,RNA destabilization,BP,ZFP36L1
3895,GO:0008535,0.922812422724607,0.286053779978926,1,24,respiratory chain complex IV assembly,BP,COA5
7231,GO:0031146,0.923008899940128,0.169523613336071,4,70,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,BP,FBXO2;WWTR1;FBXW5;FBXW4
3936,GO:0008625,0.923080123902103,0.16977560369964,4,65,extrinsic apoptotic signaling pathway via death domain receptors,BP,MOAP1;BAX;BCL2L1;DEDD2
14,GO:0000027,0.923120526987619,0.284386761233121,1,26,ribosomal large subunit assembly,BP,WDR18
9857,GO:0042116,0.923167267181987,0.215698296635207,2,38,macrophage activation,BP,LDLR;MIF
8026,GO:0032677,0.923550077104928,0.21467189922097,2,39,regulation of interleukin-8 production,BP,F2R;MAPKBP1
13693,GO:0060260,0.924237646445541,0.282837984168489,1,23,regulation of transcription initiation from RNA polymerase II promoter,BP,CTNNBIP1
10284,GO:0043039,0.924617328970223,0.183575278635984,3,52,tRNA aminoacylation,BP,DALRD3;IARS2;AARS
11477,GO:0045948,0.92481513936895,0.281327005992183,1,23,positive regulation of translational initiation,BP,IMPACT
17374,GO:1900087,0.924918391123132,0.281056353623501,1,23,positive regulation of G1/S transition of mitotic cell cycle,BP,HYAL1
5556,GO:0016567,0.924949531826433,0.0954869650666355,64,711,protein ubiquitination,BP,GID4;FBXO2;MTA1;ARRDC1;WWTR1;TMEM129;KLHL29;DDB2;MARCH9;RBCK1;RNF44;SMURF2;EPAS1;FBXW5;RNF187;AKT1;FBXO41;MARCH4;HLTF;RAG1;ASB13;PEX10;SHARPIN;FBXW8;ZNF598;MAGEF1;FBXL8;RNF135;FBXO17;FBXO44;ZER1;VHL;NEURL1B;THOP1;MIB2;STUB1;TRIM4;FBXW4;CUL9;LIMK1;LRSAM1;ASB1;JADE2;CDC34;RNF123;WFS1;DTX3;FYN;PELI1;DCAF10;KLHL36;RNF144A;CUL7;WDTC1;ZYG11B;KCTD13;UVSSA;BACH1;SOCS7;PELI3;RAB40B;PDCD6;CBLC;KLHL24
17646,GO:1901361,0.925170899883396,0.0983433766318828,48,571,organic cyclic compound catabolic process,BP,NT5E;XDH;H1F0;CYP27B1;PGM1;APOE;DNPH1;GTPBP1;ALDH4A1;RAPGEF3;ZFP36L1;ENDOG;PRODH;AKT1;ENTPD6;HK1;PFKL;CIRBP;PCBP4;PFKP;DHTKD1;ENTPD2;PNRC1;SNX17;RNH1;PFKFB2;MLXIPL;ADA;AHCY;PRKCD;BAX;DDIT4;ALDOC;PPARA;UPP1;NEIL1;APOBEC3C;APOBEC3F;INSR;PAN2;PFKM;RNASET2;PFKFB3;DNASE1L1;NT5C1B;HSD11B1;PM20D2;DEDD2
18361,GO:1903321,0.925318107277926,0.165564576502595,4,67,negative regulation of protein modification by small protein conjugation or removal,BP,AKT1;HMG20B;LIMK1;FYN
16107,GO:0090090,0.925320413659059,0.132089112617152,9,130,negative regulation of canonical Wnt signaling pathway,BP,EGR1;APOE;WWTR1;DVL1;NPHP4;LZTS2;IGFBP4;IGFBP2;LRP4
7589,GO:0031967,0.925343001419191,0.0921373409617313,87,973,organelle envelope,CC,SLC16A3;CST3;CYP27B1;PRNP;FAM210B;IDH2;CRAT;ITPR3;MTA1;GRAMD4;EGFR;VAT1;SLC2A9;HADH;ARL2;NME4;CPT2;ARMCX2;SMAD3;STAT6;HSD17B8;PRODH;S100A6;HK1;SIGMAR1;RAC2;SYNE3;TOMM34;BPHL;SORL1;NIPSNAP1;CARD19;XPOT;MRPS6;BNIP3;RETSAT;SNPH;MOAP1;TMEM173;SDHA;MDH2;CLCA2;NSMF;ANKZF1;UBXN4;HMGCL;TRAP1;PRKCZ;OXA1L;BOK;ULK1;BNIP3L;THOP1;BAX;CYC1;KLHDC2;TIMM17B;LEMD2;DNM1;MRPS26;PPOX;COQ2;RNF123;SNN;SMOX;SLC25A29;SLC22A18;CERS4;SUN1;DNM2;CKMT1A;CAT;ARMCX1;MAPK3;INSR;TAZ;PAK1;BIN1;BCL2L1;NDUFV3;LMNA;SLC25A37;RAP1GAP2;RAB40B;GCH1;TST;TNRC18
7593,GO:0031975,0.925343001419191,0.0921373409617313,87,973,envelope,CC,SLC16A3;CST3;CYP27B1;PRNP;FAM210B;IDH2;CRAT;ITPR3;MTA1;GRAMD4;EGFR;VAT1;SLC2A9;HADH;ARL2;NME4;CPT2;ARMCX2;SMAD3;STAT6;HSD17B8;PRODH;S100A6;HK1;SIGMAR1;RAC2;SYNE3;TOMM34;BPHL;SORL1;NIPSNAP1;CARD19;XPOT;MRPS6;BNIP3;RETSAT;SNPH;MOAP1;TMEM173;SDHA;MDH2;CLCA2;NSMF;ANKZF1;UBXN4;HMGCL;TRAP1;PRKCZ;OXA1L;BOK;ULK1;BNIP3L;THOP1;BAX;CYC1;KLHDC2;TIMM17B;LEMD2;DNM1;MRPS26;PPOX;COQ2;RNF123;SNN;SMOX;SLC25A29;SLC22A18;CERS4;SUN1;DNM2;CKMT1A;CAT;ARMCX1;MAPK3;INSR;TAZ;PAK1;BIN1;BCL2L1;NDUFV3;LMNA;SLC25A37;RAP1GAP2;RAB40B;GCH1;TST;TNRC18
4042,GO:0009081,0.925476816231989,0.279589918818022,1,23,branched-chain amino acid metabolic process,BP,HMGCL
12704,GO:0050931,0.925865690809024,0.278566078980729,1,23,pigment cell differentiation,BP,AP3D1
2367,GO:0005488,0.925908158976948,0.0858280122369326,1059,10187,binding,MF,TNIP1;NT5E;XDH;ERCC1;DUSP5;MEF2D;ZMYND8;ADGRL1;H1F0;SEMA4B;HTRA1;FHL1;EGR1;NR1D1;SLC16A3;H6PD;EDEM1;DLG4;PLAT;CST3;CYP27B1;MRC2;TYSND1;HS1BP3;BTBD2;EPN3;FBXO2;APLN;PGF;PDCD4;CTNNBIP1;NAGS;ACVR2B;DOCK4;XPC;PRNP;PARVB;PYGB;BBS2;FLNC;DDIT4L;POSTN;VEGFA;TNFRSF6B;PGM1;WNT7A;APOE;PYGL;DGKA;TSPAN1;ESPN;F2R;LRP5;PLD3;OSBPL5;ITGA6;ISYNA1;PITPNC1;HMGA2;LRRC20;OBSCN;NDRG1;IDH2;ZKSCAN1;NEK9;CRAT;ELK3;ITPR3;PKN1;MTA1;ACOT7;ARRDC1;ANGEL1;ACSF2;EVI5L;NISCH;AKR7A2;FCGRT;EGFR;RPS6KA2;SERPINE2;DNPH1;WWTR1;LOXL1;SCN4B;OBSL1;NOS1;VAT1;PTPRS;TMEM129;ANKS6;HADH;SPRY2;CAPN2;MST1R;NFATC4;TRIM65;BAHCC1;CRTAP;LTBP4;PRSS8;SYTL1;SDC1;ETV5;ORAI3;APPL2;SHC1;DDB2;ORAI1;LTBP2;VPS11;LTBP1;TBC1D14;ARL2;HEXB;GTPBP1;SLC7A8;KIAA0930;TCFL5;PTPRE;SLC12A7;NPEPL1;SLC2A3;ALDH4A1;TK2;RIN1;ACTA2;MMP1;CLIP2;ETV4;SNX9;NUDCD3;TRNP1;SPRY4;RAPGEF3;TXNRD3;ZFP36L1;GAA;GLUL;RNPEPL1;ARAP1;MAP2K2;NME4;ZC3H6;LPAR3;MARCH9;CTBS;PLCD3;FKBP9;MDFI;SMARCA1;PPP1R35;CMTM7;RBCK1;PLTP;PGLS;PC;FOXQ1;RNF44;MAP2K1;NAPRT;CRYL1;ACP5;NYNRIN;MCTP1;MXD4;SSH1;POU2F2;EXOC2;ENDOG;MARK4;KCNJ15;MARCKSL1;MPRIP;TMEM8A;GALE;SMURF2;KLC2;TSC22D1;SLC9A3R2;FOS;FBLN1;SMAD3;STAT6;SHANK2;PIK3R2;ERCC6;LRP1;DVL1;EPAS1;DNAJB5;HSD17B8;THBS3;HBEGF;FAM110C;RPUSD3;AP2A2;S100A4;ITGB4;CYBRD1;SH3PXD2B;PPP2R3B;PRDX5;TMEM158;SHC2;NLGN2;STOM;BRD3;PRODH;SALL2;MBOAT7;CDK18;REEP4;FBXW5;PAG1;ZXDC;RNF187;NMRK1;ADARB1;D2HGDH;SYT8;AKT1;TPCN1;GRB7;TMOD2;CORO1B;HDAC5;UROS;FAM83A;NT5DC1;S100A6;F12;SH2D2A;PPM1F;MMP28;PITPNM1;RHBDF2;HAGHL;BSG;STK39;HK1;SERPING1;ASAP2;SCMH1;DYSF;EPHA1;GGT1;PHC2;NFKBIZ;PTPRU;VEGFB;FMNL2;ASH2L;IMPACT;MARCH4;SLC15A4;WWC3;ZFYVE21;LRRC8A;CNTN1;BRSK1;DAP;IFT140;PTHLH;MYZAP;RAB31;DNAAF5;FGFR4;HEBP1;WNT2B;POLD4;LDLR;FGFR1;PRKACB;MAPKBP1;ELMO3;SIGMAR1;RAC2;SMOC2;PFKL;TTLL12;SEC14L2;OPLAH;HLTF;MXI1;NPHP4;SYNE3;RAG1;H2AFJ;B4GAT1;PACS2;PHF7;TOMM34;KLF7;RALGDS;SORL1;NAT14;CEACAM1;B3GAT3;ASB13;CIRBP;CBR4;HMG20B;LZTS2;RAB11FIP4;TENM2;ZNF385A;DOCK6;NSMCE4A;MICALCL;ABCD1;ANK3;NIPSNAP1;IGFBP4;TTC7B;TSHZ1;TRAPPC9;CCND1;EFS;PCBP4;TCF25;LHPP;TNNT1;TWF2;AIG1;STRADB;SYNGAP1;PLCH2;MAPK13;ACBD4;CEP250;EDNRA;CARD19;PLAU;GAS6;PTK6;SEMA3F;PFKP;FGFBP1;CSNK1E;R3HDM4;BRI3;CTSB;RAB3B;CARD11;SH2B3;SOX13;LAMA5;DUSP7;MPLKIP;GSN;CMTM4;PLEKHG2;MAPKAPK3;IGFBP2;PCSK9;ARHGAP22;RAD23A;DHTKD1;PHLDA1;BCR;ANTXR2;XPOT;ANGPTL4;MRPS6;EHD4;ERRFI1;GLI4;SEPT10;WIPF1;NADK;PANK4;HLCS;ZSCAN18;AIP;MYEF2;SH3D19;CCDC113;CDC25B;RGL2;PAQR6;ARPIN;SH3GLB2;ARHGAP27;ALOX15B;SPTB;SMARCD2;KHNYN;AGAP1;COMTD1;NXPH4;RSPH3;PEX10;CCS;GGACT;RSAD1;COL13A1;CORO7;NPR2;UNC119B;SNTA1;DGKQ;HAGH;PLXNB3;BNIP3;PAK6;NOL4L;GTF2IRD1;SHARPIN;MVB12B;TAGLN3;FYCO1;CEMIP;PROCR;PKD2;ACY1;GPX3;PCSK1;YPEL3;RASGEF1A;CTSZ;CDC42EP5;HES2;CRTC1;IL20RB;FBXW8;GPSM1;ITGB5;ABCA2;FAM189B;ZNF598;MAGEF1;PRSS3;SH3PXD2A;EPOR;EPHB2;GRIN3B;ADAM8;ASIC1;CADM4;APRT;CTBP1;LTA4H;MNT;GRIP2;GRK6;CDKN1C;PLCG1;FBXL8;ZMIZ2;CBS;KIF17;SH3BP2;CD81;CEBPB;MVD;RNF135;ENTPD2;LGALS9B;ADAMTS13;ZNF217;TIMP2;ZNF862;NUDCD2;UHRF1BP1;SYNJ2;WNT3;PCED1A;GNAL;C8ORF88;TGFB1;LACTB2;SNPH;CLTCL1;RFX2;SCYL1;UNK;SNTB2;ULK2;GPC1;MKNK2;ADAMTS7;DEAF1;MOAP1;TBC1D9B;NTSR1;NAB2;TMEM173;TMEM134;ZSCAN30;ATP7B;FHOD3;SHANK3;PODXL2;SDHA;MSRB2;EFNB3;RASA3;PNRC1;MIPEP;PIP5KL1;TNFSF15;MYCBPAP;JMJD7;MGAT4B;EML2;KIF26B;MDH2;MPG;GALNS;FBXO17;CLCA2;ENKD1;NSMF;PEG3;ARAP3;FARP1;MC1R;TUB;CROCC;KLRG2;RHOD;CGREF1;ABHD14B;LAMB2;TNS1;ABTB1;SNX17;RNH1;DNAH1;ERO1B;HTR7;VGF;POLL;FBXO44;POLM;PLEKHG4;SNX33;PI4K2A;SEMA4F;RHOF;YIPF3;ANKZF1;WASF3;ATG2A;SLC48A1;LLGL1;PHGDH;ARL10;PHF21A;PLEKHG3;MIF4GD;KIF7;COA5;RHOBTB2;UBXN4;ADAM19;KHDRBS3;SAC3D1;TUBG2;GIGYF1;RIMS3;BBS1;TNFAIP8L1;HMGCL;PTPN1;PEX1;TPP1;PCK2;B4GALT2;WDR59;AGRN;MBD3;OLFML2A;IFNE;CD320;CAMK2N1;OSBPL10;LRP4;ESYT2;ZDHHC24;B4GALT6;VHL;DNAJC4;TMCC3;PCED1B;CEP131;TRAP1;IDUA;ADAP1;PFKFB2;RFNG;MLXIPL;YPEL5;TRIB2;PRKCZ;KDM6B;PRKACA;MINK1;ZNF516;CENPH;GRHPR;OXA1L;RHPN1;RABGGTA;TBKBP1;ACTR1B;TOM1L2;CD9;EPN2;ADA;AREG;PIM2;MPI;MICALL2;UCKL1;LGALS9C;PLEKHG5;BOK;WDR18;TDRKH;CAPG;SDCCAG8;ALAS1;NEURL1B;ERBB2;ADGRB2;ULK1;CNDP2;NINL;AHCY;VAMP2;PRIMPOL;MMP10;TFDP2;SMTN;PLEK2;C6ORF89;NECAB3;STK17A;RILPL1;FAM50A;JAK3;IRF2BP2;RNPEP;NET1;BNIP3L;CYFIP2;FSCN1;PBX2;TRPC1;NELFCD;RASA4;PDK1;ACAD10;CYGB;ARHGAP44;THOP1;MCFD2;PRKCD;FAM20C;MIB2;REEP6;RBL2;CACNB3;USP20;STUB1;IFI6;BAX;CYC1;GRAMD1C;SV2A;SBF1;DTD1;TRIM4;ITGA1;OLFM2;ZNF395;HIST3H2BB;CCDC92;NUBP2;SH3BP1;FBXW4;CHADL;EREG;RPS6KA5;DGUOK;TMEM25;TIMM17B;ZNF524;CUL9;SOX12;TMBIM4;DDIT4;MBTPS2;ACADS;TOP3B;PPL;PPP1R13L;CARF;AHNAK2;PCSK1N;GRAMD1A;MT2A;IER2;HPCAL1;RASL10B;NAGA;MZT2B;FCHO1;NID1;LIMK1;TGFBR3;NTPCR;PDIA5;GDI1;TPM2;PADI3;DIP2A;CPNE7;UBTD1;RPL39L;LEMD2;RPS6KA6;ZHX3;DNM1;WASH3P;RGS14;TMEM8B;SCN8A;MFNG;GSTO1;GIT1;ALDOC;MRPS26;MSLN;LPCAT1;LRSAM1;ADAM15;REEP2;ASB1;EHD3;WDR60;TMEM231;FAHD2B;GPATCH2L;LONP2;SYMPK;MAPK12;IRAK1;PPOX;TGFA;HDAC7;FHOD1;INPP5D;RNF215;MTHFR;CHD2;PI4K2B;CBX7;CHEK2;DTNB;DECR2;CACFD1;ZFPM1;PPARA;COG7;SESN2;ABCG1;MYO1D;JADE2;MYH15;CDC34;RNF123;SNN;SOX7;ABCA7;RAB12;EML3;SPEG;SIX5;BCAP31;MIF;ACO2;EEF2KMT;KDM4B;PHYH;ZNF414;MEX3A;LENG9;BCAM;SLC9A7;PLA2G6;DDT;SSBP4;SYNGR1;NUDT14;ECM1;NARF;WFS1;ZNF444;SLC22A18;DTX3;DALRD3;SPPL2B;FYN;C11ORF68;PITPNM3;VWA1;EFEMP2;STK25;RAC3;ETFB;TMCO6;EEF2K;CERS4;SUN1;ICAM5;FLYWCH1;ACAP3;ARID5B;HOXC5;DNM2;CKMT1A;CYP3A5;BHLHE40;GLB1;PELI1;ATXN10;SNX15;INF2;CHKA;CAT;BEX2;NEIL1;TSPYL2;IGFBP7;ARMCX1;SLC27A1;ZMYM3;APOBEC3C;SATB1;KIF26A;ASMTL;ZDHHC1;SLC12A4;PLCB3;H1FX;IQSEC1;ZNF606;APOBEC3F;ARHGEF4;DDX50;CYP2R1;TUBB6;MAPK3;INSR;RTN2;ARHGEF1;PAN2;GRINA;CAMTA2;PFKM;ADCY1;TNS4;RERE;HLA-G;DOCK9;STX10;TSTA3;ATP8B2;GPT2;RALGAPA1;MORN4;PDXK;ETAA1;PRAF2;GLRX;BCL7A;CEP72;VANGL2;PAK1;TRIM45;CDYL2;MALL;CAMKK2;RNASET2;PPP3CB;RNF144A;LGALS3BP;ALPK1;USP21;PFKFB3;MLYCD;CUL7;GABBR1;REV1;MICAL1;HYAL1;SEMA4C;CAPRIN2;ZBTB10;WDTC1;HES7;ITGA3;ERICH2;STK32C;DNMT3A;BIN1;VPS16;MAN2B1;SRMS;NSUN7;PPP2R5B;HES6;MAP2K3;FAM214A;BCL2L1;DLG3;SGSM2;NDUFV3;KIAA0040;RRAS;DNASE1L1;PROX1;IARS2;LRCH4;TBC1D16;ALDH7A1;LMNA;PKD1;KCTD13;TNFRSF25;NATD1;RABGAP1;SIRT2;FAM129B;CDH4;ITGA4;EDA;UVSSA;GAL3ST4;DCBLD2;NMNAT2;BACH1;NT5C1B;TRIP10;ADCY7;E2F5;ZBTB22;LTB4R;AFAP1L1;MAPRE3;AZIN2;TEP1;RAB28;ZNF704;ICA1;RAP1GAP2;YDJC;LAMB1;SOCS7;MAP3K10;RGS19;NDE1;GPR3;HSD11B1;PELI3;GTF2IRD2;RAB40B;NGFR;TOLLIP;PDCD6;ATP6V1F;PCLO;ARVCF;CHST14;ZNF837;RNASE7;PXN;GRB10;TBC1D8;PHYKPL;PLEKHM1;DUSP23;GCH1;MSS51;LURAP1;KIF13B;MAFF;NR2F6;CBX6;PNMA1;CAMK1;CAMKK1;EZH1;SIRT3;HFE;TERC;ZNF513;WIPI2;GAS2L1;COL6A1;BTG1;BBS10;ZP3;VPS51;CELSR1;TACC1;MLF2;IL17RE;SEMA3B;SEPT6;CDK11B;PFN2;SSH3;FGFR3;PPP1R16A;TST;CCDC88C;TNRC18;NDRG2;MAN2B2;BLOC1S4;CBLC;FAM102A;ITPKB;SPTLC2;TCEA2;CDC42BPG;PRSS21;ZBTB47;PLAG1;LRP11;DOK4;GSDMA;CLK3;IRF2BPL;TRIM46;DHX32;KDM3A;MEGF6;FAM214B;TYMSOS;TBL3;HOMER2;PKN3;APBA1;TTLL3;DEDD2;AK3;SRSF5;CHPF;ADCY6;LRRK1;AARS;KLHL24;STRN4;SDC2
2969,GO:0006513,0.926104628107762,0.164290547432416,4,65,protein monoubiquitination,BP,DDB2;RAG1;ZNF598;PDCD6
7220,GO:0031122,0.926559711396068,0.179910442881416,3,51,cytoplasmic microtubule organization,BP,DVL1;TUBG2;CCDC88C
10669,GO:0043921,0.9268381260466,0.275996222971077,1,23,modulation by host of viral transcription,BP,HMGA2
13326,GO:0052312,0.9268381260466,0.275996222971077,1,23,modulation of transcription in other organism involved in symbiotic interaction,BP,HMGA2
13344,GO:0052472,0.9268381260466,0.275996222971077,1,23,modulation by host of symbiont transcription,BP,HMGA2
16572,GO:0097366,0.926848322212714,0.275969204403604,1,23,response to bronchodilator,BP,DNM2
12097,GO:0048147,0.926995821702001,0.27509049618169,1,24,negative regulation of fibroblast proliferation,BP,BAX
1028,GO:0002534,0.927012915081655,0.2755328427666,1,23,cytokine production involved in inflammatory response,BP,PDCD4
2544,GO:0005814,0.927123474910017,0.133324224665779,8,112,centriole,CC,CEP250;CROCC;CAPG;SDCCAG8;CCDC92;NUBP2;WASH3P;SIRT2
8088,GO:0032781,0.927473968362324,0.205988460005096,2,40,positive regulation of ATPase activity,BP,DNM2;PFN2
7836,GO:0032400,0.927607257224508,0.273953825085019,1,23,melanosome localization,BP,BBS2
104,GO:0000217,0.928131993368359,0.272555380338681,1,23,DNA secondary structure binding,MF,XPC
14283,GO:0061384,0.928425173788299,0.271772252105142,1,23,heart trabecula morphogenesis,BP,TGFBR3
17839,GO:1901989,0.92849625099199,0.159838263148707,4,66,positive regulation of cell cycle phase transition,BP,CCND1;CDC25B;TGFB1;HYAL1
3558,GO:0007602,0.928850867651193,0.270632863235964,1,23,phototransduction,BP,PITPNM1
8793,GO:0034504,0.928926971410749,0.111571373920754,16,204,protein localization to nucleus,BP,ARL2;DVL1;AKT1;LZTS2;GAS6;TGFB1;TMEM173;PRKCD;SESN2;ABCA7;FYN;TMCO6;SUN1;RERE;LMNA;NGFR
12078,GO:0048048,0.92944363627387,0.26904172930506,1,23,embryonic eye morphogenesis,BP,PROX1
6782,GO:0030225,0.929953262710584,0.267669491786681,1,23,macrophage differentiation,BP,VEGFA
6696,GO:0030101,0.929990646348822,0.200469968724364,2,40,natural killer cell activation,BP,GAS6;IFNE
4532,GO:0010605,0.93033682195616,0.0812058201833583,193,2025,negative regulation of macromolecule metabolic process,BP,TNIP1;DUSP6;XDH;ERCC1;DUSP5;ZMYND8;EGR1;NR1D1;DLG4;PLAT;CST3;APLN;PDCD4;CTNNBIP1;ACVR2B;PRNP;BBS2;VEGFA;TNFRSF6B;APOE;LRP5;HMGA2;ELK3;PKN1;MTA1;EGFR;SERPINE2;WWTR1;SPRY2;NFATC4;BAHCC1;CRTAP;SHC1;GTPBP1;TCFL5;SPRY4;ZFP36L1;MAP2K2;ZC3H6;MDFI;PPP1R35;PC;FOXQ1;MAP2K1;MXD4;SMURF2;FBLN1;SMAD3;STAT6;PIK3R2;DVL1;DNAJB5;HBEGF;PPP1R14A;PRDX5;SALL2;ADARB1;AKT1;GRB7;HDAC5;PPM1F;STK39;SERPING1;SCMH1;EPHA1;IMPACT;WWC3;DAP;LDLR;FGFR1;MXI1;RAG1;H2AFJ;SORL1;CEACAM1;CIRBP;HMG20B;TENM2;TSHZ1;CCND1;PODNL1;PCBP4;TCF25;GAS6;PTK6;DUSP7;PCSK9;ERRFI1;SNTA1;DGKQ;TFPI2;TAGLN3;CTSZ;HES2;MAGEF1;EPHB2;CTBP1;MNT;CDKN1C;CEBPB;ZNF217;TIMP2;C8ORF88;TGFB1;UNK;DEAF1;NAB2;PNRC1;PEG3;RNH1;PHF21A;PTPN1;MBD3;CAMK2N1;VHL;MLXIPL;TRIB2;PRKCZ;TDRKH;TFDP2;JAK3;NELFCD;PRKCD;RBL2;IFI6;BAX;EREG;RPS6KA5;DUSP4;DDIT4;PPP1R13L;PCSK1N;LIMK1;DIP2A;LEMD2;RPS6KA6;ZHX3;RGS14;CHAD;ASB1;HDAC7;INPP5D;CBX7;CHEK2;ZFPM1;PPARA;SESN2;SOX7;ABCA7;SIX5;MIF;MEX3A;ECM1;WFS1;FYN;ARID5B;BHLHE40;NEIL1;TSPYL2;ELFN2;SATB1;PAN2;RERE;BCL7A;MICAL1;CAPRIN2;WDTC1;HES7;DNMT3A;BIN1;HES6;PROX1;SIRT2;FAM129B;BACH1;AZIN2;SERPINB1;SOCS7;MAP3K10;NGFR;NR2F6;CBX6;SIRT3;HFE;ZP3;TNRC18;NDRG2;CBLC;PLAG1;IRF2BPL;KDM3A;DEDD2;LRRK1
19457,GO:1990089,0.930560072868517,0.199400773540718,2,39,response to nerve growth factor,BP,AKT1;EEF2K
19458,GO:1990090,0.930560072868517,0.199400773540718,2,39,cellular response to nerve growth factor stimulus,BP,AKT1;EEF2K
7405,GO:0031497,0.930574828125386,0.127265424374259,8,135,chromatin assembly,BP,H1F0;HMGA2;BAHCC1;CENPH;HIST3H2BB;TSPYL2;H1FX;TNRC18
10283,GO:0043038,0.930631624695881,0.171652804809713,3,53,amino acid activation,BP,DALRD3;IARS2;AARS
20278,GO:2001222,0.93103743120989,0.264736923699208,1,23,regulation of neuron migration,BP,NSMF
11129,GO:0045182,0.931205187166046,0.197785452053193,2,40,translation regulator activity,MF,CIRBP;MIF4GD
11399,GO:0045814,0.931437685727013,0.13037093283237,7,121,negative regulation of gene expression, epigenetic,BP,BAHCC1;HDAC5;H2AFJ;MBD3;DNMT3A;SIRT2;TNRC18
8810,GO:0034593,0.931480596854671,0.263532941824171,1,23,phosphatidylinositol bisphosphate phosphatase activity,MF,SYNJ2
12544,GO:0050702,0.931988741285462,0.261668398709347,1,24,interleukin-1 beta secretion,BP,HK1
10606,GO:0043601,0.932070915885046,0.261444283580528,1,24,nuclear replisome,CC,POLD4
12804,GO:0051117,0.932096790863336,0.168629619008449,3,54,ATPase binding,MF,SNTA1;PKD2;WFS1
11833,GO:0046822,0.932681331871322,0.134486623134124,6,91,regulation of nucleocytoplasmic transport,BP,RAPGEF3;GAS6;TGFB1;TMEM173;PRKCD;CAMK1
12527,GO:0050681,0.932813861702555,0.194393309580258,2,39,androgen receptor binding,MF,PKN1;KDM3A
8093,GO:0032786,0.933104765234744,0.258615501345184,1,24,positive regulation of DNA-templated transcription, elongation,BP,ERCC6
13145,GO:0051726,0.933364311686704,0.0822141273158408,93,1002,regulation of cell cycle,BP,FHL1;CCNG2;PDCD4;XPC;PRNP;LRP5;HMGA2;NDRG1;EGFR;RPS6KA2;OBSL1;TRNP1;ZFP36L1;MAP2K2;MAP2K1;SMAD3;GJC2;PPP2R3B;FBXW5;ADARB1;AKT1;STK39;BRSK1;FGFR1;PRKACB;CCNI;RAB11FIP4;ZNF385A;CCND1;PCBP4;STRADB;CEP250;GAS6;PTK6;CSNK1E;RAD23A;BCR;CDC25B;ALOX15B;NPR2;PAK6;PKD2;CTBP1;MNT;CDKN1C;TIMP2;TGFB1;CGREF1;CAMK2N1;CEP131;MLXIPL;PRKACA;MINK1;TOM1L2;PIM2;SDCCAG8;NINL;TFDP2;C6ORF89;RBL2;BAX;EREG;CUL9;TMEM8B;GIT1;MAPK12;TGFA;CHEK2;MIF;STK25;BEX2;TSPYL2;INSR;ETAA1;CEP72;PAK1;CUL7;HYAL1;BIN1;PPP2R5B;MAP2K3;BCL2L1;PROX1;PKD1;SIRT2;E2F5;MAPRE3;NDE1;GPR3;GAS2L1;BTG1;CDK11B;SRSF5
3690,GO:0008200,0.933831942697517,0.256177936012626,1,25,ion channel inhibitor activity,MF,PCSK9
20193,GO:2001020,0.934182895971876,0.110624918406836,12,162,regulation of response to DNA damage stimulus,BP,ERCC1;HMGA2;EGFR;ZNF385A;NSMCE4A;MAGEF1;PRKCD;CHEK2;TMEM161A;MIF;ETAA1;BCL2L1
12405,GO:0048863,0.934644541161418,0.106133957238831,14,200,stem cell differentiation,BP,SEMA4B;WNT7A;HMGA2;EDNRA;SEMA3F;LAMA5;WNT3;SEMA4F;CHD2;MAPK3;SEMA4C;PDCD6;SEMA3B;KDM3A
17010,GO:0099106,0.934656660405534,0.163500357050384,3,54,ion channel regulator activity,MF,KCNAB2;PCSK9;PRKCZ
5628,GO:0016706,0.935160326638253,0.189126641626872,2,39,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors,MF,KDM4B;PHYH
3049,GO:0006612,0.935184208554228,0.113413957929852,10,164,protein targeting to membrane,BP,PRNP;STOM;ANK3;CEMIP;ZDHHC24;ERBB2;GDI1;FYN;ZDHHC1;PAK1
729,GO:0001959,0.935193994307006,0.116783696922639,9,128,regulation of cytokine-mediated signaling pathway,BP,RBCK1;IFNGR2;GAS6;SHARPIN;PTPN1;IRAK1;ECM1;SPPL2B;PELI3
4341,GO:0009895,0.935278898910441,0.102522535360424,16,208,negative regulation of catabolic process,BP,CST3;EGFR;SERPINE2;TBC1D14;SMAD3;AKT1;DAP;CIRBP;TIMP2;DDIT4;PPARA;QSOX1;FYN;SIRT2;AZIN2;HFE
13206,GO:0051875,0.935584104500738,0.251761154618907,1,24,pigment granule localization,BP,BBS2
12245,GO:0048536,0.935724884820462,0.251368913270378,1,24,spleen development,BP,PKN1
2734,GO:0006119,0.935968612086554,0.135273899693228,5,96,oxidative phosphorylation,BP,SDHA;MLXIPL;CYC1;TAZ;NDUFV3
14169,GO:0061077,0.936211991307823,0.145356096612972,4,68,chaperone-mediated protein folding,BP,CRTAP;FKBP9;FYCO1;TRAP1
4686,GO:0010837,0.936691207243652,0.248667556945722,1,24,regulation of keratinocyte proliferation,BP,ZFP36L1
2940,GO:0006471,0.936742943160512,0.248522483475671,1,24,protein ADP-ribosylation,BP,SIRT2
8002,GO:0032637,0.936760607487528,0.185149322442888,2,41,interleukin-8 production,BP,F2R;MAPKBP1
416,GO:0001104,0.936857893691881,0.134372177720027,5,80,RNA polymerase II transcription cofactor activity,MF,ZMYND8;CITED4;CTBP1;SOX12;RERE
12533,GO:0050688,0.936871690775339,0.159021490387012,3,54,regulation of defense response to virus,BP,HTRA1;TMEM173;APOBEC3F
7739,GO:0032259,0.936884351071387,0.0936440780827435,23,283,methylation,BP,FOS;ASH2L;GAMT;RAB3B;COMTD1;RRNAD1;MBD3;TDRKH;AHCY;GSTO1;MTHFR;PCMTD2;EEF2KMT;ETFB;SATB1;ASMTL;DNMT3A;NSUN7;FAM129B;FAM86B1;EZH1;BTG1;KDM3A
591,GO:0001756,0.937129070911068,0.184664439429133,2,39,somitogenesis,BP,SMAD3;HES7
14800,GO:0070534,0.937159721000444,0.184413793145462,2,40,protein K63-linked ubiquitination,BP,STUB1;PELI3
3301,GO:0007005,0.937735020391474,0.0848001033449699,40,483,mitochondrion organization,BP,IDH2;VAT1;VPS11;EPAS1;AKT1;RAC2;TOMM34;AIP;BNIP3;SHARPIN;MOAP1;MIPEP;ATG2A;COA5;HMGCL;OXA1L;PIM2;MICALL2;BOK;ALAS1;PRIMPOL;TFDP2;BNIP3L;IFI6;BAX;TIMM17B;ZDHHC8;DNM1;SESN2;PLA2G6;NBPF3;DNM2;INF2;TAZ;CAMKK2;BCL2L1;NDUFV3;LMNA;SIRT3;WIPI2
5930,GO:0018208,0.937735163575384,0.182768845498906,2,42,peptidyl-proline modification,BP,CRTAP;FKBP9
2586,GO:0005882,0.937774645032413,0.14247648444413,4,67,intermediate filament,CC,SHANK2;NARF;MICAL1;LMNA
98,GO:0000209,0.93778915571875,0.0931175656311253,22,276,protein polyubiquitination,BP,FBXO2;TMEM129;DDB2;RBCK1;SMURF2;FBXW5;RNF187;FBXO41;SHARPIN;FBXW8;FBXL8;FBXO17;FBXO44;THOP1;MIB2;STUB1;FBXW4;LRSAM1;CDC34;PELI1;RNF144A;PELI3
11363,GO:0045739,0.937810557963008,0.182930244110018,2,40,positive regulation of DNA repair,BP,EGFR;TMEM161A
796,GO:0002066,0.937913514452338,0.182695148996133,2,40,columnar/cuboidal epithelial cell development,BP,FGFR1;SLITRK6
8091,GO:0032784,0.938846566102138,0.180559413358182,2,40,regulation of DNA-templated transcription, elongation,BP,ERCC6;TCEA2
10590,GO:0043565,0.938939647078357,0.0778321987236894,70,759,sequence-specific DNA binding,MF,MEF2D;ZMYND8;H1F0;EGR1;NR1D1;HMGA2;ELK3;MTA1;NFATC4;BAHCC1;ETV5;TCFL5;ETV4;ZC3H6;FOXQ1;POU2F2;FOS;SMAD3;STAT6;EPAS1;SALL2;HLTF;MXI1;RAG1;KLF7;SOX13;MYEF2;SMARCD2;HES2;MNT;CEBPB;ZNF217;RFX2;DEAF1;PHF21A;MBD3;MLXIPL;KDM6B;ZNF516;TFDP2;PBX2;ZNF395;SOX12;CARF;IER2;ZHX3;CHD2;ZFPM1;PPARA;SOX7;SIX5;SSBP4;ARID5B;HOXC5;BHLHE40;TSPYL2;SATB1;CAMTA2;RERE;HES7;HES6;PROX1;BACH1;ZNF704;MAFF;NR2F6;SIRT3;TNRC18;PLAG1;KDM3A
5886,GO:0018024,0.939104063676057,0.179968356891572,2,40,histone-lysine N-methyltransferase activity,MF,ASH2L;EZH1
17842,GO:1901992,0.939124028255723,0.15432789153857,3,55,positive regulation of mitotic cell cycle phase transition,BP,CCND1;TGFB1;HYAL1
9182,GO:0035567,0.939148195351378,0.110444873218427,9,132,non-canonical Wnt signaling pathway,BP,WNT7A;SMURF2;DVL1;AP2A2;CSNK1E;PLCB3;VANGL2;PPP3CB;CELSR1
3297,GO:0006998,0.939405816078179,0.129796992482394,5,80,nuclear envelope organization,BP,NEK9;REEP4;LEMD2;SUN1;LMNA
583,GO:0001738,0.93946220401225,0.113304636719258,8,121,morphogenesis of a polarized epithelium,BP,SMURF2;DVL1;AP2A2;LAMA5;SH3BP1;VANGL2;DLG3;CELSR1
12401,GO:0048857,0.939696381733306,0.178437116467394,2,41,neural nucleus development,BP,SIRT2;NDRG2
2490,GO:0005740,0.939776713443013,0.0795962628652838,51,618,mitochondrial envelope,CC,CYP27B1;FAM210B;IDH2;CRAT;GRAMD4;VAT1;HADH;ARL2;NME4;CPT2;ARMCX2;HSD17B8;PRODH;HK1;TOMM34;BPHL;NIPSNAP1;CARD19;MRPS6;BNIP3;SNPH;MOAP1;TMEM173;SDHA;MDH2;ANKZF1;HMGCL;TRAP1;OXA1L;BOK;ULK1;BNIP3L;THOP1;BAX;CYC1;TIMM17B;DNM1;MRPS26;PPOX;COQ2;SNN;SLC25A29;DNM2;CKMT1A;CAT;ARMCX1;TAZ;BCL2L1;NDUFV3;SLC25A37;TST
11080,GO:0045088,0.940059377547628,0.0892880927118304,23,289,regulation of innate immune response,BP,TNIP1;NR1D1;PTPRS;SERPING1;IFNGR2;PRKACB;CEACAM1;CTSB;CARD11;MAPKAPK3;FAM3A;ADAM8;RNF135;TMEM173;PTPN1;PRKACA;PRKCD;EREG;RPS6KA5;IRAK1;FYN;PELI1;PAK1
7892,GO:0032467,0.940603885990966,0.237138665487581,1,25,positive regulation of cytokinesis,BP,CDC25B
5408,GO:0016248,0.941123422460318,0.2352537757112,1,26,channel inhibitor activity,MF,PCSK9
4478,GO:0010494,0.9411560434838,0.175232314125393,2,40,cytoplasmic stress granule,CC,GRB7;CIRBP
2843,GO:0006325,0.941165981721239,0.0768569195336474,57,661,chromatin organization,BP,ZMYND8;H1F0;VEGFA;HMGA2;PKN1;MTA1;NOS1;BAHCC1;DDB2;SMARCA1;BRD3;HDAC5;PPM1F;SCMH1;ASH2L;HLTF;RAG1;H2AFJ;HMG20B;HLCS;SMARCD2;CTBP1;TGFB1;PHF21A;MBD3;KDM6B;CENPH;RCCD1;C6ORF89;PRKCD;RBL2;HIST3H2BB;RPS6KA5;PADI3;HDAC7;MTHFR;CHD2;CBX7;ZFPM1;JADE2;KDM4B;ARID5B;TSPYL2;SATB1;H1FX;MAPK3;RERE;INO80C;USP21;DNMT3A;SIRT2;BCORL1;CBX6;EZH1;SIRT3;TNRC18;KDM3A
12138,GO:0048255,0.941833274104653,0.233595845698218,1,25,mRNA stabilization,BP,CIRBP
7867,GO:0032435,0.941983539469885,0.232771375424142,1,26,negative regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,HFE
19198,GO:1905268,0.942028472851042,0.173204495642801,2,40,negative regulation of chromatin organization,BP,CTBP1;KDM3A
16218,GO:0090263,0.942099265908312,0.112984310858773,7,110,positive regulation of canonical Wnt signaling pathway,BP,WNT7A;SMURF2;DVL1;WNT2B;CAPRIN2;EDA;LRRK1
14383,GO:0061631,0.942106111666027,0.232416507057023,1,26,ubiquitin conjugating enzyme activity,MF,CDC34
2874,GO:0006376,0.942273011623009,0.23232185623572,1,25,mRNA splice site selection,BP,SRSF5
40,GO:0000082,0.942289984538904,0.0913026796417268,17,222,G1/S transition of mitotic cell cycle,BP,FHL1;EGFR;GJC2;AKT1;ZNF385A;CCND1;PCBP4;PKD2;PIM2;TFDP2;RBL2;BAX;CHEK2;CDC34;HYAL1;PKD1;BACH1
5795,GO:0017038,0.942356349292302,0.0982750583036081,12,166,protein import,BP,APOE;AKT1;GAS6;PEX10;TGFB1;TMEM173;SNX33;PEX1;PRKCD;TIMM17B;TMCO6;RERE
4515,GO:0010569,0.942415603387524,0.231907971624821,1,25,regulation of double-strand break repair via homologous recombination,BP,MAGEF1
297,GO:0000803,0.942451341529193,0.231804179056407,1,25,sex chromosome,CC,DNMT3A
259,GO:0000726,0.942649914372419,0.132745573901019,4,74,non-recombinational repair,BP,ERCC1;HMGA2;POLL;POLM
8419,GO:0033522,0.94269087002,0.23110790985473,1,25,histone H2A ubiquitination,BP,DDB2
15090,GO:0071108,0.942889174278438,0.230530656293319,1,25,protein K48-linked deubiquitination,BP,USP20
3228,GO:0006885,0.942913175592614,0.132531766907457,4,69,regulation of pH,BP,SLC9A7;MAPK3;ATP6V1F;SLC26A11
9592,GO:0036452,0.943280960117485,0.229000876792423,1,26,ESCRT complex,CC,MVB12B
16147,GO:0090162,0.943514593498954,0.228705217948024,1,25,establishment of epithelial cell polarity,BP,SH3BP1
7890,GO:0032465,0.943538814756811,0.131388440373041,4,68,regulation of cytokinesis,BP,RAB11FIP4;CDC25B;GIT1;BCL2L1
2807,GO:0006270,0.943586691333383,0.169396521799482,2,41,DNA replication initiation,BP,WDR18;CDC34
14822,GO:0070566,0.943717043895457,0.228112721198431,1,25,adenylyltransferase activity,MF,NMNAT2
8283,GO:0033120,0.943988536640268,0.227316929715287,1,25,positive regulation of RNA splicing,BP,SRSF5
14689,GO:0070316,0.944083231648619,0.168230153420866,2,41,regulation of G0 to G1 transition,BP,TFDP2;PPP2R5B
18362,GO:1903322,0.944172199679966,0.109566959052418,7,107,positive regulation of protein modification by small protein conjugation or removal,BP,TNIP1;MTA1;STUB1;WFS1;PELI1;TOLLIP;PDCD6
14497,GO:0061982,0.944240014465887,0.129968715337054,4,69,meiosis I cell cycle process,BP,ERCC1;CDC25B;LEMD2;SUN1
8009,GO:0032648,0.944692008546329,0.16679617824021,2,41,regulation of interferon-beta production,BP,PTPRS;RNF135
7348,GO:0031397,0.944892815017302,0.142107354910892,3,58,negative regulation of protein ubiquitination,BP,AKT1;LIMK1;FYN
1451,GO:0003682,0.944902130895551,0.0765341957885284,37,437,chromatin binding,MF,ZMYND8;H1F0;EGR1;HMGA2;PKN1;MTA1;EGFR;NFATC4;BAHCC1;SMARCA1;FOS;SMAD3;ERCC6;BRD3;HDAC5;ASH2L;HMG20B;TSHZ1;SMARCD2;MNT;CEBPB;PHF21A;MBD3;KDM6B;PRIMPOL;PBX2;RBL2;LEMD2;HDAC7;SATB1;CAMTA2;RERE;DNMT3A;SIRT2;EZH1;TNRC18;KDM3A
2862,GO:0006357,0.944910499240257,0.0657759727048767,153,1598,regulation of transcription by RNA polymerase II,BP,TNIP1;MEF2D;ZMYND8;CITED4;HTRA1;EGR1;NR1D1;APLN;PDCD4;CTNNBIP1;ACVR2B;VEGFA;WNT7A;APOE;LRP5;ITGA6;HMGA2;ELK3;PKN1;EGFR;WWTR1;NOS1;NFATC4;ETV5;HEXB;TCFL5;ETV4;ZFP36L1;ZC3H6;MDFI;FOXQ1;MXD4;POU2F2;SMURF2;TSC22D1;FOS;SMAD3;STAT6;PIK3R2;EPAS1;DNAJB5;BRD3;SALL2;AKT1;HDAC5;NFKBIZ;ASH2L;IMPACT;WWC3;FGFR1;HLTF;MXI1;KLF7;TENM2;ZNF385A;TSHZ1;CCND1;TCF25;SOX13;ZSCAN18;MYEF2;SMARCD2;DGKQ;GTF2IRD1;TAGLN3;PKD2;HES2;CRTC1;ABCA2;CTBP1;MNT;ZMIZ2;CD81;CEBPB;ZNF217;TGFB1;RFX2;DEAF1;TMEM173;PEG3;MC1R;ABHD14B;PHF21A;AGRN;MBD3;LRP4;VHL;MLXIPL;KDM6B;ERBB2;TFDP2;PBX2;RBL2;ZNF395;RPS6KA5;ZNF524;SOX12;MBTPS2;PPP1R13L;CARF;IER2;TGFBR3;LEMD2;ZHX3;TGFA;HDAC7;FHOD1;CHD2;CBX7;ZFPM1;PPARA;SESN2;SOX7;SIX5;SSBP4;ECM1;WFS1;ZNF444;ARID5B;HOXC5;BHLHE40;ZMYM3;SATB1;MAPK3;CAMTA2;PFKM;RERE;PPP3CB;CAPRIN2;WDTC1;HES7;ITGA3;DNMT3A;PPP2R5B;HES6;PROX1;PKD1;SIRT2;BACH1;E2F5;ZNF704;GTF2IRD2;NGFR;MAFF;NR2F6;CBX6;CAMK1;EZH1;HFE;TCEA2;PLAG1;IRF2BPL;KDM3A
14802,GO:0070536,0.945087619697725,0.224080747019243,1,25,protein K63-linked deubiquitination,BP,USP20
42,GO:0000086,0.945126452988824,0.0871976317911508,17,226,G2/M transition of mitotic cell cycle,BP,FHL1;HMGA2;BRSK1;CCND1;CEP250;CSNK1E;PHLDA1;CDC25B;CEP131;PRKACA;SDCCAG8;NINL;CHEK2;DNM2;CEP72;BACH1;NDE1
7091,GO:0030894,0.945165943277044,0.223465756394537,1,26,replisome,CC,POLD4
19226,GO:1905330,0.945317457887859,0.0978960159784452,10,146,regulation of morphogenesis of an epithelium,BP,VEGFA;ETV5;SMURF2;DVL1;AP2A2;WNT2B;FGFR1;TGFB1;VANGL2;CELSR1
10821,GO:0044322,0.945667680520354,0.221980783771051,1,26,endoplasmic reticulum quality control compartment,CC,EDEM1
6275,GO:0019882,0.94598208234819,0.0926724713756877,12,172,antigen processing and presentation,BP,KLC2;AP2A2;RAB3B;AP3D1;ITGB5;ACTR1B;BCAP31;DNM2;KIF26A;HLA-G;CTSF;HFE
11389,GO:0045786,0.946074269684819,0.0727582847100412,46,535,negative regulation of cell cycle,BP,FHL1;PDCD4;XPC;PRNP;HMGA2;NDRG1;EGFR;RPS6KA2;ZFP36L1;MAP2K1;SMAD3;GJC2;PPP2R3B;BRSK1;PRKACB;ZNF385A;CCND1;PCBP4;STRADB;GAS6;ALOX15B;NPR2;PKD2;CDKN1C;TIMP2;TGFB1;CGREF1;CAMK2N1;MLXIPL;PRKACA;TOM1L2;TFDP2;RBL2;BAX;MAPK12;CHEK2;MIF;TSPYL2;ETAA1;BIN1;PPP2R5B;BCL2L1;PROX1;PKD1;GAS2L1;BTG1
7588,GO:0031966,0.94645189961552,0.0720156294047112,47,578,mitochondrial membrane,CC,CYP27B1;FAM210B;IDH2;CRAT;GRAMD4;VAT1;HADH;NME4;CPT2;ARMCX2;PRODH;HK1;TOMM34;BPHL;NIPSNAP1;CARD19;MRPS6;BNIP3;SNPH;MOAP1;TMEM173;SDHA;MDH2;ANKZF1;HMGCL;TRAP1;OXA1L;BOK;ULK1;BNIP3L;BAX;CYC1;TIMM17B;DNM1;MRPS26;PPOX;COQ2;SNN;SLC25A29;DNM2;CKMT1A;ARMCX1;TAZ;BCL2L1;NDUFV3;SLC25A37;TST
411,GO:0001098,0.946795848698344,0.161653710445547,2,42,basal transcription machinery binding,MF,ERCC1;UVSSA
412,GO:0001099,0.946795848698344,0.161653710445547,2,42,basal RNA polymerase II transcription machinery binding,MF,ERCC1;UVSSA
14393,GO:0061650,0.947308533496797,0.216739342567045,1,27,ubiquitin-like protein conjugating enzyme activity,MF,CDC34
18227,GO:1903008,0.947433527494025,0.108726090142098,6,96,organelle disassembly,BP,BNIP3;ATG2A;BNIP3L;ZDHHC8;CAMKK2;WIPI2
11880,GO:0046907,0.947923944257313,0.0628885950527443,135,1460,intracellular transport,BP,EDEM1;PRNP;BBS2;APOE;EVI5L;TMEM129;SYTL1;LMF1;LTBP2;VPS11;TBC1D14;SNX9;RAPGEF3;MAP2K2;MAP2K1;CPT2;AP2A2;STOM;ADORA2B;SYT8;AKT1;ZFYVE21;IFT140;RAB31;LDLR;RAC2;TOMM34;SORL1;B3GAT3;RAB11FIP4;ABCD1;ANK3;TRAPPC9;STRADB;GAS6;RAB3B;PCSK9;BCR;XPOT;EHD4;AIP;SPTB;PEX10;CCS;CORO7;MVB12B;FYCO1;CEMIP;CTSZ;AP3D1;ABCA2;KIF17;TMED4;TGFB1;SNPH;CLTCL1;TBC1D9B;TMEM173;ATP7B;MIPEP;RHOD;SNX17;SNX33;RIMS3;PTPN1;PEX1;ZDHHC24;CEP131;PRKCZ;TOM1L2;AREG;MICALL2;ERBB2;VAMP2;RILPL1;BNIP3L;ARHGAP44;MCFD2;PRKCD;REEP6;CYC1;TIMM17B;ZDHHC8;GDI1;DNM1;WASH3P;RGS14;REEP2;EHD3;WDR60;LONP2;SYMPK;TGFA;FHOD1;COG7;ABCG1;MYO1D;RAB12;BCAP31;DOPEY2;SYNGR1;NBPF3;FYN;TMCO6;SUN1;DNM2;SNX15;ZDHHC1;MAPK3;RTN2;RERE;STX10;PAK1;BIN1;VPS16;SGSM2;TBC1D16;PKD1;RABGAP1;RAB28;NDE1;RAB40B;NGFR;PDCD6;PCLO;TBC1D8;KIF13B;CAMK1;VPS51;PFN2;CCDC88C;BLOC1S4;TRIM46;APBA1;SRSF5
16600,GO:0097431,0.948195616538893,0.214422024605662,1,26,mitotic spindle pole,CC,MAPKBP1
8070,GO:0032757,0.94822166104533,0.213995315857059,1,27,positive regulation of interleukin-8 production,BP,F2R
13279,GO:0051984,0.94826351209286,0.214217204480794,1,26,positive regulation of chromosome segregation,BP,SIRT2
7151,GO:0031018,0.948281914760259,0.214161672704825,1,26,endocrine pancreas development,BP,AKT1
13054,GO:0051567,0.948372920328254,0.213886950921354,1,26,histone H3-K9 methylation,BP,KDM3A
2815,GO:0006283,0.94849621710187,0.121432883823559,4,73,transcription-coupled nucleotide-excision repair,BP,ERCC1;ERCC6;POLD4;UVSSA
12045,GO:0048002,0.9486052452873,0.0926150656981387,10,150,antigen processing and presentation of peptide antigen,BP,KLC2;AP2A2;ITGB5;ACTR1B;BCAP31;DNM2;KIF26A;HLA-G;CTSF;HFE
3346,GO:0007077,0.948885712921064,0.15664532580338,2,42,mitotic nuclear envelope disassembly,BP,NEK9;LMNA
92,GO:0000183,0.948920510684516,0.209144923233277,1,39,chromatin silencing at rDNA,BP,SIRT2
7705,GO:0032201,0.948959512067055,0.211765364434553,1,27,telomere maintenance via semi-conservative replication,BP,POLD4
15194,GO:0071346,0.949084171124103,0.101122372992182,7,109,cellular response to interferon-gamma,BP,IFNGR2;GSN;ADAMTS13;PRKCD;MT2A;RAB12;HLA-G
4256,GO:0009593,0.94954039425405,0.209681845299295,1,28,detection of chemical stimulus,BP,ABCG1
5397,GO:0016234,0.949565817906351,0.119547693775757,4,69,inclusion body,CC,EDEM1;PRNP;STRADB;STUB1
8053,GO:0032728,0.949570793469202,0.210254628762836,1,26,positive regulation of interferon-beta production,BP,RNF135
7240,GO:0031201,0.949830664457597,0.154220832426684,2,43,SNARE complex,CC,VAMP2;STX10
6749,GO:0030177,0.950318393919452,0.0923699433715402,9,136,positive regulation of Wnt signaling pathway,BP,WNT7A;SMURF2;DVL1;WNT2B;CSNK1E;WNT3;CAPRIN2;EDA;LRRK1
11463,GO:0045930,0.950414465686639,0.0762735106278432,21,274,negative regulation of mitotic cell cycle,BP,FHL1;XPC;HMGA2;EGFR;ZFP36L1;SMAD3;GJC2;BRSK1;ZNF385A;CCND1;PCBP4;PKD2;TIMP2;TGFB1;TOM1L2;TFDP2;RBL2;BAX;CHEK2;BCL2L1;BTG1
8984,GO:0035097,0.950562663000223,0.117514710930894,4,70,histone methyltransferase complex,CC,ASH2L;KDM6B;INO80C;EZH1
11913,GO:0046966,0.950615458937129,0.206718640806395,1,27,thyroid hormone receptor binding,MF,GAS2L1
5399,GO:0016236,0.950629837563014,0.0759980966528464,21,269,macroautophagy,BP,TBC1D14;AKT1;ATG16L2;PACS2;BNIP3;FYCO1;GPSM1;ULK2;ATG2A;PRKACA;PIM2;ULK1;BNIP3L;LRSAM1;SESN2;RAB12;QSOX1;MAPK3;VPS16;WIPI2;SPTLC2
5791,GO:0017022,0.950986856559285,0.15141313569697,2,43,myosin binding,MF,RAB3B;GSN
17862,GO:1902042,0.95126264593813,0.204730092182335,1,27,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,BCL2L1
10345,GO:0043161,0.951620917447092,0.0700306419928343,30,370,proteasome-mediated ubiquitin-dependent protein catabolic process,BP,GID4;EDEM1;BTBD2;FBXO2;MTA1;WWTR1;TMEM129;RBCK1;RNF44;SMURF2;DVL1;FBXW5;RNF187;AKT1;CSNK1E;RAD23A;SHARPIN;ABTB1;ANKZF1;UBXN4;TRIB2;STUB1;FBXW4;CDC34;BCAP31;WFS1;RNF144A;KCTD13;SIRT2;HFE
7209,GO:0031110,0.952066299501696,0.126912497324394,3,57,regulation of microtubule polymerization or depolymerization,BP,ARL2;EML2;PAK1
2084,GO:0004843,0.95206783885254,0.114517487405093,4,70,thiol-dependent ubiquitin-specific protease activity,MF,JOSD2;ANKZF1;USP20;USP21
2675,GO:0006040,0.952996964364056,0.199355152885907,1,27,amino sugar metabolic process,BP,CTBS
371,GO:0000993,0.953181584034375,0.19877896088015,1,27,RNA polymerase II core binding,MF,UVSSA
4506,GO:0010558,0.95324032729389,0.0578456256994675,107,1167,negative regulation of macromolecule biosynthetic process,BP,ZMYND8;EGR1;NR1D1;PDCD4;CTNNBIP1;ACVR2B;VEGFA;HMGA2;ELK3;MTA1;EGFR;WWTR1;NFATC4;BAHCC1;SHC1;TCFL5;ZFP36L1;MAP2K2;ZC3H6;MDFI;FOXQ1;MAP2K1;MXD4;SMURF2;SMAD3;STAT6;DNAJB5;HBEGF;PRDX5;SALL2;GRB7;HDAC5;PPM1F;SCMH1;IMPACT;WWC3;DAP;FGFR1;MXI1;H2AFJ;CIRBP;TENM2;TSHZ1;CCND1;TCF25;GAS6;ERRFI1;TAGLN3;HES2;CTBP1;MNT;CDKN1C;CEBPB;ZNF217;C8ORF88;TGFB1;UNK;DEAF1;NAB2;PEG3;PHF21A;MBD3;VHL;MLXIPL;TRIB2;TFDP2;JAK3;NELFCD;EREG;RPS6KA5;PPP1R13L;ZHX3;ASB1;HDAC7;INPP5D;CBX7;CHEK2;ZFPM1;PPARA;SESN2;SOX7;ABCA7;SIX5;MEX3A;WFS1;ARID5B;BHLHE40;TSPYL2;SATB1;RERE;BCL7A;CAPRIN2;WDTC1;HES7;DNMT3A;HES6;PROX1;SIRT2;FAM129B;BACH1;MAP3K10;NR2F6;CBX6;ZP3;TNRC18;IRF2BPL;DEDD2
7433,GO:0031570,0.953335946244021,0.0831043343663161,11,156,DNA integrity checkpoint,BP,XPC;HMGA2;BRSK1;ZNF385A;CCND1;PCBP4;TFDP2;RBL2;BAX;CHEK2;ETAA1
7901,GO:0032480,0.953425850271802,0.145300577306806,2,44,negative regulation of type I interferon production,BP,PTPRS;RNF135
11035,GO:0045023,0.953478594027774,0.145300932228317,2,43,G0 to G1 transition,BP,TFDP2;PPP2R5B
12250,GO:0048545,0.953839680693127,0.0714650133588516,21,268,response to steroid hormone,BP,NR1D1;EGFR;SDC1;ZFP36L1;FOS;PTPRU;CCND1;IGFBP2;ERRFI1;PAQR6;ABCA2;TGFB1;PCK2;AREG;DDIT4;PPARA;GLB1;IGFBP7;PAK1;NR2F6;KDM3A
10788,GO:0044270,0.954169538234621,0.0627765486282501,44,546,cellular nitrogen compound catabolic process,BP,NT5E;XDH;H1F0;PGM1;DNPH1;GTPBP1;RAPGEF3;ZFP36L1;ENDOG;AKT1;ENTPD6;HK1;PFKL;CIRBP;PCBP4;PFKP;DHTKD1;ENTPD2;PNRC1;RNH1;PFKFB2;MLXIPL;ADA;AHCY;PRKCD;BAX;DDIT4;ALDOC;PPARA;UPP1;CYP3A5;NEIL1;APOBEC3C;APOBEC3F;INSR;PAN2;PFKM;RNASET2;PFKFB3;DNASE1L1;NT5C1B;TST;PM20D2;DEDD2
8689,GO:0034332,0.954400416315385,0.096255895431937,6,95,adherens junction organization,BP,VEGFA;SMAD3;PPM1F;LAMA5;RHOD;CDH4
2864,GO:0006360,0.954588376107913,0.121266545391209,3,59,transcription by RNA polymerase I,BP,ERCC6;ERBB2;MAPK3
15241,GO:0071407,0.954679546563705,0.0643193800525107,35,417,cellular response to organic cyclic compound,BP,EGR1;NR1D1;CYP27B1;FAM210B;ITGA6;EGFR;NFATC4;RAPGEF3;ZFP36L1;MAP2K2;MAP2K1;SSH1;SMAD3;AKT1;IMPACT;ERRFI1;PAQR6;PKD2;CEBPB;TGFB1;TMEM173;PCK2;PRKACA;DDIT4;CHEK2;PPARA;EEF2K;DNM2;MAPK3;ADCY1;PAK1;SIRT2;NR2F6;KDM3A;ADCY6
11802,GO:0046700,0.954722724103598,0.0620643954597609,44,546,heterocycle catabolic process,BP,NT5E;XDH;H1F0;PGM1;DNPH1;GTPBP1;ALDH4A1;RAPGEF3;ZFP36L1;ENDOG;PRODH;AKT1;ENTPD6;HK1;PFKL;CIRBP;PCBP4;PFKP;DHTKD1;ENTPD2;PNRC1;RNH1;PFKFB2;MLXIPL;ADA;AHCY;PRKCD;BAX;DDIT4;ALDOC;PPARA;UPP1;NEIL1;APOBEC3C;APOBEC3F;INSR;PAN2;PFKM;RNASET2;PFKFB3;DNASE1L1;NT5C1B;PM20D2;DEDD2
3651,GO:0008137,0.954901529341869,0.190895376796333,1,38,NADH dehydrogenase (ubiquinone) activity,MF,NDUFV3
12438,GO:0050136,0.954901529341869,0.190895376796333,1,38,NADH dehydrogenase (quinone) activity,MF,NDUFV3
7210,GO:0031111,0.954930158698815,0.193282256443676,1,27,negative regulation of microtubule polymerization or depolymerization,BP,EML2
19836,GO:2000279,0.954984257489839,0.193111039485269,1,27,negative regulation of DNA biosynthetic process,BP,FAM129B
6722,GO:0030140,0.95507802809151,0.19250583754997,1,28,trans-Golgi network transport vesicle,CC,CLTCL1
17517,GO:1900739,0.955095751941422,0.192449728411755,1,28,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,TFDP2
17518,GO:1900740,0.955095751941422,0.192449728411755,1,28,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,TFDP2
3318,GO:0007029,0.955115112569849,0.141239339627021,2,43,endoplasmic reticulum organization,BP,REEP2;DOPEY2
2866,GO:0006362,0.955194172333378,0.191852025472216,1,29,transcription elongation from RNA polymerase I promoter,BP,ERCC6
6247,GO:0019827,0.955281923581146,0.0869642494978007,8,122,stem cell population maintenance,BP,WNT7A;LRP5;HMGA2;EPAS1;EPHA1;VANGL2;PROX1;KDM3A
13083,GO:0051603,0.955528069267165,0.0598566467970976,51,593,proteolysis involved in cellular protein catabolic process,BP,GID4;NR1D1;EDEM1;BTBD2;FBXO2;MTA1;ARRDC1;WWTR1;TMEM129;CTSO;CAPN2;RBCK1;RNF44;SMURF2;DVL1;FBXW5;RNF187;AKT1;CSNK1E;CTSB;RAD23A;SHARPIN;MVB12B;CTSZ;MAGEF1;ADAMTS7;ABTB1;FBXO44;ANKZF1;UBXN4;TRIB2;PRKACA;USP20;STUB1;FBXW4;CUL9;LONP2;CDC34;RNF123;BCAP31;WFS1;RNF144A;CTSF;USP21;CUL7;PKD1;KCTD13;SIRT2;TOLLIP;HFE;CBLC
4479,GO:0010498,0.955699253506586,0.0632323225601259,34,415,proteasomal protein catabolic process,BP,GID4;NR1D1;EDEM1;BTBD2;FBXO2;MTA1;WWTR1;TMEM129;RBCK1;RNF44;SMURF2;DVL1;FBXW5;RNF187;AKT1;CSNK1E;RAD23A;SHARPIN;ABTB1;FBXO44;ANKZF1;UBXN4;TRIB2;PRKACA;STUB1;FBXW4;CDC34;BCAP31;WFS1;RNF144A;PKD1;KCTD13;SIRT2;HFE
16790,GO:0098632,0.956447849881265,0.188146848791529,1,28,cell-cell adhesion mediator activity,MF,PLXNB3
194,GO:0000413,0.956473764259072,0.187517032268303,1,30,protein peptidyl-prolyl isomerization,BP,FKBP9
1479,GO:0003755,0.956473764259072,0.187517032268303,1,30,peptidyl-prolyl cis-trans isomerase activity,MF,FKBP9
3677,GO:0008180,0.956585461129094,0.187706400167642,1,28,COP9 signalosome,CC,PLCG1
6917,GO:0030515,0.957043577509684,0.185692250907087,1,30,snoRNA binding,MF,TBL3
19756,GO:2000113,0.957167089172807,0.0534172848819808,102,1121,negative regulation of cellular macromolecule biosynthetic process,BP,ZMYND8;EGR1;NR1D1;PDCD4;CTNNBIP1;ACVR2B;VEGFA;HMGA2;ELK3;EGFR;WWTR1;NFATC4;BAHCC1;SHC1;TCFL5;ZFP36L1;MAP2K2;ZC3H6;MDFI;FOXQ1;MAP2K1;MXD4;SMURF2;SMAD3;STAT6;DNAJB5;HBEGF;PRDX5;SALL2;GRB7;HDAC5;PPM1F;SCMH1;IMPACT;WWC3;DAP;FGFR1;MXI1;H2AFJ;CIRBP;TENM2;TSHZ1;CCND1;TCF25;GAS6;TAGLN3;HES2;CTBP1;MNT;CDKN1C;CEBPB;ZNF217;C8ORF88;TGFB1;UNK;DEAF1;NAB2;PEG3;PHF21A;MBD3;VHL;MLXIPL;TFDP2;JAK3;NELFCD;EREG;RPS6KA5;PPP1R13L;ZHX3;HDAC7;CBX7;CHEK2;ZFPM1;PPARA;SESN2;SOX7;ABCA7;SIX5;MEX3A;WFS1;ARID5B;BHLHE40;TSPYL2;SATB1;RERE;BCL7A;CAPRIN2;WDTC1;HES7;DNMT3A;HES6;PROX1;SIRT2;FAM129B;BACH1;MAP3K10;NR2F6;CBX6;ZP3;TNRC18;IRF2BPL;DEDD2
3736,GO:0008276,0.957300683417746,0.10384241425579,4,72,protein methyltransferase activity,MF,ASH2L;PCMTD2;EEF2KMT;EZH1
9,GO:0000018,0.957484000952706,0.114950232913372,3,58,regulation of DNA recombination,BP,STAT6;MAGEF1;TGFB1
1151,GO:0002758,0.957502636539336,0.0721124422467503,14,197,innate immune response-activating signal transduction,BP,TNIP1;NR1D1;PTPRS;PRKACB;CTSB;CARD11;MAPKAPK3;PRKACA;PRKCD;RPS6KA5;IRAK1;FYN;PELI1;PAK1
399,GO:0001076,0.957627132032938,0.0781067514955607,10,146,transcription factor activity, RNA polymerase II transcription factor binding,MF,ZMYND8;CITED4;NR1D1;FOS;CTBP1;KDM6B;SOX12;PPARA;BHLHE40;RERE
12769,GO:0051053,0.957748505888213,0.0859937095783923,7,109,negative regulation of DNA metabolic process,BP,ERCC1;HMGA2;MAGEF1;TGFB1;CHEK2;TSPYL2;FAM129B
5761,GO:0016925,0.957857793194404,0.0952209287302714,5,85,protein sumoylation,BP,EGR1;MTA1;HMG20B;HDAC7;TOLLIP
16830,GO:0098727,0.957993962348958,0.0823010761316893,8,123,maintenance of cell number,BP,WNT7A;LRP5;HMGA2;EPAS1;EPHA1;VANGL2;PROX1;KDM3A
2799,GO:0006260,0.958008509350952,0.0661449835537449,20,259,DNA replication,BP,CST3;EGFR;SHC1;POLD4;FGFR1;TGFB1;POLL;PTMS;AREG;WDR18;PRIMPOL;DTD1;EREG;CHEK2;CDC34;TSPYL2;INSR;ETAA1;REV1;KCTD13
6649,GO:0030004,0.958210828643257,0.101930819202192,4,73,cellular monovalent inorganic cation homeostasis,BP,SLC9A7;MAPK3;ATP6V1F;SLC26A11
8222,GO:0032993,0.958518760370623,0.0784309520416047,9,163,protein-DNA complex,CC,H1F0;HMGA2;FOS;POLD4;H2AFJ;WDR18;HIST3H2BB;SOX12;H1FX
4346,GO:0009913,0.958639271406925,0.0715577542832399,13,189,epidermal cell differentiation,BP,CYP27B1;PRSS8;ZFP36L1;MAP2K1;FGFR1;ERRFI1;SLITRK6;ALOX15B;SHARPIN;LCE1E;EREG;PPL;MAFF
4352,GO:0009948,0.958862330186747,0.180349285511912,1,28,anterior/posterior axis specification,BP,WNT3
14019,GO:0060759,0.958887719270203,0.0781643572262684,9,136,regulation of response to cytokine stimulus,BP,RBCK1;IFNGR2;GAS6;SHARPIN;PTPN1;IRAK1;ECM1;SPPL2B;PELI3
482,GO:0001533,0.959126495863164,0.130184544816741,2,52,cornified envelope,CC,LCE1E;PPL
19715,GO:2000027,0.959475277690655,0.0702810110768107,13,186,regulation of organ morphogenesis,BP,VEGFA;ETV5;SMURF2;DVL1;AP2A2;WNT2B;FGFR1;CEACAM1;TGFB1;BAX;CHAD;VANGL2;CELSR1
7302,GO:0031312,0.959536664790102,0.178144504385512,1,28,extrinsic component of organelle membrane,CC,ULK1
7347,GO:0031396,0.959652815231588,0.0729221573032458,11,162,regulation of protein ubiquitination,BP,FBXO2;MTA1;AKT1;ZER1;STUB1;LIMK1;WFS1;FYN;PELI1;ZYG11B;PDCD6
5396,GO:0016233,0.959969363718804,0.128120101181441,2,51,telomere capping,BP,ERCC1;MAPK3
3925,GO:0008608,0.960020703063274,0.176554416702521,1,28,attachment of spindle microtubules to kinetochore,BP,SIRT2
5720,GO:0016859,0.960574328107072,0.17396185089824,1,31,cis-trans isomerase activity,MF,FKBP9
6803,GO:0030261,0.960959997409832,0.173450600547668,1,28,chromosome condensation,BP,HMGA2
3250,GO:0006914,0.961316682316729,0.0554565631908856,35,426,autophagy,BP,TRIM65;VPS11;TBC1D14;PIK3R2;ITGB4;AKT1;TPCN1;ATG16L2;DAP;PACS2;BNIP3;FYCO1;GPSM1;ULK2;ATG2A;PRKACA;PIM2;BOK;ULK1;BNIP3L;ZDHHC8;LRSAM1;SESN2;RAB12;QSOX1;MAPK3;CAMKK2;VPS16;SIRT2;RGS19;TOLLIP;PLEKHM1;WIPI2;VPS51;SPTLC2
14486,GO:0061919,0.961316682316729,0.0554565631908856,35,426,process utilizing autophagic mechanism,BP,TRIM65;VPS11;TBC1D14;PIK3R2;ITGB4;AKT1;TPCN1;ATG16L2;DAP;PACS2;BNIP3;FYCO1;GPSM1;ULK2;ATG2A;PRKACA;PIM2;BOK;ULK1;BNIP3L;ZDHHC8;LRSAM1;SESN2;RAB12;QSOX1;MAPK3;CAMKK2;VPS16;SIRT2;RGS19;TOLLIP;PLEKHM1;WIPI2;VPS51;SPTLC2
7208,GO:0031109,0.961408331404993,0.0882877850569877,5,86,microtubule polymerization or depolymerization,BP,ARL2;EML2;TUBG2;PAK1;NDE1
10968,GO:0044764,0.96141673506269,0.171661013830602,1,29,multi-organism cellular process,BP,GAS6
2844,GO:0006333,0.961658197811572,0.0732134615850401,9,157,chromatin assembly or disassembly,BP,H1F0;HMGA2;BAHCC1;SMARCD2;CENPH;HIST3H2BB;TSPYL2;H1FX;TNRC18
1858,GO:0004521,0.962102773036615,0.122995318766283,2,47,endoribonuclease activity,MF,LACTB2;RNASET2
6774,GO:0030216,0.962358775900129,0.07017649987022,10,156,keratinocyte differentiation,BP,CYP27B1;PRSS8;ZFP36L1;MAP2K1;ERRFI1;ALOX15B;SHARPIN;LCE1E;EREG;PPL
2947,GO:0006479,0.962607850272752,0.0698469502845025,10,149,protein methylation,BP,ASH2L;RAB3B;MTHFR;PCMTD2;EEF2KMT;ETFB;SATB1;EZH1;BTG1;KDM3A
3701,GO:0008213,0.962607850272752,0.0698469502845025,10,149,protein alkylation,BP,ASH2L;RAB3B;MTHFR;PCMTD2;EEF2KMT;ETFB;SATB1;EZH1;BTG1;KDM3A
13009,GO:0051453,0.96265167775958,0.103104956560433,3,61,regulation of intracellular pH,BP,SLC9A7;ATP6V1F;SLC26A11
5669,GO:0016779,0.962654868548081,0.0741310236337715,8,128,nucleotidyltransferase activity,MF,POLD4;POLL;POLM;PRIMPOL;REV1;NMNAT2;TEP1;TERC
5562,GO:0016574,0.96292183088204,0.121070544748032,2,45,histone ubiquitination,BP,DDB2;RAG1
12640,GO:0050853,0.963061978638253,0.166147817538234,1,29,B cell receptor signaling pathway,BP,BAX
5474,GO:0016407,0.9631903913782,0.0847199918116275,5,88,acetyltransferase activity,MF,NAGS;LPCAT4;CRAT;NAT14;LPCAT1
3359,GO:0007099,0.963219900549571,0.165614501951535,1,29,centriole replication,BP,CEP72
10535,GO:0043489,0.96330060621685,0.165341668544621,1,29,RNA stabilization,BP,CIRBP
86,GO:0000175,0.963587592356206,0.164122497325126,1,30,3'-5'-exoribonuclease activity,MF,PAN2
13001,GO:0051443,0.963672478844672,0.163834814962391,1,30,positive regulation of ubiquitin-protein transferase activity,BP,STUB1
17906,GO:1902186,0.963730374555195,0.163885543838632,1,29,regulation of viral release from host cell,BP,PC
285,GO:0000790,0.963817792652593,0.0565237406439328,22,303,nuclear chromatin,CC,MEF2D;H1F0;NR1D1;APPL2;TRNP1;SMARCA1;SMAD3;STAT6;SALL2;ASH2L;H2AFJ;ZNF385A;SMARCD2;CEBPB;NSMF;MBD3;KDM6B;CBX7;SATB1;INO80C;DNMT3A;SIRT2
17840,GO:1901990,0.963968172972043,0.0538720410938927,28,358,regulation of mitotic cell cycle phase transition,BP,FHL1;XPC;HMGA2;EGFR;ZFP36L1;GJC2;AKT1;BRSK1;ZNF385A;CCND1;PCBP4;CEP250;CSNK1E;PKD2;TGFB1;CEP131;PRKACA;SDCCAG8;NINL;TFDP2;RBL2;BAX;CHEK2;CEP72;HYAL1;PKD1;SIRT2;NDE1
9038,GO:0035258,0.963993044316931,0.089860096543854,4,74,steroid hormone receptor binding,MF,PKN1;SMAD3;CEBPB;KDM3A
870,GO:0002218,0.964076546442019,0.0609432490664615,15,212,activation of innate immune response,BP,TNIP1;NR1D1;PTPRS;PRKACB;CTSB;CARD11;MAPKAPK3;TMEM173;PRKACA;PRKCD;RPS6KA5;IRAK1;FYN;PELI1;PAK1
13751,GO:0060338,0.964135417919874,0.162508137284576,1,29,regulation of type I interferon-mediated signaling pathway,BP,PTPN1
3668,GO:0008170,0.964369481297959,0.0890650745490596,4,74,N-methyltransferase activity,MF,ASH2L;RRNAD1;EEF2KMT;EZH1
36,GO:0000075,0.964891859275209,0.0597125184203842,15,208,cell cycle checkpoint,BP,XPC;HMGA2;NDRG1;BRSK1;ZNF385A;CCND1;PCBP4;TGFB1;TFDP2;RBL2;BAX;CHEK2;ETAA1;BCL2L1;PROX1
3711,GO:0008234,0.965074552860922,0.0657126525815864,10,150,cysteine-type peptidase activity,MF,CTSO;CAPN2;CTSB;CTSZ;JOSD2;ANKZF1;USP20;CTSF;USP21;PDCD6
8850,GO:0034655,0.965091171304942,0.0490933805531517,41,522,nucleobase-containing compound catabolic process,BP,NT5E;XDH;H1F0;PGM1;DNPH1;GTPBP1;RAPGEF3;ZFP36L1;ENDOG;AKT1;ENTPD6;HK1;PFKL;CIRBP;PCBP4;PFKP;DHTKD1;ENTPD2;PNRC1;RNH1;PFKFB2;MLXIPL;ADA;AHCY;PRKCD;BAX;DDIT4;ALDOC;PPARA;UPP1;NEIL1;APOBEC3C;APOBEC3F;INSR;PAN2;PFKM;RNASET2;PFKFB3;DNASE1L1;NT5C1B;DEDD2
6881,GO:0030397,0.965288048556034,0.114727811170947,2,46,membrane disassembly,BP,NEK9;LMNA
12778,GO:0051081,0.965288048556034,0.114727811170947,2,46,nuclear envelope disassembly,BP,NEK9;LMNA
2861,GO:0006356,0.965550327917567,0.157414913096787,1,30,regulation of transcription by RNA polymerase I,BP,ERBB2
18134,GO:1902808,0.96557094089314,0.157343838141968,1,30,positive regulation of cell cycle G1/S phase transition,BP,HYAL1
15233,GO:0071396,0.96598079851646,0.0501825631204387,31,384,cellular response to lipid,BP,TNIP1;NR1D1;CYP27B1;PDCD4;FAM210B;EGFR;NFATC4;ZFP36L1;AKT1;HDAC5;LDLR;TWF2;PTK6;BCR;ERRFI1;PAQR6;CEBPB;ADAMTS13;WNT3;TGFB1;PCK2;DDIT4;IRAK1;PPARA;MIF;MAPK3;ADCY1;PAK1;NR2F6;KDM3A;ADCY6
9054,GO:0035282,0.966016489078117,0.0954034508038024,3,60,segmentation,BP,SMAD3;SEMA3F;HES7
6277,GO:0019884,0.966234198266879,0.065536564921448,9,145,antigen processing and presentation of exogenous antigen,BP,KLC2;AP2A2;AP3D1;ITGB5;ACTR1B;DNM2;KIF26A;HLA-G;CTSF
19767,GO:2000142,0.966254326138964,0.154979857516559,1,30,regulation of DNA-templated transcription, initiation,BP,CTNNBIP1
11006,GO:0044843,0.966301228093462,0.0559123471564314,17,234,cell cycle G1/S phase transition,BP,FHL1;EGFR;GJC2;AKT1;ZNF385A;CCND1;PCBP4;PKD2;PIM2;TFDP2;RBL2;BAX;CHEK2;CDC34;HYAL1;PKD1;BACH1
3045,GO:0006606,0.966461564822434,0.0701821433082569,7,114,protein import into nucleus,BP,AKT1;GAS6;TGFB1;TMEM173;PRKCD;TMCO6;RERE
15910,GO:0072686,0.967138789407048,0.0768545101327393,5,88,mitotic spindle,CC,MAPKBP1;PKD2;EML2;CAPG;SIRT2
16752,GO:0098534,0.967207400611571,0.151657833328594,1,30,centriole assembly,BP,CEP72
797,GO:0002067,0.967611450730328,0.150240458349182,1,30,glandular epithelial cell differentiation,BP,PROX1
10562,GO:0043531,0.967625967626336,0.150189432823836,1,30,ADP binding,MF,ABCG1
8280,GO:0033108,0.967842802500513,0.081160100037144,4,89,mitochondrial respiratory chain complex assembly,BP,COA5;OXA1L;TAZ;NDUFV3
10573,GO:0043543,0.968893680655678,0.0543546699555238,14,199,protein acylation,BP,NOS1;RAPGEF3;CTBP1;TGFB1;ABHD17C;MDH2;MBD3;ZDHHC24;RPS6KA5;ZDHHC8;JADE2;ZDHHC1;MAPK3;CAMK1
4449,GO:0010389,0.968975616314068,0.0562861662780881,12,181,regulation of G2/M transition of mitotic cell cycle,BP,FHL1;HMGA2;BRSK1;CCND1;CEP250;CSNK1E;CEP131;PRKACA;SDCCAG8;NINL;CEP72;NDE1
2497,GO:0005747,0.969249349338714,0.142541959421937,1,42,mitochondrial respiratory chain complex I,CC,NDUFV3
7128,GO:0030964,0.969249349338714,0.142541959421937,1,42,NADH dehydrogenase complex,CC,NDUFV3
11172,GO:0045271,0.969249349338714,0.142541959421937,1,42,respiratory chain complex I,CC,NDUFV3
2607,GO:0005913,0.969352564059847,0.0783099911438764,4,76,cell-cell adherens junction,CC,ITGA6;NDRG1;CADM4;CDH4
4265,GO:0009615,0.969441704826008,0.0518196524304602,16,225,response to virus,BP,HTRA1;HMGA2;MST1R;ACTA2;ADARB1;IFNGR2;BNIP3;TMEM173;IFNE;PIM2;BNIP3L;DDIT4;APOBEC3C;APOBEC3F;HYAL1;BCL2L1
1001,GO:0002474,0.969743185001345,0.077228273766111,4,83,antigen processing and presentation of peptide antigen via MHC class I,BP,ITGB5;BCAP31;HLA-G;HFE
4600,GO:0010717,0.969836066989677,0.0862827237803214,3,62,regulation of epithelial to mesenchymal transition,BP,WWTR1;SMAD3;TGFB1
4505,GO:0010557,0.969845838186908,0.0377042326405306,115,1248,positive regulation of macromolecule biosynthetic process,BP,TNIP1;MEF2D;CITED4;EGR1;NR1D1;CST3;APLN;VEGFA;WNT7A;F2R;LRP5;ITGA6;HMGA2;ELK3;EGFR;WWTR1;NOS1;NFATC4;ETV5;SHC1;HEXB;ETV4;MAP2K2;SMARCA1;MAP2K1;POU2F2;FOS;SMAD3;STAT6;PIK3R2;ERCC6;DVL1;EPAS1;SALL2;ZXDC;RNF187;AKT1;HDAC5;ASH2L;IMPACT;FGFR4;FGFR1;SEC14L2;HLTF;KLF7;NAT14;CIRBP;CARD11;PKD2;CRTC1;CDKN1C;ZMIZ2;CD81;CEBPB;TGFB1;RFX2;DEAF1;TMEM173;PEG3;MC1R;ABHD14B;AGRN;VHL;MLXIPL;KDM6B;ZNF516;AREG;PIM2;ERBB2;TFDP2;PBX2;EREG;RPS6KA5;SOX12;MBTPS2;CARF;IER2;IRAK1;FHOD1;CHEK2;ZFPM1;PPARA;SESN2;SOX7;SIX5;SSBP4;DNM2;MAPK3;INSR;CAMTA2;PFKM;RERE;CAMKK2;PPP3CB;USP21;CAPRIN2;PPP2R5B;MAP2K3;PROX1;PKD1;KCTD13;SIRT2;FAM129B;BACH1;E2F5;MAPRE3;NGFR;MAFF;CAMK1;EZH1;ZP3;TCEA2;PLAG1;IRF2BPL;KDM3A
7349,GO:0031398,0.970012779399369,0.0709483774595588,5,91,positive regulation of protein ubiquitination,BP,MTA1;STUB1;WFS1;PELI1;PDCD6
12784,GO:0051087,0.97026515432262,0.0762184014933443,4,79,chaperone binding,MF,PRNP;DNAJB5;BAX;BIN1
12898,GO:0051253,0.970502480757464,0.0379256915937812,88,995,negative regulation of RNA metabolic process,BP,ZMYND8;EGR1;NR1D1;PDCD4;CTNNBIP1;ACVR2B;VEGFA;HMGA2;ELK3;MTA1;WWTR1;NFATC4;BAHCC1;SHC1;TCFL5;ZC3H6;MDFI;FOXQ1;MXD4;SMURF2;SMAD3;STAT6;DNAJB5;PRDX5;SALL2;HDAC5;PPM1F;SCMH1;IMPACT;WWC3;DAP;FGFR1;MXI1;H2AFJ;CIRBP;TENM2;TSHZ1;CCND1;TCF25;GAS6;TAGLN3;HES2;CTBP1;MNT;CDKN1C;CEBPB;ZNF217;TGFB1;DEAF1;NAB2;PEG3;PHF21A;MBD3;VHL;MLXIPL;TFDP2;NELFCD;EREG;RPS6KA5;PPP1R13L;ZHX3;HDAC7;CBX7;ZFPM1;PPARA;SOX7;SIX5;WFS1;ARID5B;BHLHE40;SATB1;RERE;BCL7A;WDTC1;HES7;DNMT3A;HES6;PROX1;SIRT2;FAM129B;BACH1;MAP3K10;NR2F6;CBX6;ZP3;TNRC18;IRF2BPL;DEDD2
14743,GO:0070423,0.970608099379511,0.139340434431163,1,31,nucleotide-binding oligomerization domain containing signaling pathway,BP,IRAK1
3232,GO:0006890,0.970822008352084,0.0750686732048249,4,77,retrograde vesicle-mediated transport, Golgi to ER,BP,KLC2;SCYL1;COG7;KIF26A
13208,GO:0051879,0.97093776433375,0.138145925346495,1,31,Hsp90 protein binding,MF,STUB1
10733,GO:0044106,0.970970558312199,0.074551468875822,4,83,cellular amine metabolic process,BP,SMOX;CHKA;ALDH7A1;AZIN2
4228,GO:0009408,0.971090555425109,0.0571356415121593,9,140,response to heat,BP,NOS1;AKT1;PRKACA;STUB1;IRAK1;IGFBP7;MAPK3;PDCD6;LRP11
5749,GO:0016896,0.971173888537003,0.13709094900383,1,32,exoribonuclease activity, producing 5'-phosphomonoesters,MF,PAN2
12933,GO:0051301,0.971198503959973,0.0408430332522138,42,509,cell division,BP,CCNG2;PGF;VEGFA;WNT7A;HMGA2;NEK9;WWTR1;ETV5;SNX9;MARK4;REEP4;VEGFB;FGFR1;LZTS2;RAB11FIP4;ANK3;CCND1;MPLKIP;SEPT10;CDC25B;PAK6;TGFB1;RHOD;SNX33;RHOF;RHOBTB2;SAC3D1;EREG;RGS14;GIT1;TGFA;CHEK2;CAT;VANGL2;PAK1;CUL7;BCL2L1;SIRT2;MAPRE3;NDE1;TACC1;SEPT6
8595,GO:0034113,0.971234893148474,0.137065826520967,1,31,heterotypic cell-cell adhesion,BP,ITGA4
8304,GO:0033146,0.971455212279705,0.136262787478323,1,31,regulation of intracellular estrogen receptor signaling pathway,BP,PAK1
11005,GO:0044839,0.971686981559308,0.0476497371620055,17,240,cell cycle G2/M phase transition,BP,FHL1;HMGA2;BRSK1;CCND1;CEP250;CSNK1E;PHLDA1;CDC25B;CEP131;PRKACA;SDCCAG8;NINL;CHEK2;DNM2;CEP72;BACH1;NDE1
6996,GO:0030686,0.971953301838213,0.13424579546344,1,32,90S preribosome,CC,TBL3
582,GO:0001736,0.972247006581221,0.0622971354841409,6,109,establishment of planar polarity,BP,SMURF2;DVL1;AP2A2;VANGL2;DLG3;CELSR1
3383,GO:0007164,0.972247006581221,0.0622971354841409,6,109,establishment of tissue polarity,BP,SMURF2;DVL1;AP2A2;VANGL2;DLG3;CELSR1
3896,GO:0008536,0.972285786029207,0.133024987408922,1,32,Ran GTPase binding,MF,XPOT
5528,GO:0016504,0.972409804190084,0.132387326965022,1,33,peptidase activator activity,MF,FBLN1
7437,GO:0031577,0.97263649872101,0.131732553416562,1,32,spindle checkpoint,BP,NDRG1
1463,GO:0003712,0.973154867949206,0.0390057610712237,37,457,transcription cofactor activity,MF,ZMYND8;CITED4;NR1D1;ELK3;PKN1;MTA1;WWTR1;NFATC4;MXD4;NFKBIZ;MXI1;KLF7;CCND1;AIP;SMARCD2;CTBP1;MNT;ZMIZ2;NAB2;PHF21A;GRHPR;TFDP2;SOX12;PPP1R13L;ZHX3;HDAC7;PPARA;ARID5B;BHLHE40;RERE;CDYL2;USP21;HES6;PROX1;FAM129B;MAP3K10;BTG1
5782,GO:0017004,0.973680562937648,0.127511494250262,1,34,cytochrome complex assembly,BP,COA5
7873,GO:0032446,0.973702887851021,0.0350218961485689,68,791,protein modification by small protein conjugation,BP,GID4;EGR1;FBXO2;MTA1;ARRDC1;WWTR1;TMEM129;KLHL29;DDB2;MARCH9;RBCK1;RNF44;SMURF2;EPAS1;FBXW5;RNF187;AKT1;FBXO41;MARCH4;HLTF;RAG1;ASB13;HMG20B;PEX10;SHARPIN;FBXW8;ZNF598;MAGEF1;FBXL8;RNF135;FBXO17;FBXO44;ZER1;VHL;NEURL1B;THOP1;MIB2;STUB1;TRIM4;FBXW4;CUL9;LIMK1;LRSAM1;ASB1;HDAC7;JADE2;CDC34;RNF123;WFS1;DTX3;FYN;PELI1;DCAF10;KLHL36;RNF144A;CUL7;WDTC1;ZYG11B;KCTD13;UVSSA;BACH1;SOCS7;PELI3;RAB40B;TOLLIP;PDCD6;CBLC;KLHL24
9356,GO:0035872,0.973780148086427,0.127483748986354,1,32,nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway,BP,IRAK1
77,GO:0000154,0.973806311035043,0.127042284494512,1,34,rRNA modification,BP,RRNAD1
2898,GO:0006409,0.973895690341708,0.127051516625102,1,32,tRNA export from nucleus,BP,XPOT
15255,GO:0071431,0.973895690341708,0.127051516625102,1,32,tRNA-containing ribonucleoprotein complex export from nucleus,BP,XPOT
7179,GO:0031072,0.973944420499333,0.0590407279416477,6,104,heat shock protein binding,MF,TOMM34;MVD;STUB1;BAX;LIMK1;IRAK1
11087,GO:0045104,0.974005354439149,0.12664075929765,1,32,intermediate filament cytoskeleton organization,BP,KLHL24
7626,GO:0032040,0.974047041705636,0.126307967446636,1,33,small-subunit processome,CC,TBL3
8577,GO:0034080,0.974075789424419,0.125219768084761,1,40,CENP-A containing nucleosome assembly,BP,CENPH
14386,GO:0061641,0.974075789424419,0.125219768084761,1,40,CENP-A containing chromatin organization,BP,CENPH
12768,GO:0051052,0.974118679403554,0.0404592044726691,25,324,regulation of DNA metabolic process,BP,ERCC1;CST3;HMGA2;EGFR;SHC1;ENDOG;STAT6;AKT1;FGFR4;FGFR1;MAGEF1;TGFB1;MBD3;AREG;WDR18;PRKCD;BAX;EREG;CHEK2;TMEM161A;TSPYL2;MAPK3;INSR;KCTD13;FAM129B
17985,GO:1902373,0.974174653615192,0.12600564391197,1,32,negative regulation of mRNA catabolic process,BP,CIRBP
11104,GO:0045132,0.974249075855932,0.0898506868073154,2,49,meiotic chromosome segregation,BP,LEMD2;SUN1
18119,GO:1902749,0.974379271719082,0.0463655052515475,13,196,regulation of cell cycle G2/M phase transition,BP,FHL1;HMGA2;BRSK1;CCND1;CEP250;CSNK1E;CDC25B;CEP131;PRKACA;SDCCAG8;NINL;CEP72;NDE1
20125,GO:2000779,0.974551534819813,0.0889889537172158,2,49,regulation of double-strand break repair,BP,HMGA2;MAGEF1
7710,GO:0032206,0.974845509267246,0.0881491776307353,2,49,positive regulation of telomere maintenance,BP,ERCC1;MAPK3
9679,GO:0038061,0.975122587642603,0.0565789225781726,6,111,NIK/NF-kappaB signaling,BP,PDCD4;EGFR;AKT1;TNFSF15;IRAK1;HDAC7
2453,GO:0005667,0.975262868931447,0.0410669426062684,19,261,transcription factor complex,CC,ERCC1;NR1D1;WWTR1;NFATC4;FOS;SMAD3;EPAS1;MXI1;CTBP1;CEBPB;DEAF1;MLXIPL;TFDP2;PBX2;RBL2;ZFPM1;PPARA;HES6;E2F5
9915,GO:0042267,0.975519273608558,0.120584138772618,1,34,natural killer cell mediated cytotoxicity,BP,CEACAM1
17951,GO:1902275,0.976127008868038,0.0481401544714012,9,142,regulation of chromatin organization,BP,VEGFA;NOS1;CTBP1;TGFB1;C6ORF89;RPS6KA5;MTHFR;MAPK3;KDM3A
6351,GO:0021536,0.976225306067243,0.118044458550212,1,33,diencephalon development,BP,BAX
5280,GO:0015932,0.976230737548152,0.118023590241732,1,33,nucleobase-containing compound transmembrane transporter activity,MF,SLC29A4
9825,GO:0042054,0.976255427190727,0.0840187312766159,2,50,histone methyltransferase activity,MF,ASH2L;EZH1
6777,GO:0030219,0.976263813685015,0.0700037275905809,3,78,megakaryocyte differentiation,BP,ASH2L;ZNF385A;ZFPM1
2812,GO:0006278,0.976272320519673,0.0703922482052818,3,66,RNA-dependent DNA biosynthetic process,BP,MAPK3;TEP1;TERC
5477,GO:0016410,0.976427642145815,0.0624734169480421,4,80,N-acyltransferase activity,MF,NAGS;NAT14;ALAS1;CERS4
11081,GO:0045089,0.976534256922156,0.040093644267672,17,244,positive regulation of innate immune response,BP,TNIP1;NR1D1;PTPRS;PRKACB;CTSB;CARD11;MAPKAPK3;ADAM8;TMEM173;PRKACA;PRKCD;EREG;RPS6KA5;IRAK1;FYN;PELI1;PAK1
12753,GO:0051031,0.976774240625764,0.115928511249197,1,33,tRNA transport,BP,XPOT
1868,GO:0004532,0.976870337117119,0.11539909348685,1,34,exoribonuclease activity,MF,PAN2
11086,GO:0045103,0.976871820327153,0.115550906801339,1,33,intermediate filament-based process,BP,KLHL24
7715,GO:0032212,0.976892090460094,0.115472411217968,1,33,positive regulation of telomere maintenance via telomerase,BP,MAPK3
17837,GO:1901987,0.976943570871583,0.0352845298912131,29,380,regulation of cell cycle phase transition,BP,FHL1;XPC;HMGA2;EGFR;ZFP36L1;GJC2;AKT1;BRSK1;ZNF385A;CCND1;PCBP4;CEP250;CSNK1E;CDC25B;PKD2;TGFB1;CEP131;PRKACA;SDCCAG8;NINL;TFDP2;RBL2;BAX;CHEK2;CEP72;HYAL1;PKD1;SIRT2;NDE1
2266,GO:0005198,0.976998742114926,0.0335254406169345,38,512,structural molecule activity,MF,MARVELD1;APOE;OBSCN;OBSL1;SLC9A3R2;FBLN1;SHANK2;WWC3;NPHP4;ANK3;MRPS6;SEPT10;SPTB;SNTA1;TFPI2;GRIP2;CLTCL1;SNTB2;SHANK3;LCE1E;CROCC;LAMB2;LLGL1;TUBG2;AGRN;SMTN;PPL;TPM2;RPL39L;RGS14;EFEMP2;TUBB6;MALL;LMNA;LAMB1;SEPT6;HOMER2;DEDD2
2865,GO:0006361,0.977009131579982,0.114713835638044,1,35,transcription initiation from RNA polymerase I promoter,BP,MAPK3
6018,GO:0019076,0.97710208773917,0.114658059035299,1,33,viral release from host cell,BP,PC
9366,GO:0035890,0.97710208773917,0.114658059035299,1,33,exit from host,BP,PC
9367,GO:0035891,0.97710208773917,0.114658059035299,1,33,exit from host cell,BP,PC
13300,GO:0052126,0.97710208773917,0.114658059035299,1,33,movement in host environment,BP,PC
13309,GO:0052192,0.97710208773917,0.114658059035299,1,33,movement in environment of other organism involved in symbiotic interaction,BP,PC
13274,GO:0051973,0.977245076068993,0.114102362331203,1,33,positive regulation of telomerase activity,BP,MAPK3
10750,GO:0044183,0.97742806353173,0.113233954646875,1,34,protein binding involved in protein folding,MF,FYCO1
2455,GO:0005669,0.977747029613231,0.111843330627614,1,35,transcription factor TFIID complex,CC,ERCC1
13590,GO:0060071,0.977853627746152,0.0544090447549475,5,99,Wnt signaling pathway, planar cell polarity pathway,BP,SMURF2;DVL1;AP2A2;VANGL2;CELSR1
1592,GO:0004003,0.978074114343445,0.110860962334965,1,33,ATP-dependent DNA helicase activity,MF,CHD2
2735,GO:0006120,0.978207370069064,0.108959083638677,1,45,mitochondrial electron transport, NADH to ubiquinone,BP,NDUFV3
688,GO:0001909,0.978252536147757,0.077991062130899,2,53,leukocyte mediated cytotoxicity,BP,CEACAM1;PPP3CB
3362,GO:0007127,0.978391534683492,0.0650150404196386,3,67,meiosis I,BP,CDC25B;LEMD2;SUN1
12935,GO:0051303,0.978670093846937,0.0643439724153163,3,66,establishment of chromosome localization,BP,LEMD2;SUN1;NDE1
7831,GO:0032392,0.97889399686596,0.0567919296432396,4,81,DNA geometric change,BP,XPC;DDB2;SMARCA1;CHD2
7167,GO:0031055,0.978979182217353,0.106192153989274,1,42,chromatin remodeling at centromere,BP,CENPH
731,GO:0001961,0.979002266504698,0.107040623887313,1,34,positive regulation of cytokine-mediated signaling pathway,BP,GAS6
19732,GO:2000059,0.979073722010239,0.10648145708582,1,36,negative regulation of ubiquitin-dependent protein catabolic process,BP,HFE
16317,GO:0090503,0.979101665381617,0.106503826621313,1,35,RNA phosphodiester bond hydrolysis, exonucleolytic,BP,PAN2
7171,GO:0031060,0.979292170192544,0.0750306358787177,2,51,regulation of histone methylation,BP,MTHFR;KDM3A
222,GO:0000462,0.979361556886117,0.105210918611632,1,37,maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,TBL3
263,GO:0000731,0.979582481059961,0.0619374227741694,3,68,DNA synthesis involved in DNA repair,BP,POLD4;PRIMPOL;REV1
282,GO:0000785,0.979657438441542,0.0304514300494778,34,456,chromatin,CC,MEF2D;H1F0;NR1D1;HMGA2;CAPN2;BAHCC1;APPL2;TRNP1;SMARCA1;SMAD3;STAT6;SALL2;PHC2;ASH2L;H2AFJ;ZNF385A;HLCS;SMARCD2;CEBPB;NSMF;MBD3;KDM6B;RBL2;HIST3H2BB;LEMD2;CBX7;SATB1;H1FX;INO80C;DNMT3A;SIRT2;CBX6;TNRC18;KDM3A
7366,GO:0031424,0.979859627822744,0.0543481782871277,4,90,keratinization,BP,PRSS8;SHARPIN;LCE1E;PPL
11318,GO:0045652,0.979872126776463,0.0726271471612422,2,65,regulation of megakaryocyte differentiation,BP,ASH2L;ZFPM1
5282,GO:0015935,0.979886313234694,0.0724786696405456,2,68,small ribosomal subunit,CC,MRPS6;MRPS26
2431,GO:0005622,0.979975419750815,0.0245317745002035,1092,10573,intracellular,CC,TNIP1;DUSP6;NT5E;XDH;ERCC1;DUSP5;MEF2D;ZMYND8;ADGRL1;H1F0;CITED4;HTRA1;FHL1;EGR1;B4GALNT4;NR1D1;SLC16A3;H6PD;CCNG2;EDEM1;DLG4;PLAT;CST3;CYP27B1;TYSND1;HS1BP3;BTBD2;MARVELD1;EPN3;FBXO2;APLN;PRR7;PDCD4;CTNNBIP1;NAGS;ACVR2B;DOCK4;XPC;PRNP;PARVB;PYGB;BBS2;FLNC;DDIT4L;POSTN;VEGFA;FAM210B;PGM1;WNT7A;APOE;PYGL;DGKA;TSPAN1;ESPN;NAGLU;F2R;LRP5;PLD3;OSBPL5;LPCAT4;ISYNA1;PITPNC1;HMGA2;OBSCN;NDRG1;IDH2;ZKSCAN1;NEK9;CRAT;ELK3;ITPR3;PKN1;MTA1;GRAMD4;ACOT7;ARRDC1;ANGEL1;ACSF2;EVI5L;NISCH;AKR7A2;EGFR;RPS6KA2;SERPINE2;DNPH1;WWTR1;LOXL1;OBSL1;NOS1;VAT1;PTPRS;TMEM129;SLC2A9;ANKS6;HADH;CTSO;SPRY2;CAPN2;MST1R;NFATC4;TRIM65;BAHCC1;CRTAP;SYTL1;SDC1;KLHL29;ETV5;LMF1;APPL2;SHC1;DDB2;LTBP2;VPS11;LTBP1;TBC1D14;ARL2;HEXB;GTPBP1;SLC7A8;TCFL5;PTPRE;NPEPL1;SLC2A3;ALDH4A1;TK2;RIN1;ACTA2;CLIP2;ETV4;PHLDA2;SNX9;NUDCD3;TRNP1;SPRY4;RAPGEF3;TXNRD3;ST6GALNAC2;ZFP36L1;GAA;GLUL;RNPEPL1;ARAP1;MAP2K2;KDSR;NME4;ZC3H6;MARCH9;CTBS;PLCD3;FKBP9;MDFI;PTOV1;SMARCA1;RBCK1;SUGCT;PGLS;PC;FOXQ1;RNF44;MAP2K1;NAPRT;CRYL1;ACP5;CPT2;VWA5A;MCTP1;MXD4;SSH1;POU2F2;EXOC2;ENDOG;MARK4;MARCKSL1;MPRIP;TMEM8A;GALE;SMURF2;KLC2;TSC22D1;ARMCX2;OXLD1;SLC9A3R2;FOS;SMAD3;ARHGAP23;STAT6;SHANK2;PIK3R2;ERCC6;LRP1;SRD5A3;DVL1;EPAS1;DNAJB5;PIGQ;HSD17B8;THBS3;HBEGF;FAM110C;RPUSD3;AP2A2;S100A4;CYBRD1;PPP1R14A;SH3PXD2B;PPP2R3B;PRDX5;SHC2;STOM;BRD3;PRODH;SALL2;MBOAT7;CDK18;REEP4;LY6K;FBXW5;PAG1;ZXDC;RNF187;NMRK1;ADORA2B;ADARB1;PLCXD2;D2HGDH;SYT8;AKT1;TPCN1;GRB7;TMOD2;CORO1B;HDAC5;UROS;FBXO41;FAM83A;S100A6;F12;SH2D2A;PPM1F;MMP28;PITPNM1;ENTPD6;PLEKHH3;RHBDF2;PYCR2;BSG;STK39;HK1;SERPING1;ASAP2;SCMH1;DYSF;EPHA1;PHC2;NFKBIZ;VEGFB;FMNL2;ASH2L;IMPACT;MARCH4;SLC15A4;WWC3;ATG16L2;ZFYVE21;LRRC8A;IFNGR2;BRSK1;IFT140;PTHLH;MYZAP;RAB31;DNAAF5;FGFR4;HEBP1;WNT2B;POLD4;ACOT1;FNDC4;LDLR;FGFR1;PRKACB;FUCA1;MAPKBP1;ELMO3;SIGMAR1;RAC2;KCNAB2;PFKL;SEC14L2;OPLAH;HLTF;MXI1;NPHP4;SYNE3;RAG1;GAMT;H2AFJ;B4GAT1;PACS2;PHF7;TOMM34;BPHL;PIGV;KLF7;RALGDS;SORL1;NAT14;CEACAM1;B3GAT3;ASB13;CIRBP;CBR4;HMG20B;LZTS2;RAB11FIP4;TENM2;ZNF385A;DOCK6;NSMCE4A;MICALCL;ABCD1;ANK3;NIPSNAP1;IGFBP4;TTC7B;EVC;TSHZ1;TRAPPC9;CCND1;PODNL1;EFS;PCBP4;TCF25;LHPP;TNNT1;TWF2;STRADB;SYNGAP1;PLCH2;MAPK13;CEP250;CARD19;PLAU;GAS6;PTK6;PFKP;CSNK1E;R3HDM4;BRI3;CTSB;RAB3B;CARD11;SH2B3;SOX13;LAMA5;DUSP7;MPLKIP;GSN;PLEKHG2;MAPKAPK3;IGFBP2;PCSK9;ARHGAP22;RAD23A;DHTKD1;PHLDA1;ANO8;BCR;ANTXR2;XPOT;MRPS6;EHD4;ERRFI1;GLI4;SEPT10;WIPF1;NADK;PANK4;HLCS;ZSCAN18;AIP;DBNDD1;STON1;MYEF2;SH3D19;CCDC113;CDC25B;RGL2;SH3GLB2;ARHGAP27;ALOX15B;SPTB;SMARCD2;AGAP1;COMTD1;RSPH3;PEX10;CCS;RSAD1;COL13A1;CORO7;NPR2;UNC119B;SNTA1;DGKQ;HAGH;BNIP3;PAK6;NOL4L;GTF2IRD1;SHARPIN;MVB12B;TAGLN3;FYCO1;CEMIP;PROCR;PKD2;ACY1;PCSK1;RETSAT;YPEL3;RASGEF1A;CTSZ;CDC42EP5;HES2;CRTC1;FBXW8;GPSM1;AP3D1;ITGB5;ABCA2;PRSS3;SH3PXD2A;C19ORF33;EPHB2;ADAM8;ASIC1;APRT;TMEM9;CTBP1;JOSD2;LTA4H;MNT;PTPDC1;GRIP2;CDKN1C;PLCG1;FBXL8;ZMIZ2;CBS;KIF17;NYAP1;CEBPB;MVD;RNF135;ENTPD2;LGALS9B;ADAMTS13;ZNF217;TIMP2;ZNF862;NUDCD2;SYNJ2;WNT3;DPP7;GNAL;C8ORF88;TMED4;TGFB1;LACTB2;SNPH;CLTCL1;RFX2;SCYL1;ABHD17C;UNK;SNTB2;ULK2;GPC1;MKNK2;ADAMTS7;DEAF1;MOAP1;TBC1D9B;SLC38A10;NTSR1;B3GNT3;NAB2;TMEM173;ARHGAP25;TMEM134;ZSCAN30;ATP7B;FHOD3;SHANK3;PODXL2;SDHA;MSRB2;RASA3;PNRC1;MIPEP;PIP5KL1;TNFSF15;MYCBPAP;MGAT4B;EML2;KIF26B;MDH2;MPG;GALNS;FBXO17;CLCA2;HEXDC;GOLGA2P5;ENKD1;NSMF;PEG3;ARAP3;SCART1;FARP1;MC1R;TUB;DIRC2;LCE1E;CROCC;RHOD;ABHD14B;LAMB2;TNS1;ABTB1;SNX17;RNH1;DNAH1;ERO1B;ST6GALNAC6;VGF;POLL;FBXO44;POLM;SNX33;PI4K2A;SEMA4F;C1ORF210;PTMS;RHOF;YIPF3;ANKZF1;WASF3;ATG2A;SLC48A1;LLGL1;PHGDH;ARL10;PHF21A;MIF4GD;KIF7;COA5;RHOBTB2;UBXN4;ADAM19;KHDRBS3;SAC3D1;TUBG2;ZER1;RIMS3;BBS1;TNFAIP8L1;HMGCL;PTPN1;PEX1;TPP1;PCK2;B4GALT2;WDR59;AGRN;MBD3;CD320;CAMK2N1;OSBPL10;ESYT2;ZDHHC24;ACP6;B4GALT6;VHL;MYH16;CEP131;TRAP1;IDUA;ADAP1;PFKFB2;RFNG;MLXIPL;YPEL5;TRIB2;PRKCZ;KDM6B;PRKACA;MINK1;ZNF516;CENPH;GRHPR;OXA1L;RHPN1;RABGGTA;RCCD1;ACTR1B;TOM1L2;CD9;EPN2;ADA;AREG;PIM2;MPI;MICALL2;UCKL1;LGALS9C;PLEKHG5;BOK;WDR18;TDRKH;CAPG;SDCCAG8;ALAS1;NEURL1B;ERBB2;ADGRB2;ULK1;CNDP2;NINL;AHCY;VAMP2;CERCAM;PRIMPOL;TMEM143;TFDP2;SMTN;PLEK2;C6ORF89;MZT2A;NECAB3;STK17A;RILPL1;FAM50A;JAK3;IRF2BP2;RNPEP;NET1;BNIP3L;CYFIP2;FSCN1;PBX2;NELFCD;SLC22A17;RASA4;GLCCI1;PDK1;ACAD10;CYGB;ARHGAP44;THOP1;EHBP1L1;MCFD2;PRKCD;FAM20C;MIB2;REEP6;RBL2;CACNB3;USP20;STUB1;IFI6;BAX;CYC1;SV2A;SBF1;DTD1;XYLT2;TRIM4;ITGA1;OLFM2;ZNF395;HIST3H2BB;CCDC92;NUBP2;PPCS;SH3BP1;FBXW4;GJB4;EREG;RPS6KA5;DGUOK;DUSP4;KLHDC2;TIMM17B;ZNF524;CUL9;SOX12;PLEKHH1;TMBIM4;DDIT4;MBTPS2;ACADS;TOP3B;PPL;PPP1R13L;CARF;HSD17B7;AHNAK2;PCSK1N;MT2A;IER2;CES2;NAGA;ZDHHC8;TMX4;MZT2B;FCHO1;LIMK1;TGFBR3;PDIA5;GDI1;TPM2;PADI3;DIP2A;LTB4R2;CPNE7;SLC2A11;RPL39L;LEMD2;RPS6KA6;TMEM92;ZHX3;DNM1;WASH3P;RGS14;TMEM8B;SCN8A;MFNG;GSTO1;GIT1;ALDOC;CHAD;MRPS26;MSLN;LPCAT1;LRSAM1;ADAM15;REEP2;ASB1;EHD3;WDR60;ST3GAL3;LONP2;SYMPK;MAPK12;IRAK1;PPOX;TGFA;HDAC7;FHOD1;INPP5D;MTHFR;CHD2;PI4K2B;CBX7;PCMTD2;CHEK2;DTNB;DECR2;ZFPM1;PPARA;COG7;COQ2;SESN2;ABCG1;MYO1D;JADE2;MYH15;CDC34;RNF123;SNN;SOX7;ABCA7;RAB12;EML3;SPEG;SIX5;BCAP31;MIF;ACO2;SMOX;EEF2KMT;KDM4B;SLC25A29;DOPEY2;PHYH;ZNF414;MEX3A;SLC9A7;PLA2G6;DDT;SSBP4;SYNGR1;NUDT14;ECM1;NARF;WFS1;QSOX1;DNAAF3;CD68;ZNF444;SLC22A18;DTX3;NBPF3;SPPL2B;HSD11B1L;FYN;PITPNM3;VWA1;UPP1;STK25;RAC3;ETFB;TMCO6;GLB1L2;EEF2K;CERS4;SUN1;ARHGAP12;FLYWCH1;ACAP3;ARID5B;HOXC5;DNM2;CKMT1A;CYP3A5;BHLHE40;GLB1;PELI1;ATXN10;SNX15;INF2;CHKA;CAT;BEX2;NEIL1;TSPYL2;KIAA1147;IGFBP7;ARMCX1;SLC27A1;ZMYM3;TPBG;APOBEC3C;SATB1;SLC50A1;KIF26A;ASMTL;ZDHHC1;SLC12A4;PLCB3;H1FX;IQSEC1;ZNF606;APOBEC3F;ARHGEF4;DDX50;CYP2R1;TUBB6;MAPK3;CBLN3;INSR;RTN2;ARHGEF1;PAN2;GRINA;PDZD2;CAMTA2;TAZ;PFKM;ADCY1;TNS4;C12ORF66;RERE;HLA-G;DOCK9;STX10;TSTA3;INO80C;ATP8B2;GPT2;RALGAPA1;MORN4;PDXK;ETAA1;PRAF2;GLRX;CEP72;VANGL2;PAK1;TRIM45;CDYL2;DCAF10;KLHL36;MALL;CAMKK2;RNASET2;PPP3CB;RNF144A;LGALS3BP;ALPK1;CTSF;USP21;PFKFB3;MLYCD;CUL7;SLC37A2;GABBR1;REV1;MICAL1;HYAL1;SEMA4C;CAPRIN2;ZBTB10;WDTC1;HES7;ITGA3;STK32C;DNMT3A;SAMD8;BIN1;VPS16;MAN2B1;SRMS;TSTD1;PPP2R5B;HES6;SLC16A13;MAP2K3;NDST2;BCL2L1;DLG3;SGSM2;ABHD10;NDUFV3;RRAS;DNASE1L1;PROX1;IARS2;LRCH4;TBC1D16;ADGRF1;ALDH7A1;LMNA;ZYG11B;PKD1;KCTD13;TNFRSF25;RABGAP1;SIRT2;FAM129B;EDA;UVSSA;ANKRD13D;GAL3ST4;NMNAT2;BACH1;NT5C1B;TRIP10;ADCY7;E2F5;ZBTB22;ALG12;AFAP1L1;MAPRE3;AZIN2;TEP1;RAB28;ZNF704;SERPINB1;ST3GAL2;ICA1;SLC25A37;RAP1GAP2;LAMB1;SOCS7;MAP3K10;HSDL1;RGS19;NDE1;GPR3;HSD11B1;PELI3;GTF2IRD2;RAB40B;NGFR;TOLLIP;BCORL1;PDCD6;ATP6V1F;PCLO;ARVCF;CHST14;BIVM;ZNF837;RNASE7;PXN;GRB10;TBC1D8;PHYKPL;PLEKHM1;DUSP23;GCH1;MSS51;LURAP1;KIF13B;MAFF;NR2F6;CBX6;TCTN1;NBEAL2;PNMA1;CAMK1;CAMKK1;EZH1;SIRT3;HFE;TERC;ZNF513;WIPI2;GAS2L1;COL6A1;BTG1;ZP3;VPS51;FAM117A;CELSR1;TACC1;MLF2;IL17RE;SEMA3B;SEPT6;CDK11B;PFN2;C2CD2;SSH3;FGFR3;MFSD10;TST;CCDC88C;ST3GAL5;TNRC18;NDRG2;MAN2B2;BLOC1S4;CBLC;ITPKB;PTGR2;SPTLC2;TCEA2;CDC42BPG;PRSS21;ZBTB47;PLAG1;DOK4;GSDMA;CLK3;IRF2BPL;TRIM46;DHX32;KDM3A;PM20D2;TMEM187;FAM214B;TBL3;HOMER2;SLC23A2;PKN3;APBA1;TTLL3;DEDD2;PI4KAP2;AK3;SRSF5;CHPF;ADCY6;SLC26A11;LRRK1;AARS;KLHL24;STRN4;SDC2
10902,GO:0044455,0.980016801886234,0.0408673337299896,9,166,mitochondrial membrane part,CC,BNIP3;SDHA;ANKZF1;OXA1L;CYC1;TIMM17B;PPOX;COQ2;NDUFV3
19025,GO:1904837,0.980074050327832,0.101928361845001,1,41,beta-catenin-TCF complex assembly,BP,ASH2L
8669,GO:0034250,0.980157620108521,0.0440668130470774,7,123,positive regulation of cellular amide metabolic process,BP,IMPACT;CIRBP;TGFB1;ERBB2;PRKCD;PLA2G6;MAPK3
4198,GO:0009308,0.98046227653308,0.0529830491274301,4,88,amine metabolic process,BP,SMOX;CHKA;ALDH7A1;AZIN2
1027,GO:0002532,0.980501108997696,0.100887285277912,1,35,production of molecular mediator involved in inflammatory response,BP,PDCD4
12426,GO:0050000,0.980503374793374,0.05959817726935,3,67,chromosome localization,BP,LEMD2;SUN1;NDE1
16869,GO:0098800,0.980599315095449,0.0524637685121802,4,99,inner mitochondrial membrane protein complex,CC,SDHA;CYC1;TIMM17B;NDUFV3
877,GO:0002228,0.98062109059702,0.100272032646636,1,36,natural killer cell mediated immunity,BP,CEACAM1
2845,GO:0006334,0.98062199069961,0.0481818743724725,5,117,nucleosome assembly,BP,H1F0;CENPH;HIST3H2BB;TSPYL2;H1FX
2446,GO:0005657,0.980634494279978,0.0592239786006844,3,68,replication fork,CC,POLD4;ZMIZ2;ETAA1
17841,GO:1901991,0.980658466690745,0.0358710913855201,13,202,negative regulation of mitotic cell cycle phase transition,BP,FHL1;HMGA2;ZFP36L1;GJC2;BRSK1;ZNF385A;CCND1;PCBP4;PKD2;TFDP2;RBL2;BAX;CHEK2
1458,GO:0003697,0.980868927143344,0.0479424951187176,5,96,single-stranded DNA binding,MF,ERCC1;XPC;RAD23A;MYEF2;SSBP4
1005,GO:0002478,0.981014241168985,0.0405419981302626,8,142,antigen processing and presentation of exogenous peptide antigen,BP,KLC2;AP2A2;ITGB5;ACTR1B;DNM2;KIF26A;HLA-G;CTSF
16154,GO:0090175,0.98103598097872,0.0474944967122025,5,101,regulation of establishment of planar polarity,BP,SMURF2;DVL1;AP2A2;VANGL2;CELSR1
2901,GO:0006414,0.981420653464423,0.0436114662684662,6,125,translational elongation,BP,GTPBP1;MRPS6;ZNF598;ABTB1;MRPS26;EEF2K
2925,GO:0006446,0.981441779605671,0.0570594269060632,3,70,regulation of translational initiation,BP,IMPACT;C8ORF88;MIF4GD
18819,GO:1904358,0.981707971820157,0.0959559951114081,1,35,positive regulation of telomere maintenance via telomere lengthening,BP,MAPK3
13681,GO:0060236,0.981721355981668,0.0959008301160265,1,35,regulation of mitotic spindle organization,BP,PKD1
6694,GO:0030099,0.981737660811225,0.0306296896279592,20,289,myeloid cell differentiation,BP,CTNNBIP1;VEGFA;FAM210B;ZFP36L1;FOS;EPAS1;ASH2L;CEACAM1;ZNF385A;SH3PXD2A;CEBPB;TGFB1;JAK3;FAM20C;TGFBR3;INPP5D;ZFPM1;NBEAL2;ITPKB;LRRK1
13008,GO:0051452,0.981930647938748,0.0947947829115197,1,37,intracellular pH reduction,BP,ATP6V1F
138,GO:0000289,0.981972219962866,0.0948648650278339,1,35,nuclear-transcribed mRNA poly(A) tail shortening,BP,PAN2
14160,GO:0061053,0.982358412087359,0.0656780904998976,2,52,somite development,BP,SMAD3;HES7
7709,GO:0032205,0.982421994790687,0.0929978979426957,1,35,negative regulation of telomere maintenance,BP,ERCC1
2814,GO:0006282,0.982849880059613,0.0474412546704965,4,83,regulation of DNA repair,BP,HMGA2;EGFR;MAGEF1;TMEM161A
3296,GO:0006997,0.983312708003496,0.0377703457358994,7,124,nucleus organization,BP,NEK9;REEP4;LEMD2;SUN1;BIN1;LMNA;KDM3A
6147,GO:0019439,0.983378656021401,0.0242603239390175,42,555,aromatic compound catabolic process,BP,NT5E;XDH;H1F0;PGM1;DNPH1;GTPBP1;RAPGEF3;ZFP36L1;ENDOG;AKT1;ENTPD6;HK1;PFKL;CIRBP;PCBP4;PFKP;DHTKD1;ENTPD2;PNRC1;RNH1;PFKFB2;MLXIPL;ADA;AHCY;PRKCD;BAX;DDIT4;ALDOC;PPARA;UPP1;NEIL1;APOBEC3C;APOBEC3F;INSR;PAN2;PFKM;RNASET2;PFKFB3;DNASE1L1;NT5C1B;PM20D2;DEDD2
2941,GO:0006473,0.983505869672399,0.0334080927802247,10,163,protein acetylation,BP,NOS1;RAPGEF3;CTBP1;TGFB1;MDH2;MBD3;RPS6KA5;JADE2;MAPK3;CAMK1
10504,GO:0043414,0.98360430158892,0.029248744120087,16,234,macromolecule methylation,BP,FOS;ASH2L;RAB3B;RRNAD1;MBD3;TDRKH;MTHFR;PCMTD2;EEF2KMT;ETFB;SATB1;DNMT3A;FAM129B;EZH1;BTG1;KDM3A
1872,GO:0004540,0.983766678688731,0.0451599408460776,4,87,ribonuclease activity,MF,LACTB2;PAN2;RNASET2;RNASE7
11421,GO:0045851,0.98389066993382,0.086478354047685,1,38,pH reduction,BP,ATP6V1F
16773,GO:0098586,0.983897275601312,0.0866663544701305,1,36,cellular response to virus,BP,BCL2L1
5885,GO:0018023,0.983981525376083,0.0861966796491342,1,37,peptidyl-lysine trimethylation,BP,EEF2KMT
3666,GO:0008168,0.984074939118614,0.0314779574559597,11,175,methyltransferase activity,MF,ASH2L;GAMT;COMTD1;RRNAD1;PCMTD2;EEF2KMT;ASMTL;DNMT3A;NSUN7;FAM86B1;EZH1
872,GO:0002221,0.98416334673066,0.0360410036262989,7,125,pattern recognition receptor signaling pathway,BP,TNIP1;NR1D1;PTPRS;CTSB;MAPKAPK3;IRAK1;PELI1
11467,GO:0045934,0.984218697500285,0.0205922234980106,96,1100,negative regulation of nucleobase-containing compound metabolic process,BP,ERCC1;ZMYND8;EGR1;NR1D1;PDCD4;CTNNBIP1;ACVR2B;VEGFA;HMGA2;ELK3;MTA1;WWTR1;NFATC4;BAHCC1;SHC1;TCFL5;ZC3H6;MDFI;FOXQ1;MXD4;SMURF2;SMAD3;STAT6;DNAJB5;PRDX5;SALL2;HDAC5;PPM1F;SCMH1;IMPACT;WWC3;DAP;FGFR1;MXI1;H2AFJ;CIRBP;TENM2;TSHZ1;CCND1;TCF25;GAS6;TAGLN3;HES2;MAGEF1;CTBP1;MNT;CDKN1C;CEBPB;ZNF217;TGFB1;DEAF1;NAB2;PEG3;PHF21A;MBD3;VHL;MLXIPL;TFDP2;NELFCD;EREG;RPS6KA5;DDIT4;PPP1R13L;LTB4R2;ZHX3;HDAC7;CBX7;CHEK2;ZFPM1;PPARA;SOX7;SIX5;WFS1;ARID5B;BHLHE40;NEIL1;TSPYL2;SATB1;RERE;BCL7A;GABBR1;WDTC1;HES7;DNMT3A;HES6;PROX1;SIRT2;FAM129B;BACH1;MAP3K10;NR2F6;CBX6;ZP3;TNRC18;IRF2BPL;DEDD2
11091,GO:0045111,0.984384052085282,0.04009524616563,5,99,intermediate filament cytoskeleton,CC,SHANK2;NARF;MICAL1;LMNA;CLK3
16424,GO:0097064,0.984674575040429,0.0832281430294973,1,37,ncRNA export from nucleus,BP,XPOT
7925,GO:0032508,0.985266851923286,0.046850019552573,3,71,DNA duplex unwinding,BP,XPC;DDB2;CHD2
151,GO:0000307,0.985354267258951,0.0801834618418824,1,38,cyclin-dependent protein kinase holoenzyme complex,CC,CCND1
5831,GO:0017111,0.98543013498659,0.0205877948172668,54,651,nucleoside-triphosphatase activity,MF,ARL2;GTPBP1;SMARCA1;KLC2;ERCC6;ENTPD6;RAB31;RAC2;HLTF;ABCD1;TNNT1;RAB3B;SEPT10;AGAP1;ABCA2;KIF17;ENTPD2;GNAL;ATP7B;KIF26B;RHOD;DNAH1;RHOF;KIF7;RHOBTB2;TUBG2;PEX1;MYH16;RASL10B;NTPCR;DNM1;WDR60;LONP2;CHD2;ABCG1;MYO1D;MYH15;ABCA7;RAB12;RAC3;DNM2;KIF26A;DDX50;TUBB6;ATP8B2;RRAS;RAB28;RAB40B;ATP6V1F;GCH1;KIF13B;SEPT6;PFN2;DHX32
14391,GO:0061647,0.985514750878773,0.0795833558803654,1,37,histone H3-K9 modification,BP,KDM3A
15512,GO:0071897,0.985777753180856,0.0283881771540381,11,178,DNA biosynthetic process,BP,TK2;FGFR4;POLD4;POLL;POLM;PRIMPOL;MAPK3;REV1;FAM129B;TEP1;TERC
2943,GO:0006475,0.98590656042809,0.0310608626094862,8,139,internal protein amino acid acetylation,BP,NOS1;CTBP1;TGFB1;MDH2;MBD3;RPS6KA5;JADE2;MAPK3
1472,GO:0003727,0.986180612832551,0.0443535468956624,3,71,single-stranded RNA binding,MF,LACTB2;MEX3A;CBX6
14020,GO:0060760,0.986542832830041,0.0749546598099735,1,38,positive regulation of response to cytokine stimulus,BP,GAS6
367,GO:0000989,0.986629791893146,0.0198372547598515,41,518,transcription factor activity, transcription factor binding,MF,ZMYND8;CITED4;NR1D1;HMGA2;ELK3;PKN1;MTA1;WWTR1;NFATC4;MXD4;FOS;SMAD3;NFKBIZ;MXI1;KLF7;CCND1;AIP;SMARCD2;CTBP1;MNT;ZMIZ2;NAB2;PHF21A;KDM6B;GRHPR;TFDP2;SOX12;PPP1R13L;ZHX3;HDAC7;PPARA;ARID5B;BHLHE40;RERE;CDYL2;USP21;HES6;PROX1;FAM129B;MAP3K10;BTG1
10675,GO:0043933,0.986781815713091,0.0165979666871721,147,1670,protein-containing complex subunit organization,BP,ERCC1;H1F0;DLG4;TYSND1;CTNNBIP1;KCNG1;XPC;PRNP;VEGFA;APOE;LRP5;ITPR3;LOXL1;OBSL1;DDB2;VPS11;ARL2;MMP1;SNX9;GLUL;PLTP;EXOC2;SLC9A3R2;SMAD3;DVL1;HSD17B8;SH3PXD2B;STOM;GRB7;KCNC4;TMOD2;CORO1B;ASH2L;IMPACT;DNAAF5;PRKACB;SIGMAR1;RAC2;PFKL;SORL1;CIRBP;CBR4;TRAPPC9;TWF2;GSN;PLEKHG2;ANGPTL4;MRPS6;EHD4;SEPT10;WIPF1;ARPIN;SPTB;SMARCD2;CORO7;DGKQ;BNIP3;SHARPIN;FYCO1;PKD2;GPX3;CTSZ;CDC42EP5;CRTC1;SH3PXD2A;ASIC1;TGFB1;CLTCL1;FHOD3;MSRB2;EML2;DNAH1;WASF3;LLGL1;COA5;KHDRBS3;TUBG2;HMGCL;LRP4;PRKCZ;PRKACA;CENPH;GRHPR;OXA1L;RABGGTA;AREG;MICALL2;BOK;WDR18;CAPG;ULK1;VAMP2;PSMG4;FSCN1;MCFD2;PRKCD;STUB1;BAX;TRIM4;HIST3H2BB;SH3BP1;CHADL;SOX12;ZDHHC8;FCHO1;TGFBR3;DNM1;WASH3P;MRPS26;EHD3;IRAK1;TGFA;ABCG1;ABCA7;MIF;DNAAF3;RAC3;DNM2;ATXN10;CAT;TSPYL2;H1FX;MAPK3;INSR;TAZ;PFKM;PAK1;MICAL1;BIN1;VPS16;PPP2R5B;NDUFV3;KCTD13;SIRT2;NDE1;PDCD6;PXN;GCH1;MSS51;HFE;COL6A1;BBS10;SEPT6;PFN2;CCDC88C;APBA1;SRSF5
17984,GO:1902369,0.987106302030257,0.0724363085790249,1,38,negative regulation of RNA catabolic process,BP,CIRBP
16194,GO:0090224,0.987127553533914,0.0723408077321345,1,38,regulation of spindle organization,BP,PKD1
7314,GO:0031330,0.987129264990175,0.0259122975536693,11,180,negative regulation of cellular catabolic process,BP,CST3;TBC1D14;AKT1;DAP;CIRBP;TIMP2;DDIT4;PPARA;QSOX1;SIRT2;HFE
20001,GO:2000573,0.987170901406914,0.0502101476451378,2,56,positive regulation of DNA biosynthetic process,BP,FGFR4;MAPK3
8969,GO:0035064,0.98723377883581,0.0500039197666407,2,56,methylated histone binding,MF,ZMYND8;CDYL2
17287,GO:0140034,0.98723377883581,0.0500039197666407,2,56,methylation-dependent protein binding,MF,ZMYND8;CDYL2
240,GO:0000502,0.987266780303269,0.0496551102911285,2,63,proteasome complex,CC,RAD23A;WFS1
12741,GO:0051018,0.987301182709541,0.0715591014143885,1,38,protein kinase A binding,MF,PRKACA
1526,GO:0003899,0.987341312933963,0.0711276506330709,1,41,DNA-directed 5'-3' RNA polymerase activity,MF,PRIMPOL
8427,GO:0033554,0.987387985163493,0.0158737803411973,146,1618,cellular response to stress,BP,XDH;ERCC1;EGR1;EDEM1;CST3;FBXO2;PDCD4;XPC;VEGFA;WNT7A;APOE;HMGA2;NDRG1;PKN1;MTA1;EGFR;RPS6KA2;PTPRS;TMEM129;NFATC4;ETV5;SHC1;DDB2;ZFP36L1;GLUL;MAP2K2;MAP2K1;ENDOG;FOS;STAT6;PIK3R2;ERCC6;EPAS1;PRDX5;PRODH;ADORA2B;AKT1;PYCR2;STK39;ASH2L;IMPACT;BRSK1;DAP;WNT2B;POLD4;ZNF385A;NSMCE4A;CCND1;PCBP4;STRADB;MAPK13;GAS6;CSNK1E;PCSK9;RAD23A;ERRFI1;CCS;BNIP3;PAK6;TFPI2;PKD2;GPX3;YPEL3;CDC42EP5;MAGEF1;ADAM8;CBS;CEBPB;MOAP1;MPG;MC1R;LAMB2;POLL;POLM;ANKZF1;UBXN4;PTPN1;TPP1;WDR59;VHL;TRAP1;KDM6B;PRKACA;MINK1;BOK;ULK1;PRIMPOL;TFDP2;NET1;BNIP3L;PDK1;PRKCD;RBL2;STUB1;BAX;DDIT4;MBTPS2;TMX4;PDIA5;RPS6KA6;RGS14;MRPS26;MAPK12;IRAK1;CHD2;CHEK2;TMEM161A;SESN2;BCAP31;MIF;PLA2G6;WFS1;UPP1;STK25;EEF2K;DNM2;CAT;NEIL1;TSPYL2;MAPK3;GRINA;C12ORF66;INO80C;ETAA1;VANGL2;PAK1;CAMKK2;CUL7;REV1;SEMA4C;DNMT3A;PPP2R5B;MAP2K3;BCL2L1;LMNA;SIRT2;UVSSA;BACH1;MAP3K10;PDCD6;PXN;GCH1;HFE;TERC;GAS2L1;CCDC88C
18356,GO:1903313,0.98747639016394,0.0492063448193827,2,56,positive regulation of mRNA metabolic process,BP,GTPBP1;ZFP36L1
16316,GO:0090502,0.98756536258331,0.0488042996534274,2,59,RNA phosphodiester bond hydrolysis, endonucleolytic,BP,LACTB2;RNASET2
12476,GO:0050434,0.987580219539334,0.0701278123004475,1,40,positive regulation of viral transcription,BP,NELFCD
5511,GO:0016462,0.987609602641581,0.017492405462599,57,689,pyrophosphatase activity,MF,ARL2;GTPBP1;SMARCA1;KLC2;ERCC6;ENTPD6;RAB31;RAC2;HLTF;ABCD1;LHPP;TNNT1;RAB3B;SEPT10;AGAP1;ABCA2;KIF17;ENTPD2;GNAL;ATP7B;KIF26B;RHOD;DNAH1;RHOF;KIF7;RHOBTB2;TUBG2;PEX1;MYH16;RASL10B;NTPCR;DNM1;WDR60;LONP2;CHD2;ABCG1;MYO1D;MYH15;ABCA7;RAB12;NUDT14;RAC3;DNM2;KIF26A;ASMTL;DDX50;TUBB6;ATP8B2;RRAS;RAB28;RAB40B;ATP6V1F;GCH1;KIF13B;SEPT6;PFN2;DHX32
15222,GO:0071383,0.987613966947706,0.0244054620668811,12,190,cellular response to steroid hormone stimulus,BP,NR1D1;EGFR;ZFP36L1;ERRFI1;PAQR6;TGFB1;PCK2;DDIT4;PPARA;PAK1;NR2F6;KDM3A
9597,GO:0036459,0.987671278054473,0.0355550258328028,4,87,thiol-dependent ubiquitinyl hydrolase activity,MF,JOSD2;ANKZF1;USP20;USP21
17114,GO:0101005,0.987671278054473,0.0355550258328028,4,87,ubiquitinyl hydrolase activity,MF,JOSD2;ANKZF1;USP20;USP21
18534,GO:1903706,0.98782206362922,0.0205423516114772,22,327,regulation of hemopoiesis,BP,CTNNBIP1;FAM210B;ZFP36L1;FOS;ASH2L;RAG1;CEACAM1;GAS6;CARD11;SOX13;AP3D1;ADAM8;CEBPB;TGFB1;PRKCZ;ADA;ERBB2;JAK3;INPP5D;ZFPM1;HLA-G;ITPKB
5852,GO:0017148,0.987910323222026,0.0232914688572337,13,217,negative regulation of translation,BP,EGFR;ZFP36L1;MAP2K2;MAP2K1;SMAD3;GRB7;CIRBP;C8ORF88;TGFB1;UNK;SESN2;MEX3A;CAPRIN2
3332,GO:0007049,0.987941332843944,0.0152601823247681,140,1548,cell cycle,BP,ERCC1;FHL1;CCNG2;CYP27B1;MARVELD1;PDCD4;XPC;PRNP;LRP5;HMGA2;NDRG1;NEK9;EGFR;RPS6KA2;OBSL1;SPRY2;APPL2;ARL2;SNX9;TRNP1;ZFP36L1;ARAP1;MAP2K2;MAP2K1;MARK4;SMAD3;GJC2;PPP2R3B;REEP4;FBXW5;ADARB1;AKT1;STK39;BRSK1;POLD4;FGFR1;PRKACB;CCNI;HMG20B;LZTS2;RAB11FIP4;ZNF385A;ANK3;CCND1;PCBP4;STRADB;MAPK13;CEP250;GAS6;PTK6;CSNK1E;MPLKIP;RAD23A;PHLDA1;BCR;SEPT10;CDC25B;ALOX15B;NPR2;PAK6;PKD2;CTBP1;MNT;CDKN1C;TIMP2;TGFB1;CLTCL1;GOLGA2P5;CROCC;RHOD;CGREF1;SNX33;RHOF;LLGL1;RHOBTB2;SAC3D1;TUBG2;CAMK2N1;CEP131;MLXIPL;PRKACA;MINK1;CENPH;TOM1L2;PIM2;WDR18;TDRKH;SDCCAG8;NINL;TFDP2;C6ORF89;PRKCD;RBL2;BAX;EREG;CUL9;LEMD2;RGS14;TMEM8B;GIT1;MAPK12;TGFA;CHEK2;CDC34;MIF;STK25;SUN1;DNM2;BEX2;TSPYL2;TUBB6;MAPK3;INSR;ETAA1;CEP72;PAK1;CUL7;HYAL1;DNMT3A;BIN1;PPP2R5B;MAP2K3;BCL2L1;PROX1;LMNA;PKD1;RABGAP1;SIRT2;BACH1;E2F5;MAPRE3;NDE1;GPR3;CAMK1;GAS2L1;BTG1;TACC1;SEPT6;CDK11B;SRSF5
7408,GO:0031503,0.988035160513834,0.0226376080022338,14,218,protein-containing complex localization,BP,DLG4;IFT140;XPOT;AP3D1;KIF17;CEP131;ARHGAP44;DNM1;WDR60;SYMPK;DNM2;CEP72;DLG3;SRSF5
17284,GO:0140030,0.988062298030971,0.02955513557895,6,114,modification-dependent protein binding,MF,TNIP1;ZMYND8;BRD3;RAD23A;SHARPIN;CDYL2
8886,GO:0034708,0.988094035376287,0.034445135466631,4,90,methyltransferase complex,CC,ASH2L;KDM6B;INO80C;EZH1
11824,GO:0046782,0.988200277586217,0.0467032249394796,2,59,regulation of viral transcription,BP,HMGA2;NELFCD
5696,GO:0016817,0.988211730615204,0.0166787295665438,57,691,hydrolase activity, acting on acid anhydrides,MF,ARL2;GTPBP1;SMARCA1;KLC2;ERCC6;ENTPD6;RAB31;RAC2;HLTF;ABCD1;LHPP;TNNT1;RAB3B;SEPT10;AGAP1;ABCA2;KIF17;ENTPD2;GNAL;ATP7B;KIF26B;RHOD;DNAH1;RHOF;KIF7;RHOBTB2;TUBG2;PEX1;MYH16;RASL10B;NTPCR;DNM1;WDR60;LONP2;CHD2;ABCG1;MYO1D;MYH15;ABCA7;RAB12;NUDT14;RAC3;DNM2;KIF26A;ASMTL;DDX50;TUBB6;ATP8B2;RRAS;RAB28;RAB40B;ATP6V1F;GCH1;KIF13B;SEPT6;PFN2;DHX32
5697,GO:0016818,0.988211730615204,0.0166787295665438,57,691,hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,MF,ARL2;GTPBP1;SMARCA1;KLC2;ERCC6;ENTPD6;RAB31;RAC2;HLTF;ABCD1;LHPP;TNNT1;RAB3B;SEPT10;AGAP1;ABCA2;KIF17;ENTPD2;GNAL;ATP7B;KIF26B;RHOD;DNAH1;RHOF;KIF7;RHOBTB2;TUBG2;PEX1;MYH16;RASL10B;NTPCR;DNM1;WDR60;LONP2;CHD2;ABCG1;MYO1D;MYH15;ABCA7;RAB12;NUDT14;RAC3;DNM2;KIF26A;ASMTL;DDX50;TUBB6;ATP8B2;RRAS;RAB28;RAB40B;ATP6V1F;GCH1;KIF13B;SEPT6;PFN2;DHX32
331,GO:0000922,0.98833508798183,0.0261826459498037,8,142,spindle pole,CC,FAM110C;MAPKBP1;CDC25B;NUDCD2;NUBP2;RGS14;WDR60;NDE1
16337,GO:0090575,0.988362987500791,0.0273227988764274,7,131,RNA polymerase II transcription factor complex,CC,ERCC1;NR1D1;FOS;MXI1;CEBPB;TFDP2;PPARA
2875,GO:0006378,0.988390723331353,0.066508961711169,1,39,mRNA polyadenylation,BP,SYMPK
8667,GO:0034248,0.98847510992776,0.018142306098181,31,427,regulation of cellular amide metabolic process,BP,PRNP;APOE;EGFR;ZFP36L1;MAP2K2;MAP2K1;SMAD3;AKT1;GRB7;IMPACT;SORL1;CIRBP;ZNF385A;ZNF598;C8ORF88;TGFB1;UNK;MKNK2;MIF4GD;TRAP1;ERBB2;CYFIP2;PRKCD;SESN2;ABCA7;MEX3A;PLA2G6;MAPK3;CAPRIN2;SAMD8;BIN1
19245,GO:1905369,0.988488079233652,0.0455932147753059,2,64,endopeptidase complex,CC,RAD23A;WFS1
10990,GO:0044798,0.988632896708873,0.0246046959692741,9,157,nuclear transcription factor complex,CC,ERCC1;NR1D1;NFATC4;FOS;SMAD3;MXI1;CEBPB;TFDP2;PPARA
276,GO:0000779,0.988740233928874,0.030012262336919,5,104,condensed chromosome, centromeric region,CC,CEBPB;NUDCD2;CENPH;NDE1;SEPT6
3965,GO:0008757,0.988776856311939,0.0264568125228622,7,130,S-adenosylmethionine-dependent methyltransferase activity,MF,ASH2L;GAMT;RRNAD1;PCMTD2;EEF2KMT;DNMT3A;EZH1
16649,GO:0097525,0.988847448210777,0.0444477914048856,2,62,spliceosomal snRNP complex,CC,MAPKBP1;TEP1
12993,GO:0051427,0.988851104701939,0.0251305252067239,8,143,hormone receptor binding,MF,PKN1;SMAD3;PTHLH;CEBPB;FYN;PROX1;GAS2L1;KDM3A
366,GO:0000988,0.988925203293611,0.0165887578433026,41,523,transcription factor activity, protein binding,MF,ZMYND8;CITED4;NR1D1;HMGA2;ELK3;PKN1;MTA1;WWTR1;NFATC4;MXD4;FOS;SMAD3;NFKBIZ;MXI1;KLF7;CCND1;AIP;SMARCD2;CTBP1;MNT;ZMIZ2;NAB2;PHF21A;KDM6B;GRHPR;TFDP2;SOX12;PPP1R13L;ZHX3;HDAC7;PPARA;ARID5B;BHLHE40;RERE;CDYL2;USP21;HES6;PROX1;FAM129B;MAP3K10;BTG1
4190,GO:0009295,0.98897284291513,0.0637351031936104,1,40,nucleoid,CC,MPG
10117,GO:0042645,0.98897284291513,0.0637351031936104,1,40,mitochondrial nucleoid,CC,MPG
10532,GO:0043486,0.989042879477229,0.0629106538829218,1,48,histone exchange,BP,CENPH
5507,GO:0016458,0.989107884549504,0.0207164746483924,14,237,gene silencing,BP,EGFR;BAHCC1;MAP2K2;MAP2K1;SMAD3;HDAC5;SCMH1;H2AFJ;TGFB1;MBD3;TDRKH;DNMT3A;SIRT2;TNRC18
11307,GO:0045637,0.989125570535501,0.0228213447495461,10,181,regulation of myeloid cell differentiation,BP,CTNNBIP1;FAM210B;ZFP36L1;FOS;ASH2L;CEACAM1;CEBPB;INPP5D;ZFPM1;ITPKB
11357,GO:0045727,0.989162673287522,0.0290051693443929,5,105,positive regulation of translation,BP,IMPACT;CIRBP;TGFB1;ERBB2;MAPK3
8573,GO:0034062,0.989294371792349,0.0620260150909988,1,43,5'-3' RNA polymerase activity,MF,PRIMPOL
16731,GO:0097747,0.989294371792349,0.0620260150909988,1,43,RNA polymerase activity,MF,PRIMPOL
14098,GO:0060964,0.989418300604553,0.0309244515140905,4,103,regulation of gene silencing by miRNA,BP,EGFR;MAP2K2;MAP2K1;TGFB1
2189,GO:0005048,0.989640624964574,0.0606028430624578,1,40,signal sequence binding,MF,CEMIP
15976,GO:0080135,0.990088651150731,0.0148637997852315,42,537,regulation of cellular response to stress,BP,XDH;ERCC1;EDEM1;PDCD4;VEGFA;WNT7A;HMGA2;PKN1;EGFR;PTPRS;MAP2K2;MAP2K1;ENDOG;ERCC6;AKT1;IMPACT;ZNF385A;NSMCE4A;YPEL3;MAGEF1;PTPN1;TRAP1;MINK1;BOK;PRKCD;BAX;CHEK2;TMEM161A;BCAP31;MIF;WFS1;STK25;MAPK3;GRINA;ETAA1;VANGL2;PAK1;SEMA4C;BCL2L1;MAP3K10;GCH1;TERC
8900,GO:0034728,0.99013004698736,0.0247802248208831,6,140,nucleosome organization,BP,H1F0;SMARCD2;CENPH;HIST3H2BB;TSPYL2;H1FX
10683,GO:0043967,0.99018286642097,0.0399978411825692,2,59,histone H4 acetylation,BP,CTBP1;JADE2
12843,GO:0051170,0.990291055029958,0.0232054197360621,7,134,import into nucleus,BP,AKT1;GAS6;TGFB1;TMEM173;PRKCD;TMCO6;RERE
5647,GO:0016741,0.990340248083296,0.0199294532024007,11,183,transferase activity, transferring one-carbon groups,MF,ASH2L;GAMT;COMTD1;RRNAD1;PCMTD2;EEF2KMT;ASMTL;DNMT3A;NSUN7;FAM86B1;EZH1
11415,GO:0045839,0.990390266793517,0.0568971562437335,1,42,negative regulation of mitotic nuclear division,BP,TOM1L2
17780,GO:1901799,0.990474142970614,0.0564941601796517,1,42,negative regulation of proteasomal protein catabolic process,BP,HFE
1006,GO:0002479,0.990523767092367,0.0386395653487143,2,66,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,BP,ITGB5;HLA-G
274,GO:0000777,0.99052954070969,0.0281713547981344,4,92,condensed chromosome kinetochore,CC,NUDCD2;CENPH;NDE1;SEPT6
18172,GO:1902911,0.990589933006838,0.0280254525047591,4,91,protein kinase complex,CC,CCND1;ULK1;SESN2;INSR
17838,GO:1901988,0.990719263274509,0.018270030479218,13,215,negative regulation of cell cycle phase transition,BP,FHL1;HMGA2;ZFP36L1;GJC2;BRSK1;ZNF385A;CCND1;PCBP4;PKD2;TFDP2;RBL2;BAX;CHEK2
3660,GO:0008152,0.990792221218558,0.0108811949234957,838,8308,metabolic process,BP,TNIP1;DUSP6;NT5E;XDH;ERCC1;DUSP5;MEF2D;GID4;ZMYND8;H1F0;CITED4;HTRA1;THSD4;EGR1;NR1D1;SLC16A3;H6PD;EDEM1;DLG4;PLAT;CST3;CYP27B1;MRC2;TYSND1;BTBD2;FBXO2;APLN;PDCD4;CTNNBIP1;NAGS;ACVR2B;XPC;PRNP;PYGB;BBS2;SLC6A8;VEGFA;TNFRSF6B;PGM1;WNT7A;APOE;PYGL;DGKA;NAGLU;F2R;LRP5;PLD3;OSBPL5;LPCAT4;ITGA6;ISYNA1;HMGA2;OBSCN;IDH2;ZKSCAN1;NEK9;CRAT;ELK3;PKN1;MTA1;GRAMD4;ACOT7;ARRDC1;ACSF2;NISCH;AKR7A2;EGFR;RPS6KA2;SERPINE2;DNPH1;WWTR1;LOXL1;OBSL1;NOS1;VAT1;PTPRS;TMEM129;SLC2A9;HADH;CTSO;SPRY2;CAPN2;MST1R;NFATC4;TRIM65;BAHCC1;CRTAP;LTBP4;PRSS8;SDC1;KLHL29;ETV5;LMF1;SHC1;DDB2;VPS11;LTBP1;TBC1D14;HEXB;GTPBP1;SLC7A8;TCFL5;PTPRE;NPEPL1;SLC2A3;ALDH4A1;TK2;ACTA2;MMP1;ETV4;PHLDA2;SNX9;TRNP1;SPRY4;RAPGEF3;TXNRD3;ST6GALNAC2;ZFP36L1;GAA;GLUL;RNPEPL1;ARAP1;MAP2K2;KDSR;NME4;ZC3H6;LPAR3;MARCH9;CTBS;PLCD3;FKBP9;MDFI;PTOV1;SMARCA1;PPP1R35;RBCK1;SUGCT;PLTP;PGLS;PC;FOXQ1;RNF44;MAP2K1;NAPRT;CRYL1;ACP5;CPT2;NYNRIN;MXD4;SSH1;POU2F2;ENDOG;MARK4;GALE;SMURF2;TSC22D1;FOS;FBLN1;SMAD3;STAT6;PIK3R2;ERCC6;LRP1;GJC2;SRD5A3;DVL1;EPAS1;DNAJB5;PIGQ;HSD17B8;HBEGF;RPUSD3;AP2A2;ITGB4;CYBRD1;PPP1R14A;SH3PXD2B;PPP2R3B;PRDX5;SHC2;BRD3;PRODH;SALL2;MBOAT7;CDK18;LY6K;FBXW5;ZXDC;RNF187;NMRK1;ADORA2B;ADARB1;PLCXD2;D2HGDH;SLC6A6;AKT1;TPCN1;GRB7;HDAC5;UROS;FBXO41;NT5DC1;F12;PPM1F;MMP28;PITPNM1;ENTPD6;RHBDF2;PYCR2;BSG;STK39;HK1;SERPING1;SCMH1;EPHA1;GGT1;NFKBIZ;PTPRU;VEGFB;ASH2L;IMPACT;MARCH4;WWC3;ATG16L2;ZFYVE21;CNTN1;BRSK1;DAP;PTHLH;RAB31;FGFR4;POLD4;ACOT1;LDLR;FGFR1;PRKACB;FUCA1;MAPKBP1;RAC2;KCNAB2;PFKL;TTLL12;SEC14L2;OPLAH;HLTF;MXI1;PPM1J;RAG1;GAMT;H2AFJ;B4GAT1;PACS2;BPHL;PIGV;KLF7;SORL1;NAT14;CEACAM1;B3GAT3;ASB13;CIRBP;CBR4;HMG20B;TENM2;ZNF385A;NSMCE4A;ABCD1;ANK3;IGFBP4;TTC7B;TSHZ1;TRAPPC9;CCND1;PODNL1;PCBP4;TCF25;LHPP;AIG1;STRADB;SYNGAP1;PLCH2;MAPK13;PLAU;GAS6;PTK6;PFKP;CSNK1E;CTSB;RAB3B;CARD11;SOX13;DUSP7;GSN;MAPKAPK3;IGFBP2;PCSK9;ARHGAP22;RAD23A;DHTKD1;PHLDA1;ANO8;BCR;ANGPTL4;MRPS6;EHD4;ERRFI1;GLI4;NADK;PANK4;HLCS;ZSCAN18;PRSS22;AIP;CCDC71L;MYEF2;MN1;SH3D19;CDC25B;ALOX15B;SPTB;SMARCD2;COMTD1;PEX10;CCS;GGACT;RSAD1;COL13A1;SLC20A1;RRNAD1;NPR2;SNTA1;DGKQ;HAGH;BNIP3;PAK6;TFPI2;GTF2IRD1;SHARPIN;MVB12B;SERINC2;TAGLN3;FYCO1;CEMIP;PKD2;ACY1;GPX3;PCSK1;RETSAT;RASGEF1A;CTSZ;CDC42EP5;HES2;CRTC1;FBXW8;GPSM1;AP3D1;ABCA2;ZNF598;MAGEF1;PRSS3;SH3PXD2A;EPHB2;ADAM8;APRT;CTBP1;JOSD2;LTA4H;MNT;PTPDC1;GRK6;CDKN1C;PLCG1;FBXL8;ZMIZ2;CBS;CD81;CEBPB;MVD;RNF135;ENTPD2;ADAMTS13;ZNF217;TIMP2;ZNF862;SYNJ2;WNT3;DPP7;C8ORF88;TGFB1;LACTB2;RFX2;SCYL1;ABHD17C;UNK;ULK2;GPC1;MKNK2;ADAMTS7;DEAF1;NTSR1;B3GNT3;NAB2;TMEM173;ZSCAN30;SHANK3;PODXL2;SDHA;MSRB2;RASA3;PNRC1;MIPEP;PIP5KL1;TNFSF15;MGAT4B;MDH2;MPG;GALNS;FBXO17;CLCA2;HEXDC;NSMF;PEG3;FARP1;MC1R;LCE1E;ABHD14B;LAMB2;ABTB1;SNX17;RNH1;ERO1B;ST6GALNAC6;VGF;POLL;FBXO44;POLM;SNX33;PI4K2A;PTMS;ANKZF1;ATG2A;PHGDH;PHF21A;MIF4GD;PLPP6;UBXN4;ADAM19;KHDRBS3;ZER1;HMGCL;PTPN1;TPP1;PCK2;B4GALT2;AGRN;MBD3;IFNE;CD320;CAMK2N1;OSBPL10;LRP4;LRP10;ESYT2;ZDHHC24;ACP6;B4GALT6;VHL;TRAP1;IDUA;PFKFB2;RFNG;MLXIPL;TRIB2;PRKCZ;KDM6B;PRKACA;MINK1;ZNF516;GRHPR;OXA1L;RABGGTA;CD9;ADA;AREG;PIM2;MPI;UCKL1;BOK;WDR18;TDRKH;ALAS1;NEURL1B;ERBB2;ULK1;CNDP2;AHCY;PRIMPOL;MMP10;TFDP2;C6ORF89;NECAB3;STK17A;JAK3;IRF2BP2;RNPEP;BNIP3L;CYFIP2;PBX2;TRPC1;NELFCD;RASA4;PDK1;ACAD10;CYGB;THOP1;MCFD2;PRKCD;FAM20C;MIB2;RBL2;USP20;STUB1;IFI6;BAX;CYC1;SBF1;DTD1;XYLT2;TRIM4;ITGA1;ZNF395;NUBP2;PPCS;FBXW4;EREG;RPS6KA5;DGUOK;DUSP4;ZNF524;CUL9;SOX12;DDIT4;MBTPS2;ACADS;TOP3B;PPP1R13L;CARF;HSD17B7;AHNAK2;PCSK1N;IER2;CES2;NAGA;ZDHHC8;TMX4;LIMK1;TGFBR3;NTPCR;PDIA5;PADI3;DIP2A;LTB4R2;CPNE7;RPL39L;LEMD2;RPS6KA6;ZHX3;DNM1;RGS14;MFNG;GSTO1;ALDOC;CHAD;MRPS26;MSLN;LPCAT1;LRSAM1;ADAM15;ASB1;EHD3;ST3GAL3;FAHD2B;LONP2;SYMPK;MAPK12;IRAK1;PPOX;TGFA;HDAC7;FHOD1;INPP5D;MTHFR;CHD2;PI4K2B;CBX7;PCMTD2;CHEK2;DECR2;ZFPM1;PPARA;COG7;ABHD15;COQ2;TMEM161A;SESN2;FGGY;ABCG1;MYO1D;JADE2;CDC34;RNF123;SOX7;ABCA7;RAB12;SPEG;SIX5;BCAP31;MIF;ACO2;SMOX;EEF2KMT;KDM4B;PHYH;ZNF414;MEX3A;PLA2G6;DDT;SSBP4;NUDT14;ECM1;NARF;WFS1;QSOX1;ZNF444;DTX3;TRPT1;DALRD3;SPPL2B;HSD11B1L;FYN;PITPNM3;VWA1;UPP1;STK25;ETFB;GLB1L2;EEF2K;CERS4;ARID5B;HOXC5;DNM2;CKMT1A;CYP3A5;BHLHE40;GLB1;PELI1;CHKA;CAT;NEIL1;TSPYL2;IGFBP7;ELFN2;SLC27A1;ZMYM3;APOBEC3C;SATB1;SLC50A1;ASMTL;ZDHHC1;PLCB3;ZNF606;APOBEC3F;DDX50;CYP2R1;MAPK3;INSR;PAN2;CAMTA2;TAZ;PFKM;ADCY1;RERE;TSTA3;INO80C;GPT2;PDXK;ETAA1;GLRX;BCL7A;VANGL2;PAK1;CDYL2;DCAF10;KLHL36;CAMKK2;RNASET2;PPP3CB;RNF144A;ALPK1;CTSF;USP21;PFKFB3;MLYCD;CUL7;GABBR1;REV1;MICAL1;HYAL1;SEMA4C;CAPRIN2;ZBTB10;WDTC1;HES7;ITGA3;STK32C;DNMT3A;SAMD8;BIN1;VPS16;MAN2B1;SRMS;TSTD1;NSUN7;PPP2R5B;HES6;MAP2K3;NDST2;DLG3;ABHD10;NDUFV3;RRAS;DNASE1L1;PROX1;IARS2;MDGA1;TBC1D16;ADGRF1;ALDH7A1;ZYG11B;PKD1;KCTD13;TNFRSF25;SIRT2;FAM129B;EDA;UVSSA;GAL3ST4;NMNAT2;BACH1;NT5C1B;ADCY7;E2F5;ZBTB22;ALG12;MAPRE3;AZIN2;TEP1;ZNF704;SERPINB1;ST3GAL2;YDJC;LAMB1;SOCS7;MAP3K10;RGS19;HSD11B1;PELI3;GTF2IRD2;RAB40B;NGFR;TOLLIP;BCORL1;PDCD6;CHST14;FAM86B1;ZNF837;RNASE7;GRB10;PHYKPL;PLEKHM1;DUSP23;GCH1;MAFF;NR2F6;CBX6;CAMK1;CAMKK1;EZH1;SIRT3;HFE;TERC;ZNF513;WIPI2;COL6A1;BTG1;ZP3;VPS51;MLF2;CDK11B;PFN2;SSH3;FGFR3;PPP1R16A;TST;CCDC88C;ST3GAL5;TNRC18;NDRG2;MAN2B2;CBLC;ITPKB;PTGR2;SPTLC2;TCEA2;CDC42BPG;PRSS21;ZBTB47;PLAG1;CLK3;IRF2BPL;DHX32;KDM3A;PM20D2;TBL3;SLC23A2;PKN3;APBA1;TTLL3;DEDD2;PI4KAP2;AK3;SRSF5;CHPF;ADCY6;LRRK1;AARS;KLHL24;SDC2
10627,GO:0043631,0.990811344971838,0.0549290419878375,1,41,RNA polyadenylation,BP,SYMPK
5561,GO:0016573,0.990871524484573,0.0219651236519609,7,132,histone acetylation,BP,NOS1;CTBP1;TGFB1;MBD3;RPS6KA5;JADE2;MAPK3
7900,GO:0032479,0.99088327184477,0.0248713987896177,5,107,regulation of type I interferon production,BP,PTPRS;STAT6;RNF135;TMEM173;IRAK1
2559,GO:0005844,0.990955331135475,0.037079392510068,2,69,polysome,CC,IMPACT;UNK
2842,GO:0006323,0.991131674800325,0.0203390859047506,8,167,DNA packaging,BP,H1F0;HMGA2;BAHCC1;CENPH;HIST3H2BB;TSPYL2;H1FX;TNRC18
1593,GO:0004004,0.991238876401075,0.0363259742120484,2,59,ATP-dependent RNA helicase activity,MF,DDX50;DHX32
4481,GO:0010501,0.991311107976142,0.0524886349818876,1,41,RNA secondary structure unwinding,BP,DDX50
5992,GO:0018995,0.991379967168094,0.0357765485847661,2,61,host,CC,MVB12B;PI4K2A
10640,GO:0043657,0.991379967168094,0.0357765485847661,2,61,host cell,CC,MVB12B;PI4K2A
10763,GO:0044215,0.991379967168094,0.0357765485847661,2,61,other organism,CC,MVB12B;PI4K2A
10764,GO:0044216,0.991379967168094,0.0357765485847661,2,61,other organism cell,CC,MVB12B;PI4K2A
10765,GO:0044217,0.991379967168094,0.0357765485847661,2,61,other organism part,CC,MVB12B;PI4K2A
13631,GO:0060147,0.991426584601229,0.0256834782732293,4,106,regulation of posttranscriptional gene silencing,BP,EGFR;MAP2K2;MAP2K1;TGFB1
14100,GO:0060966,0.991426584601229,0.0256834782732293,4,106,regulation of gene silencing by RNA,BP,EGFR;MAP2K2;MAP2K1;TGFB1
7982,GO:0032606,0.991512465270061,0.0233341579831386,5,108,type I interferon production,BP,PTPRS;STAT6;RNF135;TMEM173;IRAK1
8399,GO:0033365,0.991567916129046,0.0120956258429392,57,729,protein localization to organelle,BP,BBS2;OBSCN;OBSL1;VPS11;ARL2;NUDCD3;DVL1;AKT1;HK1;IFT140;RAC2;TOMM34;SORL1;LZTS2;CEP250;GAS6;AIP;PEX10;AP3D1;CD81;TGFB1;ABHD17C;MOAP1;TMEM173;MIPEP;TUB;CROCC;BBS1;PEX1;CEP131;MICALL2;NEURL1B;TFDP2;BNIP3L;PRKCD;BAX;TIMM17B;ZDHHC8;LEMD2;WASH3P;LRSAM1;LONP2;COG7;SESN2;ABCA7;BCAP31;NBPF3;FYN;TMCO6;SUN1;C12ORF66;RERE;CEP72;LMNA;NGFR;TOLLIP;TCTN1
2847,GO:0006336,0.991570529892736,0.050756718161756,1,50,DNA replication-independent nucleosome assembly,BP,CENPH
13086,GO:0051607,0.991609706022946,0.0186584370551403,9,162,defense response to virus,BP,HTRA1;ADARB1;BNIP3;TMEM173;IFNE;BNIP3L;DDIT4;APOBEC3C;APOBEC3F
8796,GO:0034508,0.991747665716037,0.0498837124015967,1,50,centromere complex assembly,BP,CENPH
10608,GO:0043603,0.991758634046876,0.0114447769827132,71,908,cellular amide metabolic process,BP,TNIP1;NAGS;PRNP;APOE;EGFR;HEXB;GTPBP1;ZFP36L1;RNPEPL1;MAP2K2;PC;MAP2K1;AKT1;GRB7;GGT1;IMPACT;OPLAH;SORL1;CIRBP;ZNF385A;GAS6;MRPS6;HLCS;HAGH;PCSK1;CTSZ;ZNF598;LTA4H;ADAMTS13;C8ORF88;TGFB1;UNK;MKNK2;MIPEP;ABTB1;ERO1B;ST6GALNAC6;MIF4GD;TPP1;B4GALT6;TRAP1;ERBB2;CNDP2;RNPEP;CYFIP2;THOP1;PRKCD;PCSK1N;NAGA;RPL39L;GSTO1;MRPS26;MTHFR;SESN2;ABCA7;MEX3A;PLA2G6;DALRD3;SPPL2B;EEF2K;CERS4;MAPK3;CAPRIN2;SAMD8;BIN1;IARS2;GCH1;ST3GAL5;SPTLC2;PM20D2;AARS
13273,GO:0051972,0.991781852298622,0.0501016673762697,1,42,regulation of telomerase activity,BP,MAPK3
2968,GO:0006511,0.991916447308298,0.0124087275867017,39,514,ubiquitin-dependent protein catabolic process,BP,GID4;EDEM1;BTBD2;FBXO2;MTA1;ARRDC1;WWTR1;TMEM129;RBCK1;RNF44;SMURF2;DVL1;FBXW5;RNF187;AKT1;CSNK1E;RAD23A;SHARPIN;MVB12B;MAGEF1;ABTB1;ANKZF1;UBXN4;TRIB2;USP20;STUB1;FBXW4;CUL9;CDC34;BCAP31;WFS1;RNF144A;USP21;CUL7;KCTD13;SIRT2;TOLLIP;HFE;CBLC
10100,GO:0042623,0.992037999467749,0.0141411903004332,20,292,ATPase activity, coupled,MF,SMARCA1;ERCC6;ABCD1;TNNT1;ABCA2;KIF17;ATP7B;DNAH1;KIF7;PEX1;WDR60;LONP2;CHD2;ABCG1;MYO1D;ABCA7;DDX50;ATP8B2;ATP6V1F;DHX32
10084,GO:0042590,0.992074949909717,0.0331605206648481,2,68,antigen processing and presentation of exogenous peptide antigen via MHC class I,BP,ITGB5;HLA-G
3679,GO:0008186,0.992089716716183,0.0332839511795546,2,60,RNA-dependent ATPase activity,MF,DDX50;DHX32
1469,GO:0003724,0.9920897167162,0.0332839511795378,2,60,RNA helicase activity,MF,DDX50;DHX32
2869,GO:0006366,0.992167459370379,0.00991007889205412,160,1764,transcription by RNA polymerase II,BP,TNIP1;MEF2D;ZMYND8;CITED4;HTRA1;EGR1;NR1D1;APLN;PDCD4;CTNNBIP1;ACVR2B;VEGFA;WNT7A;APOE;LRP5;ITGA6;HMGA2;ELK3;PKN1;EGFR;WWTR1;NOS1;NFATC4;ETV5;HEXB;TCFL5;ETV4;ZFP36L1;ZC3H6;MDFI;FOXQ1;MXD4;POU2F2;SMURF2;TSC22D1;FOS;SMAD3;STAT6;PIK3R2;ERCC6;DVL1;EPAS1;DNAJB5;BRD3;SALL2;AKT1;HDAC5;NFKBIZ;ASH2L;IMPACT;WWC3;FGFR1;HLTF;MXI1;KLF7;TENM2;ZNF385A;TSHZ1;CCND1;TCF25;SOX13;ZSCAN18;MYEF2;SMARCD2;DGKQ;GTF2IRD1;TAGLN3;PKD2;HES2;CRTC1;ABCA2;CTBP1;MNT;ZMIZ2;CD81;CEBPB;ZNF217;TGFB1;RFX2;DEAF1;TMEM173;PEG3;MC1R;ABHD14B;PHF21A;AGRN;MBD3;LRP4;VHL;MLXIPL;KDM6B;ZNF516;ERBB2;TFDP2;PBX2;NELFCD;RBL2;BAX;ZNF395;RPS6KA5;ZNF524;SOX12;MBTPS2;PPP1R13L;CARF;IER2;TGFBR3;LEMD2;ZHX3;SYMPK;TGFA;HDAC7;FHOD1;CHD2;CBX7;ZFPM1;PPARA;SESN2;SOX7;SIX5;SSBP4;ECM1;WFS1;ZNF444;ARID5B;HOXC5;BHLHE40;ZMYM3;SATB1;MAPK3;CAMTA2;PFKM;RERE;PPP3CB;CAPRIN2;WDTC1;HES7;ITGA3;DNMT3A;PPP2R5B;HES6;PROX1;PKD1;SIRT2;BACH1;E2F5;ZNF704;GTF2IRD2;NGFR;MAFF;NR2F6;CBX6;CAMK1;EZH1;HFE;TCEA2;PLAG1;IRF2BPL;KDM3A;SRSF5
780,GO:0002039,0.992201858608475,0.0328580052708125,2,61,p53 binding,MF,ZNF385A;TEP1
20301,GO:2001252,0.992224070777683,0.0181267910145722,8,147,positive regulation of chromosome organization,BP,ERCC1;VEGFA;NOS1;CTBP1;TGFB1;C6ORF89;RPS6KA5;MAPK3
8898,GO:0034724,0.992500862481652,0.0460869992474496,1,51,DNA replication-independent nucleosome organization,BP,CENPH
18045,GO:1902554,0.992634276201507,0.0256571422813824,3,79,serine/threonine protein kinase complex,CC,CCND1;ULK1;SESN2
5965,GO:0018393,0.992693731851384,0.0179579006289405,7,135,internal peptidyl-lysine acetylation,BP,NOS1;CTBP1;TGFB1;MBD3;RPS6KA5;JADE2;MAPK3
1464,GO:0003713,0.992839244142937,0.0133479300721744,17,262,transcription coactivator activity,MF,CITED4;NR1D1;PKN1;MTA1;WWTR1;NFATC4;KLF7;AIP;SMARCD2;MNT;ZMIZ2;SOX12;PPARA;ARID5B;RERE;USP21;FAM129B
5740,GO:0016887,0.993000344936453,0.0118820271709616,25,351,ATPase activity,MF,SMARCA1;ERCC6;HLTF;ABCD1;TNNT1;ABCA2;KIF17;ATP7B;KIF26B;DNAH1;KIF7;PEX1;WDR60;LONP2;CHD2;ABCG1;MYO1D;ABCA7;KIF26A;DDX50;ATP8B2;ATP6V1F;KIF13B;PFN2;DHX32
17861,GO:1902041,0.993053307057627,0.0435665567065379,1,44,regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,BCL2L1
3650,GO:0008135,0.993099526777917,0.0242161865642549,3,81,translation factor activity, RNA binding,MF,GTPBP1;ABTB1;EEF2K
13055,GO:0051568,0.993240569321853,0.0425538717471021,1,45,histone H3-K4 methylation,BP,ASH2L
2531,GO:0005789,0.993257644199601,0.00959051745476857,64,790,endoplasmic reticulum membrane,CC,EDEM1;PLD3;OSBPL5;LPCAT4;ITPR3;EGFR;NOS1;TMEM129;LMF1;KDSR;MCTP1;SRD5A3;PIGQ;MBOAT7;REEP4;PITPNM1;RHBDF2;IFNGR2;SIGMAR1;PIGV;CARD19;ANTXR2;PKD2;RETSAT;GPSM1;ENTPD2;TMED4;TMEM173;ERO1B;UBXN4;PTPN1;ESYT2;AREG;BOK;ULK1;NECAB3;MCFD2;REEP6;BAX;SBF1;XYLT2;MBTPS2;HSD17B7;PDIA5;LPCAT1;REEP2;TGFA;ABCG1;BCAP31;WFS1;SPPL2B;CERS4;CYP3A5;CYP2R1;RTN2;HLA-G;ATP8B2;SLC37A2;SAMD8;EDA;ALG12;HSD11B1;PDCD6;SPTLC2
10892,GO:0044445,0.993335670223848,0.0145427242656928,10,204,cytosolic part,CC,PFKL;NPR2;FYCO1;PI4K2A;RPL39L;PFKM;ADCY1;ADCY7;BLOC1S4;ADCY6
5884,GO:0018022,0.993338659256564,0.0206434668578026,4,95,peptidyl-lysine methylation,BP,ASH2L;EEF2KMT;EZH1;KDM3A
3300,GO:0007004,0.993433173570358,0.0283202572396267,2,64,telomere maintenance via telomerase,BP,MAPK3;TERC
3630,GO:0008094,0.993457027461335,0.0231432385643326,3,79,DNA-dependent ATPase activity,MF,SMARCA1;ERCC6;CHD2
11400,GO:0045815,0.993481947299179,0.0279329224004754,2,77,positive regulation of gene expression, epigenetic,BP,ERCC6;SLC50A1
6269,GO:0019866,0.993706472064829,0.0102984858611441,30,451,organelle inner membrane,CC,IDH2;CRAT;HADH;NME4;CPT2;SMAD3;PRODH;SIGMAR1;NIPSNAP1;MRPS6;SDHA;MDH2;HMGCL;TRAP1;OXA1L;BOK;CYC1;TIMM17B;LEMD2;MRPS26;PPOX;COQ2;SLC25A29;SUN1;CKMT1A;TAZ;BCL2L1;NDUFV3;SLC25A37;TST
2800,GO:0006261,0.993848928915019,0.0153593952527486,7,138,DNA-dependent DNA replication,BP,POLD4;FGFR1;WDR18;PRIMPOL;CHEK2;CDC34;ETAA1
2548,GO:0005819,0.993887980138914,0.0110359638443138,20,299,spindle,CC,FAM110C;AKT1;MAPKBP1;RAB11FIP4;CDC25B;PKD2;NUDCD2;CLTCL1;EML2;SAC3D1;TUBG2;CAPG;MZT2A;NUBP2;MZT2B;RGS14;WDR60;SIRT2;NDE1;SEPT6
10786,GO:0044265,0.993993835019547,0.00833145263606638,78,963,cellular macromolecule catabolic process,BP,GID4;H1F0;NR1D1;EDEM1;CST3;BTBD2;FBXO2;APOE;MTA1;ARRDC1;WWTR1;TMEM129;CTSO;CAPN2;VPS11;GTPBP1;ZFP36L1;RBCK1;RNF44;ENDOG;SMURF2;LRP1;DVL1;AP2A2;FBXW5;RNF187;AKT1;LDLR;CIRBP;PCBP4;CSNK1E;CTSB;PCSK9;RAD23A;BNIP3;SHARPIN;MVB12B;CTSZ;MAGEF1;CD81;GPC1;ADAMTS7;PNRC1;ABTB1;RNH1;FBXO44;ANKZF1;UBXN4;TRIB2;PRKACA;BNIP3L;PRKCD;USP20;STUB1;BAX;FBXW4;CUL9;LONP2;CHEK2;CDC34;RNF123;RAB12;BCAP31;WFS1;PAN2;RNASET2;RNF144A;CTSF;USP21;CUL7;DNASE1L1;PKD1;KCTD13;SIRT2;TOLLIP;HFE;CBLC;DEDD2
15742,GO:0072331,0.994083829325633,0.0115583506097003,15,245,signal transduction by p53 class mediator,BP,NDRG1;AKT1;ZNF385A;PCBP4;MBD3;BOK;TFDP2;RBL2;BAX;DDIT4;PPP1R13L;RPS6KA6;CHEK2;SESN2;MIF
6304,GO:0019941,0.9940931781759,0.00920524388197318,39,522,modification-dependent protein catabolic process,BP,GID4;EDEM1;BTBD2;FBXO2;MTA1;ARRDC1;WWTR1;TMEM129;RBCK1;RNF44;SMURF2;DVL1;FBXW5;RNF187;AKT1;CSNK1E;RAD23A;SHARPIN;MVB12B;MAGEF1;ABTB1;ANKZF1;UBXN4;TRIB2;USP20;STUB1;FBXW4;CUL9;CDC34;BCAP31;WFS1;RNF144A;USP21;CUL7;KCTD13;SIRT2;TOLLIP;HFE;CBLC
3813,GO:0008408,0.994108524523684,0.0379589132049166,1,46,3'-5' exonuclease activity,MF,PAN2
16884,GO:0098827,0.994115006830048,0.00841542624241621,64,794,endoplasmic reticulum subcompartment,CC,EDEM1;PLD3;OSBPL5;LPCAT4;ITPR3;EGFR;NOS1;TMEM129;LMF1;KDSR;MCTP1;SRD5A3;PIGQ;MBOAT7;REEP4;PITPNM1;RHBDF2;IFNGR2;SIGMAR1;PIGV;CARD19;ANTXR2;PKD2;RETSAT;GPSM1;ENTPD2;TMED4;TMEM173;ERO1B;UBXN4;PTPN1;ESYT2;AREG;BOK;ULK1;NECAB3;MCFD2;REEP6;BAX;SBF1;XYLT2;MBTPS2;HSD17B7;PDIA5;LPCAT1;REEP2;TGFA;ABCG1;BCAP31;WFS1;SPPL2B;CERS4;CYP3A5;CYP2R1;RTN2;HLA-G;ATP8B2;SLC37A2;SAMD8;EDA;ALG12;HSD11B1;PDCD6;SPTLC2
5559,GO:0016571,0.994138527188425,0.0167622904470016,5,111,histone methylation,BP,ASH2L;MTHFR;SATB1;EZH1;KDM3A
4783,GO:0010972,0.994152770827289,0.0208981287636257,3,87,negative regulation of G2/M transition of mitotic cell cycle,BP,FHL1;HMGA2;BRSK1
9887,GO:0042175,0.994199693293525,0.00827907044521062,65,805,nuclear outer membrane-endoplasmic reticulum membrane network,CC,EDEM1;PLD3;OSBPL5;LPCAT4;ITPR3;EGFR;NOS1;TMEM129;LMF1;KDSR;MCTP1;SRD5A3;PIGQ;MBOAT7;REEP4;PITPNM1;RHBDF2;IFNGR2;SIGMAR1;SYNE3;PIGV;CARD19;ANTXR2;PKD2;RETSAT;GPSM1;ENTPD2;TMED4;TMEM173;ERO1B;UBXN4;PTPN1;ESYT2;AREG;BOK;ULK1;NECAB3;MCFD2;REEP6;BAX;SBF1;XYLT2;MBTPS2;HSD17B7;PDIA5;LPCAT1;REEP2;TGFA;ABCG1;BCAP31;WFS1;SPPL2B;CERS4;CYP3A5;CYP2R1;RTN2;HLA-G;ATP8B2;SLC37A2;SAMD8;EDA;ALG12;HSD11B1;PDCD6;SPTLC2
10620,GO:0043624,0.994223821586547,0.0132330296669663,9,179,cellular protein complex disassembly,BP,TMOD2;TWF2;GSN;MRPS6;SPTB;CAPG;SH3BP1;MRPS26;MICAL1
686,GO:0001906,0.994278618217261,0.0250720955630365,2,70,cell killing,BP,CEACAM1;PPP3CB
6925,GO:0030532,0.99436753920817,0.0247521255447494,2,69,small nuclear ribonucleoprotein complex,CC,MAPKBP1;TEP1
6921,GO:0030520,0.994409575994474,0.0363877458118245,1,45,intracellular estrogen receptor signaling pathway,BP,PAK1
2493,GO:0005743,0.994440887116445,0.00945171138581402,26,408,mitochondrial inner membrane,CC,IDH2;CRAT;HADH;NME4;CPT2;PRODH;NIPSNAP1;MRPS6;SDHA;MDH2;HMGCL;TRAP1;OXA1L;BOK;CYC1;TIMM17B;MRPS26;PPOX;COQ2;SLC25A29;CKMT1A;TAZ;BCL2L1;NDUFV3;SLC25A37;TST
9910,GO:0042255,0.994613495851652,0.0349939430442364,1,54,ribosome assembly,BP,WDR18
13169,GO:0051784,0.994636879624584,0.0350844213988292,1,47,negative regulation of nuclear division,BP,TOM1L2
6230,GO:0019783,0.994638201620668,0.017022943794882,4,97,ubiquitin-like protein-specific protease activity,MF,JOSD2;ANKZF1;USP20;USP21
8149,GO:0032886,0.9946858562642,0.0122908778698761,9,166,regulation of microtubule-based process,BP,BBS2;ARL2;FBXW5;CEP250;EML2;CEP131;ERBB2;PAK1;PKD1
3048,GO:0006611,0.99484033666255,0.0119542060105811,9,170,protein export from nucleus,BP,RAPGEF3;STRADB;GAS6;XPOT;TGFB1;SYMPK;PKD1;CAMK1;SRSF5
5966,GO:0018394,0.995058163517564,0.0125865072293051,7,141,peptidyl-lysine acetylation,BP,NOS1;CTBP1;TGFB1;MBD3;RPS6KA5;JADE2;MAPK3
1449,GO:0003678,0.995068881584342,0.0327581969287916,1,46,DNA helicase activity,MF,CHD2
2933,GO:0006458,0.995136637913522,0.0323495015448607,1,47,'de novo' protein folding,BP,FYCO1
2872,GO:0006369,0.995380432068845,0.0208716591448909,2,69,termination of RNA polymerase II transcription,BP,SYMPK;SRSF5
6598,GO:0022625,0.995419283422826,0.0303944752171387,1,63,cytosolic large ribosomal subunit,CC,RPL39L
10969,GO:0044766,0.995464790294784,0.0205558432617263,2,68,multi-organism transport,BP,MVB12B;RAB40B
18059,GO:1902579,0.995464790294784,0.0205558432617263,2,68,multi-organism localization,BP,MVB12B;RAB40B
12156,GO:0048285,0.995686490681948,0.00759656427956984,24,353,organelle fission,BP,LRP5;OBSL1;FBXW5;CDC25B;BNIP3;TGFB1;TUBG2;TOM1L2;PIM2;TDRKH;EREG;CUL9;LEMD2;DNM1;TGFA;CHEK2;SUN1;DNM2;INF2;INSR;CUL7;SIRT2;NDE1;GPR3
9540,GO:0036297,0.995725505158361,0.0290234058518323,1,48,interstrand cross-link repair,BP,ERCC1
8819,GO:0034605,0.995729655751296,0.0126095629856973,5,114,cellular response to heat,BP,PRKACA;STUB1;IRAK1;MAPK3;PDCD6
14661,GO:0070268,0.995768012197597,0.0193048903728985,2,73,cornification,BP,PRSS8;PPL
10530,GO:0043484,0.995833592589181,0.0135889955878149,4,100,regulation of RNA splicing,BP,KHDRBS3;AHNAK2;CLK3;SRSF5
5682,GO:0016796,0.995838177657229,0.0283548257200152,1,49,exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters,MF,PAN2
10628,GO:0043632,0.995890166658813,0.00651334033521272,39,531,modification-dependent macromolecule catabolic process,BP,GID4;EDEM1;BTBD2;FBXO2;MTA1;ARRDC1;WWTR1;TMEM129;RBCK1;RNF44;SMURF2;DVL1;FBXW5;RNF187;AKT1;CSNK1E;RAD23A;SHARPIN;MVB12B;MAGEF1;ABTB1;ANKZF1;UBXN4;TRIB2;USP20;STUB1;FBXW4;CUL9;CDC34;BCAP31;WFS1;RNF144A;USP21;CUL7;KCTD13;SIRT2;TOLLIP;HFE;CBLC
19835,GO:2000278,0.995927093312618,0.0152398584315878,3,84,regulation of DNA biosynthetic process,BP,FGFR4;MAPK3;FAM129B
15426,GO:0071704,0.995988419873097,0.00480253603824425,795,7950,organic substance metabolic process,BP,TNIP1;DUSP6;NT5E;XDH;ERCC1;DUSP5;MEF2D;GID4;ZMYND8;H1F0;CITED4;HTRA1;THSD4;EGR1;NR1D1;SLC16A3;H6PD;EDEM1;DLG4;PLAT;CST3;CYP27B1;TYSND1;BTBD2;FBXO2;APLN;PDCD4;CTNNBIP1;NAGS;ACVR2B;XPC;PRNP;PYGB;BBS2;SLC6A8;VEGFA;TNFRSF6B;PGM1;WNT7A;APOE;PYGL;DGKA;NAGLU;F2R;LRP5;PLD3;OSBPL5;LPCAT4;ITGA6;ISYNA1;HMGA2;OBSCN;IDH2;ZKSCAN1;NEK9;CRAT;ELK3;PKN1;MTA1;GRAMD4;ACOT7;ARRDC1;ACSF2;NISCH;AKR7A2;EGFR;RPS6KA2;SERPINE2;DNPH1;WWTR1;LOXL1;OBSL1;NOS1;PTPRS;TMEM129;SLC2A9;HADH;CTSO;SPRY2;CAPN2;MST1R;NFATC4;BAHCC1;CRTAP;LTBP4;PRSS8;SDC1;KLHL29;ETV5;LMF1;SHC1;DDB2;VPS11;LTBP1;HEXB;GTPBP1;SLC7A8;TCFL5;PTPRE;NPEPL1;SLC2A3;ALDH4A1;TK2;ACTA2;MMP1;ETV4;PHLDA2;SNX9;TRNP1;SPRY4;RAPGEF3;ST6GALNAC2;ZFP36L1;GAA;GLUL;RNPEPL1;ARAP1;MAP2K2;KDSR;NME4;ZC3H6;LPAR3;MARCH9;CTBS;PLCD3;FKBP9;MDFI;PTOV1;SMARCA1;PPP1R35;RBCK1;PLTP;PGLS;PC;FOXQ1;RNF44;MAP2K1;NAPRT;CRYL1;ACP5;CPT2;NYNRIN;MXD4;SSH1;POU2F2;ENDOG;MARK4;GALE;SMURF2;TSC22D1;FOS;FBLN1;SMAD3;STAT6;PIK3R2;ERCC6;LRP1;GJC2;SRD5A3;DVL1;EPAS1;DNAJB5;PIGQ;HSD17B8;HBEGF;RPUSD3;AP2A2;PPP1R14A;SH3PXD2B;PPP2R3B;PRDX5;SHC2;BRD3;PRODH;SALL2;MBOAT7;CDK18;LY6K;FBXW5;ZXDC;RNF187;NMRK1;ADORA2B;ADARB1;PLCXD2;D2HGDH;SLC6A6;AKT1;GRB7;HDAC5;UROS;FBXO41;F12;PPM1F;MMP28;PITPNM1;ENTPD6;RHBDF2;PYCR2;BSG;STK39;HK1;SERPING1;SCMH1;EPHA1;GGT1;NFKBIZ;PTPRU;VEGFB;ASH2L;IMPACT;MARCH4;WWC3;ZFYVE21;CNTN1;BRSK1;DAP;PTHLH;RAB31;FGFR4;POLD4;ACOT1;LDLR;FGFR1;PRKACB;FUCA1;MAPKBP1;RAC2;KCNAB2;PFKL;TTLL12;SEC14L2;OPLAH;HLTF;MXI1;PPM1J;RAG1;GAMT;H2AFJ;B4GAT1;BPHL;PIGV;KLF7;SORL1;NAT14;CEACAM1;B3GAT3;ASB13;CIRBP;CBR4;HMG20B;TENM2;ZNF385A;NSMCE4A;ABCD1;ANK3;IGFBP4;TTC7B;TSHZ1;TRAPPC9;CCND1;PODNL1;PCBP4;TCF25;LHPP;AIG1;STRADB;SYNGAP1;PLCH2;MAPK13;PLAU;GAS6;PTK6;PFKP;CSNK1E;CTSB;RAB3B;CARD11;SOX13;DUSP7;GSN;MAPKAPK3;IGFBP2;PCSK9;ARHGAP22;RAD23A;DHTKD1;PHLDA1;ANO8;BCR;ANGPTL4;MRPS6;EHD4;ERRFI1;GLI4;NADK;PANK4;HLCS;ZSCAN18;PRSS22;AIP;CCDC71L;MYEF2;MN1;SH3D19;CDC25B;ALOX15B;SPTB;SMARCD2;PEX10;GGACT;RSAD1;RRNAD1;NPR2;SNTA1;DGKQ;HAGH;BNIP3;PAK6;TFPI2;GTF2IRD1;SHARPIN;MVB12B;SERINC2;TAGLN3;CEMIP;PKD2;ACY1;PCSK1;RETSAT;RASGEF1A;CTSZ;CDC42EP5;HES2;CRTC1;FBXW8;ABCA2;ZNF598;MAGEF1;PRSS3;EPHB2;ADAM8;APRT;CTBP1;JOSD2;LTA4H;MNT;PTPDC1;GRK6;CDKN1C;PLCG1;FBXL8;ZMIZ2;CBS;CD81;CEBPB;MVD;RNF135;ENTPD2;ADAMTS13;ZNF217;TIMP2;ZNF862;SYNJ2;WNT3;DPP7;C8ORF88;TGFB1;LACTB2;RFX2;SCYL1;ABHD17C;UNK;ULK2;GPC1;MKNK2;ADAMTS7;DEAF1;NTSR1;B3GNT3;NAB2;TMEM173;ZSCAN30;SHANK3;PODXL2;SDHA;MSRB2;RASA3;PNRC1;MIPEP;PIP5KL1;TNFSF15;MGAT4B;MDH2;MPG;GALNS;FBXO17;CLCA2;HEXDC;NSMF;PEG3;MC1R;LCE1E;ABHD14B;LAMB2;ABTB1;SNX17;RNH1;ERO1B;ST6GALNAC6;VGF;POLL;FBXO44;POLM;SNX33;PI4K2A;PTMS;ANKZF1;PHGDH;PHF21A;MIF4GD;PLPP6;UBXN4;ADAM19;KHDRBS3;ZER1;HMGCL;PTPN1;TPP1;PCK2;B4GALT2;AGRN;MBD3;IFNE;CD320;CAMK2N1;OSBPL10;LRP4;LRP10;ESYT2;ZDHHC24;ACP6;B4GALT6;VHL;TRAP1;IDUA;PFKFB2;RFNG;MLXIPL;TRIB2;PRKCZ;KDM6B;PRKACA;MINK1;ZNF516;GRHPR;RABGGTA;CD9;ADA;AREG;PIM2;MPI;UCKL1;BOK;WDR18;TDRKH;ALAS1;NEURL1B;ERBB2;ULK1;CNDP2;AHCY;PRIMPOL;MMP10;TFDP2;C6ORF89;NECAB3;STK17A;JAK3;IRF2BP2;RNPEP;BNIP3L;CYFIP2;PBX2;TRPC1;NELFCD;RASA4;PDK1;ACAD10;CYGB;THOP1;MCFD2;PRKCD;FAM20C;MIB2;RBL2;USP20;STUB1;IFI6;BAX;CYC1;SBF1;DTD1;XYLT2;TRIM4;ITGA1;ZNF395;PPCS;FBXW4;EREG;RPS6KA5;DGUOK;DUSP4;ZNF524;CUL9;SOX12;DDIT4;MBTPS2;ACADS;TOP3B;PPP1R13L;CARF;HSD17B7;AHNAK2;PCSK1N;IER2;CES2;NAGA;ZDHHC8;LIMK1;TGFBR3;PADI3;DIP2A;LTB4R2;CPNE7;RPL39L;LEMD2;RPS6KA6;ZHX3;DNM1;RGS14;MFNG;GSTO1;ALDOC;CHAD;MRPS26;MSLN;LPCAT1;LRSAM1;ADAM15;ASB1;EHD3;ST3GAL3;LONP2;SYMPK;MAPK12;IRAK1;PPOX;TGFA;HDAC7;FHOD1;INPP5D;MTHFR;CHD2;PI4K2B;CBX7;PCMTD2;CHEK2;DECR2;ZFPM1;PPARA;COG7;ABHD15;COQ2;TMEM161A;SESN2;FGGY;ABCG1;JADE2;CDC34;RNF123;SOX7;ABCA7;RAB12;SPEG;SIX5;BCAP31;MIF;ACO2;SMOX;EEF2KMT;KDM4B;PHYH;ZNF414;MEX3A;PLA2G6;DDT;SSBP4;NUDT14;ECM1;WFS1;QSOX1;ZNF444;DTX3;TRPT1;DALRD3;SPPL2B;FYN;PITPNM3;VWA1;UPP1;STK25;ETFB;GLB1L2;EEF2K;CERS4;ARID5B;HOXC5;DNM2;CKMT1A;CYP3A5;BHLHE40;GLB1;PELI1;CHKA;CAT;NEIL1;TSPYL2;IGFBP7;ELFN2;SLC27A1;ZMYM3;APOBEC3C;SATB1;SLC50A1;ZDHHC1;PLCB3;ZNF606;APOBEC3F;DDX50;CYP2R1;MAPK3;INSR;PAN2;CAMTA2;TAZ;PFKM;ADCY1;RERE;TSTA3;INO80C;GPT2;PDXK;ETAA1;GLRX;BCL7A;VANGL2;PAK1;DCAF10;KLHL36;CAMKK2;RNASET2;PPP3CB;RNF144A;ALPK1;CTSF;USP21;PFKFB3;MLYCD;CUL7;GABBR1;REV1;MICAL1;HYAL1;SEMA4C;CAPRIN2;ZBTB10;WDTC1;HES7;ITGA3;STK32C;DNMT3A;SAMD8;BIN1;MAN2B1;SRMS;PPP2R5B;HES6;MAP2K3;NDST2;DLG3;ABHD10;NDUFV3;RRAS;DNASE1L1;PROX1;IARS2;MDGA1;TBC1D16;ADGRF1;ALDH7A1;ZYG11B;PKD1;KCTD13;TNFRSF25;SIRT2;FAM129B;EDA;UVSSA;GAL3ST4;NMNAT2;BACH1;NT5C1B;ADCY7;E2F5;ZBTB22;ALG12;MAPRE3;AZIN2;TEP1;ZNF704;SERPINB1;ST3GAL2;YDJC;LAMB1;SOCS7;MAP3K10;HSD11B1;PELI3;GTF2IRD2;RAB40B;NGFR;TOLLIP;BCORL1;PDCD6;CHST14;ZNF837;RNASE7;PHYKPL;DUSP23;GCH1;MAFF;NR2F6;CBX6;CAMK1;CAMKK1;EZH1;SIRT3;HFE;TERC;ZNF513;WIPI2;BTG1;ZP3;MLF2;CDK11B;PFN2;SSH3;FGFR3;PPP1R16A;TST;CCDC88C;ST3GAL5;TNRC18;NDRG2;MAN2B2;CBLC;ITPKB;PTGR2;SPTLC2;TCEA2;CDC42BPG;PRSS21;ZBTB47;PLAG1;CLK3;IRF2BPL;DHX32;KDM3A;PM20D2;TBL3;SLC23A2;PKN3;APBA1;TTLL3;DEDD2;PI4KAP2;AK3;SRSF5;CHPF;ADCY6;LRRK1;AARS;KLHL24;SDC2
10877,GO:0044424,0.996039576539865,0.00503475733779908,1071,10452,intracellular part,CC,TNIP1;DUSP6;NT5E;XDH;ERCC1;DUSP5;MEF2D;ZMYND8;H1F0;CITED4;HTRA1;FHL1;EGR1;B4GALNT4;NR1D1;SLC16A3;H6PD;CCNG2;EDEM1;DLG4;PLAT;CST3;CYP27B1;TYSND1;HS1BP3;BTBD2;MARVELD1;EPN3;FBXO2;APLN;PRR7;PDCD4;CTNNBIP1;NAGS;ACVR2B;DOCK4;XPC;PRNP;PARVB;PYGB;BBS2;FLNC;DDIT4L;POSTN;VEGFA;FAM210B;PGM1;WNT7A;APOE;PYGL;DGKA;TSPAN1;ESPN;NAGLU;F2R;LRP5;PLD3;OSBPL5;LPCAT4;ISYNA1;PITPNC1;HMGA2;OBSCN;NDRG1;IDH2;ZKSCAN1;NEK9;CRAT;ELK3;ITPR3;PKN1;MTA1;GRAMD4;ACOT7;ARRDC1;ANGEL1;ACSF2;NISCH;AKR7A2;EGFR;RPS6KA2;SERPINE2;DNPH1;WWTR1;LOXL1;OBSL1;NOS1;VAT1;PTPRS;TMEM129;SLC2A9;ANKS6;HADH;CTSO;SPRY2;CAPN2;MST1R;NFATC4;TRIM65;BAHCC1;CRTAP;SYTL1;SDC1;KLHL29;ETV5;LMF1;APPL2;SHC1;DDB2;VPS11;LTBP1;TBC1D14;ARL2;HEXB;GTPBP1;SLC7A8;TCFL5;PTPRE;NPEPL1;SLC2A3;ALDH4A1;TK2;RIN1;ACTA2;CLIP2;ETV4;PHLDA2;SNX9;NUDCD3;TRNP1;SPRY4;RAPGEF3;TXNRD3;ST6GALNAC2;ZFP36L1;GAA;GLUL;RNPEPL1;ARAP1;MAP2K2;KDSR;NME4;ZC3H6;MARCH9;CTBS;PLCD3;FKBP9;MDFI;PTOV1;SMARCA1;RBCK1;SUGCT;PGLS;PC;FOXQ1;RNF44;MAP2K1;NAPRT;CRYL1;ACP5;CPT2;VWA5A;MCTP1;MXD4;SSH1;POU2F2;EXOC2;ENDOG;MARK4;MARCKSL1;MPRIP;TMEM8A;GALE;SMURF2;KLC2;TSC22D1;ARMCX2;OXLD1;SLC9A3R2;FOS;SMAD3;ARHGAP23;STAT6;SHANK2;PIK3R2;ERCC6;LRP1;SRD5A3;DVL1;EPAS1;DNAJB5;PIGQ;HSD17B8;THBS3;HBEGF;FAM110C;RPUSD3;AP2A2;S100A4;CYBRD1;PPP1R14A;SH3PXD2B;PPP2R3B;PRDX5;SHC2;STOM;BRD3;PRODH;SALL2;MBOAT7;CDK18;REEP4;LY6K;FBXW5;ZXDC;RNF187;NMRK1;ADARB1;PLCXD2;D2HGDH;SYT8;AKT1;TPCN1;GRB7;TMOD2;CORO1B;HDAC5;UROS;FBXO41;FAM83A;S100A6;F12;SH2D2A;PPM1F;MMP28;PITPNM1;ENTPD6;PLEKHH3;RHBDF2;PYCR2;BSG;STK39;HK1;SERPING1;ASAP2;SCMH1;DYSF;EPHA1;PHC2;NFKBIZ;VEGFB;FMNL2;ASH2L;IMPACT;MARCH4;SLC15A4;WWC3;ATG16L2;ZFYVE21;LRRC8A;IFNGR2;BRSK1;IFT140;PTHLH;MYZAP;RAB31;DNAAF5;FGFR4;HEBP1;WNT2B;POLD4;ACOT1;FNDC4;LDLR;FGFR1;PRKACB;FUCA1;MAPKBP1;ELMO3;SIGMAR1;RAC2;KCNAB2;PFKL;SEC14L2;OPLAH;HLTF;MXI1;NPHP4;SYNE3;RAG1;GAMT;H2AFJ;B4GAT1;PACS2;PHF7;TOMM34;BPHL;PIGV;KLF7;RALGDS;SORL1;NAT14;CEACAM1;B3GAT3;ASB13;CIRBP;CBR4;HMG20B;LZTS2;RAB11FIP4;TENM2;ZNF385A;DOCK6;NSMCE4A;MICALCL;ABCD1;ANK3;NIPSNAP1;IGFBP4;TTC7B;EVC;TSHZ1;TRAPPC9;CCND1;PODNL1;EFS;PCBP4;TCF25;LHPP;TNNT1;TWF2;STRADB;SYNGAP1;PLCH2;MAPK13;CEP250;CARD19;PLAU;GAS6;PTK6;PFKP;CSNK1E;R3HDM4;BRI3;CTSB;RAB3B;CARD11;SH2B3;SOX13;LAMA5;DUSP7;MPLKIP;GSN;PLEKHG2;MAPKAPK3;IGFBP2;PCSK9;ARHGAP22;RAD23A;DHTKD1;PHLDA1;ANO8;BCR;ANTXR2;XPOT;MRPS6;EHD4;ERRFI1;GLI4;SEPT10;WIPF1;NADK;PANK4;HLCS;ZSCAN18;AIP;DBNDD1;STON1;MYEF2;SH3D19;CCDC113;CDC25B;SH3GLB2;ARHGAP27;ALOX15B;SPTB;SMARCD2;AGAP1;COMTD1;RSPH3;PEX10;CCS;RSAD1;COL13A1;CORO7;NPR2;UNC119B;SNTA1;DGKQ;HAGH;BNIP3;PAK6;NOL4L;GTF2IRD1;SHARPIN;MVB12B;TAGLN3;FYCO1;CEMIP;PROCR;PKD2;ACY1;PCSK1;RETSAT;YPEL3;RASGEF1A;CTSZ;CDC42EP5;HES2;CRTC1;FBXW8;GPSM1;AP3D1;ITGB5;ABCA2;PRSS3;SH3PXD2A;C19ORF33;EPHB2;ADAM8;ASIC1;APRT;TMEM9;CTBP1;JOSD2;LTA4H;MNT;PTPDC1;GRIP2;CDKN1C;PLCG1;FBXL8;ZMIZ2;CBS;KIF17;CEBPB;MVD;RNF135;ENTPD2;LGALS9B;ADAMTS13;ZNF217;TIMP2;ZNF862;NUDCD2;SYNJ2;WNT3;DPP7;GNAL;C8ORF88;TMED4;TGFB1;LACTB2;SNPH;CLTCL1;RFX2;SCYL1;ABHD17C;UNK;SNTB2;ULK2;GPC1;MKNK2;ADAMTS7;DEAF1;MOAP1;SLC38A10;NTSR1;B3GNT3;NAB2;TMEM173;ARHGAP25;TMEM134;ZSCAN30;ATP7B;FHOD3;SHANK3;PODXL2;SDHA;MSRB2;RASA3;PNRC1;MIPEP;PIP5KL1;MYCBPAP;MGAT4B;EML2;KIF26B;MDH2;MPG;GALNS;FBXO17;CLCA2;HEXDC;GOLGA2P5;ENKD1;NSMF;PEG3;ARAP3;SCART1;FARP1;TUB;DIRC2;LCE1E;CROCC;RHOD;ABHD14B;LAMB2;TNS1;ABTB1;SNX17;RNH1;DNAH1;ERO1B;ST6GALNAC6;VGF;POLL;FBXO44;POLM;SNX33;PI4K2A;SEMA4F;C1ORF210;PTMS;RHOF;YIPF3;ANKZF1;WASF3;ATG2A;SLC48A1;LLGL1;PHGDH;PHF21A;MIF4GD;KIF7;COA5;RHOBTB2;UBXN4;ADAM19;KHDRBS3;SAC3D1;TUBG2;ZER1;RIMS3;BBS1;TNFAIP8L1;HMGCL;PTPN1;PEX1;TPP1;PCK2;B4GALT2;WDR59;AGRN;MBD3;CD320;OSBPL10;ESYT2;ZDHHC24;ACP6;B4GALT6;VHL;MYH16;CEP131;TRAP1;IDUA;ADAP1;PFKFB2;RFNG;MLXIPL;YPEL5;TRIB2;PRKCZ;KDM6B;PRKACA;MINK1;ZNF516;CENPH;GRHPR;OXA1L;RHPN1;RABGGTA;RCCD1;ACTR1B;CD9;EPN2;ADA;AREG;PIM2;MPI;MICALL2;UCKL1;LGALS9C;PLEKHG5;BOK;WDR18;TDRKH;CAPG;SDCCAG8;ALAS1;NEURL1B;ERBB2;ADGRB2;ULK1;CNDP2;NINL;AHCY;VAMP2;CERCAM;PRIMPOL;TMEM143;TFDP2;SMTN;PLEK2;C6ORF89;MZT2A;NECAB3;STK17A;RILPL1;FAM50A;JAK3;IRF2BP2;RNPEP;NET1;BNIP3L;CYFIP2;FSCN1;PBX2;NELFCD;SLC22A17;RASA4;GLCCI1;PDK1;ACAD10;CYGB;ARHGAP44;THOP1;EHBP1L1;MCFD2;PRKCD;FAM20C;MIB2;REEP6;RBL2;CACNB3;USP20;STUB1;IFI6;BAX;CYC1;SV2A;SBF1;DTD1;XYLT2;TRIM4;ITGA1;OLFM2;ZNF395;HIST3H2BB;CCDC92;NUBP2;PPCS;SH3BP1;FBXW4;GJB4;RPS6KA5;DGUOK;DUSP4;KLHDC2;TIMM17B;ZNF524;CUL9;SOX12;PLEKHH1;TMBIM4;DDIT4;MBTPS2;ACADS;TOP3B;PPL;PPP1R13L;CARF;HSD17B7;AHNAK2;PCSK1N;MT2A;IER2;CES2;NAGA;ZDHHC8;TMX4;MZT2B;FCHO1;LIMK1;TGFBR3;PDIA5;GDI1;TPM2;PADI3;DIP2A;LTB4R2;CPNE7;SLC2A11;RPL39L;LEMD2;RPS6KA6;TMEM92;ZHX3;DNM1;WASH3P;RGS14;TMEM8B;SCN8A;MFNG;GSTO1;GIT1;ALDOC;CHAD;MRPS26;MSLN;LPCAT1;LRSAM1;ADAM15;REEP2;ASB1;EHD3;WDR60;ST3GAL3;LONP2;SYMPK;MAPK12;IRAK1;PPOX;TGFA;HDAC7;FHOD1;INPP5D;MTHFR;CHD2;PI4K2B;CBX7;PCMTD2;CHEK2;DTNB;DECR2;ZFPM1;PPARA;COG7;COQ2;SESN2;ABCG1;MYO1D;JADE2;MYH15;CDC34;RNF123;SNN;SOX7;ABCA7;RAB12;EML3;SPEG;SIX5;BCAP31;MIF;ACO2;SMOX;EEF2KMT;KDM4B;SLC25A29;DOPEY2;PHYH;ZNF414;MEX3A;SLC9A7;PLA2G6;DDT;SSBP4;SYNGR1;NUDT14;ECM1;NARF;WFS1;QSOX1;DNAAF3;CD68;ZNF444;SLC22A18;DTX3;NBPF3;SPPL2B;HSD11B1L;FYN;PITPNM3;VWA1;UPP1;STK25;RAC3;ETFB;GLB1L2;EEF2K;CERS4;SUN1;ARHGAP12;FLYWCH1;ACAP3;ARID5B;HOXC5;DNM2;CKMT1A;CYP3A5;BHLHE40;GLB1;PELI1;ATXN10;SNX15;INF2;CHKA;CAT;BEX2;NEIL1;TSPYL2;KIAA1147;IGFBP7;ARMCX1;SLC27A1;ZMYM3;TPBG;APOBEC3C;SATB1;SLC50A1;KIF26A;ASMTL;ZDHHC1;SLC12A4;PLCB3;H1FX;IQSEC1;ZNF606;APOBEC3F;ARHGEF4;DDX50;CYP2R1;TUBB6;MAPK3;CBLN3;INSR;RTN2;ARHGEF1;PAN2;GRINA;PDZD2;CAMTA2;TAZ;PFKM;ADCY1;TNS4;C12ORF66;RERE;HLA-G;DOCK9;STX10;TSTA3;INO80C;ATP8B2;GPT2;RALGAPA1;MORN4;PDXK;ETAA1;PRAF2;GLRX;CEP72;VANGL2;PAK1;TRIM45;CDYL2;DCAF10;KLHL36;MALL;CAMKK2;RNASET2;PPP3CB;RNF144A;LGALS3BP;ALPK1;CTSF;USP21;PFKFB3;MLYCD;CUL7;SLC37A2;GABBR1;REV1;MICAL1;HYAL1;SEMA4C;CAPRIN2;ZBTB10;WDTC1;HES7;ITGA3;DNMT3A;SAMD8;BIN1;VPS16;MAN2B1;SRMS;TSTD1;PPP2R5B;HES6;SLC16A13;MAP2K3;NDST2;BCL2L1;DLG3;SGSM2;ABHD10;NDUFV3;DNASE1L1;PROX1;IARS2;LRCH4;TBC1D16;ALDH7A1;LMNA;ZYG11B;PKD1;KCTD13;TNFRSF25;RABGAP1;SIRT2;FAM129B;EDA;UVSSA;ANKRD13D;GAL3ST4;NMNAT2;BACH1;NT5C1B;TRIP10;ADCY7;E2F5;ZBTB22;ALG12;AFAP1L1;MAPRE3;AZIN2;TEP1;RAB28;ZNF704;SERPINB1;ST3GAL2;ICA1;SLC25A37;RAP1GAP2;LAMB1;SOCS7;MAP3K10;HSDL1;RGS19;NDE1;HSD11B1;PELI3;GTF2IRD2;RAB40B;NGFR;TOLLIP;BCORL1;PDCD6;ATP6V1F;PCLO;ARVCF;CHST14;BIVM;ZNF837;RNASE7;PXN;GRB10;PHYKPL;PLEKHM1;DUSP23;GCH1;MSS51;LURAP1;KIF13B;MAFF;NR2F6;CBX6;TCTN1;NBEAL2;PNMA1;CAMK1;CAMKK1;EZH1;SIRT3;HFE;TERC;ZNF513;WIPI2;GAS2L1;COL6A1;BTG1;VPS51;FAM117A;CELSR1;TACC1;MLF2;IL17RE;SEMA3B;SEPT6;CDK11B;PFN2;C2CD2;SSH3;FGFR3;MFSD10;TST;CCDC88C;ST3GAL5;TNRC18;NDRG2;MAN2B2;BLOC1S4;CBLC;ITPKB;PTGR2;SPTLC2;TCEA2;CDC42BPG;PRSS21;ZBTB47;PLAG1;DOK4;GSDMA;CLK3;IRF2BPL;TRIM46;DHX32;KDM3A;PM20D2;TMEM187;FAM214B;TBL3;HOMER2;SLC23A2;PKN3;APBA1;TTLL3;DEDD2;PI4KAP2;AK3;SRSF5;CHPF;ADCY6;SLC26A11;LRRK1;AARS;KLHL24;STRN4;SDC2
4957,GO:0015030,0.99607036402394,0.0269744985486077,1,51,Cajal body,CC,TERC
3908,GO:0008565,0.996195675495863,0.0176157660499832,2,72,protein transporter activity,MF,LRP1;TIMM17B
17308,GO:0140101,0.996201107165293,0.0113363384375297,5,118,catalytic activity, acting on a tRNA,MF,DTD1;TRPT1;DALRD3;IARS2;AARS
8216,GO:0032984,0.996207020570295,0.00748518999763099,16,275,protein-containing complex disassembly,BP,LRP5;DVL1;TMOD2;TWF2;GSN;MRPS6;SPTB;SMARCD2;BNIP3;FYCO1;CAPG;SH3BP1;MRPS26;INSR;MICAL1;VPS16
132,GO:0000278,0.996271667026027,0.0053021395631315,74,911,mitotic cell cycle,BP,FHL1;XPC;LRP5;HMGA2;NEK9;EGFR;OBSL1;SPRY2;SNX9;ZFP36L1;MAP2K2;MAP2K1;SMAD3;GJC2;REEP4;FBXW5;AKT1;STK39;BRSK1;FGFR1;ZNF385A;ANK3;CCND1;PCBP4;STRADB;CEP250;CSNK1E;PHLDA1;SEPT10;CDC25B;PAK6;PKD2;CDKN1C;TIMP2;TGFB1;CLTCL1;SNX33;TUBG2;CEP131;PRKACA;MINK1;TOM1L2;PIM2;SDCCAG8;NINL;TFDP2;RBL2;BAX;EREG;CUL9;RGS14;TMEM8B;TGFA;CHEK2;CDC34;STK25;DNM2;TUBB6;INSR;CEP72;PAK1;CUL7;HYAL1;DNMT3A;MAP2K3;BCL2L1;LMNA;PKD1;SIRT2;BACH1;NDE1;BTG1;SEPT6;CDK11B
4249,GO:0009451,0.996285497330317,0.0103005190654397,6,133,RNA modification,BP,RPUSD3;ADARB1;RRNAD1;APOBEC3C;APOBEC3F;AARS
9037,GO:0035257,0.996301612382628,0.0102657717620295,6,131,nuclear hormone receptor binding,MF,PKN1;SMAD3;CEBPB;PROX1;GAS2L1;KDM3A
4512,GO:0010564,0.996347971081033,0.00561149742829737,47,622,regulation of cell cycle process,BP,FHL1;XPC;LRP5;HMGA2;EGFR;OBSL1;ZFP36L1;GJC2;FBXW5;AKT1;BRSK1;FGFR1;RAB11FIP4;ZNF385A;CCND1;PCBP4;CEP250;CSNK1E;CDC25B;PKD2;TGFB1;CEP131;MLXIPL;PRKACA;TOM1L2;SDCCAG8;NINL;TFDP2;RBL2;BAX;EREG;CUL9;GIT1;TGFA;CHEK2;MIF;INSR;CEP72;CUL7;HYAL1;BIN1;PPP2R5B;BCL2L1;PKD1;SIRT2;NDE1;GPR3
154,GO:0000313,0.996401846676366,0.0166815281994484,2,84,organellar ribosome,CC,MRPS6;MRPS26
2506,GO:0005761,0.996401846676366,0.0166815281994484,2,84,mitochondrial ribosome,CC,MRPS6;MRPS26
6901,GO:0030490,0.996455809472268,0.0246938384057761,1,53,maturation of SSU-rRNA,BP,TBL3
137,GO:0000288,0.996524281142808,0.0162891960877093,2,72,nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,ZFP36L1;PAN2
1147,GO:0002753,0.996677638426388,0.0234542442486997,1,50,cytoplasmic pattern recognition receptor signaling pathway,BP,IRAK1
15085,GO:0071103,0.996740613423264,0.00690929953456241,13,246,DNA conformation change,BP,H1F0;XPC;HMGA2;BAHCC1;DDB2;SMARCA1;CENPH;HIST3H2BB;TOP3B;CHD2;TSPYL2;H1FX;TNRC18
2870,GO:0006367,0.996782474792189,0.00849926100509138,7,150,transcription initiation from RNA polymerase II promoter,BP,NR1D1;CTNNBIP1;WWTR1;CCND1;BAX;PPARA;NR2F6
531,GO:0001650,0.996799346728302,0.00971238081189678,5,119,fibrillar center,CC,PAK6;DEAF1;RPS6KA6;INO80C;E2F5
4547,GO:0010629,0.996836068816954,0.00423307071650552,120,1435,negative regulation of gene expression,BP,XDH;ZMYND8;EGR1;NR1D1;APLN;PDCD4;CTNNBIP1;ACVR2B;PRNP;BBS2;VEGFA;HMGA2;ELK3;EGFR;SERPINE2;WWTR1;NFATC4;BAHCC1;SHC1;GTPBP1;TCFL5;ZFP36L1;MAP2K2;ZC3H6;MDFI;PC;FOXQ1;MAP2K1;MXD4;SMURF2;SMAD3;STAT6;DNAJB5;PRDX5;SALL2;AKT1;GRB7;HDAC5;PPM1F;SERPING1;SCMH1;IMPACT;WWC3;DAP;LDLR;FGFR1;MXI1;H2AFJ;CIRBP;TENM2;TSHZ1;CCND1;PCBP4;TCF25;GAS6;DGKQ;TAGLN3;CTSZ;HES2;CTBP1;MNT;CDKN1C;CEBPB;ZNF217;C8ORF88;TGFB1;UNK;DEAF1;NAB2;PNRC1;PEG3;RNH1;PHF21A;MBD3;VHL;MLXIPL;TDRKH;TFDP2;NELFCD;PRKCD;RBL2;EREG;RPS6KA5;PPP1R13L;DIP2A;ZHX3;HDAC7;CBX7;ZFPM1;PPARA;SESN2;SOX7;SIX5;MIF;MEX3A;WFS1;FYN;ARID5B;BHLHE40;SATB1;PAN2;RERE;BCL7A;CAPRIN2;WDTC1;HES7;DNMT3A;HES6;PROX1;SIRT2;FAM129B;BACH1;MAP3K10;NR2F6;CBX6;ZP3;TNRC18;PLAG1;IRF2BPL;DEDD2
7222,GO:0031124,0.996872984970441,0.012047228871843,3,88,mRNA 3'-end processing,BP,ZFP36L1;SYMPK;SRSF5
17282,GO:0140014,0.996877530600109,0.00650313806246811,14,239,mitotic nuclear division,BP,LRP5;OBSL1;FBXW5;TGFB1;TUBG2;TOM1L2;EREG;CUL9;TGFA;CHEK2;INSR;CUL7;SIRT2;NDE1
15959,GO:0075733,0.996956460435407,0.0217441301029061,1,52,intracellular transport of virus,BP,MVB12B
14578,GO:0070125,0.99707097442579,0.0139357323262433,2,86,mitochondrial translational elongation,BP,MRPS6;MRPS26
3621,GO:0008080,0.997076240351828,0.0140165929767529,2,72,N-acetyltransferase activity,MF,NAGS;NAT14
1855,GO:0004518,0.997093493854373,0.00704764089857769,9,178,nuclease activity,MF,ERCC1;ENDOG;RAG1;LACTB2;NEIL1;PAN2;RNASET2;DNASE1L1;RNASE7
7713,GO:0032210,0.997094136785852,0.0209317847424514,1,51,regulation of telomere maintenance via telomerase,BP,MAPK3
10973,GO:0044772,0.997118644395866,0.00477624831516276,34,485,mitotic cell cycle phase transition,BP,FHL1;XPC;HMGA2;EGFR;ZFP36L1;GJC2;AKT1;BRSK1;ZNF385A;CCND1;PCBP4;CEP250;CSNK1E;PHLDA1;CDC25B;PKD2;TGFB1;CEP131;PRKACA;PIM2;SDCCAG8;NINL;TFDP2;RBL2;BAX;CHEK2;CDC34;DNM2;CEP72;HYAL1;PKD1;SIRT2;BACH1;NDE1
8931,GO:0034968,0.997127110806601,0.0111714925852602,3,89,histone lysine methylation,BP,ASH2L;EZH1;KDM3A
3595,GO:0008026,0.99718328927696,0.0109887252904706,3,87,ATP-dependent helicase activity,MF,CHD2;DDX50;DHX32
14527,GO:0070035,0.99718328927696,0.0109887252904706,3,87,purine NTP-dependent helicase activity,MF,CHD2;DDX50;DHX32
7553,GO:0031902,0.9971968860923,0.00951629896525293,4,106,late endosome membrane,CC,VPS11;MVB12B;TMEM9;VPS16
14787,GO:0070507,0.997223663718654,0.00743220543346239,7,148,regulation of microtubule cytoskeleton organization,BP,ARL2;FBXW5;CEP250;EML2;CEP131;PAK1;PKD1
116,GO:0000245,0.997226095937284,0.0200881731562179,1,53,spliceosomal complex assembly,BP,SRSF5
18251,GO:1903051,0.997252035969379,0.0199113451315545,1,54,negative regulation of proteolysis involved in cellular protein catabolic process,BP,HFE
9012,GO:0035195,0.997352234467963,0.00814830258913601,5,134,gene silencing by miRNA,BP,EGFR;MAP2K2;MAP2K1;SMAD3;TGFB1
853,GO:0002181,0.997355350833898,0.0127534971669911,2,85,cytoplasmic translation,BP,ZNF385A;UNK
2889,GO:0006400,0.997598313933604,0.0117925839207471,2,74,tRNA modification,BP,RPUSD3;AARS
14579,GO:0070126,0.997598802316515,0.0117055772750214,2,88,mitochondrial translational termination,BP,MRPS6;MRPS26
133,GO:0000280,0.997625593866101,0.00453211598890894,20,317,nuclear division,BP,LRP5;OBSL1;FBXW5;CDC25B;TGFB1;TUBG2;TOM1L2;PIM2;TDRKH;EREG;CUL9;LEMD2;TGFA;CHEK2;SUN1;INSR;CUL7;SIRT2;NDE1;GPR3
4683,GO:0010833,0.997667410965006,0.0114955487433134,2,74,telomere maintenance via telomere lengthening,BP,MAPK3;TERC
14864,GO:0070647,0.997718085239809,0.00328559559144578,76,951,protein modification by small protein conjugation or removal,BP,TNIP1;GID4;EGR1;FBXO2;MTA1;ARRDC1;WWTR1;TMEM129;KLHL29;DDB2;MARCH9;RBCK1;RNF44;SMURF2;SMAD3;EPAS1;FBXW5;RNF187;AKT1;FBXO41;MARCH4;HLTF;RAG1;ASB13;HMG20B;RAD23A;PEX10;SHARPIN;FBXW8;ZNF598;MAGEF1;JOSD2;FBXL8;RNF135;ZNF862;FBXO17;FBXO44;ZER1;VHL;NEURL1B;THOP1;MIB2;USP20;STUB1;TRIM4;FBXW4;CUL9;LIMK1;LRSAM1;ASB1;HDAC7;JADE2;CDC34;RNF123;WFS1;DTX3;FYN;PELI1;INO80C;DCAF10;KLHL36;RNF144A;USP21;CUL7;WDTC1;ZYG11B;KCTD13;UVSSA;BACH1;SOCS7;PELI3;RAB40B;TOLLIP;PDCD6;CBLC;KLHL24
18120,GO:1902750,0.997734900043127,0.00901492962984685,3,97,negative regulation of cell cycle G2/M phase transition,BP,FHL1;HMGA2;BRSK1
2798,GO:0006259,0.997744486675907,0.00332368553972809,66,846,DNA metabolic process,BP,NT5E;ERCC1;H1F0;CST3;XPC;HMGA2;MTA1;EGFR;SHC1;DDB2;TK2;SMARCA1;NYNRIN;ENDOG;FOS;STAT6;ERCC6;AKT1;FGFR4;POLD4;FGFR1;RAG1;NSMCE4A;IGFBP4;CSNK1E;RAD23A;MAGEF1;CBS;TGFB1;MPG;MC1R;POLL;POLM;PTMS;MBD3;AREG;WDR18;TDRKH;PRIMPOL;PRKCD;STUB1;BAX;DTD1;EREG;TOP3B;CHEK2;TMEM161A;SESN2;CDC34;NEIL1;TSPYL2;APOBEC3C;APOBEC3F;MAPK3;INSR;INO80C;ETAA1;REV1;DNMT3A;DNASE1L1;KCTD13;FAM129B;UVSSA;BACH1;TEP1;TERC
17278,GO:0120114,0.997779719707591,0.0109779407944674,2,79,Sm-like protein family complex,CC,MAPKBP1;TEP1
18145,GO:1902850,0.99781022352307,0.00688581799566894,5,122,microtubule cytoskeleton organization involved in mitosis,BP,SPRY2;TUBG2;CHEK2;PKD1;NDE1
5315,GO:0016032,0.997831151212484,0.00337395957080498,49,682,viral process,BP,TNIP1;APOE;HMGA2;EGFR;SHC1;MMP1;RBCK1;PC;FBLN1;SMAD3;AP2A2;STOM;ADARB1;ATG16L2;LDLR;PACS2;RAB11FIP4;GAS6;CTSB;GSN;RAD23A;BNIP3;MVB12B;CRTC1;ITGB5;CTBP1;PLCG1;CD81;TGFB1;TMEM173;EFNB3;TBKBP1;UCKL1;BNIP3L;NELFCD;BAX;LRSAM1;IRAK1;FYN;APOBEC3C;SATB1;APOBEC3F;MAPK3;INSR;CUL7;BIN1;BCL2L1;PROX1;SEPT6
278,GO:0000781,0.997856162807925,0.00622928527206684,6,146,chromosome, telomeric region,CC,ERCC1;NSMCE4A;CHEK2;SIRT2;TEP1;TERC
11829,GO:0046794,0.99785765488973,0.0161074749123144,1,55,transport of virus,BP,MVB12B
10269,GO:0043021,0.997869430235115,0.00742848423045308,4,110,ribonucleoprotein complex binding,MF,IMPACT;ZNF598;RNF135;OXA1L
8827,GO:0034622,0.997877139315821,0.00313261417365436,66,882,cellular protein-containing complex assembly,BP,H1F0;XPC;OBSL1;DDB2;VPS11;ARL2;SNX9;EXOC2;SMAD3;GRB7;TMOD2;CORO1B;DNAAF5;RAC2;CIRBP;TWF2;GSN;PLEKHG2;SEPT10;WIPF1;ARPIN;SPTB;CORO7;DGKQ;CDC42EP5;TGFB1;CLTCL1;FHOD3;MSRB2;EML2;DNAH1;WASF3;COA5;TUBG2;CENPH;OXA1L;MICALL2;WDR18;CAPG;PSMG4;PRKCD;STUB1;HIST3H2BB;SOX12;FCHO1;TGFBR3;DNM1;WASH3P;DNAAF3;RAC3;DNM2;TSPYL2;H1FX;TAZ;PAK1;BIN1;VPS16;NDUFV3;SIRT2;NDE1;PXN;MSS51;BBS10;SEPT6;PFN2;SRSF5
10865,GO:0044403,0.997943598942125,0.0031697565273374,52,717,symbiont process,BP,TNIP1;APOE;HMGA2;EGFR;SHC1;MMP1;RBCK1;PC;EXOC2;FBLN1;SMAD3;AP2A2;STOM;ADARB1;ATG16L2;LDLR;PACS2;RAB11FIP4;GAS6;CTSB;GSN;RAD23A;BNIP3;MVB12B;CRTC1;ITGB5;CTBP1;PLCG1;CD81;TGFB1;ULK2;TMEM173;EFNB3;TBKBP1;UCKL1;ULK1;BNIP3L;NELFCD;BAX;LRSAM1;IRAK1;FYN;APOBEC3C;SATB1;APOBEC3F;MAPK3;INSR;CUL7;BIN1;BCL2L1;PROX1;SEPT6
3671,GO:0008173,0.997985260686044,0.0152871463346005,1,55,RNA methyltransferase activity,MF,RRNAD1
10774,GO:0044237,0.998044539445233,0.00237113784893307,788,7926,cellular metabolic process,BP,TNIP1;DUSP6;NT5E;XDH;ERCC1;DUSP5;MEF2D;GID4;ZMYND8;H1F0;CITED4;HTRA1;EGR1;NR1D1;SLC16A3;H6PD;EDEM1;DLG4;PLAT;CST3;CYP27B1;TYSND1;BTBD2;FBXO2;APLN;PDCD4;CTNNBIP1;NAGS;ACVR2B;XPC;PRNP;PYGB;SLC6A8;VEGFA;TNFRSF6B;PGM1;WNT7A;APOE;PYGL;DGKA;F2R;LRP5;OSBPL5;LPCAT4;ITGA6;ISYNA1;HMGA2;OBSCN;IDH2;ZKSCAN1;NEK9;CRAT;ELK3;PKN1;MTA1;GRAMD4;ACOT7;ARRDC1;ACSF2;AKR7A2;EGFR;RPS6KA2;SERPINE2;DNPH1;WWTR1;LOXL1;OBSL1;NOS1;PTPRS;TMEM129;SLC2A9;HADH;CTSO;SPRY2;CAPN2;MST1R;NFATC4;TRIM65;BAHCC1;CRTAP;SDC1;KLHL29;ETV5;LMF1;SHC1;DDB2;VPS11;LTBP1;TBC1D14;HEXB;GTPBP1;SLC7A8;TCFL5;PTPRE;SLC2A3;ALDH4A1;TK2;MMP1;ETV4;PHLDA2;SNX9;TRNP1;SPRY4;RAPGEF3;TXNRD3;ST6GALNAC2;ZFP36L1;GAA;GLUL;RNPEPL1;ARAP1;MAP2K2;KDSR;NME4;ZC3H6;LPAR3;MARCH9;CTBS;PLCD3;FKBP9;MDFI;PTOV1;SMARCA1;PPP1R35;RBCK1;PLTP;PGLS;PC;FOXQ1;RNF44;MAP2K1;NAPRT;CRYL1;ACP5;CPT2;NYNRIN;MXD4;SSH1;POU2F2;ENDOG;MARK4;SMURF2;TSC22D1;FOS;FBLN1;SMAD3;STAT6;PIK3R2;ERCC6;LRP1;GJC2;SRD5A3;DVL1;EPAS1;DNAJB5;PIGQ;HSD17B8;HBEGF;RPUSD3;AP2A2;ITGB4;PPP1R14A;SH3PXD2B;PPP2R3B;PRDX5;SHC2;BRD3;PRODH;SALL2;MBOAT7;CDK18;LY6K;FBXW5;ZXDC;RNF187;NMRK1;ADORA2B;ADARB1;D2HGDH;SLC6A6;AKT1;TPCN1;GRB7;HDAC5;UROS;FBXO41;NT5DC1;F12;PPM1F;PITPNM1;ENTPD6;PYCR2;BSG;STK39;HK1;SERPING1;SCMH1;EPHA1;GGT1;NFKBIZ;PTPRU;VEGFB;ASH2L;IMPACT;MARCH4;WWC3;ATG16L2;ZFYVE21;CNTN1;BRSK1;DAP;PTHLH;RAB31;FGFR4;POLD4;ACOT1;LDLR;FGFR1;PRKACB;FUCA1;MAPKBP1;RAC2;KCNAB2;PFKL;TTLL12;SEC14L2;OPLAH;HLTF;MXI1;PPM1J;RAG1;GAMT;H2AFJ;B4GAT1;PACS2;BPHL;PIGV;KLF7;SORL1;NAT14;CEACAM1;B3GAT3;ASB13;CIRBP;CBR4;HMG20B;TENM2;ZNF385A;NSMCE4A;ABCD1;IGFBP4;TTC7B;TSHZ1;TRAPPC9;CCND1;PODNL1;PCBP4;TCF25;LHPP;AIG1;STRADB;SYNGAP1;PLCH2;MAPK13;GAS6;PTK6;PFKP;CSNK1E;CTSB;RAB3B;CARD11;SOX13;DUSP7;GSN;MAPKAPK3;IGFBP2;PCSK9;ARHGAP22;RAD23A;DHTKD1;PHLDA1;ANO8;BCR;MRPS6;EHD4;ERRFI1;GLI4;NADK;PANK4;HLCS;ZSCAN18;AIP;CCDC71L;MYEF2;MN1;SH3D19;CDC25B;ALOX15B;SPTB;SMARCD2;PEX10;CCS;RSAD1;SLC20A1;RRNAD1;NPR2;SNTA1;DGKQ;HAGH;BNIP3;PAK6;TFPI2;GTF2IRD1;SHARPIN;MVB12B;SERINC2;TAGLN3;FYCO1;CEMIP;PKD2;ACY1;GPX3;PCSK1;RETSAT;RASGEF1A;CTSZ;CDC42EP5;HES2;CRTC1;FBXW8;GPSM1;ABCA2;ZNF598;MAGEF1;PRSS3;SH3PXD2A;EPHB2;ADAM8;APRT;CTBP1;JOSD2;LTA4H;MNT;PTPDC1;GRK6;CDKN1C;PLCG1;FBXL8;ZMIZ2;CBS;CD81;CEBPB;MVD;RNF135;ENTPD2;ADAMTS13;ZNF217;TIMP2;ZNF862;SYNJ2;C8ORF88;TGFB1;LACTB2;RFX2;SCYL1;ABHD17C;UNK;ULK2;GPC1;MKNK2;ADAMTS7;DEAF1;NTSR1;B3GNT3;NAB2;TMEM173;ZSCAN30;SHANK3;PODXL2;SDHA;MSRB2;RASA3;PNRC1;MIPEP;PIP5KL1;TNFSF15;MGAT4B;MDH2;MPG;GALNS;FBXO17;NSMF;PEG3;FARP1;MC1R;LCE1E;ABHD14B;LAMB2;ABTB1;RNH1;ERO1B;ST6GALNAC6;VGF;POLL;FBXO44;POLM;SNX33;PI4K2A;PTMS;ANKZF1;ATG2A;PHGDH;PHF21A;MIF4GD;PLPP6;UBXN4;KHDRBS3;ZER1;HMGCL;PTPN1;TPP1;PCK2;B4GALT2;AGRN;MBD3;IFNE;CD320;CAMK2N1;OSBPL10;LRP4;ESYT2;ZDHHC24;ACP6;B4GALT6;VHL;TRAP1;IDUA;PFKFB2;RFNG;MLXIPL;TRIB2;PRKCZ;KDM6B;PRKACA;MINK1;ZNF516;GRHPR;OXA1L;RABGGTA;CD9;ADA;AREG;PIM2;MPI;UCKL1;BOK;WDR18;TDRKH;ALAS1;NEURL1B;ERBB2;ULK1;CNDP2;AHCY;PRIMPOL;TFDP2;C6ORF89;NECAB3;STK17A;JAK3;IRF2BP2;RNPEP;BNIP3L;CYFIP2;PBX2;TRPC1;NELFCD;RASA4;PDK1;ACAD10;CYGB;THOP1;MCFD2;PRKCD;FAM20C;MIB2;RBL2;USP20;STUB1;IFI6;BAX;CYC1;SBF1;DTD1;XYLT2;TRIM4;ITGA1;ZNF395;NUBP2;PPCS;FBXW4;EREG;RPS6KA5;DGUOK;DUSP4;ZNF524;CUL9;SOX12;DDIT4;MBTPS2;ACADS;TOP3B;PPP1R13L;CARF;HSD17B7;AHNAK2;PCSK1N;IER2;CES2;NAGA;ZDHHC8;LIMK1;TGFBR3;NTPCR;PADI3;LTB4R2;CPNE7;RPL39L;LEMD2;RPS6KA6;ZHX3;DNM1;RGS14;MFNG;GSTO1;ALDOC;CHAD;MRPS26;MSLN;LPCAT1;LRSAM1;ASB1;EHD3;ST3GAL3;LONP2;SYMPK;MAPK12;IRAK1;PPOX;TGFA;HDAC7;FHOD1;INPP5D;MTHFR;CHD2;PI4K2B;CBX7;PCMTD2;CHEK2;DECR2;ZFPM1;PPARA;COG7;ABHD15;COQ2;TMEM161A;SESN2;FGGY;ABCG1;MYO1D;JADE2;CDC34;RNF123;SOX7;ABCA7;RAB12;SPEG;SIX5;BCAP31;MIF;ACO2;SMOX;EEF2KMT;KDM4B;PHYH;ZNF414;MEX3A;PLA2G6;DDT;SSBP4;NUDT14;ECM1;WFS1;QSOX1;ZNF444;DTX3;TRPT1;DALRD3;SPPL2B;FYN;PITPNM3;VWA1;UPP1;STK25;ETFB;EEF2K;CERS4;ARID5B;HOXC5;DNM2;CKMT1A;CYP3A5;BHLHE40;GLB1;PELI1;CHKA;CAT;NEIL1;TSPYL2;IGFBP7;ELFN2;SLC27A1;ZMYM3;APOBEC3C;SATB1;ZDHHC1;PLCB3;ZNF606;APOBEC3F;DDX50;CYP2R1;MAPK3;INSR;PAN2;CAMTA2;TAZ;PFKM;ADCY1;RERE;TSTA3;INO80C;GPT2;PDXK;ETAA1;GLRX;BCL7A;VANGL2;PAK1;DCAF10;KLHL36;CAMKK2;RNASET2;PPP3CB;RNF144A;ALPK1;CTSF;USP21;PFKFB3;MLYCD;CUL7;GABBR1;REV1;MICAL1;HYAL1;SEMA4C;CAPRIN2;ZBTB10;WDTC1;HES7;ITGA3;STK32C;DNMT3A;SAMD8;BIN1;VPS16;MAN2B1;SRMS;TSTD1;PPP2R5B;HES6;MAP2K3;NDST2;DLG3;ABHD10;NDUFV3;RRAS;DNASE1L1;PROX1;IARS2;MDGA1;TBC1D16;ADGRF1;ALDH7A1;ZYG11B;PKD1;KCTD13;TNFRSF25;SIRT2;FAM129B;EDA;UVSSA;GAL3ST4;NMNAT2;BACH1;NT5C1B;ADCY7;E2F5;ZBTB22;ALG12;MAPRE3;AZIN2;TEP1;ZNF704;SERPINB1;ST3GAL2;LAMB1;SOCS7;MAP3K10;RGS19;PELI3;GTF2IRD2;RAB40B;NGFR;TOLLIP;BCORL1;PDCD6;CHST14;ZNF837;RNASE7;GRB10;PHYKPL;PLEKHM1;DUSP23;GCH1;MAFF;NR2F6;CBX6;CAMK1;CAMKK1;EZH1;SIRT3;HFE;TERC;ZNF513;WIPI2;BTG1;ZP3;VPS51;MLF2;CDK11B;PFN2;SSH3;FGFR3;PPP1R16A;TST;CCDC88C;ST3GAL5;TNRC18;NDRG2;MAN2B2;CBLC;ITPKB;PTGR2;SPTLC2;TCEA2;CDC42BPG;PRSS21;ZBTB47;PLAG1;CLK3;IRF2BPL;DHX32;KDM3A;PM20D2;TBL3;SLC23A2;PKN3;TTLL3;DEDD2;PI4KAP2;AK3;SRSF5;CHPF;ADCY6;LRRK1;AARS;KLHL24;SDC2
10873,GO:0044419,0.998061210843644,0.00298427483572528,53,732,interspecies interaction between organisms,BP,TNIP1;APOE;HMGA2;EGFR;SHC1;MMP1;RBCK1;PC;EXOC2;FBLN1;SMAD3;AP2A2;STOM;ADARB1;ATG16L2;LDLR;PACS2;RAB11FIP4;GAS6;CTSB;GSN;RAD23A;BNIP3;MVB12B;CRTC1;ITGB5;CTBP1;PLCG1;CD81;TGFB1;ULK2;TMEM173;EFNB3;TBKBP1;UCKL1;ULK1;BNIP3L;NELFCD;BAX;LRSAM1;IRAK1;FYN;APOBEC3C;SATB1;APOBEC3F;MAPK3;INSR;CUL7;BIN1;BCL2L1;PROX1;RNASE7;SEPT6
9984,GO:0042393,0.998088975880623,0.00499662096012189,8,173,histone binding,MF,ZMYND8;PKN1;BRD3;RAG1;PHF21A;CHD2;CDYL2;WDTC1
15869,GO:0072594,0.998194109598034,0.00316992279493945,29,460,establishment of protein localization to organelle,BP,VPS11;AKT1;HK1;RAC2;TOMM34;SORL1;GAS6;AIP;PEX10;AP3D1;TGFB1;MOAP1;TMEM173;MIPEP;PEX1;MICALL2;NEURL1B;TFDP2;BNIP3L;PRKCD;BAX;TIMM17B;ZDHHC8;WASH3P;LRSAM1;LONP2;NBPF3;TMCO6;RERE
10682,GO:0043966,0.998194448150919,0.0139101577590761,1,56,histone H3 acetylation,BP,JADE2
9011,GO:0035194,0.998335357930306,0.00534117594420226,5,140,posttranscriptional gene silencing by RNA,BP,EGFR;MAP2K2;MAP2K1;SMAD3;TGFB1
7708,GO:0032204,0.998363092050529,0.00841624893603363,2,76,regulation of telomere maintenance,BP,ERCC1;MAPK3
2582,GO:0005876,0.998397682179698,0.0125598901999229,1,56,spindle microtubule,CC,TUBG2
4763,GO:0010948,0.998410580333893,0.00324954278408176,17,295,negative regulation of cell cycle process,BP,FHL1;HMGA2;ZFP36L1;GJC2;BRSK1;ZNF385A;CCND1;PCBP4;PKD2;MLXIPL;TOM1L2;TFDP2;RBL2;BAX;CHEK2;MIF;PPP2R5B
7160,GO:0031047,0.998417825549752,0.00470985493060144,6,155,gene silencing by RNA,BP,EGFR;MAP2K2;MAP2K1;SMAD3;TGFB1;TDRKH
19244,GO:1905368,0.998451592661671,0.00797430770376894,2,85,peptidase complex,CC,RAD23A;WFS1
12841,GO:0051168,0.998460151637118,0.00391339507508859,9,187,nuclear export,BP,RAPGEF3;STRADB;GAS6;XPOT;TGFB1;SYMPK;PKD1;CAMK1;SRSF5
5499,GO:0016441,0.998473907094678,0.0049339964373589,5,141,posttranscriptional gene silencing,BP,EGFR;MAP2K2;MAP2K1;SMAD3;TGFB1
2973,GO:0006518,0.998544103883476,0.00224768601448226,55,785,peptide metabolic process,BP,TNIP1;PRNP;APOE;EGFR;GTPBP1;ZFP36L1;RNPEPL1;MAP2K2;MAP2K1;AKT1;GRB7;GGT1;IMPACT;OPLAH;SORL1;CIRBP;ZNF385A;GAS6;MRPS6;HAGH;PCSK1;CTSZ;ZNF598;LTA4H;ADAMTS13;C8ORF88;TGFB1;UNK;MKNK2;MIPEP;ABTB1;ERO1B;MIF4GD;TPP1;TRAP1;ERBB2;CNDP2;RNPEP;CYFIP2;THOP1;PCSK1N;RPL39L;GSTO1;MRPS26;SESN2;ABCA7;MEX3A;DALRD3;SPPL2B;EEF2K;MAPK3;CAPRIN2;BIN1;IARS2;AARS
6922,GO:0030521,0.998604908308368,0.0111335792149066,1,58,androgen receptor signaling pathway,BP,KDM3A
16867,GO:0098798,0.998614784975062,0.00353037771954938,9,218,mitochondrial protein complex,CC,MRPS6;SDHA;ANKZF1;PDK1;BAX;CYC1;TIMM17B;MRPS26;NDUFV3
14102,GO:0060968,0.998668056226738,0.00483561527063144,4,127,regulation of gene silencing,BP,EGFR;MAP2K2;MAP2K1;TGFB1
18817,GO:1904356,0.9987195150475,0.0103426133210898,1,58,regulation of telomere maintenance via telomere lengthening,BP,MAPK3
4302,GO:0009755,0.998783284496673,0.00347827774676509,7,158,hormone-mediated signaling pathway,BP,NR1D1;PAQR6;PPARA;SLC27A1;PAK1;NR2F6;KDM3A
9921,GO:0042273,0.998805252039911,0.00967619457614943,1,67,ribosomal large subunit biogenesis,BP,WDR18
2838,GO:0006310,0.998872580539452,0.00271971102799597,11,215,DNA recombination,BP,ERCC1;ENDOG;STAT6;RAG1;NSMCE4A;MAGEF1;TGFB1;POLL;POLM;INO80C;TEP1
468,GO:0001510,0.998960536838773,0.00861824803461778,1,61,RNA methylation,BP,RRNAD1
18355,GO:1903312,0.998982651924555,0.00846662737565851,1,60,negative regulation of mRNA metabolic process,BP,CIRBP
14506,GO:0065004,0.999042330965154,0.00250737645382274,9,214,protein-DNA complex assembly,BP,H1F0;XPC;DDB2;CENPH;WDR18;HIST3H2BB;SOX12;TSPYL2;H1FX
12529,GO:0050684,0.999042744903147,0.00416937198934211,3,99,regulation of mRNA processing,BP,ZFP36L1;KHDRBS3;CDK11B
8301,GO:0033143,0.999045607372677,0.00800467667360523,1,61,regulation of intracellular steroid hormone receptor signaling pathway,BP,PAK1
16248,GO:0090305,0.999055835496011,0.00216978658318321,13,250,nucleic acid phosphodiester bond hydrolysis,BP,ERCC1;H1F0;DDB2;ENDOG;POLD4;RAG1;LACTB2;PNRC1;BAX;PAN2;RNASET2;DNASE1L1;RNASE7
9796,GO:0040029,0.999062226238914,0.00205215455114469,15,290,regulation of gene expression, epigenetic,BP,MTA1;EGFR;BAHCC1;MAP2K2;MAP2K1;SMAD3;ERCC6;HDAC5;H2AFJ;TGFB1;MBD3;SLC50A1;DNMT3A;SIRT2;TNRC18
10493,GO:0043401,0.99909133411784,0.00283784596993934,6,147,steroid hormone mediated signaling pathway,BP,NR1D1;PAQR6;PPARA;PAK1;NR2F6;KDM3A
16250,GO:0090307,0.999093368704209,0.00765656208780188,1,61,mitotic spindle assembly,BP,CHEK2
12878,GO:0051225,0.99909420908276,0.00396539538986498,3,100,spindle assembly,BP,GOLGA2P5;TUBG2;CHEK2
18377,GO:1903363,0.999118314709376,0.00745558116286195,1,64,negative regulation of cellular protein catabolic process,BP,HFE
2903,GO:0006417,0.999165732008014,0.00161496346894453,23,388,regulation of translation,BP,EGFR;ZFP36L1;MAP2K2;MAP2K1;SMAD3;AKT1;GRB7;IMPACT;CIRBP;ZNF385A;ZNF598;C8ORF88;TGFB1;UNK;MKNK2;MIF4GD;TRAP1;ERBB2;CYFIP2;SESN2;MEX3A;MAPK3;CAPRIN2
9922,GO:0042274,0.999208972836691,0.00675637377549067,1,70,ribosomal small subunit biogenesis,BP,TBL3
10971,GO:0044770,0.999209364773449,0.00138654669505766,34,512,cell cycle phase transition,BP,FHL1;XPC;HMGA2;EGFR;ZFP36L1;GJC2;AKT1;BRSK1;ZNF385A;CCND1;PCBP4;CEP250;CSNK1E;PHLDA1;CDC25B;PKD2;TGFB1;CEP131;PRKACA;PIM2;SDCCAG8;NINL;TFDP2;RBL2;BAX;CHEK2;CDC34;DNM2;CEP72;HYAL1;PKD1;SIRT2;BACH1;NDE1
10534,GO:0043488,0.999217731533447,0.00268058349694777,5,141,regulation of mRNA stability,BP,ZFP36L1;AKT1;CIRBP;PCBP4;PRKCD
16315,GO:0090501,0.999226031413255,0.0029575568942702,4,124,RNA phosphodiester bond hydrolysis,BP,LACTB2;PAN2;RNASET2;RNASE7
273,GO:0000776,0.999248766273801,0.00288134799911036,4,121,kinetochore,CC,NUDCD2;CENPH;NDE1;SEPT6
12065,GO:0048024,0.999261809553604,0.00639468334556093,1,63,regulation of mRNA splicing, via spliceosome,BP,KHDRBS3
2857,GO:0006352,0.999266355800158,0.00195950108566211,9,205,DNA-templated transcription, initiation,BP,NR1D1;CTNNBIP1;WWTR1;NAT14;CCND1;BAX;PPARA;MAPK3;NR2F6
6570,GO:0022402,0.999269961363227,0.00105767028924623,91,1140,cell cycle process,BP,ERCC1;FHL1;CYP27B1;XPC;PRNP;LRP5;HMGA2;NEK9;EGFR;OBSL1;SPRY2;ARL2;SNX9;ZFP36L1;ARAP1;MAP2K1;SMAD3;GJC2;PPP2R3B;REEP4;FBXW5;AKT1;BRSK1;POLD4;FGFR1;RAB11FIP4;ZNF385A;ANK3;CCND1;PCBP4;STRADB;CEP250;GAS6;CSNK1E;PHLDA1;SEPT10;CDC25B;PAK6;PKD2;CDKN1C;TGFB1;GOLGA2P5;CROCC;RHOD;CGREF1;SNX33;RHOF;LLGL1;RHOBTB2;TUBG2;CEP131;MLXIPL;PRKACA;CENPH;TOM1L2;PIM2;WDR18;TDRKH;SDCCAG8;NINL;TFDP2;RBL2;BAX;EREG;CUL9;LEMD2;RGS14;GIT1;MAPK12;TGFA;CHEK2;CDC34;MIF;SUN1;DNM2;INSR;CEP72;PAK1;CUL7;HYAL1;BIN1;PPP2R5B;BCL2L1;LMNA;PKD1;SIRT2;BACH1;NDE1;GPR3;GAS2L1;SEPT6
2902,GO:0006415,0.999278796446938,0.00402350657837126,2,100,translational termination,BP,MRPS6;MRPS26
4193,GO:0009301,0.999366988741563,0.00557586068353815,1,67,snRNA transcription,BP,POU2F2
10187,GO:0042795,0.999366988741563,0.00557586068353815,1,67,snRNA transcription by RNA polymerase II,BP,POU2F2
14132,GO:0061013,0.99943778452353,0.0018175140443892,6,160,regulation of mRNA catabolic process,BP,GTPBP1;ZFP36L1;AKT1;CIRBP;PCBP4;PRKCD
3335,GO:0007052,0.999445641042687,0.00254042478309767,3,105,mitotic spindle organization,BP,TUBG2;CHEK2;PKD1
10775,GO:0044238,0.999460472751382,0.000667364994779474,762,7737,primary metabolic process,BP,TNIP1;DUSP6;NT5E;XDH;ERCC1;DUSP5;MEF2D;GID4;ZMYND8;H1F0;CITED4;HTRA1;THSD4;EGR1;NR1D1;H6PD;EDEM1;DLG4;PLAT;CST3;CYP27B1;TYSND1;BTBD2;FBXO2;APLN;PDCD4;CTNNBIP1;NAGS;ACVR2B;XPC;PRNP;PYGB;SLC6A8;VEGFA;TNFRSF6B;PGM1;WNT7A;APOE;PYGL;DGKA;F2R;LRP5;PLD3;OSBPL5;LPCAT4;ITGA6;ISYNA1;HMGA2;OBSCN;IDH2;ZKSCAN1;NEK9;CRAT;ELK3;PKN1;MTA1;GRAMD4;ACOT7;ARRDC1;ACSF2;NISCH;AKR7A2;EGFR;RPS6KA2;SERPINE2;DNPH1;WWTR1;LOXL1;OBSL1;NOS1;PTPRS;TMEM129;HADH;CTSO;SPRY2;CAPN2;MST1R;NFATC4;BAHCC1;CRTAP;LTBP4;PRSS8;SDC1;KLHL29;ETV5;LMF1;SHC1;DDB2;VPS11;LTBP1;HEXB;GTPBP1;SLC7A8;TCFL5;PTPRE;NPEPL1;SLC2A3;ALDH4A1;TK2;MMP1;ETV4;PHLDA2;SNX9;TRNP1;SPRY4;RAPGEF3;ST6GALNAC2;ZFP36L1;GAA;GLUL;RNPEPL1;MAP2K2;KDSR;NME4;ZC3H6;LPAR3;MARCH9;CTBS;PLCD3;FKBP9;MDFI;PTOV1;SMARCA1;PPP1R35;RBCK1;PLTP;PGLS;PC;FOXQ1;RNF44;MAP2K1;NAPRT;CRYL1;CPT2;NYNRIN;MXD4;SSH1;POU2F2;ENDOG;MARK4;GALE;SMURF2;TSC22D1;FOS;FBLN1;SMAD3;STAT6;PIK3R2;ERCC6;LRP1;GJC2;SRD5A3;DVL1;EPAS1;DNAJB5;PIGQ;HSD17B8;HBEGF;RPUSD3;AP2A2;PPP1R14A;PPP2R3B;PRDX5;SHC2;BRD3;PRODH;SALL2;MBOAT7;CDK18;LY6K;FBXW5;ZXDC;RNF187;NMRK1;ADORA2B;ADARB1;PLCXD2;D2HGDH;SLC6A6;AKT1;GRB7;HDAC5;FBXO41;F12;PPM1F;MMP28;PITPNM1;ENTPD6;RHBDF2;PYCR2;STK39;HK1;SERPING1;SCMH1;EPHA1;GGT1;NFKBIZ;PTPRU;VEGFB;ASH2L;IMPACT;MARCH4;WWC3;ZFYVE21;CNTN1;BRSK1;DAP;PTHLH;FGFR4;POLD4;ACOT1;LDLR;FGFR1;PRKACB;FUCA1;MAPKBP1;RAC2;KCNAB2;PFKL;TTLL12;SEC14L2;HLTF;MXI1;PPM1J;RAG1;GAMT;H2AFJ;B4GAT1;BPHL;PIGV;KLF7;SORL1;NAT14;CEACAM1;B3GAT3;ASB13;CIRBP;CBR4;HMG20B;TENM2;ZNF385A;NSMCE4A;ABCD1;IGFBP4;TTC7B;TSHZ1;TRAPPC9;CCND1;PODNL1;PCBP4;TCF25;LHPP;AIG1;STRADB;SYNGAP1;PLCH2;MAPK13;PLAU;GAS6;PTK6;PFKP;CSNK1E;CTSB;RAB3B;CARD11;SOX13;DUSP7;GSN;MAPKAPK3;IGFBP2;PCSK9;ARHGAP22;RAD23A;DHTKD1;PHLDA1;ANO8;BCR;ANGPTL4;MRPS6;EHD4;ERRFI1;GLI4;NADK;PANK4;HLCS;ZSCAN18;PRSS22;AIP;CCDC71L;MYEF2;MN1;SH3D19;CDC25B;ALOX15B;SPTB;SMARCD2;PEX10;RRNAD1;NPR2;SNTA1;DGKQ;BNIP3;PAK6;TFPI2;GTF2IRD1;SHARPIN;MVB12B;SERINC2;TAGLN3;CEMIP;PKD2;ACY1;PCSK1;RETSAT;RASGEF1A;CTSZ;CDC42EP5;HES2;CRTC1;FBXW8;ABCA2;ZNF598;MAGEF1;PRSS3;EPHB2;ADAM8;APRT;CTBP1;JOSD2;LTA4H;MNT;PTPDC1;GRK6;CDKN1C;PLCG1;FBXL8;ZMIZ2;CBS;CD81;CEBPB;MVD;RNF135;ENTPD2;ADAMTS13;ZNF217;TIMP2;ZNF862;SYNJ2;DPP7;C8ORF88;TGFB1;LACTB2;RFX2;SCYL1;ABHD17C;UNK;ULK2;GPC1;MKNK2;ADAMTS7;DEAF1;NTSR1;B3GNT3;NAB2;TMEM173;ZSCAN30;SHANK3;PODXL2;SDHA;MSRB2;RASA3;PNRC1;MIPEP;PIP5KL1;TNFSF15;MGAT4B;MDH2;MPG;FBXO17;CLCA2;HEXDC;NSMF;PEG3;MC1R;LCE1E;ABHD14B;LAMB2;ABTB1;SNX17;RNH1;ERO1B;ST6GALNAC6;VGF;POLL;FBXO44;POLM;SNX33;PI4K2A;PTMS;ANKZF1;PHGDH;PHF21A;MIF4GD;PLPP6;UBXN4;ADAM19;KHDRBS3;ZER1;HMGCL;PTPN1;TPP1;PCK2;B4GALT2;AGRN;MBD3;IFNE;CAMK2N1;OSBPL10;LRP4;LRP10;ESYT2;ZDHHC24;ACP6;B4GALT6;VHL;TRAP1;IDUA;PFKFB2;RFNG;MLXIPL;TRIB2;PRKCZ;KDM6B;PRKACA;MINK1;ZNF516;RABGGTA;ADA;AREG;PIM2;MPI;UCKL1;BOK;WDR18;TDRKH;ALAS1;NEURL1B;ERBB2;ULK1;CNDP2;AHCY;PRIMPOL;MMP10;TFDP2;C6ORF89;NECAB3;STK17A;JAK3;IRF2BP2;RNPEP;BNIP3L;CYFIP2;PBX2;NELFCD;RASA4;PDK1;ACAD10;CYGB;THOP1;MCFD2;PRKCD;FAM20C;MIB2;RBL2;USP20;STUB1;IFI6;BAX;CYC1;SBF1;DTD1;XYLT2;TRIM4;ITGA1;ZNF395;PPCS;FBXW4;EREG;RPS6KA5;DGUOK;DUSP4;ZNF524;CUL9;SOX12;DDIT4;MBTPS2;ACADS;TOP3B;PPP1R13L;CARF;HSD17B7;AHNAK2;PCSK1N;IER2;CES2;NAGA;ZDHHC8;LIMK1;TGFBR3;PADI3;LTB4R2;CPNE7;RPL39L;LEMD2;RPS6KA6;ZHX3;RGS14;MFNG;GSTO1;ALDOC;CHAD;MRPS26;MSLN;LPCAT1;LRSAM1;ADAM15;ASB1;ST3GAL3;LONP2;SYMPK;MAPK12;IRAK1;TGFA;HDAC7;FHOD1;INPP5D;MTHFR;CHD2;PI4K2B;CBX7;PCMTD2;CHEK2;DECR2;ZFPM1;PPARA;COG7;ABHD15;COQ2;TMEM161A;SESN2;FGGY;ABCG1;JADE2;CDC34;RNF123;SOX7;ABCA7;RAB12;SPEG;SIX5;BCAP31;MIF;ACO2;EEF2KMT;KDM4B;PHYH;ZNF414;MEX3A;PLA2G6;DDT;SSBP4;NUDT14;ECM1;WFS1;QSOX1;ZNF444;DTX3;TRPT1;DALRD3;SPPL2B;FYN;PITPNM3;VWA1;UPP1;STK25;ETFB;GLB1L2;EEF2K;CERS4;ARID5B;HOXC5;DNM2;CKMT1A;CYP3A5;BHLHE40;GLB1;PELI1;CHKA;CAT;NEIL1;TSPYL2;IGFBP7;ELFN2;SLC27A1;ZMYM3;APOBEC3C;SATB1;ZDHHC1;PLCB3;ZNF606;APOBEC3F;DDX50;CYP2R1;MAPK3;INSR;PAN2;CAMTA2;TAZ;PFKM;ADCY1;RERE;TSTA3;INO80C;GPT2;ETAA1;GLRX;BCL7A;VANGL2;PAK1;DCAF10;KLHL36;CAMKK2;RNASET2;PPP3CB;RNF144A;ALPK1;CTSF;USP21;PFKFB3;MLYCD;CUL7;GABBR1;REV1;MICAL1;HYAL1;SEMA4C;CAPRIN2;ZBTB10;WDTC1;HES7;ITGA3;STK32C;DNMT3A;SAMD8;BIN1;MAN2B1;SRMS;PPP2R5B;HES6;MAP2K3;NDST2;DLG3;ABHD10;NDUFV3;RRAS;DNASE1L1;PROX1;IARS2;MDGA1;ADGRF1;ALDH7A1;ZYG11B;PKD1;KCTD13;TNFRSF25;SIRT2;FAM129B;EDA;UVSSA;GAL3ST4;NMNAT2;BACH1;NT5C1B;ADCY7;E2F5;ZBTB22;ALG12;MAPRE3;AZIN2;TEP1;ZNF704;SERPINB1;ST3GAL2;YDJC;LAMB1;SOCS7;MAP3K10;HSD11B1;PELI3;GTF2IRD2;RAB40B;NGFR;TOLLIP;BCORL1;PDCD6;CHST14;ZNF837;RNASE7;PHYKPL;DUSP23;MAFF;NR2F6;CBX6;CAMK1;CAMKK1;EZH1;SIRT3;HFE;TERC;ZNF513;WIPI2;BTG1;ZP3;MLF2;CDK11B;PFN2;SSH3;FGFR3;PPP1R16A;CCDC88C;ST3GAL5;TNRC18;NDRG2;MAN2B2;CBLC;ITPKB;PTGR2;SPTLC2;TCEA2;CDC42BPG;PRSS21;ZBTB47;PLAG1;CLK3;IRF2BPL;DHX32;KDM3A;PM20D2;TBL3;SLC23A2;PKN3;TTLL3;DEDD2;PI4KAP2;AK3;SRSF5;CHPF;ADCY6;LRRK1;AARS;KLHL24;SDC2
1778,GO:0004386,0.99948445652489,0.00183068270076095,5,137,helicase activity,MF,SMARCA1;HLTF;CHD2;DDX50;DHX32
18249,GO:1903047,0.999496180575182,0.000807675148557073,55,759,mitotic cell cycle process,BP,FHL1;XPC;LRP5;HMGA2;NEK9;EGFR;OBSL1;SPRY2;SNX9;ZFP36L1;GJC2;REEP4;FBXW5;AKT1;BRSK1;FGFR1;ZNF385A;ANK3;CCND1;PCBP4;CEP250;CSNK1E;PHLDA1;SEPT10;CDC25B;PKD2;TGFB1;SNX33;TUBG2;CEP131;PRKACA;TOM1L2;PIM2;SDCCAG8;NINL;TFDP2;RBL2;BAX;EREG;CUL9;TGFA;CHEK2;CDC34;DNM2;INSR;CEP72;CUL7;HYAL1;BCL2L1;LMNA;PKD1;SIRT2;BACH1;NDE1;SEPT6
15473,GO:0071824,0.999519714338192,0.00126247112497142,10,238,protein-DNA complex subunit organization,BP,H1F0;XPC;DDB2;SMARCD2;CENPH;WDR18;HIST3H2BB;SOX12;TSPYL2;H1FX
19493,GO:1990234,0.999532799502402,0.00076263059175665,51,716,transferase complex,CC,ERCC1;BTBD2;FBXO2;KLHL29;DDB2;RBCK1;SMURF2;PIK3R2;PIGQ;FBXW5;PHC2;ASH2L;POLD4;PFKL;PIGV;NSMCE4A;CCND1;DHTKD1;SHARPIN;FBXW8;FBXO17;ABTB1;FBXO44;ZER1;VHL;KDM6B;RABGGTA;ULK1;MIB2;STUB1;FBXW4;CUL9;ASB1;CBX7;SESN2;JADE2;INSR;PFKM;INO80C;DCAF10;KLHL36;RNF144A;CUL7;ZYG11B;KCTD13;BACH1;PDCD6;EZH1;TERC;SPTLC2;KLHL24
17777,GO:1901796,0.999539627541871,0.00151112121931861,6,160,regulation of signal transduction by p53 class mediator,BP,AKT1;ZNF385A;MBD3;PPP1R13L;CHEK2;MIF
3334,GO:0007051,0.999554722385496,0.00146674373862533,6,156,spindle organization,BP,GOLGA2P5;TUBG2;RGS14;CHEK2;CEP72;PKD1
10533,GO:0043487,0.99957984318419,0.00151180859930703,5,148,regulation of RNA stability,BP,ZFP36L1;AKT1;CIRBP;PCBP4;PRKCD
1863,GO:0004527,0.99959084207064,0.00379936151245676,1,69,exonuclease activity,MF,PAN2
288,GO:0000793,0.999601161267328,0.00123482927700875,7,174,condensed chromosome,CC,NSMCE4A;CEBPB;NUDCD2;CENPH;TOP3B;NDE1;SEPT6
10899,GO:0044452,0.999657049614545,0.00114954768037373,6,164,nucleolar part,CC,PAK6;DEAF1;RPS6KA6;INO80C;E2F5;TBL3
15054,GO:0071013,0.999663006430589,0.00203899780234347,2,96,catalytic step 2 spliceosome,CC,MAPKBP1;TEP1
256,GO:0000723,0.999675665198893,0.0011893330404413,5,153,telomere maintenance,BP,ERCC1;POLD4;MAPK3;TEP1;TERC
20300,GO:2001251,0.999683350233998,0.00152434598330513,3,111,negative regulation of chromosome organization,BP,ERCC1;CTBP1;KDM3A
1473,GO:0003729,0.999683435813475,0.000994818680084927,7,180,mRNA binding,MF,ZFP36L1;ADARB1;CIRBP;ZNF385A;PCBP4;MYEF2;UNK
5588,GO:0016607,0.999686495574525,0.000674099774431022,19,340,nuclear speck,CC,NFATC4;SMURF2;EPAS1;HDAC5;NFKBIZ;PHF7;LHPP;DGKQ;ZNF217;PRKACA;STK17A;BNIP3L;CYGB;LIMK1;CDC34;LMNA;PLAG1;CLK3;SRSF5
10390,GO:0043228,0.999695499107698,0.000391482063977481,292,3274,non-membrane-bounded organelle,CC,ERCC1;MEF2D;H1F0;NR1D1;DLG4;CST3;BTBD2;MARVELD1;DOCK4;XPC;PARVB;BBS2;FLNC;PGM1;ESPN;HMGA2;OBSCN;NDRG1;NEK9;ITPR3;MTA1;OBSL1;NOS1;SPRY2;CAPN2;MST1R;BAHCC1;APPL2;ARL2;RIN1;ACTA2;CLIP2;ETV4;NUDCD3;TRNP1;RAPGEF3;ZFP36L1;MAP2K2;SMARCA1;MAP2K1;CPT2;SSH1;MARK4;MPRIP;KLC2;SMAD3;STAT6;SHANK2;ERCC6;DVL1;FAM110C;SH3PXD2B;STOM;SALL2;REEP4;ADARB1;AKT1;GRB7;TMOD2;CORO1B;PITPNM1;PLEKHH3;STK39;SCMH1;DYSF;PHC2;NFKBIZ;ASH2L;BRSK1;IFT140;MYZAP;POLD4;FGFR1;PRKACB;MAPKBP1;SIGMAR1;RAC2;KCNAB2;HLTF;MXI1;NPHP4;H2AFJ;CIRBP;HMG20B;LZTS2;RAB11FIP4;ZNF385A;NSMCE4A;ANK3;EVC;TNNT1;TWF2;CEP250;CTSB;MPLKIP;GSN;RAD23A;PHLDA1;MRPS6;SEPT10;WIPF1;HLCS;CCDC113;CDC25B;ALOX15B;SPTB;SMARCD2;RSPH3;SNTA1;DGKQ;PAK6;PROCR;PKD2;YPEL3;CDC42EP5;ABCA2;SH3PXD2A;ADAM8;ZMIZ2;KIF17;CEBPB;NUDCD2;SYNJ2;SNPH;CLTCL1;SCYL1;SNTB2;DEAF1;FHOD3;SDHA;PNRC1;EML2;KIF26B;MPG;ENKD1;NSMF;ARAP3;FARP1;CROCC;ABHD14B;TNS1;ABTB1;DNAH1;RHOF;WASF3;ATG2A;LLGL1;MIF4GD;KIF7;SAC3D1;TUBG2;RIMS3;BBS1;MBD3;OSBPL10;MYH16;CEP131;TRIB2;PRKCZ;KDM6B;PRKACA;CENPH;RCCD1;ACTR1B;MICALL2;WDR18;TDRKH;CAPG;SDCCAG8;ADGRB2;NINL;SMTN;PLEK2;C6ORF89;MZT2A;RILPL1;JAK3;FSCN1;PDK1;RBL2;USP20;STUB1;DTD1;HIST3H2BB;CCDC92;NUBP2;GJB4;PLEKHH1;TOP3B;PPL;CARF;AHNAK2;MZT2B;TPM2;RPL39L;LEMD2;RPS6KA6;DNM1;WASH3P;RGS14;SCN8A;ALDOC;MRPS26;LPCAT1;REEP2;WDR60;SYMPK;IRAK1;FHOD1;INPP5D;CHD2;CBX7;CHEK2;COG7;MYO1D;MYH15;EML3;BCAP31;MEX3A;PLA2G6;NARF;SPPL2B;FYN;RAC3;DNM2;SNX15;NEIL1;TSPYL2;APOBEC3C;SATB1;KIF26A;H1FX;IQSEC1;APOBEC3F;DDX50;TUBB6;MAPK3;PAN2;TNS4;INO80C;ETAA1;CEP72;VANGL2;PAK1;PPP3CB;CUL7;MICAL1;CAPRIN2;DNMT3A;BIN1;TSTD1;BCL2L1;LMNA;RABGAP1;SIRT2;EDA;UVSSA;TRIP10;E2F5;AFAP1L1;MAPRE3;TEP1;RAB28;RAP1GAP2;NDE1;PCLO;PXN;PLEKHM1;MSS51;LURAP1;KIF13B;CBX6;TCTN1;PNMA1;HFE;TERC;GAS2L1;VPS51;TACC1;SEPT6;PFN2;SSH3;CCDC88C;TNRC18;CDC42BPG;CLK3;TRIM46;KDM3A;TBL3;TTLL3;DEDD2;SRSF5
10394,GO:0043232,0.999695499107698,0.000391482063977481,292,3274,intracellular non-membrane-bounded organelle,CC,ERCC1;MEF2D;H1F0;NR1D1;DLG4;CST3;BTBD2;MARVELD1;DOCK4;XPC;PARVB;BBS2;FLNC;PGM1;ESPN;HMGA2;OBSCN;NDRG1;NEK9;ITPR3;MTA1;OBSL1;NOS1;SPRY2;CAPN2;MST1R;BAHCC1;APPL2;ARL2;RIN1;ACTA2;CLIP2;ETV4;NUDCD3;TRNP1;RAPGEF3;ZFP36L1;MAP2K2;SMARCA1;MAP2K1;CPT2;SSH1;MARK4;MPRIP;KLC2;SMAD3;STAT6;SHANK2;ERCC6;DVL1;FAM110C;SH3PXD2B;STOM;SALL2;REEP4;ADARB1;AKT1;GRB7;TMOD2;CORO1B;PITPNM1;PLEKHH3;STK39;SCMH1;DYSF;PHC2;NFKBIZ;ASH2L;BRSK1;IFT140;MYZAP;POLD4;FGFR1;PRKACB;MAPKBP1;SIGMAR1;RAC2;KCNAB2;HLTF;MXI1;NPHP4;H2AFJ;CIRBP;HMG20B;LZTS2;RAB11FIP4;ZNF385A;NSMCE4A;ANK3;EVC;TNNT1;TWF2;CEP250;CTSB;MPLKIP;GSN;RAD23A;PHLDA1;MRPS6;SEPT10;WIPF1;HLCS;CCDC113;CDC25B;ALOX15B;SPTB;SMARCD2;RSPH3;SNTA1;DGKQ;PAK6;PROCR;PKD2;YPEL3;CDC42EP5;ABCA2;SH3PXD2A;ADAM8;ZMIZ2;KIF17;CEBPB;NUDCD2;SYNJ2;SNPH;CLTCL1;SCYL1;SNTB2;DEAF1;FHOD3;SDHA;PNRC1;EML2;KIF26B;MPG;ENKD1;NSMF;ARAP3;FARP1;CROCC;ABHD14B;TNS1;ABTB1;DNAH1;RHOF;WASF3;ATG2A;LLGL1;MIF4GD;KIF7;SAC3D1;TUBG2;RIMS3;BBS1;MBD3;OSBPL10;MYH16;CEP131;TRIB2;PRKCZ;KDM6B;PRKACA;CENPH;RCCD1;ACTR1B;MICALL2;WDR18;TDRKH;CAPG;SDCCAG8;ADGRB2;NINL;SMTN;PLEK2;C6ORF89;MZT2A;RILPL1;JAK3;FSCN1;PDK1;RBL2;USP20;STUB1;DTD1;HIST3H2BB;CCDC92;NUBP2;GJB4;PLEKHH1;TOP3B;PPL;CARF;AHNAK2;MZT2B;TPM2;RPL39L;LEMD2;RPS6KA6;DNM1;WASH3P;RGS14;SCN8A;ALDOC;MRPS26;LPCAT1;REEP2;WDR60;SYMPK;IRAK1;FHOD1;INPP5D;CHD2;CBX7;CHEK2;COG7;MYO1D;MYH15;EML3;BCAP31;MEX3A;PLA2G6;NARF;SPPL2B;FYN;RAC3;DNM2;SNX15;NEIL1;TSPYL2;APOBEC3C;SATB1;KIF26A;H1FX;IQSEC1;APOBEC3F;DDX50;TUBB6;MAPK3;PAN2;TNS4;INO80C;ETAA1;CEP72;VANGL2;PAK1;PPP3CB;CUL7;MICAL1;CAPRIN2;DNMT3A;BIN1;TSTD1;BCL2L1;LMNA;RABGAP1;SIRT2;EDA;UVSSA;TRIP10;E2F5;AFAP1L1;MAPRE3;TEP1;RAB28;RAP1GAP2;NDE1;PCLO;PXN;PLEKHM1;MSS51;LURAP1;KIF13B;CBX6;TCTN1;PNMA1;HFE;TERC;GAS2L1;VPS51;TACC1;SEPT6;PFN2;SSH3;CCDC88C;TNRC18;CDC42BPG;CLK3;TRIM46;KDM3A;TBL3;TTLL3;DEDD2;SRSF5
8792,GO:0034502,0.999725193831126,0.00266935776689253,1,72,protein localization to chromosome,BP,LEMD2
6995,GO:0030684,0.999727807910519,0.00264319041648341,1,74,preribosome,CC,TBL3
7942,GO:0032543,0.999729861804365,0.00131042195373324,3,129,mitochondrial translation,BP,MRPS6;MRPS26;IARS2
17350,GO:1900034,0.999738625835022,0.00255366113609518,1,72,regulation of cellular response to heat,BP,MAPK3
5567,GO:0016579,0.999765729024285,0.000620587533609305,11,243,protein deubiquitination,BP,TNIP1;DDB2;SMURF2;SMAD3;RAD23A;JOSD2;RNF135;USP20;RNF123;INO80C;USP21
10609,GO:0043604,0.999776202474185,0.000380533076825393,47,735,amide biosynthetic process,BP,TNIP1;NAGS;EGFR;GTPBP1;ZFP36L1;MAP2K2;MAP2K1;AKT1;GRB7;GGT1;IMPACT;OPLAH;CIRBP;ZNF385A;MRPS6;HAGH;PCSK1;ZNF598;C8ORF88;TGFB1;UNK;MKNK2;ABTB1;ST6GALNAC6;MIF4GD;B4GALT6;TRAP1;ERBB2;CNDP2;CYFIP2;PRKCD;RPL39L;MRPS26;SESN2;MEX3A;PLA2G6;DALRD3;EEF2K;CERS4;MAPK3;CAPRIN2;SAMD8;IARS2;GCH1;ST3GAL5;SPTLC2;AARS
10388,GO:0043226,0.999799634675538,0.000262687502964621,987,9815,organelle,CC,TNIP1;DUSP6;NT5E;XDH;ERCC1;DUSP5;MEF2D;ZMYND8;H1F0;CITED4;HTRA1;FHL1;THSD4;EGR1;B4GALNT4;NR1D1;SLC16A3;H6PD;EDEM1;DLG4;PLAT;CST3;CYP27B1;TYSND1;HS1BP3;BTBD2;MARVELD1;EPN3;FBXO2;PRR7;PDCD4;CTNNBIP1;NAGS;DOCK4;XPC;PRNP;PARVB;PYGB;BBS2;FLNC;POSTN;VEGFA;FAM210B;PGM1;WNT7A;APOE;PYGL;TSPAN1;ESPN;NAGLU;F2R;LRP5;PLD3;OSBPL5;LPCAT4;PITPNC1;HMGA2;OBSCN;NDRG1;IDH2;ZKSCAN1;NEK9;CRAT;ELK3;ITPR3;PKN1;MTA1;GRAMD4;ACOT7;ARRDC1;ANGEL1;ACSF2;NISCH;AKR7A2;SH2D5;EGFR;RPS6KA2;SERPINE2;DNPH1;WWTR1;LOXL1;OBSL1;NOS1;VAT1;PTPRS;TMEM129;SLC2A9;ANKS6;HADH;CTSO;SPRY2;CAPN2;MST1R;NFATC4;TRIM65;BAHCC1;CRTAP;LTBP4;PRSS8;SYTL1;SDC1;ETV5;LMF1;APPL2;SHC1;DDB2;LTBP2;VPS11;LTBP1;TBC1D14;ARL2;HEXB;SLC7A8;TCFL5;PTPRE;NPEPL1;SLC2A3;ALDH4A1;TK2;RIN1;ACTA2;CLIP2;ETV4;SNX9;NUDCD3;TRNP1;RAPGEF3;TXNRD3;ST6GALNAC2;ZFP36L1;GAA;GLUL;ARAP1;MAP2K2;KDSR;NME4;ZC3H6;MARCH9;CTBS;FKBP9;MDFI;PTOV1;SMARCA1;SUGCT;PGLS;PC;FOXQ1;RNF44;MAP2K1;NAPRT;CRYL1;ACP5;CPT2;VWA5A;MCTP1;MXD4;SSH1;POU2F2;ENDOG;MARK4;MARCKSL1;MPRIP;TMEM8A;GALE;SMURF2;KLC2;TSC22D1;ARMCX2;OXLD1;SLC9A3R2;FOS;FBLN1;SMAD3;ARHGAP23;STAT6;SHANK2;PIK3R2;ERCC6;LRP1;SRD5A3;DVL1;EPAS1;DNAJB5;PIGQ;HSD17B8;HBEGF;FAM110C;RPUSD3;AP2A2;S100A4;ITGB4;CYBRD1;SH3PXD2B;PPP2R3B;PRDX5;STOM;BRD3;PRODH;SALL2;MBOAT7;CDK18;REEP4;LY6K;ZXDC;RNF187;ADARB1;PLCXD2;D2HGDH;SYT8;AKT1;TPCN1;GRB7;TMOD2;CORO1B;TTYH3;HDAC5;UROS;S100A6;F12;PITPNM1;ENTPD6;PLEKHH3;RHBDF2;PYCR2;BSG;STK39;HK1;SERPING1;ASAP2;SCMH1;DYSF;GGT1;PHC2;NFKBIZ;VEGFB;ASH2L;MARCH4;SLC15A4;ATG16L2;ZFYVE21;CNTN1;IFNGR2;BRSK1;IFT140;PTHLH;MYZAP;RAB31;FGFR4;HEBP1;WNT2B;POLD4;FNDC4;LDLR;FGFR1;PRKACB;FUCA1;MAPKBP1;SIGMAR1;RAC2;KCNAB2;PFKL;SEC14L2;HLTF;MXI1;NPHP4;SYNE3;RAG1;GAMT;H2AFJ;B4GAT1;PACS2;PHF7;TOMM34;BPHL;PIGV;KLF7;RALGDS;SORL1;NAT14;CEACAM1;B3GAT3;CIRBP;CBR4;HMG20B;LZTS2;RAB11FIP4;TENM2;ZNF385A;NSMCE4A;ABCD1;ANK3;NIPSNAP1;IGFBP4;EVC;TSHZ1;TRAPPC9;CCND1;TCF25;LHPP;TNNT1;TWF2;STRADB;SYNGAP1;MAPK13;CEP250;CARD19;PLAU;GAS6;PTK6;PFKP;CSNK1E;R3HDM4;BRI3;CTSB;RAB3B;CARD11;SOX13;LAMA5;DUSP7;MPLKIP;GSN;MAPKAPK3;IGFBP2;PCSK9;ARHGAP22;RAD23A;DHTKD1;PHLDA1;ANO8;BCR;ANTXR2;XPOT;MRPS6;EHD4;ERRFI1;GLI4;SEPT10;WIPF1;HLCS;ZSCAN18;AIP;DBNDD1;MYEF2;SH3D19;CCDC113;CDC25B;SH3GLB2;ARHGAP27;ALOX15B;SPTB;SMARCD2;AGAP1;COMTD1;RSPH3;PEX10;CCS;GGACT;RSAD1;COL13A1;CORO7;OAF;UNC119B;SNTA1;DGKQ;HAGH;BNIP3;PAK6;NOL4L;GTF2IRD1;SHARPIN;MVB12B;SERINC2;TAGLN3;FYCO1;CEMIP;PROCR;PKD2;ACY1;GPX3;PCSK1;RETSAT;YPEL3;CTSZ;CDC42EP5;HES2;CRTC1;FBXW8;GPSM1;AP3D1;ITGB5;ABCA2;MAGEF1;PRSS3;SH3PXD2A;C19ORF33;EPHB2;ADAM8;ASIC1;CADM4;APRT;TMEM9;CTBP1;LTA4H;MNT;PTPDC1;CDKN1C;PLCG1;ZMIZ2;CBS;KIF17;CD81;CEBPB;ENTPD2;ADAMTS13;ZNF217;TIMP2;ZNF862;NUDCD2;SYNJ2;WNT3;DPP7;GNAL;TMED4;TGFB1;LACTB2;SNPH;CLTCL1;RFX2;SCYL1;ABHD17C;SNTB2;ULK2;GPC1;MKNK2;ADAMTS7;DEAF1;MOAP1;SLC38A10;NTSR1;B3GNT3;NAB2;TMEM173;ZSCAN30;ATP7B;FHOD3;SHANK3;PODXL2;SDHA;MSRB2;PNRC1;MIPEP;MGAT4B;EML2;KIF26B;MDH2;MPG;GALNS;CLCA2;HEXDC;GOLGA2P5;ABHD8;ENKD1;NSMF;PEG3;ARAP3;FARP1;TUB;DIRC2;CROCC;RHOD;ABHD14B;LAMB2;TNS1;ABTB1;SNX17;RNH1;DNAH1;ERO1B;ST6GALNAC6;VGF;POLL;POLM;SNX33;PI4K2A;SEMA4F;C1ORF210;PTMS;RHOF;YIPF3;ANKZF1;WASF3;ATG2A;SLC48A1;LLGL1;PHGDH;PHF21A;MIF4GD;KIF7;COA5;RHOBTB2;UBXN4;ADAM19;KHDRBS3;SAC3D1;TUBG2;RIMS3;BBS1;HMGCL;PTPN1;PEX1;TPP1;PCK2;B4GALT2;WDR59;AGRN;MBD3;CD320;CAMK2N1;OSBPL10;LRP4;ESYT2;ZDHHC24;ACP6;B4GALT6;VHL;MYH16;CEP131;TRAP1;IDUA;ADAP1;PFKFB2;RFNG;MLXIPL;YPEL5;TRIB2;PRKCZ;KDM6B;PRKACA;MINK1;ZNF516;CENPH;GRHPR;OXA1L;RABGGTA;RCCD1;ACTR1B;TOM1L2;CD9;EPN2;ADA;AREG;MPI;MICALL2;UCKL1;PLEKHG5;BOK;WDR18;TDRKH;CAPG;SDCCAG8;ALAS1;NEURL1B;ERBB2;ADGRB2;ULK1;CNDP2;NINL;AHCY;VAMP2;CERCAM;PRIMPOL;TMEM143;TFDP2;SMTN;PLEK2;C6ORF89;MZT2A;NECAB3;STK17A;RILPL1;FAM50A;JAK3;IRF2BP2;RNPEP;NET1;BNIP3L;CYFIP2;FSCN1;PBX2;NELFCD;SLC22A17;PDK1;ACAD10;CYGB;ARHGAP44;THOP1;EHBP1L1;MCFD2;PRKCD;FAM20C;MIB2;REEP6;RBL2;USP20;STUB1;IFI6;BAX;CYC1;SV2A;SBF1;DTD1;XYLT2;ITGA1;OLFM2;ZNF395;HIST3H2BB;CCDC92;NUBP2;PPCS;SH3BP1;GJB4;RPS6KA5;DGUOK;DUSP4;KLHDC2;TIMM17B;ZNF524;SOX12;PLEKHH1;TMBIM4;DDIT4;MBTPS2;ACADS;TOP3B;PPL;PPP1R13L;CARF;HSD17B7;AHNAK2;PCSK1N;MT2A;IER2;HPCAL1;CES2;NAGA;ZDHHC8;TMX4;MZT2B;FCHO1;NID1;LIMK1;TGFBR3;NTPCR;PDIA5;GDI1;TPM2;PADI3;DIP2A;LTB4R2;CPNE7;SLC2A11;RPL39L;LEMD2;RPS6KA6;TMEM92;ZHX3;DNM1;WASH3P;RGS14;TMEM8B;SCN8A;MFNG;GSTO1;GIT1;ALDOC;MRPS26;MSLN;LPCAT1;ADAM15;REEP2;EHD3;WDR60;ST3GAL3;TMEM231;LONP2;SYMPK;MAPK12;IRAK1;PPOX;TGFA;HDAC7;FHOD1;INPP5D;CHD2;PI4K2B;CBX7;CHEK2;DECR2;ZFPM1;PPARA;COG7;COQ2;SESN2;ABCG1;MYO1D;JADE2;MYH15;CDC34;RNF123;SNN;SOX7;ABCA7;RAB12;EML3;SPEG;SIX5;BCAP31;MIF;ACO2;SMOX;KDM4B;SLC25A29;DOPEY2;PHYH;ZNF414;MEX3A;BCAM;SLC9A7;PLA2G6;DDT;SSBP4;SYNGR1;NUDT14;ECM1;NARF;WFS1;QSOX1;CD68;ZNF444;SLC22A18;SPPL2B;HSD11B1L;FYN;VWA1;UPP1;EFEMP2;STK25;RAC3;ETFB;GLB1L2;EEF2K;CERS4;SUN1;FLYWCH1;ACAP3;ARID5B;HOXC5;DNM2;CKMT1A;CYP3A5;BHLHE40;GLB1;PELI1;SNX15;CAT;BEX2;NEIL1;TSPYL2;IGFBP7;ARMCX1;SLC27A1;ZMYM3;TPBG;APOBEC3C;SATB1;SLC50A1;KIF26A;ZDHHC1;SLC12A4;PLCB3;H1FX;IQSEC1;ZNF606;APOBEC3F;DDX50;CYP2R1;TUBB6;MAPK3;CBLN3;INSR;SLC13A3;RTN2;PAN2;GRINA;PDZD2;CAMTA2;TAZ;PFKM;ADCY1;TNS4;C12ORF66;RERE;HLA-G;STX10;TSTA3;INO80C;ATP8B2;GPT2;RALGAPA1;MORN4;PDXK;ETAA1;PRAF2;GLRX;CEP72;VANGL2;PAK1;TRIM45;CDYL2;DCAF10;MALL;CAMKK2;RNASET2;PPP3CB;RNF144A;LGALS3BP;CTSF;ROBO4;USP21;PFKFB3;MLYCD;CUL7;SLC37A2;REV1;MICAL1;HYAL1;SEMA4C;CAPRIN2;ZBTB10;WDTC1;HES7;ITGA3;DNMT3A;SAMD8;BIN1;VPS16;MAN2B1;TSTD1;HES6;SLC16A13;MAP2K3;NDST2;BCL2L1;DLG3;SGSM2;ABHD10;NDUFV3;RRAS;DNASE1L1;PROX1;IARS2;LRCH4;TBC1D16;ALDH7A1;LMNA;PKD1;KCTD13;TNFRSF25;RABGAP1;SIRT2;FAM129B;ITGA4;EDA;UVSSA;ANKRD13D;GAL3ST4;NMNAT2;BACH1;NT5C1B;TRIP10;E2F5;ZBTB22;ALG12;AFAP1L1;MAPRE3;AZIN2;TEP1;RAB28;ZNF704;SERPINB1;ST3GAL2;ICA1;SLC25A37;RAP1GAP2;LAMB1;SOCS7;HSDL1;RGS19;NDE1;HSD11B1;GTF2IRD2;RAB40B;NGFR;TOLLIP;BCORL1;PDCD6;ATP6V1F;PCLO;ARVCF;CHST14;BIVM;ZNF837;RNASE7;PXN;PHYKPL;PLEKHM1;DUSP23;GCH1;MSS51;LURAP1;KIF13B;MAFF;NR2F6;CBX6;TCTN1;NBEAL2;PNMA1;CAMK1;CAMKK1;EZH1;SIRT3;HFE;TERC;ZNF513;WIPI2;GAS2L1;COL6A1;BTG1;BBS10;VPS51;CELSR1;TACC1;MLF2;SEMA3B;SEPT6;CDK11B;PFN2;C2CD2;SSH3;FGFR3;MFSD10;TST;CCDC88C;ST3GAL5;TNRC18;NDRG2;MAN2B2;CBLC;ITPKB;PTGR2;SPTLC2;TCEA2;CDC42BPG;ZBTB47;PLAG1;CLK3;IRF2BPL;TRIM46;DHX32;KDM3A;PM20D2;TMEM187;FAM214B;TBL3;HOMER2;PKN3;APBA1;TTLL3;DEDD2;AK3;SRSF5;CHPF;ADCY6;SLC26A11;LRRK1;AARS;SDC2
3597,GO:0008033,0.999807379640212,0.000965192357740941,3,120,tRNA processing,BP,RPUSD3;TRPT1;AARS
7221,GO:0031123,0.999811000718704,0.000948947820850964,3,119,RNA 3'-end processing,BP,ZFP36L1;SYMPK;SRSF5
2441,GO:0005643,0.99981545126303,0.00187035082420099,1,76,nuclear pore,CC,XPOT
2859,GO:0006354,0.999821826307026,0.000898428881485718,3,121,DNA-templated transcription, elongation,BP,ERCC6;NELFCD;TCEA2
15252,GO:0071426,0.999844403645624,0.000793627542306253,3,121,ribonucleoprotein complex export from nucleus,BP,XPOT;SYMPK;SRSF5
5928,GO:0018205,0.999846992432697,0.000346295246439413,18,338,peptidyl-lysine modification,BP,EGR1;MTA1;NOS1;ASH2L;HMG20B;CTBP1;TGFB1;MBD3;RPS6KA5;HDAC7;JADE2;EEF2KMT;MAPK3;SIRT2;TOLLIP;EZH1;SIRT3;KDM3A
7704,GO:0032200,0.999847674585898,0.000589129923735407,5,166,telomere organization,BP,ERCC1;POLD4;MAPK3;TEP1;TERC
3249,GO:0006913,0.999852298359864,0.000356762027751664,15,302,nucleocytoplasmic transport,BP,RAPGEF3;AKT1;STRADB;GAS6;XPOT;TGFB1;TMEM173;PRKCD;RGS14;SYMPK;TMCO6;RERE;PKD1;CAMK1;SRSF5
15106,GO:0071166,0.999859244443852,0.000723708954184918,3,122,ribonucleoprotein complex localization,BP,XPOT;SYMPK;SRSF5
7307,GO:0031323,0.999861537657923,0.000175600084493228,433,4633,regulation of cellular metabolic process,BP,TNIP1;DUSP6;XDH;ERCC1;DUSP5;MEF2D;ZMYND8;CITED4;HTRA1;EGR1;NR1D1;EDEM1;DLG4;PLAT;CST3;CYP27B1;TYSND1;FBXO2;APLN;PDCD4;CTNNBIP1;ACVR2B;PRNP;VEGFA;TNFRSF6B;WNT7A;APOE;F2R;LRP5;ITGA6;HMGA2;ZKSCAN1;ELK3;PKN1;MTA1;GRAMD4;EGFR;SERPINE2;WWTR1;NOS1;SPRY2;MST1R;NFATC4;TRIM65;BAHCC1;CRTAP;ETV5;LMF1;SHC1;VPS11;TBC1D14;HEXB;GTPBP1;TCFL5;ETV4;PHLDA2;SNX9;TRNP1;SPRY4;RAPGEF3;ZFP36L1;ARAP1;MAP2K2;ZC3H6;LPAR3;MDFI;PTOV1;SMARCA1;PPP1R35;RBCK1;FOXQ1;MAP2K1;ACP5;MXD4;SSH1;POU2F2;ENDOG;SMURF2;TSC22D1;FOS;FBLN1;SMAD3;STAT6;PIK3R2;ERCC6;LRP1;GJC2;DVL1;EPAS1;DNAJB5;HBEGF;PPP1R14A;PPP2R3B;PRDX5;SHC2;BRD3;SALL2;ZXDC;RNF187;ADORA2B;ADARB1;AKT1;TPCN1;GRB7;HDAC5;F12;PPM1F;STK39;SERPING1;SCMH1;EPHA1;NFKBIZ;ASH2L;IMPACT;WWC3;CNTN1;DAP;PTHLH;FGFR4;LDLR;FGFR1;PRKACB;RAC2;SEC14L2;HLTF;MXI1;RAG1;H2AFJ;KLF7;SORL1;NAT14;CEACAM1;B3GAT3;CIRBP;HMG20B;TENM2;ZNF385A;IGFBP4;TSHZ1;TRAPPC9;CCND1;PODNL1;PCBP4;TCF25;STRADB;SYNGAP1;MAPK13;GAS6;PTK6;CSNK1E;CARD11;SOX13;DUSP7;GSN;MAPKAPK3;PCSK9;ARHGAP22;RAD23A;BCR;EHD4;ERRFI1;GLI4;ZSCAN18;AIP;MYEF2;MN1;SH3D19;CDC25B;SMARCD2;SNTA1;DGKQ;BNIP3;PAK6;TFPI2;GTF2IRD1;TAGLN3;FYCO1;CEMIP;PKD2;CTSZ;HES2;CRTC1;GPSM1;ABCA2;ZNF598;MAGEF1;EPHB2;ADAM8;CTBP1;MNT;CDKN1C;PLCG1;ZMIZ2;CD81;CEBPB;ZNF217;TIMP2;ZNF862;C8ORF88;TGFB1;RFX2;SCYL1;UNK;ULK2;MKNK2;DEAF1;NTSR1;NAB2;TMEM173;ZSCAN30;MSRB2;PNRC1;TNFSF15;NSMF;PEG3;FARP1;MC1R;ABHD14B;SNX33;PHF21A;MIF4GD;KHDRBS3;ZER1;PTPN1;AGRN;MBD3;IFNE;CAMK2N1;LRP4;VHL;TRAP1;PFKFB2;MLXIPL;TRIB2;PRKCZ;KDM6B;PRKACA;MINK1;ZNF516;AREG;PIM2;BOK;WDR18;ERBB2;ULK1;TFDP2;C6ORF89;NECAB3;STK17A;JAK3;IRF2BP2;BNIP3L;CYFIP2;PBX2;NELFCD;PDK1;PRKCD;FAM20C;RBL2;STUB1;IFI6;BAX;ITGA1;ZNF395;EREG;RPS6KA5;DUSP4;ZNF524;SOX12;DDIT4;MBTPS2;PPP1R13L;CARF;AHNAK2;PCSK1N;IER2;ZDHHC8;LIMK1;TGFBR3;LTB4R2;LEMD2;RPS6KA6;ZHX3;RGS14;CHAD;LPCAT1;LRSAM1;ASB1;LONP2;SYMPK;MAPK12;IRAK1;TGFA;HDAC7;FHOD1;INPP5D;MTHFR;CHD2;CBX7;CHEK2;ZFPM1;PPARA;TMEM161A;SESN2;ABCG1;MYO1D;SOX7;ABCA7;RAB12;SIX5;BCAP31;MIF;KDM4B;ZNF414;MEX3A;PLA2G6;DDT;SSBP4;ECM1;WFS1;QSOX1;ZNF444;TRPT1;FYN;STK25;EEF2K;ARID5B;HOXC5;DNM2;BHLHE40;PELI1;CAT;NEIL1;TSPYL2;ELFN2;SLC27A1;ZMYM3;SATB1;ZNF606;MAPK3;INSR;CAMTA2;TAZ;PFKM;ADCY1;RERE;INO80C;ETAA1;BCL7A;VANGL2;PAK1;CAMKK2;PPP3CB;RNF144A;USP21;PFKFB3;MLYCD;GABBR1;MICAL1;SEMA4C;CAPRIN2;ZBTB10;WDTC1;HES7;ITGA3;DNMT3A;SAMD8;BIN1;PPP2R5B;HES6;MAP2K3;DLG3;RRAS;PROX1;TBC1D16;ADGRF1;ZYG11B;PKD1;KCTD13;TNFRSF25;SIRT2;FAM129B;EDA;BACH1;ADCY7;E2F5;ZBTB22;MAPRE3;ZNF704;SERPINB1;SOCS7;MAP3K10;GTF2IRD2;NGFR;TOLLIP;BCORL1;PDCD6;ZNF837;GRB10;GCH1;MAFF;NR2F6;CBX6;CAMK1;CAMKK1;EZH1;SIRT3;HFE;ZNF513;BTG1;ZP3;MLF2;CDK11B;PFN2;FGFR3;PPP1R16A;CCDC88C;TNRC18;NDRG2;CBLC;ITPKB;SPTLC2;TCEA2;ZBTB47;PLAG1;CLK3;IRF2BPL;KDM3A;PM20D2;DEDD2;SRSF5;ADCY6;LRRK1
10876,GO:0044422,0.999864018148719,0.000171094710501807,694,7181,organelle part,CC,TNIP1;DUSP6;NT5E;ERCC1;DUSP5;MEF2D;H1F0;CITED4;EGR1;B4GALNT4;NR1D1;SLC16A3;H6PD;EDEM1;DLG4;CST3;CYP27B1;EPN3;FBXO2;CTNNBIP1;NAGS;DOCK4;XPC;PRNP;PARVB;PYGB;BBS2;FLNC;POSTN;VEGFA;FAM210B;PGM1;WNT7A;APOE;PYGL;TSPAN1;ESPN;NAGLU;PLD3;OSBPL5;LPCAT4;PITPNC1;HMGA2;OBSCN;NDRG1;IDH2;NEK9;CRAT;ELK3;ITPR3;PKN1;MTA1;GRAMD4;ACOT7;ANGEL1;ACSF2;EGFR;RPS6KA2;WWTR1;OBSL1;NOS1;VAT1;PTPRS;TMEM129;SLC2A9;HADH;SPRY2;CAPN2;MST1R;NFATC4;TRIM65;BAHCC1;CRTAP;SDC1;ETV5;LMF1;APPL2;SHC1;DDB2;VPS11;LTBP1;TBC1D14;ARL2;HEXB;SLC2A3;ALDH4A1;TK2;CLIP2;ETV4;SNX9;NUDCD3;TRNP1;RAPGEF3;ST6GALNAC2;GAA;ARAP1;MAP2K2;KDSR;NME4;MARCH9;SMARCA1;PC;RNF44;MAP2K1;NAPRT;CPT2;VWA5A;MCTP1;POU2F2;MARK4;TMEM8A;SMURF2;KLC2;ARMCX2;FOS;SMAD3;STAT6;SHANK2;ERCC6;LRP1;SRD5A3;DVL1;EPAS1;PIGQ;HSD17B8;HBEGF;FAM110C;RPUSD3;AP2A2;CYBRD1;SH3PXD2B;PPP2R3B;PRDX5;STOM;PRODH;SALL2;MBOAT7;REEP4;RNF187;ADARB1;D2HGDH;SYT8;AKT1;TPCN1;TMOD2;CORO1B;HDAC5;S100A6;PITPNM1;ENTPD6;RHBDF2;PYCR2;BSG;STK39;HK1;SERPING1;ASAP2;SCMH1;DYSF;PHC2;NFKBIZ;VEGFB;ASH2L;MARCH4;SLC15A4;ATG16L2;ZFYVE21;IFNGR2;BRSK1;IFT140;PTHLH;MYZAP;RAB31;POLD4;LDLR;FGFR1;PRKACB;FUCA1;MAPKBP1;SIGMAR1;RAC2;KCNAB2;PFKL;HLTF;MXI1;NPHP4;SYNE3;RAG1;H2AFJ;B4GAT1;PHF7;TOMM34;BPHL;PIGV;SORL1;CEACAM1;B3GAT3;CIRBP;CBR4;HMG20B;LZTS2;RAB11FIP4;TENM2;ZNF385A;NSMCE4A;ABCD1;ANK3;NIPSNAP1;IGFBP4;EVC;TRAPPC9;CCND1;LHPP;TNNT1;TWF2;CEP250;CARD19;PLAU;GAS6;PTK6;CSNK1E;BRI3;CTSB;RAB3B;SOX13;DUSP7;MPLKIP;GSN;MAPKAPK3;PCSK9;RAD23A;DHTKD1;PHLDA1;ANO8;ANTXR2;XPOT;MRPS6;EHD4;SEPT10;WIPF1;HLCS;AIP;DBNDD1;SH3D19;CCDC113;CDC25B;SH3GLB2;ARHGAP27;SPTB;SMARCD2;PEX10;COL13A1;CORO7;UNC119B;DGKQ;HAGH;BNIP3;PAK6;NOL4L;GTF2IRD1;MVB12B;CEMIP;PROCR;PKD2;PCSK1;RETSAT;YPEL3;CTSZ;CRTC1;GPSM1;AP3D1;ABCA2;PRSS3;SH3PXD2A;ADAM8;APRT;TMEM9;CTBP1;LTA4H;MNT;PTPDC1;PLCG1;ZMIZ2;KIF17;CEBPB;ENTPD2;ADAMTS13;ZNF217;TIMP2;NUDCD2;WNT3;DPP7;TMED4;TGFB1;LACTB2;SNPH;CLTCL1;SCYL1;ABHD17C;SNTB2;ULK2;GPC1;MKNK2;ADAMTS7;DEAF1;MOAP1;B3GNT3;TMEM173;ATP7B;FHOD3;SHANK3;PODXL2;SDHA;MIPEP;MGAT4B;EML2;KIF26B;MDH2;MPG;GALNS;CLCA2;GOLGA2P5;ENKD1;NSMF;DIRC2;CROCC;RHOD;ABHD14B;LAMB2;ABTB1;SNX17;RNH1;DNAH1;ERO1B;ST6GALNAC6;VGF;POLL;POLM;SNX33;PI4K2A;RHOF;ANKZF1;SLC48A1;LLGL1;PHF21A;MIF4GD;KIF7;UBXN4;KHDRBS3;SAC3D1;TUBG2;BBS1;HMGCL;PTPN1;PEX1;TPP1;PCK2;B4GALT2;WDR59;AGRN;MBD3;CD320;ESYT2;ACP6;B4GALT6;VHL;MYH16;CEP131;TRAP1;IDUA;PFKFB2;RFNG;MLXIPL;YPEL5;PRKCZ;KDM6B;PRKACA;CENPH;GRHPR;OXA1L;RABGGTA;ACTR1B;CD9;EPN2;ADA;AREG;MICALL2;BOK;WDR18;CAPG;SDCCAG8;ALAS1;ERBB2;ADGRB2;ULK1;CNDP2;NINL;VAMP2;CERCAM;PRIMPOL;TFDP2;C6ORF89;MZT2A;NECAB3;STK17A;RILPL1;FAM50A;IRF2BP2;BNIP3L;FSCN1;NELFCD;SLC22A17;PDK1;ACAD10;CYGB;THOP1;MCFD2;PRKCD;FAM20C;REEP6;RBL2;USP20;STUB1;BAX;CYC1;SV2A;SBF1;DTD1;XYLT2;OLFM2;HIST3H2BB;CCDC92;NUBP2;GJB4;RPS6KA5;DGUOK;DUSP4;KLHDC2;TIMM17B;SOX12;TMBIM4;MBTPS2;ACADS;PPP1R13L;CARF;HSD17B7;AHNAK2;PCSK1N;IER2;CES2;ZDHHC8;MZT2B;FCHO1;LIMK1;PDIA5;TPM2;LTB4R2;RPL39L;LEMD2;RPS6KA6;TMEM92;ZHX3;DNM1;WASH3P;RGS14;SCN8A;MFNG;ALDOC;MRPS26;MSLN;LPCAT1;REEP2;EHD3;WDR60;ST3GAL3;TMEM231;LONP2;SYMPK;MAPK12;IRAK1;PPOX;TGFA;HDAC7;FHOD1;CHD2;PI4K2B;CBX7;CHEK2;DECR2;ZFPM1;PPARA;COG7;COQ2;ABCG1;MYO1D;JADE2;MYH15;CDC34;RNF123;SNN;SOX7;ABCA7;RAB12;EML3;BCAP31;MIF;ACO2;SMOX;KDM4B;SLC25A29;DOPEY2;PHYH;SLC9A7;PLA2G6;SYNGR1;ECM1;NARF;WFS1;QSOX1;CD68;SLC22A18;SPPL2B;HSD11B1L;FYN;VWA1;UPP1;STK25;RAC3;ETFB;CERS4;SUN1;FLYWCH1;ARID5B;HOXC5;DNM2;CKMT1A;CYP3A5;BHLHE40;GLB1;SNX15;CAT;NEIL1;TSPYL2;IGFBP7;ARMCX1;ZMYM3;SATB1;SLC50A1;KIF26A;SLC12A4;PLCB3;H1FX;IQSEC1;APOBEC3F;DDX50;CYP2R1;TUBB6;MAPK3;INSR;RTN2;TAZ;PFKM;C12ORF66;RERE;HLA-G;STX10;INO80C;ATP8B2;GPT2;MORN4;PDXK;ETAA1;PRAF2;CEP72;VANGL2;PAK1;TRIM45;DCAF10;MALL;RNASET2;PPP3CB;RNF144A;LGALS3BP;CTSF;USP21;PFKFB3;MLYCD;CUL7;SLC37A2;REV1;MICAL1;HYAL1;SEMA4C;CAPRIN2;ZBTB10;WDTC1;DNMT3A;SAMD8;BIN1;VPS16;MAN2B1;SLC16A13;MAP2K3;NDST2;BCL2L1;DLG3;ABHD10;NDUFV3;DNASE1L1;IARS2;LRCH4;ALDH7A1;LMNA;PKD1;KCTD13;RABGAP1;SIRT2;FAM129B;EDA;UVSSA;GAL3ST4;NMNAT2;TRIP10;E2F5;ALG12;AFAP1L1;MAPRE3;AZIN2;TEP1;RAB28;SERPINB1;ST3GAL2;ICA1;SLC25A37;RAP1GAP2;LAMB1;NDE1;HSD11B1;GTF2IRD2;RAB40B;NGFR;TOLLIP;BCORL1;PDCD6;ATP6V1F;CHST14;PXN;PHYKPL;PLEKHM1;DUSP23;GCH1;MSS51;LURAP1;KIF13B;MAFF;NR2F6;CBX6;TCTN1;NBEAL2;PNMA1;EZH1;SIRT3;HFE;TERC;WIPI2;COL6A1;VPS51;CELSR1;TACC1;SEPT6;MFSD10;TST;CCDC88C;ST3GAL5;TNRC18;MAN2B2;SPTLC2;TCEA2;CDC42BPG;PLAG1;CLK3;IRF2BPL;DHX32;KDM3A;PM20D2;TBL3;HOMER2;TTLL3;DEDD2;AK3;SRSF5;CHPF;SLC26A11;SDC2
60,GO:0000123,0.999866331983226,0.00140052957590559,1,79,histone acetyltransferase complex,CC,JADE2
257,GO:0000724,0.999877997981622,0.000811704566210737,2,101,double-strand break repair via homologous recombination,BP,MAGEF1;POLL
12842,GO:0051169,0.99987860852428,0.000296000806895332,15,305,nuclear transport,BP,RAPGEF3;AKT1;STRADB;GAS6;XPOT;TGFB1;TMEM173;PRKCD;RGS14;SYMPK;TMCO6;RERE;PKD1;CAMK1;SRSF5
272,GO:0000775,0.999881714226896,0.000426363409278236,6,173,chromosome, centromeric region,CC,CEBPB;NUDCD2;CENPH;DNMT3A;NDE1;SEPT6
2895,GO:0006406,0.99988317403184,0.000779593480909062,2,103,mRNA export from nucleus,BP,SYMPK;SRSF5
15253,GO:0071427,0.99988317403184,0.000779593480909062,2,103,mRNA-containing ribonucleoprotein complex export from nucleus,BP,SYMPK;SRSF5
2830,GO:0006302,0.999886932783126,0.000379396930464975,7,194,double-strand break repair,BP,ERCC1;HMGA2;MTA1;MAGEF1;POLL;POLM;CHEK2
5336,GO:0016073,0.999888253651432,0.00118967907870182,1,84,snRNA metabolic process,BP,POU2F2
881,GO:0002244,0.999889245906898,0.000491607812531121,4,158,hematopoietic progenitor cell differentiation,BP,KCNAB2;DHTKD1;TGFB1;CHD2
2858,GO:0006353,0.999889634046199,0.000738938713156783,2,107,DNA-templated transcription, termination,BP,SYMPK;SRSF5
258,GO:0000725,0.999890507065573,0.000735323526382683,2,102,recombinational repair,BP,MAGEF1;POLL
10783,GO:0044260,0.999892134784358,0.00013594135276994,598,6261,cellular macromolecule metabolic process,BP,TNIP1;DUSP6;NT5E;XDH;ERCC1;DUSP5;MEF2D;GID4;ZMYND8;H1F0;CITED4;HTRA1;EGR1;NR1D1;EDEM1;DLG4;PLAT;CST3;BTBD2;FBXO2;APLN;PDCD4;CTNNBIP1;ACVR2B;XPC;PRNP;PYGB;VEGFA;TNFRSF6B;PGM1;WNT7A;APOE;PYGL;F2R;LRP5;ITGA6;HMGA2;OBSCN;ZKSCAN1;NEK9;ELK3;PKN1;MTA1;GRAMD4;ARRDC1;EGFR;RPS6KA2;SERPINE2;WWTR1;LOXL1;OBSL1;NOS1;PTPRS;TMEM129;CTSO;SPRY2;CAPN2;MST1R;NFATC4;BAHCC1;CRTAP;KLHL29;ETV5;LMF1;SHC1;DDB2;VPS11;LTBP1;HEXB;GTPBP1;TCFL5;PTPRE;TK2;MMP1;ETV4;PHLDA2;SNX9;TRNP1;SPRY4;RAPGEF3;ST6GALNAC2;ZFP36L1;GAA;ARAP1;MAP2K2;ZC3H6;LPAR3;MARCH9;FKBP9;MDFI;PTOV1;SMARCA1;PPP1R35;RBCK1;FOXQ1;RNF44;MAP2K1;NYNRIN;MXD4;SSH1;POU2F2;ENDOG;MARK4;SMURF2;TSC22D1;FOS;FBLN1;SMAD3;STAT6;PIK3R2;ERCC6;LRP1;GJC2;SRD5A3;DVL1;EPAS1;DNAJB5;PIGQ;HBEGF;AP2A2;PPP1R14A;PPP2R3B;PRDX5;SHC2;BRD3;SALL2;CDK18;LY6K;FBXW5;ZXDC;RNF187;ADORA2B;ADARB1;D2HGDH;AKT1;GRB7;HDAC5;FBXO41;F12;PPM1F;STK39;SERPING1;SCMH1;EPHA1;GGT1;NFKBIZ;PTPRU;VEGFB;ASH2L;IMPACT;MARCH4;WWC3;CNTN1;BRSK1;DAP;RAB31;FGFR4;POLD4;LDLR;FGFR1;PRKACB;RAC2;TTLL12;SEC14L2;HLTF;MXI1;PPM1J;RAG1;H2AFJ;B4GAT1;PIGV;KLF7;SORL1;NAT14;CEACAM1;B3GAT3;ASB13;CIRBP;HMG20B;TENM2;ZNF385A;NSMCE4A;IGFBP4;TSHZ1;TRAPPC9;CCND1;PODNL1;PCBP4;TCF25;LHPP;STRADB;SYNGAP1;MAPK13;GAS6;PTK6;CSNK1E;CTSB;RAB3B;CARD11;SOX13;DUSP7;GSN;MAPKAPK3;IGFBP2;PCSK9;ARHGAP22;RAD23A;PHLDA1;ANO8;BCR;MRPS6;EHD4;ERRFI1;GLI4;HLCS;ZSCAN18;MYEF2;MN1;SH3D19;CDC25B;SPTB;SMARCD2;PEX10;RRNAD1;NPR2;SNTA1;DGKQ;BNIP3;PAK6;TFPI2;GTF2IRD1;SHARPIN;MVB12B;TAGLN3;CEMIP;PKD2;RASGEF1A;CTSZ;CDC42EP5;HES2;CRTC1;FBXW8;ABCA2;ZNF598;MAGEF1;EPHB2;ADAM8;CTBP1;JOSD2;LTA4H;MNT;PTPDC1;GRK6;CDKN1C;PLCG1;FBXL8;ZMIZ2;CBS;CD81;CEBPB;MVD;RNF135;ADAMTS13;ZNF217;TIMP2;ZNF862;C8ORF88;TGFB1;RFX2;SCYL1;ABHD17C;UNK;ULK2;GPC1;MKNK2;ADAMTS7;DEAF1;B3GNT3;NAB2;TMEM173;ZSCAN30;SHANK3;MSRB2;RASA3;PNRC1;MIPEP;TNFSF15;MGAT4B;MDH2;MPG;FBXO17;NSMF;PEG3;MC1R;LCE1E;ABHD14B;LAMB2;ABTB1;RNH1;ERO1B;ST6GALNAC6;VGF;POLL;FBXO44;POLM;SNX33;PTMS;ANKZF1;PHF21A;MIF4GD;UBXN4;KHDRBS3;ZER1;PTPN1;B4GALT2;AGRN;MBD3;IFNE;CAMK2N1;LRP4;ZDHHC24;B4GALT6;VHL;TRAP1;IDUA;RFNG;MLXIPL;TRIB2;PRKCZ;KDM6B;PRKACA;MINK1;ZNF516;RABGGTA;CD9;AREG;PIM2;MPI;BOK;WDR18;TDRKH;NEURL1B;ERBB2;ULK1;PRIMPOL;TFDP2;C6ORF89;NECAB3;STK17A;JAK3;IRF2BP2;BNIP3L;CYFIP2;PBX2;NELFCD;RASA4;PDK1;THOP1;MCFD2;PRKCD;FAM20C;MIB2;RBL2;USP20;STUB1;IFI6;BAX;SBF1;DTD1;XYLT2;TRIM4;ITGA1;ZNF395;FBXW4;EREG;RPS6KA5;DGUOK;DUSP4;ZNF524;CUL9;SOX12;DDIT4;MBTPS2;TOP3B;PPP1R13L;CARF;PCSK1N;IER2;ZDHHC8;LIMK1;TGFBR3;PADI3;RPL39L;LEMD2;RPS6KA6;ZHX3;DNM1;RGS14;MFNG;CHAD;MRPS26;MSLN;LRSAM1;ASB1;EHD3;ST3GAL3;LONP2;SYMPK;MAPK12;IRAK1;TGFA;HDAC7;FHOD1;MTHFR;CHD2;CBX7;PCMTD2;CHEK2;ZFPM1;PPARA;COG7;TMEM161A;SESN2;ABCG1;JADE2;CDC34;RNF123;SOX7;ABCA7;RAB12;SPEG;SIX5;BCAP31;MIF;EEF2KMT;KDM4B;ZNF414;MEX3A;PLA2G6;DDT;SSBP4;NUDT14;ECM1;WFS1;QSOX1;ZNF444;DTX3;TRPT1;DALRD3;SPPL2B;FYN;VWA1;STK25;ETFB;EEF2K;ARID5B;HOXC5;DNM2;BHLHE40;PELI1;CAT;NEIL1;TSPYL2;IGFBP7;ELFN2;SLC27A1;ZMYM3;APOBEC3C;SATB1;ZDHHC1;ZNF606;APOBEC3F;MAPK3;INSR;PAN2;CAMTA2;PFKM;ADCY1;RERE;INO80C;ETAA1;GLRX;BCL7A;VANGL2;PAK1;DCAF10;KLHL36;CAMKK2;RNASET2;PPP3CB;RNF144A;ALPK1;CTSF;USP21;CUL7;REV1;MICAL1;HYAL1;SEMA4C;CAPRIN2;ZBTB10;WDTC1;HES7;ITGA3;STK32C;DNMT3A;BIN1;MAN2B1;SRMS;PPP2R5B;HES6;MAP2K3;NDST2;DLG3;RRAS;DNASE1L1;PROX1;IARS2;MDGA1;TBC1D16;ADGRF1;ZYG11B;PKD1;KCTD13;TNFRSF25;SIRT2;FAM129B;EDA;UVSSA;GAL3ST4;BACH1;ADCY7;E2F5;ZBTB22;ALG12;MAPRE3;TEP1;ZNF704;SERPINB1;ST3GAL2;LAMB1;SOCS7;MAP3K10;PELI3;GTF2IRD2;RAB40B;NGFR;TOLLIP;BCORL1;PDCD6;CHST14;ZNF837;DUSP23;MAFF;NR2F6;CBX6;CAMK1;CAMKK1;EZH1;SIRT3;HFE;TERC;ZNF513;WIPI2;BTG1;ZP3;MLF2;CDK11B;PFN2;SSH3;FGFR3;PPP1R16A;CCDC88C;ST3GAL5;TNRC18;NDRG2;MAN2B2;CBLC;ITPKB;TCEA2;CDC42BPG;PRSS21;ZBTB47;PLAG1;CLK3;IRF2BPL;KDM3A;PM20D2;PKN3;TTLL3;DEDD2;SRSF5;CHPF;ADCY6;LRRK1;AARS;KLHL24;SDC2
10901,GO:0044454,0.99989249021549,0.00021942008662954,26,462,nuclear chromosome part,CC,ERCC1;MEF2D;H1F0;NR1D1;APPL2;TRNP1;SMARCA1;SMAD3;STAT6;SALL2;ASH2L;POLD4;H2AFJ;ZNF385A;SMARCD2;ZMIZ2;CEBPB;NSMF;MBD3;KDM6B;CBX7;SATB1;INO80C;ETAA1;DNMT3A;SIRT2
13673,GO:0060218,0.999908304414482,0.000988515304580705,1,100,hematopoietic stem cell differentiation,BP,CHD2
6599,GO:0022626,0.999912332974943,0.000945752275692801,1,110,cytosolic ribosome,CC,RPL39L
14406,GO:0061695,0.999918813691597,0.000236970438004295,10,242,transferase complex, transferring phosphorus-containing groups,CC,ERCC1;PIK3R2;POLD4;PFKL;CCND1;ULK1;SESN2;INSR;PFKM;TERC
6923,GO:0030522,0.999920948592019,0.000242084306603634,9,221,intracellular receptor signaling pathway,BP,NR1D1;CYP27B1;ALOX15B;IRAK1;PPARA;PAK1;DCBLD2;NR2F6;KDM3A
10893,GO:0044446,0.999923116867188,9.74777554480905e-05,681,7084,intracellular organelle part,CC,TNIP1;DUSP6;NT5E;ERCC1;DUSP5;MEF2D;H1F0;CITED4;EGR1;B4GALNT4;NR1D1;SLC16A3;H6PD;EDEM1;DLG4;CST3;CYP27B1;EPN3;CTNNBIP1;NAGS;DOCK4;XPC;PRNP;PYGB;BBS2;POSTN;VEGFA;FAM210B;PGM1;WNT7A;APOE;PYGL;TSPAN1;ESPN;NAGLU;PLD3;OSBPL5;LPCAT4;PITPNC1;HMGA2;OBSCN;NDRG1;IDH2;NEK9;CRAT;ELK3;ITPR3;PKN1;MTA1;GRAMD4;ACOT7;ANGEL1;ACSF2;EGFR;RPS6KA2;WWTR1;OBSL1;NOS1;VAT1;PTPRS;TMEM129;SLC2A9;HADH;SPRY2;CAPN2;MST1R;NFATC4;TRIM65;BAHCC1;CRTAP;SDC1;ETV5;LMF1;APPL2;SHC1;DDB2;VPS11;LTBP1;TBC1D14;ARL2;HEXB;SLC2A3;ALDH4A1;TK2;CLIP2;ETV4;SNX9;NUDCD3;TRNP1;RAPGEF3;ST6GALNAC2;GAA;ARAP1;MAP2K2;KDSR;NME4;MARCH9;SMARCA1;PC;RNF44;MAP2K1;NAPRT;CPT2;VWA5A;MCTP1;POU2F2;MARK4;TMEM8A;SMURF2;KLC2;ARMCX2;FOS;SMAD3;STAT6;SHANK2;ERCC6;LRP1;SRD5A3;DVL1;EPAS1;PIGQ;HSD17B8;HBEGF;FAM110C;RPUSD3;AP2A2;CYBRD1;SH3PXD2B;PPP2R3B;PRDX5;STOM;PRODH;SALL2;MBOAT7;REEP4;RNF187;ADARB1;D2HGDH;SYT8;AKT1;TPCN1;TMOD2;CORO1B;HDAC5;S100A6;PITPNM1;ENTPD6;RHBDF2;PYCR2;BSG;STK39;HK1;SERPING1;ASAP2;SCMH1;DYSF;PHC2;NFKBIZ;VEGFB;ASH2L;MARCH4;SLC15A4;ATG16L2;ZFYVE21;IFNGR2;BRSK1;IFT140;PTHLH;MYZAP;RAB31;POLD4;LDLR;FGFR1;PRKACB;FUCA1;MAPKBP1;SIGMAR1;RAC2;KCNAB2;PFKL;HLTF;MXI1;NPHP4;SYNE3;RAG1;H2AFJ;B4GAT1;PHF7;TOMM34;BPHL;PIGV;SORL1;CEACAM1;B3GAT3;CIRBP;CBR4;HMG20B;LZTS2;RAB11FIP4;TENM2;ZNF385A;NSMCE4A;ABCD1;NIPSNAP1;IGFBP4;EVC;TRAPPC9;CCND1;LHPP;TNNT1;TWF2;CEP250;CARD19;PLAU;GAS6;PTK6;CSNK1E;BRI3;CTSB;RAB3B;SOX13;DUSP7;MPLKIP;GSN;MAPKAPK3;PCSK9;RAD23A;DHTKD1;PHLDA1;ANO8;ANTXR2;XPOT;MRPS6;EHD4;SEPT10;WIPF1;HLCS;AIP;DBNDD1;SH3D19;CCDC113;CDC25B;SH3GLB2;ARHGAP27;SPTB;SMARCD2;PEX10;COL13A1;CORO7;DGKQ;HAGH;BNIP3;PAK6;NOL4L;GTF2IRD1;MVB12B;CEMIP;PROCR;PKD2;PCSK1;RETSAT;YPEL3;CTSZ;CRTC1;GPSM1;AP3D1;ABCA2;PRSS3;SH3PXD2A;ADAM8;APRT;TMEM9;CTBP1;LTA4H;MNT;PTPDC1;PLCG1;ZMIZ2;KIF17;CEBPB;ENTPD2;ADAMTS13;ZNF217;TIMP2;NUDCD2;WNT3;DPP7;TMED4;TGFB1;LACTB2;SNPH;CLTCL1;SCYL1;ABHD17C;SNTB2;ULK2;GPC1;MKNK2;ADAMTS7;DEAF1;MOAP1;B3GNT3;TMEM173;ATP7B;FHOD3;PODXL2;SDHA;MIPEP;MGAT4B;EML2;KIF26B;MDH2;MPG;GALNS;CLCA2;GOLGA2P5;ENKD1;NSMF;DIRC2;CROCC;RHOD;ABHD14B;LAMB2;ABTB1;SNX17;RNH1;DNAH1;ERO1B;ST6GALNAC6;VGF;POLL;POLM;SNX33;PI4K2A;RHOF;ANKZF1;SLC48A1;LLGL1;PHF21A;MIF4GD;KIF7;UBXN4;KHDRBS3;SAC3D1;TUBG2;BBS1;HMGCL;PTPN1;PEX1;TPP1;PCK2;B4GALT2;WDR59;AGRN;MBD3;CD320;ESYT2;ACP6;B4GALT6;VHL;MYH16;CEP131;TRAP1;IDUA;PFKFB2;RFNG;MLXIPL;YPEL5;PRKCZ;KDM6B;PRKACA;CENPH;GRHPR;OXA1L;RABGGTA;ACTR1B;CD9;EPN2;ADA;AREG;MICALL2;BOK;WDR18;CAPG;SDCCAG8;ALAS1;ERBB2;ADGRB2;ULK1;CNDP2;NINL;VAMP2;CERCAM;PRIMPOL;TFDP2;C6ORF89;MZT2A;NECAB3;STK17A;RILPL1;FAM50A;IRF2BP2;BNIP3L;FSCN1;NELFCD;SLC22A17;PDK1;ACAD10;CYGB;THOP1;MCFD2;PRKCD;FAM20C;REEP6;RBL2;USP20;STUB1;BAX;CYC1;SV2A;SBF1;DTD1;XYLT2;OLFM2;HIST3H2BB;CCDC92;NUBP2;GJB4;RPS6KA5;DGUOK;DUSP4;KLHDC2;TIMM17B;SOX12;TMBIM4;MBTPS2;ACADS;PPP1R13L;CARF;HSD17B7;AHNAK2;PCSK1N;IER2;CES2;ZDHHC8;MZT2B;FCHO1;LIMK1;PDIA5;TPM2;LTB4R2;RPL39L;LEMD2;RPS6KA6;TMEM92;ZHX3;DNM1;WASH3P;RGS14;MFNG;ALDOC;MRPS26;MSLN;LPCAT1;REEP2;EHD3;WDR60;ST3GAL3;LONP2;SYMPK;MAPK12;IRAK1;PPOX;TGFA;HDAC7;FHOD1;CHD2;PI4K2B;CBX7;CHEK2;DECR2;ZFPM1;PPARA;COG7;COQ2;ABCG1;MYO1D;JADE2;MYH15;CDC34;RNF123;SNN;SOX7;ABCA7;RAB12;EML3;BCAP31;MIF;ACO2;SMOX;KDM4B;SLC25A29;DOPEY2;PHYH;SLC9A7;PLA2G6;SYNGR1;ECM1;NARF;WFS1;QSOX1;CD68;SLC22A18;SPPL2B;HSD11B1L;FYN;VWA1;UPP1;STK25;RAC3;ETFB;CERS4;SUN1;FLYWCH1;ARID5B;HOXC5;DNM2;CKMT1A;CYP3A5;BHLHE40;GLB1;SNX15;CAT;NEIL1;TSPYL2;IGFBP7;ARMCX1;ZMYM3;SATB1;SLC50A1;KIF26A;SLC12A4;PLCB3;H1FX;IQSEC1;APOBEC3F;DDX50;CYP2R1;TUBB6;MAPK3;INSR;RTN2;TAZ;C12ORF66;RERE;HLA-G;STX10;INO80C;ATP8B2;GPT2;PDXK;ETAA1;PRAF2;CEP72;VANGL2;PAK1;TRIM45;DCAF10;MALL;RNASET2;PPP3CB;RNF144A;LGALS3BP;CTSF;USP21;PFKFB3;MLYCD;CUL7;SLC37A2;REV1;MICAL1;HYAL1;SEMA4C;CAPRIN2;ZBTB10;WDTC1;DNMT3A;SAMD8;BIN1;VPS16;MAN2B1;SLC16A13;MAP2K3;NDST2;BCL2L1;ABHD10;NDUFV3;DNASE1L1;IARS2;LRCH4;ALDH7A1;LMNA;PKD1;KCTD13;RABGAP1;SIRT2;FAM129B;EDA;UVSSA;GAL3ST4;NMNAT2;TRIP10;E2F5;ALG12;AFAP1L1;MAPRE3;AZIN2;TEP1;RAB28;SERPINB1;ST3GAL2;ICA1;SLC25A37;RAP1GAP2;LAMB1;NDE1;HSD11B1;GTF2IRD2;RAB40B;NGFR;TOLLIP;BCORL1;PDCD6;ATP6V1F;CHST14;PXN;PHYKPL;PLEKHM1;DUSP23;GCH1;MSS51;LURAP1;KIF13B;MAFF;NR2F6;CBX6;NBEAL2;PNMA1;EZH1;SIRT3;HFE;TERC;WIPI2;COL6A1;VPS51;CELSR1;TACC1;SEPT6;MFSD10;TST;CCDC88C;ST3GAL5;TNRC18;MAN2B2;SPTLC2;TCEA2;CDC42BPG;PLAG1;CLK3;IRF2BPL;DHX32;KDM3A;PM20D2;TBL3;TTLL3;DEDD2;AK3;SRSF5;CHPF;SLC26A11;SDC2
14863,GO:0070646,0.999924315076246,0.000213049216857575,11,258,protein modification by small protein removal,BP,TNIP1;DDB2;SMURF2;SMAD3;RAD23A;JOSD2;RNF135;USP20;RNF123;INO80C;USP21
12844,GO:0051171,0.999928063752923,9.24227561999889e-05,407,4408,regulation of nitrogen compound metabolic process,BP,TNIP1;DUSP6;XDH;ERCC1;DUSP5;MEF2D;ZMYND8;CITED4;HTRA1;EGR1;NR1D1;EDEM1;DLG4;PLAT;CST3;BTBD2;FBXO2;APLN;PDCD4;CTNNBIP1;ACVR2B;PRNP;VEGFA;TNFRSF6B;WNT7A;APOE;F2R;LRP5;ITGA6;HMGA2;ZKSCAN1;ELK3;PKN1;MTA1;GRAMD4;EGFR;SERPINE2;WWTR1;NOS1;SPRY2;MST1R;NFATC4;BAHCC1;CRTAP;LTBP4;ETV5;SHC1;VPS11;HEXB;GTPBP1;TCFL5;ETV4;SNX9;TRNP1;SPRY4;RAPGEF3;ZFP36L1;MAP2K2;ZC3H6;LPAR3;MDFI;PTOV1;SMARCA1;PPP1R35;RBCK1;FOXQ1;MAP2K1;ACP5;MXD4;SSH1;POU2F2;ENDOG;SMURF2;TSC22D1;FOS;FBLN1;SMAD3;STAT6;PIK3R2;ERCC6;LRP1;GJC2;DVL1;EPAS1;DNAJB5;HBEGF;PPP1R14A;PPP2R3B;PRDX5;SHC2;BRD3;SALL2;ZXDC;RNF187;ADORA2B;ADARB1;AKT1;GRB7;HDAC5;F12;PPM1F;STK39;SERPING1;SCMH1;EPHA1;NFKBIZ;ASH2L;IMPACT;WWC3;CNTN1;DAP;PTHLH;FGFR4;LDLR;FGFR1;PRKACB;RAC2;SEC14L2;HLTF;MXI1;RAG1;H2AFJ;KLF7;SORL1;NAT14;CEACAM1;B3GAT3;CIRBP;HMG20B;TENM2;ZNF385A;IGFBP4;TSHZ1;TRAPPC9;CCND1;PODNL1;PCBP4;TCF25;STRADB;SYNGAP1;MAPK13;GAS6;PTK6;CSNK1E;CARD11;SOX13;DUSP7;GSN;MAPKAPK3;PCSK9;ARHGAP22;RAD23A;BCR;EHD4;ERRFI1;GLI4;ZSCAN18;AIP;MYEF2;MN1;SH3D19;CDC25B;SMARCD2;SNTA1;DGKQ;PAK6;TFPI2;GTF2IRD1;TAGLN3;CEMIP;PKD2;CTSZ;HES2;CRTC1;ABCA2;ZNF598;MAGEF1;EPHB2;ADAM8;CTBP1;MNT;CDKN1C;PLCG1;ZMIZ2;CD81;CEBPB;ZNF217;TIMP2;ZNF862;C8ORF88;TGFB1;RFX2;SCYL1;UNK;MKNK2;DEAF1;NAB2;TMEM173;ZSCAN30;MSRB2;PNRC1;TNFSF15;NSMF;PEG3;MC1R;ABHD14B;ABTB1;SNX33;PHF21A;MIF4GD;KHDRBS3;ZER1;PTPN1;AGRN;MBD3;IFNE;CAMK2N1;LRP4;VHL;TRAP1;PFKFB2;MLXIPL;TRIB2;PRKCZ;KDM6B;PRKACA;MINK1;ZNF516;AREG;PIM2;BOK;WDR18;ERBB2;TFDP2;C6ORF89;NECAB3;JAK3;IRF2BP2;CYFIP2;PBX2;NELFCD;PRKCD;RBL2;STUB1;IFI6;BAX;ITGA1;ZNF395;EREG;RPS6KA5;DUSP4;ZNF524;SOX12;DDIT4;MBTPS2;PPP1R13L;CARF;AHNAK2;PCSK1N;IER2;LIMK1;TGFBR3;LTB4R2;LEMD2;RPS6KA6;ZHX3;RGS14;CHAD;LPCAT1;ASB1;SYMPK;MAPK12;IRAK1;TGFA;HDAC7;FHOD1;INPP5D;MTHFR;CHD2;CBX7;CHEK2;ZFPM1;PPARA;TMEM161A;SESN2;ABCG1;SOX7;ABCA7;SIX5;BCAP31;MIF;KDM4B;ZNF414;MEX3A;PLA2G6;DDT;SSBP4;ECM1;WFS1;ZNF444;TRPT1;FYN;STK25;EEF2K;ARID5B;HOXC5;DNM2;BHLHE40;PELI1;CAT;NEIL1;TSPYL2;ELFN2;SLC27A1;ZMYM3;SATB1;ZNF606;MAPK3;INSR;CAMTA2;TAZ;PFKM;ADCY1;RERE;INO80C;ETAA1;BCL7A;VANGL2;PAK1;CAMKK2;PPP3CB;RNF144A;USP21;PFKFB3;GABBR1;MICAL1;SEMA4C;CAPRIN2;ZBTB10;WDTC1;HES7;ITGA3;DNMT3A;SAMD8;BIN1;PPP2R5B;HES6;MAP2K3;DLG3;RRAS;PROX1;ADGRF1;ZYG11B;PKD1;KCTD13;TNFRSF25;SIRT2;FAM129B;EDA;BACH1;ADCY7;E2F5;ZBTB22;MAPRE3;AZIN2;ZNF704;SERPINB1;SOCS7;MAP3K10;GTF2IRD2;NGFR;TOLLIP;BCORL1;PDCD6;ZNF837;MAFF;NR2F6;CBX6;CAMK1;CAMKK1;EZH1;SIRT3;HFE;ZNF513;BTG1;ZP3;MLF2;CDK11B;PFN2;FGFR3;PPP1R16A;CCDC88C;TNRC18;NDRG2;CBLC;ITPKB;TCEA2;ZBTB47;PLAG1;CLK3;IRF2BPL;KDM3A;PM20D2;DEDD2;SRSF5;ADCY6;LRRK1
2888,GO:0006399,0.99993687350933,0.000236501075470009,6,184,tRNA metabolic process,BP,RPUSD3;DTD1;TRPT1;DALRD3;IARS2;AARS
3282,GO:0006974,0.999939210841121,0.000106760727744406,49,741,cellular response to DNA damage stimulus,BP,ERCC1;XPC;HMGA2;NDRG1;MTA1;EGFR;NFATC4;DDB2;ERCC6;AKT1;ASH2L;BRSK1;POLD4;ZNF385A;NSMCE4A;CCND1;PCBP4;CSNK1E;RAD23A;MAGEF1;MOAP1;MPG;MC1R;POLL;POLM;BOK;PRIMPOL;TFDP2;PRKCD;RBL2;STUB1;BAX;DDIT4;RPS6KA6;MRPS26;MAPK12;CHD2;CHEK2;TMEM161A;SESN2;MIF;NEIL1;MAPK3;INO80C;ETAA1;REV1;BCL2L1;UVSSA;BACH1
6071,GO:0019222,0.999945703902595,6.96025724066783e-05,458,4929,regulation of metabolic process,BP,TNIP1;DUSP6;XDH;ERCC1;DUSP5;MEF2D;ZMYND8;CITED4;HTRA1;EGR1;NR1D1;EDEM1;DLG4;PLAT;CST3;CYP27B1;TYSND1;BTBD2;FBXO2;APLN;PDCD4;CTNNBIP1;ACVR2B;PRNP;BBS2;VEGFA;TNFRSF6B;WNT7A;APOE;F2R;LRP5;ITGA6;HMGA2;ZKSCAN1;ELK3;PKN1;MTA1;GRAMD4;EGFR;SERPINE2;WWTR1;NOS1;SPRY2;MST1R;NFATC4;TRIM65;BAHCC1;CRTAP;LTBP4;ETV5;LMF1;SHC1;VPS11;TBC1D14;HEXB;GTPBP1;TCFL5;ACTA2;ETV4;PHLDA2;SNX9;TRNP1;SPRY4;RAPGEF3;ZFP36L1;ARAP1;MAP2K2;ZC3H6;LPAR3;MDFI;PTOV1;SMARCA1;PPP1R35;RBCK1;PC;FOXQ1;MAP2K1;ACP5;CPT2;MXD4;SSH1;POU2F2;ENDOG;SMURF2;TSC22D1;FOS;FBLN1;SMAD3;STAT6;PIK3R2;ERCC6;LRP1;GJC2;DVL1;EPAS1;DNAJB5;HBEGF;PPP1R14A;SH3PXD2B;PPP2R3B;PRDX5;SHC2;BRD3;SALL2;ZXDC;RNF187;ADORA2B;ADARB1;AKT1;TPCN1;GRB7;HDAC5;F12;PPM1F;STK39;SERPING1;SCMH1;EPHA1;NFKBIZ;ASH2L;IMPACT;WWC3;CNTN1;DAP;PTHLH;FGFR4;LDLR;FGFR1;PRKACB;RAC2;SEC14L2;HLTF;MXI1;RAG1;H2AFJ;KLF7;SORL1;NAT14;CEACAM1;B3GAT3;CIRBP;HMG20B;TENM2;ZNF385A;ANK3;IGFBP4;TSHZ1;TRAPPC9;CCND1;PODNL1;PCBP4;TCF25;STRADB;SYNGAP1;MAPK13;GAS6;PTK6;CSNK1E;CARD11;SOX13;DUSP7;GSN;MAPKAPK3;PCSK9;ARHGAP22;RAD23A;BCR;ANGPTL4;EHD4;ERRFI1;GLI4;ZSCAN18;AIP;MYEF2;MN1;SH3D19;CDC25B;SMARCD2;CCS;SNTA1;DGKQ;BNIP3;PAK6;TFPI2;GTF2IRD1;TAGLN3;FYCO1;CEMIP;PKD2;CTSZ;HES2;CRTC1;GPSM1;ABCA2;ZNF598;MAGEF1;EPHB2;ADAM8;CTBP1;MNT;CDKN1C;PLCG1;ZMIZ2;CD81;CEBPB;MVD;ZNF217;TIMP2;ZNF862;WNT3;C8ORF88;TGFB1;RFX2;SCYL1;UNK;ULK2;MKNK2;DEAF1;NTSR1;NAB2;TMEM173;ZSCAN30;MSRB2;PNRC1;TNFSF15;NSMF;PEG3;FARP1;MC1R;ABHD14B;ABTB1;RNH1;SNX33;PHF21A;MIF4GD;KHDRBS3;ZER1;PTPN1;AGRN;MBD3;IFNE;CD320;CAMK2N1;LRP4;VHL;TRAP1;PFKFB2;MLXIPL;TRIB2;PRKCZ;KDM6B;PRKACA;MINK1;ZNF516;OXA1L;AREG;PIM2;BOK;WDR18;TDRKH;ALAS1;ERBB2;ULK1;TFDP2;C6ORF89;NECAB3;STK17A;JAK3;IRF2BP2;BNIP3L;CYFIP2;PBX2;NELFCD;PDK1;CYGB;PRKCD;FAM20C;RBL2;STUB1;IFI6;BAX;ITGA1;ZNF395;EREG;RPS6KA5;DUSP4;ZNF524;SOX12;DDIT4;MBTPS2;PPP1R13L;CARF;AHNAK2;PCSK1N;IER2;ZDHHC8;LIMK1;TGFBR3;DIP2A;LTB4R2;LEMD2;RPS6KA6;ZHX3;RGS14;CHAD;LPCAT1;LRSAM1;ASB1;LONP2;SYMPK;MAPK12;IRAK1;TGFA;HDAC7;FHOD1;INPP5D;MTHFR;CHD2;CBX7;CHEK2;ZFPM1;PPARA;TMEM161A;SESN2;ABCG1;MYO1D;SOX7;ABCA7;RAB12;SIX5;BCAP31;MIF;KDM4B;ZNF414;MEX3A;PLA2G6;DDT;SSBP4;ECM1;WFS1;QSOX1;ZNF444;TRPT1;FYN;STK25;EEF2K;ARID5B;HOXC5;DNM2;BHLHE40;PELI1;CAT;NEIL1;TSPYL2;IGFBP7;ELFN2;SLC27A1;ZMYM3;SATB1;SLC50A1;ZNF606;MAPK3;INSR;PAN2;CAMTA2;TAZ;PFKM;ADCY1;RERE;INO80C;ETAA1;BCL7A;VANGL2;PAK1;CAMKK2;PPP3CB;RNF144A;USP21;PFKFB3;MLYCD;GABBR1;MICAL1;SEMA4C;CAPRIN2;ZBTB10;WDTC1;HES7;ITGA3;DNMT3A;SAMD8;BIN1;PPP2R5B;HES6;MAP2K3;DLG3;RRAS;PROX1;TBC1D16;ADGRF1;ZYG11B;PKD1;KCTD13;TNFRSF25;SIRT2;FAM129B;EDA;BACH1;ADCY7;E2F5;ZBTB22;MAPRE3;AZIN2;ZNF704;SERPINB1;SOCS7;MAP3K10;GTF2IRD2;NGFR;TOLLIP;BCORL1;PDCD6;ZNF837;GRB10;GCH1;MAFF;NR2F6;CBX6;CAMK1;CAMKK1;EZH1;SIRT3;HFE;ZNF513;BTG1;ZP3;MLF2;CDK11B;PFN2;FGFR3;PPP1R16A;CCDC88C;TNRC18;NDRG2;CBLC;ITPKB;SPTLC2;TCEA2;ZBTB47;PLAG1;CLK3;IRF2BPL;KDM3A;PM20D2;APBA1;DEDD2;SRSF5;ADCY6;LRRK1
15968,GO:0080090,0.99994677526604,6.85728783579991e-05,418,4525,regulation of primary metabolic process,BP,TNIP1;DUSP6;XDH;ERCC1;DUSP5;MEF2D;ZMYND8;CITED4;HTRA1;EGR1;NR1D1;EDEM1;DLG4;PLAT;CST3;CYP27B1;TYSND1;BTBD2;FBXO2;APLN;PDCD4;CTNNBIP1;ACVR2B;PRNP;VEGFA;TNFRSF6B;WNT7A;APOE;F2R;LRP5;ITGA6;HMGA2;ZKSCAN1;ELK3;PKN1;MTA1;GRAMD4;EGFR;SERPINE2;WWTR1;NOS1;SPRY2;MST1R;NFATC4;BAHCC1;CRTAP;LTBP4;ETV5;LMF1;SHC1;VPS11;HEXB;GTPBP1;TCFL5;ETV4;PHLDA2;SNX9;TRNP1;SPRY4;RAPGEF3;ZFP36L1;MAP2K2;ZC3H6;LPAR3;MDFI;PTOV1;SMARCA1;PPP1R35;RBCK1;FOXQ1;MAP2K1;CPT2;MXD4;SSH1;POU2F2;ENDOG;SMURF2;TSC22D1;FOS;FBLN1;SMAD3;STAT6;PIK3R2;ERCC6;LRP1;GJC2;DVL1;EPAS1;DNAJB5;HBEGF;PPP1R14A;PPP2R3B;PRDX5;SHC2;BRD3;SALL2;ZXDC;RNF187;ADORA2B;ADARB1;AKT1;GRB7;HDAC5;F12;PPM1F;STK39;SERPING1;SCMH1;EPHA1;NFKBIZ;ASH2L;IMPACT;WWC3;CNTN1;DAP;PTHLH;FGFR4;LDLR;FGFR1;PRKACB;RAC2;SEC14L2;HLTF;MXI1;RAG1;H2AFJ;KLF7;SORL1;NAT14;CEACAM1;B3GAT3;CIRBP;HMG20B;TENM2;ZNF385A;IGFBP4;TSHZ1;TRAPPC9;CCND1;PODNL1;PCBP4;TCF25;STRADB;SYNGAP1;MAPK13;GAS6;PTK6;CSNK1E;CARD11;SOX13;DUSP7;GSN;MAPKAPK3;PCSK9;ARHGAP22;RAD23A;ANGPTL4;EHD4;ERRFI1;GLI4;ZSCAN18;AIP;MYEF2;MN1;SH3D19;CDC25B;SMARCD2;SNTA1;DGKQ;PAK6;TFPI2;GTF2IRD1;TAGLN3;CEMIP;PKD2;CTSZ;HES2;CRTC1;ABCA2;ZNF598;MAGEF1;EPHB2;ADAM8;CTBP1;MNT;CDKN1C;PLCG1;ZMIZ2;CD81;CEBPB;MVD;ZNF217;TIMP2;ZNF862;C8ORF88;TGFB1;RFX2;SCYL1;UNK;MKNK2;DEAF1;NTSR1;NAB2;TMEM173;ZSCAN30;MSRB2;PNRC1;TNFSF15;NSMF;PEG3;MC1R;ABHD14B;ABTB1;SNX33;PHF21A;MIF4GD;KHDRBS3;ZER1;PTPN1;AGRN;MBD3;IFNE;CAMK2N1;LRP4;VHL;TRAP1;PFKFB2;MLXIPL;TRIB2;PRKCZ;KDM6B;PRKACA;MINK1;ZNF516;AREG;PIM2;BOK;WDR18;ALAS1;ERBB2;TFDP2;C6ORF89;NECAB3;JAK3;IRF2BP2;CYFIP2;PBX2;NELFCD;PDK1;PRKCD;RBL2;STUB1;IFI6;BAX;ITGA1;ZNF395;EREG;RPS6KA5;DUSP4;ZNF524;SOX12;DDIT4;MBTPS2;PPP1R13L;CARF;AHNAK2;PCSK1N;IER2;LIMK1;TGFBR3;LTB4R2;LEMD2;RPS6KA6;ZHX3;RGS14;CHAD;LPCAT1;ASB1;LONP2;SYMPK;MAPK12;IRAK1;TGFA;HDAC7;FHOD1;INPP5D;MTHFR;CHD2;CBX7;CHEK2;ZFPM1;PPARA;TMEM161A;SESN2;ABCG1;SOX7;ABCA7;SIX5;BCAP31;MIF;KDM4B;ZNF414;MEX3A;PLA2G6;DDT;SSBP4;ECM1;WFS1;ZNF444;TRPT1;FYN;STK25;EEF2K;ARID5B;HOXC5;DNM2;BHLHE40;PELI1;CAT;NEIL1;TSPYL2;IGFBP7;ELFN2;SLC27A1;ZMYM3;SATB1;ZNF606;MAPK3;INSR;CAMTA2;TAZ;PFKM;ADCY1;RERE;INO80C;ETAA1;BCL7A;VANGL2;PAK1;CAMKK2;PPP3CB;RNF144A;USP21;PFKFB3;MLYCD;GABBR1;MICAL1;SEMA4C;CAPRIN2;ZBTB10;WDTC1;HES7;ITGA3;DNMT3A;SAMD8;BIN1;PPP2R5B;HES6;MAP2K3;DLG3;RRAS;PROX1;ADGRF1;ZYG11B;PKD1;KCTD13;TNFRSF25;SIRT2;FAM129B;EDA;BACH1;ADCY7;E2F5;ZBTB22;MAPRE3;AZIN2;ZNF704;SERPINB1;SOCS7;MAP3K10;GTF2IRD2;NGFR;TOLLIP;BCORL1;PDCD6;ZNF837;MAFF;NR2F6;CBX6;CAMK1;CAMKK1;EZH1;SIRT3;HFE;ZNF513;BTG1;ZP3;MLF2;CDK11B;PFN2;FGFR3;PPP1R16A;CCDC88C;TNRC18;NDRG2;CBLC;ITPKB;TCEA2;ZBTB47;PLAG1;CLK3;IRF2BPL;KDM3A;PM20D2;DEDD2;SRSF5;ADCY6;LRRK1
7262,GO:0031248,0.999950198260581,0.000574175908659089,1,88,protein acetyltransferase complex,CC,JADE2
18021,GO:1902493,0.999950198260581,0.000574175908659089,1,88,acetyltransferase complex,CC,JADE2
2894,GO:0006405,0.999952402798748,0.000265719836398241,3,133,RNA export from nucleus,BP,XPOT;SYMPK;SRSF5
13278,GO:0051983,0.999956102614367,0.00051205125462292,1,89,regulation of chromosome segregation,BP,SIRT2
6920,GO:0030518,0.999964756535625,0.000259633432919009,2,113,intracellular steroid hormone receptor signaling pathway,BP,PAK1;KDM3A
5281,GO:0015934,0.999965243776617,0.000409609380980182,1,115,large ribosomal subunit,CC,RPL39L
110,GO:0000228,0.999966148298319,7.13143385337697e-05,27,493,nuclear chromosome,CC,ERCC1;MEF2D;H1F0;NR1D1;HMGA2;APPL2;TRNP1;SMARCA1;SMAD3;STAT6;SALL2;ASH2L;POLD4;H2AFJ;ZNF385A;SMARCD2;ZMIZ2;CEBPB;NSMF;MBD3;KDM6B;CBX7;SATB1;INO80C;ETAA1;DNMT3A;SIRT2
12750,GO:0051028,0.999967704335193,0.000185483161277028,3,135,mRNA transport,BP,ZFP36L1;SYMPK;SRSF5
3180,GO:0006807,0.999968438883948,4.05816454863017e-05,715,7420,nitrogen compound metabolic process,BP,TNIP1;DUSP6;NT5E;XDH;ERCC1;DUSP5;MEF2D;GID4;ZMYND8;H1F0;CITED4;HTRA1;THSD4;EGR1;NR1D1;H6PD;EDEM1;DLG4;PLAT;CST3;TYSND1;BTBD2;FBXO2;APLN;PDCD4;CTNNBIP1;NAGS;ACVR2B;XPC;PRNP;SLC6A8;VEGFA;TNFRSF6B;PGM1;WNT7A;APOE;NAGLU;F2R;LRP5;OSBPL5;LPCAT4;ITGA6;HMGA2;OBSCN;IDH2;ZKSCAN1;NEK9;CRAT;ELK3;PKN1;MTA1;GRAMD4;ACOT7;ARRDC1;AKR7A2;EGFR;RPS6KA2;SERPINE2;DNPH1;WWTR1;LOXL1;OBSL1;NOS1;PTPRS;TMEM129;SLC2A9;CTSO;SPRY2;CAPN2;MST1R;NFATC4;BAHCC1;CRTAP;LTBP4;PRSS8;SDC1;KLHL29;ETV5;LMF1;SHC1;DDB2;VPS11;LTBP1;HEXB;GTPBP1;SLC7A8;TCFL5;PTPRE;NPEPL1;ALDH4A1;TK2;MMP1;ETV4;SNX9;TRNP1;SPRY4;RAPGEF3;ST6GALNAC2;ZFP36L1;GLUL;RNPEPL1;MAP2K2;KDSR;NME4;ZC3H6;LPAR3;MARCH9;CTBS;FKBP9;MDFI;PTOV1;SMARCA1;PPP1R35;RBCK1;PGLS;PC;FOXQ1;RNF44;MAP2K1;NAPRT;ACP5;NYNRIN;MXD4;SSH1;POU2F2;ENDOG;MARK4;SMURF2;TSC22D1;FOS;FBLN1;SMAD3;STAT6;PIK3R2;ERCC6;LRP1;GJC2;SRD5A3;DVL1;EPAS1;DNAJB5;PIGQ;HBEGF;RPUSD3;AP2A2;PPP1R14A;PPP2R3B;PRDX5;SHC2;BRD3;PRODH;SALL2;CDK18;LY6K;FBXW5;ZXDC;RNF187;NMRK1;ADORA2B;ADARB1;D2HGDH;SLC6A6;AKT1;GRB7;HDAC5;UROS;FBXO41;F12;PPM1F;MMP28;ENTPD6;RHBDF2;PYCR2;STK39;HK1;SERPING1;SCMH1;EPHA1;GGT1;NFKBIZ;PTPRU;VEGFB;ASH2L;IMPACT;MARCH4;WWC3;CNTN1;BRSK1;DAP;PTHLH;FGFR4;POLD4;LDLR;FGFR1;PRKACB;FUCA1;MAPKBP1;RAC2;KCNAB2;PFKL;TTLL12;SEC14L2;OPLAH;HLTF;MXI1;PPM1J;RAG1;GAMT;H2AFJ;B4GAT1;BPHL;PIGV;KLF7;SORL1;NAT14;CEACAM1;B3GAT3;ASB13;CIRBP;CBR4;HMG20B;TENM2;ZNF385A;NSMCE4A;IGFBP4;TSHZ1;TRAPPC9;CCND1;PODNL1;PCBP4;TCF25;LHPP;STRADB;SYNGAP1;MAPK13;PLAU;GAS6;PTK6;PFKP;CSNK1E;CTSB;RAB3B;CARD11;SOX13;DUSP7;GSN;MAPKAPK3;IGFBP2;PCSK9;ARHGAP22;RAD23A;DHTKD1;PHLDA1;ANO8;BCR;MRPS6;EHD4;ERRFI1;GLI4;NADK;PANK4;HLCS;ZSCAN18;PRSS22;AIP;MYEF2;MN1;SH3D19;CDC25B;SPTB;SMARCD2;PEX10;GGACT;RSAD1;RRNAD1;NPR2;SNTA1;DGKQ;HAGH;BNIP3;PAK6;TFPI2;GTF2IRD1;SHARPIN;MVB12B;SERINC2;TAGLN3;CEMIP;PKD2;ACY1;PCSK1;RASGEF1A;CTSZ;CDC42EP5;HES2;CRTC1;FBXW8;ABCA2;ZNF598;MAGEF1;PRSS3;EPHB2;ADAM8;APRT;CTBP1;JOSD2;LTA4H;MNT;PTPDC1;GRK6;CDKN1C;PLCG1;FBXL8;ZMIZ2;CBS;CD81;CEBPB;MVD;RNF135;ENTPD2;ADAMTS13;ZNF217;TIMP2;ZNF862;DPP7;C8ORF88;TGFB1;LACTB2;RFX2;SCYL1;ABHD17C;UNK;ULK2;GPC1;MKNK2;ADAMTS7;DEAF1;B3GNT3;NAB2;TMEM173;ZSCAN30;SHANK3;PODXL2;SDHA;MSRB2;RASA3;PNRC1;MIPEP;TNFSF15;MGAT4B;MDH2;MPG;GALNS;FBXO17;CLCA2;NSMF;PEG3;MC1R;LCE1E;ABHD14B;LAMB2;ABTB1;RNH1;ERO1B;ST6GALNAC6;VGF;POLL;FBXO44;POLM;SNX33;PTMS;ANKZF1;PHGDH;PHF21A;MIF4GD;UBXN4;ADAM19;KHDRBS3;ZER1;HMGCL;PTPN1;TPP1;PCK2;B4GALT2;AGRN;MBD3;IFNE;CD320;CAMK2N1;OSBPL10;LRP4;ESYT2;ZDHHC24;B4GALT6;VHL;TRAP1;IDUA;PFKFB2;RFNG;MLXIPL;TRIB2;PRKCZ;KDM6B;PRKACA;MINK1;ZNF516;GRHPR;RABGGTA;ADA;AREG;PIM2;MPI;UCKL1;BOK;WDR18;TDRKH;ALAS1;NEURL1B;ERBB2;ULK1;CNDP2;AHCY;PRIMPOL;MMP10;TFDP2;C6ORF89;NECAB3;STK17A;JAK3;IRF2BP2;RNPEP;BNIP3L;CYFIP2;PBX2;NELFCD;RASA4;PDK1;THOP1;MCFD2;PRKCD;FAM20C;MIB2;RBL2;USP20;STUB1;IFI6;BAX;CYC1;SBF1;DTD1;XYLT2;TRIM4;ITGA1;ZNF395;PPCS;FBXW4;EREG;RPS6KA5;DGUOK;DUSP4;ZNF524;CUL9;SOX12;DDIT4;MBTPS2;TOP3B;PPP1R13L;CARF;AHNAK2;PCSK1N;IER2;NAGA;ZDHHC8;LIMK1;TGFBR3;PADI3;LTB4R2;RPL39L;LEMD2;RPS6KA6;ZHX3;RGS14;MFNG;GSTO1;ALDOC;CHAD;MRPS26;MSLN;LPCAT1;LRSAM1;ADAM15;ASB1;ST3GAL3;LONP2;SYMPK;MAPK12;IRAK1;PPOX;TGFA;HDAC7;FHOD1;INPP5D;MTHFR;CHD2;CBX7;PCMTD2;CHEK2;ZFPM1;PPARA;COG7;TMEM161A;SESN2;ABCG1;JADE2;CDC34;RNF123;SOX7;ABCA7;RAB12;SPEG;SIX5;BCAP31;MIF;SMOX;EEF2KMT;KDM4B;ZNF414;MEX3A;PLA2G6;DDT;SSBP4;NUDT14;ECM1;WFS1;QSOX1;ZNF444;DTX3;TRPT1;DALRD3;SPPL2B;FYN;VWA1;UPP1;STK25;ETFB;EEF2K;CERS4;ARID5B;HOXC5;DNM2;CKMT1A;CYP3A5;BHLHE40;GLB1;PELI1;CHKA;CAT;NEIL1;TSPYL2;IGFBP7;ELFN2;SLC27A1;ZMYM3;APOBEC3C;SATB1;ZDHHC1;ZNF606;APOBEC3F;DDX50;MAPK3;INSR;PAN2;CAMTA2;TAZ;PFKM;ADCY1;RERE;TSTA3;INO80C;GPT2;PDXK;ETAA1;GLRX;BCL7A;VANGL2;PAK1;DCAF10;KLHL36;CAMKK2;RNASET2;PPP3CB;RNF144A;ALPK1;CTSF;USP21;PFKFB3;CUL7;GABBR1;REV1;MICAL1;HYAL1;SEMA4C;CAPRIN2;ZBTB10;WDTC1;HES7;ITGA3;STK32C;DNMT3A;SAMD8;BIN1;MAN2B1;SRMS;PPP2R5B;HES6;MAP2K3;NDST2;DLG3;NDUFV3;RRAS;DNASE1L1;PROX1;IARS2;MDGA1;ADGRF1;ALDH7A1;ZYG11B;PKD1;KCTD13;TNFRSF25;SIRT2;FAM129B;EDA;UVSSA;GAL3ST4;NMNAT2;BACH1;NT5C1B;ADCY7;E2F5;ZBTB22;ALG12;MAPRE3;AZIN2;TEP1;ZNF704;SERPINB1;ST3GAL2;LAMB1;SOCS7;MAP3K10;PELI3;GTF2IRD2;RAB40B;NGFR;TOLLIP;BCORL1;PDCD6;CHST14;ZNF837;RNASE7;PHYKPL;DUSP23;GCH1;MAFF;NR2F6;CBX6;CAMK1;CAMKK1;EZH1;SIRT3;HFE;TERC;ZNF513;WIPI2;BTG1;ZP3;MLF2;CDK11B;PFN2;SSH3;FGFR3;PPP1R16A;TST;CCDC88C;ST3GAL5;TNRC18;NDRG2;MAN2B2;CBLC;ITPKB;SPTLC2;TCEA2;CDC42BPG;PRSS21;ZBTB47;PLAG1;CLK3;IRF2BPL;DHX32;KDM3A;PM20D2;TBL3;SLC23A2;PKN3;TTLL3;DEDD2;AK3;SRSF5;CHPF;ADCY6;LRRK1;AARS;KLHL24;SDC2
12508,GO:0050657,0.99996866625698,0.000134717955324397,5,173,nucleic acid transport,BP,ZFP36L1;XPOT;SYMPK;TST;SRSF5
12509,GO:0050658,0.99996866625698,0.000134717955324397,5,173,RNA transport,BP,ZFP36L1;XPOT;SYMPK;TST;SRSF5
16857,GO:0098781,0.999968739051789,0.000375562699895541,1,94,ncRNA transcription,BP,POU2F2
1475,GO:0003735,0.999971422892129,0.000211256403258303,2,154,structural constituent of ribosome,MF,MRPS6;RPL39L
1459,GO:0003700,0.99997477025505,4.06501657674878e-05,81,1096,DNA binding transcription factor activity,MF,MEF2D;EGR1;NR1D1;HMGA2;ZKSCAN1;ELK3;MTA1;NFATC4;ETV5;TCFL5;ETV4;ZFP36L1;ZC3H6;FOXQ1;MXD4;POU2F2;TSC22D1;FOS;SMAD3;STAT6;EPAS1;SALL2;ZXDC;HLTF;MXI1;KLF7;ZNF385A;TSHZ1;TCF25;SOX13;GLI4;ZSCAN18;MYEF2;GTF2IRD1;HES2;CTBP1;MNT;CEBPB;ZNF217;RFX2;DEAF1;ZSCAN30;MSRB2;PEG3;MLXIPL;ZNF516;TFDP2;PBX2;RBL2;ZNF395;ZNF524;SOX12;CARF;IER2;ZHX3;ZFPM1;PPARA;SOX7;SIX5;SSBP4;ZNF444;ARID5B;HOXC5;BHLHE40;ZMYM3;SATB1;ZNF606;CAMTA2;RERE;HES7;HES6;PROX1;BACH1;E2F5;GTF2IRD2;ZNF837;MAFF;NR2F6;EZH1;PLAG1;KDM3A
17292,GO:0140053,0.999974993042681,0.000145499371278515,3,153,mitochondrial gene expression,BP,MRPS6;MRPS26;IARS2
12886,GO:0051236,0.99997644350624,0.000103052974504022,5,176,establishment of RNA localization,BP,ZFP36L1;XPOT;SYMPK;TST;SRSF5
2871,GO:0006368,0.999977216370312,0.000281384102724208,1,97,transcription elongation from RNA polymerase II promoter,BP,NELFCD
3340,GO:0007062,0.999977746991202,0.000169608087596663,2,120,sister chromatid cohesion,BP,CENPH;NDE1
93,GO:0000184,0.999977890883667,0.000271214487104332,1,119,nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,PNRC1
2813,GO:0006281,0.999981763928281,3.97533349820539e-05,26,484,DNA repair,BP,ERCC1;XPC;HMGA2;MTA1;EGFR;DDB2;ERCC6;POLD4;NSMCE4A;CSNK1E;RAD23A;MAGEF1;MPG;MC1R;POLL;POLM;PRIMPOL;STUB1;CHEK2;TMEM161A;NEIL1;INO80C;ETAA1;REV1;UVSSA;BACH1
10861,GO:0044391,0.999983270768037,9.94497165234849e-05,3,182,ribosomal subunit,CC,MRPS6;RPL39L;MRPS26
15025,GO:0070972,0.999985851156164,0.000180171064270336,1,125,protein localization to endoplasmic reticulum,BP,BCAP31
5586,GO:0016604,0.999986120162136,2.683944709189e-05,40,652,nuclear body,CC,H1F0;NR1D1;OBSCN;WWTR1;NFATC4;SMURF2;EPAS1;HDAC5;NFKBIZ;PHF7;HMG20B;TENM2;NSMCE4A;LHPP;PTK6;DGKQ;CRTC1;ZNF217;MKNK2;PRKACA;STK17A;BNIP3L;CYGB;SBF1;KLHDC2;LIMK1;RGS14;CHEK2;CDC34;FLYWCH1;BHLHE40;SATB1;LRCH4;LMNA;KCTD13;TOLLIP;TERC;PLAG1;CLK3;SRSF5
16817,GO:0098687,0.999986715663033,3.78706025452414e-05,13,312,chromosomal region,CC,ERCC1;SCMH1;NSMCE4A;CEBPB;NUDCD2;CENPH;CHEK2;DNMT3A;SIRT2;TEP1;NDE1;TERC;SEPT6
17647,GO:1901362,0.999987964874772,1.61822143030037e-05,311,3537,organic cyclic compound biosynthetic process,BP,TNIP1;NT5E;XDH;MEF2D;ZMYND8;CITED4;HTRA1;EGR1;NR1D1;CYP27B1;APLN;PDCD4;CTNNBIP1;ACVR2B;PRNP;VEGFA;PGM1;WNT7A;APOE;F2R;LRP5;ITGA6;HMGA2;IDH2;ZKSCAN1;ELK3;PKN1;MTA1;ACOT7;EGFR;DNPH1;WWTR1;NOS1;NFATC4;BAHCC1;ETV5;SHC1;HEXB;TCFL5;TK2;ETV4;TRNP1;RAPGEF3;ZFP36L1;MAP2K2;NME4;ZC3H6;MDFI;PTOV1;SMARCA1;RBCK1;PLTP;FOXQ1;MAP2K1;NAPRT;MXD4;POU2F2;SMURF2;TSC22D1;FOS;SMAD3;STAT6;PIK3R2;ERCC6;SRD5A3;DVL1;EPAS1;DNAJB5;HSD17B8;PRDX5;BRD3;SALL2;ZXDC;RNF187;NMRK1;ADORA2B;AKT1;HDAC5;UROS;PPM1F;PYCR2;HK1;SCMH1;NFKBIZ;ASH2L;IMPACT;WWC3;DAP;PTHLH;FGFR4;POLD4;FGFR1;PFKL;SEC14L2;HLTF;MXI1;H2AFJ;KLF7;NAT14;HMG20B;TENM2;ZNF385A;TSHZ1;TRAPPC9;CCND1;TCF25;LHPP;MAPK13;GAS6;PFKP;CARD11;SOX13;ARHGAP22;DHTKD1;GLI4;NADK;PANK4;ZSCAN18;AIP;MYEF2;MN1;SMARCD2;RSAD1;NPR2;DGKQ;PAK6;GTF2IRD1;TAGLN3;PKD2;HES2;CRTC1;ABCA2;ADAM8;APRT;CTBP1;MNT;CDKN1C;ZMIZ2;CD81;CEBPB;MVD;ENTPD2;ZNF217;TIMP2;ZNF862;TGFB1;RFX2;SCYL1;DEAF1;NAB2;TMEM173;ZSCAN30;MSRB2;PNRC1;PEG3;MC1R;ABHD14B;POLL;POLM;PHF21A;PLPP6;KHDRBS3;AGRN;MBD3;LRP4;VHL;PFKFB2;MLXIPL;PRKCZ;KDM6B;ZNF516;ADA;PIM2;MPI;UCKL1;ALAS1;ERBB2;PRIMPOL;TFDP2;IRF2BP2;PBX2;TRPC1;NELFCD;RBL2;BAX;CYC1;ZNF395;PPCS;EREG;RPS6KA5;DGUOK;ZNF524;SOX12;DDIT4;MBTPS2;PPP1R13L;CARF;HSD17B7;IER2;TGFBR3;LTB4R2;LEMD2;ZHX3;RGS14;ALDOC;SYMPK;MAPK12;IRAK1;PPOX;TGFA;HDAC7;FHOD1;CHD2;CBX7;CHEK2;ZFPM1;PPARA;SESN2;ABCG1;SOX7;SIX5;KDM4B;ZNF414;DDT;SSBP4;ECM1;WFS1;ZNF444;UPP1;ARID5B;HOXC5;DNM2;BHLHE40;PELI1;CAT;NEIL1;TSPYL2;IGFBP7;ZMYM3;SATB1;ZNF606;CYP2R1;MAPK3;INSR;CAMTA2;TAZ;PFKM;ADCY1;RERE;TSTA3;INO80C;PDXK;BCL7A;CAMKK2;PPP3CB;USP21;PFKFB3;GABBR1;REV1;CAPRIN2;ZBTB10;WDTC1;HES7;ITGA3;DNMT3A;PPP2R5B;HES6;MAP2K3;PROX1;ADGRF1;PKD1;SIRT2;FAM129B;EDA;NMNAT2;BACH1;NT5C1B;ADCY7;E2F5;ZBTB22;MAPRE3;TEP1;ZNF704;MAP3K10;HSD11B1;GTF2IRD2;NGFR;BCORL1;ZNF837;GCH1;MAFF;NR2F6;CBX6;CAMK1;EZH1;HFE;TERC;ZNF513;BTG1;ZP3;MLF2;CDK11B;TNRC18;TCEA2;ZBTB47;PLAG1;IRF2BPL;KDM3A;DEDD2;SRSF5;ADCY6
5574,GO:0016591,0.999988107069232,0.000155121246601288,1,103,DNA-directed RNA polymerase II, holoenzyme,CC,ERCC1
10286,GO:0043043,0.999988604495819,2.26061196451132e-05,37,674,peptide biosynthetic process,BP,TNIP1;EGFR;GTPBP1;ZFP36L1;MAP2K2;MAP2K1;AKT1;GRB7;GGT1;IMPACT;OPLAH;CIRBP;ZNF385A;MRPS6;HAGH;PCSK1;ZNF598;C8ORF88;TGFB1;UNK;MKNK2;ABTB1;MIF4GD;TRAP1;ERBB2;CNDP2;CYFIP2;RPL39L;MRPS26;SESN2;MEX3A;DALRD3;EEF2K;MAPK3;CAPRIN2;IARS2;AARS
10391,GO:0043229,0.999990522982519,1.28005860182951e-05,922,9333,intracellular organelle,CC,TNIP1;DUSP6;NT5E;XDH;ERCC1;DUSP5;MEF2D;ZMYND8;H1F0;CITED4;FHL1;EGR1;B4GALNT4;NR1D1;SLC16A3;H6PD;EDEM1;DLG4;PLAT;CST3;CYP27B1;TYSND1;HS1BP3;BTBD2;MARVELD1;EPN3;FBXO2;PRR7;PDCD4;CTNNBIP1;NAGS;DOCK4;XPC;PRNP;PARVB;PYGB;BBS2;FLNC;POSTN;VEGFA;FAM210B;PGM1;WNT7A;APOE;PYGL;TSPAN1;ESPN;NAGLU;F2R;LRP5;PLD3;OSBPL5;LPCAT4;PITPNC1;HMGA2;OBSCN;NDRG1;IDH2;ZKSCAN1;NEK9;CRAT;ELK3;ITPR3;PKN1;MTA1;GRAMD4;ACOT7;ARRDC1;ANGEL1;ACSF2;NISCH;AKR7A2;EGFR;RPS6KA2;SERPINE2;DNPH1;WWTR1;LOXL1;OBSL1;NOS1;VAT1;PTPRS;TMEM129;SLC2A9;HADH;CTSO;SPRY2;CAPN2;MST1R;NFATC4;TRIM65;BAHCC1;CRTAP;SYTL1;SDC1;ETV5;LMF1;APPL2;SHC1;DDB2;VPS11;LTBP1;TBC1D14;ARL2;HEXB;TCFL5;PTPRE;NPEPL1;SLC2A3;ALDH4A1;TK2;RIN1;ACTA2;CLIP2;ETV4;SNX9;NUDCD3;TRNP1;RAPGEF3;TXNRD3;ST6GALNAC2;ZFP36L1;GAA;GLUL;ARAP1;MAP2K2;KDSR;NME4;ZC3H6;MARCH9;CTBS;FKBP9;MDFI;PTOV1;SMARCA1;SUGCT;PC;FOXQ1;RNF44;MAP2K1;NAPRT;ACP5;CPT2;VWA5A;MCTP1;MXD4;SSH1;POU2F2;ENDOG;MARK4;MPRIP;TMEM8A;SMURF2;KLC2;TSC22D1;ARMCX2;OXLD1;SLC9A3R2;FOS;SMAD3;STAT6;SHANK2;PIK3R2;ERCC6;LRP1;SRD5A3;DVL1;EPAS1;DNAJB5;PIGQ;HSD17B8;HBEGF;FAM110C;RPUSD3;AP2A2;S100A4;CYBRD1;SH3PXD2B;PPP2R3B;PRDX5;STOM;BRD3;PRODH;SALL2;MBOAT7;CDK18;REEP4;LY6K;ZXDC;RNF187;ADARB1;PLCXD2;D2HGDH;SYT8;AKT1;TPCN1;GRB7;TMOD2;CORO1B;HDAC5;UROS;S100A6;F12;PITPNM1;ENTPD6;PLEKHH3;RHBDF2;PYCR2;BSG;STK39;HK1;SERPING1;ASAP2;SCMH1;DYSF;PHC2;NFKBIZ;VEGFB;ASH2L;MARCH4;SLC15A4;ATG16L2;ZFYVE21;IFNGR2;BRSK1;IFT140;PTHLH;MYZAP;RAB31;FGFR4;WNT2B;POLD4;FNDC4;LDLR;FGFR1;PRKACB;FUCA1;MAPKBP1;SIGMAR1;RAC2;KCNAB2;PFKL;SEC14L2;HLTF;MXI1;NPHP4;SYNE3;RAG1;GAMT;H2AFJ;B4GAT1;PACS2;PHF7;TOMM34;BPHL;PIGV;KLF7;RALGDS;SORL1;NAT14;CEACAM1;B3GAT3;CIRBP;CBR4;HMG20B;LZTS2;RAB11FIP4;TENM2;ZNF385A;NSMCE4A;ABCD1;ANK3;NIPSNAP1;IGFBP4;EVC;TSHZ1;TRAPPC9;CCND1;TCF25;LHPP;TNNT1;TWF2;STRADB;MAPK13;CEP250;CARD19;PLAU;GAS6;PTK6;PFKP;CSNK1E;R3HDM4;BRI3;CTSB;RAB3B;SOX13;LAMA5;DUSP7;MPLKIP;GSN;MAPKAPK3;IGFBP2;PCSK9;ARHGAP22;RAD23A;DHTKD1;PHLDA1;ANO8;ANTXR2;XPOT;MRPS6;EHD4;ERRFI1;GLI4;SEPT10;WIPF1;HLCS;ZSCAN18;AIP;DBNDD1;MYEF2;SH3D19;CCDC113;CDC25B;SH3GLB2;ARHGAP27;ALOX15B;SPTB;SMARCD2;AGAP1;COMTD1;RSPH3;PEX10;CCS;RSAD1;COL13A1;CORO7;SNTA1;DGKQ;HAGH;BNIP3;PAK6;NOL4L;GTF2IRD1;MVB12B;TAGLN3;FYCO1;CEMIP;PROCR;PKD2;PCSK1;RETSAT;YPEL3;CTSZ;CDC42EP5;HES2;CRTC1;FBXW8;GPSM1;AP3D1;ITGB5;ABCA2;PRSS3;SH3PXD2A;C19ORF33;EPHB2;ADAM8;ASIC1;APRT;TMEM9;CTBP1;LTA4H;MNT;PTPDC1;CDKN1C;PLCG1;ZMIZ2;CBS;KIF17;CEBPB;ENTPD2;ADAMTS13;ZNF217;TIMP2;ZNF862;NUDCD2;SYNJ2;WNT3;DPP7;TMED4;TGFB1;LACTB2;SNPH;CLTCL1;RFX2;SCYL1;ABHD17C;SNTB2;ULK2;GPC1;MKNK2;ADAMTS7;DEAF1;MOAP1;SLC38A10;NTSR1;B3GNT3;NAB2;TMEM173;ZSCAN30;ATP7B;FHOD3;PODXL2;SDHA;MSRB2;PNRC1;MIPEP;MGAT4B;EML2;KIF26B;MDH2;MPG;GALNS;CLCA2;HEXDC;GOLGA2P5;ENKD1;NSMF;PEG3;ARAP3;FARP1;TUB;DIRC2;CROCC;RHOD;ABHD14B;LAMB2;TNS1;ABTB1;SNX17;RNH1;DNAH1;ERO1B;ST6GALNAC6;VGF;POLL;POLM;SNX33;PI4K2A;SEMA4F;C1ORF210;PTMS;RHOF;YIPF3;ANKZF1;WASF3;ATG2A;SLC48A1;LLGL1;PHF21A;MIF4GD;KIF7;COA5;RHOBTB2;UBXN4;ADAM19;KHDRBS3;SAC3D1;TUBG2;RIMS3;BBS1;HMGCL;PTPN1;PEX1;TPP1;PCK2;B4GALT2;WDR59;AGRN;MBD3;CD320;OSBPL10;ESYT2;ZDHHC24;ACP6;B4GALT6;VHL;MYH16;CEP131;TRAP1;IDUA;ADAP1;PFKFB2;RFNG;MLXIPL;YPEL5;TRIB2;PRKCZ;KDM6B;PRKACA;MINK1;ZNF516;CENPH;GRHPR;OXA1L;RABGGTA;RCCD1;ACTR1B;CD9;EPN2;ADA;AREG;MICALL2;UCKL1;PLEKHG5;BOK;WDR18;TDRKH;CAPG;SDCCAG8;ALAS1;NEURL1B;ERBB2;ADGRB2;ULK1;CNDP2;NINL;AHCY;VAMP2;CERCAM;PRIMPOL;TMEM143;TFDP2;SMTN;PLEK2;C6ORF89;MZT2A;NECAB3;STK17A;RILPL1;FAM50A;JAK3;IRF2BP2;RNPEP;NET1;BNIP3L;CYFIP2;FSCN1;PBX2;NELFCD;SLC22A17;PDK1;ACAD10;CYGB;ARHGAP44;THOP1;EHBP1L1;MCFD2;PRKCD;FAM20C;MIB2;REEP6;RBL2;USP20;STUB1;IFI6;BAX;CYC1;SV2A;SBF1;DTD1;XYLT2;ITGA1;OLFM2;ZNF395;HIST3H2BB;CCDC92;NUBP2;SH3BP1;GJB4;RPS6KA5;DGUOK;DUSP4;KLHDC2;TIMM17B;ZNF524;SOX12;PLEKHH1;TMBIM4;DDIT4;MBTPS2;ACADS;TOP3B;PPL;PPP1R13L;CARF;HSD17B7;AHNAK2;PCSK1N;MT2A;IER2;CES2;NAGA;ZDHHC8;TMX4;MZT2B;FCHO1;LIMK1;PDIA5;GDI1;TPM2;PADI3;DIP2A;LTB4R2;CPNE7;SLC2A11;RPL39L;LEMD2;RPS6KA6;TMEM92;ZHX3;DNM1;WASH3P;RGS14;TMEM8B;SCN8A;MFNG;GIT1;ALDOC;MRPS26;MSLN;LPCAT1;ADAM15;REEP2;EHD3;WDR60;ST3GAL3;LONP2;SYMPK;MAPK12;IRAK1;PPOX;TGFA;HDAC7;FHOD1;INPP5D;CHD2;PI4K2B;CBX7;CHEK2;DECR2;ZFPM1;PPARA;COG7;COQ2;SESN2;ABCG1;MYO1D;JADE2;MYH15;CDC34;RNF123;SNN;SOX7;ABCA7;RAB12;EML3;SPEG;SIX5;BCAP31;MIF;ACO2;SMOX;KDM4B;SLC25A29;DOPEY2;PHYH;ZNF414;MEX3A;SLC9A7;PLA2G6;SSBP4;SYNGR1;ECM1;NARF;WFS1;QSOX1;CD68;ZNF444;SLC22A18;SPPL2B;HSD11B1L;FYN;VWA1;UPP1;STK25;RAC3;ETFB;GLB1L2;CERS4;SUN1;FLYWCH1;ACAP3;ARID5B;HOXC5;DNM2;CKMT1A;CYP3A5;BHLHE40;GLB1;PELI1;SNX15;CAT;BEX2;NEIL1;TSPYL2;IGFBP7;ARMCX1;SLC27A1;ZMYM3;TPBG;APOBEC3C;SATB1;SLC50A1;KIF26A;ZDHHC1;SLC12A4;PLCB3;H1FX;IQSEC1;ZNF606;APOBEC3F;DDX50;CYP2R1;TUBB6;MAPK3;CBLN3;INSR;RTN2;PAN2;GRINA;PDZD2;CAMTA2;TAZ;PFKM;ADCY1;TNS4;C12ORF66;RERE;HLA-G;STX10;INO80C;ATP8B2;GPT2;RALGAPA1;PDXK;ETAA1;PRAF2;GLRX;CEP72;VANGL2;PAK1;TRIM45;CDYL2;DCAF10;MALL;CAMKK2;RNASET2;PPP3CB;RNF144A;LGALS3BP;CTSF;USP21;PFKFB3;MLYCD;CUL7;SLC37A2;REV1;MICAL1;HYAL1;SEMA4C;CAPRIN2;ZBTB10;WDTC1;HES7;DNMT3A;SAMD8;BIN1;VPS16;MAN2B1;TSTD1;HES6;SLC16A13;MAP2K3;NDST2;BCL2L1;SGSM2;ABHD10;NDUFV3;DNASE1L1;PROX1;IARS2;LRCH4;TBC1D16;ALDH7A1;LMNA;PKD1;KCTD13;TNFRSF25;RABGAP1;SIRT2;FAM129B;EDA;UVSSA;ANKRD13D;GAL3ST4;NMNAT2;BACH1;NT5C1B;TRIP10;E2F5;ZBTB22;ALG12;AFAP1L1;MAPRE3;AZIN2;TEP1;RAB28;ZNF704;SERPINB1;ST3GAL2;ICA1;SLC25A37;RAP1GAP2;LAMB1;SOCS7;HSDL1;RGS19;NDE1;HSD11B1;GTF2IRD2;RAB40B;NGFR;TOLLIP;BCORL1;PDCD6;ATP6V1F;PCLO;ARVCF;CHST14;BIVM;ZNF837;PXN;PHYKPL;PLEKHM1;DUSP23;GCH1;MSS51;LURAP1;KIF13B;MAFF;NR2F6;CBX6;TCTN1;NBEAL2;PNMA1;CAMK1;CAMKK1;EZH1;SIRT3;HFE;TERC;ZNF513;WIPI2;GAS2L1;COL6A1;BTG1;VPS51;CELSR1;TACC1;MLF2;SEMA3B;SEPT6;CDK11B;PFN2;C2CD2;SSH3;FGFR3;MFSD10;TST;CCDC88C;ST3GAL5;TNRC18;NDRG2;MAN2B2;CBLC;ITPKB;SPTLC2;TCEA2;CDC42BPG;ZBTB47;PLAG1;CLK3;IRF2BPL;TRIM46;DHX32;KDM3A;PM20D2;TMEM187;FAM214B;TBL3;PKN3;APBA1;TTLL3;DEDD2;AK3;SRSF5;CHPF;SLC26A11;LRRK1;AARS;SDC2
10879,GO:0044427,0.999991197388812,1.64913990531318e-05,47,770,chromosomal part,CC,ERCC1;MEF2D;H1F0;NR1D1;HMGA2;CAPN2;BAHCC1;APPL2;TRNP1;SMARCA1;SMAD3;STAT6;SALL2;SCMH1;PHC2;ASH2L;POLD4;H2AFJ;ZNF385A;NSMCE4A;HLCS;SMARCD2;ZMIZ2;CEBPB;NUDCD2;NSMF;MBD3;KDM6B;CENPH;RBL2;HIST3H2BB;LEMD2;CBX7;CHEK2;SATB1;H1FX;INO80C;ETAA1;DNMT3A;SIRT2;TEP1;NDE1;CBX6;TERC;SEPT6;TNRC18;KDM3A
20098,GO:2000736,0.999991437942268,0.000113947957512921,1,121,regulation of stem cell differentiation,BP,KDM3A
17704,GO:1901576,0.999992075053577,1.04372433662023e-05,446,4908,organic substance biosynthetic process,BP,TNIP1;NT5E;XDH;MEF2D;ZMYND8;CITED4;HTRA1;EGR1;NR1D1;CST3;CYP27B1;APLN;PDCD4;CTNNBIP1;NAGS;ACVR2B;PRNP;VEGFA;PGM1;WNT7A;APOE;PYGL;DGKA;F2R;LRP5;LPCAT4;ITGA6;ISYNA1;HMGA2;IDH2;ZKSCAN1;ELK3;PKN1;MTA1;ACOT7;EGFR;DNPH1;WWTR1;NOS1;NFATC4;BAHCC1;SDC1;ETV5;LMF1;SHC1;HEXB;GTPBP1;TCFL5;TK2;ETV4;TRNP1;RAPGEF3;ST6GALNAC2;ZFP36L1;GLUL;MAP2K2;KDSR;NME4;ZC3H6;MDFI;PTOV1;SMARCA1;RBCK1;PLTP;PC;FOXQ1;MAP2K1;NAPRT;CRYL1;MXD4;POU2F2;SMURF2;TSC22D1;FOS;SMAD3;STAT6;PIK3R2;ERCC6;SRD5A3;DVL1;EPAS1;DNAJB5;PIGQ;HSD17B8;HBEGF;PRDX5;BRD3;SALL2;MBOAT7;LY6K;ZXDC;RNF187;NMRK1;ADORA2B;AKT1;GRB7;HDAC5;UROS;PPM1F;PITPNM1;PYCR2;HK1;SCMH1;GGT1;NFKBIZ;VEGFB;ASH2L;IMPACT;WWC3;DAP;PTHLH;FGFR4;POLD4;LDLR;FGFR1;PFKL;SEC14L2;OPLAH;HLTF;MXI1;GAMT;H2AFJ;B4GAT1;PIGV;KLF7;NAT14;CEACAM1;B3GAT3;CIRBP;CBR4;HMG20B;TENM2;ZNF385A;TSHZ1;TRAPPC9;CCND1;TCF25;LHPP;MAPK13;GAS6;PFKP;CARD11;SOX13;ARHGAP22;DHTKD1;PHLDA1;MRPS6;ERRFI1;GLI4;NADK;PANK4;ZSCAN18;AIP;MYEF2;MN1;ALOX15B;SMARCD2;RSAD1;NPR2;DGKQ;HAGH;PAK6;GTF2IRD1;TAGLN3;CEMIP;PKD2;PCSK1;HES2;CRTC1;ABCA2;ZNF598;ADAM8;APRT;CTBP1;LTA4H;MNT;CDKN1C;ZMIZ2;CBS;CD81;CEBPB;MVD;ENTPD2;ADAMTS13;ZNF217;TIMP2;ZNF862;SYNJ2;C8ORF88;TGFB1;RFX2;SCYL1;ABHD17C;UNK;GPC1;MKNK2;ADAMTS7;DEAF1;NTSR1;B3GNT3;NAB2;TMEM173;ZSCAN30;MSRB2;PNRC1;MGAT4B;MDH2;PEG3;MC1R;ABHD14B;ABTB1;ST6GALNAC6;POLL;POLM;PI4K2A;PTMS;PHGDH;PHF21A;MIF4GD;PLPP6;KHDRBS3;HMGCL;PCK2;B4GALT2;AGRN;MBD3;LRP4;ZDHHC24;ACP6;B4GALT6;VHL;TRAP1;PFKFB2;RFNG;MLXIPL;TRIB2;PRKCZ;KDM6B;ZNF516;ADA;AREG;PIM2;MPI;UCKL1;WDR18;ALAS1;ERBB2;CNDP2;AHCY;PRIMPOL;TFDP2;NECAB3;JAK3;IRF2BP2;CYFIP2;PBX2;TRPC1;NELFCD;PDK1;MCFD2;PRKCD;RBL2;BAX;CYC1;SBF1;DTD1;XYLT2;ZNF395;PPCS;EREG;RPS6KA5;DGUOK;ZNF524;SOX12;DDIT4;MBTPS2;PPP1R13L;CARF;HSD17B7;IER2;ZDHHC8;TGFBR3;LTB4R2;CPNE7;RPL39L;LEMD2;ZHX3;RGS14;MFNG;GSTO1;ALDOC;MRPS26;MSLN;LPCAT1;ASB1;ST3GAL3;SYMPK;MAPK12;IRAK1;PPOX;TGFA;HDAC7;FHOD1;INPP5D;CHD2;PI4K2B;CBX7;CHEK2;DECR2;ZFPM1;PPARA;COG7;COQ2;SESN2;ABCG1;CDC34;SOX7;ABCA7;SIX5;MIF;SMOX;KDM4B;ZNF414;MEX3A;PLA2G6;DDT;SSBP4;NUDT14;ECM1;WFS1;ZNF444;DALRD3;PITPNM3;UPP1;EEF2K;CERS4;ARID5B;HOXC5;DNM2;BHLHE40;PELI1;CHKA;CAT;NEIL1;TSPYL2;IGFBP7;SLC27A1;ZMYM3;SATB1;ZDHHC1;ZNF606;CYP2R1;MAPK3;INSR;CAMTA2;TAZ;PFKM;ADCY1;RERE;TSTA3;INO80C;GPT2;PDXK;ETAA1;BCL7A;VANGL2;CAMKK2;PPP3CB;USP21;PFKFB3;MLYCD;GABBR1;REV1;HYAL1;CAPRIN2;ZBTB10;WDTC1;HES7;ITGA3;DNMT3A;SAMD8;PPP2R5B;HES6;MAP2K3;NDST2;PROX1;IARS2;MDGA1;ADGRF1;ALDH7A1;PKD1;KCTD13;SIRT2;FAM129B;EDA;GAL3ST4;NMNAT2;BACH1;NT5C1B;ADCY7;E2F5;ZBTB22;ALG12;MAPRE3;AZIN2;TEP1;ZNF704;ST3GAL2;MAP3K10;HSD11B1;GTF2IRD2;NGFR;BCORL1;CHST14;ZNF837;GCH1;MAFF;NR2F6;CBX6;CAMK1;EZH1;HFE;TERC;ZNF513;WIPI2;BTG1;ZP3;MLF2;CDK11B;FGFR3;ST3GAL5;TNRC18;ITPKB;SPTLC2;TCEA2;PRSS21;ZBTB47;PLAG1;IRF2BPL;KDM3A;DEDD2;SRSF5;CHPF;ADCY6;AARS;SDC2
6146,GO:0019438,0.999992604882789,1.00449112045424e-05,300,3442,aromatic compound biosynthetic process,BP,TNIP1;NT5E;XDH;MEF2D;ZMYND8;CITED4;HTRA1;EGR1;NR1D1;APLN;PDCD4;CTNNBIP1;ACVR2B;PRNP;VEGFA;PGM1;WNT7A;APOE;F2R;LRP5;ITGA6;HMGA2;IDH2;ZKSCAN1;ELK3;PKN1;MTA1;ACOT7;EGFR;DNPH1;WWTR1;NOS1;NFATC4;BAHCC1;ETV5;SHC1;HEXB;TCFL5;TK2;ETV4;TRNP1;RAPGEF3;ZFP36L1;MAP2K2;NME4;ZC3H6;MDFI;PTOV1;SMARCA1;RBCK1;FOXQ1;MAP2K1;NAPRT;MXD4;POU2F2;SMURF2;TSC22D1;FOS;SMAD3;STAT6;PIK3R2;ERCC6;DVL1;EPAS1;DNAJB5;PRDX5;BRD3;SALL2;ZXDC;RNF187;NMRK1;ADORA2B;AKT1;HDAC5;UROS;PPM1F;HK1;SCMH1;NFKBIZ;ASH2L;IMPACT;WWC3;DAP;PTHLH;FGFR4;POLD4;FGFR1;PFKL;SEC14L2;HLTF;MXI1;H2AFJ;KLF7;NAT14;HMG20B;TENM2;ZNF385A;TSHZ1;TRAPPC9;CCND1;TCF25;LHPP;MAPK13;GAS6;PFKP;CARD11;SOX13;ARHGAP22;DHTKD1;GLI4;NADK;PANK4;ZSCAN18;AIP;MYEF2;MN1;SMARCD2;RSAD1;NPR2;DGKQ;PAK6;GTF2IRD1;TAGLN3;PKD2;HES2;CRTC1;ABCA2;ADAM8;APRT;CTBP1;MNT;CDKN1C;ZMIZ2;CD81;CEBPB;ENTPD2;ZNF217;TIMP2;ZNF862;TGFB1;RFX2;SCYL1;DEAF1;NAB2;TMEM173;ZSCAN30;MSRB2;PNRC1;PEG3;MC1R;ABHD14B;POLL;POLM;PHF21A;KHDRBS3;AGRN;MBD3;LRP4;VHL;PFKFB2;MLXIPL;PRKCZ;KDM6B;ZNF516;ADA;PIM2;MPI;UCKL1;ALAS1;ERBB2;PRIMPOL;TFDP2;IRF2BP2;PBX2;TRPC1;NELFCD;RBL2;BAX;CYC1;ZNF395;PPCS;EREG;RPS6KA5;DGUOK;ZNF524;SOX12;DDIT4;MBTPS2;PPP1R13L;CARF;IER2;TGFBR3;LTB4R2;LEMD2;ZHX3;RGS14;ALDOC;SYMPK;MAPK12;IRAK1;PPOX;TGFA;HDAC7;FHOD1;CHD2;CBX7;CHEK2;ZFPM1;PPARA;SESN2;ABCG1;SOX7;SIX5;KDM4B;ZNF414;DDT;SSBP4;ECM1;WFS1;ZNF444;UPP1;ARID5B;HOXC5;DNM2;BHLHE40;PELI1;CAT;NEIL1;TSPYL2;ZMYM3;SATB1;ZNF606;MAPK3;INSR;CAMTA2;TAZ;PFKM;ADCY1;RERE;TSTA3;INO80C;PDXK;BCL7A;CAMKK2;PPP3CB;USP21;PFKFB3;GABBR1;REV1;CAPRIN2;ZBTB10;WDTC1;HES7;ITGA3;DNMT3A;PPP2R5B;HES6;MAP2K3;PROX1;ADGRF1;PKD1;SIRT2;FAM129B;EDA;NMNAT2;BACH1;NT5C1B;ADCY7;E2F5;ZBTB22;MAPRE3;TEP1;ZNF704;MAP3K10;GTF2IRD2;NGFR;BCORL1;ZNF837;GCH1;MAFF;NR2F6;CBX6;CAMK1;EZH1;HFE;TERC;ZNF513;BTG1;ZP3;MLF2;CDK11B;TNRC18;TCEA2;ZBTB47;PLAG1;IRF2BPL;KDM3A;DEDD2;SRSF5;ADCY6
5908,GO:0018130,0.999993270014697,9.15346222064003e-06,300,3445,heterocycle biosynthetic process,BP,TNIP1;NT5E;XDH;MEF2D;ZMYND8;CITED4;HTRA1;EGR1;NR1D1;APLN;PDCD4;CTNNBIP1;ACVR2B;PRNP;VEGFA;PGM1;WNT7A;APOE;F2R;LRP5;ITGA6;HMGA2;IDH2;ZKSCAN1;ELK3;PKN1;MTA1;ACOT7;EGFR;DNPH1;WWTR1;NOS1;NFATC4;BAHCC1;ETV5;SHC1;HEXB;TCFL5;TK2;ETV4;TRNP1;RAPGEF3;ZFP36L1;MAP2K2;NME4;ZC3H6;MDFI;PTOV1;SMARCA1;RBCK1;PLTP;FOXQ1;MAP2K1;NAPRT;MXD4;POU2F2;SMURF2;TSC22D1;FOS;SMAD3;STAT6;PIK3R2;ERCC6;DVL1;EPAS1;DNAJB5;PRDX5;BRD3;SALL2;ZXDC;RNF187;NMRK1;ADORA2B;AKT1;HDAC5;UROS;PPM1F;PYCR2;HK1;SCMH1;NFKBIZ;ASH2L;IMPACT;WWC3;DAP;PTHLH;FGFR4;POLD4;FGFR1;PFKL;SEC14L2;HLTF;MXI1;H2AFJ;KLF7;NAT14;HMG20B;TENM2;ZNF385A;TSHZ1;TRAPPC9;CCND1;TCF25;LHPP;MAPK13;GAS6;PFKP;CARD11;SOX13;ARHGAP22;DHTKD1;GLI4;NADK;PANK4;ZSCAN18;AIP;MYEF2;MN1;SMARCD2;RSAD1;NPR2;DGKQ;PAK6;GTF2IRD1;TAGLN3;PKD2;HES2;CRTC1;ABCA2;ADAM8;APRT;CTBP1;MNT;CDKN1C;ZMIZ2;CD81;CEBPB;ENTPD2;ZNF217;TIMP2;ZNF862;TGFB1;RFX2;SCYL1;DEAF1;NAB2;TMEM173;ZSCAN30;MSRB2;PNRC1;PEG3;MC1R;ABHD14B;POLL;POLM;PHF21A;KHDRBS3;AGRN;MBD3;LRP4;VHL;PFKFB2;MLXIPL;PRKCZ;KDM6B;ZNF516;ADA;PIM2;MPI;UCKL1;ALAS1;ERBB2;PRIMPOL;TFDP2;IRF2BP2;PBX2;NELFCD;RBL2;BAX;CYC1;ZNF395;PPCS;EREG;RPS6KA5;DGUOK;ZNF524;SOX12;DDIT4;MBTPS2;PPP1R13L;CARF;IER2;TGFBR3;LTB4R2;LEMD2;ZHX3;RGS14;ALDOC;SYMPK;MAPK12;IRAK1;PPOX;TGFA;HDAC7;FHOD1;CHD2;CBX7;CHEK2;ZFPM1;PPARA;SESN2;ABCG1;SOX7;SIX5;KDM4B;ZNF414;SSBP4;ECM1;WFS1;ZNF444;UPP1;ARID5B;HOXC5;DNM2;BHLHE40;PELI1;CAT;NEIL1;TSPYL2;ZMYM3;SATB1;ZNF606;MAPK3;INSR;CAMTA2;TAZ;PFKM;ADCY1;RERE;TSTA3;INO80C;PDXK;BCL7A;CAMKK2;PPP3CB;USP21;PFKFB3;GABBR1;REV1;CAPRIN2;ZBTB10;WDTC1;HES7;ITGA3;DNMT3A;PPP2R5B;HES6;MAP2K3;PROX1;ADGRF1;PKD1;SIRT2;FAM129B;EDA;NMNAT2;BACH1;NT5C1B;ADCY7;E2F5;ZBTB22;MAPRE3;TEP1;ZNF704;MAP3K10;GTF2IRD2;NGFR;BCORL1;ZNF837;GCH1;MAFF;NR2F6;CBX6;CAMK1;EZH1;HFE;TERC;ZNF513;BTG1;ZP3;MLF2;CDK11B;TNRC18;TCEA2;ZBTB47;PLAG1;IRF2BPL;KDM3A;DEDD2;SRSF5;ADCY6
7592,GO:0031974,0.999993574051981,8.56879612874106e-06,382,4318,membrane-enclosed lumen,CC,TNIP1;DUSP6;NT5E;ERCC1;DUSP5;MEF2D;H1F0;CITED4;EGR1;NR1D1;H6PD;CST3;EPN3;CTNNBIP1;NAGS;DOCK4;XPC;PYGB;VEGFA;PGM1;WNT7A;APOE;PYGL;TSPAN1;NAGLU;PITPNC1;HMGA2;OBSCN;IDH2;CRAT;ELK3;ITPR3;PKN1;MTA1;ACOT7;ACSF2;EGFR;RPS6KA2;WWTR1;NOS1;VAT1;HADH;NFATC4;TRIM65;BAHCC1;CRTAP;SDC1;ETV5;APPL2;SHC1;DDB2;LTBP1;TBC1D14;ARL2;HEXB;ALDH4A1;TK2;ETV4;TRNP1;GAA;ARAP1;NME4;SMARCA1;PC;RNF44;NAPRT;CPT2;VWA5A;POU2F2;SMURF2;KLC2;FOS;SMAD3;STAT6;ERCC6;EPAS1;HSD17B8;RPUSD3;PPP2R3B;PRDX5;PRODH;SALL2;RNF187;ADARB1;D2HGDH;AKT1;HDAC5;PYCR2;STK39;SERPING1;SCMH1;PHC2;NFKBIZ;VEGFB;ASH2L;ATG16L2;BRSK1;PTHLH;POLD4;FGFR1;PRKACB;FUCA1;PFKL;HLTF;MXI1;RAG1;H2AFJ;PHF7;TOMM34;SORL1;CIRBP;CBR4;HMG20B;TENM2;ZNF385A;NSMCE4A;IGFBP4;CCND1;LHPP;GAS6;PTK6;CSNK1E;CTSB;SOX13;DUSP7;MPLKIP;GSN;MAPKAPK3;PCSK9;RAD23A;DHTKD1;PHLDA1;ANO8;XPOT;MRPS6;HLCS;AIP;SH3D19;CCDC113;CDC25B;SH3GLB2;ARHGAP27;SMARCD2;COL13A1;DGKQ;HAGH;BNIP3;PAK6;NOL4L;GTF2IRD1;PCSK1;YPEL3;CTSZ;CRTC1;PRSS3;APRT;CTBP1;LTA4H;MNT;PTPDC1;ZMIZ2;CEBPB;ADAMTS13;ZNF217;TIMP2;WNT3;DPP7;TGFB1;LACTB2;GPC1;MKNK2;ADAMTS7;DEAF1;PODXL2;SDHA;MIPEP;MDH2;MPG;GALNS;NSMF;ABHD14B;LAMB2;ABTB1;RNH1;VGF;POLL;POLM;PHF21A;MIF4GD;KHDRBS3;HMGCL;TPP1;PCK2;B4GALT2;AGRN;MBD3;ACP6;VHL;TRAP1;IDUA;PFKFB2;MLXIPL;YPEL5;PRKCZ;KDM6B;PRKACA;CENPH;GRHPR;RABGGTA;ACTR1B;ADA;WDR18;CAPG;ALAS1;CNDP2;CERCAM;PRIMPOL;TFDP2;C6ORF89;MZT2A;STK17A;RILPL1;FAM50A;IRF2BP2;BNIP3L;NELFCD;PDK1;ACAD10;CYGB;THOP1;PRKCD;FAM20C;RBL2;STUB1;SBF1;DTD1;OLFM2;HIST3H2BB;CCDC92;GJB4;RPS6KA5;DGUOK;DUSP4;KLHDC2;SOX12;ACADS;PPP1R13L;CARF;IER2;CES2;MZT2B;FCHO1;LIMK1;PDIA5;LTB4R2;RPS6KA6;TMEM92;ZHX3;DNM1;RGS14;ALDOC;MRPS26;MSLN;LONP2;SYMPK;MAPK12;PPOX;HDAC7;CHD2;CBX7;CHEK2;ZFPM1;PPARA;COG7;JADE2;CDC34;SOX7;MIF;ACO2;SMOX;KDM4B;PHYH;ECM1;NARF;WFS1;QSOX1;SPPL2B;HSD11B1L;VWA1;UPP1;ETFB;FLYWCH1;ARID5B;HOXC5;BHLHE40;GLB1;SNX15;CAT;NEIL1;TSPYL2;IGFBP7;ZMYM3;SATB1;PLCB3;H1FX;IQSEC1;DDX50;MAPK3;INSR;RERE;INO80C;GPT2;PDXK;ETAA1;TRIM45;DCAF10;RNASET2;PPP3CB;LGALS3BP;CTSF;USP21;PFKFB3;MLYCD;REV1;HYAL1;ZBTB10;WDTC1;DNMT3A;MAN2B1;MAP2K3;BCL2L1;ABHD10;NDUFV3;DNASE1L1;IARS2;LRCH4;ALDH7A1;LMNA;KCTD13;SIRT2;FAM129B;UVSSA;TRIP10;E2F5;TEP1;SERPINB1;LAMB1;GTF2IRD2;NGFR;TOLLIP;BCORL1;PHYKPL;PLEKHM1;DUSP23;GCH1;MAFF;NR2F6;CBX6;PNMA1;EZH1;SIRT3;TERC;WIPI2;COL6A1;VPS51;CELSR1;TST;TNRC18;MAN2B2;TCEA2;PLAG1;CLK3;IRF2BPL;KDM3A;PM20D2;TBL3;DEDD2;AK3;SRSF5;CHPF;SLC26A11;SDC2
10395,GO:0043233,0.999993574051981,8.56879612874106e-06,382,4318,organelle lumen,CC,TNIP1;DUSP6;NT5E;ERCC1;DUSP5;MEF2D;H1F0;CITED4;EGR1;NR1D1;H6PD;CST3;EPN3;CTNNBIP1;NAGS;DOCK4;XPC;PYGB;VEGFA;PGM1;WNT7A;APOE;PYGL;TSPAN1;NAGLU;PITPNC1;HMGA2;OBSCN;IDH2;CRAT;ELK3;ITPR3;PKN1;MTA1;ACOT7;ACSF2;EGFR;RPS6KA2;WWTR1;NOS1;VAT1;HADH;NFATC4;TRIM65;BAHCC1;CRTAP;SDC1;ETV5;APPL2;SHC1;DDB2;LTBP1;TBC1D14;ARL2;HEXB;ALDH4A1;TK2;ETV4;TRNP1;GAA;ARAP1;NME4;SMARCA1;PC;RNF44;NAPRT;CPT2;VWA5A;POU2F2;SMURF2;KLC2;FOS;SMAD3;STAT6;ERCC6;EPAS1;HSD17B8;RPUSD3;PPP2R3B;PRDX5;PRODH;SALL2;RNF187;ADARB1;D2HGDH;AKT1;HDAC5;PYCR2;STK39;SERPING1;SCMH1;PHC2;NFKBIZ;VEGFB;ASH2L;ATG16L2;BRSK1;PTHLH;POLD4;FGFR1;PRKACB;FUCA1;PFKL;HLTF;MXI1;RAG1;H2AFJ;PHF7;TOMM34;SORL1;CIRBP;CBR4;HMG20B;TENM2;ZNF385A;NSMCE4A;IGFBP4;CCND1;LHPP;GAS6;PTK6;CSNK1E;CTSB;SOX13;DUSP7;MPLKIP;GSN;MAPKAPK3;PCSK9;RAD23A;DHTKD1;PHLDA1;ANO8;XPOT;MRPS6;HLCS;AIP;SH3D19;CCDC113;CDC25B;SH3GLB2;ARHGAP27;SMARCD2;COL13A1;DGKQ;HAGH;BNIP3;PAK6;NOL4L;GTF2IRD1;PCSK1;YPEL3;CTSZ;CRTC1;PRSS3;APRT;CTBP1;LTA4H;MNT;PTPDC1;ZMIZ2;CEBPB;ADAMTS13;ZNF217;TIMP2;WNT3;DPP7;TGFB1;LACTB2;GPC1;MKNK2;ADAMTS7;DEAF1;PODXL2;SDHA;MIPEP;MDH2;MPG;GALNS;NSMF;ABHD14B;LAMB2;ABTB1;RNH1;VGF;POLL;POLM;PHF21A;MIF4GD;KHDRBS3;HMGCL;TPP1;PCK2;B4GALT2;AGRN;MBD3;ACP6;VHL;TRAP1;IDUA;PFKFB2;MLXIPL;YPEL5;PRKCZ;KDM6B;PRKACA;CENPH;GRHPR;RABGGTA;ACTR1B;ADA;WDR18;CAPG;ALAS1;CNDP2;CERCAM;PRIMPOL;TFDP2;C6ORF89;MZT2A;STK17A;RILPL1;FAM50A;IRF2BP2;BNIP3L;NELFCD;PDK1;ACAD10;CYGB;THOP1;PRKCD;FAM20C;RBL2;STUB1;SBF1;DTD1;OLFM2;HIST3H2BB;CCDC92;GJB4;RPS6KA5;DGUOK;DUSP4;KLHDC2;SOX12;ACADS;PPP1R13L;CARF;IER2;CES2;MZT2B;FCHO1;LIMK1;PDIA5;LTB4R2;RPS6KA6;TMEM92;ZHX3;DNM1;RGS14;ALDOC;MRPS26;MSLN;LONP2;SYMPK;MAPK12;PPOX;HDAC7;CHD2;CBX7;CHEK2;ZFPM1;PPARA;COG7;JADE2;CDC34;SOX7;MIF;ACO2;SMOX;KDM4B;PHYH;ECM1;NARF;WFS1;QSOX1;SPPL2B;HSD11B1L;VWA1;UPP1;ETFB;FLYWCH1;ARID5B;HOXC5;BHLHE40;GLB1;SNX15;CAT;NEIL1;TSPYL2;IGFBP7;ZMYM3;SATB1;PLCB3;H1FX;IQSEC1;DDX50;MAPK3;INSR;RERE;INO80C;GPT2;PDXK;ETAA1;TRIM45;DCAF10;RNASET2;PPP3CB;LGALS3BP;CTSF;USP21;PFKFB3;MLYCD;REV1;HYAL1;ZBTB10;WDTC1;DNMT3A;MAN2B1;MAP2K3;BCL2L1;ABHD10;NDUFV3;DNASE1L1;IARS2;LRCH4;ALDH7A1;LMNA;KCTD13;SIRT2;FAM129B;UVSSA;TRIP10;E2F5;TEP1;SERPINB1;LAMB1;GTF2IRD2;NGFR;TOLLIP;BCORL1;PHYKPL;PLEKHM1;DUSP23;GCH1;MAFF;NR2F6;CBX6;PNMA1;EZH1;SIRT3;TERC;WIPI2;COL6A1;VPS51;CELSR1;TST;TNRC18;MAN2B2;TCEA2;PLAG1;CLK3;IRF2BPL;KDM3A;PM20D2;TBL3;DEDD2;AK3;SRSF5;CHPF;SLC26A11;SDC2
14519,GO:0070013,0.999993574051981,8.56879612874106e-06,382,4318,intracellular organelle lumen,CC,TNIP1;DUSP6;NT5E;ERCC1;DUSP5;MEF2D;H1F0;CITED4;EGR1;NR1D1;H6PD;CST3;EPN3;CTNNBIP1;NAGS;DOCK4;XPC;PYGB;VEGFA;PGM1;WNT7A;APOE;PYGL;TSPAN1;NAGLU;PITPNC1;HMGA2;OBSCN;IDH2;CRAT;ELK3;ITPR3;PKN1;MTA1;ACOT7;ACSF2;EGFR;RPS6KA2;WWTR1;NOS1;VAT1;HADH;NFATC4;TRIM65;BAHCC1;CRTAP;SDC1;ETV5;APPL2;SHC1;DDB2;LTBP1;TBC1D14;ARL2;HEXB;ALDH4A1;TK2;ETV4;TRNP1;GAA;ARAP1;NME4;SMARCA1;PC;RNF44;NAPRT;CPT2;VWA5A;POU2F2;SMURF2;KLC2;FOS;SMAD3;STAT6;ERCC6;EPAS1;HSD17B8;RPUSD3;PPP2R3B;PRDX5;PRODH;SALL2;RNF187;ADARB1;D2HGDH;AKT1;HDAC5;PYCR2;STK39;SERPING1;SCMH1;PHC2;NFKBIZ;VEGFB;ASH2L;ATG16L2;BRSK1;PTHLH;POLD4;FGFR1;PRKACB;FUCA1;PFKL;HLTF;MXI1;RAG1;H2AFJ;PHF7;TOMM34;SORL1;CIRBP;CBR4;HMG20B;TENM2;ZNF385A;NSMCE4A;IGFBP4;CCND1;LHPP;GAS6;PTK6;CSNK1E;CTSB;SOX13;DUSP7;MPLKIP;GSN;MAPKAPK3;PCSK9;RAD23A;DHTKD1;PHLDA1;ANO8;XPOT;MRPS6;HLCS;AIP;SH3D19;CCDC113;CDC25B;SH3GLB2;ARHGAP27;SMARCD2;COL13A1;DGKQ;HAGH;BNIP3;PAK6;NOL4L;GTF2IRD1;PCSK1;YPEL3;CTSZ;CRTC1;PRSS3;APRT;CTBP1;LTA4H;MNT;PTPDC1;ZMIZ2;CEBPB;ADAMTS13;ZNF217;TIMP2;WNT3;DPP7;TGFB1;LACTB2;GPC1;MKNK2;ADAMTS7;DEAF1;PODXL2;SDHA;MIPEP;MDH2;MPG;GALNS;NSMF;ABHD14B;LAMB2;ABTB1;RNH1;VGF;POLL;POLM;PHF21A;MIF4GD;KHDRBS3;HMGCL;TPP1;PCK2;B4GALT2;AGRN;MBD3;ACP6;VHL;TRAP1;IDUA;PFKFB2;MLXIPL;YPEL5;PRKCZ;KDM6B;PRKACA;CENPH;GRHPR;RABGGTA;ACTR1B;ADA;WDR18;CAPG;ALAS1;CNDP2;CERCAM;PRIMPOL;TFDP2;C6ORF89;MZT2A;STK17A;RILPL1;FAM50A;IRF2BP2;BNIP3L;NELFCD;PDK1;ACAD10;CYGB;THOP1;PRKCD;FAM20C;RBL2;STUB1;SBF1;DTD1;OLFM2;HIST3H2BB;CCDC92;GJB4;RPS6KA5;DGUOK;DUSP4;KLHDC2;SOX12;ACADS;PPP1R13L;CARF;IER2;CES2;MZT2B;FCHO1;LIMK1;PDIA5;LTB4R2;RPS6KA6;TMEM92;ZHX3;DNM1;RGS14;ALDOC;MRPS26;MSLN;LONP2;SYMPK;MAPK12;PPOX;HDAC7;CHD2;CBX7;CHEK2;ZFPM1;PPARA;COG7;JADE2;CDC34;SOX7;MIF;ACO2;SMOX;KDM4B;PHYH;ECM1;NARF;WFS1;QSOX1;SPPL2B;HSD11B1L;VWA1;UPP1;ETFB;FLYWCH1;ARID5B;HOXC5;BHLHE40;GLB1;SNX15;CAT;NEIL1;TSPYL2;IGFBP7;ZMYM3;SATB1;PLCB3;H1FX;IQSEC1;DDX50;MAPK3;INSR;RERE;INO80C;GPT2;PDXK;ETAA1;TRIM45;DCAF10;RNASET2;PPP3CB;LGALS3BP;CTSF;USP21;PFKFB3;MLYCD;REV1;HYAL1;ZBTB10;WDTC1;DNMT3A;MAN2B1;MAP2K3;BCL2L1;ABHD10;NDUFV3;DNASE1L1;IARS2;LRCH4;ALDH7A1;LMNA;KCTD13;SIRT2;FAM129B;UVSSA;TRIP10;E2F5;TEP1;SERPINB1;LAMB1;GTF2IRD2;NGFR;TOLLIP;BCORL1;PHYKPL;PLEKHM1;DUSP23;GCH1;MAFF;NR2F6;CBX6;PNMA1;EZH1;SIRT3;TERC;WIPI2;COL6A1;VPS51;CELSR1;TST;TNRC18;MAN2B2;TCEA2;PLAG1;CLK3;IRF2BPL;KDM3A;PM20D2;TBL3;DEDD2;AK3;SRSF5;CHPF;SLC26A11;SDC2
13691,GO:0060255,0.999994043761063,7.90652739029331e-06,415,4593,regulation of macromolecule metabolic process,BP,TNIP1;DUSP6;XDH;ERCC1;DUSP5;MEF2D;ZMYND8;CITED4;HTRA1;EGR1;NR1D1;EDEM1;DLG4;PLAT;CST3;BTBD2;FBXO2;APLN;PDCD4;CTNNBIP1;ACVR2B;PRNP;BBS2;VEGFA;TNFRSF6B;WNT7A;APOE;F2R;LRP5;ITGA6;HMGA2;ZKSCAN1;ELK3;PKN1;MTA1;GRAMD4;EGFR;SERPINE2;WWTR1;NOS1;SPRY2;MST1R;NFATC4;BAHCC1;CRTAP;LTBP4;ETV5;SHC1;VPS11;HEXB;GTPBP1;TCFL5;ACTA2;ETV4;PHLDA2;SNX9;TRNP1;SPRY4;RAPGEF3;ZFP36L1;ARAP1;MAP2K2;ZC3H6;LPAR3;MDFI;PTOV1;SMARCA1;PPP1R35;RBCK1;PC;FOXQ1;MAP2K1;MXD4;SSH1;POU2F2;ENDOG;SMURF2;TSC22D1;FOS;FBLN1;SMAD3;STAT6;PIK3R2;ERCC6;LRP1;GJC2;DVL1;EPAS1;DNAJB5;HBEGF;PPP1R14A;SH3PXD2B;PPP2R3B;PRDX5;SHC2;BRD3;SALL2;ZXDC;RNF187;ADORA2B;ADARB1;AKT1;GRB7;HDAC5;F12;PPM1F;STK39;SERPING1;SCMH1;EPHA1;NFKBIZ;ASH2L;IMPACT;WWC3;CNTN1;DAP;PTHLH;FGFR4;LDLR;FGFR1;PRKACB;RAC2;SEC14L2;HLTF;MXI1;RAG1;H2AFJ;KLF7;SORL1;NAT14;CEACAM1;B3GAT3;CIRBP;HMG20B;TENM2;ZNF385A;ANK3;IGFBP4;TSHZ1;TRAPPC9;CCND1;PODNL1;PCBP4;TCF25;STRADB;SYNGAP1;MAPK13;GAS6;PTK6;CSNK1E;CARD11;SOX13;DUSP7;GSN;MAPKAPK3;PCSK9;ARHGAP22;RAD23A;EHD4;ERRFI1;GLI4;ZSCAN18;AIP;MYEF2;MN1;SH3D19;CDC25B;SMARCD2;SNTA1;DGKQ;PAK6;TFPI2;GTF2IRD1;TAGLN3;CEMIP;PKD2;CTSZ;HES2;CRTC1;ABCA2;ZNF598;MAGEF1;EPHB2;ADAM8;CTBP1;MNT;CDKN1C;PLCG1;ZMIZ2;CD81;CEBPB;ZNF217;TIMP2;ZNF862;WNT3;C8ORF88;TGFB1;RFX2;SCYL1;UNK;MKNK2;DEAF1;NAB2;TMEM173;ZSCAN30;MSRB2;PNRC1;TNFSF15;NSMF;PEG3;MC1R;ABHD14B;ABTB1;RNH1;SNX33;PHF21A;MIF4GD;KHDRBS3;ZER1;PTPN1;AGRN;MBD3;IFNE;CAMK2N1;LRP4;VHL;TRAP1;MLXIPL;TRIB2;PRKCZ;KDM6B;PRKACA;MINK1;ZNF516;AREG;PIM2;BOK;WDR18;TDRKH;ERBB2;TFDP2;C6ORF89;NECAB3;JAK3;IRF2BP2;CYFIP2;PBX2;NELFCD;PRKCD;RBL2;STUB1;IFI6;BAX;ITGA1;ZNF395;EREG;RPS6KA5;DUSP4;ZNF524;SOX12;DDIT4;MBTPS2;PPP1R13L;CARF;AHNAK2;PCSK1N;IER2;LIMK1;TGFBR3;DIP2A;LEMD2;RPS6KA6;ZHX3;RGS14;CHAD;LPCAT1;ASB1;SYMPK;MAPK12;IRAK1;TGFA;HDAC7;FHOD1;INPP5D;MTHFR;CHD2;CBX7;CHEK2;ZFPM1;PPARA;TMEM161A;SESN2;ABCG1;SOX7;ABCA7;SIX5;BCAP31;MIF;KDM4B;ZNF414;MEX3A;PLA2G6;DDT;SSBP4;ECM1;WFS1;ZNF444;TRPT1;FYN;STK25;EEF2K;ARID5B;HOXC5;DNM2;BHLHE40;PELI1;CAT;NEIL1;TSPYL2;ELFN2;SLC27A1;ZMYM3;SATB1;SLC50A1;ZNF606;MAPK3;INSR;PAN2;CAMTA2;PFKM;ADCY1;RERE;INO80C;ETAA1;BCL7A;VANGL2;PAK1;CAMKK2;PPP3CB;RNF144A;USP21;MICAL1;SEMA4C;CAPRIN2;ZBTB10;WDTC1;HES7;ITGA3;DNMT3A;SAMD8;BIN1;PPP2R5B;HES6;MAP2K3;DLG3;RRAS;PROX1;TBC1D16;ADGRF1;ZYG11B;PKD1;KCTD13;TNFRSF25;SIRT2;FAM129B;EDA;BACH1;ADCY7;E2F5;ZBTB22;MAPRE3;AZIN2;ZNF704;SERPINB1;SOCS7;MAP3K10;GTF2IRD2;NGFR;TOLLIP;BCORL1;PDCD6;ZNF837;MAFF;NR2F6;CBX6;CAMK1;CAMKK1;EZH1;SIRT3;HFE;ZNF513;BTG1;ZP3;MLF2;CDK11B;PFN2;FGFR3;PPP1R16A;CCDC88C;TNRC18;NDRG2;CBLC;ITPKB;TCEA2;ZBTB47;PLAG1;CLK3;IRF2BPL;KDM3A;PM20D2;APBA1;DEDD2;SRSF5;ADCY6;LRRK1
5279,GO:0015931,0.999994069017695,2.54095232078602e-05,6,208,nucleobase-containing compound transport,BP,ZFP36L1;XPOT;SLC29A4;SYMPK;TST;SRSF5
2892,GO:0006403,0.99999411300148,2.52260045966322e-05,6,209,RNA localization,BP,ZFP36L1;ZNF385A;XPOT;SYMPK;TST;SRSF5
281,GO:0000784,0.999994767861102,7.27124414993328e-05,1,114,nuclear chromosome, telomeric region,CC,ERCC1
4024,GO:0009058,0.999995737909154,5.65598367612892e-06,448,4949,biosynthetic process,BP,TNIP1;NT5E;XDH;MEF2D;ZMYND8;CITED4;HTRA1;EGR1;NR1D1;CST3;CYP27B1;APLN;PDCD4;CTNNBIP1;NAGS;ACVR2B;PRNP;VEGFA;PGM1;WNT7A;APOE;PYGL;DGKA;F2R;LRP5;LPCAT4;ITGA6;ISYNA1;HMGA2;IDH2;ZKSCAN1;ELK3;PKN1;MTA1;ACOT7;EGFR;DNPH1;WWTR1;NOS1;NFATC4;BAHCC1;SDC1;ETV5;LMF1;SHC1;HEXB;GTPBP1;TCFL5;TK2;ETV4;TRNP1;RAPGEF3;ST6GALNAC2;ZFP36L1;GLUL;MAP2K2;KDSR;NME4;ZC3H6;MDFI;PTOV1;SMARCA1;RBCK1;PLTP;PC;FOXQ1;MAP2K1;NAPRT;CRYL1;ACP5;MXD4;POU2F2;SMURF2;TSC22D1;FOS;SMAD3;STAT6;PIK3R2;ERCC6;SRD5A3;DVL1;EPAS1;DNAJB5;PIGQ;HSD17B8;HBEGF;PRDX5;BRD3;SALL2;MBOAT7;LY6K;ZXDC;RNF187;NMRK1;ADORA2B;AKT1;GRB7;HDAC5;UROS;PPM1F;PITPNM1;PYCR2;HK1;SCMH1;GGT1;NFKBIZ;VEGFB;ASH2L;IMPACT;WWC3;DAP;PTHLH;FGFR4;POLD4;LDLR;FGFR1;PFKL;SEC14L2;OPLAH;HLTF;MXI1;GAMT;H2AFJ;B4GAT1;PIGV;KLF7;NAT14;CEACAM1;B3GAT3;CIRBP;CBR4;HMG20B;TENM2;ZNF385A;TSHZ1;TRAPPC9;CCND1;TCF25;LHPP;MAPK13;GAS6;PFKP;CARD11;SOX13;ARHGAP22;DHTKD1;PHLDA1;MRPS6;ERRFI1;GLI4;NADK;PANK4;ZSCAN18;AIP;MYEF2;MN1;ALOX15B;SMARCD2;RSAD1;NPR2;DGKQ;HAGH;PAK6;GTF2IRD1;TAGLN3;CEMIP;PKD2;PCSK1;HES2;CRTC1;ABCA2;ZNF598;ADAM8;APRT;CTBP1;LTA4H;MNT;CDKN1C;ZMIZ2;CBS;CD81;CEBPB;MVD;ENTPD2;ADAMTS13;ZNF217;TIMP2;ZNF862;SYNJ2;C8ORF88;TGFB1;RFX2;SCYL1;ABHD17C;UNK;GPC1;MKNK2;ADAMTS7;DEAF1;NTSR1;B3GNT3;NAB2;TMEM173;ZSCAN30;MSRB2;PNRC1;MGAT4B;MDH2;PEG3;MC1R;ABHD14B;ABTB1;ST6GALNAC6;POLL;POLM;PI4K2A;PTMS;PHGDH;PHF21A;MIF4GD;PLPP6;KHDRBS3;HMGCL;PCK2;B4GALT2;AGRN;MBD3;LRP4;ZDHHC24;ACP6;B4GALT6;VHL;TRAP1;PFKFB2;RFNG;MLXIPL;TRIB2;PRKCZ;KDM6B;ZNF516;ADA;AREG;PIM2;MPI;UCKL1;WDR18;ALAS1;ERBB2;CNDP2;AHCY;PRIMPOL;TFDP2;NECAB3;JAK3;IRF2BP2;CYFIP2;PBX2;TRPC1;NELFCD;PDK1;CYGB;MCFD2;PRKCD;RBL2;BAX;CYC1;SBF1;DTD1;XYLT2;ZNF395;PPCS;EREG;RPS6KA5;DGUOK;ZNF524;SOX12;DDIT4;MBTPS2;PPP1R13L;CARF;HSD17B7;IER2;ZDHHC8;TGFBR3;LTB4R2;CPNE7;RPL39L;LEMD2;ZHX3;RGS14;MFNG;GSTO1;ALDOC;MRPS26;MSLN;LPCAT1;ASB1;ST3GAL3;SYMPK;MAPK12;IRAK1;PPOX;TGFA;HDAC7;FHOD1;INPP5D;CHD2;PI4K2B;CBX7;CHEK2;DECR2;ZFPM1;PPARA;COG7;COQ2;SESN2;ABCG1;CDC34;SOX7;ABCA7;SIX5;MIF;SMOX;KDM4B;ZNF414;MEX3A;PLA2G6;DDT;SSBP4;NUDT14;ECM1;WFS1;ZNF444;DALRD3;PITPNM3;UPP1;EEF2K;CERS4;ARID5B;HOXC5;DNM2;BHLHE40;PELI1;CHKA;CAT;NEIL1;TSPYL2;IGFBP7;SLC27A1;ZMYM3;SATB1;ZDHHC1;ZNF606;CYP2R1;MAPK3;INSR;CAMTA2;TAZ;PFKM;ADCY1;RERE;TSTA3;INO80C;GPT2;PDXK;ETAA1;BCL7A;VANGL2;CAMKK2;PPP3CB;USP21;PFKFB3;MLYCD;GABBR1;REV1;HYAL1;CAPRIN2;ZBTB10;WDTC1;HES7;ITGA3;DNMT3A;SAMD8;PPP2R5B;HES6;MAP2K3;NDST2;PROX1;IARS2;MDGA1;ADGRF1;ALDH7A1;PKD1;KCTD13;SIRT2;FAM129B;EDA;GAL3ST4;NMNAT2;BACH1;NT5C1B;ADCY7;E2F5;ZBTB22;ALG12;MAPRE3;AZIN2;TEP1;ZNF704;ST3GAL2;MAP3K10;HSD11B1;GTF2IRD2;NGFR;BCORL1;CHST14;ZNF837;GCH1;MAFF;NR2F6;CBX6;CAMK1;EZH1;HFE;TERC;ZNF513;WIPI2;BTG1;ZP3;MLF2;CDK11B;FGFR3;ST3GAL5;TNRC18;ITPKB;SPTLC2;TCEA2;PRSS21;ZBTB47;PLAG1;IRF2BPL;KDM3A;DEDD2;SRSF5;CHPF;ADCY6;AARS;SDC2
4534,GO:0010608,0.999996162778021,8.92507811259955e-06,25,507,posttranscriptional regulation of gene expression,BP,EGFR;ZFP36L1;MAP2K2;MAP2K1;SMAD3;AKT1;GRB7;IMPACT;CIRBP;ZNF385A;PCBP4;ZNF598;C8ORF88;TGFB1;UNK;MKNK2;MIF4GD;TRAP1;ERBB2;CYFIP2;PRKCD;SESN2;MEX3A;MAPK3;CAPRIN2
18354,GO:1903311,0.999996655172615,1.26872362549671e-05,8,250,regulation of mRNA metabolic process,BP,GTPBP1;ZFP36L1;AKT1;CIRBP;PCBP4;KHDRBS3;PRKCD;CDK11B
10780,GO:0044249,0.999996942378421,4.08058795956994e-06,436,4844,cellular biosynthetic process,BP,TNIP1;NT5E;XDH;MEF2D;ZMYND8;CITED4;HTRA1;EGR1;NR1D1;CST3;CYP27B1;APLN;PDCD4;CTNNBIP1;NAGS;ACVR2B;PRNP;VEGFA;PGM1;WNT7A;APOE;DGKA;F2R;LRP5;LPCAT4;ITGA6;ISYNA1;HMGA2;IDH2;ZKSCAN1;ELK3;PKN1;MTA1;ACOT7;EGFR;DNPH1;WWTR1;NOS1;NFATC4;BAHCC1;ETV5;LMF1;SHC1;HEXB;GTPBP1;TCFL5;TK2;ETV4;TRNP1;RAPGEF3;ST6GALNAC2;ZFP36L1;GLUL;MAP2K2;KDSR;NME4;ZC3H6;MDFI;PTOV1;SMARCA1;RBCK1;PLTP;FOXQ1;MAP2K1;NAPRT;ACP5;MXD4;POU2F2;SMURF2;TSC22D1;FOS;SMAD3;STAT6;PIK3R2;ERCC6;SRD5A3;DVL1;EPAS1;DNAJB5;PIGQ;HSD17B8;HBEGF;PRDX5;BRD3;SALL2;MBOAT7;LY6K;ZXDC;RNF187;NMRK1;ADORA2B;AKT1;GRB7;HDAC5;UROS;PPM1F;PITPNM1;PYCR2;HK1;SCMH1;GGT1;NFKBIZ;VEGFB;ASH2L;IMPACT;WWC3;DAP;PTHLH;FGFR4;POLD4;LDLR;FGFR1;PFKL;SEC14L2;OPLAH;HLTF;MXI1;GAMT;H2AFJ;B4GAT1;PIGV;KLF7;NAT14;CEACAM1;B3GAT3;CIRBP;CBR4;HMG20B;TENM2;ZNF385A;TSHZ1;TRAPPC9;CCND1;TCF25;LHPP;MAPK13;GAS6;PFKP;CARD11;SOX13;ARHGAP22;DHTKD1;PHLDA1;MRPS6;ERRFI1;GLI4;NADK;PANK4;ZSCAN18;AIP;MYEF2;MN1;ALOX15B;SMARCD2;RSAD1;NPR2;DGKQ;HAGH;PAK6;GTF2IRD1;TAGLN3;CEMIP;PKD2;PCSK1;HES2;CRTC1;ABCA2;ZNF598;ADAM8;APRT;CTBP1;LTA4H;MNT;CDKN1C;ZMIZ2;CBS;CD81;CEBPB;MVD;ENTPD2;ADAMTS13;ZNF217;TIMP2;ZNF862;SYNJ2;C8ORF88;TGFB1;RFX2;SCYL1;ABHD17C;UNK;MKNK2;ADAMTS7;DEAF1;NTSR1;B3GNT3;NAB2;TMEM173;ZSCAN30;MSRB2;PNRC1;MGAT4B;PEG3;MC1R;ABHD14B;ABTB1;ST6GALNAC6;POLL;POLM;PI4K2A;PTMS;PHGDH;PHF21A;MIF4GD;KHDRBS3;HMGCL;PCK2;B4GALT2;AGRN;MBD3;LRP4;ZDHHC24;ACP6;B4GALT6;VHL;TRAP1;PFKFB2;RFNG;MLXIPL;TRIB2;PRKCZ;KDM6B;ZNF516;ADA;AREG;PIM2;MPI;UCKL1;WDR18;ALAS1;ERBB2;CNDP2;AHCY;PRIMPOL;TFDP2;NECAB3;JAK3;IRF2BP2;CYFIP2;PBX2;TRPC1;NELFCD;PDK1;MCFD2;PRKCD;RBL2;BAX;CYC1;SBF1;DTD1;XYLT2;ZNF395;PPCS;EREG;RPS6KA5;DGUOK;ZNF524;SOX12;DDIT4;MBTPS2;PPP1R13L;CARF;HSD17B7;IER2;ZDHHC8;TGFBR3;LTB4R2;CPNE7;RPL39L;LEMD2;ZHX3;RGS14;MFNG;GSTO1;ALDOC;MRPS26;MSLN;LPCAT1;ASB1;ST3GAL3;SYMPK;MAPK12;IRAK1;PPOX;TGFA;HDAC7;FHOD1;INPP5D;CHD2;PI4K2B;CBX7;CHEK2;DECR2;ZFPM1;PPARA;COG7;COQ2;SESN2;ABCG1;CDC34;SOX7;ABCA7;SIX5;MIF;SMOX;KDM4B;ZNF414;MEX3A;PLA2G6;DDT;SSBP4;NUDT14;ECM1;WFS1;ZNF444;DALRD3;PITPNM3;UPP1;EEF2K;CERS4;ARID5B;HOXC5;DNM2;BHLHE40;PELI1;CHKA;CAT;NEIL1;TSPYL2;SLC27A1;ZMYM3;SATB1;ZDHHC1;ZNF606;CYP2R1;MAPK3;INSR;CAMTA2;TAZ;PFKM;ADCY1;RERE;TSTA3;INO80C;GPT2;PDXK;ETAA1;BCL7A;VANGL2;CAMKK2;PPP3CB;USP21;PFKFB3;MLYCD;GABBR1;REV1;HYAL1;CAPRIN2;ZBTB10;WDTC1;HES7;ITGA3;DNMT3A;SAMD8;PPP2R5B;HES6;MAP2K3;NDST2;PROX1;IARS2;MDGA1;ADGRF1;ALDH7A1;PKD1;KCTD13;SIRT2;FAM129B;EDA;GAL3ST4;NMNAT2;BACH1;NT5C1B;ADCY7;E2F5;ZBTB22;ALG12;MAPRE3;AZIN2;TEP1;ZNF704;ST3GAL2;MAP3K10;GTF2IRD2;NGFR;BCORL1;CHST14;ZNF837;GCH1;MAFF;NR2F6;CBX6;CAMK1;EZH1;HFE;TERC;ZNF513;WIPI2;BTG1;ZP3;MLF2;CDK11B;FGFR3;ST3GAL5;TNRC18;SPTLC2;TCEA2;PRSS21;ZBTB47;PLAG1;IRF2BPL;KDM3A;DEDD2;SRSF5;CHPF;ADCY6;AARS
2900,GO:0006413,0.999997051910835,1.96173618335221e-05,3,186,translational initiation,BP,IMPACT;C8ORF88;MIF4GD
8849,GO:0034654,0.999997578688313,3.34835576327696e-06,292,3396,nucleobase-containing compound biosynthetic process,BP,TNIP1;NT5E;XDH;MEF2D;ZMYND8;CITED4;HTRA1;EGR1;NR1D1;APLN;PDCD4;CTNNBIP1;ACVR2B;PRNP;VEGFA;PGM1;WNT7A;APOE;F2R;LRP5;ITGA6;HMGA2;IDH2;ZKSCAN1;ELK3;PKN1;MTA1;ACOT7;EGFR;DNPH1;WWTR1;NOS1;NFATC4;BAHCC1;ETV5;SHC1;HEXB;TCFL5;TK2;ETV4;TRNP1;RAPGEF3;ZFP36L1;MAP2K2;NME4;ZC3H6;MDFI;PTOV1;SMARCA1;RBCK1;FOXQ1;MAP2K1;NAPRT;MXD4;POU2F2;SMURF2;TSC22D1;FOS;SMAD3;STAT6;PIK3R2;ERCC6;DVL1;EPAS1;DNAJB5;PRDX5;BRD3;SALL2;ZXDC;RNF187;NMRK1;ADORA2B;AKT1;HDAC5;PPM1F;HK1;SCMH1;NFKBIZ;ASH2L;IMPACT;WWC3;DAP;PTHLH;FGFR4;POLD4;FGFR1;PFKL;SEC14L2;HLTF;MXI1;H2AFJ;KLF7;NAT14;HMG20B;TENM2;ZNF385A;TSHZ1;TRAPPC9;CCND1;TCF25;LHPP;MAPK13;GAS6;PFKP;CARD11;SOX13;ARHGAP22;DHTKD1;GLI4;NADK;PANK4;ZSCAN18;AIP;MYEF2;MN1;SMARCD2;NPR2;DGKQ;PAK6;GTF2IRD1;TAGLN3;PKD2;HES2;CRTC1;ABCA2;ADAM8;APRT;CTBP1;MNT;CDKN1C;ZMIZ2;CD81;CEBPB;ENTPD2;ZNF217;TIMP2;ZNF862;TGFB1;RFX2;SCYL1;DEAF1;NAB2;TMEM173;ZSCAN30;MSRB2;PNRC1;PEG3;MC1R;ABHD14B;POLL;POLM;PHF21A;KHDRBS3;AGRN;MBD3;LRP4;VHL;PFKFB2;MLXIPL;PRKCZ;KDM6B;ZNF516;ADA;PIM2;MPI;UCKL1;ERBB2;PRIMPOL;TFDP2;IRF2BP2;PBX2;NELFCD;RBL2;BAX;CYC1;ZNF395;PPCS;EREG;RPS6KA5;DGUOK;ZNF524;SOX12;DDIT4;MBTPS2;PPP1R13L;CARF;IER2;TGFBR3;LTB4R2;LEMD2;ZHX3;RGS14;ALDOC;SYMPK;MAPK12;IRAK1;TGFA;HDAC7;FHOD1;CHD2;CBX7;CHEK2;ZFPM1;PPARA;SESN2;ABCG1;SOX7;SIX5;KDM4B;ZNF414;SSBP4;ECM1;WFS1;ZNF444;UPP1;ARID5B;HOXC5;DNM2;BHLHE40;PELI1;CAT;NEIL1;TSPYL2;ZMYM3;SATB1;ZNF606;MAPK3;INSR;CAMTA2;TAZ;PFKM;ADCY1;RERE;TSTA3;INO80C;BCL7A;CAMKK2;PPP3CB;USP21;PFKFB3;GABBR1;REV1;CAPRIN2;ZBTB10;WDTC1;HES7;ITGA3;DNMT3A;PPP2R5B;HES6;MAP2K3;PROX1;ADGRF1;PKD1;SIRT2;FAM129B;EDA;NMNAT2;BACH1;NT5C1B;ADCY7;E2F5;ZBTB22;MAPRE3;TEP1;ZNF704;MAP3K10;GTF2IRD2;NGFR;BCORL1;ZNF837;MAFF;NR2F6;CBX6;CAMK1;EZH1;HFE;TERC;ZNF513;BTG1;ZP3;MLF2;CDK11B;TNRC18;TCEA2;ZBTB47;PLAG1;IRF2BPL;KDM3A;DEDD2;SRSF5;ADCY6
17307,GO:0140098,0.999997782824938,6.80706495739736e-06,13,332,catalytic activity, acting on RNA,MF,RRNAD1;LACTB2;PRIMPOL;DTD1;TRPT1;DALRD3;DDX50;PAN2;RNASET2;IARS2;RNASE7;DHX32;AARS
8254,GO:0033044,0.999997800363825,7.62671505982872e-06,10,280,regulation of chromosome organization,BP,ERCC1;VEGFA;NOS1;CTBP1;TGFB1;C6ORF89;RPS6KA5;MTHFR;MAPK3;KDM3A
2899,GO:0006412,0.999998221124128,3.85572347848183e-06,33,655,translation,BP,TNIP1;EGFR;GTPBP1;ZFP36L1;MAP2K2;MAP2K1;AKT1;GRB7;GGT1;IMPACT;CIRBP;ZNF385A;MRPS6;ZNF598;C8ORF88;TGFB1;UNK;MKNK2;ABTB1;MIF4GD;TRAP1;ERBB2;CYFIP2;RPL39L;MRPS26;SESN2;MEX3A;DALRD3;EEF2K;MAPK3;CAPRIN2;IARS2;AARS
6595,GO:0022618,0.999998386118233,9.32771893862473e-06,4,193,ribonucleoprotein complex assembly,BP,GRB7;CIRBP;WDR18;SRSF5
6023,GO:0019083,0.999998545205857,1.32524049427096e-05,2,170,viral transcription,BP,HMGA2;NELFCD
10351,GO:0043170,0.999998762324863,1.65248239852024e-06,648,6891,macromolecule metabolic process,BP,TNIP1;DUSP6;NT5E;XDH;ERCC1;DUSP5;MEF2D;GID4;ZMYND8;H1F0;CITED4;HTRA1;THSD4;EGR1;NR1D1;EDEM1;DLG4;PLAT;CST3;TYSND1;BTBD2;FBXO2;APLN;PDCD4;CTNNBIP1;ACVR2B;XPC;PRNP;PYGB;BBS2;VEGFA;TNFRSF6B;PGM1;WNT7A;APOE;PYGL;NAGLU;F2R;LRP5;ITGA6;HMGA2;OBSCN;ZKSCAN1;NEK9;ELK3;PKN1;MTA1;GRAMD4;ARRDC1;EGFR;RPS6KA2;SERPINE2;WWTR1;LOXL1;OBSL1;NOS1;PTPRS;TMEM129;CTSO;SPRY2;CAPN2;MST1R;NFATC4;BAHCC1;CRTAP;LTBP4;PRSS8;SDC1;KLHL29;ETV5;LMF1;SHC1;DDB2;VPS11;LTBP1;HEXB;GTPBP1;TCFL5;PTPRE;NPEPL1;TK2;ACTA2;MMP1;ETV4;PHLDA2;SNX9;TRNP1;SPRY4;RAPGEF3;ST6GALNAC2;ZFP36L1;GAA;RNPEPL1;ARAP1;MAP2K2;ZC3H6;LPAR3;MARCH9;CTBS;FKBP9;MDFI;PTOV1;SMARCA1;PPP1R35;RBCK1;PC;FOXQ1;RNF44;MAP2K1;NYNRIN;MXD4;SSH1;POU2F2;ENDOG;MARK4;SMURF2;TSC22D1;FOS;FBLN1;SMAD3;STAT6;PIK3R2;ERCC6;LRP1;GJC2;SRD5A3;DVL1;EPAS1;DNAJB5;PIGQ;HBEGF;RPUSD3;AP2A2;PPP1R14A;SH3PXD2B;PPP2R3B;PRDX5;SHC2;BRD3;SALL2;CDK18;LY6K;FBXW5;ZXDC;RNF187;ADORA2B;ADARB1;D2HGDH;AKT1;GRB7;HDAC5;FBXO41;F12;PPM1F;MMP28;RHBDF2;STK39;SERPING1;SCMH1;EPHA1;GGT1;NFKBIZ;PTPRU;VEGFB;ASH2L;IMPACT;MARCH4;WWC3;CNTN1;BRSK1;DAP;PTHLH;RAB31;FGFR4;POLD4;LDLR;FGFR1;PRKACB;FUCA1;MAPKBP1;RAC2;TTLL12;SEC14L2;HLTF;MXI1;PPM1J;RAG1;H2AFJ;B4GAT1;PIGV;KLF7;SORL1;NAT14;CEACAM1;B3GAT3;ASB13;CIRBP;HMG20B;TENM2;ZNF385A;NSMCE4A;ANK3;IGFBP4;TSHZ1;TRAPPC9;CCND1;PODNL1;PCBP4;TCF25;LHPP;STRADB;SYNGAP1;MAPK13;PLAU;GAS6;PTK6;CSNK1E;CTSB;RAB3B;CARD11;SOX13;DUSP7;GSN;MAPKAPK3;IGFBP2;PCSK9;ARHGAP22;RAD23A;PHLDA1;ANO8;BCR;MRPS6;EHD4;ERRFI1;GLI4;HLCS;ZSCAN18;PRSS22;AIP;MYEF2;MN1;SH3D19;CDC25B;SPTB;SMARCD2;PEX10;RRNAD1;NPR2;SNTA1;DGKQ;BNIP3;PAK6;TFPI2;GTF2IRD1;SHARPIN;MVB12B;TAGLN3;CEMIP;PKD2;ACY1;PCSK1;RASGEF1A;CTSZ;CDC42EP5;HES2;CRTC1;FBXW8;ABCA2;ZNF598;MAGEF1;PRSS3;EPHB2;ADAM8;CTBP1;JOSD2;LTA4H;MNT;PTPDC1;GRK6;CDKN1C;PLCG1;FBXL8;ZMIZ2;CBS;CD81;CEBPB;MVD;RNF135;ADAMTS13;ZNF217;TIMP2;ZNF862;WNT3;DPP7;C8ORF88;TGFB1;LACTB2;RFX2;SCYL1;ABHD17C;UNK;ULK2;GPC1;MKNK2;ADAMTS7;DEAF1;B3GNT3;NAB2;TMEM173;ZSCAN30;SHANK3;MSRB2;RASA3;PNRC1;MIPEP;TNFSF15;MGAT4B;MDH2;MPG;GALNS;FBXO17;CLCA2;NSMF;PEG3;MC1R;LCE1E;ABHD14B;LAMB2;ABTB1;RNH1;ERO1B;ST6GALNAC6;VGF;POLL;FBXO44;POLM;SNX33;PTMS;ANKZF1;PHF21A;MIF4GD;UBXN4;ADAM19;KHDRBS3;ZER1;PTPN1;TPP1;B4GALT2;AGRN;MBD3;IFNE;CAMK2N1;LRP4;ZDHHC24;B4GALT6;VHL;TRAP1;IDUA;RFNG;MLXIPL;TRIB2;PRKCZ;KDM6B;PRKACA;MINK1;ZNF516;RABGGTA;CD9;AREG;PIM2;MPI;BOK;WDR18;TDRKH;NEURL1B;ERBB2;ULK1;CNDP2;PRIMPOL;MMP10;TFDP2;C6ORF89;NECAB3;STK17A;JAK3;IRF2BP2;RNPEP;BNIP3L;CYFIP2;PBX2;NELFCD;RASA4;PDK1;THOP1;MCFD2;PRKCD;FAM20C;MIB2;RBL2;USP20;STUB1;IFI6;BAX;SBF1;DTD1;XYLT2;TRIM4;ITGA1;ZNF395;FBXW4;EREG;RPS6KA5;DGUOK;DUSP4;ZNF524;CUL9;SOX12;DDIT4;MBTPS2;TOP3B;PPP1R13L;CARF;AHNAK2;PCSK1N;IER2;ZDHHC8;LIMK1;TGFBR3;PADI3;DIP2A;RPL39L;LEMD2;RPS6KA6;ZHX3;DNM1;RGS14;MFNG;CHAD;MRPS26;MSLN;LPCAT1;LRSAM1;ADAM15;ASB1;EHD3;ST3GAL3;LONP2;SYMPK;MAPK12;IRAK1;TGFA;HDAC7;FHOD1;INPP5D;MTHFR;CHD2;CBX7;PCMTD2;CHEK2;ZFPM1;PPARA;COG7;TMEM161A;SESN2;ABCG1;JADE2;CDC34;RNF123;SOX7;ABCA7;RAB12;SPEG;SIX5;BCAP31;MIF;EEF2KMT;KDM4B;ZNF414;MEX3A;PLA2G6;DDT;SSBP4;NUDT14;ECM1;WFS1;QSOX1;ZNF444;DTX3;TRPT1;DALRD3;SPPL2B;FYN;VWA1;STK25;ETFB;EEF2K;ARID5B;HOXC5;DNM2;BHLHE40;GLB1;PELI1;CAT;NEIL1;TSPYL2;IGFBP7;ELFN2;SLC27A1;ZMYM3;APOBEC3C;SATB1;SLC50A1;ZDHHC1;ZNF606;APOBEC3F;DDX50;MAPK3;INSR;PAN2;CAMTA2;PFKM;ADCY1;RERE;INO80C;ETAA1;GLRX;BCL7A;VANGL2;PAK1;DCAF10;KLHL36;CAMKK2;RNASET2;PPP3CB;RNF144A;ALPK1;CTSF;USP21;CUL7;REV1;MICAL1;HYAL1;SEMA4C;CAPRIN2;ZBTB10;WDTC1;HES7;ITGA3;STK32C;DNMT3A;SAMD8;BIN1;MAN2B1;SRMS;PPP2R5B;HES6;MAP2K3;NDST2;DLG3;RRAS;DNASE1L1;PROX1;IARS2;MDGA1;TBC1D16;ADGRF1;ZYG11B;PKD1;KCTD13;TNFRSF25;SIRT2;FAM129B;EDA;UVSSA;GAL3ST4;BACH1;ADCY7;E2F5;ZBTB22;ALG12;MAPRE3;AZIN2;TEP1;ZNF704;SERPINB1;ST3GAL2;LAMB1;SOCS7;MAP3K10;PELI3;GTF2IRD2;RAB40B;NGFR;TOLLIP;BCORL1;PDCD6;CHST14;ZNF837;RNASE7;DUSP23;MAFF;NR2F6;CBX6;CAMK1;CAMKK1;EZH1;SIRT3;HFE;TERC;ZNF513;WIPI2;BTG1;ZP3;MLF2;CDK11B;PFN2;SSH3;FGFR3;PPP1R16A;CCDC88C;ST3GAL5;TNRC18;NDRG2;MAN2B2;CBLC;ITPKB;TCEA2;CDC42BPG;PRSS21;ZBTB47;PLAG1;CLK3;IRF2BPL;DHX32;KDM3A;PM20D2;TBL3;PKN3;APBA1;TTLL3;DEDD2;SRSF5;CHPF;ADCY6;LRRK1;AARS;KLHL24;SDC2
2484,GO:0005730,0.999998850301776,2.23121416467032e-06,50,836,nucleolus,CC,DOCK4;XPC;ITPR3;ARL2;ETV4;CPT2;ERCC6;ADARB1;POLD4;FGFR1;HLTF;MXI1;CIRBP;ZNF385A;CTSB;PHLDA1;PAK6;YPEL3;DEAF1;SDHA;ABHD14B;ABTB1;MIF4GD;CENPH;WDR18;CAPG;C6ORF89;PDK1;RBL2;DTD1;GJB4;CARF;RPS6KA6;CHD2;COG7;NARF;SNX15;TSPYL2;H1FX;IQSEC1;DDX50;INO80C;SIRT2;E2F5;PLEKHM1;PNMA1;VPS51;TBL3;DEDD2;SRSF5
10389,GO:0043227,0.999999173860882,1.1497873953598e-06,907,9278,membrane-bounded organelle,CC,TNIP1;DUSP6;NT5E;XDH;ERCC1;DUSP5;MEF2D;ZMYND8;H1F0;CITED4;HTRA1;FHL1;THSD4;EGR1;B4GALNT4;NR1D1;SLC16A3;H6PD;EDEM1;DLG4;PLAT;CST3;CYP27B1;TYSND1;HS1BP3;MARVELD1;EPN3;FBXO2;PRR7;PDCD4;CTNNBIP1;NAGS;DOCK4;XPC;PRNP;PYGB;BBS2;POSTN;VEGFA;FAM210B;PGM1;WNT7A;APOE;PYGL;TSPAN1;NAGLU;F2R;LRP5;PLD3;OSBPL5;LPCAT4;PITPNC1;HMGA2;OBSCN;NDRG1;IDH2;ZKSCAN1;NEK9;CRAT;ELK3;ITPR3;PKN1;MTA1;GRAMD4;ACOT7;ARRDC1;ANGEL1;ACSF2;NISCH;AKR7A2;EGFR;RPS6KA2;SERPINE2;DNPH1;WWTR1;LOXL1;OBSL1;NOS1;VAT1;PTPRS;TMEM129;SLC2A9;HADH;CTSO;SPRY2;CAPN2;MST1R;NFATC4;TRIM65;BAHCC1;CRTAP;LTBP4;PRSS8;SYTL1;SDC1;ETV5;LMF1;APPL2;SHC1;DDB2;LTBP2;VPS11;LTBP1;TBC1D14;ARL2;HEXB;SLC7A8;TCFL5;PTPRE;NPEPL1;SLC2A3;ALDH4A1;TK2;ACTA2;ETV4;SNX9;TRNP1;RAPGEF3;TXNRD3;ST6GALNAC2;ZFP36L1;GAA;GLUL;ARAP1;MAP2K2;KDSR;NME4;ZC3H6;MARCH9;CTBS;FKBP9;MDFI;PTOV1;SMARCA1;SUGCT;PGLS;PC;FOXQ1;RNF44;MAP2K1;NAPRT;CRYL1;ACP5;CPT2;VWA5A;MCTP1;MXD4;POU2F2;ENDOG;MARCKSL1;TMEM8A;GALE;SMURF2;KLC2;TSC22D1;ARMCX2;OXLD1;SLC9A3R2;FOS;FBLN1;SMAD3;ARHGAP23;STAT6;SHANK2;PIK3R2;ERCC6;LRP1;SRD5A3;DVL1;EPAS1;DNAJB5;PIGQ;HSD17B8;HBEGF;FAM110C;RPUSD3;AP2A2;S100A4;ITGB4;CYBRD1;PPP2R3B;PRDX5;STOM;BRD3;PRODH;SALL2;MBOAT7;CDK18;REEP4;LY6K;ZXDC;RNF187;ADARB1;PLCXD2;D2HGDH;SYT8;AKT1;TPCN1;CORO1B;TTYH3;HDAC5;UROS;S100A6;F12;PITPNM1;ENTPD6;RHBDF2;PYCR2;BSG;STK39;HK1;SERPING1;ASAP2;SCMH1;DYSF;GGT1;PHC2;NFKBIZ;VEGFB;ASH2L;MARCH4;SLC15A4;ATG16L2;ZFYVE21;CNTN1;IFNGR2;BRSK1;PTHLH;RAB31;FGFR4;HEBP1;WNT2B;POLD4;FNDC4;LDLR;FGFR1;PRKACB;FUCA1;MAPKBP1;SIGMAR1;RAC2;KCNAB2;PFKL;SEC14L2;HLTF;MXI1;NPHP4;SYNE3;RAG1;GAMT;H2AFJ;B4GAT1;PACS2;PHF7;TOMM34;BPHL;PIGV;KLF7;RALGDS;SORL1;NAT14;CEACAM1;B3GAT3;CIRBP;CBR4;HMG20B;LZTS2;RAB11FIP4;TENM2;ZNF385A;NSMCE4A;ABCD1;ANK3;NIPSNAP1;IGFBP4;EVC;TSHZ1;TRAPPC9;CCND1;TCF25;LHPP;TWF2;STRADB;MAPK13;CEP250;CARD19;PLAU;GAS6;PTK6;PFKP;CSNK1E;R3HDM4;BRI3;CTSB;RAB3B;CARD11;SOX13;LAMA5;DUSP7;MPLKIP;GSN;MAPKAPK3;IGFBP2;PCSK9;ARHGAP22;RAD23A;DHTKD1;PHLDA1;ANO8;BCR;ANTXR2;XPOT;MRPS6;EHD4;ERRFI1;GLI4;WIPF1;HLCS;ZSCAN18;AIP;DBNDD1;MYEF2;SH3D19;CCDC113;CDC25B;SH3GLB2;ARHGAP27;ALOX15B;SPTB;SMARCD2;AGAP1;COMTD1;PEX10;CCS;GGACT;RSAD1;COL13A1;CORO7;OAF;DGKQ;HAGH;BNIP3;PAK6;NOL4L;GTF2IRD1;MVB12B;SERINC2;TAGLN3;FYCO1;CEMIP;PROCR;PKD2;ACY1;GPX3;PCSK1;RETSAT;YPEL3;CTSZ;HES2;CRTC1;FBXW8;GPSM1;AP3D1;ITGB5;ABCA2;MAGEF1;PRSS3;C19ORF33;EPHB2;ADAM8;ASIC1;CADM4;APRT;TMEM9;CTBP1;LTA4H;MNT;PTPDC1;CDKN1C;PLCG1;ZMIZ2;CBS;CD81;CEBPB;ENTPD2;ADAMTS13;ZNF217;TIMP2;ZNF862;NUDCD2;WNT3;DPP7;GNAL;TMED4;TGFB1;LACTB2;SNPH;CLTCL1;RFX2;SCYL1;ABHD17C;SNTB2;ULK2;GPC1;MKNK2;ADAMTS7;DEAF1;MOAP1;SLC38A10;NTSR1;B3GNT3;NAB2;TMEM173;ZSCAN30;ATP7B;SHANK3;PODXL2;SDHA;MSRB2;PNRC1;MIPEP;MGAT4B;MDH2;MPG;GALNS;CLCA2;HEXDC;GOLGA2P5;ABHD8;NSMF;PEG3;ARAP3;TUB;DIRC2;CROCC;RHOD;ABHD14B;LAMB2;ABTB1;SNX17;RNH1;ERO1B;ST6GALNAC6;VGF;POLL;POLM;SNX33;PI4K2A;SEMA4F;C1ORF210;PTMS;RHOF;YIPF3;ANKZF1;WASF3;ATG2A;SLC48A1;LLGL1;PHGDH;PHF21A;MIF4GD;COA5;RHOBTB2;UBXN4;ADAM19;KHDRBS3;TUBG2;BBS1;HMGCL;PTPN1;PEX1;TPP1;PCK2;B4GALT2;WDR59;AGRN;MBD3;CD320;ESYT2;ZDHHC24;ACP6;B4GALT6;VHL;CEP131;TRAP1;IDUA;ADAP1;PFKFB2;RFNG;MLXIPL;YPEL5;TRIB2;PRKCZ;KDM6B;PRKACA;MINK1;ZNF516;CENPH;GRHPR;OXA1L;RABGGTA;ACTR1B;TOM1L2;CD9;EPN2;ADA;AREG;MPI;MICALL2;UCKL1;PLEKHG5;BOK;WDR18;TDRKH;CAPG;ALAS1;NEURL1B;ERBB2;ULK1;CNDP2;AHCY;VAMP2;CERCAM;PRIMPOL;TMEM143;TFDP2;C6ORF89;MZT2A;NECAB3;STK17A;RILPL1;FAM50A;JAK3;IRF2BP2;RNPEP;NET1;BNIP3L;CYFIP2;FSCN1;PBX2;NELFCD;SLC22A17;PDK1;ACAD10;CYGB;ARHGAP44;THOP1;EHBP1L1;MCFD2;PRKCD;FAM20C;MIB2;REEP6;RBL2;STUB1;IFI6;BAX;CYC1;SV2A;SBF1;DTD1;XYLT2;ITGA1;OLFM2;ZNF395;HIST3H2BB;CCDC92;NUBP2;PPCS;SH3BP1;GJB4;RPS6KA5;DGUOK;DUSP4;KLHDC2;TIMM17B;ZNF524;SOX12;TMBIM4;DDIT4;MBTPS2;ACADS;TOP3B;PPL;PPP1R13L;CARF;HSD17B7;AHNAK2;PCSK1N;MT2A;IER2;HPCAL1;CES2;NAGA;ZDHHC8;TMX4;MZT2B;FCHO1;NID1;LIMK1;TGFBR3;NTPCR;PDIA5;GDI1;PADI3;DIP2A;LTB4R2;CPNE7;SLC2A11;LEMD2;RPS6KA6;TMEM92;ZHX3;DNM1;WASH3P;RGS14;TMEM8B;SCN8A;MFNG;GSTO1;GIT1;ALDOC;MRPS26;MSLN;LPCAT1;ADAM15;REEP2;EHD3;WDR60;ST3GAL3;TMEM231;LONP2;SYMPK;MAPK12;IRAK1;PPOX;TGFA;HDAC7;FHOD1;CHD2;PI4K2B;CBX7;CHEK2;DECR2;ZFPM1;PPARA;COG7;COQ2;SESN2;ABCG1;MYO1D;JADE2;CDC34;RNF123;SNN;SOX7;ABCA7;RAB12;SPEG;SIX5;BCAP31;MIF;ACO2;SMOX;KDM4B;SLC25A29;DOPEY2;PHYH;ZNF414;MEX3A;BCAM;SLC9A7;PLA2G6;DDT;SSBP4;SYNGR1;NUDT14;ECM1;NARF;WFS1;QSOX1;CD68;ZNF444;SLC22A18;SPPL2B;HSD11B1L;FYN;VWA1;UPP1;EFEMP2;STK25;RAC3;ETFB;GLB1L2;CERS4;SUN1;FLYWCH1;ACAP3;ARID5B;HOXC5;DNM2;CKMT1A;CYP3A5;BHLHE40;GLB1;PELI1;SNX15;CAT;BEX2;NEIL1;TSPYL2;IGFBP7;ARMCX1;SLC27A1;ZMYM3;TPBG;APOBEC3C;SATB1;SLC50A1;ZDHHC1;SLC12A4;PLCB3;H1FX;IQSEC1;ZNF606;APOBEC3F;DDX50;CYP2R1;TUBB6;MAPK3;CBLN3;INSR;SLC13A3;RTN2;PAN2;GRINA;PDZD2;CAMTA2;TAZ;PFKM;ADCY1;C12ORF66;RERE;HLA-G;STX10;TSTA3;INO80C;ATP8B2;GPT2;RALGAPA1;PDXK;ETAA1;PRAF2;GLRX;VANGL2;PAK1;TRIM45;CDYL2;DCAF10;MALL;CAMKK2;RNASET2;PPP3CB;RNF144A;LGALS3BP;CTSF;ROBO4;USP21;PFKFB3;MLYCD;CUL7;SLC37A2;REV1;HYAL1;SEMA4C;CAPRIN2;ZBTB10;WDTC1;HES7;ITGA3;DNMT3A;SAMD8;BIN1;VPS16;MAN2B1;TSTD1;HES6;SLC16A13;MAP2K3;NDST2;BCL2L1;SGSM2;ABHD10;NDUFV3;RRAS;DNASE1L1;PROX1;IARS2;LRCH4;TBC1D16;ALDH7A1;LMNA;PKD1;KCTD13;TNFRSF25;SIRT2;FAM129B;ITGA4;EDA;UVSSA;ANKRD13D;GAL3ST4;NMNAT2;BACH1;NT5C1B;TRIP10;E2F5;ZBTB22;ALG12;AZIN2;TEP1;ZNF704;SERPINB1;ST3GAL2;ICA1;SLC25A37;RAP1GAP2;LAMB1;SOCS7;HSDL1;RGS19;HSD11B1;GTF2IRD2;RAB40B;NGFR;TOLLIP;BCORL1;PDCD6;ATP6V1F;PCLO;ARVCF;CHST14;BIVM;ZNF837;RNASE7;PHYKPL;PLEKHM1;DUSP23;GCH1;LURAP1;MAFF;NR2F6;CBX6;NBEAL2;PNMA1;CAMK1;CAMKK1;EZH1;SIRT3;HFE;TERC;ZNF513;WIPI2;COL6A1;BTG1;VPS51;CELSR1;TACC1;MLF2;SEMA3B;SEPT6;CDK11B;PFN2;C2CD2;SSH3;FGFR3;MFSD10;TST;ST3GAL5;TNRC18;NDRG2;MAN2B2;CBLC;ITPKB;PTGR2;SPTLC2;TCEA2;ZBTB47;PLAG1;CLK3;IRF2BPL;DHX32;KDM3A;PM20D2;TMEM187;FAM214B;TBL3;PKN3;APBA1;DEDD2;AK3;SRSF5;CHPF;SLC26A11;LRRK1;AARS;SDC2
13480,GO:0055029,0.999999174424495,1.31218998328501e-05,1,127,nuclear DNA-directed RNA polymerase complex,CC,ERCC1
2860,GO:0006355,0.999999175463535,1.1859466534862e-06,235,2840,regulation of transcription, DNA-templated,BP,TNIP1;MEF2D;ZMYND8;CITED4;HTRA1;EGR1;NR1D1;APLN;PDCD4;CTNNBIP1;ACVR2B;PRNP;VEGFA;WNT7A;APOE;F2R;LRP5;ITGA6;HMGA2;ZKSCAN1;ELK3;PKN1;MTA1;EGFR;WWTR1;NOS1;NFATC4;BAHCC1;ETV5;SHC1;HEXB;TCFL5;ETV4;TRNP1;ZFP36L1;MAP2K2;ZC3H6;MDFI;PTOV1;SMARCA1;RBCK1;FOXQ1;MAP2K1;MXD4;POU2F2;SMURF2;TSC22D1;FOS;SMAD3;STAT6;PIK3R2;ERCC6;DVL1;EPAS1;DNAJB5;PRDX5;BRD3;SALL2;ZXDC;RNF187;AKT1;HDAC5;PPM1F;SCMH1;NFKBIZ;ASH2L;IMPACT;WWC3;DAP;FGFR1;SEC14L2;HLTF;MXI1;H2AFJ;KLF7;NAT14;HMG20B;TENM2;ZNF385A;TSHZ1;TRAPPC9;CCND1;TCF25;MAPK13;GAS6;CARD11;SOX13;ARHGAP22;GLI4;ZSCAN18;MYEF2;MN1;SMARCD2;DGKQ;PAK6;GTF2IRD1;TAGLN3;PKD2;HES2;CRTC1;ABCA2;ADAM8;CTBP1;MNT;CDKN1C;ZMIZ2;CD81;CEBPB;ZNF217;ZNF862;TGFB1;RFX2;SCYL1;DEAF1;NAB2;TMEM173;ZSCAN30;MSRB2;PNRC1;PEG3;MC1R;ABHD14B;PHF21A;KHDRBS3;AGRN;MBD3;LRP4;VHL;MLXIPL;PRKCZ;KDM6B;ZNF516;PIM2;ERBB2;TFDP2;IRF2BP2;PBX2;NELFCD;RBL2;ZNF395;EREG;RPS6KA5;ZNF524;SOX12;MBTPS2;PPP1R13L;CARF;IER2;TGFBR3;LEMD2;ZHX3;RGS14;MAPK12;IRAK1;TGFA;HDAC7;FHOD1;CHD2;CBX7;CHEK2;ZFPM1;PPARA;SESN2;ABCG1;SOX7;SIX5;KDM4B;ZNF414;SSBP4;ECM1;WFS1;ZNF444;ARID5B;HOXC5;DNM2;BHLHE40;PELI1;CAT;TSPYL2;ZMYM3;SATB1;ZNF606;MAPK3;INSR;CAMTA2;PFKM;RERE;INO80C;BCL7A;CAMKK2;PPP3CB;USP21;CAPRIN2;ZBTB10;WDTC1;HES7;ITGA3;DNMT3A;PPP2R5B;HES6;MAP2K3;PROX1;ADGRF1;PKD1;SIRT2;FAM129B;EDA;BACH1;E2F5;ZBTB22;MAPRE3;ZNF704;MAP3K10;GTF2IRD2;NGFR;BCORL1;ZNF837;MAFF;NR2F6;CBX6;CAMK1;EZH1;HFE;ZNF513;BTG1;ZP3;MLF2;CDK11B;TNRC18;TCEA2;ZBTB47;PLAG1;IRF2BPL;KDM3A;DEDD2
12914,GO:0051276,0.999999264596795,1.33555744234123e-06,67,1049,chromosome organization,BP,ERCC1;ZMYND8;H1F0;XPC;VEGFA;HMGA2;PKN1;MTA1;NOS1;BAHCC1;DDB2;SMARCA1;BRD3;HDAC5;PPM1F;SCMH1;ASH2L;POLD4;HLTF;RAG1;H2AFJ;HMG20B;HLCS;SMARCD2;CTBP1;TGFB1;PHF21A;TUBG2;MBD3;KDM6B;CENPH;RCCD1;C6ORF89;PRKCD;RBL2;HIST3H2BB;RPS6KA5;TOP3B;PADI3;LEMD2;HDAC7;MTHFR;CHD2;CBX7;ZFPM1;JADE2;KDM4B;SUN1;ARID5B;TSPYL2;SATB1;H1FX;MAPK3;RERE;INO80C;USP21;DNMT3A;SIRT2;TEP1;NDE1;BCORL1;CBX6;EZH1;SIRT3;TERC;TNRC18;KDM3A
202,GO:0000428,0.999999266158543,1.17566325845619e-05,1,128,DNA-directed RNA polymerase complex,CC,ERCC1
18436,GO:1903506,0.999999345291673,9.44147380932513e-07,236,2857,regulation of nucleic acid-templated transcription,BP,TNIP1;MEF2D;ZMYND8;CITED4;HTRA1;EGR1;NR1D1;APLN;PDCD4;CTNNBIP1;ACVR2B;PRNP;VEGFA;WNT7A;APOE;F2R;LRP5;ITGA6;HMGA2;ZKSCAN1;ELK3;PKN1;MTA1;EGFR;WWTR1;NOS1;NFATC4;BAHCC1;ETV5;SHC1;HEXB;TCFL5;ETV4;TRNP1;ZFP36L1;MAP2K2;ZC3H6;MDFI;PTOV1;SMARCA1;RBCK1;FOXQ1;MAP2K1;MXD4;POU2F2;SMURF2;TSC22D1;FOS;SMAD3;STAT6;PIK3R2;ERCC6;DVL1;EPAS1;DNAJB5;PRDX5;BRD3;SALL2;ZXDC;RNF187;AKT1;HDAC5;PPM1F;SCMH1;NFKBIZ;ASH2L;IMPACT;WWC3;DAP;FGFR1;SEC14L2;HLTF;MXI1;H2AFJ;KLF7;NAT14;HMG20B;TENM2;ZNF385A;TSHZ1;TRAPPC9;CCND1;TCF25;MAPK13;GAS6;CARD11;SOX13;ARHGAP22;GLI4;ZSCAN18;AIP;MYEF2;MN1;SMARCD2;DGKQ;PAK6;GTF2IRD1;TAGLN3;PKD2;HES2;CRTC1;ABCA2;ADAM8;CTBP1;MNT;CDKN1C;ZMIZ2;CD81;CEBPB;ZNF217;ZNF862;TGFB1;RFX2;SCYL1;DEAF1;NAB2;TMEM173;ZSCAN30;MSRB2;PNRC1;PEG3;MC1R;ABHD14B;PHF21A;KHDRBS3;AGRN;MBD3;LRP4;VHL;MLXIPL;PRKCZ;KDM6B;ZNF516;PIM2;ERBB2;TFDP2;IRF2BP2;PBX2;NELFCD;RBL2;ZNF395;EREG;RPS6KA5;ZNF524;SOX12;MBTPS2;PPP1R13L;CARF;IER2;TGFBR3;LEMD2;ZHX3;RGS14;MAPK12;IRAK1;TGFA;HDAC7;FHOD1;CHD2;CBX7;CHEK2;ZFPM1;PPARA;SESN2;ABCG1;SOX7;SIX5;KDM4B;ZNF414;SSBP4;ECM1;WFS1;ZNF444;ARID5B;HOXC5;DNM2;BHLHE40;PELI1;CAT;TSPYL2;ZMYM3;SATB1;ZNF606;MAPK3;INSR;CAMTA2;PFKM;RERE;INO80C;BCL7A;CAMKK2;PPP3CB;USP21;CAPRIN2;ZBTB10;WDTC1;HES7;ITGA3;DNMT3A;PPP2R5B;HES6;MAP2K3;PROX1;ADGRF1;PKD1;SIRT2;FAM129B;EDA;BACH1;E2F5;ZBTB22;MAPRE3;ZNF704;MAP3K10;GTF2IRD2;NGFR;BCORL1;ZNF837;MAFF;NR2F6;CBX6;CAMK1;EZH1;HFE;ZNF513;BTG1;ZP3;MLF2;CDK11B;TNRC18;TCEA2;ZBTB47;PLAG1;IRF2BPL;KDM3A;DEDD2
342,GO:0000956,0.999999357367647,4.66432136941123e-06,3,200,nuclear-transcribed mRNA catabolic process,BP,ZFP36L1;PNRC1;PAN2
7079,GO:0030880,0.999999380747493,1.00314417333194e-05,1,130,RNA polymerase complex,CC,ERCC1
20235,GO:2001141,0.999999388209529,8.83062605092067e-07,236,2859,regulation of RNA biosynthetic process,BP,TNIP1;MEF2D;ZMYND8;CITED4;HTRA1;EGR1;NR1D1;APLN;PDCD4;CTNNBIP1;ACVR2B;PRNP;VEGFA;WNT7A;APOE;F2R;LRP5;ITGA6;HMGA2;ZKSCAN1;ELK3;PKN1;MTA1;EGFR;WWTR1;NOS1;NFATC4;BAHCC1;ETV5;SHC1;HEXB;TCFL5;ETV4;TRNP1;ZFP36L1;MAP2K2;ZC3H6;MDFI;PTOV1;SMARCA1;RBCK1;FOXQ1;MAP2K1;MXD4;POU2F2;SMURF2;TSC22D1;FOS;SMAD3;STAT6;PIK3R2;ERCC6;DVL1;EPAS1;DNAJB5;PRDX5;BRD3;SALL2;ZXDC;RNF187;AKT1;HDAC5;PPM1F;SCMH1;NFKBIZ;ASH2L;IMPACT;WWC3;DAP;FGFR1;SEC14L2;HLTF;MXI1;H2AFJ;KLF7;NAT14;HMG20B;TENM2;ZNF385A;TSHZ1;TRAPPC9;CCND1;TCF25;MAPK13;GAS6;CARD11;SOX13;ARHGAP22;GLI4;ZSCAN18;AIP;MYEF2;MN1;SMARCD2;DGKQ;PAK6;GTF2IRD1;TAGLN3;PKD2;HES2;CRTC1;ABCA2;ADAM8;CTBP1;MNT;CDKN1C;ZMIZ2;CD81;CEBPB;ZNF217;ZNF862;TGFB1;RFX2;SCYL1;DEAF1;NAB2;TMEM173;ZSCAN30;MSRB2;PNRC1;PEG3;MC1R;ABHD14B;PHF21A;KHDRBS3;AGRN;MBD3;LRP4;VHL;MLXIPL;PRKCZ;KDM6B;ZNF516;PIM2;ERBB2;TFDP2;IRF2BP2;PBX2;NELFCD;RBL2;ZNF395;EREG;RPS6KA5;ZNF524;SOX12;MBTPS2;PPP1R13L;CARF;IER2;TGFBR3;LEMD2;ZHX3;RGS14;MAPK12;IRAK1;TGFA;HDAC7;FHOD1;CHD2;CBX7;CHEK2;ZFPM1;PPARA;SESN2;ABCG1;SOX7;SIX5;KDM4B;ZNF414;SSBP4;ECM1;WFS1;ZNF444;ARID5B;HOXC5;DNM2;BHLHE40;PELI1;CAT;TSPYL2;ZMYM3;SATB1;ZNF606;MAPK3;INSR;CAMTA2;PFKM;RERE;INO80C;BCL7A;CAMKK2;PPP3CB;USP21;CAPRIN2;ZBTB10;WDTC1;HES7;ITGA3;DNMT3A;PPP2R5B;HES6;MAP2K3;PROX1;ADGRF1;PKD1;SIRT2;FAM129B;EDA;BACH1;E2F5;ZBTB22;MAPRE3;ZNF704;MAP3K10;GTF2IRD2;NGFR;BCORL1;ZNF837;MAFF;NR2F6;CBX6;CAMK1;EZH1;HFE;ZNF513;BTG1;ZP3;MLF2;CDK11B;TNRC18;TCEA2;ZBTB47;PLAG1;IRF2BPL;KDM3A;DEDD2
18022,GO:1902494,0.999999399329894,1.04408692648326e-06,82,1232,catalytic complex,CC,ERCC1;BTBD2;FBXO2;KLHL29;APPL2;DDB2;GTPBP1;NUDCD3;SMARCA1;RBCK1;SMURF2;PIK3R2;PIGQ;PPP2R3B;SALL2;FBXW5;HDAC5;PHC2;ASH2L;POLD4;MAPKBP1;PFKL;PIGV;CBR4;NSMCE4A;CCND1;RAD23A;DHTKD1;SMARCD2;SHARPIN;FBXW8;ABCA2;ZNF217;GNAL;SDHA;FBXO17;ABTB1;DNAH1;FBXO44;PHF21A;ZER1;MBD3;VHL;KDM6B;RABGGTA;ULK1;PDK1;MIB2;STUB1;CYC1;FBXW4;CUL9;ASB1;WDR60;HDAC7;CBX7;SESN2;JADE2;ABCA7;WFS1;INSR;PFKM;RERE;INO80C;DCAF10;KLHL36;PPP3CB;RNF144A;CUL7;PPP2R5B;NDUFV3;ZYG11B;KCTD13;BACH1;TEP1;RGS19;PDCD6;EZH1;TERC;SPTLC2;KLHL24;STRN4
15475,GO:0071826,0.999999450418284,3.35884780912375e-06,4,204,ribonucleoprotein complex subunit organization,BP,GRB7;CIRBP;WDR18;SRSF5
2474,GO:0005694,0.999999490413171,9.96879096535289e-07,52,880,chromosome,CC,ERCC1;MEF2D;H1F0;NR1D1;HMGA2;CAPN2;BAHCC1;APPL2;TRNP1;SMARCA1;SMAD3;STAT6;SALL2;SCMH1;PHC2;ASH2L;POLD4;H2AFJ;HMG20B;ZNF385A;NSMCE4A;HLCS;SMARCD2;ZMIZ2;CEBPB;NUDCD2;NSMF;MBD3;KDM6B;CENPH;RCCD1;RBL2;HIST3H2BB;TOP3B;LEMD2;CBX7;CHEK2;NEIL1;SATB1;H1FX;INO80C;ETAA1;DNMT3A;SIRT2;UVSSA;TEP1;NDE1;CBX6;TERC;SEPT6;TNRC18;KDM3A
2890,GO:0006401,0.999999500789699,1.74822017064318e-06,11,346,RNA catabolic process,BP,GTPBP1;ZFP36L1;AKT1;CIRBP;PCBP4;PNRC1;RNH1;PRKCD;PAN2;RNASET2;DEDD2
2463,GO:0005681,0.999999501257867,3.6886021797863e-06,3,181,spliceosomal complex,CC,MAPKBP1;TEP1;DHX32
17312,GO:0140110,0.999999621507135,6.3454857936734e-07,101,1413,transcription regulator activity,MF,MEF2D;ZMYND8;CITED4;EGR1;NR1D1;HMGA2;ZKSCAN1;ELK3;PKN1;MTA1;WWTR1;NFATC4;ETV5;TCFL5;ETV4;ZFP36L1;ZC3H6;FOXQ1;MXD4;POU2F2;TSC22D1;FOS;SMAD3;STAT6;EPAS1;SALL2;ZXDC;NFKBIZ;HLTF;MXI1;KLF7;ZNF385A;TSHZ1;CCND1;TCF25;SOX13;GLI4;ZSCAN18;AIP;MYEF2;SMARCD2;GTF2IRD1;HES2;CTBP1;MNT;ZMIZ2;CEBPB;ZNF217;RFX2;DEAF1;NAB2;ZSCAN30;MSRB2;PEG3;PHF21A;MLXIPL;KDM6B;ZNF516;GRHPR;TFDP2;PBX2;RBL2;ZNF395;ZNF524;SOX12;PPP1R13L;CARF;IER2;ZHX3;HDAC7;ZFPM1;PPARA;SOX7;SIX5;SSBP4;ZNF444;ARID5B;HOXC5;BHLHE40;ZMYM3;SATB1;ZNF606;CAMTA2;RERE;CDYL2;USP21;HES7;HES6;PROX1;FAM129B;BACH1;E2F5;MAP3K10;GTF2IRD2;ZNF837;MAFF;NR2F6;EZH1;BTG1;PLAG1;KDM3A
6020,GO:0019080,0.999999675733452,3.22916740188126e-06,2,184,viral gene expression,BP,HMGA2;NELFCD
2891,GO:0006402,0.999999748054405,1.00109558517586e-06,9,322,mRNA catabolic process,BP,GTPBP1;ZFP36L1;AKT1;CIRBP;PCBP4;PNRC1;RNH1;PRKCD;PAN2
2558,GO:0005840,0.999999772282354,1.74071761786011e-06,3,225,ribosome,CC,MRPS6;RPL39L;MRPS26
35,GO:0000070,0.999999896881683,1.87128040319574e-06,1,142,mitotic sister chromatid segregation,BP,TUBG2
10789,GO:0044271,0.999999911462488,1.2585056966456e-07,335,3963,cellular nitrogen compound biosynthetic process,BP,TNIP1;NT5E;XDH;MEF2D;ZMYND8;CITED4;HTRA1;EGR1;NR1D1;APLN;PDCD4;CTNNBIP1;NAGS;ACVR2B;PRNP;VEGFA;PGM1;WNT7A;APOE;F2R;LRP5;ITGA6;HMGA2;IDH2;ZKSCAN1;ELK3;PKN1;MTA1;ACOT7;EGFR;DNPH1;WWTR1;NOS1;NFATC4;BAHCC1;ETV5;SHC1;HEXB;GTPBP1;TCFL5;TK2;ETV4;TRNP1;RAPGEF3;ZFP36L1;MAP2K2;NME4;ZC3H6;MDFI;PTOV1;SMARCA1;RBCK1;FOXQ1;MAP2K1;NAPRT;ACP5;MXD4;POU2F2;SMURF2;TSC22D1;FOS;SMAD3;STAT6;PIK3R2;ERCC6;DVL1;EPAS1;DNAJB5;PRDX5;BRD3;SALL2;ZXDC;RNF187;NMRK1;ADORA2B;AKT1;GRB7;HDAC5;UROS;PPM1F;HK1;SCMH1;GGT1;NFKBIZ;ASH2L;IMPACT;WWC3;DAP;PTHLH;FGFR4;POLD4;FGFR1;PFKL;SEC14L2;OPLAH;HLTF;MXI1;H2AFJ;KLF7;NAT14;CIRBP;HMG20B;TENM2;ZNF385A;TSHZ1;TRAPPC9;CCND1;TCF25;LHPP;MAPK13;GAS6;PFKP;CARD11;SOX13;ARHGAP22;DHTKD1;MRPS6;GLI4;NADK;PANK4;ZSCAN18;AIP;MYEF2;MN1;SMARCD2;RSAD1;NPR2;DGKQ;HAGH;PAK6;GTF2IRD1;TAGLN3;PKD2;PCSK1;HES2;CRTC1;ABCA2;ZNF598;ADAM8;APRT;CTBP1;MNT;CDKN1C;ZMIZ2;CD81;CEBPB;ENTPD2;ZNF217;TIMP2;ZNF862;C8ORF88;TGFB1;RFX2;SCYL1;UNK;MKNK2;DEAF1;NAB2;TMEM173;ZSCAN30;MSRB2;PNRC1;PEG3;MC1R;ABHD14B;ABTB1;ST6GALNAC6;POLL;POLM;PHF21A;MIF4GD;KHDRBS3;AGRN;MBD3;LRP4;B4GALT6;VHL;TRAP1;PFKFB2;MLXIPL;PRKCZ;KDM6B;ZNF516;ADA;PIM2;MPI;UCKL1;ALAS1;ERBB2;CNDP2;PRIMPOL;TFDP2;IRF2BP2;CYFIP2;PBX2;NELFCD;PRKCD;RBL2;BAX;CYC1;ZNF395;PPCS;EREG;RPS6KA5;DGUOK;ZNF524;SOX12;DDIT4;MBTPS2;PPP1R13L;CARF;IER2;TGFBR3;LTB4R2;RPL39L;LEMD2;ZHX3;RGS14;ALDOC;MRPS26;SYMPK;MAPK12;IRAK1;PPOX;TGFA;HDAC7;FHOD1;CHD2;CBX7;CHEK2;ZFPM1;PPARA;SESN2;ABCG1;SOX7;SIX5;SMOX;KDM4B;ZNF414;MEX3A;PLA2G6;SSBP4;ECM1;WFS1;ZNF444;DALRD3;UPP1;EEF2K;CERS4;ARID5B;HOXC5;DNM2;BHLHE40;PELI1;CAT;NEIL1;TSPYL2;ZMYM3;SATB1;ZNF606;MAPK3;INSR;CAMTA2;TAZ;PFKM;ADCY1;RERE;TSTA3;INO80C;PDXK;BCL7A;CAMKK2;PPP3CB;USP21;PFKFB3;GABBR1;REV1;CAPRIN2;ZBTB10;WDTC1;HES7;ITGA3;DNMT3A;SAMD8;PPP2R5B;HES6;MAP2K3;PROX1;IARS2;ADGRF1;ALDH7A1;PKD1;SIRT2;FAM129B;EDA;NMNAT2;BACH1;NT5C1B;ADCY7;E2F5;ZBTB22;MAPRE3;AZIN2;TEP1;ZNF704;MAP3K10;GTF2IRD2;NGFR;BCORL1;ZNF837;GCH1;MAFF;NR2F6;CBX6;CAMK1;EZH1;HFE;TERC;ZNF513;BTG1;ZP3;MLF2;CDK11B;ST3GAL5;TNRC18;SPTLC2;TCEA2;ZBTB47;PLAG1;IRF2BPL;KDM3A;DEDD2;SRSF5;ADCY6;AARS
16877,GO:0098813,0.999999912156229,4.57422205958896e-07,6,253,nuclear chromosome segregation,BP,TUBG2;CENPH;LEMD2;SUN1;SIRT2;NDE1
7310,GO:0031326,0.999999912400509,1.26960751569619e-07,280,3362,regulation of cellular biosynthetic process,BP,TNIP1;MEF2D;ZMYND8;CITED4;HTRA1;EGR1;NR1D1;CST3;CYP27B1;APLN;PDCD4;CTNNBIP1;ACVR2B;PRNP;VEGFA;WNT7A;APOE;F2R;LRP5;ITGA6;HMGA2;ZKSCAN1;ELK3;PKN1;MTA1;EGFR;WWTR1;NOS1;NFATC4;BAHCC1;ETV5;SHC1;HEXB;TCFL5;ETV4;TRNP1;RAPGEF3;ZFP36L1;MAP2K2;ZC3H6;MDFI;PTOV1;SMARCA1;RBCK1;FOXQ1;MAP2K1;ACP5;MXD4;POU2F2;SMURF2;TSC22D1;FOS;SMAD3;STAT6;PIK3R2;ERCC6;DVL1;EPAS1;DNAJB5;HBEGF;PRDX5;BRD3;SALL2;ZXDC;RNF187;ADORA2B;AKT1;GRB7;HDAC5;PPM1F;SCMH1;NFKBIZ;ASH2L;IMPACT;WWC3;DAP;PTHLH;FGFR4;LDLR;FGFR1;SEC14L2;HLTF;MXI1;H2AFJ;KLF7;NAT14;CEACAM1;CIRBP;HMG20B;TENM2;ZNF385A;TSHZ1;TRAPPC9;CCND1;TCF25;MAPK13;GAS6;CARD11;SOX13;ARHGAP22;ERRFI1;GLI4;ZSCAN18;AIP;MYEF2;MN1;SMARCD2;DGKQ;PAK6;GTF2IRD1;TAGLN3;PKD2;HES2;CRTC1;ABCA2;ZNF598;ADAM8;CTBP1;MNT;CDKN1C;ZMIZ2;CD81;CEBPB;ZNF217;TIMP2;ZNF862;C8ORF88;TGFB1;RFX2;SCYL1;UNK;MKNK2;DEAF1;NTSR1;NAB2;TMEM173;ZSCAN30;MSRB2;PNRC1;PEG3;MC1R;ABHD14B;PHF21A;MIF4GD;KHDRBS3;AGRN;MBD3;LRP4;VHL;TRAP1;PFKFB2;MLXIPL;TRIB2;PRKCZ;KDM6B;ZNF516;AREG;PIM2;WDR18;ERBB2;TFDP2;NECAB3;JAK3;IRF2BP2;CYFIP2;PBX2;NELFCD;PDK1;PRKCD;RBL2;ZNF395;EREG;RPS6KA5;ZNF524;SOX12;DDIT4;MBTPS2;PPP1R13L;CARF;IER2;TGFBR3;LTB4R2;LEMD2;ZHX3;RGS14;LPCAT1;ASB1;MAPK12;IRAK1;TGFA;HDAC7;FHOD1;INPP5D;CHD2;CBX7;CHEK2;ZFPM1;PPARA;SESN2;ABCG1;SOX7;ABCA7;SIX5;KDM4B;ZNF414;MEX3A;PLA2G6;SSBP4;ECM1;WFS1;ZNF444;ARID5B;HOXC5;DNM2;BHLHE40;PELI1;CAT;TSPYL2;SLC27A1;ZMYM3;SATB1;ZNF606;MAPK3;INSR;CAMTA2;TAZ;PFKM;RERE;INO80C;BCL7A;CAMKK2;PPP3CB;USP21;PFKFB3;GABBR1;CAPRIN2;ZBTB10;WDTC1;HES7;ITGA3;DNMT3A;SAMD8;PPP2R5B;HES6;MAP2K3;PROX1;ADGRF1;PKD1;KCTD13;SIRT2;FAM129B;EDA;BACH1;E2F5;ZBTB22;MAPRE3;ZNF704;MAP3K10;GTF2IRD2;NGFR;BCORL1;ZNF837;MAFF;NR2F6;CBX6;CAMK1;EZH1;HFE;ZNF513;BTG1;ZP3;MLF2;CDK11B;TNRC18;TCEA2;ZBTB47;PLAG1;IRF2BPL;KDM3A;DEDD2
10898,GO:0044451,0.99999991841004,1.60407102036614e-07,59,975,nucleoplasm part,CC,ERCC1;H1F0;NR1D1;OBSCN;WWTR1;NFATC4;BAHCC1;APPL2;SMURF2;ERCC6;EPAS1;SALL2;HDAC5;NFKBIZ;ASH2L;PHF7;HMG20B;TENM2;NSMCE4A;LHPP;PTK6;DGKQ;CRTC1;ZNF217;MKNK2;PHF21A;MBD3;KDM6B;PRKACA;WDR18;STK17A;BNIP3L;NELFCD;CYGB;SBF1;KLHDC2;LIMK1;RGS14;HDAC7;CHEK2;JADE2;CDC34;FLYWCH1;BHLHE40;SATB1;RERE;INO80C;LRCH4;LMNA;KCTD13;SIRT2;TOLLIP;EZH1;TERC;TNRC18;TCEA2;PLAG1;CLK3;SRSF5
16475,GO:0097159,0.99999994178113,8.18061148363992e-08,404,4632,organic cyclic compound binding,MF,NT5E;XDH;ERCC1;MEF2D;ZMYND8;H1F0;EGR1;NR1D1;SLC16A3;H6PD;CYP27B1;PDCD4;ACVR2B;XPC;PYGB;APOE;PYGL;DGKA;OSBPL5;HMGA2;OBSCN;IDH2;ZKSCAN1;NEK9;ELK3;PKN1;MTA1;ACSF2;EGFR;RPS6KA2;NOS1;HADH;MST1R;NFATC4;BAHCC1;ETV5;DDB2;VPS11;ARL2;GTPBP1;TCFL5;TK2;ACTA2;ETV4;TRNP1;RAPGEF3;TXNRD3;ZFP36L1;GLUL;MAP2K2;NME4;ZC3H6;FKBP9;SMARCA1;PC;FOXQ1;MAP2K1;CRYL1;NYNRIN;MXD4;POU2F2;ENDOG;MARK4;FOS;SMAD3;STAT6;ERCC6;LRP1;EPAS1;HSD17B8;RPUSD3;S100A4;PRDX5;PRODH;SALL2;CDK18;ZXDC;NMRK1;ADARB1;D2HGDH;AKT1;GRB7;HDAC5;STK39;HK1;EPHA1;PHC2;ASH2L;BRSK1;RAB31;FGFR4;HEBP1;FGFR1;PRKACB;MAPKBP1;RAC2;PFKL;TTLL12;SEC14L2;OPLAH;HLTF;MXI1;RAG1;H2AFJ;KLF7;NAT14;CIRBP;CBR4;HMG20B;ZNF385A;ABCD1;TSHZ1;PCBP4;TCF25;TWF2;STRADB;MAPK13;PTK6;PFKP;CSNK1E;R3HDM4;RAB3B;SOX13;MAPKAPK3;PCSK9;RAD23A;DHTKD1;BCR;XPOT;MRPS6;EHD4;GLI4;SEPT10;NADK;PANK4;HLCS;ZSCAN18;MYEF2;PAQR6;SMARCD2;KHNYN;AGAP1;NPR2;DGKQ;PAK6;GTF2IRD1;FYCO1;HES2;ABCA2;ZNF598;EPHB2;APRT;CTBP1;LTA4H;MNT;GRK6;CBS;KIF17;CEBPB;MVD;ENTPD2;ZNF217;ZNF862;SYNJ2;GNAL;LACTB2;RFX2;SCYL1;UNK;SNTB2;ULK2;MKNK2;DEAF1;TMEM173;ZSCAN30;ATP7B;SDHA;PIP5KL1;KIF26B;MDH2;MPG;PEG3;RHOD;TNS1;ABTB1;DNAH1;HTR7;POLL;POLM;PI4K2A;RHOF;ANKZF1;SLC48A1;PHGDH;ARL10;PHF21A;MIF4GD;KIF7;RHOBTB2;KHDRBS3;TUBG2;PTPN1;PEX1;PCK2;MBD3;CD320;OSBPL10;TRAP1;PFKFB2;MLXIPL;PRKCZ;KDM6B;PRKACA;MINK1;ZNF516;GRHPR;ACTR1B;ADA;PIM2;UCKL1;TDRKH;ALAS1;ERBB2;ULK1;AHCY;TFDP2;STK17A;FAM50A;JAK3;CYFIP2;FSCN1;PBX2;NELFCD;PDK1;ACAD10;CYGB;PRKCD;FAM20C;RBL2;CYC1;DTD1;ZNF395;HIST3H2BB;NUBP2;RPS6KA5;DGUOK;ZNF524;CUL9;SOX12;ACADS;TOP3B;CARF;AHNAK2;IER2;RASL10B;LIMK1;NTPCR;RPL39L;LEMD2;RPS6KA6;ZHX3;DNM1;SCN8A;MRPS26;EHD3;LONP2;MAPK12;IRAK1;PPOX;MTHFR;CHD2;PI4K2B;CHEK2;ZFPM1;PPARA;ABCG1;MYO1D;MYH15;CDC34;SOX7;ABCA7;RAB12;SPEG;SIX5;ZNF414;MEX3A;SSBP4;ZNF444;DALRD3;FYN;C11ORF68;STK25;RAC3;EEF2K;CERS4;FLYWCH1;ARID5B;HOXC5;DNM2;CKMT1A;CYP3A5;BHLHE40;CHKA;CAT;NEIL1;TSPYL2;SLC27A1;ZMYM3;APOBEC3C;SATB1;KIF26A;ZDHHC1;H1FX;ZNF606;APOBEC3F;DDX50;CYP2R1;TUBB6;MAPK3;INSR;ARHGEF1;PAN2;CAMTA2;PFKM;ADCY1;RERE;ATP8B2;GPT2;PDXK;PAK1;CAMKK2;RNASET2;ALPK1;PFKFB3;REV1;MICAL1;CAPRIN2;ZBTB10;HES7;STK32C;DNMT3A;SRMS;NSUN7;HES6;MAP2K3;NDUFV3;RRAS;DNASE1L1;PROX1;IARS2;SIRT2;GAL3ST4;NMNAT2;BACH1;NT5C1B;ADCY7;E2F5;ZBTB22;LTB4R;TEP1;RAB28;ZNF704;MAP3K10;HSD11B1;GTF2IRD2;RAB40B;ZNF837;RNASE7;PHYKPL;GCH1;KIF13B;MAFF;NR2F6;CBX6;CAMK1;CAMKK1;SIRT3;TERC;ZNF513;BBS10;MLF2;SEPT6;CDK11B;FGFR3;TST;TNRC18;ITPKB;SPTLC2;TCEA2;CDC42BPG;ZBTB47;PLAG1;CLK3;DHX32;KDM3A;TBL3;PKN3;TTLL3;DEDD2;AK3;SRSF5;ADCY6;LRRK1;AARS
4335,GO:0009889,0.999999956490438,6.35358087153879e-08,283,3412,regulation of biosynthetic process,BP,TNIP1;MEF2D;ZMYND8;CITED4;HTRA1;EGR1;NR1D1;CST3;CYP27B1;APLN;PDCD4;CTNNBIP1;ACVR2B;PRNP;VEGFA;WNT7A;APOE;F2R;LRP5;ITGA6;HMGA2;ZKSCAN1;ELK3;PKN1;MTA1;EGFR;WWTR1;NOS1;NFATC4;BAHCC1;ETV5;SHC1;HEXB;TCFL5;ETV4;TRNP1;RAPGEF3;ZFP36L1;MAP2K2;ZC3H6;MDFI;PTOV1;SMARCA1;RBCK1;FOXQ1;MAP2K1;ACP5;MXD4;POU2F2;SMURF2;TSC22D1;FOS;SMAD3;STAT6;PIK3R2;ERCC6;DVL1;EPAS1;DNAJB5;HBEGF;PRDX5;BRD3;SALL2;ZXDC;RNF187;ADORA2B;AKT1;GRB7;HDAC5;PPM1F;SCMH1;NFKBIZ;ASH2L;IMPACT;WWC3;DAP;PTHLH;FGFR4;LDLR;FGFR1;SEC14L2;HLTF;MXI1;H2AFJ;KLF7;NAT14;CEACAM1;CIRBP;HMG20B;TENM2;ZNF385A;TSHZ1;TRAPPC9;CCND1;TCF25;MAPK13;GAS6;CARD11;SOX13;ARHGAP22;ERRFI1;GLI4;ZSCAN18;AIP;MYEF2;MN1;SMARCD2;DGKQ;PAK6;GTF2IRD1;TAGLN3;PKD2;HES2;CRTC1;ABCA2;ZNF598;ADAM8;CTBP1;MNT;CDKN1C;ZMIZ2;CD81;CEBPB;MVD;ZNF217;TIMP2;ZNF862;C8ORF88;TGFB1;RFX2;SCYL1;UNK;MKNK2;DEAF1;NTSR1;NAB2;TMEM173;ZSCAN30;MSRB2;PNRC1;PEG3;MC1R;ABHD14B;PHF21A;MIF4GD;KHDRBS3;AGRN;MBD3;LRP4;VHL;TRAP1;PFKFB2;MLXIPL;TRIB2;PRKCZ;KDM6B;ZNF516;AREG;PIM2;WDR18;ERBB2;TFDP2;NECAB3;JAK3;IRF2BP2;CYFIP2;PBX2;NELFCD;PDK1;CYGB;PRKCD;RBL2;ZNF395;EREG;RPS6KA5;ZNF524;SOX12;DDIT4;MBTPS2;PPP1R13L;CARF;IER2;TGFBR3;LTB4R2;LEMD2;ZHX3;RGS14;LPCAT1;ASB1;MAPK12;IRAK1;TGFA;HDAC7;FHOD1;INPP5D;CHD2;CBX7;CHEK2;ZFPM1;PPARA;SESN2;ABCG1;SOX7;ABCA7;SIX5;KDM4B;ZNF414;MEX3A;PLA2G6;SSBP4;ECM1;WFS1;ZNF444;ARID5B;HOXC5;DNM2;BHLHE40;PELI1;CAT;TSPYL2;IGFBP7;SLC27A1;ZMYM3;SATB1;ZNF606;MAPK3;INSR;CAMTA2;TAZ;PFKM;RERE;INO80C;BCL7A;CAMKK2;PPP3CB;USP21;PFKFB3;GABBR1;CAPRIN2;ZBTB10;WDTC1;HES7;ITGA3;DNMT3A;SAMD8;PPP2R5B;HES6;MAP2K3;PROX1;ADGRF1;PKD1;KCTD13;SIRT2;FAM129B;EDA;BACH1;E2F5;ZBTB22;MAPRE3;ZNF704;MAP3K10;GTF2IRD2;NGFR;BCORL1;ZNF837;MAFF;NR2F6;CBX6;CAMK1;EZH1;HFE;ZNF513;BTG1;ZP3;MLF2;CDK11B;TNRC18;TCEA2;ZBTB47;PLAG1;IRF2BPL;KDM3A;DEDD2
17648,GO:1901363,0.999999962613894,5.28763597099269e-08,399,4595,heterocyclic compound binding,MF,NT5E;XDH;ERCC1;MEF2D;ZMYND8;H1F0;EGR1;NR1D1;SLC16A3;H6PD;CYP27B1;PDCD4;ACVR2B;XPC;PYGB;PYGL;DGKA;HMGA2;OBSCN;IDH2;ZKSCAN1;NEK9;ELK3;PKN1;MTA1;ACSF2;EGFR;RPS6KA2;NOS1;HADH;MST1R;NFATC4;BAHCC1;ETV5;DDB2;VPS11;ARL2;GTPBP1;TCFL5;TK2;ACTA2;ETV4;TRNP1;RAPGEF3;TXNRD3;ZFP36L1;GLUL;MAP2K2;NME4;ZC3H6;FKBP9;SMARCA1;PC;FOXQ1;MAP2K1;CRYL1;NYNRIN;MXD4;POU2F2;ENDOG;MARK4;FOS;SMAD3;STAT6;ERCC6;LRP1;EPAS1;HSD17B8;RPUSD3;S100A4;PRDX5;PRODH;SALL2;CDK18;ZXDC;NMRK1;ADARB1;D2HGDH;AKT1;GRB7;HDAC5;STK39;HK1;EPHA1;PHC2;ASH2L;BRSK1;RAB31;FGFR4;HEBP1;FGFR1;PRKACB;MAPKBP1;RAC2;PFKL;TTLL12;SEC14L2;OPLAH;HLTF;MXI1;RAG1;H2AFJ;KLF7;NAT14;CIRBP;CBR4;HMG20B;ZNF385A;ABCD1;TSHZ1;PCBP4;TCF25;TWF2;STRADB;MAPK13;PTK6;PFKP;CSNK1E;R3HDM4;RAB3B;SOX13;MAPKAPK3;PCSK9;RAD23A;DHTKD1;BCR;XPOT;MRPS6;EHD4;GLI4;SEPT10;NADK;PANK4;HLCS;ZSCAN18;MYEF2;SMARCD2;KHNYN;AGAP1;NPR2;DGKQ;PAK6;GTF2IRD1;FYCO1;HES2;ABCA2;ZNF598;EPHB2;APRT;CTBP1;LTA4H;MNT;GRK6;CBS;KIF17;CEBPB;MVD;ENTPD2;ZNF217;ZNF862;SYNJ2;GNAL;LACTB2;RFX2;SCYL1;UNK;SNTB2;ULK2;MKNK2;DEAF1;TMEM173;ZSCAN30;ATP7B;SDHA;PIP5KL1;KIF26B;MDH2;MPG;PEG3;RHOD;TNS1;ABTB1;DNAH1;HTR7;POLL;POLM;PI4K2A;RHOF;ANKZF1;SLC48A1;PHGDH;ARL10;PHF21A;MIF4GD;KIF7;RHOBTB2;KHDRBS3;TUBG2;PTPN1;PEX1;PCK2;MBD3;CD320;TRAP1;PFKFB2;MLXIPL;PRKCZ;KDM6B;PRKACA;MINK1;ZNF516;GRHPR;ACTR1B;ADA;PIM2;UCKL1;TDRKH;ALAS1;ERBB2;ULK1;AHCY;TFDP2;STK17A;FAM50A;JAK3;CYFIP2;FSCN1;PBX2;NELFCD;PDK1;ACAD10;CYGB;PRKCD;FAM20C;RBL2;CYC1;DTD1;ZNF395;HIST3H2BB;NUBP2;RPS6KA5;DGUOK;ZNF524;CUL9;SOX12;ACADS;TOP3B;CARF;AHNAK2;IER2;RASL10B;LIMK1;NTPCR;RPL39L;LEMD2;RPS6KA6;ZHX3;DNM1;SCN8A;MRPS26;EHD3;LONP2;MAPK12;IRAK1;PPOX;MTHFR;CHD2;PI4K2B;CHEK2;ZFPM1;PPARA;ABCG1;MYO1D;MYH15;CDC34;SOX7;ABCA7;RAB12;SPEG;SIX5;ZNF414;MEX3A;SSBP4;ZNF444;DALRD3;FYN;C11ORF68;STK25;RAC3;EEF2K;CERS4;FLYWCH1;ARID5B;HOXC5;DNM2;CKMT1A;CYP3A5;BHLHE40;CHKA;CAT;NEIL1;TSPYL2;SLC27A1;ZMYM3;APOBEC3C;SATB1;KIF26A;ZDHHC1;H1FX;ZNF606;APOBEC3F;DDX50;CYP2R1;TUBB6;MAPK3;INSR;ARHGEF1;PAN2;CAMTA2;PFKM;ADCY1;RERE;ATP8B2;GPT2;PDXK;PAK1;CAMKK2;RNASET2;ALPK1;PFKFB3;REV1;MICAL1;CAPRIN2;ZBTB10;HES7;STK32C;DNMT3A;SRMS;NSUN7;HES6;MAP2K3;NDUFV3;RRAS;DNASE1L1;PROX1;IARS2;SIRT2;GAL3ST4;NMNAT2;BACH1;NT5C1B;ADCY7;E2F5;ZBTB22;LTB4R;TEP1;RAB28;ZNF704;MAP3K10;GTF2IRD2;RAB40B;ZNF837;RNASE7;PHYKPL;GCH1;KIF13B;MAFF;NR2F6;CBX6;CAMK1;CAMKK1;SIRT3;TERC;ZNF513;BBS10;MLF2;SEPT6;CDK11B;FGFR3;TST;TNRC18;ITPKB;SPTLC2;TCEA2;CDC42BPG;ZBTB47;PLAG1;CLK3;DHX32;KDM3A;TBL3;PKN3;TTLL3;DEDD2;AK3;SRSF5;ADCY6;LRRK1;AARS
3338,GO:0007059,0.999999972114797,1.28768797622315e-07,8,301,chromosome segregation,BP,TUBG2;CENPH;TOP3B;LEMD2;RGS14;SUN1;SIRT2;NDE1
2868,GO:0006364,0.999999972716884,1.90983822979168e-07,4,255,rRNA processing,BP,CSNK1E;RRNAD1;WDR18;TBL3
12897,GO:0051252,0.99999998823733,1.78402389258884e-08,243,3034,regulation of RNA metabolic process,BP,TNIP1;MEF2D;ZMYND8;CITED4;HTRA1;EGR1;NR1D1;APLN;PDCD4;CTNNBIP1;ACVR2B;PRNP;VEGFA;WNT7A;APOE;F2R;LRP5;ITGA6;HMGA2;ZKSCAN1;ELK3;PKN1;MTA1;EGFR;WWTR1;NOS1;NFATC4;BAHCC1;ETV5;SHC1;HEXB;GTPBP1;TCFL5;ETV4;TRNP1;ZFP36L1;MAP2K2;ZC3H6;MDFI;PTOV1;SMARCA1;RBCK1;FOXQ1;MAP2K1;MXD4;POU2F2;SMURF2;TSC22D1;FOS;SMAD3;STAT6;PIK3R2;ERCC6;DVL1;EPAS1;DNAJB5;PRDX5;BRD3;SALL2;ZXDC;RNF187;AKT1;HDAC5;PPM1F;SCMH1;NFKBIZ;ASH2L;IMPACT;WWC3;DAP;FGFR1;SEC14L2;HLTF;MXI1;H2AFJ;KLF7;NAT14;CIRBP;HMG20B;TENM2;ZNF385A;TSHZ1;TRAPPC9;CCND1;PCBP4;TCF25;MAPK13;GAS6;CARD11;SOX13;ARHGAP22;GLI4;ZSCAN18;AIP;MYEF2;MN1;SMARCD2;DGKQ;PAK6;GTF2IRD1;TAGLN3;PKD2;HES2;CRTC1;ABCA2;ADAM8;CTBP1;MNT;CDKN1C;ZMIZ2;CD81;CEBPB;ZNF217;ZNF862;TGFB1;RFX2;SCYL1;DEAF1;NAB2;TMEM173;ZSCAN30;MSRB2;PNRC1;PEG3;MC1R;ABHD14B;PHF21A;KHDRBS3;AGRN;MBD3;LRP4;VHL;MLXIPL;PRKCZ;KDM6B;ZNF516;PIM2;ERBB2;TFDP2;IRF2BP2;PBX2;NELFCD;PRKCD;RBL2;ZNF395;EREG;RPS6KA5;ZNF524;SOX12;MBTPS2;PPP1R13L;CARF;AHNAK2;IER2;TGFBR3;LEMD2;ZHX3;RGS14;MAPK12;IRAK1;TGFA;HDAC7;FHOD1;CHD2;CBX7;CHEK2;ZFPM1;PPARA;SESN2;ABCG1;SOX7;SIX5;KDM4B;ZNF414;SSBP4;ECM1;WFS1;ZNF444;ARID5B;HOXC5;DNM2;BHLHE40;PELI1;CAT;TSPYL2;ZMYM3;SATB1;ZNF606;MAPK3;INSR;CAMTA2;PFKM;RERE;INO80C;BCL7A;CAMKK2;PPP3CB;USP21;CAPRIN2;ZBTB10;WDTC1;HES7;ITGA3;DNMT3A;PPP2R5B;HES6;MAP2K3;PROX1;ADGRF1;PKD1;SIRT2;FAM129B;EDA;BACH1;E2F5;ZBTB22;MAPRE3;ZNF704;MAP3K10;GTF2IRD2;NGFR;BCORL1;ZNF837;MAFF;NR2F6;CBX6;CAMK1;EZH1;HFE;ZNF513;BTG1;ZP3;MLF2;CDK11B;TNRC18;TCEA2;ZBTB47;PLAG1;CLK3;IRF2BPL;KDM3A;DEDD2;SRSF5
2856,GO:0006351,0.999999988425543,1.7606810323394e-08,238,2987,transcription, DNA-templated,BP,TNIP1;MEF2D;ZMYND8;CITED4;HTRA1;EGR1;NR1D1;APLN;PDCD4;CTNNBIP1;ACVR2B;PRNP;VEGFA;WNT7A;APOE;F2R;LRP5;ITGA6;HMGA2;ZKSCAN1;ELK3;PKN1;MTA1;EGFR;WWTR1;NOS1;NFATC4;BAHCC1;ETV5;SHC1;HEXB;TCFL5;ETV4;TRNP1;ZFP36L1;MAP2K2;ZC3H6;MDFI;PTOV1;SMARCA1;RBCK1;FOXQ1;MAP2K1;MXD4;POU2F2;SMURF2;TSC22D1;FOS;SMAD3;STAT6;PIK3R2;ERCC6;DVL1;EPAS1;DNAJB5;PRDX5;BRD3;SALL2;ZXDC;RNF187;AKT1;HDAC5;PPM1F;SCMH1;NFKBIZ;ASH2L;IMPACT;WWC3;DAP;FGFR1;SEC14L2;HLTF;MXI1;H2AFJ;KLF7;NAT14;HMG20B;TENM2;ZNF385A;TSHZ1;TRAPPC9;CCND1;TCF25;MAPK13;GAS6;CARD11;SOX13;ARHGAP22;GLI4;ZSCAN18;MYEF2;MN1;SMARCD2;DGKQ;PAK6;GTF2IRD1;TAGLN3;PKD2;HES2;CRTC1;ABCA2;ADAM8;CTBP1;MNT;CDKN1C;ZMIZ2;CD81;CEBPB;ZNF217;ZNF862;TGFB1;RFX2;SCYL1;DEAF1;NAB2;TMEM173;ZSCAN30;MSRB2;PNRC1;PEG3;MC1R;ABHD14B;PHF21A;KHDRBS3;AGRN;MBD3;LRP4;VHL;MLXIPL;PRKCZ;KDM6B;ZNF516;PIM2;ERBB2;TFDP2;IRF2BP2;PBX2;NELFCD;RBL2;BAX;ZNF395;EREG;RPS6KA5;ZNF524;SOX12;MBTPS2;PPP1R13L;CARF;IER2;TGFBR3;LEMD2;ZHX3;RGS14;SYMPK;MAPK12;IRAK1;TGFA;HDAC7;FHOD1;CHD2;CBX7;CHEK2;ZFPM1;PPARA;SESN2;ABCG1;SOX7;SIX5;KDM4B;ZNF414;SSBP4;ECM1;WFS1;ZNF444;ARID5B;HOXC5;DNM2;BHLHE40;PELI1;CAT;TSPYL2;ZMYM3;SATB1;ZNF606;MAPK3;INSR;CAMTA2;PFKM;RERE;INO80C;BCL7A;CAMKK2;PPP3CB;USP21;CAPRIN2;ZBTB10;WDTC1;HES7;ITGA3;DNMT3A;PPP2R5B;HES6;MAP2K3;PROX1;ADGRF1;PKD1;SIRT2;FAM129B;EDA;BACH1;E2F5;ZBTB22;MAPRE3;ZNF704;MAP3K10;GTF2IRD2;NGFR;BCORL1;ZNF837;MAFF;NR2F6;CBX6;CAMK1;EZH1;HFE;ZNF513;BTG1;ZP3;MLF2;CDK11B;TNRC18;TCEA2;ZBTB47;PLAG1;IRF2BPL;KDM3A;DEDD2;SRSF5
5335,GO:0016072,0.99999998907217,6.88468814560313e-08,5,284,rRNA metabolic process,BP,CSNK1E;RRNAD1;WDR18;TBL3;DEDD2
8083,GO:0032774,0.999999989501099,1.59702497679553e-08,240,3011,RNA biosynthetic process,BP,TNIP1;MEF2D;ZMYND8;CITED4;HTRA1;EGR1;NR1D1;APLN;PDCD4;CTNNBIP1;ACVR2B;PRNP;VEGFA;WNT7A;APOE;F2R;LRP5;ITGA6;HMGA2;ZKSCAN1;ELK3;PKN1;MTA1;EGFR;WWTR1;NOS1;NFATC4;BAHCC1;ETV5;SHC1;HEXB;TCFL5;ETV4;TRNP1;ZFP36L1;MAP2K2;ZC3H6;MDFI;PTOV1;SMARCA1;RBCK1;FOXQ1;MAP2K1;MXD4;POU2F2;SMURF2;TSC22D1;FOS;SMAD3;STAT6;PIK3R2;ERCC6;DVL1;EPAS1;DNAJB5;PRDX5;BRD3;SALL2;ZXDC;RNF187;AKT1;HDAC5;PPM1F;SCMH1;NFKBIZ;ASH2L;IMPACT;WWC3;DAP;FGFR1;SEC14L2;HLTF;MXI1;H2AFJ;KLF7;NAT14;HMG20B;TENM2;ZNF385A;TSHZ1;TRAPPC9;CCND1;TCF25;MAPK13;GAS6;CARD11;SOX13;ARHGAP22;GLI4;ZSCAN18;AIP;MYEF2;MN1;SMARCD2;DGKQ;PAK6;GTF2IRD1;TAGLN3;PKD2;HES2;CRTC1;ABCA2;ADAM8;CTBP1;MNT;CDKN1C;ZMIZ2;CD81;CEBPB;ZNF217;ZNF862;TGFB1;RFX2;SCYL1;DEAF1;NAB2;TMEM173;ZSCAN30;MSRB2;PNRC1;PEG3;MC1R;ABHD14B;PHF21A;KHDRBS3;AGRN;MBD3;LRP4;VHL;MLXIPL;PRKCZ;KDM6B;ZNF516;PIM2;ERBB2;PRIMPOL;TFDP2;IRF2BP2;PBX2;NELFCD;RBL2;BAX;ZNF395;EREG;RPS6KA5;ZNF524;SOX12;MBTPS2;PPP1R13L;CARF;IER2;TGFBR3;LEMD2;ZHX3;RGS14;SYMPK;MAPK12;IRAK1;TGFA;HDAC7;FHOD1;CHD2;CBX7;CHEK2;ZFPM1;PPARA;SESN2;ABCG1;SOX7;SIX5;KDM4B;ZNF414;SSBP4;ECM1;WFS1;ZNF444;ARID5B;HOXC5;DNM2;BHLHE40;PELI1;CAT;TSPYL2;ZMYM3;SATB1;ZNF606;MAPK3;INSR;CAMTA2;PFKM;RERE;INO80C;BCL7A;CAMKK2;PPP3CB;USP21;CAPRIN2;ZBTB10;WDTC1;HES7;ITGA3;DNMT3A;PPP2R5B;HES6;MAP2K3;PROX1;ADGRF1;PKD1;SIRT2;FAM129B;EDA;BACH1;E2F5;ZBTB22;MAPRE3;ZNF704;MAP3K10;GTF2IRD2;NGFR;BCORL1;ZNF837;MAFF;NR2F6;CBX6;CAMK1;EZH1;HFE;ZNF513;BTG1;ZP3;MLF2;CDK11B;TNRC18;TCEA2;ZBTB47;PLAG1;IRF2BPL;KDM3A;DEDD2;SRSF5
16700,GO:0097659,0.999999989673104,1.57204354733303e-08,239,3001,nucleic acid-templated transcription,BP,TNIP1;MEF2D;ZMYND8;CITED4;HTRA1;EGR1;NR1D1;APLN;PDCD4;CTNNBIP1;ACVR2B;PRNP;VEGFA;WNT7A;APOE;F2R;LRP5;ITGA6;HMGA2;ZKSCAN1;ELK3;PKN1;MTA1;EGFR;WWTR1;NOS1;NFATC4;BAHCC1;ETV5;SHC1;HEXB;TCFL5;ETV4;TRNP1;ZFP36L1;MAP2K2;ZC3H6;MDFI;PTOV1;SMARCA1;RBCK1;FOXQ1;MAP2K1;MXD4;POU2F2;SMURF2;TSC22D1;FOS;SMAD3;STAT6;PIK3R2;ERCC6;DVL1;EPAS1;DNAJB5;PRDX5;BRD3;SALL2;ZXDC;RNF187;AKT1;HDAC5;PPM1F;SCMH1;NFKBIZ;ASH2L;IMPACT;WWC3;DAP;FGFR1;SEC14L2;HLTF;MXI1;H2AFJ;KLF7;NAT14;HMG20B;TENM2;ZNF385A;TSHZ1;TRAPPC9;CCND1;TCF25;MAPK13;GAS6;CARD11;SOX13;ARHGAP22;GLI4;ZSCAN18;AIP;MYEF2;MN1;SMARCD2;DGKQ;PAK6;GTF2IRD1;TAGLN3;PKD2;HES2;CRTC1;ABCA2;ADAM8;CTBP1;MNT;CDKN1C;ZMIZ2;CD81;CEBPB;ZNF217;ZNF862;TGFB1;RFX2;SCYL1;DEAF1;NAB2;TMEM173;ZSCAN30;MSRB2;PNRC1;PEG3;MC1R;ABHD14B;PHF21A;KHDRBS3;AGRN;MBD3;LRP4;VHL;MLXIPL;PRKCZ;KDM6B;ZNF516;PIM2;ERBB2;TFDP2;IRF2BP2;PBX2;NELFCD;RBL2;BAX;ZNF395;EREG;RPS6KA5;ZNF524;SOX12;MBTPS2;PPP1R13L;CARF;IER2;TGFBR3;LEMD2;ZHX3;RGS14;SYMPK;MAPK12;IRAK1;TGFA;HDAC7;FHOD1;CHD2;CBX7;CHEK2;ZFPM1;PPARA;SESN2;ABCG1;SOX7;SIX5;KDM4B;ZNF414;SSBP4;ECM1;WFS1;ZNF444;ARID5B;HOXC5;DNM2;BHLHE40;PELI1;CAT;TSPYL2;ZMYM3;SATB1;ZNF606;MAPK3;INSR;CAMTA2;PFKM;RERE;INO80C;BCL7A;CAMKK2;PPP3CB;USP21;CAPRIN2;ZBTB10;WDTC1;HES7;ITGA3;DNMT3A;PPP2R5B;HES6;MAP2K3;PROX1;ADGRF1;PKD1;SIRT2;FAM129B;EDA;BACH1;E2F5;ZBTB22;MAPRE3;ZNF704;MAP3K10;GTF2IRD2;NGFR;BCORL1;ZNF837;MAFF;NR2F6;CBX6;CAMK1;EZH1;HFE;ZNF513;BTG1;ZP3;MLF2;CDK11B;TNRC18;TCEA2;ZBTB47;PLAG1;IRF2BPL;KDM3A;DEDD2;SRSF5
307,GO:0000819,0.999999990426577,8.56872696197033e-08,3,216,sister chromatid segregation,BP,TUBG2;CENPH;NDE1
6068,GO:0019219,0.999999994754857,7.98710744713859e-09,265,3279,regulation of nucleobase-containing compound metabolic process,BP,TNIP1;ERCC1;MEF2D;ZMYND8;CITED4;HTRA1;EGR1;NR1D1;CST3;APLN;PDCD4;CTNNBIP1;ACVR2B;PRNP;VEGFA;WNT7A;APOE;F2R;LRP5;ITGA6;HMGA2;ZKSCAN1;ELK3;PKN1;MTA1;EGFR;WWTR1;NOS1;NFATC4;BAHCC1;ETV5;SHC1;HEXB;GTPBP1;TCFL5;ETV4;TRNP1;RAPGEF3;ZFP36L1;MAP2K2;ZC3H6;MDFI;PTOV1;SMARCA1;RBCK1;FOXQ1;MAP2K1;MXD4;POU2F2;ENDOG;SMURF2;TSC22D1;FOS;SMAD3;STAT6;PIK3R2;ERCC6;DVL1;EPAS1;DNAJB5;PRDX5;BRD3;SALL2;ZXDC;RNF187;ADORA2B;AKT1;HDAC5;PPM1F;SCMH1;NFKBIZ;ASH2L;IMPACT;WWC3;DAP;PTHLH;FGFR4;FGFR1;SEC14L2;HLTF;MXI1;H2AFJ;KLF7;NAT14;CIRBP;HMG20B;TENM2;ZNF385A;TSHZ1;TRAPPC9;CCND1;PCBP4;TCF25;MAPK13;GAS6;CARD11;SOX13;ARHGAP22;GLI4;ZSCAN18;AIP;MYEF2;MN1;SMARCD2;DGKQ;PAK6;GTF2IRD1;TAGLN3;PKD2;HES2;CRTC1;ABCA2;MAGEF1;ADAM8;CTBP1;MNT;CDKN1C;ZMIZ2;CD81;CEBPB;ZNF217;TIMP2;ZNF862;TGFB1;RFX2;SCYL1;DEAF1;NAB2;TMEM173;ZSCAN30;MSRB2;PNRC1;PEG3;MC1R;ABHD14B;PHF21A;KHDRBS3;PTPN1;AGRN;MBD3;LRP4;VHL;PFKFB2;MLXIPL;PRKCZ;KDM6B;ZNF516;AREG;PIM2;WDR18;ERBB2;TFDP2;IRF2BP2;PBX2;NELFCD;PRKCD;RBL2;BAX;ZNF395;EREG;RPS6KA5;ZNF524;SOX12;DDIT4;MBTPS2;PPP1R13L;CARF;AHNAK2;IER2;TGFBR3;LTB4R2;LEMD2;ZHX3;RGS14;MAPK12;IRAK1;TGFA;HDAC7;FHOD1;CHD2;CBX7;CHEK2;ZFPM1;PPARA;TMEM161A;SESN2;ABCG1;SOX7;SIX5;KDM4B;ZNF414;SSBP4;ECM1;WFS1;ZNF444;ARID5B;HOXC5;DNM2;BHLHE40;PELI1;CAT;NEIL1;TSPYL2;ZMYM3;SATB1;ZNF606;MAPK3;INSR;CAMTA2;TAZ;PFKM;RERE;INO80C;BCL7A;CAMKK2;PPP3CB;USP21;PFKFB3;GABBR1;CAPRIN2;ZBTB10;WDTC1;HES7;ITGA3;DNMT3A;PPP2R5B;HES6;MAP2K3;PROX1;ADGRF1;PKD1;KCTD13;SIRT2;FAM129B;EDA;BACH1;E2F5;ZBTB22;MAPRE3;ZNF704;MAP3K10;GTF2IRD2;NGFR;BCORL1;ZNF837;MAFF;NR2F6;CBX6;CAMK1;EZH1;HFE;ZNF513;BTG1;ZP3;MLF2;CDK11B;TNRC18;TCEA2;ZBTB47;PLAG1;CLK3;IRF2BPL;KDM3A;DEDD2;SRSF5
4504,GO:0010556,0.999999997412759,3.99825339647607e-09,262,3268,regulation of macromolecule biosynthetic process,BP,TNIP1;MEF2D;ZMYND8;CITED4;HTRA1;EGR1;NR1D1;CST3;APLN;PDCD4;CTNNBIP1;ACVR2B;PRNP;VEGFA;WNT7A;APOE;F2R;LRP5;ITGA6;HMGA2;ZKSCAN1;ELK3;PKN1;MTA1;EGFR;WWTR1;NOS1;NFATC4;BAHCC1;ETV5;SHC1;HEXB;TCFL5;ETV4;TRNP1;ZFP36L1;MAP2K2;ZC3H6;MDFI;PTOV1;SMARCA1;RBCK1;FOXQ1;MAP2K1;MXD4;POU2F2;SMURF2;TSC22D1;FOS;SMAD3;STAT6;PIK3R2;ERCC6;DVL1;EPAS1;DNAJB5;HBEGF;PRDX5;BRD3;SALL2;ZXDC;RNF187;AKT1;GRB7;HDAC5;PPM1F;SCMH1;NFKBIZ;ASH2L;IMPACT;WWC3;DAP;FGFR4;FGFR1;SEC14L2;HLTF;MXI1;H2AFJ;KLF7;NAT14;CIRBP;HMG20B;TENM2;ZNF385A;TSHZ1;TRAPPC9;CCND1;TCF25;MAPK13;GAS6;CARD11;SOX13;ARHGAP22;ERRFI1;GLI4;ZSCAN18;AIP;MYEF2;MN1;SMARCD2;DGKQ;PAK6;GTF2IRD1;TAGLN3;PKD2;HES2;CRTC1;ABCA2;ZNF598;ADAM8;CTBP1;MNT;CDKN1C;ZMIZ2;CD81;CEBPB;ZNF217;ZNF862;C8ORF88;TGFB1;RFX2;SCYL1;UNK;MKNK2;DEAF1;NAB2;TMEM173;ZSCAN30;MSRB2;PNRC1;PEG3;MC1R;ABHD14B;PHF21A;MIF4GD;KHDRBS3;AGRN;MBD3;LRP4;VHL;TRAP1;MLXIPL;TRIB2;PRKCZ;KDM6B;ZNF516;AREG;PIM2;WDR18;ERBB2;TFDP2;NECAB3;JAK3;IRF2BP2;CYFIP2;PBX2;NELFCD;PRKCD;RBL2;ZNF395;EREG;RPS6KA5;ZNF524;SOX12;MBTPS2;PPP1R13L;CARF;IER2;TGFBR3;LEMD2;ZHX3;RGS14;ASB1;MAPK12;IRAK1;TGFA;HDAC7;FHOD1;INPP5D;CHD2;CBX7;CHEK2;ZFPM1;PPARA;SESN2;ABCG1;SOX7;ABCA7;SIX5;KDM4B;ZNF414;MEX3A;PLA2G6;SSBP4;ECM1;WFS1;ZNF444;ARID5B;HOXC5;DNM2;BHLHE40;PELI1;CAT;TSPYL2;ZMYM3;SATB1;ZNF606;MAPK3;INSR;CAMTA2;PFKM;RERE;INO80C;BCL7A;CAMKK2;PPP3CB;USP21;CAPRIN2;ZBTB10;WDTC1;HES7;ITGA3;DNMT3A;SAMD8;PPP2R5B;HES6;MAP2K3;PROX1;ADGRF1;PKD1;KCTD13;SIRT2;FAM129B;EDA;BACH1;E2F5;ZBTB22;MAPRE3;ZNF704;MAP3K10;GTF2IRD2;NGFR;BCORL1;ZNF837;MAFF;NR2F6;CBX6;CAMK1;EZH1;HFE;ZNF513;BTG1;ZP3;MLF2;CDK11B;TNRC18;TCEA2;ZBTB47;PLAG1;IRF2BPL;KDM3A;DEDD2
4470,GO:0010468,0.999999999060391,1.49130096447802e-09,283,3527,regulation of gene expression,BP,TNIP1;XDH;MEF2D;ZMYND8;CITED4;HTRA1;EGR1;NR1D1;APLN;PDCD4;CTNNBIP1;ACVR2B;PRNP;BBS2;VEGFA;WNT7A;APOE;F2R;LRP5;ITGA6;HMGA2;ZKSCAN1;ELK3;PKN1;MTA1;EGFR;SERPINE2;WWTR1;NOS1;SPRY2;NFATC4;BAHCC1;ETV5;SHC1;HEXB;GTPBP1;TCFL5;ACTA2;ETV4;PHLDA2;TRNP1;ZFP36L1;MAP2K2;ZC3H6;MDFI;PTOV1;SMARCA1;RBCK1;PC;FOXQ1;MAP2K1;MXD4;POU2F2;SMURF2;TSC22D1;FOS;SMAD3;STAT6;PIK3R2;ERCC6;GJC2;DVL1;EPAS1;DNAJB5;SH3PXD2B;PRDX5;BRD3;SALL2;ZXDC;RNF187;AKT1;GRB7;HDAC5;F12;PPM1F;SERPING1;SCMH1;NFKBIZ;ASH2L;IMPACT;WWC3;CNTN1;DAP;PTHLH;FGFR4;LDLR;FGFR1;PRKACB;SEC14L2;HLTF;MXI1;RAG1;H2AFJ;KLF7;NAT14;CIRBP;HMG20B;TENM2;ZNF385A;ANK3;TSHZ1;TRAPPC9;CCND1;PCBP4;TCF25;MAPK13;GAS6;CSNK1E;CARD11;SOX13;GSN;ARHGAP22;GLI4;ZSCAN18;MYEF2;MN1;SMARCD2;DGKQ;PAK6;GTF2IRD1;TAGLN3;PKD2;CTSZ;HES2;CRTC1;ABCA2;ZNF598;EPHB2;ADAM8;CTBP1;MNT;CDKN1C;ZMIZ2;CD81;CEBPB;ZNF217;ZNF862;WNT3;C8ORF88;TGFB1;RFX2;SCYL1;UNK;MKNK2;DEAF1;NAB2;TMEM173;ZSCAN30;MSRB2;PNRC1;PEG3;MC1R;ABHD14B;RNH1;PHF21A;MIF4GD;KHDRBS3;AGRN;MBD3;CAMK2N1;LRP4;VHL;TRAP1;MLXIPL;PRKCZ;KDM6B;ZNF516;PIM2;TDRKH;ERBB2;TFDP2;IRF2BP2;CYFIP2;PBX2;NELFCD;PRKCD;RBL2;ZNF395;EREG;RPS6KA5;ZNF524;SOX12;MBTPS2;PPP1R13L;CARF;AHNAK2;IER2;TGFBR3;DIP2A;LEMD2;ZHX3;RGS14;MAPK12;IRAK1;TGFA;HDAC7;FHOD1;CHD2;CBX7;CHEK2;ZFPM1;PPARA;SESN2;ABCG1;SOX7;SIX5;MIF;KDM4B;ZNF414;MEX3A;SSBP4;ECM1;WFS1;ZNF444;FYN;ARID5B;HOXC5;DNM2;BHLHE40;PELI1;CAT;TSPYL2;ZMYM3;SATB1;SLC50A1;ZNF606;MAPK3;INSR;PAN2;CAMTA2;PFKM;RERE;INO80C;BCL7A;CAMKK2;PPP3CB;USP21;CAPRIN2;ZBTB10;WDTC1;HES7;ITGA3;DNMT3A;PPP2R5B;HES6;MAP2K3;PROX1;ADGRF1;PKD1;SIRT2;FAM129B;EDA;BACH1;E2F5;ZBTB22;MAPRE3;ZNF704;MAP3K10;GTF2IRD2;NGFR;BCORL1;ZNF837;MAFF;NR2F6;CBX6;CAMK1;EZH1;HFE;ZNF513;BTG1;ZP3;MLF2;CDK11B;TNRC18;TCEA2;ZBTB47;PLAG1;CLK3;IRF2BPL;KDM3A;APBA1;DEDD2;SRSF5
19755,GO:2000112,0.999999999527757,8.23661935911172e-10,254,3220,regulation of cellular macromolecule biosynthetic process,BP,TNIP1;MEF2D;ZMYND8;CITED4;HTRA1;EGR1;NR1D1;CST3;APLN;PDCD4;CTNNBIP1;ACVR2B;PRNP;VEGFA;WNT7A;APOE;F2R;LRP5;ITGA6;HMGA2;ZKSCAN1;ELK3;PKN1;MTA1;EGFR;WWTR1;NOS1;NFATC4;BAHCC1;ETV5;SHC1;HEXB;TCFL5;ETV4;TRNP1;ZFP36L1;MAP2K2;ZC3H6;MDFI;PTOV1;SMARCA1;RBCK1;FOXQ1;MAP2K1;MXD4;POU2F2;SMURF2;TSC22D1;FOS;SMAD3;STAT6;PIK3R2;ERCC6;DVL1;EPAS1;DNAJB5;HBEGF;PRDX5;BRD3;SALL2;ZXDC;RNF187;AKT1;GRB7;HDAC5;PPM1F;SCMH1;NFKBIZ;ASH2L;IMPACT;WWC3;DAP;FGFR4;FGFR1;SEC14L2;HLTF;MXI1;H2AFJ;KLF7;NAT14;CIRBP;HMG20B;TENM2;ZNF385A;TSHZ1;TRAPPC9;CCND1;TCF25;MAPK13;GAS6;CARD11;SOX13;ARHGAP22;GLI4;ZSCAN18;MYEF2;MN1;SMARCD2;DGKQ;PAK6;GTF2IRD1;TAGLN3;PKD2;HES2;CRTC1;ABCA2;ZNF598;ADAM8;CTBP1;MNT;CDKN1C;ZMIZ2;CD81;CEBPB;ZNF217;ZNF862;C8ORF88;TGFB1;RFX2;SCYL1;UNK;MKNK2;DEAF1;NAB2;TMEM173;ZSCAN30;MSRB2;PNRC1;PEG3;MC1R;ABHD14B;PHF21A;MIF4GD;KHDRBS3;AGRN;MBD3;LRP4;VHL;TRAP1;MLXIPL;PRKCZ;KDM6B;ZNF516;AREG;PIM2;WDR18;ERBB2;TFDP2;NECAB3;JAK3;IRF2BP2;CYFIP2;PBX2;NELFCD;RBL2;ZNF395;EREG;RPS6KA5;ZNF524;SOX12;MBTPS2;PPP1R13L;CARF;IER2;TGFBR3;LEMD2;ZHX3;RGS14;MAPK12;IRAK1;TGFA;HDAC7;FHOD1;CHD2;CBX7;CHEK2;ZFPM1;PPARA;SESN2;ABCG1;SOX7;ABCA7;SIX5;KDM4B;ZNF414;MEX3A;SSBP4;ECM1;WFS1;ZNF444;ARID5B;HOXC5;DNM2;BHLHE40;PELI1;CAT;TSPYL2;ZMYM3;SATB1;ZNF606;MAPK3;INSR;CAMTA2;PFKM;RERE;INO80C;BCL7A;CAMKK2;PPP3CB;USP21;CAPRIN2;ZBTB10;WDTC1;HES7;ITGA3;DNMT3A;PPP2R5B;HES6;MAP2K3;PROX1;ADGRF1;PKD1;KCTD13;SIRT2;FAM129B;EDA;BACH1;E2F5;ZBTB22;MAPRE3;ZNF704;MAP3K10;GTF2IRD2;NGFR;BCORL1;ZNF837;MAFF;NR2F6;CBX6;CAMK1;EZH1;HFE;ZNF513;BTG1;ZP3;MLF2;CDK11B;TNRC18;TCEA2;ZBTB47;PLAG1;IRF2BPL;KDM3A;DEDD2
9909,GO:0042254,0.999999999947961,4.98130573828783e-10,4,317,ribosome biogenesis,BP,CSNK1E;RRNAD1;WDR18;TBL3
3800,GO:0008380,0.999999999952032,2.93334391444438e-10,9,391,RNA splicing,BP,MAPKBP1;KHDRBS3;AHNAK2;SYMPK;TRPT1;TEP1;CLK3;DHX32;SRSF5
8777,GO:0034470,0.999999999955738,2.87082615037762e-10,8,396,ncRNA processing,BP,SMAD3;RPUSD3;CSNK1E;RRNAD1;WDR18;TRPT1;TBL3;AARS
16418,GO:0097057,0.999999999956921,0.818668560771427,0,2,TRAF2-GSTP1 complex,CC,
1267,GO:0003032,0.999999999957546,0.792920988938112,0,2,detection of oxygen,BP,
1723,GO:0004314,0.999999999960702,0.795080777416742,0,2,[acyl-carrier-protein] S-malonyltransferase activity,MF,
5485,GO:0016419,0.999999999960702,0.795080777416742,0,2,S-malonyltransferase activity,MF,
5486,GO:0016420,0.999999999960702,0.795080777416742,0,2,malonyltransferase activity,MF,
17873,GO:1902093,0.999999999962798,0.751317531765358,0,3,positive regulation of flagellated sperm motility,BP,
19122,GO:1905041,0.999999999962823,0.792981878835467,0,2,regulation of epithelium regeneration,BP,
19524,GO:1990399,0.999999999962823,0.792981878835467,0,2,epithelium regeneration,BP,
1352,GO:0003219,0.999999999963314,0.798606441720626,0,2,cardiac right ventricle formation,BP,
1489,GO:0003826,0.999999999963643,0.797259699205901,0,2,alpha-ketoacid dehydrogenase activity,MF,
1507,GO:0003863,0.999999999963643,0.797259699205901,0,2,3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity,MF,
4848,GO:0014062,0.999999999965511,0.811167138681242,0,2,regulation of serotonin secretion,BP,
7727,GO:0032229,0.999999999965511,0.811167138681242,0,2,negative regulation of synaptic transmission, GABAergic,BP,
14728,GO:0070401,0.999999999965526,0.799772337351838,0,2,NADP+ binding,MF,
7339,GO:0031379,0.999999999965952,0.845454608255292,0,2,RNA-directed RNA polymerase complex,CC,
437,GO:0001172,0.999999999965954,0.845454608255289,0,2,transcription, RNA-templated,BP,
1565,GO:0003968,0.999999999965954,0.845454608255289,0,2,RNA-directed 5'-3' RNA polymerase activity,MF,
17480,GO:1900369,0.999999999965954,0.845454608255289,0,2,negative regulation of RNA interference,BP,
18141,GO:1902824,0.999999999966091,0.818204794006515,0,2,positive regulation of late endosome to lysosome transport,BP,
18367,GO:1903337,0.999999999966091,0.818204794006515,0,2,positive regulation of vacuolar transport,BP,
16379,GO:0090725,0.999999999966223,0.820555482337388,0,2,peripheral region of growth cone,CC,
19489,GO:1990189,0.999999999966223,0.820555482337388,0,2,peptide-serine-N-acetyltransferase activity,MF,
6868,GO:0030366,0.999999999966558,0.811462772149978,0,2,molybdopterin synthase activity,MF,
5287,GO:0015942,0.999999999966576,0.730395894152972,0,3,formate metabolic process,BP,
5412,GO:0016256,0.999999999966576,0.808786265467668,0,2,N-glycan processing to lysosome,BP,
5806,GO:0017060,0.999999999966767,0.79311784509174,0,2,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity,MF,
14134,GO:0061015,0.999999999966849,0.820708623605848,0,2,snRNA import into nucleus,BP,
9532,GO:0036284,0.999999999967015,0.802326048216219,0,2,tubulobulbar complex,CC,
5997,GO:0019008,0.999999999967016,0.804175896727631,0,2,molybdopterin synthase complex,CC,
19,GO:0000035,0.999999999967515,0.86797861036329,0,2,acyl binding,MF,
20,GO:0000036,0.999999999967515,0.86797861036329,0,2,acyl carrier activity,MF,
4171,GO:0009245,0.999999999967515,0.86797861036329,0,2,lipid A biosynthetic process,BP,
10943,GO:0044620,0.999999999967515,0.86797861036329,0,2,ACP phosphopantetheine attachment site binding,MF,
11692,GO:0046493,0.999999999967515,0.86797861036329,0,2,lipid A metabolic process,BP,
12860,GO:0051192,0.999999999967515,0.86797861036329,0,2,prosthetic group binding,MF,
17612,GO:1901269,0.999999999967515,0.86797861036329,0,2,lipooligosaccharide metabolic process,BP,
17613,GO:1901271,0.999999999967515,0.86797861036329,0,2,lipooligosaccharide biosynthetic process,BP,
439,GO:0001181,0.999999999967809,0.799963625393887,0,2,transcription factor activity, core RNA polymerase I binding,MF,
12027,GO:0047750,0.999999999967827,0.837461674020665,0,2,cholestenol delta-isomerase activity,MF,
19255,GO:1905397,0.999999999967871,0.804172414469358,0,2,activated CD8-positive, alpha-beta T cell apoptotic process,BP,
19256,GO:1905402,0.999999999967871,0.804172414469358,0,2,regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
5994,GO:0019002,0.999999999967889,0.799752160772411,0,2,GMP binding,MF,
2208,GO:0005094,0.999999999967969,0.813751622157693,0,2,Rho GDP-dissociation inhibitor activity,MF,
221,GO:0000461,0.999999999968988,0.861476990067483,0,2,endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
1249,GO:0002949,0.999999999968993,0.717452502531217,0,3,tRNA threonylcarbamoyladenosine modification,BP,
15949,GO:0075341,0.999999999969042,0.890732866844113,0,1,host cell PML body,CC,
3616,GO:0008073,0.999999999969124,0.815274245098123,0,2,ornithine decarboxylase inhibitor activity,MF,
17948,GO:1902268,0.999999999969124,0.815274245098123,0,2,negative regulation of polyamine transmembrane transport,BP,
20255,GO:2001180,0.999999999969196,0.795768824374263,0,2,negative regulation of interleukin-10 secretion,BP,
7411,GO:0031508,0.999999999969264,0.811349097230505,0,2,pericentric heterochromatin assembly,BP,
3875,GO:0008508,0.999999999969292,0.805960193921671,0,2,bile acid:sodium symporter activity,MF,
6037,GO:0019135,0.999999999969378,0.894100916955944,0,1,deoxyhypusine monooxygenase activity,MF,
175,GO:0000384,0.999999999969815,0.807110917303702,0,2,first spliceosomal transesterification activity,MF,
3058,GO:0006624,0.999999999969945,0.825655561792164,0,2,vacuolar protein processing,BP,
18092,GO:1902683,0.999999999969958,0.79283720140091,0,2,regulation of receptor localization to synapse,BP,
16313,GO:0090498,0.99999999997013,0.792946714124812,0,2,extrinsic component of Golgi membrane,CC,
9487,GO:0036128,0.999999999970977,0.795221845681999,0,2,CatSper complex,CC,
2926,GO:0006447,0.999999999971164,0.711140859509155,0,3,regulation of translational initiation by iron,BP,
4587,GO:0010693,0.999999999971164,0.711140859509155,0,3,negative regulation of alkaline phosphatase activity,BP,
13947,GO:0060664,0.999999999971164,0.711140859509155,0,3,epithelial cell proliferation involved in salivary gland morphogenesis,BP,
18333,GO:1903276,0.999999999971443,0.799877725000791,0,2,regulation of sodium ion export across plasma membrane,BP,
18334,GO:1903278,0.999999999971443,0.799877725000791,0,2,positive regulation of sodium ion export across plasma membrane,BP,
18341,GO:1903288,0.999999999971443,0.799877725000791,0,2,positive regulation of potassium ion import,BP,
12780,GO:0051083,0.999999999971508,0.79808108750066,0,2,'de novo' cotranslational protein folding,BP,
8943,GO:0034991,0.999999999971529,0.792770568263566,0,2,nuclear meiotic cohesin complex,CC,
19616,GO:1990737,0.999999999971553,0.710350646010858,0,3,response to manganese-induced endoplasmic reticulum stress,BP,
2136,GO:0004947,0.999999999971685,0.807802241925445,0,2,bradykinin receptor activity,MF,
12735,GO:0051012,0.999999999971721,0.798166637378477,0,2,microtubule sliding,BP,
15034,GO:0070985,0.999999999972072,0.815158928023146,0,2,TFIIK complex,CC,
5046,GO:0015230,0.999999999972172,0.792883428864476,0,2,FAD transmembrane transporter activity,MF,
9084,GO:0035350,0.999999999972172,0.792883428864476,0,2,FAD transmembrane transport,BP,
15972,GO:0080121,0.999999999972172,0.792883428864476,0,2,AMP transport,BP,
14746,GO:0070426,0.999999999972345,0.792522081334997,0,2,positive regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
14753,GO:0070434,0.999999999972345,0.792522081334997,0,2,positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
2997,GO:0006546,0.999999999972389,0.715696908339186,0,3,glycine catabolic process,BP,
6150,GO:0019464,0.999999999972389,0.715696908339186,0,3,glycine decarboxylation via glycine cleavage system,BP,
3115,GO:0006696,0.999999999972473,0.795128721915358,0,2,ergosterol biosynthetic process,BP,
3694,GO:0008204,0.999999999972473,0.795128721915358,0,2,ergosterol metabolic process,BP,
8167,GO:0032911,0.999999999972543,0.705769805717087,0,3,negative regulation of transforming growth factor beta1 production,BP,
18812,GO:1904351,0.999999999972543,0.705769805717087,0,3,negative regulation of protein catabolic process in the vacuole,BP,
19166,GO:1905166,0.999999999972543,0.705769805717087,0,3,negative regulation of lysosomal protein catabolic process,BP,
7413,GO:0031510,0.999999999972569,0.715328195081056,0,3,SUMO activating enzyme complex,CC,
1190,GO:0002836,0.999999999972842,0.705522781869167,0,3,positive regulation of response to tumor cell,BP,
1193,GO:0002839,0.999999999972842,0.705522781869167,0,3,positive regulation of immune response to tumor cell,BP,
5708,GO:0016838,0.999999999973149,0.820465888293243,0,2,carbon-oxygen lyase activity, acting on phosphates,MF,
7137,GO:0030984,0.999999999973168,0.81131871824292,0,2,kininogen binding,MF,
17924,GO:1902226,0.999999999973483,0.7986270503631,0,2,regulation of macrophage colony-stimulating factor signaling pathway,BP,
18663,GO:1903969,0.999999999973483,0.7986270503631,0,2,regulation of response to macrophage colony-stimulating factor,BP,
18666,GO:1903972,0.999999999973483,0.7986270503631,0,2,regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
13137,GO:0051715,0.999999999973503,0.766871758602085,0,3,cytolysis in other organism,BP,
17014,GO:0099122,0.999999999973532,0.706174312478459,0,3,RNA polymerase II C-terminal domain binding,MF,
2772,GO:0006203,0.999999999973635,0.738081506213034,0,3,dGTP catabolic process,BP,
15365,GO:0071611,0.999999999973686,0.792677636664249,0,2,granulocyte colony-stimulating factor production,BP,
15394,GO:0071655,0.999999999973686,0.792677636664249,0,2,regulation of granulocyte colony-stimulating factor production,BP,
19476,GO:1990166,0.9999999999737,0.705376094675108,0,3,protein localization to site of double-strand break,BP,
5202,GO:0015801,0.999999999973745,0.793073068584771,0,2,aromatic amino acid transport,BP,
5223,GO:0015827,0.999999999973745,0.793073068584771,0,2,tryptophan transport,BP,
5962,GO:0018352,0.999999999973793,0.798105854796688,0,2,protein-pyridoxal-5-phosphate linkage,BP,
8744,GO:0034414,0.999999999973827,0.793031867498832,0,2,tRNA 3'-trailer cleavage, endonucleolytic,BP,
10180,GO:0042779,0.999999999973827,0.793031867498832,0,2,tRNA 3'-trailer cleavage,BP,
10182,GO:0042781,0.999999999973827,0.793031867498832,0,2,3'-tRNA processing endoribonuclease activity,MF,
19197,GO:1905267,0.999999999973827,0.793031867498832,0,2,endonucleolytic cleavage involved in tRNA processing,BP,
14887,GO:0070685,0.999999999973923,0.891791167709717,0,1,macropinocytic cup,CC,
16461,GO:0097135,0.999999999974066,0.792982257812996,0,2,cyclin E2-CDK2 complex,CC,
171,GO:0000377,0.999999999974138,2.53887016563343e-10,4,298,RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,BP,KHDRBS3;SYMPK;DHX32;SRSF5
183,GO:0000398,0.999999999974138,2.53887016563343e-10,4,298,mRNA splicing, via spliceosome,BP,KHDRBS3;SYMPK;DHX32;SRSF5
5809,GO:0017064,0.999999999974189,0.796064141522915,0,2,fatty acid amide hydrolase activity,MF,
17124,GO:0102077,0.999999999974189,0.796064141522915,0,2,oleamide hydrolase activity,MF,
17188,GO:0103073,0.999999999974189,0.796064141522915,0,2,anandamide amidohydrolase activity,MF,
20319,GO:2001287,0.999999999974288,0.802014928514059,0,2,negative regulation of caveolin-mediated endocytosis,BP,
18,GO:0000033,0.999999999974337,0.719234838242825,0,3,alpha-1,3-mannosyltransferase activity,MF,
15339,GO:0071568,0.999999999974402,0.812612539551546,0,2,UFM1 transferase activity,MF,
49,GO:0000103,0.999999999974403,0.720490927160838,0,3,sulfate assimilation,BP,
9613,GO:0036482,0.999999999974441,0.818880096142618,0,2,neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
18199,GO:1902958,0.999999999974441,0.818880096142618,0,2,positive regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
18389,GO:1903383,0.999999999974441,0.818880096142618,0,2,regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,BP,
18390,GO:1903384,0.999999999974441,0.818880096142618,0,2,negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,BP,
14199,GO:0061140,0.999999999974455,0.733839570281625,0,3,lung secretory cell differentiation,BP,
11956,GO:0047179,0.999999999974555,0.83292125177791,0,2,platelet-activating factor acetyltransferase activity,MF,
2053,GO:0004802,0.999999999974586,0.891802541190318,0,1,transketolase activity,MF,
16913,GO:0098881,0.999999999974622,0.705362623012501,0,3,exocytic insertion of neurotransmitter receptor to plasma membrane,BP,
16958,GO:0098967,0.999999999974622,0.705362623012501,0,3,exocytic insertion of neurotransmitter receptor to postsynaptic membrane,BP,
6478,GO:0021826,0.999999999974735,0.792500984300459,0,2,substrate-independent telencephalic tangential migration,BP,
6481,GO:0021830,0.999999999974735,0.792500984300459,0,2,interneuron migration from the subpallium to the cortex,BP,
6485,GO:0021843,0.999999999974735,0.792500984300459,0,2,substrate-independent telencephalic tangential interneuron migration,BP,
17200,GO:0106020,0.999999999974828,0.792912536193011,0,2,regulation of vesicle docking,BP,
14557,GO:0070091,0.999999999974835,0.705051694054199,0,3,glucagon secretion,BP,
14558,GO:0070092,0.999999999974835,0.705051694054199,0,3,regulation of glucagon secretion,BP,
204,GO:0000430,0.999999999974859,0.805010660917532,0,2,regulation of transcription from RNA polymerase II promoter by glucose,BP,
206,GO:0000432,0.999999999974859,0.805010660917532,0,2,positive regulation of transcription from RNA polymerase II promoter by glucose,BP,
15103,GO:0071159,0.99999999997499,0.822237566703197,0,2,NF-kappaB complex,CC,
579,GO:0001732,0.999999999975006,0.794984517235699,0,2,formation of cytoplasmic translation initiation complex,BP,
2994,GO:0006543,0.999999999975007,0.705025882933257,0,3,glutamine catabolic process,BP,
16874,GO:0098808,0.999999999975013,0.794984517235692,0,2,mRNA cap binding,MF,
16696,GO:0097647,0.999999999975053,0.742755049521641,0,3,amylin receptor signaling pathway,BP,
2485,GO:0005731,0.999999999975058,0.896764336183855,0,1,nucleolus organizer region,CC,
3344,GO:0007072,0.999999999975058,0.896764336183855,0,1,positive regulation of transcription involved in exit from mitosis,BP,
7075,GO:0030874,0.999999999975058,0.896764336183855,0,1,nucleolar chromatin,CC,
16576,GO:0097372,0.999999999975058,0.896764336183855,0,1,NAD-dependent histone deacetylase activity (H3-K18 specific),MF,
14045,GO:0060830,0.999999999975069,0.728609267448211,0,3,ciliary receptor clustering involved in smoothened signaling pathway,BP,
15845,GO:0072563,0.999999999975125,0.800158768235613,0,2,endothelial microparticle,CC,
7361,GO:0031416,0.999999999975133,0.814425750345871,0,2,NatB complex,CC,
3528,GO:0007518,0.999999999975143,0.890470014191171,0,1,myoblast fate determination,BP,
3847,GO:0008459,0.999999999975147,0.792723893803891,0,2,chondroitin 6-sulfotransferase activity,MF,
5383,GO:0016206,0.999999999975151,0.79286510584994,0,2,catechol O-methyltransferase activity,MF,
11449,GO:0045914,0.999999999975151,0.79286510584994,0,2,negative regulation of catecholamine metabolic process,BP,
11483,GO:0045963,0.999999999975151,0.79286510584994,0,2,negative regulation of dopamine metabolic process,BP,
17125,GO:0102084,0.999999999975151,0.79286510584994,0,2,L-dopa O-methyltransferase activity,MF,
17177,GO:0102938,0.999999999975151,0.79286510584994,0,2,orcinol O-methyltransferase activity,MF,
12824,GO:0051140,0.999999999975161,0.835551371616944,0,2,regulation of NK T cell proliferation,BP,
12825,GO:0051142,0.999999999975161,0.835551371616944,0,2,positive regulation of NK T cell proliferation,BP,
18985,GO:1904753,0.9999999999752,0.709356395022736,0,3,negative regulation of vascular associated smooth muscle cell migration,BP,
2221,GO:0005124,0.999999999975262,0.890373734714059,0,1,scavenger receptor binding,MF,
5424,GO:0016277,0.999999999975262,0.890373734714059,0,1,[myelin basic protein]-arginine N-methyltransferase activity,MF,
17782,GO:1901804,0.999999999975262,0.890373734714059,0,1,beta-glucoside metabolic process,BP,
17783,GO:1901805,0.999999999975262,0.890373734714059,0,1,beta-glucoside catabolic process,BP,
18860,GO:1904457,0.999999999975262,0.890373734714059,0,1,positive regulation of neuronal action potential,BP,
10456,GO:0043321,0.999999999975325,0.792222478079585,0,2,regulation of natural killer cell degranulation,BP,
10457,GO:0043323,0.999999999975325,0.792222478079585,0,2,positive regulation of natural killer cell degranulation,BP,
13363,GO:0052593,0.999999999975354,0.792165827546933,0,2,tryptamine:oxygen oxidoreductase (deaminating) activity,MF,
13364,GO:0052594,0.999999999975354,0.792165827546933,0,2,aminoacetone:oxygen oxidoreductase(deaminating) activity,MF,
13365,GO:0052595,0.999999999975354,0.792165827546933,0,2,aliphatic-amine oxidase activity,MF,
13366,GO:0052596,0.999999999975354,0.792165827546933,0,2,phenethylamine:oxygen oxidoreductase (deaminating) activity,MF,
14820,GO:0070563,0.999999999975425,0.793813760639851,0,2,negative regulation of vitamin D receptor signaling pathway,BP,
18085,GO:1902659,0.999999999975443,0.725668008042331,0,3,regulation of glucose mediated signaling pathway,BP,
18086,GO:1902661,0.999999999975443,0.725668008042331,0,3,positive regulation of glucose mediated signaling pathway,BP,
15661,GO:0072185,0.999999999975447,0.89049304716604,0,1,metanephric cap development,BP,
15662,GO:0072186,0.999999999975447,0.89049304716604,0,1,metanephric cap morphogenesis,BP,
16110,GO:0090094,0.999999999975447,0.89049304716604,0,1,metanephric cap mesenchymal cell proliferation involved in metanephros development,BP,
16111,GO:0090095,0.999999999975447,0.89049304716604,0,1,regulation of metanephric cap mesenchymal cell proliferation,BP,
16112,GO:0090096,0.999999999975447,0.89049304716604,0,1,positive regulation of metanephric cap mesenchymal cell proliferation,BP,
11989,GO:0047408,0.999999999975501,0.797652391314412,0,2,alkenylglycerophosphocholine hydrolase activity,MF,
11990,GO:0047409,0.999999999975501,0.797652391314412,0,2,alkenylglycerophosphoethanolamine hydrolase activity,MF,
344,GO:0000958,0.999999999975519,0.705147349822341,0,3,mitochondrial mRNA catabolic process,BP,
6153,GO:0019474,0.999999999975527,0.705829430285462,0,3,L-lysine catabolic process to acetyl-CoA,BP,
6154,GO:0019477,0.999999999975527,0.705829430285462,0,3,L-lysine catabolic process,BP,
8418,GO:0033512,0.999999999975527,0.705829430285462,0,3,L-lysine catabolic process to acetyl-CoA via saccharopine,BP,
11658,GO:0046440,0.999999999975527,0.705829430285462,0,3,L-lysine metabolic process,BP,
7565,GO:0031933,0.999999999975569,0.712514059823607,0,3,telomeric heterochromatin,CC,
1779,GO:0004392,0.999999999975603,0.806979527115962,0,2,heme oxygenase (decyclizing) activity,MF,
3171,GO:0006788,0.999999999975603,0.806979527115962,0,2,heme oxidation,BP,
7502,GO:0031691,0.999999999975613,0.796590453841547,0,2,alpha-1A adrenergic receptor binding,MF,
7503,GO:0031692,0.999999999975613,0.796590453841547,0,2,alpha-1B adrenergic receptor binding,MF,
7526,GO:0031762,0.999999999975613,0.796590453841547,0,2,follicle-stimulating hormone receptor binding,MF,
10132,GO:0042699,0.999999999975613,0.796590453841547,0,2,follicle-stimulating hormone signaling pathway,BP,
18464,GO:1903542,0.999999999975676,0.793022636240974,0,2,negative regulation of exosomal secretion,BP,
14429,GO:0061741,0.999999999975708,0.794288966443069,0,2,chaperone-mediated protein transport involved in chaperone-mediated autophagy,BP,
2142,GO:0004955,0.999999999975774,0.79611536843358,0,2,prostaglandin receptor activity,MF,
15168,GO:0071306,0.999999999975774,0.79611536843358,0,2,cellular response to vitamin E,BP,
8605,GO:0034124,0.999999999975795,0.794798352984423,0,2,regulation of MyD88-dependent toll-like receptor signaling pathway,BP,
8542,GO:0033906,0.999999999975805,0.796168440952249,0,2,hyaluronoglucuronidase activity,MF,
1547,GO:0003941,0.999999999975827,0.804939690194354,0,2,L-serine ammonia-lyase activity,MF,
2224,GO:0005127,0.999999999975873,0.709259444587061,0,3,ciliary neurotrophic factor receptor binding,MF,
14845,GO:0070611,0.999999999975884,0.890051603550384,0,1,histone methyltransferase activity (H3-R2 specific),MF,
14846,GO:0070612,0.999999999975884,0.890051603550384,0,1,histone methyltransferase activity (H2A-R3 specific),MF,
17959,GO:1902298,0.999999999975913,0.79298858322199,0,2,cell cycle DNA replication maintenance of fidelity,BP,
19542,GO:1990426,0.999999999975913,0.79298858322199,0,2,mitotic recombination-dependent replication fork processing,BP,
19565,GO:1990505,0.999999999975913,0.79298858322199,0,2,mitotic DNA replication maintenance of fidelity,BP,
1266,GO:0003025,0.999999999975943,0.793275774493427,0,2,regulation of systemic arterial blood pressure by baroreceptor feedback,BP,
16496,GO:0097195,0.999999999975943,0.793275774493427,0,2,pilomotor reflex,BP,
1642,GO:0004084,0.999999999975977,0.799876711849532,0,2,branched-chain-amino-acid transaminase activity,MF,
4043,GO:0009082,0.999999999975977,0.799876711849532,0,2,branched-chain amino acid biosynthetic process,BP,
4051,GO:0009098,0.999999999975977,0.799876711849532,0,2,leucine biosynthetic process,BP,
4052,GO:0009099,0.999999999975977,0.799876711849532,0,2,valine biosynthetic process,BP,
13373,GO:0052654,0.999999999975977,0.799876711849532,0,2,L-leucine transaminase activity,MF,
13374,GO:0052655,0.999999999975977,0.799876711849532,0,2,L-valine transaminase activity,MF,
13375,GO:0052656,0.999999999975977,0.799876711849532,0,2,L-isoleucine transaminase activity,MF,
407,GO:0001093,0.999999999976049,0.709171771763384,0,3,TFIIB-class transcription factor binding,MF,
423,GO:0001129,0.999999999976049,0.709171771763384,0,3,RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly,MF,
424,GO:0001132,0.999999999976049,0.709171771763384,0,3,RNA polymerase II transcription factor activity, TBP-class protein binding,MF,
12498,GO:0050613,0.999999999976058,0.800476708169607,0,2,delta14-sterol reductase activity,MF,
657,GO:0001849,0.999999999976162,0.725090869175526,0,3,complement component C1q binding,MF,
4898,GO:0014826,0.999999999976188,0.891899227437668,0,1,vein smooth muscle contraction,BP,
6753,GO:0030185,0.999999999976188,0.891899227437668,0,1,nitric oxide transport,BP,
7441,GO:0031583,0.999999999976188,0.891899227437668,0,1,phospholipase D-activating G-protein coupled receptor signaling pathway,BP,
7512,GO:0031705,0.999999999976188,0.891899227437668,0,1,bombesin receptor binding,MF,
7513,GO:0031707,0.999999999976188,0.891899227437668,0,1,endothelin A receptor binding,MF,
7514,GO:0031708,0.999999999976188,0.891899227437668,0,1,endothelin B receptor binding,MF,
9331,GO:0035815,0.999999999976188,0.891899227437668,0,1,positive regulation of renal sodium excretion,BP,
9945,GO:0042313,0.999999999976188,0.891899227437668,0,1,protein kinase C deactivation,BP,
10359,GO:0043179,0.999999999976188,0.891899227437668,0,1,rhythmic excitation,BP,
14287,GO:0061395,0.999999999976252,0.896773597976591,0,1,positive regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance,BP,
14816,GO:0070557,0.999999999976291,0.807433950897878,0,2,PCNA-p21 complex,CC,
19920,GO:2000395,0.999999999976341,0.826052901276866,0,2,regulation of ubiquitin-dependent endocytosis,BP,
19921,GO:2000397,0.999999999976341,0.826052901276866,0,2,positive regulation of ubiquitin-dependent endocytosis,BP,
11173,GO:0045272,0.99999999997636,0.758230631528278,0,3,plasma membrane respiratory chain complex I,CC,
4097,GO:0009153,0.999999999976388,0.81895515730519,0,2,purine deoxyribonucleotide biosynthetic process,BP,
2349,GO:0005415,0.999999999976396,0.793243901134641,0,2,nucleoside:sodium symporter activity,MF,
5238,GO:0015860,0.999999999976396,0.793243901134641,0,2,purine nucleoside transmembrane transport,BP,
2454,GO:0005668,0.999999999976434,0.808794530094577,0,2,RNA polymerase transcription factor SL1 complex,CC,
8478,GO:0033634,0.999999999976608,0.72046555695761,0,3,positive regulation of cell-cell adhesion mediated by integrin,BP,
3993,GO:0008893,0.999999999976645,0.915910570112603,0,1,guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity,MF,
5681,GO:0016794,0.999999999976645,0.915910570112603,0,1,diphosphoric monoester hydrolase activity,MF,
2300,GO:0005280,0.999999999976676,0.705003703009628,0,3,amino acid:proton symporter activity,MF,
11932,GO:0047006,0.999999999976686,0.90472897369588,0,1,17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity,MF,
11941,GO:0047042,0.999999999976686,0.90472897369588,0,1,androsterone dehydrogenase (B-specific) activity,MF,
12023,GO:0047718,0.999999999976686,0.90472897369588,0,1,indanol dehydrogenase activity,MF,
3531,GO:0007525,0.999999999976699,0.792183667313797,0,2,somatic muscle development,BP,
8364,GO:0033269,0.999999999976792,0.792891669807196,0,2,internode region of axon,CC,
9235,GO:0035633,0.999999999976792,0.792891669807196,0,2,maintenance of permeability of blood-brain barrier,BP,
18946,GO:1904685,0.999999999976792,0.792891669807196,0,2,positive regulation of metalloendopeptidase activity,BP,
6296,GO:0019912,0.999999999976824,0.793684275624951,0,2,cyclin-dependent protein kinase activating kinase activity,MF,
2568,GO:0005854,0.999999999976825,0.813368081904697,0,2,nascent polypeptide-associated complex,CC,
3601,GO:0008043,0.999999999976831,0.839105372278613,0,2,intracellular ferritin complex,CC,
14670,GO:0070288,0.999999999976831,0.839105372278613,0,2,ferritin complex,CC,
16894,GO:0098840,0.999999999976842,0.82023530220614,0,2,protein transport along microtubule,BP,
17013,GO:0099118,0.999999999976842,0.82023530220614,0,2,microtubule-based protein transport,BP,
1806,GO:0004452,0.999999999976899,0.807265485734307,0,2,isopentenyl-diphosphate delta-isomerase activity,MF,
12720,GO:0050992,0.999999999976899,0.807265485734307,0,2,dimethylallyl diphosphate biosynthetic process,BP,
12721,GO:0050993,0.999999999976899,0.807265485734307,0,2,dimethylallyl diphosphate metabolic process,BP,
6224,GO:0019777,0.999999999977011,0.80928422524661,0,2,Atg12 transferase activity,MF,
9608,GO:0036476,0.999999999977046,0.735784077312012,0,3,neuron death in response to hydrogen peroxide,BP,
18311,GO:1903207,0.999999999977046,0.735784077312012,0,3,regulation of hydrogen peroxide-induced neuron death,BP,
18312,GO:1903208,0.999999999977046,0.735784077312012,0,3,negative regulation of hydrogen peroxide-induced neuron death,BP,
15387,GO:0071641,0.999999999977083,0.794760226313784,0,2,negative regulation of macrophage inflammatory protein 1 alpha production,BP,
19993,GO:2000562,0.999999999977083,0.794760226313784,0,2,negative regulation of CD4-positive, alpha-beta T cell proliferation,BP,
20061,GO:2000666,0.999999999977083,0.794760226313784,0,2,negative regulation of interleukin-13 secretion,BP,
974,GO:0002424,0.999999999977089,0.792692955270878,0,2,T cell mediated immune response to tumor cell,BP,
1194,GO:0002840,0.999999999977089,0.792692955270878,0,2,regulation of T cell mediated immune response to tumor cell,BP,
11800,GO:0046696,0.999999999977089,0.792692955270878,0,2,lipopolysaccharide receptor complex,CC,
4307,GO:0009786,0.999999999977099,0.804768879793407,0,2,regulation of asymmetric cell division,BP,
10463,GO:0043335,0.999999999977099,0.804768879793407,0,2,protein unfolding,BP,
5470,GO:0016403,0.999999999977162,0.806524851947962,0,2,dimethylargininase activity,MF,
16297,GO:0090403,0.999999999977204,0.705048575874099,0,3,oxidative stress-induced premature senescence,BP,
14405,GO:0061689,0.999999999977213,0.706966337169599,0,3,tricellular tight junction,CC,
2628,GO:0005956,0.999999999977246,0.812366261107051,0,2,protein kinase CK2 complex,CC,
19675,GO:1990911,0.999999999977315,0.795542085011934,0,2,response to psychosocial stress,BP,
14240,GO:0061300,0.999999999977319,0.801948926179607,0,2,cerebellum vasculature development,BP,
9354,GO:0035870,0.999999999977325,0.813288837721951,0,2,dITP diphosphatase activity,MF,
16762,GO:0098559,0.999999999977325,0.705199349455035,0,3,cytoplasmic side of early endosome membrane,CC,
3871,GO:0008503,0.999999999977334,0.825213911846661,0,2,benzodiazepine receptor activity,MF,
6824,GO:0030292,0.999999999977398,0.709402611591592,0,3,protein tyrosine kinase inhibitor activity,MF,
2024,GO:0004756,0.999999999977402,0.792939234319051,0,2,selenide, water dikinase activity,MF,
5414,GO:0016260,0.999999999977402,0.792939234319051,0,2,selenocysteine biosynthetic process,BP,
5671,GO:0016781,0.999999999977402,0.792939234319051,0,2,phosphotransferase activity, paired acceptors,MF,
14698,GO:0070329,0.999999999977402,0.792939234319051,0,2,tRNA seleno-modification,BP,
19016,GO:1904815,0.999999999977472,0.79536073838526,0,2,negative regulation of protein localization to chromosome, telomeric region,BP,
7242,GO:0031205,0.999999999977505,0.832944428150136,0,2,endoplasmic reticulum Sec complex,CC,
12357,GO:0048752,0.999999999977577,0.713621444080773,0,3,semicircular canal morphogenesis,BP,
12944,GO:0051316,0.999999999977665,0.79292950269457,0,2,attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation,BP,
9010,GO:0035189,0.999999999977725,0.705984547734664,0,3,Rb-E2F complex,CC,
1054,GO:0002581,0.999999999977734,0.805478489239518,0,2,negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
17915,GO:1902214,0.999999999977754,0.798367193749879,0,2,regulation of interleukin-4-mediated signaling pathway,BP,
10644,GO:0043686,0.99999999997778,0.722463085786917,0,3,co-translational protein modification,BP,
1956,GO:0004660,0.999999999977879,0.800217847777832,0,2,protein farnesyltransferase activity,MF,
2632,GO:0005965,0.999999999977879,0.800217847777832,0,2,protein farnesyltransferase complex,CC,
16085,GO:0090065,0.999999999977988,0.949928400395546,0,1,regulation of production of siRNA involved in RNA interference,BP,
16816,GO:0098680,0.999999999977988,0.949928400395546,0,1,template-free RNA nucleotidyltransferase,MF,
18533,GO:1903704,0.999999999977988,0.949928400395546,0,1,negative regulation of production of siRNA involved in RNA interference,BP,
19577,GO:1990572,0.999999999977988,0.949928400395546,0,1,TERT-RMRP complex,CC,
19254,GO:1905395,0.999999999978006,0.826008213535223,0,2,response to flavonoid,BP,
9558,GO:0036343,0.999999999978064,0.833753073888743,0,2,psychomotor behavior,BP,
8224,GO:0032996,0.999999999978093,0.89436445069023,0,1,Bcl3-Bcl10 complex,CC,
11074,GO:0045082,0.999999999978093,0.89436445069023,0,1,positive regulation of interleukin-10 biosynthetic process,BP,
6232,GO:0019785,0.999999999978185,0.794247679638083,0,2,ISG15-specific protease activity,MF,
1748,GO:0004348,0.999999999978208,0.79244540117403,0,2,glucosylceramidase activity,MF,
13272,GO:0051971,0.999999999978208,0.79244540117403,0,2,positive regulation of transmission of nerve impulse,BP,
16930,GO:0098908,0.999999999978208,0.79244540117403,0,2,regulation of neuronal action potential,BP,
2332,GO:0005350,0.999999999978242,0.793069432461699,0,2,pyrimidine nucleobase transmembrane transporter activity,MF,
5236,GO:0015855,0.999999999978242,0.793069432461699,0,2,pyrimidine nucleobase transport,BP,
19018,GO:1904823,0.999999999978242,0.793069432461699,0,2,purine nucleobase transmembrane transport,BP,
8266,GO:0033078,0.999999999978288,0.798283120641229,0,2,extrathymic T cell differentiation,BP,
3764,GO:0008311,0.999999999978333,0.805296443330507,0,2,double-stranded DNA 3'-5' exodeoxyribonuclease activity,MF,
14463,GO:0061833,0.999999999978396,0.793069432461546,0,2,protein localization to tricellular tight junction,BP,
1738,GO:0004335,0.999999999978407,0.805710598536501,0,2,galactokinase activity,MF,
18432,GO:1903487,0.999999999978409,0.79678951541801,0,2,regulation of lactation,BP,
1686,GO:0004152,0.999999999978415,0.892132666397023,0,1,dihydroorotate dehydrogenase activity,MF,
18486,GO:1903576,0.999999999978415,0.892132666397023,0,1,response to L-arginine,BP,
2036,GO:0004776,0.999999999978417,0.803730553110998,0,2,succinate-CoA ligase (GDP-forming) activity,MF,
1628,GO:0004064,0.999999999978473,0.71774484726998,0,3,arylesterase activity,MF,
14449,GO:0061783,0.999999999978501,0.734755172106124,0,3,peptidoglycan muralytic activity,MF,
1619,GO:0004047,0.99999999997851,0.804148343644253,0,2,aminomethyltransferase activity,MF,
20042,GO:2000645,0.999999999978528,0.711607071062386,0,3,negative regulation of receptor catabolic process,BP,
12528,GO:0050682,0.999999999978592,0.79297742879909,0,2,AF-2 domain binding,MF,
19103,GO:1904995,0.999999999978645,0.823165121494496,0,2,negative regulation of leukocyte adhesion to vascular endothelial cell,BP,
4301,GO:0009753,0.999999999978702,0.815789406800937,0,2,response to jasmonic acid,BP,
5978,GO:0018636,0.999999999978702,0.815789406800937,0,2,phenanthrene 9,10-monooxygenase activity,MF,
11938,GO:0047023,0.999999999978702,0.815789406800937,0,2,androsterone dehydrogenase activity,MF,
11945,GO:0047086,0.999999999978702,0.815789406800937,0,2,ketosteroid monooxygenase activity,MF,
11947,GO:0047115,0.999999999978702,0.815789406800937,0,2,trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity,MF,
15232,GO:0071395,0.999999999978702,0.815789406800937,0,2,cellular response to jasmonic acid stimulus,BP,
17787,GO:1901837,0.999999999978721,0.796510038731707,0,2,negative regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
9155,GO:0035514,0.99999999997874,0.736457598005363,0,3,DNA demethylase activity,MF,
11590,GO:0046203,0.999999999978809,0.8171262709413,0,2,spermidine catabolic process,BP,
19754,GO:2000111,0.999999999978816,0.811531811444952,0,2,positive regulation of macrophage apoptotic process,BP,
4378,GO:0010025,0.999999999978834,0.793778824485362,0,2,wax biosynthetic process,BP,
4409,GO:0010166,0.999999999978834,0.793778824485362,0,2,wax metabolic process,BP,
15962,GO:0080019,0.999999999978834,0.793778824485362,0,2,fatty-acyl-CoA reductase (alcohol-forming) activity,MF,
17179,GO:0102965,0.999999999978834,0.793778824485362,0,2,alcohol-forming fatty acyl-CoA reductase activity,MF,
7066,GO:0030860,0.99999999997886,0.79227752533265,0,2,regulation of polarized epithelial cell differentiation,BP,
15926,GO:0072717,0.999999999978867,0.740767192608963,0,3,cellular response to actinomycin D,BP,
15214,GO:0071373,0.999999999978881,0.792147038537927,0,2,cellular response to luteinizing hormone stimulus,BP,
218,GO:0000455,0.99999999997892,0.798413575657181,0,2,enzyme-directed rRNA pseudouridine synthesis,BP,
4789,GO:0010982,0.999999999978966,0.792787281079106,0,2,regulation of high-density lipoprotein particle clearance,BP,
4790,GO:0010983,0.999999999978966,0.792787281079106,0,2,positive regulation of high-density lipoprotein particle clearance,BP,
8695,GO:0034342,0.999999999978995,0.793611405307519,0,2,response to type III interferon,BP,
4500,GO:0010533,0.999999999979029,0.758073761625567,0,3,regulation of activation of Janus kinase activity,BP,
7178,GO:0031071,0.999999999979074,0.890441937865435,0,1,cysteine desulfurase activity,MF,
19417,GO:1905936,0.999999999979098,0.84529024717913,0,2,regulation of germ cell proliferation,BP,
19821,GO:2000254,0.999999999979098,0.84529024717913,0,2,regulation of male germ cell proliferation,BP,
11040,GO:0045031,0.999999999979171,0.794856234406184,0,2,ATP-activated adenosine receptor activity,MF,
4589,GO:0010698,0.999999999979228,0.832984749311186,0,2,acetyltransferase activator activity,MF,
16733,GO:0097752,0.999999999979248,0.705003056608828,0,3,regulation of DNA stability,BP,
1715,GO:0004306,0.999999999979279,0.894489835985957,0,1,ethanolamine-phosphate cytidylyltransferase activity,MF,
2896,GO:0006407,0.999999999979318,0.735613128312812,0,3,rRNA export from nucleus,BP,
5972,GO:0018423,0.999999999979339,0.80759498916609,0,2,protein C-terminal leucine carboxyl O-methyltransferase activity,MF,
6360,GO:0021546,0.999999999979359,0.800336747447072,0,2,rhombomere development,BP,
2047,GO:0004794,0.999999999979411,0.904218918656691,0,1,L-threonine ammonia-lyase activity,MF,
16281,GO:0090362,0.999999999979458,0.793740959088982,0,2,positive regulation of platelet-derived growth factor production,BP,
7600,GO:0031990,0.999999999979464,0.792669654597857,0,2,mRNA export from nucleus in response to heat stress,BP,
8741,GO:0034402,0.999999999979464,0.792669654597857,0,2,recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex,BP,
10372,GO:0043199,0.999999999979481,0.714136002440137,0,3,sulfate binding,MF,
552,GO:0001674,0.999999999979485,0.793008908443394,0,2,female germ cell nucleus,CC,
10079,GO:0042585,0.999999999979485,0.793008908443394,0,2,germinal vesicle,CC,
16406,GO:0097036,0.999999999979529,0.903171496596939,0,1,regulation of plasma membrane sterol distribution,BP,
9265,GO:0035692,0.999999999979543,0.807035086359404,0,2,macrophage migration inhibitory factor receptor complex,CC,
9904,GO:0042245,0.999999999979593,0.792187109527876,0,2,RNA repair,BP,
8870,GO:0034685,0.999999999979608,0.792438594479929,0,2,integrin alphav-beta6 complex,CC,
19584,GO:1990590,0.999999999979611,0.798379950523443,0,2,ATF1-ATF4 transcription factor complex,CC,
18828,GO:1904383,0.999999999979644,0.891462211355837,0,1,response to sodium phosphate,BP,
18909,GO:1904585,0.999999999979644,0.891462211355837,0,1,response to putrescine,BP,
18910,GO:1904586,0.999999999979644,0.891462211355837,0,1,cellular response to putrescine,BP,
19651,GO:1990828,0.999999999979644,0.891462211355837,0,1,hepatocyte dedifferentiation,BP,
3007,GO:0006556,0.999999999979662,0.793888732959461,0,2,S-adenosylmethionine biosynthetic process,BP,
12150,GO:0048269,0.999999999979662,0.793888732959461,0,2,methionine adenosyltransferase complex,CC,
17930,GO:1902232,0.999999999979673,0.798374172295108,0,2,regulation of positive thymic T cell selection,BP,
18041,GO:1902544,0.999999999979724,0.822176631583401,0,2,regulation of DNA N-glycosylase activity,BP,
235,GO:0000493,0.999999999979761,0.797286468730744,0,2,box H/ACA snoRNP assembly,BP,
3685,GO:0008193,0.99999999997982,0.807252432388542,0,2,tRNA guanylyltransferase activity,MF,
1138,GO:0002729,0.999999999979871,0.813108867006448,0,2,positive regulation of natural killer cell cytokine production,BP,
320,GO:0000839,0.999999999979885,0.712093492412488,0,3,Hrd1p ubiquitin ligase ERAD-L complex,CC,
8102,GO:0032796,0.999999999979904,0.799790359276471,0,2,uropod organization,BP,
5950,GO:0018298,0.99999999997991,0.705027863482111,0,3,protein-chromophore linkage,BP,
14751,GO:0070432,0.999999999979975,0.705348582207801,0,3,regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
2786,GO:0006226,0.999999999979988,0.717352104560659,0,3,dUMP biosynthetic process,BP,
1414,GO:0003350,0.999999999979993,0.793013468534277,0,2,pulmonary myocardium development,BP,
13620,GO:0060126,0.999999999979993,0.793013468534277,0,2,somatotropin secreting cell differentiation,BP,
6865,GO:0030348,0.99999999998006,0.795623433734144,0,2,syntaxin-3 binding,MF,
9583,GO:0036435,0.999999999980061,0.718801510664572,0,3,K48-linked polyubiquitin modification-dependent protein binding,MF,
1820,GO:0004471,0.999999999980082,0.705738173650874,0,3,malate dehydrogenase (decarboxylating) (NAD+) activity,MF,
1821,GO:0004473,0.999999999980082,0.705738173650874,0,3,malate dehydrogenase (decarboxylating) (NADP+) activity,MF,
7849,GO:0032416,0.999999999980119,0.892736028985532,0,1,negative regulation of sodium:proton antiporter activity,BP,
16541,GO:0097291,0.999999999980119,0.892736028985532,0,1,renal phosphate ion absorption,BP,
5217,GO:0015820,0.99999999998012,0.79288754181977,0,2,leucine transport,BP,
14437,GO:0061757,0.999999999980155,0.799029660719351,0,2,leukocyte adhesion to arterial endothelial cell,BP,
19105,GO:1904997,0.999999999980155,0.799029660719351,0,2,regulation of leukocyte adhesion to arterial endothelial cell,BP,
13177,GO:0051793,0.999999999980166,0.706712615310291,0,3,medium-chain fatty acid catabolic process,BP,
14104,GO:0060971,0.999999999980175,0.709367556353956,0,3,embryonic heart tube left/right pattern formation,BP,
1066,GO:0002606,0.999999999980185,0.718266347897165,0,3,positive regulation of dendritic cell antigen processing and presentation,BP,
10481,GO:0043383,0.999999999980185,0.718266347897165,0,3,negative T cell selection,BP,
11054,GO:0045060,0.999999999980185,0.718266347897165,0,3,negative thymic T cell selection,BP,
14074,GO:0060907,0.999999999980185,0.718266347897165,0,3,positive regulation of macrophage cytokine production,BP,
18267,GO:1903094,0.999999999980206,0.834889122439033,0,2,negative regulation of protein K48-linked deubiquitination,BP,
19775,GO:2000157,0.999999999980206,0.834889122439033,0,2,negative regulation of ubiquitin-specific protease activity,BP,
11493,GO:0045988,0.999999999980223,0.707155691872286,0,3,negative regulation of striated muscle contraction,BP,
13524,GO:0055118,0.999999999980223,0.707155691872286,0,3,negative regulation of cardiac muscle contraction,BP,
7287,GO:0031291,0.999999999980304,0.732133347842954,0,3,Ran protein signal transduction,BP,
9955,GO:0042335,0.999999999980307,0.705876671345161,0,3,cuticle development,BP,
11499,GO:0045994,0.999999999980318,0.799029660719187,0,2,positive regulation of translational initiation by iron,BP,
1053,GO:0002580,0.999999999980385,0.742314568713249,0,3,regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
4121,GO:0009182,0.999999999980409,0.736083368107419,0,3,purine deoxyribonucleoside diphosphate metabolic process,BP,
11527,GO:0046066,0.999999999980409,0.736083368107419,0,3,dGDP metabolic process,BP,
13642,GO:0060161,0.999999999980421,0.705214199801476,0,3,positive regulation of dopamine receptor signaling pathway,BP,
4726,GO:0010890,0.99999999998047,0.745850209387481,0,3,positive regulation of sequestering of triglyceride,BP,
18992,GO:1904768,0.999999999980511,0.820128880653403,0,2,all-trans-retinol binding,MF,
8292,GO:0033132,0.999999999980528,0.812863092376324,0,2,negative regulation of glucokinase activity,BP,
18349,GO:1903300,0.999999999980528,0.812863092376324,0,2,negative regulation of hexokinase activity,BP,
16768,GO:0098575,0.999999999980552,0.795112757700472,0,2,lumenal side of lysosomal membrane,CC,
3605,GO:0008048,0.999999999980559,0.890852088997011,0,1,calcium sensitive guanylate cyclase activator activity,MF,
4694,GO:0010851,0.999999999980559,0.890852088997011,0,1,cyclase regulator activity,MF,
4695,GO:0010853,0.999999999980559,0.890852088997011,0,1,cyclase activator activity,MF,
6797,GO:0030249,0.999999999980559,0.890852088997011,0,1,guanylate cyclase regulator activity,MF,
6798,GO:0030250,0.999999999980559,0.890852088997011,0,1,guanylate cyclase activator activity,MF,
5523,GO:0016493,0.999999999980564,0.793703680443311,0,2,C-C chemokine receptor activity,MF,
1630,GO:0004066,0.999999999980573,0.792835669480652,0,2,asparagine synthase (glutamine-hydrolyzing) activity,MF,
2982,GO:0006529,0.999999999980573,0.792835669480652,0,2,asparagine biosynthetic process,BP,
8387,GO:0033319,0.999999999980662,0.891934875612242,0,1,UDP-D-xylose metabolic process,BP,
8388,GO:0033320,0.999999999980662,0.891934875612242,0,1,UDP-D-xylose biosynthetic process,BP,
12076,GO:0048040,0.999999999980662,0.891934875612242,0,1,UDP-glucuronate decarboxylase activity,MF,
4093,GO:0009149,0.999999999980666,0.816689575253164,0,2,pyrimidine nucleoside triphosphate catabolic process,BP,
4149,GO:0009213,0.999999999980666,0.816689575253164,0,2,pyrimidine deoxyribonucleoside triphosphate catabolic process,BP,
7951,GO:0032556,0.999999999980666,0.816689575253164,0,2,pyrimidine deoxyribonucleotide binding,MF,
5963,GO:0018364,0.999999999980692,0.852289347105387,0,2,peptidyl-glutamine methylation,BP,
2418,GO:0005594,0.999999999980709,0.79225926191803,0,2,collagen type IX trimer,CC,
1898,GO:0004582,0.99999999998073,0.775890091969374,0,3,dolichyl-phosphate beta-D-mannosyltransferase activity,MF,
8330,GO:0033185,0.99999999998073,0.775890091969374,0,3,dolichol-phosphate-mannose synthase complex,CC,
170,GO:0000375,0.999999999980732,1.9084523385591e-10,4,301,RNA splicing, via transesterification reactions,BP,KHDRBS3;SYMPK;DHX32;SRSF5
11875,GO:0046900,0.999999999980787,0.802728086473888,0,2,tetrahydrofolylpolyglutamate metabolic process,BP,
7629,GO:0032044,0.999999999980819,0.802642258591531,0,2,DSIF complex,CC,
16570,GO:0097362,0.999999999980867,0.792324097408258,0,2,MCM8-MCM9 complex,CC,
16745,GO:0098518,0.999999999980874,0.716789629030832,0,3,polynucleotide phosphatase activity,MF,
658,GO:0001850,0.999999999980884,0.894925279659011,0,1,complement component C3a binding,MF,
11316,GO:0045650,0.999999999980903,0.799582273028815,0,2,negative regulation of macrophage differentiation,BP,
14617,GO:0070191,0.999999999980905,0.795173955104025,0,2,methionine-R-sulfoxide reductase activity,MF,
16391,GO:0097010,0.99999999998091,0.70510759760407,0,3,eukaryotic translation initiation factor 4F complex assembly,BP,
16973,GO:0098989,0.999999999980918,0.802247789467633,0,2,NMDA selective glutamate receptor signaling pathway,BP,
1945,GO:0004648,0.999999999980922,0.89172394539807,0,1,O-phospho-L-serine:2-oxoglutarate aminotransferase activity,MF,
5585,GO:0016603,0.99999999998093,0.799625390911615,0,2,glutaminyl-peptide cyclotransferase activity,MF,
5873,GO:0017186,0.99999999998093,0.799625390911615,0,2,peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase,BP,
2063,GO:0004816,0.999999999980983,0.792833274022018,0,2,asparagine-tRNA ligase activity,MF,
355,GO:0000973,0.999999999981015,0.710416976878809,0,3,posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery,BP,
659,GO:0001851,0.999999999981039,0.796496690207285,0,2,complement component C3b binding,MF,
11452,GO:0045917,0.999999999981039,0.796496690207285,0,2,positive regulation of complement activation,BP,
19826,GO:2000259,0.999999999981039,0.796496690207285,0,2,positive regulation of protein activation cascade,BP,
15629,GO:0072131,0.999999999981048,0.705374856299422,0,3,kidney mesenchyme morphogenesis,BP,
15631,GO:0072133,0.999999999981048,0.705374856299422,0,3,metanephric mesenchyme morphogenesis,BP,
19629,GO:1990761,0.999999999981069,0.792157632443531,0,2,growth cone lamellipodium,CC,
83,GO:0000171,0.999999999981132,0.79229673865868,0,2,ribonuclease MRP activity,MF,
15371,GO:0071619,0.999999999981143,0.890827250921712,0,1,phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
20244,GO:2001163,0.999999999981143,0.890827250921712,0,1,regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
20245,GO:2001165,0.999999999981143,0.890827250921712,0,1,positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
861,GO:0002192,0.999999999981153,0.829185076180723,0,2,IRES-dependent translational initiation of linear mRNA,BP,
17231,GO:0110017,0.999999999981153,0.829185076180723,0,2,cap-independent translational initiation of linear mRNA,BP,
5532,GO:0016509,0.999999999981163,0.706027011312551,0,3,long-chain-3-hydroxyacyl-CoA dehydrogenase activity,MF,
7189,GO:0031085,0.99999999998119,0.792145689882331,0,2,BLOC-3 complex,CC,
7998,GO:0032632,0.999999999981218,0.792672942822854,0,2,interleukin-3 production,BP,
8022,GO:0032672,0.999999999981218,0.792672942822854,0,2,regulation of interleukin-3 production,BP,
4123,GO:0009184,0.999999999981221,0.901075446277087,0,1,purine deoxyribonucleoside diphosphate catabolic process,BP,
4131,GO:0009192,0.999999999981221,0.901075446277087,0,1,deoxyribonucleoside diphosphate catabolic process,BP,
10954,GO:0044716,0.999999999981221,0.901075446277087,0,1,8-oxo-GDP phosphatase activity,MF,
10955,GO:0044717,0.999999999981221,0.901075446277087,0,1,8-hydroxy-dADP phosphatase activity,MF,
11522,GO:0046057,0.999999999981221,0.901075446277087,0,1,dADP catabolic process,BP,
11528,GO:0046067,0.999999999981221,0.901075446277087,0,1,dGDP catabolic process,BP,
11808,GO:0046712,0.999999999981221,0.901075446277087,0,1,GDP catabolic process,BP,
15048,GO:0071006,0.999999999981224,0.705805281138448,0,3,U2-type catalytic step 1 spliceosome,CC,
16483,GO:0097169,0.999999999981232,0.764002455191946,0,3,AIM2 inflammasome complex,CC,
2352,GO:0005432,0.999999999981244,0.705673871788508,0,3,calcium:sodium antiporter activity,MF,
11906,GO:0046952,0.999999999981278,0.706244850036695,0,3,ketone body catabolic process,BP,
12199,GO:0048388,0.999999999981292,0.803764503372162,0,2,endosomal lumen acidification,BP,
123,GO:0000254,0.999999999981326,0.792133854587585,0,2,C-4 methylsterol oxidase activity,MF,
499,GO:0001555,0.999999999981326,0.792133854587585,0,2,oocyte growth,BP,
1490,GO:0003827,0.999999999981326,0.792133854587585,0,2,alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity,MF,
1667,GO:0004127,0.999999999981326,0.792133854587585,0,2,cytidylate kinase activity,MF,
1828,GO:0004483,0.999999999981326,0.792133854587585,0,2,mRNA (nucleoside-2'-O-)-methyltransferase activity,MF,
2884,GO:0006393,0.999999999981326,0.792133854587585,0,2,termination of mitochondrial transcription,BP,
3206,GO:0006850,0.999999999981326,0.792133854587585,0,2,mitochondrial pyruvate transmembrane transport,BP,
4008,GO:0008988,0.999999999981326,0.792133854587585,0,2,rRNA (adenine-N6-)-methyltransferase activity,MF,
7447,GO:0031590,0.999999999981326,0.792133854587585,0,2,wybutosine metabolic process,BP,
7448,GO:0031591,0.999999999981326,0.792133854587585,0,2,wybutosine biosynthetic process,BP,
7716,GO:0032213,0.999999999981326,0.792133854587585,0,2,regulation of telomere maintenance via semi-conservative replication,BP,
7717,GO:0032214,0.999999999981326,0.792133854587585,0,2,negative regulation of telomere maintenance via semi-conservative replication,BP,
8104,GO:0032798,0.999999999981326,0.792133854587585,0,2,Swi5-Sfr1 complex,CC,
8745,GO:0034416,0.999999999981326,0.792133854587585,0,2,bisphosphoglycerate phosphatase activity,MF,
9591,GO:0036451,0.999999999981326,0.792133854587585,0,2,cap mRNA methylation,BP,
13052,GO:0051562,0.999999999981326,0.792133854587585,0,2,negative regulation of mitochondrial calcium ion concentration,BP,
15353,GO:0071595,0.999999999981326,0.792133854587585,0,2,Nem1-Spo7 phosphatase complex,CC,
15963,GO:0080023,0.999999999981326,0.792133854587585,0,2,3R-hydroxyacyl-CoA dehydratase activity,MF,
16547,GO:0097309,0.999999999981326,0.792133854587585,0,2,cap1 mRNA methylation,BP,
18886,GO:1904534,0.999999999981326,0.792133854587585,0,2,negative regulation of telomeric loop disassembly,BP,
19374,GO:1905778,0.999999999981326,0.792133854587585,0,2,negative regulation of exonuclease activity,BP,
19385,GO:1905838,0.999999999981326,0.792133854587585,0,2,regulation of telomeric D-loop disassembly,BP,
19386,GO:1905839,0.999999999981326,0.792133854587585,0,2,negative regulation of telomeric D-loop disassembly,BP,
19461,GO:1990112,0.999999999981326,0.792133854587585,0,2,RQC complex,CC,
19462,GO:1990116,0.999999999981326,0.792133854587585,0,2,ribosome-associated ubiquitin-dependent protein catabolic process,BP,
19666,GO:1990879,0.999999999981326,0.792133854587585,0,2,CST complex,CC,
19986,GO:2000543,0.999999999981326,0.792133854587585,0,2,positive regulation of gastrulation,BP,
1682,GO:0004146,0.99999999998133,0.81419960007765,0,2,dihydrofolate reductase activity,MF,
9749,GO:0039506,0.999999999981334,0.792134494731846,0,2,modulation by virus of host molecular function,BP,
9750,GO:0039507,0.999999999981334,0.792134494731846,0,2,suppression by virus of host molecular function,BP,
13295,GO:0052055,0.999999999981334,0.792134494731846,0,2,modulation by symbiont of host molecular function,BP,
13296,GO:0052056,0.999999999981334,0.792134494731846,0,2,negative regulation by symbiont of host molecular function,BP,
5951,GO:0018307,0.999999999981341,0.819081669696902,0,2,enzyme active site formation,BP,
11231,GO:0045416,0.999999999981371,0.711140859509297,0,3,positive regulation of interleukin-8 biosynthetic process,BP,
15041,GO:0070992,0.999999999981383,0.840693471489062,0,2,translation initiation complex,CC,
9709,GO:0038129,0.999999999981417,0.792731731895874,0,2,ERBB3 signaling pathway,BP,
1681,GO:0004145,0.999999999981454,0.839047378785458,0,2,diamine N-acetyltransferase activity,MF,
6240,GO:0019809,0.999999999981454,0.839047378785458,0,2,spermidine binding,MF,
8173,GO:0032917,0.999999999981454,0.839047378785458,0,2,polyamine acetylation,BP,
8174,GO:0032918,0.999999999981454,0.839047378785458,0,2,spermidine acetylation,BP,
5041,GO:0015222,0.999999999981457,0.795549393676859,0,2,serotonin transmembrane transporter activity,MF,
3409,GO:0007195,0.999999999981497,0.792371103671641,0,2,adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
15063,GO:0071030,0.999999999981534,0.798283201280066,0,2,nuclear mRNA surveillance of spliceosomal pre-mRNA splicing,BP,
15075,GO:0071048,0.999999999981534,0.798283201280066,0,2,nuclear retention of unspliced pre-mRNA at the site of transcription,BP,
15056,GO:0071020,0.999999999981539,0.803596742512947,0,2,post-spliceosomal complex,CC,
17967,GO:1902309,0.999999999981541,0.796299877821347,0,2,negative regulation of peptidyl-serine dephosphorylation,BP,
1428,GO:0003400,0.999999999981548,0.891397276922114,0,1,regulation of COPII vesicle coating,BP,
2205,GO:0005090,0.999999999981548,0.891397276922114,0,1,Sar guanyl-nucleotide exchange factor activity,MF,
13945,GO:0060661,0.999999999981548,0.891397276922114,0,1,submandibular salivary gland formation,BP,
15187,GO:0071335,0.999999999981548,0.891397276922114,0,1,hair follicle cell proliferation,BP,
15188,GO:0071336,0.999999999981548,0.891397276922114,0,1,regulation of hair follicle cell proliferation,BP,
15189,GO:0071338,0.999999999981548,0.891397276922114,0,1,positive regulation of hair follicle cell proliferation,BP,
16121,GO:0090113,0.999999999981548,0.891397276922114,0,1,regulation of ER to Golgi vesicle-mediated transport by GTP hydrolysis,BP,
6936,GO:0030550,0.99999999998158,0.721850053379669,0,3,acetylcholine receptor inhibitor activity,MF,
6309,GO:0019957,0.999999999981591,0.797746518517614,0,2,C-C chemokine binding,MF,
18771,GO:1904245,0.999999999981591,0.797746518517614,0,2,regulation of polynucleotide adenylyltransferase activity,BP,
13550,GO:0060024,0.999999999981603,0.793803228267255,0,2,rhythmic synaptic transmission,BP,
13913,GO:0060584,0.999999999981603,0.793803228267255,0,2,regulation of prostaglandin-endoperoxide synthase activity,BP,
13914,GO:0060585,0.999999999981603,0.793803228267255,0,2,positive regulation of prostaglandin-endoperoxide synthase activity,BP,
14566,GO:0070101,0.999999999981603,0.793803228267255,0,2,positive regulation of chemokine-mediated signaling pathway,BP,
5736,GO:0016882,0.999999999981614,0.82066251284459,0,2,cyclo-ligase activity,MF,
13722,GO:0060302,0.99999999998163,0.803360048230283,0,2,negative regulation of cytokine activity,BP,
875,GO:0002225,0.999999999981696,0.807299014300934,0,2,positive regulation of antimicrobial peptide production,BP,
1153,GO:0002760,0.999999999981696,0.807299014300934,0,2,positive regulation of antimicrobial humoral response,BP,
1172,GO:0002803,0.999999999981696,0.807299014300934,0,2,positive regulation of antibacterial peptide production,BP,
20220,GO:2001069,0.999999999981714,0.7923534544398,0,2,glycogen binding,MF,
8611,GO:0034137,0.99999999998175,0.741454467155366,0,3,positive regulation of toll-like receptor 2 signaling pathway,BP,
4323,GO:0009826,0.999999999981791,0.796222849561423,0,2,unidimensional cell growth,BP,
19393,GO:1905867,0.999999999981821,0.719572192807296,0,3,epididymis development,BP,
6845,GO:0030321,0.999999999981826,0.792151642062008,0,2,transepithelial chloride transport,BP,
3824,GO:0008426,0.999999999981856,0.743799139904518,0,3,protein kinase C inhibitor activity,MF,
18065,GO:1902603,0.999999999981865,0.709360152351949,0,3,carnitine transmembrane transport,BP,
11049,GO:0045054,0.999999999981873,0.711800936106265,0,3,constitutive secretory pathway,BP,
14416,GO:0061723,0.999999999981881,0.792353454439633,0,2,glycophagy,BP,
20221,GO:2001070,0.999999999981881,0.792353454439633,0,2,starch binding,MF,
2254,GO:0005169,0.9999999999819,0.816772795659049,0,2,neurotrophin TRKB receptor binding,MF,
12403,GO:0048859,0.9999999999819,0.816772795659049,0,2,formation of anatomical boundary,BP,
17407,GO:1900138,0.999999999981924,0.717953595543117,0,3,negative regulation of phospholipase A2 activity,BP,
217,GO:0000454,0.999999999981929,0.766028226726878,0,3,snoRNA guided rRNA pseudouridine synthesis,BP,
5048,GO:0015234,0.999999999981994,0.799431974875665,0,2,thiamine transmembrane transporter activity,MF,
15532,GO:0071934,0.999999999981994,0.799431974875665,0,2,thiamine transmembrane transport,BP,
10066,GO:0042567,0.999999999981995,0.792168662337898,0,2,insulin-like growth factor ternary complex,CC,
3098,GO:0006679,0.999999999982019,0.79963823289507,0,2,glucosylceramide biosynthetic process,BP,
9095,GO:0035370,0.999999999982021,0.792770061416109,0,2,UBC13-UEV1A complex,CC,
17462,GO:1900245,0.99999999998203,0.705029527871305,0,3,positive regulation of MDA-5 signaling pathway,BP,
17384,GO:1900107,0.999999999982053,0.797954100858973,0,2,regulation of nodal signaling pathway,BP,
17411,GO:1900145,0.999999999982053,0.797954100858973,0,2,regulation of nodal signaling pathway involved in determination of left/right asymmetry,BP,
17428,GO:1900175,0.999999999982053,0.797954100858973,0,2,regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
15104,GO:0071163,0.999999999982056,0.723661495296057,0,3,DNA replication preinitiation complex assembly,BP,
6483,GO:0021840,0.999999999982115,0.890436181295897,0,1,directional guidance of interneurons involved in migration from the subpallium to the cortex,BP,
6484,GO:0021842,0.999999999982115,0.890436181295897,0,1,chemorepulsion involved in interneuron migration from the subpallium to the cortex,BP,
18479,GO:1903567,0.999999999982117,0.792532444055604,0,2,regulation of protein localization to ciliary membrane,BP,
17184,GO:0103053,0.999999999982131,0.818571546014571,0,2,1-ethyladenine demethylase activity,MF,
299,GO:0000806,0.999999999982137,0.792979651864112,0,2,Y chromosome,CC,
5776,GO:0016998,0.999999999982138,0.802059060986232,0,2,cell wall macromolecule catabolic process,BP,
7803,GO:0032361,0.999999999982155,0.892756225686672,0,1,pyridoxal phosphate catabolic process,BP,
10200,GO:0042820,0.999999999982155,0.892756225686672,0,1,vitamin B6 catabolic process,BP,
7135,GO:0030981,0.999999999982187,0.705030387250937,0,3,cortical microtubule cytoskeleton,CC,
18880,GO:1904527,0.999999999982187,0.705030387250937,0,3,negative regulation of microtubule binding,BP,
9927,GO:0042281,0.999999999982212,0.798199772932339,0,2,dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity,MF,
5306,GO:0016012,0.999999999982215,0.798199772932336,0,2,sarcoglycan complex,CC,
14760,GO:0070458,0.999999999982244,0.735874807277566,0,3,cellular detoxification of nitrogen compound,BP,
3071,GO:0006642,0.999999999982278,0.705355413527976,0,3,triglyceride mobilization,BP,
4247,GO:0009449,0.999999999982278,0.705355413527976,0,3,gamma-aminobutyric acid biosynthetic process,BP,
6228,GO:0019781,0.99999999998234,0.798105486079561,0,2,NEDD8 activating enzyme activity,MF,
16604,GO:0097441,0.999999999982345,0.715819832880485,0,3,basal dendrite,CC,
15841,GO:0072558,0.99999999998235,0.750382007635709,0,3,NLRP1 inflammasome complex,CC,
5308,GO:0016015,0.999999999982351,0.800104174243956,0,2,morphogen activity,MF,
7569,GO:0031938,0.999999999982372,0.802790132677578,0,2,regulation of chromatin silencing at telomere,BP,
9510,GO:0036194,0.999999999982402,0.730214281321293,0,3,muscle cell projection,CC,
9511,GO:0036195,0.999999999982402,0.730214281321293,0,3,muscle cell projection membrane,CC,
16460,GO:0097134,0.999999999982428,0.796804547037192,0,2,cyclin E1-CDK2 complex,CC,
8960,GO:0035034,0.999999999982468,0.793877888499682,0,2,histone acetyltransferase regulator activity,MF,
17809,GO:1901894,0.999999999982471,0.715143383835196,0,3,regulation of calcium-transporting ATPase activity,BP,
18864,GO:1904468,0.99999999998248,0.707344540233845,0,3,negative regulation of tumor necrosis factor secretion,BP,
20165,GO:2000848,0.999999999982499,0.733783224821956,0,3,positive regulation of corticosteroid hormone secretion,BP,
7125,GO:0030956,0.999999999982554,0.746857966655547,0,3,glutamyl-tRNA(Gln) amidotransferase complex,CC,
12494,GO:0050567,0.999999999982554,0.746857966655547,0,3,glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity,MF,
14885,GO:0070681,0.999999999982554,0.746857966655547,0,3,glutaminyl-tRNAGln biosynthesis via transamidation,BP,
20022,GO:2000616,0.999999999982587,0.795822141778789,0,2,negative regulation of histone H3-K9 acetylation,BP,
9908,GO:0042253,0.999999999982617,0.811868739576881,0,2,granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
2176,GO:0005021,0.999999999982619,0.792294524028771,0,2,vascular endothelial growth factor-activated receptor activity,MF,
6405,GO:0021648,0.999999999982619,0.792294524028771,0,2,vestibulocochlear nerve morphogenesis,BP,
6476,GO:0021824,0.999999999982619,0.792294524028771,0,2,cerebral cortex tangential migration using cell-axon interactions,BP,
6480,GO:0021828,0.999999999982619,0.792294524028771,0,2,gonadotrophin-releasing hormone neuronal migration to the hypothalamus,BP,
6491,GO:0021856,0.999999999982619,0.792294524028771,0,2,hypothalamic tangential migration using cell-axon interactions,BP,
13787,GO:0060385,0.999999999982619,0.792294524028771,0,2,axonogenesis involved in innervation,BP,
14109,GO:0060978,0.999999999982619,0.792294524028771,0,2,angiogenesis involved in coronary vascular morphogenesis,BP,
16439,GO:0097102,0.999999999982619,0.792294524028771,0,2,endothelial tip cell fate specification,BP,
18383,GO:1903375,0.999999999982619,0.792294524028771,0,2,facioacoustic ganglion development,BP,
19643,GO:1990791,0.999999999982619,0.792294524028771,0,2,dorsal root ganglion development,BP,
3930,GO:0008614,0.999999999982625,0.793647211319953,0,2,pyridoxine metabolic process,BP,
3931,GO:0008615,0.999999999982625,0.793647211319953,0,2,pyridoxine biosynthetic process,BP,
19293,GO:1905502,0.999999999982665,0.910664985621858,0,1,acetyl-CoA binding,MF,
11828,GO:0046790,0.999999999982691,0.71404914830225,0,3,virion binding,MF,
6899,GO:0030485,0.999999999982697,0.800842726719569,0,2,smooth muscle contractile fiber,CC,
16070,GO:0090031,0.999999999982765,0.705116884109901,0,3,positive regulation of steroid hormone biosynthetic process,BP,
9933,GO:0042289,0.99999999998278,0.815803189431246,0,2,MHC class II protein binding,MF,
1677,GO:0004140,0.99999999998279,0.794838766188725,0,2,dephospho-CoA kinase activity,MF,
18485,GO:1903575,0.999999999982795,0.803196061226137,0,2,cornified envelope assembly,BP,
4873,GO:0014735,0.999999999982799,0.805248328379924,0,2,regulation of muscle atrophy,BP,
4874,GO:0014736,0.999999999982799,0.805248328379924,0,2,negative regulation of muscle atrophy,BP,
9321,GO:0035800,0.999999999982799,0.805248328379924,0,2,deubiquitinase activator activity,MF,
19776,GO:2000158,0.999999999982799,0.805248328379924,0,2,positive regulation of ubiquitin-specific protease activity,BP,
15936,GO:0072741,0.999999999982816,0.705937070373639,0,3,protein localization to cell division site,BP,
18274,GO:1903119,0.999999999982816,0.705937070373639,0,3,protein localization to actin cytoskeleton,BP,
18871,GO:1904498,0.999999999982816,0.705937070373639,0,3,protein localization to mitotic actomyosin contractile ring,BP,
19485,GO:1990179,0.999999999982816,0.705937070373639,0,3,protein localization to actomyosin contractile ring,BP,
18607,GO:1903860,0.999999999982844,0.792364495362464,0,2,negative regulation of dendrite extension,BP,
19780,GO:2000172,0.999999999982844,0.792364495362464,0,2,regulation of branching morphogenesis of a nerve,BP,
15543,GO:0071962,0.999999999982896,0.734249893892019,0,3,mitotic sister chromatid cohesion, centromeric,BP,
19307,GO:1905550,0.999999999982911,0.808964764083916,0,2,regulation of protein localization to endoplasmic reticulum,BP,
19308,GO:1905552,0.999999999982911,0.808964764083916,0,2,positive regulation of protein localization to endoplasmic reticulum,BP,
10144,GO:0042727,0.999999999982996,0.794847282304699,0,2,flavin-containing compound biosynthetic process,BP,
1944,GO:0004647,0.999999999983039,0.796093929901664,0,2,phosphoserine phosphatase activity,MF,
7508,GO:0031700,0.999999999983073,0.902902568752678,0,1,adrenomedullin receptor binding,MF,
11663,GO:0046452,0.999999999983106,0.726167401272176,0,3,dihydrofolate metabolic process,BP,
306,GO:0000818,0.999999999983108,0.793073317647527,0,2,nuclear MIS12/MIND complex,CC,
517,GO:0001588,0.99999999998311,0.826387479815741,0,2,dopamine neurotransmitter receptor activity, coupled via Gs,MF,
2139,GO:0004952,0.99999999998311,0.826387479815741,0,2,dopamine neurotransmitter receptor activity,MF,
10797,GO:0044284,0.999999999983119,0.921395937184032,0,1,mitochondrial crista junction,CC,
15614,GO:0072106,0.999999999983138,0.73717056445047,0,3,regulation of ureteric bud formation,BP,
15615,GO:0072107,0.999999999983138,0.73717056445047,0,3,positive regulation of ureteric bud formation,BP,
15616,GO:0072108,0.999999999983138,0.73717056445047,0,3,positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
19205,GO:1905278,0.999999999983138,0.73717056445047,0,3,positive regulation of epithelial tube formation,BP,
10315,GO:0043111,0.999999999983152,0.807857726008808,0,2,replication fork arrest,BP,
19253,GO:1905394,0.999999999983276,0.705980278578216,0,3,retromer complex binding,MF,
348,GO:0000962,0.999999999983315,0.792295998201941,0,2,positive regulation of mitochondrial RNA catabolic process,BP,
8771,GO:0034458,0.999999999983315,0.792295998201941,0,2,3'-5' RNA helicase activity,MF,
11036,GO:0045025,0.999999999983315,0.792295998201941,0,2,mitochondrial degradosome,CC,
14202,GO:0061146,0.999999999983336,0.709316453650675,0,3,Peyer's patch morphogenesis,BP,
19392,GO:1905863,0.999999999983337,0.792137516581116,0,2,invadopodium organization,BP,
14692,GO:0070320,0.999999999983352,0.890038209327128,0,1,inward rectifier potassium channel inhibitor activity,MF,
17372,GO:1900085,0.999999999983352,0.890038209327128,0,1,negative regulation of peptidyl-tyrosine autophosphorylation,BP,
18497,GO:1903596,0.999999999983352,0.890038209327128,0,1,regulation of gap junction assembly,BP,
18498,GO:1903598,0.999999999983352,0.890038209327128,0,1,positive regulation of gap junction assembly,BP,
18501,GO:1903609,0.999999999983352,0.890038209327128,0,1,negative regulation of inward rectifier potassium channel activity,BP,
1503,GO:0003854,0.999999999983396,0.71325653045762,0,3,3-beta-hydroxy-delta5-steroid dehydrogenase activity,MF,
1298,GO:0003130,0.999999999983412,0.79712434159786,0,2,BMP signaling pathway involved in heart induction,BP,
1300,GO:0003133,0.999999999983412,0.79712434159786,0,2,endodermal-mesodermal cell signaling,BP,
1301,GO:0003134,0.999999999983412,0.79712434159786,0,2,endodermal-mesodermal cell signaling involved in heart induction,BP,
3522,GO:0007500,0.999999999983412,0.79712434159786,0,2,mesodermal cell fate determination,BP,
13660,GO:0060197,0.999999999983412,0.79712434159786,0,2,cloacal septation,BP,
14117,GO:0060994,0.999999999983412,0.79712434159786,0,2,regulation of transcription from RNA polymerase II promoter involved in kidney development,BP,
15604,GO:0072095,0.999999999983412,0.79712434159786,0,2,regulation of branch elongation involved in ureteric bud branching,BP,
15612,GO:0072103,0.999999999983412,0.79712434159786,0,2,glomerulus vasculature morphogenesis,BP,
15613,GO:0072104,0.999999999983412,0.79712434159786,0,2,glomerular capillary formation,BP,
15636,GO:0072138,0.999999999983412,0.79712434159786,0,2,mesenchymal cell proliferation involved in ureteric bud development,BP,
15658,GO:0072179,0.999999999983412,0.79712434159786,0,2,nephric duct formation,BP,
15664,GO:0072190,0.999999999983412,0.79712434159786,0,2,ureter urothelium development,BP,
15665,GO:0072191,0.999999999983412,0.79712434159786,0,2,ureter smooth muscle development,BP,
15667,GO:0072193,0.999999999983412,0.79712434159786,0,2,ureter smooth muscle cell differentiation,BP,
15669,GO:0072197,0.999999999983412,0.79712434159786,0,2,ureter morphogenesis,BP,
15714,GO:0072278,0.999999999983412,0.79712434159786,0,2,metanephric comma-shaped body morphogenesis,BP,
17825,GO:1901963,0.999999999983412,0.79712434159786,0,2,regulation of cell proliferation involved in outflow tract morphogenesis,BP,
19765,GO:2000137,0.999999999983412,0.79712434159786,0,2,negative regulation of cell proliferation involved in heart morphogenesis,BP,
1381,GO:0003278,0.999999999983425,0.70557964439071,0,3,apoptotic process involved in heart morphogenesis,BP,
13918,GO:0060591,0.999999999983425,0.70557964439071,0,3,chondroblast differentiation,BP,
12127,GO:0048237,0.999999999983447,0.802509833105564,0,2,rough endoplasmic reticulum lumen,CC,
14229,GO:0061209,0.999999999983447,0.709444969411967,0,3,cell proliferation involved in mesonephros development,BP,
15623,GO:0072125,0.999999999983447,0.709444969411967,0,3,negative regulation of glomerular mesangial cell proliferation,BP,
16172,GO:0090194,0.999999999983447,0.709444969411967,0,3,negative regulation of glomerulus development,BP,
3214,GO:0006864,0.999999999983504,0.803266320048967,0,2,pyrimidine nucleotide transport,BP,
5039,GO:0015218,0.999999999983504,0.803266320048967,0,2,pyrimidine nucleotide transmembrane transporter activity,MF,
19568,GO:1990519,0.999999999983504,0.803266320048967,0,2,pyrimidine nucleotide import into mitochondrion,BP,
10415,GO:0043262,0.99999999998353,0.713458266910957,0,3,adenosine-diphosphatase activity,MF,
1486,GO:0003810,0.99999999998354,0.70500311776956,0,3,protein-glutamine gamma-glutamyltransferase activity,MF,
16891,GO:0098837,0.999999999983663,0.708992198193617,0,3,postsynaptic recycling endosome,CC,
7762,GO:0032289,0.999999999983771,0.70611675924729,0,3,central nervous system myelin formation,BP,
10126,GO:0042668,0.999999999983785,0.81889291172123,0,2,auditory receptor cell fate determination,BP,
20181,GO:2000978,0.999999999983785,0.81889291172123,0,2,negative regulation of forebrain neuron differentiation,BP,
209,GO:0000438,0.999999999983788,0.721765661747915,0,3,core TFIIH complex portion of holo TFIIH complex,CC,
15513,GO:0071898,0.999999999983808,0.714174915963576,0,3,regulation of estrogen receptor binding,BP,
15514,GO:0071899,0.999999999983808,0.714174915963576,0,3,negative regulation of estrogen receptor binding,BP,
16537,GO:0097278,0.999999999983814,0.79222149859966,0,2,complement-dependent cytotoxicity,BP,
3804,GO:0008391,0.999999999983825,0.796115010703876,0,2,arachidonic acid monooxygenase activity,MF,
3805,GO:0008392,0.999999999983825,0.796115010703876,0,2,arachidonic acid epoxygenase activity,MF,
2690,GO:0006059,0.999999999983825,0.728554393974371,0,3,hexitol metabolic process,BP,
1602,GO:0004020,0.99999999998383,0.792218582903347,0,2,adenylylsulfate kinase activity,MF,
2039,GO:0004779,0.99999999998383,0.792218582903347,0,2,sulfate adenylyltransferase activity,MF,
2040,GO:0004781,0.99999999998383,0.792218582903347,0,2,sulfate adenylyltransferase (ATP) activity,MF,
18069,GO:1902612,0.999999999983836,0.890025188563674,0,1,regulation of anti-Mullerian hormone signaling pathway,BP,
18070,GO:1902613,0.999999999983836,0.890025188563674,0,1,negative regulation of anti-Mullerian hormone signaling pathway,BP,
19503,GO:1990262,0.999999999983836,0.890025188563674,0,1,anti-Mullerian hormone signaling pathway,BP,
5204,GO:0015803,0.999999999983857,0.705674017553036,0,3,branched-chain amino acid transport,BP,
2270,GO:0005212,0.999999999983868,0.738082318732777,0,3,structural constituent of eye lens,MF,
10098,GO:0042613,0.999999999983897,0.746412710345954,0,3,MHC class II protein complex,CC,
17897,GO:1902167,0.999999999983917,0.934925315931204,0,1,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
19010,GO:1904803,0.999999999983917,0.934925315931204,0,1,regulation of translation involved in cellular response to UV,BP,
2078,GO:0004831,0.999999999983917,0.793408384101146,0,2,tyrosine-tRNA ligase activity,MF,
2923,GO:0006437,0.999999999983917,0.793408384101146,0,2,tyrosyl-tRNA aminoacylation,BP,
532,GO:0001651,0.999999999983944,0.811197412494426,0,2,dense fibrillar component,CC,
4488,GO:0010512,0.999999999983949,0.792134168363253,0,2,negative regulation of phosphatidylinositol biosynthetic process,BP,
9313,GO:0035788,0.999999999983949,0.792134168363253,0,2,cell migration involved in metanephros development,BP,
9314,GO:0035789,0.999999999983949,0.792134168363253,0,2,metanephric mesenchymal cell migration,BP,
9317,GO:0035793,0.999999999983949,0.792134168363253,0,2,positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,
17456,GO:1900238,0.999999999983949,0.792134168363253,0,2,regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,
20011,GO:2000589,0.999999999983949,0.792134168363253,0,2,regulation of metanephric mesenchymal cell migration,BP,
20012,GO:2000591,0.999999999983949,0.792134168363253,0,2,positive regulation of metanephric mesenchymal cell migration,BP,
687,GO:0001907,0.999999999983952,0.737597934915022,0,3,killing by symbiont of host cells,BP,
10704,GO:0044004,0.999999999983952,0.737597934915022,0,3,disruption by symbiont of host cell,BP,
10916,GO:0044533,0.999999999983952,0.737597934915022,0,3,positive regulation of apoptotic process in other organism,BP,
13292,GO:0052042,0.999999999983952,0.737597934915022,0,3,positive regulation by symbiont of host programmed cell death,BP,
13328,GO:0052330,0.999999999983952,0.737597934915022,0,3,positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction,BP,
13347,GO:0052501,0.999999999983952,0.737597934915022,0,3,positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction,BP,
15518,GO:0071907,0.999999999984003,0.719749009115631,0,3,determination of digestive tract left/right asymmetry,BP,
4591,GO:0010701,0.999999999984007,0.793737545945007,0,2,positive regulation of norepinephrine secretion,BP,
14043,GO:0060825,0.999999999984104,0.802726819455162,0,2,fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
19858,GO:2000313,0.999999999984104,0.802726819455162,0,2,regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
15529,GO:0071930,0.999999999984113,0.705008721972658,0,3,negative regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
19456,GO:1990086,0.999999999984113,0.705008721972658,0,3,lens fiber cell apoptotic process,BP,
12996,GO:0051430,0.999999999984159,0.795692725320138,0,2,corticotropin-releasing hormone receptor 1 binding,MF,
48,GO:0000101,0.999999999984179,0.705003174440443,0,3,sulfur amino acid transport,BP,
5019,GO:0015183,0.999999999984179,0.705003174440443,0,3,L-aspartate transmembrane transporter activity,MF,
16738,GO:0098502,0.999999999984183,0.734259626836507,0,3,DNA dephosphorylation,BP,
19841,GO:2000286,0.999999999984206,0.705109314684275,0,3,receptor internalization involved in canonical Wnt signaling pathway,BP,
8409,GO:0033484,0.999999999984228,0.728006213220062,0,3,nitric oxide homeostasis,BP,
15305,GO:0071502,0.99999999998424,0.722771187578556,0,3,cellular response to temperature stimulus,BP,
13594,GO:0060075,0.999999999984247,0.70615603013151,0,3,regulation of resting membrane potential,BP,
1815,GO:0004465,0.999999999984266,0.706627078717646,0,3,lipoprotein lipase activity,MF,
2076,GO:0004829,0.999999999984275,0.705323041945023,0,3,threonine-tRNA ligase activity,MF,
2921,GO:0006435,0.999999999984275,0.705323041945023,0,3,threonyl-tRNA aminoacylation,BP,
4831,GO:0014038,0.999999999984279,0.709981496153945,0,3,regulation of Schwann cell differentiation,BP,
3674,GO:0008176,0.999999999984314,0.814300707489845,0,2,tRNA (guanine-N7-)-methyltransferase activity,MF,
17193,GO:0106004,0.999999999984314,0.814300707489845,0,2,tRNA (guanine-N7)-methylation,BP,
1363,GO:0003245,0.999999999984327,0.799544059758399,0,2,cardiac muscle tissue growth involved in heart morphogenesis,BP,
7385,GO:0031445,0.999999999984327,0.799544059758399,0,2,regulation of heterochromatin assembly,BP,
7386,GO:0031453,0.999999999984327,0.799544059758399,0,2,positive regulation of heterochromatin assembly,BP,
7677,GO:0032129,0.999999999984327,0.799544059758399,0,2,histone deacetylase activity (H3-K9 specific),MF,
11395,GO:0045799,0.999999999984327,0.799544059758399,0,2,positive regulation of chromatin assembly or disassembly,BP,
11916,GO:0046969,0.999999999984327,0.799544059758399,0,2,NAD-dependent histone deacetylase activity (H3-K9 specific),MF,
19310,GO:1905555,0.999999999984327,0.799544059758399,0,2,positive regulation blood vessel branching,BP,
19592,GO:1990619,0.999999999984327,0.799544059758399,0,2,histone H3-K9 deacetylation,BP,
19865,GO:2000321,0.999999999984351,0.81789080614241,0,2,positive regulation of T-helper 17 cell differentiation,BP,
19873,GO:2000330,0.999999999984351,0.81789080614241,0,2,positive regulation of T-helper 17 cell lineage commitment,BP,
11320,GO:0045654,0.999999999984415,0.803215995390733,0,2,positive regulation of megakaryocyte differentiation,BP,
4685,GO:0010836,0.999999999984423,0.713697303132752,0,3,negative regulation of protein ADP-ribosylation,BP,
16895,GO:0098842,0.999999999984423,0.793783653067486,0,2,postsynaptic early endosome,CC,
12256,GO:0048560,0.999999999984485,0.794230451401215,0,2,establishment of anatomical structure orientation,BP,
1837,GO:0004492,0.999999999984517,0.891757338922175,0,1,methylmalonyl-CoA decarboxylase activity,MF,
18512,GO:1903644,0.999999999984527,0.83306792798275,0,2,regulation of chaperone-mediated protein folding,BP,
6345,GO:0021526,0.999999999984536,0.894309489328205,0,1,medial motor column neuron differentiation,BP,
18071,GO:1902616,0.999999999984536,0.894309489328205,0,1,acyl carnitine transmembrane transport,BP,
14413,GO:0061711,0.999999999984554,0.801811652696969,0,2,N(6)-L-threonylcarbamoyladenine synthase activity,MF,
4924,GO:0014876,0.999999999984555,0.904757569270035,0,1,response to injury involved in regulation of muscle adaptation,BP,
12450,GO:0050253,0.999999999984565,0.792134789614279,0,2,retinyl-palmitate esterase activity,MF,
3224,GO:0006880,0.999999999984571,0.749087782780284,0,3,intracellular sequestering of iron ion,BP,
16671,GO:0097577,0.999999999984571,0.749087782780284,0,3,sequestering of iron ion,BP,
581,GO:0001735,0.999999999984601,0.792214803578241,0,2,prenylcysteine oxidase activity,MF,
6852,GO:0030328,0.999999999984601,0.792214803578241,0,2,prenylcysteine catabolic process,BP,
6853,GO:0030329,0.999999999984601,0.792214803578241,0,2,prenylcysteine metabolic process,BP,
5633,GO:0016714,0.999999999984615,0.730077451632846,0,3,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen,MF,
1600,GO:0004018,0.999999999984631,0.902061081101813,0,1,N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity,MF,
14851,GO:0070626,0.999999999984631,0.902061081101813,0,1,(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity,MF,
9929,GO:0042284,0.999999999984658,0.894560531643366,0,1,sphingolipid delta-4 desaturase activity,MF,
19129,GO:1905051,0.999999999984725,0.827555510370117,0,2,regulation of base-excision repair,BP,
19130,GO:1905053,0.999999999984725,0.827555510370117,0,2,positive regulation of base-excision repair,BP,
950,GO:0002368,0.999999999984732,0.890651857015493,0,1,B cell cytokine production,BP,
1195,GO:0002842,0.999999999984732,0.890651857015493,0,1,positive regulation of T cell mediated immune response to tumor cell,BP,
9560,GO:0036351,0.999999999984732,0.890651857015493,0,1,histone H2A-K13 ubiquitination,BP,
9561,GO:0036352,0.999999999984732,0.890651857015493,0,1,histone H2A-K15 ubiquitination,BP,
2261,GO:0005176,0.999999999984769,0.812137482023986,0,2,ErbB-2 class receptor binding,MF,
382,GO:0001018,0.999999999984784,0.795200183200734,0,2,mitochondrial promoter sequence-specific DNA binding,MF,
7608,GO:0032002,0.999999999984784,0.795200183200734,0,2,interleukin-28 receptor complex,CC,
4493,GO:0010520,0.999999999984817,0.792161301242705,0,2,regulation of reciprocal meiotic recombination,BP,
11580,GO:0046166,0.99999999998482,0.804918930007835,0,2,glyceraldehyde-3-phosphate biosynthetic process,BP,
1059,GO:0002586,0.999999999984827,0.83405300812739,0,2,regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
10140,GO:0042720,0.999999999984876,0.833962947044089,0,2,mitochondrial inner membrane peptidase complex,CC,
7415,GO:0031515,0.999999999984881,0.709208375291688,0,3,tRNA (m1A) methyltransferase complex,CC,
1826,GO:0004479,0.999999999984904,0.890025058891486,0,1,methionyl-tRNA formyltransferase activity,MF,
6319,GO:0019988,0.999999999984904,0.890025058891486,0,1,charged-tRNA amino acid modification,BP,
15539,GO:0071951,0.999999999984904,0.890025058891486,0,1,conversion of methionyl-tRNA to N-formyl-methionyl-tRNA,BP,
17821,GO:1901917,0.999999999984904,0.890025058891486,0,1,regulation of exoribonuclease activity,BP,
17822,GO:1901919,0.999999999984904,0.890025058891486,0,1,positive regulation of exoribonuclease activity,BP,
19375,GO:1905779,0.999999999984904,0.890025058891486,0,1,positive regulation of exonuclease activity,BP,
1952,GO:0004656,0.999999999984923,0.705798648281523,0,3,procollagen-proline 4-dioxygenase activity,MF,
2141,GO:0004954,0.999999999984961,0.709201043408969,0,3,prostanoid receptor activity,MF,
18977,GO:1904744,0.999999999984977,0.816924586732787,0,2,positive regulation of telomeric DNA binding,BP,
14072,GO:0060903,0.999999999984978,0.792161301242543,0,2,positive regulation of meiosis I,BP,
4849,GO:0014063,0.99999999998499,0.911407228493937,0,1,negative regulation of serotonin secretion,BP,
1631,GO:0004069,0.999999999984995,0.793800329490699,0,2,L-aspartate:2-oxoglutarate aminotransferase activity,MF,
2984,GO:0006532,0.999999999984995,0.793800329490699,0,2,aspartate biosynthetic process,BP,
2985,GO:0006533,0.999999999984995,0.793800329490699,0,2,aspartate catabolic process,BP,
6177,GO:0019550,0.999999999984995,0.793800329490699,0,2,glutamate catabolic process to aspartate,BP,
6178,GO:0019551,0.999999999984995,0.793800329490699,0,2,glutamate catabolic process to 2-oxoglutarate,BP,
3664,GO:0008158,0.99999999998505,0.819003335237779,0,2,hedgehog receptor activity,MF,
16346,GO:0090615,0.999999999985072,0.795382561622922,0,2,mitochondrial mRNA processing,BP,
9116,GO:0035425,0.999999999985082,0.709510179599203,0,3,autocrine signaling,BP,
19350,GO:1905671,0.999999999985082,0.706953047061901,0,3,regulation of lysosome organization,BP,
16927,GO:0098905,0.999999999985084,0.822614523460231,0,2,regulation of bundle of His cell action potential,BP,
19793,GO:2000195,0.9999999999851,0.795158290543496,0,2,negative regulation of female gonad development,BP,
526,GO:0001635,0.999999999985119,0.729675038352451,0,3,calcitonin gene-related peptide receptor activity,MF,
16692,GO:0097642,0.999999999985119,0.729675038352451,0,3,calcitonin family receptor activity,MF,
19628,GO:1990758,0.999999999985127,0.894836012403899,0,1,mitotic sister chromatid biorientation,BP,
11092,GO:0045112,0.999999999985133,0.740826498412417,0,3,integrin biosynthetic process,BP,
4,GO:0000010,0.999999999985136,0.799828668855802,0,2,trans-hexaprenyltranstransferase activity,MF,
12464,GO:0050347,0.999999999985136,0.799828668855802,0,2,trans-octaprenyltranstransferase activity,MF,
19670,GO:1990889,0.999999999985139,0.894419882231113,0,1,H4K20me3 modified histone binding,MF,
10246,GO:0042986,0.999999999985178,0.795055238229658,0,2,positive regulation of amyloid precursor protein biosynthetic process,BP,
7346,GO:0031394,0.999999999985191,0.804594461773685,0,2,positive regulation of prostaglandin biosynthetic process,BP,
9535,GO:0036292,0.999999999985191,0.804594461773685,0,2,DNA rewinding,BP,
20317,GO:2001280,0.999999999985191,0.804594461773685,0,2,positive regulation of unsaturated fatty acid biosynthetic process,BP,
9389,GO:0035931,0.999999999985193,0.792138272066933,0,2,mineralocorticoid secretion,BP,
9390,GO:0035932,0.999999999985193,0.792138272066933,0,2,aldosterone secretion,BP,
20169,GO:2000855,0.999999999985193,0.792138272066933,0,2,regulation of mineralocorticoid secretion,BP,
20170,GO:2000857,0.999999999985193,0.792138272066933,0,2,positive regulation of mineralocorticoid secretion,BP,
20171,GO:2000858,0.999999999985193,0.792138272066933,0,2,regulation of aldosterone secretion,BP,
20172,GO:2000860,0.999999999985193,0.792138272066933,0,2,positive regulation of aldosterone secretion,BP,
17623,GO:1901301,0.999999999985195,0.792138272066931,0,2,regulation of cargo loading into COPII-coated vesicle,BP,
20036,GO:2000638,0.999999999985195,0.792138272066931,0,2,regulation of SREBP signaling pathway,BP,
20037,GO:2000639,0.999999999985195,0.792138272066931,0,2,negative regulation of SREBP signaling pathway,BP,
20314,GO:2001274,0.999999999985195,0.792138272066931,0,2,negative regulation of glucose import in response to insulin stimulus,BP,
2068,GO:0004821,0.999999999985196,0.795000398570189,0,2,histidine-tRNA ligase activity,MF,
2913,GO:0006427,0.999999999985196,0.795000398570189,0,2,histidyl-tRNA aminoacylation,BP,
2458,GO:0005673,0.999999999985197,0.80155788206107,0,2,transcription factor TFIIE complex,CC,
16979,GO:0099022,0.999999999985222,0.799886341232427,0,2,vesicle tethering,BP,
16983,GO:0099044,0.999999999985222,0.799886341232427,0,2,vesicle tethering to endoplasmic reticulum,BP,
16507,GO:0097210,0.999999999985225,0.706421356638441,0,3,response to gonadotropin-releasing hormone,BP,
16508,GO:0097211,0.999999999985225,0.706421356638441,0,3,cellular response to gonadotropin-releasing hormone,BP,
17636,GO:1901338,0.999999999985287,0.71049169354386,0,3,catecholamine binding,MF,
17790,GO:1901842,0.999999999985298,0.804558934606418,0,2,negative regulation of high voltage-gated calcium channel activity,BP,
16103,GO:0090086,0.999999999985299,0.745994913469258,0,3,negative regulation of protein deubiquitination,BP,
17603,GO:1901252,0.999999999985328,0.818689985106557,0,2,regulation of intracellular transport of viral material,BP,
20185,GO:2000983,0.99999999998535,0.846510704104264,0,2,regulation of ATP citrate synthase activity,BP,
20186,GO:2000984,0.99999999998535,0.846510704104264,0,2,negative regulation of ATP citrate synthase activity,BP,
4730,GO:0010896,0.999999999985358,0.707210020060094,0,3,regulation of triglyceride catabolic process,BP,
8539,GO:0033883,0.999999999985405,0.815107553288652,0,2,pyridoxal phosphatase activity,MF,
253,GO:0000718,0.999999999985429,0.896599025997373,0,1,nucleotide-excision repair, DNA damage removal,BP,
1676,GO:0004139,0.999999999985429,0.896599025997373,0,1,deoxyribose-phosphate aldolase activity,MF,
10844,GO:0044349,0.999999999985429,0.896599025997373,0,1,DNA excision,BP,
11648,GO:0046403,0.999999999985429,0.896599025997373,0,1,polynucleotide 3'-phosphatase activity,MF,
16739,GO:0098503,0.999999999985429,0.896599025997373,0,1,DNA 3' dephosphorylation,BP,
16740,GO:0098504,0.999999999985429,0.896599025997373,0,1,DNA 3' dephosphorylation involved in DNA repair,BP,
16742,GO:0098506,0.999999999985429,0.896599025997373,0,1,polynucleotide 3' dephosphorylation,BP,
4501,GO:0010536,0.99999999998543,0.833119632391615,0,2,positive regulation of activation of Janus kinase activity,BP,
14977,GO:0070893,0.999999999985442,0.792133891008994,0,2,transposon integration,BP,
14978,GO:0070894,0.999999999985442,0.792133891008994,0,2,regulation of transposon integration,BP,
14979,GO:0070895,0.999999999985442,0.792133891008994,0,2,negative regulation of transposon integration,BP,
16039,GO:0086072,0.999999999985451,0.890226554532354,0,1,AV node cell-bundle of His cell adhesion involved in cell communication,BP,
16047,GO:0086082,0.999999999985451,0.890226554532354,0,1,cell adhesive protein binding involved in AV node cell-bundle of His cell communication,MF,
19379,GO:1905799,0.999999999985462,0.930844369798826,0,1,regulation of intraciliary retrograde transport,BP,
13312,GO:0052203,0.999999999985493,0.797676467964779,0,2,modulation of catalytic activity in other organism involved in symbiotic interaction,BP,
6370,GO:0021560,0.999999999985507,0.792368256292254,0,2,abducens nerve development,BP,
6389,GO:0021598,0.999999999985507,0.792368256292254,0,2,abducens nerve morphogenesis,BP,
6390,GO:0021599,0.999999999985507,0.792368256292254,0,2,abducens nerve formation,BP,
19195,GO:1905258,0.999999999985509,0.828517074173152,0,2,regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,BP,
19196,GO:1905259,0.999999999985509,0.828517074173152,0,2,negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,BP,
4348,GO:0009918,0.999999999985521,0.890043701950435,0,1,sterol delta7 reductase activity,MF,
5123,GO:0015499,0.999999999985521,0.890043701950435,0,1,formate transmembrane transporter activity,MF,
5139,GO:0015660,0.999999999985521,0.890043701950435,0,1,formate efflux transmembrane transporter activity,MF,
5171,GO:0015724,0.999999999985521,0.890043701950435,0,1,formate transport,BP,
5199,GO:0015797,0.999999999985521,0.890043701950435,0,1,mannitol transport,BP,
5359,GO:0016131,0.999999999985521,0.890043701950435,0,1,brassinosteroid metabolic process,BP,
5360,GO:0016132,0.999999999985521,0.890043701950435,0,1,brassinosteroid biosynthetic process,BP,
11815,GO:0046724,0.999999999985521,0.890043701950435,0,1,oxalic acid secretion,BP,
12008,GO:0047598,0.999999999985521,0.890043701950435,0,1,7-dehydrocholesterol reductase activity,MF,
19586,GO:1990597,0.999999999985581,0.705609999561512,0,3,AIP1-IRE1 complex,CC,
19589,GO:1990604,0.999999999985581,0.705609999561512,0,3,IRE1-TRAF2-ASK1 complex,CC,
9135,GO:0035482,0.999999999985612,0.830387498569441,0,2,gastric motility,BP,
19229,GO:1905333,0.999999999985612,0.830387498569441,0,2,regulation of gastric motility,BP,
15351,GO:0071586,0.999999999985625,0.803033014209614,0,2,CAAX-box protein processing,BP,
15971,GO:0080120,0.999999999985625,0.803033014209614,0,2,CAAX-box protein maturation,BP,
17513,GO:1900673,0.999999999985633,0.793181367110269,0,2,olefin metabolic process,BP,
1588,GO:0003998,0.999999999985698,0.848017446162827,0,2,acylphosphatase activity,MF,
9222,GO:0035614,0.999999999985728,0.727574429706265,0,3,snRNA stem-loop binding,MF,
6732,GO:0030156,0.999999999985737,0.928080846555859,0,1,benzodiazepine receptor binding,MF,
13983,GO:0060708,0.999999999985762,0.719099858011416,0,3,spongiotrophoblast differentiation,BP,
14726,GO:0070390,0.999999999985774,0.896857322200346,0,1,transcription export complex 2,CC,
2931,GO:0006452,0.999999999985785,0.807089284009823,0,2,translational frameshifting,BP,
11442,GO:0045905,0.999999999985785,0.807089284009823,0,2,positive regulation of translational termination,BP,
12968,GO:0051379,0.999999999985785,0.79488427358031,0,2,epinephrine binding,MF,
6404,GO:0021644,0.999999999985811,0.900635583303025,0,1,vagus nerve morphogenesis,BP,
1756,GO:0004359,0.999999999985818,0.705229518333095,0,3,glutaminase activity,MF,
8575,GO:0034066,0.999999999985832,0.807389024053871,0,2,RIC1-RGP1 guanyl-nucleotide exchange factor complex,CC,
3987,GO:0008859,0.999999999985861,0.91919840597514,0,1,exoribonuclease II activity,MF,
15273,GO:0071460,0.999999999985872,0.828042706183271,0,2,cellular response to cell-matrix adhesion,BP,
2775,GO:0006208,0.999999999985905,0.793262235153122,0,2,pyrimidine nucleobase catabolic process,BP,
2776,GO:0006210,0.999999999985905,0.793262235153122,0,2,thymine catabolic process,BP,
6263,GO:0019859,0.999999999985905,0.793262235153122,0,2,thymine metabolic process,BP,
19739,GO:2000077,0.999999999985905,0.793262235153122,0,2,negative regulation of type B pancreatic cell development,BP,
15778,GO:0072387,0.999999999986016,0.794841685996397,0,2,flavin adenine dinucleotide metabolic process,BP,
18135,GO:1902809,0.999999999986035,0.713410321204919,0,3,regulation of skeletal muscle fiber differentiation,BP,
11572,GO:0046136,0.999999999986085,0.809378436514615,0,2,positive regulation of vitamin metabolic process,BP,
13895,GO:0060557,0.999999999986085,0.809378436514615,0,2,positive regulation of vitamin D biosynthetic process,BP,
13897,GO:0060559,0.999999999986085,0.809378436514615,0,2,positive regulation of calcidiol 1-monooxygenase activity,BP,
16181,GO:0090204,0.999999999986107,0.740804057229596,0,3,protein localization to nuclear pore,BP,
20018,GO:2000609,0.999999999986147,0.708270034713825,0,3,regulation of thyroid hormone generation,BP,
11973,GO:0047290,0.999999999986155,0.898160476666412,0,1,(alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3)-N-acetyl-galactosaminide 6-alpha-sialyltransferase activity,MF,
14315,GO:0061484,0.999999999986157,0.705020903338437,0,3,hematopoietic stem cell homeostasis,BP,
18340,GO:1903286,0.99999999998617,0.711895706302972,0,3,regulation of potassium ion import,BP,
15284,GO:0071475,0.999999999986188,0.717432864688728,0,3,cellular hyperosmotic salinity response,BP,
1985,GO:0004705,0.999999999986189,0.71581943240209,0,3,JUN kinase activity,MF,
5756,GO:0016909,0.999999999986189,0.71581943240209,0,3,SAP kinase activity,MF,
4005,GO:0008967,0.999999999986194,0.794398827503541,0,2,phosphoglycolate phosphatase activity,MF,
7417,GO:0031523,0.999999999986205,0.792137285367348,0,2,Myb complex,CC,
11622,GO:0046338,0.999999999986205,0.792137285367348,0,2,phosphatidylethanolamine catabolic process,BP,
17747,GO:1901671,0.99999999998621,0.825992227981206,0,2,positive regulation of superoxide dismutase activity,BP,
19023,GO:1904833,0.99999999998621,0.825992227981206,0,2,positive regulation of removal of superoxide radicals,BP,
15064,GO:0071031,0.999999999986235,0.813031850702124,0,2,nuclear mRNA surveillance of mRNA 3'-end processing,BP,
15076,GO:0071049,0.999999999986235,0.813031850702124,0,2,nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription,BP,
9813,GO:0042025,0.999999999986237,0.705564854220104,0,3,host cell nucleus,CC,
10731,GO:0044094,0.999999999986237,0.705564854220104,0,3,host cell nuclear part,CC,
3425,GO:0007217,0.999999999986245,0.890098940958102,0,1,tachykinin receptor signaling pathway,BP,
16459,GO:0097129,0.999999999986251,0.729856656481161,0,3,cyclin D2-CDK4 complex,CC,
8298,GO:0033140,0.999999999986264,0.796046940869244,0,2,negative regulation of peptidyl-serine phosphorylation of STAT protein,BP,
18903,GO:1904576,0.99999999998627,0.799265741927248,0,2,response to tunicamycin,BP,
18904,GO:1904577,0.99999999998627,0.799265741927248,0,2,cellular response to tunicamycin,BP,
15710,GO:0072268,0.999999999986279,0.709255428974459,0,3,pattern specification involved in metanephros development,BP,
1958,GO:0004662,0.999999999986296,0.800220477496853,0,2,CAAX-protein geranylgeranyltransferase activity,MF,
2625,GO:0005953,0.999999999986296,0.800220477496853,0,2,CAAX-protein geranylgeranyltransferase complex,CC,
16118,GO:0090108,0.9999999999863,0.892115684522963,0,1,positive regulation of high-density lipoprotein particle assembly,BP,
16165,GO:0090187,0.9999999999863,0.892115684522963,0,1,positive regulation of pancreatic juice secretion,BP,
16272,GO:0090340,0.9999999999863,0.892115684522963,0,1,positive regulation of secretion of lysosomal enzymes,BP,
2119,GO:0004909,0.999999999986315,0.794865962337636,0,2,interleukin-1, Type I, activating receptor activity,MF,
1716,GO:0004307,0.999999999986318,0.814809343505023,0,2,ethanolaminephosphotransferase activity,MF,
2080,GO:0004833,0.999999999986319,0.899807965493504,0,1,tryptophan 2,3-dioxygenase activity,MF,
8515,GO:0033754,0.999999999986319,0.899807965493504,0,1,indoleamine 2,3-dioxygenase activity,MF,
8674,GO:0034275,0.999999999986319,0.899807965493504,0,1,kynurenic acid metabolic process,BP,
8675,GO:0034276,0.999999999986319,0.899807965493504,0,1,kynurenic acid biosynthetic process,BP,
9530,GO:0036269,0.999999999986319,0.899807965493504,0,1,swimming behavior,BP,
144,GO:0000296,0.999999999986319,0.890755727929969,0,1,spermine transport,BP,
4017,GO:0009041,0.999999999986322,0.722815730567406,0,3,uridylate kinase activity,MF,
4082,GO:0009138,0.999999999986322,0.722815730567406,0,3,pyrimidine nucleoside diphosphate metabolic process,BP,
3667,GO:0008169,0.999999999986332,0.71942666723978,0,3,C-methyltransferase activity,MF,
12425,GO:0048936,0.999999999986337,0.707653085545362,0,3,peripheral nervous system neuron axonogenesis,BP,
11422,GO:0045852,0.999999999986345,0.708064073445522,0,3,pH elevation,BP,
13010,GO:0051454,0.999999999986345,0.708064073445522,0,3,intracellular pH elevation,BP,
1561,GO:0003960,0.999999999986346,0.721740054090862,0,3,NADPH:quinone reductase activity,MF,
5982,GO:0018872,0.999999999986347,0.890230144891704,0,1,arsonoacetate metabolic process,BP,
7017,GO:0030791,0.999999999986347,0.890230144891704,0,1,arsenite methyltransferase activity,MF,
7018,GO:0030792,0.999999999986347,0.890230144891704,0,1,methylarsonite methyltransferase activity,MF,
18077,GO:1902626,0.999999999986363,0.772082273627799,0,3,assembly of large subunit precursor of preribosome,BP,
13336,GO:0052405,0.999999999986372,0.736403230490567,0,3,negative regulation by host of symbiont molecular function,BP,
17577,GO:1901164,0.999999999986373,0.748643948778499,0,3,negative regulation of trophoblast cell migration,BP,
10127,GO:0042670,0.999999999986395,0.705299046312809,0,3,retinal cone cell differentiation,BP,
11726,GO:0046549,0.999999999986395,0.705299046312809,0,3,retinal cone cell development,BP,
843,GO:0002155,0.999999999986417,0.706286796713542,0,3,regulation of thyroid hormone mediated signaling pathway,BP,
15470,GO:0071819,0.999999999986417,0.832622285324652,0,2,DUBm complex,CC,
4651,GO:0010796,0.999999999986422,0.725485072195728,0,3,regulation of multivesicular body size,BP,
15344,GO:0071579,0.999999999986431,0.892626729041845,0,1,regulation of zinc ion transport,BP,
15345,GO:0071580,0.999999999986431,0.892626729041845,0,1,regulation of zinc ion transmembrane transport,BP,
15346,GO:0071581,0.999999999986431,0.892626729041845,0,1,regulation of zinc ion transmembrane import,BP,
15347,GO:0071582,0.999999999986431,0.892626729041845,0,1,negative regulation of zinc ion transport,BP,
15348,GO:0071583,0.999999999986431,0.892626729041845,0,1,negative regulation of zinc ion transmembrane transport,BP,
15349,GO:0071584,0.999999999986431,0.892626729041845,0,1,negative regulation of zinc ion transmembrane import,BP,
15350,GO:0071585,0.999999999986431,0.892626729041845,0,1,detoxification of cadmium ion,BP,
19480,GO:1990170,0.999999999986431,0.892626729041845,0,1,stress response to cadmium ion,BP,
14272,GO:0061357,0.999999999986431,0.70524437188299,0,3,positive regulation of Wnt protein secretion,BP,
6860,GO:0030337,0.999999999986449,0.806378729342996,0,2,DNA polymerase processivity factor activity,MF,
14953,GO:0070852,0.999999999986457,0.705681233682818,0,3,cell body fiber,CC,
15591,GO:0072076,0.999999999986457,0.705681233682818,0,3,nephrogenic mesenchyme development,BP,
17670,GO:1901492,0.999999999986462,0.793921536479972,0,2,positive regulation of lymphangiogenesis,BP,
19762,GO:2000124,0.999999999986484,0.792466428114931,0,2,regulation of endocannabinoid signaling pathway,BP,
19846,GO:2000298,0.999999999986484,0.792466428114931,0,2,regulation of Rho-dependent protein serine/threonine kinase activity,BP,
3101,GO:0006682,0.999999999986518,0.707594242564879,0,3,galactosylceramide biosynthetic process,BP,
6125,GO:0019375,0.999999999986518,0.707594242564879,0,3,galactolipid biosynthetic process,BP,
12396,GO:0048852,0.99999999998652,0.706106502247667,0,3,diencephalon morphogenesis,BP,
9053,GO:0035281,0.999999999986528,0.814231848438393,0,2,pre-miRNA export from nucleus,BP,
10065,GO:0042565,0.999999999986528,0.814231848438393,0,2,RNA nuclear export complex,CC,
13890,GO:0060545,0.99999999998657,0.795328187857576,0,2,positive regulation of necroptotic process,BP,
18905,GO:1904578,0.999999999986573,0.735154018396272,0,3,response to thapsigargin,BP,
18906,GO:1904579,0.999999999986573,0.735154018396272,0,3,cellular response to thapsigargin,BP,
4128,GO:0009189,0.999999999986668,0.745423370095045,0,3,deoxyribonucleoside diphosphate biosynthetic process,BP,
3141,GO:0006740,0.999999999986672,0.705879187383411,0,3,NADPH regeneration,BP,
3897,GO:0008537,0.999999999986674,0.751883568739706,0,3,proteasome activator complex,CC,
14286,GO:0061394,0.99999999998669,0.800222496173003,0,2,regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance,BP,
5416,GO:0016263,0.999999999986721,0.799867181068495,0,2,glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity,MF,
5419,GO:0016267,0.999999999986721,0.799867181068495,0,2,O-glycan processing, core 1,BP,
11711,GO:0046525,0.999999999986742,0.896617262416535,0,1,xylosylprotein 4-beta-galactosyltransferase activity,MF,
11044,GO:0045041,0.999999999986742,0.802592029611723,0,2,protein import into mitochondrial intermembrane space,BP,
2495,GO:0005745,0.999999999986761,0.792140511259443,0,2,m-AAA complex,CC,
7819,GO:0032379,0.999999999986765,0.722491702408643,0,3,positive regulation of intracellular lipid transport,BP,
7822,GO:0032382,0.999999999986765,0.722491702408643,0,3,positive regulation of intracellular sterol transport,BP,
7825,GO:0032385,0.999999999986765,0.722491702408643,0,3,positive regulation of intracellular cholesterol transport,BP,
8370,GO:0033277,0.999999999986767,0.792916754952951,0,2,abortive mitotic cell cycle,BP,
17285,GO:0140031,0.999999999986767,0.792916754952951,0,2,phosphorylation-dependent protein binding,MF,
13850,GO:0060474,0.999999999986803,0.837032332903051,0,2,positive regulation of flagellated sperm motility involved in capacitation,BP,
19619,GO:1990742,0.999999999986803,0.837032332903051,0,2,microvesicle,CC,
7537,GO:0031826,0.999999999986806,0.716475594786863,0,3,type 2A serotonin receptor binding,MF,
13755,GO:0060342,0.999999999986815,0.894174129442506,0,1,photoreceptor inner segment membrane,CC,
7243,GO:0031208,0.999999999986815,0.792201633037167,0,2,POZ domain binding,MF,
17233,GO:0110021,0.999999999986879,0.793663676569329,0,2,cardiac muscle myoblast proliferation,BP,
17234,GO:0110022,0.999999999986879,0.793663676569329,0,2,regulation of cardiac muscle myoblast proliferation,BP,
17235,GO:0110024,0.999999999986879,0.793663676569329,0,2,positive regulation of cardiac muscle myoblast proliferation,BP,
14252,GO:0061317,0.999999999986888,0.797268484665944,0,2,canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
17617,GO:1901295,0.999999999986888,0.797268484665944,0,2,regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
19135,GO:1905066,0.999999999986888,0.797268484665944,0,2,regulation of canonical Wnt signaling pathway involved in heart development,BP,
9594,GO:0036455,0.999999999986935,0.912978488842082,0,1,iron-sulfur transferase activity,MF,
5984,GO:0018894,0.999999999986935,0.705049158447235,0,3,dibenzo-p-dioxin metabolic process,BP,
8065,GO:0032747,0.999999999986971,0.733750354826111,0,3,positive regulation of interleukin-23 production,BP,
824,GO:0002101,0.999999999986972,0.715510394633472,0,3,tRNA wobble cytosine modification,BP,
2130,GO:0004935,0.999999999986992,0.795409119027793,0,2,adrenergic receptor activity,MF,
16744,GO:0098508,0.999999999987002,0.794964523751484,0,2,endothelial to hematopoietic transition,BP,
2241,GO:0005152,0.999999999987017,0.709457960470068,0,3,interleukin-1 receptor antagonist activity,MF,
9269,GO:0035697,0.999999999987019,0.79942086457357,0,2,CD8-positive, alpha-beta T cell extravasation,BP,
9270,GO:0035698,0.999999999987019,0.79942086457357,0,2,CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
15908,GO:0072683,0.999999999987019,0.79942086457357,0,2,T cell extravasation,BP,
19928,GO:2000407,0.999999999987019,0.79942086457357,0,2,regulation of T cell extravasation,BP,
19946,GO:2000449,0.999999999987019,0.79942086457357,0,2,regulation of CD8-positive, alpha-beta T cell extravasation,BP,
19948,GO:2000452,0.999999999987019,0.79942086457357,0,2,regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
1894,GO:0004577,0.999999999987047,0.814717921325356,0,2,N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity,MF,
16148,GO:0090164,0.999999999987074,0.792145819465655,0,2,asymmetric Golgi ribbon formation,BP,
1245,GO:0002944,0.999999999987102,0.792849071773454,0,2,cyclin K-CDK12 complex,CC,
1246,GO:0002945,0.999999999987102,0.792849071773454,0,2,cyclin K-CDK13 complex,CC,
1035,GO:0002543,0.999999999987161,0.792580016723995,0,2,activation of blood coagulation via clotting cascade,BP,
15127,GO:0071224,0.99999999998718,0.70510022810792,0,3,cellular response to peptidoglycan,BP,
14279,GO:0061370,0.999999999987182,0.792147028535494,0,2,testosterone biosynthetic process,BP,
511,GO:0001575,0.999999999987185,0.797292160822988,0,2,globoside metabolic process,BP,
15509,GO:0071894,0.999999999987189,0.793566658258596,0,2,histone H2B conserved C-terminal lysine ubiquitination,BP,
18569,GO:1903775,0.999999999987189,0.793566658258596,0,2,regulation of DNA double-strand break processing,BP,
20274,GO:2001206,0.999999999987206,0.706448737473761,0,3,positive regulation of osteoclast development,BP,
18570,GO:1903778,0.999999999987227,0.792181022878867,0,2,protein localization to vacuolar membrane,BP,
8456,GO:0033603,0.999999999987242,0.737185152461955,0,3,positive regulation of dopamine secretion,BP,
12123,GO:0048211,0.999999999987244,0.792133903064502,0,2,Golgi vesicle docking,BP,
8563,GO:0034039,0.999999999987289,0.799620016787715,0,2,8-oxo-7,8-dihydroguanine DNA N-glycosylase activity,MF,
18525,GO:1903677,0.999999999987295,0.710503353730393,0,3,regulation of cap-independent translational initiation,BP,
18526,GO:1903679,0.999999999987295,0.710503353730393,0,3,positive regulation of cap-independent translational initiation,BP,
7241,GO:0031204,0.999999999987304,0.741327838044296,0,3,posttranslational protein targeting to membrane, translocation,BP,
16160,GO:0090182,0.999999999987335,0.802974684075988,0,2,regulation of secretion of lysosomal enzymes,BP,
410,GO:0001097,0.999999999987345,0.713391184144989,0,3,TFIIH-class transcription factor binding,MF,
2818,GO:0006286,0.999999999987372,0.818952743387605,0,2,base-excision repair, base-free sugar-phosphate removal,BP,
13653,GO:0060180,0.999999999987397,0.705248099770995,0,3,female mating behavior,BP,
17811,GO:1901896,0.999999999987401,0.803526463622472,0,2,positive regulation of calcium-transporting ATPase activity,BP,
4864,GO:0014717,0.999999999987408,0.804994892265886,0,2,regulation of satellite cell activation involved in skeletal muscle regeneration,BP,
4865,GO:0014718,0.999999999987408,0.804994892265886,0,2,positive regulation of satellite cell activation involved in skeletal muscle regeneration,BP,
4939,GO:0014901,0.999999999987408,0.804994892265886,0,2,satellite cell activation involved in skeletal muscle regeneration,BP,
5393,GO:0016230,0.999999999987408,0.804994892265886,0,2,sphingomyelin phosphodiesterase activator activity,MF,
10446,GO:0043309,0.999999999987408,0.804994892265886,0,2,regulation of eosinophil degranulation,BP,
10447,GO:0043311,0.999999999987408,0.804994892265886,0,2,positive regulation of eosinophil degranulation,BP,
18053,GO:1902566,0.999999999987408,0.804994892265886,0,2,regulation of eosinophil activation,BP,
18054,GO:1902568,0.999999999987408,0.804994892265886,0,2,positive regulation of eosinophil activation,BP,
3040,GO:0006597,0.999999999987441,0.798554698813068,0,2,spermine biosynthetic process,BP,
18510,GO:1903636,0.999999999987443,0.935918820681131,0,1,regulation of protein import into mitochondrial outer membrane,BP,
18511,GO:1903638,0.999999999987443,0.935918820681131,0,1,positive regulation of protein import into mitochondrial outer membrane,BP,
18513,GO:1903645,0.999999999987443,0.935918820681131,0,1,negative regulation of chaperone-mediated protein folding,BP,
9698,GO:0038107,0.999999999987465,0.714580099517359,0,3,nodal signaling pathway involved in determination of left/right asymmetry,BP,
17375,GO:1900094,0.999999999987465,0.714580099517359,0,3,regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry,BP,
17424,GO:1900164,0.999999999987465,0.714580099517359,0,3,nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
7833,GO:0032395,0.999999999987484,0.740590312738367,0,3,MHC class II receptor activity,MF,
1913,GO:0004605,0.999999999987495,0.705007456843555,0,3,phosphatidate cytidylyltransferase activity,MF,
2630,GO:0005960,0.999999999987545,0.802270116607414,0,2,glycine cleavage complex,CC,
16497,GO:0097196,0.999999999987557,0.795163506047102,0,2,Shu complex,CC,
17466,GO:1900259,0.999999999987571,0.894002482722437,0,1,regulation of RNA-directed 5'-3' RNA polymerase activity,BP,
17467,GO:1900260,0.999999999987571,0.894002482722437,0,1,negative regulation of RNA-directed 5'-3' RNA polymerase activity,BP,
6406,GO:0021649,0.999999999987577,0.890204227118277,0,1,vestibulocochlear nerve structural organization,BP,
9687,GO:0038085,0.999999999987577,0.890204227118277,0,1,vascular endothelial growth factor binding,MF,
13721,GO:0060301,0.999999999987577,0.890204227118277,0,1,positive regulation of cytokine activity,BP,
14342,GO:0061552,0.999999999987577,0.890204227118277,0,1,ganglion morphogenesis,BP,
16577,GO:0097374,0.999999999987577,0.890204227118277,0,1,sensory neuron axon guidance,BP,
17986,GO:1902378,0.999999999987577,0.890204227118277,0,1,VEGF-activated neuropilin signaling pathway involved in axon guidance,BP,
19024,GO:1904835,0.999999999987577,0.890204227118277,0,1,dorsal root ganglion morphogenesis,BP,
19121,GO:1905040,0.999999999987577,0.890204227118277,0,1,otic placode development,BP,
1789,GO:0004418,0.999999999987587,0.902347043218819,0,1,hydroxymethylbilane synthase activity,MF,
5913,GO:0018160,0.999999999987587,0.902347043218819,0,1,peptidyl-pyrromethane cofactor linkage,BP,
2035,GO:0004775,0.999999999987607,0.804523826712545,0,2,succinate-CoA ligase (ADP-forming) activity,MF,
3484,GO:0007354,0.999999999987609,0.709406148761319,0,3,zygotic determination of anterior/posterior axis, embryo,BP,
1395,GO:0003308,0.99999999998761,0.796838397592391,0,2,negative regulation of Wnt signaling pathway involved in heart development,BP,
4372,GO:0009996,0.99999999998761,0.796838397592391,0,2,negative regulation of cell fate specification,BP,
8328,GO:0033183,0.999999999987612,0.705289586571913,0,3,negative regulation of histone ubiquitination,BP,
17627,GO:1901314,0.999999999987612,0.705289586571913,0,3,regulation of histone H2A K63-linked ubiquitination,BP,
17628,GO:1901315,0.999999999987612,0.705289586571913,0,3,negative regulation of histone H2A K63-linked ubiquitination,BP,
4734,GO:0010900,0.99999999998763,0.940466183218918,0,1,negative regulation of phosphatidylcholine catabolic process,BP,
3969,GO:0008781,0.999999999987639,0.814788952134214,0,2,N-acylneuraminate cytidylyltransferase activity,MF,
7869,GO:0032437,0.999999999987647,0.713201112349193,0,3,cuticular plate,CC,
19047,GO:1904879,0.999999999987655,0.792614256523093,0,2,positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
1917,GO:0004610,0.999999999987667,0.892776522707741,0,1,phosphoacetylglucosamine mutase activity,MF,
8263,GO:0033065,0.999999999987698,0.818801233904369,0,2,Rad51C-XRCC3 complex,CC,
12128,GO:0048239,0.999999999987718,0.793690269142008,0,2,negative regulation of DNA recombination at telomere,BP,
15912,GO:0072695,0.999999999987718,0.793690269142008,0,2,regulation of DNA recombination at telomere,BP,
18446,GO:1903518,0.999999999987718,0.793690269142008,0,2,positive regulation of single strand break repair,BP,
19043,GO:1904875,0.999999999987718,0.793690269142008,0,2,regulation of DNA ligase activity,BP,
9440,GO:0036022,0.999999999987766,0.796510028175082,0,2,limb joint morphogenesis,BP,
9441,GO:0036023,0.999999999987766,0.796510028175082,0,2,embryonic skeletal limb joint morphogenesis,BP,
2235,GO:0005142,0.999999999987771,0.890518475252107,0,1,interleukin-11 receptor binding,MF,
5843,GO:0017133,0.999999999987771,0.890518475252107,0,1,mitochondrial electron transfer flavoprotein complex,CC,
10653,GO:0043783,0.999999999987771,0.890518475252107,0,1,oxidoreductase activity, oxidizing metal ions with flavin as acceptor,MF,
11166,GO:0045251,0.999999999987771,0.890518475252107,0,1,electron transfer flavoprotein complex,CC,
844,GO:0002158,0.999999999987792,0.725835926525719,0,3,osteoclast proliferation,BP,
10142,GO:0042723,0.999999999987793,0.715826459081191,0,3,thiamine-containing compound metabolic process,BP,
14857,GO:0070634,0.999999999987857,0.711261875517769,0,3,transepithelial ammonium transport,BP,
6516,GO:0021898,0.99999999998787,0.706170144156264,0,3,commitment of multipotent stem cells to neuronal lineage in forebrain,BP,
18277,GO:1903126,0.999999999987876,0.891633445581681,0,1,negative regulation of centriole-centriole cohesion,BP,
20251,GO:2001173,0.999999999987876,0.891633445581681,0,1,regulation of histone H2B conserved C-terminal lysine ubiquitination,BP,
2459,GO:0005674,0.999999999987877,0.80353046640988,0,2,transcription factor TFIIF complex,CC,
10926,GO:0044565,0.999999999987881,0.803621031454421,0,2,dendritic cell proliferation,BP,
3545,GO:0007576,0.999999999987916,0.890121080396611,0,1,nucleolar fragmentation,BP,
952,GO:0002370,0.999999999987922,0.723672517142753,0,3,natural killer cell cytokine production,BP,
1136,GO:0002727,0.999999999987922,0.723672517142753,0,3,regulation of natural killer cell cytokine production,BP,
13163,GO:0051771,0.999999999987922,0.729531057099561,0,3,negative regulation of nitric-oxide synthase biosynthetic process,BP,
10589,GO:0043564,0.999999999987928,0.793516637755204,0,2,Ku70:Ku80 complex,CC,
5357,GO:0016128,0.99999999998793,0.707684596911709,0,3,phytosteroid metabolic process,BP,
5358,GO:0016129,0.99999999998793,0.707684596911709,0,3,phytosteroid biosynthetic process,BP,
6085,GO:0019249,0.999999999987937,0.728794971245559,0,3,lactate biosynthetic process,BP,
13423,GO:0052836,0.999999999987953,0.806484929817139,0,2,inositol 5-diphosphate pentakisphosphate 5-kinase activity,MF,
13424,GO:0052839,0.999999999987953,0.806484929817139,0,2,inositol diphosphate tetrakisphosphate kinase activity,MF,
3260,GO:0006933,0.999999999987963,0.797943467059502,0,2,negative regulation of cell adhesion involved in substrate-bound cell migration,BP,
2067,GO:0004820,0.999999999987977,0.800377324008954,0,2,glycine-tRNA ligase activity,MF,
2912,GO:0006426,0.999999999987977,0.800377324008954,0,2,glycyl-tRNA aminoacylation,BP,
14592,GO:0070150,0.999999999987977,0.800377324008954,0,2,mitochondrial glycyl-tRNA aminoacylation,BP,
7085,GO:0030886,0.999999999987992,0.800258316821362,0,2,negative regulation of myeloid dendritic cell activation,BP,
19280,GO:1905457,0.999999999988029,0.728820800565424,0,3,negative regulation of lymphoid progenitor cell differentiation,BP,
20179,GO:2000974,0.999999999988029,0.728820800565424,0,3,negative regulation of pro-B cell differentiation,BP,
11373,GO:0045759,0.99999999998805,0.803525886357769,0,2,negative regulation of action potential,BP,
10514,GO:0043435,0.999999999988051,0.890076346935243,0,1,response to corticotropin-releasing hormone,BP,
15217,GO:0071376,0.999999999988051,0.890076346935243,0,1,cellular response to corticotropin-releasing hormone stimulus,BP,
5847,GO:0017143,0.999999999988053,0.79218568089859,0,2,insecticide metabolic process,BP,
5239,GO:0015862,0.999999999988079,0.890596664767166,0,1,uridine transport,BP,
15045,GO:0071001,0.999999999988114,0.732920498649094,0,3,U4/U6 snRNP,CC,
9501,GO:0036153,0.999999999988118,0.890023718388917,0,1,triglyceride acyl-chain remodeling,BP,
12908,GO:0051264,0.999999999988118,0.890023718388917,0,1,mono-olein transacylation activity,MF,
12909,GO:0051265,0.999999999988118,0.890023718388917,0,1,diolein transacylation activity,MF,
17336,GO:1900003,0.99999999998812,0.738877272209601,0,3,regulation of serine-type endopeptidase activity,BP,
17337,GO:1900004,0.99999999998812,0.738877272209601,0,3,negative regulation of serine-type endopeptidase activity,BP,
18056,GO:1902571,0.99999999998812,0.738877272209601,0,3,regulation of serine-type peptidase activity,BP,
18057,GO:1902572,0.99999999998812,0.738877272209601,0,3,negative regulation of serine-type peptidase activity,BP,
5834,GO:0017116,0.999999999988163,0.705016433615357,0,3,single-stranded DNA-dependent ATP-dependent DNA helicase activity,MF,
16458,GO:0097125,0.999999999988165,0.799395315320921,0,2,cyclin B1-CDK1 complex,CC,
19315,GO:1905573,0.999999999988253,0.795448623691069,0,2,ganglioside GM1 binding,MF,
19318,GO:1905576,0.999999999988253,0.795448623691069,0,2,ganglioside GT1b binding,MF,
6972,GO:0030644,0.999999999988258,0.803933027482449,0,2,cellular chloride ion homeostasis,BP,
5240,GO:0015864,0.999999999988266,0.793580008937147,0,2,pyrimidine nucleoside transport,BP,
338,GO:0000939,0.999999999988267,0.717260151907959,0,3,condensed chromosome inner kinetochore,CC,
1758,GO:0004361,0.999999999988281,0.8968760174685,0,1,glutaryl-CoA dehydrogenase activity,MF,
2264,GO:0005183,0.999999999988281,0.8968760174685,0,1,gonadotropin hormone-releasing hormone activity,MF,
7422,GO:0031530,0.999999999988281,0.8968760174685,0,1,gonadotropin-releasing hormone receptor binding,MF,
19435,GO:1990008,0.999999999988281,0.8968760174685,0,1,neurosecretory vesicle,CC,
924,GO:0002318,0.999999999988294,0.705722689540296,0,3,myeloid progenitor cell differentiation,BP,
9976,GO:0042374,0.999999999988295,0.813051858662461,0,2,phylloquinone metabolic process,BP,
9977,GO:0042376,0.999999999988295,0.813051858662461,0,2,phylloquinone catabolic process,BP,
17742,GO:1901662,0.999999999988295,0.813051858662461,0,2,quinone catabolic process,BP,
9624,GO:0036496,0.999999999988301,0.803407782965801,0,2,regulation of translational initiation by eIF2 alpha dephosphorylation,BP,
2057,GO:0004809,0.999999999988306,0.708542868954075,0,3,tRNA (guanine-N2-)-methyltransferase activity,MF,
28,GO:0000053,0.999999999988319,0.89494776858011,0,1,argininosuccinate metabolic process,BP,
1622,GO:0004055,0.999999999988319,0.89494776858011,0,1,argininosuccinate synthase activity,MF,
4003,GO:0008962,0.999999999988332,0.79461910076399,0,2,phosphatidylglycerophosphatase activity,MF,
12312,GO:0048674,0.999999999988336,0.890282838577745,0,1,collateral sprouting of injured axon,BP,
12320,GO:0048686,0.999999999988336,0.890282838577745,0,1,regulation of sprouting of injured axon,BP,
12321,GO:0048687,0.999999999988336,0.890282838577745,0,1,positive regulation of sprouting of injured axon,BP,
12322,GO:0048688,0.999999999988336,0.890282838577745,0,1,negative regulation of sprouting of injured axon,BP,
12323,GO:0048689,0.999999999988336,0.890282838577745,0,1,formation of growth cone in injured axon,BP,
12324,GO:0048693,0.999999999988336,0.890282838577745,0,1,regulation of collateral sprouting of injured axon,BP,
12325,GO:0048694,0.999999999988336,0.890282838577745,0,1,positive regulation of collateral sprouting of injured axon,BP,
19320,GO:1905578,0.999999999988336,0.890282838577745,0,1,regulation of ERBB3 signaling pathway,BP,
19321,GO:1905580,0.999999999988336,0.890282838577745,0,1,positive regulation of ERBB3 signaling pathway,BP,
19423,GO:1905942,0.999999999988336,0.890282838577745,0,1,regulation of formation of growth cone in injured axon,BP,
19424,GO:1905943,0.999999999988336,0.890282838577745,0,1,negative regulation of formation of growth cone in injured axon,BP,
1832,GO:0004487,0.999999999988355,0.706153046293483,0,3,methylenetetrahydrofolate dehydrogenase (NAD+) activity,MF,
16778,GO:0098594,0.999999999988369,0.927995544162951,0,1,mucin granule,CC,
12407,GO:0048865,0.999999999988394,0.726933719635535,0,3,stem cell fate commitment,BP,
20311,GO:2001271,0.999999999988405,0.706851836539084,0,3,negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
9710,GO:0038131,0.999999999988409,0.795448623690913,0,2,neuregulin receptor activity,MF,
4261,GO:0009608,0.999999999988462,0.815306968829274,0,2,response to symbiont,BP,
4262,GO:0009609,0.999999999988462,0.815306968829274,0,2,response to symbiotic bacterium,BP,
4010,GO:0009000,0.999999999988482,0.890237452246427,0,1,selenocysteine lyase activity,MF,
15837,GO:0072554,0.999999999988492,0.890504061882424,0,1,blood vessel lumenization,BP,
17584,GO:1901189,0.999999999988492,0.890504061882424,0,1,positive regulation of ephrin receptor signaling pathway,BP,
17619,GO:1901297,0.999999999988492,0.890504061882424,0,1,positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
19137,GO:1905068,0.999999999988492,0.890504061882424,0,1,positive regulation of canonical Wnt signaling pathway involved in heart development,BP,
8326,GO:0033181,0.999999999988509,0.897630433824019,0,1,plasma membrane proton-transporting V-type ATPase complex,CC,
7848,GO:0032415,0.999999999988541,0.707151866289308,0,3,regulation of sodium:proton antiporter activity,BP,
894,GO:0002266,0.999999999988548,0.795997501313388,0,2,follicular dendritic cell activation,BP,
895,GO:0002268,0.999999999988548,0.795997501313388,0,2,follicular dendritic cell differentiation,BP,
8357,GO:0033257,0.999999999988548,0.795997501313388,0,2,Bcl3/NF-kappaB2 complex,CC,
10386,GO:0043224,0.999999999988567,0.8433441359127,0,2,nuclear SCF ubiquitin ligase complex,CC,
5390,GO:0016222,0.999999999988578,0.792188529634732,0,2,procollagen-proline 4-dioxygenase complex,CC,
5827,GO:0017102,0.999999999988578,0.792188529634732,0,2,methionyl glutamyl tRNA synthetase complex,CC,
51,GO:0000105,0.999999999988583,0.792557183849112,0,2,histidine biosynthetic process,BP,
9519,GO:0036228,0.999999999988583,0.792557183849112,0,2,protein localization to nuclear inner membrane,BP,
13720,GO:0060300,0.999999999988592,0.715140294782015,0,3,regulation of cytokine activity,BP,
6239,GO:0019808,0.999999999988595,0.746759985685249,0,3,polyamine binding,MF,
2029,GO:0004768,0.999999999988622,0.705047666454485,0,3,stearoyl-CoA 9-desaturase activity,MF,
5389,GO:0016215,0.999999999988622,0.705047666454485,0,3,acyl-CoA desaturase activity,MF,
3130,GO:0006722,0.999999999988624,0.890367354237617,0,1,triterpenoid metabolic process,BP,
6213,GO:0019742,0.999999999988624,0.890367354237617,0,1,pentacyclic triterpenoid metabolic process,BP,
19071,GO:1904924,0.999999999988624,0.890367354237617,0,1,negative regulation of mitophagy in response to mitochondrial depolarization,BP,
19246,GO:1905370,0.999999999988624,0.890367354237617,0,1,serine-type endopeptidase complex,CC,
6410,GO:0021678,0.99999999998863,0.771602684586533,0,3,third ventricle development,BP,
2075,GO:0004828,0.99999999998863,0.797446139406688,0,2,serine-tRNA ligase activity,MF,
2920,GO:0006434,0.99999999998863,0.797446139406688,0,2,seryl-tRNA aminoacylation,BP,
14023,GO:0060763,0.999999999988637,0.792391683748627,0,2,mammary duct terminal end bud growth,BP,
18671,GO:1903977,0.999999999988637,0.792391683748627,0,2,positive regulation of glial cell migration,BP,
5524,GO:0016494,0.999999999988643,0.707612375210661,0,3,C-X-C chemokine receptor activity,MF,
6310,GO:0019958,0.999999999988643,0.707612375210661,0,3,C-X-C chemokine binding,MF,
19028,GO:1904844,0.999999999988648,0.829218362939064,0,2,response to L-glutamine,BP,
19029,GO:1904845,0.999999999988648,0.829218362939064,0,2,cellular response to L-glutamine,BP,
3647,GO:0008127,0.999999999988672,0.907193365607256,0,1,quercetin 2,3-dioxygenase activity,MF,
5917,GO:0018192,0.999999999988673,0.890260405116328,0,1,enzyme active site formation via cysteine modification to L-cysteine persulfide,BP,
7874,GO:0032447,0.999999999988673,0.890260405116328,0,1,protein urmylation,BP,
9934,GO:0042292,0.999999999988673,0.890260405116328,0,1,URM1 activating enzyme activity,MF,
14365,GO:0061604,0.999999999988673,0.890260405116328,0,1,molybdopterin-synthase sulfurtransferase activity,MF,
14366,GO:0061605,0.999999999988673,0.890260405116328,0,1,molybdopterin-synthase adenylyltransferase activity,MF,
16882,GO:0098822,0.999999999988673,0.890260405116328,0,1,peptidyl-cysteine modification to L-cysteine persulfide,BP,
1689,GO:0004161,0.999999999988681,0.802687844757597,0,2,dimethylallyltranstransferase activity,MF,
1740,GO:0004337,0.999999999988681,0.802687844757597,0,2,geranyltranstransferase activity,MF,
8400,GO:0033383,0.999999999988681,0.802687844757597,0,2,geranyl diphosphate metabolic process,BP,
8401,GO:0033384,0.999999999988681,0.802687844757597,0,2,geranyl diphosphate biosynthetic process,BP,
1946,GO:0004649,0.999999999988689,0.798589165331936,0,2,poly(ADP-ribose) glycohydrolase activity,MF,
14460,GO:0061827,0.999999999988708,0.801668065416152,0,2,sperm head,CC,
1145,GO:0002740,0.99999999998872,0.806675821742766,0,2,negative regulation of cytokine secretion involved in immune response,BP,
1209,GO:0002874,0.99999999998872,0.806675821742766,0,2,regulation of chronic inflammatory response to antigenic stimulus,BP,
19421,GO:1905940,0.999999999988738,0.707695023283753,0,3,negative regulation of gonad development,BP,
1924,GO:0004618,0.999999999988756,0.890317934610169,0,1,phosphoglycerate kinase activity,MF,
3203,GO:0006843,0.99999999998878,0.899105926534861,0,1,mitochondrial citrate transmembrane transport,BP,
16079,GO:0090044,0.99999999998878,0.899105926534861,0,1,positive regulation of tubulin deacetylation,BP,
19572,GO:1990546,0.99999999998878,0.899105926534861,0,1,mitochondrial tricarboxylic acid transmembrane transport,BP,
8747,GO:0034418,0.999999999988799,0.793709836548723,0,2,urate biosynthetic process,BP,
3022,GO:0006572,0.999999999988836,0.732299028010125,0,3,tyrosine catabolic process,BP,
2680,GO:0006046,0.999999999988847,0.712283824260054,0,3,N-acetylglucosamine catabolic process,BP,
8770,GO:0034457,0.999999999988874,0.740976495424925,0,3,Mpp10 complex,CC,
14813,GO:0070552,0.999999999988885,0.705761814228569,0,3,BRISC complex,CC,
1838,GO:0004493,0.999999999988904,0.922638462129291,0,1,methylmalonyl-CoA epimerase activity,MF,
11691,GO:0046491,0.999999999988904,0.922638462129291,0,1,L-methylmalonyl-CoA metabolic process,BP,
9225,GO:0035617,0.999999999988905,0.705984410891718,0,3,stress granule disassembly,BP,
9653,GO:0038001,0.999999999988936,0.797197604735214,0,2,paracrine signaling,BP,
8331,GO:0033186,0.99999999998894,0.705593007339129,0,3,CAF-1 complex,CC,
7654,GO:0032090,0.999999999988944,0.820235302205974,0,2,Pyrin domain binding,MF,
10913,GO:0044530,0.999999999988949,0.706673850147075,0,3,supraspliceosomal complex,CC,
5979,GO:0018738,0.999999999988968,0.910497910801425,0,1,S-formylglutathione hydrolase activity,MF,
1092,GO:0002679,0.999999999988986,0.732268039617061,0,3,respiratory burst involved in defense response,BP,
11348,GO:0045716,0.999999999989003,0.720855727182716,0,3,positive regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
7367,GO:0031427,0.999999999989033,0.705465479000809,0,3,response to methotrexate,BP,
6503,GO:0021882,0.999999999989039,0.793445100198082,0,2,regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment,BP,
6511,GO:0021893,0.999999999989039,0.793445100198082,0,2,cerebral cortex GABAergic interneuron fate commitment,BP,
9362,GO:0035881,0.999999999989039,0.793445100198082,0,2,amacrine cell differentiation,BP,
14167,GO:0061074,0.999999999989039,0.793445100198082,0,2,regulation of neural retina development,BP,
14168,GO:0061075,0.999999999989039,0.793445100198082,0,2,positive regulation of neural retina development,BP,
18151,GO:1902866,0.999999999989039,0.793445100198082,0,2,regulation of retina development in camera-type eye,BP,
18152,GO:1902868,0.999999999989039,0.793445100198082,0,2,positive regulation of retina development in camera-type eye,BP,
18153,GO:1902869,0.999999999989039,0.793445100198082,0,2,regulation of amacrine cell differentiation,BP,
18154,GO:1902871,0.999999999989039,0.793445100198082,0,2,positive regulation of amacrine cell differentiation,BP,
4997,GO:0015140,0.999999999989075,0.800779012983452,0,2,malate transmembrane transporter activity,MF,
3017,GO:0006566,0.999999999989103,0.725319220523904,0,3,threonine metabolic process,BP,
3590,GO:0008020,0.999999999989105,0.792161756158391,0,2,G-protein coupled photoreceptor activity,MF,
7371,GO:0031431,0.999999999989111,0.792133854602854,0,2,Dbf4-dependent protein kinase complex,CC,
6879,GO:0030389,0.999999999989114,0.930451864966635,0,1,fructosamine metabolic process,BP,
5551,GO:0016557,0.99999999998913,0.72606578892816,0,3,peroxisome membrane biogenesis,BP,
4832,GO:0014040,0.999999999989133,0.792192564626125,0,2,positive regulation of Schwann cell differentiation,BP,
4459,GO:0010454,0.99999999998916,0.709190455853088,0,3,negative regulation of cell fate commitment,BP,
16207,GO:0090244,0.99999999998916,0.709190455853088,0,3,Wnt signaling pathway involved in somitogenesis,BP,
2981,GO:0006528,0.999999999989169,0.719834156159083,0,3,asparagine metabolic process,BP,
228,GO:0000472,0.999999999989173,0.705726539957869,0,3,endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
353,GO:0000967,0.999999999989173,0.705726539957869,0,3,rRNA 5'-end processing,BP,
215,GO:0000451,0.999999999989194,0.796443610819718,0,2,rRNA 2'-O-methylation,BP,
216,GO:0000453,0.999999999989194,0.796443610819718,0,2,enzyme-directed rRNA 2'-O-methylation,BP,
14529,GO:0070039,0.999999999989194,0.796443610819718,0,2,rRNA (guanosine-2'-O-)-methyltransferase activity,MF,
7768,GO:0032299,0.999999999989211,0.730484901096258,0,3,ribonuclease H2 complex,CC,
7322,GO:0031339,0.999999999989245,0.71181794363677,0,3,negative regulation of vesicle fusion,BP,
1621,GO:0004053,0.999999999989272,0.80621382977194,0,2,arginase activity,MF,
6176,GO:0019547,0.999999999989272,0.80621382977194,0,2,arginine catabolic process to ornithine,BP,
1237,GO:0002924,0.999999999989291,0.890903291678888,0,1,negative regulation of humoral immune response mediated by circulating immunoglobulin,BP,
9851,GO:0042105,0.999999999989291,0.890903291678888,0,1,alpha-beta T cell receptor complex,CC,
1793,GO:0004422,0.99999999998932,0.807536343565877,0,2,hypoxanthine phosphoribosyltransferase activity,MF,
2761,GO:0006178,0.99999999998932,0.807536343565877,0,2,guanine salvage,BP,
7742,GO:0032263,0.99999999998932,0.807536343565877,0,2,GMP salvage,BP,
11547,GO:0046099,0.99999999998932,0.807536343565877,0,2,guanine biosynthetic process,BP,
9204,GO:0035594,0.999999999989427,0.707953443491226,0,3,ganglioside binding,MF,
2696,GO:0006065,0.99999999998945,0.706217393984965,0,3,UDP-glucuronate biosynthetic process,BP,
11647,GO:0046398,0.99999999998945,0.706217393984965,0,3,UDP-glucuronate metabolic process,BP,
10432,GO:0043293,0.999999999989476,0.797406573493936,0,2,apoptosome,CC,
917,GO:0002309,0.9999999999895,0.924185939446541,0,1,T cell proliferation involved in immune response,BP,
1678,GO:0004142,0.999999999989524,0.713578784839244,0,3,diacylglycerol cholinephosphotransferase activity,MF,
16388,GO:0097003,0.999999999989535,0.793569824042555,0,2,adipokinetic hormone receptor activity,MF,
1916,GO:0004609,0.99999999998955,0.793595743690638,0,2,phosphatidylserine decarboxylase activity,MF,
19578,GO:1990573,0.999999999989554,0.708307145821088,0,3,potassium ion import across plasma membrane,BP,
2820,GO:0006288,0.999999999989575,0.720785080926629,0,3,base-excision repair, DNA ligation,BP,
8402,GO:0033385,0.999999999989592,0.890023718102509,0,1,geranylgeranyl diphosphate metabolic process,BP,
8403,GO:0033386,0.999999999989592,0.890023718102509,0,1,geranylgeranyl diphosphate biosynthetic process,BP,
1728,GO:0004320,0.999999999989598,0.797497874798097,0,2,oleoyl-[acyl-carrier-protein] hydrolase activity,MF,
5433,GO:0016295,0.999999999989598,0.797497874798097,0,2,myristoyl-[acyl-carrier-protein] hydrolase activity,MF,
5434,GO:0016296,0.999999999989598,0.797497874798097,0,2,palmitoyl-[acyl-carrier-protein] hydrolase activity,MF,
5435,GO:0016297,0.999999999989598,0.797497874798097,0,2,acyl-[acyl-carrier-protein] hydrolase activity,MF,
7133,GO:0030974,0.999999999989599,0.799452992222079,0,2,thiamine pyrophosphate transmembrane transport,BP,
16302,GO:0090422,0.999999999989599,0.799452992222079,0,2,thiamine pyrophosphate transmembrane transporter activity,MF,
7115,GO:0030942,0.999999999989618,0.723986143871466,0,3,endoplasmic reticulum signal peptide binding,MF,
12673,GO:0050893,0.999999999989618,0.707279856579191,0,3,sensory processing,BP,
1090,GO:0002677,0.99999999998963,0.799714073461901,0,2,negative regulation of chronic inflammatory response,BP,
8041,GO:0032701,0.99999999998963,0.799714073461901,0,2,negative regulation of interleukin-18 production,BP,
13076,GO:0051595,0.999999999989638,0.740351524284942,0,3,response to methylglyoxal,BP,
5468,GO:0016401,0.999999999989645,0.796536786057771,0,2,palmitoyl-CoA oxidase activity,MF,
2187,GO:0005046,0.999999999989654,0.801156872083646,0,2,KDEL sequence binding,MF,
19969,GO:2000501,0.999999999989667,0.812297860133855,0,2,regulation of natural killer cell chemotaxis,BP,
19970,GO:2000503,0.999999999989667,0.812297860133855,0,2,positive regulation of natural killer cell chemotaxis,BP,
8780,GO:0034473,0.999999999989681,0.740918159513275,0,3,U1 snRNA 3'-end processing,BP,
8783,GO:0034476,0.999999999989681,0.740918159513275,0,3,U5 snRNA 3'-end processing,BP,
6965,GO:0030626,0.999999999989731,0.795686916144126,0,2,U12 snRNA binding,MF,
10937,GO:0044609,0.999999999989741,0.793547761392525,0,2,DBIRD complex,CC,
13997,GO:0060729,0.999999999989781,0.71138369610117,0,3,intestinal epithelial structure maintenance,BP,
9248,GO:0035658,0.999999999989788,0.707294584372807,0,3,Mon1-Ccz1 complex,CC,
9284,GO:0035727,0.999999999989799,0.792133854878815,0,2,lysophosphatidic acid binding,MF,
11076,GO:0045084,0.999999999989816,0.705147143567321,0,3,positive regulation of interleukin-12 biosynthetic process,BP,
2363,GO:0005476,0.999999999989826,0.795948580693662,0,2,carnitine:acyl carnitine antiporter activity,MF,
14392,GO:0061649,0.999999999989838,0.706225587778334,0,3,ubiquitin modification-dependent histone binding,MF,
19753,GO:2000110,0.99999999998986,0.722889156700655,0,3,negative regulation of macrophage apoptotic process,BP,
14803,GO:0070537,0.999999999989869,0.705034963783497,0,3,histone H2A K63-linked deubiquitination,BP,
6659,GO:0030020,0.999999999989876,0.705114651540696,0,3,extracellular matrix structural constituent conferring tensile strength,MF,
1297,GO:0003129,0.999999999989919,0.713658761270626,0,3,heart induction,BP,
2362,GO:0005471,0.999999999989923,0.72707791792413,0,3,ATP:ADP antiporter activity,MF,
5034,GO:0015207,0.999999999989923,0.72707791792413,0,3,adenine transmembrane transporter activity,MF,
630,GO:0001820,0.999999999989927,0.721944217281125,0,3,serotonin secretion,BP,
12140,GO:0048257,0.999999999989932,0.792434112234649,0,2,3'-flap endonuclease activity,MF,
9541,GO:0036301,0.999999999990013,0.705487039111844,0,3,macrophage colony-stimulating factor production,BP,
17607,GO:1901256,0.999999999990013,0.705487039111844,0,3,regulation of macrophage colony-stimulating factor production,BP,
13878,GO:0060528,0.999999999990044,0.705264371883911,0,3,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,BP,
9598,GO:0036461,0.999999999990058,0.822979740996902,0,2,BLOC-2 complex binding,MF,
1922,GO:0004616,0.999999999990061,0.710030786065177,0,3,phosphogluconate dehydrogenase (decarboxylating) activity,MF,
14289,GO:0061408,0.999999999990073,0.706206525677705,0,3,positive regulation of transcription from RNA polymerase II promoter in response to heat stress,BP,
10660,GO:0043874,0.999999999990076,0.892636541423318,0,1,acireductone synthase activity,MF,
5009,GO:0015168,0.999999999990078,0.796590630418362,0,2,glycerol transmembrane transporter activity,MF,
5055,GO:0015254,0.999999999990078,0.796590630418362,0,2,glycerol channel activity,MF,
5198,GO:0015793,0.999999999990078,0.796590630418362,0,2,glycerol transport,BP,
1724,GO:0004315,0.999999999990083,0.808052636232106,0,2,3-oxoacyl-[acyl-carrier-protein] synthase activity,MF,
6999,GO:0030689,0.999999999990085,0.711532107296923,0,3,Noc complex,CC,
19583,GO:1990589,0.999999999990097,0.798141862147626,0,2,ATF4-CREB1 transcription factor complex,CC,
9504,GO:0036157,0.999999999990103,0.736997988340099,0,3,outer dynein arm,CC,
11848,GO:0046848,0.999999999990125,0.904786192017216,0,1,hydroxyapatite binding,MF,
1737,GO:0004334,0.999999999990125,0.902689461441424,0,1,fumarylacetoacetase activity,MF,
1577,GO:0003986,0.999999999990147,0.749747676502369,0,3,acetyl-CoA hydrolase activity,MF,
8039,GO:0032696,0.999999999990155,0.707340713629875,0,3,negative regulation of interleukin-13 production,BP,
11773,GO:0046642,0.999999999990155,0.707340713629875,0,3,negative regulation of alpha-beta T cell proliferation,BP,
7520,GO:0031731,0.999999999990168,0.838789954772222,0,3,CCR6 chemokine receptor binding,MF,
2893,GO:0006404,0.999999999990187,0.730436936606144,0,3,RNA import into nucleus,BP,
15040,GO:0070991,0.99999999999021,0.705081743417058,0,3,medium-chain-acyl-CoA dehydrogenase activity,MF,
13303,GO:0052151,0.999999999990239,0.813479234038277,0,2,positive regulation by symbiont of host apoptotic process,BP,
13628,GO:0060139,0.999999999990239,0.813479234038277,0,2,positive regulation of apoptotic process by virus,BP,
19740,GO:2000078,0.999999999990239,0.813479234038277,0,2,positive regulation of type B pancreatic cell development,BP,
858,GO:0002189,0.999999999990241,0.890130678788511,0,1,ribose phosphate diphosphokinase complex,CC,
14676,GO:0070295,0.999999999990242,0.70987065779588,0,3,renal water absorption,BP,
7912,GO:0032493,0.999999999990247,0.709432003791594,0,3,response to bacterial lipoprotein,BP,
14672,GO:0070291,0.999999999990247,0.709432003791594,0,3,N-acylethanolamine metabolic process,BP,
14703,GO:0070339,0.999999999990247,0.709432003791594,0,3,response to bacterial lipopeptide,BP,
15123,GO:0071220,0.999999999990247,0.709432003791594,0,3,cellular response to bacterial lipoprotein,BP,
15124,GO:0071221,0.999999999990247,0.709432003791594,0,3,cellular response to bacterial lipopeptide,BP,
10976,GO:0044778,0.999999999990273,0.793594922002995,0,2,meiotic DNA integrity checkpoint,BP,
19646,GO:1990812,0.999999999990305,0.705024193040509,0,3,growth cone filopodium,CC,
12684,GO:0050910,0.999999999990318,0.792178473736751,0,2,detection of mechanical stimulus involved in sensory perception of sound,BP,
13207,GO:0051877,0.999999999990321,0.792178473736748,0,2,pigment granule aggregation in cell center,BP,
5674,GO:0016784,0.999999999990328,0.902203627915027,0,1,3-mercaptopyruvate sulfurtransferase activity,MF,
6258,GO:0019853,0.999999999990328,0.902203627915027,0,1,L-ascorbic acid biosynthetic process,BP,
6699,GO:0030108,0.999999999990328,0.902203627915027,0,1,HLA-A specific activating MHC class I receptor activity,MF,
7557,GO:0031906,0.999999999990328,0.902203627915027,0,1,late endosome lumen,CC,
7834,GO:0032397,0.999999999990328,0.902203627915027,0,1,activating MHC class I receptor activity,MF,
10210,GO:0042839,0.999999999990328,0.902203627915027,0,1,D-glucuronate metabolic process,BP,
10211,GO:0042840,0.999999999990328,0.902203627915027,0,1,D-glucuronate catabolic process,BP,
12043,GO:0047939,0.999999999990328,0.902203627915027,0,1,L-glucuronate reductase activity,MF,
16627,GO:0097486,0.999999999990328,0.902203627915027,0,1,multivesicular body lumen,CC,
7228,GO:0031134,0.999999999990328,0.708815586003033,0,3,sister chromatid biorientation,BP,
1640,GO:0004082,0.999999999990371,0.719134924758834,0,3,bisphosphoglycerate mutase activity,MF,
1925,GO:0004619,0.999999999990371,0.719134924758834,0,3,phosphoglycerate mutase activity,MF,
11718,GO:0046538,0.999999999990371,0.719134924758834,0,3,2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity,MF,
16231,GO:0090283,0.999999999990382,0.710657055897695,0,3,regulation of protein glycosylation in Golgi,BP,
3726,GO:0008265,0.999999999990399,0.890026053165563,0,1,Mo-molybdopterin cofactor sulfurase activity,MF,
17176,GO:0102867,0.999999999990399,0.890026053165563,0,1,molybdenum cofactor sulfurtransferase activity,MF,
293,GO:0000798,0.999999999990406,0.705569755800167,0,3,nuclear cohesin complex,CC,
7090,GO:0030893,0.999999999990406,0.705569755800167,0,3,meiotic cohesin complex,CC,
18543,GO:1903722,0.999999999990408,0.819881160409237,0,2,regulation of centriole elongation,BP,
2236,GO:0005143,0.999999999990417,0.794708400439351,0,2,interleukin-12 receptor binding,MF,
2723,GO:0006106,0.999999999990436,0.710821585566235,0,3,fumarate metabolic process,BP,
19591,GO:1990617,0.999999999990441,0.825957222440034,0,2,CHOP-ATF4 complex,CC,
6328,GO:0021501,0.999999999990452,0.891991223525705,0,1,prechordal plate formation,BP,
6361,GO:0021547,0.999999999990452,0.891991223525705,0,1,midbrain-hindbrain boundary initiation,BP,
20104,GO:2000742,0.999999999990452,0.891991223525705,0,1,regulation of anterior head development,BP,
20105,GO:2000744,0.999999999990452,0.891991223525705,0,1,positive regulation of anterior head development,BP,
18415,GO:1903433,0.999999999990458,0.792133859857849,0,2,regulation of constitutive secretory pathway,BP,
8077,GO:0032767,0.999999999990468,0.74397445613413,0,3,copper-dependent protein binding,MF,
2797,GO:0006258,0.999999999990487,0.807514119777022,0,2,UDP-glucose catabolic process,BP,
12039,GO:0047894,0.999999999990504,0.813724769529381,0,2,flavonol 3-sulfotransferase activity,MF,
7754,GO:0032277,0.999999999990506,0.891378185491808,0,1,negative regulation of gonadotropin secretion,BP,
10549,GO:0043509,0.999999999990506,0.891378185491808,0,1,activin A complex,CC,
10550,GO:0043511,0.999999999990506,0.891378185491808,0,1,inhibin complex,CC,
10551,GO:0043512,0.999999999990506,0.891378185491808,0,1,inhibin A complex,CC,
11069,GO:0045077,0.999999999990506,0.891378185491808,0,1,negative regulation of interferon-gamma biosynthetic process,BP,
11864,GO:0046882,0.999999999990506,0.891378185491808,0,1,negative regulation of follicle-stimulating hormone secretion,BP,
12110,GO:0048180,0.999999999990506,0.891378185491808,0,1,activin complex,CC,
13703,GO:0060278,0.999999999990506,0.891378185491808,0,1,regulation of ovulation,BP,
13704,GO:0060279,0.999999999990506,0.891378185491808,0,1,positive regulation of ovulation,BP,
7362,GO:0031417,0.999999999990562,0.705013911728219,0,3,NatC complex,CC,
4268,GO:0009624,0.999999999990569,0.890067142533845,0,1,response to nematode,BP,
4286,GO:0009692,0.999999999990569,0.890067142533845,0,1,ethylene metabolic process,BP,
4287,GO:0009698,0.999999999990569,0.890067142533845,0,1,phenylpropanoid metabolic process,BP,
4316,GO:0009804,0.999999999990569,0.890067142533845,0,1,coumarin metabolic process,BP,
5631,GO:0016711,0.999999999990569,0.890067142533845,0,1,flavonoid 3'-monooxygenase activity,MF,
6103,GO:0019341,0.999999999990569,0.890067142533845,0,1,dibenzo-p-dioxin catabolic process,BP,
10516,GO:0043449,0.999999999990569,0.890067142533845,0,1,cellular alkene metabolic process,BP,
7753,GO:0032276,0.999999999990592,0.706076110062751,0,3,regulation of gonadotropin secretion,BP,
7755,GO:0032278,0.999999999990592,0.706076110062751,0,3,positive regulation of gonadotropin secretion,BP,
11262,GO:0045578,0.999999999990592,0.706076110062751,0,3,negative regulation of B cell differentiation,BP,
11862,GO:0046880,0.999999999990592,0.706076110062751,0,3,regulation of follicle-stimulating hormone secretion,BP,
11863,GO:0046881,0.999999999990592,0.706076110062751,0,3,positive regulation of follicle-stimulating hormone secretion,BP,
4055,GO:0009106,0.999999999990595,0.798860170695809,0,2,lipoate metabolic process,BP,
18081,GO:1902636,0.999999999990606,0.817462946692085,0,2,kinociliary basal body,CC,
11056,GO:0045062,0.999999999990609,0.896932299100495,0,1,extrathymic T cell selection,BP,
15057,GO:0071021,0.999999999990609,0.896932299100495,0,1,U2-type post-spliceosomal complex,CC,
5531,GO:0016508,0.999999999990613,0.705010387143284,0,3,long-chain-enoyl-CoA hydratase activity,MF,
3816,GO:0008413,0.999999999990621,0.829297212691198,0,2,8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity,MF,
9170,GO:0035539,0.999999999990621,0.829297212691198,0,2,8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity,MF,
15256,GO:0071435,0.999999999990629,0.705254715624371,0,3,potassium ion export,BP,
2476,GO:0005712,0.999999999990656,0.792319205120912,0,2,chiasma,CC,
3339,GO:0007060,0.999999999990656,0.792319205120912,0,2,male meiosis chromosome segregation,BP,
11478,GO:0045950,0.999999999990656,0.792319205120912,0,2,negative regulation of mitotic recombination,BP,
5743,GO:0016890,0.999999999990696,0.802596775532234,0,2,site-specific endodeoxyribonuclease activity, specific for altered base,MF,
3086,GO:0006663,0.999999999990711,0.712791317412033,0,3,platelet activating factor biosynthetic process,BP,
3924,GO:0008607,0.999999999990711,0.712791317412033,0,3,phosphorylase kinase regulator activity,MF,
17864,GO:1902044,0.999999999990755,0.792568500281921,0,2,regulation of Fas signaling pathway,BP,
2883,GO:0006391,0.999999999990766,0.712178420069331,0,3,transcription initiation from mitochondrial promoter,BP,
1759,GO:0004362,0.999999999990782,0.890842998565079,0,1,glutathione-disulfide reductase activity,MF,
5194,GO:0015786,0.999999999990782,0.890842998565079,0,1,UDP-glucose transmembrane transport,BP,
18659,GO:1903961,0.999999999990784,0.705670210923346,0,3,positive regulation of anion transmembrane transport,BP,
2123,GO:0004917,0.999999999990793,0.895277752308565,0,1,interleukin-7 receptor activity,MF,
6962,GO:0030622,0.999999999990821,0.705974144514806,0,3,U4atac snRNA binding,MF,
8493,GO:0033680,0.99999999999083,0.792148914785166,0,2,ATP-dependent DNA/RNA helicase activity,MF,
18983,GO:1904751,0.999999999990832,0.729001605869742,0,3,positive regulation of protein localization to nucleolus,BP,
8347,GO:0033227,0.999999999990844,0.70879220516679,0,3,dsRNA transport,BP,
19724,GO:2000049,0.999999999990844,0.70879220516679,0,3,positive regulation of cell-cell adhesion mediated by cadherin,BP,
13391,GO:0052735,0.999999999990851,0.706106357599332,0,3,tRNA (cytosine-3-)-methyltransferase activity,MF,
5409,GO:0016250,0.999999999990854,0.890024153765583,0,1,N-sulfoglucosamine sulfohydrolase activity,MF,
5700,GO:0016826,0.999999999990854,0.890024153765583,0,1,hydrolase activity, acting on acid sulfur-nitrogen bonds,MF,
237,GO:0000495,0.999999999990855,0.890089677671998,0,1,box H/ACA snoRNA 3'-end processing,BP,
2733,GO:0006117,0.999999999990855,0.890089677671998,0,1,acetaldehyde metabolic process,BP,
8548,GO:0033979,0.999999999990855,0.890089677671998,0,1,box H/ACA snoRNA metabolic process,BP,
8930,GO:0034964,0.999999999990855,0.890089677671998,0,1,box H/ACA snoRNA processing,BP,
9166,GO:0035525,0.999999999990855,0.890089677671998,0,1,NF-kappaB p50/p65 complex,CC,
6010,GO:0019061,0.999999999990874,0.890820564237259,0,1,uncoating of virus,BP,
15392,GO:0071650,0.999999999990896,0.714298437893943,0,3,negative regulation of chemokine (C-C motif) ligand 5 production,BP,
7964,GO:0032581,0.999999999990902,0.894667975015079,0,1,ER-dependent peroxisome organization,BP,
17226,GO:0106101,0.999999999990902,0.894667975015079,0,1,ER-dependent peroxisome localization,BP,
304,GO:0000814,0.999999999990957,0.739986838618205,0,3,ESCRT II complex,CC,
7789,GO:0032345,0.999999999990969,0.705004193824216,0,3,negative regulation of aldosterone metabolic process,BP,
7792,GO:0032348,0.999999999990969,0.705004193824216,0,3,negative regulation of aldosterone biosynthetic process,BP,
19735,GO:2000065,0.999999999990969,0.705004193824216,0,3,negative regulation of cortisol biosynthetic process,BP,
14130,GO:0061009,0.999999999990972,0.715399949384012,0,3,common bile duct development,BP,
9023,GO:0035241,0.999999999990981,0.705302431674914,0,3,protein-arginine omega-N monomethyltransferase activity,MF,
6490,GO:0021855,0.999999999990983,0.70592912439722,0,3,hypothalamus cell migration,BP,
3684,GO:0008192,0.999999999990991,0.718459803855102,0,3,RNA guanylyltransferase activity,MF,
19551,GO:1990442,0.999999999990997,0.76308673038908,0,3,intrinsic apoptotic signaling pathway in response to nitrosative stress,BP,
1587,GO:0003997,0.999999999991014,0.708921996920124,0,3,acyl-CoA oxidase activity,MF,
864,GO:0002196,0.999999999991046,0.893944193054029,0,1,Ser-tRNA(Ala) hydrolase activity,MF,
4978,GO:0015098,0.999999999991046,0.893944193054029,0,1,molybdate ion transmembrane transporter activity,MF,
5151,GO:0015689,0.999999999991046,0.893944193054029,0,1,molybdate ion transport,BP,
9134,GO:0035473,0.999999999991061,0.80082216217499,0,2,lipase binding,MF,
17450,GO:1900222,0.999999999991061,0.80082216217499,0,2,negative regulation of amyloid-beta clearance,BP,
11017,GO:0044861,0.999999999991079,0.795846005567105,0,2,protein transport into plasma membrane raft,BP,
18335,GO:1903279,0.999999999991079,0.795846005567105,0,2,regulation of calcium:sodium antiporter activity,BP,
18336,GO:1903281,0.999999999991079,0.795846005567105,0,2,positive regulation of calcium:sodium antiporter activity,BP,
15469,GO:0071818,0.999999999991081,0.707065551816498,0,3,BAT3 complex,CC,
15772,GO:0072379,0.999999999991081,0.707065551816498,0,3,ER membrane insertion complex,CC,
11894,GO:0046933,0.999999999991101,0.755987844325922,0,3,proton-transporting ATP synthase activity, rotational mechanism,MF,
4211,GO:0009368,0.999999999991109,0.812121298171813,0,2,endopeptidase Clp complex,CC,
1742,GO:0004342,0.99999999999111,0.796029152220891,0,2,glucosamine-6-phosphate deaminase activity,MF,
2677,GO:0006043,0.99999999999111,0.796029152220891,0,2,glucosamine catabolic process,BP,
2691,GO:0006060,0.999999999991115,0.804799926717271,0,2,sorbitol metabolic process,BP,
11637,GO:0046370,0.999999999991115,0.804799926717271,0,2,fructose biosynthetic process,BP,
667,GO:0001875,0.999999999991125,0.705011727812759,0,3,lipopolysaccharide receptor activity,MF,
4722,GO:0010886,0.999999999991125,0.705011727812759,0,3,positive regulation of cholesterol storage,BP,
13156,GO:0051754,0.99999999999114,0.70534361308176,0,3,meiotic sister chromatid cohesion, centromeric,BP,
11301,GO:0045629,0.999999999991162,0.71609399028706,0,3,negative regulation of T-helper 2 cell differentiation,BP,
16563,GO:0097350,0.999999999991162,0.71609399028706,0,3,neutrophil clearance,BP,
12428,GO:0050023,0.999999999991177,0.894433813823262,0,1,L-fuconate dehydratase activity,MF,
17291,GO:0140052,0.999999999991181,0.705013332785129,0,3,cellular response to oxidised low-density lipoprotein particle stimulus,BP,
3582,GO:0007634,0.999999999991183,0.89028706391085,0,1,optokinetic behavior,BP,
14066,GO:0060876,0.999999999991183,0.89028706391085,0,1,semicircular canal formation,BP,
5420,GO:0016269,0.999999999991206,0.890191337452638,0,1,O-glycan processing, core 3,BP,
11963,GO:0047224,0.999999999991206,0.890191337452638,0,1,acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity,MF,
1786,GO:0004408,0.99999999999121,0.890764161406839,0,1,holocytochrome-c synthase activity,MF,
5781,GO:0017003,0.99999999999121,0.890764161406839,0,1,protein-heme linkage,BP,
5784,GO:0017006,0.99999999999121,0.890764161406839,0,1,protein-tetrapyrrole linkage,BP,
5892,GO:0018063,0.99999999999121,0.890764161406839,0,1,cytochrome c-heme linkage,BP,
11217,GO:0045358,0.999999999991223,0.810737407594611,0,2,negative regulation of interferon-beta biosynthetic process,BP,
11624,GO:0046340,0.999999999991224,0.705005837661546,0,3,diacylglycerol catabolic process,BP,
7379,GO:0031439,0.999999999991226,0.792403961404978,0,2,positive regulation of mRNA cleavage,BP,
18967,GO:1904720,0.999999999991229,0.792403961404975,0,2,regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
6935,GO:0030549,0.999999999991245,0.912074713373652,0,1,acetylcholine receptor activator activity,MF,
13497,GO:0055077,0.999999999991248,0.705003449532439,0,3,gap junction hemi-channel activity,MF,
19277,GO:1905449,0.999999999991251,0.7960654508756,0,2,regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
19278,GO:1905451,0.999999999991251,0.7960654508756,0,2,positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
2907,GO:0006421,0.999999999991261,0.705625569030168,0,3,asparaginyl-tRNA aminoacylation,BP,
13968,GO:0060689,0.999999999991273,0.709146946719588,0,3,cell differentiation involved in salivary gland development,BP,
14150,GO:0061043,0.999999999991273,0.709146946719588,0,3,regulation of vascular wound healing,BP,
8116,GO:0032810,0.999999999991286,0.801091602016301,0,2,sterol response element binding,MF,
19048,GO:1904880,0.999999999991308,0.792305833107479,0,2,response to hydrogen sulfide,BP,
1514,GO:0003874,0.999999999991309,0.920054364024154,0,1,6-pyruvoyltetrahydropterin synthase activity,MF,
4241,GO:0009441,0.999999999991309,0.920054364024154,0,1,glycolate metabolic process,BP,
5956,GO:0018323,0.999999999991309,0.920054364024154,0,1,enzyme active site formation via L-cysteine sulfinic acid,BP,
8679,GO:0034309,0.999999999991309,0.920054364024154,0,1,primary alcohol biosynthetic process,BP,
9603,GO:0036470,0.999999999991309,0.920054364024154,0,1,tyrosine 3-monooxygenase activator activity,MF,
9604,GO:0036471,0.999999999991309,0.920054364024154,0,1,cellular response to glyoxal,BP,
9610,GO:0036478,0.999999999991309,0.920054364024154,0,1,L-dopa decarboxylase activator activity,MF,
9645,GO:0036524,0.999999999991309,0.920054364024154,0,1,protein deglycase activity,MF,
9646,GO:0036525,0.999999999991309,0.920054364024154,0,1,protein deglycation,BP,
9647,GO:0036526,0.999999999991309,0.920054364024154,0,1,peptidyl-cysteine deglycation,BP,
9648,GO:0036527,0.999999999991309,0.920054364024154,0,1,peptidyl-arginine deglycation,BP,
9649,GO:0036528,0.999999999991309,0.920054364024154,0,1,peptidyl-lysine deglycation,BP,
9650,GO:0036529,0.999999999991309,0.920054364024154,0,1,protein deglycation, glyoxal removal,BP,
9651,GO:0036530,0.999999999991309,0.920054364024154,0,1,protein deglycation, methylglyoxal removal,BP,
9652,GO:0036531,0.999999999991309,0.920054364024154,0,1,glutathione deglycation,BP,
11200,GO:0045340,0.999999999991309,0.920054364024154,0,1,mercury ion binding,MF,
11602,GO:0046295,0.999999999991309,0.920054364024154,0,1,glycolate biosynthetic process,BP,
17205,GO:0106044,0.999999999991309,0.920054364024154,0,1,guanine deglycation,BP,
17206,GO:0106045,0.999999999991309,0.920054364024154,0,1,guanine deglycation, methylglyoxal removal,BP,
17207,GO:0106046,0.999999999991309,0.920054364024154,0,1,guanine deglycation, glyoxal removal,BP,
17290,GO:0140041,0.999999999991309,0.920054364024154,0,1,cellular detoxification of methylglyoxal,BP,
18261,GO:1903072,0.999999999991309,0.920054364024154,0,1,regulation of death-inducing signaling complex assembly,BP,
18262,GO:1903073,0.999999999991309,0.920054364024154,0,1,negative regulation of death-inducing signaling complex assembly,BP,
18276,GO:1903122,0.999999999991309,0.920054364024154,0,1,negative regulation of TRAIL-activated apoptotic signaling pathway,BP,
18288,GO:1903167,0.999999999991309,0.920054364024154,0,1,regulation of pyrroline-5-carboxylate reductase activity,BP,
18289,GO:1903168,0.999999999991309,0.920054364024154,0,1,positive regulation of pyrroline-5-carboxylate reductase activity,BP,
18293,GO:1903176,0.999999999991309,0.920054364024154,0,1,regulation of tyrosine 3-monooxygenase activity,BP,
18294,GO:1903178,0.999999999991309,0.920054364024154,0,1,positive regulation of tyrosine 3-monooxygenase activity,BP,
18298,GO:1903184,0.999999999991309,0.920054364024154,0,1,L-dopa metabolic process,BP,
18299,GO:1903185,0.999999999991309,0.920054364024154,0,1,L-dopa biosynthetic process,BP,
18300,GO:1903189,0.999999999991309,0.920054364024154,0,1,glyoxal metabolic process,BP,
18301,GO:1903195,0.999999999991309,0.920054364024154,0,1,regulation of L-dopa biosynthetic process,BP,
18302,GO:1903197,0.999999999991309,0.920054364024154,0,1,positive regulation of L-dopa biosynthetic process,BP,
18303,GO:1903198,0.999999999991309,0.920054364024154,0,1,regulation of L-dopa decarboxylase activity,BP,
18304,GO:1903200,0.999999999991309,0.920054364024154,0,1,positive regulation of L-dopa decarboxylase activity,BP,
19834,GO:2000277,0.999999999991309,0.920054364024154,0,1,positive regulation of oxidative phosphorylation uncoupler activity,BP,
19840,GO:2000284,0.999999999991309,0.920054364024154,0,1,positive regulation of cellular amino acid biosynthetic process,BP,
15867,GO:0072592,0.999999999991309,0.795039070691586,0,2,oxygen metabolic process,BP,
19674,GO:1990910,0.999999999991329,0.736336935499533,0,3,response to hypobaric hypoxia,BP,
1654,GO:0004105,0.999999999991335,0.800618004242252,0,2,choline-phosphate cytidylyltransferase activity,MF,
697,GO:0001918,0.999999999991337,0.890023780294107,0,1,farnesylated protein binding,MF,
10953,GO:0044715,0.999999999991358,0.820061843040698,0,2,8-oxo-dGDP phosphatase activity,MF,
2050,GO:0004798,0.999999999991423,0.812146275552845,0,2,thymidylate kinase activity,MF,
2787,GO:0006227,0.999999999991423,0.812146275552845,0,2,dUDP biosynthetic process,BP,
2790,GO:0006233,0.999999999991423,0.812146275552845,0,2,dTDP biosynthetic process,BP,
4083,GO:0009139,0.999999999991423,0.812146275552845,0,2,pyrimidine nucleoside diphosphate biosynthetic process,BP,
4134,GO:0009196,0.999999999991423,0.812146275552845,0,2,pyrimidine deoxyribonucleoside diphosphate metabolic process,BP,
4135,GO:0009197,0.999999999991423,0.812146275552845,0,2,pyrimidine deoxyribonucleoside diphosphate biosynthetic process,BP,
11532,GO:0046072,0.999999999991423,0.812146275552845,0,2,dTDP metabolic process,BP,
11535,GO:0046077,0.999999999991423,0.812146275552845,0,2,dUDP metabolic process,BP,
18033,GO:1902524,0.99999999999144,0.802802260205334,0,2,positive regulation of protein K48-linked ubiquitination,BP,
10719,GO:0044062,0.999999999991454,0.709296501180413,0,3,regulation of excretion,BP,
3860,GO:0008482,0.999999999991471,0.890586029684666,0,1,sulfite oxidase activity,MF,
9863,GO:0042128,0.999999999991471,0.890586029684666,0,1,nitrate assimilation,BP,
1236,GO:0002923,0.999999999991534,0.799819371743847,0,2,regulation of humoral immune response mediated by circulating immunoglobulin,BP,
4743,GO:0010915,0.999999999991538,0.846212743217296,0,2,regulation of very-low-density lipoprotein particle clearance,BP,
4744,GO:0010916,0.999999999991538,0.846212743217296,0,2,negative regulation of very-low-density lipoprotein particle clearance,BP,
9236,GO:0035634,0.999999999991544,0.843703319008761,0,2,response to stilbenoid,BP,
1003,GO:0002476,0.99999999999156,0.798798375095744,0,2,antigen processing and presentation of endogenous peptide antigen via MHC class Ib,BP,
9293,GO:0035740,0.99999999999156,0.798798375095744,0,2,CD8-positive, alpha-beta T cell proliferation,BP,
19995,GO:2000564,0.99999999999156,0.798798375095744,0,2,regulation of CD8-positive, alpha-beta T cell proliferation,BP,
17531,GO:1901004,0.999999999991584,0.908002380391456,0,1,ubiquinone-6 metabolic process,BP,
17532,GO:1901006,0.999999999991584,0.908002380391456,0,1,ubiquinone-6 biosynthetic process,BP,
246,GO:0000703,0.999999999991607,0.823345012181062,0,2,oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity,MF,
13842,GO:0060456,0.999999999991611,0.706660396198198,0,3,positive regulation of digestive system process,BP,
2021,GO:0004750,0.999999999991627,0.890718569839033,0,1,ribulose-phosphate 3-epimerase activity,MF,
16677,GO:0097621,0.999999999991627,0.890718569839033,0,1,monoamine oxidase activity,MF,
13792,GO:0060392,0.999999999991628,0.807076944569907,0,2,negative regulation of SMAD protein signal transduction,BP,
7504,GO:0031694,0.999999999991629,0.912855917544253,0,1,alpha-2A adrenergic receptor binding,MF,
17585,GO:1901193,0.999999999991629,0.912855917544253,0,1,regulation of formation of translation preinitiation complex,BP,
17586,GO:1901194,0.999999999991629,0.912855917544253,0,1,negative regulation of formation of translation preinitiation complex,BP,
18948,GO:1904689,0.999999999991629,0.912855917544253,0,1,negative regulation of cytoplasmic translational initiation,BP,
8583,GO:0034092,0.999999999991633,0.730300628006188,0,3,negative regulation of maintenance of sister chromatid cohesion,BP,
8633,GO:0034183,0.999999999991633,0.730300628006188,0,3,negative regulation of maintenance of mitotic sister chromatid cohesion,BP,
11746,GO:0046604,0.999999999991633,0.730300628006188,0,3,positive regulation of mitotic centrosome separation,BP,
14843,GO:0070602,0.999999999991633,0.730300628006188,0,3,regulation of centromeric sister chromatid cohesion,BP,
15296,GO:0071492,0.999999999991653,0.796364806020847,0,2,cellular response to UV-A,BP,
1800,GO:0004441,0.999999999991676,0.891946858162617,0,1,inositol-1,4-bisphosphate 1-phosphatase activity,MF,
13416,GO:0052829,0.999999999991676,0.891946858162617,0,1,inositol-1,3,4-trisphosphate 1-phosphatase activity,MF,
518,GO:0001595,0.999999999991705,0.910967233768174,0,1,angiotensin receptor activity,MF,
2135,GO:0004945,0.999999999991705,0.910967233768174,0,1,angiotensin type II receptor activity,MF,
19131,GO:1905062,0.999999999991706,0.890029639167114,0,1,positive regulation of cardioblast proliferation,BP,
16657,GO:0097534,0.99999999999171,0.792140778684688,0,2,lymphoid lineage cell migration,BP,
16658,GO:0097535,0.99999999999171,0.792140778684688,0,2,lymphoid lineage cell migration into thymus,BP,
3635,GO:0008108,0.999999999991715,0.906012666854616,0,1,UDP-glucose:hexose-1-phosphate uridylyltransferase activity,MF,
5316,GO:0016034,0.999999999991715,0.906012666854616,0,1,maleylacetoacetate isomerase activity,MF,
15559,GO:0072011,0.999999999991715,0.906012666854616,0,1,glomerular endothelium development,BP,
17118,GO:0101030,0.999999999991715,0.906012666854616,0,1,tRNA-guanine transglycosylation,BP,
5,GO:0000011,0.999999999991726,0.890023718061521,0,1,vacuole inheritance,BP,
58,GO:0000121,0.999999999991726,0.890023718061521,0,1,glycerol-1-phosphatase activity,MF,
193,GO:0000412,0.999999999991726,0.890023718061521,0,1,histone peptidyl-prolyl isomerization,BP,
333,GO:0000928,0.999999999991726,0.890023718061521,0,1,gamma-tubulin small complex, spindle pole body,CC,
419,GO:0001112,0.999999999991726,0.890023718061521,0,1,DNA-templated transcriptional open complex formation,BP,
420,GO:0001113,0.999999999991726,0.890023718061521,0,1,transcriptional open complex formation at RNA polymerase II promoter,BP,
421,GO:0001120,0.999999999991726,0.890023718061521,0,1,protein-DNA complex remodeling,BP,
557,GO:0001681,0.999999999991726,0.890023718061521,0,1,sialate O-acetylesterase activity,MF,
643,GO:0001834,0.999999999991726,0.890023718061521,0,1,trophectodermal cell proliferation,BP,
1161,GO:0002774,0.999999999991726,0.890023718061521,0,1,Fc receptor mediated inhibitory signaling pathway,BP,
1499,GO:0003844,0.999999999991726,0.890023718061521,0,1,1,4-alpha-glucan branching enzyme activity,MF,
1566,GO:0003972,0.999999999991726,0.890023718061521,0,1,RNA ligase (ATP) activity,MF,
1641,GO:0004083,0.999999999991726,0.890023718061521,0,1,bisphosphoglycerate 2-phosphatase activity,MF,
1655,GO:0004108,0.999999999991726,0.890023718061521,0,1,citrate (Si)-synthase activity,MF,
1684,GO:0004149,0.999999999991726,0.890023718061521,0,1,dihydrolipoyllysine-residue succinyltransferase activity,MF,
1739,GO:0004336,0.999999999991726,0.890023718061521,0,1,galactosylceramidase activity,MF,
1767,GO:0004371,0.999999999991726,0.890023718061521,0,1,glycerone kinase activity,MF,
1773,GO:0004378,0.999999999991726,0.890023718061521,0,1,GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity,MF,
1802,GO:0004446,0.999999999991726,0.890023718061521,0,1,inositol-hexakisphosphate phosphatase activity,MF,
1825,GO:0004478,0.999999999991726,0.890023718061521,0,1,methionine adenosyltransferase activity,MF,
1839,GO:0004494,0.999999999991726,0.890023718061521,0,1,methylmalonyl-CoA mutase activity,MF,
1844,GO:0004500,0.999999999991726,0.890023718061521,0,1,dopamine beta-monooxygenase activity,MF,
1847,GO:0004506,0.999999999991726,0.890023718061521,0,1,squalene monooxygenase activity,MF,
2016,GO:0004743,0.999999999991726,0.890023718061521,0,1,pyruvate kinase activity,MF,
2231,GO:0005136,0.999999999991726,0.890023718061521,0,1,interleukin-4 receptor binding,MF,
2299,GO:0005275,0.999999999991726,0.890023718061521,0,1,amine transmembrane transporter activity,MF,
2554,GO:0005833,0.999999999991726,0.890023718061521,0,1,hemoglobin complex,CC,
2648,GO:0005991,0.999999999991726,0.890023718061521,0,1,trehalose metabolic process,BP,
2683,GO:0006049,0.999999999991726,0.890023718061521,0,1,UDP-N-acetylglucosamine catabolic process,BP,
2730,GO:0006113,0.999999999991726,0.890023718061521,0,1,fermentation,BP,
2758,GO:0006174,0.999999999991726,0.890023718061521,0,1,dADP phosphorylation,BP,
2765,GO:0006186,0.999999999991726,0.890023718061521,0,1,dGDP phosphorylation,BP,
2778,GO:0006212,0.999999999991726,0.890023718061521,0,1,uracil catabolic process,BP,
2780,GO:0006214,0.999999999991726,0.890023718061521,0,1,thymidine catabolic process,BP,
2796,GO:0006256,0.999999999991726,0.890023718061521,0,1,UDP catabolic process,BP,
2948,GO:0006480,0.999999999991726,0.890023718061521,0,1,N-terminal protein amino acid methylation,BP,
3034,GO:0006589,0.999999999991726,0.890023718061521,0,1,octopamine biosynthetic process,BP,
3092,GO:0006669,0.999999999991726,0.890023718061521,0,1,sphinganine-1-phosphate biosynthetic process,BP,
3102,GO:0006683,0.999999999991726,0.890023718061521,0,1,galactosylceramide catabolic process,BP,
3152,GO:0006756,0.999999999991726,0.890023718061521,0,1,AMP phosphorylation,BP,
3371,GO:0007146,0.999999999991726,0.890023718061521,0,1,meiotic recombination nodule assembly,BP,
3512,GO:0007439,0.999999999991726,0.890023718061521,0,1,ectodermal digestive tract development,BP,
3646,GO:0008126,0.999999999991726,0.890023718061521,0,1,acetylesterase activity,MF,
3807,GO:0008398,0.999999999991726,0.890023718061521,0,1,sterol 14-demethylase activity,MF,
3840,GO:0008452,0.999999999991726,0.890023718061521,0,1,RNA ligase activity,MF,
3865,GO:0008489,0.999999999991726,0.890023718061521,0,1,UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity,MF,
3868,GO:0008495,0.999999999991726,0.890023718061521,0,1,protoheme IX farnesyltransferase activity,MF,
3883,GO:0008518,0.999999999991726,0.890023718061521,0,1,reduced folate carrier activity,MF,
3954,GO:0008700,0.999999999991726,0.890023718061521,0,1,4-hydroxy-2-oxoglutarate aldolase activity,MF,
3985,GO:0008852,0.999999999991726,0.890023718061521,0,1,exodeoxyribonuclease I activity,MF,
3995,GO:0008897,0.999999999991726,0.890023718061521,0,1,holo-[acyl-carrier-protein] synthase activity,MF,
4084,GO:0009140,0.999999999991726,0.890023718061521,0,1,pyrimidine nucleoside diphosphate catabolic process,BP,
4132,GO:0009193,0.999999999991726,0.890023718061521,0,1,pyrimidine ribonucleoside diphosphate metabolic process,BP,
4133,GO:0009195,0.999999999991726,0.890023718061521,0,1,pyrimidine ribonucleoside diphosphate catabolic process,BP,
4158,GO:0009222,0.999999999991726,0.890023718061521,0,1,pyrimidine ribonucleotide catabolic process,BP,
4169,GO:0009237,0.999999999991726,0.890023718061521,0,1,siderophore metabolic process,BP,
4223,GO:0009400,0.999999999991726,0.890023718061521,0,1,signal transducer, downstream of receptor, with serine/threonine phosphatase activity,MF,
4236,GO:0009436,0.999999999991726,0.890023718061521,0,1,glyoxylate catabolic process,BP,
4421,GO:0010232,0.999999999991726,0.890023718061521,0,1,vascular transport,BP,
4428,GO:0010260,0.999999999991726,0.890023718061521,0,1,animal organ senescence,BP,
4442,GO:0010348,0.999999999991726,0.890023718061521,0,1,lithium:proton antiporter activity,MF,
4590,GO:0010700,0.999999999991726,0.890023718061521,0,1,negative regulation of norepinephrine secretion,BP,
4815,GO:0014011,0.999999999991726,0.890023718061521,0,1,Schwann cell proliferation involved in axon regeneration,BP,
4876,GO:0014739,0.999999999991726,0.890023718061521,0,1,positive regulation of muscle hyperplasia,BP,
4913,GO:0014852,0.999999999991726,0.890023718061521,0,1,regulation of skeletal muscle contraction by neural stimulation via neuromuscular junction,BP,
4914,GO:0014853,0.999999999991726,0.890023718061521,0,1,regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction,BP,
5054,GO:0015252,0.999999999991726,0.890023718061521,0,1,proton channel activity,MF,
5056,GO:0015265,0.999999999991726,0.890023718061521,0,1,urea channel activity,MF,
5060,GO:0015272,0.999999999991726,0.890023718061521,0,1,ATP-activated inward rectifier potassium channel activity,MF,
5068,GO:0015292,0.999999999991726,0.890023718061521,0,1,uniporter activity,MF,
5114,GO:0015439,0.999999999991726,0.890023718061521,0,1,heme-transporting ATPase activity,MF,
5348,GO:0016098,0.999999999991726,0.890023718061521,0,1,monoterpenoid metabolic process,BP,
5395,GO:0016232,0.999999999991726,0.890023718061521,0,1,HNK-1 sulfotransferase activity,MF,
5457,GO:0016333,0.999999999991726,0.890023718061521,0,1,morphogenesis of follicular epithelium,BP,
5458,GO:0016334,0.999999999991726,0.890023718061521,0,1,establishment or maintenance of polarity of follicular epithelium,BP,
5469,GO:0016402,0.999999999991726,0.890023718061521,0,1,pristanoyl-CoA oxidase activity,MF,
5494,GO:0016430,0.999999999991726,0.890023718061521,0,1,tRNA (adenine-N6-)-methyltransferase activity,MF,
5530,GO:0016507,0.999999999991726,0.890023718061521,0,1,mitochondrial fatty acid beta-oxidation multienzyme complex,CC,
5579,GO:0016596,0.999999999991726,0.890023718061521,0,1,thienylcyclohexylpiperidine binding,MF,
5655,GO:0016751,0.999999999991726,0.890023718061521,0,1,S-succinyltransferase activity,MF,
5689,GO:0016807,0.999999999991726,0.890023718061521,0,1,cysteine-type carboxypeptidase activity,MF,
5712,GO:0016843,0.999999999991726,0.890023718061521,0,1,amine-lyase activity,MF,
5713,GO:0016844,0.999999999991726,0.890023718061521,0,1,strictosidine synthase activity,MF,
5790,GO:0017020,0.999999999991726,0.890023718061521,0,1,myosin phosphatase regulator activity,MF,
5817,GO:0017082,0.999999999991726,0.890023718061521,0,1,mineralocorticoid receptor activity,MF,
5833,GO:0017113,0.999999999991726,0.890023718061521,0,1,dihydropyrimidine dehydrogenase (NADP+) activity,MF,
5869,GO:0017178,0.999999999991726,0.890023718061521,0,1,diphthine-ammonia ligase activity,MF,
5880,GO:0018011,0.999999999991726,0.890023718061521,0,1,N-terminal peptidyl-alanine methylation,BP,
5881,GO:0018012,0.999999999991726,0.890023718061521,0,1,N-terminal peptidyl-alanine trimethylation,BP,
5882,GO:0018013,0.999999999991726,0.890023718061521,0,1,N-terminal peptidyl-glycine methylation,BP,
5883,GO:0018016,0.999999999991726,0.890023718061521,0,1,N-terminal peptidyl-proline dimethylation,BP,
5887,GO:0018025,0.999999999991726,0.890023718061521,0,1,calmodulin-lysine N-methyltransferase activity,MF,
5919,GO:0018194,0.999999999991726,0.890023718061521,0,1,peptidyl-alanine modification,BP,
5991,GO:0018993,0.999999999991726,0.890023718061521,0,1,somatic sex determination,BP,
6031,GO:0019101,0.999999999991726,0.890023718061521,0,1,female somatic sex determination,BP,
6090,GO:0019276,0.999999999991726,0.890023718061521,0,1,UDP-N-acetylgalactosamine metabolic process,BP,
6093,GO:0019290,0.999999999991726,0.890023718061521,0,1,siderophore biosynthetic process,BP,
6126,GO:0019376,0.999999999991726,0.890023718061521,0,1,galactolipid catabolic process,BP,
6156,GO:0019483,0.999999999991726,0.890023718061521,0,1,beta-alanine biosynthetic process,BP,
6190,GO:0019659,0.999999999991726,0.890023718061521,0,1,glucose catabolic process to lactate,BP,
6191,GO:0019660,0.999999999991726,0.890023718061521,0,1,glycolytic fermentation,BP,
6192,GO:0019661,0.999999999991726,0.890023718061521,0,1,glucose catabolic process to lactate via pyruvate,BP,
6193,GO:0019666,0.999999999991726,0.890023718061521,0,1,nitrogenous compound fermentation,BP,
6238,GO:0019799,0.999999999991726,0.890023718061521,0,1,tubulin N-acetyltransferase activity,MF,
6321,GO:0020003,0.999999999991726,0.890023718061521,0,1,symbiont-containing vacuole,CC,
6660,GO:0030021,0.999999999991726,0.890023718061521,0,1,extracellular matrix structural constituent conferring compression resistance,MF,
6806,GO:0030264,0.999999999991726,0.890023718061521,0,1,nuclear fragmentation involved in apoptotic nuclear change,BP,
6863,GO:0030345,0.999999999991726,0.890023718061521,0,1,structural constituent of tooth enamel,MF,
6867,GO:0030351,0.999999999991726,0.890023718061521,0,1,inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity,MF,
6870,GO:0030369,0.999999999991726,0.890023718061521,0,1,ICAM-3 receptor activity,MF,
6896,GO:0030474,0.999999999991726,0.890023718061521,0,1,spindle pole body duplication,BP,
6957,GO:0030617,0.999999999991726,0.890023718061521,0,1,transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity,MF,
6968,GO:0030629,0.999999999991726,0.890023718061521,0,1,U6 snRNA 3'-end binding,MF,
7000,GO:0030690,0.999999999991726,0.890023718061521,0,1,Noc1p-Noc2p complex,CC,
7001,GO:0030691,0.999999999991726,0.890023718061521,0,1,Noc2p-Noc3p complex,CC,
7014,GO:0030735,0.999999999991726,0.890023718061521,0,1,carnosine N-methyltransferase activity,MF,
7127,GO:0030961,0.999999999991726,0.890023718061521,0,1,peptidyl-arginine hydroxylation,BP,
7285,GO:0031289,0.999999999991726,0.890023718061521,0,1,actin phosphorylation,BP,
7342,GO:0031389,0.999999999991726,0.890023718061521,0,1,Rad17 RFC-like complex,CC,
7378,GO:0031438,0.999999999991726,0.890023718061521,0,1,negative regulation of mRNA cleavage,BP,
7497,GO:0031682,0.999999999991726,0.890023718061521,0,1,G-protein gamma-subunit binding,MF,
7500,GO:0031686,0.999999999991726,0.890023718061521,0,1,A1 adenosine receptor binding,MF,
7657,GO:0032093,0.999999999991726,0.890023718061521,0,1,SAM domain binding,MF,
7711,GO:0032207,0.999999999991726,0.890023718061521,0,1,regulation of telomere maintenance via recombination,BP,
7712,GO:0032208,0.999999999991726,0.890023718061521,0,1,negative regulation of telomere maintenance via recombination,BP,
7737,GO:0032253,0.999999999991726,0.890023718061521,0,1,dense core granule localization,BP,
8005,GO:0032641,0.999999999991726,0.890023718061521,0,1,lymphotoxin A production,BP,
8076,GO:0032765,0.999999999991726,0.890023718061521,0,1,positive regulation of mast cell cytokine production,BP,
8386,GO:0033316,0.999999999991726,0.890023718061521,0,1,meiotic spindle assembly checkpoint,BP,
8410,GO:0033488,0.999999999991726,0.890023718061521,0,1,cholesterol biosynthetic process via 24,25-dihydrolanosterol,BP,
8461,GO:0033609,0.999999999991726,0.890023718061521,0,1,oxalate metabolic process,BP,
8506,GO:0033695,0.999999999991726,0.890023718061521,0,1,oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor,MF,
8520,GO:0033787,0.999999999991726,0.890023718061521,0,1,cyanocobalamin reductase (cyanide-eliminating) activity,MF,
8522,GO:0033823,0.999999999991726,0.890023718061521,0,1,procollagen glucosyltransferase activity,MF,
8528,GO:0033862,0.999999999991726,0.890023718061521,0,1,UMP kinase activity,MF,
8552,GO:0034012,0.999999999991726,0.890023718061521,0,1,FAD-AMP lyase (cyclizing) activity,MF,
8698,GO:0034346,0.999999999991726,0.890023718061521,0,1,positive regulation of type III interferon production,BP,
8702,GO:0034353,0.999999999991726,0.890023718061521,0,1,RNA pyrophosphohydrolase activity,MF,
8711,GO:0034366,0.999999999991726,0.890023718061521,0,1,spherical high-density lipoprotein particle,CC,
8746,GO:0034417,0.999999999991726,0.890023718061521,0,1,bisphosphoglycerate 3-phosphatase activity,MF,
8784,GO:0034477,0.999999999991726,0.890023718061521,0,1,U6 snRNA 3'-end processing,BP,
8798,GO:0034512,0.999999999991726,0.890023718061521,0,1,box C/D snoRNA binding,MF,
8872,GO:0034687,0.999999999991726,0.890023718061521,0,1,integrin alphaL-beta2 complex,CC,
8873,GO:0034688,0.999999999991726,0.890023718061521,0,1,integrin alphaM-beta2 complex,CC,
8927,GO:0034875,0.999999999991726,0.890023718061521,0,1,caffeine oxidase activity,MF,
8934,GO:0034971,0.999999999991726,0.890023718061521,0,1,histone H3-R17 methylation,BP,
8946,GO:0034998,0.999999999991726,0.890023718061521,0,1,oligosaccharyltransferase I complex,CC,
9016,GO:0035226,0.999999999991726,0.890023718061521,0,1,glutamate-cysteine ligase catalytic subunit binding,MF,
9017,GO:0035227,0.999999999991726,0.890023718061521,0,1,regulation of glutamate-cysteine ligase activity,BP,
9018,GO:0035229,0.999999999991726,0.890023718061521,0,1,positive regulation of glutamate-cysteine ligase activity,BP,
9028,GO:0035248,0.999999999991726,0.890023718061521,0,1,alpha-1,4-N-acetylgalactosaminyltransferase activity,MF,
9125,GO:0035445,0.999999999991726,0.890023718061521,0,1,borate transmembrane transport,BP,
9143,GO:0035498,0.999999999991726,0.890023718061521,0,1,carnosine metabolic process,BP,
9183,GO:0035568,0.999999999991726,0.890023718061521,0,1,N-terminal peptidyl-proline methylation,BP,
9184,GO:0035570,0.999999999991726,0.890023718061521,0,1,N-terminal peptidyl-serine methylation,BP,
9185,GO:0035572,0.999999999991726,0.890023718061521,0,1,N-terminal peptidyl-serine dimethylation,BP,
9186,GO:0035573,0.999999999991726,0.890023718061521,0,1,N-terminal peptidyl-serine trimethylation,BP,
9197,GO:0035585,0.999999999991726,0.890023718061521,0,1,calcium-mediated signaling using extracellular calcium source,BP,
9219,GO:0035611,0.999999999991726,0.890023718061521,0,1,protein branching point deglutamylation,BP,
9243,GO:0035642,0.999999999991726,0.890023718061521,0,1,histone methyltransferase activity (H3-R17 specific),MF,
9340,GO:0035851,0.999999999991726,0.890023718061521,0,1,Krueppel-associated box domain binding,MF,
9485,GO:0036125,0.999999999991726,0.890023718061521,0,1,fatty acid beta-oxidation multienzyme complex,CC,
9514,GO:0036215,0.999999999991726,0.890023718061521,0,1,response to stem cell factor,BP,
9515,GO:0036216,0.999999999991726,0.890023718061521,0,1,cellular response to stem cell factor stimulus,BP,
9551,GO:0036317,0.999999999991726,0.890023718061521,0,1,tyrosyl-RNA phosphodiesterase activity,MF,
9585,GO:0036440,0.999999999991726,0.890023718061521,0,1,citrate synthase activity,MF,
9630,GO:0036502,0.999999999991726,0.890023718061521,0,1,Derlin-1-VIMP complex,CC,
9632,GO:0036505,0.999999999991726,0.890023718061521,0,1,prosaposin receptor activity,MF,
9700,GO:0038109,0.999999999991726,0.890023718061521,0,1,Kit signaling pathway,BP,
9716,GO:0038161,0.999999999991726,0.890023718061521,0,1,prolactin signaling pathway,BP,
9854,GO:0042109,0.999999999991726,0.890023718061521,0,1,lymphotoxin A biosynthetic process,BP,
9872,GO:0042140,0.999999999991726,0.890023718061521,0,1,late meiotic recombination nodule assembly,BP,
9906,GO:0042247,0.999999999991726,0.890023718061521,0,1,establishment of planar polarity of follicular epithelium,BP,
10116,GO:0042643,0.999999999991726,0.890023718061521,0,1,actomyosin, actin portion,CC,
10177,GO:0042774,0.999999999991726,0.890023718061521,0,1,plasma membrane ATP synthesis coupled electron transport,BP,
10195,GO:0042806,0.999999999991726,0.890023718061521,0,1,fucose binding,MF,
10333,GO:0043136,0.999999999991726,0.890023718061521,0,1,glycerol-3-phosphatase activity,MF,
10522,GO:0043465,0.999999999991726,0.890023718061521,0,1,regulation of fermentation,BP,
10569,GO:0043538,0.999999999991726,0.890023718061521,0,1,regulation of actin phosphorylation,BP,
10658,GO:0043849,0.999999999991726,0.890023718061521,0,1,Ras palmitoyltransferase activity,MF,
10701,GO:0043997,0.999999999991726,0.890023718061521,0,1,histone acetyltransferase activity (H4-K12 specific),MF,
10827,GO:0044328,0.999999999991726,0.890023718061521,0,1,canonical Wnt signaling pathway involved in positive regulation of endothelial cell migration,BP,
10828,GO:0044329,0.999999999991726,0.890023718061521,0,1,canonical Wnt signaling pathway involved in positive regulation of cell-cell adhesion,BP,
10829,GO:0044330,0.999999999991726,0.890023718061521,0,1,canonical Wnt signaling pathway involved in positive regulation of wound healing,BP,
10933,GO:0044599,0.999999999991726,0.890023718061521,0,1,AP-5 adaptor complex,CC,
10944,GO:0044648,0.999999999991726,0.890023718061521,0,1,histone H3-K4 dimethylation,BP,
10962,GO:0044732,0.999999999991726,0.890023718061521,0,1,mitotic spindle pole body,CC,
10966,GO:0044753,0.999999999991726,0.890023718061521,0,1,amphisome,CC,
10977,GO:0044779,0.999999999991726,0.890023718061521,0,1,meiotic spindle checkpoint,BP,
10981,GO:0044785,0.999999999991726,0.890023718061521,0,1,metaphase/anaphase transition of meiotic cell cycle,BP,
11041,GO:0045032,0.999999999991726,0.890023718061521,0,1,ADP-activated adenosine receptor activity,MF,
11103,GO:0045131,0.999999999991726,0.890023718061521,0,1,pre-mRNA branch point binding,MF,
11130,GO:0045183,0.999999999991726,0.890023718061521,0,1,translation factor activity, non-nucleic acid binding,MF,
11517,GO:0046048,0.999999999991726,0.890023718061521,0,1,UDP metabolic process,BP,
11563,GO:0046127,0.999999999991726,0.890023718061521,0,1,pyrimidine deoxyribonucleoside catabolic process,BP,
11585,GO:0046176,0.999999999991726,0.890023718061521,0,1,aldonic acid catabolic process,BP,
11586,GO:0046177,0.999999999991726,0.890023718061521,0,1,D-gluconate catabolic process,BP,
11604,GO:0046316,0.999999999991726,0.890023718061521,0,1,gluconokinase activity,MF,
11620,GO:0046333,0.999999999991726,0.890023718061521,0,1,octopamine metabolic process,BP,
11710,GO:0046523,0.999999999991726,0.890023718061521,0,1,S-methyl-5-thioribose-1-phosphate isomerase activity,MF,
11736,GO:0046587,0.999999999991726,0.890023718061521,0,1,positive regulation of calcium-dependent cell-cell adhesion,BP,
11809,GO:0046713,0.999999999991726,0.890023718061521,0,1,borate transport,BP,
11810,GO:0046715,0.999999999991726,0.890023718061521,0,1,active borate transmembrane transporter activity,MF,
11820,GO:0046745,0.999999999991726,0.890023718061521,0,1,viral capsid secondary envelopment,BP,
11931,GO:0046996,0.999999999991726,0.890023718061521,0,1,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, with NAD(P)H as one donor, and the other dehydrogenated,MF,
11936,GO:0047017,0.999999999991726,0.890023718061521,0,1,prostaglandin-F synthase activity,MF,
11967,GO:0047263,0.999999999991726,0.890023718061521,0,1,N-acylsphingosine galactosyltransferase activity,MF,
11988,GO:0047395,0.999999999991726,0.890023718061521,0,1,glycerophosphoinositol glycerophosphodiesterase activity,MF,
12010,GO:0047620,0.999999999991726,0.890023718061521,0,1,acylglycerol kinase activity,MF,
12025,GO:0047734,0.999999999991726,0.890023718061521,0,1,CDP-glycerol diphosphatase activity,MF,
12071,GO:0048033,0.999999999991726,0.890023718061521,0,1,heme o metabolic process,BP,
12072,GO:0048034,0.999999999991726,0.890023718061521,0,1,heme O biosynthetic process,BP,
12124,GO:0048213,0.999999999991726,0.890023718061521,0,1,Golgi vesicle prefusion complex stabilization,BP,
12146,GO:0048264,0.999999999991726,0.890023718061521,0,1,determination of ventral identity,BP,
12278,GO:0048611,0.999999999991726,0.890023718061521,0,1,embryonic ectodermal digestive tract development,BP,
12280,GO:0048619,0.999999999991726,0.890023718061521,0,1,embryonic hindgut morphogenesis,BP,
12430,GO:0050046,0.999999999991726,0.890023718061521,0,1,lathosterol oxidase activity,MF,
12463,GO:0050346,0.999999999991726,0.890023718061521,0,1,trans-L-3-hydroxyproline dehydratase activity,MF,
12465,GO:0050353,0.999999999991726,0.890023718061521,0,1,trimethyllysine dioxygenase activity,MF,
12466,GO:0050354,0.999999999991726,0.890023718061521,0,1,triokinase activity,MF,
12748,GO:0051025,0.999999999991726,0.890023718061521,0,1,negative regulation of immunoglobulin secretion,BP,
12803,GO:0051107,0.999999999991726,0.890023718061521,0,1,negative regulation of DNA ligation,BP,
12932,GO:0051300,0.999999999991726,0.890023718061521,0,1,spindle pole body organization,BP,
12940,GO:0051308,0.999999999991726,0.890023718061521,0,1,male meiosis chromosome separation,BP,
12961,GO:0051352,0.999999999991726,0.890023718061521,0,1,negative regulation of ligase activity,BP,
12990,GO:0051417,0.999999999991726,0.890023718061521,0,1,microtubule nucleation by spindle pole body,BP,
13011,GO:0051455,0.999999999991726,0.890023718061521,0,1,attachment of spindle microtubules to kinetochore involved in homologous chromosome segregation,BP,
13121,GO:0051685,0.999999999991726,0.890023718061521,0,1,maintenance of ER location,BP,
13146,GO:0051728,0.999999999991726,0.890023718061521,0,1,cell cycle switching, mitotic to meiotic cell cycle,BP,
13147,GO:0051729,0.999999999991726,0.890023718061521,0,1,germline cell cycle switching, mitotic to meiotic cell cycle,BP,
13413,GO:0052826,0.999999999991726,0.890023718061521,0,1,inositol hexakisphosphate 2-phosphatase activity,MF,
13447,GO:0052907,0.999999999991726,0.890023718061521,0,1,23S rRNA (adenine(1618)-N(6))-methyltransferase activity,MF,
13448,GO:0052909,0.999999999991726,0.890023718061521,0,1,18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity,MF,
13542,GO:0060014,0.999999999991726,0.890023718061521,0,1,granulosa cell differentiation,BP,
13638,GO:0060156,0.999999999991726,0.890023718061521,0,1,milk ejection reflex,BP,
13655,GO:0060184,0.999999999991726,0.890023718061521,0,1,cell cycle switching,BP,
13742,GO:0060327,0.999999999991726,0.890023718061521,0,1,cytoplasmic actin-based contraction involved in cell motility,BP,
13935,GO:0060620,0.999999999991726,0.890023718061521,0,1,regulation of cholesterol import,BP,
14067,GO:0060887,0.999999999991726,0.890023718061521,0,1,limb epidermis development,BP,
14076,GO:0060912,0.999999999991726,0.890023718061521,0,1,cardiac cell fate specification,BP,
14097,GO:0060957,0.999999999991726,0.890023718061521,0,1,endocardial cell fate commitment,BP,
14141,GO:0061032,0.999999999991726,0.890023718061521,0,1,visceral serous pericardium development,BP,
14163,GO:0061056,0.999999999991726,0.890023718061521,0,1,sclerotome development,BP,
14214,GO:0061163,0.999999999991726,0.890023718061521,0,1,endoplasmic reticulum polarization,BP,
14303,GO:0061445,0.999999999991726,0.890023718061521,0,1,endocardial cushion cell fate commitment,BP,
14317,GO:0061495,0.999999999991726,0.890023718061521,0,1,gamma-tubulin small complex, mitotic spindle pole body,CC,
14321,GO:0061508,0.999999999991726,0.890023718061521,0,1,CDP phosphorylation,BP,
14326,GO:0061517,0.999999999991726,0.890023718061521,0,1,macrophage proliferation,BP,
14327,GO:0061518,0.999999999991726,0.890023718061521,0,1,microglial cell proliferation,BP,
14344,GO:0061565,0.999999999991726,0.890023718061521,0,1,dAMP phosphorylation,BP,
14345,GO:0061566,0.999999999991726,0.890023718061521,0,1,CMP phosphorylation,BP,
14346,GO:0061567,0.999999999991726,0.890023718061521,0,1,dCMP phosphorylation,BP,
14347,GO:0061568,0.999999999991726,0.890023718061521,0,1,GDP phosphorylation,BP,
14348,GO:0061569,0.999999999991726,0.890023718061521,0,1,UDP phosphorylation,BP,
14349,GO:0061570,0.999999999991726,0.890023718061521,0,1,dCDP phosphorylation,BP,
14350,GO:0061571,0.999999999991726,0.890023718061521,0,1,TDP phosphorylation,BP,
14352,GO:0061573,0.999999999991726,0.890023718061521,0,1,actin filament bundle retrograde transport,BP,
14403,GO:0061685,0.999999999991726,0.890023718061521,0,1,diphthine methylesterase activity,MF,
14511,GO:0065010,0.999999999991726,0.890023718061521,0,1,extracellular membrane-bounded organelle,CC,
14514,GO:0070004,0.999999999991726,0.890023718061521,0,1,cysteine-type exopeptidase activity,MF,
14530,GO:0070042,0.999999999991726,0.890023718061521,0,1,rRNA (uridine-N3-)-methyltransferase activity,MF,
14582,GO:0070130,0.999999999991726,0.890023718061521,0,1,negative regulation of mitochondrial translation,BP,
14599,GO:0070165,0.999999999991726,0.890023718061521,0,1,positive regulation of adiponectin secretion,BP,
14613,GO:0070183,0.999999999991726,0.890023718061521,0,1,mitochondrial tryptophanyl-tRNA aminoacylation,BP,
14656,GO:0070260,0.999999999991726,0.890023718061521,0,1,5'-tyrosyl-DNA phosphodiesterase activity,MF,
14720,GO:0070376,0.999999999991726,0.890023718061521,0,1,regulation of ERK5 cascade,BP,
14721,GO:0070377,0.999999999991726,0.890023718061521,0,1,negative regulation of ERK5 cascade,BP,
14733,GO:0070407,0.999999999991726,0.890023718061521,0,1,oxidation-dependent protein catabolic process,BP,
14739,GO:0070413,0.999999999991726,0.890023718061521,0,1,trehalose metabolism in response to stress,BP,
14773,GO:0070481,0.999999999991726,0.890023718061521,0,1,nuclear-transcribed mRNA catabolic process, non-stop decay,BP,
14812,GO:0070551,0.999999999991726,0.890023718061521,0,1,endoribonuclease activity, cleaving siRNA-paired mRNA,MF,
14814,GO:0070553,0.999999999991726,0.890023718061521,0,1,nicotinic acid receptor activity,MF,
14817,GO:0070560,0.999999999991726,0.890023718061521,0,1,protein secretion by platelet,BP,
14829,GO:0070573,0.999999999991726,0.890023718061521,0,1,metallodipeptidase activity,MF,
14854,GO:0070631,0.999999999991726,0.890023718061521,0,1,spindle pole body localization,BP,
14855,GO:0070632,0.999999999991726,0.890023718061521,0,1,establishment of spindle pole body localization,BP,
14866,GO:0070650,0.999999999991726,0.890023718061521,0,1,actin filament bundle distribution,BP,
14867,GO:0070651,0.999999999991726,0.890023718061521,0,1,nonfunctional rRNA decay,BP,
14875,GO:0070667,0.999999999991726,0.890023718061521,0,1,negative regulation of mast cell proliferation,BP,
14912,GO:0070762,0.999999999991726,0.890023718061521,0,1,nuclear pore transmembrane ring,CC,
14914,GO:0070772,0.999999999991726,0.890023718061521,0,1,PAS complex,CC,
14982,GO:0070899,0.999999999991726,0.890023718061521,0,1,mitochondrial tRNA wobble uridine modification,BP,
15014,GO:0070950,0.999999999991726,0.890023718061521,0,1,regulation of neutrophil mediated killing of bacterium,BP,
15015,GO:0070951,0.999999999991726,0.890023718061521,0,1,regulation of neutrophil mediated killing of gram-negative bacterium,BP,
15019,GO:0070962,0.999999999991726,0.890023718061521,0,1,positive regulation of neutrophil mediated killing of bacterium,BP,
15020,GO:0070963,0.999999999991726,0.890023718061521,0,1,positive regulation of neutrophil mediated killing of gram-negative bacterium,BP,
15130,GO:0071228,0.999999999991726,0.890023718061521,0,1,cellular response to tumor cell,BP,
15250,GO:0071424,0.999999999991726,0.890023718061521,0,1,rRNA (cytosine-N4-)-methyltransferase activity,MF,
15337,GO:0071566,0.999999999991726,0.890023718061521,0,1,UFM1 activating enzyme activity,MF,
15341,GO:0071573,0.999999999991726,0.890023718061521,0,1,shelterin complex assembly,BP,
15368,GO:0071615,0.999999999991726,0.890023718061521,0,1,oxidative deethylation,BP,
15379,GO:0071633,0.999999999991726,0.890023718061521,0,1,dihydroceramidase activity,MF,
15404,GO:0071673,0.999999999991726,0.890023718061521,0,1,positive regulation of smooth muscle cell chemotaxis,BP,
15451,GO:0071789,0.999999999991726,0.890023718061521,0,1,spindle pole body localization to nuclear envelope,BP,
15452,GO:0071790,0.999999999991726,0.890023718061521,0,1,establishment of spindle pole body localization to nuclear envelope,BP,
15464,GO:0071812,0.999999999991726,0.890023718061521,0,1,positive regulation of fever generation by positive regulation of prostaglandin secretion,BP,
15483,GO:0071848,0.999999999991726,0.890023718061521,0,1,positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling,BP,
15504,GO:0071885,0.999999999991726,0.890023718061521,0,1,N-terminal protein N-methyltransferase activity,MF,
15530,GO:0071931,0.999999999991726,0.890023718061521,0,1,positive regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
15648,GO:0072166,0.999999999991726,0.890023718061521,0,1,posterior mesonephric tubule development,BP,
15680,GO:0072209,0.999999999991726,0.890023718061521,0,1,metanephric mesangial cell differentiation,BP,
15703,GO:0072254,0.999999999991726,0.890023718061521,0,1,metanephric glomerular mesangial cell differentiation,BP,
15704,GO:0072255,0.999999999991726,0.890023718061521,0,1,metanephric glomerular mesangial cell development,BP,
15722,GO:0072299,0.999999999991726,0.890023718061521,0,1,negative regulation of metanephric glomerulus development,BP,
15725,GO:0072302,0.999999999991726,0.890023718061521,0,1,negative regulation of metanephric glomerular mesangial cell proliferation,BP,
15843,GO:0072560,0.999999999991726,0.890023718061521,0,1,type B pancreatic cell maturation,BP,
15929,GO:0072720,0.999999999991726,0.890023718061521,0,1,response to dithiothreitol,BP,
15965,GO:0080048,0.999999999991726,0.890023718061521,0,1,GDP-D-glucose phosphorylase activity,MF,
16017,GO:0086038,0.999999999991726,0.890023718061521,0,1,calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential,MF,
16049,GO:0086089,0.999999999991726,0.890023718061521,0,1,voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,MF,
16176,GO:0090198,0.999999999991726,0.890023718061521,0,1,negative regulation of chemokine secretion,BP,
16348,GO:0090624,0.999999999991726,0.890023718061521,0,1,endoribonuclease activity, cleaving miRNA-paired mRNA,MF,
16349,GO:0090625,0.999999999991726,0.890023718061521,0,1,mRNA cleavage involved in gene silencing by siRNA,BP,
16404,GO:0097029,0.999999999991726,0.890023718061521,0,1,mature conventional dendritic cell differentiation,BP,
16548,GO:0097310,0.999999999991726,0.890023718061521,0,1,cap2 mRNA methylation,BP,
16661,GO:0097541,0.999999999991726,0.890023718061521,0,1,axonemal basal plate,CC,
16683,GO:0097630,0.999999999991726,0.890023718061521,0,1,intrinsic component of omegasome membrane,CC,
16684,GO:0097631,0.999999999991726,0.890023718061521,0,1,integral component of omegasome membrane,CC,
16699,GO:0097655,0.999999999991726,0.890023718061521,0,1,serpin family protein binding,MF,
16717,GO:0097712,0.999999999991726,0.890023718061521,0,1,vesicle targeting, trans-Golgi to periciliary membrane compartment,BP,
16829,GO:0098725,0.999999999991726,0.890023718061521,0,1,symmetric cell division,BP,
16892,GO:0098838,0.999999999991726,0.890023718061521,0,1,reduced folate transmembrane transport,BP,
17046,GO:0099519,0.999999999991726,0.890023718061521,0,1,dense core granule cytoskeletal transport,BP,
17095,GO:0099627,0.999999999991726,0.890023718061521,0,1,neurotransmitter receptor cycle,BP,
17097,GO:0099630,0.999999999991726,0.890023718061521,0,1,postsynaptic neurotransmitter receptor cycle,BP,
17162,GO:0102524,0.999999999991726,0.890023718061521,0,1,tRNAPhe (7-(3-amino-3-carboxypropyl)wyosine37-C2)-hydroxylase activity,MF,
17166,GO:0102704,0.999999999991726,0.890023718061521,0,1,GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity,MF,
17169,GO:0102752,0.999999999991726,0.890023718061521,0,1,1,4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis),MF,
17219,GO:0106075,0.999999999991726,0.890023718061521,0,1,peptide N-succinyltransferase activity,MF,
17221,GO:0106078,0.999999999991726,0.890023718061521,0,1,histone succinyltransferase activity,MF,
17228,GO:0110008,0.999999999991726,0.890023718061521,0,1,ncRNA deadenylation,BP,
17236,GO:0110025,0.999999999991726,0.890023718061521,0,1,DNA strand resection involved in replication fork processing,BP,
17237,GO:0110026,0.999999999991726,0.890023718061521,0,1,regulation of DNA strand resection involved in replication fork processing,BP,
17263,GO:0120048,0.999999999991726,0.890023718061521,0,1,U6 snRNA (adenine-(43)-N(6))-methyltransferase activity,MF,
17264,GO:0120049,0.999999999991726,0.890023718061521,0,1,snRNA (adenine-N6)-methylation,BP,
17406,GO:1900135,0.999999999991726,0.890023718061521,0,1,positive regulation of renin secretion into blood stream,BP,
17414,GO:1900148,0.999999999991726,0.890023718061521,0,1,negative regulation of Schwann cell migration,BP,
17427,GO:1900170,0.999999999991726,0.890023718061521,0,1,negative regulation of glucocorticoid mediated signaling pathway,BP,
17458,GO:1900241,0.999999999991726,0.890023718061521,0,1,positive regulation of phenotypic switching,BP,
17530,GO:1901003,0.999999999991726,0.890023718061521,0,1,negative regulation of fermentation,BP,
17630,GO:1901318,0.999999999991726,0.890023718061521,0,1,negative regulation of flagellated sperm motility,BP,
17675,GO:1901523,0.999999999991726,0.890023718061521,0,1,icosanoid catabolic process,BP,
17823,GO:1901950,0.999999999991726,0.890023718061521,0,1,dense core granule transport,BP,
17878,GO:1902102,0.999999999991726,0.890023718061521,0,1,regulation of metaphase/anaphase transition of meiotic cell cycle,BP,
17879,GO:1902103,0.999999999991726,0.890023718061521,0,1,negative regulation of metaphase/anaphase transition of meiotic cell cycle,BP,
17890,GO:1902145,0.999999999991726,0.890023718061521,0,1,regulation of response to cell cycle checkpoint signaling,BP,
17891,GO:1902151,0.999999999991726,0.890023718061521,0,1,regulation of response to DNA integrity checkpoint signaling,BP,
17892,GO:1902153,0.999999999991726,0.890023718061521,0,1,regulation of response to DNA damage checkpoint signaling,BP,
17913,GO:1902211,0.999999999991726,0.890023718061521,0,1,regulation of prolactin signaling pathway,BP,
17914,GO:1902213,0.999999999991726,0.890023718061521,0,1,positive regulation of prolactin signaling pathway,BP,
17952,GO:1902282,0.999999999991726,0.890023718061521,0,1,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,MF,
17989,GO:1902387,0.999999999991726,0.890023718061521,0,1,ceramide 1-phosphate binding,MF,
17990,GO:1902388,0.999999999991726,0.890023718061521,0,1,ceramide 1-phosphate transporter activity,MF,
17991,GO:1902389,0.999999999991726,0.890023718061521,0,1,ceramide 1-phosphate transport,BP,
18026,GO:1902504,0.999999999991726,0.890023718061521,0,1,regulation of signal transduction involved in mitotic G2 DNA damage checkpoint,BP,
18095,GO:1902688,0.999999999991726,0.890023718061521,0,1,regulation of NAD metabolic process,BP,
18096,GO:1902689,0.999999999991726,0.890023718061521,0,1,negative regulation of NAD metabolic process,BP,
18126,GO:1902773,0.999999999991726,0.890023718061521,0,1,GTPase activator complex,CC,
18144,GO:1902847,0.999999999991726,0.890023718061521,0,1,regulation of neuronal signal transduction,BP,
18173,GO:1902912,0.999999999991726,0.890023718061521,0,1,pyruvate kinase complex,CC,
18184,GO:1902939,0.999999999991726,0.890023718061521,0,1,negative regulation of intracellular calcium activated chloride channel activity,BP,
18220,GO:1902998,0.999999999991726,0.890023718061521,0,1,positive regulation of neurofibrillary tangle assembly,BP,
18269,GO:1903096,0.999999999991726,0.890023718061521,0,1,protein localization to meiotic spindle midzone,BP,
18319,GO:1903231,0.999999999991726,0.890023718061521,0,1,mRNA binding involved in posttranscriptional gene silencing,MF,
18331,GO:1903259,0.999999999991726,0.890023718061521,0,1,exon-exon junction complex disassembly,BP,
18380,GO:1903367,0.999999999991726,0.890023718061521,0,1,positive regulation of fear response,BP,
18428,GO:1903461,0.999999999991726,0.890023718061521,0,1,Okazaki fragment processing involved in mitotic DNA replication,BP,
18445,GO:1903517,0.999999999991726,0.890023718061521,0,1,negative regulation of single strand break repair,BP,
18566,GO:1903770,0.999999999991726,0.890023718061521,0,1,negative regulation of beta-galactosidase activity,BP,
18588,GO:1903823,0.999999999991726,0.890023718061521,0,1,telomere single strand break repair,BP,
18589,GO:1903824,0.999999999991726,0.890023718061521,0,1,negative regulation of telomere single strand break repair,BP,
18688,GO:1904023,0.999999999991726,0.890023718061521,0,1,regulation of glucose catabolic process to lactate via pyruvate,BP,
18689,GO:1904024,0.999999999991726,0.890023718061521,0,1,negative regulation of glucose catabolic process to lactate via pyruvate,BP,
18692,GO:1904028,0.999999999991726,0.890023718061521,0,1,positive regulation of collagen fibril organization,BP,
18718,GO:1904106,0.999999999991726,0.890023718061521,0,1,protein localization to microvillus,BP,
18773,GO:1904247,0.999999999991726,0.890023718061521,0,1,positive regulation of polynucleotide adenylyltransferase activity,BP,
18883,GO:1904530,0.999999999991726,0.890023718061521,0,1,negative regulation of actin filament binding,BP,
18894,GO:1904565,0.999999999991726,0.890023718061521,0,1,response to 1-oleoyl-sn-glycerol 3-phosphate,BP,
18895,GO:1904566,0.999999999991726,0.890023718061521,0,1,cellular response to 1-oleoyl-sn-glycerol 3-phosphate,BP,
18896,GO:1904567,0.999999999991726,0.890023718061521,0,1,response to wortmannin,BP,
18897,GO:1904568,0.999999999991726,0.890023718061521,0,1,cellular response to wortmannin,BP,
18925,GO:1904617,0.999999999991726,0.890023718061521,0,1,negative regulation of actin binding,BP,
18961,GO:1904713,0.999999999991726,0.890023718061521,0,1,beta-catenin destruction complex binding,MF,
18968,GO:1904721,0.999999999991726,0.890023718061521,0,1,negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
18995,GO:1904777,0.999999999991726,0.890023718061521,0,1,negative regulation of protein localization to cell cortex,BP,
19002,GO:1904790,0.999999999991726,0.890023718061521,0,1,regulation of shelterin complex assembly,BP,
19003,GO:1904792,0.999999999991726,0.890023718061521,0,1,positive regulation of shelterin complex assembly,BP,
19011,GO:1904806,0.999999999991726,0.890023718061521,0,1,regulation of protein oxidation,BP,
19012,GO:1904808,0.999999999991726,0.890023718061521,0,1,positive regulation of protein oxidation,BP,
19032,GO:1904850,0.999999999991726,0.890023718061521,0,1,negative regulation of establishment of protein localization to telomere,BP,
19044,GO:1904876,0.999999999991726,0.890023718061521,0,1,negative regulation of DNA ligase activity,BP,
19066,GO:1904910,0.999999999991726,0.890023718061521,0,1,regulation of establishment of RNA localization to telomere,BP,
19067,GO:1904911,0.999999999991726,0.890023718061521,0,1,negative regulation of establishment of RNA localization to telomere,BP,
19068,GO:1904913,0.999999999991726,0.890023718061521,0,1,regulation of establishment of protein-containing complex localization to telomere,BP,
19069,GO:1904914,0.999999999991726,0.890023718061521,0,1,negative regulation of establishment of protein-containing complex localization to telomere,BP,
19078,GO:1904947,0.999999999991726,0.890023718061521,0,1,folic acid import into mitochondrion,BP,
19090,GO:1904970,0.999999999991726,0.890023718061521,0,1,brush border assembly,BP,
19095,GO:1904977,0.999999999991726,0.890023718061521,0,1,lymphatic endothelial cell migration,BP,
19106,GO:1904998,0.999999999991726,0.890023718061521,0,1,negative regulation of leukocyte adhesion to arterial endothelial cell,BP,
19124,GO:1905044,0.999999999991726,0.890023718061521,0,1,regulation of Schwann cell proliferation involved in axon regeneration,BP,
19125,GO:1905045,0.999999999991726,0.890023718061521,0,1,negative regulation of Schwann cell proliferation involved in axon regeneration,BP,
19152,GO:1905132,0.999999999991726,0.890023718061521,0,1,regulation of meiotic chromosome separation,BP,
19153,GO:1905133,0.999999999991726,0.890023718061521,0,1,negative regulation of meiotic chromosome separation,BP,
19173,GO:1905176,0.999999999991726,0.890023718061521,0,1,positive regulation of vascular smooth muscle cell dedifferentiation,BP,
19185,GO:1905222,0.999999999991726,0.890023718061521,0,1,atrioventricular canal morphogenesis,BP,
19204,GO:1905277,0.999999999991726,0.890023718061521,0,1,negative regulation of epithelial tube formation,BP,
19206,GO:1905279,0.999999999991726,0.890023718061521,0,1,regulation of retrograde transport, endosome to Golgi,BP,
19222,GO:1905319,0.999999999991726,0.890023718061521,0,1,mesenchymal stem cell migration,BP,
19223,GO:1905320,0.999999999991726,0.890023718061521,0,1,regulation of mesenchymal stem cell migration,BP,
19224,GO:1905322,0.999999999991726,0.890023718061521,0,1,positive regulation of mesenchymal stem cell migration,BP,
19235,GO:1905344,0.999999999991726,0.890023718061521,0,1,prostaglandin catabolic process,BP,
19240,GO:1905359,0.999999999991726,0.890023718061521,0,1,protein localization to meiotic spindle,BP,
19269,GO:1905435,0.999999999991726,0.890023718061521,0,1,regulation of histone H3-K4 trimethylation,BP,
19270,GO:1905437,0.999999999991726,0.890023718061521,0,1,positive regulation of histone H3-K4 trimethylation,BP,
19314,GO:1905572,0.999999999991726,0.890023718061521,0,1,ganglioside GM1 transport to membrane,BP,
19316,GO:1905574,0.999999999991726,0.890023718061521,0,1,ganglioside GM2 binding,MF,
19317,GO:1905575,0.999999999991726,0.890023718061521,0,1,ganglioside GM3 binding,MF,
19319,GO:1905577,0.999999999991726,0.890023718061521,0,1,ganglioside GP1c binding,MF,
19323,GO:1905590,0.999999999991726,0.890023718061521,0,1,fibronectin fibril organization,BP,
19340,GO:1905642,0.999999999991726,0.890023718061521,0,1,negative regulation of DNA methylation,BP,
19400,GO:1905891,0.999999999991726,0.890023718061521,0,1,regulation of cellular response to thapsigargin,BP,
19401,GO:1905892,0.999999999991726,0.890023718061521,0,1,negative regulation of cellular response to thapsigargin,BP,
19402,GO:1905894,0.999999999991726,0.890023718061521,0,1,regulation of cellular response to tunicamycin,BP,
19403,GO:1905895,0.999999999991726,0.890023718061521,0,1,negative regulation of cellular response to tunicamycin,BP,
19448,GO:1990048,0.999999999991726,0.890023718061521,0,1,anterograde neuronal dense core vesicle transport,BP,
19502,GO:1990261,0.999999999991726,0.890023718061521,0,1,pre-mRNA catabolic process,BP,
19507,GO:1990275,0.999999999991726,0.890023718061521,0,1,preribosome binding,MF,
19576,GO:1990570,0.999999999991726,0.890023718061521,0,1,GDP-mannose transmembrane transport,BP,
19598,GO:1990646,0.999999999991726,0.890023718061521,0,1,cellular response to prolactin,BP,
19617,GO:1990738,0.999999999991726,0.890023718061521,0,1,pseudouridine 5'-phosphatase activity,MF,
19626,GO:1990755,0.999999999991726,0.890023718061521,0,1,mitotic spindle microtubule depolymerization,BP,
19644,GO:1990796,0.999999999991726,0.890023718061521,0,1,photoreceptor cell terminal bouton,CC,
19699,GO:2000003,0.999999999991726,0.890023718061521,0,1,positive regulation of DNA damage checkpoint,BP,
19796,GO:2000199,0.999999999991726,0.890023718061521,0,1,positive regulation of ribonucleoprotein complex localization,BP,
19797,GO:2000200,0.999999999991726,0.890023718061521,0,1,regulation of ribosomal subunit export from nucleus,BP,
19798,GO:2000202,0.999999999991726,0.890023718061521,0,1,positive regulation of ribosomal subunit export from nucleus,BP,
19799,GO:2000206,0.999999999991726,0.890023718061521,0,1,regulation of ribosomal small subunit export from nucleus,BP,
19800,GO:2000208,0.999999999991726,0.890023718061521,0,1,positive regulation of ribosomal small subunit export from nucleus,BP,
19872,GO:2000329,0.999999999991726,0.890023718061521,0,1,negative regulation of T-helper 17 cell lineage commitment,BP,
19967,GO:2000492,0.999999999991726,0.890023718061521,0,1,regulation of interleukin-18-mediated signaling pathway,BP,
19968,GO:2000494,0.999999999991726,0.890023718061521,0,1,positive regulation of interleukin-18-mediated signaling pathway,BP,
20016,GO:2000606,0.999999999991726,0.890023718061521,0,1,regulation of cell proliferation involved in mesonephros development,BP,
20017,GO:2000607,0.999999999991726,0.890023718061521,0,1,negative regulation of cell proliferation involved in mesonephros development,BP,
20081,GO:2000699,0.999999999991726,0.890023718061521,0,1,fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
20082,GO:2000701,0.999999999991726,0.890023718061521,0,1,glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
20083,GO:2000702,0.999999999991726,0.890023718061521,0,1,regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
20084,GO:2000703,0.999999999991726,0.890023718061521,0,1,negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
20091,GO:2000722,0.999999999991726,0.890023718061521,0,1,regulation of cardiac vascular smooth muscle cell differentiation,BP,
20092,GO:2000724,0.999999999991726,0.890023718061521,0,1,positive regulation of cardiac vascular smooth muscle cell differentiation,BP,
20096,GO:2000733,0.999999999991726,0.890023718061521,0,1,regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
20097,GO:2000734,0.999999999991726,0.890023718061521,0,1,negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
20176,GO:2000909,0.999999999991726,0.890023718061521,0,1,regulation of sterol import,BP,
20187,GO:2000987,0.999999999991726,0.890023718061521,0,1,positive regulation of behavioral fear response,BP,
20302,GO:2001253,0.999999999991726,0.890023718061521,0,1,regulation of histone H3-K36 trimethylation,BP,
10583,GO:0043553,0.999999999991731,0.705225419541015,0,3,negative regulation of phosphatidylinositol 3-kinase activity,BP,
79,GO:0000160,0.999999999991732,0.890023718061515,0,1,phosphorelay signal transduction system,BP,
99,GO:0000210,0.999999999991732,0.890023718061515,0,1,NAD+ diphosphatase activity,MF,
117,GO:0000246,0.999999999991732,0.890023718061515,0,1,delta24(24-1) sterol reductase activity,MF,
120,GO:0000250,0.999999999991732,0.890023718061515,0,1,lanosterol synthase activity,MF,
191,GO:0000409,0.999999999991732,0.890023718061515,0,1,regulation of transcription by galactose,BP,
192,GO:0000411,0.999999999991732,0.890023718061515,0,1,positive regulation of transcription by galactose,BP,
196,GO:0000415,0.999999999991732,0.890023718061515,0,1,negative regulation of histone H3-K36 methylation,BP,
197,GO:0000416,0.999999999991732,0.890023718061515,0,1,positive regulation of histone H3-K36 methylation,BP,
198,GO:0000417,0.999999999991732,0.890023718061515,0,1,HIR complex,CC,
205,GO:0000431,0.999999999991732,0.890023718061515,0,1,regulation of transcription from RNA polymerase II promoter by galactose,BP,
207,GO:0000435,0.999999999991732,0.890023718061515,0,1,positive regulation of transcription from RNA polymerase II promoter by galactose,BP,
232,GO:0000481,0.999999999991732,0.890023718061515,0,1,maturation of 5S rRNA,BP,
292,GO:0000797,0.999999999991732,0.890023718061515,0,1,condensin core heterodimer,CC,
296,GO:0000801,0.999999999991732,0.890023718061515,0,1,central element,CC,
309,GO:0000821,0.999999999991732,0.890023718061515,0,1,regulation of arginine metabolic process,BP,
378,GO:0001011,0.999999999991732,0.890023718061515,0,1,transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting,MF,
405,GO:0001087,0.999999999991732,0.890023718061515,0,1,transcription factor activity, TFIIB-class binding,MF,
409,GO:0001096,0.999999999991732,0.890023718061515,0,1,TFIIF-class transcription factor binding,MF,
436,GO:0001165,0.999999999991732,0.890023718061515,0,1,RNA polymerase I upstream control element sequence-specific DNA binding,MF,
452,GO:0001226,0.999999999991732,0.890023718061515,0,1,RNA polymerase II transcription corepressor binding,MF,
475,GO:0001519,0.999999999991732,0.890023718061515,0,1,peptide amidation,BP,
483,GO:0001534,0.999999999991732,0.890023718061515,0,1,radial spoke,CC,
484,GO:0001536,0.999999999991732,0.890023718061515,0,1,radial spoke stalk,CC,
490,GO:0001543,0.999999999991732,0.890023718061515,0,1,ovarian follicle rupture,BP,
491,GO:0001544,0.999999999991732,0.890023718061515,0,1,initiation of primordial ovarian follicle growth,BP,
492,GO:0001545,0.999999999991732,0.890023718061515,0,1,primary ovarian follicle growth,BP,
519,GO:0001605,0.999999999991732,0.890023718061515,0,1,adrenomedullin receptor activity,MF,
528,GO:0001640,0.999999999991732,0.890023718061515,0,1,adenylate cyclase inhibiting G-protein coupled glutamate receptor activity,MF,
529,GO:0001642,0.999999999991732,0.890023718061515,0,1,group III metabotropic glutamate receptor activity,MF,
572,GO:0001715,0.999999999991732,0.890023718061515,0,1,ectodermal cell fate specification,BP,
601,GO:0001770,0.999999999991732,0.890023718061515,0,1,establishment of natural killer cell polarity,BP,
618,GO:0001792,0.999999999991732,0.890023718061515,0,1,polymeric immunoglobulin receptor activity,MF,
619,GO:0001794,0.999999999991732,0.890023718061515,0,1,type IIa hypersensitivity,BP,
620,GO:0001796,0.999999999991732,0.890023718061515,0,1,regulation of type IIa hypersensitivity,BP,
621,GO:0001798,0.999999999991732,0.890023718061515,0,1,positive regulation of type IIa hypersensitivity,BP,
640,GO:0001831,0.999999999991732,0.890023718061515,0,1,trophectodermal cellular morphogenesis,BP,
644,GO:0001835,0.999999999991732,0.890023718061515,0,1,blastocyst hatching,BP,
738,GO:0001970,0.999999999991732,0.890023718061515,0,1,positive regulation of activation of membrane attack complex,BP,
739,GO:0001971,0.999999999991732,0.890023718061515,0,1,negative regulation of activation of membrane attack complex,BP,
751,GO:0001992,0.999999999991732,0.890023718061515,0,1,regulation of systemic arterial blood pressure by vasopressin,BP,
807,GO:0002081,0.999999999991732,0.890023718061515,0,1,outer acrosomal membrane,CC,
823,GO:0002100,0.999999999991732,0.890023718061515,0,1,tRNA wobble adenosine to inosine editing,BP,
826,GO:0002114,0.999999999991732,0.890023718061515,0,1,interleukin-33 receptor activity,MF,
829,GO:0002118,0.999999999991732,0.890023718061515,0,1,aggressive behavior,BP,
830,GO:0002121,0.999999999991732,0.890023718061515,0,1,inter-male aggressive behavior,BP,
836,GO:0002139,0.999999999991732,0.890023718061515,0,1,stereocilia coupling link,CC,
837,GO:0002140,0.999999999991732,0.890023718061515,0,1,stereocilia tip link,CC,
880,GO:0002238,0.999999999991732,0.890023718061515,0,1,response to molecule of fungal origin,BP,
922,GO:0002316,0.999999999991732,0.890023718061515,0,1,follicular B cell differentiation,BP,
934,GO:0002332,0.999999999991732,0.890023718061515,0,1,transitional stage B cell differentiation,BP,
935,GO:0002333,0.999999999991732,0.890023718061515,0,1,transitional one stage B cell differentiation,BP,
941,GO:0002351,0.999999999991732,0.890023718061515,0,1,serotonin production involved in inflammatory response,BP,
958,GO:0002378,0.999999999991732,0.890023718061515,0,1,immunoglobulin biosynthetic process,BP,
961,GO:0002384,0.999999999991732,0.890023718061515,0,1,hepatic immune response,BP,
967,GO:0002408,0.999999999991732,0.890023718061515,0,1,myeloid dendritic cell chemotaxis,BP,
979,GO:0002432,0.999999999991732,0.890023718061515,0,1,granuloma formation,BP,
986,GO:0002442,0.999999999991732,0.890023718061515,0,1,serotonin secretion involved in inflammatory response,BP,
989,GO:0002445,0.999999999991732,0.890023718061515,0,1,type II hypersensitivity,BP,
1010,GO:0002488,0.999999999991732,0.890023718061515,0,1,antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway,BP,
1011,GO:0002489,0.999999999991732,0.890023718061515,0,1,antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent,BP,
1018,GO:0002514,0.999999999991732,0.890023718061515,0,1,B cell tolerance induction,BP,
1030,GO:0002537,0.999999999991732,0.890023718061515,0,1,nitric oxide production involved in inflammatory response,BP,
1031,GO:0002538,0.999999999991732,0.890023718061515,0,1,arachidonic acid metabolite production involved in inflammatory response,BP,
1032,GO:0002540,0.999999999991732,0.890023718061515,0,1,leukotriene production involved in inflammatory response,BP,
1041,GO:0002554,0.999999999991732,0.890023718061515,0,1,serotonin secretion by platelet,BP,
1065,GO:0002605,0.999999999991732,0.890023718061515,0,1,negative regulation of dendritic cell antigen processing and presentation,BP,
1070,GO:0002635,0.999999999991732,0.890023718061515,0,1,negative regulation of germinal center formation,BP,
1077,GO:0002649,0.999999999991732,0.890023718061515,0,1,regulation of tolerance induction to self antigen,BP,
1078,GO:0002651,0.999999999991732,0.890023718061515,0,1,positive regulation of tolerance induction to self antigen,BP,
1080,GO:0002661,0.999999999991732,0.890023718061515,0,1,regulation of B cell tolerance induction,BP,
1081,GO:0002663,0.999999999991732,0.890023718061515,0,1,positive regulation of B cell tolerance induction,BP,
1085,GO:0002669,0.999999999991732,0.890023718061515,0,1,positive regulation of T cell anergy,BP,
1137,GO:0002728,0.999999999991732,0.890023718061515,0,1,negative regulation of natural killer cell cytokine production,BP,
1141,GO:0002732,0.999999999991732,0.890023718061515,0,1,positive regulation of dendritic cell cytokine production,BP,
1165,GO:0002785,0.999999999991732,0.890023718061515,0,1,negative regulation of antimicrobial peptide production,BP,
1167,GO:0002787,0.999999999991732,0.890023718061515,0,1,negative regulation of antibacterial peptide production,BP,
1223,GO:0002892,0.999999999991732,0.890023718061515,0,1,regulation of type II hypersensitivity,BP,
1224,GO:0002894,0.999999999991732,0.890023718061515,0,1,positive regulation of type II hypersensitivity,BP,
1232,GO:0002913,0.999999999991732,0.890023718061515,0,1,positive regulation of lymphocyte anergy,BP,
1239,GO:0002930,0.999999999991732,0.890023718061515,0,1,trabecular meshwork development,BP,
1248,GO:0002947,0.999999999991732,0.890023718061515,0,1,tumor necrosis factor receptor superfamily complex,CC,
1264,GO:0003017,0.999999999991732,0.890023718061515,0,1,lymph circulation,BP,
1318,GO:0003165,0.999999999991732,0.890023718061515,0,1,Purkinje myocyte development,BP,
1319,GO:0003166,0.999999999991732,0.890023718061515,0,1,bundle of His development,BP,
1320,GO:0003167,0.999999999991732,0.890023718061515,0,1,atrioventricular bundle cell differentiation,BP,
1337,GO:0003193,0.999999999991732,0.890023718061515,0,1,pulmonary valve formation,BP,
1353,GO:0003220,0.999999999991732,0.890023718061515,0,1,left ventricular cardiac muscle tissue morphogenesis,BP,
1354,GO:0003221,0.999999999991732,0.890023718061515,0,1,right ventricular cardiac muscle tissue morphogenesis,BP,
1357,GO:0003226,0.999999999991732,0.890023718061515,0,1,right ventricular compact myocardium morphogenesis,BP,
1367,GO:0003251,0.999999999991732,0.890023718061515,0,1,positive regulation of cell proliferation involved in heart valve morphogenesis,BP,
1368,GO:0003252,0.999999999991732,0.890023718061515,0,1,negative regulation of cell proliferation involved in heart valve morphogenesis,BP,
1372,GO:0003257,0.999999999991732,0.890023718061515,0,1,positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,
1376,GO:0003270,0.999999999991732,0.890023718061515,0,1,Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation,BP,
1387,GO:0003292,0.999999999991732,0.890023718061515,0,1,cardiac septum cell differentiation,BP,
1412,GO:0003345,0.999999999991732,0.890023718061515,0,1,proepicardium cell migration involved in pericardium morphogenesis,BP,
1420,GO:0003363,0.999999999991732,0.890023718061515,0,1,lamellipodium assembly involved in ameboidal cell migration,BP,
1431,GO:0003404,0.999999999991732,0.890023718061515,0,1,optic vesicle morphogenesis,BP,
1435,GO:0003409,0.999999999991732,0.890023718061515,0,1,optic cup structural organization,BP,
1509,GO:0003867,0.999999999991732,0.890023718061515,0,1,4-aminobutyrate transaminase activity,MF,
1515,GO:0003875,0.999999999991732,0.890023718061515,0,1,ADP-ribosylarginine hydrolase activity,MF,
1518,GO:0003878,0.999999999991732,0.890023718061515,0,1,ATP citrate synthase activity,MF,
1559,GO:0003957,0.999999999991732,0.890023718061515,0,1,NAD(P)+ transhydrogenase (B-specific) activity,MF,
1567,GO:0003973,0.999999999991732,0.890023718061515,0,1,(S)-2-hydroxy-acid oxidase activity,MF,
1573,GO:0003979,0.999999999991732,0.890023718061515,0,1,UDP-glucose 6-dehydrogenase activity,MF,
1597,GO:0004014,0.999999999991732,0.890023718061515,0,1,adenosylmethionine decarboxylase activity,MF,
1609,GO:0004031,0.999999999991732,0.890023718061515,0,1,aldehyde oxidase activity,MF,
1616,GO:0004044,0.999999999991732,0.890023718061515,0,1,amidophosphoribosyltransferase activity,MF,
1659,GO:0004113,0.999999999991732,0.890023718061515,0,1,2',3'-cyclic-nucleotide 3'-phosphodiesterase activity,MF,
1663,GO:0004118,0.999999999991732,0.890023718061515,0,1,cGMP-stimulated cyclic-nucleotide phosphodiesterase activity,MF,
1671,GO:0004133,0.999999999991732,0.890023718061515,0,1,glycogen debranching enzyme activity,MF,
1672,GO:0004134,0.999999999991732,0.890023718061515,0,1,4-alpha-glucanotransferase activity,MF,
1673,GO:0004135,0.999999999991732,0.890023718061515,0,1,amylo-alpha-1,6-glucosidase activity,MF,
1683,GO:0004148,0.999999999991732,0.890023718061515,0,1,dihydrolipoyl dehydrogenase activity,MF,
1688,GO:0004157,0.999999999991732,0.890023718061515,0,1,dihydropyrimidinase activity,MF,
1722,GO:0004313,0.999999999991732,0.890023718061515,0,1,[acyl-carrier-protein] S-acetyltransferase activity,MF,
1725,GO:0004316,0.999999999991732,0.890023718061515,0,1,3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity,MF,
1726,GO:0004317,0.999999999991732,0.890023718061515,0,1,3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity,MF,
1727,GO:0004319,0.999999999991732,0.890023718061515,0,1,enoyl-[acyl-carrier-protein] reductase (NADPH, B-specific) activity,MF,
1731,GO:0004325,0.999999999991732,0.890023718061515,0,1,ferrochelatase activity,MF,
1743,GO:0004343,0.999999999991732,0.890023718061515,0,1,glucosamine 6-phosphate N-acetyltransferase activity,MF,
1749,GO:0004349,0.999999999991732,0.890023718061515,0,1,glutamate 5-kinase activity,MF,
1750,GO:0004350,0.999999999991732,0.890023718061515,0,1,glutamate-5-semialdehyde dehydrogenase activity,MF,
1752,GO:0004352,0.999999999991732,0.890023718061515,0,1,glutamate dehydrogenase (NAD+) activity,MF,
1753,GO:0004353,0.999999999991732,0.890023718061515,0,1,glutamate dehydrogenase [NAD(P)+] activity,MF,
1757,GO:0004360,0.999999999991732,0.890023718061515,0,1,glutamine-fructose-6-phosphate transaminase (isomerizing) activity,MF,
1764,GO:0004367,0.999999999991732,0.890023718061515,0,1,glycerol-3-phosphate dehydrogenase [NAD+] activity,MF,
1765,GO:0004368,0.999999999991732,0.890023718061515,0,1,glycerol-3-phosphate dehydrogenase activity,MF,
1769,GO:0004373,0.999999999991732,0.890023718061515,0,1,glycogen (starch) synthase activity,MF,
1770,GO:0004375,0.999999999991732,0.890023718061515,0,1,glycine dehydrogenase (decarboxylating) activity,MF,
1780,GO:0004394,0.999999999991732,0.890023718061515,0,1,heparan sulfate 2-O-sulfotransferase activity,MF,
1783,GO:0004397,0.999999999991732,0.890023718061515,0,1,histidine ammonia-lyase activity,MF,
1791,GO:0004420,0.999999999991732,0.890023718061515,0,1,hydroxymethylglutaryl-CoA reductase (NADPH) activity,MF,
1792,GO:0004421,0.999999999991732,0.890023718061515,0,1,hydroxymethylglutaryl-CoA synthase activity,MF,
1794,GO:0004423,0.999999999991732,0.890023718061515,0,1,iduronate-2-sulfatase activity,MF,
1827,GO:0004482,0.999999999991732,0.890023718061515,0,1,mRNA (guanine-N7-)-methyltransferase activity,MF,
1829,GO:0004484,0.999999999991732,0.890023718061515,0,1,mRNA guanylyltransferase activity,MF,
1831,GO:0004486,0.999999999991732,0.890023718061515,0,1,methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity,MF,
1845,GO:0004504,0.999999999991732,0.890023718061515,0,1,peptidylglycine monooxygenase activity,MF,
1886,GO:0004567,0.999999999991732,0.890023718061515,0,1,beta-mannosidase activity,MF,
1888,GO:0004569,0.999999999991732,0.890023718061515,0,1,glycoprotein endo-alpha-1,2-mannosidase activity,MF,
1895,GO:0004578,0.999999999991732,0.890023718061515,0,1,chitobiosyldiphosphodolichol beta-mannosyltransferase activity,MF,
1909,GO:0004597,0.999999999991732,0.890023718061515,0,1,peptide-aspartate beta-dioxygenase activity,MF,
1910,GO:0004598,0.999999999991732,0.890023718061515,0,1,peptidylamidoglycolate lyase activity,MF,
1936,GO:0004637,0.999999999991732,0.890023718061515,0,1,phosphoribosylamine-glycine ligase activity,MF,
1937,GO:0004638,0.999999999991732,0.890023718061515,0,1,phosphoribosylaminoimidazole carboxylase activity,MF,
1938,GO:0004639,0.999999999991732,0.890023718061515,0,1,phosphoribosylaminoimidazolesuccinocarboxamide synthase activity,MF,
1939,GO:0004641,0.999999999991732,0.890023718061515,0,1,phosphoribosylformylglycinamidine cyclo-ligase activity,MF,
1940,GO:0004642,0.999999999991732,0.890023718061515,0,1,phosphoribosylformylglycinamidine synthase activity,MF,
1942,GO:0004644,0.999999999991732,0.890023718061515,0,1,phosphoribosylglycinamide formyltransferase activity,MF,
1950,GO:0004654,0.999999999991732,0.890023718061515,0,1,polyribonucleotide nucleotidyltransferase activity,MF,
1951,GO:0004655,0.999999999991732,0.890023718061515,0,1,porphobilinogen synthase activity,MF,
1962,GO:0004671,0.999999999991732,0.890023718061515,0,1,protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity,MF,
1967,GO:0004676,0.999999999991732,0.890023718061515,0,1,3-phosphoinositide-dependent protein kinase activity,MF,
1976,GO:0004692,0.999999999991732,0.890023718061515,0,1,cGMP-dependent protein kinase activity,MF,
1980,GO:0004698,0.999999999991732,0.890023718061515,0,1,calcium-dependent protein kinase C activity,MF,
2008,GO:0004733,0.999999999991732,0.890023718061515,0,1,pyridoxamine-phosphate oxidase activity,MF,
2015,GO:0004742,0.999999999991732,0.890023718061515,0,1,dihydrolipoyllysine-residue acetyltransferase activity,MF,
2023,GO:0004753,0.999999999991732,0.890023718061515,0,1,saccharopine dehydrogenase activity,MF,
2032,GO:0004772,0.999999999991732,0.890023718061515,0,1,sterol O-acyltransferase activity,MF,
2033,GO:0004773,0.999999999991732,0.890023718061515,0,1,steryl-sulfatase activity,MF,
2037,GO:0004777,0.999999999991732,0.890023718061515,0,1,succinate-semialdehyde dehydrogenase (NAD+) activity,MF,
2081,GO:0004835,0.999999999991732,0.890023718061515,0,1,tubulin-tyrosine ligase activity,MF,
2092,GO:0004856,0.999999999991732,0.890023718061515,0,1,xylulokinase activity,MF,
2106,GO:0004882,0.999999999991732,0.890023718061515,0,1,androgen receptor activity,MF,
2107,GO:0004883,0.999999999991732,0.890023718061515,0,1,glucocorticoid receptor activity,MF,
2111,GO:0004890,0.999999999991732,0.890023718061515,0,1,GABA-A receptor activity,MF,
2125,GO:0004921,0.999999999991732,0.890023718061515,0,1,interleukin-11 receptor activity,MF,
2137,GO:0004948,0.999999999991732,0.890023718061515,0,1,calcitonin receptor activity,MF,
2143,GO:0004957,0.999999999991732,0.890023718061515,0,1,prostaglandin E receptor activity,MF,
2159,GO:0004990,0.999999999991732,0.890023718061515,0,1,oxytocin receptor activity,MF,
2160,GO:0004992,0.999999999991732,0.890023718061515,0,1,platelet activating factor receptor activity,MF,
2162,GO:0004996,0.999999999991732,0.890023718061515,0,1,thyroid-stimulating hormone receptor activity,MF,
2163,GO:0004998,0.999999999991732,0.890023718061515,0,1,transferrin receptor activity,MF,
2168,GO:0005004,0.999999999991732,0.890023718061515,0,1,GPI-linked ephrin receptor activity,MF,
2172,GO:0005008,0.999999999991732,0.890023718061515,0,1,hepatocyte growth factor-activated receptor activity,MF,
2179,GO:0005026,0.999999999991732,0.890023718061515,0,1,transforming growth factor beta receptor activity, type II,MF,
2180,GO:0005030,0.999999999991732,0.890023718061515,0,1,neurotrophin receptor activity,MF,
2182,GO:0005034,0.999999999991732,0.890023718061515,0,1,osmosensor activity,MF,
2185,GO:0005042,0.999999999991732,0.890023718061515,0,1,netrin receptor activity,MF,
2218,GO:0005115,0.999999999991732,0.890023718061515,0,1,receptor tyrosine kinase-like orphan receptor binding,MF,
2225,GO:0005128,0.999999999991732,0.890023718061515,0,1,erythropoietin receptor binding,MF,
2230,GO:0005135,0.999999999991732,0.890023718061515,0,1,interleukin-3 receptor binding,MF,
2255,GO:0005170,0.999999999991732,0.890023718061515,0,1,neurotrophin TRKC receptor binding,MF,
2267,GO:0005199,0.999999999991732,0.890023718061515,0,1,structural constituent of cell wall,MF,
2282,GO:0005237,0.999999999991732,0.890023718061515,0,1,inhibitory extracellular ligand-gated ion channel activity,MF,
2306,GO:0005294,0.999999999991732,0.890023718061515,0,1,neutral L-amino acid secondary active transmembrane transporter activity,MF,
2307,GO:0005295,0.999999999991732,0.890023718061515,0,1,neutral amino acid:sodium symporter activity,MF,
2308,GO:0005298,0.999999999991732,0.890023718061515,0,1,proline:sodium symporter activity,MF,
2321,GO:0005330,0.999999999991732,0.890023718061515,0,1,dopamine:sodium symporter activity,MF,
2323,GO:0005335,0.999999999991732,0.890023718061515,0,1,serotonin:sodium symporter activity,MF,
2336,GO:0005366,0.999999999991732,0.890023718061515,0,1,myo-inositol:proton symporter activity,MF,
2337,GO:0005367,0.999999999991732,0.890023718061515,0,1,myo-inositol:sodium symporter activity,MF,
2351,GO:0005427,0.999999999991732,0.890023718061515,0,1,proton-dependent oligopeptide secondary active transmembrane transporter activity,MF,
2359,GO:0005461,0.999999999991732,0.890023718061515,0,1,UDP-glucuronic acid transmembrane transporter activity,MF,
2361,GO:0005464,0.999999999991732,0.890023718061515,0,1,UDP-xylose transmembrane transporter activity,MF,
2364,GO:0005477,0.999999999991732,0.890023718061515,0,1,pyruvate secondary active transmembrane transporter activity,MF,
2372,GO:0005502,0.999999999991732,0.890023718061515,0,1,11-cis retinal binding,MF,
2373,GO:0005503,0.999999999991732,0.890023718061515,0,1,all-trans retinal binding,MF,
2382,GO:0005519,0.999999999991732,0.890023718061515,0,1,cytoskeletal regulatory protein binding,MF,
2407,GO:0005579,0.999999999991732,0.890023718061515,0,1,membrane attack complex,CC,
2414,GO:0005590,0.999999999991732,0.890023718061515,0,1,collagen type VII trimer,CC,
2416,GO:0005592,0.999999999991732,0.890023718061515,0,1,collagen type XI trimer,CC,
2419,GO:0005595,0.999999999991732,0.890023718061515,0,1,collagen type XII trimer,CC,
2420,GO:0005597,0.999999999991732,0.890023718061515,0,1,collagen type XVI trimer,CC,
2473,GO:0005691,0.999999999991732,0.890023718061515,0,1,U6atac snRNP,CC,
2574,GO:0005863,0.999999999991732,0.890023718061515,0,1,striated muscle myosin thick filament,CC,
2598,GO:0005898,0.999999999991732,0.890023718061515,0,1,interleukin-13 receptor complex,CC,
2635,GO:0005969,0.999999999991732,0.890023718061515,0,1,serine-pyruvate aminotransferase complex,CC,
2651,GO:0005998,0.999999999991732,0.890023718061515,0,1,xylulose catabolic process,BP,
2739,GO:0006127,0.999999999991732,0.890023718061515,0,1,glycerophosphate shuttle,BP,
2744,GO:0006147,0.999999999991732,0.890023718061515,0,1,guanine catabolic process,BP,
2839,GO:0006311,0.999999999991732,0.890023718061515,0,1,meiotic gene conversion,BP,
2841,GO:0006313,0.999999999991732,0.890023718061515,0,1,transposition, DNA-mediated,BP,
2851,GO:0006343,0.999999999991732,0.890023718061515,0,1,establishment of chromatin silencing,BP,
2934,GO:0006463,0.999999999991732,0.890023718061515,0,1,steroid hormone receptor complex assembly,BP,
3008,GO:0006557,0.999999999991732,0.890023718061515,0,1,S-adenosylmethioninamine biosynthetic process,BP,
3037,GO:0006592,0.999999999991732,0.890023718061515,0,1,ornithine biosynthetic process,BP,
3094,GO:0006671,0.999999999991732,0.890023718061515,0,1,phytosphingosine metabolic process,BP,
3143,GO:0006742,0.999999999991732,0.890023718061515,0,1,NADP catabolic process,BP,
3304,GO:0007008,0.999999999991732,0.890023718061515,0,1,outer mitochondrial membrane organization,BP,
3307,GO:0007014,0.999999999991732,0.890023718061515,0,1,actin ubiquitination,BP,
3372,GO:0007147,0.999999999991732,0.890023718061515,0,1,female meiosis II,BP,
3410,GO:0007196,0.999999999991732,0.890023718061515,0,1,adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway,BP,
3417,GO:0007206,0.999999999991732,0.890023718061515,0,1,phospholipase C-activating G-protein coupled glutamate receptor signaling pathway,BP,
3432,GO:0007225,0.999999999991732,0.890023718061515,0,1,patched ligand maturation,BP,
3483,GO:0007352,0.999999999991732,0.890023718061515,0,1,zygotic specification of dorsal/ventral axis,BP,
3488,GO:0007371,0.999999999991732,0.890023718061515,0,1,ventral midline determination,BP,
3497,GO:0007403,0.999999999991732,0.890023718061515,0,1,glial cell fate determination,BP,
3518,GO:0007495,0.999999999991732,0.890023718061515,0,1,visceral mesoderm-endoderm interaction involved in midgut development,BP,
3519,GO:0007497,0.999999999991732,0.890023718061515,0,1,posterior midgut development,BP,
3521,GO:0007499,0.999999999991732,0.890023718061515,0,1,ectoderm and mesoderm interaction,BP,
3525,GO:0007509,0.999999999991732,0.890023718061515,0,1,mesoderm migration involved in gastrulation,BP,
3573,GO:0007621,0.999999999991732,0.890023718061515,0,1,negative regulation of female receptivity,BP,
3576,GO:0007624,0.999999999991732,0.890023718061515,0,1,ultradian rhythm,BP,
3610,GO:0008057,0.999999999991732,0.890023718061515,0,1,eye pigment granule organization,BP,
3619,GO:0008078,0.999999999991732,0.890023718061515,0,1,mesodermal cell migration,BP,
3639,GO:0008116,0.999999999991732,0.890023718061515,0,1,prostaglandin-I synthase activity,MF,
3640,GO:0008117,0.999999999991732,0.890023718061515,0,1,sphinganine-1-phosphate aldolase activity,MF,
3642,GO:0008119,0.999999999991732,0.890023718061515,0,1,thiopurine S-methyltransferase activity,MF,
3723,GO:0008254,0.999999999991732,0.890023718061515,0,1,3'-nucleotidase activity,MF,
3724,GO:0008260,0.999999999991732,0.890023718061515,0,1,3-oxoacid CoA-transferase activity,MF,
3739,GO:0008281,0.999999999991732,0.890023718061515,0,1,sulfonylurea receptor activity,MF,
3780,GO:0008343,0.999999999991732,0.890023718061515,0,1,adult feeding behavior,BP,
3783,GO:0008348,0.999999999991732,0.890023718061515,0,1,negative regulation of antimicrobial humoral response,BP,
3788,GO:0008355,0.999999999991732,0.890023718061515,0,1,olfactory learning,BP,
3809,GO:0008403,0.999999999991732,0.890023718061515,0,1,25-hydroxycholecalciferol-24-hydroxylase activity,MF,
3822,GO:0008424,0.999999999991732,0.890023718061515,0,1,glycoprotein 6-alpha-L-fucosyltransferase activity,MF,
3831,GO:0008434,0.999999999991732,0.890023718061515,0,1,calcitriol receptor activity,MF,
3845,GO:0008457,0.999999999991732,0.890023718061515,0,1,beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity,MF,
3846,GO:0008458,0.999999999991732,0.890023718061515,0,1,carnitine O-octanoyltransferase activity,MF,
3853,GO:0008470,0.999999999991732,0.890023718061515,0,1,isovaleryl-CoA dehydrogenase activity,MF,
3864,GO:0008488,0.999999999991732,0.890023718061515,0,1,gamma-glutamyl carboxylase activity,MF,
3874,GO:0008507,0.999999999991732,0.890023718061515,0,1,sodium:iodide symporter activity,MF,
3878,GO:0008511,0.999999999991732,0.890023718061515,0,1,sodium:potassium:chloride symporter activity,MF,
3887,GO:0008523,0.999999999991732,0.890023718061515,0,1,sodium-dependent multivitamin transmembrane transporter activity,MF,
3905,GO:0008555,0.999999999991732,0.890023718061515,0,1,chloride-transporting ATPase activity,MF,
3912,GO:0008579,0.999999999991732,0.890023718061515,0,1,JUN kinase phosphatase activity,MF,
3918,GO:0008592,0.999999999991732,0.890023718061515,0,1,regulation of Toll signaling pathway,BP,
3926,GO:0008609,0.999999999991732,0.890023718061515,0,1,alkylglycerone-phosphate synthase activity,MF,
3947,GO:0008650,0.999999999991732,0.890023718061515,0,1,rRNA (uridine-2'-O-)-methyltransferase activity,MF,
3955,GO:0008705,0.999999999991732,0.890023718061515,0,1,methionine synthase activity,MF,
3961,GO:0008746,0.999999999991732,0.890023718061515,0,1,NAD(P)+ transhydrogenase activity,MF,
3963,GO:0008750,0.999999999991732,0.890023718061515,0,1,NAD(P)+ transhydrogenase (AB-specific) activity,MF,
3966,GO:0008761,0.999999999991732,0.890023718061515,0,1,UDP-N-acetylglucosamine 2-epimerase activity,MF,
3975,GO:0008798,0.999999999991732,0.890023718061515,0,1,beta-aspartyl-peptidase activity,MF,
3978,GO:0008808,0.999999999991732,0.890023718061515,0,1,cardiolipin synthase activity,MF,
3979,GO:0008817,0.999999999991732,0.890023718061515,0,1,cob(I)yrinic acid a,c-diamide adenosyltransferase activity,MF,
3983,GO:0008832,0.999999999991732,0.890023718061515,0,1,dGTPase activity,MF,
3989,GO:0008887,0.999999999991732,0.890023718061515,0,1,glycerate kinase activity,MF,
3992,GO:0008892,0.999999999991732,0.890023718061515,0,1,guanine deaminase activity,MF,
3996,GO:0008900,0.999999999991732,0.890023718061515,0,1,potassium:proton exchanging ATPase activity,MF,
4007,GO:0008973,0.999999999991732,0.890023718061515,0,1,phosphopentomutase activity,MF,
4011,GO:0009007,0.999999999991732,0.890023718061515,0,1,site-specific DNA-methyltransferase (adenine-specific) activity,MF,
4013,GO:0009013,0.999999999991732,0.890023718061515,0,1,succinate-semialdehyde dehydrogenase [NAD(P)+] activity,MF,
4166,GO:0009234,0.999999999991732,0.890023718061515,0,1,menaquinone biosynthetic process,BP,
4179,GO:0009258,0.999999999991732,0.890023718061515,0,1,10-formyltetrahydrofolate catabolic process,BP,
4208,GO:0009346,0.999999999991732,0.890023718061515,0,1,citrate lyase complex,CC,
4212,GO:0009372,0.999999999991732,0.890023718061515,0,1,quorum sensing,BP,
4216,GO:0009384,0.999999999991732,0.890023718061515,0,1,N-acylmannosamine kinase activity,MF,
4271,GO:0009631,0.999999999991732,0.890023718061515,0,1,cold acclimation,BP,
4277,GO:0009645,0.999999999991732,0.890023718061515,0,1,response to low light intensity stimulus,BP,
4278,GO:0009646,0.999999999991732,0.890023718061515,0,1,response to absence of light,BP,
4285,GO:0009674,0.999999999991732,0.890023718061515,0,1,potassium:sodium symporter activity,MF,
4294,GO:0009737,0.999999999991732,0.890023718061515,0,1,response to abscisic acid,BP,
4295,GO:0009738,0.999999999991732,0.890023718061515,0,1,abscisic acid-activated signaling pathway,BP,
4305,GO:0009758,0.999999999991732,0.890023718061515,0,1,carbohydrate utilization,BP,
4308,GO:0009787,0.999999999991732,0.890023718061515,0,1,regulation of abscisic acid-activated signaling pathway,BP,
4309,GO:0009789,0.999999999991732,0.890023718061515,0,1,positive regulation of abscisic acid-activated signaling pathway,BP,
4358,GO:0009956,0.999999999991732,0.890023718061515,0,1,radial pattern formation,BP,
4381,GO:0010034,0.999999999991732,0.890023718061515,0,1,response to acetate,BP,
4402,GO:0010142,0.999999999991732,0.890023718061515,0,1,farnesyl diphosphate biosynthetic process, mevalonate pathway,BP,
4404,GO:0010157,0.999999999991732,0.890023718061515,0,1,response to chlorate,BP,
4440,GO:0010335,0.999999999991732,0.890023718061515,0,1,response to non-ionic osmotic stress,BP,
4451,GO:0010412,0.999999999991732,0.890023718061515,0,1,mannan metabolic process,BP,
4454,GO:0010428,0.999999999991732,0.890023718061515,0,1,methyl-CpNpG binding,MF,
4455,GO:0010430,0.999999999991732,0.890023718061515,0,1,fatty acid omega-oxidation,BP,
4467,GO:0010465,0.999999999991732,0.890023718061515,0,1,nerve growth factor receptor activity,MF,
4473,GO:0010477,0.999999999991732,0.890023718061515,0,1,response to sulfur dioxide,BP,
4485,GO:0010509,0.999999999991732,0.890023718061515,0,1,polyamine homeostasis,BP,
4540,GO:0010615,0.999999999991732,0.890023718061515,0,1,positive regulation of cardiac muscle adaptation,BP,
4592,GO:0010705,0.999999999991732,0.890023718061515,0,1,meiotic DNA double-strand break processing involved in reciprocal meiotic recombination,BP,
4605,GO:0010722,0.999999999991732,0.890023718061515,0,1,regulation of ferrochelatase activity,BP,
4616,GO:0010736,0.999999999991732,0.890023718061515,0,1,serum response element binding,MF,
4630,GO:0010754,0.999999999991732,0.890023718061515,0,1,negative regulation of cGMP-mediated signaling,BP,
4659,GO:0010808,0.999999999991732,0.890023718061515,0,1,positive regulation of synaptic vesicle priming,BP,
4664,GO:0010814,0.999999999991732,0.890023718061515,0,1,substance P catabolic process,BP,
4666,GO:0010816,0.999999999991732,0.890023718061515,0,1,calcitonin catabolic process,BP,
4692,GO:0010848,0.999999999991732,0.890023718061515,0,1,regulation of chromatin disassembly,BP,
4696,GO:0010856,0.999999999991732,0.890023718061515,0,1,adenylate cyclase activator activity,MF,
4699,GO:0010859,0.999999999991732,0.890023718061515,0,1,calcium-dependent cysteine-type endopeptidase inhibitor activity,MF,
4752,GO:0010931,0.999999999991732,0.890023718061515,0,1,macrophage tolerance induction,BP,
4753,GO:0010932,0.999999999991732,0.890023718061515,0,1,regulation of macrophage tolerance induction,BP,
4754,GO:0010933,0.999999999991732,0.890023718061515,0,1,positive regulation of macrophage tolerance induction,BP,
4803,GO:0010999,0.999999999991732,0.890023718061515,0,1,regulation of eIF2 alpha phosphorylation by heme,BP,
4829,GO:0014036,0.999999999991732,0.890023718061515,0,1,neural crest cell fate specification,BP,
4844,GO:0014053,0.999999999991732,0.890023718061515,0,1,negative regulation of gamma-aminobutyric acid secretion,BP,
4850,GO:0014064,0.999999999991732,0.890023718061515,0,1,positive regulation of serotonin secretion,BP,
4904,GO:0014835,0.999999999991732,0.890023718061515,0,1,myoblast differentiation involved in skeletal muscle regeneration,BP,
4908,GO:0014843,0.999999999991732,0.890023718061515,0,1,growth factor dependent regulation of skeletal muscle satellite cell proliferation,BP,
4926,GO:0014878,0.999999999991732,0.890023718061515,0,1,response to electrical stimulus involved in regulation of muscle adaptation,BP,
4942,GO:0014908,0.999999999991732,0.890023718061515,0,1,myotube differentiation involved in skeletal muscle regeneration,BP,
4954,GO:0015019,0.999999999991732,0.890023718061515,0,1,heparan-alpha-glucosaminide N-acetyltransferase activity,MF,
4972,GO:0015086,0.999999999991732,0.890023718061515,0,1,cadmium ion transmembrane transporter activity,MF,
4973,GO:0015087,0.999999999991732,0.890023718061515,0,1,cobalt ion transmembrane transporter activity,MF,
4974,GO:0015091,0.999999999991732,0.890023718061515,0,1,ferric iron transmembrane transporter activity,MF,
4976,GO:0015094,0.999999999991732,0.890023718061515,0,1,lead ion transmembrane transporter activity,MF,
4991,GO:0015127,0.999999999991732,0.890023718061515,0,1,bilirubin transmembrane transporter activity,MF,
4993,GO:0015130,0.999999999991732,0.890023718061515,0,1,mevalonate transmembrane transporter activity,MF,
4995,GO:0015136,0.999999999991732,0.890023718061515,0,1,sialic acid transmembrane transporter activity,MF,
5029,GO:0015195,0.999999999991732,0.890023718061515,0,1,L-threonine transmembrane transporter activity,MF,
5083,GO:0015322,0.999999999991732,0.890023718061515,0,1,secondary active oligopeptide transmembrane transporter activity,MF,
5084,GO:0015327,0.999999999991732,0.890023718061515,0,1,cystine:glutamate antiporter activity,MF,
5085,GO:0015328,0.999999999991732,0.890023718061515,0,1,cystine secondary active transmembrane transporter activity,MF,
5094,GO:0015369,0.999999999991732,0.890023718061515,0,1,calcium:proton antiporter activity,MF,
5097,GO:0015375,0.999999999991732,0.890023718061515,0,1,glycine:sodium symporter activity,MF,
5099,GO:0015378,0.999999999991732,0.890023718061515,0,1,sodium:chloride symporter activity,MF,
5109,GO:0015420,0.999999999991732,0.890023718061515,0,1,cobalamin-transporting ATPase activity,MF,
5110,GO:0015421,0.999999999991732,0.890023718061515,0,1,oligopeptide-transporting ATPase activity,MF,
5111,GO:0015431,0.999999999991732,0.890023718061515,0,1,glutathione S-conjugate-exporting ATPase activity,MF,
5112,GO:0015432,0.999999999991732,0.890023718061515,0,1,bile acid-exporting ATPase activity,MF,
5126,GO:0015538,0.999999999991732,0.890023718061515,0,1,sialic acid:proton symporter activity,MF,
5153,GO:0015692,0.999999999991732,0.890023718061515,0,1,lead ion transport,BP,
5155,GO:0015694,0.999999999991732,0.890023718061515,0,1,mercury ion transport,BP,
5170,GO:0015723,0.999999999991732,0.890023718061515,0,1,bilirubin transport,BP,
5173,GO:0015728,0.999999999991732,0.890023718061515,0,1,mevalonate transport,BP,
5177,GO:0015739,0.999999999991732,0.890023718061515,0,1,sialic acid transport,BP,
5195,GO:0015787,0.999999999991732,0.890023718061515,0,1,UDP-glucuronic acid transmembrane transport,BP,
5196,GO:0015790,0.999999999991732,0.890023718061515,0,1,UDP-xylose transmembrane transport,BP,
5222,GO:0015826,0.999999999991732,0.890023718061515,0,1,threonine transport,BP,
5250,GO:0015878,0.999999999991732,0.890023718061515,0,1,biotin transport,BP,
5257,GO:0015887,0.999999999991732,0.890023718061515,0,1,pantothenate transmembrane transport,BP,
5314,GO:0016031,0.999999999991732,0.890023718061515,0,1,tRNA import into mitochondrion,BP,
5339,GO:0016077,0.999999999991732,0.890023718061515,0,1,snoRNA catabolic process,BP,
5351,GO:0016103,0.999999999991732,0.890023718061515,0,1,diterpenoid catabolic process,BP,
5353,GO:0016115,0.999999999991732,0.890023718061515,0,1,terpenoid catabolic process,BP,
5363,GO:0016149,0.999999999991732,0.890023718061515,0,1,translation release factor activity, codon specific,MF,
5366,GO:0016155,0.999999999991732,0.890023718061515,0,1,formyltetrahydrofolate dehydrogenase activity,MF,
5376,GO:0016189,0.999999999991732,0.890023718061515,0,1,synaptic vesicle to endosome fusion,BP,
5388,GO:0016213,0.999999999991732,0.890023718061515,0,1,linoleoyl-CoA desaturase activity,MF,
5394,GO:0016231,0.999999999991732,0.890023718061515,0,1,beta-N-acetylglucosaminidase activity,MF,
5400,GO:0016237,0.999999999991732,0.890023718061515,0,1,lysosomal microautophagy,BP,
5405,GO:0016243,0.999999999991732,0.890023718061515,0,1,regulation of autophagosome size,BP,
5428,GO:0016282,0.999999999991732,0.890023718061515,0,1,eukaryotic 43S preinitiation complex,CC,
5456,GO:0016332,0.999999999991732,0.890023718061515,0,1,establishment or maintenance of polarity of embryonic epithelium,BP,
5471,GO:0016404,0.999999999991732,0.890023718061515,0,1,15-hydroxyprostaglandin dehydrogenase (NAD+) activity,MF,
5480,GO:0016414,0.999999999991732,0.890023718061515,0,1,O-octanoyltransferase activity,MF,
5481,GO:0016415,0.999999999991732,0.890023718061515,0,1,octanoyltransferase activity,MF,
5536,GO:0016520,0.999999999991732,0.890023718061515,0,1,growth hormone-releasing hormone receptor activity,MF,
5545,GO:0016534,0.999999999991732,0.890023718061515,0,1,cyclin-dependent protein kinase 5 activator activity,MF,
5573,GO:0016590,0.999999999991732,0.890023718061515,0,1,ACF complex,CC,
5594,GO:0016623,0.999999999991732,0.890023718061515,0,1,oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor,MF,
5601,GO:0016639,0.999999999991732,0.890023718061515,0,1,oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor,MF,
5603,GO:0016642,0.999999999991732,0.890023718061515,0,1,oxidoreductase activity, acting on the CH-NH2 group of donors, disulfide as acceptor,MF,
5609,GO:0016652,0.999999999991732,0.890023718061515,0,1,oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor,MF,
5675,GO:0016785,0.999999999991732,0.890023718061515,0,1,transferase activity, transferring selenium-containing groups,MF,
5680,GO:0016793,0.999999999991732,0.890023718061515,0,1,triphosphoric monoester hydrolase activity,MF,
5753,GO:0016901,0.999999999991732,0.890023718061515,0,1,oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor,MF,
5759,GO:0016920,0.999999999991732,0.890023718061515,0,1,pyroglutamyl-peptidase activity,MF,
5783,GO:0017005,0.999999999991732,0.890023718061515,0,1,3'-tyrosyl-DNA phosphodiesterase activity,MF,
5807,GO:0017061,0.999999999991732,0.890023718061515,0,1,S-methyl-5-thioadenosine phosphorylase activity,MF,
5818,GO:0017084,0.999999999991732,0.890023718061515,0,1,delta1-pyrroline-5-carboxylate synthetase activity,MF,
5820,GO:0017087,0.999999999991732,0.890023718061515,0,1,mitochondrial processing peptidase complex,CC,
5839,GO:0017126,0.999999999991732,0.890023718061515,0,1,nucleologenesis,BP,
5842,GO:0017130,0.999999999991732,0.890023718061515,0,1,poly(C) RNA binding,MF,
5868,GO:0017177,0.999999999991732,0.890023718061515,0,1,glucosidase II complex,CC,
5890,GO:0018032,0.999999999991732,0.890023718061515,0,1,protein amidation,BP,
5914,GO:0018166,0.999999999991732,0.890023718061515,0,1,C-terminal protein-tyrosinylation,BP,
5937,GO:0018217,0.999999999991732,0.890023718061515,0,1,peptidyl-aspartic acid phosphorylation,BP,
5953,GO:0018315,0.999999999991732,0.890023718061515,0,1,molybdenum incorporation into molybdenum-molybdopterin complex,BP,
5955,GO:0018322,0.999999999991732,0.890023718061515,0,1,protein tyrosinylation,BP,
5967,GO:0018395,0.999999999991732,0.890023718061515,0,1,peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine,BP,
5999,GO:0019035,0.999999999991732,0.890023718061515,0,1,viral integration complex,CC,
6022,GO:0019082,0.999999999991732,0.890023718061515,0,1,viral protein processing,BP,
6028,GO:0019089,0.999999999991732,0.890023718061515,0,1,transmission of virus,BP,
6045,GO:0019171,0.999999999991732,0.890023718061515,0,1,3-hydroxyacyl-[acyl-carrier-protein] dehydratase activity,MF,
6048,GO:0019187,0.999999999991732,0.890023718061515,0,1,beta-1,4-mannosyltransferase activity,MF,
6053,GO:0019202,0.999999999991732,0.890023718061515,0,1,amino acid kinase activity,MF,
6115,GO:0019364,0.999999999991732,0.890023718061515,0,1,pyridine nucleotide catabolic process,BP,
6179,GO:0019556,0.999999999991732,0.890023718061515,0,1,histidine catabolic process to glutamate and formamide,BP,
6180,GO:0019557,0.999999999991732,0.890023718061515,0,1,histidine catabolic process to glutamate and formate,BP,
6197,GO:0019677,0.999999999991732,0.890023718061515,0,1,NAD catabolic process,BP,
6225,GO:0019778,0.999999999991732,0.890023718061515,0,1,Atg12 activating enzyme activity,MF,
6226,GO:0019779,0.999999999991732,0.890023718061515,0,1,Atg8 activating enzyme activity,MF,
6227,GO:0019780,0.999999999991732,0.890023718061515,0,1,FAT10 activating enzyme activity,MF,
6229,GO:0019782,0.999999999991732,0.890023718061515,0,1,ISG15 activating enzyme activity,MF,
6241,GO:0019810,0.999999999991732,0.890023718061515,0,1,putrescine binding,MF,
6242,GO:0019811,0.999999999991732,0.890023718061515,0,1,cocaine binding,MF,
6243,GO:0019814,0.999999999991732,0.890023718061515,0,1,immunoglobulin complex,CC,
6244,GO:0019815,0.999999999991732,0.890023718061515,0,1,B cell receptor complex,CC,
6313,GO:0019962,0.999999999991732,0.890023718061515,0,1,type I interferon binding,MF,
6314,GO:0019964,0.999999999991732,0.890023718061515,0,1,interferon-gamma binding,MF,
6316,GO:0019970,0.999999999991732,0.890023718061515,0,1,interleukin-11 binding,MF,
6330,GO:0021503,0.999999999991732,0.890023718061515,0,1,neural fold bending,BP,
6331,GO:0021508,0.999999999991732,0.890023718061515,0,1,floor plate formation,BP,
6334,GO:0021512,0.999999999991732,0.890023718061515,0,1,spinal cord anterior/posterior patterning,BP,
6355,GO:0021541,0.999999999991732,0.890023718061515,0,1,ammon gyrus development,BP,
6364,GO:0021553,0.999999999991732,0.890023718061515,0,1,olfactory nerve development,BP,
6378,GO:0021571,0.999999999991732,0.890023718061515,0,1,rhombomere 5 development,BP,
6379,GO:0021572,0.999999999991732,0.890023718061515,0,1,rhombomere 6 development,BP,
6381,GO:0021577,0.999999999991732,0.890023718061515,0,1,hindbrain structural organization,BP,
6383,GO:0021586,0.999999999991732,0.890023718061515,0,1,pons maturation,BP,
6385,GO:0021589,0.999999999991732,0.890023718061515,0,1,cerebellum structural organization,BP,
6388,GO:0021592,0.999999999991732,0.890023718061515,0,1,fourth ventricle development,BP,
6396,GO:0021615,0.999999999991732,0.890023718061515,0,1,glossopharyngeal nerve morphogenesis,BP,
6398,GO:0021622,0.999999999991732,0.890023718061515,0,1,oculomotor nerve morphogenesis,BP,
6399,GO:0021623,0.999999999991732,0.890023718061515,0,1,oculomotor nerve formation,BP,
6407,GO:0021650,0.999999999991732,0.890023718061515,0,1,vestibulocochlear nerve formation,BP,
6414,GO:0021682,0.999999999991732,0.890023718061515,0,1,nerve maturation,BP,
6417,GO:0021685,0.999999999991732,0.890023718061515,0,1,cerebellar granular layer structural organization,BP,
6419,GO:0021688,0.999999999991732,0.890023718061515,0,1,cerebellar molecular layer formation,BP,
6432,GO:0021718,0.999999999991732,0.890023718061515,0,1,superior olivary nucleus development,BP,
6433,GO:0021722,0.999999999991732,0.890023718061515,0,1,superior olivary nucleus maturation,BP,
6434,GO:0021730,0.999999999991732,0.890023718061515,0,1,trigeminal sensory nucleus development,BP,
6435,GO:0021740,0.999999999991732,0.890023718061515,0,1,principal sensory nucleus of trigeminal nerve development,BP,
6438,GO:0021757,0.999999999991732,0.890023718061515,0,1,caudate nucleus development,BP,
6439,GO:0021758,0.999999999991732,0.890023718061515,0,1,putamen development,BP,
6445,GO:0021768,0.999999999991732,0.890023718061515,0,1,nucleus accumbens development,BP,
6447,GO:0021771,0.999999999991732,0.890023718061515,0,1,lateral geniculate nucleus development,BP,
6452,GO:0021778,0.999999999991732,0.890023718061515,0,1,oligodendrocyte cell fate specification,BP,
6453,GO:0021779,0.999999999991732,0.890023718061515,0,1,oligodendrocyte cell fate commitment,BP,
6454,GO:0021780,0.999999999991732,0.890023718061515,0,1,glial cell fate specification,BP,
6463,GO:0021797,0.999999999991732,0.890023718061515,0,1,forebrain anterior/posterior pattern specification,BP,
6496,GO:0021870,0.999999999991732,0.890023718061515,0,1,Cajal-Retzius cell differentiation,BP,
6502,GO:0021881,0.999999999991732,0.890023718061515,0,1,Wnt-activated signaling pathway involved in forebrain neuron fate commitment,BP,
6532,GO:0021941,0.999999999991732,0.890023718061515,0,1,negative regulation of cerebellar granule cell precursor proliferation,BP,
6543,GO:0021966,0.999999999991732,0.890023718061515,0,1,corticospinal neuron axon guidance,BP,
6544,GO:0021972,0.999999999991732,0.890023718061515,0,1,corticospinal neuron axon guidance through spinal cord,BP,
6551,GO:0021993,0.999999999991732,0.890023718061515,0,1,initiation of neural tube closure,BP,
6553,GO:0021998,0.999999999991732,0.890023718061515,0,1,neural plate mediolateral regionalization,BP,
6560,GO:0022012,0.999999999991732,0.890023718061515,0,1,subpallium cell proliferation in forebrain,BP,
6561,GO:0022018,0.999999999991732,0.890023718061515,0,1,lateral ganglionic eminence cell proliferation,BP,
6617,GO:0022849,0.999999999991732,0.890023718061515,0,1,glutamate-gated calcium ion channel activity,MF,
6618,GO:0022851,0.999999999991732,0.890023718061515,0,1,GABA-gated chloride ion channel activity,MF,
6633,GO:0023024,0.999999999991732,0.890023718061515,0,1,MHC class I protein complex binding,MF,
6697,GO:0030103,0.999999999991732,0.890023718061515,0,1,vasopressin secretion,BP,
6779,GO:0030222,0.999999999991732,0.890023718061515,0,1,eosinophil differentiation,BP,
6822,GO:0030290,0.999999999991732,0.890023718061515,0,1,sphingolipid activator protein activity,MF,
6861,GO:0030342,0.999999999991732,0.890023718061515,0,1,1-alpha,25-dihydroxyvitamin D3 24-hydroxylase activity,MF,
6872,GO:0030372,0.999999999991732,0.890023718061515,0,1,high molecular weight B cell growth factor receptor binding,MF,
6877,GO:0030379,0.999999999991732,0.890023718061515,0,1,neurotensin receptor activity, non-G-protein coupled,MF,
6907,GO:0030504,0.999999999991732,0.890023718061515,0,1,inorganic diphosphate transmembrane transporter activity,MF,
6924,GO:0030523,0.999999999991732,0.890023718061515,0,1,dihydrolipoamide S-acyltransferase activity,MF,
6941,GO:0030572,0.999999999991732,0.890023718061515,0,1,phosphatidyltransferase activity,MF,
6949,GO:0030586,0.999999999991732,0.890023718061515,0,1,[methionine synthase] reductase activity,MF,
6956,GO:0030616,0.999999999991732,0.890023718061515,0,1,transforming growth factor beta receptor, common-partner cytoplasmic mediator activity,MF,
6963,GO:0030623,0.999999999991732,0.890023718061515,0,1,U5 snRNA binding,MF,
6964,GO:0030624,0.999999999991732,0.890023718061515,0,1,U6atac snRNA binding,MF,
6974,GO:0030653,0.999999999991732,0.890023718061515,0,1,beta-lactam antibiotic metabolic process,BP,
7004,GO:0030696,0.999999999991732,0.890023718061515,0,1,tRNA (m5U54) methyltransferase activity,MF,
7005,GO:0030697,0.999999999991732,0.890023718061515,0,1,S-adenosylmethionine-dependent tRNA (m5U54) methyltransferase activity,MF,
7006,GO:0030702,0.999999999991732,0.890023718061515,0,1,chromatin silencing at centromere,BP,
7008,GO:0030718,0.999999999991732,0.890023718061515,0,1,germ-line stem cell population maintenance,BP,
7011,GO:0030729,0.999999999991732,0.890023718061515,0,1,acetoacetate-CoA ligase activity,MF,
7054,GO:0030846,0.999999999991732,0.890023718061515,0,1,termination of RNA polymerase II transcription, poly(A)-coupled,BP,
7055,GO:0030849,0.999999999991732,0.890023718061515,0,1,autosome,CC,
7067,GO:0030862,0.999999999991732,0.890023718061515,0,1,positive regulation of polarized epithelial cell differentiation,BP,
7081,GO:0030882,0.999999999991732,0.890023718061515,0,1,lipid antigen binding,MF,
7082,GO:0030883,0.999999999991732,0.890023718061515,0,1,endogenous lipid antigen binding,MF,
7083,GO:0030884,0.999999999991732,0.890023718061515,0,1,exogenous lipid antigen binding,MF,
7205,GO:0031104,0.999999999991732,0.890023718061515,0,1,dendrite regeneration,BP,
7232,GO:0031151,0.999999999991732,0.890023718061515,0,1,histone methyltransferase activity (H3-K79 specific),MF,
7233,GO:0031161,0.999999999991732,0.890023718061515,0,1,phosphatidylinositol catabolic process,BP,
7239,GO:0031179,0.999999999991732,0.890023718061515,0,1,peptide modification,BP,
7296,GO:0031302,0.999999999991732,0.890023718061515,0,1,intrinsic component of endosome membrane,CC,
7305,GO:0031315,0.999999999991732,0.890023718061515,0,1,extrinsic component of mitochondrial outer membrane,CC,
7336,GO:0031370,0.999999999991732,0.890023718061515,0,1,eukaryotic initiation factor 4G binding,MF,
7340,GO:0031380,0.999999999991732,0.890023718061515,0,1,nuclear RNA-directed RNA polymerase complex,CC,
7356,GO:0031405,0.999999999991732,0.890023718061515,0,1,lipoic acid binding,MF,
7373,GO:0031433,0.999999999991732,0.890023718061515,0,1,telethonin binding,MF,
7383,GO:0031443,0.999999999991732,0.890023718061515,0,1,fast-twitch skeletal muscle fiber contraction,BP,
7389,GO:0031460,0.999999999991732,0.890023718061515,0,1,glycine betaine transport,BP,
7399,GO:0031477,0.999999999991732,0.890023718061515,0,1,myosin VII complex,CC,
7425,GO:0031533,0.999999999991732,0.890023718061515,0,1,mRNA cap methyltransferase complex,CC,
7431,GO:0031554,0.999999999991732,0.890023718061515,0,1,regulation of DNA-templated transcription, termination,BP,
7432,GO:0031559,0.999999999991732,0.890023718061515,0,1,oxidosqualene cyclase activity,MF,
7449,GO:0031592,0.999999999991732,0.890023718061515,0,1,centrosomal corona,CC,
7461,GO:0031626,0.999999999991732,0.890023718061515,0,1,beta-endorphin binding,MF,
7465,GO:0031630,0.999999999991732,0.890023718061515,0,1,regulation of synaptic vesicle fusion to presynaptic active zone membrane,BP,
7480,GO:0031651,0.999999999991732,0.890023718061515,0,1,negative regulation of heat generation,BP,
7494,GO:0031673,0.999999999991732,0.890023718061515,0,1,H zone,CC,
7507,GO:0031699,0.999999999991732,0.890023718061515,0,1,beta-3 adrenergic receptor binding,MF,
7515,GO:0031714,0.999999999991732,0.890023718061515,0,1,C5a anaphylatoxin chemotactic receptor binding,MF,
7516,GO:0031715,0.999999999991732,0.890023718061515,0,1,C5L2 anaphylatoxin chemotactic receptor binding,MF,
7531,GO:0031775,0.999999999991732,0.890023718061515,0,1,lutropin-choriogonadotropic hormone receptor binding,MF,
7532,GO:0031798,0.999999999991732,0.890023718061515,0,1,type 1 metabotropic glutamate receptor binding,MF,
7541,GO:0031849,0.999999999991732,0.890023718061515,0,1,olfactory receptor binding,MF,
7546,GO:0031867,0.999999999991732,0.890023718061515,0,1,EP4 subtype prostaglandin E2 receptor binding,MF,
7547,GO:0031870,0.999999999991732,0.890023718061515,0,1,thromboxane A2 receptor binding,MF,
7574,GO:0031945,0.999999999991732,0.890023718061515,0,1,positive regulation of glucocorticoid metabolic process,BP,
7577,GO:0031948,0.999999999991732,0.890023718061515,0,1,positive regulation of glucocorticoid biosynthetic process,BP,
7623,GO:0032029,0.999999999991732,0.890023718061515,0,1,myosin tail binding,MF,
7646,GO:0032072,0.999999999991732,0.890023718061515,0,1,regulation of restriction endodeoxyribonuclease activity,BP,
7685,GO:0032144,0.999999999991732,0.890023718061515,0,1,4-aminobutyrate transaminase complex,CC,
7686,GO:0032145,0.999999999991732,0.890023718061515,0,1,succinate-semialdehyde dehydrogenase binding,MF,
7701,GO:0032194,0.999999999991732,0.890023718061515,0,1,ubiquinone biosynthetic process via 3,4-dihydroxy-5-polyprenylbenzoate,BP,
7703,GO:0032197,0.999999999991732,0.890023718061515,0,1,transposition, RNA-mediated,BP,
7721,GO:0032222,0.999999999991732,0.890023718061515,0,1,regulation of synaptic transmission, cholinergic,BP,
7722,GO:0032224,0.999999999991732,0.890023718061515,0,1,positive regulation of synaptic transmission, cholinergic,BP,
7773,GO:0032304,0.999999999991732,0.890023718061515,0,1,negative regulation of icosanoid secretion,BP,
7856,GO:0032423,0.999999999991732,0.890023718061515,0,1,regulation of mismatch repair,BP,
7857,GO:0032425,0.999999999991732,0.890023718061515,0,1,positive regulation of mismatch repair,BP,
7860,GO:0032428,0.999999999991732,0.890023718061515,0,1,beta-N-acetylgalactosaminidase activity,MF,
7883,GO:0032458,0.999999999991732,0.890023718061515,0,1,slow endocytic recycling,BP,
7893,GO:0032468,0.999999999991732,0.890023718061515,0,1,Golgi calcium ion homeostasis,BP,
7895,GO:0032470,0.999999999991732,0.890023718061515,0,1,positive regulation of endoplasmic reticulum calcium ion concentration,BP,
7917,GO:0032498,0.999999999991732,0.890023718061515,0,1,detection of muramyl dipeptide,BP,
7918,GO:0032499,0.999999999991732,0.890023718061515,0,1,detection of peptidoglycan,BP,
7919,GO:0032500,0.999999999991732,0.890023718061515,0,1,muramyl dipeptide binding,MF,
7955,GO:0032560,0.999999999991732,0.890023718061515,0,1,guanyl deoxyribonucleotide binding,MF,
7958,GO:0032567,0.999999999991732,0.890023718061515,0,1,dGTP binding,MF,
7961,GO:0032574,0.999999999991732,0.890023718061515,0,1,5'-3' RNA helicase activity,MF,
7962,GO:0032575,0.999999999991732,0.890023718061515,0,1,ATP-dependent 5'-3' RNA helicase activity,MF,
7996,GO:0032625,0.999999999991732,0.890023718061515,0,1,interleukin-21 production,BP,
8030,GO:0032685,0.999999999991732,0.890023718061515,0,1,negative regulation of granulocyte macrophage colony-stimulating factor production,BP,
8066,GO:0032752,0.999999999991732,0.890023718061515,0,1,positive regulation of interleukin-3 production,BP,
8081,GO:0032771,0.999999999991732,0.890023718061515,0,1,regulation of monophenol monooxygenase activity,BP,
8082,GO:0032773,0.999999999991732,0.890023718061515,0,1,positive regulation of monophenol monooxygenase activity,BP,
8084,GO:0032775,0.999999999991732,0.890023718061515,0,1,DNA methylation on adenine,BP,
8133,GO:0032848,0.999999999991732,0.890023718061515,0,1,negative regulation of cellular pH reduction,BP,
8150,GO:0032887,0.999999999991732,0.890023718061515,0,1,regulation of spindle elongation,BP,
8151,GO:0032888,0.999999999991732,0.890023718061515,0,1,regulation of mitotic spindle elongation,BP,
8158,GO:0032899,0.999999999991732,0.890023718061515,0,1,regulation of neurotrophin production,BP,
8159,GO:0032901,0.999999999991732,0.890023718061515,0,1,positive regulation of neurotrophin production,BP,
8168,GO:0032912,0.999999999991732,0.890023718061515,0,1,negative regulation of transforming growth factor beta2 production,BP,
8210,GO:0032977,0.999999999991732,0.890023718061515,0,1,membrane insertase activity,MF,
8211,GO:0032978,0.999999999991732,0.890023718061515,0,1,protein insertion into membrane from inner side,BP,
8212,GO:0032979,0.999999999991732,0.890023718061515,0,1,protein insertion into mitochondrial membrane from inner side,BP,
8241,GO:0033026,0.999999999991732,0.890023718061515,0,1,negative regulation of mast cell apoptotic process,BP,
8250,GO:0033037,0.999999999991732,0.890023718061515,0,1,polysaccharide localization,BP,
8270,GO:0033082,0.999999999991732,0.890023718061515,0,1,regulation of extrathymic T cell differentiation,BP,
8316,GO:0033167,0.999999999991732,0.890023718061515,0,1,ARC complex,CC,
8317,GO:0033168,0.999999999991732,0.890023718061515,0,1,conversion of ds siRNA to ss siRNA involved in RNA interference,BP,
8354,GO:0033241,0.999999999991732,0.890023718061515,0,1,regulation of cellular amine catabolic process,BP,
8355,GO:0033242,0.999999999991732,0.890023718061515,0,1,negative regulation of cellular amine catabolic process,BP,
8373,GO:0033283,0.999999999991732,0.890023718061515,0,1,organic acid-transporting ATPase activity,MF,
8374,GO:0033284,0.999999999991732,0.890023718061515,0,1,carboxylic acid-transporting ATPase activity,MF,
8375,GO:0033285,0.999999999991732,0.890023718061515,0,1,monocarboxylic acid-transporting ATPase activity,MF,
8376,GO:0033290,0.999999999991732,0.890023718061515,0,1,eukaryotic 48S preinitiation complex,CC,
8382,GO:0033301,0.999999999991732,0.890023718061515,0,1,cell cycle comprising mitosis without cytokinesis,BP,
8389,GO:0033326,0.999999999991732,0.890023718061515,0,1,cerebrospinal fluid secretion,BP,
8391,GO:0033328,0.999999999991732,0.890023718061515,0,1,peroxisome membrane targeting sequence binding,MF,
8394,GO:0033343,0.999999999991732,0.890023718061515,0,1,positive regulation of collagen binding,BP,
8398,GO:0033364,0.999999999991732,0.890023718061515,0,1,mast cell secretory granule organization,BP,
8417,GO:0033505,0.999999999991732,0.890023718061515,0,1,floor plate morphogenesis,BP,
8432,GO:0033560,0.999999999991732,0.890023718061515,0,1,folate reductase activity,MF,
8438,GO:0033570,0.999999999991732,0.890023718061515,0,1,transferrin transmembrane transporter activity,MF,
8447,GO:0033593,0.999999999991732,0.890023718061515,0,1,BRCA2-MAGE-D1 complex,CC,
8455,GO:0033602,0.999999999991732,0.890023718061515,0,1,negative regulation of dopamine secretion,BP,
8477,GO:0033633,0.999999999991732,0.890023718061515,0,1,negative regulation of cell-cell adhesion mediated by integrin,BP,
8492,GO:0033679,0.999999999991732,0.890023718061515,0,1,3'-5' DNA/RNA helicase activity,MF,
8494,GO:0033681,0.999999999991732,0.890023718061515,0,1,ATP-dependent 3'-5' DNA/RNA helicase activity,MF,
8512,GO:0033746,0.999999999991732,0.890023718061515,0,1,histone demethylase activity (H3-R2 specific),MF,
8513,GO:0033749,0.999999999991732,0.890023718061515,0,1,histone demethylase activity (H4-R3 specific),MF,
8526,GO:0033858,0.999999999991732,0.890023718061515,0,1,N-acetylgalactosamine kinase activity,MF,
8537,GO:0033878,0.999999999991732,0.890023718061515,0,1,hormone-sensitive lipase activity,MF,
8543,GO:0033919,0.999999999991732,0.890023718061515,0,1,glucan 1,3-alpha-glucosidase activity,MF,
8544,GO:0033925,0.999999999991732,0.890023718061515,0,1,mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity,MF,
8620,GO:0034146,0.999999999991732,0.890023718061515,0,1,toll-like receptor 5 signaling pathway,BP,
8621,GO:0034147,0.999999999991732,0.890023718061515,0,1,regulation of toll-like receptor 5 signaling pathway,BP,
8622,GO:0034148,0.999999999991732,0.890023718061515,0,1,negative regulation of toll-like receptor 5 signaling pathway,BP,
8623,GO:0034150,0.999999999991732,0.890023718061515,0,1,toll-like receptor 6 signaling pathway,BP,
8625,GO:0034155,0.999999999991732,0.890023718061515,0,1,regulation of toll-like receptor 7 signaling pathway,BP,
8626,GO:0034157,0.999999999991732,0.890023718061515,0,1,positive regulation of toll-like receptor 7 signaling pathway,BP,
8631,GO:0034166,0.999999999991732,0.890023718061515,0,1,toll-like receptor 10 signaling pathway,BP,
8646,GO:0034203,0.999999999991732,0.890023718061515,0,1,glycolipid translocation,BP,
8659,GO:0034238,0.999999999991732,0.890023718061515,0,1,macrophage fusion,BP,
8660,GO:0034239,0.999999999991732,0.890023718061515,0,1,regulation of macrophage fusion,BP,
8661,GO:0034241,0.999999999991732,0.890023718061515,0,1,positive regulation of macrophage fusion,BP,
8665,GO:0034245,0.999999999991732,0.890023718061515,0,1,mitochondrial DNA-directed RNA polymerase complex,CC,
8729,GO:0034386,0.999999999991732,0.890023718061515,0,1,4-aminobutyrate:2-oxoglutarate transaminase activity,MF,
8772,GO:0034459,0.999999999991732,0.890023718061515,0,1,ATP-dependent 3'-5' RNA helicase activity,MF,
8781,GO:0034474,0.999999999991732,0.890023718061515,0,1,U2 snRNA 3'-end processing,BP,
8795,GO:0034506,0.999999999991732,0.890023718061515,0,1,chromosome, centromeric core domain,CC,
8806,GO:0034584,0.999999999991732,0.890023718061515,0,1,piRNA binding,MF,
8808,GO:0034589,0.999999999991732,0.890023718061515,0,1,hydroxyproline transport,BP,
8809,GO:0034590,0.999999999991732,0.890023718061515,0,1,L-hydroxyproline transmembrane transporter activity,MF,
8816,GO:0034602,0.999999999991732,0.890023718061515,0,1,oxoglutarate dehydrogenase (NAD+) activity,MF,
8833,GO:0034634,0.999999999991732,0.890023718061515,0,1,glutathione transmembrane transporter activity,MF,
8837,GO:0034640,0.999999999991732,0.890023718061515,0,1,establishment of mitochondrion localization by microtubule attachment,BP,
8839,GO:0034642,0.999999999991732,0.890023718061515,0,1,mitochondrion migration along actin filament,BP,
8845,GO:0034649,0.999999999991732,0.890023718061515,0,1,histone demethylase activity (H3-monomethyl-K4 specific),MF,
8848,GO:0034653,0.999999999991732,0.890023718061515,0,1,retinoic acid catabolic process,BP,
8859,GO:0034668,0.999999999991732,0.890023718061515,0,1,integrin alpha4-beta1 complex,CC,
8861,GO:0034670,0.999999999991732,0.890023718061515,0,1,chemotaxis to arachidonic acid,BP,
8864,GO:0034677,0.999999999991732,0.890023718061515,0,1,integrin alpha7-beta1 complex,CC,
8867,GO:0034681,0.999999999991732,0.890023718061515,0,1,integrin alpha11-beta1 complex,CC,
8868,GO:0034683,0.999999999991732,0.890023718061515,0,1,integrin alphav-beta3 complex,CC,
8892,GO:0034718,0.999999999991732,0.890023718061515,0,1,SMN-Gemin2 complex,CC,
8899,GO:0034727,0.999999999991732,0.890023718061515,0,1,piecemeal microautophagy of the nucleus,BP,
8902,GO:0034736,0.999999999991732,0.890023718061515,0,1,cholesterol O-acyltransferase activity,MF,
8906,GO:0034752,0.999999999991732,0.890023718061515,0,1,cytosolic aryl hydrocarbon receptor complex,CC,
8907,GO:0034753,0.999999999991732,0.890023718061515,0,1,nuclear aryl hydrocarbon receptor complex,CC,
8911,GO:0034757,0.999999999991732,0.890023718061515,0,1,negative regulation of iron ion transport,BP,
8912,GO:0034759,0.999999999991732,0.890023718061515,0,1,regulation of iron ion transmembrane transport,BP,
8913,GO:0034760,0.999999999991732,0.890023718061515,0,1,negative regulation of iron ion transmembrane transport,BP,
8920,GO:0034769,0.999999999991732,0.890023718061515,0,1,basement membrane disassembly,BP,
8924,GO:0034775,0.999999999991732,0.890023718061515,0,1,glutathione transmembrane transport,BP,
8928,GO:0034959,0.999999999991732,0.890023718061515,0,1,endothelin maturation,BP,
8940,GO:0034986,0.999999999991732,0.890023718061515,0,1,iron chaperone activity,MF,
8941,GO:0034987,0.999999999991732,0.890023718061515,0,1,immunoglobulin receptor binding,MF,
8942,GO:0034988,0.999999999991732,0.890023718061515,0,1,Fc-gamma receptor I complex binding,MF,
8963,GO:0035037,0.999999999991732,0.890023718061515,0,1,sperm entry,BP,
8966,GO:0035054,0.999999999991732,0.890023718061515,0,1,embryonic heart tube anterior/posterior pattern specification,BP,
8968,GO:0035063,0.999999999991732,0.890023718061515,0,1,nuclear speck organization,BP,
8994,GO:0035120,0.999999999991732,0.890023718061515,0,1,post-embryonic appendage morphogenesis,BP,
8995,GO:0035127,0.999999999991732,0.890023718061515,0,1,post-embryonic limb morphogenesis,BP,
8996,GO:0035128,0.999999999991732,0.890023718061515,0,1,post-embryonic forelimb morphogenesis,BP,
9009,GO:0035188,0.999999999991732,0.890023718061515,0,1,hatching,BP,
9041,GO:0035262,0.999999999991732,0.890023718061515,0,1,gonad morphogenesis,BP,
9049,GO:0035276,0.999999999991732,0.890023718061515,0,1,ethanol binding,MF,
9055,GO:0035283,0.999999999991732,0.890023718061515,0,1,central nervous system segmentation,BP,
9056,GO:0035284,0.999999999991732,0.890023718061515,0,1,brain segmentation,BP,
9060,GO:0035299,0.999999999991732,0.890023718061515,0,1,inositol pentakisphosphate 2-kinase activity,MF,
9086,GO:0035354,0.999999999991732,0.890023718061515,0,1,Toll-like receptor 1-Toll-like receptor 2 protein complex,CC,
9087,GO:0035355,0.999999999991732,0.890023718061515,0,1,Toll-like receptor 2-Toll-like receptor 6 protein complex,CC,
9091,GO:0035359,0.999999999991732,0.890023718061515,0,1,negative regulation of peroxisome proliferator activated receptor signaling pathway,BP,
9105,GO:0035400,0.999999999991732,0.890023718061515,0,1,histone tyrosine kinase activity,MF,
9106,GO:0035401,0.999999999991732,0.890023718061515,0,1,histone kinase activity (H3-Y41 specific),MF,
9108,GO:0035403,0.999999999991732,0.890023718061515,0,1,histone kinase activity (H3-T6 specific),MF,
9111,GO:0035406,0.999999999991732,0.890023718061515,0,1,histone-tyrosine phosphorylation,BP,
9113,GO:0035408,0.999999999991732,0.890023718061515,0,1,histone H3-T6 phosphorylation,BP,
9114,GO:0035409,0.999999999991732,0.890023718061515,0,1,histone H3-Y41 phosphorylation,BP,
9122,GO:0035441,0.999999999991732,0.890023718061515,0,1,cell migration involved in vasculogenesis,BP,
9124,GO:0035443,0.999999999991732,0.890023718061515,0,1,tripeptide transmembrane transport,BP,
9132,GO:0035469,0.999999999991732,0.890023718061515,0,1,determination of pancreatic left/right asymmetry,BP,
9138,GO:0035490,0.999999999991732,0.890023718061515,0,1,regulation of leukotriene production involved in inflammatory response,BP,
9139,GO:0035491,0.999999999991732,0.890023718061515,0,1,positive regulation of leukotriene production involved in inflammatory response,BP,
9150,GO:0035508,0.999999999991732,0.890023718061515,0,1,positive regulation of myosin-light-chain-phosphatase activity,BP,
9157,GO:0035516,0.999999999991732,0.890023718061515,0,1,oxidative DNA demethylase activity,MF,
9172,GO:0035544,0.999999999991732,0.890023718061515,0,1,negative regulation of SNARE complex assembly,BP,
9207,GO:0035598,0.999999999991732,0.890023718061515,0,1,N6-threonylcarbomyladenosine methylthiotransferase activity,MF,
9210,GO:0035602,0.999999999991732,0.890023718061515,0,1,fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow,BP,
9211,GO:0035603,0.999999999991732,0.890023718061515,0,1,fibroblast growth factor receptor signaling pathway involved in hemopoiesis,BP,
9212,GO:0035604,0.999999999991732,0.890023718061515,0,1,fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow,BP,
9217,GO:0035609,0.999999999991732,0.890023718061515,0,1,C-terminal protein deglutamylation,BP,
9218,GO:0035610,0.999999999991732,0.890023718061515,0,1,protein side chain deglutamylation,BP,
9228,GO:0035622,0.999999999991732,0.890023718061515,0,1,intrahepatic bile duct development,BP,
9229,GO:0035623,0.999999999991732,0.890023718061515,0,1,renal glucose absorption,BP,
9231,GO:0035625,0.999999999991732,0.890023718061515,0,1,epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway,BP,
9239,GO:0035638,0.999999999991732,0.890023718061515,0,1,signal maturation,BP,
9268,GO:0035695,0.999999999991732,0.890023718061515,0,1,mitophagy by induced vacuole formation,BP,
9275,GO:0035711,0.999999999991732,0.890023718061515,0,1,T-helper 1 cell activation,BP,
9276,GO:0035712,0.999999999991732,0.890023718061515,0,1,T-helper 2 cell activation,BP,
9300,GO:0035750,0.999999999991732,0.890023718061515,0,1,protein localization to myelin sheath abaxonal region,BP,
9315,GO:0035790,0.999999999991732,0.890023718061515,0,1,platelet-derived growth factor receptor-alpha signaling pathway,BP,
9336,GO:0035841,0.999999999991732,0.890023718061515,0,1,new growing cell tip,CC,
9341,GO:0035853,0.999999999991732,0.890023718061515,0,1,chromosome passenger complex localization to spindle midzone,BP,
9346,GO:0035862,0.999999999991732,0.890023718061515,0,1,dITP metabolic process,BP,
9347,GO:0035863,0.999999999991732,0.890023718061515,0,1,dITP catabolic process,BP,
9381,GO:0035922,0.999999999991732,0.890023718061515,0,1,foramen ovale closure,BP,
9392,GO:0035935,0.999999999991732,0.890023718061515,0,1,androgen secretion,BP,
9393,GO:0035936,0.999999999991732,0.890023718061515,0,1,testosterone secretion,BP,
9394,GO:0035938,0.999999999991732,0.890023718061515,0,1,estradiol secretion,BP,
9399,GO:0035962,0.999999999991732,0.890023718061515,0,1,response to interleukin-13,BP,
9400,GO:0035963,0.999999999991732,0.890023718061515,0,1,cellular response to interleukin-13,BP,
9423,GO:0035995,0.999999999991732,0.890023718061515,0,1,detection of muscle stretch,BP,
9449,GO:0036046,0.999999999991732,0.890023718061515,0,1,protein demalonylation,BP,
9450,GO:0036047,0.999999999991732,0.890023718061515,0,1,peptidyl-lysine demalonylation,BP,
9451,GO:0036048,0.999999999991732,0.890023718061515,0,1,protein desuccinylation,BP,
9452,GO:0036049,0.999999999991732,0.890023718061515,0,1,peptidyl-lysine desuccinylation,BP,
9453,GO:0036054,0.999999999991732,0.890023718061515,0,1,protein-malonyllysine demalonylase activity,MF,
9454,GO:0036055,0.999999999991732,0.890023718061515,0,1,protein-succinyllysine desuccinylase activity,MF,
9460,GO:0036071,0.999999999991732,0.890023718061515,0,1,N-glycan fucosylation,BP,
9464,GO:0036085,0.999999999991732,0.890023718061515,0,1,GDP-fucose import into Golgi lumen,BP,
9471,GO:0036105,0.999999999991732,0.890023718061515,0,1,peroxisome membrane class-1 targeting sequence binding,MF,
9491,GO:0036138,0.999999999991732,0.890023718061515,0,1,peptidyl-histidine hydroxylation,BP,
9492,GO:0036139,0.999999999991732,0.890023718061515,0,1,peptidyl-histidine dioxygenase activity,MF,
9493,GO:0036140,0.999999999991732,0.890023718061515,0,1,peptidyl-asparagine 3-dioxygenase activity,MF,
9523,GO:0036255,0.999999999991732,0.890023718061515,0,1,response to methylamine,BP,
9527,GO:0036261,0.999999999991732,0.890023718061515,0,1,7-methylguanosine cap hypermethylation,BP,
9534,GO:0036290,0.999999999991732,0.890023718061515,0,1,protein trans-autophosphorylation,BP,
9554,GO:0036335,0.999999999991732,0.890023718061515,0,1,intestinal stem cell homeostasis,BP,
9567,GO:0036371,0.999999999991732,0.890023718061515,0,1,protein localization to T-tubule,BP,
9575,GO:0036392,0.999999999991732,0.890023718061515,0,1,chemokine (C-C motif) ligand 20 production,BP,
9577,GO:0036398,0.999999999991732,0.890023718061515,0,1,TCR signalosome,CC,
9578,GO:0036399,0.999999999991732,0.890023718061515,0,1,TCR signalosome assembly,BP,
9581,GO:0036404,0.999999999991732,0.890023718061515,0,1,conversion of ds siRNA to ss siRNA,BP,
9614,GO:0036483,0.999999999991732,0.890023718061515,0,1,neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,
9617,GO:0036487,0.999999999991732,0.890023718061515,0,1,nitric-oxide synthase inhibitor activity,MF,
9623,GO:0036494,0.999999999991732,0.890023718061515,0,1,positive regulation of translation initiation in response to endoplasmic reticulum stress,BP,
9629,GO:0036501,0.999999999991732,0.890023718061515,0,1,UFD1-NPL4 complex,CC,
9643,GO:0036517,0.999999999991732,0.890023718061515,0,1,chemoattraction of serotonergic neuron axon,BP,
9654,GO:0038002,0.999999999991732,0.890023718061515,0,1,endocrine signaling,BP,
9659,GO:0038021,0.999999999991732,0.890023718061515,0,1,leptin receptor activity,MF,
9677,GO:0038051,0.999999999991732,0.890023718061515,0,1,glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity,MF,
9680,GO:0038062,0.999999999991732,0.890023718061515,0,1,protein tyrosine kinase collagen receptor activity,MF,
9705,GO:0038123,0.999999999991732,0.890023718061515,0,1,toll-like receptor TLR1:TLR2 signaling pathway,BP,
9713,GO:0038154,0.999999999991732,0.890023718061515,0,1,interleukin-11-mediated signaling pathway,BP,
9722,GO:0038172,0.999999999991732,0.890023718061515,0,1,interleukin-33-mediated signaling pathway,BP,
9725,GO:0038181,0.999999999991732,0.890023718061515,0,1,bile acid receptor activity,MF,
9726,GO:0038183,0.999999999991732,0.890023718061515,0,1,bile acid signaling pathway,BP,
9727,GO:0038186,0.999999999991732,0.890023718061515,0,1,lithocholic acid receptor activity,MF,
9734,GO:0038194,0.999999999991732,0.890023718061515,0,1,thyroid-stimulating hormone signaling pathway,BP,
9739,GO:0039003,0.999999999991732,0.890023718061515,0,1,pronephric field specification,BP,
9740,GO:0039007,0.999999999991732,0.890023718061515,0,1,pronephric nephron morphogenesis,BP,
9741,GO:0039008,0.999999999991732,0.890023718061515,0,1,pronephric nephron tubule morphogenesis,BP,
9742,GO:0039017,0.999999999991732,0.890023718061515,0,1,pattern specification involved in pronephros development,BP,
9744,GO:0039020,0.999999999991732,0.890023718061515,0,1,pronephric nephron tubule development,BP,
9745,GO:0039022,0.999999999991732,0.890023718061515,0,1,pronephric duct development,BP,
9746,GO:0039023,0.999999999991732,0.890023718061515,0,1,pronephric duct morphogenesis,BP,
9747,GO:0039502,0.999999999991732,0.890023718061515,0,1,suppression by virus of host type I interferon-mediated signaling pathway,BP,
9748,GO:0039503,0.999999999991732,0.890023718061515,0,1,suppression by virus of host innate immune response,BP,
9752,GO:0039514,0.999999999991732,0.890023718061515,0,1,suppression by virus of host JAK-STAT cascade,BP,
9755,GO:0039520,0.999999999991732,0.890023718061515,0,1,induction by virus of host autophagy,BP,
9756,GO:0039521,0.999999999991732,0.890023718061515,0,1,suppression by virus of host autophagy,BP,
9767,GO:0039552,0.999999999991732,0.890023718061515,0,1,RIG-I binding,MF,
9768,GO:0039562,0.999999999991732,0.890023718061515,0,1,suppression by virus of host STAT activity,BP,
9769,GO:0039563,0.999999999991732,0.890023718061515,0,1,suppression by virus of host STAT1 activity,BP,
9770,GO:0039564,0.999999999991732,0.890023718061515,0,1,suppression by virus of host STAT2 activity,BP,
9777,GO:0039695,0.999999999991732,0.890023718061515,0,1,DNA-templated viral transcription,BP,
9780,GO:0039713,0.999999999991732,0.890023718061515,0,1,viral factory,CC,
9781,GO:0039714,0.999999999991732,0.890023718061515,0,1,cytoplasmic viral factory,CC,
9797,GO:0040030,0.999999999991732,0.890023718061515,0,1,regulation of molecular function, epigenetic,BP,
9807,GO:0042008,0.999999999991732,0.890023718061515,0,1,interleukin-18 receptor activity,MF,
9819,GO:0042040,0.999999999991732,0.890023718061515,0,1,metal incorporation into metallo-molybdopterin complex,BP,
9836,GO:0042084,0.999999999991732,0.890023718061515,0,1,5-methyltetrahydrofolate-dependent methyltransferase activity,MF,
9899,GO:0042223,0.999999999991732,0.890023718061515,0,1,interleukin-3 biosynthetic process,BP,
9903,GO:0042241,0.999999999991732,0.890023718061515,0,1,interleukin-18 biosynthetic process,BP,
9914,GO:0042265,0.999999999991732,0.890023718061515,0,1,peptidyl-asparagine hydroxylation,BP,
9928,GO:0042282,0.999999999991732,0.890023718061515,0,1,hydroxymethylglutaryl-CoA reductase activity,MF,
9946,GO:0042316,0.999999999991732,0.890023718061515,0,1,penicillin metabolic process,BP,
9947,GO:0042320,0.999999999991732,0.890023718061515,0,1,regulation of circadian sleep/wake cycle, REM sleep,BP,
9960,GO:0042352,0.999999999991732,0.890023718061515,0,1,GDP-L-fucose salvage,BP,
9967,GO:0042361,0.999999999991732,0.890023718061515,0,1,menaquinone catabolic process,BP,
9974,GO:0042371,0.999999999991732,0.890023718061515,0,1,vitamin K biosynthetic process,BP,
9978,GO:0042377,0.999999999991732,0.890023718061515,0,1,vitamin K catabolic process,BP,
10029,GO:0042483,0.999999999991732,0.890023718061515,0,1,negative regulation of odontogenesis,BP,
10037,GO:0042495,0.999999999991732,0.890023718061515,0,1,detection of triacyl bacterial lipopeptide,BP,
10039,GO:0042497,0.999999999991732,0.890023718061515,0,1,triacyl lipopeptide binding,MF,
10064,GO:0042564,0.999999999991732,0.890023718061515,0,1,NLS-dependent protein nuclear import complex,CC,
10088,GO:0042595,0.999999999991732,0.890023718061515,0,1,behavioral response to starvation,BP,
10107,GO:0042631,0.999999999991732,0.890023718061515,0,1,cellular response to water deprivation,BP,
10120,GO:0042660,0.999999999991732,0.890023718061515,0,1,positive regulation of cell fate specification,BP,
10124,GO:0042665,0.999999999991732,0.890023718061515,0,1,regulation of ectodermal cell fate specification,BP,
10125,GO:0042666,0.999999999991732,0.890023718061515,0,1,negative regulation of ectodermal cell fate specification,BP,
10145,GO:0042728,0.999999999991732,0.890023718061515,0,1,flavin-containing compound catabolic process,BP,
10171,GO:0042766,0.999999999991732,0.890023718061515,0,1,nucleosome mobilization,BP,
10209,GO:0042835,0.999999999991732,0.890023718061515,0,1,BRE binding,MF,
10227,GO:0042937,0.999999999991732,0.890023718061515,0,1,tripeptide transmembrane transporter activity,MF,
10248,GO:0042988,0.999999999991732,0.890023718061515,0,1,X11-like protein binding,MF,
10255,GO:0042999,0.999999999991732,0.890023718061515,0,1,regulation of Golgi to plasma membrane CFTR protein transport,BP,
10258,GO:0043002,0.999999999991732,0.890023718061515,0,1,negative regulation of Golgi to plasma membrane CFTR protein transport,BP,
10259,GO:0043004,0.999999999991732,0.890023718061515,0,1,cytoplasmic sequestering of CFTR protein,BP,
10280,GO:0043033,0.999999999991732,0.890023718061515,0,1,isoamylase complex,CC,
10282,GO:0043035,0.999999999991732,0.890023718061515,0,1,chromatin insulator sequence binding,MF,
10285,GO:0043041,0.999999999991732,0.890023718061515,0,1,amino acid activation for nonribosomal peptide biosynthetic process,BP,
10331,GO:0043131,0.999999999991732,0.890023718061515,0,1,erythrocyte enucleation,BP,
10344,GO:0043159,0.999999999991732,0.890023718061515,0,1,acrosomal matrix,CC,
10385,GO:0043221,0.999999999991732,0.890023718061515,0,1,SMC family protein binding,MF,
10422,GO:0043273,0.999999999991732,0.890023718061515,0,1,CTPase activity,MF,
10464,GO:0043337,0.999999999991732,0.890023718061515,0,1,CDP-diacylglycerol-phosphatidylglycerol phosphatidyltransferase activity,MF,
10466,GO:0043354,0.999999999991732,0.890023718061515,0,1,enucleate erythrocyte maturation,BP,
10476,GO:0043375,0.999999999991732,0.890023718061515,0,1,CD8-positive, alpha-beta T cell lineage commitment,BP,
10477,GO:0043376,0.999999999991732,0.890023718061515,0,1,regulation of CD8-positive, alpha-beta T cell differentiation,BP,
10509,GO:0043423,0.999999999991732,0.890023718061515,0,1,3-phosphoinositide-dependent protein kinase binding,MF,
10563,GO:0043532,0.999999999991732,0.890023718061515,0,1,angiostatin binding,MF,
10574,GO:0043544,0.999999999991732,0.890023718061515,0,1,lipoamide binding,MF,
10610,GO:0043606,0.999999999991732,0.890023718061515,0,1,formamide metabolic process,BP,
10611,GO:0043610,0.999999999991732,0.890023718061515,0,1,regulation of carbohydrate utilization,BP,
10625,GO:0043629,0.999999999991732,0.890023718061515,0,1,ncRNA polyadenylation,BP,
10626,GO:0043630,0.999999999991732,0.890023718061515,0,1,ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process,BP,
10651,GO:0043739,0.999999999991732,0.890023718061515,0,1,G/U mismatch-specific uracil-DNA glycosylase activity,MF,
10652,GO:0043754,0.999999999991732,0.890023718061515,0,1,dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity,MF,
10667,GO:0043914,0.999999999991732,0.890023718061515,0,1,NADPH:sulfur oxidoreductase activity,MF,
10685,GO:0043969,0.999999999991732,0.890023718061515,0,1,histone H2B acetylation,BP,
10687,GO:0043972,0.999999999991732,0.890023718061515,0,1,histone H3-K23 acetylation,BP,
10698,GO:0043994,0.999999999991732,0.890023718061515,0,1,histone acetyltransferase activity (H3-K23 specific),MF,
10702,GO:0043998,0.999999999991732,0.890023718061515,0,1,H2A histone acetyltransferase activity,MF,
10705,GO:0044007,0.999999999991732,0.890023718061515,0,1,dissemination or transmission of symbiont from host,BP,
10742,GO:0044128,0.999999999991732,0.890023718061515,0,1,positive regulation of growth of symbiont in host,BP,
10748,GO:0044148,0.999999999991732,0.890023718061515,0,1,positive regulation of growth of symbiont involved in interaction with host,BP,
10755,GO:0044207,0.999999999991732,0.890023718061515,0,1,translation initiation ternary complex,CC,
10767,GO:0044220,0.999999999991732,0.890023718061515,0,1,host cell perinuclear region of cytoplasm,CC,
10770,GO:0044228,0.999999999991732,0.890023718061515,0,1,host cell surface,CC,
10804,GO:0044299,0.999999999991732,0.890023718061515,0,1,C-fiber,CC,
10806,GO:0044301,0.999999999991732,0.890023718061515,0,1,climbing fiber,CC,
10809,GO:0044305,0.999999999991732,0.890023718061515,0,1,calyx of Held,CC,
10811,GO:0044307,0.999999999991732,0.890023718061515,0,1,dendritic branch,CC,
10816,GO:0044316,0.999999999991732,0.890023718061515,0,1,cone cell pedicle,CC,
10833,GO:0044335,0.999999999991732,0.890023718061515,0,1,canonical Wnt signaling pathway involved in neural crest cell differentiation,BP,
10840,GO:0044343,0.999999999991732,0.890023718061515,0,1,canonical Wnt signaling pathway involved in regulation of type B pancreatic cell proliferation,BP,
10842,GO:0044345,0.999999999991732,0.890023718061515,0,1,stromal-epithelial cell signaling involved in prostate gland development,BP,
10869,GO:0044414,0.999999999991732,0.890023718061515,0,1,suppression of host defenses,BP,
10957,GO:0044725,0.999999999991732,0.890023718061515,0,1,chromatin reprogramming in the zygote,BP,
10958,GO:0044727,0.999999999991732,0.890023718061515,0,1,DNA demethylation of male pronucleus,BP,
11018,GO:0044868,0.999999999991732,0.890023718061515,0,1,modulation by host of viral molecular function,BP,
11031,GO:0045016,0.999999999991732,0.890023718061515,0,1,mitochondrial magnesium ion transmembrane transport,BP,
11075,GO:0045083,0.999999999991732,0.890023718061515,0,1,negative regulation of interleukin-12 biosynthetic process,BP,
11088,GO:0045105,0.999999999991732,0.890023718061515,0,1,intermediate filament polymerization or depolymerization,BP,
11102,GO:0045128,0.999999999991732,0.890023718061515,0,1,negative regulation of reciprocal meiotic recombination,BP,
11133,GO:0045186,0.999999999991732,0.890023718061515,0,1,zonula adherens assembly,BP,
11145,GO:0045208,0.999999999991732,0.890023718061515,0,1,MAPK phosphatase export from nucleus,BP,
11146,GO:0045209,0.999999999991732,0.890023718061515,0,1,MAPK phosphatase export from nucleus, leptomycin B sensitive,BP,
11221,GO:0045381,0.999999999991732,0.890023718061515,0,1,regulation of interleukin-18 biosynthetic process,BP,
11222,GO:0045399,0.999999999991732,0.890023718061515,0,1,regulation of interleukin-3 biosynthetic process,BP,
11223,GO:0045401,0.999999999991732,0.890023718061515,0,1,positive regulation of interleukin-3 biosynthetic process,BP,
11232,GO:0045423,0.999999999991732,0.890023718061515,0,1,regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
11233,GO:0045425,0.999999999991732,0.890023718061515,0,1,positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
11245,GO:0045485,0.999999999991732,0.890023718061515,0,1,omega-6 fatty acid desaturase activity,MF,
11272,GO:0045590,0.999999999991732,0.890023718061515,0,1,negative regulation of regulatory T cell differentiation,BP,
11310,GO:0045643,0.999999999991732,0.890023718061515,0,1,regulation of eosinophil differentiation,BP,
11311,GO:0045645,0.999999999991732,0.890023718061515,0,1,positive regulation of eosinophil differentiation,BP,
11347,GO:0045715,0.999999999991732,0.890023718061515,0,1,negative regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
11356,GO:0045726,0.999999999991732,0.890023718061515,0,1,positive regulation of integrin biosynthetic process,BP,
11372,GO:0045751,0.999999999991732,0.890023718061515,0,1,negative regulation of Toll signaling pathway,BP,
11381,GO:0045769,0.999999999991732,0.890023718061515,0,1,negative regulation of asymmetric cell division,BP,
11394,GO:0045795,0.999999999991732,0.890023718061515,0,1,positive regulation of cell volume,BP,
11401,GO:0045819,0.999999999991732,0.890023718061515,0,1,positive regulation of glycogen catabolic process,BP,
11428,GO:0045870,0.999999999991732,0.890023718061515,0,1,positive regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
11498,GO:0045993,0.999999999991732,0.890023718061515,0,1,negative regulation of translational initiation by iron,BP,
11582,GO:0046168,0.999999999991732,0.890023718061515,0,1,glycerol-3-phosphate catabolic process,BP,
11605,GO:0046317,0.999999999991732,0.890023718061515,0,1,regulation of glucosylceramide biosynthetic process,BP,
11606,GO:0046318,0.999999999991732,0.890023718061515,0,1,negative regulation of glucosylceramide biosynthetic process,BP,
11629,GO:0046355,0.999999999991732,0.890023718061515,0,1,mannan catabolic process,BP,
11639,GO:0046380,0.999999999991732,0.890023718061515,0,1,N-acetylneuraminate biosynthetic process,BP,
11697,GO:0046499,0.999999999991732,0.890023718061515,0,1,S-adenosylmethioninamine metabolic process,BP,
11717,GO:0046534,0.999999999991732,0.890023718061515,0,1,positive regulation of photoreceptor cell differentiation,BP,
11722,GO:0046544,0.999999999991732,0.890023718061515,0,1,development of secondary male sexual characteristics,BP,
11730,GO:0046577,0.999999999991732,0.890023718061515,0,1,long-chain-alcohol oxidase activity,MF,
11755,GO:0046623,0.999999999991732,0.890023718061515,0,1,sphingolipid-translocating ATPase activity,MF,
11786,GO:0046668,0.999999999991732,0.890023718061515,0,1,regulation of retinal cell programmed cell death,BP,
11787,GO:0046671,0.999999999991732,0.890023718061515,0,1,negative regulation of retinal cell programmed cell death,BP,
11798,GO:0046690,0.999999999991732,0.890023718061515,0,1,response to tellurium ion,BP,
11816,GO:0046725,0.999999999991732,0.890023718061515,0,1,negative regulation by virus of viral protein levels in host cell,BP,
11827,GO:0046786,0.999999999991732,0.890023718061515,0,1,viral replication complex formation and maintenance,BP,
11830,GO:0046811,0.999999999991732,0.890023718061515,0,1,histone deacetylase inhibitor activity,MF,
11887,GO:0046921,0.999999999991732,0.890023718061515,0,1,alpha-(1->6)-fucosyltransferase activity,MF,
11908,GO:0046959,0.999999999991732,0.890023718061515,0,1,habituation,BP,
11915,GO:0046968,0.999999999991732,0.890023718061515,0,1,peptide antigen transport,BP,
11925,GO:0046980,0.999999999991732,0.890023718061515,0,1,tapasin binding,MF,
11930,GO:0046986,0.999999999991732,0.890023718061515,0,1,negative regulation of hemoglobin biosynthetic process,BP,
11948,GO:0047117,0.999999999991732,0.890023718061515,0,1,enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity,MF,
11949,GO:0047130,0.999999999991732,0.890023718061515,0,1,saccharopine dehydrogenase (NADP+, L-lysine-forming) activity,MF,
11950,GO:0047131,0.999999999991732,0.890023718061515,0,1,saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity,MF,
11958,GO:0047186,0.999999999991732,0.890023718061515,0,1,N-acetylneuraminate 7-O(or 9-O)-acetyltransferase activity,MF,
11966,GO:0047256,0.999999999991732,0.890023718061515,0,1,lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity,MF,
11968,GO:0047273,0.999999999991732,0.890023718061515,0,1,galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity,MF,
11969,GO:0047275,0.999999999991732,0.890023718061515,0,1,glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity,MF,
11971,GO:0047280,0.999999999991732,0.890023718061515,0,1,nicotinamide phosphoribosyltransferase activity,MF,
11976,GO:0047298,0.999999999991732,0.890023718061515,0,1,(S)-3-amino-2-methylpropionate transaminase activity,MF,
11979,GO:0047325,0.999999999991732,0.890023718061515,0,1,inositol tetrakisphosphate 1-kinase activity,MF,
11981,GO:0047341,0.999999999991732,0.890023718061515,0,1,fucose-1-phosphate guanylyltransferase activity,MF,
11982,GO:0047349,0.999999999991732,0.890023718061515,0,1,D-ribitol-5-phosphate cytidylyltransferase activity,MF,
11993,GO:0047451,0.999999999991732,0.890023718061515,0,1,3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity,MF,
11994,GO:0047464,0.999999999991732,0.890023718061515,0,1,heparosan-N-sulfate-glucuronate 5-epimerase activity,MF,
12004,GO:0047545,0.999999999991732,0.890023718061515,0,1,2-hydroxyglutarate dehydrogenase activity,MF,
12017,GO:0047676,0.999999999991732,0.890023718061515,0,1,arachidonate-CoA ligase activity,MF,
12031,GO:0047760,0.999999999991732,0.890023718061515,0,1,butyrate-CoA ligase activity,MF,
12032,GO:0047800,0.999999999991732,0.890023718061515,0,1,cysteamine dioxygenase activity,MF,
12041,GO:0047933,0.999999999991732,0.890023718061515,0,1,glucose-1,6-bisphosphate synthase activity,MF,
12047,GO:0048006,0.999999999991732,0.890023718061515,0,1,antigen processing and presentation, endogenous lipid antigen via MHC class Ib,BP,
12055,GO:0048014,0.999999999991732,0.890023718061515,0,1,Tie signaling pathway,BP,
12064,GO:0048023,0.999999999991732,0.890023718061515,0,1,positive regulation of melanin biosynthetic process,BP,
12080,GO:0048058,0.999999999991732,0.890023718061515,0,1,compound eye corneal lens development,BP,
12085,GO:0048075,0.999999999991732,0.890023718061515,0,1,positive regulation of eye pigmentation,BP,
12177,GO:0048320,0.999999999991732,0.890023718061515,0,1,axial mesoderm formation,BP,
12180,GO:0048338,0.999999999991732,0.890023718061515,0,1,mesoderm structural organization,BP,
12184,GO:0048352,0.999999999991732,0.890023718061515,0,1,paraxial mesoderm structural organization,BP,
12204,GO:0048403,0.999999999991732,0.890023718061515,0,1,brain-derived neurotrophic factor binding,MF,
12356,GO:0048749,0.999999999991732,0.890023718061515,0,1,compound eye development,BP,
12377,GO:0048807,0.999999999991732,0.890023718061515,0,1,female genitalia morphogenesis,BP,
12399,GO:0048855,0.999999999991732,0.890023718061515,0,1,adenohypophysis morphogenesis,BP,
12408,GO:0048866,0.999999999991732,0.890023718061515,0,1,stem cell fate specification,BP,
12415,GO:0048874,0.999999999991732,0.890023718061515,0,1,homeostasis of number of cells in a free-living population,BP,
12434,GO:0050115,0.999999999991732,0.890023718061515,0,1,myosin-light-chain-phosphatase activity,MF,
12436,GO:0050124,0.999999999991732,0.890023718061515,0,1,N-acylneuraminate-9-phosphatase activity,MF,
12441,GO:0050146,0.999999999991732,0.890023718061515,0,1,nucleoside phosphotransferase activity,MF,
12444,GO:0050185,0.999999999991732,0.890023718061515,0,1,phosphatidylinositol deacylase activity,MF,
12445,GO:0050201,0.999999999991732,0.890023718061515,0,1,fucokinase activity,MF,
12453,GO:0050277,0.999999999991732,0.890023718061515,0,1,sedoheptulokinase activity,MF,
12454,GO:0050290,0.999999999991732,0.890023718061515,0,1,sphingomyelin phosphodiesterase D activity,MF,
12467,GO:0050355,0.999999999991732,0.890023718061515,0,1,triphosphatase activity,MF,
12468,GO:0050379,0.999999999991732,0.890023718061515,0,1,UDP-glucuronate 5'-epimerase activity,MF,
12479,GO:0050444,0.999999999991732,0.890023718061515,0,1,aquacobalamin reductase (NADPH) activity,MF,
12492,GO:0050560,0.999999999991732,0.890023718061515,0,1,aspartate-tRNA(Asn) ligase activity,MF,
12493,GO:0050561,0.999999999991732,0.890023718061515,0,1,glutamate-tRNA(Gln) ligase activity,MF,
12499,GO:0050614,0.999999999991732,0.890023718061515,0,1,delta24-sterol reductase activity,MF,
12503,GO:0050652,0.999999999991732,0.890023718061515,0,1,dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
12504,GO:0050653,0.999999999991732,0.890023718061515,0,1,chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
12573,GO:0050748,0.999999999991732,0.890023718061515,0,1,negative regulation of lipoprotein metabolic process,BP,
12626,GO:0050822,0.999999999991732,0.890023718061515,0,1,peptide stabilization,BP,
12627,GO:0050823,0.999999999991732,0.890023718061515,0,1,peptide antigen stabilization,BP,
12675,GO:0050897,0.999999999991732,0.890023718061515,0,1,cobalt ion binding,MF,
12697,GO:0050924,0.999999999991732,0.890023718061515,0,1,positive regulation of negative chemotaxis,BP,
12701,GO:0050928,0.999999999991732,0.890023718061515,0,1,negative regulation of positive chemotaxis,BP,
12702,GO:0050929,0.999999999991732,0.890023718061515,0,1,induction of negative chemotaxis,BP,
12710,GO:0050955,0.999999999991732,0.890023718061515,0,1,thermoception,BP,
12712,GO:0050960,0.999999999991732,0.890023718061515,0,1,detection of temperature stimulus involved in thermoception,BP,
12717,GO:0050968,0.999999999991732,0.890023718061515,0,1,detection of chemical stimulus involved in sensory perception of pain,BP,
12754,GO:0051032,0.999999999991732,0.890023718061515,0,1,nucleic acid transmembrane transporter activity,MF,
12755,GO:0051033,0.999999999991732,0.890023718061515,0,1,RNA transmembrane transporter activity,MF,
12757,GO:0051040,0.999999999991732,0.890023718061515,0,1,regulation of calcium-independent cell-cell adhesion,BP,
12758,GO:0051042,0.999999999991732,0.890023718061515,0,1,negative regulation of calcium-independent cell-cell adhesion,BP,
12777,GO:0051068,0.999999999991732,0.890023718061515,0,1,dihydrolipoamide metabolic process,BP,
12786,GO:0051089,0.999999999991732,0.890023718061515,0,1,constitutive protein ectodomain proteolysis,BP,
12799,GO:0051102,0.999999999991732,0.890023718061515,0,1,DNA ligation involved in DNA recombination,BP,
12806,GO:0051120,0.999999999991732,0.890023718061515,0,1,hepoxilin A3 synthase activity,MF,
12823,GO:0051139,0.999999999991732,0.890023718061515,0,1,metal ion:proton antiporter activity,MF,
12879,GO:0051228,0.999999999991732,0.890023718061515,0,1,mitotic spindle disassembly,BP,
12880,GO:0051230,0.999999999991732,0.890023718061515,0,1,spindle disassembly,BP,
12910,GO:0051267,0.999999999991732,0.890023718061515,0,1,CP2 mannose-ethanolamine phosphotransferase activity,MF,
12964,GO:0051365,0.999999999991732,0.890023718061515,0,1,cellular response to potassium ion starvation,BP,
12978,GO:0051391,0.999999999991732,0.890023718061515,0,1,tRNA acetylation,BP,
12979,GO:0051392,0.999999999991732,0.890023718061515,0,1,tRNA N-acetyltransferase activity,MF,
12998,GO:0051433,0.999999999991732,0.890023718061515,0,1,BH2 domain binding,MF,
13018,GO:0051463,0.999999999991732,0.890023718061515,0,1,negative regulation of cortisol secretion,BP,
13068,GO:0051585,0.999999999991732,0.890023718061515,0,1,negative regulation of dopamine uptake involved in synaptic transmission,BP,
13079,GO:0051598,0.999999999991732,0.890023718061515,0,1,meiotic recombination checkpoint,BP,
13091,GO:0051615,0.999999999991732,0.890023718061515,0,1,histamine uptake,BP,
13092,GO:0051620,0.999999999991732,0.890023718061515,0,1,norepinephrine uptake,BP,
13093,GO:0051621,0.999999999991732,0.890023718061515,0,1,regulation of norepinephrine uptake,BP,
13094,GO:0051622,0.999999999991732,0.890023718061515,0,1,negative regulation of norepinephrine uptake,BP,
13122,GO:0051686,0.999999999991732,0.890023718061515,0,1,establishment of ER localization,BP,
13165,GO:0051780,0.999999999991732,0.890023718061515,0,1,behavioral response to nutrient,BP,
13180,GO:0051796,0.999999999991732,0.890023718061515,0,1,negative regulation of timing of catagen,BP,
13184,GO:0051800,0.999999999991732,0.890023718061515,0,1,phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity,MF,
13191,GO:0051821,0.999999999991732,0.890023718061515,0,1,dissemination or transmission of organism from other organism involved in symbiotic interaction,BP,
13195,GO:0051833,0.999999999991732,0.890023718061515,0,1,suppression of defenses of other organism involved in symbiotic interaction,BP,
13204,GO:0051870,0.999999999991732,0.890023718061515,0,1,methotrexate binding,MF,
13214,GO:0051885,0.999999999991732,0.890023718061515,0,1,positive regulation of timing of anagen,BP,
13215,GO:0051886,0.999999999991732,0.890023718061515,0,1,negative regulation of timing of anagen,BP,
13217,GO:0051891,0.999999999991732,0.890023718061515,0,1,positive regulation of cardioblast differentiation,BP,
13218,GO:0051892,0.999999999991732,0.890023718061515,0,1,negative regulation of cardioblast differentiation,BP,
13232,GO:0051908,0.999999999991732,0.890023718061515,0,1,double-stranded DNA 5'-3' exodeoxyribonuclease activity,MF,
13244,GO:0051933,0.999999999991732,0.890023718061515,0,1,amino acid neurotransmitter reuptake,BP,
13246,GO:0051935,0.999999999991732,0.890023718061515,0,1,glutamate reuptake,BP,
13250,GO:0051941,0.999999999991732,0.890023718061515,0,1,regulation of amino acid uptake involved in synaptic transmission,BP,
13252,GO:0051945,0.999999999991732,0.890023718061515,0,1,negative regulation of catecholamine uptake involved in synaptic transmission,BP,
13253,GO:0051946,0.999999999991732,0.890023718061515,0,1,regulation of glutamate uptake involved in transmission of nerve impulse,BP,
13287,GO:0052029,0.999999999991732,0.890023718061515,0,1,negative regulation by symbiont of host signal transduction pathway,BP,
13289,GO:0052037,0.999999999991732,0.890023718061515,0,1,negative regulation by symbiont of host defense response,BP,
13293,GO:0052047,0.999999999991732,0.890023718061515,0,1,interaction with other organism via secreted substance involved in symbiotic interaction,BP,
13297,GO:0052066,0.999999999991732,0.890023718061515,0,1,entry of symbiont into host cell by promotion of host phagocytosis,BP,
13298,GO:0052097,0.999999999991732,0.890023718061515,0,1,interspecies quorum sensing,BP,
13299,GO:0052106,0.999999999991732,0.890023718061515,0,1,quorum sensing involved in interaction with host,BP,
13304,GO:0052167,0.999999999991732,0.890023718061515,0,1,modulation by symbiont of host innate immune response,BP,
13305,GO:0052170,0.999999999991732,0.890023718061515,0,1,negative regulation by symbiont of host innate immune response,BP,
13307,GO:0052190,0.999999999991732,0.890023718061515,0,1,modulation by symbiont of host phagocytosis,BP,
13308,GO:0052191,0.999999999991732,0.890023718061515,0,1,positive regulation by symbiont of host phagocytosis,BP,
13318,GO:0052231,0.999999999991732,0.890023718061515,0,1,modulation of phagocytosis in other organism involved in symbiotic interaction,BP,
13323,GO:0052261,0.999999999991732,0.890023718061515,0,1,suppression of defense response of other organism involved in symbiotic interaction,BP,
13324,GO:0052306,0.999999999991732,0.890023718061515,0,1,modulation by organism of innate immune response in other organism involved in symbiotic interaction,BP,
13325,GO:0052309,0.999999999991732,0.890023718061515,0,1,negative regulation by organism of innate immune response in other organism involved in symbiotic interaction,BP,
13334,GO:0052370,0.999999999991732,0.890023718061515,0,1,entry of organism into cell of other organism by promotion of phagocytosis in other organism involved in symbiotic interaction,BP,
13346,GO:0052493,0.999999999991732,0.890023718061515,0,1,negative regulation by organism of signal transduction in other organism involved in symbiotic interaction,BP,
13350,GO:0052522,0.999999999991732,0.890023718061515,0,1,positive regulation by organism of phagocytosis in other organism involved in symbiotic interaction,BP,
13356,GO:0052561,0.999999999991732,0.890023718061515,0,1,negative regulation by organism of immune response of other organism involved in symbiotic interaction,BP,
13357,GO:0052562,0.999999999991732,0.890023718061515,0,1,negative regulation by symbiont of host immune response,BP,
13361,GO:0052590,0.999999999991732,0.890023718061515,0,1,sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity,MF,
13362,GO:0052591,0.999999999991732,0.890023718061515,0,1,sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity,MF,
13385,GO:0052717,0.999999999991732,0.890023718061515,0,1,tRNA-specific adenosine-34 deaminase activity,MF,
13386,GO:0052718,0.999999999991732,0.890023718061515,0,1,tRNA-specific adenosine-34 deaminase complex,CC,
13389,GO:0052725,0.999999999991732,0.890023718061515,0,1,inositol-1,3,4-trisphosphate 6-kinase activity,MF,
13390,GO:0052726,0.999999999991732,0.890023718061515,0,1,inositol-1,3,4-trisphosphate 5-kinase activity,MF,
13405,GO:0052810,0.999999999991732,0.890023718061515,0,1,1-phosphatidylinositol-5-kinase activity,MF,
13412,GO:0052825,0.999999999991732,0.890023718061515,0,1,inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity,MF,
13417,GO:0052830,0.999999999991732,0.890023718061515,0,1,inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity,MF,
13418,GO:0052831,0.999999999991732,0.890023718061515,0,1,inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity,MF,
13422,GO:0052835,0.999999999991732,0.890023718061515,0,1,inositol-3,4,6-trisphosphate 1-kinase activity,MF,
13435,GO:0052858,0.999999999991732,0.890023718061515,0,1,peptidyl-lysine acetyltransferase activity,MF,
13446,GO:0052906,0.999999999991732,0.890023718061515,0,1,tRNA (guanine(37)-N(1))-methyltransferase activity,MF,
13450,GO:0052918,0.999999999991732,0.890023718061515,0,1,dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
13452,GO:0052926,0.999999999991732,0.890023718061515,0,1,dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
13479,GO:0055028,0.999999999991732,0.890023718061515,0,1,cortical microtubule,CC,
13483,GO:0055048,0.999999999991732,0.890023718061515,0,1,anastral spindle assembly,BP,
13513,GO:0055095,0.999999999991732,0.890023718061515,0,1,lipoprotein particle mediated signaling,BP,
13514,GO:0055096,0.999999999991732,0.890023718061515,0,1,low-density lipoprotein particle mediated signaling,BP,
13517,GO:0055103,0.999999999991732,0.890023718061515,0,1,ligase regulator activity,MF,
13521,GO:0055113,0.999999999991732,0.890023718061515,0,1,epiboly involved in gastrulation with mouth forming second,BP,
13530,GO:0060001,0.999999999991732,0.890023718061515,0,1,minus-end directed microfilament motor activity,MF,
13538,GO:0060010,0.999999999991732,0.890023718061515,0,1,Sertoli cell fate commitment,BP,
13540,GO:0060012,0.999999999991732,0.890023718061515,0,1,synaptic transmission, glycinergic,BP,
13544,GO:0060018,0.999999999991732,0.890023718061515,0,1,astrocyte fate commitment,BP,
13556,GO:0060031,0.999999999991732,0.890023718061515,0,1,mediolateral intercalation,BP,
13557,GO:0060032,0.999999999991732,0.890023718061515,0,1,notochord regression,BP,
13582,GO:0060060,0.999999999991732,0.890023718061515,0,1,post-embryonic retina morphogenesis in camera-type eye,BP,
13587,GO:0060067,0.999999999991732,0.890023718061515,0,1,cervix development,BP,
13591,GO:0060072,0.999999999991732,0.890023718061515,0,1,large conductance calcium-activated potassium channel activity,MF,
13602,GO:0060084,0.999999999991732,0.890023718061515,0,1,synaptic transmission involved in micturition,BP,
13609,GO:0060092,0.999999999991732,0.890023718061515,0,1,regulation of synaptic transmission, glycinergic,BP,
13622,GO:0060128,0.999999999991732,0.890023718061515,0,1,corticotropin hormone secreting cell differentiation,BP,
13648,GO:0060171,0.999999999991732,0.890023718061515,0,1,stereocilium membrane,CC,
13663,GO:0060200,0.999999999991732,0.890023718061515,0,1,clathrin-sculpted acetylcholine transport vesicle,CC,
13664,GO:0060201,0.999999999991732,0.890023718061515,0,1,clathrin-sculpted acetylcholine transport vesicle membrane,CC,
13675,GO:0060221,0.999999999991732,0.890023718061515,0,1,retinal rod cell differentiation,BP,
13684,GO:0060245,0.999999999991732,0.890023718061515,0,1,detection of cell density,BP,
13685,GO:0060246,0.999999999991732,0.890023718061515,0,1,detection of cell density by contact stimulus,BP,
13686,GO:0060248,0.999999999991732,0.890023718061515,0,1,detection of cell density by contact stimulus involved in contact inhibition,BP,
13769,GO:0060366,0.999999999991732,0.890023718061515,0,1,lambdoid suture morphogenesis,BP,
13770,GO:0060367,0.999999999991732,0.890023718061515,0,1,sagittal suture morphogenesis,BP,
13773,GO:0060370,0.999999999991732,0.890023718061515,0,1,susceptibility to T cell mediated cytotoxicity,BP,
13775,GO:0060372,0.999999999991732,0.890023718061515,0,1,regulation of atrial cardiac muscle cell membrane repolarization,BP,
13785,GO:0060383,0.999999999991732,0.890023718061515,0,1,positive regulation of DNA strand elongation,BP,
13788,GO:0060386,0.999999999991732,0.890023718061515,0,1,synapse assembly involved in innervation,BP,
13800,GO:0060400,0.999999999991732,0.890023718061515,0,1,negative regulation of growth hormone receptor signaling pathway,BP,
13835,GO:0060447,0.999999999991732,0.890023718061515,0,1,bud outgrowth involved in lung branching,BP,
13840,GO:0060454,0.999999999991732,0.890023718061515,0,1,positive regulation of gastric acid secretion,BP,
13848,GO:0060465,0.999999999991732,0.890023718061515,0,1,pharynx development,BP,
13872,GO:0060516,0.999999999991732,0.890023718061515,0,1,primary prostatic bud elongation,BP,
13873,GO:0060517,0.999999999991732,0.890023718061515,0,1,epithelial cell proliferation involved in prostatic bud elongation,BP,
13888,GO:0060542,0.999999999991732,0.890023718061515,0,1,regulation of strand invasion,BP,
13902,GO:0060566,0.999999999991732,0.890023718061515,0,1,positive regulation of DNA-templated transcription, termination,BP,
13921,GO:0060595,0.999999999991732,0.890023718061515,0,1,fibroblast growth factor receptor signaling pathway involved in mammary gland specification,BP,
13922,GO:0060596,0.999999999991732,0.890023718061515,0,1,mammary placode formation,BP,
13924,GO:0060599,0.999999999991732,0.890023718061515,0,1,lateral sprouting involved in mammary gland duct morphogenesis,BP,
13934,GO:0060615,0.999999999991732,0.890023718061515,0,1,mammary gland bud formation,BP,
13944,GO:0060648,0.999999999991732,0.890023718061515,0,1,mammary gland bud morphogenesis,BP,
13950,GO:0060667,0.999999999991732,0.890023718061515,0,1,branch elongation involved in salivary gland morphogenesis,BP,
13951,GO:0060668,0.999999999991732,0.890023718061515,0,1,regulation of branching involved in salivary gland morphogenesis by extracellular matrix-epithelial cell signaling,BP,
13998,GO:0060730,0.999999999991732,0.890023718061515,0,1,regulation of intestinal epithelial structure maintenance,BP,
13999,GO:0060731,0.999999999991732,0.890023718061515,0,1,positive regulation of intestinal epithelial structure maintenance,BP,
14002,GO:0060734,0.999999999991732,0.890023718061515,0,1,regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,BP,
14006,GO:0060739,0.999999999991732,0.890023718061515,0,1,mesenchymal-epithelial cell signaling involved in prostate gland development,BP,
14013,GO:0060748,0.999999999991732,0.890023718061515,0,1,tertiary branching involved in mammary gland duct morphogenesis,BP,
14029,GO:0060769,0.999999999991732,0.890023718061515,0,1,positive regulation of epithelial cell proliferation involved in prostate gland development,BP,
14031,GO:0060775,0.999999999991732,0.890023718061515,0,1,planar cell polarity pathway involved in gastrula mediolateral intercalation,BP,
14032,GO:0060784,0.999999999991732,0.890023718061515,0,1,regulation of cell proliferation involved in tissue homeostasis,BP,
14037,GO:0060804,0.999999999991732,0.890023718061515,0,1,positive regulation of Wnt signaling pathway by BMP signaling pathway,BP,
14038,GO:0060809,0.999999999991732,0.890023718061515,0,1,mesodermal to mesenchymal transition involved in gastrulation,BP,
14041,GO:0060821,0.999999999991732,0.890023718061515,0,1,inactivation of X chromosome by DNA methylation,BP,
14042,GO:0060823,0.999999999991732,0.890023718061515,0,1,canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
14054,GO:0060843,0.999999999991732,0.890023718061515,0,1,venous endothelial cell differentiation,BP,
14060,GO:0060853,0.999999999991732,0.890023718061515,0,1,Notch signaling pathway involved in arterial endothelial cell fate commitment,BP,
14064,GO:0060873,0.999999999991732,0.890023718061515,0,1,anterior semicircular canal development,BP,
14065,GO:0060875,0.999999999991732,0.890023718061515,0,1,lateral semicircular canal development,BP,
14071,GO:0060901,0.999999999991732,0.890023718061515,0,1,regulation of hair cycle by canonical Wnt signaling pathway,BP,
14073,GO:0060904,0.999999999991732,0.890023718061515,0,1,regulation of protein folding in endoplasmic reticulum,BP,
14079,GO:0060915,0.999999999991732,0.890023718061515,0,1,mesenchymal cell differentiation involved in lung development,BP,
14083,GO:0060922,0.999999999991732,0.890023718061515,0,1,atrioventricular node cell differentiation,BP,
14086,GO:0060928,0.999999999991732,0.890023718061515,0,1,atrioventricular node cell development,BP,
14088,GO:0060932,0.999999999991732,0.890023718061515,0,1,His-Purkinje system cell differentiation,BP,
14131,GO:0061010,0.999999999991732,0.890023718061515,0,1,gall bladder development,BP,
14139,GO:0061030,0.999999999991732,0.890023718061515,0,1,epithelial cell differentiation involved in mammary gland alveolus development,BP,
14142,GO:0061034,0.999999999991732,0.890023718061515,0,1,olfactory bulb mitral cell layer development,BP,
14147,GO:0061040,0.999999999991732,0.890023718061515,0,1,female gonad morphogenesis,BP,
14151,GO:0061044,0.999999999991732,0.890023718061515,0,1,negative regulation of vascular wound healing,BP,
14161,GO:0061054,0.999999999991732,0.890023718061515,0,1,dermatome development,BP,
14179,GO:0061091,0.999999999991732,0.890023718061515,0,1,regulation of phospholipid translocation,BP,
14180,GO:0061092,0.999999999991732,0.890023718061515,0,1,positive regulation of phospholipid translocation,BP,
14200,GO:0061141,0.999999999991732,0.890023718061515,0,1,lung ciliated cell differentiation,BP,
14218,GO:0061183,0.999999999991732,0.890023718061515,0,1,regulation of dermatome development,BP,
14219,GO:0061184,0.999999999991732,0.890023718061515,0,1,positive regulation of dermatome development,BP,
14228,GO:0061205,0.999999999991732,0.890023718061515,0,1,paramesonephric duct development,BP,
14241,GO:0061301,0.999999999991732,0.890023718061515,0,1,cerebellum vasculature morphogenesis,BP,
14255,GO:0061324,0.999999999991732,0.890023718061515,0,1,canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation,BP,
14264,GO:0061347,0.999999999991732,0.890023718061515,0,1,planar cell polarity pathway involved in outflow tract morphogenesis,BP,
14265,GO:0061348,0.999999999991732,0.890023718061515,0,1,planar cell polarity pathway involved in ventricular septum morphogenesis,BP,
14266,GO:0061349,0.999999999991732,0.890023718061515,0,1,planar cell polarity pathway involved in cardiac right atrium morphogenesis,BP,
14267,GO:0061350,0.999999999991732,0.890023718061515,0,1,planar cell polarity pathway involved in cardiac muscle tissue morphogenesis,BP,
14269,GO:0061354,0.999999999991732,0.890023718061515,0,1,planar cell polarity pathway involved in pericardium morphogenesis,BP,
14276,GO:0061366,0.999999999991732,0.890023718061515,0,1,behavioral response to chemical pain,BP,
14277,GO:0061368,0.999999999991732,0.890023718061515,0,1,behavioral response to formalin induced pain,BP,
14278,GO:0061369,0.999999999991732,0.890023718061515,0,1,negative regulation of testicular blood vessel morphogenesis,BP,
14302,GO:0061444,0.999999999991732,0.890023718061515,0,1,endocardial cushion cell development,BP,
14307,GO:0061459,0.999999999991732,0.890023718061515,0,1,L-arginine transmembrane transporter activity,MF,
14316,GO:0061485,0.999999999991732,0.890023718061515,0,1,memory T cell proliferation,BP,
14328,GO:0061519,0.999999999991732,0.890023718061515,0,1,macrophage homeostasis,BP,
14331,GO:0061528,0.999999999991732,0.890023718061515,0,1,aspartate secretion,BP,
14332,GO:0061534,0.999999999991732,0.890023718061515,0,1,gamma-aminobutyric acid secretion, neurotransmission,BP,
14334,GO:0061536,0.999999999991732,0.890023718061515,0,1,glycine secretion,BP,
14335,GO:0061537,0.999999999991732,0.890023718061515,0,1,glycine secretion, neurotransmission,BP,
14337,GO:0061547,0.999999999991732,0.890023718061515,0,1,glycogen synthase activity, transferring glucose-1-phosphate,MF,
14357,GO:0061580,0.999999999991732,0.890023718061515,0,1,colon epithelial cell migration,BP,
14363,GO:0061598,0.999999999991732,0.890023718061515,0,1,molybdopterin adenylyltransferase activity,MF,
14364,GO:0061599,0.999999999991732,0.890023718061515,0,1,molybdopterin molybdotransferase activity,MF,
14372,GO:0061618,0.999999999991732,0.890023718061515,0,1,sublamina densa,CC,
14387,GO:0061642,0.999999999991732,0.890023718061515,0,1,chemoattraction of axon,BP,
14390,GO:0061646,0.999999999991732,0.890023718061515,0,1,positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization,BP,
14396,GO:0061663,0.999999999991732,0.890023718061515,0,1,NEDD8 ligase activity,MF,
14407,GO:0061697,0.999999999991732,0.890023718061515,0,1,protein-glutaryllysine deglutarylase activity,MF,
14408,GO:0061698,0.999999999991732,0.890023718061515,0,1,protein deglutarylation,BP,
14409,GO:0061699,0.999999999991732,0.890023718061515,0,1,peptidyl-lysine deglutarylation,BP,
14412,GO:0061709,0.999999999991732,0.890023718061515,0,1,reticulophagy,BP,
14414,GO:0061712,0.999999999991732,0.890023718061515,0,1,tRNA (N(6)-L-threonylcarbamoyladenosine(37)-C(2))-methylthiotransferase,MF,
14424,GO:0061736,0.999999999991732,0.890023718061515,0,1,engulfment of target by autophagosome,BP,
14435,GO:0061753,0.999999999991732,0.890023718061515,0,1,substrate localization to autophagosome,BP,
14442,GO:0061768,0.999999999991732,0.890023718061515,0,1,magnesium:sodium antiporter activity,MF,
14446,GO:0061772,0.999999999991732,0.890023718061515,0,1,drug transport across blood-nerve barrier,BP,
14448,GO:0061780,0.999999999991732,0.890023718061515,0,1,mitotic cohesin loading,BP,
14450,GO:0061789,0.999999999991732,0.890023718061515,0,1,dense core granule priming,BP,
14451,GO:0061792,0.999999999991732,0.890023718061515,0,1,secretory granule maturation,BP,
14452,GO:0061798,0.999999999991732,0.890023718061515,0,1,GTP 3',8'-cyclase activity,MF,
14453,GO:0061799,0.999999999991732,0.890023718061515,0,1,cyclic pyranopterin monophosphate synthase activity,MF,
14459,GO:0061825,0.999999999991732,0.890023718061515,0,1,podosome core,CC,
14461,GO:0061828,0.999999999991732,0.890023718061515,0,1,apical tubulobulbar complex,CC,
14462,GO:0061829,0.999999999991732,0.890023718061515,0,1,basal tubulobulbar complex,CC,
14466,GO:0061845,0.999999999991732,0.890023718061515,0,1,neuron projection branch point,CC,
14467,GO:0061846,0.999999999991732,0.890023718061515,0,1,dendritic spine cytoplasm,CC,
14480,GO:0061896,0.999999999991732,0.890023718061515,0,1,all-trans retinol 3,4-desaturase activity,MF,
14481,GO:0061897,0.999999999991732,0.890023718061515,0,1,all-trans retinal 3,4-desaturase activity,MF,
14482,GO:0061898,0.999999999991732,0.890023718061515,0,1,all-trans retinoic acid 3,4-desaturase activity,MF,
14483,GO:0061899,0.999999999991732,0.890023718061515,0,1,11-cis-retinal 3,4-desaturase activity,MF,
14487,GO:0061920,0.999999999991732,0.890023718061515,0,1,protein propionyltransferase activity,MF,
14488,GO:0061921,0.999999999991732,0.890023718061515,0,1,peptidyl-lysine propionylation,BP,
14489,GO:0061930,0.999999999991732,0.890023718061515,0,1,regulation of erythrocyte enucleation,BP,
14490,GO:0061931,0.999999999991732,0.890023718061515,0,1,positive regulation of erythrocyte enucleation,BP,
14491,GO:0061944,0.999999999991732,0.890023718061515,0,1,negative regulation of protein K48-linked ubiquitination,BP,
14539,GO:0070060,0.999999999991732,0.890023718061515,0,1,'de novo' actin filament nucleation,BP,
14549,GO:0070077,0.999999999991732,0.890023718061515,0,1,histone arginine demethylation,BP,
14550,GO:0070078,0.999999999991732,0.890023718061515,0,1,histone H3-R2 demethylation,BP,
14551,GO:0070079,0.999999999991732,0.890023718061515,0,1,histone H4-R3 demethylation,BP,
14561,GO:0070096,0.999999999991732,0.890023718061515,0,1,mitochondrial outer membrane translocase complex assembly,BP,
14572,GO:0070119,0.999999999991732,0.890023718061515,0,1,ciliary neurotrophic factor binding,MF,
14574,GO:0070121,0.999999999991732,0.890023718061515,0,1,Kupffer's vesicle development,BP,
14590,GO:0070143,0.999999999991732,0.890023718061515,0,1,mitochondrial alanyl-tRNA aminoacylation,BP,
14591,GO:0070145,0.999999999991732,0.890023718061515,0,1,mitochondrial asparaginyl-tRNA aminoacylation,BP,
14605,GO:0070171,0.999999999991732,0.890023718061515,0,1,negative regulation of tooth mineralization,BP,
14606,GO:0070172,0.999999999991732,0.890023718061515,0,1,positive regulation of tooth mineralization,BP,
14621,GO:0070195,0.999999999991732,0.890023718061515,0,1,growth hormone receptor complex,CC,
14632,GO:0070209,0.999999999991732,0.890023718061515,0,1,ASTRA complex,CC,
14660,GO:0070267,0.999999999991732,0.890023718061515,0,1,oncosis,BP,
14667,GO:0070280,0.999999999991732,0.890023718061515,0,1,pyridoxal binding,MF,
14673,GO:0070292,0.999999999991732,0.890023718061515,0,1,N-acylphosphatidylethanolamine metabolic process,BP,
14700,GO:0070335,0.999999999991732,0.890023718061515,0,1,aspartate binding,MF,
14702,GO:0070337,0.999999999991732,0.890023718061515,0,1,3'-flap-structured DNA binding,MF,
14706,GO:0070343,0.999999999991732,0.890023718061515,0,1,white fat cell proliferation,BP,
14710,GO:0070350,0.999999999991732,0.890023718061515,0,1,regulation of white fat cell proliferation,BP,
14734,GO:0070408,0.999999999991732,0.890023718061515,0,1,carbamoyl phosphate metabolic process,BP,
14735,GO:0070409,0.999999999991732,0.890023718061515,0,1,carbamoyl phosphate biosynthetic process,BP,
14741,GO:0070418,0.999999999991732,0.890023718061515,0,1,DNA-dependent protein kinase complex,CC,
14745,GO:0070425,0.999999999991732,0.890023718061515,0,1,negative regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
14748,GO:0070428,0.999999999991732,0.890023718061515,0,1,regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
14749,GO:0070429,0.999999999991732,0.890023718061515,0,1,negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
14752,GO:0070433,0.999999999991732,0.890023718061515,0,1,negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
14762,GO:0070460,0.999999999991732,0.890023718061515,0,1,thyroid-stimulating hormone secretion,BP,
14764,GO:0070463,0.999999999991732,0.890023718061515,0,1,tubulin-dependent ATPase activity,MF,
14772,GO:0070478,0.999999999991732,0.890023718061515,0,1,nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay,BP,
14775,GO:0070483,0.999999999991732,0.890023718061515,0,1,detection of hypoxia,BP,
14779,GO:0070489,0.999999999991732,0.890023718061515,0,1,T cell aggregation,BP,
14790,GO:0070510,0.999999999991732,0.890023718061515,0,1,regulation of histone H4-K20 methylation,BP,
14791,GO:0070512,0.999999999991732,0.890023718061515,0,1,positive regulation of histone H4-K20 methylation,BP,
14805,GO:0070539,0.999999999991732,0.890023718061515,0,1,linoleic acid binding,MF,
14810,GO:0070548,0.999999999991732,0.890023718061515,0,1,L-glutamine aminotransferase activity,MF,
14811,GO:0070550,0.999999999991732,0.890023718061515,0,1,rDNA condensation,BP,
14841,GO:0070593,0.999999999991732,0.890023718061515,0,1,dendrite self-avoidance,BP,
14852,GO:0070627,0.999999999991732,0.890023718061515,0,1,ferrous iron import,BP,
14895,GO:0070715,0.999999999991732,0.890023718061515,0,1,sodium-dependent organic cation transport,BP,
14898,GO:0070724,0.999999999991732,0.890023718061515,0,1,BMP receptor complex,CC,
14916,GO:0070774,0.999999999991732,0.890023718061515,0,1,phytoceramidase activity,MF,
14933,GO:0070826,0.999999999991732,0.890023718061515,0,1,paraferritin complex,CC,
14945,GO:0070843,0.999999999991732,0.890023718061515,0,1,misfolded protein transport,BP,
14946,GO:0070844,0.999999999991732,0.890023718061515,0,1,polyubiquitinated protein transport,BP,
14947,GO:0070845,0.999999999991732,0.890023718061515,0,1,polyubiquitinated misfolded protein transport,BP,
14948,GO:0070846,0.999999999991732,0.890023718061515,0,1,Hsp90 deacetylation,BP,
14955,GO:0070856,0.999999999991732,0.890023718061515,0,1,myosin VI light chain binding,MF,
14981,GO:0070898,0.999999999991732,0.890023718061515,0,1,RNA polymerase III transcriptional preinitiation complex assembly,BP,
14996,GO:0070926,0.999999999991732,0.890023718061515,0,1,regulation of ATP:ADP antiporter activity,BP,
14997,GO:0070931,0.999999999991732,0.890023718061515,0,1,Golgi-associated vesicle lumen,CC,
15027,GO:0070975,0.999999999991732,0.890023718061515,0,1,FHA domain binding,MF,
15033,GO:0070984,0.999999999991732,0.890023718061515,0,1,SET domain binding,MF,
15078,GO:0071062,0.999999999991732,0.890023718061515,0,1,alphav-beta3 integrin-vitronectin complex,CC,
15087,GO:0071105,0.999999999991732,0.890023718061515,0,1,response to interleukin-11,BP,
15105,GO:0071164,0.999999999991732,0.890023718061515,0,1,RNA trimethylguanosine synthase activity,MF,
15119,GO:0071215,0.999999999991732,0.890023718061515,0,1,cellular response to abscisic acid stimulus,BP,
15129,GO:0071226,0.999999999991732,0.890023718061515,0,1,cellular response to molecule of fungal origin,BP,
15144,GO:0071258,0.999999999991732,0.890023718061515,0,1,cellular response to gravity,BP,
15166,GO:0071301,0.999999999991732,0.890023718061515,0,1,cellular response to vitamin B1,BP,
15181,GO:0071324,0.999999999991732,0.890023718061515,0,1,cellular response to disaccharide stimulus,BP,
15183,GO:0071329,0.999999999991732,0.890023718061515,0,1,cellular response to sucrose stimulus,BP,
15196,GO:0071348,0.999999999991732,0.890023718061515,0,1,cellular response to interleukin-11,BP,
15226,GO:0071387,0.999999999991732,0.890023718061515,0,1,cellular response to cortisol stimulus,BP,
15230,GO:0071393,0.999999999991732,0.890023718061515,0,1,cellular response to progesterone stimulus,BP,
15261,GO:0071441,0.999999999991732,0.890023718061515,0,1,negative regulation of histone H3-K14 acetylation,BP,
15281,GO:0071471,0.999999999991732,0.890023718061515,0,1,cellular response to non-ionic osmotic stress,BP,
15294,GO:0071485,0.999999999991732,0.890023718061515,0,1,cellular response to absence of light,BP,
15295,GO:0071486,0.999999999991732,0.890023718061515,0,1,cellular response to high light intensity,BP,
15317,GO:0071540,0.999999999991732,0.890023718061515,0,1,eukaryotic translation initiation factor 3 complex, eIF3e,CC,
15334,GO:0071561,0.999999999991732,0.890023718061515,0,1,nucleus-vacuole junction,CC,
15358,GO:0071602,0.999999999991732,0.890023718061515,0,1,phytosphingosine biosynthetic process,BP,
15366,GO:0071612,0.999999999991732,0.890023718061515,0,1,IP-10 production,BP,
15374,GO:0071623,0.999999999991732,0.890023718061515,0,1,negative regulation of granulocyte chemotaxis,BP,
15397,GO:0071658,0.999999999991732,0.890023718061515,0,1,regulation of IP-10 production,BP,
15398,GO:0071660,0.999999999991732,0.890023718061515,0,1,positive regulation of IP-10 production,BP,
15400,GO:0071665,0.999999999991732,0.890023718061515,0,1,gamma-catenin-TCF7L2 complex,CC,
15409,GO:0071678,0.999999999991732,0.890023718061515,0,1,olfactory bulb axon guidance,BP,
15414,GO:0071684,0.999999999991732,0.890023718061515,0,1,organism emergence from protective structure,BP,
15416,GO:0071691,0.999999999991732,0.890023718061515,0,1,cardiac muscle thin filament assembly,BP,
15424,GO:0071701,0.999999999991732,0.890023718061515,0,1,regulation of MAPK export from nucleus,BP,
15437,GO:0071725,0.999999999991732,0.890023718061515,0,1,response to triacyl bacterial lipopeptide,BP,
15439,GO:0071727,0.999999999991732,0.890023718061515,0,1,cellular response to triacyl bacterial lipopeptide,BP,
15444,GO:0071765,0.999999999991732,0.890023718061515,0,1,nuclear inner membrane organization,BP,
15459,GO:0071802,0.999999999991732,0.890023718061515,0,1,negative regulation of podosome assembly,BP,
15472,GO:0071821,0.999999999991732,0.890023718061515,0,1,FANCM-MHF complex,CC,
15496,GO:0071873,0.999999999991732,0.890023718061515,0,1,response to norepinephrine,BP,
15497,GO:0071874,0.999999999991732,0.890023718061515,0,1,cellular response to norepinephrine stimulus,BP,
15500,GO:0071878,0.999999999991732,0.890023718061515,0,1,negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway,BP,
15519,GO:0071908,0.999999999991732,0.890023718061515,0,1,determination of intestine left/right asymmetry,BP,
15520,GO:0071909,0.999999999991732,0.890023718061515,0,1,determination of stomach left/right asymmetry,BP,
15522,GO:0071914,0.999999999991732,0.890023718061515,0,1,prominosome,CC,
15549,GO:0071988,0.999999999991732,0.890023718061515,0,1,protein localization to spindle pole body,BP,
15550,GO:0071997,0.999999999991732,0.890023718061515,0,1,glutathione S-conjugate-transporting ATPase activity,MF,
15552,GO:0072003,0.999999999991732,0.890023718061515,0,1,kidney rudiment formation,BP,
15553,GO:0072004,0.999999999991732,0.890023718061515,0,1,kidney field specification,BP,
15566,GO:0072025,0.999999999991732,0.890023718061515,0,1,distal convoluted tubule development,BP,
15570,GO:0072036,0.999999999991732,0.890023718061515,0,1,mesenchymal to epithelial transition involved in renal vesicle formation,BP,
15583,GO:0072060,0.999999999991732,0.890023718061515,0,1,outer medullary collecting duct development,BP,
15585,GO:0072069,0.999999999991732,0.890023718061515,0,1,DCT cell differentiation,BP,
15621,GO:0072114,0.999999999991732,0.890023718061515,0,1,pronephros morphogenesis,BP,
15660,GO:0072183,0.999999999991732,0.890023718061515,0,1,negative regulation of nephron tubule epithelial cell differentiation,BP,
15689,GO:0072221,0.999999999991732,0.890023718061515,0,1,metanephric distal convoluted tubule development,BP,
15698,GO:0072240,0.999999999991732,0.890023718061515,0,1,metanephric DCT cell differentiation,BP,
15718,GO:0072285,0.999999999991732,0.890023718061515,0,1,mesenchymal to epithelial transition involved in metanephric renal vesicle formation,BP,
15727,GO:0072304,0.999999999991732,0.890023718061515,0,1,regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
15728,GO:0072305,0.999999999991732,0.890023718061515,0,1,negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
15730,GO:0072308,0.999999999991732,0.890023718061515,0,1,negative regulation of metanephric nephron tubule epithelial cell differentiation,BP,
15731,GO:0072309,0.999999999991732,0.890023718061515,0,1,mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis,BP,
15757,GO:0072356,0.999999999991732,0.890023718061515,0,1,chromosome passenger complex localization to kinetochore,BP,
15762,GO:0072362,0.999999999991732,0.890023718061515,0,1,regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter,BP,
15765,GO:0072365,0.999999999991732,0.890023718061515,0,1,regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter,BP,
15773,GO:0072382,0.999999999991732,0.890023718061515,0,1,minus-end-directed vesicle transport along microtubule,BP,
15780,GO:0072389,0.999999999991732,0.890023718061515,0,1,flavin adenine dinucleotide catabolic process,BP,
15787,GO:0072414,0.999999999991732,0.890023718061515,0,1,response to mitotic cell cycle checkpoint signaling,BP,
15794,GO:0072432,0.999999999991732,0.890023718061515,0,1,response to G1 DNA damage checkpoint signaling,BP,
15808,GO:0072510,0.999999999991732,0.890023718061515,0,1,trivalent inorganic cation transmembrane transporter activity,MF,
15812,GO:0072517,0.999999999991732,0.890023718061515,0,1,host cell viral assembly compartment,CC,
15813,GO:0072518,0.999999999991732,0.890023718061515,0,1,Rho-dependent protein serine/threonine kinase activity,MF,
15826,GO:0072534,0.999999999991732,0.890023718061515,0,1,perineuronal net,CC,
15849,GO:0072570,0.999999999991732,0.890023718061515,0,1,ADP-D-ribose binding,MF,
15851,GO:0072573,0.999999999991732,0.890023718061515,0,1,tolerance induction to lipopolysaccharide,BP,
15857,GO:0072579,0.999999999991732,0.890023718061515,0,1,glycine receptor clustering,BP,
15861,GO:0072586,0.999999999991732,0.890023718061515,0,1,DNA topoisomerase (ATP-hydrolyzing) regulator activity,MF,
15862,GO:0072587,0.999999999991732,0.890023718061515,0,1,DNA topoisomerase (ATP-hydrolyzing) activator activity,MF,
15865,GO:0072590,0.999999999991732,0.890023718061515,0,1,N-acetyl-L-aspartate-L-glutamate ligase activity,MF,
15866,GO:0072591,0.999999999991732,0.890023718061515,0,1,citrate-L-glutamate ligase activity,MF,
15880,GO:0072616,0.999999999991732,0.890023718061515,0,1,interleukin-18 secretion,BP,
15881,GO:0072619,0.999999999991732,0.890023718061515,0,1,interleukin-21 secretion,BP,
15907,GO:0072682,0.999999999991732,0.890023718061515,0,1,eosinophil extravasation,BP,
15909,GO:0072684,0.999999999991732,0.890023718061515,0,1,mitochondrial tRNA 3'-trailer cleavage, endonucleolytic,BP,
15915,GO:0072702,0.999999999991732,0.890023718061515,0,1,response to methyl methanesulfonate,BP,
15916,GO:0072703,0.999999999991732,0.890023718061515,0,1,cellular response to methyl methanesulfonate,BP,
15939,GO:0072752,0.999999999991732,0.890023718061515,0,1,cellular response to rapamycin,BP,
15944,GO:0075109,0.999999999991732,0.890023718061515,0,1,modulation by symbiont of host receptor-mediated signal transduction,BP,
15945,GO:0075111,0.999999999991732,0.890023718061515,0,1,negative regulation by symbiont of host receptor-mediated signal transduction,BP,
15946,GO:0075112,0.999999999991732,0.890023718061515,0,1,modulation by symbiont of host transmembrane receptor-mediated signal transduction,BP,
15947,GO:0075114,0.999999999991732,0.890023718061515,0,1,negative regulation by symbiont of host transmembrane receptor-mediated signal transduction,BP,
16010,GO:0086024,0.999999999991732,0.890023718061515,0,1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in positive regulation of heart rate,BP,
16018,GO:0086039,0.999999999991732,0.890023718061515,0,1,calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential,MF,
16019,GO:0086040,0.999999999991732,0.890023718061515,0,1,sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential,MF,
16022,GO:0086044,0.999999999991732,0.890023718061515,0,1,atrial cardiac muscle cell to AV node cell communication by electrical coupling,BP,
16024,GO:0086046,0.999999999991732,0.890023718061515,0,1,membrane depolarization during SA node cell action potential,BP,
16025,GO:0086047,0.999999999991732,0.890023718061515,0,1,membrane depolarization during Purkinje myocyte cell action potential,BP,
16028,GO:0086054,0.999999999991732,0.890023718061515,0,1,bundle of His cell to Purkinje myocyte communication by electrical coupling,BP,
16029,GO:0086055,0.999999999991732,0.890023718061515,0,1,Purkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling,BP,
16030,GO:0086056,0.999999999991732,0.890023718061515,0,1,voltage-gated calcium channel activity involved in AV node cell action potential,MF,
16031,GO:0086057,0.999999999991732,0.890023718061515,0,1,voltage-gated calcium channel activity involved in bundle of His cell action potential,MF,
16042,GO:0086076,0.999999999991732,0.890023718061515,0,1,gap junction channel activity involved in atrial cardiac muscle cell-AV node cell electrical coupling,MF,
16044,GO:0086078,0.999999999991732,0.890023718061515,0,1,gap junction channel activity involved in bundle of His cell-Purkinje myocyte electrical coupling,MF,
16045,GO:0086079,0.999999999991732,0.890023718061515,0,1,gap junction channel activity involved in Purkinje myocyte-ventricular cardiac muscle cell electrical coupling,MF,
16051,GO:0086092,0.999999999991732,0.890023718061515,0,1,regulation of the force of heart contraction by cardiac conduction,BP,
16065,GO:0090024,0.999999999991732,0.890023718061515,0,1,negative regulation of neutrophil chemotaxis,BP,
16087,GO:0090067,0.999999999991732,0.890023718061515,0,1,regulation of thalamus size,BP,
16125,GO:0090119,0.999999999991732,0.890023718061515,0,1,vesicle-mediated cholesterol transport,BP,
16133,GO:0090138,0.999999999991732,0.890023718061515,0,1,regulation of actin cytoskeleton organization by cell-cell adhesion,BP,
16155,GO:0090176,0.999999999991732,0.890023718061515,0,1,microtubule cytoskeleton organization involved in establishment of planar polarity,BP,
16188,GO:0090212,0.999999999991732,0.890023718061515,0,1,negative regulation of establishment of blood-brain barrier,BP,
16209,GO:0090246,0.999999999991732,0.890023718061515,0,1,convergent extension involved in somitogenesis,BP,
16216,GO:0090260,0.999999999991732,0.890023718061515,0,1,negative regulation of retinal ganglion cell axon guidance,BP,
16232,GO:0090284,0.999999999991732,0.890023718061515,0,1,positive regulation of protein glycosylation in Golgi,BP,
16239,GO:0090291,0.999999999991732,0.890023718061515,0,1,negative regulation of osteoclast proliferation,BP,
16265,GO:0090326,0.999999999991732,0.890023718061515,0,1,positive regulation of locomotion involved in locomotory behavior,BP,
16266,GO:0090327,0.999999999991732,0.890023718061515,0,1,negative regulation of locomotion involved in locomotory behavior,BP,
16284,GO:0090370,0.999999999991732,0.890023718061515,0,1,negative regulation of cholesterol efflux,BP,
16291,GO:0090389,0.999999999991732,0.890023718061515,0,1,phagosome-lysosome fusion involved in apoptotic cell clearance,BP,
16306,GO:0090461,0.999999999991732,0.890023718061515,0,1,glutamate homeostasis,BP,
16307,GO:0090472,0.999999999991732,0.890023718061515,0,1,dibasic protein processing,BP,
16343,GO:0090600,0.999999999991732,0.890023718061515,0,1,alpha-1,3-glucosidase activity,MF,
16344,GO:0090601,0.999999999991732,0.890023718061515,0,1,enucleation,BP,
16347,GO:0090616,0.999999999991732,0.890023718061515,0,1,mitochondrial mRNA 3'-end processing,BP,
16363,GO:0090667,0.999999999991732,0.890023718061515,0,1,cell chemotaxis to vascular endothelial growth factor,BP,
16364,GO:0090668,0.999999999991732,0.890023718061515,0,1,endothelial cell chemotaxis to vascular endothelial growth factor,BP,
16369,GO:0090673,0.999999999991732,0.890023718061515,0,1,endothelial cell-matrix adhesion,BP,
16398,GO:0097020,0.999999999991732,0.890023718061515,0,1,COPII adaptor activity,MF,
16401,GO:0097026,0.999999999991732,0.890023718061515,0,1,dendritic cell dendrite assembly,BP,
16407,GO:0097037,0.999999999991732,0.890023718061515,0,1,heme export,BP,
16410,GO:0097045,0.999999999991732,0.890023718061515,0,1,phosphatidylserine exposure on blood platelet,BP,
16430,GO:0097070,0.999999999991732,0.890023718061515,0,1,ductus arteriosus closure,BP,
16432,GO:0097086,0.999999999991732,0.890023718061515,0,1,amniotic stem cell differentiation,BP,
16444,GO:0097108,0.999999999991732,0.890023718061515,0,1,hedgehog family protein binding,MF,
16448,GO:0097112,0.999999999991732,0.890023718061515,0,1,gamma-aminobutyric acid receptor clustering,BP,
16472,GO:0097156,0.999999999991732,0.890023718061515,0,1,fasciculation of motor neuron axon,BP,
16476,GO:0097161,0.999999999991732,0.890023718061515,0,1,DH domain binding,MF,
16477,GO:0097162,0.999999999991732,0.890023718061515,0,1,MADS box domain binding,MF,
16480,GO:0097166,0.999999999991732,0.890023718061515,0,1,lens epithelial cell proliferation,BP,
16482,GO:0097168,0.999999999991732,0.890023718061515,0,1,mesenchymal stem cell proliferation,BP,
16511,GO:0097222,0.999999999991732,0.890023718061515,0,1,mitochondrial mRNA polyadenylation,BP,
16520,GO:0097232,0.999999999991732,0.890023718061515,0,1,lamellar body membrane,CC,
16521,GO:0097233,0.999999999991732,0.890023718061515,0,1,alveolar lamellar body membrane,CC,
16531,GO:0097272,0.999999999991732,0.890023718061515,0,1,ammonia homeostasis,BP,
16532,GO:0097273,0.999999999991732,0.890023718061515,0,1,creatinine homeostasis,BP,
16534,GO:0097275,0.999999999991732,0.890023718061515,0,1,cellular ammonia homeostasis,BP,
16535,GO:0097276,0.999999999991732,0.890023718061515,0,1,cellular creatinine homeostasis,BP,
16536,GO:0097277,0.999999999991732,0.890023718061515,0,1,cellular urea homeostasis,BP,
16543,GO:0097298,0.999999999991732,0.890023718061515,0,1,regulation of nucleus size,BP,
16566,GO:0097356,0.999999999991732,0.890023718061515,0,1,perinucleolar compartment,CC,
16580,GO:0097382,0.999999999991732,0.890023718061515,0,1,deoxynucleoside-diphosphatase activity,MF,
16581,GO:0097383,0.999999999991732,0.890023718061515,0,1,dIDP diphosphatase activity,MF,
16584,GO:0097393,0.999999999991732,0.890023718061515,0,1,telomeric repeat-containing RNA transcription,BP,
16585,GO:0097394,0.999999999991732,0.890023718061515,0,1,telomeric repeat-containing RNA transcription by RNA polymerase II,BP,
16605,GO:0097442,0.999999999991732,0.890023718061515,0,1,CA3 pyramidal cell dendrite,CC,
16607,GO:0097444,0.999999999991732,0.890023718061515,0,1,spine apparatus,CC,
16621,GO:0097473,0.999999999991732,0.890023718061515,0,1,retinal rod cell apoptotic process,BP,
16634,GO:0097497,0.999999999991732,0.890023718061515,0,1,blood vessel endothelial cell delamination,BP,
16642,GO:0097505,0.999999999991732,0.890023718061515,0,1,Rad6-Rad18 complex,CC,
16673,GO:0097598,0.999999999991732,0.890023718061515,0,1,sperm cytoplasmic droplet,CC,
16675,GO:0097603,0.999999999991732,0.890023718061515,0,1,temperature-gated ion channel activity,MF,
16679,GO:0097625,0.999999999991732,0.890023718061515,0,1,low-affinity basic amino acid transmembrane transporter activity,MF,
16680,GO:0097626,0.999999999991732,0.890023718061515,0,1,low-affinity L-arginine transmembrane transporter activity,MF,
16681,GO:0097627,0.999999999991732,0.890023718061515,0,1,high-affinity L-ornithine transmembrane transporter activity,MF,
16690,GO:0097639,0.999999999991732,0.890023718061515,0,1,L-lysine import across plasma membrane,BP,
16691,GO:0097640,0.999999999991732,0.890023718061515,0,1,L-ornithine import across plasma membrane,BP,
16707,GO:0097692,0.999999999991732,0.890023718061515,0,1,histone H3-K4 monomethylation,BP,
16712,GO:0097699,0.999999999991732,0.890023718061515,0,1,vascular endothelial cell response to fluid shear stress,BP,
16732,GO:0097749,0.999999999991732,0.890023718061515,0,1,membrane tubulation,BP,
16734,GO:0097753,0.999999999991732,0.890023718061515,0,1,membrane bending,BP,
16748,GO:0098530,0.999999999991732,0.890023718061515,0,1,positive regulation of strand invasion,BP,
16770,GO:0098577,0.999999999991732,0.890023718061515,0,1,inactive sex chromosome,CC,
16785,GO:0098621,0.999999999991732,0.890023718061515,0,1,phosphoseryl-selenocysteinyl-tRNA selenium transferase activity,MF,
16786,GO:0098625,0.999999999991732,0.890023718061515,0,1,methylselenol reductase activity,MF,
16787,GO:0098626,0.999999999991732,0.890023718061515,0,1,methylseleninic acid reductase activity,MF,
16794,GO:0098637,0.999999999991732,0.890023718061515,0,1,protein complex involved in cell-matrix adhesion,CC,
16796,GO:0098640,0.999999999991732,0.890023718061515,0,1,integrin binding involved in cell-matrix adhesion,MF,
16804,GO:0098648,0.999999999991732,0.890023718061515,0,1,collagen anchoring fibril,CC,
16806,GO:0098652,0.999999999991732,0.890023718061515,0,1,collagen type VII anchoring fibril,CC,
16822,GO:0098705,0.999999999991732,0.890023718061515,0,1,copper ion import across plasma membrane,BP,
16835,GO:0098736,0.999999999991732,0.890023718061515,0,1,negative regulation of the force of heart contraction,BP,
16840,GO:0098746,0.999999999991732,0.890023718061515,0,1,fast, calcium ion-dependent exocytosis of neurotransmitter,BP,
16842,GO:0098749,0.999999999991732,0.890023718061515,0,1,cerebellar neuron development,BP,
16886,GO:0098829,0.999999999991732,0.890023718061515,0,1,intestinal folate absorption,BP,
16889,GO:0098833,0.999999999991732,0.890023718061515,0,1,presynaptic endocytic zone,CC,
16890,GO:0098835,0.999999999991732,0.890023718061515,0,1,presynaptic endocytic zone membrane,CC,
16909,GO:0098875,0.999999999991732,0.890023718061515,0,1,epididymosome,CC,
16916,GO:0098885,0.999999999991732,0.890023718061515,0,1,modification of postsynaptic actin cytoskeleton,BP,
16919,GO:0098888,0.999999999991732,0.890023718061515,0,1,extrinsic component of presynaptic membrane,CC,
16920,GO:0098889,0.999999999991732,0.890023718061515,0,1,intrinsic component of presynaptic membrane,CC,
16921,GO:0098890,0.999999999991732,0.890023718061515,0,1,extrinsic component of postsynaptic membrane,CC,
16928,GO:0098906,0.999999999991732,0.890023718061515,0,1,regulation of Purkinje myocyte action potential,BP,
16929,GO:0098907,0.999999999991732,0.890023718061515,0,1,regulation of SA node cell action potential,BP,
16934,GO:0098912,0.999999999991732,0.890023718061515,0,1,membrane depolarization during atrial cardiac muscle cell action potential,BP,
16944,GO:0098926,0.999999999991732,0.890023718061515,0,1,postsynaptic signal transduction,BP,
16951,GO:0098939,0.999999999991732,0.890023718061515,0,1,dendritic transport of mitochondrion,BP,
16953,GO:0098945,0.999999999991732,0.890023718061515,0,1,intrinsic component of presynaptic active zone membrane,CC,
16959,GO:0098968,0.999999999991732,0.890023718061515,0,1,neurotransmitter receptor transport postsynaptic membrane to endosome,BP,
16963,GO:0098972,0.999999999991732,0.890023718061515,0,1,anterograde dendritic transport of mitochondrion,BP,
16972,GO:0098988,0.999999999991732,0.890023718061515,0,1,G-protein coupled glutamate receptor activity,MF,
16982,GO:0099039,0.999999999991732,0.890023718061515,0,1,sphingolipid translocation,BP,
16988,GO:0099056,0.999999999991732,0.890023718061515,0,1,integral component of presynaptic membrane,CC,
16989,GO:0099059,0.999999999991732,0.890023718061515,0,1,integral component of presynaptic active zone membrane,CC,
16997,GO:0099077,0.999999999991732,0.890023718061515,0,1,histone-dependent DNA binding,MF,
17005,GO:0099089,0.999999999991732,0.890023718061515,0,1,establishment of endoplasmic reticulum localization to postsynapse,BP,
17008,GO:0099095,0.999999999991732,0.890023718061515,0,1,ligand-gated anion channel activity,MF,
17009,GO:0099098,0.999999999991732,0.890023718061515,0,1,microtubule polymerization based movement,BP,
17020,GO:0099159,0.999999999991732,0.890023718061515,0,1,regulation of modification of postsynaptic structure,BP,
17031,GO:0099243,0.999999999991732,0.890023718061515,0,1,extrinsic component of synaptic membrane,CC,
17052,GO:0099527,0.999999999991732,0.890023718061515,0,1,postsynapse to nucleus signaling pathway,BP,
17079,GO:0099580,0.999999999991732,0.890023718061515,0,1,ion antiporter activity involved in regulation of postsynaptic membrane potential,MF,
17086,GO:0099606,0.999999999991732,0.890023718061515,0,1,microtubule plus-end directed mitotic chromosome migration,BP,
17087,GO:0099607,0.999999999991732,0.890023718061515,0,1,lateral attachment of mitotic spindle microtubules to kinetochore,BP,
17090,GO:0099617,0.999999999991732,0.890023718061515,0,1,matrix side of mitochondrial inner membrane,CC,
17111,GO:0100057,0.999999999991732,0.890023718061515,0,1,regulation of phenotypic switching by transcription from RNA polymerase II promoter,BP,
17127,GO:0102113,0.999999999991732,0.890023718061515,0,1,hypoxia-inducible factor-asparagine oxygenase activity,MF,
17129,GO:0102131,0.999999999991732,0.890023718061515,0,1,3-oxo-glutaryl-[acp] methyl ester reductase activity,MF,
17130,GO:0102132,0.999999999991732,0.890023718061515,0,1,3-oxo-pimeloyl-[acp] methyl ester reductase activity,MF,
17133,GO:0102166,0.999999999991732,0.890023718061515,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity,MF,
17134,GO:0102167,0.999999999991732,0.890023718061515,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity,MF,
17135,GO:0102200,0.999999999991732,0.890023718061515,0,1,N-acetylphosphatidylethanolamine-hydrolysing phospholipas activity,MF,
17159,GO:0102500,0.999999999991732,0.890023718061515,0,1,beta-maltose 4-alpha-glucanotransferase activity,MF,
17165,GO:0102571,0.999999999991732,0.890023718061515,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity,MF,
17173,GO:0102773,0.999999999991732,0.890023718061515,0,1,dihydroceramide kinase activity,MF,
17174,GO:0102797,0.999999999991732,0.890023718061515,0,1,geranial:oxygen oxidoreductase activity,MF,
17175,GO:0102798,0.999999999991732,0.890023718061515,0,1,heptaldehyde:oxygen oxidoreductase activity,MF,
17194,GO:0106005,0.999999999991732,0.890023718061515,0,1,RNA 5'-cap (guanine-N7)-methylation,BP,
17201,GO:0106022,0.999999999991732,0.890023718061515,0,1,positive regulation of vesicle docking,BP,
17223,GO:0106088,0.999999999991732,0.890023718061515,0,1,regulation of cell adhesion involved in sprouting angiogenesis,BP,
17224,GO:0106089,0.999999999991732,0.890023718061515,0,1,negative regulation of cell adhesion involved in sprouting angiogenesis,BP,
17238,GO:0110028,0.999999999991732,0.890023718061515,0,1,positive regulation of mitotic spindle organization,BP,
17239,GO:0110029,0.999999999991732,0.890023718061515,0,1,negative regulation of meiosis I,BP,
17241,GO:0110057,0.999999999991732,0.890023718061515,0,1,regulation of blood vessel endothelial cell differentiation,BP,
17242,GO:0110059,0.999999999991732,0.890023718061515,0,1,negative regulation of blood vessel endothelial cell differentiation,BP,
17248,GO:0120012,0.999999999991732,0.890023718061515,0,1,intermembrane sphingolipid transfer,BP,
17250,GO:0120016,0.999999999991732,0.890023718061515,0,1,intermembrane sphingolipid transfer activity,MF,
17251,GO:0120017,0.999999999991732,0.890023718061515,0,1,intermembrane ceramide transfer activity,MF,
17261,GO:0120043,0.999999999991732,0.890023718061515,0,1,stereocilium shaft,CC,
17262,GO:0120044,0.999999999991732,0.890023718061515,0,1,stereocilium base,CC,
17270,GO:0120077,0.999999999991732,0.890023718061515,0,1,angiogenic sprout fusion,BP,
17271,GO:0120078,0.999999999991732,0.890023718061515,0,1,cell adhesion involved in sprouting angiogenesis,BP,
17272,GO:0120092,0.999999999991732,0.890023718061515,0,1,crotonyl-CoA hydratase activity,MF,
17273,GO:0120093,0.999999999991732,0.890023718061515,0,1,regulation of peptidyl-lysine crotonylation,BP,
17274,GO:0120094,0.999999999991732,0.890023718061515,0,1,negative regulation of peptidyl-lysine crotonylation,BP,
17280,GO:0140009,0.999999999991732,0.890023718061515,0,1,L-aspartate import across plasma membrane,BP,
17296,GO:0140064,0.999999999991732,0.890023718061515,0,1,peptide crotonyltransferase activity,MF,
17297,GO:0140065,0.999999999991732,0.890023718061515,0,1,peptide butyryltransferase activity,MF,
17299,GO:0140067,0.999999999991732,0.890023718061515,0,1,peptidyl-lysine butyrylation,BP,
17300,GO:0140068,0.999999999991732,0.890023718061515,0,1,histone crotonyltransferase activity,MF,
17301,GO:0140069,0.999999999991732,0.890023718061515,0,1,histone butyryltransferase activity,MF,
17302,GO:0140074,0.999999999991732,0.890023718061515,0,1,cardiac endothelial to mesenchymal transition,BP,
17323,GO:0140199,0.999999999991732,0.890023718061515,0,1,negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
17324,GO:0140200,0.999999999991732,0.890023718061515,0,1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in regulation of heart rate,BP,
17332,GO:0150031,0.999999999991732,0.890023718061515,0,1,regulation of protein localization to lysosome,BP,
17333,GO:0150033,0.999999999991732,0.890023718061515,0,1,negative regulation of protein localization to lysosome,BP,
17364,GO:1900062,0.999999999991732,0.890023718061515,0,1,regulation of replicative cell aging,BP,
17369,GO:1900081,0.999999999991732,0.890023718061515,0,1,regulation of arginine catabolic process,BP,
17370,GO:1900082,0.999999999991732,0.890023718061515,0,1,negative regulation of arginine catabolic process,BP,
17376,GO:1900095,0.999999999991732,0.890023718061515,0,1,regulation of dosage compensation by inactivation of X chromosome,BP,
17402,GO:1900130,0.999999999991732,0.890023718061515,0,1,regulation of lipid binding,BP,
17403,GO:1900131,0.999999999991732,0.890023718061515,0,1,negative regulation of lipid binding,BP,
17408,GO:1900139,0.999999999991732,0.890023718061515,0,1,negative regulation of arachidonic acid secretion,BP,
17415,GO:1900149,0.999999999991732,0.890023718061515,0,1,positive regulation of Schwann cell migration,BP,
17437,GO:1900200,0.999999999991732,0.890023718061515,0,1,mesenchymal cell apoptotic process involved in metanephros development,BP,
17438,GO:1900204,0.999999999991732,0.890023718061515,0,1,apoptotic process involved in metanephric collecting duct development,BP,
17439,GO:1900205,0.999999999991732,0.890023718061515,0,1,apoptotic process involved in metanephric nephron tubule development,BP,
17442,GO:1900211,0.999999999991732,0.890023718061515,0,1,regulation of mesenchymal cell apoptotic process involved in metanephros development,BP,
17443,GO:1900212,0.999999999991732,0.890023718061515,0,1,negative regulation of mesenchymal cell apoptotic process involved in metanephros development,BP,
17444,GO:1900214,0.999999999991732,0.890023718061515,0,1,regulation of apoptotic process involved in metanephric collecting duct development,BP,
17445,GO:1900215,0.999999999991732,0.890023718061515,0,1,negative regulation of apoptotic process involved in metanephric collecting duct development,BP,
17446,GO:1900217,0.999999999991732,0.890023718061515,0,1,regulation of apoptotic process involved in metanephric nephron tubule development,BP,
17447,GO:1900218,0.999999999991732,0.890023718061515,0,1,negative regulation of apoptotic process involved in metanephric nephron tubule development,BP,
17452,GO:1900224,0.999999999991732,0.890023718061515,0,1,positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
17460,GO:1900243,0.999999999991732,0.890023718061515,0,1,negative regulation of synaptic vesicle endocytosis,BP,
17475,GO:1900276,0.999999999991732,0.890023718061515,0,1,regulation of proteinase activated receptor activity,BP,
17481,GO:1900370,0.999999999991732,0.890023718061515,0,1,positive regulation of RNA interference,BP,
17515,GO:1900737,0.999999999991732,0.890023718061515,0,1,negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
17525,GO:1900753,0.999999999991732,0.890023718061515,0,1,doxorubicin transport,BP,
17555,GO:1901078,0.999999999991732,0.890023718061515,0,1,negative regulation of relaxation of muscle,BP,
17557,GO:1901086,0.999999999991732,0.890023718061515,0,1,benzylpenicillin metabolic process,BP,
17572,GO:1901147,0.999999999991732,0.890023718061515,0,1,mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
17590,GO:1901207,0.999999999991732,0.890023718061515,0,1,regulation of heart looping,BP,
17598,GO:1901228,0.999999999991732,0.890023718061515,0,1,positive regulation of transcription from RNA polymerase II promoter involved in heart development,BP,
17605,GO:1901254,0.999999999991732,0.890023718061515,0,1,positive regulation of intracellular transport of viral material,BP,
17634,GO:1901331,0.999999999991732,0.890023718061515,0,1,positive regulation of odontoblast differentiation,BP,
17638,GO:1901340,0.999999999991732,0.890023718061515,0,1,negative regulation of store-operated calcium channel activity,BP,
17643,GO:1901350,0.999999999991732,0.890023718061515,0,1,cell-cell signaling involved in cell-cell junction organization,BP,
17664,GO:1901419,0.999999999991732,0.890023718061515,0,1,regulation of response to alcohol,BP,
17665,GO:1901421,0.999999999991732,0.890023718061515,0,1,positive regulation of response to alcohol,BP,
17689,GO:1901551,0.999999999991732,0.890023718061515,0,1,negative regulation of endothelial cell development,BP,
17691,GO:1901555,0.999999999991732,0.890023718061515,0,1,response to paclitaxel,BP,
17705,GO:1901580,0.999999999991732,0.890023718061515,0,1,regulation of telomeric RNA transcription from RNA pol II promoter,BP,
17706,GO:1901581,0.999999999991732,0.890023718061515,0,1,negative regulation of telomeric RNA transcription from RNA pol II promoter,BP,
17707,GO:1901582,0.999999999991732,0.890023718061515,0,1,positive regulation of telomeric RNA transcription from RNA pol II promoter,BP,
17709,GO:1901594,0.999999999991732,0.890023718061515,0,1,response to capsazepine,BP,
17728,GO:1901639,0.999999999991732,0.890023718061515,0,1,XDP catabolic process,BP,
17729,GO:1901640,0.999999999991732,0.890023718061515,0,1,XTP binding,MF,
17730,GO:1901641,0.999999999991732,0.890023718061515,0,1,ITP binding,MF,
17750,GO:1901675,0.999999999991732,0.890023718061515,0,1,negative regulation of histone H3-K27 acetylation,BP,
17751,GO:1901676,0.999999999991732,0.890023718061515,0,1,positive regulation of histone H3-K27 acetylation,BP,
17754,GO:1901680,0.999999999991732,0.890023718061515,0,1,sulfur-containing amino acid secondary active transmembrane transporter activity,MF,
17769,GO:1901726,0.999999999991732,0.890023718061515,0,1,negative regulation of histone deacetylase activity,BP,
17810,GO:1901895,0.999999999991732,0.890023718061515,0,1,negative regulation of calcium-transporting ATPase activity,BP,
17813,GO:1901898,0.999999999991732,0.890023718061515,0,1,negative regulation of relaxation of cardiac muscle,BP,
17832,GO:1901980,0.999999999991732,0.890023718061515,0,1,positive regulation of inward rectifier potassium channel activity,BP,
17860,GO:1902038,0.999999999991732,0.890023718061515,0,1,positive regulation of hematopoietic stem cell differentiation,BP,
17874,GO:1902098,0.999999999991732,0.890023718061515,0,1,calcitriol binding,MF,
17889,GO:1902121,0.999999999991732,0.890023718061515,0,1,lithocholic acid binding,MF,
17900,GO:1902173,0.999999999991732,0.890023718061515,0,1,negative regulation of keratinocyte apoptotic process,BP,
17910,GO:1902203,0.999999999991732,0.890023718061515,0,1,negative regulation of hepatocyte growth factor receptor signaling pathway,BP,
17917,GO:1902216,0.999999999991732,0.890023718061515,0,1,positive regulation of interleukin-4-mediated signaling pathway,BP,
17935,GO:1902238,0.999999999991732,0.890023718061515,0,1,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
17936,GO:1902239,0.999999999991732,0.890023718061515,0,1,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
17941,GO:1902257,0.999999999991732,0.890023718061515,0,1,negative regulation of apoptotic process involved in outflow tract morphogenesis,BP,
17950,GO:1902271,0.999999999991732,0.890023718061515,0,1,D3 vitamins binding,MF,
17953,GO:1902283,0.999999999991732,0.890023718061515,0,1,negative regulation of primary amine oxidase activity,BP,
17958,GO:1902296,0.999999999991732,0.890023718061515,0,1,DNA strand elongation involved in cell cycle DNA replication,BP,
17962,GO:1902304,0.999999999991732,0.890023718061515,0,1,positive regulation of potassium ion export,BP,
17971,GO:1902319,0.999999999991732,0.890023718061515,0,1,DNA strand elongation involved in nuclear cell cycle DNA replication,BP,
17980,GO:1902363,0.999999999991732,0.890023718061515,0,1,regulation of protein localization to spindle pole body,BP,
17981,GO:1902365,0.999999999991732,0.890023718061515,0,1,positive regulation of protein localization to spindle pole body,BP,
17987,GO:1902379,0.999999999991732,0.890023718061515,0,1,chemoattractant activity involved in axon guidance,MF,
17992,GO:1902396,0.999999999991732,0.890023718061515,0,1,protein localization to bicellular tight junction,BP,
18005,GO:1902442,0.999999999991732,0.890023718061515,0,1,regulation of ripoptosome assembly involved in necroptotic process,BP,
18006,GO:1902443,0.999999999991732,0.890023718061515,0,1,negative regulation of ripoptosome assembly involved in necroptotic process,BP,
18010,GO:1902460,0.999999999991732,0.890023718061515,0,1,regulation of mesenchymal stem cell proliferation,BP,
18011,GO:1902462,0.999999999991732,0.890023718061515,0,1,positive regulation of mesenchymal stem cell proliferation,BP,
18013,GO:1902464,0.999999999991732,0.890023718061515,0,1,regulation of histone H3-K27 trimethylation,BP,
18014,GO:1902466,0.999999999991732,0.890023718061515,0,1,positive regulation of histone H3-K27 trimethylation,BP,
18020,GO:1902488,0.999999999991732,0.890023718061515,0,1,cholangiocyte apoptotic process,BP,
18036,GO:1902528,0.999999999991732,0.890023718061515,0,1,regulation of protein linear polyubiquitination,BP,
18037,GO:1902530,0.999999999991732,0.890023718061515,0,1,positive regulation of protein linear polyubiquitination,BP,
18073,GO:1902618,0.999999999991732,0.890023718061515,0,1,cellular response to fluoride,BP,
18075,GO:1902623,0.999999999991732,0.890023718061515,0,1,negative regulation of neutrophil migration,BP,
18093,GO:1902685,0.999999999991732,0.890023718061515,0,1,positive regulation of receptor localization to synapse,BP,
18098,GO:1902710,0.999999999991732,0.890023718061515,0,1,GABA receptor complex,CC,
18099,GO:1902711,0.999999999991732,0.890023718061515,0,1,GABA-A receptor complex,CC,
18106,GO:1902725,0.999999999991732,0.890023718061515,0,1,negative regulation of satellite cell differentiation,BP,
18109,GO:1902731,0.999999999991732,0.890023718061515,0,1,negative regulation of chondrocyte proliferation,BP,
18111,GO:1902737,0.999999999991732,0.890023718061515,0,1,dendritic filopodium,CC,
18123,GO:1902767,0.999999999991732,0.890023718061515,0,1,isoprenoid biosynthetic process via mevalonate,BP,
18140,GO:1902823,0.999999999991732,0.890023718061515,0,1,negative regulation of late endosome to lysosome transport,BP,
18142,GO:1902838,0.999999999991732,0.890023718061515,0,1,regulation of nuclear migration along microtubule,BP,
18143,GO:1902846,0.999999999991732,0.890023718061515,0,1,positive regulation of mitotic spindle elongation,BP,
18158,GO:1902889,0.999999999991732,0.890023718061515,0,1,protein localization to spindle microtubule,BP,
18170,GO:1902908,0.999999999991732,0.890023718061515,0,1,regulation of melanosome transport,BP,
18171,GO:1902910,0.999999999991732,0.890023718061515,0,1,positive regulation of melanosome transport,BP,
18174,GO:1902913,0.999999999991732,0.890023718061515,0,1,positive regulation of neuroepithelial cell differentiation,BP,
18185,GO:1902941,0.999999999991732,0.890023718061515,0,1,regulation of voltage-gated chloride channel activity,BP,
18186,GO:1902943,0.999999999991732,0.890023718061515,0,1,positive regulation of voltage-gated chloride channel activity,BP,
18198,GO:1902957,0.999999999991732,0.890023718061515,0,1,negative regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
18210,GO:1902983,0.999999999991732,0.890023718061515,0,1,DNA strand elongation involved in mitotic DNA replication,BP,
18224,GO:1903004,0.999999999991732,0.890023718061515,0,1,regulation of protein K63-linked deubiquitination,BP,
18225,GO:1903006,0.999999999991732,0.890023718061515,0,1,positive regulation of protein K63-linked deubiquitination,BP,
18226,GO:1903007,0.999999999991732,0.890023718061515,0,1,positive regulation of Lys63-specific deubiquitinase activity,BP,
18236,GO:1903027,0.999999999991732,0.890023718061515,0,1,regulation of opsonization,BP,
18237,GO:1903028,0.999999999991732,0.890023718061515,0,1,positive regulation of opsonization,BP,
18247,GO:1903045,0.999999999991732,0.890023718061515,0,1,neural crest cell migration involved in sympathetic nervous system development,BP,
18270,GO:1903108,0.999999999991732,0.890023718061515,0,1,regulation of mitochondrial transcription,BP,
18271,GO:1903109,0.999999999991732,0.890023718061515,0,1,positive regulation of mitochondrial transcription,BP,
18282,GO:1903141,0.999999999991732,0.890023718061515,0,1,negative regulation of establishment of endothelial barrier,BP,
18284,GO:1903143,0.999999999991732,0.890023718061515,0,1,adrenomedullin receptor complex,CC,
18327,GO:1903244,0.999999999991732,0.890023718061515,0,1,positive regulation of cardiac muscle hypertrophy in response to stress,BP,
18328,GO:1903248,0.999999999991732,0.890023718061515,0,1,regulation of citrulline biosynthetic process,BP,
18329,GO:1903249,0.999999999991732,0.890023718061515,0,1,negative regulation of citrulline biosynthetic process,BP,
18337,GO:1903282,0.999999999991732,0.890023718061515,0,1,regulation of glutathione peroxidase activity,BP,
18338,GO:1903284,0.999999999991732,0.890023718061515,0,1,positive regulation of glutathione peroxidase activity,BP,
18339,GO:1903285,0.999999999991732,0.890023718061515,0,1,positive regulation of hydrogen peroxide catabolic process,BP,
18366,GO:1903336,0.999999999991732,0.890023718061515,0,1,negative regulation of vacuolar transport,BP,
18387,GO:1903381,0.999999999991732,0.890023718061515,0,1,regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,BP,
18388,GO:1903382,0.999999999991732,0.890023718061515,0,1,negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,BP,
18392,GO:1903387,0.999999999991732,0.890023718061515,0,1,positive regulation of homophilic cell adhesion,BP,
18404,GO:1903420,0.999999999991732,0.890023718061515,0,1,protein localization to endoplasmic reticulum tubular network,BP,
18416,GO:1903434,0.999999999991732,0.890023718061515,0,1,negative regulation of constitutive secretory pathway,BP,
18423,GO:1903442,0.999999999991732,0.890023718061515,0,1,response to lipoic acid,BP,
18424,GO:1903444,0.999999999991732,0.890023718061515,0,1,negative regulation of brown fat cell differentiation,BP,
18443,GO:1903515,0.999999999991732,0.890023718061515,0,1,calcium ion transport from cytosol to endoplasmic reticulum,BP,
18466,GO:1903544,0.999999999991732,0.890023718061515,0,1,response to butyrate,BP,
18467,GO:1903545,0.999999999991732,0.890023718061515,0,1,cellular response to butyrate,BP,
18477,GO:1903565,0.999999999991732,0.890023718061515,0,1,negative regulation of protein localization to cilium,BP,
18480,GO:1903568,0.999999999991732,0.890023718061515,0,1,negative regulation of protein localization to ciliary membrane,BP,
18490,GO:1903584,0.999999999991732,0.890023718061515,0,1,regulation of histone deubiquitination,BP,
18491,GO:1903586,0.999999999991732,0.890023718061515,0,1,positive regulation of histone deubiquitination,BP,
18502,GO:1903613,0.999999999991732,0.890023718061515,0,1,regulation of protein tyrosine phosphatase activity,BP,
18503,GO:1903615,0.999999999991732,0.890023718061515,0,1,positive regulation of protein tyrosine phosphatase activity,BP,
18530,GO:1903697,0.999999999991732,0.890023718061515,0,1,negative regulation of microvillus assembly,BP,
18531,GO:1903699,0.999999999991732,0.890023718061515,0,1,tarsal gland development,BP,
18532,GO:1903701,0.999999999991732,0.890023718061515,0,1,substantia propria of cornea development,BP,
18537,GO:1903709,0.999999999991732,0.890023718061515,0,1,uterine gland development,BP,
18539,GO:1903717,0.999999999991732,0.890023718061515,0,1,response to ammonia,BP,
18540,GO:1903718,0.999999999991732,0.890023718061515,0,1,cellular response to ammonia,BP,
18545,GO:1903724,0.999999999991732,0.890023718061515,0,1,positive regulation of centriole elongation,BP,
18559,GO:1903759,0.999999999991732,0.890023718061515,0,1,signal transduction involved in regulation of aerobic respiration,BP,
18561,GO:1903762,0.999999999991732,0.890023718061515,0,1,positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,BP,
18563,GO:1903764,0.999999999991732,0.890023718061515,0,1,regulation of potassium ion export across plasma membrane,BP,
18580,GO:1903797,0.999999999991732,0.890023718061515,0,1,positive regulation of inorganic anion transmembrane transport,BP,
18612,GO:1903881,0.999999999991732,0.890023718061515,0,1,regulation of interleukin-17-mediated signaling pathway,BP,
18613,GO:1903883,0.999999999991732,0.890023718061515,0,1,positive regulation of interleukin-17-mediated signaling pathway,BP,
18614,GO:1903884,0.999999999991732,0.890023718061515,0,1,regulation of chemokine (C-C motif) ligand 20 production,BP,
18615,GO:1903886,0.999999999991732,0.890023718061515,0,1,positive regulation of chemokine (C-C motif) ligand 20 production,BP,
18638,GO:1903918,0.999999999991732,0.890023718061515,0,1,regulation of actin filament severing,BP,
18639,GO:1903919,0.999999999991732,0.890023718061515,0,1,negative regulation of actin filament severing,BP,
18645,GO:1903929,0.999999999991732,0.890023718061515,0,1,primary palate development,BP,
18648,GO:1903937,0.999999999991732,0.890023718061515,0,1,response to acrylamide,BP,
18649,GO:1903939,0.999999999991732,0.890023718061515,0,1,regulation of TORC2 signaling,BP,
18652,GO:1903947,0.999999999991732,0.890023718061515,0,1,positive regulation of ventricular cardiac muscle cell action potential,BP,
18654,GO:1903952,0.999999999991732,0.890023718061515,0,1,regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,BP,
18655,GO:1903954,0.999999999991732,0.890023718061515,0,1,positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,BP,
18680,GO:1904000,0.999999999991732,0.890023718061515,0,1,positive regulation of eating behavior,BP,
18686,GO:1904021,0.999999999991732,0.890023718061515,0,1,negative regulation of G-protein coupled receptor internalization,BP,
18699,GO:1904041,0.999999999991732,0.890023718061515,0,1,regulation of cystathionine beta-synthase activity,BP,
18700,GO:1904042,0.999999999991732,0.890023718061515,0,1,negative regulation of cystathionine beta-synthase activity,BP,
18705,GO:1904048,0.999999999991732,0.890023718061515,0,1,regulation of spontaneous neurotransmitter secretion,BP,
18706,GO:1904050,0.999999999991732,0.890023718061515,0,1,positive regulation of spontaneous neurotransmitter secretion,BP,
18707,GO:1904054,0.999999999991732,0.890023718061515,0,1,regulation of cholangiocyte proliferation,BP,
18708,GO:1904056,0.999999999991732,0.890023718061515,0,1,positive regulation of cholangiocyte proliferation,BP,
18711,GO:1904059,0.999999999991732,0.890023718061515,0,1,regulation of locomotor rhythm,BP,
18729,GO:1904155,0.999999999991732,0.890023718061515,0,1,DN2 thymocyte differentiation,BP,
18730,GO:1904156,0.999999999991732,0.890023718061515,0,1,DN3 thymocyte differentiation,BP,
18731,GO:1904167,0.999999999991732,0.890023718061515,0,1,regulation of thyroid hormone receptor activity,BP,
18732,GO:1904168,0.999999999991732,0.890023718061515,0,1,negative regulation of thyroid hormone receptor activity,BP,
18733,GO:1904170,0.999999999991732,0.890023718061515,0,1,regulation of bleb assembly,BP,
18734,GO:1904172,0.999999999991732,0.890023718061515,0,1,positive regulation of bleb assembly,BP,
18739,GO:1904192,0.999999999991732,0.890023718061515,0,1,regulation of cholangiocyte apoptotic process,BP,
18740,GO:1904193,0.999999999991732,0.890023718061515,0,1,negative regulation of cholangiocyte apoptotic process,BP,
18741,GO:1904195,0.999999999991732,0.890023718061515,0,1,regulation of granulosa cell proliferation,BP,
18742,GO:1904197,0.999999999991732,0.890023718061515,0,1,positive regulation of granulosa cell proliferation,BP,
18743,GO:1904199,0.999999999991732,0.890023718061515,0,1,positive regulation of regulation of vascular smooth muscle cell membrane depolarization,BP,
18744,GO:1904200,0.999999999991732,0.890023718061515,0,1,iodide transmembrane transport,BP,
18745,GO:1904201,0.999999999991732,0.890023718061515,0,1,regulation of iodide transport,BP,
18746,GO:1904202,0.999999999991732,0.890023718061515,0,1,negative regulation of iodide transport,BP,
18748,GO:1904205,0.999999999991732,0.890023718061515,0,1,negative regulation of skeletal muscle hypertrophy,BP,
18749,GO:1904206,0.999999999991732,0.890023718061515,0,1,positive regulation of skeletal muscle hypertrophy,BP,
18754,GO:1904212,0.999999999991732,0.890023718061515,0,1,regulation of iodide transmembrane transport,BP,
18755,GO:1904213,0.999999999991732,0.890023718061515,0,1,negative regulation of iodide transmembrane transport,BP,
18762,GO:1904229,0.999999999991732,0.890023718061515,0,1,regulation of succinate dehydrogenase activity,BP,
18763,GO:1904231,0.999999999991732,0.890023718061515,0,1,positive regulation of succinate dehydrogenase activity,BP,
18764,GO:1904232,0.999999999991732,0.890023718061515,0,1,regulation of aconitate hydratase activity,BP,
18765,GO:1904234,0.999999999991732,0.890023718061515,0,1,positive regulation of aconitate hydratase activity,BP,
18766,GO:1904235,0.999999999991732,0.890023718061515,0,1,regulation of substrate-dependent cell migration, cell attachment to substrate,BP,
18767,GO:1904237,0.999999999991732,0.890023718061515,0,1,positive regulation of substrate-dependent cell migration, cell attachment to substrate,BP,
18781,GO:1904265,0.999999999991732,0.890023718061515,0,1,ubiquitin-specific protease activity involved in negative regulation of retrograde protein transport, ER to cytosol,MF,
18782,GO:1904266,0.999999999991732,0.890023718061515,0,1,regulation of Schwann cell chemotaxis,BP,
18783,GO:1904268,0.999999999991732,0.890023718061515,0,1,positive regulation of Schwann cell chemotaxis,BP,
18790,GO:1904290,0.999999999991732,0.890023718061515,0,1,negative regulation of mitotic DNA damage checkpoint,BP,
18794,GO:1904298,0.999999999991732,0.890023718061515,0,1,regulation of transcytosis,BP,
18795,GO:1904300,0.999999999991732,0.890023718061515,0,1,positive regulation of transcytosis,BP,
18796,GO:1904301,0.999999999991732,0.890023718061515,0,1,regulation of maternal process involved in parturition,BP,
18797,GO:1904303,0.999999999991732,0.890023718061515,0,1,positive regulation of maternal process involved in parturition,BP,
18800,GO:1904313,0.999999999991732,0.890023718061515,0,1,response to methamphetamine hydrochloride,BP,
18802,GO:1904316,0.999999999991732,0.890023718061515,0,1,response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,BP,
18803,GO:1904317,0.999999999991732,0.890023718061515,0,1,cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,BP,
18809,GO:1904339,0.999999999991732,0.890023718061515,0,1,negative regulation of dopaminergic neuron differentiation,BP,
18836,GO:1904404,0.999999999991732,0.890023718061515,0,1,response to formaldehyde,BP,
18840,GO:1904412,0.999999999991732,0.890023718061515,0,1,regulation of cardiac ventricle development,BP,
18841,GO:1904414,0.999999999991732,0.890023718061515,0,1,positive regulation of cardiac ventricle development,BP,
18855,GO:1904447,0.999999999991732,0.890023718061515,0,1,folic acid import across plasma membrane,BP,
18856,GO:1904448,0.999999999991732,0.890023718061515,0,1,regulation of aspartate secretion,BP,
18857,GO:1904450,0.999999999991732,0.890023718061515,0,1,positive regulation of aspartate secretion,BP,
18858,GO:1904454,0.999999999991732,0.890023718061515,0,1,ubiquitin-specific protease activity involved in positive regulation of ERAD pathway,MF,
18867,GO:1904477,0.999999999991732,0.890023718061515,0,1,positive regulation of Ras GTPase binding,BP,
18872,GO:1904499,0.999999999991732,0.890023718061515,0,1,regulation of chromatin-mediated maintenance of transcription,BP,
18873,GO:1904501,0.999999999991732,0.890023718061515,0,1,positive regulation of chromatin-mediated maintenance of transcription,BP,
18878,GO:1904515,0.999999999991732,0.890023718061515,0,1,positive regulation of TORC2 signaling,BP,
18884,GO:1904531,0.999999999991732,0.890023718061515,0,1,positive regulation of actin filament binding,BP,
18887,GO:1904535,0.999999999991732,0.890023718061515,0,1,positive regulation of telomeric loop disassembly,BP,
18915,GO:1904594,0.999999999991732,0.890023718061515,0,1,regulation of termination of RNA polymerase II transcription,BP,
18916,GO:1904595,0.999999999991732,0.890023718061515,0,1,positive regulation of termination of RNA polymerase II transcription,BP,
18926,GO:1904618,0.999999999991732,0.890023718061515,0,1,positive regulation of actin binding,BP,
18934,GO:1904647,0.999999999991732,0.890023718061515,0,1,response to rotenone,BP,
18941,GO:1904674,0.999999999991732,0.890023718061515,0,1,positive regulation of somatic stem cell population maintenance,BP,
18982,GO:1904750,0.999999999991732,0.890023718061515,0,1,negative regulation of protein localization to nucleolus,BP,
18989,GO:1904762,0.999999999991732,0.890023718061515,0,1,positive regulation of myofibroblast differentiation,BP,
18991,GO:1904766,0.999999999991732,0.890023718061515,0,1,negative regulation of macroautophagy by TORC1 signaling,BP,
19001,GO:1904784,0.999999999991732,0.890023718061515,0,1,NLRP1 inflammasome complex assembly,BP,
19004,GO:1904793,0.999999999991732,0.890023718061515,0,1,regulation of euchromatin binding,BP,
19006,GO:1904797,0.999999999991732,0.890023718061515,0,1,negative regulation of core promoter binding,BP,
19008,GO:1904799,0.999999999991732,0.890023718061515,0,1,regulation of neuron remodeling,BP,
19009,GO:1904800,0.999999999991732,0.890023718061515,0,1,negative regulation of neuron remodeling,BP,
19013,GO:1904812,0.999999999991732,0.890023718061515,0,1,rRNA acetylation involved in maturation of SSU-rRNA,BP,
19019,GO:1904826,0.999999999991732,0.890023718061515,0,1,regulation of hydrogen sulfide biosynthetic process,BP,
19020,GO:1904828,0.999999999991732,0.890023718061515,0,1,positive regulation of hydrogen sulfide biosynthetic process,BP,
19034,GO:1904854,0.999999999991732,0.890023718061515,0,1,proteasome core complex binding,MF,
19046,GO:1904878,0.999999999991732,0.890023718061515,0,1,negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
19075,GO:1904933,0.999999999991732,0.890023718061515,0,1,regulation of cell proliferation in midbrain,BP,
19076,GO:1904934,0.999999999991732,0.890023718061515,0,1,negative regulation of cell proliferation in midbrain,BP,
19085,GO:1904955,0.999999999991732,0.890023718061515,0,1,planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation,BP,
19091,GO:1904971,0.999999999991732,0.890023718061515,0,1,regulation of viral translation,BP,
19092,GO:1904973,0.999999999991732,0.890023718061515,0,1,positive regulation of viral translation,BP,
19098,GO:1904980,0.999999999991732,0.890023718061515,0,1,positive regulation of endosome organization,BP,
19108,GO:1905000,0.999999999991732,0.890023718061515,0,1,regulation of membrane repolarization during atrial cardiac muscle cell action potential,BP,
19113,GO:1905026,0.999999999991732,0.890023718061515,0,1,positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
19115,GO:1905033,0.999999999991732,0.890023718061515,0,1,positive regulation of membrane repolarization during cardiac muscle cell action potential,BP,
19138,GO:1905069,0.999999999991732,0.890023718061515,0,1,allantois development,BP,
19144,GO:1905089,0.999999999991732,0.890023718061515,0,1,regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
19145,GO:1905090,0.999999999991732,0.890023718061515,0,1,negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
19148,GO:1905099,0.999999999991732,0.890023718061515,0,1,positive regulation of guanyl-nucleotide exchange factor activity,BP,
19149,GO:1905103,0.999999999991732,0.890023718061515,0,1,integral component of lysosomal membrane,CC,
19159,GO:1905152,0.999999999991732,0.890023718061515,0,1,positive regulation of voltage-gated sodium channel activity,BP,
19161,GO:1905154,0.999999999991732,0.890023718061515,0,1,negative regulation of membrane invagination,BP,
19163,GO:1905161,0.999999999991732,0.890023718061515,0,1,protein localization to phagocytic vesicle,BP,
19164,GO:1905162,0.999999999991732,0.890023718061515,0,1,regulation of phagosome maturation,BP,
19168,GO:1905168,0.999999999991732,0.890023718061515,0,1,positive regulation of double-strand break repair via homologous recombination,BP,
19169,GO:1905169,0.999999999991732,0.890023718061515,0,1,regulation of protein localization to phagocytic vesicle,BP,
19170,GO:1905171,0.999999999991732,0.890023718061515,0,1,positive regulation of protein localization to phagocytic vesicle,BP,
19171,GO:1905172,0.999999999991732,0.890023718061515,0,1,RISC complex binding,MF,
19177,GO:1905205,0.999999999991732,0.890023718061515,0,1,positive regulation of connective tissue replacement,BP,
19186,GO:1905223,0.999999999991732,0.890023718061515,0,1,epicardium morphogenesis,BP,
19189,GO:1905242,0.999999999991732,0.890023718061515,0,1,response to 3,3',5-triiodo-L-thyronine,BP,
19194,GO:1905255,0.999999999991732,0.890023718061515,0,1,regulation of RNA binding transcription factor activity,BP,
19202,GO:1905274,0.999999999991732,0.890023718061515,0,1,regulation of modification of postsynaptic actin cytoskeleton,BP,
19207,GO:1905285,0.999999999991732,0.890023718061515,0,1,fibrous ring of heart morphogenesis,BP,
19212,GO:1905301,0.999999999991732,0.890023718061515,0,1,regulation of macropinocytosis,BP,
19213,GO:1905302,0.999999999991732,0.890023718061515,0,1,negative regulation of macropinocytosis,BP,
19214,GO:1905304,0.999999999991732,0.890023718061515,0,1,regulation of cardiac myofibril assembly,BP,
19215,GO:1905305,0.999999999991732,0.890023718061515,0,1,negative regulation of cardiac myofibril assembly,BP,
19216,GO:1905309,0.999999999991732,0.890023718061515,0,1,positive regulation of cohesin loading,BP,
19221,GO:1905317,0.999999999991732,0.890023718061515,0,1,inferior endocardial cushion morphogenesis,BP,
19230,GO:1905335,0.999999999991732,0.890023718061515,0,1,regulation of aggrephagy,BP,
19231,GO:1905337,0.999999999991732,0.890023718061515,0,1,positive regulation of aggrephagy,BP,
19239,GO:1905355,0.999999999991732,0.890023718061515,0,1,spine apparatus assembly,BP,
19259,GO:1905405,0.999999999991732,0.890023718061515,0,1,regulation of mitotic cohesin loading,BP,
19260,GO:1905406,0.999999999991732,0.890023718061515,0,1,positive regulation of mitotic cohesin loading,BP,
19271,GO:1905438,0.999999999991732,0.890023718061515,0,1,non-canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
19272,GO:1905443,0.999999999991732,0.890023718061515,0,1,regulation of clathrin coat assembly,BP,
19273,GO:1905445,0.999999999991732,0.890023718061515,0,1,positive regulation of clathrin coat assembly,BP,
19275,GO:1905447,0.999999999991732,0.890023718061515,0,1,negative regulation of mitochondrial ATP synthesis coupled electron transport,BP,
19281,GO:1905458,0.999999999991732,0.890023718061515,0,1,positive regulation of lymphoid progenitor cell differentiation,BP,
19285,GO:1905463,0.999999999991732,0.890023718061515,0,1,negative regulation of DNA duplex unwinding,BP,
19286,GO:1905464,0.999999999991732,0.890023718061515,0,1,positive regulation of DNA duplex unwinding,BP,
19287,GO:1905468,0.999999999991732,0.890023718061515,0,1,regulation of clathrin-coated pit assembly,BP,
19288,GO:1905469,0.999999999991732,0.890023718061515,0,1,negative regulation of clathrin-coated pit assembly,BP,
19301,GO:1905524,0.999999999991732,0.890023718061515,0,1,negative regulation of protein autoubiquitination,BP,
19302,GO:1905535,0.999999999991732,0.890023718061515,0,1,regulation of eukaryotic translation initiation factor 4F complex assembly,BP,
19303,GO:1905537,0.999999999991732,0.890023718061515,0,1,positive regulation of eukaryotic translation initiation factor 4F complex assembly,BP,
19334,GO:1905610,0.999999999991732,0.890023718061515,0,1,regulation of mRNA cap binding,BP,
19335,GO:1905612,0.999999999991732,0.890023718061515,0,1,positive regulation of mRNA cap binding,BP,
19341,GO:1905643,0.999999999991732,0.890023718061515,0,1,positive regulation of DNA methylation,BP,
19352,GO:1905687,0.999999999991732,0.890023718061515,0,1,regulation of diacylglycerol kinase activity,BP,
19353,GO:1905689,0.999999999991732,0.890023718061515,0,1,positive regulation of diacylglycerol kinase activity,BP,
19355,GO:1905698,0.999999999991732,0.890023718061515,0,1,positive regulation of polysome binding,BP,
19356,GO:1905705,0.999999999991732,0.890023718061515,0,1,cellular response to paclitaxel,BP,
19359,GO:1905711,0.999999999991732,0.890023718061515,0,1,response to phosphatidylethanolamine,BP,
19363,GO:1905720,0.999999999991732,0.890023718061515,0,1,cytoplasmic microtubule bundle,CC,
19366,GO:1905767,0.999999999991732,0.890023718061515,0,1,regulation of double-stranded telomeric DNA binding,BP,
19367,GO:1905768,0.999999999991732,0.890023718061515,0,1,negative regulation of double-stranded telomeric DNA binding,BP,
19371,GO:1905774,0.999999999991732,0.890023718061515,0,1,regulation of DNA helicase activity,BP,
19372,GO:1905776,0.999999999991732,0.890023718061515,0,1,positive regulation of DNA helicase activity,BP,
19377,GO:1905794,0.999999999991732,0.890023718061515,0,1,response to puromycin,BP,
19378,GO:1905795,0.999999999991732,0.890023718061515,0,1,cellular response to puromycin,BP,
19387,GO:1905843,0.999999999991732,0.890023718061515,0,1,regulation of cellular response to gamma radiation,BP,
19395,GO:1905878,0.999999999991732,0.890023718061515,0,1,invadopodium disassembly,BP,
19415,GO:1905927,0.999999999991732,0.890023718061515,0,1,regulation of invadopodium disassembly,BP,
19416,GO:1905929,0.999999999991732,0.890023718061515,0,1,positive regulation of invadopodium disassembly,BP,
19428,GO:1905957,0.999999999991732,0.890023718061515,0,1,regulation of cellular response to alcohol,BP,
19429,GO:1905959,0.999999999991732,0.890023718061515,0,1,positive regulation of cellular response to alcohol,BP,
19433,GO:1990003,0.999999999991732,0.890023718061515,0,1,IDP phosphatase activity,MF,
19436,GO:1990009,0.999999999991732,0.890023718061515,0,1,retinal cell apoptotic process,BP,
19439,GO:1990029,0.999999999991732,0.890023718061515,0,1,vasomotion,BP,
19441,GO:1990032,0.999999999991732,0.890023718061515,0,1,parallel fiber,CC,
19443,GO:1990036,0.999999999991732,0.890023718061515,0,1,calcium ion import into sarcoplasmic reticulum,BP,
19450,GO:1990051,0.999999999991732,0.890023718061515,0,1,activation of protein kinase C activity,BP,
19454,GO:1990074,0.999999999991732,0.890023718061515,0,1,polyuridylation-dependent mRNA catabolic process,BP,
19466,GO:1990127,0.999999999991732,0.890023718061515,0,1,intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
19469,GO:1990134,0.999999999991732,0.890023718061515,0,1,epithelial cell apoptotic process involved in palatal shelf morphogenesis,BP,
19481,GO:1990172,0.999999999991732,0.890023718061515,0,1,G-protein coupled receptor catabolic process,BP,
19483,GO:1990174,0.999999999991732,0.890023718061515,0,1,phosphodiesterase decapping endonuclease activity,MF,
19499,GO:1990256,0.999999999991732,0.890023718061515,0,1,signal clustering,BP,
19508,GO:1990280,0.999999999991732,0.890023718061515,0,1,RNA localization to chromatin,BP,
19512,GO:1990332,0.999999999991732,0.890023718061515,0,1,Ire1 complex,CC,
19521,GO:1990390,0.999999999991732,0.890023718061515,0,1,protein K33-linked ubiquitination,BP,
19533,GO:1990409,0.999999999991732,0.890023718061515,0,1,adrenomedullin binding,MF,
19539,GO:1990421,0.999999999991732,0.890023718061515,0,1,subtelomeric heterochromatin,CC,
19543,GO:1990427,0.999999999991732,0.890023718061515,0,1,stereocilia tip-link density,CC,
19547,GO:1990435,0.999999999991732,0.890023718061515,0,1,upper tip-link density,CC,
19553,GO:1990448,0.999999999991732,0.890023718061515,0,1,exon-exon junction complex binding,MF,
19557,GO:1990456,0.999999999991732,0.890023718061515,0,1,mitochondrion-endoplasmic reticulum membrane tethering,BP,
19563,GO:1990502,0.999999999991732,0.890023718061515,0,1,dense core granule maturation,BP,
19567,GO:1990518,0.999999999991732,0.890023718061515,0,1,single-stranded DNA-dependent ATP-dependent 3'-5' DNA helicase activity,MF,
19580,GO:1990578,0.999999999991732,0.890023718061515,0,1,perinuclear endoplasmic reticulum membrane,CC,
19581,GO:1990579,0.999999999991732,0.890023718061515,0,1,peptidyl-serine trans-autophosphorylation,BP,
19588,GO:1990603,0.999999999991732,0.890023718061515,0,1,dark adaptation,BP,
19590,GO:1990613,0.999999999991732,0.890023718061515,0,1,mitochondrial membrane fusion,BP,
19594,GO:1990630,0.999999999991732,0.890023718061515,0,1,IRE1-RACK1-PP2A complex,CC,
19599,GO:1990654,0.999999999991732,0.890023718061515,0,1,sebum secreting cell proliferation,BP,
19605,GO:1990700,0.999999999991732,0.890023718061515,0,1,nucleolar chromatin organization,BP,
19606,GO:1990705,0.999999999991732,0.890023718061515,0,1,cholangiocyte proliferation,BP,
19607,GO:1990707,0.999999999991732,0.890023718061515,0,1,nuclear subtelomeric heterochromatin,CC,
19615,GO:1990736,0.999999999991732,0.890023718061515,0,1,regulation of vascular smooth muscle cell membrane depolarization,BP,
19618,GO:1990739,0.999999999991732,0.890023718061515,0,1,granulosa cell proliferation,BP,
19624,GO:1990751,0.999999999991732,0.890023718061515,0,1,Schwann cell chemotaxis,BP,
19640,GO:1990784,0.999999999991732,0.890023718061515,0,1,response to dsDNA,BP,
19642,GO:1990786,0.999999999991732,0.890023718061515,0,1,cellular response to dsDNA,BP,
19665,GO:1990876,0.999999999991732,0.890023718061515,0,1,cytoplasmic side of nuclear pore,CC,
19667,GO:1990882,0.999999999991732,0.890023718061515,0,1,rRNA acetylation,BP,
19668,GO:1990883,0.999999999991732,0.890023718061515,0,1,rRNA cytidine N-acetyltransferase activity,MF,
19669,GO:1990884,0.999999999991732,0.890023718061515,0,1,RNA acetylation,BP,
19680,GO:1990926,0.999999999991732,0.890023718061515,0,1,short-term synaptic potentiation,BP,
19684,GO:1990931,0.999999999991732,0.890023718061515,0,1,RNA N6-methyladenosine dioxygenase activity,MF,
19686,GO:1990938,0.999999999991732,0.890023718061515,0,1,peptidyl-aspartic acid autophosphorylation,BP,
19689,GO:1990955,0.999999999991732,0.890023718061515,0,1,G-rich single-stranded DNA binding,MF,
19692,GO:1990968,0.999999999991732,0.890023718061515,0,1,modulation by host of RNA binding by virus,BP,
19693,GO:1990969,0.999999999991732,0.890023718061515,0,1,modulation by host of viral RNA-binding transcription factor activity,BP,
19694,GO:1990971,0.999999999991732,0.890023718061515,0,1,EMILIN complex,CC,
19712,GO:2000019,0.999999999991732,0.890023718061515,0,1,negative regulation of male gonad development,BP,
19718,GO:2000040,0.999999999991732,0.890023718061515,0,1,regulation of planar cell polarity pathway involved in axis elongation,BP,
19719,GO:2000041,0.999999999991732,0.890023718061515,0,1,negative regulation of planar cell polarity pathway involved in axis elongation,BP,
19729,GO:2000054,0.999999999991732,0.890023718061515,0,1,negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
19730,GO:2000055,0.999999999991732,0.890023718061515,0,1,positive regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
19736,GO:2000066,0.999999999991732,0.890023718061515,0,1,positive regulation of cortisol biosynthetic process,BP,
19741,GO:2000079,0.999999999991732,0.890023718061515,0,1,regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,
19742,GO:2000080,0.999999999991732,0.890023718061515,0,1,negative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,
19746,GO:2000098,0.999999999991732,0.890023718061515,0,1,negative regulation of smooth muscle cell-matrix adhesion,BP,
19760,GO:2000118,0.999999999991732,0.890023718061515,0,1,regulation of sodium-dependent phosphate transport,BP,
19777,GO:2000167,0.999999999991732,0.890023718061515,0,1,regulation of planar cell polarity pathway involved in neural tube closure,BP,
19781,GO:2000173,0.999999999991732,0.890023718061515,0,1,negative regulation of branching morphogenesis of a nerve,BP,
19782,GO:2000174,0.999999999991732,0.890023718061515,0,1,regulation of pro-T cell differentiation,BP,
19783,GO:2000176,0.999999999991732,0.890023718061515,0,1,positive regulation of pro-T cell differentiation,BP,
19803,GO:2000211,0.999999999991732,0.890023718061515,0,1,regulation of glutamate metabolic process,BP,
19804,GO:2000212,0.999999999991732,0.890023718061515,0,1,negative regulation of glutamate metabolic process,BP,
19805,GO:2000224,0.999999999991732,0.890023718061515,0,1,regulation of testosterone biosynthetic process,BP,
19806,GO:2000225,0.999999999991732,0.890023718061515,0,1,negative regulation of testosterone biosynthetic process,BP,
19839,GO:2000283,0.999999999991732,0.890023718061515,0,1,negative regulation of cellular amino acid biosynthetic process,BP,
19844,GO:2000295,0.999999999991732,0.890023718061515,0,1,regulation of hydrogen peroxide catabolic process,BP,
19847,GO:2000299,0.999999999991732,0.890023718061515,0,1,negative regulation of Rho-dependent protein serine/threonine kinase activity,BP,
19869,GO:2000325,0.999999999991732,0.890023718061515,0,1,regulation of ligand-dependent nuclear receptor transcription coactivator activity,BP,
19870,GO:2000327,0.999999999991732,0.890023718061515,0,1,positive regulation of ligand-dependent nuclear receptor transcription coactivator activity,BP,
19874,GO:2000331,0.999999999991732,0.890023718061515,0,1,regulation of terminal button organization,BP,
19887,GO:2000349,0.999999999991732,0.890023718061515,0,1,negative regulation of CD40 signaling pathway,BP,
19895,GO:2000361,0.999999999991732,0.890023718061515,0,1,regulation of prostaglandin-E synthase activity,BP,
19896,GO:2000363,0.999999999991732,0.890023718061515,0,1,positive regulation of prostaglandin-E synthase activity,BP,
19909,GO:2000382,0.999999999991732,0.890023718061515,0,1,positive regulation of mesoderm development,BP,
19910,GO:2000383,0.999999999991732,0.890023718061515,0,1,regulation of ectoderm development,BP,
19911,GO:2000384,0.999999999991732,0.890023718061515,0,1,negative regulation of ectoderm development,BP,
19926,GO:2000405,0.999999999991732,0.890023718061515,0,1,negative regulation of T cell migration,BP,
19935,GO:2000417,0.999999999991732,0.890023718061515,0,1,negative regulation of eosinophil migration,BP,
19937,GO:2000419,0.999999999991732,0.890023718061515,0,1,regulation of eosinophil extravasation,BP,
19938,GO:2000420,0.999999999991732,0.890023718061515,0,1,negative regulation of eosinophil extravasation,BP,
19942,GO:2000426,0.999999999991732,0.890023718061515,0,1,negative regulation of apoptotic cell clearance,BP,
19955,GO:2000468,0.999999999991732,0.890023718061515,0,1,regulation of peroxidase activity,BP,
19956,GO:2000470,0.999999999991732,0.890023718061515,0,1,positive regulation of peroxidase activity,BP,
19957,GO:2000474,0.999999999991732,0.890023718061515,0,1,regulation of opioid receptor signaling pathway,BP,
19966,GO:2000491,0.999999999991732,0.890023718061515,0,1,positive regulation of hepatic stellate cell activation,BP,
19982,GO:2000536,0.999999999991732,0.890023718061515,0,1,negative regulation of entry of bacterium into host cell,BP,
19983,GO:2000537,0.999999999991732,0.890023718061515,0,1,regulation of B cell chemotaxis,BP,
19984,GO:2000538,0.999999999991732,0.890023718061515,0,1,positive regulation of B cell chemotaxis,BP,
19999,GO:2000569,0.999999999991732,0.890023718061515,0,1,regulation of T-helper 2 cell activation,BP,
20000,GO:2000570,0.999999999991732,0.890023718061515,0,1,positive regulation of T-helper 2 cell activation,BP,
20006,GO:2000583,0.999999999991732,0.890023718061515,0,1,regulation of platelet-derived growth factor receptor-alpha signaling pathway,BP,
20007,GO:2000584,0.999999999991732,0.890023718061515,0,1,negative regulation of platelet-derived growth factor receptor-alpha signaling pathway,BP,
20013,GO:2000592,0.999999999991732,0.890023718061515,0,1,regulation of metanephric DCT cell differentiation,BP,
20014,GO:2000594,0.999999999991732,0.890023718061515,0,1,positive regulation of metanephric DCT cell differentiation,BP,
20020,GO:2000612,0.999999999991732,0.890023718061515,0,1,regulation of thyroid-stimulating hormone secretion,BP,
20033,GO:2000631,0.999999999991732,0.890023718061515,0,1,regulation of pre-miRNA processing,BP,
20034,GO:2000632,0.999999999991732,0.890023718061515,0,1,negative regulation of pre-miRNA processing,BP,
20050,GO:2000654,0.999999999991732,0.890023718061515,0,1,regulation of cellular response to testosterone stimulus,BP,
20051,GO:2000655,0.999999999991732,0.890023718061515,0,1,negative regulation of cellular response to testosterone stimulus,BP,
20056,GO:2000661,0.999999999991732,0.890023718061515,0,1,positive regulation of interleukin-1-mediated signaling pathway,BP,
20058,GO:2000663,0.999999999991732,0.890023718061515,0,1,negative regulation of interleukin-5 secretion,BP,
20076,GO:2000690,0.999999999991732,0.890023718061515,0,1,regulation of cardiac muscle cell myoblast differentiation,BP,
20077,GO:2000691,0.999999999991732,0.890023718061515,0,1,negative regulation of cardiac muscle cell myoblast differentiation,BP,
20086,GO:2000706,0.999999999991732,0.890023718061515,0,1,negative regulation of dense core granule biogenesis,BP,
20090,GO:2000721,0.999999999991732,0.890023718061515,0,1,positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,
20102,GO:2000740,0.999999999991732,0.890023718061515,0,1,negative regulation of mesenchymal stem cell differentiation,BP,
20113,GO:2000759,0.999999999991732,0.890023718061515,0,1,regulation of N-terminal peptidyl-lysine acetylation,BP,
20114,GO:2000761,0.999999999991732,0.890023718061515,0,1,positive regulation of N-terminal peptidyl-lysine acetylation,BP,
20134,GO:2000795,0.999999999991732,0.890023718061515,0,1,negative regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
20135,GO:2000797,0.999999999991732,0.890023718061515,0,1,regulation of amniotic stem cell differentiation,BP,
20136,GO:2000798,0.999999999991732,0.890023718061515,0,1,negative regulation of amniotic stem cell differentiation,BP,
20137,GO:2000804,0.999999999991732,0.890023718061515,0,1,regulation of termination of RNA polymerase II transcription, poly(A)-coupled,BP,
20138,GO:2000806,0.999999999991732,0.890023718061515,0,1,positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled,BP,
20140,GO:2000808,0.999999999991732,0.890023718061515,0,1,negative regulation of synaptic vesicle clustering,BP,
20144,GO:2000812,0.999999999991732,0.890023718061515,0,1,regulation of barbed-end actin filament capping,BP,
20147,GO:2000820,0.999999999991732,0.890023718061515,0,1,negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,
20159,GO:2000834,0.999999999991732,0.890023718061515,0,1,regulation of androgen secretion,BP,
20160,GO:2000836,0.999999999991732,0.890023718061515,0,1,positive regulation of androgen secretion,BP,
20161,GO:2000843,0.999999999991732,0.890023718061515,0,1,regulation of testosterone secretion,BP,
20162,GO:2000845,0.999999999991732,0.890023718061515,0,1,positive regulation of testosterone secretion,BP,
20173,GO:2000864,0.999999999991732,0.890023718061515,0,1,regulation of estradiol secretion,BP,
20202,GO:2001029,0.999999999991732,0.890023718061515,0,1,regulation of cellular glucuronidation,BP,
20203,GO:2001031,0.999999999991732,0.890023718061515,0,1,positive regulation of cellular glucuronidation,BP,
20225,GO:2001108,0.999999999991732,0.890023718061515,0,1,positive regulation of Rho guanyl-nucleotide exchange factor activity,BP,
20226,GO:2001109,0.999999999991732,0.890023718061515,0,1,regulation of lens epithelial cell proliferation,BP,
20227,GO:2001111,0.999999999991732,0.890023718061515,0,1,positive regulation of lens epithelial cell proliferation,BP,
20228,GO:2001112,0.999999999991732,0.890023718061515,0,1,regulation of cellular response to hepatocyte growth factor stimulus,BP,
20229,GO:2001113,0.999999999991732,0.890023718061515,0,1,negative regulation of cellular response to hepatocyte growth factor stimulus,BP,
20231,GO:2001136,0.999999999991732,0.890023718061515,0,1,negative regulation of endocytic recycling,BP,
20240,GO:2001151,0.999999999991732,0.890023718061515,0,1,regulation of renal water transport,BP,
20241,GO:2001153,0.999999999991732,0.890023718061515,0,1,positive regulation of renal water transport,BP,
20270,GO:2001202,0.999999999991732,0.890023718061515,0,1,negative regulation of transforming growth factor-beta secretion,BP,
20271,GO:2001203,0.999999999991732,0.890023718061515,0,1,positive regulation of transforming growth factor-beta secretion,BP,
20284,GO:2001229,0.999999999991732,0.890023718061515,0,1,negative regulation of response to gamma radiation,BP,
20299,GO:2001247,0.999999999991732,0.890023718061515,0,1,positive regulation of phosphatidylcholine biosynthetic process,BP,
20320,GO:2001288,0.999999999991732,0.890023718061515,0,1,positive regulation of caveolin-mediated endocytosis,BP,
15013,GO:0070949,0.999999999991751,0.803549634852538,0,2,regulation of neutrophil mediated killing of symbiont cell,BP,
15017,GO:0070960,0.999999999991751,0.803549634852538,0,2,positive regulation of neutrophil mediated cytotoxicity,BP,
15018,GO:0070961,0.999999999991751,0.803549634852538,0,2,positive regulation of neutrophil mediated killing of symbiont cell,BP,
14473,GO:0061880,0.999999999991753,0.897064763086637,0,1,regulation of anterograde axonal transport of mitochondrion,BP,
14474,GO:0061881,0.999999999991753,0.897064763086637,0,1,positive regulation of anterograde axonal transport of mitochondrion,BP,
5430,GO:0016287,0.99999999999176,0.890033236180349,0,1,glycerone-phosphate O-acyltransferase activity,MF,
8187,GO:0032937,0.999999999991762,0.705056266591335,0,3,SREBP-SCAP-Insig complex,CC,
3502,GO:0007412,0.999999999991784,0.812456606104945,0,2,axon target recognition,BP,
12029,GO:0047756,0.999999999991786,0.794049156945435,0,2,chondroitin 4-sulfotransferase activity,MF,
1274,GO:0003065,0.999999999991793,0.895516547749343,0,1,positive regulation of heart rate by epinephrine,BP,
1840,GO:0004496,0.999999999991803,0.892094585992469,0,1,mevalonate kinase activity,MF,
2157,GO:0004984,0.99999999999181,0.753710116990761,0,3,olfactory receptor activity,MF,
12685,GO:0050911,0.99999999999181,0.753710116990761,0,3,detection of chemical stimulus involved in sensory perception of smell,BP,
5317,GO:0016035,0.99999999999182,0.812099903349128,0,2,zeta DNA polymerase complex,CC,
1932,GO:0004631,0.999999999991822,0.907224160599122,0,1,phosphomevalonate kinase activity,MF,
7338,GO:0031372,0.999999999991844,0.802011785471856,0,2,UBC13-MMS2 complex,CC,
4080,GO:0009136,0.999999999991845,0.81759922870918,0,2,purine nucleoside diphosphate biosynthetic process,BP,
4119,GO:0009180,0.999999999991845,0.81759922870918,0,2,purine ribonucleoside diphosphate biosynthetic process,BP,
4127,GO:0009188,0.999999999991845,0.81759922870918,0,2,ribonucleoside diphosphate biosynthetic process,BP,
5448,GO:0016320,0.999999999991848,0.80820655881939,0,2,endoplasmic reticulum membrane fusion,BP,
3259,GO:0006931,0.99999999999187,0.725893236818631,0,3,substrate-dependent cell migration, cell attachment to substrate,BP,
1620,GO:0004052,0.999999999991873,0.890163215731956,0,1,arachidonate 12-lipoxygenase activity,MF,
19470,GO:1990136,0.999999999991873,0.890163215731956,0,1,linoleate 9S-lipoxygenase activity,MF,
7898,GO:0032474,0.99999999999188,0.705021565300576,0,3,otolith morphogenesis,BP,
17245,GO:0110095,0.999999999991894,0.745583081756711,0,3,cellular detoxification of aldehyde,BP,
1501,GO:0003846,0.9999999999919,0.792342771715461,0,2,2-acylglycerol O-acyltransferase activity,MF,
1680,GO:0004144,0.9999999999919,0.792342771715461,0,2,diacylglycerol O-acyltransferase activity,MF,
12449,GO:0050252,0.9999999999919,0.792342771715461,0,2,retinol O-fatty-acyltransferase activity,MF,
15236,GO:0071400,0.9999999999919,0.792342771715461,0,2,cellular response to oleic acid,BP,
15407,GO:0071676,0.999999999991901,0.794268256309696,0,2,negative regulation of mononuclear cell migration,BP,
16068,GO:0090027,0.999999999991901,0.794268256309696,0,2,negative regulation of monocyte chemotaxis,BP,
5581,GO:0016598,0.999999999991913,0.797396675633656,0,2,protein arginylation,BP,
1198,GO:0002857,0.999999999991959,0.792158675202901,0,2,positive regulation of natural killer cell mediated immune response to tumor cell,BP,
1201,GO:0002860,0.999999999991959,0.792158675202901,0,2,positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
8933,GO:0034970,0.999999999991959,0.792158675202901,0,2,histone H3-R2 methylation,BP,
18631,GO:1903905,0.999999999991959,0.792158675202901,0,2,positive regulation of establishment of T cell polarity,BP,
10347,GO:0043163,0.999999999991962,0.792133954528133,0,2,cell envelope organization,BP,
11160,GO:0045229,0.999999999991962,0.792133954528133,0,2,external encapsulating structure organization,BP,
4985,GO:0015112,0.999999999991982,0.890044668760537,0,1,nitrate transmembrane transporter activity,MF,
5163,GO:0015706,0.999999999991982,0.890044668760537,0,1,nitrate transport,BP,
18122,GO:1902766,0.999999999991985,0.80995084116561,0,2,skeletal muscle satellite cell migration,BP,
963,GO:0002386,0.99999999999199,0.795344435509271,0,2,immune response in mucosal-associated lymphoid tissue,BP,
969,GO:0002415,0.99999999999199,0.795344435509271,0,2,immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor,BP,
7556,GO:0031905,0.999999999991997,0.728010023980314,0,3,early endosome lumen,CC,
14882,GO:0070676,0.999999999992031,0.721152377360717,0,3,intralumenal vesicle formation,BP,
4835,GO:0014043,0.999999999992045,0.796824396311879,0,2,negative regulation of neuron maturation,BP,
19208,GO:1905286,0.999999999992045,0.792886056264502,0,2,serine-type peptidase complex,CC,
13644,GO:0060166,0.999999999992047,0.804273740080226,0,2,olfactory pit development,BP,
1576,GO:0003985,0.999999999992053,0.714363050442519,0,3,acetyl-CoA C-acetyltransferase activity,MF,
10853,GO:0044375,0.999999999992059,0.819723662460549,0,2,regulation of peroxisome size,BP,
16214,GO:0090258,0.999999999992062,0.792149529418948,0,2,negative regulation of mitochondrial fission,BP,
16995,GO:0099074,0.999999999992062,0.792149529418948,0,2,mitochondrion to lysosome transport,BP,
16996,GO:0099075,0.999999999992062,0.792149529418948,0,2,mitochondrion-derived vesicle mediated transport,BP,
19723,GO:2000048,0.999999999992084,0.818217055331309,0,2,negative regulation of cell-cell adhesion mediated by cadherin,BP,
17318,GO:0140161,0.999999999992112,0.719545008928867,0,3,monocarboxylate:sodium symporter activity,MF,
7355,GO:0031404,0.999999999992137,0.722705755408947,0,3,chloride ion binding,MF,
13855,GO:0060482,0.99999999999218,0.717883406012178,0,3,lobar bronchus development,BP,
13882,GO:0060535,0.99999999999218,0.717883406012178,0,3,trachea cartilage morphogenesis,BP,
16271,GO:0090336,0.99999999999218,0.717883406012178,0,3,positive regulation of brown fat cell differentiation,BP,
5514,GO:0016476,0.999999999992185,0.705100340466302,0,3,regulation of embryonic cell shape,BP,
8527,GO:0033860,0.999999999992189,0.761696176440678,0,3,regulation of NAD(P)H oxidase activity,BP,
8529,GO:0033864,0.999999999992189,0.761696176440678,0,3,positive regulation of NAD(P)H oxidase activity,BP,
8734,GO:0034392,0.999999999992194,0.709535418435334,0,3,negative regulation of smooth muscle cell apoptotic process,BP,
16784,GO:0098619,0.999999999992216,0.893912058368502,0,1,selenocysteine-tRNA ligase activity,MF,
1441,GO:0003419,0.999999999992225,0.792261770193355,0,2,growth plate cartilage chondrocyte proliferation,BP,
1442,GO:0003420,0.999999999992225,0.792261770193355,0,2,regulation of growth plate cartilage chondrocyte proliferation,BP,
8407,GO:0033477,0.999999999992228,0.892838018221336,0,1,S-methylmethionine metabolic process,BP,
11953,GO:0047150,0.999999999992228,0.892838018221336,0,1,betaine-homocysteine S-methyltransferase activity,MF,
14379,GO:0061627,0.999999999992228,0.892838018221336,0,1,S-methylmethionine-homocysteine S-methyltransferase activity,MF,
1732,GO:0004326,0.99999999999223,0.890194500303157,0,1,tetrahydrofolylpolyglutamate synthase activity,MF,
3984,GO:0008841,0.99999999999223,0.890194500303157,0,1,dihydrofolate synthase activity,MF,
11876,GO:0046901,0.99999999999223,0.890194500303157,0,1,tetrahydrofolylpolyglutamate biosynthetic process,BP,
15811,GO:0072513,0.999999999992232,0.925259763462241,0,1,positive regulation of secondary heart field cardioblast proliferation,BP,
8834,GO:0034635,0.999999999992241,0.79454805774087,0,2,glutathione transport,BP,
10229,GO:0042939,0.999999999992241,0.79454805774087,0,2,tripeptide transport,BP,
10825,GO:0044326,0.999999999992241,0.79454805774087,0,2,dendritic spine neck,CC,
1211,GO:0002876,0.999999999992283,0.897771022074509,0,1,positive regulation of chronic inflammatory response to antigenic stimulus,BP,
1238,GO:0002925,0.999999999992283,0.897771022074509,0,1,positive regulation of humoral immune response mediated by circulating immunoglobulin,BP,
14155,GO:0061048,0.999999999992283,0.897771022074509,0,1,negative regulation of branching involved in lung morphogenesis,BP,
15846,GO:0072564,0.999999999992283,0.897771022074509,0,1,blood microparticle formation,BP,
19060,GO:1904895,0.999999999992283,0.897771022074509,0,1,ESCRT complex assembly,BP,
19062,GO:1904902,0.999999999992283,0.897771022074509,0,1,ESCRT III complex assembly,BP,
19107,GO:1904999,0.999999999992283,0.897771022074509,0,1,positive regulation of leukocyte adhesion to arterial endothelial cell,BP,
19875,GO:2000332,0.999999999992283,0.897771022074509,0,1,regulation of blood microparticle formation,BP,
19876,GO:2000334,0.999999999992283,0.897771022074509,0,1,positive regulation of blood microparticle formation,BP,
18128,GO:1902775,0.999999999992285,0.705049188113273,0,3,mitochondrial large ribosomal subunit assembly,BP,
16484,GO:0097176,0.999999999992291,0.7151675656723,0,3,epoxide metabolic process,BP,
9227,GO:0035621,0.999999999992306,0.794750752005447,0,2,ER to Golgi ceramide transport,BP,
17957,GO:1902292,0.999999999992312,0.911068413884901,0,1,cell cycle DNA replication initiation,BP,
17970,GO:1902315,0.999999999992312,0.911068413884901,0,1,nuclear cell cycle DNA replication initiation,BP,
18208,GO:1902975,0.999999999992312,0.911068413884901,0,1,mitotic DNA replication initiation,BP,
5496,GO:0016434,0.999999999992327,0.705007993026212,0,3,rRNA (cytosine) methyltransferase activity,MF,
7116,GO:0030943,0.999999999992339,0.711086461393333,0,3,mitochondrion targeting sequence binding,MF,
9297,GO:0035747,0.999999999992351,0.722950653465317,0,3,natural killer cell chemotaxis,BP,
11441,GO:0045903,0.999999999992384,0.754028542296253,0,3,positive regulation of translational fidelity,BP,
14233,GO:0061218,0.999999999992407,0.71114675594154,0,3,negative regulation of mesonephros development,BP,
10965,GO:0044752,0.999999999992412,0.705468346364482,0,3,response to human chorionic gonadotropin,BP,
10756,GO:0044208,0.999999999992413,0.802848749014996,0,2,'de novo' AMP biosynthetic process,BP,
923,GO:0002317,0.999999999992416,0.750795165946535,0,3,plasma cell differentiation,BP,
11978,GO:0047323,0.999999999992416,0.891640564221416,0,1,[3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity,MF,
13335,GO:0052381,0.999999999992416,0.891640564221416,0,1,tRNA dimethylallyltransferase activity,MF,
2062,GO:0004815,0.999999999992426,0.792637505224435,0,2,aspartate-tRNA ligase activity,MF,
2908,GO:0006422,0.999999999992428,0.890589559947733,0,1,aspartyl-tRNA aminoacylation,BP,
9250,GO:0035662,0.999999999992431,0.789894472076721,0,3,Toll-like receptor 4 binding,MF,
11071,GO:0045079,0.999999999992446,0.897590553473738,0,1,negative regulation of chemokine biosynthetic process,BP,
1639,GO:0004081,0.999999999992464,0.816976221688892,0,2,bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity,MF,
3974,GO:0008796,0.999999999992464,0.816976221688892,0,2,bis(5'-nucleosyl)-tetraphosphatase activity,MF,
6541,GO:0021960,0.999999999992466,0.705007993026073,0,3,anterior commissure morphogenesis,BP,
10148,GO:0042732,0.999999999992467,0.8225048337101,0,2,D-xylose metabolic process,BP,
5527,GO:0016503,0.999999999992476,0.906947936750972,0,1,pheromone receptor activity,MF,
16926,GO:0098904,0.999999999992491,0.792314397453543,0,2,regulation of AV node cell action potential,BP,
9322,GO:0035801,0.999999999992502,0.797037368629876,0,2,adrenal cortex development,BP,
9323,GO:0035802,0.999999999992502,0.797037368629876,0,2,adrenal cortex formation,BP,
512,GO:0001576,0.999999999992515,0.891966940441326,0,1,globoside biosynthetic process,BP,
1551,GO:0003948,0.999999999992515,0.891966940441326,0,1,N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity,MF,
12488,GO:0050512,0.999999999992515,0.891966940441326,0,1,lactosylceramide 4-alpha-galactosyltransferase activity,MF,
20258,GO:2001183,0.999999999992529,0.894107536607184,0,1,negative regulation of interleukin-12 secretion,BP,
12165,GO:0048297,0.999999999992563,0.891626347905044,0,1,negative regulation of isotype switching to IgA isotypes,BP,
1822,GO:0004475,0.999999999992584,0.899061645885674,0,1,mannose-1-phosphate guanylyltransferase activity,MF,
3998,GO:0008905,0.999999999992584,0.899061645885674,0,1,mannose-phosphate guanylyltransferase activity,MF,
11093,GO:0045113,0.999999999992586,0.832381179086294,0,2,regulation of integrin biosynthetic process,BP,
2663,GO:0006014,0.999999999992596,0.741364622577019,0,3,D-ribose metabolic process,BP,
19929,GO:2000409,0.99999999999263,0.894603306827752,0,1,positive regulation of T cell extravasation,BP,
19947,GO:2000451,0.99999999999263,0.894603306827752,0,1,positive regulation of CD8-positive, alpha-beta T cell extravasation,BP,
19949,GO:2000454,0.99999999999263,0.894603306827752,0,1,positive regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
9547,GO:0036313,0.999999999992666,0.792383708968184,0,2,phosphatidylinositol 3-kinase catalytic subunit binding,MF,
5331,GO:0016062,0.999999999992672,0.890100798310999,0,1,adaptation of rhodopsin mediated signaling,BP,
9565,GO:0036367,0.999999999992672,0.890100798310999,0,1,light adaption,BP,
12456,GO:0050294,0.999999999992692,0.740051342421485,0,3,steroid sulfotransferase activity,MF,
7992,GO:0032618,0.999999999992694,0.803798428214716,0,2,interleukin-15 production,BP,
11207,GO:0045348,0.999999999992698,0.715933591181336,0,3,positive regulation of MHC class II biosynthetic process,BP,
11198,GO:0045337,0.99999999999275,0.714396943945323,0,3,farnesyl diphosphate biosynthetic process,BP,
13575,GO:0060053,0.999999999992752,0.792485895355389,0,2,neurofilament cytoskeleton,CC,
14518,GO:0070012,0.999999999992752,0.792485895355389,0,2,oligopeptidase activity,MF,
5216,GO:0015819,0.999999999992754,0.894081101125397,0,1,lysine transport,BP,
11910,GO:0046963,0.999999999992764,0.796138075080519,0,2,3'-phosphoadenosine 5'-phosphosulfate transport,BP,
11911,GO:0046964,0.999999999992764,0.796138075080519,0,2,3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity,MF,
18047,GO:1902559,0.999999999992764,0.796138075080519,0,2,3'-phospho-5'-adenylyl sulfate transmembrane transport,BP,
7398,GO:0031475,0.999999999992791,0.901050758285965,0,1,myosin V complex,CC,
954,GO:0002373,0.999999999992802,0.919858982654134,0,1,plasmacytoid dendritic cell cytokine production,BP,
1142,GO:0002736,0.999999999992802,0.919858982654134,0,1,regulation of plasmacytoid dendritic cell cytokine production,BP,
1143,GO:0002737,0.999999999992802,0.919858982654134,0,1,negative regulation of plasmacytoid dendritic cell cytokine production,BP,
17604,GO:1901253,0.999999999992802,0.919858982654134,0,1,negative regulation of intracellular transport of viral material,BP,
18752,GO:1904210,0.999999999992816,0.904614863456144,0,1,VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
18769,GO:1904239,0.999999999992816,0.904614863456144,0,1,regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
18770,GO:1904240,0.999999999992816,0.904614863456144,0,1,negative regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
14886,GO:0070682,0.999999999992817,0.714431471913363,0,3,proteasome regulatory particle assembly,BP,
16253,GO:0090310,0.999999999992826,0.792133885814431,0,2,negative regulation of methylation-dependent chromatin silencing,BP,
14077,GO:0060913,0.99999999999284,0.890028987919112,0,1,cardiac cell fate determination,BP,
15396,GO:0071657,0.99999999999284,0.890028987919112,0,1,positive regulation of granulocyte colony-stimulating factor production,BP,
17609,GO:1901258,0.99999999999284,0.890028987919112,0,1,positive regulation of macrophage colony-stimulating factor production,BP,
3411,GO:0007197,0.999999999992921,0.792135416160512,0,2,adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway,BP,
5755,GO:0016907,0.999999999992921,0.792135416160512,0,2,G-protein coupled acetylcholine receptor activity,MF,
8568,GO:0034056,0.999999999992952,0.705184345722113,0,3,estrogen response element binding,MF,
10256,GO:0043000,0.999999999992952,0.80365681466872,0,2,Golgi to plasma membrane CFTR protein transport,BP,
3418,GO:0007207,0.999999999992955,0.793561905064523,0,2,phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway,BP,
801,GO:0002071,0.999999999993011,0.792133854587427,0,2,glandular epithelial cell maturation,BP,
1443,GO:0003430,0.999999999993011,0.792133854587427,0,2,growth plate cartilage chondrocyte growth,BP,
2242,GO:0005153,0.999999999993011,0.792133854587427,0,2,interleukin-8 receptor binding,MF,
2999,GO:0006548,0.999999999993011,0.792133854587427,0,2,histidine catabolic process,BP,
8519,GO:0033768,0.999999999993011,0.792133854587427,0,2,SUMO-targeted ubiquitin ligase complex,CC,
8800,GO:0034515,0.999999999993011,0.792133854587427,0,2,proteasome storage granule,CC,
10972,GO:0044771,0.999999999993011,0.792133854587427,0,2,meiotic cell cycle phase transition,BP,
11112,GO:0045145,0.999999999993011,0.792133854587427,0,2,single-stranded DNA 5'-3' exodeoxyribonuclease activity,MF,
11190,GO:0045322,0.999999999993011,0.792133854587427,0,2,unmethylated CpG binding,MF,
12446,GO:0050211,0.999999999993011,0.792133854587427,0,2,procollagen galactosyltransferase activity,MF,
13404,GO:0052805,0.999999999993011,0.792133854587427,0,2,imidazole-containing compound catabolic process,BP,
13414,GO:0052827,0.999999999993011,0.792133854587427,0,2,inositol pentakisphosphate phosphatase activity,MF,
14036,GO:0060800,0.999999999993011,0.792133854587427,0,2,regulation of cell differentiation involved in embryonic placenta development,BP,
15528,GO:0071929,0.999999999993011,0.792133854587427,0,2,alpha-tubulin acetylation,BP,
17684,GO:1901536,0.999999999993011,0.792133854587427,0,2,negative regulation of DNA demethylation,BP,
17843,GO:1901993,0.999999999993011,0.792133854587427,0,2,regulation of meiotic cell cycle phase transition,BP,
17844,GO:1901994,0.999999999993011,0.792133854587427,0,2,negative regulation of meiotic cell cycle phase transition,BP,
20282,GO:2001226,0.999999999993011,0.792133854587427,0,2,negative regulation of chloride transport,BP,
63,GO:0000126,0.999999999993015,0.792133854587423,0,2,transcription factor TFIIIB complex,CC,
119,GO:0000248,0.999999999993015,0.792133854587423,0,2,C-5 sterol desaturase activity,MF,
152,GO:0000308,0.999999999993015,0.792133854587423,0,2,cytoplasmic cyclin-dependent protein kinase holoenzyme complex,CC,
169,GO:0000354,0.999999999993015,0.792133854587423,0,2,cis assembly of pre-catalytic spliceosome,BP,
188,GO:0000406,0.999999999993015,0.792133854587423,0,2,double-strand/single-strand DNA junction binding,MF,
247,GO:0000706,0.999999999993015,0.792133854587423,0,2,meiotic DNA double-strand break processing,BP,
308,GO:0000820,0.999999999993015,0.792133854587423,0,2,regulation of glutamine family amino acid metabolic process,BP,
347,GO:0000961,0.999999999993015,0.792133854587423,0,2,negative regulation of mitochondrial RNA catabolic process,BP,
384,GO:0001026,0.999999999993015,0.792133854587423,0,2,TFIIIB-type transcription factor activity,MF,
396,GO:0001069,0.999999999993015,0.792133854587423,0,2,regulatory region RNA binding,MF,
428,GO:0001147,0.999999999993015,0.792133854587423,0,2,transcription termination site sequence-specific DNA binding,MF,
431,GO:0001160,0.999999999993015,0.792133854587423,0,2,transcription termination site DNA binding,MF,
451,GO:0001225,0.999999999993015,0.792133854587423,0,2,RNA polymerase II transcription coactivator binding,MF,
455,GO:0001300,0.999999999993015,0.792133854587423,0,2,chronological cell aging,BP,
476,GO:0001520,0.999999999993015,0.792133854587423,0,2,outer dense fiber,CC,
563,GO:0001705,0.999999999993015,0.792133854587423,0,2,ectoderm formation,BP,
570,GO:0001712,0.999999999993015,0.792133854587423,0,2,ectodermal cell fate commitment,BP,
576,GO:0001729,0.999999999993015,0.792133854587423,0,2,ceramide kinase activity,MF,
592,GO:0001757,0.999999999993015,0.792133854587423,0,2,somite specification,BP,
637,GO:0001827,0.999999999993015,0.792133854587423,0,2,inner cell mass cell fate commitment,BP,
638,GO:0001828,0.999999999993015,0.792133854587423,0,2,inner cell mass cellular morphogenesis,BP,
669,GO:0001880,0.999999999993015,0.792133854587423,0,2,Mullerian duct regression,BP,
677,GO:0001888,0.999999999993015,0.792133854587423,0,2,glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,
685,GO:0001905,0.999999999993015,0.792133854587423,0,2,activation of membrane attack complex,BP,
737,GO:0001969,0.999999999993015,0.792133854587423,0,2,regulation of activation of membrane attack complex,BP,
805,GO:0002079,0.999999999993015,0.792133854587423,0,2,inner acrosomal membrane,CC,
856,GO:0002184,0.999999999993015,0.792133854587423,0,2,cytoplasmic translational termination,BP,
884,GO:0002249,0.999999999993015,0.792133854587423,0,2,lymphocyte anergy,BP,
926,GO:0002322,0.999999999993015,0.792133854587423,0,2,B cell proliferation involved in immune response,BP,
1047,GO:0002572,0.999999999993015,0.792133854587423,0,2,pro-T cell differentiation,BP,
1084,GO:0002667,0.999999999993015,0.792133854587423,0,2,regulation of T cell anergy,BP,
1208,GO:0002870,0.999999999993015,0.792133854587423,0,2,T cell anergy,BP,
1231,GO:0002911,0.999999999993015,0.792133854587423,0,2,regulation of lymphocyte anergy,BP,
1315,GO:0003162,0.999999999993015,0.792133854587423,0,2,atrioventricular node development,BP,
1316,GO:0003163,0.999999999993015,0.792133854587423,0,2,sinoatrial node development,BP,
1317,GO:0003164,0.999999999993015,0.792133854587423,0,2,His-Purkinje system development,BP,
1349,GO:0003213,0.999999999993015,0.792133854587423,0,2,cardiac right atrium morphogenesis,BP,
1365,GO:0003249,0.999999999993015,0.792133854587423,0,2,cell proliferation involved in heart valve morphogenesis,BP,
1366,GO:0003250,0.999999999993015,0.792133854587423,0,2,regulation of cell proliferation involved in heart valve morphogenesis,BP,
1380,GO:0003275,0.999999999993015,0.792133854587423,0,2,apoptotic process involved in outflow tract morphogenesis,BP,
1388,GO:0003294,0.999999999993015,0.792133854587423,0,2,atrial ventricular junction remodeling,BP,
1407,GO:0003340,0.999999999993015,0.792133854587423,0,2,negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
1418,GO:0003357,0.999999999993015,0.792133854587423,0,2,noradrenergic neuron differentiation,BP,
1434,GO:0003408,0.999999999993015,0.792133854587423,0,2,optic cup formation involved in camera-type eye development,BP,
1491,GO:0003828,0.999999999993015,0.792133854587423,0,2,alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity,MF,
1492,GO:0003829,0.999999999993015,0.792133854587423,0,2,beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity,MF,
1494,GO:0003835,0.999999999993015,0.792133854587423,0,2,beta-galactoside alpha-2,6-sialyltransferase activity,MF,
1505,GO:0003858,0.999999999993015,0.792133854587423,0,2,3-hydroxybutyrate dehydrogenase activity,MF,
1516,GO:0003876,0.999999999993015,0.792133854587423,0,2,AMP deaminase activity,MF,
1522,GO:0003883,0.999999999993015,0.792133854587423,0,2,CTP synthase activity,MF,
1534,GO:0003918,0.999999999993015,0.792133854587423,0,2,DNA topoisomerase type II (ATP-hydrolyzing) activity,MF,
1574,GO:0003980,0.999999999993015,0.792133854587423,0,2,UDP-glucose:glycoprotein glucosyltransferase activity,MF,
1578,GO:0003987,0.999999999993015,0.792133854587423,0,2,acetate-CoA ligase activity,MF,
1580,GO:0003989,0.999999999993015,0.792133854587423,0,2,acetyl-CoA carboxylase activity,MF,
1632,GO:0004070,0.999999999993015,0.792133854587423,0,2,aspartate carbamoyltransferase activity,MF,
1644,GO:0004087,0.999999999993015,0.792133854587423,0,2,carbamoyl-phosphate synthase (ammonia) activity,MF,
1645,GO:0004088,0.999999999993015,0.792133854587423,0,2,carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity,MF,
1685,GO:0004151,0.999999999993015,0.792133854587423,0,2,dihydroorotase activity,MF,
1733,GO:0004329,0.999999999993015,0.792133854587423,0,2,formate-tetrahydrofolate ligase activity,MF,
1755,GO:0004357,0.999999999993015,0.792133854587423,0,2,glutamate-cysteine ligase activity,MF,
1766,GO:0004370,0.999999999993015,0.792133854587423,0,2,glycerol kinase activity,MF,
1774,GO:0004379,0.999999999993015,0.792133854587423,0,2,glycylpeptide N-tetradecanoyltransferase activity,MF,
1866,GO:0004530,0.999999999993015,0.792133854587423,0,2,deoxyribonuclease I activity,MF,
1890,GO:0004572,0.999999999993015,0.792133854587423,0,2,mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity,MF,
1960,GO:0004666,0.999999999993015,0.792133854587423,0,2,prostaglandin-endoperoxide synthase activity,MF,
1972,GO:0004687,0.999999999993015,0.792133854587423,0,2,myosin light chain kinase activity,MF,
2054,GO:0004803,0.999999999993015,0.792133854587423,0,2,transposase activity,MF,
2065,GO:0004818,0.999999999993015,0.792133854587423,0,2,glutamate-tRNA ligase activity,MF,
2070,GO:0004823,0.999999999993015,0.792133854587423,0,2,leucine-tRNA ligase activity,MF,
2104,GO:0004874,0.999999999993015,0.792133854587423,0,2,aryl hydrocarbon receptor activity,MF,
2108,GO:0004886,0.999999999993015,0.792133854587423,0,2,9-cis retinoic acid receptor activity,MF,
2122,GO:0004915,0.999999999993015,0.792133854587423,0,2,interleukin-6 receptor activity,MF,
2126,GO:0004923,0.999999999993015,0.792133854587423,0,2,leukemia inhibitory factor receptor activity,MF,
2149,GO:0004968,0.999999999993015,0.792133854587423,0,2,gonadotropin-releasing hormone receptor activity,MF,
2150,GO:0004969,0.999999999993015,0.792133854587423,0,2,histamine receptor activity,MF,
2165,GO:0005000,0.999999999993015,0.792133854587423,0,2,vasopressin receptor activity,MF,
2178,GO:0005025,0.999999999993015,0.792133854587423,0,2,transforming growth factor beta receptor activity, type I,MF,
2191,GO:0005052,0.999999999993015,0.792133854587423,0,2,peroxisome matrix targeting signal-1 binding,MF,
2320,GO:0005329,0.999999999993015,0.792133854587423,0,2,dopamine transmembrane transporter activity,MF,
2335,GO:0005365,0.999999999993015,0.792133854587423,0,2,myo-inositol transmembrane transporter activity,MF,
2357,GO:0005457,0.999999999993015,0.792133854587423,0,2,GDP-fucose transmembrane transporter activity,MF,
2410,GO:0005584,0.999999999993015,0.792133854587423,0,2,collagen type I trimer,CC,
2505,GO:0005760,0.999999999993015,0.792133854587423,0,2,gamma DNA polymerase complex,CC,
2592,GO:0005889,0.999999999993015,0.792133854587423,0,2,potassium:proton exchanging ATPase complex,CC,
2597,GO:0005896,0.999999999993015,0.792133854587423,0,2,interleukin-6 receptor complex,CC,
2600,GO:0005900,0.999999999993015,0.792133854587423,0,2,oncostatin-M receptor complex,CC,
2621,GO:0005943,0.999999999993015,0.792133854587423,0,2,phosphatidylinositol 3-kinase complex, class IA,CC,
2646,GO:0005988,0.999999999993015,0.792133854587423,0,2,lactose metabolic process,BP,
2647,GO:0005989,0.999999999993015,0.792133854587423,0,2,lactose biosynthetic process,BP,
2679,GO:0006045,0.999999999993015,0.792133854587423,0,2,N-acetylglucosamine biosynthetic process,BP,
2910,GO:0006424,0.999999999993015,0.792133854587423,0,2,glutamyl-tRNA aminoacylation,BP,
2915,GO:0006429,0.999999999993015,0.792133854587423,0,2,leucyl-tRNA aminoacylation,BP,
3091,GO:0006668,0.999999999993015,0.792133854587423,0,2,sphinganine-1-phosphate metabolic process,BP,
3169,GO:0006784,0.999999999993015,0.792133854587423,0,2,heme a biosynthetic process,BP,
3434,GO:0007228,0.999999999993015,0.792133854587423,0,2,positive regulation of hh target transcription factor activity,BP,
3462,GO:0007284,0.999999999993015,0.792133854587423,0,2,spermatogonial cell division,BP,
3506,GO:0007418,0.999999999993015,0.792133854587423,0,2,ventral midline development,BP,
3535,GO:0007538,0.999999999993015,0.792133854587423,0,2,primary sex determination,BP,
3536,GO:0007542,0.999999999993015,0.792133854587423,0,2,primary sex determination, germ-line,BP,
3614,GO:0008065,0.999999999993015,0.792133854587423,0,2,establishment of blood-nerve barrier,BP,
3634,GO:0008107,0.999999999993015,0.792133854587423,0,2,galactoside 2-alpha-L-fucosyltransferase activity,MF,
3636,GO:0008109,0.999999999993015,0.792133854587423,0,2,N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity,MF,
3709,GO:0008228,0.999999999993015,0.792133854587423,0,2,opsonization,BP,
3733,GO:0008273,0.999999999993015,0.792133854587423,0,2,calcium, potassium:sodium antiporter activity,MF,
3740,GO:0008282,0.999999999993015,0.792133854587423,0,2,inward rectifying potassium channel,CC,
3768,GO:0008321,0.999999999993015,0.792133854587423,0,2,Ral guanyl-nucleotide exchange factor activity,MF,
3821,GO:0008422,0.999999999993015,0.792133854587423,0,2,beta-glucosidase activity,MF,
3873,GO:0008506,0.999999999993015,0.792133854587423,0,2,sucrose:proton symporter activity,MF,
3881,GO:0008515,0.999999999993015,0.792133854587423,0,2,sucrose transmembrane transporter activity,MF,
3903,GO:0008545,0.999999999993015,0.792133854587423,0,2,JUN kinase kinase activity,MF,
3920,GO:0008594,0.999999999993015,0.792133854587423,0,2,photoreceptor cell morphogenesis,BP,
4046,GO:0009085,0.999999999993015,0.792133854587423,0,2,lysine biosynthetic process,BP,
4165,GO:0009233,0.999999999993015,0.792133854587423,0,2,menaquinone metabolic process,BP,
4178,GO:0009257,0.999999999993015,0.792133854587423,0,2,10-formyltetrahydrofolate biosynthetic process,BP,
4206,GO:0009330,0.999999999993015,0.792133854587423,0,2,DNA topoisomerase complex (ATP-hydrolyzing),CC,
4207,GO:0009331,0.999999999993015,0.792133854587423,0,2,glycerol-3-phosphate dehydrogenase complex,CC,
4226,GO:0009405,0.999999999993015,0.792133854587423,0,2,pathogenesis,BP,
4248,GO:0009450,0.999999999993015,0.792133854587423,0,2,gamma-aminobutyric acid catabolic process,BP,
4274,GO:0009637,0.999999999993015,0.792133854587423,0,2,response to blue light,BP,
4284,GO:0009669,0.999999999993015,0.792133854587423,0,2,sucrose:cation symporter activity,MF,
4306,GO:0009785,0.999999999993015,0.792133854587423,0,2,blue light signaling pathway,BP,
4331,GO:0009882,0.999999999993015,0.792133854587423,0,2,blue light photoreceptor activity,MF,
4562,GO:0010645,0.999999999993015,0.792133854587423,0,2,regulation of cell communication by chemical coupling,BP,
4568,GO:0010652,0.999999999993015,0.792133854587423,0,2,positive regulation of cell communication by chemical coupling,BP,
4628,GO:0010751,0.999999999993015,0.792133854587423,0,2,negative regulation of nitric oxide mediated signal transduction,BP,
4629,GO:0010752,0.999999999993015,0.792133854587423,0,2,regulation of cGMP-mediated signaling,BP,
4644,GO:0010768,0.999999999993015,0.792133854587423,0,2,negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,BP,
4704,GO:0010868,0.999999999993015,0.792133854587423,0,2,negative regulation of triglyceride biosynthetic process,BP,
4774,GO:0010961,0.999999999993015,0.792133854587423,0,2,cellular magnesium ion homeostasis,BP,
4797,GO:0010991,0.999999999993015,0.792133854587423,0,2,negative regulation of SMAD protein complex assembly,BP,
4811,GO:0014004,0.999999999993015,0.792133854587423,0,2,microglia differentiation,BP,
4812,GO:0014005,0.999999999993015,0.792133854587423,0,2,microglia development,BP,
4828,GO:0014034,0.999999999993015,0.792133854587423,0,2,neural crest cell fate commitment,BP,
4872,GO:0014734,0.999999999993015,0.792133854587423,0,2,skeletal muscle hypertrophy,BP,
4891,GO:0014816,0.999999999993015,0.792133854587423,0,2,skeletal muscle satellite cell differentiation,BP,
4909,GO:0014846,0.999999999993015,0.792133854587423,0,2,esophagus smooth muscle contraction,BP,
4919,GO:0014858,0.999999999993015,0.792133854587423,0,2,positive regulation of skeletal muscle cell proliferation,BP,
4975,GO:0015093,0.999999999993015,0.792133854587423,0,2,ferrous iron transmembrane transporter activity,MF,
5005,GO:0015154,0.999999999993015,0.792133854587423,0,2,disaccharide transmembrane transporter activity,MF,
5006,GO:0015157,0.999999999993015,0.792133854587423,0,2,oligosaccharide transmembrane transporter activity,MF,
5020,GO:0015184,0.999999999993015,0.792133854587423,0,2,L-cystine transmembrane transporter activity,MF,
5061,GO:0015275,0.999999999993015,0.792133854587423,0,2,stretch-activated, cation-selective, calcium channel activity,MF,
5089,GO:0015350,0.999999999993015,0.792133854587423,0,2,methotrexate transmembrane transporter activity,MF,
5096,GO:0015373,0.999999999993015,0.792133854587423,0,2,anion:sodium symporter activity,MF,
5113,GO:0015433,0.999999999993015,0.792133854587423,0,2,peptide antigen-transporting ATPase activity,MF,
5146,GO:0015679,0.999999999993015,0.792133854587423,0,2,plasma membrane copper ion transport,BP,
5149,GO:0015684,0.999999999993015,0.792133854587423,0,2,ferrous iron transport,BP,
5188,GO:0015766,0.999999999993015,0.792133854587423,0,2,disaccharide transport,BP,
5189,GO:0015770,0.999999999993015,0.792133854587423,0,2,sucrose transport,BP,
5190,GO:0015772,0.999999999993015,0.792133854587423,0,2,oligosaccharide transport,BP,
5193,GO:0015783,0.999999999993015,0.792133854587423,0,2,GDP-fucose transmembrane transport,BP,
5210,GO:0015810,0.999999999993015,0.792133854587423,0,2,aspartate transmembrane transport,BP,
5211,GO:0015811,0.999999999993015,0.792133854587423,0,2,L-cystine transport,BP,
5447,GO:0016316,0.999999999993015,0.792133854587423,0,2,phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity,MF,
5461,GO:0016340,0.999999999993015,0.792133854587423,0,2,calcium-dependent cell-matrix adhesion,BP,
5484,GO:0016418,0.999999999993015,0.792133854587423,0,2,S-acetyltransferase activity,MF,
5498,GO:0016436,0.999999999993015,0.792133854587423,0,2,rRNA (uridine) methyltransferase activity,MF,
5571,GO:0016586,0.999999999993015,0.792133854587423,0,2,RSC-type complex,CC,
5634,GO:0016715,0.999999999993015,0.792133854587423,0,2,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen,MF,
5649,GO:0016743,0.999999999993015,0.792133854587423,0,2,carboxyl- or carbamoyltransferase activity,MF,
5751,GO:0016899,0.999999999993015,0.792133854587423,0,2,oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor,MF,
5789,GO:0017018,0.999999999993015,0.792133854587423,0,2,myosin phosphatase activity,MF,
5823,GO:0017095,0.999999999993015,0.792133854587423,0,2,heparan sulfate 6-O-sulfotransferase activity,MF,
5829,GO:0017109,0.999999999993015,0.792133854587423,0,2,glutamate-cysteine ligase complex,CC,
5861,GO:0017161,0.999999999993015,0.792133854587423,0,2,inositol-1,3,4-trisphosphate 4-phosphatase activity,MF,
5878,GO:0018008,0.999999999993015,0.792133854587423,0,2,N-terminal peptidyl-glycine N-myristoylation,BP,
5990,GO:0018992,0.999999999993015,0.792133854587423,0,2,germ-line sex determination,BP,
5998,GO:0019034,0.999999999993015,0.792133854587423,0,2,viral replication complex,CC,
6002,GO:0019045,0.999999999993015,0.792133854587423,0,2,latent virus replication,BP,
6003,GO:0019046,0.999999999993015,0.792133854587423,0,2,release from viral latency,BP,
6024,GO:0019085,0.999999999993015,0.792133854587423,0,2,early viral transcription,BP,
6030,GO:0019100,0.999999999993015,0.792133854587423,0,2,male germ-line sex determination,BP,
6034,GO:0019107,0.999999999993015,0.792133854587423,0,2,myristoyltransferase activity,MF,
6076,GO:0019230,0.999999999993015,0.792133854587423,0,2,proprioception,BP,
6139,GO:0019413,0.999999999993015,0.792133854587423,0,2,acetate biosynthetic process,BP,
6142,GO:0019427,0.999999999993015,0.792133854587423,0,2,acetyl-CoA biosynthetic process from acetate,BP,
6155,GO:0019482,0.999999999993015,0.792133854587423,0,2,beta-alanine metabolic process,BP,
6173,GO:0019542,0.999999999993015,0.792133854587423,0,2,propionate biosynthetic process,BP,
6274,GO:0019878,0.999999999993015,0.792133854587423,0,2,lysine biosynthetic process via aminoadipic acid,BP,
6312,GO:0019961,0.999999999993015,0.792133854587423,0,2,interferon binding,MF,
6317,GO:0019981,0.999999999993015,0.792133854587423,0,2,interleukin-6 binding,MF,
6329,GO:0021502,0.999999999993015,0.792133854587423,0,2,neural fold elevation formation,BP,
6373,GO:0021563,0.999999999993015,0.792133854587423,0,2,glossopharyngeal nerve development,BP,
6411,GO:0021679,0.999999999993015,0.792133854587423,0,2,cerebellar molecular layer development,BP,
6418,GO:0021687,0.999999999993015,0.792133854587423,0,2,cerebellar molecular layer morphogenesis,BP,
6422,GO:0021693,0.999999999993015,0.792133854587423,0,2,cerebellar Purkinje cell layer structural organization,BP,
6427,GO:0021698,0.999999999993015,0.792133854587423,0,2,cerebellar cortex structural organization,BP,
6443,GO:0021764,0.999999999993015,0.792133854587423,0,2,amygdala development,BP,
6464,GO:0021798,0.999999999993015,0.792133854587423,0,2,forebrain dorsal/ventral pattern formation,BP,
6471,GO:0021816,0.999999999993015,0.792133854587423,0,2,extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration,BP,
6475,GO:0021823,0.999999999993015,0.792133854587423,0,2,cerebral cortex tangential migration using cell-cell interactions,BP,
6479,GO:0021827,0.999999999993015,0.792133854587423,0,2,postnatal olfactory bulb interneuron migration,BP,
6482,GO:0021836,0.999999999993015,0.792133854587423,0,2,chemorepulsion involved in postnatal olfactory bulb interneuron migration,BP,
6488,GO:0021849,0.999999999993015,0.792133854587423,0,2,neuroblast division in subventricular zone,BP,
6514,GO:0021896,0.999999999993015,0.792133854587423,0,2,forebrain astrocyte differentiation,BP,
6515,GO:0021897,0.999999999993015,0.792133854587423,0,2,forebrain astrocyte development,BP,
6517,GO:0021902,0.999999999993015,0.792133854587423,0,2,commitment of neuronal cell to specific neuron type in forebrain,BP,
6526,GO:0021934,0.999999999993015,0.792133854587423,0,2,hindbrain tangential cell migration,BP,
6527,GO:0021935,0.999999999993015,0.792133854587423,0,2,cerebellar granule cell precursor tangential migration,BP,
6529,GO:0021937,0.999999999993015,0.792133854587423,0,2,cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation,BP,
6530,GO:0021938,0.999999999993015,0.792133854587423,0,2,smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation,BP,
6531,GO:0021940,0.999999999993015,0.792133854587423,0,2,positive regulation of cerebellar granule cell precursor proliferation,BP,
6552,GO:0021997,0.999999999993015,0.792133854587423,0,2,neural plate axis specification,BP,
6789,GO:0030237,0.999999999993015,0.792133854587423,0,2,female sex determination,BP,
6793,GO:0030241,0.999999999993015,0.792133854587423,0,2,skeletal muscle myosin thick filament assembly,BP,
6839,GO:0030314,0.999999999993015,0.792133854587423,0,2,junctional membrane complex,CC,
6866,GO:0030350,0.999999999993015,0.792133854587423,0,2,iron-responsive element binding,MF,
6908,GO:0030505,0.999999999993015,0.792133854587423,0,2,inorganic diphosphate transport,BP,
6927,GO:0030538,0.999999999993015,0.792133854587423,0,2,embryonic genitalia morphogenesis,BP,
7026,GO:0030806,0.999999999993015,0.792133854587423,0,2,negative regulation of cyclic nucleotide catabolic process,BP,
7041,GO:0030821,0.999999999993015,0.792133854587423,0,2,negative regulation of cAMP catabolic process,BP,
7112,GO:0030934,0.999999999993015,0.792133854587423,0,2,anchoring collagen complex,CC,
7153,GO:0031022,0.999999999993015,0.792133854587423,0,2,nuclear migration along microfilament,BP,
7161,GO:0031048,0.999999999993015,0.792133854587423,0,2,chromatin silencing by small RNA,BP,
7175,GO:0031064,0.999999999993015,0.792133854587423,0,2,negative regulation of histone deacetylation,BP,
7185,GO:0031081,0.999999999993015,0.792133854587423,0,2,nuclear pore distribution,BP,
7225,GO:0031127,0.999999999993015,0.792133854587423,0,2,alpha-(1,2)-fucosyltransferase activity,MF,
7247,GO:0031213,0.999999999993015,0.792133854587423,0,2,RSF complex,CC,
7345,GO:0031393,0.999999999993015,0.792133854587423,0,2,negative regulation of prostaglandin biosynthetic process,BP,
7430,GO:0031547,0.999999999993015,0.792133854587423,0,2,brain-derived neurotrophic factor receptor signaling pathway,BP,
7499,GO:0031685,0.999999999993015,0.792133854587423,0,2,adenosine receptor binding,MF,
7523,GO:0031752,0.999999999993015,0.792133854587423,0,2,D5 dopamine receptor binding,MF,
7545,GO:0031862,0.999999999993015,0.792133854587423,0,2,prostanoid receptor binding,MF,
7584,GO:0031959,0.999999999993015,0.792133854587423,0,2,mineralocorticoid receptor signaling pathway,BP,
7653,GO:0032089,0.999999999993015,0.792133854587423,0,2,NACHT domain binding,MF,
7674,GO:0032116,0.999999999993015,0.792133854587423,0,2,SMC loading complex,CC,
7684,GO:0032143,0.999999999993015,0.792133854587423,0,2,single thymine insertion binding,MF,
7695,GO:0032181,0.999999999993015,0.792133854587423,0,2,dinucleotide repeat insertion binding,MF,
7734,GO:0032240,0.999999999993015,0.792133854587423,0,2,negative regulation of nucleobase-containing compound transport,BP,
7770,GO:0032301,0.999999999993015,0.792133854587423,0,2,MutSalpha complex,CC,
7771,GO:0032302,0.999999999993015,0.792133854587423,0,2,MutSbeta complex,CC,
7790,GO:0032346,0.999999999993015,0.792133854587423,0,2,positive regulation of aldosterone metabolic process,BP,
7793,GO:0032349,0.999999999993015,0.792133854587423,0,2,positive regulation of aldosterone biosynthetic process,BP,
7850,GO:0032417,0.999999999993015,0.792133854587423,0,2,positive regulation of sodium:proton antiporter activity,BP,
7872,GO:0032444,0.999999999993015,0.792133854587423,0,2,activin responsive factor complex,CC,
8046,GO:0032714,0.999999999993015,0.792133854587423,0,2,negative regulation of interleukin-5 production,BP,
8063,GO:0032741,0.999999999993015,0.792133854587423,0,2,positive regulation of interleukin-18 production,BP,
8143,GO:0032877,0.999999999993015,0.792133854587423,0,2,positive regulation of DNA endoreduplication,BP,
8160,GO:0032902,0.999999999993015,0.792133854587423,0,2,nerve growth factor production,BP,
8195,GO:0032954,0.999999999993015,0.792133854587423,0,2,regulation of cytokinetic process,BP,
8238,GO:0033023,0.999999999993015,0.792133854587423,0,2,mast cell homeostasis,BP,
8239,GO:0033024,0.999999999993015,0.792133854587423,0,2,mast cell apoptotic process,BP,
8240,GO:0033025,0.999999999993015,0.792133854587423,0,2,regulation of mast cell apoptotic process,BP,
8285,GO:0033122,0.999999999993015,0.792133854587423,0,2,negative regulation of purine nucleotide catabolic process,BP,
8307,GO:0033149,0.999999999993015,0.792133854587423,0,2,FFAT motif binding,MF,
8378,GO:0033292,0.999999999993015,0.792133854587423,0,2,T-tubule organization,BP,
8434,GO:0033564,0.999999999993015,0.792133854587423,0,2,anterior/posterior axon guidance,BP,
8469,GO:0033624,0.999999999993015,0.792133854587423,0,2,negative regulation of integrin activation,BP,
8470,GO:0033625,0.999999999993015,0.792133854587423,0,2,positive regulation of integrin activation,BP,
8497,GO:0033684,0.999999999993015,0.792133854587423,0,2,regulation of luteinizing hormone secretion,BP,
8498,GO:0033686,0.999999999993015,0.792133854587423,0,2,positive regulation of luteinizing hormone secretion,BP,
8525,GO:0033857,0.999999999993015,0.792133854587423,0,2,diphosphoinositol-pentakisphosphate kinase activity,MF,
8580,GO:0034087,0.999999999993015,0.792133854587423,0,2,establishment of mitotic sister chromatid cohesion,BP,
8630,GO:0034165,0.999999999993015,0.792133854587423,0,2,positive regulation of toll-like receptor 9 signaling pathway,BP,
8814,GO:0034597,0.999999999993015,0.792133854587423,0,2,phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity,MF,
8843,GO:0034647,0.999999999993015,0.792133854587423,0,2,histone demethylase activity (H3-trimethyl-K4 specific),MF,
8865,GO:0034678,0.999999999993015,0.792133854587423,0,2,integrin alpha8-beta1 complex,CC,
8866,GO:0034680,0.999999999993015,0.792133854587423,0,2,integrin alpha10-beta1 complex,CC,
8871,GO:0034686,0.999999999993015,0.792133854587423,0,2,integrin alphav-beta8 complex,CC,
8895,GO:0034721,0.999999999993015,0.792133854587423,0,2,histone H3-K4 demethylation, trimethyl-H3-K4-specific,BP,
8904,GO:0034750,0.999999999993015,0.792133854587423,0,2,Scrib-APC-beta-catenin complex,CC,
8925,GO:0034776,0.999999999993015,0.792133854587423,0,2,response to histamine,BP,
8957,GO:0035026,0.999999999993015,0.792133854587423,0,2,leading edge cell differentiation,BP,
8981,GO:0035093,0.999999999993015,0.792133854587423,0,2,spermatogenesis, exchange of chromosomal proteins,BP,
9040,GO:0035261,0.999999999993015,0.792133854587423,0,2,external genitalia morphogenesis,BP,
9051,GO:0035279,0.999999999993015,0.792133854587423,0,2,mRNA cleavage involved in gene silencing by miRNA,BP,
9076,GO:0035332,0.999999999993015,0.792133854587423,0,2,positive regulation of hippo signaling,BP,
9098,GO:0035373,0.999999999993015,0.792133854587423,0,2,chondroitin sulfate proteoglycan binding,MF,
9167,GO:0035526,0.999999999993015,0.792133854587423,0,2,retrograde transport, plasma membrane to Golgi,BP,
9187,GO:0035574,0.999999999993015,0.792133854587423,0,2,histone H4-K20 demethylation,BP,
9188,GO:0035575,0.999999999993015,0.792133854587423,0,2,histone demethylase activity (H4-K20 specific),MF,
9216,GO:0035608,0.999999999993015,0.792133854587423,0,2,protein deglutamylation,BP,
9230,GO:0035624,0.999999999993015,0.792133854587423,0,2,receptor transactivation,BP,
9233,GO:0035630,0.999999999993015,0.792133854587423,0,2,bone mineralization involved in bone maturation,BP,
9255,GO:0035668,0.999999999993015,0.792133854587423,0,2,TRAM-dependent toll-like receptor signaling pathway,BP,
9256,GO:0035669,0.999999999993015,0.792133854587423,0,2,TRAM-dependent toll-like receptor 4 signaling pathway,BP,
9333,GO:0035822,0.999999999993015,0.792133854587423,0,2,gene conversion,BP,
9350,GO:0035866,0.999999999993015,0.792133854587423,0,2,alphav-beta3 integrin-PKCalpha complex,CC,
9351,GO:0035867,0.999999999993015,0.792133854587423,0,2,alphav-beta3 integrin-IGF-1-IGF1R complex,CC,
9352,GO:0035868,0.999999999993015,0.792133854587423,0,2,alphav-beta3 integrin-HMGB1 complex,CC,
9463,GO:0036080,0.999999999993015,0.792133854587423,0,2,purine nucleotide-sugar transmembrane transporter activity,MF,
9489,GO:0036135,0.999999999993015,0.792133854587423,0,2,Schwann cell migration,BP,
9566,GO:0036369,0.999999999993015,0.792133854587423,0,2,transcription factor catabolic process,BP,
9644,GO:0036518,0.999999999993015,0.792133854587423,0,2,chemorepulsion of dopaminergic neuron axon,BP,
9658,GO:0038018,0.999999999993015,0.792133854587423,0,2,Wnt receptor catabolic process,BP,
9662,GO:0038025,0.999999999993015,0.792133854587423,0,2,reelin receptor activity,MF,
9676,GO:0038049,0.999999999993015,0.792133854587423,0,2,transcription factor activity, ligand-activated RNA polymerase II transcription factor binding,MF,
9682,GO:0038064,0.999999999993015,0.792133854587423,0,2,collagen receptor activity,MF,
9706,GO:0038124,0.999999999993015,0.792133854587423,0,2,toll-like receptor TLR6:TLR2 signaling pathway,BP,
9743,GO:0039019,0.999999999993015,0.792133854587423,0,2,pronephric nephron development,BP,
9754,GO:0039519,0.999999999993015,0.792133854587423,0,2,modulation by virus of host autophagy,BP,
9804,GO:0040038,0.999999999993015,0.792133854587423,0,2,polar body extrusion after meiotic divisions,BP,
9815,GO:0042030,0.999999999993015,0.792133854587423,0,2,ATPase inhibitor activity,MF,
9913,GO:0042264,0.999999999993015,0.792133854587423,0,2,peptidyl-aspartic acid hydroxylation,BP,
9919,GO:0042271,0.999999999993015,0.792133854587423,0,2,susceptibility to natural killer cell mediated cytotoxicity,BP,
9920,GO:0042272,0.999999999993015,0.792133854587423,0,2,nuclear RNA export factor complex,CC,
10036,GO:0042494,0.999999999993015,0.792133854587423,0,2,detection of bacterial lipoprotein,BP,
10038,GO:0042496,0.999999999993015,0.792133854587423,0,2,detection of diacyl bacterial lipopeptide,BP,
10051,GO:0042539,0.999999999993015,0.792133854587423,0,2,hypotonic salinity response,BP,
10135,GO:0042704,0.999999999993015,0.792133854587423,0,2,uterine wall breakdown,BP,
10254,GO:0042998,0.999999999993015,0.792133854587423,0,2,positive regulation of Golgi to plasma membrane protein transport,BP,
10430,GO:0043291,0.999999999993015,0.792133854587423,0,2,RAVE complex,CC,
10451,GO:0043315,0.999999999993015,0.792133854587423,0,2,positive regulation of neutrophil degranulation,BP,
10536,GO:0043490,0.999999999993015,0.792133854587423,0,2,malate-aspartate shuttle,BP,
10571,GO:0043541,0.999999999993015,0.792133854587423,0,2,UDP-N-acetylglucosamine transferase complex,CC,
10600,GO:0043585,0.999999999993015,0.792133854587423,0,2,nose morphogenesis,BP,
10612,GO:0043614,0.999999999993015,0.792133854587423,0,2,multi-eIF complex,CC,
10758,GO:0044210,0.999999999993015,0.792133854587423,0,2,'de novo' CTP biosynthetic process,BP,
10812,GO:0044308,0.999999999993015,0.792133854587423,0,2,axonal spine,CC,
10822,GO:0044323,0.999999999993015,0.792133854587423,0,2,retinoic acid-responsive element binding,MF,
10832,GO:0044334,0.999999999993015,0.792133854587423,0,2,canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition,BP,
10948,GO:0044691,0.999999999993015,0.792133854587423,0,2,tooth eruption,BP,
10994,GO:0044805,0.999999999993015,0.792133854587423,0,2,late nucleophagy,BP,
11003,GO:0044830,0.999999999993015,0.792133854587423,0,2,modulation by host of viral RNA genome replication,BP,
11024,GO:0045004,0.999999999993015,0.792133854587423,0,2,DNA replication proofreading,BP,
11109,GO:0045142,0.999999999993015,0.792133854587423,0,2,triplex DNA binding,MF,
11138,GO:0045196,0.999999999993015,0.792133854587423,0,2,establishment or maintenance of neuroblast polarity,BP,
11142,GO:0045200,0.999999999993015,0.792133854587423,0,2,establishment of neuroblast polarity,BP,
11215,GO:0045356,0.999999999993015,0.792133854587423,0,2,positive regulation of interferon-alpha biosynthetic process,BP,
11252,GO:0045509,0.999999999993015,0.792133854587423,0,2,interleukin-27 receptor activity,MF,
11270,GO:0045588,0.999999999993015,0.792133854587423,0,2,positive regulation of gamma-delta T cell differentiation,BP,
11377,GO:0045763,0.999999999993015,0.792133854587423,0,2,negative regulation of cellular amino acid metabolic process,BP,
11485,GO:0045967,0.999999999993015,0.792133854587423,0,2,negative regulation of growth rate,BP,
11487,GO:0045976,0.999999999993015,0.792133854587423,0,2,negative regulation of mitotic cell cycle, embryonic,BP,
11530,GO:0046069,0.999999999993015,0.792133854587423,0,2,cGMP catabolic process,BP,
11577,GO:0046160,0.999999999993015,0.792133854587423,0,2,heme a metabolic process,BP,
11581,GO:0046167,0.999999999993015,0.792133854587423,0,2,glycerol-3-phosphate biosynthetic process,BP,
11628,GO:0046351,0.999999999993015,0.792133854587423,0,2,disaccharide biosynthetic process,BP,
11840,GO:0046832,0.999999999993015,0.792133854587423,0,2,negative regulation of RNA export from nucleus,BP,
11888,GO:0046922,0.999999999993015,0.792133854587423,0,2,peptide-O-fucosyltransferase activity,MF,
11907,GO:0046958,0.999999999993015,0.792133854587423,0,2,nonassociative learning,BP,
11914,GO:0046967,0.999999999993015,0.792133854587423,0,2,cytosol to ER transport,BP,
11964,GO:0047237,0.999999999993015,0.792133854587423,0,2,glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,MF,
11977,GO:0047322,0.999999999993015,0.792133854587423,0,2,[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity,MF,
11986,GO:0047389,0.999999999993015,0.792133854587423,0,2,glycerophosphocholine phosphodiesterase activity,MF,
12012,GO:0047623,0.999999999993015,0.792133854587423,0,2,adenosine-phosphate deaminase activity,MF,
12030,GO:0047757,0.999999999993015,0.792133854587423,0,2,chondroitin-glucuronate 5-epimerase activity,MF,
12063,GO:0048022,0.999999999993015,0.792133854587423,0,2,negative regulation of melanin biosynthetic process,BP,
12084,GO:0048073,0.999999999993015,0.792133854587423,0,2,regulation of eye pigmentation,BP,
12162,GO:0048294,0.999999999993015,0.792133854587423,0,2,negative regulation of isotype switching to IgE isotypes,BP,
12176,GO:0048319,0.999999999993015,0.792133854587423,0,2,axial mesoderm morphogenesis,BP,
12367,GO:0048769,0.999999999993015,0.792133854587423,0,2,sarcomerogenesis,BP,
12381,GO:0048817,0.999999999993015,0.792133854587423,0,2,negative regulation of hair follicle maturation,BP,
12395,GO:0048850,0.999999999993015,0.792133854587423,0,2,hypophysis morphogenesis,BP,
12469,GO:0050405,0.999999999993015,0.792133854587423,0,2,[acetyl-CoA carboxylase] kinase activity,MF,
12485,GO:0050508,0.999999999993015,0.792133854587423,0,2,glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,
12486,GO:0050509,0.999999999993015,0.792133854587423,0,2,N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity,MF,
12510,GO:0050659,0.999999999993015,0.792133854587423,0,2,N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity,MF,
12698,GO:0050925,0.999999999993015,0.792133854587423,0,2,negative regulation of negative chemotaxis,BP,
12711,GO:0050957,0.999999999993015,0.792133854587423,0,2,equilibrioception,BP,
13048,GO:0051548,0.999999999993015,0.792133854587423,0,2,negative regulation of keratinocyte migration,BP,
13053,GO:0051563,0.999999999993015,0.792133854587423,0,2,smooth endoplasmic reticulum calcium ion homeostasis,BP,
13113,GO:0051664,0.999999999993015,0.792133854587423,0,2,nuclear pore localization,BP,
13139,GO:0051717,0.999999999993015,0.792133854587423,0,2,inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity,MF,
13216,GO:0051890,0.999999999993015,0.792133854587423,0,2,regulation of cardioblast differentiation,BP,
13260,GO:0051958,0.999999999993015,0.792133854587423,0,2,methotrexate transport,BP,
13398,GO:0052746,0.999999999993015,0.792133854587423,0,2,inositol phosphorylation,BP,
13407,GO:0052812,0.999999999993015,0.792133854587423,0,2,phosphatidylinositol-3,4-bisphosphate 5-kinase activity,MF,
13415,GO:0052828,0.999999999993015,0.792133854587423,0,2,inositol-3,4-bisphosphate 4-phosphatase activity,MF,
13531,GO:0060002,0.999999999993015,0.792133854587423,0,2,plus-end directed microfilament motor activity,MF,
13551,GO:0060025,0.999999999993015,0.792133854587423,0,2,regulation of synaptic activity,BP,
13601,GO:0060083,0.999999999993015,0.792133854587423,0,2,smooth muscle contraction involved in micturition,BP,
13618,GO:0060124,0.999999999993015,0.792133854587423,0,2,positive regulation of growth hormone secretion,BP,
13619,GO:0060125,0.999999999993015,0.792133854587423,0,2,negative regulation of growth hormone secretion,BP,
13623,GO:0060129,0.999999999993015,0.792133854587423,0,2,thyroid-stimulating hormone-secreting cell differentiation,BP,
13639,GO:0060157,0.999999999993015,0.792133854587423,0,2,urinary bladder development,BP,
13784,GO:0060382,0.999999999993015,0.792133854587423,0,2,regulation of DNA strand elongation,BP,
13799,GO:0060399,0.999999999993015,0.792133854587423,0,2,positive regulation of growth hormone receptor signaling pathway,BP,
13804,GO:0060406,0.999999999993015,0.792133854587423,0,2,positive regulation of penile erection,BP,
13821,GO:0060430,0.999999999993015,0.792133854587423,0,2,lung saccule development,BP,
13874,GO:0060523,0.999999999993015,0.792133854587423,0,2,prostate epithelial cord elongation,BP,
13879,GO:0060529,0.999999999993015,0.792133854587423,0,2,squamous basal epithelial stem cell differentiation involved in prostate gland acinus development,BP,
13880,GO:0060532,0.999999999993015,0.792133854587423,0,2,bronchus cartilage development,BP,
13920,GO:0060594,0.999999999993015,0.792133854587423,0,2,mammary gland specification,BP,
13975,GO:0060698,0.999999999993015,0.792133854587423,0,2,endoribonuclease inhibitor activity,MF,
13978,GO:0060701,0.999999999993015,0.792133854587423,0,2,negative regulation of ribonuclease activity,BP,
13979,GO:0060702,0.999999999993015,0.792133854587423,0,2,negative regulation of endoribonuclease activity,BP,
14039,GO:0060816,0.999999999993015,0.792133854587423,0,2,random inactivation of X chromosome,BP,
14040,GO:0060819,0.999999999993015,0.792133854587423,0,2,inactivation of X chromosome by genetic imprinting,BP,
14082,GO:0060921,0.999999999993015,0.792133854587423,0,2,sinoatrial node cell differentiation,BP,
14087,GO:0060931,0.999999999993015,0.792133854587423,0,2,sinoatrial node cell development,BP,
14118,GO:0060995,0.999999999993015,0.792133854587423,0,2,cell-cell signaling involved in kidney development,BP,
14162,GO:0061055,0.999999999993015,0.792133854587423,0,2,myotome development,BP,
14201,GO:0061145,0.999999999993015,0.792133854587423,0,2,lung smooth muscle development,BP,
14220,GO:0061187,0.999999999993015,0.792133854587423,0,2,regulation of chromatin silencing at rDNA,BP,
14221,GO:0061188,0.999999999993015,0.792133854587423,0,2,negative regulation of chromatin silencing at rDNA,BP,
14236,GO:0061289,0.999999999993015,0.792133854587423,0,2,Wnt signaling pathway involved in kidney development,BP,
14237,GO:0061290,0.999999999993015,0.792133854587423,0,2,canonical Wnt signaling pathway involved in metanephric kidney development,BP,
14284,GO:0061386,0.999999999993015,0.792133854587423,0,2,closure of optic fissure,BP,
14301,GO:0061443,0.999999999993015,0.792133854587423,0,2,endocardial cushion cell differentiation,BP,
14319,GO:0061505,0.999999999993015,0.792133854587423,0,2,DNA topoisomerase II activity,MF,
14358,GO:0061582,0.999999999993015,0.792133854587423,0,2,intestinal epithelial cell migration,BP,
14388,GO:0061643,0.999999999993015,0.792133854587423,0,2,chemorepulsion of axon,BP,
14399,GO:0061669,0.999999999993015,0.792133854587423,0,2,spontaneous neurotransmitter secretion,BP,
14432,GO:0061749,0.999999999993015,0.792133854587423,0,2,forked DNA-dependent helicase activity,MF,
14469,GO:0061849,0.999999999993015,0.792133854587423,0,2,telomeric G-quadruplex DNA binding,MF,
14472,GO:0061857,0.999999999993015,0.792133854587423,0,2,endoplasmic reticulum stress-induced pre-emptive quality control,BP,
14503,GO:0065001,0.999999999993015,0.792133854587423,0,2,specification of axis polarity,BP,
14534,GO:0070052,0.999999999993015,0.792133854587423,0,2,collagen V binding,MF,
14562,GO:0070097,0.999999999993015,0.792133854587423,0,2,delta-catenin binding,MF,
14571,GO:0070110,0.999999999993015,0.792133854587423,0,2,ciliary neurotrophic factor receptor complex,CC,
14604,GO:0070170,0.999999999993015,0.792133854587423,0,2,regulation of tooth mineralization,BP,
14655,GO:0070259,0.999999999993015,0.792133854587423,0,2,tyrosyl-DNA phosphodiesterase activity,MF,
14688,GO:0070315,0.999999999993015,0.792133854587423,0,2,G1 to G0 transition involved in cell differentiation,BP,
14701,GO:0070336,0.999999999993015,0.792133854587423,0,2,flap-structured DNA binding,MF,
14704,GO:0070340,0.999999999993015,0.792133854587423,0,2,detection of bacterial lipopeptide,BP,
14722,GO:0070381,0.999999999993015,0.792133854587423,0,2,endosome to plasma membrane transport vesicle,CC,
14755,GO:0070436,0.999999999993015,0.792133854587423,0,2,Grb2-EGFR complex,CC,
14865,GO:0070649,0.999999999993015,0.792133854587423,0,2,formin-nucleated actin cable assembly,BP,
14870,GO:0070662,0.999999999993015,0.792133854587423,0,2,mast cell proliferation,BP,
14874,GO:0070666,0.999999999993015,0.792133854587423,0,2,regulation of mast cell proliferation,BP,
14876,GO:0070668,0.999999999993015,0.792133854587423,0,2,positive regulation of mast cell proliferation,BP,
14894,GO:0070704,0.999999999993015,0.792133854587423,0,2,sterol desaturase activity,MF,
14954,GO:0070853,0.999999999993015,0.792133854587423,0,2,myosin VI binding,MF,
14967,GO:0070877,0.999999999993015,0.792133854587423,0,2,microprocessor complex,CC,
15042,GO:0070993,0.999999999993015,0.792133854587423,0,2,translation preinitiation complex,CC,
15091,GO:0071109,0.999999999993015,0.792133854587423,0,2,superior temporal gyrus development,BP,
15098,GO:0071148,0.999999999993015,0.792133854587423,0,2,TEAD-1-YAP complex,CC,
15215,GO:0071374,0.999999999993015,0.792133854587423,0,2,cellular response to parathyroid hormone stimulus,BP,
15225,GO:0071386,0.999999999993015,0.792133854587423,0,2,cellular response to corticosterone stimulus,BP,
15242,GO:0071409,0.999999999993015,0.792133854587423,0,2,cellular response to cycloheximide,BP,
15246,GO:0071420,0.999999999993015,0.792133854587423,0,2,cellular response to histamine,BP,
15247,GO:0071421,0.999999999993015,0.792133854587423,0,2,manganese ion transmembrane transport,BP,
15286,GO:0071477,0.999999999993015,0.792133854587423,0,2,cellular hypotonic salinity response,BP,
15292,GO:0071483,0.999999999993015,0.792133854587423,0,2,cellular response to blue light,BP,
15293,GO:0071484,0.999999999993015,0.792133854587423,0,2,cellular response to light intensity,BP,
15359,GO:0071603,0.999999999993015,0.792133854587423,0,2,endothelial cell-cell adhesion,BP,
15388,GO:0071642,0.999999999993015,0.792133854587423,0,2,positive regulation of macrophage inflammatory protein 1 alpha production,BP,
15436,GO:0071724,0.999999999993015,0.792133854587423,0,2,response to diacyl bacterial lipopeptide,BP,
15438,GO:0071726,0.999999999993015,0.792133854587423,0,2,cellular response to diacyl bacterial lipopeptide,BP,
15482,GO:0071847,0.999999999993015,0.792133854587423,0,2,TNFSF11-mediated signaling pathway,BP,
15523,GO:0071918,0.999999999993015,0.792133854587423,0,2,urea transmembrane transport,BP,
15569,GO:0072034,0.999999999993015,0.792133854587423,0,2,renal vesicle induction,BP,
15571,GO:0072038,0.999999999993015,0.792133854587423,0,2,mesenchymal stem cell maintenance involved in nephron morphogenesis,BP,
15572,GO:0072039,0.999999999993015,0.792133854587423,0,2,regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
15573,GO:0072040,0.999999999993015,0.792133854587423,0,2,negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
15579,GO:0072053,0.999999999993015,0.792133854587423,0,2,renal inner medulla development,BP,
15580,GO:0072054,0.999999999993015,0.792133854587423,0,2,renal outer medulla development,BP,
15632,GO:0072134,0.999999999993015,0.792133854587423,0,2,nephrogenic mesenchyme morphogenesis,BP,
15633,GO:0072135,0.999999999993015,0.792133854587423,0,2,kidney mesenchymal cell proliferation,BP,
15634,GO:0072136,0.999999999993015,0.792133854587423,0,2,metanephric mesenchymal cell proliferation involved in metanephros development,BP,
15635,GO:0072137,0.999999999993015,0.792133854587423,0,2,condensed mesenchymal cell proliferation,BP,
15645,GO:0072162,0.999999999993015,0.792133854587423,0,2,metanephric mesenchymal cell differentiation,BP,
15676,GO:0072204,0.999999999993015,0.792133854587423,0,2,cell-cell signaling involved in metanephros development,BP,
15720,GO:0072289,0.999999999993015,0.792133854587423,0,2,metanephric nephron tubule formation,BP,
15768,GO:0072368,0.999999999993015,0.792133854587423,0,2,regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter,BP,
15795,GO:0072434,0.999999999993015,0.792133854587423,0,2,signal transduction involved in mitotic G2 DNA damage checkpoint,BP,
15958,GO:0075732,0.999999999993015,0.792133854587423,0,2,viral penetration into host nucleus,BP,
15994,GO:0086007,0.999999999993015,0.792133854587423,0,2,voltage-gated calcium channel activity involved in cardiac muscle cell action potential,MF,
16002,GO:0086015,0.999999999993015,0.792133854587423,0,2,SA node cell action potential,BP,
16004,GO:0086017,0.999999999993015,0.792133854587423,0,2,Purkinje myocyte action potential,BP,
16005,GO:0086018,0.999999999993015,0.792133854587423,0,2,SA node cell to atrial cardiac muscle cell signaling,BP,
16007,GO:0086020,0.999999999993015,0.792133854587423,0,2,gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling,MF,
16008,GO:0086021,0.999999999993015,0.792133854587423,0,2,SA node cell to atrial cardiac muscle cell communication by electrical coupling,BP,
16014,GO:0086029,0.999999999993015,0.792133854587423,0,2,Purkinje myocyte to ventricular cardiac muscle cell signaling,BP,
16023,GO:0086045,0.999999999993015,0.792133854587423,0,2,membrane depolarization during AV node cell action potential,BP,
16026,GO:0086048,0.999999999993015,0.792133854587423,0,2,membrane depolarization during bundle of His cell action potential,BP,
16027,GO:0086053,0.999999999993015,0.792133854587423,0,2,AV node cell to bundle of His cell communication by electrical coupling,BP,
16036,GO:0086068,0.999999999993015,0.792133854587423,0,2,Purkinje myocyte to ventricular cardiac muscle cell communication,BP,
16043,GO:0086077,0.999999999993015,0.792133854587423,0,2,gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling,MF,
16076,GO:0090038,0.999999999993015,0.792133854587423,0,2,negative regulation of protein kinase C signaling,BP,
16187,GO:0090210,0.999999999993015,0.792133854587423,0,2,regulation of establishment of blood-brain barrier,BP,
16193,GO:0090222,0.999999999993015,0.792133854587423,0,2,centrosome-templated microtubule nucleation,BP,
16223,GO:0090271,0.999999999993015,0.792133854587423,0,2,positive regulation of fibroblast growth factor production,BP,
16264,GO:0090325,0.999999999993015,0.792133854587423,0,2,regulation of locomotion involved in locomotory behavior,BP,
16289,GO:0090386,0.999999999993015,0.792133854587423,0,2,phagosome maturation involved in apoptotic cell clearance,BP,
16290,GO:0090387,0.999999999993015,0.792133854587423,0,2,phagolysosome assembly involved in apoptotic cell clearance,BP,
16326,GO:0090541,0.999999999993015,0.792133854587423,0,2,MIT domain binding,MF,
16373,GO:0090694,0.999999999993015,0.792133854587423,0,2,Scc2-Scc4 cohesin loading complex,CC,
16395,GO:0097016,0.999999999993015,0.792133854587423,0,2,L27 domain binding,MF,
16429,GO:0097069,0.999999999993015,0.792133854587423,0,2,cellular response to thyroxine stimulus,BP,
16447,GO:0097111,0.999999999993015,0.792133854587423,0,2,endoplasmic reticulum-Golgi intermediate compartment organization,BP,
16453,GO:0097118,0.999999999993015,0.792133854587423,0,2,neuroligin clustering involved in postsynaptic membrane assembly,BP,
16471,GO:0097155,0.999999999993015,0.792133854587423,0,2,fasciculation of sensory neuron axon,BP,
16499,GO:0097198,0.999999999993015,0.792133854587423,0,2,histone H3-K36 trimethylation,BP,
16533,GO:0097274,0.999999999993015,0.792133854587423,0,2,urea homeostasis,BP,
16567,GO:0097359,0.999999999993015,0.792133854587423,0,2,UDP-glucosylation,BP,
16571,GO:0097363,0.999999999993015,0.792133854587423,0,2,protein O-GlcNAc transferase activity,MF,
16610,GO:0097450,0.999999999993015,0.792133854587423,0,2,astrocyte end-foot,CC,
16611,GO:0097451,0.999999999993015,0.792133854587423,0,2,glial limiting end-foot,CC,
16663,GO:0097543,0.999999999993015,0.792133854587423,0,2,ciliary inversin compartment,CC,
16668,GO:0097574,0.999999999993015,0.792133854587423,0,2,lateral part of cell,CC,
16669,GO:0097575,0.999999999993015,0.792133854587423,0,2,lateral cell cortex,CC,
16687,GO:0097636,0.999999999993015,0.792133854587423,0,2,intrinsic component of autophagosome membrane,CC,
16688,GO:0097637,0.999999999993015,0.792133854587423,0,2,integral component of autophagosome membrane,CC,
16689,GO:0097638,0.999999999993015,0.792133854587423,0,2,L-arginine import across plasma membrane,BP,
16698,GO:0097651,0.999999999993015,0.792133854587423,0,2,phosphatidylinositol 3-kinase complex, class I,CC,
16704,GO:0097681,0.999999999993015,0.792133854587423,0,2,double-strand break repair via alternative nonhomologous end joining,BP,
16772,GO:0098582,0.999999999993015,0.792133854587423,0,2,innate vocalization behavior,BP,
16851,GO:0098770,0.999999999993015,0.792133854587423,0,2,FBXO family protein binding,MF,
16864,GO:0098795,0.999999999993015,0.792133854587423,0,2,mRNA cleavage involved in gene silencing,BP,
16935,GO:0098914,0.999999999993015,0.792133854587423,0,2,membrane repolarization during atrial cardiac muscle cell action potential,BP,
16967,GO:0098978,0.999999999993015,0.792133854587423,0,2,glutamatergic synapse,CC,
16971,GO:0098985,0.999999999993015,0.792133854587423,0,2,asymmetric, glutamatergic, excitatory synapse,CC,
16978,GO:0099011,0.999999999993015,0.792133854587423,0,2,neuronal dense core vesicle exocytosis,BP,
16994,GO:0099073,0.999999999993015,0.792133854587423,0,2,mitochondrion-derived vesicle,CC,
17006,GO:0099093,0.999999999993015,0.792133854587423,0,2,calcium export from the mitochondrion,BP,
17033,GO:0099403,0.999999999993015,0.792133854587423,0,2,maintenance of mitotic sister chromatid cohesion, telomeric,BP,
17034,GO:0099404,0.999999999993015,0.792133854587423,0,2,mitotic sister chromatid cohesion, telomeric,BP,
17050,GO:0099525,0.999999999993015,0.792133854587423,0,2,presynaptic dense core vesicle exocytosis,BP,
17088,GO:0099609,0.999999999993015,0.792133854587423,0,2,microtubule lateral binding,MF,
17093,GO:0099624,0.999999999993015,0.792133854587423,0,2,atrial cardiac muscle cell membrane repolarization,BP,
17126,GO:0102092,0.999999999993015,0.792133854587423,0,2,5-diphosphoinositol pentakisphosphate 3-kinase activity,MF,
17217,GO:0106073,0.999999999993015,0.792133854587423,0,2,dolichyl pyrophosphate Glc2Man9GlcNAc2 alpha-1,2-glucosyltransferase activity,MF,
17229,GO:0110009,0.999999999993015,0.792133854587423,0,2,formin-nucleated actin cable organization,BP,
17298,GO:0140066,0.999999999993015,0.792133854587423,0,2,peptidyl-lysine crotonylation,BP,
17316,GO:0140135,0.999999999993015,0.792133854587423,0,2,mechanosensitive cation channel activity,MF,
17357,GO:1900042,0.999999999993015,0.792133854587423,0,2,positive regulation of interleukin-2 secretion,BP,
17390,GO:1900114,0.999999999993015,0.792133854587423,0,2,positive regulation of histone H3-K9 trimethylation,BP,
17413,GO:1900147,0.999999999993015,0.792133854587423,0,2,regulation of Schwann cell migration,BP,
17426,GO:1900169,0.999999999993015,0.792133854587423,0,2,regulation of glucocorticoid mediated signaling pathway,BP,
17448,GO:1900220,0.999999999993015,0.792133854587423,0,2,semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis,BP,
17465,GO:1900248,0.999999999993015,0.792133854587423,0,2,negative regulation of cytoplasmic translational elongation,BP,
17474,GO:1900275,0.999999999993015,0.792133854587423,0,2,negative regulation of phospholipase C activity,BP,
17486,GO:1900377,0.999999999993015,0.792133854587423,0,2,negative regulation of secondary metabolite biosynthetic process,BP,
17487,GO:1900378,0.999999999993015,0.792133854587423,0,2,positive regulation of secondary metabolite biosynthetic process,BP,
17511,GO:1900623,0.999999999993015,0.792133854587423,0,2,regulation of monocyte aggregation,BP,
17512,GO:1900625,0.999999999993015,0.792133854587423,0,2,positive regulation of monocyte aggregation,BP,
17551,GO:1901073,0.999999999993015,0.792133854587423,0,2,glucosamine-containing compound biosynthetic process,BP,
17571,GO:1901145,0.999999999993015,0.792133854587423,0,2,mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
17669,GO:1901491,0.999999999993015,0.792133854587423,0,2,negative regulation of lymphangiogenesis,BP,
17679,GO:1901529,0.999999999993015,0.792133854587423,0,2,positive regulation of anion channel activity,BP,
17682,GO:1901534,0.999999999993015,0.792133854587423,0,2,positive regulation of hematopoietic progenitor cell differentiation,BP,
17690,GO:1901552,0.999999999993015,0.792133854587423,0,2,positive regulation of endothelial cell development,BP,
17791,GO:1901843,0.999999999993015,0.792133854587423,0,2,positive regulation of high voltage-gated calcium channel activity,BP,
17940,GO:1902256,0.999999999993015,0.792133854587423,0,2,regulation of apoptotic process involved in outflow tract morphogenesis,BP,
17944,GO:1902261,0.999999999993015,0.792133854587423,0,2,positive regulation of delayed rectifier potassium channel activity,BP,
17961,GO:1902302,0.999999999993015,0.792133854587423,0,2,regulation of potassium ion export,BP,
18032,GO:1902523,0.999999999993015,0.792133854587423,0,2,positive regulation of protein K63-linked ubiquitination,BP,
18052,GO:1902565,0.999999999993015,0.792133854587423,0,2,positive regulation of neutrophil activation,BP,
18062,GO:1902594,0.999999999993015,0.792133854587423,0,2,multi-organism nuclear import,BP,
18102,GO:1902715,0.999999999993015,0.792133854587423,0,2,positive regulation of interferon-gamma secretion,BP,
18105,GO:1902724,0.999999999993015,0.792133854587423,0,2,positive regulation of skeletal muscle satellite cell proliferation,BP,
18107,GO:1902728,0.999999999993015,0.792133854587423,0,2,positive regulation of growth factor dependent skeletal muscle satellite cell proliferation,BP,
18131,GO:1902805,0.999999999993015,0.792133854587423,0,2,positive regulation of synaptic vesicle transport,BP,
18164,GO:1902896,0.999999999993015,0.792133854587423,0,2,terminal web assembly,BP,
18268,GO:1903095,0.999999999993015,0.792133854587423,0,2,ribonuclease III complex,CC,
18273,GO:1903116,0.999999999993015,0.792133854587423,0,2,positive regulation of actin filament-based movement,BP,
18283,GO:1903142,0.999999999993015,0.792133854587423,0,2,positive regulation of establishment of endothelial barrier,BP,
18318,GO:1903225,0.999999999993015,0.792133854587423,0,2,negative regulation of endodermal cell differentiation,BP,
18321,GO:1903233,0.999999999993015,0.792133854587423,0,2,regulation of calcium ion-dependent exocytosis of neurotransmitter,BP,
18342,GO:1903292,0.999999999993015,0.792133854587423,0,2,protein localization to Golgi membrane,BP,
18344,GO:1903294,0.999999999993015,0.792133854587423,0,2,regulation of glutamate secretion, neurotransmission,BP,
18345,GO:1903296,0.999999999993015,0.792133854587423,0,2,positive regulation of glutamate secretion, neurotransmission,BP,
18386,GO:1903378,0.999999999993015,0.792133854587423,0,2,positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
18418,GO:1903436,0.999999999993015,0.792133854587423,0,2,regulation of mitotic cytokinetic process,BP,
18419,GO:1903438,0.999999999993015,0.792133854587423,0,2,positive regulation of mitotic cytokinetic process,BP,
18434,GO:1903490,0.999999999993015,0.792133854587423,0,2,positive regulation of mitotic cytokinesis,BP,
18529,GO:1903691,0.999999999993015,0.792133854587423,0,2,positive regulation of wound healing, spreading of epidermal cells,BP,
18560,GO:1903760,0.999999999993015,0.792133854587423,0,2,regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,BP,
18572,GO:1903781,0.999999999993015,0.792133854587423,0,2,positive regulation of cardiac conduction,BP,
18579,GO:1903796,0.999999999993015,0.792133854587423,0,2,negative regulation of inorganic anion transmembrane transport,BP,
18602,GO:1903847,0.999999999993015,0.792133854587423,0,2,regulation of aorta morphogenesis,BP,
18603,GO:1903849,0.999999999993015,0.792133854587423,0,2,positive regulation of aorta morphogenesis,BP,
18611,GO:1903874,0.999999999993015,0.792133854587423,0,2,ferrous iron transmembrane transport,BP,
18653,GO:1903949,0.999999999993015,0.792133854587423,0,2,positive regulation of atrial cardiac muscle cell action potential,BP,
18682,GO:1904017,0.999999999993015,0.792133854587423,0,2,cellular response to Thyroglobulin triiodothyronine,BP,
18747,GO:1904204,0.999999999993015,0.792133854587423,0,2,regulation of skeletal muscle hypertrophy,BP,
18789,GO:1904289,0.999999999993015,0.792133854587423,0,2,regulation of mitotic DNA damage checkpoint,BP,
18806,GO:1904327,0.999999999993015,0.792133854587423,0,2,protein localization to cytosolic proteasome complex,BP,
18824,GO:1904379,0.999999999993015,0.792133854587423,0,2,protein localization to cytosolic proteasome complex involved in ERAD pathway,BP,
18826,GO:1904381,0.999999999993015,0.792133854587423,0,2,Golgi apparatus mannose trimming,BP,
18831,GO:1904387,0.999999999993015,0.792133854587423,0,2,cellular response to L-phenylalanine derivative,BP,
18859,GO:1904455,0.999999999993015,0.792133854587423,0,2,ubiquitin-specific protease activity involved in negative regulation of ERAD pathway,MF,
18866,GO:1904475,0.999999999993015,0.792133854587423,0,2,regulation of Ras GTPase binding,BP,
18882,GO:1904529,0.999999999993015,0.792133854587423,0,2,regulation of actin filament binding,BP,
18893,GO:1904562,0.999999999993015,0.792133854587423,0,2,phosphatidylinositol 5-phosphate metabolic process,BP,
18922,GO:1904612,0.999999999993015,0.792133854587423,0,2,response to 2,3,7,8-tetrachlorodibenzodioxine,BP,
18923,GO:1904613,0.999999999993015,0.792133854587423,0,2,cellular response to 2,3,7,8-tetrachlorodibenzodioxine,BP,
18924,GO:1904616,0.999999999993015,0.792133854587423,0,2,regulation of actin binding,BP,
18940,GO:1904673,0.999999999993015,0.792133854587423,0,2,negative regulation of somatic stem cell population maintenance,BP,
18976,GO:1904743,0.999999999993015,0.792133854587423,0,2,negative regulation of telomeric DNA binding,BP,
19038,GO:1904868,0.999999999993015,0.792133854587423,0,2,telomerase catalytic core complex assembly,BP,
19050,GO:1904882,0.999999999993015,0.792133854587423,0,2,regulation of telomerase catalytic core complex assembly,BP,
19051,GO:1904884,0.999999999993015,0.792133854587423,0,2,positive regulation of telomerase catalytic core complex assembly,BP,
19064,GO:1904907,0.999999999993015,0.792133854587423,0,2,regulation of maintenance of mitotic sister chromatid cohesion, telomeric,BP,
19065,GO:1904908,0.999999999993015,0.792133854587423,0,2,negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric,BP,
19093,GO:1904975,0.999999999993015,0.792133854587423,0,2,response to bleomycin,BP,
19094,GO:1904976,0.999999999993015,0.792133854587423,0,2,cellular response to bleomycin,BP,
19112,GO:1905024,0.999999999993015,0.792133854587423,0,2,regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
19139,GO:1905071,0.999999999993015,0.792133854587423,0,2,occluding junction disassembly,BP,
19140,GO:1905073,0.999999999993015,0.792133854587423,0,2,regulation of occluding junction disassembly,BP,
19141,GO:1905075,0.999999999993015,0.792133854587423,0,2,positive regulation of occluding junction disassembly,BP,
19151,GO:1905123,0.999999999993015,0.792133854587423,0,2,regulation of glucosylceramidase activity,BP,
19158,GO:1905150,0.999999999993015,0.792133854587423,0,2,regulation of voltage-gated sodium channel activity,BP,
19187,GO:1905224,0.999999999993015,0.792133854587423,0,2,clathrin-coated pit assembly,BP,
19284,GO:1905462,0.999999999993015,0.792133854587423,0,2,regulation of DNA duplex unwinding,BP,
19304,GO:1905538,0.999999999993015,0.792133854587423,0,2,polysome binding,MF,
19336,GO:1905616,0.999999999993015,0.792133854587423,0,2,regulation of miRNA mediated inhibition of translation,BP,
19337,GO:1905618,0.999999999993015,0.792133854587423,0,2,positive regulation of miRNA mediated inhibition of translation,BP,
19354,GO:1905696,0.999999999993015,0.792133854587423,0,2,regulation of polysome binding,BP,
19459,GO:1990108,0.999999999993015,0.792133854587423,0,2,protein linear deubiquitination,BP,
19473,GO:1990145,0.999999999993015,0.792133854587423,0,2,maintenance of translational fidelity,BP,
19544,GO:1990428,0.999999999993015,0.792133854587423,0,2,miRNA transport,BP,
19546,GO:1990430,0.999999999993015,0.792133854587423,0,2,extracellular matrix protein binding,MF,
19555,GO:1990452,0.999999999993015,0.792133854587423,0,2,Parkin-FBXW7-Cul1 ubiquitin ligase complex,CC,
19562,GO:1990498,0.999999999993015,0.792133854587423,0,2,mitotic spindle microtubule,CC,
19611,GO:1990723,0.999999999993015,0.792133854587423,0,2,cytoplasmic periphery of the nuclear pore complex,CC,
19614,GO:1990730,0.999999999993015,0.792133854587423,0,2,VCP-NSFL1C complex,CC,
19678,GO:1990918,0.999999999993015,0.792133854587423,0,2,double-strand break repair involved in meiotic recombination,BP,
19679,GO:1990923,0.999999999993015,0.792133854587423,0,2,PET complex,CC,
19681,GO:1990927,0.999999999993015,0.792133854587423,0,2,calcium ion regulated lysosome exocytosis,BP,
19682,GO:1990928,0.999999999993015,0.792133854587423,0,2,response to amino acid starvation,BP,
19710,GO:2000017,0.999999999993015,0.792133854587423,0,2,positive regulation of determination of dorsal identity,BP,
19728,GO:2000053,0.999999999993015,0.792133854587423,0,2,regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
19774,GO:2000156,0.999999999993015,0.792133854587423,0,2,regulation of retrograde vesicle-mediated transport, Golgi to ER,BP,
19812,GO:2000233,0.999999999993015,0.792133854587423,0,2,negative regulation of rRNA processing,BP,
19820,GO:2000253,0.999999999993015,0.792133854587423,0,2,positive regulation of feeding behavior,BP,
19850,GO:2000302,0.999999999993015,0.792133854587423,0,2,positive regulation of synaptic vesicle exocytosis,BP,
19994,GO:2000563,0.999999999993015,0.792133854587423,0,2,positive regulation of CD4-positive, alpha-beta T cell proliferation,BP,
20010,GO:2000588,0.999999999993015,0.792133854587423,0,2,positive regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
20019,GO:2000611,0.999999999993015,0.792133854587423,0,2,positive regulation of thyroid hormone generation,BP,
20026,GO:2000620,0.999999999993015,0.792133854587423,0,2,positive regulation of histone H4-K16 acetylation,BP,
20065,GO:2000670,0.999999999993015,0.792133854587423,0,2,positive regulation of dendritic cell apoptotic process,BP,
20079,GO:2000697,0.999999999993015,0.792133854587423,0,2,negative regulation of epithelial cell differentiation involved in kidney development,BP,
20130,GO:2000790,0.999999999993015,0.792133854587423,0,2,regulation of mesenchymal cell proliferation involved in lung development,BP,
20131,GO:2000791,0.999999999993015,0.792133854587423,0,2,negative regulation of mesenchymal cell proliferation involved in lung development,BP,
20132,GO:2000793,0.999999999993015,0.792133854587423,0,2,cell proliferation involved in heart valve development,BP,
20157,GO:2000832,0.999999999993015,0.792133854587423,0,2,negative regulation of steroid hormone secretion,BP,
20164,GO:2000847,0.999999999993015,0.792133854587423,0,2,negative regulation of corticosteroid hormone secretion,BP,
20167,GO:2000850,0.999999999993015,0.792133854587423,0,2,negative regulation of glucocorticoid secretion,BP,
20189,GO:2001013,0.999999999993015,0.792133854587423,0,2,epithelial cell proliferation involved in renal tubule morphogenesis,BP,
20191,GO:2001015,0.999999999993015,0.792133854587423,0,2,negative regulation of skeletal muscle cell differentiation,BP,
20200,GO:2001027,0.999999999993015,0.792133854587423,0,2,negative regulation of endothelial cell chemotaxis,BP,
20213,GO:2001045,0.999999999993015,0.792133854587423,0,2,negative regulation of integrin-mediated signaling pathway,BP,
20224,GO:2001106,0.999999999993015,0.792133854587423,0,2,regulation of Rho guanyl-nucleotide exchange factor activity,BP,
20269,GO:2001201,0.999999999993015,0.792133854587423,0,2,regulation of transforming growth factor-beta secretion,BP,
20283,GO:2001228,0.999999999993015,0.792133854587423,0,2,regulation of response to gamma radiation,BP,
20323,GO:2001295,0.999999999993015,0.792133854587423,0,2,malonyl-CoA biosynthetic process,BP,
7180,GO:0031074,0.999999999993024,0.724672064268839,0,3,nucleocytoplasmic transport complex,CC,
496,GO:0001552,0.999999999993033,0.893421613719097,0,1,ovarian follicle atresia,BP,
19892,GO:2000355,0.999999999993033,0.893421613719097,0,1,negative regulation of ovarian follicle development,BP,
12848,GO:0051176,0.999999999993056,0.705655545539046,0,3,positive regulation of sulfur metabolic process,BP,
1562,GO:0003962,0.999999999993067,0.89628522943732,0,1,cystathionine gamma-synthase activity,MF,
1665,GO:0004123,0.999999999993067,0.89628522943732,0,1,cystathionine gamma-lyase activity,MF,
5944,GO:0018272,0.999999999993067,0.89628522943732,0,1,protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine,BP,
9365,GO:0035887,0.999999999993067,0.89628522943732,0,1,aortic smooth muscle cell differentiation,BP,
10911,GO:0044524,0.999999999993067,0.89628522943732,0,1,protein sulfhydration,BP,
10918,GO:0044540,0.999999999993067,0.89628522943732,0,1,L-cystine L-cysteine-lyase (deaminating),MF,
12044,GO:0047982,0.999999999993067,0.89628522943732,0,1,homocysteine desulfhydrase activity,MF,
15149,GO:0071266,0.999999999993067,0.89628522943732,0,1,'de novo' L-methionine biosynthetic process,BP,
15978,GO:0080146,0.999999999993067,0.89628522943732,0,1,L-cysteine desulfhydrase activity,MF,
19021,GO:1904829,0.999999999993067,0.89628522943732,0,1,regulation of aortic smooth muscle cell differentiation,BP,
19022,GO:1904831,0.999999999993067,0.89628522943732,0,1,positive regulation of aortic smooth muscle cell differentiation,BP,
18678,GO:1903998,0.999999999993086,0.73259065591827,0,3,regulation of eating behavior,BP,
18710,GO:1904058,0.999999999993086,0.73259065591827,0,3,positive regulation of sensory perception of pain,BP,
15264,GO:0071449,0.999999999993097,0.920761808168413,0,1,cellular response to lipid hydroperoxide,BP,
14664,GO:0070274,0.999999999993111,0.804181517241998,0,2,RES complex,CC,
15850,GO:0072572,0.999999999993119,0.891584200317594,0,1,poly-ADP-D-ribose binding,MF,
6250,GO:0019834,0.999999999993146,0.729823657082314,0,3,phospholipase A2 inhibitor activity,MF,
3725,GO:0008263,0.999999999993163,0.792312813574553,0,2,pyrimidine-specific mismatch base pair DNA N-glycosylase activity,MF,
17151,GO:0102485,0.999999999993167,0.792133869952849,0,2,dATP phosphohydrolase activity,MF,
17152,GO:0102486,0.999999999993167,0.792133869952849,0,2,dCTP phosphohydrolase activity,MF,
17153,GO:0102487,0.999999999993167,0.792133869952849,0,2,dUTP phosphohydrolase activity,MF,
17154,GO:0102488,0.999999999993167,0.792133869952849,0,2,dTTP phosphohydrolase activity,MF,
17155,GO:0102489,0.999999999993167,0.792133869952849,0,2,GTP phosphohydrolase activity,MF,
17156,GO:0102490,0.999999999993167,0.792133869952849,0,2,8-oxo-dGTP phosphohydrolase activity,MF,
17157,GO:0102491,0.999999999993167,0.792133869952849,0,2,dGTP phosphohydrolase activity,MF,
18845,GO:1904426,0.999999999993167,0.792133869952849,0,2,positive regulation of GTP binding,BP,
17547,GO:1901069,0.999999999993212,0.81433599438443,0,2,guanosine-containing compound catabolic process,BP,
6892,GO:0030432,0.999999999993219,0.828273780135956,0,2,peristalsis,BP,
585,GO:0001740,0.999999999993223,0.708898189612819,0,3,Barr body,CC,
5516,GO:0016479,0.999999999993223,0.708898189612819,0,3,negative regulation of transcription by RNA polymerase I,BP,
17098,GO:0099631,0.999999999993254,0.831357572423125,0,2,postsynaptic endocytic zone cytoplasmic component,CC,
2012,GO:0004739,0.999999999993254,0.801708939750473,0,2,pyruvate dehydrogenase (acetyl-transferring) activity,MF,
4474,GO:0010481,0.999999999993266,0.718314588292206,0,3,epidermal cell division,BP,
4475,GO:0010482,0.999999999993266,0.718314588292206,0,3,regulation of epidermal cell division,BP,
11440,GO:0045901,0.999999999993266,0.718314588292206,0,3,positive regulation of translational elongation,BP,
10752,GO:0044194,0.999999999993272,0.708238771704981,0,3,cytolytic granule,CC,
19593,GO:1990622,0.999999999993273,0.821876879877857,0,2,CHOP-ATF3 complex,CC,
9918,GO:0042270,0.99999999999329,0.716290645841716,0,3,protection from natural killer cell mediated cytotoxicity,BP,
8277,GO:0033091,0.999999999993322,0.890080441412429,0,1,positive regulation of immature T cell proliferation,BP,
1885,GO:0004566,0.999999999993325,0.797999614359375,0,2,beta-glucuronidase activity,MF,
5415,GO:0016262,0.999999999993333,0.70839844606508,0,3,protein N-acetylglucosaminyltransferase activity,MF,
6009,GO:0019060,0.999999999993336,0.831808519371437,0,2,intracellular transport of viral protein in host cell,BP,
6948,GO:0030581,0.999999999993336,0.831808519371437,0,2,symbiont intracellular protein transport in host,BP,
13132,GO:0051708,0.999999999993336,0.831808519371437,0,2,intracellular protein transport in other organism involved in symbiotic interaction,BP,
244,GO:0000701,0.999999999993338,0.810613045208513,0,2,purine-specific mismatch base pair DNA N-glycosylase activity,MF,
9799,GO:0040032,0.999999999993378,0.894022040801814,0,1,post-embryonic body morphogenesis,BP,
14440,GO:0061763,0.999999999993394,0.792162681015146,0,2,multivesicular body-lysosome fusion,BP,
10220,GO:0042904,0.999999999993425,0.792172506308166,0,2,9-cis-retinoic acid biosynthetic process,BP,
10221,GO:0042905,0.999999999993425,0.792172506308166,0,2,9-cis-retinoic acid metabolic process,BP,
14831,GO:0070576,0.999999999993425,0.792172506308166,0,2,vitamin D 24-hydroxylase activity,MF,
19486,GO:1990180,0.99999999999343,0.728903398765092,0,3,mitochondrial tRNA 3'-end processing,BP,
10676,GO:0043946,0.999999999993434,0.896250012581128,0,1,positive regulation of catalytic activity in other organism involved in symbiotic interaction,BP,
10677,GO:0043947,0.999999999993434,0.896250012581128,0,1,positive regulation by host of symbiont catalytic activity,BP,
13341,GO:0052422,0.999999999993434,0.896250012581128,0,1,modulation by host of symbiont catalytic activity,BP,
975,GO:0002428,0.999999999993449,0.733323193859013,0,3,antigen processing and presentation of peptide antigen via MHC class Ib,BP,
5947,GO:0018282,0.999999999993452,0.792506108169864,0,2,metal incorporation into metallo-sulfur cluster,BP,
5948,GO:0018283,0.999999999993452,0.792506108169864,0,2,iron incorporation into metallo-sulfur cluster,BP,
8569,GO:0034057,0.999999999993463,0.792251336870902,0,2,RNA strand-exchange activity,MF,
811,GO:0002085,0.999999999993479,0.715121754343819,0,3,inhibition of neuroepithelial cell differentiation,BP,
9373,GO:0035905,0.999999999993479,0.715121754343819,0,3,ascending aorta development,BP,
9376,GO:0035910,0.999999999993479,0.715121754343819,0,3,ascending aorta morphogenesis,BP,
11287,GO:0045608,0.999999999993479,0.715121754343819,0,3,negative regulation of inner ear auditory receptor cell differentiation,BP,
15932,GO:0072737,0.999999999993499,0.793464960321038,0,2,response to diamide,BP,
15933,GO:0072738,0.999999999993499,0.793464960321038,0,2,cellular response to diamide,BP,
11649,GO:0046404,0.999999999993501,0.715174558269846,0,3,ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity,MF,
13150,GO:0051733,0.999999999993501,0.715174558269846,0,3,polydeoxyribonucleotide kinase activity,MF,
13151,GO:0051734,0.999999999993501,0.715174558269846,0,3,ATP-dependent polynucleotide kinase activity,MF,
3932,GO:0008616,0.999999999993503,0.733348292209759,0,3,queuosine biosynthetic process,BP,
11558,GO:0046116,0.999999999993503,0.733348292209759,0,3,queuosine metabolic process,BP,
14577,GO:0070124,0.999999999993537,0.814816947604932,0,2,mitochondrial translational initiation,BP,
8671,GO:0034271,0.999999999993538,0.706184985532591,0,3,phosphatidylinositol 3-kinase complex, class III, type I,CC,
8672,GO:0034272,0.999999999993538,0.706184985532591,0,3,phosphatidylinositol 3-kinase complex, class III, type II,CC,
3818,GO:0008418,0.99999999999355,0.913312596128395,0,1,protein-N-terminal asparagine amidohydrolase activity,MF,
5952,GO:0018312,0.999999999993561,0.795869972549526,0,2,peptidyl-serine ADP-ribosylation,BP,
19528,GO:1990404,0.999999999993561,0.795869972549526,0,2,protein ADP-ribosylase activity,MF,
4863,GO:0014707,0.999999999993595,0.890439052928726,0,1,branchiomeric skeletal muscle development,BP,
9625,GO:0036497,0.999999999993595,0.890439052928726,0,1,eIF2alpha dephosphorylation in response to endoplasmic reticulum stress,BP,
17968,GO:1902310,0.999999999993595,0.890439052928726,0,1,positive regulation of peptidyl-serine dephosphorylation,BP,
18636,GO:1903916,0.999999999993595,0.890439052928726,0,1,regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation,BP,
18637,GO:1903917,0.999999999993595,0.890439052928726,0,1,positive regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation,BP,
9867,GO:0042134,0.999999999993646,0.817546560871993,0,2,rRNA primary transcript binding,MF,
860,GO:0002191,0.99999999999365,0.710521224484892,0,3,cap-dependent translational initiation,BP,
7832,GO:0032393,0.999999999993674,0.819452895648509,0,2,MHC class I receptor activity,MF,
15185,GO:0071332,0.999999999993708,0.796807407363164,0,2,cellular response to fructose stimulus,BP,
1520,GO:0003881,0.999999999993725,0.894268575622605,0,1,CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity,MF,
913,GO:0002299,0.999999999993736,0.900052383299956,0,1,alpha-beta intraepithelial T cell differentiation,BP,
914,GO:0002300,0.999999999993736,0.900052383299956,0,1,CD8-positive, alpha-beta intraepithelial T cell differentiation,BP,
915,GO:0002304,0.999999999993736,0.900052383299956,0,1,gamma-delta intraepithelial T cell differentiation,BP,
916,GO:0002305,0.999999999993736,0.900052383299956,0,1,CD8-positive, gamma-delta intraepithelial T cell differentiation,BP,
3638,GO:0008113,0.999999999993746,0.817282723730106,0,2,peptide-methionine (S)-S-oxide reductase activity,MF,
19362,GO:1905719,0.999999999993782,0.792134003769941,0,2,protein localization to perinuclear region of cytoplasm,BP,
1273,GO:0003064,0.999999999993784,0.894704164792473,0,1,regulation of heart rate by hormone,BP,
19411,GO:1905912,0.999999999993784,0.894704164792473,0,1,regulation of calcium ion export across plasma membrane,BP,
19412,GO:1905913,0.999999999993784,0.894704164792473,0,1,negative regulation of calcium ion export across plasma membrane,BP,
1563,GO:0003963,0.999999999993834,0.793328212910035,0,2,RNA-3'-phosphate cyclase activity,MF,
6344,GO:0021524,0.999999999993876,0.796899401820451,0,2,visceral motor neuron differentiation,BP,
10480,GO:0043382,0.999999999993887,0.727928842586289,0,3,positive regulation of memory T cell differentiation,BP,
6474,GO:0021822,0.999999999993889,0.891580721821325,0,1,negative regulation of cell motility involved in cerebral cortex radial glia guided migration,BP,
19871,GO:2000328,0.99999999999389,0.727928842586285,0,3,regulation of T-helper 17 cell lineage commitment,BP,
16230,GO:0090281,0.999999999993891,0.707065273018719,0,3,negative regulation of calcium ion import,BP,
5152,GO:0015691,0.999999999993892,0.707065273018718,0,3,cadmium ion transport,BP,
14830,GO:0070574,0.999999999993892,0.707065273018718,0,3,cadmium ion transmembrane transport,BP,
18197,GO:1902956,0.999999999993896,0.728809393625562,0,3,regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
899,GO:0002277,0.999999999993904,0.921595111941282,0,1,myeloid dendritic cell activation involved in immune response,BP,
1055,GO:0002582,0.999999999993904,0.921595111941282,0,1,positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1058,GO:0002585,0.999999999993904,0.921595111941282,0,1,positive regulation of antigen processing and presentation of peptide antigen,BP,
1061,GO:0002588,0.999999999993904,0.921595111941282,0,1,positive regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
5792,GO:0017024,0.999999999993904,0.921595111941282,0,1,myosin I binding,MF,
17104,GO:0099640,0.999999999993904,0.921595111941282,0,1,axo-dendritic protein transport,BP,
17105,GO:0099641,0.999999999993904,0.921595111941282,0,1,anterograde axonal protein transport,BP,
4405,GO:0010159,0.999999999993915,0.709444969411822,0,3,specification of animal organ position,BP,
9337,GO:0035844,0.999999999993915,0.709444969411822,0,3,cloaca development,BP,
13680,GO:0060235,0.999999999993915,0.709444969411822,0,3,lens induction in camera-type eye,BP,
13961,GO:0060681,0.999999999993915,0.709444969411822,0,3,branch elongation involved in ureteric bud branching,BP,
14210,GO:0061156,0.999999999993915,0.709444969411822,0,3,pulmonary artery morphogenesis,BP,
15611,GO:0072102,0.999999999993915,0.709444969411822,0,3,glomerulus morphogenesis,BP,
19210,GO:1905292,0.999999999993915,0.709444969411822,0,3,regulation of neural crest cell differentiation,BP,
19211,GO:1905294,0.999999999993915,0.709444969411822,0,3,positive regulation of neural crest cell differentiation,BP,
19217,GO:1905310,0.999999999993915,0.709444969411822,0,3,regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
19218,GO:1905312,0.999999999993915,0.709444969411822,0,3,positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
2360,GO:0005462,0.999999999993954,0.793449783277554,0,2,UDP-N-acetylglucosamine transmembrane transporter activity,MF,
19506,GO:1990269,0.999999999993954,0.793449783277554,0,2,RNA polymerase II C-terminal domain phosphoserine binding,MF,
19575,GO:1990569,0.999999999993954,0.793449783277554,0,2,UDP-N-acetylglucosamine transmembrane transport,BP,
12495,GO:0050571,0.999999999993982,0.898951484703122,0,1,1,5-anhydro-D-fructose reductase activity,MF,
9805,GO:0042000,0.999999999994005,0.890345027279462,0,1,translocation of peptides or proteins into host,BP,
10715,GO:0044053,0.999999999994005,0.890345027279462,0,1,translocation of peptides or proteins into host cell cytoplasm,BP,
13188,GO:0051808,0.999999999994005,0.890345027279462,0,1,translocation of peptides or proteins into other organism involved in symbiotic interaction,BP,
11038,GO:0045027,0.999999999994011,0.891871810258281,0,1,DNA end binding,MF,
11159,GO:0045226,0.999999999994027,0.792143070574359,0,2,extracellular polysaccharide biosynthetic process,BP,
11638,GO:0046379,0.999999999994027,0.792143070574359,0,2,extracellular polysaccharide metabolic process,BP,
17365,GO:1900063,0.999999999994036,0.707065273018574,0,3,regulation of peroxisome organization,BP,
10467,GO:0043366,0.999999999994039,0.795393510192802,0,2,beta selection,BP,
16635,GO:0097498,0.999999999994039,0.795393510192802,0,2,endothelial tube lumen extension,BP,
5305,GO:0016011,0.999999999994044,0.710402191353727,0,3,dystroglycan complex,CC,
15116,GO:0071209,0.999999999994046,0.743627589032369,0,3,U7 snRNA binding,MF,
6462,GO:0021796,0.999999999994051,0.705003037717199,0,3,cerebral cortex regionalization,BP,
13954,GO:0060671,0.999999999994065,0.710357990189997,0,3,epithelial cell differentiation involved in embryonic placenta development,BP,
13955,GO:0060672,0.999999999994065,0.710357990189997,0,3,epithelial cell morphogenesis involved in placental branching,BP,
6013,GO:0019065,0.999999999994077,0.705014509565303,0,3,receptor-mediated endocytosis of virus by host cell,BP,
15950,GO:0075509,0.999999999994077,0.705014509565303,0,3,endocytosis involved in viral entry into host cell,BP,
8768,GO:0034455,0.999999999994137,0.705170900481568,0,3,t-UTP complex,CC,
6246,GO:0019826,0.999999999994144,0.793670296028429,0,2,oxygen sensor activity,MF,
1947,GO:0004651,0.99999999999415,0.799469224461263,0,2,polynucleotide 5'-phosphatase activity,MF,
7002,GO:0030692,0.99999999999415,0.799469224461263,0,2,Noc4p-Nop14p complex,CC,
16743,GO:0098507,0.99999999999415,0.799469224461263,0,2,polynucleotide 5' dephosphorylation,BP,
12418,GO:0048880,0.999999999994176,0.705025740471526,0,3,sensory system development,BP,
369,GO:0000991,0.999999999994185,0.803454792197063,0,2,transcription factor activity, core RNA polymerase II binding,MF,
8089,GO:0032782,0.999999999994194,0.797107044230424,0,2,bile acid secretion,BP,
4163,GO:0009227,0.999999999994198,0.718692727299436,0,3,nucleotide-sugar catabolic process,BP,
14125,GO:0061002,0.999999999994219,0.713535285840107,0,3,negative regulation of dendritic spine morphogenesis,BP,
11214,GO:0045355,0.999999999994226,0.810484497091443,0,2,negative regulation of interferon-alpha biosynthetic process,BP,
7548,GO:0031871,0.999999999994239,0.708886308334569,0,3,proteinase activated receptor binding,MF,
2370,GO:0005499,0.999999999994267,0.794095612645784,0,2,vitamin D binding,MF,
13562,GO:0060040,0.999999999994267,0.794095612645784,0,2,retinal bipolar neuron differentiation,BP,
11790,GO:0046680,0.999999999994268,0.891950863471826,0,1,response to DDT,BP,
20122,GO:2000775,0.999999999994268,0.891950863471826,0,1,histone H3-S10 phosphorylation involved in chromosome condensation,BP,
19134,GO:1905065,0.999999999994269,0.709963734006392,0,3,positive regulation of vascular smooth muscle cell differentiation,BP,
6724,GO:0030144,0.999999999994281,0.705389347584955,0,3,alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity,MF,
13869,GO:0060510,0.999999999994312,0.809739055622956,0,2,Type II pneumocyte differentiation,BP,
13936,GO:0060623,0.999999999994329,0.706529816148319,0,3,regulation of chromosome condensation,BP,
14568,GO:0070103,0.999999999994338,0.89702675357434,0,1,regulation of interleukin-6-mediated signaling pathway,BP,
14569,GO:0070104,0.999999999994338,0.89702675357434,0,1,negative regulation of interleukin-6-mediated signaling pathway,BP,
17911,GO:1902205,0.999999999994338,0.89702675357434,0,1,regulation of interleukin-2-mediated signaling pathway,BP,
17912,GO:1902206,0.999999999994338,0.89702675357434,0,1,negative regulation of interleukin-2-mediated signaling pathway,BP,
17916,GO:1902215,0.999999999994338,0.89702675357434,0,1,negative regulation of interleukin-4-mediated signaling pathway,BP,
17925,GO:1902227,0.999999999994338,0.89702675357434,0,1,negative regulation of macrophage colony-stimulating factor signaling pathway,BP,
17931,GO:1902233,0.999999999994338,0.89702675357434,0,1,negative regulation of positive thymic T cell selection,BP,
18664,GO:1903970,0.999999999994338,0.89702675357434,0,1,negative regulation of response to macrophage colony-stimulating factor,BP,
18667,GO:1903973,0.999999999994338,0.89702675357434,0,1,negative regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
12599,GO:0050787,0.999999999994359,0.818863892748472,0,2,detoxification of mercury ion,BP,
18295,GO:1903179,0.999999999994359,0.818863892748472,0,2,regulation of dopamine biosynthetic process,BP,
18296,GO:1903181,0.999999999994359,0.818863892748472,0,2,positive regulation of dopamine biosynthetic process,BP,
19838,GO:2000282,0.999999999994359,0.818863892748472,0,2,regulation of cellular amino acid biosynthetic process,BP,
11521,GO:0046056,0.999999999994362,0.801970900755054,0,2,dADP metabolic process,BP,
11378,GO:0045764,0.999999999994362,0.819619802138227,0,2,positive regulation of cellular amino acid metabolic process,BP,
4431,GO:0010269,0.999999999994366,0.736087054695916,0,3,response to selenium ion,BP,
4875,GO:0014738,0.999999999994367,0.705173828764717,0,3,regulation of muscle hyperplasia,BP,
2034,GO:0004774,0.999999999994408,0.716424036700023,0,3,succinate-CoA ligase activity,MF,
8959,GO:0035033,0.999999999994411,0.804285998370158,0,2,histone deacetylase regulator activity,MF,
14353,GO:0061574,0.999999999994417,0.707914224364034,0,3,ASAP complex,CC,
1544,GO:0003938,0.99999999999444,0.798644269904144,0,2,IMP dehydrogenase activity,MF,
11170,GO:0045259,0.99999999999444,0.806006674712245,0,2,proton-transporting ATP synthase complex,CC,
4359,GO:0009957,0.999999999994445,0.792561404184427,0,2,epidermal cell fate specification,BP,
13858,GO:0060486,0.999999999994445,0.792561404184427,0,2,Clara cell differentiation,BP,
14055,GO:0060844,0.999999999994445,0.792561404184427,0,2,arterial endothelial cell fate commitment,BP,
17583,GO:1901187,0.999999999994445,0.792561404184427,0,2,regulation of ephrin receptor signaling pathway,BP,
5974,GO:0018455,0.999999999994447,0.907814150309933,0,1,alcohol dehydrogenase [NAD(P)+] activity,MF,
19519,GO:1990384,0.999999999994447,0.907814150309933,0,1,hyaloid vascular plexus regression,BP,
15840,GO:0072557,0.999999999994461,0.829010338273032,0,2,IPAF inflammasome complex,CC,
18568,GO:1903774,0.999999999994485,0.714447547702802,0,3,positive regulation of viral budding via host ESCRT complex,BP,
14883,GO:0070678,0.999999999994492,0.890035482145654,0,1,preprotein binding,MF,
2358,GO:0005459,0.999999999994494,0.816574688531472,0,2,UDP-galactose transmembrane transporter activity,MF,
15744,GO:0072334,0.999999999994494,0.816574688531472,0,2,UDP-galactose transmembrane transport,BP,
1781,GO:0004395,0.999999999994508,0.908223137474521,0,1,hexaprenyldihydroxybenzoate methyltransferase activity,MF,
3823,GO:0008425,0.999999999994508,0.908223137474521,0,1,2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity,MF,
3953,GO:0008689,0.999999999994508,0.908223137474521,0,1,3-demethylubiquinone-9 3-O-methyltransferase activity,MF,
4452,GO:0010420,0.999999999994508,0.908223137474521,0,1,polyprenyldihydroxybenzoate methyltransferase activity,MF,
4650,GO:0010795,0.999999999994508,0.908223137474521,0,1,regulation of ubiquinone biosynthetic process,BP,
6947,GO:0030580,0.999999999994508,0.908223137474521,0,1,quinone cofactor methyltransferase activity,MF,
10929,GO:0044595,0.999999999994508,0.908223137474521,0,1,decaprenyldihydroxybenzoate methyltransferase activity,MF,
10930,GO:0044596,0.999999999994508,0.908223137474521,0,1,3-demethylubiquinone-10 3-O-methyltransferase activity,MF,
13155,GO:0051750,0.999999999994508,0.908223137474521,0,1,delta3,5-delta2,4-dienoyl-CoA isomerase activity,MF,
14336,GO:0061542,0.999999999994508,0.908223137474521,0,1,3-demethylubiquinone-n 3-O-methyltransferase activity,MF,
2260,GO:0005175,0.999999999994517,0.930931761500677,0,1,CD27 receptor binding,MF,
9521,GO:0036245,0.999999999994518,0.802871217592129,0,2,cellular response to menadione,BP,
11149,GO:0045213,0.99999999999452,0.800588721551994,0,2,neurotransmitter receptor metabolic process,BP,
14492,GO:0061945,0.999999999994545,0.714498783117414,0,3,regulation of protein K48-linked ubiquitination,BP,
3275,GO:0006957,0.99999999999455,0.705024376547111,0,3,complement activation, alternative pathway,BP,
422,GO:0001128,0.999999999994566,0.905775415945073,0,1,RNA polymerase II transcription coactivator activity involved in preinitiation complex assembly,MF,
7649,GO:0032076,0.999999999994583,0.890028681015683,0,1,negative regulation of deoxyribonuclease activity,BP,
9550,GO:0036316,0.999999999994583,0.890028681015683,0,1,SREBP-SCAP complex retention in endoplasmic reticulum,BP,
13980,GO:0060703,0.999999999994583,0.890028681015683,0,1,deoxyribonuclease inhibitor activity,MF,
14709,GO:0070346,0.999999999994583,0.890028681015683,0,1,positive regulation of fat cell proliferation,BP,
17624,GO:1901303,0.999999999994583,0.890028681015683,0,1,negative regulation of cargo loading into COPII-coated vesicle,BP,
18028,GO:1902511,0.999999999994583,0.890028681015683,0,1,negative regulation of apoptotic DNA fragmentation,BP,
18506,GO:1903625,0.999999999994583,0.890028681015683,0,1,negative regulation of DNA catabolic process,BP,
7621,GO:0032027,0.999999999994595,0.709928874581611,0,3,myosin light chain binding,MF,
1729,GO:0004322,0.999999999994596,0.720439701079669,0,3,ferroxidase activity,MF,
5639,GO:0016724,0.999999999994596,0.720439701079669,0,3,oxidoreductase activity, oxidizing metal ions, oxygen as acceptor,MF,
12224,GO:0048496,0.999999999994597,0.705282370003733,0,3,maintenance of animal organ identity,BP,
2077,GO:0004830,0.999999999994616,0.792142020389018,0,2,tryptophan-tRNA ligase activity,MF,
2922,GO:0006436,0.999999999994616,0.792142020389018,0,2,tryptophanyl-tRNA aminoacylation,BP,
11230,GO:0045415,0.999999999994631,0.708809448638166,0,3,negative regulation of interleukin-8 biosynthetic process,BP,
5387,GO:0016212,0.999999999994637,0.793276775647345,0,2,kynurenine-oxoglutarate transaminase activity,MF,
9490,GO:0036137,0.999999999994637,0.793276775647345,0,2,kynurenine aminotransferase activity,MF,
16415,GO:0097052,0.999999999994637,0.793276775647345,0,2,L-kynurenine metabolic process,BP,
17644,GO:1901355,0.999999999994639,0.793414244237299,0,2,response to rapamycin,BP,
19345,GO:1905661,0.999999999994639,0.793414244237299,0,2,regulation of telomerase RNA reverse transcriptase activity,BP,
19346,GO:1905663,0.999999999994639,0.793414244237299,0,2,positive regulation of telomerase RNA reverse transcriptase activity,BP,
10492,GO:0043400,0.99999999999466,0.824463544567024,0,2,cortisol secretion,BP,
13017,GO:0051462,0.99999999999466,0.824463544567024,0,2,regulation of cortisol secretion,BP,
19343,GO:1905651,0.999999999994672,0.705019317792048,0,3,regulation of artery morphogenesis,BP,
19344,GO:1905653,0.999999999994672,0.705019317792048,0,3,positive regulation of artery morphogenesis,BP,
4517,GO:0010572,0.999999999994705,0.792137516581275,0,2,positive regulation of platelet activation,BP,
17771,GO:1901731,0.999999999994705,0.792137516581275,0,2,positive regulation of platelet aggregation,BP,
20025,GO:2000619,0.99999999999472,0.719825042394066,0,3,negative regulation of histone H4-K16 acetylation,BP,
16705,GO:0097682,0.999999999994741,0.891833109263487,0,1,intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity,MF,
6851,GO:0030327,0.999999999994752,0.705075080001421,0,3,prenylated protein catabolic process,BP,
10622,GO:0043626,0.999999999994754,0.906027551364393,0,1,PCNA complex,CC,
10989,GO:0044796,0.999999999994754,0.906027551364393,0,1,DNA polymerase processivity factor complex,CC,
15174,GO:0071315,0.999999999994777,0.70846390067473,0,3,cellular response to morphine,BP,
15176,GO:0071317,0.999999999994777,0.70846390067473,0,3,cellular response to isoquinoline alkaloid,BP,
2365,GO:0005483,0.999999999994822,0.708653935178675,0,3,soluble NSF attachment protein activity,MF,
397,GO:0001074,0.999999999994839,0.890081207958707,0,1,transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding involved in preinitiation complex assembly,MF,
403,GO:0001084,0.999999999994839,0.890081207958707,0,1,transcription factor activity, TFIID-class binding,MF,
8425,GO:0033552,0.999999999994839,0.890081207958707,0,1,response to vitamin B3,BP,
10134,GO:0042701,0.999999999994842,0.793339453583773,0,2,progesterone secretion,BP,
14891,GO:0070697,0.999999999994842,0.793339453583773,0,2,activin receptor binding,MF,
14892,GO:0070699,0.999999999994842,0.793339453583773,0,2,type II activin receptor binding,MF,
9419,GO:0035990,0.999999999994846,0.797124341598025,0,2,tendon cell differentiation,BP,
9420,GO:0035992,0.999999999994846,0.797124341598025,0,2,tendon formation,BP,
764,GO:0002017,0.999999999994859,0.894187534689077,0,1,regulation of blood volume by renal aldosterone,BP,
8170,GO:0032914,0.999999999994867,0.708326100562414,0,3,positive regulation of transforming growth factor beta1 production,BP,
11929,GO:0046985,0.999999999994901,0.716616312399581,0,3,positive regulation of hemoglobin biosynthetic process,BP,
13989,GO:0060715,0.999999999994916,0.707023436693299,0,3,syncytiotrophoblast cell differentiation involved in labyrinthine layer development,BP,
236,GO:0000494,0.999999999994965,0.911441240477281,0,1,box C/D snoRNA 3'-end processing,BP,
8547,GO:0033967,0.999999999994965,0.911441240477281,0,1,box C/D snoRNA metabolic process,BP,
8929,GO:0034963,0.999999999994965,0.911441240477281,0,1,box C/D snoRNA processing,BP,
9431,GO:0036009,0.999999999994965,0.911441240477281,0,1,protein-glutamine N-methyltransferase activity,MF,
19500,GO:1990258,0.999999999994965,0.911441240477281,0,1,histone glutamine methylation,BP,
19501,GO:1990259,0.999999999994965,0.911441240477281,0,1,histone-glutamine methyltransferase activity,MF,
370,GO:0000992,0.999999999994983,0.792379784017361,0,2,polymerase III regulatory region sequence-specific DNA binding,MF,
374,GO:0001002,0.999999999994983,0.792379784017361,0,2,RNA polymerase III type 1 promoter sequence-specific DNA binding,MF,
375,GO:0001003,0.999999999994983,0.792379784017361,0,2,RNA polymerase III type 2 promoter sequence-specific DNA binding,MF,
2129,GO:0004931,0.999999999995,0.892454293985319,0,1,extracellularly ATP-gated cation channel activity,MF,
5535,GO:0016519,0.999999999995,0.892454293985319,0,1,gastric inhibitory peptide receptor activity,MF,
9101,GO:0035381,0.999999999995,0.892454293985319,0,1,ATP-gated ion channel activity,MF,
9732,GO:0038192,0.999999999995,0.892454293985319,0,1,gastric inhibitory peptide signaling pathway,BP,
9278,GO:0035720,0.999999999995006,0.710872517064897,0,3,intraciliary anterograde transport,BP,
19655,GO:1990834,0.999999999995035,0.705311980158035,0,3,response to odorant,BP,
11601,GO:0046294,0.999999999995049,0.810379845560288,0,2,formaldehyde catabolic process,BP,
14849,GO:0070618,0.999999999995078,0.890033708071916,0,1,Grb2-Sos complex,CC,
13573,GO:0060051,0.999999999995083,0.798486111225238,0,2,negative regulation of protein glycosylation,BP,
16233,GO:0090285,0.999999999995083,0.798486111225238,0,2,negative regulation of protein glycosylation in Golgi,BP,
10136,GO:0042709,0.999999999995116,0.890512034212397,0,1,succinate-CoA ligase complex,CC,
11165,GO:0045244,0.999999999995116,0.890512034212397,0,1,succinate-CoA ligase complex (GDP-forming),CC,
17865,GO:1902045,0.999999999995116,0.890512034212397,0,1,negative regulation of Fas signaling pathway,BP,
19971,GO:2000504,0.999999999995116,0.890512034212397,0,1,positive regulation of blood vessel remodeling,BP,
3648,GO:0008131,0.99999999999512,0.705031487349078,0,3,primary amine oxidase activity,MF,
1964,GO:0004673,0.999999999995138,0.928379920166197,0,1,protein histidine kinase activity,MF,
5900,GO:0018106,0.999999999995138,0.928379920166197,0,1,peptidyl-histidine phosphorylation,BP,
15012,GO:0070948,0.999999999995143,0.715164008140069,0,3,regulation of neutrophil mediated cytotoxicity,BP,
15917,GO:0072706,0.999999999995146,0.890097567697955,0,1,response to sodium dodecyl sulfate,BP,
15918,GO:0072707,0.999999999995146,0.890097567697955,0,1,cellular response to sodium dodecyl sulfate,BP,
16399,GO:0097021,0.99999999999517,0.796979955139919,0,2,lymphocyte migration into lymphoid organs,BP,
14341,GO:0061551,0.999999999995208,0.705146037688282,0,3,trigeminal ganglion development,BP,
17329,GO:0150018,0.999999999995208,0.705146037688282,0,3,basal dendrite development,BP,
17330,GO:0150019,0.999999999995208,0.705146037688282,0,3,basal dendrite morphogenesis,BP,
17331,GO:0150020,0.999999999995208,0.705146037688282,0,3,basal dendrite arborization,BP,
3361,GO:0007113,0.999999999995214,0.729245034958925,0,3,endomitotic cell cycle,BP,
8874,GO:0034693,0.999999999995278,0.890243044537753,0,1,U11/U12 snRNP,CC,
850,GO:0002176,0.999999999995286,0.752362094114916,0,3,male germ cell proliferation,BP,
9469,GO:0036093,0.999999999995286,0.752362094114916,0,3,germ cell proliferation,BP,
5989,GO:0018963,0.999999999995302,0.795551327633809,0,2,phthalate metabolic process,BP,
8484,GO:0033650,0.999999999995306,0.896136475402825,0,1,host cell mitochondrion,CC,
10751,GO:0044190,0.999999999995306,0.896136475402825,0,1,host cell mitochondrial envelope,CC,
15798,GO:0072492,0.999999999995306,0.896136475402825,0,1,host cell mitochondrial intermembrane space,CC,
15384,GO:0071638,0.999999999995324,0.817964412404474,0,2,negative regulation of monocyte chemotactic protein-1 production,BP,
5911,GO:0018153,0.999999999995331,0.79357934941785,0,2,isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine,BP,
5942,GO:0018262,0.999999999995331,0.79357934941785,0,2,isopeptide cross-linking,BP,
18515,GO:1903650,0.99999999999535,0.842601941253381,0,2,negative regulation of cytoplasmic transport,BP,
20039,GO:2000642,0.99999999999535,0.842601941253381,0,2,negative regulation of early endosome to late endosome transport,BP,
8377,GO:0033291,0.999999999995354,0.944579382488324,0,1,eukaryotic 80S initiation complex,CC,
8774,GO:0034463,0.999999999995354,0.944579382488324,0,1,90S preribosome assembly,BP,
4494,GO:0010521,0.999999999995389,0.725321734460382,0,3,telomerase inhibitor activity,MF,
1810,GO:0004459,0.999999999995403,0.723441124525754,0,3,L-lactate dehydrogenase activity,MF,
16694,GO:0097644,0.999999999995412,0.819845840220042,0,2,calcitonin family binding,MF,
18420,GO:1903439,0.999999999995412,0.819845840220042,0,2,calcitonin family receptor complex,CC,
19530,GO:1990406,0.999999999995412,0.819845840220042,0,2,CGRP receptor complex,CC,
19532,GO:1990408,0.999999999995412,0.819845840220042,0,2,calcitonin gene-related peptide receptor signaling pathway,BP,
7604,GO:0031997,0.999999999995418,0.719210918154011,0,3,N-terminal myristoylation domain binding,MF,
12952,GO:0051343,0.999999999995418,0.719210918154011,0,3,positive regulation of cyclic-nucleotide phosphodiesterase activity,BP,
15338,GO:0071567,0.999999999995422,0.817306518100954,0,2,UFM1 hydrolase activity,MF,
14225,GO:0061198,0.999999999995423,0.706473370270256,0,3,fungiform papilla formation,BP,
6073,GO:0019227,0.999999999995425,0.727643674496603,0,3,neuronal action potential propagation,BP,
16907,GO:0098870,0.999999999995425,0.727643674496603,0,3,action potential propagation,BP,
7953,GO:0032558,0.999999999995432,0.733793819623518,0,3,adenyl deoxyribonucleotide binding,MF,
7957,GO:0032564,0.999999999995432,0.733793819623518,0,3,dATP binding,MF,
1519,GO:0003880,0.999999999995442,0.718764707753331,0,3,protein C-terminal carboxyl O-methyltransferase activity,MF,
2949,GO:0006481,0.999999999995442,0.718764707753331,0,3,C-terminal protein methylation,BP,
9443,GO:0036034,0.999999999995457,0.79260863097271,0,2,mediator complex assembly,BP,
20252,GO:2001176,0.999999999995457,0.79260863097271,0,2,regulation of mediator complex assembly,BP,
20253,GO:2001178,0.999999999995457,0.79260863097271,0,2,positive regulation of mediator complex assembly,BP,
1271,GO:0003057,0.999999999995482,0.706201976580634,0,3,regulation of the force of heart contraction by chemical signal,BP,
15192,GO:0071344,0.999999999995487,0.8156514093318,0,2,diphosphate metabolic process,BP,
18929,GO:1904631,0.999999999995496,0.890983989364721,0,1,response to glucoside,BP,
2074,GO:0004827,0.999999999995573,0.723443238473003,0,3,proline-tRNA ligase activity,MF,
2919,GO:0006433,0.999999999995573,0.723443238473003,0,3,prolyl-tRNA aminoacylation,BP,
3810,GO:0008404,0.999999999995614,0.894461765681279,0,1,arachidonic acid 14,15-epoxygenase activity,MF,
3811,GO:0008405,0.999999999995614,0.894461765681279,0,1,arachidonic acid 11,12-epoxygenase activity,MF,
15367,GO:0071614,0.999999999995614,0.894461765681279,0,1,linoleic acid epoxygenase activity,MF,
11935,GO:0047016,0.999999999995615,0.891279350174423,0,1,cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity,MF,
16518,GO:0097229,0.999999999995615,0.906251611599885,0,1,sperm end piece,CC,
1521,GO:0003882,0.999999999995627,0.890266389313245,0,1,CDP-diacylglycerol-serine O-phosphatidyltransferase activity,MF,
8300,GO:0033142,0.999999999995646,0.891255417491533,0,1,progesterone receptor binding,MF,
5488,GO:0016422,0.999999999995648,0.708930833577231,0,3,mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity,MF,
19154,GO:1905143,0.999999999995651,0.900229003380239,0,1,eukaryotic translation initiation factor 2 complex assembly,BP,
19708,GO:2000015,0.99999999999567,0.729574764746285,0,3,regulation of determination of dorsal identity,BP,
13179,GO:0051795,0.999999999995718,0.734732352957165,0,3,positive regulation of timing of catagen,BP,
12620,GO:0050816,0.999999999995739,0.726873715088832,0,3,phosphothreonine residue binding,MF,
3053,GO:0006617,0.99999999999574,0.821427003669702,0,2,SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition,BP,
9214,GO:0035606,0.999999999995753,0.848010540437925,0,2,peptidyl-cysteine S-trans-nitrosylation,BP,
6264,GO:0019860,0.999999999995768,0.800577497970443,0,2,uracil metabolic process,BP,
17606,GO:1901255,0.999999999995768,0.800577497970443,0,2,nucleotide-excision repair involved in interstrand cross-link repair,BP,
16488,GO:0097180,0.999999999995775,0.83111950039687,0,2,serine protease inhibitor complex,CC,
8227,GO:0033004,0.999999999995778,0.713163382045732,0,3,negative regulation of mast cell activation,BP,
8230,GO:0033007,0.999999999995778,0.713163382045732,0,3,negative regulation of mast cell activation involved in immune response,BP,
6880,GO:0030395,0.99999999999579,0.936100152438489,0,1,lactose binding,MF,
8599,GO:0034117,0.99999999999579,0.936100152438489,0,1,erythrocyte aggregation,BP,
8600,GO:0034118,0.99999999999579,0.936100152438489,0,1,regulation of erythrocyte aggregation,BP,
8601,GO:0034120,0.99999999999579,0.936100152438489,0,1,positive regulation of erythrocyte aggregation,BP,
12070,GO:0048030,0.99999999999579,0.936100152438489,0,1,disaccharide binding,MF,
15008,GO:0070943,0.999999999995791,0.721165527494649,0,3,neutrophil mediated killing of symbiont cell,BP,
14434,GO:0061752,0.999999999995797,0.796203742773887,0,2,telomeric repeat-containing RNA binding,MF,
9277,GO:0035718,0.999999999995809,0.817741029502998,0,2,macrophage migration inhibitory factor binding,MF,
4015,GO:0009020,0.999999999995842,0.893215138410606,0,1,tRNA (guanosine-2'-O-)-methyltransferase activity,MF,
13379,GO:0052666,0.999999999995842,0.893215138410606,0,1,tRNA (cytosine-2'-O-)-methyltransferase activity,MF,
17209,GO:0106050,0.999999999995842,0.893215138410606,0,1,tRNA 2'-O-methyltransferase activity,MF,
16523,GO:0097238,0.999999999995845,0.831847551320473,0,2,cellular response to methylglyoxal,BP,
18661,GO:1903964,0.999999999995856,0.792184004655475,0,2,monounsaturated fatty acid metabolic process,BP,
18662,GO:1903966,0.999999999995856,0.792184004655475,0,2,monounsaturated fatty acid biosynthetic process,BP,
8074,GO:0032763,0.999999999995919,0.71316338204559,0,3,regulation of mast cell cytokine production,BP,
9576,GO:0036396,0.999999999995931,0.714183676177569,0,3,RNA N6-methyladenosine methyltransferase complex,CC,
11182,GO:0045293,0.999999999995931,0.714183676177569,0,3,mRNA editing complex,CC,
14665,GO:0070278,0.99999999999595,0.792612732590718,0,2,extracellular matrix constituent secretion,BP,
13153,GO:0051747,0.999999999995959,0.827472770489176,0,2,cytosine C-5 DNA demethylase activity,MF,
1210,GO:0002875,0.999999999995982,0.898539946160075,0,1,negative regulation of chronic inflammatory response to antigenic stimulus,BP,
2234,GO:0005141,0.999999999995982,0.898539946160075,0,1,interleukin-10 receptor binding,MF,
18709,GO:1904057,0.999999999995982,0.898539946160075,0,1,negative regulation of sensory perception of pain,BP,
2897,GO:0006408,0.999999999995994,0.799343701240855,0,2,snRNA export from nucleus,BP,
4152,GO:0009216,0.999999999996,0.794119120261561,0,2,purine deoxyribonucleoside triphosphate biosynthetic process,BP,
20146,GO:2000819,0.999999999996029,0.792144565478546,0,2,regulation of nucleotide-excision repair,BP,
1720,GO:0004311,0.999999999996038,0.706424381717453,0,3,farnesyltranstransferase activity,MF,
7084,GO:0030885,0.999999999996082,0.733042290186651,0,3,regulation of myeloid dendritic cell activation,BP,
18444,GO:1903516,0.999999999996085,0.706388364493927,0,3,regulation of single strand break repair,BP,
668,GO:0001878,0.999999999996143,0.890682691953277,0,1,response to yeast,BP,
14468,GO:0061847,0.999999999996143,0.890682691953277,0,1,response to cholecystokinin,BP,
15315,GO:0071538,0.999999999996143,0.890682691953277,0,1,SH2 domain-mediated complex assembly,BP,
19657,GO:1990839,0.999999999996143,0.890682691953277,0,1,response to endothelin,BP,
19661,GO:1990859,0.999999999996143,0.890682691953277,0,1,cellular response to endothelin,BP,
3336,GO:0007056,0.999999999996162,0.794215838312075,0,2,spindle assembly involved in female meiosis,BP,
3337,GO:0007057,0.999999999996162,0.794215838312075,0,2,spindle assembly involved in female meiosis I,BP,
8490,GO:0033677,0.999999999996163,0.705019102097357,0,3,DNA/RNA helicase activity,MF,
203,GO:0000429,0.999999999996171,0.716464441885895,0,3,carbon catabolite regulation of transcription from RNA polymerase II promoter,BP,
208,GO:0000436,0.999999999996171,0.716464441885895,0,3,carbon catabolite activation of transcription from RNA polymerase II promoter,BP,
11504,GO:0046016,0.999999999996171,0.716464441885895,0,3,positive regulation of transcription by glucose,BP,
14009,GO:0060743,0.999999999996192,0.890111562443999,0,1,epithelial cell maturation involved in prostate gland development,BP,
15173,GO:0071314,0.999999999996209,0.890023729298982,0,1,cellular response to cocaine,BP,
17979,GO:1902362,0.999999999996209,0.890023729298982,0,1,melanocyte apoptotic process,BP,
3917,GO:0008591,0.999999999996218,0.89530918121249,0,1,regulation of Wnt signaling pathway, calcium modulating pathway,BP,
10122,GO:0042662,0.999999999996218,0.89530918121249,0,1,negative regulation of mesodermal cell fate specification,BP,
11398,GO:0045813,0.999999999996218,0.89530918121249,0,1,positive regulation of Wnt signaling pathway, calcium modulating pathway,BP,
14430,GO:0061743,0.999999999996218,0.89530918121249,0,1,motor learning,BP,
16098,GO:0090081,0.999999999996218,0.89530918121249,0,1,regulation of heart induction by regulation of canonical Wnt signaling pathway,BP,
16099,GO:0090082,0.999999999996218,0.89530918121249,0,1,positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway,BP,
16285,GO:0090381,0.999999999996218,0.89530918121249,0,1,regulation of heart induction,BP,
16914,GO:0098883,0.999999999996218,0.89530918121249,0,1,synapse disassembly,BP,
17110,GO:0100012,0.999999999996218,0.89530918121249,0,1,regulation of heart induction by canonical Wnt signaling pathway,BP,
17618,GO:1901296,0.999999999996218,0.89530918121249,0,1,negative regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
17631,GO:1901321,0.999999999996218,0.89530918121249,0,1,positive regulation of heart induction,BP,
18955,GO:1904701,0.999999999996218,0.89530918121249,0,1,Wnt-Frizzled-LRP5/6 complex assembly,BP,
18960,GO:1904711,0.999999999996218,0.89530918121249,0,1,regulation of Wnt-Frizzled-LRP5/6 complex assembly,BP,
18970,GO:1904723,0.999999999996218,0.89530918121249,0,1,negative regulation of Wnt-Frizzled-LRP5/6 complex assembly,BP,
19136,GO:1905067,0.999999999996218,0.89530918121249,0,1,negative regulation of canonical Wnt signaling pathway involved in heart development,BP,
19369,GO:1905771,0.999999999996218,0.89530918121249,0,1,negative regulation of mesodermal cell differentiation,BP,
19407,GO:1905903,0.999999999996218,0.89530918121249,0,1,negative regulation of mesoderm formation,BP,
16551,GO:0097325,0.999999999996245,0.792133864589685,0,2,melanocyte proliferation,BP,
16053,GO:0086098,0.999999999996291,0.79214675312875,0,2,angiotensin-activated signaling pathway involved in heart process,BP,
17831,GO:1901979,0.999999999996291,0.79214675312875,0,2,regulation of inward rectifier potassium channel activity,BP,
3018,GO:0006567,0.999999999996296,0.813367671694717,0,2,threonine catabolic process,BP,
1554,GO:0003952,0.999999999996299,0.890280742971442,0,1,NAD+ synthase (glutamine-hydrolyzing) activity,MF,
1581,GO:0003990,0.999999999996299,0.890280742971442,0,1,acetylcholinesterase activity,MF,
4820,GO:0014016,0.999999999996299,0.890280742971442,0,1,neuroblast differentiation,BP,
11661,GO:0046448,0.999999999996299,0.890280742971442,0,1,tropane alkaloid metabolic process,BP,
12596,GO:0050783,0.999999999996299,0.890280742971442,0,1,cocaine metabolic process,BP,
1768,GO:0004372,0.999999999996303,0.793188553130733,0,2,glycine hydroxymethyltransferase activity,MF,
2046,GO:0004793,0.999999999996303,0.793188553130733,0,2,threonine aldolase activity,MF,
2996,GO:0006545,0.999999999996303,0.793188553130733,0,2,glycine biosynthetic process,BP,
3959,GO:0008732,0.999999999996303,0.793188553130733,0,2,L-allo-threonine aldolase activity,MF,
6089,GO:0019264,0.999999999996303,0.793188553130733,0,2,glycine biosynthetic process from serine,BP,
10226,GO:0042923,0.999999999996333,0.796604564229653,0,2,neuropeptide binding,MF,
16243,GO:0090298,0.999999999996337,0.70500696073033,0,3,negative regulation of mitochondrial DNA replication,BP,
17796,GO:1901859,0.999999999996337,0.70500696073033,0,3,negative regulation of mitochondrial DNA metabolic process,BP,
4446,GO:0010370,0.999999999996342,0.794459504760345,0,2,perinucleolar chromocenter,CC,
851,GO:0002177,0.999999999996354,0.726029787400305,0,3,manchette,CC,
9141,GO:0035494,0.999999999996373,0.708653978550541,0,3,SNARE complex disassembly,BP,
6875,GO:0030377,0.999999999996405,0.903144477046837,0,1,urokinase plasminogen activator receptor activity,MF,
9735,GO:0038195,0.999999999996405,0.903144477046837,0,1,urokinase plasminogen activator signaling pathway,BP,
17773,GO:1901740,0.999999999996415,0.893203920486378,0,1,negative regulation of myoblast fusion,BP,
18650,GO:1903943,0.999999999996415,0.893203920486378,0,1,regulation of hepatocyte apoptotic process,BP,
18651,GO:1903944,0.999999999996415,0.893203920486378,0,1,negative regulation of hepatocyte apoptotic process,BP,
19613,GO:1990729,0.999999999996415,0.893203920486378,0,1,primary miRNA modification,BP,
19621,GO:1990744,0.999999999996415,0.893203920486378,0,1,primary miRNA methylation,BP,
3607,GO:0008050,0.999999999996451,0.792409190043032,0,2,female courtship behavior,BP,
5802,GO:0017055,0.999999999996451,0.792409190043032,0,2,negative regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,
11459,GO:0045924,0.999999999996451,0.792409190043032,0,2,regulation of female receptivity,BP,
9993,GO:0042414,0.999999999996457,0.795538097109343,0,2,epinephrine metabolic process,BP,
11792,GO:0046684,0.999999999996457,0.795538097109343,0,2,response to pyrethroid,BP,
3172,GO:0006789,0.999999999996461,0.890456563186664,0,1,bilirubin conjugation,BP,
2213,GO:0005105,0.999999999996476,0.890813914785148,0,1,type 1 fibroblast growth factor receptor binding,MF,
11206,GO:0045347,0.999999999996514,0.711750043000515,0,3,negative regulation of MHC class II biosynthetic process,BP,
16519,GO:0097231,0.99999999999652,0.896801432458715,0,1,cell motility in response to calcium ion,BP,
19610,GO:1990716,0.99999999999652,0.896801432458715,0,1,axonemal central apparatus,CC,
1747,GO:0004347,0.999999999996523,0.891975012420764,0,1,glucose-6-phosphate isomerase activity,MF,
6083,GO:0019242,0.999999999996523,0.891975012420764,0,1,methylglyoxal biosynthetic process,BP,
8507,GO:0033699,0.999999999996531,0.892568371697393,0,1,DNA 5'-adenosine monophosphate hydrolase activity,MF,
17276,GO:0120108,0.999999999996531,0.892568371697393,0,1,DNA-3'-diphospho-5'-guanosine diphosphatase,MF,
19475,GO:1990165,0.999999999996531,0.892568371697393,0,1,single-strand break-containing DNA binding,MF,
7952,GO:0032557,0.99999999999657,0.706295533865022,0,3,pyrimidine ribonucleotide binding,MF,
2116,GO:0004905,0.999999999996581,0.804421247526402,0,2,type I interferon receptor activity,MF,
1517,GO:0003877,0.999999999996596,0.891798744614809,0,1,ATP adenylyltransferase activity,MF,
2071,GO:0004824,0.999999999996596,0.891798744614809,0,1,lysine-tRNA ligase activity,MF,
2916,GO:0006430,0.999999999996596,0.891798744614809,0,1,lysyl-tRNA aminoacylation,BP,
14939,GO:0070836,0.999999999996598,0.706405827909781,0,3,caveola assembly,BP,
142,GO:0000294,0.999999999996642,0.792138139551147,0,2,nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay,BP,
18101,GO:1902714,0.999999999996642,0.792138139551147,0,2,negative regulation of interferon-gamma secretion,BP,
20029,GO:2000625,0.999999999996642,0.792138139551147,0,2,regulation of miRNA catabolic process,BP,
20030,GO:2000627,0.999999999996642,0.792138139551147,0,2,positive regulation of miRNA catabolic process,BP,
270,GO:0000773,0.999999999996665,0.917742963203734,0,1,phosphatidyl-N-methylethanolamine N-methyltransferase activity,MF,
1915,GO:0004608,0.999999999996665,0.917742963203734,0,1,phosphatidylethanolamine N-methyltransferase activity,MF,
15969,GO:0080101,0.999999999996665,0.917742963203734,0,1,phosphatidyl-N-dimethylethanolamine N-methyltransferase activity,MF,
106,GO:0000221,0.999999999996672,0.706436524970477,0,3,vacuolar proton-transporting V-type ATPase, V1 domain,CC,
2745,GO:0006148,0.999999999996703,0.890348679151846,0,1,inosine catabolic process,BP,
3139,GO:0006738,0.999999999996703,0.890348679151846,0,1,nicotinamide riboside catabolic process,BP,
11693,GO:0046495,0.999999999996703,0.890348679151846,0,1,nicotinamide riboside metabolic process,BP,
14858,GO:0070637,0.999999999996703,0.890348679151846,0,1,pyridine nucleoside metabolic process,BP,
14859,GO:0070638,0.999999999996703,0.890348679151846,0,1,pyridine nucleoside catabolic process,BP,
107,GO:0000224,0.999999999996718,0.890130097446819,0,1,peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity,MF,
16908,GO:0098871,0.999999999996718,0.897218099061673,0,1,postsynaptic actin cytoskeleton,CC,
17076,GO:0099571,0.999999999996718,0.897218099061673,0,1,postsynaptic cytoskeleton,CC,
9206,GO:0035597,0.99999999999673,0.892529956813404,0,1,N6-isopentenyladenosine methylthiotransferase activity,MF,
1569,GO:0003975,0.999999999996752,0.891549648083097,0,1,UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity,MF,
4004,GO:0008963,0.999999999996752,0.891549648083097,0,1,phospho-N-acetylmuramoyl-pentapeptide-transferase activity,MF,
4732,GO:0010898,0.999999999996757,0.79395846251665,0,2,positive regulation of triglyceride catabolic process,BP,
2561,GO:0005846,0.999999999996813,0.793859914056776,0,2,nuclear cap binding complex,CC,
19413,GO:1905918,0.999999999996831,0.891449064006173,0,1,regulation of CoA-transferase activity,BP,
19414,GO:1905920,0.999999999996831,0.891449064006173,0,1,positive regulation of CoA-transferase activity,BP,
2072,GO:0004825,0.999999999996859,0.792133854710377,0,2,methionine-tRNA ligase activity,MF,
2917,GO:0006431,0.999999999996859,0.792133854710377,0,2,methionyl-tRNA aminoacylation,BP,
9622,GO:0036493,0.999999999996881,0.708519605817536,0,3,positive regulation of translation in response to endoplasmic reticulum stress,BP,
907,GO:0002291,0.999999999996882,0.716603493617086,0,3,T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
16457,GO:0097124,0.999999999996901,0.792979661877064,0,2,cyclin A2-CDK2 complex,CC,
18063,GO:1902595,0.999999999996926,0.804297120615485,0,2,regulation of DNA replication origin binding,BP,
10823,GO:0044324,0.999999999996934,0.921038631455939,0,1,regulation of transcription involved in anterior/posterior axis specification,BP,
19709,GO:2000016,0.999999999996934,0.921038631455939,0,1,negative regulation of determination of dorsal identity,BP,
769,GO:0002025,0.999999999996939,0.892417042003833,0,1,norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,
2133,GO:0004939,0.999999999996939,0.892417042003833,0,1,beta-adrenergic receptor activity,MF,
2134,GO:0004941,0.999999999996939,0.892417042003833,0,1,beta2-adrenergic receptor activity,MF,
12969,GO:0051380,0.999999999996939,0.892417042003833,0,1,norepinephrine binding,MF,
14475,GO:0061884,0.999999999996939,0.892417042003833,0,1,regulation of mini excitatory postsynaptic potential,BP,
14476,GO:0061885,0.999999999996939,0.892417042003833,0,1,positive regulation of mini excitatory postsynaptic potential,BP,
16880,GO:0098816,0.999999999996939,0.892417042003833,0,1,mini excitatory postsynaptic potential,BP,
3851,GO:0008467,0.999999999996941,0.712129519626051,0,3,[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity,MF,
2051,GO:0004799,0.999999999996954,0.899509986318903,0,1,thymidylate synthase activity,MF,
6027,GO:0019088,0.999999999996954,0.899509986318903,0,1,immortalization of host cell by virus,BP,
6325,GO:0020021,0.999999999996954,0.899509986318903,0,1,immortalization of host cell,BP,
9835,GO:0042083,0.999999999996954,0.899509986318903,0,1,5,10-methylenetetrahydrofolate-dependent methyltransferase activity,MF,
129,GO:0000270,0.999999999996962,0.815344294361207,0,2,peptidoglycan metabolic process,BP,
3960,GO:0008745,0.999999999996962,0.815344294361207,0,2,N-acetylmuramoyl-L-alanine amidase activity,MF,
4176,GO:0009253,0.999999999996962,0.815344294361207,0,2,peptidoglycan catabolic process,BP,
5310,GO:0016019,0.999999999996962,0.815344294361207,0,2,peptidoglycan receptor activity,MF,
13134,GO:0051710,0.999999999996962,0.815344294361207,0,2,regulation of cytolysis in other organism,BP,
13136,GO:0051714,0.999999999996962,0.815344294361207,0,2,positive regulation of cytolysis in other organism,BP,
14433,GO:0061750,0.999999999996986,0.890614686635698,0,1,acid sphingomyelin phosphodiesterase activity,MF,
1633,GO:0004074,0.999999999997001,0.844248710926338,0,2,biliverdin reductase activity,MF,
301,GO:0000811,0.999999999997014,0.721675789249741,0,3,GINS complex,CC,
19468,GO:1990131,0.999999999997014,0.723204692928712,0,3,Gtr1-Gtr2 GTPase complex,CC,
19953,GO:2000466,0.999999999997029,0.706007379369236,0,3,negative regulation of glycogen (starch) synthase activity,BP,
19954,GO:2000467,0.999999999997029,0.706007379369236,0,3,positive regulation of glycogen (starch) synthase activity,BP,
16613,GO:0097454,0.999999999997043,0.716182571623099,0,3,Schwann cell microvillus,CC,
2064,GO:0004817,0.999999999997063,0.795955864677659,0,2,cysteine-tRNA ligase activity,MF,
2909,GO:0006423,0.999999999997063,0.795955864677659,0,2,cysteinyl-tRNA aminoacylation,BP,
17939,GO:1902255,0.999999999997065,0.797456772238788,0,3,positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
11299,GO:0045627,0.999999999997073,0.716139636020662,0,3,positive regulation of T-helper 1 cell differentiation,BP,
14056,GO:0060846,0.999999999997077,0.705526668759312,0,3,blood vessel endothelial cell fate commitment,BP,
14057,GO:0060847,0.999999999997077,0.705526668759312,0,3,endothelial cell fate specification,BP,
16438,GO:0097101,0.999999999997077,0.705526668759312,0,3,blood vessel endothelial cell fate specification,BP,
328,GO:0000917,0.999999999997101,0.894617625047839,0,1,division septum assembly,BP,
16323,GO:0090529,0.999999999997101,0.894617625047839,0,1,cell septum assembly,BP,
16703,GO:0097680,0.999999999997136,0.706233818410608,0,3,double-strand break repair via classical nonhomologous end joining,BP,
17386,GO:1900109,0.99999999999718,0.815350781406517,0,2,regulation of histone H3-K9 dimethylation,BP,
17387,GO:1900110,0.99999999999718,0.815350781406517,0,2,negative regulation of histone H3-K9 dimethylation,BP,
5465,GO:0016361,0.999999999997234,0.797095236601264,0,2,activin receptor activity, type I,MF,
12109,GO:0048179,0.999999999997234,0.797095236601264,0,2,activin receptor complex,CC,
6846,GO:0030322,0.999999999997264,0.793429243194911,0,2,stabilization of membrane potential,BP,
1394,GO:0003307,0.999999999997278,0.709573268538157,0,3,regulation of Wnt signaling pathway involved in heart development,BP,
14251,GO:0061316,0.999999999997278,0.709573268538157,0,3,canonical Wnt signaling pathway involved in heart development,BP,
17022,GO:0099170,0.99999999999729,0.70500339807676,0,3,postsynaptic modulation of chemical synaptic transmission,BP,
17065,GO:0099547,0.99999999999729,0.70500339807676,0,3,regulation of translation at synapse, modulating synaptic transmission,BP,
17078,GO:0099578,0.99999999999729,0.70500339807676,0,3,regulation of translation at postsynapse, modulating synaptic transmission,BP,
2322,GO:0005332,0.999999999997296,0.892796920301765,0,1,gamma-aminobutyric acid:sodium symporter activity,MF,
5021,GO:0015185,0.999999999997296,0.892796920301765,0,1,gamma-aminobutyric acid transmembrane transporter activity,MF,
3729,GO:0008269,0.999999999997306,0.891157098638693,0,1,JAK pathway signal transduction adaptor activity,MF,
4317,GO:0009810,0.999999999997306,0.891157098638693,0,1,stilbene metabolic process,BP,
8540,GO:0033885,0.999999999997306,0.891157098638693,0,1,10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activity,MF,
11598,GO:0046272,0.999999999997306,0.891157098638693,0,1,stilbene catabolic process,BP,
3192,GO:0006824,0.999999999997317,0.793588916900685,0,2,cobalt ion transport,BP,
15031,GO:0070981,0.999999999997342,0.890607433193252,0,1,L-asparagine biosynthetic process,BP,
15032,GO:0070982,0.999999999997342,0.890607433193252,0,1,L-asparagine metabolic process,BP,
9328,GO:0035812,0.999999999997352,0.794536019522867,0,2,renal sodium excretion,BP,
9329,GO:0035813,0.999999999997352,0.794536019522867,0,2,regulation of renal sodium excretion,BP,
168,GO:0000350,0.999999999997391,0.71650541464584,0,3,generation of catalytic spliceosome for second transesterification step,BP,
11630,GO:0046356,0.999999999997395,0.817639679758509,0,2,acetyl-CoA catabolic process,BP,
13854,GO:0060481,0.999999999997395,0.806604854580231,0,2,lobar bronchus epithelium development,BP,
12122,GO:0048210,0.99999999999742,0.723359764250069,0,3,Golgi vesicle fusion to target membrane,BP,
11924,GO:0046979,0.999999999997426,0.718949179876534,0,3,TAP2 binding,MF,
2251,GO:0005166,0.999999999997441,0.917705062688791,0,1,neurotrophin p75 receptor binding,MF,
3496,GO:0007402,0.999999999997441,0.917705062688791,0,1,ganglion mother cell fate determination,BP,
3608,GO:0008052,0.999999999997441,0.917705062688791,0,1,sensory organ boundary specification,BP,
4406,GO:0010160,0.999999999997441,0.917705062688791,0,1,formation of animal organ boundary,BP,
12409,GO:0048867,0.999999999997441,0.917705062688791,0,1,stem cell fate determination,BP,
14222,GO:0061193,0.999999999997441,0.917705062688791,0,1,taste bud development,BP,
17001,GO:0099082,0.999999999997441,0.917705062688791,0,1,retrograde trans-synaptic signaling by neuropeptide,BP,
17002,GO:0099083,0.999999999997441,0.917705062688791,0,1,retrograde trans-synaptic signaling by neuropeptide, modulating synaptic transmission,BP,
17059,GO:0099538,0.999999999997441,0.917705062688791,0,1,synaptic signaling via neuropeptide,BP,
17060,GO:0099540,0.999999999997441,0.917705062688791,0,1,trans-synaptic signaling by neuropeptide,BP,
17068,GO:0099551,0.999999999997441,0.917705062688791,0,1,trans-synaptic signaling by neuropeptide, modulating synaptic transmission,BP,
5300,GO:0015990,0.999999999997464,0.925926491916383,0,1,electron transport coupled proton transport,BP,
2961,GO:0006500,0.999999999997465,0.891612215315525,0,1,N-terminal protein palmitoylation,BP,
5879,GO:0018009,0.999999999997465,0.891612215315525,0,1,N-terminal peptidyl-L-cysteine N-palmitoylation,BP,
19559,GO:1990460,0.999999999997469,0.706717202917566,0,3,leptin receptor binding,MF,
6078,GO:0019236,0.999999999997488,0.807197957141452,0,2,response to pheromone,BP,
3720,GO:0008251,0.999999999997491,0.792136185566347,0,2,tRNA-specific adenosine deaminase activity,MF,
2232,GO:0005137,0.999999999997513,0.891403680432462,0,1,interleukin-5 receptor binding,MF,
2596,GO:0005895,0.999999999997513,0.891403680432462,0,1,interleukin-5 receptor complex,CC,
3001,GO:0006550,0.999999999997524,0.801285516836227,0,2,isoleucine catabolic process,BP,
1626,GO:0004061,0.99999999999753,0.897160355002923,0,1,arylformamidase activity,MF,
4779,GO:0010967,0.99999999999753,0.897160355002923,0,1,regulation of polyamine biosynthetic process,BP,
7147,GO:0031013,0.99999999999753,0.897160355002923,0,1,troponin I binding,MF,
13440,GO:0052899,0.99999999999753,0.897160355002923,0,1,N(1),N(12)-diacetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
13442,GO:0052902,0.99999999999753,0.897160355002923,0,1,spermidine:oxygen oxidoreductase (3-aminopropanal-forming) activity,MF,
13443,GO:0052903,0.99999999999753,0.897160355002923,0,1,N1-acetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
13444,GO:0052904,0.99999999999753,0.897160355002923,0,1,N1-acetylspermidine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
17625,GO:1901304,0.99999999999753,0.897160355002923,0,1,regulation of spermidine biosynthetic process,BP,
17626,GO:1901307,0.99999999999753,0.897160355002923,0,1,positive regulation of spermidine biosynthetic process,BP,
17160,GO:0102521,0.999999999997532,0.792482188879596,0,2,tRNA-4-demethylwyosine synthase activity,MF,
16659,GO:0097536,0.999999999997552,0.890031497153081,0,1,thymus epithelium morphogenesis,BP,
5821,GO:0017089,0.999999999997603,0.795189702329991,0,2,glycolipid transporter activity,MF,
2237,GO:0005146,0.999999999997634,0.799147103913153,0,2,leukemia inhibitory factor receptor binding,MF,
15937,GO:0072749,0.99999999999766,0.895215270940881,0,1,cellular response to cytochalasin B,BP,
16939,GO:0098918,0.99999999999766,0.895215270940881,0,1,structural constituent of synapse,MF,
16964,GO:0098973,0.99999999999766,0.895215270940881,0,1,structural constituent of postsynaptic actin cytoskeleton,MF,
16965,GO:0098974,0.99999999999766,0.895215270940881,0,1,postsynaptic actin cytoskeleton organization,BP,
17028,GO:0099186,0.99999999999766,0.895215270940881,0,1,structural constituent of postsynapse,MF,
17029,GO:0099188,0.99999999999766,0.895215270940881,0,1,postsynaptic cytoskeleton organization,BP,
17632,GO:1901328,0.99999999999766,0.895215270940881,0,1,response to cytochalasin B,BP,
5044,GO:0015228,0.999999999997661,0.705747419488903,0,3,coenzyme A transmembrane transporter activity,MF,
5252,GO:0015880,0.999999999997661,0.705747419488903,0,3,coenzyme A transport,BP,
9083,GO:0035349,0.999999999997661,0.705747419488903,0,3,coenzyme A transmembrane transport,BP,
15084,GO:0071077,0.999999999997661,0.705747419488903,0,3,adenosine 3',5'-bisphosphate transmembrane transporter activity,MF,
15088,GO:0071106,0.999999999997661,0.705747419488903,0,3,adenosine 3',5'-bisphosphate transmembrane transport,BP,
15973,GO:0080122,0.999999999997661,0.705747419488903,0,3,AMP transmembrane transporter activity,MF,
4643,GO:0010767,0.999999999997667,0.705011527073351,0,3,regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,BP,
19683,GO:1990930,0.999999999997676,0.899761788123528,0,1,RNA N1-methyladenosine dioxygenase activity,MF,
12033,GO:0047801,0.999999999997679,0.891654864514512,0,1,L-cysteine:2-oxoglutarate aminotransferase activity,MF,
3020,GO:0006569,0.99999999999768,0.719312964551463,0,3,tryptophan catabolic process,BP,
6148,GO:0019441,0.99999999999768,0.719312964551463,0,3,tryptophan catabolic process to kynurenine,BP,
10005,GO:0042436,0.99999999999768,0.719312964551463,0,3,indole-containing compound catabolic process,BP,
11595,GO:0046218,0.99999999999768,0.719312964551463,0,3,indolalkylamine catabolic process,BP,
763,GO:0002016,0.999999999997704,0.930190888480805,0,1,regulation of blood volume by renin-angiotensin,BP,
765,GO:0002019,0.999999999997704,0.930190888480805,0,1,regulation of renal output by angiotensin,BP,
1282,GO:0003083,0.999999999997704,0.930190888480805,0,1,negative regulation of renal output by angiotensin,BP,
1294,GO:0003106,0.999999999997704,0.930190888480805,0,1,negative regulation of glomerular filtration by angiotensin,BP,
4934,GO:0014895,0.999999999997704,0.930190888480805,0,1,smooth muscle hypertrophy,BP,
17047,GO:0099522,0.999999999997713,0.89244494491725,0,1,region of cytosol,CC,
17048,GO:0099523,0.999999999997713,0.89244494491725,0,1,presynaptic cytosol,CC,
17049,GO:0099524,0.999999999997713,0.89244494491725,0,1,postsynaptic cytosol,CC,
18990,GO:1904764,0.999999999997713,0.89244494491725,0,1,chaperone-mediated autophagy translocation complex disassembly,BP,
19653,GO:1990832,0.999999999997713,0.89244494491725,0,1,slow axonal transport,BP,
19654,GO:1990833,0.999999999997713,0.89244494491725,0,1,clathrin-uncoating ATPase activity,MF,
20242,GO:2001160,0.999999999997718,0.810417182300069,0,2,regulation of histone H3-K79 methylation,BP,
20243,GO:2001162,0.999999999997718,0.810417182300069,0,2,positive regulation of histone H3-K79 methylation,BP,
5493,GO:0016429,0.999999999997725,0.708711129220371,0,3,tRNA (adenine-N1-)-methyltransferase activity,MF,
14494,GO:0061953,0.999999999997725,0.708711129220371,0,3,mRNA (adenine-N1-)-methyltransferase activity,MF,
19442,GO:1990034,0.999999999997725,0.708711129220371,0,3,calcium ion export across plasma membrane,BP,
3833,GO:0008441,0.999999999997732,0.792329075055044,0,2,3'(2'),5'-bisphosphate nucleotidase activity,MF,
18544,GO:1903723,0.999999999997734,0.921197241557708,0,1,negative regulation of centriole elongation,BP,
7216,GO:0031117,0.999999999997735,0.792149842909592,0,2,positive regulation of microtubule depolymerization,BP,
673,GO:0001884,0.999999999997744,0.792221493328807,0,2,pyrimidine nucleoside binding,MF,
833,GO:0002134,0.999999999997744,0.792221493328807,0,2,UTP binding,MF,
7946,GO:0032551,0.999999999997744,0.792221493328807,0,2,pyrimidine ribonucleoside binding,MF,
9564,GO:0036363,0.999999999997744,0.792221493328807,0,2,transforming growth factor beta activation,BP,
15977,GO:0080144,0.999999999997761,0.795745294387599,0,2,amino acid homeostasis,BP,
19110,GO:1905006,0.999999999997761,0.795745294387599,0,2,negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
13,GO:0000026,0.999999999997762,0.705096260596686,0,3,alpha-1,2-mannosyltransferase activity,MF,
1543,GO:0003937,0.999999999997785,0.891895294173713,0,1,IMP cyclohydrolase activity,MF,
1941,GO:0004643,0.999999999997785,0.891895294173713,0,1,phosphoribosylaminoimidazolecarboxamide formyltransferase activity,MF,
13402,GO:0052798,0.999999999997785,0.891895294173713,0,1,beta-galactoside alpha-2,3-sialyltransferase activity,MF,
848,GO:0002169,0.999999999997802,0.792219545767965,0,2,3-methylcrotonyl-CoA carboxylase complex, mitochondrial,CC,
1830,GO:0004485,0.999999999997802,0.792219545767965,0,2,methylcrotonoyl-CoA carboxylase activity,MF,
19174,GO:1905202,0.999999999997802,0.792219545767965,0,2,methylcrotonoyl-CoA carboxylase complex,CC,
17325,GO:0150003,0.999999999997809,0.717599699633466,0,3,regulation of spontaneous synaptic transmission,BP,
1591,GO:0004001,0.999999999997853,0.892254126008689,0,1,adenosine kinase activity,MF,
2003,GO:0004727,0.999999999997853,0.892254126008689,0,1,prenylated protein tyrosine phosphatase activity,MF,
2755,GO:0006169,0.999999999997853,0.892254126008689,0,1,adenosine salvage,BP,
2759,GO:0006175,0.999999999997853,0.892254126008689,0,1,dATP biosynthetic process,BP,
8640,GO:0034191,0.999999999997856,0.707751159140074,0,3,apolipoprotein A-I receptor binding,MF,
2144,GO:0004960,0.999999999997857,0.890845264899844,0,1,thromboxane receptor activity,MF,
2145,GO:0004961,0.999999999997857,0.890845264899844,0,1,thromboxane A2 receptor activity,MF,
5318,GO:0016036,0.999999999997857,0.890845264899844,0,1,cellular response to phosphate starvation,BP,
7319,GO:0031335,0.999999999997857,0.890845264899844,0,1,regulation of sulfur amino acid metabolic process,BP,
7320,GO:0031337,0.999999999997857,0.890845264899844,0,1,positive regulation of sulfur amino acid metabolic process,BP,
9330,GO:0035814,0.999999999997857,0.890845264899844,0,1,negative regulation of renal sodium excretion,BP,
9733,GO:0038193,0.999999999997857,0.890845264899844,0,1,thromboxane A2 signaling pathway,BP,
12517,GO:0050666,0.999999999997857,0.890845264899844,0,1,regulation of homocysteine metabolic process,BP,
12519,GO:0050668,0.999999999997857,0.890845264899844,0,1,positive regulation of homocysteine metabolic process,BP,
9406,GO:0035971,0.999999999997861,0.90970438456386,0,1,peptidyl-histidine dephosphorylation,BP,
5555,GO:0016561,0.999999999997866,0.79529585784233,0,2,protein import into peroxisome matrix, translocation,BP,
17558,GO:1901090,0.999999999997866,0.79529585784233,0,2,regulation of protein tetramerization,BP,
17559,GO:1901091,0.999999999997866,0.79529585784233,0,2,negative regulation of protein tetramerization,BP,
17560,GO:1901093,0.999999999997866,0.79529585784233,0,2,regulation of protein homotetramerization,BP,
17561,GO:1901094,0.999999999997866,0.79529585784233,0,2,negative regulation of protein homotetramerization,BP,
19444,GO:1990037,0.999999999997876,0.713962632598601,0,3,Lewy body core,CC,
1162,GO:0002775,0.999999999997892,0.718501265613793,0,3,antimicrobial peptide production,BP,
1163,GO:0002778,0.999999999997892,0.718501265613793,0,3,antibacterial peptide production,BP,
1164,GO:0002784,0.999999999997892,0.718501265613793,0,3,regulation of antimicrobial peptide production,BP,
1166,GO:0002786,0.999999999997892,0.718501265613793,0,3,regulation of antibacterial peptide production,BP,
2795,GO:0006253,0.999999999997894,0.913242086496467,0,1,dCTP catabolic process,BP,
11526,GO:0046065,0.999999999997894,0.913242086496467,0,1,dCTP metabolic process,BP,
12034,GO:0047840,0.999999999997894,0.913242086496467,0,1,dCTP diphosphatase activity,MF,
9678,GO:0038052,0.999999999997895,0.792337562828771,0,2,RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding,MF,
2043,GO:0004790,0.999999999997906,0.890109535249294,0,1,thioether S-methyltransferase activity,MF,
7016,GO:0030748,0.999999999997906,0.890109535249294,0,1,amine N-methyltransferase activity,MF,
17167,GO:0102707,0.999999999997906,0.890109535249294,0,1,S-adenosyl-L-methionine:beta-alanine N-methyltransferase activity,MF,
8535,GO:0033872,0.999999999997921,0.892491931582236,0,1,[heparan sulfate]-glucosamine 3-sulfotransferase 3 activity,MF,
15009,GO:0070944,0.999999999997923,0.798780783463137,0,2,neutrophil mediated killing of bacterium,BP,
15010,GO:0070945,0.999999999997923,0.798780783463137,0,2,neutrophil mediated killing of gram-negative bacterium,BP,
18964,GO:1904716,0.999999999997937,0.890477606033736,0,1,positive regulation of chaperone-mediated autophagy,BP,
9006,GO:0035175,0.999999999997968,0.896913505935378,0,1,histone kinase activity (H3-S10 specific),MF,
15755,GO:0072354,0.999999999997968,0.896913505935378,0,1,histone kinase activity (H3-T3 specific),MF,
15756,GO:0072355,0.999999999997968,0.896913505935378,0,1,histone H3-T3 phosphorylation,BP,
19695,GO:1990983,0.999999999997972,0.890083548972949,0,1,tRNA demethylation,BP,
19696,GO:1990984,0.999999999997972,0.890083548972949,0,1,tRNA demethylase activity,MF,
16940,GO:0098920,0.999999999997988,0.79213701030713,0,2,retrograde trans-synaptic signaling by lipid,BP,
16941,GO:0098921,0.999999999997988,0.79213701030713,0,2,retrograde trans-synaptic signaling by endocannabinoid,BP,
2880,GO:0006386,0.999999999997995,0.925675946927237,0,1,termination of RNA polymerase III transcription,BP,
1719,GO:0004310,0.999999999997995,0.891817781737227,0,1,farnesyl-diphosphate farnesyltransferase activity,MF,
7158,GO:0031038,0.999999999997995,0.891817781737227,0,1,myosin II filament organization,BP,
10556,GO:0043519,0.999999999997995,0.891817781737227,0,1,regulation of myosin II filament organization,BP,
13284,GO:0051996,0.999999999997995,0.891817781737227,0,1,squalene synthase activity,MF,
7404,GO:0031493,0.999999999998002,0.710461488679157,0,3,nucleosomal histone binding,MF,
17966,GO:1902308,0.999999999998064,0.709041909092872,0,3,regulation of peptidyl-serine dephosphorylation,BP,
10762,GO:0044214,0.999999999998083,0.70513090746571,0,3,spanning component of plasma membrane,CC,
11161,GO:0045234,0.999999999998123,0.895581433432951,0,1,protein palmitoleylation,BP,
6829,GO:0030298,0.999999999998158,0.909540837011891,0,1,receptor signaling protein tyrosine kinase activator activity,MF,
7517,GO:0031726,0.999999999998158,0.909540837011891,0,1,CCR1 chemokine receptor binding,MF,
7518,GO:0031729,0.999999999998158,0.909540837011891,0,1,CCR4 chemokine receptor binding,MF,
11832,GO:0046817,0.999999999998158,0.909540837011891,0,1,chemokine receptor antagonist activity,MF,
2809,GO:0006272,0.999999999998186,0.717682135846278,0,3,leading strand elongation,BP,
7682,GO:0032139,0.999999999998186,0.717682135846278,0,3,dinucleotide insertion or deletion binding,MF,
18212,GO:1902990,0.999999999998186,0.717682135846278,0,3,mitotic telomere maintenance via semi-conservative replication,BP,
16334,GO:0090560,0.999999999998192,0.891472124833834,0,1,2-(3-amino-3-carboxypropyl)histidine synthase activity,MF,
17479,GO:1900368,0.999999999998206,0.752462971141356,0,3,regulation of RNA interference,BP,
15094,GO:0071139,0.999999999998268,0.792174236774963,0,2,resolution of recombination intermediates,BP,
15095,GO:0071140,0.999999999998268,0.792174236774963,0,2,resolution of mitotic recombination intermediates,BP,
5272,GO:0015920,0.999999999998272,0.890034698135698,0,1,lipopolysaccharide transport,BP,
7916,GO:0032497,0.999999999998272,0.890034698135698,0,1,detection of lipopolysaccharide,BP,
14786,GO:0070506,0.999999999998272,0.890034698135698,0,1,high-density lipoprotein particle receptor activity,MF,
6266,GO:0019863,0.999999999998274,0.904050874507428,0,1,IgE binding,MF,
3785,GO:0008352,0.999999999998282,0.890041680636885,0,1,katanin complex,CC,
1604,GO:0004022,0.999999999998307,0.890047971159457,0,1,alcohol dehydrogenase (NAD) activity,MF,
5975,GO:0018467,0.999999999998307,0.890047971159457,0,1,formaldehyde dehydrogenase activity,MF,
13229,GO:0051903,0.999999999998307,0.890047971159457,0,1,S-(hydroxymethyl)glutathione dehydrogenase activity,MF,
18972,GO:1904732,0.999999999998325,0.838655156511594,0,2,regulation of electron transfer activity,BP,
19088,GO:1904959,0.999999999998325,0.838655156511594,0,2,regulation of cytochrome-c oxidase activity,BP,
43,GO:0000095,0.999999999998331,0.891048309548308,0,1,S-adenosyl-L-methionine transmembrane transporter activity,MF,
5206,GO:0015805,0.999999999998331,0.891048309548308,0,1,S-adenosyl-L-methionine transport,BP,
17824,GO:1901962,0.999999999998331,0.891048309548308,0,1,S-adenosyl-L-methionine transmembrane transport,BP,
11059,GO:0045065,0.99999999999835,0.799083716541923,0,2,cytotoxic T cell differentiation,BP,
11267,GO:0045583,0.99999999999835,0.799083716541923,0,2,regulation of cytotoxic T cell differentiation,BP,
11268,GO:0045585,0.99999999999835,0.799083716541923,0,2,positive regulation of cytotoxic T cell differentiation,BP,
372,GO:0000994,0.99999999999836,0.895712743385595,0,1,RNA polymerase III core binding,MF,
1775,GO:0004382,0.999999999998365,0.794103427729008,0,2,guanosine-diphosphatase activity,MF,
14528,GO:0070037,0.99999999999837,0.915616270140181,0,1,rRNA (pseudouridine) methyltransferase activity,MF,
5977,GO:0018479,0.999999999998371,0.89185626418745,0,1,benzaldehyde dehydrogenase (NAD+) activity,MF,
13227,GO:0051901,0.999999999998376,0.735656138315781,0,3,positive regulation of mitochondrial depolarization,BP,
1362,GO:0003241,0.999999999998382,0.711598716852069,0,3,growth involved in heart morphogenesis,BP,
2052,GO:0004801,0.999999999998384,0.908892819021965,0,1,sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity,MF,
2022,GO:0004751,0.999999999998391,0.894791790304037,0,1,ribose-5-phosphate isomerase activity,MF,
2192,GO:0005053,0.999999999998407,0.901906569216364,0,1,peroxisome matrix targeting signal-2 binding,MF,
7897,GO:0032472,0.99999999999843,0.794905106606722,0,2,Golgi calcium ion transport,BP,
17859,GO:1902037,0.999999999998482,0.7050183474361,0,3,negative regulation of hematopoietic stem cell differentiation,BP,
3997,GO:0008903,0.999999999998537,0.913489268401532,0,1,hydroxypyruvate isomerase activity,MF,
13399,GO:0052794,0.999999999998545,0.793997393864498,0,2,exo-alpha-(2->3)-sialidase activity,MF,
13400,GO:0052795,0.999999999998545,0.793997393864498,0,2,exo-alpha-(2->6)-sialidase activity,MF,
13401,GO:0052796,0.999999999998545,0.793997393864498,0,2,exo-alpha-(2->8)-sialidase activity,MF,
5544,GO:0016533,0.999999999998545,0.811761262020809,0,2,cyclin-dependent protein kinase 5 holoenzyme complex,CC,
1623,GO:0004056,0.999999999998549,0.892848355954884,0,1,argininosuccinate lyase activity,MF,
10014,GO:0042450,0.999999999998549,0.892848355954884,0,1,arginine biosynthetic process via ornithine,BP,
4553,GO:0010636,0.999999999998578,0.792197583473525,0,2,positive regulation of mitochondrial fusion,BP,
172,GO:0000379,0.999999999998605,0.709579338227706,0,3,tRNA-type intron splice site recognition and cleavage,BP,
2048,GO:0004795,0.999999999998619,0.891764818714889,0,1,threonine synthase activity,MF,
4048,GO:0009088,0.999999999998619,0.891764818714889,0,1,threonine biosynthetic process,BP,
11632,GO:0046360,0.999999999998619,0.891764818714889,0,1,2-oxobutyrate biosynthetic process,BP,
11633,GO:0046361,0.999999999998619,0.891764818714889,0,1,2-oxobutyrate metabolic process,BP,
11453,GO:0045918,0.999999999998621,0.846641109556904,0,2,negative regulation of cytolysis,BP,
12646,GO:0050859,0.999999999998652,0.708938489043651,0,3,negative regulation of B cell receptor signaling pathway,BP,
9137,GO:0035485,0.99999999999868,0.894696911773172,0,1,adenine/guanine mispair binding,MF,
18019,GO:1902480,0.999999999998683,0.890320227578007,0,1,protein localization to mitotic spindle,BP,
1535,GO:0003919,0.999999999998703,0.893065914648655,0,1,FMN adenylyltransferase activity,MF,
3146,GO:0006747,0.999999999998703,0.893065914648655,0,1,FAD biosynthetic process,BP,
11659,GO:0046443,0.999999999998703,0.893065914648655,0,1,FAD metabolic process,BP,
15779,GO:0072388,0.999999999998703,0.893065914648655,0,1,flavin adenine dinucleotide biosynthetic process,BP,
493,GO:0001546,0.999999999998706,0.898077535490176,0,1,preantral ovarian follicle growth,BP,
1687,GO:0004155,0.999999999998706,0.898077535490176,0,1,6,7-dihydropteridine reductase activity,MF,
12102,GO:0048162,0.999999999998706,0.898077535490176,0,1,multi-layer follicle stage,BP,
18868,GO:1904481,0.999999999998758,0.890250651539055,0,1,response to tetrahydrofolate,BP,
18869,GO:1904482,0.999999999998758,0.890250651539055,0,1,cellular response to tetrahydrofolate,BP,
9379,GO:0035915,0.999999999998777,0.892357324781247,0,1,pore formation in membrane of other organism,BP,
19903,GO:2000374,0.999999999998777,0.892357324781247,0,1,regulation of oxygen metabolic process,BP,
6991,GO:0030678,0.99999999999879,0.728289421522269,0,3,mitochondrial ribonuclease P complex,CC,
16729,GO:0097745,0.99999999999879,0.728289421522269,0,3,mitochondrial tRNA 5'-end processing,BP,
12995,GO:0051429,0.999999999998816,0.717709104080094,0,3,corticotropin-releasing hormone receptor binding,MF,
1746,GO:0004346,0.999999999998828,0.898370036722667,0,1,glucose-6-phosphatase activity,MF,
12458,GO:0050309,0.999999999998828,0.898370036722667,0,1,sugar-terminal-phosphatase activity,MF,
6374,GO:0021564,0.999999999998832,0.80157938238843,0,2,vagus nerve development,BP,
9411,GO:0035981,0.999999999998832,0.80157938238843,0,2,tongue muscle cell differentiation,BP,
18136,GO:1902811,0.999999999998832,0.80157938238843,0,2,positive regulation of skeletal muscle fiber differentiation,BP,
20207,GO:2001035,0.999999999998832,0.80157938238843,0,2,regulation of tongue muscle cell differentiation,BP,
20208,GO:2001037,0.999999999998832,0.80157938238843,0,2,positive regulation of tongue muscle cell differentiation,BP,
13962,GO:0060683,0.999999999998833,0.890024070582714,0,1,regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling,BP,
19525,GO:1990401,0.999999999998833,0.890024070582714,0,1,embryonic lung development,BP,
18504,GO:1903621,0.999999999998859,0.893369181521622,0,1,protein localization to photoreceptor connecting cilium,BP,
19832,GO:2000275,0.999999999998861,0.819970056226061,0,2,regulation of oxidative phosphorylation uncoupler activity,BP,
13141,GO:0051722,0.999999999998894,0.890246826419802,0,1,protein C-terminal methylesterase activity,MF,
13142,GO:0051723,0.999999999998894,0.890246826419802,0,1,protein methylesterase activity,MF,
9380,GO:0035921,0.999999999998921,0.891911060355551,0,1,desmosome disassembly,BP,
17488,GO:1900387,0.999999999998921,0.891911060355551,0,1,negative regulation of cell-cell adhesion by negative regulation of transcription from RNA polymerase II promoter,BP,
9772,GO:0039656,0.999999999998928,0.797030167127278,0,2,modulation by virus of host gene expression,BP,
11823,GO:0046778,0.999999999998928,0.797030167127278,0,2,modification by virus of host mRNA processing,BP,
15792,GO:0072429,0.999999999998985,0.705703497899965,0,3,response to intra-S DNA damage checkpoint signaling,BP,
779,GO:0002038,0.999999999998995,0.890865850456175,0,1,positive regulation of L-glutamate import across plasma membrane,BP,
4715,GO:0010879,0.999999999998995,0.890865850456175,0,1,cholesterol transport involved in cholesterol storage,BP,
9085,GO:0035352,0.999999999998995,0.890865850456175,0,1,NAD transmembrane transport,BP,
10332,GO:0043132,0.999999999998995,0.890865850456175,0,1,NAD transport,BP,
10938,GO:0044610,0.999999999998995,0.890865850456175,0,1,FMN transmembrane transporter activity,MF,
13143,GO:0051724,0.999999999998995,0.890865850456175,0,1,NAD transmembrane transporter activity,MF,
14959,GO:0070860,0.999999999999003,0.890686615866135,0,1,RNA polymerase I core factor complex,CC,
12037,GO:0047874,0.99999999999905,0.8917798429087,0,1,dolichyldiphosphatase activity,MF,
778,GO:0002037,0.999999999999054,0.891698271755006,0,1,negative regulation of L-glutamate import across plasma membrane,BP,
19373,GO:1905777,0.99999999999908,0.705004091091131,0,3,regulation of exonuclease activity,BP,
16273,GO:0090341,0.999999999999092,0.900087571884754,0,1,negative regulation of secretion of lysosomal enzymes,BP,
14444,GO:0061770,0.999999999999094,0.891455627605284,0,1,translation elongation factor binding,MF,
14614,GO:0070184,0.999999999999094,0.891455627605284,0,1,mitochondrial tyrosyl-tRNA aminoacylation,BP,
15834,GO:0072545,0.999999999999094,0.891455627605284,0,1,tyrosine binding,MF,
18182,GO:1902937,0.999999999999094,0.891455627605284,0,1,inward rectifier potassium channel complex,CC,
19026,GO:1904842,0.999999999999094,0.891455627605284,0,1,response to nitroglycerin,BP,
19027,GO:1904843,0.999999999999094,0.891455627605284,0,1,cellular response to nitroglycerin,BP,
2226,GO:0005129,0.999999999999096,0.926303473805527,0,1,granulocyte macrophage colony-stimulating factor receptor binding,MF,
8554,GO:0034021,0.999999999999096,0.926303473805527,0,1,response to silicon dioxide,BP,
4276,GO:0009644,0.9999999999991,0.793885113148529,0,2,response to high light intensity,BP,
179,GO:0000390,0.9999999999991,0.810268792180195,0,2,spliceosomal complex disassembly,BP,
14922,GO:0070780,0.9999999999991,0.810268792180195,0,2,dihydrosphingosine-1-phosphate phosphatase activity,MF,
8901,GO:0034729,0.999999999999135,0.721276693761836,0,3,histone H3-K79 methylation,BP,
13505,GO:0055087,0.999999999999135,0.721276693761836,0,3,Ski complex,CC,
1571,GO:0003977,0.999999999999148,0.792643829158882,0,2,UDP-N-acetylglucosamine diphosphorylase activity,MF,
9302,GO:0035752,0.999999999999188,0.893867366787537,0,1,lysosomal lumen pH elevation,BP,
4245,GO:0009447,0.999999999999229,0.752748657014328,0,3,putrescine catabolic process,BP,
15158,GO:0071283,0.999999999999241,0.818846384005085,0,2,cellular response to iron(III) ion,BP,
1814,GO:0004464,0.999999999999257,0.862027913897752,0,2,leukotriene-C4 synthase activity,MF,
11669,GO:0046462,0.999999999999286,0.797138936950721,0,2,monoacylglycerol metabolic process,BP,
13371,GO:0052651,0.999999999999286,0.797138936950721,0,2,monoacylglycerol catabolic process,BP,
18209,GO:1902977,0.999999999999289,0.893636842396111,0,1,mitotic DNA replication preinitiation complex assembly,BP,
167,GO:0000349,0.999999999999322,0.792599737967531,0,2,generation of catalytic spliceosome for first transesterification step,BP,
8132,GO:0032847,0.999999999999335,0.798993765360492,0,2,regulation of cellular pH reduction,BP,
12386,GO:0048822,0.999999999999352,0.706295309957075,0,3,enucleate erythrocyte development,BP,
4009,GO:0008995,0.999999999999355,0.890079681711061,0,1,ribonuclease E activity,MF,
16210,GO:0090247,0.999999999999355,0.890079681711061,0,1,cell motility involved in somitogenic axis elongation,BP,
16211,GO:0090249,0.999999999999355,0.890079681711061,0,1,regulation of cell motility involved in somitogenic axis elongation,BP,
17599,GO:1901229,0.999999999999355,0.890079681711061,0,1,regulation of non-canonical Wnt signaling pathway via JNK cascade,BP,
17600,GO:1901231,0.999999999999355,0.890079681711061,0,1,positive regulation of non-canonical Wnt signaling pathway via JNK cascade,BP,
17601,GO:1901232,0.999999999999355,0.890079681711061,0,1,regulation of convergent extension involved in axis elongation,BP,
17602,GO:1901233,0.999999999999355,0.890079681711061,0,1,negative regulation of convergent extension involved in axis elongation,BP,
4877,GO:0014740,0.999999999999358,0.792325747103063,0,2,negative regulation of muscle hyperplasia,BP,
2946,GO:0006478,0.999999999999372,0.797110315249185,0,2,peptidyl-tyrosine sulfation,BP,
3856,GO:0008476,0.999999999999372,0.797110315249185,0,2,protein-tyrosine sulfotransferase activity,MF,
4611,GO:0010730,0.999999999999383,0.705644957443215,0,3,negative regulation of hydrogen peroxide biosynthetic process,BP,
8748,GO:0034421,0.999999999999383,0.705644957443215,0,3,post-translational protein acetylation,BP,
16299,GO:0090409,0.99999999999939,0.890759936611195,0,1,malonyl-CoA synthetase activity,MF,
16300,GO:0090410,0.99999999999939,0.890759936611195,0,1,malonate catabolic process,BP,
3775,GO:0008332,0.9999999999994,0.893492374836315,0,1,low voltage-gated calcium channel activity,MF,
4612,GO:0010731,0.999999999999409,0.890563440475722,0,1,protein glutathionylation,BP,
4613,GO:0010732,0.999999999999409,0.890563440475722,0,1,regulation of protein glutathionylation,BP,
4614,GO:0010734,0.999999999999409,0.890563440475722,0,1,negative regulation of protein glutathionylation,BP,
8383,GO:0033306,0.999999999999414,0.795875980445975,0,2,phytol metabolic process,BP,
18292,GO:1903173,0.999999999999414,0.795875980445975,0,2,fatty alcohol metabolic process,BP,
5980,GO:0018773,0.999999999999423,0.897491413419905,0,1,acetylpyruvate hydrolase activity,MF,
8802,GO:0034545,0.999999999999423,0.897491413419905,0,1,fumarylpyruvate hydrolase activity,MF,
12011,GO:0047621,0.999999999999423,0.897491413419905,0,1,acylpyruvate hydrolase activity,MF,
13353,GO:0052550,0.999999999999423,0.897491413419905,0,1,response to defense-related reactive oxygen species production by other organism involved in symbiotic interaction,BP,
13359,GO:0052567,0.999999999999423,0.897491413419905,0,1,response to defense-related host reactive oxygen species production,BP,
785,GO:0002046,0.999999999999427,0.918428704682294,0,1,opsin binding,MF,
9568,GO:0036372,0.999999999999427,0.918428704682294,0,1,opsin transport,BP,
2240,GO:0005151,0.999999999999446,0.797138936950561,0,2,interleukin-1, Type II receptor binding,MF,
6613,GO:0022841,0.999999999999451,0.710696852798044,0,3,potassium ion leak channel activity,MF,
9999,GO:0042421,0.999999999999453,0.708033082140984,0,3,norepinephrine biosynthetic process,BP,
5292,GO:0015960,0.999999999999469,0.706409938816801,0,3,diadenosine polyphosphate biosynthetic process,BP,
5294,GO:0015965,0.999999999999469,0.706409938816801,0,3,diadenosine tetraphosphate metabolic process,BP,
5295,GO:0015966,0.999999999999469,0.706409938816801,0,3,diadenosine tetraphosphate biosynthetic process,BP,
176,GO:0000386,0.999999999999475,0.710476377643514,0,3,second spliceosomal transesterification activity,MF,
18716,GO:1904098,0.999999999999475,0.710476377643514,0,3,regulation of protein O-linked glycosylation,BP,
18717,GO:1904100,0.999999999999475,0.710476377643514,0,3,positive regulation of protein O-linked glycosylation,BP,
12117,GO:0048203,0.999999999999483,0.795263747572398,0,2,vesicle targeting, trans-Golgi to endosome,BP,
3935,GO:0008623,0.999999999999484,0.79239573401665,0,2,CHRAC,CC,
16117,GO:0090107,0.999999999999499,0.718958724814126,0,3,regulation of high-density lipoprotein particle assembly,BP,
928,GO:0002325,0.99999999999952,0.911203654489358,0,1,natural killer cell differentiation involved in immune response,BP,
8124,GO:0032824,0.99999999999952,0.911203654489358,0,1,negative regulation of natural killer cell differentiation,BP,
8126,GO:0032826,0.99999999999952,0.911203654489358,0,1,regulation of natural killer cell differentiation involved in immune response,BP,
8127,GO:0032827,0.99999999999952,0.911203654489358,0,1,negative regulation of natural killer cell differentiation involved in immune response,BP,
19237,GO:1905349,0.999999999999583,0.910381317207056,0,1,ciliary transition zone assembly,BP,
1029,GO:0002536,0.999999999999585,0.822765848209527,0,2,respiratory burst involved in inflammatory response,BP,
13696,GO:0060264,0.999999999999585,0.822765848209527,0,2,regulation of respiratory burst involved in inflammatory response,BP,
13698,GO:0060266,0.999999999999585,0.822765848209527,0,2,negative regulation of respiratory burst involved in inflammatory response,BP,
5710,GO:0016841,0.999999999999597,0.716401272081974,0,3,ammonia-lyase activity,MF,
16509,GO:0097212,0.999999999999621,0.795653140448535,0,2,lysosomal membrane organization,BP,
5773,GO:0016979,0.999999999999622,0.903856078310498,0,1,lipoate-protein ligase activity,MF,
4215,GO:0009383,0.999999999999649,0.792139431843881,0,2,rRNA (cytosine-C5-)-methyltransferase activity,MF,
14166,GO:0061073,0.999999999999649,0.792139431843881,0,2,ciliary body morphogenesis,BP,
15711,GO:0072272,0.999999999999661,0.796145579914436,0,2,proximal/distal pattern formation involved in metanephric nephron development,BP,
19977,GO:2000520,0.999999999999674,0.805166884321278,0,2,regulation of immunological synapse formation,BP,
19978,GO:2000521,0.999999999999674,0.805166884321278,0,2,negative regulation of immunological synapse formation,BP,
20263,GO:2001188,0.999999999999674,0.805166884321278,0,2,regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
20264,GO:2001189,0.999999999999674,0.805166884321278,0,2,negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
4885,GO:0014806,0.999999999999698,0.801496060204141,0,2,smooth muscle hyperplasia,BP,
7524,GO:0031753,0.999999999999707,0.89002376543031,0,1,endothelial differentiation G-protein coupled receptor binding,MF,
7525,GO:0031755,0.999999999999707,0.89002376543031,0,1,Edg-2 lysophosphatidic acid receptor binding,MF,
2652,GO:0005999,0.999999999999744,0.810545942533306,0,2,xylulose biosynthetic process,BP,
5650,GO:0016744,0.999999999999744,0.810545942533306,0,2,transferase activity, transferring aldehyde or ketonic groups,MF,
3125,GO:0006710,0.999999999999752,0.894254996085497,0,1,androgen catabolic process,BP,
18139,GO:1902822,0.999999999999759,0.728208318099265,0,3,regulation of late endosome to lysosome transport,BP,
2991,GO:0006540,0.999999999999769,0.792529756273737,0,2,glutamate decarboxylation to succinate,BP,
2274,GO:0005219,0.99999999999977,0.918601179108768,0,1,ryanodine-sensitive calcium-release channel activity,MF,
7188,GO:0031084,0.999999999999774,0.705023291266799,0,3,BLOC-2 complex,CC,
8043,GO:0032707,0.999999999999778,0.890468506058802,0,1,negative regulation of interleukin-23 production,BP,
12026,GO:0047747,0.999999999999778,0.890468506058802,0,1,cholate-CoA ligase activity,MF,
4209,GO:0009353,0.99999999999978,0.906371716530868,0,1,mitochondrial oxoglutarate dehydrogenase complex,CC,
7423,GO:0031531,0.99999999999978,0.906371716530868,0,1,thyrotropin-releasing hormone receptor binding,MF,
15981,GO:0080163,0.999999999999817,0.890401395828972,0,1,regulation of protein serine/threonine phosphatase activity,BP,
15114,GO:0071207,0.999999999999847,0.797970274352707,0,2,histone pre-mRNA stem-loop binding,MF,
8110,GO:0032804,0.999999999999875,0.799553445646387,0,2,negative regulation of low-density lipoprotein particle receptor catabolic process,BP,
10737,GO:0044111,0.999999999999875,0.799553445646387,0,2,development involved in symbiotic interaction,BP,
19332,GO:1905602,0.999999999999875,0.799553445646387,0,2,positive regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
2567,GO:0005853,0.999999999999883,0.741413091645278,0,3,eukaryotic translation elongation factor 1 complex,CC,
11407,GO:0045829,0.999999999999896,0.706272717576003,0,3,negative regulation of isotype switching,BP,
3166,GO:0006781,0.999999999999897,0.891390893282734,0,1,succinyl-CoA pathway,BP,
5142,GO:0015670,0.999999999999902,0.897730694352327,0,1,carbon dioxide transport,BP,
8134,GO:0032849,0.999999999999902,0.897730694352327,0,1,positive regulation of cellular pH reduction,BP,
3392,GO:0007174,0.99999999999993,0.891022247279507,0,1,epidermal growth factor catabolic process,BP,
7852,GO:0032419,0.99999999999993,0.891022247279507,0,1,extrinsic component of lysosome membrane,CC,
19097,GO:1904979,0.99999999999993,0.891022247279507,0,1,negative regulation of endosome organization,BP,
19242,GO:1905365,0.99999999999993,0.891022247279507,0,1,regulation of intralumenal vesicle formation,BP,
19243,GO:1905366,0.99999999999993,0.891022247279507,0,1,negative regulation of intralumenal vesicle formation,BP,
2369,GO:0005497,0.999999999999933,0.826913113115709,0,2,androgen binding,MF,
3837,GO:0008446,0.999999999999943,0.897550801244629,0,1,GDP-mannose 4,6-dehydratase activity,MF,
19944,GO:2000434,0.999999999999977,0.855505964396039,0,2,regulation of protein neddylation,BP,
19945,GO:2000435,0.999999999999977,0.855505964396039,0,2,negative regulation of protein neddylation,BP,
8532,GO:0033867,0.999999999999983,0.898202136702182,0,1,Fas-activated serine/threonine kinase activity,MF,
6,GO:0000012,1,0.395528492360507,0,8,single strand break repair,BP,
11,GO:0000022,1,0.318468071919103,0,10,mitotic spindle elongation,BP,
15,GO:0000028,1,0.21804474628399,0,18,ribosomal small subunit assembly,BP,
27,GO:0000052,1,0.452829368091158,0,7,citrulline metabolic process,BP,
29,GO:0000054,1,0.263956805214804,0,13,ribosomal subunit export from nucleus,BP,
30,GO:0000055,1,0.434613065254258,0,8,ribosomal large subunit export from nucleus,BP,
31,GO:0000056,1,0.489944753080771,0,7,ribosomal small subunit export from nucleus,BP,
34,GO:0000064,1,0.630471703748548,0,4,L-ornithine transmembrane transporter activity,MF,
37,GO:0000076,1,0.181457661203329,0,15,DNA replication checkpoint,BP,
47,GO:0000099,1,0.627449667077517,0,4,sulfur amino acid transmembrane transporter activity,MF,
57,GO:0000120,1,0.573602235790966,0,5,RNA polymerase I transcription factor complex,CC,
61,GO:0000124,1,0.243617924407057,0,13,SAGA complex,CC,
62,GO:0000125,1,0.600419359229226,0,5,PCAF complex,CC,
64,GO:0000127,1,0.513569363932843,0,6,transcription factor TFIIIC complex,CC,
67,GO:0000138,1,0.522084433791501,0,6,Golgi trans cisterna,CC,
73,GO:0000150,1,0.407903076926367,0,8,recombinase activity,MF,
80,GO:0000164,1,0.285146712540462,0,11,protein phosphatase type 1 complex,CC,
84,GO:0000172,1,0.536667901382417,0,6,ribonuclease MRP complex,CC,
87,GO:0000176,1,0.274596059210701,0,13,nuclear exosome (RNase complex),CC,
101,GO:0000213,1,0.633819887961564,0,4,tRNA-intron endonuclease activity,MF,
102,GO:0000214,1,0.635935583933699,0,4,tRNA-intron endonuclease complex,CC,
105,GO:0000220,1,0.591338671166632,0,5,vacuolar proton-transporting V-type ATPase, V0 domain,CC,
112,GO:0000235,1,0.394116169879923,0,8,astral microtubule,CC,
114,GO:0000243,1,0.428702985861748,0,8,commitment complex,CC,
115,GO:0000244,1,0.278041337597368,0,11,spliceosomal tri-snRNP complex assembly,BP,
128,GO:0000268,1,0.635828890696879,0,4,peroxisome targeting sequence binding,MF,
139,GO:0000290,1,0.36838647526826,0,9,deadenylation-dependent decapping of nuclear-transcribed mRNA,BP,
140,GO:0000291,1,0.0273040858244145,0,35,nuclear-transcribed mRNA catabolic process, exonucleolytic,BP,
143,GO:0000295,1,0.287881857192163,0,11,adenine nucleotide transmembrane transporter activity,MF,
145,GO:0000298,1,0.640827166600949,0,4,endopolyphosphatase activity,MF,
156,GO:0000315,1,0.00861966259679623,0,51,organellar large ribosomal subunit,CC,
162,GO:0000338,1,0.330015895679386,0,10,protein deneddylation,BP,
165,GO:0000346,1,0.237739005531562,0,13,transcription export complex,CC,
166,GO:0000347,1,0.524805859222812,0,6,THO complex,CC,
173,GO:0000380,1,0.00591606549901931,0,45,alternative mRNA splicing, via spliceosome,BP,
174,GO:0000381,1,0.0230909266070057,0,33,regulation of alternative mRNA splicing, via spliceosome,BP,
177,GO:0000387,1,0.0210524835931799,0,36,spliceosomal snRNP assembly,BP,
178,GO:0000389,1,0.504797097911775,0,6,mRNA 3'-splice site recognition,BP,
180,GO:0000393,1,0.567867677551567,0,5,spliceosomal conformational changes to generate catalytic conformation,BP,
182,GO:0000395,1,0.571292764026593,0,5,mRNA 5'-splice site recognition,BP,
184,GO:0000400,1,0.162613008427206,0,16,four-way junction DNA binding,MF,
185,GO:0000403,1,0.496982205834915,0,6,Y-form DNA binding,MF,
190,GO:0000408,1,0.59240373954421,0,5,EKC/KEOPS complex,CC,
195,GO:0000414,1,0.627449537468743,0,4,regulation of histone H3-K36 methylation,BP,
201,GO:0000423,1,0.115057486730685,0,19,mitophagy,BP,
210,GO:0000439,1,0.359914042500096,0,9,core TFIIH complex,CC,
211,GO:0000444,1,0.645491797249226,0,4,MIS12/MIND type complex,CC,
212,GO:0000445,1,0.524805859222812,0,6,THO complex part of transcription export complex,CC,
213,GO:0000447,1,0.385148006036583,0,9,endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
219,GO:0000459,1,0.477193779168414,0,7,exonucleolytic trimming involved in rRNA processing,BP,
220,GO:0000460,1,0.0291302325641029,0,33,maturation of 5.8S rRNA,BP,
223,GO:0000463,1,0.361175782915005,0,10,maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
224,GO:0000466,1,0.0914054681298984,0,22,maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
225,GO:0000467,1,0.477193779168414,0,7,exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
226,GO:0000469,1,0.0609809990652715,0,26,cleavage involved in rRNA processing,BP,
227,GO:0000470,1,0.0853415167394727,0,24,maturation of LSU-rRNA,BP,
229,GO:0000478,1,0.191453564373671,0,15,endonucleolytic cleavage involved in rRNA processing,BP,
230,GO:0000479,1,0.215079029902562,0,14,endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
231,GO:0000480,1,0.498435710161785,0,6,endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
233,GO:0000491,1,0.375423454256287,0,9,small nucleolar ribonucleoprotein complex assembly,BP,
234,GO:0000492,1,0.470939366535749,0,7,box C/D snoRNP assembly,BP,
243,GO:0000700,1,0.642234538290475,0,4,mismatch base pair DNA N-glycosylase activity,MF,
245,GO:0000702,1,0.608143190252788,0,5,oxidized base lesion DNA N-glycosylase activity,MF,
248,GO:0000707,1,0.40768292438833,0,8,meiotic DNA recombinase assembly,BP,
250,GO:0000712,1,0.357054512910872,0,9,resolution of meiotic recombination intermediates,BP,
260,GO:0000727,1,0.57416884126002,0,5,double-strand break repair via break-induced replication,BP,
261,GO:0000729,1,0.0782004600866184,0,22,DNA double-strand break processing,BP,
262,GO:0000730,1,0.32289116890521,0,10,DNA recombinase assembly,BP,
264,GO:0000732,1,0.0561734133521967,0,25,strand displacement,BP,
267,GO:0000738,1,0.648141746632869,0,4,DNA catabolic process, exonucleolytic,BP,
271,GO:0000774,1,0.295944229432324,0,11,adenyl-nucleotide exchange factor activity,MF,
275,GO:0000778,1,0.253747441938376,0,12,condensed nuclear chromosome kinetochore,CC,
277,GO:0000780,1,0.102035585229966,0,20,condensed nuclear chromosome, centromeric region,CC,
279,GO:0000782,1,0.314592379241085,0,10,telomere cap complex,CC,
280,GO:0000783,1,0.314592379241085,0,10,nuclear telomere cap complex,CC,
284,GO:0000788,1,0.121247186966188,0,31,nuclear nucleosome,CC,
289,GO:0000794,1,0.000564105809487592,0,65,condensed nuclear chromosome,CC,
290,GO:0000795,1,0.143057611584337,0,17,synaptonemal complex,CC,
291,GO:0000796,1,0.442297753202712,0,7,condensin complex,CC,
295,GO:0000800,1,0.443131260030756,0,7,lateral element,CC,
298,GO:0000805,1,0.445217376011893,0,7,X chromosome,CC,
300,GO:0000808,1,0.350758045569075,0,9,origin recognition complex,CC,
302,GO:0000812,1,0.333563246283012,0,10,Swr1 complex,CC,
305,GO:0000815,1,0.265420455904209,0,12,ESCRT III complex,CC,
314,GO:0000827,1,0.638818999806948,0,4,inositol-1,3,4,5,6-pentakisphosphate kinase activity,MF,
315,GO:0000828,1,0.638818999806948,0,4,inositol hexakisphosphate kinase activity,MF,
316,GO:0000829,1,0.638818999806948,0,4,inositol heptakisphosphate kinase activity,MF,
317,GO:0000832,1,0.638818999806948,0,4,inositol hexakisphosphate 5-kinase activity,MF,
318,GO:0000835,1,0.501982034716143,0,6,ER ubiquitin ligase complex,CC,
319,GO:0000836,1,0.564039030815963,0,5,Hrd1p ubiquitin ligase complex,CC,
321,GO:0000900,1,0.315173232850962,0,10,translation repressor activity, mRNA regulatory element binding,MF,
325,GO:0000912,1,0.497640632277198,0,6,assembly of actomyosin apparatus involved in cytokinesis,BP,
326,GO:0000915,1,0.497640632277198,0,6,actomyosin contractile ring assembly,BP,
329,GO:0000920,1,0.155182342929106,0,17,cell separation after cytokinesis,BP,
332,GO:0000923,1,0.49698202295828,0,6,equatorial microtubule organizing center,CC,
339,GO:0000940,1,0.222036215814226,0,13,condensed chromosome outer kinetochore,CC,
341,GO:0000942,1,0.630658137558118,0,4,condensed nuclear chromosome outer kinetochore,CC,
343,GO:0000957,1,0.558535711987102,0,5,mitochondrial RNA catabolic process,BP,
345,GO:0000959,1,0.00948049610980903,0,41,mitochondrial RNA metabolic process,BP,
346,GO:0000960,1,0.627577993545858,0,4,regulation of mitochondrial RNA catabolic process,BP,
349,GO:0000963,1,0.164366380540916,0,16,mitochondrial RNA processing,BP,
350,GO:0000964,1,0.648176131518899,0,4,mitochondrial RNA 5'-end processing,BP,
351,GO:0000965,1,0.577473984725177,0,5,mitochondrial RNA 3'-end processing,BP,
352,GO:0000966,1,0.109178632055409,0,21,RNA 5'-end processing,BP,
354,GO:0000972,1,0.448717236009752,0,7,transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery,BP,
356,GO:0000974,1,0.23045301742458,0,13,Prp19 complex,CC,
368,GO:0000990,1,0.358854095745361,0,9,transcription factor activity, core RNA polymerase binding,MF,
373,GO:0000995,1,0.627449537468743,0,4,transcription factor activity, core RNA polymerase III binding,MF,
376,GO:0001007,1,0.629575662853931,0,4,transcription factor activity, RNA polymerase III transcription factor binding,MF,
380,GO:0001013,1,0.405471294877927,0,8,RNA polymerase I regulatory region DNA binding,MF,
385,GO:0001030,1,0.562166556458017,0,5,RNA polymerase III type 1 promoter DNA binding,MF,
386,GO:0001031,1,0.562166556458017,0,5,RNA polymerase III type 2 promoter DNA binding,MF,
387,GO:0001032,1,0.633600936637943,0,4,RNA polymerase III type 3 promoter DNA binding,MF,
392,GO:0001054,1,0.330158614124237,0,11,RNA polymerase I activity,MF,
393,GO:0001055,1,0.325827626411535,0,11,RNA polymerase II activity,MF,
394,GO:0001056,1,0.208301191219859,0,15,RNA polymerase III activity,MF,
398,GO:0001075,1,0.508313494102147,0,6,transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly,MF,
402,GO:0001083,1,0.561760236190878,0,5,transcription factor activity, RNA polymerase II basal transcription factor binding,MF,
427,GO:0001135,1,0.442299669634803,0,7,transcription factor activity, RNA polymerase II transcription factor recruiting,MF,
434,GO:0001163,1,0.405471294877927,0,8,RNA polymerase I regulatory region sequence-specific DNA binding,MF,
435,GO:0001164,1,0.405471294877927,0,8,RNA polymerase I CORE element sequence-specific DNA binding,MF,
440,GO:0001188,1,0.405471294877927,0,8,RNA polymerase I transcriptional preinitiation complex assembly,BP,
461,GO:0001405,1,0.574331520838697,0,5,presequence translocase-associated import motor,CC,
470,GO:0001514,1,0.451191063878389,0,7,selenocysteine incorporation,BP,
473,GO:0001517,1,0.558837438319759,0,5,N-acetylglucosamine 6-O-sulfotransferase activity,MF,
489,GO:0001542,1,0.497102457028657,0,6,ovulation from ovarian follicle,BP,
497,GO:0001553,1,0.559271494264795,0,5,luteinization,BP,
498,GO:0001554,1,0.558421378043368,0,5,luteolysis,BP,
504,GO:0001562,1,0.373626498689642,0,9,response to protozoan,BP,
515,GO:0001580,1,0.46774196385671,0,8,detection of chemical stimulus involved in sensory perception of bitter taste,BP,
520,GO:0001608,1,0.56737067553382,0,5,G-protein coupled nucleotide receptor activity,MF,
522,GO:0001614,1,0.506326923190499,0,6,purinergic nucleotide receptor activity,MF,
527,GO:0001637,1,0.499810807020128,0,6,G-protein coupled chemoattractant receptor activity,MF,
533,GO:0001652,1,0.643323091671635,0,4,granular component,CC,
541,GO:0001660,1,0.454787361888236,0,7,fever generation,BP,
549,GO:0001671,1,0.0847352201229212,0,22,ATPase activator activity,MF,
550,GO:0001672,1,0.446437118464691,0,7,regulation of chromatin assembly or disassembly,BP,
558,GO:0001682,1,0.296034369980892,0,12,tRNA 5'-leader removal,BP,
559,GO:0001696,1,0.516490212567004,0,6,gastric acid secretion,BP,
575,GO:0001727,1,0.561163150116239,0,5,lipid kinase activity,MF,
577,GO:0001730,1,0.639518229482916,0,4,2'-5'-oligoadenylate synthetase activity,MF,
578,GO:0001731,1,0.403790320948408,0,8,formation of translation preinitiation complex,BP,
584,GO:0001739,1,0.503251346396853,0,6,sex chromatin,CC,
597,GO:0001765,1,0.366431098839803,0,9,membrane raft assembly,BP,
602,GO:0001771,1,0.505551693803825,0,6,immunological synapse formation,BP,
617,GO:0001787,1,0.593610672991019,0,5,natural killer cell proliferation,BP,
636,GO:0001826,1,0.55843553858696,0,5,inner cell mass cell differentiation,BP,
641,GO:0001832,1,0.199505590549098,0,14,blastocyst growth,BP,
642,GO:0001833,1,0.315240231313182,0,10,inner cell mass cell proliferation,BP,
651,GO:0001842,1,0.576622323545719,0,5,neural fold formation,BP,
654,GO:0001845,1,0.32871301661541,0,10,phagolysosome assembly,BP,
655,GO:0001846,1,0.462294708128089,0,7,opsonin binding,MF,
656,GO:0001848,1,0.411436853994321,0,8,complement binding,MF,
662,GO:0001866,1,0.666985187571568,0,4,NK T cell proliferation,BP,
666,GO:0001871,1,0.497652224340917,0,6,pattern binding,MF,
675,GO:0001886,1,0.454141592136469,0,7,endothelial cell morphogenesis,BP,
676,GO:0001887,1,0.628238459140219,0,4,selenium compound metabolic process,BP,
691,GO:0001912,1,0.156555892824719,0,17,positive regulation of leukocyte mediated cytotoxicity,BP,
695,GO:0001916,1,0.425494252526195,0,8,positive regulation of T cell mediated cytotoxicity,BP,
705,GO:0001931,1,0.397698918339086,0,8,uropod,CC,
713,GO:0001939,1,0.500253570856883,0,6,female pronucleus,CC,
714,GO:0001940,1,0.562097053967211,0,5,male pronucleus,CC,
725,GO:0001955,1,0.577887649244493,0,5,blood vessel maturation,BP,
726,GO:0001956,1,0.356163187302135,0,9,positive regulation of neurotransmitter secretion,BP,
735,GO:0001967,1,0.453667547394526,0,7,suckling behavior,BP,
740,GO:0001972,1,0.406674275306249,0,8,retinoic acid binding,MF,
743,GO:0001975,1,0.261626144302616,0,12,response to amphetamine,BP,
744,GO:0001976,1,0.64713250176561,0,4,neurological system process involved in regulation of systemic arterial blood pressure,BP,
752,GO:0001993,1,0.633933668630124,0,4,regulation of systemic arterial blood pressure by norepinephrine-epinephrine,BP,
768,GO:0002024,1,0.562282891350106,0,5,diet induced thermogenesis,BP,
777,GO:0002036,1,0.629225326821773,0,4,regulation of L-glutamate import across plasma membrane,BP,
793,GO:0002063,1,0.138328004683235,0,17,chondrocyte development,BP,
798,GO:0002068,1,0.127184039395258,0,18,glandular epithelial cell development,BP,
799,GO:0002069,1,0.512129861824308,0,6,columnar/cuboidal epithelial cell maturation,BP,
800,GO:0002070,1,0.287963940218997,0,11,epithelial cell maturation,BP,
802,GO:0002072,1,0.496982022965512,0,6,optic cup morphogenesis involved in camera-type eye development,BP,
821,GO:0002097,1,0.162990637663694,0,16,tRNA wobble base modification,BP,
822,GO:0002098,1,0.256074783897651,0,12,tRNA wobble uridine modification,BP,
835,GO:0002138,1,0.578190096922489,0,5,retinoic acid biosynthetic process,BP,
838,GO:0002143,1,0.636088111202964,0,4,tRNA wobble position uridine thiolation,BP,
840,GO:0002151,1,0.499512727300349,0,6,G-quadruplex RNA binding,MF,
842,GO:0002154,1,0.559438404438551,0,5,thyroid hormone mediated signaling pathway,BP,
845,GO:0002159,1,0.627449537468743,0,4,desmosome assembly,BP,
849,GO:0002175,1,0.627449537468743,0,4,protein localization to paranode region of axon,BP,
854,GO:0002182,1,0.279962772270869,0,11,cytoplasmic translational elongation,BP,
855,GO:0002183,1,0.136023596185333,0,18,cytoplasmic translational initiation,BP,
859,GO:0002190,1,0.5891090237817,0,5,cap-independent translational initiation,BP,
865,GO:0002199,1,0.44951166157162,0,7,zona pellucida receptor complex,CC,
876,GO:0002227,1,0.508840909791532,0,10,innate immune response in mucosa,BP,
886,GO:0002251,1,0.285209489852128,0,15,organ or tissue specific immune response,BP,
902,GO:0002281,1,0.558806270175716,0,5,macrophage activation involved in immune response,BP,
925,GO:0002320,1,0.228579329298864,0,13,lymphoid progenitor cell differentiation,BP,
931,GO:0002328,1,0.36214994500367,0,9,pro-B cell differentiation,BP,
940,GO:0002349,1,0.583026854743708,0,5,histamine production involved in inflammatory response,BP,
962,GO:0002385,1,0.320485380031491,0,14,mucosal immune response,BP,
985,GO:0002441,1,0.583026854743708,0,5,histamine secretion involved in inflammatory response,BP,
1000,GO:0002468,1,0.63925485524164,0,4,dendritic cell antigen processing and presentation,BP,
1038,GO:0002548,1,0.131788590436677,0,19,monocyte chemotaxis,BP,
1040,GO:0002553,1,0.583026854743708,0,5,histamine secretion by mast cell,BP,
1046,GO:0002568,1,0.558421378043368,0,5,somatic diversification of T cell receptor genes,BP,
1052,GO:0002579,1,0.661936487965827,0,4,positive regulation of antigen processing and presentation,BP,
1064,GO:0002604,1,0.63925485524164,0,4,regulation of dendritic cell antigen processing and presentation,BP,
1073,GO:0002638,1,0.559427250661622,0,5,negative regulation of immunoglobulin production,BP,
1093,GO:0002681,1,0.558421378043368,0,5,somatic recombination of T cell receptor gene segments,BP,
1125,GO:0002713,1,0.629201010495945,0,4,negative regulation of B cell mediated immunity,BP,
1129,GO:0002717,1,0.334345389260551,0,10,positive regulation of natural killer cell mediated immunity,BP,
1149,GO:0002756,1,0.0480104456468132,0,27,MyD88-independent toll-like receptor signaling pathway,BP,
1152,GO:0002759,1,0.642848483122668,0,4,regulation of antimicrobial humoral response,BP,
1181,GO:0002827,1,0.465249345389049,0,7,positive regulation of T-helper 1 type immune response,BP,
1221,GO:0002890,1,0.629201010495945,0,4,negative regulation of immunoglobulin mediated immune response,BP,
1242,GO:0002934,1,0.35105055942564,0,9,desmosome organization,BP,
1244,GO:0002943,1,0.635435125595602,0,4,tRNA dihydrouridine synthesis,BP,
1272,GO:0003062,1,0.634643714057686,0,4,regulation of heart rate by chemical signal,BP,
1283,GO:0003084,1,0.524755600264354,0,6,positive regulation of systemic arterial blood pressure,BP,
1288,GO:0003096,1,0.561517197832693,0,5,renal sodium ion transport,BP,
1289,GO:0003097,1,0.631782078781483,0,4,renal water transport,BP,
1291,GO:0003100,1,0.631512905681299,0,4,regulation of systemic arterial blood pressure by endothelin,BP,
1296,GO:0003128,1,0.570209769902997,0,5,heart field specification,BP,
1302,GO:0003139,1,0.636910705689301,0,4,secondary heart field specification,BP,
1303,GO:0003140,1,0.635973824416288,0,4,determination of left/right asymmetry in lateral mesoderm,BP,
1305,GO:0003148,1,0.157911826747413,0,16,outflow tract septum morphogenesis,BP,
1312,GO:0003159,1,0.257513343729531,0,12,morphogenesis of an endothelium,BP,
1314,GO:0003161,1,0.351010903567141,0,9,cardiac conduction system development,BP,
1326,GO:0003176,1,0.639045331179288,0,4,aortic valve development,BP,
1327,GO:0003177,1,0.500114116247584,0,6,pulmonary valve development,BP,
1329,GO:0003180,1,0.639045331179288,0,4,aortic valve morphogenesis,BP,
1332,GO:0003184,1,0.500114116247584,0,6,pulmonary valve morphogenesis,BP,
1339,GO:0003197,1,0.061797916063575,0,24,endocardial cushion development,BP,
1340,GO:0003198,1,0.279808919442182,0,11,epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
1342,GO:0003203,1,0.123659497970415,0,18,endocardial cushion morphogenesis,BP,
1345,GO:0003207,1,0.632577360435138,0,4,cardiac chamber formation,BP,
1348,GO:0003211,1,0.632577360435138,0,4,cardiac ventricle formation,BP,
1350,GO:0003214,1,0.49811853980045,0,6,cardiac left ventricle morphogenesis,BP,
1355,GO:0003222,1,0.277716031158247,0,11,ventricular trabecula myocardium morphogenesis,BP,
1369,GO:0003253,1,0.632104435512116,0,4,cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
1373,GO:0003263,1,0.588877946296053,0,5,cardioblast proliferation,BP,
1374,GO:0003264,1,0.524090050019043,0,6,regulation of cardioblast proliferation,BP,
1375,GO:0003266,1,0.588874027464477,0,5,regulation of secondary heart field cardioblast proliferation,BP,
1377,GO:0003272,1,0.197197769605237,0,14,endocardial cushion formation,BP,
1378,GO:0003273,1,0.628780420493722,0,4,cell migration involved in endocardial cushion formation,BP,
1385,GO:0003284,1,0.627449537468743,0,4,septum primum development,BP,
1396,GO:0003309,1,0.1606121585135,0,16,type B pancreatic cell differentiation,BP,
1399,GO:0003323,1,0.180486275875217,0,15,type B pancreatic cell development,BP,
1401,GO:0003334,1,0.283720238743862,0,11,keratinocyte development,BP,
1404,GO:0003337,1,0.465400640718081,0,7,mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
1406,GO:0003339,1,0.583905232282768,0,5,regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
1411,GO:0003344,1,0.496982022965512,0,6,pericardium morphogenesis,BP,
1413,GO:0003348,1,0.627740391020842,0,4,cardiac endothelial cell differentiation,BP,
1415,GO:0003351,1,0.391427407562578,0,9,epithelial cilium movement,BP,
1425,GO:0003376,1,0.353034529461424,0,9,sphingosine-1-phosphate signaling pathway,BP,
1436,GO:0003413,1,0.443462311828109,0,7,chondrocyte differentiation involved in endochondral bone morphogenesis,BP,
1437,GO:0003415,1,0.627449537468743,0,4,chondrocyte hypertrophy,BP,
1440,GO:0003418,1,0.628276836987866,0,4,growth plate cartilage chondrocyte differentiation,BP,
1444,GO:0003431,1,0.628276836987866,0,4,growth plate cartilage chondrocyte development,BP,
1445,GO:0003433,1,0.559891434316977,0,5,chondrocyte development involved in endochondral bone morphogenesis,BP,
1447,GO:0003676,1,0,200,3246,nucleic acid binding,MF,ERCC1;MEF2D;ZMYND8;H1F0;EGR1;NR1D1;SLC16A3;PDCD4;XPC;HMGA2;ZKSCAN1;ELK3;MTA1;EGFR;NFATC4;BAHCC1;ETV5;DDB2;GTPBP1;TCFL5;ETV4;TRNP1;ZFP36L1;ZC3H6;SMARCA1;FOXQ1;NYNRIN;MXD4;POU2F2;ENDOG;FOS;SMAD3;STAT6;ERCC6;LRP1;EPAS1;RPUSD3;S100A4;PRDX5;SALL2;ZXDC;ADARB1;GRB7;HDAC5;PHC2;ASH2L;MAPKBP1;HLTF;MXI1;RAG1;H2AFJ;KLF7;NAT14;CIRBP;HMG20B;ZNF385A;TSHZ1;PCBP4;TCF25;TWF2;CSNK1E;R3HDM4;SOX13;PCSK9;RAD23A;XPOT;MRPS6;EHD4;GLI4;ZSCAN18;MYEF2;SMARCD2;KHNYN;GTF2IRD1;HES2;ZNF598;LTA4H;MNT;CEBPB;ZNF217;ZNF862;SYNJ2;LACTB2;RFX2;SCYL1;UNK;SNTB2;DEAF1;ZSCAN30;MDH2;MPG;PEG3;TNS1;ABTB1;POLL;POLM;ANKZF1;PHF21A;MIF4GD;KHDRBS3;PTPN1;MBD3;TRAP1;MLXIPL;KDM6B;ZNF516;TDRKH;TFDP2;FAM50A;CYFIP2;FSCN1;PBX2;NELFCD;RBL2;DTD1;ZNF395;HIST3H2BB;ZNF524;SOX12;TOP3B;CARF;AHNAK2;IER2;NTPCR;RPL39L;LEMD2;ZHX3;DNM1;MRPS26;EHD3;CHD2;ZFPM1;PPARA;SOX7;SIX5;ZNF414;MEX3A;SSBP4;ZNF444;C11ORF68;EEF2K;CERS4;FLYWCH1;ARID5B;HOXC5;BHLHE40;NEIL1;TSPYL2;ZMYM3;APOBEC3C;SATB1;ZDHHC1;H1FX;ZNF606;APOBEC3F;DDX50;ARHGEF1;PAN2;CAMTA2;RERE;RNASET2;REV1;CAPRIN2;ZBTB10;HES7;DNMT3A;NSUN7;HES6;NDUFV3;DNASE1L1;PROX1;IARS2;BACH1;E2F5;ZBTB22;TEP1;ZNF704;GTF2IRD2;ZNF837;RNASE7;MAFF;NR2F6;CBX6;SIRT3;TERC;ZNF513;MLF2;CDK11B;TST;TNRC18;TCEA2;ZBTB47;PLAG1;CLK3;DHX32;KDM3A;TBL3;DEDD2;SRSF5;AARS
1453,GO:0003688,1,0.196529326951121,0,14,DNA replication origin binding,MF,
1454,GO:0003689,1,0.405769183125271,0,8,DNA clamp loader activity,MF,
1456,GO:0003691,1,0.355786729835575,0,9,double-stranded telomeric DNA binding,MF,
1457,GO:0003696,1,0.629752423411923,0,4,satellite DNA binding,MF,
1462,GO:0003708,1,0.627449537468743,0,4,retinoic acid receptor activity,MF,
1470,GO:0003725,1,0.00068989175098434,0,63,double-stranded RNA binding,MF,
1476,GO:0003743,1,0.00468990093678397,0,49,translation initiation factor activity,MF,
1478,GO:0003747,1,0.502599015513903,0,6,translation release factor activity,MF,
1502,GO:0003847,1,0.663722864969205,0,4,1-alkyl-2-acetylglycerophosphocholine esterase activity,MF,
1530,GO:0003909,1,0.445493972394322,0,7,DNA ligase activity,MF,
1531,GO:0003910,1,0.499591153226696,0,6,DNA ligase (ATP) activity,MF,
1539,GO:0003923,1,0.563339160646453,0,5,GPI-anchor transamidase activity,MF,
1552,GO:0003950,1,0.139919358172766,0,17,NAD+ ADP-ribosyltransferase activity,MF,
1579,GO:0003988,1,0.509016342014873,0,6,acetyl-CoA C-acyltransferase activity,MF,
1599,GO:0004017,1,0.559420234659479,0,5,adenylate kinase activity,MF,
1606,GO:0004028,1,0.443316580841965,0,7,3-chloroallyl aldehyde dehydrogenase activity,MF,
1608,GO:0004030,1,0.558680607990694,0,5,aldehyde dehydrogenase [NAD(P)+] activity,MF,
1617,GO:0004045,1,0.684782475387799,0,4,aminoacyl-tRNA hydrolase activity,MF,
1627,GO:0004062,1,0.661597476736848,0,4,aryl sulfotransferase activity,MF,
1629,GO:0004065,1,0.395330131962584,0,8,arylsulfatase activity,MF,
1646,GO:0004089,1,0.563258580834505,0,5,carbonate dehydratase activity,MF,
1647,GO:0004090,1,0.696600337300728,0,4,carbonyl reductase (NADPH) activity,MF,
1658,GO:0004112,1,0.225438471803409,0,13,cyclic-nucleotide phosphodiesterase activity,MF,
1660,GO:0004114,1,0.253326472068919,0,12,3',5'-cyclic-nucleotide phosphodiesterase activity,MF,
1661,GO:0004115,1,0.442297753196275,0,7,3',5'-cyclic-AMP phosphodiesterase activity,MF,
1668,GO:0004128,1,0.454787608846604,0,7,cytochrome-b5 reductase activity, acting on NAD(P)H,MF,
1669,GO:0004129,1,0.241748364368132,0,18,cytochrome-c oxidase activity,MF,
1695,GO:0004169,1,0.612031352778966,0,5,dolichyl-phosphate-mannose-protein mannosyltransferase activity,MF,
1702,GO:0004181,1,0.3547761401401,0,9,metallocarboxypeptidase activity,MF,
1703,GO:0004185,1,0.399015096374099,0,8,serine-type carboxypeptidase activity,MF,
1709,GO:0004298,1,0.201666904553088,0,18,threonine-type endopeptidase activity,MF,
1710,GO:0004300,1,0.415953762009747,0,8,enoyl-CoA hydratase activity,MF,
1718,GO:0004309,1,0.628053572213517,0,4,exopolyphosphatase activity,MF,
1721,GO:0004312,1,0.365946689394482,0,9,fatty acid synthase activity,MF,
1763,GO:0004366,1,0.558427351970019,0,5,glycerol-3-phosphate O-acyltransferase activity,MF,
1784,GO:0004402,1,0.00298133233942988,0,51,histone acetyltransferase activity,MF,
1816,GO:0004466,1,0.643143631661684,0,4,long-chain-acyl-CoA dehydrogenase activity,MF,
1818,GO:0004468,1,0.627449537468743,0,4,lysine N-acetyltransferase activity, acting on acetyl phosphate as donor,MF,
1819,GO:0004470,1,0.640817197180126,0,4,malic enzyme activity,MF,
1824,GO:0004477,1,0.628473135831577,0,4,methenyltetrahydrofolate cyclohydrolase activity,MF,
1833,GO:0004488,1,0.628473135831577,0,4,methylenetetrahydrofolate dehydrogenase (NADP+) activity,MF,
1860,GO:0004523,1,0.527221829193482,0,6,RNA-DNA hybrid ribonuclease activity,MF,
1861,GO:0004525,1,0.631858706141197,0,4,ribonuclease III activity,MF,
1862,GO:0004526,1,0.329608747291757,0,11,ribonuclease P activity,MF,
1864,GO:0004528,1,0.637877434724017,0,4,phosphodiesterase I activity,MF,
1865,GO:0004529,1,0.133406611760752,0,18,exodeoxyribonuclease activity,MF,
1873,GO:0004549,1,0.185836687089005,0,16,tRNA-specific ribonuclease activity,MF,
1875,GO:0004551,1,0.282344461875519,0,12,nucleotide diphosphatase activity,MF,
1893,GO:0004576,1,0.347604352006453,0,10,oligosaccharyl transferase activity,MF,
1896,GO:0004579,1,0.381441380750359,0,9,dolichyl-diphosphooligosaccharide-protein glycotransferase activity,MF,
1899,GO:0004583,1,0.632255182179315,0,4,dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity,MF,
1908,GO:0004596,1,0.333858207913937,0,10,peptide alpha-N-acetyltransferase activity,MF,
1928,GO:0004622,1,0.158146137892849,0,16,lysophospholipase activity,MF,
1948,GO:0004652,1,0.393977045712881,0,8,polynucleotide adenylyltransferase activity,MF,
1949,GO:0004653,1,0.246899125258341,0,12,polypeptide N-acetylgalactosaminyltransferase activity,MF,
1969,GO:0004679,1,0.445907503909391,0,7,AMP-activated protein kinase activity,MF,
1973,GO:0004689,1,0.566707421990021,0,5,phosphorylase kinase activity,MF,
1978,GO:0004694,1,0.62745371281127,0,4,eukaryotic translation initiation factor 2alpha kinase activity,MF,
2002,GO:0004726,1,0.402467553450652,0,8,non-membrane spanning protein tyrosine phosphatase activity,MF,
2011,GO:0004738,1,0.565183911828934,0,5,pyruvate dehydrogenase activity,MF,
2017,GO:0004745,1,0.461989769808316,0,7,retinol dehydrogenase activity,MF,
2020,GO:0004749,1,0.631655770447302,0,4,ribose phosphate diphosphokinase activity,MF,
2028,GO:0004767,1,0.567505270739686,0,5,sphingomyelin phosphodiesterase activity,MF,
2073,GO:0004826,1,0.564759007587897,0,5,phenylalanine-tRNA ligase activity,MF,
2082,GO:0004839,1,0.558557859104734,0,5,ubiquitin activating enzyme activity,MF,
2085,GO:0004844,1,0.582169710813063,0,5,uracil DNA N-glycosylase activity,MF,
2094,GO:0004859,1,0.443042683395263,0,8,phospholipase inhibitor activity,MF,
2097,GO:0004862,1,0.453692849606489,0,7,cAMP-dependent protein kinase inhibitor activity,MF,
2118,GO:0004908,1,0.568730894103949,0,5,interleukin-1 receptor activity,MF,
2138,GO:0004950,1,0.499810807020128,0,6,chemokine receptor activity,MF,
2188,GO:0005047,1,0.564910816180469,0,5,signal recognition particle binding,MF,
2190,GO:0005049,1,0.396000380181011,0,8,nuclear export signal receptor activity,MF,
2198,GO:0005078,1,0.442297753196275,0,7,MAP-kinase scaffold activity,MF,
2202,GO:0005087,1,0.660233122231826,0,4,Ran guanyl-nucleotide exchange factor activity,MF,
2212,GO:0005104,1,0.312510991977483,0,10,fibroblast growth factor receptor binding,MF,
2215,GO:0005112,1,0.176833301758514,0,15,Notch binding,MF,
2220,GO:0005123,1,0.20091655534997,0,14,death receptor binding,MF,
2227,GO:0005131,1,0.628248754871556,0,4,growth hormone receptor binding,MF,
2233,GO:0005138,1,0.578236922030473,0,5,interleukin-6 receptor binding,MF,
2277,GO:0005227,1,0.227405064696058,0,13,calcium activated cation channel activity,MF,
2287,GO:0005246,1,0.136076735259799,0,18,calcium channel regulator activity,MF,
2288,GO:0005247,1,0.453598022723085,0,7,voltage-gated chloride channel activity,MF,
2312,GO:0005313,1,0.496982601037291,0,6,L-glutamate transmembrane transporter activity,MF,
2325,GO:0005338,1,0.290872454962941,0,11,nucleotide-sugar transmembrane transporter activity,MF,
2329,GO:0005345,1,0.576589946185076,0,5,purine nucleobase transmembrane transporter activity,MF,
2330,GO:0005346,1,0.287881857192163,0,11,purine ribonucleotide transmembrane transporter activity,MF,
2331,GO:0005347,1,0.406341228453062,0,8,ATP transmembrane transporter activity,MF,
2340,GO:0005372,1,0.640261483934734,0,4,water transmembrane transporter activity,MF,
2343,GO:0005384,1,0.627449537468743,0,4,manganese ion transmembrane transporter activity,MF,
2345,GO:0005388,1,0.393626380044218,0,8,calcium-transporting ATPase activity,MF,
2346,GO:0005391,1,0.563881897605147,0,5,sodium:potassium-exchanging ATPase activity,MF,
2371,GO:0005501,1,0.285768202176116,0,12,retinoid binding,MF,
2378,GO:0005513,1,0.409158758451417,0,8,detection of calcium ion,BP,
2396,GO:0005542,1,0.540000034521765,0,6,folic acid binding,MF,
2409,GO:0005583,1,0.393626380044218,0,8,fibrillar collagen trimer,CC,
2411,GO:0005587,1,0.558421378043368,0,5,collagen type IV trimer,CC,
2417,GO:0005593,1,0.627548889713494,0,4,FACIT collagen trimer,CC,
2440,GO:0005642,1,0.56896707488669,0,5,annulate lamellae,CC,
2443,GO:0005654,1,7.45021171664406e-11,231,3049,nucleoplasm,CC,TNIP1;DUSP6;NT5E;ERCC1;DUSP5;MEF2D;H1F0;CITED4;EGR1;NR1D1;EPN3;CTNNBIP1;XPC;TSPAN1;PITPNC1;HMGA2;OBSCN;ELK3;ITPR3;PKN1;MTA1;ACOT7;RPS6KA2;WWTR1;NOS1;HADH;NFATC4;TRIM65;BAHCC1;ETV5;APPL2;DDB2;TBC1D14;ETV4;ARAP1;SMARCA1;RNF44;CPT2;VWA5A;POU2F2;SMURF2;KLC2;FOS;SMAD3;STAT6;ERCC6;EPAS1;PPP2R3B;SALL2;RNF187;ADARB1;AKT1;HDAC5;STK39;SCMH1;PHC2;NFKBIZ;ASH2L;ATG16L2;BRSK1;PTHLH;POLD4;PRKACB;HLTF;RAG1;PHF7;TOMM34;CIRBP;HMG20B;TENM2;ZNF385A;NSMCE4A;CCND1;LHPP;PTK6;CSNK1E;SOX13;DUSP7;MPLKIP;MAPKAPK3;RAD23A;XPOT;AIP;SH3D19;CCDC113;CDC25B;SH3GLB2;ARHGAP27;SMARCD2;DGKQ;BNIP3;NOL4L;GTF2IRD1;CRTC1;APRT;CTBP1;LTA4H;MNT;PTPDC1;ZMIZ2;CEBPB;ZNF217;GPC1;MKNK2;MPG;NSMF;RNH1;POLL;POLM;PHF21A;KHDRBS3;B4GALT2;MBD3;VHL;TRAP1;PFKFB2;MLXIPL;KDM6B;PRKACA;CENPH;RABGGTA;WDR18;CAPG;ALAS1;CNDP2;TFDP2;MZT2A;STK17A;RILPL1;FAM50A;IRF2BP2;BNIP3L;NELFCD;CYGB;PRKCD;RBL2;STUB1;SBF1;OLFM2;HIST3H2BB;CCDC92;RPS6KA5;DUSP4;KLHDC2;SOX12;ACADS;PPP1R13L;CARF;IER2;MZT2B;FCHO1;LIMK1;LTB4R2;RPS6KA6;TMEM92;ZHX3;DNM1;RGS14;MRPS26;SYMPK;MAPK12;HDAC7;CHD2;CBX7;CHEK2;ZFPM1;PPARA;JADE2;CDC34;SOX7;MIF;SMOX;KDM4B;SPPL2B;HSD11B1L;UPP1;FLYWCH1;ARID5B;HOXC5;BHLHE40;NEIL1;TSPYL2;ZMYM3;SATB1;PLCB3;MAPK3;RERE;INO80C;PDXK;TRIM45;DCAF10;PPP3CB;USP21;PFKFB3;REV1;ZBTB10;WDTC1;DNMT3A;MAP2K3;NDUFV3;LRCH4;LMNA;KCTD13;SIRT2;FAM129B;UVSSA;TRIP10;E2F5;GTF2IRD2;NGFR;TOLLIP;BCORL1;DUSP23;GCH1;MAFF;NR2F6;CBX6;EZH1;TERC;WIPI2;CELSR1;TNRC18;TCEA2;PLAG1;CLK3;IRF2BPL;KDM3A;PM20D2;TBL3;SRSF5;SLC26A11
2444,GO:0005655,1,0.467299063728069,0,8,nucleolar ribonuclease P complex,CC,
2447,GO:0005658,1,0.504450399964083,0,6,alpha DNA polymerase:primase complex,CC,
2448,GO:0005662,1,0.206418044275784,0,14,DNA replication factor A complex,CC,
2449,GO:0005663,1,0.521051815211649,0,6,DNA replication factor C complex,CC,
2450,GO:0005664,1,0.350758045569075,0,9,nuclear origin of replication recognition complex,CC,
2451,GO:0005665,1,0.17436889435586,0,17,DNA-directed RNA polymerase II, core complex,CC,
2452,GO:0005666,1,0.168929701184284,0,17,DNA-directed RNA polymerase III complex,CC,
2456,GO:0005671,1,0.206374011555636,0,14,Ada2/Gcn5/Ada3 transcription activator complex,CC,
2457,GO:0005672,1,0.657347353239298,0,4,transcription factor TFIIA complex,CC,
2460,GO:0005675,1,0.236221664782214,0,13,holo TFIIH complex,CC,
2465,GO:0005683,1,0.53013212005453,0,7,U7 snRNP,CC,
2466,GO:0005684,1,0.00196678071813456,0,58,U2-type spliceosomal complex,CC,
2467,GO:0005685,1,0.12690659448392,0,20,U1 snRNP,CC,
2468,GO:0005686,1,0.131596027774474,0,20,U2 snRNP,CC,
2469,GO:0005687,1,0.340274710374875,0,11,U4 snRNP,CC,
2470,GO:0005688,1,0.479681416486844,0,8,U6 snRNP,CC,
2471,GO:0005689,1,0.0757152231655077,0,26,U12-type spliceosomal complex,CC,
2481,GO:0005721,1,0.12605925361384,0,18,pericentric heterochromatin,CC,
2483,GO:0005726,1,0.627449537468743,0,4,perichromatin fibrils,CC,
2487,GO:0005736,1,0.293819231047774,0,12,DNA-directed RNA polymerase I complex,CC,
2492,GO:0005742,1,0.453144846614715,0,8,mitochondrial outer membrane translocase complex,CC,
2500,GO:0005751,1,0.458678771117175,0,10,mitochondrial respiratory chain complex IV,CC,
2507,GO:0005762,1,0.00861966259679623,0,51,mitochondrial large ribosomal subunit,CC,
2527,GO:0005785,1,0.470800465301645,0,7,signal recognition particle receptor complex,CC,
2528,GO:0005786,1,0.534756809259188,0,6,signal recognition particle, endoplasmic reticulum targeting,CC,
2529,GO:0005787,1,0.606981116927532,0,5,signal peptidase complex,CC,
2538,GO:0005797,1,0.46464009746329,0,7,Golgi medial cisterna,CC,
2546,GO:0005816,1,0.442297753196275,0,7,spindle pole body,CC,
2547,GO:0005818,1,0.394116169879923,0,8,aster,CC,
2549,GO:0005826,1,0.560186470683775,0,5,actomyosin contractile ring,CC,
2550,GO:0005827,1,0.560499000603997,0,5,polar microtubule,CC,
2551,GO:0005828,1,0.442487559126309,0,7,kinetochore microtubule,CC,
2556,GO:0005838,1,0.105153938527035,0,21,proteasome regulatory particle,CC,
2557,GO:0005839,1,0.159614066955634,0,20,proteasome core complex,CC,
2560,GO:0005845,1,0.298501174342413,0,11,mRNA cap binding complex,CC,
2562,GO:0005847,1,0.159510859850866,0,16,mRNA cleavage and polyadenylation specificity factor complex,CC,
2563,GO:0005849,1,0.127195513368219,0,18,mRNA cleavage factor complex,CC,
2564,GO:0005850,1,0.627487422527174,0,4,eukaryotic translation initiation factor 2 complex,CC,
2565,GO:0005851,1,0.511767665999114,0,6,eukaryotic translation initiation factor 2B complex,CC,
2566,GO:0005852,1,0.163176435090743,0,17,eukaryotic translation initiation factor 3 complex,CC,
2583,GO:0005879,1,0.567795049037118,0,5,axonemal microtubule,CC,
2589,GO:0005885,1,0.351267902510183,0,10,Arp2/3 protein complex,CC,
2593,GO:0005890,1,0.63358451893783,0,4,sodium:potassium-exchanging ATPase complex,CC,
2595,GO:0005892,1,0.559665210871402,0,5,acetylcholine-gated channel complex,CC,
2608,GO:0005915,1,0.442297753196275,0,7,zonula adherens,CC,
2609,GO:0005916,1,0.442297753196275,0,7,fascia adherens,CC,
2623,GO:0005947,1,0.573402964880191,0,5,mitochondrial alpha-ketoglutarate dehydrogenase complex,CC,
2631,GO:0005964,1,0.566707421990021,0,5,phosphorylase kinase complex,CC,
2643,GO:0005981,1,0.636084259047913,0,4,regulation of glycogen catabolic process,BP,
2650,GO:0005997,1,0.666656331267412,0,4,xylulose metabolic process,BP,
2654,GO:0006001,1,0.62896456409707,0,4,fructose catabolic process,BP,
2660,GO:0006011,1,0.507507785231157,0,6,UDP-glucose metabolic process,BP,
2676,GO:0006041,1,0.632486251027379,0,4,glucosamine metabolic process,BP,
2678,GO:0006044,1,0.224568934179595,0,13,N-acetylglucosamine metabolic process,BP,
2681,GO:0006047,1,0.226003185948945,0,13,UDP-N-acetylglucosamine metabolic process,BP,
2682,GO:0006048,1,0.359112939437633,0,9,UDP-N-acetylglucosamine biosynthetic process,BP,
2686,GO:0006054,1,0.324286146031956,0,10,N-acetylneuraminate metabolic process,BP,
2698,GO:0006067,1,0.289384104246425,0,11,ethanol metabolic process,BP,
2699,GO:0006068,1,0.460375833730857,0,7,ethanol catabolic process,BP,
2700,GO:0006069,1,0.498212395526869,0,6,ethanol oxidation,BP,
2702,GO:0006072,1,0.442302485669809,0,7,glycerol-3-phosphate metabolic process,BP,
2721,GO:0006104,1,0.509881811430508,0,6,succinyl-CoA metabolic process,BP,
2738,GO:0006123,1,0.328982388734413,0,14,mitochondrial electron transport, cytochrome c to oxygen,BP,
2760,GO:0006177,1,0.574101373521677,0,5,GMP biosynthetic process,BP,
2766,GO:0006188,1,0.322797657352512,0,10,IMP biosynthetic process,BP,
2767,GO:0006189,1,0.504766153783877,0,6,'de novo' IMP biosynthetic process,BP,
2774,GO:0006207,1,0.498171022347821,0,6,'de novo' pyrimidine nucleobase biosynthetic process,BP,
2791,GO:0006235,1,0.662261753373343,0,4,dTTP biosynthetic process,BP,
2805,GO:0006268,1,0.444289574547122,0,7,DNA unwinding involved in DNA replication,BP,
2808,GO:0006271,1,0.108340739602147,0,20,DNA strand elongation involved in DNA replication,BP,
2810,GO:0006273,1,0.28885633758417,0,11,lagging strand elongation,BP,
2846,GO:0006335,1,0.0955658322900545,0,32,DNA replication-dependent nucleosome assembly,BP,
2852,GO:0006344,1,0.627471281703224,0,4,maintenance of chromatin silencing,BP,
2867,GO:0006363,1,0.0398669615632155,0,30,termination of RNA polymerase I transcription,BP,
2873,GO:0006370,1,0.0324789865028432,0,32,7-methylguanosine mRNA capping,BP,
2876,GO:0006379,1,0.051720413511274,0,27,mRNA cleavage,BP,
2879,GO:0006384,1,0.460236074395795,0,7,transcription initiation from RNA polymerase III promoter,BP,
2882,GO:0006390,1,0.232026938699766,0,13,mitochondrial transcription,BP,
2885,GO:0006396,1,0,26,876,RNA processing,BP,EGFR;ZFP36L1;MAP2K2;MAP2K1;SMAD3;RPUSD3;ADARB1;MAPKBP1;CSNK1E;RRNAD1;TGFB1;KHDRBS3;PRKACA;WDR18;AHNAK2;SYMPK;TRPT1;PAN2;TEP1;CDK11B;CLK3;DHX32;TBL3;DEDD2;SRSF5;AARS
2887,GO:0006398,1,0.563394687405188,0,5,mRNA 3'-end processing by stem-loop binding and cleavage,BP,
2918,GO:0006432,1,0.564759007587897,0,5,phenylalanyl-tRNA aminoacylation,BP,
2927,GO:0006448,1,0.14432909558409,0,17,regulation of translational elongation,BP,
2928,GO:0006449,1,0.451315867773059,0,7,regulation of translational termination,BP,
2930,GO:0006451,1,0.451191063878389,0,7,translational readthrough,BP,
2942,GO:0006474,1,0.209395557732273,0,14,N-terminal protein amino acid acetylation,BP,
2945,GO:0006477,1,0.561930482303805,0,5,protein sulfation,BP,
2959,GO:0006498,1,0.559440789678559,0,5,N-terminal protein lipidation,BP,
2960,GO:0006499,1,0.627474669708726,0,4,N-terminal protein myristoylation,BP,
2975,GO:0006521,1,0.00582686912264216,0,51,regulation of cellular amino acid metabolic process,BP,
2989,GO:0006537,1,0.627469879270232,0,4,glutamate biosynthetic process,BP,
2995,GO:0006544,1,0.404409573794115,0,8,glycine metabolic process,BP,
2998,GO:0006547,1,0.627784914348046,0,4,histidine metabolic process,BP,
3000,GO:0006549,1,0.564874590639299,0,5,isoleucine metabolic process,BP,
3009,GO:0006558,1,0.673709723299949,0,4,L-phenylalanine metabolic process,BP,
3010,GO:0006559,1,0.673709723299949,0,4,L-phenylalanine catabolic process,BP,
3019,GO:0006568,1,0.574146033292074,0,5,tryptophan metabolic process,BP,
3021,GO:0006570,1,0.654546301430006,0,4,tyrosine metabolic process,BP,
3023,GO:0006573,1,0.35729519253903,0,9,valine metabolic process,BP,
3024,GO:0006574,1,0.633764707676704,0,4,valine catabolic process,BP,
3033,GO:0006586,1,0.574146033292074,0,5,indolalkylamine metabolic process,BP,
3035,GO:0006590,1,0.351931376580943,0,9,thyroid hormone generation,BP,
3047,GO:0006610,1,0.413576750553142,0,8,ribosomal protein import into nucleus,BP,
3050,GO:0006613,1,0.000361072438114337,0,96,cotranslational protein targeting to membrane,BP,
3051,GO:0006614,1,0.000631817737280764,0,91,SRP-dependent cotranslational protein targeting to membrane,BP,
3052,GO:0006616,1,0.558881133023408,0,6,SRP-dependent cotranslational protein targeting to membrane, translocation,BP,
3054,GO:0006620,1,0.475376996110854,0,7,posttranslational protein targeting to endoplasmic reticulum membrane,BP,
3055,GO:0006621,1,0.406531419226429,0,8,protein retention in ER lumen,BP,
3085,GO:0006662,1,0.390076401971643,0,9,glycerol ether metabolic process,BP,
3100,GO:0006681,1,0.500964208839968,0,6,galactosylceramide metabolic process,BP,
3122,GO:0006705,1,0.558422300974127,0,5,mineralocorticoid biosynthetic process,BP,
3162,GO:0006777,1,0.504912573431934,0,6,Mo-molybdopterin cofactor biosynthetic process,BP,
3170,GO:0006787,1,0.606621611906653,0,5,porphyrin-containing compound catabolic process,BP,
3176,GO:0006797,1,0.558959006789779,0,5,polyphosphate metabolic process,BP,
3177,GO:0006798,1,0.628053572213517,0,4,polyphosphate catabolic process,BP,
3197,GO:0006833,1,0.500426061662741,0,6,water transport,BP,
3207,GO:0006851,1,0.103708802139493,0,20,mitochondrial calcium ion transmembrane transport,BP,
3212,GO:0006862,1,0.164432027618142,0,16,nucleotide transport,BP,
3213,GO:0006863,1,0.520791317989972,0,6,purine nucleobase transport,BP,
3217,GO:0006868,1,0.629963240970508,0,4,glutamine transport,BP,
3226,GO:0006883,1,0.397476449696486,0,8,cellular sodium ion homeostasis,BP,
3233,GO:0006891,1,0.0339939606600382,0,30,intra-Golgi vesicle-mediated transport,BP,
3258,GO:0006930,1,0.395979039572952,0,8,substrate-dependent cell migration, cell extension,BP,
3293,GO:0006991,1,0.352748294829125,0,9,response to sterol depletion,BP,
3294,GO:0006995,1,0.354490576982915,0,10,cellular response to nitrogen starvation,BP,
3298,GO:0006999,1,0.180828062388536,0,15,nuclear pore organization,BP,
3299,GO:0007000,1,0.459385762140372,0,7,nucleolus organization,BP,
3312,GO:0007019,1,0.025105650208254,0,32,microtubule depolymerization,BP,
3315,GO:0007023,1,0.664580693946966,0,4,post-chaperonin tubulin folding pathway,BP,
3316,GO:0007026,1,0.127351336932439,0,18,negative regulation of microtubule depolymerization,BP,
3317,GO:0007028,1,0.39707784045181,0,8,cytoplasm organization,BP,
3324,GO:0007035,1,0.128288155157027,0,19,vacuolar acidification,BP,
3328,GO:0007042,1,0.428672423152609,0,8,lysosomal lumen acidification,BP,
3341,GO:0007063,1,0.0924020651863815,0,21,regulation of sister chromatid cohesion,BP,
3342,GO:0007064,1,0.0829662796081474,0,22,mitotic sister chromatid cohesion,BP,
3345,GO:0007076,1,0.15570718749693,0,16,mitotic chromosome condensation,BP,
3348,GO:0007080,1,0.0076526257038917,0,43,mitotic metaphase plate congression,BP,
3351,GO:0007089,1,0.63192114124895,0,4,traversing start control point of mitotic cell cycle,BP,
3352,GO:0007091,1,0.00419900370504221,0,49,metaphase/anaphase transition of mitotic cell cycle,BP,
3354,GO:0007094,1,0.0380312559434312,0,29,mitotic spindle assembly checkpoint,BP,
3364,GO:0007130,1,0.444338417137138,0,7,synaptonemal complex assembly,BP,
3365,GO:0007131,1,0.0169972590055359,0,36,reciprocal meiotic recombination,BP,
3366,GO:0007135,1,0.514457299549359,0,6,meiosis II,BP,
3368,GO:0007141,1,0.27236895448578,0,12,male meiosis I,BP,
3428,GO:0007220,1,0.184859930489535,0,15,Notch receptor processing,BP,
3429,GO:0007221,1,0.15520239469461,0,16,positive regulation of transcription of Notch receptor target,BP,
3440,GO:0007253,1,0.479345207222103,0,7,cytoplasmic sequestering of NF-kappaB,BP,
3444,GO:0007258,1,0.637076921220207,0,4,JUN phosphorylation,BP,
3468,GO:0007296,1,0.632898420358026,0,4,vitellogenesis,BP,
3482,GO:0007351,1,0.35420703915455,0,9,tripartite regional subdivision,BP,
3489,GO:0007379,1,0.284400757584463,0,11,segment specification,BP,
3490,GO:0007386,1,0.559972585957579,0,5,compartment pattern specification,BP,
3514,GO:0007442,1,0.627449537468743,0,4,hindgut morphogenesis,BP,
3538,GO:0007549,1,0.252843612893116,0,12,dosage compensation,BP,
3559,GO:0007603,1,0.158445268756307,0,16,phototransduction, visible light,BP,
3567,GO:0007614,1,0.521930398227794,0,6,short-term memory,BP,
3585,GO:0008009,1,0.276584360662724,0,13,chemokine activity,MF,
3594,GO:0008024,1,0.39478660971321,0,8,cyclin/CDK positive transcription elongation factor complex,CC,
3598,GO:0008035,1,0.627928243775739,0,4,high-density lipoprotein particle binding,MF,
3620,GO:0008079,1,0.502599015513903,0,6,translation termination factor activity,MF,
3626,GO:0008090,1,0.470318547516264,0,7,retrograde axonal transport,BP,
3644,GO:0008121,1,0.511292137866183,0,7,ubiquinol-cytochrome-c reductase activity,MF,
3653,GO:0008139,1,0.0694994851831429,0,23,nuclear localization sequence binding,MF,
3656,GO:0008143,1,0.200740547156877,0,14,poly(A) binding,MF,
3663,GO:0008157,1,0.204374369867012,0,14,protein phosphatase 1 binding,MF,
3670,GO:0008172,1,0.571721604939684,0,5,S-methyltransferase activity,MF,
3672,GO:0008174,1,0.354113619153566,0,9,mRNA methyltransferase activity,MF,
3673,GO:0008175,1,0.0404695419811489,0,28,tRNA methyltransferase activity,MF,
3676,GO:0008179,1,0.318894593635756,0,10,adenylate cyclase binding,MF,
3680,GO:0008187,1,0.0991706547840889,0,20,poly-pyrimidine tract binding,MF,
3687,GO:0008195,1,0.350307203388121,0,9,phosphatidate phosphatase activity,MF,
3700,GO:0008212,1,0.558422300974127,0,5,mineralocorticoid metabolic process,BP,
3704,GO:0008216,1,0.493667219597462,0,7,spermidine metabolic process,BP,
3719,GO:0008250,1,0.298638384330359,0,12,oligosaccharyltransferase complex,CC,
3727,GO:0008266,1,0.15815945768181,0,16,poly(U) RNA binding,MF,
3735,GO:0008275,1,0.627449537468743,0,4,gamma-tubulin small complex,CC,
3738,GO:0008278,1,0.393972715160994,0,8,cohesin complex,CC,
3751,GO:0008295,1,0.646057830016501,0,4,spermidine biosynthetic process,BP,
3752,GO:0008296,1,0.378933053358684,0,9,3'-5'-exodeoxyribonuclease activity,MF,
3753,GO:0008297,1,0.513280041769723,0,6,single-stranded DNA exodeoxyribonuclease activity,MF,
3761,GO:0008308,1,0.263142944898503,0,12,voltage-gated anion channel activity,MF,
3762,GO:0008309,1,0.638556844193137,0,4,double-stranded DNA exodeoxyribonuclease activity,MF,
3763,GO:0008310,1,0.648022513966625,0,4,single-stranded DNA 3'-5' exodeoxyribonuclease activity,MF,
3765,GO:0008312,1,0.476555988988203,0,7,7S RNA binding,MF,
3772,GO:0008329,1,0.455422968399034,0,7,signaling pattern recognition receptor activity,MF,
3777,GO:0008334,1,0.0797748307868459,0,24,histone mRNA metabolic process,BP,
3786,GO:0008353,1,0.168570570184588,0,16,RNA polymerase II carboxy-terminal domain kinase activity,MF,
3803,GO:0008385,1,0.367596904351011,0,9,IkappaB kinase complex,CC,
3814,GO:0008409,1,0.155668508446241,0,16,5'-3' exonuclease activity,MF,
3817,GO:0008417,1,0.312934900618685,0,10,fucosyltransferase activity,MF,
3820,GO:0008420,1,0.405916392890695,0,8,CTD phosphatase activity,MF,
3830,GO:0008432,1,0.417165454848795,0,8,JUN kinase binding,MF,
3852,GO:0008469,1,0.40045922850995,0,8,histone-arginine N-methyltransferase activity,MF,
3858,GO:0008479,1,0.664406763942799,0,4,queuine tRNA-ribosyltransferase activity,MF,
3863,GO:0008486,1,0.640827166600949,0,4,diphosphoinositol-polyphosphate diphosphatase activity,MF,
3877,GO:0008510,1,0.558421378043368,0,5,sodium:bicarbonate symporter activity,MF,
3882,GO:0008517,1,0.627449537468743,0,4,folic acid transmembrane transporter activity,MF,
3890,GO:0008527,1,0.51501059493671,0,7,taste receptor activity,MF,
3894,GO:0008534,1,0.675828740197328,0,4,oxidized purine nucleobase lesion DNA N-glycosylase activity,MF,
3898,GO:0008540,1,0.275266381120013,0,12,proteasome regulatory particle, base subcomplex,CC,
3899,GO:0008541,1,0.469703237597433,0,7,proteasome regulatory particle, lid subcomplex,CC,
3904,GO:0008553,1,0.364470488319668,0,9,proton-exporting ATPase activity, phosphorylative mechanism,MF,
3906,GO:0008556,1,0.563881897605147,0,5,potassium-transporting ATPase activity,MF,
3907,GO:0008559,1,0.627449537468743,0,4,xenobiotic transmembrane transporting ATPase activity,MF,
3909,GO:0008568,1,0.316030714323738,0,10,microtubule-severing ATPase activity,MF,
3921,GO:0008595,1,0.35420703915455,0,9,anterior/posterior axis specification, embryo,BP,
3923,GO:0008603,1,0.562940976751927,0,5,cAMP-dependent protein kinase regulator activity,MF,
3928,GO:0008611,1,0.57534786197682,0,5,ether lipid biosynthetic process,BP,
3929,GO:0008612,1,0.657221968990105,0,4,peptidyl-lysine modification to peptidyl-hypusine,BP,
3934,GO:0008622,1,0.588633054608771,0,5,epsilon DNA polymerase complex,CC,
3938,GO:0008627,1,0.454250360659952,0,7,intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
3943,GO:0008641,1,0.314268950830493,0,10,ubiquitin-like modifier activating enzyme activity,MF,
3951,GO:0008656,1,0.222633198959654,0,14,cysteine-type endopeptidase activator activity involved in apoptotic process,MF,
3980,GO:0008821,1,0.368995637521344,0,9,crossover junction endodeoxyribonuclease activity,MF,
3981,GO:0008823,1,0.568947958157703,0,5,cupric reductase activity,MF,
3986,GO:0008853,1,0.647611226209084,0,4,exodeoxyribonuclease III activity,MF,
3999,GO:0008934,1,0.635524173552956,0,4,inositol monophosphate 1-phosphatase activity,MF,
4002,GO:0008948,1,0.633375300079262,0,4,oxaloacetate decarboxylase activity,MF,
4006,GO:0008970,1,0.443406610047579,0,7,phosphatidylcholine 1-acylhydrolase activity,MF,
4014,GO:0009019,1,0.627449537468743,0,4,tRNA (guanine-N1-)-methyltransferase activity,MF,
4018,GO:0009048,1,0.3175039552437,0,10,dosage compensation by inactivation of X chromosome,BP,
4020,GO:0009052,1,0.574915311652491,0,5,pentose-phosphate shunt, non-oxidative branch,BP,
4033,GO:0009067,1,0.0906023327967779,0,21,aspartate family amino acid biosynthetic process,BP,
4038,GO:0009072,1,0.309481477942985,0,11,aromatic amino acid family metabolic process,BP,
4039,GO:0009074,1,0.433856144255987,0,8,aromatic amino acid family catabolic process,BP,
4047,GO:0009086,1,0.289514177545907,0,11,methionine biosynthetic process,BP,
4077,GO:0009133,1,0.66398820804437,0,4,nucleoside diphosphate biosynthetic process,BP,
4116,GO:0009176,1,0.574409238648955,0,5,pyrimidine deoxyribonucleoside monophosphate metabolic process,BP,
4117,GO:0009177,1,0.574409238648955,0,5,pyrimidine deoxyribonucleoside monophosphate biosynthetic process,BP,
4125,GO:0009186,1,0.59777730814702,0,5,deoxyribonucleoside diphosphate metabolic process,BP,
4139,GO:0009202,1,0.525875562749768,0,6,deoxyribonucleoside triphosphate biosynthetic process,BP,
4147,GO:0009211,1,0.540826636454168,0,6,pyrimidine deoxyribonucleoside triphosphate metabolic process,BP,
4148,GO:0009212,1,0.662261753373343,0,4,pyrimidine deoxyribonucleoside triphosphate biosynthetic process,BP,
4157,GO:0009221,1,0.422861607483633,0,8,pyrimidine deoxyribonucleotide biosynthetic process,BP,
4173,GO:0009249,1,0.523634678991282,0,7,protein lipoylation,BP,
4177,GO:0009256,1,0.627784914348046,0,4,10-formyltetrahydrofolate metabolic process,BP,
4184,GO:0009263,1,0.244041985601779,0,13,deoxyribonucleotide biosynthetic process,BP,
4186,GO:0009265,1,0.346257763932611,0,10,2'-deoxyribonucleotide biosynthetic process,BP,
4194,GO:0009303,1,0.0502466983906547,0,27,rRNA transcription,BP,
4195,GO:0009304,1,0.45706123338479,0,7,tRNA transcription,BP,
4205,GO:0009328,1,0.631249514270264,0,4,phenylalanine-tRNA ligase complex,CC,
4214,GO:0009378,1,0.558421378043368,0,5,four-way junction helicase activity,MF,
4246,GO:0009448,1,0.627763185216266,0,4,gamma-aminobutyric acid metabolic process,BP,
4250,GO:0009452,1,0.0288980372642457,0,33,7-methylguanosine RNA capping,BP,
4257,GO:0009595,1,0.360582324342835,0,9,detection of biotic stimulus,BP,
4258,GO:0009597,1,0.561426239980083,0,5,detection of virus,BP,
4300,GO:0009750,1,0.631375735423428,0,4,response to fructose,BP,
4313,GO:0009794,1,0.636501623204643,0,4,regulation of mitotic cell cycle, embryonic,BP,
4318,GO:0009812,1,0.408615911085699,0,8,flavonoid metabolic process,BP,
4324,GO:0009838,1,0.574721862731457,0,5,abscission,BP,
4330,GO:0009881,1,0.627471642100302,0,4,photoreceptor activity,MF,
4345,GO:0009912,1,0.577602002676994,0,5,auditory receptor cell fate commitment,BP,
4349,GO:0009922,1,0.565895648572829,0,5,fatty acid elongase activity,MF,
4374,GO:0010002,1,0.394023907822431,0,8,cardioblast differentiation,BP,
4376,GO:0010009,1,0.5585769071372,0,5,cytoplasmic side of endosome membrane,CC,
4379,GO:0010032,1,0.558421378043368,0,5,meiotic chromosome condensation,BP,
4385,GO:0010040,1,0.649341799810818,0,4,response to iron(II) ion,BP,
4386,GO:0010041,1,0.577635891297339,0,5,response to iron(III) ion,BP,
4389,GO:0010044,1,0.634190334819517,0,4,response to aluminum ion,BP,
4403,GO:0010155,1,0.404416699964476,0,9,regulation of proton transport,BP,
4411,GO:0010172,1,0.314489371854679,0,10,embryonic body morphogenesis,BP,
4417,GO:0010216,1,0.496982022965512,0,6,maintenance of DNA methylation,BP,
4429,GO:0010265,1,0.523929233622331,0,6,SCF complex assembly,BP,
4433,GO:0010286,1,0.586618007673139,0,5,heat acclimation,BP,
4457,GO:0010452,1,0.354291665746914,0,9,histone H3-K36 methylation,BP,
4460,GO:0010455,1,0.64820491776421,0,4,positive regulation of cell fate commitment,BP,
4463,GO:0010459,1,0.651019902945735,0,4,negative regulation of heart rate,BP,
4476,GO:0010484,1,0.627449537468743,0,4,H3 histone acetyltransferase activity,MF,
4477,GO:0010485,1,0.124393814779143,0,18,H4 histone acetyltransferase activity,MF,
4480,GO:0010499,1,0.126402702249397,0,22,proteasomal ubiquitin-independent protein catabolic process,BP,
4492,GO:0010519,1,0.515024352955363,0,6,negative regulation of phospholipase activity,BP,
4508,GO:0010560,1,0.230023401994126,0,13,positive regulation of glycoprotein biosynthetic process,BP,
4522,GO:0010586,1,0.0928370020134993,0,21,miRNA metabolic process,BP,
4523,GO:0010587,1,0.558424399538881,0,5,miRNA catabolic process,BP,
4530,GO:0010603,1,0.442297753196275,0,7,regulation of cytoplasmic mRNA processing body assembly,BP,
4533,GO:0010606,1,0.558421378043368,0,5,positive regulation of cytoplasmic mRNA processing body assembly,BP,
4538,GO:0010613,1,0.1131095531694,0,19,positive regulation of cardiac muscle hypertrophy,BP,
4544,GO:0010624,1,0.627449537468743,0,4,regulation of Schwann cell proliferation,BP,
4545,GO:0010626,1,0.627449537468743,0,4,negative regulation of Schwann cell proliferation,BP,
4558,GO:0010641,1,0.627803003383896,0,4,positive regulation of platelet-derived growth factor receptor signaling pathway,BP,
4602,GO:0010719,1,0.134764188783058,0,18,negative regulation of epithelial to mesenchymal transition,BP,
4608,GO:0010727,1,0.628020900155347,0,4,negative regulation of hydrogen peroxide metabolic process,BP,
4609,GO:0010728,1,0.629783078809472,0,4,regulation of hydrogen peroxide biosynthetic process,BP,
4648,GO:0010792,1,0.496988745257492,0,6,DNA double-strand break processing involved in repair via single-strand annealing,BP,
4649,GO:0010793,1,0.559476980113556,0,5,regulation of mRNA export from nucleus,BP,
4658,GO:0010807,1,0.500568049540685,0,6,regulation of synaptic vesicle priming,BP,
4665,GO:0010815,1,0.63617096865979,0,4,bradykinin catabolic process,BP,
4668,GO:0010818,1,0.341912640887938,0,10,T cell chemotaxis,BP,
4669,GO:0010819,1,0.479821725697304,0,7,regulation of T cell chemotaxis,BP,
4670,GO:0010820,1,0.479821725697304,0,7,positive regulation of T cell chemotaxis,BP,
4675,GO:0010825,1,0.497637412190749,0,6,positive regulation of centrosome duplication,BP,
4676,GO:0010826,1,0.265502567563916,0,12,negative regulation of centrosome duplication,BP,
4684,GO:0010835,1,0.44775878346114,0,7,regulation of protein ADP-ribosylation,BP,
4687,GO:0010838,1,0.55842144850479,0,5,positive regulation of keratinocyte proliferation,BP,
4688,GO:0010839,1,0.224343873631618,0,13,negative regulation of keratinocyte proliferation,BP,
4691,GO:0010847,1,0.633320176738677,0,4,regulation of chromatin assembly,BP,
4706,GO:0010870,1,0.329645456643107,0,10,positive regulation of receptor biosynthetic process,BP,
4720,GO:0010884,1,0.233008947732012,0,13,positive regulation of lipid storage,BP,
4741,GO:0010911,1,0.443575080225387,0,7,regulation of isomerase activity,BP,
4742,GO:0010912,1,0.443575080225387,0,7,positive regulation of isomerase activity,BP,
4762,GO:0010944,1,0.52837010907348,0,6,negative regulation of transcription by competitive promoter binding,BP,
4771,GO:0010958,1,0.629225326821773,0,4,regulation of amino acid import across plasma membrane,BP,
4777,GO:0010965,1,0.00390025164746391,0,50,regulation of mitotic sister chromatid separation,BP,
4798,GO:0010992,1,0.47098042236594,0,7,ubiquitin recycling,BP,
4799,GO:0010994,1,0.594628157279257,0,5,free ubiquitin chain polymerization,BP,
4801,GO:0010997,1,0.563978541217447,0,5,anaphase-promoting complex binding,MF,
4814,GO:0014010,1,0.558421378043368,0,5,Schwann cell proliferation,BP,
4816,GO:0014012,1,0.653656856937831,0,4,peripheral nervous system axon regeneration,BP,
4834,GO:0014042,1,0.627449537468743,0,4,positive regulation of neuron maturation,BP,
4838,GO:0014046,1,0.380612549685797,0,9,dopamine secretion,BP,
4846,GO:0014059,1,0.380612549685797,0,9,regulation of dopamine secretion,BP,
4879,GO:0014742,1,0.1131095531694,0,19,positive regulation of muscle hypertrophy,BP,
4884,GO:0014805,1,0.672120721473267,0,4,smooth muscle adaptation,BP,
4894,GO:0014821,1,0.65821702149969,0,4,phasic smooth muscle contraction,BP,
4901,GO:0014831,1,0.580941713765519,0,5,gastro-intestinal system smooth muscle contraction,BP,
4922,GO:0014870,1,0.505592599367625,0,6,response to muscle inactivity,BP,
4923,GO:0014874,1,0.457414194540238,0,7,response to stimulus involved in regulation of muscle adaptation,BP,
4925,GO:0014877,1,0.568095598008415,0,5,response to muscle inactivity involved in regulation of muscle adaptation,BP,
4933,GO:0014894,1,0.568095598008415,0,5,response to denervation involved in regulation of muscle adaptation,BP,
4938,GO:0014900,1,0.634866625419157,0,4,muscle hyperplasia,BP,
4948,GO:0015002,1,0.241748364368132,0,18,heme-copper terminal oxidase activity,MF,
4950,GO:0015014,1,0.627449537468743,0,4,heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
4951,GO:0015015,1,0.629190029247504,0,4,heparan sulfate proteoglycan biosynthetic process, enzymatic modification,BP,
4977,GO:0015095,1,0.141657905566596,0,17,magnesium ion transmembrane transporter activity,MF,
5007,GO:0015165,1,0.367268010274362,0,9,pyrimidine nucleotide-sugar transmembrane transporter activity,MF,
5008,GO:0015166,1,0.630980359383257,0,4,polyol transmembrane transporter activity,MF,
5011,GO:0015172,1,0.496982601037291,0,6,acidic amino acid transmembrane transporter activity,MF,
5016,GO:0015180,1,0.558552191508101,0,5,L-alanine transmembrane transporter activity,MF,
5022,GO:0015186,1,0.629963240970508,0,4,L-glutamine transmembrane transporter activity,MF,
5023,GO:0015187,1,0.561194247059628,0,5,glycine transmembrane transporter activity,MF,
5027,GO:0015193,1,0.558552076122966,0,5,L-proline transmembrane transporter activity,MF,
5036,GO:0015215,1,0.184778509560051,0,15,nucleotide transmembrane transporter activity,MF,
5037,GO:0015216,1,0.287881857192163,0,11,purine nucleotide transmembrane transporter activity,MF,
5038,GO:0015217,1,0.36166333667482,0,9,ADP transmembrane transporter activity,MF,
5040,GO:0015220,1,0.558714292028626,0,5,choline transmembrane transporter activity,MF,
5042,GO:0015226,1,0.63132769193922,0,4,carnitine transmembrane transporter activity,MF,
5053,GO:0015250,1,0.640261483934734,0,4,water channel activity,MF,
5058,GO:0015269,1,0.455988098711818,0,7,calcium-activated potassium channel activity,MF,
5066,GO:0015288,1,0.517852199905009,0,6,porin activity,MF,
5090,GO:0015355,1,0.640392957466353,0,4,secondary active monocarboxylate transmembrane transporter activity,MF,
5093,GO:0015368,1,0.497455046253434,0,6,calcium:cation antiporter activity,MF,
5115,GO:0015440,1,0.627449537468743,0,4,peptide-transporting ATPase activity,MF,
5118,GO:0015464,1,0.44568939030269,0,7,acetylcholine receptor activity,MF,
5128,GO:0015562,1,0.627463629345149,0,4,efflux transmembrane transporter activity,MF,
5131,GO:0015616,1,0.627449537468743,0,4,DNA translocase activity,MF,
5135,GO:0015643,1,0.502952703289471,0,6,toxic substance binding,MF,
5154,GO:0015693,1,0.141657905566596,0,17,magnesium ion transport,BP,
5162,GO:0015705,1,0.627449537468743,0,4,iodide transport,BP,
5191,GO:0015780,1,0.259092838419356,0,12,nucleotide-sugar transmembrane transport,BP,
5197,GO:0015791,1,0.499790378417203,0,6,polyol transport,BP,
5208,GO:0015808,1,0.558552191508101,0,5,L-alanine transport,BP,
5214,GO:0015816,1,0.499450024299096,0,6,glycine transport,BP,
5220,GO:0015824,1,0.497098351202682,0,6,proline transport,BP,
5226,GO:0015838,1,0.500054310159415,0,6,amino-acid betaine transport,BP,
5235,GO:0015853,1,0.656728193289172,0,4,adenine transport,BP,
5241,GO:0015865,1,0.256192709646414,0,12,purine nucleotide transport,BP,
5242,GO:0015866,1,0.36166333667482,0,9,ADP transport,BP,
5243,GO:0015867,1,0.361623751261598,0,9,ATP transport,BP,
5244,GO:0015868,1,0.256192709646414,0,12,purine ribonucleotide transport,BP,
5246,GO:0015871,1,0.442529795639038,0,7,choline transport,BP,
5251,GO:0015879,1,0.63132769193922,0,4,carnitine transport,BP,
5255,GO:0015884,1,0.579477669550009,0,5,folic acid transport,BP,
5269,GO:0015917,1,0.627449537468743,0,4,aminophospholipid transport,BP,
5286,GO:0015939,1,0.574000327648521,0,5,pantothenate metabolic process,BP,
5291,GO:0015959,1,0.452632056224032,0,7,diadenosine polyphosphate metabolic process,BP,
5293,GO:0015961,1,0.640827166600949,0,4,diadenosine polyphosphate catabolic process,BP,
5302,GO:0016004,1,0.410194747167627,0,8,phospholipase activator activity,MF,
5309,GO:0016018,1,0.340094397519798,0,10,cyclosporin A binding,MF,
5313,GO:0016024,1,0.223002769559349,0,13,CDP-diacylglycerol biosynthetic process,BP,
5321,GO:0016045,1,0.455263236879152,0,7,detection of bacterium,BP,
5330,GO:0016056,1,0.222187013952294,0,13,rhodopsin mediated signaling pathway,BP,
5333,GO:0016070,1,0,270,3774,RNA metabolic process,BP,TNIP1;MEF2D;ZMYND8;CITED4;HTRA1;EGR1;NR1D1;APLN;PDCD4;CTNNBIP1;ACVR2B;PRNP;VEGFA;WNT7A;APOE;F2R;LRP5;ITGA6;HMGA2;ZKSCAN1;ELK3;PKN1;MTA1;EGFR;WWTR1;NOS1;NFATC4;BAHCC1;ETV5;SHC1;HEXB;GTPBP1;TCFL5;ETV4;TRNP1;ZFP36L1;MAP2K2;ZC3H6;MDFI;PTOV1;SMARCA1;RBCK1;FOXQ1;MAP2K1;MXD4;POU2F2;SMURF2;TSC22D1;FOS;SMAD3;STAT6;PIK3R2;ERCC6;DVL1;EPAS1;DNAJB5;RPUSD3;PRDX5;BRD3;SALL2;ZXDC;RNF187;ADARB1;AKT1;HDAC5;PPM1F;SCMH1;NFKBIZ;ASH2L;IMPACT;WWC3;DAP;FGFR1;MAPKBP1;SEC14L2;HLTF;MXI1;H2AFJ;KLF7;NAT14;CIRBP;HMG20B;TENM2;ZNF385A;TSHZ1;TRAPPC9;CCND1;PCBP4;TCF25;MAPK13;GAS6;CSNK1E;CARD11;SOX13;ARHGAP22;GLI4;ZSCAN18;AIP;MYEF2;MN1;SMARCD2;RRNAD1;DGKQ;PAK6;GTF2IRD1;TAGLN3;PKD2;HES2;CRTC1;ABCA2;ADAM8;CTBP1;MNT;CDKN1C;ZMIZ2;CD81;CEBPB;ZNF217;ZNF862;TGFB1;LACTB2;RFX2;SCYL1;DEAF1;NAB2;TMEM173;ZSCAN30;MSRB2;PNRC1;PEG3;MC1R;ABHD14B;RNH1;PHF21A;KHDRBS3;AGRN;MBD3;LRP4;VHL;MLXIPL;PRKCZ;KDM6B;PRKACA;ZNF516;PIM2;WDR18;TDRKH;ERBB2;PRIMPOL;TFDP2;IRF2BP2;PBX2;NELFCD;PRKCD;RBL2;BAX;DTD1;ZNF395;EREG;RPS6KA5;ZNF524;SOX12;MBTPS2;PPP1R13L;CARF;AHNAK2;IER2;TGFBR3;LEMD2;ZHX3;RGS14;SYMPK;MAPK12;IRAK1;TGFA;HDAC7;FHOD1;CHD2;CBX7;CHEK2;ZFPM1;PPARA;SESN2;ABCG1;SOX7;SIX5;KDM4B;ZNF414;SSBP4;ECM1;WFS1;ZNF444;TRPT1;DALRD3;ARID5B;HOXC5;DNM2;BHLHE40;PELI1;CAT;TSPYL2;ZMYM3;APOBEC3C;SATB1;ZNF606;APOBEC3F;DDX50;MAPK3;INSR;PAN2;CAMTA2;PFKM;RERE;INO80C;BCL7A;CAMKK2;RNASET2;PPP3CB;USP21;CAPRIN2;ZBTB10;WDTC1;HES7;ITGA3;DNMT3A;PPP2R5B;HES6;MAP2K3;PROX1;IARS2;ADGRF1;PKD1;SIRT2;FAM129B;EDA;BACH1;E2F5;ZBTB22;MAPRE3;TEP1;ZNF704;MAP3K10;GTF2IRD2;NGFR;BCORL1;ZNF837;RNASE7;MAFF;NR2F6;CBX6;CAMK1;EZH1;HFE;ZNF513;BTG1;ZP3;MLF2;CDK11B;TNRC18;TCEA2;ZBTB47;PLAG1;CLK3;IRF2BPL;DHX32;KDM3A;TBL3;DEDD2;SRSF5;AARS
5334,GO:0016071,1,0,18,737,mRNA metabolic process,BP,GTPBP1;ZFP36L1;RPUSD3;ADARB1;AKT1;CIRBP;PCBP4;PNRC1;RNH1;KHDRBS3;PRKACA;PRKCD;EREG;SYMPK;PAN2;CDK11B;DHX32;SRSF5
5337,GO:0016074,1,0.309546312021948,0,12,snoRNA metabolic process,BP,
5340,GO:0016078,1,0.536090332202946,0,6,tRNA catabolic process,BP,
5344,GO:0016082,1,0.279901623517214,0,11,synaptic vesicle priming,BP,
5350,GO:0016102,1,0.578190096922489,0,5,diterpenoid biosynthetic process,BP,
5352,GO:0016114,1,0.412997704869972,0,8,terpenoid biosynthetic process,BP,
5369,GO:0016174,1,0.628861295707211,0,4,NAD(P)H oxidase activity,MF,
5372,GO:0016180,1,0.0900999818739111,0,22,snRNA processing,BP,
5377,GO:0016191,1,0.627626396391168,0,4,synaptic vesicle uncoating,BP,
5381,GO:0016199,1,0.627449537468743,0,4,axon midline choice point recognition,BP,
5402,GO:0016240,1,0.654225983494016,0,4,autophagosome membrane docking,BP,
5406,GO:0016246,1,0.192118253244538,0,15,RNA interference,BP,
5411,GO:0016255,1,0.45277473065063,0,7,attachment of GPI anchor to protein,BP,
5413,GO:0016259,1,0.630832287599545,0,4,selenocysteine metabolic process,BP,
5417,GO:0016264,1,0.442596989715827,0,7,gap junction assembly,BP,
5421,GO:0016272,1,0.54279157997716,0,7,prefoldin complex,CC,
5422,GO:0016273,1,0.28238040643095,0,11,arginine N-methyltransferase activity,MF,
5423,GO:0016274,1,0.28238040643095,0,11,protein-arginine N-methyltransferase activity,MF,
5427,GO:0016281,1,0.369696792235236,0,9,eukaryotic translation initiation factor 4F complex,CC,
5445,GO:0016312,1,0.628805663771099,0,4,inositol bisphosphate phosphatase activity,MF,
5450,GO:0016322,1,0.49777096709265,0,6,neuron remodeling,BP,
5453,GO:0016327,1,0.228104763700672,0,13,apicolateral plasma membrane,CC,
5459,GO:0016338,1,0.377066253942313,0,9,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules,BP,
5487,GO:0016421,1,0.499923326993048,0,6,CoA carboxylase activity,MF,
5489,GO:0016423,1,0.228008287683128,0,13,tRNA (guanine) methyltransferase activity,MF,
5490,GO:0016426,1,0.630750014366725,0,4,tRNA (adenine) methyltransferase activity,MF,
5491,GO:0016427,1,0.40165729737813,0,8,tRNA (cytosine) methyltransferase activity,MF,
5492,GO:0016428,1,0.636961507866412,0,4,tRNA (cytosine-5-)-methyltransferase activity,MF,
5497,GO:0016435,1,0.66282690650001,0,4,rRNA (guanine) methyltransferase activity,MF,
5500,GO:0016442,1,0.281447134268423,0,11,RISC complex,CC,
5505,GO:0016453,1,0.642575007262319,0,4,C-acetyltransferase activity,MF,
5510,GO:0016461,1,0.43081601276599,0,8,unconventional myosin complex,CC,
5526,GO:0016502,1,0.506326923190499,0,6,nucleotide receptor activity,MF,
5529,GO:0016505,1,0.178300681752166,0,16,peptidase activator activity involved in apoptotic process,MF,
5550,GO:0016556,1,0.180074151482405,0,15,mRNA modification,BP,
5553,GO:0016559,1,0.490395701743522,0,7,peroxisome fission,BP,
5554,GO:0016560,1,0.629954592527601,0,4,protein import into peroxisome matrix, docking,BP,
5568,GO:0016580,1,0.286607090858506,0,11,Sin3 complex,CC,
5570,GO:0016584,1,0.500853865844801,0,7,nucleosome positioning,BP,
5575,GO:0016592,1,0.0215165905453901,0,35,mediator complex,CC,
5576,GO:0016593,1,0.404096628924164,0,8,Cdc73/Paf1 complex,CC,
5584,GO:0016602,1,0.645285671339206,0,4,CCAAT-binding factor complex,CC,
5620,GO:0016675,1,0.215168155389056,0,19,oxidoreductase activity, acting on a heme group of donors,MF,
5621,GO:0016676,1,0.241748364368132,0,18,oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor,MF,
5622,GO:0016679,1,0.45505635636413,0,8,oxidoreductase activity, acting on diphenols and related substances as donors,MF,
5623,GO:0016681,1,0.511292137866183,0,7,oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor,MF,
5635,GO:0016717,1,0.558456740856591,0,5,oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water,MF,
5648,GO:0016742,1,0.49869163006032,0,6,hydroxymethyl-, formyl- and related transferase activity,MF,
5668,GO:0016778,1,0.631655770447302,0,4,diphosphotransferase activity,MF,
5714,GO:0016846,1,0.498320785830538,0,7,carbon-sulfur lyase activity,MF,
5737,GO:0016884,1,0.33074025335724,0,10,carbon-nitrogen ligase activity, with glutamine as amido-N-donor,MF,
5739,GO:0016886,1,0.314479270383028,0,10,ligase activity, forming phosphoric ester bonds,MF,
5741,GO:0016888,1,0.285806649041126,0,11,endodeoxyribonuclease activity, producing 5'-phosphomonoesters,MF,
5744,GO:0016891,1,0.0545021369663506,0,27,endoribonuclease activity, producing 5'-phosphomonoesters,MF,
5746,GO:0016893,1,0.0220315143767129,0,35,endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters,MF,
5748,GO:0016895,1,0.133406611760752,0,18,exodeoxyribonuclease activity, producing 5'-phosphomonoesters,MF,
5758,GO:0016918,1,0.574843757051713,0,6,retinal binding,MF,
5762,GO:0016926,1,0.446137391504645,0,7,protein desumoylation,BP,
5763,GO:0016929,1,0.497079216307098,0,6,SUMO-specific protease activity,MF,
5772,GO:0016973,1,0.33021626072503,0,10,poly(A)+ mRNA export from nucleus,BP,
5793,GO:0017025,1,0.0794170160302161,0,23,TBP-class protein binding,MF,
5796,GO:0017040,1,0.657599140704355,0,4,N-acylsphingosine amidohydrolase activity,MF,
5803,GO:0017056,1,0.0566444858451828,0,25,structural constituent of nuclear pore,MF,
5808,GO:0017062,1,0.371223339889346,0,9,respiratory chain complex III assembly,BP,
5811,GO:0017069,1,0.0171549442446199,0,38,snRNA binding,MF,
5812,GO:0017070,1,0.316849891399824,0,11,U6 snRNA binding,MF,
5816,GO:0017081,1,0.24243060686677,0,13,chloride channel regulator activity,MF,
5825,GO:0017099,1,0.643143631661684,0,4,very-long-chain-acyl-CoA dehydrogenase activity,MF,
5826,GO:0017101,1,0.263136091926666,0,12,aminoacyl-tRNA synthetase multienzyme complex,CC,
5828,GO:0017108,1,0.497511460422389,0,6,5'-flap endonuclease activity,MF,
5836,GO:0017121,1,0.446717852450893,0,7,phospholipid scrambling,BP,
5841,GO:0017128,1,0.501130437817902,0,6,phospholipid scramblase activity,MF,
5853,GO:0017150,1,0.635435125595602,0,4,tRNA dihydrouridine synthase activity,MF,
5865,GO:0017169,1,0.462944022732802,0,7,CDP-alcohol phosphatidyltransferase activity,MF,
5870,GO:0017182,1,0.353495299982735,0,9,peptidyl-diphthamide metabolic process,BP,
5871,GO:0017183,1,0.353495299982735,0,9,peptidyl-diphthamide biosynthetic process from peptidyl-histidine,BP,
5872,GO:0017185,1,0.393634973258638,0,8,peptidyl-lysine hydroxylation,BP,
5874,GO:0017187,1,0.66468022485683,0,4,peptidyl-glutamic acid carboxylation,BP,
5875,GO:0017196,1,0.513762238341454,0,6,N-terminal peptidyl-methionine acetylation,BP,
5888,GO:0018026,1,0.354606189847273,0,9,peptidyl-lysine monomethylation,BP,
5893,GO:0018065,1,0.343139145518043,0,11,protein-cofactor linkage,BP,
5894,GO:0018076,1,0.627449537468743,0,4,N-terminal peptidyl-lysine acetylation,BP,
5896,GO:0018095,1,0.442312585046318,0,7,protein polyglutamylation,BP,
5898,GO:0018103,1,0.525538695949392,0,6,protein C-linked glycosylation,BP,
5912,GO:0018158,1,0.381613156946664,0,9,protein oxidation,BP,
5915,GO:0018171,1,0.664068495722617,0,4,peptidyl-cysteine oxidation,BP,
5924,GO:0018199,1,0.634540608871775,0,4,peptidyl-glutamine modification,BP,
5927,GO:0018202,1,0.292038476249787,0,11,peptidyl-histidine modification,BP,
5929,GO:0018206,1,0.330204203687965,0,10,peptidyl-methionine modification,BP,
5933,GO:0018211,1,0.525538695949392,0,6,peptidyl-tryptophan modification,BP,
5935,GO:0018214,1,0.66468022485683,0,4,protein carboxylation,BP,
5936,GO:0018216,1,0.223631752239934,0,13,peptidyl-arginine methylation,BP,
5940,GO:0018242,1,0.219718208276051,0,13,protein O-linked glycosylation via serine,BP,
5941,GO:0018243,1,0.246899125258341,0,12,protein O-linked glycosylation via threonine,BP,
5954,GO:0018317,1,0.525538695949392,0,6,protein C-linked glycosylation via tryptophan,BP,
5957,GO:0018335,1,0.627449537468743,0,4,protein succinylation,BP,
5964,GO:0018377,1,0.627474669708726,0,4,protein myristoylation,BP,
5969,GO:0018401,1,0.559546000313875,0,5,peptidyl-proline hydroxylation to 4-hydroxy-L-proline,BP,
5970,GO:0018406,1,0.525538695949392,0,6,protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan,BP,
5981,GO:0018812,1,0.627449537459612,0,4,3-hydroxyacyl-CoA dehydratase activity,MF,
5985,GO:0018904,1,0.278900918733203,0,12,ether metabolic process,BP,
5986,GO:0018916,1,0.665898850721391,0,4,nitrobenzene metabolic process,BP,
6000,GO:0019042,1,0.289866532722747,0,11,viral latency,BP,
6001,GO:0019043,1,0.365998107667057,0,9,establishment of viral latency,BP,
6021,GO:0019081,1,0.208062043969833,0,14,viral translation,BP,
6025,GO:0019086,1,0.637651026848987,0,4,late viral transcription,BP,
6032,GO:0019103,1,0.530503176191287,0,6,pyrimidine nucleotide binding,MF,
6064,GO:0019215,1,0.290146644048532,0,11,intermediate filament binding,MF,
6079,GO:0019237,1,0.49698202295828,0,6,centromeric DNA binding,MF,
6082,GO:0019240,1,0.627449537468743,0,4,citrulline biosynthetic process,BP,
6088,GO:0019262,1,0.57678671933799,0,5,N-acetylneuraminate catabolic process,BP,
6095,GO:0019317,1,0.49698202295828,0,6,fucose catabolic process,BP,
6100,GO:0019322,1,0.644853665528459,0,4,pentose biosynthetic process,BP,
6101,GO:0019323,1,0.656809796253823,0,4,pentose catabolic process,BP,
6102,GO:0019336,1,0.566075344923699,0,5,phenol-containing compound catabolic process,BP,
6117,GO:0019367,1,0.565895648572829,0,5,fatty acid elongation, saturated fatty acid,BP,
6118,GO:0019368,1,0.565895648572829,0,5,fatty acid elongation, unsaturated fatty acid,BP,
6121,GO:0019371,1,0.461266583377398,0,7,cyclooxygenase pathway,BP,
6123,GO:0019373,1,0.500141381415757,0,6,epoxygenase P450 pathway,BP,
6124,GO:0019374,1,0.500964208839968,0,6,galactolipid metabolic process,BP,
6135,GO:0019405,1,0.504064764541518,0,6,alditol catabolic process,BP,
6158,GO:0019509,1,0.576511602599206,0,5,L-methionine salvage from methylthioadenosine,BP,
6167,GO:0019530,1,0.627453955969744,0,4,taurine metabolic process,BP,
6181,GO:0019563,1,0.566304456561936,0,5,glycerol catabolic process,BP,
6184,GO:0019614,1,0.566075344923699,0,5,catechol-containing compound catabolic process,BP,
6189,GO:0019646,1,0.328982388734413,0,14,aerobic electron transport chain,BP,
6201,GO:0019694,1,0.627453955969744,0,4,alkanesulfonate metabolic process,BP,
6205,GO:0019720,1,0.504912573431934,0,6,Mo-molybdopterin cofactor metabolic process,BP,
6218,GO:0019755,1,0.636445595595557,0,4,one-carbon compound transport,BP,
6221,GO:0019773,1,0.532212646348067,0,7,proteasome core complex, alpha-subunit complex,CC,
6222,GO:0019774,1,0.425757108818808,0,10,proteasome core complex, beta-subunit complex,CC,
6234,GO:0019788,1,0.546108514349062,0,6,NEDD8 transferase activity,MF,
6237,GO:0019798,1,0.497543028382693,0,6,procollagen-proline dioxygenase activity,MF,
6253,GO:0019840,1,0.254312252971309,0,13,isoprenoid binding,MF,
6254,GO:0019841,1,0.645900688020862,0,5,retinol binding,MF,
6259,GO:0019855,1,0.427576927348215,0,8,calcium channel inhibitor activity,MF,
6260,GO:0019856,1,0.498171022347821,0,6,pyrimidine nucleobase biosynthetic process,BP,
6271,GO:0019869,1,0.432241459706437,0,8,chloride channel inhibitor activity,MF,
6272,GO:0019870,1,0.570022651801444,0,5,potassium channel inhibitor activity,MF,
6283,GO:0019896,1,0.286813928957703,0,11,axonal transport of mitochondrion,BP,
6293,GO:0019907,1,0.460275478042059,0,7,cyclin-dependent protein kinase activating kinase holoenzyme complex,CC,
6294,GO:0019908,1,0.16396194140798,0,16,nuclear cyclin-dependent protein kinase holoenzyme complex,CC,
6298,GO:0019918,1,0.627884387292312,0,4,peptidyl-arginine methylation, to symmetrical-dimethyl arginine,BP,
6299,GO:0019919,1,0.449840022781912,0,7,peptidyl-arginine methylation, to asymmetrical-dimethyl arginine,BP,
6315,GO:0019966,1,0.463778104179507,0,7,interleukin-1 binding,MF,
6333,GO:0021511,1,0.393663037209409,0,8,spinal cord patterning,BP,
6335,GO:0021513,1,0.442338939430418,0,7,spinal cord dorsal/ventral patterning,BP,
6336,GO:0021514,1,0.627449537468743,0,4,ventral spinal cord interneuron differentiation,BP,
6340,GO:0021520,1,0.50179823801759,0,6,spinal cord motor neuron cell fate specification,BP,
6354,GO:0021540,1,0.660426596316629,0,4,corpus callosum morphogenesis,BP,
6362,GO:0021548,1,0.564403899461296,0,5,pons development,BP,
6392,GO:0021603,1,0.627635239047895,0,4,cranial nerve formation,BP,
6408,GO:0021670,1,0.412502174390465,0,8,lateral ventricle development,BP,
6421,GO:0021692,1,0.394136697106695,0,8,cerebellar Purkinje cell layer morphogenesis,BP,
6423,GO:0021694,1,0.559145156961678,0,5,cerebellar Purkinje cell layer formation,BP,
6430,GO:0021702,1,0.559145156961678,0,5,cerebellar Purkinje cell differentiation,BP,
6448,GO:0021772,1,0.157489075420463,0,16,olfactory bulb development,BP,
6455,GO:0021781,1,0.569384430224918,0,5,glial cell fate commitment,BP,
6460,GO:0021794,1,0.447467217951797,0,7,thalamus development,BP,
6466,GO:0021800,1,0.55853467248765,0,5,cerebral cortex tangential migration,BP,
6477,GO:0021825,1,0.627576825651205,0,4,substrate-dependent cerebral cortex tangential migration,BP,
6492,GO:0021859,1,0.564403899461296,0,5,pyramidal neuron differentiation,BP,
6493,GO:0021860,1,0.564403899461296,0,5,pyramidal neuron development,BP,
6494,GO:0021861,1,0.461686642356694,0,7,forebrain radial glial cell differentiation,BP,
6500,GO:0021877,1,0.559345989946256,0,5,forebrain neuron fate commitment,BP,
6508,GO:0021889,1,0.505097378784569,0,6,olfactory bulb interneuron differentiation,BP,
6509,GO:0021891,1,0.558970457658313,0,5,olfactory bulb interneuron development,BP,
6518,GO:0021903,1,0.569211393906637,0,5,rostrocaudal neural tube patterning,BP,
6520,GO:0021910,1,0.497028297362242,0,6,smoothened signaling pathway involved in ventral spinal cord patterning,BP,
6534,GO:0021943,1,0.627449537468743,0,4,formation of radial glial scaffolds,BP,
6540,GO:0021957,1,0.627449537468743,0,4,corticospinal tract morphogenesis,BP,
6545,GO:0021978,1,0.561940379941227,0,5,telencephalon regionalization,BP,
6546,GO:0021979,1,0.647827558468442,0,4,hypothalamus cell differentiation,BP,
6547,GO:0021983,1,0.126116953344443,0,18,pituitary gland development,BP,
6548,GO:0021984,1,0.567066790371996,0,5,adenohypophysis development,BP,
6550,GO:0021988,1,0.140145506424404,0,17,olfactory lobe development,BP,
6554,GO:0021999,1,0.56714230320319,0,5,neural plate anterior/posterior regionalization,BP,
6558,GO:0022010,1,0.401804141589388,0,8,central nervous system myelination,BP,
6562,GO:0022027,1,0.627449537468743,0,4,interkinetic nuclear migration,BP,
6563,GO:0022028,1,0.627449537468743,0,4,tangential migration from the subventricular zone to the olfactory bulb,BP,
6568,GO:0022400,1,0.280532127970114,0,11,regulation of rhodopsin mediated signaling pathway,BP,
6591,GO:0022614,1,0.627449537468743,0,4,membrane to membrane docking,BP,
6592,GO:0022615,1,0.641342995225359,0,4,protein to membrane docking,BP,
6593,GO:0022616,1,0.0604386560106097,0,25,DNA strand elongation,BP,
6597,GO:0022624,1,0.0790233377021885,0,24,proteasome accessory complex,CC,
6600,GO:0022627,1,0.0295745667426248,0,43,cytosolic small ribosomal subunit,CC,
6612,GO:0022840,1,0.63251782972374,0,4,leak channel activity,MF,
6614,GO:0022842,1,0.63251782972374,0,4,narrow pore channel activity,MF,
6616,GO:0022848,1,0.628847004082548,0,4,acetylcholine-gated cation-selective channel activity,MF,
6621,GO:0022858,1,0.558552191508101,0,5,alanine transmembrane transporter activity,MF,
6636,GO:0023029,1,0.628264722514815,0,4,MHC class Ib protein binding,MF,
6647,GO:0030002,1,0.505925090298432,0,6,cellular anion homeostasis,BP,
6650,GO:0030007,1,0.446623505356659,0,7,cellular potassium ion homeostasis,BP,
6654,GO:0030014,1,0.176395179580096,0,15,CCR4-NOT complex,CC,
6655,GO:0030015,1,0.558980892248616,0,5,CCR4-NOT core complex,CC,
6661,GO:0030023,1,0.627449537468743,0,4,extracellular matrix constituent conferring elasticity,MF,
6674,GO:0030043,1,0.645949189025185,0,4,actin filament fragmentation,BP,
6679,GO:0030050,1,0.49698202295828,0,6,vesicle transport along actin filament,BP,
6685,GO:0030061,1,0.563408154506982,0,5,mitochondrial crista,CC,
6686,GO:0030062,1,0.510596549754248,0,6,mitochondrial tricarboxylic acid cycle enzyme complex,CC,
6688,GO:0030071,1,0.00596434658012749,0,46,regulation of mitotic metaphase/anaphase transition,BP,
6705,GO:0030121,1,0.506625224611979,0,6,AP-1 adaptor complex,CC,
6708,GO:0030124,1,0.638767027529554,0,4,AP-4 adaptor complex,CC,
6729,GO:0030151,1,0.627847706122881,0,4,molybdenum ion binding,MF,
6794,GO:0030242,1,0.558421378043368,0,5,autophagy of peroxisome,BP,
6796,GO:0030247,1,0.497652224340917,0,6,polysaccharide binding,MF,
6805,GO:0030263,1,0.627449537468743,0,4,apoptotic chromosome condensation,BP,
6809,GO:0030274,1,0.628343906906079,0,4,LIM domain binding,MF,
6812,GO:0030277,1,0.400607904453737,0,8,maintenance of gastrointestinal epithelium,BP,
6815,GO:0030280,1,0.291453973445009,0,12,structural constituent of epidermis,MF,
6818,GO:0030284,1,0.558565020880918,0,5,estrogen receptor activity,MF,
6821,GO:0030289,1,0.647840526456921,0,4,protein phosphatase 4 complex,CC,
6843,GO:0030318,1,0.222341861020967,0,13,melanocyte differentiation,BP,
6844,GO:0030320,1,0.505925090298432,0,6,cellular monovalent inorganic anion homeostasis,BP,
6855,GO:0030331,1,0.0234724161789362,0,33,estrogen receptor binding,MF,
6856,GO:0030332,1,0.0585796679058318,0,25,cyclin binding,MF,
6884,GO:0030422,1,0.384085990022455,0,9,production of siRNA involved in RNA interference,BP,
6885,GO:0030423,1,0.64096002148739,0,4,targeting of mRNA for destruction involved in RNA interference,BP,
6890,GO:0030430,1,0.631760027422731,0,4,host cell cytoplasm,CC,
6900,GO:0030488,1,0.0275538282282413,0,32,tRNA methylation,BP,
6903,GO:0030497,1,0.323510740779335,0,10,fatty acid elongation,BP,
6915,GO:0030513,1,0.072356808128556,0,23,positive regulation of BMP signaling pathway,BP,
6934,GO:0030548,1,0.532549841257361,0,6,acetylcholine receptor regulator activity,MF,
6943,GO:0030575,1,0.356108559638938,0,9,nuclear body organization,BP,
6945,GO:0030578,1,0.636474731253986,0,4,PML body organization,BP,
6959,GO:0030619,1,0.473322512072821,0,7,U1 snRNA binding,MF,
6960,GO:0030620,1,0.551507848615412,0,6,U2 snRNA binding,MF,
6961,GO:0030621,1,0.497667797995226,0,6,U4 snRNA binding,MF,
6967,GO:0030628,1,0.541549590623354,0,6,pre-mRNA 3'-splice site binding,MF,
6971,GO:0030643,1,0.629362157668493,0,4,cellular phosphate ion homeostasis,BP,
6990,GO:0030677,1,0.269657214881952,0,13,ribonuclease P complex,CC,
6992,GO:0030681,1,0.370353137258086,0,10,multimeric ribonuclease P complex,CC,
6997,GO:0030687,1,0.072448576368016,0,24,preribosome, large subunit precursor,CC,
6998,GO:0030688,1,0.255209494498113,0,12,preribosome, small subunit precursor,CC,
7051,GO:0030836,1,0.456740481660172,0,7,positive regulation of actin filament depolymerization,BP,
7060,GO:0030854,1,0.575109541550002,0,5,positive regulation of granulocyte differentiation,BP,
7074,GO:0030870,1,0.559518868451194,0,5,Mre11 complex,CC,
7093,GO:0030896,1,0.629774657771585,0,4,checkpoint clamp complex,CC,
7100,GO:0030903,1,0.288110846101129,0,11,notochord development,BP,
7101,GO:0030904,1,0.103245597421775,0,20,retromer complex,CC,
7102,GO:0030905,1,0.63014426716987,0,4,retromer, tubulation complex,CC,
7103,GO:0030906,1,0.644407689818892,0,4,retromer, cargo-selective complex,CC,
7107,GO:0030914,1,0.271241507049921,0,12,STAGA complex,CC,
7110,GO:0030917,1,0.637863248767593,0,4,midbrain-hindbrain boundary development,BP,
7123,GO:0030953,1,0.442487559126309,0,7,astral microtubule organization,BP,
7126,GO:0030957,1,0.326905311914299,0,10,Tat protein binding,MF,
7142,GO:0031000,1,0.29095946556593,0,11,response to caffeine,BP,
7166,GO:0031054,1,0.225697424993274,0,13,pre-miRNA processing,BP,
7173,GO:0031062,1,0.0323403995447794,0,30,positive regulation of histone methylation,BP,
7184,GO:0031080,1,0.323489495213364,0,10,nuclear pore outer ring,CC,
7192,GO:0031088,1,0.585729073302038,0,5,platelet dense granule membrane,CC,
7213,GO:0031114,1,0.0798467445657106,0,22,regulation of microtubule depolymerization,BP,
7217,GO:0031118,1,0.455994106042205,0,8,rRNA pseudouridine synthesis,BP,
7219,GO:0031120,1,0.698807885294587,0,4,snRNA pseudouridine synthesis,BP,
7223,GO:0031125,1,0.311890709157289,0,12,rRNA 3'-end processing,BP,
7224,GO:0031126,1,0.500494499719311,0,7,snoRNA 3'-end processing,BP,
7230,GO:0031145,1,0.000378344896224335,0,77,anaphase-promoting complex-dependent catabolic process,BP,
7267,GO:0031254,1,0.397698918339086,0,8,cell trailing edge,CC,
7271,GO:0031261,1,0.57395123361944,0,5,DNA replication preinitiation complex,CC,
7272,GO:0031262,1,0.672088504325629,0,4,Ndc80 complex,CC,
7273,GO:0031264,1,0.358201245050161,0,9,death-inducing signaling complex,CC,
7274,GO:0031265,1,0.501391015567699,0,6,CD95 death-inducing signaling complex,CC,
7293,GO:0031298,1,0.368736339986995,0,9,replication fork protection complex,CC,
7303,GO:0031313,1,0.450188972373216,0,7,extrinsic component of endosome membrane,CC,
7304,GO:0031314,1,0.558421378035242,0,5,extrinsic component of mitochondrial inner membrane,CC,
7316,GO:0031332,1,0.281447134268423,0,11,RNAi effector complex,CC,
7323,GO:0031340,1,0.509532328471761,0,6,positive regulation of vesicle fusion,BP,
7326,GO:0031343,1,0.0940776330330542,0,22,positive regulation of cell killing,BP,
7334,GO:0031365,1,0.0669131864544802,0,24,N-terminal protein amino acid modification,BP,
7341,GO:0031386,1,0.313872777219487,0,12,protein tag,MF,
7343,GO:0031390,1,0.405769183125271,0,8,Ctf18 RFC-like complex,CC,
7344,GO:0031392,1,0.637321297819458,0,4,regulation of prostaglandin biosynthetic process,BP,
7359,GO:0031414,1,0.375145051829376,0,9,N-terminal protein acetyltransferase complex,CC,
7360,GO:0031415,1,0.653513899693698,0,4,NatA complex,CC,
7368,GO:0031428,1,0.581998259178245,0,5,box C/D snoRNP complex,CC,
7369,GO:0031429,1,0.637638363260678,0,5,box H/ACA snoRNP complex,CC,
7375,GO:0031435,1,0.155691556153367,0,16,mitogen-activated protein kinase kinase kinase binding,MF,
7381,GO:0031441,1,0.350433376242524,0,9,negative regulation of mRNA 3'-end processing,BP,
7382,GO:0031442,1,0.353605946503504,0,9,positive regulation of mRNA 3'-end processing,BP,
7393,GO:0031464,1,0.262317713926519,0,12,Cul4A-RING E3 ubiquitin ligase complex,CC,
7395,GO:0031466,1,0.668020408901461,0,4,Cul5-RING ubiquitin ligase complex,CC,
7427,GO:0031543,1,0.312711332370068,0,10,peptidyl-proline dioxygenase activity,MF,
7428,GO:0031544,1,0.627449537468743,0,4,peptidyl-proline 3-dioxygenase activity,MF,
7429,GO:0031545,1,0.498510711025055,0,6,peptidyl-proline 4-dioxygenase activity,MF,
7452,GO:0031595,1,0.428114941472843,0,8,nuclear proteasome complex,CC,
7453,GO:0031597,1,0.270892374964974,0,12,cytosolic proteasome complex,CC,
7455,GO:0031618,1,0.402261997415463,0,8,nuclear pericentric heterochromatin,CC,
7456,GO:0031620,1,0.64111134902837,0,4,regulation of fever generation,BP,
7457,GO:0031622,1,0.64111134902837,0,4,positive regulation of fever generation,BP,
7463,GO:0031628,1,0.630484782932135,0,4,opioid receptor binding,MF,
7464,GO:0031629,1,0.327358023359488,0,10,synaptic vesicle fusion to presynaptic active zone membrane,BP,
7469,GO:0031640,1,0.174945940341561,0,19,killing of cells of other organism,BP,
7471,GO:0031642,1,0.51672419262526,0,6,negative regulation of myelination,BP,
7474,GO:0031645,1,0.464271613318388,0,7,negative regulation of neurological system process,BP,
7483,GO:0031658,1,0.473093013496044,0,7,negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,
7487,GO:0031665,1,0.420386636301063,0,8,negative regulation of lipopolysaccharide-mediated signaling pathway,BP,
7506,GO:0031698,1,0.632190214270449,0,4,beta-2 adrenergic receptor binding,MF,
7519,GO:0031730,1,0.59838046085732,0,5,CCR5 chemokine receptor binding,MF,
7536,GO:0031821,1,0.505071548684546,0,6,G-protein coupled serotonin receptor binding,MF,
7542,GO:0031852,1,0.630484782932135,0,4,mu-type opioid receptor binding,MF,
7563,GO:0031931,1,0.447686178596926,0,7,TORC1 complex,CC,
7566,GO:0031935,1,0.0987434103271275,0,20,regulation of chromatin silencing,BP,
7567,GO:0031936,1,0.395019864579205,0,8,negative regulation of chromatin silencing,BP,
7568,GO:0031937,1,0.397310558813147,0,8,positive regulation of chromatin silencing,BP,
7573,GO:0031944,1,0.627450574421857,0,4,negative regulation of glucocorticoid metabolic process,BP,
7576,GO:0031947,1,0.627450574421857,0,4,negative regulation of glucocorticoid biosynthetic process,BP,
7581,GO:0031956,1,0.627449537468743,0,4,medium-chain fatty acid-CoA ligase activity,MF,
7583,GO:0031958,1,0.157684548865831,0,16,corticosteroid receptor signaling pathway,BP,
7603,GO:0031996,1,0.314210696762197,0,10,thioesterase binding,MF,
7612,GO:0032009,1,0.449476113189379,0,7,early phagosome,CC,
7616,GO:0032020,1,0.542309105287372,0,6,ISG15-protein conjugation,BP,
7624,GO:0032036,1,0.58296242764435,0,5,myosin heavy chain binding,MF,
7625,GO:0032039,1,0.221634371765032,0,13,integrator complex,CC,
7639,GO:0032057,1,0.632209303085855,0,4,negative regulation of translational initiation in response to stress,BP,
7678,GO:0032133,1,0.642100774945675,0,4,chromosome passenger complex,CC,
7681,GO:0032138,1,0.627449537468743,0,4,single base insertion or deletion binding,MF,
7698,GO:0032184,1,0.627449537468743,0,4,SUMO polymer binding,MF,
7706,GO:0032202,1,0.633991172393128,0,4,telomere assembly,BP,
7714,GO:0032211,1,0.113438428856372,0,19,negative regulation of telomere maintenance via telomerase,BP,
7732,GO:0032237,1,0.627449537468743,0,4,activation of store-operated calcium channel activity,BP,
7733,GO:0032239,1,0.155470077238024,0,16,regulation of nucleobase-containing compound transport,BP,
7735,GO:0032241,1,0.443266912203898,0,7,positive regulation of nucleobase-containing compound transport,BP,
7743,GO:0032264,1,0.639651970742118,0,4,IMP salvage,BP,
7752,GO:0032275,1,0.558958665352152,0,5,luteinizing hormone secretion,BP,
7764,GO:0032291,1,0.401804141589388,0,8,axon ensheathment in central nervous system,BP,
7766,GO:0032296,1,0.631858706141197,0,4,double-stranded RNA-specific ribonuclease activity,MF,
7769,GO:0032300,1,0.246964974840242,0,12,mismatch repair complex,CC,
7780,GO:0032324,1,0.453429799717745,0,7,molybdopterin cofactor biosynthetic process,BP,
7781,GO:0032328,1,0.497098453907234,0,6,alanine transport,BP,
7786,GO:0032341,1,0.558422300974127,0,5,aldosterone metabolic process,BP,
7787,GO:0032342,1,0.558422300974127,0,5,aldosterone biosynthetic process,BP,
7788,GO:0032344,1,0.558422300974127,0,5,regulation of aldosterone metabolic process,BP,
7791,GO:0032347,1,0.558422300974127,0,5,regulation of aldosterone biosynthetic process,BP,
7800,GO:0032356,1,0.327286308241904,0,10,oxidized DNA binding,MF,
7801,GO:0032357,1,0.367039477289444,0,9,oxidized purine DNA binding,MF,
7804,GO:0032364,1,0.576336273528368,0,5,oxygen homeostasis,BP,
7829,GO:0032389,1,0.442401290427834,0,7,MutLalpha complex,CC,
7839,GO:0032404,1,0.406551505680798,0,8,mismatch repair complex binding,MF,
7840,GO:0032405,1,0.573605186183183,0,5,MutLalpha complex binding,MF,
7841,GO:0032407,1,0.566561935771865,0,5,MutSalpha complex binding,MF,
7879,GO:0032453,1,0.496982022965512,0,6,histone demethylase activity (H3-K4 specific),MF,
7888,GO:0032463,1,0.295720007111142,0,11,negative regulation of protein homooligomerization,BP,
7889,GO:0032464,1,0.523505651029771,0,6,positive regulation of protein homooligomerization,BP,
7891,GO:0032466,1,0.511490338833102,0,6,negative regulation of cytokinesis,BP,
7904,GO:0032483,1,0.627449537468743,0,4,regulation of Rab protein signal transduction,BP,
7911,GO:0032490,1,0.627457280204154,0,4,detection of molecule of bacterial origin,BP,
7913,GO:0032494,1,0.558498381234586,0,5,response to peptidoglycan,BP,
7914,GO:0032495,1,0.249680605877297,0,12,response to muramyl dipeptide,BP,
7926,GO:0032509,1,0.107175095494918,0,20,endosome transport via multivesicular body sorting pathway,BP,
7927,GO:0032510,1,0.499409691426251,0,6,endosome to lysosome transport via multivesicular body sorting pathway,BP,
7928,GO:0032511,1,0.429262139602226,0,8,late endosome to vacuole transport via multivesicular body sorting pathway,BP,
7931,GO:0032525,1,0.500913368880842,0,6,somite rostral/caudal axis specification,BP,
7940,GO:0032541,1,0.576856955662117,0,5,cortical endoplasmic reticulum,CC,
7947,GO:0032552,1,0.533323657004585,0,6,deoxyribonucleotide binding,MF,
7949,GO:0032554,1,0.653075457127304,0,4,purine deoxyribonucleotide binding,MF,
7966,GO:0032585,1,0.333130606320583,0,10,multivesicular body membrane,CC,
7971,GO:0032591,1,0.49698202295828,0,6,dendritic spine membrane,CC,
7973,GO:0032593,1,0.524653355565467,0,6,insulin-responsive compartment,CC,
7981,GO:0032604,1,0.420595606010941,0,8,granulocyte macrophage colony-stimulating factor production,BP,
7986,GO:0032610,1,0.545592711996966,0,6,interleukin-1 alpha production,BP,
7994,GO:0032621,1,0.501739467652312,0,6,interleukin-18 production,BP,
8007,GO:0032645,1,0.420595606010941,0,8,regulation of granulocyte macrophage colony-stimulating factor production,BP,
8011,GO:0032650,1,0.584286178445158,0,5,regulation of interleukin-1 alpha production,BP,
8019,GO:0032661,1,0.563766500078476,0,5,regulation of interleukin-18 production,BP,
8029,GO:0032682,1,0.329117916314438,0,10,negative regulation of chemokine production,BP,
8051,GO:0032725,1,0.472598997467826,0,7,positive regulation of granulocyte macrophage colony-stimulating factor production,BP,
8052,GO:0032727,1,0.157016746939151,0,16,positive regulation of interferon-alpha production,BP,
8055,GO:0032730,1,0.646833185476182,0,4,positive regulation of interleukin-1 alpha production,BP,
8073,GO:0032762,1,0.636374203335928,0,4,mast cell cytokine production,BP,
8086,GO:0032777,1,0.633028428507165,0,4,Piccolo NuA4 histone acetyltransferase complex,CC,
8090,GO:0032783,1,0.646279749235266,0,4,ELL-EAF complex,CC,
8092,GO:0032785,1,0.286283914417644,0,11,negative regulation of DNA-templated transcription, elongation,BP,
8097,GO:0032790,1,0.407041092324205,0,8,ribosome disassembly,BP,
8098,GO:0032792,1,0.65016376210022,0,4,negative regulation of CREB transcription factor activity,BP,
8103,GO:0032797,1,0.297730856344069,0,11,SMN complex,CC,
8112,GO:0032806,1,0.0589666023005573,0,25,carboxy-terminal domain protein kinase complex,CC,
8113,GO:0032807,1,0.634342081515634,0,4,DNA ligase IV complex,CC,
8114,GO:0032808,1,0.627449537468743,0,4,lacrimal gland development,BP,
8119,GO:0032815,1,0.585927729487973,0,5,negative regulation of natural killer cell activation,BP,
8121,GO:0032817,1,0.666985187571568,0,4,regulation of natural killer cell proliferation,BP,
8122,GO:0032819,1,0.666985187571568,0,4,positive regulation of natural killer cell proliferation,BP,
8141,GO:0032875,1,0.442297753196275,0,7,regulation of DNA endoreduplication,BP,
8142,GO:0032876,1,0.627449537468743,0,4,negative regulation of DNA endoreduplication,BP,
8161,GO:0032905,1,0.499868396319717,0,6,transforming growth factor beta1 production,BP,
8164,GO:0032908,1,0.499868396319717,0,6,regulation of transforming growth factor beta1 production,BP,
8180,GO:0032926,1,0.455249759494859,0,7,negative regulation of activin receptor signaling pathway,BP,
8185,GO:0032933,1,0.396369101694202,0,8,SREBP signaling pathway,BP,
8199,GO:0032959,1,0.49698202295828,0,6,inositol trisphosphate biosynthetic process,BP,
8200,GO:0032960,1,0.627449537468743,0,4,regulation of inositol trisphosphate biosynthetic process,BP,
8207,GO:0032968,1,0.184434881810304,0,15,positive regulation of transcription elongation from RNA polymerase II promoter,BP,
8218,GO:0032988,1,0.232737926684528,0,13,ribonucleoprotein complex disassembly,BP,
8235,GO:0033015,1,0.606621611906653,0,5,tetrapyrrole catabolic process,BP,
8245,GO:0033031,1,0.637321297819458,0,4,positive regulation of neutrophil apoptotic process,BP,
8248,GO:0033034,1,0.517168353780617,0,6,positive regulation of myeloid cell apoptotic process,BP,
8251,GO:0033038,1,0.578622769747745,0,6,bitter taste receptor activity,MF,
8255,GO:0033045,1,0.000392904176896787,0,70,regulation of sister chromatid segregation,BP,
8256,GO:0033046,1,0.0181570054307527,0,36,negative regulation of sister chromatid segregation,BP,
8257,GO:0033047,1,0.00112132517514079,0,61,regulation of mitotic sister chromatid segregation,BP,
8258,GO:0033048,1,0.02293739328779,0,34,negative regulation of mitotic sister chromatid segregation,BP,
8261,GO:0033061,1,0.362817897556095,0,9,DNA recombinase mediator complex,CC,
8262,GO:0033063,1,0.458090989682049,0,7,Rad51B-Rad51C-Rad51D-XRCC2 complex,CC,
8278,GO:0033093,1,0.628772080562359,0,4,Weibel-Palade body,CC,
8282,GO:0033119,1,0.0880629237528844,0,22,negative regulation of RNA splicing,BP,
8302,GO:0033144,1,0.062876154637498,0,24,negative regulation of intracellular steroid hormone receptor signaling pathway,BP,
8305,GO:0033147,1,0.35554649741608,0,9,negative regulation of intracellular estrogen receptor signaling pathway,BP,
8309,GO:0033152,1,0.640238549272208,0,4,immunoglobulin V(D)J recombination,BP,
8310,GO:0033153,1,0.558421378043368,0,5,T cell receptor V(D)J recombination,BP,
8315,GO:0033162,1,0.526752231509104,0,6,melanosome membrane,CC,
8319,GO:0033170,1,0.405769183125271,0,8,protein-DNA loading ATPase activity,MF,
8322,GO:0033177,1,0.393906583426241,0,9,proton-transporting two-sector ATPase complex, proton-transporting domain,CC,
8324,GO:0033179,1,0.435579179410489,0,8,proton-transporting V-type ATPase, V0 domain,CC,
8327,GO:0033182,1,0.312546461042646,0,10,regulation of histone ubiquitination,BP,
8329,GO:0033184,1,0.55854645888871,0,5,positive regulation of histone ubiquitination,BP,
8340,GO:0033206,1,0.627452533223287,0,4,meiotic cytokinesis,BP,
8344,GO:0033216,1,0.576009910280038,0,5,ferric iron import,BP,
8346,GO:0033220,1,0.627449537468743,0,4,amide-transporting ATPase activity,MF,
8351,GO:0033238,1,0.00233904970076584,0,59,regulation of cellular amine metabolic process,BP,
8352,GO:0033239,1,0.628028861400054,0,4,negative regulation of cellular amine metabolic process,BP,
8353,GO:0033240,1,0.468438843356743,0,7,positive regulation of cellular amine metabolic process,BP,
8356,GO:0033256,1,0.449870860541776,0,7,I-kappaB/NF-kappaB complex,CC,
8360,GO:0033263,1,0.627449537468743,0,4,CORVET complex,CC,
8369,GO:0033276,1,0.21416400033258,0,14,transcription factor TFTC complex,CC,
8371,GO:0033278,1,0.627449537468743,0,4,cell proliferation in midbrain,BP,
8380,GO:0033299,1,0.566939884298472,0,5,secretion of lysosomal enzymes,BP,
8384,GO:0033313,1,0.559451635340748,0,5,meiotic cell cycle checkpoint,BP,
8385,GO:0033314,1,0.400122895727377,0,8,mitotic DNA replication checkpoint,BP,
8406,GO:0033391,1,0.496982023327114,0,6,chromatoid body,CC,
8408,GO:0033483,1,0.419518806631222,0,8,gas homeostasis,BP,
8411,GO:0033489,1,0.642880159446194,0,4,cholesterol biosynthetic process via desmosterol,BP,
8412,GO:0033490,1,0.642880159446194,0,4,cholesterol biosynthetic process via lathosterol,BP,
8415,GO:0033503,1,0.631288065345925,0,4,HULC complex,CC,
8420,GO:0033523,1,0.251933570026083,0,12,histone H2B ubiquitination,BP,
8426,GO:0033553,1,0.63280167420849,0,4,rDNA heterochromatin,CC,
8433,GO:0033561,1,0.0803174769195946,0,22,regulation of water loss via skin,BP,
8437,GO:0033567,1,0.578357095344034,0,5,DNA replication, Okazaki fragment processing,BP,
8440,GO:0033574,1,0.0290013926171232,0,32,response to testosterone,BP,
8443,GO:0033588,1,0.564680825744143,0,5,Elongator holoenzyme complex,CC,
8446,GO:0033592,1,0.558504512078108,0,5,RNA strand annealing activity,MF,
8453,GO:0033600,1,0.636826019874354,0,4,negative regulation of mammary gland epithelial cell proliferation,BP,
8458,GO:0033605,1,0.585099209003664,0,5,positive regulation of catecholamine secretion,BP,
8467,GO:0033622,1,0.278881931593851,0,11,integrin activation,BP,
8468,GO:0033623,1,0.496982135271878,0,6,regulation of integrin activation,BP,
8473,GO:0033629,1,0.457123317763914,0,7,negative regulation of cell adhesion mediated by integrin,BP,
8481,GO:0033646,1,0.445692076958823,0,7,host intracellular part,CC,
8482,GO:0033647,1,0.562706129886092,0,5,host intracellular organelle,CC,
8483,GO:0033648,1,0.562706129886092,0,5,host intracellular membrane-bounded organelle,CC,
8485,GO:0033655,1,0.631760027422731,0,4,host cell cytoplasm part,CC,
8514,GO:0033750,1,0.263956805214804,0,13,ribosome localization,BP,
8546,GO:0033962,1,0.131411823791615,0,18,cytoplasmic mRNA processing body assembly,BP,
8561,GO:0034036,1,0.499548567501526,0,6,purine ribonucleoside bisphosphate biosynthetic process,BP,
8567,GO:0034046,1,0.445046382158728,0,7,poly(G) binding,MF,
8578,GO:0034085,1,0.444391625190385,0,7,establishment of sister chromatid cohesion,BP,
8579,GO:0034086,1,0.262776858720072,0,12,maintenance of sister chromatid cohesion,BP,
8581,GO:0034088,1,0.262776858720072,0,12,maintenance of mitotic sister chromatid cohesion,BP,
8582,GO:0034091,1,0.418553013385945,0,8,regulation of maintenance of sister chromatid cohesion,BP,
8584,GO:0034093,1,0.573202926915628,0,5,positive regulation of maintenance of sister chromatid cohesion,BP,
8586,GO:0034098,1,0.357193585046847,0,9,VCP-NPL4-UFD1 AAA ATPase complex,CC,
8596,GO:0034114,1,0.204455822560658,0,14,regulation of heterotypic cell-cell adhesion,BP,
8597,GO:0034115,1,0.450018132234145,0,7,negative regulation of heterotypic cell-cell adhesion,BP,
8598,GO:0034116,1,0.408405510505099,0,8,positive regulation of heterotypic cell-cell adhesion,BP,
8606,GO:0034127,1,0.560304995410526,0,5,regulation of MyD88-independent toll-like receptor signaling pathway,BP,
8607,GO:0034128,1,0.627454881125093,0,4,negative regulation of MyD88-independent toll-like receptor signaling pathway,BP,
8609,GO:0034135,1,0.522684744049637,0,6,regulation of toll-like receptor 2 signaling pathway,BP,
8624,GO:0034154,1,0.628306616185327,0,4,toll-like receptor 7 signaling pathway,BP,
8632,GO:0034182,1,0.418553013385945,0,8,regulation of maintenance of mitotic sister chromatid cohesion,BP,
8634,GO:0034184,1,0.573202926915628,0,5,positive regulation of maintenance of mitotic sister chromatid cohesion,BP,
8636,GO:0034186,1,0.638828814632008,0,4,apolipoprotein A-I binding,MF,
8645,GO:0034201,1,0.57362419420091,0,5,response to oleic acid,BP,
8649,GO:0034212,1,0.00111344540453634,0,60,peptide N-acetyltransferase activity,MF,
8651,GO:0034214,1,0.394925322376054,0,8,protein hexamerization,BP,
8655,GO:0034227,1,0.572701892883304,0,5,tRNA thio-modification,BP,
8656,GO:0034235,1,0.56295045768359,0,5,GPI anchor binding,MF,
8657,GO:0034236,1,0.285433926086625,0,11,protein kinase A catalytic subunit binding,MF,
8663,GO:0034243,1,0.0582158053194695,0,25,regulation of transcription elongation from RNA polymerase II promoter,BP,
8664,GO:0034244,1,0.321691873070548,0,10,negative regulation of transcription elongation from RNA polymerase II promoter,BP,
8680,GO:0034310,1,0.460375833730857,0,7,primary alcohol catabolic process,BP,
8691,GO:0034334,1,0.627449537468743,0,4,adherens junction maintenance,BP,
8722,GO:0034379,1,0.526958178681317,0,6,very-low-density lipoprotein particle assembly,BP,
8731,GO:0034389,1,0.18631138689496,0,15,lipid particle organization,BP,
8750,GO:0034427,1,0.36201946852626,0,10,nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5',BP,
8751,GO:0034431,1,0.640827166600949,0,4,bis(5'-adenosyl)-hexaphosphatase activity,MF,
8752,GO:0034432,1,0.640827166600949,0,4,bis(5'-adenosyl)-pentaphosphatase activity,MF,
8762,GO:0034448,1,0.647305322613626,0,4,EGO complex,CC,
8765,GO:0034452,1,0.312425686798857,0,10,dynactin binding,MF,
8766,GO:0034453,1,0.07003484171058,0,23,microtubule anchoring,BP,
8767,GO:0034454,1,0.35036780693586,0,9,microtubule anchoring at centrosome,BP,
8778,GO:0034471,1,0.137878371721414,0,19,ncRNA 5'-end processing,BP,
8779,GO:0034472,1,0.227160702610122,0,14,snRNA 3'-end processing,BP,
8782,GO:0034475,1,0.457083581369365,0,8,U4 snRNA 3'-end processing,BP,
8785,GO:0034481,1,0.629435490352045,0,4,chondroitin sulfotransferase activity,MF,
8791,GO:0034501,1,0.161376455568932,0,16,protein localization to kinetochore,BP,
8797,GO:0034511,1,0.519181537718542,0,6,U3 snoRNA binding,MF,
8799,GO:0034513,1,0.637638363260678,0,5,box H/ACA snoRNA binding,MF,
8801,GO:0034518,1,0.265643912017244,0,12,RNA cap binding complex,CC,
8803,GO:0034551,1,0.371223339889346,0,9,mitochondrial respiratory chain complex III assembly,BP,
8804,GO:0034552,1,0.658092298278963,0,4,respiratory chain complex II assembly,BP,
8805,GO:0034553,1,0.658092298278963,0,4,mitochondrial respiratory chain complex II assembly,BP,
8817,GO:0034603,1,0.565183911828934,0,5,pyruvate dehydrogenase [NAD(P)+] activity,MF,
8818,GO:0034604,1,0.565183911828934,0,5,pyruvate dehydrogenase (NAD+) activity,MF,
8828,GO:0034625,1,0.565895648572829,0,5,fatty acid elongation, monounsaturated fatty acid,BP,
8829,GO:0034626,1,0.565895648572829,0,5,fatty acid elongation, polyunsaturated fatty acid,BP,
8840,GO:0034643,1,0.121978949833719,0,19,establishment of mitochondrion localization, microtubule-mediated,BP,
8844,GO:0034648,1,0.627449537468743,0,4,histone demethylase activity (H3-dimethyl-K4 specific),MF,
8852,GO:0034657,1,0.632223570402212,0,4,GID complex,CC,
8855,GO:0034663,1,0.420429490236858,0,8,endoplasmic reticulum chaperone complex,CC,
8887,GO:0034709,1,0.321664968571037,0,12,methylosome,CC,
8891,GO:0034715,1,0.567684243433431,0,6,pICln-Sm protein complex,CC,
8893,GO:0034719,1,0.20157834576896,0,16,SMN-Sm protein complex,CC,
8894,GO:0034720,1,0.496982022965512,0,6,histone H3-K4 demethylation,BP,
8897,GO:0034723,1,0.0955658322900545,0,32,DNA replication-dependent nucleosome organization,BP,
8921,GO:0034770,1,0.352038695524506,0,9,histone H4-K20 methylation,BP,
8922,GO:0034773,1,0.499437862223188,0,6,histone H4-K20 trimethylation,BP,
8932,GO:0034969,1,0.317164624476229,0,10,histone arginine methylation,BP,
8948,GO:0035005,1,0.496982022965512,0,6,1-phosphatidylinositol-4-phosphate 3-kinase activity,MF,
8953,GO:0035022,1,0.655559868208385,0,4,positive regulation of Rac protein signal transduction,BP,
8958,GO:0035032,1,0.500041832598896,0,6,phosphatidylinositol 3-kinase complex, class III,CC,
8967,GO:0035061,1,0.627449537468743,0,4,interchromatin granule,CC,
8973,GO:0035068,1,0.355369208377653,0,9,micro-ribonucleoprotein complex,CC,
8975,GO:0035087,1,0.64096002148739,0,4,siRNA loading onto RISC involved in RNA interference,BP,
8990,GO:0035112,1,0.49698202295828,0,6,genitalia morphogenesis,BP,
8999,GO:0035145,1,0.0924458058158789,0,21,exon-exon junction complex,CC,
9005,GO:0035174,1,0.512267228511817,0,6,histone serine kinase activity,MF,
9014,GO:0035197,1,0.356593435321122,0,9,siRNA binding,MF,
9015,GO:0035198,1,0.089211266166622,0,21,miRNA binding,MF,
9024,GO:0035242,1,0.449840022781912,0,7,protein-arginine omega-N asymmetric methyltransferase activity,MF,
9025,GO:0035243,1,0.627884387292312,0,4,protein-arginine omega-N symmetric methyltransferase activity,MF,
9026,GO:0035246,1,0.28238040643095,0,11,peptidyl-arginine N-methylation,BP,
9027,GO:0035247,1,0.356388613535035,0,9,peptidyl-arginine omega-N-methylation,BP,
9031,GO:0035251,1,0.459881117899159,0,7,UDP-glucosyltransferase activity,MF,
9044,GO:0035267,1,0.117757575526362,0,19,NuA4 histone acetyltransferase complex,CC,
9050,GO:0035278,1,0.257800651500524,0,12,miRNA mediated inhibition of translation,BP,
9052,GO:0035280,1,0.448687933026684,0,7,miRNA loading onto RISC involved in gene silencing by miRNA,BP,
9067,GO:0035312,1,0.498403548026786,0,6,5'-3' exodeoxyribonuclease activity,MF,
9072,GO:0035327,1,0.115475748543784,0,20,transcriptionally active chromatin,CC,
9077,GO:0035333,1,0.262306359549803,0,12,Notch receptor processing, ligand-dependent,BP,
9081,GO:0035338,1,0.228220843015849,0,13,long-chain fatty-acyl-CoA biosynthetic process,BP,
9082,GO:0035339,1,0.644320213642823,0,4,SPOTS complex,CC,
9088,GO:0035356,1,0.580276144968512,0,5,cellular triglyceride homeostasis,BP,
9093,GO:0035363,1,0.633776077504519,0,4,histone locus body,CC,
9094,GO:0035368,1,0.632690639036435,0,4,selenocysteine insertion sequence binding,MF,
9104,GO:0035385,1,0.444118605628201,0,7,Roundabout signaling pathway,BP,
9120,GO:0035437,1,0.286537183922692,0,11,maintenance of protein localization in endoplasmic reticulum,BP,
9130,GO:0035459,1,0.0986570652148819,0,20,cargo loading into vesicle,BP,
9149,GO:0035507,1,0.501309920607521,0,6,regulation of myosin-light-chain-phosphatase activity,BP,
9151,GO:0035509,1,0.632912650442929,0,4,negative regulation of myosin-light-chain-phosphatase activity,BP,
9153,GO:0035511,1,0.583379628658238,0,5,oxidative DNA demethylation,BP,
9154,GO:0035513,1,0.634359119109851,0,4,oxidative RNA demethylation,BP,
9156,GO:0035515,1,0.634359119109851,0,4,oxidative RNA demethylase activity,MF,
9160,GO:0035519,1,0.674977177224973,0,4,protein K29-linked ubiquitination,BP,
9161,GO:0035520,1,0.350325595414408,0,9,monoubiquitinated protein deubiquitination,BP,
9162,GO:0035521,1,0.627482466043201,0,4,monoubiquitinated histone deubiquitination,BP,
9163,GO:0035522,1,0.627482466043201,0,4,monoubiquitinated histone H2A deubiquitination,BP,
9164,GO:0035523,1,0.632646136663253,0,4,protein K29-linked deubiquitination,BP,
9165,GO:0035524,1,0.558552076122966,0,5,proline transmembrane transport,BP,
9168,GO:0035529,1,0.590126257122976,0,5,NADH pyrophosphatase activity,MF,
9173,GO:0035546,1,0.627449537468743,0,4,interferon-beta secretion,BP,
9174,GO:0035547,1,0.627449537468743,0,4,regulation of interferon-beta secretion,BP,
9175,GO:0035549,1,0.627449537468743,0,4,positive regulation of interferon-beta secretion,BP,
9181,GO:0035563,1,0.253429179267298,0,12,positive regulation of chromatin binding,BP,
9201,GO:0035589,1,0.56737067553382,0,5,G-protein coupled purinergic nucleotide receptor signaling pathway,BP,
9202,GO:0035590,1,0.45061512998227,0,7,purinergic nucleotide receptor signaling pathway,BP,
9221,GO:0035613,1,0.184538884875888,0,15,RNA stem-loop binding,MF,
9234,GO:0035631,1,0.281251195690614,0,11,CD40 receptor complex,CC,
9245,GO:0035650,1,0.651886853374492,0,4,AP-1 adaptor complex binding,MF,
9254,GO:0035666,1,0.060639905601045,0,25,TRIF-dependent toll-like receptor signaling pathway,BP,
9258,GO:0035672,1,0.501298652460456,0,6,oligopeptide transmembrane transport,BP,
9259,GO:0035673,1,0.627449537468743,0,4,oligopeptide transmembrane transporter activity,MF,
9262,GO:0035686,1,0.66039921570812,0,4,sperm fibrous sheath,CC,
9292,GO:0035739,1,0.629530245447681,0,4,CD4-positive, alpha-beta T cell proliferation,BP,
9299,GO:0035749,1,0.572806991856439,0,5,myelin sheath adaxonal region,CC,
9301,GO:0035751,1,0.305168987582445,0,11,regulation of lysosomal lumen pH,BP,
9326,GO:0035810,1,0.560309605448955,0,5,positive regulation of urine volume,BP,
9334,GO:0035825,1,0.0169972590055359,0,36,homologous recombination,BP,
9345,GO:0035861,1,0.0246121563450421,0,32,site of double-strand break,CC,
9355,GO:0035871,1,0.353209733802011,0,9,protein K11-linked deubiquitination,BP,
9358,GO:0035877,1,0.641122626429227,0,4,death effector domain binding,MF,
9363,GO:0035883,1,0.14497869762263,0,17,enteroendocrine cell differentiation,BP,
9374,GO:0035907,1,0.558722860374953,0,5,dorsal aorta development,BP,
9377,GO:0035912,1,0.627788257857795,0,4,dorsal aorta morphogenesis,BP,
9387,GO:0035929,1,0.410326207707812,0,8,steroid hormone secretion,BP,
9388,GO:0035930,1,0.581221695550529,0,5,corticosteroid hormone secretion,BP,
9401,GO:0035964,1,0.506029851794699,0,6,COPI-coated vesicle budding,BP,
9407,GO:0035973,1,0.452560789599818,0,7,aggrephagy,BP,
9418,GO:0035989,1,0.631403185261663,0,4,tendon development,BP,
9426,GO:0036002,1,0.0288286920374464,0,32,pre-mRNA binding,MF,
9442,GO:0036033,1,0.627449537468743,0,4,mediator complex binding,MF,
9447,GO:0036041,1,0.564654840982065,0,6,long-chain fatty acid binding,MF,
9455,GO:0036056,1,0.627449537468743,0,4,filtration diaphragm,CC,
9456,GO:0036057,1,0.627449537468743,0,4,slit diaphragm,CC,
9484,GO:0036124,1,0.201263831644739,0,14,histone H3-K9 trimethylation,BP,
9502,GO:0036155,1,0.55985563765163,0,5,acylglycerol acyl-chain remodeling,BP,
9524,GO:0036257,1,0.0360081670288122,0,30,multivesicular body organization,BP,
9525,GO:0036258,1,0.0404693456857734,0,29,multivesicular body assembly,BP,
9526,GO:0036260,1,0.0288980372642457,0,33,RNA capping,BP,
9528,GO:0036265,1,0.677690241205636,0,4,RNA (guanine-N7)-methylation,BP,
9531,GO:0036270,1,0.29095946556593,0,11,response to diuretic,BP,
9538,GO:0036295,1,0.230807499291331,0,13,cellular response to increased oxygen levels,BP,
9542,GO:0036302,1,0.558722860374953,0,5,atrioventricular canal development,BP,
9549,GO:0036315,1,0.220234111463364,0,13,cellular response to sterol,BP,
9556,GO:0036337,1,0.627838364465494,0,4,Fas signaling pathway,BP,
9562,GO:0036353,1,0.408257070268751,0,8,histone H2A-K119 monoubiquitination,BP,
9570,GO:0036376,1,0.446623505356659,0,7,sodium ion export across plasma membrane,BP,
9579,GO:0036402,1,0.537019316950673,0,6,proteasome-activating ATPase activity,MF,
9587,GO:0036444,1,0.393626380044218,0,8,calcium import into the mitochondrion,BP,
9590,GO:0036449,1,0.442297753196275,0,7,microtubule minus-end,CC,
9595,GO:0036457,1,0.627449537468743,0,4,keratohyalin granule,CC,
9599,GO:0036462,1,0.463939316476208,0,7,TRAIL-activated apoptotic signaling pathway,BP,
9611,GO:0036480,1,0.457238369895179,0,7,neuron intrinsic apoptotic signaling pathway in response to oxidative stress,BP,
9620,GO:0036491,1,0.444712245045971,0,7,regulation of translation initiation in response to endoplasmic reticulum stress,BP,
9621,GO:0036492,1,0.499461625092044,0,6,eiF2alpha phosphorylation in response to endoplasmic reticulum stress,BP,
9640,GO:0036513,1,0.318899811946527,0,10,Derlin-1 retrotranslocation complex,CC,
9665,GO:0038028,1,0.627449537468743,0,4,insulin receptor signaling pathway via phosphatidylinositol 3-kinase,BP,
9666,GO:0038030,1,0.497013286026661,0,6,non-canonical Wnt signaling pathway via MAPK cascade,BP,
9667,GO:0038031,1,0.558456502974363,0,5,non-canonical Wnt signaling pathway via JNK cascade,BP,
9670,GO:0038036,1,0.499632097750798,0,6,sphingosine-1-phosphate receptor activity,MF,
9673,GO:0038042,1,0.661051628077042,0,4,dimeric G-protein coupled receptor signaling pathway,BP,
9674,GO:0038044,1,0.627690963524692,0,4,transforming growth factor-beta secretion,BP,
9681,GO:0038063,1,0.442297753202712,0,7,collagen-activated tyrosine kinase receptor signaling pathway,BP,
9683,GO:0038065,1,0.393626380044218,0,8,collagen-activated signaling pathway,BP,
9714,GO:0038155,1,0.513182916147923,0,6,interleukin-23-mediated signaling pathway,BP,
9720,GO:0038166,1,0.576526766981343,0,5,angiotensin-activated signaling pathway,BP,
9721,GO:0038171,1,0.627715515457927,0,4,cannabinoid signaling pathway,BP,
9724,GO:0038180,1,0.411836321339124,0,8,nerve growth factor signaling pathway,BP,
9728,GO:0038187,1,0.455422968399034,0,7,pattern recognition receptor activity,MF,
9738,GO:0038203,1,0.445819924650884,0,7,TORC2 signaling,BP,
9758,GO:0039528,1,0.0900426760664267,0,21,cytoplasmic pattern recognition receptor signaling pathway in response to virus,BP,
9759,GO:0039529,1,0.17854958745916,0,15,RIG-I signaling pathway,BP,
9760,GO:0039530,1,0.363578304675902,0,9,MDA-5 signaling pathway,BP,
9761,GO:0039531,1,0.159260946446234,0,16,regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,BP,
9762,GO:0039532,1,0.320654836379736,0,10,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,BP,
9763,GO:0039533,1,0.509041862041002,0,6,regulation of MDA-5 signaling pathway,BP,
9764,GO:0039534,1,0.642672673906029,0,4,negative regulation of MDA-5 signaling pathway,BP,
9765,GO:0039535,1,0.225464264003703,0,13,regulation of RIG-I signaling pathway,BP,
9766,GO:0039536,1,0.453862234111932,0,7,negative regulation of RIG-I signaling pathway,BP,
9778,GO:0039702,1,0.111288105282774,0,20,viral budding via host ESCRT complex,BP,
9785,GO:0040009,1,0.62796276683221,0,4,regulation of growth rate,BP,
9791,GO:0040016,1,0.446128302829024,0,7,embryonic cleavage,BP,
9798,GO:0040031,1,0.553513851815446,0,6,snRNA modification,BP,
9800,GO:0040033,1,0.257800651500524,0,12,negative regulation of translation, ncRNA-mediated,BP,
9812,GO:0042023,1,0.393626380044218,0,8,DNA endoreduplication,BP,
9814,GO:0042026,1,0.0596704925404719,0,25,protein refolding,BP,
9821,GO:0042044,1,0.259304315656003,0,12,fluid transport,BP,
9822,GO:0042045,1,0.58243029939177,0,5,epithelial fluid transport,BP,
9824,GO:0042053,1,0.368061813141798,0,9,regulation of dopamine metabolic process,BP,
9831,GO:0042069,1,0.368061813141798,0,9,regulation of catecholamine metabolic process,BP,
9839,GO:0042090,1,0.55853554859468,0,5,interleukin-12 biosynthetic process,BP,
9858,GO:0042117,1,0.559313004727479,0,5,monocyte activation,BP,
9859,GO:0042118,1,0.444760316757237,0,7,endothelial cell activation,BP,
9861,GO:0042126,1,0.627947461872337,0,4,nitrate metabolic process,BP,
9875,GO:0042148,1,0.40768292438833,0,8,strand invasion,BP,
9880,GO:0042162,1,0.0174886997842898,0,35,telomeric DNA binding,MF,
9882,GO:0042166,1,0.559666314452407,0,5,acetylcholine binding,MF,
9883,GO:0042167,1,0.606621611906653,0,5,heme catabolic process,BP,
9901,GO:0042228,1,0.448559419514382,0,7,interleukin-8 biosynthetic process,BP,
9911,GO:0042256,1,0.593529384805153,0,5,mature ribosome assembly,BP,
9916,GO:0042268,1,0.552255202532828,0,6,regulation of cytolysis,BP,
9935,GO:0042296,1,0.654203076605201,0,4,ISG15 transferase activity,MF,
9961,GO:0042354,1,0.49698202295828,0,6,L-fucose metabolic process,BP,
9962,GO:0042355,1,0.49698202295828,0,6,L-fucose catabolic process,BP,
9975,GO:0042373,1,0.604147184527705,0,5,vitamin K metabolic process,BP,
9979,GO:0042379,1,0.11062345566971,0,23,chemokine receptor binding,MF,
9980,GO:0042382,1,0.499480322645406,0,6,paraspeckles,CC,
9983,GO:0042392,1,0.571209085170902,0,5,sphingosine-1-phosphate phosphatase activity,MF,
9988,GO:0042403,1,0.313197610571219,0,10,thyroid hormone metabolic process,BP,
9990,GO:0042406,1,0.634527952983635,0,4,extrinsic component of endoplasmic reticulum membrane,CC,
9998,GO:0042420,1,0.636048890792832,0,4,dopamine catabolic process,BP,
10001,GO:0042424,1,0.566075344923699,0,5,catecholamine catabolic process,BP,
10003,GO:0042428,1,0.628053188624617,0,4,serotonin metabolic process,BP,
10004,GO:0042430,1,0.405102938969894,0,8,indole-containing compound metabolic process,BP,
10012,GO:0042447,1,0.508424895529469,0,6,hormone catabolic process,BP,
10030,GO:0042487,1,0.562396793440167,0,5,regulation of odontogenesis of dentin-containing tooth,BP,
10044,GO:0042532,1,0.28603483906966,0,11,negative regulation of tyrosine phosphorylation of STAT protein,BP,
10047,GO:0042535,1,0.649712595319392,0,4,positive regulation of tumor necrosis factor biosynthetic process,BP,
10049,GO:0042537,1,0.30348696485527,0,11,benzene-containing compound metabolic process,BP,
10050,GO:0042538,1,0.568268553890084,0,5,hyperosmotic salinity response,BP,
10052,GO:0042541,1,0.505939878761607,0,6,hemoglobin biosynthetic process,BP,
10059,GO:0042555,1,0.277530880022566,0,11,MCM complex,CC,
10069,GO:0042573,1,0.334725499961097,0,10,retinoic acid metabolic process,BP,
10070,GO:0042574,1,0.400168617648477,0,8,retinal metabolic process,BP,
10077,GO:0042583,1,0.500533347142514,0,6,chromaffin granule,CC,
10078,GO:0042584,1,0.630282608289271,0,4,chromaffin granule membrane,CC,
10081,GO:0042587,1,0.572171624637013,0,5,glycogen granule,CC,
10090,GO:0042599,1,0.304170148749851,0,11,lamellar body,CC,
10099,GO:0042622,1,0.499908344440653,0,6,photoreceptor outer segment membrane,CC,
10106,GO:0042629,1,0.302079580938718,0,11,mast cell granule,CC,
10110,GO:0042634,1,0.0757772541724751,0,23,regulation of hair cycle,BP,
10111,GO:0042635,1,0.307298576021321,0,11,positive regulation of hair cycle,BP,
10112,GO:0042636,1,0.627449537468743,0,4,negative regulation of hair cycle,BP,
10113,GO:0042637,1,0.653910822247441,0,4,catagen,BP,
10114,GO:0042640,1,0.627449537468743,0,4,anagen,BP,
10129,GO:0042693,1,0.506171134357254,0,6,muscle cell fate commitment,BP,
10137,GO:0042711,1,0.444525808886331,0,7,maternal behavior,BP,
10139,GO:0042719,1,0.621778447075194,0,5,mitochondrial intermembrane space protein transporter complex,CC,
10141,GO:0042721,1,0.605372571095228,0,5,mitochondrial inner membrane protein insertion complex,CC,
10147,GO:0042731,1,0.643059917103825,0,4,PH domain binding,MF,
10161,GO:0042753,1,0.498873661779055,0,6,positive regulation of circadian rhythm,BP,
10163,GO:0042755,1,0.23715503221805,0,13,eating behavior,BP,
10168,GO:0042761,1,0.323510740779335,0,10,very long-chain fatty acid biosynthetic process,BP,
10170,GO:0042765,1,0.563339160646453,0,5,GPI-anchor transamidase complex,CC,
10181,GO:0042780,1,0.462035686155324,0,7,tRNA 3'-end processing,BP,
10183,GO:0042788,1,0.0897765511993846,0,29,polysomal ribosome,CC,
10184,GO:0042789,1,0.208828637136755,0,14,mRNA transcription by RNA polymerase II,BP,
10185,GO:0042790,1,0.255797522796965,0,12,nucleolar large rRNA transcription by RNA polymerase I,BP,
10186,GO:0042791,1,0.513569363932843,0,6,5S class rRNA transcription by RNA polymerase III,BP,
10188,GO:0042796,1,0.502004268156268,0,6,snRNA transcription by RNA polymerase III,BP,
10189,GO:0042797,1,0.513569363932843,0,6,tRNA transcription by RNA polymerase III,BP,
10190,GO:0042799,1,0.627449537468743,0,4,histone methyltransferase activity (H4-K20 specific),MF,
10196,GO:0042809,1,0.182761766641459,0,15,vitamin D receptor binding,MF,
10203,GO:0042824,1,0.630066847458165,0,4,MHC class I peptide loading complex,CC,
10207,GO:0042832,1,0.373626498689642,0,9,defense response to protozoan,BP,
10224,GO:0042921,1,0.199121321700842,0,14,glucocorticoid receptor signaling pathway,BP,
10236,GO:0042974,1,0.110843910413251,0,19,retinoic acid receptor binding,MF,
10238,GO:0042976,1,0.475604599328659,0,7,activation of Janus kinase activity,BP,
10252,GO:0042996,1,0.558572784113034,0,5,regulation of Golgi to plasma membrane protein transport,BP,
10271,GO:0043023,1,0.305185369770899,0,11,ribosomal large subunit binding,MF,
10272,GO:0043024,1,0.213309082869084,0,14,ribosomal small subunit binding,MF,
10279,GO:0043032,1,0.287751682357476,0,11,positive regulation of macrophage activation,BP,
10290,GO:0043047,1,0.281495537843706,0,11,single-stranded telomeric DNA binding,MF,
10312,GO:0043102,1,0.514706363824922,0,6,amino acid salvage,BP,
10334,GO:0043137,1,0.649847611622503,0,4,DNA replication, removal of RNA primer,BP,
10335,GO:0043138,1,0.253767862229124,0,12,3'-5' DNA helicase activity,MF,
10336,GO:0043139,1,0.45168241940759,0,7,5'-3' DNA helicase activity,MF,
10337,GO:0043140,1,0.442297753202712,0,7,ATP-dependent 3'-5' DNA helicase activity,MF,
10338,GO:0043141,1,0.569368293120896,0,5,ATP-dependent 5'-3' DNA helicase activity,MF,
10339,GO:0043142,1,0.226746302758398,0,13,single-stranded DNA-dependent ATPase activity,MF,
10340,GO:0043144,1,0.454144724360304,0,8,snoRNA processing,BP,
10365,GO:0043189,1,0.117757575526362,0,19,H4/H2A histone acetyltransferase complex,CC,
10379,GO:0043208,1,0.63007561927728,0,4,glycosphingolipid binding,MF,
10387,GO:0043225,1,0.393626380044218,0,8,ATPase-coupled anion transmembrane transporter activity,MF,
10399,GO:0043240,1,0.279497714282943,0,11,Fanconi anaemia nuclear complex,CC,
10433,GO:0043295,1,0.321268031437291,0,11,glutathione binding,MF,
10455,GO:0043320,1,0.501873400428871,0,6,natural killer cell degranulation,BP,
10460,GO:0043328,1,0.678698447820375,0,4,protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,BP,
10465,GO:0043353,1,0.497893233435276,0,6,enucleate erythrocyte differentiation,BP,
10478,GO:0043379,1,0.576583709854335,0,5,memory T cell differentiation,BP,
10479,GO:0043380,1,0.647855189433958,0,4,regulation of memory T cell differentiation,BP,
10505,GO:0043415,1,0.637638534325753,0,4,positive regulation of skeletal muscle tissue regeneration,BP,
10506,GO:0043416,1,0.637638534325753,0,4,regulation of skeletal muscle tissue regeneration,BP,
10517,GO:0043455,1,0.401520105306973,0,8,regulation of secondary metabolic process,BP,
10518,GO:0043456,1,0.640027952410205,0,4,regulation of pentose-phosphate shunt,BP,
10525,GO:0043471,1,0.362768679040059,0,9,regulation of cellular carbohydrate catabolic process,BP,
10557,GO:0043522,1,0.336508765373398,0,10,leucine zipper domain binding,MF,
10561,GO:0043527,1,0.577476916183304,0,5,tRNA methyltransferase complex,CC,
10575,GO:0043545,1,0.453429799717745,0,7,molybdopterin cofactor metabolic process,BP,
10588,GO:0043562,1,0.354490576982915,0,10,cellular response to nitrogen levels,BP,
10593,GO:0043569,1,0.627449537468743,0,4,negative regulation of insulin-like growth factor receptor signaling pathway,BP,
10594,GO:0043570,1,0.627449537468743,0,4,maintenance of DNA repeat elements,BP,
10602,GO:0043587,1,0.402464508964041,0,8,tongue morphogenesis,BP,
10619,GO:0043622,1,0.627449537468743,0,4,cortical microtubule organization,BP,
10624,GO:0043628,1,0.057996621656981,0,27,ncRNA 3'-end processing,BP,
10629,GO:0043633,1,0.424607037572003,0,8,polyadenylation-dependent RNA catabolic process,BP,
10630,GO:0043634,1,0.477106022489083,0,7,polyadenylation-dependent ncRNA catabolic process,BP,
10634,GO:0043650,1,0.394467702952723,0,8,dicarboxylic acid biosynthetic process,BP,
10639,GO:0043656,1,0.445692076958823,0,7,intracellular region of host,CC,
10650,GO:0043734,1,0.655490491796313,0,4,DNA-N1-methyladenine dioxygenase activity,MF,
10671,GO:0043923,1,0.160007564112703,0,16,positive regulation by host of viral transcription,BP,
10672,GO:0043928,1,0.0332241028669755,0,33,exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,BP,
10684,GO:0043968,1,0.165946276852653,0,16,histone H2A acetylation,BP,
10686,GO:0043970,1,0.227264173249068,0,13,histone H3-K9 acetylation,BP,
10693,GO:0043984,1,0.112046046463607,0,19,histone H4-K16 acetylation,BP,
10694,GO:0043985,1,0.504882343061564,0,6,histone H4-R3 methylation,BP,
10699,GO:0043995,1,0.313339940283365,0,10,histone acetyltransferase activity (H4-K5 specific),MF,
10700,GO:0043996,1,0.313339940283365,0,10,histone acetyltransferase activity (H4-K8 specific),MF,
10706,GO:0044020,1,0.637422119624279,0,4,histone methyltransferase activity (H4-R3 specific),MF,
10736,GO:0044110,1,0.521413659759053,0,6,growth involved in symbiotic interaction,BP,
10739,GO:0044116,1,0.521413659759053,0,6,growth of symbiont involved in interaction with host,BP,
10740,GO:0044117,1,0.521413659759053,0,6,growth of symbiont in host,BP,
10741,GO:0044126,1,0.572248632274808,0,5,regulation of growth of symbiont in host,BP,
10743,GO:0044130,1,0.642984669916188,0,4,negative regulation of growth of symbiont in host,BP,
10744,GO:0044144,1,0.572248632274808,0,5,modulation of growth of symbiont involved in interaction with host,BP,
10746,GO:0044146,1,0.642984669916188,0,4,negative regulation of growth of symbiont involved in interaction with host,BP,
10749,GO:0044154,1,0.395820778856116,0,8,histone H3-K14 acetylation,BP,
10773,GO:0044233,1,0.25840620386849,0,12,ER-mitochondrion membrane contact site,CC,
10799,GO:0044292,1,0.324483868217878,0,10,dendrite terminus,CC,
10800,GO:0044294,1,0.442426589648313,0,7,dendritic growth cone,CC,
10801,GO:0044295,1,0.101878737444017,0,20,axonal growth cone,CC,
10815,GO:0044314,1,0.674977177224973,0,4,protein K27-linked ubiquitination,BP,
10846,GO:0044352,1,0.633327612591056,0,4,pinosome,CC,
10847,GO:0044354,1,0.633327612591056,0,4,macropinosome,CC,
10850,GO:0044359,1,0.519123404414988,0,6,modulation of molecular function in other organism,BP,
10851,GO:0044362,1,0.583297802072998,0,5,negative regulation of molecular function in other organism,BP,
10852,GO:0044364,1,0.174945940341561,0,19,disruption of cells of other organism,BP,
10858,GO:0044388,1,0.599094313907903,0,5,small protein activating enzyme binding,MF,
10872,GO:0044417,1,0.370058189762263,0,9,translocation of molecules into host,BP,
10912,GO:0044528,1,0.630272935396216,0,4,regulation of mitochondrial mRNA stability,BP,
10919,GO:0044545,1,0.56126440158594,0,5,NSL complex,CC,
10921,GO:0044547,1,0.559340986144379,0,5,DNA topoisomerase binding,MF,
10927,GO:0044571,1,0.680601492664566,0,4,[2Fe-2S] cluster assembly,BP,
10940,GO:0044613,1,0.266837210525798,0,12,nuclear pore central transport channel,CC,
10941,GO:0044614,1,0.627449537916142,0,4,nuclear pore cytoplasmic filaments,CC,
10942,GO:0044615,1,0.353602847337015,0,9,nuclear pore nuclear basket,CC,
10967,GO:0044754,1,0.430858772743551,0,8,autolysosome,CC,
10980,GO:0044784,1,0.00419900370504221,0,49,metaphase/anaphase transition of cell cycle,BP,
10986,GO:0044793,1,0.628019556399331,0,4,negative regulation by host of viral process,BP,
10995,GO:0044806,1,0.442306165853901,0,7,G-quadruplex DNA unwinding,BP,
11001,GO:0044828,1,0.628019556399331,0,4,negative regulation by host of viral genome replication,BP,
11004,GO:0044837,1,0.443527241183868,0,7,actomyosin contractile ring organization,BP,
11007,GO:0044848,1,0.410232517666479,0,8,biological phase,BP,
11009,GO:0044851,1,0.410232517666479,0,8,hair cycle phase,BP,
11011,GO:0044854,1,0.632077476756339,0,4,plasma membrane raft assembly,BP,
11014,GO:0044857,1,0.632077476756339,0,4,plasma membrane raft organization,BP,
11016,GO:0044860,1,0.630420462706224,0,4,protein localization to plasma membrane raft,BP,
11021,GO:0044878,1,0.645763378875223,0,4,mitotic cytokinesis checkpoint,BP,
11022,GO:0045002,1,0.444152306097288,0,7,double-strand break repair via single-strand annealing,BP,
11023,GO:0045003,1,0.32289116890521,0,10,double-strand break repair via synthesis-dependent strand annealing,BP,
11029,GO:0045009,1,0.526752231509104,0,6,chitosome,CC,
11039,GO:0045028,1,0.56737067553382,0,5,G-protein coupled purinergic nucleotide receptor activity,MF,
11042,GO:0045039,1,0.569101730922396,0,6,protein import into mitochondrial inner membrane,BP,
11043,GO:0045040,1,0.558120486184506,0,6,protein import into mitochondrial outer membrane,BP,
11045,GO:0045046,1,0.499598381957108,0,6,protein import into peroxisome membrane,BP,
11046,GO:0045047,1,0.000221674170847127,0,101,protein targeting to ER,BP,
11047,GO:0045048,1,0.56704327449831,0,5,protein insertion into ER membrane,BP,
11067,GO:0045075,1,0.55853554859468,0,5,regulation of interleukin-12 biosynthetic process,BP,
11084,GO:0045095,1,0.0753768750818084,0,23,keratin filament,CC,
11090,GO:0045110,1,0.501644550466603,0,6,intermediate filament bundle assembly,BP,
11094,GO:0045116,1,0.244638172954556,0,14,protein neddylation,BP,
11096,GO:0045120,1,0.249531009632985,0,12,pronucleus,CC,
11111,GO:0045144,1,0.578055318306487,0,5,meiotic sister chromatid segregation,BP,
11162,GO:0045236,1,0.476240046707698,0,7,CXCR chemokine receptor binding,MF,
11177,GO:0045277,1,0.431482856778353,0,11,respiratory chain complex IV,CC,
11181,GO:0045292,1,0.166055327860052,0,16,mRNA cis splicing, via spliceosome,BP,
11183,GO:0045294,1,0.312339077329,0,10,alpha-catenin binding,MF,
11184,GO:0045295,1,0.311752070884584,0,10,gamma-catenin binding,MF,
11187,GO:0045298,1,0.651539566292413,0,4,tubulin complex,CC,
11192,GO:0045324,1,0.303068694573192,0,11,late endosome to vacuole transport,BP,
11193,GO:0045329,1,0.561213271922104,0,5,carnitine biosynthetic process,BP,
11199,GO:0045338,1,0.63709275576367,0,4,farnesyl diphosphate metabolic process,BP,
11201,GO:0045341,1,0.627449537468743,0,4,MHC class I biosynthetic process,BP,
11202,GO:0045342,1,0.567080796516431,0,5,MHC class II biosynthetic process,BP,
11203,GO:0045343,1,0.627449537468743,0,4,regulation of MHC class I biosynthetic process,BP,
11204,GO:0045345,1,0.627449537468743,0,4,positive regulation of MHC class I biosynthetic process,BP,
11205,GO:0045346,1,0.567080796516431,0,5,regulation of MHC class II biosynthetic process,BP,
11208,GO:0045349,1,0.641987613860447,0,4,interferon-alpha biosynthetic process,BP,
11209,GO:0045350,1,0.508662216827154,0,6,interferon-beta biosynthetic process,BP,
11210,GO:0045351,1,0.408105136640617,0,8,type I interferon biosynthetic process,BP,
11213,GO:0045354,1,0.641987613860447,0,4,regulation of interferon-alpha biosynthetic process,BP,
11216,GO:0045357,1,0.508662216827154,0,6,regulation of interferon-beta biosynthetic process,BP,
11218,GO:0045359,1,0.627454881125093,0,4,positive regulation of interferon-beta biosynthetic process,BP,
11229,GO:0045414,1,0.5040172529457,0,6,regulation of interleukin-8 biosynthetic process,BP,
11239,GO:0045448,1,0.636501623204643,0,4,mitotic cell cycle, embryonic,BP,
11257,GO:0045545,1,0.563001291212045,0,5,syndecan binding,MF,
11258,GO:0045569,1,0.642127605534472,0,4,TRAIL binding,MF,
11284,GO:0045605,1,0.317631176744454,0,10,negative regulation of epidermal cell differentiation,BP,
11286,GO:0045607,1,0.577290340504065,0,5,regulation of inner ear auditory receptor cell differentiation,BP,
11289,GO:0045617,1,0.49916789478035,0,6,negative regulation of keratinocyte differentiation,BP,
11303,GO:0045631,1,0.577290340504065,0,5,regulation of mechanoreceptor differentiation,BP,
11304,GO:0045632,1,0.648649098432387,0,4,negative regulation of mechanoreceptor differentiation,BP,
11305,GO:0045634,1,0.565073080841565,0,5,regulation of melanocyte differentiation,BP,
11315,GO:0045649,1,0.281582312905656,0,11,regulation of macrophage differentiation,BP,
11317,GO:0045651,1,0.352225900877329,0,9,positive regulation of macrophage differentiation,BP,
11319,GO:0045653,1,0.332733617337753,0,17,negative regulation of megakaryocyte differentiation,BP,
11340,GO:0045683,1,0.223861026584842,0,13,negative regulation of epidermis development,BP,
11345,GO:0045713,1,0.454520793745581,0,7,low-density lipoprotein particle receptor biosynthetic process,BP,
11346,GO:0045714,1,0.508160072639204,0,6,regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
11350,GO:0045719,1,0.559217044430059,0,5,negative regulation of glycogen biosynthetic process,BP,
11351,GO:0045721,1,0.444137340060759,0,7,negative regulation of gluconeogenesis,BP,
11360,GO:0045736,1,0.0530995930687025,0,26,negative regulation of cyclin-dependent protein serine/threonine kinase activity,BP,
11384,GO:0045777,1,0.242809047615683,0,13,positive regulation of blood pressure,BP,
11392,GO:0045793,1,0.356219111469501,0,9,positive regulation of cell size,BP,
11404,GO:0045822,1,0.323471048935194,0,10,negative regulation of heart contraction,BP,
11411,GO:0045835,1,0.497738671649227,0,6,negative regulation of meiotic nuclear division,BP,
11417,GO:0045841,1,0.0338386613572353,0,30,negative regulation of mitotic metaphase/anaphase transition,BP,
11418,GO:0045842,1,0.417221306193947,0,8,positive regulation of mitotic metaphase/anaphase transition,BP,
11430,GO:0045875,1,0.578462695883589,0,5,negative regulation of sister chromatid cohesion,BP,
11431,GO:0045876,1,0.320348832264883,0,10,positive regulation of sister chromatid cohesion,BP,
11437,GO:0045898,1,0.237526044616184,0,13,regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,
11438,GO:0045899,1,0.336897828668134,0,10,positive regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,
11439,GO:0045900,1,0.639177189466457,0,4,negative regulation of translational elongation,BP,
11450,GO:0045915,1,0.586172626018232,0,5,positive regulation of catecholamine metabolic process,BP,
11454,GO:0045919,1,0.65232663978337,0,4,positive regulation of cytolysis,BP,
11480,GO:0045954,1,0.407833194795242,0,8,positive regulation of natural killer cell mediated cytotoxicity,BP,
11481,GO:0045955,1,0.444566473433184,0,7,negative regulation of calcium ion-dependent exocytosis,BP,
11484,GO:0045964,1,0.586172626018232,0,5,positive regulation of dopamine metabolic process,BP,
11486,GO:0045974,1,0.257800651500524,0,12,regulation of translation, ncRNA-mediated,BP,
11495,GO:0045990,1,0.637651026848987,0,4,carbon catabolite regulation of transcription,BP,
11496,GO:0045991,1,0.637651026848987,0,4,carbon catabolite activation of transcription,BP,
11503,GO:0046015,1,0.643087850651192,0,4,regulation of transcription by glucose,BP,
11515,GO:0046040,1,0.255646614176402,0,12,IMP metabolic process,BP,
11534,GO:0046075,1,0.662261753373343,0,4,dTTP metabolic process,BP,
11536,GO:0046078,1,0.645247580440056,0,4,dUMP metabolic process,BP,
11546,GO:0046098,1,0.639651970742118,0,4,guanine metabolic process,BP,
11576,GO:0046149,1,0.606621611906653,0,5,pigment catabolic process,BP,
11625,GO:0046341,1,0.199398271816336,0,14,CDP-diacylglycerol metabolic process,BP,
11627,GO:0046349,1,0.284412625889099,0,11,amino sugar biosynthetic process,BP,
11641,GO:0046385,1,0.346257763932611,0,10,deoxyribose phosphate biosynthetic process,BP,
11662,GO:0046449,1,0.627449537468743,0,4,creatinine metabolic process,BP,
11675,GO:0046469,1,0.567980505613599,0,5,platelet activating factor metabolic process,BP,
11681,GO:0046476,1,0.565785271954653,0,5,glycosylceramide biosynthetic process,BP,
11686,GO:0046485,1,0.458882776935479,0,7,ether lipid metabolic process,BP,
11702,GO:0046504,1,0.57534786197682,0,5,glycerol ether biosynthetic process,BP,
11713,GO:0046527,1,0.205270374701322,0,14,glucosyltransferase activity,MF,
11715,GO:0046532,1,0.559345989946256,0,5,regulation of photoreceptor cell differentiation,BP,
11716,GO:0046533,1,0.628488354171539,0,4,negative regulation of photoreceptor cell differentiation,BP,
11719,GO:0046540,1,0.0809776994373625,0,24,U4/U6 x U5 tri-snRNP complex,CC,
11734,GO:0046581,1,0.629470704728874,0,4,intercellular canaliculus,CC,
11741,GO:0046598,1,0.534705823197095,0,6,positive regulation of viral entry into host cell,BP,
11742,GO:0046599,1,0.145056624952711,0,17,regulation of centriole replication,BP,
11743,GO:0046600,1,0.407436131996846,0,8,negative regulation of centriole replication,BP,
11745,GO:0046602,1,0.408499871569206,0,8,regulation of mitotic centrosome separation,BP,
11748,GO:0046606,1,0.236702843128764,0,13,negative regulation of centrosome cycle,BP,
11749,GO:0046607,1,0.363362519747479,0,9,positive regulation of centrosome cycle,BP,
11764,GO:0046633,1,0.236335499881684,0,13,alpha-beta T cell proliferation,BP,
11771,GO:0046640,1,0.296118208915594,0,11,regulation of alpha-beta T cell proliferation,BP,
11772,GO:0046641,1,0.470507970273964,0,7,positive regulation of alpha-beta T cell proliferation,BP,
11803,GO:0046703,1,0.421722797710293,0,9,natural killer cell lectin-like receptor binding,MF,
11814,GO:0046719,1,0.46446034291833,0,7,regulation by virus of viral protein levels in host cell,BP,
11817,GO:0046726,1,0.627449537468743,0,4,positive regulation by virus of viral protein levels in host cell,BP,
11825,GO:0046784,1,0.415667679108089,0,8,viral mRNA export from host cell nucleus,BP,
11837,GO:0046826,1,0.493990310909865,0,7,negative regulation of protein export from nucleus,BP,
11839,GO:0046831,1,0.174708467458807,0,15,regulation of RNA export from nucleus,BP,
11841,GO:0046833,1,0.443266912203898,0,7,positive regulation of RNA export from nucleus,BP,
11844,GO:0046836,1,0.580417898805287,0,5,glycolipid transport,BP,
11845,GO:0046838,1,0.316448905106873,0,10,phosphorylated carbohydrate dephosphorylation,BP,
11854,GO:0046855,1,0.316448905106873,0,10,inositol phosphate dephosphorylation,BP,
11866,GO:0046884,1,0.628404657034227,0,4,follicle-stimulating hormone secretion,BP,
11886,GO:0046920,1,0.560539193098256,0,5,alpha-(1->3)-fucosyltransferase activity,MF,
11893,GO:0046931,1,0.18554414061584,0,15,pore complex assembly,BP,
11898,GO:0046940,1,0.572532981903265,0,5,nucleoside monophosphate phosphorylation,BP,
11912,GO:0046965,1,0.28095519174381,0,11,retinoid X receptor binding,MF,
11918,GO:0046972,1,0.313339940283365,0,10,histone acetyltransferase activity (H4-K16 specific),MF,
11919,GO:0046974,1,0.558423349560734,0,5,histone methyltransferase activity (H3-K9 specific),MF,
11920,GO:0046975,1,0.502633328412853,0,6,histone methyltransferase activity (H3-K36 specific),MF,
11921,GO:0046976,1,0.559165534952464,0,5,histone methyltransferase activity (H3-K27 specific),MF,
11922,GO:0046977,1,0.639862625821932,0,4,TAP binding,MF,
11923,GO:0046978,1,0.639862625821932,0,4,TAP1 binding,MF,
11928,GO:0046984,1,0.637786202703882,0,4,regulation of hemoglobin biosynthetic process,BP,
11951,GO:0047134,1,0.600087439474293,0,5,protein-disulfide reductase activity,MF,
11984,GO:0047372,1,0.35423329438311,0,9,acylglycerol lipase activity,MF,
11995,GO:0047484,1,0.510378702280901,0,6,regulation of response to osmotic stress,BP,
11999,GO:0047497,1,0.121978949833719,0,19,mitochondrion transport along microtubule,BP,
12000,GO:0047498,1,0.497020810323213,0,6,calcium-dependent phospholipase A2 activity,MF,
12005,GO:0047555,1,0.627449537468743,0,4,3',5'-cyclic-GMP phosphodiesterase activity,MF,
12060,GO:0048019,1,0.331502265030589,0,10,receptor antagonist activity,MF,
12061,GO:0048020,1,0.446655055371521,0,9,CCR chemokine receptor binding,MF,
12066,GO:0048025,1,0.143323562746134,0,17,negative regulation of mRNA splicing, via spliceosome,BP,
12067,GO:0048026,1,0.255103046254365,0,12,positive regulation of mRNA splicing, via spliceosome,BP,
12068,GO:0048027,1,0.10887887875936,0,22,mRNA 5'-UTR binding,MF,
12075,GO:0048039,1,0.527703959138143,0,6,ubiquinone binding,MF,
12087,GO:0048096,1,0.406195995578046,0,8,chromatin-mediated maintenance of transcription,BP,
12099,GO:0048149,1,0.630529963074671,0,4,behavioral response to ethanol,BP,
12116,GO:0048200,1,0.506029851794699,0,6,Golgi transport vesicle coating,BP,
12118,GO:0048205,1,0.506029851794699,0,6,COPI coating of Golgi vesicle,BP,
12125,GO:0048227,1,0.414306913281923,0,8,plasma membrane to endosome transport,BP,
12132,GO:0048245,1,0.651342037852334,0,4,eosinophil chemotaxis,BP,
12137,GO:0048254,1,0.658301402467037,0,4,snoRNA localization,BP,
12139,GO:0048256,1,0.394195223912872,0,8,flap endonuclease activity,MF,
12144,GO:0048262,1,0.579445129930666,0,5,determination of dorsal/ventral asymmetry,BP,
12145,GO:0048263,1,0.651070032690972,0,4,determination of dorsal identity,BP,
12152,GO:0048273,1,0.505079987284555,0,6,mitogen-activated protein kinase p38 binding,MF,
12154,GO:0048280,1,0.326281821825695,0,10,vesicle fusion with Golgi apparatus,BP,
12160,GO:0048291,1,0.398163348389241,0,8,isotype switching to IgG isotypes,BP,
12167,GO:0048302,1,0.447079582063212,0,7,regulation of isotype switching to IgG isotypes,BP,
12168,GO:0048304,1,0.564457615616936,0,5,positive regulation of isotype switching to IgG isotypes,BP,
12172,GO:0048311,1,0.195580713061762,0,14,mitochondrion distribution,BP,
12173,GO:0048312,1,0.49698202295828,0,6,intracellular distribution of mitochondria,BP,
12175,GO:0048318,1,0.595365582803194,0,5,axial mesoderm development,BP,
12183,GO:0048341,1,0.627449537468743,0,4,paraxial mesoderm formation,BP,
12195,GO:0048384,1,0.0920433543598256,0,21,retinoic acid receptor signaling pathway,BP,
12196,GO:0048385,1,0.290448692828853,0,11,regulation of retinoic acid receptor signaling pathway,BP,
12197,GO:0048386,1,0.628651075342683,0,4,positive regulation of retinoic acid receptor signaling pathway,BP,
12198,GO:0048387,1,0.564071212884526,0,5,negative regulation of retinoic acid receptor signaling pathway,BP,
12212,GO:0048476,1,0.588171939418043,0,5,Holliday junction resolvase complex,CC,
12214,GO:0048478,1,0.455848418127736,0,7,replication fork protection,BP,
12219,GO:0048487,1,0.0308296597832519,0,32,beta-tubulin binding,MF,
12223,GO:0048495,1,0.631110427681067,0,4,Roundabout binding,MF,
12226,GO:0048500,1,0.38663149071832,0,9,signal recognition particle,CC,
12235,GO:0048520,1,0.627449537468743,0,4,positive regulation of behavior,BP,
12252,GO:0048548,1,0.355310188196931,0,9,regulation of pinocytosis,BP,
12253,GO:0048549,1,0.627803003383896,0,4,positive regulation of pinocytosis,BP,
12254,GO:0048550,1,0.566074913535251,0,5,negative regulation of pinocytosis,BP,
12255,GO:0048557,1,0.447868891295206,0,7,embryonic digestive tract morphogenesis,BP,
12264,GO:0048570,1,0.567758182802622,0,5,notochord morphogenesis,BP,
12302,GO:0048663,1,0.0721577559605601,0,23,neuron fate commitment,BP,
12304,GO:0048665,1,0.446584397123287,0,7,neuron fate specification,BP,
12317,GO:0048680,1,0.64807788940096,0,4,positive regulation of axon regeneration,BP,
12330,GO:0048702,1,0.442469888940027,0,7,embryonic neurocranium morphogenesis,BP,
12331,GO:0048703,1,0.447574059341957,0,7,embryonic viscerocranium morphogenesis,BP,
12340,GO:0048713,1,0.071602020542655,0,23,regulation of oligodendrocyte differentiation,BP,
12341,GO:0048714,1,0.249300485650647,0,12,positive regulation of oligodendrocyte differentiation,BP,
12342,GO:0048715,1,0.408040948417969,0,8,negative regulation of oligodendrocyte differentiation,BP,
12347,GO:0048733,1,0.558994677275426,0,5,sebaceous gland development,BP,
12371,GO:0048787,1,0.559552205241183,0,5,presynaptic active zone membrane,CC,
12374,GO:0048793,1,0.627449537468743,0,4,pronephros development,BP,
12382,GO:0048818,1,0.653910822247441,0,4,positive regulation of hair follicle maturation,BP,
12383,GO:0048819,1,0.410232517666479,0,8,regulation of hair follicle maturation,BP,
12384,GO:0048820,1,0.181726949763807,0,15,hair follicle maturation,BP,
12388,GO:0048840,1,0.627466036273652,0,4,otolith development,BP,
12397,GO:0048853,1,0.446440026242858,0,7,forebrain morphogenesis,BP,
12404,GO:0048861,1,0.633005693349448,0,4,leukemia inhibitory factor signaling pathway,BP,
12423,GO:0048934,1,0.501849808700662,0,6,peripheral nervous system neuron differentiation,BP,
12424,GO:0048935,1,0.501849808700662,0,6,peripheral nervous system neuron development,BP,
12431,GO:0050072,1,0.457856037229348,0,7,m7G(5')pppN diphosphatase activity,MF,
12440,GO:0050145,1,0.572532981903265,0,5,nucleoside phosphate kinase activity,MF,
12447,GO:0050220,1,0.662852047820495,0,4,prostaglandin-E synthase activity,MF,
12472,GO:0050428,1,0.499548567501526,0,6,3'-phosphoadenosine 5'-phosphosulfate biosynthetic process,BP,
12475,GO:0050433,1,0.239841469015631,0,13,regulation of catecholamine secretion,BP,
12489,GO:0050542,1,0.702132305902253,0,4,icosanoid binding,MF,
12490,GO:0050543,1,0.702132305902253,0,4,icosatetraenoic acid binding,MF,
12491,GO:0050544,1,0.702132305902253,0,4,arachidonic acid binding,MF,
12515,GO:0050664,1,0.520916730012493,0,6,oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor,MF,
12516,GO:0050665,1,0.337676495993158,0,10,hydrogen peroxide biosynthetic process,BP,
12530,GO:0050685,1,0.0901368754076136,0,21,positive regulation of mRNA processing,BP,
12531,GO:0050686,1,0.0446187061091732,0,27,negative regulation of mRNA processing,BP,
12534,GO:0050689,1,0.575261338009457,0,5,negative regulation of defense response to virus by host,BP,
12545,GO:0050703,1,0.613033014845636,0,5,interleukin-1 alpha secretion,BP,
12547,GO:0050705,1,0.656505123501763,0,4,regulation of interleukin-1 alpha secretion,BP,
12555,GO:0050713,1,0.582632925178506,0,5,negative regulation of interleukin-1 beta secretion,BP,
12570,GO:0050733,1,0.631549357362309,0,4,RS domain binding,MF,
12571,GO:0050746,1,0.412822502116381,0,8,regulation of lipoprotein metabolic process,BP,
12572,GO:0050747,1,0.585492480983185,0,5,positive regulation of lipoprotein metabolic process,BP,
12617,GO:0050811,1,0.378261114264696,0,9,GABA receptor binding,MF,
12619,GO:0050815,1,0.515955194639918,0,6,phosphoserine residue binding,MF,
12634,GO:0050847,1,0.446404497217582,0,7,progesterone receptor signaling pathway,BP,
12642,GO:0050855,1,0.248937001285573,0,12,regulation of B cell receptor signaling pathway,BP,
12648,GO:0050861,1,0.629117695961213,0,4,positive regulation of B cell receptor signaling pathway,BP,
12666,GO:0050882,1,0.497958847863467,0,6,voluntary musculoskeletal movement,BP,
12681,GO:0050907,1,0.279185397354686,0,13,detection of chemical stimulus involved in sensory perception,BP,
12686,GO:0050912,1,0.416311651181556,0,9,detection of chemical stimulus involved in sensory perception of taste,BP,
12705,GO:0050932,1,0.447567146101543,0,7,regulation of pigment cell differentiation,BP,
12706,GO:0050942,1,0.558421378043368,0,5,positive regulation of pigment cell differentiation,BP,
12729,GO:0051001,1,0.654081626852145,0,4,negative regulation of nitric-oxide synthase activity,BP,
12734,GO:0051011,1,0.311752070884584,0,10,microtubule minus-end binding,MF,
12736,GO:0051013,1,0.503086715252355,0,6,microtubule severing,BP,
12746,GO:0051023,1,0.36927760794063,0,9,regulation of immunoglobulin secretion,BP,
12747,GO:0051024,1,0.648202198627677,0,4,positive regulation of immunoglobulin secretion,BP,
12749,GO:0051026,1,0.634618668985552,0,4,chiasma assembly,BP,
12752,GO:0051030,1,0.656005423663954,0,4,snRNA transport,BP,
12756,GO:0051036,1,0.574724982770778,0,5,regulation of endosome size,BP,
12775,GO:0051059,1,0.050016013054997,0,27,NF-kappaB binding,MF,
12781,GO:0051084,1,0.0262585556351813,0,32,'de novo' posttranslational protein folding,BP,
12782,GO:0051085,1,0.0462279739303584,0,27,chaperone cofactor-dependent protein refolding,BP,
12792,GO:0051095,1,0.3690152779649,0,9,regulation of helicase activity,BP,
12793,GO:0051096,1,0.520842988947229,0,6,positive regulation of helicase activity,BP,
12800,GO:0051103,1,0.291681946161916,0,11,DNA ligation involved in DNA repair,BP,
12801,GO:0051105,1,0.498760195946255,0,6,regulation of DNA ligation,BP,
12802,GO:0051106,1,0.56041920556964,0,5,positive regulation of DNA ligation,BP,
12809,GO:0051123,1,0.0456556124518887,0,28,RNA polymerase II transcriptional preinitiation complex assembly,BP,
12818,GO:0051132,1,0.593610672991019,0,5,NK T cell activation,BP,
12849,GO:0051177,1,0.648856729048446,0,4,meiotic sister chromatid cohesion,BP,
12859,GO:0051189,1,0.453429799717745,0,7,prosthetic group metabolic process,BP,
12881,GO:0051231,1,0.28355171378,0,11,spindle elongation,BP,
12883,GO:0051233,1,0.029656644950207,0,31,spindle midzone,CC,
12900,GO:0051255,1,0.318542640040949,0,10,spindle midzone assembly,BP,
12901,GO:0051256,1,0.402104707408187,0,8,mitotic spindle midzone assembly,BP,
12926,GO:0051292,1,0.320791625181762,0,10,nuclear pore complex assembly,BP,
12936,GO:0051304,1,0.000433647027626016,0,69,chromosome separation,BP,
12937,GO:0051305,1,0.558424044450857,0,5,chromosome movement towards spindle pole,BP,
12938,GO:0051306,1,0.00308789833988209,0,52,mitotic sister chromatid separation,BP,
12939,GO:0051307,1,0.251653931794824,0,12,meiotic chromosome separation,BP,
12941,GO:0051310,1,0.00213349997962033,0,54,metaphase plate congression,BP,
12943,GO:0051315,1,0.222536057301729,0,13,attachment of mitotic spindle microtubules to kinetochore,BP,
12949,GO:0051340,1,0.410492953747445,0,8,regulation of ligase activity,BP,
12960,GO:0051351,1,0.461248193726856,0,7,positive regulation of ligase activity,BP,
12985,GO:0051410,1,0.582878700188948,0,5,detoxification of nitrogen compound,BP,
12989,GO:0051415,1,0.49698202295828,0,6,microtubule nucleation by interphase microtubule organizing center,BP,
12991,GO:0051418,1,0.393626380044218,0,8,microtubule nucleation by microtubule organizing center,BP,
13006,GO:0051450,1,0.412982645716416,0,8,myoblast proliferation,BP,
13035,GO:0051503,1,0.256192709646414,0,12,adenine nucleotide transport,BP,
13056,GO:0051569,1,0.0907827079246161,0,21,regulation of histone H3-K4 methylation,BP,
13058,GO:0051571,1,0.200407475411038,0,14,positive regulation of histone H3-K4 methylation,BP,
13061,GO:0051574,1,0.460211437872005,0,7,positive regulation of histone H3-K9 methylation,BP,
13078,GO:0051597,1,0.504149982553733,0,6,response to methylmercury,BP,
13081,GO:0051601,1,0.501178433966811,0,6,exocyst localization,BP,
13101,GO:0051646,1,0.0188392886431028,0,35,mitochondrion localization,BP,
13108,GO:0051654,1,0.108543386160002,0,20,establishment of mitochondrion localization,BP,
13110,GO:0051657,1,0.393626380044218,0,8,maintenance of organelle location,BP,
13112,GO:0051661,1,0.558421378043368,0,5,maintenance of centrosome location,BP,
13125,GO:0051697,1,0.635006419751329,0,4,protein delipidation,BP,
13133,GO:0051709,1,0.483185755243777,0,7,regulation of killing of cells of other organism,BP,
13135,GO:0051712,1,0.483185755243777,0,7,positive regulation of killing of cells of other organism,BP,
13148,GO:0051731,1,0.636502936111739,0,4,polynucleotide 5'-hydroxyl-kinase activity,MF,
13157,GO:0051764,1,0.277896573833855,0,11,actin crosslink formation,BP,
13160,GO:0051767,1,0.36250126509052,0,9,nitric-oxide synthase biosynthetic process,BP,
13161,GO:0051769,1,0.36250126509052,0,9,regulation of nitric-oxide synthase biosynthetic process,BP,
13162,GO:0051770,1,0.496982022965512,0,6,positive regulation of nitric-oxide synthase biosynthetic process,BP,
13167,GO:0051782,1,0.209127667341096,0,14,negative regulation of cell division,BP,
13174,GO:0051790,1,0.641313416928346,0,4,short-chain fatty acid biosynthetic process,BP,
13178,GO:0051794,1,0.653910822247441,0,4,regulation of timing of catagen,BP,
13181,GO:0051797,1,0.13582234016683,0,18,regulation of hair follicle development,BP,
13182,GO:0051798,1,0.307298576021321,0,11,positive regulation of hair follicle development,BP,
13190,GO:0051818,1,0.53188855996806,0,6,disruption of cells of other organism involved in symbiotic interaction,BP,
13198,GO:0051836,1,0.370058189762263,0,9,translocation of molecules into other organism involved in symbiotic interaction,BP,
13200,GO:0051852,1,0.653889196813972,0,4,disruption by host of symbiont cells,BP,
13201,GO:0051861,1,0.250908510335287,0,12,glycolipid binding,MF,
13205,GO:0051873,1,0.653889196813972,0,4,killing by host of symbiont cells,BP,
13209,GO:0051880,1,0.442297753196275,0,7,G-quadruplex DNA binding,MF,
13212,GO:0051883,1,0.53188855996806,0,6,killing of cells in other organism involved in symbiotic interaction,BP,
13213,GO:0051884,1,0.627449537468743,0,4,regulation of timing of anagen,BP,
13221,GO:0051895,1,0.248182734607993,0,12,negative regulation of focal adhesion assembly,BP,
13234,GO:0051918,1,0.63136289297795,0,4,negative regulation of fibrinolysis,BP,
13237,GO:0051923,1,0.366749586484651,0,9,sulfation,BP,
13266,GO:0051964,1,0.627449537468743,0,4,negative regulation of synapse assembly,BP,
13271,GO:0051969,1,0.633233131960279,0,4,regulation of transmission of nerve impulse,BP,
13275,GO:0051974,1,0.407038927437708,0,8,negative regulation of telomerase activity,BP,
13280,GO:0051985,1,0.0181570054307527,0,36,negative regulation of chromosome segregation,BP,
13313,GO:0052204,1,0.583297802072998,0,5,negative regulation of molecular function in other organism involved in symbiotic interaction,BP,
13314,GO:0052205,1,0.519123404414988,0,6,modulation of molecular function in other organism involved in symbiotic interaction,BP,
13342,GO:0052428,1,0.655398028890652,0,4,modulation by host of symbiont molecular function,BP,
13370,GO:0052650,1,0.461722127128327,0,7,NADP-retinol dehydrogenase activity,MF,
13377,GO:0052658,1,0.497514253313742,0,6,inositol-1,4,5-trisphosphate 5-phosphatase activity,MF,
13383,GO:0052696,1,0.629878964924356,0,4,flavonoid glucuronidation,BP,
13384,GO:0052697,1,0.629878964924356,0,4,xenobiotic glucuronidation,BP,
13387,GO:0052723,1,0.638818999806948,0,4,inositol hexakisphosphate 1-kinase activity,MF,
13388,GO:0052724,1,0.638818999806948,0,4,inositol hexakisphosphate 3-kinase activity,MF,
13403,GO:0052803,1,0.627784914348046,0,4,imidazole-containing compound metabolic process,BP,
13406,GO:0052811,1,0.627449537468743,0,4,1-phosphatidylinositol-3-phosphate 4-kinase activity,MF,
13419,GO:0052832,1,0.635524173552956,0,4,inositol monophosphate 3-phosphatase activity,MF,
13420,GO:0052833,1,0.635524173552956,0,4,inositol monophosphate 4-phosphatase activity,MF,
13421,GO:0052834,1,0.635524173552956,0,4,inositol monophosphate phosphatase activity,MF,
13425,GO:0052840,1,0.640827166600949,0,4,inositol diphosphate tetrakisphosphate diphosphatase activity,MF,
13426,GO:0052841,1,0.640827166600949,0,4,inositol bisdiphosphate tetrakisphosphate diphosphatase activity,MF,
13427,GO:0052842,1,0.640827166600949,0,4,inositol diphosphate pentakisphosphate diphosphatase activity,MF,
13428,GO:0052843,1,0.640827166600949,0,4,inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity,MF,
13429,GO:0052844,1,0.640827166600949,0,4,inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity,MF,
13430,GO:0052845,1,0.640827166600949,0,4,inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity,MF,
13431,GO:0052846,1,0.640827166600949,0,4,inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity,MF,
13432,GO:0052847,1,0.640827166600949,0,4,inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity,MF,
13433,GO:0052848,1,0.640827166600949,0,4,inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity,MF,
13434,GO:0052851,1,0.568947958157703,0,5,ferric-chelate reductase (NADPH) activity,MF,
13486,GO:0055059,1,0.627449537468743,0,4,asymmetric neuroblast division,BP,
13498,GO:0055078,1,0.222539903115677,0,13,sodium ion homeostasis,BP,
13516,GO:0055102,1,0.394289174110013,0,9,lipase inhibitor activity,MF,
13518,GO:0055105,1,0.590731497106271,0,6,ubiquitin-protein transferase inhibitor activity,MF,
13525,GO:0055119,1,0.258307108299318,0,12,relaxation of cardiac muscle,BP,
13529,GO:0055131,1,0.56683270596507,0,5,C3HC4-type RING finger domain binding,MF,
13541,GO:0060013,1,0.558421378043368,0,5,righting reflex,BP,
13543,GO:0060017,1,0.565081807621333,0,5,parathyroid gland development,BP,
13545,GO:0060019,1,0.333459001574968,0,10,radial glial cell differentiation,BP,
13548,GO:0060022,1,0.498642302073843,0,6,hard palate development,BP,
13559,GO:0060037,1,0.14297667751818,0,17,pharyngeal system development,BP,
13566,GO:0060044,1,0.313306945559891,0,10,negative regulation of cardiac muscle cell proliferation,BP,
13571,GO:0060049,1,0.29170405467318,0,11,regulation of protein glycosylation,BP,
13572,GO:0060050,1,0.410568417383071,0,8,positive regulation of protein glycosylation,BP,
13574,GO:0060052,1,0.456853184260639,0,7,neurofilament cytoskeleton organization,BP,
13577,GO:0060055,1,0.229329422334923,0,13,angiogenesis involved in wound healing,BP,
13592,GO:0060073,1,0.628354208141891,0,4,micturition,BP,
13605,GO:0060088,1,0.51467181597794,0,6,auditory receptor cell stereocilium organization,BP,
13608,GO:0060091,1,0.576429335308446,0,5,kinocilium,CC,
13615,GO:0060120,1,0.577602002676994,0,5,inner ear receptor cell fate commitment,BP,
13617,GO:0060123,1,0.558421378043368,0,5,regulation of growth hormone secretion,BP,
13626,GO:0060136,1,0.63210411111469,0,4,embryonic process involved in female pregnancy,BP,
13627,GO:0060137,1,0.450794398187621,0,7,maternal process involved in parturition,BP,
13640,GO:0060158,1,0.638005265190831,0,4,phospholipase C-activating dopamine receptor signaling pathway,BP,
13641,GO:0060159,1,0.636835489069314,0,4,regulation of dopamine receptor signaling pathway,BP,
13667,GO:0060211,1,0.291903222071731,0,11,regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
13669,GO:0060213,1,0.291903222071731,0,11,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
13677,GO:0060229,1,0.410194747167627,0,8,lipase activator activity,MF,
13678,GO:0060231,1,0.232644324498236,0,13,mesenchymal to epithelial transition,BP,
13679,GO:0060232,1,0.62976334772333,0,4,delamination,BP,
13692,GO:0060259,1,0.45961146469886,0,7,regulation of feeding behavior,BP,
13694,GO:0060261,1,0.152422784910792,0,17,positive regulation of transcription initiation from RNA polymerase II promoter,BP,
13710,GO:0060287,1,0.640574532615538,0,4,epithelial cilium movement involved in determination of left/right asymmetry,BP,
13723,GO:0060304,1,0.558422527026412,0,5,regulation of phosphatidylinositol dephosphorylation,BP,
13744,GO:0060331,1,0.517661103663753,0,6,negative regulation of response to interferon-gamma,BP,
13749,GO:0060336,1,0.517661103663753,0,6,negative regulation of interferon-gamma-mediated signaling pathway,BP,
13752,GO:0060339,1,0.446252796841597,0,7,negative regulation of type I interferon-mediated signaling pathway,BP,
13753,GO:0060340,1,0.356790254365937,0,9,positive regulation of type I interferon-mediated signaling pathway,BP,
13763,GO:0060352,1,0.568714370442196,0,5,cell adhesion molecule production,BP,
13771,GO:0060368,1,0.500183645266133,0,6,regulation of Fc receptor mediated stimulatory signaling pathway,BP,
13772,GO:0060369,1,0.630584053982502,0,4,positive regulation of Fc receptor mediated stimulatory signaling pathway,BP,
13776,GO:0060373,1,0.627449537468743,0,4,regulation of ventricular cardiac muscle cell membrane depolarization,BP,
13781,GO:0060379,1,0.442744396364205,0,7,cardiac muscle cell myoblast differentiation,BP,
13794,GO:0060394,1,0.45080035579715,0,7,negative regulation of pathway-restricted SMAD protein phosphorylation,BP,
13823,GO:0060433,1,0.403385065615577,0,8,bronchus development,BP,
13831,GO:0060442,1,0.352550306223318,0,9,branching involved in prostate gland morphogenesis,BP,
13838,GO:0060452,1,0.50809425261221,0,6,positive regulation of cardiac muscle contraction,BP,
13839,GO:0060453,1,0.580339346671713,0,5,regulation of gastric acid secretion,BP,
13846,GO:0060462,1,0.558421378043368,0,5,lung lobe development,BP,
13847,GO:0060463,1,0.558421378043368,0,5,lung lobe morphogenesis,BP,
13852,GO:0060479,1,0.228914527940517,0,13,lung cell differentiation,BP,
13859,GO:0060487,1,0.257232197541938,0,12,lung epithelial cell differentiation,BP,
13865,GO:0060501,1,0.628418119597932,0,4,positive regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
13868,GO:0060509,1,0.627667668251616,0,4,Type I pneumocyte differentiation,BP,
13870,GO:0060512,1,0.110309318300598,0,19,prostate gland morphogenesis,BP,
13871,GO:0060513,1,0.447115520313864,0,7,prostatic bud formation,BP,
13875,GO:0060525,1,0.393772359168495,0,8,prostate glandular acinus development,BP,
13876,GO:0060526,1,0.627449537468743,0,4,prostate glandular acinus morphogenesis,BP,
13877,GO:0060527,1,0.627449537468743,0,4,prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis,BP,
13881,GO:0060534,1,0.450381317269102,0,7,trachea cartilage development,BP,
13883,GO:0060536,1,0.640269192081867,0,4,cartilage morphogenesis,BP,
13886,GO:0060539,1,0.561909618336394,0,5,diaphragm development,BP,
13906,GO:0060574,1,0.646570646434182,0,4,intestinal epithelial cell maturation,BP,
13908,GO:0060576,1,0.370750802483635,0,9,intestinal epithelial cell development,BP,
13917,GO:0060590,1,0.0198042950836485,0,35,ATPase regulator activity,MF,
13919,GO:0060592,1,0.631403185261663,0,4,mammary gland formation,BP,
13949,GO:0060666,1,0.55853467248765,0,5,dichotomous subdivision of terminal units involved in salivary gland branching,BP,
13953,GO:0060670,1,0.321826099709945,0,10,branching involved in labyrinthine layer morphogenesis,BP,
13958,GO:0060676,1,0.659072593170026,0,4,ureteric bud formation,BP,
13963,GO:0060684,1,0.632378116844538,0,4,epithelial-mesenchymal cell signaling,BP,
13964,GO:0060685,1,0.631403185261663,0,4,regulation of prostatic bud formation,BP,
13965,GO:0060686,1,0.631403185261663,0,4,negative regulation of prostatic bud formation,BP,
13966,GO:0060687,1,0.500114116247584,0,6,regulation of branching involved in prostate gland morphogenesis,BP,
13976,GO:0060699,1,0.638361711418019,0,4,regulation of endoribonuclease activity,BP,
13977,GO:0060700,1,0.363260809281068,0,9,regulation of ribonuclease activity,BP,
14007,GO:0060740,1,0.123959137148165,0,18,prostate gland epithelium morphogenesis,BP,
14008,GO:0060742,1,0.39381124743089,0,8,epithelial cell differentiation involved in prostate gland development,BP,
14011,GO:0060745,1,0.627449537468743,0,4,mammary gland branching involved in pregnancy,BP,
14012,GO:0060746,1,0.395609426575556,0,8,parental behavior,BP,
14025,GO:0060765,1,0.084987278520331,0,22,regulation of androgen receptor signaling pathway,BP,
14026,GO:0060766,1,0.397320213864473,0,8,negative regulation of androgen receptor signaling pathway,BP,
14027,GO:0060767,1,0.365333313305009,0,9,epithelial cell proliferation involved in prostate gland development,BP,
14028,GO:0060768,1,0.410509145628263,0,8,regulation of epithelial cell proliferation involved in prostate gland development,BP,
14030,GO:0060770,1,0.518294007141904,0,6,negative regulation of epithelial cell proliferation involved in prostate gland development,BP,
14048,GO:0060837,1,0.50004154988982,0,6,blood vessel endothelial cell differentiation,BP,
14063,GO:0060872,1,0.635120551167102,0,4,semicircular canal development,BP,
14068,GO:0060896,1,0.399775281071156,0,8,neural plate pattern specification,BP,
14069,GO:0060897,1,0.50474411511961,0,6,neural plate regionalization,BP,
14075,GO:0060911,1,0.445168610073442,0,7,cardiac cell fate commitment,BP,
14080,GO:0060916,1,0.627449537468743,0,4,mesenchymal cell proliferation involved in lung development,BP,
14084,GO:0060923,1,0.562042014058654,0,5,cardiac muscle cell fate commitment,BP,
14096,GO:0060956,1,0.627740391020842,0,4,endocardial cell differentiation,BP,
14105,GO:0060972,1,0.170701015839048,0,16,left/right pattern formation,BP,
14106,GO:0060973,1,0.280090096657379,0,11,cell migration involved in heart development,BP,
14127,GO:0061004,1,0.45669167063519,0,7,pattern specification involved in kidney development,BP,
14149,GO:0061042,1,0.503223101348175,0,6,vascular wound healing,BP,
14158,GO:0061051,1,0.576961453007282,0,5,positive regulation of cell growth involved in cardiac muscle cell development,BP,
14173,GO:0061083,1,0.629964406916652,0,4,regulation of protein refolding,BP,
14174,GO:0061084,1,0.629964406916652,0,4,negative regulation of protein refolding,BP,
14175,GO:0061085,1,0.352487303266975,0,9,regulation of histone H3-K27 methylation,BP,
14176,GO:0061086,1,0.63051540934968,0,4,negative regulation of histone H3-K27 methylation,BP,
14177,GO:0061087,1,0.498044579018235,0,6,positive regulation of histone H3-K27 methylation,BP,
14184,GO:0061101,1,0.645706210632744,0,4,neuroendocrine cell differentiation,BP,
14194,GO:0061133,1,0.609483156371784,0,5,endopeptidase activator activity,MF,
14208,GO:0061154,1,0.257513343729531,0,12,endothelial tube morphogenesis,BP,
14216,GO:0061179,1,0.505588271746877,0,7,negative regulation of insulin secretion involved in cellular response to glucose stimulus,BP,
14223,GO:0061196,1,0.628758247275733,0,4,fungiform papilla development,BP,
14224,GO:0061197,1,0.628758247275733,0,4,fungiform papilla morphogenesis,BP,
14247,GO:0061309,1,0.507857458666672,0,6,cardiac neural crest cell development involved in outflow tract morphogenesis,BP,
14249,GO:0061312,1,0.565236443547116,0,5,BMP signaling pathway involved in heart development,BP,
14250,GO:0061314,1,0.558724764156283,0,5,Notch signaling involved in heart development,BP,
14254,GO:0061323,1,0.294907990881231,0,11,cell proliferation involved in heart morphogenesis,BP,
14262,GO:0061343,1,0.627449537468743,0,4,cell adhesion involved in heart morphogenesis,BP,
14270,GO:0061355,1,0.63074582966384,0,4,Wnt protein secretion,BP,
14271,GO:0061356,1,0.63074582966384,0,4,regulation of Wnt protein secretion,BP,
14295,GO:0061436,1,0.101396025959016,0,20,establishment of skin barrier,BP,
14310,GO:0061470,1,0.631426333900549,0,4,T follicular helper cell differentiation,BP,
14322,GO:0061511,1,0.649432029606055,0,4,centriole elongation,BP,
14329,GO:0061525,1,0.558421378043368,0,5,hindgut development,BP,
14340,GO:0061550,1,0.627576825651205,0,4,cranial ganglion development,BP,
14354,GO:0061575,1,0.695328127742758,0,4,cyclin-dependent protein serine/threonine kinase activator activity,MF,
14356,GO:0061578,1,0.280982327657279,0,11,Lys63-specific deubiquitinase activity,MF,
14359,GO:0061588,1,0.62754073401619,0,4,calcium activated phospholipid scrambling,BP,
14360,GO:0061589,1,0.62754073401619,0,4,calcium activated phosphatidylserine scrambling,BP,
14361,GO:0061590,1,0.62754073401619,0,4,calcium activated phosphatidylcholine scrambling,BP,
14362,GO:0061591,1,0.62754073401619,0,4,calcium activated galactosylceramide scrambling,BP,
14371,GO:0061617,1,0.437583102233975,0,8,MICOS complex,CC,
14377,GO:0061624,1,0.62896456409707,0,4,fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate,BP,
14378,GO:0061626,1,0.509607537065369,0,6,pharyngeal arch artery morphogenesis,BP,
14384,GO:0061635,1,0.455185890245376,0,7,regulation of protein complex stability,BP,
14397,GO:0061665,1,0.563852554008627,0,5,SUMO ligase activity,MF,
14398,GO:0061668,1,0.505650233496199,0,6,mitochondrial ribosome assembly,BP,
14400,GO:0061673,1,0.559116043358041,0,5,mitotic spindle astral microtubule,CC,
14401,GO:0061676,1,0.510851056550539,0,6,importin-alpha family protein binding,MF,
14402,GO:0061684,1,0.314339829072562,0,10,chaperone-mediated autophagy,BP,
14411,GO:0061702,1,0.480582809951943,0,7,inflammasome complex,CC,
14421,GO:0061732,1,0.503001040620515,0,6,mitochondrial acetyl-CoA biosynthetic process from pyruvate,BP,
14422,GO:0061733,1,0.002359117360448,0,53,peptide-lysine-N-acetyltransferase activity,MF,
14423,GO:0061734,1,0.558421378043368,0,5,parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
14457,GO:0061820,1,0.350307203388121,0,9,telomeric D-loop disassembly,BP,
14458,GO:0061821,1,0.627449537468743,0,4,telomeric D-loop binding,MF,
14496,GO:0061980,1,0.0401054958826554,0,28,regulatory RNA binding,MF,
14498,GO:0061983,1,0.514457299549359,0,6,meiosis II cell cycle process,BP,
14513,GO:0070003,1,0.201666904553088,0,18,threonine-type peptidase activity,MF,
14516,GO:0070008,1,0.316020672333123,0,10,serine-type exopeptidase activity,MF,
14521,GO:0070022,1,0.627449537468743,0,4,transforming growth factor beta receptor complex,CC,
14545,GO:0070070,1,0.399341984159114,0,8,proton-transporting V-type ATPase complex assembly,BP,
14547,GO:0070072,1,0.399341984159114,0,8,vacuolar proton-transporting V-type ATPase complex assembly,BP,
14556,GO:0070087,1,0.49698202295828,0,6,chromo shadow domain binding,MF,
14563,GO:0070098,1,0.0988669098166587,0,21,chemokine-mediated signaling pathway,BP,
14564,GO:0070099,1,0.508955643602886,0,6,regulation of chemokine-mediated signaling pathway,BP,
14565,GO:0070100,1,0.641212312930953,0,4,negative regulation of chemokine-mediated signaling pathway,BP,
14567,GO:0070102,1,0.221447777662325,0,13,interleukin-6-mediated signaling pathway,BP,
14570,GO:0070106,1,0.393626380044218,0,8,interleukin-27-mediated signaling pathway,BP,
14580,GO:0070127,1,0.398545998025445,0,8,tRNA aminoacylation for mitochondrial protein translation,BP,
14581,GO:0070129,1,0.132328554352498,0,18,regulation of mitochondrial translation,BP,
14583,GO:0070131,1,0.291229530438753,0,11,positive regulation of mitochondrial translation,BP,
14584,GO:0070137,1,0.627449537468743,0,4,ubiquitin-like protein-specific endopeptidase activity,MF,
14586,GO:0070139,1,0.627449537468743,0,4,SUMO-specific endopeptidase activity,MF,
14596,GO:0070162,1,0.56565579198714,0,5,adiponectin secretion,BP,
14597,GO:0070163,1,0.56565579198714,0,5,regulation of adiponectin secretion,BP,
14598,GO:0070164,1,0.635577516679322,0,4,negative regulation of adiponectin secretion,BP,
14615,GO:0070187,1,0.500634135521686,0,6,shelterin complex,CC,
14616,GO:0070189,1,0.640359571682026,0,4,kynurenine metabolic process,BP,
14619,GO:0070193,1,0.313672229341608,0,10,synaptonemal complex organization,BP,
14623,GO:0070198,1,0.0512560270865275,0,26,protein localization to chromosome, telomeric region,BP,
14624,GO:0070199,1,0.0757528730343284,0,23,establishment of protein localization to chromosome,BP,
14625,GO:0070200,1,0.199813752467021,0,14,establishment of protein localization to telomere,BP,
14627,GO:0070202,1,0.282832710311153,0,11,regulation of establishment of protein localization to chromosome,BP,
14628,GO:0070203,1,0.31781415082812,0,10,regulation of establishment of protein localization to telomere,BP,
14633,GO:0070212,1,0.627858609764051,0,4,protein poly-ADP-ribosylation,BP,
14634,GO:0070213,1,0.627527873629118,0,4,protein auto-ADP-ribosylation,BP,
14644,GO:0070235,1,0.565966849887244,0,5,regulation of activation-induced cell death of T cells,BP,
14645,GO:0070236,1,0.633372454953569,0,4,negative regulation of activation-induced cell death of T cells,BP,
14654,GO:0070257,1,0.519537272335148,0,6,positive regulation of mucus secretion,BP,
14657,GO:0070262,1,0.227974433342615,0,13,peptidyl-serine dephosphorylation,BP,
14675,GO:0070294,1,0.629010366677828,0,4,renal sodium ion absorption,BP,
14691,GO:0070318,1,0.638024075337901,0,4,positive regulation of G0 to G1 transition,BP,
14693,GO:0070324,1,0.566262783241869,0,5,thyroid hormone binding,MF,
14705,GO:0070341,1,0.4970495436523,0,6,fat cell proliferation,BP,
14707,GO:0070344,1,0.4970495436523,0,6,regulation of fat cell proliferation,BP,
14708,GO:0070345,1,0.627531268843812,0,4,negative regulation of fat cell proliferation,BP,
14711,GO:0070358,1,0.587092798804037,0,5,actin polymerization-dependent cell motility,BP,
14714,GO:0070370,1,0.586618007673139,0,5,cellular heat acclimation,BP,
14727,GO:0070391,1,0.562007587912777,0,5,response to lipoteichoic acid,BP,
14737,GO:0070411,1,0.352351971369181,0,9,I-SMAD binding,MF,
14740,GO:0070417,1,0.448393412781582,0,7,cellular response to cold,BP,
14742,GO:0070419,1,0.447938568021798,0,7,nonhomologous end joining complex,CC,
14744,GO:0070424,1,0.497225678778286,0,6,regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
14750,GO:0070431,1,0.398257636636179,0,8,nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
14763,GO:0070461,1,0.0562274395073998,0,26,SAGA-type complex,CC,
14770,GO:0070475,1,0.385605300272855,0,9,rRNA base methylation,BP,
14777,GO:0070487,1,0.635577516688571,0,4,monocyte aggregation,BP,
14781,GO:0070492,1,0.662090212161401,0,4,oligosaccharide binding,MF,
14795,GO:0070525,1,0.236117007205694,0,13,tRNA threonylcarbamoyladenosine metabolic process,BP,
14798,GO:0070530,1,0.1100454080998,0,19,K63-linked polyubiquitin modification-dependent protein binding,MF,
14799,GO:0070531,1,0.55847770267541,0,5,BRCA1-A complex,CC,
14801,GO:0070535,1,0.559042799198268,0,5,histone H2A K63-linked ubiquitination,BP,
14809,GO:0070545,1,0.628825855837594,0,4,PeBoW complex,CC,
14823,GO:0070567,1,0.366024750428775,0,9,cytidylyltransferase activity,MF,
14824,GO:0070568,1,0.574862897479375,0,5,guanylyltransferase activity,MF,
14825,GO:0070569,1,0.451313897425773,0,7,uridylyltransferase activity,MF,
14828,GO:0070572,1,0.64807788940096,0,4,positive regulation of neuron projection regeneration,BP,
14833,GO:0070578,1,0.35986097378696,0,9,RISC-loading complex,CC,
14834,GO:0070579,1,0.62749172798581,0,4,methylcytosine dioxygenase activity,MF,
14837,GO:0070586,1,0.400500937359557,0,8,cell-cell adhesion involved in gastrulation,BP,
14838,GO:0070587,1,0.450018132234145,0,7,regulation of cell-cell adhesion involved in gastrulation,BP,
14842,GO:0070601,1,0.410161155504335,0,8,centromeric sister chromatid cohesion,BP,
14853,GO:0070628,1,0.152853712168823,0,18,proteasome binding,MF,
14868,GO:0070652,1,0.414910511457747,0,8,HAUS complex,CC,
14889,GO:0070695,1,0.559141978590338,0,5,FHF complex,CC,
14896,GO:0070717,1,0.0892483674650072,0,21,poly-purine tract binding,MF,
14905,GO:0070739,1,0.558440100714131,0,5,protein-glutamic acid ligase activity,MF,
14906,GO:0070740,1,0.558440100714131,0,5,tubulin-glutamic acid ligase activity,MF,
14907,GO:0070741,1,0.0780770916904588,0,22,response to interleukin-6,BP,
14910,GO:0070757,1,0.393626380044218,0,8,interleukin-35-mediated signaling pathway,BP,
14911,GO:0070761,1,0.52219162552545,0,6,pre-snoRNP complex,CC,
14913,GO:0070765,1,0.521490429292002,0,6,gamma-secretase complex,CC,
14917,GO:0070775,1,0.44303953239612,0,7,H3 histone acetyltransferase complex,CC,
14918,GO:0070776,1,0.44303953239612,0,7,MOZ/MORF histone acetyltransferase complex,CC,
14920,GO:0070778,1,0.627449667077517,0,4,L-aspartate transmembrane transport,BP,
14927,GO:0070815,1,0.627449537468743,0,4,peptidyl-lysine 5-dioxygenase activity,MF,
14928,GO:0070816,1,0.181231755416752,0,15,phosphorylation of RNA polymerase II C-terminal domain,BP,
14932,GO:0070822,1,0.205222302297912,0,14,Sin3-type complex,CC,
14938,GO:0070831,1,0.442297753196275,0,7,basement membrane assembly,BP,
14942,GO:0070840,1,0.122612553066259,0,18,dynein complex binding,MF,
14949,GO:0070847,1,0.427278051202022,0,8,core mediator complex,CC,
14961,GO:0070862,1,0.325020419701306,0,10,negative regulation of protein exit from endoplasmic reticulum,BP,
14964,GO:0070874,1,0.559217044430059,0,5,negative regulation of glycogen metabolic process,BP,
14966,GO:0070876,1,0.627449537468743,0,4,SOSS complex,CC,
14969,GO:0070883,1,0.585502884228165,0,5,pre-miRNA binding,MF,
14972,GO:0070886,1,0.409487336005808,0,8,positive regulation of calcineurin-NFAT signaling cascade,BP,
14980,GO:0070897,1,0.0130526290348267,0,39,DNA-templated transcriptional preinitiation complex assembly,BP,
14983,GO:0070900,1,0.369910933845148,0,9,mitochondrial tRNA modification,BP,
14984,GO:0070901,1,0.651554685277945,0,4,mitochondrial tRNA methylation,BP,
14994,GO:0070922,1,0.357853427301674,0,9,small RNA loading onto RISC,BP,
15000,GO:0070934,1,0.634780092433599,0,4,CRD-mediated mRNA stabilization,BP,
15001,GO:0070935,1,0.281162922011903,0,11,3'-UTR-mediated mRNA stabilization,BP,
15003,GO:0070937,1,0.564946033767668,0,5,CRD-mediated mRNA stability complex,CC,
15004,GO:0070938,1,0.279867444227728,0,11,contractile ring,CC,
15006,GO:0070940,1,0.56913985917548,0,5,dephosphorylation of RNA polymerase II C-terminal domain,BP,
15007,GO:0070942,1,0.641835338240872,0,4,neutrophil mediated cytotoxicity,BP,
15030,GO:0070979,1,0.0559144002258017,0,27,protein K11-linked ubiquitination,BP,
15035,GO:0070986,1,0.261750870352771,0,12,left/right axis specification,BP,
15036,GO:0070987,1,0.141004382889316,0,18,error-free translesion synthesis,BP,
15039,GO:0070990,1,0.529555552835076,0,6,snRNP binding,MF,
15046,GO:0071004,1,0.161461334346002,0,17,U2-type prespliceosome,CC,
15049,GO:0071007,1,0.0460313224212208,0,29,U2-type catalytic step 2 spliceosome,CC,
15050,GO:0071008,1,0.641816723892711,0,4,U2-type post-mRNA release spliceosomal complex,CC,
15051,GO:0071010,1,0.0946560677505395,0,22,prespliceosome,CC,
15053,GO:0071012,1,0.500869474116457,0,6,catalytic step 1 spliceosome,CC,
15055,GO:0071014,1,0.364138189935357,0,9,post-mRNA release spliceosomal complex,CC,
15058,GO:0071025,1,0.205243077299367,0,15,RNA surveillance,BP,
15060,GO:0071027,1,0.259112295006043,0,13,nuclear RNA surveillance,BP,
15061,GO:0071028,1,0.259112295006043,0,13,nuclear mRNA surveillance,BP,
15062,GO:0071029,1,0.536090386374073,0,6,nuclear ncRNA surveillance,BP,
15065,GO:0071033,1,0.582044239689801,0,5,nuclear retention of pre-mRNA at the site of transcription,BP,
15066,GO:0071034,1,0.644005793764909,0,4,CUT catabolic process,BP,
15067,GO:0071035,1,0.536090386374073,0,6,nuclear polyadenylation-dependent rRNA catabolic process,BP,
15068,GO:0071038,1,0.602360529554652,0,5,nuclear polyadenylation-dependent tRNA catabolic process,BP,
15069,GO:0071042,1,0.659416656655025,0,4,nuclear polyadenylation-dependent mRNA catabolic process,BP,
15070,GO:0071043,1,0.644005793764909,0,4,CUT metabolic process,BP,
15071,GO:0071044,1,0.299971179619522,0,11,histone mRNA catabolic process,BP,
15073,GO:0071046,1,0.536090386374073,0,6,nuclear polyadenylation-dependent ncRNA catabolic process,BP,
15074,GO:0071047,1,0.659416656655025,0,4,polyadenylation-dependent mRNA catabolic process,BP,
15077,GO:0071051,1,0.616985946844443,0,5,polyadenylation-dependent snoRNA 3'-end processing,BP,
15108,GO:0071169,1,0.426516681819033,0,8,establishment of protein localization to chromatin,BP,
15109,GO:0071173,1,0.0380312559434312,0,29,spindle assembly checkpoint,BP,
15110,GO:0071174,1,0.0380312559434312,0,29,mitotic spindle checkpoint,BP,
15112,GO:0071204,1,0.520451674020367,0,6,histone pre-mRNA 3'end processing complex,CC,
15113,GO:0071205,1,0.627449537468743,0,4,protein localization to juxtaparanode region of axon,BP,
15115,GO:0071208,1,0.684945173521822,0,4,histone pre-mRNA DCP binding,MF,
15117,GO:0071211,1,0.629156895999217,0,4,protein targeting to vacuole involved in autophagy,BP,
15126,GO:0071223,1,0.562007587912777,0,5,cellular response to lipoteichoic acid,BP,
15128,GO:0071225,1,0.627489536646192,0,4,cellular response to muramyl dipeptide,BP,
15141,GO:0071253,1,0.558548686040963,0,5,connexin binding,MF,
15148,GO:0071265,1,0.461297449051346,0,7,L-methionine biosynthetic process,BP,
15150,GO:0071267,1,0.514706363824922,0,6,L-methionine salvage,BP,
15159,GO:0071284,1,0.627449537468743,0,4,cellular response to lead ion,BP,
15162,GO:0071287,1,0.502905470291973,0,6,cellular response to manganese ion,BP,
15175,GO:0071316,1,0.517074703991838,0,6,cellular response to nicotine,BP,
15202,GO:0071354,1,0.0780770916904588,0,22,cellular response to interleukin-6,BP,
15213,GO:0071372,1,0.394296028180554,0,8,cellular response to follicle-stimulating hormone stimulus,BP,
15227,GO:0071389,1,0.512570503643853,0,6,cellular response to mineralocorticoid stimulus,BP,
15228,GO:0071391,1,0.278836044365045,0,11,cellular response to estrogen stimulus,BP,
15231,GO:0071394,1,0.453180275782387,0,7,cellular response to testosterone stimulus,BP,
15234,GO:0071397,1,0.278089376080081,0,11,cellular response to cholesterol,BP,
15254,GO:0071428,1,0.21446435670939,0,15,rRNA-containing ribonucleoprotein complex export from nucleus,BP,
15260,GO:0071440,1,0.498915475487917,0,6,regulation of histone H3-K14 acetylation,BP,
15262,GO:0071442,1,0.629890139080732,0,4,positive regulation of histone H3-K14 acetylation,BP,
15269,GO:0071455,1,0.499524406485188,0,6,cellular response to hyperoxia,BP,
15272,GO:0071459,1,0.103403821491421,0,20,protein localization to chromosome, centromeric region,BP,
15302,GO:0071499,1,0.499993193068668,0,6,cellular response to laminar fluid shear stress,BP,
15303,GO:0071500,1,0.60443674835643,0,5,cellular response to nitrosative stress,BP,
15304,GO:0071501,1,0.396369101694202,0,8,cellular response to sterol depletion,BP,
15313,GO:0071532,1,0.627496049691122,0,4,ankyrin repeat binding,MF,
15314,GO:0071535,1,0.641769818944754,0,4,RING-like zinc finger domain binding,MF,
15318,GO:0071541,1,0.478701709170166,0,7,eukaryotic translation initiation factor 3 complex, eIF3m,CC,
15320,GO:0071543,1,0.640827166600949,0,4,diphosphoinositol polyphosphate metabolic process,BP,
15327,GO:0071550,1,0.372913758258586,0,9,death-inducing signaling complex assembly,BP,
15335,GO:0071564,1,0.254413171337556,0,12,npBAF complex,CC,
15336,GO:0071565,1,0.251206382810526,0,12,nBAF complex,CC,
15340,GO:0071569,1,0.52289122147849,0,6,protein ufmylation,BP,
15343,GO:0071578,1,0.498965144234026,0,6,zinc ion import across plasma membrane,BP,
15355,GO:0071598,1,0.576177817710426,0,5,neuronal ribonucleoprotein granule,CC,
15361,GO:0071605,1,0.47091362715035,0,7,monocyte chemotactic protein-1 production,BP,
15363,GO:0071608,1,0.629530245447681,0,4,macrophage inflammatory protein-1 alpha production,BP,
15364,GO:0071609,1,0.357908407905273,0,9,chemokine (C-C motif) ligand 5 production,BP,
15381,GO:0071635,1,0.498317733514813,0,6,negative regulation of transforming growth factor beta production,BP,
15383,GO:0071637,1,0.47091362715035,0,7,regulation of monocyte chemotactic protein-1 production,BP,
15385,GO:0071639,1,0.575764330418707,0,5,positive regulation of monocyte chemotactic protein-1 production,BP,
15386,GO:0071640,1,0.629530245447681,0,4,regulation of macrophage inflammatory protein 1 alpha production,BP,
15391,GO:0071649,1,0.398818556589387,0,8,regulation of chemokine (C-C motif) ligand 5 production,BP,
15393,GO:0071651,1,0.558421378043368,0,5,positive regulation of chemokine (C-C motif) ligand 5 production,BP,
15399,GO:0071664,1,0.627449537468743,0,4,catenin-TCF7L2 complex,CC,
15411,GO:0071680,1,0.558421378043368,0,5,response to indole-3-methanol,BP,
15412,GO:0071681,1,0.558421378043368,0,5,cellular response to indole-3-methanol,BP,
15432,GO:0071712,1,0.296195962658316,0,11,ER-associated misfolded protein catabolic process,BP,
15443,GO:0071763,1,0.497997350066686,0,6,nuclear membrane organization,BP,
15448,GO:0071782,1,0.126839040188754,0,18,endoplasmic reticulum tubular network,CC,
15450,GO:0071787,1,0.628259005663157,0,4,endoplasmic reticulum tubular network formation,BP,
15467,GO:0071816,1,0.637136374338457,0,4,tail-anchored membrane protein insertion into ER membrane,BP,
15468,GO:0071817,1,0.592632769214757,0,5,MMXD complex,CC,
15478,GO:0071837,1,0.400992623203072,0,8,HMG box domain binding,MF,
15484,GO:0071850,1,0.208416704074586,0,14,mitotic cell cycle arrest,BP,
15488,GO:0071865,1,0.645782147559632,0,4,regulation of apoptotic process in bone marrow,BP,
15489,GO:0071866,1,0.645782147559632,0,4,negative regulation of apoptotic process in bone marrow,BP,
15506,GO:0071888,1,0.417746066349421,0,8,macrophage apoptotic process,BP,
15511,GO:0071896,1,0.627449537468743,0,4,protein localization to adherens junction,BP,
15525,GO:0071921,1,0.499334571987611,0,6,cohesin loading,BP,
15526,GO:0071922,1,0.561064533134332,0,5,regulation of cohesin loading,BP,
15527,GO:0071926,1,0.627715515457927,0,4,endocannabinoid signaling pathway,BP,
15546,GO:0071985,1,0.0434178185229618,0,28,multivesicular body sorting pathway,BP,
15547,GO:0071986,1,0.497037644141321,0,6,Ragulator complex,CC,
15548,GO:0071987,1,0.627481995619697,0,4,WD40-repeat domain binding,MF,
15575,GO:0072047,1,0.643188169386281,0,4,proximal/distal pattern formation involved in nephron development,BP,
15576,GO:0072048,1,0.45669167063519,0,7,renal system pattern specification,BP,
15577,GO:0072049,1,0.652736232835721,0,4,comma-shaped body morphogenesis,BP,
15594,GO:0072079,1,0.298742955959834,0,11,nephron tubule formation,BP,
15596,GO:0072081,1,0.643188169386281,0,4,specification of nephron tubule identity,BP,
15597,GO:0072086,1,0.643188169386281,0,4,specification of loop of Henle identity,BP,
15644,GO:0072161,1,0.631403185261663,0,4,mesenchymal cell differentiation involved in kidney development,BP,
15651,GO:0072172,1,0.659072593170026,0,4,mesonephric tubule formation,BP,
15657,GO:0072178,1,0.5619403728515,0,5,nephric duct morphogenesis,BP,
15663,GO:0072189,1,0.445085454030229,0,7,ureter development,BP,
15686,GO:0072217,1,0.5619403728515,0,5,negative regulation of metanephros development,BP,
15736,GO:0072318,1,0.560098877706305,0,5,clathrin coat disassembly,BP,
15737,GO:0072319,1,0.499199067943778,0,6,vesicle uncoating,BP,
15739,GO:0072321,1,0.359658100101552,0,10,chaperone-mediated protein transport,BP,
15746,GO:0072338,1,0.558421378043368,0,5,cellular lactam metabolic process,BP,
15758,GO:0072357,1,0.448477050615165,0,7,PTW/PP1 phosphatase complex,CC,
15776,GO:0072385,1,0.627449537468743,0,4,minus-end-directed organelle transport along microtubule,BP,
15781,GO:0072393,1,0.277485422694482,0,11,microtubule anchoring at microtubule organizing center,BP,
15783,GO:0072396,1,0.497475936148162,0,6,response to cell cycle checkpoint signaling,BP,
15785,GO:0072402,1,0.497475936148162,0,6,response to DNA integrity checkpoint signaling,BP,
15789,GO:0072423,1,0.497475936148162,0,6,response to DNA damage checkpoint signaling,BP,
15790,GO:0072425,1,0.277870039726734,0,11,signal transduction involved in G2 DNA damage checkpoint,BP,
15796,GO:0072487,1,0.558800350230821,0,5,MSL complex,CC,
15797,GO:0072488,1,0.448989089464288,0,7,ammonium transmembrane transport,BP,
15801,GO:0072501,1,0.629362157668493,0,4,cellular divalent inorganic anion homeostasis,BP,
15802,GO:0072502,1,0.629362157668493,0,4,cellular trivalent inorganic anion homeostasis,BP,
15814,GO:0072520,1,0.330522657652871,0,10,seminiferous tubule development,BP,
15820,GO:0072526,1,0.636928204841651,0,4,pyridine-containing compound catabolic process,BP,
15824,GO:0072530,1,0.396590342006086,0,8,purine-containing compound transmembrane transport,BP,
15825,GO:0072531,1,0.453197183431671,0,7,pyrimidine-containing compound transmembrane transport,BP,
15830,GO:0072538,1,0.362755335515065,0,9,T-helper 17 type immune response,BP,
15831,GO:0072539,1,0.456685742575257,0,7,T-helper 17 cell differentiation,BP,
15832,GO:0072540,1,0.647855189433958,0,4,T-helper 17 cell lineage commitment,BP,
15835,GO:0072546,1,0.311752070889121,0,10,ER membrane protein complex,CC,
15842,GO:0072559,1,0.539996670484003,0,6,NLRP3 inflammasome complex,CC,
15864,GO:0072589,1,0.704376864690303,0,4,box H/ACA scaRNP complex,CC,
15871,GO:0072599,1,0.000155914926828979,0,104,establishment of protein localization to endoplasmic reticulum,BP,
15872,GO:0072602,1,0.627788257857795,0,4,interleukin-4 secretion,BP,
15877,GO:0072610,1,0.630595884011974,0,4,interleukin-12 secretion,BP,
15882,GO:0072641,1,0.496982022965512,0,6,type I interferon secretion,BP,
15883,GO:0072642,1,0.496982022965512,0,6,interferon-alpha secretion,BP,
15884,GO:0072643,1,0.350309099481112,0,9,interferon-gamma secretion,BP,
15895,GO:0072669,1,0.496845708910074,0,7,tRNA-splicing ligase complex,CC,
15913,GO:0072697,1,0.283770510330037,0,11,protein localization to cell cortex,BP,
15921,GO:0072710,1,0.350685419471779,0,9,response to hydroxyurea,BP,
15922,GO:0072711,1,0.394051329999035,0,8,cellular response to hydroxyurea,BP,
15925,GO:0072716,1,0.659282284681343,0,4,response to actinomycin D,BP,
15927,GO:0072718,1,0.355110920640117,0,9,response to cisplatin,BP,
15928,GO:0072719,1,0.503278685268638,0,6,cellular response to cisplatin,BP,
15941,GO:0072757,1,0.628126684691218,0,4,cellular response to camptothecin,BP,
15953,GO:0075522,1,0.322322452939513,0,10,IRES-dependent viral translational initiation,BP,
15954,GO:0075525,1,0.576786748681147,0,5,viral translational termination-reinitiation,BP,
15957,GO:0075713,1,0.409876707841223,0,8,establishment of integrated proviral latency,BP,
15961,GO:0080009,1,0.317699159868317,0,10,mRNA methylation,BP,
15967,GO:0080084,1,0.562166556458017,0,5,5S rDNA binding,MF,
15983,GO:0080182,1,0.179088894291247,0,16,histone H3-K4 trimethylation,BP,
15985,GO:0085020,1,0.475836025920831,0,7,protein K6-linked ubiquitination,BP,
15991,GO:0086004,1,0.102594473905484,0,20,regulation of cardiac muscle cell contraction,BP,
16000,GO:0086013,1,0.397694909006291,0,8,membrane repolarization during cardiac muscle cell action potential,BP,
16001,GO:0086014,1,0.311752070884584,0,10,atrial cardiac muscle cell action potential,BP,
16011,GO:0086026,1,0.311752070884584,0,10,atrial cardiac muscle cell to AV node cell signaling,BP,
16013,GO:0086028,1,0.651597512851477,0,4,bundle of His cell to Purkinje myocyte signaling,BP,
16020,GO:0086042,1,0.497095333855401,0,6,cardiac muscle cell-cardiac muscle cell adhesion,BP,
16021,GO:0086043,1,0.651597512851477,0,4,bundle of His cell action potential,BP,
16034,GO:0086066,1,0.311752070884584,0,10,atrial cardiac muscle cell to AV node cell communication,BP,
16037,GO:0086069,1,0.363795001401404,0,9,bundle of His cell to Purkinje myocyte communication,BP,
16040,GO:0086073,1,0.558421378043368,0,5,bundle of His cell-Purkinje myocyte adhesion involved in cell communication,BP,
16046,GO:0086080,1,0.393716141481188,0,8,protein binding involved in heterotypic cell-cell adhesion,MF,
16048,GO:0086083,1,0.558421378043368,0,5,cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication,MF,
16057,GO:0089701,1,0.608494118872394,0,5,U2AF,CC,
16061,GO:0089720,1,0.529863336614625,0,6,caspase binding,MF,
16062,GO:0090009,1,0.627449537468743,0,4,primitive streak formation,BP,
16066,GO:0090025,1,0.278543909381539,0,12,regulation of monocyte chemotaxis,BP,
16067,GO:0090026,1,0.394133973457081,0,9,positive regulation of monocyte chemotaxis,BP,
16071,GO:0090032,1,0.627450574421857,0,4,negative regulation of steroid hormone biosynthetic process,BP,
16078,GO:0090043,1,0.457143109221692,0,7,regulation of tubulin deacetylation,BP,
16084,GO:0090063,1,0.627757104848903,0,4,positive regulation of microtubule nucleation,BP,
16089,GO:0090069,1,0.231267744153714,0,13,regulation of ribosome biogenesis,BP,
16090,GO:0090070,1,0.414311587421598,0,8,positive regulation of ribosome biogenesis,BP,
16091,GO:0090071,1,0.627449537468743,0,4,negative regulation of ribosome biogenesis,BP,
16092,GO:0090073,1,0.40985063867294,0,8,positive regulation of protein homodimerization activity,BP,
16120,GO:0090110,1,0.222828413613685,0,13,cargo loading into COPII-coated vesicle,BP,
16139,GO:0090151,1,0.317544213242272,0,12,establishment of protein localization to mitochondrial membrane,BP,
16142,GO:0090155,1,0.641314371505962,0,4,negative regulation of sphingolipid biosynthetic process,BP,
16144,GO:0090158,1,0.560017753391511,0,5,endoplasmic reticulum membrane organization,BP,
16146,GO:0090161,1,0.278036069363085,0,11,Golgi ribbon formation,BP,
16149,GO:0090166,1,0.507622025444388,0,6,Golgi disassembly,BP,
16151,GO:0090169,1,0.0577278885271109,0,25,regulation of spindle assembly,BP,
16163,GO:0090185,1,0.35336326748799,0,9,negative regulation of kidney development,BP,
16191,GO:0090219,1,0.627647481207295,0,4,negative regulation of lipid kinase activity,BP,
16196,GO:0090230,1,0.627449537468743,0,4,regulation of centromere complex assembly,BP,
16201,GO:0090235,1,0.443041930004852,0,7,regulation of metaphase plate congression,BP,
16205,GO:0090240,1,0.470145363944293,0,7,positive regulation of histone H4 acetylation,BP,
16208,GO:0090245,1,0.627489000911279,0,4,axis elongation involved in somitogenesis,BP,
16219,GO:0090266,1,0.230627136376189,0,13,regulation of mitotic cell cycle spindle assembly checkpoint,BP,
16220,GO:0090267,1,0.453071596352575,0,7,positive regulation of mitotic cell cycle spindle assembly checkpoint,BP,
16229,GO:0090280,1,0.567225386232609,0,5,positive regulation of calcium ion import,BP,
16241,GO:0090296,1,0.640020359115862,0,4,regulation of mitochondrial DNA replication,BP,
16247,GO:0090304,1,0,303,4188,nucleic acid metabolic process,BP,TNIP1;NT5E;ERCC1;MEF2D;ZMYND8;H1F0;CITED4;HTRA1;EGR1;NR1D1;CST3;APLN;PDCD4;CTNNBIP1;ACVR2B;XPC;PRNP;VEGFA;WNT7A;APOE;F2R;LRP5;ITGA6;HMGA2;ZKSCAN1;ELK3;PKN1;MTA1;EGFR;WWTR1;NOS1;NFATC4;BAHCC1;ETV5;SHC1;DDB2;HEXB;GTPBP1;TCFL5;TK2;ETV4;TRNP1;ZFP36L1;MAP2K2;ZC3H6;MDFI;PTOV1;SMARCA1;RBCK1;FOXQ1;MAP2K1;NYNRIN;MXD4;POU2F2;ENDOG;SMURF2;TSC22D1;FOS;SMAD3;STAT6;PIK3R2;ERCC6;DVL1;EPAS1;DNAJB5;RPUSD3;PRDX5;BRD3;SALL2;ZXDC;RNF187;ADARB1;AKT1;HDAC5;PPM1F;SCMH1;NFKBIZ;ASH2L;IMPACT;WWC3;DAP;FGFR4;POLD4;FGFR1;MAPKBP1;SEC14L2;HLTF;MXI1;RAG1;H2AFJ;KLF7;NAT14;CIRBP;HMG20B;TENM2;ZNF385A;NSMCE4A;IGFBP4;TSHZ1;TRAPPC9;CCND1;PCBP4;TCF25;MAPK13;GAS6;CSNK1E;CARD11;SOX13;ARHGAP22;RAD23A;GLI4;ZSCAN18;AIP;MYEF2;MN1;SMARCD2;RRNAD1;DGKQ;PAK6;GTF2IRD1;TAGLN3;PKD2;HES2;CRTC1;ABCA2;MAGEF1;ADAM8;CTBP1;MNT;CDKN1C;ZMIZ2;CBS;CD81;CEBPB;ZNF217;ZNF862;TGFB1;LACTB2;RFX2;SCYL1;DEAF1;NAB2;TMEM173;ZSCAN30;MSRB2;PNRC1;MPG;PEG3;MC1R;ABHD14B;RNH1;POLL;POLM;PTMS;PHF21A;KHDRBS3;AGRN;MBD3;LRP4;VHL;MLXIPL;PRKCZ;KDM6B;PRKACA;ZNF516;AREG;PIM2;WDR18;TDRKH;ERBB2;PRIMPOL;TFDP2;IRF2BP2;PBX2;NELFCD;PRKCD;RBL2;STUB1;BAX;DTD1;ZNF395;EREG;RPS6KA5;ZNF524;SOX12;MBTPS2;TOP3B;PPP1R13L;CARF;AHNAK2;IER2;TGFBR3;LEMD2;ZHX3;RGS14;SYMPK;MAPK12;IRAK1;TGFA;HDAC7;FHOD1;CHD2;CBX7;CHEK2;ZFPM1;PPARA;TMEM161A;SESN2;ABCG1;CDC34;SOX7;SIX5;KDM4B;ZNF414;SSBP4;ECM1;WFS1;ZNF444;TRPT1;DALRD3;ARID5B;HOXC5;DNM2;BHLHE40;PELI1;CAT;NEIL1;TSPYL2;ZMYM3;APOBEC3C;SATB1;ZNF606;APOBEC3F;DDX50;MAPK3;INSR;PAN2;CAMTA2;PFKM;RERE;INO80C;ETAA1;BCL7A;CAMKK2;RNASET2;PPP3CB;USP21;REV1;CAPRIN2;ZBTB10;WDTC1;HES7;ITGA3;DNMT3A;PPP2R5B;HES6;MAP2K3;DNASE1L1;PROX1;IARS2;ADGRF1;PKD1;KCTD13;SIRT2;FAM129B;EDA;UVSSA;BACH1;E2F5;ZBTB22;MAPRE3;TEP1;ZNF704;MAP3K10;GTF2IRD2;NGFR;BCORL1;ZNF837;RNASE7;MAFF;NR2F6;CBX6;CAMK1;EZH1;HFE;TERC;ZNF513;BTG1;ZP3;MLF2;CDK11B;TNRC18;TCEA2;ZBTB47;PLAG1;CLK3;IRF2BPL;DHX32;KDM3A;TBL3;DEDD2;SRSF5;AARS
16249,GO:0090306,1,0.629098961206894,0,4,spindle assembly involved in meiosis,BP,
16251,GO:0090308,1,0.393626395567147,0,8,regulation of methylation-dependent chromatin silencing,BP,
16252,GO:0090309,1,0.627449537468743,0,4,positive regulation of methylation-dependent chromatin silencing,BP,
16270,GO:0090335,1,0.401250352927337,0,8,regulation of brown fat cell differentiation,BP,
16288,GO:0090385,1,0.516035457002316,0,6,phagosome-lysosome fusion,BP,
16292,GO:0090394,1,0.63192114124895,0,4,negative regulation of excitatory postsynaptic potential,BP,
16295,GO:0090400,1,0.444042529886216,0,7,stress-induced premature senescence,BP,
16305,GO:0090435,1,0.465712762085065,0,7,protein localization to nuclear envelope,BP,
16309,GO:0090481,1,0.327148574584035,0,10,pyrimidine nucleotide-sugar transmembrane transport,BP,
16320,GO:0090520,1,0.353034529461424,0,9,sphingolipid mediated signaling pathway,BP,
16321,GO:0090521,1,0.62745031653703,0,4,glomerular visceral epithelial cell migration,BP,
16324,GO:0090533,1,0.446623505356659,0,7,cation-transporting ATPase complex,CC,
16338,GO:0090576,1,0.40676640323637,0,8,RNA polymerase III transcription factor complex,CC,
16345,GO:0090611,1,0.567315500015999,0,5,ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway,BP,
16352,GO:0090646,1,0.260962289619842,0,12,mitochondrial tRNA processing,BP,
16354,GO:0090649,1,0.56226878963957,0,5,response to oxygen-glucose deprivation,BP,
16355,GO:0090650,1,0.56226878963957,0,5,cellular response to oxygen-glucose deprivation,BP,
16357,GO:0090657,1,0.277451571865562,0,11,telomeric loop disassembly,BP,
16362,GO:0090666,1,0.633427044915594,0,4,scaRNA localization to Cajal body,BP,
16365,GO:0090669,1,0.631578443040552,0,4,telomerase RNA stabilization,BP,
16366,GO:0090670,1,0.125251155734893,0,19,RNA localization to Cajal body,BP,
16367,GO:0090671,1,0.125251155734893,0,19,telomerase RNA localization to Cajal body,BP,
16368,GO:0090672,1,0.125251155734893,0,19,telomerase RNA localization,BP,
16372,GO:0090685,1,0.125251155734893,0,19,RNA localization to nucleus,BP,
16374,GO:0090713,1,0.576583709854335,0,5,immunological memory process,BP,
16375,GO:0090715,1,0.576583709854335,0,5,immunological memory formation process,BP,
16377,GO:0090723,1,0.289049475733869,0,11,growth cone part,CC,
16378,GO:0090724,1,0.631030379923379,0,4,central region of growth cone,CC,
16381,GO:0090734,1,0.0173341422140482,0,35,site of DNA damage,CC,
16382,GO:0090735,1,0.32289116890521,0,10,DNA repair complex assembly,BP,
16384,GO:0090741,1,0.526752231509104,0,6,pigment granule membrane,CC,
16402,GO:0097027,1,0.459350184334674,0,7,ubiquitin-protein transferase activator activity,MF,
16417,GO:0097056,1,0.636616050667584,0,4,selenocysteinyl-tRNA(Sec) biosynthetic process,BP,
16425,GO:0097065,1,0.628836948583029,0,4,anterior head development,BP,
16437,GO:0097100,1,0.58766778263415,0,5,supercoiled DNA binding,MF,
16468,GO:0097152,1,0.448155694582053,0,7,mesenchymal cell apoptotic process,BP,
16469,GO:0097153,1,0.284819222399275,0,12,cysteine-type endopeptidase activity involved in apoptotic process,MF,
16473,GO:0097157,1,0.400259181653144,0,8,pre-mRNA intronic binding,MF,
16481,GO:0097167,1,0.634269859028304,0,4,circadian regulation of translation,BP,
16487,GO:0097179,1,0.706035492723095,0,4,protease inhibitor complex,CC,
16498,GO:0097197,1,0.562843324164489,0,5,tetraspanin-enriched microdomain,CC,
16500,GO:0097199,1,0.586513987510498,0,5,cysteine-type endopeptidase activity involved in apoptotic signaling pathway,MF,
16501,GO:0097200,1,0.309073962559264,0,11,cysteine-type endopeptidase activity involved in execution phase of apoptosis,MF,
16505,GO:0097208,1,0.636823373927287,0,4,alveolar lamellar body,CC,
16506,GO:0097209,1,0.639463949239057,0,4,epidermal lamellar body,CC,
16514,GO:0097225,1,0.343544937174867,0,10,sperm midpiece,CC,
16528,GO:0097255,1,0.582177815831493,0,5,R2TP complex,CC,
16530,GO:0097267,1,0.627480158762602,0,4,omega-hydroxylase P450 pathway,BP,
16550,GO:0097322,1,0.50621832382887,0,6,7SK snRNA binding,MF,
16553,GO:0097329,1,0.247326067356452,0,12,response to antimetabolite,BP,
16556,GO:0097340,1,0.295771900273821,0,11,inhibition of cysteine-type endopeptidase activity,BP,
16557,GO:0097341,1,0.295771900273821,0,11,zymogen inhibition,BP,
16558,GO:0097342,1,0.501330706766594,0,6,ripoptosome,CC,
16569,GO:0097361,1,0.65470597003663,0,4,CIA complex,CC,
16574,GO:0097368,1,0.64284152141937,0,4,establishment of Sertoli cell barrier,BP,
16579,GO:0097381,1,0.558941295678441,0,5,photoreceptor disc membrane,CC,
16582,GO:0097384,1,0.45743033850742,0,7,cellular lipid biosynthetic process,BP,
16592,GO:0097413,1,0.461038891490401,0,7,Lewy body,CC,
16594,GO:0097418,1,0.558421378043368,0,5,neurofibrillary tangle,CC,
16596,GO:0097422,1,0.55955009014291,0,5,tubular endosome,CC,
16598,GO:0097427,1,0.558421378043368,0,5,microtubule bundle,CC,
16601,GO:0097433,1,0.563983952187632,0,5,dense body,CC,
16609,GO:0097449,1,0.497319970817577,0,6,astrocyte projection,CC,
16612,GO:0097452,1,0.655636034664277,0,4,GAIT complex,CC,
16641,GO:0097504,1,0.296446398127828,0,11,Gemini of coiled bodies,CC,
16643,GO:0097506,1,0.582169710813063,0,5,deaminated base DNA N-glycosylase activity,MF,
16648,GO:0097524,1,0.627518968070717,0,4,sperm plasma membrane,CC,
16650,GO:0097526,1,0.052653947773946,0,29,spliceosomal tri-snRNP complex,CC,
16651,GO:0097527,1,0.566223354494132,0,5,necroptotic signaling pathway,BP,
16660,GO:0097539,1,0.311752070884584,0,10,ciliary transition fiber,CC,
16665,GO:0097550,1,0.51816051200575,0,6,transcriptional preinitiation complex,CC,
16674,GO:0097602,1,0.154689590080304,0,17,cullin family protein binding,MF,
16695,GO:0097646,1,0.661051628077042,0,4,calcitonin family receptor signaling pathway,BP,
16702,GO:0097677,1,0.531201458574598,0,6,STAT family protein binding,MF,
16725,GO:0097732,1,0.576429335308446,0,5,9+2 non-motile cilium,CC,
16737,GO:0098501,1,0.586986116392853,0,5,polynucleotide dephosphorylation,BP,
16741,GO:0098505,1,0.316311722402924,0,10,G-rich strand telomeric DNA binding,MF,
16747,GO:0098528,1,0.634932636414187,0,4,skeletal muscle fiber differentiation,BP,
16750,GO:0098532,1,0.561800777203435,0,6,histone H3-K27 trimethylation,BP,
16756,GO:0098543,1,0.455263236879152,0,7,detection of other organism,BP,
16761,GO:0098556,1,0.694800059058291,0,5,cytoplasmic side of rough endoplasmic reticulum membrane,CC,
16767,GO:0098574,1,0.627517043003951,0,4,cytoplasmic side of lysosomal membrane,CC,
16769,GO:0098576,1,0.630455931298981,0,4,lumenal side of membrane,CC,
16771,GO:0098581,1,0.405171121704713,0,8,detection of external biotic stimulus,BP,
16797,GO:0098641,1,0.139919769389152,0,18,cadherin binding involved in cell-cell adhesion,MF,
16798,GO:0098642,1,0.497000558437333,0,6,network-forming collagen trimer,CC,
16799,GO:0098643,1,0.393626380044218,0,8,banded collagen fibril,CC,
16800,GO:0098644,1,0.174003522075878,0,15,complex of collagen trimers,CC,
16801,GO:0098645,1,0.497000558437333,0,6,collagen network,CC,
16805,GO:0098651,1,0.497000558437333,0,6,basement membrane collagen trimer,CC,
16823,GO:0098706,1,0.627449537468743,0,4,ferric iron import across plasma membrane,BP,
16855,GO:0098779,1,0.414225360465813,0,8,positive regulation of mitophagy in response to mitochondrial depolarization,BP,
16856,GO:0098780,1,0.14539656695888,0,17,response to mitochondrial depolarisation,BP,
16858,GO:0098787,1,0.197846063496149,0,14,mRNA cleavage involved in mRNA processing,BP,
16859,GO:0098789,1,0.280632797362555,0,11,pre-mRNA cleavage required for polyadenylation,BP,
16878,GO:0098814,1,0.568400724217563,0,5,spontaneous synaptic transmission,BP,
16883,GO:0098826,1,0.628244602871734,0,4,endoplasmic reticulum tubular network membrane,CC,
16898,GO:0098845,1,0.500836148886242,0,6,postsynaptic endosome,CC,
16899,GO:0098847,1,0.224864603579068,0,13,sequence-specific single stranded DNA binding,MF,
16931,GO:0098909,1,0.579924066856585,0,5,regulation of cardiac muscle cell action potential involved in regulation of contraction,BP,
16932,GO:0098910,1,0.558421378043368,0,5,regulation of atrial cardiac muscle cell action potential,BP,
16933,GO:0098911,1,0.350312910972375,0,9,regulation of ventricular cardiac muscle cell action potential,BP,
16956,GO:0098957,1,0.632414622147709,0,4,anterograde axonal transport of mitochondrion,BP,
16957,GO:0098960,1,0.559665210871402,0,5,postsynaptic neurotransmitter receptor activity,MF,
16998,GO:0099078,1,0.427255590157646,0,8,BORC complex,CC,
17004,GO:0099086,1,0.143057611584337,0,17,synaptonemal structure,CC,
17012,GO:0099116,1,0.195458025778642,0,16,tRNA 5'-end processing,BP,
17018,GO:0099133,1,0.393626380044218,0,8,ATP hydrolysis coupled anion transmembrane transport,BP,
17035,GO:0099500,1,0.327358023359488,0,10,vesicle fusion to plasma membrane,BP,
17042,GO:0099515,1,0.350307203388121,0,9,actin filament-based transport,BP,
17054,GO:0099529,1,0.559665210871402,0,5,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential,MF,
17084,GO:0099602,1,0.532549841257361,0,6,neurotransmitter receptor regulator activity,MF,
17132,GO:0102158,1,0.627449537459612,0,4,very-long-chain 3-hydroxyacyl-CoA dehydratase activity,MF,
17137,GO:0102336,1,0.565895648572829,0,5,3-oxo-arachidoyl-CoA synthase activity,MF,
17138,GO:0102337,1,0.565895648572829,0,5,3-oxo-cerotoyl-CoA synthase activity,MF,
17139,GO:0102338,1,0.565895648572829,0,5,3-oxo-lignoceronyl-CoA synthase activity,MF,
17144,GO:0102343,1,0.627449537459612,0,4,3-hydroxy-arachidoyl-CoA dehydratase activity,MF,
17145,GO:0102344,1,0.627449537459612,0,4,3-hydroxy-behenoyl-CoA dehydratase activity,MF,
17146,GO:0102345,1,0.627449537459612,0,4,3-hydroxy-lignoceroyl-CoA dehydratase activity,MF,
17149,GO:0102391,1,0.627449537468743,0,4,decanoate-CoA ligase activity,MF,
17150,GO:0102420,1,0.627449537468743,0,4,sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity,MF,
17170,GO:0102756,1,0.565895648572829,0,5,very-long-chain 3-ketoacyl-CoA synthase activity,MF,
17208,GO:0106049,1,0.57347291047177,0,5,regulation of cellular response to osmotic stress,BP,
17212,GO:0106058,1,0.409487336005808,0,8,positive regulation of calcineurin-mediated signaling,BP,
17220,GO:0106077,1,0.627449537468743,0,4,histone succinylation,BP,
17230,GO:0110011,1,0.558421378043368,0,5,regulation of basement membrane organization,BP,
17246,GO:0110096,1,0.600688911445211,0,5,cellular response to aldehyde,BP,
17247,GO:0120009,1,0.560576179558436,0,5,intermembrane lipid transfer,BP,
17249,GO:0120013,1,0.560576179558436,0,5,intermembrane lipid transfer activity,MF,
17275,GO:0120103,1,0.350307203388121,0,9,centriolar subdistal appendage,CC,
17288,GO:0140035,1,0.497844071074518,0,6,ubiquitination-like modification-dependent protein binding,MF,
17289,GO:0140036,1,0.497844071074518,0,6,ubiquitin-dependent protein binding,MF,
17295,GO:0140059,1,0.559429456203534,0,5,dendrite arborization,BP,
17314,GO:0140115,1,0.353860210488887,0,9,export across plasma membrane,BP,
17315,GO:0140131,1,0.381343597609844,0,9,positive regulation of lymphocyte chemotaxis,BP,
17326,GO:0150005,1,0.332470924523942,0,10,enzyme activator complex,CC,
17341,GO:1900017,1,0.356087910411492,0,9,positive regulation of cytokine production involved in inflammatory response,BP,
17352,GO:1900037,1,0.339102811815152,0,10,regulation of cellular response to hypoxia,BP,
17353,GO:1900038,1,0.508083608326843,0,6,negative regulation of cellular response to hypoxia,BP,
17355,GO:1900040,1,0.558421378043368,0,5,regulation of interleukin-2 secretion,BP,
17358,GO:1900044,1,0.393786443404572,0,8,regulation of protein K63-linked ubiquitination,BP,
17359,GO:1900045,1,0.558648394761675,0,5,negative regulation of protein K63-linked ubiquitination,BP,
17363,GO:1900060,1,0.641314371505962,0,4,negative regulation of ceramide biosynthetic process,BP,
17388,GO:1900112,1,0.360581424738778,0,9,regulation of histone H3-K9 trimethylation,BP,
17389,GO:1900113,1,0.574792622786847,0,5,negative regulation of histone H3-K9 trimethylation,BP,
17455,GO:1900227,1,0.627449537468743,0,4,positive regulation of NLRP3 inflammasome complex assembly,BP,
17459,GO:1900242,1,0.498137500319516,0,6,regulation of synaptic vesicle endocytosis,BP,
17463,GO:1900246,1,0.558442371105468,0,5,positive regulation of RIG-I signaling pathway,BP,
17464,GO:1900247,1,0.279962772270869,0,11,regulation of cytoplasmic translational elongation,BP,
17468,GO:1900262,1,0.512310523923483,0,6,regulation of DNA-directed DNA polymerase activity,BP,
17469,GO:1900264,1,0.512310523923483,0,6,positive regulation of DNA-directed DNA polymerase activity,BP,
17476,GO:1900363,1,0.249884467890101,0,12,regulation of mRNA polyadenylation,BP,
17477,GO:1900364,1,0.393746262686061,0,8,negative regulation of mRNA polyadenylation,BP,
17485,GO:1900376,1,0.627449537468743,0,4,regulation of secondary metabolite biosynthetic process,BP,
17496,GO:1900426,1,0.472812780185785,0,7,positive regulation of defense response to bacterium,BP,
17524,GO:1900750,1,0.321268031437291,0,11,oligopeptide binding,MF,
17529,GO:1900864,1,0.369910933845148,0,9,mitochondrial RNA modification,BP,
17554,GO:1901077,1,0.561589988406699,0,5,regulation of relaxation of muscle,BP,
17563,GO:1901097,1,0.629143761671981,0,4,negative regulation of autophagosome maturation,BP,
17591,GO:1901213,1,0.398646666261425,0,8,regulation of transcription from RNA polymerase II promoter involved in heart development,BP,
17629,GO:1901317,1,0.668672891222563,0,4,regulation of flagellated sperm motility,BP,
17639,GO:1901341,1,0.627449537468743,0,4,positive regulation of store-operated calcium channel activity,BP,
17658,GO:1901386,1,0.567182816448309,0,5,negative regulation of voltage-gated calcium channel activity,BP,
17662,GO:1901407,1,0.357581326343791,0,9,regulation of phosphorylation of RNA polymerase II C-terminal domain,BP,
17663,GO:1901409,1,0.451380235880969,0,7,positive regulation of phosphorylation of RNA polymerase II C-terminal domain,BP,
17668,GO:1901490,1,0.628865804488213,0,4,regulation of lymphangiogenesis,BP,
17671,GO:1901503,1,0.57534786197682,0,5,ether biosynthetic process,BP,
17676,GO:1901524,1,0.205843077258807,0,14,regulation of mitophagy,BP,
17677,GO:1901525,1,0.497173989050113,0,6,negative regulation of mitophagy,BP,
17678,GO:1901526,1,0.414225360465813,0,8,positive regulation of mitophagy,BP,
17680,GO:1901532,1,6.71341181470977e-05,0,103,regulation of hematopoietic progenitor cell differentiation,BP,
17681,GO:1901533,1,0.513787592848107,0,6,negative regulation of hematopoietic progenitor cell differentiation,BP,
17683,GO:1901535,1,0.558421378043368,0,5,regulation of DNA demethylation,BP,
17688,GO:1901550,1,0.358394065684791,0,9,regulation of endothelial cell development,BP,
17694,GO:1901563,1,0.559024081449612,0,5,response to camptothecin,BP,
17722,GO:1901623,1,0.339375046380618,0,10,regulation of lymphocyte chemotaxis,BP,
17740,GO:1901660,1,0.499596671825823,0,6,calcium ion export,BP,
17748,GO:1901673,1,0.116293260279059,0,19,regulation of mitotic spindle assembly,BP,
17753,GO:1901679,1,0.40160372972851,0,8,nucleotide transmembrane transport,BP,
17766,GO:1901723,1,0.561943142602722,0,5,negative regulation of cell proliferation involved in kidney development,BP,
17772,GO:1901739,1,0.331330738216076,0,10,regulation of myoblast fusion,BP,
17774,GO:1901741,1,0.370978834996054,0,9,positive regulation of myoblast fusion,BP,
17786,GO:1901836,1,0.287223721181252,0,11,regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
17788,GO:1901838,1,0.360668059189754,0,9,positive regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
17789,GO:1901841,1,0.568911858857918,0,5,regulation of high voltage-gated calcium channel activity,BP,
17792,GO:1901844,1,0.452597571132111,0,7,regulation of cell communication by electrical coupling involved in cardiac conduction,BP,
17794,GO:1901857,1,0.596111645246592,0,5,positive regulation of cellular respiration,BP,
17795,GO:1901858,1,0.640020359115862,0,4,regulation of mitochondrial DNA metabolic process,BP,
17805,GO:1901881,1,0.361755388397205,0,9,positive regulation of protein depolymerization,BP,
17807,GO:1901889,1,0.156999979698283,0,16,negative regulation of cell junction assembly,BP,
17812,GO:1901897,1,0.62909189970339,0,4,regulation of relaxation of cardiac muscle,BP,
17815,GO:1901906,1,0.640827166600949,0,4,diadenosine pentaphosphate metabolic process,BP,
17816,GO:1901907,1,0.640827166600949,0,4,diadenosine pentaphosphate catabolic process,BP,
17817,GO:1901908,1,0.640827166600949,0,4,diadenosine hexaphosphate metabolic process,BP,
17818,GO:1901909,1,0.640827166600949,0,4,diadenosine hexaphosphate catabolic process,BP,
17819,GO:1901910,1,0.640827166600949,0,4,adenosine 5'-(hexahydrogen pentaphosphate) metabolic process,BP,
17820,GO:1901911,1,0.640827166600949,0,4,adenosine 5'-(hexahydrogen pentaphosphate) catabolic process,BP,
17827,GO:1901970,1,0.417221306193947,0,8,positive regulation of mitotic sister chromatid separation,BP,
17848,GO:1902004,1,0.355623316935163,0,9,positive regulation of amyloid-beta formation,BP,
17855,GO:1902031,1,0.506946697896102,0,6,regulation of NADP metabolic process,BP,
17856,GO:1902033,1,0.563154121750928,0,5,regulation of hematopoietic stem cell proliferation,BP,
17857,GO:1902035,1,0.632762640681287,0,4,positive regulation of hematopoietic stem cell proliferation,BP,
17858,GO:1902036,1,0.000164604735279519,0,95,regulation of hematopoietic stem cell differentiation,BP,
17863,GO:1902043,1,0.197879168493124,0,14,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,
17875,GO:1902099,1,0.00596434658012749,0,46,regulation of metaphase/anaphase transition of cell cycle,BP,
17876,GO:1902100,1,0.0338386613572353,0,30,negative regulation of metaphase/anaphase transition of cell cycle,BP,
17877,GO:1902101,1,0.417221306193947,0,8,positive regulation of metaphase/anaphase transition of cell cycle,BP,
17904,GO:1902177,1,0.595998369620677,0,5,positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
17907,GO:1902187,1,0.196301824691312,0,14,negative regulation of viral release from host cell,BP,
17918,GO:1902218,1,0.57347291047177,0,5,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
17919,GO:1902219,1,0.627449537468743,0,4,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
17921,GO:1902221,1,0.673709723299949,0,4,erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process,BP,
17922,GO:1902222,1,0.673709723299949,0,4,erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process,BP,
17929,GO:1902231,1,0.547986619848479,0,6,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,
17996,GO:1902410,1,0.503286441576989,0,6,mitotic cytokinetic process,BP,
17998,GO:1902414,1,0.395262255988933,0,8,protein localization to cell junction,BP,
17999,GO:1902415,1,0.365486055538446,0,9,regulation of mRNA binding,BP,
18000,GO:1902416,1,0.458193065222604,0,7,positive regulation of mRNA binding,BP,
18008,GO:1902455,1,0.627450828380627,0,4,negative regulation of stem cell population maintenance,BP,
18009,GO:1902459,1,0.558421378043368,0,5,positive regulation of stem cell population maintenance,BP,
18030,GO:1902513,1,0.500971441632598,0,6,regulation of organelle transport along microtubule,BP,
18046,GO:1902555,1,0.0433913300136563,0,29,endoribonuclease complex,CC,
18049,GO:1902562,1,0.00956352851243895,0,41,H4 histone acetyltransferase complex,CC,
18055,GO:1902570,1,0.387656096466929,0,9,protein localization to nucleolus,BP,
18060,GO:1902581,1,0.587055839281079,0,5,multi-organism cellular localization,BP,
18061,GO:1902583,1,0.587055839281079,0,5,multi-organism intracellular transport,BP,
18072,GO:1902617,1,0.654286136170361,0,4,response to fluoride,BP,
18100,GO:1902713,1,0.627452932168296,0,4,regulation of interferon-gamma secretion,BP,
18112,GO:1902739,1,0.496982022965512,0,6,regulation of interferon-alpha secretion,BP,
18113,GO:1902741,1,0.496982022965512,0,6,positive regulation of interferon-alpha secretion,BP,
18127,GO:1902774,1,0.513401363566918,0,6,late endosome to lysosome transport,BP,
18148,GO:1902857,1,0.46136883556824,0,7,positive regulation of non-motile cilium assembly,BP,
18166,GO:1902902,1,0.289925518537916,0,11,negative regulation of autophagosome assembly,BP,
18175,GO:1902914,1,0.18036893863588,0,15,regulation of protein polyubiquitination,BP,
18176,GO:1902915,1,0.497184079915174,0,6,negative regulation of protein polyubiquitination,BP,
18177,GO:1902916,1,0.407866619441653,0,8,positive regulation of protein polyubiquitination,BP,
18202,GO:1902961,1,0.506252355073583,0,6,positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
18215,GO:1902993,1,0.283471286030097,0,11,positive regulation of amyloid precursor protein catabolic process,BP,
18228,GO:1903010,1,0.278051661540079,0,11,regulation of bone development,BP,
18230,GO:1903012,1,0.628736322292054,0,4,positive regulation of bone development,BP,
18233,GO:1903020,1,0.182850565477534,0,15,positive regulation of glycoprotein metabolic process,BP,
18234,GO:1903025,1,0.417192807001252,0,9,regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
18235,GO:1903026,1,0.651355006677399,0,5,negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
18256,GO:1903059,1,0.637989548136875,0,4,regulation of protein lipidation,BP,
18257,GO:1903061,1,0.637989548136875,0,4,positive regulation of protein lipidation,BP,
18272,GO:1903115,1,0.0912930569333725,0,21,regulation of actin filament-based movement,BP,
18275,GO:1903121,1,0.650317238269254,0,4,regulation of TRAIL-activated apoptotic signaling pathway,BP,
18281,GO:1903140,1,0.358394065684791,0,9,regulation of establishment of endothelial barrier,BP,
18286,GO:1903147,1,0.410239677881082,0,8,negative regulation of autophagy of mitochondrion,BP,
18307,GO:1903203,1,0.129406138038506,0,18,regulation of oxidative stress-induced neuron death,BP,
18308,GO:1903204,1,0.206359842625471,0,14,negative regulation of oxidative stress-induced neuron death,BP,
18320,GO:1903232,1,0.603401806451768,0,5,melanosome assembly,BP,
18330,GO:1903251,1,0.568006588163484,0,5,multi-ciliated epithelial cell differentiation,BP,
18332,GO:1903265,1,0.413449077168973,0,8,positive regulation of tumor necrosis factor-mediated signaling pathway,BP,
18346,GO:1903297,1,0.570894312620576,0,5,regulation of hypoxia-induced intrinsic apoptotic signaling pathway,BP,
18347,GO:1903298,1,0.570894312620576,0,5,negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway,BP,
18363,GO:1903332,1,0.467028697324766,0,7,regulation of protein folding,BP,
18364,GO:1903333,1,0.589580940490274,0,5,negative regulation of protein folding,BP,
18365,GO:1903335,1,0.648142541112921,0,4,regulation of vacuolar transport,BP,
18368,GO:1903347,1,0.632912650442929,0,4,negative regulation of bicellular tight junction assembly,BP,
18375,GO:1903361,1,0.572907618100707,0,5,protein localization to basolateral plasma membrane,BP,
18381,GO:1903371,1,0.628046635990706,0,4,regulation of endoplasmic reticulum tubular network organization,BP,
18384,GO:1903376,1,0.457238369895179,0,7,regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
18385,GO:1903377,1,0.648638945414881,0,4,negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
18394,GO:1903392,1,0.220860604579345,0,13,negative regulation of adherens junction organization,BP,
18399,GO:1903405,1,0.35783078221746,0,9,protein localization to nuclear body,BP,
18435,GO:1903504,1,0.230627136376189,0,13,regulation of mitotic spindle checkpoint,BP,
18500,GO:1903608,1,0.451592572903275,0,7,protein localization to cytoplasmic stress granule,BP,
18527,GO:1903689,1,0.496982022965512,0,6,regulation of wound healing, spreading of epidermal cells,BP,
18528,GO:1903690,1,0.627449537468743,0,4,negative regulation of wound healing, spreading of epidermal cells,BP,
18551,GO:1903748,1,0.635765190426202,0,4,negative regulation of establishment of protein localization to mitochondrion,BP,
18555,GO:1903753,1,0.628121373236911,0,4,negative regulation of p38MAPK cascade,BP,
18567,GO:1903772,1,0.578546645328871,0,5,regulation of viral budding via host ESCRT complex,BP,
18595,GO:1903830,1,0.141657905566596,0,17,magnesium ion transmembrane transport,BP,
18606,GO:1903859,1,0.311925206108708,0,10,regulation of dendrite extension,BP,
18608,GO:1903861,1,0.393730248458066,0,8,positive regulation of dendrite extension,BP,
18609,GO:1903862,1,0.582574466073437,0,5,positive regulation of oxidative phosphorylation,BP,
18622,GO:1903895,1,0.627769602185044,0,4,negative regulation of IRE1-mediated unfolded protein response,BP,
18635,GO:1903912,1,0.630579544682679,0,4,negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,BP,
18715,GO:1904090,1,0.706035492723095,0,4,peptidase inhibitor complex,CC,
18727,GO:1904153,1,0.365213135342158,0,9,negative regulation of retrograde protein transport, ER to cytosol,BP,
18777,GO:1904259,1,0.558421378043368,0,5,regulation of basement membrane assembly involved in embryonic body morphogenesis,BP,
18778,GO:1904261,1,0.558421378043368,0,5,positive regulation of basement membrane assembly involved in embryonic body morphogenesis,BP,
18780,GO:1904263,1,0.411929964331596,0,8,positive regulation of TORC1 signaling,BP,
18788,GO:1904288,1,0.627876622840206,0,4,BAT3 complex binding,MF,
18792,GO:1904293,1,0.233715157935654,0,13,negative regulation of ERAD pathway,BP,
18801,GO:1904315,1,0.559665210871402,0,5,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential,MF,
18818,GO:1904357,1,0.0501041735416429,0,26,negative regulation of telomere maintenance via telomere lengthening,BP,
18863,GO:1904467,1,0.313001124566662,0,10,regulation of tumor necrosis factor secretion,BP,
18865,GO:1904469,1,0.442598889120798,0,7,positive regulation of tumor necrosis factor secretion,BP,
18936,GO:1904666,1,0.168685059547438,0,18,regulation of ubiquitin protein ligase activity,BP,
18937,GO:1904667,1,0.612074139973705,0,6,negative regulation of ubiquitin protein ligase activity,BP,
18938,GO:1904668,1,0.275735141356017,0,12,positive regulation of ubiquitin protein ligase activity,BP,
18947,GO:1904688,1,0.577221022522727,0,5,regulation of cytoplasmic translational initiation,BP,
18949,GO:1904690,1,0.632345224033098,0,4,positive regulation of cytoplasmic translational initiation,BP,
18962,GO:1904714,1,0.499745803462161,0,6,regulation of chaperone-mediated autophagy,BP,
18975,GO:1904742,1,0.647089711076637,0,4,regulation of telomeric DNA binding,BP,
18981,GO:1904749,1,0.648810028636617,0,4,regulation of protein localization to nucleolus,BP,
18994,GO:1904776,1,0.49698202295828,0,6,regulation of protein localization to cell cortex,BP,
18996,GO:1904778,1,0.558421378043368,0,5,positive regulation of protein localization to cell cortex,BP,
19005,GO:1904796,1,0.563541393476986,0,5,regulation of core promoter binding,BP,
19007,GO:1904798,1,0.633201957221622,0,4,positive regulation of core promoter binding,BP,
19015,GO:1904814,1,0.225478763543419,0,13,regulation of protein localization to chromosome, telomeric region,BP,
19017,GO:1904816,1,0.283556240828815,0,11,positive regulation of protein localization to chromosome, telomeric region,BP,
19033,GO:1904851,1,0.357118404535828,0,9,positive regulation of establishment of protein localization to telomere,BP,
19037,GO:1904867,1,0.35783078221746,0,9,protein localization to Cajal body,BP,
19039,GO:1904869,1,0.400067712220693,0,8,regulation of protein localization to Cajal body,BP,
19040,GO:1904871,1,0.400067712220693,0,8,positive regulation of protein localization to Cajal body,BP,
19041,GO:1904872,1,0.140048174112789,0,18,regulation of telomerase RNA localization to Cajal body,BP,
19042,GO:1904874,1,0.198736751464361,0,15,positive regulation of telomerase RNA localization to Cajal body,BP,
19052,GO:1904885,1,0.558421378043368,0,5,beta-catenin destruction complex assembly,BP,
19061,GO:1904896,1,0.327362139538942,0,10,ESCRT complex disassembly,BP,
19063,GO:1904903,1,0.327362139538942,0,10,ESCRT III complex disassembly,BP,
19070,GO:1904923,1,0.260093538853507,0,12,regulation of autophagy of mitochondrion in response to mitochondrial depolarization,BP,
19072,GO:1904925,1,0.292151918585587,0,11,positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization,BP,
19074,GO:1904929,1,0.49698202295828,0,6,coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway,MF,
19109,GO:1905005,1,0.499248607961633,0,6,regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
19111,GO:1905007,1,0.558421378043368,0,5,positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
19182,GO:1905214,1,0.289460923352836,0,11,regulation of RNA binding,BP,
19184,GO:1905216,1,0.407773775404943,0,8,positive regulation of RNA binding,BP,
19190,GO:1905244,1,0.395247208661287,0,8,regulation of modification of synaptic structure,BP,
19193,GO:1905247,1,0.506252355073583,0,6,positive regulation of aspartic-type peptidase activity,BP,
19220,GO:1905314,1,0.356783980913457,0,9,semi-lunar valve development,BP,
19225,GO:1905323,1,0.502344441858532,0,6,telomerase holoenzyme complex assembly,BP,
19227,GO:1905331,1,0.198962789306411,0,14,negative regulation of morphogenesis of an epithelium,BP,
19232,GO:1905340,1,0.632940096704656,0,4,regulation of protein localization to kinetochore,BP,
19234,GO:1905342,1,0.632940096704656,0,4,positive regulation of protein localization to kinetochore,BP,
19236,GO:1905348,1,0.0433913300136563,0,29,endonuclease complex,CC,
19274,GO:1905446,1,0.582574466073437,0,5,regulation of mitochondrial ATP synthesis coupled electron transport,BP,
19276,GO:1905448,1,0.654585881634123,0,4,positive regulation of mitochondrial ATP synthesis coupled electron transport,BP,
19279,GO:1905456,1,0.457247782866507,0,7,regulation of lymphoid progenitor cell differentiation,BP,
19338,GO:1905634,1,0.499334571987611,0,6,regulation of protein localization to chromatin,BP,
19381,GO:1905818,1,0.00276985029367767,0,53,regulation of chromosome separation,BP,
19382,GO:1905819,1,0.0314349890031152,0,31,negative regulation of chromosome separation,BP,
19383,GO:1905820,1,0.371307329396748,0,9,positive regulation of chromosome separation,BP,
19384,GO:1905832,1,0.627449537468743,0,4,positive regulation of spindle assembly,BP,
19432,GO:1990001,1,0.402192345567144,0,8,inhibition of cysteine-type endopeptidase activity involved in apoptotic process,BP,
19437,GO:1990023,1,0.232060223122993,0,13,mitotic spindle midzone,CC,
19460,GO:1990111,1,0.678243292099721,0,4,spermatoproteasome complex,CC,
19464,GO:1990124,1,0.457561446137195,0,7,messenger ribonucleoprotein complex,CC,
19467,GO:1990130,1,0.563567580606785,0,5,GATOR1 complex,CC,
19482,GO:1990173,1,0.318448179145509,0,10,protein localization to nucleoplasm,BP,
19492,GO:1990226,1,0.563449217702334,0,5,histone methyltransferase binding,MF,
19494,GO:1990239,1,0.641166303021087,0,4,steroid hormone binding,MF,
19495,GO:1990246,1,0.627449537459612,0,4,uniplex complex,CC,
19496,GO:1990247,1,0.442297753196275,0,7,N6-methyladenosine-containing RNA binding,MF,
19498,GO:1990254,1,0.634440813922806,0,4,keratin filament binding,MF,
19517,GO:1990380,1,0.350310689518836,0,9,Lys48-specific deubiquitinase activity,MF,
19535,GO:1990414,1,0.629361063027041,0,4,replication-born double-strand break repair via sister chromatid exchange,BP,
19550,GO:1990441,1,0.630579544682679,0,4,negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,BP,
19552,GO:1990446,1,0.653504639847599,0,4,U1 snRNP binding,MF,
19561,GO:1990481,1,0.636274701610933,0,4,mRNA pseudouridine synthesis,BP,
19566,GO:1990511,1,0.627449537468743,0,4,piRNA biosynthetic process,BP,
19573,GO:1990564,1,0.584898335293371,0,5,protein polyufmylation,BP,
19585,GO:1990592,1,0.584898335293371,0,5,protein K69-linked ufmylation,BP,
19595,GO:1990635,1,0.629838770777757,0,4,proximal dendrite,CC,
19602,GO:1990668,1,0.510015259284133,0,6,vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane,BP,
19612,GO:1990726,1,0.660129318954123,0,5,Lsm1-7-Pat1 complex,CC,
19635,GO:1990774,1,0.278549083097833,0,11,tumor necrosis factor secretion,BP,
19645,GO:1990809,1,0.628241343415956,0,4,endoplasmic reticulum tubular network membrane organization,BP,
19650,GO:1990825,1,0.324093799208984,0,10,sequence-specific mRNA binding,MF,
19659,GO:1990845,1,0.500418976093429,0,6,adaptive thermogenesis,BP,
19662,GO:1990868,1,0.56072292669788,0,5,response to chemokine,BP,
19663,GO:1990869,1,0.56072292669788,0,5,cellular response to chemokine,BP,
19672,GO:1990907,1,0.277797194068638,0,11,beta-catenin-TCF complex,CC,
19688,GO:1990948,1,0.662017981923758,0,5,ubiquitin ligase inhibitor activity,MF,
19690,GO:1990966,1,0.641606190041193,0,4,ATP generation from poly-ADP-D-ribose,BP,
19711,GO:2000018,1,0.517828005307338,0,6,regulation of male gonad development,BP,
19713,GO:2000020,1,0.581842389668071,0,5,positive regulation of male gonad development,BP,
19716,GO:2000035,1,0.640059935999826,0,4,regulation of stem cell division,BP,
19722,GO:2000047,1,0.579914425068739,0,5,regulation of cell-cell adhesion mediated by cadherin,BP,
19726,GO:2000051,1,0.627449537468743,0,4,negative regulation of non-canonical Wnt signaling pathway,BP,
19738,GO:2000074,1,0.455908352998956,0,7,regulation of type B pancreatic cell development,BP,
19743,GO:2000095,1,0.352548297959561,0,9,regulation of Wnt signaling pathway, planar cell polarity pathway,BP,
19744,GO:2000096,1,0.49996610264528,0,6,positive regulation of Wnt signaling pathway, planar cell polarity pathway,BP,
19752,GO:2000109,1,0.522265611019528,0,6,regulation of macrophage apoptotic process,BP,
19764,GO:2000136,1,0.294580638485288,0,11,regulation of cell proliferation involved in heart morphogenesis,BP,
19766,GO:2000138,1,0.562247495447562,0,5,positive regulation of cell proliferation involved in heart morphogenesis,BP,
19769,GO:2000144,1,0.0763318263886256,0,23,positive regulation of DNA-templated transcription, initiation,BP,
19773,GO:2000152,1,0.672272232728827,0,4,regulation of ubiquitin-specific protease activity,BP,
19795,GO:2000197,1,0.497921564995003,0,6,regulation of ribonucleoprotein complex localization,BP,
19811,GO:2000232,1,0.292020708659286,0,11,regulation of rRNA processing,BP,
19813,GO:2000234,1,0.414311587421598,0,8,positive regulation of rRNA processing,BP,
19818,GO:2000251,1,0.337245755058602,0,10,positive regulation of actin cytoskeleton reorganization,BP,
19842,GO:2000288,1,0.506591605579772,0,6,positive regulation of myoblast proliferation,BP,
19843,GO:2000291,1,0.45085070926605,0,7,regulation of myoblast proliferation,BP,
19860,GO:2000316,1,0.4580120129235,0,7,regulation of T-helper 17 type immune response,BP,
19862,GO:2000318,1,0.649736153453228,0,4,positive regulation of T-helper 17 type immune response,BP,
19863,GO:2000319,1,0.576583709845944,0,5,regulation of T-helper 17 cell differentiation,BP,
19866,GO:2000322,1,0.445793465757189,0,7,regulation of glucocorticoid receptor signaling pathway,BP,
19867,GO:2000323,1,0.499720194234389,0,6,negative regulation of glucocorticoid receptor signaling pathway,BP,
19885,GO:2000347,1,0.633393656847804,0,4,positive regulation of hepatocyte proliferation,BP,
19900,GO:2000370,1,0.627449537468743,0,4,positive regulation of clathrin-dependent endocytosis,BP,
19901,GO:2000371,1,0.498417151142788,0,6,regulation of DNA topoisomerase (ATP-hydrolyzing) activity,BP,
19902,GO:2000373,1,0.498417151142788,0,6,positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity,BP,
19952,GO:2000465,1,0.497690208408044,0,6,regulation of glycogen (starch) synthase activity,BP,
19959,GO:2000480,1,0.453692849606489,0,7,negative regulation of cAMP-dependent protein kinase activity,BP,
19960,GO:2000481,1,0.629137219916025,0,4,positive regulation of cAMP-dependent protein kinase activity,BP,
19985,GO:2000542,1,0.631176649763831,0,4,negative regulation of gastrulation,BP,
19992,GO:2000561,1,0.629530245447681,0,4,regulation of CD4-positive, alpha-beta T cell proliferation,BP,
20003,GO:2000576,1,0.597551437026647,0,5,positive regulation of microtubule motor activity,BP,
20004,GO:2000580,1,0.671412676646905,0,4,regulation of ATP-dependent microtubule motor activity, plus-end-directed,BP,
20005,GO:2000582,1,0.671412676646905,0,4,positive regulation of ATP-dependent microtubule motor activity, plus-end-directed,BP,
20015,GO:2000601,1,0.49698202295828,0,6,positive regulation of Arp2/3 complex-mediated actin nucleation,BP,
20021,GO:2000615,1,0.286948464323667,0,11,regulation of histone H3-K9 acetylation,BP,
20023,GO:2000617,1,0.455328745990537,0,7,positive regulation of histone H3-K9 acetylation,BP,
20024,GO:2000618,1,0.570163690457512,0,5,regulation of histone H4-K16 acetylation,BP,
20027,GO:2000622,1,0.627449537468743,0,4,regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
20028,GO:2000623,1,0.627449537468743,0,4,negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
20031,GO:2000628,1,0.453272096182334,0,7,regulation of miRNA metabolic process,BP,
20032,GO:2000630,1,0.572274584553012,0,5,positive regulation of miRNA metabolic process,BP,
20054,GO:2000659,1,0.510021913140288,0,6,regulation of interleukin-1-mediated signaling pathway,BP,
20055,GO:2000660,1,0.64168043747736,0,4,negative regulation of interleukin-1-mediated signaling pathway,BP,
20070,GO:2000676,1,0.633308668695781,0,4,positive regulation of type B pancreatic cell apoptotic process,BP,
20080,GO:2000698,1,0.65705651663217,0,4,positive regulation of epithelial cell differentiation involved in kidney development,BP,
20099,GO:2000737,1,0.16007735004084,0,16,negative regulation of stem cell differentiation,BP,
20100,GO:2000738,1,0.316024949223058,0,10,positive regulation of stem cell differentiation,BP,
20101,GO:2000739,1,0.627449537468743,0,4,regulation of mesenchymal stem cell differentiation,BP,
20117,GO:2000767,1,0.396698716615105,0,8,positive regulation of cytoplasmic translation,BP,
20127,GO:2000781,1,0.199863699215649,0,14,positive regulation of double-strand break repair,BP,
20133,GO:2000794,1,0.497749336728679,0,6,regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
20143,GO:2000811,1,0.229015872979711,0,13,negative regulation of anoikis,BP,
20145,GO:2000816,1,0.0314349890031152,0,31,negative regulation of mitotic sister chromatid separation,BP,
20150,GO:2000823,1,0.683229876218204,0,4,regulation of androgen receptor activity,BP,
20151,GO:2000825,1,0.683229876218204,0,4,positive regulation of androgen receptor activity,BP,
20152,GO:2000826,1,0.0653122242138502,0,24,regulation of heart morphogenesis,BP,
20156,GO:2000831,1,0.51727555263213,0,6,regulation of steroid hormone secretion,BP,
20158,GO:2000833,1,0.653066026949667,0,4,positive regulation of steroid hormone secretion,BP,
20163,GO:2000846,1,0.581221695550529,0,5,regulation of corticosteroid hormone secretion,BP,
20178,GO:2000973,1,0.513778959189729,0,6,regulation of pro-B cell differentiation,BP,
20183,GO:2000980,1,0.577290340504065,0,5,regulation of inner ear receptor cell differentiation,BP,
20184,GO:2000981,1,0.648649098432387,0,4,negative regulation of inner ear receptor cell differentiation,BP,
20188,GO:2001012,1,0.631403185261663,0,4,mesenchymal cell differentiation involved in renal system development,BP,
20206,GO:2001034,1,0.559338794812744,0,5,positive regulation of double-strand break repair via nonhomologous end joining,BP,
20212,GO:2001044,1,0.375283003105522,0,9,regulation of integrin-mediated signaling pathway,BP,
20214,GO:2001046,1,0.575275328512935,0,5,positive regulation of integrin-mediated signaling pathway,BP,
20215,GO:2001053,1,0.503563652250724,0,6,regulation of mesenchymal cell apoptotic process,BP,
20216,GO:2001054,1,0.565081807621333,0,5,negative regulation of mesenchymal cell apoptotic process,BP,
20246,GO:2001166,1,0.559557012423483,0,5,regulation of histone H2B ubiquitination,BP,
20247,GO:2001168,1,0.62759006786322,0,4,positive regulation of histone H2B ubiquitination,BP,
20257,GO:2001182,1,0.630595884011974,0,4,regulation of interleukin-12 secretion,BP,
20265,GO:2001197,1,0.558421378043368,0,5,basement membrane assembly involved in embryonic body morphogenesis,BP,
20272,GO:2001204,1,0.443205059421831,0,7,regulation of osteoclast development,BP,
20279,GO:2001223,1,0.562983021420367,0,5,negative regulation of neuron migration,BP,
20308,GO:2001268,1,0.598472249282404,0,5,negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
20310,GO:2001270,1,0.652958546001151,0,4,regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
20316,GO:2001279,1,0.637321297819458,0,4,regulation of unsaturated fatty acid biosynthetic process,BP,
20318,GO:2001286,1,0.635277692657886,0,4,regulation of caveolin-mediated endocytosis,BP,
1468,GO:0003723,1,0,71,1483,RNA binding,MF,H1F0;SLC16A3;PDCD4;GTPBP1;ZFP36L1;SMAD3;LRP1;RPUSD3;S100A4;ADARB1;GRB7;MAPKBP1;HLTF;CIRBP;ZNF385A;PCBP4;TWF2;CSNK1E;PCSK9;XPOT;MRPS6;MYEF2;KHNYN;ZNF598;LTA4H;SYNJ2;LACTB2;UNK;SNTB2;MDH2;TNS1;ABTB1;MIF4GD;KHDRBS3;PTPN1;TRAP1;TDRKH;FAM50A;CYFIP2;FSCN1;NELFCD;DTD1;TOP3B;AHNAK2;NTPCR;RPL39L;DNM1;MRPS26;CHD2;MEX3A;C11ORF68;EEF2K;APOBEC3C;H1FX;APOBEC3F;DDX50;ARHGEF1;RNASET2;CAPRIN2;NSUN7;NDUFV3;IARS2;TEP1;CBX6;CDK11B;TST;CLK3;DHX32;TBL3;SRSF5;AARS
4469,GO:0010467,1,0,323,4283,gene expression,BP,TNIP1;XDH;MEF2D;ZMYND8;CITED4;HTRA1;EGR1;NR1D1;PLAT;TYSND1;APLN;PDCD4;CTNNBIP1;ACVR2B;PRNP;BBS2;VEGFA;WNT7A;APOE;F2R;LRP5;ITGA6;HMGA2;ZKSCAN1;ELK3;PKN1;MTA1;EGFR;SERPINE2;WWTR1;NOS1;SPRY2;CAPN2;NFATC4;BAHCC1;ETV5;LMF1;SHC1;HEXB;GTPBP1;TCFL5;ACTA2;ETV4;PHLDA2;TRNP1;ZFP36L1;MAP2K2;ZC3H6;MDFI;PTOV1;SMARCA1;RBCK1;PC;FOXQ1;MAP2K1;MXD4;POU2F2;SMURF2;TSC22D1;FOS;SMAD3;STAT6;PIK3R2;ERCC6;GJC2;DVL1;EPAS1;DNAJB5;RPUSD3;SH3PXD2B;PRDX5;BRD3;SALL2;ZXDC;RNF187;ADARB1;AKT1;GRB7;HDAC5;F12;PPM1F;RHBDF2;SERPING1;SCMH1;GGT1;NFKBIZ;ASH2L;IMPACT;WWC3;CNTN1;DAP;PTHLH;FGFR4;LDLR;FGFR1;PRKACB;MAPKBP1;SEC14L2;HLTF;MXI1;RAG1;H2AFJ;KLF7;SORL1;NAT14;CIRBP;HMG20B;TENM2;ZNF385A;ANK3;TSHZ1;TRAPPC9;CCND1;PCBP4;TCF25;MAPK13;PLAU;GAS6;CSNK1E;CARD11;SOX13;GSN;PCSK9;ARHGAP22;MRPS6;GLI4;ZSCAN18;AIP;MYEF2;MN1;SMARCD2;RRNAD1;DGKQ;PAK6;GTF2IRD1;TAGLN3;PKD2;PCSK1;CTSZ;HES2;CRTC1;ABCA2;ZNF598;MAGEF1;PRSS3;EPHB2;ADAM8;CTBP1;MNT;CDKN1C;ZMIZ2;CD81;CEBPB;ADAMTS13;ZNF217;ZNF862;WNT3;C8ORF88;TGFB1;RFX2;SCYL1;UNK;MKNK2;DEAF1;NAB2;TMEM173;ZSCAN30;MSRB2;PNRC1;MIPEP;PEG3;MC1R;ABHD14B;ABTB1;RNH1;ERO1B;PHF21A;MIF4GD;KHDRBS3;AGRN;MBD3;CAMK2N1;LRP4;VHL;TRAP1;MLXIPL;PRKCZ;KDM6B;PRKACA;ZNF516;PIM2;WDR18;TDRKH;ERBB2;TFDP2;IRF2BP2;CYFIP2;PBX2;NELFCD;PRKCD;RBL2;STUB1;BAX;ZNF395;EREG;RPS6KA5;ZNF524;SOX12;MBTPS2;PPP1R13L;CARF;AHNAK2;PCSK1N;IER2;TGFBR3;DIP2A;RPL39L;LEMD2;ZHX3;RGS14;MRPS26;LONP2;SYMPK;MAPK12;IRAK1;TGFA;HDAC7;FHOD1;CHD2;CBX7;CHEK2;ZFPM1;PPARA;SESN2;ABCG1;SOX7;SIX5;MIF;KDM4B;ZNF414;MEX3A;SSBP4;ECM1;WFS1;ZNF444;TRPT1;DALRD3;SPPL2B;FYN;EEF2K;ARID5B;HOXC5;DNM2;BHLHE40;PELI1;CAT;TSPYL2;ZMYM3;SATB1;SLC50A1;ZNF606;MAPK3;INSR;PAN2;CAMTA2;PFKM;RERE;INO80C;BCL7A;CAMKK2;PPP3CB;USP21;CAPRIN2;ZBTB10;WDTC1;HES7;ITGA3;DNMT3A;PPP2R5B;HES6;MAP2K3;PROX1;IARS2;ADGRF1;PKD1;SIRT2;FAM129B;EDA;BACH1;E2F5;ZBTB22;MAPRE3;TEP1;ZNF704;MAP3K10;GTF2IRD2;NGFR;BCORL1;ZNF837;MAFF;NR2F6;CBX6;CAMK1;EZH1;HFE;ZNF513;BTG1;ZP3;MLF2;CDK11B;TNRC18;TCEA2;ZBTB47;PLAG1;CLK3;IRF2BPL;DHX32;KDM3A;TBL3;APBA1;DEDD2;SRSF5;AARS
2433,GO:0005634,1,0,472,5727,nucleus,CC,TNIP1;DUSP6;NT5E;ERCC1;DUSP5;MEF2D;ZMYND8;H1F0;CITED4;FHL1;EGR1;NR1D1;SLC16A3;CST3;MARVELD1;EPN3;PRR7;PDCD4;CTNNBIP1;DOCK4;XPC;PRNP;APOE;TSPAN1;PITPNC1;HMGA2;OBSCN;NDRG1;ZKSCAN1;NEK9;ELK3;ITPR3;PKN1;MTA1;ACOT7;ANGEL1;EGFR;RPS6KA2;DNPH1;WWTR1;NOS1;SLC2A9;HADH;SPRY2;CAPN2;NFATC4;TRIM65;BAHCC1;ETV5;APPL2;DDB2;TBC1D14;ARL2;TCFL5;PTPRE;NPEPL1;ETV4;TRNP1;TXNRD3;ZFP36L1;GLUL;ARAP1;MAP2K2;ZC3H6;MDFI;PTOV1;SMARCA1;FOXQ1;RNF44;MAP2K1;CPT2;VWA5A;MXD4;POU2F2;ENDOG;SMURF2;KLC2;TSC22D1;SLC9A3R2;FOS;SMAD3;STAT6;PIK3R2;ERCC6;LRP1;EPAS1;DNAJB5;FAM110C;S100A4;PPP2R3B;PRDX5;BRD3;SALL2;CDK18;ZXDC;RNF187;ADARB1;PLCXD2;AKT1;HDAC5;S100A6;STK39;SCMH1;PHC2;NFKBIZ;ASH2L;ATG16L2;BRSK1;PTHLH;POLD4;FGFR1;PRKACB;MAPKBP1;SIGMAR1;RAC2;SEC14L2;HLTF;MXI1;NPHP4;SYNE3;RAG1;GAMT;H2AFJ;PHF7;TOMM34;KLF7;RALGDS;SORL1;NAT14;CIRBP;HMG20B;TENM2;ZNF385A;NSMCE4A;TSHZ1;CCND1;TCF25;LHPP;STRADB;MAPK13;CARD19;PTK6;PFKP;CSNK1E;R3HDM4;CTSB;SOX13;LAMA5;DUSP7;MPLKIP;GSN;MAPKAPK3;ARHGAP22;RAD23A;PHLDA1;XPOT;EHD4;ERRFI1;GLI4;HLCS;ZSCAN18;AIP;MYEF2;SH3D19;CCDC113;CDC25B;SH3GLB2;ARHGAP27;ALOX15B;SMARCD2;AGAP1;CCS;DGKQ;BNIP3;PAK6;NOL4L;GTF2IRD1;MVB12B;TAGLN3;CEMIP;RETSAT;YPEL3;HES2;CRTC1;C19ORF33;EPHB2;APRT;CTBP1;LTA4H;MNT;PTPDC1;CDKN1C;PLCG1;ZMIZ2;CBS;CEBPB;ZNF217;ZNF862;TGFB1;RFX2;SCYL1;GPC1;MKNK2;DEAF1;NAB2;ZSCAN30;SDHA;PNRC1;MDH2;MPG;CLCA2;HEXDC;NSMF;PEG3;TUB;ABHD14B;ABTB1;RNH1;POLL;POLM;PTMS;ATG2A;PHF21A;MIF4GD;UBXN4;KHDRBS3;TUBG2;B4GALT2;MBD3;VHL;TRAP1;ADAP1;PFKFB2;MLXIPL;TRIB2;PRKCZ;KDM6B;PRKACA;ZNF516;CENPH;GRHPR;RABGGTA;AREG;UCKL1;BOK;WDR18;CAPG;ALAS1;ERBB2;CNDP2;AHCY;PRIMPOL;TFDP2;C6ORF89;MZT2A;NECAB3;STK17A;RILPL1;FAM50A;IRF2BP2;NET1;BNIP3L;CYFIP2;PBX2;NELFCD;PDK1;CYGB;PRKCD;REEP6;RBL2;STUB1;BAX;CYC1;SBF1;DTD1;OLFM2;ZNF395;HIST3H2BB;CCDC92;NUBP2;SH3BP1;GJB4;RPS6KA5;DGUOK;DUSP4;KLHDC2;ZNF524;SOX12;ACADS;TOP3B;PPL;PPP1R13L;CARF;AHNAK2;MT2A;IER2;MZT2B;FCHO1;LIMK1;PADI3;DIP2A;LTB4R2;CPNE7;SLC2A11;LEMD2;RPS6KA6;TMEM92;ZHX3;DNM1;RGS14;TMEM8B;MRPS26;EHD3;LONP2;SYMPK;MAPK12;IRAK1;HDAC7;FHOD1;CHD2;CBX7;CHEK2;ZFPM1;PPARA;COG7;SESN2;JADE2;CDC34;RNF123;SOX7;SPEG;SIX5;MIF;SMOX;KDM4B;ZNF414;MEX3A;SSBP4;NARF;ZNF444;SLC22A18;SPPL2B;HSD11B1L;FYN;UPP1;CERS4;SUN1;FLYWCH1;ARID5B;HOXC5;DNM2;BHLHE40;PELI1;SNX15;BEX2;NEIL1;TSPYL2;ZMYM3;APOBEC3C;SATB1;SLC50A1;PLCB3;H1FX;IQSEC1;ZNF606;APOBEC3F;DDX50;TUBB6;MAPK3;INSR;PAN2;PDZD2;CAMTA2;TAZ;PFKM;ADCY1;RERE;INO80C;RALGAPA1;PDXK;ETAA1;GLRX;PAK1;TRIM45;CDYL2;DCAF10;CAMKK2;PPP3CB;USP21;PFKFB3;CUL7;REV1;CAPRIN2;ZBTB10;WDTC1;HES7;DNMT3A;BIN1;HES6;MAP2K3;BCL2L1;NDUFV3;DNASE1L1;PROX1;LRCH4;ALDH7A1;LMNA;PKD1;KCTD13;SIRT2;FAM129B;UVSSA;BACH1;NT5C1B;TRIP10;E2F5;ZBTB22;AZIN2;TEP1;ZNF704;RAP1GAP2;SOCS7;GTF2IRD2;RAB40B;NGFR;TOLLIP;BCORL1;PDCD6;ARVCF;BIVM;ZNF837;PLEKHM1;DUSP23;GCH1;MAFF;NR2F6;CBX6;PNMA1;CAMK1;CAMKK1;EZH1;TERC;ZNF513;WIPI2;BTG1;VPS51;CELSR1;TACC1;MLF2;CDK11B;C2CD2;SSH3;FGFR3;TNRC18;NDRG2;CBLC;ITPKB;TCEA2;ZBTB47;PLAG1;CLK3;IRF2BPL;DHX32;KDM3A;PM20D2;FAM214B;TBL3;PKN3;APBA1;DEDD2;SRSF5;SLC26A11
2740,GO:0006139,1.00000000000001,0,363,4625,nucleobase-containing compound metabolic process,BP,TNIP1;NT5E;XDH;ERCC1;MEF2D;ZMYND8;H1F0;CITED4;HTRA1;EGR1;NR1D1;H6PD;DLG4;CST3;APLN;PDCD4;CTNNBIP1;ACVR2B;XPC;PRNP;VEGFA;PGM1;WNT7A;APOE;F2R;LRP5;ITGA6;HMGA2;IDH2;ZKSCAN1;ELK3;PKN1;MTA1;ACOT7;EGFR;DNPH1;WWTR1;NOS1;NFATC4;BAHCC1;ETV5;SHC1;DDB2;HEXB;GTPBP1;TCFL5;TK2;ETV4;TRNP1;RAPGEF3;ZFP36L1;MAP2K2;NME4;ZC3H6;MDFI;PTOV1;SMARCA1;RBCK1;PGLS;FOXQ1;MAP2K1;NAPRT;NYNRIN;MXD4;POU2F2;ENDOG;SMURF2;TSC22D1;FOS;SMAD3;STAT6;PIK3R2;ERCC6;DVL1;EPAS1;DNAJB5;RPUSD3;PRDX5;BRD3;SALL2;ZXDC;RNF187;NMRK1;ADORA2B;ADARB1;AKT1;HDAC5;PPM1F;ENTPD6;HK1;SCMH1;NFKBIZ;ASH2L;IMPACT;WWC3;DAP;PTHLH;FGFR4;POLD4;FGFR1;MAPKBP1;KCNAB2;PFKL;SEC14L2;HLTF;MXI1;RAG1;GAMT;H2AFJ;KLF7;NAT14;CIRBP;HMG20B;TENM2;ZNF385A;NSMCE4A;IGFBP4;TSHZ1;TRAPPC9;CCND1;PCBP4;TCF25;LHPP;MAPK13;GAS6;PFKP;CSNK1E;CARD11;SOX13;ARHGAP22;RAD23A;DHTKD1;GLI4;NADK;PANK4;ZSCAN18;AIP;MYEF2;MN1;SMARCD2;RRNAD1;NPR2;DGKQ;PAK6;GTF2IRD1;TAGLN3;PKD2;HES2;CRTC1;ABCA2;MAGEF1;ADAM8;APRT;CTBP1;MNT;CDKN1C;ZMIZ2;CBS;CD81;CEBPB;ENTPD2;ZNF217;TIMP2;ZNF862;TGFB1;LACTB2;RFX2;SCYL1;DEAF1;NAB2;TMEM173;ZSCAN30;PODXL2;SDHA;MSRB2;PNRC1;MDH2;MPG;PEG3;MC1R;ABHD14B;RNH1;POLL;POLM;PTMS;PHF21A;KHDRBS3;PTPN1;PCK2;AGRN;MBD3;LRP4;VHL;PFKFB2;MLXIPL;PRKCZ;KDM6B;PRKACA;ZNF516;ADA;AREG;PIM2;MPI;UCKL1;WDR18;TDRKH;ERBB2;AHCY;PRIMPOL;TFDP2;IRF2BP2;PBX2;NELFCD;PRKCD;FAM20C;RBL2;STUB1;BAX;CYC1;DTD1;ZNF395;PPCS;EREG;RPS6KA5;DGUOK;ZNF524;SOX12;DDIT4;MBTPS2;TOP3B;PPP1R13L;CARF;AHNAK2;IER2;TGFBR3;LTB4R2;LEMD2;ZHX3;RGS14;ALDOC;SYMPK;MAPK12;IRAK1;TGFA;HDAC7;FHOD1;CHD2;CBX7;CHEK2;ZFPM1;PPARA;TMEM161A;SESN2;ABCG1;CDC34;SOX7;SIX5;KDM4B;ZNF414;SSBP4;ECM1;WFS1;ZNF444;TRPT1;DALRD3;UPP1;ARID5B;HOXC5;DNM2;BHLHE40;PELI1;CAT;NEIL1;TSPYL2;ZMYM3;APOBEC3C;SATB1;ZNF606;APOBEC3F;DDX50;MAPK3;INSR;PAN2;CAMTA2;TAZ;PFKM;ADCY1;RERE;TSTA3;INO80C;ETAA1;GLRX;BCL7A;CAMKK2;RNASET2;PPP3CB;USP21;PFKFB3;GABBR1;REV1;CAPRIN2;ZBTB10;WDTC1;HES7;ITGA3;DNMT3A;PPP2R5B;HES6;MAP2K3;DLG3;NDUFV3;DNASE1L1;PROX1;IARS2;ADGRF1;PKD1;KCTD13;SIRT2;FAM129B;EDA;UVSSA;NMNAT2;BACH1;NT5C1B;ADCY7;E2F5;ZBTB22;MAPRE3;TEP1;ZNF704;MAP3K10;GTF2IRD2;NGFR;BCORL1;ZNF837;RNASE7;MAFF;NR2F6;CBX6;CAMK1;EZH1;HFE;TERC;ZNF513;BTG1;ZP3;MLF2;CDK11B;TNRC18;TCEA2;ZBTB47;PLAG1;CLK3;IRF2BPL;DHX32;KDM3A;TBL3;SLC23A2;DEDD2;AK3;SRSF5;ADCY6;AARS
6808,GO:0030272,1.00000000000001,0.922075073513813,0,1,5-formyltetrahydrofolate cyclo-ligase activity,MF,
12257,GO:0048561,1.00000000000003,0.891085553795715,0,1,establishment of animal organ orientation,BP,
3131,GO:0006725,1.00000000000003,0,378,4740,cellular aromatic compound metabolic process,BP,TNIP1;NT5E;XDH;ERCC1;MEF2D;ZMYND8;H1F0;CITED4;HTRA1;EGR1;NR1D1;H6PD;DLG4;CST3;APLN;PDCD4;CTNNBIP1;ACVR2B;XPC;PRNP;VEGFA;PGM1;WNT7A;APOE;F2R;LRP5;ITGA6;HMGA2;IDH2;ZKSCAN1;ELK3;PKN1;MTA1;ACOT7;AKR7A2;EGFR;DNPH1;WWTR1;NOS1;SLC2A9;NFATC4;BAHCC1;ETV5;SHC1;DDB2;HEXB;GTPBP1;TCFL5;TK2;ETV4;TRNP1;RAPGEF3;ZFP36L1;MAP2K2;NME4;ZC3H6;MDFI;PTOV1;SMARCA1;RBCK1;PGLS;FOXQ1;MAP2K1;NAPRT;NYNRIN;MXD4;POU2F2;ENDOG;SMURF2;TSC22D1;FOS;SMAD3;STAT6;PIK3R2;ERCC6;DVL1;EPAS1;DNAJB5;RPUSD3;PRDX5;BRD3;SALL2;ZXDC;RNF187;NMRK1;ADORA2B;ADARB1;AKT1;HDAC5;UROS;PPM1F;ENTPD6;HK1;SCMH1;NFKBIZ;ASH2L;IMPACT;WWC3;DAP;PTHLH;FGFR4;POLD4;FGFR1;MAPKBP1;KCNAB2;PFKL;SEC14L2;HLTF;MXI1;RAG1;GAMT;H2AFJ;KLF7;NAT14;CIRBP;CBR4;HMG20B;TENM2;ZNF385A;NSMCE4A;IGFBP4;TSHZ1;TRAPPC9;CCND1;PCBP4;TCF25;LHPP;MAPK13;GAS6;PFKP;CSNK1E;CARD11;SOX13;ARHGAP22;RAD23A;DHTKD1;GLI4;NADK;PANK4;ZSCAN18;AIP;MYEF2;MN1;SMARCD2;RSAD1;RRNAD1;NPR2;DGKQ;PAK6;GTF2IRD1;TAGLN3;PKD2;HES2;CRTC1;ABCA2;MAGEF1;PRSS3;ADAM8;APRT;CTBP1;MNT;CDKN1C;ZMIZ2;CBS;CD81;CEBPB;ENTPD2;ZNF217;TIMP2;ZNF862;TGFB1;LACTB2;RFX2;SCYL1;DEAF1;NAB2;TMEM173;ZSCAN30;PODXL2;SDHA;MSRB2;PNRC1;MDH2;MPG;PEG3;MC1R;ABHD14B;RNH1;POLL;POLM;PTMS;PHF21A;KHDRBS3;PTPN1;PCK2;AGRN;MBD3;CD320;LRP4;VHL;PFKFB2;MLXIPL;PRKCZ;KDM6B;PRKACA;ZNF516;ADA;AREG;PIM2;MPI;UCKL1;WDR18;TDRKH;ALAS1;ERBB2;AHCY;PRIMPOL;TFDP2;IRF2BP2;PBX2;TRPC1;NELFCD;PRKCD;FAM20C;RBL2;STUB1;BAX;CYC1;DTD1;ZNF395;PPCS;EREG;RPS6KA5;DGUOK;ZNF524;SOX12;DDIT4;MBTPS2;TOP3B;PPP1R13L;CARF;AHNAK2;IER2;TGFBR3;LTB4R2;LEMD2;ZHX3;RGS14;ALDOC;SYMPK;MAPK12;IRAK1;PPOX;TGFA;HDAC7;FHOD1;MTHFR;CHD2;CBX7;CHEK2;ZFPM1;PPARA;TMEM161A;SESN2;ABCG1;CDC34;SOX7;SIX5;KDM4B;ZNF414;DDT;SSBP4;ECM1;WFS1;ZNF444;TRPT1;DALRD3;UPP1;ARID5B;HOXC5;DNM2;BHLHE40;PELI1;CAT;NEIL1;TSPYL2;ZMYM3;APOBEC3C;SATB1;ZNF606;APOBEC3F;DDX50;MAPK3;INSR;PAN2;CAMTA2;TAZ;PFKM;ADCY1;RERE;TSTA3;INO80C;PDXK;ETAA1;GLRX;BCL7A;CAMKK2;RNASET2;PPP3CB;USP21;PFKFB3;GABBR1;REV1;CAPRIN2;ZBTB10;WDTC1;HES7;ITGA3;DNMT3A;PPP2R5B;HES6;MAP2K3;DLG3;NDUFV3;DNASE1L1;PROX1;IARS2;ADGRF1;PKD1;KCTD13;SIRT2;FAM129B;EDA;UVSSA;NMNAT2;BACH1;NT5C1B;ADCY7;E2F5;ZBTB22;MAPRE3;TEP1;ZNF704;MAP3K10;GTF2IRD2;NGFR;BCORL1;ZNF837;RNASE7;GCH1;MAFF;NR2F6;CBX6;CAMK1;EZH1;HFE;TERC;ZNF513;BTG1;ZP3;MLF2;CDK11B;TNRC18;TCEA2;ZBTB47;PLAG1;CLK3;IRF2BPL;DHX32;KDM3A;PM20D2;TBL3;SLC23A2;DEDD2;AK3;SRSF5;ADCY6;AARS
18701,GO:1904044,1.00000000000004,0.737750244911338,0,3,response to aldosterone,BP,
1537,GO:0003921,1.00000000000004,0.890239305647042,0,1,GMP synthase activity,MF,
1538,GO:0003922,1.00000000000004,0.890239305647042,0,1,GMP synthase (glutamine-hydrolyzing) activity,MF,
16701,GO:0097676,1.00000000000006,0.706161061913862,0,3,histone H3-K36 dimethylation,BP,
14747,GO:0070427,1.0000000000001,0.712891956688466,0,3,nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
7802,GO:0032358,1.00000000000012,0.923776151790808,0,1,oxidized pyrimidine DNA binding,MF,
14314,GO:0061481,1.00000000000012,0.923776151790808,0,1,response to TNF agonist,BP,
18042,GO:1902546,1.00000000000012,0.923776151790808,0,1,positive regulation of DNA N-glycosylase activity,BP,
20312,GO:2001272,1.00000000000012,0.923776151790808,0,1,positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
8413,GO:0033499,1.00000000000013,0.806530535429968,0,2,galactose catabolic process via UDP-galactose,BP,
15564,GO:0072019,1.00000000000013,0.891591172872597,0,1,proximal convoluted tubule development,BP,
15692,GO:0072229,1.00000000000013,0.891591172872597,0,1,metanephric proximal convoluted tubule development,BP,
18149,GO:1902858,1.00000000000013,0.891591172872597,0,1,propionyl-CoA metabolic process,BP,
18150,GO:1902860,1.00000000000013,0.891591172872597,0,1,propionyl-CoA biosynthetic process,BP,
18963,GO:1904715,1.00000000000014,0.708561220054082,0,3,negative regulation of chaperone-mediated autophagy,BP,
977,GO:0002430,1.00000000000014,0.890757830258144,0,1,complement receptor mediated signaling pathway,BP,
1927,GO:0004621,1.00000000000014,0.890757830258144,0,1,glycosylphosphatidylinositol phospholipase D activity,MF,
2965,GO:0006507,1.00000000000014,0.890757830258144,0,1,GPI anchor release,BP,
4731,GO:0010897,1.00000000000014,0.890757830258144,0,1,negative regulation of triglyceride catabolic process,BP,
8553,GO:0034014,1.00000000000014,0.890757830258144,0,1,response to triglyceride,BP,
15237,GO:0071401,1.00000000000014,0.890757830258144,0,1,cellular response to triglyceride,BP,
17195,GO:0106014,1.00000000000014,0.806286112991294,0,2,regulation of inflammatory response to wounding,BP,
17196,GO:0106015,1.00000000000014,0.806286112991294,0,2,negative regulation of inflammatory response to wounding,BP,
14479,GO:0061890,1.00000000000014,0.806286112991292,0,2,positive regulation of astrocyte activation,BP,
18674,GO:1903980,1.00000000000014,0.806286112991292,0,2,positive regulation of microglial cell activation,BP,
20268,GO:2001200,1.00000000000014,0.806286112991292,0,2,positive regulation of dendritic cell differentiation,BP,
9271,GO:0035700,1.0000000000002,0.895663261015269,0,1,astrocyte chemotaxis,BP,
9494,GO:0036145,1.0000000000002,0.895663261015269,0,1,dendritic cell homeostasis,BP,
19950,GO:2000458,1.0000000000002,0.895663261015269,0,1,regulation of astrocyte chemotaxis,BP,
11685,GO:0046483,1.00000000000022,0,381,4726,heterocycle metabolic process,BP,TNIP1;NT5E;XDH;ERCC1;MEF2D;ZMYND8;H1F0;CITED4;HTRA1;EGR1;NR1D1;H6PD;DLG4;CST3;APLN;PDCD4;CTNNBIP1;ACVR2B;XPC;PRNP;VEGFA;PGM1;WNT7A;APOE;F2R;LRP5;ITGA6;HMGA2;IDH2;ZKSCAN1;ELK3;PKN1;MTA1;ACOT7;EGFR;DNPH1;WWTR1;NOS1;SLC2A9;NFATC4;BAHCC1;ETV5;SHC1;DDB2;HEXB;GTPBP1;TCFL5;ALDH4A1;TK2;ETV4;TRNP1;RAPGEF3;ZFP36L1;MAP2K2;NME4;ZC3H6;MDFI;PTOV1;SMARCA1;RBCK1;PLTP;PGLS;PC;FOXQ1;MAP2K1;NAPRT;ACP5;NYNRIN;MXD4;POU2F2;ENDOG;SMURF2;TSC22D1;FOS;SMAD3;STAT6;PIK3R2;ERCC6;DVL1;EPAS1;DNAJB5;RPUSD3;PRDX5;BRD3;PRODH;SALL2;ZXDC;RNF187;NMRK1;ADORA2B;ADARB1;AKT1;HDAC5;UROS;PPM1F;ENTPD6;PYCR2;HK1;SCMH1;NFKBIZ;ASH2L;IMPACT;WWC3;DAP;PTHLH;FGFR4;POLD4;FGFR1;MAPKBP1;KCNAB2;PFKL;SEC14L2;HLTF;MXI1;RAG1;GAMT;H2AFJ;KLF7;NAT14;CIRBP;HMG20B;TENM2;ZNF385A;NSMCE4A;IGFBP4;TSHZ1;TRAPPC9;CCND1;PCBP4;TCF25;LHPP;MAPK13;GAS6;PFKP;CSNK1E;CARD11;SOX13;ARHGAP22;RAD23A;DHTKD1;GLI4;NADK;PANK4;HLCS;ZSCAN18;AIP;MYEF2;MN1;SMARCD2;RSAD1;RRNAD1;NPR2;DGKQ;PAK6;GTF2IRD1;TAGLN3;PKD2;HES2;CRTC1;ABCA2;MAGEF1;PRSS3;ADAM8;APRT;CTBP1;MNT;CDKN1C;ZMIZ2;CBS;CD81;CEBPB;ENTPD2;ZNF217;TIMP2;ZNF862;TGFB1;LACTB2;RFX2;SCYL1;DEAF1;NAB2;TMEM173;ZSCAN30;PODXL2;SDHA;MSRB2;PNRC1;MDH2;MPG;PEG3;MC1R;ABHD14B;RNH1;POLL;POLM;PTMS;PHF21A;KHDRBS3;PTPN1;PCK2;AGRN;MBD3;CD320;LRP4;VHL;PFKFB2;MLXIPL;PRKCZ;KDM6B;PRKACA;ZNF516;ADA;AREG;PIM2;MPI;UCKL1;WDR18;TDRKH;ALAS1;ERBB2;AHCY;PRIMPOL;TFDP2;IRF2BP2;PBX2;NELFCD;PRKCD;FAM20C;RBL2;STUB1;BAX;CYC1;DTD1;ZNF395;PPCS;EREG;RPS6KA5;DGUOK;ZNF524;SOX12;DDIT4;MBTPS2;TOP3B;PPP1R13L;CARF;AHNAK2;IER2;TGFBR3;LTB4R2;LEMD2;ZHX3;RGS14;ALDOC;SYMPK;MAPK12;IRAK1;PPOX;TGFA;HDAC7;FHOD1;MTHFR;CHD2;CBX7;CHEK2;ZFPM1;PPARA;TMEM161A;SESN2;ABCG1;CDC34;SOX7;SIX5;KDM4B;ZNF414;SSBP4;ECM1;WFS1;ZNF444;TRPT1;DALRD3;UPP1;ARID5B;HOXC5;DNM2;BHLHE40;PELI1;CAT;NEIL1;TSPYL2;ZMYM3;APOBEC3C;SATB1;ZNF606;APOBEC3F;DDX50;MAPK3;INSR;PAN2;CAMTA2;TAZ;PFKM;ADCY1;RERE;TSTA3;INO80C;PDXK;ETAA1;GLRX;BCL7A;CAMKK2;RNASET2;PPP3CB;USP21;PFKFB3;GABBR1;REV1;CAPRIN2;ZBTB10;WDTC1;HES7;ITGA3;DNMT3A;PPP2R5B;HES6;MAP2K3;DLG3;NDUFV3;DNASE1L1;PROX1;IARS2;ADGRF1;PKD1;KCTD13;SIRT2;FAM129B;EDA;UVSSA;NMNAT2;BACH1;NT5C1B;ADCY7;E2F5;ZBTB22;MAPRE3;TEP1;ZNF704;MAP3K10;GTF2IRD2;NGFR;BCORL1;ZNF837;RNASE7;GCH1;MAFF;NR2F6;CBX6;CAMK1;EZH1;HFE;TERC;ZNF513;BTG1;ZP3;MLF2;CDK11B;TNRC18;TCEA2;ZBTB47;PLAG1;CLK3;IRF2BPL;DHX32;KDM3A;PM20D2;TBL3;SLC23A2;DEDD2;AK3;SRSF5;ADCY6;AARS
3161,GO:0006776,1.00000000000025,0.729920916664712,0,3,vitamin A metabolic process,BP,
6458,GO:0021784,1.00000000000026,0.930626158053475,0,1,postganglionic parasympathetic fiber development,BP,
14783,GO:0070494,1.00000000000028,0.711937720831519,0,3,regulation of thrombin-activated receptor signaling pathway,BP,
14784,GO:0070495,1.00000000000028,0.711937720831519,0,3,negative regulation of thrombin-activated receptor signaling pathway,BP,
5463,GO:0016344,1.00000000000028,0.792137635985122,0,2,meiotic chromosome movement towards spindle pole,BP,
1397,GO:0003310,1.00000000000029,0.902795788375844,0,1,pancreatic A cell differentiation,BP,
6368,GO:0021558,1.00000000000029,0.902795788375844,0,1,trochlear nerve development,BP,
11488,GO:0045977,1.00000000000029,0.902795788375844,0,1,positive regulation of mitotic cell cycle, embryonic,BP,
13643,GO:0060164,1.00000000000029,0.902795788375844,0,1,regulation of timing of neuron differentiation,BP,
14185,GO:0061102,1.00000000000029,0.902795788375844,0,1,stomach neuroendocrine cell differentiation,BP,
14186,GO:0061105,1.00000000000029,0.902795788375844,0,1,regulation of stomach neuroendocrine cell differentiation,BP,
14187,GO:0061106,1.00000000000029,0.902795788375844,0,1,negative regulation of stomach neuroendocrine cell differentiation,BP,
15471,GO:0071820,1.00000000000029,0.902795788375844,0,1,N-box binding,MF,
15587,GO:0072071,1.00000000000029,0.902795788375844,0,1,kidney interstitial fibroblast differentiation,BP,
15638,GO:0072141,1.00000000000029,0.902795788375844,0,1,renal interstitial fibroblast development,BP,
19807,GO:2000226,1.00000000000029,0.902795788375844,0,1,regulation of pancreatic A cell differentiation,BP,
19808,GO:2000227,1.00000000000029,0.902795788375844,0,1,negative regulation of pancreatic A cell differentiation,BP,
16143,GO:0090156,1.0000000000003,0.720580220038905,0,3,cellular sphingolipid homeostasis,BP,
17501,GO:1900453,1.0000000000003,0.806286112991134,0,2,negative regulation of long term synaptic depression,BP,
19175,GO:1905203,1.0000000000003,0.806286112991134,0,2,regulation of connective tissue replacement,BP,
6265,GO:0019862,1.00000000000033,0.899900683930205,0,1,IgA binding,MF,
18604,GO:1903850,1.00000000000035,0.890041328436292,0,1,regulation of cristae formation,BP,
18605,GO:1903852,1.00000000000035,0.890041328436292,0,1,positive regulation of cristae formation,BP,
18888,GO:1904542,1.00000000000035,0.890041328436292,0,1,regulation of free ubiquitin chain polymerization,BP,
18889,GO:1904544,1.00000000000035,0.890041328436292,0,1,positive regulation of free ubiquitin chain polymerization,BP,
19049,GO:1904881,1.00000000000035,0.890041328436292,0,1,cellular response to hydrogen sulfide,BP,
8392,GO:0033341,1.00000000000035,0.792242616039874,0,2,regulation of collagen binding,BP,
1859,GO:0004522,1.00000000000036,0.899970540471048,0,1,ribonuclease A activity,MF,
3971,GO:0008785,1.00000000000036,0.899970540471048,0,1,alkyl hydroperoxide reductase activity,MF,
18675,GO:1903984,1.00000000000037,0.706841031815726,0,3,positive regulation of TRAIL-activated apoptotic signaling pathway,BP,
5752,GO:0016900,1.00000000000037,0.839128034036781,0,2,oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor,MF,
11943,GO:0047057,1.00000000000037,0.839128034036781,0,2,vitamin-K-epoxide reductase (warfarin-sensitive) activity,MF,
6590,GO:0022613,1.00000000000037,0,7,447,ribonucleoprotein complex biogenesis,BP,GRB7;CIRBP;CSNK1E;RRNAD1;WDR18;TBL3;SRSF5
8393,GO:0033342,1.00000000000042,0.89014590948176,0,1,negative regulation of collagen binding,BP,
14380,GO:0061628,1.00000000000045,0.792785409816107,0,2,H3K27me3 modified histone binding,MF,
4652,GO:0010797,1.00000000000046,0.909901450736642,0,1,regulation of multivesicular body size involved in endosome transport,BP,
121,GO:0000252,1.00000000000048,0.899172578710924,0,1,C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity,MF,
11933,GO:0047012,1.00000000000048,0.899172578710924,0,1,sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity,MF,
17185,GO:0103066,1.00000000000048,0.899172578710924,0,1,4alpha-carboxy-4beta-methyl-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-oxidoreductase (decarboxylating) activity,MF,
17186,GO:0103067,1.00000000000048,0.899172578710924,0,1,4alpha-carboxy-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-dehydrogenase (decarboxylating) activity,MF,
13059,GO:0051572,1.00000000000052,0.707875218392213,0,3,negative regulation of histone H3-K4 methylation,BP,
2244,GO:0005157,1.00000000000053,0.8903133842112,0,1,macrophage colony-stimulating factor receptor binding,MF,
10031,GO:0042488,1.00000000000053,0.8903133842112,0,1,positive regulation of odontogenesis of dentin-containing tooth,BP,
13931,GO:0060611,1.00000000000053,0.8903133842112,0,1,mammary gland fat development,BP,
17926,GO:1902228,1.00000000000053,0.8903133842112,0,1,positive regulation of macrophage colony-stimulating factor signaling pathway,BP,
18665,GO:1903971,1.00000000000053,0.8903133842112,0,1,positive regulation of response to macrophage colony-stimulating factor,BP,
18668,GO:1903974,1.00000000000053,0.8903133842112,0,1,positive regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
18723,GO:1904124,1.00000000000053,0.8903133842112,0,1,microglial cell migration,BP,
18724,GO:1904139,1.00000000000053,0.8903133842112,0,1,regulation of microglial cell migration,BP,
18725,GO:1904141,1.00000000000053,0.8903133842112,0,1,positive regulation of microglial cell migration,BP,
19603,GO:1990682,1.00000000000053,0.8903133842112,0,1,CSF1-CSF1R complex,CC,
7594,GO:0031981,1.00000000000057,0,265,3525,nuclear lumen,CC,TNIP1;DUSP6;NT5E;ERCC1;DUSP5;MEF2D;H1F0;CITED4;EGR1;NR1D1;EPN3;CTNNBIP1;DOCK4;XPC;TSPAN1;PITPNC1;HMGA2;OBSCN;ELK3;ITPR3;PKN1;MTA1;ACOT7;RPS6KA2;WWTR1;NOS1;HADH;NFATC4;TRIM65;BAHCC1;ETV5;APPL2;DDB2;TBC1D14;ARL2;ETV4;TRNP1;ARAP1;SMARCA1;RNF44;CPT2;VWA5A;POU2F2;SMURF2;KLC2;FOS;SMAD3;STAT6;ERCC6;EPAS1;PPP2R3B;SALL2;RNF187;ADARB1;AKT1;HDAC5;STK39;SCMH1;PHC2;NFKBIZ;ASH2L;ATG16L2;BRSK1;PTHLH;POLD4;FGFR1;PRKACB;HLTF;MXI1;RAG1;H2AFJ;PHF7;TOMM34;CIRBP;HMG20B;TENM2;ZNF385A;NSMCE4A;CCND1;LHPP;PTK6;CSNK1E;CTSB;SOX13;DUSP7;MPLKIP;MAPKAPK3;RAD23A;PHLDA1;XPOT;HLCS;AIP;SH3D19;CCDC113;CDC25B;SH3GLB2;ARHGAP27;SMARCD2;DGKQ;BNIP3;PAK6;NOL4L;GTF2IRD1;YPEL3;CRTC1;APRT;CTBP1;LTA4H;MNT;PTPDC1;ZMIZ2;CEBPB;ZNF217;GPC1;MKNK2;DEAF1;SDHA;MPG;NSMF;ABHD14B;ABTB1;RNH1;POLL;POLM;PHF21A;MIF4GD;KHDRBS3;B4GALT2;MBD3;VHL;TRAP1;PFKFB2;MLXIPL;PRKCZ;KDM6B;PRKACA;CENPH;RABGGTA;WDR18;CAPG;ALAS1;CNDP2;TFDP2;C6ORF89;MZT2A;STK17A;RILPL1;FAM50A;IRF2BP2;BNIP3L;NELFCD;PDK1;CYGB;PRKCD;RBL2;STUB1;SBF1;DTD1;OLFM2;HIST3H2BB;CCDC92;GJB4;RPS6KA5;DUSP4;KLHDC2;SOX12;ACADS;PPP1R13L;CARF;IER2;MZT2B;FCHO1;LIMK1;LTB4R2;RPS6KA6;TMEM92;ZHX3;DNM1;RGS14;MRPS26;SYMPK;MAPK12;HDAC7;CHD2;CBX7;CHEK2;ZFPM1;PPARA;COG7;JADE2;CDC34;SOX7;MIF;SMOX;KDM4B;NARF;SPPL2B;HSD11B1L;UPP1;FLYWCH1;ARID5B;HOXC5;BHLHE40;SNX15;NEIL1;TSPYL2;ZMYM3;SATB1;PLCB3;H1FX;IQSEC1;DDX50;MAPK3;INSR;RERE;INO80C;PDXK;ETAA1;TRIM45;DCAF10;PPP3CB;USP21;PFKFB3;REV1;ZBTB10;WDTC1;DNMT3A;MAP2K3;NDUFV3;LRCH4;LMNA;KCTD13;SIRT2;FAM129B;UVSSA;TRIP10;E2F5;TEP1;GTF2IRD2;NGFR;TOLLIP;BCORL1;PLEKHM1;DUSP23;GCH1;MAFF;NR2F6;CBX6;PNMA1;EZH1;TERC;WIPI2;VPS51;CELSR1;TNRC18;TCEA2;PLAG1;CLK3;IRF2BPL;KDM3A;PM20D2;TBL3;DEDD2;SRSF5;SLC26A11
746,GO:0001978,1.00000000000059,0.891306643255178,0,1,regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback,BP,
747,GO:0001983,1.00000000000059,0.891306643255178,0,1,baroreceptor response to increased systemic arterial blood pressure,BP,
748,GO:0001985,1.00000000000059,0.891306643255178,0,1,negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure,BP,
753,GO:0001994,1.00000000000059,0.891306643255178,0,1,norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure,BP,
755,GO:0001997,1.00000000000059,0.891306643255178,0,1,positive regulation of the force of heart contraction by epinephrine-norepinephrine,BP,
1290,GO:0003099,1.00000000000059,0.891306643255178,0,1,positive regulation of the force of heart contraction by chemical signal,BP,
2131,GO:0004936,1.00000000000059,0.891306643255178,0,1,alpha-adrenergic receptor activity,MF,
2132,GO:0004937,1.00000000000059,0.891306643255178,0,1,alpha1-adrenergic receptor activity,MF,
18676,GO:1903995,1.00000000000059,0.891306643255178,0,1,regulation of non-membrane spanning protein tyrosine kinase activity,BP,
18677,GO:1903997,1.00000000000059,0.891306643255178,0,1,positive regulation of non-membrane spanning protein tyrosine kinase activity,BP,
13939,GO:0060631,1.0000000000006,0.705027458570148,0,3,regulation of meiosis I,BP,
9923,GO:0042275,1.00000000000065,0.901026099755051,0,1,error-free postreplication DNA repair,BP,
7718,GO:0032216,1.00000000000069,0.890927247358394,0,1,glucosaminyl-phosphotidylinositol O-acyltransferase activity,MF,
6087,GO:0019255,1.00000000000072,0.795952648517118,0,2,glucose 1-phosphate metabolic process,BP,
12036,GO:0047860,1.00000000000073,0.908033841057795,0,1,diiodophenylpyruvate reductase activity,MF,
10231,GO:0042942,1.00000000000078,0.890086768015091,0,1,D-serine transport,BP,
17502,GO:1900477,1.00000000000078,0.892056967827358,0,1,negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter,BP,
18847,GO:1904428,1.0000000000008,0.720660096535917,0,3,negative regulation of tubulin deacetylation,BP,
17433,GO:1900186,1.00000000000083,0.713797993090346,0,3,negative regulation of clathrin-dependent endocytosis,BP,
8838,GO:0034641,1.00000000000083,0,426,5157,cellular nitrogen compound metabolic process,BP,TNIP1;NT5E;XDH;ERCC1;MEF2D;ZMYND8;H1F0;CITED4;HTRA1;EGR1;NR1D1;H6PD;DLG4;CST3;APLN;PDCD4;CTNNBIP1;NAGS;ACVR2B;XPC;PRNP;VEGFA;PGM1;WNT7A;APOE;F2R;LRP5;ITGA6;HMGA2;IDH2;ZKSCAN1;CRAT;ELK3;PKN1;MTA1;ACOT7;EGFR;DNPH1;WWTR1;NOS1;SLC2A9;NFATC4;BAHCC1;ETV5;SHC1;DDB2;HEXB;GTPBP1;TCFL5;TK2;ETV4;TRNP1;RAPGEF3;ZFP36L1;RNPEPL1;MAP2K2;NME4;ZC3H6;MDFI;PTOV1;SMARCA1;RBCK1;PGLS;PC;FOXQ1;MAP2K1;NAPRT;ACP5;NYNRIN;MXD4;POU2F2;ENDOG;SMURF2;TSC22D1;FOS;SMAD3;STAT6;PIK3R2;ERCC6;DVL1;EPAS1;DNAJB5;RPUSD3;PRDX5;BRD3;SALL2;ZXDC;RNF187;NMRK1;ADORA2B;ADARB1;AKT1;GRB7;HDAC5;UROS;PPM1F;ENTPD6;HK1;SCMH1;GGT1;NFKBIZ;ASH2L;IMPACT;WWC3;DAP;PTHLH;FGFR4;POLD4;FGFR1;MAPKBP1;KCNAB2;PFKL;SEC14L2;OPLAH;HLTF;MXI1;RAG1;GAMT;H2AFJ;KLF7;SORL1;NAT14;CIRBP;HMG20B;TENM2;ZNF385A;NSMCE4A;IGFBP4;TSHZ1;TRAPPC9;CCND1;PCBP4;TCF25;LHPP;MAPK13;GAS6;PFKP;CSNK1E;CARD11;SOX13;ARHGAP22;RAD23A;DHTKD1;MRPS6;GLI4;NADK;PANK4;HLCS;ZSCAN18;AIP;MYEF2;MN1;SMARCD2;RSAD1;RRNAD1;NPR2;DGKQ;HAGH;PAK6;GTF2IRD1;TAGLN3;PKD2;PCSK1;CTSZ;HES2;CRTC1;ABCA2;ZNF598;MAGEF1;ADAM8;APRT;CTBP1;LTA4H;MNT;CDKN1C;ZMIZ2;CBS;CD81;CEBPB;ENTPD2;ADAMTS13;ZNF217;TIMP2;ZNF862;C8ORF88;TGFB1;LACTB2;RFX2;SCYL1;UNK;MKNK2;DEAF1;NAB2;TMEM173;ZSCAN30;PODXL2;SDHA;MSRB2;PNRC1;MIPEP;MDH2;MPG;PEG3;MC1R;ABHD14B;ABTB1;RNH1;ERO1B;ST6GALNAC6;POLL;POLM;PTMS;PHF21A;MIF4GD;KHDRBS3;PTPN1;TPP1;PCK2;AGRN;MBD3;LRP4;B4GALT6;VHL;TRAP1;PFKFB2;MLXIPL;PRKCZ;KDM6B;PRKACA;ZNF516;GRHPR;ADA;AREG;PIM2;MPI;UCKL1;WDR18;TDRKH;ALAS1;ERBB2;CNDP2;AHCY;PRIMPOL;TFDP2;IRF2BP2;RNPEP;CYFIP2;PBX2;NELFCD;THOP1;PRKCD;FAM20C;RBL2;STUB1;BAX;CYC1;DTD1;ZNF395;PPCS;EREG;RPS6KA5;DGUOK;ZNF524;SOX12;DDIT4;MBTPS2;TOP3B;PPP1R13L;CARF;AHNAK2;PCSK1N;IER2;NAGA;TGFBR3;LTB4R2;RPL39L;LEMD2;ZHX3;RGS14;GSTO1;ALDOC;MRPS26;SYMPK;MAPK12;IRAK1;PPOX;TGFA;HDAC7;FHOD1;MTHFR;CHD2;CBX7;CHEK2;ZFPM1;PPARA;TMEM161A;SESN2;ABCG1;CDC34;SOX7;ABCA7;SIX5;SMOX;KDM4B;ZNF414;MEX3A;PLA2G6;SSBP4;ECM1;WFS1;ZNF444;TRPT1;DALRD3;SPPL2B;UPP1;EEF2K;CERS4;ARID5B;HOXC5;DNM2;CYP3A5;BHLHE40;PELI1;CHKA;CAT;NEIL1;TSPYL2;ZMYM3;APOBEC3C;SATB1;ZNF606;APOBEC3F;DDX50;MAPK3;INSR;PAN2;CAMTA2;TAZ;PFKM;ADCY1;RERE;TSTA3;INO80C;PDXK;ETAA1;GLRX;BCL7A;CAMKK2;RNASET2;PPP3CB;USP21;PFKFB3;GABBR1;REV1;CAPRIN2;ZBTB10;WDTC1;HES7;ITGA3;DNMT3A;SAMD8;BIN1;PPP2R5B;HES6;MAP2K3;DLG3;NDUFV3;DNASE1L1;PROX1;IARS2;ADGRF1;ALDH7A1;PKD1;KCTD13;SIRT2;FAM129B;EDA;UVSSA;NMNAT2;BACH1;NT5C1B;ADCY7;E2F5;ZBTB22;MAPRE3;AZIN2;TEP1;ZNF704;MAP3K10;GTF2IRD2;NGFR;BCORL1;ZNF837;RNASE7;GCH1;MAFF;NR2F6;CBX6;CAMK1;EZH1;HFE;TERC;ZNF513;BTG1;ZP3;MLF2;CDK11B;TST;ST3GAL5;TNRC18;SPTLC2;TCEA2;ZBTB47;PLAG1;CLK3;IRF2BPL;DHX32;KDM3A;PM20D2;TBL3;SLC23A2;DEDD2;AK3;SRSF5;ADCY6;AARS
19045,GO:1904877,1.00000000000086,0.891772320033176,0,1,positive regulation of DNA ligase activity,BP,
1612,GO:0004034,1.00000000000086,0.890205883323901,0,1,aldose 1-epimerase activity,MF,
9395,GO:0035945,1.00000000000086,0.890205883323901,0,1,mitochondrial ncRNA surveillance,BP,
9396,GO:0035946,1.00000000000086,0.890205883323901,0,1,mitochondrial mRNA surveillance,BP,
15059,GO:0071026,1.00000000000086,0.890205883323901,0,1,cytoplasmic RNA surveillance,BP,
20153,GO:2000827,1.00000000000086,0.890205883323901,0,1,mitochondrial RNA surveillance,BP,
8896,GO:0034722,1.00000000000086,0.901753097723335,0,1,gamma-glutamyl-peptidase activity,MF,
6305,GO:0019948,1.00000000000087,0.792339115818458,0,2,SUMO activating enzyme activity,MF,
4210,GO:0009360,1.0000000000009,0.890031098303367,0,1,DNA polymerase III complex,CC,
16985,GO:0099053,1.0000000000009,0.706921286407276,0,3,activating signal cointegrator 1 complex,CC,
2629,GO:0005958,1.00000000000094,0.711269667991851,0,3,DNA-dependent protein kinase-DNA ligase 4 complex,CC,
9412,GO:0035983,1.00000000000094,0.708309450941984,0,3,response to trichostatin A,BP,
9413,GO:0035984,1.00000000000094,0.708309450941984,0,3,cellular response to trichostatin A,BP,
2789,GO:0006231,1.00000000000095,0.714665710627804,0,3,dTMP biosynthetic process,BP,
11533,GO:0046073,1.00000000000095,0.714665710627804,0,3,dTMP metabolic process,BP,
1485,GO:0003796,1.00000000000096,0.901174492512822,0,1,lysozyme activity,MF,
841,GO:0002153,1.00000000000097,0.890333052198968,0,1,steroid receptor RNA activator RNA binding,MF,
11460,GO:0045925,1.00000000000097,0.890333052198968,0,1,positive regulation of female receptivity,BP,
1555,GO:0003953,1.00000000000097,0.901702172372253,0,1,NAD+ nucleosidase activity,MF,
12437,GO:0050135,1.00000000000097,0.901702172372253,0,1,NAD(P)+ nucleosidase activity,MF,
14454,GO:0061809,1.00000000000097,0.901702172372253,0,1,NAD+ nucleotidase, cyclic ADP-ribose generating,MF,
1243,GO:0002940,1.000000000001,0.793246129935413,0,2,tRNA N2-guanine methylation,BP,
9361,GO:0035880,1.00000000000103,0.793162821338937,0,2,embryonic nail plate morphogenesis,BP,
6634,GO:0023025,1.00000000000103,0.793162821338935,0,2,MHC class Ib protein complex binding,MF,
6637,GO:0023030,1.00000000000103,0.793162821338935,0,2,MHC class Ib protein binding, via antigen binding groove,MF,
15524,GO:0071920,1.00000000000103,0.794384694132086,0,2,cleavage body,CC,
19604,GO:1990698,1.00000000000104,0.797080726899118,0,2,palmitoleoyltransferase activity,MF,
3485,GO:0007356,1.00000000000104,0.797080726899111,0,2,thorax and anterior abdomen determination,BP,
20222,GO:2001074,1.00000000000104,0.797080726899111,0,2,regulation of metanephric ureteric bud development,BP,
20223,GO:2001076,1.00000000000104,0.797080726899111,0,2,positive regulation of metanephric ureteric bud development,BP,
8213,GO:0032980,1.00000000000105,0.890341402879403,0,1,keratinocyte activation,BP,
18130,GO:1902804,1.00000000000106,0.708502470077426,0,3,negative regulation of synaptic vesicle transport,BP,
19849,GO:2000301,1.00000000000106,0.708502470077426,0,3,negative regulation of synaptic vesicle exocytosis,BP,
19477,GO:1990167,1.00000000000108,0.710841430266704,0,3,protein K27-linked deubiquitination,BP,
19478,GO:1990168,1.00000000000108,0.710841430266704,0,3,protein K33-linked deubiquitination,BP,
1696,GO:0004170,1.00000000000109,0.89428218432062,0,1,dUTP diphosphatase activity,MF,
11537,GO:0046080,1.00000000000109,0.89428218432062,0,1,dUTP metabolic process,BP,
11538,GO:0046081,1.00000000000109,0.89428218432062,0,1,dUTP catabolic process,BP,
8288,GO:0033128,1.00000000000113,0.795388296770691,0,2,negative regulation of histone phosphorylation,BP,
16199,GO:0090233,1.00000000000114,0.890036025023507,0,1,negative regulation of spindle checkpoint,BP,
18003,GO:1902426,1.00000000000114,0.890036025023507,0,1,deactivation of mitotic spindle assembly checkpoint,BP,
19233,GO:1905341,1.00000000000114,0.890036025023507,0,1,negative regulation of protein localization to kinetochore,BP,
8075,GO:0032764,1.00000000000117,0.801301948294909,0,2,negative regulation of mast cell cytokine production,BP,
10442,GO:0043305,1.00000000000117,0.801301948294909,0,2,negative regulation of mast cell degranulation,BP,
4377,GO:0010015,1.00000000000119,0.926345446474727,0,1,root morphogenesis,BP,
4391,GO:0010053,1.00000000000119,0.926345446474727,0,1,root epidermal cell differentiation,BP,
4392,GO:0010054,1.00000000000119,0.926345446474727,0,1,trichoblast differentiation,BP,
6596,GO:0022622,1.00000000000119,0.926345446474727,0,1,root system development,BP,
7527,GO:0031763,1.00000000000119,0.926345446474727,0,1,galanin receptor binding,MF,
7528,GO:0031764,1.00000000000119,0.926345446474727,0,1,type 1 galanin receptor binding,MF,
7529,GO:0031765,1.00000000000119,0.926345446474727,0,1,type 2 galanin receptor binding,MF,
7530,GO:0031766,1.00000000000119,0.926345446474727,0,1,type 3 galanin receptor binding,MF,
12185,GO:0048364,1.00000000000119,0.926345446474727,0,1,root development,BP,
12364,GO:0048764,1.00000000000119,0.926345446474727,0,1,trichoblast maturation,BP,
12365,GO:0048765,1.00000000000119,0.926345446474727,0,1,root hair cell differentiation,BP,
12366,GO:0048767,1.00000000000119,0.926345446474727,0,1,root hair elongation,BP,
13019,GO:0051464,1.00000000000119,0.926345446474727,0,1,positive regulation of cortisol secretion,BP,
15979,GO:0080147,1.00000000000119,0.926345446474727,0,1,root hair cell development,BP,
16332,GO:0090558,1.00000000000119,0.926345446474727,0,1,plant epidermis development,BP,
16350,GO:0090627,1.00000000000119,0.926345446474727,0,1,plant epidermal cell differentiation,BP,
17032,GO:0099402,1.00000000000119,0.926345446474727,0,1,plant organ development,BP,
18067,GO:1902606,1.00000000000119,0.926345446474727,0,1,regulation of large conductance calcium-activated potassium channel activity,BP,
18068,GO:1902608,1.00000000000119,0.926345446474727,0,1,positive regulation of large conductance calcium-activated potassium channel activity,BP,
18159,GO:1902890,1.00000000000119,0.926345446474727,0,1,regulation of root hair elongation,BP,
18160,GO:1902891,1.00000000000119,0.926345446474727,0,1,negative regulation of root hair elongation,BP,
18616,GO:1903888,1.00000000000119,0.926345446474727,0,1,regulation of plant epidermal cell differentiation,BP,
18617,GO:1903889,1.00000000000119,0.926345446474727,0,1,negative regulation of plant epidermal cell differentiation,BP,
19252,GO:1905392,1.00000000000119,0.926345446474727,0,1,plant organ morphogenesis,BP,
19263,GO:1905421,1.00000000000119,0.926345446474727,0,1,regulation of plant organ morphogenesis,BP,
19264,GO:1905422,1.00000000000119,0.926345446474727,0,1,negative regulation of plant organ morphogenesis,BP,
19737,GO:2000067,1.00000000000119,0.926345446474727,0,1,regulation of root morphogenesis,BP,
19837,GO:2000280,1.00000000000119,0.926345446474727,0,1,regulation of root development,BP,
20168,GO:2000851,1.00000000000119,0.926345446474727,0,1,positive regulation of glucocorticoid secretion,BP,
6047,GO:0019185,1.0000000000012,0.792150160552396,0,2,snRNA-activating protein complex,CC,
12559,GO:0050717,1.00000000000122,0.726776315516855,0,3,positive regulation of interleukin-1 alpha secretion,BP,
15923,GO:0072714,1.00000000000122,0.896364952635754,0,1,response to selenite ion,BP,
15924,GO:0072715,1.00000000000122,0.896364952635754,0,1,cellular response to selenite ion,BP,
18898,GO:1904569,1.00000000000122,0.896364952635754,0,1,regulation of selenocysteine incorporation,BP,
18899,GO:1904570,1.00000000000122,0.896364952635754,0,1,negative regulation of selenocysteine incorporation,BP,
18900,GO:1904572,1.00000000000122,0.896364952635754,0,1,negative regulation of mRNA binding,BP,
18901,GO:1904573,1.00000000000122,0.896364952635754,0,1,regulation of selenocysteine insertion sequence binding,BP,
18902,GO:1904574,1.00000000000122,0.896364952635754,0,1,negative regulation of selenocysteine insertion sequence binding,BP,
19183,GO:1905215,1.00000000000122,0.896364952635754,0,1,negative regulation of RNA binding,BP,
3879,GO:0008513,1.00000000000123,0.89123179128369,0,1,secondary active organic cation transmembrane transporter activity,MF,
3838,GO:0008448,1.00000000000125,0.894813867150918,0,1,N-acetylglucosamine-6-phosphate deacetylase activity,MF,
944,GO:0002357,1.00000000000125,0.890024283724056,0,1,defense response to tumor cell,BP,
7562,GO:0031930,1.00000000000132,0.902530823548002,0,1,mitochondria-nucleus signaling pathway,BP,
8692,GO:0034338,1.00000000000132,0.706680604403868,0,3,short-chain carboxylesterase activity,MF,
12597,GO:0050785,1.00000000000133,0.905923498815153,0,1,advanced glycation end-product receptor activity,MF,
18917,GO:1904596,1.00000000000133,0.905923498815153,0,1,regulation of connective tissue replacement involved in inflammatory response wound healing,BP,
18918,GO:1904597,1.00000000000133,0.905923498815153,0,1,negative regulation of connective tissue replacement involved in inflammatory response wound healing,BP,
18919,GO:1904599,1.00000000000133,0.905923498815153,0,1,advanced glycation end-product binding,MF,
18920,GO:1904603,1.00000000000133,0.905923498815153,0,1,regulation of advanced glycation end-product receptor activity,BP,
18921,GO:1904604,1.00000000000133,0.905923498815153,0,1,negative regulation of advanced glycation end-product receptor activity,BP,
19176,GO:1905204,1.00000000000133,0.905923498815153,0,1,negative regulation of connective tissue replacement,BP,
268,GO:0000741,1.00000000000137,0.89624122912968,0,1,karyogamy,BP,
3479,GO:0007344,1.00000000000137,0.89624122912968,0,1,pronuclear fusion,BP,
13149,GO:0051732,1.00000000000137,0.89624122912968,0,1,polyribonucleotide kinase activity,MF,
13152,GO:0051736,1.00000000000137,0.89624122912968,0,1,ATP-dependent polyribonucleotide 5'-hydroxyl-kinase activity,MF,
16513,GO:0097224,1.00000000000137,0.89624122912968,0,1,sperm connecting piece,CC,
17514,GO:1900736,1.00000000000139,0.794206924926689,0,2,regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
20087,GO:2000707,1.00000000000139,0.794206924926689,0,2,positive regulation of dense core granule biogenesis,BP,
4905,GO:0014839,1.00000000000139,0.808747733170532,0,2,myoblast migration involved in skeletal muscle regeneration,BP,
19309,GO:1905553,1.00000000000141,0.724384457586826,0,3,regulation of blood vessel branching,BP,
9751,GO:0039513,1.00000000000143,0.890024437251665,0,1,suppression by virus of host catalytic activity,BP,
9753,GO:0039516,1.00000000000143,0.890024437251665,0,1,modulation by virus of host catalytic activity,BP,
9771,GO:0039650,1.00000000000143,0.890024437251665,0,1,suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process,BP,
13294,GO:0052053,1.00000000000143,0.890024437251665,0,1,negative regulation by symbiont of host catalytic activity,BP,
13301,GO:0052148,1.00000000000143,0.890024437251665,0,1,modulation by symbiont of host catalytic activity,BP,
13310,GO:0052199,1.00000000000143,0.890024437251665,0,1,negative regulation of catalytic activity in other organism involved in symbiotic interaction,BP,
19447,GO:1990047,1.00000000000146,0.890798543602012,0,1,spindle matrix,CC,
16474,GO:0097158,1.00000000000147,0.898243922858743,0,1,pre-mRNA intronic pyrimidine-rich binding,MF,
1625,GO:0004060,1.00000000000151,0.892607178254537,0,1,arylamine N-acetyltransferase activity,MF,
4610,GO:0010729,1.00000000000155,0.892520414054574,0,1,positive regulation of hydrogen peroxide biosynthetic process,BP,
5228,GO:0015842,1.00000000000157,0.798968304422219,0,2,aminergic neurotransmitter loading into synaptic vesicle,BP,
16820,GO:0098700,1.00000000000157,0.798968304422219,0,2,neurotransmitter loading into synaptic vesicle,BP,
1921,GO:0004615,1.00000000000157,0.808314240768099,0,2,phosphomannomutase activity,MF,
8888,GO:0034711,1.00000000000157,0.710498861757845,0,3,inhibin binding,MF,
17721,GO:1901622,1.00000000000159,0.890085952695702,0,1,positive regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
5129,GO:0015578,1.0000000000016,0.890258432474563,0,1,mannose transmembrane transporter activity,MF,
5187,GO:0015761,1.0000000000016,0.890258432474563,0,1,mannose transmembrane transport,BP,
15584,GO:0072061,1.00000000000162,0.804693982134712,0,2,inner medullary collecting duct development,BP,
6322,GO:0020012,1.00000000000164,0.792139124908637,0,2,evasion or tolerance of host immune response,BP,
6993,GO:0030682,1.00000000000164,0.792139124908637,0,2,evasion or tolerance of host defense response,BP,
6994,GO:0030683,1.00000000000164,0.792139124908637,0,2,evasion or tolerance by virus of host immune response,BP,
13185,GO:0051805,1.00000000000164,0.792139124908637,0,2,evasion or tolerance of immune response of other organism involved in symbiotic interaction,BP,
13187,GO:0051807,1.00000000000164,0.792139124908637,0,2,evasion or tolerance of defense response of other organism involved in symbiotic interaction,BP,
17978,GO:1902359,1.00000000000164,0.793402197541689,0,2,Notch signaling pathway involved in somitogenesis,BP,
17982,GO:1902366,1.00000000000164,0.793402197541689,0,2,regulation of Notch signaling pathway involved in somitogenesis,BP,
17983,GO:1902367,1.00000000000164,0.793402197541689,0,2,negative regulation of Notch signaling pathway involved in somitogenesis,BP,
16314,GO:0090500,1.00000000000169,0.801719779114712,0,2,endocardial cushion to mesenchymal transition,BP,
18950,GO:1904691,1.00000000000178,0.891662046230386,0,1,negative regulation of type B pancreatic cell proliferation,BP,
16336,GO:0090571,1.00000000000178,0.7147994075181,0,3,RNA polymerase II transcription repressor complex,CC,
3962,GO:0008747,1.00000000000186,0.900111068595674,0,1,N-acetylneuraminate lyase activity,MF,
862,GO:0002193,1.00000000000187,0.705383582744111,0,3,MAML1-RBP-Jkappa- ICN1 complex,CC,
1371,GO:0003256,1.00000000000187,0.705383582744111,0,3,regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,
14053,GO:0060842,1.00000000000187,0.705383582744111,0,3,arterial endothelial cell differentiation,BP,
9553,GO:0036333,1.00000000000189,0.890053300504158,0,1,hepatocyte homeostasis,BP,
16644,GO:0097510,1.00000000000189,0.892285204414421,0,1,base-excision repair, AP site formation via deaminated base removal,BP,
18993,GO:1904772,1.00000000000189,0.890053300504158,0,1,response to tetrachloromethane,BP,
2348,GO:0005412,1.00000000000192,0.79361787293515,0,2,glucose:sodium symporter activity,MF,
18382,GO:1903373,1.00000000000192,0.705673871788368,0,3,positive regulation of endoplasmic reticulum tubular network organization,BP,
10854,GO:0044378,1.00000000000194,0.80314934906544,0,2,non-sequence-specific DNA binding, bending,MF,
7270,GO:0031260,1.00000000000195,0.914417060401367,0,1,pseudopodium membrane,CC,
8017,GO:0032658,1.00000000000198,0.895614068206596,0,1,regulation of interleukin-15 production,BP,
8061,GO:0032738,1.00000000000198,0.895614068206596,0,1,positive regulation of interleukin-15 production,BP,
9252,GO:0035664,1.00000000000198,0.895614068206596,0,1,TIRAP-dependent toll-like receptor signaling pathway,BP,
9253,GO:0035665,1.00000000000198,0.895614068206596,0,1,TIRAP-dependent toll-like receptor 4 signaling pathway,BP,
12200,GO:0048389,1.00000000000201,0.895630433690412,0,1,intermediate mesoderm development,BP,
12201,GO:0048390,1.00000000000201,0.895630433690412,0,1,intermediate mesoderm morphogenesis,BP,
12202,GO:0048391,1.00000000000201,0.895630433690412,0,1,intermediate mesoderm formation,BP,
12203,GO:0048392,1.00000000000201,0.895630433690412,0,1,intermediate mesodermal cell differentiation,BP,
13471,GO:0055018,1.00000000000201,0.895630433690412,0,1,regulation of cardiac muscle fiber development,BP,
13472,GO:0055020,1.00000000000201,0.895630433690412,0,1,positive regulation of cardiac muscle fiber development,BP,
13867,GO:0060503,1.00000000000201,0.895630433690412,0,1,bud dilation involved in lung branching,BP,
14203,GO:0061149,1.00000000000201,0.895630433690412,0,1,BMP signaling pathway involved in ureter morphogenesis,BP,
14204,GO:0061150,1.00000000000201,0.895630433690412,0,1,renal system segmentation,BP,
14205,GO:0061151,1.00000000000201,0.895630433690412,0,1,BMP signaling pathway involved in renal system segmentation,BP,
14209,GO:0061155,1.00000000000201,0.895630433690412,0,1,pulmonary artery endothelial tube morphogenesis,BP,
14231,GO:0061216,1.00000000000201,0.895630433690412,0,1,regulation of transcription from RNA polymerase II promoter involved in mesonephros development,BP,
14234,GO:0061227,1.00000000000201,0.895630433690412,0,1,pattern specification involved in mesonephros development,BP,
15508,GO:0071893,1.00000000000201,0.895630433690412,0,1,BMP signaling pathway involved in nephric duct formation,BP,
15605,GO:0072096,1.00000000000201,0.895630433690412,0,1,negative regulation of branch elongation involved in ureteric bud branching,BP,
15606,GO:0072097,1.00000000000201,0.895630433690412,0,1,negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway,BP,
15607,GO:0072098,1.00000000000201,0.895630433690412,0,1,anterior/posterior pattern specification involved in kidney development,BP,
15608,GO:0072099,1.00000000000201,0.895630433690412,0,1,anterior/posterior pattern specification involved in ureteric bud development,BP,
15609,GO:0072100,1.00000000000201,0.895630433690412,0,1,specification of ureteric bud anterior/posterior symmetry,BP,
15610,GO:0072101,1.00000000000201,0.895630433690412,0,1,specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway,BP,
15666,GO:0072192,1.00000000000201,0.895630433690412,0,1,ureter epithelial cell differentiation,BP,
15670,GO:0072198,1.00000000000201,0.895630433690412,0,1,mesenchymal cell proliferation involved in ureter development,BP,
15671,GO:0072199,1.00000000000201,0.895630433690412,0,1,regulation of mesenchymal cell proliferation involved in ureter development,BP,
15672,GO:0072200,1.00000000000201,0.895630433690412,0,1,negative regulation of mesenchymal cell proliferation involved in ureter development,BP,
17826,GO:1901964,1.00000000000201,0.895630433690412,0,1,positive regulation of cell proliferation involved in outflow tract morphogenesis,BP,
19700,GO:2000004,1.00000000000201,0.895630433690412,0,1,regulation of metanephric S-shaped body morphogenesis,BP,
19701,GO:2000005,1.00000000000201,0.895630433690412,0,1,negative regulation of metanephric S-shaped body morphogenesis,BP,
19702,GO:2000006,1.00000000000201,0.895630433690412,0,1,regulation of metanephric comma-shaped body morphogenesis,BP,
19703,GO:2000007,1.00000000000201,0.895630433690412,0,1,negative regulation of metanephric comma-shaped body morphogenesis,BP,
10308,GO:0043095,1.00000000000204,0.929195691420205,0,1,regulation of GTP cyclohydrolase I activity,BP,
10314,GO:0043105,1.00000000000204,0.929195691420205,0,1,negative regulation of GTP cyclohydrolase I activity,BP,
10923,GO:0044549,1.00000000000204,0.929195691420205,0,1,GTP cyclohydrolase binding,MF,
16721,GO:0097726,1.0000000000021,0.913083773530802,0,1,LEM domain binding,MF,
1843,GO:0004499,1.0000000000021,0.891563406993702,0,1,N,N-dimethylaniline monooxygenase activity,MF,
5429,GO:0016286,1.0000000000021,0.8901681391319,0,1,small conductance calcium-activated potassium channel activity,MF,
9466,GO:0036090,1.00000000000211,0.796772818747964,0,2,cleavage furrow ingression,BP,
9636,GO:0036509,1.00000000000214,0.795395362639112,0,2,trimming of terminal mannose on B branch,BP,
9638,GO:0036511,1.00000000000214,0.795395362639112,0,2,trimming of first mannose on A branch,BP,
9639,GO:0036512,1.00000000000214,0.795395362639112,0,2,trimming of second mannose on A branch,BP,
5004,GO:0015152,1.00000000000215,0.891825434612233,0,1,glucose-6-phosphate transmembrane transporter activity,MF,
7622,GO:0032028,1.00000000000215,0.891825434612233,0,1,myosin head/neck binding,MF,
11804,GO:0046707,1.0000000000022,0.801633248989901,0,2,IDP metabolic process,BP,
11805,GO:0046709,1.0000000000022,0.801633248989901,0,2,IDP catabolic process,BP,
660,GO:0001855,1.0000000000022,0.899521351869688,0,1,complement component C4b binding,MF,
8641,GO:0034196,1.00000000000223,0.890076710738731,0,1,acylglycerol transport,BP,
8642,GO:0034197,1.00000000000223,0.890076710738731,0,1,triglyceride transport,BP,
10863,GO:0044395,1.00000000000223,0.890076710738731,0,1,protein targeting to vacuolar membrane,BP,
17503,GO:1900483,1.00000000000223,0.890076710738731,0,1,regulation of protein targeting to vacuolar membrane,BP,
9287,GO:0035730,1.00000000000225,0.919043817812909,0,1,S-nitrosoglutathione binding,MF,
9288,GO:0035731,1.00000000000225,0.919043817812909,0,1,dinitrosyl-iron complex binding,MF,
9289,GO:0035732,1.00000000000225,0.919043817812909,0,1,nitric oxide storage,BP,
124,GO:0000255,1.00000000000226,0.705003028814307,0,3,allantoin metabolic process,BP,
294,GO:0000799,1.00000000000226,0.705003028814307,0,3,nuclear condensin complex,CC,
383,GO:0001025,1.00000000000226,0.705003028814307,0,3,RNA polymerase III transcription factor binding,MF,
429,GO:0001156,1.00000000000226,0.705003028814307,0,3,TFIIIC-class transcription factor binding,MF,
450,GO:0001224,1.00000000000226,0.705003028814307,0,3,RNA polymerase II transcription cofactor binding,MF,
701,GO:0001922,1.00000000000226,0.705003028814307,0,3,B-1 B cell homeostasis,BP,
721,GO:0001951,1.00000000000226,0.705003028814307,0,3,intestinal D-glucose absorption,BP,
857,GO:0002188,1.00000000000226,0.705003028814307,0,3,translation reinitiation,BP,
929,GO:0002326,1.00000000000226,0.705003028814307,0,3,B cell lineage commitment,BP,
1379,GO:0003274,1.00000000000226,0.705003028814307,0,3,endocardial cushion fusion,BP,
1386,GO:0003289,1.00000000000226,0.705003028814307,0,3,atrial septum primum morphogenesis,BP,
1421,GO:0003365,1.00000000000226,0.705003028814307,0,3,establishment of cell polarity involved in ameboidal cell migration,BP,
1427,GO:0003383,1.00000000000226,0.705003028814307,0,3,apical constriction,BP,
1432,GO:0003406,1.00000000000226,0.705003028814307,0,3,retinal pigment epithelium development,BP,
1692,GO:0004165,1.00000000000226,0.705003028814307,0,3,dodecenoyl-CoA delta-isomerase activity,MF,
1869,GO:0004534,1.00000000000226,0.705003028814307,0,3,5'-3' exoribonuclease activity,MF,
2014,GO:0004741,1.00000000000226,0.705003028814307,0,3,[pyruvate dehydrogenase (lipoamide)] phosphatase activity,MF,
2019,GO:0004748,1.00000000000226,0.705003028814307,0,3,ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor,MF,
2079,GO:0004832,1.00000000000226,0.705003028814307,0,3,valine-tRNA ligase activity,MF,
2113,GO:0004897,1.00000000000226,0.705003028814307,0,3,ciliary neurotrophic factor receptor activity,MF,
2127,GO:0004924,1.00000000000226,0.705003028814307,0,3,oncostatin-M receptor activity,MF,
2152,GO:0004972,1.00000000000226,0.705003028814307,0,3,NMDA glutamate receptor activity,MF,
2174,GO:0005010,1.00000000000226,0.705003028814307,0,3,insulin-like growth factor-activated receptor activity,MF,
2258,GO:0005173,1.00000000000226,0.705003028814307,0,3,stem cell factor receptor binding,MF,
2412,GO:0005588,1.00000000000226,0.705003028814307,0,3,collagen type V trimer,CC,
2579,GO:0005873,1.00000000000226,0.705003028814307,0,3,plus-end kinesin complex,CC,
2636,GO:0005971,1.00000000000226,0.705003028814307,0,3,ribonucleoside-diphosphate reductase complex,CC,
2706,GO:0006083,1.00000000000226,0.705003028814307,0,3,acetate metabolic process,BP,
2777,GO:0006211,1.00000000000226,0.705003028814307,0,3,5-methylcytosine catabolic process,BP,
2924,GO:0006438,1.00000000000226,0.705003028814307,0,3,valyl-tRNA aminoacylation,BP,
3205,GO:0006848,1.00000000000226,0.705003028814307,0,3,pyruvate transport,BP,
3347,GO:0007079,1.00000000000226,0.705003028814307,0,3,mitotic chromosome movement towards spindle pole,BP,
3433,GO:0007227,1.00000000000226,0.705003028814307,0,3,signal transduction downstream of smoothened,BP,
3801,GO:0008381,1.00000000000226,0.705003028814307,0,3,mechanosensitive ion channel activity,MF,
3802,GO:0008384,1.00000000000226,0.705003028814307,0,3,IkappaB kinase activity,MF,
3839,GO:0008449,1.00000000000226,0.705003028814307,0,3,N-acetylglucosamine-6-sulfatase activity,MF,
3855,GO:0008475,1.00000000000226,0.705003028814307,0,3,procollagen-lysine 5-dioxygenase activity,MF,
3990,GO:0008889,1.00000000000226,0.705003028814307,0,3,glycerophosphodiester phosphodiesterase activity,MF,
4000,GO:0008940,1.00000000000226,0.705003028814307,0,3,nitrate reductase activity,MF,
4168,GO:0009236,1.00000000000226,0.705003028814307,0,3,cobalamin biosynthetic process,BP,
4444,GO:0010360,1.00000000000226,0.705003028814307,0,3,negative regulation of anion channel activity,BP,
4560,GO:0010643,1.00000000000226,0.705003028814307,0,3,cell communication by chemical coupling,BP,
4615,GO:0010735,1.00000000000226,0.705003028814307,0,3,positive regulation of transcription via serum response element binding,BP,
4739,GO:0010908,1.00000000000226,0.705003028814307,0,3,regulation of heparan sulfate proteoglycan biosynthetic process,BP,
4740,GO:0010909,1.00000000000226,0.705003028814307,0,3,positive regulation of heparan sulfate proteoglycan biosynthetic process,BP,
4796,GO:0010990,1.00000000000226,0.705003028814307,0,3,regulation of SMAD protein complex assembly,BP,
4860,GO:0014701,1.00000000000226,0.705003028814307,0,3,junctional sarcoplasmic reticulum membrane,CC,
4881,GO:0014744,1.00000000000226,0.705003028814307,0,3,positive regulation of muscle adaptation,BP,
4984,GO:0015111,1.00000000000226,0.705003028814307,0,3,iodide transmembrane transporter activity,MF,
5051,GO:0015247,1.00000000000226,0.705003028814307,0,3,aminophospholipid transmembrane transporter activity,MF,
5108,GO:0015410,1.00000000000226,0.705003028814307,0,3,manganese-transporting ATPase activity,MF,
5169,GO:0015722,1.00000000000226,0.705003028814307,0,3,canalicular bile acid transport,BP,
5200,GO:0015798,1.00000000000226,0.705003028814307,0,3,myo-inositol transport,BP,
5342,GO:0016080,1.00000000000226,0.705003028814307,0,3,synaptic vesicle targeting,BP,
5437,GO:0016300,1.00000000000226,0.705003028814307,0,3,tRNA (uracil) methyltransferase activity,MF,
5442,GO:0016309,1.00000000000226,0.705003028814307,0,3,1-phosphatidylinositol-5-phosphate 4-kinase activity,MF,
5643,GO:0016728,1.00000000000226,0.705003028814307,0,3,oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor,MF,
5766,GO:0016939,1.00000000000226,0.705003028814307,0,3,kinesin II complex,CC,
5891,GO:0018057,1.00000000000226,0.705003028814307,0,3,peptidyl-lysine oxidation,BP,
5922,GO:0018197,1.00000000000226,0.705003028814307,0,3,peptidyl-aspartic acid modification,BP,
5926,GO:0018201,1.00000000000226,0.705003028814307,0,3,peptidyl-glycine modification,BP,
5973,GO:0018444,1.00000000000226,0.705003028814307,0,3,translation release factor complex,CC,
6261,GO:0019857,1.00000000000226,0.705003028814307,0,3,5-methylcytosine metabolic process,BP,
6341,GO:0021521,1.00000000000226,0.705003028814307,0,3,ventral spinal cord interneuron specification,BP,
6436,GO:0021747,1.00000000000226,0.705003028814307,0,3,cochlear nucleus development,BP,
6450,GO:0021775,1.00000000000226,0.705003028814307,0,3,smoothened signaling pathway involved in ventral spinal cord interneuron specification,BP,
6451,GO:0021776,1.00000000000226,0.705003028814307,0,3,smoothened signaling pathway involved in spinal cord motor neuron cell fate specification,BP,
6528,GO:0021936,1.00000000000226,0.705003028814307,0,3,regulation of cerebellar granule cell precursor proliferation,BP,
6676,GO:0030047,1.00000000000226,0.705003028814307,0,3,actin modification,BP,
6874,GO:0030375,1.00000000000226,0.705003028814307,0,3,thyroid hormone receptor coactivator activity,MF,
6939,GO:0030553,1.00000000000226,0.705003028814307,0,3,cGMP binding,MF,
7235,GO:0031166,1.00000000000226,0.705003028814307,0,3,integral component of vacuolar membrane,CC,
7301,GO:0031310,1.00000000000226,0.705003028814307,0,3,intrinsic component of vacuolar membrane,CC,
7462,GO:0031627,1.00000000000226,0.705003028814307,0,3,telomeric loop formation,BP,
7544,GO:0031860,1.00000000000226,0.705003028814307,0,3,telomeric 3' overhang formation,BP,
7683,GO:0032142,1.00000000000226,0.705003028814307,0,3,single guanine insertion binding,MF,
7725,GO:0032227,1.00000000000226,0.705003028814307,0,3,negative regulation of synaptic transmission, dopaminergic,BP,
7736,GO:0032252,1.00000000000226,0.705003028814307,0,3,secretory granule localization,BP,
7759,GO:0032286,1.00000000000226,0.705003028814307,0,3,central nervous system myelin maintenance,BP,
7881,GO:0032455,1.00000000000226,0.705003028814307,0,3,nerve growth factor processing,BP,
7965,GO:0032584,1.00000000000226,0.705003028814307,0,3,growth cone membrane,CC,
8157,GO:0032898,1.00000000000226,0.705003028814307,0,3,neurotrophin production,BP,
8201,GO:0032962,1.00000000000226,0.705003028814307,0,3,positive regulation of inositol trisphosphate biosynthetic process,BP,
8416,GO:0033504,1.00000000000226,0.705003028814307,0,3,floor plate development,BP,
8435,GO:0033565,1.00000000000226,0.705003028814307,0,3,ESCRT-0 complex,CC,
8449,GO:0033596,1.00000000000226,0.705003028814307,0,3,TSC1-TSC2 complex,CC,
8505,GO:0033693,1.00000000000226,0.705003028814307,0,3,neurofilament bundle assembly,BP,
8610,GO:0034136,1.00000000000226,0.705003028814307,0,3,negative regulation of toll-like receptor 2 signaling pathway,BP,
8614,GO:0034140,1.00000000000226,0.705003028814307,0,3,negative regulation of toll-like receptor 3 signaling pathway,BP,
8673,GO:0034274,1.00000000000226,0.705003028814307,0,3,Atg12-Atg5-Atg16 complex,CC,
8696,GO:0034343,1.00000000000226,0.705003028814307,0,3,type III interferon production,BP,
8697,GO:0034344,1.00000000000226,0.705003028814307,0,3,regulation of type III interferon production,BP,
8857,GO:0034666,1.00000000000226,0.705003028814307,0,3,integrin alpha2-beta1 complex,CC,
8980,GO:0035092,1.00000000000226,0.705003028814307,0,3,sperm chromatin condensation,BP,
8986,GO:0035101,1.00000000000226,0.705003028814307,0,3,FACT complex,CC,
9158,GO:0035517,1.00000000000226,0.705003028814307,0,3,PR-DUB complex,CC,
9224,GO:0035616,1.00000000000226,0.705003028814307,0,3,histone H2B conserved C-terminal lysine deubiquitination,BP,
9320,GO:0035799,1.00000000000226,0.705003028814307,0,3,ureter maturation,BP,
9344,GO:0035860,1.00000000000226,0.705003028814307,0,3,glial cell-derived neurotrophic factor receptor signaling pathway,BP,
9398,GO:0035948,1.00000000000226,0.705003028814307,0,3,positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter,BP,
9656,GO:0038007,1.00000000000226,0.705003028814307,0,3,netrin-activated signaling pathway,BP,
9663,GO:0038026,1.00000000000226,0.705003028814307,0,3,reelin-mediated signaling pathway,BP,
9719,GO:0038165,1.00000000000226,0.705003028814307,0,3,oncostatin-M-mediated signaling pathway,BP,
9953,GO:0042328,1.00000000000226,0.705003028814307,0,3,heparan sulfate N-acetylglucosaminyltransferase activity,MF,
10138,GO:0042713,1.00000000000226,0.705003028814307,0,3,sperm ejaculation,BP,
10204,GO:0042825,1.00000000000226,0.705003028814307,0,3,TAP complex,CC,
10494,GO:0043402,1.00000000000226,0.705003028814307,0,3,glucocorticoid mediated signaling pathway,BP,
10545,GO:0043504,1.00000000000226,0.705003028814307,0,3,mitochondrial DNA repair,BP,
10655,GO:0043812,1.00000000000226,0.705003028814307,0,3,phosphatidylinositol-4-phosphate phosphatase activity,MF,
10689,GO:0043974,1.00000000000226,0.705003028814307,0,3,histone H3-K27 acetylation,BP,
10814,GO:0044313,1.00000000000226,0.705003028814307,0,3,protein K6-linked deubiquitination,BP,
10834,GO:0044336,1.00000000000226,0.705003028814307,0,3,canonical Wnt signaling pathway involved in negative regulation of apoptotic process,BP,
10917,GO:0044539,1.00000000000226,0.705003028814307,0,3,long-chain fatty acid import,BP,
10939,GO:0044611,1.00000000000226,0.705003028814307,0,3,nuclear pore inner ring,CC,
11144,GO:0045204,1.00000000000226,0.705003028814307,0,3,MAPK export from nucleus,BP,
11153,GO:0045218,1.00000000000226,0.705003028814307,0,3,zonula adherens maintenance,BP,
11306,GO:0045636,1.00000000000226,0.705003028814307,0,3,positive regulation of melanocyte differentiation,BP,
11744,GO:0046601,1.00000000000226,0.705003028814307,0,3,positive regulation of centriole replication,BP,
11775,GO:0046645,1.00000000000226,0.705003028814307,0,3,positive regulation of gamma-delta T cell activation,BP,
11882,GO:0046912,1.00000000000226,0.705003028814307,0,3,transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer,MF,
11901,GO:0046946,1.00000000000226,0.705003028814307,0,3,hydroxylysine metabolic process,BP,
11902,GO:0046947,1.00000000000226,0.705003028814307,0,3,hydroxylysine biosynthetic process,BP,
12062,GO:0048021,1.00000000000226,0.705003028814307,0,3,regulation of melanin biosynthetic process,BP,
12283,GO:0048630,1.00000000000226,0.705003028814307,0,3,skeletal muscle tissue growth,BP,
12284,GO:0048631,1.00000000000226,0.705003028814307,0,3,regulation of skeletal muscle tissue growth,BP,
12285,GO:0048633,1.00000000000226,0.705003028814307,0,3,positive regulation of skeletal muscle tissue growth,BP,
12452,GO:0050265,1.00000000000226,0.705003028814307,0,3,RNA uridylyltransferase activity,MF,
12631,GO:0050833,1.00000000000226,0.705003028814307,0,3,pyruvate transmembrane transporter activity,MF,
12696,GO:0050923,1.00000000000226,0.705003028814307,0,3,regulation of negative chemotaxis,BP,
12785,GO:0051088,1.00000000000226,0.705003028814307,0,3,PMA-inducible membrane protein ectodomain proteolysis,BP,
12929,GO:0051295,1.00000000000226,0.705003028814307,0,3,establishment of meiotic spindle localization,BP,
12966,GO:0051377,1.00000000000226,0.705003028814307,0,3,mannose-ethanolamine phosphotransferase activity,MF,
13120,GO:0051684,1.00000000000226,0.705003028814307,0,3,maintenance of Golgi location,BP,
13183,GO:0051799,1.00000000000226,0.705003028814307,0,3,negative regulation of hair follicle development,BP,
13745,GO:0060332,1.00000000000226,0.705003028814307,0,3,positive regulation of response to interferon-gamma,BP,
13748,GO:0060335,1.00000000000226,0.705003028814307,0,3,positive regulation of interferon-gamma-mediated signaling pathway,BP,
13774,GO:0060371,1.00000000000226,0.705003028814307,0,3,regulation of atrial cardiac muscle cell membrane depolarization,BP,
13798,GO:0060398,1.00000000000226,0.705003028814307,0,3,regulation of growth hormone receptor signaling pathway,BP,
13905,GO:0060573,1.00000000000226,0.705003028814307,0,3,cell fate specification involved in pattern specification,BP,
13911,GO:0060579,1.00000000000226,0.705003028814307,0,3,ventral spinal cord interneuron fate commitment,BP,
13912,GO:0060581,1.00000000000226,0.705003028814307,0,3,cell fate commitment involved in pattern specification,BP,
14005,GO:0060737,1.00000000000226,0.705003028814307,0,3,prostate gland morphogenetic growth,BP,
14081,GO:0060920,1.00000000000226,0.705003028814307,0,3,cardiac pacemaker cell differentiation,BP,
14085,GO:0060926,1.00000000000226,0.705003028814307,0,3,cardiac pacemaker cell development,BP,
14274,GO:0061364,1.00000000000226,0.705003028814307,0,3,apoptotic process involved in luteolysis,BP,
14333,GO:0061535,1.00000000000226,0.705003028814307,0,3,glutamate secretion, neurotransmission,BP,
14420,GO:0061731,1.00000000000226,0.705003028814307,0,3,ribonucleoside-diphosphate reductase activity,MF,
14573,GO:0070120,1.00000000000226,0.705003028814307,0,3,ciliary neurotrophic factor-mediated signaling pathway,BP,
14585,GO:0070138,1.00000000000226,0.705003028814307,0,3,ubiquitin-like protein-specific isopeptidase activity,MF,
14587,GO:0070140,1.00000000000226,0.705003028814307,0,3,SUMO-specific isopeptidase activity,MF,
14683,GO:0070305,1.00000000000226,0.705003028814307,0,3,response to cGMP,BP,
14713,GO:0070369,1.00000000000226,0.705003028814307,0,3,beta-catenin-TCF7L2 complex,CC,
14725,GO:0070384,1.00000000000226,0.705003028814307,0,3,Harderian gland development,BP,
14767,GO:0070471,1.00000000000226,0.705003028814307,0,3,uterine smooth muscle contraction,BP,
14768,GO:0070472,1.00000000000226,0.705003028814307,0,3,regulation of uterine smooth muscle contraction,BP,
14769,GO:0070474,1.00000000000226,0.705003028814307,0,3,positive regulation of uterine smooth muscle contraction,BP,
14862,GO:0070644,1.00000000000226,0.705003028814307,0,3,vitamin D response element binding,MF,
14944,GO:0070842,1.00000000000226,0.705003028814307,0,3,aggresome assembly,BP,
15005,GO:0070939,1.00000000000226,0.705003028814307,0,3,Dsl1/NZR complex,CC,
15022,GO:0070966,1.00000000000226,0.705003028814307,0,3,nuclear-transcribed mRNA catabolic process, no-go decay,BP,
15089,GO:0071107,1.00000000000226,0.705003028814307,0,3,response to parathyroid hormone,BP,
15179,GO:0071321,1.00000000000226,0.705003028814307,0,3,cellular response to cGMP,BP,
15354,GO:0071596,1.00000000000226,0.705003028814307,0,3,ubiquitin-dependent protein catabolic process via the N-end rule pathway,BP,
15435,GO:0071723,1.00000000000226,0.705003028814307,0,3,lipopeptide binding,MF,
15537,GO:0071947,1.00000000000226,0.705003028814307,0,3,protein deubiquitination involved in ubiquitin-dependent protein catabolic process,BP,
15653,GO:0072174,1.00000000000226,0.705003028814307,0,3,metanephric tubule formation,BP,
16038,GO:0086070,1.00000000000226,0.705003028814307,0,3,SA node cell to atrial cardiac muscle cell communication,BP,
16041,GO:0086075,1.00000000000226,0.705003028814307,0,3,gap junction channel activity involved in cardiac conduction electrical coupling,MF,
16200,GO:0090234,1.00000000000226,0.705003028814307,0,3,regulation of kinetochore assembly,BP,
16308,GO:0090480,1.00000000000226,0.705003028814307,0,3,purine nucleotide-sugar transmembrane transport,BP,
16400,GO:0097025,1.00000000000226,0.705003028814307,0,3,MPP7-DLG1-LIN7 complex,CC,
16414,GO:0097051,1.00000000000226,0.705003028814307,0,3,establishment of protein localization to endoplasmic reticulum membrane,BP,
16428,GO:0097068,1.00000000000226,0.705003028814307,0,3,response to thyroxine,BP,
16465,GO:0097149,1.00000000000226,0.705003028814307,0,3,centralspindlin complex,CC,
16559,GO:0097343,1.00000000000226,0.705003028814307,0,3,ripoptosome assembly,BP,
16646,GO:0097513,1.00000000000226,0.705003028814307,0,3,myosin II filament,CC,
16708,GO:0097694,1.00000000000226,0.705003028814307,0,3,establishment of RNA localization to telomere,BP,
16709,GO:0097695,1.00000000000226,0.705003028814307,0,3,establishment of protein-containing complex localization to telomere,BP,
16728,GO:0097742,1.00000000000226,0.705003028814307,0,3,de novo centriole assembly,BP,
16753,GO:0098535,1.00000000000226,0.705003028814307,0,3,de novo centriole assembly involved in multi-ciliated epithelial cell differentiation,BP,
16754,GO:0098536,1.00000000000226,0.705003028814307,0,3,deuterosome,CC,
16777,GO:0098592,1.00000000000226,0.705003028814307,0,3,cytoplasmic side of apical plasma membrane,CC,
16881,GO:0098821,1.00000000000226,0.705003028814307,0,3,BMP receptor activity,MF,
16936,GO:0098915,1.00000000000226,0.705003028814307,0,3,membrane repolarization during ventricular cardiac muscle cell action potential,BP,
17025,GO:0099174,1.00000000000226,0.705003028814307,0,3,regulation of presynapse organization,BP,
17191,GO:0106001,1.00000000000226,0.705003028814307,0,3,intestinal hexose absorption,BP,
17197,GO:0106017,1.00000000000226,0.705003028814307,0,3,phosphatidylinositol-3,4-bisphosphate phosphatase activity,MF,
17356,GO:1900041,1.00000000000226,0.705003028814307,0,3,negative regulation of interleukin-2 secretion,BP,
17401,GO:1900127,1.00000000000226,0.705003028814307,0,3,positive regulation of hyaluronan biosynthetic process,BP,
17523,GO:1900748,1.00000000000226,0.705003028814307,0,3,positive regulation of vascular endothelial growth factor signaling pathway,BP,
17539,GO:1901026,1.00000000000226,0.705003028814307,0,3,ripoptosome assembly involved in necroptotic process,BP,
17667,GO:1901475,1.00000000000226,0.705003028814307,0,3,pyruvate transmembrane transport,BP,
17673,GO:1901509,1.00000000000226,0.705003028814307,0,3,regulation of endothelial tube morphogenesis,BP,
17685,GO:1901537,1.00000000000226,0.705003028814307,0,3,positive regulation of DNA demethylation,BP,
17749,GO:1901674,1.00000000000226,0.705003028814307,0,3,regulation of histone H3-K27 acetylation,BP,
17974,GO:1902338,1.00000000000226,0.705003028814307,0,3,negative regulation of apoptotic process involved in morphogenesis,BP,
17997,GO:1902412,1.00000000000226,0.705003028814307,0,3,regulation of mitotic cytokinesis,BP,
18108,GO:1902730,1.00000000000226,0.705003028814307,0,3,positive regulation of proteoglycan biosynthetic process,BP,
18229,GO:1903011,1.00000000000226,0.705003028814307,0,3,negative regulation of bone development,BP,
18316,GO:1903223,1.00000000000226,0.705003028814307,0,3,positive regulation of oxidative stress-induced neuron death,BP,
18406,GO:1903422,1.00000000000226,0.705003028814307,0,3,negative regulation of synaptic vesicle recycling,BP,
18454,GO:1903527,1.00000000000226,0.705003028814307,0,3,positive regulation of membrane tubulation,BP,
18587,GO:1903818,1.00000000000226,0.705003028814307,0,3,positive regulation of voltage-gated potassium channel activity,BP,
18830,GO:1904386,1.00000000000226,0.705003028814307,0,3,response to L-phenylalanine derivative,BP,
18849,GO:1904430,1.00000000000226,0.705003028814307,0,3,negative regulation of t-circle formation,BP,
18885,GO:1904533,1.00000000000226,0.705003028814307,0,3,regulation of telomeric loop disassembly,BP,
18939,GO:1904672,1.00000000000226,0.705003028814307,0,3,regulation of somatic stem cell population maintenance,BP,
18951,GO:1904693,1.00000000000226,0.705003028814307,0,3,midbrain morphogenesis,BP,
18978,GO:1904746,1.00000000000226,0.705003028814307,0,3,negative regulation of apoptotic process involved in development,BP,
19114,GO:1905031,1.00000000000226,0.705003028814307,0,3,regulation of membrane repolarization during cardiac muscle cell action potential,BP,
19333,GO:1905606,1.00000000000226,0.705003028814307,0,3,regulation of presynapse assembly,BP,
19370,GO:1905773,1.00000000000226,0.705003028814307,0,3,8-hydroxy-2'-deoxyguanosine DNA binding,MF,
19540,GO:1990423,1.00000000000226,0.705003028814307,0,3,RZZ complex,CC,
19564,GO:1990504,1.00000000000226,0.705003028814307,0,3,dense core granule exocytosis,BP,
19641,GO:1990785,1.00000000000226,0.705003028814307,0,3,response to water-immersion restraint stress,BP,
19861,GO:2000317,1.00000000000226,0.705003028814307,0,3,negative regulation of T-helper 17 type immune response,BP,
19864,GO:2000320,1.00000000000226,0.705003028814307,0,3,negative regulation of T-helper 17 cell differentiation,BP,
19923,GO:2000402,1.00000000000226,0.705003028814307,0,3,negative regulation of lymphocyte migration,BP,
20049,GO:2000653,1.00000000000226,0.705003028814307,0,3,regulation of genetic imprinting,BP,
20066,GO:2000671,1.00000000000226,0.705003028814307,0,3,regulation of motor neuron apoptotic process,BP,
20067,GO:2000672,1.00000000000226,0.705003028814307,0,3,negative regulation of motor neuron apoptotic process,BP,
20103,GO:2000741,1.00000000000226,0.705003028814307,0,3,positive regulation of mesenchymal stem cell differentiation,BP,
20273,GO:2001205,1.00000000000226,0.705003028814307,0,3,negative regulation of osteoclast development,BP,
146,GO:0000301,1.00000000000227,0.705003028814304,0,3,retrograde transport, vesicle recycling within Golgi,BP,
6236,GO:0019797,1.00000000000227,0.705003028814304,0,3,procollagen-proline 3-dioxygenase activity,MF,
7719,GO:0032217,1.00000000000227,0.705003028814304,0,3,riboflavin transmembrane transporter activity,MF,
7720,GO:0032218,1.00000000000227,0.705003028814304,0,3,riboflavin transport,BP,
8429,GO:0033557,1.00000000000227,0.705003028814304,0,3,Slx1-Slx4 complex,CC,
13445,GO:0052905,1.00000000000227,0.705003028814304,0,3,tRNA (guanine(9)-N(1))-methyltransferase activity,MF,
20259,GO:2001184,1.00000000000232,0.792468821226549,0,2,positive regulation of interleukin-12 secretion,BP,
18417,GO:1903435,1.00000000000233,0.890023723982731,0,1,positive regulation of constitutive secretory pathway,BP,
10880,GO:0044428,1.00000000000235,0,295,3804,nuclear part,CC,TNIP1;DUSP6;NT5E;ERCC1;DUSP5;MEF2D;H1F0;CITED4;EGR1;NR1D1;SLC16A3;CST3;EPN3;CTNNBIP1;DOCK4;XPC;PRNP;TSPAN1;PITPNC1;HMGA2;OBSCN;ELK3;ITPR3;PKN1;MTA1;ACOT7;EGFR;RPS6KA2;WWTR1;NOS1;SLC2A9;HADH;NFATC4;TRIM65;BAHCC1;ETV5;APPL2;DDB2;TBC1D14;ARL2;ETV4;TRNP1;ARAP1;SMARCA1;RNF44;CPT2;VWA5A;POU2F2;SMURF2;KLC2;FOS;SMAD3;STAT6;ERCC6;EPAS1;PPP2R3B;SALL2;RNF187;ADARB1;AKT1;HDAC5;S100A6;STK39;SCMH1;PHC2;NFKBIZ;ASH2L;ATG16L2;BRSK1;PTHLH;POLD4;FGFR1;PRKACB;MAPKBP1;SIGMAR1;RAC2;HLTF;MXI1;SYNE3;RAG1;H2AFJ;PHF7;TOMM34;SORL1;CIRBP;HMG20B;TENM2;ZNF385A;NSMCE4A;CCND1;LHPP;PTK6;CSNK1E;CTSB;SOX13;DUSP7;MPLKIP;MAPKAPK3;RAD23A;PHLDA1;XPOT;HLCS;AIP;SH3D19;CCDC113;CDC25B;SH3GLB2;ARHGAP27;SMARCD2;DGKQ;BNIP3;PAK6;NOL4L;GTF2IRD1;RETSAT;YPEL3;CRTC1;APRT;CTBP1;LTA4H;MNT;PTPDC1;PLCG1;ZMIZ2;CEBPB;ZNF217;GPC1;MKNK2;DEAF1;SDHA;MPG;CLCA2;NSMF;ABHD14B;ABTB1;RNH1;POLL;POLM;PHF21A;MIF4GD;UBXN4;KHDRBS3;B4GALT2;MBD3;VHL;TRAP1;PFKFB2;MLXIPL;PRKCZ;KDM6B;PRKACA;CENPH;RABGGTA;BOK;WDR18;CAPG;ALAS1;CNDP2;TFDP2;C6ORF89;MZT2A;STK17A;RILPL1;FAM50A;IRF2BP2;BNIP3L;NELFCD;PDK1;CYGB;PRKCD;RBL2;STUB1;BAX;SBF1;DTD1;OLFM2;HIST3H2BB;CCDC92;GJB4;RPS6KA5;DUSP4;KLHDC2;SOX12;ACADS;PPP1R13L;CARF;IER2;MZT2B;FCHO1;LIMK1;LTB4R2;LEMD2;RPS6KA6;TMEM92;ZHX3;DNM1;RGS14;MRPS26;SYMPK;MAPK12;HDAC7;CHD2;CBX7;CHEK2;ZFPM1;PPARA;COG7;JADE2;CDC34;RNF123;SOX7;MIF;SMOX;KDM4B;NARF;SLC22A18;SPPL2B;HSD11B1L;UPP1;CERS4;SUN1;FLYWCH1;ARID5B;HOXC5;BHLHE40;SNX15;NEIL1;TSPYL2;ZMYM3;SATB1;PLCB3;H1FX;IQSEC1;APOBEC3F;DDX50;MAPK3;INSR;RERE;INO80C;PDXK;ETAA1;PAK1;TRIM45;DCAF10;PPP3CB;USP21;PFKFB3;CUL7;REV1;ZBTB10;WDTC1;DNMT3A;BIN1;MAP2K3;BCL2L1;NDUFV3;LRCH4;LMNA;KCTD13;SIRT2;FAM129B;UVSSA;TRIP10;E2F5;TEP1;RAP1GAP2;GTF2IRD2;RAB40B;NGFR;TOLLIP;BCORL1;PLEKHM1;DUSP23;GCH1;MAFF;NR2F6;CBX6;PNMA1;EZH1;TERC;WIPI2;VPS51;CELSR1;TNRC18;TCEA2;PLAG1;CLK3;IRF2BPL;DHX32;KDM3A;PM20D2;TBL3;DEDD2;SRSF5;SLC26A11
2155,GO:0004979,1.00000000000235,0.894392107559604,0,1,beta-endorphin receptor activity,MF,
7466,GO:0031635,1.00000000000235,0.894392107559604,0,1,adenylate cyclase-inhibiting opioid receptor signaling pathway,BP,
7661,GO:0032097,1.00000000000235,0.894392107559604,0,1,positive regulation of response to food,BP,
7664,GO:0032100,1.00000000000235,0.894392107559604,0,1,positive regulation of appetite,BP,
9675,GO:0038047,1.00000000000235,0.894392107559604,0,1,morphine receptor activity,MF,
11709,GO:0046521,1.00000000000235,0.894392107559604,0,1,sphingoid catabolic process,BP,
14273,GO:0061358,1.00000000000235,0.894392107559604,0,1,negative regulation of Wnt protein secretion,BP,
12819,GO:0051133,1.00000000000237,0.743648240110059,0,3,regulation of NK T cell activation,BP,
12820,GO:0051135,1.00000000000237,0.743648240110059,0,3,positive regulation of NK T cell activation,BP,
19100,GO:1904990,1.0000000000024,0.890290262887145,0,1,regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
19101,GO:1904992,1.0000000000024,0.890290262887145,0,1,positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
17645,GO:1901360,1.00000000000242,0,401,4872,organic cyclic compound metabolic process,BP,TNIP1;NT5E;XDH;ERCC1;MEF2D;ZMYND8;H1F0;CITED4;HTRA1;EGR1;NR1D1;H6PD;DLG4;CST3;CYP27B1;APLN;PDCD4;CTNNBIP1;ACVR2B;XPC;PRNP;VEGFA;PGM1;WNT7A;APOE;F2R;LRP5;OSBPL5;ITGA6;HMGA2;IDH2;ZKSCAN1;ELK3;PKN1;MTA1;ACOT7;AKR7A2;EGFR;DNPH1;WWTR1;NOS1;SLC2A9;NFATC4;BAHCC1;ETV5;LMF1;SHC1;DDB2;HEXB;GTPBP1;TCFL5;ALDH4A1;TK2;ETV4;TRNP1;RAPGEF3;ZFP36L1;MAP2K2;NME4;ZC3H6;MDFI;PTOV1;SMARCA1;RBCK1;PLTP;PGLS;PC;FOXQ1;MAP2K1;NAPRT;ACP5;NYNRIN;MXD4;POU2F2;ENDOG;SMURF2;TSC22D1;FOS;SMAD3;STAT6;PIK3R2;ERCC6;SRD5A3;DVL1;EPAS1;DNAJB5;HSD17B8;RPUSD3;PRDX5;BRD3;PRODH;SALL2;ZXDC;RNF187;NMRK1;ADORA2B;ADARB1;AKT1;HDAC5;UROS;PPM1F;ENTPD6;PYCR2;HK1;SCMH1;NFKBIZ;ASH2L;IMPACT;WWC3;DAP;PTHLH;FGFR4;POLD4;LDLR;FGFR1;MAPKBP1;KCNAB2;PFKL;SEC14L2;HLTF;MXI1;RAG1;GAMT;H2AFJ;KLF7;SORL1;NAT14;CIRBP;CBR4;HMG20B;TENM2;ZNF385A;NSMCE4A;IGFBP4;TSHZ1;TRAPPC9;CCND1;PCBP4;TCF25;LHPP;MAPK13;GAS6;PFKP;CSNK1E;CARD11;SOX13;PCSK9;ARHGAP22;RAD23A;DHTKD1;GLI4;NADK;PANK4;HLCS;ZSCAN18;AIP;MYEF2;MN1;SMARCD2;RSAD1;RRNAD1;NPR2;DGKQ;PAK6;GTF2IRD1;TAGLN3;PKD2;HES2;CRTC1;ABCA2;MAGEF1;PRSS3;ADAM8;APRT;CTBP1;MNT;CDKN1C;ZMIZ2;CBS;CD81;CEBPB;MVD;ENTPD2;ZNF217;TIMP2;ZNF862;TGFB1;LACTB2;RFX2;SCYL1;DEAF1;NAB2;TMEM173;ZSCAN30;PODXL2;SDHA;MSRB2;PNRC1;MDH2;MPG;PEG3;MC1R;ABHD14B;SNX17;RNH1;POLL;POLM;PTMS;PHF21A;PLPP6;KHDRBS3;PTPN1;PCK2;AGRN;MBD3;CD320;LRP4;VHL;PFKFB2;MLXIPL;PRKCZ;KDM6B;PRKACA;ZNF516;ADA;AREG;PIM2;MPI;UCKL1;WDR18;TDRKH;ALAS1;ERBB2;AHCY;PRIMPOL;TFDP2;IRF2BP2;PBX2;TRPC1;NELFCD;PRKCD;FAM20C;RBL2;STUB1;BAX;CYC1;DTD1;ZNF395;PPCS;EREG;RPS6KA5;DGUOK;ZNF524;SOX12;DDIT4;MBTPS2;TOP3B;PPP1R13L;CARF;HSD17B7;AHNAK2;IER2;TGFBR3;LTB4R2;LEMD2;ZHX3;RGS14;ALDOC;SYMPK;MAPK12;IRAK1;PPOX;TGFA;HDAC7;FHOD1;MTHFR;CHD2;CBX7;CHEK2;ZFPM1;PPARA;TMEM161A;SESN2;ABCG1;CDC34;SOX7;SIX5;KDM4B;ZNF414;DDT;SSBP4;ECM1;WFS1;ZNF444;TRPT1;DALRD3;UPP1;ARID5B;HOXC5;DNM2;CYP3A5;BHLHE40;PELI1;CAT;NEIL1;TSPYL2;IGFBP7;ZMYM3;APOBEC3C;SATB1;ZNF606;APOBEC3F;DDX50;CYP2R1;MAPK3;INSR;PAN2;CAMTA2;TAZ;PFKM;ADCY1;RERE;TSTA3;INO80C;PDXK;ETAA1;GLRX;BCL7A;CAMKK2;RNASET2;PPP3CB;USP21;PFKFB3;GABBR1;REV1;CAPRIN2;ZBTB10;WDTC1;HES7;ITGA3;DNMT3A;PPP2R5B;HES6;MAP2K3;DLG3;NDUFV3;DNASE1L1;PROX1;IARS2;ADGRF1;PKD1;KCTD13;SIRT2;FAM129B;EDA;UVSSA;NMNAT2;BACH1;NT5C1B;ADCY7;E2F5;ZBTB22;MAPRE3;TEP1;ZNF704;MAP3K10;HSD11B1;GTF2IRD2;NGFR;BCORL1;ZNF837;RNASE7;GCH1;MAFF;NR2F6;CBX6;CAMK1;EZH1;HFE;TERC;ZNF513;BTG1;ZP3;MLF2;CDK11B;TNRC18;TCEA2;ZBTB47;PLAG1;CLK3;IRF2BPL;DHX32;KDM3A;PM20D2;TBL3;SLC23A2;DEDD2;AK3;SRSF5;ADCY6;AARS
5810,GO:0017065,1.00000000000247,0.899877458900226,0,1,single-strand selective uracil DNA N-glycosylase activity,MF,
10253,GO:0042997,1.00000000000248,0.705194145075196,0,3,negative regulation of Golgi to plasma membrane protein transport,BP,
19536,GO:1990415,1.00000000000249,0.707827041008058,0,3,Pex17p-Pex14p docking complex,CC,
19545,GO:1990429,1.00000000000249,0.707827041008058,0,3,peroxisomal importomer complex,CC,
7130,GO:0030969,1.00000000000255,0.705243445857739,0,3,mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response,BP,
7377,GO:0031437,1.00000000000255,0.705243445857739,0,3,regulation of mRNA cleavage,BP,
14536,GO:0070054,1.00000000000255,0.705243445857739,0,3,mRNA splicing, via endonucleolytic cleavage and ligation,BP,
14537,GO:0070055,1.00000000000255,0.705243445857739,0,3,mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
9194,GO:0035582,1.00000000000261,0.712097264720957,0,3,sequestering of BMP in extracellular matrix,BP,
1836,GO:0004491,1.00000000000272,0.891291432065982,0,1,methylmalonate-semialdehyde dehydrogenase (acylating) activity,MF,
4735,GO:0010904,1.00000000000272,0.891291432065982,0,1,regulation of UDP-glucose catabolic process,BP,
4736,GO:0010905,1.00000000000272,0.891291432065982,0,1,negative regulation of UDP-glucose catabolic process,BP,
5976,GO:0018478,1.00000000000272,0.891291432065982,0,1,malonate-semialdehyde dehydrogenase (acetylating) activity,MF,
18760,GO:1904226,1.00000000000272,0.891291432065982,0,1,regulation of glycogen synthase activity, transferring glucose-1-phosphate,BP,
18761,GO:1904227,1.00000000000272,0.891291432065982,0,1,negative regulation of glycogen synthase activity, transferring glucose-1-phosphate,BP,
2615,GO:0005927,1.00000000000274,0.900371515648199,0,1,muscle tendon junction,CC,
8650,GO:0034213,1.00000000000274,0.900371515648199,0,1,quinolinate catabolic process,BP,
9482,GO:0036122,1.00000000000274,0.706902820193371,0,3,BMP binding,MF,
11859,GO:0046874,1.00000000000274,0.900371515648199,0,1,quinolinate metabolic process,BP,
7943,GO:0032545,1.00000000000275,0.721065596259602,0,3,CURI complex,CC,
8769,GO:0034456,1.00000000000275,0.721065596259602,0,3,UTP-C complex,CC,
4663,GO:0010813,1.00000000000276,0.802975085901608,0,2,neuropeptide catabolic process,BP,
16826,GO:0098713,1.0000000000028,0.890870471282775,0,1,leucine import across plasma membrane,BP,
18584,GO:1903801,1.0000000000028,0.890870471282775,0,1,L-leucine import across plasma membrane,BP,
18620,GO:1903893,1.00000000000282,0.890183601728143,0,1,positive regulation of ATF6-mediated unfolded protein response,BP,
1846,GO:0004505,1.00000000000283,0.816794597558107,0,2,phenylalanine 4-monooxygenase activity,MF,
3645,GO:0008124,1.00000000000283,0.816794597558107,0,2,4-alpha-hydroxytetrahydrobiopterin dehydratase activity,MF,
14003,GO:0060735,1.00000000000283,0.905189754427014,0,1,regulation of eIF2 alpha phosphorylation by dsRNA,BP,
18078,GO:1902629,1.00000000000283,0.905189754427014,0,1,regulation of mRNA stability involved in cellular response to UV,BP,
4607,GO:0010726,1.00000000000286,0.794356140839228,0,2,positive regulation of hydrogen peroxide metabolic process,BP,
7376,GO:0031436,1.00000000000286,0.792177851135672,0,2,BRCA1-BARD1 complex,CC,
18703,GO:1904046,1.00000000000288,0.824140549782047,0,2,negative regulation of vascular endothelial growth factor production,BP,
9391,GO:0035933,1.00000000000295,0.733779132530803,0,3,glucocorticoid secretion,BP,
20166,GO:2000849,1.00000000000295,0.733779132530803,0,3,regulation of glucocorticoid secretion,BP,
5876,GO:0017198,1.00000000000295,0.921954827140894,0,1,N-terminal peptidyl-serine acetylation,BP,
5877,GO:0018002,1.00000000000295,0.921954827140894,0,1,N-terminal peptidyl-glutamic acid acetylation,BP,
7111,GO:0030920,1.00000000000295,0.921954827140894,0,1,peptidyl-serine acetylation,BP,
14470,GO:0061850,1.00000000000295,0.921954827140894,0,1,growth cone leading edge,CC,
15542,GO:0071960,1.00000000000295,0.921954827140894,0,1,maintenance of mitotic sister chromatid cohesion, centromeric,BP,
19490,GO:1990190,1.00000000000295,0.921954827140894,0,1,peptide-glutamate-N-acetyltransferase activity,MF,
20088,GO:2000718,1.00000000000295,0.921954827140894,0,1,regulation of maintenance of mitotic sister chromatid cohesion, centromeric,BP,
20089,GO:2000719,1.00000000000295,0.921954827140894,0,1,negative regulation of maintenance of mitotic sister chromatid cohesion, centromeric,BP,
5032,GO:0015204,1.00000000000302,0.708969922803963,0,3,urea transmembrane transporter activity,MF,
5227,GO:0015840,1.00000000000302,0.708969922803963,0,3,urea transport,BP,
18259,GO:1903070,1.00000000000306,0.717050620767374,0,3,negative regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
8441,GO:0033577,1.00000000000308,0.792231674872949,0,2,protein glycosylation in endoplasmic reticulum,BP,
2056,GO:0004807,1.00000000000308,0.902583589002589,0,1,triose-phosphate isomerase activity,MF,
6164,GO:0019520,1.00000000000313,0.795127123644582,0,2,aldonic acid metabolic process,BP,
6165,GO:0019521,1.00000000000313,0.795127123644582,0,2,D-gluconate metabolic process,BP,
3778,GO:0008336,1.00000000000313,0.894054780488568,0,1,gamma-butyrobetaine dioxygenase activity,MF,
4988,GO:0015117,1.00000000000313,0.894054780488568,0,1,thiosulfate transmembrane transporter activity,MF,
4994,GO:0015131,1.00000000000313,0.894054780488568,0,1,oxaloacetate transmembrane transporter activity,MF,
5164,GO:0015709,1.00000000000313,0.894054780488568,0,1,thiosulfate transport,BP,
5174,GO:0015729,1.00000000000313,0.894054780488568,0,1,oxaloacetate transport,BP,
5180,GO:0015743,1.00000000000313,0.894054780488568,0,1,malate transport,BP,
15249,GO:0071423,1.00000000000313,0.894054780488568,0,1,malate transmembrane transport,BP,
17976,GO:1902356,1.00000000000313,0.894054780488568,0,1,oxaloacetate(2-) transmembrane transport,BP,
1760,GO:0004363,1.00000000000313,0.893835655676955,0,1,glutathione synthase activity,MF,
15172,GO:0071313,1.00000000000319,0.806259704251968,0,2,cellular response to caffeine,BP,
15243,GO:0071415,1.00000000000319,0.806259704251968,0,2,cellular response to purine-containing compound,BP,
9516,GO:0036219,1.0000000000032,0.929109547823149,0,1,GTP diphosphatase activity,MF,
10951,GO:0044713,1.0000000000032,0.929109547823149,0,1,2-hydroxy-adenosine triphosphate pyrophosphatase activity,MF,
10952,GO:0044714,1.0000000000032,0.929109547823149,0,1,2-hydroxy-(deoxy)adenosine-triphosphate pyrophosphatase activity,MF,
12019,GO:0047693,1.0000000000032,0.929109547823149,0,1,ATP diphosphatase activity,MF,
8,GO:0000015,1.00000000000321,0.796874984199148,0,2,phosphopyruvate hydratase complex,CC,
1935,GO:0004634,1.00000000000321,0.796874984199148,0,2,phosphopyruvate hydratase activity,MF,
16419,GO:0097058,1.00000000000323,0.895396260275473,0,1,CRLF-CLCF1 complex,CC,
16420,GO:0097059,1.00000000000323,0.895396260275473,0,1,CNTFR-CLCF1 complex,CC,
8654,GO:0034224,1.00000000000327,0.890944272850369,0,1,cellular response to zinc ion starvation,BP,
9871,GO:0042138,1.00000000000327,0.890582514145035,0,1,meiotic DNA double-strand break formation,BP,
1634,GO:0004075,1.00000000000329,0.705079300935969,0,3,biotin carboxylase activity,MF,
5370,GO:0016175,1.00000000000333,0.828406161420536,0,2,superoxide-generating NADPH oxidase activity,MF,
10268,GO:0043020,1.00000000000333,0.828406161420536,0,2,NADPH oxidase complex,CC,
754,GO:0001996,1.00000000000341,0.710377413964726,0,3,positive regulation of heart rate by epinephrine-norepinephrine,BP,
1398,GO:0003321,1.00000000000341,0.710377413964726,0,3,positive regulation of blood pressure by epinephrine-norepinephrine,BP,
9177,GO:0035553,1.00000000000343,0.712718052857956,0,3,oxidative single-stranded RNA demethylation,BP,
3968,GO:0008775,1.00000000000344,0.894970326562433,0,1,acetate CoA-transferase activity,MF,
4326,GO:0009850,1.00000000000344,0.894970326562433,0,1,auxin metabolic process,BP,
4327,GO:0009852,1.00000000000344,0.894970326562433,0,1,auxin catabolic process,BP,
4398,GO:0010124,1.00000000000344,0.894970326562433,0,1,phenylacetate catabolic process,BP,
13515,GO:0055100,1.00000000000346,0.706281158540271,0,3,adiponectin binding,MF,
8853,GO:0034660,1.00000000000349,0,14,546,ncRNA metabolic process,BP,POU2F2;SMAD3;RPUSD3;CSNK1E;RRNAD1;WDR18;TDRKH;DTD1;TRPT1;DALRD3;IARS2;TBL3;DEDD2;AARS
756,GO:0001998,1.0000000000035,0.893685878427073,0,1,angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure,BP,
776,GO:0002034,1.0000000000035,0.893685878427073,0,1,regulation of blood vessel diameter by renin-angiotensin,BP,
1279,GO:0003072,1.0000000000035,0.893685878427073,0,1,renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure,BP,
18522,GO:1903673,1.0000000000035,0.893685878427073,0,1,mitotic cleavage furrow formation,BP,
18953,GO:1904695,1.0000000000035,0.893685878427073,0,1,positive regulation of vascular smooth muscle contraction,BP,
10753,GO:0044205,1.00000000000351,0.706689270819018,0,3,'de novo' UMP biosynthetic process,BP,
13144,GO:0051725,1.00000000000352,0.808445781181699,0,2,protein de-ADP-ribosylation,BP,
13841,GO:0060455,1.00000000000353,0.823128304119865,0,2,negative regulation of gastric acid secretion,BP,
18679,GO:1903999,1.00000000000353,0.823128304119865,0,2,negative regulation of eating behavior,BP,
18798,GO:1904304,1.00000000000353,0.823128304119865,0,2,regulation of gastro-intestinal system smooth muscle contraction,BP,
18799,GO:1904306,1.00000000000353,0.823128304119865,0,2,positive regulation of gastro-intestinal system smooth muscle contraction,BP,
19819,GO:2000252,1.00000000000353,0.823128304119865,0,2,negative regulation of feeding behavior,BP,
11513,GO:0046038,1.00000000000357,0.903745375210781,0,1,GMP catabolic process,BP,
13376,GO:0052657,1.00000000000357,0.903745375210781,0,1,guanine phosphoribosyltransferase activity,MF,
1891,GO:0004573,1.00000000000364,0.8900265901381,0,1,mannosyl-oligosaccharide glucosidase activity,MF,
3436,GO:0007231,1.00000000000367,0.799311689217986,0,2,osmosensory signaling pathway,BP,
12794,GO:0051097,1.00000000000368,0.708620638151763,0,3,negative regulation of helicase activity,BP,
14426,GO:0061738,1.00000000000374,0.707947715729881,0,3,late endosomal microautophagy,BP,
16237,GO:0090289,1.00000000000377,0.815274080465107,0,2,regulation of osteoclast proliferation,BP,
15099,GO:0071149,1.00000000000381,0.793367863817978,0,2,TEAD-2-YAP complex,CC,
3973,GO:0008794,1.00000000000381,0.920959442244604,0,1,arsenate reductase (glutaredoxin) activity,MF,
6953,GO:0030611,1.00000000000381,0.920959442244604,0,1,arsenate reductase activity,MF,
18066,GO:1902605,1.00000000000383,0.890025548726944,0,1,heterotrimeric G-protein complex assembly,BP,
1954,GO:0004658,1.00000000000384,0.796734161403277,0,2,propionyl-CoA carboxylase activity,MF,
12997,GO:0051431,1.00000000000391,0.90200946176047,0,1,corticotropin-releasing hormone receptor 2 binding,MF,
8171,GO:0032915,1.00000000000394,0.891742443789164,0,1,positive regulation of transforming growth factor beta2 production,BP,
11077,GO:0045085,1.00000000000394,0.896329437213706,0,1,negative regulation of interleukin-2 biosynthetic process,BP,
16839,GO:0098745,1.00000000000394,0.896329437213706,0,1,Dcp1-Dcp2 complex,CC,
17784,GO:1901834,1.00000000000394,0.896329437213706,0,1,regulation of deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
17785,GO:1901835,1.00000000000394,0.896329437213706,0,1,positive regulation of deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
18772,GO:1904246,1.00000000000394,0.896329437213706,0,1,negative regulation of polynucleotide adenylyltransferase activity,BP,
16763,GO:0098560,1.00000000000395,0.792219063428933,0,2,cytoplasmic side of late endosome membrane,CC,
19880,GO:2000342,1.00000000000395,0.792544689747437,0,2,negative regulation of chemokine (C-X-C motif) ligand 2 production,BP,
7261,GO:0031247,1.00000000000396,0.794566071175632,0,2,actin rod assembly,BP,
2792,GO:0006238,1.00000000000397,0.908860678855684,0,1,CMP salvage,BP,
4160,GO:0009224,1.00000000000397,0.908860678855684,0,1,CMP biosynthetic process,BP,
11510,GO:0046035,1.00000000000397,0.908860678855684,0,1,CMP metabolic process,BP,
2025,GO:0004757,1.00000000000399,0.902662950681621,0,1,sepiapterin reductase activity,MF,
13764,GO:0060353,1.00000000000401,0.717984760854989,0,3,regulation of cell adhesion molecule production,BP,
13765,GO:0060355,1.00000000000401,0.717984760854989,0,3,positive regulation of cell adhesion molecule production,BP,
10054,GO:0042543,1.00000000000404,0.936508918029014,0,1,protein N-linked glycosylation via arginine,BP,
18266,GO:1903093,1.00000000000406,0.743058781791033,0,3,regulation of protein K48-linked deubiquitination,BP,
111,GO:0000229,1.00000000000411,0.899284281106106,0,1,cytoplasmic chromosome,CC,
126,GO:0000262,1.00000000000411,0.899284281106106,0,1,mitochondrial chromosome,CC,
4325,GO:0009841,1.00000000000411,0.890502477907039,0,1,mitochondrial endopeptidase Clp complex,CC,
15995,GO:0086008,1.00000000000414,0.792416622906552,0,2,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization,MF,
2291,GO:0005250,1.00000000000414,0.79241662290655,0,2,A-type (transient outward) potassium channel activity,MF,
11118,GO:0045163,1.00000000000414,0.79241662290655,0,2,clustering of voltage-gated potassium channels,BP,
16678,GO:0097623,1.00000000000414,0.79241662290655,0,2,potassium ion export across plasma membrane,BP,
17354,GO:1900039,1.00000000000415,0.911169808625481,0,1,positive regulation of cellular response to hypoxia,BP,
17868,GO:1902071,1.00000000000415,0.911169808625481,0,1,regulation of hypoxia-inducible factor-1alpha signaling pathway,BP,
17869,GO:1902073,1.00000000000415,0.911169808625481,0,1,positive regulation of hypoxia-inducible factor-1alpha signaling pathway,BP,
1510,GO:0003868,1.0000000000042,0.895420174970288,0,1,4-hydroxyphenylpyruvate dioxygenase activity,MF,
214,GO:0000448,1.0000000000042,0.792493387034362,0,2,cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
6521,GO:0021914,1.00000000000421,0.792207585482106,0,2,negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning,BP,
13824,GO:0060434,1.00000000000421,0.792207585482106,0,2,bronchus morphogenesis,BP,
17128,GO:0102121,1.00000000000421,0.792207585482106,0,2,ceramidase activity,MF,
460,GO:0001401,1.00000000000421,0.797391458742344,0,2,mitochondrial sorting and assembly machinery complex,CC,
16645,GO:0097512,1.00000000000422,0.930147446658077,0,1,cardiac myofibril,CC,
13520,GO:0055108,1.00000000000423,0.893006483476258,0,1,Golgi to transport vesicle transport,BP,
19520,GO:1990386,1.00000000000423,0.893006483476258,0,1,mitotic cleavage furrow ingression,BP,
19582,GO:1990583,1.00000000000423,0.893006483476258,0,1,phospholipase D activator activity,MF,
839,GO:0002144,1.00000000000424,0.891848524019678,0,1,cytosolic tRNA wobble base thiouridylase complex,CC,
13392,GO:0052739,1.00000000000424,0.892141191770342,0,1,phosphatidylserine 1-acylhydrolase activity,MF,
13393,GO:0052740,1.00000000000424,0.892141191770342,0,1,1-acyl-2-lysophosphatidylserine acylhydrolase activity,MF,
18890,GO:1904550,1.00000000000424,0.892141191770342,0,1,response to arachidonic acid,BP,
19868,GO:2000324,1.00000000000424,0.892141191770342,0,1,positive regulation of glucocorticoid receptor signaling pathway,BP,
10688,GO:0043973,1.00000000000425,0.891176895696818,0,1,histone H3-K4 acetylation,BP,
19534,GO:1990410,1.00000000000428,0.803597207415296,0,2,adrenomedullin receptor signaling pathway,BP,
10,GO:0000019,1.00000000000429,0.705168005868329,0,3,regulation of mitotic recombination,BP,
7680,GO:0032137,1.00000000000429,0.705168005868329,0,3,guanine/thymine mispair binding,MF,
4870,GO:0014732,1.00000000000433,0.713015450709024,0,3,skeletal muscle atrophy,BP,
9251,GO:0035663,1.00000000000439,0.797109774824496,0,2,Toll-like receptor 2 binding,MF,
11987,GO:0047391,1.00000000000439,0.797109774824496,0,2,alkylglycerophosphoethanolamine phosphodiesterase activity,MF,
15847,GO:0072566,1.00000000000439,0.797109774824496,0,2,chemokine (C-X-C motif) ligand 1 production,BP,
19877,GO:2000338,1.00000000000439,0.797109774824496,0,2,regulation of chemokine (C-X-C motif) ligand 1 production,BP,
19878,GO:2000340,1.00000000000439,0.797109774824496,0,2,positive regulation of chemokine (C-X-C motif) ligand 1 production,BP,
10482,GO:0043385,1.0000000000044,0.890025790726607,0,1,mycotoxin metabolic process,BP,
10483,GO:0043387,1.0000000000044,0.890025790726607,0,1,mycotoxin catabolic process,BP,
11596,GO:0046222,1.0000000000044,0.890025790726607,0,1,aflatoxin metabolic process,BP,
11597,GO:0046223,1.0000000000044,0.890025790726607,0,1,aflatoxin catabolic process,BP,
17651,GO:1901376,1.0000000000044,0.890025790726607,0,1,organic heteropentacyclic compound metabolic process,BP,
17652,GO:1901377,1.0000000000044,0.890025790726607,0,1,organic heteropentacyclic compound catabolic process,BP,
18573,GO:1903786,1.0000000000044,0.890025790726607,0,1,regulation of glutathione biosynthetic process,BP,
18574,GO:1903788,1.0000000000044,0.890025790726607,0,1,positive regulation of glutathione biosynthetic process,BP,
7835,GO:0032398,1.00000000000444,0.897511177270056,0,1,MHC class Ib protein complex,CC,
8003,GO:0032639,1.00000000000444,0.897511177270056,0,1,TRAIL production,BP,
8027,GO:0032679,1.00000000000444,0.897511177270056,0,1,regulation of TRAIL production,BP,
8071,GO:0032759,1.00000000000444,0.897511177270056,0,1,positive regulation of TRAIL production,BP,
19996,GO:2000566,1.00000000000444,0.897511177270056,0,1,positive regulation of CD8-positive, alpha-beta T cell proliferation,BP,
20262,GO:2001187,1.00000000000444,0.897511177270056,0,1,positive regulation of CD8-positive, alpha-beta T cell activation,BP,
8491,GO:0033678,1.00000000000446,0.890040637906914,0,1,5'-3' DNA/RNA helicase activity,MF,
8495,GO:0033682,1.00000000000446,0.890040637906914,0,1,ATP-dependent 5'-3' DNA/RNA helicase activity,MF,
2066,GO:0004819,1.00000000000446,0.792355269558826,0,2,glutamine-tRNA ligase activity,MF,
2911,GO:0006425,1.00000000000446,0.792355269558826,0,2,glutaminyl-tRNA aminoacylation,BP,
9264,GO:0035691,1.00000000000456,0.906764954822341,0,1,macrophage migration inhibitory factor signaling pathway,BP,
9266,GO:0035693,1.00000000000456,0.906764954822341,0,1,NOS2-CD74 complex,CC,
10118,GO:0042658,1.00000000000456,0.906764954822341,0,1,MHC class II protein binding, via antigen binding groove,MF,
19096,GO:1904978,1.00000000000458,0.705794116823554,0,3,regulation of endosome organization,BP,
7073,GO:0030868,1.00000000000458,0.719571723666539,0,3,smooth endoplasmic reticulum membrane,CC,
16597,GO:0097425,1.00000000000458,0.719571723666539,0,3,smooth endoplasmic reticulum part,CC,
5285,GO:0015938,1.0000000000046,0.917063945147222,0,1,coenzyme A catabolic process,BP,
8533,GO:0033869,1.0000000000046,0.917063945147222,0,1,nucleoside bisphosphate catabolic process,BP,
8556,GO:0034031,1.0000000000046,0.917063945147222,0,1,ribonucleoside bisphosphate catabolic process,BP,
8559,GO:0034034,1.0000000000046,0.917063945147222,0,1,purine nucleoside bisphosphate catabolic process,BP,
2391,GO:0005534,1.00000000000462,0.717087444189687,0,3,galactose binding,MF,
13451,GO:0052925,1.00000000000464,0.901087801314964,0,1,dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity,MF,
18973,GO:1904734,1.00000000000464,0.94228938587019,0,1,positive regulation of electron transfer activity,BP,
19089,GO:1904960,1.00000000000464,0.94228938587019,0,1,positive regulation of cytochrome-c oxidase activity,BP,
14719,GO:0070375,1.00000000000464,0.705368705534875,0,3,ERK5 cascade,BP,
11326,GO:0045660,1.00000000000464,0.892858719053375,0,1,positive regulation of neutrophil differentiation,BP,
471,GO:0001515,1.00000000000467,0.893017230848803,0,1,opioid peptide activity,MF,
17478,GO:1900365,1.00000000000467,0.706137463838601,0,3,positive regulation of mRNA polyadenylation,BP,
11937,GO:0047021,1.00000000000468,0.908957174146538,0,1,15-hydroxyprostaglandin dehydrogenase (NADP+) activity,MF,
12448,GO:0050221,1.00000000000468,0.908957174146538,0,1,prostaglandin-E2 9-reductase activity,MF,
3808,GO:0008401,1.00000000000472,0.792164591594404,0,2,retinoic acid 4-hydroxylase activity,MF,
1902,GO:0004587,1.00000000000472,0.89295843961396,0,1,ornithine-oxo-acid transaminase activity,MF,
4397,GO:0010121,1.00000000000472,0.89295843961396,0,1,arginine catabolic process to proline via ornithine,BP,
6157,GO:0019493,1.00000000000472,0.89295843961396,0,1,arginine catabolic process to proline,BP,
6175,GO:0019544,1.00000000000472,0.89295843961396,0,1,arginine catabolic process to glutamate,BP,
2584,GO:0005880,1.00000000000474,0.902623237838981,0,1,nuclear microtubule,CC,
5103,GO:0015389,1.00000000000477,0.891074821937298,0,1,pyrimidine- and adenine-specific:sodium symporter activity,MF,
5104,GO:0015390,1.00000000000477,0.891074821937298,0,1,purine-specific nucleoside:sodium symporter activity,MF,
5105,GO:0015391,1.00000000000477,0.891074821937298,0,1,nucleobase:cation symporter activity,MF,
18785,GO:1904274,1.00000000000477,0.891074821937298,0,1,tricellular tight junction assembly,BP,
2472,GO:0005690,1.00000000000477,0.793224896037281,0,2,U4atac snRNP,CC,
15047,GO:0071005,1.00000000000477,0.793224896037281,0,2,U2-type precatalytic spliceosome,CC,
3859,GO:0008481,1.00000000000488,0.796022118446957,0,2,sphinganine kinase activity,MF,
5800,GO:0017050,1.00000000000488,0.796022118446957,0,2,D-erythro-sphingosine kinase activity,MF,
17216,GO:0106072,1.00000000000488,0.796022118446957,0,2,negative regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,
8550,GO:0033989,1.00000000000488,0.890033005912145,0,1,3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity,MF,
9473,GO:0036111,1.00000000000488,0.890033005912145,0,1,very long-chain fatty-acyl-CoA metabolic process,BP,
10928,GO:0044594,1.00000000000488,0.890033005912145,0,1,17-beta-hydroxysteroid dehydrogenase (NAD+) activity,MF,
18702,GO:1904045,1.00000000000488,0.891140311385816,0,1,cellular response to aldosterone,BP,
4776,GO:0010963,1.00000000000494,0.902849121949665,0,1,regulation of L-arginine import,BP,
15011,GO:0070947,1.00000000000494,0.902849121949665,0,1,neutrophil mediated killing of fungus,BP,
15016,GO:0070953,1.00000000000494,0.902849121949665,0,1,regulation of neutrophil mediated killing of fungus,BP,
15021,GO:0070965,1.00000000000494,0.902849121949665,0,1,positive regulation of neutrophil mediated killing of fungus,BP,
19990,GO:2000552,1.00000000000494,0.902849121949665,0,1,negative regulation of T-helper 2 cell cytokine production,BP,
9697,GO:0038101,1.00000000000494,0.896562651878119,0,1,sequestering of nodal from receptor via nodal binding,BP,
17385,GO:1900108,1.00000000000494,0.896562651878119,0,1,negative regulation of nodal signaling pathway,BP,
17412,GO:1900146,1.00000000000494,0.896562651878119,0,1,negative regulation of nodal signaling pathway involved in determination of left/right asymmetry,BP,
17429,GO:1900176,1.00000000000494,0.896562651878119,0,1,negative regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
11171,GO:0045263,1.00000000000498,0.904387952271144,0,1,proton-transporting ATP synthase complex, coupling factor F(o),CC,
8175,GO:0032919,1.00000000000499,0.918851036778227,0,1,spermine acetylation,BP,
8176,GO:0032920,1.00000000000499,0.918851036778227,0,1,putrescine acetylation,BP,
11591,GO:0046204,1.00000000000499,0.918851036778227,0,1,nor-spermidine metabolic process,BP,
12459,GO:0050313,1.00000000000499,0.918851036778227,0,1,sulfur dioxygenase activity,MF,
6639,GO:0023041,1.00000000000501,0.710386717020523,0,3,neuronal signal transduction,BP,
438,GO:0001179,1.00000000000501,0.894447774962513,0,1,RNA polymerase I transcription factor binding,MF,
9696,GO:0038098,1.00000000000501,0.892421677482133,0,1,sequestering of BMP from receptor via BMP binding,BP,
8842,GO:0034645,1.00000000000503,0,322,4055,cellular macromolecule biosynthetic process,BP,TNIP1;MEF2D;ZMYND8;CITED4;HTRA1;EGR1;NR1D1;CST3;APLN;PDCD4;CTNNBIP1;ACVR2B;PRNP;VEGFA;PGM1;WNT7A;APOE;F2R;LRP5;ITGA6;HMGA2;ZKSCAN1;ELK3;PKN1;MTA1;EGFR;WWTR1;NOS1;NFATC4;BAHCC1;ETV5;LMF1;SHC1;HEXB;GTPBP1;TCFL5;TK2;ETV4;TRNP1;ST6GALNAC2;ZFP36L1;MAP2K2;ZC3H6;MDFI;PTOV1;SMARCA1;RBCK1;FOXQ1;MAP2K1;MXD4;POU2F2;SMURF2;TSC22D1;FOS;SMAD3;STAT6;PIK3R2;ERCC6;SRD5A3;DVL1;EPAS1;DNAJB5;PIGQ;HBEGF;PRDX5;BRD3;SALL2;LY6K;ZXDC;RNF187;AKT1;GRB7;HDAC5;PPM1F;SCMH1;GGT1;NFKBIZ;VEGFB;ASH2L;IMPACT;WWC3;DAP;FGFR4;POLD4;FGFR1;SEC14L2;HLTF;MXI1;H2AFJ;B4GAT1;PIGV;KLF7;NAT14;B3GAT3;CIRBP;HMG20B;TENM2;ZNF385A;TSHZ1;TRAPPC9;CCND1;TCF25;MAPK13;GAS6;CARD11;SOX13;ARHGAP22;PHLDA1;MRPS6;GLI4;ZSCAN18;MYEF2;MN1;SMARCD2;DGKQ;PAK6;GTF2IRD1;TAGLN3;PKD2;HES2;CRTC1;ABCA2;ZNF598;ADAM8;CTBP1;MNT;CDKN1C;ZMIZ2;CD81;CEBPB;MVD;ADAMTS13;ZNF217;ZNF862;C8ORF88;TGFB1;RFX2;SCYL1;ABHD17C;UNK;MKNK2;ADAMTS7;DEAF1;B3GNT3;NAB2;TMEM173;ZSCAN30;MSRB2;PNRC1;MGAT4B;PEG3;MC1R;ABHD14B;ABTB1;ST6GALNAC6;POLL;POLM;PTMS;PHF21A;MIF4GD;KHDRBS3;B4GALT2;AGRN;MBD3;LRP4;ZDHHC24;B4GALT6;VHL;TRAP1;RFNG;MLXIPL;PRKCZ;KDM6B;ZNF516;AREG;PIM2;MPI;WDR18;ERBB2;PRIMPOL;TFDP2;NECAB3;JAK3;IRF2BP2;CYFIP2;PBX2;NELFCD;MCFD2;RBL2;BAX;DTD1;XYLT2;ZNF395;EREG;RPS6KA5;ZNF524;SOX12;MBTPS2;PPP1R13L;CARF;IER2;ZDHHC8;TGFBR3;RPL39L;LEMD2;ZHX3;RGS14;MFNG;MRPS26;MSLN;ST3GAL3;SYMPK;MAPK12;IRAK1;TGFA;HDAC7;FHOD1;CHD2;CBX7;CHEK2;ZFPM1;PPARA;COG7;SESN2;ABCG1;CDC34;SOX7;ABCA7;SIX5;KDM4B;ZNF414;MEX3A;SSBP4;NUDT14;ECM1;WFS1;ZNF444;DALRD3;EEF2K;ARID5B;HOXC5;DNM2;BHLHE40;PELI1;CAT;TSPYL2;ZMYM3;SATB1;ZDHHC1;ZNF606;MAPK3;INSR;CAMTA2;PFKM;RERE;INO80C;ETAA1;BCL7A;VANGL2;CAMKK2;PPP3CB;USP21;REV1;CAPRIN2;ZBTB10;WDTC1;HES7;ITGA3;DNMT3A;PPP2R5B;HES6;MAP2K3;NDST2;PROX1;IARS2;MDGA1;ADGRF1;PKD1;KCTD13;SIRT2;FAM129B;EDA;GAL3ST4;BACH1;E2F5;ZBTB22;ALG12;MAPRE3;TEP1;ZNF704;ST3GAL2;MAP3K10;GTF2IRD2;NGFR;BCORL1;CHST14;ZNF837;MAFF;NR2F6;CBX6;CAMK1;EZH1;HFE;TERC;ZNF513;WIPI2;BTG1;ZP3;MLF2;CDK11B;ST3GAL5;TNRC18;TCEA2;PRSS21;ZBTB47;PLAG1;IRF2BPL;KDM3A;DEDD2;SRSF5;CHPF;AARS
3819,GO:0008419,1.00000000000503,0.890045064051129,0,1,RNA lariat debranching enzyme activity,MF,
10988,GO:0044795,1.00000000000519,0.911851225432552,0,1,trans-Golgi network to recycling endosome transport,BP,
8339,GO:0033204,1.0000000000052,0.890206715212807,0,1,ribonuclease P RNA binding,MF,
13465,GO:0055011,1.0000000000053,0.897122020925594,0,1,atrial cardiac muscle cell differentiation,BP,
13468,GO:0055014,1.0000000000053,0.897122020925594,0,1,atrial cardiac muscle cell development,BP,
11253,GO:0045519,1.0000000000053,0.915984361156992,0,1,interleukin-23 receptor binding,MF,
14909,GO:0070743,1.0000000000053,0.915984361156992,0,1,interleukin-23 complex,CC,
4016,GO:0009032,1.00000000000531,0.897872398989481,0,1,thymidine phosphorylase activity,MF,
5365,GO:0016154,1.00000000000531,0.897872398989481,0,1,pyrimidine-nucleoside phosphorylase activity,MF,
6108,GO:0019353,1.00000000000532,0.8900294715982,0,1,protoporphyrinogen IX biosynthetic process from glutamate,BP,
8421,GO:0033526,1.00000000000532,0.8900294715982,0,1,tetrapyrrole biosynthetic process from glutamate,BP,
16510,GO:0097213,1.00000000000534,0.890991561252765,0,1,regulation of lysosomal membrane permeability,BP,
5904,GO:0018117,1.00000000000534,0.898118942884752,0,1,protein adenylylation,BP,
5916,GO:0018175,1.00000000000534,0.898118942884752,0,1,protein nucleotidylation,BP,
10934,GO:0044601,1.00000000000534,0.898118942884752,0,1,protein denucleotidylation,BP,
10935,GO:0044602,1.00000000000534,0.898118942884752,0,1,protein deadenylylation,BP,
10936,GO:0044603,1.00000000000534,0.898118942884752,0,1,protein adenylylhydrolase activity,MF,
14901,GO:0070733,1.00000000000534,0.898118942884752,0,1,protein adenylyltransferase activity,MF,
10711,GO:0044035,1.00000000000535,0.898359484013483,0,1,multi-organism catabolic process,BP,
10738,GO:0044115,1.00000000000535,0.898359484013483,0,1,development of symbiont involved in interaction with host,BP,
10745,GO:0044145,1.00000000000535,0.898359484013483,0,1,modulation of development of symbiont involved in interaction with host,BP,
10747,GO:0044147,1.00000000000535,0.898359484013483,0,1,negative regulation of development of symbiont involved in interaction with host,BP,
10961,GO:0044730,1.00000000000535,0.898359484013483,0,1,bone sialoprotein binding,MF,
13315,GO:0052214,1.00000000000535,0.898359484013483,0,1,metabolism of substance in other organism involved in symbiotic interaction,BP,
13316,GO:0052227,1.00000000000535,0.898359484013483,0,1,catabolism of substance in other organism involved in symbiotic interaction,BP,
13317,GO:0052229,1.00000000000535,0.898359484013483,0,1,metabolism of macromolecule in other organism involved in symbiotic interaction,BP,
13329,GO:0052360,1.00000000000535,0.898359484013483,0,1,catabolism by host of symbiont macromolecule,BP,
13330,GO:0052361,1.00000000000535,0.898359484013483,0,1,catabolism by organism of macromolecule in other organism involved in symbiotic interaction,BP,
13331,GO:0052362,1.00000000000535,0.898359484013483,0,1,catabolism by host of symbiont protein,BP,
13332,GO:0052363,1.00000000000535,0.898359484013483,0,1,catabolism by organism of protein in other organism involved in symbiotic interaction,BP,
13333,GO:0052364,1.00000000000535,0.898359484013483,0,1,catabolism by host of substance in symbiont,BP,
13337,GO:0052416,1.00000000000535,0.898359484013483,0,1,metabolism by host of symbiont macromolecule,BP,
13338,GO:0052417,1.00000000000535,0.898359484013483,0,1,metabolism by host of symbiont protein,BP,
13339,GO:0052418,1.00000000000535,0.898359484013483,0,1,metabolism by organism of protein in other organism involved in symbiotic interaction,BP,
13340,GO:0052419,1.00000000000535,0.898359484013483,0,1,metabolism by host of substance in symbiont,BP,
19322,GO:1905581,1.00000000000535,0.898359484013483,0,1,positive regulation of low-density lipoprotein particle clearance,BP,
19327,GO:1905597,1.00000000000535,0.898359484013483,0,1,positive regulation of low-density lipoprotein particle receptor binding,BP,
19329,GO:1905599,1.00000000000535,0.898359484013483,0,1,positive regulation of low-density lipoprotein receptor activity,BP,
5949,GO:0018293,1.0000000000054,0.910165572818586,0,1,protein-FAD linkage,BP,
5303,GO:0016005,1.00000000000541,0.792184343517037,0,2,phospholipase A2 activator activity,MF,
18118,GO:1902746,1.00000000000545,0.890356065729501,0,1,regulation of lens fiber cell differentiation,BP,
12882,GO:0051232,1.00000000000549,0.890453611268032,0,1,meiotic spindle elongation,BP,
15362,GO:0071606,1.0000000000055,0.892974396272718,0,1,chemokine (C-C motif) ligand 4 production,BP,
15389,GO:0071643,1.0000000000055,0.892974396272718,0,1,regulation of chemokine (C-C motif) ligand 4 production,BP,
15390,GO:0071644,1.0000000000055,0.892974396272718,0,1,negative regulation of chemokine (C-C motif) ligand 4 production,BP,
15879,GO:0072615,1.0000000000055,0.892974396272718,0,1,interleukin-17 secretion,BP,
19142,GO:1905076,1.0000000000055,0.892974396272718,0,1,regulation of interleukin-17 secretion,BP,
19143,GO:1905077,1.0000000000055,0.892974396272718,0,1,negative regulation of interleukin-17 secretion,BP,
19257,GO:1905403,1.0000000000055,0.892974396272718,0,1,negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
2692,GO:0006061,1.00000000000555,0.904134772676937,0,1,sorbitol biosynthetic process,BP,
5987,GO:0018931,1.00000000000555,0.904134772676937,0,1,naphthalene metabolic process,BP,
6136,GO:0019406,1.00000000000555,0.904134772676937,0,1,hexitol biosynthetic process,BP,
10654,GO:0043795,1.00000000000555,0.904134772676937,0,1,glyceraldehyde oxidoreductase activity,MF,
16301,GO:0090420,1.00000000000555,0.904134772676937,0,1,naphthalene-containing compound metabolic process,BP,
8562,GO:0034038,1.00000000000556,0.910799078393626,0,1,deoxyhypusine synthase activity,MF,
7859,GO:0032427,1.00000000000556,0.793356446691414,0,2,GBD domain binding,MF,
12121,GO:0048209,1.00000000000556,0.793356446691414,0,2,regulation of vesicle targeting, to, from or within Golgi,BP,
1907,GO:0004595,1.00000000000561,0.890722634883451,0,1,pantetheine-phosphate adenylyltransferase activity,MF,
14988,GO:0070905,1.0000000000057,0.793885978578496,0,2,serine binding,MF,
9633,GO:0036506,1.00000000000578,0.706523474117468,0,3,maintenance of unfolded protein,BP,
18823,GO:1904378,1.00000000000578,0.706523474117468,0,3,maintenance of unfolded protein involved in ERAD pathway,BP,
11737,GO:0046588,1.00000000000582,0.92111789793903,0,1,negative regulation of calcium-dependent cell-cell adhesion,BP,
15455,GO:0071798,1.00000000000585,0.802528744456396,0,2,response to prostaglandin D,BP,
15456,GO:0071799,1.00000000000585,0.802528744456396,0,2,cellular response to prostaglandin D stimulus,BP,
10848,GO:0044355,1.00000000000586,0.903009801519248,0,1,clearance of foreign intracellular DNA,BP,
10849,GO:0044356,1.00000000000586,0.903009801519248,0,1,clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine,BP,
16984,GO:0099046,1.00000000000586,0.903009801519248,0,1,clearance of foreign intracellular nucleic acids,BP,
18927,GO:1904627,1.00000000000586,0.903009801519248,0,1,response to phorbol 13-acetate 12-myristate,BP,
18928,GO:1904628,1.00000000000586,0.903009801519248,0,1,cellular response to phorbol 13-acetate 12-myristate,BP,
1341,GO:0003199,1.00000000000594,0.900793316190284,0,1,endocardial cushion to mesenchymal transition involved in heart valve formation,BP,
4823,GO:0014028,1.00000000000594,0.900793316190284,0,1,notochord formation,BP,
12021,GO:0047708,1.00000000000598,0.892184164256262,0,1,biotinidase activity,MF,
13782,GO:0060380,1.00000000000598,0.892184164256262,0,1,regulation of single-stranded telomeric DNA binding,BP,
13783,GO:0060381,1.00000000000598,0.892184164256262,0,1,positive regulation of single-stranded telomeric DNA binding,BP,
3515,GO:0007468,1.00000000000598,0.892289667673341,0,1,regulation of rhodopsin gene expression,BP,
11429,GO:0045872,1.00000000000598,0.892289667673341,0,1,positive regulation of rhodopsin gene expression,BP,
3076,GO:0006651,1.00000000000598,0.817348792282739,0,2,diacylglycerol biosynthetic process,BP,
2027,GO:0004766,1.00000000000599,0.90790815084134,0,1,spermidine synthase activity,MF,
6134,GO:0019402,1.00000000000599,0.905276920245303,0,1,galactitol metabolic process,BP,
14376,GO:0061623,1.00000000000599,0.905276920245303,0,1,glycolytic process from galactose,BP,
18481,GO:1903569,1.00000000000601,0.8904715257304,0,1,positive regulation of protein localization to ciliary membrane,BP,
469,GO:0001512,1.00000000000604,0.912368455270631,0,1,dihydronicotinamide riboside quinone reductase activity,MF,
18839,GO:1904408,1.00000000000604,0.912368455270631,0,1,melatonin binding,MF,
19324,GO:1905594,1.00000000000604,0.912368455270631,0,1,resveratrol binding,MF,
14778,GO:0070488,1.00000000000606,0.881968491407839,0,2,neutrophil aggregation,BP,
1613,GO:0004040,1.00000000000608,0.793751227630008,0,2,amidase activity,MF,
17461,GO:1900244,1.00000000000608,0.793751227630008,0,2,positive regulation of synaptic vesicle endocytosis,BP,
6366,GO:0021555,1.00000000000615,0.803502163073931,0,2,midbrain-hindbrain boundary morphogenesis,BP,
6367,GO:0021557,1.00000000000615,0.803502163073931,0,2,oculomotor nerve development,BP,
11121,GO:0045168,1.00000000000615,0.803502163073931,0,2,cell-cell signaling involved in cell fate commitment,BP,
11618,GO:0046331,1.00000000000615,0.803502163073931,0,2,lateral inhibition,BP,
8450,GO:0033597,1.00000000000622,0.891492088443084,0,1,mitotic checkpoint complex,CC,
19509,GO:1990298,1.00000000000622,0.891492088443084,0,1,bub1-bub3 complex,CC,
15951,GO:0075519,1.00000000000623,0.929887122863411,0,1,microtubule-dependent intracellular transport of viral material,BP,
15952,GO:0075521,1.00000000000623,0.929887122863411,0,1,microtubule-dependent intracellular transport of viral material towards nucleus,BP,
15956,GO:0075606,1.00000000000623,0.929887122863411,0,1,transport of viral material towards nucleus,BP,
5768,GO:0016942,1.00000000000623,0.727843111104159,0,3,insulin-like growth factor binding protein complex,CC,
9593,GO:0036454,1.00000000000623,0.727843111104159,0,3,growth factor complex,CC,
3469,GO:0007308,1.00000000000624,0.890095316251595,0,1,oocyte construction,BP,
3470,GO:0007309,1.00000000000624,0.890095316251595,0,1,oocyte axis specification,BP,
3471,GO:0007314,1.00000000000624,0.890095316251595,0,1,oocyte anterior/posterior axis specification,BP,
3472,GO:0007315,1.00000000000624,0.890095316251595,0,1,pole plasm assembly,BP,
3790,GO:0008358,1.00000000000624,0.890095316251595,0,1,maternal determination of anterior/posterior axis, embryo,BP,
7009,GO:0030719,1.00000000000624,0.890095316251595,0,1,P granule organization,BP,
9304,GO:0035755,1.00000000000624,0.890095316251595,0,1,cardiolipin hydrolase activity,MF,
1662,GO:0004117,1.00000000000624,0.890029984002906,0,1,calmodulin-dependent cyclic-nucleotide phosphodiesterase activity,MF,
2041,GO:0004782,1.00000000000624,0.890029984002906,0,1,sulfinoalanine decarboxylase activity,MF,
3843,GO:0008455,1.00000000000624,0.890029984002906,0,1,alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity,MF,
3892,GO:0008531,1.00000000000624,0.890029984002906,0,1,riboflavin kinase activity,MF,
4164,GO:0009231,1.00000000000624,0.890029984002906,0,1,riboflavin biosynthetic process,BP,
4222,GO:0009398,1.00000000000624,0.890029984002906,0,1,FMN biosynthetic process,BP,
9992,GO:0042412,1.00000000000624,0.890029984002906,0,1,taurine biosynthetic process,BP,
11603,GO:0046305,1.00000000000624,0.890029984002906,0,1,alkanesulfonate biosynthetic process,BP,
11660,GO:0046444,1.00000000000624,0.890029984002906,0,1,FMN metabolic process,BP,
9718,GO:0038163,1.00000000000624,0.918313951687352,0,1,thrombopoietin-mediated signaling pathway,BP,
19419,GO:1905938,1.00000000000624,0.918313951687352,0,1,positive regulation of germ cell proliferation,BP,
19823,GO:2000256,1.00000000000624,0.918313951687352,0,1,positive regulation of male germ cell proliferation,BP,
2313,GO:0005314,1.00000000000627,0.792134612041009,0,2,high-affinity glutamate transmembrane transporter activity,MF,
5124,GO:0015501,1.00000000000627,0.792134612041009,0,2,glutamate:sodium symporter activity,MF,
834,GO:0002135,1.00000000000631,0.890122178518443,0,1,CTP binding,MF,
5824,GO:0017098,1.00000000000631,0.890122178518443,0,1,sulfonylurea receptor binding,MF,
17660,GO:1901388,1.00000000000631,0.890122178518443,0,1,regulation of transforming growth factor beta activation,BP,
17661,GO:1901389,1.00000000000631,0.890122178518443,0,1,negative regulation of transforming growth factor beta activation,BP,
18517,GO:1903659,1.00000000000631,0.890122178518443,0,1,regulation of complement-dependent cytotoxicity,BP,
18518,GO:1903660,1.00000000000631,0.890122178518443,0,1,negative regulation of complement-dependent cytotoxicity,BP,
19676,GO:1990913,1.00000000000631,0.890122178518443,0,1,sperm head plasma membrane,CC,
19677,GO:1990917,1.00000000000631,0.890122178518443,0,1,ooplasm,CC,
8538,GO:0033882,1.00000000000635,0.911782659167818,0,1,choloyl-CoA hydrolase activity,MF,
11156,GO:0045222,1.00000000000635,0.911782659167818,0,1,CD4 biosynthetic process,BP,
11157,GO:0045223,1.00000000000635,0.911782659167818,0,1,regulation of CD4 biosynthetic process,BP,
11158,GO:0045225,1.00000000000635,0.911782659167818,0,1,negative regulation of CD4 biosynthetic process,BP,
13409,GO:0052815,1.00000000000635,0.911782659167818,0,1,medium-chain acyl-CoA hydrolase activity,MF,
1730,GO:0004324,1.00000000000636,0.893950641255937,0,1,ferredoxin-NADP+ reductase activity,MF,
4963,GO:0015039,1.00000000000636,0.893950641255937,0,1,NADPH-adrenodoxin reductase activity,MF,
5644,GO:0016730,1.00000000000636,0.893950641255937,0,1,oxidoreductase activity, acting on iron-sulfur proteins as donors,MF,
5645,GO:0016731,1.00000000000636,0.893950641255937,0,1,oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor,MF,
12151,GO:0048270,1.00000000000639,0.891995290313487,0,1,methionine adenosyltransferase regulator activity,MF,
3643,GO:0008120,1.00000000000639,0.898454740796502,0,1,ceramide glucosyltransferase activity,MF,
17172,GO:0102769,1.00000000000639,0.898454740796502,0,1,dihydroceramide glucosyltransferase activity,MF,
2164,GO:0004999,1.0000000000064,0.890023735324209,0,1,vasoactive intestinal polypeptide receptor activity,MF,
7550,GO:0031893,1.00000000000641,0.891188311257534,0,1,vasopressin receptor binding,MF,
7551,GO:0031896,1.00000000000641,0.891188311257534,0,1,V2 vasopressin receptor binding,MF,
9421,GO:0035993,1.0000000000065,0.710232826884318,0,3,deltoid tuberosity development,BP,
14256,GO:0061325,1.0000000000065,0.710232826884318,0,3,cell proliferation involved in outflow tract morphogenesis,BP,
8237,GO:0033018,1.00000000000653,0.795437551476762,0,2,sarcoplasmic reticulum lumen,CC,
15274,GO:0071461,1.00000000000658,0.809739060276854,0,2,cellular response to redox state,BP,
2626,GO:0005954,1.00000000000663,0.890217761337037,0,1,calcium- and calmodulin-dependent protein kinase complex,CC,
1060,GO:0002587,1.00000000000665,0.905016150246256,0,1,negative regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
4448,GO:0010387,1.00000000000675,0.890747358786575,0,1,COP9 signalosome assembly,BP,
12442,GO:0050152,1.00000000000677,0.907939535266637,0,1,omega-amidase activity,MF,
17746,GO:1901668,1.00000000000678,0.735139789901627,0,3,regulation of superoxide dismutase activity,BP,
3886,GO:0008521,1.00000000000686,0.890042037502584,0,1,acetyl-CoA transmembrane transporter activity,MF,
5249,GO:0015876,1.00000000000686,0.890042037502584,0,1,acetyl-CoA transport,BP,
5268,GO:0015916,1.00000000000686,0.890042037502584,0,1,fatty-acyl-CoA transport,BP,
17635,GO:1901337,1.00000000000686,0.890042037502584,0,1,thioester transport,BP,
10067,GO:0042568,1.00000000000689,0.918812541295377,0,1,insulin-like growth factor binary complex,CC,
17351,GO:1900036,1.00000000000689,0.890579013297756,0,1,positive regulation of cellular response to heat,BP,
3343,GO:0007066,1.0000000000069,0.919937075844062,0,1,female meiosis sister chromatid cohesion,BP,
2259,GO:0005174,1.00000000000693,0.890789850314886,0,1,CD40 receptor binding,MF,
14535,GO:0070053,1.00000000000694,0.792171940668772,0,2,thrombospondin receptor activity,MF,
85,GO:0000173,1.00000000000695,0.89808787548273,0,1,inactivation of MAPK activity involved in osmosensory signaling pathway,BP,
2477,GO:0005713,1.00000000000699,0.890231955854727,0,1,recombination nodule,CC,
2478,GO:0005715,1.00000000000699,0.890231955854727,0,1,late recombination nodule,CC,
5012,GO:0015173,1.00000000000699,0.890231955854727,0,1,aromatic amino acid transmembrane transporter activity,MF,
5030,GO:0015196,1.00000000000699,0.890231955854727,0,1,L-tryptophan transmembrane transporter activity,MF,
10293,GO:0043060,1.00000000000699,0.890231955854727,0,1,meiotic metaphase I plate congression,BP,
12902,GO:0051257,1.00000000000699,0.890231955854727,0,1,meiotic spindle midzone assembly,BP,
12942,GO:0051311,1.00000000000699,0.890231955854727,0,1,meiotic metaphase plate congression,BP,
18784,GO:1904271,1.00000000000699,0.890231955854727,0,1,L-proline import across plasma membrane,BP,
18891,GO:1904555,1.00000000000699,0.890231955854727,0,1,L-proline transmembrane transport,BP,
18892,GO:1904556,1.00000000000699,0.890231955854727,0,1,L-tryptophan transmembrane transport,BP,
19342,GO:1905647,1.00000000000699,0.890231955854727,0,1,proline import across plasma membrane,BP,
16137,GO:0090149,1.00000000000702,0.792656635498074,0,2,mitochondrial membrane fission,BP,
18001,GO:1902423,1.00000000000702,0.793461774375428,0,2,regulation of attachment of mitotic spindle microtubules to kinetochore,BP,
18002,GO:1902425,1.00000000000702,0.793461774375428,0,2,positive regulation of attachment of mitotic spindle microtubules to kinetochore,BP,
7738,GO:0032258,1.00000000000702,0.793461774375423,0,2,protein localization by the Cvt pathway,BP,
3991,GO:0008890,1.00000000000705,0.899532725051907,0,1,glycine C-acetyltransferase activity,MF,
6162,GO:0019518,1.00000000000705,0.899532725051907,0,1,L-threonine catabolic process to glycine,BP,
6353,GO:0021539,1.00000000000707,0.80150703269886,0,2,subthalamus development,BP,
327,GO:0000916,1.00000000000708,0.89131582819531,0,1,actomyosin contractile ring contraction,BP,
9513,GO:0036213,1.00000000000708,0.89131582819531,0,1,contractile ring contraction,BP,
125,GO:0000257,1.00000000000715,0.905247838073576,0,1,nitrilase activity,MF,
5695,GO:0016815,1.00000000000715,0.905247838073576,0,1,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in nitriles,MF,
12003,GO:0047536,1.00000000000715,0.891066820727094,0,1,2-aminoadipate transaminase activity,MF,
1867,GO:0004531,1.00000000000722,0.892685974471498,0,1,deoxyribonuclease II activity,MF,
3922,GO:0008597,1.00000000000724,0.798802463999902,0,2,calcium-dependent protein serine/threonine phosphatase regulator activity,MF,
19452,GO:1990071,1.00000000000728,0.824875501214457,0,2,TRAPPII protein complex,CC,
19453,GO:1990072,1.00000000000728,0.824875501214457,0,2,TRAPPIII protein complex,CC,
2768,GO:0006193,1.00000000000729,0.913790911847675,0,1,ITP catabolic process,BP,
4140,GO:0009203,1.00000000000729,0.913790911847675,0,1,ribonucleoside triphosphate catabolic process,BP,
4144,GO:0009207,1.00000000000729,0.913790911847675,0,1,purine ribonucleoside triphosphate catabolic process,BP,
9517,GO:0036220,1.00000000000729,0.913790911847675,0,1,ITP diphosphatase activity,MF,
9518,GO:0036222,1.00000000000729,0.913790911847675,0,1,XTP diphosphatase activity,MF,
13697,GO:0060265,1.0000000000073,0.92344962838176,0,1,positive regulation of respiratory burst involved in inflammatory response,BP,
388,GO:0001034,1.00000000000734,0.895285597752502,0,1,RNA polymerase III transcription factor activity, sequence-specific DNA binding,MF,
19418,GO:1905937,1.00000000000734,0.920485937267309,0,1,negative regulation of germ cell proliferation,BP,
19822,GO:2000255,1.00000000000734,0.920485937267309,0,1,negative regulation of male germ cell proliferation,BP,
1804,GO:0004449,1.00000000000739,0.720941036391742,0,3,isocitrate dehydrogenase (NAD+) activity,MF,
19554,GO:1990450,1.00000000000741,0.891958890802194,0,1,linear polyubiquitin binding,MF,
1713,GO:0004304,1.0000000000075,0.895646831282298,0,1,estrone sulfotransferase activity,MF,
3083,GO:0006660,1.0000000000075,0.895646831282298,0,1,phosphatidylserine catabolic process,BP,
3126,GO:0006711,1.0000000000075,0.895646831282298,0,1,estrogen catabolic process,BP,
11211,GO:0045352,1.0000000000075,0.895646831282298,0,1,interleukin-1 Type I receptor antagonist activity,MF,
11212,GO:0045353,1.0000000000075,0.895646831282298,0,1,interleukin-1 Type II receptor antagonist activity,MF,
5035,GO:0015211,1.0000000000075,0.890219499218869,0,1,purine nucleoside transmembrane transporter activity,MF,
6223,GO:0019776,1.00000000000752,0.719875830374131,0,3,Atg8 ligase activity,MF,
7238,GO:0031177,1.00000000000758,0.772511300055861,0,3,phosphopantetheine binding,MF,
5959,GO:0018343,1.00000000000759,0.712198493307477,0,3,protein farnesylation,BP,
4981,GO:0015105,1.0000000000076,0.907689173287951,0,1,arsenite transmembrane transporter activity,MF,
5160,GO:0015700,1.0000000000076,0.907689173287951,0,1,arsenite transport,BP,
15028,GO:0070976,1.00000000000766,0.890029146004812,0,1,TIR domain binding,MF,
1570,GO:0003976,1.00000000000767,0.721059364021816,0,3,UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity,MF,
108,GO:0000225,1.00000000000768,0.911954250788302,0,1,N-acetylglucosaminylphosphatidylinositol deacetylase activity,MF,
1934,GO:0004633,1.00000000000773,0.891096358542634,0,1,phosphopantothenoylcysteine decarboxylase activity,MF,
3748,GO:0008291,1.00000000000773,0.890047115236909,0,1,acetylcholine metabolic process,BP,
3749,GO:0008292,1.00000000000773,0.890047115236909,0,1,acetylcholine biosynthetic process,BP,
5245,GO:0015870,1.00000000000773,0.890047115236909,0,1,acetylcholine transport,BP,
7899,GO:0032475,1.00000000000773,0.890047115236909,0,1,otolith formation,BP,
9261,GO:0035675,1.00000000000773,0.890047115236909,0,1,neuromast hair cell development,BP,
12419,GO:0048882,1.00000000000773,0.890047115236909,0,1,lateral line development,BP,
12420,GO:0048884,1.00000000000773,0.890047115236909,0,1,neuromast development,BP,
12421,GO:0048886,1.00000000000773,0.890047115236909,0,1,neuromast hair cell differentiation,BP,
12422,GO:0048925,1.00000000000773,0.890047115236909,0,1,lateral line system development,BP,
14330,GO:0061526,1.00000000000773,0.890047115236909,0,1,acetylcholine secretion,BP,
17509,GO:1900619,1.00000000000773,0.890047115236909,0,1,acetate ester metabolic process,BP,
17510,GO:1900620,1.00000000000773,0.890047115236909,0,1,acetate ester biosynthetic process,BP,
17650,GO:1901374,1.00000000000773,0.890047115236909,0,1,acetate ester transport,BP,
2121,GO:0004913,1.0000000000078,0.890413683473812,0,1,interleukin-4 receptor activity,MF,
8877,GO:0034696,1.00000000000781,0.79385247434825,0,2,response to prostaglandin F,BP,
14593,GO:0070159,1.00000000000787,0.890427645912514,0,1,mitochondrial threonyl-tRNA aminoacylation,BP,
17123,GO:0102009,1.00000000000789,0.89398947965792,0,1,proline dipeptidase activity,MF,
6039,GO:0019144,1.00000000000802,0.819716579851358,0,2,ADP-sugar diphosphatase activity,MF,
8457,GO:0033604,1.00000000000804,0.706848230260792,0,3,negative regulation of catecholamine secretion,BP,
14190,GO:0061110,1.00000000000804,0.706848230260792,0,3,dense core granule biogenesis,BP,
20085,GO:2000705,1.00000000000804,0.706848230260792,0,3,regulation of dense core granule biogenesis,BP,
2256,GO:0005171,1.00000000000804,0.89235277285655,0,1,hepatocyte growth factor receptor binding,MF,
16015,GO:0086030,1.00000000000804,0.89235277285655,0,1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in cardiac muscle relaxation,BP,
17516,GO:1900738,1.00000000000804,0.89235277285655,0,1,positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
17556,GO:1901079,1.00000000000804,0.89235277285655,0,1,positive regulation of relaxation of muscle,BP,
17814,GO:1901899,1.00000000000804,0.89235277285655,0,1,positive regulation of relaxation of cardiac muscle,BP,
4401,GO:0010139,1.00000000000807,0.898820312771581,0,1,pyrimidine deoxyribonucleotide salvage,BP,
2415,GO:0005591,1.00000000000808,0.890056898189725,0,1,collagen type VIII trimer,CC,
2421,GO:0005598,1.00000000000808,0.890056898189725,0,1,short-chain collagen trimer,CC,
7113,GO:0030935,1.00000000000808,0.890056898189725,0,1,sheet-forming collagen trimer,CC,
16802,GO:0098646,1.00000000000808,0.890056898189725,0,1,collagen sheet,CC,
13158,GO:0051765,1.0000000000081,0.796965672562606,0,2,inositol tetrakisphosphate kinase activity,MF,
13381,GO:0052692,1.00000000000814,0.903662639356612,0,1,raffinose alpha-galactosidase activity,MF,
16578,GO:0097376,1.00000000000814,0.903662639356612,0,1,interneuron axon guidance,BP,
4430,GO:0010266,1.00000000000816,0.73444702276822,0,3,response to vitamin B1,BP,
6042,GO:0019153,1.00000000000819,0.899217167436693,0,1,protein-disulfide reductase (glutathione) activity,MF,
15838,GO:0072555,1.00000000000819,0.899217167436693,0,1,17-beta-ketosteroid reductase activity,MF,
15858,GO:0072582,1.00000000000819,0.899217167436693,0,1,17-beta-hydroxysteroid dehydrogenase (NADP+) activity,MF,
6094,GO:0019303,1.00000000000836,0.828546786746877,0,2,D-ribose catabolic process,BP,
4847,GO:0014061,1.00000000000836,0.706430444701576,0,3,regulation of norepinephrine secretion,BP,
14610,GO:0070180,1.00000000000837,0.935105467613255,0,1,large ribosomal subunit rRNA binding,MF,
14771,GO:0070476,1.00000000000837,0.935105467613255,0,1,rRNA (guanine-N7)-methylation,BP,
19123,GO:1905042,1.00000000000842,0.890976457114629,0,1,negative regulation of epithelium regeneration,BP,
8773,GO:0034462,1.00000000000842,0.890936950235175,0,1,small-subunit processome assembly,BP,
16757,GO:0098547,1.00000000000842,0.890936950235175,0,1,lumenal side of Golgi membrane,CC,
3665,GO:0008160,1.00000000000843,0.890062823906457,0,1,protein tyrosine phosphatase activator activity,MF,
158,GO:0000322,1.00000000000853,0.717556270160898,0,3,storage vacuole,CC,
2089,GO:0004853,1.00000000000863,0.904557971800825,0,1,uroporphyrinogen decarboxylase activity,MF,
19258,GO:1905404,1.00000000000864,0.900563207039023,0,1,positive regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
4521,GO:0010585,1.00000000000875,0.893588247816371,0,1,glutamine secretion,BP,
18585,GO:1903803,1.00000000000875,0.893588247816371,0,1,L-glutamine import across plasma membrane,BP,
7263,GO:0031249,1.0000000000088,0.890327177923994,0,1,denatured protein binding,MF,
17988,GO:1902380,1.0000000000088,0.890327177923994,0,1,positive regulation of endoribonuclease activity,BP,
18969,GO:1904722,1.0000000000088,0.890327177923994,0,1,positive regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
5698,GO:0016822,1.0000000000088,0.810148983882803,0,2,hydrolase activity, acting on acid carbon-carbon bonds,MF,
5699,GO:0016823,1.0000000000088,0.810148983882803,0,2,hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances,MF,
11507,GO:0046032,1.00000000000881,0.90069610134248,0,1,ADP catabolic process,BP,
782,GO:0002041,1.00000000000884,0.890751535332015,0,1,intussusceptive angiogenesis,BP,
457,GO:0001306,1.00000000000884,0.916615049978059,0,1,age-dependent response to oxidative stress,BP,
458,GO:0001315,1.00000000000884,0.916615049978059,0,1,age-dependent response to reactive oxygen species,BP,
1275,GO:0003068,1.00000000000884,0.916615049978059,0,1,regulation of systemic arterial blood pressure by acetylcholine,BP,
1276,GO:0003069,1.00000000000884,0.916615049978059,0,1,acetylcholine-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,
1277,GO:0003070,1.00000000000884,0.916615049978059,0,1,regulation of systemic arterial blood pressure by neurotransmitter,BP,
3544,GO:0007571,1.00000000000884,0.916615049978059,0,1,age-dependent general metabolic decline,BP,
4056,GO:0009107,1.00000000000885,0.897580603399877,0,1,lipoate biosynthetic process,BP,
5774,GO:0016992,1.00000000000885,0.897580603399877,0,1,lipoate synthase activity,MF,
14668,GO:0070283,1.00000000000885,0.897580603399877,0,1,radical SAM enzyme activity,MF,
17120,GO:0102005,1.00000000000886,0.901298961182096,0,1,2-octaprenyl-6-methoxy-1,4-benzoquinone methylase activity,MF,
11799,GO:0046695,1.00000000000893,0.721188818333817,0,3,SLIK (SAGA-like) complex,CC,
3977,GO:0008803,1.00000000000897,0.917932776713071,0,1,bis(5'-nucleosyl)-tetraphosphatase (symmetrical) activity,MF,
14381,GO:0061629,1.00000000000897,0.706742638332207,0,3,RNA polymerase II sequence-specific DNA binding transcription factor binding,MF,
1807,GO:0004454,1.00000000000901,0.890339001823807,0,1,ketohexokinase activity,MF,
8759,GO:0034441,1.00000000000903,0.895364484721637,0,1,plasma lipoprotein particle oxidation,BP,
1812,GO:0004462,1.00000000000904,0.892343686819299,0,1,lactoylglutathione lyase activity,MF,
9205,GO:0035596,1.00000000000908,0.794364634762587,0,2,methylthiotransferase activity,MF,
9208,GO:0035600,1.00000000000908,0.794364634762587,0,2,tRNA methylthiolation,BP,
12483,GO:0050497,1.00000000000908,0.794364634762587,0,2,transferase activity, transferring alkylthio groups,MF,
9147,GO:0035504,1.0000000000091,0.901550093603882,0,1,regulation of myosin light chain kinase activity,BP,
9148,GO:0035505,1.0000000000091,0.901550093603882,0,1,positive regulation of myosin light chain kinase activity,BP,
6966,GO:0030627,1.00000000000916,0.810387461323699,0,2,pre-mRNA 5'-splice site binding,MF,
11795,GO:0046687,1.00000000000919,0.914004817998088,0,1,response to chromate,BP,
15139,GO:0071247,1.00000000000919,0.914004817998088,0,1,cellular response to chromate,BP,
17920,GO:1902220,1.00000000000919,0.914004817998088,0,1,positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
6833,GO:0030305,1.00000000000929,0.895930534550371,0,1,heparanase activity,MF,
4542,GO:0010621,1.00000000000929,0.913844312431771,0,1,negative regulation of transcription by transcription factor localization,BP,
9507,GO:0036164,1.00000000000929,0.913844312431771,0,1,cell-abiotic substrate adhesion,BP,
1914,GO:0004607,1.00000000000935,0.90551054381296,0,1,phosphatidylcholine-sterol O-acyltransferase activity,MF,
14620,GO:0070194,1.00000000000947,0.793323188848693,0,2,synaptonemal complex disassembly,BP,
1835,GO:0004490,1.00000000000953,0.899374195720055,0,1,methylglutaconyl-CoA hydratase activity,MF,
12427,GO:0050011,1.00000000000953,0.899374195720055,0,1,itaconyl-CoA hydratase activity,MF,
3834,GO:0008442,1.00000000000971,0.892995761943854,0,1,3-hydroxyisobutyrate dehydrogenase activity,MF,
7767,GO:0032298,1.00000000000977,0.890973955154945,0,1,positive regulation of DNA-dependent DNA replication initiation,BP,
16456,GO:0097123,1.00000000000977,0.890973955154945,0,1,cyclin A1-CDK2 complex,CC,
8101,GO:0032795,1.00000000000986,0.914597215745074,0,1,heterotrimeric G-protein binding,MF,
8737,GO:0034395,1.00000000000986,0.900323891693257,0,1,regulation of transcription from RNA polymerase II promoter in response to iron,BP,
8749,GO:0034423,1.00000000000989,0.890053053981149,0,1,autophagosome lumen,CC,
19939,GO:2000422,1.00000000000989,0.890053053981149,0,1,regulation of eosinophil chemotaxis,BP,
19940,GO:2000424,1.00000000000989,0.890053053981149,0,1,positive regulation of eosinophil chemotaxis,BP,
3957,GO:0008721,1.00000000000997,0.890212609472025,0,1,D-serine ammonia-lyase activity,MF,
5718,GO:0016855,1.00000000000997,0.890212609472025,0,1,racemase and epimerase activity, acting on amino acids and derivatives,MF,
5903,GO:0018114,1.00000000000997,0.890212609472025,0,1,threonine racemase activity,MF,
6876,GO:0030378,1.00000000000997,0.890212609472025,0,1,serine racemase activity,MF,
9563,GO:0036361,1.00000000000997,0.890212609472025,0,1,racemase activity, acting on amino acids and derivatives,MF,
11651,GO:0046416,1.00000000000997,0.890212609472025,0,1,D-amino acid metabolic process,BP,
11656,GO:0046437,1.00000000000997,0.890212609472025,0,1,D-amino acid biosynthetic process,BP,
12016,GO:0047661,1.00000000000997,0.890212609472025,0,1,amino-acid racemase activity,MF,
14608,GO:0070178,1.00000000000997,0.890212609472025,0,1,D-serine metabolic process,BP,
14609,GO:0070179,1.00000000000997,0.890212609472025,0,1,D-serine biosynthetic process,BP,
18597,GO:1903837,1.00000000001,0.890223006056732,0,1,regulation of mRNA 3'-UTR binding,BP,
18598,GO:1903839,1.00000000001,0.890223006056732,0,1,positive regulation of mRNA 3'-UTR binding,BP,
13276,GO:0051977,1.00000000001,0.891264356225653,0,1,lysophospholipid transport,BP,
13277,GO:0051978,1.00000000001,0.891264356225653,0,1,lysophospholipid transporter activity,MF,
12007,GO:0047578,1.00000000001001,0.890264383504796,0,1,4-hydroxyglutamate transaminase activity,MF,
10732,GO:0044105,1.00000000001002,0.924144879447484,0,1,L-xylulose reductase (NAD+) activity,MF,
12429,GO:0050038,1.00000000001002,0.924144879447484,0,1,L-xylulose reductase (NADP+) activity,MF,
13825,GO:0060435,1.00000000001004,0.906281598371659,0,1,bronchiole development,BP,
13853,GO:0060480,1.00000000001004,0.906281598371659,0,1,lung goblet cell differentiation,BP,
311,GO:0000823,1.00000000001005,0.895452172144715,0,1,inositol-1,4,5-trisphosphate 6-kinase activity,MF,
312,GO:0000824,1.00000000001005,0.895452172144715,0,1,inositol tetrakisphosphate 3-kinase activity,MF,
313,GO:0000825,1.00000000001005,0.895452172144715,0,1,inositol tetrakisphosphate 6-kinase activity,MF,
11980,GO:0047326,1.00000000001005,0.895452172144715,0,1,inositol tetrakisphosphate 5-kinase activity,MF,
18753,GO:1904211,1.00000000001006,0.797212343420091,0,2,membrane protein proteolysis involved in retrograde protein transport, ER to cytosol,BP,
6944,GO:0030576,1.00000000001009,0.706510842904863,0,3,Cajal body organization,BP,
1772,GO:0004377,1.00000000001012,0.890133617289246,0,1,GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
118,GO:0000247,1.00000000001022,0.911885543773223,0,1,C-8 sterol isomerase activity,MF,
2030,GO:0004769,1.00000000001022,0.911885543773223,0,1,steroid delta-isomerase activity,MF,
10080,GO:0042586,1.00000000001022,0.911885543773223,0,1,peptide deformylase activity,MF,
7707,GO:0032203,1.00000000001023,0.894496872099555,0,1,telomere formation via telomerase,BP,
13972,GO:0060694,1.00000000001023,0.894496872099555,0,1,regulation of cholesterol transporter activity,BP,
15748,GO:0072343,1.00000000001023,0.894496872099555,0,1,pancreatic stellate cell proliferation,BP,
17692,GO:1901558,1.00000000001023,0.894496872099555,0,1,response to metformin,BP,
19312,GO:1905563,1.00000000001023,0.894496872099555,0,1,negative regulation of vascular endothelial cell proliferation,BP,
19809,GO:2000229,1.00000000001023,0.894496872099555,0,1,regulation of pancreatic stellate cell proliferation,BP,
19810,GO:2000230,1.00000000001023,0.894496872099555,0,1,negative regulation of pancreatic stellate cell proliferation,BP,
14471,GO:0061851,1.00000000001024,0.890027832241792,0,1,leading edge of lamellipodium,CC,
18807,GO:1904328,1.00000000001024,0.890027832241792,0,1,regulation of myofibroblast contraction,BP,
19631,GO:1990764,1.00000000001024,0.890027832241792,0,1,myofibroblast contraction,BP,
556,GO:0001680,1.00000000001031,0.890816127138672,0,1,tRNA 3'-terminal CCA addition,BP,
2058,GO:0004810,1.00000000001031,0.890816127138672,0,1,tRNA adenylyltransferase activity,MF,
13453,GO:0052927,1.00000000001031,0.890816127138672,0,1,CTP:tRNA cytidylyltransferase activity,MF,
13454,GO:0052928,1.00000000001031,0.890816127138672,0,1,CTP:3'-cytidine-tRNA cytidylyltransferase activity,MF,
13455,GO:0052929,1.00000000001031,0.890816127138672,0,1,ATP:3'-cytidine-cytidine-tRNA adenylyltransferase activity,MF,
19647,GO:1990817,1.00000000001031,0.890816127138672,0,1,RNA adenylyltransferase activity,MF,
14428,GO:0061740,1.00000000001033,0.706921253901031,0,3,protein targeting to lysosome involved in chaperone-mediated autophagy,BP,
1903,GO:0004588,1.00000000001043,0.890043136396545,0,1,orotate phosphoribosyltransferase activity,MF,
1904,GO:0004590,1.00000000001043,0.890043136396545,0,1,orotidine-5'-phosphate decarboxylase activity,MF,
1624,GO:0004057,1.00000000001051,0.8911181876962,0,1,arginyltransferase activity,MF,
1364,GO:0003247,1.00000000001051,0.898348939155582,0,1,post-embryonic cardiac muscle cell growth involved in heart morphogenesis,BP,
1558,GO:0003956,1.00000000001051,0.898348939155582,0,1,NAD(P)+-protein-arginine ADP-ribosyltransferase activity,MF,
2482,GO:0005724,1.00000000001051,0.898348939155582,0,1,nuclear telomeric heterochromatin,CC,
7412,GO:0031509,1.00000000001051,0.898348939155582,0,1,telomeric heterochromatin assembly,BP,
7570,GO:0031940,1.00000000001051,0.898348939155582,0,1,positive regulation of chromatin silencing at telomere,BP,
18110,GO:1902732,1.00000000001051,0.898348939155582,0,1,positive regulation of chondrocyte proliferation,BP,
19305,GO:1905547,1.00000000001051,0.898348939155582,0,1,regulation of telomeric heterochromatin assembly,BP,
19306,GO:1905549,1.00000000001051,0.898348939155582,0,1,positive regulation of telomeric heterochromatin assembly,BP,
1419,GO:0003360,1.00000000001058,0.706485791179783,0,3,brainstem development,BP,
13960,GO:0060678,1.00000000001066,0.890879763632061,0,1,dichotomous subdivision of terminal units involved in ureteric bud branching,BP,
15625,GO:0072127,1.00000000001066,0.890879763632061,0,1,renal capsule development,BP,
15626,GO:0072128,1.00000000001066,0.890879763632061,0,1,renal capsule morphogenesis,BP,
15627,GO:0072129,1.00000000001066,0.890879763632061,0,1,renal capsule formation,BP,
15628,GO:0072130,1.00000000001066,0.890879763632061,0,1,renal capsule specification,BP,
15682,GO:0072213,1.00000000001066,0.890879763632061,0,1,metanephric capsule development,BP,
15707,GO:0072265,1.00000000001066,0.890879763632061,0,1,metanephric capsule morphogenesis,BP,
15708,GO:0072266,1.00000000001066,0.890879763632061,0,1,metanephric capsule formation,BP,
15709,GO:0072267,1.00000000001066,0.890879763632061,0,1,metanephric capsule specification,BP,
3848,GO:0008460,1.00000000001069,0.89382302043965,0,1,dTDP-glucose 4,6-dehydratase activity,MF,
5449,GO:0016321,1.00000000001075,0.706226350316683,0,3,female meiosis chromosome segregation,BP,
8666,GO:0034247,1.00000000001084,0.907440447260258,0,1,snoRNA splicing,BP,
15453,GO:0071796,1.00000000001084,0.907440447260258,0,1,K6-linked polyubiquitin modification-dependent protein binding,MF,
10393,GO:0043231,1.00000000001088,0,772,8331,intracellular membrane-bounded organelle,CC,TNIP1;DUSP6;NT5E;XDH;ERCC1;DUSP5;MEF2D;ZMYND8;H1F0;CITED4;FHL1;EGR1;B4GALNT4;NR1D1;SLC16A3;H6PD;EDEM1;DLG4;CST3;CYP27B1;TYSND1;HS1BP3;MARVELD1;EPN3;FBXO2;PRR7;PDCD4;CTNNBIP1;NAGS;DOCK4;XPC;PRNP;PYGB;POSTN;FAM210B;WNT7A;APOE;TSPAN1;NAGLU;F2R;LRP5;PLD3;OSBPL5;LPCAT4;PITPNC1;HMGA2;OBSCN;NDRG1;IDH2;ZKSCAN1;NEK9;CRAT;ELK3;ITPR3;PKN1;MTA1;GRAMD4;ACOT7;ANGEL1;ACSF2;AKR7A2;EGFR;RPS6KA2;DNPH1;WWTR1;OBSL1;NOS1;VAT1;TMEM129;SLC2A9;HADH;CTSO;SPRY2;CAPN2;MST1R;NFATC4;TRIM65;BAHCC1;CRTAP;SDC1;ETV5;LMF1;APPL2;SHC1;DDB2;VPS11;LTBP1;TBC1D14;ARL2;HEXB;TCFL5;PTPRE;NPEPL1;ALDH4A1;TK2;ETV4;SNX9;TRNP1;TXNRD3;ST6GALNAC2;ZFP36L1;GAA;GLUL;ARAP1;MAP2K2;KDSR;NME4;ZC3H6;MARCH9;CTBS;FKBP9;MDFI;PTOV1;SMARCA1;SUGCT;PC;FOXQ1;RNF44;MAP2K1;NAPRT;ACP5;CPT2;VWA5A;MCTP1;MXD4;POU2F2;ENDOG;TMEM8A;SMURF2;KLC2;TSC22D1;ARMCX2;OXLD1;SLC9A3R2;FOS;SMAD3;STAT6;PIK3R2;ERCC6;LRP1;SRD5A3;EPAS1;DNAJB5;PIGQ;HSD17B8;FAM110C;RPUSD3;AP2A2;S100A4;CYBRD1;PPP2R3B;PRDX5;STOM;BRD3;PRODH;SALL2;MBOAT7;CDK18;REEP4;ZXDC;RNF187;ADARB1;PLCXD2;D2HGDH;AKT1;TPCN1;HDAC5;UROS;S100A6;F12;PITPNM1;ENTPD6;RHBDF2;PYCR2;BSG;STK39;HK1;ASAP2;SCMH1;PHC2;NFKBIZ;ASH2L;MARCH4;SLC15A4;ATG16L2;IFNGR2;BRSK1;PTHLH;RAB31;FGFR4;WNT2B;POLD4;FNDC4;LDLR;FGFR1;PRKACB;FUCA1;MAPKBP1;SIGMAR1;RAC2;SEC14L2;HLTF;MXI1;NPHP4;SYNE3;RAG1;GAMT;H2AFJ;B4GAT1;PACS2;PHF7;TOMM34;BPHL;PIGV;KLF7;RALGDS;SORL1;NAT14;B3GAT3;CIRBP;CBR4;HMG20B;TENM2;ZNF385A;NSMCE4A;ABCD1;ANK3;NIPSNAP1;IGFBP4;TSHZ1;TRAPPC9;CCND1;TCF25;LHPP;STRADB;MAPK13;CARD19;GAS6;PTK6;PFKP;CSNK1E;R3HDM4;BRI3;CTSB;SOX13;LAMA5;DUSP7;MPLKIP;GSN;MAPKAPK3;PCSK9;ARHGAP22;RAD23A;DHTKD1;PHLDA1;ANO8;ANTXR2;XPOT;MRPS6;EHD4;ERRFI1;GLI4;HLCS;ZSCAN18;AIP;MYEF2;SH3D19;CCDC113;CDC25B;SH3GLB2;ARHGAP27;ALOX15B;SPTB;SMARCD2;AGAP1;COMTD1;PEX10;CCS;RSAD1;COL13A1;CORO7;DGKQ;HAGH;BNIP3;PAK6;NOL4L;GTF2IRD1;MVB12B;TAGLN3;FYCO1;CEMIP;PKD2;RETSAT;YPEL3;CTSZ;HES2;CRTC1;FBXW8;GPSM1;AP3D1;ABCA2;C19ORF33;EPHB2;ADAM8;ASIC1;APRT;TMEM9;CTBP1;LTA4H;MNT;PTPDC1;CDKN1C;PLCG1;ZMIZ2;CBS;CEBPB;ENTPD2;ADAMTS13;ZNF217;ZNF862;WNT3;DPP7;TMED4;TGFB1;LACTB2;SNPH;CLTCL1;RFX2;SCYL1;GPC1;MKNK2;ADAMTS7;DEAF1;MOAP1;SLC38A10;NTSR1;B3GNT3;NAB2;TMEM173;ZSCAN30;ATP7B;PODXL2;SDHA;MSRB2;PNRC1;MIPEP;MGAT4B;MDH2;MPG;GALNS;CLCA2;HEXDC;GOLGA2P5;NSMF;PEG3;ARAP3;TUB;DIRC2;RHOD;ABHD14B;LAMB2;ABTB1;SNX17;RNH1;ERO1B;ST6GALNAC6;VGF;POLL;POLM;PI4K2A;SEMA4F;PTMS;RHOF;YIPF3;ANKZF1;ATG2A;SLC48A1;LLGL1;PHF21A;MIF4GD;COA5;RHOBTB2;UBXN4;ADAM19;KHDRBS3;TUBG2;HMGCL;PTPN1;PEX1;TPP1;PCK2;B4GALT2;WDR59;AGRN;MBD3;CD320;ESYT2;ZDHHC24;ACP6;B4GALT6;VHL;CEP131;TRAP1;IDUA;ADAP1;PFKFB2;RFNG;MLXIPL;TRIB2;PRKCZ;KDM6B;PRKACA;MINK1;ZNF516;CENPH;GRHPR;OXA1L;RABGGTA;EPN2;ADA;AREG;UCKL1;BOK;WDR18;TDRKH;CAPG;ALAS1;ERBB2;ULK1;CNDP2;AHCY;VAMP2;CERCAM;PRIMPOL;TMEM143;TFDP2;C6ORF89;MZT2A;NECAB3;STK17A;RILPL1;FAM50A;IRF2BP2;NET1;BNIP3L;CYFIP2;PBX2;NELFCD;SLC22A17;PDK1;ACAD10;CYGB;THOP1;MCFD2;PRKCD;FAM20C;REEP6;RBL2;STUB1;IFI6;BAX;CYC1;SV2A;SBF1;DTD1;XYLT2;OLFM2;ZNF395;HIST3H2BB;CCDC92;NUBP2;SH3BP1;GJB4;RPS6KA5;DGUOK;DUSP4;KLHDC2;TIMM17B;ZNF524;SOX12;TMBIM4;DDIT4;MBTPS2;ACADS;TOP3B;PPL;PPP1R13L;CARF;HSD17B7;AHNAK2;PCSK1N;MT2A;IER2;CES2;NAGA;ZDHHC8;TMX4;MZT2B;FCHO1;LIMK1;PDIA5;GDI1;PADI3;DIP2A;LTB4R2;CPNE7;SLC2A11;LEMD2;RPS6KA6;TMEM92;ZHX3;DNM1;WASH3P;RGS14;TMEM8B;MFNG;GIT1;ALDOC;MRPS26;MSLN;LPCAT1;REEP2;EHD3;ST3GAL3;LONP2;SYMPK;MAPK12;IRAK1;PPOX;TGFA;HDAC7;FHOD1;CHD2;PI4K2B;CBX7;CHEK2;DECR2;ZFPM1;PPARA;COG7;COQ2;SESN2;ABCG1;MYO1D;JADE2;CDC34;RNF123;SNN;SOX7;ABCA7;RAB12;SPEG;SIX5;BCAP31;MIF;ACO2;SMOX;KDM4B;SLC25A29;DOPEY2;PHYH;ZNF414;MEX3A;SLC9A7;PLA2G6;SSBP4;SYNGR1;NARF;WFS1;QSOX1;CD68;ZNF444;SLC22A18;SPPL2B;HSD11B1L;FYN;VWA1;UPP1;STK25;ETFB;GLB1L2;CERS4;SUN1;FLYWCH1;ACAP3;ARID5B;HOXC5;DNM2;CKMT1A;CYP3A5;BHLHE40;GLB1;PELI1;SNX15;CAT;BEX2;NEIL1;TSPYL2;IGFBP7;ARMCX1;SLC27A1;ZMYM3;TPBG;APOBEC3C;SATB1;SLC50A1;ZDHHC1;SLC12A4;PLCB3;H1FX;IQSEC1;ZNF606;APOBEC3F;DDX50;CYP2R1;TUBB6;MAPK3;CBLN3;INSR;RTN2;PAN2;GRINA;PDZD2;CAMTA2;TAZ;PFKM;ADCY1;C12ORF66;RERE;HLA-G;STX10;INO80C;ATP8B2;GPT2;RALGAPA1;PDXK;ETAA1;GLRX;PAK1;TRIM45;CDYL2;DCAF10;MALL;CAMKK2;RNASET2;PPP3CB;RNF144A;CTSF;USP21;PFKFB3;MLYCD;CUL7;SLC37A2;REV1;HYAL1;CAPRIN2;ZBTB10;WDTC1;HES7;DNMT3A;SAMD8;BIN1;VPS16;MAN2B1;TSTD1;HES6;SLC16A13;MAP2K3;NDST2;BCL2L1;ABHD10;NDUFV3;DNASE1L1;PROX1;IARS2;LRCH4;ALDH7A1;LMNA;PKD1;KCTD13;TNFRSF25;SIRT2;FAM129B;EDA;UVSSA;GAL3ST4;NMNAT2;BACH1;NT5C1B;TRIP10;E2F5;ZBTB22;ALG12;AZIN2;TEP1;ZNF704;ST3GAL2;ICA1;SLC25A37;RAP1GAP2;LAMB1;SOCS7;HSDL1;RGS19;HSD11B1;GTF2IRD2;RAB40B;NGFR;TOLLIP;BCORL1;PDCD6;ATP6V1F;ARVCF;CHST14;BIVM;ZNF837;PHYKPL;PLEKHM1;DUSP23;GCH1;LURAP1;MAFF;NR2F6;CBX6;NBEAL2;PNMA1;CAMK1;CAMKK1;EZH1;SIRT3;TERC;ZNF513;WIPI2;COL6A1;BTG1;VPS51;CELSR1;TACC1;MLF2;SEMA3B;CDK11B;C2CD2;SSH3;FGFR3;TST;ST3GAL5;TNRC18;NDRG2;MAN2B2;CBLC;ITPKB;SPTLC2;TCEA2;ZBTB47;PLAG1;CLK3;IRF2BPL;DHX32;KDM3A;PM20D2;FAM214B;TBL3;PKN3;APBA1;DEDD2;AK3;SRSF5;CHPF;SLC26A11;LRRK1;AARS;SDC2
17015,GO:0099130,1.00000000001089,0.891069483263564,0,1,estrogen binding,MF,
18642,GO:1903924,1.00000000001089,0.891069483263564,0,1,estradiol binding,MF,
1402,GO:0003335,1.000000000011,0.890124399473763,0,1,corneocyte development,BP,
1403,GO:0003336,1.000000000011,0.890124399473763,0,1,corneocyte desquamation,BP,
19360,GO:1905715,1.000000000011,0.890124399473763,0,1,regulation of cornification,BP,
19361,GO:1905716,1.000000000011,0.890124399473763,0,1,negative regulation of cornification,BP,
19200,GO:1905271,1.00000000001104,0.932913917830846,0,1,regulation of proton-transporting ATP synthase activity, rotational mechanism,BP,
19201,GO:1905273,1.00000000001104,0.932913917830846,0,1,positive regulation of proton-transporting ATP synthase activity, rotational mechanism,BP,
15429,GO:0071707,1.00000000001106,0.908159937365558,0,1,immunoglobulin heavy chain V-D-J recombination,BP,
14062,GO:0060857,1.00000000001108,0.890811706556846,0,1,establishment of glial blood-brain barrier,BP,
6376,GO:0021569,1.00000000001112,0.899239507932192,0,1,rhombomere 3 development,BP,
6377,GO:0021570,1.00000000001112,0.899239507932192,0,1,rhombomere 4 development,BP,
1697,GO:0004174,1.00000000001115,0.792574233391844,0,2,electron-transferring-flavoprotein dehydrogenase activity,MF,
5607,GO:0016649,1.00000000001115,0.792574233391844,0,2,oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor,MF,
6214,GO:0019747,1.00000000001116,0.921515384678528,0,1,regulation of isoprenoid metabolic process,BP,
6883,GO:0030421,1.00000000001116,0.921515384678528,0,1,defecation,BP,
18495,GO:1903593,1.00000000001121,0.735223967878972,0,3,regulation of histamine secretion by mast cell,BP,
18496,GO:1903595,1.00000000001121,0.735223967878972,0,3,positive regulation of histamine secretion by mast cell,BP,
10363,GO:0043185,1.00000000001122,0.892032144437151,0,1,vascular endothelial growth factor receptor 3 binding,MF,
14850,GO:0070625,1.00000000001122,0.892032144437151,0,1,zymogen granule exocytosis,BP,
1529,GO:0003908,1.00000000001126,0.908254775459955,0,1,methylated-DNA-[protein]-cysteine S-methyltransferase activity,MF,
2501,GO:0005753,1.00000000001127,0.891225932384917,0,1,mitochondrial proton-transporting ATP synthase complex,CC,
4693,GO:0010849,1.00000000001127,0.891225932384917,0,1,regulation of proton-transporting ATPase activity, rotational mechanism,BP,
19833,GO:2000276,1.00000000001127,0.891225932384917,0,1,negative regulation of oxidative phosphorylation uncoupler activity,BP,
775,GO:0002032,1.00000000001131,0.797688848353638,0,2,desensitization of G-protein coupled receptor protein signaling pathway by arrestin,BP,
12040,GO:0047915,1.00000000001133,0.89745198207752,0,1,ganglioside galactosyltransferase activity,MF,
2684,GO:0006050,1.00000000001135,0.899692749751197,0,1,mannosamine metabolic process,BP,
2685,GO:0006051,1.00000000001135,0.899692749751197,0,1,N-acetylmannosamine metabolic process,BP,
11101,GO:0045127,1.00000000001135,0.899692749751197,0,1,N-acetylglucosamine kinase activity,MF,
14311,GO:0061474,1.0000000000114,0.890123284867132,0,1,phagolysosome membrane,CC,
11944,GO:0047066,1.00000000001146,0.919780968765772,0,1,phospholipid-hydroperoxide glutathione peroxidase activity,MF,
16713,GO:0097707,1.00000000001146,0.919780968765772,0,1,ferroptosis,BP,
17243,GO:0110075,1.00000000001146,0.919780968765772,0,1,regulation of ferroptosis,BP,
17244,GO:0110076,1.00000000001146,0.919780968765772,0,1,negative regulation of ferroptosis,BP,
6262,GO:0019858,1.00000000001152,0.818067583917837,0,2,cytosine metabolic process,BP,
1848,GO:0004511,1.00000000001154,0.893848319016394,0,1,tyrosine 3-monooxygenase activity,MF,
3032,GO:0006585,1.00000000001154,0.893848319016394,0,1,dopamine biosynthetic process from tyrosine,BP,
8264,GO:0033076,1.00000000001154,0.893848319016394,0,1,isoquinoline alkaloid metabolic process,BP,
9022,GO:0035240,1.00000000001154,0.893848319016394,0,1,dopamine binding,MF,
9894,GO:0042214,1.00000000001154,0.893848319016394,0,1,terpene metabolic process,BP,
9997,GO:0042418,1.00000000001154,0.893848319016394,0,1,epinephrine biosynthetic process,BP,
13327,GO:0052314,1.00000000001154,0.893848319016394,0,1,phytoalexin metabolic process,BP,
11942,GO:0047045,1.00000000001154,0.909021628883728,0,1,testosterone 17-beta-dehydrogenase (NADP+) activity,MF,
2886,GO:0006397,1.0000000000117,0,10,439,mRNA processing,BP,ZFP36L1;RPUSD3;ADARB1;KHDRBS3;PRKACA;SYMPK;PAN2;CDK11B;DHX32;SRSF5
16711,GO:0097698,1.0000000000117,0.901778603905015,0,1,telomere maintenance via base-excision repair,BP,
15930,GO:0072733,1.00000000001186,0.713655707775665,0,3,response to staurosporine,BP,
15931,GO:0072734,1.00000000001186,0.713655707775665,0,3,cellular response to staurosporine,BP,
16195,GO:0090226,1.00000000001194,0.924268113394767,0,1,regulation of microtubule nucleation by Ran protein signal transduction,BP,
2757,GO:0006172,1.00000000001212,0.890776932789234,0,1,ADP biosynthetic process,BP,
16515,GO:0097226,1.00000000001212,0.890776932789234,0,1,sperm mitochondrial sheath,CC,
15152,GO:0071275,1.00000000001217,0.891515610553529,0,1,cellular response to aluminum ion,BP,
19351,GO:1905672,1.00000000001217,0.891515610553529,0,1,negative regulation of lysosome organization,BP,
17614,GO:1901291,1.0000000000122,0.893741574179308,0,1,negative regulation of double-strand break repair via single-strand annealing,BP,
12303,GO:0048664,1.00000000001221,0.72994574492073,0,3,neuron fate determination,BP,
11970,GO:0047277,1.00000000001224,0.893328777296026,0,1,globoside alpha-N-acetylgalactosaminyltransferase activity,MF,
14924,GO:0070782,1.00000000001225,0.891475439435867,0,1,phosphatidylserine exposure on apoptotic cell surface,BP,
16242,GO:0090297,1.00000000001229,0.907845458346488,0,1,positive regulation of mitochondrial DNA replication,BP,
17797,GO:1901860,1.00000000001229,0.907845458346488,0,1,positive regulation of mitochondrial DNA metabolic process,BP,
19446,GO:1990046,1.00000000001229,0.907845458346488,0,1,stress-induced mitochondrial fusion,BP,
19671,GO:1990904,1.00000000001232,0,24,702,ribonucleoprotein complex,CC,BTBD2;ZFP36L1;GRB7;PITPNM1;NFKBIZ;IMPACT;MAPKBP1;CIRBP;MRPS6;UNK;PNRC1;TDRKH;RPL39L;MRPS26;SYMPK;MEX3A;APOBEC3C;APOBEC3F;PAN2;TSTD1;TEP1;TERC;DHX32;TBL3
10607,GO:0043602,1.0000000000124,0.890167428808409,0,1,nitrate catabolic process,BP,
11594,GO:0046210,1.0000000000124,0.890167428808409,0,1,nitric oxide catabolic process,BP,
12024,GO:0047726,1.0000000000124,0.890167428808409,0,1,iron-cytochrome-c reductase activity,MF,
16277,GO:0090345,1.0000000000124,0.890167428808409,0,1,cellular organohalogen metabolic process,BP,
16278,GO:0090346,1.0000000000124,0.890167428808409,0,1,cellular organofluorine metabolic process,BP,
11735,GO:0046586,1.00000000001246,0.819810537180367,0,2,regulation of calcium-dependent cell-cell adhesion,BP,
3836,GO:0008444,1.00000000001252,0.891237669212518,0,1,CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity,MF,
9596,GO:0036458,1.00000000001252,0.891237669212518,0,1,hepatocyte growth factor binding,MF,
1536,GO:0003920,1.00000000001253,0.894160753132122,0,1,GMP reductase activity,MF,
5289,GO:0015950,1.00000000001253,0.894160753132122,0,1,purine nucleotide interconversion,BP,
5290,GO:0015951,1.00000000001253,0.894160753132122,0,1,purine ribonucleotide interconversion,BP,
5612,GO:0016657,1.00000000001253,0.894160753132122,0,1,oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor,MF,
18048,GO:1902560,1.00000000001253,0.894160753132122,0,1,GMP reductase complex,CC,
9133,GO:0035470,1.0000000000126,0.895254263048053,0,1,positive regulation of vascular wound healing,BP,
13969,GO:0060690,1.0000000000126,0.895254263048053,0,1,epithelial cell differentiation involved in salivary gland development,BP,
13970,GO:0060691,1.0000000000126,0.895254263048053,0,1,epithelial cell maturation involved in salivary gland development,BP,
17377,GO:1900098,1.0000000000126,0.895254263048053,0,1,regulation of plasma cell differentiation,BP,
17378,GO:1900100,1.0000000000126,0.895254263048053,0,1,positive regulation of plasma cell differentiation,BP,
18433,GO:1903489,1.0000000000126,0.895254263048053,0,1,positive regulation of lactation,BP,
16590,GO:0097409,1.00000000001264,0.893220757287007,0,1,glial cytoplasmic inclusion,CC,
16593,GO:0097414,1.00000000001264,0.893220757287007,0,1,classical Lewy body,CC,
16616,GO:0097462,1.00000000001264,0.893220757287007,0,1,Lewy neurite,CC,
19445,GO:1990038,1.00000000001264,0.893220757287007,0,1,Lewy body corona,CC,
5983,GO:0018879,1.00000000001269,0.890038518741308,0,1,biphenyl metabolic process,BP,
11720,GO:0046541,1.00000000001279,0.890025472459111,0,1,saliva secretion,BP,
12022,GO:0047710,1.0000000000128,0.914255396238925,0,1,bis(5'-adenosyl)-triphosphatase activity,MF,
18459,GO:1903537,1.00000000001307,0.792516498557672,0,2,meiotic cell cycle process involved in oocyte maturation,BP,
18460,GO:1903538,1.00000000001307,0.792516498557672,0,2,regulation of meiotic cell cycle process involved in oocyte maturation,BP,
2687,GO:0006055,1.00000000001325,0.909053893565802,0,1,CMP-N-acetylneuraminate biosynthetic process,BP,
11640,GO:0046381,1.00000000001325,0.909053893565802,0,1,CMP-N-acetylneuraminate metabolic process,BP,
11992,GO:0047444,1.00000000001325,0.909053893565802,0,1,N-acylneuraminate-9-phosphate synthase activity,MF,
12480,GO:0050462,1.00000000001325,0.909053893565802,0,1,N-acetylneuraminate synthase activity,MF,
3216,GO:0006867,1.00000000001329,0.890023901874272,0,1,asparagine transport,BP,
5018,GO:0015182,1.00000000001329,0.890023901874272,0,1,L-asparagine transmembrane transporter activity,MF,
5025,GO:0015190,1.00000000001329,0.890023901874272,0,1,L-leucine transmembrane transporter activity,MF,
5026,GO:0015191,1.00000000001329,0.890023901874272,0,1,L-methionine transmembrane transporter activity,MF,
5138,GO:0015658,1.00000000001329,0.890023901874272,0,1,branched-chain amino acid transmembrane transporter activity,MF,
5218,GO:0015821,1.00000000001329,0.890023901874272,0,1,methionine transport,BP,
10659,GO:0043865,1.00000000001329,0.890023901874272,0,1,methionine transmembrane transporter activity,MF,
3956,GO:0008709,1.00000000001334,0.919372702250223,0,1,cholate 7-alpha-dehydrogenase activity,MF,
6817,GO:0030283,1.00000000001334,0.919372702250223,0,1,testosterone dehydrogenase [NAD(P)] activity,MF,
11934,GO:0047015,1.00000000001334,0.919372702250223,0,1,3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity,MF,
19099,GO:1904983,1.0000000000134,0.891683718031255,0,1,glycine import into mitochondrion,BP,
964,GO:0002396,1.00000000001347,0.89373535795338,0,1,MHC protein complex assembly,BP,
965,GO:0002397,1.00000000001347,0.89373535795338,0,1,MHC class I protein complex assembly,BP,
1013,GO:0002501,1.00000000001347,0.89373535795338,0,1,peptide antigen assembly with MHC protein complex,BP,
1014,GO:0002502,1.00000000001347,0.89373535795338,0,1,peptide antigen assembly with MHC class I protein complex,BP,
3554,GO:0007598,1.00000000001351,0.89052497271517,0,1,blood coagulation, extrinsic pathway,BP,
17588,GO:1901202,1.00000000001351,0.89052497271517,0,1,negative regulation of extracellular matrix assembly,BP,
18396,GO:1903394,1.00000000001351,0.89052497271517,0,1,protein localization to kinetochore involved in kinetochore assembly,BP,
1575,GO:0003983,1.0000000000137,0.891556517228772,0,1,UTP:glucose-1-phosphate uridylyltransferase activity,MF,
13154,GO:0051748,1.0000000000137,0.891556517228772,0,1,UTP-monosaccharide-1-phosphate uridylyltransferase activity,MF,
4357,GO:0009955,1.00000000001371,0.891179742551719,0,1,adaxial/abaxial pattern specification,BP,
9273,GO:0035709,1.00000000001371,0.891179742551719,0,1,memory T cell activation,BP,
16304,GO:0090427,1.00000000001371,0.891179742551719,0,1,activation of meiosis,BP,
19707,GO:2000011,1.00000000001371,0.891179742551719,0,1,regulation of adaxial/abaxial pattern formation,BP,
19997,GO:2000567,1.00000000001371,0.891179742551719,0,1,regulation of memory T cell activation,BP,
19998,GO:2000568,1.00000000001371,0.891179742551719,0,1,positive regulation of memory T cell activation,BP,
20217,GO:2001055,1.00000000001371,0.891179742551719,0,1,positive regulation of mesenchymal cell apoptotic process,BP,
8534,GO:0033871,1.00000000001374,0.893351825194805,0,1,[heparan sulfate]-glucosamine 3-sulfotransferase 2 activity,MF,
4690,GO:0010845,1.00000000001394,0.890054553856105,0,1,positive regulation of reciprocal meiotic recombination,BP,
14394,GO:0061656,1.00000000001404,0.910331439179043,0,1,SUMO conjugating enzyme activity,MF,
18297,GO:1903182,1.00000000001404,0.910331439179043,0,1,regulation of SUMO transferase activity,BP,
18556,GO:1903755,1.00000000001404,0.910331439179043,0,1,positive regulation of SUMO transferase activity,BP,
19514,GO:1990356,1.00000000001404,0.910331439179043,0,1,sumoylated E2 ligase complex,CC,
12018,GO:0047685,1.00000000001409,0.901386525139994,0,1,amine sulfotransferase activity,MF,
16282,GO:0090365,1.00000000001425,0.891309700041965,0,1,regulation of mRNA modification,BP,
16283,GO:0090367,1.00000000001425,0.891309700041965,0,1,negative regulation of mRNA modification,BP,
18315,GO:1903215,1.00000000001425,0.891309700041965,0,1,negative regulation of protein targeting to mitochondrion,BP,
20236,GO:2001144,1.00000000001425,0.891309700041965,0,1,regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,BP,
20237,GO:2001145,1.00000000001425,0.891309700041965,0,1,negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,BP,
11961,GO:0047220,1.00000000001426,0.890023818737295,0,1,galactosylxylosylprotein 3-beta-galactosyltransferase activity,MF,
9123,GO:0035442,1.00000000001435,0.799011706767621,0,2,dipeptide transmembrane transport,BP,
10228,GO:0042938,1.00000000001435,0.799011706767621,0,2,dipeptide transport,BP,
16105,GO:0090088,1.00000000001435,0.799011706767621,0,2,regulation of oligopeptide transport,BP,
16106,GO:0090089,1.00000000001435,0.799011706767621,0,2,regulation of dipeptide transport,BP,
20174,GO:2000878,1.00000000001435,0.799011706767621,0,2,positive regulation of oligopeptide transport,BP,
20175,GO:2000880,1.00000000001435,0.799011706767621,0,2,positive regulation of dipeptide transport,BP,
20238,GO:2001148,1.00000000001435,0.799011706767621,0,2,regulation of dipeptide transmembrane transport,BP,
20239,GO:2001150,1.00000000001435,0.799011706767621,0,2,positive regulation of dipeptide transmembrane transport,BP,
16693,GO:0097643,1.0000000000144,0.921157560114855,0,1,amylin receptor activity,MF,
18421,GO:1903440,1.0000000000144,0.921157560114855,0,1,amylin receptor complex,CC,
19531,GO:1990407,1.0000000000144,0.921157560114855,0,1,calcitonin gene-related peptide binding,MF,
14915,GO:0070773,1.00000000001443,0.905686885263669,0,1,protein-N-terminal glutamine amidohydrolase activity,MF,
15321,GO:0071544,1.00000000001443,0.905686885263669,0,1,diphosphoinositol polyphosphate catabolic process,BP,
15499,GO:0071877,1.00000000001443,0.905686885263669,0,1,regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway,BP,
15503,GO:0071881,1.00000000001443,0.905686885263669,0,1,adenylate cyclase-inhibiting adrenergic receptor signaling pathway,BP,
16052,GO:0086096,1.00000000001443,0.905686885263669,0,1,adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,
17320,GO:0140193,1.00000000001443,0.905686885263669,0,1,regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,
17321,GO:0140194,1.00000000001443,0.905686885263669,0,1,negative regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,
1691,GO:0004164,1.00000000001444,0.895484296317501,0,1,diphthine synthase activity,MF,
1736,GO:0004333,1.00000000001444,0.895484296317501,0,1,fumarate hydratase activity,MF,
16244,GO:0090299,1.00000000001445,0.897831752716614,0,1,regulation of neural crest formation,BP,
16245,GO:0090301,1.00000000001445,0.897831752716614,0,1,negative regulation of neural crest formation,BP,
19859,GO:2000314,1.00000000001445,0.897831752716614,0,1,negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
9295,GO:0035744,1.0000000000145,0.912195462107313,0,1,T-helper 1 cell cytokine production,BP,
9902,GO:0042231,1.0000000000145,0.912195462107313,0,1,interleukin-13 biosynthetic process,BP,
2018,GO:0004747,1.00000000001452,0.910397955312055,0,1,ribokinase activity,MF,
1601,GO:0004019,1.0000000000146,0.890024319819654,0,1,adenylosuccinate synthase activity,MF,
3982,GO:0008829,1.00000000001466,0.895030819647313,0,1,dCTP deaminase activity,MF,
13668,GO:0060212,1.00000000001466,0.895030819647313,0,1,negative regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
17418,GO:1900152,1.00000000001466,0.895030819647313,0,1,negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
14607,GO:0070176,1.00000000001469,0.895372416761056,0,1,DRM complex,CC,
5092,GO:0015367,1.00000000001476,0.895679722921606,0,1,oxoglutarate:malate antiporter activity,MF,
5179,GO:0015742,1.00000000001476,0.895679722921606,0,1,alpha-ketoglutarate transport,BP,
1545,GO:0003939,1.00000000001477,0.890140888227668,0,1,L-iditol 2-dehydrogenase activity,MF,
2693,GO:0006062,1.00000000001477,0.890140888227668,0,1,sorbitol catabolic process,BP,
6137,GO:0019407,1.00000000001477,0.890140888227668,0,1,hexitol catabolic process,BP,
6163,GO:0019519,1.00000000001477,0.890140888227668,0,1,pentitol metabolic process,BP,
6166,GO:0019527,1.00000000001477,0.890140888227668,0,1,pentitol catabolic process,BP,
7306,GO:0031320,1.00000000001477,0.890140888227668,0,1,hexitol dehydrogenase activity,MF,
11712,GO:0046526,1.00000000001477,0.890140888227668,0,1,D-xylulose reductase activity,MF,
12838,GO:0051160,1.00000000001477,0.890140888227668,0,1,L-xylitol catabolic process,BP,
12839,GO:0051164,1.00000000001477,0.890140888227668,0,1,L-xylitol metabolic process,BP,
2038,GO:0004778,1.0000000000148,0.898561325702912,0,1,succinyl-CoA hydrolase activity,MF,
8095,GO:0032788,1.0000000000148,0.898561325702912,0,1,saturated monocarboxylic acid metabolic process,BP,
8096,GO:0032789,1.0000000000148,0.898561325702912,0,1,unsaturated monocarboxylic acid metabolic process,BP,
1897,GO:0004581,1.00000000001486,0.911356254927485,0,1,dolichyl-phosphate beta-glucosyltransferase activity,MF,
16169,GO:0090191,1.0000000000149,0.799036285313712,0,2,negative regulation of branching involved in ureteric bud morphogenesis,BP,
8545,GO:0033961,1.00000000001508,0.896214928638445,0,1,cis-stilbene-oxide hydrolase activity,MF,
2006,GO:0004730,1.00000000001509,0.897750842265058,0,1,pseudouridylate synthase activity,MF,
14985,GO:0070902,1.00000000001509,0.897750842265058,0,1,mitochondrial tRNA pseudouridine synthesis,BP,
6442,GO:0021763,1.00000000001516,0.891011947536466,0,1,subthalamic nucleus development,BP,
13621,GO:0060127,1.00000000001516,0.891011947536466,0,1,prolactin secreting cell differentiation,BP,
13844,GO:0060459,1.00000000001516,0.891011947536466,0,1,left lung development,BP,
13845,GO:0060460,1.00000000001516,0.891011947536466,0,1,left lung morphogenesis,BP,
13909,GO:0060577,1.00000000001516,0.891011947536466,0,1,pulmonary vein morphogenesis,BP,
13910,GO:0060578,1.00000000001516,0.891011947536466,0,1,superior vena cava morphogenesis,BP,
14140,GO:0061031,1.00000000001516,0.891011947536466,0,1,endodermal digestive tract morphogenesis,BP,
9176,GO:0035552,1.00000000001519,0.712765972447589,0,3,oxidative single-stranded DNA demethylation,BP,
17171,GO:0102758,1.00000000001534,0.91137324019243,0,1,very-long-chain enoyl-CoA reductase activity,MF,
14559,GO:0070094,1.00000000001539,0.890085144436099,0,1,positive regulation of glucagon secretion,BP,
3127,GO:0006713,1.00000000001541,0.895532721268774,0,1,glucocorticoid catabolic process,BP,
11085,GO:0045098,1.00000000001555,0.897791233764071,0,1,type III intermediate filament,CC,
9522,GO:0036250,1.00000000001576,0.893576167908482,0,1,peroxisome transport along microtubule,BP,
10956,GO:0044721,1.00000000001576,0.893576167908482,0,1,protein import into peroxisome matrix, substrate release,BP,
18508,GO:1903630,1.0000000000158,0.909802807514944,0,1,regulation of aminoacyl-tRNA ligase activity,BP,
18509,GO:1903632,1.0000000000158,0.909802807514944,0,1,positive regulation of aminoacyl-tRNA ligase activity,BP,
6506,GO:0021886,1.00000000001588,0.727897799155124,0,3,hypothalamus gonadotrophin-releasing hormone neuron differentiation,BP,
6507,GO:0021888,1.00000000001588,0.727897799155124,0,3,hypothalamus gonadotrophin-releasing hormone neuron development,BP,
340,GO:0000941,1.00000000001593,0.890917613522792,0,1,condensed nuclear chromosome inner kinetochore,CC,
13012,GO:0051456,1.00000000001593,0.890917613522792,0,1,attachment of spindle microtubules to kinetochore involved in meiotic sister chromatid segregation,BP,
593,GO:0001758,1.00000000001594,0.706454869538605,0,3,retinal dehydrogenase activity,MF,
3637,GO:0008111,1.00000000001595,0.89304421253935,0,1,alpha-methylacyl-CoA racemase activity,MF,
9806,GO:0042007,1.00000000001615,0.903690190182686,0,1,interleukin-18 binding,MF,
15974,GO:0080129,1.00000000001646,0.914094184261443,0,1,proteasome core complex assembly,BP,
4435,GO:0010309,1.00000000001652,0.897610477642105,0,1,acireductone dioxygenase [iron(II)-requiring] activity,MF,
19574,GO:1990565,1.00000000001652,0.897610477642105,0,1,HSP90-CDC37 chaperone complex,CC,
3292,GO:0006990,1.00000000001655,0.712751050268501,0,3,positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response,BP,
7975,GO:0032595,1.00000000001659,0.891346761573264,0,1,B cell receptor transport within lipid bilayer,BP,
7977,GO:0032597,1.00000000001659,0.891346761573264,0,1,B cell receptor transport into membrane raft,BP,
7978,GO:0032599,1.00000000001659,0.891346761573264,0,1,protein transport out of membrane raft,BP,
7979,GO:0032600,1.00000000001659,0.891346761573264,0,1,chemokine receptor transport out of membrane raft,BP,
8169,GO:0032913,1.00000000001659,0.891346761573264,0,1,negative regulation of transforming growth factor beta3 production,BP,
8459,GO:0033606,1.00000000001659,0.891346761573264,0,1,chemokine receptor transport within lipid bilayer,BP,
15637,GO:0072139,1.00000000001659,0.891346761573264,0,1,glomerular parietal epithelial cell differentiation,BP,
20118,GO:2000768,1.00000000001659,0.891346761573264,0,1,positive regulation of nephron tubule epithelial cell differentiation,BP,
5079,GO:0015317,1.00000000001685,0.897432314618597,0,1,phosphate:proton symporter activity,MF,
8489,GO:0033676,1.0000000000172,0.904022963596348,0,1,double-stranded DNA-dependent ATPase activity,MF,
1506,GO:0003860,1.00000000001724,0.893558099470092,0,1,3-hydroxyisobutyryl-CoA hydrolase activity,MF,
2120,GO:0004910,1.00000000001728,0.903334203630487,0,1,interleukin-1, Type II, blocking receptor activity,MF,
8034,GO:0032690,1.00000000001728,0.903334203630487,0,1,negative regulation of interleukin-1 alpha production,BP,
12554,GO:0050712,1.00000000001728,0.903334203630487,0,1,negative regulation of interleukin-1 alpha secretion,BP,
1651,GO:0004098,1.00000000001734,0.89387373013035,0,1,cerebroside-sulfatase activity,MF,
12783,GO:0051086,1.00000000001736,0.893148226406038,0,1,chaperone mediated protein folding independent of cofactor,BP,
7543,GO:0031859,1.00000000001769,0.89386101049037,0,1,platelet activating factor receptor binding,MF,
9870,GO:0042137,1.00000000001769,0.89386101049037,0,1,sequestering of neurotransmitter,BP,
1605,GO:0004027,1.0000000000177,0.909475590120688,0,1,alcohol sulfotransferase activity,MF,
15938,GO:0072750,1.00000000001818,0.907626838081604,0,1,cellular response to leptomycin B,BP,
17642,GO:1901344,1.00000000001818,0.907626838081604,0,1,response to leptomycin B,BP,
17764,GO:1901707,1.00000000001818,0.907626838081604,0,1,leptomycin B binding,MF,
19451,GO:1990070,1.00000000001822,0.926808270326397,0,1,TRAPPI protein complex,CC,
10406,GO:0043250,1.00000000001827,0.901474447257953,0,1,sodium-dependent organic anion transmembrane transporter activity,MF,
10407,GO:0043251,1.00000000001827,0.901474447257953,0,1,sodium-dependent organic anion transport,BP,
12576,GO:0050757,1.0000000000185,0.890050432030065,0,1,thymidylate synthase biosynthetic process,BP,
12577,GO:0050758,1.0000000000185,0.890050432030065,0,1,regulation of thymidylate synthase biosynthetic process,BP,
12578,GO:0050760,1.0000000000185,0.890050432030065,0,1,negative regulation of thymidylate synthase biosynthetic process,BP,
1670,GO:0004132,1.00000000001855,0.892477772166032,0,1,dCMP deaminase activity,MF,
14986,GO:0070903,1.00000000001887,0.893104143884316,0,1,mitochondrial tRNA thio-modification,BP,
6786,GO:0030233,1.000000000019,0.898223014023688,0,1,deoxynucleotide transmembrane transporter activity,MF,
6832,GO:0030302,1.000000000019,0.898223014023688,0,1,deoxynucleotide transport,BP,
15072,GO:0071045,1.000000000019,0.898223014023688,0,1,nuclear histone mRNA catabolic process,BP,
15377,GO:0071629,1.000000000019,0.898223014023688,0,1,cytoplasm protein quality control by the ubiquitin-proteasome system,BP,
6040,GO:0019145,1.00000000001954,0.890171725884102,0,1,aminobutyraldehyde dehydrogenase activity,MF,
8509,GO:0033737,1.00000000001954,0.890171725884102,0,1,1-pyrroline dehydrogenase activity,MF,
11946,GO:0047105,1.00000000001954,0.890171725884102,0,1,4-trimethylammoniobutyraldehyde dehydrogenase activity,MF,
5364,GO:0016150,1.00000000001963,0.898755145732777,0,1,translation release factor activity, codon nonspecific,MF,
11728,GO:0046570,1.00000000001974,0.908413344040947,0,1,methylthioribulose 1-phosphate dehydratase activity,MF,
2356,GO:0005456,1.00000000001976,0.895137872375688,0,1,CMP-N-acetylneuraminate transmembrane transporter activity,MF,
5192,GO:0015782,1.00000000001976,0.895137872375688,0,1,CMP-N-acetylneuraminate transmembrane transport,BP,
17161,GO:0102522,1.00000000001988,0.891129212599656,0,1,tRNA 4-demethylwyosine alpha-amino-alpha-carboxypropyltransferase activity,MF,
11729,GO:0046573,1.00000000002019,0.898327873002158,0,1,lactonohydrolase activity,MF,
17121,GO:0102007,1.00000000002019,0.898327873002158,0,1,acyl-L-homoserine-lactone lactonohydrolase activity,MF,
7871,GO:0032440,1.00000000002027,0.908668362437939,0,1,2-alkenal reductase [NAD(P)] activity,MF,
19339,GO:1905636,1.00000000002027,0.908668362437939,0,1,positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
3491,GO:0007387,1.00000000002047,0.890029066572616,0,1,anterior compartment pattern formation,BP,
3492,GO:0007388,1.00000000002047,0.890029066572616,0,1,posterior compartment specification,BP,
516,GO:0001582,1.00000000002052,0.89010753948763,0,1,detection of chemical stimulus involved in sensory perception of sweet taste,BP,
8252,GO:0033041,1.00000000002052,0.89010753948763,0,1,sweet taste receptor activity,MF,
10657,GO:0043843,1.00000000002052,0.89010753948763,0,1,ADP-specific glucokinase activity,MF,
18564,GO:1903767,1.00000000002052,0.89010753948763,0,1,sweet taste receptor complex,CC,
18565,GO:1903768,1.00000000002052,0.89010753948763,0,1,taste receptor complex,CC,
4370,GO:0009992,1.00000000002066,0.891325056933543,0,1,cellular water homeostasis,BP,
2007,GO:0004731,1.00000000002087,0.792423099449397,0,2,purine-nucleoside phosphorylase activity,MF,
831,GO:0002127,1.00000000002118,0.903225620010684,0,1,tRNA wobble base cytosine methylation,BP,
1247,GO:0002946,1.00000000002118,0.903225620010684,0,1,tRNA C5-cytosine methylation,BP,
1549,GO:0003944,1.00000000002122,0.891162731600125,0,1,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase activity,MF,
1694,GO:0004168,1.0000000000213,0.891208469559335,0,1,dolichol kinase activity,MF,
10291,GO:0043048,1.0000000000213,0.891208469559335,0,1,dolichyl monophosphate biosynthetic process,BP,
3159,GO:0006772,1.00000000002131,0.895436157698866,0,1,thiamine metabolic process,BP,
9964,GO:0042357,1.00000000002131,0.895436157698866,0,1,thiamine diphosphate metabolic process,BP,
12461,GO:0050333,1.00000000002131,0.895436157698866,0,1,thiamin-triphosphatase activity,MF,
6825,GO:0030294,1.00000000002133,0.891154289144548,0,1,receptor signaling protein tyrosine kinase inhibitor activity,MF,
1004,GO:0002477,1.00000000002159,0.918046912962014,0,1,antigen processing and presentation of exogenous peptide antigen via MHC class Ib,BP,
1008,GO:0002481,1.00000000002159,0.918046912962014,0,1,antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent,BP,
15083,GO:0071074,1.0000000000223,0.893772759872844,0,1,eukaryotic initiation factor eIF2 binding,MF,
18523,GO:1903674,1.0000000000223,0.893772759872844,0,1,regulation of cap-dependent translational initiation,BP,
18524,GO:1903676,1.0000000000223,0.893772759872844,0,1,positive regulation of cap-dependent translational initiation,BP,
8521,GO:0033814,1.00000000002242,0.903635116344372,0,1,propanoyl-CoA C-acyltransferase activity,MF,
12500,GO:0050632,1.00000000002242,0.903635116344372,0,1,propionyl-CoA C2-trimethyltridecanoyltransferase activity,MF,
14804,GO:0070538,1.00000000002242,0.903635116344372,0,1,oleic acid binding,MF,
17649,GO:1901373,1.00000000002242,0.903635116344372,0,1,lipid hydroperoxide transport,BP,
8926,GO:0034777,1.00000000002245,0.891009383727594,0,1,recycling endosome lumen,CC,
704,GO:0001928,1.00000000002246,0.890898551983016,0,1,regulation of exocyst assembly,BP,
13651,GO:0060178,1.00000000002246,0.890898551983016,0,1,regulation of exocyst localization,BP,
17969,GO:1902311,1.00000000002253,0.895812580337486,0,1,regulation of copper ion transmembrane transport,BP,
3970,GO:0008783,1.0000000000229,0.891214271553937,0,1,agmatinase activity,MF,
8405,GO:0033388,1.0000000000229,0.891214271553937,0,1,putrescine biosynthetic process from arginine,BP,
4899,GO:0014827,1.0000000000229,0.891043061209126,0,1,intestine smooth muscle contraction,BP,
5534,GO:0016517,1.00000000002376,0.892916170905894,0,1,interleukin-12 receptor activity,MF,
9809,GO:0042019,1.00000000002376,0.892916170905894,0,1,interleukin-23 binding,MF,
9810,GO:0042020,1.00000000002376,0.892916170905894,0,1,interleukin-23 receptor activity,MF,
9811,GO:0042022,1.00000000002376,0.892916170905894,0,1,interleukin-12 receptor complex,CC,
15828,GO:0072536,1.00000000002376,0.892916170905894,0,1,interleukin-23 receptor complex,CC,
5661,GO:0016768,1.00000000002491,0.897237411799073,0,1,spermine synthase activity,MF,
16238,GO:0090290,1.0000000000253,0.916021288995041,0,1,positive regulation of osteoclast proliferation,BP,
3850,GO:0008466,1.00000000002617,0.895246448971406,0,1,glycogenin glucosyltransferase activity,MF,
17168,GO:0102751,1.00000000002617,0.895246448971406,0,1,UDP-alpha-D-glucose:glucosyl-glycogenin alpha-D-glucosyltransferase activity,MF,
18323,GO:1903237,1.00000000002632,0.924886697781607,0,1,negative regulation of leukocyte tethering or rolling,BP,
1877,GO:0004556,1.00000000002663,0.891297502008533,0,1,alpha-amylase activity,MF,
5367,GO:0016160,1.00000000002663,0.891297502008533,0,1,amylase activity,MF,
17181,GO:0103025,1.00000000002663,0.891297502008533,0,1,alpha-amylase activity (releasing maltohexaose),MF,
17140,GO:0102339,1.00000000002674,0.890125522368537,0,1,3-oxo-arachidoyl-CoA reductase activity,MF,
17141,GO:0102340,1.00000000002674,0.890125522368537,0,1,3-oxo-behenoyl-CoA reductase activity,MF,
17142,GO:0102341,1.00000000002674,0.890125522368537,0,1,3-oxo-lignoceroyl-CoA reductase activity,MF,
17143,GO:0102342,1.00000000002674,0.890125522368537,0,1,3-oxo-cerotoyl-CoA reductase activity,MF,
16464,GO:0097145,1.00000000002721,0.89124356620268,0,1,BAK complex,CC,
13526,GO:0055120,1.00000000002726,0.915763247018265,0,1,striated muscle dense body,CC,
998,GO:0002461,1.00000000002885,0.890629373412496,0,1,tolerance induction dependent upon immune response,BP,
1020,GO:0002519,1.00000000002885,0.890629373412496,0,1,natural killer cell tolerance induction,BP,
1079,GO:0002652,1.00000000002885,0.890629373412496,0,1,regulation of tolerance induction dependent upon immune response,BP,
8044,GO:0032712,1.00000000002885,0.890629373412496,0,1,negative regulation of interleukin-3 production,BP,
15395,GO:0071656,1.00000000002885,0.890629373412496,0,1,negative regulation of granulocyte colony-stimulating factor production,BP,
17608,GO:1901257,1.00000000002885,0.890629373412496,0,1,negative regulation of macrophage colony-stimulating factor production,BP,
4897,GO:0014825,1.00000000002886,0.924845334298524,0,1,stomach fundus smooth muscle contraction,BP,
4910,GO:0014847,1.00000000002886,0.924845334298524,0,1,proximal stomach smooth muscle contraction,BP,
7538,GO:0031839,1.00000000002886,0.924845334298524,0,1,type 1 neuromedin U receptor binding,MF,
7539,GO:0031840,1.00000000002886,0.924845334298524,0,1,type 2 neuromedin U receptor binding,MF,
9136,GO:0035483,1.00000000002886,0.924845334298524,0,1,gastric emptying,BP,
10225,GO:0042922,1.00000000002886,0.924845334298524,0,1,neuromedin U receptor binding,MF,
10908,GO:0044495,1.00000000002886,0.924845334298524,0,1,modulation of blood pressure in other organism,BP,
10909,GO:0044497,1.00000000002886,0.924845334298524,0,1,positive regulation of blood pressure in other organism,BP,
17265,GO:0120060,1.00000000002886,0.924845334298524,0,1,regulation of gastric emptying,BP,
17266,GO:0120061,1.00000000002886,0.924845334298524,0,1,negative regulation of gastric emptying,BP,
17267,GO:0120063,1.00000000002886,0.924845334298524,0,1,stomach smooth muscle contraction,BP,
17268,GO:0120068,1.00000000002886,0.924845334298524,0,1,regulation of stomach fundus smooth muscle contraction,BP,
17269,GO:0120069,1.00000000002886,0.924845334298524,0,1,positive regulation of stomach fundus smooth muscle contraction,BP,
1762,GO:0004365,1.00000000003029,0.906734548931533,0,1,glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity,MF,
6248,GO:0019828,1.00000000003029,0.906734548931533,0,1,aspartic-type endopeptidase inhibitor activity,MF,
9213,GO:0035605,1.00000000003029,0.906734548931533,0,1,peptidyl-cysteine S-nitrosylase activity,MF,
10662,GO:0043891,1.00000000003029,0.906734548931533,0,1,glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity,MF,
10091,GO:0042602,1.00000000003271,0.923124275978553,0,1,riboflavin reductase (NADPH) activity,MF,
2764,GO:0006185,1.00000000003877,0.917856789189554,0,1,dGDP biosynthetic process,BP,
4113,GO:0009170,1.00000000003877,0.917856789189554,0,1,purine deoxyribonucleoside monophosphate metabolic process,BP,
4122,GO:0009183,1.00000000003877,0.917856789189554,0,1,purine deoxyribonucleoside diphosphate biosynthetic process,BP,
11520,GO:0046054,1.00000000003877,0.917856789189554,0,1,dGMP metabolic process,BP,
11807,GO:0046711,1.00000000003877,0.917856789189554,0,1,GDP biosynthetic process,BP,
443,GO:0001192,1.0000000000389,0.92247711914669,0,1,maintenance of transcriptional fidelity during DNA-templated transcription elongation,BP,
444,GO:0001193,1.0000000000389,0.92247711914669,0,1,maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter,BP,
8221,GO:0032991,1.00000000004342,0,302,3851,protein-containing complex,CC,ERCC1;H1F0;NR1D1;DLG4;BTBD2;FBXO2;CTNNBIP1;KCNG1;ACVR2B;XPC;PRNP;BBS2;APOE;ESPN;LRP5;ITGA6;HMGA2;ITPR3;EGFR;WWTR1;SCN4B;OBSL1;NOS1;MST1R;NFATC4;BAHCC1;CRTAP;KLHL29;APPL2;SHC1;DDB2;VPS11;LTBP1;GTPBP1;CLIP2;NUDCD3;ZFP36L1;SMARCA1;RBCK1;PLTP;EXOC2;SMURF2;KLC2;FOS;FBLN1;SMAD3;SHANK2;PIK3R2;ERCC6;LRP1;GJC2;DVL1;EPAS1;PIGQ;AP2A2;ITGB4;SH3PXD2B;PPP2R3B;SALL2;FBXW5;AKT1;GRB7;KCNC4;TTYH3;HDAC5;PPM1F;PITPNM1;EPHA1;PHC2;NFKBIZ;ASH2L;IMPACT;LRRC8A;IFT140;FGFR4;POLD4;LDLR;FGFR1;PRKACB;MAPKBP1;KCNAB2;PFKL;MXI1;SYNE3;H2AFJ;PIGV;SORL1;CEACAM1;CIRBP;CBR4;NSMCE4A;EVC;TRAPPC9;CCND1;TNNT1;CEP250;CARD11;LAMA5;GSN;PCSK9;RAD23A;DHTKD1;XPOT;MRPS6;SEPT10;AIP;CCDC113;SPTB;SMARCD2;COL13A1;NPR2;SNTA1;PLXNB3;SHARPIN;MVB12B;FYCO1;PKD2;FBXW8;GPSM1;AP3D1;ITGB5;ABCA2;SH3PXD2A;EPHB2;GRIN3B;ADAM8;CTBP1;PLCG1;KIF17;CEBPB;ZNF217;NUDCD2;WNT3;GNAL;CLTCL1;SCYL1;UNK;SNTB2;DEAF1;SHANK3;SDHA;PNRC1;EML2;KIF26B;FBXO17;LAMB2;ABTB1;RNH1;DNAH1;FBXO44;PI4K2A;ANKZF1;PHF21A;KIF7;TUBG2;ZER1;GIGYF1;BBS1;WDR59;MBD3;LRP4;VHL;MYH16;MLXIPL;PRKCZ;KDM6B;PRKACA;CENPH;OXA1L;RABGGTA;ACTR1B;EPN2;WDR18;TDRKH;CAPG;ERBB2;ULK1;VAMP2;TFDP2;MZT2A;CYFIP2;FSCN1;PBX2;TRPC1;NELFCD;PDK1;MIB2;RBL2;CACNB3;STUB1;BAX;CYC1;ITGA1;OLFM2;HIST3H2BB;SH3BP1;FBXW4;GJB4;TIMM17B;CUL9;SOX12;MZT2B;TGFBR3;RPL39L;DNM1;WASH3P;SCN8A;MRPS26;ASB1;WDR60;TMEM231;SYMPK;IRAK1;HDAC7;CBX7;ZFPM1;PPARA;COG7;SESN2;MYO1D;JADE2;MYH15;ABCA7;BCAP31;EEF2KMT;MEX3A;WFS1;RAC3;SUN1;APOBEC3C;KIF26A;H1FX;APOBEC3F;INSR;PAN2;PFKM;ADCY1;C12ORF66;RERE;HLA-G;STX10;INO80C;PAK1;DCAF10;KLHL36;PPP3CB;RNF144A;CUL7;GABBR1;CAPRIN2;ITGA3;BIN1;VPS16;TSTD1;PPP2R5B;HES6;BCL2L1;DLG3;NDUFV3;ZYG11B;PKD1;KCTD13;RABGAP1;SIRT2;CDH4;ITGA4;EDA;BACH1;ADCY7;E2F5;AFAP1L1;TEP1;LAMB1;RGS19;NDE1;TOLLIP;PDCD6;ATP6V1F;PXN;GRB10;GCH1;KIF13B;CBX6;TCTN1;EZH1;SIRT3;HFE;TERC;WIPI2;COL6A1;VPS51;SEPT6;FGFR3;TNRC18;BLOC1S4;SPTLC2;TCEA2;DHX32;TBL3;ADCY6;KLHL24;STRN4
1448,GO:0003677,1.00000000004624,0,129,1925,DNA binding,MF,ERCC1;MEF2D;ZMYND8;H1F0;EGR1;NR1D1;XPC;HMGA2;ZKSCAN1;ELK3;MTA1;EGFR;NFATC4;BAHCC1;ETV5;DDB2;TCFL5;ETV4;TRNP1;ZFP36L1;ZC3H6;SMARCA1;FOXQ1;MXD4;POU2F2;FOS;SMAD3;STAT6;ERCC6;EPAS1;PRDX5;SALL2;HDAC5;PHC2;ASH2L;HLTF;MXI1;RAG1;H2AFJ;KLF7;NAT14;HMG20B;ZNF385A;TSHZ1;PCBP4;TCF25;SOX13;RAD23A;GLI4;ZSCAN18;MYEF2;SMARCD2;GTF2IRD1;HES2;MNT;CEBPB;ZNF217;RFX2;SCYL1;DEAF1;ZSCAN30;MPG;POLL;POLM;PHF21A;MBD3;MLXIPL;KDM6B;ZNF516;TFDP2;PBX2;RBL2;DTD1;ZNF395;HIST3H2BB;ZNF524;SOX12;TOP3B;CARF;IER2;LEMD2;ZHX3;CHD2;ZFPM1;PPARA;SOX7;SIX5;ZNF414;SSBP4;ZNF444;CERS4;FLYWCH1;ARID5B;HOXC5;BHLHE40;NEIL1;TSPYL2;ZMYM3;SATB1;ZDHHC1;H1FX;ZNF606;CAMTA2;RERE;REV1;ZBTB10;HES7;DNMT3A;HES6;DNASE1L1;PROX1;BACH1;E2F5;ZBTB22;ZNF704;GTF2IRD2;ZNF837;MAFF;NR2F6;SIRT3;TERC;ZNF513;MLF2;TNRC18;TCEA2;ZBTB47;PLAG1;KDM3A;DEDD2
4025,GO:0009059,1.00000000006496,0,335,4125,macromolecule biosynthetic process,BP,TNIP1;MEF2D;ZMYND8;CITED4;HTRA1;EGR1;NR1D1;CST3;APLN;PDCD4;CTNNBIP1;ACVR2B;PRNP;VEGFA;PGM1;WNT7A;APOE;F2R;LRP5;ITGA6;HMGA2;ZKSCAN1;ELK3;PKN1;MTA1;EGFR;WWTR1;NOS1;NFATC4;BAHCC1;SDC1;ETV5;LMF1;SHC1;HEXB;GTPBP1;TCFL5;TK2;ETV4;TRNP1;ST6GALNAC2;ZFP36L1;MAP2K2;ZC3H6;MDFI;PTOV1;SMARCA1;RBCK1;FOXQ1;MAP2K1;MXD4;POU2F2;SMURF2;TSC22D1;FOS;SMAD3;STAT6;PIK3R2;ERCC6;SRD5A3;DVL1;EPAS1;DNAJB5;PIGQ;HBEGF;PRDX5;BRD3;SALL2;LY6K;ZXDC;RNF187;AKT1;GRB7;HDAC5;PPM1F;SCMH1;GGT1;NFKBIZ;VEGFB;ASH2L;IMPACT;WWC3;DAP;FGFR4;POLD4;FGFR1;SEC14L2;HLTF;MXI1;H2AFJ;B4GAT1;PIGV;KLF7;NAT14;B3GAT3;CIRBP;HMG20B;TENM2;ZNF385A;TSHZ1;TRAPPC9;CCND1;TCF25;MAPK13;GAS6;CARD11;SOX13;ARHGAP22;PHLDA1;MRPS6;ERRFI1;GLI4;ZSCAN18;AIP;MYEF2;MN1;SMARCD2;DGKQ;PAK6;GTF2IRD1;TAGLN3;CEMIP;PKD2;HES2;CRTC1;ABCA2;ZNF598;ADAM8;CTBP1;MNT;CDKN1C;ZMIZ2;CD81;CEBPB;MVD;ADAMTS13;ZNF217;ZNF862;C8ORF88;TGFB1;RFX2;SCYL1;ABHD17C;UNK;GPC1;MKNK2;ADAMTS7;DEAF1;B3GNT3;NAB2;TMEM173;ZSCAN30;MSRB2;PNRC1;MGAT4B;PEG3;MC1R;ABHD14B;ABTB1;ST6GALNAC6;POLL;POLM;PTMS;PHF21A;MIF4GD;KHDRBS3;B4GALT2;AGRN;MBD3;LRP4;ZDHHC24;B4GALT6;VHL;TRAP1;RFNG;MLXIPL;TRIB2;PRKCZ;KDM6B;ZNF516;AREG;PIM2;MPI;WDR18;ERBB2;PRIMPOL;TFDP2;NECAB3;JAK3;IRF2BP2;CYFIP2;PBX2;NELFCD;MCFD2;PRKCD;RBL2;BAX;DTD1;XYLT2;ZNF395;EREG;RPS6KA5;ZNF524;SOX12;MBTPS2;PPP1R13L;CARF;IER2;ZDHHC8;TGFBR3;RPL39L;LEMD2;ZHX3;RGS14;MFNG;MRPS26;MSLN;ASB1;ST3GAL3;SYMPK;MAPK12;IRAK1;TGFA;HDAC7;FHOD1;INPP5D;CHD2;CBX7;CHEK2;ZFPM1;PPARA;COG7;SESN2;ABCG1;CDC34;SOX7;ABCA7;SIX5;KDM4B;ZNF414;MEX3A;PLA2G6;SSBP4;NUDT14;ECM1;WFS1;ZNF444;DALRD3;EEF2K;ARID5B;HOXC5;DNM2;BHLHE40;PELI1;CAT;TSPYL2;ZMYM3;SATB1;ZDHHC1;ZNF606;MAPK3;INSR;CAMTA2;PFKM;RERE;INO80C;ETAA1;BCL7A;VANGL2;CAMKK2;PPP3CB;USP21;REV1;HYAL1;CAPRIN2;ZBTB10;WDTC1;HES7;ITGA3;DNMT3A;SAMD8;PPP2R5B;HES6;MAP2K3;NDST2;PROX1;IARS2;MDGA1;ADGRF1;PKD1;KCTD13;SIRT2;FAM129B;EDA;GAL3ST4;BACH1;E2F5;ZBTB22;ALG12;MAPRE3;TEP1;ZNF704;ST3GAL2;MAP3K10;GTF2IRD2;NGFR;BCORL1;CHST14;ZNF837;MAFF;NR2F6;CBX6;CAMK1;EZH1;HFE;TERC;ZNF513;WIPI2;BTG1;ZP3;MLF2;CDK11B;ST3GAL5;TNRC18;TCEA2;PRSS21;ZBTB47;PLAG1;IRF2BPL;KDM3A;DEDD2;SRSF5;CHPF;AARS;SDC2
